Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" AATK "AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77" ENSG00000181409 "Apoptosis associated tyrosine kinase" Q6ZMQ8 17 81117295-81166077 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.3;intestine: 28.7" "Group enriched" "Detected in some" 6 "CACO-2: 29.6;SH-SY5Y: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 21 "granulocytes: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009073 Enhanced Uncertain Mitochondria Mitochondria "HPA009073: AB_1078076" "unprognostic (3.47e-3)" "unprognostic (3.01e-2)" "unprognostic (1.12e-1)" "unprognostic (1.95e-4)" "unprognostic (1.96e-1)" "unprognostic (1.94e-1)" "unprognostic (7.29e-2)" "unprognostic (9.85e-2)" "unprognostic (6.09e-2)" "unprognostic (4.27e-2)" "unprognostic (2.88e-3)" "unprognostic (2.48e-1)" "unprognostic (4.28e-6)" "unprognostic (1.58e-3)" "unprognostic (1.21e-1)" "unprognostic (1.39e-1)" "unprognostic (4.57e-2)" 2.8 4.7 14.3 3.2 16.6 3.7 0.9 19.0 29.0 1.2 3.3 16.5 0.0 28.7 1.0 1.1 1.7 1.2 2.7 2.3 23.6 13.9 1.2 1.2 9.7 1.5 20.1 13.6 1.0 17.9 3.6 6.4 2.6 11.0 2.4 1.1 4.1 5.6 3.6 1.1 1.9 20.3 1.3 35.3 5.9 4.5 1.3 9.8 0.0 1.3 0.0 1.0 1.3 1.1 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.2 0.3 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 1.6 1.1 1.4 1.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 3.1 0.0 0.1 0.5 0.1 1.3 2.4 0.2 0.0 0.0 2.8 10.2 0.2 0.0 1.4 0.3 0.8 1.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 14.3 16.6 19.0 22.3 23.6 13.9 20.1 13.6 11.0 9.8 ABCA2 ABC2 ENSG00000107331 "ATP binding cassette subfamily A member 2" Q9BZC7 9 137007227-137028922 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 84.3" "Cell line enhanced" "Detected in many" "T-47d: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "dendritic cells: 2.7;NK-cells: 1.2;T-cells: 2.2" "Low region specificity" "Detected in all" HPA042886 Approved "HPA042886: " "unprognostic (1.01e-2)" "unprognostic (9.21e-3)" "unprognostic (9.59e-2)" "unprognostic (6.15e-2)" "unprognostic (1.02e-1)" "unprognostic (8.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.13e-2)" "unprognostic (5.61e-3)" "unprognostic (1.76e-1)" "unprognostic (2.93e-2)" "unprognostic (2.74e-2)" "unprognostic (6.78e-3)" "unprognostic (3.14e-3)" "unprognostic (1.37e-1)" "unprognostic (2.80e-1)" "unprognostic (1.36e-1)" 7.8 6.1 20.0 3.9 42.4 5.7 2.6 16.7 54.2 4.0 4.5 84.3 0.9 3.2 2.8 4.7 3.5 6.3 5.7 7.1 32.2 17.6 4.8 3.8 4.1 4.1 57.5 21.9 2.5 8.6 8.1 7.8 3.3 31.1 5.2 2.5 3.8 8.0 5.1 5.7 6.3 4.1 2.7 70.5 8.3 6.1 3.0 47.7 0.2 9.5 0.1 2.2 3.3 1.8 0.4 2.7 0.4 0.3 1.2 2.2 1.1 4.3 4.8 2.4 9.5 6.0 6.4 4.1 4.8 1.9 2.2 0.8 1.4 5.3 0.2 13.8 5.2 7.4 1.5 3.6 0.4 3.2 3.0 0.4 13.7 1.7 2.9 6.8 7.6 2.7 3.3 1.5 0.4 1.2 1.1 0.8 2.7 13.0 0.0 14.7 1.2 4.8 6.7 2.4 6.4 1.5 1.0 9.1 10.5 5.2 10.2 3.7 34.6 8.9 6.2 6.0 3.3 8.5 2.0 0.1 0.1 0.0 10.1 1.3 3.0 0.0 0.3 0.0 2.2 0.2 1.3 0.4 0.2 0.7 0.3 0.2 0.0 0.9 0.4 1.2 0.0 2.7 1.0 1.1 20.0 42.4 16.7 30.7 32.2 17.6 57.5 21.9 31.1 47.7 ABCA3 "ABC-C, ABC3, EST111653, LBM180" ENSG00000167972 "ATP binding cassette subfamily A member 3" Q99758 16 2275881-2340746 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;lung: 75.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 20.8;T-47d: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007884 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007884: AB_1078077" "unprognostic (2.64e-1)" "unprognostic (2.19e-2)" "unprognostic (6.09e-3)" "unprognostic (2.61e-3)" "unprognostic (2.20e-1)" "unprognostic (1.35e-1)" "unprognostic (2.90e-2)" "unprognostic (1.86e-1)" "unprognostic (6.58e-3)" "unprognostic (3.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-2)" "unprognostic (5.33e-2)" "unprognostic (3.32e-2)" "unprognostic (7.85e-2)" "unprognostic (2.91e-1)" "unprognostic (1.30e-1)" 6.3 6.2 12.9 3.4 15.3 1.6 7.0 21.9 30.8 3.0 3.8 13.1 1.8 2.7 3.2 4.2 3.6 4.9 3.3 5.6 14.6 13.8 3.9 1.5 75.8 3.9 11.4 13.1 3.2 9.6 14.8 6.0 4.7 18.3 5.3 2.1 4.9 8.5 5.0 5.0 4.2 2.5 5.0 11.3 3.7 3.0 7.2 6.1 5.6 16.2 0.5 6.4 3.0 1.3 0.2 0.5 0.0 0.6 2.0 1.5 0.4 0.3 9.5 1.8 14.8 0.4 0.0 0.1 2.6 0.6 1.0 1.1 1.3 1.5 0.1 3.8 1.1 0.2 8.5 0.1 0.3 14.9 5.7 0.9 1.1 0.2 1.3 0.1 1.6 0.1 0.2 0.1 0.5 14.4 10.2 0.0 0.0 12.7 0.0 1.0 2.0 4.6 2.3 0.3 1.6 8.5 0.3 20.8 14.9 1.8 10.5 0.2 34.2 0.9 4.1 0.1 0.5 4.0 4.2 2.8 1.2 0.0 2.1 5.1 0.1 0.0 0.1 0.0 1.5 0.1 0.8 0.2 0.6 1.4 0.5 0.1 0.6 1.5 0.0 2.0 0.6 0.0 0.3 0.4 12.9 15.3 21.9 30.8 14.6 13.8 11.4 13.1 18.3 6.1 ABCC12 MRP9 ENSG00000140798 "ATP binding cassette subfamily C member 12" Q96J65 16 48082973-48156018 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 3.5;testis: 13.4" "Group enriched" "Detected in some" 6 "RPMI-8226: 2.1;T-47d: 4.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 4 "cerebral cortex: 3.5;hippocampal formation: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA043100 Uncertain "HPA043100: AB_10794922" "unprognostic (1.53e-1)" "unprognostic (6.87e-2)" "unprognostic (2.37e-2)" "unprognostic (4.62e-3)" "unprognostic (1.88e-1)" "unprognostic (1.59e-2)" "unprognostic (2.65e-1)" "unprognostic (7.53e-2)" "unprognostic (4.23e-1)" 0.1 0.0 0.6 0.1 0.1 0.0 1.9 0.3 3.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 2.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 13.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.3 3.5 2.0 0.0 0.1 0.1 0.1 0.1 ABCC8 "ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2" ENSG00000006071 "ATP binding cassette subfamily C member 8" Q09428 11 17392498-17476879 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;pancreas: 25.5;pituitary gland: 26.6" "Group enriched" "Detected in some" 5 "A549: 4.6;AN3-CA: 3.7;SCLC-21H: 6.5" "Cancer enriched" "Detected in some" 9 "pancreatic cancer: 16.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011451, HPA042318" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" Nucleoli "Golgi apparatus, Cytosol" "CAB011451: , HPA042318: " "unprognostic (4.30e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (4.73e-2)" "unprognostic (9.48e-3)" "unprognostic (2.23e-1)" "unprognostic (4.46e-3)" "unprognostic (2.53e-3)" "unprognostic (6.04e-2)" "unprognostic (2.34e-2)" "unprognostic (8.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.22e-2)" "unprognostic (1.96e-2)" "unprognostic (6.88e-5)" "unprognostic (2.72e-2)" "unprognostic (1.85e-1)" 1.3 6.7 4.4 0.8 6.1 0.9 4.0 28.0 12.3 3.0 1.3 2.6 7.7 1.9 3.1 3.7 0.8 1.2 0.9 2.9 5.1 4.8 1.0 0.8 2.9 0.8 3.6 7.2 0.9 25.5 1.0 26.6 1.6 8.5 2.8 1.3 0.7 0.9 8.5 2.3 1.1 1.5 1.3 4.0 0.9 3.5 1.1 2.3 0.0 6.2 0.0 0.8 0.7 0.8 0.1 0.0 0.5 0.0 0.1 0.2 0.0 0.0 4.6 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.9 0.0 0.1 0.1 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 4.4 6.1 28.0 12.3 5.1 4.8 3.6 7.2 8.5 2.3 ABCD2 "ALDL1, ALDR, ALDRP" ENSG00000173208 "ATP binding cassette subfamily D member 2" Q9UBJ2 12 39550033-39619751 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 24.1;brain: 30.1" "Group enriched" "Detected in some" 5 "ASC diff: 9.0;HDLM-2: 12.1;Karpas-707: 21.7;SH-SY5Y: 13.1;U-266/70: 7.4" "Cancer enriched" "Detected in single" 7 "glioma: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.26e-3)" "unprognostic (4.06e-4)" "unprognostic (9.27e-2)" "unprognostic (1.15e-2)" "unprognostic (2.06e-1)" "unprognostic (7.31e-5)" "unprognostic (3.42e-2)" "unprognostic (2.90e-2)" "unprognostic (8.06e-3)" "unprognostic (3.43e-2)" "unprognostic (1.24e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-4)" "unprognostic (5.04e-2)" "unprognostic (8.04e-2)" "unprognostic (1.13e-1)" "unprognostic (6.74e-2)" 24.1 3.6 6.8 3.5 6.8 0.9 5.5 30.1 13.4 10.6 1.7 1.3 0.0 1.4 5.4 1.0 1.3 5.2 1.4 7.4 5.1 4.1 1.4 0.7 1.4 4.8 4.8 8.4 0.7 0.7 0.7 5.1 0.5 11.4 1.2 1.7 2.9 4.6 1.6 0.7 0.7 1.7 5.1 2.1 3.0 1.6 0.9 2.6 0.9 1.0 0.6 3.2 2.8 1.9 0.8 0.8 0.1 0.0 1.4 6.5 1.8 0.0 0.0 0.1 0.0 9.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.4 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 1.9 0.8 4.3 5.7 0.2 0.4 5.0 6.5 0.1 1.4 0.0 0.8 5.1 1.8 6.8 6.8 30.1 13.4 5.1 4.1 4.8 8.4 11.4 2.6 ABCG4 WHITE2 ENSG00000172350 "ATP binding cassette subfamily G member 4" Q9H172 11 119149012-119162653 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 20.7;parathyroid gland: 7.4;retina: 7.5;testis: 7.2" "Cell line enhanced" "Detected in some" "AN3-CA: 5.6;HAP1: 3.0;U-2 OS: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA057635 Enhanced "HPA057635: " "unprognostic (3.26e-2)" "unprognostic (4.75e-4)" "unprognostic (6.31e-2)" "unprognostic (1.83e-3)" "unprognostic (3.76e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "unprognostic (9.35e-2)" "unprognostic (1.67e-1)" "unprognostic (9.07e-2)" "unprognostic (3.29e-2)" "unprognostic (8.78e-2)" "unprognostic (2.25e-1)" "unprognostic (4.15e-4)" "unprognostic (2.26e-1)" "unprognostic (6.48e-3)" "unprognostic (2.65e-3)" 0.7 1.6 3.9 0.7 5.7 0.3 0.4 20.7 12.8 0.8 0.8 0.8 0.0 0.9 1.1 1.3 1.9 0.6 1.2 2.2 4.9 6.6 0.8 0.5 0.5 0.5 4.7 5.2 0.5 1.2 7.4 0.3 0.7 12.7 0.9 0.7 7.5 0.4 2.0 0.4 1.2 0.7 1.4 1.5 0.5 0.5 7.2 0.5 0.6 1.5 0.0 1.5 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 1.2 5.6 0.8 0.0 0.1 0.2 0.1 0.7 1.5 0.0 0.1 0.0 0.6 0.2 0.5 3.0 0.3 0.7 0.3 1.0 1.0 0.1 0.0 1.9 0.0 1.6 0.5 0.0 1.0 0.0 1.2 0.1 0.1 0.9 0.2 0.4 0.0 2.4 0.6 0.1 0.0 0.1 0.0 0.0 0.5 1.1 1.7 0.2 0.1 0.4 0.0 0.2 0.4 2.9 0.5 0.2 0.3 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.7 20.7 12.8 4.9 6.6 4.7 5.2 12.7 0.5 ABHD12B "BEM46L3, C14orf29" ENSG00000131969 "Abhydrolase domain containing 12B" Q7Z5M8 14 50872160-50904970 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.0;retina: 10.0;skin 1: 21.6" "Cell line enhanced" "Detected in some" "HEK 293: 1.4;Hep G2: 1.5;NB-4: 2.5;NTERA-2: 1.7;RH-30: 2.1;SH-SY5Y: 1.4;T-47d: 1.4;THP-1: 2.0" "Cancer enriched" "Detected in many" 5 "testis cancer: 7.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 2.3;neutrophil: 5.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.4" "Region enriched" "Detected in single" 5 "thalamus: 2.3" "Low region specificity" "Detected in many" HPA002873 Uncertain Uncertain Nucleoplasm Nucleoplasm "HPA002873: AB_2220573" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (2.92e-3)" "unprognostic (1.99e-3)" "unprognostic (4.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.62e-2)" "unprognostic (2.09e-1)" "unprognostic (4.31e-2)" "unprognostic (6.27e-2)" "unprognostic (3.30e-1)" "unprognostic (3.35e-1)" "unprognostic (1.70e-3)" "unprognostic (3.16e-2)" "unprognostic (9.62e-2)" "unprognostic (3.18e-3)" "unprognostic (1.68e-1)" 1.1 0.2 2.4 0.4 10.0 2.4 2.8 0.3 5.2 0.2 1.5 5.4 0.3 0.2 0.8 0.4 0.7 2.0 0.4 0.5 1.4 1.2 0.6 0.2 0.8 0.4 2.2 2.7 0.3 1.1 1.3 0.3 0.4 2.2 0.3 2.4 10.0 0.2 0.2 0.2 21.6 0.3 0.2 0.7 0.2 0.2 1.2 3.9 0.0 0.4 0.0 0.3 0.2 0.2 0.0 0.1 5.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.5 0.5 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.7 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.9 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 2.4 10.0 0.3 5.2 1.4 1.2 2.2 2.7 2.2 3.9 ABHD8 "FLJ11743, MGC14280, MGC2512" ENSG00000127220 "Abhydrolase domain containing 8" Q96I13 19 17292131-17310236 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.0" "Cell line enhanced" "Detected in many" "PC-3: 27.9;U-266/70: 21.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037658, HPA058209" Approved Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA037658: AB_10672602, HPA058209: " "unprognostic (4.71e-3)" "unprognostic (5.06e-2)" "prognostic unfavourable (5.25e-4)" "unprognostic (7.45e-3)" "unprognostic (7.09e-2)" "unprognostic (1.96e-2)" "unprognostic (5.61e-2)" "unprognostic (9.62e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "prognostic favourable (3.04e-5)" "unprognostic (3.77e-1)" "unprognostic (6.36e-3)" "unprognostic (1.56e-1)" "unprognostic (3.14e-1)" "unprognostic (1.50e-1)" "unprognostic (9.24e-2)" 5.4 14.7 24.7 6.0 23.6 6.4 3.7 20.3 34.0 4.6 5.4 4.1 6.1 4.6 5.9 3.7 3.9 6.2 5.4 6.8 22.0 17.5 6.1 12.4 7.3 6.5 12.3 17.1 9.3 11.0 11.4 9.1 8.9 9.0 7.9 1.6 8.5 12.6 11.6 11.4 6.8 3.6 4.6 4.6 7.7 6.5 19.6 6.9 4.8 6.6 3.2 3.8 4.8 4.6 1.3 6.0 5.6 4.8 3.2 3.6 1.7 11.2 3.2 1.7 6.5 2.2 0.7 17.7 2.3 3.1 2.5 3.2 2.8 7.7 0.8 3.2 1.8 1.5 1.6 4.0 0.5 13.2 10.9 3.7 4.9 4.8 7.2 0.2 5.2 2.0 2.4 4.2 0.5 1.8 3.2 6.5 1.0 0.5 4.4 0.6 3.1 27.9 6.7 5.2 3.2 2.2 1.1 2.0 11.1 5.1 1.7 7.0 7.1 6.4 1.1 2.3 5.1 11.8 4.0 21.3 16.0 4.0 7.9 4.4 2.1 0.1 4.8 5.6 2.5 3.7 1.7 0.7 3.6 2.1 6.0 1.3 2.9 2.6 3.0 3.2 4.0 2.9 2.5 1.7 24.7 23.6 20.3 34.0 22.0 17.5 12.3 17.1 9.0 6.9 ABLIM2 KIAA1808 ENSG00000163995 "Actin binding LIM protein family member 2" Q6H8Q1 4 7965310-8158832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0;skeletal muscle: 71.8" "Group enriched" "Detected in some" 5 "SCLC-21H: 12.9;SiHa: 5.7;U-2197: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.0" "Lineage enriched" "Detected in single" 4 "T-cells: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035808 Uncertain Uncertain Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA035808: AB_10601962" "unprognostic (7.57e-2)" "unprognostic (3.24e-3)" "unprognostic (7.78e-2)" "unprognostic (3.33e-1)" "unprognostic (2.86e-2)" "unprognostic (6.09e-2)" "unprognostic (1.49e-2)" "unprognostic (5.54e-2)" "unprognostic (1.46e-1)" "unprognostic (5.01e-3)" "unprognostic (2.04e-2)" "unprognostic (3.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.32e-2)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.45e-2)" 4.0 3.8 8.2 1.9 19.1 0.8 2.1 4.0 26.0 1.4 2.1 2.3 0.0 1.1 1.2 1.3 10.5 1.4 1.7 5.7 3.4 5.1 2.5 1.2 1.8 1.4 2.8 7.6 1.1 3.3 2.4 6.1 1.2 9.9 1.8 2.1 1.3 2.6 1.2 71.8 3.8 1.8 2.1 1.8 14.8 1.8 1.5 4.0 0.0 2.4 1.9 2.3 1.5 1.7 0.7 0.5 0.0 0.2 0.0 3.0 0.2 1.0 0.0 0.2 1.5 0.4 0.1 0.4 0.0 0.0 0.1 0.0 0.0 1.3 2.8 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.7 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.0 0.0 0.6 1.9 0.1 0.0 1.1 0.9 0.1 1.0 0.6 0.2 0.0 12.9 1.0 5.7 0.0 0.3 0.0 0.0 0.0 0.0 0.4 19.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.0 0.1 3.0 0.0 2.5 0.0 0.5 0.7 1.2 0.9 0.0 0.0 0.2 0.0 1.2 0.2 8.2 19.1 4.0 26.0 3.4 5.1 2.8 7.6 9.9 4.0 ABR MDB ENSG00000159842 "Active BCR-related" Q12979 17 1003518-1229021 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.6" "Cell line enhanced" "Detected in some" "Daudi: 19.2;HEK 293: 10.4;LHCN-M2: 12.9;RPMI-8226: 11.0;TIME: 21.3;U-251 MG: 21.5;U-698: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "basophil: 8.9" "Lineage enriched" "Detected in single" 10 "granulocytes: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053618, HPA054824" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA053618: , HPA054824: " "unprognostic (1.69e-1)" "prognostic favourable (4.03e-4)" "unprognostic (1.58e-1)" "unprognostic (1.94e-3)" "unprognostic (1.12e-1)" "unprognostic (2.20e-2)" "unprognostic (4.99e-2)" "unprognostic (7.53e-2)" "unprognostic (1.91e-1)" "unprognostic (9.61e-2)" "unprognostic (7.20e-3)" "unprognostic (4.43e-3)" "prognostic favourable (2.21e-4)" "unprognostic (2.27e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-1)" "unprognostic (1.74e-2)" 12.9 5.8 31.8 18.0 28.7 6.0 5.8 7.0 43.6 6.6 19.9 12.0 2.3 9.4 7.9 4.0 11.0 6.1 6.7 26.6 24.0 16.9 6.8 4.0 9.3 6.9 14.1 27.0 3.9 5.0 8.3 6.0 7.2 11.3 4.6 21.6 19.4 23.7 3.4 2.9 5.9 11.9 25.1 8.1 8.1 13.6 3.8 11.3 2.9 7.0 2.3 18.0 7.2 7.4 0.3 0.7 8.9 0.8 0.0 0.8 0.0 0.5 0.6 0.2 0.0 0.9 0.1 0.5 0.1 0.1 0.0 0.0 0.4 0.0 19.2 0.3 0.1 0.1 2.1 0.0 0.4 5.9 10.4 0.0 0.2 0.0 0.4 2.3 6.8 0.2 0.0 0.1 6.8 0.0 0.0 0.0 12.9 0.8 0.0 2.6 0.1 0.1 0.1 0.0 11.0 0.1 0.2 0.2 0.3 0.1 0.0 1.0 6.0 3.0 21.3 0.1 0.2 2.1 21.5 0.0 0.2 15.7 1.0 4.2 0.4 8.9 0.3 1.0 0.2 0.8 0.4 0.1 0.3 0.0 0.7 0.3 0.0 0.3 0.9 0.0 0.4 0.0 0.8 0.0 31.8 28.7 7.0 43.6 24.0 16.9 14.1 27.0 11.3 11.3 AC004593.3 ENSG00000285162 "Beta-chimaerin isoform 3 " 7 29122340-29514667 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 6.3;brain: 16.3" "Cell line enhanced" "Detected in some" "EFO-21: 2.7;HaCaT: 3.5;HEL: 2.6;U-266/84: 4.2" "Group enriched" "Detected in some" 34 "classical monocyte: 6.2;intermediate monocyte: 5.1;myeloid DC: 6.3;non-classical monocyte: 2.5" "Group enriched" "Detected in many" 59 "dendritic cells: 6.3;monocytes: 6.2" 0.1 0.3 0.1 0.2 0.1 0.2 0.1 16.3 0.1 0.1 0.2 0.1 0.1 2.6 0.4 0.1 0.1 0.0 0.4 1.2 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.5 0.7 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.0 0.1 0.1 0.5 1.9 2.9 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.0 6.3 0.1 6.2 0.0 0.0 2.2 0.0 0.2 0.8 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.4 1.5 0.0 2.7 0.0 3.5 0.1 0.0 0.0 0.1 1.2 2.6 0.8 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.2 0.0 1.6 0.7 0.0 0.2 0.0 0.3 0.6 0.2 0.1 0.9 1.3 1.0 0.4 0.1 0.7 0.6 0.0 0.0 0.1 0.4 4.2 0.0 0.0 0.0 1.8 0.0 6.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.0 2.5 0.1 0.0 2.2 AC005697.1 ENSG00000266202 17 27798806-27893365 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8" "Cell line enriched" "Detected in single" 15 "SCLC-21H: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" HPA023051 Uncertain "HPA023051: AB_10602333" "unprognostic (1.92e-2)" 2.7 1.7 5.1 1.3 8.7 1.3 2.1 4.0 11.8 1.9 1.9 2.0 3.2 1.3 2.4 2.9 1.7 3.2 2.0 2.0 7.0 2.5 2.0 1.5 1.4 2.0 3.1 9.1 7.2 11.5 1.3 1.5 1.3 4.9 1.6 1.7 4.1 3.5 3.1 5.9 2.2 1.8 2.0 3.0 1.4 2.5 3.1 1.0 0.3 2.1 0.9 1.5 1.9 1.7 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 8.7 4.0 11.8 7.0 2.5 3.1 9.1 4.9 1.0 AC005726.1 ENSG00000258472 17 28455752-28614197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.8" "Cell line enhanced" "Detected in some" "A549: 6.4;Karpas-707: 3.4;PC-3: 3.2;THP-1: 3.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: " "unprognostic (1.26e-2)" "unprognostic (1.82e-1)" "unprognostic (6.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (7.25e-2)" "unprognostic (5.96e-2)" "unprognostic (4.58e-2)" "unprognostic (9.22e-3)" "unprognostic (3.17e-3)" "unprognostic (1.49e-4)" "unprognostic (1.25e-1)" "unprognostic (2.65e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-4)" 0.5 0.6 6.3 0.4 16.4 1.6 0.5 3.5 16.8 2.8 0.9 0.0 0.0 1.6 1.3 0.6 1.4 2.3 2.4 1.0 5.1 3.6 0.9 1.5 3.6 0.5 1.6 6.6 0.8 3.6 0.2 3.1 0.4 6.9 1.0 0.2 3.6 0.5 0.2 0.6 0.5 0.5 0.8 1.1 0.5 1.0 0.6 2.1 0.0 2.6 0.0 1.3 3.5 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.4 0.2 0.8 0.0 0.0 0.2 0.3 0.0 0.2 0.0 2.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 3.4 0.0 0.5 0.0 0.9 0.0 3.2 0.3 0.0 0.0 0.2 1.3 0.0 0.4 0.3 0.9 0.0 0.6 3.4 0.0 0.8 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 6.3 16.4 3.5 16.8 5.1 3.6 1.6 6.6 6.9 2.1 AC009477.2 ENSG00000284479 2 131035092-131035262 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "adipose tissue: 8.5;brain: 18.5" "Group enriched" "Detected in some" 12 "BJ: 2.8;HaCaT: 3.4;HEK 293: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" 8.5 0.9 7.3 0.9 11.6 0.9 0.9 0.0 18.5 0.9 2.0 4.0 0.0 0.9 0.9 1.2 0.9 0.9 1.2 0.9 8.1 1.1 0.9 0.9 0.9 1.3 9.7 0.9 0.9 0.9 1.0 0.9 5.5 1.2 0.9 0.5 0.9 0.9 2.2 0.9 1.7 1.9 0.8 0.9 0.9 1.1 1.8 0.0 0.9 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012309.1 ENSG00000267360 19 37093019-37210512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.6;thyroid gland: 2.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.3;LHCN-M2: 1.9;MOLT-4: 1.7;SCLC-21H: 2.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.9" "Low lineage specificity" "Detected in single" "unprognostic (2.21e-2)" "unprognostic (1.81e-1)" "unprognostic (7.33e-2)" "unprognostic (1.96e-1)" "unprognostic (2.68e-1)" "unprognostic (2.08e-1)" "unprognostic (3.62e-1)" "unprognostic (1.47e-1)" "unprognostic (1.09e-4)" "unprognostic (5.94e-2)" "unprognostic (1.68e-1)" "unprognostic (1.49e-2)" "unprognostic (1.36e-1)" 1.1 0.0 0.6 0.0 1.0 0.2 0.2 0.6 2.6 0.9 0.6 0.0 0.5 0.0 0.0 0.4 1.5 1.1 0.6 0.3 0.1 0.0 0.1 1.7 0.7 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.5 1.2 0.1 0.0 0.4 0.4 0.3 1.3 2.7 0.0 0.2 0.3 0.8 0.2 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.9 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 AC013470.2 ENSG00000226690 7 12469621-12542222 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.7;epididymis: 6.3;fallopian tube: 10.6" "Cell line enhanced" "Detected in some" "HAP1: 4.7;hTCEpi: 2.9;Karpas-707: 2.0;U-266/70: 2.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "unprognostic (3.89e-1)" "unprognostic (1.12e-1)" "unprognostic (2.80e-1)" "unprognostic (1.48e-1)" "unprognostic (8.16e-2)" "unprognostic (1.53e-4)" "unprognostic (1.14e-3)" "unprognostic (3.62e-3)" "unprognostic (7.82e-3)" "unprognostic (3.61e-1)" "unprognostic (8.04e-2)" "unprognostic (8.40e-2)" "unprognostic (1.98e-1)" "unprognostic (2.88e-2)" "unprognostic (2.67e-1)" 0.1 0.1 0.0 0.0 6.7 0.2 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.7 6.3 0.0 10.6 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 2.8 0.4 0.0 1.1 0.1 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.3 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.9 0.7 2.3 0.5 0.8 0.4 0.0 0.1 0.2 1.0 0.4 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.1 1.1 0.1 0.2 0.1 0.2 4.7 0.0 0.0 0.1 0.1 0.0 0.8 0.5 0.0 1.1 0.2 0.1 2.9 0.0 0.0 0.0 0.1 2.0 0.0 0.1 0.0 0.2 1.6 0.0 0.3 0.1 0.4 0.0 0.5 1.2 0.1 0.0 0.3 0.2 0.2 0.3 0.0 0.5 0.6 0.0 0.0 2.4 0.1 0.0 0.2 0.0 0.0 2.3 0.5 0.3 0.3 0.2 0.4 0.8 0.3 0.3 0.2 0.9 0.4 0.3 1.8 0.8 0.4 0.7 0.3 0.0 AC026316.5 ENSG00000285218 3 170418868-170860380 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 64.6;testis: 27.4" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" 2.4 3.9 6.2 3.5 30.3 9.0 3.1 2.1 18.4 1.2 1.4 64.6 0.0 2.7 3.4 4.2 2.8 1.9 4.9 2.4 9.0 2.4 1.8 2.1 3.0 44.6 12.4 7.2 1.7 2.6 0.0 2.2 27.8 4.4 1.2 0.0 3.8 2.2 3.1 6.2 2.7 2.1 27.1 2.1 1.9 27.4 35.8 0.0 2.5 0.2 1.6 1.8 1.6 1.0 0.6 2.4 0.9 0.4 1.3 0.3 1.5 2.4 2.8 2.4 0.7 0.6 2.3 1.6 1.0 0.5 0.1 0.5 2.2 2.4 3.5 1.2 3.0 0.1 0.0 0.5 2.3 1.9 3.1 3.5 2.0 0.0 1.9 3.3 0.7 0.6 0.7 0.3 0.6 1.4 2.6 0.7 0.7 0.8 3.4 3.9 3.0 1.5 0.8 0.9 1.4 2.0 5.5 1.7 1.8 1.6 0.8 1.8 0.5 1.9 1.5 2.2 5.7 0.5 1.6 1.9 1.0 1.0 2.3 1.2 0.6 0.6 0.5 0.8 0.9 1.3 0.8 1.1 1.1 0.6 1.0 1.3 1.2 2.4 0.4 0.9 0.5 0.9 0.3 AC058822.1 ENSG00000282278 4 53377839-54295272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 19.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.3;fHDF/TERT166: 12.4;HDLM-2: 3.3;NTERA-2: 2.8;U-2197: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA058202 Supported Nucleoplasm Nucleoplasm "HPA058202: " 4.3 2.6 3.6 9.5 5.0 2.7 3.4 4.3 19.1 4.7 4.6 3.4 2.6 2.6 5.5 2.6 3.2 2.6 2.6 4.5 2.6 3.0 3.3 5.4 3.9 3.6 5.1 7.8 6.6 2.6 5.3 5.3 3.8 4.0 2.8 2.6 3.0 3.1 3.2 2.6 7.1 6.5 3.3 4.7 4.1 4.7 4.2 9.3 4.3 3.0 4.2 4.5 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 2.0 0.0 0.2 5.3 0.0 0.1 0.9 0.0 0.0 0.0 12.4 0.0 1.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.0 2.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 AC068775.1 ENSG00000255641 12 10412312-10436001 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 43.7;brain: 11.4;lymphoid tissue: 9.2" "Cell line enriched" "Detected in some" 6 "HeLa: 13.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "NK-cell: 43.7" "Lineage enriched" "Detected in many" 6 "NK-cells: 43.7" HPA062570 Uncertain "HPA062570: " "unprognostic (6.09e-2)" 0.3 0.5 7.0 0.8 4.5 3.0 0.6 1.0 11.4 0.3 1.4 2.0 0.0 0.8 1.0 0.8 0.3 0.3 0.4 0.6 6.8 4.9 0.2 1.1 1.5 1.3 5.7 2.4 0.4 0.3 0.1 0.0 0.5 3.4 0.3 1.0 0.0 1.0 0.1 0.1 0.2 1.6 0.4 3.9 9.2 1.0 0.5 1.5 2.0 0.1 0.0 1.0 1.0 0.0 0.0 0.0 0.3 0.0 43.7 7.6 2.6 0.0 0.8 0.1 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.9 13.6 0.4 0.1 0.0 0.0 2.4 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 7.6 0.3 43.7 0.0 0.0 0.0 2.6 7.0 4.5 1.0 3.3 6.8 4.9 5.7 2.4 3.4 1.5 AC073610.3 ENSG00000272822 12 48903503-48957365 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 27.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA068942 Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA068942: " "unprognostic (7.48e-2)" "unprognostic (6.47e-2)" "unprognostic (7.52e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (2.57e-3)" "unprognostic (1.26e-1)" "unprognostic (7.66e-2)" "unprognostic (7.25e-2)" "unprognostic (1.01e-2)" "unprognostic (6.24e-2)" "unprognostic (5.78e-2)" "unprognostic (1.01e-12)" "unprognostic (1.92e-2)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (9.06e-2)" 6.8 3.4 10.5 2.2 20.7 3.6 4.6 7.7 27.5 6.4 4.9 6.3 2.6 2.2 9.7 7.3 5.1 4.7 7.6 7.2 8.8 7.2 5.0 4.1 5.5 5.5 5.7 13.7 6.1 7.4 2.2 5.3 3.3 10.6 5.4 4.6 3.5 4.8 4.5 3.4 4.4 4.2 10.6 4.6 4.7 4.0 8.4 4.3 3.3 5.0 2.3 4.4 4.9 3.9 0.8 1.8 1.1 1.1 1.3 3.2 2.0 1.1 0.4 4.0 3.1 4.3 1.7 0.0 1.7 8.3 2.4 1.1 0.0 1.2 1.2 2.5 1.5 0.4 1.5 0.0 2.3 5.4 0.7 1.1 0.7 0.0 3.0 0.0 1.1 0.5 2.1 0.7 1.4 1.1 0.1 1.5 1.4 0.5 0.2 0.6 0.0 1.2 2.3 0.7 0.2 0.2 0.3 2.0 0.6 1.0 0.8 0.9 0.2 0.6 4.6 0.8 0.5 0.2 0.5 2.1 0.3 0.8 1.9 1.2 0.4 0.9 1.1 0.3 2.7 0.4 3.2 0.6 0.9 1.8 0.9 0.8 2.3 2.6 1.1 1.3 0.4 1.8 0.5 2.0 10.5 20.7 7.7 27.5 8.8 7.2 5.7 13.7 10.6 4.3 AC079341.3 ENSG00000284849 4 121758930-121765185 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "brain: 16.4" "Cell line enriched" "Detected in some" 5 "MOLT-4: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA077585 Approved "HPA077585: " 0.3 0.3 1.1 0.3 7.1 0.3 0.3 0.0 16.4 0.3 0.3 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 6.8 0.3 0.3 0.3 0.4 0.0 7.6 0.3 0.3 0.3 0.0 1.1 0.4 0.3 0.3 0.5 0.3 0.4 0.3 0.3 0.5 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 AC091167.6 ENSG00000275674 15 90266317-90314499 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.0" "Cell line enhanced" "Detected in some" "BEWO: 5.7;CACO-2: 2.9;U-266/84: 3.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "unprognostic (1.02e-1)" "unprognostic (6.86e-2)" "unprognostic (7.11e-2)" "unprognostic (9.39e-2)" "unprognostic (4.70e-2)" "unprognostic (2.50e-2)" "unprognostic (6.17e-2)" "unprognostic (1.27e-1)" "unprognostic (1.23e-1)" "unprognostic (9.18e-2)" "unprognostic (4.73e-2)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" 3.0 0.6 1.4 1.0 4.2 0.8 4.0 1.3 12.0 1.3 2.6 0.3 1.1 6.8 1.4 2.3 2.6 2.0 2.1 2.8 1.6 1.3 4.1 1.5 0.6 0.9 3.0 2.8 6.6 0.6 1.2 0.7 1.5 1.7 1.1 0.0 3.5 1.9 7.7 0.6 4.2 2.2 0.7 0.7 2.8 5.6 0.8 0.9 2.6 2.4 0.9 1.9 2.8 1.1 1.5 0.0 0.6 0.0 0.9 0.9 0.9 0.9 1.0 0.7 0.0 0.0 5.7 0.5 0.0 0.4 0.4 2.9 1.0 0.0 1.2 0.0 0.0 1.4 0.7 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.2 0.6 1.7 0.4 0.0 0.4 0.0 0.9 0.7 0.2 0.0 0.4 0.0 0.3 0.0 1.3 0.9 0.6 0.3 0.3 1.3 3.2 0.8 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.6 0.8 0.0 0.3 0.0 0.0 1.1 0.5 0.9 0.0 0.0 0.0 1.5 0.0 0.9 AC091980.2 ENSG00000275038 5 171305981-171308755 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "brain: 3.4" "Group enriched" "Detected in some" 20 "HeLa: 3.3;RH-30: 1.4;SH-SY5Y: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.98e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093525.2 ENSG00000260272 16 2496032-2520218 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.5;brain: 5.4" "Cell line enhanced" "Detected in some" "HEK 293: 3.9;RPMI-8226: 3.2;SCLC-21H: 3.4;SH-SY5Y: 4.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" HPA044712 Uncertain "HPA044712: AB_10795619" "unprognostic (4.12e-1)" "unprognostic (9.64e-2)" "unprognostic (4.36e-3)" "unprognostic (1.13e-1)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (3.34e-2)" "unprognostic (2.34e-1)" "unprognostic (1.37e-1)" "unprognostic (9.77e-3)" "unprognostic (9.13e-2)" "unprognostic (9.83e-2)" "unprognostic (5.98e-3)" 0.4 0.1 1.1 0.1 1.0 4.5 0.4 5.4 1.8 0.1 0.4 0.1 0.2 0.1 0.3 0.5 0.7 0.1 1.0 0.9 3.2 0.2 1.0 0.7 0.6 0.1 0.3 0.1 1.5 0.1 0.2 0.2 0.6 0.4 1.1 0.4 0.1 0.5 0.1 0.4 0.2 0.6 0.4 0.2 0.6 0.0 0.1 1.7 0.5 0.8 0.7 0.4 0.0 0.5 0.0 0.7 1.8 0.0 0.0 0.0 0.8 1.2 0.0 0.6 0.0 0.8 0.1 0.0 1.7 0.0 0.9 0.0 0.0 0.3 3.9 0.5 0.5 0.4 1.1 1.3 0.0 0.0 0.4 0.5 0.0 0.9 0.1 0.5 0.0 2.2 0.2 1.1 0.2 1.2 0.4 0.0 3.2 0.6 0.2 3.4 4.3 0.0 0.8 0.9 0.3 0.0 0.0 0.0 0.9 0.0 0.0 1.7 0.6 1.9 0.7 0.3 0.3 0.0 0.8 0.5 0.4 0.7 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.7 0.3 1.7 0.0 0.0 AC116565.1 ENSG00000273238 4 573880-576300 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "brain: 12.7;skin 1: 7.0" "Cell line enhanced" "Detected in some" "NB-4: 2.6;NTERA-2: 4.7;SCLC-21H: 10.4;U-2 OS: 2.6;U-251 MG: 3.2" "Cancer enriched" "Detected in single" 5 "glioma: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (4.13e-3)" "unprognostic (6.97e-3)" "unprognostic (2.65e-2)" 0.0 1.8 1.3 0.0 3.1 0.0 0.1 0.0 12.7 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 0.0 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.6 4.7 0.0 0.0 1.2 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC117457.1 ENSG00000275163 3 178419123-178843300 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 11.1;epididymis: 11.8;fallopian tube: 12.2;kidney: 5.2;pituitary gland: 19.9" "Cell line enriched" "Detected in single" 14 "HSkMC: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.1 2.9 0.0 0.0 0.0 11.8 0.0 12.2 0.3 0.2 0.3 5.2 0.2 1.5 0.0 0.0 0.0 2.6 2.9 0.0 19.9 0.0 11.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 AC126755.2 ENSG00000233024 "Nuclear pore complex-interacting protein family member A5 isoform 2 " 16 18358086-18379331 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.5" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 4.7" "Group enriched" "Detected in many" 6 "B-cells: 4.7;T-cells: 1.8" HPA053611 Approved Uncertain Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (9.10e-2)" "unprognostic (6.00e-3)" "unprognostic (1.66e-1)" "unprognostic (5.77e-2)" "unprognostic (8.31e-2)" "unprognostic (6.34e-2)" "unprognostic (6.34e-2)" "unprognostic (6.76e-2)" "unprognostic (1.30e-3)" "unprognostic (5.87e-2)" "unprognostic (5.79e-3)" "unprognostic (1.60e-2)" "unprognostic (1.25e-5)" "unprognostic (1.96e-1)" "unprognostic (1.90e-2)" "unprognostic (5.38e-2)" "unprognostic (6.45e-3)" 4.1 5.4 5.2 3.3 5.5 3.3 6.0 46.5 10.1 5.4 6.9 3.4 9.5 10.0 4.7 6.3 4.4 3.3 6.4 6.4 3.5 4.6 5.4 4.2 3.3 11.5 6.6 14.3 27.8 2.8 5.4 6.3 3.7 7.0 17.5 9.8 4.5 7.6 2.8 4.9 4.0 4.6 6.5 3.6 4.6 3.8 4.7 0.5 0.5 0.5 0.3 1.8 0.5 7.0 4.6 25.7 21.0 22.1 20.7 6.0 27.0 9.8 13.3 19.8 4.6 4.2 9.7 10.5 23.7 12.7 8.0 7.3 16.3 8.3 7.6 25.9 22.5 22.4 22.4 12.3 59.6 21.2 33.0 16.6 22.4 6.5 6.0 19.5 13.3 10.7 20.1 26.9 10.9 5.8 29.0 6.4 9.7 13.1 13.3 7.3 11.5 16.9 10.7 14.5 9.8 14.7 12.3 18.0 7.9 15.0 8.2 14.7 11.5 14.9 8.0 17.2 9.2 0.0 0.5 0.5 1.8 0.1 0.6 4.7 1.2 0.9 0.2 1.1 1.0 0.4 0.0 0.3 0.3 0.5 0.4 0.5 AC129492.3 ENSG00000263620 17 8150816-8162975 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 49.9;brain: 39.2;skeletal muscle: 55.4" "Cell line enhanced" "Detected in some" "HDLM-2: 22.9;HEK 293: 9.4;PC-3: 7.5;REH: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" 14.0 6.0 11.2 2.6 25.6 2.6 2.7 14.6 39.2 4.9 20.3 11.0 1.3 2.6 5.9 2.6 3.4 3.3 2.6 32.0 8.5 3.0 3.6 4.4 7.5 2.9 5.3 15.7 2.6 2.6 2.6 5.4 2.6 19.9 3.3 2.6 7.6 3.1 2.6 55.4 2.6 2.6 2.6 3.7 14.9 18.7 3.0 7.0 0.7 2.6 0.6 2.6 5.2 3.1 31.4 23.7 49.9 12.9 29.2 45.5 15.5 1.5 0.2 0.2 0.0 0.0 0.0 3.5 3.2 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 3.8 0.0 0.0 0.0 22.9 9.4 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 7.5 11.3 0.0 3.0 0.0 0.0 1.1 0.0 0.0 0.0 0.4 0.5 0.5 0.7 0.0 2.8 0.0 2.6 3.8 5.7 2.6 0.0 0.0 3.6 18.0 9.8 36.6 37.5 11.4 33.1 31.4 38.0 42.3 8.7 28.3 45.5 39.7 49.9 29.2 12.9 23.7 27.2 15.5 11.2 25.6 14.6 39.2 8.5 3.0 5.3 15.7 19.9 7.0 AC135068.3 ENSG00000279408 15 21651844-21652968 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;testis: 2.2" "Cell line enriched" "Detected in single" 5 "U-2 OS: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Uncertain Centrosome Centrosome "HPA057442: " 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 AC245033.1 ENSG00000260836 15 82536788-82573194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 11.3" "Cell line enriched" "Detected in some" 5 "U-2197: 18.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA055060 Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum" "Nucleoli, Cytosol" "HPA055060: " "unprognostic (2.91e-2)" 1.5 0.9 5.3 0.9 7.1 0.9 1.3 6.1 11.3 0.9 1.0 1.4 0.0 0.9 0.9 0.9 1.5 0.9 0.9 1.3 3.9 1.6 0.9 1.0 1.1 0.9 3.2 6.1 0.9 1.0 0.9 2.0 1.0 7.3 1.1 1.1 1.9 0.9 0.9 2.0 0.9 1.4 0.9 2.4 1.1 0.9 1.4 1.7 0.0 1.0 0.0 1.0 1.7 0.8 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.7 0.7 18.5 0.3 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.1 6.1 11.3 3.9 1.6 3.2 6.1 7.3 1.7 ACAP3 "CENTB5, KIAA1716" ENSG00000131584 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 3" Q96P50 1 1292376-1309609 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049317, HPA058381" Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA049317: , HPA058381: " "unprognostic (5.92e-2)" "unprognostic (1.55e-1)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (7.94e-2)" "unprognostic (3.77e-3)" "unprognostic (2.98e-3)" "unprognostic (1.01e-3)" "unprognostic (1.29e-2)" "unprognostic (8.05e-2)" "unprognostic (1.56e-3)" "unprognostic (5.35e-3)" "unprognostic (3.70e-2)" "unprognostic (6.76e-3)" "unprognostic (3.45e-1)" "unprognostic (1.51e-1)" "unprognostic (6.35e-2)" 8.7 7.8 16.4 4.2 24.5 10.4 7.3 42.0 23.6 6.4 6.4 11.5 4.3 7.9 5.9 4.2 10.6 3.7 5.1 7.9 19.5 8.7 4.8 4.9 4.7 4.0 13.0 15.4 5.5 8.2 5.1 11.2 4.3 10.4 5.8 3.4 5.6 14.6 7.7 14.2 26.5 7.7 11.8 8.1 6.0 8.0 3.1 12.8 3.1 2.7 4.5 3.5 5.6 6.4 0.9 1.2 1.5 2.0 0.0 1.4 0.7 5.2 5.9 2.7 4.7 7.0 4.8 2.9 13.3 4.3 3.8 3.0 7.5 4.6 5.8 6.9 7.4 12.1 2.7 3.6 0.9 6.4 11.8 2.4 21.9 14.0 4.8 4.9 6.1 3.3 2.9 3.2 2.0 1.8 6.7 8.0 4.3 7.3 10.3 7.1 2.9 13.8 10.0 6.3 22.3 2.3 2.9 21.0 14.8 7.9 5.0 12.5 5.3 3.8 5.8 7.1 5.0 5.7 4.6 6.5 4.7 5.0 9.9 13.1 3.1 0.0 1.4 1.5 1.3 2.0 0.0 0.9 1.0 0.6 1.2 0.8 1.4 1.2 0.2 0.0 1.4 1.0 0.5 0.7 16.4 24.5 42.0 22.1 19.5 8.7 13.0 15.4 10.4 12.8 ACBD7 "bA455B2.2, FLJ38219" ENSG00000176244 "Acyl-CoA binding domain containing 7" Q8N6N7 10 15077523-15088776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 35.3" "Cell line enhanced" "Detected in many" "MOLT-4: 21.7;U-266/84: 16.3;U-698: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 5 "olfactory region: 21.6" "Low region specificity" "Detected in all" "HPA043326, HPA062478" Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA043326: , HPA062478: " "unprognostic (2.15e-1)" "unprognostic (8.94e-2)" "unprognostic (7.79e-3)" "unprognostic (6.53e-3)" "unprognostic (7.30e-2)" "unprognostic (6.89e-3)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.32e-1)" "unprognostic (6.34e-2)" "unprognostic (3.59e-3)" "unprognostic (3.06e-1)" "unprognostic (2.18e-4)" "unprognostic (9.72e-2)" "unprognostic (2.95e-1)" "unprognostic (2.14e-1)" "unprognostic (6.90e-2)" 1.1 1.1 25.0 1.5 27.1 3.9 8.3 12.9 35.3 1.1 1.4 9.3 0.0 2.5 1.4 2.7 1.7 4.4 1.7 1.2 25.3 9.8 1.4 1.7 1.4 2.1 15.0 16.2 1.7 1.5 1.5 0.7 1.3 14.0 1.5 1.6 0.0 4.7 1.4 2.0 3.0 1.9 1.3 6.6 1.6 1.8 5.9 11.7 2.9 4.2 0.0 1.7 1.4 0.5 1.7 1.5 3.8 0.6 2.1 1.1 0.2 2.6 0.6 10.5 5.0 0.6 0.5 1.2 0.7 0.6 1.9 3.2 2.9 3.2 2.4 3.6 2.4 0.6 6.2 1.9 2.7 5.4 8.5 2.6 0.8 1.6 0.1 0.5 1.1 0.1 0.2 0.7 0.1 2.6 2.0 2.9 2.1 8.3 21.7 2.3 5.2 1.9 11.7 3.7 5.7 1.2 1.0 8.6 5.2 2.6 5.9 1.1 8.5 0.7 0.7 0.4 5.8 1.0 2.2 8.2 16.3 18.7 1.7 0.5 0.7 3.8 0.6 0.8 1.1 0.6 0.9 1.3 0.6 0.6 0.3 1.7 1.1 1.1 3.7 2.1 0.5 1.5 0.5 0.2 25.0 27.1 12.9 21.8 25.3 9.8 15.0 16.2 14.0 11.7 ACHE YT ENSG00000087085 "Acetylcholinesterase (Cartwright blood group)" P22303 7 100889994-100896974 "Blood group antigen proteins, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter degradation" "Blood group antigen, Hydrolase, Serine esterase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 43.8;skeletal muscle: 98.2" "Cell line enhanced" "Detected in some" "BEWO: 8.0;CACO-2: 12.6;K-562: 14.8;Karpas-707: 24.7;U-2 OS: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027098 Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" 650000 "Golgi apparatus" Vesicles "HPA027098: " "unprognostic (2.23e-1)" "unprognostic (9.44e-2)" "unprognostic (2.71e-2)" "unprognostic (5.80e-3)" "prognostic unfavourable (5.27e-4)" "unprognostic (2.49e-1)" "unprognostic (2.54e-1)" "unprognostic (1.36e-2)" "unprognostic (2.48e-2)" "unprognostic (8.92e-2)" "unprognostic (2.65e-2)" "unprognostic (1.78e-1)" "prognostic unfavourable (3.88e-5)" "unprognostic (2.95e-1)" "unprognostic (2.59e-2)" "unprognostic (9.28e-2)" "unprognostic (8.38e-2)" 1.4 4.8 5.8 3.5 16.1 10.3 1.4 22.8 11.8 1.4 4.2 2.7 1.4 5.7 1.9 2.6 2.8 1.8 3.1 4.5 5.5 43.8 1.4 1.8 1.8 5.9 22.2 4.8 1.7 1.6 7.0 3.2 2.0 37.9 3.3 3.4 4.6 6.5 3.3 98.2 1.4 7.9 1.9 8.7 2.3 2.1 1.9 2.6 3.5 1.6 15.9 3.2 2.1 1.2 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.3 0.2 0.5 0.0 8.0 0.3 0.0 0.1 0.2 12.6 0.3 0.0 0.4 0.0 0.4 2.1 0.1 0.0 4.3 0.5 0.2 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 14.8 24.7 0.1 3.5 0.0 0.1 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 1.0 0.0 0.0 0.0 0.1 0.7 5.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 16.1 22.8 11.8 5.5 43.8 22.2 4.8 37.9 2.6 ACOT7 "ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126" ENSG00000097021 "Acyl-CoA thioesterase 7" O00154 1 6264269-6394391 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NK-cell: 20.5;plasmacytoid DC: 19.4" "Group enriched" "Detected in many" 4 "dendritic cells: 19.4;NK-cells: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025735, HPA025762" Enhanced Supported Nucleoplasm,Cytosol 29000 Cytosol Nucleoplasm "HPA025735: AB_1844523, HPA025762: AB_1844524" "unprognostic (3.94e-2)" "unprognostic (1.74e-1)" "unprognostic (7.09e-2)" "unprognostic (4.33e-2)" "unprognostic (4.10e-2)" "unprognostic (5.06e-2)" "prognostic unfavourable (2.31e-5)" "prognostic unfavourable (1.29e-4)" "unprognostic (2.35e-2)" "unprognostic (4.05e-2)" "unprognostic (1.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavourable (2.55e-6)" "unprognostic (2.68e-2)" "unprognostic (1.45e-1)" "unprognostic (9.06e-2)" "unprognostic (3.72e-2)" 4.7 13.3 25.8 10.8 29.8 7.7 3.9 23.9 50.0 4.4 18.3 11.3 0.5 33.2 5.1 3.8 14.3 4.4 5.3 6.3 27.8 43.9 29.4 9.1 8.6 12.3 36.0 20.7 5.3 4.0 1.9 18.5 7.4 49.9 5.6 13.5 6.6 4.1 4.9 1.5 9.4 33.2 14.3 14.2 8.9 6.2 13.1 6.9 9.0 2.3 6.5 11.6 9.1 6.6 1.0 19.4 0.4 0.6 20.5 4.4 2.8 23.4 20.4 20.2 21.7 4.6 7.7 7.6 20.2 10.5 30.0 18.0 70.5 7.6 28.7 14.9 16.4 23.2 32.5 54.0 11.3 25.2 28.4 15.1 16.2 24.9 19.0 17.6 12.6 6.8 10.3 24.8 29.4 16.8 12.3 6.2 15.8 27.3 36.8 18.7 10.1 47.4 44.1 23.2 19.4 16.8 9.0 11.0 31.3 18.2 28.0 64.4 9.9 8.3 27.2 27.3 16.0 27.1 31.9 5.2 21.4 40.4 17.3 30.9 16.6 0.0 0.1 0.1 4.1 0.6 1.0 1.0 3.4 3.6 2.9 0.4 1.2 2.3 0.4 20.5 0.5 19.4 4.4 2.8 25.8 29.8 23.9 50.0 27.8 43.9 36.0 20.7 49.9 6.9 ACP7 "FLJ16165, PAPL, PAPL1" ENSG00000183760 "Acid phosphatase 7, tartrate resistant (putative)" Q6ZNF0 19 39083913-39111493 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 15.2;lymphoid tissue: 6.1;skin 1: 14.1;tongue: 5.5" "Cell line enriched" "Detected in some" 5 "U-87 MG: 31.2" "Group enriched" "Detected in some" 5 "cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA042613 Uncertain "Secreted - unknown location" "HPA042613: AB_10963214" "unprognostic (6.35e-2)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (6.74e-3)" "unprognostic (1.92e-3)" "unprognostic (1.41e-1)" "unprognostic (3.41e-1)" "unprognostic (4.94e-3)" "unprognostic (2.66e-1)" "unprognostic (2.15e-1)" "unprognostic (1.50e-1)" "unprognostic (9.81e-2)" "unprognostic (1.51e-5)" "unprognostic (4.36e-3)" "unprognostic (5.08e-2)" "unprognostic (2.31e-2)" "unprognostic (2.42e-1)" 0.3 0.3 1.6 0.3 5.5 0.3 1.0 15.2 5.4 0.9 0.3 4.2 0.3 0.4 0.4 1.4 1.1 0.3 0.9 0.3 2.5 1.2 0.3 0.3 0.4 0.3 6.5 0.7 0.3 0.3 0.3 0.0 0.3 5.2 1.2 0.3 0.0 0.6 0.3 0.3 14.1 0.3 0.3 4.1 0.3 0.6 0.4 5.3 0.0 0.3 5.5 6.1 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.4 0.5 0.3 3.5 0.0 0.0 0.0 0.2 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.4 0.2 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.2 0.8 0.0 0.0 0.0 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 5.5 15.2 5.4 2.5 1.2 6.5 0.7 5.2 5.3 ACSBG1 "BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352" ENSG00000103740 "Acyl-CoA synthetase bubblegum family member 1" Q96GR2 15 78167468-78245688 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 11.4;brain: 40.5;skin 1: 19.9" "Cell line enhanced" "Detected in some" "NTERA-2: 7.9;SK-MEL-30: 3.7" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041642, CAB045955, HPA058869" Approved Approved Vesicles Vesicles "CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840" "unprognostic (1.28e-1)" "unprognostic (1.63e-2)" "unprognostic (1.29e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-2)" "unprognostic (4.18e-2)" "unprognostic (1.32e-2)" "unprognostic (1.58e-2)" "unprognostic (1.86e-1)" "unprognostic (5.64e-2)" "unprognostic (2.02e-1)" "unprognostic (4.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (4.19e-2)" "unprognostic (1.42e-2)" 1.1 11.4 16.9 1.5 26.9 4.5 3.8 6.6 27.0 1.1 1.2 10.5 0.0 1.6 1.2 2.3 1.3 5.9 1.3 1.1 16.4 8.5 1.0 1.0 1.7 1.6 21.1 13.9 1.2 1.0 0.9 0.3 1.1 32.9 2.0 1.1 0.0 1.5 1.4 1.2 19.9 1.5 1.2 40.5 1.3 1.2 5.4 19.0 0.0 1.2 0.0 1.1 1.5 0.2 0.4 3.9 1.2 0.2 0.6 0.2 1.5 0.7 0.1 1.6 2.3 0.0 0.0 0.6 0.5 0.0 0.5 0.1 0.5 0.6 0.7 0.2 0.1 0.9 0.1 0.3 0.2 0.4 1.3 0.7 1.4 0.6 0.0 0.7 1.6 0.6 0.0 0.4 0.2 0.2 0.5 1.1 0.1 0.4 0.6 1.4 7.9 0.3 0.3 1.0 0.5 0.0 0.9 0.5 0.9 0.4 1.0 3.7 0.5 0.5 0.9 0.6 0.6 0.5 0.3 0.9 0.3 0.8 0.3 0.5 1.5 0.4 0.2 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.1 0.4 0.2 0.1 1.2 0.6 0.2 3.9 0.0 1.5 16.9 26.9 6.6 17.9 16.4 8.5 21.1 13.9 32.9 19.0 ACSL6 "ACS2, FACL6, KIAA0837, LACS2, LACS5" ENSG00000164398 "Acyl-CoA synthetase long chain family member 6" Q9UKU0 5 131949973-132012243 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.0;ductus deferens: 30.1;seminal vesicle: 35.8;testis: 23.0" "Group enriched" "Detected in some" 5 "SCLC-21H: 14.6;U-937: 8.5" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA040470 Enhanced "HPA040470: AB_10794033" "unprognostic (1.99e-2)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (5.89e-2)" "unprognostic (6.97e-2)" "unprognostic (1.92e-2)" "unprognostic (8.38e-3)" "unprognostic (5.84e-2)" "unprognostic (8.69e-2)" "unprognostic (7.57e-2)" "unprognostic (9.28e-4)" "unprognostic (8.69e-2)" "unprognostic (3.22e-2)" "unprognostic (6.24e-3)" "unprognostic (1.79e-1)" "unprognostic (6.44e-3)" "unprognostic (1.70e-1)" 0.6 4.8 16.5 1.5 15.7 21.3 0.7 22.8 34.0 0.5 0.7 5.3 30.1 5.4 0.5 1.0 0.9 0.7 0.9 2.0 12.4 9.7 2.3 2.6 0.8 2.5 9.6 12.1 0.5 1.9 13.0 2.7 1.1 12.1 0.8 0.8 3.3 0.8 35.8 3.6 0.6 3.3 0.5 4.2 1.2 1.2 23.0 4.7 0.0 0.9 0.0 1.5 0.7 0.3 0.1 0.0 0.6 0.1 1.2 4.2 1.1 0.0 0.0 0.2 0.1 0.5 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.1 1.6 0.2 0.0 0.0 0.9 0.1 0.0 2.2 0.0 0.2 2.1 0.0 0.1 0.0 0.1 0.0 1.0 0.2 0.0 0.0 0.0 1.4 0.9 0.1 0.1 0.0 0.0 0.0 0.0 14.6 0.7 0.2 0.2 1.1 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.5 0.0 0.3 8.5 0.5 0.6 0.1 0.1 1.5 0.0 3.5 0.1 2.1 4.2 0.0 0.1 3.9 1.8 0.2 1.2 0.0 0.0 0.1 1.1 16.5 15.7 22.8 18.8 12.4 9.7 9.6 12.1 12.1 4.7 ACTL6B "ACTL6, BAF53B" ENSG00000077080 "Actin like 6B" O94805 7 100643097-100656461 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 43.6" "Group enriched" "Detected in some" 75 "SCLC-21H: 21.0;SH-SY5Y: 21.4" "Group enriched" "Detected in some" 11 "glioma: 3.9;pancreatic cancer: 1.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045126 Uncertain Approved Nucleoli Nucleoli "HPA045126: AB_10961265" "unprognostic (3.31e-2)" "unprognostic (6.89e-2)" "unprognostic (4.59e-3)" "unprognostic (4.15e-2)" "unprognostic (1.27e-3)" "unprognostic (4.81e-3)" "unprognostic (6.00e-2)" "unprognostic (8.26e-3)" "unprognostic (1.29e-1)" "unprognostic (4.72e-3)" "unprognostic (1.28e-1)" "unprognostic (3.01e-4)" "unprognostic (1.64e-1)" "unprognostic (6.84e-2)" "unprognostic (2.01e-2)" 1.1 3.8 9.4 1.1 17.4 1.1 1.0 25.9 43.6 1.0 1.2 0.8 0.0 1.3 1.0 1.0 1.0 1.0 1.0 1.0 9.7 9.9 1.1 1.0 1.1 1.0 5.3 12.2 1.0 2.2 1.0 7.0 1.0 9.4 1.0 1.1 0.3 1.0 1.0 1.0 1.1 1.2 1.1 1.6 1.0 2.0 1.7 1.9 0.0 1.1 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 17.4 25.9 26.8 9.7 9.9 5.3 12.2 9.4 1.9 ACTR3B "ARP11, ARP3beta" ENSG00000133627 "ARP3 actin related protein 3 homolog B" Q9P1U1 7 152759749-152855378 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047016, HPA051683" Uncertain "HPA047016: , HPA051683: " "unprognostic (1.20e-1)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.06e-1)" "unprognostic (1.25e-1)" "unprognostic (1.50e-1)" "unprognostic (7.34e-3)" "unprognostic (5.89e-2)" "unprognostic (5.72e-2)" "unprognostic (9.28e-3)" "unprognostic (6.11e-3)" "unprognostic (5.62e-2)" "prognostic favourable (1.66e-4)" "prognostic favourable (4.53e-4)" "unprognostic (4.14e-2)" "unprognostic (3.04e-1)" "unprognostic (7.48e-2)" 3.3 8.2 16.4 3.8 38.1 3.9 7.5 12.7 37.3 4.6 4.0 6.2 7.8 4.4 5.2 8.8 3.3 8.6 3.2 5.1 21.9 11.2 7.1 7.0 3.5 4.5 8.1 14.1 6.8 8.7 11.7 10.9 3.9 7.9 4.4 4.5 5.3 13.6 5.4 6.6 4.4 3.6 3.7 5.1 3.3 5.0 14.8 5.8 2.6 5.7 1.8 4.8 4.2 2.7 2.7 1.9 0.4 0.8 2.5 4.7 2.7 11.7 5.7 10.8 13.4 3.2 4.1 9.0 6.2 4.0 2.6 2.6 6.9 7.0 10.0 4.8 4.0 4.3 9.9 2.9 3.2 3.7 5.2 4.1 4.0 6.4 3.5 5.5 1.6 2.0 3.7 1.5 3.9 3.3 21.0 0.2 5.5 12.3 8.1 10.9 23.3 6.4 6.6 4.1 7.9 4.2 6.7 21.3 17.9 7.9 6.2 5.2 6.4 4.4 1.9 2.6 0.6 3.3 5.4 9.0 9.7 6.9 5.2 8.0 5.4 0.0 0.8 0.0 2.1 0.5 2.7 1.7 2.2 4.3 1.9 2.7 4.7 2.7 0.4 2.5 0.3 1.0 3.0 2.7 16.4 38.1 12.7 23.9 21.9 11.2 8.1 14.1 7.9 5.8 ADAM11 MDC ENSG00000073670 "ADAM metallopeptidase domain 11" O75078 17 44759031-44781846 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 42.3;heart muscle: 11.2" "Cell line enriched" "Detected in some" 4 "HEK 293: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074550 Enhanced "HPA074550: " "unprognostic (1.79e-1)" "unprognostic (7.78e-2)" "unprognostic (1.73e-3)" "unprognostic (2.59e-3)" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (6.37e-2)" "unprognostic (5.41e-2)" "unprognostic (5.46e-3)" "unprognostic (7.16e-2)" "unprognostic (9.99e-16)" "unprognostic (1.39e-1)" "unprognostic (2.51e-1)" "unprognostic (3.11e-1)" "unprognostic (3.00e-1)" 1.2 0.5 8.5 0.6 7.5 1.0 0.6 42.3 23.1 0.9 0.8 0.7 0.0 0.8 4.0 1.1 1.1 1.2 1.5 11.2 11.4 4.2 0.7 0.6 0.7 0.7 2.7 9.8 0.9 0.6 0.7 0.6 0.7 5.5 1.6 0.6 0.2 0.5 2.2 0.8 2.5 0.7 2.6 1.5 0.7 0.7 2.3 1.1 0.0 0.6 0.0 0.6 0.7 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.6 4.8 0.2 0.0 0.3 0.1 0.0 1.3 0.4 0.7 0.2 0.1 0.3 0.0 0.0 3.6 0.0 0.4 1.4 20.5 0.2 0.4 0.3 0.1 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.1 4.1 0.0 2.4 0.8 1.3 2.8 0.0 0.3 0.0 0.1 3.7 1.9 0.0 0.1 1.0 1.4 0.7 0.0 0.6 1.7 1.8 0.4 0.7 0.2 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 8.5 7.5 42.3 21.0 11.4 4.2 2.7 9.8 5.5 1.1 ADAM22 MDC2 ENSG00000008277 "ADAM metallopeptidase domain 22" Q9P0K1 7 87934143-88202889 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.9" "Cell line enhanced" "Detected in many" "Karpas-707: 35.5;SH-SY5Y: 33.8;U-266/84: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050325, CAB079064" Supported Approved "Cell Junctions" "Intracellular and membrane" 78000 "Cell Junctions" "CAB079064: , HPA050325: " "unprognostic (1.20e-2)" "unprognostic (8.61e-2)" "unprognostic (3.38e-1)" "unprognostic (1.94e-2)" "unprognostic (2.89e-2)" "unprognostic (3.09e-1)" "unprognostic (7.84e-3)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-1)" "unprognostic (3.71e-3)" "unprognostic (1.69e-1)" "unprognostic (3.47e-2)" "unprognostic (4.13e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-4)" "unprognostic (4.70e-2)" 2.9 11.7 10.9 1.5 15.7 1.5 2.1 46.9 36.4 8.6 2.3 6.2 1.6 1.3 6.3 11.2 1.6 3.7 3.7 3.0 14.0 10.6 5.5 0.8 2.0 2.9 8.8 14.4 5.6 1.8 4.5 3.7 0.9 17.0 14.5 2.3 2.9 1.5 7.1 3.3 1.8 1.9 5.0 8.2 2.9 1.4 2.7 5.7 2.8 4.5 0.0 1.9 2.1 2.9 0.4 1.2 1.9 0.0 0.5 1.6 0.1 1.0 0.3 2.1 2.5 0.6 0.1 1.5 0.0 0.2 0.1 0.2 2.1 3.5 3.1 0.8 0.0 0.0 3.0 0.0 0.0 8.5 3.9 2.3 2.2 0.6 0.0 2.8 0.0 0.3 0.0 0.0 0.1 0.2 0.1 35.5 0.1 2.8 3.6 0.5 5.0 1.1 2.1 8.2 4.5 0.0 1.7 11.3 33.8 1.7 0.0 0.3 1.5 0.3 0.0 2.1 1.5 0.4 1.5 8.2 13.6 2.5 1.8 6.0 3.1 1.9 0.0 0.0 1.0 0.0 0.1 0.4 0.3 1.0 0.0 0.3 1.6 1.2 0.2 0.5 0.0 1.2 0.0 0.1 10.9 15.7 46.9 21.8 14.0 10.6 8.8 14.4 17.0 5.7 ADAM23 MDC3 ENSG00000114948 "ADAM metallopeptidase domain 23" O75077 2 206443539-206621130 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 30.5;heart muscle: 19.3;parathyroid gland: 67.6" "Cell line enhanced" "Detected in many" "RH-30: 21.8;RPMI-8226: 56.8;U-266/70: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory CD4 T-cell: 5.7" "Lineage enriched" "Detected in single" 14 "T-cells: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033276 Approved "Intracellular and membrane" 24000 "CAB033276: AB_2305247" "unprognostic (7.33e-2)" "unprognostic (7.80e-2)" "unprognostic (4.60e-1)" "unprognostic (5.77e-2)" "unprognostic (1.58e-1)" "unprognostic (3.59e-2)" "unprognostic (4.27e-2)" "unprognostic (1.53e-1)" "unprognostic (1.09e-1)" "unprognostic (6.84e-2)" "unprognostic (1.09e-2)" "unprognostic (2.64e-2)" "unprognostic (9.75e-6)" "unprognostic (3.32e-3)" "unprognostic (1.25e-2)" "unprognostic (2.16e-3)" "unprognostic (1.03e-3)" 2.0 4.7 8.5 2.5 30.5 2.3 1.7 14.2 27.4 3.4 2.4 3.4 0.3 2.0 2.5 3.8 3.8 1.2 4.0 19.3 8.7 11.4 1.5 1.4 2.0 2.3 9.8 13.5 2.4 5.7 67.6 4.8 1.0 22.4 1.8 2.6 2.4 1.5 2.8 8.1 1.6 2.4 4.2 3.9 1.4 2.0 6.5 4.0 0.8 1.3 1.6 2.7 3.2 2.4 0.4 0.0 0.0 0.0 0.0 5.7 0.4 0.0 0.3 7.6 0.0 4.1 6.0 0.3 0.8 0.9 1.1 0.2 8.9 0.1 1.0 0.0 1.2 11.4 4.9 0.2 0.1 4.3 4.2 0.0 0.6 0.1 4.0 0.0 0.5 2.2 0.0 0.0 0.0 13.2 0.0 0.0 2.7 0.1 0.1 0.0 14.9 1.5 0.0 21.8 56.8 0.0 5.5 5.9 2.4 0.0 0.0 4.2 0.0 0.0 11.4 3.8 3.5 2.0 1.7 15.5 0.0 0.0 7.2 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.5 30.5 14.2 25.6 8.7 11.4 9.8 13.5 22.4 4.0 ADAMTS14 ENSG00000138316 "ADAM metallopeptidase with thrombospondin type 1 motif 14" Q8WXS8 10 70672803-70762441 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;gallbladder: 12.3;placenta: 13.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.2;K-562: 11.4;RH-30: 6.2;U-138 MG: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.1" "Lineage enriched" "Detected in single" 11 "monocytes: 1.1" "Region enriched" "Detected in single" 5 "hippocampal formation: 0.4" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" "unprognostic (1.30e-1)" "unprognostic (1.04e-2)" "unprognostic (5.98e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-3)" "unprognostic (2.40e-1)" "unprognostic (5.33e-3)" "unprognostic (2.35e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.98e-2)" "unprognostic (6.81e-2)" "unprognostic (3.84e-13)" "unprognostic (3.90e-2)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" "unprognostic (2.16e-2)" 1.7 0.5 4.6 5.4 10.7 1.1 0.6 1.0 4.7 1.3 3.3 13.4 1.0 4.1 1.4 1.0 1.8 1.1 12.3 2.8 7.2 3.0 0.7 0.5 2.7 2.0 8.1 5.7 0.7 0.5 0.2 0.4 13.5 4.0 1.1 3.6 2.6 1.6 0.4 0.4 2.5 5.7 3.9 4.6 0.8 2.6 0.9 5.9 0.5 0.4 2.3 2.3 6.7 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 4.7 0.0 1.2 3.6 0.3 2.0 0.0 10.2 0.0 0.8 1.8 0.8 0.0 0.0 0.1 3.9 0.0 0.4 0.0 0.3 0.0 0.0 2.7 0.4 0.1 0.9 0.2 0.0 11.4 0.0 1.4 0.0 0.0 1.0 0.4 0.0 0.0 6.2 0.2 0.0 0.0 3.9 0.6 0.0 0.1 0.3 0.0 0.0 0.0 10.3 0.1 0.8 0.5 0.9 0.0 0.0 0.5 1.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.6 10.7 1.0 4.7 7.2 3.0 8.1 5.7 4.0 5.9 ADAMTS16 ADAMTS16s ENSG00000145536 "ADAM metallopeptidase with thrombospondin type 1 motif 16" Q8TE57 5 5140330-5320304 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4;ovary: 16.3" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 6.2;U-2 OS: 4.9;U-2197: 9.1;U-87 MG: 4.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;cerebral cortex: 5.2" "Cell type enriched" "Detected in single" 10 "NK-cell: 3.6" "Lineage enriched" "Detected in single" 10 "NK-cells: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA067668 Approved "Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria" "Secreted to extracellular matrix" "Nuclear membrane, Mitochondria" "Nucleoplasm, Midbody ring" "HPA067668: " "unprognostic (8.48e-2)" "unprognostic (1.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.98e-4)" "unprognostic (1.91e-2)" "unprognostic (5.04e-2)" "unprognostic (7.64e-2)" "unprognostic (7.80e-3)" "unprognostic (2.12e-2)" "unprognostic (5.44e-2)" "unprognostic (1.51e-2)" "unprognostic (2.18e-1)" "prognostic favourable (3.29e-5)" "unprognostic (1.20e-4)" "unprognostic (1.46e-1)" "unprognostic (4.59e-3)" "unprognostic (2.86e-3)" 7.4 0.4 1.8 0.5 2.8 0.6 1.0 20.4 5.2 2.6 0.9 0.1 3.7 0.6 2.3 11.0 1.9 1.1 8.8 0.9 1.7 0.5 5.4 0.6 0.9 0.2 0.5 1.9 16.3 6.3 0.0 0.5 0.2 2.2 0.7 0.4 0.0 0.4 0.8 0.5 0.5 0.6 10.4 0.6 0.4 0.6 0.8 0.0 0.0 0.8 0.0 0.1 3.4 1.5 0.2 0.1 0.3 0.0 3.6 0.2 0.0 2.6 2.7 2.7 0.1 0.2 0.6 0.2 0.1 0.1 0.6 0.9 0.1 2.4 0.2 3.3 0.0 0.2 0.0 0.0 0.8 0.1 1.6 0.1 3.9 0.1 0.0 0.3 0.1 0.0 0.0 6.2 0.2 0.0 0.8 0.4 1.2 0.1 0.1 0.3 1.7 2.5 0.5 3.3 0.2 0.1 0.0 1.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 3.3 4.9 9.1 2.1 0.5 0.2 0.1 4.7 0.1 0.4 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.3 3.6 0.0 0.0 0.0 0.0 1.8 2.8 20.4 5.2 1.7 0.5 0.5 1.9 2.2 0.0 ADAMTS18 ADAMTS21 ENSG00000140873 "ADAM metallopeptidase with thrombospondin type 1 motif 18" Q8TE60 16 77247813-77435114 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adipose tissue: 16.1;brain: 31.9;placenta: 27.6" "Group enriched" "Detected in some" 8 "HUVEC TERT2: 12.1;TIME: 3.7;U-87 MG: 7.4" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in all" 5 "cerebellum: 31.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 3.7" "Not detected" "Not detected" HPA044326 Uncertain Approved "Midbody,Mitotic spindle" "Secreted to extracellular matrix" "Midbody, Mitotic spindle" "HPA044326: AB_10961006" "unprognostic (1.10e-2)" "unprognostic (2.78e-1)" "unprognostic (1.38e-1)" "unprognostic (2.50e-1)" "unprognostic (8.13e-2)" "unprognostic (2.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.27e-2)" "unprognostic (2.46e-2)" "unprognostic (2.98e-1)" "unprognostic (4.11e-2)" "unprognostic (2.20e-2)" "unprognostic (8.17e-4)" "unprognostic (1.77e-5)" "unprognostic (2.17e-1)" "unprognostic (3.41e-1)" "unprognostic (2.47e-4)" 16.1 0.6 1.1 0.8 5.1 0.4 3.2 31.9 3.3 2.2 0.4 8.2 0.0 0.5 1.6 0.4 0.5 0.7 1.1 0.4 2.0 1.3 0.5 0.3 0.5 0.5 1.8 1.4 0.5 0.8 0.4 1.4 27.6 6.4 1.0 0.4 0.2 2.1 0.5 1.0 0.4 0.4 1.2 3.7 0.3 0.3 0.7 2.4 0.0 0.4 0.0 0.3 0.8 0.4 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 5.1 31.9 3.3 2.0 1.3 1.8 1.4 6.4 2.4 ADAMTS20 GON-1 ENSG00000173157 "ADAM metallopeptidase with thrombospondin type 1 motif 20" P59510 12 43353866-43551921 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "brain: 5.1;placenta: 3.6;retina: 1.5;testis: 2.3" "Cell line enhanced" "Detected in some" "EFO-21: 2.4;Karpas-707: 6.6;NB-4: 2.9;NTERA-2: 5.2;U-266/70: 7.5;U-266/84: 3.8" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027608, HPA027609" Uncertain "Secreted to extracellular matrix" "HPA027608: AB_10600098, HPA027609: AB_10599024" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (1.91e-2)" "unprognostic (2.04e-1)" "unprognostic (9.61e-2)" "unprognostic (3.29e-1)" "unprognostic (6.67e-2)" "unprognostic (2.26e-1)" "unprognostic (1.05e-4)" "unprognostic (7.42e-2)" "unprognostic (2.02e-1)" "unprognostic (9.81e-3)" "unprognostic (2.57e-1)" 0.2 0.0 0.7 0.1 1.4 0.1 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.2 0.0 3.6 5.1 0.0 0.0 1.5 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 2.3 1.1 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.6 0.2 0.0 0.0 2.9 5.2 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.7 0.0 0.0 7.5 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 1.2 0.3 0.7 0.6 0.0 5.1 1.1 ADAP1 "CENTA1, GCS1L" ENSG00000105963 "ArfGAP with dual PH domains 1" O75689 7 897901-955407 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8;intestine: 30.8" "Cell line enhanced" "Detected in many" "A-431: 35.6;CAPAN-2: 25.7;HaCaT: 16.3;HMC-1: 24.6;THP-1: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007033, HPA012049" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA007033: AB_1846529, HPA012049: AB_1846527" "unprognostic (2.45e-1)" "unprognostic (7.15e-2)" "prognostic unfavourable (5.25e-4)" "unprognostic (4.41e-2)" "unprognostic (1.97e-1)" "prognostic unfavourable (9.13e-4)" "unprognostic (3.06e-1)" "unprognostic (9.10e-3)" "unprognostic (1.70e-2)" "unprognostic (1.38e-1)" "unprognostic (5.74e-2)" "unprognostic (1.69e-1)" "prognostic favourable (4.13e-5)" "unprognostic (5.88e-2)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-2)" 3.0 2.1 32.9 8.9 25.9 8.1 1.2 13.8 41.8 3.6 30.8 30.3 1.7 16.7 2.6 1.3 4.5 4.2 6.2 3.9 36.1 17.7 6.5 1.6 5.8 3.3 28.0 20.1 0.7 5.4 3.7 1.3 3.0 19.3 1.9 20.6 0.9 3.0 3.1 0.8 2.0 22.8 7.7 36.1 7.4 16.3 1.1 19.3 0.0 4.8 0.4 2.3 5.1 1.0 1.3 5.5 3.4 11.7 1.6 6.8 3.7 35.6 1.3 0.0 1.2 0.5 0.0 0.4 1.1 0.0 0.3 0.1 14.2 25.7 0.0 3.5 0.2 16.3 1.9 2.7 0.1 0.2 1.5 0.0 2.2 8.0 0.6 0.2 24.6 0.6 7.6 0.0 0.0 0.0 0.1 0.0 0.0 11.4 0.0 9.6 1.1 0.0 4.8 0.0 0.1 1.9 8.6 1.1 0.3 1.1 0.4 0.1 9.2 41.9 0.2 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 7.5 1.3 1.1 7.6 3.4 6.8 8.1 3.3 1.3 2.0 6.1 5.5 1.1 0.6 3.1 3.4 1.6 11.7 0.4 0.9 3.7 32.9 25.9 13.8 33.4 36.1 17.7 28.0 20.1 19.3 19.3 ADARB2 "ADAR3, hRED2, RED2" ENSG00000185736 "Adenosine deaminase, RNA specific B2 (inactive)" Q9NS39 10 1177318-1737476 "Predicted intracellular proteins" "mRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2" "Cell line enhanced" "Detected in some" "HDLM-2: 2.8;REH: 2.3;SH-SY5Y: 3.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 8.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.83e-1)" "unprognostic (4.73e-3)" "unprognostic (4.64e-2)" "unprognostic (7.44e-3)" "unprognostic (2.12e-1)" "unprognostic (2.62e-2)" "unprognostic (2.53e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (9.58e-2)" "unprognostic (9.28e-3)" "unprognostic (3.41e-1)" "unprognostic (3.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.04e-1)" "unprognostic (3.11e-1)" "unprognostic (3.81e-3)" 1.1 1.3 13.3 1.0 21.8 1.5 2.9 3.8 20.8 1.3 1.6 24.9 0.0 1.2 0.9 0.9 1.2 3.8 0.9 1.2 12.2 7.0 1.1 1.0 1.7 1.3 33.2 9.4 1.3 9.3 0.9 0.4 1.1 15.3 1.2 1.0 0.0 9.8 3.1 1.0 0.9 1.1 0.9 22.8 1.1 1.5 3.5 26.2 0.0 0.9 0.0 1.8 1.1 0.5 0.1 0.1 8.5 0.0 1.6 0.9 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.4 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 2.3 0.1 0.0 0.0 0.0 0.7 3.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.5 0.0 0.1 0.3 0.2 8.5 1.6 0.0 0.1 0.6 0.1 13.3 21.8 3.8 13.4 12.2 7.0 33.2 9.4 15.3 26.2 ADCY1 "AC1, DFNB44" ENSG00000164742 "Adenylate cyclase 1" Q08828 7 45574140-45723116 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, cAMP biosynthesis" "Calmodulin-binding, Lyase" "Cancer-related genes, Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0" "Cell line enhanced" "Detected in many" "hTERT-HME1: 15.0;SCLC-21H: 9.1;SH-SY5Y: 17.3;SK-MEL-30: 19.9;WM-115: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018364, HPA068274" Uncertain Approved Mitochondria Mitochondria "CAB018364: AB_2223098, HPA068274: " "unprognostic (9.41e-3)" "unprognostic (7.30e-4)" "unprognostic (9.31e-2)" "unprognostic (2.98e-1)" "unprognostic (4.18e-2)" "unprognostic (3.07e-3)" "unprognostic (1.32e-1)" "unprognostic (7.31e-2)" "unprognostic (1.64e-3)" "unprognostic (2.89e-1)" "unprognostic (7.73e-3)" "unprognostic (1.54e-1)" "unprognostic (4.74e-6)" "unprognostic (2.49e-1)" "unprognostic (7.65e-3)" "unprognostic (2.87e-1)" "unprognostic (2.23e-1)" 2.8 2.8 11.5 0.7 11.7 0.4 6.8 22.7 29.0 7.8 0.9 2.0 0.0 0.7 2.7 1.1 1.2 2.4 1.2 4.0 11.6 4.0 1.8 9.6 1.0 0.8 5.8 13.4 1.2 3.6 1.0 1.5 0.9 6.2 4.1 1.0 5.0 0.8 2.1 9.2 0.6 0.7 1.6 2.2 1.0 1.8 3.9 1.2 0.0 3.0 0.2 0.8 1.0 1.5 0.5 0.4 0.6 0.1 0.0 0.2 0.0 0.5 3.8 1.4 2.2 2.8 0.0 2.7 0.1 0.0 0.5 0.2 0.4 0.0 0.0 0.2 0.1 1.2 2.5 0.1 0.0 6.9 1.8 0.0 0.0 0.3 0.0 0.1 0.0 3.4 1.9 0.3 15.0 0.1 0.2 4.6 0.2 4.6 0.0 0.0 5.6 0.0 0.0 0.0 7.5 0.0 3.7 9.1 17.3 1.4 0.0 19.9 1.3 2.3 0.0 0.4 2.9 0.3 2.3 0.0 0.0 0.0 0.0 0.0 11.3 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 11.5 11.7 22.7 29.0 11.6 4.0 5.8 13.4 6.2 1.2 ADCY2 "AC2, HBAC2, KIAA1060" ENSG00000078295 "Adenylate cyclase 2" Q08462 5 7396208-7830081 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 35.9;skeletal muscle: 58.6" "Group enriched" "Detected in some" 7 "AF22: 9.2;NTERA-2: 7.0;SK-MEL-30: 7.7" "Cancer enhanced" "Detected in some" "glioma: 4.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031482, HPA038015, HPA038483" Approved "CAB031482: AB_630838, HPA038015: AB_10673653, HPA038483: AB_10675799" "unprognostic (6.48e-2)" "unprognostic (2.60e-2)" "unprognostic (1.49e-1)" "unprognostic (5.65e-2)" "unprognostic (3.77e-1)" "unprognostic (4.03e-4)" "unprognostic (1.94e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-1)" "unprognostic (1.48e-1)" "unprognostic (2.67e-2)" "unprognostic (7.68e-2)" "unprognostic (1.09e-5)" "unprognostic (1.05e-1)" "unprognostic (7.33e-3)" "unprognostic (4.90e-2)" "unprognostic (3.92e-3)" 1.8 3.3 16.8 1.3 14.5 1.2 2.8 6.6 35.9 4.9 1.9 6.7 0.7 1.9 3.9 1.7 4.0 4.1 2.1 1.2 14.5 9.4 1.2 1.1 1.3 1.1 12.8 10.0 5.1 1.9 1.0 5.1 1.8 11.3 6.2 1.6 2.0 1.5 5.1 58.6 6.3 1.8 4.3 12.5 1.2 2.6 3.6 5.4 0.0 1.1 5.1 1.2 1.9 2.1 0.9 0.4 1.5 0.4 0.3 0.6 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.0 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.4 0.1 0.4 0.2 0.4 0.5 0.3 0.3 0.1 0.9 0.4 0.6 1.5 0.3 0.3 0.4 0.2 0.0 16.8 14.5 6.6 22.5 14.5 9.4 12.8 10.0 11.3 5.4 ADCY8 "AC8, ADCY3, HBAC1" ENSG00000155897 "Adenylate cyclase 8" P40145 8 130780301-131042426 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.6;epididymis: 27.8" "Group enriched" "Detected in some" 5 "U-138 MG: 13.5;U-87 MG: 26.2" "Group enriched" "Detected in some" 5 "glioma: 6.0;ovarian cancer: 1.8;thyroid cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018652, HPA024291" Supported "CAB018652: AB_633654, HPA024291: AB_1844597" "unprognostic (5.59e-3)" "unprognostic (3.10e-1)" "unprognostic (1.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.05e-1)" "unprognostic (8.22e-3)" "unprognostic (4.91e-2)" "unprognostic (7.39e-3)" "unprognostic (1.92e-1)" "unprognostic (2.44e-2)" "unprognostic (6.67e-2)" 0.2 0.2 8.2 0.2 5.1 0.2 0.9 5.3 9.6 0.8 0.2 1.2 1.4 0.2 0.3 27.8 0.2 4.8 0.2 0.3 6.4 6.2 0.5 0.2 1.6 0.2 7.8 0.6 0.3 0.2 0.2 0.0 0.2 5.7 0.2 0.2 0.0 2.8 2.0 0.2 1.5 0.2 0.9 5.0 0.2 0.3 0.7 1.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.3 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 5.1 5.3 5.0 6.4 6.2 7.8 0.6 5.7 1.1 ADCYAP1 PACAP ENSG00000141433 "Adenylate cyclase activating polypeptide 1" P18509 18 904943-912172 "Predicted secreted proteins" Neurogenesis Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;lymphoid tissue: 16.5" "Cell line enriched" "Detected in some" 12 "SCLC-21H: 19.8" "Cancer enhanced" "Detected in some" "pancreatic cancer: 3.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065887 Supported Supported "Secreted in other tissues" "HPA065887: " "unprognostic (2.68e-1)" "unprognostic (1.83e-2)" "unprognostic (7.09e-2)" "unprognostic (4.04e-2)" "unprognostic (2.23e-1)" "unprognostic (3.87e-4)" "unprognostic (9.58e-3)" "unprognostic (1.00e-1)" "unprognostic (2.34e-1)" "unprognostic (6.86e-2)" "unprognostic (4.16e-2)" "unprognostic (9.94e-2)" "prognostic favourable (2.91e-6)" "unprognostic (2.24e-3)" "unprognostic (9.22e-2)" "unprognostic (1.74e-1)" "unprognostic (5.74e-4)" 2.1 0.5 2.5 16.5 7.7 0.1 1.6 2.1 12.5 3.4 2.6 0.8 0.0 0.1 4.0 0.1 2.2 0.5 12.3 1.0 1.2 18.4 0.6 0.3 1.7 1.6 2.8 6.2 0.2 7.7 0.1 4.5 0.3 33.8 1.4 1.4 2.5 2.2 1.0 0.3 0.9 1.3 1.5 5.9 0.2 1.8 3.6 0.2 0.1 0.3 0.0 1.4 3.1 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 7.7 2.1 12.1 1.2 18.4 2.8 6.2 33.8 0.2 ADCYAP1R1 "PAC1, PAC1R, PACAPR" ENSG00000078549 "ADCYAP receptor type I" P41586 7 31052461-31111479 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.2;fallopian tube: 25.1" "Group enriched" "Detected in some" 6 "AF22: 5.4;NTERA-2: 7.2;SCLC-21H: 6.1;SH-SY5Y: 10.9" "Cancer enriched" "Detected in some" 11 "glioma: 45.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030739, HPA049877" Enhanced Enhanced Vesicles Vesicles "HPA030739: , HPA049877: " "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.16e-2)" "prognostic favourable (5.78e-4)" "unprognostic (2.17e-1)" "unprognostic (8.36e-2)" "unprognostic (4.93e-2)" "unprognostic (5.75e-2)" "unprognostic (3.50e-2)" "unprognostic (3.88e-1)" "unprognostic (1.58e-1)" "unprognostic (6.67e-3)" "unprognostic (6.43e-4)" "unprognostic (1.09e-3)" "unprognostic (9.55e-2)" "unprognostic (3.85e-2)" "unprognostic (2.75e-4)" 5.4 10.6 23.6 2.7 24.2 0.9 2.9 13.7 71.2 12.8 2.7 13.4 0.0 1.6 5.4 2.3 3.3 25.1 2.0 2.8 22.1 21.6 1.0 1.1 1.6 1.0 19.0 20.2 1.9 2.2 2.9 4.4 1.0 18.7 2.1 2.0 0.0 2.6 3.7 1.9 1.8 2.0 3.9 6.5 1.3 1.6 2.2 13.3 0.0 2.3 0.9 1.6 1.4 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 10.9 0.0 0.0 0.0 0.0 0.0 0.3 0.9 1.3 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.6 24.2 13.7 17.3 22.1 21.6 19.0 20.2 18.7 13.3 ADD2 ADDB ENSG00000075340 "Adducin 2" P35612 2 70607618-70768225 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "bone marrow: 53.6;brain: 35.0" "Cell line enhanced" "Detected in some" "HAP1: 14.1;K-562: 18.5;NTERA-2: 36.5;RPMI-8226: 17.4;SCLC-21H: 18.1;U-251 MG: 19.2" "Cancer enhanced" "Detected in many" "testis cancer: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 4.7;non-classical monocyte: 4.4" "Group enriched" "Detected in many" 20 "B-cells: 4.7;monocytes: 4.4;T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009796, HPA034509, HPA034510" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" 66000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009796: AB_2223572, HPA034509: , HPA034510: " "unprognostic (3.58e-2)" "unprognostic (2.68e-4)" "unprognostic (3.83e-2)" "unprognostic (3.01e-4)" "unprognostic (1.94e-1)" "unprognostic (2.25e-3)" "unprognostic (1.35e-1)" "unprognostic (3.26e-1)" "unprognostic (3.49e-1)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (8.93e-2)" "unprognostic (4.47e-7)" "unprognostic (2.81e-4)" "unprognostic (1.77e-1)" "unprognostic (1.71e-3)" "unprognostic (1.31e-3)" 1.9 2.6 14.0 2.6 17.9 53.6 1.5 29.7 35.0 1.3 1.3 1.2 0.0 1.0 1.3 1.2 2.3 1.4 1.2 1.5 14.1 10.7 0.9 0.9 1.8 3.1 6.0 19.7 1.0 2.1 1.3 2.8 1.6 14.0 1.3 1.2 1.7 1.1 1.1 1.6 1.2 1.2 1.9 6.0 1.9 1.1 2.9 2.7 0.0 2.3 0.0 2.9 1.5 0.5 4.7 0.1 0.1 4.4 0.0 1.9 0.6 7.0 8.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.1 0.0 14.1 0.0 0.0 0.0 8.3 0.7 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.1 0.6 36.5 0.2 0.0 0.2 17.4 2.4 0.0 18.1 8.2 8.9 0.0 0.0 0.0 4.3 0.3 0.0 0.4 0.0 19.2 5.9 6.9 0.0 0.3 2.9 3.2 0.1 0.1 0.0 0.0 2.4 0.1 4.7 0.0 0.0 0.1 4.0 1.9 1.0 0.1 0.0 4.4 0.0 0.0 0.6 14.0 17.9 29.7 35.0 14.1 10.7 6.0 19.7 14.0 2.7 ADGB "C6orf103, CAPN16, dJ408K24.1, FLJ23121" ENSG00000118492 Androglobin Q8N7X0 6 146598965-146815462 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.9;epididymis: 13.1;testis: 30.6" "Cell line enriched" "Detected in single" 25 "HDLM-2: 17.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 6.6;pons and medulla: 20.9" "Cell type enriched" "Detected in single" 10 "myeloid DC: 2.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 2.6" "Low region specificity" "Detected in all" "HPA036340, HPA036341" Enhanced Uncertain Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA036340: , HPA036341: AB_10672241" "unprognostic (4.15e-3)" "unprognostic (1.23e-2)" "unprognostic (9.30e-3)" "unprognostic (1.09e-1)" "unprognostic (2.07e-2)" "unprognostic (3.11e-2)" "unprognostic (5.05e-1)" "unprognostic (2.34e-1)" "unprognostic (4.83e-3)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (2.68e-1)" 0.1 0.1 1.6 0.1 6.6 0.1 0.2 0.0 0.2 1.0 0.5 5.1 0.0 0.1 0.4 13.1 0.2 9.8 0.1 0.1 2.2 2.7 0.2 0.2 4.8 0.2 0.0 0.0 4.3 0.1 0.3 0.8 0.2 20.9 0.2 0.4 0.0 0.1 0.3 0.1 0.3 0.1 0.1 0.4 0.1 0.2 30.6 1.2 0.0 0.2 0.1 0.2 0.1 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 6.6 0.0 0.1 2.2 2.7 0.0 0.0 20.9 1.2 ADGRA1 "GPR123, KIAA1828" ENSG00000197177 "Adhesion G protein-coupled receptor A1" Q86SQ6 10 133070929-133131675 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.8;brain: 26.6" "Cell line enriched" "Detected in single" 18 "RH-30: 11.9" "Cancer enriched" "Detected in single" 13 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042773 Approved "HPA042773: AB_10794764" "unprognostic (8.31e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (1.09e-2)" "unprognostic (7.51e-3)" "unprognostic (2.48e-2)" "unprognostic (3.33e-1)" "unprognostic (1.66e-1)" 0.8 7.8 9.9 0.7 9.3 0.7 0.7 3.5 26.6 0.7 0.7 3.2 0.0 0.7 0.7 0.7 0.7 4.3 0.7 0.7 11.6 14.6 1.0 1.1 0.9 0.7 7.5 6.6 0.7 0.8 0.7 1.9 0.7 5.3 0.7 0.7 0.3 4.1 0.7 0.7 0.7 0.7 0.7 4.6 1.0 0.8 1.0 1.4 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 9.3 3.5 19.0 11.6 14.6 7.5 6.6 5.3 1.4 ADGRB1 BAI1 ENSG00000181790 "Adhesion G protein-coupled receptor B1" O14514 8 142449430-142545009 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity, Myogenesis, Neurogenesis, Phagocytosis" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 27.4" "Cell line enhanced" "Detected in some" "AN3-CA: 11.5;MCF7: 4.2;NB-4: 5.6;RPMI-8226: 15.9;U-2 OS: 10.9" "Cancer enhanced" "Detected in many" "glioma: 11.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" "unprognostic (9.57e-4)" "unprognostic (1.28e-1)" "unprognostic (3.87e-3)" "unprognostic (8.50e-3)" "unprognostic (9.98e-2)" "unprognostic (5.87e-2)" "unprognostic (3.39e-1)" "unprognostic (2.14e-2)" "unprognostic (2.76e-1)" "unprognostic (2.55e-1)" "unprognostic (6.48e-2)" "unprognostic (3.43e-1)" "unprognostic (7.30e-11)" "unprognostic (6.27e-2)" "unprognostic (7.42e-2)" "unprognostic (4.52e-3)" "unprognostic (3.29e-2)" 1.0 3.4 13.6 1.4 18.1 0.9 1.1 5.4 27.4 2.0 1.0 3.1 0.1 1.4 1.8 2.3 0.9 1.4 0.9 0.9 11.0 11.9 1.1 0.8 1.2 1.6 8.7 9.2 1.6 1.1 0.9 2.7 2.5 9.1 1.3 0.9 0.9 2.6 1.9 0.7 3.1 1.4 1.0 2.3 3.7 1.5 2.1 3.2 0.0 0.9 0.0 1.0 0.9 0.4 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 5.6 1.8 0.0 0.1 0.0 15.9 0.0 0.0 3.1 3.1 0.0 0.0 0.2 0.1 0.3 0.0 0.1 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 18.1 5.4 19.5 11.0 11.9 8.7 9.2 9.1 3.2 ADGRB2 BAI2 ENSG00000121753 "Adhesion G protein-coupled receptor B2" O60241 1 31727117-31764893 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 52.0" "Cell line enhanced" "Detected in many" "HeLa: 20.5;SH-SY5Y: 15.0;T-47d: 17.3;U-2 OS: 16.9" "Cancer enhanced" "Detected in many" "glioma: 20.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052612, HPA054617" Enhanced Centrosome 49000 Centrosome "HPA052612: , HPA054617: " "prognostic favourable (6.46e-4)" "unprognostic (1.74e-1)" "unprognostic (7.98e-2)" "unprognostic (4.34e-2)" "unprognostic (1.90e-1)" "unprognostic (2.40e-1)" "unprognostic (8.17e-4)" "prognostic unfavourable (4.02e-5)" "unprognostic (2.31e-2)" "unprognostic (1.54e-2)" "unprognostic (1.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-3)" "unprognostic (1.63e-1)" "unprognostic (1.23e-1)" "unprognostic (1.75e-3)" "unprognostic (7.98e-2)" 2.2 5.4 15.9 1.3 26.8 1.1 1.4 7.9 52.0 2.4 1.4 7.3 0.0 5.2 2.4 1.2 1.6 2.2 2.1 2.8 18.9 8.0 1.4 0.9 1.3 1.3 7.4 16.5 1.8 1.4 1.3 2.7 3.8 8.4 2.4 1.1 1.3 1.4 3.1 1.1 1.5 5.0 2.4 2.9 1.8 1.8 3.2 6.3 1.5 3.2 0.0 1.1 2.0 0.5 0.4 0.0 0.0 0.0 0.0 0.9 0.3 0.5 4.4 4.1 11.9 1.2 0.7 2.0 2.8 4.5 2.7 4.9 0.2 1.3 0.0 2.8 1.2 0.4 1.8 0.2 0.4 3.1 1.8 0.0 20.5 0.0 0.1 0.0 1.5 0.7 0.3 3.8 0.0 0.4 0.4 0.1 3.0 0.4 7.8 0.1 5.1 1.3 11.9 0.4 0.4 0.0 5.6 3.1 15.0 6.4 0.4 0.5 17.3 0.0 0.1 2.1 16.9 0.3 0.7 0.0 0.0 0.4 6.6 0.0 5.0 0.0 0.0 0.0 0.9 0.0 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 15.9 26.8 7.9 37.6 18.9 8.0 7.4 16.5 8.4 6.3 ADGRB3 "BAI3, KIAA0550" ENSG00000135298 "Adhesion G protein-coupled receptor B3" O60242 6 68635367-69389511 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 55.0;pituitary gland: 17.1" "Group enriched" "Detected in some" 5 "SCLC-21H: 9.1;SH-SY5Y: 19.6" "Cancer enriched" "Detected in single" 10 "glioma: 3.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 6 "dendritic cells: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" 9200 "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (2.69e-1)" "unprognostic (3.72e-3)" "unprognostic (3.27e-2)" "unprognostic (1.04e-1)" "unprognostic (2.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (5.08e-5)" "unprognostic (4.93e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-3)" "unprognostic (2.43e-1)" "unprognostic (1.01e-1)" "unprognostic (8.16e-3)" 2.7 8.0 20.0 2.8 22.5 1.5 2.1 46.9 55.0 3.1 3.4 6.2 0.0 2.2 5.2 3.1 2.7 2.4 3.0 3.2 17.6 15.2 2.4 2.4 3.6 1.6 9.0 22.7 4.3 1.9 1.8 17.1 1.8 9.6 2.6 3.6 1.2 3.2 3.9 1.9 1.9 3.2 6.7 10.1 2.4 1.9 4.4 11.1 0.0 2.1 0.0 1.6 2.9 1.8 0.0 2.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 1.0 0.0 1.2 1.0 0.0 0.0 9.1 19.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 20.0 22.5 46.9 25.1 17.6 15.2 9.0 22.7 9.6 11.1 ADGRL1 "CIRL1, KIAA0821, LEC2, LPHN1" ENSG00000072071 "Adhesion G protein-coupled receptor L1" O94910 19 14147743-14206187 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9" "Cell line enhanced" "Detected in many" "AN3-CA: 31.2;HMC-1: 22.6;SCLC-21H: 24.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037974 Uncertain 63000 "HPA037974: AB_10675623" "unprognostic (5.52e-2)" "unprognostic (3.89e-1)" "unprognostic (1.04e-1)" "unprognostic (5.52e-3)" "unprognostic (6.29e-2)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" "unprognostic (5.39e-2)" "unprognostic (2.73e-1)" "unprognostic (5.68e-2)" "prognostic favourable (1.14e-4)" "unprognostic (2.09e-1)" "prognostic favourable (4.45e-4)" "unprognostic (7.65e-3)" "unprognostic (1.32e-1)" "unprognostic (3.06e-2)" "unprognostic (2.18e-1)" 10.5 4.6 12.1 3.5 18.0 1.8 3.9 27.0 30.9 7.7 6.4 12.7 4.3 6.1 9.0 4.1 6.5 10.8 4.1 5.5 12.7 9.3 3.4 0.5 5.4 2.6 8.7 9.0 4.0 5.8 12.8 9.1 3.7 11.8 5.4 3.7 9.4 9.8 8.1 1.6 9.1 5.4 8.1 8.1 4.4 5.0 5.5 6.9 2.8 9.2 2.0 1.8 4.6 3.4 0.4 1.7 1.3 1.3 4.6 1.3 0.6 9.8 3.8 8.8 31.2 2.3 0.7 3.1 0.7 1.0 1.0 0.6 3.3 3.4 0.8 10.5 1.1 0.6 10.5 2.9 0.3 1.4 8.9 1.8 1.6 0.5 5.3 0.5 22.6 1.9 2.7 0.3 0.5 0.8 8.6 0.9 0.1 16.6 0.8 0.9 13.0 7.5 4.8 1.1 11.0 1.7 3.1 24.2 6.1 1.8 12.5 4.3 12.3 4.6 1.2 8.2 12.6 2.2 2.8 2.5 2.0 13.5 2.4 11.5 3.0 0.0 1.3 0.5 1.3 1.1 0.9 0.4 0.7 0.4 0.5 0.2 1.0 0.6 1.3 4.6 1.1 1.7 0.7 0.6 12.1 18.0 27.0 27.6 12.7 9.3 8.7 9.0 11.8 6.9 ADGRL3 "KIAA0768, LEC3, LPHN3" ENSG00000150471 "Adhesion G protein-coupled receptor L3" Q9HAR2 4 61201258-62078335 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;parathyroid gland: 23.1" "Group enriched" "Detected in some" 4 "AF22: 29.6;EFO-21: 7.7" "Cancer enriched" "Detected in some" 8 "glioma: 5.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015027, HPA015762, CAB022698" Uncertain "CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245" "unprognostic (2.88e-2)" "unprognostic (1.12e-1)" "unprognostic (6.43e-4)" "unprognostic (1.79e-2)" "unprognostic (1.88e-1)" "unprognostic (7.56e-2)" "unprognostic (8.70e-2)" "unprognostic (5.42e-2)" "unprognostic (1.62e-2)" "unprognostic (1.28e-1)" "unprognostic (6.81e-2)" "unprognostic (1.28e-1)" "unprognostic (1.62e-5)" "unprognostic (1.03e-2)" "unprognostic (1.44e-1)" "unprognostic (9.85e-3)" "unprognostic (4.23e-3)" 4.9 7.6 19.7 1.6 19.0 0.4 2.7 11.3 30.5 7.3 4.8 5.0 0.4 3.3 4.9 2.6 1.6 3.3 2.3 3.2 13.1 12.3 2.4 0.9 3.4 0.8 11.8 11.9 1.8 0.7 23.1 0.9 4.9 9.8 2.0 5.0 0.4 0.8 5.6 0.8 2.6 4.4 3.9 8.5 0.8 3.9 4.8 6.1 0.0 0.9 0.6 0.6 2.2 2.9 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.7 0.0 0.0 4.1 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 2.3 0.0 0.0 0.7 0.0 2.8 0.1 0.1 0.0 3.2 0.1 0.0 4.5 0.2 0.0 0.0 0.0 0.0 2.2 0.0 0.1 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 19.7 19.0 11.3 23.3 13.1 12.3 11.8 11.9 9.8 6.1 ADORA1 RDC7 ENSG00000163485 "Adenosine A1 receptor" P30542 1 203090654-203167405 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.7" "Cell line enhanced" "Detected in some" "CACO-2: 19.3;MCF7: 11.6;RH-30: 31.9;RPTEC TERT1: 15.5;SK-BR-3: 17.3;U-138 MG: 10.4" "Cancer enhanced" "Detected in many" "glioma: 24.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044383 Supported "Plasma membrane" "Plasma membrane" "HPA044383: " "unprognostic (3.93e-3)" "unprognostic (8.16e-2)" "unprognostic (6.16e-2)" "unprognostic (2.38e-3)" "unprognostic (2.25e-2)" "unprognostic (2.34e-1)" "unprognostic (4.64e-2)" "unprognostic (4.17e-2)" "unprognostic (3.04e-1)" "unprognostic (4.80e-3)" "unprognostic (1.42e-1)" "unprognostic (2.98e-1)" "unprognostic (2.96e-3)" "unprognostic (1.54e-1)" "unprognostic (1.27e-1)" "unprognostic (4.13e-2)" "unprognostic (5.76e-4)" 4.5 1.0 19.7 2.6 21.7 0.8 6.1 9.7 38.7 1.1 1.6 27.4 0.0 2.0 2.0 1.6 1.6 2.0 1.8 13.8 19.8 12.1 4.2 1.0 2.8 1.4 22.8 13.4 0.8 15.5 15.5 0.9 8.9 25.0 1.2 1.6 1.8 8.9 1.3 2.0 1.9 1.8 1.3 20.7 7.4 1.6 16.3 15.9 0.0 3.2 0.0 1.4 3.4 0.3 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 1.4 0.3 0.1 0.1 0.8 0.1 0.9 1.4 0.3 0.2 19.3 0.3 0.0 4.4 3.5 0.0 0.3 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 3.0 11.6 0.0 0.0 5.0 0.0 0.0 31.9 1.0 15.5 0.0 0.3 0.3 2.1 17.3 0.2 1.0 0.4 0.0 10.4 5.3 0.0 5.6 0.0 0.0 0.0 5.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 19.7 21.7 9.7 25.7 19.8 12.1 22.8 13.4 25.0 15.9 ADORA2A "ADORA2, RDC8" ENSG00000128271 "Adenosine A2a receptor" P29274 22 24417879-24442360 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 22.8;bone marrow: 28.1;brain: 43.9;lymphoid tissue: 59.0" "Cell line enhanced" "Detected in many" "Daudi: 15.0;Karpas-707: 20.7;RPMI-8226: 14.6;SK-BR-3: 29.7;U-266/70: 20.8;U-266/84: 27.1;U-698: 21.2" "Not detected" "Not detected" "Region enriched" "Detected in all" 8 "basal ganglia: 43.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in some" 10 "basal ganglia: 357.5" "Region enriched" "Detected in single" 95 "basal ganglia: 166.0" "CAB001943, HPA065566, HPA075997" Enhanced Supported "CAB001943: , HPA065566: , HPA075997: " "unprognostic (7.30e-2)" "unprognostic (2.42e-2)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (7.44e-2)" "unprognostic (1.88e-3)" "unprognostic (9.85e-2)" "unprognostic (3.63e-1)" "unprognostic (2.88e-2)" "unprognostic (4.57e-3)" "unprognostic (2.15e-3)" "unprognostic (1.87e-3)" "unprognostic (6.81e-4)" "unprognostic (1.50e-1)" "unprognostic (9.78e-3)" "unprognostic (1.30e-1)" "unprognostic (7.10e-3)" 1.0 2.4 1.9 10.4 43.9 28.1 1.5 3.4 3.8 0.8 2.0 1.7 0.3 5.4 1.4 1.4 1.0 0.9 2.4 3.5 2.4 1.8 3.5 4.3 5.1 14.8 2.6 1.6 1.2 0.8 0.0 2.1 1.4 2.3 1.6 0.8 3.3 2.7 1.5 1.2 0.9 2.6 0.7 1.3 7.5 2.8 2.0 5.7 59.0 1.3 0.9 8.6 3.8 1.3 17.7 1.1 13.7 9.0 2.2 22.8 11.2 0.2 0.3 0.4 0.1 0.2 0.1 0.4 0.2 9.3 0.5 0.9 1.7 0.1 15.0 1.0 0.2 0.3 0.9 0.0 0.0 1.8 2.6 0.2 0.0 2.1 0.1 0.3 7.5 0.1 0.0 2.8 0.0 3.3 0.1 20.7 0.0 0.2 5.2 1.6 0.6 0.0 0.1 0.7 14.6 0.0 0.1 1.5 8.7 0.4 29.7 0.1 0.3 1.4 0.2 0.9 1.4 0.2 0.1 20.8 27.1 21.2 4.7 5.1 0.1 3.0 0.8 4.8 8.6 2.6 20.1 9.6 16.1 16.9 1.1 17.7 22.8 18.3 13.7 2.2 9.0 1.1 21.4 11.2 1.9 43.9 3.4 3.8 2.4 1.8 2.6 1.6 2.3 5.7 ADORA3 AD026 ENSG00000282608 "Adenosine A3 receptor" P0DMS8 1 111499429-111503760 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 88.6;brain: 25.5" "Cell line enriched" "Detected in some" 9 "HMC-1: 47.5" "Cell type enriched" "Detected in some" 40 "eosinophil: 88.6" "Lineage enriched" "Detected in many" 40 "granulocytes: 88.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" 5.2 13.4 8.7 3.1 12.0 0.0 4.5 1.0 6.7 3.7 5.2 10.3 0.0 3.5 0.5 1.0 1.8 2.8 4.8 1.6 7.5 1.9 2.1 2.8 3.8 17.7 2.2 1.2 1.0 0.9 1.2 2.0 12.1 1.0 4.2 2.7 1.1 1.9 0.5 0.0 7.9 3.8 25.5 1.5 2.2 1.1 13.3 0.4 0.5 0.0 1.9 3.4 0.0 0.0 2.2 88.6 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 47.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 88.6 0.0 0.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.3 0.4 0.0 0.3 ADRA1B ENSG00000170214 "Adrenoceptor alpha 1B" P35368 5 159865080-159972544 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.6;liver: 20.3;lymphoid tissue: 17.4" "Cell line enhanced" "Detected in some" "EFO-21: 13.0;HaCaT: 6.6;TIME: 11.0;U-2 OS: 9.2;U-251 MG: 7.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074416 Supported "Plasma membrane" "Plasma membrane" "HPA074416: " "unprognostic (4.93e-3)" "unprognostic (2.94e-2)" "unprognostic (1.79e-1)" "prognostic unfavourable (6.00e-5)" "prognostic unfavourable (6.98e-4)" "unprognostic (4.08e-3)" "unprognostic (1.67e-3)" "unprognostic (1.68e-1)" "unprognostic (6.12e-2)" "prognostic favourable (2.67e-4)" "unprognostic (2.28e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (1.40e-6)" "unprognostic (5.24e-4)" "unprognostic (2.54e-1)" "prognostic favourable (3.19e-5)" "unprognostic (1.59e-2)" 5.3 2.9 5.3 0.9 9.0 0.4 2.3 1.3 21.6 0.9 1.2 0.7 0.8 1.2 1.5 3.6 1.1 3.6 1.3 3.3 6.2 5.8 7.4 20.3 4.7 2.3 1.2 13.9 6.2 0.8 1.0 0.8 1.1 5.2 1.6 1.1 0.9 1.0 1.9 1.6 1.3 1.7 1.2 0.9 17.4 0.9 0.8 0.5 0.0 2.0 0.0 1.1 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.7 0.3 0.0 2.4 0.9 0.1 0.5 0.2 0.6 0.3 0.0 4.2 0.0 13.0 3.8 6.6 0.0 0.5 0.3 0.0 0.3 0.0 1.6 0.0 5.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.6 0.0 0.7 0.0 4.5 0.0 0.4 0.0 0.0 0.3 0.4 0.1 0.0 11.0 0.1 9.2 0.0 7.0 0.0 0.0 0.0 3.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 9.0 1.3 21.6 6.2 5.8 1.2 13.9 5.2 0.5 ADRA1D "ADRA1, ADRA1A, ADRA1R" ENSG00000171873 "Adrenoceptor alpha 1D" P25100 20 4220631-4249074 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7" "Cell line enhanced" "Detected in some" "A549: 2.7;BJ: 11.7;CAPAN-2: 5.3;fHDF/TERT166: 6.9" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "cerebral cortex: 7.4;hippocampal formation: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebral cortex: 23.5;hippocampal formation: 31.8;olfactory region: 11.0" "Low region specificity" "Detected in many" HPA038789 Uncertain "HPA038789: AB_10673475" "unprognostic (5.37e-2)" "unprognostic (4.65e-1)" "unprognostic (8.73e-2)" "unprognostic (7.75e-11)" "unprognostic (7.83e-3)" "unprognostic (1.54e-2)" "unprognostic (7.62e-2)" "unprognostic (7.82e-4)" "unprognostic (4.41e-3)" "unprognostic (8.37e-2)" "unprognostic (6.09e-2)" "unprognostic (7.24e-3)" "unprognostic (7.71e-7)" "unprognostic (5.21e-3)" "unprognostic (2.76e-1)" "unprognostic (6.01e-3)" "unprognostic (3.32e-5)" 2.5 1.1 1.9 0.5 2.8 0.3 1.0 0.1 7.4 9.1 2.4 1.4 1.1 0.6 4.7 1.8 0.9 3.5 1.2 0.4 17.7 1.7 0.5 0.4 2.9 1.5 0.5 1.1 1.0 1.2 0.4 0.0 0.7 2.9 8.8 1.0 0.0 0.8 6.0 1.2 0.4 0.8 1.6 0.5 3.6 2.5 1.5 0.0 0.0 0.9 0.0 0.4 3.3 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 11.7 2.1 0.8 0.2 0.5 5.3 0.0 0.0 6.9 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.8 0.1 7.4 17.7 1.7 0.5 1.1 2.9 0.0 AF241726.2 ENSG00000250349 X 37349330-38687674 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 17.4;skeletal muscle: 16.5" "Cell line enhanced" "Detected in some" "A-431: 1.3;CACO-2: 2.0;HDLM-2: 1.7;HEK 293: 2.0;MOLT-4: 1.2;SCLC-21H: 1.5;U-266/70: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA003140 Uncertain "HPA003140: AB_1078454" 2.7 1.9 3.3 1.7 10.2 1.8 1.9 2.1 6.1 1.7 1.9 17.4 1.3 1.7 1.7 1.7 1.8 1.7 1.7 2.1 3.7 1.9 2.2 2.0 2.1 1.7 14.9 4.1 1.9 1.8 1.7 1.7 3.7 9.9 1.8 1.7 0.6 1.8 1.7 16.5 1.8 1.8 1.7 12.2 1.9 1.7 1.7 11.1 0.0 2.0 0.5 1.7 1.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.7 2.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.4 0.0 0.0 0.4 0.3 0.0 0.4 0.0 1.2 0.1 0.0 0.0 0.5 0.4 0.0 0.5 0.0 1.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.3 10.2 2.1 6.1 3.7 1.9 14.9 4.1 9.9 11.1 AFF2 "FMR2, FRAXE" ENSG00000155966 "AF4/FMR2 family member 2" P51816 X 148500619-149000663 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.6;brain: 13.6;epididymis: 15.1;pituitary gland: 17.4;placenta: 17.4" "Cell line enhanced" "Detected in some" "Daudi: 29.6;HL-60: 12.5;U-698: 43.2;U-937: 9.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 1.7;eosinophil: 2.5;neutrophil: 4.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003139 Approved "HPA003139: AB_1078107" "unprognostic (5.68e-2)" "unprognostic (1.96e-1)" "unprognostic (6.60e-2)" "unprognostic (9.29e-3)" "unprognostic (1.88e-2)" "unprognostic (3.96e-1)" "unprognostic (1.54e-1)" "unprognostic (5.00e-2)" "unprognostic (5.37e-2)" "unprognostic (1.59e-1)" "unprognostic (1.08e-2)" "unprognostic (5.31e-2)" "unprognostic (6.80e-2)" "unprognostic (9.78e-5)" "unprognostic (2.54e-2)" "unprognostic (1.23e-1)" "unprognostic (9.34e-2)" 1.9 0.6 4.2 5.3 3.7 13.6 1.1 13.6 5.9 4.8 0.4 0.2 1.2 0.2 0.8 15.1 0.5 0.6 2.9 1.3 10.7 5.2 0.7 0.3 3.6 6.3 2.3 5.9 2.0 0.5 0.2 17.4 17.4 3.9 1.0 0.3 0.2 0.8 2.1 0.4 1.3 0.5 0.3 2.4 0.8 0.4 2.8 0.0 5.5 1.1 0.0 7.3 1.0 0.7 0.1 0.0 4.5 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.6 0.0 1.7 0.0 4.6 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 12.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.6 3.8 1.1 0.0 3.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.5 0.0 1.3 0.1 0.1 43.2 0.0 9.2 0.0 1.7 0.1 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 4.5 0.0 0.0 0.0 0.0 0.0 4.2 3.7 13.6 5.9 10.7 5.2 2.3 5.9 3.9 0.0 AGAP2 CENTG1 ENSG00000135439 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 2" Q99490 12 57723761-57742157 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 55.9;lymphoid tissue: 18.8" "Cell line enhanced" "Detected in many" "HMC-1: 17.6;Karpas-707: 17.2;RH-30: 43.0" "Cancer enriched" "Detected in many" 12 "glioma: 20.6" "Group enriched" "Detected in many" 4 "amygdala: 34.3;basal ganglia: 40.2;cerebellum: 48.2;cerebral cortex: 35.4;hippocampal formation: 37.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023474, HPA075831" Enhanced Supported "Nucleoplasm,Midbody ring,Cytosol" "Nucleoplasm, Cytosol" "Midbody ring" "HPA023474: AB_1855378, HPA075831: " "unprognostic (1.87e-1)" "unprognostic (2.46e-3)" "unprognostic (9.26e-2)" "unprognostic (5.56e-4)" "unprognostic (3.95e-1)" "unprognostic (1.14e-2)" "unprognostic (5.00e-2)" "unprognostic (2.36e-2)" "unprognostic (3.39e-1)" "unprognostic (2.80e-1)" "unprognostic (1.93e-3)" "unprognostic (4.18e-1)" "unprognostic (4.81e-9)" "unprognostic (3.30e-1)" "unprognostic (2.72e-2)" "unprognostic (3.07e-1)" "unprognostic (5.75e-2)" 3.8 1.8 34.3 11.8 40.2 8.1 0.7 48.2 55.9 0.6 2.1 1.2 0.0 2.0 1.5 0.9 1.6 0.8 2.8 4.3 37.6 8.9 1.2 0.8 2.2 13.5 6.3 3.1 1.2 2.4 1.7 1.2 1.7 2.5 1.0 1.2 0.7 4.5 0.9 8.3 2.1 2.2 0.8 2.1 10.0 2.1 0.9 0.7 18.8 0.9 1.5 16.6 2.9 0.6 1.9 1.4 6.3 1.2 2.3 6.3 1.7 3.0 4.4 8.6 2.5 0.0 0.0 4.9 2.0 0.4 0.0 0.2 0.5 2.8 7.7 0.6 0.0 1.9 0.0 0.0 0.0 8.4 1.3 8.5 0.7 1.4 0.0 8.7 17.6 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 5.2 15.4 5.6 1.4 4.6 6.4 43.0 5.5 0.0 2.5 2.4 8.9 1.1 1.5 1.8 1.1 6.2 4.7 2.4 4.0 4.5 1.5 7.3 4.3 3.9 4.3 5.8 4.0 6.0 0.8 1.0 4.8 1.2 5.1 1.9 4.8 5.1 1.4 1.6 2.0 3.0 6.3 2.3 0.7 1.2 6.3 1.7 34.3 40.2 48.2 35.4 37.6 8.9 6.3 3.1 2.5 0.7 AGAP3 CENTG3 ENSG00000133612 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 3" Q96P47 7 151085831-151144436 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012883 Approved "HPA012883: AB_1846533" "unprognostic (3.63e-2)" "unprognostic (8.93e-2)" "prognostic unfavourable (9.52e-4)" "unprognostic (4.35e-2)" "unprognostic (3.27e-1)" "unprognostic (1.71e-1)" "prognostic unfavourable (6.21e-4)" "unprognostic (2.05e-2)" "unprognostic (1.55e-1)" "unprognostic (7.30e-2)" "unprognostic (2.89e-2)" "unprognostic (3.15e-3)" "prognostic unfavourable (8.58e-5)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (1.55e-2)" "unprognostic (9.50e-3)" 16.4 16.8 47.0 11.2 38.3 5.0 16.3 40.9 67.8 15.1 10.1 24.4 8.7 14.1 18.3 9.6 16.9 16.9 12.2 12.0 47.2 30.3 6.7 11.5 21.4 8.9 24.6 44.1 18.6 28.0 21.8 20.2 15.1 27.6 15.4 6.7 12.4 23.3 16.0 21.1 27.0 14.2 12.1 17.2 12.9 11.5 7.0 21.8 0.9 9.5 6.7 6.8 12.9 12.5 3.4 2.5 0.5 5.7 3.8 3.5 3.0 14.1 11.4 10.3 22.4 9.7 7.8 15.8 11.1 10.6 8.7 7.7 11.0 14.8 0.2 14.4 6.4 20.1 7.2 15.7 2.8 16.4 22.5 12.8 12.6 14.9 13.8 8.5 5.2 7.8 19.5 7.1 7.5 12.9 22.8 10.3 5.0 37.3 3.5 39.6 19.4 12.8 8.9 7.1 20.0 10.8 34.7 30.9 25.8 8.5 2.7 26.3 7.4 13.0 12.4 11.9 4.0 14.4 13.6 13.3 5.9 0.1 23.5 14.6 14.8 0.0 5.7 0.4 2.1 3.4 1.5 3.4 2.9 3.5 2.5 0.6 2.2 1.1 0.5 3.8 1.2 0.1 0.5 3.0 47.0 38.3 40.9 67.8 47.2 30.3 24.6 44.1 27.6 21.8 AGBL4 "CCP6, FLJ14442" ENSG00000186094 "ATP/GTP binding protein like 4" Q5VU57 1 48532855-50023913 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 20.4;pituitary gland: 31.5" "Cell line enhanced" "Detected in some" "NTERA-2: 3.6;SCLC-21H: 5.2;SH-SY5Y: 2.0;U-937: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA037994 Approved "HPA037994: AB_10673036" "unprognostic (3.06e-2)" "unprognostic (2.76e-1)" "unprognostic (2.58e-2)" "unprognostic (3.31e-4)" "unprognostic (3.42e-4)" "unprognostic (1.72e-1)" "unprognostic (3.86e-3)" "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (5.85e-3)" "unprognostic (3.91e-2)" "unprognostic (1.51e-4)" "unprognostic (5.95e-2)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.85e-1)" 1.4 4.5 7.8 0.8 13.6 1.1 1.5 1.3 20.4 1.0 0.8 3.0 0.1 0.7 1.0 4.5 0.9 7.8 1.0 3.7 7.1 7.2 10.2 4.6 1.6 0.8 3.2 11.6 1.3 2.7 3.6 31.5 2.7 6.7 1.0 0.7 4.6 0.8 1.5 0.9 1.5 0.8 0.7 1.5 1.3 1.1 10.7 1.9 0.0 3.4 0.0 0.8 0.7 0.7 0.8 0.5 2.2 0.3 0.6 1.8 0.2 0.0 0.5 0.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.1 0.4 3.6 0.4 0.1 0.1 0.1 0.1 0.3 5.2 2.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 1.4 0.2 0.0 0.2 0.0 0.1 0.1 2.2 0.5 2.2 0.3 0.4 0.3 0.3 1.8 0.5 0.2 0.1 0.2 0.8 0.4 0.2 1.0 0.6 0.2 0.5 0.3 0.2 7.8 13.6 1.3 20.4 7.1 7.2 3.2 11.6 6.7 1.9 AGPAT4 "dJ473J16.2, LPAAT-delta" ENSG00000026652 "1-acylglycerol-3-phosphate O-acyltransferase 4" Q9NRZ5 6 161129979-161274061 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.0" "Cell line enhanced" "Detected in many" "AF22: 19.8;HEL: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053287, HPA060525" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoli, Vesicles" "HPA053287: , HPA060525: " "unprognostic (5.69e-2)" "prognostic unfavourable (1.45e-4)" "unprognostic (1.73e-1)" "unprognostic (3.43e-2)" "unprognostic (4.14e-2)" "unprognostic (6.67e-3)" "unprognostic (1.94e-4)" "unprognostic (1.05e-1)" "unprognostic (3.42e-2)" "unprognostic (2.77e-2)" "unprognostic (1.76e-3)" "unprognostic (1.67e-1)" "prognostic unfavourable (4.08e-4)" "unprognostic (1.82e-2)" "unprognostic (8.87e-2)" "unprognostic (3.63e-4)" "unprognostic (5.51e-2)" 5.6 4.2 10.5 3.5 19.1 8.0 4.5 9.6 26.6 5.3 4.2 35.6 1.0 2.6 10.7 4.5 5.2 7.2 8.0 2.9 14.2 11.8 5.2 2.0 6.1 2.0 25.8 12.4 10.0 2.3 1.3 9.8 14.6 27.4 3.7 4.4 0.7 2.7 4.9 2.1 1.9 2.5 8.5 49.0 5.2 3.0 4.2 19.8 0.6 4.8 2.0 2.2 4.0 3.8 1.1 1.9 0.6 3.5 5.8 7.0 2.1 0.3 0.8 19.8 3.9 3.7 7.6 0.8 0.7 0.2 1.5 2.5 1.1 3.5 0.5 1.4 3.1 0.3 3.6 3.0 1.4 2.2 6.2 14.8 3.5 0.0 2.9 0.1 2.1 9.1 1.5 4.0 2.1 4.6 7.3 6.8 1.8 0.0 1.0 1.6 4.7 7.6 0.0 0.9 0.4 4.3 0.3 11.5 4.4 3.0 1.6 0.8 0.8 1.0 5.1 2.1 2.6 1.4 3.3 0.5 0.7 0.0 7.8 0.8 1.3 0.0 3.5 0.0 7.0 2.8 2.3 0.4 3.3 4.1 1.9 1.1 1.7 2.7 0.6 5.8 2.5 1.5 2.9 2.1 10.5 19.1 9.6 15.8 14.2 11.8 25.8 12.4 27.4 19.8 AGRP "Agrt, ART, ASIP2" ENSG00000159723 "Agouti related neuropeptide" O00253 16 67482571-67483813 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.4;epididymis: 49.8" "Cell line enhanced" "Detected in some" "CACO-2: 2.6;CAPAN-2: 2.7;HeLa: 1.5;Hep G2: 2.1;HMC-1: 1.8" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 13 "hypothalamus: 19.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 16 "hypothalamus: 18.9" "Region enhanced" "Detected in some" "hypothalamus: 3.9" HPA041017 Enhanced Supported "Secreted in other tissues" "HPA041017: AB_10795498" "unprognostic (1.32e-1)" "unprognostic (6.26e-2)" "unprognostic (1.13e-1)" "unprognostic (4.16e-1)" "unprognostic (3.15e-1)" "unprognostic (1.10e-1)" "unprognostic (3.61e-1)" "unprognostic (3.34e-1)" "unprognostic (4.68e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (3.17e-1)" "unprognostic (2.80e-1)" "unprognostic (1.72e-1)" "unprognostic (5.63e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-2)" 0.1 9.6 0.1 0.1 1.4 0.0 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.1 49.8 0.1 0.0 0.1 0.1 0.1 19.4 0.5 0.1 2.1 0.3 0.1 0.3 0.1 0.1 0.0 0.4 0.1 0.2 0.1 0.0 0.3 0.5 0.1 0.1 0.4 0.1 0.1 0.3 0.3 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.2 2.1 1.4 3.8 0.3 3.2 1.0 0.1 0.0 0.4 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.6 2.7 0.8 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 1.5 2.1 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.2 0.0 0.1 1.0 0.5 0.9 0.0 0.4 0.3 0.0 3.8 1.4 3.2 2.3 1.6 2.2 0.8 1.1 1.5 1.9 2.1 2.2 0.6 0.3 1.2 2.1 1.3 1.0 0.1 1.4 0.1 0.2 0.1 19.4 0.1 0.3 0.2 0.1 AIFM3 "AIFL, FLJ30473" ENSG00000183773 "Apoptosis inducing factor, mitochondria associated 3" Q96NN9 22 20965108-20981360 "Predicted intracellular proteins" "Apoptosis, Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 21.7;intestine: 28.0" "Cell line enhanced" "Detected in some" "Hep G2: 8.6;HMC-1: 12.9;T-47d: 6.2;THP-1: 8.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 7.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "classical monocyte: 2.2;intermediate monocyte: 5.7;myeloid DC: 3.8;non-classical monocyte: 3.4" "Group enriched" "Detected in many" 22 "dendritic cells: 3.8;monocytes: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001271 Approved Mitochondria Mitochondria "HPA001271: AB_1078114" "unprognostic (1.39e-1)" "unprognostic (1.97e-1)" "unprognostic (7.49e-2)" "unprognostic (9.99e-2)" "unprognostic (6.79e-2)" "unprognostic (2.03e-1)" "unprognostic (1.47e-1)" "unprognostic (2.73e-3)" "unprognostic (3.28e-1)" "unprognostic (1.56e-1)" "unprognostic (4.13e-3)" "unprognostic (5.13e-2)" "unprognostic (7.99e-2)" "unprognostic (6.78e-2)" "unprognostic (1.47e-1)" "unprognostic (3.37e-1)" "prognostic favourable (7.13e-5)" 1.3 1.3 20.3 4.6 19.0 5.4 0.8 14.4 18.4 1.2 28.0 9.7 0.0 4.3 0.9 0.8 0.9 1.2 1.6 0.9 14.6 9.9 0.9 0.8 1.5 1.4 14.8 12.4 1.0 0.9 0.9 1.9 1.3 21.7 1.2 13.0 5.0 2.2 1.9 0.7 0.9 3.4 1.9 9.6 2.7 1.6 1.1 7.6 0.0 1.0 0.0 0.8 1.9 0.1 0.2 3.8 0.0 5.7 0.0 0.0 0.9 1.2 2.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.1 0.0 1.4 0.2 0.0 0.0 0.3 0.0 2.2 0.0 8.6 0.2 0.0 12.9 0.6 0.7 0.1 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.0 1.5 1.7 1.1 1.0 0.1 0.0 6.2 8.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 5.7 0.0 0.2 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.9 20.3 19.0 14.4 18.4 14.6 9.9 14.8 12.4 21.7 7.6 AIRE "APECED, APS1, PGA1" ENSG00000160224 "Autoimmune regulator" O43918 21 44285838-44298648 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3;lymphoid tissue: 8.3" "Cell line enhanced" "Detected in some" "HMC-1: 1.3;NTERA-2: 1.1;U-87 MG: 1.3" "Cancer enriched" "Detected in single" 14 "testis cancer: 6.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038267 Uncertain "HPA038267: AB_10697247" "unprognostic (3.24e-2)" "unprognostic (2.37e-2)" "unprognostic (1.77e-2)" "unprognostic (1.56e-1)" "unprognostic (1.86e-2)" "unprognostic (2.47e-2)" "unprognostic (2.68e-1)" "unprognostic (1.37e-2)" "unprognostic (1.43e-1)" "unprognostic (8.53e-3)" "unprognostic (3.69e-3)" "unprognostic (1.79e-1)" "unprognostic (6.29e-7)" "unprognostic (5.04e-2)" "unprognostic (3.18e-1)" "unprognostic (2.27e-1)" "unprognostic (3.57e-2)" 0.3 0.3 1.4 0.9 3.4 1.3 1.2 0.2 3.5 0.5 0.3 1.0 0.0 0.0 0.4 0.8 0.4 0.3 0.2 0.5 1.0 5.3 0.4 0.2 0.6 2.3 1.1 1.8 0.3 1.1 0.0 0.3 0.1 3.6 0.4 0.0 0.2 2.2 1.2 0.5 0.3 0.8 0.1 1.3 0.5 0.8 0.4 0.4 8.3 0.3 0.0 0.2 0.2 0.2 0.4 0.3 1.3 0.3 0.3 0.6 0.2 0.1 0.0 0.4 0.1 0.3 0.2 0.0 0.5 0.0 0.0 0.1 0.3 0.3 0.1 0.3 0.0 0.3 0.2 0.6 0.0 0.3 0.3 0.0 0.6 0.3 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.3 0.0 0.3 1.1 0.0 0.1 0.0 0.5 0.0 0.7 0.3 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.3 0.3 0.3 0.8 0.0 0.3 1.3 0.2 0.3 0.8 0.3 0.1 0.5 0.3 0.1 0.3 0.2 0.0 0.0 0.4 0.1 0.6 1.3 0.3 0.2 0.3 0.2 0.2 1.4 3.4 0.2 3.5 1.0 5.3 1.1 1.8 3.6 0.4 AJAP1 "MOT8, SHREW-1, SHREW1" ENSG00000196581 "Adherens junctions associated protein 1" Q9UKB5 1 4654732-4792534 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9;ovary: 13.1" "Cell line enhanced" "Detected in some" "BEWO: 6.9;EFO-21: 6.0;hTERT-HME1: 3.5;RPTEC TERT1: 22.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "eosinophil: 4.8;plasmacytoid DC: 2.1" "Group enriched" "Detected in many" 18 "dendritic cells: 2.1;granulocytes: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.11e-1)" "unprognostic (1.40e-1)" "unprognostic (2.35e-2)" "unprognostic (2.75e-2)" "unprognostic (7.52e-2)" "unprognostic (6.81e-2)" "unprognostic (2.57e-2)" "unprognostic (6.54e-2)" "unprognostic (1.16e-1)" "unprognostic (8.87e-2)" "unprognostic (4.04e-2)" "unprognostic (3.58e-1)" "prognostic favourable (1.89e-7)" "unprognostic (2.57e-1)" "unprognostic (1.70e-1)" "unprognostic (2.50e-1)" "unprognostic (5.49e-2)" 1.4 1.8 18.9 1.1 9.9 0.9 1.1 3.8 18.0 3.0 1.2 4.7 1.6 1.4 2.8 2.5 1.3 2.4 1.2 0.8 10.8 6.0 8.2 1.0 1.2 1.2 6.3 13.4 13.1 3.1 0.9 0.7 1.5 5.5 2.3 1.1 2.2 1.3 6.7 1.3 1.2 1.2 1.6 4.1 3.2 1.3 2.6 7.2 0.0 1.2 0.0 1.2 1.3 1.1 0.0 2.1 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 2.9 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.6 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.8 0.0 0.0 0.0 0.7 22.2 0.0 1.1 0.6 0.0 2.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 18.9 9.9 3.8 14.9 10.8 6.0 6.3 13.4 5.5 7.2 AJM1 "ajm-1, C9orf172" ENSG00000232434 "Apical junction component 1 homolog" C9J069 9 136844415-136848801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.7;testis: 15.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 22.7" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 11 "dendritic cells: 3.9;monocytes: 1.6;T-cells: 1.9" "Low region specificity" "Detected in all" HPA021200 Uncertain Approved "Focal adhesion sites,Cytosol" "Focal adhesion sites, Cytosol" "HPA021200: AB_10601695" "unprognostic (3.30e-3)" "unprognostic (1.67e-1)" "unprognostic (7.68e-3)" "unprognostic (9.54e-2)" "unprognostic (2.34e-1)" "unprognostic (1.08e-2)" "unprognostic (1.27e-2)" "unprognostic (8.00e-2)" "unprognostic (6.29e-2)" "unprognostic (4.33e-1)" "unprognostic (2.72e-3)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" "unprognostic (2.71e-3)" "unprognostic (2.94e-1)" "unprognostic (6.07e-3)" "unprognostic (7.27e-2)" 1.1 1.9 4.6 1.3 6.3 1.4 1.1 22.7 7.9 1.1 4.0 1.1 1.1 3.3 1.2 1.1 1.1 0.3 1.1 1.2 4.4 3.1 1.1 1.1 1.1 1.1 2.1 1.1 1.1 7.6 1.1 5.2 1.1 1.1 2.6 1.1 1.1 2.0 2.2 3.9 1.5 4.3 1.1 1.3 3.6 2.3 15.0 1.1 1.1 1.1 1.1 1.1 2.6 1.1 0.2 3.9 0.1 1.6 0.2 1.9 0.8 3.6 2.9 0.4 1.1 0.5 0.4 4.8 2.9 0.5 0.4 0.2 1.0 2.0 2.2 2.5 0.8 4.1 0.4 1.1 0.0 5.7 2.2 0.6 5.5 0.8 1.6 1.3 4.1 0.9 1.4 0.5 0.3 0.2 3.4 1.5 0.7 4.1 0.4 4.5 1.1 3.8 2.7 0.9 7.2 0.8 0.7 7.3 2.6 1.9 7.5 3.9 5.9 2.8 3.1 5.0 3.4 1.7 1.7 6.5 4.4 0.8 8.7 4.5 1.2 0.0 1.6 0.1 1.9 1.0 0.4 0.2 0.5 0.9 1.5 0.0 0.2 0.9 0.1 0.2 1.5 3.9 0.1 0.8 4.6 6.3 22.7 6.8 4.4 3.1 2.1 1.1 1.1 1.1 AK5 ENSG00000154027 "Adenylate kinase 5" Q9Y6K8 1 77282051-77559969 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.5" "Cell line enhanced" "Detected in many" "ASC TERT1: 29.7;BJ: 20.3;fHDF/TERT166: 23.1;LHCN-M2: 58.2;U-2 OS: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 10.9;naive CD4 T-cell: 14.2" "Group enriched" "Detected in many" 15 "dendritic cells: 10.9;T-cells: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019128, HPA057255" Enhanced Supported "Centriolar satellite,Cytosol" Cytosol "Centriolar satellite" "HPA019128: AB_1844682, HPA057255: " "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (1.13e-1)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (6.04e-2)" "unprognostic (2.20e-1)" "unprognostic (2.01e-2)" "unprognostic (1.84e-1)" "unprognostic (1.51e-1)" "unprognostic (1.91e-2)" "prognostic favourable (3.88e-4)" "unprognostic (3.56e-3)" "unprognostic (6.17e-4)" "unprognostic (1.18e-1)" "unprognostic (5.96e-2)" "unprognostic (6.76e-2)" 1.8 2.1 43.8 1.9 35.7 3.7 14.1 1.3 95.5 2.0 1.8 20.4 0.0 1.8 1.6 1.5 1.8 1.8 1.7 1.5 35.8 11.8 2.0 1.2 1.4 2.5 13.0 41.1 1.5 2.1 2.4 1.4 1.8 11.4 2.7 1.8 0.0 3.1 2.7 1.3 2.4 1.7 1.7 14.2 2.4 2.9 7.3 13.9 0.0 1.7 0.0 2.1 1.5 0.4 0.8 10.9 0.7 0.7 0.1 14.2 1.9 0.0 1.1 0.8 0.0 10.9 29.7 0.4 20.3 4.3 3.3 1.4 0.1 0.5 0.1 0.1 23.1 0.1 0.0 0.0 1.7 0.7 0.2 0.1 0.1 0.0 0.5 0.1 0.0 3.6 0.1 0.6 1.3 9.5 0.2 0.2 58.2 0.2 0.0 0.1 1.1 7.4 0.5 2.1 0.3 9.0 0.3 4.5 1.1 0.0 0.0 1.2 0.1 0.1 2.3 8.0 18.2 0.4 0.6 4.7 4.2 0.0 1.6 1.0 2.9 0.7 0.7 0.0 3.4 0.1 0.5 0.8 3.2 1.6 10.9 0.8 14.2 7.8 0.5 0.1 0.2 1.2 1.4 1.9 43.8 35.7 1.3 47.1 35.8 11.8 13.0 41.1 11.4 13.9 AKAIN1 C18orf42 ENSG00000231824 "A-kinase anchor inhibitor 1" P0CW23 18 5145285-5197503 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "adrenal gland: 21.6;brain: 40.8" "Cell line enhanced" "Detected in some" "Hep G2: 1.0;Karpas-707: 1.0;NTERA-2: 2.2;SCLC-21H: 3.8;SK-MEL-30: 2.4;U-2197: 1.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "cerebellum: 40.8" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.1;T-reg: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049365 Uncertain "HPA049365: " "unprognostic (4.86e-1)" "unprognostic (1.49e-3)" "unprognostic (7.05e-2)" 0.2 21.6 0.4 0.1 0.8 0.1 0.1 40.8 3.1 0.1 0.3 0.4 0.0 0.2 0.1 0.1 0.1 0.2 0.3 0.1 5.4 0.6 0.4 2.3 0.1 0.2 1.1 0.9 0.3 1.2 1.1 3.1 0.1 3.7 0.2 0.3 0.6 0.1 0.6 0.1 0.5 0.2 0.3 1.3 0.1 0.3 1.3 0.1 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.4 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.8 40.8 3.1 5.4 0.6 1.1 0.9 3.7 0.1 AKAP14 AKAP28 ENSG00000186471 "A-kinase anchoring protein 14" Q86UN6 X 119895837-119920716 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.1;fallopian tube: 31.0;testis: 33.5" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;LHCN-M2: 2.0;REH: 1.6;SCLC-21H: 7.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.5" "Region enriched" "Detected in many" 7 "pons and medulla: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA060999 Enhanced "HPA060999: " "unprognostic (1.36e-2)" "unprognostic (2.36e-2)" "unprognostic (2.82e-2)" "unprognostic (1.25e-3)" "unprognostic (1.52e-1)" "unprognostic (1.95e-1)" "unprognostic (4.16e-1)" "unprognostic (4.68e-2)" "unprognostic (2.20e-1)" "unprognostic (1.02e-2)" "unprognostic (2.72e-1)" "unprognostic (3.73e-2)" "unprognostic (3.17e-1)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" 0.0 0.0 2.6 0.1 1.5 0.2 0.1 0.2 0.6 1.0 0.1 2.4 0.0 0.3 0.6 9.0 0.0 31.0 0.0 0.0 1.3 2.9 0.1 0.1 7.5 0.1 0.6 0.2 4.2 0.0 0.0 0.3 0.1 21.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.4 0.1 0.2 0.1 0.0 33.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.4 2.0 0.3 0.0 0.6 0.2 0.0 1.6 0.0 0.0 0.0 0.7 7.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.6 1.5 0.2 0.6 1.3 2.9 0.6 0.2 21.1 0.5 AKAP5 "AKAP75, AKAP79" ENSG00000179841 "A-kinase anchoring protein 5" P24588 14 64465499-64474503 "Plasma proteins, Predicted intracellular proteins, Transporters" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 39.1" "Cell line enhanced" "Detected in many" "CACO-2: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "basophil: 5.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 5.7" "Group enriched" "Detected in many" 5 "amygdala: 34.7;basal ganglia: 98.5;cerebral cortex: 52.2;hippocampal formation: 56.3" "CAB004308, HPA053891" Enhanced Supported Approved Nucleoplasm Nucleoplasm "CAB004308: AB_626655, HPA053891: " "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (3.44e-4)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-3)" "unprognostic (1.08e-1)" "unprognostic (3.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.02e-3)" "unprognostic (8.23e-2)" "unprognostic (1.42e-1)" "unprognostic (5.44e-2)" "unprognostic (4.49e-4)" "unprognostic (2.11e-1)" "unprognostic (2.42e-1)" "unprognostic (7.45e-2)" 0.7 0.8 17.3 2.2 39.1 1.0 1.1 2.9 21.8 0.7 5.9 0.2 0.0 1.1 2.3 0.6 1.0 0.8 1.6 0.6 9.9 1.4 2.4 1.2 3.0 2.9 1.3 9.2 0.7 0.5 1.5 1.3 1.8 0.9 1.0 6.1 0.0 0.7 1.0 0.6 1.0 2.4 2.2 0.7 2.0 1.1 0.7 1.3 0.1 1.1 0.0 2.5 1.4 0.7 0.7 0.4 5.7 0.3 0.9 1.0 0.2 1.7 1.4 1.7 1.0 0.6 0.1 5.7 1.3 0.6 1.6 2.1 14.0 4.3 1.3 2.7 1.0 0.6 3.7 0.3 1.6 2.6 3.1 4.2 2.6 1.2 0.1 0.5 0.6 0.6 0.1 1.1 0.0 0.6 0.5 1.0 1.0 1.0 3.3 0.3 1.3 0.7 4.2 0.8 0.3 2.6 1.6 4.4 2.0 1.5 0.1 0.3 1.3 0.3 0.8 1.9 5.8 0.2 2.1 2.9 3.2 3.2 1.3 0.5 0.3 5.7 0.3 0.2 1.0 0.1 0.2 0.5 0.3 0.9 0.2 0.7 0.4 0.5 0.7 0.9 0.1 0.4 0.1 0.2 17.3 39.1 2.9 19.9 9.9 1.4 1.3 9.2 0.9 1.3 AKAP6 "ADAP6, AKAP100, KIAA0311, mAKAP, PRKA6" ENSG00000151320 "A-kinase anchoring protein 6" Q13023 14 32329273-32837681 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 47.0;heart muscle: 46.6;skeletal muscle: 37.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "naive B-cell: 7.8" "Lineage enriched" "Detected in many" 6 "B-cells: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001983, HPA048741" Enhanced "CAB001983: , HPA048741: " "unprognostic (1.99e-1)" "unprognostic (9.92e-2)" "unprognostic (1.88e-1)" "unprognostic (1.37e-1)" "unprognostic (2.52e-1)" "unprognostic (4.33e-2)" "unprognostic (1.41e-4)" "unprognostic (1.81e-3)" "unprognostic (1.93e-2)" "unprognostic (4.49e-3)" "unprognostic (1.24e-3)" "unprognostic (3.54e-1)" "unprognostic (3.33e-16)" "unprognostic (8.57e-2)" "unprognostic (1.27e-1)" "unprognostic (5.14e-3)" "unprognostic (1.79e-3)" 2.1 5.9 17.9 2.9 28.0 1.2 4.5 32.5 34.3 2.3 4.1 28.3 0.0 2.3 4.2 5.9 5.6 3.2 4.0 46.6 16.8 13.7 3.4 2.6 2.8 1.3 27.5 22.2 3.0 1.5 5.3 3.1 4.5 47.0 2.5 2.7 2.3 2.6 1.8 37.0 1.8 2.8 7.3 16.5 1.4 2.1 5.5 29.8 0.0 5.0 6.6 1.4 3.2 1.4 7.8 0.8 1.2 0.3 0.3 1.2 0.5 0.6 0.9 1.2 1.1 0.2 2.0 0.3 1.4 4.1 0.2 0.5 1.3 1.1 1.5 1.1 17.3 0.9 1.3 1.5 0.6 1.4 1.1 1.4 1.8 1.2 0.6 0.1 0.4 2.0 1.5 0.0 0.5 0.1 0.3 4.6 1.2 0.8 0.8 0.3 0.2 1.2 0.8 5.5 0.6 0.5 1.4 5.9 4.7 1.2 0.8 3.7 3.3 0.1 0.3 0.2 0.9 0.9 0.5 2.9 2.5 0.6 1.8 0.1 6.1 0.5 0.3 0.1 0.1 0.2 0.2 0.5 0.1 0.4 0.4 7.8 0.8 1.2 1.2 0.3 0.2 0.8 0.1 0.5 17.9 28.0 32.5 34.3 16.8 13.7 27.5 22.2 47.0 29.8 AL035078.4 ENSG00000285283 "Reticulocalbin-1 " Q15293 11 31812391-32104665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.2" "Cell line enhanced" "Detected in many" "BJ: 62.6;RT4: 42.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA038474 Uncertain Supported "Endoplasmic reticulum" 2300000 "Endoplasmic reticulum" "HPA038474: AB_10672595" 4.7 0.9 1.6 7.5 2.4 0.0 0.3 16.2 3.2 0.3 5.9 1.7 0.3 0.9 3.8 0.3 1.7 4.3 0.3 0.3 3.1 0.4 2.8 1.4 0.3 2.2 1.9 6.1 0.3 0.0 1.8 1.6 3.0 0.3 0.8 6.9 0.3 0.3 3.3 0.0 2.4 4.6 3.6 0.5 2.2 0.3 1.0 0.3 0.5 0.3 0.7 1.9 0.3 0.6 5.3 0.4 3.5 3.2 2.1 1.7 7.3 12.2 11.8 11.3 3.4 2.0 6.6 62.6 20.8 11.0 10.2 5.9 9.4 0.0 20.6 23.6 6.4 8.8 7.1 12.1 5.0 1.4 3.6 8.9 0.7 0.0 3.1 1.5 10.4 1.3 12.1 7.9 15.5 1.2 3.8 0.1 2.5 4.8 0.0 5.0 0.1 2.7 38.9 1.5 0.0 42.4 4.9 1.8 12.2 0.8 7.5 8.9 0.1 37.1 28.2 11.9 17.0 23.9 0.0 0.0 0.1 29.9 1.2 12.8 0.0 3.5 0.0 2.1 3.4 1.9 0.6 0.2 1.8 5.3 0.1 0.3 0.9 0.4 3.2 2.0 0.6 0.0 1.7 AL109810.2 ENSG00000235710 1 231184098-231187627 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "brain: 1.4" "Cell line enriched" "Detected in single" 5 "A549: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL121758.1 ENSG00000270299 20 646626-675800 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 19.1;retina: 6.0" "Cell line enhanced" "Detected in many" "HEL: 6.5;Hep G2: 14.8;Karpas-707: 8.7;SK-BR-3: 9.1" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebral cortex: 19.1" "Group enriched" "Detected in some" 6 "naive CD8 T-cell: 1.0;neutrophil: 2.0;non-classical monocyte: 2.1" "Group enriched" "Detected in many" 14 "granulocytes: 2.0;monocytes: 2.1;T-cells: 1.0" "unprognostic (2.38e-2)" "unprognostic (1.45e-1)" "unprognostic (3.40e-2)" "unprognostic (1.26e-2)" "unprognostic (1.58e-2)" "unprognostic (9.37e-2)" "unprognostic (7.42e-3)" "unprognostic (4.14e-3)" "unprognostic (2.22e-1)" "unprognostic (3.74e-2)" "unprognostic (1.99e-2)" "unprognostic (1.87e-3)" "unprognostic (5.93e-2)" "unprognostic (1.14e-1)" "unprognostic (2.42e-2)" "unprognostic (5.00e-2)" "unprognostic (2.03e-2)" 0.3 2.4 0.9 0.0 0.8 0.3 0.3 3.6 19.1 0.3 0.3 0.8 0.0 0.0 2.9 0.0 2.3 0.3 0.9 4.7 1.0 0.9 0.3 0.4 0.4 0.3 0.7 0.0 0.3 0.4 0.0 0.5 0.4 3.3 0.4 0.0 6.0 2.2 0.0 0.7 0.7 0.4 0.0 0.8 0.5 0.6 2.6 0.2 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.1 2.0 2.1 0.0 1.0 0.0 0.3 4.4 0.0 1.9 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.6 0.4 0.7 0.3 0.0 0.0 0.0 0.8 0.0 0.5 0.1 6.5 0.9 14.8 0.0 1.2 3.4 0.0 0.0 0.7 0.0 0.0 0.4 8.7 0.0 0.0 0.0 0.0 3.2 0.2 0.0 2.1 2.8 0.0 0.5 1.0 2.5 1.5 9.1 1.6 1.1 2.7 5.3 0.9 1.2 0.0 1.5 0.5 4.2 0.3 0.4 0.1 4.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 2.0 0.0 2.1 0.0 0.0 0.0 0.9 0.8 3.6 19.1 1.0 0.9 0.7 0.0 3.3 0.2 AL136373.1 ENSG00000282881 "Uncharacterized protein LOC105378696 " 1 46532166-46533614 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.9;testis: 1.2" "Cell line enriched" "Detected in single" 16 "BEWO: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 1.2;basal ganglia: 1.6;hypothalamus: 1.4" 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 AL138694.1 ENSG00000283384 13 108335354-108448316 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.1;brain: 7.4" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" 0.0 0.4 3.6 0.7 2.8 2.0 0.8 0.0 7.4 0.0 0.2 0.2 0.0 0.2 0.7 2.0 0.5 1.1 0.4 0.6 2.0 0.1 0.0 0.6 0.8 0.0 3.2 1.2 0.6 0.5 0.0 0.3 0.4 0.4 0.5 0.0 0.7 0.7 0.9 2.4 0.3 0.3 0.0 0.8 1.2 1.7 0.0 0.0 1.6 0.0 0.1 0.0 0.0 2.2 1.4 4.1 1.4 1.8 1.7 0.2 0.7 0.2 1.7 2.3 1.5 1.5 0.5 0.6 0.6 0.5 0.4 1.3 1.6 1.2 0.9 1.2 0.7 0.8 0.5 0.8 1.0 0.5 0.5 1.8 1.5 2.9 1.6 1.4 1.0 1.3 0.4 0.7 1.0 1.5 1.5 1.7 1.0 4.6 2.3 1.7 1.2 0.9 0.8 0.4 2.1 1.3 1.8 0.8 0.6 0.7 0.9 1.5 1.7 0.4 1.3 0.7 1.7 0.8 1.2 1.0 1.3 1.6 2.0 2.2 3.3 1.4 1.1 1.0 0.7 0.8 1.2 0.9 0.8 0.4 2.2 1.2 1.7 4.1 1.8 0.8 1.4 0.4 0.2 AL590132.1 ENSG00000284299 1 210858125-211134146 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "brain: 17.5" "Cell line enhanced" "Detected in some" "RH-30: 2.1;SH-SY5Y: 4.7;SK-MEL-30: 3.0;T-47d: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" 0.8 1.3 5.3 1.3 11.4 0.6 0.6 16.5 17.5 0.6 0.7 2.6 0.0 0.7 0.7 0.6 0.6 0.6 0.6 0.6 3.1 0.7 0.6 0.6 0.7 0.0 6.3 0.6 0.6 0.8 0.2 0.6 1.2 0.7 0.7 0.0 0.8 0.6 1.5 0.6 0.6 0.6 0.0 0.7 0.7 0.7 1.1 0.0 0.6 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.3 0.0 0.4 0.1 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.2 0.0 0.2 2.1 0.1 0.1 0.0 0.2 4.7 0.0 0.2 3.0 2.0 0.0 0.0 0.7 0.2 1.1 0.6 0.0 0.0 0.0 0.6 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL592490.1 ENSG00000197991 13 61409858-61427849 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "brain: 1.6;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062669 Approved "Vesicles,Cytokinetic bridge" Vesicles "Cytokinetic bridge" "HPA062669: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL662899.1 ENSG00000204422 6 31686962-31714072 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.8;brain: 5.3" "Cell line enriched" "Detected in single" 25 "HEL: 10.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 2.9;cerebral cortex: 5.3;hippocampal formation: 1.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "unprognostic (1.83e-1)" "unprognostic (2.84e-1)" "unprognostic (3.49e-1)" 0.1 0.0 2.9 0.1 0.5 3.8 0.1 0.1 5.3 0.4 0.7 0.1 0.1 0.0 0.5 0.7 0.9 0.2 0.4 0.1 1.8 0.2 0.1 0.1 1.1 0.1 0.1 0.1 0.6 0.1 0.3 0.2 0.1 0.7 0.1 0.5 0.1 0.2 0.1 0.1 2.7 0.1 0.1 0.1 1.7 0.0 0.9 0.1 0.6 2.3 0.1 0.1 0.1 0.8 0.8 1.3 2.9 1.5 0.7 0.9 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.6 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 1.3 1.7 0.9 1.5 0.6 0.5 0.6 0.6 1.3 0.8 0.4 0.4 2.9 0.7 1.4 1.1 0.6 1.5 2.9 0.5 0.1 5.3 1.8 0.2 0.1 0.1 0.7 0.1 ALDOC ENSG00000109107 "Aldolase, fructose-bisphosphate C" P09972 17 28573115-28577264 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 166.7;heart muscle: 56.9" "Cell line enhanced" "Detected in many" "RPMI-8226: 62.2;U-266/70: 42.9" "Cancer enriched" "Detected in all" 6 "glioma: 128.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003282, CAB020828, HPA067442" Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" 280000000 "Nucleoplasm, Nucleoli fibrillar center" "Vesicles, Cytosol" "CAB020828: , HPA003282: AB_1078130, HPA067442: " "unprognostic (2.90e-1)" "unprognostic (4.45e-3)" "unprognostic (5.69e-3)" "unprognostic (1.43e-1)" "unprognostic (3.56e-1)" "prognostic unfavourable (9.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (6.03e-3)" "unprognostic (3.90e-1)" "unprognostic (3.24e-2)" "prognostic unfavourable (1.29e-7)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.74e-2)" "unprognostic (1.23e-1)" 26.0 9.4 86.7 4.8 78.9 7.5 9.8 100.1 166.7 3.8 5.3 17.4 0.3 7.0 4.4 4.6 7.1 3.9 4.4 56.9 64.6 54.3 3.3 26.2 4.6 6.5 69.9 51.4 12.8 1.6 4.7 2.3 2.1 98.1 6.0 5.6 16.5 4.2 6.1 1.7 12.5 15.0 4.6 34.4 6.7 8.7 4.6 23.4 0.0 2.1 0.5 10.0 3.4 3.5 12.2 4.6 8.8 4.1 13.7 20.5 8.8 7.4 0.5 3.5 14.4 7.2 7.4 0.7 3.8 8.6 2.9 18.1 4.3 0.7 3.5 4.6 3.4 9.7 2.3 23.6 5.5 3.0 2.2 6.7 2.7 7.4 6.8 2.4 7.8 6.8 3.3 0.3 5.9 1.3 4.6 18.8 2.5 3.5 2.8 8.1 5.4 3.9 2.4 0.4 62.2 0.4 1.0 9.2 16.4 2.2 17.7 0.1 9.6 5.5 0.9 0.3 1.4 0.5 0.6 42.9 12.3 2.6 28.1 7.0 0.5 0.1 3.5 1.4 11.4 4.1 16.2 12.2 15.6 9.2 4.6 11.5 20.5 15.1 8.8 13.7 2.3 2.2 19.5 8.8 86.7 78.9 100.1 78.5 64.6 54.3 69.9 51.4 98.1 23.4 ALK CD246 ENSG00000171094 "ALK receptor tyrosine kinase" Q9UM73 2 29192774-29921566 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.1;pituitary gland: 17.9" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 26.4" "Group enriched" "Detected in some" 5 "glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010694 Approved Supported "Plasma membrane" "Plasma membrane" "HPA010694: AB_1078133" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.56e-7)" "unprognostic (7.17e-2)" "unprognostic (1.71e-1)" "unprognostic (9.07e-3)" "unprognostic (6.29e-3)" "unprognostic (1.18e-1)" "unprognostic (1.01e-1)" "unprognostic (2.67e-4)" "unprognostic (3.70e-2)" "unprognostic (2.06e-2)" "unprognostic (7.15e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (3.61e-2)" 1.8 3.1 3.6 1.2 4.4 0.3 1.1 0.5 8.1 0.7 2.1 2.0 0.0 0.7 0.5 0.5 0.6 0.5 1.2 0.4 3.4 4.9 0.4 0.5 1.1 0.5 2.7 4.2 0.6 0.4 0.4 17.9 0.5 5.5 0.5 1.2 2.4 0.9 0.8 0.3 0.9 1.5 0.9 2.1 0.5 0.8 4.9 0.9 0.0 1.6 0.0 0.3 0.6 1.2 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 3.5 0.0 0.0 0.1 0.3 26.4 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 4.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 4.4 0.5 5.9 3.4 4.9 2.7 4.2 5.5 0.9 ALS2 ALS2CR6 ENSG00000003393 "ALS2, alsin Rho guanine nucleotide exchange factor" Q96Q42 2 201700554-201781189 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.8" "Cell line enhanced" "Detected in many" "HMC-1: 52.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 66.8" "Group enriched" "Detected in many" 6 "basophil: 19.0;eosinophil: 5.5" "Lineage enriched" "Detected in all" 10 "granulocytes: 19.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 158.8" HPA046588 Enhanced Approved "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA046588: " "unprognostic (3.43e-2)" "unprognostic (2.11e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-3)" "unprognostic (2.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.04e-3)" "unprognostic (9.17e-2)" "unprognostic (4.16e-2)" "unprognostic (1.52e-1)" "unprognostic (2.99e-1)" "unprognostic (2.83e-2)" "unprognostic (1.09e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (2.10e-1)" "unprognostic (1.84e-1)" 6.9 5.3 8.2 4.2 14.7 7.8 8.1 66.8 15.6 5.9 5.6 10.1 5.5 7.4 10.3 10.7 4.7 6.7 6.4 19.9 8.3 7.3 10.4 18.3 7.9 4.1 6.8 11.0 6.8 5.6 8.8 16.8 7.2 13.6 6.6 6.0 8.5 5.2 5.5 12.2 6.9 8.4 7.4 8.3 5.3 6.7 6.1 9.0 3.5 7.5 5.9 4.5 5.5 5.3 1.2 1.0 19.0 1.2 1.7 1.8 0.7 5.1 3.6 8.8 8.2 6.0 6.5 6.5 9.1 12.4 12.2 14.1 8.4 5.1 0.6 4.0 9.5 5.3 5.0 9.2 15.4 1.7 5.0 12.1 3.5 4.8 7.4 9.6 52.8 5.6 5.2 10.2 8.8 12.2 5.7 3.6 9.2 4.1 3.4 12.6 7.3 5.5 2.8 4.9 1.8 7.7 7.0 4.1 5.4 5.3 5.8 8.2 3.7 4.0 7.3 10.7 5.1 3.7 4.6 4.1 5.6 2.1 7.8 1.9 6.8 19.0 0.7 5.5 1.7 1.2 1.8 1.2 1.2 1.2 1.0 1.2 1.3 1.5 0.6 1.7 0.8 0.5 1.8 0.7 8.2 14.7 66.8 15.6 8.3 7.3 6.8 11.0 13.6 9.0 ALS2CR12 ENSG00000155749 "Amyotrophic lateral sclerosis 2 chromosome region 12" Q96Q35 2 201288271-201357398 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.3;epididymis: 14.4;testis: 29.9" "Cell line enhanced" "Detected in many" "SK-MEL-30: 6.9;U-2197: 9.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 14.3" "Cell type enhanced" "Detected in many" "neutrophil: 7.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035793 Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA035793: AB_10602429" "unprognostic (1.45e-1)" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (2.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.40e-3)" "unprognostic (1.40e-5)" "unprognostic (1.37e-1)" "unprognostic (3.62e-2)" "unprognostic (1.14e-1)" "unprognostic (6.23e-2)" "unprognostic (1.13e-1)" "unprognostic (2.73e-2)" "unprognostic (2.23e-1)" "unprognostic (8.25e-2)" 0.8 0.9 1.5 0.7 3.6 4.3 0.5 0.7 1.1 0.9 0.6 7.6 0.4 0.3 0.7 14.4 1.1 9.9 0.9 4.7 2.1 2.6 1.3 0.7 3.7 1.4 1.0 1.3 5.3 0.7 1.2 1.3 0.9 14.3 0.4 0.9 0.5 0.7 0.7 1.4 1.1 0.9 0.9 0.9 0.8 0.5 29.9 1.3 0.4 1.7 0.4 0.5 0.6 0.4 1.8 0.5 7.3 1.1 2.8 1.5 0.4 0.3 0.4 2.0 1.4 5.6 2.2 0.1 1.5 0.5 1.2 0.8 0.0 0.4 0.7 1.2 2.1 2.0 0.7 0.2 0.6 1.2 0.2 0.3 2.5 0.7 1.1 2.1 1.8 1.0 0.5 1.3 0.3 0.2 1.0 2.9 1.2 0.0 1.1 1.8 0.6 1.2 0.5 1.0 1.3 0.7 0.5 0.5 1.3 1.6 0.0 6.9 1.5 2.4 1.5 2.8 1.7 9.4 1.0 1.6 3.0 1.0 2.7 1.0 1.3 5.4 1.1 1.0 1.5 0.5 0.7 0.6 1.0 0.9 0.5 1.8 1.2 1.4 7.3 2.8 0.6 0.4 0.6 0.4 1.5 3.6 0.7 1.0 2.1 2.6 1.0 1.3 14.3 1.3 AMBN ENSG00000178522 Ameloblastin Q9NP70 4 70592256-70607288 "Disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 10.6" "Cell line enriched" "Detected in some" 8 "HEK 293: 12.1" "Group enriched" "Detected in some" 7 "cervical cancer: 2.6;endometrial cancer: 2.9" "Region enriched" "Detected in some" 5 "basal ganglia: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036099 Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "HPA036099: " "unprognostic (3.22e-1)" 0.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 2.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.1 0.0 1.2 0.2 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 10.6 0.0 2.0 0.0 0.4 0.1 0.0 0.4 2.0 AMER2 "FAM123A, FLJ25477" ENSG00000165566 "APC membrane recruitment protein 2" Q8N7J2 13 25161684-25172288 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "brain: 57.0" "Group enriched" "Detected in some" 6 "AF22: 5.9;SCLC-21H: 5.0;U-266/70: 11.3" "Cancer enriched" "Detected in single" 24 "glioma: 4.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039458 Enhanced "HPA039458: AB_10795677" "unprognostic (1.69e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-3)" "unprognostic (2.32e-1)" "unprognostic (3.00e-3)" "unprognostic (5.00e-3)" "unprognostic (7.28e-2)" "unprognostic (2.34e-2)" "unprognostic (5.90e-4)" "unprognostic (1.60e-2)" "unprognostic (1.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.13e-1)" "unprognostic (1.34e-1)" 1.2 1.4 15.5 1.2 33.5 1.2 1.2 11.7 57.0 1.2 1.2 24.7 0.0 1.2 1.2 1.2 1.2 2.2 1.2 1.2 19.9 9.7 1.2 1.2 1.2 1.2 41.9 9.2 1.2 1.2 1.1 1.6 1.2 15.8 1.4 1.2 0.0 1.2 1.5 1.4 1.3 1.2 1.2 15.9 1.2 1.2 2.0 47.8 0.0 1.2 0.0 1.2 1.2 0.0 0.4 0.4 1.1 0.4 0.7 0.3 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.4 0.0 0.2 0.0 0.1 1.1 0.3 0.2 0.2 0.3 0.3 0.3 0.2 0.2 0.1 0.4 0.3 0.3 0.9 0.7 0.4 0.4 0.3 0.0 15.5 33.5 11.7 20.9 19.9 9.7 41.9 9.2 15.8 47.8 AMER3 "FAM123C, FLJ38377" ENSG00000178171 "APC membrane recruitment protein 3" Q8N944 2 130755435-130768134 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.1" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 15.0" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Region enhanced" "Detected in many" "cerebellum: 30.1" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045593, HPA054230" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA045593: AB_10965021, HPA054230: " "unprognostic (6.68e-2)" "unprognostic (3.73e-1)" "unprognostic (2.17e-2)" "unprognostic (1.83e-1)" "unprognostic (2.71e-1)" "unprognostic (5.33e-3)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (6.46e-3)" 0.5 2.4 4.8 0.7 6.0 0.8 0.5 30.1 13.9 0.5 0.8 0.0 0.0 2.0 0.6 0.5 0.5 0.5 0.5 0.5 2.7 4.3 0.5 0.5 0.5 0.6 1.8 5.6 0.6 3.3 0.4 3.4 0.5 3.0 0.6 0.8 0.7 0.5 0.5 0.5 0.7 1.2 0.5 0.8 0.6 2.5 1.6 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.3 0.3 1.5 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 15.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.1 0.2 1.5 0.2 0.1 0.3 0.1 0.0 4.8 6.0 30.1 10.3 2.7 4.3 1.8 5.6 3.0 0.7 AMIGO1 "AMIGO, KIAA1163" ENSG00000181754 "Adhesion molecule with Ig like domain 1" Q86WK6 1 109504175-109509738 "Predicted membrane proteins, Transporters" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.9" "Cell line enhanced" "Detected in many" "SK-BR-3: 12.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "gdT-cell: 1.5;MAIT T-cell: 1.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 2.5;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.9;NK-cell: 1.9;T-reg: 1.5" "Group enriched" "Detected in many" 21 "NK-cells: 1.9;T-cells: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046152 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA046152: " "unprognostic (1.35e-1)" "unprognostic (3.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-2)" "prognostic unfavourable (1.21e-4)" "unprognostic (2.44e-2)" "unprognostic (9.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.16e-3)" "unprognostic (3.11e-1)" "unprognostic (9.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" 5.3 14.8 11.8 3.7 19.1 1.0 4.7 23.4 33.9 4.8 6.6 4.8 4.0 3.2 5.7 16.4 4.1 4.9 4.3 11.0 12.2 14.3 7.6 3.5 6.4 5.2 9.9 15.0 12.8 9.2 21.1 8.1 3.0 15.6 9.2 3.7 10.3 9.6 11.1 22.4 3.3 4.1 6.5 6.0 4.6 5.0 4.1 5.3 1.7 9.1 1.9 4.6 4.5 3.8 0.1 0.0 0.0 0.1 1.9 5.4 0.9 2.5 1.2 2.7 9.3 3.5 1.5 3.3 4.3 2.2 5.0 2.4 0.5 0.1 0.2 1.2 2.7 1.4 7.2 0.3 4.2 1.0 0.6 0.0 1.7 0.8 2.9 2.1 5.3 0.7 3.2 1.7 0.0 1.2 2.0 0.0 0.1 4.3 0.4 4.3 1.6 2.9 0.7 0.0 0.3 5.8 1.2 9.4 3.1 1.0 12.3 3.5 3.6 3.0 1.1 0.1 5.8 3.4 1.8 0.2 0.0 0.0 1.8 0.0 2.7 0.0 0.0 0.0 1.5 0.1 1.6 0.1 2.2 2.5 0.0 0.0 5.4 3.9 0.0 1.9 0.0 0.0 1.5 0.9 11.8 19.1 23.4 33.9 12.2 14.3 9.9 15.0 15.6 5.3 AMPH ENSG00000078053 Amphiphysin P49418 7 38383704-38631567 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 57.2" "Cell line enhanced" "Detected in some" "ASC diff: 31.8;ASC TERT1: 18.8;BJ hTERT+ SV40 Large T+: 12.3;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HBF TERT88: 11.3;HSkMC: 11.0;U-138 MG: 12.1;WM-115: 10.8" "Cancer enhanced" "Detected in many" "glioma: 3.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008559, HPA019828, HPA019829" Enhanced Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802" "unprognostic (1.76e-2)" "unprognostic (1.59e-1)" "unprognostic (5.94e-2)" "unprognostic (7.36e-2)" "unprognostic (3.24e-3)" "unprognostic (2.92e-1)" "unprognostic (4.90e-2)" "unprognostic (2.55e-2)" "unprognostic (4.37e-1)" "unprognostic (1.08e-1)" "prognostic favourable (9.96e-4)" "unprognostic (5.06e-2)" "unprognostic (5.81e-5)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (8.03e-2)" "unprognostic (1.68e-3)" 3.8 2.4 17.4 2.5 17.7 1.0 2.8 29.7 57.2 7.7 2.2 1.8 0.0 1.4 5.1 4.7 4.5 5.7 4.2 6.5 13.5 16.0 3.7 1.4 1.6 1.3 10.4 20.4 1.7 2.9 1.2 12.6 1.0 26.5 2.4 2.5 4.8 1.5 4.2 2.9 1.3 1.9 5.0 4.9 1.9 2.0 3.5 1.5 0.0 1.2 0.2 1.1 2.9 1.7 0.2 1.6 0.0 0.8 0.7 2.9 0.2 0.0 0.0 8.0 0.0 31.8 18.8 0.0 1.1 0.0 12.3 14.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 11.3 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 11.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.1 0.0 0.1 4.0 0.0 0.0 0.0 0.9 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.1 8.5 4.2 4.5 0.0 0.1 0.0 8.2 0.1 10.8 0.0 0.8 0.0 2.9 0.2 1.7 0.0 1.0 1.5 0.2 0.2 0.4 2.0 0.0 0.7 0.2 1.6 0.2 0.2 17.4 17.7 29.7 32.9 13.5 16.0 10.4 20.4 26.5 1.5 AMZ1 KIAA1950 ENSG00000174945 "Archaelysin family metallopeptidase 1" Q400G9 7 2679522-2775500 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.0" "Cell line enhanced" "Detected in some" "BEWO: 6.1;MCF7: 6.3;SK-BR-3: 4.5;T-47d: 23.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 4.2;naive B-cell: 2.4;T-reg: 1.0" "Group enriched" "Detected in many" 6 "B-cells: 4.2;T-cells: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA020233 Uncertain "HPA020233: AB_1844818" "unprognostic (9.08e-3)" "unprognostic (1.66e-1)" "unprognostic (3.23e-3)" "unprognostic (1.81e-1)" "unprognostic (5.72e-2)" "unprognostic (7.79e-2)" "unprognostic (2.02e-2)" "unprognostic (3.42e-1)" "unprognostic (1.98e-1)" "unprognostic (7.16e-3)" "unprognostic (1.08e-1)" "unprognostic (1.21e-1)" "unprognostic (3.64e-9)" "unprognostic (1.60e-3)" "unprognostic (1.60e-1)" "unprognostic (1.44e-1)" "unprognostic (1.13e-1)" 0.7 0.7 8.4 1.2 7.1 2.0 0.9 1.4 10.0 3.2 0.6 6.5 0.0 0.8 4.0 0.6 0.7 1.4 1.0 0.9 5.9 4.9 0.5 1.2 2.8 1.2 6.0 4.8 1.4 0.8 0.7 1.1 3.6 4.2 0.8 0.7 0.2 0.6 0.6 0.6 0.8 0.6 3.3 3.8 2.0 0.7 1.4 4.4 0.0 0.7 0.0 1.8 0.7 0.7 4.2 0.1 0.4 0.1 0.1 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 6.1 1.9 2.9 1.4 1.9 0.0 0.8 0.5 0.2 1.8 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.4 0.0 6.3 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 4.5 0.0 23.9 0.0 0.0 0.1 0.1 0.1 0.0 0.9 0.2 0.0 0.5 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.0 4.2 0.1 0.0 0.0 2.4 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.1 8.4 7.1 1.4 8.7 5.9 4.9 6.0 4.8 4.2 4.4 ANK2 LQT4 ENSG00000145362 "Ankyrin 2" Q01484 4 112818109-113383740 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9" "Cell line enhanced" "Detected in many" "ASC diff: 16.1;ASC TERT1: 22.5;RH-30: 30.8;SH-SY5Y: 15.5" "Cancer enhanced" "Detected in many" "glioma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008007, CAB015178, HPA035970" Enhanced Approved Supported "Plasma membrane" "Plasma membrane" "CAB015178: AB_2242828, HPA008007: , HPA035970: " "unprognostic (8.33e-2)" "unprognostic (9.47e-2)" "unprognostic (1.33e-2)" "unprognostic (7.63e-2)" "unprognostic (2.73e-1)" "unprognostic (1.71e-1)" "unprognostic (1.54e-1)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (1.63e-1)" "unprognostic (1.79e-3)" "unprognostic (2.94e-2)" "prognostic unfavourable (2.41e-6)" "unprognostic (1.18e-2)" "unprognostic (3.16e-1)" "unprognostic (1.51e-3)" "unprognostic (2.04e-3)" 17.3 8.7 34.0 6.3 42.1 0.8 10.7 43.7 58.5 20.9 9.5 24.5 0.6 4.3 10.5 4.3 8.3 5.8 13.0 56.7 29.4 30.3 59.8 2.0 4.6 5.1 28.7 38.7 19.0 2.4 1.6 8.6 2.0 42.1 5.4 7.2 7.8 2.6 8.7 66.9 3.5 4.7 15.2 19.0 15.1 3.8 5.8 24.2 0.0 5.6 4.4 4.5 4.5 4.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 10.2 4.2 16.1 22.5 0.0 1.0 1.8 0.7 2.0 4.0 0.0 4.2 1.4 3.6 0.0 7.5 0.4 0.6 1.9 6.2 2.4 0.0 1.7 1.0 1.0 0.7 9.6 1.6 0.9 3.9 0.0 0.0 6.9 3.4 0.1 0.2 0.0 5.3 1.7 0.5 30.8 0.0 0.1 0.0 8.3 15.5 0.1 0.3 5.3 0.1 0.6 0.0 3.2 1.7 0.2 1.9 4.1 1.1 0.6 12.7 0.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 42.1 43.7 54.3 29.4 30.3 28.7 38.7 42.1 24.2 ANK3 ENSG00000151150 "Ankyrin 3" Q12955 10 60026298-60733490 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism spectrum disorder, Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 95.4;parathyroid gland: 74.4" "Cell line enhanced" "Detected in many" "RT4: 24.3;SK-BR-3: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "CAB013249, CAB015179, HPA038455" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: " "unprognostic (1.91e-1)" "unprognostic (5.33e-3)" "unprognostic (6.76e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (3.70e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (1.89e-1)" "unprognostic (1.21e-2)" "unprognostic (3.83e-1)" "unprognostic (2.28e-2)" "prognostic favourable (8.88e-16)" "unprognostic (5.75e-2)" "unprognostic (2.59e-1)" "unprognostic (1.00e-1)" "unprognostic (2.83e-2)" 2.7 3.1 21.1 3.1 24.8 1.1 9.1 95.4 29.1 5.5 10.5 21.5 19.4 15.7 9.7 52.9 7.1 8.2 8.9 31.2 24.4 16.4 38.9 6.6 10.1 2.5 26.8 19.8 5.2 5.0 74.4 10.5 31.9 31.9 8.6 8.8 6.5 16.1 19.4 29.2 16.0 10.6 5.9 16.5 5.9 6.3 3.4 30.0 0.6 17.2 4.6 3.4 5.6 6.6 6.2 3.5 1.7 0.4 2.1 7.7 1.3 4.1 2.4 15.0 0.2 0.0 0.9 11.6 0.3 0.2 0.0 0.3 10.7 8.1 0.2 4.9 0.3 5.9 8.0 7.2 0.2 0.2 5.4 0.1 4.6 0.0 3.1 0.0 0.2 7.4 4.6 3.8 0.2 1.7 2.0 10.1 3.4 13.8 0.0 0.4 6.8 13.0 0.0 10.8 2.0 2.7 24.3 7.8 1.4 0.3 24.4 0.0 14.2 0.0 4.9 0.4 1.5 6.6 0.7 0.4 0.0 0.0 2.7 0.1 9.3 1.7 0.4 0.6 4.1 0.3 3.7 6.2 7.0 2.2 0.2 1.9 7.7 1.9 1.1 2.1 0.4 3.5 1.0 1.3 21.1 24.8 95.4 29.1 24.4 16.4 26.8 19.8 31.9 30.0 ANKFN1 FLJ38335 ENSG00000153930 "Ankyrin repeat and fibronectin type III domain containing 1" Q8N957 17 55882301-56511659 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9" "Cell line enhanced" "Detected in some" "HeLa: 7.9;MOLT-4: 16.4;T-47d: 5.7;U-2197: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA021566, HPA022538, HPA048953" Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: " "unprognostic (6.64e-2)" "unprognostic (1.29e-1)" "unprognostic (3.52e-2)" "unprognostic (9.38e-5)" "unprognostic (2.39e-1)" "unprognostic (2.31e-3)" "unprognostic (3.84e-2)" "unprognostic (1.68e-1)" "unprognostic (3.31e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-2)" "unprognostic (6.81e-3)" "unprognostic (3.44e-8)" "unprognostic (1.24e-1)" "unprognostic (1.69e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-2)" 3.9 1.0 5.5 0.5 10.2 0.5 1.2 2.6 4.7 19.9 0.7 11.4 0.5 0.7 0.8 3.4 0.7 10.9 0.9 0.5 6.8 4.6 0.7 0.6 2.0 0.6 6.3 3.7 0.5 0.5 0.5 1.0 2.1 11.8 0.9 0.8 0.0 0.7 0.8 0.6 5.2 0.8 0.5 7.5 0.6 1.1 3.6 10.0 0.0 0.6 0.0 0.5 3.2 5.3 0.2 0.5 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.3 0.0 2.8 0.2 0.3 0.0 0.1 0.3 0.2 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.1 7.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.1 0.1 0.4 16.4 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 1.5 0.0 1.7 0.0 0.3 5.7 0.0 0.0 0.0 0.4 5.5 0.1 1.5 0.3 0.0 0.8 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.1 0.3 0.1 0.5 0.0 0.0 5.5 10.2 2.6 4.7 6.8 4.6 6.3 3.7 11.8 10.0 ANKLE1 "ANKRD41, FLJ39369, LEMD6" ENSG00000160117 "Ankyrin repeat and LEM domain containing 1" Q8NAG6 19 17281645-17287646 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.6;brain: 8.3;lymphoid tissue: 12.9" "Cell line enhanced" "Detected in many" "Daudi: 30.2;HL-60: 13.3;NB-4: 17.0;U-937: 23.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.3" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.3" "Group enriched" "Detected in many" 4 "B-cells: 3.0;dendritic cells: 2.2;monocytes: 4.3" "Low region specificity" "Detected in many" "HPA026789, HPA073498" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA026789: AB_10611675, HPA073498: " "unprognostic (5.66e-2)" "unprognostic (2.21e-1)" "unprognostic (6.90e-2)" "prognostic unfavourable (4.86e-5)" "unprognostic (2.73e-1)" "unprognostic (1.72e-3)" "unprognostic (2.19e-2)" "unprognostic (2.09e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "unprognostic (7.89e-4)" "unprognostic (5.86e-2)" "unprognostic (0.00e+0)" "unprognostic (2.03e-1)" "unprognostic (1.61e-1)" "unprognostic (2.00e-3)" "unprognostic (4.30e-2)" 0.6 0.5 1.0 12.9 3.1 22.6 0.6 8.3 1.4 0.7 0.7 0.6 0.2 0.3 0.9 1.3 0.5 0.8 0.5 0.2 1.0 1.2 0.5 0.5 1.3 3.7 1.6 0.7 1.7 0.2 0.6 0.9 1.1 1.4 1.0 0.5 0.4 0.7 0.6 0.9 1.4 1.2 0.9 1.2 5.7 0.3 1.0 0.5 8.9 0.6 0.2 5.3 1.0 0.7 3.0 2.2 0.7 4.3 0.0 0.4 0.8 0.1 0.3 1.5 0.7 0.0 0.3 1.4 0.5 0.1 0.3 0.2 6.9 0.4 30.2 0.3 0.1 0.6 11.7 0.1 0.2 9.1 1.5 12.3 4.8 0.0 0.1 13.3 5.1 0.1 0.4 1.2 0.0 0.2 1.6 3.6 0.1 0.2 9.1 17.0 3.7 1.0 7.3 0.0 3.1 0.1 0.1 0.4 2.7 2.9 0.2 0.2 0.0 8.7 0.5 0.1 0.5 0.5 0.3 0.3 0.3 10.7 0.1 23.7 0.6 0.0 1.8 0.7 0.0 4.3 0.0 3.0 0.0 0.4 2.2 1.7 0.1 0.0 0.0 0.0 3.1 1.1 0.0 0.8 1.0 3.1 8.3 1.4 1.0 1.2 1.6 0.7 1.4 0.5 ANKRD13B FLJ25555 ENSG00000198720 "Ankyrin repeat domain 13B" Q86YJ7 17 29589769-29614761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.9" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.1;SH-SY5Y: 31.6;SK-BR-3: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051886, HPA063748" Uncertain Supported Vesicles Vesicles "HPA051886: AB_2681652, HPA063748: " "unprognostic (1.61e-1)" "unprognostic (2.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.66e-2)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (3.10e-4)" "unprognostic (1.84e-1)" "unprognostic (1.84e-1)" "unprognostic (1.03e-2)" "prognostic favourable (7.58e-4)" "unprognostic (3.94e-2)" "prognostic unfavourable (5.92e-6)" "unprognostic (9.93e-2)" "unprognostic (1.18e-1)" "unprognostic (3.94e-2)" "unprognostic (5.36e-3)" 8.0 6.6 10.2 4.2 14.3 2.6 12.0 34.9 28.6 7.2 4.2 16.4 2.6 2.7 12.3 3.5 5.4 9.9 7.5 6.4 12.4 9.3 1.7 1.1 3.9 3.6 14.7 10.0 10.5 3.6 5.5 6.9 2.7 7.7 5.2 2.7 3.4 4.8 4.8 8.5 10.0 3.3 8.2 13.7 3.1 3.5 16.1 12.7 2.0 2.8 2.2 2.2 7.2 8.5 0.7 0.3 0.0 0.0 0.1 1.6 0.1 3.6 7.7 8.2 17.4 4.6 4.3 2.7 0.9 0.6 1.4 1.6 3.5 0.6 4.1 3.4 1.6 13.6 4.8 4.0 0.2 6.9 16.4 2.2 15.1 2.9 1.7 1.9 2.4 4.0 5.2 1.4 2.7 6.0 3.4 3.4 1.4 3.5 10.3 4.9 6.6 6.0 16.6 5.0 11.5 1.7 1.6 28.1 31.6 3.0 24.3 2.8 3.9 2.4 4.3 3.7 4.0 3.9 3.6 5.7 7.4 5.0 2.5 6.7 2.6 0.0 0.0 0.0 0.2 0.0 0.8 0.7 0.0 1.6 0.3 0.1 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.1 10.2 14.3 34.9 17.5 12.4 9.3 14.7 10.0 7.7 12.7 ANKRD18A "FLJ35740, KIAA2015" ENSG00000180071 "Ankyrin repeat domain 18A" Q8IVF6 9 38571358-38620660 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "bone marrow: 24.4;brain: 11.1;testis: 19.1" "Cell line enhanced" "Detected in many" "HL-60: 16.9;THP-1: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Supported Nucleoli,Cytosol Nucleoli Cytosol "HPA046346: , HPA046695: , HPA049923: , HPA051288: " "unprognostic (4.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (1.26e-1)" "unprognostic (2.37e-1)" "unprognostic (4.34e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-2)" "unprognostic (1.94e-5)" "unprognostic (2.31e-2)" "unprognostic (1.63e-2)" "unprognostic (1.58e-2)" "unprognostic (7.03e-2)" "unprognostic (2.14e-1)" 0.5 0.7 1.4 0.8 9.1 24.4 1.1 0.4 4.1 1.0 2.1 8.5 2.4 0.9 0.7 1.1 1.4 1.2 2.7 1.1 3.0 2.2 1.5 1.2 1.5 0.8 4.8 2.3 0.4 4.1 2.5 3.2 0.7 8.7 1.6 1.5 0.4 0.9 3.9 0.4 2.4 1.5 0.7 11.1 0.5 2.0 19.1 6.9 0.0 3.8 0.0 0.5 0.7 0.8 0.4 0.0 1.1 0.0 0.1 1.7 0.1 4.6 3.6 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 2.0 0.0 0.9 3.5 3.3 0.0 0.0 4.8 0.0 4.8 2.8 0.0 16.9 0.4 0.0 2.3 0.0 3.1 0.0 1.6 0.4 0.3 4.3 0.1 0.8 3.7 2.1 0.0 6.4 6.4 2.1 1.9 1.5 3.0 2.3 0.5 0.1 2.5 8.0 4.4 0.0 1.3 0.1 0.0 0.3 0.5 0.0 0.0 0.0 2.0 0.0 0.0 1.1 0.5 0.0 0.7 0.0 1.3 0.8 0.0 0.4 0.7 1.7 0.5 0.1 0.0 0.0 1.0 0.1 1.4 9.1 0.4 4.1 3.0 2.2 4.8 2.3 8.7 6.9 ANKRD18B bA255A11.3 ENSG00000230453 "Ankyrin repeat domain 18B" A2A2Z9 9 33524394-33573009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.9;testis: 26.9" "Cell line enhanced" "Detected in many" "NB-4: 20.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA046346: , HPA046695: , HPA049923: , HPA051288: " "unprognostic (4.71e-2)" "unprognostic (1.85e-1)" "unprognostic (4.85e-3)" "unprognostic (1.00e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.29e-4)" "unprognostic (1.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.65e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-2)" "unprognostic (6.43e-5)" "unprognostic (4.89e-2)" "unprognostic (9.75e-4)" "unprognostic (8.25e-2)" "unprognostic (5.18e-2)" 1.5 0.9 4.3 0.1 0.4 0.2 1.3 12.9 3.9 0.3 0.2 0.2 0.1 0.0 0.5 1.0 2.1 1.0 0.9 0.3 2.1 1.3 0.1 0.4 0.7 0.1 1.0 1.4 0.1 0.1 0.1 1.6 1.3 2.6 2.0 0.3 0.2 0.2 0.1 1.4 5.5 0.2 0.1 1.0 0.9 0.0 26.9 0.1 0.1 0.9 1.6 0.7 1.2 1.1 0.5 0.8 0.1 0.2 0.0 0.8 0.1 7.4 8.4 0.7 0.2 0.3 1.4 0.7 1.6 1.7 2.1 2.3 1.5 0.2 0.2 0.4 0.2 1.7 4.5 1.6 2.8 0.1 4.5 8.1 9.8 3.1 0.0 2.7 0.6 1.1 4.5 2.9 7.5 3.8 4.4 2.1 2.6 1.2 0.2 20.5 7.2 3.7 0.0 10.3 1.5 1.2 1.8 0.2 7.2 3.4 0.3 0.5 5.9 10.0 3.8 1.7 7.5 3.4 2.9 1.2 0.8 0.1 0.8 0.1 1.2 0.0 0.1 0.1 0.3 0.1 0.7 0.4 0.2 0.6 0.0 0.5 0.4 0.8 0.1 0.0 0.2 0.8 0.1 0.1 4.3 0.4 12.9 3.9 2.1 1.3 1.0 1.4 2.6 0.1 ANKRD24 KIAA1981 ENSG00000089847 "Ankyrin repeat domain 24" Q8TF21 19 4183354-4224814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Cell line enhanced" "Detected in some" "Karpas-707: 5.5;U-266/70: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 9 "B-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041534, HPA048498" Uncertain Uncertain Microtubules,Cytosol "Microtubules, Cytosol" "HPA041534: , HPA048498: " "unprognostic (3.70e-2)" "unprognostic (3.96e-3)" "unprognostic (5.23e-9)" "unprognostic (7.03e-2)" "unprognostic (5.01e-2)" "unprognostic (2.31e-1)" "prognostic favourable (9.13e-5)" "unprognostic (1.53e-1)" "unprognostic (3.52e-2)" "unprognostic (3.41e-2)" "unprognostic (1.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.27e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-4)" 1.4 2.1 6.0 0.8 8.5 1.1 1.2 1.4 22.1 1.0 1.1 0.8 0.1 1.9 1.0 2.1 0.5 1.4 1.3 0.6 5.1 4.4 1.8 5.5 1.1 1.0 4.1 9.4 1.4 3.3 2.4 3.8 1.9 2.3 4.3 0.9 1.0 1.7 1.7 2.5 1.1 1.5 0.7 2.3 1.5 1.6 7.3 1.8 0.1 1.9 0.1 0.6 0.6 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 3.2 0.3 3.3 0.2 0.0 0.0 0.0 0.1 0.1 0.1 2.0 0.4 0.1 0.1 0.5 0.0 2.4 0.3 0.1 0.1 0.1 1.8 0.1 0.3 1.7 0.1 0.3 0.8 0.1 0.1 5.5 0.0 0.7 0.0 0.1 2.4 0.7 0.4 0.0 0.4 0.0 0.2 0.9 0.2 0.1 0.1 0.3 0.7 0.4 0.0 0.1 1.2 0.9 0.0 18.5 1.6 0.1 0.8 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.0 8.5 1.4 22.1 5.1 4.4 4.1 9.4 2.3 1.8 ANKRD33B ENSG00000164236 "Ankyrin repeat domain 33B" A6NCL7 5 10564330-10657816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.3" "Cell line enhanced" "Detected in many" "HDLM-2: 27.1;HMC-1: 18.3" "Cancer enhanced" "Detected in many" "renal cancer: 7.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.1;memory B-cell: 1.4" "Group enriched" "Detected in many" 4 "B-cells: 1.4;granulocytes: 2.1" "Group enriched" "Detected in many" 9 "amygdala: 13.6;basal ganglia: 16.9;cerebral cortex: 26.5;hippocampal formation: 22.4;olfactory region: 16.5" "Group enriched" "Detected in many" 6 "amygdala: 13.7;basal ganglia: 24.2;cerebral cortex: 30.1;hippocampal formation: 25.2;olfactory region: 26.0" HPA056974 Uncertain Approved Mitochondria Mitochondria "HPA056974: " "unprognostic (6.19e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-2)" "unprognostic (5.65e-3)" "unprognostic (2.84e-2)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (4.50e-3)" "unprognostic (4.41e-1)" "unprognostic (2.42e-3)" "unprognostic (1.14e-1)" "unprognostic (1.00e-1)" "prognostic favourable (4.16e-5)" "unprognostic (1.17e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (5.47e-2)" 3.8 1.1 6.3 8.6 9.3 13.2 3.6 1.4 25.3 5.2 3.2 0.1 0.4 0.9 7.8 1.1 3.3 5.4 1.9 7.0 8.4 2.3 10.0 1.5 3.0 5.4 2.0 7.5 1.7 2.7 0.5 1.7 3.5 1.3 3.5 2.0 12.7 2.3 4.4 9.0 11.3 3.3 6.9 1.7 11.1 3.1 5.2 1.1 7.2 1.6 12.5 7.2 4.9 16.6 1.4 0.0 2.1 0.0 0.0 0.4 0.4 2.5 3.7 0.2 0.3 8.9 4.2 11.3 0.7 1.2 1.5 1.8 4.6 2.0 13.8 12.7 2.3 2.5 1.3 1.2 1.7 27.1 0.9 5.5 3.3 0.0 4.1 4.1 18.3 2.1 0.9 0.8 5.1 1.9 1.2 6.8 0.4 0.0 0.1 5.0 3.0 1.1 1.1 2.8 0.4 5.1 1.8 0.0 0.1 0.0 0.2 0.4 0.0 5.2 5.4 0.9 5.5 4.6 1.3 7.9 8.6 1.2 0.2 6.7 0.3 0.0 0.0 2.1 0.2 0.0 0.0 1.4 0.4 0.1 0.0 0.8 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.4 6.3 9.3 1.4 25.3 8.4 2.3 2.0 7.5 1.3 1.1 ANKRD34A ANKRD34 ENSG00000272031 "Ankyrin repeat domain 34A" Q69YU3 1 145959442-145964582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 18.1" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.4" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.5;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029642, HPA029643" Uncertain Enhanced Cytosol Cytosol "HPA029642: AB_10599277, HPA029643: AB_10601878" "unprognostic (1.98e-1)" "unprognostic (5.66e-2)" "unprognostic (1.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-2)" "unprognostic (4.36e-2)" "unprognostic (1.41e-1)" "unprognostic (2.51e-1)" "unprognostic (3.19e-1)" "unprognostic (2.15e-2)" "unprognostic (6.68e-3)" "unprognostic (9.66e-8)" "unprognostic (6.36e-2)" "unprognostic (9.01e-2)" "unprognostic (1.76e-1)" "unprognostic (9.23e-2)" 0.8 1.3 6.4 2.0 10.5 0.3 0.6 7.8 18.1 0.9 0.7 1.2 0.0 1.6 1.5 1.2 0.9 0.7 1.1 1.7 4.2 0.5 0.2 0.7 1.4 0.4 6.7 1.6 0.5 2.0 1.2 0.5 5.7 1.7 0.4 1.3 0.8 2.2 2.3 0.8 1.6 1.6 0.0 1.4 1.1 0.5 1.0 0.0 0.6 0.0 1.5 0.9 0.0 1.5 0.4 0.6 0.3 0.3 3.5 1.0 1.4 0.7 0.7 2.4 3.5 2.7 0.3 2.7 5.1 0.6 1.7 0.2 0.8 2.7 0.3 3.4 0.6 1.1 0.8 0.4 5.8 1.7 0.2 2.1 0.0 0.5 0.3 2.3 2.4 0.3 2.2 2.5 0.9 1.3 6.3 4.0 2.5 1.1 0.8 0.3 3.0 0.3 0.6 12.4 1.1 0.1 3.4 2.5 0.5 0.1 1.6 3.6 0.4 0.8 6.2 4.2 5.3 1.3 4.4 8.4 0.4 6.1 2.2 0.4 0.0 0.1 0.6 3.5 0.3 2.6 1.5 1.7 1.9 0.4 1.4 2.3 3.4 0.3 0.3 0.0 0.1 1.7 1.0 ANKRD34B DP58 ENSG00000189127 "Ankyrin repeat domain 34B" A5PLL1 5 80556755-80570488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 31.0" "Cell line enriched" "Detected in some" 29 "RPTEC TERT1: 45.8" "Cancer enhanced" "Detected in some" "prostate cancer: 2.3" "Region enriched" "Detected in many" 6 "basal ganglia: 31.0" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043327 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA043327: AB_10794180" "unprognostic (1.05e-1)" "unprognostic (4.16e-6)" "unprognostic (2.07e-4)" "unprognostic (1.05e-1)" "unprognostic (3.03e-1)" "unprognostic (8.25e-4)" "unprognostic (6.44e-2)" "unprognostic (1.80e-1)" "unprognostic (9.41e-2)" "unprognostic (6.52e-3)" "unprognostic (1.93e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.94e-2)" 0.1 0.3 0.9 1.5 31.0 5.7 0.3 0.0 0.9 0.5 0.1 0.4 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.0 4.1 2.8 0.1 0.2 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.2 0.0 0.3 0.2 0.0 0.1 0.1 0.2 0.4 1.0 0.1 1.0 5.1 0.0 0.1 0.0 4.6 0.1 0.0 0.0 0.0 7.2 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 45.8 0.0 0.1 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 0.9 31.0 0.0 0.9 1.0 4.1 1.2 0.2 0.7 5.1 ANKRD34C ENSG00000235711 "Ankyrin repeat domain 34C" P0C6C1 15 79293285-79298235 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 5.8;skin 1: 3.0" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 13.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045329 Uncertain Approved Mitochondria Mitochondria "HPA045329: " "unprognostic (3.20e-1)" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.42e-3)" "unprognostic (5.31e-2)" "unprognostic (2.48e-1)" 0.5 0.3 0.6 0.0 0.5 0.0 0.0 5.8 5.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.9 5.0 0.1 0.0 0.3 0.0 2.4 0.0 0.7 0.1 1.2 0.0 0.1 0.1 0.0 0.2 0.2 3.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ANKRD40 MGC15396 ENSG00000154945 "Ankyrin repeat domain 40" Q6AI12 17 50693190-50707924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021668, HPA021759, HPA074884" Uncertain Approved "Nucleoli fibrillar center,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoli fibrillar center, Cytosol" "HPA021668: AB_1844843, HPA021759: AB_2227411, HPA074884: " "unprognostic (2.73e-1)" "unprognostic (1.82e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (4.99e-1)" "unprognostic (2.03e-2)" "prognostic unfavourable (7.02e-4)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (3.84e-2)" "unprognostic (1.53e-1)" "unprognostic (4.77e-2)" "unprognostic (1.00e-2)" "unprognostic (9.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" 25.1 13.0 39.1 9.3 44.1 4.4 20.2 13.7 27.0 12.3 11.3 42.9 7.8 7.4 14.6 9.2 11.9 9.2 10.4 14.8 42.1 29.0 11.5 11.2 14.1 9.6 58.5 15.1 13.8 10.9 19.0 4.9 14.4 26.1 12.2 10.7 7.6 8.8 16.7 59.2 7.8 7.7 17.9 67.2 12.2 9.1 6.4 34.1 4.7 10.9 8.6 8.9 10.6 16.4 9.5 13.3 6.6 10.8 9.6 13.8 3.8 18.8 18.2 16.5 16.6 23.8 19.8 14.5 17.0 18.8 20.0 18.9 38.5 9.7 20.1 23.9 21.8 10.7 23.5 13.9 32.7 18.4 15.1 27.4 11.9 18.8 13.1 19.0 11.6 16.9 14.2 19.4 24.4 15.6 15.4 20.2 16.4 14.8 23.7 6.9 18.2 17.2 16.2 29.8 14.3 15.6 16.3 8.7 24.5 9.5 13.1 18.2 15.0 12.7 19.0 27.2 21.5 14.0 21.7 21.4 19.5 18.2 14.9 7.4 22.1 6.6 7.1 2.8 10.9 10.3 12.4 9.5 12.2 12.3 6.6 9.4 11.5 13.8 1.8 9.6 10.8 13.3 8.5 3.8 39.1 44.1 13.7 27.0 42.1 29.0 58.5 15.1 26.1 34.1 ANKRD45 "CT117, FLJ45235" ENSG00000183831 "Ankyrin repeat domain 45" Q5TZF3 1 173609561-173669862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8" "Cell line enhanced" "Detected in some" "AF22: 11.8;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.2;SH-SY5Y: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031655, HPA031656, HPA031657" Enhanced Approved "Plasma membrane,Centrosome,Cytosol" Cytosol "Plasma membrane, Centrosome" "HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196" "unprognostic (1.93e-1)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-1)" "unprognostic (3.57e-2)" "unprognostic (2.69e-3)" "unprognostic (4.15e-2)" "unprognostic (6.93e-2)" "unprognostic (2.45e-1)" "unprognostic (3.05e-2)" "unprognostic (4.49e-2)" "unprognostic (8.80e-3)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (1.61e-1)" 0.5 1.3 5.9 0.4 14.6 0.5 0.6 1.1 7.0 2.8 0.7 9.0 1.3 0.4 3.3 2.5 0.5 24.8 1.0 0.9 7.7 4.7 2.7 0.5 2.8 0.4 2.4 5.3 2.4 1.0 16.8 7.9 0.4 9.2 1.9 0.5 1.8 0.4 1.2 0.4 0.4 0.5 2.4 2.7 1.3 0.5 20.8 4.2 0.0 1.3 0.0 0.4 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.4 11.8 0.0 0.0 0.9 2.0 0.1 4.2 3.8 6.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.5 0.0 2.3 0.0 0.1 0.2 0.2 0.5 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.3 0.4 0.0 1.6 10.7 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.1 0.9 0.0 2.2 0.1 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.9 14.6 1.1 7.0 7.7 4.7 2.4 5.3 9.2 4.2 ANKRD55 FLJ11795 ENSG00000164512 "Ankyrin repeat domain 55" Q3KP44 5 56099678-56233359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 14.3;brain: 20.0;liver: 5.7;lymphoid tissue: 6.1;testis: 16.7" "Group enriched" "Detected in some" 6 "HEL: 23.9;HMC-1: 12.4;NB-4: 15.7" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 12.6;eosinophil: 13.1;naive CD4 T-cell: 14.3" "Group enriched" "Detected in many" 67 "granulocytes: 13.1;T-cells: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051049, HPA061649" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" "Nucleoplasm, Nuclear speckles" Cytosol "HPA051049: , HPA061649: " "unprognostic (1.00e-4)" "unprognostic (1.58e-4)" "unprognostic (2.63e-1)" "unprognostic (1.93e-1)" "unprognostic (7.78e-4)" "unprognostic (1.46e-3)" "unprognostic (1.47e-1)" "unprognostic (1.33e-2)" "unprognostic (1.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.33e-1)" "unprognostic (1.40e-1)" "unprognostic (7.19e-6)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (1.01e-1)" 0.9 0.5 3.3 1.3 20.0 1.4 0.5 0.5 6.7 0.3 0.5 1.5 0.0 0.5 0.3 0.2 0.6 0.6 0.8 0.4 4.3 7.8 1.1 5.7 0.6 6.1 2.3 3.5 0.5 0.3 0.2 0.5 1.4 9.9 0.3 0.7 0.7 2.1 0.3 0.3 0.9 2.4 0.5 4.1 3.0 0.7 16.7 1.8 0.0 0.4 0.0 3.8 1.0 0.3 0.0 0.0 13.1 0.2 0.0 14.3 2.1 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.1 0.9 0.0 1.1 12.4 0.0 0.0 0.0 0.0 3.0 1.9 0.8 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.3 12.6 0.2 13.1 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 14.3 0.5 1.2 0.0 0.0 0.0 0.6 2.1 3.3 20.0 0.5 6.7 4.3 7.8 2.3 3.5 9.9 1.8 ANKRD6 KIAA0957 ENSG00000135299 "Ankyrin repeat domain 6" Q9Y2G4 6 89433170-89633834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.8" "Cell line enhanced" "Detected in many" "AF22: 10.0;BEWO: 30.6;HAP1: 9.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.0;intermediate monocyte: 2.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020693, HPA035694, HPA064642" Approved Enhanced Vesicles Vesicles "CAB020693: , HPA035694: , HPA064642: " "unprognostic (3.80e-1)" "unprognostic (3.16e-2)" "unprognostic (2.39e-3)" "unprognostic (2.03e-1)" "unprognostic (1.36e-1)" "unprognostic (3.06e-2)" "unprognostic (2.91e-2)" "unprognostic (3.29e-2)" "unprognostic (4.95e-2)" "unprognostic (2.09e-1)" "unprognostic (7.84e-2)" "unprognostic (2.26e-1)" "unprognostic (1.81e-1)" "unprognostic (1.43e-3)" "unprognostic (2.28e-1)" "unprognostic (3.01e-1)" "unprognostic (2.10e-1)" 3.9 2.2 11.7 3.0 7.8 1.6 3.9 47.8 17.8 5.7 2.9 2.8 1.1 1.0 6.1 4.4 4.9 11.7 5.7 8.9 7.8 9.1 5.4 4.5 5.7 2.5 4.2 12.0 15.6 4.3 9.3 4.2 4.3 7.3 3.6 1.1 6.6 7.7 2.3 4.0 1.9 1.8 5.4 5.0 2.0 2.6 6.1 3.7 2.0 5.6 3.3 2.5 4.4 4.0 0.3 0.1 3.0 2.9 0.6 1.0 0.3 0.0 1.2 10.0 4.2 0.1 0.4 30.6 0.1 0.1 0.0 0.6 0.3 0.8 0.0 1.0 0.0 0.0 9.1 5.1 0.4 0.0 6.8 3.6 0.0 0.3 0.1 0.0 1.4 0.6 1.4 0.0 0.0 1.0 0.3 2.3 0.0 1.1 0.1 0.3 2.8 1.0 3.6 0.0 0.0 1.5 5.1 6.6 2.3 0.8 6.7 3.3 1.9 2.2 0.0 1.6 0.6 0.1 0.8 0.3 0.0 0.0 0.1 0.0 1.2 0.0 0.4 3.0 1.0 2.9 0.0 0.0 0.7 0.0 0.1 0.3 0.3 0.4 0.7 0.6 0.0 0.0 0.2 0.3 11.7 7.8 47.8 11.6 7.8 9.1 4.2 12.0 7.3 3.7 ANKRD63 ENSG00000230778 "Ankyrin repeat domain 63" C9JTQ0 15 40281444-40282586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 22.4" "Cell line enhanced" "Detected in some" "EFO-21: 2.1;HEK 293: 5.4;HEL: 2.6;NB-4: 1.9;SCLC-21H: 2.0;THP-1: 3.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 8 "basal ganglia: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 50.7" "Region enhanced" "Detected in many" "basal ganglia: 40.3" "unprognostic (9.36e-2)" "unprognostic (7.45e-2)" "unprognostic (8.32e-2)" "unprognostic (4.42e-1)" 0.2 0.2 1.8 0.4 22.4 0.2 0.2 0.3 4.7 0.2 0.2 0.0 0.0 0.2 0.3 0.2 0.2 0.7 0.3 0.5 0.3 0.4 1.3 0.2 0.2 0.3 0.3 1.1 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.5 0.2 0.0 0.7 0.3 0.7 1.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.1 0.0 0.0 0.4 0.0 0.0 0.0 5.4 2.6 1.1 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.2 1.9 0.2 0.4 1.4 0.0 0.4 0.0 0.1 2.0 0.2 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 22.4 0.3 2.8 0.3 0.4 0.3 1.1 0.0 1.8 ANKRD65 ENSG00000235098 "Ankyrin repeat domain 65" E5RJM6 1 1418420-1421769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;fallopian tube: 33.6" "Group enriched" "Detected in some" 7 "Hep G2: 19.9;RT4: 19.5;SCLC-21H: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "myeloid DC: 4.8;plasmacytoid DC: 10.4" "Lineage enriched" "Detected in single" 20 "dendritic cells: 10.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065720 Enhanced Approved Nucleoplasm Nucleoplasm "HPA065720: " "unprognostic (2.17e-2)" "unprognostic (2.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.77e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-2)" "unprognostic (1.59e-1)" "prognostic favourable (1.08e-5)" "unprognostic (1.64e-1)" "unprognostic (4.39e-1)" "unprognostic (1.16e-1)" "unprognostic (4.43e-2)" "unprognostic (5.14e-2)" "unprognostic (3.02e-3)" "unprognostic (1.81e-2)" "unprognostic (8.04e-2)" "unprognostic (2.76e-2)" 4.6 1.1 12.4 2.8 20.8 0.4 4.2 8.0 13.3 6.7 4.8 21.0 3.7 2.2 4.0 5.6 6.7 33.6 2.7 2.2 12.0 8.6 1.9 0.9 9.9 7.1 37.8 8.2 6.9 13.3 1.1 0.6 6.3 13.7 8.9 1.8 2.1 14.0 21.2 2.8 4.8 2.1 3.8 16.7 1.4 4.3 3.1 28.0 4.2 1.8 1.0 6.3 13.2 3.3 0.5 10.4 0.3 0.3 0.0 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.5 2.6 0.2 2.5 0.0 0.3 0.2 0.0 0.0 19.9 0.5 0.0 0.0 0.2 3.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 2.6 0.0 0.0 19.5 27.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 4.8 0.5 0.1 0.4 0.0 0.0 0.0 10.4 0.0 0.2 12.4 20.8 8.0 13.3 12.0 8.6 37.8 8.2 13.7 28.0 ANKRD66 ENSG00000230062 "Ankyrin repeat domain 66" B4E2M5 6 46746917-46759506 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 15.0;epididymis: 12.1;fallopian tube: 36.0;ovary: 11.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Region enhanced" "Detected in many" "pons and medulla: 15.0" "Cell type enriched" "Detected in single" 6 "myeloid DC: 1.0" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.67e-3)" "unprognostic (2.52e-1)" "unprognostic (2.44e-2)" "unprognostic (2.03e-2)" "unprognostic (9.36e-2)" "unprognostic (4.30e-3)" "unprognostic (2.19e-1)" 0.1 0.2 2.0 0.2 4.3 0.1 0.2 0.0 0.6 1.7 0.1 5.9 0.0 0.1 0.9 12.1 0.1 36.0 0.1 0.1 3.0 3.0 0.1 0.1 7.1 0.2 0.0 0.0 11.1 0.1 0.1 0.5 0.2 15.0 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.2 0.9 1.9 0.0 0.2 0.1 0.2 0.2 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.3 0.0 0.6 3.0 3.0 0.0 0.0 15.0 1.9 ANKS1B "AIDA-1, ANKS2, cajalin-2, EB-1" ENSG00000185046 "Ankyrin repeat and sterile alpha motif domain containing 1B" Q7Z6G8 12 98726457-99984654 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 66.2;skeletal muscle: 28.2" "Cell line enhanced" "Detected in some" "AF22: 11.8;ASC TERT1: 7.0;SCLC-21H: 12.9" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA044628, HPA078230" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "HPA044628: , HPA078230: " "unprognostic (5.50e-2)" "unprognostic (3.26e-2)" "unprognostic (1.01e-2)" "unprognostic (6.87e-3)" "unprognostic (1.18e-1)" "unprognostic (1.14e-4)" "unprognostic (7.94e-2)" "unprognostic (2.47e-1)" "unprognostic (1.84e-2)" "unprognostic (3.03e-2)" "unprognostic (4.97e-4)" "unprognostic (2.81e-1)" "unprognostic (1.14e-3)" "unprognostic (1.64e-2)" "unprognostic (1.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.75e-3)" 2.3 4.5 21.4 1.7 41.2 1.2 3.7 21.0 66.2 3.3 2.3 27.5 0.0 1.5 3.3 2.4 3.9 4.4 2.2 2.2 28.3 17.3 5.4 1.8 2.0 1.6 20.3 24.8 9.7 2.1 1.9 4.4 2.7 16.0 4.1 2.1 0.1 3.8 3.7 28.2 1.9 1.6 3.3 25.8 2.0 1.8 7.6 23.0 0.0 6.3 0.0 1.3 2.1 0.8 2.1 2.4 5.3 3.1 3.1 8.3 1.3 0.3 2.5 11.8 2.8 4.8 7.0 0.7 0.0 1.2 0.9 0.9 0.2 0.9 1.0 0.5 1.7 0.5 0.1 0.1 0.2 1.4 0.8 0.1 0.8 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.3 0.3 0.9 0.2 0.7 0.5 0.5 3.4 2.2 0.8 0.0 0.3 0.1 0.0 12.9 1.4 1.1 3.8 1.5 4.4 0.1 0.1 1.0 1.1 0.7 0.7 0.1 0.7 0.6 1.1 0.3 1.1 5.3 1.4 2.1 1.7 2.1 2.5 1.9 2.9 1.6 1.3 2.1 2.4 2.3 3.9 3.1 3.1 2.4 8.3 1.3 21.4 41.2 21.0 27.9 28.3 17.3 20.3 24.8 16.0 23.0 ANKS6 "ANKRD14, FLJ36928, NPHP16, SAMD6" ENSG00000165138 "Ankyrin repeat and sterile alpha motif domain containing 6" Q68DC2 9 98731329-98796965 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008355 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA008355: AB_2058277" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (9.31e-2)" "unprognostic (9.15e-3)" "unprognostic (6.90e-3)" "unprognostic (1.22e-1)" "unprognostic (4.29e-3)" "unprognostic (4.10e-2)" "unprognostic (1.48e-1)" "unprognostic (3.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.94e-2)" "prognostic favourable (3.44e-5)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (3.95e-2)" "unprognostic (2.68e-1)" 5.0 3.7 5.8 4.3 9.9 1.8 4.8 31.2 9.5 7.3 6.5 9.4 2.6 5.9 6.0 7.4 7.5 7.8 7.7 2.9 6.9 6.1 7.7 1.8 7.2 3.4 10.1 4.4 9.6 18.1 10.0 2.8 2.8 11.4 3.6 7.3 4.2 3.1 3.5 3.3 4.4 5.4 8.9 6.1 2.5 7.7 6.1 9.2 1.8 13.4 2.4 4.5 5.4 6.4 0.9 0.0 0.0 0.1 0.0 2.1 0.2 5.4 8.3 7.7 13.4 6.4 5.2 5.2 4.0 6.9 4.5 5.4 4.6 4.0 10.2 3.1 5.7 16.5 5.6 6.8 2.4 14.2 5.8 2.5 5.0 1.9 6.3 1.3 1.7 6.4 8.5 6.2 6.3 5.1 17.2 2.4 3.4 9.1 0.5 2.6 12.1 9.1 6.8 19.1 0.8 8.2 3.4 5.0 5.7 1.7 9.9 4.5 0.0 2.8 5.2 4.8 5.2 12.9 3.9 4.8 8.0 1.7 6.7 4.6 6.8 0.0 0.1 0.0 1.3 0.0 0.7 0.9 0.7 2.1 0.0 0.6 1.8 0.9 0.0 0.0 0.0 0.0 1.1 0.2 5.8 9.9 31.2 9.5 6.9 6.1 10.1 4.4 11.4 9.2 ANLN "ANILLIN, scra, Scraps" ENSG00000011426 "Anillin actin binding protein" Q9NQW6 7 36389806-36453791 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.4;lymphoid tissue: 32.7" "Cell line enhanced" "Detected in many" "HBF TERT88: 98.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005680, CAB033902, HPA050556, CAB062547, CAB068175" Enhanced Enhanced Nucleoplasm,Midbody Nucleoplasm Midbody "CAB033902: AB_2058302, CAB062547: , CAB068175: , HPA005680: , HPA050556: " "unprognostic (4.23e-2)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "prognostic unfavourable (1.73e-4)" "unprognostic (1.67e-2)" "unprognostic (3.44e-2)" "prognostic unfavourable (5.97e-7)" "prognostic unfavourable (6.99e-5)" "unprognostic (2.69e-2)" "unprognostic (3.66e-2)" "prognostic unfavourable (2.00e-6)" "unprognostic (3.13e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (5.29e-2)" "unprognostic (1.34e-1)" "unprognostic (2.94e-2)" "unprognostic (4.04e-3)" 1.7 0.6 13.9 7.2 10.5 20.9 1.3 1.8 36.7 1.9 3.9 1.6 0.0 2.9 1.3 2.4 12.8 0.6 1.4 0.6 24.0 12.1 0.7 0.8 3.3 4.2 30.5 2.5 0.9 0.4 0.3 0.3 12.9 9.7 0.7 5.5 0.0 0.9 0.3 0.4 8.9 3.4 9.4 63.4 1.6 3.3 9.2 12.5 32.7 0.6 17.7 6.7 2.6 1.3 0.0 0.3 0.6 0.9 0.0 1.7 2.0 67.1 14.1 11.7 8.9 1.6 4.1 12.7 42.4 24.8 51.2 38.4 9.6 20.8 3.4 12.3 21.4 34.6 9.2 24.8 98.4 2.2 6.7 4.6 15.9 8.0 0.2 6.6 5.4 0.9 1.1 33.3 22.0 15.9 9.7 7.1 41.7 10.1 5.6 7.7 13.0 15.0 4.1 35.3 2.2 11.3 11.0 5.0 5.9 22.3 25.9 3.9 17.5 7.6 15.1 32.1 36.1 18.9 49.5 3.0 4.7 6.2 10.9 10.7 67.3 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.9 0.5 0.3 0.0 0.6 0.0 0.6 0.0 0.3 0.2 1.7 2.0 13.9 10.5 1.8 7.7 24.0 12.1 30.5 2.5 9.7 12.5 ANO3 "C11orf25, DYT23, GENX-3947, TMEM16C" ENSG00000134343 "Anoctamin 3" Q9BYT9 11 26309599-26663288 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "brain: 83.1;epididymis: 47.3" "Cell line enhanced" "Detected in some" "HDLM-2: 10.3;U-2 OS: 2.8;U-2197: 7.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "basal ganglia: 83.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 142.2" "Region enriched" "Detected in many" 5 "basal ganglia: 149.8" HPA041629 Uncertain "HPA041629: AB_10793969" "unprognostic (7.01e-3)" "unprognostic (4.31e-1)" "unprognostic (2.94e-1)" "unprognostic (9.29e-2)" "unprognostic (9.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.35e-1)" "unprognostic (2.75e-2)" "unprognostic (1.66e-1)" "unprognostic (2.45e-2)" "unprognostic (7.02e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-4)" "unprognostic (9.48e-3)" "unprognostic (3.50e-2)" "unprognostic (4.33e-1)" "unprognostic (4.01e-1)" 2.8 1.2 6.4 0.5 83.1 0.4 0.6 0.2 13.3 1.1 0.6 0.1 0.0 0.6 0.6 47.3 0.5 0.7 2.0 0.5 7.0 0.6 1.4 1.4 0.8 0.5 1.1 5.4 0.5 0.7 0.5 0.3 0.5 5.9 0.5 0.6 0.0 0.6 0.6 0.4 0.5 0.5 0.7 0.5 0.8 0.5 1.9 9.0 0.0 1.4 0.0 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 2.1 2.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.5 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.8 7.5 0.0 0.7 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 83.1 0.2 13.3 7.0 0.6 1.1 5.4 5.9 9.0 ANO4 "FLJ34221, FLJ34272, FLJ35277, TMEM16D" ENSG00000151572 "Anoctamin 4" Q32M45 12 100717526-101128641 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.3;brain: 19.2;seminal vesicle: 14.0" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 14.1;LHCN-M2: 6.8;SK-MEL-30: 10.9;TIME: 22.4;WM-115: 7.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053412 Uncertain "HPA053412: " "unprognostic (1.11e-1)" "unprognostic (3.03e-2)" "unprognostic (4.58e-2)" "unprognostic (1.04e-1)" "unprognostic (1.20e-2)" "unprognostic (2.02e-1)" "unprognostic (3.76e-2)" "unprognostic (1.95e-2)" "unprognostic (1.39e-1)" "unprognostic (1.97e-1)" "unprognostic (4.72e-1)" "unprognostic (6.54e-2)" "prognostic favourable (5.48e-5)" "unprognostic (1.16e-3)" "unprognostic (8.46e-2)" "unprognostic (2.01e-2)" "unprognostic (1.41e-1)" 0.9 20.3 10.3 0.6 16.7 0.6 0.7 2.8 13.0 13.3 0.8 17.2 1.4 1.1 7.9 1.2 0.7 1.0 0.8 0.8 9.5 5.8 0.8 0.6 0.7 0.6 10.9 8.6 13.8 1.6 0.8 2.2 0.7 12.1 8.7 0.9 0.0 3.6 14.0 0.6 0.7 0.9 1.5 4.4 0.6 0.6 2.1 19.2 0.0 0.8 0.0 1.3 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.8 1.1 0.0 4.9 4.4 4.2 2.0 0.0 0.0 0.0 0.0 14.1 0.2 5.1 4.2 3.9 0.0 0.0 0.0 2.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 6.8 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 10.9 0.0 0.0 22.4 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 16.7 2.8 13.0 9.5 5.8 10.9 8.6 12.1 19.2 ANO8 "KIAA1623, TMEM16H" ENSG00000074855 "Anoctamin 8" Q9HCE9 19 17323223-17334829 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031787, HPA049206" Uncertain Uncertain "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA031787: , HPA049206: " "unprognostic (5.12e-2)" "unprognostic (2.79e-1)" "unprognostic (1.59e-1)" "unprognostic (3.07e-1)" "unprognostic (2.91e-1)" "unprognostic (2.20e-3)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (3.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-1)" "unprognostic (5.89e-2)" "unprognostic (3.05e-3)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.48e-2)" "unprognostic (4.59e-2)" 8.5 18.1 19.2 6.6 17.9 3.8 6.6 25.1 30.6 4.3 4.3 11.6 4.9 6.6 5.1 2.2 12.5 4.0 7.9 7.1 15.7 10.6 6.1 6.0 6.6 6.2 13.3 10.3 3.2 7.0 14.4 4.0 5.3 23.3 5.4 4.0 3.2 7.9 4.8 11.1 23.2 6.2 4.5 20.1 5.4 12.2 3.4 14.1 5.3 5.2 5.2 4.4 5.1 5.2 0.1 1.8 0.1 0.1 0.0 0.8 0.1 4.1 3.7 10.1 11.5 3.1 2.2 17.6 4.2 2.4 2.2 2.5 1.6 8.9 0.3 4.6 4.1 3.9 2.1 3.4 1.3 18.7 5.2 2.8 10.7 2.4 1.6 0.6 4.8 2.5 3.2 2.8 2.1 1.6 2.0 4.2 1.4 3.1 3.6 1.1 5.8 15.2 6.1 2.1 4.9 3.7 6.8 3.8 12.3 4.6 4.4 3.5 6.3 1.8 1.7 5.2 2.9 15.8 4.6 7.5 6.1 0.7 8.1 5.2 4.9 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.5 0.5 0.0 0.0 0.1 1.8 0.8 0.1 19.2 17.9 25.1 18.6 15.7 10.6 13.3 10.3 23.3 14.1 ANOS1 "ADMLX, KAL, KAL1, KALIG-1, WFDC19" ENSG00000011201 "Anosmin 1" P23352 X 8528874-8732186 "Disease related genes, Predicted secreted proteins" "Cell adhesion, Chemotaxis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.5;lung: 37.1;parathyroid gland: 27.7" "Group enriched" "Detected in some" 5 "NTERA-2: 26.9;U-2 OS: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in brain" "unprognostic (2.93e-1)" "unprognostic (5.33e-2)" "unprognostic (9.54e-2)" "unprognostic (4.16e-3)" "unprognostic (7.77e-3)" "unprognostic (1.58e-1)" "unprognostic (1.55e-2)" "unprognostic (1.17e-3)" "unprognostic (4.53e-2)" "unprognostic (6.43e-2)" "unprognostic (2.09e-2)" "unprognostic (6.24e-2)" "unprognostic (1.71e-2)" "unprognostic (9.38e-3)" "unprognostic (6.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.56e-2)" 5.4 4.0 13.8 1.3 14.0 0.6 3.6 1.3 18.0 4.5 1.0 7.3 1.3 0.7 0.9 3.2 1.6 1.4 1.9 4.6 11.1 7.9 1.1 1.1 37.1 1.8 5.7 6.0 0.9 0.8 27.7 1.0 1.4 19.3 4.1 1.3 6.0 2.8 4.5 10.9 3.0 0.9 1.1 25.5 1.1 1.1 5.0 8.5 1.3 8.5 1.0 1.2 1.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.6 0.5 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.5 3.0 0.1 4.0 0.4 4.4 0.0 0.0 0.0 1.1 0.1 2.2 0.2 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.0 26.9 0.0 0.0 0.0 0.0 1.5 0.5 1.5 0.0 1.3 0.4 0.0 0.0 0.7 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 14.0 1.3 7.6 11.1 7.9 5.7 6.0 19.3 8.5 AP000790.3 ENSG00000284873 11 59938432-59957480 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.6" "Cell line enhanced" "Detected in some" "NB-4: 1.4;THP-1: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" 0.1 0.0 0.0 0.5 0.0 1.6 0.0 0.1 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.8 0.0 0.1 0.3 0.0 0.3 0.1 0.3 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.3 0.5 0.0 0.0 0.1 0.7 0.2 0.1 0.0 0.0 0.3 0.3 0.0 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 1.4 0.3 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.7 0.0 5.1 0.0 0.6 0.0 0.0 0.4 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.1 AP1S1 "AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2" ENSG00000106367 "Adaptor related protein complex 1 sigma 1 subunit" P61966 7 101154400-101161596 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Deafness, Ichthyosis, Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060945 Supported Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA060945: " "unprognostic (1.98e-2)" "unprognostic (5.41e-3)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.98e-3)" "unprognostic (8.70e-3)" "unprognostic (7.06e-3)" "unprognostic (1.12e-1)" "unprognostic (1.76e-1)" "unprognostic (7.79e-2)" "unprognostic (1.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.81e-2)" "unprognostic (2.14e-2)" "unprognostic (1.74e-1)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" 7.6 9.7 30.6 7.9 41.1 3.0 10.8 7.9 45.8 6.8 16.5 6.4 4.6 23.3 6.6 10.6 10.9 8.9 9.3 4.2 22.9 14.6 16.6 15.5 6.7 6.9 12.3 25.3 7.9 8.0 6.3 10.5 10.2 10.1 10.9 14.2 4.6 10.4 6.1 3.5 12.3 18.0 7.9 8.7 7.7 13.2 6.9 9.3 4.7 9.3 7.4 8.5 8.7 6.1 4.4 8.2 2.1 5.5 1.9 5.9 4.2 26.2 21.3 14.3 27.1 10.6 17.5 31.1 17.6 11.9 12.0 12.8 11.4 33.5 5.9 30.8 19.2 13.0 8.2 27.1 10.7 13.3 13.3 4.0 13.4 14.2 13.1 10.7 19.9 19.5 20.7 11.8 5.1 17.7 12.8 23.7 29.6 65.4 8.9 23.1 22.9 43.0 5.6 6.5 12.3 28.8 22.4 11.3 37.0 10.0 26.6 32.1 11.7 10.0 18.3 17.3 30.2 6.5 12.1 5.3 11.2 11.3 44.0 11.9 34.8 0.8 5.5 0.5 4.2 4.9 3.7 4.4 5.9 4.7 7.4 3.8 3.5 3.2 2.1 1.9 2.8 8.2 5.5 4.2 30.6 41.1 7.9 35.1 22.9 14.6 12.3 25.3 10.1 9.3 AP3B2 NAPTB ENSG00000103723 "Adaptor related protein complex 3 beta 2 subunit" Q13367 15 82659281-82709914 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.8" "Cell line enhanced" "Detected in some" "RT4: 11.5;SCLC-21H: 18.8;SH-SY5Y: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039467, HPA039818" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039467: AB_10795143, HPA039818: AB_10795299" "unprognostic (3.17e-1)" "unprognostic (9.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.48e-6)" "unprognostic (8.44e-2)" "unprognostic (7.62e-2)" "unprognostic (5.82e-2)" "unprognostic (2.32e-1)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (3.57e-3)" "unprognostic (1.12e-1)" "unprognostic (8.66e-2)" "unprognostic (4.95e-2)" "unprognostic (3.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.43e-2)" 1.5 5.4 17.0 2.0 15.5 2.4 1.6 32.3 35.8 1.6 1.6 2.7 0.0 1.8 2.0 2.2 1.6 1.4 1.4 1.1 12.1 11.0 1.3 1.2 1.3 1.6 5.7 18.6 1.8 2.7 8.3 12.3 1.4 16.0 1.7 1.5 3.5 1.7 2.0 1.1 1.8 1.5 1.8 3.7 1.3 2.1 2.6 2.7 0.0 1.7 0.0 1.9 1.8 0.6 1.0 0.5 3.2 1.0 1.1 0.9 0.2 0.2 0.2 5.1 1.9 0.5 0.1 4.5 0.3 0.0 0.6 0.1 0.5 0.5 0.5 3.4 0.1 0.7 0.5 0.0 0.1 1.5 0.5 0.3 0.4 0.2 0.3 0.3 1.2 0.5 0.6 0.1 0.2 0.1 0.6 0.5 0.1 0.8 0.3 0.3 5.9 0.1 0.3 0.1 0.1 0.0 11.5 18.8 14.6 2.8 0.7 1.3 0.2 1.0 0.3 0.4 0.8 0.3 1.0 1.0 5.6 0.5 1.4 0.2 0.9 0.7 1.0 0.5 0.6 0.4 0.3 0.6 0.5 0.3 0.1 1.0 0.9 0.5 3.2 1.1 0.6 0.5 0.3 0.2 17.0 15.5 32.3 25.6 12.1 11.0 5.7 18.6 16.0 2.7 APBA1 "D9S411E, MINT1, X11" ENSG00000107282 "Amyloid beta precursor protein binding family A member 1" Q02410 9 69427530-69672306 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7" "Cell line enhanced" "Detected in some" "BJ: 7.0;BJ hTERT+: 5.9;HAP1: 16.8;SCLC-21H: 6.5;TIME: 7.6;U-138 MG: 7.0;U-266/70: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061287 Supported "Golgi apparatus" "Golgi apparatus" "HPA061287: " "unprognostic (4.02e-2)" "unprognostic (4.64e-2)" "unprognostic (7.29e-2)" "unprognostic (8.94e-3)" "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (4.21e-3)" "unprognostic (8.49e-3)" "unprognostic (2.22e-1)" "unprognostic (2.33e-1)" "unprognostic (2.46e-5)" "unprognostic (1.60e-1)" "unprognostic (3.09e-2)" "unprognostic (4.99e-3)" "unprognostic (3.14e-2)" "unprognostic (2.28e-1)" "unprognostic (4.66e-3)" 2.9 2.9 20.2 1.8 18.6 0.6 4.0 15.5 21.7 4.2 4.1 6.2 0.6 1.7 4.0 1.2 3.4 2.6 3.0 2.9 16.0 19.3 2.3 8.7 1.9 1.6 19.1 13.7 7.5 2.9 14.5 3.5 3.1 15.7 2.2 4.2 2.7 5.5 2.8 4.0 3.8 2.1 2.2 5.5 6.0 1.7 3.5 6.7 0.0 1.5 0.6 1.2 2.4 2.0 0.0 0.1 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.6 0.0 3.1 2.3 0.1 7.0 5.9 0.1 0.1 0.0 0.0 0.0 3.2 2.9 0.1 16.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.0 0.0 2.8 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 2.4 6.5 4.3 0.3 0.9 0.1 0.0 0.0 7.6 7.0 0.8 0.0 0.5 6.9 3.0 0.0 0.2 0.1 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.7 0.1 0.0 0.0 20.2 18.6 15.5 19.7 16.0 19.3 19.1 13.7 15.7 6.7 APBA2 "D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L" ENSG00000034053 "Amyloid beta precursor protein binding family A member 2" Q99767 15 28884483-29118315 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 33.4" "Cell line enhanced" "Detected in some" "HEL: 7.4;SH-SY5Y: 18.3;U-937: 13.1" "Cancer enhanced" "Detected in many" "glioma: 17.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.8;naive CD8 T-cell: 7.5" "Lineage enriched" "Detected in many" 4 "T-cells: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037065, HPA058796, HPA070376" Uncertain Enhanced "Golgi apparatus" "Golgi apparatus" "CAB037065: AB_477178, HPA058796: , HPA070376: " "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.42e-1)" "unprognostic (5.96e-2)" "unprognostic (1.41e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-1)" "unprognostic (8.19e-2)" "unprognostic (4.71e-2)" "unprognostic (9.25e-2)" "unprognostic (4.21e-5)" "unprognostic (1.98e-2)" "unprognostic (4.74e-2)" "unprognostic (7.63e-3)" "unprognostic (4.28e-1)" 1.8 3.3 17.6 3.0 12.1 3.0 1.7 33.4 28.9 1.2 2.0 3.6 0.0 2.5 2.1 2.5 6.7 1.4 2.1 1.6 24.2 14.9 1.4 1.8 2.1 3.6 15.1 14.9 1.8 2.6 1.2 2.3 1.6 7.5 3.0 2.1 1.6 1.8 1.7 1.6 1.8 2.7 1.4 16.2 7.9 1.8 5.6 2.7 1.9 1.9 0.0 3.4 2.9 0.4 0.0 0.0 0.1 0.0 1.8 7.8 2.5 0.0 1.4 0.6 3.4 0.0 0.0 0.0 0.8 1.2 0.1 0.5 0.0 0.0 0.0 3.2 0.0 0.0 0.5 0.0 0.0 0.0 2.8 7.4 0.0 0.1 2.9 0.0 0.2 0.4 2.3 0.4 0.0 3.9 4.3 0.1 0.0 0.4 0.2 2.1 1.0 3.0 0.0 0.3 0.1 0.0 0.0 4.9 18.3 0.0 0.0 0.1 0.0 0.9 3.9 0.0 4.0 0.0 0.8 0.0 0.1 0.0 0.1 13.1 1.6 0.0 0.0 0.0 1.4 0.0 0.2 0.0 2.1 4.7 0.0 0.0 7.8 7.5 0.1 1.8 0.0 0.0 0.0 2.5 17.6 12.1 33.4 28.9 24.2 14.9 15.1 14.9 7.5 2.7 APBB1 "Fe65, RIR" ENSG00000166313 "Amyloid beta precursor protein binding family B member 1" O00213 11 6395124-6419414 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, DNA damage, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 34.4" "Lineage enriched" "Detected in many" 5 "T-cells: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038521, HPA038522" Approved Supported "Plasma membrane" "Plasma membrane" "HPA038521: , HPA038522: " "unprognostic (4.76e-2)" "unprognostic (1.98e-1)" "unprognostic (4.46e-3)" "unprognostic (1.97e-2)" "unprognostic (6.84e-2)" "unprognostic (1.75e-1)" "prognostic unfavourable (2.44e-4)" "unprognostic (7.30e-2)" "unprognostic (3.22e-3)" "unprognostic (2.36e-1)" "prognostic favourable (1.86e-5)" "unprognostic (2.21e-1)" "prognostic favourable (7.44e-13)" "unprognostic (1.32e-2)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" "unprognostic (1.09e-2)" 7.9 14.0 26.0 6.9 26.0 1.9 5.5 54.3 84.6 11.5 9.6 31.1 3.7 4.5 15.7 3.2 9.2 19.7 7.0 21.8 29.5 23.9 9.2 2.3 9.4 7.5 27.0 30.7 21.3 9.5 14.8 15.7 5.4 25.8 10.9 3.3 5.5 8.0 16.5 21.5 4.6 5.2 19.5 36.4 5.9 5.7 7.2 24.7 6.0 7.7 2.5 6.6 7.7 5.8 6.3 0.6 3.0 0.6 5.5 34.4 11.3 0.0 5.9 20.6 9.2 11.2 11.5 0.0 9.6 16.8 16.8 21.2 10.7 4.1 0.0 1.5 17.6 0.2 17.9 3.0 8.0 10.7 13.5 0.1 3.8 0.3 8.0 0.0 4.0 10.3 0.7 7.8 1.2 20.8 0.4 0.3 6.1 0.2 0.2 0.0 7.4 6.3 0.1 0.8 0.0 0.7 0.0 28.3 16.0 1.4 1.2 6.4 0.8 1.3 9.1 1.7 10.4 11.1 1.9 5.6 2.6 0.7 8.7 0.0 5.7 3.0 0.6 0.1 9.1 0.5 9.8 2.6 12.7 11.7 0.6 6.3 34.4 20.0 0.5 5.5 0.2 0.1 17.0 11.3 26.0 26.0 54.3 49.3 29.5 23.9 27.0 30.7 25.8 24.7 APBB3 FE65L2 ENSG00000113108 "Amyloid beta precursor protein binding family B member 3" O95704 5 140558268-140564781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 9.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005571, HPA076196" Approved Supported "Actin filaments,Cytosol" "Actin filaments, Cytosol" "HPA005571: AB_1844912, HPA076196: " "unprognostic (7.63e-2)" "unprognostic (4.58e-2)" "unprognostic (1.13e-2)" "unprognostic (1.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.40e-3)" "unprognostic (1.44e-1)" "unprognostic (5.06e-2)" "unprognostic (7.22e-2)" "unprognostic (1.98e-1)" "prognostic favourable (6.79e-4)" "unprognostic (9.65e-2)" "prognostic unfavourable (2.06e-6)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.38e-2)" "unprognostic (4.67e-2)" 4.2 5.6 7.5 4.3 9.2 3.3 3.4 26.6 23.8 4.5 4.3 8.2 5.7 2.0 4.7 6.3 4.2 6.0 7.8 8.2 9.7 13.1 3.3 3.4 3.2 2.6 7.9 7.3 4.3 3.5 8.2 11.0 5.7 10.9 5.9 3.6 8.7 8.8 7.4 2.5 3.4 2.8 4.1 4.2 4.7 4.4 11.8 5.5 2.0 6.7 3.3 3.4 3.8 2.3 1.4 1.8 7.7 3.6 0.7 1.4 1.1 0.6 0.7 0.5 2.9 0.0 1.2 5.7 1.4 1.7 2.1 3.9 1.9 1.7 2.4 3.3 2.5 1.1 0.0 2.2 0.6 2.3 1.2 0.8 5.2 0.1 3.5 0.8 1.0 7.6 0.9 1.8 1.4 1.5 0.4 6.5 2.2 1.4 0.3 1.8 1.2 3.6 0.4 0.7 1.4 1.8 1.5 9.0 4.4 3.8 1.3 5.1 4.0 3.9 1.1 0.4 1.0 0.0 0.2 2.5 1.9 0.3 0.9 0.6 0.8 7.7 1.4 0.0 1.4 3.6 0.9 0.5 1.0 1.3 1.0 1.4 0.6 1.3 3.3 0.7 0.6 1.8 1.0 1.1 7.5 9.2 26.6 17.4 9.7 13.1 7.9 7.3 10.9 5.5 APC "DP2, DP2.5, DP3, PPP1R46" ENSG00000134982 "APC, WNT signaling pathway regulator" P25054 5 112707498-112846239 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013349 Supported "HPA013349: AB_1844913" "unprognostic (4.80e-2)" "unprognostic (1.19e-1)" "unprognostic (3.72e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (7.09e-3)" "unprognostic (1.62e-1)" "unprognostic (8.10e-3)" "unprognostic (2.35e-1)" "unprognostic (4.85e-3)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.02e-2)" "unprognostic (1.07e-1)" "unprognostic (3.35e-1)" "unprognostic (2.23e-2)" "unprognostic (1.96e-1)" 7.2 5.4 40.9 6.4 21.7 8.5 6.3 19.1 39.7 6.8 7.1 10.3 2.0 6.6 6.3 3.9 8.4 5.0 5.5 7.4 37.9 12.9 6.9 6.2 6.7 5.6 23.6 20.7 7.6 4.6 13.8 7.2 5.5 39.1 5.9 6.9 4.0 4.0 4.9 7.0 6.1 8.8 8.1 19.1 6.2 5.4 5.3 20.6 3.6 6.5 2.7 6.2 6.2 3.9 3.8 3.0 12.9 2.9 3.0 3.4 1.1 8.3 7.7 12.8 9.3 10.6 8.8 5.2 13.5 6.4 7.5 8.9 6.1 6.8 16.1 13.1 17.2 6.8 13.1 11.0 12.4 9.6 8.9 12.2 11.1 4.6 5.2 6.1 6.7 7.4 7.6 12.7 8.4 10.4 15.0 5.6 10.9 5.8 7.0 3.1 4.6 2.7 6.0 15.9 7.8 6.9 10.6 13.0 7.8 12.8 5.0 5.5 6.9 5.0 16.6 15.3 7.4 15.0 10.2 4.4 6.6 6.3 8.5 11.4 8.5 10.4 2.9 5.0 3.4 1.4 2.9 3.1 1.8 2.1 2.3 3.8 2.9 2.8 12.9 3.0 2.5 3.0 1.6 1.1 40.9 21.7 19.1 31.4 37.9 12.9 23.6 20.7 39.1 20.6 APC2 APCL ENSG00000115266 "APC2, WNT signaling pathway regulator" O95996 19 1446302-1473244 "Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 59.4" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 7.6;SH-SY5Y: 25.9" "Cancer enriched" "Detected in some" 27 "glioma: 17.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078002 Supported "Cytokinetic bridge,Midbody,Cytosol" "Cytokinetic bridge, Midbody" Cytosol "HPA078002: " "unprognostic (1.78e-3)" "unprognostic (1.65e-1)" "unprognostic (2.88e-5)" "unprognostic (3.64e-2)" "unprognostic (3.59e-1)" "unprognostic (1.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (1.38e-2)" "unprognostic (1.30e-2)" "unprognostic (3.45e-2)" "unprognostic (9.49e-3)" "unprognostic (7.39e-2)" "unprognostic (3.70e-2)" "unprognostic (4.99e-2)" "unprognostic (1.98e-3)" 1.5 4.7 17.3 1.4 16.4 1.5 1.3 21.7 59.4 1.4 1.6 20.7 0.0 2.1 1.4 1.4 1.4 1.5 1.6 1.4 16.8 13.9 1.3 1.3 1.4 1.4 15.0 14.0 1.3 2.0 1.3 3.0 1.4 17.1 1.4 1.4 0.8 1.7 1.4 1.6 1.4 1.8 1.5 13.9 1.4 1.4 1.8 14.5 0.0 1.5 0.0 1.3 1.6 0.0 1.1 0.2 0.4 0.0 0.0 0.1 0.1 0.2 0.5 6.3 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.4 0.1 0.0 0.7 0.0 0.0 7.6 25.9 0.9 0.0 0.4 0.1 0.0 0.0 0.5 0.5 0.2 0.2 1.9 0.4 0.3 0.7 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 17.3 16.4 21.7 21.3 16.8 13.9 15.0 14.0 17.1 14.5 APLN "apelin, XNPEP2" ENSG00000171388 Apelin Q9ULZ1 X 129645259-129654937 "Predicted secreted proteins" "Angiogenesis, Gastrulation, Host-virus interaction" "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;placenta: 52.0" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 104.4" "Group enriched" "Detected in all" 6 "glioma: 44.2;renal cancer: 21.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" "unprognostic (1.50e-1)" "prognostic unfavourable (2.92e-4)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (4.50e-2)" "unprognostic (5.94e-2)" "prognostic unfavourable (9.32e-4)" "prognostic unfavourable (6.09e-4)" "unprognostic (4.71e-2)" "unprognostic (2.25e-1)" "unprognostic (3.30e-1)" "unprognostic (9.12e-2)" "prognostic unfavourable (9.61e-5)" "unprognostic (1.55e-1)" "unprognostic (1.15e-1)" "unprognostic (2.26e-1)" "unprognostic (8.42e-2)" 3.8 9.7 10.0 2.8 8.0 0.7 2.3 2.0 10.9 0.9 1.2 21.8 0.0 1.5 1.4 1.0 1.3 0.9 1.1 8.3 9.7 10.3 5.2 1.0 13.6 0.8 13.9 7.6 12.5 0.9 0.9 4.3 52.0 14.5 1.5 1.0 0.0 1.3 1.2 2.9 1.2 1.0 2.5 19.3 1.1 1.1 1.6 10.7 0.0 1.6 0.2 0.9 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.3 0.1 0.4 0.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.2 2.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 1.6 0.0 1.5 0.0 104.4 0.0 0.4 0.5 0.0 0.0 0.1 0.3 5.6 0.0 0.1 0.1 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.1 17.7 0.4 0.0 7.6 0.4 0.1 0.0 0.0 7.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 8.0 2.0 8.1 9.7 10.3 13.9 7.6 14.5 10.7 APLNR "AGTRL1, APJ, APJR, FLJ90771" ENSG00000134817 "Apelin receptor" P35414 11 57233577-57237314 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Angiogenesis, Gastrulation, Host-virus interaction" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 63.8;lymphoid tissue: 44.1;placenta: 40.4" "Group enriched" "Detected in some" 19 "AF22: 10.1;HEL: 8.7;K-562: 2.6;NTERA-2: 3.0" "Cancer enhanced" "Detected in all" "glioma: 50.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" CAB025842 Approved "CAB025842: " "unprognostic (5.06e-2)" "unprognostic (3.56e-1)" "unprognostic (2.70e-2)" "unprognostic (1.00e-1)" "unprognostic (2.79e-1)" "unprognostic (6.68e-3)" "unprognostic (1.32e-2)" "unprognostic (2.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "unprognostic (4.72e-1)" "unprognostic (1.77e-3)" "unprognostic (3.27e-2)" "unprognostic (8.13e-2)" "unprognostic (1.13e-1)" "unprognostic (7.13e-3)" 8.4 2.1 26.1 3.8 14.2 0.0 3.3 3.8 21.0 1.2 2.3 30.8 0.0 1.8 1.6 0.0 1.8 1.2 5.7 7.2 24.8 9.3 2.5 8.0 3.5 4.0 17.3 10.2 1.2 1.4 1.9 1.5 40.4 32.8 1.2 2.8 0.2 1.7 0.8 5.8 3.0 1.7 4.7 63.8 44.1 1.5 1.2 18.2 0.1 3.1 0.6 1.8 3.8 1.5 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 26.1 14.2 3.8 16.3 24.8 9.3 17.3 10.2 32.8 18.2 APLP1 APLP ENSG00000105290 "Amyloid beta precursor like protein 1" P51693 19 35867899-35879791 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Endocytosis" Heparin-binding Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 147.5" "Cell line enhanced" "Detected in many" "AF22: 24.8;AN3-CA: 46.0;EFO-21: 24.4;HMC-1: 23.8;SCLC-21H: 26.8;SH-SY5Y: 27.2" "Cancer enhanced" "Detected in many" "glioma: 63.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028970, HPA028971" Enhanced 3900000 "HPA028970: AB_2672847, HPA028971: AB_10601334" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (9.36e-3)" "prognostic unfavourable (3.87e-4)" "unprognostic (7.32e-3)" "unprognostic (1.26e-2)" "unprognostic (1.04e-3)" "unprognostic (2.24e-2)" "unprognostic (4.98e-2)" "unprognostic (6.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.57e-11)" "unprognostic (1.38e-3)" "unprognostic (7.12e-2)" "unprognostic (5.43e-2)" "prognostic unfavourable (2.65e-5)" 2.6 15.6 37.0 2.9 47.9 1.6 1.6 13.1 147.5 2.4 2.6 91.6 0.0 2.0 2.3 2.1 2.2 2.3 4.3 6.0 53.2 37.4 2.4 1.5 2.4 2.1 54.6 24.6 1.9 32.1 5.6 17.6 1.9 38.4 2.3 2.6 3.3 2.4 2.4 1.5 2.0 2.4 2.9 118.2 1.7 9.6 5.7 36.9 0.0 2.2 0.0 2.2 2.1 0.1 1.5 0.4 2.2 0.7 3.0 0.6 0.2 1.4 10.4 24.8 46.0 2.4 1.0 3.2 2.1 1.1 2.4 0.3 2.4 1.4 0.2 24.4 5.3 0.7 7.7 0.5 1.6 17.3 0.9 0.1 3.1 1.4 0.7 0.0 23.8 1.1 0.6 1.0 0.0 0.8 0.9 0.4 7.0 2.3 0.0 0.0 1.2 6.1 2.4 0.1 0.3 0.4 0.3 26.8 27.2 8.0 1.1 0.3 6.0 1.3 0.6 16.7 9.6 9.4 1.3 1.1 0.4 0.1 11.0 0.3 8.4 2.2 0.7 0.4 0.4 0.5 0.3 0.7 0.4 0.6 0.2 1.5 0.5 0.6 2.1 3.0 0.7 0.4 0.2 0.2 37.0 47.9 13.1 54.6 53.2 37.4 54.6 24.6 38.4 36.9 AQP4 MIWC ENSG00000171885 "Aquaporin 4" P55087 18 26852038-26865818 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 185.1;lung: 53.5" "Cell line enhanced" "Detected in some" "AF22: 6.7;Karpas-707: 2.0;RPTEC TERT1: 3.8;U-87 MG: 1.7" "Cancer enriched" "Detected in some" 22 "glioma: 223.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005079, HPA014784, CAB058689" Enhanced Supported Approved "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "CAB005079: AB_2274338, CAB058689: , HPA014784: AB_1844967" "unprognostic (7.23e-5)" "unprognostic (1.55e-1)" "unprognostic (3.19e-8)" "unprognostic (3.68e-1)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.34e-1)" "unprognostic (5.38e-3)" "unprognostic (1.64e-3)" "unprognostic (8.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.14e-2)" "unprognostic (1.35e-1)" "unprognostic (4.10e-2)" 1.7 1.7 60.7 1.6 57.1 1.6 1.8 21.8 185.1 1.9 1.6 41.3 0.0 1.6 1.6 2.0 1.9 2.1 1.6 2.7 64.3 27.1 2.7 2.0 53.5 1.7 39.8 36.4 2.8 1.7 2.9 0.8 1.6 39.1 1.8 1.6 0.0 1.8 1.7 25.4 1.6 1.6 1.6 67.2 1.8 6.1 1.7 42.2 0.0 8.4 0.1 1.6 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.2 0.9 0.0 0.0 0.0 0.0 3.8 0.0 1.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 57.1 21.8 31.7 64.3 27.1 39.8 36.4 39.1 42.2 ARF3 ENSG00000134287 "ADP ribosylation factor 3" P61204 12 48935723-48957551 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 92.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.99e-2)" "unprognostic (2.40e-1)" "unprognostic (9.60e-2)" "unprognostic (1.58e-2)" "unprognostic (9.12e-3)" "unprognostic (2.25e-3)" "unprognostic (2.00e-3)" "unprognostic (1.24e-2)" "unprognostic (1.39e-1)" "unprognostic (1.15e-1)" "unprognostic (1.52e-1)" "unprognostic (1.55e-1)" "unprognostic (1.57e-3)" "unprognostic (1.64e-1)" "unprognostic (3.88e-2)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" 20.4 23.0 60.9 24.5 84.1 18.7 17.4 29.2 92.1 23.3 31.1 24.6 12.9 18.5 17.4 23.9 23.3 19.9 16.0 13.0 58.4 45.8 28.7 16.7 22.6 14.8 37.6 48.1 16.3 14.9 43.1 21.4 18.8 38.3 18.6 29.5 15.7 16.8 20.8 4.7 21.5 20.7 23.6 32.1 18.4 17.6 15.5 18.3 15.1 23.0 11.9 21.6 17.2 13.7 5.8 24.7 26.0 18.2 8.2 8.4 8.8 42.4 63.0 27.5 24.3 22.9 16.7 26.2 28.4 35.9 33.4 29.0 83.3 56.3 34.1 42.7 30.9 35.4 37.9 38.4 30.2 41.6 19.5 55.4 51.7 23.8 14.3 42.2 45.1 18.7 30.5 36.3 21.7 35.4 33.7 18.6 28.4 52.0 31.3 23.0 38.8 33.9 30.3 15.7 22.5 36.0 54.5 28.4 26.0 30.6 35.8 26.7 60.5 33.9 49.0 25.0 40.2 15.6 17.7 18.2 41.1 25.0 32.8 33.0 14.1 2.6 18.2 12.5 6.7 11.7 5.5 5.8 7.9 8.4 24.7 5.3 4.3 4.9 26.0 8.2 7.7 19.1 6.1 8.8 60.9 84.1 29.2 92.1 58.4 45.8 37.6 48.1 38.3 18.3 ARFGEF3 "BIG3, C6orf92, dJ171N11.1, KIAA1244, PPP1R33" ENSG00000112379 "ARFGEF family member 3" Q5TH69 6 138161921-138344663 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.2;parathyroid gland: 24.5;salivary gland: 26.6" "Cell line enhanced" "Detected in many" "MCF7: 11.2;RH-30: 10.6;RT4: 15.0;SK-BR-3: 17.5" "Cancer enhanced" "Detected in all" "prostate cancer: 24.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036350 Uncertain "HPA036350: AB_10672084" "prognostic unfavourable (8.20e-4)" "unprognostic (4.31e-2)" "unprognostic (9.91e-3)" "unprognostic (5.91e-2)" "unprognostic (2.20e-2)" "unprognostic (4.53e-2)" "unprognostic (4.30e-3)" "unprognostic (1.21e-2)" "unprognostic (7.41e-2)" "unprognostic (7.82e-2)" "unprognostic (3.46e-2)" "unprognostic (4.93e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-1)" "unprognostic (2.38e-1)" "unprognostic (8.87e-2)" "unprognostic (1.69e-2)" 1.6 5.5 15.1 1.5 15.7 1.1 11.0 26.2 19.7 7.3 5.7 17.1 2.1 3.2 1.5 1.8 1.0 3.4 2.7 1.7 10.9 10.2 3.5 0.7 8.4 0.9 13.9 13.6 0.7 11.2 24.5 9.3 2.4 11.7 15.8 6.6 0.7 26.6 1.9 0.9 1.7 2.9 1.5 12.4 1.1 13.1 1.3 14.5 0.0 2.9 0.0 1.1 4.2 0.9 0.2 0.1 1.0 0.0 0.6 0.1 0.0 6.0 2.4 0.0 0.4 0.0 0.0 3.7 0.3 0.2 0.1 0.0 0.1 0.3 0.0 2.5 0.2 2.0 2.9 1.5 0.0 0.0 3.8 0.0 1.2 0.7 0.0 2.3 0.0 0.0 0.7 0.0 0.7 3.2 0.0 3.8 0.0 11.2 0.0 0.0 2.1 2.6 0.5 10.6 2.0 2.0 15.0 5.5 0.0 6.1 17.5 0.7 3.5 0.0 0.3 0.2 1.8 0.0 6.0 1.3 4.9 0.0 2.6 1.4 0.4 1.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.6 0.0 0.1 0.0 0.0 15.1 15.7 26.2 19.7 10.9 10.2 13.9 13.6 11.7 14.5 ARHGAP21 "ARHGAP10, KIAA1424" ENSG00000107863 "Rho GTPase activating protein 21" Q5T5U3 10 24583609-24723668 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036610, HPA057861" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" "Cell Junctions, Actin filaments" "Plasma membrane" "HPA036610: AB_10669910, HPA057861: " "unprognostic (7.65e-2)" "unprognostic (1.61e-2)" "unprognostic (1.88e-1)" "unprognostic (5.84e-2)" "unprognostic (2.69e-1)" "unprognostic (3.59e-1)" "unprognostic (1.12e-3)" "unprognostic (5.35e-2)" "unprognostic (9.75e-2)" "unprognostic (3.34e-2)" "unprognostic (2.65e-3)" "unprognostic (3.23e-1)" "unprognostic (3.14e-2)" "unprognostic (1.53e-1)" "unprognostic (3.32e-1)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" 19.6 13.6 34.5 7.1 38.5 4.7 15.6 37.9 39.3 16.2 12.0 39.1 4.4 9.4 14.8 6.0 8.4 14.0 13.5 15.0 43.1 25.2 8.5 9.8 15.7 3.5 42.3 24.0 25.5 11.0 12.4 9.7 12.1 27.3 8.2 14.1 6.7 16.0 9.1 10.9 4.7 11.5 13.7 54.8 6.0 19.5 10.4 43.7 2.7 9.8 3.7 4.2 9.2 9.3 0.2 1.6 3.6 1.9 1.0 2.0 1.0 22.6 10.0 24.7 20.9 17.4 25.1 8.5 16.3 10.8 10.0 14.2 7.3 14.4 4.2 5.6 25.8 15.0 13.0 16.3 14.8 13.9 8.3 24.9 21.6 5.2 10.4 0.0 3.9 10.2 17.9 13.1 14.2 17.1 10.5 38.1 19.6 4.4 11.7 0.8 3.8 5.4 2.6 8.7 2.3 6.7 4.0 4.2 4.3 11.1 6.2 13.2 6.5 3.5 19.0 14.4 9.2 15.8 11.7 4.2 7.5 3.0 14.9 4.3 9.7 3.6 0.8 1.6 0.5 1.9 0.4 0.2 0.6 1.6 1.3 0.0 2.0 1.2 0.1 1.0 0.9 1.6 1.0 1.0 34.5 38.5 37.9 36.1 43.1 25.2 42.3 24.0 27.3 43.7 ARHGAP22 RhoGAP2 ENSG00000128805 "Rho GTPase activating protein 22" Q7Z5H3 10 48446034-48656265 "Predicted intracellular proteins" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 32.3" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 15.4;LHCN-M2: 26.1;TIME: 27.7;U-87 MG: 34.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.2;myeloid DC: 2.9;naive B-cell: 2.6" "Group enriched" "Detected in many" 29 "B-cells: 2.6;dendritic cells: 2.9;monocytes: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020696, HPA040391, HPA064439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB020696: , HPA040391: , HPA064439: " "unprognostic (1.87e-1)" "unprognostic (3.98e-2)" "unprognostic (2.38e-2)" "unprognostic (2.62e-1)" "unprognostic (1.07e-1)" "unprognostic (6.74e-3)" "unprognostic (4.81e-3)" "unprognostic (2.78e-1)" "unprognostic (1.66e-1)" "unprognostic (3.03e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "prognostic unfavourable (2.16e-8)" "unprognostic (7.40e-2)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (3.66e-2)" 2.6 3.1 10.2 6.7 12.5 3.0 2.0 7.3 12.2 1.8 2.7 32.3 1.0 1.7 2.1 1.9 1.6 2.2 4.4 3.3 12.5 9.6 1.2 0.8 2.9 6.0 18.3 6.6 7.7 1.5 2.7 1.8 2.2 24.6 3.2 2.8 1.6 3.4 3.2 3.9 3.4 2.5 3.4 27.3 6.2 2.3 4.6 18.4 2.0 6.0 0.4 5.4 3.1 1.9 2.6 2.9 0.0 3.2 0.0 0.0 0.9 2.5 0.5 0.1 0.0 2.2 8.8 1.7 13.5 6.2 1.2 1.7 2.7 0.3 0.0 0.5 5.2 4.9 0.1 4.5 2.2 0.2 4.6 7.1 0.0 0.0 1.1 0.8 0.8 2.1 4.6 15.4 1.2 8.4 6.7 1.3 26.1 0.1 0.1 0.0 2.9 0.2 0.0 0.0 3.2 2.6 0.2 0.4 2.7 0.6 0.0 0.2 0.1 0.1 27.7 12.7 0.2 1.6 9.4 0.0 0.0 0.0 34.4 0.1 2.0 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 2.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 10.2 12.5 7.3 9.2 12.5 9.6 18.3 6.6 24.6 18.4 ARHGAP23 KIAA1501 ENSG00000275832 "Rho GTPase activating protein 23" Q9P227 17 38419280-38512392 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.4" "Cell line enhanced" "Detected in many" "HaCaT: 75.4;RT4: 29.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019818, HPA047291" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "HPA019818: AB_1844993, HPA047291: " "unprognostic (3.35e-1)" "unprognostic (5.11e-2)" "unprognostic (6.43e-2)" "prognostic unfavourable (6.87e-5)" "unprognostic (9.53e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (1.99e-1)" "unprognostic (5.56e-2)" "unprognostic (1.50e-3)" "prognostic unfavourable (3.24e-4)" "unprognostic (3.67e-2)" "prognostic unfavourable (5.38e-5)" "unprognostic (8.36e-2)" "unprognostic (5.83e-2)" "unprognostic (4.57e-2)" "unprognostic (2.25e-1)" 4.3 2.7 11.7 3.5 32.1 4.2 1.7 3.6 20.1 4.4 1.4 52.4 0.0 1.0 5.1 1.5 13.3 4.0 3.6 7.8 12.6 1.6 0.5 5.7 1.3 42.3 12.6 6.1 0.8 1.5 0.0 9.5 20.2 3.7 0.9 0.9 0.7 6.6 2.1 16.3 1.1 5.5 16.3 10.5 0.5 5.2 39.0 1.4 0.9 0.5 5.0 11.6 2.3 0.0 0.8 0.0 0.1 0.0 0.1 0.1 8.1 4.3 3.9 1.3 2.5 8.3 4.9 11.1 12.5 9.8 5.7 14.3 14.2 0.1 9.2 25.7 75.4 0.4 15.7 7.0 0.8 0.8 0.0 13.8 0.1 12.5 0.8 0.0 4.8 3.0 7.1 4.5 10.0 0.1 2.1 5.5 0.0 2.4 1.5 2.3 1.6 4.2 8.5 2.6 4.1 29.3 0.9 2.2 6.7 0.0 0.0 1.7 1.9 14.5 16.5 5.8 3.3 2.9 1.7 1.7 0.4 4.1 2.0 14.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 ARHGAP32 "GC-GAP, GRIT, KIAA0712, MGC1892, RICS" ENSG00000134909 "Rho GTPase activating protein 32" A7KAX9 11 128965060-129279324 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.9" "Cell line enhanced" "Detected in many" "RT4: 21.4;SK-BR-3: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038382, HPA038389, HPA061505" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA038382: , HPA038389: AB_10670972, HPA061505: " "unprognostic (1.17e-1)" "unprognostic (3.58e-2)" "unprognostic (2.54e-2)" "unprognostic (1.82e-1)" "unprognostic (3.89e-2)" "unprognostic (5.64e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" "prognostic unfavourable (6.64e-4)" "unprognostic (1.47e-1)" "unprognostic (6.17e-3)" "unprognostic (1.17e-1)" "unprognostic (4.01e-1)" "unprognostic (5.80e-2)" "unprognostic (1.64e-2)" 4.0 5.9 22.1 3.4 32.8 1.7 9.4 4.7 46.9 8.2 12.3 5.1 1.5 18.4 7.3 8.4 21.9 12.2 6.8 3.8 9.9 6.8 6.5 4.5 5.2 1.5 6.4 21.7 10.2 13.3 14.9 5.3 7.5 5.4 6.0 14.3 4.5 13.4 4.1 6.2 16.0 19.0 5.5 4.3 2.6 10.8 9.2 8.4 5.8 3.6 12.8 12.9 8.0 13.1 1.3 1.6 0.7 2.1 3.0 1.2 0.6 6.5 3.5 10.9 0.0 3.6 3.6 7.9 2.4 3.4 1.6 1.9 8.0 13.5 0.0 3.8 4.7 14.9 5.0 6.2 3.0 0.0 1.7 0.1 1.7 3.0 1.7 0.0 0.0 3.5 8.1 1.5 9.2 1.9 0.3 0.1 2.7 5.0 5.3 0.1 2.9 3.7 13.2 3.3 1.3 1.7 21.4 10.8 4.4 3.7 23.4 4.5 12.1 2.1 3.6 5.6 2.9 3.3 4.7 0.1 0.0 0.0 2.4 14.9 3.5 0.0 0.4 0.0 0.3 2.1 1.2 0.0 0.4 0.6 1.0 1.3 0.8 0.2 0.7 3.0 0.7 1.6 0.4 0.6 22.1 32.8 4.7 46.9 9.9 6.8 6.4 21.7 5.4 8.4 ARHGAP36 FLJ30058 ENSG00000147256 "Rho GTPase activating protein 36" Q6ZRI8 X 131058242-131089883 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3" "Cell line enriched" "Detected in single" 164 "SH-SY5Y: 62.9" "Cancer enriched" "Detected in some" 21 "thyroid cancer: 62.5" "Region enriched" "Detected in many" 5 "hypothalamus: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 104.3" "Group enriched" "Detected in many" 5 "basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1" "HPA002064, HPA076209" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" Nucleoplasm "Vesicles, Plasma membrane" "HPA002064: AB_1078891, HPA076209: " "unprognostic (2.92e-2)" "unprognostic (7.71e-9)" "unprognostic (2.19e-1)" "unprognostic (8.15e-2)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (2.31e-1)" 6.9 58.4 1.4 0.2 3.6 0.1 1.0 0.0 2.7 0.5 0.2 0.0 0.0 0.1 0.1 2.0 0.3 0.2 0.2 0.1 1.0 25.5 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 50.3 0.3 5.4 0.3 0.2 0.6 0.2 0.2 13.7 0.1 0.1 0.1 0.8 0.1 0.2 0.6 0.0 0.5 0.5 4.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 62.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.6 0.0 0.4 1.0 25.5 0.5 0.0 5.4 0.0 ARHGAP44 "KIAA0672, RICH-2, RICH2" ENSG00000006740 "Rho GTPase activating protein 44" Q17R89 17 12789539-12991643 "Predicted intracellular proteins" Exocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;parathyroid gland: 33.8" "Cell line enhanced" "Detected in many" "HEK 293: 11.8;SK-BR-3: 9.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038814 Approved "HPA038814: AB_10673295" "unprognostic (4.30e-2)" "unprognostic (3.48e-1)" "unprognostic (5.18e-3)" "unprognostic (2.69e-2)" "unprognostic (1.42e-1)" "unprognostic (1.80e-1)" "unprognostic (1.83e-1)" "unprognostic (1.68e-2)" "unprognostic (5.35e-2)" "unprognostic (2.17e-1)" "unprognostic (1.45e-2)" "unprognostic (4.02e-2)" "unprognostic (3.95e-2)" "unprognostic (6.31e-3)" "unprognostic (7.53e-3)" "unprognostic (3.98e-1)" "unprognostic (9.58e-2)" 3.6 2.5 13.5 4.3 17.2 0.5 2.0 23.6 24.7 2.5 15.4 2.7 3.8 7.5 3.3 3.7 1.6 10.6 5.7 4.5 16.8 11.5 3.2 1.0 12.3 2.0 7.1 11.1 5.1 4.5 33.8 11.3 9.8 15.5 3.7 12.5 4.6 5.6 4.8 2.6 1.5 7.6 3.6 3.4 1.2 3.7 2.5 2.8 0.0 7.3 0.0 2.0 2.3 3.6 0.6 0.0 0.0 0.4 0.3 0.6 0.0 0.5 1.8 1.5 1.1 0.1 0.8 5.0 1.2 5.9 0.3 0.6 0.9 0.3 4.6 0.5 1.9 0.8 3.1 0.0 0.1 0.3 11.8 0.1 1.9 1.9 0.2 0.0 0.4 0.2 0.5 0.3 0.0 0.0 0.3 0.1 0.0 5.8 0.6 0.5 4.9 0.4 4.3 0.5 1.1 0.1 1.7 4.9 0.4 0.2 9.1 0.2 1.3 1.7 0.0 4.7 2.7 1.8 0.1 0.0 0.0 0.5 1.0 0.1 0.7 0.0 0.0 0.0 0.1 0.4 0.3 0.6 0.2 0.4 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.6 0.0 13.5 17.2 23.6 24.7 16.8 11.5 7.1 11.1 15.5 2.8 ARHGDIG RHOGDI-3 ENSG00000242173 "Rho GDP dissociation inhibitor gamma" Q99819 16 268727-283010 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 60.4;intestine: 31.7;pancreas: 45.3" "Cell line enhanced" "Detected in some" "HAP1: 5.1;HEK 293: 18.4;MCF7: 23.6;SCLC-21H: 8.3;SH-SY5Y: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078260 Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA078260: " "unprognostic (1.11e-2)" "unprognostic (5.69e-2)" "unprognostic (7.98e-2)" "unprognostic (2.66e-2)" "unprognostic (9.04e-2)" "unprognostic (2.13e-2)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-1)" "unprognostic (1.44e-2)" "unprognostic (3.18e-1)" "unprognostic (2.94e-1)" "unprognostic (5.86e-6)" "unprognostic (2.81e-2)" "unprognostic (4.34e-1)" "unprognostic (2.15e-1)" "unprognostic (6.32e-2)" 3.7 3.1 37.3 1.8 15.6 1.0 1.1 43.3 60.4 1.0 1.8 3.7 0.0 31.7 1.1 2.3 1.1 1.0 0.9 3.6 29.0 27.4 1.0 0.9 1.0 1.0 21.2 21.4 1.0 45.3 0.9 1.7 2.4 12.7 1.1 1.2 0.6 1.3 1.3 2.0 0.9 12.0 1.3 8.6 1.0 9.3 2.0 2.0 0.0 0.9 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 2.0 0.0 0.6 0.1 0.3 0.0 0.3 0.0 0.3 0.1 0.0 0.6 0.4 0.1 5.1 0.0 0.0 0.0 18.4 0.0 0.3 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.2 0.2 0.0 23.6 0.0 0.3 2.5 0.0 0.0 0.0 0.4 0.0 0.0 8.3 10.3 0.1 0.1 0.0 1.8 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 37.3 15.6 43.3 43.8 29.0 27.4 21.2 21.4 12.7 2.0 ARHGEF33 ENSG00000214694 "Rho guanine nucleotide exchange factor 33" A8MVX0 2 38889841-38975449 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 42.5" "Group enriched" "Detected in some" 4 "BEWO: 8.8;HeLa: 3.9;SiHa: 11.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 42.5" "Cell type enriched" "Detected in single" 8 "eosinophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Region enriched" "Detected in single" 32 "cerebellum: 314.4" "Region enriched" "Detected in many" 11 "cerebellum: 47.0" "HPA034661, HPA041051" Enhanced Supported Vesicles Vesicles "HPA034661: AB_10669679, HPA041051: " "unprognostic (8.38e-2)" "unprognostic (7.05e-4)" "unprognostic (1.95e-1)" "unprognostic (4.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-1)" "unprognostic (3.66e-1)" "unprognostic (3.37e-1)" "unprognostic (5.82e-2)" "unprognostic (2.05e-3)" "unprognostic (4.99e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.56e-1)" "unprognostic (2.42e-1)" "unprognostic (1.99e-1)" 0.3 4.0 3.7 1.0 8.6 0.0 1.7 42.5 3.4 2.3 0.7 0.6 0.7 0.1 2.8 5.1 0.7 2.2 1.4 0.8 3.3 3.6 1.4 0.2 1.2 0.5 2.0 2.9 6.8 0.2 2.2 3.5 0.8 3.2 1.7 0.6 0.8 0.4 1.2 0.4 1.3 0.6 1.0 1.5 0.5 0.9 10.1 2.4 0.2 1.4 0.2 0.4 1.2 0.6 0.2 0.1 6.7 0.8 0.0 0.2 0.1 0.3 0.0 0.4 0.2 0.2 0.2 8.8 0.8 0.0 0.0 0.0 0.1 0.2 0.4 0.1 0.8 0.0 0.0 0.0 0.0 1.8 0.9 0.2 3.9 0.3 0.7 0.3 0.3 0.8 0.9 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.9 0.4 0.4 0.3 11.0 0.4 0.0 0.0 0.3 0.6 0.2 1.4 0.0 0.1 0.5 0.2 0.0 0.2 0.2 0.1 0.0 0.6 6.7 0.0 0.8 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 3.7 8.6 42.5 3.4 3.3 3.6 2.0 2.9 3.2 2.4 ARHGEF4 "ASEF, KIAA1112, STM6" ENSG00000136002 "Rho guanine nucleotide exchange factor 4" Q9NR80 2 130836916-131047263 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.3;skin 1: 35.1" "Cell line enhanced" "Detected in some" "HaCaT: 17.3;hTCEpi: 35.9;SCLC-21H: 22.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 4.3" "Group enriched" "Detected in many" 35 "dendritic cells: 2.6;T-cells: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018267 Approved "HPA018267: AB_1845006" "unprognostic (2.30e-3)" "unprognostic (8.84e-2)" "unprognostic (5.32e-2)" "unprognostic (1.18e-2)" "unprognostic (4.44e-1)" "unprognostic (2.60e-2)" "unprognostic (4.69e-2)" "unprognostic (2.14e-2)" "unprognostic (8.97e-2)" "unprognostic (1.29e-1)" "unprognostic (7.85e-2)" "unprognostic (1.65e-1)" "unprognostic (1.75e-1)" "unprognostic (4.68e-2)" "prognostic favourable (7.00e-4)" "unprognostic (3.93e-3)" "unprognostic (9.71e-3)" 5.4 5.5 24.0 1.5 25.7 0.7 2.0 8.9 37.3 3.5 1.9 14.7 0.5 0.8 2.9 2.1 13.2 8.8 3.4 1.5 28.5 12.7 0.9 1.2 3.6 0.9 15.0 16.5 8.3 13.6 2.4 5.2 0.8 14.9 5.4 1.4 0.6 3.2 9.0 8.0 35.1 1.6 4.5 23.5 0.7 1.5 4.4 20.5 0.0 5.2 10.1 4.0 4.2 6.1 0.0 2.6 0.0 0.0 0.0 4.3 0.6 1.6 1.0 0.3 7.9 0.0 0.0 0.1 2.5 0.1 0.1 0.0 0.3 0.5 0.0 0.1 1.0 17.3 1.1 4.0 0.0 0.0 0.9 0.0 2.7 0.0 0.3 0.0 0.0 0.0 35.9 0.8 3.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.2 2.9 7.8 0.1 0.3 1.2 0.0 22.0 3.3 0.2 3.2 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.0 0.8 1.6 0.0 0.0 1.6 4.3 0.0 0.0 0.0 2.6 1.3 0.6 24.0 25.7 8.9 26.6 28.5 12.7 15.0 16.5 14.9 20.5 ARHGEF9 "KIAA0424, PEM-2" ENSG00000131089 "Cdc42 guanine nucleotide exchange factor 9" O43307 X 63634967-63809274 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035419, HPA055291" Approved Supported Cytosol Cytosol "HPA035419: AB_10669859, HPA055291: " "unprognostic (3.19e-1)" "unprognostic (6.15e-2)" "unprognostic (4.02e-2)" "unprognostic (2.67e-2)" "unprognostic (2.10e-1)" "unprognostic (2.14e-1)" "unprognostic (1.66e-1)" "unprognostic (1.98e-3)" "unprognostic (1.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.08e-3)" "unprognostic (1.67e-1)" "prognostic favourable (1.02e-5)" "unprognostic (4.56e-2)" "unprognostic (9.27e-2)" "unprognostic (3.15e-2)" "unprognostic (8.98e-2)" 5.7 9.6 22.6 4.5 42.6 3.2 6.9 19.5 38.2 6.0 8.2 7.1 1.2 10.9 6.2 4.2 7.7 5.4 6.0 22.0 24.6 22.4 6.8 4.1 4.3 4.6 12.5 28.3 10.4 4.8 11.8 8.3 4.4 17.4 8.2 8.7 9.9 4.5 7.0 3.9 7.0 8.1 8.4 8.5 4.9 6.9 2.2 9.9 2.1 6.1 0.8 5.4 7.3 3.2 5.4 3.7 1.8 3.6 11.5 8.5 2.8 4.5 7.0 11.0 7.0 5.0 6.8 0.9 8.3 6.9 7.7 6.7 0.5 4.9 9.6 6.1 5.1 0.1 4.9 10.1 7.5 13.1 5.0 8.1 3.1 0.4 2.5 4.1 3.5 8.3 4.5 3.8 12.6 5.1 1.1 15.8 7.5 6.5 8.3 2.3 7.6 8.1 12.6 22.6 9.5 4.8 4.1 0.2 3.1 3.9 7.5 4.2 5.3 4.8 2.6 5.1 5.2 24.1 3.5 5.4 4.1 7.5 6.1 7.4 3.6 1.0 2.8 1.8 8.5 3.6 5.6 3.5 4.6 4.9 3.7 5.4 5.6 5.2 1.6 11.5 2.4 2.9 4.1 2.8 22.6 42.6 19.5 37.2 24.6 22.4 12.5 28.3 17.4 9.9 ARL9 ENSG00000196503 "ADP ribosylation factor like GTPase 9" Q6T311 4 56505209-56525481 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.7;testis: 12.6" "Cell line enhanced" "Detected in some" "HSkMC: 4.3;REH: 8.5;SCLC-21H: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072942 Enhanced Approved Nucleoli,Mitochondria Mitochondria Nucleoli "HPA072942: " "unprognostic (9.91e-2)" "unprognostic (2.19e-1)" "unprognostic (2.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.24e-3)" "unprognostic (6.86e-3)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (4.46e-2)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (6.79e-6)" "unprognostic (1.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" 1.3 1.1 4.4 0.8 4.9 3.4 2.0 1.5 7.1 1.3 1.3 0.6 2.4 1.0 2.0 1.1 1.1 1.2 2.4 0.8 3.9 3.2 0.5 0.5 0.6 1.0 1.3 2.9 3.0 0.4 0.4 1.6 0.3 8.7 2.2 1.0 1.9 0.9 3.8 0.4 4.1 1.0 3.7 2.5 0.8 1.0 12.6 0.6 0.1 1.1 1.2 0.7 1.5 2.5 2.1 2.2 1.6 0.4 1.4 1.4 0.1 0.0 0.5 0.5 0.5 1.1 2.8 0.1 0.9 0.5 2.1 2.1 0.4 0.7 0.7 0.0 1.4 0.2 0.4 0.2 1.1 0.1 0.1 0.3 0.0 0.1 2.7 0.2 0.7 4.3 0.6 1.8 0.4 2.0 0.2 0.9 2.0 0.0 0.3 0.1 2.2 1.3 8.5 0.0 0.1 0.1 0.3 9.0 0.1 0.3 0.4 0.2 0.2 0.1 0.4 0.3 0.4 0.0 0.1 0.3 0.4 0.4 0.1 0.0 0.3 0.8 0.4 0.4 0.7 0.4 0.4 1.0 1.2 1.0 0.3 2.1 1.4 0.6 1.6 1.4 0.4 2.2 1.0 0.1 4.4 4.9 1.5 7.1 3.9 3.2 1.3 2.9 8.7 0.6 ARMC3 "CT81, FLJ32827" ENSG00000165309 "Armadillo repeat containing 3" Q5W041 10 22928024-23038523 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 40.2;fallopian tube: 38.6;testis: 25.7" "Cell line enriched" "Detected in some" 9 "CAPAN-2: 11.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 4.0" "Region enhanced" "Detected in many" "pons and medulla: 40.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037823, HPA037824" Enhanced "HPA037823: AB_2675689, HPA037824: AB_10671634" "unprognostic (8.11e-3)" "unprognostic (5.78e-2)" "unprognostic (6.63e-2)" "unprognostic (7.81e-3)" "unprognostic (1.01e-1)" "unprognostic (2.28e-1)" "unprognostic (5.23e-1)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (7.37e-3)" "unprognostic (4.02e-1)" "unprognostic (3.61e-2)" "unprognostic (2.97e-1)" "unprognostic (6.21e-3)" "unprognostic (9.53e-4)" "unprognostic (1.40e-2)" 0.3 0.4 3.5 0.3 10.1 0.3 0.4 0.0 1.0 1.9 0.3 11.3 0.0 0.3 1.7 9.0 0.5 38.6 0.3 0.4 4.7 4.1 0.7 0.3 4.1 0.3 1.9 2.2 4.5 0.6 0.3 4.1 0.3 40.2 0.3 0.3 0.0 0.3 0.5 0.3 0.3 0.3 0.4 1.0 0.3 0.3 25.7 6.3 0.0 0.6 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.9 2.3 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.8 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 3.5 10.1 0.0 1.0 4.7 4.1 1.9 2.2 40.2 6.3 ARNT2 "bHLHe1, KIAA0307" ENSG00000172379 "Aryl hydrocarbon receptor nuclear translocator 2" Q9HBZ2 15 80404350-80597937 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 73.2" "Cell line enhanced" "Detected in many" "AF22: 16.0;BJ hTERT+ SV40 Large T+ RasG12V: 16.2;LHCN-M2: 14.5;SK-MEL-30: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001056, CAB005081" Enhanced Supported Nucleoplasm Nucleoplasm "CAB005081: AB_2243005, HPA001056: AB_1845042" "unprognostic (2.04e-3)" "unprognostic (8.32e-2)" "unprognostic (2.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.11e-1)" "unprognostic (5.65e-2)" "unprognostic (2.61e-2)" "unprognostic (1.48e-1)" "unprognostic (2.74e-2)" "unprognostic (3.00e-1)" "prognostic favourable (1.46e-6)" "unprognostic (2.20e-1)" "prognostic favourable (7.51e-4)" "unprognostic (2.53e-1)" "unprognostic (2.31e-1)" "unprognostic (3.39e-1)" "unprognostic (3.62e-2)" 1.4 2.3 30.6 2.3 35.5 1.0 1.8 9.1 73.2 4.2 2.4 14.3 0.0 2.0 5.3 7.2 2.3 4.9 2.7 3.7 32.8 17.4 11.5 1.0 4.4 2.3 19.2 23.4 9.3 3.2 4.2 3.6 1.7 11.9 5.1 2.4 2.0 1.5 4.8 7.0 2.3 2.5 3.7 13.2 3.2 3.9 8.0 12.7 0.0 6.0 0.0 2.9 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.9 16.0 0.0 0.1 2.1 0.0 6.8 9.6 7.9 16.2 0.0 0.0 0.0 1.7 8.0 0.2 5.8 0.3 10.1 0.0 1.6 0.3 0.0 0.5 0.5 0.0 4.1 7.6 0.3 3.5 0.1 0.0 0.0 0.1 14.5 7.5 0.0 0.0 3.2 0.1 0.0 0.2 0.0 3.4 11.3 8.5 11.7 0.8 0.1 17.3 0.3 0.0 0.0 12.6 2.5 0.3 8.0 0.0 0.0 0.0 4.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 35.5 9.1 36.0 32.8 17.4 19.2 23.4 11.9 12.7 ARPP19 "ARPP-16, ARPP-19, ARPP16, ENSAL" ENSG00000128989 "CAMP regulated phosphoprotein 19" P56211 15 52547045-52569883 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 130.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056851 Approved "HPA056851: " "unprognostic (2.83e-1)" "unprognostic (2.80e-1)" "unprognostic (3.44e-1)" "unprognostic (8.09e-2)" "unprognostic (1.58e-1)" "unprognostic (6.14e-2)" "unprognostic (3.63e-2)" "unprognostic (2.33e-2)" "unprognostic (7.21e-2)" "unprognostic (5.67e-2)" "unprognostic (6.80e-2)" "unprognostic (2.15e-1)" "prognostic favourable (1.72e-4)" "unprognostic (1.40e-2)" "unprognostic (4.82e-2)" "unprognostic (3.05e-1)" "unprognostic (3.27e-1)" 16.4 15.4 49.2 10.3 130.4 25.7 13.5 18.3 92.3 11.8 10.2 21.1 7.3 8.1 14.1 10.9 15.1 9.8 11.4 22.5 33.7 26.1 16.7 11.9 12.7 12.6 35.5 27.2 13.9 13.0 29.0 12.8 16.0 16.1 11.7 10.5 7.2 8.2 12.6 60.0 8.4 8.6 16.6 40.5 11.7 10.8 22.7 35.4 7.3 16.6 8.5 14.2 13.4 9.0 32.7 20.8 42.7 26.1 30.8 38.5 25.6 25.1 28.2 40.6 18.5 16.3 18.3 21.0 23.2 20.1 17.4 17.8 24.8 12.7 26.5 25.5 16.7 22.5 28.4 26.2 22.7 89.8 13.4 30.2 29.4 22.0 14.0 28.5 22.8 17.3 26.8 17.9 29.6 27.1 18.5 51.0 25.7 28.4 27.2 11.3 25.0 14.3 29.4 23.4 53.4 24.7 32.6 41.1 33.5 17.1 22.7 22.6 22.5 19.8 24.3 27.9 19.9 19.9 33.4 23.9 61.3 33.9 19.7 25.9 26.3 22.6 20.1 42.7 25.8 22.2 25.4 32.7 27.5 30.6 16.4 23.1 26.6 29.4 32.6 30.8 26.1 20.8 38.5 25.6 49.2 130.4 18.3 68.1 33.7 26.1 35.5 27.2 16.1 35.4 ARPP21 "ARPP-21, R3HDM3, TARPP" ENSG00000172995 "CAMP regulated phosphoprotein 21" Q9UBL0 3 35638945-35794496 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 146.9;lymphoid tissue: 41.2;skeletal muscle: 43.6" "Group enriched" "Detected in some" 8 "MOLT-4: 34.9;REH: 19.4;RH-30: 11.1" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Region enriched" "Detected in all" 5 "basal ganglia: 146.9" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 12.1" "Lineage enriched" "Detected in single" 30 "dendritic cells: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017303 Enhanced Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA017303: AB_1845049" "unprognostic (1.72e-4)" "unprognostic (2.35e-1)" "unprognostic (1.10e-2)" "unprognostic (6.61e-2)" "unprognostic (6.30e-3)" "unprognostic (8.90e-2)" "unprognostic (2.42e-3)" "unprognostic (1.27e-1)" "unprognostic (7.42e-4)" "unprognostic (1.32e-1)" "unprognostic (2.35e-1)" "unprognostic (1.52e-1)" 1.2 1.3 12.3 1.5 146.9 4.6 1.1 27.8 67.9 1.1 1.4 0.3 0.0 1.3 1.1 1.1 3.2 1.1 1.1 1.1 6.8 2.8 2.0 2.9 1.2 1.2 3.9 11.5 1.1 1.1 1.1 1.9 1.1 6.7 2.0 1.5 0.0 1.1 1.3 43.6 1.1 1.4 1.1 0.8 1.2 1.1 1.1 14.8 41.2 1.5 3.5 1.5 1.1 0.1 0.1 12.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 34.9 0.0 0.0 1.4 19.4 11.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 12.1 0.0 0.0 12.3 146.9 27.8 14.7 6.8 2.8 3.9 11.5 6.7 14.8 ARRDC4 FLJ36045 ENSG00000140450 "Arrestin domain containing 4" Q8NCT1 15 97960698-97973838 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.7;BJ: 38.5;HSkMC: 21.7;hTCEpi: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 2.3;classical monocyte: 5.1;eosinophil: 3.1;intermediate monocyte: 3.6;myeloid DC: 2.4;neutrophil: 3.0" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 3.1;monocytes: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039934, HPA042109" Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA039934: , HPA042109: AB_10795606" "unprognostic (2.13e-1)" "unprognostic (1.10e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-3)" "unprognostic (4.49e-3)" "unprognostic (8.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.78e-1)" "unprognostic (7.65e-2)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-2)" "unprognostic (2.02e-3)" "unprognostic (2.90e-2)" "unprognostic (1.65e-1)" "unprognostic (3.04e-2)" "unprognostic (6.77e-2)" 9.2 9.3 11.4 11.5 18.4 6.7 14.8 3.3 16.3 9.4 27.4 67.3 11.6 11.2 10.7 11.9 11.8 10.8 14.7 9.7 18.7 9.2 14.1 21.8 14.1 6.4 18.1 15.2 7.4 25.0 3.7 6.5 13.0 29.4 8.3 17.0 4.6 6.5 13.5 10.1 25.3 15.3 14.0 48.7 5.9 18.1 10.2 41.9 1.9 14.9 4.5 3.5 11.7 12.4 0.5 2.4 3.1 5.1 0.1 0.1 0.8 2.1 0.0 0.3 5.6 2.5 18.7 0.0 38.5 17.2 5.1 2.3 2.3 1.3 0.0 5.4 1.7 2.2 1.4 13.4 8.3 0.0 3.6 3.7 0.7 1.5 1.0 2.5 5.8 21.7 33.3 5.8 6.9 0.2 5.1 0.0 1.8 6.9 0.4 2.1 1.1 0.8 0.0 0.3 0.0 10.0 4.7 1.9 3.3 5.8 2.1 10.4 0.8 3.9 0.0 1.5 1.1 8.0 1.8 0.0 0.0 0.0 3.3 0.4 4.0 2.3 5.1 3.1 0.1 3.6 0.0 0.5 0.0 0.0 2.4 0.4 0.1 0.0 3.0 0.1 0.6 0.6 0.0 0.8 11.4 18.4 3.3 16.3 18.7 9.2 18.1 15.2 29.4 41.9 ARSF ENSG00000062096 "Arylsulfatase F" P54793 X 3041471-3112726 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3;kidney: 11.5;skin 1: 8.3" "Cell line enhanced" "Detected in some" "BEWO: 2.0;U-266/70: 1.1" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" HPA000549 Uncertain Cytosol "Secreted in other tissues" Cytosol "HPA000549: AB_1845055" "unprognostic (2.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.87e-1)" "unprognostic (5.41e-3)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (9.72e-2)" "unprognostic (4.70e-1)" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (3.59e-1)" "unprognostic (1.23e-1)" "unprognostic (9.76e-2)" "unprognostic (1.48e-1)" 0.0 4.6 2.7 0.0 5.3 0.0 0.1 0.0 1.9 0.4 0.0 0.0 0.0 2.5 3.1 0.0 0.0 0.0 1.3 0.5 11.5 1.7 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.6 1.5 0.3 0.2 1.9 0.3 0.8 0.3 0.0 0.2 0.4 0.5 0.7 0.0 0.2 2.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.2 0.3 0.2 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.1 0.5 0.1 0.1 1.1 0.1 0.1 0.8 0.3 0.3 1.9 0.3 0.4 0.2 0.3 0.3 0.1 0.3 0.2 0.0 0.3 0.3 0.3 1.2 0.8 0.1 0.2 0.1 0.0 ART3 ENSG00000156219 "ADP-ribosyltransferase 3" Q13508 4 76011184-76112802 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "brain: 29.1;heart muscle: 55.1;skeletal muscle: 85.2;testis: 42.6;tongue: 27.2" "Group enriched" "Detected in some" 8 "NB-4: 6.1;NTERA-2: 16.5;SK-MEL-30: 7.3" "Cancer enhanced" "Detected in some" "breast cancer: 2.3" "Region enhanced" "Detected in many" "cerebellum: 29.1" "Cell type enriched" "Detected in single" 5 "gdT-cell: 1.9" "Lineage enriched" "Detected in single" 18 "T-cells: 1.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 5 "cerebellum: 1.2" HPA011268 Enhanced "Intracellular and membrane" 45000000 "HPA011268: AB_1845059" "unprognostic (2.45e-1)" "unprognostic (2.84e-2)" "unprognostic (3.12e-2)" "unprognostic (2.77e-3)" "unprognostic (4.53e-2)" "unprognostic (1.34e-1)" "unprognostic (3.34e-1)" "unprognostic (9.85e-4)" "unprognostic (2.35e-1)" "unprognostic (5.10e-2)" "unprognostic (1.64e-2)" "unprognostic (2.95e-1)" "unprognostic (1.73e-2)" "unprognostic (2.53e-1)" "unprognostic (1.48e-1)" "unprognostic (2.58e-2)" "unprognostic (6.61e-3)" 3.5 0.6 4.9 0.9 1.9 0.4 0.7 29.1 9.0 1.0 1.3 6.0 0.0 0.6 0.5 1.1 2.5 0.5 0.5 55.1 3.0 0.9 0.5 0.5 0.6 0.5 3.9 2.0 0.5 3.8 0.4 1.1 0.5 2.7 1.0 1.4 0.4 1.3 1.0 85.2 0.5 0.8 0.6 3.0 1.5 0.9 42.6 7.2 0.0 0.5 27.2 0.5 0.6 0.7 0.0 0.0 0.1 0.0 0.0 1.9 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.1 16.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.9 1.9 29.1 9.0 3.0 0.9 3.9 2.0 2.7 7.2 ARVCF ENSG00000099889 "ARVCF, delta catenin family member" O00192 22 19969896-20016808 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.8" "Cell line enhanced" "Detected in many" "K-562: 15.4;SCLC-21H: 14.7;SH-SY5Y: 11.3;U-2 OS: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016162, HPA055264, HPA063675" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "CAB016162: AB_2058690, HPA055264: , HPA063675: " "unprognostic (1.66e-1)" "unprognostic (1.48e-2)" "unprognostic (4.00e-2)" "unprognostic (4.28e-2)" "unprognostic (3.35e-1)" "unprognostic (3.18e-2)" "unprognostic (4.79e-3)" "unprognostic (1.67e-2)" "unprognostic (2.06e-2)" "unprognostic (1.71e-2)" "unprognostic (2.09e-3)" "unprognostic (5.77e-2)" "unprognostic (4.00e-3)" "unprognostic (9.84e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "prognostic favourable (5.76e-6)" 3.4 6.6 9.0 1.8 6.1 6.0 3.2 30.8 11.1 3.4 3.2 7.7 3.5 2.7 4.2 14.6 3.1 2.6 8.0 6.2 8.1 8.1 5.0 4.9 3.9 1.4 3.8 6.8 2.9 8.7 4.9 7.3 2.7 5.9 6.1 1.1 6.4 8.7 4.6 13.4 5.3 3.7 3.6 4.0 13.4 5.2 5.2 2.8 0.5 12.1 1.6 1.5 2.8 1.8 0.0 0.6 0.0 0.2 0.7 1.2 0.8 3.2 0.3 4.4 5.7 0.0 0.0 4.6 0.8 0.3 0.2 0.5 0.9 0.7 1.3 3.6 0.4 3.0 0.7 1.4 0.0 0.4 5.5 0.4 0.3 3.4 1.3 0.4 1.0 0.1 0.5 0.2 0.2 3.6 15.4 0.4 0.0 2.9 0.2 2.0 4.5 1.8 8.2 0.2 0.4 0.8 0.7 14.7 11.3 0.9 1.4 2.2 1.2 0.3 1.3 0.1 12.9 0.5 0.3 1.8 0.5 0.4 0.2 0.2 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 1.2 0.0 0.7 0.0 0.6 0.0 0.8 9.0 6.1 30.8 8.9 8.1 8.1 3.8 6.8 5.9 2.8 ARX "CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS" ENSG00000004848 "Aristaless related homeobox" Q96QS3 X 25003694-25016420 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Epilepsy, Lissencephaly, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 25.2;ovary: 58.7;skeletal muscle: 16.9" "Cell line enhanced" "Detected in some" "HAP1: 2.9;PC-3: 6.0;THP-1: 2.5;U-266/70: 12.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 9.5;basal ganglia: 6.7;cerebral cortex: 25.2;hippocampal formation: 10.4;olfactory region: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (8.28e-2)" "unprognostic (3.06e-2)" "unprognostic (1.98e-1)" "prognostic unfavourable (3.54e-7)" "unprognostic (9.85e-2)" "unprognostic (7.96e-3)" "unprognostic (1.18e-1)" "unprognostic (2.77e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-3)" "unprognostic (1.32e-1)" "unprognostic (1.06e-6)" "unprognostic (6.01e-2)" "unprognostic (1.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.91e-1)" 0.5 0.5 9.5 0.5 6.7 0.5 0.7 0.3 25.2 0.5 1.1 1.9 0.0 2.9 0.5 1.8 0.5 1.1 0.5 0.5 10.4 2.6 0.6 0.5 0.8 0.5 0.9 17.1 58.7 2.7 4.4 0.5 0.5 0.0 0.7 1.1 0.0 0.5 0.5 16.9 0.5 1.0 0.5 0.3 0.6 4.9 13.6 3.1 0.0 0.5 0.5 0.8 0.5 0.5 0.0 0.1 0.6 0.4 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 6.0 0.6 0.0 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.5 2.5 0.0 0.0 0.2 0.0 0.0 12.8 0.4 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 9.5 6.7 0.3 25.2 10.4 2.6 0.9 17.1 0.0 3.1 ASCL1 "ASH1, bHLHa46, HASH1" ENSG00000139352 "Achaete-scute family bHLH transcription factor 1" P50553 12 102957686-102960516 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3;liver: 23.0;pituitary gland: 29.4" "Group enriched" "Detected in some" 22 "SCLC-21H: 32.6;SH-SY5Y: 17.6" "Group enriched" "Detected in many" 6 "glioma: 21.4;lung cancer: 11.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029217, HPA076307" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA029217: AB_10669595, HPA076307: " "unprognostic (7.92e-2)" "unprognostic (4.37e-3)" "unprognostic (4.55e-2)" "unprognostic (5.02e-2)" "unprognostic (3.12e-1)" "unprognostic (1.22e-2)" "unprognostic (1.56e-1)" "unprognostic (2.09e-1)" "unprognostic (4.84e-2)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (7.10e-6)" "unprognostic (3.40e-1)" "unprognostic (2.17e-1)" "unprognostic (3.76e-1)" "unprognostic (5.52e-2)" 0.9 2.8 11.1 0.7 6.9 0.7 0.7 3.3 19.3 1.3 0.9 6.6 0.0 0.9 1.0 0.8 0.7 2.2 0.8 0.7 8.5 5.8 0.8 23.0 1.7 1.4 7.6 4.7 1.6 0.9 0.7 29.4 0.8 13.9 1.1 1.0 0.0 0.7 0.8 0.8 0.7 0.8 0.9 18.7 0.7 3.2 0.9 7.3 6.0 1.0 0.0 0.8 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 6.9 3.3 10.7 8.5 5.8 7.6 4.7 13.9 7.3 ASCL5 bHLHa47 ENSG00000232237 "Achaete-scute family bHLH transcription factor 5" Q7RTU5 1 201113953-201127184 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 5.2;pancreas: 7.3" "Cell line enhanced" "Detected in some" "CACO-2: 2.2;MCF7: 1.8;PC-3: 2.8;SCLC-21H: 3.2;U-2 OS: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 2.9;cerebral cortex: 2.1;hippocampal formation: 1.8" "unprognostic (9.71e-2)" "unprognostic (2.78e-2)" "unprognostic (1.52e-2)" "unprognostic (6.32e-2)" "unprognostic (9.43e-2)" "unprognostic (8.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.37e-1)" "unprognostic (4.84e-2)" "unprognostic (9.50e-2)" "unprognostic (7.48e-2)" "unprognostic (9.82e-2)" "unprognostic (2.25e-7)" "unprognostic (2.95e-1)" "unprognostic (1.38e-1)" "unprognostic (4.70e-2)" "unprognostic (1.48e-2)" 0.2 0.4 2.5 0.3 5.2 0.1 0.2 0.4 1.8 0.2 0.2 1.3 0.2 0.3 1.6 0.2 0.2 0.3 0.2 0.2 1.2 1.8 0.2 0.2 0.6 0.5 0.6 0.2 0.9 7.3 0.1 0.5 0.2 1.9 0.5 0.1 0.2 0.2 0.2 1.4 0.1 0.5 0.2 0.2 0.5 0.5 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.9 0.6 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.2 0.3 0.1 0.2 0.0 0.3 0.0 0.0 0.2 0.0 1.1 0.0 1.1 0.3 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.1 0.3 2.8 0.0 0.0 0.0 0.0 0.2 3.2 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.8 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 5.2 0.4 1.8 1.2 1.8 0.6 0.2 1.9 0.2 ASIC1 "ACCN2, BNaC2, hBNaC2" ENSG00000110881 "Acid sensing ion channel subunit 1" P78348 12 50057548-50083611 "FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 43.7" "Cell line enhanced" "Detected in many" "HEK 293: 16.8;SH-SY5Y: 19.4" "Cancer enhanced" "Detected in many" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058870 Supported "Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" "HPA058870: " "unprognostic (5.32e-3)" "unprognostic (1.70e-1)" "unprognostic (4.00e-2)" "unprognostic (3.56e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-3)" "unprognostic (2.92e-3)" "unprognostic (3.00e-2)" "unprognostic (1.72e-1)" "unprognostic (9.37e-2)" "unprognostic (2.34e-2)" "unprognostic (2.86e-3)" "unprognostic (6.97e-7)" "unprognostic (7.19e-2)" "unprognostic (3.73e-1)" "unprognostic (2.78e-3)" "unprognostic (8.27e-5)" 2.5 1.7 13.9 1.8 20.3 0.8 2.9 20.1 43.7 5.3 3.1 12.8 0.3 2.3 2.5 1.2 3.4 3.6 4.0 2.2 12.3 14.3 1.6 0.9 1.3 1.3 12.9 8.5 1.4 1.4 5.2 0.5 1.5 10.2 4.5 2.5 1.8 5.6 3.4 1.3 1.5 2.5 3.6 5.4 1.1 4.3 1.4 11.0 0.4 1.1 0.0 1.0 2.6 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 2.1 4.7 6.2 14.0 1.9 2.9 3.5 1.5 4.1 2.7 2.7 3.3 1.7 1.3 3.2 0.9 2.2 6.1 5.2 1.6 1.3 16.8 4.2 6.6 2.0 2.7 6.3 15.8 7.4 2.5 0.4 0.6 0.5 2.8 0.1 2.2 2.6 6.0 12.3 2.6 8.3 6.1 5.9 2.8 1.3 0.2 9.2 19.4 3.5 1.2 2.1 7.7 4.1 0.4 2.7 9.1 1.8 0.8 0.0 0.0 0.0 3.5 5.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 13.9 20.3 20.1 18.3 12.3 14.3 12.9 8.5 10.2 11.0 ASIC2 "ACCN, ACCN1, ASIC2a, BNaC1, BNC1, hBNaC1, MDEG" ENSG00000108684 "Acid sensing ion channel subunit 2" Q16515 17 33013087-34174964 "Plasma proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 13.1;cervix, uterine: 6.8;endometrium 1: 9.5;smooth muscle: 3.9" "Group enriched" "Detected in some" 4 "NTERA-2: 4.2;PC-3: 1.1;RPTEC TERT1: 3.8" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052112 Enhanced "HPA052112: AB_2681733" "unprognostic (3.40e-1)" "unprognostic (2.45e-2)" "unprognostic (8.50e-2)" "unprognostic (7.33e-2)" "unprognostic (1.88e-3)" "unprognostic (5.29e-2)" "unprognostic (4.88e-2)" "unprognostic (1.26e-1)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (1.28e-2)" "unprognostic (1.08e-1)" "unprognostic (1.29e-2)" "unprognostic (1.28e-2)" "unprognostic (1.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" 0.4 1.9 8.1 0.4 6.3 0.3 0.7 8.7 13.1 6.8 0.7 1.1 0.0 1.2 9.5 0.5 0.4 1.5 0.5 0.4 7.7 10.0 1.2 0.4 0.5 0.4 4.6 5.5 0.4 0.4 0.3 0.5 0.5 3.7 0.6 0.8 0.2 0.3 1.7 0.3 0.6 1.2 3.9 2.3 0.4 0.5 1.1 0.8 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.2 1.1 0.0 0.0 0.5 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 6.3 8.7 9.6 7.7 10.0 4.6 5.5 3.7 0.8 ASIC3 "ACCN3, DRASIC, TNaC1" ENSG00000213199 "Acid sensing ion channel subunit 3" Q9UHC3 7 151048292-151052756 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1" "Cell line enhanced" "Detected in many" "U-266/70: 16.9;U-266/84: 8.9" "Cancer enhanced" "Detected in many" "testis cancer: 7.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049155, HPA054805" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA049155: , HPA054805: " "unprognostic (8.71e-3)" "unprognostic (1.09e-1)" "unprognostic (1.92e-4)" "unprognostic (2.73e-1)" "unprognostic (7.06e-2)" "unprognostic (2.02e-2)" "unprognostic (2.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.42e-1)" "unprognostic (4.45e-2)" "unprognostic (8.64e-3)" "unprognostic (1.67e-2)" "unprognostic (1.33e-12)" "unprognostic (1.49e-2)" "unprognostic (7.38e-2)" "unprognostic (1.65e-2)" "unprognostic (5.31e-3)" 2.6 2.4 6.8 0.9 27.1 1.5 1.3 20.1 15.4 3.6 2.3 0.9 0.5 2.9 4.9 3.5 0.6 2.4 1.9 2.4 6.5 5.3 1.5 1.3 2.7 1.9 4.2 9.9 3.0 1.4 1.4 7.1 1.8 6.2 1.9 1.8 0.7 1.7 1.4 9.0 3.5 2.7 2.4 6.0 2.1 2.8 10.2 2.2 0.5 1.1 0.5 1.9 0.9 1.2 0.0 0.0 0.0 0.8 0.0 0.7 0.0 1.3 3.5 1.6 2.4 3.3 0.0 7.2 0.4 0.0 0.3 0.4 0.7 1.6 0.8 0.4 0.2 2.2 0.9 0.0 0.7 7.7 4.1 1.6 2.6 0.0 0.0 0.1 3.8 0.5 0.5 0.2 0.0 0.1 3.8 6.3 0.5 5.9 0.3 0.4 1.7 2.8 2.9 1.6 0.5 0.3 1.3 2.1 8.4 0.6 0.4 4.1 1.7 0.4 0.1 1.5 2.2 4.0 1.0 16.9 8.9 0.1 2.0 5.6 1.4 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.8 27.1 20.1 15.4 6.5 5.3 4.2 9.9 6.2 2.2 ASIC4 "ACCN4, BNAC4" ENSG00000072182 "Acid sensing ion channel subunit family member 4" Q96FT7 2 219514170-219538772 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.7;pituitary gland: 20.6" "Group enriched" "Detected in some" 30 "HEL: 18.7;HMC-1: 5.6;K-562: 10.7;SH-SY5Y: 5.1" "Cancer enriched" "Detected in single" 38 "glioma: 8.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 65.5" "Low region specificity" "Detected in many" "HPA036042, HPA057078" Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite" "Golgi apparatus, Centriolar satellite" "Nucleoplasm, Plasma membrane" "HPA036042: AB_10672998, HPA057078: " "unprognostic (3.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.55e-1)" "unprognostic (1.61e-2)" "unprognostic (2.62e-1)" "unprognostic (8.74e-2)" "unprognostic (3.04e-2)" "unprognostic (2.54e-1)" "unprognostic (6.53e-2)" "unprognostic (1.90e-2)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (7.80e-8)" "unprognostic (3.82e-2)" "unprognostic (2.30e-1)" "unprognostic (5.51e-1)" "unprognostic (2.48e-2)" 0.8 3.3 4.9 0.6 4.7 0.5 0.6 6.9 17.7 1.0 0.5 1.6 0.0 0.5 0.8 0.6 0.5 0.6 0.6 0.6 3.9 4.5 0.5 0.6 0.9 0.6 4.8 2.9 0.5 0.5 0.5 20.6 0.6 3.0 0.6 0.5 4.9 0.6 0.8 0.5 0.6 0.5 0.7 1.9 0.6 0.7 1.6 3.1 0.0 0.5 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 4.7 6.9 4.9 3.9 4.5 4.8 2.9 3.0 3.1 ASMT "ASMTY, HIOMT, HIOMTY" ENSG00000196433 "Acetylserotonin O-methyltransferase" P46597 X 1615001-1643081 "Enzymes, Predicted intracellular proteins" "Melatonin biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.8;epididymis: 7.0" "Cell line enhanced" "Detected in some" "BEWO: 2.9;NTERA-2: 1.4;U-266/70: 2.1;U-266/84: 3.7" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "pons and medulla: 8.8" "Group enriched" "Detected in some" 4 "memory B-cell: 2.2;memory CD8 T-cell: 2.0;naive B-cell: 3.8;NK-cell: 1.0" "Group enriched" "Detected in many" 4 "B-cells: 3.8;NK-cells: 1.0;T-cells: 2.0" "unprognostic (1.84e-2)" "unprognostic (1.63e-3)" "unprognostic (1.89e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-1)" "unprognostic (8.55e-4)" "unprognostic (1.54e-1)" "unprognostic (2.27e-2)" "unprognostic (4.30e-3)" "unprognostic (1.56e-1)" "unprognostic (1.43e-3)" "unprognostic (2.64e-1)" "unprognostic (4.04e-3)" "unprognostic (1.49e-1)" "unprognostic (3.27e-2)" "unprognostic (2.23e-1)" "unprognostic (2.79e-3)" 0.6 2.3 0.6 1.2 0.7 2.4 0.8 1.2 0.6 1.3 0.8 0.6 0.6 0.3 1.4 7.0 0.6 0.9 0.7 0.6 0.8 0.7 0.6 0.6 0.8 0.8 1.8 0.6 0.7 1.3 0.7 3.8 0.6 8.8 1.0 0.2 0.6 1.2 1.0 0.8 1.6 0.7 0.9 4.1 1.4 0.6 0.6 0.6 0.6 1.1 0.6 0.6 0.6 0.9 3.8 0.0 0.5 0.0 1.0 2.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 2.9 0.2 0.0 0.6 0.0 0.0 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.1 1.4 0.0 0.8 0.1 0.2 0.8 0.1 0.1 0.0 0.0 0.4 0.1 0.1 0.4 0.0 0.0 0.0 1.2 0.0 2.1 3.7 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.5 2.0 0.0 3.8 0.2 0.1 0.5 1.0 0.0 0.0 0.0 0.1 0.6 0.7 1.2 0.6 0.8 0.7 1.8 0.6 8.8 0.6 ASPA "ACY2, ASP" ENSG00000108381 Aspartoacylase P45381 17 3472374-3503419 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.3;kidney: 33.2" "Cell line enhanced" "Detected in some" "ASC diff: 8.1;ASC TERT1: 6.3;CACO-2: 5.4;HSkMC: 11.4" "Cancer enhanced" "Detected in some" "renal cancer: 7.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022142, HPA022145" Enhanced Uncertain Cytosol Cytosol "HPA022142: AB_1845102, HPA022145: AB_1845103" "unprognostic (4.42e-2)" "unprognostic (4.79e-2)" "unprognostic (2.02e-2)" "unprognostic (2.79e-3)" "unprognostic (4.36e-2)" "unprognostic (5.01e-1)" "unprognostic (1.08e-3)" "unprognostic (3.57e-1)" "unprognostic (4.17e-1)" "unprognostic (3.43e-1)" "unprognostic (5.27e-2)" "unprognostic (6.27e-2)" "unprognostic (1.25e-1)" "unprognostic (7.07e-4)" "unprognostic (2.77e-1)" "unprognostic (4.68e-1)" "unprognostic (1.49e-1)" 10.9 4.1 14.5 1.8 37.6 1.7 3.3 3.0 19.4 6.2 3.6 35.2 3.1 9.7 4.1 5.5 4.5 5.0 3.3 2.2 21.9 11.0 33.2 12.6 3.2 1.3 50.2 11.3 2.9 1.0 0.9 0.9 3.1 18.9 4.0 4.6 2.6 1.9 4.8 9.3 4.6 13.3 2.9 22.4 4.6 3.9 5.6 51.3 0.0 1.8 1.1 0.8 4.5 3.5 1.7 1.2 3.6 0.7 1.6 1.3 0.2 0.4 0.2 0.9 0.7 8.1 6.3 0.5 0.4 0.3 0.3 0.3 5.4 0.3 1.1 0.3 1.0 0.5 0.5 0.3 0.4 2.8 0.3 0.5 0.9 0.4 0.9 0.7 0.8 11.4 0.6 0.7 0.2 0.1 0.6 1.9 0.4 0.4 0.3 0.9 0.8 0.5 0.4 0.5 0.9 0.4 1.6 0.7 0.5 1.6 0.6 1.2 0.6 0.3 0.6 1.0 0.7 0.7 0.4 1.2 0.6 0.7 0.4 0.6 0.8 3.4 0.7 0.8 1.2 0.6 1.0 1.1 1.0 0.9 0.5 1.7 1.2 1.3 3.6 1.6 0.7 1.2 0.5 0.2 14.5 37.6 3.0 19.4 21.9 11.0 50.2 11.3 18.9 51.3 ASPDH ENSG00000204653 "Aspartate dehydrogenase domain containing" A6ND91 19 50511600-50514690 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.9;kidney: 24.7;liver: 59.8" "Cell line enhanced" "Detected in some" "HEK 293: 13.3;MOLT-4: 15.5;SH-SY5Y: 9.2" "Cancer enriched" "Detected in some" 13 "liver cancer: 24.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042631, HPA042654" Approved Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" 51000 Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA042631: AB_10794530, HPA042654: AB_10794383" "unprognostic (5.79e-2)" "unprognostic (9.47e-2)" "unprognostic (8.97e-3)" "unprognostic (6.13e-3)" "unprognostic (5.13e-1)" "unprognostic (3.64e-2)" "unprognostic (3.15e-3)" "unprognostic (3.32e-2)" "unprognostic (2.87e-2)" "unprognostic (2.09e-2)" "unprognostic (2.87e-3)" "unprognostic (6.70e-3)" "unprognostic (9.65e-3)" "unprognostic (3.36e-2)" "unprognostic (1.07e-1)" "unprognostic (5.31e-4)" "unprognostic (1.99e-3)" 1.3 3.2 11.7 1.6 16.2 1.3 0.9 7.4 26.9 0.9 1.0 8.9 0.0 6.9 1.1 0.9 1.2 0.9 2.3 1.2 12.9 8.3 24.7 59.8 1.1 1.6 9.2 9.8 0.9 1.5 0.9 7.7 0.9 4.1 1.2 0.9 1.0 2.3 0.9 1.1 1.8 2.9 0.9 5.1 1.4 1.1 1.1 6.6 1.3 1.7 0.0 0.9 1.1 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 13.3 0.0 0.5 3.7 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.0 1.6 15.5 0.1 0.0 0.3 0.3 0.3 1.0 0.0 0.2 1.7 9.2 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.7 0.0 0.0 3.7 0.7 1.9 0.2 2.3 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.7 16.2 7.4 26.9 12.9 8.3 9.2 9.8 4.1 6.6 ASPHD1 ENSG00000174939 "Aspartate beta-hydroxylase domain containing 1" Q5U4P2 16 29900375-29919864 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.0;HeLa: 20.6;Hep G2: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA045175 Uncertain "HPA045175: AB_10959899" "unprognostic (1.58e-1)" "unprognostic (5.50e-2)" "unprognostic (4.74e-3)" "unprognostic (2.20e-3)" "unprognostic (1.34e-3)" "unprognostic (6.96e-2)" "unprognostic (5.75e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-2)" "unprognostic (8.37e-2)" "prognostic favourable (7.38e-4)" "unprognostic (5.55e-2)" "unprognostic (6.17e-2)" "unprognostic (1.97e-2)" "unprognostic (1.90e-1)" "unprognostic (2.97e-1)" "unprognostic (9.03e-2)" 1.8 5.5 32.0 2.0 38.6 1.5 2.2 22.0 52.3 2.2 2.4 16.2 0.0 5.1 2.4 1.5 1.4 2.6 12.8 1.5 32.5 17.1 2.3 1.6 2.0 1.6 29.8 19.4 1.8 11.6 2.3 10.6 1.6 17.1 2.5 2.3 0.3 7.0 2.1 1.6 1.4 3.4 2.7 24.6 1.5 15.8 4.3 13.4 0.0 1.4 0.0 1.7 1.8 0.0 0.5 0.0 0.0 0.0 0.8 0.3 0.0 1.2 6.2 0.0 4.6 0.0 0.6 0.3 6.8 1.4 4.5 3.1 15.0 20.0 2.5 16.6 3.1 0.7 0.6 1.1 0.9 0.2 0.9 1.4 20.6 28.2 9.3 0.1 15.7 5.4 1.2 6.8 0.3 0.2 0.0 4.3 1.1 12.0 0.2 0.1 9.3 5.4 0.3 0.0 0.9 4.0 0.1 16.2 8.4 0.0 9.9 1.6 3.2 4.3 0.5 2.4 5.2 0.0 1.8 0.3 0.1 0.1 9.9 15.9 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 32.0 38.6 22.0 26.3 32.5 17.1 29.8 19.4 17.1 13.4 ASPHD2 FLJ39838 ENSG00000128203 "Aspartate beta-hydroxylase domain containing 2" Q6ICH7 22 26429273-26445015 "Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Cell line enhanced" "Detected in many" "Karpas-707: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000820 Uncertain "HPA000820: AB_1078231" "unprognostic (1.12e-1)" "unprognostic (1.64e-1)" "unprognostic (1.07e-2)" "unprognostic (2.71e-1)" "unprognostic (1.94e-1)" "unprognostic (9.07e-2)" "unprognostic (2.02e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-2)" "unprognostic (8.98e-2)" "unprognostic (1.73e-1)" "unprognostic (1.79e-1)" "prognostic unfavourable (4.06e-5)" "unprognostic (6.55e-2)" "unprognostic (9.26e-2)" "unprognostic (1.09e-2)" "unprognostic (1.11e-2)" 0.9 1.1 7.6 3.8 23.9 2.1 1.1 17.6 13.1 1.8 3.3 1.2 0.3 2.0 2.1 10.5 2.0 0.7 2.7 0.5 5.8 5.0 3.6 0.6 1.5 6.4 3.3 4.4 1.0 1.1 0.4 5.6 2.0 3.9 1.4 3.5 1.1 1.3 1.3 0.6 8.5 2.2 1.4 1.7 4.1 13.0 2.7 4.2 2.4 3.4 0.6 5.3 3.5 1.0 1.7 4.0 0.9 7.7 0.0 1.5 0.7 1.3 0.7 3.5 5.6 0.5 0.3 1.9 1.7 3.9 3.7 5.4 0.0 0.3 1.1 0.4 1.7 1.6 3.9 6.0 2.0 7.9 5.2 0.3 0.0 0.2 3.6 1.9 0.9 0.6 2.9 1.9 2.6 3.9 1.4 18.8 1.1 0.4 1.5 0.8 3.4 0.8 10.1 2.0 3.0 5.2 0.5 9.5 4.1 1.8 0.2 1.9 0.2 2.9 3.6 2.4 11.8 0.5 3.6 5.4 1.3 2.3 3.6 7.1 1.5 0.0 2.1 0.9 0.7 5.4 1.5 1.6 1.2 1.2 3.5 1.7 0.8 0.7 0.6 0.0 7.7 4.0 0.7 0.7 7.6 23.9 17.6 11.4 5.8 5.0 3.3 4.4 3.9 4.2 ASTN1 ASTN ENSG00000152092 "Astrotactin 1" O14525 1 176857302-177164973 "Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 19.9;brain: 52.5" "Cell line enhanced" "Detected in some" "Karpas-707: 5.9;NTERA-2: 4.5;SCLC-21H: 2.8;U-2 OS: 3.6;U-266/84: 20.1" "Cancer enriched" "Detected in some" 14 "glioma: 15.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074112 Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA074112: " "unprognostic (4.41e-3)" "unprognostic (1.48e-2)" "unprognostic (4.03e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "unprognostic (7.61e-2)" "unprognostic (2.03e-4)" "unprognostic (3.86e-3)" "unprognostic (1.08e-1)" "unprognostic (4.36e-1)" "unprognostic (1.67e-3)" "unprognostic (1.98e-1)" "unprognostic (6.77e-2)" "unprognostic (4.74e-3)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (1.16e-1)" 1.4 19.9 21.5 1.6 23.8 1.1 1.7 15.0 52.5 1.3 1.5 7.4 1.9 1.5 2.3 5.4 1.2 3.2 1.9 1.7 17.4 13.7 1.3 1.4 1.4 1.2 8.5 18.8 8.9 1.7 1.2 8.2 1.6 9.8 2.4 1.6 2.2 2.0 3.3 1.3 1.1 1.5 2.2 5.8 3.6 1.2 1.9 7.2 0.0 1.2 0.0 1.5 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.9 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 23.8 15.0 27.2 17.4 13.7 8.5 18.8 9.8 7.2 ASXL3 KIAA1713 ENSG00000141431 "Additional sex combs like 3, transcriptional regulator" Q9C0F0 18 33578233-33751192 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Cell line enhanced" "Detected in some" "AF22: 4.0;RPMI-8226: 11.9;SCLC-21H: 4.6;SH-SY5Y: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039539, HPA040034" Uncertain "HPA039539: , HPA040034: " "unprognostic (2.05e-2)" "unprognostic (6.88e-2)" "unprognostic (2.91e-1)" "unprognostic (3.73e-4)" "unprognostic (1.30e-1)" "unprognostic (3.19e-1)" "unprognostic (1.87e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (9.16e-2)" "unprognostic (5.35e-3)" "unprognostic (5.92e-2)" "unprognostic (2.47e-12)" "unprognostic (4.69e-2)" "unprognostic (2.32e-1)" "unprognostic (4.98e-3)" "unprognostic (1.67e-2)" 1.0 0.7 6.6 0.7 5.4 0.4 0.8 0.4 10.3 3.4 1.7 1.7 1.7 1.5 1.4 1.8 0.6 2.6 2.0 2.1 4.0 3.3 2.8 1.3 0.9 0.6 5.4 8.8 9.2 1.7 3.7 2.5 1.0 4.3 2.3 1.1 0.9 1.0 2.8 0.4 0.5 1.8 7.4 5.5 0.8 2.3 6.1 5.4 0.0 3.2 0.0 0.5 1.7 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 11.9 0.0 0.0 4.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.6 5.4 0.4 10.3 4.0 3.3 5.4 8.8 4.3 5.4 ATCAY BNIP-H ENSG00000167654 "ATCAY, caytaxin" Q86WG3 19 3879864-3928079 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 70.1" "Cell line enhanced" "Detected in some" "NTERA-2: 8.1;SCLC-21H: 15.0;SH-SY5Y: 10.6" "Cancer enriched" "Detected in some" 8 "glioma: 15.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017755 Enhanced "HPA017755: " "unprognostic (7.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.63e-2)" "unprognostic (1.91e-1)" "unprognostic (7.11e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" "unprognostic (3.05e-2)" "unprognostic (4.89e-2)" "unprognostic (9.83e-4)" "unprognostic (7.22e-2)" "unprognostic (8.78e-3)" "unprognostic (1.78e-1)" "unprognostic (1.36e-1)" "unprognostic (1.24e-2)" "unprognostic (2.67e-1)" 1.3 8.2 19.6 1.8 19.8 1.5 1.3 14.1 70.1 1.8 1.5 3.4 0.1 1.7 1.3 1.3 1.4 1.2 1.4 1.3 16.9 25.5 1.3 1.3 1.3 1.4 12.2 21.4 1.3 1.5 1.2 10.1 1.3 16.0 3.1 1.6 1.1 1.3 4.6 2.3 1.6 1.8 1.4 4.3 1.3 1.6 1.4 4.2 0.0 1.4 0.0 1.2 1.4 0.3 1.4 0.8 3.2 0.7 1.7 0.8 0.6 0.5 0.1 3.1 0.3 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.2 0.7 0.5 0.2 0.0 0.5 0.2 0.0 0.0 0.2 0.3 0.9 1.1 0.2 0.0 1.1 1.3 0.0 0.0 0.0 0.1 0.0 0.5 0.6 0.1 0.2 0.2 0.4 8.1 0.1 0.3 0.5 0.3 0.1 0.2 15.0 10.6 0.2 0.2 0.1 0.2 0.3 0.5 0.5 0.7 0.5 0.7 0.4 0.3 0.3 0.4 1.5 0.2 2.2 0.7 0.9 0.6 0.5 0.5 0.6 0.7 0.6 0.3 1.4 0.8 0.8 3.2 1.7 0.4 0.8 0.5 0.6 19.6 19.8 14.1 33.0 16.9 25.5 12.2 21.4 16.0 4.2 ATL1 "AD-FSP, FSP1, SPG3, SPG3A" ENSG00000198513 "Atlastin GTPase 1" Q8WXF7 14 50532509-50633068 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.7" "Cell line enhanced" "Detected in many" "HDLM-2: 14.7;SCLC-21H: 13.5;SH-SY5Y: 12.3;SiHa: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 16.0" "Group enriched" "Detected in many" 5 "granulocytes: 16.0;T-cells: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027550 Enhanced 9500 "HPA027550: AB_10600983" "unprognostic (2.06e-2)" "unprognostic (7.57e-3)" "unprognostic (1.82e-1)" "unprognostic (7.93e-2)" "unprognostic (2.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.29e-1)" "unprognostic (1.88e-1)" "unprognostic (7.31e-2)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (6.50e-2)" "unprognostic (1.22e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-1)" "unprognostic (4.95e-2)" "unprognostic (1.23e-2)" 3.4 5.7 19.0 3.6 26.8 1.1 10.1 15.9 52.7 5.7 5.4 12.5 0.4 3.6 7.7 3.3 5.3 6.1 4.8 2.0 23.7 19.6 4.0 1.0 4.3 1.9 15.6 23.9 9.7 2.9 2.5 7.7 1.2 24.2 8.0 5.4 0.9 10.6 8.4 1.2 8.8 4.6 13.4 13.9 1.5 3.2 6.6 13.8 0.0 2.7 0.6 2.1 6.3 2.7 1.7 2.0 16.0 0.6 0.3 4.3 1.3 1.1 1.2 4.0 4.1 0.4 0.0 2.4 4.4 7.0 4.5 5.8 0.0 3.0 2.7 2.0 0.1 1.2 6.2 1.0 2.0 14.7 1.6 1.4 0.8 0.4 0.2 0.2 2.6 2.9 1.6 6.6 1.4 0.5 0.0 0.8 6.7 0.4 1.1 0.7 3.9 1.3 0.7 10.0 0.4 1.1 2.0 13.5 12.3 14.5 0.9 0.3 0.1 1.6 0.7 4.9 4.0 0.0 2.1 0.6 2.9 1.2 3.1 0.2 0.3 16.0 0.2 3.9 2.7 0.0 0.4 1.7 1.0 1.9 1.1 1.1 1.5 4.3 0.5 0.3 0.6 2.0 0.2 1.3 19.0 26.8 15.9 34.6 23.7 19.6 15.6 23.9 24.2 13.8 ATOH7 "bHLHa13, Math5" ENSG00000179774 "Atonal bHLH transcription factor 7" Q8N100 10 68230624-68232103 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 10.4;liver: 3.9" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 9 "cerebellum: 32.2" "Low region specificity" "Detected in many" HPA027008 Uncertain "HPA027008: AB_10600783" "unprognostic (7.17e-2)" "unprognostic (2.81e-1)" "unprognostic (7.66e-2)" "unprognostic (1.86e-2)" "unprognostic (2.20e-3)" "unprognostic (7.40e-2)" "unprognostic (7.76e-2)" "unprognostic (6.16e-2)" "unprognostic (2.46e-1)" "unprognostic (9.28e-4)" "unprognostic (4.96e-3)" "unprognostic (1.17e-1)" "unprognostic (5.06e-4)" "unprognostic (1.72e-1)" "unprognostic (2.52e-2)" "unprognostic (1.36e-1)" "unprognostic (7.18e-2)" 0.4 0.4 5.5 0.2 5.7 0.3 0.4 4.9 10.4 0.5 0.7 0.2 0.0 1.4 1.1 0.9 0.3 0.4 0.4 0.4 3.9 0.9 1.6 3.9 0.2 0.2 0.5 5.0 0.3 1.5 0.2 0.2 0.2 0.2 0.3 0.5 0.0 0.4 0.4 0.5 0.3 1.6 0.5 0.2 0.3 0.7 0.8 0.5 0.0 0.3 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.3 0.0 0.4 0.0 0.1 0.0 13.1 0.5 0.5 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 5.7 4.9 10.4 3.9 0.9 0.5 5.0 0.2 0.5 ATP10B "ATPVB, FLJ21477, KIAA0715" ENSG00000118322 "ATPase phospholipid transporting 10B (putative)" O94823 5 160563120-160852214 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;intestine: 35.4" "Cell line enriched" "Detected in single" 23 "WM-115: 17.4" "Group enriched" "Detected in many" 7 "colorectal cancer: 19.0;pancreatic cancer: 4.2;stomach cancer: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034574 Uncertain "HPA034574: AB_10669992" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (4.47e-4)" "unprognostic (3.99e-2)" "unprognostic (6.10e-3)" "unprognostic (4.69e-2)" "unprognostic (4.86e-2)" "unprognostic (2.54e-1)" "unprognostic (1.20e-2)" "unprognostic (3.42e-2)" "unprognostic (5.12e-2)" "unprognostic (2.38e-3)" "unprognostic (5.13e-2)" "unprognostic (2.56e-1)" "unprognostic (3.38e-1)" "unprognostic (2.14e-1)" 0.5 0.4 4.3 4.1 9.4 0.4 0.7 5.1 10.0 1.7 33.8 27.8 1.5 18.9 0.4 11.4 8.2 0.7 12.8 0.5 5.5 2.8 0.5 0.4 0.5 0.4 13.8 6.8 0.4 4.2 0.4 0.4 0.4 13.1 0.5 35.4 0.0 2.8 1.0 0.4 8.4 21.1 1.6 20.2 0.4 4.1 0.7 14.0 0.0 0.5 0.0 2.5 1.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 9.4 5.1 10.0 5.5 2.8 13.8 6.8 13.1 14.0 ATP13A2 "CLN12, HSA9947, PARK9" ENSG00000159363 "ATPase 13A2" Q9NQ11 1 16985958-17011928 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 17.9" "Lineage enriched" "Detected in many" 6 "dendritic cells: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037038, CAB037111, HPA050910, HPA054717" Enhanced "CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: , HPA054717: " "unprognostic (3.81e-2)" "unprognostic (1.84e-2)" "unprognostic (5.61e-2)" "unprognostic (2.17e-2)" "unprognostic (1.66e-2)" "unprognostic (2.03e-1)" "prognostic unfavourable (3.33e-7)" "unprognostic (1.04e-1)" "unprognostic (9.71e-3)" "unprognostic (4.51e-1)" "unprognostic (9.85e-3)" "unprognostic (1.85e-1)" "unprognostic (5.75e-2)" "unprognostic (3.25e-2)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (6.84e-3)" 9.6 12.3 21.9 16.3 25.8 8.7 6.7 25.5 45.3 6.0 12.5 12.0 4.7 10.4 5.3 6.1 8.9 7.1 7.6 4.5 23.8 34.6 6.5 2.5 9.6 13.2 28.4 20.3 5.3 30.1 7.8 22.2 10.5 52.2 7.2 8.3 9.6 15.6 7.2 7.5 10.0 11.1 7.3 10.9 16.1 10.7 6.2 9.9 5.2 8.6 2.9 8.1 9.2 5.2 2.1 17.9 0.4 2.9 2.2 2.5 1.1 10.2 10.8 5.9 23.0 5.5 4.8 15.7 5.9 5.7 6.5 6.9 19.0 11.9 4.6 25.5 9.9 16.2 11.8 21.7 2.3 6.2 22.7 15.9 10.2 9.8 7.2 5.8 7.5 3.8 12.1 18.4 13.5 12.8 10.2 8.8 26.7 8.4 6.7 3.2 8.7 7.4 7.4 22.4 18.1 7.4 15.7 15.9 10.3 26.9 35.0 22.7 11.7 7.0 12.8 7.3 13.7 12.2 11.9 1.8 2.1 4.8 13.7 31.6 11.6 0.0 1.3 0.3 2.4 2.9 2.5 1.2 1.9 2.0 0.4 2.1 1.0 1.4 0.4 2.2 2.7 17.9 1.5 1.1 21.9 25.8 25.5 45.3 23.8 34.6 28.4 20.3 52.2 9.9 ATP13A5 FLJ16025 ENSG00000187527 "ATPase 13A5" Q4VNC0 3 193274790-193378843 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 15.2;breast: 17.5;salivary gland: 28.9" "Cell line enhanced" "Detected in some" "PC-3: 1.7;SK-BR-3: 5.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Region enriched" "Detected in many" 10 "pons and medulla: 15.2" "Cell type enriched" "Detected in single" 9 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA031771, HPA031774" Uncertain "HPA031771: , HPA031774: " "unprognostic (7.98e-2)" "unprognostic (3.01e-4)" "unprognostic (2.06e-3)" "unprognostic (2.72e-3)" "unprognostic (3.93e-1)" "unprognostic (1.67e-4)" "unprognostic (3.03e-1)" "unprognostic (2.31e-1)" "unprognostic (2.14e-2)" "unprognostic (1.73e-1)" "unprognostic (7.15e-2)" "unprognostic (1.10e-1)" "unprognostic (8.10e-2)" 0.1 0.0 1.4 0.1 1.5 0.1 17.5 0.3 0.9 0.1 0.1 2.8 0.1 0.0 0.3 0.9 0.9 0.0 0.1 0.1 1.0 0.7 0.1 0.1 0.4 0.1 0.9 0.1 0.2 0.1 0.1 0.2 0.1 15.2 0.3 0.0 0.4 28.9 0.1 1.3 5.1 0.1 0.1 0.3 0.1 1.4 0.3 0.1 0.4 1.4 1.3 0.7 0.1 0.1 0.4 0.4 4.1 0.3 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.7 1.0 1.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.2 0.7 1.7 0.3 1.0 0.0 0.0 0.4 0.6 0.0 0.0 5.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.9 0.3 0.9 0.0 0.3 0.4 0.3 0.4 0.3 0.3 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.2 0.2 4.1 0.3 0.0 0.4 0.1 0.1 1.4 1.5 0.3 0.9 1.0 0.7 0.9 0.1 15.2 0.1 ATP1A2 "FHM2, MHP2" ENSG00000018625 "ATPase Na+/K+ transporting subunit alpha 2" P50993 1 160115759-160143591 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "brain: 109.8;skeletal muscle: 305.8" "Cell line enhanced" "Detected in some" "AF22: 32.2;HHSteC: 9.4;RH-30: 10.5;U-87 MG: 6.5" "Cancer enriched" "Detected in many" 18 "glioma: 91.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022230 Enhanced "CAB022230: " "unprognostic (1.08e-2)" "unprognostic (4.42e-2)" "unprognostic (3.41e-2)" "unprognostic (2.83e-1)" "unprognostic (2.83e-1)" "unprognostic (7.98e-2)" "unprognostic (2.16e-2)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (8.85e-2)" "unprognostic (8.63e-4)" "unprognostic (1.70e-2)" "unprognostic (9.40e-3)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (7.16e-2)" "unprognostic (5.32e-3)" 12.6 3.9 61.4 2.8 80.1 2.3 6.5 30.4 109.8 4.7 6.6 27.4 2.4 3.7 4.2 7.4 15.3 6.0 5.3 35.4 42.2 27.0 3.3 2.5 3.8 2.4 45.6 37.9 9.9 2.6 2.4 4.6 3.6 58.0 13.8 5.6 12.5 3.1 14.2 305.8 2.8 4.4 5.4 51.5 2.7 2.8 3.9 28.3 0.0 2.6 17.7 2.5 5.5 1.3 0.6 1.4 1.7 0.4 0.6 0.5 0.3 0.0 0.0 32.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 2.8 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.3 0.4 0.3 0.3 0.3 0.2 0.4 0.3 0.2 0.7 0.6 0.3 0.5 1.7 0.6 0.2 1.4 0.2 0.3 61.4 80.1 30.4 52.0 42.2 27.0 45.6 37.9 58.0 28.3 ATP1A3 DYT12 ENSG00000105409 "ATPase Na+/K+ transporting subunit alpha 3" P13637 19 41966582-41997497 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Deafness, Disease mutation, Dystonia, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 146.4;heart muscle: 78.3" "Cell line enhanced" "Detected in many" "Daudi: 20.4;Karpas-707: 13.0;REH: 12.8;SCLC-21H: 48.3;SH-SY5Y: 20.8" "Group enriched" "Detected in many" 6 "glioma: 21.6;testis cancer: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "CAB033630, HPA045367, HPA056446" Enhanced Approved "CAB033630: AB_781528, HPA045367: , HPA056446: " "unprognostic (1.90e-1)" "unprognostic (8.65e-2)" "unprognostic (4.57e-2)" "unprognostic (8.20e-3)" "unprognostic (8.94e-2)" "unprognostic (2.52e-1)" "unprognostic (3.16e-2)" "unprognostic (7.66e-2)" "unprognostic (8.02e-2)" "prognostic unfavourable (3.44e-4)" "prognostic favourable (6.15e-5)" "unprognostic (4.02e-3)" "prognostic unfavourable (3.02e-6)" "unprognostic (6.84e-2)" "unprognostic (6.48e-2)" "unprognostic (3.45e-1)" "unprognostic (1.27e-1)" 1.9 12.8 34.0 2.5 30.8 2.1 1.8 42.8 146.4 1.8 2.4 4.8 0.0 2.4 1.8 1.8 2.0 1.8 1.9 78.3 48.3 54.6 1.8 1.8 1.9 2.3 39.9 42.6 1.8 2.3 1.8 3.0 1.8 94.4 1.8 2.3 17.3 2.2 1.8 1.8 2.0 2.7 2.2 18.5 2.1 2.0 18.6 6.9 0.0 1.8 0.0 2.1 1.9 0.1 0.3 0.1 0.0 0.0 0.1 2.2 0.3 0.0 0.8 0.2 8.5 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.3 1.6 20.4 0.9 0.1 0.2 6.0 0.0 0.2 3.8 1.1 1.7 0.0 0.1 0.0 0.0 6.7 0.0 0.0 0.0 0.1 0.0 0.0 13.0 0.1 0.3 3.7 0.0 1.1 5.2 12.8 7.0 0.6 0.0 0.2 48.3 20.8 0.1 1.5 0.0 1.2 0.9 0.0 1.1 1.1 0.0 0.3 1.3 0.9 4.6 1.9 7.1 0.1 0.0 0.0 0.0 2.2 0.0 0.2 0.3 0.6 1.7 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.1 0.7 0.3 34.0 30.8 42.8 66.6 48.3 54.6 39.9 42.6 94.4 6.9 ATP1B2 AMOG ENSG00000129244 "ATPase Na+/K+ transporting subunit beta 2" P14415 17 7646627-7657768 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 148.8" "Cell line enhanced" "Detected in some" "AF22: 13.9;HAP1: 4.2;K-562: 6.3" "Cancer enriched" "Detected in many" 17 "glioma: 200.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010698 Enhanced 17000 "HPA010698: AB_1845174" "unprognostic (9.39e-2)" "unprognostic (1.86e-2)" "unprognostic (3.89e-3)" "unprognostic (4.96e-3)" "unprognostic (3.90e-3)" "unprognostic (9.33e-2)" "unprognostic (4.86e-1)" "unprognostic (5.93e-2)" "unprognostic (5.43e-2)" "unprognostic (1.29e-2)" "prognostic favourable (1.05e-4)" "unprognostic (1.10e-1)" "prognostic unfavourable (4.17e-4)" "unprognostic (4.60e-3)" "unprognostic (1.43e-1)" "unprognostic (2.24e-1)" "unprognostic (3.79e-2)" 4.1 6.5 54.7 2.5 61.6 8.1 2.5 62.9 148.8 9.4 3.4 25.1 0.0 2.7 8.0 15.1 3.4 10.9 4.4 5.0 46.1 33.4 6.9 3.4 3.9 2.9 42.4 41.9 23.3 3.3 3.8 10.8 5.0 68.9 4.6 3.8 28.4 3.3 7.6 4.6 2.7 3.0 5.8 58.7 4.8 2.4 4.3 25.7 0.0 4.4 0.0 2.6 3.3 2.0 1.3 0.7 1.5 1.0 1.3 2.0 0.5 0.0 0.0 13.9 0.6 0.4 0.3 0.1 0.2 0.0 0.5 0.4 0.5 0.0 0.4 0.3 0.1 0.4 4.2 0.3 0.2 0.1 1.7 0.3 0.1 0.1 0.2 0.1 1.3 0.8 0.0 0.5 0.0 0.0 6.3 0.8 0.0 0.4 0.3 0.4 2.9 0.3 0.2 0.1 0.2 0.1 0.1 0.2 2.7 0.0 0.1 0.1 0.2 0.3 0.0 0.2 1.1 0.1 0.2 0.6 0.2 0.1 1.3 0.3 0.3 0.9 1.0 0.5 2.0 0.3 1.8 1.3 0.7 1.4 0.3 0.8 1.1 1.0 1.5 1.3 0.2 0.7 0.2 0.5 54.7 61.6 62.9 50.8 46.1 33.4 42.4 41.9 68.9 25.7 ATP2B1 PMCA1 ENSG00000070961 "ATPase plasma membrane Ca2+ transporting 1" P20020 12 89588049-89709300 "Enzymes, Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.8" "Cell line enhanced" "Detected in many" "hTERT-HME1: 58.4;LHCN-M2: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005605, HPA011166, HPA012945" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483" "unprognostic (6.78e-2)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (8.23e-2)" "unprognostic (1.72e-1)" "unprognostic (6.44e-2)" "prognostic unfavourable (7.74e-4)" "unprognostic (2.77e-2)" "unprognostic (2.46e-2)" "unprognostic (7.82e-2)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (4.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" 8.7 5.1 23.4 12.5 53.8 40.5 8.8 30.9 44.1 9.0 14.0 4.1 4.0 17.8 8.2 5.8 6.5 8.4 11.3 5.2 29.0 11.8 7.4 10.0 9.2 11.8 7.8 31.5 7.6 7.4 13.7 8.7 11.7 9.2 6.4 14.8 2.9 5.6 6.9 10.9 11.3 12.8 8.7 6.1 12.7 12.4 9.8 16.4 5.7 6.3 6.0 12.3 9.9 7.4 27.1 16.2 41.5 25.6 8.4 16.3 6.2 4.1 21.1 8.3 4.0 12.1 19.3 3.8 12.8 41.9 12.4 19.8 8.4 3.9 8.2 0.9 17.7 3.7 7.3 3.5 34.7 2.8 8.5 2.9 7.4 7.4 39.5 12.2 4.9 15.9 6.7 38.6 58.4 3.1 4.8 3.0 90.7 6.6 3.8 5.2 6.5 10.1 5.4 26.8 3.4 11.8 19.3 7.9 4.3 14.8 4.2 3.5 6.1 1.4 2.2 33.7 5.5 12.3 13.9 2.3 3.5 8.8 15.3 3.5 7.4 2.7 13.0 6.7 7.1 13.6 9.0 27.1 12.4 9.0 16.2 27.0 4.6 5.7 41.5 8.4 25.6 2.9 16.3 6.2 23.4 53.8 30.9 44.1 29.0 11.8 7.8 31.5 9.2 16.4 ATP2B2 PMCA2 ENSG00000157087 "ATPase plasma membrane Ca2+ transporting 2" Q01814 3 10324023-10708007 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 55.1;liver: 15.2;salivary gland: 28.6;skeletal muscle: 30.3" "Group enriched" "Detected in some" 4 "EFO-21: 5.3;RPMI-8226: 15.0;SCLC-21H: 5.7" "Cancer enhanced" "Detected in some" "liver cancer: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005606 Enhanced "CAB005606: AB_2243199" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (6.84e-2)" "unprognostic (1.59e-2)" "unprognostic (3.59e-1)" "unprognostic (3.62e-1)" "unprognostic (4.09e-2)" "unprognostic (4.65e-1)" "unprognostic (5.61e-2)" "unprognostic (1.93e-1)" "unprognostic (2.32e-4)" "unprognostic (2.70e-1)" "unprognostic (1.46e-3)" "unprognostic (1.08e-3)" "unprognostic (1.33e-2)" "unprognostic (8.34e-2)" "unprognostic (7.95e-3)" 1.0 1.5 7.6 1.0 23.0 0.9 1.0 39.9 55.1 3.0 1.0 2.4 0.0 1.0 3.2 1.1 1.1 4.3 1.0 1.0 10.0 6.2 1.1 15.2 1.0 1.0 7.9 14.7 1.0 1.1 0.9 1.7 0.9 15.5 1.0 1.0 0.7 28.6 0.9 30.3 1.3 1.0 2.3 2.5 1.0 1.0 1.5 4.2 0.0 0.9 0.0 1.0 0.9 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 15.0 0.0 0.0 5.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 7.6 23.0 39.9 55.1 10.0 6.2 7.9 14.7 15.5 4.2 ATP2B3 "CFAP39, CLA2, PMCA3, SCAX1" ENSG00000067842 "ATPase plasma membrane Ca2+ transporting 3" Q16720 X 153517676-153582939 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" Calmodulin-binding "Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 18.6;brain: 23.2" "Cell line enhanced" "Detected in some" "SCLC-21H: 14.3;SH-SY5Y: 4.2;THP-1: 3.5;U-937: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001583 Enhanced "HPA001583: AB_1079641" "unprognostic (1.35e-1)" "unprognostic (3.07e-2)" "unprognostic (3.28e-1)" "unprognostic (6.82e-2)" "unprognostic (1.30e-1)" "unprognostic (4.32e-2)" "unprognostic (2.67e-1)" "unprognostic (6.34e-2)" "unprognostic (2.68e-2)" "unprognostic (8.58e-2)" "unprognostic (1.38e-3)" "unprognostic (3.44e-1)" "unprognostic (2.71e-12)" "unprognostic (1.44e-3)" "unprognostic (2.04e-1)" "unprognostic (2.42e-2)" 0.8 18.6 5.4 0.9 11.3 0.8 0.8 16.1 23.2 0.8 0.9 3.9 0.0 0.9 0.9 2.6 0.8 3.1 0.8 0.8 7.8 5.5 1.0 0.8 0.8 0.8 4.3 11.5 0.8 0.9 0.8 1.2 1.7 13.6 0.8 0.8 1.4 1.3 1.3 0.8 0.9 0.9 0.9 1.4 0.8 0.8 1.1 0.9 0.0 0.8 0.0 0.8 0.8 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.3 4.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 11.3 16.1 20.7 7.8 5.5 4.3 11.5 13.6 0.9 ATP6V0A1 "a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1" ENSG00000033627 "ATPase H+ transporting V0 subunit a1" Q93050 17 42458844-42522611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.2;parathyroid gland: 65.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022144 Enhanced Approved "Nuclear speckles,Golgi apparatus,Vesicles,Cytosol" 21000 "Golgi apparatus, Vesicles" "Nuclear speckles, Cytosol" "HPA022144: AB_1845189" "unprognostic (3.93e-2)" "unprognostic (2.02e-1)" "unprognostic (4.35e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-2)" "unprognostic (8.69e-2)" "unprognostic (1.84e-2)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.85e-1)" "prognostic favourable (2.05e-4)" "unprognostic (3.25e-1)" "prognostic favourable (1.28e-4)" "unprognostic (3.07e-1)" "unprognostic (3.68e-2)" "unprognostic (2.62e-2)" "prognostic unfavourable (6.90e-4)" 9.4 15.6 19.3 9.3 46.1 9.9 9.1 55.8 66.2 8.0 11.6 25.8 5.1 17.9 11.4 11.1 9.6 9.7 12.2 9.9 23.8 32.8 20.3 11.3 12.7 6.6 23.6 24.8 11.4 9.3 65.6 23.6 11.2 43.3 9.9 11.3 19.7 8.2 10.7 28.9 14.7 12.4 11.7 23.7 11.1 8.8 9.8 13.1 5.2 16.3 6.7 7.8 6.7 6.9 6.3 9.1 14.2 10.5 0.1 2.8 4.2 6.5 13.5 8.3 14.8 14.0 12.1 4.8 4.6 8.6 9.9 13.0 8.6 14.7 1.2 8.5 9.5 14.2 12.7 7.8 11.5 10.1 13.4 10.5 10.2 6.8 8.6 4.5 19.2 9.0 11.3 15.8 6.8 7.0 38.1 41.4 14.7 5.6 1.8 4.0 5.3 0.1 0.1 8.6 18.2 11.4 5.2 22.9 12.2 7.2 6.6 13.7 15.9 6.8 4.1 8.4 0.3 12.3 5.5 16.9 22.9 2.5 11.3 0.1 9.8 12.1 10.5 8.0 0.8 3.4 1.2 3.5 0.6 0.1 9.1 6.3 1.0 0.8 14.2 0.1 2.4 4.7 2.8 4.2 19.3 46.1 55.8 65.9 23.8 32.8 23.6 24.8 43.3 13.1 ATP6V0E2 "ATP6V0E2L, C7orf32" ENSG00000171130 "ATPase H+ transporting V0 subunit e2" Q8NHE4 7 149872968-149880698 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 92.7" "Cell line enhanced" "Detected in many" "SCLC-21H: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "unprognostic (8.72e-2)" "unprognostic (4.73e-2)" "unprognostic (3.10e-3)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (1.32e-1)" "unprognostic (1.23e-1)" "unprognostic (2.42e-2)" "unprognostic (5.84e-3)" "unprognostic (3.57e-2)" "prognostic favourable (5.80e-4)" "unprognostic (1.21e-1)" "prognostic favourable (8.26e-7)" "unprognostic (1.96e-1)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (1.48e-3)" 11.8 17.3 60.1 6.5 56.5 3.6 8.6 70.5 92.7 6.4 6.7 26.4 14.2 5.0 4.3 6.2 6.0 13.4 5.9 27.9 73.7 55.3 26.9 27.9 6.8 12.1 61.1 39.7 4.9 11.7 14.0 25.3 3.1 57.1 26.2 5.3 18.7 37.0 24.8 8.7 4.7 4.6 6.3 29.4 8.3 7.3 3.2 12.2 8.4 26.6 2.0 8.1 4.9 1.7 7.0 6.4 1.5 6.9 12.0 30.6 11.2 7.3 20.8 8.7 28.1 3.6 0.5 5.4 3.8 5.3 10.6 10.9 7.3 9.3 15.1 16.3 5.1 6.6 18.4 6.5 4.6 19.5 20.4 4.7 6.4 41.8 5.2 3.4 10.4 1.2 6.8 11.7 0.7 8.8 5.0 7.4 0.7 12.6 2.4 7.9 7.5 14.7 16.5 0.3 7.0 8.2 8.0 50.1 28.4 5.0 17.5 11.7 9.9 2.3 1.6 3.1 3.3 32.2 14.2 10.4 13.2 7.3 19.6 6.0 10.0 1.5 3.1 0.7 16.7 5.8 15.4 7.0 21.0 19.5 6.4 6.3 27.5 24.7 0.4 12.0 6.9 3.0 30.6 11.2 60.1 56.5 70.5 66.4 73.7 55.3 61.1 39.7 57.1 12.2 ATP6V1G2 "ATP6G, ATP6G2, Em:AC004181.3, NG38, Vma10" ENSG00000213760 "ATPase H+ transporting V1 subunit G2" O95670 6 31544462-31548427 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "brain: 91.9" "Cell line enhanced" "Detected in some" "HDLM-2: 6.4;Karpas-707: 7.1" "Cancer enriched" "Detected in many" 11 "glioma: 15.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "CAB004616, HPA068667" Enhanced "CAB004616: AB_667829, HPA068667: " "unprognostic (9.95e-2)" "unprognostic (8.75e-2)" "unprognostic (9.21e-3)" "unprognostic (2.11e-4)" "unprognostic (2.40e-1)" "unprognostic (1.63e-1)" "unprognostic (2.34e-1)" "unprognostic (1.65e-2)" "unprognostic (1.52e-1)" "unprognostic (1.78e-2)" "unprognostic (1.41e-5)" "unprognostic (1.36e-1)" "unprognostic (7.22e-3)" "unprognostic (3.94e-2)" "unprognostic (1.77e-1)" "unprognostic (3.86e-2)" "unprognostic (1.02e-1)" 2.8 3.3 41.8 3.5 25.7 1.8 1.6 91.9 53.3 1.8 2.3 8.1 0.0 1.5 2.5 2.4 2.2 1.8 1.9 2.9 39.4 27.1 2.6 1.6 2.0 4.7 26.6 29.5 3.1 2.1 2.9 1.2 1.7 43.7 2.6 2.0 2.0 2.0 3.3 4.3 2.0 2.7 2.1 16.3 3.4 1.9 2.7 6.4 0.0 2.3 0.0 4.8 1.7 0.2 0.7 0.7 0.0 0.1 0.8 1.5 0.1 0.2 1.7 3.1 1.5 1.3 1.7 0.0 0.6 0.0 0.0 0.2 0.0 0.9 1.7 0.7 0.6 1.4 0.1 0.6 0.1 6.4 0.0 0.5 0.0 0.9 0.2 0.7 0.6 1.3 0.8 0.5 0.3 0.5 0.7 7.1 0.8 0.2 3.3 1.2 0.0 0.5 0.8 0.0 0.7 0.0 0.0 2.8 3.9 0.0 0.0 0.0 2.1 0.3 1.6 2.0 0.3 0.1 0.0 0.7 1.5 2.4 0.7 0.7 1.4 0.0 0.1 0.0 0.1 0.0 1.5 0.1 0.0 0.8 0.7 0.7 1.2 1.5 0.0 0.8 0.0 0.0 1.1 0.1 41.8 25.7 91.9 53.3 39.4 27.1 26.6 29.5 43.7 6.4 ATP8A2 "ATPIB, ML-1" ENSG00000132932 "ATPase phospholipid transporting 8A2" Q9NTI2 13 25372071-26025851 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 34.9;pituitary gland: 37.0;testis: 10.4" "Cell line enriched" "Detected in some" 6 "HMC-1: 21.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3;naive CD8 T-cell: 3.3" "Lineage enriched" "Detected in single" 12 "T-cells: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039926, HPA040033" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA039926: AB_10794205, HPA040033: " "unprognostic (3.79e-2)" "unprognostic (4.28e-2)" "unprognostic (3.32e-2)" "unprognostic (1.95e-4)" "unprognostic (3.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.31e-2)" "unprognostic (2.97e-3)" "unprognostic (2.77e-1)" "unprognostic (3.66e-1)" "unprognostic (4.96e-4)" "unprognostic (1.24e-1)" "unprognostic (1.18e-2)" "unprognostic (4.20e-5)" "unprognostic (9.10e-2)" "unprognostic (2.95e-1)" "unprognostic (7.22e-2)" 1.1 4.9 11.2 1.4 11.4 0.8 2.2 34.9 30.2 1.1 1.3 1.3 0.0 1.4 2.1 4.8 0.9 0.9 1.0 1.0 9.4 11.8 1.3 0.8 2.3 1.9 6.7 10.4 1.2 1.9 0.9 37.0 1.2 19.8 1.1 1.3 3.1 1.0 1.0 1.3 0.9 1.5 1.0 3.5 1.3 1.8 10.4 1.4 0.0 1.0 0.0 1.2 1.2 0.3 0.0 0.0 0.2 0.0 0.2 3.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.0 0.0 0.6 1.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 21.9 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.7 0.3 3.7 0.0 2.0 0.7 0.0 2.7 1.0 0.2 0.1 3.3 0.0 0.2 0.3 0.1 0.0 0.4 0.2 0.1 1.1 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.8 0.6 0.0 0.0 2.3 3.3 0.2 0.2 0.0 0.0 0.7 0.6 11.2 11.4 34.9 18.4 9.4 11.8 6.7 10.4 19.8 1.4 ATP9A "ATPIIA, KIAA0611" ENSG00000054793 "ATPase phospholipid transporting 9A (putative)" O75110 20 51596514-51768634 "Enzymes, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.7" "Cell line enhanced" "Detected in many" "EFO-21: 28.8;SK-BR-3: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 6.3;NK-cell: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 6.3;NK-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020699, HPA035630" Enhanced "CAB020699: , HPA035630: AB_10669526" "unprognostic (5.19e-2)" "unprognostic (5.28e-2)" "unprognostic (3.46e-1)" "unprognostic (1.05e-1)" "unprognostic (3.76e-1)" "unprognostic (1.37e-1)" "unprognostic (3.76e-2)" "unprognostic (4.79e-2)" "unprognostic (7.45e-2)" "unprognostic (1.58e-1)" "unprognostic (1.26e-2)" "unprognostic (1.79e-1)" "prognostic favourable (5.67e-5)" "unprognostic (5.82e-2)" "unprognostic (5.81e-1)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" 18.5 8.2 23.7 3.9 31.8 2.0 11.2 29.8 64.7 5.6 12.2 19.9 8.2 9.1 8.6 13.1 8.8 16.9 8.2 7.7 24.3 26.8 6.8 5.4 6.7 2.6 21.1 23.9 13.2 10.0 22.7 8.3 3.6 22.5 14.3 11.3 4.1 14.9 11.3 9.2 4.1 11.5 8.7 18.9 2.2 14.0 12.4 15.8 0.8 18.7 2.9 2.4 7.4 5.6 0.0 0.0 6.3 0.2 2.2 0.8 1.8 9.5 8.2 6.7 15.1 19.9 14.9 0.1 3.4 6.6 2.2 0.7 18.8 19.9 0.0 28.8 14.2 7.7 8.9 5.0 2.3 7.4 2.7 0.0 9.1 7.5 2.7 0.0 0.0 4.9 10.2 0.5 1.4 12.2 0.0 0.0 2.6 13.4 0.7 0.0 1.2 10.4 1.5 0.0 0.0 4.6 13.5 12.8 9.1 13.8 27.6 5.1 5.2 0.2 8.0 19.0 5.1 7.4 1.4 0.0 0.1 0.3 5.0 0.0 1.7 6.3 0.0 0.0 0.8 0.2 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.4 2.2 0.1 0.0 0.0 1.8 23.7 31.8 29.8 34.9 24.3 26.8 21.1 23.9 22.5 15.8 ATRNL1 "ALP, FLJ45344, KIAA0534" ENSG00000107518 "Attractin like 1" Q5VV63 10 115093365-115948992 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell line enhanced" "Detected in many" "AN3-CA: 20.4;LHCN-M2: 9.3;RH-30: 13.7;SH-SY5Y: 9.8;U-266/70: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038070 Uncertain Approved Nucleoplasm,Mitochondria 33000000 "Nucleoplasm, Mitochondria" "HPA038070: AB_10697237" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "unprognostic (5.88e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.88e-2)" "unprognostic (5.17e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" "unprognostic (2.50e-2)" "unprognostic (1.04e-3)" "unprognostic (3.10e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (2.08e-3)" 0.9 11.7 8.6 0.7 15.9 0.3 2.1 2.2 26.0 0.9 2.3 2.1 1.1 0.8 12.0 1.1 1.5 1.0 0.8 2.9 9.3 5.8 4.8 2.9 0.6 1.0 4.0 15.7 17.5 2.3 0.3 11.1 3.3 8.4 6.9 0.9 2.0 1.8 8.3 3.8 0.6 1.0 13.4 2.0 0.8 0.9 13.0 2.5 0.0 2.0 0.0 0.9 1.1 1.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.2 20.4 0.0 0.0 0.0 0.1 0.4 3.0 4.4 0.1 0.1 0.0 1.4 0.5 0.0 1.1 0.0 3.5 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 6.9 9.3 0.2 8.0 0.0 6.6 0.1 5.9 13.7 8.8 3.1 0.0 3.4 9.8 0.0 0.0 0.2 1.2 0.0 0.0 0.0 2.5 0.0 2.9 11.3 0.0 3.3 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 15.9 2.2 26.0 9.3 5.8 4.0 15.7 8.4 2.5 AVP "ADH, ARVP" ENSG00000101200 "Arginine vasopressin" P01185 20 3082556-3084724 "Disease related genes, Predicted secreted proteins" "Hormone, Vasoactive, Vasoconstrictor" "Diabetes insipidus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "brain: 270.1" "Cell line enriched" "Detected in single" 13 "NB-4: 6.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 18 "hypothalamus: 270.1" "Cell type enriched" "Detected in some" 6 "eosinophil: 6.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.1" "Region enriched" "Detected in some" 10 "hypothalamus: 273.6" "Group enriched" "Detected in some" 645 "basal ganglia: 1065.4;hypothalamus: 1058.2" "CAB025318, HPA071892" Enhanced Supported "Secreted to blood" 19255 "CAB025318: , HPA071892: " "unprognostic (1.15e-1)" "unprognostic (2.61e-1)" 0.7 0.9 11.7 0.4 15.0 4.2 0.0 0.0 0.9 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 270.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 1.0 0.1 11.7 15.0 0.0 0.9 3.4 270.1 0.0 0.0 0.8 0.0 AZIN2 "ADC, KIAA1945, ODC-p, ODC1L, ODCp" ENSG00000142920 "Antizyme inhibitor 2" Q96A70 1 33081104-33120530 "Predicted intracellular proteins" "Polyamine biosynthesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1;testis: 22.9" "Cell line enhanced" "Detected in many" "SK-MEL-30: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 17.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028527 Approved Cytosol Cytosol "HPA028527: AB_10602077" "unprognostic (5.33e-2)" "unprognostic (1.60e-1)" "unprognostic (2.16e-3)" "unprognostic (7.50e-2)" "unprognostic (8.28e-2)" "unprognostic (4.56e-2)" "unprognostic (1.15e-4)" "unprognostic (9.19e-3)" "unprognostic (3.89e-2)" "unprognostic (1.54e-2)" "unprognostic (1.06e-3)" "unprognostic (2.16e-1)" "unprognostic (3.18e-1)" "unprognostic (6.91e-2)" "unprognostic (2.91e-1)" "unprognostic (9.45e-2)" "unprognostic (2.41e-1)" 1.5 5.3 7.8 3.1 11.9 0.2 3.6 5.8 14.6 5.1 4.4 23.1 0.5 1.4 3.8 3.4 1.7 7.0 4.1 5.7 10.1 7.8 3.5 0.9 2.5 1.9 10.2 12.2 9.9 3.0 4.4 2.9 1.4 13.6 3.9 3.0 3.4 3.5 3.6 0.9 1.8 1.3 3.4 18.1 1.9 1.8 22.9 10.1 0.7 4.3 0.0 3.0 2.3 1.9 0.2 17.9 3.5 0.0 0.0 1.6 0.7 0.5 0.7 2.2 1.3 1.1 4.8 0.6 0.8 3.3 3.4 2.7 0.3 2.7 0.0 1.0 0.6 1.5 1.4 0.6 1.0 0.0 0.0 0.1 0.1 0.5 5.2 0.0 0.2 4.7 3.0 2.8 1.1 0.5 0.1 0.2 2.5 0.0 0.2 0.9 1.0 0.4 1.5 2.0 0.1 2.4 0.2 0.4 2.2 0.5 0.0 19.7 0.8 0.3 0.1 0.8 1.5 2.3 0.5 1.2 0.0 0.0 5.3 0.0 0.9 3.5 0.0 0.0 1.3 0.0 1.4 0.2 1.4 1.4 0.0 0.0 1.6 1.6 0.0 0.0 0.0 17.9 0.0 0.7 7.8 11.9 5.8 12.8 10.1 7.8 10.2 12.2 13.6 10.1 B3GALT1 beta3Gal-T1 ENSG00000172318 "Beta-1,3-galactosyltransferase 1" Q9Y5Z6 2 167868948-167874041 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 2.4;brain: 5.1;intestine: 5.8;skeletal muscle: 7.1" "Cell line enriched" "Detected in some" 8 "AN3-CA: 27.9" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.98e-2)" "unprognostic (4.34e-2)" "unprognostic (1.12e-2)" "unprognostic (7.22e-2)" "unprognostic (1.67e-1)" "unprognostic (4.23e-3)" "unprognostic (2.49e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-1)" "unprognostic (3.94e-2)" "unprognostic (8.72e-2)" "unprognostic (6.44e-2)" "unprognostic (2.30e-3)" "unprognostic (8.34e-2)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (3.79e-1)" 0.1 0.6 0.5 0.0 1.6 0.0 0.3 0.9 5.1 0.2 5.6 0.0 0.2 0.3 0.0 0.8 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.8 0.0 0.1 5.8 0.1 0.9 7.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 1.4 0.8 2.0 0.5 1.0 2.4 0.4 0.0 0.0 2.2 27.9 0.2 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.0 0.1 0.0 0.0 0.0 0.0 3.6 1.0 0.0 0.1 0.0 0.4 0.0 1.8 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.6 0.0 0.5 0.0 2.6 2.0 0.5 0.3 0.6 0.3 0.7 1.1 0.7 0.7 0.2 1.4 2.4 1.3 1.5 1.0 0.3 0.8 0.6 0.4 B3GALT2 beta3Gal-T2 ENSG00000162630 "Beta-1,3-galactosyltransferase 2" O43825 1 193179045-193186654 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9;gallbladder: 19.0;heart muscle: 25.1" "Group enriched" "Detected in some" 4 "AF22: 16.0;ASC TERT1: 7.3;LHCN-M2: 10.9;WM-115: 19.0" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 11.9" "Lineage enriched" "Detected in single" 57 "T-cells: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078659 Approved "Plasma membrane,Microtubules" "Plasma membrane, Microtubules" "HPA078659: " "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (1.58e-3)" "unprognostic (2.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (2.44e-1)" "unprognostic (6.14e-4)" "unprognostic (4.41e-2)" "unprognostic (8.10e-3)" "unprognostic (2.72e-1)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-3)" 0.7 2.0 11.3 1.3 8.9 0.7 0.9 1.4 32.9 0.8 1.7 1.2 0.9 1.6 0.6 1.8 1.2 0.7 19.0 25.1 10.1 7.9 1.7 0.8 2.6 0.7 5.7 19.1 13.8 0.8 0.4 0.9 0.9 5.0 6.5 2.0 0.3 0.5 7.1 0.6 0.7 4.1 0.8 6.5 1.4 2.1 1.4 4.7 0.0 1.8 0.0 1.6 2.0 0.7 0.0 0.2 0.1 0.0 0.0 11.9 0.3 0.0 0.0 16.0 0.0 0.4 7.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.4 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.2 0.0 11.9 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.3 0.3 11.3 8.9 1.4 32.9 10.1 7.9 5.7 19.1 5.0 4.7 B3GALT5 "B3GalT-V, B3T5, beta3Gal-T5, GLCT5" ENSG00000183778 "Beta-1,3-galactosyltransferase 5" Q9Y2C3 21 39556442-39673137 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8;intestine: 27.1;lymphoid tissue: 14.8" "Group enriched" "Detected in some" 4 "CAPAN-2: 18.1;RPTEC TERT1: 21.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "basal ganglia: 15.8" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054092, HPA054684" Approved "Intracellular and membrane" "HPA054092: , HPA054684: " "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "prognostic favourable (6.36e-4)" "unprognostic (9.23e-2)" "unprognostic (4.62e-2)" "unprognostic (4.06e-2)" "unprognostic (2.04e-1)" "unprognostic (2.48e-1)" "unprognostic (3.25e-2)" "unprognostic (7.86e-3)" "unprognostic (1.67e-1)" "unprognostic (6.09e-4)" "unprognostic (1.12e-1)" "unprognostic (2.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" 0.1 0.3 0.5 3.1 15.8 0.1 1.8 0.3 1.5 3.0 16.2 0.6 0.0 19.4 1.4 1.6 2.3 1.0 12.9 0.2 1.3 1.5 0.6 0.3 0.2 0.1 0.7 0.1 0.7 6.2 0.1 7.9 0.7 2.2 1.0 27.1 2.2 5.5 0.1 0.2 1.1 23.4 0.7 2.0 0.2 3.8 0.6 3.6 1.8 1.1 0.8 14.8 1.1 5.9 0.2 0.2 1.0 0.2 0.3 0.2 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 18.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 4.9 0.5 0.0 2.1 0.1 21.5 1.3 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.1 0.8 0.0 0.0 0.0 0.9 0.0 0.2 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 0.3 0.0 0.2 0.0 0.0 0.5 15.8 0.3 1.5 1.3 1.5 0.7 0.1 2.2 3.6 B3GAT1 "CD57, GlcAT-P, HNK-1, LEU7, NK-1" ENSG00000109956 "Beta-1,3-glucuronyltransferase 1" Q9P2W7 11 134378504-134411918 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 76.0" "Cell line enhanced" "Detected in some" "AF22: 17.0;HMC-1: 18.8;NTERA-2: 16.3;SH-SY5Y: 6.2" "Group enriched" "Detected in some" 11 "glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.8;naive CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 39 "T-cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002500, CAB010893, HPA069468" Enhanced Supported Vesicles "Secreted in brain" Vesicles "CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: " "unprognostic (6.72e-2)" "unprognostic (3.97e-4)" "unprognostic (2.13e-2)" "unprognostic (1.40e-3)" "unprognostic (5.52e-2)" "unprognostic (2.60e-3)" "unprognostic (6.30e-2)" "unprognostic (1.96e-2)" "unprognostic (8.74e-2)" "unprognostic (2.72e-1)" "unprognostic (1.57e-3)" "unprognostic (1.58e-1)" "unprognostic (9.34e-3)" "unprognostic (3.87e-3)" "unprognostic (2.42e-1)" "unprognostic (4.07e-2)" "unprognostic (2.26e-2)" 1.5 5.8 38.9 1.7 23.7 2.1 5.6 9.2 76.0 1.7 1.5 25.8 0.0 1.8 1.6 1.7 1.4 1.6 1.7 1.5 43.4 14.9 2.1 6.0 1.8 3.3 30.3 19.5 1.5 1.7 1.4 0.9 1.4 19.7 4.2 1.5 2.1 2.2 1.8 1.4 1.8 1.6 1.5 45.1 2.1 6.0 1.8 25.2 0.0 7.7 0.0 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.4 0.0 0.0 17.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.9 0.0 0.8 1.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 16.3 0.0 0.3 0.0 1.2 0.0 0.1 2.3 6.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.2 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.8 1.9 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.4 38.9 23.7 9.2 33.7 43.4 14.9 30.3 19.5 19.7 25.2 B3GAT2 GlcAT-S ENSG00000112309 "Beta-1,3-glucuronyltransferase 2" Q9NPZ5 6 70856679-70957038 "Enzymes, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 27.2" "Cell line enriched" "Detected in some" 20 "SCLC-21H: 22.2" "Group enriched" "Detected in some" 20 "glioma: 4.7;testis cancer: 1.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012059 Uncertain "HPA012059: AB_2061050" "unprognostic (7.10e-3)" "unprognostic (7.81e-2)" "unprognostic (1.63e-1)" "unprognostic (1.10e-3)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.96e-2)" "unprognostic (4.88e-2)" "unprognostic (4.22e-2)" "unprognostic (9.16e-4)" "unprognostic (8.09e-2)" "unprognostic (7.43e-3)" "unprognostic (6.88e-7)" "unprognostic (2.72e-2)" "unprognostic (3.35e-2)" "unprognostic (2.53e-2)" "unprognostic (3.45e-3)" 1.8 1.5 9.5 1.9 7.8 1.6 1.1 3.2 27.2 0.8 1.1 26.2 0.0 2.3 1.4 1.1 1.4 1.1 1.4 1.5 19.2 11.5 1.0 1.3 1.2 2.0 9.7 13.6 1.1 2.2 0.8 0.5 1.2 21.0 1.3 0.9 0.4 1.5 0.9 1.5 1.9 2.4 1.1 17.3 2.0 1.5 2.9 16.3 0.0 1.5 0.0 0.9 1.3 0.9 1.2 1.0 2.0 1.2 1.1 2.2 0.2 0.3 0.0 0.6 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.2 1.1 0.1 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.5 0.7 0.1 0.1 0.2 0.2 0.0 0.2 22.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 1.3 1.2 1.2 1.0 1.0 0.9 1.0 1.5 2.1 0.4 1.2 1.7 1.8 2.0 1.1 1.1 1.0 2.2 0.2 9.5 7.8 3.2 11.2 19.2 11.5 9.7 13.6 21.0 16.3 B3GNT4 "B3GN-T4, beta3Gn-T4" ENSG00000176383 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4" Q9C0J1 12 122203543-122208952 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3;skin 1: 8.5" "Cell line enhanced" "Detected in many" "HDLM-2: 8.0;hTCEpi: 9.7;T-47d: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055261 Uncertain Approved Nucleoli,Mitochondria Mitochondria Nucleoli "HPA055261: " "unprognostic (1.67e-1)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.60e-2)" "unprognostic (1.32e-3)" "unprognostic (1.98e-1)" "unprognostic (3.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.82e-2)" "unprognostic (3.69e-1)" "prognostic unfavourable (3.52e-6)" "unprognostic (1.24e-1)" "unprognostic (2.79e-1)" "unprognostic (8.97e-2)" "unprognostic (9.47e-2)" 0.7 3.2 7.3 0.8 6.8 4.6 0.8 16.3 9.1 0.5 0.7 0.5 0.0 1.0 0.6 0.7 1.8 1.1 1.1 0.8 4.9 4.0 6.1 0.6 1.1 0.9 1.5 7.3 0.8 0.8 0.8 1.9 0.8 4.0 0.7 0.6 1.0 1.7 0.7 1.1 8.5 1.0 0.6 0.6 1.0 0.7 2.0 0.3 0.0 0.8 0.3 0.8 0.6 0.5 0.8 1.0 0.8 1.7 0.4 1.9 0.4 5.4 1.0 0.3 2.1 0.2 0.1 1.0 0.1 0.0 0.3 0.6 3.4 0.4 0.5 0.9 0.0 2.0 2.6 2.1 0.1 8.0 2.8 0.2 1.5 0.3 0.6 0.7 1.1 0.7 9.7 0.1 0.4 0.0 1.5 0.6 0.2 4.8 0.0 0.7 0.6 2.0 0.4 0.6 1.0 1.4 0.6 1.3 1.7 1.5 1.0 0.5 7.5 0.1 0.1 0.5 2.8 0.5 0.3 0.6 4.9 1.2 0.5 0.8 0.3 0.8 0.4 0.2 0.8 0.1 0.4 0.8 1.3 0.2 0.2 0.5 1.9 0.2 0.5 0.4 1.7 1.0 0.6 0.4 7.3 6.8 16.3 8.1 4.9 4.0 1.5 7.3 4.0 0.3 B4GALNT1 "beta1-4GalNAc-T, GALGT, SPG26" ENSG00000135454 "Beta-1,4-N-acetyl-galactosaminyltransferase 1" Q00973 12 57623410-57633355 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.4" "Cell line enhanced" "Detected in many" "EFO-21: 22.0;HDLM-2: 18.7" "Cancer enriched" "Detected in many" 6 "glioma: 10.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Lineage enhanced" "Detected in single" "T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008968 Enhanced "Intracellular and membrane" 9500 "HPA008968: AB_1078253" "unprognostic (3.18e-1)" "unprognostic (8.34e-2)" "unprognostic (2.05e-2)" "unprognostic (3.33e-3)" "unprognostic (2.54e-1)" "unprognostic (2.70e-3)" "unprognostic (3.73e-5)" "unprognostic (1.26e-2)" "unprognostic (1.72e-1)" "unprognostic (2.66e-1)" "unprognostic (2.00e-1)" "unprognostic (1.67e-1)" "prognostic unfavourable (3.18e-14)" "unprognostic (2.52e-2)" "unprognostic (1.81e-1)" "unprognostic (1.44e-2)" "unprognostic (4.92e-4)" 3.0 2.1 12.9 2.3 16.4 1.0 1.5 26.5 32.4 1.9 2.4 1.0 0.0 1.4 2.2 3.8 1.3 1.4 1.5 3.9 15.3 11.2 1.3 1.3 1.7 1.6 6.5 14.3 1.0 1.2 1.1 1.0 1.3 11.6 4.2 2.2 1.6 3.2 6.8 8.1 1.6 1.9 3.2 2.3 1.3 1.4 1.6 2.3 0.0 1.3 0.6 1.8 1.5 0.9 0.0 0.0 0.0 0.0 0.8 1.9 0.0 2.8 14.6 3.2 5.6 0.2 0.0 0.0 1.4 3.0 6.0 6.4 0.9 7.6 0.8 22.0 4.1 1.4 2.5 1.1 2.0 18.7 0.9 0.2 3.7 4.8 0.2 0.7 1.4 0.0 0.4 3.6 0.2 0.1 2.3 4.6 1.0 3.8 0.6 0.0 3.8 2.9 0.0 4.4 2.3 0.0 0.0 12.3 3.1 0.8 0.4 0.1 2.7 1.0 0.0 3.5 8.3 6.9 9.1 11.5 8.6 0.8 8.1 0.9 9.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 12.9 16.4 26.5 25.9 15.3 11.2 6.5 14.3 11.6 2.3 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369796-382116 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1;ovary: 18.6" "Cell line enhanced" "Detected in many" "AF22: 19.7;NTERA-2: 17.6;SCLC-21H: 21.9;SH-SY5Y: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053126 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle" "Intracellular and membrane" "Nucleoplasm, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA053126: " "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 1.6 2.5 20.6 2.8 16.7 1.2 3.5 26.5 35.1 5.9 2.0 8.6 0.8 2.4 8.6 2.4 1.8 8.7 2.1 1.4 17.6 16.8 1.2 1.1 1.3 1.6 11.5 14.9 18.6 1.8 6.3 6.1 1.1 13.0 3.8 1.6 2.3 4.0 3.7 1.1 3.8 2.9 3.1 8.3 1.5 1.5 1.8 11.0 0.0 1.1 0.0 1.7 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 19.7 11.3 0.0 0.0 4.6 3.5 0.9 1.6 0.5 2.0 0.0 0.0 2.6 0.4 0.7 2.6 4.7 0.5 0.0 6.7 0.0 6.2 6.1 0.2 0.0 4.8 0.3 2.8 0.1 2.1 0.2 6.0 0.0 0.0 5.8 0.2 0.0 17.6 7.7 0.0 0.0 2.6 0.2 0.0 21.9 26.7 1.3 0.9 0.2 7.7 0.0 4.8 1.1 6.3 1.9 0.2 0.0 0.9 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.6 16.7 26.5 21.2 17.6 16.8 11.5 14.9 13.0 11.0 B4GALT6 beta4GalT-VI ENSG00000118276 "Beta-1,4-galactosyltransferase 6" Q9UBX8 18 31622247-31685836 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3" "Cell line enhanced" "Detected in many" "REH: 18.1;WM-115: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.8" "Group enriched" "Detected in many" 5 "NK-cells: 3.8;T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020701, HPA058284" Approved "Intracellular and membrane" "CAB020701: , HPA058284: " "unprognostic (3.79e-1)" "unprognostic (4.52e-1)" "unprognostic (6.54e-3)" "unprognostic (2.23e-4)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.31e-2)" "unprognostic (4.50e-2)" "unprognostic (5.18e-1)" "unprognostic (1.13e-1)" "prognostic favourable (5.65e-4)" "unprognostic (2.77e-1)" "prognostic favourable (6.40e-5)" "unprognostic (5.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.10e-2)" "unprognostic (4.00e-1)" 3.6 13.8 7.8 2.8 16.0 4.4 2.1 20.6 22.3 2.2 3.5 2.6 0.0 7.7 2.5 2.2 4.8 2.5 7.2 3.8 10.7 7.9 3.7 2.7 1.8 1.2 6.1 10.0 4.3 2.1 7.3 14.8 2.7 16.3 5.8 3.6 13.2 4.6 4.4 3.3 2.2 9.7 1.7 3.1 1.5 3.4 5.4 2.3 5.0 2.1 1.5 1.0 3.6 2.1 0.0 0.5 0.0 0.4 3.8 1.1 0.3 2.3 5.3 9.5 5.3 0.1 0.2 3.5 0.7 0.0 0.1 0.0 9.8 2.0 3.6 4.4 0.9 0.9 5.0 4.2 0.6 14.3 4.4 4.8 0.5 0.2 1.1 8.6 0.8 1.0 0.9 1.4 3.0 5.2 0.7 0.0 0.0 1.4 9.6 0.6 4.1 2.9 18.1 1.6 0.0 1.1 4.8 5.1 7.9 3.4 0.6 6.2 0.6 2.6 5.2 10.8 2.2 0.0 5.8 3.6 0.2 7.5 4.4 7.9 50.1 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.1 0.9 0.5 0.0 0.0 1.1 0.0 3.8 0.4 0.0 0.0 0.3 7.8 16.0 20.6 22.3 10.7 7.9 6.1 10.0 16.3 2.3 B4GAT1 "B3GN-T1, B3GNT1, B3GNT6, BETA3GNTI, iGAT, iGNT" ENSG00000174684 "Beta-1,4-glucuronyltransferase 1" O43505 11 66345372-66347692 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015484 Uncertain "Intracellular and membrane" 48000000 "HPA015484: AB_1845235" "unprognostic (1.80e-1)" "unprognostic (7.20e-2)" "unprognostic (1.70e-1)" "unprognostic (3.81e-2)" "unprognostic (3.96e-2)" "unprognostic (1.45e-1)" "unprognostic (9.23e-2)" "unprognostic (1.59e-1)" "unprognostic (2.65e-2)" "unprognostic (3.43e-3)" "prognostic favourable (3.55e-5)" "unprognostic (2.20e-1)" "unprognostic (3.50e-1)" "unprognostic (1.23e-1)" "unprognostic (2.02e-1)" "unprognostic (1.88e-1)" "unprognostic (2.76e-3)" 8.3 24.8 29.3 3.6 47.1 1.0 5.4 28.5 69.5 7.8 6.5 11.8 4.2 9.5 10.0 9.5 5.2 10.5 6.0 19.6 33.3 57.9 15.0 9.7 9.7 3.7 24.7 32.0 18.9 12.8 11.9 15.6 12.9 31.0 10.2 4.9 10.1 9.1 14.2 12.9 5.8 7.2 8.5 13.2 5.1 7.7 4.4 11.6 1.1 10.7 1.7 2.8 5.5 4.1 5.6 6.8 0.4 1.1 3.9 9.7 4.2 4.2 10.7 12.3 14.9 13.8 12.4 16.3 7.4 17.4 11.6 9.5 8.0 6.0 3.5 31.7 6.8 6.8 13.0 8.3 5.6 6.9 23.7 0.5 8.8 30.5 8.2 2.7 1.1 12.1 6.4 7.2 3.0 13.7 3.3 5.6 5.5 7.1 6.5 7.5 8.3 11.4 9.5 9.6 6.2 12.0 1.1 7.4 14.0 6.4 4.3 28.8 17.4 2.7 7.9 9.1 6.7 11.5 3.8 10.8 7.4 2.0 15.4 2.3 10.6 0.0 1.1 0.0 7.1 0.4 9.7 5.6 7.8 7.6 2.8 3.5 9.2 8.4 0.4 3.9 0.2 6.8 5.3 4.2 29.3 47.1 28.5 59.9 33.3 57.9 24.7 32.0 31.0 11.6 BAALC ENSG00000164929 "BAALC, MAP3K1 and KLF4 binding" Q8WXS3 8 103140710-103230305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 121.3" "Cell line enhanced" "Detected in some" "AF22: 24.4;BJ hTERT+: 8.5;SCLC-21H: 13.3;SH-SY5Y: 9.8;U-87 MG: 36.2" "Cancer enriched" "Detected in many" 8 "glioma: 139.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "NK-cell: 6.9" "Lineage enriched" "Detected in single" 25 "NK-cells: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027132, HPA068307" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA027132: AB_10600985, HPA068307: " "unprognostic (1.68e-1)" "unprognostic (9.17e-3)" "unprognostic (1.40e-2)" "unprognostic (4.62e-4)" "unprognostic (1.75e-2)" "unprognostic (2.84e-2)" "unprognostic (1.39e-1)" "unprognostic (7.87e-2)" "unprognostic (2.00e-1)" "unprognostic (4.99e-2)" "unprognostic (4.17e-2)" "unprognostic (2.18e-2)" "unprognostic (7.58e-2)" "unprognostic (2.51e-3)" "unprognostic (2.76e-2)" "unprognostic (1.70e-1)" "unprognostic (9.27e-3)" 7.8 11.1 42.3 3.2 51.9 3.9 3.0 12.5 121.3 2.8 2.9 18.9 0.0 2.3 3.0 2.0 2.2 4.6 2.9 3.2 38.1 34.5 2.8 3.4 4.9 2.6 48.3 25.1 2.7 2.6 1.9 5.2 5.7 41.4 2.0 2.9 0.0 2.1 2.4 3.0 2.7 2.8 3.1 51.2 8.8 2.4 2.6 24.6 0.0 2.8 0.0 2.2 2.8 0.3 0.2 0.1 0.0 0.0 6.9 0.1 0.4 0.2 1.4 24.4 0.2 0.2 7.3 0.0 1.2 8.5 0.0 0.1 0.2 0.0 0.1 0.2 4.6 0.4 0.4 0.0 0.0 0.0 1.4 0.2 0.3 0.0 0.5 0.0 0.5 1.4 1.4 0.3 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.4 0.1 0.1 0.5 0.0 0.0 13.3 9.8 0.2 0.0 0.0 0.1 0.1 1.4 7.7 0.5 0.2 0.5 0.0 0.1 0.1 36.2 0.1 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.9 0.0 0.1 0.0 0.4 42.3 51.9 12.5 43.6 38.1 34.5 48.3 25.1 41.4 24.6 BACE1 BACE ENSG00000186318 "Beta-secretase 1" P56817 11 117285207-117316259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 53.0;pancreas: 161.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016358 Approved Supported "Plasma membrane" "Plasma membrane" "CAB016358: AB_626716" "unprognostic (7.96e-3)" "unprognostic (8.05e-2)" "unprognostic (3.55e-2)" "unprognostic (3.05e-3)" "unprognostic (8.94e-2)" "unprognostic (3.39e-1)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (8.09e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.35e-2)" "unprognostic (1.16e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (6.76e-4)" 6.5 7.1 12.1 3.8 18.8 2.2 5.5 9.6 22.4 9.8 4.6 42.5 2.7 3.4 9.3 5.6 7.6 8.6 9.1 5.9 16.9 12.4 6.8 12.1 7.3 2.8 28.8 15.0 11.4 161.1 12.8 4.2 6.3 26.4 6.5 4.7 6.9 5.3 9.9 6.2 7.2 3.6 11.7 53.0 5.7 4.9 4.1 21.4 0.0 6.3 2.3 2.8 6.7 5.5 4.0 2.2 0.7 3.2 2.2 6.7 1.1 3.9 4.6 9.6 14.7 32.0 34.5 0.4 21.2 18.5 10.3 8.4 3.6 6.2 0.7 5.2 38.3 6.9 10.3 6.1 8.5 2.3 5.5 2.3 7.9 4.3 15.8 0.8 0.5 29.9 9.5 13.2 12.8 8.9 0.8 0.4 18.9 14.2 0.6 1.9 6.2 10.4 1.8 4.3 0.8 4.4 2.2 12.5 14.0 7.9 1.0 2.3 10.2 2.7 12.1 18.6 2.0 19.4 6.8 0.3 0.3 0.4 8.7 1.2 13.0 0.6 2.0 0.7 2.0 3.2 5.2 4.0 6.7 5.3 2.2 1.8 3.1 2.7 0.0 2.2 1.3 1.3 6.3 1.1 12.1 18.8 9.6 21.7 16.9 12.4 28.8 15.0 26.4 21.4 BAHCC1 "BAHD2, KIAA1447" ENSG00000266074 "BAH domain and coiled-coil containing 1" 17 81395475-81466332 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 22.2" "Cell line enhanced" "Detected in many" "MOLT-4: 13.3;NB-4: 45.8;REH: 14.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 1.4;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 8 "dendritic cells: 1.1;granulocytes: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023386, HPA076910" Uncertain Approved Nucleoli Nucleoli "HPA023386: AB_1859537, HPA076910: " "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (2.28e-1)" "unprognostic (1.52e-1)" "unprognostic (1.85e-2)" "unprognostic (1.08e-1)" "unprognostic (1.16e-2)" "unprognostic (5.77e-3)" "unprognostic (1.94e-1)" "unprognostic (2.05e-2)" "prognostic favourable (7.38e-4)" "unprognostic (1.43e-1)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (1.18e-1)" "unprognostic (2.18e-1)" "unprognostic (3.78e-2)" 5.9 4.8 5.0 3.0 8.3 8.1 3.6 22.2 7.4 5.1 3.1 10.6 1.1 6.0 4.5 2.3 2.5 3.8 5.6 2.2 4.8 2.8 1.1 4.4 1.1 8.5 5.7 6.0 4.3 5.3 3.2 1.6 4.9 4.4 1.5 9.5 6.1 3.8 6.2 4.4 5.5 4.0 3.2 4.9 3.6 4.4 10.4 9.6 2.5 1.6 0.5 3.7 4.4 0.0 1.1 1.4 0.1 0.0 0.0 0.0 1.7 2.9 2.2 7.1 0.8 1.2 1.0 1.3 1.1 0.7 0.4 0.5 0.7 0.0 1.9 1.4 1.7 1.0 0.8 0.1 0.0 3.3 2.3 0.7 0.9 0.7 10.7 2.3 2.0 0.3 0.6 0.6 0.7 1.6 0.0 0.3 1.0 13.3 45.8 0.1 2.0 14.0 1.5 0.0 0.9 0.1 10.0 1.6 1.6 0.0 5.7 0.3 8.6 0.9 3.9 0.5 2.1 0.6 0.0 0.0 0.0 0.0 5.0 0.7 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 BAIAP3 "BAP3, KIAA0734" ENSG00000007516 "BAI1 associated protein 3" O94812 16 1333601-1349441 "Predicted intracellular proteins" "Exocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.1;pituitary gland: 88.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 19.7;MCF7: 6.0;RT4: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 4.9" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 144.1" "Low region specificity" "Detected in many" "HPA015627, HPA015979" Uncertain Supported "HPA015627: AB_10603678, HPA015979: " "unprognostic (1.37e-2)" "unprognostic (3.93e-2)" "unprognostic (2.44e-2)" "unprognostic (3.92e-3)" "unprognostic (4.43e-2)" "unprognostic (1.10e-1)" "unprognostic (2.25e-1)" "unprognostic (1.06e-1)" "unprognostic (5.60e-2)" "unprognostic (6.75e-3)" "unprognostic (1.44e-1)" "unprognostic (2.02e-1)" "prognostic favourable (1.52e-5)" "unprognostic (5.26e-2)" "unprognostic (3.11e-1)" "unprognostic (7.12e-3)" "unprognostic (6.43e-2)" 2.2 20.6 30.6 1.3 16.5 1.2 1.4 0.2 24.1 1.4 1.9 9.5 0.7 4.3 1.6 2.6 1.0 28.1 0.9 1.5 19.4 38.4 2.8 3.0 3.1 1.5 4.1 39.1 1.2 7.8 5.1 88.2 2.1 18.5 3.5 1.1 0.0 4.6 3.0 2.8 1.5 3.8 0.4 4.2 2.6 7.0 7.6 6.1 0.0 0.7 0.0 1.1 1.0 0.5 4.9 0.0 1.8 0.0 1.3 1.6 0.3 0.1 2.3 4.0 1.3 0.4 0.0 1.0 0.2 0.1 0.2 0.0 3.6 19.7 0.3 2.7 0.0 0.1 0.0 0.2 0.0 0.2 1.3 0.1 0.3 1.4 0.4 0.0 2.7 0.0 0.0 0.2 0.1 0.1 0.6 0.0 0.0 6.0 0.0 0.8 2.3 3.4 0.6 0.0 3.7 2.3 5.4 0.5 0.2 0.0 1.8 0.1 4.2 0.3 0.2 0.0 2.2 0.5 0.0 1.5 0.5 0.1 0.1 0.4 0.1 0.0 0.0 0.5 1.0 0.0 0.5 4.9 0.5 1.6 0.0 0.3 0.0 0.1 1.8 1.3 0.0 0.0 0.0 0.3 30.6 16.5 0.2 24.1 19.4 38.4 4.1 39.1 18.5 6.1 BARHL1 ENSG00000125492 "BarH like homeobox 1" Q9BZE3 9 132582185-132590266 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 44 "brain: 40.1" "Cell line enriched" "Detected in single" 105 "SCLC-21H: 19.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "cerebellum: 23.8;pons and medulla: 40.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebellum: 3.6;midbrain: 2.9;pons and medulla: 1.1" "Region enhanced" "Detected in many" "cerebellum: 16.3" HPA004809 Enhanced "HPA004809: AB_1078266" "unprognostic (2.29e-1)" "unprognostic (6.42e-2)" "unprognostic (8.07e-2)" "unprognostic (9.31e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 2.2 0.0 0.2 0.9 0.0 0.0 0.0 40.1 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.9 0.0 0.5 2.2 0.0 40.1 0.0 BARHL2 ENSG00000143032 "BarH like homeobox 2" Q9NY43 1 90711539-90717237 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 29.3" "Cell line enhanced" "Detected in some" "HAP1: 2.4;HEK 293: 8.7;HEL: 1.2;HMC-1: 2.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 42 "cerebellum: 29.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "cerebellum: 14.5" "Region enriched" "Detected in single" 21 "cerebellum: 48.3" "unprognostic (1.83e-1)" "unprognostic (1.73e-1)" "unprognostic (6.80e-2)" "unprognostic (3.10e-1)" "unprognostic (1.60e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 8.7 1.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 BASP1 "CAP-23, CAP23, NAP-22, NAP22" ENSG00000176788 "Brain abundant membrane attached signal protein 1" P80723 5 17065598-17276843 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.3;epididymis: 126.9" "Cell line enhanced" "Detected in many" "HeLa: 113.7;SiHa: 109.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 42.4" "Lineage enriched" "Detected in many" 17 "granulocytes: 42.4" "Low region specificity" "Detected in many" "HPA045218, HPA050333" Enhanced Enhanced "Plasma membrane" 85000000 "Plasma membrane" "HPA045218: AB_2679263, HPA050333: " "unprognostic (3.35e-2)" "unprognostic (3.13e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (2.78e-1)" "prognostic unfavourable (5.63e-4)" "unprognostic (2.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (5.25e-11)" "unprognostic (1.95e-3)" "unprognostic (1.04e-1)" "unprognostic (3.61e-2)" "unprognostic (1.70e-1)" 9.2 6.7 64.3 28.4 37.4 31.1 4.8 37.2 107.3 16.2 5.2 4.0 15.1 3.8 15.5 126.9 4.0 3.6 12.7 4.4 65.0 55.8 4.2 7.7 9.1 30.2 30.1 56.6 11.7 2.5 3.6 6.4 36.4 21.9 32.2 5.5 7.9 3.8 11.5 1.6 6.0 5.7 14.2 11.0 21.9 9.2 2.2 4.3 3.7 3.6 1.3 35.4 17.6 13.0 2.5 1.6 42.4 1.1 0.6 0.1 0.2 0.0 17.0 21.2 0.0 10.2 10.9 30.4 21.2 7.0 17.9 19.0 0.8 0.0 6.6 3.0 15.2 1.4 13.5 14.8 23.3 2.7 7.6 0.0 113.7 0.0 22.7 13.1 0.1 18.7 18.5 20.2 17.0 19.3 0.0 0.0 19.0 24.4 0.0 12.0 15.6 5.2 0.0 0.0 3.6 6.4 4.2 13.6 2.8 109.2 10.0 0.0 0.0 13.6 24.6 23.7 0.0 1.9 3.4 0.2 0.0 3.5 23.9 16.3 3.1 6.2 1.1 7.8 0.0 0.4 0.0 1.8 0.0 0.0 1.6 2.5 0.0 0.0 42.4 0.6 0.6 0.1 0.1 0.2 64.3 37.4 37.2 107.3 65.0 55.8 30.1 56.6 21.9 4.3 BCAN "BEHAB, CSPG7, MGC13038" ENSG00000132692 Brevican Q96GW7 1 156641390-156659532 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 144.2" "Cell line enhanced" "Detected in many" "HDLM-2: 24.2;K-562: 34.1;U-266/70: 20.5;U-266/84: 39.4" "Group enriched" "Detected in many" 77 "glioma: 348.5;melanoma: 75.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 8.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007865, CAB025862" Enhanced Supported "Secreted in brain" 98000 "CAB025862: , HPA007865: AB_1078299" "unprognostic (7.14e-2)" "unprognostic (3.14e-1)" "unprognostic (1.95e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (9.03e-2)" "unprognostic (4.58e-2)" "unprognostic (2.02e-2)" "unprognostic (4.80e-2)" "unprognostic (6.87e-2)" "unprognostic (1.65e-1)" "unprognostic (1.30e-2)" "unprognostic (9.47e-3)" "unprognostic (2.76e-2)" "unprognostic (8.54e-2)" "unprognostic (5.40e-1)" "unprognostic (1.90e-1)" 1.4 5.8 51.8 1.6 35.9 1.3 1.4 10.4 144.2 2.3 2.4 30.5 1.3 4.6 2.7 9.5 1.6 2.4 3.1 1.5 40.8 22.9 1.4 1.3 1.5 1.5 26.6 21.5 1.4 1.3 1.3 0.7 1.7 15.1 1.4 1.3 4.3 2.0 2.4 1.6 9.0 5.0 2.4 13.0 1.6 2.4 2.0 26.7 0.0 1.4 0.0 1.3 2.3 0.3 0.6 0.0 8.2 0.4 0.0 0.0 0.0 13.7 9.5 0.0 2.6 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.3 6.8 0.0 14.7 0.0 9.7 0.1 0.0 0.0 24.2 0.8 2.4 6.3 7.8 0.0 0.9 2.4 0.0 0.0 0.0 0.0 0.0 34.1 6.7 0.0 4.0 0.0 0.0 0.7 1.4 0.0 15.8 0.0 0.0 1.7 0.0 0.2 0.0 0.0 14.3 0.0 0.9 2.9 0.0 7.8 2.8 3.7 20.5 39.4 0.0 2.9 6.4 1.1 8.2 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.8 35.9 10.4 33.3 40.8 22.9 26.6 21.5 15.1 26.7 BCAS1 "AIBC1, NABC1" ENSG00000064787 "Breast carcinoma amplified sequence 1" O75363 20 53936777-54070594 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 134.0;intestine: 40.3;stomach 1: 85.5" "Group enriched" "Detected in some" 6 "RT4: 41.0;SK-BR-3: 85.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033558, HPA051816, HPA054745" Enhanced Approved Vesicles Vesicles "CAB033558: AB_2274632, HPA051816: AB_2681623, HPA054745: AB_2682590" "unprognostic (6.41e-2)" "unprognostic (1.01e-2)" "unprognostic (6.20e-2)" "unprognostic (7.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "unprognostic (5.54e-2)" "unprognostic (1.86e-1)" "unprognostic (3.80e-1)" "unprognostic (1.19e-1)" "unprognostic (5.25e-2)" "unprognostic (2.91e-2)" "unprognostic (4.70e-3)" "unprognostic (3.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.75e-1)" "unprognostic (7.77e-3)" 1.3 1.0 49.8 3.8 63.4 0.9 2.8 5.4 37.2 5.1 36.9 97.6 0.0 10.7 1.6 2.1 4.7 1.7 5.4 0.9 51.6 35.6 1.7 0.9 2.4 1.1 75.3 14.7 0.9 1.0 0.8 0.3 0.9 69.7 19.1 40.3 0.0 2.9 1.0 0.9 1.1 17.1 2.4 134.0 1.1 85.5 2.5 49.2 0.0 0.8 0.0 4.1 21.8 1.1 1.6 0.2 1.0 0.2 0.3 5.7 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 41.0 0.0 0.0 0.0 85.9 0.0 2.8 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.5 0.2 0.1 0.5 0.2 3.0 1.6 1.0 0.3 0.0 0.5 0.2 0.1 1.0 0.3 0.2 0.2 5.7 0.2 49.8 63.4 5.4 32.3 51.6 35.6 75.3 14.7 69.7 49.2 BCL11B "CTIP-2, CTIP2, hRIT1-alpha, ZNF856B" ENSG00000127152 "B cell CLL/lymphoma 11B" Q9C0K0 14 99169287-99271524 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease mutation, Mental retardation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.7;lymphoid tissue: 25.4;skin 1: 17.6" "Cell line enriched" "Detected in some" 6 "MOLT-4: 32.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 13.7" "Group enriched" "Detected in many" 8 "gdT-cell: 3.3;MAIT T-cell: 3.0;memory CD4 T-cell: 4.5;memory CD8 T-cell: 3.7;naive CD4 T-cell: 7.4;naive CD8 T-cell: 4.9;T-reg: 3.0" "Lineage enriched" "Detected in single" 14 "T-cells: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049117 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA049117: AB_2680639" "unprognostic (1.64e-5)" "unprognostic (4.66e-2)" "unprognostic (2.35e-2)" "unprognostic (1.87e-2)" "unprognostic (9.37e-2)" "unprognostic (5.97e-2)" "unprognostic (4.75e-2)" "unprognostic (6.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-2)" "unprognostic (1.90e-1)" "unprognostic (1.12e-1)" "unprognostic (1.60e-6)" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (3.31e-3)" "prognostic favourable (7.48e-4)" 0.3 0.4 4.4 6.6 13.7 5.2 1.3 0.3 3.8 0.8 1.3 0.1 0.0 2.3 1.9 0.8 3.9 0.3 3.0 0.8 4.8 1.0 0.3 0.5 1.1 10.8 0.8 2.6 0.2 0.1 0.0 0.1 0.0 0.6 0.6 1.7 0.3 5.0 0.7 0.1 17.6 3.0 0.2 0.7 4.9 2.1 0.4 1.6 25.4 0.9 1.5 8.8 2.0 2.3 0.0 0.0 0.1 0.0 0.5 7.4 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 1.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.1 0.0 0.0 3.0 0.0 1.8 32.6 0.5 0.3 0.0 5.1 0.0 0.0 0.0 1.8 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 2.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.1 3.3 0.0 3.0 0.0 4.5 3.7 0.0 0.0 7.4 4.9 0.0 0.5 0.0 0.0 3.0 1.1 4.4 13.7 0.3 3.8 4.8 1.0 0.8 2.6 0.6 1.6 BDNF ENSG00000176697 "Brain derived neurotrophic factor" P23560 11 27654893-27722058 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.5;smooth muscle: 10.5" "Cell line enhanced" "Detected in many" "BJ: 22.4;BJ hTERT+ SV40 Large T+: 17.2;BJ hTERT+ SV40 Large T+ RasG12V: 13.1;HBF TERT88: 16.5;U-138 MG: 24.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009564, HPA031440, HPA056104" Enhanced Supported "Nuclear speckles,Mitochondria" "Secreted to blood" 19244000 "Nuclear speckles, Mitochondria" "CAB009564: AB_2064213, HPA031440: , HPA056104: " "unprognostic (1.25e-2)" "unprognostic (2.84e-1)" "unprognostic (4.35e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-2)" "unprognostic (6.82e-2)" "unprognostic (2.39e-2)" "unprognostic (2.21e-1)" "unprognostic (3.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (3.22e-2)" "unprognostic (3.88e-2)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (2.84e-3)" 0.9 1.3 5.0 0.6 4.5 0.5 0.6 9.4 14.5 1.6 0.8 0.6 0.7 0.8 0.7 8.2 1.4 0.5 2.1 5.8 8.5 5.7 0.9 0.5 4.1 0.4 2.5 4.7 1.2 1.0 0.2 2.3 3.7 12.7 4.9 0.4 3.0 0.9 4.2 1.3 2.1 0.5 10.5 1.0 0.6 0.9 1.3 0.0 0.0 2.3 0.0 0.4 3.2 1.2 0.1 0.4 0.0 0.2 0.1 1.0 0.1 1.6 6.6 0.2 0.0 2.3 1.9 0.0 22.4 4.3 17.2 13.1 0.0 2.6 0.0 2.1 8.1 1.0 0.1 0.2 16.5 0.1 0.1 0.0 2.2 0.0 10.0 0.1 0.1 5.8 2.2 3.8 2.2 0.7 0.0 0.0 2.7 0.0 0.0 0.0 2.1 1.8 0.0 1.3 0.0 2.5 0.0 0.1 0.6 4.3 0.0 0.0 0.1 0.0 7.4 24.1 4.0 9.3 5.0 0.3 0.0 0.0 9.3 0.6 1.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.1 0.7 0.4 0.0 0.1 0.0 0.4 1.0 0.1 5.0 4.5 9.4 9.4 8.5 5.7 2.5 4.7 12.7 0.0 BEAN1 SCA31 ENSG00000166546 "Brain expressed associated with NEDD4 1" Q3B7T3 16 66427297-66493529 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell line enhanced" "Detected in some" "AN3-CA: 9.5;BEWO: 4.8;RPTEC TERT1: 8.4;U-87 MG: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053851 Uncertain Uncertain Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA053851: " "unprognostic (1.92e-1)" "unprognostic (5.79e-4)" "unprognostic (3.83e-2)" "unprognostic (3.38e-3)" "unprognostic (1.01e-1)" "unprognostic (4.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.13e-1)" "unprognostic (4.89e-1)" "unprognostic (1.59e-1)" "unprognostic (2.13e-3)" "unprognostic (4.18e-2)" "unprognostic (3.38e-2)" "unprognostic (1.63e-1)" "unprognostic (3.10e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-2)" 1.2 1.2 2.9 1.1 2.5 2.9 1.2 6.9 9.6 1.2 0.7 0.1 0.0 0.6 1.2 1.9 1.8 1.9 1.4 3.0 4.6 4.1 0.9 1.1 1.4 0.9 2.3 3.2 1.4 1.9 0.1 0.4 4.5 11.6 1.0 0.9 5.0 1.9 0.4 3.6 3.2 0.8 0.8 1.7 1.2 1.2 3.1 0.2 0.0 1.9 3.1 0.9 1.0 1.0 0.3 2.4 5.2 0.5 0.4 0.2 0.1 0.8 0.9 1.0 9.5 0.3 0.1 4.8 0.3 0.0 0.1 0.1 0.0 1.0 0.1 0.5 0.3 0.2 0.1 0.1 0.3 0.0 0.6 0.0 0.2 0.7 0.7 0.1 0.0 0.7 1.9 0.6 0.3 0.0 0.1 0.3 0.2 0.5 0.0 0.4 0.3 0.5 0.1 0.2 0.5 8.4 0.6 0.1 0.2 0.2 0.2 1.4 0.2 0.1 0.3 0.4 2.6 0.1 0.4 0.5 0.1 0.1 5.5 0.2 1.3 0.4 0.5 1.9 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.2 0.1 5.2 0.4 0.2 2.4 0.1 0.1 2.9 2.5 6.9 9.6 4.6 4.1 2.3 3.2 11.6 0.2 BEGAIN KIAA1446 ENSG00000183092 "Brain enriched guanylate kinase associated" Q9BUH8 14 100537147-100587413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9" "Group enriched" "Detected in some" 7 "HeLa: 21.3;SH-SY5Y: 51.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "eosinophil: 6.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA002899 Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA002899: AB_1078277" "unprognostic (2.98e-4)" "unprognostic (2.75e-3)" "unprognostic (2.66e-2)" "unprognostic (2.66e-4)" "unprognostic (2.77e-3)" "unprognostic (1.93e-2)" "unprognostic (5.16e-2)" "unprognostic (6.35e-2)" "unprognostic (3.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.15e-2)" "unprognostic (5.47e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (3.11e-1)" "unprognostic (2.75e-1)" "unprognostic (2.60e-1)" 1.8 5.5 16.4 1.1 10.8 6.4 1.5 24.9 21.6 1.3 1.3 0.9 0.0 4.6 2.0 1.8 1.4 3.0 2.5 1.5 15.3 7.1 0.9 0.8 1.0 1.3 4.4 6.0 3.5 13.0 2.3 8.2 3.1 3.6 2.6 0.9 2.1 2.8 2.7 0.9 1.3 3.0 1.7 2.0 3.3 1.0 2.6 1.4 5.4 1.0 0.4 1.3 0.8 0.6 0.6 1.0 6.8 1.5 0.0 0.4 0.1 0.3 1.3 0.7 4.4 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.4 1.9 21.3 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.5 0.0 0.2 0.0 0.0 1.6 0.1 0.6 0.5 0.7 0.0 0.1 2.6 0.0 0.0 1.1 51.9 1.1 0.0 1.2 0.3 5.3 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 3.7 0.9 0.1 1.3 0.1 6.8 0.0 1.5 0.0 0.6 0.4 0.0 0.0 0.2 0.1 0.0 0.6 0.0 1.4 1.0 0.0 0.1 16.4 10.8 24.9 17.3 15.3 7.1 4.4 6.0 3.6 1.4 BEND6 "bA203B9.1, C6orf65, FLJ30162" ENSG00000151917 "BEN domain containing 6" Q5SZJ8 6 56955126-57027342 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.0;fHDF/TERT166: 18.2" "Cancer enriched" "Detected in many" 6 "glioma: 4.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 11.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031605, HPA052973" Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA031605: AB_10602395, HPA052973: " "unprognostic (4.27e-1)" "unprognostic (7.05e-2)" "unprognostic (4.42e-2)" "unprognostic (1.18e-6)" "unprognostic (2.44e-1)" "unprognostic (2.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-2)" "unprognostic (9.41e-3)" "unprognostic (1.57e-1)" "unprognostic (8.82e-2)" "unprognostic (1.94e-2)" "unprognostic (9.84e-6)" "unprognostic (9.27e-3)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.98e-3)" 1.5 3.1 12.0 2.0 10.7 1.0 1.1 29.2 29.7 5.8 1.7 2.5 0.6 0.8 3.2 1.3 1.8 1.1 5.2 3.1 11.2 10.0 1.0 0.5 1.0 1.2 11.3 8.6 2.9 0.8 2.8 1.1 2.7 33.0 3.4 2.2 0.2 1.0 3.4 4.3 1.5 1.2 4.8 7.2 1.2 1.3 1.5 4.1 0.0 1.3 0.0 1.3 3.9 1.6 0.0 11.1 0.0 0.0 2.1 0.0 0.1 3.3 1.4 0.8 0.4 12.0 20.0 3.2 10.2 10.0 4.6 5.3 0.1 1.6 0.0 3.3 18.2 0.4 1.1 0.5 5.8 1.5 0.6 2.2 4.9 0.2 3.2 6.2 0.1 8.6 2.9 6.4 2.9 3.0 2.8 5.9 9.3 3.4 3.7 1.6 2.9 0.8 0.0 0.1 1.6 1.7 3.4 4.0 4.0 6.8 0.8 0.8 0.2 3.8 3.9 14.0 0.4 9.4 2.2 8.2 9.0 2.6 8.2 4.3 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.1 0.0 11.1 0.0 0.1 12.0 10.7 29.2 20.8 11.2 10.0 11.3 8.6 33.0 4.1 BEX1 ENSG00000133169 "Brain expressed X-linked 1" Q9HBH7 X 103062651-103064240 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 150.2;pituitary gland: 64.3" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 42.0;BJ hTERT+ SV40 Large T+ RasG12V: 62.4;HBF TERT88: 69.6;HL-60: 152.4;SCLC-21H: 47.7;THP-1: 43.1;U-937: 47.8" "Cancer enhanced" "Detected in many" "glioma: 111.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.4" "Low lineage specificity" "Detected in many" "HPA045384, HPA078630" Approved Approved Cytosol Cytosol "HPA045384: , HPA078630: " "prognostic favourable (6.43e-4)" "unprognostic (1.51e-1)" "unprognostic (8.92e-2)" "unprognostic (2.94e-2)" "unprognostic (1.66e-1)" "unprognostic (7.75e-2)" "unprognostic (2.27e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-1)" "unprognostic (1.12e-2)" "unprognostic (5.28e-3)" "unprognostic (2.09e-1)" "prognostic favourable (8.16e-8)" "unprognostic (1.14e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (6.88e-4)" "unprognostic (7.34e-2)" 1.8 37.4 66.4 2.8 65.1 16.3 1.9 44.7 150.2 1.8 3.0 6.2 0.0 3.3 7.7 25.2 1.6 10.1 1.8 3.6 77.4 81.0 4.5 3.0 2.1 1.7 38.9 67.8 9.5 30.9 48.1 64.3 1.5 35.8 3.8 3.1 4.7 2.2 2.9 1.3 1.5 3.9 3.3 24.3 2.3 5.0 27.5 12.0 0.0 12.1 0.0 1.5 1.5 0.4 2.4 0.2 6.4 0.5 1.7 3.1 1.5 0.0 0.0 3.8 0.0 0.0 0.0 0.1 2.1 0.0 42.0 62.4 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 69.6 0.0 0.1 12.7 0.0 8.2 0.7 152.4 0.2 0.9 0.0 9.1 0.0 0.0 0.0 0.0 8.4 0.0 28.6 0.0 34.7 6.2 0.0 0.0 0.7 0.0 0.0 47.7 27.5 0.0 0.0 0.1 0.0 43.1 0.0 0.0 14.4 0.1 1.6 7.4 0.2 0.0 5.6 47.8 2.7 0.6 0.5 6.4 0.7 0.1 0.7 1.2 2.0 1.2 0.1 2.4 3.1 1.4 1.2 1.7 0.4 0.2 0.9 1.5 66.4 65.1 44.7 89.0 77.4 81.0 38.9 67.8 35.8 12.0 BEX2 DJ79P11.1 ENSG00000133134 "Brain expressed X-linked 2" Q9BXY8 X 103309346-103311046 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 79.2;epididymis: 67.1" "Cell line enhanced" "Detected in many" "hTCEpi: 30.7;NTERA-2: 29.6;SCLC-21H: 43.6;SH-SY5Y: 19.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 18.0;NK-cells: 21.3;T-cells: 26.8" "HPA045384, HPA078630" Uncertain Uncertain Cytosol Cytosol "HPA045384: , HPA078630: " "unprognostic (7.56e-2)" "unprognostic (7.08e-2)" "unprognostic (3.46e-2)" "prognostic unfavourable (8.54e-7)" "unprognostic (3.21e-1)" "unprognostic (1.65e-1)" "unprognostic (4.27e-2)" "prognostic favourable (1.52e-4)" "unprognostic (7.36e-3)" "unprognostic (6.82e-2)" "unprognostic (8.22e-3)" "unprognostic (6.63e-2)" "prognostic favourable (3.05e-13)" "unprognostic (4.14e-3)" "unprognostic (6.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.38e-3)" 1.7 39.6 49.1 4.1 62.6 6.8 10.9 44.9 79.2 5.8 4.7 11.5 3.0 2.7 14.7 67.1 3.0 8.9 4.8 7.3 53.4 57.6 26.4 1.4 6.6 7.3 32.5 40.3 29.0 13.5 29.6 40.1 5.0 29.6 12.4 4.1 11.5 11.1 12.8 2.5 4.2 4.2 5.7 18.7 7.9 6.5 13.2 13.6 3.1 52.8 1.3 9.2 3.7 2.2 18.0 3.5 4.0 0.1 21.3 26.8 7.1 0.0 0.8 3.7 0.0 0.0 0.0 14.7 0.1 2.0 2.5 3.6 2.5 1.2 0.0 10.3 0.0 0.6 0.0 3.0 2.2 0.0 8.0 0.4 0.4 0.1 15.0 0.0 8.2 0.9 30.7 1.2 9.4 0.1 5.3 0.2 0.3 1.3 6.1 0.0 29.6 2.6 0.0 0.0 0.0 1.2 1.1 43.6 19.9 1.9 0.4 6.5 3.6 0.0 0.0 0.0 2.9 0.1 0.6 10.1 6.4 0.0 4.9 0.0 0.4 4.0 0.1 0.3 8.5 0.1 11.8 18.0 16.8 9.8 0.5 15.0 26.8 19.2 0.5 21.3 0.0 3.5 11.3 7.1 49.1 62.6 44.9 60.5 53.4 57.6 32.5 40.3 29.6 13.6 BEX5 NGFRAP1L1 ENSG00000184515 "Brain expressed X-linked 5" Q5H9J7 X 102153708-102156057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.7" "Group enriched" "Detected in some" 4 "HAP1: 8.8;Karpas-707: 34.0" "Cancer enhanced" "Detected in all" "endometrial cancer: 45.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.6;MAIT T-cell: 11.2;memory CD4 T-cell: 8.5;memory CD8 T-cell: 5.9;naive CD4 T-cell: 12.4;naive CD8 T-cell: 7.4;NK-cell: 6.5;T-reg: 7.9" "Group enriched" "Detected in many" 6 "NK-cells: 6.5;T-cells: 12.4" "Low region specificity" "Detected in all" HPA059058 Enhanced "HPA059058: " "unprognostic (1.88e-2)" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (2.63e-3)" "unprognostic (5.03e-2)" "unprognostic (1.94e-1)" "unprognostic (5.25e-2)" "prognostic favourable (3.09e-4)" "unprognostic (1.23e-1)" "unprognostic (2.83e-2)" "unprognostic (4.97e-3)" "unprognostic (4.63e-2)" "prognostic favourable (1.97e-4)" "unprognostic (3.79e-1)" "unprognostic (8.96e-2)" "unprognostic (3.26e-2)" "unprognostic (2.48e-2)" 2.7 12.1 35.4 2.9 28.1 1.8 6.0 18.7 49.7 3.6 4.0 3.5 2.9 3.3 4.8 24.8 1.8 4.1 9.5 2.4 31.2 41.7 13.4 2.6 5.7 3.6 22.5 26.1 10.5 13.0 15.3 25.1 0.5 26.1 5.1 4.8 3.7 7.8 3.5 0.8 2.2 2.7 3.0 15.7 3.0 5.8 9.2 3.7 0.0 15.6 0.0 5.6 1.9 1.2 1.6 0.6 0.0 0.0 6.5 12.4 2.3 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.7 8.8 0.2 0.0 0.0 0.4 2.9 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 1.3 0.1 1.2 34.0 0.1 3.7 0.2 0.0 4.0 1.4 0.0 0.0 0.1 3.1 0.0 4.9 0.5 0.0 0.0 0.0 0.8 0.0 3.2 0.2 2.3 0.3 0.0 3.9 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.6 0.0 11.2 1.6 8.5 5.9 0.0 0.7 12.4 7.4 0.0 6.5 0.0 0.6 7.9 2.3 35.4 28.1 18.7 47.2 31.2 41.7 22.5 26.1 26.1 3.7 BGLAP OCN ENSG00000242252 "Bone gamma-carboxyglutamate protein" P02818 1 156241962-156243321 "FDA approved drug targets, Predicted secreted proteins" Biomineralization "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.0" "Cell line enhanced" "Detected in some" "U-87 MG: 7.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "NK-cell: 2.2;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 16 "dendritic cells: 4.2;NK-cells: 2.2" "Secreted to blood" 15530000 430000 "unprognostic (2.50e-2)" "unprognostic (4.49e-2)" "unprognostic (3.82e-4)" "unprognostic (1.13e-1)" "unprognostic (1.57e-1)" "unprognostic (8.44e-5)" "unprognostic (2.63e-2)" "unprognostic (6.54e-2)" "unprognostic (5.64e-2)" "unprognostic (2.00e-1)" "unprognostic (1.53e-3)" "unprognostic (4.70e-2)" "unprognostic (9.67e-6)" "unprognostic (3.02e-2)" "unprognostic (1.72e-1)" "unprognostic (4.34e-2)" "unprognostic (8.64e-3)" 1.6 0.7 6.0 6.7 6.9 2.2 1.4 5.2 11.0 1.1 9.3 6.2 0.0 3.2 4.8 1.4 0.8 2.3 1.7 0.7 4.3 2.9 1.2 1.6 1.4 2.3 6.2 6.8 3.4 0.8 1.5 1.3 3.1 9.7 2.1 3.4 0.0 3.6 2.8 2.2 6.8 6.4 3.9 8.4 2.1 2.3 0.3 4.1 0.6 1.6 0.0 1.2 0.7 1.2 0.0 4.2 0.2 0.0 2.2 0.1 0.1 0.4 0.8 1.8 0.5 0.0 0.6 1.3 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.5 0.0 0.6 0.0 0.4 0.0 2.0 1.0 0.0 2.2 1.2 0.5 0.0 0.4 0.0 0.7 0.7 0.6 0.7 0.5 2.5 0.0 2.1 0.0 1.6 1.0 0.4 1.0 0.1 1.5 0.6 0.0 0.2 2.1 0.7 0.4 0.8 1.3 0.0 0.0 0.0 0.5 0.4 0.5 3.1 2.8 1.6 7.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 4.2 0.0 0.1 6.0 6.9 5.2 11.0 4.3 2.9 6.2 6.8 9.7 4.1 BHLHA9 "bHLHa9, BHLHF42" ENSG00000205899 "Basic helix-loop-helix family member a9" Q7RTU4 17 1270559-1271460 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "brain: 4.0" "Cell line enhanced" "Detected in some" "CACO-2: 1.1;HDLM-2: 1.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "unprognostic (9.27e-2)" "unprognostic (2.63e-1)" "unprognostic (2.99e-1)" "unprognostic (7.74e-2)" 0.1 0.0 1.4 0.0 0.3 0.0 0.0 0.4 4.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.9 1.6 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.4 3.2 0.9 1.6 0.5 0.0 1.6 0.0 BHLHB9 "GASP3, KIAA1701, p60TRP" ENSG00000198908 "Basic helix-loop-helix family member b9" Q6PI77 X 102720688-102753540 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 21.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000887 Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA000887: " "unprognostic (4.07e-2)" "unprognostic (4.15e-2)" "unprognostic (4.87e-2)" "unprognostic (1.70e-3)" "unprognostic (6.42e-3)" "unprognostic (2.36e-1)" "unprognostic (2.40e-3)" "unprognostic (5.06e-3)" "unprognostic (2.65e-1)" "unprognostic (7.65e-2)" "unprognostic (2.74e-2)" "unprognostic (4.27e-2)" "unprognostic (1.29e-3)" "unprognostic (1.43e-1)" "unprognostic (7.46e-2)" "unprognostic (4.95e-2)" "unprognostic (8.88e-2)" 2.8 6.4 8.6 1.6 13.0 2.7 3.7 15.3 20.6 5.5 3.4 8.7 2.3 2.1 7.5 5.8 2.9 4.5 3.0 4.9 8.9 12.5 6.3 3.8 2.6 1.5 7.2 12.7 9.9 3.6 9.1 7.1 4.8 21.1 7.2 2.9 3.9 3.6 8.2 4.8 3.4 2.5 7.2 6.3 2.7 2.5 4.4 7.3 1.7 6.6 1.2 2.0 4.1 3.4 0.7 0.3 0.9 0.2 5.3 2.0 0.5 0.5 4.0 13.0 3.9 4.1 2.4 5.2 3.4 4.7 5.7 10.9 3.3 2.3 0.0 3.6 3.9 2.8 7.1 3.8 6.4 0.0 4.2 1.0 3.3 0.7 6.6 0.7 1.3 4.3 3.4 2.5 0.3 5.7 3.0 3.5 5.0 2.2 2.6 0.4 7.6 3.0 1.4 3.8 0.0 3.7 5.8 5.8 5.4 3.8 1.1 0.4 3.2 1.8 5.8 1.5 4.0 2.2 3.3 1.9 4.7 0.0 3.5 0.9 2.4 0.9 0.2 0.2 1.0 0.1 0.9 0.4 1.1 2.0 0.1 0.7 1.3 1.7 0.7 5.3 0.1 0.3 1.6 0.5 8.6 13.0 15.3 20.6 8.9 12.5 7.2 12.7 21.1 7.3 BHLHE22 "Beta3, BHLHB5, bHLHe22, CAGL85, TNRC20" ENSG00000180828 "Basic helix-loop-helix family member e22" Q8NFJ8 8 64580367-64583628 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 30.7" "Cell line enriched" "Detected in some" 23 "THP-1: 40.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 31.9;cerebellum: 34.4;cerebral cortex: 22.4;hippocampal formation: 50.8" "Group enriched" "Detected in many" 8 "amygdala: 37.8;cerebellum: 21.5;cerebral cortex: 22.5;hippocampal formation: 63.6" "HPA064128, HPA064872, HPA067500" Enhanced "HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855" "unprognostic (9.17e-2)" "unprognostic (1.11e-2)" "unprognostic (5.44e-2)" "unprognostic (2.28e-5)" "unprognostic (7.22e-3)" "unprognostic (6.47e-4)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (1.30e-1)" "unprognostic (6.58e-2)" "unprognostic (1.52e-1)" "unprognostic (3.71e-2)" "unprognostic (2.86e-7)" "unprognostic (3.20e-2)" "unprognostic (2.29e-1)" "unprognostic (6.72e-3)" "unprognostic (1.86e-1)" 2.9 1.3 30.7 2.9 1.4 0.3 1.7 21.1 15.8 1.7 1.7 1.2 0.3 1.1 0.5 0.4 2.2 0.6 1.1 0.8 27.2 2.1 0.5 1.3 1.4 2.4 1.7 6.5 0.4 1.3 0.5 1.2 0.2 3.4 0.5 1.4 2.5 1.2 5.4 0.5 0.8 1.7 1.1 2.6 2.9 1.1 0.7 0.2 0.0 0.6 0.0 1.3 2.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 1.4 21.1 10.6 27.2 2.1 1.7 6.5 3.4 0.2 BHLHE23 "bA305P22.3, Beta4, BHLHB4, bHLHe23" ENSG00000125533 "Basic helix-loop-helix family member e23" Q8NDY6 20 63005927-63007035 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 1.0;lymphoid tissue: 4.1;retina: 1.3;testis: 1.8" "Cell line enriched" "Detected in single" 23 "MOLT-4: 16.5" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 3.0" HPA030575 Uncertain "HPA030575: AB_10601459" "unprognostic (1.74e-1)" 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.8 0.0 4.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.7 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BICD1 ENSG00000151746 "BICD cargo adaptor 1" Q96G01 12 32106835-32383633 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 39.0" "Cell line enhanced" "Detected in many" "NTERA-2: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041309 Approved Approved Vesicles Vesicles "HPA041309: AB_10804000" "unprognostic (1.40e-1)" "unprognostic (1.18e-2)" "unprognostic (1.73e-2)" "unprognostic (2.10e-1)" "unprognostic (2.06e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-6)" "unprognostic (5.93e-2)" "unprognostic (4.57e-1)" "unprognostic (3.64e-1)" "unprognostic (8.19e-2)" "unprognostic (9.66e-2)" "prognostic unfavourable (2.33e-7)" "unprognostic (1.72e-1)" "unprognostic (1.74e-1)" "unprognostic (5.37e-2)" "unprognostic (1.36e-1)" 6.2 5.3 11.7 8.3 10.6 4.1 5.3 39.0 13.7 19.9 4.4 9.2 1.9 3.3 13.8 10.4 3.1 14.8 7.7 6.0 10.7 7.6 6.7 1.9 6.6 8.6 6.6 10.9 29.0 2.5 12.6 9.9 12.1 8.3 6.5 4.5 5.6 3.7 4.1 4.6 2.9 4.5 8.2 8.3 10.4 4.0 4.4 8.0 8.8 9.5 1.9 7.4 6.2 4.9 5.4 6.3 0.1 0.9 2.8 4.7 1.6 8.4 6.8 4.5 2.7 4.1 4.7 4.3 10.0 4.2 10.0 6.7 6.3 5.1 13.4 7.5 9.1 3.3 18.9 7.8 14.4 8.4 5.5 13.8 5.2 3.3 4.9 11.2 8.4 3.2 3.6 11.0 9.0 9.5 7.1 22.6 4.3 3.4 12.1 4.2 38.1 6.1 9.4 13.5 7.9 11.5 4.6 17.7 10.6 6.7 0.4 6.2 5.3 2.9 10.6 14.1 13.3 9.4 13.5 7.6 10.8 21.7 9.4 5.8 16.3 0.0 0.9 0.0 3.5 0.3 4.7 5.4 3.2 2.2 1.5 5.2 3.6 2.8 0.1 2.8 0.0 6.3 4.1 1.6 11.7 10.6 39.0 13.7 10.7 7.6 6.6 10.9 8.3 8.0 BIVM-ERCC5 ENSG00000270181 "BIVM-ERCC5 readthrough" 13 102799110-102875994 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 10.6" "Cell line enhanced" "Detected in some" "HaCaT: 2.9;HEK 293: 11.9;HeLa: 5.1;PC-3: 6.6;SCLC-21H: 3.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "MAIT T-cell: 2.9" "Low lineage specificity" "Detected in many" "HPA045845, HPA050126, HPA050374" Uncertain Enhanced Nucleoplasm Nucleoplasm "HPA045845: , HPA050126: , HPA050374: " "unprognostic (6.01e-2)" 1.0 1.0 2.7 3.7 4.5 1.1 1.4 10.6 5.7 1.0 2.9 1.3 2.6 1.0 2.1 1.1 1.0 2.6 1.0 1.9 2.7 3.2 2.4 2.3 1.5 2.2 2.7 1.0 1.9 1.0 2.7 1.3 2.6 2.0 1.0 1.1 1.0 2.7 1.0 1.0 1.0 2.6 0.6 1.8 2.6 1.2 2.3 0.3 1.7 1.5 1.0 1.0 1.0 0.0 2.8 0.0 1.4 1.3 2.9 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.7 0.0 0.1 0.6 2.9 0.3 0.0 0.0 0.0 11.9 0.0 5.1 0.0 0.5 2.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.4 0.1 3.3 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.6 2.9 0.0 0.7 1.0 2.8 0.0 0.2 0.1 0.0 1.3 0.0 0.0 0.3 1.0 BOK "BCL2L9, BOKL, MGC4631" ENSG00000176720 "BOK, BCL2 family apoptosis regulator" Q9UMX3 2 241551424-241574138 "Plasma proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 56.0;brain: 64.1" "Cell line enhanced" "Detected in many" "TIME: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 5.7" "Lineage enriched" "Detected in many" 4 "T-cells: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (6.16e-2)" "unprognostic (3.01e-2)" "unprognostic (1.24e-3)" "unprognostic (6.30e-2)" "unprognostic (8.63e-2)" "unprognostic (1.33e-1)" "unprognostic (2.24e-3)" "unprognostic (1.16e-2)" "unprognostic (8.45e-2)" "unprognostic (2.33e-1)" "unprognostic (2.47e-2)" "unprognostic (2.27e-1)" "prognostic favourable (1.09e-9)" "unprognostic (9.48e-3)" "unprognostic (6.81e-2)" "unprognostic (2.46e-1)" "unprognostic (1.09e-1)" 56.0 5.4 15.0 4.5 44.5 0.8 25.6 8.6 24.7 10.5 13.7 45.2 3.3 5.9 15.4 12.0 20.1 13.2 15.5 4.4 19.8 16.0 10.9 46.2 13.8 2.6 64.1 12.8 5.5 11.0 2.9 2.0 4.3 38.6 14.7 4.0 3.0 7.7 19.1 2.1 12.9 4.9 14.1 44.8 3.7 8.5 4.4 56.2 0.0 5.4 3.0 2.7 13.2 13.8 0.0 0.0 0.0 0.0 1.4 5.7 1.5 14.0 3.5 6.4 14.7 11.0 6.6 1.8 11.5 4.6 15.2 15.8 6.4 5.9 0.0 4.0 20.4 13.2 0.7 11.6 5.7 0.0 0.1 0.0 3.6 16.5 9.2 0.1 0.5 6.7 12.0 6.4 1.8 18.1 2.5 0.0 14.8 18.1 0.0 0.1 4.0 10.9 0.1 10.6 0.0 9.8 0.3 5.8 2.2 5.3 3.5 9.2 9.9 0.5 26.1 0.0 22.2 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 5.7 0.0 0.6 0.0 1.7 2.3 0.0 0.0 0.0 2.6 0.0 1.4 0.0 0.0 0.0 1.5 15.0 44.5 8.6 24.7 19.8 16.0 64.1 12.8 38.6 56.2 BRICD5 "C16orf79, MGC21830" ENSG00000182685 "BRICHOS domain containing 5" Q6PL45 16 2209253-2211950 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 29.7;testis: 42.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 29.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA063522 Approved "Nucleoplasm,Actin filaments" "Actin filaments" Nucleoplasm "HPA063522: " "prognostic favourable (9.74e-4)" "unprognostic (7.12e-3)" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (1.93e-3)" "unprognostic (2.02e-1)" "unprognostic (4.62e-2)" "unprognostic (4.34e-3)" "unprognostic (7.56e-2)" "prognostic favourable (7.01e-4)" "unprognostic (9.84e-3)" "unprognostic (2.65e-2)" "unprognostic (9.79e-2)" "unprognostic (2.88e-1)" "unprognostic (3.57e-1)" "prognostic favourable (8.06e-5)" 2.0 4.0 3.2 3.7 4.9 3.0 2.0 29.7 5.3 2.0 2.0 2.0 2.0 5.4 2.8 2.0 2.0 1.6 2.0 2.9 3.5 4.4 2.9 2.0 2.1 4.6 3.1 2.8 2.0 3.0 2.2 3.6 2.9 2.5 2.4 0.5 9.9 3.7 4.0 9.1 2.7 5.2 2.0 3.3 6.3 2.7 42.8 2.0 2.4 6.1 2.0 2.0 2.0 2.0 0.8 0.6 2.3 0.8 0.8 1.7 0.4 2.7 5.5 7.6 4.3 1.2 1.3 13.9 2.7 0.5 1.5 2.3 7.0 6.9 1.5 1.8 0.5 7.4 1.0 1.0 1.1 5.1 3.3 1.7 13.2 1.8 0.7 0.7 4.3 1.5 2.0 2.2 0.5 0.9 1.8 3.9 0.6 7.4 4.7 10.7 7.4 3.1 14.6 5.7 4.9 1.7 2.2 5.3 4.8 2.7 3.3 2.6 3.4 3.9 2.2 7.3 5.9 6.3 2.3 11.9 5.1 3.9 1.3 4.4 3.5 0.4 0.7 2.2 0.6 0.8 0.3 0.3 0.3 0.1 0.6 0.8 1.7 0.4 2.3 0.8 0.2 0.4 0.4 0.4 3.2 4.9 29.7 5.3 3.5 4.4 3.1 2.8 2.5 2.0 BRINP1 "DBC1, DBCCR1, FAM5A" ENSG00000078725 "BMP/retinoic acid inducible neural specific 1" O60477 9 119153458-119369467 "Predicted intracellular proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.0" "Cell line enhanced" "Detected in some" "HSkMC: 9.2;NTERA-2: 17.5;SCLC-21H: 7.8;SH-SY5Y: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038828 Approved Uncertain Microtubules "Intracellular and membrane" Microtubules "HPA038828: AB_10670909" "unprognostic (8.60e-5)" "unprognostic (2.31e-2)" "unprognostic (1.24e-1)" "unprognostic (5.09e-5)" "unprognostic (1.12e-1)" "unprognostic (1.14e-2)" "unprognostic (1.37e-1)" "unprognostic (2.98e-1)" "unprognostic (1.76e-1)" "unprognostic (1.02e-1)" "unprognostic (2.28e-4)" "unprognostic (1.51e-2)" "unprognostic (5.06e-3)" "unprognostic (1.39e-3)" "unprognostic (1.56e-1)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" 1.0 5.6 17.7 1.0 16.5 0.9 3.8 19.7 47.0 1.4 1.1 5.1 0.0 1.1 1.2 7.2 1.2 1.0 2.7 2.8 16.0 12.4 3.0 1.7 1.1 0.9 7.4 10.7 1.0 0.9 1.0 1.0 0.9 5.8 2.9 1.0 0.2 1.7 7.6 1.2 0.9 1.7 1.0 9.7 1.3 1.0 1.5 5.1 0.0 1.3 0.0 0.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 17.5 0.0 0.0 1.8 0.0 0.1 0.0 7.8 3.3 0.0 0.0 0.0 0.7 0.0 0.0 1.2 1.9 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 16.5 19.7 32.2 16.0 12.4 7.4 10.7 5.8 5.1 BRINP2 "DBCCR1L2, FAM5B" ENSG00000198797 "BMP/retinoic acid inducible neural specific 2" Q9C0B6 1 177171497-177282422 "Predicted secreted proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "adrenal gland: 11.5;brain: 27.9" "Cell line enhanced" "Detected in some" "HDLM-2: 10.5;PC-3: 2.6;REH: 3.0;SCLC-21H: 9.5;SH-SY5Y: 2.1" "Cancer enriched" "Detected in some" 5 "glioma: 11.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050681 Uncertain "Secreted in other tissues" "HPA050681: " "unprognostic (7.78e-2)" "unprognostic (4.49e-1)" "unprognostic (2.53e-1)" "unprognostic (1.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.43e-2)" "unprognostic (1.77e-1)" "unprognostic (5.77e-2)" "unprognostic (1.23e-2)" "unprognostic (1.95e-2)" "unprognostic (2.20e-4)" "unprognostic (8.95e-2)" "unprognostic (1.78e-2)" "unprognostic (2.60e-3)" "unprognostic (1.17e-1)" "unprognostic (2.60e-2)" "unprognostic (4.82e-3)" 0.4 11.5 12.2 0.3 8.2 0.3 1.9 0.4 27.9 0.3 0.4 0.6 0.0 0.3 0.5 0.9 0.3 0.6 0.4 0.4 7.0 6.0 0.3 0.4 0.3 0.3 4.5 3.6 0.3 0.3 0.3 2.0 1.0 0.8 0.4 0.3 0.0 0.3 0.4 0.3 0.3 0.3 0.4 1.5 0.5 0.3 1.8 0.3 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 2.6 3.0 0.0 0.0 0.0 0.0 9.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 8.2 0.4 15.9 7.0 6.0 4.5 3.6 0.8 0.3 BRINP3 "DBCCR1L, DBCCR1L1, FAM5C" ENSG00000162670 "BMP/retinoic acid inducible neural specific 3" Q76B58 1 190097662-190478404 "Predicted intracellular proteins, Predicted secreted proteins" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.4;intestine: 18.6" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 17.7" "Group enriched" "Detected in some" 14 "breast cancer: 3.4;glioma: 8.6;prostate cancer: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054693 Uncertain "Secreted in other tissues" "HPA054693: " "unprognostic (3.18e-2)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-1)" "unprognostic (8.25e-2)" "unprognostic (3.65e-1)" "unprognostic (2.38e-2)" "unprognostic (2.62e-1)" "unprognostic (9.84e-2)" "unprognostic (4.58e-3)" 0.7 2.4 11.3 1.0 11.9 0.3 2.0 18.4 30.4 0.5 7.2 2.1 0.0 5.3 0.6 3.7 2.2 0.9 2.0 5.6 8.9 12.2 2.8 0.4 1.6 0.3 6.0 12.7 0.4 0.3 0.4 0.4 0.3 7.4 7.8 7.6 0.0 1.6 6.3 0.4 0.4 18.6 1.0 6.8 0.3 0.7 3.7 2.7 0.0 2.4 0.0 0.5 1.1 0.3 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 11.3 11.9 18.4 19.1 8.9 12.2 6.0 12.7 7.4 2.7 BRSK1 KIAA1811 ENSG00000160469 "BR serine/threonine kinase 1" Q8TDC3 19 55282072-55312533 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 65.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 25.9;SH-SY5Y: 23.2;WM-115: 21.1" "Cancer enhanced" "Detected in all" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021212, HPA061719" Enhanced Supported Nucleoplasm Nucleoplasm "HPA021212: AB_1845455, HPA061719: " "unprognostic (1.42e-3)" "unprognostic (2.92e-2)" "unprognostic (1.20e-1)" "unprognostic (6.69e-3)" "unprognostic (2.71e-1)" "unprognostic (4.21e-2)" "unprognostic (3.06e-6)" "unprognostic (4.24e-1)" "unprognostic (2.06e-2)" "unprognostic (3.04e-1)" "prognostic favourable (1.02e-4)" "unprognostic (3.00e-1)" "prognostic unfavourable (7.98e-6)" "unprognostic (1.16e-1)" "unprognostic (6.61e-3)" "unprognostic (1.34e-1)" "unprognostic (2.09e-1)" 1.4 9.8 28.6 3.2 23.6 1.0 1.6 26.7 65.0 1.8 2.2 7.9 0.1 3.3 5.4 3.7 3.0 2.3 3.9 6.5 33.4 20.0 1.4 0.8 1.7 2.4 20.4 14.8 2.4 2.6 12.4 11.0 1.5 13.3 3.8 1.9 2.8 2.5 4.6 1.0 1.1 2.6 4.9 9.2 1.5 1.9 4.4 7.2 0.0 3.0 0.0 1.6 3.2 0.7 0.0 0.3 0.0 0.9 0.1 0.8 0.2 0.3 1.2 15.3 8.0 0.0 0.6 0.1 2.4 3.4 3.3 4.8 5.9 2.7 3.1 1.7 2.7 0.1 3.2 0.1 3.1 14.4 12.6 2.0 1.6 0.6 3.3 0.6 5.9 2.1 0.3 3.3 0.0 0.1 2.8 18.8 2.9 0.8 3.6 0.7 11.1 1.0 8.3 3.8 0.5 0.2 0.0 25.9 23.2 0.0 0.4 5.6 1.3 1.7 0.0 6.3 6.7 3.5 4.6 15.6 11.4 7.0 6.5 1.4 21.1 0.0 0.9 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.2 28.6 23.6 26.7 40.2 33.4 20.0 20.4 14.8 13.3 7.2 BRSK2 "C11orf7, PEN11B, STK29" ENSG00000174672 "BR serine/threonine kinase 2" Q8IWQ3 11 1389899-1462689 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, Exocytosis, Mitosis, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 34.9;pancreas: 78.8" "Cell line enhanced" "Detected in some" "AF22: 8.9;AN3-CA: 9.7;CACO-2: 7.7;HAP1: 7.2;NTERA-2: 15.0;SCLC-21H: 35.0" "Cancer enhanced" "Detected in many" "glioma: 3.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "NK-cell: 1.3" "Lineage enriched" "Detected in single" 13 "NK-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073690 Approved "Golgi apparatus" "Golgi apparatus" "HPA073690: " "unprognostic (5.47e-2)" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-2)" "unprognostic (1.05e-2)" "unprognostic (3.63e-1)" "unprognostic (6.42e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.17e-7)" "unprognostic (3.24e-2)" "unprognostic (1.57e-1)" "unprognostic (1.49e-3)" "unprognostic (1.86e-1)" 1.5 3.5 13.6 1.5 12.8 1.3 1.3 30.8 34.9 1.3 1.5 10.0 0.0 1.7 1.4 1.3 1.3 1.4 1.9 1.5 15.6 10.6 1.4 1.3 1.4 1.3 8.3 17.2 1.4 78.8 1.6 4.6 1.8 9.5 1.6 1.4 2.2 1.6 1.4 1.5 1.5 1.9 1.4 6.5 1.3 1.9 5.5 9.2 0.0 1.9 0.0 1.3 1.3 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 3.9 8.9 9.7 0.1 0.3 0.0 0.1 0.1 0.7 0.3 7.7 0.5 0.0 1.3 0.1 0.0 7.2 0.0 0.6 0.9 3.8 0.0 0.0 0.1 0.4 0.0 0.3 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.9 0.0 0.0 15.0 1.2 0.0 0.0 0.0 0.1 0.1 35.0 5.2 1.7 0.1 2.4 0.2 0.4 0.2 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 13.6 12.8 30.8 23.3 15.6 10.6 8.3 17.2 9.5 9.2 BSN ZNF231 ENSG00000164061 "Bassoon presynaptic cytomatrix protein" Q9UPA5 3 49554489-49671545 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 36.9" "Cell line enhanced" "Detected in some" "K-562: 3.8;SCLC-21H: 8.9;SH-SY5Y: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034757 Enhanced "HPA034757: AB_10671233" "unprognostic (8.57e-2)" "unprognostic (3.45e-1)" "unprognostic (7.31e-2)" "unprognostic (3.50e-4)" "unprognostic (7.40e-2)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (5.46e-3)" "unprognostic (1.14e-1)" "unprognostic (1.70e-1)" "unprognostic (6.21e-5)" "unprognostic (2.50e-3)" "unprognostic (5.38e-5)" "unprognostic (9.33e-2)" "unprognostic (3.03e-1)" "unprognostic (2.30e-1)" "unprognostic (7.34e-2)" 1.2 3.9 23.0 1.3 22.4 1.1 1.2 25.4 36.9 1.3 1.2 1.8 0.0 1.3 1.5 7.0 1.2 1.4 1.2 1.3 13.1 5.1 1.4 1.3 1.3 1.2 3.9 19.1 1.6 2.1 1.7 4.4 1.3 7.9 1.3 1.2 0.7 1.3 1.4 1.4 1.3 1.3 1.3 1.6 1.3 1.7 5.1 4.0 0.0 1.4 0.0 1.1 1.1 0.3 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.2 0.4 2.1 1.4 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.5 0.4 2.4 0.5 0.0 0.3 0.3 0.0 0.1 0.4 1.0 0.3 0.6 1.1 0.0 0.4 0.9 0.1 0.0 0.0 0.4 0.0 3.8 0.4 0.1 0.8 0.4 0.2 1.7 1.0 0.0 0.2 0.4 0.0 0.4 8.9 5.5 0.8 0.1 0.1 0.1 0.4 0.0 0.2 0.2 0.2 0.1 0.3 1.0 0.2 0.2 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 23.0 22.4 25.4 36.9 13.1 5.1 3.9 19.1 7.9 4.0 BSX BSX1 ENSG00000188909 "Brain specific homeobox" Q3C1V8 11 122977570-122981720 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.9;pituitary gland: 1.7;testis: 1.7" "Group enriched" "Detected in some" 21 "HDLM-2: 1.5;SCLC-21H: 2.6;SH-SY5Y: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "hypothalamus: 5.3" "Region enriched" "Detected in single" 8 "hypothalamus: 4.5" HPA015654 Uncertain "HPA015654: AB_1845470" 0.0 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 1.7 0.0 4.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.8 0.0 4.9 0.0 1.2 4.5 0.0 BTBD17 "BTBD17A, LGALS3BPL, TANGO10A" ENSG00000204347 "BTB domain containing 17" A6NE02 17 74356416-74361946 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 18.2" "Group enriched" "Detected in some" 20 "AF22: 3.8;NTERA-2: 5.0;SCLC-21H: 15.0" "Group enriched" "Detected in some" 11 "glioma: 9.5;testis cancer: 1.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025022 Approved "Secreted in brain" "HPA025022: AB_2067352" "unprognostic (2.63e-1)" "unprognostic (2.77e-1)" "unprognostic (4.82e-5)" "unprognostic (3.89e-2)" "unprognostic (2.55e-1)" "unprognostic (9.89e-3)" 0.4 1.5 5.4 0.4 5.1 0.4 0.4 5.6 18.2 0.4 0.4 2.7 0.0 1.2 0.4 0.4 0.4 0.4 0.4 0.4 3.7 5.7 0.4 0.4 0.4 0.4 3.8 1.8 0.4 0.4 0.4 0.2 0.4 6.1 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.5 0.4 3.7 0.6 1.4 0.5 2.2 0.0 0.6 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.3 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.4 5.1 5.6 8.2 3.7 5.7 3.8 1.8 6.1 2.2 BTBD3 "dJ742J24.1, KIAA0952" ENSG00000132640 "BTB domain containing 3" Q9Y2F9 20 11890723-11926609 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell line enhanced" "Detected in many" "AN3-CA: 65.0;HeLa: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041424, HPA042048" Uncertain Supported Vesicles Vesicles "HPA041424: AB_10794667, HPA042048: AB_10796469" "unprognostic (3.93e-2)" "unprognostic (2.25e-1)" "unprognostic (1.32e-1)" "unprognostic (3.56e-3)" "unprognostic (4.24e-3)" "unprognostic (8.45e-2)" "prognostic unfavourable (2.51e-5)" "prognostic unfavourable (6.94e-4)" "unprognostic (4.87e-2)" "unprognostic (2.95e-1)" "unprognostic (1.07e-2)" "unprognostic (7.05e-2)" "unprognostic (6.66e-2)" "unprognostic (7.68e-3)" "unprognostic (1.67e-1)" "unprognostic (6.29e-2)" "unprognostic (1.37e-2)" 8.9 18.5 32.9 5.5 25.2 8.7 10.4 53.8 40.7 12.2 17.1 32.4 3.8 8.7 15.8 10.1 8.3 12.9 11.1 11.1 56.8 19.8 9.8 6.2 10.0 3.0 25.6 21.2 9.0 10.6 10.5 6.7 33.6 20.9 13.0 14.7 8.4 10.9 9.3 11.5 16.7 8.7 13.8 24.3 6.0 21.2 11.7 22.5 4.1 9.6 5.0 2.5 13.8 7.3 0.3 2.9 0.6 6.3 1.4 0.7 1.1 1.8 5.2 14.1 65.0 2.9 3.1 3.8 5.8 3.7 6.6 4.2 2.9 2.8 0.5 4.9 8.4 4.8 7.3 4.1 10.7 0.0 6.5 1.8 51.3 6.2 3.1 3.0 1.1 5.6 5.1 5.9 4.8 3.7 3.2 5.0 6.5 1.3 3.5 2.7 6.7 1.4 4.7 2.8 1.8 6.0 9.0 6.2 10.9 16.2 6.6 14.0 3.9 3.0 2.8 3.6 9.2 3.3 6.4 1.8 2.4 0.0 2.3 0.8 23.5 0.0 2.2 0.2 0.0 3.4 0.0 0.1 0.0 0.0 2.9 0.3 0.7 0.0 0.6 1.4 6.3 2.0 0.0 1.1 32.9 25.2 53.8 40.7 56.8 19.8 25.6 21.2 20.9 22.5 BTBD8 ENSG00000189195 "BTB domain containing 8" Q5XKL5 1 92080305-92184725 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 42.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA024216, HPA035311" Enhanced Supported Nucleoplasm Nucleoplasm "HPA024216: AB_1852385, HPA035311: AB_10671933" "unprognostic (2.94e-1)" "unprognostic (2.97e-2)" "unprognostic (1.99e-1)" "unprognostic (3.06e-2)" "unprognostic (1.83e-1)" "unprognostic (3.17e-2)" "unprognostic (2.72e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-2)" "unprognostic (2.97e-1)" "unprognostic (2.82e-2)" "unprognostic (8.42e-2)" "unprognostic (3.73e-3)" "unprognostic (5.04e-2)" "unprognostic (9.49e-2)" "unprognostic (2.39e-2)" "unprognostic (3.15e-1)" 3.4 4.6 11.7 1.2 27.3 0.7 3.3 20.3 42.3 2.3 2.4 4.0 0.6 1.7 3.4 4.7 2.0 3.3 2.3 2.8 7.8 2.1 2.4 1.9 2.5 1.4 4.5 23.3 5.0 2.7 5.1 6.0 2.5 16.4 3.3 2.5 1.2 2.8 2.7 2.3 1.8 2.1 2.0 6.6 1.8 2.4 8.3 9.9 0.2 3.7 0.0 1.1 4.7 2.7 0.5 0.8 0.6 0.7 0.9 2.3 0.4 2.8 2.3 1.7 0.0 5.2 10.5 5.7 1.8 2.5 1.5 1.9 0.5 3.3 1.2 6.7 1.6 0.8 1.3 3.3 2.4 2.9 1.9 2.1 0.6 0.9 1.1 1.1 1.3 6.1 2.8 0.9 1.8 1.6 2.5 0.8 2.8 1.7 0.8 2.2 1.7 1.8 1.8 1.7 0.2 3.3 2.1 0.9 1.5 3.0 1.5 1.5 2.3 1.6 1.1 2.0 1.2 1.1 0.7 2.2 0.9 0.0 1.6 0.2 0.4 0.0 0.6 0.0 2.3 0.1 0.5 0.5 1.0 0.9 0.0 0.5 1.8 1.4 0.6 0.9 0.7 0.8 0.9 0.4 11.7 27.3 20.3 42.3 7.8 2.1 4.5 23.3 16.4 9.9 BUB1B-PAK6 ENSG00000259288 "BUB1B-PAK6 readthrough" 15 40217428-40276396 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031124 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.83e-1)" "unprognostic (1.29e-3)" "unprognostic (1.32e-1)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-2)" 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 C10orf105 FLJ00245 ENSG00000214688 "Chromosome 10 open reading frame 105" Q8TEF2 10 71711702-71737824 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 20.1;lymphoid tissue: 8.6" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 8.3" "Cancer enriched" "Detected in single" 9 "glioma: 0.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.3;myeloid DC: 1.6;non-classical monocyte: 4.8" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;monocytes: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (2.60e-3)" "unprognostic (6.76e-3)" "unprognostic (5.45e-1)" "unprognostic (4.14e-1)" "unprognostic (1.17e-1)" "unprognostic (1.37e-6)" "unprognostic (5.25e-2)" "unprognostic (2.10e-3)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (3.87e-2)" "unprognostic (1.35e-1)" "unprognostic (7.37e-2)" "unprognostic (4.64e-1)" "unprognostic (1.53e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" 1.2 0.7 6.8 2.8 8.8 1.8 0.5 0.7 5.6 0.7 0.8 20.1 0.0 1.0 0.8 0.3 0.9 0.8 1.2 0.6 8.9 10.6 0.4 0.7 1.1 3.7 11.7 5.2 1.0 0.3 0.4 0.1 0.8 13.7 0.6 0.7 0.0 0.6 0.4 0.8 1.9 1.3 0.6 4.2 8.6 0.5 3.0 8.7 0.5 0.4 0.0 2.0 1.2 0.2 0.0 1.6 0.7 4.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.2 0.9 0.0 0.0 0.1 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 4.3 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.0 4.8 0.0 0.0 0.3 6.8 8.8 0.7 4.9 8.9 10.6 11.7 5.2 13.7 8.7 C10orf90 "bA422P15.2, FATS, FLJ32938" ENSG00000154493 "Chromosome 10 open reading frame 90" Q96M02 10 126424997-126670446 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3" "Cell line enhanced" "Detected in some" "SK-MEL-30: 48.4;U-2197: 14.8;U-266/84: 10.4;U-87 MG: 15.4;WM-115: 12.1" "Cancer enriched" "Detected in some" 5 "melanoma: 4.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038648, HPA075229" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA038648: AB_10672721, HPA075229: " "unprognostic (1.21e-2)" "unprognostic (3.34e-1)" "unprognostic (7.50e-2)" "unprognostic (2.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.30e-2)" "unprognostic (1.98e-3)" "unprognostic (5.06e-2)" "unprognostic (9.34e-3)" "unprognostic (3.73e-2)" "unprognostic (9.52e-2)" "unprognostic (1.22e-1)" "unprognostic (5.06e-11)" "unprognostic (2.69e-3)" "unprognostic (9.91e-3)" "unprognostic (1.26e-1)" "unprognostic (2.88e-1)" 1.9 0.8 7.5 1.0 21.5 0.8 9.2 1.4 18.7 0.9 0.9 30.9 0.0 0.7 0.8 0.8 0.9 0.7 1.1 0.8 10.8 5.9 0.9 0.8 0.8 0.7 26.0 5.9 0.9 1.1 0.7 0.5 1.3 14.4 0.9 1.0 1.7 18.6 0.7 0.9 1.9 0.8 0.8 17.2 0.8 0.7 12.3 28.0 0.0 1.3 0.0 2.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 48.4 0.0 0.1 0.0 1.9 0.0 14.8 0.2 0.0 10.4 0.0 15.4 0.0 12.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 21.5 1.4 11.3 10.8 5.9 26.0 5.9 14.4 28.0 C11orf87 "LOC399947, LOH11CR1A, NEURIM1" ENSG00000185742 "Chromosome 11 open reading frame 87" Q6NUJ2 11 109422120-109429114 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 32.3" "Group enriched" "Detected in some" 4 "BJ hTERT+ SV40 Large T+: 3.9;fHDF/TERT166: 15.4;SCLC-21H: 4.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034656 Approved "HPA034656: AB_10600788" "unprognostic (5.42e-2)" "unprognostic (2.09e-1)" "unprognostic (2.28e-1)" "unprognostic (8.55e-2)" "unprognostic (3.87e-2)" "unprognostic (1.85e-1)" "unprognostic (1.63e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-1)" "unprognostic (2.44e-2)" "unprognostic (2.45e-1)" "unprognostic (5.28e-5)" "unprognostic (8.38e-2)" "unprognostic (9.65e-2)" "unprognostic (2.72e-6)" 0.7 1.0 5.8 0.7 18.1 0.7 0.8 2.7 32.3 2.3 0.8 1.5 0.0 0.8 2.2 1.2 0.8 1.1 0.7 0.7 8.3 3.8 0.8 0.7 0.7 0.7 2.5 12.0 0.7 0.7 0.7 0.3 0.8 11.1 0.9 0.7 0.0 0.8 0.8 0.7 0.8 0.7 0.8 1.2 2.2 0.8 0.8 0.1 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.5 0.0 0.1 0.2 3.9 1.9 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 18.1 2.7 27.7 8.3 3.8 2.5 12.0 11.1 0.1 C11orf88 FLJ46266 ENSG00000183644 "Chromosome 11 open reading frame 88" Q6PI97 11 111514785-111537031 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 48.8;fallopian tube: 53.7" "Cell line enhanced" "Detected in some" "CACO-2: 4.7;CAPAN-2: 2.2;Karpas-707: 5.0;U-266/70: 2.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7" "Region enriched" "Detected in many" 4 "pons and medulla: 48.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (2.25e-1)" "unprognostic (3.07e-5)" "unprognostic (3.85e-4)" "unprognostic (4.16e-2)" "unprognostic (4.44e-5)" "unprognostic (2.56e-3)" "unprognostic (6.91e-2)" "unprognostic (5.49e-3)" "unprognostic (2.86e-1)" "unprognostic (9.96e-3)" "unprognostic (2.70e-1)" "unprognostic (4.40e-2)" "unprognostic (6.80e-3)" "unprognostic (7.57e-2)" "unprognostic (6.22e-2)" "unprognostic (8.45e-2)" "unprognostic (1.11e-1)" 0.2 0.2 5.7 0.3 10.9 0.3 0.2 0.2 1.0 5.8 0.2 5.7 0.0 0.4 2.2 13.1 0.2 53.7 0.4 0.2 7.3 7.6 0.2 0.2 13.9 0.3 0.6 0.2 8.3 0.2 0.2 0.5 0.4 48.8 0.3 0.2 0.0 0.3 0.3 0.2 0.3 0.3 0.2 1.1 0.3 0.3 13.5 1.5 0.1 0.7 0.0 0.2 0.2 0.0 0.7 0.6 2.6 0.5 0.6 0.4 0.0 0.3 1.0 0.1 0.1 0.0 0.0 0.6 1.6 0.0 0.1 0.0 4.7 2.2 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.2 0.5 0.4 0.0 0.5 0.0 0.0 0.1 5.0 0.0 0.5 0.3 0.2 0.2 0.5 0.0 0.8 0.0 0.1 0.2 0.2 0.5 0.3 0.1 0.0 0.9 0.0 0.0 0.7 0.6 0.7 1.0 2.9 0.4 0.2 0.4 0.4 1.0 1.7 0.5 1.2 0.3 0.2 0.4 0.5 0.2 0.1 0.4 0.7 0.3 0.3 2.6 0.6 0.5 0.6 0.4 0.0 5.7 10.9 0.2 1.0 7.3 7.6 0.6 0.2 48.8 1.5 C11orf97 LINC01171 ENSG00000257057 "Chromosome 11 open reading frame 97" A0A1B0GVM6 11 94512432-94532123 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 19.2;fallopian tube: 22.9;testis: 17.9" "Cell line enhanced" "Detected in some" "HL-60: 1.0;RPTEC TERT1: 3.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.6" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (3.62e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (4.18e-1)" "unprognostic (4.70e-1)" "unprognostic (9.64e-3)" "unprognostic (9.44e-3)" "unprognostic (3.86e-3)" 0.1 0.1 3.4 0.1 19.2 0.4 0.1 0.0 3.4 1.1 0.1 1.5 0.0 0.1 0.8 7.0 0.1 22.9 0.3 0.1 8.2 1.1 1.7 5.5 0.1 0.0 1.9 1.8 0.8 0.1 0.0 0.1 14.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 17.9 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.4 0.0 0.0 0.4 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C12orf76 FLJ40142 ENSG00000174456 "Chromosome 12 open reading frame 76" Q8N812 12 110027028-110073686 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 47.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA039713, HPA042013" Uncertain Approved "Plasma membrane,Actin filaments" "Actin filaments" "Plasma membrane" "HPA039713: AB_2676640, HPA042013: " "unprognostic (9.20e-2)" "unprognostic (3.31e-2)" "unprognostic (2.35e-3)" "unprognostic (9.54e-2)" "unprognostic (3.50e-2)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "prognostic favourable (6.44e-5)" "unprognostic (1.39e-1)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (1.75e-1)" "prognostic unfavourable (5.74e-5)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" 5.7 8.8 34.6 8.4 26.1 11.6 9.4 19.7 47.6 6.6 6.1 32.6 2.5 7.6 8.1 14.0 5.9 12.0 6.7 5.3 36.1 33.5 8.5 7.9 9.7 11.4 36.2 21.2 11.9 8.4 5.1 7.5 9.4 26.1 7.5 6.4 5.9 7.7 7.9 8.3 14.6 7.4 5.3 38.7 11.1 9.2 9.8 27.4 4.8 11.1 1.8 7.9 6.3 5.0 14.0 12.8 31.3 9.4 14.3 16.3 11.1 6.4 9.5 11.6 10.4 8.3 17.1 12.7 5.7 3.2 5.5 4.1 7.8 6.3 7.9 6.8 2.5 12.8 4.7 4.7 4.1 11.7 10.1 7.9 14.5 15.7 7.8 12.8 15.4 13.7 15.6 4.8 8.8 8.5 11.7 20.7 5.6 6.9 6.5 21.1 9.0 8.7 12.4 7.1 12.8 9.9 6.2 23.2 12.6 7.1 5.3 12.7 11.5 6.7 10.9 8.4 6.1 6.3 3.3 9.5 10.9 6.5 9.3 7.4 4.8 31.3 9.4 11.2 8.3 6.2 9.2 14.0 13.1 9.3 8.8 11.8 16.3 10.6 12.8 14.3 6.1 12.8 12.6 11.1 34.6 26.1 19.7 35.1 36.1 33.5 36.2 21.2 26.1 27.4 C14orf132 C14orf88 ENSG00000227051 "Chromosome 14 open reading frame 132" Q9NPU4 14 96039324-96093889 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 49.2" "Cell line enhanced" "Detected in many" "MCF7: 21.7;SCLC-21H: 23.9;SH-SY5Y: 23.7;U-87 MG: 21.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.82e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-2)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.47e-2)" "unprognostic (2.50e-2)" "unprognostic (1.27e-1)" "unprognostic (1.82e-1)" "unprognostic (4.42e-2)" "prognostic favourable (3.54e-4)" "unprognostic (2.51e-2)" "unprognostic (5.55e-3)" "unprognostic (1.47e-2)" "unprognostic (3.09e-2)" "unprognostic (1.33e-5)" "prognostic unfavourable (4.95e-4)" 4.1 14.3 22.4 3.6 16.6 0.9 5.8 43.5 49.2 20.4 6.2 15.1 10.9 2.8 17.8 14.7 6.8 21.8 5.5 4.2 24.4 16.7 3.9 2.0 12.5 1.5 15.0 16.6 3.9 3.5 1.0 17.5 1.5 13.8 6.3 5.1 4.6 1.9 20.7 1.8 13.5 4.7 21.5 19.8 3.7 5.7 2.0 8.0 0.0 1.8 3.1 1.9 4.5 3.9 1.1 0.6 0.4 0.1 0.1 3.5 0.8 0.0 2.8 14.0 4.4 10.2 10.3 0.0 4.7 10.6 6.2 3.8 0.0 0.0 0.0 1.0 10.5 0.3 1.6 0.3 5.4 0.0 0.6 0.0 0.5 0.0 1.2 0.0 0.1 5.5 0.5 5.8 0.4 0.1 0.0 0.0 2.8 21.7 0.3 0.0 6.7 0.0 12.4 2.2 0.0 5.0 9.9 23.9 23.7 3.7 0.4 0.6 13.0 0.6 0.0 5.0 3.0 8.2 0.0 0.0 0.0 0.0 21.1 0.0 2.8 0.2 0.1 0.0 0.0 0.0 0.0 0.1 1.7 0.4 0.0 1.1 3.5 0.7 0.4 0.1 0.0 0.6 0.3 0.8 22.4 16.6 43.5 25.7 24.4 16.7 15.0 16.6 13.8 8.0 C14orf37 UT2 ENSG00000139971 "Chromosome 14 open reading frame 37" Q86TY3 14 57999735-58298139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Cell line enhanced" "Detected in many" "AF22: 11.0;AN3-CA: 6.9;fHDF/TERT166: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001580, HPA001789" Enhanced Approved "Plasma membrane" 270000 "Plasma membrane" "HPA001580: , HPA001789: AB_1078328" "unprognostic (2.56e-2)" "unprognostic (2.04e-2)" "unprognostic (1.20e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.97e-3)" "unprognostic (1.94e-1)" "unprognostic (7.84e-3)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (2.42e-1)" "unprognostic (1.01e-1)" "unprognostic (3.87e-8)" "unprognostic (5.22e-6)" "unprognostic (4.93e-2)" "unprognostic (8.74e-4)" "unprognostic (3.01e-4)" 2.8 5.3 11.4 1.5 11.7 1.8 2.4 10.1 14.0 4.1 2.3 3.9 1.1 1.6 6.7 4.0 1.9 4.7 3.9 6.3 8.6 4.6 16.5 2.2 1.8 1.1 5.1 7.8 9.3 2.4 9.2 5.8 1.4 21.5 4.0 2.7 3.9 2.0 3.3 1.2 2.5 1.8 5.0 3.3 1.3 3.0 5.1 5.0 0.0 3.4 0.3 0.9 2.6 3.0 0.3 0.6 0.5 0.3 0.1 0.0 0.0 0.0 0.0 11.0 6.9 5.4 2.3 0.0 2.1 1.7 0.4 0.3 0.5 0.1 0.0 0.7 12.0 0.1 3.4 0.0 0.4 0.1 1.1 0.0 0.0 0.5 0.2 0.0 5.5 2.3 0.2 0.2 0.2 0.5 0.1 0.3 1.4 0.3 0.0 0.0 5.1 2.3 1.6 0.3 2.7 4.4 0.5 1.3 0.1 0.1 0.0 0.3 0.3 0.2 0.1 1.6 4.1 0.6 2.9 0.3 0.3 0.0 3.4 0.3 1.2 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 11.4 11.7 10.1 14.0 8.6 4.6 5.1 7.8 21.5 5.0 C15orf59 "INSYN1, LOC388135, MGC131524" ENSG00000205363 "Chromosome 15 open reading frame 59" Q2T9L4 15 73735431-73752747 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 24.1;heart muscle: 16.2" "Cell line enhanced" "Detected in some" "ASC diff: 11.3;fHDF/TERT166: 7.5;HEK 293: 7.8;NTERA-2: 4.8;SK-BR-3: 6.7;U-2 OS: 6.6" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041563 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041563: AB_10794670" "unprognostic (2.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.85e-2)" "unprognostic (2.36e-1)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" "unprognostic (3.37e-2)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (8.36e-2)" "unprognostic (2.67e-4)" "unprognostic (2.67e-2)" "prognostic favourable (5.38e-9)" "unprognostic (4.98e-2)" "unprognostic (5.19e-2)" "unprognostic (2.46e-4)" "unprognostic (1.20e-3)" 1.2 1.9 9.3 0.4 9.7 0.0 0.9 5.5 24.1 2.2 0.7 0.3 1.0 2.4 9.4 6.5 1.5 16.2 9.1 8.3 3.5 0.0 1.7 0.0 14.4 4.8 1.0 0.0 0.7 0.2 4.5 0.2 0.7 10.1 1.4 8.4 1.0 2.1 4.2 0.0 0.8 1.9 0.4 0.4 1.6 3.8 0.8 0.6 1.5 0.5 0.8 0.5 0.0 0.0 0.5 2.8 1.8 11.3 0.2 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.1 0.9 7.5 2.9 2.4 0.0 0.0 0.0 7.8 0.4 0.0 0.0 0.8 0.0 0.2 0.8 0.1 0.1 0.0 0.0 0.0 0.2 0.7 1.0 0.0 0.2 4.8 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.7 0.6 6.7 0.7 3.1 0.2 0.1 1.8 6.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.5 0.3 0.4 0.2 0.3 0.3 0.3 0.4 0.1 0.8 0.5 0.5 1.5 0.8 0.3 0.6 0.3 0.0 C16orf45 FLJ32618 ENSG00000166780 "Chromosome 16 open reading frame 45" Q96MC5 16 15434295-15625028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 72.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 32.5;U-2197: 23.6;U-87 MG: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 11.1" "Lineage enriched" "Detected in many" 4 "T-cells: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041114, HPA063757" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA041114: AB_10794542, HPA063757: " "unprognostic (1.02e-1)" "unprognostic (2.22e-1)" "unprognostic (1.67e-2)" "unprognostic (6.96e-2)" "unprognostic (3.79e-2)" "unprognostic (1.21e-1)" "prognostic favourable (1.53e-4)" "unprognostic (3.23e-2)" "unprognostic (1.90e-2)" "unprognostic (1.16e-2)" "unprognostic (3.64e-2)" "unprognostic (5.28e-2)" "prognostic favourable (1.75e-4)" "unprognostic (3.79e-3)" "unprognostic (8.31e-2)" "unprognostic (1.71e-1)" "unprognostic (1.58e-1)" 11.5 10.2 38.8 6.8 27.6 1.3 8.4 30.6 72.3 28.4 10.4 10.1 3.8 5.9 21.3 12.7 14.2 12.3 14.6 28.7 39.2 30.4 9.4 12.9 6.0 4.1 21.8 33.8 26.1 5.6 2.2 11.3 1.4 61.3 15.0 6.2 8.5 6.5 17.8 25.5 4.9 4.4 21.5 12.5 5.3 7.6 13.8 12.0 0.0 5.7 4.4 3.0 14.2 10.7 2.7 0.5 0.6 0.1 0.2 11.1 1.5 0.4 10.5 4.4 0.4 19.8 16.9 0.0 5.7 19.7 5.1 2.8 0.0 0.2 0.0 1.3 32.5 0.0 1.2 1.6 2.7 0.2 0.2 2.5 4.1 0.3 6.5 0.0 4.3 8.2 1.7 11.4 0.1 7.8 0.1 0.1 7.6 6.3 1.4 0.1 5.6 4.0 0.3 6.0 0.0 2.8 1.8 8.7 8.6 0.3 2.9 1.7 0.1 0.1 4.5 11.5 5.9 23.6 2.8 1.9 4.5 0.0 40.5 0.0 2.8 0.1 0.1 0.2 11.1 0.0 2.0 2.7 2.1 6.2 0.5 1.6 2.0 3.3 0.6 0.2 0.1 0.3 2.7 1.5 38.8 27.6 30.6 52.4 39.2 30.4 21.8 33.8 61.3 12.0 C17orf51 "FLJ12977, FLJ31874, FLJ33618" ENSG00000212719 "Chromosome 17 open reading frame 51" A8MQB3 17 21524790-21574458 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 41.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA052106 Enhanced Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA052106: " "unprognostic (1.99e-1)" "unprognostic (5.29e-2)" "unprognostic (6.35e-3)" "unprognostic (2.78e-3)" "unprognostic (3.72e-1)" "unprognostic (4.09e-2)" "unprognostic (4.36e-3)" "unprognostic (5.80e-2)" "unprognostic (2.55e-1)" "unprognostic (1.53e-1)" "unprognostic (2.51e-3)" "unprognostic (7.42e-3)" "unprognostic (2.29e-2)" "unprognostic (1.23e-1)" "unprognostic (3.17e-1)" "unprognostic (6.42e-5)" "unprognostic (9.05e-3)" 6.1 7.2 8.0 4.2 8.4 0.8 3.0 41.2 20.5 5.3 4.5 5.2 3.1 3.2 8.3 10.1 3.2 6.7 3.6 6.5 8.6 7.3 4.0 3.8 3.0 3.0 5.9 8.1 5.9 6.6 7.8 8.9 2.1 5.5 6.3 3.2 3.8 5.0 7.0 7.3 3.0 2.4 6.6 5.0 3.3 4.1 9.2 5.9 1.2 2.9 2.2 3.0 4.0 4.7 4.2 4.1 1.2 3.9 2.6 6.0 1.8 2.6 6.1 2.3 7.9 7.3 6.9 2.1 7.1 3.5 5.2 5.9 12.1 0.4 3.5 4.0 3.9 0.3 9.8 3.7 8.6 11.0 15.2 0.7 5.6 5.0 13.6 0.9 3.9 6.5 3.4 10.5 11.4 3.7 1.9 0.8 4.4 0.0 7.6 0.3 4.3 5.2 7.4 4.8 0.5 1.9 0.5 5.1 0.9 6.6 0.2 5.2 0.1 0.3 6.6 6.1 6.3 14.5 8.5 2.3 2.8 13.5 7.3 1.3 7.1 0.0 3.9 0.0 4.0 1.8 3.1 2.2 1.9 1.8 1.9 4.2 6.0 5.1 1.2 2.6 1.0 4.1 1.7 1.8 8.0 8.4 41.2 14.5 8.6 7.3 5.9 8.1 5.5 5.9 C1orf115 FLJ14146 ENSG00000162817 "Chromosome 1 open reading frame 115" Q9H7X2 1 220689845-220699157 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 32.9;intestine: 32.1" "Cell line enhanced" "Detected in many" "Hep G2: 23.2;HUVEC TERT2: 19.1;TIME: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6" "Lineage enhanced" "Detected in single" "B-cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (5.16e-2)" "prognostic favourable (6.52e-4)" "unprognostic (1.31e-1)" "unprognostic (3.93e-2)" "unprognostic (2.03e-1)" "unprognostic (5.69e-3)" "unprognostic (8.65e-2)" "prognostic favourable (5.12e-5)" "unprognostic (3.11e-1)" "unprognostic (1.33e-1)" "unprognostic (1.74e-2)" "unprognostic (4.24e-1)" "unprognostic (4.54e-2)" "unprognostic (9.21e-3)" "unprognostic (1.07e-1)" 12.4 1.6 16.2 3.2 27.0 0.0 8.9 3.1 32.9 3.9 8.1 2.1 2.4 30.6 3.1 5.8 2.9 3.8 4.6 4.7 9.6 2.9 14.4 27.6 6.2 1.7 2.5 17.8 4.9 3.9 8.5 6.2 19.0 5.7 8.6 6.2 3.3 20.2 2.8 3.3 2.6 32.1 3.2 1.1 12.7 5.5 2.8 3.7 1.0 5.5 1.1 2.2 2.1 2.3 3.6 0.2 0.0 0.6 0.0 0.9 0.3 0.6 2.7 0.1 3.9 0.0 0.0 11.3 0.7 3.1 1.6 7.2 2.7 2.9 0.0 1.2 0.2 0.0 6.5 1.3 1.5 0.0 6.5 0.1 0.6 23.2 3.7 0.0 0.1 0.5 2.2 0.1 0.8 19.1 1.7 0.0 0.1 2.5 0.0 0.1 4.8 2.0 0.0 0.0 0.2 3.5 3.7 2.0 2.9 0.0 4.7 11.4 7.7 0.1 35.6 0.0 0.0 0.1 0.6 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.8 0.0 0.3 1.9 0.9 0.2 0.2 3.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 16.2 27.0 3.1 32.9 9.6 2.9 2.5 17.8 5.7 3.7 C1orf141 ENSG00000203963 "Chromosome 1 open reading frame 141" Q5JVX7 1 67092165-67231853 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 14.9;fallopian tube: 12.8;testis: 18.7" "Cell line enriched" "Detected in single" 37 "HEL: 17.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 14.9" "Group enriched" "Detected in some" 5 "basophil: 2.5;neutrophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.5" "Low region specificity" "Detected in all" HPA035316 Uncertain "Intermediate filaments" "Intermediate filaments" "HPA035316: AB_10600886" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (1.01e-1)" "unprognostic (2.20e-2)" 0.0 0.0 1.1 0.0 2.6 0.0 0.0 0.1 1.3 0.3 0.1 1.9 0.0 0.0 0.1 1.1 0.0 12.8 0.2 0.0 2.6 1.8 0.1 0.1 2.0 0.1 0.3 0.7 1.8 0.0 0.0 1.0 0.0 14.9 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.2 18.7 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 2.5 0.1 0.4 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 17.7 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.4 0.0 0.1 0.0 0.5 1.1 2.6 0.1 1.3 2.6 1.8 0.3 0.7 14.9 0.9 C1orf194 ENSG00000179902 "Chromosome 1 open reading frame 194" Q5T5A4 1 109105951-109113857 "Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 36.5;fallopian tube: 60.2;testis: 77.6" "Cell line enhanced" "Detected in some" "AF22: 4.4;RPTEC TERT1: 1.0;SCLC-21H: 6.1;U-87 MG: 1.7" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8" "Region enriched" "Detected in many" 5 "pons and medulla: 36.5" "Cell type enriched" "Detected in some" 5 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031144, HPA049684" Enhanced Uncertain "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA031144: AB_10602109, HPA049684: " "unprognostic (9.91e-3)" "unprognostic (7.60e-3)" "unprognostic (2.28e-2)" "prognostic favourable (1.36e-4)" "unprognostic (3.03e-1)" "unprognostic (1.14e-2)" "unprognostic (4.53e-1)" "unprognostic (3.91e-3)" "unprognostic (5.27e-2)" "unprognostic (9.21e-3)" "unprognostic (3.98e-3)" "unprognostic (1.52e-1)" "unprognostic (6.08e-6)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.27e-3)" 0.3 0.4 1.5 0.3 6.8 0.3 0.4 0.3 2.6 1.8 0.3 12.3 0.0 0.4 1.0 11.1 0.4 60.2 0.3 0.3 3.0 1.6 0.3 0.3 7.5 0.4 0.5 1.8 10.3 0.7 0.4 2.7 0.3 36.5 0.4 0.4 0.0 0.3 0.3 0.3 0.3 0.4 0.4 0.7 0.3 0.5 77.6 2.3 0.0 0.5 0.0 0.3 0.5 0.2 0.2 0.0 5.3 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 6.1 0.3 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 6.8 0.3 2.6 3.0 1.6 0.5 1.8 36.5 2.3 C1orf216 FLJ38984 ENSG00000142686 "Chromosome 1 open reading frame 216" Q8TAB5 1 35713875-35719472 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028299, HPA031343" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA028299: AB_10601122, HPA031343: " "unprognostic (1.17e-1)" "unprognostic (2.43e-2)" "unprognostic (9.84e-2)" "unprognostic (1.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (2.15e-4)" "unprognostic (2.23e-1)" "unprognostic (3.81e-1)" "unprognostic (2.07e-1)" "unprognostic (4.67e-3)" "unprognostic (1.86e-1)" "prognostic unfavourable (7.68e-10)" "unprognostic (3.31e-1)" "unprognostic (3.08e-1)" "unprognostic (2.48e-1)" "unprognostic (5.93e-2)" 4.3 4.4 12.5 2.1 10.5 1.1 2.4 5.0 22.1 4.7 3.5 1.0 4.1 5.0 2.1 2.5 3.0 4.0 12.1 9.7 0.7 1.8 3.1 2.4 7.0 3.5 1.2 2.0 1.8 1.6 3.1 2.0 1.1 4.4 5.1 2.9 1.2 7.0 5.2 2.2 1.2 3.4 1.4 2.5 2.4 1.4 2.5 3.2 0.1 3.7 0.8 7.3 3.0 3.3 7.9 4.4 5.7 19.9 14.6 2.9 9.7 11.4 14.4 13.8 4.7 7.2 4.3 7.0 14.2 3.2 10.8 6.4 12.4 13.9 5.1 25.5 11.6 1.3 7.6 12.6 16.8 15.0 8.1 10.3 3.3 9.4 10.1 11.5 15.4 5.5 5.1 10.8 6.3 6.7 3.4 5.8 3.5 4.9 4.0 5.9 5.8 9.2 1.9 18.9 3.6 5.7 11.1 11.7 9.3 8.7 10.1 3.5 8.7 3.2 11.7 12.2 18.2 0.0 3.2 0.1 5.9 3.7 1.9 2.5 4.7 7.3 3.2 1.4 1.1 4.4 0.1 0.8 2.7 0.7 1.6 3.0 C1orf61 CROC4 ENSG00000125462 "Chromosome 1 open reading frame 61" Q13536 1 156404250-156430701 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 29 "brain: 184.8" "Cell line enriched" "Detected in some" 9 "BEWO: 16.9" "Cancer enriched" "Detected in some" 116 "glioma: 77.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 6.3;MAIT T-cell: 5.2" "Lineage enriched" "Detected in single" 34 "T-cells: 6.3" "unprognostic (6.20e-2)" "unprognostic (2.46e-3)" "unprognostic (3.32e-1)" "unprognostic (1.28e-1)" "unprognostic (7.12e-2)" "unprognostic (2.37e-1)" "unprognostic (1.35e-2)" "unprognostic (9.00e-2)" "unprognostic (1.75e-1)" "unprognostic (2.64e-1)" "unprognostic (1.37e-2)" "unprognostic (3.64e-2)" "unprognostic (8.16e-7)" "unprognostic (5.87e-3)" "unprognostic (9.89e-2)" "unprognostic (1.44e-2)" "unprognostic (5.88e-2)" 2.0 1.9 71.9 1.9 69.5 2.1 2.0 20.2 184.8 1.9 2.0 19.3 0.0 2.0 2.0 2.0 2.0 2.0 1.9 1.9 48.9 45.2 1.9 2.0 1.9 2.1 65.3 23.6 1.9 1.9 2.0 0.0 1.9 27.4 1.9 2.0 1.4 2.0 1.9 1.9 1.9 2.0 2.0 22.7 2.1 1.9 3.1 14.8 0.0 1.9 0.0 2.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.5 0.0 0.8 0.0 0.3 0.0 0.0 16.9 0.0 0.0 0.0 0.1 0.3 0.3 1.2 0.0 0.0 0.2 0.6 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 1.3 0.8 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.3 0.4 0.0 0.0 0.0 6.3 0.0 5.2 0.0 1.5 3.3 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.6 0.5 71.9 69.5 20.2 43.5 48.9 45.2 65.3 23.6 27.4 14.8 C1orf87 "CREF, MGC34837" ENSG00000162598 "Chromosome 1 open reading frame 87" Q8N0U7 1 59987269-60073770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.1;fallopian tube: 33.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.2;HSkMC: 3.2;SCLC-21H: 1.4" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Group enriched" "Detected in many" 4 "basal ganglia: 19.1;pons and medulla: 17.7" "Cell type enriched" "Detected in single" 19 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 1.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA031366, HPA031368" Enhanced "HPA031366: AB_2673847, HPA031368: AB_10600795" "unprognostic (1.16e-2)" "unprognostic (9.87e-2)" "unprognostic (3.83e-2)" "unprognostic (1.92e-2)" "unprognostic (6.69e-2)" "unprognostic (7.11e-2)" "unprognostic (8.95e-3)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" 0.3 0.3 3.2 0.3 19.1 0.3 0.3 0.0 0.9 1.7 0.3 3.4 0.0 0.3 0.9 4.8 0.3 33.4 0.3 0.3 3.8 4.5 0.5 0.3 6.8 0.3 1.3 0.7 5.1 0.4 0.7 0.8 0.3 17.7 0.4 0.3 2.5 3.4 0.6 0.3 0.3 0.3 0.3 0.9 0.3 0.3 1.2 3.6 0.0 0.3 0.0 0.3 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.2 19.1 0.0 0.9 3.8 4.5 1.3 0.7 17.7 3.6 C1QL1 "C1QRF, C1QTNF14, CRF" ENSG00000131094 "Complement C1q like 1" O75973 17 44959693-44968071 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.5" "Cell line enhanced" "Detected in some" "SCLC-21H: 17.8;SH-SY5Y: 12.7;U-2 OS: 44.5;U-251 MG: 13.4;U-87 MG: 14.4" "Cancer enriched" "Detected in all" 7 "glioma: 116.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted in brain" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (3.63e-3)" "unprognostic (3.15e-2)" "unprognostic (2.05e-2)" "unprognostic (7.65e-2)" "unprognostic (3.40e-3)" "unprognostic (2.34e-1)" "unprognostic (6.64e-3)" "unprognostic (1.49e-2)" "unprognostic (1.44e-1)" "prognostic unfavourable (1.31e-8)" "unprognostic (2.67e-2)" "unprognostic (1.05e-1)" "unprognostic (1.61e-2)" "unprognostic (3.04e-1)" 2.5 2.3 20.2 2.0 9.7 1.3 1.5 4.9 42.5 1.6 2.9 12.7 0.0 5.2 5.0 2.0 2.5 1.8 1.8 1.8 14.4 16.3 6.4 1.4 1.3 1.3 13.3 10.4 1.3 4.3 1.2 0.7 1.3 35.2 11.6 1.8 10.3 1.4 1.4 1.2 1.6 3.9 2.5 12.8 1.3 4.4 1.6 8.5 0.0 1.4 0.0 1.2 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.5 0.6 9.0 0.2 0.0 0.2 0.3 0.3 0.3 0.8 0.3 0.3 0.1 1.4 0.2 0.2 1.4 0.1 0.1 5.7 3.8 0.0 4.1 0.0 1.1 0.0 1.1 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.2 0.5 1.9 0.0 1.5 5.4 3.2 0.1 0.1 0.0 0.2 17.8 12.7 7.6 0.6 0.5 2.1 0.1 0.0 0.7 44.5 0.5 13.4 0.5 0.0 0.0 14.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 9.7 4.9 13.9 14.4 16.3 13.3 10.4 35.2 8.5 C1QL2 "C1QTNF10, CTRP10" ENSG00000144119 "Complement C1q like 2" Q7Z5L3 2 119156243-119158889 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 15.4" "Group enriched" "Detected in some" 14 "NTERA-2: 2.2;SCLC-21H: 7.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hippocampal formation: 25.0" "Low region specificity" "Detected in many" HPA057934 Uncertain "Secreted in brain" "HPA057934: " "unprognostic (6.95e-2)" "unprognostic (9.74e-2)" "unprognostic (4.48e-3)" "unprognostic (1.08e-1)" "unprognostic (9.91e-4)" "unprognostic (2.60e-5)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" 0.7 0.7 15.3 0.7 6.8 0.7 1.1 0.9 15.1 0.7 0.7 3.1 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.8 15.4 9.0 0.7 0.8 0.7 1.3 4.5 5.4 0.7 0.7 0.7 0.3 0.7 1.3 0.7 0.7 2.4 1.0 0.7 0.7 0.9 0.7 0.7 1.5 0.8 0.7 1.1 3.1 0.0 0.7 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 6.8 0.9 15.1 15.4 9.0 4.5 5.4 1.3 3.1 C1QL3 "C1ql, C1QTNF13, CTRP13, K100" ENSG00000165985 "Complement C1q like 3" Q5VWW1 10 16513743-16522005 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 33.8" "Group enriched" "Detected in some" 7 "HDLM-2: 24.3;SCLC-21H: 15.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 99.4;cerebral cortex: 74.9;hippocampal formation: 78.6" "Secreted in brain" "unprognostic (7.24e-2)" "unprognostic (2.54e-1)" "unprognostic (1.62e-1)" "unprognostic (1.16e-1)" "unprognostic (8.19e-3)" "unprognostic (6.31e-2)" "unprognostic (5.12e-2)" "unprognostic (3.89e-2)" "unprognostic (2.76e-2)" "unprognostic (2.00e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "prognostic favourable (6.29e-5)" "unprognostic (3.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.59e-2)" "unprognostic (6.12e-2)" 1.2 1.5 24.8 1.0 14.6 0.5 0.5 7.4 33.8 0.5 0.6 0.1 0.0 2.6 0.7 0.4 0.7 0.5 0.6 1.4 22.8 4.3 1.9 0.8 0.9 1.3 1.4 23.4 0.4 0.9 0.4 0.3 0.6 2.3 1.0 0.4 0.2 1.0 0.5 1.7 1.6 1.2 0.4 0.9 1.0 0.9 0.5 0.0 0.0 1.6 0.0 0.5 1.2 0.4 1.0 0.9 0.8 2.0 0.7 2.8 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 1.6 0.8 2.7 0.0 0.0 0.3 0.0 0.0 0.0 24.3 0.2 1.3 0.9 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.1 0.1 0.9 0.1 0.9 0.2 1.3 0.1 0.5 15.0 1.2 1.3 0.2 0.8 0.1 0.2 0.0 0.0 0.1 0.7 0.0 0.5 0.7 0.7 0.1 1.4 0.6 0.0 1.1 0.8 2.1 2.0 1.3 1.0 1.6 1.8 0.5 0.8 1.7 2.8 0.2 0.7 1.4 0.9 1.7 0.6 24.8 14.6 7.4 29.5 22.8 4.3 1.4 23.4 2.3 0.0 C1QL4 "C1QTNF11, CTRP11" ENSG00000186897 "Complement C1q like 4" Q86Z23 12 49332411-49337188 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.2;testis: 7.4" "Cell line enhanced" "Detected in some" "AN3-CA: 27.3;HAP1: 4.2;PC-3: 4.6;U-2 OS: 7.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 7.4" "Group enriched" "Detected in some" 5 "midbrain: 5.1;pons and medulla: 9.7" "Secreted in brain" "unprognostic (1.97e-2)" "unprognostic (2.77e-2)" "unprognostic (4.87e-2)" "unprognostic (7.37e-2)" "unprognostic (4.48e-1)" "unprognostic (1.86e-2)" "unprognostic (2.49e-3)" "unprognostic (8.64e-3)" "unprognostic (2.89e-1)" "unprognostic (5.11e-3)" "unprognostic (7.62e-2)" "unprognostic (5.03e-2)" "prognostic unfavourable (3.03e-5)" "unprognostic (9.73e-2)" "unprognostic (2.85e-2)" "unprognostic (9.40e-2)" "unprognostic (3.72e-2)" 0.4 0.3 2.0 0.1 1.0 0.1 0.4 0.4 2.3 0.7 0.1 0.3 0.0 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.6 2.4 0.8 0.2 0.1 0.1 1.4 0.0 0.6 0.1 0.1 0.4 0.1 9.2 0.2 0.1 0.8 0.1 0.1 0.4 1.7 0.1 0.2 2.1 0.4 0.1 7.4 0.9 0.0 3.6 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.3 27.3 0.0 0.0 0.1 0.0 0.1 0.3 1.5 0.7 0.1 0.3 1.5 0.0 0.0 4.2 0.0 0.5 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.5 4.6 0.1 0.1 0.0 0.1 0.0 0.0 2.3 0.0 0.2 1.2 0.5 0.1 0.0 0.4 7.2 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.0 0.4 2.1 0.6 2.4 1.4 0.0 9.2 0.9 C1QTNF4 "CTRP4, ZACRP4" ENSG00000172247 "C1q and TNF related 4" Q9BXJ3 11 47589664-47594659 "Predicted secreted proteins" Cytokine "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 37.8" "Cell line enriched" "Detected in some" 6 "REH: 10.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041032 Approved "Secreted in brain" "HPA041032: AB_10671170" "unprognostic (1.84e-3)" "unprognostic (1.58e-1)" "unprognostic (8.98e-4)" "unprognostic (8.19e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-3)" "unprognostic (6.78e-2)" "unprognostic (6.11e-2)" "unprognostic (6.35e-2)" "unprognostic (4.00e-1)" "unprognostic (4.91e-4)" "unprognostic (1.22e-1)" "unprognostic (8.22e-6)" "unprognostic (6.02e-3)" "unprognostic (1.00e-1)" "unprognostic (2.80e-2)" "unprognostic (6.28e-2)" 2.5 1.5 14.2 1.4 34.2 4.1 1.6 16.8 37.8 1.6 1.5 2.0 0.0 1.7 2.1 1.4 1.3 1.5 1.6 1.4 9.7 7.1 1.4 1.4 1.4 1.5 7.9 15.5 3.3 2.2 6.3 4.7 1.4 14.5 1.8 1.4 0.0 1.3 1.7 1.8 1.5 1.6 1.8 5.2 1.6 1.5 2.0 3.7 0.0 1.5 0.0 1.4 1.3 0.3 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.0 0.7 0.0 10.9 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 14.2 34.2 16.8 37.8 9.7 7.1 7.9 15.5 14.5 3.7 C1QTNF8 "CTRP8, UNQ5829" ENSG00000184471 "C1q and TNF related 8" P60827 16 1090005-1096244 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.6;brain: 2.1;fallopian tube: 4.5;pituitary gland: 4.1" "Cell line enhanced" "Detected in single" "A549: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA056438 Uncertain "Secreted - unknown location" "HPA056438: " "unprognostic (8.65e-2)" "unprognostic (2.56e-2)" "unprognostic (5.46e-2)" 0.0 2.6 0.7 0.0 1.7 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 4.5 0.0 0.0 0.8 2.1 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C20orf204 "DKFZp434G015, FLJ27267, LINC00176, NCRNA00176, PRR17" ENSG00000196421 "Chromosome 20 open reading frame 204" 20 64034344-64039962 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 6 "blood: 8.2;brain: 11.2;lymphoid tissue: 19.1" "Cell line enriched" "Detected in some" 6 "Hep G2: 32.0" "Cancer enriched" "Detected in some" 6 "ovarian cancer: 7.2" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 8.2;naive CD8 T-cell: 6.6" "Lineage enriched" "Detected in single" 10 "T-cells: 8.2" "Low region specificity" "Detected in many" "unprognostic (2.84e-1)" "unprognostic (4.02e-2)" "unprognostic (2.36e-2)" "unprognostic (2.49e-1)" "unprognostic (9.66e-2)" "unprognostic (3.49e-2)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (3.50e-1)" "unprognostic (9.20e-3)" "unprognostic (4.43e-3)" "unprognostic (4.34e-2)" "unprognostic (2.49e-6)" "unprognostic (5.83e-2)" "unprognostic (4.58e-2)" "unprognostic (1.88e-2)" "unprognostic (2.79e-4)" 1.3 0.0 0.0 0.7 0.0 0.2 0.0 11.2 0.0 0.7 1.2 0.0 0.3 0.6 0.1 2.0 0.2 0.7 1.0 1.1 0.0 0.0 0.8 1.2 9.8 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.3 0.2 0.0 0.2 0.3 0.0 0.6 0.0 2.3 0.1 0.0 1.2 0.4 0.8 0.0 19.1 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.8 8.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 32.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.7 1.1 0.0 0.0 8.2 6.6 0.4 0.8 0.0 0.0 1.7 0.4 C20orf27 FLJ20550 ENSG00000101220 "Chromosome 20 open reading frame 27" Q9GZN8 20 3753508-3768387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 64.7" "Group enriched" "Detected in many" 5 "classical monocyte: 28.1;intermediate monocyte: 46.6;myeloid DC: 38.5;non-classical monocyte: 42.2" "Group enriched" "Detected in all" 5 "dendritic cells: 38.5;monocytes: 46.6" "Low region specificity" "Detected in all" HPA047483 Approved Approved Nucleoplasm,Cytosol 87000 "Nucleoplasm, Cytosol" "HPA047483: " "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.21e-3)" "unprognostic (2.99e-1)" "unprognostic (2.48e-1)" "prognostic unfavourable (1.69e-5)" "unprognostic (8.36e-2)" "unprognostic (2.07e-1)" "unprognostic (4.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.84e-1)" "prognostic unfavourable (6.18e-6)" "unprognostic (1.80e-1)" "unprognostic (2.16e-1)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" 23.1 9.7 10.2 11.8 64.7 51.9 17.2 4.9 15.8 12.0 22.6 7.7 3.7 10.3 16.9 10.9 14.4 18.7 26.6 7.3 9.2 14.4 5.0 5.4 8.4 13.5 14.5 6.1 20.9 8.5 3.9 5.3 6.7 13.7 18.3 4.9 5.0 9.0 7.1 11.2 9.6 9.4 22.3 5.7 13.4 21.2 6.0 13.2 6.0 5.4 7.9 6.1 27.4 10.3 7.8 38.5 1.1 46.6 5.8 8.5 13.8 34.0 36.1 5.7 24.0 11.7 6.5 8.9 8.8 5.8 16.3 12.0 24.7 13.0 21.4 8.6 10.3 29.4 15.1 22.1 6.2 4.9 27.1 12.1 7.3 44.0 8.4 17.3 5.3 9.1 9.3 20.8 10.4 11.0 21.4 13.5 8.4 48.2 22.9 41.3 24.4 48.9 17.7 13.9 25.3 10.2 12.4 25.4 11.6 8.0 35.8 17.6 7.9 21.8 6.7 22.9 15.8 36.2 26.9 10.4 17.3 15.9 6.8 32.9 11.1 0.2 28.1 0.4 5.9 46.6 8.5 7.8 7.0 7.8 38.5 7.3 8.0 7.8 1.1 5.8 42.2 7.3 6.4 13.8 10.2 64.7 4.9 15.8 9.2 14.4 14.5 6.1 13.7 13.2 C21orf62 "B37, C21orf120, PRED81" ENSG00000205929 "Chromosome 21 open reading frame 62" Q9NYP8 21 32793564-32813743 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 13.4;kidney: 18.2;ovary: 16.2;pituitary gland: 38.6" "Group enriched" "Detected in some" 11 "AF22: 7.0;RPTEC TERT1: 4.0" "Cancer enriched" "Detected in some" 6 "glioma: 11.0" "Region enriched" "Detected in many" 4 "pons and medulla: 13.4" "Cell type enhanced" "Detected in some" "T-reg: 1.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA016899 Enhanced "Secreted - unknown location" "HPA016899: AB_1845704" "unprognostic (1.31e-1)" "unprognostic (3.84e-2)" "unprognostic (1.23e-1)" "unprognostic (4.37e-3)" "unprognostic (9.56e-2)" "unprognostic (3.05e-3)" "unprognostic (2.95e-2)" "unprognostic (1.17e-1)" "unprognostic (3.27e-1)" "unprognostic (1.85e-1)" "unprognostic (1.80e-1)" "unprognostic (1.78e-1)" "prognostic favourable (1.14e-4)" "unprognostic (2.59e-1)" "unprognostic (1.65e-1)" "unprognostic (1.13e-1)" "unprognostic (3.07e-2)" 2.2 0.4 1.6 1.1 2.1 0.3 0.3 0.3 2.4 0.1 0.3 3.9 0.0 0.1 0.2 8.4 0.3 1.2 0.4 0.4 3.0 2.4 18.2 0.3 0.2 0.2 1.5 1.0 16.2 5.6 0.1 38.6 0.1 13.4 4.1 0.1 0.0 0.3 0.3 0.3 0.3 0.6 0.3 1.8 0.2 0.3 0.4 3.1 0.0 0.2 0.0 1.1 0.2 0.3 0.0 0.4 1.1 0.0 0.0 1.7 0.1 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.6 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.4 1.7 0.1 1.6 2.1 0.3 2.4 3.0 2.4 1.5 1.0 13.4 3.1 C22orf31 "bK747E2.1, HS747E2A" ENSG00000100249 "Chromosome 22 open reading frame 31" O95567 22 29058672-29061844 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.4;testis: 12.7" "Cell line enhanced" "Detected in single" "RT4: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA000604 Uncertain "HPA000604: AB_1079086" 0.0 0.4 0.9 0.0 3.4 0.0 0.4 0.4 0.9 0.5 0.3 0.2 0.4 1.6 0.5 0.5 0.0 0.0 1.0 0.2 0.2 0.0 0.2 0.0 0.8 1.1 0.0 0.2 0.4 0.0 0.2 0.3 0.5 0.0 0.1 0.6 0.4 0.1 0.0 0.0 0.6 12.7 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.8 0.0 1.0 0.9 0.0 0.0 0.5 0.7 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C22orf42 ENSG00000205856 "Chromosome 22 open reading frame 42" Q6IC83 22 32149006-32159322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 12.9;testis: 28.6" "Cell line enhanced" "Detected in single" "THP-1: 1.4" "Group enriched" "Detected in some" 5 "pancreatic cancer: 0.8;prostate cancer: 1.0" "Group enriched" "Detected in some" 14 "hypothalamus: 12.9;pons and medulla: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA019531 Enhanced "HPA019531: AB_1853016" "unprognostic (5.67e-2)" "unprognostic (6.13e-3)" "unprognostic (8.21e-3)" "unprognostic (7.06e-2)" "unprognostic (4.54e-2)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.1 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 12.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.4 0.0 3.8 0.0 5.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.5 1.0 28.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.4 0.1 12.9 0.6 0.0 5.9 0.1 C22orf46 "CTA-216E10.6, FLJ23584" ENSG00000184208 "Chromosome 22 open reading frame 46" C9J442 22 41688939-41698136 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 19.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA052741 Uncertain Approved Nucleoplasm,Nucleoli "Secreted - unknown location" Nucleoplasm Nucleoli "HPA052741: " "unprognostic (3.76e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-2)" "prognostic favourable (4.70e-4)" "unprognostic (1.56e-1)" "unprognostic (6.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" "unprognostic (8.38e-2)" "unprognostic (3.32e-2)" "unprognostic (7.03e-2)" "unprognostic (1.20e-1)" "unprognostic (3.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" 3.9 2.0 8.1 3.1 6.8 1.0 3.9 2.2 5.7 2.7 2.4 2.3 3.1 4.5 1.7 2.4 2.7 4.8 8.7 7.5 2.7 2.3 2.2 3.1 12.8 5.2 1.4 8.3 3.5 2.1 3.3 2.8 2.8 3.0 3.3 3.3 2.6 2.9 19.8 2.8 2.4 6.2 3.5 3.1 2.2 1.5 1.1 0.4 0.1 2.6 3.5 1.2 0.7 8.7 4.5 11.0 6.7 8.1 8.6 9.9 7.4 8.0 6.3 8.5 4.5 5.7 5.5 5.4 6.1 4.1 5.6 5.7 7.6 19.5 5.3 6.0 9.3 3.7 4.7 4.4 11.9 6.8 7.7 10.5 7.5 1.6 9.8 8.1 5.5 14.4 3.5 5.4 4.5 3.5 5.1 9.1 6.0 5.4 6.0 2.7 4.2 8.6 7.8 11.1 9.0 5.5 4.3 8.3 14.2 4.4 3.9 17.3 17.6 5.1 5.0 5.4 11.2 0.1 0.5 0.0 0.7 0.4 0.9 1.1 1.1 1.1 0.2 0.5 0.9 1.2 0.1 3.5 2.6 0.4 0.7 0.7 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.1" "Cell line enhanced" "Detected in all" "HMC-1: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011044 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" "Nucleoplasm, Nucleoli" "Nuclear membrane, Cytosol" "HPA011044: " "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favourable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavourable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 5.2 7.0 15.9 7.3 33.1 14.7 4.8 18.2 31.2 5.8 10.3 7.5 8.3 18.7 4.1 6.1 9.4 10.9 6.3 7.9 15.8 13.6 6.3 7.3 8.3 8.5 9.1 12.6 3.9 7.5 7.8 14.2 4.8 11.7 4.8 8.8 5.6 8.7 7.0 8.3 12.5 19.4 6.1 7.3 9.2 5.5 2.6 9.1 7.0 5.5 6.7 6.6 6.6 5.3 0.4 1.1 5.7 4.2 1.7 1.6 1.1 3.3 2.5 3.5 7.1 4.5 1.9 2.2 5.1 4.5 5.1 4.3 4.0 3.5 5.1 13.4 3.5 7.6 4.3 2.2 2.0 8.0 3.6 20.0 3.2 2.9 6.0 5.7 29.2 2.2 4.5 9.5 3.5 3.2 8.3 9.1 4.7 8.9 6.4 13.8 1.3 6.8 4.1 3.1 5.8 5.0 2.1 10.7 6.1 2.1 11.5 3.2 20.2 7.7 3.8 4.7 1.6 5.6 8.9 4.0 2.4 2.0 2.9 9.9 5.2 1.1 3.0 5.7 0.6 3.2 1.0 0.4 1.4 1.4 1.1 0.1 1.6 0.8 1.0 1.7 4.2 0.7 1.6 1.1 15.9 33.1 18.2 31.2 15.8 13.6 9.1 12.6 11.7 9.1 C2CD4C "FAM148C, KIAA1957, NLF3" ENSG00000183186 "C2 calcium dependent domain containing 4C" Q8TF44 19 405438-409170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4" "Cell line enhanced" "Detected in some" "HDLM-2: 7.2;MCF7: 4.9;NTERA-2: 7.3;SCLC-21H: 13.1;U-2 OS: 7.8" "Cancer enhanced" "Detected in many" "testis cancer: 7.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055915 Uncertain Approved Vesicles Vesicles "HPA055915: " "unprognostic (1.29e-1)" "unprognostic (9.43e-2)" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "unprognostic (9.39e-3)" "unprognostic (2.14e-1)" "unprognostic (1.67e-1)" "unprognostic (9.81e-2)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (1.35e-1)" "unprognostic (1.12e-2)" "unprognostic (1.43e-2)" "unprognostic (5.04e-2)" "unprognostic (5.09e-2)" "unprognostic (1.74e-1)" 6.9 2.1 15.8 1.7 7.4 0.8 5.4 1.0 19.4 2.2 1.3 0.7 0.0 2.0 2.4 0.9 1.2 1.6 8.6 2.2 7.1 13.5 1.6 1.0 1.5 1.2 4.7 10.8 0.9 1.1 0.9 1.7 2.0 6.5 1.1 1.0 2.2 1.1 1.0 3.1 2.4 1.8 1.3 3.0 1.2 1.6 1.9 3.0 0.0 6.7 0.0 0.9 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 1.5 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.1 2.3 0.0 0.6 0.0 2.8 2.8 0.2 0.1 7.2 1.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 4.9 0.0 0.0 7.3 0.1 0.0 0.0 0.0 0.0 0.0 13.1 3.8 1.2 0.0 0.0 0.2 0.0 0.0 0.1 7.8 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 7.4 1.0 18.2 7.1 13.5 4.7 10.8 6.5 3.0 C2orf50 FLJ25143 ENSG00000150873 "Chromosome 2 open reading frame 50" Q96LR7 2 11133053-11146790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.3;fallopian tube: 21.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.1;T-47d: 3.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 4 "pons and medulla: 17.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA062894 Enhanced "HPA062894: " "unprognostic (6.29e-2)" "unprognostic (1.33e-1)" "unprognostic (3.53e-4)" "unprognostic (1.92e-3)" "unprognostic (3.35e-2)" "unprognostic (6.19e-2)" "unprognostic (3.55e-1)" "unprognostic (1.31e-1)" "unprognostic (3.32e-1)" "unprognostic (2.98e-2)" "unprognostic (2.00e-2)" "unprognostic (2.45e-1)" "unprognostic (3.97e-4)" "unprognostic (7.03e-2)" "unprognostic (2.92e-1)" "unprognostic (8.25e-3)" "unprognostic (7.36e-2)" 0.4 0.5 2.1 0.5 2.7 0.7 0.6 0.5 4.0 1.2 0.3 2.2 0.0 0.6 0.7 5.5 0.2 21.1 0.4 0.2 4.1 3.2 0.6 0.3 4.0 0.6 1.0 1.7 5.0 0.5 0.3 3.8 0.4 17.3 0.5 0.3 0.0 1.1 0.3 0.4 0.6 0.4 0.4 0.6 0.6 0.4 0.6 0.5 0.0 0.5 0.0 0.5 0.2 0.0 1.1 0.8 2.0 0.7 1.3 2.4 0.4 0.3 1.7 0.8 0.4 0.1 0.2 0.9 0.2 0.4 0.6 0.5 0.8 4.1 0.3 0.6 0.3 0.8 2.6 0.2 0.5 1.7 0.5 0.3 0.2 0.5 0.0 0.2 0.8 0.1 0.3 0.1 0.3 0.0 0.2 1.4 0.0 3.0 0.7 0.4 0.7 0.5 1.8 0.0 0.3 0.5 0.6 1.2 0.7 0.2 0.8 0.6 3.6 0.7 1.3 0.4 0.6 0.2 0.4 1.2 0.4 0.2 0.6 0.2 0.6 1.8 0.6 0.5 0.5 0.3 0.4 0.9 0.8 0.7 0.8 1.1 2.4 0.7 2.0 1.3 0.7 0.5 0.8 0.4 2.1 2.7 0.5 4.0 4.1 3.2 1.0 1.7 17.3 0.5 C2orf73 FLJ40298 ENSG00000177994 "Chromosome 2 open reading frame 73" Q8N5S3 2 54330034-54383742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.8;pituitary gland: 11.9;testis: 39.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.5;BJ hTERT+: 1.6;CAPAN-2: 1.6;HSkMC: 1.7;RPTEC TERT1: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enhanced" "Detected in single" "B-cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055221, HPA059596" Uncertain "HPA055221: , HPA059596: " "unprognostic (1.56e-2)" "unprognostic (7.00e-3)" "unprognostic (1.51e-2)" "unprognostic (1.39e-2)" "unprognostic (5.46e-2)" "unprognostic (2.74e-2)" "unprognostic (6.69e-3)" "unprognostic (2.36e-2)" "unprognostic (1.62e-3)" "unprognostic (7.69e-2)" "unprognostic (3.00e-2)" "unprognostic (5.01e-3)" "unprognostic (1.17e-2)" "unprognostic (8.99e-2)" "unprognostic (3.80e-2)" 0.4 0.9 2.0 0.3 6.4 0.3 0.4 0.9 1.6 0.7 0.4 4.1 1.6 0.3 0.6 3.5 0.4 7.3 0.3 0.4 2.7 1.2 0.8 0.4 1.6 0.3 0.9 4.4 0.9 0.9 1.0 11.9 0.3 11.8 0.6 0.3 0.3 0.4 0.6 0.4 0.4 0.4 0.3 1.5 0.4 0.4 39.2 1.7 0.0 1.7 0.0 0.3 0.4 0.4 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.4 0.7 0.0 2.5 0.0 0.0 1.6 0.0 0.8 0.0 1.6 0.0 0.6 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.7 0.4 1.0 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 2.6 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.4 0.9 1.6 2.7 1.2 0.9 4.4 11.8 1.7 C2orf80 "GONDA1, LOC389073" ENSG00000188674 "Chromosome 2 open reading frame 80" Q0P641 2 208165343-208190073 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 35.3" "Cell line enhanced" "Detected in some" "NTERA-2: 5.8" "Cancer enriched" "Detected in single" 41 "glioma: 11.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 8.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.4" "Low region specificity" "Detected in all" HPA042639 Approved "Golgi apparatus" "Golgi apparatus" "HPA042639: AB_10794915" "unprognostic (6.36e-2)" "unprognostic (2.12e-1)" "unprognostic (2.95e-1)" "unprognostic (3.05e-1)" "unprognostic (1.83e-1)" "unprognostic (2.98e-2)" 0.9 1.0 20.8 1.3 20.8 2.4 0.9 0.4 35.3 0.7 1.1 1.1 0.0 1.0 1.0 0.9 2.2 1.0 1.4 0.9 16.3 14.2 0.9 1.1 1.0 1.1 8.0 13.1 1.0 0.7 0.8 0.4 0.9 9.6 1.1 1.1 0.5 1.4 1.4 1.2 2.0 1.3 0.9 2.1 1.0 1.2 1.7 2.4 0.0 1.1 0.0 0.8 0.9 0.0 1.5 1.7 8.4 1.2 1.0 0.7 0.2 0.4 0.5 2.7 0.9 0.0 0.0 0.2 0.6 0.6 0.0 0.0 0.9 1.1 1.5 0.9 0.3 0.4 0.0 0.0 0.0 0.4 0.3 0.9 1.3 0.4 0.0 1.1 1.8 0.4 0.5 0.3 0.3 0.0 0.5 1.4 0.0 0.8 0.0 1.5 5.8 1.8 0.4 0.3 0.4 0.0 1.2 0.8 1.3 0.3 0.9 0.2 0.5 0.0 0.7 0.5 0.3 0.3 0.5 0.8 0.3 1.1 0.0 0.6 0.9 4.3 1.2 0.9 0.7 0.7 0.5 0.9 0.7 0.7 0.3 1.5 0.6 0.7 8.4 1.0 0.5 1.7 0.3 0.2 20.8 20.8 0.4 23.1 16.3 14.2 8.0 13.1 9.6 2.4 C2orf91 ENSG00000205086 "Chromosome 2 open reading frame 91" Q6ZV80 2 41935368-41954266 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;lung: 4.7" "Group enriched" "Detected in some" 6 "AN3-CA: 5.1;HDLM-2: 17.5" "Cancer enriched" "Detected in single" 9 "testis cancer: 0.8" "Region enhanced" "Detected in some" "midbrain: 5.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA042517 Uncertain "HPA042517: AB_10795508" "unprognostic (9.49e-3)" "unprognostic (2.24e-2)" "unprognostic (1.73e-1)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (8.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-2)" "unprognostic (3.37e-1)" "unprognostic (3.92e-2)" "unprognostic (1.16e-1)" "unprognostic (4.79e-2)" "unprognostic (1.08e-2)" "unprognostic (2.91e-2)" "unprognostic (7.61e-2)" "unprognostic (2.78e-2)" "unprognostic (1.47e-1)" 0.3 2.1 0.3 0.3 1.3 1.5 0.3 0.3 0.8 0.4 0.3 0.8 0.2 0.0 0.4 1.0 0.3 0.3 0.3 0.5 0.3 0.4 0.9 0.3 4.7 0.9 5.1 0.2 0.4 0.4 0.4 0.5 0.2 1.9 0.8 0.2 0.8 3.5 0.2 0.2 1.3 0.3 0.2 2.2 0.6 1.3 1.1 0.2 0.2 0.2 0.2 0.6 0.2 0.3 1.2 1.4 2.8 1.2 1.2 0.9 0.3 0.2 0.4 0.7 5.1 0.2 0.1 0.3 0.1 0.1 0.0 0.3 0.4 0.3 0.3 0.3 0.2 0.2 0.0 0.1 0.1 17.5 0.3 0.2 0.3 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.1 1.8 0.1 0.3 0.1 0.1 0.3 0.1 0.0 0.6 0.1 0.1 0.3 0.2 1.8 0.0 0.0 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.4 0.1 0.2 0.2 0.0 0.2 1.3 1.2 1.4 0.6 0.9 0.5 0.6 0.7 0.5 1.4 1.2 0.7 0.9 2.8 1.2 1.0 1.3 0.4 0.3 0.3 1.3 0.3 0.8 0.3 0.4 5.1 0.2 1.9 0.2 C3orf49 ENSG00000163632 "Chromosome 3 open reading frame 49" Q96BT1 3 63819362-63848636 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.0" "Cell line enhanced" "Detected in many" "HeLa: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA053582 Uncertain "HPA053582: " "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (4.81e-2)" "unprognostic (1.64e-1)" "unprognostic (1.07e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-1)" "unprognostic (2.14e-2)" "unprognostic (9.29e-3)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.61e-3)" "unprognostic (1.02e-1)" "unprognostic (7.68e-2)" "unprognostic (5.79e-2)" "unprognostic (1.07e-1)" 0.4 0.1 0.5 0.4 1.0 0.9 0.4 1.8 4.0 0.4 0.4 0.4 0.4 1.3 0.5 0.4 1.7 0.4 0.4 0.8 0.5 0.5 0.4 0.6 0.6 0.4 0.4 0.4 1.2 1.3 0.0 0.4 0.4 0.4 0.4 0.0 0.4 0.5 0.4 2.6 2.0 0.4 0.4 0.4 0.4 0.3 3.6 0.4 0.4 0.7 0.4 0.4 0.5 0.4 1.1 0.5 1.7 0.9 2.2 1.1 0.1 0.7 1.9 1.0 1.3 0.0 0.3 1.1 1.6 0.0 0.1 0.0 1.1 1.0 2.6 0.4 0.0 1.1 0.0 0.1 0.3 1.5 1.7 2.2 4.6 0.5 0.0 0.8 0.8 0.2 0.1 0.0 0.1 0.0 1.3 1.2 0.0 4.3 1.2 1.1 1.3 0.4 1.7 1.1 2.5 0.1 1.1 1.2 0.8 0.3 2.6 0.3 0.7 1.0 1.4 0.8 1.0 1.7 1.9 0.8 2.3 0.5 2.7 3.7 1.0 1.7 0.6 0.2 1.1 0.4 0.4 0.6 0.6 0.8 0.4 1.1 1.1 1.0 1.2 2.2 0.9 0.5 0.8 0.1 0.5 1.0 1.8 1.3 0.5 0.5 0.4 0.4 0.4 0.4 C3orf80 ENSG00000180044 "Chromosome 3 open reading frame 80" F5H4A9 3 160225496-160228213 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.0;intestine: 8.6" "Cell line enriched" "Detected in some" 5 "HMC-1: 55.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047439 Uncertain "HPA047439: AB_10965171" "unprognostic (5.34e-2)" "unprognostic (2.31e-1)" "unprognostic (6.35e-2)" "unprognostic (6.62e-3)" "unprognostic (1.92e-3)" "unprognostic (6.70e-3)" "unprognostic (4.28e-3)" "unprognostic (1.69e-1)" "unprognostic (4.64e-3)" "unprognostic (1.51e-1)" "unprognostic (9.20e-2)" "unprognostic (2.65e-1)" "unprognostic (6.09e-10)" "unprognostic (1.32e-2)" "unprognostic (1.78e-2)" "unprognostic (4.11e-3)" "unprognostic (5.00e-2)" 1.3 0.4 5.2 1.6 9.3 1.4 0.7 5.4 25.0 0.5 8.6 0.1 0.0 1.8 1.2 0.5 5.7 0.3 1.4 0.6 4.3 2.0 0.6 0.8 2.0 0.3 1.7 9.3 0.3 0.4 1.4 0.7 0.3 1.2 1.8 3.3 0.0 0.6 0.8 0.2 0.2 1.3 1.8 0.5 2.7 2.5 1.3 0.0 0.0 0.5 0.0 0.4 2.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 1.1 0.7 4.6 1.3 0.0 0.0 0.9 55.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.5 0.0 0.0 0.1 11.4 0.0 0.0 0.2 0.0 1.4 0.1 0.0 0.0 0.4 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.2 9.3 5.4 25.0 4.3 2.0 1.7 9.3 1.2 0.0 C4orf22 ENSG00000197826 "Chromosome 4 open reading frame 22" Q6V702 4 80335720-80963756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.0;fallopian tube: 19.8;testis: 34.8" "Cell line enhanced" "Detected in some" "A-431: 3.5;ASC TERT1: 2.1;BJ: 4.5;LHCN-M2: 2.7;SCLC-21H: 3.0;U-251 MG: 2.9;U-87 MG: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 8.4;pons and medulla: 22.0" "Cell type enhanced" "Detected in some" "memory B-cell: 1.2;naive B-cell: 2.1" "Lineage enhanced" "Detected in single" "B-cells: 2.1" "Low region specificity" "Detected in many" HPA043383 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA043383: AB_10797140" "unprognostic (4.77e-4)" "unprognostic (1.52e-1)" "unprognostic (4.06e-2)" "unprognostic (1.45e-2)" "unprognostic (7.24e-2)" "unprognostic (3.27e-1)" "unprognostic (6.93e-2)" "unprognostic (5.90e-2)" "unprognostic (2.67e-3)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.61e-2)" 0.1 0.1 1.4 0.1 8.4 0.1 0.3 0.6 0.2 0.9 0.1 5.1 0.1 0.3 0.4 7.8 0.2 19.8 0.3 0.1 2.8 2.5 0.4 0.1 5.9 0.3 0.1 0.1 3.5 0.1 0.1 1.2 0.1 22.0 0.2 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.2 0.4 0.1 0.1 34.8 2.4 2.9 0.7 0.0 0.2 0.1 0.0 2.1 0.5 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.3 2.1 0.0 4.5 0.8 0.1 0.2 0.0 0.0 1.3 0.0 1.5 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 2.9 0.0 0.0 1.2 2.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.4 8.4 0.6 0.2 2.8 2.5 0.1 0.1 22.0 2.4 C4orf47 LOC441054 ENSG00000205129 "Chromosome 4 open reading frame 47" A7E2U8 4 185426249-185449826 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8;fallopian tube: 20.3;testis: 20.6" "Cell line enhanced" "Detected in some" "A-431: 4.1;ASC TERT1: 4.3;U-87 MG: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 4 "granulocytes: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043662, HPA063485" Enhanced Approved Vesicles Vesicles "HPA043662: AB_10964715, HPA063485: " "unprognostic (3.38e-2)" "unprognostic (2.66e-1)" "unprognostic (5.78e-3)" "unprognostic (2.84e-3)" "unprognostic (3.61e-3)" "unprognostic (1.31e-1)" "unprognostic (5.82e-5)" "unprognostic (3.72e-2)" "unprognostic (4.62e-2)" "unprognostic (2.84e-1)" "unprognostic (1.25e-1)" "unprognostic (8.71e-3)" "prognostic unfavourable (4.75e-4)" "unprognostic (1.05e-1)" "unprognostic (3.64e-2)" "unprognostic (9.88e-3)" "unprognostic (1.50e-1)" 0.9 0.5 4.4 0.7 13.3 0.8 3.7 1.7 4.0 1.8 0.7 3.6 0.8 0.6 2.2 12.3 0.7 20.3 1.8 1.2 3.8 3.8 2.4 1.0 3.3 0.5 2.4 2.9 3.0 1.3 1.0 7.1 0.7 20.8 1.2 0.7 2.1 1.0 1.4 0.6 1.9 0.7 1.0 4.7 0.8 0.5 20.6 5.5 0.0 7.3 0.0 0.6 1.0 0.6 0.1 0.7 4.1 0.6 0.9 0.6 0.2 4.1 0.0 0.4 2.2 0.8 4.3 1.3 0.1 0.3 0.4 0.5 0.6 2.5 0.1 0.8 0.2 0.3 0.5 0.6 1.0 0.8 0.7 0.0 0.1 0.6 1.0 0.0 0.3 0.9 1.0 1.0 0.5 0.0 0.6 0.3 3.2 0.5 0.0 0.0 0.5 1.6 0.1 0.1 0.3 1.2 0.1 2.3 1.0 0.7 0.1 2.6 0.2 0.7 1.3 0.7 0.3 0.0 0.1 1.8 0.0 0.0 10.7 0.0 0.3 0.0 0.6 0.6 0.2 0.1 0.4 0.0 0.6 0.6 0.2 0.1 0.1 0.2 4.1 0.9 0.2 0.7 0.0 0.2 4.4 13.3 1.7 4.0 3.8 3.8 2.4 2.9 20.8 5.5 C4orf48 ENSG00000243449 "Chromosome 4 open reading frame 48" Q5BLP8 4 2041993-2043970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 78.4;brain: 37.2" "Cell line enhanced" "Detected in many" "HEK 293: 37.8;NB-4: 27.1;PC-3: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052447 Uncertain Supported Cytosol "Secreted to blood" 32000 Cytosol "HPA052447: " "unprognostic (7.96e-2)" "unprognostic (2.57e-3)" "unprognostic (2.08e-1)" "unprognostic (3.20e-2)" "unprognostic (4.01e-2)" "unprognostic (8.26e-2)" "unprognostic (4.85e-3)" "unprognostic (2.51e-3)" "unprognostic (2.28e-3)" "unprognostic (1.80e-1)" "unprognostic (1.95e-2)" "unprognostic (5.55e-2)" "unprognostic (3.42e-2)" "unprognostic (5.38e-3)" "unprognostic (2.68e-1)" "unprognostic (5.55e-2)" "unprognostic (3.17e-3)" 11.4 7.8 25.5 9.7 22.2 5.6 4.8 7.7 37.2 3.4 19.7 18.2 3.2 6.5 4.1 3.0 1.2 3.2 3.1 3.8 26.4 26.2 5.2 2.5 4.7 8.7 24.8 15.6 2.9 16.8 5.6 19.8 5.3 14.9 3.9 3.1 4.3 5.1 4.3 3.3 3.7 16.6 2.4 30.7 9.6 9.8 13.9 15.7 1.2 2.2 0.7 2.4 2.6 2.6 29.8 49.4 67.5 78.4 4.5 31.0 28.4 7.6 6.4 1.2 5.9 0.5 0.9 8.5 7.4 1.4 1.3 1.3 4.4 4.6 1.0 7.1 0.2 2.1 0.1 0.8 0.4 4.6 37.8 2.4 3.5 2.4 1.3 4.9 16.9 0.7 1.4 0.3 0.0 1.4 8.0 0.0 0.9 4.7 5.6 27.1 3.8 82.0 13.0 2.0 2.5 1.1 2.9 10.3 14.5 3.6 0.1 9.9 2.0 2.4 6.2 3.6 7.7 2.6 8.2 5.7 4.9 0.0 3.5 3.1 4.9 11.5 78.4 67.5 21.5 50.6 22.0 29.8 27.8 23.9 44.2 22.6 16.0 16.7 59.0 4.5 44.0 49.4 31.0 28.4 25.5 22.2 7.7 37.2 26.4 26.2 24.8 15.6 14.9 15.7 C4orf50 FLJ46481 ENSG00000181215 "Chromosome 4 open reading frame 50" Q6ZRC1 4 5897373-6018507 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "brain: 6.0" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (7.02e-3)" "unprognostic (6.55e-3)" "unprognostic (2.35e-1)" "unprognostic (1.09e-1)" "unprognostic (1.19e-1)" "unprognostic (6.64e-3)" "unprognostic (1.11e-1)" "unprognostic (4.35e-2)" "unprognostic (9.94e-5)" "unprognostic (4.31e-2)" "unprognostic (4.86e-3)" "unprognostic (2.61e-1)" "unprognostic (2.88e-6)" "unprognostic (3.29e-1)" "unprognostic (2.23e-1)" "unprognostic (2.47e-2)" "unprognostic (4.68e-2)" 0.0 0.5 1.0 0.2 6.0 0.2 0.0 0.0 4.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.7 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 C5orf49 LOC134121 ENSG00000215217 "Chromosome 5 open reading frame 49" A4QMS7 5 7830378-7851490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 35.9;fallopian tube: 65.6;testis: 28.9" "Cell line enhanced" "Detected in some" "AF22: 3.1;CAPAN-2: 2.0;RPTEC TERT1: 2.2;SCLC-21H: 1.4;T-47d: 2.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043759 Enhanced "HPA043759: " "unprognostic (1.55e-1)" "unprognostic (5.82e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-2)" "unprognostic (2.13e-3)" "unprognostic (4.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-1)" "unprognostic (7.93e-2)" "unprognostic (7.54e-3)" "unprognostic (1.85e-1)" "unprognostic (3.27e-2)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (2.28e-2)" "unprognostic (2.20e-2)" 1.0 1.3 9.7 1.0 16.9 0.8 1.6 0.5 7.4 3.0 0.9 12.2 1.2 1.0 2.1 9.9 0.9 65.6 1.3 0.9 10.4 12.4 3.5 1.3 10.1 0.9 5.7 6.3 6.9 2.4 2.7 5.9 0.9 35.9 2.3 0.9 0.7 0.9 2.0 0.9 1.1 0.9 1.1 2.7 0.9 1.4 28.9 4.0 0.0 1.6 0.0 0.9 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 3.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.2 1.1 0.0 0.0 0.2 0.0 2.2 0.1 1.4 0.8 0.9 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 16.9 0.5 7.4 10.4 12.4 5.7 6.3 35.9 4.0 C6orf118 "bA85G2.1, MGC23884" ENSG00000112539 "Chromosome 6 open reading frame 118" Q5T5N4 6 165279664-165309607 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.5;fallopian tube: 23.9;pituitary gland: 10.4;testis: 9.6" "Group enriched" "Detected in some" 5 "AF22: 7.2;SCLC-21H: 4.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA029787, HPA029789" Approved Uncertain Mitochondria Mitochondria "HPA029787: AB_10599999, HPA029789: AB_10601002" "unprognostic (2.84e-1)" "unprognostic (3.09e-4)" "unprognostic (2.70e-2)" "unprognostic (7.99e-2)" "unprognostic (5.34e-2)" "unprognostic (1.41e-1)" "unprognostic (2.50e-1)" "unprognostic (4.27e-2)" "unprognostic (4.89e-2)" "unprognostic (8.18e-9)" "unprognostic (3.22e-3)" "unprognostic (3.03e-2)" "unprognostic (6.55e-3)" "unprognostic (4.50e-1)" 0.3 0.3 4.4 0.3 11.4 0.3 0.3 0.1 0.8 1.5 0.3 7.5 0.1 0.3 1.0 7.2 0.3 23.9 0.3 0.3 4.3 2.7 0.3 0.3 4.7 0.3 0.3 1.0 3.4 0.3 0.3 10.4 0.3 14.5 0.3 0.3 0.0 0.3 0.4 0.3 0.3 0.3 0.3 0.8 0.3 0.3 9.6 3.9 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.2 0.0 0.2 0.0 4.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 11.4 0.1 0.8 4.3 2.7 0.3 1.0 14.5 3.9 C6orf141 MGC46457 ENSG00000197261 "Chromosome 6 open reading frame 141" Q5SZD1 6 49550646-49561907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6;gallbladder: 18.9" "Cell line enhanced" "Detected in many" "HaCaT: 8.9;HeLa: 7.0;hTCEpi: 7.0;PC-3: 12.0;T-47d: 7.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 10 "basal ganglia: 30.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA036199 Uncertain Approved "Nuclear membrane" "Nuclear membrane" "HPA036199: " "prognostic favourable (3.92e-6)" "unprognostic (1.58e-1)" "unprognostic (9.87e-2)" "prognostic favourable (1.15e-4)" "unprognostic (4.95e-2)" "unprognostic (2.15e-2)" "unprognostic (1.39e-3)" "unprognostic (8.13e-2)" "unprognostic (7.02e-2)" "unprognostic (2.85e-2)" "unprognostic (6.37e-3)" "unprognostic (1.41e-1)" "unprognostic (1.89e-8)" "unprognostic (2.33e-2)" "unprognostic (5.81e-1)" "unprognostic (3.77e-1)" "unprognostic (4.43e-1)" 4.7 0.2 1.0 3.0 30.6 0.0 4.9 3.1 1.8 3.7 2.1 0.3 4.4 10.5 4.4 3.6 2.9 1.9 18.9 0.4 0.3 0.4 0.3 1.1 0.6 0.6 0.5 0.1 0.5 3.3 0.0 2.0 0.2 2.8 1.1 1.4 0.0 2.2 0.9 1.2 4.6 1.4 1.4 0.3 0.1 9.1 3.1 2.9 0.0 1.1 0.4 0.8 1.7 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 3.1 0.0 0.0 0.0 0.0 1.6 0.8 0.9 0.0 0.0 0.2 3.3 0.0 0.5 1.5 8.9 1.0 2.3 0.0 0.0 5.6 0.0 7.0 0.0 0.3 0.0 0.0 0.3 7.0 0.0 5.0 1.7 0.1 0.0 0.0 0.1 0.0 0.0 3.3 12.0 0.0 0.0 0.0 1.6 5.2 0.2 0.0 2.2 0.0 0.0 7.5 0.0 2.7 0.4 0.0 0.0 5.7 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 30.6 3.1 1.3 0.3 0.4 0.5 0.1 2.8 2.9 C7orf57 ENSG00000164746 "Chromosome 7 open reading frame 57" Q8NEG2 7 48035511-48061304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.0;fallopian tube: 20.9;testis: 11.4" "Cell line enhanced" "Detected in some" "hTERT-HME1: 10.1;U-266/70: 5.9;U-698: 3.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 20.0" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.3" "Lineage enhanced" "Detected in single" "T-cells: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021286 Enhanced "HPA021286: AB_1845760" "unprognostic (1.74e-2)" "unprognostic (4.82e-2)" "unprognostic (3.13e-2)" "unprognostic (1.28e-2)" "unprognostic (2.77e-3)" "unprognostic (3.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.32e-1)" "unprognostic (3.29e-1)" "unprognostic (1.37e-1)" "unprognostic (4.98e-2)" "unprognostic (2.88e-1)" "unprognostic (3.93e-5)" "unprognostic (5.17e-3)" "unprognostic (6.18e-2)" "unprognostic (3.42e-3)" "unprognostic (1.20e-1)" 0.2 0.2 2.3 0.2 5.0 0.5 0.3 0.1 1.0 0.8 0.2 3.5 0.0 0.3 0.9 7.1 1.4 20.9 0.2 0.3 3.7 4.0 0.3 0.2 4.3 0.3 0.1 0.4 1.6 0.1 0.7 0.4 0.2 20.0 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.7 0.2 0.2 11.4 2.1 0.0 0.5 1.8 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.6 2.3 0.1 0.8 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.5 0.3 0.4 0.0 2.4 0.0 0.2 0.2 0.3 0.0 1.0 0.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.0 0.0 0.1 0.4 0.1 0.2 0.0 0.2 1.0 0.0 0.1 0.0 0.1 0.1 1.0 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.6 0.9 0.5 0.6 5.9 0.8 3.4 1.4 0.0 1.0 0.0 0.0 0.0 0.6 0.0 2.3 0.0 0.6 0.6 0.1 0.0 0.4 0.2 0.0 0.6 0.0 0.0 0.0 0.1 2.3 5.0 0.1 1.0 3.7 4.0 0.1 0.4 20.0 2.1 C8orf46 MGC33510 ENSG00000169085 "Chromosome 8 open reading frame 46" Q8TAG6 8 66460003-66518524 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 51.7" "Cell line enhanced" "Detected in some" "A-431: 3.2;CAPAN-2: 3.2;fHDF/TERT166: 3.2;LHCN-M2: 4.2;SK-MEL-30: 4.6;T-47d: 5.9;WM-115: 5.8" "Cancer enriched" "Detected in many" 6 "glioma: 16.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "amygdala: 164.2;basal ganglia: 80.3;cerebral cortex: 305.1;hippocampal formation: 240.3" "Low region specificity" "Detected in all" HPA075134 Approved "Nuclear speckles" "Nuclear speckles" "HPA075134: " "unprognostic (6.87e-2)" "unprognostic (7.85e-2)" "unprognostic (2.01e-1)" "unprognostic (8.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (7.53e-4)" "unprognostic (7.87e-3)" "unprognostic (1.45e-1)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "unprognostic (1.82e-1)" "unprognostic (6.36e-3)" "unprognostic (3.53e-4)" "unprognostic (1.86e-1)" "unprognostic (4.98e-2)" "unprognostic (2.91e-2)" 1.2 1.4 14.9 1.2 16.6 1.2 1.2 1.8 51.7 1.6 1.2 16.3 0.0 1.0 1.6 1.3 1.5 1.2 1.7 2.2 39.1 8.3 1.3 1.2 1.4 1.4 13.8 19.4 1.1 1.8 1.1 0.2 1.1 10.9 2.2 1.3 0.0 1.7 5.3 3.1 1.4 1.4 2.0 17.9 1.2 1.1 1.4 10.0 0.0 1.3 0.0 1.1 1.5 0.2 0.0 0.7 0.0 0.0 0.0 0.7 0.1 3.2 0.2 0.5 2.1 0.0 0.1 0.0 0.3 0.4 0.5 0.1 0.0 3.2 0.0 0.3 3.2 0.1 0.0 0.0 2.3 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.2 4.2 0.5 0.0 0.0 0.2 0.2 0.0 0.5 0.0 1.3 0.1 0.5 0.0 0.0 0.0 4.6 5.9 0.0 0.0 0.4 0.7 0.2 2.8 0.1 1.2 0.0 1.2 0.1 5.8 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.9 16.6 1.8 26.7 39.1 8.3 13.8 19.4 10.9 10.0 C8orf48 FLJ25402 ENSG00000164743 "Chromosome 8 open reading frame 48" Q96LL4 8 13566843-13568287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7;testis: 17.3" "Cell line enhanced" "Detected in many" "U-87 MG: 11.7;WM-115: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA026107, HPA027440" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA026107: AB_10600765, HPA027440: AB_10601678" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (5.07e-2)" "unprognostic (9.01e-2)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (4.84e-3)" "unprognostic (7.70e-2)" "unprognostic (1.76e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-1)" "unprognostic (1.41e-3)" "unprognostic (7.74e-4)" "unprognostic (1.78e-1)" "unprognostic (8.42e-3)" "unprognostic (8.70e-2)" 2.7 0.7 3.6 1.2 11.7 0.1 3.7 0.8 2.9 3.0 1.3 0.9 0.2 0.9 2.3 6.0 1.4 3.9 2.5 4.0 2.8 1.6 4.1 1.7 2.4 1.2 1.7 3.0 2.1 1.2 0.5 1.5 2.8 2.8 2.2 1.0 2.4 2.2 1.0 0.9 2.7 0.9 1.9 1.1 1.1 1.9 17.3 1.5 0.0 8.9 0.3 0.5 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.1 1.8 0.0 6.2 6.2 0.0 5.4 6.0 2.9 5.0 0.0 0.0 0.0 0.0 2.8 0.6 0.2 1.0 5.7 0.0 0.6 0.5 0.0 0.0 2.2 0.0 0.9 1.9 3.7 3.9 1.0 3.7 0.1 0.0 7.3 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 2.2 0.0 3.2 0.0 0.2 6.0 0.0 0.0 1.7 5.1 5.0 6.0 4.8 0.0 0.0 0.0 11.7 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 11.7 0.8 2.9 2.8 1.6 1.7 3.0 2.8 1.5 C9orf129 bA165J3.3 ENSG00000204352 "Chromosome 9 open reading frame 129" Q5T035 9 93318199-93346414 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in many" 4 "brain: 12.7;testis: 4.3" "Cell line enriched" "Detected in single" 8 "NTERA-2: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA071515 Uncertain Mitochondria Mitochondria "HPA071515: " "unprognostic (1.12e-1)" "unprognostic (2.46e-2)" "unprognostic (1.23e-1)" "unprognostic (9.47e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-1)" "unprognostic (4.58e-2)" "unprognostic (1.35e-1)" "unprognostic (3.45e-1)" 0.7 0.6 5.9 1.3 7.2 0.7 0.7 4.7 12.7 1.4 0.8 0.7 0.0 1.1 0.9 2.0 1.0 1.3 0.6 0.9 4.3 5.7 0.6 0.7 0.7 0.7 3.2 9.3 0.6 1.1 0.6 0.6 0.8 4.3 1.0 0.8 0.6 0.6 1.2 1.3 0.6 0.8 1.0 2.1 1.0 1.1 4.3 1.1 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 6.9 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 7.2 4.7 12.7 4.3 5.7 3.2 9.3 4.3 1.1 C9orf135 ENSG00000204711 "Chromosome 9 open reading frame 135" Q5VTT2 9 69820793-69906232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.6;fallopian tube: 31.8;pituitary gland: 35.4;testis: 18.4" "Group enriched" "Detected in some" 7 "HAP1: 9.3;NTERA-2: 24.7" "Cancer enriched" "Detected in some" 6 "testis cancer: 7.8" "Region enriched" "Detected in many" 5 "pons and medulla: 17.6" "Group enriched" "Detected in some" 5 "naive CD4 T-cell: 3.3;naive CD8 T-cell: 4.0;T-reg: 3.6" "Lineage enriched" "Detected in single" 41 "T-cells: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021261, HPA021325" Uncertain "HPA021261: AB_1845811, HPA021325: AB_1845812" "unprognostic (1.05e-2)" "unprognostic (4.39e-1)" "unprognostic (1.97e-1)" "unprognostic (1.39e-1)" "unprognostic (1.90e-1)" "unprognostic (5.22e-3)" "unprognostic (5.72e-1)" "unprognostic (3.25e-3)" "unprognostic (4.11e-2)" "unprognostic (2.04e-1)" "unprognostic (7.60e-2)" 0.1 0.5 3.2 0.1 2.4 0.1 0.1 0.0 0.1 0.8 0.1 3.1 0.0 0.1 0.6 9.8 0.1 31.8 1.3 0.1 2.2 2.2 1.3 0.3 7.0 0.1 0.3 0.0 3.2 0.7 3.1 35.4 0.1 17.6 0.1 0.1 0.4 0.2 0.4 0.5 0.1 0.1 0.1 0.4 0.1 0.2 18.4 0.4 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.1 0.0 0.0 3.3 4.0 0.0 0.0 0.0 0.0 3.6 0.1 3.2 2.4 0.0 0.1 2.2 2.2 0.3 0.0 17.6 0.4 C9orf16 "EST00098, FLJ12823, MGC4639" ENSG00000171159 "Chromosome 9 open reading frame 16" Q9BUW7 9 128160260-128163928 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 98.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020725 Uncertain Approved Microtubules Microtubules "HPA020725: AB_1845816" "unprognostic (8.85e-2)" "prognostic favourable (7.60e-4)" "prognostic unfavourable (9.91e-4)" "unprognostic (6.42e-3)" "unprognostic (3.98e-1)" "unprognostic (1.60e-1)" "prognostic unfavourable (3.13e-5)" "unprognostic (8.26e-2)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (7.04e-3)" "unprognostic (2.13e-1)" "unprognostic (3.09e-3)" "unprognostic (4.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.00e-3)" "unprognostic (2.48e-2)" 19.6 83.4 70.6 13.9 34.4 38.7 13.1 16.9 59.7 16.3 17.0 12.1 13.3 16.9 12.3 10.3 16.8 16.9 18.7 22.7 98.6 20.3 16.0 12.2 13.5 23.9 27.4 22.1 14.2 35.0 4.2 14.7 9.5 19.1 15.6 6.9 16.1 27.0 25.4 14.0 31.4 15.4 15.1 12.1 24.3 20.1 12.1 9.1 33.2 13.3 13.7 16.6 31.0 16.4 52.3 43.6 58.3 37.1 45.5 73.7 42.0 9.2 12.4 6.4 39.4 4.8 10.9 16.5 8.8 7.4 7.4 5.9 6.1 24.4 10.4 18.2 3.7 26.2 1.9 7.1 0.3 19.7 15.9 7.3 14.8 12.3 8.7 8.0 18.9 8.2 10.6 3.8 1.9 10.5 19.4 20.8 3.9 54.2 27.2 35.2 15.4 23.5 25.9 4.2 43.3 9.3 8.0 17.7 26.3 15.8 14.1 18.4 15.8 7.5 12.5 7.6 18.3 9.5 7.5 20.4 14.8 15.6 21.5 11.3 7.6 53.4 37.1 58.3 50.1 30.4 54.0 50.7 58.0 48.8 40.7 52.3 46.6 47.1 42.3 45.5 25.6 43.6 73.7 42.0 70.6 34.4 16.9 59.7 98.6 20.3 27.4 22.1 19.1 9.1 C9orf24 "bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1" ENSG00000164972 "Chromosome 9 open reading frame 24" Q8NCR6 9 34379019-34397832 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 47.6;fallopian tube: 76.2;testis: 23.7" "Cell line enhanced" "Detected in some" "Hep G2: 4.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 17.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053008 Enhanced "HPA053008: " "unprognostic (3.62e-3)" "unprognostic (9.06e-3)" "unprognostic (1.00e-1)" "prognostic favourable (3.23e-5)" "unprognostic (7.66e-2)" "unprognostic (1.21e-2)" "unprognostic (2.40e-1)" "unprognostic (1.25e-1)" "unprognostic (2.72e-1)" "unprognostic (1.58e-1)" "prognostic favourable (1.75e-4)" "unprognostic (1.33e-1)" "unprognostic (6.39e-3)" "unprognostic (1.50e-1)" "unprognostic (7.43e-3)" "unprognostic (4.72e-2)" "unprognostic (1.90e-2)" 1.5 1.2 12.7 1.0 20.0 0.8 1.0 1.5 10.8 3.3 1.6 12.2 0.0 2.1 1.3 7.2 1.1 76.2 1.0 4.8 11.2 11.0 1.9 1.0 10.3 0.9 5.3 6.4 6.2 1.5 0.8 3.1 0.9 47.6 1.5 1.3 0.0 2.0 1.1 1.6 1.2 4.3 1.2 2.0 0.9 1.4 23.7 3.0 0.0 1.2 0.1 1.0 0.9 0.0 0.6 0.4 0.1 0.1 0.9 3.6 0.5 0.8 0.0 1.5 0.6 0.3 0.0 1.3 0.6 0.6 0.3 1.3 1.3 0.0 0.3 0.5 0.0 1.2 0.5 0.2 0.0 2.3 1.2 0.0 1.6 4.0 0.0 0.1 2.0 0.3 0.2 0.4 0.0 0.6 0.0 0.6 0.2 0.0 1.3 0.8 0.6 0.8 0.6 0.1 0.1 0.5 0.1 1.6 0.6 0.0 0.4 0.1 1.0 0.0 0.0 1.2 1.0 0.5 0.8 2.4 1.3 0.4 1.3 0.2 2.4 0.0 0.0 0.0 1.1 0.1 0.0 0.6 1.3 0.4 0.4 0.0 3.6 1.1 0.1 0.9 0.0 0.0 1.7 0.5 12.7 20.0 1.5 10.8 11.2 11.0 5.3 6.4 47.6 3.0 CA10 "CA-RPX, CARPX, HUCEP-15" ENSG00000154975 "Carbonic anhydrase 10" Q9NS85 17 51630313-52160017 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 59.5;cervix, uterine: 23.4" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.1;RT4: 3.7;SCLC-21H: 11.4" "Cancer enhanced" "Detected in some" "glioma: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054825, HPA057837" Supported Approved Vesicles "Secreted in brain" Vesicles "HPA054825: , HPA057837: " "unprognostic (2.66e-1)" "unprognostic (1.76e-1)" "unprognostic (6.06e-2)" "unprognostic (2.10e-1)" "unprognostic (3.43e-1)" "unprognostic (8.22e-2)" "unprognostic (4.43e-3)" "unprognostic (1.02e-3)" "unprognostic (1.01e-1)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (7.21e-3)" "unprognostic (9.18e-5)" "unprognostic (1.60e-1)" "unprognostic (1.51e-1)" 0.5 3.8 14.4 0.5 6.3 0.5 0.5 59.5 36.7 23.4 0.8 1.7 0.0 0.8 0.7 0.5 0.6 0.7 0.6 0.5 8.0 12.4 7.8 0.5 0.5 0.5 7.0 5.0 2.5 0.8 0.5 1.8 14.2 18.3 0.5 0.7 2.9 1.5 0.5 0.5 0.5 1.1 0.6 4.2 0.5 0.6 6.0 1.3 0.0 0.5 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.1 3.7 11.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 6.3 59.5 17.9 8.0 12.4 7.0 5.0 18.3 1.3 CA11 "CARP2, CARPX1" ENSG00000063180 "Carbonic anhydrase 11" O75493 19 48637942-48646312 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.7" "Cell line enhanced" "Detected in many" "AN3-CA: 24.6;SCLC-21H: 17.6;U-266/84: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041778 Approved Vesicles,Microtubules "Secreted in brain" "Vesicles, Microtubules" "HPA041778: AB_10794525" "unprognostic (1.39e-1)" "prognostic favourable (4.33e-4)" "unprognostic (2.59e-3)" "unprognostic (5.72e-2)" "unprognostic (1.54e-1)" "unprognostic (9.80e-3)" "unprognostic (6.02e-2)" "prognostic favourable (2.11e-5)" "unprognostic (3.79e-2)" "unprognostic (2.98e-1)" "prognostic favourable (8.60e-5)" "unprognostic (4.88e-2)" "unprognostic (8.64e-3)" "unprognostic (1.21e-1)" "unprognostic (7.15e-2)" "unprognostic (4.09e-3)" "unprognostic (1.75e-1)" 2.3 9.6 60.2 2.3 58.2 1.5 4.1 54.1 87.7 3.8 2.5 4.5 1.7 5.3 17.7 16.0 3.5 10.5 3.5 2.9 44.1 12.2 4.2 1.2 3.2 3.0 18.5 31.6 24.6 3.3 16.7 5.4 1.3 8.9 4.6 2.0 2.7 4.0 8.4 5.0 6.6 4.0 10.7 11.0 2.8 3.1 2.7 17.8 0.1 4.3 0.8 3.4 2.1 1.8 3.4 4.5 0.0 1.1 2.6 3.7 1.4 1.0 6.7 12.2 24.6 1.7 0.7 0.3 0.8 7.8 0.8 1.8 1.6 8.5 4.0 1.0 0.8 2.7 5.0 2.5 0.7 0.8 7.1 1.7 3.6 0.1 1.6 0.1 5.5 3.0 5.0 0.7 1.1 0.9 3.1 11.3 0.4 2.5 2.1 0.7 5.4 2.6 1.4 0.5 8.3 5.4 0.2 17.6 10.2 0.9 0.9 1.5 3.5 0.4 0.1 2.2 8.2 0.0 0.2 10.7 17.9 0.7 3.1 2.3 1.1 0.0 0.9 0.0 3.7 1.1 3.1 2.4 2.9 2.8 1.6 3.4 3.6 3.3 0.0 2.6 0.0 4.5 3.0 1.4 60.2 58.2 54.1 63.8 44.1 12.2 18.5 31.6 8.9 17.8 CA14 ENSG00000118298 "Carbonic anhydrase 14" Q9ULX7 1 150257159-150265078 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1" "Group enriched" "Detected in some" 18 "AF22: 28.0;AN3-CA: 16.6;NTERA-2: 21.8;SK-MEL-30: 55.8" "Group enriched" "Detected in many" 7 "glioma: 4.9;melanoma: 23.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008482 Approved Approved "Plasma membrane" "Plasma membrane" "HPA008482: AB_1078395" "unprognostic (3.06e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (3.25e-2)" "prognostic favourable (8.47e-4)" "unprognostic (7.28e-2)" "unprognostic (4.48e-2)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (2.47e-1)" "unprognostic (5.46e-2)" "unprognostic (1.73e-1)" "unprognostic (5.89e-3)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (1.22e-1)" "unprognostic (5.80e-2)" 0.1 0.3 4.6 0.2 5.2 0.9 0.3 1.4 6.8 0.1 1.7 10.8 0.1 0.3 0.1 0.5 1.6 1.3 0.7 4.4 6.4 4.1 0.3 6.3 0.2 0.2 11.3 3.2 1.4 0.3 0.8 0.1 0.3 4.4 3.2 0.7 29.4 0.6 16.5 24.1 3.7 0.6 0.5 20.9 0.3 0.8 0.5 2.7 0.1 0.9 0.1 0.1 0.2 0.1 2.8 2.2 2.1 2.0 0.2 1.6 0.2 0.2 0.0 28.0 16.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 21.8 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.1 55.8 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 1.2 0.1 0.1 0.1 0.0 0.0 0.9 1.3 1.6 2.0 0.6 2.0 1.0 1.2 0.2 2.8 1.2 1.3 2.1 0.2 0.5 2.2 0.0 0.2 4.6 5.2 1.4 4.7 6.4 4.1 11.3 3.2 4.4 2.7 CA8 "CALS, CARP" ENSG00000178538 "Carbonic anhydrase 8" P35219 8 60187347-60281412 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.0;brain: 26.8;parathyroid gland: 56.8" "Cell line enhanced" "Detected in some" "HEK 293: 12.6;K-562: 22.7;NB-4: 13.1;WM-115: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 20 "basophil: 41.0" "Lineage enriched" "Detected in many" 20 "granulocytes: 41.0" "Region enriched" "Detected in some" 37 "cerebellum: 1413.4" "Region enriched" "Detected in all" 9 "cerebellum: 163.0" "HPA024748, CAB025545, CAB047309" Enhanced "CAB025545: , CAB047309: , HPA024748: AB_1846003" "unprognostic (1.55e-1)" "unprognostic (2.89e-2)" "unprognostic (4.43e-2)" "unprognostic (3.46e-3)" "unprognostic (6.67e-2)" "unprognostic (3.19e-1)" "unprognostic (3.85e-2)" "unprognostic (3.54e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "prognostic favourable (5.79e-5)" "unprognostic (3.23e-2)" "unprognostic (1.68e-2)" "unprognostic (2.12e-1)" "unprognostic (1.71e-2)" "unprognostic (1.95e-1)" "unprognostic (1.41e-1)" 2.3 1.5 9.2 1.1 11.6 1.1 6.5 26.8 6.9 6.3 2.2 3.6 0.6 1.8 2.8 12.8 0.9 2.5 1.0 3.8 7.8 6.0 7.4 0.6 1.6 1.0 4.2 5.3 0.7 3.0 56.8 9.8 8.1 3.4 3.3 3.1 1.5 6.6 0.9 2.0 0.9 1.7 1.3 1.9 1.3 5.9 9.3 6.2 1.7 0.7 1.3 1.0 1.3 2.1 0.1 2.0 41.0 0.0 0.0 0.0 0.0 0.0 2.9 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.1 0.0 12.6 5.2 0.0 0.0 4.2 2.1 1.4 0.0 0.0 0.0 0.0 0.0 22.7 0.2 0.0 0.0 3.6 13.1 0.2 0.0 0.0 0.0 0.3 0.5 1.0 5.8 0.0 0.0 1.2 0.0 5.3 0.8 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.6 41.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 9.2 11.6 26.8 6.9 7.8 6.0 4.2 5.3 3.4 6.2 CABP1 ENSG00000157782 "Calcium binding protein 1" Q9NZU7 12 120640552-120667324 "Predicted intracellular proteins" "Sensory transduction, Vision" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 90.6" "Cell line enhanced" "Detected in some" "AF22: 3.9;NTERA-2: 9.1;RPTEC TERT1: 3.6;RT4: 5.2;SCLC-21H: 4.3;U-87 MG: 11.7" "Cancer enhanced" "Detected in some" "renal cancer: 2.2" "Region enhanced" "Detected in many" "cerebral cortex: 90.6" "Cell type enhanced" "Detected in single" "myeloid DC: 3.1" "Lineage enriched" "Detected in single" 6 "dendritic cells: 3.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 177.9" HPA051438 Uncertain "Intracellular and membrane" "HPA051438: " "unprognostic (2.57e-1)" "unprognostic (4.79e-2)" "unprognostic (1.92e-4)" "unprognostic (1.16e-1)" "unprognostic (4.13e-3)" "unprognostic (6.28e-2)" "unprognostic (4.61e-2)" "unprognostic (2.85e-1)" "unprognostic (8.12e-3)" "unprognostic (7.59e-2)" "unprognostic (1.04e-2)" "unprognostic (6.60e-2)" "unprognostic (7.73e-3)" "unprognostic (1.60e-1)" "unprognostic (1.82e-1)" "unprognostic (3.61e-2)" "unprognostic (2.85e-1)" 9.0 2.0 26.2 1.0 18.1 0.4 1.1 13.1 90.6 1.8 2.0 0.3 0.2 1.1 2.6 3.6 1.7 2.0 1.3 3.7 29.3 5.7 8.9 0.5 0.9 0.6 6.7 18.4 1.2 0.9 3.7 1.0 1.4 3.5 1.9 1.9 1.0 0.8 3.9 2.6 0.8 1.4 2.5 2.5 1.0 1.6 0.9 0.0 0.0 0.6 0.0 0.6 2.1 0.6 0.0 3.1 0.5 0.4 0.0 0.0 0.2 0.2 0.7 3.9 1.2 0.0 0.1 0.0 0.1 0.4 0.2 0.2 0.3 0.0 0.0 0.6 0.0 0.3 3.4 0.0 0.2 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.1 9.1 0.6 2.2 0.0 0.0 3.6 5.2 4.3 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 11.7 0.0 0.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.5 0.0 0.1 0.9 0.0 0.2 26.2 18.1 13.1 90.6 29.3 5.7 6.7 18.4 3.5 0.0 CABP7 MGC57793 ENSG00000100314 "Calcium binding protein 7" Q86V35 22 29720084-29731839 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 30.3;pancreas: 9.6" "Group enriched" "Detected in some" 12 "HEL: 12.5;SCLC-21H: 12.3;SH-SY5Y: 3.9;U-2 OS: 4.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 3.9" "Region enhanced" "Detected in all" "hippocampal formation: 30.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 83.4;hippocampal formation: 224.8;midbrain: 72.1;pons and medulla: 115.1" "Region enriched" "Detected in many" 4 "hippocampal formation: 65.6" HPA016439 Uncertain "HPA016439: AB_2669357" "unprognostic (1.88e-1)" "unprognostic (4.75e-2)" "unprognostic (1.18e-1)" "unprognostic (5.37e-2)" "unprognostic (4.55e-1)" "unprognostic (2.29e-4)" "unprognostic (2.05e-3)" "unprognostic (7.96e-2)" "unprognostic (8.69e-3)" "unprognostic (3.32e-2)" "unprognostic (2.61e-1)" "unprognostic (1.22e-1)" "unprognostic (7.44e-7)" "unprognostic (1.25e-4)" "unprognostic (3.60e-2)" "unprognostic (2.71e-1)" "unprognostic (4.72e-3)" 0.4 6.0 2.7 0.5 2.6 0.8 0.3 7.2 6.5 0.3 0.5 1.2 0.0 1.5 0.3 1.8 0.7 0.4 0.5 0.3 30.3 2.0 0.3 0.3 0.4 0.5 3.9 1.2 0.4 9.6 0.3 0.1 0.3 16.9 0.4 0.5 2.4 0.8 0.4 0.6 1.0 3.8 0.4 4.1 0.5 0.4 1.2 2.8 0.0 0.7 0.0 0.3 0.4 0.0 0.6 0.6 1.8 1.6 0.5 1.4 0.6 0.1 0.6 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 12.5 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.3 0.0 0.0 12.3 3.9 0.1 0.2 0.1 0.5 0.0 0.1 0.2 4.1 0.1 0.2 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.8 1.8 0.8 1.3 0.5 0.6 1.1 0.5 0.6 0.4 1.0 1.4 1.3 0.5 1.6 0.6 0.5 0.6 2.7 2.6 7.2 3.0 30.3 2.0 3.9 1.2 16.9 2.8 CACNA1A "APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6" ENSG00000141837 "Calcium voltage-gated channel subunit alpha1 A" O00555 19 13206442-13633025 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 77.9" "Group enriched" "Detected in some" 5 "SCLC-21H: 30.5;U-87 MG: 17.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 77.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064258, HPA071902" Enhanced Supported Uncertain "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA064258: , HPA071902: " "unprognostic (1.09e-1)" "unprognostic (3.73e-3)" "unprognostic (2.27e-1)" "unprognostic (2.78e-4)" "unprognostic (4.00e-2)" "unprognostic (2.29e-3)" "unprognostic (5.47e-2)" "unprognostic (3.13e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-2)" "prognostic favourable (4.32e-4)" "unprognostic (5.31e-3)" "unprognostic (5.03e-6)" "unprognostic (6.29e-2)" "unprognostic (1.59e-1)" "unprognostic (2.61e-2)" "unprognostic (6.25e-2)" 2.2 5.3 7.6 1.0 12.2 0.7 0.9 77.9 19.7 0.8 1.5 1.8 0.0 3.9 1.2 2.8 0.7 2.2 0.8 1.1 5.7 5.1 0.7 0.5 0.7 1.3 3.9 7.3 1.1 3.0 0.7 1.5 0.6 7.2 0.8 1.7 1.2 0.9 0.8 1.3 0.7 2.8 0.9 3.3 1.3 7.7 1.9 2.8 0.0 0.7 0.0 1.0 0.8 0.3 2.8 0.8 1.9 1.1 0.8 0.8 0.4 0.0 0.1 0.0 3.8 0.1 0.3 0.0 1.6 1.5 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 2.0 0.0 1.2 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.1 0.9 0.2 0.4 0.0 0.1 0.0 0.1 30.5 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 17.2 0.0 0.4 1.9 0.4 0.7 0.5 0.5 0.8 2.8 0.5 0.3 0.4 1.7 0.6 0.7 1.6 0.8 1.1 0.8 0.6 0.4 7.6 12.2 77.9 17.4 5.7 5.1 3.9 7.3 7.2 2.8 CACNA1B "CACNL1A5, CACNN, Cav2.2" ENSG00000148408 "Calcium voltage-gated channel subunit alpha1 B" Q00975 9 137877789-138124624 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 6.2;brain: 18.9;fallopian tube: 6.6;pituitary gland: 4.8;testis: 8.1" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 20.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044347 Uncertain "HPA044347: AB_10960837" "unprognostic (1.34e-3)" "unprognostic (2.70e-2)" "unprognostic (8.08e-2)" "unprognostic (2.51e-7)" "unprognostic (8.10e-2)" "unprognostic (1.51e-2)" "unprognostic (1.33e-1)" "unprognostic (3.10e-1)" "unprognostic (2.50e-1)" "unprognostic (2.36e-2)" "unprognostic (9.73e-4)" "unprognostic (5.98e-2)" "unprognostic (6.63e-6)" "unprognostic (4.25e-2)" "unprognostic (4.72e-1)" "unprognostic (7.77e-3)" "unprognostic (8.69e-2)" 0.5 6.2 5.7 0.7 8.7 0.5 0.5 18.7 18.9 1.2 0.8 0.2 0.0 0.6 0.6 1.7 0.4 6.6 1.4 1.0 4.5 7.3 0.4 1.2 0.5 0.5 2.9 9.1 0.5 1.2 0.4 4.8 0.4 3.6 1.6 0.8 0.4 0.4 1.3 0.4 0.9 0.7 0.8 4.5 0.6 0.6 8.1 1.4 0.0 0.9 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 20.7 3.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 8.7 18.7 10.9 4.5 7.3 2.9 9.1 3.6 1.4 CACNA1E "BII, CACH6, CACNL1A6, Cav2.3" ENSG00000198216 "Calcium voltage-gated channel subunit alpha1 E" Q15878 1 181317690-181808084 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 30.8" "Cell line enhanced" "Detected in some" "CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042515, CAB079032" Approved Approved "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane" "Actin filaments, Cytosol" "CAB079032: , HPA042515: " "unprognostic (3.96e-3)" "unprognostic (1.89e-1)" "unprognostic (1.05e-2)" "unprognostic (1.54e-5)" "unprognostic (6.56e-2)" "unprognostic (3.16e-2)" "unprognostic (4.30e-3)" "unprognostic (1.18e-1)" "unprognostic (2.40e-1)" "unprognostic (9.48e-3)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (9.85e-7)" "unprognostic (1.74e-2)" "unprognostic (2.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.75e-2)" 0.6 3.0 17.9 2.1 19.7 3.1 0.5 3.9 22.5 0.6 0.8 1.3 0.0 0.6 0.6 4.4 1.1 2.3 0.6 0.6 30.8 5.8 3.8 0.6 0.6 1.4 2.4 10.6 0.5 0.6 0.5 0.2 0.8 4.2 0.5 0.8 0.5 0.5 0.5 0.6 0.5 1.1 1.0 5.2 0.9 0.8 2.8 2.4 0.0 0.6 0.0 1.0 0.6 0.1 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.9 0.0 0.0 0.0 1.0 1.3 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 7.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 17.9 19.7 3.9 22.5 30.8 5.8 2.4 10.6 4.2 2.4 CACNA1G "Cav3.1, NBR13" ENSG00000006283 "Calcium voltage-gated channel subunit alpha1 G" O43497 17 50561068-50627474 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.8;cervix, uterine: 13.6" "Cell line enhanced" "Detected in some" "A549: 13.3;HeLa: 4.6;SCLC-21H: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004714 Uncertain "HPA004714: AB_1078368" "unprognostic (1.90e-2)" "unprognostic (5.83e-2)" "unprognostic (2.85e-2)" "unprognostic (1.08e-1)" "unprognostic (4.00e-1)" "unprognostic (9.89e-2)" "unprognostic (1.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.02e-4)" "unprognostic (1.47e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (4.87e-12)" "unprognostic (3.34e-2)" "unprognostic (1.62e-1)" "unprognostic (1.56e-3)" "unprognostic (6.63e-2)" 1.7 1.0 3.5 0.9 5.2 1.3 2.1 22.8 17.1 13.6 1.0 2.7 0.0 0.9 7.4 1.0 1.6 5.7 1.2 3.8 2.4 8.8 0.7 1.1 0.9 1.2 5.3 7.9 7.1 0.6 0.6 0.4 1.4 6.1 2.5 0.8 4.3 1.1 1.6 0.8 3.9 0.8 2.1 5.9 0.9 0.9 1.7 2.3 0.0 1.2 0.0 1.0 1.0 3.9 1.3 1.3 2.7 0.8 0.7 1.4 0.0 0.0 13.3 3.1 3.5 0.9 0.1 0.2 0.1 0.0 0.1 0.1 2.8 0.5 0.0 1.0 0.1 0.5 1.6 0.0 0.3 1.8 0.6 0.9 4.6 0.7 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.0 1.2 0.8 1.4 1.1 0.0 0.0 0.2 4.1 1.8 2.8 0.1 0.0 0.2 0.1 0.3 1.4 3.9 0.5 0.1 1.0 0.1 0.0 0.5 0.1 0.5 0.5 0.8 0.6 1.4 0.4 0.7 0.8 0.7 0.8 0.2 1.3 0.9 1.0 2.7 0.7 0.4 1.3 0.5 0.0 3.5 5.2 22.8 17.1 2.4 8.8 5.3 7.9 6.1 2.3 CACNA1I Cav3.3 ENSG00000100346 "Calcium voltage-gated channel subunit alpha1 I" Q9P0X4 22 39570753-39689737 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.6;brain: 8.1;lymphoid tissue: 4.3;thyroid gland: 4.1" "Group enriched" "Detected in some" 5 "SK-BR-3: 6.0;T-47d: 3.6" "Cancer enhanced" "Detected in single" "thyroid cancer: 2.1" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.97e-2)" "unprognostic (1.42e-1)" "unprognostic (1.02e-1)" "unprognostic (4.60e-2)" "unprognostic (3.52e-2)" "unprognostic (1.58e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-1)" "unprognostic (7.21e-2)" "unprognostic (5.20e-3)" "unprognostic (1.64e-2)" "unprognostic (8.64e-2)" "unprognostic (1.62e-2)" "unprognostic (6.14e-3)" "unprognostic (1.57e-1)" "unprognostic (3.78e-2)" "unprognostic (8.27e-4)" 0.0 4.6 3.4 1.9 5.8 1.3 0.2 8.1 7.5 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.0 5.0 3.6 0.0 0.0 0.2 4.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.4 1.3 0.5 1.1 4.1 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 6.0 0.0 3.6 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.5 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.8 0.1 CACNA2D3 HSA272268 ENSG00000157445 "Calcium voltage-gated channel auxiliary subunit alpha2delta 3" Q8IZS8 3 54122547-55074557 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;skeletal muscle: 19.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.0;HAP1: 2.7;HeLa: 13.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030849 Uncertain Nucleoplasm 49000 Nucleoplasm "HPA030849: " "unprognostic (6.92e-2)" "unprognostic (1.35e-2)" "unprognostic (1.89e-1)" "unprognostic (4.34e-5)" "unprognostic (5.53e-3)" "unprognostic (2.64e-3)" "unprognostic (3.24e-1)" "unprognostic (1.17e-2)" "unprognostic (5.84e-3)" "unprognostic (7.22e-3)" "unprognostic (1.14e-2)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (1.47e-3)" "unprognostic (2.19e-1)" "unprognostic (3.62e-2)" "unprognostic (6.95e-2)" 1.5 10.3 6.4 1.3 21.9 1.0 1.5 2.4 23.2 1.5 2.0 1.4 0.2 1.4 1.4 4.0 2.1 2.1 1.6 5.1 8.9 8.0 3.8 1.1 2.2 2.2 4.8 12.8 6.7 1.2 1.1 2.4 2.1 9.0 3.4 1.7 2.4 1.9 4.4 19.5 1.2 1.7 2.4 1.7 1.6 1.9 3.9 4.2 0.0 2.1 3.6 2.1 1.0 2.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 1.6 0.2 13.7 0.0 0.8 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 6.4 21.9 2.4 16.1 8.9 8.0 4.8 12.8 9.0 4.2 CACNB3 CACNLB3 ENSG00000167535 "Calcium voltage-gated channel auxiliary subunit beta 3" P54284 12 48813794-48828941 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.9" "Cell line enhanced" "Detected in many" "U-937: 45.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.7" "Lineage enriched" "Detected in single" 9 "T-cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059515 Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA059515: " "unprognostic (1.77e-2)" "unprognostic (4.84e-2)" "unprognostic (2.16e-3)" "unprognostic (2.12e-2)" "unprognostic (8.76e-2)" "unprognostic (2.68e-1)" "unprognostic (2.06e-1)" "unprognostic (3.60e-2)" "unprognostic (3.27e-2)" "unprognostic (2.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.04e-1)" "unprognostic (5.44e-3)" "unprognostic (6.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" 3.8 3.7 27.4 2.9 22.4 1.2 4.2 18.5 42.9 11.9 9.1 1.5 3.0 3.8 22.6 8.1 11.6 16.1 6.7 2.6 16.4 12.2 3.9 1.3 6.1 1.7 10.0 14.5 24.1 2.1 2.8 4.2 5.3 4.4 5.7 7.8 3.4 4.5 9.1 2.1 7.8 5.8 20.4 2.4 2.2 4.7 4.7 2.3 4.6 6.1 3.4 3.6 7.5 6.9 0.2 0.5 0.0 0.3 0.0 4.7 0.5 6.8 5.4 9.1 18.5 11.1 7.9 5.5 7.0 14.8 10.4 6.2 1.7 5.6 0.8 9.2 11.7 7.3 8.2 7.6 3.9 7.9 2.5 3.6 4.4 0.2 4.4 0.6 3.9 5.0 4.6 4.3 2.1 11.8 0.5 2.9 6.7 17.0 8.4 0.9 5.6 4.6 9.7 2.0 2.7 7.5 12.9 12.9 12.8 2.1 15.5 5.1 10.6 3.0 11.3 6.6 9.4 3.2 3.8 3.3 1.3 0.2 5.5 45.1 2.0 0.0 0.3 0.0 0.9 0.1 0.4 0.2 1.8 1.8 0.5 0.0 0.4 0.2 0.0 0.0 0.0 0.4 4.7 0.5 27.4 22.4 18.5 42.9 16.4 12.2 10.0 14.5 4.4 2.3 CACNB4 EJM4 ENSG00000182389 "Calcium voltage-gated channel auxiliary subunit beta 4" O00305 2 151832768-152099475 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.7" "Cell line enriched" "Detected in some" 4 "HMC-1: 20.7" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in all" 4 "basal ganglia: 28.0;cerebellum: 35.7;cerebral cortex: 21.7;olfactory region: 10.9;pons and medulla: 9.8" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.0" HPA015601 Approved "HPA015601: AB_1845873" "unprognostic (2.92e-1)" "unprognostic (1.98e-1)" "unprognostic (1.80e-1)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (1.49e-2)" "unprognostic (3.70e-1)" "unprognostic (9.42e-4)" "unprognostic (1.23e-1)" "unprognostic (1.98e-1)" "unprognostic (1.05e-3)" "unprognostic (2.02e-1)" "unprognostic (1.55e-2)" "unprognostic (7.26e-3)" "unprognostic (3.93e-2)" "unprognostic (9.55e-3)" "unprognostic (2.45e-1)" 1.6 1.7 5.2 1.3 28.0 1.7 3.2 35.7 28.0 1.4 1.2 2.6 0.0 1.2 1.4 1.7 3.1 1.1 2.1 1.1 4.5 4.4 2.8 0.9 3.9 1.1 4.3 10.9 1.3 1.2 1.0 3.8 2.1 9.8 3.9 1.4 0.9 2.1 3.9 0.8 11.7 1.1 4.2 3.0 1.2 1.6 4.1 3.4 0.0 3.1 0.0 2.2 3.5 0.8 0.4 1.3 7.0 0.6 0.2 0.1 0.1 0.0 0.0 0.7 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.9 0.0 0.1 0.3 3.2 0.0 0.1 4.0 0.0 0.2 20.7 0.2 0.1 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.3 0.5 0.6 1.8 0.2 0.6 1.2 0.6 1.4 0.7 0.0 0.0 0.0 3.3 0.8 0.0 1.9 2.1 0.6 0.4 0.4 0.0 0.0 0.5 4.8 0.1 1.2 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.4 0.1 0.1 7.0 0.2 0.0 1.3 0.0 0.1 5.2 28.0 35.7 21.7 4.5 4.4 4.3 10.9 9.8 3.4 CACNG2 "MGC138502, MGC138504, stargazin" ENSG00000166862 "Calcium voltage-gated channel auxiliary subunit gamma 2" Q9Y698 22 36563921-36703558 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 30.7" "Group enriched" "Detected in some" 8 "SCLC-21H: 7.6;SH-SY5Y: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (7.54e-2)" "unprognostic (3.06e-1)" "unprognostic (8.80e-3)" "unprognostic (2.34e-2)" "unprognostic (3.07e-2)" 0.7 2.7 5.6 0.8 6.4 0.9 0.7 30.7 21.9 0.6 0.7 0.3 0.0 0.8 0.6 0.6 0.7 0.6 0.6 0.6 3.8 4.7 0.7 0.7 0.7 0.7 2.9 7.8 0.6 1.1 0.6 2.7 0.7 6.9 0.7 0.7 0.1 0.6 0.6 1.0 0.8 0.8 0.7 1.7 0.7 0.7 1.0 0.8 0.0 0.7 0.0 0.6 0.7 0.1 0.3 1.0 1.0 0.3 0.3 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.2 7.6 3.4 0.0 0.1 0.0 0.3 0.0 0.3 0.2 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.4 0.4 0.3 0.1 0.3 0.3 0.2 0.0 0.3 0.4 0.4 1.0 0.3 0.2 1.0 0.2 0.1 5.6 6.4 30.7 12.3 3.8 4.7 2.9 7.8 6.9 0.8 CACNG3 ENSG00000006116 "Calcium voltage-gated channel auxiliary subunit gamma 3" O60359 16 24255553-24362801 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 32.2" "Cell line enhanced" "Detected in some" "HeLa: 1.3;Karpas-707: 1.0;U-266/70: 1.0" "Cancer enriched" "Detected in single" 15 "glioma: 0.7" "Group enriched" "Detected in many" 6 "amygdala: 12.8;basal ganglia: 13.1;cerebral cortex: 20.0;hippocampal formation: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077238 Enhanced "HPA077238: " "unprognostic (5.61e-2)" "unprognostic (3.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.17e-1)" 0.4 1.8 12.8 0.4 13.1 0.5 0.3 0.2 32.2 0.3 0.4 0.1 0.0 0.3 0.3 0.4 0.3 0.4 0.3 0.3 12.7 2.2 0.3 0.4 0.3 0.4 1.8 2.3 0.4 0.3 0.3 0.0 0.4 0.3 0.4 0.4 0.1 0.3 0.4 0.3 0.4 0.3 0.4 0.3 0.4 0.4 0.6 0.0 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.0 0.2 0.9 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 12.8 13.1 0.2 20.0 12.7 2.2 1.8 2.3 0.3 0.0 CACNG4 "MGC11138, MGC24983" ENSG00000075461 "Calcium voltage-gated channel auxiliary subunit gamma 4" Q9UBN1 17 66964910-67033398 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;prostate: 16.5" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 95.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 159.8" "HPA005803, HPA065370" Enhanced Approved Cytosol Cytosol "HPA005803: , HPA065370: " "unprognostic (1.27e-1)" "unprognostic (3.16e-1)" "unprognostic (8.87e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-2)" "unprognostic (8.64e-3)" "unprognostic (2.91e-1)" "unprognostic (7.08e-2)" "unprognostic (3.37e-2)" "unprognostic (3.85e-2)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (2.38e-10)" "unprognostic (8.57e-3)" "unprognostic (1.23e-1)" "unprognostic (8.71e-2)" "unprognostic (4.28e-1)" 0.7 1.8 16.0 0.8 32.3 0.7 8.1 3.5 37.8 1.2 0.9 11.4 0.2 1.0 1.2 0.8 0.8 6.2 1.2 0.7 9.6 12.9 0.8 0.7 8.0 0.7 7.5 7.1 0.7 1.2 4.9 0.1 1.6 6.8 16.5 0.8 0.1 0.9 2.4 0.8 0.9 0.9 2.0 4.2 0.7 1.7 0.9 10.3 0.0 0.7 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 3.8 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 3.8 0.0 0.0 0.1 2.0 0.0 2.6 3.8 95.2 0.8 2.5 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 32.3 3.5 13.0 9.6 12.9 7.5 7.1 6.8 10.3 CACNG5 ENSG00000075429 "Calcium voltage-gated channel auxiliary subunit gamma 5" Q9UF02 17 66835117-66885486 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 6.5;lymphoid tissue: 3.3;retina: 8.8" "Cell line enhanced" "Detected in some" "NTERA-2: 1.7;RPMI-8226: 1.5;SH-SY5Y: 3.5;THP-1: 1.5" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in all" "olfactory region: 152.3" "Low region specificity" "Detected in all" HPA050115 Uncertain "HPA050115: " "unprognostic (1.85e-3)" "unprognostic (3.84e-2)" "unprognostic (1.44e-1)" "unprognostic (2.46e-6)" "unprognostic (4.52e-2)" "unprognostic (1.29e-1)" 0.3 0.3 2.7 0.7 2.6 0.3 0.3 1.7 6.5 0.4 0.7 6.3 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.4 2.1 2.0 1.0 0.3 0.3 3.3 1.1 2.3 0.3 0.7 0.3 0.8 0.3 0.7 0.5 0.5 8.8 0.3 0.3 0.3 0.4 0.7 0.3 1.7 1.3 0.3 0.7 3.8 0.0 0.3 0.0 3.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.5 0.0 0.0 0.4 3.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.6 1.7 6.5 2.1 2.0 1.1 2.3 0.7 3.8 CACNG7 ENSG00000105605 "Calcium voltage-gated channel auxiliary subunit gamma 7" P62955 19 53909335-53943941 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "brain: 54.4" "Cell line enhanced" "Detected in some" "AF22: 28.8;HMC-1: 22.4;NTERA-2: 7.6;SH-SY5Y: 17.7;U-2 OS: 6.1" "Cancer enriched" "Detected in some" 16 "glioma: 29.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.11e-2)" "unprognostic (7.18e-2)" "unprognostic (6.24e-2)" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (1.01e-5)" "unprognostic (1.51e-1)" "unprognostic (7.36e-2)" 1.2 1.8 22.2 1.3 15.6 1.2 1.2 22.7 54.4 1.2 1.3 8.3 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 21.4 13.7 1.2 1.2 1.3 1.2 16.5 10.3 1.2 1.3 1.2 1.8 1.2 9.9 1.2 1.2 0.3 1.2 1.3 1.2 1.2 1.4 1.3 13.5 1.2 1.3 1.5 4.5 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 28.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 22.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 1.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 15.6 22.7 25.9 21.4 13.7 16.5 10.3 9.9 4.5 CACNG8 ENSG00000142408 "Calcium voltage-gated channel auxiliary subunit gamma 8" Q8WXS5 19 53963040-53990215 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 7.9;brain: 22.8" "Group enriched" "Detected in some" 5 "AF22: 6.4;HMC-1: 21.2;TIME: 12.9" "Cancer enriched" "Detected in single" 5 "glioma: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 9.4;basal ganglia: 9.1;cerebral cortex: 13.6;hippocampal formation: 20.3;hypothalamus: 5.4" "Cell type enriched" "Detected in some" 7 "basophil: 7.9" "Lineage enriched" "Detected in single" 17 "granulocytes: 7.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041351 Enhanced "HPA041351: AB_10796666" "unprognostic (7.01e-2)" "unprognostic (6.27e-2)" "unprognostic (3.06e-1)" "unprognostic (5.29e-4)" "unprognostic (9.66e-2)" "unprognostic (2.17e-2)" "unprognostic (1.38e-1)" "unprognostic (9.40e-3)" "unprognostic (6.13e-2)" "unprognostic (2.03e-1)" "unprognostic (7.63e-2)" "unprognostic (2.58e-1)" "unprognostic (2.82e-8)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" 0.4 0.4 9.4 0.4 9.1 0.6 0.4 0.7 22.8 0.3 0.3 2.1 0.0 0.4 0.5 0.4 0.3 0.4 0.4 0.3 20.3 5.4 0.3 0.3 0.4 0.4 2.3 2.0 0.4 0.3 0.5 0.0 0.3 1.5 0.4 0.4 0.0 0.4 0.3 0.9 0.7 0.4 0.4 0.9 0.4 0.6 1.5 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.4 0.3 7.9 0.2 0.3 0.3 0.1 0.0 2.1 6.4 0.2 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.4 0.3 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.9 2.3 0.5 0.0 1.0 0.0 21.2 0.3 0.0 0.0 0.2 2.1 0.1 0.2 0.0 0.1 0.0 0.0 1.3 2.6 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.1 0.1 0.0 0.2 0.0 12.9 0.1 1.2 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.1 7.9 0.2 1.1 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.4 0.3 0.2 0.5 0.3 0.1 0.3 0.1 0.1 9.4 9.1 0.7 13.6 20.3 5.4 2.3 2.0 1.5 0.0 CADM2 "IGSF4D, Necl-3, NECL3, SynCAM2" ENSG00000175161 "Cell adhesion molecule 2" Q8N3J6 3 84958981-86074429 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 52.7" "Cell line enhanced" "Detected in some" "AF22: 6.3;AN3-CA: 17.9;U-266/70: 3.1" "Cancer enriched" "Detected in some" 9 "glioma: 7.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 5.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010024 Enhanced 350000 "HPA010024: AB_2068039" "unprognostic (2.23e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (1.90e-4)" "unprognostic (8.64e-2)" "unprognostic (2.27e-1)" "unprognostic (4.76e-3)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (1.90e-1)" "unprognostic (8.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.07e-5)" "unprognostic (9.82e-3)" "unprognostic (1.26e-2)" "unprognostic (4.17e-3)" "unprognostic (1.16e-2)" 5.8 6.3 33.5 2.1 22.7 1.7 3.6 44.8 52.7 2.3 3.0 7.0 0.0 2.0 2.0 2.2 2.7 4.6 2.6 4.2 28.6 11.7 1.9 2.5 2.2 1.8 16.3 31.0 2.3 2.4 3.0 5.5 1.9 24.2 3.4 2.7 8.8 2.3 6.2 4.9 2.0 2.6 2.1 14.0 2.0 3.2 2.2 20.5 0.0 2.1 0.0 1.8 2.0 1.1 1.0 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 6.3 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 22.7 44.8 49.5 28.6 11.7 16.3 31.0 24.2 20.5 CADM3 "BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1" ENSG00000162706 "Cell adhesion molecule 3" Q8N126 1 159171609-159203313 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.5;placenta: 43.1" "Cell line enhanced" "Detected in some" "HHSteC: 19.3;HSkMC: 64.8;hTERT-HME1: 34.7;WM-115: 17.2" "Cancer enhanced" "Detected in many" "glioma: 27.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002981, CAB025746" Enhanced Approved Cytosol "Intracellular and membrane" 790000 Cytosol "CAB025746: , HPA002981: AB_1078916" "unprognostic (1.74e-2)" "unprognostic (8.26e-2)" "unprognostic (1.34e-2)" "unprognostic (1.33e-2)" "unprognostic (9.32e-2)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (6.12e-3)" "prognostic unfavourable (1.03e-5)" "unprognostic (5.52e-2)" "unprognostic (2.59e-1)" "unprognostic (3.64e-1)" "prognostic unfavourable (5.75e-4)" 8.9 5.4 23.3 8.5 41.0 0.9 6.1 88.4 96.5 18.0 8.8 6.9 0.7 3.2 2.2 1.6 7.2 3.2 4.1 4.3 23.2 27.4 1.1 1.1 2.9 7.8 18.5 22.4 1.2 2.0 1.0 7.4 43.1 30.4 1.7 8.9 4.5 2.6 3.6 2.0 7.7 6.4 4.1 9.6 7.6 2.8 2.4 4.6 0.0 4.8 0.7 5.9 10.2 7.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.3 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 19.3 0.0 0.0 64.8 0.0 0.0 34.7 1.5 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 1.1 0.0 0.0 0.0 0.0 2.5 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 41.0 88.4 55.6 23.2 27.4 18.5 22.4 30.4 4.6 CADM4 "IGSF4C, Necl-4, SynCAM4, TSLL2" ENSG00000105767 "Cell adhesion molecule 4" Q8NFZ8 19 43622368-43639839 "Predicted membrane proteins" "Cell adhesion" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.9" "Cell line enriched" "Detected in many" 5 "WM-115: 109.8" "Cancer enhanced" "Detected in all" "glioma: 108.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012612 Enhanced Approved "Nucleoplasm,Nuclear membrane" 5900000 "Nuclear membrane" Nucleoplasm "HPA012612: AB_1851530" "unprognostic (8.80e-3)" "unprognostic (2.57e-2)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (2.87e-1)" "unprognostic (9.29e-3)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (5.03e-1)" "unprognostic (3.19e-3)" "unprognostic (3.81e-1)" "prognostic favourable (2.28e-6)" "unprognostic (1.39e-1)" "unprognostic (3.35e-2)" "unprognostic (2.59e-1)" "unprognostic (3.93e-2)" 3.0 12.6 29.7 3.4 31.0 0.9 6.6 22.2 68.9 4.6 5.3 32.8 2.5 3.0 10.4 6.7 10.8 3.0 3.7 5.5 31.2 26.5 13.2 3.4 3.1 1.8 37.2 20.4 5.2 10.9 26.1 7.5 1.1 29.1 13.7 2.8 4.9 13.3 10.8 5.0 10.8 3.0 6.8 47.8 1.9 4.0 1.9 26.4 0.0 3.3 1.7 3.4 2.9 2.9 0.1 4.7 0.6 0.3 0.0 0.0 0.0 8.5 2.5 13.4 17.5 0.0 0.2 0.7 0.4 0.7 1.2 1.8 3.7 1.5 0.0 3.2 0.1 2.0 2.9 1.7 1.5 0.1 2.3 0.0 0.5 5.4 1.6 0.0 1.3 0.5 3.9 6.4 0.2 0.8 0.8 0.1 0.1 1.2 1.2 0.1 1.4 0.8 6.9 0.1 0.8 1.7 1.8 1.5 8.6 0.9 2.7 3.4 2.0 0.4 0.3 0.1 20.7 0.1 0.8 1.2 0.8 0.0 0.9 0.1 109.8 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 4.7 0.0 0.0 29.7 31.0 22.2 34.0 31.2 26.5 37.2 20.4 29.1 26.4 CADPS "CAPS, CAPS1, KIAA1121, UNC-31" ENSG00000163618 "Calcium dependent secretion activator" Q9ULU8 3 62398346-62875389 "Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.0" "Cell line enhanced" "Detected in some" "SCLC-21H: 16.5;SK-MEL-30: 7.3;U-698: 10.5;U-87 MG: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 11 "B-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059328 Enhanced Approved Vesicles Vesicles "HPA059328: " "unprognostic (3.46e-3)" "unprognostic (1.40e-2)" "unprognostic (1.61e-2)" "unprognostic (3.87e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (3.12e-2)" "unprognostic (9.27e-2)" "unprognostic (5.73e-2)" "unprognostic (2.08e-3)" "unprognostic (3.21e-1)" "unprognostic (4.20e-3)" "unprognostic (1.90e-2)" "unprognostic (2.04e-1)" "unprognostic (7.91e-3)" "unprognostic (5.35e-3)" 1.2 17.2 18.2 2.8 16.0 1.0 1.6 22.4 58.0 4.0 3.5 2.4 0.0 3.9 1.5 3.4 1.1 1.1 3.2 11.6 21.9 24.7 1.1 1.1 1.6 1.4 33.7 18.4 2.8 13.5 0.9 19.6 1.1 43.6 4.5 3.3 5.3 1.3 3.8 1.0 2.2 4.0 1.7 7.1 1.4 4.1 3.2 2.7 0.0 1.1 0.0 1.6 1.2 0.6 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 3.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 16.5 1.2 0.0 0.0 7.3 0.0 0.0 0.0 1.4 0.1 2.7 0.7 0.0 1.4 10.5 17.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.2 16.0 22.4 32.0 21.9 24.7 33.7 18.4 43.6 2.7 CADPS2 CAPS2 ENSG00000081803 "Calcium dependent secretion activator 2" Q86UW7 7 122318425-122886759 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 105.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 21.6;Karpas-707: 28.2;MCF7: 14.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 105.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 325.7" HPA056398 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA056398: " "unprognostic (1.93e-1)" "unprognostic (5.05e-2)" "unprognostic (1.91e-1)" "unprognostic (3.67e-3)" "unprognostic (8.69e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (1.33e-1)" "unprognostic (4.07e-1)" "unprognostic (4.33e-2)" "unprognostic (3.93e-2)" "unprognostic (1.30e-1)" "prognostic favourable (1.01e-7)" "unprognostic (9.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.71e-2)" "unprognostic (3.45e-2)" 5.1 11.2 5.1 1.9 7.1 0.0 9.5 105.4 21.1 16.5 5.3 1.4 13.3 6.1 16.3 16.4 5.7 5.7 8.0 4.6 6.8 8.8 20.3 6.2 9.0 1.3 14.0 9.3 5.2 13.2 15.4 17.7 2.7 7.0 10.4 5.4 4.7 23.0 11.5 2.6 2.4 4.7 11.2 4.1 3.3 9.8 1.9 1.4 0.4 9.4 2.4 1.6 4.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.6 2.7 0.1 0.2 6.7 1.5 6.8 0.0 6.2 0.0 0.0 3.1 0.0 0.2 0.9 0.6 0.0 5.5 2.1 0.0 12.1 8.7 0.0 0.1 2.8 1.2 1.1 0.9 21.6 0.0 28.2 0.1 14.8 0.0 0.0 6.3 10.7 0.0 0.0 11.1 0.3 7.0 10.9 0.0 0.3 12.2 0.5 4.7 0.0 6.1 2.4 1.6 0.0 4.3 8.4 0.3 0.0 9.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 7.1 105.4 21.1 6.8 8.8 14.0 9.3 7.0 1.4 CALB1 CALB ENSG00000104327 "Calbindin 1" P05937 8 90058608-90095475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 15 "brain: 73.8;kidney: 121.9" "Cell line enhanced" "Detected in many" "A-431: 39.2;EFO-21: 59.4;NTERA-2: 19.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.4" "Group enriched" "Detected in many" 7 "granulocytes: 6.4;monocytes: 2.5" "Region enhanced" "Detected in many" "cerebellum: 483.1" "Group enriched" "Detected in many" 4 "basal ganglia: 88.7;cerebellum: 312.3" "CAB002138, HPA023099, HPA056734" Enhanced Supported Vesicles Vesicles "CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220" "unprognostic (2.19e-1)" "unprognostic (2.28e-3)" "unprognostic (2.61e-2)" "prognostic unfavourable (1.60e-4)" "unprognostic (1.82e-1)" "unprognostic (5.39e-2)" "unprognostic (2.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" "unprognostic (1.37e-2)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (2.11e-1)" "unprognostic (7.88e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-1)" 1.6 1.2 19.6 1.4 73.8 1.0 1.4 66.0 10.9 3.1 1.3 0.5 0.0 1.0 1.0 2.0 1.7 2.0 0.9 1.0 13.8 15.2 121.9 1.5 2.1 1.0 2.8 6.4 0.9 2.0 1.3 3.2 2.2 12.8 0.9 1.4 0.8 1.3 0.8 1.4 1.7 1.1 1.2 14.7 1.1 1.3 2.1 10.6 0.0 1.4 0.0 1.0 1.0 0.1 0.5 0.6 6.4 2.5 0.0 0.2 1.0 39.2 2.1 8.8 0.6 0.2 1.4 1.2 0.6 4.0 0.3 0.5 0.3 4.7 0.2 59.4 0.0 13.7 12.7 15.7 2.7 0.1 0.7 1.4 16.5 0.3 1.7 0.2 0.7 0.6 5.1 0.8 7.8 10.5 2.7 1.1 10.5 0.2 0.6 0.1 19.3 7.9 0.3 0.2 0.7 4.7 0.3 1.4 0.9 10.6 0.7 0.1 0.5 0.4 0.0 1.5 8.4 1.9 3.4 1.0 1.3 0.3 0.2 0.1 0.1 2.6 0.5 1.5 0.2 0.7 0.0 0.0 0.0 0.1 0.1 0.5 0.2 0.2 6.4 0.0 2.5 0.6 0.0 1.0 19.6 73.8 66.0 10.9 13.8 15.2 2.8 6.4 12.8 10.6 CALB2 CAL2 ENSG00000172137 "Calbindin 2" P22676 16 71358713-71390438 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 50.6;brain: 118.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.1;HEL: 23.4;HMC-1: 51.0;U-2 OS: 14.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000106, HPA007305, HPA007306" Enhanced Supported Enhanced Cytosol 6400 Cytosol "CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385" "unprognostic (1.10e-1)" "unprognostic (1.90e-2)" "prognostic unfavourable (5.78e-5)" "unprognostic (1.75e-3)" "unprognostic (5.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.59e-1)" "unprognostic (4.55e-3)" "unprognostic (4.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.06e-3)" "unprognostic (1.35e-2)" "unprognostic (5.54e-4)" "unprognostic (1.97e-3)" "unprognostic (6.30e-2)" "unprognostic (4.72e-2)" "unprognostic (1.04e-2)" 50.6 11.6 10.1 5.1 7.5 0.9 18.2 31.2 9.9 1.7 8.9 1.7 0.0 1.7 1.4 3.0 3.0 2.4 2.0 2.2 5.9 74.2 0.9 0.9 2.1 0.9 17.7 7.5 5.6 1.4 0.9 3.0 0.9 118.9 1.1 6.0 4.9 2.1 1.3 1.0 1.0 2.7 2.7 7.5 0.9 1.2 14.6 1.5 0.0 0.8 0.2 1.8 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.7 6.5 0.0 0.2 0.0 1.2 0.2 0.1 0.2 0.0 0.0 8.1 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.2 0.0 0.0 51.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 14.6 0.1 1.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 7.5 31.2 9.9 5.9 74.2 17.7 7.5 118.9 1.5 CALCB "CALC2, CGRP-II, FLJ30166" ENSG00000175868 "Calcitonin related polypeptide beta" P10092 11 14904997-15082342 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 14.3;pancreas: 7.9;thyroid gland: 26.0" "Cell line enhanced" "Detected in some" "HEK 293: 6.2;Karpas-707: 11.0;SH-SY5Y: 3.8;U-266/70: 16.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Group enriched" "Detected in many" 8 "hypothalamus: 13.5;pons and medulla: 14.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 7 "pons and medulla: 10.1" HPA059886 Supported "Secreted to blood" "HPA059886: " "unprognostic (7.84e-2)" "unprognostic (4.07e-1)" "unprognostic (3.92e-1)" "prognostic unfavourable (3.42e-5)" "unprognostic (2.02e-1)" "unprognostic (8.40e-2)" "unprognostic (1.75e-1)" "unprognostic (7.21e-2)" "unprognostic (2.07e-1)" "unprognostic (3.32e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-1)" "unprognostic (1.02e-2)" "unprognostic (2.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-1)" "unprognostic (2.33e-1)" 0.5 0.2 0.0 1.6 1.6 0.3 1.5 1.5 0.8 0.3 1.5 0.0 0.0 0.9 0.4 0.3 0.3 0.2 0.3 0.9 0.0 13.5 0.4 1.1 1.3 1.0 0.7 0.2 0.2 7.9 0.3 2.7 0.4 14.3 0.4 0.5 1.8 0.7 0.2 1.2 0.3 0.8 0.4 3.9 0.9 0.3 1.4 0.3 0.6 26.0 0.0 0.3 0.3 0.0 0.2 0.3 1.1 0.2 1.8 1.2 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.3 6.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 2.0 0.4 0.0 11.0 0.0 0.0 0.0 0.6 3.0 0.1 0.5 0.0 0.2 0.0 0.0 1.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 16.6 0.6 0.4 2.2 0.0 0.0 0.0 0.2 1.1 0.8 0.1 1.2 0.0 0.5 0.7 0.3 0.2 1.2 1.1 0.6 1.8 0.0 0.0 0.1 0.4 0.0 1.6 1.5 0.8 0.0 13.5 0.7 0.2 14.3 0.3 CALCR CTR ENSG00000004948 "Calcitonin receptor" 7 93424487-93574730 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;kidney: 7.5" "Group enriched" "Detected in some" 6 "MCF7: 2.6;RPTEC TERT1: 4.5;T-47d: 8.6" "Cancer enriched" "Detected in single" 5 "renal cancer: 1.1" "Region enhanced" "Detected in many" "hypothalamus: 10.8" "Cell type enhanced" "Detected in single" "classical monocyte: 1.1" "Lineage enhanced" "Detected in single" "monocytes: 1.1" "Group enriched" "Detected in some" 5 "basal ganglia: 6.7;hypothalamus: 28.7" "Low region specificity" "Detected in all" "HPA028962, HPA061428" Enhanced Supported "HPA028962: AB_10602339, HPA061428: AB_2732661" "unprognostic (1.95e-1)" "unprognostic (2.43e-1)" "unprognostic (3.88e-2)" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "unprognostic (3.43e-1)" "unprognostic (7.73e-5)" "unprognostic (1.64e-1)" "unprognostic (9.24e-3)" "unprognostic (8.70e-2)" "unprognostic (1.86e-2)" "unprognostic (6.68e-2)" "unprognostic (2.71e-3)" "unprognostic (1.46e-3)" "unprognostic (1.69e-1)" "unprognostic (2.49e-4)" "unprognostic (1.05e-2)" 0.3 0.7 1.4 0.0 2.1 0.0 1.3 0.1 1.5 0.5 0.2 0.0 0.0 0.1 0.1 0.5 0.3 0.1 0.4 0.4 2.1 10.8 7.5 0.1 0.9 0.0 0.8 0.0 0.7 0.1 0.3 3.2 2.1 5.9 0.1 0.2 0.2 1.4 0.0 3.7 0.1 0.2 0.3 2.5 0.1 0.1 2.3 0.7 0.0 0.1 2.5 0.7 0.1 0.1 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.2 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 2.1 0.1 1.5 2.1 10.8 0.8 0.0 5.9 0.7 CALHM1 FAM26C ENSG00000185933 "Calcium homeostasis modulator 1" Q8IU99 10 103453387-103458888 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.7;kidney: 2.4;lymphoid tissue: 2.0" "Cell line enhanced" "Detected in some" "RPMI-8226: 4.1;U-266/70: 4.3;U-266/84: 4.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA061816 Enhanced "HPA061816: " "unprognostic (2.46e-1)" "unprognostic (2.66e-1)" "unprognostic (2.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.65e-3)" "unprognostic (3.44e-2)" "unprognostic (2.86e-2)" "unprognostic (1.67e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.44e-1)" "unprognostic (2.21e-8)" "unprognostic (1.96e-1)" "unprognostic (1.37e-1)" "unprognostic (1.06e-1)" "unprognostic (1.38e-2)" 0.0 0.0 1.1 0.5 0.3 0.8 0.0 3.4 5.7 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.4 0.1 1.2 2.5 2.4 0.0 0.0 0.4 1.3 0.1 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.2 0.3 0.1 0.2 0.0 2.0 0.2 0.0 1.0 1.6 0.8 1.6 1.3 1.0 0.2 0.4 0.3 0.3 0.4 0.1 0.0 0.5 0.3 0.1 0.1 0.2 0.0 0.2 0.3 0.2 0.0 0.4 0.0 0.3 0.3 0.4 0.7 0.3 0.9 0.2 0.0 0.0 0.4 0.2 0.2 0.1 0.4 0.0 0.2 1.1 0.3 0.5 0.0 0.8 0.4 0.5 0.4 0.3 4.1 0.3 0.5 0.6 0.3 0.2 1.0 0.1 0.0 0.0 1.0 0.4 0.3 0.2 0.4 4.3 4.9 0.6 0.5 1.1 0.1 0.6 0.6 0.4 1.0 1.6 0.2 0.5 0.4 1.0 1.6 1.0 0.4 0.9 0.8 1.3 1.4 0.3 0.3 0.2 CALM1 "CALML2, CAMI, DD132, PHKD" ENSG00000198668 "Calmodulin 1" P0DP23 14 90396502-90408261 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 176.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB018558, HPA044999" Supported Approved Vesicles Vesicles "CAB018558: AB_2069454, HPA044999: " "unprognostic (5.35e-3)" "unprognostic (3.96e-1)" "unprognostic (4.99e-3)" "unprognostic (2.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.87e-2)" "unprognostic (1.99e-3)" "unprognostic (1.52e-1)" "unprognostic (6.44e-2)" "unprognostic (1.16e-3)" "prognostic favourable (5.62e-4)" "unprognostic (2.77e-1)" "prognostic favourable (6.49e-4)" "unprognostic (2.66e-1)" "unprognostic (2.68e-1)" "unprognostic (1.11e-2)" "prognostic unfavourable (2.38e-5)" 47.5 28.1 141.5 26.9 148.2 57.2 21.5 149.6 176.0 27.4 55.9 49.4 20.7 53.9 20.3 41.7 58.8 48.6 29.5 52.3 139.8 86.1 61.5 39.0 38.7 27.8 85.2 100.1 20.9 22.6 41.4 27.6 38.6 106.1 33.7 60.5 22.2 33.2 43.5 100.2 19.3 50.6 42.6 71.1 29.3 35.6 22.3 49.8 12.6 22.7 18.8 37.8 32.7 21.8 45.7 42.8 90.3 53.7 88.8 118.3 109.4 27.0 37.7 45.0 17.3 50.6 44.6 38.4 49.9 42.8 38.6 41.9 40.1 48.0 29.3 26.0 58.8 45.3 28.1 69.3 64.3 56.9 18.0 30.9 32.4 36.7 27.7 46.9 25.0 28.0 34.7 37.8 13.4 86.9 14.3 40.2 52.8 91.9 15.5 45.9 26.1 52.7 31.0 40.2 19.7 31.9 83.4 94.2 39.6 43.6 76.4 27.8 50.5 16.4 53.9 32.6 20.9 34.1 41.5 22.4 50.7 32.1 51.5 39.4 45.2 90.3 31.8 71.0 96.0 37.9 118.3 45.7 102.5 101.0 42.8 35.7 74.8 88.1 47.0 88.8 53.7 40.5 105.6 109.4 141.5 148.2 149.6 176.0 139.8 86.1 85.2 100.1 106.1 49.8 CALM3 PHKD ENSG00000160014 "Calmodulin 3" P0DP25 19 46601074-46610793 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 181.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA044999 Approved "HPA044999: " "unprognostic (3.39e-1)" "unprognostic (1.30e-1)" "unprognostic (5.81e-2)" "unprognostic (1.13e-1)" "unprognostic (9.81e-2)" "unprognostic (1.29e-2)" "unprognostic (2.39e-2)" "prognostic unfavourable (2.07e-4)" "unprognostic (4.01e-3)" "unprognostic (5.28e-2)" "unprognostic (1.67e-1)" "unprognostic (5.34e-2)" "unprognostic (2.72e-2)" "unprognostic (2.59e-1)" "unprognostic (1.07e-1)" "prognostic favourable (9.10e-4)" "unprognostic (2.72e-1)" 23.0 29.0 113.3 27.0 142.8 30.5 15.6 76.6 181.1 27.4 31.6 21.5 8.2 37.4 24.5 18.8 22.5 25.9 25.2 47.5 120.2 75.6 23.4 25.3 19.3 29.7 70.1 110.8 37.4 19.3 16.5 16.0 24.5 90.5 25.6 30.0 17.8 12.4 31.6 52.7 15.3 41.7 31.3 34.7 18.5 22.8 44.7 20.5 27.1 22.3 8.6 30.6 28.5 17.4 13.0 17.4 82.2 34.2 18.8 35.3 26.8 52.7 62.2 73.3 25.8 38.8 52.0 15.8 54.1 49.6 53.3 71.3 52.5 51.2 45.1 22.7 86.7 37.3 72.8 47.0 68.0 55.0 47.1 61.8 30.4 60.0 21.0 49.0 84.7 50.8 16.0 41.3 33.2 66.0 45.5 67.8 50.5 36.1 47.3 109.8 34.3 24.5 83.4 39.0 17.1 50.5 66.6 37.2 39.6 44.0 29.6 17.2 34.3 53.1 47.2 28.9 50.3 22.1 42.1 42.6 34.3 36.7 29.4 39.9 37.9 28.5 30.2 46.3 13.0 34.2 11.7 13.0 18.7 17.4 17.4 11.5 21.7 14.0 82.2 18.8 33.2 10.4 35.3 26.8 113.3 142.8 76.6 181.1 120.2 75.6 70.1 110.8 90.5 20.5 CALN1 CABP8 ENSG00000183166 "Calneuron 1" Q9BXU9 7 71779491-72447151 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.0;brain: 48.5;lymphoid tissue: 20.0" "Cell line enriched" "Detected in some" 6 "Karpas-707: 30.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036278, HPA036708" Approved Uncertain "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA036278: AB_10673125, HPA036708: " "unprognostic (6.38e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (1.32e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-2)" "unprognostic (3.67e-4)" "unprognostic (3.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.57e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (7.72e-4)" "unprognostic (2.99e-1)" 0.8 16.0 10.8 0.8 17.7 1.5 1.0 48.5 39.1 2.3 0.9 5.1 0.0 0.9 1.4 0.8 0.8 1.0 1.3 0.8 9.5 4.4 0.8 1.0 0.9 0.8 6.8 7.3 1.0 1.9 0.8 0.3 0.8 18.6 1.0 0.9 0.0 0.8 2.4 0.9 4.2 0.8 0.9 8.4 0.8 0.8 11.3 3.3 20.0 0.9 0.0 0.8 0.9 1.9 0.3 1.3 0.6 0.4 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 30.7 0.0 0.0 0.0 0.0 4.1 0.0 4.7 0.0 0.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 4.9 4.7 0.0 0.2 0.0 0.0 0.6 0.4 0.3 0.2 0.1 0.1 0.2 0.2 0.2 1.3 0.3 0.2 0.2 0.5 0.3 0.1 0.4 0.1 0.1 10.8 17.7 48.5 11.6 9.5 4.4 6.8 7.3 18.6 3.3 CALY "CALCYON, DRD1IP, NSG3" ENSG00000130643 "Calcyon neuron specific vesicular protein" Q9NYX4 10 133324072-133336935 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "adrenal gland: 26.5;brain: 98.9;pituitary gland: 47.7" "Cell line enhanced" "Detected in some" "SH-SY5Y: 2.7;U-266/70: 2.6" "Group enriched" "Detected in some" 14 "glioma: 1.7;pancreatic cancer: 7.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.3;naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042283 Enhanced "HPA042283: AB_10794417" "unprognostic (1.43e-2)" "unprognostic (7.84e-2)" "unprognostic (3.77e-3)" "unprognostic (1.41e-2)" "unprognostic (7.32e-2)" "unprognostic (9.81e-3)" "unprognostic (2.56e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "prognostic favourable (3.54e-4)" "unprognostic (1.23e-2)" "unprognostic (4.19e-10)" "unprognostic (8.04e-3)" "unprognostic (1.29e-1)" "unprognostic (3.60e-1)" "unprognostic (1.63e-1)" 1.8 26.5 27.1 2.7 57.4 1.8 1.8 12.7 67.1 1.7 2.6 3.6 0.0 5.0 1.7 1.9 1.8 2.0 1.8 1.7 31.8 98.9 1.7 1.7 1.9 2.0 25.1 39.8 1.7 6.3 1.7 47.7 1.7 33.9 1.8 2.4 0.7 2.1 2.0 1.7 1.9 3.8 2.1 14.3 1.9 4.1 4.3 4.8 0.0 1.9 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.1 0.8 0.3 0.0 0.0 0.0 0.3 0.6 0.6 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.8 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.3 0.0 0.1 2.6 0.0 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 27.1 57.4 12.7 45.9 31.8 98.9 25.1 39.8 33.9 4.8 CAMK1G "CLICKIII, dJ272L16.1, VWS1" ENSG00000008118 "Calcium/calmodulin dependent protein kinase IG" Q96NX5 1 209583717-209613938 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 34.4;ovary: 29.2" "Cell line enhanced" "Detected in some" "BJ: 2.0;hTEC/SVTERT24-B: 12.1;NTERA-2: 1.9;SK-MEL-30: 3.6;U-138 MG: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (5.17e-2)" "unprognostic (9.64e-2)" "unprognostic (1.73e-1)" "unprognostic (1.49e-3)" "unprognostic (2.56e-2)" "unprognostic (1.93e-1)" "unprognostic (6.79e-2)" "unprognostic (3.98e-1)" "unprognostic (3.59e-3)" "unprognostic (8.55e-3)" "unprognostic (3.17e-2)" "unprognostic (1.14e-2)" "unprognostic (4.25e-2)" "unprognostic (1.75e-1)" "unprognostic (2.27e-1)" "unprognostic (9.10e-2)" "unprognostic (3.43e-2)" 0.7 3.5 7.5 0.9 34.4 1.0 0.7 1.3 27.8 1.1 0.8 0.7 1.2 0.8 1.8 6.1 0.6 0.9 1.5 0.6 10.9 9.2 6.9 0.9 1.2 0.8 3.6 17.7 29.2 1.3 0.6 2.0 2.8 3.9 4.6 0.8 0.6 0.6 7.4 0.6 0.6 0.8 2.3 0.9 6.1 0.7 1.4 2.7 0.0 0.7 0.0 0.8 1.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 2.0 0.3 0.8 0.3 0.0 0.2 0.0 0.0 0.8 0.2 0.0 0.0 1.3 0.6 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 12.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.2 2.1 0.2 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 34.4 1.3 27.8 10.9 9.2 3.6 17.7 3.9 2.7 CAMK2A "CAMKA, CaMKIINalpha, KIAA0968" ENSG00000070808 "Calcium/calmodulin dependent protein kinase II alpha" Q9UQM7 5 150219491-150290291 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "brain: 105.7;skeletal muscle: 50.1" "Cell line enhanced" "Detected in some" "HaCaT: 2.6;SCLC-21H: 9.5;U-87 MG: 8.0" "Cancer enriched" "Detected in single" 13 "glioma: 6.0" "Group enriched" "Detected in all" 6 "amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1" "Low region specificity" "Detected in all" "CAB004330, HPA051783, HPA051785, HPA053973" Supported Approved "Plasma membrane,Cell Junctions,Cytosol" 21000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB004330: AB_626788, HPA051783: , HPA051785: , HPA053973: " "unprognostic (7.20e-3)" "unprognostic (6.47e-3)" "unprognostic (6.16e-3)" "unprognostic (4.85e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-3)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (3.07e-1)" "unprognostic (1.05e-1)" "unprognostic (4.49e-2)" "unprognostic (1.41e-2)" "unprognostic (2.00e-8)" "unprognostic (2.71e-4)" "unprognostic (1.68e-1)" "unprognostic (1.70e-2)" "unprognostic (1.36e-3)" 1.3 1.7 60.7 1.3 50.6 1.3 1.1 1.4 105.7 1.8 1.3 3.7 0.0 1.2 2.1 1.4 1.9 1.7 1.3 3.7 74.6 10.5 1.6 1.2 1.5 1.2 5.1 39.8 1.3 1.1 1.1 0.4 1.3 2.4 1.6 1.3 0.0 1.2 1.4 50.1 1.6 1.3 2.5 1.7 1.2 1.3 1.2 2.3 0.0 1.2 0.0 1.1 1.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.6 0.0 0.5 1.3 0.8 0.7 0.0 0.1 0.0 0.2 0.6 2.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 0.5 0.2 1.7 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.0 9.5 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 8.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 60.7 50.6 1.4 99.6 74.6 10.5 5.1 39.8 2.4 2.3 CAMK2B "CAM2, CAMK2, CAMKB" ENSG00000058404 "Calcium/calmodulin dependent protein kinase II beta" Q13554 7 44217150-44334577 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 41.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006849, HPA026307, HPA051783, HPA051785, HPA053973" Enhanced Supported Supported "Plasma membrane,Cell Junctions,Cytosol" 680000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB006849: , HPA026307: AB_1845941, HPA051783: , HPA051785: , HPA053973: " "unprognostic (1.88e-3)" "unprognostic (4.49e-2)" "unprognostic (3.55e-3)" "unprognostic (1.36e-2)" "unprognostic (5.25e-2)" "unprognostic (2.90e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-1)" "unprognostic (1.17e-2)" "unprognostic (1.60e-2)" "unprognostic (5.23e-7)" "unprognostic (7.04e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (3.95e-2)" 1.4 8.1 20.6 1.4 46.7 1.2 2.0 60.1 81.9 1.2 1.4 4.0 0.7 1.7 1.3 18.8 2.0 1.8 1.2 39.2 36.5 18.0 1.7 3.5 1.2 1.8 10.3 21.3 1.1 3.3 5.6 9.9 1.1 13.4 3.0 1.4 2.7 1.8 2.2 70.7 1.8 1.6 1.2 4.1 1.3 2.4 2.3 4.8 0.0 7.7 2.4 2.0 1.1 0.0 1.3 1.0 3.2 1.2 3.2 1.2 0.8 0.0 0.3 0.2 0.3 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.8 0.2 0.1 0.2 0.7 0.0 1.0 2.4 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 5.2 0.0 0.2 0.1 2.3 0.1 0.9 0.1 0.0 0.0 41.0 2.2 0.2 0.0 0.0 1.9 0.1 0.2 0.2 0.3 0.2 0.0 0.5 0.4 0.1 0.1 0.0 0.2 3.2 0.7 1.0 0.8 0.9 1.2 1.1 1.0 0.5 0.5 1.3 1.2 1.1 2.0 3.2 1.2 1.0 0.9 0.8 20.6 46.7 60.1 42.4 36.5 18.0 10.3 21.3 13.4 4.8 CAMK2N1 CaMKIINalpha ENSG00000162545 "Calcium/calmodulin dependent protein kinase II inhibitor 1" Q7Z7J9 1 20482391-20486220 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 128.2" "Cell line enhanced" "Detected in many" "AN3-CA: 49.9;CAPAN-2: 46.6;Hep G2: 37.6;SK-BR-3: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 4.4" "Group enriched" "Detected in many" 15 "B-cells: 1.5;T-cells: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075200 Approved "HPA075200: " "unprognostic (1.67e-1)" "unprognostic (2.70e-3)" "unprognostic (9.71e-3)" "unprognostic (3.13e-1)" "unprognostic (6.89e-3)" "prognostic unfavourable (1.37e-7)" "prognostic unfavourable (5.49e-4)" "prognostic unfavourable (1.66e-4)" "unprognostic (4.77e-2)" "unprognostic (1.31e-1)" "unprognostic (7.48e-3)" "unprognostic (1.93e-2)" "unprognostic (1.40e-3)" "unprognostic (4.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.96e-2)" "unprognostic (1.31e-2)" 4.9 30.8 128.2 4.8 50.1 1.0 10.7 12.4 120.1 9.1 40.3 26.9 5.9 38.0 11.8 19.7 12.2 5.1 13.8 5.9 76.6 39.3 37.8 25.6 18.7 1.6 42.1 71.0 11.0 4.9 9.3 9.6 6.2 27.6 15.1 37.6 2.2 14.4 21.4 3.7 3.0 40.4 12.0 44.3 6.1 7.3 2.9 28.8 0.0 2.9 0.1 4.0 9.6 5.7 1.5 0.0 0.2 0.0 0.0 4.4 0.2 14.2 4.1 3.5 49.9 6.9 12.9 0.5 12.2 27.9 2.2 1.1 4.6 46.6 1.4 3.5 5.0 24.0 1.0 20.9 1.4 2.6 0.9 0.3 0.2 37.6 7.6 0.0 1.4 2.0 9.8 1.3 5.1 3.8 1.4 0.1 24.8 3.9 0.0 0.1 0.6 0.9 1.2 2.2 0.0 14.0 21.6 13.7 3.8 6.6 37.7 3.5 7.2 0.1 1.1 8.4 10.9 11.5 4.8 0.0 0.0 0.5 28.6 3.1 5.1 0.0 0.0 0.0 4.4 0.0 3.2 1.5 1.6 1.2 0.0 0.1 0.8 1.2 0.2 0.0 0.0 0.0 0.0 0.2 128.2 50.1 12.4 120.1 76.6 39.3 42.1 71.0 27.6 28.8 CAMK2N2 CaM-KIIN ENSG00000163888 "Calcium/calmodulin dependent protein kinase II inhibitor 2" Q96S95 3 184259213-184261463 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5" "Cell line enhanced" "Detected in many" "REH: 18.7;SCLC-21H: 19.6;U-138 MG: 20.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050835, HPA075200" Approved Supported Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA050835: , HPA075200: " "unprognostic (7.28e-2)" "prognostic favourable (9.77e-4)" "unprognostic (1.24e-1)" "unprognostic (4.69e-2)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (2.20e-1)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (4.21e-2)" "unprognostic (5.98e-2)" "unprognostic (9.72e-3)" "unprognostic (5.17e-9)" "unprognostic (3.47e-1)" "unprognostic (2.39e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-3)" 1.3 14.2 22.2 1.3 9.6 1.1 1.3 29.7 38.3 1.3 1.3 3.2 0.0 1.4 1.2 1.2 1.2 1.3 1.3 1.2 12.3 32.7 1.3 1.7 1.2 1.2 18.0 8.2 1.1 37.0 2.0 12.5 1.3 25.1 1.4 1.3 1.1 1.2 1.4 1.1 1.2 1.4 1.4 9.3 1.2 1.7 1.3 4.5 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.5 0.0 0.2 0.0 0.3 0.0 11.1 0.2 1.4 0.6 0.4 0.4 1.0 0.3 4.1 2.6 2.7 0.4 0.5 0.4 2.7 0.2 1.4 0.7 0.4 1.5 9.1 0.4 0.3 0.2 0.4 0.1 0.2 1.4 0.3 0.6 0.4 1.9 0.0 0.0 3.3 0.4 5.9 0.1 0.1 7.9 3.6 18.7 5.4 1.5 0.6 2.1 19.6 4.2 1.8 0.5 0.1 6.0 0.1 0.0 20.4 8.9 1.9 3.3 2.2 3.3 2.7 4.7 1.1 1.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 22.2 9.6 29.7 38.3 12.3 32.7 18.0 8.2 25.1 4.5 CAMK4 CaMK-GR ENSG00000152495 "Calcium/calmodulin dependent protein kinase IV" Q16566 5 111223653-111494886 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Inflammatory response" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.9;lymphoid tissue: 71.7" "Cell line enhanced" "Detected in many" "HDLM-2: 41.2;MOLT-4: 12.6;SH-SY5Y: 16.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 14.1;memory CD4 T-cell: 10.3;memory CD8 T-cell: 7.8;naive CD4 T-cell: 19.8;naive CD8 T-cell: 10.9;T-reg: 11.3" "Lineage enriched" "Detected in single" 26 "T-cells: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004347, HPA011753, HPA017206" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949" "unprognostic (2.99e-5)" "unprognostic (7.19e-2)" "unprognostic (3.43e-3)" "unprognostic (5.11e-2)" "unprognostic (4.75e-3)" "unprognostic (3.48e-2)" "unprognostic (7.66e-4)" "unprognostic (7.22e-3)" "unprognostic (2.49e-1)" "unprognostic (2.92e-1)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (2.23e-5)" "unprognostic (2.42e-2)" "unprognostic (3.01e-2)" "unprognostic (1.66e-1)" "unprognostic (9.99e-3)" 1.1 6.5 9.5 6.4 34.2 4.6 1.0 48.9 16.5 1.8 2.3 1.0 0.0 2.4 1.3 0.8 1.4 0.9 2.7 0.9 5.9 3.2 1.4 2.5 1.9 12.0 2.3 6.8 1.4 0.9 0.3 1.3 0.6 3.4 5.8 2.5 0.1 1.7 2.6 0.8 0.9 3.8 1.5 2.0 4.2 2.6 13.8 6.6 71.7 1.0 0.0 8.1 2.8 1.1 0.7 0.0 0.4 0.0 0.6 19.8 3.4 0.0 0.0 1.4 1.0 0.3 1.1 0.0 0.3 3.2 3.8 3.7 0.0 0.0 0.0 2.0 0.1 0.1 3.1 0.3 2.8 41.2 2.6 0.6 1.3 0.0 0.1 0.2 0.1 0.1 0.0 8.0 0.8 0.6 0.0 1.5 0.2 0.0 12.6 0.0 1.9 0.1 1.9 2.4 0.1 1.4 0.0 9.1 16.1 0.5 0.0 2.7 0.0 0.2 0.0 7.8 4.6 0.0 6.9 1.3 0.1 0.0 3.8 0.0 3.0 0.0 0.0 0.0 2.8 0.0 14.1 0.7 10.3 7.8 0.0 0.2 19.8 10.9 0.4 0.6 0.0 0.0 11.3 3.4 9.5 34.2 48.9 15.1 5.9 3.2 2.3 6.8 3.4 6.6 CAMKK1 "CAMKKA, DKFZp761M0423, MGC34095" ENSG00000004660 "Calcium/calmodulin dependent protein kinase kinase 1" Q8N5S9 17 3860315-3894891 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.9;salivary gland: 27.1" "Cell line enhanced" "Detected in many" "HeLa: 17.8;U-87 MG: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009111, HPA028062" Approved Supported Cytosol Cytosol "CAB009111: AB_2068406, HPA028062: AB_1845954" "unprognostic (1.39e-2)" "unprognostic (2.13e-1)" "unprognostic (8.66e-3)" "unprognostic (4.40e-3)" "unprognostic (2.94e-3)" "unprognostic (4.79e-2)" "unprognostic (1.98e-1)" "unprognostic (4.47e-3)" "unprognostic (8.23e-2)" "unprognostic (1.03e-2)" "prognostic favourable (2.65e-4)" "unprognostic (1.98e-1)" "unprognostic (1.59e-1)" "unprognostic (7.19e-2)" "unprognostic (8.70e-2)" "unprognostic (8.36e-2)" "unprognostic (3.10e-1)" 4.3 10.2 15.3 5.1 21.4 3.7 4.7 23.2 38.9 4.1 3.2 2.2 4.0 3.1 7.5 5.2 4.2 3.7 3.8 5.7 13.8 6.8 1.5 1.0 4.0 2.5 5.5 16.0 6.0 7.5 5.0 10.1 2.3 11.2 3.3 3.1 2.5 27.1 11.2 2.2 7.8 3.7 6.2 2.2 4.3 2.9 6.1 5.0 1.7 7.2 2.3 2.5 5.6 4.9 0.1 1.6 5.6 4.1 0.0 1.0 1.1 4.8 8.4 0.9 4.2 3.0 5.4 0.3 3.4 3.7 3.2 1.5 3.0 1.5 2.9 3.6 6.4 14.5 2.3 4.1 2.0 0.1 7.7 3.3 17.8 1.1 3.1 0.5 2.6 4.1 3.5 6.1 2.1 1.4 2.6 0.1 1.6 1.3 4.0 1.9 0.9 7.9 2.1 3.7 3.4 3.5 3.1 4.9 2.7 1.3 10.0 2.2 3.8 1.1 2.0 5.6 7.6 7.1 2.7 0.4 0.2 0.1 20.5 2.8 0.7 0.0 1.8 3.6 0.6 3.9 1.0 0.0 0.6 0.5 1.6 0.1 0.6 0.3 5.6 0.0 4.1 0.8 0.0 1.1 15.3 21.4 23.2 38.9 13.8 6.8 5.5 16.0 11.2 5.0 CAMKK2 "CAMKK, CAMKKB, KIAA0787, MGC15254" ENSG00000110931 "Calcium/calmodulin dependent protein kinase kinase 2" Q96RR4 12 121237691-121298308 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 125.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 125.5" "Group enriched" "Detected in many" 5 "classical monocyte: 14.2;eosinophil: 26.1;intermediate monocyte: 19.4;myeloid DC: 7.2;neutrophil: 17.2;non-classical monocyte: 16.5" "Group enriched" "Detected in all" 5 "dendritic cells: 7.2;granulocytes: 26.1;monocytes: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017389, HPA063713" Approved Supported Supported Cytosol Cytosol "HPA017389: AB_1845956, HPA063713: " "unprognostic (5.08e-2)" "unprognostic (1.81e-1)" "unprognostic (1.38e-1)" "unprognostic (3.08e-1)" "unprognostic (1.88e-1)" "unprognostic (1.12e-1)" "unprognostic (2.62e-3)" "unprognostic (2.80e-2)" "unprognostic (1.93e-1)" "unprognostic (7.76e-2)" "unprognostic (5.01e-2)" "unprognostic (1.70e-1)" "unprognostic (1.75e-1)" "unprognostic (4.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.67e-1)" "unprognostic (1.38e-1)" 11.7 6.5 19.7 7.8 30.2 13.8 8.8 125.5 45.5 9.0 9.5 7.1 2.6 12.8 8.6 5.3 8.3 11.8 6.3 6.9 11.2 5.1 7.1 8.9 9.6 6.9 6.2 17.3 10.5 5.8 6.4 4.1 7.5 9.1 12.2 9.7 6.2 7.5 13.2 5.1 9.1 13.2 10.3 6.2 14.1 7.6 3.6 5.8 5.2 6.1 4.5 7.2 7.2 7.4 2.2 7.2 26.1 19.4 3.6 2.2 6.3 12.3 9.3 6.9 13.4 20.8 19.4 10.6 10.2 10.9 8.4 7.7 9.7 5.3 19.1 8.6 20.7 10.2 8.5 11.0 6.6 13.1 16.7 9.5 6.2 9.5 14.1 21.6 9.1 12.5 16.4 7.9 18.0 19.6 11.0 10.4 8.1 12.0 23.9 17.8 5.0 10.5 15.6 8.0 16.9 8.1 13.8 26.6 10.6 13.4 7.2 8.5 17.9 26.4 14.3 6.9 5.6 5.8 5.6 39.7 23.6 14.5 12.9 15.1 6.8 0.7 14.2 26.1 2.1 19.4 2.2 2.2 1.7 1.9 7.2 1.2 1.5 1.7 17.2 3.6 16.5 1.6 1.3 6.3 19.7 30.2 125.5 45.5 11.2 5.1 6.2 17.3 9.1 5.8 CAMKV "MGC8407, VACAMKL" ENSG00000164076 "CaM kinase like vesicle associated" Q8NCB2 3 49857988-49870222 "Enzymes, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 36 "brain: 77.2" "Cell line enhanced" "Detected in some" "AF22: 5.2;HAP1: 6.9;NTERA-2: 24.6;RPMI-8226: 4.7;SCLC-21H: 8.4;SH-SY5Y: 5.4" "Group enriched" "Detected in some" 11 "glioma: 4.0;testis cancer: 5.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007656, CAB034931" Enhanced Supported Approved "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "CAB034931: AB_2068550, HPA007656: AB_1078391" "unprognostic (9.47e-4)" "unprognostic (5.65e-3)" "unprognostic (1.42e-1)" "unprognostic (2.70e-7)" "unprognostic (2.76e-1)" "unprognostic (7.95e-4)" "unprognostic (3.09e-2)" "unprognostic (2.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (8.11e-2)" "unprognostic (1.00e-3)" "unprognostic (7.61e-2)" "unprognostic (9.51e-2)" "unprognostic (1.67e-3)" 1.2 2.1 20.7 1.2 77.2 1.2 1.2 0.5 62.8 1.2 1.2 1.7 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 33.4 11.7 1.2 1.2 1.2 1.2 3.3 23.5 1.2 1.2 1.2 1.8 1.2 2.1 1.2 1.2 0.0 1.2 1.2 1.2 1.3 1.2 1.2 1.9 1.2 1.3 2.1 6.0 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 5.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.7 0.1 24.6 0.1 0.7 0.0 4.7 0.0 0.0 8.4 5.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 20.7 77.2 0.5 34.0 33.4 11.7 3.3 23.5 2.1 6.0 CAMTA2 KIAA0909 ENSG00000108509 "Calmodulin binding transcription activator 2" O94983 17 4967992-4987652 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051147 Approved "Nucleoplasm,Actin filaments,Mitochondria" Nucleoplasm "Actin filaments, Mitochondria" "HPA051147: " "unprognostic (2.82e-1)" "unprognostic (3.06e-1)" "unprognostic (1.11e-2)" "unprognostic (1.01e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (2.78e-2)" "unprognostic (7.08e-2)" "prognostic favourable (6.00e-8)" "unprognostic (3.42e-2)" "unprognostic (9.02e-2)" "unprognostic (3.73e-2)" "unprognostic (1.20e-1)" "unprognostic (4.56e-2)" "unprognostic (1.19e-1)" 9.8 6.4 27.0 9.2 25.2 6.4 5.4 63.6 44.9 6.2 8.0 6.4 3.8 7.3 6.2 3.1 8.4 6.8 6.1 8.0 33.8 17.4 5.5 4.2 8.8 6.2 11.7 19.1 6.7 11.7 14.8 21.3 5.1 18.5 6.8 8.0 5.5 8.7 9.1 20.1 8.6 9.0 10.5 6.5 8.7 8.0 9.0 8.8 2.7 6.5 2.9 6.5 6.5 4.7 1.3 2.2 5.7 8.1 1.1 2.7 2.1 7.8 14.1 2.6 3.7 17.7 12.4 5.4 7.7 8.5 7.2 6.4 3.5 2.1 9.3 7.5 11.9 8.0 10.0 11.9 4.1 13.0 12.9 5.9 7.6 3.9 10.2 3.4 25.2 8.5 15.0 6.8 10.8 12.1 9.5 8.5 6.8 5.2 6.0 2.2 0.4 5.8 5.3 3.0 3.6 8.2 8.3 3.7 3.2 4.8 8.8 2.3 7.8 3.4 16.0 5.8 3.4 6.0 12.4 4.3 4.6 3.3 14.1 6.9 5.6 1.0 2.2 1.8 2.7 3.0 2.1 1.3 1.2 2.5 1.4 0.9 1.8 2.0 5.7 1.1 8.1 2.2 1.1 2.1 27.0 25.2 63.6 44.9 33.8 17.4 11.7 19.1 18.5 8.8 CAPN3 "CANP3, LGMD2, LGMD2A, nCL-1, p94" ENSG00000092529 "Calpain 3" P20807 15 42359500-42412318 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 65.6;skeletal muscle: 210.9" "Cell line enriched" "Detected in some" 23 "SK-MEL-30: 75.1" "Cancer enriched" "Detected in some" 10 "melanoma: 9.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040052 Enhanced "HPA040052: " "unprognostic (1.06e-2)" "unprognostic (1.31e-1)" "unprognostic (4.00e-2)" "unprognostic (8.71e-2)" "unprognostic (1.53e-1)" "unprognostic (1.72e-2)" "unprognostic (2.11e-4)" "unprognostic (3.12e-3)" "unprognostic (2.82e-1)" "unprognostic (2.47e-1)" "unprognostic (2.37e-3)" "unprognostic (3.26e-2)" "unprognostic (3.91e-4)" "unprognostic (5.56e-3)" "unprognostic (2.43e-1)" "unprognostic (8.93e-3)" "unprognostic (1.38e-1)" 5.7 1.8 13.0 2.3 32.1 16.7 3.8 3.1 22.9 2.1 2.4 65.6 0.0 2.2 3.1 47.0 4.2 2.5 3.0 3.6 19.9 11.5 22.1 6.3 6.7 3.4 50.7 19.5 3.1 1.4 3.4 1.7 2.0 39.0 3.0 3.2 5.0 3.1 3.1 210.9 19.7 2.3 2.8 52.6 3.3 2.1 4.1 47.3 0.0 1.6 27.6 3.0 2.7 2.3 1.5 1.7 0.9 2.6 1.3 3.2 1.4 0.1 0.2 0.2 0.3 3.2 3.1 0.3 1.2 0.7 0.1 0.2 0.3 0.2 0.0 0.4 0.6 1.8 0.1 1.3 0.1 0.3 0.3 0.2 0.4 1.0 0.1 0.5 0.6 2.1 1.9 0.2 0.5 0.0 0.0 0.9 0.1 0.0 0.0 0.5 0.1 0.2 0.5 0.0 0.7 0.8 0.5 0.0 0.0 0.0 0.1 75.1 0.0 1.7 0.3 0.0 0.1 1.6 0.2 0.4 0.7 0.0 0.2 0.9 0.7 0.0 2.6 0.0 2.8 0.6 2.8 0.4 0.3 1.0 1.7 1.5 0.2 3.2 0.9 1.3 0.2 1.6 1.3 1.4 13.0 32.1 3.1 22.9 19.9 11.5 50.7 19.5 39.0 47.3 CAPS "CAPS1, MGC126562" ENSG00000105519 Calcyphosine 19 5911707-5915877 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4;fallopian tube: 116.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 36.0;U-266/70: 10.0" "Cancer enriched" "Detected in all" 5 "endometrial cancer: 171.3" "Region enhanced" "Detected in all" "pons and medulla: 71.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043520 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA043520: AB_10964138" "unprognostic (2.06e-1)" "unprognostic (1.13e-2)" "unprognostic (7.94e-3)" "prognostic favourable (7.63e-5)" "unprognostic (5.18e-1)" "prognostic favourable (8.60e-4)" "unprognostic (7.07e-2)" "unprognostic (2.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (9.99e-2)" "unprognostic (4.01e-2)" "unprognostic (8.47e-2)" "unprognostic (3.25e-1)" "unprognostic (6.86e-3)" "unprognostic (5.96e-3)" 2.6 4.1 8.0 4.3 14.7 4.3 2.8 1.4 3.3 12.4 3.3 34.4 15.6 3.1 9.1 49.4 2.8 116.0 13.6 2.0 13.4 6.6 8.9 5.0 25.4 4.4 8.0 7.8 26.7 6.5 2.5 7.5 17.7 71.4 9.4 2.0 3.3 7.7 12.7 2.0 5.7 5.0 2.9 7.5 7.6 9.4 2.1 17.9 0.4 7.8 0.9 2.5 8.8 11.3 4.9 4.0 5.2 2.2 5.3 4.8 2.4 1.0 1.1 0.7 3.4 1.3 1.8 2.1 0.5 0.4 0.2 0.3 0.8 7.4 0.8 2.2 0.9 1.3 0.3 0.3 0.1 2.4 1.0 0.6 2.2 2.0 1.2 0.6 1.8 2.2 2.1 0.2 0.5 0.5 0.5 2.9 0.4 2.1 1.4 2.0 0.6 5.6 1.7 0.3 2.3 1.0 3.1 0.7 2.5 0.5 36.0 3.6 2.2 2.3 1.0 0.6 0.4 2.6 9.5 10.0 3.4 0.6 4.2 1.0 1.4 3.3 2.2 1.6 4.8 1.8 2.6 3.1 3.0 3.6 2.1 4.9 2.4 2.0 5.2 5.3 1.6 4.0 3.2 2.4 8.0 14.7 1.4 3.3 13.4 6.6 8.0 7.8 71.4 17.9 CAPSL MGC26610 ENSG00000152611 "Calcyphosine like" Q8WWF8 5 35904295-35938779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 34.9;epididymis: 18.3;fallopian tube: 59.4" "Group enriched" "Detected in some" 4 "BJ hTERT+ SV40 Large T+: 7.3;BJ hTERT+ SV40 Large T+ RasG12V: 6.2;HBF TERT88: 4.8;REH: 7.6;U-698: 18.6" "Group enriched" "Detected in many" 5 "endometrial cancer: 14.1;ovarian cancer: 3.4" "Region enriched" "Detected in many" 7 "pons and medulla: 34.9" "Cell type enriched" "Detected in single" 13 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046811, HPA058495" Enhanced Approved Nucleoplasm,Microtubules "Nucleoplasm, Microtubules" "HPA046811: AB_2679819, HPA058495: AB_2683735" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (2.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.20e-2)" "unprognostic (7.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-3)" "unprognostic (4.42e-1)" "unprognostic (3.62e-4)" "unprognostic (1.46e-1)" "unprognostic (1.36e-2)" "unprognostic (1.52e-1)" 0.1 0.2 3.6 0.1 4.4 0.2 0.2 0.0 0.5 2.4 0.1 4.3 0.4 0.1 1.3 18.3 0.2 59.4 0.2 0.2 5.2 5.3 0.7 0.1 11.8 0.1 0.3 0.0 6.7 0.4 0.1 17.0 0.2 34.9 0.2 0.1 0.0 0.4 0.4 0.2 0.2 0.1 0.2 0.8 0.1 0.2 5.4 0.5 0.5 3.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 7.3 6.2 0.0 0.0 2.1 0.0 0.9 0.0 0.1 0.0 4.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 1.3 0.0 0.0 1.2 2.2 0.0 0.5 0.0 0.0 18.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.6 4.4 0.0 0.3 5.2 5.3 0.3 0.0 34.9 0.5 CARMIL3 "BC008134, C14orf121, crml-1, LRRC16B" ENSG00000186648 "Capping protein regulator and myosin 1 linker 3" Q8ND23 14 24052000-24069728 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 30.6;pituitary gland: 7.8;skin 1: 9.4" "Cell line enhanced" "Detected in some" "Daudi: 8.2;HMC-1: 5.8;Karpas-707: 5.2;SCLC-21H: 8.5;SH-SY5Y: 4.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030596 Uncertain "HPA030596: AB_10603012" "unprognostic (2.67e-2)" "unprognostic (2.07e-3)" "unprognostic (1.50e-1)" "unprognostic (3.09e-2)" "unprognostic (6.17e-2)" "unprognostic (1.29e-4)" "unprognostic (6.13e-2)" "unprognostic (8.92e-4)" "unprognostic (4.02e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-4)" "unprognostic (4.49e-2)" "unprognostic (1.17e-1)" "unprognostic (7.01e-2)" "unprognostic (1.25e-2)" "unprognostic (4.19e-1)" "unprognostic (2.16e-1)" 0.6 1.6 6.5 1.4 5.2 1.0 0.8 30.6 7.9 0.6 0.9 3.3 0.0 2.3 0.6 0.5 1.0 0.6 1.6 0.4 7.4 5.2 1.0 0.8 0.9 1.4 2.8 2.4 0.6 1.3 0.5 7.8 0.5 7.2 0.8 1.0 1.7 1.6 0.7 0.5 9.4 1.6 0.7 2.9 1.0 1.2 3.1 2.8 0.0 1.0 0.0 2.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.1 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.1 0.3 0.0 0.0 1.3 0.0 0.1 0.1 0.1 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.3 1.2 0.0 0.5 0.1 0.6 0.0 0.0 0.0 0.0 8.5 4.2 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 5.2 30.6 7.7 7.4 5.2 2.8 2.4 7.2 2.8 CARNS1 "ATPGD1, KIAA1394" ENSG00000172508 "Carnosine synthase 1" A5YM72 11 67414968-67425607 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 14 "brain: 88.7;skeletal muscle: 64.8" "Cell line enriched" "Detected in some" 12 "RPMI-8226: 12.8" "Group enriched" "Detected in many" 5 "glioma: 4.1;thyroid cancer: 10.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 20 "B-cells: 1.9;NK-cells: 1.3;T-cells: 3.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA038569 Enhanced "Intracellular and membrane" "HPA038569: " "unprognostic (1.07e-4)" "unprognostic (4.33e-3)" "unprognostic (2.00e-2)" "unprognostic (6.15e-2)" "unprognostic (9.45e-2)" "unprognostic (1.05e-1)" "unprognostic (7.28e-2)" "unprognostic (7.54e-3)" "unprognostic (1.29e-1)" "unprognostic (1.82e-1)" "unprognostic (5.19e-3)" "unprognostic (1.00e-1)" "unprognostic (6.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (3.83e-3)" "unprognostic (8.33e-2)" 2.9 1.3 9.2 1.5 24.3 1.5 1.2 3.0 23.9 1.3 1.4 88.7 0.0 1.5 1.2 2.5 2.0 1.5 1.6 5.3 19.7 10.2 1.2 1.3 1.5 2.1 36.9 14.5 1.4 1.6 2.0 0.4 1.1 30.6 1.8 1.3 0.0 1.3 1.3 64.8 1.3 1.9 1.3 51.1 1.8 2.1 1.1 28.1 0.0 2.3 0.9 1.6 1.1 0.3 1.9 0.1 0.0 0.0 1.3 3.2 0.9 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.2 0.3 0.5 0.7 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.8 0.0 0.2 0.0 0.0 0.1 0.4 0.1 0.1 1.0 0.6 0.2 0.0 0.1 0.1 12.8 0.0 0.0 0.1 0.2 0.1 0.8 0.1 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.9 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 2.9 0.0 1.4 1.7 1.0 3.1 0.1 1.9 1.3 3.2 0.0 1.3 0.0 0.0 0.7 0.9 9.2 24.3 3.0 22.2 19.7 10.2 36.9 14.5 30.6 28.1 CARTPT CART ENSG00000164326 "CART prepropeptide" Q16568 5 71719163-71721048 "FDA approved drug targets, Predicted secreted proteins" "Neuropeptide, Neurotransmitter" "FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "adrenal gland: 67.5;brain: 101.4" "Group enriched" "Detected in some" 7 "NB-4: 1.0;SH-SY5Y: 3.4" "Cancer enriched" "Detected in many" 9 "breast cancer: 117.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 179.9" "CAB025515, HPA046278, CAB079776" Enhanced Supported "Secreted to blood" "CAB025515: , CAB079776: , HPA046278: AB_10961570" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (2.27e-1)" "unprognostic (3.45e-2)" "unprognostic (6.67e-2)" "prognostic unfavourable (4.36e-4)" "unprognostic (1.14e-1)" 1.6 67.5 8.0 2.8 22.3 0.5 5.8 0.1 29.0 0.5 3.4 2.1 0.0 3.5 0.6 0.9 3.5 0.7 0.6 0.5 31.1 101.4 0.5 0.5 0.5 0.5 1.0 4.5 0.5 5.3 0.5 1.7 0.5 54.1 3.3 3.1 1.6 0.5 0.5 0.5 0.5 1.4 8.1 8.6 0.5 3.4 1.9 9.7 0.0 3.4 0.0 0.5 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 22.3 0.1 29.0 31.1 101.4 1.0 4.5 54.1 9.7 CASC10 "bA418C1.3, C10orf114" ENSG00000204682 "Cancer susceptibility 10" Q5T4H9 10 21492658-21497262 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;liver: 13.6" "Cell line enhanced" "Detected in many" "A549: 10.1;AF22: 10.2;AN3-CA: 14.1;BEWO: 13.6;SK-BR-3: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" HPA064131 Uncertain Approved Nucleoplasm Nucleoplasm "HPA064131: " "unprognostic (2.69e-2)" "unprognostic (1.46e-2)" "unprognostic (5.37e-3)" "unprognostic (1.87e-3)" "prognostic unfavourable (8.87e-4)" "unprognostic (3.22e-2)" "unprognostic (1.34e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.00e-1)" "unprognostic (8.55e-2)" "unprognostic (1.85e-1)" "unprognostic (4.04e-3)" "unprognostic (1.09e-3)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "prognostic unfavourable (5.86e-4)" 1.8 2.6 8.9 0.9 6.2 0.9 0.9 2.0 8.0 2.5 0.8 6.1 0.1 1.0 1.3 1.1 1.2 2.4 1.7 3.8 11.8 3.8 6.3 13.6 1.5 1.3 3.3 4.2 2.6 1.3 3.7 3.3 7.2 2.7 1.9 0.7 2.0 1.0 1.8 5.0 3.3 0.9 1.5 2.2 0.8 0.9 2.6 5.3 0.1 5.6 0.0 0.8 2.3 1.6 0.6 0.4 2.2 0.3 1.0 0.4 0.2 1.7 10.1 10.2 14.1 1.9 1.0 13.6 0.9 0.4 0.1 0.2 1.5 3.5 0.5 1.5 0.8 2.2 1.8 0.5 0.1 0.3 1.9 0.1 1.4 2.3 0.5 0.0 0.1 1.3 1.8 0.1 0.1 0.9 0.6 0.1 0.1 1.6 0.6 0.6 1.4 0.9 0.7 0.1 0.0 2.0 1.4 1.3 5.0 4.7 8.9 0.6 1.6 7.7 2.4 0.8 8.0 0.2 1.0 0.1 0.2 0.1 4.4 0.0 4.4 1.5 0.3 0.3 0.3 0.2 0.2 0.3 0.2 0.1 0.0 0.6 0.2 0.4 2.2 1.0 0.3 0.4 0.2 0.2 8.9 6.2 2.0 8.0 11.8 3.8 3.3 4.2 2.7 5.3 CASKIN1 "ANKS5A, KIAA1306" ENSG00000167971 "CASK interacting protein 1" Q8WXD9 16 2177180-2196525 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 30.4" "Cell line enhanced" "Detected in some" "AN3-CA: 4.5;HDLM-2: 16.6;HEK 293: 3.7;SCLC-21H: 7.7;SH-SY5Y: 3.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055990, CAB079050" Enhanced Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB079050: , HPA055990: " "unprognostic (4.91e-2)" "unprognostic (2.48e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (8.02e-2)" "unprognostic (6.58e-2)" "unprognostic (4.59e-1)" "unprognostic (2.21e-4)" "unprognostic (2.67e-2)" "unprognostic (2.62e-1)" "unprognostic (9.70e-3)" "unprognostic (1.72e-1)" "unprognostic (7.34e-3)" "unprognostic (3.39e-1)" 1.1 1.8 17.7 1.2 18.1 1.1 1.4 15.0 30.4 1.5 1.2 2.3 0.0 1.2 1.5 1.3 1.2 1.4 1.2 2.5 16.4 12.8 1.3 1.1 1.1 1.1 12.4 11.7 1.2 1.5 1.9 1.4 1.2 11.1 1.8 1.2 1.8 2.5 1.4 1.3 2.2 1.3 1.2 2.8 1.1 1.3 1.8 4.0 0.0 1.6 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 4.5 0.0 0.0 2.2 0.0 0.0 0.1 0.0 1.5 0.1 0.0 0.9 0.0 0.0 1.2 0.3 0.0 16.6 3.7 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 1.3 0.0 0.9 0.7 0.0 0.9 0.0 0.4 0.2 0.0 7.7 3.7 0.1 0.2 0.2 1.0 0.5 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 18.1 15.0 21.7 16.4 12.8 12.4 11.7 11.1 4.0 CASTOR2 "GATSL1, GATSL2" ENSG00000274070 "Cytosolic arginine sensor for mTORC1 subunit 2" A6NHX0 7 74964818-75024798 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 7.5;skeletal muscle: 28.1" "Cell line enhanced" "Detected in many" "A549: 21.8" "Cancer enhanced" "Detected in all" "testis cancer: 11.6" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.2" HPA057229 Uncertain "HPA057229: " "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (3.23e-1)" "unprognostic (1.31e-1)" "unprognostic (8.28e-2)" "unprognostic (2.78e-5)" "unprognostic (1.28e-2)" "unprognostic (1.45e-1)" "unprognostic (1.04e-2)" "unprognostic (1.35e-2)" "unprognostic (6.27e-2)" "unprognostic (9.72e-3)" "unprognostic (1.11e-1)" "unprognostic (3.30e-1)" "unprognostic (2.50e-1)" "unprognostic (9.20e-3)" 1.3 1.2 4.1 0.4 4.8 4.4 0.7 2.6 7.5 1.1 1.9 5.0 0.0 1.8 1.7 1.2 2.1 1.4 1.7 2.7 5.6 0.8 0.1 0.8 0.1 3.3 4.5 3.7 3.6 1.4 1.3 2.2 4.2 1.7 0.4 1.1 2.1 2.1 28.1 0.9 1.1 1.7 2.8 0.3 0.7 2.1 4.0 2.1 0.4 1.4 0.8 0.9 0.5 0.0 0.0 2.2 0.0 0.0 0.3 0.0 2.4 21.8 3.4 10.4 4.5 2.3 7.4 2.6 2.0 1.8 1.9 7.8 1.0 0.4 1.8 5.7 1.2 6.5 1.8 1.3 2.0 3.4 1.7 8.9 8.0 1.9 0.4 3.0 5.3 0.8 4.3 0.6 3.5 3.1 1.1 1.1 4.3 3.6 1.3 5.8 2.6 8.3 2.4 2.3 4.4 5.0 10.3 5.7 3.0 5.5 0.6 3.3 0.7 4.8 2.9 5.1 5.2 0.9 1.2 3.4 2.6 1.8 2.0 1.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.2 0.0 CASTOR3 "DKFZp686B07267, GATS, STAG3OS" ENSG00000239521 "CASTOR family member 3" Q8NAP1 7 100200653-100272218 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 14.8;skeletal muscle: 20.4" "Cell line enhanced" "Detected in some" "A549: 4.3;HMC-1: 3.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA043176 Uncertain "HPA043176: AB_10794883" "unprognostic (8.29e-2)" "prognostic favourable (7.56e-7)" "unprognostic (7.67e-2)" "unprognostic (5.96e-2)" "unprognostic (3.46e-2)" "unprognostic (1.96e-1)" "unprognostic (2.66e-3)" "unprognostic (9.42e-2)" "unprognostic (3.90e-1)" "unprognostic (2.50e-1)" "unprognostic (4.00e-3)" "unprognostic (1.62e-1)" "unprognostic (3.56e-3)" "unprognostic (5.14e-3)" "unprognostic (4.44e-2)" "unprognostic (1.92e-1)" "unprognostic (4.86e-2)" 1.8 1.6 3.8 1.3 8.2 4.4 1.5 10.0 10.2 1.8 1.4 14.8 0.0 1.2 2.1 1.2 1.5 1.7 2.1 1.7 4.5 1.4 1.2 1.5 1.8 6.5 5.6 2.6 1.7 1.2 2.6 1.3 10.4 1.6 1.3 0.6 1.9 2.1 20.4 1.4 2.1 1.5 5.3 1.4 1.2 1.5 7.4 2.6 1.5 2.5 1.4 1.2 0.0 0.8 0.0 1.8 0.3 0.6 1.6 0.1 0.5 4.3 1.6 0.0 0.3 0.0 2.5 0.0 0.3 0.3 0.4 1.6 0.3 0.2 2.0 0.3 0.5 0.1 0.7 0.0 2.8 0.5 0.1 0.4 1.1 0.2 0.0 3.5 0.0 0.9 0.3 0.0 0.9 0.1 0.5 0.0 0.3 2.5 0.2 0.3 1.3 0.9 0.3 0.0 0.7 0.0 2.6 3.0 0.5 0.0 0.0 0.0 0.0 1.2 0.1 0.6 0.0 0.0 1.8 1.9 0.9 0.1 0.1 0.3 0.0 0.0 1.6 1.6 0.3 0.5 0.8 0.3 0.1 0.0 0.0 0.9 0.6 1.8 0.6 0.1 0.0 0.0 0.1 CBARP "BARP, C19orf26, DOS, MGC40084" ENSG00000099625 "CACN beta subunit associated regulatory protein" Q8N350 19 1228287-1238027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;pituitary gland: 13.1" "Cell line enhanced" "Detected in many" "SH-SY5Y: 8.6" "Cancer enhanced" "Detected in many" "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA012777 Approved Nucleoplasm Nucleoplasm "HPA012777: AB_2067005" "unprognostic (1.31e-1)" "unprognostic (4.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" "unprognostic (3.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (2.17e-1)" "unprognostic (4.58e-2)" "unprognostic (2.86e-3)" "unprognostic (3.03e-1)" "unprognostic (5.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (7.42e-5)" 2.3 8.1 7.2 1.5 12.1 1.0 1.2 3.6 17.9 1.2 1.3 5.2 0.0 1.3 1.8 1.1 1.5 1.1 1.8 1.5 8.5 5.6 1.8 1.5 1.4 1.1 3.3 4.7 2.9 2.1 1.6 13.1 1.4 10.6 1.4 1.0 1.2 1.2 1.5 1.3 4.5 1.1 1.2 6.5 1.2 1.9 3.0 2.2 0.0 1.3 0.0 1.2 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.0 5.2 0.2 0.6 1.5 4.4 1.3 0.9 0.9 2.3 0.2 0.0 4.9 0.9 2.3 0.8 0.9 0.2 0.9 1.1 0.1 1.7 1.4 2.2 0.1 1.8 1.2 0.5 1.1 0.3 0.6 2.7 0.1 0.6 3.9 0.0 1.3 3.6 2.1 4.3 0.8 0.3 0.2 0.5 3.2 8.6 0.0 0.1 4.5 0.6 0.9 1.7 1.8 5.5 5.1 1.6 0.5 0.5 0.0 1.4 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 12.1 3.6 17.9 8.5 5.6 3.3 4.7 10.6 2.2 CBLN1 ENSG00000102924 "Cerebellin 1 precursor" P23435 16 49277917-49281831 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 106.6" "Group enriched" "Detected in some" 28 "NTERA-2: 16.3;SCLC-21H: 51.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.5" "Region enriched" "Detected in many" 12 "cerebellum: 106.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "cerebellum: 688.3" "Region enriched" "Detected in many" 15 "cerebellum: 300.1" "Secreted in brain" 2900000 "unprognostic (1.39e-2)" "unprognostic (1.88e-2)" "unprognostic (1.53e-1)" "unprognostic (3.16e-1)" "unprognostic (1.62e-1)" "unprognostic (6.07e-2)" "unprognostic (9.65e-3)" "unprognostic (1.18e-2)" "unprognostic (6.31e-2)" "unprognostic (1.89e-2)" "unprognostic (2.02e-1)" "unprognostic (4.04e-2)" "unprognostic (7.68e-2)" "unprognostic (2.45e-1)" "unprognostic (1.06e-2)" "prognostic favourable (7.10e-4)" "unprognostic (1.60e-2)" 9.9 0.8 0.9 0.1 1.0 0.0 1.2 106.6 4.9 2.0 0.4 0.4 0.4 0.6 5.9 1.4 0.8 0.9 9.0 4.2 0.7 9.2 0.2 0.7 0.1 0.9 4.5 1.0 0.5 2.4 0.0 0.9 0.4 4.6 0.3 0.4 1.1 0.7 3.0 0.5 0.3 0.5 1.5 2.3 0.1 0.5 16.0 0.4 0.2 0.6 0.6 2.4 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.1 1.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.1 0.0 0.0 0.0 0.0 0.0 51.9 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 106.6 1.4 0.7 9.2 4.5 1.0 4.6 0.4 CBLN2 ENSG00000141668 "Cerebellin 2 precursor" Q8IUK8 18 72536680-72638521 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 33.8" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 34.7" "Cancer enriched" "Detected in single" 7 "breast cancer: 3.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in brain" 1300000 "unprognostic (2.03e-2)" "unprognostic (3.52e-1)" "unprognostic (1.13e-3)" "unprognostic (9.09e-5)" "unprognostic (7.10e-2)" "unprognostic (6.27e-3)" "unprognostic (7.39e-2)" "unprognostic (2.17e-1)" "unprognostic (1.37e-4)" "unprognostic (5.01e-4)" "unprognostic (8.15e-2)" "unprognostic (6.07e-4)" "unprognostic (7.19e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (4.93e-2)" 0.6 0.7 5.4 0.8 10.4 0.4 0.6 0.8 33.8 1.0 2.9 0.9 0.0 2.5 0.5 0.4 0.5 0.5 0.4 0.4 4.5 9.5 1.5 0.9 0.4 0.5 7.0 16.4 0.6 0.4 0.4 0.3 0.4 17.8 1.8 2.6 1.9 0.4 8.2 0.4 0.9 3.8 1.5 2.6 0.4 0.6 0.6 0.0 0.0 0.4 0.0 1.3 0.5 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 34.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 10.4 0.8 33.8 4.5 9.5 7.0 16.4 17.8 0.0 CBLN3 ENSG00000139899 "Cerebellin 3 precursor" Q6UW01 14 24426532-24430954 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 105.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.8;HDLM-2: 12.5;HSkMC: 18.6;Karpas-707: 14.0;U-266/70: 9.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 23 "cerebellum: 105.2" "Cell type enhanced" "Detected in some" "memory B-cell: 1.5;naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 25 "cerebellum: 481.8" "Region enriched" "Detected in some" 48 "cerebellum: 583.0" HPA041266 Enhanced Supported Approved Nucleoplasm "Secreted in brain" Nucleoplasm "HPA041266: AB_10674430" "unprognostic (5.02e-2)" "unprognostic (3.26e-1)" "unprognostic (1.43e-3)" "prognostic unfavourable (4.22e-4)" "unprognostic (4.39e-4)" "unprognostic (5.39e-3)" "unprognostic (1.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (6.20e-2)" "unprognostic (2.71e-2)" "prognostic unfavourable (6.20e-6)" "unprognostic (2.75e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (9.02e-2)" 2.1 7.7 1.2 4.5 1.3 0.0 1.2 105.2 1.7 1.8 1.1 1.9 1.0 0.6 1.3 4.8 1.0 1.2 3.1 1.6 1.0 1.1 1.2 1.4 1.3 7.9 1.3 1.4 3.3 1.0 1.0 1.3 1.7 4.6 1.2 0.7 1.7 1.6 1.6 1.4 1.6 1.3 1.3 2.0 7.4 1.4 1.6 1.1 1.1 1.2 1.5 5.3 1.9 1.3 2.3 0.3 0.1 0.8 0.0 0.3 0.0 1.1 1.0 0.5 1.9 4.9 10.8 0.3 4.1 8.5 1.6 2.1 0.5 2.0 1.8 0.9 2.6 0.3 0.6 2.2 1.1 12.5 0.4 0.0 3.4 0.8 2.7 0.3 0.7 18.6 1.0 2.1 1.7 1.4 0.5 14.0 2.1 0.6 0.0 0.5 0.1 1.1 0.0 0.0 1.3 1.0 0.4 0.7 0.4 0.3 0.1 0.5 0.6 0.4 6.5 6.0 1.2 2.4 0.2 9.8 2.3 1.9 0.3 0.8 1.0 0.0 0.0 0.1 0.0 0.8 0.3 1.5 0.1 0.1 0.0 2.3 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.0 1.2 1.3 105.2 1.7 1.0 1.1 1.3 1.4 4.6 1.1 CBLN4 "CBLNL1, dJ885A10.1" ENSG00000054803 "Cerebellin 4 precursor" Q9NTU7 20 55997440-56005472 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.5;brain: 16.8;epididymis: 11.8" "Cell line enriched" "Detected in single" 49 "SH-SY5Y: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074497 Supported "Secreted in brain" 10000000 "HPA074497: " "unprognostic (3.61e-1)" "unprognostic (8.43e-3)" "unprognostic (2.43e-1)" "unprognostic (1.61e-2)" "unprognostic (1.99e-1)" "unprognostic (4.00e-1)" "unprognostic (3.25e-1)" "unprognostic (2.11e-1)" "unprognostic (1.42e-1)" "unprognostic (3.88e-1)" "unprognostic (9.63e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-3)" "unprognostic (3.22e-4)" "unprognostic (7.50e-2)" "unprognostic (3.58e-2)" "unprognostic (1.79e-3)" 1.3 23.5 11.9 0.3 8.9 0.2 1.8 0.1 16.8 2.8 0.3 0.5 0.8 0.3 1.2 11.8 0.3 5.4 0.9 0.2 5.9 14.8 1.0 1.3 1.1 0.2 1.6 5.0 2.2 1.2 0.4 0.1 0.5 2.4 0.4 0.2 0.1 0.3 0.7 0.5 0.3 0.3 0.6 0.4 0.2 0.7 2.7 0.0 0.0 1.3 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 8.9 0.1 16.8 5.9 14.8 1.6 5.0 2.4 0.0 CBSL ENSG00000274276 "Cystathionine-beta-synthase like" P0DN79 21 6444869-6468040 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.5;liver: 21.2;pancreas: 18.5" "Cell line enhanced" "Detected in many" "AN3-CA: 35.7;NTERA-2: 66.2;SH-SY5Y: 21.1;U-266/70: 20.9" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 47 "neutrophil: 4.6" "Lineage enriched" "Detected in single" 47 "granulocytes: 4.6" HPA001223 Supported Approved Nucleoli,Vesicles 190000 Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (2.39e-1)" "unprognostic (1.54e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-3)" "unprognostic (6.49e-2)" "unprognostic (1.42e-2)" "unprognostic (1.28e-2)" "unprognostic (6.62e-3)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (7.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (3.17e-3)" "unprognostic (8.44e-2)" "unprognostic (2.46e-1)" "unprognostic (3.61e-1)" 0.0 0.0 0.0 0.0 0.0 11.5 1.8 0.0 0.4 0.0 0.0 0.0 0.3 0.0 1.0 0.0 21.2 0.0 0.0 1.6 18.5 0.0 0.0 1.8 0.0 0.0 3.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 5.0 0.0 0.3 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 11.9 35.7 0.0 0.0 0.4 7.4 4.3 2.7 8.3 0.1 4.8 0.0 0.0 0.0 3.1 0.0 3.8 1.7 0.0 9.4 0.0 0.0 0.0 0.2 0.0 5.1 4.2 13.9 0.0 7.0 0.0 0.2 16.5 0.1 0.0 5.6 0.6 66.2 0.0 0.0 0.0 0.0 10.8 0.0 13.8 21.1 0.0 1.1 14.4 0.0 0.0 0.0 0.7 0.0 4.6 1.4 20.9 7.7 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 CCDC129 FLJ38344 ENSG00000180347 "Coiled-coil domain containing 129" Q6ZRS4 7 31514071-31658720 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 17.2;salivary gland: 10.9" "Cell line enhanced" "Detected in some" "AF22: 1.5;CACO-2: 1.3;RH-30: 2.1;T-47d: 2.6;U-2 OS: 5.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebellum: 7.9;midbrain: 5.0;pons and medulla: 17.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA024103 Uncertain Uncertain Nucleoplasm Nucleoplasm "HPA024103: AB_1846132" "unprognostic (1.11e-2)" "unprognostic (1.39e-1)" "unprognostic (1.57e-1)" "unprognostic (1.78e-5)" "unprognostic (9.72e-3)" "unprognostic (1.78e-1)" "unprognostic (3.89e-2)" "unprognostic (6.42e-3)" "unprognostic (1.01e-1)" "unprognostic (5.77e-2)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" 0.1 0.0 0.1 0.6 2.0 0.1 3.3 7.9 0.3 3.7 0.9 1.2 0.0 2.1 1.1 0.2 0.1 0.1 0.1 0.0 0.4 1.4 0.1 0.0 0.4 0.0 5.0 0.0 0.0 0.2 0.0 0.4 0.9 17.2 0.1 0.2 0.0 10.9 0.0 0.0 4.5 0.9 1.1 0.2 0.0 0.8 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.8 1.1 0.0 0.1 1.0 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.5 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.2 0.1 2.1 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.0 5.4 0.2 0.3 0.2 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.7 0.2 0.1 0.1 0.8 1.0 0.4 1.1 0.1 0.0 0.8 0.0 0.1 0.1 2.0 7.9 0.3 0.4 1.4 5.0 0.0 17.2 0.0 CCDC13 FLJ25467 ENSG00000244607 "Coiled-coil domain containing 13" Q8IYE1 3 42692663-42773253 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.2;fallopian tube: 13.6;testis: 15.0" "Cell line enhanced" "Detected in some" "ASC diff: 2.3;Daudi: 1.2;HDLM-2: 2.9;NTERA-2: 1.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA047429 Approved Supported Centrosome Centrosome "HPA047429: " "unprognostic (3.34e-2)" "unprognostic (3.72e-2)" "unprognostic (2.18e-2)" "unprognostic (1.67e-3)" "unprognostic (2.19e-2)" "unprognostic (5.35e-2)" "unprognostic (4.75e-2)" "unprognostic (8.06e-2)" "unprognostic (4.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.05e-2)" "unprognostic (2.31e-1)" "unprognostic (1.83e-7)" "unprognostic (6.21e-2)" "unprognostic (2.40e-1)" "unprognostic (5.71e-2)" "unprognostic (2.04e-2)" 0.7 1.0 3.0 0.7 12.2 0.6 0.7 0.8 4.0 1.3 0.9 6.3 2.3 1.1 2.1 7.0 0.7 13.6 1.5 1.7 3.7 2.7 1.1 1.7 2.5 0.7 1.9 4.6 1.5 2.0 1.0 3.7 0.7 8.1 0.7 1.4 1.5 1.6 1.1 2.0 0.6 1.1 0.9 3.4 0.8 0.8 15.0 2.5 0.0 1.9 0.3 0.6 0.7 0.5 0.0 0.0 0.1 0.2 0.5 1.2 0.2 0.0 0.0 0.0 1.1 2.3 0.9 0.7 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.0 0.1 2.9 0.8 0.0 0.3 0.0 0.0 0.0 0.4 0.6 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 3.0 12.2 0.8 4.0 3.7 2.7 1.9 4.6 8.1 2.5 CCDC136 "DKFZP434G156, KIAA1793, NAG6" ENSG00000128596 "Coiled-coil domain containing 136" Q96JN2 7 128790757-128822132 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 34.7;testis: 109.6" "Cell line enhanced" "Detected in many" "U-87 MG: 18.4;U-937: 27.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010647, HPA071015" Enhanced Uncertain Nucleoli Nucleoli "HPA010647: AB_2259798, HPA071015: " "unprognostic (2.07e-2)" "unprognostic (2.32e-2)" "unprognostic (1.29e-4)" "unprognostic (4.65e-2)" "unprognostic (4.52e-1)" "unprognostic (2.16e-1)" "unprognostic (1.66e-2)" "unprognostic (2.53e-1)" "unprognostic (5.43e-4)" "unprognostic (2.58e-2)" "unprognostic (8.44e-3)" "unprognostic (4.35e-1)" "unprognostic (1.18e-4)" "unprognostic (5.27e-3)" "unprognostic (4.85e-2)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" 2.1 4.0 11.2 2.6 11.7 1.8 2.4 34.7 28.7 2.9 6.5 8.3 2.6 2.4 3.9 2.9 2.5 2.8 2.8 4.9 12.5 20.0 1.5 1.5 1.9 3.0 15.3 16.6 2.8 1.8 1.8 3.8 2.2 11.2 9.9 3.5 13.9 2.0 11.0 3.5 1.6 2.6 17.3 9.7 1.9 2.4 109.6 7.4 0.7 1.7 0.0 2.4 6.4 2.0 0.1 0.6 1.3 0.3 2.7 1.6 0.3 0.7 0.8 7.2 4.8 3.9 3.3 1.2 2.7 3.6 2.8 2.6 1.0 0.6 3.6 0.3 3.7 1.5 4.5 0.5 2.6 10.1 4.6 6.2 1.7 0.0 1.3 0.7 13.5 3.7 0.5 3.0 0.2 1.6 2.2 3.8 1.0 1.3 4.5 1.9 9.9 2.9 11.3 1.2 1.7 0.2 1.2 4.2 12.5 1.6 1.9 2.8 0.1 1.7 1.4 4.5 2.6 2.1 2.1 2.2 0.9 3.7 18.4 27.1 1.1 0.0 0.3 1.3 1.4 0.0 1.6 0.0 1.5 1.1 0.6 0.1 0.0 1.0 0.1 2.7 0.1 0.1 0.0 0.3 11.2 11.7 34.7 28.7 12.5 20.0 15.3 16.6 11.2 7.4 CCDC140 FLJ32447 ENSG00000163081 "Coiled-coil domain containing 140" Q96MF4 2 222298147-222305217 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.6;salivary gland: 1.2;skeletal muscle: 3.1;skin 1: 1.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.1;NB-4: 3.7;RH-30: 2.1;SK-MEL-30: 3.9;WM-115: 2.3" "Cancer enriched" "Detected in single" 9 "melanoma: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042500, HPA048166" Uncertain "HPA042500: , HPA048166: AB_2680295" "unprognostic (2.50e-2)" "unprognostic (3.54e-1)" "unprognostic (5.25e-2)" 0.3 0.0 0.0 0.0 0.0 0.4 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 3.1 1.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 2.2 1.5 2.1 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 2.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC144NL MGC87631 ENSG00000205212 "Coiled-coil domain containing 144 family, N-terminal like" Q6NUI1 17 20836447-20896140 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 13.1;testis: 10.6" "Cell line enriched" "Detected in some" 5 "U-2 OS: 26.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" HPA023457 Uncertain Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA023457: AB_2671217" "unprognostic (1.29e-1)" "unprognostic (6.71e-2)" "unprognostic (1.21e-1)" "unprognostic (3.53e-1)" "unprognostic (7.53e-2)" "unprognostic (5.17e-2)" "unprognostic (6.33e-2)" "unprognostic (1.08e-1)" "unprognostic (1.22e-1)" "unprognostic (2.28e-1)" 0.3 0.9 0.9 0.2 13.1 0.5 1.0 2.4 6.6 0.3 0.4 1.4 0.0 0.5 1.5 0.3 0.3 0.9 0.2 0.5 1.2 1.1 0.3 0.6 0.5 0.5 1.7 1.4 1.3 0.4 0.2 1.2 0.8 4.5 1.6 0.5 0.6 0.3 1.8 0.8 0.3 0.2 1.2 4.5 0.4 0.5 10.6 0.0 0.4 0.4 0.0 0.7 0.9 0.2 0.0 0.1 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 2.3 0.0 0.0 26.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 1.2 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 13.1 2.4 6.6 1.2 1.1 1.7 1.4 4.5 0.0 CCDC146 KIAA1505 ENSG00000135205 "Coiled-coil domain containing 146" Q8IYE0 7 77122434-77329533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.7;fallopian tube: 27.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "pons and medulla: 32.7" "Cell type enhanced" "Detected in many" "eosinophil: 12.5;neutrophil: 14.0" "Group enriched" "Detected in many" 4 "granulocytes: 14.0;NK-cells: 5.0;T-cells: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA020082, HPA020105" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA020082: AB_1852410, HPA020105: AB_2072056" "unprognostic (3.07e-3)" "unprognostic (9.94e-3)" "unprognostic (1.56e-1)" "unprognostic (2.54e-3)" "unprognostic (1.85e-1)" "prognostic favourable (7.37e-4)" "unprognostic (1.95e-3)" "unprognostic (8.02e-3)" "unprognostic (4.05e-4)" "unprognostic (1.73e-1)" "unprognostic (4.63e-1)" "unprognostic (4.09e-2)" "unprognostic (7.38e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-1)" "unprognostic (2.70e-3)" "unprognostic (5.58e-3)" 1.8 0.8 6.5 1.9 7.2 1.3 1.9 1.8 8.3 4.3 3.2 4.5 2.7 1.9 3.7 9.1 3.5 27.9 2.6 1.4 7.4 3.4 4.2 1.3 4.9 2.2 1.6 4.2 6.4 1.8 2.9 10.9 1.5 32.7 3.4 2.2 4.4 3.9 1.8 1.6 7.4 2.2 2.4 2.8 2.8 2.5 22.2 2.9 0.5 6.3 0.9 2.0 3.1 3.4 1.0 1.8 14.0 0.7 5.0 4.4 0.6 1.0 1.5 4.4 2.4 2.9 3.0 0.5 1.1 1.0 1.1 1.9 0.0 7.5 2.5 0.2 0.3 1.5 0.6 1.4 1.9 3.0 0.5 2.9 2.0 1.3 0.9 3.2 2.4 1.7 2.2 2.0 0.3 1.0 0.0 2.8 0.3 0.3 2.6 4.7 0.5 1.1 6.9 0.7 0.3 4.6 0.8 3.4 2.2 1.6 1.5 0.9 1.4 1.1 1.4 1.7 0.6 2.4 0.7 4.4 6.8 2.1 3.9 4.9 4.0 0.6 0.5 12.5 4.4 0.7 3.1 1.0 1.9 3.0 0.8 0.2 1.2 1.9 14.0 5.0 0.3 1.8 1.4 0.6 6.5 7.2 1.8 8.3 7.4 3.4 1.6 4.2 32.7 2.9 CCDC151 MGC20983 ENSG00000198003 "Coiled-coil domain containing 151" A5D8V7 19 11420604-11435782 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.7;fallopian tube: 18.2" "Cell line enhanced" "Detected in some" "SCLC-21H: 4.0;T-47d: 9.2;U-87 MG: 3.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.3;memory B-cell: 1.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044184, HPA054626" Enhanced Approved Nucleoplasm Nucleoplasm "HPA044184: AB_10959331, HPA054626: " "unprognostic (1.50e-1)" "unprognostic (6.59e-2)" "unprognostic (2.05e-3)" "unprognostic (4.41e-3)" "unprognostic (1.35e-2)" "unprognostic (6.30e-2)" "unprognostic (4.41e-3)" "unprognostic (2.32e-2)" "unprognostic (2.22e-1)" "unprognostic (5.09e-2)" "unprognostic (6.76e-4)" "unprognostic (3.01e-1)" "unprognostic (2.63e-3)" "unprognostic (4.27e-2)" "unprognostic (1.85e-1)" "unprognostic (2.35e-1)" "unprognostic (2.05e-1)" 0.8 3.1 5.7 0.6 9.9 0.6 0.6 4.4 7.7 1.6 0.6 4.0 1.4 0.6 1.0 2.8 0.6 18.2 0.6 1.2 7.7 4.3 2.0 0.8 2.7 0.6 2.3 4.6 2.5 0.6 9.8 10.4 1.4 12.7 0.8 0.6 0.7 4.0 1.8 0.5 0.5 0.6 0.6 1.7 1.9 0.9 8.5 5.4 0.0 2.1 0.0 0.7 0.6 0.4 1.5 0.7 0.1 2.3 0.0 0.0 0.1 0.5 0.1 1.2 0.1 0.1 0.4 1.0 0.5 0.1 0.6 0.7 0.1 0.0 0.3 0.5 0.2 0.2 0.9 0.4 0.0 1.0 1.0 0.4 0.6 0.0 0.5 0.0 0.5 0.3 0.0 0.6 0.0 0.0 0.0 0.9 0.2 0.8 0.0 0.1 0.4 2.1 0.4 0.1 1.4 0.7 0.0 4.0 2.7 1.2 0.2 0.1 9.2 0.4 0.0 1.4 0.3 3.4 0.1 3.4 2.7 0.2 3.6 0.6 0.1 0.0 0.6 0.0 0.0 2.3 0.0 1.5 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 5.7 9.9 4.4 7.7 7.7 4.3 2.3 4.6 12.7 5.4 CCDC175 C14orf38 ENSG00000151838 "Coiled-coil domain containing 175" P0C221 14 59504539-59576831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.1;pituitary gland: 6.6;testis: 8.2" "Cell line enhanced" "Detected in some" "HDLM-2: 1.5;SCLC-21H: 1.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA004200 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA004200: AB_1078743" "unprognostic (3.64e-3)" "unprognostic (8.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (3.83e-1)" "unprognostic (2.02e-2)" "unprognostic (5.98e-2)" "unprognostic (1.27e-1)" 0.2 0.1 0.9 0.2 2.9 0.5 0.2 17.1 3.3 0.2 0.9 1.2 0.0 0.3 0.2 1.0 0.2 1.3 0.5 0.2 0.8 0.5 0.4 0.2 0.5 0.2 0.8 0.9 0.2 0.1 0.3 6.6 0.1 3.0 0.2 1.8 0.6 0.2 0.2 0.2 0.3 0.9 0.2 0.4 0.4 0.2 8.2 1.5 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.1 0.5 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.4 0.9 2.9 17.1 3.3 0.8 0.5 0.8 0.9 3.0 1.5 CCDC177 "C14orf162, PLPL" ENSG00000267909 "Coiled-coil domain containing 177" Q9NQR7 14 69569816-69574837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 17.5" "Cell line enhanced" "Detected in some" "AF22: 1.9;NTERA-2: 2.8;SCLC-21H: 5.5;SH-SY5Y: 1.0;SK-BR-3: 1.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (2.21e-1)" "unprognostic (2.33e-2)" "unprognostic (6.94e-3)" "unprognostic (1.34e-2)" "unprognostic (2.64e-3)" "unprognostic (1.77e-3)" "unprognostic (6.34e-4)" "unprognostic (2.58e-2)" "unprognostic (1.19e-1)" "unprognostic (1.99e-2)" "unprognostic (3.16e-1)" "unprognostic (7.84e-5)" "unprognostic (2.15e-4)" "unprognostic (3.81e-1)" "unprognostic (1.45e-1)" 0.4 1.1 3.2 0.4 3.7 0.3 1.0 17.5 8.5 0.3 0.3 0.2 0.0 0.3 0.4 3.1 0.4 0.4 0.3 0.3 2.2 1.6 0.3 0.6 0.3 0.3 0.5 4.4 0.4 0.3 0.3 0.3 0.3 2.3 0.3 0.3 1.8 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.3 1.5 0.0 0.0 0.3 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.7 17.5 8.5 2.2 1.6 0.5 4.4 2.3 0.0 CCDC184 "C12orf68, LOC387856" ENSG00000177875 "Coiled-coil domain containing 184" Q52MB2 12 48183584-48185926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Cell line enhanced" "Detected in some" "A549: 4.2;AF22: 9.8;NTERA-2: 3.3;SH-SY5Y: 6.7;U-2 OS: 3.9;U-87 MG: 4.9" "Cancer enhanced" "Detected in many" "glioma: 6.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039947, HPA041715" Uncertain Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA039947: , HPA041715: " "unprognostic (2.02e-1)" "unprognostic (1.16e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (1.61e-2)" "unprognostic (4.59e-1)" "unprognostic (1.33e-2)" "unprognostic (6.65e-2)" "unprognostic (9.79e-2)" "unprognostic (8.38e-2)" "unprognostic (1.03e-2)" "unprognostic (1.07e-1)" "unprognostic (5.87e-4)" "unprognostic (1.08e-2)" "unprognostic (2.39e-2)" "unprognostic (2.55e-1)" "unprognostic (2.36e-2)" 2.0 11.4 9.0 2.3 14.4 0.8 1.3 14.9 30.5 3.0 1.8 2.2 0.1 1.1 6.1 1.3 1.7 1.3 3.3 1.9 9.3 17.6 1.3 1.3 1.5 1.0 11.5 10.6 8.8 1.3 8.7 7.3 5.1 23.7 1.6 1.5 0.8 0.9 2.3 2.2 1.5 2.1 3.6 3.6 1.4 1.5 5.1 0.4 0.0 1.2 0.5 0.8 2.1 1.8 0.0 0.3 0.6 0.2 0.0 1.2 0.3 0.0 4.2 9.8 0.4 0.8 0.8 0.0 0.3 1.8 0.5 0.8 0.5 0.1 0.0 0.2 0.3 0.1 1.0 0.2 0.1 2.3 0.2 0.0 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 2.0 6.7 0.8 0.1 0.2 0.0 0.0 0.2 1.1 3.9 0.0 0.2 0.0 0.0 0.0 4.9 0.0 1.0 0.0 0.2 0.0 0.5 0.2 0.0 0.0 1.2 0.4 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.3 9.0 14.4 14.9 30.5 9.3 17.6 11.5 10.6 23.7 0.4 CCDC39 ENSG00000284862 "Coiled-coil domain containing 39" Q9UFE4 3 180602858-180679500 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.3" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA035363, HPA035364" Enhanced "HPA035363: AB_2674588, HPA035364: AB_10601095" 0.0 1.7 1.1 3.6 7.5 1.8 0.0 0.3 2.9 0.6 0.1 3.3 0.0 3.1 2.0 10.4 1.2 5.8 3.4 1.4 1.7 0.1 0.0 5.7 10.3 0.0 1.3 4.6 0.3 0.0 6.4 0.0 23.3 0.7 0.0 1.4 1.6 0.0 0.2 10.7 2.7 0.0 0.2 4.2 1.6 12.4 1.1 0.0 3.5 0.0 0.0 1.9 0.0 1.2 0.6 0.0 0.2 0.7 1.5 0.3 3.9 2.6 8.4 2.2 0.0 0.0 2.7 1.9 0.0 0.0 0.0 3.1 3.7 10.5 3.5 0.0 3.5 0.1 0.0 0.0 5.8 5.1 5.0 6.8 6.7 0.0 8.0 5.0 0.0 0.0 0.0 0.0 0.0 3.5 0.7 0.3 1.0 4.1 0.1 5.1 5.2 5.5 2.7 13.3 0.0 5.6 4.0 4.5 2.3 2.3 1.5 5.8 5.3 6.3 6.9 3.0 2.2 6.5 6.7 4.6 11.0 4.4 7.6 1.4 0.0 0.2 0.0 0.8 0.1 1.5 1.2 0.4 0.0 0.2 0.3 1.1 0.3 0.0 0.7 0.2 0.6 1.1 0.3 CCDC60 MGC39827 ENSG00000183273 "Coiled-coil domain containing 60" Q8IWA6 12 119334712-119541047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0;fallopian tube: 21.1;smooth muscle: 17.5;testis: 25.7" "Cell line enhanced" "Detected in some" "AF22: 1.0;BEWO: 1.8;HBEC3-KT: 2.4;HeLa: 1.7;RT4: 2.6;U-2 OS: 1.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 7 "pons and medulla: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (2.96e-1)" "unprognostic (2.05e-2)" "unprognostic (7.73e-3)" "unprognostic (2.78e-3)" "unprognostic (1.19e-1)" "unprognostic (1.98e-3)" "unprognostic (1.00e-1)" "unprognostic (2.70e-1)" "unprognostic (1.70e-1)" "unprognostic (2.93e-2)" "unprognostic (3.56e-3)" "unprognostic (3.92e-1)" "unprognostic (4.29e-2)" "unprognostic (4.11e-1)" "unprognostic (2.54e-1)" 0.1 0.0 1.8 0.6 3.3 0.0 0.0 0.0 0.1 6.9 2.1 5.2 3.6 0.2 1.4 4.9 2.8 21.1 0.2 0.1 2.4 2.6 0.1 0.1 3.2 0.1 0.1 0.0 5.3 0.1 0.0 0.1 0.6 22.0 5.4 5.7 8.9 3.5 2.1 0.2 0.2 0.2 17.5 0.4 0.1 0.4 25.7 0.3 0.0 0.1 0.4 2.6 10.8 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.3 0.0 0.1 2.4 2.6 0.1 0.0 22.0 0.3 CCDC78 "C16orf25, FLJ34512" ENSG00000162004 "Coiled-coil domain containing 78" A2IDD5 16 722582-726954 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.1;epididymis: 21.3;fallopian tube: 47.9;lung: 13.3" "Cell line enhanced" "Detected in many" "HDLM-2: 8.6;RPMI-8226: 10.1;SCLC-21H: 12.1;U-266/70: 10.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.2" "Low lineage specificity" "Detected in many" "unprognostic (1.10e-1)" "unprognostic (6.48e-2)" "unprognostic (2.62e-4)" "unprognostic (1.02e-2)" "unprognostic (1.24e-1)" "unprognostic (2.58e-2)" "unprognostic (3.47e-2)" "unprognostic (2.06e-2)" "unprognostic (9.39e-2)" "unprognostic (1.48e-1)" "unprognostic (7.82e-3)" "unprognostic (6.14e-2)" "unprognostic (2.02e-2)" "unprognostic (2.45e-3)" "unprognostic (5.20e-1)" "unprognostic (1.44e-1)" "unprognostic (7.22e-3)" 0.3 1.1 3.6 1.1 11.3 1.2 0.5 2.0 1.2 2.5 0.4 6.4 1.3 0.3 1.1 21.3 0.3 47.9 0.6 0.4 4.3 4.7 0.4 0.4 13.3 1.1 1.9 0.1 5.7 0.3 0.7 2.3 0.6 20.1 0.6 0.5 0.3 0.7 1.0 0.4 0.4 0.6 0.4 2.6 0.9 0.9 1.1 1.7 0.2 0.5 0.1 1.6 1.0 0.1 0.4 1.2 1.3 0.0 1.2 3.2 0.1 0.5 1.0 1.2 2.8 1.3 1.1 1.3 1.0 2.4 0.6 0.4 0.4 4.7 1.0 1.0 0.6 0.8 2.7 1.5 0.1 8.6 0.0 2.4 1.4 0.0 1.5 0.8 1.5 3.7 0.8 0.3 4.3 0.4 0.3 3.3 0.8 6.0 0.0 2.0 1.8 0.3 2.1 0.9 10.1 4.1 1.8 12.1 1.2 1.1 7.1 0.6 4.6 1.6 1.0 0.9 0.4 0.0 0.1 10.0 0.2 2.6 0.9 1.1 2.8 0.0 0.0 1.3 0.2 0.0 3.2 0.4 0.1 1.9 0.0 0.1 0.0 0.0 0.0 1.2 0.0 1.2 0.1 0.1 3.6 11.3 2.0 1.2 4.3 4.7 1.9 0.1 20.1 1.7 CCDC81 "FLJ16339, FLJ23514" ENSG00000149201 "Coiled-coil domain containing 81" Q6ZN84 11 86374736-86423109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.2;fallopian tube: 28.9" "Cell line enhanced" "Detected in some" "BJ: 7.6;BJ hTERT+: 4.2;HBF TERT88: 4.4" "Cancer enhanced" "Detected in single" "testis cancer: 1.5" "Region enriched" "Detected in many" 8 "pons and medulla: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "unprognostic (1.02e-1)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (2.30e-1)" "unprognostic (1.53e-1)" "unprognostic (6.76e-2)" "unprognostic (7.00e-3)" "unprognostic (8.54e-3)" "unprognostic (1.46e-3)" "unprognostic (2.82e-1)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (8.14e-4)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (2.27e-1)" "unprognostic (6.62e-2)" 0.5 0.3 0.9 0.3 1.6 0.3 0.3 0.4 0.7 1.6 0.3 7.4 0.8 0.0 2.0 4.5 0.3 28.9 0.5 0.3 1.5 1.8 0.2 0.1 1.5 1.1 0.5 0.6 4.3 0.1 0.3 5.5 3.1 15.2 0.6 0.3 0.8 0.1 0.9 0.7 0.2 0.2 1.1 0.7 0.3 0.2 5.6 1.7 0.0 0.5 0.4 0.4 0.6 0.3 0.0 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.3 2.4 0.0 0.8 0.3 0.9 7.6 4.2 1.3 0.9 0.8 0.7 0.4 3.0 1.1 0.5 1.3 0.2 4.4 0.5 0.4 0.8 0.2 0.7 0.4 0.4 0.5 0.2 1.4 2.2 0.6 1.4 0.4 0.1 1.0 1.2 1.0 2.2 0.2 0.0 0.4 0.2 0.7 0.6 0.0 0.4 0.4 0.3 0.6 0.0 0.4 0.9 0.4 1.9 1.0 1.7 0.2 0.1 0.6 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.9 1.6 0.4 0.7 1.5 1.8 0.5 0.6 15.2 1.7 CCDC85A KIAA1912 ENSG00000055813 "Coiled-coil domain containing 85A" Q96PX6 2 56184123-56386173 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.8" "Cell line enhanced" "Detected in some" "Daudi: 22.2;fHDF/TERT166: 36.4;U-266/70: 16.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 2.3" "Lineage enriched" "Detected in single" 23 "B-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043106, HPA057020" Uncertain "Intracellular and membrane" "HPA043106: AB_10794770, HPA057020: " "unprognostic (2.29e-1)" "unprognostic (1.28e-1)" "unprognostic (6.87e-2)" "unprognostic (3.66e-2)" "unprognostic (7.87e-2)" "unprognostic (7.62e-2)" "unprognostic (3.07e-2)" "unprognostic (8.04e-2)" "unprognostic (7.10e-2)" "unprognostic (2.94e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-1)" "unprognostic (6.55e-5)" "unprognostic (3.28e-2)" "unprognostic (1.00e-1)" "unprognostic (2.88e-2)" "unprognostic (1.83e-2)" 16.0 1.4 10.5 1.3 7.5 0.4 7.8 3.4 18.8 4.2 1.6 4.9 3.0 0.9 9.3 1.6 1.4 3.5 2.1 6.5 7.9 8.5 1.9 0.7 8.1 1.1 6.6 10.2 1.2 1.4 3.0 1.0 14.4 8.8 3.4 1.4 1.0 1.9 4.5 7.2 2.7 1.3 7.3 10.6 1.4 1.3 1.0 5.2 0.0 13.5 2.2 1.3 1.8 3.9 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.2 0.4 0.0 5.6 0.5 4.9 0.5 0.0 0.0 22.2 0.8 36.4 0.9 0.0 0.0 2.8 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 1.7 0.1 0.0 0.6 4.8 0.0 3.0 0.6 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.1 0.0 0.0 2.6 0.0 7.4 4.0 1.1 0.0 0.4 16.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 7.5 3.4 18.8 7.9 8.5 6.6 10.2 8.8 5.2 CCDC88B "BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3" ENSG00000168071 "Coiled-coil domain containing 88B" A6NC98 11 64340223-64357534 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5" "Cell line enhanced" "Detected in some" "HMC-1: 39.8;Karpas-707: 10.4;THP-1: 15.8;U-937: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" HPA026652 Approved Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" Centrosome "Nucleoplasm, Cytosol" "HPA026652: AB_1846168" "unprognostic (1.18e-2)" "unprognostic (3.33e-3)" "unprognostic (3.65e-1)" "unprognostic (1.58e-2)" "unprognostic (2.36e-1)" "prognostic favourable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (1.55e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-1)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" "prognostic unfavourable (7.65e-5)" "unprognostic (3.77e-2)" "unprognostic (7.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.83e-2)" 3.5 2.5 5.2 29.5 5.4 32.5 2.7 23.7 2.8 2.6 6.1 4.5 6.9 3.2 2.0 1.3 4.2 2.5 8.5 2.3 4.1 2.6 2.0 1.6 11.4 18.6 8.6 2.2 1.3 2.1 0.7 1.6 1.4 6.5 2.9 2.9 1.7 7.5 8.9 0.8 1.9 11.1 1.3 7.2 26.6 3.3 7.3 6.5 16.8 1.9 2.7 20.8 4.1 2.8 3.0 3.5 11.3 6.5 7.1 4.6 1.6 0.1 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 1.5 9.0 1.4 0.5 0.7 0.0 0.2 0.0 9.8 0.0 6.8 1.8 0.5 0.4 4.2 39.8 0.0 0.0 0.1 0.0 0.2 0.2 10.4 0.3 0.4 5.7 3.5 0.3 0.2 5.4 0.1 8.4 0.1 0.1 2.2 0.0 0.0 0.2 0.4 1.2 15.8 0.0 0.0 0.3 0.0 0.1 2.2 0.7 7.3 0.5 11.5 0.2 3.6 6.5 7.6 4.6 4.7 1.4 2.2 2.7 3.8 2.1 3.0 2.6 3.2 11.3 7.1 3.1 3.5 0.8 1.6 5.2 5.4 23.7 2.8 4.1 2.6 8.6 2.2 6.5 6.5 CCER2 ENSG00000262484 "Coiled-coil glutamate rich protein 2" I3L3R5 19 38908980-38912158 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.5;skin 1: 9.9" "Cell line enhanced" "Detected in some" "A549: 4.0;THP-1: 4.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA069716 Uncertain "Secreted - unknown location" "HPA069716: " "unprognostic (6.58e-2)" "unprognostic (2.24e-2)" "unprognostic (5.03e-3)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (2.76e-3)" "unprognostic (3.88e-2)" "unprognostic (2.16e-1)" "unprognostic (5.97e-2)" "unprognostic (1.45e-1)" "unprognostic (4.08e-3)" "unprognostic (3.82e-2)" "unprognostic (1.01e-9)" "unprognostic (1.75e-2)" "unprognostic (3.87e-2)" "unprognostic (3.61e-1)" "prognostic favourable (2.32e-4)" 0.9 1.0 2.7 1.1 5.1 2.4 1.6 4.7 4.6 1.2 0.9 2.7 0.4 1.3 1.5 1.6 3.9 1.0 0.6 0.6 3.1 2.4 0.9 2.1 0.9 1.5 2.5 0.4 1.0 0.6 1.4 2.6 0.7 9.5 1.1 0.9 1.4 1.1 1.2 4.4 9.9 1.4 0.8 3.5 1.2 1.1 4.0 1.4 0.4 0.8 0.4 0.8 0.4 0.4 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.3 4.0 1.0 0.4 0.7 0.2 0.8 0.0 0.0 0.1 0.2 0.3 1.5 2.8 0.3 0.2 0.4 0.6 0.1 0.0 1.1 1.3 0.2 0.8 0.0 0.0 1.6 1.6 0.4 0.7 0.3 0.0 0.0 0.7 2.7 0.0 2.6 0.6 1.2 0.9 0.5 2.0 0.4 0.7 0.3 1.9 1.2 0.8 0.5 0.5 0.0 3.0 4.0 0.0 0.2 2.0 0.1 0.1 1.8 1.3 0.7 0.3 2.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 2.7 5.1 4.7 4.6 3.1 2.4 2.5 0.4 9.5 1.4 CCK ENSG00000187094 Cholecystokinin P06307 3 42257825-42266207 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 95.1;intestine: 71.6" "Group enriched" "Detected in some" 7 "CAPAN-2: 8.7;RPTEC TERT1: 22.7" "Group enriched" "Detected in many" 5 "glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0" "Group enriched" "Detected in many" 5 "amygdala: 59.0;basal ganglia: 29.8;cerebral cortex: 95.1;hippocampal formation: 35.8;olfactory region: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 565.3" "HPA045039, HPA069515" Enhanced Supported "Secreted to blood" "HPA045039: , HPA069515: " "unprognostic (3.36e-1)" "unprognostic (1.58e-1)" "unprognostic (1.92e-1)" "unprognostic (1.40e-3)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.39e-3)" "unprognostic (1.97e-2)" "unprognostic (3.91e-1)" "unprognostic (8.77e-2)" "unprognostic (1.35e-1)" "unprognostic (2.42e-1)" "unprognostic (1.37e-1)" "unprognostic (5.10e-2)" 0.9 1.1 59.0 1.1 29.8 0.8 0.9 0.2 95.1 0.8 11.3 1.4 0.0 71.6 0.8 0.8 0.9 0.9 0.9 0.9 35.8 10.8 0.8 0.9 1.1 0.8 8.0 26.9 0.8 1.1 0.8 4.1 9.4 1.3 13.5 0.9 0.0 0.8 1.0 0.8 0.9 10.5 1.0 1.3 0.8 1.7 1.7 0.5 0.0 0.8 0.0 0.8 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 8.7 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 22.7 0.1 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.0 29.8 0.2 95.1 35.8 10.8 8.0 26.9 1.3 0.5 CCKBR ENSG00000110148 "Cholecystokinin B receptor" P32239 11 6259736-6272127 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 12.9;pancreas: 34.7;stomach 1: 21.4" "Cell line enriched" "Detected in some" 9 "NTERA-2: 39.2" "Cancer enriched" "Detected in some" 8 "testis cancer: 9.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 15.5;basal ganglia: 15.3;cerebral cortex: 31.4;hippocampal formation: 26.8;olfactory region: 19.2" "unprognostic (2.82e-1)" "unprognostic (4.62e-2)" "unprognostic (1.79e-3)" "unprognostic (2.19e-1)" "unprognostic (1.95e-1)" "unprognostic (6.34e-4)" "unprognostic (8.01e-2)" "unprognostic (3.01e-2)" "unprognostic (9.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.06e-1)" "unprognostic (2.92e-1)" "unprognostic (1.30e-2)" 0.3 0.4 6.5 0.3 5.6 0.3 0.3 10.8 12.9 0.3 0.3 0.0 0.0 0.6 0.4 0.3 0.3 0.6 0.4 0.3 3.3 0.8 0.3 0.3 0.3 0.3 1.0 6.9 0.3 34.7 0.3 0.4 0.4 2.1 0.9 0.3 0.3 0.3 0.4 0.4 0.8 0.3 0.3 0.3 0.3 21.4 0.6 0.0 0.0 0.6 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.5 5.6 10.8 12.9 3.3 0.8 1.0 6.9 2.1 0.0 CCL3L1 "CCL3L3, D17S1718, G0S19-2, LD78BETA, MGC12815, SCYA3L, SCYA3L1" ENSG00000276085 "C-C motif chemokine ligand 3 like 1" P16619 17 36194869-36196758 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 17.7;brain: 16.5" "Group enriched" "Detected in some" 38 "U-266/70: 22.3;U-266/84: 44.3" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 7.7;neutrophil: 2.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 7.7" "Secreted to blood" "unprognostic (6.30e-2)" "unprognostic (8.18e-2)" "unprognostic (5.37e-2)" "unprognostic (1.46e-1)" "unprognostic (9.50e-2)" "unprognostic (2.18e-1)" "unprognostic (4.36e-2)" "unprognostic (3.69e-1)" "unprognostic (5.75e-2)" "unprognostic (5.55e-2)" "unprognostic (2.40e-2)" "unprognostic (3.66e-1)" "unprognostic (9.08e-2)" "unprognostic (2.09e-1)" "unprognostic (3.21e-1)" "unprognostic (1.90e-2)" "unprognostic (8.58e-2)" 0.4 0.1 0.0 3.5 2.2 17.7 0.2 0.0 9.0 0.7 0.4 16.5 0.0 0.4 0.6 0.6 0.1 0.2 1.9 0.1 0.0 0.6 2.7 4.0 0.9 0.0 0.1 1.2 0.3 0.1 0.0 3.0 4.4 0.9 0.3 1.9 2.3 0.4 0.1 0.1 0.6 0.3 0.2 2.7 0.3 2.5 0.0 1.3 0.3 0.6 0.7 0.9 0.0 0.0 0.1 7.7 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 22.3 44.3 0.5 0.0 0.0 0.0 0.3 0.1 7.7 0.9 0.0 0.6 0.0 0.0 0.6 0.1 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.1 CCNB3 ENSG00000147082 "Cyclin B3" Q8WWL7 X 50202713-50351910 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 6.1;epididymis: 11.6;pituitary gland: 3.7;testis: 14.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.8;Karpas-707: 3.9;U-2 OS: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA000496 Supported "Nuclear speckles" "Nuclear speckles" "HPA000496: AB_1078605" "unprognostic (1.57e-1)" "unprognostic (1.99e-1)" "unprognostic (7.19e-2)" "unprognostic (1.06e-1)" "unprognostic (9.96e-3)" "unprognostic (8.11e-2)" "unprognostic (1.86e-1)" "unprognostic (1.82e-2)" "unprognostic (1.34e-2)" "unprognostic (1.48e-3)" "unprognostic (6.93e-2)" "unprognostic (2.50e-1)" "unprognostic (1.67e-1)" "unprognostic (4.73e-2)" "unprognostic (1.87e-1)" "unprognostic (4.51e-2)" "unprognostic (2.63e-2)" 0.7 0.7 0.9 0.3 3.5 0.2 0.8 0.4 1.7 0.4 0.4 5.8 0.0 0.4 0.3 11.6 0.4 0.7 0.6 0.6 1.3 1.5 0.7 1.1 0.7 0.4 2.4 2.0 0.4 0.9 0.7 3.7 0.9 4.3 0.5 0.4 0.0 0.5 0.8 1.4 1.0 0.3 0.3 6.1 0.6 1.0 14.8 1.3 0.1 0.9 1.1 0.5 0.4 0.2 0.3 0.3 0.0 0.5 0.0 2.2 0.1 0.4 1.5 0.8 0.5 0.2 0.2 0.0 0.1 0.3 0.3 0.4 1.2 4.8 1.4 1.0 0.3 0.2 0.7 0.5 0.3 1.2 1.6 1.0 0.0 0.0 1.3 1.1 1.0 0.8 0.2 0.3 0.9 0.5 0.2 3.9 1.2 0.0 0.6 0.2 0.7 0.1 0.0 1.7 0.1 0.2 0.5 0.1 0.9 0.4 0.2 1.0 3.4 0.3 0.4 2.0 3.5 0.9 0.6 1.0 0.7 2.1 0.6 0.4 0.3 0.0 0.0 0.0 2.2 0.5 0.3 0.3 0.5 0.0 0.3 0.3 0.4 1.0 0.0 0.0 0.3 0.0 0.1 0.1 0.9 3.5 0.4 1.7 1.3 1.5 2.4 2.0 4.3 1.3 CCNE2 CYCE2 ENSG00000175305 "Cyclin E2" O96020 8 94879770-94896678 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.2;brain: 22.2;testis: 18.9" "Cell line enhanced" "Detected in many" "Karpas-707: 39.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 8.8" "Group enriched" "Detected in many" 4 "NK-cells: 2.2;T-cells: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007825, CAB019374" Enhanced "CAB007825: AB_598148, CAB019374: " "unprognostic (1.80e-2)" "unprognostic (4.81e-2)" "unprognostic (7.49e-2)" "unprognostic (2.08e-2)" "unprognostic (2.36e-1)" "prognostic favourable (5.87e-4)" "unprognostic (8.37e-4)" "prognostic unfavourable (8.77e-4)" "unprognostic (3.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.64e-2)" "unprognostic (1.04e-2)" "unprognostic (7.01e-12)" "unprognostic (1.81e-2)" "unprognostic (1.50e-1)" "unprognostic (1.06e-2)" "unprognostic (3.03e-1)" 1.3 0.9 3.1 4.9 11.3 24.2 1.5 3.3 6.3 1.7 4.0 10.4 0.0 2.6 1.3 0.1 3.6 1.0 1.7 0.9 5.7 3.5 0.9 1.6 1.7 7.9 8.0 6.5 1.4 2.3 0.5 1.1 3.1 11.8 1.3 4.3 0.6 1.5 0.0 0.8 4.4 3.1 1.4 22.2 1.9 2.9 18.9 4.9 12.7 1.1 2.4 7.0 1.9 1.9 1.1 1.3 1.1 0.3 2.2 8.8 1.1 17.7 2.4 9.5 5.9 1.1 2.1 6.5 18.3 6.4 11.5 11.3 4.2 8.0 9.3 12.5 7.7 9.4 7.3 6.7 15.6 6.5 6.8 18.8 10.0 1.6 0.1 7.5 11.5 0.6 0.4 8.3 0.8 5.9 8.0 39.3 16.3 5.1 28.7 3.5 3.2 5.5 20.5 16.4 4.4 3.2 10.0 13.8 5.8 12.3 3.3 2.3 16.5 8.0 5.0 12.2 8.0 9.0 16.3 7.5 7.8 22.7 9.9 13.8 8.9 0.0 0.3 0.2 1.6 0.3 0.5 0.7 2.0 2.3 1.3 1.1 0.6 1.3 1.1 2.2 0.3 0.1 8.8 1.1 3.1 11.3 3.3 5.7 5.7 3.5 8.0 6.5 11.8 4.9 CCNI CCNI1 ENSG00000118816 "Cyclin I" Q14094 4 77047158-77076005 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 248.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010206, HPA039853, HPA061470" Uncertain Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "CAB010206: AB_2073599, HPA039853: , HPA061470: " "unprognostic (3.68e-1)" "unprognostic (2.25e-1)" "unprognostic (7.59e-2)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (1.38e-1)" "unprognostic (8.57e-3)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (2.16e-1)" "prognostic favourable (2.10e-4)" "unprognostic (3.81e-2)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" 49.0 26.6 48.1 47.1 45.8 50.3 121.1 101.3 248.9 66.3 56.8 21.6 36.9 25.6 56.7 69.0 56.2 50.7 45.2 87.7 44.8 34.1 48.2 34.5 64.7 70.1 55.8 33.5 94.9 65.4 36.5 33.1 35.4 46.7 61.4 34.9 32.7 45.5 62.9 64.3 38.5 45.8 61.6 58.1 41.3 42.4 53.0 20.3 55.4 81.2 28.2 60.0 82.7 62.6 49.2 42.9 70.5 39.8 33.6 56.2 24.3 25.1 15.1 49.3 43.1 74.2 67.9 18.9 19.4 47.7 30.8 29.7 18.5 38.3 46.5 29.9 48.7 13.2 33.7 68.1 49.2 33.0 13.2 27.8 17.6 17.6 72.9 47.7 56.3 53.1 81.5 28.4 69.7 43.1 23.8 50.7 43.7 29.0 62.0 45.1 21.6 9.4 38.9 46.6 19.6 45.8 28.8 62.6 34.2 25.8 39.7 31.4 22.5 20.4 29.1 37.8 22.6 40.1 26.5 28.1 12.7 49.1 32.0 33.0 24.4 43.1 32.9 70.5 31.7 33.4 44.9 46.6 52.4 47.2 37.3 49.2 56.2 47.4 47.0 33.6 39.8 42.9 44.8 24.3 48.1 45.8 101.3 248.9 44.8 34.1 55.8 33.5 46.7 20.3 CCNJL FLJ14166 ENSG00000135083 "Cyclin J like" Q8IV13 5 160249106-160345396 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 48.9" "Cell line enhanced" "Detected in many" "HBEC3-KT: 26.3;WM-115: 19.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 19 "cerebellum: 48.9" "Group enriched" "Detected in some" 19 "neutrophil: 13.5;NK-cell: 4.1" "Group enriched" "Detected in many" 35 "granulocytes: 13.5;NK-cells: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049970 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA049970: " "unprognostic (1.09e-2)" "unprognostic (2.36e-2)" "prognostic favourable (7.31e-4)" "unprognostic (1.50e-3)" "unprognostic (1.79e-1)" "unprognostic (4.31e-2)" "unprognostic (1.60e-4)" "unprognostic (1.26e-2)" "unprognostic (6.92e-2)" "unprognostic (3.09e-1)" "unprognostic (2.57e-1)" "unprognostic (1.75e-2)" "unprognostic (6.27e-3)" "unprognostic (6.63e-3)" "unprognostic (2.62e-1)" "prognostic favourable (7.10e-4)" "prognostic favourable (8.02e-4)" 1.0 3.0 0.9 3.4 1.2 1.3 2.1 48.9 1.5 2.1 9.0 0.9 1.5 1.8 1.1 1.5 0.8 1.0 1.0 4.4 2.5 0.8 2.7 1.2 9.0 2.5 1.5 1.1 5.3 0.2 0.0 17.0 1.7 2.1 2.0 7.9 3.9 7.6 2.0 0.6 0.4 2.7 1.0 0.9 5.8 4.4 10.7 1.2 4.8 8.4 1.7 2.6 4.0 5.4 0.1 0.2 13.5 0.0 4.1 0.0 0.2 3.0 11.0 9.0 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.4 4.8 8.7 0.0 8.6 0.1 3.7 1.2 26.3 0.7 0.0 0.2 4.7 3.9 3.5 0.1 0.0 1.0 0.0 2.3 1.5 6.6 6.7 0.0 0.0 2.9 1.5 0.0 7.7 8.4 6.2 1.7 3.0 1.0 7.0 14.0 3.0 8.2 1.4 2.2 10.0 5.0 0.5 8.1 1.6 10.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 19.9 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 13.5 4.1 0.0 0.2 0.0 0.2 0.9 1.2 48.9 1.5 2.5 0.8 1.5 1.1 2.1 1.2 CCP110 "CP110, KIAA0419" ENSG00000103540 "Centriolar coiled-coil protein 110" O43303 16 19523811-19553408 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039402 Approved Supported Centrosome Centrosome "HPA039402: AB_10671041" "unprognostic (2.83e-1)" "unprognostic (2.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-1)" "unprognostic (4.88e-2)" "unprognostic (9.68e-2)" "unprognostic (3.25e-2)" "unprognostic (2.68e-1)" "unprognostic (6.50e-2)" "unprognostic (1.92e-2)" "unprognostic (8.99e-3)" "unprognostic (2.74e-2)" "unprognostic (1.82e-1)" "unprognostic (3.01e-2)" "unprognostic (1.37e-1)" 5.2 5.9 19.0 6.0 39.1 12.6 9.0 19.1 28.4 7.6 4.5 13.2 4.6 3.7 8.9 7.3 6.4 13.0 5.7 4.4 23.6 15.0 4.5 3.4 8.1 7.1 40.0 13.3 10.6 3.7 9.6 17.2 4.6 20.6 7.3 5.5 2.1 4.8 7.1 4.3 5.5 4.5 7.6 16.0 5.8 6.1 31.6 36.6 10.9 6.9 1.9 7.1 5.7 6.6 4.5 4.0 13.0 5.3 2.3 5.6 2.5 11.2 5.2 12.9 12.5 6.5 5.8 6.7 12.0 7.0 10.7 12.1 4.2 6.0 16.5 7.6 5.9 7.9 13.2 3.8 18.1 7.5 6.0 8.2 7.2 7.2 3.2 21.1 10.6 2.8 5.3 12.0 7.4 8.2 8.6 8.3 12.5 8.7 21.6 8.2 9.9 3.9 27.6 24.1 5.8 4.9 4.7 25.5 12.9 13.0 6.2 3.9 11.3 12.9 4.8 12.5 8.3 8.4 9.8 9.3 8.6 12.0 8.0 9.1 7.3 13.0 3.8 6.7 5.5 3.6 3.5 3.3 4.9 5.2 4.0 4.5 5.6 3.2 7.7 2.3 5.3 2.6 3.9 2.5 19.0 39.1 19.1 28.4 23.6 15.0 40.0 13.3 20.6 36.6 CCSAP "C1orf96, CSAP, FLJ41471" ENSG00000154429 "Centriole, cilia and spindle associated protein" Q6IQ19 1 229321005-229343294 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.6;placenta: 28.7" "Cell line enhanced" "Detected in all" "BEWO: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028402, HPA043443" Enhanced "HPA028402: AB_10603681, HPA043443: AB_2678485" "unprognostic (4.93e-2)" "unprognostic (7.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (1.48e-1)" "prognostic unfavourable (1.41e-4)" "unprognostic (2.63e-1)" "unprognostic (1.18e-1)" "unprognostic (3.26e-1)" "unprognostic (4.97e-2)" "unprognostic (1.57e-1)" "prognostic unfavourable (4.50e-13)" "unprognostic (9.67e-2)" "unprognostic (4.93e-1)" "unprognostic (4.15e-2)" "unprognostic (1.03e-1)" 3.4 3.9 19.3 4.9 20.5 13.3 6.8 29.9 39.6 3.7 3.1 9.8 1.4 3.8 3.7 3.0 4.1 2.3 3.7 3.1 14.1 8.9 2.2 3.8 4.8 4.6 9.8 20.7 6.9 3.0 4.3 5.7 28.7 8.9 4.7 3.7 4.9 4.7 3.8 3.0 13.3 3.4 3.0 10.7 5.3 3.4 2.7 11.3 8.5 2.8 0.4 4.2 3.7 2.8 1.0 1.9 5.8 3.2 0.5 2.0 0.4 6.4 3.5 4.7 8.6 3.2 3.0 38.5 4.7 2.4 5.4 5.2 4.3 4.0 4.1 3.5 4.1 5.1 10.0 3.5 5.5 7.6 9.7 4.3 3.5 3.1 2.0 7.0 8.5 1.1 2.8 4.2 5.4 3.8 5.8 6.3 4.3 2.2 19.7 7.4 4.4 5.2 5.8 12.1 2.7 2.5 4.0 9.6 12.9 8.8 5.3 4.5 4.2 9.8 2.5 4.7 7.2 6.4 7.3 5.8 8.9 3.0 5.6 7.0 5.5 5.8 1.5 3.1 0.9 3.0 2.0 0.5 1.1 1.3 1.3 1.0 1.1 0.9 2.4 0.5 3.2 1.9 1.4 0.4 19.3 20.5 29.9 22.1 14.1 8.9 9.8 20.7 8.9 11.3 CCSER1 "FAM190A, KIAA1680" ENSG00000184305 "Coiled-coil serine rich protein 1" Q9C0I3 4 90127535-91601913 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0" "Cell line enhanced" "Detected in some" "HDLM-2: 4.5;RT4: 3.7;SCLC-21H: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 1.0;myeloid DC: 1.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041880, HPA054709" Uncertain "HPA041880: AB_10796461, HPA054709: AB_2682581" "unprognostic (4.03e-4)" "unprognostic (4.21e-3)" "unprognostic (6.45e-2)" "unprognostic (2.44e-2)" "unprognostic (3.32e-1)" "unprognostic (3.45e-2)" "unprognostic (5.61e-2)" "unprognostic (8.13e-2)" "unprognostic (1.24e-1)" "unprognostic (5.36e-3)" "unprognostic (2.87e-1)" "unprognostic (2.04e-1)" "unprognostic (2.42e-6)" "unprognostic (1.21e-1)" "unprognostic (1.14e-1)" "unprognostic (1.64e-4)" "unprognostic (6.94e-2)" 2.9 6.4 2.4 1.9 5.2 3.4 4.5 17.0 7.6 2.2 3.4 0.0 6.3 2.0 2.1 2.1 2.1 4.1 1.9 4.7 7.4 1.9 5.6 1.7 2.1 2.3 1.8 7.6 1.9 3.3 1.7 10.4 1.4 2.1 3.0 1.8 2.9 5.0 7.1 1.7 3.0 6.4 1.7 2.5 2.7 2.6 11.4 0.5 0.0 4.6 0.0 2.6 4.9 5.9 1.0 1.0 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.1 0.0 0.2 0.3 0.0 0.0 4.5 0.3 1.2 0.9 0.1 0.0 1.6 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.1 0.2 0.4 0.8 0.1 0.0 0.3 0.3 3.7 3.9 1.5 0.0 1.2 0.0 0.8 0.0 0.4 0.0 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 1.0 0.9 0.1 0.1 0.0 0.3 0.0 0.3 0.0 0.0 2.4 5.2 17.0 7.6 7.4 1.9 1.8 7.6 2.1 0.5 CD160 "BY55, NK1, NK28" ENSG00000117281 "CD160 molecule" O95971 1 145719471-145739288 "CD markers, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.9;brain: 15.2;intestine: 19.9;lymphoid tissue: 17.4" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 15.2" "Group enriched" "Detected in many" 9 "gdT-cell: 33.9;MAIT T-cell: 14.4;memory CD8 T-cell: 22.9;naive CD8 T-cell: 27.3;NK-cell: 23.2" "Group enriched" "Detected in many" 11 "NK-cells: 23.2;T-cells: 33.9" "Not detected" "Not detected" "Intracellular and membrane" "unprognostic (6.54e-4)" "unprognostic (1.06e-1)" "unprognostic (4.25e-2)" "unprognostic (6.91e-2)" "unprognostic (3.33e-1)" "unprognostic (3.40e-2)" "unprognostic (1.35e-1)" "unprognostic (8.25e-3)" "unprognostic (5.76e-2)" "unprognostic (2.68e-1)" "unprognostic (2.24e-2)" "unprognostic (7.49e-3)" "unprognostic (3.48e-5)" "unprognostic (4.05e-2)" "unprognostic (2.03e-1)" "unprognostic (2.89e-2)" "unprognostic (2.92e-4)" 0.6 0.2 2.2 3.6 2.6 5.1 0.6 15.2 3.1 0.8 9.3 0.4 0.3 5.6 0.8 1.4 0.9 0.6 1.2 0.6 1.6 2.2 0.5 5.9 3.8 6.0 1.6 0.3 1.1 2.2 0.0 0.4 1.8 0.6 1.3 1.0 0.9 3.0 0.4 1.0 1.1 19.9 1.4 1.0 17.4 0.8 0.8 0.3 2.9 0.4 0.3 3.1 0.7 0.3 0.2 0.3 2.7 0.4 23.2 33.9 20.2 1.3 1.0 1.6 0.9 0.0 0.3 0.3 0.1 0.0 0.2 0.1 0.6 0.1 1.7 1.3 0.2 1.6 0.2 0.2 0.1 3.5 1.6 3.1 4.6 1.2 0.1 2.0 3.2 0.2 0.4 0.1 0.3 0.0 0.8 1.5 0.1 1.5 1.2 4.0 1.1 2.8 0.3 0.2 1.0 0.0 0.6 1.2 1.5 0.9 1.3 0.6 1.5 2.0 1.8 1.3 0.6 0.7 3.0 2.3 1.6 0.6 0.7 2.4 0.2 2.7 0.1 0.1 33.9 0.1 14.4 0.2 0.4 22.9 0.0 0.2 0.2 27.3 1.7 23.2 0.4 0.3 0.0 20.2 2.2 2.6 15.2 3.1 1.6 2.2 1.6 0.3 0.6 0.3 CD300A "CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60" ENSG00000167851 "CD300a molecule" Q9UGN4 17 74466416-74484796 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 81.1;brain: 28.7;lymphoid tissue: 57.8" "Group enriched" "Detected in some" 5 "HMC-1: 41.3;NB-4: 16.8;RPMI-8226: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA011645 Approved "Intracellular and membrane" 2800000 "HPA011645: AB_1846988" "unprognostic (1.99e-1)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.01e-1)" "unprognostic (1.04e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.17e-2)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (1.91e-5)" "unprognostic (5.97e-2)" "unprognostic (5.45e-3)" "unprognostic (1.36e-1)" "unprognostic (5.72e-2)" 8.6 4.5 9.8 16.0 17.7 11.9 4.4 2.2 11.5 2.0 4.8 3.7 0.0 6.0 1.9 1.3 2.1 2.1 7.7 3.4 7.3 4.2 3.0 7.5 10.6 19.0 20.1 0.3 1.5 2.1 0.3 3.0 6.9 12.6 2.8 4.7 2.3 3.0 1.3 1.1 2.3 7.4 6.0 28.7 57.8 2.4 1.5 17.4 4.1 1.9 0.5 6.0 5.4 2.1 2.2 19.4 81.1 45.7 52.1 29.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 1.9 41.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.5 16.8 0.0 0.0 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.0 81.1 20.4 57.3 29.5 45.7 6.2 2.2 6.1 8.7 19.4 0.6 2.3 7.1 71.6 52.1 44.2 18.1 0.3 19.2 9.8 17.7 2.2 11.5 7.3 4.2 20.1 0.3 12.6 17.4 CD86 "B7-2, B7.2, CD28LG2" ENSG00000114013 "CD86 molecule" P42081 3 122055366-122121139 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.0;brain: 26.1" "Cell line enriched" "Detected in some" 7 "HDLM-2: 78.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 25.6;intermediate monocyte: 26.4;memory B-cell: 13.6;myeloid DC: 25.9;naive B-cell: 8.0;non-classical monocyte: 27.0" "Group enriched" "Detected in many" 17 "B-cells: 13.6;dendritic cells: 25.9;monocytes: 27.0" "Low region specificity" "Detected in all" CAB004319 Approved 220000 "CAB004319: AB_627200" "unprognostic (1.81e-1)" "unprognostic (3.78e-3)" "unprognostic (3.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-1)" "unprognostic (1.15e-1)" "unprognostic (8.56e-2)" "unprognostic (7.72e-3)" "unprognostic (1.21e-1)" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "prognostic unfavourable (9.83e-5)" "unprognostic (9.72e-2)" "unprognostic (1.70e-2)" "unprognostic (9.78e-2)" "unprognostic (8.67e-2)" 10.5 4.7 7.1 23.6 9.5 6.0 3.6 1.5 6.3 2.9 4.3 9.8 0.6 2.5 2.6 5.2 2.8 3.3 10.4 3.5 7.3 6.0 4.0 7.8 13.0 17.8 11.7 3.0 2.5 2.3 2.1 2.6 10.3 8.1 3.1 5.6 3.0 3.6 1.8 1.3 2.4 6.9 5.1 26.1 22.5 3.4 2.4 10.3 7.7 2.3 2.1 15.0 9.2 2.2 13.6 25.9 0.3 27.0 1.2 0.4 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 78.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 4.2 0.1 9.4 0.0 0.2 0.0 0.0 25.6 0.2 0.0 26.4 0.0 13.6 0.1 0.1 25.9 8.0 0.0 0.0 0.3 1.2 27.0 2.6 0.4 9.3 7.1 9.5 1.5 6.3 7.3 6.0 11.7 3.0 8.1 10.3 CD99 MIC2 ENSG00000002586 "CD99 molecule (Xg blood group)" P14209 X 2691133-2741309 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 359.1;breast: 433.0;heart muscle: 347.0" "Cell line enhanced" "Detected in many" "ASC diff: 124.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000020, HPA035304" Supported Approved "Golgi apparatus" 34000000 "Golgi apparatus" "CAB000020: AB_2076419, HPA035304: AB_10672861" "unprognostic (3.71e-3)" "unprognostic (2.90e-1)" "unprognostic (5.97e-3)" "unprognostic (7.01e-3)" "unprognostic (2.14e-2)" "unprognostic (6.98e-3)" "unprognostic (3.89e-3)" "unprognostic (1.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "prognostic unfavourable (5.87e-7)" "unprognostic (2.11e-2)" "unprognostic (2.18e-1)" "unprognostic (5.37e-2)" "unprognostic (3.61e-2)" 45.7 14.1 85.8 14.4 100.5 11.1 433.0 45.7 60.9 243.9 31.8 4.5 4.5 19.9 258.4 18.3 26.1 22.2 35.2 347.0 103.4 14.7 66.4 24.6 24.5 16.6 161.0 56.6 187.4 28.9 3.3 67.0 138.7 185.5 30.5 20.6 4.5 18.1 37.7 18.9 28.0 23.8 31.1 359.1 18.5 21.7 23.3 101.3 4.5 15.2 4.5 16.1 24.7 208.8 32.7 62.6 4.3 47.1 32.1 107.1 103.6 23.8 27.4 30.6 41.4 124.2 94.2 18.4 64.0 100.3 40.2 58.6 39.5 16.8 1.6 12.5 88.7 9.3 12.2 16.1 33.4 32.4 30.8 4.6 19.1 34.3 39.4 7.3 36.5 58.5 19.9 22.0 15.5 73.3 5.7 0.0 37.9 18.7 63.6 24.9 10.0 29.9 10.8 25.6 45.2 23.2 16.4 0.1 13.5 15.4 13.8 38.4 12.2 22.8 67.6 49.6 8.4 47.3 21.5 0.1 0.0 10.4 33.2 18.3 30.9 1.8 47.1 1.5 107.1 11.6 60.4 32.7 72.6 94.6 44.6 20.2 26.8 57.1 4.3 32.1 2.6 62.6 74.3 103.6 85.8 100.5 45.7 60.9 103.4 14.7 161.0 56.6 185.5 101.3 CDH10 ENSG00000040731 "Cadherin 10" Q9Y6N8 5 24487100-24644978 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 45.4" "Cell line enhanced" "Detected in some" "AF22: 11.5;AN3-CA: 1.8;HAP1: 7.3;U-138 MG: 2.5" "Group enriched" "Detected in some" 7 "glioma: 5.3;prostate cancer: 1.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010651 Approved "HPA010651: AB_1078370" "unprognostic (4.31e-3)" "unprognostic (2.77e-1)" "unprognostic (1.88e-1)" "unprognostic (3.66e-2)" "unprognostic (4.48e-1)" "unprognostic (6.11e-3)" "unprognostic (6.27e-2)" "unprognostic (1.59e-7)" "unprognostic (1.65e-2)" "unprognostic (1.41e-1)" "unprognostic (8.74e-3)" 0.9 2.1 9.4 0.8 9.6 0.8 1.0 45.4 34.0 0.9 1.1 1.5 0.0 0.9 0.9 0.8 0.9 0.9 1.2 0.9 9.4 5.2 1.0 0.8 1.1 0.8 3.6 13.4 0.8 0.9 0.8 2.1 0.8 6.0 8.6 1.3 0.0 0.8 1.4 0.8 0.8 1.1 0.9 7.0 0.8 1.0 1.4 3.7 0.0 0.8 0.0 0.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 2.5 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 9.6 45.4 21.3 9.4 5.2 3.6 13.4 6.0 3.7 CDH12 "Br-cadherin, CDHB" ENSG00000154162 "Cadherin 12" P55289 5 21750673-22853622 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;cervix, uterine: 9.3;pituitary gland: 8.6" "Cell line enhanced" "Detected in some" "HeLa: 1.5;PC-3: 5.1;SCLC-21H: 7.4;U-2 OS: 3.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029325 Uncertain Uncertain Vesicles Vesicles "HPA029325: " "unprognostic (2.38e-1)" "unprognostic (3.21e-1)" "unprognostic (4.95e-2)" "unprognostic (8.61e-2)" "unprognostic (3.31e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (3.26e-2)" "unprognostic (1.34e-1)" "unprognostic (3.51e-2)" "unprognostic (3.25e-4)" "unprognostic (7.35e-2)" "unprognostic (3.48e-2)" "unprognostic (5.19e-2)" 0.5 5.2 5.8 0.3 17.7 0.4 1.7 2.0 13.8 9.3 0.5 0.0 0.0 0.5 1.3 1.0 0.4 6.7 0.3 0.5 6.3 3.4 0.7 0.5 0.8 0.3 1.4 4.8 0.5 0.5 0.6 8.6 0.7 4.2 0.5 0.6 1.4 3.1 0.9 0.5 2.5 0.4 0.9 2.5 0.3 0.4 2.9 0.5 0.0 0.4 0.0 0.5 1.5 0.2 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.0 1.0 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.7 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.1 0.2 0.0 0.1 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.0 5.8 17.7 2.0 13.8 6.3 3.4 1.4 4.8 4.2 0.5 CDH15 "CDH14, CDH3" ENSG00000129910 "Cadherin 15" P55291 16 89171767-89195492 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 44.2;skeletal muscle: 60.3" "Cell line enriched" "Detected in some" 5 "RH-30: 56.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 24 "cerebellum: 44.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "cerebellum: 17.6" "Region enriched" "Detected in many" 6 "cerebellum: 17.9" "HPA009139, HPA070961" Enhanced Supported Enhanced "Golgi apparatus,Plasma membrane" 390000 "Golgi apparatus, Plasma membrane" "HPA009139: AB_1078372, HPA070961: " "unprognostic (1.26e-1)" "unprognostic (7.70e-3)" "unprognostic (6.64e-3)" "unprognostic (2.81e-1)" "unprognostic (7.79e-3)" "unprognostic (2.70e-3)" "unprognostic (2.84e-3)" "unprognostic (4.37e-2)" "unprognostic (2.30e-3)" "unprognostic (7.66e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.14e-7)" "unprognostic (3.09e-2)" "unprognostic (3.13e-1)" "unprognostic (5.50e-2)" "unprognostic (2.64e-2)" 0.8 0.2 0.0 0.1 0.0 0.1 0.1 44.2 0.2 0.7 0.1 0.0 0.0 0.2 0.1 2.8 0.6 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.2 0.1 0.0 0.0 0.1 0.9 0.1 0.0 0.8 1.8 0.5 0.1 0.0 0.3 0.2 60.3 0.1 0.1 0.1 0.3 0.6 0.1 0.3 0.0 0.0 0.1 6.5 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 12.0 0.0 0.0 0.0 0.0 0.1 0.0 56.6 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 44.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 CDH18 "CDH14, EY-CADHERIN" ENSG00000145526 "Cadherin 18" Q13634 5 19472951-20575873 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 105.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;BEWO: 3.7;EFO-21: 6.3;U-2 OS: 9.9;U-2197: 8.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 7 "cerebellum: 105.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014416 Uncertain "Intracellular and membrane" "HPA014416: " "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (5.26e-7)" "unprognostic (6.36e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (8.78e-2)" "unprognostic (3.30e-2)" "unprognostic (1.51e-2)" "unprognostic (8.69e-2)" "unprognostic (1.76e-2)" 0.7 9.3 6.9 0.7 7.1 0.7 0.6 105.4 23.2 1.0 0.6 0.0 0.0 0.7 0.6 0.6 0.7 0.7 0.7 0.6 4.6 8.1 0.9 0.6 0.7 0.8 1.8 8.3 0.7 1.2 2.1 11.3 0.6 7.1 0.8 0.7 2.2 0.6 0.8 0.9 0.8 0.7 0.6 2.2 0.7 0.6 3.7 1.3 0.0 0.6 0.0 0.6 0.6 0.3 0.7 0.3 1.2 0.5 0.6 0.4 0.5 1.6 0.0 0.3 0.0 1.0 4.1 3.7 0.2 2.3 0.1 0.7 0.0 0.0 0.0 6.3 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.1 2.5 0.0 0.2 0.7 0.4 0.2 0.0 0.2 0.3 0.2 0.0 0.1 1.2 0.0 0.0 0.8 0.2 0.1 0.1 0.0 0.1 0.0 0.0 1.9 9.9 8.7 0.0 2.4 0.0 0.0 2.8 0.0 0.0 1.1 0.5 0.3 0.4 0.1 0.2 0.3 0.2 0.2 0.2 0.7 0.4 0.4 1.2 0.6 0.4 0.3 0.2 0.5 6.9 7.1 105.4 14.1 4.6 8.1 1.8 8.3 7.1 1.3 CDH20 "Cdh7, CDH7L3" ENSG00000101542 "Cadherin 20" Q9HBT6 18 61333582-61555773 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 8.8;brain: 32.8" "Cell line enhanced" "Detected in some" "AF22: 3.1;ASC diff: 9.9;HHSteC: 4.6;SH-SY5Y: 6.7" "Cancer enriched" "Detected in single" 15 "glioma: 6.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "basophil: 4.5" "Lineage enriched" "Detected in single" 39 "granulocytes: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015490 Uncertain "HPA015490: AB_1845900" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (1.42e-2)" "unprognostic (3.68e-3)" "unprognostic (2.11e-1)" "unprognostic (5.15e-2)" "unprognostic (2.87e-2)" "unprognostic (1.40e-2)" "unprognostic (1.52e-1)" "unprognostic (3.69e-2)" "unprognostic (1.82e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-1)" "unprognostic (3.82e-2)" "unprognostic (1.27e-1)" "unprognostic (3.01e-2)" "unprognostic (1.93e-1)" 8.8 1.2 13.4 1.1 13.7 1.0 1.2 6.9 32.8 1.5 1.1 16.8 0.0 1.0 1.1 2.3 2.5 1.3 1.1 1.1 16.0 7.3 1.2 1.0 1.0 1.1 20.4 9.8 1.0 1.3 1.0 1.1 1.1 12.6 1.5 1.0 0.5 1.0 1.1 3.4 2.0 1.0 1.1 12.8 1.2 1.1 1.4 18.9 0.0 1.2 0.5 1.0 1.1 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.4 0.0 0.0 3.1 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 13.4 13.7 6.9 14.0 16.0 7.3 20.4 9.8 12.6 18.9 CDH22 "C20orf25, dJ998H6.1" ENSG00000149654 "Cadherin 22" Q9UJ99 20 46173733-46308498 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.8" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 8.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "cerebellum: 55.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012164, HPA012715" Uncertain Supported "HPA012164: AB_1845902, HPA012715: " "unprognostic (2.41e-4)" "unprognostic (1.72e-2)" "unprognostic (3.10e-1)" "unprognostic (4.32e-3)" "unprognostic (3.39e-2)" "unprognostic (4.73e-1)" "unprognostic (4.32e-1)" "unprognostic (2.54e-2)" "unprognostic (5.54e-2)" "unprognostic (4.50e-4)" "unprognostic (2.62e-1)" "unprognostic (3.09e-1)" "unprognostic (7.26e-3)" "unprognostic (5.93e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (9.83e-2)" 0.7 4.2 10.2 0.5 5.7 0.5 0.8 55.8 15.5 0.7 0.6 1.0 0.0 0.6 0.7 0.7 1.2 4.0 0.5 1.0 3.5 3.7 0.7 0.5 0.6 0.5 1.2 8.7 0.9 4.2 0.5 1.1 0.5 3.0 1.5 0.7 1.8 1.0 1.8 1.2 10.4 0.9 0.5 1.9 0.5 0.9 1.4 1.3 0.0 0.7 0.0 0.5 0.5 0.6 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 10.2 5.7 55.8 14.8 3.5 3.7 1.2 8.7 3.0 1.3 CDH4 ENSG00000179242 "Cadherin 4" P55283 20 61252426-61940617 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;lymphoid tissue: 10.2;skeletal muscle: 9.8" "Cell line enhanced" "Detected in some" "AF22: 7.9;hTERT-HME1: 10.4;U-2 OS: 14.2;U-251 MG: 24.7" "Group enriched" "Detected in many" 6 "glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015613 Supported "Plasma membrane" "Plasma membrane" "HPA015613: AB_1845905" "unprognostic (1.64e-1)" "unprognostic (1.19e-2)" "unprognostic (3.39e-4)" "unprognostic (2.16e-1)" "unprognostic (2.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.64e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" "unprognostic (6.72e-2)" "unprognostic (6.08e-3)" "unprognostic (1.75e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-2)" "unprognostic (6.78e-2)" 1.0 1.2 17.4 0.7 15.8 0.9 0.9 1.3 13.6 0.9 0.7 4.0 0.0 0.8 0.9 0.7 1.4 2.6 0.9 1.0 10.2 6.9 0.8 0.9 1.0 0.9 2.8 11.8 6.2 2.0 0.7 0.5 0.9 3.3 0.8 0.7 0.6 1.5 3.6 9.8 2.7 0.8 0.7 1.6 10.2 0.8 1.9 3.1 0.0 1.7 0.0 0.7 0.8 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.9 7.9 0.0 0.1 0.5 0.1 2.2 0.0 4.0 0.4 0.2 0.0 0.0 0.2 2.6 2.9 0.0 4.3 1.6 0.2 0.0 0.0 0.1 0.1 5.5 0.0 0.1 0.8 1.0 0.8 10.4 0.8 0.0 0.0 1.6 0.3 0.1 0.0 0.9 0.0 0.0 0.0 1.1 2.5 0.0 0.7 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 14.2 0.1 24.7 4.6 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.0 17.4 15.8 1.3 13.6 10.2 6.9 2.8 11.8 3.3 3.1 CDH7 ENSG00000081138 "Cadherin 7" Q9ULB5 18 65750252-65890341 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 16.7" "Cell line enhanced" "Detected in some" "AF22: 16.9;HEK 293: 3.2;Karpas-707: 6.2;RH-30: 8.1;U-87 MG: 3.8" "Cancer enhanced" "Detected in single" "prostate cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061419 Approved "HPA061419: " "unprognostic (2.81e-3)" "unprognostic (6.95e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (3.45e-2)" "unprognostic (2.41e-1)" "unprognostic (3.95e-3)" "unprognostic (2.88e-1)" "unprognostic (4.28e-4)" "unprognostic (2.70e-2)" "unprognostic (1.49e-1)" "unprognostic (1.72e-1)" 0.4 0.6 2.6 0.3 4.3 0.6 0.4 15.3 7.5 0.3 0.3 0.0 0.0 0.4 0.3 0.6 0.3 0.3 0.4 0.4 0.5 2.5 0.3 0.6 0.4 0.3 1.5 2.1 1.6 0.3 0.3 1.2 0.3 16.7 3.6 0.5 1.3 0.4 1.9 1.0 0.5 0.3 0.2 1.3 0.4 0.3 1.8 0.1 0.7 0.5 0.0 0.4 0.3 0.2 0.8 0.5 1.9 0.4 0.6 0.4 0.1 0.0 0.2 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.1 0.7 0.3 0.1 8.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.8 1.3 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 3.8 0.0 0.0 1.2 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.8 0.4 0.4 1.9 0.6 0.3 0.5 0.2 0.1 2.6 4.3 15.3 5.2 0.5 2.5 1.5 2.1 16.7 0.1 CDH8 ENSG00000150394 "Cadherin 8" P55286 16 61647242-62037035 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 29.6;seminal vesicle: 9.5" "Group enriched" "Detected in some" 4 "AF22: 6.8;fHDF/TERT166: 6.0;HaCaT: 13.6;LHCN-M2: 16.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014908, HPA076441" Approved Approved "Plasma membrane" "Plasma membrane" "HPA014908: AB_1845908, HPA076441: " "unprognostic (1.91e-1)" "unprognostic (2.41e-1)" "unprognostic (4.02e-2)" "unprognostic (7.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.26e-2)" "unprognostic (1.83e-1)" "unprognostic (8.71e-2)" "unprognostic (3.66e-2)" "unprognostic (5.41e-2)" "unprognostic (2.85e-1)" "unprognostic (6.59e-2)" "unprognostic (2.91e-4)" "unprognostic (6.02e-2)" "unprognostic (4.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.06e-1)" 0.9 0.9 13.0 0.7 20.4 0.7 1.2 0.5 29.6 1.4 0.8 5.5 0.0 1.2 0.9 1.1 1.0 0.7 1.1 1.1 10.4 7.7 0.8 0.7 0.9 0.7 9.3 12.2 3.7 0.7 0.8 0.9 1.3 12.8 1.4 0.9 0.0 1.4 9.5 1.4 0.9 1.0 1.4 7.7 0.8 0.8 1.2 5.6 0.0 1.0 0.0 0.8 1.7 0.3 0.0 0.0 1.0 0.2 0.1 0.1 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.0 13.6 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.3 0.0 16.4 0.0 0.0 0.0 1.2 1.2 0.0 0.0 1.0 0.0 1.8 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.0 13.0 20.4 0.5 17.8 10.4 7.7 9.3 12.2 12.8 5.6 CDH9 ENSG00000113100 "Cadherin 9" Q9ULB4 5 26880600-27121150 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 46.8" "Cell line enhanced" "Detected in some" "K-562: 9.2;NTERA-2: 13.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "amygdala: 46.8;basal ganglia: 24.6;cerebral cortex: 23.7;hippocampal formation: 15.9;olfactory region: 15.6" "Cell type enhanced" "Detected in some" "neutrophil: 8.3" "Group enriched" "Detected in many" 5 "B-cells: 4.1;granulocytes: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007167 Approved "HPA007167: AB_1078489" "unprognostic (1.49e-1)" "unprognostic (2.27e-4)" 0.7 0.5 46.8 1.0 24.6 2.8 0.7 0.5 23.7 0.5 0.8 0.0 0.0 0.6 0.9 1.2 0.7 0.5 0.7 0.5 15.9 3.5 10.5 0.5 0.6 1.6 1.2 15.6 0.6 1.1 1.0 0.5 0.8 1.5 1.0 1.2 0.0 0.5 0.1 0.5 1.9 1.5 0.8 0.6 0.8 0.9 3.7 2.6 0.0 1.9 0.0 1.7 0.5 0.5 4.1 0.9 8.3 1.1 0.1 0.8 1.1 2.4 0.9 0.5 0.8 0.4 0.0 1.6 0.0 0.9 0.3 0.6 0.0 0.9 1.3 0.3 0.3 0.3 0.1 0.5 0.0 0.1 0.2 0.5 0.7 2.5 0.0 0.0 1.5 0.6 0.7 0.0 0.0 0.2 9.2 2.3 0.0 1.5 0.8 0.5 13.6 0.5 0.3 0.3 0.4 0.5 0.5 3.1 0.3 0.0 0.4 0.4 0.5 0.9 1.7 0.1 0.8 0.8 0.3 2.7 1.0 4.3 1.0 1.0 0.8 1.3 0.2 0.4 0.2 0.7 0.6 4.1 0.4 0.2 0.1 2.5 0.3 0.5 8.3 0.1 1.1 0.9 0.8 1.1 46.8 24.6 0.5 23.7 15.9 3.5 1.2 15.6 1.5 2.6 CDHR1 "CORD15, KIAA1775, PCDH21, RP65" ENSG00000148600 "Cadherin related family member 1" Q96JP9 10 84194635-84219621 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cone-rod dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 31.2;intestine: 22.6;retina: 42.5;skin 1: 86.8" "Cell line enhanced" "Detected in some" "HAP1: 10.3;HEK 293: 5.3;HEL: 6.2;K-562: 4.4;NTERA-2: 4.5;RPTEC TERT1: 16.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 13.8" "Region enhanced" "Detected in many" "basal ganglia: 31.2" "Cell type enriched" "Detected in single" 11 "NK-cell: 10.5" "Lineage enriched" "Detected in single" 11 "NK-cells: 10.5" "Region enriched" "Detected in some" 21 "olfactory region: 408.8" "Low region specificity" "Detected in all" HPA036819 Enhanced "Intracellular and membrane" "HPA036819: AB_10671750" "unprognostic (8.91e-4)" "unprognostic (5.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.71e-2)" "unprognostic (2.63e-2)" "unprognostic (3.03e-2)" "unprognostic (6.40e-2)" "unprognostic (7.77e-2)" "unprognostic (1.41e-1)" "unprognostic (2.67e-1)" "unprognostic (6.69e-4)" "unprognostic (1.90e-1)" "unprognostic (5.51e-3)" "unprognostic (1.26e-1)" "unprognostic (2.27e-1)" "unprognostic (4.56e-3)" "unprognostic (5.07e-2)" 0.3 1.2 1.9 0.7 31.2 0.5 2.3 0.9 7.7 2.8 12.3 2.2 0.0 0.3 0.6 2.2 4.8 0.6 0.5 0.9 3.4 2.1 0.5 0.5 0.4 0.7 1.5 3.1 0.8 0.4 0.3 1.5 0.4 9.3 0.9 22.6 42.5 1.0 2.2 0.7 86.8 5.3 0.9 1.2 3.0 0.4 0.4 3.0 2.4 0.4 3.3 0.9 0.4 1.5 0.0 0.0 0.0 0.0 10.5 0.9 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 10.3 2.0 0.0 0.0 5.3 6.2 0.0 0.0 0.2 0.0 0.2 0.0 2.2 0.0 0.7 0.0 4.4 0.0 0.0 0.0 0.0 1.5 4.5 0.0 0.0 0.0 1.3 16.8 0.0 3.5 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.1 1.9 31.2 0.9 7.7 3.4 2.1 1.5 3.1 9.3 3.0 CDK18 "PCTAIRE3, PCTK3" ENSG00000117266 "Cyclin dependent kinase 18" Q07002 1 205504595-205532793 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 98.7;heart muscle: 58.9" "Cell line enhanced" "Detected in many" "HBEC3-KT: 20.9;HeLa: 18.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045429 Approved Approved "Actin filaments" "Actin filaments" "HPA045429: AB_10961257" "unprognostic (7.95e-2)" "unprognostic (3.42e-1)" "unprognostic (1.51e-1)" "unprognostic (1.33e-1)" "unprognostic (4.38e-2)" "unprognostic (1.30e-1)" "unprognostic (7.06e-3)" "unprognostic (2.93e-1)" "unprognostic (2.95e-1)" "unprognostic (1.13e-1)" "unprognostic (8.89e-2)" "unprognostic (2.81e-1)" "prognostic unfavourable (5.07e-6)" "unprognostic (6.07e-2)" "unprognostic (1.45e-1)" "unprognostic (6.12e-2)" "prognostic favourable (2.81e-5)" 2.6 4.3 13.6 2.7 31.8 1.0 2.4 4.2 25.0 7.6 6.9 38.1 20.2 17.3 3.4 4.0 2.7 5.7 6.4 58.9 22.1 16.2 13.7 4.7 6.5 1.9 47.8 16.7 7.5 10.7 3.7 4.0 9.6 22.1 3.1 6.1 5.3 16.5 23.5 3.9 1.6 15.1 4.8 98.7 3.5 9.1 0.9 36.4 0.4 4.8 1.4 2.5 3.7 4.7 0.1 1.4 0.0 2.1 0.6 0.9 0.6 12.2 0.8 0.1 0.6 0.0 0.0 13.2 0.2 2.5 0.6 3.2 5.5 9.2 7.3 1.8 0.1 11.0 2.7 20.9 0.5 2.0 2.4 1.7 18.4 5.6 2.3 0.0 0.0 1.4 1.1 0.0 0.4 0.0 0.1 8.8 0.1 9.9 0.7 0.3 10.4 0.4 0.9 0.0 9.1 2.0 7.8 4.3 1.7 3.7 1.8 8.1 8.2 3.5 0.0 0.0 5.0 0.1 0.0 2.5 1.2 1.5 0.1 5.2 2.1 0.0 0.8 0.0 0.1 2.1 0.9 0.0 0.2 0.0 1.4 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.6 13.6 31.8 4.2 19.7 22.1 16.2 47.8 16.7 22.1 36.4 CDK19 "bA346C16.3, CDC2L6, CDK11, KIAA1028" ENSG00000155111 "Cyclin dependent kinase 19" Q9BWU1 6 110609978-110815958 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007053 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA007053: AB_1846369" "unprognostic (1.66e-2)" "unprognostic (1.84e-1)" "unprognostic (3.63e-1)" "unprognostic (3.00e-3)" "unprognostic (1.62e-1)" "unprognostic (2.66e-3)" "prognostic unfavourable (3.56e-4)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" "unprognostic (2.00e-3)" "unprognostic (3.94e-1)" "unprognostic (4.04e-1)" "prognostic unfavourable (4.72e-5)" "unprognostic (1.75e-1)" "unprognostic (9.78e-2)" "unprognostic (6.51e-2)" "unprognostic (9.50e-3)" 5.3 3.3 18.1 6.1 29.4 9.7 6.0 13.8 21.3 6.6 6.3 31.1 2.4 4.8 9.6 3.7 7.8 5.3 7.8 4.1 20.8 10.1 6.3 4.6 6.2 8.0 22.1 12.9 9.7 3.1 8.0 4.1 10.5 14.4 25.8 6.1 3.4 4.5 5.9 3.2 7.9 5.9 7.1 20.8 7.0 6.5 16.4 26.3 6.1 5.8 1.3 8.4 5.9 6.4 1.3 1.8 8.5 2.2 1.3 0.8 0.6 3.6 3.8 13.4 16.2 7.3 10.5 7.0 11.6 12.4 4.4 5.8 4.8 4.0 9.1 4.2 8.2 2.1 5.1 2.5 10.1 11.3 3.0 15.6 5.7 5.6 4.4 6.3 11.7 7.2 5.5 6.0 9.3 4.3 4.7 12.8 9.4 5.8 8.4 9.4 1.3 2.6 9.1 6.9 3.5 5.1 6.6 6.9 12.8 8.9 7.2 10.4 2.4 23.2 4.8 9.2 4.9 18.6 7.1 1.4 1.8 7.9 9.7 8.5 9.5 3.3 2.2 1.5 0.8 1.2 0.8 1.1 0.7 0.7 1.8 1.3 0.5 0.7 8.5 1.3 0.7 0.9 0.8 0.6 18.1 29.4 13.8 21.3 20.8 10.1 22.1 12.9 14.4 26.3 CDK5 PSSALRE ENSG00000164885 "Cyclin dependent kinase 5" Q00535 7 151053812-151058530 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Lissencephaly, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008909, HPA064535" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB008909: , HPA064535: " "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (4.22e-2)" "unprognostic (1.43e-1)" "unprognostic (1.10e-1)" "unprognostic (3.48e-1)" "unprognostic (5.67e-3)" "unprognostic (1.05e-2)" "unprognostic (1.22e-1)" "unprognostic (5.78e-3)" "unprognostic (6.25e-3)" "unprognostic (3.35e-1)" "unprognostic (4.47e-2)" "unprognostic (1.46e-2)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" 4.5 11.3 24.4 6.9 30.4 6.1 5.3 13.6 36.1 5.3 6.1 6.7 4.5 7.9 4.5 17.4 6.5 5.0 6.2 5.8 25.0 19.7 9.0 7.7 5.3 6.0 15.4 15.4 3.2 5.8 8.9 7.9 5.3 20.8 5.8 6.3 3.2 6.0 6.3 5.7 6.5 6.2 6.0 8.6 5.2 5.7 3.1 7.7 6.8 6.0 3.6 6.9 6.7 3.1 6.6 21.5 9.0 21.7 9.5 14.9 10.6 11.6 14.0 13.1 21.3 14.5 10.7 6.5 7.7 12.8 15.2 12.6 9.9 10.9 11.5 27.7 9.5 8.3 21.0 11.8 7.0 9.1 12.5 12.6 12.3 9.8 9.6 10.2 23.7 11.5 8.8 12.5 3.9 10.2 12.8 8.4 15.2 22.6 27.4 20.8 14.4 22.1 13.4 5.4 12.8 13.2 8.8 8.3 35.7 11.1 13.7 14.6 6.4 9.0 8.6 15.0 3.9 11.2 14.4 19.6 21.4 4.5 23.6 14.7 26.8 7.8 19.0 9.0 6.9 21.7 5.4 6.6 6.8 6.8 21.5 5.9 5.1 6.2 2.8 9.5 16.4 12.8 14.9 10.6 24.4 30.4 13.6 36.1 25.0 19.7 15.4 15.4 20.8 7.7 CDK5R1 "Nck5a, p35, p35nck5a" ENSG00000176749 "Cyclin dependent kinase 5 regulatory subunit 1" Q15078 17 32486619-32491256 "Predicted intracellular proteins" "Biological rhythms" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 58.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 31.5;SK-MEL-30: 22.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000252 Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000252: " "unprognostic (1.08e-1)" "unprognostic (9.13e-2)" "unprognostic (1.79e-2)" "unprognostic (3.65e-1)" "unprognostic (1.97e-1)" "unprognostic (8.09e-2)" "unprognostic (2.74e-5)" "unprognostic (1.81e-2)" "unprognostic (3.32e-1)" "unprognostic (2.18e-1)" "unprognostic (5.90e-2)" "unprognostic (5.60e-1)" "unprognostic (6.98e-2)" "unprognostic (1.60e-1)" "unprognostic (7.92e-2)" "unprognostic (8.81e-2)" "unprognostic (1.03e-1)" 1.6 3.3 21.9 6.4 21.1 4.9 1.8 26.0 58.8 1.2 1.6 3.6 0.0 2.0 1.6 1.0 5.5 1.5 1.6 1.6 21.4 17.3 1.5 1.3 1.4 11.5 7.6 24.5 3.2 2.0 1.3 3.0 1.4 7.8 1.4 1.5 0.9 1.2 1.3 1.8 2.2 2.0 1.3 4.1 7.7 2.2 5.2 3.2 1.2 1.1 0.3 12.3 1.7 1.1 0.6 1.8 2.9 0.9 0.7 4.2 1.5 2.0 1.1 5.2 1.6 0.6 1.0 0.6 1.2 0.7 1.5 2.0 3.0 0.5 1.0 1.2 1.0 0.9 2.0 1.2 2.1 0.3 3.9 0.3 0.5 1.1 0.2 0.6 1.1 0.6 3.1 1.6 1.3 1.1 2.0 1.2 3.2 0.8 1.7 0.8 3.3 1.1 1.5 3.1 3.6 0.7 0.9 31.5 8.5 1.2 0.7 22.6 1.3 2.4 1.1 2.1 3.2 0.8 3.2 0.6 0.8 1.0 1.8 2.9 5.1 0.0 0.9 1.2 2.3 0.8 1.8 0.6 3.1 1.3 0.2 0.5 4.2 2.6 2.9 0.7 0.4 1.8 0.4 1.5 21.9 21.1 26.0 37.3 21.4 17.3 7.6 24.5 7.8 3.2 CDK5R2 "NCK5AI, P39, p39nck5ai" ENSG00000171450 "Cyclin dependent kinase 5 regulatory subunit 2" Q13319 2 218959655-218962162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 48.6;pituitary gland: 14.3" "Group enriched" "Detected in some" 9 "SCLC-21H: 18.2;SH-SY5Y: 13.2" "Cancer enhanced" "Detected in some" "glioma: 3.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.96e-1)" "unprognostic (6.53e-2)" "unprognostic (3.85e-5)" "unprognostic (1.73e-6)" "unprognostic (3.67e-2)" "unprognostic (2.83e-4)" "unprognostic (1.27e-3)" "unprognostic (7.21e-2)" "unprognostic (1.78e-1)" "unprognostic (6.71e-3)" "unprognostic (3.53e-3)" "unprognostic (2.34e-10)" "unprognostic (1.54e-1)" "unprognostic (1.64e-4)" "unprognostic (6.46e-2)" 1.2 7.0 13.2 1.6 26.0 1.2 1.2 8.3 48.6 1.2 1.5 2.2 0.0 1.7 1.2 1.2 1.2 1.2 1.2 1.2 16.5 14.4 1.2 1.2 1.2 1.2 10.0 11.9 1.2 2.6 1.2 14.3 1.2 13.8 1.2 1.4 4.4 1.2 1.2 1.2 1.2 1.8 1.3 1.6 1.2 2.7 1.6 2.0 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 18.2 13.2 0.7 0.0 0.1 0.0 0.0 0.0 0.2 1.4 0.0 0.3 0.0 0.0 0.0 0.6 0.1 1.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 26.0 8.3 42.2 16.5 14.4 10.0 11.9 13.8 2.0 CDKL5 "CFAP247, EIEE2, STK9" ENSG00000008086 "Cyclin dependent kinase like 5" O76039 X 18425583-18653629 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0" "Cell line enhanced" "Detected in many" "A549: 12.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 7.7;eosinophil: 2.1;neutrophil: 4.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002847, CAB011577" Supported Supported Nucleoplasm Nucleoplasm "CAB011577: AB_727019, HPA002847: AB_1080107" "unprognostic (7.01e-2)" "unprognostic (4.86e-2)" "unprognostic (1.41e-1)" "unprognostic (1.25e-4)" "unprognostic (1.17e-1)" "unprognostic (1.61e-2)" "unprognostic (1.72e-2)" "unprognostic (1.67e-1)" "unprognostic (2.07e-1)" "unprognostic (9.63e-3)" "unprognostic (2.05e-3)" "unprognostic (1.66e-1)" "prognostic favourable (5.54e-4)" "unprognostic (7.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.67e-3)" "unprognostic (1.99e-1)" 3.3 3.2 8.0 1.8 24.7 3.2 4.3 3.9 28.0 5.4 2.7 7.7 1.8 1.5 4.5 2.8 5.2 2.8 3.1 5.0 8.0 3.7 6.3 2.2 6.9 1.4 3.5 13.2 6.7 4.5 6.2 5.0 5.4 5.9 6.7 2.2 2.0 3.9 4.4 3.0 3.5 1.9 4.0 5.7 2.3 4.9 14.0 5.7 1.6 5.1 0.8 2.1 5.6 4.6 0.7 1.0 7.7 1.0 0.5 0.6 0.2 1.7 12.3 3.5 3.1 3.3 4.5 2.5 2.0 3.8 2.8 3.2 4.0 2.3 1.9 0.4 1.3 0.5 4.0 3.0 5.9 0.5 2.6 0.0 7.1 3.1 1.6 0.1 0.8 2.6 3.1 6.8 7.1 1.3 0.1 1.9 4.2 1.7 0.8 0.8 7.1 3.0 0.7 3.8 0.1 2.4 8.9 0.7 4.4 4.5 1.1 2.2 1.6 0.7 7.3 4.3 1.9 7.9 1.5 0.3 0.1 0.3 2.4 0.5 4.2 7.7 1.0 2.1 0.6 0.6 0.3 0.2 0.4 0.3 0.3 0.7 0.6 0.6 4.7 0.5 0.6 1.0 0.2 0.2 8.0 24.7 3.9 28.0 8.0 3.7 3.5 13.2 5.9 5.7 CDR1 "CDR, CDR34, CDR62A" ENSG00000184258 "Cerebellar degeneration related protein 1" P51861 X 140782405-140784871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 56.2" "Cell line enhanced" "Detected in some" "AF22: 3.3;BJ: 6.5;MOLT-4: 4.1;U-87 MG: 23.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA073147 Approved "Nucleoplasm,Golgi apparatus,Centrosome" "Nucleoplasm, Golgi apparatus, Centrosome" "HPA073147: " "unprognostic (7.10e-2)" "unprognostic (2.87e-2)" "unprognostic (2.85e-1)" "unprognostic (3.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-3)" "unprognostic (1.46e-4)" "unprognostic (1.55e-1)" "unprognostic (1.84e-1)" 3.2 1.3 9.1 0.5 26.3 0.0 0.0 56.2 28.7 0.0 0.1 0.2 0.4 0.0 0.6 0.2 1.5 1.5 9.2 2.8 0.1 0.0 0.6 0.1 3.7 0.1 3.9 0.0 7.1 0.4 0.1 0.0 0.6 0.0 0.2 9.4 0.1 0.0 3.6 0.9 0.5 0.1 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 3.3 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.1 0.0 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.4 0.0 1.2 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDR2L HUMPPA ENSG00000109089 "Cerebellar degeneration related protein 2 like" Q86X02 17 74987632-75005800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 27.0;U-138 MG: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022015 Enhanced Approved Cytosol Cytosol "HPA022015: AB_1846462" "unprognostic (4.60e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-2)" "unprognostic (3.85e-2)" "unprognostic (2.17e-1)" "unprognostic (7.36e-3)" "unprognostic (9.22e-2)" "unprognostic (1.78e-2)" "unprognostic (9.11e-2)" "unprognostic (2.11e-1)" "unprognostic (4.21e-2)" "unprognostic (1.84e-1)" "unprognostic (5.89e-2)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-1)" 9.5 6.1 7.0 4.2 18.7 0.8 20.1 40.0 14.3 6.8 9.9 19.1 4.2 31.0 14.3 2.1 4.3 6.8 12.9 8.3 11.7 8.3 6.9 2.3 8.9 1.8 22.0 6.9 2.4 6.3 4.3 4.1 10.2 21.9 5.4 2.7 2.7 10.2 8.3 3.2 3.1 15.8 8.3 25.1 2.2 17.7 5.6 14.0 0.0 3.2 1.0 1.7 7.0 10.1 0.3 0.1 0.0 0.4 0.0 0.1 1.5 6.2 18.0 4.0 8.4 7.1 6.3 1.8 9.1 4.1 5.4 6.9 10.6 5.8 0.0 9.7 15.9 16.8 4.8 2.2 3.5 0.1 8.1 0.0 11.2 6.8 4.1 0.7 0.3 3.6 3.5 12.7 1.3 11.5 2.7 0.9 5.6 5.6 0.8 0.6 5.2 8.9 2.9 6.1 2.7 14.1 3.9 7.0 23.5 11.5 27.0 0.8 7.4 1.2 8.1 27.7 5.9 17.4 5.7 0.8 0.5 0.0 7.7 2.1 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.4 0.1 0.0 1.5 7.0 18.7 40.0 14.3 11.7 8.3 22.0 6.9 21.9 14.0 CDYL2 FLJ38866 ENSG00000166446 "Chromodomain Y like 2" Q8N8U2 16 80597906-80804329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7" "Cell line enhanced" "Detected in many" "HDLM-2: 10.3;HUVEC TERT2: 15.8;MCF7: 13.4;TIME: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 1.9;non-classical monocyte: 7.1" "Lineage enriched" "Detected in single" 7 "monocytes: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041016 Approved "HPA041016: AB_10794183" "unprognostic (8.63e-2)" "unprognostic (7.37e-2)" "unprognostic (2.93e-3)" "prognostic favourable (6.13e-4)" "unprognostic (1.48e-1)" "unprognostic (4.38e-2)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (1.02e-1)" "unprognostic (2.40e-1)" "unprognostic (2.30e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (4.33e-2)" "unprognostic (9.11e-2)" "unprognostic (2.12e-1)" "unprognostic (3.69e-3)" 4.6 2.6 11.5 5.2 16.8 7.8 8.0 24.7 17.2 7.4 2.1 1.0 4.3 5.2 4.3 3.4 3.3 1.7 2.9 2.1 7.2 6.6 6.0 3.3 3.7 6.0 5.1 9.1 1.3 2.2 7.9 2.0 22.8 7.6 16.0 2.6 0.7 4.1 10.3 1.3 1.9 4.6 4.9 5.4 3.7 3.0 16.5 5.0 0.9 2.6 0.0 5.3 5.3 5.2 0.0 0.4 0.9 7.1 0.0 0.7 0.2 0.0 0.0 0.2 0.0 3.8 3.8 3.2 3.9 2.6 1.0 0.3 0.1 1.9 0.3 1.2 2.3 0.1 0.1 3.8 0.5 10.3 2.1 1.4 5.5 0.1 0.1 0.1 0.2 1.2 1.5 2.0 1.9 15.8 0.0 0.1 0.5 13.4 0.0 0.0 1.2 4.2 0.0 0.0 0.0 6.2 4.9 1.0 0.0 0.4 3.2 0.0 3.1 2.2 23.4 0.1 6.9 0.0 0.9 0.0 0.0 0.0 2.4 2.9 0.0 0.7 0.4 0.9 0.2 1.9 0.0 0.0 0.2 0.7 0.4 0.0 0.2 0.4 0.0 0.0 7.1 0.1 0.5 0.2 11.5 16.8 24.7 17.2 7.2 6.6 5.1 9.1 7.6 5.0 CECR2 KIAA1740 ENSG00000099954 "CECR2, histone acetyl-lysine reader" Q9BXF3 22 17359949-17558149 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.1;skeletal muscle: 30.6" "Cell line enhanced" "Detected in some" "AF22: 12.6;HAP1: 11.6;HEK 293: 5.8;K-562: 6.4;NTERA-2: 18.5;SCLC-21H: 8.3" "Cancer enriched" "Detected in many" 6 "testis cancer: 8.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002943 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA002943: AB_1078496" "unprognostic (2.46e-2)" "unprognostic (4.10e-2)" "unprognostic (7.99e-2)" "unprognostic (1.92e-3)" "unprognostic (7.48e-3)" "unprognostic (2.46e-3)" "unprognostic (2.49e-1)" "unprognostic (6.67e-2)" "unprognostic (8.18e-2)" "unprognostic (3.94e-1)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (8.13e-6)" "unprognostic (1.13e-1)" "unprognostic (1.59e-1)" "unprognostic (6.56e-2)" "unprognostic (1.94e-2)" 1.8 1.3 4.6 1.0 8.8 1.5 2.0 25.1 8.4 1.1 1.2 10.6 0.8 1.0 4.3 1.7 1.4 2.5 1.0 4.4 6.1 2.8 1.9 6.5 4.1 0.9 8.0 4.0 5.4 5.6 0.8 8.4 4.7 5.8 2.3 1.1 4.9 1.9 1.1 30.6 1.6 1.2 2.2 5.7 1.4 1.1 6.0 8.0 0.0 2.7 2.2 0.9 2.3 2.5 0.2 0.1 0.9 0.8 0.5 0.1 0.0 0.1 0.0 12.6 4.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 11.6 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.1 0.0 0.4 18.5 0.0 1.4 0.8 0.0 0.0 4.0 8.3 0.0 0.0 0.1 0.7 1.3 1.9 0.1 0.1 2.8 0.0 0.0 4.7 1.1 1.0 0.0 0.0 0.1 0.3 0.8 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.9 0.5 0.1 0.0 0.0 0.0 4.6 8.8 25.1 5.0 6.1 2.8 8.0 4.0 5.8 8.0 CELF3 "BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4" ENSG00000159409 "CUGBP Elav-like family member 3" Q5SZQ8 1 151702404-151716814 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.8;brain: 44.0;pituitary gland: 31.2" "Group enriched" "Detected in some" 7 "SCLC-21H: 27.9;SH-SY5Y: 19.5" "Group enriched" "Detected in many" 5 "glioma: 4.4;pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006292 Uncertain Approved Nucleoplasm Nucleoplasm "HPA006292: AB_10602250" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (7.67e-2)" "unprognostic (1.96e-1)" "unprognostic (1.75e-1)" "unprognostic (6.64e-2)" "unprognostic (1.38e-1)" "unprognostic (3.02e-2)" "unprognostic (3.12e-1)" "unprognostic (3.48e-3)" "unprognostic (3.49e-3)" "unprognostic (6.90e-2)" "unprognostic (1.82e-8)" "unprognostic (8.50e-2)" "unprognostic (9.01e-2)" "unprognostic (2.41e-1)" "unprognostic (3.05e-2)" 1.1 16.8 21.4 1.4 28.9 1.1 1.0 29.2 44.0 1.0 2.1 2.0 0.0 5.0 1.0 1.0 1.1 2.1 1.0 1.0 19.5 16.2 1.1 1.0 1.1 1.0 5.3 15.3 1.0 8.8 1.0 31.2 1.2 3.7 1.1 2.1 3.7 1.0 1.0 1.0 1.0 3.8 1.2 1.5 1.0 8.5 2.0 4.4 0.0 1.1 0.0 1.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 27.9 19.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 28.9 29.2 29.1 19.5 16.2 5.3 15.3 3.7 4.4 CELF4 BRUNOL4 ENSG00000101489 "CUGBP Elav-like family member 4" Q9BZC1 18 37243047-37566037 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 69.1" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 31.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013322, HPA037986" Enhanced Supported Nucleoplasm Nucleoplasm "HPA013322: , HPA037986: AB_10673035" "unprognostic (7.87e-3)" "unprognostic (2.31e-2)" "unprognostic (4.31e-3)" "unprognostic (3.42e-7)" "unprognostic (2.95e-2)" "unprognostic (2.95e-2)" "unprognostic (3.72e-3)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.92e-2)" "unprognostic (1.00e-2)" "unprognostic (3.49e-1)" "unprognostic (1.69e-2)" "unprognostic (2.48e-1)" "unprognostic (8.32e-3)" "unprognostic (6.13e-2)" 1.4 10.7 40.2 1.7 25.2 1.1 1.3 45.3 69.1 1.1 1.6 0.9 0.0 1.6 1.3 1.5 1.4 1.3 2.0 1.7 27.0 26.3 1.4 1.3 1.4 1.6 13.5 26.3 2.0 4.2 1.2 8.1 1.7 13.1 1.5 1.3 0.5 2.5 1.1 8.3 2.0 1.9 1.3 3.7 1.7 1.6 3.9 5.6 0.0 2.3 0.0 1.0 1.2 0.0 0.7 0.5 2.4 0.9 0.9 0.9 0.4 0.1 0.1 0.5 0.4 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.2 0.7 0.0 0.4 0.0 0.1 0.0 0.5 0.3 0.0 1.2 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.2 0.1 0.4 1.1 0.2 0.1 0.0 1.4 0.0 0.1 31.0 7.6 0.8 0.2 0.0 0.1 0.1 0.0 1.0 0.4 0.2 0.1 2.0 0.3 0.1 0.1 0.1 0.1 2.4 0.5 0.5 0.7 0.6 0.7 0.7 0.4 0.4 0.3 0.7 0.8 0.9 1.3 0.9 0.9 0.5 0.6 0.4 40.2 25.2 45.3 31.1 27.0 26.3 13.5 26.3 13.1 5.6 CELF5 BRUNOL5 ENSG00000161082 "CUGBP Elav-like family member 5" Q8N6W0 19 3224703-3297076 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 35.8" "Cell line enhanced" "Detected in some" "NTERA-2: 6.0;REH: 7.4;SCLC-21H: 7.6;SH-SY5Y: 4.6" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042012, HPA060336" Enhanced "HPA042012: AB_10796896, HPA060336: " "unprognostic (1.09e-1)" "unprognostic (9.24e-2)" "unprognostic (9.25e-3)" "unprognostic (3.48e-2)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.17e-1)" "unprognostic (1.22e-3)" "unprognostic (1.35e-1)" "unprognostic (4.70e-3)" "unprognostic (1.11e-2)" "unprognostic (1.74e-3)" "unprognostic (1.23e-2)" "unprognostic (2.63e-2)" "unprognostic (1.25e-1)" "unprognostic (8.07e-2)" 0.8 1.1 16.2 0.8 21.2 0.7 1.5 19.6 35.8 0.8 1.0 0.8 0.0 0.8 1.3 1.1 0.8 1.5 0.7 0.8 9.5 12.2 0.8 0.8 0.8 0.7 2.6 15.5 7.1 1.1 2.6 0.5 0.8 3.4 0.9 1.0 0.0 2.0 1.0 1.3 0.8 0.9 0.8 0.9 0.8 1.2 2.5 2.7 0.2 0.8 0.0 0.7 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.4 1.3 1.6 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 1.0 0.1 0.0 6.0 0.1 7.4 0.0 0.0 0.0 0.0 7.6 4.6 0.3 0.5 0.0 0.8 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.2 21.2 19.6 19.6 9.5 12.2 2.6 15.5 3.4 2.7 CELF6 BRUNOL6 ENSG00000140488 "CUGBP Elav-like family member 6" Q96J87 15 72284727-72320129 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.5" "Cell line enhanced" "Detected in some" "U-266/70: 7.5;U-937: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.2" "Low lineage specificity" "Detected in single" "HPA046985, HPA053526" Uncertain "HPA046985: , HPA053526: " "unprognostic (6.83e-3)" "unprognostic (7.06e-3)" "unprognostic (9.55e-2)" "unprognostic (2.77e-1)" "unprognostic (7.49e-2)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-4)" "unprognostic (1.16e-1)" "unprognostic (1.14e-2)" "unprognostic (2.16e-1)" 2.0 9.8 18.4 1.6 14.0 3.9 2.3 10.6 18.5 4.5 3.3 2.1 0.7 1.7 6.8 12.6 0.8 5.6 3.2 2.0 13.7 17.5 5.9 1.7 2.7 2.7 5.2 17.3 8.5 1.5 2.2 12.3 2.9 13.7 3.5 2.8 3.8 1.7 7.2 0.7 2.5 3.1 3.5 5.5 3.1 2.0 7.2 2.6 0.7 7.3 0.7 2.1 1.8 2.1 0.3 0.1 1.2 0.0 0.3 0.7 0.1 0.0 0.0 0.3 0.1 1.4 0.7 0.8 0.1 0.4 0.0 0.4 0.0 0.0 1.5 0.0 0.1 0.7 0.5 0.0 0.2 0.5 0.7 0.1 0.0 1.4 0.9 0.2 2.4 1.3 3.1 0.1 0.2 0.0 0.0 3.1 0.0 0.0 0.2 0.6 0.0 0.0 3.0 0.2 0.2 0.2 1.4 1.3 2.3 0.0 0.2 2.8 0.0 0.4 0.0 0.0 0.5 2.6 0.1 7.5 2.2 0.1 0.1 4.1 0.0 0.0 0.0 1.2 0.7 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 18.4 14.0 10.6 18.5 13.7 17.5 5.2 17.3 13.7 2.6 CELSR2 "ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3" ENSG00000143126 "Cadherin EGF LAG seven-pass G-type receptor 2" Q9HCU4 1 109250019-109275750 "G-protein coupled receptors, Predicted membrane proteins" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.7;skin 1: 27.8" "Cell line enhanced" "Detected in many" "AF22: 24.7;HaCaT: 24.4;MCF7: 28.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013952 Uncertain Approved Cytosol Cytosol "HPA013952: AB_1846518" "unprognostic (4.46e-3)" "unprognostic (1.07e-2)" "unprognostic (3.00e-2)" "unprognostic (4.71e-2)" "unprognostic (2.19e-1)" "unprognostic (5.30e-2)" "unprognostic (3.51e-2)" "unprognostic (2.98e-1)" "unprognostic (1.33e-1)" "unprognostic (1.59e-2)" "unprognostic (1.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.94e-2)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-2)" "unprognostic (5.16e-2)" 1.5 2.3 12.6 1.1 16.0 0.9 5.4 9.2 31.7 6.9 1.8 13.7 3.4 1.4 3.1 4.3 10.9 18.8 1.8 5.3 17.1 8.1 5.6 1.2 1.8 1.3 10.0 15.4 1.2 4.8 7.8 2.3 1.6 8.3 3.5 1.4 5.4 6.4 10.4 9.3 27.8 1.5 2.4 14.1 1.0 2.0 11.0 8.6 0.5 10.9 2.7 3.2 2.3 6.1 0.0 0.1 0.0 0.0 0.0 0.6 0.1 6.8 6.4 24.7 4.5 0.0 0.0 6.7 0.8 0.6 1.5 0.4 1.0 0.2 1.2 5.6 0.5 24.4 6.4 3.9 0.8 0.1 2.6 0.5 5.9 1.4 0.5 0.3 3.2 0.1 9.6 0.6 0.4 0.3 4.0 0.3 0.0 28.1 0.7 0.3 8.0 1.2 6.2 2.2 0.3 5.4 2.3 10.0 4.7 3.8 8.3 5.3 7.8 1.5 0.0 0.0 4.5 0.4 6.1 1.6 0.4 0.3 1.3 0.5 2.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 16.0 9.2 31.7 17.1 8.1 10.0 15.4 8.3 8.6 CELSR3 "ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2" ENSG00000008300 "Cadherin EGF LAG seven-pass G-type receptor 3" Q9NYQ7 3 48636469-48662915 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.7;pituitary gland: 11.2" "Cell line enhanced" "Detected in many" "HDLM-2: 12.9;SH-SY5Y: 14.7;SiHa: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 4 "T-cells: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062866 Approved "HPA062866: " "unprognostic (7.80e-2)" "unprognostic (3.80e-2)" "unprognostic (4.89e-1)" "unprognostic (9.12e-4)" "unprognostic (1.51e-1)" "unprognostic (1.59e-6)" "unprognostic (3.61e-6)" "unprognostic (1.86e-1)" "unprognostic (1.46e-3)" "unprognostic (5.07e-2)" "unprognostic (2.13e-3)" "unprognostic (2.87e-3)" "unprognostic (3.26e-3)" "unprognostic (9.53e-2)" "unprognostic (1.42e-1)" "unprognostic (3.86e-2)" "unprognostic (1.73e-1)" 0.7 4.0 10.9 1.2 8.3 1.7 0.8 19.7 11.1 0.6 1.3 0.0 0.0 1.2 0.8 1.2 0.6 0.7 0.7 0.5 7.1 1.4 0.6 0.6 0.8 1.4 2.0 10.4 0.9 2.6 1.4 11.2 1.0 3.6 0.7 1.2 1.4 0.6 0.8 0.5 1.2 1.3 0.8 3.3 1.0 2.1 5.4 1.4 0.0 0.9 0.0 1.0 0.7 0.7 0.3 0.1 0.0 0.1 0.2 1.5 0.4 3.8 2.9 4.8 2.8 0.6 0.9 1.2 0.2 0.5 0.6 0.9 5.4 2.9 0.8 0.7 0.2 0.4 1.5 0.2 0.3 12.9 0.8 1.3 11.1 1.9 0.9 1.2 2.1 0.4 3.8 0.3 6.9 0.0 0.5 3.9 0.9 4.1 0.1 0.0 2.7 1.3 0.3 0.7 4.0 0.0 2.6 10.8 14.7 12.9 0.3 0.5 6.4 2.5 0.0 4.8 4.6 6.2 2.3 0.3 7.0 3.4 3.4 0.9 7.4 0.0 0.1 0.0 1.0 0.0 0.2 0.3 0.2 0.2 0.1 0.0 0.3 1.5 0.0 0.2 0.0 0.0 1.1 0.4 10.9 8.3 19.7 11.1 7.1 1.4 2.0 10.4 3.6 1.4 CEND1 "BM88, FLJ90066" ENSG00000184524 "Cell cycle exit and neuronal differentiation 1" Q8N111 11 787104-790123 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 85.2" "Cell line enhanced" "Detected in some" "Karpas-707: 16.7;SCLC-21H: 30.0;SH-SY5Y: 11.2;U-266/70: 11.7;U-87 MG: 15.6" "Cancer enriched" "Detected in many" 13 "glioma: 24.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042527 Enhanced Approved Mitochondria Mitochondria "HPA042527: AB_2678038" "unprognostic (4.62e-3)" "unprognostic (1.34e-4)" "unprognostic (9.66e-3)" "unprognostic (1.27e-2)" "prognostic unfavourable (4.38e-5)" "unprognostic (2.20e-3)" "unprognostic (4.11e-2)" "unprognostic (6.72e-2)" "unprognostic (2.60e-2)" "unprognostic (2.26e-1)" "unprognostic (2.00e-3)" "unprognostic (4.24e-3)" "unprognostic (1.94e-3)" "unprognostic (4.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" 1.9 8.2 28.5 2.9 34.7 1.8 1.8 46.5 85.2 1.8 2.3 8.3 1.3 2.5 1.9 2.0 2.2 1.8 1.9 2.1 34.2 25.3 2.1 1.8 1.8 2.1 32.0 30.7 1.8 1.9 1.9 5.1 1.8 42.4 3.2 1.9 2.1 1.8 3.6 1.8 1.9 2.7 2.3 10.2 1.8 1.9 1.9 5.9 0.0 1.8 0.0 2.0 2.1 0.1 3.6 0.2 0.0 0.7 0.0 1.9 0.3 0.0 0.4 0.4 0.7 0.1 0.1 0.1 0.7 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.1 0.0 2.9 0.3 0.0 0.4 0.0 0.1 0.0 16.7 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 30.0 11.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 11.7 3.2 0.7 15.6 0.1 0.2 0.0 0.0 0.0 0.9 0.7 0.3 3.6 1.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.3 28.5 34.7 46.5 65.2 34.2 25.3 32.0 30.7 42.4 5.9 CENPVL1 "CENPVP1, PRR6L1" ENSG00000223591 "Centromere protein V like 1" X 51710512-51712131 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.6;testis: 2.5" "Cell line enhanced" "Detected in some" "NTERA-2: 3.1;PC-3: 2.8;SH-SY5Y: 1.6;U-2 OS: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CENPVL2 CENPVP2 ENSG00000283093 "Centromere protein V like 2" X 51681212-51682831 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.6;testis: 2.5" "Cell line enhanced" "Detected in some" "NTERA-2: 3.1;PC-3: 2.8;SH-SY5Y: 1.6;U-2 OS: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CENPVL3 CENPVP3 ENSG00000224109 "Centromere protein V like 3" X 51617024-51618968 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 4.7;testis: 8.0" "Group enriched" "Detected in some" 8 "NTERA-2: 4.8;PC-3: 15.5;U-2 OS: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.07e-2)" "unprognostic (1.48e-1)" 0.0 1.4 0.6 0.0 4.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CER1 DAND4 ENSG00000147869 "Cerberus 1, DAN family BMP antagonist" O95813 9 14719724-14722717 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.5;epididymis: 5.5" "Group enriched" "Detected in some" 9 "HEL: 6.3;NTERA-2: 11.5;SCLC-21H: 4.4" "Cancer enriched" "Detected in single" 82 "testis cancer: 17.3" "Group enriched" "Detected in many" 8 "basal ganglia: 2.5;cerebellum: 2.2;cerebral cortex: 1.1;pons and medulla: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA019917 Uncertain "Secreted - unknown location" "HPA019917: AB_1846539" "unprognostic (2.98e-2)" "unprognostic (5.36e-2)" "unprognostic (5.99e-2)" 0.1 0.0 0.1 0.1 2.5 0.1 0.2 2.2 1.1 0.1 0.2 0.1 0.1 0.7 0.7 5.5 0.1 0.0 0.4 0.2 0.1 0.2 1.2 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.2 0.1 0.1 1.5 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.9 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 2.2 1.1 0.1 0.2 0.1 0.1 1.5 0.1 CERCAM "CEECAM1, CerCAM, GLT25D3" ENSG00000167123 "Cerebral endothelial cell adhesion molecule" Q5T4B2 9 128411751-128437351 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.1" "Cell line enhanced" "Detected in many" "ASC diff: 55.3;ASC TERT1: 59.0;fHDF/TERT166: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021657, HPA051595" Uncertain Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Intracellular and membrane" "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA021657: AB_1846507, HPA051595: " "unprognostic (2.87e-2)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" "unprognostic (2.19e-1)" "unprognostic (4.68e-3)" "unprognostic (7.79e-3)" "unprognostic (3.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (5.22e-4)" "unprognostic (1.59e-1)" "unprognostic (5.93e-2)" "prognostic unfavourable (3.33e-16)" "unprognostic (1.34e-2)" "unprognostic (1.04e-1)" "unprognostic (6.05e-3)" "prognostic unfavourable (3.30e-5)" 12.7 5.1 40.0 7.2 65.5 1.6 9.0 10.0 62.1 19.1 6.9 61.2 5.0 4.8 11.4 10.9 8.2 6.0 17.3 8.8 72.8 34.7 4.9 1.8 5.3 2.3 59.5 28.1 14.1 18.8 15.8 21.6 27.4 31.4 11.1 5.2 3.5 13.2 13.6 4.3 8.9 6.0 27.7 78.1 3.3 5.4 5.2 62.1 0.0 6.7 2.4 2.7 15.1 6.6 0.3 2.0 0.3 1.6 1.1 5.3 2.2 9.4 6.1 6.8 7.3 55.3 59.0 5.9 30.7 29.0 8.0 6.0 2.2 0.4 0.0 12.6 50.1 6.5 3.0 4.0 3.1 2.4 4.8 0.5 5.5 3.3 16.9 1.1 17.2 32.7 2.1 8.7 2.1 9.1 2.7 7.5 10.4 18.0 0.4 11.6 0.4 4.6 0.9 4.8 1.3 3.7 3.6 1.0 1.9 6.9 8.4 3.5 6.8 2.3 10.0 21.4 5.8 29.4 4.7 8.8 6.9 0.1 20.3 3.3 4.2 0.3 1.1 0.1 3.8 1.6 0.3 0.3 0.3 4.7 1.5 0.1 0.1 5.3 0.3 1.1 0.1 2.0 0.0 2.2 40.0 65.5 10.0 24.5 72.8 34.7 59.5 28.1 31.4 62.1 CERKL RP26 ENSG00000188452 "Ceramide kinase like" Q49MI3 2 181536676-181680665 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5" "Cell line enhanced" "Detected in some" "HEL: 26.2;HL-60: 14.5;MOLT-4: 35.2;NB-4: 30.9;SCLC-21H: 23.7;THP-1: 14.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 11 "cerebellum: 49.5;pons and medulla: 13.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 31.8" "HPA035443, HPA035444, HPA043203" Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA035443: , HPA035444: AB_10672093, HPA043203: " "unprognostic (7.52e-3)" "unprognostic (6.13e-3)" "unprognostic (2.09e-1)" "unprognostic (3.92e-3)" "unprognostic (4.46e-1)" "unprognostic (2.71e-3)" "unprognostic (2.59e-1)" "unprognostic (1.39e-2)" "unprognostic (2.76e-1)" "unprognostic (2.27e-1)" "prognostic favourable (5.25e-4)" "unprognostic (4.54e-2)" "prognostic unfavourable (2.10e-4)" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (3.07e-2)" "unprognostic (8.45e-2)" 1.2 0.6 1.2 9.2 2.0 14.4 1.1 49.5 2.5 3.7 1.7 4.2 0.4 3.1 1.0 5.3 0.6 5.8 4.1 0.5 2.9 1.3 8.1 1.3 5.0 13.8 0.6 1.4 2.9 0.8 0.1 2.1 2.0 13.7 1.0 0.0 6.8 1.0 0.4 0.5 0.5 6.4 0.4 1.0 17.9 2.8 1.1 1.1 0.4 0.9 0.4 1.1 4.3 1.3 4.0 5.2 12.6 12.7 4.7 6.9 4.2 0.0 0.5 0.6 0.0 0.0 0.1 0.0 4.1 0.1 0.1 0.1 0.0 0.1 4.4 0.0 0.1 2.6 0.1 0.1 0.1 0.0 0.4 26.2 0.3 0.0 0.1 14.5 0.7 0.1 0.3 0.1 0.2 0.0 0.0 4.6 0.0 0.0 35.2 30.9 0.6 0.2 7.5 2.2 0.6 0.3 0.0 23.7 0.7 0.0 0.0 0.1 0.0 14.6 2.4 1.2 0.6 0.1 1.0 11.3 6.3 2.0 0.9 9.8 10.7 2.0 4.7 12.6 4.5 12.7 3.7 4.0 6.4 6.9 5.2 3.4 3.5 4.5 0.7 4.7 10.9 2.9 1.4 4.2 1.2 2.0 49.5 2.5 2.9 1.3 0.6 1.4 13.7 1.1 CERS1 "LAG1, LASS1, UOG1" ENSG00000223802 "Ceramide synthase 1" P27544 19 18868545-18896727 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 86.3" "Cell line enhanced" "Detected in many" "AN3-CA: 17.4;EFO-21: 12.7;HEK 293: 17.7;NB-4: 19.0;NTERA-2: 13.0" "Cancer enhanced" "Detected in many" "glioma: 13.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.7" HPA045724 Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" "Endoplasmic reticulum" "HPA045724: AB_10969762" "unprognostic (8.25e-2)" "unprognostic (8.91e-2)" "unprognostic (2.12e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-2)" "unprognostic (6.47e-2)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "unprognostic (4.02e-1)" "unprognostic (7.04e-3)" "unprognostic (3.52e-3)" "unprognostic (1.92e-1)" "unprognostic (4.59e-2)" "unprognostic (2.99e-2)" "unprognostic (3.15e-2)" "unprognostic (9.15e-2)" "unprognostic (3.49e-1)" 2.4 4.7 28.9 2.3 32.9 1.7 1.7 12.5 86.3 2.2 2.1 40.5 0.0 1.6 2.0 2.1 2.5 2.1 3.9 3.4 29.5 23.2 1.6 1.6 1.9 1.6 31.9 20.5 4.3 2.4 1.7 3.2 1.9 33.8 2.0 1.8 1.8 2.3 2.1 17.8 2.0 1.9 3.0 37.8 1.7 1.8 15.7 22.2 0.0 2.4 0.0 1.6 2.6 0.4 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.1 1.7 10.7 17.4 0.6 0.2 0.3 1.1 0.1 3.0 2.2 8.5 0.6 0.0 12.7 0.8 0.1 7.8 0.3 1.2 0.0 17.7 0.1 0.4 6.4 1.4 1.7 0.2 0.6 0.1 1.0 0.3 0.7 1.1 0.1 2.0 4.4 0.1 19.0 13.0 0.3 0.0 0.3 0.3 2.3 0.0 9.1 9.1 0.4 0.0 7.7 2.9 10.6 0.2 0.0 2.4 1.7 2.5 0.3 0.2 0.0 0.0 0.6 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 28.9 32.9 12.5 35.7 29.5 23.2 31.9 20.5 33.8 22.2 CFAP100 "CCDC37, FLJ40083, MIA1" ENSG00000163885 "Cilia and flagella associated protein 100" Q494V2 3 126394939-126436556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 38.7;fallopian tube: 29.2;testis: 21.9" "Cell line enhanced" "Detected in some" "AF22: 1.2;BEWO: 1.4;HaCaT: 1.2;Hep G2: 1.1;NTERA-2: 1.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.0" "Group enriched" "Detected in many" 6 "basal ganglia: 14.7;pons and medulla: 38.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046354 Enhanced "HPA046354: " "unprognostic (1.79e-2)" "unprognostic (3.75e-3)" "unprognostic (7.17e-5)" "unprognostic (1.61e-3)" "unprognostic (6.75e-2)" "unprognostic (9.99e-3)" "unprognostic (1.47e-1)" "unprognostic (7.83e-2)" "unprognostic (1.61e-1)" "unprognostic (3.70e-1)" "unprognostic (1.45e-2)" "unprognostic (1.63e-1)" "unprognostic (2.70e-5)" "unprognostic (3.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.96e-2)" "unprognostic (3.58e-4)" 0.3 0.3 1.6 0.3 14.7 0.3 0.3 0.0 0.8 3.2 0.3 10.9 0.0 0.3 1.5 12.0 0.3 29.2 0.3 0.3 4.5 3.0 0.4 0.3 8.2 0.4 0.1 1.1 3.4 0.3 0.3 1.9 0.3 38.7 0.3 0.3 0.0 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.3 21.9 4.5 0.0 0.3 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 14.7 0.0 0.8 4.5 3.0 0.1 1.1 38.7 4.5 CFAP126 "C1orf192, Flattop, Fltp" ENSG00000188931 "Cilia and flagella associated protein 126" Q5VTH2 1 161364731-161367874 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 53.4;fallopian tube: 85.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;RPTEC TERT1: 2.5;SCLC-21H: 2.4;T-47d: 1.3" "Not detected" "Not detected" "Region enriched" "Detected in all" 7 "pons and medulla: 53.4" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045904 Enhanced "HPA045904: AB_10960411" 0.7 0.7 5.8 0.7 7.5 0.7 1.1 1.2 2.7 3.0 0.7 23.3 0.0 0.7 2.7 14.8 0.7 85.7 0.8 0.7 7.0 8.0 1.8 0.8 8.1 0.7 4.1 3.9 11.2 0.8 0.7 3.3 0.7 53.4 0.8 0.7 0.0 0.7 1.2 2.8 0.7 0.7 0.7 3.3 0.7 0.7 15.3 4.3 0.0 2.7 0.1 0.8 0.7 0.0 0.0 0.1 0.6 0.5 0.0 1.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 2.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 5.8 7.5 1.2 2.7 7.0 8.0 4.1 3.9 53.4 4.3 CFAP157 C9orf117 ENSG00000160401 "Cilia and flagella associated protein 157" Q5JU67 9 127706989-127716002 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5" "Cell line enhanced" "Detected in many" "A549: 9.1;HeLa: 7.4;MCF7: 6.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 19.8;pons and medulla: 30.2" "Cell type enriched" "Detected in single" 11 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA021474, HPA021786" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA021474: AB_1845801, HPA021786: AB_1845802" "unprognostic (1.69e-1)" "unprognostic (2.80e-2)" "unprognostic (2.41e-2)" "prognostic favourable (1.45e-4)" "unprognostic (3.02e-1)" "unprognostic (1.58e-1)" "unprognostic (4.71e-3)" "unprognostic (1.49e-1)" "unprognostic (3.14e-4)" "unprognostic (7.72e-2)" "unprognostic (4.93e-4)" "unprognostic (9.32e-3)" "unprognostic (4.95e-3)" "unprognostic (5.71e-4)" "unprognostic (4.34e-2)" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" 0.4 0.4 3.1 0.3 19.8 0.3 0.3 0.1 0.4 5.3 0.3 7.0 1.6 0.2 1.0 24.0 0.8 44.8 0.6 0.4 4.6 5.8 0.4 0.3 6.1 0.4 0.0 0.0 4.4 0.9 0.2 4.4 0.3 30.2 0.4 0.2 0.0 0.5 1.3 0.4 0.6 0.3 0.2 0.5 0.4 0.4 11.5 3.5 0.0 0.4 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.5 9.1 0.9 1.2 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.9 1.3 1.4 1.4 0.0 4.5 0.0 0.0 0.0 3.4 1.0 0.9 7.4 2.2 0.0 0.7 2.0 0.0 0.0 0.0 0.0 0.0 3.0 0.7 0.0 6.5 1.3 0.5 0.8 4.9 2.0 0.9 1.5 0.0 0.4 6.3 1.1 1.9 3.6 0.7 3.2 0.3 1.7 1.9 1.5 4.9 0.8 1.0 2.5 1.1 0.7 0.7 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 19.8 0.1 0.3 4.6 5.8 0.0 0.0 30.2 3.5 CFAP161 "C15orf26, FLJ38615" ENSG00000156206 "Cilia and flagella associated protein 161" Q6P656 15 81007033-81149175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.0;fallopian tube: 22.4;retina: 14.9;testis: 18.2" "Group enriched" "Detected in some" 5 "HEL: 41.4;K-562: 13.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Region enhanced" "Detected in many" "pons and medulla: 18.0" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA076975 Supported "HPA076975: " "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (6.07e-2)" "prognostic favourable (3.05e-4)" "unprognostic (1.57e-3)" "unprognostic (2.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.73e-1)" "unprognostic (3.33e-2)" "unprognostic (3.13e-1)" "unprognostic (1.29e-3)" "unprognostic (8.93e-2)" "unprognostic (1.47e-1)" "unprognostic (9.24e-2)" "unprognostic (6.22e-2)" 0.8 0.4 2.3 0.4 5.2 0.9 0.6 0.4 1.1 1.5 0.4 6.8 0.2 0.2 1.1 5.4 0.4 22.4 0.5 1.1 3.3 3.3 0.5 0.5 4.0 0.3 0.6 1.1 4.2 2.7 0.2 9.9 2.1 18.0 0.4 0.3 14.9 0.5 0.5 0.5 0.9 0.4 0.6 0.8 0.9 0.5 18.2 1.5 0.0 1.0 0.0 0.6 0.5 0.2 0.0 0.3 2.3 0.4 0.0 0.7 7.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 41.4 0.0 0.1 0.0 0.0 5.6 0.0 0.0 0.1 0.5 0.8 13.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 0.0 0.0 0.5 0.4 0.0 0.2 0.4 0.0 0.0 0.2 0.7 0.3 0.0 0.0 0.1 2.3 0.0 0.1 0.1 0.0 7.3 2.3 5.2 0.4 1.1 3.3 3.3 0.6 1.1 18.0 1.5 CFAP43 "bA373N18.2, C10orf79, FLJ22944, FLJ36006, WDR96" ENSG00000197748 "Cilia and flagella associated protein 43" Q8NDM7 10 104129888-104232362 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.5;epididymis: 21.6;fallopian tube: 37.7;testis: 40.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.0;U-266/70: 6.4;U-266/84: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "unprognostic (1.20e-2)" "unprognostic (3.05e-2)" "unprognostic (3.61e-2)" "unprognostic (6.46e-3)" "unprognostic (2.03e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "unprognostic (1.78e-1)" "unprognostic (1.56e-1)" "unprognostic (2.80e-1)" "unprognostic (6.88e-3)" "unprognostic (2.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.41e-1)" "unprognostic (3.35e-2)" "unprognostic (9.11e-4)" "unprognostic (6.67e-2)" 0.5 0.9 5.3 0.6 15.3 0.5 2.4 0.9 4.4 4.6 0.6 7.1 3.2 0.7 2.7 21.6 0.5 37.7 1.1 0.5 6.0 7.5 2.5 0.8 9.1 0.6 1.1 1.9 5.2 1.3 4.3 10.9 0.7 25.5 1.3 0.6 1.8 1.2 1.5 0.5 1.1 0.8 0.6 1.7 0.6 0.9 40.3 2.9 0.0 4.1 0.1 0.6 0.7 0.3 0.0 0.0 0.5 0.4 0.0 1.1 0.0 3.1 1.2 1.1 2.0 0.0 0.6 0.2 0.0 0.9 0.7 0.5 0.2 8.0 0.0 0.1 0.0 1.1 0.2 1.2 1.5 0.4 1.3 0.0 0.5 0.4 0.2 0.0 0.3 0.7 1.1 0.9 0.6 0.3 2.2 0.2 0.0 2.0 0.2 0.4 0.3 0.5 0.2 0.0 0.0 2.8 0.0 1.8 1.8 0.8 0.1 1.6 1.1 0.0 0.1 0.3 0.7 1.0 0.4 6.4 5.2 0.7 0.4 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 1.1 0.0 5.3 15.3 0.9 4.4 6.0 7.5 1.1 1.9 25.5 2.9 CFAP44 "FLJ11142, WDR52" ENSG00000206530 "Cilia and flagella associated protein 44" Q96MT7 3 113286947-113441610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.2;epididymis: 20.2;testis: 20.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "pons and medulla: 38.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" HPA067258 Uncertain "HPA067258: " "unprognostic (2.83e-1)" "unprognostic (7.07e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.35e-1)" "unprognostic (3.39e-3)" "unprognostic (7.51e-4)" "unprognostic (6.73e-2)" "unprognostic (1.10e-1)" "unprognostic (2.89e-1)" "unprognostic (1.62e-2)" "unprognostic (2.18e-3)" "unprognostic (2.13e-6)" "unprognostic (8.77e-2)" "unprognostic (1.04e-1)" "unprognostic (1.77e-2)" "prognostic favourable (7.09e-6)" 1.5 1.2 2.8 1.5 10.1 1.4 3.6 3.9 2.3 2.8 2.3 15.4 0.7 1.1 3.2 20.2 1.6 11.1 1.6 1.7 6.1 1.3 2.6 1.9 7.0 2.1 1.2 1.0 8.8 4.0 6.0 5.8 1.1 38.2 3.9 3.9 0.8 5.7 1.9 1.3 3.7 2.9 1.2 2.0 1.8 3.5 20.3 5.9 0.9 3.4 0.7 1.9 2.6 2.6 1.3 0.3 0.8 0.2 0.1 0.7 0.0 3.9 2.6 4.2 4.5 2.8 4.0 5.6 1.8 0.9 1.2 2.3 1.3 2.3 4.4 0.6 1.1 4.8 2.8 1.4 2.4 1.9 3.0 2.9 7.9 1.5 0.1 4.9 3.0 0.9 3.3 1.0 1.1 0.9 1.2 2.7 1.5 2.5 2.7 4.9 2.6 6.1 3.3 1.1 0.7 2.1 6.2 4.3 4.7 2.6 0.6 2.6 3.3 3.5 2.8 3.3 3.7 1.3 1.7 3.9 2.2 0.4 2.1 3.0 2.7 0.0 0.2 0.8 0.4 0.1 0.4 0.4 0.5 0.0 0.0 1.3 0.7 0.4 0.6 0.1 0.0 0.3 0.2 0.0 2.8 10.1 3.9 2.3 6.1 1.3 1.2 1.0 38.2 5.9 CFAP47 "CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1" ENSG00000165164 "Cilia and flagella associated protein 47" Q6ZTR5 X 35919734-36385319 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.4;fallopian tube: 12.8;pituitary gland: 24.5" "Group enriched" "Detected in some" 7 "Karpas-707: 4.1;U-266/70: 7.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044633, HPA054859" Uncertain "HPA044633: AB_10960684, HPA054859: " "unprognostic (1.88e-1)" "unprognostic (4.38e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (1.09e-1)" "unprognostic (3.13e-2)" "unprognostic (2.15e-1)" "unprognostic (4.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (5.61e-2)" "unprognostic (1.50e-5)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "unprognostic (1.48e-2)" "unprognostic (5.19e-3)" 0.3 0.3 2.0 0.2 5.9 0.2 0.3 0.3 1.2 0.9 0.3 6.2 1.2 0.2 0.7 7.0 0.3 12.8 0.2 0.3 3.7 1.3 0.4 0.5 3.7 0.2 1.2 1.5 5.3 0.3 2.3 24.5 0.3 12.4 0.3 0.2 2.0 0.3 0.3 0.3 0.3 0.3 0.2 1.1 0.3 0.3 2.1 2.7 0.0 1.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.9 0.3 1.2 3.7 1.3 1.2 1.5 12.4 2.7 CFAP52 "FLJ37528, WDR16, WDRPUH" ENSG00000166596 "Cilia and flagella associated protein 52" Q8N1V2 17 9576627-9643459 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 29.5;fallopian tube: 46.9;testis: 26.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.2;HeLa: 2.8;MCF7: 5.2;REH: 3.5;T-47d: 3.1" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA023247 Enhanced "HPA023247: AB_1858797" "unprognostic (1.76e-2)" "unprognostic (2.31e-1)" "unprognostic (1.38e-1)" "unprognostic (1.68e-2)" "unprognostic (2.09e-1)" "unprognostic (2.04e-1)" "unprognostic (3.99e-1)" "unprognostic (3.16e-2)" "unprognostic (2.11e-1)" "unprognostic (3.66e-1)" "unprognostic (2.22e-2)" "unprognostic (2.66e-1)" "unprognostic (7.85e-2)" "unprognostic (1.85e-1)" "unprognostic (9.23e-2)" "unprognostic (4.50e-2)" "unprognostic (7.09e-2)" 0.4 0.6 3.7 0.4 8.4 0.4 0.4 0.3 2.5 2.6 0.4 8.5 0.1 0.9 1.3 6.4 0.4 46.9 0.5 0.4 5.9 6.0 0.5 0.4 3.9 0.3 0.5 0.5 4.8 0.3 0.7 5.4 0.5 29.5 0.5 0.3 0.7 1.3 0.5 0.3 0.5 0.9 0.3 1.1 0.4 0.4 26.8 3.5 0.0 0.8 0.0 0.3 0.5 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 1.7 2.1 0.0 0.7 1.4 1.0 1.0 0.0 0.1 0.0 0.0 0.1 4.2 0.0 0.5 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.0 2.8 0.4 0.1 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 5.2 0.0 0.8 0.4 0.2 3.5 0.0 0.1 0.4 1.0 0.9 0.0 0.7 1.4 0.0 3.1 0.2 0.0 0.1 0.6 0.0 0.0 0.1 0.3 0.0 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.7 8.4 0.3 2.5 5.9 6.0 0.5 0.5 29.5 3.5 CFAP53 "CCDC11, FLJ32743" ENSG00000172361 "Cilia and flagella associated protein 53" Q96M91 18 50227193-50266522 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Ciliopathy, Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.1;fallopian tube: 19.7;testis: 44.9" "Cell line enhanced" "Detected in many" "hTERT-HME1: 9.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "pons and medulla: 17.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA041069, HPA066142" Enhanced Approved Midbody Midbody "HPA041069: AB_10805835, HPA066142: " "unprognostic (1.73e-2)" "unprognostic (1.13e-2)" "unprognostic (5.83e-2)" "unprognostic (3.12e-3)" "unprognostic (3.31e-2)" "unprognostic (1.19e-1)" "unprognostic (3.64e-4)" "unprognostic (2.90e-2)" "unprognostic (3.68e-2)" "unprognostic (9.75e-3)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "prognostic favourable (5.85e-4)" "unprognostic (3.22e-1)" "unprognostic (1.17e-2)" "unprognostic (4.34e-3)" "unprognostic (4.61e-3)" 0.4 1.0 2.1 0.4 4.8 0.6 1.0 2.9 1.0 1.6 0.3 4.9 1.7 0.4 1.0 9.3 0.3 19.7 0.7 0.4 2.7 3.3 2.2 0.4 4.5 0.4 1.0 1.1 4.8 1.6 2.7 12.3 0.4 17.1 1.1 0.3 1.2 0.8 2.5 1.4 0.9 0.4 0.5 1.4 0.4 0.5 44.9 2.2 0.2 4.3 0.0 0.4 0.5 0.4 2.1 1.0 2.2 1.0 1.4 1.2 0.4 2.4 1.6 1.0 2.0 1.4 2.7 1.8 0.5 0.3 0.3 0.4 0.2 2.1 1.4 1.4 0.5 1.0 0.8 1.0 0.5 1.1 1.5 0.5 0.8 0.2 0.8 1.0 0.9 0.8 4.1 1.1 9.5 0.7 2.7 0.7 0.6 2.3 2.3 0.5 0.5 1.0 0.3 0.5 2.0 2.8 0.0 1.7 1.3 0.3 0.1 0.8 1.3 0.2 0.1 1.4 1.0 0.9 0.8 4.3 1.5 0.3 1.6 1.1 0.3 2.2 0.4 0.0 0.9 1.0 0.5 0.5 0.4 0.9 0.4 2.1 1.2 0.8 0.1 1.4 0.4 1.0 1.0 0.4 2.1 4.8 2.9 1.0 2.7 3.3 1.0 1.1 17.1 2.2 CFAP54 "C12orf55, C12orf63, FLJ31514, FLJ44112" ENSG00000188596 "Cilia and flagella associated protein 54" Q96N23 12 96489571-96875555 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7;testis: 15.1" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 10.5;TIME: 12.7" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "basal ganglia: 16.5;pons and medulla: 30.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039897 Enhanced Approved Microtubules,Cytosol Microtubules Cytosol "HPA039897: AB_10674427" "unprognostic (1.87e-4)" "unprognostic (3.63e-2)" "unprognostic (8.07e-2)" "unprognostic (7.89e-2)" "unprognostic (4.66e-2)" "unprognostic (5.55e-2)" "unprognostic (2.75e-2)" "unprognostic (2.91e-2)" "unprognostic (6.16e-2)" "unprognostic (8.40e-2)" "unprognostic (2.86e-1)" "unprognostic (2.36e-1)" "unprognostic (3.55e-5)" "unprognostic (2.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.26e-2)" "unprognostic (8.00e-2)" 1.0 0.9 3.4 1.9 16.5 4.5 1.4 1.0 3.4 2.0 1.4 9.5 1.8 2.3 3.3 8.6 1.2 8.9 1.5 0.9 5.3 3.6 1.4 1.5 8.1 1.9 1.3 3.1 3.8 0.7 1.3 11.7 0.9 30.7 1.7 1.5 0.3 1.8 1.9 1.8 2.9 1.5 1.9 1.7 1.9 1.6 15.1 5.2 0.0 2.4 0.5 1.6 1.0 1.1 2.7 1.6 3.7 1.4 1.5 1.7 0.1 1.6 0.8 1.3 1.8 0.8 1.1 1.1 1.4 0.3 0.4 0.6 0.8 2.4 1.4 2.1 0.5 1.3 0.7 0.4 0.5 2.2 1.0 1.4 3.0 0.8 0.2 2.6 1.7 0.4 0.5 1.9 0.7 10.5 0.7 4.9 1.3 0.7 1.2 2.4 2.4 1.4 1.5 1.5 1.7 3.0 1.8 2.3 1.7 1.3 0.7 1.5 2.3 0.7 12.7 2.4 2.9 2.2 2.4 5.4 2.3 1.1 1.7 1.2 1.7 3.7 1.4 1.4 1.7 0.9 1.4 1.4 1.3 1.3 0.4 2.7 1.6 1.5 3.7 1.5 1.1 1.6 1.0 0.1 3.4 16.5 1.0 3.4 5.3 3.6 1.3 3.1 30.7 5.2 CFAP65 "CCDC108, DKFZp434O0527, MGC35338" ENSG00000181378 "Cilia and flagella associated protein 65" Q6ZU64 2 219002846-219041527 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.3;fallopian tube: 29.2;testis: 20.4" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.6;SH-SY5Y: 4.1;U-87 MG: 2.0" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.1" "Region enhanced" "Detected in many" "pons and medulla: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 13.1" HPA055156 Uncertain "Intracellular and membrane" "HPA055156: " "unprognostic (3.95e-2)" "unprognostic (1.80e-1)" "unprognostic (9.88e-3)" "prognostic favourable (6.08e-5)" "unprognostic (2.18e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-1)" "unprognostic (3.76e-3)" "unprognostic (3.71e-1)" "unprognostic (3.03e-1)" "unprognostic (5.58e-3)" "unprognostic (1.43e-1)" "unprognostic (6.62e-3)" "unprognostic (8.04e-2)" "unprognostic (2.81e-2)" "unprognostic (9.60e-2)" "unprognostic (6.60e-2)" 0.2 0.4 1.8 0.3 6.4 0.3 0.3 0.0 2.1 2.2 0.4 5.4 0.3 0.3 0.9 6.0 0.2 29.2 0.6 0.2 2.9 3.2 0.5 0.2 3.6 0.3 0.4 1.2 4.2 0.6 0.3 6.1 0.2 16.3 0.3 0.5 2.8 0.4 0.4 0.2 0.2 0.7 0.2 0.6 0.3 0.6 20.4 2.5 0.0 1.3 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.5 0.5 0.0 1.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.3 1.0 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 1.6 4.1 0.0 0.1 0.7 1.1 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.8 6.4 0.0 2.1 2.9 3.2 0.4 1.2 16.3 2.5 CFAP73 "CCDC42B, MIA2" ENSG00000186710 "Cilia and flagella associated protein 73" A6NFT4 12 113149858-113159276 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;epididymis: 17.8;fallopian tube: 35.5" "Cell line enhanced" "Detected in some" "Daudi: 6.3;REH: 3.2;T-47d: 3.8;U-698: 12.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Region enhanced" "Detected in many" "pons and medulla: 27.2" "Cell type enhanced" "Detected in some" "naive B-cell: 1.0;naive CD4 T-cell: 1.3" "Group enriched" "Detected in many" 9 "B-cells: 1.0;T-cells: 1.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA048539 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA048539: " "unprognostic (2.42e-2)" "prognostic favourable (1.29e-4)" "unprognostic (1.90e-3)" "prognostic favourable (5.52e-4)" "unprognostic (2.32e-2)" "unprognostic (1.18e-3)" "unprognostic (6.49e-2)" "unprognostic (2.94e-1)" "unprognostic (1.33e-1)" "unprognostic (3.14e-1)" "unprognostic (5.68e-2)" "unprognostic (3.43e-2)" "unprognostic (1.62e-4)" "unprognostic (2.03e-4)" "unprognostic (1.60e-1)" "unprognostic (4.03e-2)" "unprognostic (1.55e-2)" 0.2 0.3 4.3 0.5 16.9 2.0 0.3 0.5 0.9 3.1 0.3 15.3 1.0 0.5 1.0 17.8 0.6 35.5 0.4 0.2 5.8 6.1 0.6 0.2 5.7 0.9 0.2 0.9 6.8 0.3 0.7 0.9 0.2 27.2 0.3 0.3 0.0 2.2 0.9 0.5 4.5 0.6 0.2 1.1 0.5 3.9 1.5 4.7 0.0 0.5 0.5 1.3 0.4 0.0 1.0 0.1 0.0 0.0 0.0 1.3 0.2 0.3 0.1 0.4 0.4 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.5 3.0 6.3 0.2 0.0 1.0 0.0 0.0 0.0 0.2 0.5 0.3 2.1 0.2 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.3 1.1 0.4 0.2 3.2 0.0 0.5 0.8 0.7 0.6 0.1 0.0 0.9 0.0 3.8 0.0 0.1 0.1 1.0 0.3 0.2 0.6 0.2 12.7 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 4.3 16.9 0.5 0.9 5.8 6.1 0.2 0.9 27.2 4.7 CFAP74 "C1orf222, FLJ45476, KIAA1751" ENSG00000142609 "Cilia and flagella associated protein 74" Q9C0B2 1 1921951-2003837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;fallopian tube: 12.1;testis: 26.4" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028521, HPA029274, HPA030240" Enhanced "HPA028521: AB_10601881, HPA029274: AB_10601997, HPA030240: AB_10601961" "unprognostic (5.41e-3)" "unprognostic (1.53e-1)" "unprognostic (3.02e-1)" "unprognostic (9.12e-3)" "unprognostic (3.95e-2)" "unprognostic (2.21e-1)" "unprognostic (2.21e-2)" "unprognostic (1.81e-1)" "unprognostic (1.91e-1)" "unprognostic (1.09e-2)" "unprognostic (3.68e-2)" "unprognostic (1.47e-1)" "unprognostic (1.26e-6)" "unprognostic (1.28e-1)" "unprognostic (2.11e-1)" "unprognostic (1.86e-1)" "unprognostic (1.03e-1)" 0.4 2.3 1.3 0.5 4.8 1.6 0.3 11.8 3.8 1.7 0.4 3.9 0.4 0.4 1.0 6.6 1.6 12.1 1.2 0.3 1.9 1.8 0.2 1.7 3.1 1.0 0.8 1.5 2.5 0.1 0.3 2.4 0.5 5.4 0.2 0.4 0.0 0.5 0.7 1.2 5.5 0.3 0.2 0.4 0.4 0.3 26.4 1.0 0.0 1.9 0.0 0.2 0.9 0.1 1.4 1.2 1.5 1.4 1.9 1.1 0.1 1.5 0.0 2.4 1.5 0.0 3.5 2.1 0.3 0.0 0.0 1.2 3.4 0.3 2.0 3.1 0.6 0.5 0.0 0.6 0.5 1.8 2.8 4.2 5.1 2.3 0.6 3.2 1.4 2.3 2.1 0.0 0.0 0.0 5.8 1.6 1.2 0.6 1.6 1.1 1.9 2.6 1.7 0.7 1.0 0.0 3.3 3.1 1.1 0.6 0.3 0.1 0.7 0.9 3.6 2.0 2.0 0.8 2.3 2.2 0.8 2.2 0.2 3.2 1.0 0.3 1.4 1.1 0.8 0.6 0.3 1.0 0.6 0.5 0.5 1.4 0.8 1.1 1.5 1.9 0.9 1.2 0.6 0.1 1.3 4.8 11.8 3.8 1.9 1.8 0.8 1.5 5.4 1.0 CFAP97D2 ENSG00000283361 "CFAP97 domain containing 2" 13 114154691-114223084 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 7.7;brain: 8.4;fallopian tube: 22.4;pancreas: 7.8" "Cell line enhanced" "Detected in some" "HL-60: 1.7;NTERA-2: 1.0" "Cell type enriched" "Detected in single" 12 "naive CD8 T-cell: 7.7" "Lineage enriched" "Detected in single" 78 "T-cells: 7.7" 0.0 0.0 0.5 0.0 7.0 0.8 0.0 0.0 1.4 0.3 0.0 8.4 0.0 0.0 0.0 2.1 0.0 22.4 0.0 0.0 1.9 0.0 0.0 2.6 0.3 0.0 2.0 3.6 7.8 0.0 0.1 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 2.4 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 7.7 0.0 0.0 0.0 0.0 0.0 0.7 CFAP99 ENSG00000206113 "Cilia and flagella associated protein 99" D6REC4 4 2418974-2462942 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.9;fallopian tube: 8.8;testis: 37.2" "Cell line enhanced" "Detected in some" "HEK 293: 3.3;SCLC-21H: 1.5;T-47d: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (7.54e-3)" "unprognostic (6.46e-3)" "unprognostic (1.12e-1)" "unprognostic (2.31e-3)" "unprognostic (2.68e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-2)" "unprognostic (5.22e-2)" "unprognostic (1.89e-1)" "unprognostic (8.14e-2)" "unprognostic (7.93e-5)" "unprognostic (1.15e-1)" "unprognostic (5.97e-3)" "unprognostic (1.92e-2)" "unprognostic (1.36e-1)" "unprognostic (6.94e-2)" "unprognostic (3.49e-1)" 0.0 1.7 0.8 0.1 5.5 0.0 0.1 0.0 0.6 0.4 0.1 3.5 0.0 0.1 0.5 4.5 0.0 8.8 0.2 0.0 2.4 0.6 0.3 2.9 0.0 0.0 0.0 0.8 0.8 0.0 2.9 0.0 9.9 0.1 0.1 1.0 0.1 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.3 37.2 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.0 0.0 0.2 0.5 0.0 0.6 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.6 3.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.2 0.6 1.2 1.3 0.2 0.1 0.0 0.6 1.1 0.0 1.5 0.7 0.0 0.1 0.1 1.8 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.7 0.1 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 CFC1 "CRYPTIC, HTX2" ENSG00000136698 "Cripto, FRL-1, cryptic family 1" P0CG37 2 130592168-130599575 "Disease related genes, Predicted secreted proteins" Gastrulation "Developmental protein" "Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 13.0;pancreas: 21.9;pituitary gland: 22.4;prostate: 7.6;stomach 1: 9.4" "Group enriched" "Detected in some" 21 "RPMI-8226: 19.1;SCLC-21H: 10.9" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA041773 Uncertain "Secreted - unknown location" "HPA041773: " "unprognostic (6.65e-2)" "unprognostic (2.19e-3)" "unprognostic (1.11e-3)" "unprognostic (2.01e-1)" 0.1 0.1 0.9 0.0 2.1 0.0 0.0 2.3 1.1 0.1 0.5 0.1 0.1 0.1 0.0 1.2 0.1 0.3 0.2 13.0 0.1 0.0 0.0 0.0 2.5 0.1 21.9 0.0 22.4 0.0 7.6 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 9.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 CFC1B ENSG00000152093 "Cripto, FRL-1, cryptic family 1B" P0CG36 2 130521197-130528604 "Predicted secreted proteins" Gastrulation "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 9 "brain: 3.4;pancreas: 13.0;pituitary gland: 8.1" "Group enriched" "Detected in some" 9 "SCLC-21H: 2.2;U-2 OS: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA041773 Approved "Secreted - unknown location" "HPA041773: " 0.3 0.1 0.4 0.1 1.6 0.1 0.1 1.5 0.5 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.3 0.1 0.3 0.1 3.4 0.2 0.1 0.2 0.1 0.6 0.1 0.1 13.0 0.1 8.1 0.1 1.0 0.8 0.7 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.6 1.5 0.5 0.1 3.4 0.6 0.1 1.0 0.1 CGB2 ENSG00000104818 "Chorionic gonadotropin beta subunit 2" 19 49031912-49033238 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.1;testis: 4.1" "Group enriched" "Detected in some" 5 "HMC-1: 24.8;U-266/70: 9.9;U-266/84: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted in other tissues" Cytosol "HPA038925: , HPA038934: " "unprognostic (3.05e-2)" 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 1.1 1.0 0.9 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.1 1.4 0.4 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.3 4.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 3.3 0.0 0.4 0.0 0.0 0.1 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 2.9 9.9 12.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CGREF1 CGR11 ENSG00000138028 "Cell growth regulator with EF-hand domain 1" Q99674 2 27098889-27119115 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.6" "Cell line enhanced" "Detected in many" "SK-BR-3: 38.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008241, HPA071103" Uncertain Approved "Golgi apparatus" "Secreted in brain" 22000 "Golgi apparatus" "HPA008241: AB_1846605, HPA071103: " "unprognostic (1.39e-2)" "unprognostic (1.26e-2)" "unprognostic (1.62e-1)" "prognostic unfavourable (3.18e-4)" "unprognostic (8.45e-2)" "unprognostic (3.99e-2)" "prognostic unfavourable (7.57e-4)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" "unprognostic (1.92e-1)" "unprognostic (2.57e-1)" "unprognostic (2.27e-1)" "unprognostic (2.52e-3)" "unprognostic (1.05e-1)" "unprognostic (2.30e-2)" "unprognostic (7.24e-4)" "unprognostic (1.20e-2)" 5.0 3.0 15.7 1.4 28.8 2.2 7.1 14.8 31.6 2.1 3.2 2.8 0.2 4.6 5.6 2.0 3.4 5.9 4.6 2.8 16.1 13.8 3.4 10.3 0.9 0.8 8.5 15.9 11.0 3.8 0.4 1.4 0.7 10.3 5.1 4.6 0.8 13.7 1.4 3.1 2.1 6.3 6.4 2.6 1.0 13.4 4.0 3.6 0.0 0.7 1.6 2.8 4.0 0.5 1.0 0.9 0.9 1.0 0.9 1.1 0.6 3.5 3.0 0.1 3.9 9.1 3.4 0.2 4.3 0.0 0.4 0.2 0.8 3.0 0.0 1.2 8.5 0.2 0.6 0.9 0.2 0.0 1.8 0.1 5.2 7.6 8.4 2.3 0.3 2.3 8.7 1.2 1.0 0.3 0.1 0.1 0.5 11.2 1.7 3.1 1.0 8.3 0.1 0.0 0.2 0.0 0.1 8.7 13.1 8.5 38.3 4.3 12.3 6.4 0.0 0.0 3.5 0.0 0.3 1.1 0.3 0.3 0.0 0.1 4.9 0.9 1.0 0.0 0.7 0.8 0.5 1.0 1.0 0.7 0.5 0.7 0.6 1.1 0.6 0.9 0.4 0.9 0.7 0.6 15.7 28.8 14.8 20.5 16.1 13.8 8.5 15.9 10.3 3.6 CH25H ENSG00000138135 "Cholesterol 25-hydroxylase" O95992 10 89205629-89207314 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.4" "Cell line enhanced" "Detected in some" "ASC diff: 7.2;fHDF/TERT166: 25.7;HSkMC: 6.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "unprognostic (6.07e-3)" "unprognostic (2.96e-3)" "unprognostic (1.57e-1)" "unprognostic (5.11e-2)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "unprognostic (3.15e-2)" "unprognostic (2.13e-1)" "unprognostic (2.54e-1)" "unprognostic (8.65e-3)" "unprognostic (7.74e-2)" "unprognostic (4.76e-2)" "unprognostic (2.62e-5)" "unprognostic (2.47e-2)" "unprognostic (1.40e-1)" "unprognostic (2.32e-2)" "unprognostic (2.29e-2)" 18.5 6.8 5.1 8.5 30.7 4.1 7.9 1.0 15.7 5.2 3.6 22.6 2.4 4.3 1.6 17.6 18.4 7.4 18.3 4.2 11.3 6.5 2.8 4.7 17.0 4.6 9.4 1.6 3.4 1.8 2.2 9.8 5.4 44.4 5.7 7.5 5.3 2.3 2.1 2.1 3.2 6.8 6.9 41.9 2.6 6.2 0.6 2.2 7.2 3.0 8.5 5.7 14.0 2.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 7.2 3.7 0.0 0.0 2.4 0.6 0.7 0.0 0.0 0.0 0.9 25.7 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 6.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.4 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 30.7 1.0 10.6 11.3 6.5 9.4 1.6 44.4 2.2 CHADL SLRR4B ENSG00000100399 "Chondroadherin like" Q6NUI6 22 41229510-41240934 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 45.8;salivary gland: 14.2" "Cell line enhanced" "Detected in some" "BEWO: 15.8;Hep G2: 4.3;hTCEpi: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA005696, HPA024654" Uncertain "Secreted to extracellular matrix" "HPA005696: AB_1079724, HPA024654: AB_1846615" "unprognostic (6.14e-2)" "unprognostic (4.42e-3)" "unprognostic (1.49e-1)" "unprognostic (6.45e-3)" "unprognostic (1.32e-1)" "unprognostic (9.51e-3)" "unprognostic (2.20e-2)" "prognostic favourable (1.56e-4)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (2.83e-3)" "unprognostic (1.51e-2)" "unprognostic (4.67e-8)" "unprognostic (8.36e-3)" "unprognostic (4.10e-1)" "unprognostic (3.40e-1)" "unprognostic (4.09e-2)" 3.2 6.3 8.6 0.7 20.3 1.2 2.4 2.7 22.4 2.8 4.1 45.8 0.4 2.0 1.5 2.1 4.3 3.1 3.4 6.9 12.7 9.8 1.3 1.7 2.8 1.0 18.6 10.1 2.8 4.5 0.5 1.7 0.9 17.2 4.6 0.5 7.3 14.2 5.3 2.6 7.0 1.8 1.2 39.8 1.0 3.3 2.0 20.3 0.0 4.0 0.2 0.6 1.8 1.3 0.3 4.2 1.6 1.4 0.0 1.6 1.2 0.8 0.3 0.3 0.4 0.2 0.1 15.8 0.6 0.0 0.0 0.3 0.2 0.1 0.2 0.1 0.8 0.7 0.0 0.8 0.0 0.2 0.3 0.0 0.4 4.3 0.5 0.2 0.1 1.4 4.5 0.4 0.0 0.5 0.0 0.6 0.0 0.4 0.2 0.7 0.4 0.6 0.2 0.7 0.2 0.3 0.4 1.0 0.2 1.7 0.3 0.2 0.1 1.6 0.3 0.2 0.2 0.2 0.1 0.3 0.2 0.1 0.3 0.1 2.1 0.0 0.6 1.6 0.7 1.4 0.9 0.0 0.6 1.0 0.5 0.3 1.6 0.7 0.7 0.0 0.2 4.2 0.1 1.2 8.6 20.3 2.7 15.2 12.7 9.8 18.6 10.1 17.2 20.3 CHAT ENSG00000070748 "Choline O-acetyltransferase" P28329 10 49609095-49665104 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Acyltransferase, Transferase" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.4;placenta: 10.4" "Cell line enriched" "Detected in some" 11 "NB-4: 15.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "basal ganglia: 5.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 18.4" "Group enriched" "Detected in many" 4 "basal ganglia: 7.7;pons and medulla: 8.1" "CAB002313, HPA048547, CAB079053" Supported Supported "CAB002313: AB_563661, CAB079053: , HPA048547: " "unprognostic (2.34e-2)" "unprognostic (6.10e-2)" "unprognostic (5.28e-2)" "unprognostic (6.96e-2)" "unprognostic (2.80e-2)" "unprognostic (3.98e-1)" "unprognostic (1.09e-1)" 0.2 0.0 0.2 0.3 5.4 0.0 0.2 0.2 0.2 0.2 0.6 0.2 0.2 1.6 0.2 0.5 0.2 0.0 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.9 0.0 0.2 10.4 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 1.1 0.2 0.4 0.2 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 1.0 0.3 0.2 0.6 1.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 15.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.7 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.3 0.4 0.1 0.5 0.3 1.0 0.4 0.1 0.6 0.5 0.3 0.0 0.6 0.1 1.0 0.2 0.0 0.2 5.4 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 CHD5 ENSG00000116254 "Chromodomain helicase DNA binding protein 5" Q8TDI0 1 6101793-6180123 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.4;pituitary gland: 22.3;testis: 16.4" "Group enriched" "Detected in some" 4 "SCLC-21H: 16.6;U-2 OS: 7.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015809 Supported "Nucleoplasm,Nuclear speckles,Cytosol" "Nucleoplasm, Nuclear speckles" Cytosol "HPA015809: " "unprognostic (5.03e-4)" "unprognostic (1.89e-1)" "unprognostic (2.47e-3)" "unprognostic (9.40e-6)" "unprognostic (1.91e-2)" "unprognostic (2.98e-2)" "unprognostic (1.06e-1)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.95e-2)" "unprognostic (6.64e-4)" "unprognostic (1.34e-1)" "unprognostic (1.34e-4)" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.96e-1)" "unprognostic (1.98e-1)" 1.1 7.9 19.8 1.3 17.1 1.0 1.0 12.1 41.4 1.2 1.4 0.7 0.0 1.3 1.2 1.2 1.5 1.2 1.2 1.6 15.3 10.1 1.3 1.0 1.2 1.0 4.3 19.1 1.1 1.4 1.3 22.3 1.0 8.0 1.9 1.3 2.3 1.2 4.8 1.2 1.0 1.4 1.2 1.6 1.1 1.2 16.4 0.8 0.0 1.0 0.0 1.0 1.1 0.4 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.1 0.1 0.0 0.0 0.1 0.2 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.3 1.5 0.0 0.3 1.3 0.0 0.0 0.0 0.0 16.6 0.2 0.1 0.0 0.0 2.8 0.1 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.8 17.1 12.1 34.2 15.3 10.1 4.3 19.1 8.0 0.8 CHD7 "CRG, FLJ20357, FLJ20361, KIAA1416" ENSG00000171316 "Chromodomain helicase DNA binding protein 7" Q9P2D1 8 60678778-60868028 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.1" "Cell line enhanced" "Detected in many" "AF22: 25.8;SCLC-21H: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 110.3" HPA053075 Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA053075: " "unprognostic (3.77e-2)" "unprognostic (3.28e-3)" "unprognostic (3.17e-2)" "prognostic unfavourable (5.34e-5)" "unprognostic (9.59e-2)" "unprognostic (1.14e-1)" "unprognostic (1.86e-3)" "unprognostic (3.41e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (9.09e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-1)" "unprognostic (8.20e-2)" "unprognostic (2.17e-1)" 3.9 2.2 7.0 7.9 11.2 25.1 4.1 47.1 9.0 2.3 5.7 13.4 3.1 5.9 2.6 3.2 5.1 3.2 3.1 4.1 8.1 4.3 3.6 3.6 4.7 7.0 8.1 3.3 1.4 6.4 12.4 9.9 5.6 9.9 2.9 5.5 6.4 5.7 2.8 10.3 5.7 6.6 2.4 7.5 6.1 4.5 4.3 12.2 1.6 5.4 2.2 7.3 2.9 5.9 12.2 0.6 12.6 0.6 0.0 5.5 0.4 3.8 1.9 25.8 4.5 0.0 0.0 8.1 0.2 0.0 0.9 0.8 4.8 3.6 7.5 0.4 0.0 2.3 13.2 3.8 0.8 2.8 7.1 17.6 3.2 6.3 1.1 5.3 3.3 0.5 2.9 0.0 4.3 3.8 1.3 6.7 0.6 3.9 8.3 6.0 17.7 0.9 17.3 6.1 2.4 2.0 4.4 23.6 11.7 0.7 2.9 7.2 5.2 5.0 4.4 0.2 4.2 0.2 2.1 7.1 4.1 11.7 1.5 0.6 6.6 10.4 0.3 12.6 2.6 0.1 3.3 8.0 2.9 0.9 0.1 12.2 5.5 2.0 7.1 0.0 0.6 0.6 0.2 0.4 7.0 11.2 47.1 6.5 8.1 4.3 8.1 3.3 9.9 12.2 CHL1 "CALL, FLJ44930, L1CAM2, MGC132578" ENSG00000134121 "Cell adhesion molecule L1 like" O00533 3 196596-409417 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.9" "Group enriched" "Detected in some" 5 "SK-MEL-30: 44.1;WM-115: 14.0" "Cancer enhanced" "Detected in many" "glioma: 15.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 56 "memory B-cell: 4.5;naive B-cell: 6.7" "Lineage enriched" "Detected in single" 67 "B-cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003345, CAB026120" Enhanced "Intracellular and membrane" 6900000000 "CAB026120: , HPA003345: AB_1078516" "unprognostic (5.54e-2)" "unprognostic (2.08e-1)" "unprognostic (7.45e-2)" "unprognostic (7.14e-3)" "unprognostic (1.16e-3)" "unprognostic (1.12e-1)" "unprognostic (3.10e-2)" "unprognostic (2.22e-1)" "unprognostic (5.14e-1)" "unprognostic (1.06e-1)" "unprognostic (7.81e-2)" "unprognostic (3.51e-1)" "prognostic favourable (1.21e-6)" "unprognostic (1.11e-1)" "unprognostic (6.07e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" 12.8 4.7 17.8 7.9 32.1 1.1 8.4 7.3 62.9 2.9 10.8 5.0 0.9 4.6 3.9 2.4 8.8 2.8 5.1 10.0 21.2 19.0 17.2 1.5 5.3 5.8 11.1 28.7 16.5 2.4 2.0 3.7 0.8 17.8 3.1 8.1 2.3 7.1 6.9 0.9 12.1 6.1 5.5 9.9 3.3 3.9 2.2 7.5 0.0 1.7 0.0 3.3 2.4 5.3 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 32.1 7.3 36.1 21.2 19.0 11.1 28.7 17.8 7.5 CHN1 "ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2" ENSG00000128656 "Chimerin 1" P15882 2 174799363-175005369 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Neurogenesis "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 145.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 58.9;BJ hTERT+ SV40 Large T+ RasG12V: 29.7" "Cancer enhanced" "Detected in all" "glioma: 18.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 9.0;memory CD8 T-cell: 2.9;T-reg: 10.0" "Lineage enriched" "Detected in single" 35 "T-cells: 10.0" "Low region specificity" "Detected in all" HPA036111 Approved Cytosol Cytosol "HPA036111: AB_10671241" "unprognostic (3.18e-3)" "unprognostic (4.19e-2)" "unprognostic (9.69e-2)" "unprognostic (3.42e-3)" "unprognostic (1.92e-1)" "unprognostic (2.65e-2)" "unprognostic (7.45e-2)" "unprognostic (9.14e-2)" "unprognostic (3.71e-2)" "unprognostic (1.34e-2)" "unprognostic (5.29e-2)" "unprognostic (2.95e-1)" "prognostic unfavourable (5.07e-4)" "unprognostic (7.31e-3)" "unprognostic (4.07e-1)" "unprognostic (2.08e-2)" "unprognostic (9.46e-2)" 3.8 5.2 63.4 3.4 60.8 1.0 2.4 9.1 145.3 4.7 2.5 4.4 0.2 1.7 3.9 15.1 3.2 2.9 4.7 5.2 74.0 21.4 2.1 1.4 7.1 7.4 21.4 51.7 2.8 1.9 31.7 5.2 14.4 23.0 7.2 2.6 3.1 1.4 4.6 1.2 1.9 1.8 5.5 5.1 2.7 2.1 7.5 9.1 0.0 4.0 0.0 7.2 4.5 1.2 0.2 0.2 0.0 0.0 0.1 10.0 1.1 0.0 3.3 14.6 4.2 4.5 20.7 0.1 14.1 58.9 20.3 29.7 0.1 1.9 0.1 0.4 21.2 0.5 18.6 0.4 8.2 0.2 8.1 2.5 4.8 1.4 10.0 1.3 0.3 18.4 0.5 9.8 3.1 7.5 0.1 0.6 14.9 2.7 6.7 0.6 17.3 5.0 2.1 20.6 0.1 0.2 0.1 18.0 19.5 11.2 0.1 1.7 0.6 0.3 2.3 8.6 1.3 2.8 5.1 1.6 7.8 0.2 1.9 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.7 0.2 9.0 2.9 0.0 0.0 1.3 0.3 0.0 0.1 0.0 0.2 10.0 1.1 63.4 60.8 9.1 135.3 74.0 21.4 21.4 51.7 23.0 9.1 CHN2 "ARHGAP3, RhoGAP3" ENSG00000106069 "Chimerin 2" P52757 7 29146569-29514328 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.2;intestine: 44.3" "Cell line enhanced" "Detected in many" "HEL: 18.2;HMC-1: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA018989 Approved Approved Nucleoplasm Nucleoplasm "HPA018989: AB_1846681" "unprognostic (3.88e-2)" "unprognostic (2.36e-1)" "unprognostic (6.87e-2)" "unprognostic (2.56e-1)" "unprognostic (1.52e-1)" "unprognostic (8.12e-2)" "unprognostic (6.87e-2)" "unprognostic (1.19e-1)" "unprognostic (6.64e-2)" "unprognostic (4.71e-2)" "unprognostic (7.54e-2)" "unprognostic (7.85e-2)" "unprognostic (1.61e-2)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "unprognostic (1.15e-2)" "unprognostic (1.58e-3)" 2.7 4.4 7.9 3.3 21.8 1.4 2.1 89.2 14.7 6.6 14.1 19.2 0.3 44.3 2.7 2.1 1.9 5.0 4.8 6.9 10.5 7.0 8.2 22.0 3.7 2.0 34.7 6.9 13.4 13.9 0.5 1.9 6.4 16.5 5.3 5.9 4.6 1.6 2.9 2.7 1.5 36.3 3.0 16.5 5.1 4.2 2.3 29.2 0.8 4.7 0.0 1.7 3.5 4.0 0.3 8.5 3.9 11.2 9.3 2.5 2.6 0.1 0.4 1.6 0.0 0.0 0.0 9.4 0.0 0.0 0.4 0.0 5.0 1.5 0.5 3.1 0.1 2.6 5.0 0.0 0.0 8.9 1.6 18.2 0.8 9.7 0.1 0.0 35.5 0.0 3.3 0.0 0.7 1.9 0.7 0.2 0.1 0.2 4.9 0.2 0.6 1.7 0.4 0.0 0.9 9.2 6.2 9.5 0.7 2.2 3.3 5.8 0.3 1.0 0.2 0.5 0.1 0.0 0.2 1.8 7.0 0.0 0.1 1.1 0.7 3.9 10.5 0.1 2.5 11.2 1.8 0.3 0.4 2.2 8.5 0.2 0.5 1.0 0.6 9.3 6.4 1.0 0.0 2.6 7.9 21.8 89.2 14.7 10.5 7.0 34.7 6.9 16.5 29.2 CHRD ENSG00000090539 Chordin Q9H2X0 3 184380073-184390736 "Plasma proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.8;liver: 48.3" "Cell line enhanced" "Detected in some" "CACO-2: 3.6;Hep G2: 15.0;MCF7: 3.2;U-2 OS: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035827 Approved "Secreted in other tissues" 120000 "HPA035827: AB_10669657" "unprognostic (2.26e-1)" "unprognostic (3.25e-2)" "unprognostic (1.63e-2)" "unprognostic (2.21e-1)" "unprognostic (6.52e-2)" "unprognostic (3.16e-1)" "unprognostic (2.88e-1)" "unprognostic (9.58e-2)" "unprognostic (1.87e-1)" "unprognostic (1.12e-1)" "unprognostic (3.12e-2)" "unprognostic (6.55e-2)" "prognostic unfavourable (6.09e-7)" "unprognostic (5.53e-3)" "unprognostic (1.85e-1)" "unprognostic (9.84e-2)" "unprognostic (7.99e-3)" 8.9 6.2 8.9 3.1 6.4 0.4 4.2 32.8 15.9 13.0 2.9 2.4 1.8 2.7 14.9 6.4 3.2 5.7 3.9 4.6 6.5 1.1 10.1 48.3 3.0 2.2 1.8 7.0 7.9 13.9 0.8 2.5 3.8 4.7 4.2 1.6 2.6 2.0 8.3 4.9 3.2 3.0 7.0 2.9 4.6 3.4 1.2 1.8 0.0 3.2 2.3 0.9 3.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.1 0.1 1.9 0.5 0.0 0.3 0.2 3.6 0.0 0.0 1.4 0.4 0.0 2.3 0.0 0.0 0.0 1.0 0.0 0.1 15.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 2.0 2.5 0.0 0.0 0.9 0.0 0.1 0.1 0.1 1.9 0.0 0.0 0.0 5.2 0.0 0.5 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 6.4 32.8 15.9 6.5 1.1 1.8 7.0 4.7 1.8 CHRM1 ENSG00000168539 "Cholinergic receptor muscarinic 1" P11229 11 62908679-62921807 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 34.7;prostate: 28.2;salivary gland: 25.3" "Cell line enhanced" "Detected in some" "MCF7: 8.0;SK-BR-3: 4.0;T-47d: 2.6;WM-115: 1.4" "Cancer enriched" "Detected in some" 16 "prostate cancer: 27.9" "Group enriched" "Detected in many" 10 "amygdala: 13.2;basal ganglia: 22.0;cerebral cortex: 34.7;hippocampal formation: 14.2;olfactory region: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "amygdala: 74.1;basal ganglia: 65.6;cerebral cortex: 83.5;hippocampal formation: 100.4;olfactory region: 36.8" "HPA014101, CAB022366" Enhanced Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB022366: , HPA014101: AB_1854210" "unprognostic (3.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.16e-2)" "unprognostic (2.89e-2)" "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (2.08e-1)" "unprognostic (8.57e-4)" "unprognostic (4.88e-1)" "unprognostic (6.43e-2)" "unprognostic (1.75e-1)" 0.5 3.7 13.2 0.8 22.0 0.5 3.2 0.2 34.7 0.6 1.3 0.5 0.0 1.0 0.7 0.6 0.8 0.8 0.7 0.6 14.2 1.7 0.7 0.6 2.9 0.6 1.4 14.0 0.5 1.2 1.0 0.1 0.8 0.1 28.2 1.3 1.3 25.3 0.6 0.6 2.6 1.3 0.6 0.3 0.6 1.9 0.6 1.8 0.0 0.8 0.0 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.0 0.7 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 22.0 0.2 34.7 14.2 1.7 1.4 14.0 0.1 1.8 CHRM4 ENSG00000180720 "Cholinergic receptor muscarinic 4" P08173 11 46385098-46386608 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.7;intestine: 8.0;lymphoid tissue: 17.2" "Cell line enhanced" "Detected in some" "RH-30: 4.9;SCLC-21H: 14.2;U-2 OS: 4.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 26.8;basal ganglia: 65.9;cerebral cortex: 30.5;hippocampal formation: 26.4;olfactory region: 36.4" "Group enriched" "Detected in many" 7 "amygdala: 5.5;basal ganglia: 15.3;cerebral cortex: 8.6;hippocampal formation: 7.6;olfactory region: 20.1" "CAB022444, HPA072083" Enhanced Uncertain "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "CAB022444: , HPA072083: " "unprognostic (7.11e-2)" "unprognostic (3.79e-1)" "unprognostic (5.31e-2)" "unprognostic (7.38e-2)" "unprognostic (8.63e-3)" "unprognostic (1.38e-1)" "unprognostic (6.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (2.96e-3)" "unprognostic (4.08e-3)" "unprognostic (5.02e-2)" "unprognostic (3.83e-2)" "unprognostic (3.64e-1)" "unprognostic (1.71e-1)" "unprognostic (3.56e-1)" "unprognostic (5.08e-2)" 0.0 0.5 1.1 0.2 11.7 1.6 0.0 0.0 6.0 0.0 0.6 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.2 8.0 0.1 0.0 17.2 0.8 4.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.3 0.1 0.2 0.0 3.0 0.0 0.1 0.2 0.1 1.4 0.2 0.3 0.3 0.0 0.1 1.8 0.1 0.0 2.1 0.3 0.5 0.2 0.0 0.2 0.5 0.6 0.0 0.0 0.1 0.1 0.1 0.6 0.2 0.0 1.0 0.2 0.2 0.6 0.2 0.0 4.9 0.0 0.0 0.1 14.2 0.3 0.4 0.1 0.1 0.1 2.4 0.0 0.4 4.1 0.0 0.1 0.7 0.5 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 CHRM5 ENSG00000184984 "Cholinergic receptor muscarinic 5" P08912 15 33968720-34067457 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 22.8" "Group enriched" "Detected in some" 5 "BEWO: 5.4;HMC-1: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.8" "Region enhanced" "Detected in many" "hypothalamus: 15.4" "Low region specificity" "Detected in many" HPA013172 Uncertain "HPA013172: AB_1854212" "unprognostic (8.19e-2)" "unprognostic (2.13e-1)" "unprognostic (7.67e-2)" "unprognostic (4.32e-1)" "unprognostic (3.05e-3)" "unprognostic (2.77e-1)" "unprognostic (2.49e-2)" "unprognostic (2.79e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-2)" "unprognostic (4.61e-4)" "unprognostic (7.95e-2)" "unprognostic (1.33e-6)" "unprognostic (1.42e-1)" "unprognostic (4.53e-2)" "unprognostic (1.38e-1)" "unprognostic (9.07e-2)" 0.3 0.5 1.2 0.9 15.7 1.3 2.1 0.8 6.9 0.3 0.4 5.1 0.0 1.1 0.5 0.8 0.5 0.3 0.6 0.3 6.8 4.4 0.6 0.9 0.4 1.0 5.8 4.5 0.5 1.0 0.1 0.5 4.8 17.8 0.6 0.3 0.0 0.5 0.1 0.7 1.8 1.8 0.2 22.8 0.7 0.6 5.2 0.0 0.0 2.3 0.0 0.3 0.4 0.3 0.3 0.9 4.8 0.3 0.2 0.3 0.0 0.1 0.2 0.8 0.3 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.5 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.7 0.3 0.2 0.0 0.5 18.8 0.4 0.0 0.2 0.1 0.0 0.6 1.2 0.1 0.2 0.2 2.2 0.2 0.3 0.1 0.3 0.2 0.0 0.4 0.3 0.3 0.3 0.7 0.2 0.2 1.1 0.2 0.2 0.2 0.2 0.1 0.9 0.3 0.4 0.1 0.2 0.3 1.5 0.3 0.2 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.3 0.1 0.2 4.8 0.2 0.1 0.9 0.2 0.0 1.2 15.7 0.8 6.9 6.8 4.4 5.8 4.5 17.8 0.0 CHRNA2 ENSG00000120903 "Cholinergic receptor nicotinic alpha 2 subunit" Q15822 8 27459761-27479883 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 11.6;prostate: 33.5" "Cell line enhanced" "Detected in some" "BEWO: 1.4;SiHa: 1.9;U-2197: 1.8;U-266/84: 1.2" "Cancer enriched" "Detected in single" 421 "prostate cancer: 30.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 1.8;plasmacytoid DC: 1.0" "Group enriched" "Detected in many" 14 "dendritic cells: 1.0;granulocytes: 1.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (2.23e-2)" "unprognostic (3.19e-1)" "unprognostic (6.19e-2)" "unprognostic (6.29e-3)" "unprognostic (1.19e-2)" "unprognostic (2.13e-1)" "unprognostic (1.91e-1)" "unprognostic (7.60e-2)" "unprognostic (1.70e-1)" "unprognostic (1.47e-1)" 0.3 0.8 1.2 0.6 2.0 1.2 2.1 2.0 11.6 0.3 0.3 11.3 0.0 0.6 0.3 1.4 0.3 0.4 0.4 0.4 1.6 2.9 0.3 0.4 0.6 0.4 1.6 0.6 0.3 0.6 0.4 0.5 0.3 7.0 33.5 0.3 2.4 0.3 0.4 0.4 0.5 0.6 0.3 0.8 0.4 0.4 0.4 1.0 2.4 0.4 0.0 0.4 0.4 0.1 0.0 1.0 1.8 0.0 0.0 0.1 1.8 0.0 0.0 0.1 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.5 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.6 0.5 1.9 0.7 0.0 0.0 0.0 0.0 0.5 0.7 1.8 0.2 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.0 0.0 1.8 1.2 2.0 2.0 11.6 1.6 2.9 1.6 0.6 7.0 1.0 CHRNA4 "BFNC, EBN, EBN1" ENSG00000101204 "Cholinergic receptor nicotinic alpha 4 subunit" P43681 20 63343223-63378401 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 16.4;liver: 38.8;parathyroid gland: 21.6" "Cell line enriched" "Detected in some" 5 "U-2 OS: 7.5" "Cancer enhanced" "Detected in some" "liver cancer: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "midbrain: 22.6;pons and medulla: 19.3;thalamus: 29.6" CAB034064 Uncertain "CAB034064: AB_2080535" "unprognostic (3.40e-1)" "unprognostic (1.71e-1)" "unprognostic (2.87e-2)" "unprognostic (3.98e-1)" "unprognostic (8.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.22e-1)" "unprognostic (1.74e-1)" "unprognostic (2.10e-3)" "unprognostic (5.72e-4)" "unprognostic (9.02e-3)" "unprognostic (9.79e-4)" "unprognostic (6.77e-2)" "unprognostic (1.08e-1)" "unprognostic (3.81e-2)" 0.6 0.8 5.2 0.6 8.7 0.6 0.6 3.1 14.5 0.6 0.6 11.0 0.0 0.6 0.6 0.6 0.6 2.0 0.6 0.6 5.1 6.8 2.1 38.8 0.7 0.6 11.3 8.2 0.7 0.6 21.6 1.0 0.6 16.4 1.3 0.6 5.7 0.6 0.6 0.6 0.6 0.6 0.6 3.9 4.8 0.6 1.9 3.9 0.0 1.2 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 8.7 3.1 14.5 5.1 6.8 11.3 8.2 16.4 3.9 CHRNA6 ENSG00000147434 "Cholinergic receptor nicotinic alpha 6 subunit" Q15825 8 42752620-42796392 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.3;retina: 5.1" "Cell line enhanced" "Detected in some" "Daudi: 7.8;HDLM-2: 4.9;HMC-1: 2.4;RPMI-8226: 1.9;U-698: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 3.4" "Lineage enriched" "Detected in single" 8 "T-cells: 3.4" "Group enriched" "Detected in some" 7 "midbrain: 24.1;thalamus: 7.0" "Region enriched" "Detected in all" 6 "midbrain: 93.1" "unprognostic (1.91e-1)" "unprognostic (7.49e-2)" "unprognostic (2.66e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (7.60e-4)" "unprognostic (4.99e-2)" "unprognostic (2.48e-2)" "unprognostic (7.73e-2)" "unprognostic (6.24e-2)" "unprognostic (2.13e-1)" "unprognostic (6.56e-2)" "unprognostic (2.63e-1)" "unprognostic (3.97e-2)" "unprognostic (1.92e-1)" "unprognostic (3.27e-3)" "unprognostic (3.66e-2)" 0.1 2.2 0.6 0.6 0.6 0.0 0.9 8.3 3.8 1.2 0.1 1.7 1.4 0.0 0.9 0.0 0.1 1.7 0.2 0.1 0.8 1.6 1.1 0.1 0.4 0.7 4.3 1.7 0.6 0.3 0.0 0.5 0.2 3.6 0.1 0.1 5.1 1.3 1.5 0.1 0.1 0.2 0.0 0.8 0.2 0.1 1.3 0.0 2.0 0.8 0.0 2.8 0.2 0.1 0.4 0.1 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 1.3 0.0 0.0 0.3 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 1.0 0.0 0.1 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.6 8.3 3.8 0.8 1.6 4.3 1.7 3.6 0.0 CHRNA9 NACHRA9 ENSG00000174343 "Cholinergic receptor nicotinic alpha 9 subunit" Q9UGM1 4 40335329-40355217 "Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.3;fallopian tube: 3.9;pituitary gland: 4.6;salivary gland: 2.7;skin 1: 2.7" "Cell line enriched" "Detected in some" 8 "U-87 MG: 18.8" "Cancer enhanced" "Detected in some" "glioma: 3.5" "Region enhanced" "Detected in some" "pons and medulla: 2.6" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 4 "T-cells: 1.5" "Region enriched" "Detected in single" 6 "basal ganglia: 1.0" "Low region specificity" "Detected in many" "unprognostic (6.20e-3)" "unprognostic (9.18e-2)" "unprognostic (6.93e-2)" "unprognostic (1.06e-1)" "unprognostic (3.54e-1)" "unprognostic (3.48e-1)" "unprognostic (1.58e-1)" "unprognostic (1.89e-1)" "unprognostic (7.30e-2)" "unprognostic (1.94e-1)" "unprognostic (8.96e-6)" "unprognostic (9.00e-2)" "unprognostic (1.76e-1)" "unprognostic (5.01e-2)" "unprognostic (9.18e-3)" 0.0 0.0 0.9 0.0 0.2 0.0 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.2 4.6 0.7 2.6 0.0 0.0 0.0 2.7 0.0 0.0 2.7 0.0 0.0 3.3 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.4 0.7 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.1 0.1 0.1 0.1 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.4 0.5 0.0 0.3 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.0 1.4 0.2 0.6 0.0 0.0 2.6 0.0 CHRNB2 ENSG00000160716 "Cholinergic receptor nicotinic beta 2 subunit" P17787 1 154567781-154580026 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 28.4" "Group enriched" "Detected in some" 6 "SCLC-21H: 20.2;SH-SY5Y: 20.0" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.13e-1)" "unprognostic (6.33e-2)" "unprognostic (8.15e-3)" "unprognostic (3.32e-1)" "unprognostic (4.37e-3)" "unprognostic (2.25e-1)" "unprognostic (3.51e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.37e-1)" "unprognostic (1.24e-3)" "unprognostic (1.83e-1)" "unprognostic (4.36e-1)" "unprognostic (2.32e-1)" "unprognostic (1.45e-1)" "unprognostic (5.65e-2)" "unprognostic (1.84e-1)" 0.9 3.2 7.8 1.2 16.4 1.0 1.8 8.1 28.4 0.9 1.1 1.6 0.0 1.4 1.0 0.9 1.1 1.0 0.9 0.9 9.4 8.9 0.9 0.9 0.9 0.9 7.9 9.8 1.0 2.1 0.9 3.3 0.9 15.4 0.9 1.2 3.1 1.0 0.9 0.9 1.3 1.2 1.1 1.4 0.9 1.6 2.0 1.7 0.0 0.9 0.0 0.9 0.9 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 20.2 20.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 7.8 16.4 8.1 22.1 9.4 8.9 7.9 9.8 15.4 1.7 CHRNB3 ENSG00000147432 "Cholinergic receptor nicotinic beta 3 subunit" Q05901 8 42697376-42737407 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 19.6;pancreas: 6.8;testis: 5.0" "Group enriched" "Detected in some" 6 "NTERA-2: 3.3;U-266/84: 7.1" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.6" "Group enriched" "Detected in many" 5 "cerebellum: 19.6;midbrain: 8.2" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 1.5;T-reg: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 32 "cerebellum: 21.0;midbrain: 30.4" HPA045555 Enhanced "HPA045555: AB_10960891" "unprognostic (8.63e-2)" "unprognostic (4.12e-1)" "unprognostic (7.29e-2)" "unprognostic (1.62e-1)" 0.1 0.1 0.3 0.1 0.8 0.1 0.1 19.6 2.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.4 0.1 0.1 0.1 0.8 8.2 2.3 0.1 6.8 0.1 0.9 0.1 1.1 0.1 0.1 3.4 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 5.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 3.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.8 19.6 2.7 0.4 0.4 8.2 2.3 1.1 0.0 CHST1 "C6ST, KSGal6ST" ENSG00000175264 "Carbohydrate sulfotransferase 1" O43916 11 45648877-45665622 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.5" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 10.1;TIME: 9.6;WM-115: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (1.77e-2)" "unprognostic (1.67e-1)" "unprognostic (6.37e-3)" "unprognostic (1.32e-1)" "unprognostic (2.18e-2)" "unprognostic (2.50e-1)" "prognostic unfavourable (3.95e-4)" "unprognostic (6.22e-2)" "unprognostic (1.64e-1)" "unprognostic (1.39e-1)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "prognostic unfavourable (4.64e-7)" "unprognostic (5.37e-3)" "unprognostic (1.06e-1)" "unprognostic (1.30e-1)" "unprognostic (9.11e-3)" 2.2 8.6 21.2 2.0 21.5 1.2 4.8 2.3 42.5 2.2 1.6 5.0 0.0 1.9 2.5 1.2 1.3 6.5 2.1 2.8 18.6 15.5 2.6 1.5 2.5 2.0 13.6 17.0 4.4 2.5 17.7 4.9 1.7 10.6 1.4 1.2 1.3 14.8 1.6 3.6 1.7 1.7 2.0 2.5 4.7 1.9 3.2 5.5 0.1 9.0 0.4 1.7 2.3 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 2.2 0.0 0.0 0.3 10.1 0.0 0.0 0.9 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.5 0.2 0.0 9.6 1.9 2.8 0.0 0.0 0.0 0.0 0.0 4.1 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 21.5 2.3 35.8 18.6 15.5 13.6 17.0 10.6 5.5 CHST10 HNK-1ST ENSG00000115526 "Carbohydrate sulfotransferase 10" O43529 2 100391860-100417656 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "B-cells: 2.3;dendritic cells: 3.1;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012884, HPA051545" Approved Approved Cytosol "Intracellular and membrane" 290000 Cytosol "HPA012884: AB_1846710, HPA051545: " "unprognostic (5.40e-3)" "unprognostic (3.62e-2)" "unprognostic (3.44e-2)" "unprognostic (2.03e-1)" "unprognostic (3.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.89e-2)" "unprognostic (1.44e-1)" "unprognostic (1.78e-1)" "unprognostic (4.54e-2)" "prognostic favourable (4.05e-4)" "unprognostic (8.02e-2)" "unprognostic (2.18e-1)" "unprognostic (1.78e-2)" "unprognostic (3.73e-2)" "unprognostic (3.06e-2)" "unprognostic (3.27e-1)" 4.1 6.7 14.6 3.9 18.7 2.6 5.0 12.6 28.2 6.2 4.1 12.1 2.4 2.2 11.4 13.5 4.1 9.7 5.3 10.1 12.4 9.5 4.4 1.2 7.8 4.0 9.8 12.2 12.9 5.3 8.8 8.6 7.8 9.3 8.1 2.4 7.3 5.5 5.4 5.1 1.6 2.5 11.7 8.9 3.7 3.4 5.8 7.6 3.1 9.8 1.6 5.1 5.8 4.9 2.3 3.1 0.0 0.0 0.1 3.5 1.0 0.1 7.8 15.5 7.9 4.7 6.7 7.8 8.9 6.4 12.3 7.9 0.1 4.6 10.8 7.8 5.4 0.0 10.9 1.2 7.9 15.2 11.5 5.5 4.3 12.0 5.7 11.1 14.5 4.9 1.5 5.8 1.1 9.6 15.9 0.0 5.2 2.5 9.8 8.8 22.9 9.6 7.1 9.5 0.1 3.4 3.4 16.8 13.7 0.6 0.0 12.4 4.2 15.4 8.7 8.6 13.6 6.4 8.3 0.0 0.0 11.1 10.5 9.9 10.0 0.0 0.0 0.0 3.5 0.0 1.3 2.3 0.6 2.9 0.6 1.8 0.8 2.3 0.0 0.1 0.0 3.1 0.0 1.0 14.6 18.7 12.6 24.8 12.4 9.5 9.8 12.2 9.3 7.6 CHST2 C6ST ENSG00000175040 "Carbohydrate sulfotransferase 2" Q9Y4C5 3 143119331-143124014 "Predicted membrane proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9" "Cell line enhanced" "Detected in many" "ASC diff: 20.0;ASC TERT1: 20.6;HEL: 15.9;HHSteC: 41.3;HMC-1: 19.0;HSkMC: 21.7;U-266/70: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.4" "Group enriched" "Detected in many" 4 "monocytes: 11.4;NK-cells: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013620 Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA013620: " "unprognostic (1.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.64e-3)" "unprognostic (2.75e-1)" "unprognostic (8.97e-3)" "unprognostic (2.83e-1)" "unprognostic (2.70e-2)" "unprognostic (2.06e-1)" "unprognostic (2.76e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-3)" "unprognostic (9.15e-2)" "unprognostic (1.31e-2)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.58e-3)" "unprognostic (1.34e-1)" 6.5 2.6 8.2 11.6 16.6 20.0 4.1 9.8 15.1 4.6 3.1 6.5 2.6 3.6 6.4 2.7 2.0 1.6 3.1 2.6 7.3 10.4 4.8 1.6 5.1 10.2 10.6 5.8 3.6 2.0 1.5 5.5 15.3 14.0 7.6 2.3 5.9 4.0 15.9 2.7 3.0 4.9 6.0 32.9 17.0 5.4 2.3 4.8 24.7 5.4 0.1 8.1 7.4 5.4 1.4 1.8 0.8 11.4 4.8 0.8 0.9 0.0 0.1 1.0 0.9 20.0 20.6 0.0 1.1 3.2 0.8 0.7 0.0 0.0 0.2 0.7 0.7 0.0 0.7 2.7 0.4 0.2 0.5 15.9 0.0 0.0 41.3 0.4 19.0 21.7 3.3 1.0 3.4 1.2 1.8 1.0 5.2 0.0 2.9 4.0 5.6 2.7 0.1 0.3 0.0 0.5 0.7 1.3 0.0 0.2 0.0 1.8 0.0 0.6 4.1 2.4 1.4 3.2 4.6 18.2 0.2 1.1 4.7 3.0 12.6 0.7 0.6 0.8 0.4 4.5 0.0 1.4 0.1 0.2 1.8 1.0 0.8 0.6 0.3 4.8 11.4 0.1 0.5 0.9 8.2 16.6 9.8 15.1 7.3 10.4 10.6 5.8 14.0 4.8 CHST6 MCDC1 ENSG00000183196 "Carbohydrate sulfotransferase 6" Q9GZX3 16 75472052-75495384 "Disease related genes, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 7.2;brain: 22.6;cervix, uterine: 18.6;intestine: 16.8;salivary gland: 20.1" "Cell line enhanced" "Detected in some" "AN3-CA: 12.1;CAPAN-2: 13.3;NTERA-2: 6.4;SK-MEL-30: 5.3;U-2 OS: 8.1;WM-115: 7.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Intracellular and membrane" "unprognostic (2.28e-2)" "unprognostic (2.25e-2)" "unprognostic (1.07e-1)" "unprognostic (3.93e-3)" "unprognostic (3.30e-2)" "unprognostic (4.02e-2)" "unprognostic (7.15e-2)" "unprognostic (1.73e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (3.16e-2)" "unprognostic (1.07e-1)" "unprognostic (1.10e-7)" "unprognostic (1.23e-1)" "unprognostic (1.14e-1)" "unprognostic (5.78e-2)" "unprognostic (2.80e-4)" 0.8 7.2 10.1 1.1 17.4 0.8 0.7 8.3 11.6 18.6 5.9 22.6 0.0 16.8 1.4 1.1 2.5 2.9 0.8 2.3 9.4 5.5 1.1 0.6 1.4 0.8 17.6 4.9 0.7 0.7 1.1 1.4 0.8 18.5 1.3 5.9 0.4 20.1 1.0 0.9 0.9 15.5 1.3 19.5 0.9 1.3 1.3 13.6 0.0 0.8 0.0 0.8 0.9 0.5 1.2 0.8 2.5 0.5 1.4 0.7 0.2 0.2 0.6 0.8 12.1 0.2 0.5 0.2 0.1 0.0 0.0 0.1 0.2 13.3 0.1 1.8 0.1 0.1 1.1 0.2 0.1 0.0 0.3 0.0 0.2 1.2 0.0 0.0 0.2 0.4 0.0 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 6.4 0.2 0.0 0.0 0.1 1.1 0.1 0.3 0.1 0.0 0.1 5.3 0.1 0.4 0.2 0.1 8.1 0.1 0.0 0.3 0.2 3.1 0.4 0.0 7.0 2.5 0.5 0.4 0.6 0.3 0.5 0.8 0.4 0.4 0.1 1.2 0.5 0.7 2.0 1.4 0.3 0.8 0.3 0.2 10.1 17.4 8.3 11.6 9.4 5.5 17.6 4.9 18.5 13.6 CHST8 GALNAC-4-ST1 ENSG00000124302 "Carbohydrate sulfotransferase 8" Q9H2A9 19 33621955-33773509 "Disease related genes, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 27.1;pituitary gland: 36.7" "Group enriched" "Detected in some" 4 "RPMI-8226: 18.4;SCLC-21H: 10.7;SH-SY5Y: 18.5" "Cancer enhanced" "Detected in many" "glioma: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016004 Enhanced "Intracellular and membrane" "HPA016004: AB_1846731" "unprognostic (1.00e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (1.45e-2)" "unprognostic (9.44e-2)" "unprognostic (2.96e-2)" "unprognostic (1.15e-2)" "unprognostic (5.75e-2)" "unprognostic (8.41e-2)" "unprognostic (1.16e-1)" "unprognostic (2.83e-2)" "unprognostic (1.54e-1)" "unprognostic (6.98e-8)" "unprognostic (9.37e-3)" "unprognostic (2.61e-1)" "unprognostic (3.28e-1)" "unprognostic (3.87e-2)" 2.0 3.8 3.6 1.7 2.8 0.4 7.0 16.6 9.2 3.4 1.1 1.0 0.0 0.5 1.3 0.4 0.7 2.0 4.0 0.8 9.2 7.9 0.5 0.7 0.6 2.0 5.3 1.5 1.4 3.4 0.4 36.7 0.4 27.1 1.8 0.5 1.4 0.7 0.8 0.6 0.9 0.8 0.8 7.2 3.3 0.9 2.9 0.9 0.0 0.6 0.3 1.4 0.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.1 0.0 0.0 0.0 1.2 0.0 3.8 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.9 0.0 0.0 0.1 18.4 0.0 0.3 10.7 18.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.6 2.8 16.6 9.2 9.2 7.9 5.3 1.5 27.1 0.9 CIT "CITK, CRIK, KIAA0949, STK21" ENSG00000122966 "Citron rho-interacting serine/threonine kinase" O14578 12 119685790-119877291 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.3;brain: 35.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA019082, HPA048812, HPA075506" Uncertain Approved Cytosol Cytosol "HPA019082: AB_1846803, HPA048812: , HPA075506: " "unprognostic (5.64e-2)" "unprognostic (5.00e-2)" "unprognostic (8.16e-2)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (3.55e-2)" "unprognostic (3.61e-6)" "unprognostic (6.02e-2)" "unprognostic (7.78e-2)" "unprognostic (4.42e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-2)" "unprognostic (2.55e-3)" "unprognostic (8.56e-2)" "unprognostic (1.50e-1)" "unprognostic (1.70e-1)" "unprognostic (3.30e-1)" 1.4 4.4 14.7 3.3 14.0 15.3 1.6 12.7 35.0 1.6 4.6 2.9 0.0 4.0 1.3 1.5 3.2 0.9 1.6 1.0 9.8 5.7 5.7 1.4 3.0 3.4 3.2 21.9 0.7 0.7 1.2 2.9 2.6 7.4 1.0 5.3 0.6 1.3 1.0 1.3 5.1 3.5 2.6 5.0 5.6 3.5 8.3 9.5 5.9 1.5 0.1 4.9 1.7 1.7 0.4 0.0 0.0 0.1 0.0 1.2 0.8 15.0 13.5 11.9 11.2 1.1 3.3 7.0 11.5 9.6 12.1 9.1 8.6 6.2 10.8 6.2 8.9 9.4 8.1 6.7 16.7 7.7 5.9 13.7 8.7 5.3 0.1 7.2 12.6 0.7 0.7 14.4 8.9 9.2 8.7 9.2 11.3 7.5 13.0 11.0 6.4 9.1 11.9 21.6 3.6 2.4 6.6 8.5 4.7 19.1 3.7 9.1 13.5 5.2 7.0 15.1 13.9 10.3 12.5 6.3 7.0 7.4 10.0 7.9 23.3 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 14.7 14.0 12.7 35.0 9.8 5.7 3.2 21.9 7.4 9.5 CKB CKBB ENSG00000166165 "Creatine kinase B" P12277 14 103519659-103523111 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 158.5" "Cell line enhanced" "Detected in many" "CACO-2: 53.1;HEK 293: 135.1;SCLC-21H: 76.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "non-classical monocyte: 50.0" "Lineage enriched" "Detected in many" 17 "monocytes: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001254, CAB047313" Enhanced Supported Cytosol 50000000 Cytosol "CAB047313: , HPA001254: AB_1078528" "unprognostic (9.97e-2)" "unprognostic (1.33e-3)" "unprognostic (4.25e-3)" "unprognostic (1.10e-1)" "unprognostic (7.63e-2)" "unprognostic (3.62e-2)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (4.24e-1)" "unprognostic (4.60e-2)" "unprognostic (2.68e-3)" "unprognostic (9.89e-3)" "prognostic favourable (4.02e-8)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.67e-2)" "unprognostic (2.13e-1)" 32.4 27.3 75.4 10.4 114.6 3.1 5.3 94.3 158.5 29.1 121.5 51.4 23.8 17.6 37.3 8.9 28.6 35.7 17.8 36.4 60.7 43.2 26.7 3.4 12.8 3.6 63.4 93.3 15.8 10.2 20.3 9.7 3.7 63.3 107.5 55.0 43.9 18.3 92.1 19.1 14.4 17.5 53.2 31.9 3.6 66.7 22.1 50.9 0.0 19.8 7.8 3.9 43.0 13.0 0.0 2.9 1.4 50.0 0.0 0.1 0.9 0.3 6.7 26.9 1.4 0.2 0.2 0.5 2.9 0.0 0.3 0.1 53.1 0.8 0.0 3.2 2.0 5.9 7.8 0.1 0.0 1.2 135.1 10.0 29.7 18.2 1.1 0.0 8.2 1.0 0.0 0.2 0.1 0.0 17.4 0.4 0.4 2.2 0.2 0.3 10.5 21.0 1.7 0.5 27.6 4.9 0.2 76.9 31.6 5.7 0.9 2.1 2.5 4.1 0.1 0.1 5.2 0.5 12.6 1.3 0.3 0.9 0.7 0.2 0.9 0.3 0.1 1.4 0.0 5.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.1 0.0 50.0 0.0 0.1 0.9 75.4 114.6 94.3 152.7 60.7 43.2 63.4 93.3 63.3 50.9 CKMT1A CKMT1 ENSG00000223572 "Creatine kinase, mitochondrial 1A" P12532 15 43692886-43699222 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.2;esophagus: 19.9;intestine: 25.5" "Cell line enhanced" "Detected in many" "HaCaT: 42.6;hTCEpi: 19.3;SCLC-21H: 15.1;SK-BR-3: 33.5;T-47d: 29.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA043491 Uncertain "Intracellular and membrane" 2100000 "HPA043491: " "unprognostic (2.04e-2)" "unprognostic (2.53e-2)" "unprognostic (1.17e-1)" "unprognostic (4.02e-3)" "unprognostic (3.80e-1)" "unprognostic (7.44e-2)" "unprognostic (2.21e-1)" "unprognostic (3.10e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.51e-2)" "unprognostic (3.78e-9)" "unprognostic (3.52e-2)" "unprognostic (1.03e-1)" "unprognostic (7.37e-2)" "unprognostic (1.73e-3)" 0.0 0.7 4.8 1.9 6.3 0.0 2.1 17.2 12.6 1.8 25.5 24.7 0.0 0.0 19.9 0.4 3.0 0.0 5.6 7.9 0.9 0.0 0.0 0.0 5.0 0.0 0.1 2.1 1.4 2.5 0.5 24.1 7.2 0.0 0.0 13.0 21.7 0.9 1.1 0.0 7.8 0.0 0.6 4.4 1.4 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.3 0.0 10.6 0.0 0.0 0.0 0.0 2.2 7.3 0.0 0.4 0.0 42.6 6.1 12.5 0.0 0.0 4.7 0.0 0.7 0.2 0.0 0.0 2.0 0.0 19.3 0.0 3.3 0.0 1.9 0.0 0.0 9.9 0.0 0.0 3.0 2.3 0.0 0.0 1.9 2.0 1.5 15.1 5.9 0.0 33.5 2.2 29.9 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CKMT1B "CKMT, CKMT1, UMTCK" ENSG00000237289 "Creatine kinase, mitochondrial 1B" P12532 15 43593054-43604901 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.7;intestine: 28.1" "Cell line enhanced" "Detected in many" "HaCaT: 40.4;HBEC3-KT: 15.5;hTCEpi: 20.8;SCLC-21H: 15.6;SK-BR-3: 49.7;T-47d: 28.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA043491 Uncertain "Intracellular and membrane" 2100000 "HPA043491: " "unprognostic (3.47e-2)" "unprognostic (9.73e-3)" "unprognostic (3.10e-1)" "prognostic unfavourable (2.55e-5)" "unprognostic (1.29e-1)" "unprognostic (1.96e-1)" "unprognostic (5.19e-2)" "unprognostic (2.84e-1)" "unprognostic (3.64e-1)" "unprognostic (5.75e-2)" "unprognostic (2.39e-1)" "unprognostic (1.15e-2)" "unprognostic (2.26e-8)" "unprognostic (1.71e-2)" "unprognostic (1.69e-1)" "unprognostic (4.43e-2)" "unprognostic (4.36e-2)" 0.0 0.3 5.4 1.6 8.8 0.0 1.6 52.7 13.6 0.7 28.1 22.4 0.0 0.0 13.8 0.2 2.8 0.0 6.8 7.4 0.9 0.0 0.0 0.0 5.4 0.0 0.2 1.4 1.3 3.7 0.6 23.1 4.8 0.0 0.0 7.6 16.2 1.2 1.8 0.0 10.0 0.0 1.7 4.1 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 9.8 0.0 0.0 0.0 0.0 2.3 6.9 0.0 0.3 0.0 40.4 8.1 15.5 0.0 0.1 4.7 0.0 1.0 1.0 0.0 0.0 2.3 0.0 20.8 0.0 1.8 0.0 2.6 0.0 0.0 9.8 0.0 0.0 3.2 4.3 0.0 0.0 0.2 0.7 1.0 15.6 5.5 0.2 49.7 2.9 28.9 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLASP2 KIAA0627 ENSG00000163539 "Cytoplasmic linker associated protein 2" O75122 3 33496245-33718356 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067071 Supported "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA067071: " "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (7.24e-3)" "unprognostic (5.46e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (1.27e-2)" "unprognostic (4.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-2)" "unprognostic (2.60e-3)" "unprognostic (3.25e-2)" "prognostic favourable (1.48e-6)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "unprognostic (1.07e-2)" "unprognostic (5.72e-2)" 7.9 14.5 20.6 6.5 31.6 6.0 9.0 45.4 67.1 13.0 8.9 50.7 3.4 5.6 11.7 6.7 10.2 9.4 10.0 22.0 19.1 16.8 10.4 6.1 8.6 7.9 33.4 22.1 16.1 6.5 11.6 16.1 8.7 44.7 9.8 7.7 13.4 6.5 12.4 31.7 7.3 6.7 11.2 29.7 7.7 6.8 6.5 37.3 4.1 8.1 4.9 8.6 8.0 7.5 8.4 8.7 4.7 8.4 12.3 7.2 5.6 7.2 16.0 18.4 15.4 12.0 11.8 13.2 13.6 12.8 16.0 17.3 9.3 7.6 23.9 7.9 10.6 6.3 23.7 10.8 19.5 19.2 16.9 23.5 14.1 8.2 5.7 23.1 20.1 7.2 10.8 17.3 16.5 15.4 22.8 13.7 17.2 4.0 17.1 9.9 13.6 10.2 18.5 17.3 12.9 10.2 8.3 15.4 26.1 15.7 12.3 13.5 11.6 20.6 14.7 12.6 11.0 9.4 14.9 9.7 18.1 19.8 11.4 16.0 15.9 4.7 5.9 3.3 4.8 6.3 7.2 8.4 4.2 4.5 8.7 5.6 5.7 5.2 1.2 12.3 8.4 8.3 4.5 5.6 20.6 31.6 45.4 38.7 19.1 16.8 33.4 22.1 44.7 37.3 CLCN4 "ClC-4, CLC4" ENSG00000073464 "Chloride voltage-gated channel 4" P51793 X 10156945-10237660 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;epididymis: 22.8;skeletal muscle: 34.6" "Cell line enhanced" "Detected in many" "HEL: 16.7;SCLC-21H: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.3;memory B-cell: 1.7;naive B-cell: 6.8;neutrophil: 4.4" "Group enriched" "Detected in many" 9 "B-cells: 6.8;granulocytes: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031313, HPA063637" Enhanced Approved Vesicles Vesicles "HPA031313: AB_10601358, HPA063637: " "unprognostic (1.01e-1)" "unprognostic (1.20e-2)" "unprognostic (5.07e-2)" "prognostic unfavourable (2.13e-5)" "unprognostic (2.96e-1)" "unprognostic (3.75e-1)" "unprognostic (1.04e-2)" "unprognostic (3.66e-1)" "unprognostic (1.75e-1)" "unprognostic (5.99e-2)" "prognostic favourable (9.55e-4)" "unprognostic (9.70e-2)" "unprognostic (9.78e-3)" "unprognostic (1.68e-1)" "unprognostic (1.49e-1)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" 3.1 3.4 9.7 2.0 21.3 2.1 1.6 18.6 29.1 2.0 1.4 15.7 0.0 1.2 1.3 22.8 2.3 3.0 2.8 11.4 13.0 10.5 3.4 3.5 3.4 2.9 23.5 10.4 2.2 2.4 8.9 3.9 1.7 18.2 2.1 1.1 6.0 2.3 1.7 34.6 1.2 1.2 1.4 15.2 3.2 2.1 2.2 17.9 0.0 6.8 2.0 2.2 2.3 0.8 6.8 0.6 4.4 0.5 0.0 0.0 0.6 4.9 3.1 2.3 0.0 1.1 2.0 0.1 0.1 0.0 0.0 0.0 6.0 3.4 3.7 9.0 1.0 1.1 1.4 3.4 0.1 0.0 3.5 16.7 1.7 2.5 5.5 0.0 0.0 10.0 2.7 4.3 1.1 6.4 1.2 0.0 2.3 0.5 0.0 0.1 2.9 10.8 0.0 3.8 0.0 1.5 0.5 17.3 6.5 7.1 0.7 0.0 1.8 2.1 6.3 2.7 4.6 11.8 0.4 0.4 8.3 1.3 8.6 0.0 3.4 2.3 0.5 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.6 6.8 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.6 9.7 21.3 18.6 26.7 13.0 10.5 23.5 10.4 18.2 17.9 CLDN11 "OSP, OTM" ENSG00000013297 "Claudin 11" O75508 3 170418865-170454733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.9;ovary: 47.7;testis: 86.1" "Cell line enhanced" "Detected in some" "ASC diff: 56.4;ASC TERT1: 71.2;EFO-21: 42.2;HUVEC TERT2: 60.9;TIME: 96.3" "Cancer enhanced" "Detected in many" "glioma: 11.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009789, HPA013166, HPA013657" Enhanced Supported "Lipid droplets,Cell Junctions" "Cell Junctions" "Lipid droplets" "CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: " "prognostic favourable (6.31e-4)" "unprognostic (3.18e-1)" "unprognostic (2.32e-2)" "unprognostic (5.28e-4)" "unprognostic (3.45e-2)" "unprognostic (4.60e-1)" "unprognostic (5.25e-2)" "unprognostic (5.40e-2)" "unprognostic (2.52e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" "unprognostic (5.48e-2)" "unprognostic (8.70e-11)" "unprognostic (2.50e-3)" "unprognostic (1.93e-1)" "unprognostic (6.68e-3)" "unprognostic (2.29e-1)" 8.2 1.9 14.1 2.0 40.6 1.7 6.3 3.5 50.3 1.9 3.4 85.9 0.5 2.2 2.7 4.6 4.6 4.2 18.9 4.0 28.7 13.0 3.2 2.8 2.8 2.1 59.5 17.1 47.7 2.1 1.8 5.5 4.2 37.3 5.1 2.5 0.6 4.7 4.2 1.7 3.6 2.6 2.8 80.6 2.6 2.5 86.1 47.9 0.0 2.0 0.9 2.0 6.3 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 56.4 71.2 0.0 0.7 3.6 4.6 7.7 0.0 9.4 0.0 42.2 5.7 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 3.2 17.4 0.0 0.0 26.0 0.0 25.3 0.0 60.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 96.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 14.1 40.6 3.5 25.0 28.7 13.0 59.5 17.1 37.3 47.9 CLDN19 ENSG00000164007 "Claudin 19" Q8N6F1 1 42733093-42740254 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "Disease mutation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0" "Group enriched" "Detected in some" 6 "CACO-2: 5.3;Hep G2: 11.0" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Group enriched" "Detected in some" 54 "midbrain: 13.8;pons and medulla: 9.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in some" "olfactory region: 6.7" "Low region specificity" "Detected in all" "unprognostic (6.23e-4)" "unprognostic (1.80e-1)" "unprognostic (1.85e-6)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (3.21e-2)" "unprognostic (3.22e-1)" "unprognostic (9.45e-2)" "unprognostic (1.95e-1)" "unprognostic (2.68e-1)" "unprognostic (7.22e-2)" "unprognostic (8.76e-3)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (3.29e-3)" 1.0 0.2 0.1 0.1 0.2 0.2 1.6 0.2 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.9 0.6 0.3 0.1 0.4 0.2 0.1 22.5 0.2 0.2 0.1 13.8 0.0 0.2 0.2 0.1 0.2 20.9 9.5 0.4 0.1 37.0 1.2 2.7 0.4 0.8 0.3 1.0 6.2 0.1 0.5 0.2 0.0 1.3 0.1 2.6 0.1 0.8 1.0 0.5 0.4 1.4 0.3 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.3 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.5 0.5 0.5 1.4 0.2 0.2 0.4 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 13.8 0.0 9.5 0.0 CLDN2 ENSG00000165376 "Claudin 2" P57739 X 106900164-106930861 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7" "Group enriched" "Detected in some" 20 "A549: 16.6;CACO-2: 13.4;RPTEC TERT1: 29.0" "Group enriched" "Detected in many" 5 "colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5" "Region enriched" "Detected in some" 6 "pons and medulla: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5" "Not detected" "Not detected" "CAB002609, HPA051548" Enhanced Supported "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "CAB002609: , HPA051548: " "unprognostic (2.31e-1)" "unprognostic (2.62e-1)" "unprognostic (3.99e-1)" "unprognostic (1.73e-1)" "unprognostic (1.30e-2)" "unprognostic (1.42e-2)" "unprognostic (6.07e-2)" "unprognostic (7.47e-3)" "unprognostic (2.24e-1)" "unprognostic (8.67e-2)" "unprognostic (8.83e-2)" "unprognostic (8.15e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "prognostic favourable (1.70e-4)" "unprognostic (9.76e-2)" 0.4 1.2 0.4 0.4 0.6 0.0 0.4 0.4 3.4 0.4 0.4 19.4 0.4 5.3 0.4 9.6 0.4 0.1 28.4 0.4 5.0 0.1 46.1 25.2 0.4 0.4 0.4 0.4 0.4 7.8 0.0 0.4 0.4 31.7 0.6 1.0 11.0 0.4 27.7 0.4 0.2 11.3 0.4 0.4 0.4 2.1 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.6 0.4 3.4 5.0 0.1 0.4 0.4 31.7 0.5 CLDN9 ENSG00000213937 "Claudin 9" O95484 16 3012456-3014505 "Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2" "Group enriched" "Detected in some" 4 "CAPAN-2: 5.5;MCF7: 19.1;SCLC-21H: 15.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076613 Supported "Vesicles,Cell Junctions" "Cell Junctions" Vesicles "HPA076613: " "unprognostic (7.93e-2)" "unprognostic (1.40e-1)" "unprognostic (1.43e-2)" "prognostic unfavourable (2.24e-6)" "unprognostic (4.91e-2)" "unprognostic (6.04e-2)" "unprognostic (1.13e-1)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (5.06e-2)" "unprognostic (8.97e-3)" "unprognostic (4.51e-2)" "unprognostic (2.89e-2)" "prognostic unfavourable (4.67e-4)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.55e-2)" 0.3 0.4 0.4 0.5 2.1 5.2 0.3 16.5 1.4 0.6 1.0 0.3 0.3 1.8 0.3 0.9 0.3 2.3 1.1 0.4 0.8 0.8 0.6 2.6 1.5 0.3 1.4 0.3 0.3 9.6 4.8 15.9 10.2 0.5 0.3 0.1 0.3 1.7 0.3 1.5 0.4 1.2 0.3 2.2 1.0 0.3 0.3 0.3 1.2 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.2 0.1 0.0 2.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 5.5 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 19.1 0.0 1.6 0.0 0.1 0.0 0.0 0.2 0.2 0.1 15.0 0.1 0.7 0.8 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 2.1 16.5 1.4 0.8 0.8 1.4 0.3 0.5 0.3 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 75.9;brain: 227.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavourable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 14.7 12.4 61.6 10.7 76.1 11.7 14.1 11.9 77.1 14.1 10.4 100.5 3.3 10.0 16.9 12.6 22.6 10.9 14.3 15.9 85.4 52.3 11.0 14.0 12.2 13.6 133.4 28.9 19.1 5.8 7.0 6.7 20.5 72.7 14.6 13.6 4.9 6.8 15.7 9.7 17.6 9.4 18.5 227.4 11.5 7.5 28.5 95.4 4.3 11.5 4.7 14.8 14.7 11.1 19.9 19.7 28.1 18.6 49.5 75.9 28.6 17.9 7.3 23.0 14.1 27.8 21.7 12.5 14.3 19.6 20.1 27.8 14.8 18.4 9.0 19.3 13.7 24.4 17.6 10.8 35.2 21.2 7.5 18.8 5.2 13.3 22.2 16.9 18.7 25.3 58.5 15.7 16.8 21.8 9.3 27.8 28.2 9.4 12.4 11.2 20.0 15.6 8.4 30.9 11.5 18.7 8.2 8.3 22.9 19.7 6.6 28.2 6.6 14.3 20.1 26.2 24.2 17.8 18.5 36.8 15.7 14.5 43.8 16.3 33.4 28.1 18.6 19.8 21.7 10.7 40.8 19.9 40.9 39.8 19.7 16.4 16.6 16.9 13.8 49.5 10.5 12.7 75.9 28.6 61.6 76.1 11.9 38.8 85.4 52.3 133.4 28.9 72.7 95.4 CLEC19A ENSG00000261210 "C-type lectin domain containing 19A" Q6UXS0 16 19285739-19322145 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 13 "brain: 7.2;retina: 24.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;EFO-21: 1.3;MCF7: 1.8;NTERA-2: 1.1;RPMI-8226: 2.0;U-2 OS: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" "unprognostic (3.19e-1)" "unprognostic (3.72e-1)" "unprognostic (1.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.20e-1)" "unprognostic (1.53e-1)" 0.1 0.0 2.6 0.0 0.2 0.0 0.0 0.8 7.2 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 4.5 1.3 0.0 0.1 0.5 0.3 0.3 0.2 0.0 0.1 0.0 0.3 0.1 1.2 0.8 0.1 24.4 0.4 0.0 0.3 1.2 0.1 0.0 0.1 0.0 0.8 0.5 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.1 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 2.6 0.2 0.8 5.0 4.5 1.3 0.3 0.2 1.2 0.0 CLEC2L FLJ32986 ENSG00000236279 "C-type lectin domain family 2 member L" P0C7M8 7 139523856-139544984 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.8;parathyroid gland: 15.5" "Group enriched" "Detected in some" 5 "U-266/70: 4.3;U-266/84: 15.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045050 Enhanced "HPA045050: AB_10965839" "unprognostic (1.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.20e-4)" "unprognostic (1.24e-2)" "unprognostic (1.33e-2)" "unprognostic (6.17e-2)" "unprognostic (2.29e-6)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (6.73e-2)" "unprognostic (2.68e-1)" "unprognostic (8.31e-2)" "unprognostic (7.94e-4)" "unprognostic (3.57e-3)" "unprognostic (4.03e-2)" "unprognostic (8.42e-3)" "unprognostic (3.02e-2)" 1.1 0.9 9.8 1.0 9.4 1.1 0.8 14.0 24.1 2.3 0.9 1.4 0.0 0.9 2.5 0.5 1.6 0.8 1.9 0.5 13.8 9.2 0.7 0.6 0.7 0.8 15.1 7.2 0.7 0.7 15.5 0.1 0.7 26.8 0.6 0.9 2.2 0.7 0.6 5.5 0.7 1.2 2.2 3.8 0.7 0.6 1.3 0.5 1.8 0.8 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 9.8 9.4 14.0 24.1 13.8 9.2 15.1 7.2 26.8 0.5 CLEC7A "CD369, CLECSF12, dectin-1, hDectin-1, SCARE2" ENSG00000172243 "C-type lectin domain containing 7A" Q9BXN2 12 10116777-10130258 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 53.9;bone marrow: 43.9;brain: 18.7;lung: 32.8;lymphoid tissue: 28.8" "Group enriched" "Detected in some" 16 "Karpas-707: 59.3;U-266/84: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 53.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "unprognostic (1.79e-1)" "unprognostic (1.88e-2)" "unprognostic (2.98e-2)" "unprognostic (3.64e-1)" "unprognostic (3.03e-2)" "unprognostic (5.49e-2)" "unprognostic (5.19e-2)" "unprognostic (5.88e-3)" "unprognostic (2.10e-1)" "unprognostic (9.87e-2)" "unprognostic (7.46e-2)" "unprognostic (4.40e-1)" "prognostic unfavourable (1.31e-4)" "unprognostic (1.83e-2)" "unprognostic (3.89e-2)" "unprognostic (5.13e-2)" "unprognostic (1.14e-1)" 7.1 5.0 6.3 27.7 7.4 43.9 3.7 0.9 3.4 3.9 4.5 9.5 0.5 3.7 3.2 8.9 8.7 5.3 7.4 5.2 6.2 4.2 8.7 6.9 32.8 24.2 8.9 4.3 2.4 2.8 1.6 2.6 7.8 8.6 2.7 5.0 6.4 6.5 2.4 1.2 3.2 6.5 5.7 18.7 28.8 3.1 1.6 7.3 5.1 2.3 3.2 9.1 5.5 3.8 0.1 13.1 53.9 30.1 0.1 0.1 7.4 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 59.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.3 46.2 0.0 0.1 0.3 0.0 0.2 26.4 0.4 0.0 29.5 0.1 0.0 0.0 0.0 13.1 0.1 0.0 0.0 53.9 0.1 30.1 0.2 0.0 7.4 6.3 7.4 0.9 3.4 6.2 4.2 8.9 4.3 8.6 7.3 CLEC9A "CD370, DNGR-1, HEEE9341, UNQ9341" ENSG00000197992 "C-type lectin domain containing 9A" Q6UXN8 12 10030677-10066027 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 17.3;brain: 7.8;lymphoid tissue: 8.9;testis: 21.1" "Group enriched" "Detected in some" 6 "Karpas-707: 1.3;U-266/84: 3.9" "Cancer enriched" "Detected in some" 5 "testis cancer: 2.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 103 "myeloid DC: 17.3;neutrophil: 6.1" "Group enriched" "Detected in many" 103 "dendritic cells: 17.3;granulocytes: 6.1" "Not detected" "Not detected" "unprognostic (1.13e-3)" "unprognostic (1.21e-2)" "unprognostic (5.00e-3)" "unprognostic (7.85e-3)" "unprognostic (1.28e-2)" "unprognostic (1.56e-5)" "unprognostic (6.58e-4)" "unprognostic (4.73e-3)" "unprognostic (9.65e-2)" "unprognostic (7.45e-3)" "unprognostic (8.15e-3)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (7.93e-2)" "unprognostic (3.45e-5)" "unprognostic (2.17e-1)" 0.6 0.0 3.3 1.7 2.5 0.3 0.6 0.6 1.1 0.6 0.6 0.6 0.6 0.9 0.6 0.6 0.6 0.0 1.0 0.6 3.2 3.1 0.6 0.8 0.6 8.9 5.0 0.6 0.8 0.6 0.0 0.6 1.0 0.6 0.6 0.6 0.6 1.2 0.6 0.6 0.0 1.8 0.8 7.8 6.4 0.2 21.1 0.6 0.6 0.6 0.6 2.8 0.8 0.6 0.0 17.3 6.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 6.1 0.1 0.0 0.0 0.0 0.3 3.3 2.5 0.6 1.0 3.2 3.1 5.0 0.6 0.6 0.6 CLIC6 "CLIC1L, CLIC5" ENSG00000159212 "Chloride intracellular channel 6" Q96NY7 21 34669389-34718227 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 63.3;retina: 85.1;stomach 1: 45.1" "Group enriched" "Detected in some" 4 "HMC-1: 4.3;NTERA-2: 5.8;T-47d: 11.7;THP-1: 5.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 12 "pons and medulla: 63.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA055123, HPA065285" Enhanced "HPA055123: , HPA065285: " "prognostic favourable (6.11e-5)" "unprognostic (2.17e-2)" "unprognostic (1.65e-2)" "unprognostic (4.27e-2)" "unprognostic (2.93e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-2)" "prognostic favourable (3.15e-5)" "unprognostic (4.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.66e-2)" "unprognostic (1.16e-2)" "unprognostic (3.48e-1)" "unprognostic (1.99e-1)" "unprognostic (1.43e-3)" 7.7 0.0 0.8 3.0 1.7 0.0 5.7 0.6 2.3 8.7 1.8 12.4 0.6 0.9 1.0 5.2 1.2 6.1 4.5 6.3 5.4 1.0 0.9 0.6 6.4 0.4 0.4 0.5 2.3 1.2 0.0 1.3 0.6 63.3 4.0 1.3 85.1 10.9 3.8 1.9 2.3 1.1 1.9 0.6 0.7 45.1 1.1 0.6 2.4 8.2 0.9 1.8 7.5 2.0 0.3 0.1 0.4 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 1.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.0 4.3 0.2 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.4 11.7 5.2 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.1 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.1 0.8 1.7 0.6 2.3 5.4 1.0 0.4 0.5 63.3 0.6 CLIP2 "CLIP, CLIP-115, CYLN2, KIAA0291, WBSCR3, WBSCR4, WSCR3, WSCR4" ENSG00000106665 "CAP-Gly domain containing linker protein 2" Q9UDT6 7 74289475-74405943 "Plasma proteins, Predicted intracellular proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.0" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in all" "glioma: 43.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA020430, CAB020767" Enhanced 960000 "CAB020767: , HPA020430: AB_1846958" "unprognostic (7.46e-2)" "unprognostic (2.49e-1)" "unprognostic (1.11e-1)" "prognostic unfavourable (5.35e-4)" "unprognostic (1.10e-1)" "unprognostic (1.67e-1)" "unprognostic (5.94e-2)" "unprognostic (2.48e-2)" "unprognostic (1.66e-1)" "unprognostic (6.38e-3)" "unprognostic (3.18e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (1.22e-1)" "unprognostic (6.96e-2)" "unprognostic (4.89e-2)" "unprognostic (1.38e-1)" 6.3 7.1 27.8 9.3 24.1 3.7 2.9 16.0 44.0 8.6 15.3 28.2 3.3 10.5 8.9 2.6 6.3 4.8 10.3 4.7 28.3 24.9 4.9 2.3 6.0 4.8 30.9 17.9 16.7 11.9 6.3 5.6 8.3 19.3 5.4 9.5 4.0 3.7 9.5 2.2 9.0 12.7 8.0 34.7 6.0 11.1 3.0 18.3 2.0 1.9 1.0 6.8 7.4 10.5 2.8 0.7 2.9 2.1 0.1 0.6 0.9 3.2 11.6 9.1 9.8 10.7 12.1 0.1 8.5 16.9 4.9 5.4 2.5 15.2 0.5 1.7 15.1 12.5 1.7 9.3 2.1 22.5 0.8 2.6 1.6 6.4 10.5 0.5 3.2 13.5 4.2 14.9 12.4 7.2 0.6 0.2 9.4 1.0 0.3 17.3 4.1 11.4 17.7 3.5 0.7 6.4 11.7 1.9 10.3 4.7 1.4 16.7 1.0 2.0 8.6 13.3 8.2 18.3 5.1 0.5 0.1 0.0 15.5 4.8 11.3 2.9 1.2 0.0 0.1 2.1 0.6 2.8 0.0 0.0 0.7 0.9 0.0 0.4 0.8 0.1 0.9 0.0 0.0 0.9 27.8 24.1 16.0 27.6 28.3 24.9 30.9 17.9 19.3 18.3 CLIP3 "CLIPR-59, RSNL1" ENSG00000105270 "CAP-Gly domain containing linker protein 3" Q96DZ5 19 36014660-36033343 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 108.3" "Cell line enhanced" "Detected in many" "ASC diff: 19.9;ASC TERT1: 31.2;fHDF/TERT166: 21.7;HHSteC: 20.1;HSkMC: 34.6" "Cancer enhanced" "Detected in all" "glioma: 65.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "unprognostic (1.91e-2)" "unprognostic (8.70e-2)" "unprognostic (1.16e-2)" "unprognostic (5.01e-2)" "unprognostic (1.19e-1)" "unprognostic (1.38e-1)" "unprognostic (3.60e-2)" "unprognostic (2.92e-2)" "unprognostic (2.55e-2)" "unprognostic (3.26e-2)" "prognostic favourable (2.80e-4)" "unprognostic (9.44e-2)" "prognostic unfavourable (1.56e-10)" "unprognostic (6.31e-3)" "unprognostic (1.52e-1)" "unprognostic (9.63e-2)" "unprognostic (1.09e-2)" 6.4 10.9 38.4 7.5 35.2 1.6 4.1 52.9 108.3 17.6 15.1 14.9 2.8 5.7 24.0 10.4 12.7 10.6 17.0 5.1 33.3 37.6 4.8 2.3 4.2 5.5 30.6 37.8 28.2 3.6 2.1 10.9 7.5 30.2 16.7 7.4 4.9 3.9 25.4 2.4 3.7 5.8 27.7 20.3 6.3 6.7 6.6 16.9 2.9 2.2 0.1 5.4 17.4 7.4 1.2 0.7 1.7 0.9 2.6 1.8 0.8 0.4 1.3 11.9 0.5 19.9 31.2 0.4 6.8 16.5 5.7 8.6 1.4 0.4 0.6 2.8 21.7 0.5 0.2 0.0 4.0 0.8 0.4 0.3 1.2 0.2 20.1 0.3 0.3 34.6 0.3 4.9 0.1 6.3 0.6 1.2 12.6 1.0 6.3 0.4 1.4 0.3 0.8 0.2 0.4 0.2 0.4 11.7 13.7 0.8 0.3 0.3 0.4 0.1 1.7 9.8 8.2 0.4 0.4 1.0 0.8 0.5 15.1 0.6 3.6 0.0 0.6 1.7 1.1 0.9 0.3 1.2 1.7 0.6 0.2 1.0 1.8 1.2 0.5 2.6 0.4 0.7 1.1 0.8 38.4 35.2 52.9 50.6 33.3 37.6 30.6 37.8 30.2 16.9 CLMN "FLJ12383, KIAA0500, KIAA1188" ENSG00000165959 Calmin Q96JQ2 14 95181940-95319906 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.1" "Cell line enhanced" "Detected in many" "SK-BR-3: 13.9;T-47d: 11.6;WM-115: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012634 Enhanced Approved "Nuclear bodies,Cytosol" "Nuclear bodies" Cytosol "HPA012634: AB_1846973" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (4.20e-2)" "unprognostic (6.07e-2)" "unprognostic (8.88e-2)" "unprognostic (4.31e-1)" "unprognostic (4.18e-2)" "unprognostic (7.24e-2)" "unprognostic (8.31e-2)" "unprognostic (2.64e-1)" "unprognostic (1.29e-3)" "unprognostic (3.09e-2)" "prognostic favourable (2.68e-7)" "unprognostic (8.27e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (9.91e-3)" 14.1 2.3 11.0 5.9 36.3 2.0 13.0 3.1 20.1 7.8 15.3 31.6 5.6 4.6 5.6 11.0 4.3 8.2 8.3 3.7 13.0 5.6 18.9 18.8 5.2 2.3 38.1 8.0 3.5 18.1 4.7 3.4 9.2 17.2 8.0 17.6 7.1 9.4 7.9 4.6 3.5 6.9 4.5 14.5 3.6 10.0 33.4 34.0 0.0 6.6 1.8 2.9 7.3 7.1 3.8 3.0 7.2 8.4 0.0 0.1 2.1 5.2 7.1 1.1 0.2 4.4 2.0 0.4 0.1 0.0 0.3 0.2 0.6 9.0 0.0 0.8 0.0 4.7 0.5 3.2 0.0 3.6 1.3 0.1 0.2 4.2 0.4 0.0 0.1 2.1 3.2 1.4 5.1 3.6 0.0 1.0 2.6 4.6 0.2 0.4 0.4 1.7 4.0 3.8 2.3 3.4 8.7 1.4 1.4 1.8 13.9 7.1 11.6 0.3 1.0 0.1 3.2 0.0 0.2 1.4 0.1 4.9 2.5 2.1 13.2 6.0 8.4 0.7 0.0 3.0 0.0 3.8 0.0 0.0 1.8 2.2 0.0 0.1 7.2 0.0 1.8 3.0 0.0 2.1 11.0 36.3 3.1 20.1 13.0 5.6 38.1 8.0 17.2 34.0 CLSTN1 "CDHR12, CSTN1, KIAA0911" ENSG00000171603 "Calsyntenin 1" O94985 1 9729026-9824526 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012412 Enhanced 70000000 "HPA012412: AB_1846981" "unprognostic (4.63e-2)" "unprognostic (2.89e-1)" "unprognostic (9.76e-2)" "unprognostic (1.43e-1)" "unprognostic (9.79e-2)" "unprognostic (1.63e-1)" "unprognostic (2.44e-3)" "unprognostic (3.07e-2)" "unprognostic (2.54e-1)" "unprognostic (3.24e-2)" "unprognostic (1.34e-1)" "unprognostic (1.25e-1)" "prognostic favourable (4.10e-7)" "unprognostic (1.12e-1)" "unprognostic (2.65e-1)" "unprognostic (4.05e-2)" "unprognostic (4.72e-2)" 13.6 20.1 38.2 15.0 51.2 5.2 15.4 90.5 102.0 24.2 28.6 25.1 11.7 16.7 35.9 14.2 21.0 35.1 25.6 16.3 32.1 31.2 23.3 4.7 16.0 16.4 25.8 53.8 33.6 31.1 27.8 21.0 22.8 32.3 33.6 26.1 29.8 30.0 24.9 10.3 45.6 18.6 28.8 22.0 14.4 15.1 8.1 21.6 15.3 20.9 12.9 16.1 18.0 23.6 2.5 2.7 8.5 1.7 0.9 6.3 2.5 27.2 16.2 23.4 21.8 25.0 16.6 7.7 17.4 19.5 22.3 20.4 11.4 65.8 21.5 45.6 34.3 39.0 13.7 61.5 17.9 24.4 16.7 6.4 20.4 12.0 34.7 12.0 10.4 16.9 42.4 28.8 19.6 31.1 2.9 16.8 10.9 12.7 13.3 6.2 9.8 13.0 20.1 8.6 10.3 27.6 7.9 25.0 15.8 25.1 48.4 19.4 9.8 20.6 46.3 26.4 21.0 17.6 28.8 17.1 15.8 31.1 22.6 19.3 29.8 8.5 1.4 4.3 6.3 1.7 3.3 2.3 4.0 4.7 2.7 2.5 2.9 2.6 0.8 0.9 1.7 1.7 3.6 2.5 38.2 51.2 90.5 99.9 32.1 31.2 25.8 53.8 32.3 21.6 CLSTN2 "CDHR13, CS2, CSTN2, FLJ39113" ENSG00000158258 "Calsyntenin 2" Q9H4D0 3 139935185-140577397 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;ovary: 59.4" "Cell line enhanced" "Detected in some" "AF22: 5.7;SCLC-21H: 16.1;THP-1: 10.1" "Cancer enriched" "Detected in many" 7 "breast cancer: 15.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031342, HPA061800" Approved Uncertain "Vesicles,Cytokinetic bridge" 9100 Vesicles "Cytokinetic bridge" "HPA031342: AB_10602800, HPA061800: " "unprognostic (7.58e-2)" "unprognostic (2.64e-2)" "unprognostic (8.02e-2)" "unprognostic (1.51e-3)" "unprognostic (5.52e-3)" "unprognostic (8.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (5.58e-1)" "unprognostic (6.25e-2)" "unprognostic (2.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-2)" "unprognostic (3.16e-2)" "unprognostic (7.63e-5)" "unprognostic (7.22e-5)" 14.2 5.0 4.9 1.0 9.8 0.8 8.5 1.5 19.7 4.1 1.8 2.4 0.3 1.2 5.2 1.8 1.6 3.6 2.6 5.9 15.4 4.0 4.5 1.5 1.7 2.8 4.1 14.3 59.4 2.0 1.5 1.3 1.5 23.7 5.4 1.4 3.0 1.6 1.8 1.9 2.1 1.5 6.6 1.4 0.8 1.4 1.9 0.5 0.0 2.9 0.5 1.0 1.9 4.7 0.3 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.1 5.7 0.0 2.5 0.6 0.1 0.7 0.0 0.0 0.0 3.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 2.3 0.0 0.0 0.0 2.4 10.1 0.0 1.2 0.5 1.6 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 4.9 9.8 1.5 19.7 15.4 4.0 4.1 14.3 23.7 0.5 CLSTN3 "CDHR14, CSTN3, KIAA0726" ENSG00000139182 "Calsyntenin 3" Q9BQT9 12 7129698-7158945 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.0" "Cell line enhanced" "Detected in many" "HMC-1: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 12.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" 50000 "prognostic favourable (5.08e-4)" "unprognostic (2.84e-2)" "unprognostic (1.06e-3)" "unprognostic (1.33e-2)" "unprognostic (6.73e-3)" "unprognostic (6.35e-2)" "unprognostic (9.52e-2)" "unprognostic (2.58e-1)" "unprognostic (2.94e-1)" "unprognostic (1.85e-1)" "prognostic favourable (1.19e-5)" "unprognostic (1.16e-1)" "prognostic unfavourable (4.49e-5)" "unprognostic (2.19e-2)" "unprognostic (6.14e-2)" "unprognostic (1.91e-1)" "prognostic favourable (8.07e-4)" 11.0 16.2 22.1 14.9 37.1 14.4 6.8 51.4 64.0 5.9 6.0 5.7 1.7 8.1 8.1 4.2 4.9 7.2 12.2 4.1 19.2 33.3 14.1 14.6 7.8 15.4 13.3 31.6 13.2 6.9 14.4 15.0 4.1 37.6 5.8 6.0 7.6 8.1 5.7 1.4 11.1 7.1 8.9 6.0 14.1 6.1 3.5 4.0 6.7 6.5 1.0 11.3 12.0 5.6 0.3 0.2 2.6 0.0 12.4 7.2 1.9 6.9 11.7 4.0 9.7 4.9 7.1 18.0 4.1 9.7 7.1 11.7 16.9 11.0 11.2 3.1 8.1 9.1 7.2 8.0 4.3 11.4 6.9 18.6 18.2 15.9 6.7 2.9 33.8 21.1 8.0 9.2 11.2 8.6 17.3 6.9 1.6 2.1 7.2 3.0 11.4 0.7 4.9 0.0 3.3 10.9 13.0 5.2 8.6 9.8 2.4 1.6 4.8 6.8 5.1 4.5 13.6 10.3 2.2 8.5 2.0 1.5 8.0 3.9 2.7 2.6 0.0 0.0 7.2 0.0 4.1 0.3 3.2 6.1 0.2 0.3 1.1 2.5 0.5 12.4 0.0 0.1 3.3 1.9 22.1 37.1 51.4 64.0 19.2 33.3 13.3 31.6 37.6 4.0 CLVS1 "C6orf212L, CRALBPL, MGC34646, RLBP1L1" ENSG00000177182 "Clavesin 1" Q8IUQ0 8 61057158-61501645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.8;pituitary gland: 10.3" "Cell line enhanced" "Detected in some" "SCLC-21H: 8.2;SH-SY5Y: 3.6;U-266/70: 3.6" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076650 Approved "HPA076650: " "unprognostic (1.86e-2)" "unprognostic (3.09e-4)" "unprognostic (2.79e-1)" "unprognostic (2.96e-7)" "unprognostic (1.11e-1)" "unprognostic (7.29e-2)" "unprognostic (2.99e-1)" "unprognostic (8.02e-4)" "unprognostic (2.23e-1)" "unprognostic (8.44e-3)" "unprognostic (7.25e-3)" "unprognostic (2.94e-1)" "unprognostic (5.79e-8)" "unprognostic (2.49e-1)" "unprognostic (3.19e-2)" "unprognostic (9.71e-2)" "unprognostic (1.14e-2)" 4.0 1.1 9.7 1.3 20.5 1.1 1.9 33.8 16.8 0.7 1.0 2.3 0.0 0.9 0.6 0.7 4.4 1.8 1.3 1.4 5.9 7.7 0.7 0.8 1.0 1.6 4.4 8.0 0.7 0.5 0.5 10.3 0.8 10.2 1.1 0.8 0.5 3.3 0.6 1.6 4.1 1.2 0.6 2.3 1.5 0.8 5.3 3.7 0.0 3.7 0.0 2.6 0.7 0.4 2.2 1.2 4.3 1.2 2.6 1.4 0.7 0.4 0.8 0.4 1.3 0.4 0.1 0.1 0.4 0.0 0.0 0.3 0.4 0.3 3.1 0.0 0.0 0.6 0.0 0.5 0.2 0.4 0.8 0.2 0.6 0.2 0.0 0.3 0.8 0.0 0.0 0.4 0.3 0.2 0.0 0.8 0.0 0.2 0.3 1.1 1.7 0.6 2.7 2.2 0.3 0.9 0.1 8.2 3.6 0.3 0.4 0.0 0.6 1.1 0.7 0.5 0.5 0.3 0.4 3.6 1.6 0.6 2.1 0.2 0.1 2.7 1.2 0.8 1.0 0.9 0.6 1.3 1.1 0.7 0.2 2.2 0.7 1.4 4.3 2.6 0.6 1.2 0.3 0.7 9.7 20.5 33.8 13.7 5.9 7.7 4.4 8.0 10.2 3.7 CLVS2 "bA160A10.4, C6orf212, C6orf213, RLBP1L2" ENSG00000146352 "Clavesin 2" Q5SYC1 6 122995971-123072927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 39.9" "Group enriched" "Detected in some" 8 "HEL: 14.3;SCLC-21H: 11.2" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043764 Uncertain "HPA043764: AB_10960281" "unprognostic (1.35e-1)" "unprognostic (3.28e-2)" "unprognostic (4.68e-2)" "unprognostic (3.60e-1)" "unprognostic (2.38e-1)" "unprognostic (7.04e-2)" "unprognostic (1.43e-2)" "unprognostic (5.72e-3)" "unprognostic (9.60e-2)" "unprognostic (8.71e-2)" 0.7 2.8 5.0 0.9 9.6 0.7 0.8 39.9 22.6 2.1 1.1 0.6 0.0 0.9 3.1 0.7 0.8 0.7 0.8 0.7 5.8 3.9 0.7 0.8 0.7 0.8 3.0 10.2 0.7 0.7 0.7 6.3 0.7 8.5 7.9 1.1 0.1 0.8 1.1 0.7 0.8 0.9 2.8 1.3 0.7 0.8 1.0 1.8 0.0 0.7 0.0 0.7 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 9.6 39.9 22.6 5.8 3.9 3.0 10.2 8.5 1.8 CMTM5 "CKLFSF5, FLJ37521" ENSG00000166091 "CKLF like MARVEL transmembrane domain containing 5" Q96DZ9 14 23376808-23379772 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 19.4;brain: 67.3" "Cell line enriched" "Detected in some" 6 "HEL: 41.7" "Group enriched" "Detected in some" 37 "glioma: 8.4;melanoma: 3.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 7.6;neutrophil: 2.8" "Lineage enriched" "Detected in single" 11 "granulocytes: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052338 Enhanced Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA052338: AB_2681793" "unprognostic (2.73e-3)" "unprognostic (1.51e-1)" "unprognostic (5.24e-1)" "unprognostic (2.43e-3)" "unprognostic (2.63e-1)" "unprognostic (6.40e-2)" "unprognostic (8.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.27e-2)" "unprognostic (8.40e-2)" "unprognostic (6.24e-4)" "unprognostic (3.03e-3)" "unprognostic (1.97e-3)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" 1.7 1.8 14.1 1.3 19.4 6.6 1.3 4.8 55.4 2.6 1.9 47.0 0.0 1.3 1.6 1.6 2.1 1.7 2.5 5.8 19.6 12.1 1.1 1.0 1.7 1.1 26.9 10.3 1.7 1.1 0.9 0.1 1.5 18.4 1.9 1.6 0.6 3.1 4.2 1.4 1.5 2.0 1.7 67.3 1.9 1.1 1.1 12.7 0.0 1.0 0.0 1.0 1.3 0.7 0.1 0.7 7.6 0.4 0.0 0.3 19.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 7.6 0.4 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.7 0.3 19.4 14.1 19.4 4.8 24.8 19.6 12.1 26.9 10.3 18.4 12.7 CNDP1 "CN1, CPGL2, HsT2308, MGC10825" ENSG00000150656 "Carnosine dipeptidase 1" Q96KN2 18 74534440-74587212 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 60.3;liver: 41.4" "Cell line enriched" "Detected in single" 69 "U-266/84: 41.2" "Group enriched" "Detected in some" 10 "glioma: 4.4;liver cancer: 1.0;melanoma: 1.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA008933 Enhanced "Secreted in brain" 1900000000 "HPA008933: AB_1847033" "unprognostic (7.43e-3)" "unprognostic (6.00e-2)" "unprognostic (8.55e-3)" "unprognostic (3.93e-1)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (8.04e-3)" "unprognostic (1.12e-2)" "unprognostic (2.81e-1)" "unprognostic (1.16e-1)" "unprognostic (1.16e-1)" "unprognostic (1.66e-1)" "unprognostic (6.90e-3)" "unprognostic (1.14e-1)" "unprognostic (3.30e-2)" "unprognostic (1.33e-1)" "unprognostic (1.28e-1)" 1.1 1.2 14.9 1.2 28.2 1.3 1.1 4.5 60.3 1.1 1.1 54.9 0.0 5.7 1.1 2.1 1.1 1.1 1.3 1.1 28.9 15.1 1.9 41.4 1.1 1.2 44.1 12.9 1.1 1.2 1.1 0.1 1.1 50.0 1.2 1.1 0.5 1.1 1.3 2.2 1.1 1.9 1.1 51.1 1.1 1.2 1.4 28.8 0.0 1.3 0.0 1.1 1.1 0.0 0.7 0.7 1.9 0.5 1.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 41.2 0.0 0.0 0.0 0.0 1.3 0.5 0.4 0.4 0.2 0.2 0.3 0.3 0.2 0.1 0.7 0.4 0.4 1.9 1.0 0.2 0.7 0.2 0.2 14.9 28.2 4.5 22.5 28.9 15.1 44.1 12.9 50.0 28.8 CNIH2 "CNIH-2, Cnil, MGC50896" ENSG00000174871 "Cornichon family AMPA receptor auxiliary protein 2" Q6PI25 11 66278190-66285301 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 74.5" "Cell line enhanced" "Detected in some" "AF22: 8.9;NTERA-2: 8.3;SCLC-21H: 34.7;SH-SY5Y: 16.0" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.84e-2)" "unprognostic (3.53e-3)" "unprognostic (3.40e-3)" "unprognostic (1.04e-2)" "prognostic unfavourable (9.18e-4)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (3.29e-1)" "unprognostic (3.25e-1)" "unprognostic (3.80e-2)" "unprognostic (7.66e-3)" "unprognostic (4.16e-2)" "unprognostic (6.95e-8)" "unprognostic (3.53e-1)" "unprognostic (3.19e-2)" "unprognostic (3.17e-2)" "unprognostic (3.55e-2)" 1.5 6.5 33.9 1.5 37.6 3.2 1.4 8.4 49.5 1.2 1.4 6.2 0.0 2.1 1.5 1.3 1.3 2.0 1.5 1.2 74.5 17.3 1.2 1.2 1.4 1.4 9.6 15.5 1.2 4.2 1.6 8.8 2.0 4.6 1.4 1.6 0.0 1.3 1.2 1.2 3.1 1.6 1.6 2.4 1.6 2.8 2.6 4.7 0.5 1.3 0.0 1.3 1.3 0.0 0.8 0.3 0.0 0.0 0.0 0.8 0.0 0.2 0.4 8.9 7.7 0.1 0.1 1.1 0.5 0.6 1.1 0.1 0.2 0.0 0.0 0.1 0.1 0.1 2.0 0.0 0.1 0.8 0.7 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.1 1.1 0.5 7.5 1.2 0.1 8.3 0.6 3.6 0.0 0.0 0.0 0.4 34.7 16.0 0.0 4.3 0.3 7.5 0.1 0.0 1.0 0.4 0.2 0.3 0.2 0.2 0.3 2.3 0.2 5.8 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.1 0.8 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 33.9 37.6 8.4 36.5 74.5 17.3 9.6 15.5 4.6 4.7 CNIH3 "CNIH-3, FLJ38993" ENSG00000143786 "Cornichon family AMPA receptor auxiliary protein 3" Q8TBE1 1 224434660-224740549 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 16.1;pancreas: 21.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.8;hTEC/SVTERT24-B: 24.9;NTERA-2: 9.1;U-266/70: 13.2;U-87 MG: 29.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.36e-1)" "unprognostic (1.66e-1)" "unprognostic (4.90e-2)" "unprognostic (5.18e-2)" "unprognostic (2.88e-1)" "unprognostic (7.18e-2)" "unprognostic (4.96e-2)" "unprognostic (6.11e-2)" "unprognostic (1.41e-1)" "unprognostic (4.63e-2)" "unprognostic (3.15e-1)" "unprognostic (2.30e-1)" "unprognostic (5.23e-5)" "unprognostic (1.03e-1)" "unprognostic (3.66e-1)" "unprognostic (5.87e-2)" "unprognostic (2.63e-1)" 2.0 0.8 7.0 0.5 5.1 0.2 1.3 1.0 16.1 1.7 0.6 0.6 0.0 0.8 1.5 0.9 0.6 1.9 1.2 0.6 9.8 5.0 1.5 0.6 0.9 0.9 5.4 8.0 3.6 21.7 0.3 0.7 0.4 3.5 0.9 0.7 0.2 0.6 1.1 0.7 0.4 0.6 1.0 1.4 0.6 0.6 3.9 0.1 0.2 1.0 0.0 0.9 0.7 0.9 0.9 0.3 0.0 0.0 1.8 0.9 0.1 0.2 0.2 0.3 0.3 0.3 0.5 0.1 1.8 9.8 0.2 0.5 0.0 2.2 0.0 0.9 4.2 0.0 0.0 0.0 1.7 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.7 0.3 0.0 24.9 0.3 0.0 0.0 0.0 1.4 0.0 0.0 3.0 9.1 1.1 0.0 0.5 0.0 1.5 0.9 0.3 0.2 0.0 0.0 6.1 0.0 0.2 0.0 0.0 2.3 0.0 0.2 13.2 0.5 0.0 29.6 0.1 3.7 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.3 0.3 0.0 0.6 0.0 1.8 0.0 0.0 0.9 0.1 7.0 5.1 1.0 11.1 9.8 5.0 5.4 8.0 3.5 0.1 CNKSR2 "CNK2, KIAA0902, KSR2" ENSG00000149970 "Connector enhancer of kinase suppressor of Ras 2" Q8WXI2 X 21372801-21654695 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 38.4" "Cell line enhanced" "Detected in some" "A549: 6.7;AF22: 4.7;NTERA-2: 10.8;PC-3: 5.5;RH-30: 10.1;U-251 MG: 6.7" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.9;naive CD4 T-cell: 3.0" "Group enriched" "Detected in many" 5 "B-cells: 2.9;T-cells: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001502 Approved "Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" "HPA001502: AB_1078542" "unprognostic (1.33e-2)" "unprognostic (1.00e-3)" "unprognostic (5.35e-2)" "unprognostic (4.90e-4)" "unprognostic (1.26e-1)" "unprognostic (5.40e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-2)" "unprognostic (3.47e-1)" "unprognostic (7.16e-2)" "unprognostic (1.35e-2)" "unprognostic (2.01e-1)" "unprognostic (1.78e-2)" "unprognostic (2.72e-2)" "unprognostic (3.93e-2)" "unprognostic (2.27e-2)" "unprognostic (4.13e-2)" 2.0 5.2 23.5 1.4 29.6 1.3 2.1 31.3 38.4 1.4 1.2 1.7 0.0 1.1 1.4 1.8 1.1 2.3 1.2 1.7 26.4 4.4 1.0 2.0 2.8 2.4 3.1 20.8 1.9 4.9 1.0 1.0 1.1 1.8 2.2 1.1 3.5 1.7 1.2 7.4 1.1 1.2 1.2 1.7 1.8 1.3 1.8 5.0 0.6 1.2 0.0 2.6 1.3 0.7 2.9 0.1 0.6 0.0 0.0 3.0 0.3 0.0 6.7 4.7 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.1 10.8 5.5 0.0 10.1 0.0 0.0 0.0 4.6 1.8 0.0 0.1 0.2 0.0 0.6 0.0 0.1 2.1 0.0 6.7 3.5 0.0 3.5 0.9 0.0 2.6 0.1 0.0 0.6 0.1 0.0 0.4 1.1 0.6 0.0 0.0 2.9 3.0 1.0 0.0 0.0 0.0 0.1 0.8 0.3 23.5 29.6 31.3 24.4 26.4 4.4 3.1 20.8 1.8 5.0 CNMD "BRICD3, CHM-I, CHM1, LECT1, MYETS1" ENSG00000136110 Chondromodulin O75829 13 52703264-52739812 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.1;salivary gland: 15.1;thyroid gland: 8.0" "Cell line enriched" "Detected in single" 137 "NTERA-2: 32.4" "Group enriched" "Detected in many" 5 "glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010510 Uncertain "Secreted to extracellular matrix" "HPA010510: AB_10602021" "unprognostic (7.52e-3)" "unprognostic (1.34e-1)" "unprognostic (7.36e-2)" "unprognostic (1.45e-2)" "unprognostic (1.15e-1)" "unprognostic (3.22e-1)" "unprognostic (2.84e-2)" "unprognostic (2.63e-2)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-1)" 0.3 0.3 3.1 0.3 11.1 0.3 0.4 0.9 2.5 0.3 0.5 4.3 0.0 0.3 0.3 0.3 0.6 0.4 0.3 0.4 3.0 2.6 0.3 0.3 3.9 0.3 3.7 0.9 0.4 1.1 0.3 2.5 0.5 3.1 1.6 0.5 6.1 15.1 0.4 0.5 0.5 0.4 0.3 4.4 1.0 0.4 4.2 4.1 0.0 8.0 0.0 0.6 0.3 0.0 0.0 0.6 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 3.1 11.1 0.9 2.3 3.0 2.6 3.7 0.9 3.1 4.1 CNNM1 ACDP1 ENSG00000119946 "Cyclin and CBS domain divalent metal cation transport mediator 1" Q9NRU3 10 99329099-99394330 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.5;testis: 16.8" "Cell line enhanced" "Detected in some" "A549: 17.3;BJ hTERT+: 6.6;BJ hTERT+ SV40 Large T+: 6.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HAP1: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 6 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040408 Approved Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA040408: AB_10793963" "unprognostic (9.04e-4)" "unprognostic (2.93e-1)" "unprognostic (1.70e-1)" "unprognostic (7.60e-4)" "unprognostic (4.08e-3)" "unprognostic (9.51e-2)" "unprognostic (6.01e-2)" "unprognostic (2.27e-2)" "unprognostic (6.03e-2)" "unprognostic (1.94e-1)" "unprognostic (3.09e-2)" "unprognostic (2.45e-1)" "unprognostic (8.94e-2)" "unprognostic (1.50e-1)" "unprognostic (4.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.03e-1)" 0.6 2.5 3.4 0.7 15.5 0.5 1.3 8.1 12.7 2.0 1.0 0.3 1.1 1.2 2.1 3.7 1.4 2.4 1.0 0.5 2.8 5.0 2.4 0.8 0.6 0.5 2.1 7.1 5.4 1.7 0.4 4.2 0.5 4.8 3.6 1.2 0.7 1.0 2.1 0.5 2.5 1.2 1.5 1.0 0.5 1.6 16.8 2.3 0.0 0.5 0.2 0.6 2.2 1.2 0.1 0.1 0.2 0.0 0.1 1.3 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 2.5 6.6 6.0 10.4 0.0 3.9 0.0 0.0 1.2 1.6 7.8 0.0 4.4 0.0 0.8 1.7 2.6 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.2 0.0 0.8 0.7 0.0 0.0 0.0 0.8 0.0 2.0 5.5 1.8 0.4 0.8 0.0 0.0 0.0 0.6 0.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.3 0.1 0.2 0.1 0.0 0.1 0.0 0.0 3.4 15.5 8.1 12.4 2.8 5.0 2.1 7.1 4.8 2.3 CNP ENSG00000173786 "2',3'-cyclic nucleotide 3' phosphodiesterase" P09543 17 41966741-41977731 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 211.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 49.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002672, HPA023266, HPA023278, HPA023280, HPA023338" Enhanced Supported Enhanced Nucleoplasm,Cytosol 730000 Nucleoplasm Cytosol "CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062" "unprognostic (2.17e-1)" "unprognostic (4.48e-2)" "unprognostic (3.85e-3)" "unprognostic (1.41e-1)" "unprognostic (3.09e-1)" "unprognostic (9.71e-2)" "unprognostic (2.58e-3)" "unprognostic (2.08e-1)" "unprognostic (2.23e-1)" "unprognostic (1.62e-1)" "unprognostic (5.76e-3)" "unprognostic (1.87e-1)" "unprognostic (2.99e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (8.86e-2)" "unprognostic (1.10e-3)" 9.1 8.9 51.4 9.5 72.8 6.7 8.1 13.4 125.3 10.3 7.5 211.7 2.3 7.1 8.0 12.7 15.0 9.3 10.8 7.6 78.4 40.7 14.7 9.6 6.7 10.5 86.7 49.0 11.2 9.2 5.8 4.4 7.8 66.7 11.7 6.4 3.6 15.1 13.2 7.6 11.1 6.4 10.1 160.2 7.1 7.4 4.6 63.5 2.1 7.2 2.2 11.2 9.8 5.7 9.9 49.1 7.3 13.1 7.3 7.5 9.1 13.7 23.5 22.3 27.5 19.1 18.0 9.6 17.2 26.5 44.8 50.6 18.4 12.6 14.6 13.9 22.4 23.7 15.0 11.4 15.6 14.5 19.0 14.2 16.2 31.9 20.6 13.8 12.9 29.7 8.2 24.5 6.0 20.4 10.0 12.0 15.6 8.7 35.4 12.5 5.2 16.8 22.1 32.8 14.2 11.9 14.1 13.1 17.7 21.8 32.9 38.3 14.7 20.7 20.4 17.5 19.2 23.7 20.3 13.5 15.3 11.7 17.3 10.7 68.2 4.9 12.1 7.3 7.5 13.1 5.9 9.9 6.5 6.0 11.1 7.0 5.9 6.9 2.6 7.3 10.3 49.1 7.2 9.1 51.4 72.8 13.4 93.8 78.4 40.7 86.7 49.0 66.7 63.5 CNPY1 ENSG00000146910 "Canopy FGF signaling regulator 1" Q3B7I2 7 155474206-155555450 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 7 "brain: 21.1;pancreas: 8.5" "Cell line enriched" "Detected in some" 8 "AF22: 26.0" "Cancer enriched" "Detected in single" 10 "glioma: 1.6" "Region enriched" "Detected in some" 17 "cerebellum: 21.1" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in single" 29 "cerebellum: 215.6" HPA047400 Uncertain "HPA047400: AB_10960413" "unprognostic (4.28e-3)" "unprognostic (2.12e-1)" "unprognostic (4.18e-2)" "unprognostic (8.27e-12)" "unprognostic (1.44e-1)" "unprognostic (2.16e-1)" 0.1 0.0 0.2 0.1 0.3 0.7 0.1 21.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.3 0.9 0.1 0.2 8.5 0.0 0.2 0.1 1.2 0.1 0.1 0.5 0.2 0.1 0.1 1.2 0.5 0.1 0.5 0.1 0.2 2.1 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.3 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 2.2 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.3 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.3 21.1 0.5 0.2 0.2 0.9 0.1 1.2 0.4 CNR1 "CANN6, CB-R, CB1, CB1A, CB1K5, CNR" ENSG00000118432 "Cannabinoid receptor 1" P21554 6 88139864-88166359 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Group enriched" "Detected in some" 7 "ASC diff: 39.4;HSkMC: 26.0" "Cancer enriched" "Detected in many" 13 "glioma: 12.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.9;naive B-cell: 2.1" "Lineage enriched" "Detected in single" 6 "B-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042256, HPA069945" Enhanced Supported "Plasma membrane,Actin filaments" "Plasma membrane" "Actin filaments" "HPA042256: , HPA069945: " "unprognostic (1.28e-1)" "unprognostic (7.04e-2)" "unprognostic (4.61e-2)" "unprognostic (4.08e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-3)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-2)" "unprognostic (2.74e-2)" "unprognostic (2.68e-1)" "unprognostic (1.70e-1)" "unprognostic (5.59e-3)" "unprognostic (2.68e-3)" "unprognostic (5.88e-2)" "unprognostic (7.00e-2)" 19.4 6.4 18.0 5.2 15.8 1.5 14.9 13.8 30.5 3.9 5.5 0.8 0.8 2.3 3.1 4.7 3.7 5.5 3.6 1.4 17.6 7.7 0.9 0.7 6.4 6.5 2.3 14.7 4.1 1.8 1.3 18.3 5.2 4.2 1.5 5.1 0.0 4.3 4.0 1.7 2.4 4.2 5.8 3.2 2.3 2.3 2.7 2.8 0.0 2.6 0.0 9.9 2.7 3.1 2.9 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 39.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.8 1.3 0.0 2.6 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.0 3.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 2.2 0.0 0.0 0.0 0.0 0.0 0.7 3.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 18.0 15.8 13.8 21.4 17.6 7.7 2.3 14.7 4.2 2.8 CNRIP1 "C2orf32, CRIP1, CRIP1a, CRIP1b, DKFZP566K1924" ENSG00000119865 "Cannabinoid receptor interacting protein 1" Q96F85 2 68284171-68320051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.2" "Cell line enhanced" "Detected in many" "HEL: 52.5" "Cancer enhanced" "Detected in all" "glioma: 14.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 79 "basophil: 11.1" "Lineage enriched" "Detected in single" 79 "granulocytes: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035337 Approved Cytosol 50000 Cytosol "HPA035337: AB_10601359" "unprognostic (1.23e-1)" "unprognostic (8.88e-2)" "unprognostic (1.32e-1)" "unprognostic (2.85e-1)" "unprognostic (1.31e-1)" "unprognostic (1.20e-1)" "unprognostic (6.51e-2)" "unprognostic (3.52e-2)" "unprognostic (2.86e-2)" "unprognostic (4.58e-2)" "unprognostic (4.71e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (1.21e-4)" "unprognostic (1.04e-2)" "unprognostic (3.63e-2)" "unprognostic (1.69e-1)" "unprognostic (3.38e-3)" 26.6 8.6 26.9 7.1 21.9 6.4 11.8 28.3 42.2 15.3 7.3 7.5 2.0 4.9 15.7 8.0 6.3 9.3 10.3 8.8 26.9 22.4 5.0 3.8 10.0 5.7 16.0 22.9 24.5 2.6 2.7 7.2 14.7 12.7 10.1 6.3 10.9 3.3 11.6 7.8 3.6 7.0 11.8 10.8 10.8 5.7 4.0 6.5 0.1 4.1 3.0 4.1 9.3 13.6 0.1 0.0 11.1 0.1 0.0 0.1 0.1 0.0 0.3 3.0 0.0 11.2 8.3 0.0 11.3 8.7 10.2 7.4 0.0 0.0 0.0 0.4 10.8 0.0 0.2 0.1 10.8 0.0 2.7 52.5 0.7 0.0 11.8 0.0 7.4 7.7 0.0 6.7 3.9 15.7 0.0 0.0 7.3 0.0 0.0 0.1 5.1 5.2 0.0 4.6 0.0 0.0 0.0 15.5 15.7 0.8 0.0 8.7 0.0 0.5 16.7 7.2 4.6 6.3 16.4 0.0 0.0 0.0 5.7 0.0 5.2 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 26.9 21.9 28.3 31.9 26.9 22.4 16.0 22.9 12.7 6.5 CNTD2 "CCNP, FLJ13265" ENSG00000105219 "Cyclin N-terminal domain containing 2" Q9H8S5 19 40222208-40226697 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 8.0;brain: 12.0;liver: 7.9" "Cell line enhanced" "Detected in some" "Hep G2: 1.8;Karpas-707: 1.4;SCLC-21H: 6.6;T-47d: 1.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 12.0" "Cell type enriched" "Detected in single" 81 "basophil: 8.0" "Lineage enriched" "Detected in single" 81 "granulocytes: 8.0" "Low region specificity" "Detected in single" HPA045615 Uncertain "HPA045615: " "unprognostic (1.69e-2)" "unprognostic (1.17e-1)" "unprognostic (4.41e-2)" "unprognostic (1.07e-2)" "unprognostic (9.79e-4)" "unprognostic (5.27e-2)" "unprognostic (3.10e-2)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (1.23e-1)" "unprognostic (2.23e-1)" "unprognostic (9.43e-3)" "unprognostic (1.97e-2)" "unprognostic (3.10e-1)" "unprognostic (7.65e-2)" "unprognostic (1.61e-1)" "unprognostic (2.10e-2)" 3.9 1.0 0.7 0.1 1.2 0.3 1.4 12.0 1.8 1.0 0.2 0.4 0.0 0.4 0.3 2.1 0.1 1.9 0.7 1.5 1.1 0.8 5.6 7.9 0.3 0.2 0.5 0.0 0.4 0.1 0.1 3.5 2.8 1.3 1.5 0.5 0.4 0.4 0.3 0.7 0.6 0.6 0.4 0.8 0.6 0.7 1.0 0.0 0.0 1.4 0.7 0.1 0.2 0.1 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.9 0.7 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 1.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.2 0.1 0.0 6.6 0.3 0.5 0.0 0.6 1.5 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.4 0.0 0.3 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 12.0 1.8 1.1 0.8 0.5 0.0 1.3 0.0 CNTF HCNTF ENSG00000242689 "Ciliary neurotrophic factor" P26441 11 58622673-58625733 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.5" "Cell line enhanced" "Detected in many" "U-2197: 12.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "midbrain: 47.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA019654 Approved Approved Vesicles Vesicles "HPA019654: AB_1859050" "unprognostic (1.88e-1)" "unprognostic (2.64e-3)" "unprognostic (1.01e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-1)" "unprognostic (5.91e-2)" "unprognostic (1.63e-1)" "unprognostic (9.24e-2)" "unprognostic (5.87e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-4)" "unprognostic (5.42e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-1)" "unprognostic (1.91e-1)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" 2.0 0.7 1.4 0.9 4.8 10.0 0.8 1.2 1.6 0.3 0.9 2.5 1.1 1.4 0.3 1.4 0.9 8.3 0.8 2.5 1.8 1.6 0.9 0.9 0.8 0.6 47.5 0.9 0.3 0.5 1.2 0.5 0.6 9.3 0.6 1.3 3.1 1.3 0.4 3.7 0.9 0.9 0.6 22.8 0.6 0.5 0.7 1.2 0.2 1.0 3.7 0.6 0.6 0.3 0.4 0.0 0.0 0.3 0.0 0.7 0.2 2.1 0.8 3.4 3.5 1.0 0.3 1.7 1.6 2.2 1.6 1.2 2.9 2.9 4.3 1.2 2.2 3.8 3.6 3.9 3.2 3.0 2.1 2.3 4.3 1.6 0.4 3.3 4.2 1.0 1.3 5.3 1.7 1.7 3.4 1.0 2.0 0.9 3.2 3.1 2.1 1.5 2.2 2.4 3.0 1.9 2.5 1.5 4.2 2.2 2.3 5.8 2.9 2.4 1.2 2.5 1.9 12.7 4.0 2.4 4.9 3.7 6.6 1.7 2.9 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 1.4 4.8 1.2 1.4 1.8 1.6 47.5 0.9 9.3 1.2 CNTN1 "F3, GP135" ENSG00000018236 "Contactin 1" Q12860 12 40692442-41072418 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.2" "Cell line enhanced" "Detected in some" "A549: 70.2;HaCaT: 12.7;SCLC-21H: 21.6;SH-SY5Y: 13.1" "Cancer enhanced" "Detected in many" "glioma: 17.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025200, HPA070467" Enhanced "Intracellular and membrane" 490000000 "CAB025200: , HPA070467: " "unprognostic (3.18e-2)" "unprognostic (5.96e-3)" "unprognostic (3.66e-2)" "unprognostic (7.34e-2)" "unprognostic (2.00e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (2.05e-1)" "unprognostic (9.13e-2)" "unprognostic (1.08e-1)" "unprognostic (1.72e-2)" "unprognostic (1.86e-1)" "unprognostic (1.32e-2)" "unprognostic (8.15e-4)" "unprognostic (6.98e-2)" "unprognostic (5.46e-2)" "prognostic unfavourable (3.75e-4)" 2.9 21.0 27.8 2.1 21.5 0.8 5.7 47.1 81.2 9.9 2.5 14.3 0.7 1.8 7.9 2.2 6.5 2.1 8.2 1.1 27.5 22.1 8.2 1.4 3.3 3.1 23.0 27.7 32.3 4.5 0.8 7.7 0.8 27.0 18.4 3.0 6.9 3.8 18.1 1.1 8.3 2.5 14.4 32.2 5.3 3.0 5.9 17.8 0.0 1.4 0.5 2.9 11.8 3.6 1.6 2.2 6.4 1.4 1.9 1.3 0.2 0.0 70.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 12.7 1.9 3.3 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 21.6 13.1 0.0 0.7 0.8 0.0 0.1 0.0 0.0 1.3 0.0 2.9 0.9 0.0 0.0 0.1 0.0 0.2 6.4 1.4 1.9 1.1 0.8 1.0 1.3 0.9 0.6 0.2 1.6 1.3 0.9 4.1 1.9 0.9 2.2 0.7 0.2 27.8 21.5 47.1 32.6 27.5 22.1 23.0 27.7 27.0 17.8 CNTN2 "AXT, TAG-1, TAX, TAX1" ENSG00000184144 "Contactin 2" Q02246 1 205042937-205078284 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Cell adhesion" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 78.5" "Group enriched" "Detected in some" 7 "NTERA-2: 5.6;SCLC-21H: 14.0" "Cancer enriched" "Detected in some" 9 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001397, HPA012497" Approved "Secreted in brain" 13000 "HPA001397: AB_1847146, HPA012497: AB_1847147" "unprognostic (1.90e-1)" "unprognostic (1.86e-1)" "unprognostic (2.87e-2)" "unprognostic (4.52e-3)" "unprognostic (2.98e-2)" "unprognostic (5.96e-2)" "unprognostic (3.25e-1)" "unprognostic (1.43e-2)" "unprognostic (8.56e-2)" "unprognostic (2.40e-1)" "unprognostic (3.44e-3)" "unprognostic (5.62e-2)" "unprognostic (1.73e-7)" "unprognostic (9.82e-3)" "unprognostic (1.19e-1)" "unprognostic (3.35e-2)" "unprognostic (3.07e-2)" 2.0 2.4 15.6 2.1 52.5 1.6 1.6 11.0 68.8 1.8 2.3 78.5 0.0 1.7 1.6 1.7 1.9 1.7 1.8 1.7 27.4 15.9 1.6 1.6 1.6 1.7 59.8 22.0 1.6 1.6 1.6 2.7 1.6 41.9 1.8 2.3 0.0 2.2 2.4 1.6 2.3 2.2 1.8 55.4 1.7 1.7 9.1 48.3 0.0 1.6 0.0 2.0 1.6 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 15.6 52.5 11.0 28.4 27.4 15.9 59.8 22.0 41.9 48.3 CNTN3 "BIG-1, PANG" ENSG00000113805 "Contactin 3" Q9P232 3 74262568-74521140 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.9;fallopian tube: 8.7" "Group enriched" "Detected in some" 5 "BJ: 7.3;fHDF/TERT166: 19.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003341 Approved "Intracellular and membrane" 54000000 "HPA003341: AB_1078556" "unprognostic (1.66e-2)" "unprognostic (1.86e-1)" "unprognostic (2.35e-3)" "unprognostic (9.86e-2)" "unprognostic (1.82e-2)" "unprognostic (1.94e-5)" "unprognostic (4.25e-2)" "unprognostic (2.13e-3)" "unprognostic (8.42e-2)" "unprognostic (3.85e-2)" "unprognostic (1.50e-1)" "unprognostic (7.25e-2)" "unprognostic (9.30e-7)" "unprognostic (4.23e-2)" "unprognostic (1.63e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-2)" 2.2 3.3 5.3 0.0 3.0 0.0 1.2 1.2 8.9 2.6 3.3 0.1 0.7 1.7 0.1 8.7 2.1 1.7 4.4 3.9 4.1 3.2 0.6 0.0 1.4 0.9 1.6 0.0 3.7 0.0 6.9 3.0 0.3 5.1 0.0 0.3 0.2 0.1 0.5 1.7 1.0 0.4 1.5 0.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 7.3 0.0 1.2 0.4 0.0 0.0 0.0 0.0 19.9 0.0 0.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 2.5 0.0 1.5 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CNTN5 "hNB-2, NB-2" ENSG00000149972 "Contactin 5" O94779 11 99020953-100358885 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.9;pituitary gland: 12.0;salivary gland: 28.4" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.2;TIME: 2.1;U-138 MG: 1.0;U-266/70: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039492, HPA041223" Approved "Intracellular and membrane" 100000 "HPA039492: AB_10795108, HPA041223: AB_10794549" "unprognostic (2.09e-2)" "unprognostic (3.40e-1)" "unprognostic (8.99e-3)" "unprognostic (4.20e-2)" "unprognostic (6.51e-5)" "unprognostic (3.85e-2)" "unprognostic (9.25e-2)" "unprognostic (6.13e-2)" "unprognostic (3.02e-2)" "unprognostic (8.72e-2)" "unprognostic (5.48e-3)" "unprognostic (1.81e-2)" "unprognostic (1.76e-1)" "unprognostic (5.25e-2)" "unprognostic (1.25e-1)" 0.3 0.5 6.5 0.3 4.0 0.2 0.2 0.6 10.9 0.7 0.4 0.5 0.0 0.3 0.6 0.3 0.3 3.8 0.3 0.4 5.0 3.4 1.4 0.5 0.7 0.3 1.4 2.0 0.4 0.9 0.2 12.0 7.4 3.9 0.5 0.3 0.0 28.4 1.1 0.2 0.2 0.3 0.4 0.5 0.2 0.5 0.8 0.3 0.0 5.9 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.0 0.0 0.1 0.0 0.8 0.2 2.1 1.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 4.0 0.6 10.9 5.0 3.4 1.4 2.0 3.9 0.3 CNTN6 NB-3 ENSG00000134115 "Contactin 6" Q9UQ52 3 1092576-1404217 "Predicted membrane proteins" "Cell adhesion, Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 41.4;thyroid gland: 18.9" "Group enriched" "Detected in some" 59 "AF22: 5.4;SH-SY5Y: 6.3" "Group enriched" "Detected in some" 15 "renal cancer: 2.7;thyroid cancer: 3.2" "Region enriched" "Detected in many" 5 "cerebellum: 41.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016645 Uncertain 2100000 "HPA016645: AB_1847149" "unprognostic (1.09e-1)" "unprognostic (3.70e-1)" "unprognostic (2.27e-1)" "unprognostic (3.99e-1)" "unprognostic (3.16e-1)" "unprognostic (1.05e-4)" "unprognostic (1.45e-1)" "unprognostic (1.86e-1)" "unprognostic (3.80e-2)" "unprognostic (2.61e-2)" "unprognostic (4.65e-2)" "unprognostic (1.26e-3)" "unprognostic (5.45e-2)" "unprognostic (5.23e-2)" "unprognostic (1.15e-1)" "unprognostic (4.46e-2)" 0.2 4.7 1.6 0.2 2.2 0.2 0.4 41.4 6.3 0.3 0.3 0.1 0.0 0.2 0.3 0.8 0.3 0.4 0.2 0.4 1.5 3.0 0.5 0.2 5.6 0.2 2.4 2.6 0.2 0.3 0.2 0.5 3.4 7.8 0.2 0.3 0.4 0.3 0.3 0.2 0.2 0.2 0.3 1.7 0.2 0.2 0.4 0.3 0.0 18.9 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.2 41.4 6.3 1.5 3.0 2.4 2.6 7.8 0.3 CNTNAP1 "Caspr, CNTNAP, NRXN4, p190" ENSG00000108797 "Contactin associated protein 1" P78357 17 42682613-42699814 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.7;smooth muscle: 26.7" "Cell line enhanced" "Detected in many" "TIME: 29.6;U-138 MG: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011772 Approved Approved Nucleoplasm Nucleoplasm "HPA011772: AB_1079541" "unprognostic (4.04e-2)" "unprognostic (3.69e-1)" "unprognostic (2.37e-3)" "unprognostic (1.89e-1)" "unprognostic (5.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" "unprognostic (2.59e-1)" "unprognostic (9.76e-3)" "unprognostic (1.99e-2)" "unprognostic (1.67e-1)" "prognostic unfavourable (4.16e-14)" "unprognostic (9.52e-3)" "unprognostic (2.27e-2)" "unprognostic (3.11e-2)" "unprognostic (7.37e-3)" 6.1 2.5 35.5 5.9 18.8 1.1 1.7 31.7 48.7 4.7 8.5 2.9 1.4 2.3 12.1 7.1 2.9 7.0 7.1 4.0 29.2 14.8 1.7 0.9 3.9 2.8 10.5 23.9 8.7 6.5 1.7 7.2 5.0 18.4 4.2 4.7 2.1 2.0 7.6 3.5 2.5 2.7 26.7 11.5 3.2 3.9 2.3 13.3 0.0 1.7 0.2 2.9 5.8 3.3 0.0 0.7 0.1 0.0 0.1 1.4 0.0 1.7 2.6 5.7 1.9 8.9 18.2 0.3 10.8 18.8 8.0 7.2 0.3 0.4 0.0 0.6 11.8 2.1 2.8 0.8 6.3 4.2 0.9 0.0 10.6 2.6 4.4 0.0 0.1 17.7 0.0 7.6 1.5 10.0 0.5 3.3 3.0 0.3 0.0 1.5 2.0 2.5 0.3 0.7 1.0 2.1 0.0 1.1 3.4 3.2 0.0 2.0 2.0 0.9 29.6 34.3 5.8 7.9 2.9 4.0 2.4 0.1 9.5 0.7 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 1.4 0.0 35.5 18.8 31.7 48.7 29.2 14.8 10.5 23.9 18.4 13.3 CNTNAP2 "Caspr2, KIAA0868, NRXN4" ENSG00000174469 "Contactin associated protein like 2" Q9UHC6 7 146116002-148420998 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Autism, Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Group enriched" "Detected in some" 4 "AF22: 7.3;CACO-2: 6.1;NTERA-2: 10.9;SCLC-21H: 19.7" "Cancer enhanced" "Detected in many" "prostate cancer: 10.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 31 "memory B-cell: 1.8;naive B-cell: 6.1" "Lineage enriched" "Detected in single" 48 "B-cells: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002739 Enhanced "HPA002739: AB_1078545" "unprognostic (2.49e-2)" "unprognostic (1.49e-2)" "unprognostic (4.05e-1)" "unprognostic (3.08e-3)" "unprognostic (1.77e-1)" "unprognostic (2.29e-1)" "unprognostic (2.51e-2)" "unprognostic (1.45e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-1)" "unprognostic (3.67e-2)" "unprognostic (2.68e-1)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.00e-3)" 0.9 2.0 14.0 1.2 16.6 0.9 2.2 4.4 25.8 0.7 2.3 1.2 0.0 0.7 0.9 0.7 1.4 2.2 0.8 1.0 9.6 6.4 1.0 3.5 0.8 1.6 7.5 16.2 1.7 1.1 0.7 2.7 1.9 17.0 8.7 1.6 2.5 0.9 1.0 0.7 0.8 2.0 0.8 18.1 1.7 1.2 1.4 0.5 2.4 1.5 0.0 1.3 0.8 0.5 6.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 7.3 1.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 6.1 0.1 0.0 0.0 0.2 1.8 1.6 0.5 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 2.0 0.0 0.0 19.7 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 14.0 16.6 4.4 25.8 9.6 6.4 7.5 16.2 17.0 0.5 CNTNAP4 "CASPR4, KIAA1763" ENSG00000152910 "Contactin associated protein like 4" Q9C0A0 16 76277278-76559238 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "brain: 36.9" "Group enriched" "Detected in some" 6 "Daudi: 13.7;HSkMC: 5.5;Karpas-707: 4.7;RPMI-8226: 8.7" "Cancer enriched" "Detected in single" 5 "glioma: 1.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031859 Enhanced 73000 "HPA031859: AB_10601360" "unprognostic (7.88e-2)" "unprognostic (7.19e-2)" "unprognostic (6.58e-2)" "unprognostic (2.46e-1)" "unprognostic (1.55e-2)" "unprognostic (1.50e-3)" "unprognostic (9.42e-3)" "unprognostic (1.91e-2)" "unprognostic (5.26e-4)" "unprognostic (1.83e-2)" "unprognostic (2.00e-2)" "unprognostic (4.56e-1)" "unprognostic (1.09e-1)" 0.9 2.4 10.2 0.9 19.1 0.9 0.9 13.2 36.9 1.3 0.9 27.6 0.0 1.2 0.9 0.9 0.9 0.9 0.9 0.9 9.9 2.2 1.0 0.9 0.9 1.0 23.1 15.1 1.0 0.9 0.9 0.8 0.9 25.0 1.3 0.9 0.0 0.9 1.4 0.9 0.9 1.1 1.0 30.9 0.9 0.9 2.2 21.4 0.0 0.9 0.0 1.0 0.9 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.3 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.2 19.1 13.2 14.4 9.9 2.2 23.1 15.1 25.0 21.4 CNTNAP5 "caspr5, FLJ31966" ENSG00000155052 "Contactin associated protein like 5" Q8WYK1 2 124025287-124915287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 22.4" "Cell line enhanced" "Detected in some" "AF22: 3.2;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.2" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA069095, HPA069356" Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA069095: , HPA069356: " "unprognostic (6.32e-3)" "unprognostic (6.38e-2)" "unprognostic (1.23e-1)" "unprognostic (2.25e-1)" "unprognostic (1.68e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (3.11e-2)" "unprognostic (2.62e-6)" "unprognostic (3.65e-3)" "unprognostic (5.32e-2)" "unprognostic (9.58e-2)" 0.7 2.8 12.9 0.7 7.9 1.0 0.7 3.3 22.4 0.6 0.8 1.5 0.0 1.0 0.7 0.7 0.7 0.6 4.2 0.7 14.0 4.0 1.2 0.7 0.7 0.7 2.2 8.4 0.6 1.1 0.7 0.8 0.7 15.2 0.8 0.8 0.4 0.6 1.0 0.7 0.8 0.9 0.8 1.9 0.7 0.7 0.9 2.8 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.1 0.0 1.3 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 7.9 3.3 22.4 14.0 4.0 2.2 8.4 15.2 2.8 COCH "COCH-5B2, DFNA31, DFNA9" ENSG00000100473 Cochlin O43405 14 30874514-30895065 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 63.0;pancreas: 136.8" "Cell line enhanced" "Detected in many" "HEK 293: 30.1;Hep G2: 19.7;K-562: 38.7;NB-4: 32.1;SCLC-21H: 35.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "basal ganglia: 63.0" "Group enriched" "Detected in some" 13 "memory B-cell: 24.0;naive B-cell: 7.7" "Lineage enriched" "Detected in many" 20 "B-cells: 24.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 25.4;basal ganglia: 40.0;cerebral cortex: 16.6;hippocampal formation: 15.6" HPA065086 Supported Vesicles "Secreted to extracellular matrix" 88000 Vesicles "HPA065086: " "unprognostic (8.36e-3)" "unprognostic (2.51e-2)" "unprognostic (8.61e-2)" "unprognostic (1.64e-2)" "unprognostic (6.48e-2)" "unprognostic (6.53e-2)" "unprognostic (9.61e-2)" "unprognostic (4.03e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" "unprognostic (1.27e-2)" "unprognostic (2.91e-3)" "unprognostic (5.42e-3)" "unprognostic (3.92e-2)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (1.72e-1)" 1.1 1.4 2.1 1.1 63.0 1.3 0.9 1.1 2.3 4.0 0.8 1.4 1.6 0.6 0.6 1.0 0.6 2.2 1.2 0.9 1.2 2.9 1.8 0.5 0.5 3.1 0.8 1.9 0.6 136.8 0.4 3.3 0.9 2.1 14.7 1.0 0.8 1.8 21.8 0.6 4.6 0.7 0.7 1.4 0.8 0.8 1.8 7.9 0.0 0.6 0.7 2.4 1.1 7.8 24.0 0.0 0.1 0.3 0.0 1.1 0.6 0.0 11.0 1.0 0.0 0.2 0.0 6.9 0.0 0.0 2.0 5.5 6.5 0.3 0.1 0.5 0.0 0.0 6.9 0.0 3.4 0.0 30.1 5.5 2.5 19.7 0.0 0.5 2.3 0.4 0.0 0.2 0.0 0.1 38.7 1.6 0.5 0.2 2.7 32.1 3.7 1.1 8.1 0.0 0.2 0.3 1.0 35.7 9.6 0.8 0.1 0.0 0.0 15.0 0.2 0.0 0.0 0.1 0.0 1.8 4.7 3.4 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 24.0 0.2 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.6 2.1 63.0 1.1 2.3 1.2 2.9 0.8 1.9 2.1 7.9 COL13A1 ENSG00000197467 "Collagen type XIII alpha 1 chain" Q5TAT6 10 69801867-69964275 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Osteogenesis" "Developmental protein, Heparin-binding" "Congenital myasthenic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.6;epididymis: 22.3" "Cell line enhanced" "Detected in many" "BJ: 19.7;BJ hTERT+: 18.3;HUVEC TERT2: 31.9;PC-3: 29.3;TIME: 45.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 18 "cerebellum: 54.6" "Group enriched" "Detected in some" 18 "gdT-cell: 1.9;NK-cell: 1.9" "Group enriched" "Detected in many" 18 "NK-cells: 1.9;T-cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050392 Approved "HPA050392: " "unprognostic (2.79e-2)" "unprognostic (2.82e-3)" "unprognostic (1.38e-1)" "unprognostic (3.86e-1)" "unprognostic (4.67e-4)" "unprognostic (3.13e-1)" "unprognostic (1.69e-1)" "unprognostic (7.43e-2)" "unprognostic (6.16e-3)" "unprognostic (1.22e-1)" "unprognostic (2.60e-1)" "unprognostic (2.53e-2)" "unprognostic (1.36e-5)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.52e-2)" "unprognostic (3.93e-2)" 0.7 1.2 0.5 3.3 1.0 0.0 1.3 54.6 1.3 3.5 3.1 0.6 4.3 1.8 1.4 22.3 1.3 2.0 2.7 2.7 0.6 0.5 1.3 0.5 8.2 0.7 0.9 0.7 1.1 1.2 0.9 2.7 0.9 3.0 10.7 2.3 3.8 1.0 6.2 2.7 3.1 2.9 2.0 1.7 5.0 3.9 0.9 0.7 0.3 1.0 1.1 0.6 2.2 1.2 0.0 0.0 0.1 0.0 1.9 1.9 0.4 0.4 0.1 7.0 0.0 0.0 1.3 0.0 19.7 18.3 3.3 1.6 0.0 0.4 0.0 3.3 8.8 0.7 0.0 0.0 5.6 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 2.8 0.0 8.4 2.6 31.9 0.0 0.0 3.1 0.0 0.0 0.0 1.3 29.3 0.0 0.0 3.5 0.1 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 45.5 0.1 5.4 1.8 15.0 4.4 0.0 0.0 11.7 0.0 16.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.4 0.5 1.0 54.6 1.3 0.6 0.5 0.9 0.7 3.0 0.7 COL19A1 ENSG00000082293 "Collagen type XIX alpha 1 chain" Q14993 6 69866571-70209976 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Differentiation, Myogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 23.1;brain: 14.4;lymphoid tissue: 18.8;smooth muscle: 37.8;urinary bladder: 12.4" "Cell line enhanced" "Detected in some" "HDLM-2: 5.5;RH-30: 14.2;SCLC-21H: 4.0;SK-MEL-30: 11.9;WM-115: 10.0" "Cancer enhanced" "Detected in single" "melanoma: 0.7" "Region enhanced" "Detected in many" "cerebellum: 14.4" "Group enriched" "Detected in some" 156 "memory B-cell: 7.9;naive B-cell: 23.1" "Lineage enriched" "Detected in single" 232 "B-cells: 23.1" "Low region specificity" "Detected in many" HPA042422 Uncertain "Secreted to extracellular matrix" "HPA042422: AB_10794798" "unprognostic (2.65e-2)" "unprognostic (2.55e-1)" "unprognostic (2.71e-1)" "unprognostic (9.24e-2)" "unprognostic (2.26e-2)" "unprognostic (6.20e-2)" "unprognostic (3.17e-1)" "unprognostic (1.10e-3)" "unprognostic (3.41e-1)" "unprognostic (1.28e-1)" "unprognostic (2.76e-1)" "unprognostic (1.62e-2)" "unprognostic (1.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.20e-1)" "unprognostic (3.35e-1)" "unprognostic (8.91e-2)" 4.2 0.7 1.1 18.8 2.7 1.1 0.5 14.4 4.1 0.5 1.6 0.0 0.0 0.8 0.5 0.2 0.6 0.7 0.6 2.6 6.0 1.0 4.5 0.6 0.6 7.3 0.7 1.1 0.5 0.9 0.2 4.2 0.4 0.7 5.2 2.2 0.0 0.8 0.4 3.7 0.5 2.3 37.8 0.6 4.2 4.4 1.5 0.0 1.3 0.6 0.0 8.8 12.4 2.3 23.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 14.2 0.0 0.0 0.0 4.0 2.9 0.0 0.0 11.9 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 2.7 14.4 4.1 6.0 1.0 0.7 1.1 0.7 0.0 COL20A1 KIAA1510 ENSG00000101203 "Collagen type XX alpha 1 chain" Q9P218 20 63293186-63334851 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 21.6" "Cell line enhanced" "Detected in some" "MCF7: 1.6;SK-MEL-30: 3.3;U-266/70: 2.4" "Cancer enriched" "Detected in single" 19 "glioma: 8.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051962 Uncertain "Secreted to extracellular matrix" "HPA051962: " "unprognostic (6.34e-4)" "unprognostic (2.52e-1)" "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "unprognostic (2.01e-1)" "unprognostic (5.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.45e-1)" "unprognostic (1.21e-1)" "unprognostic (1.70e-2)" "unprognostic (1.71e-1)" "unprognostic (2.89e-1)" "unprognostic (8.41e-7)" "unprognostic (7.85e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-2)" "unprognostic (1.16e-1)" 0.6 0.9 6.9 0.6 3.9 0.6 0.5 2.2 21.6 1.0 0.6 14.0 0.0 0.5 0.5 1.2 0.5 0.6 0.5 0.6 5.6 3.0 0.6 0.6 0.5 0.5 4.7 4.5 0.7 0.5 0.5 1.1 0.6 3.5 0.6 0.5 0.7 0.8 0.6 0.5 0.5 0.6 0.5 4.3 2.0 0.5 3.0 5.0 0.0 0.5 0.2 0.5 0.5 0.1 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.9 0.0 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.6 0.7 0.1 2.4 0.5 0.3 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 6.9 3.9 2.2 6.3 5.6 3.0 4.7 4.5 3.5 5.0 COL24A1 ENSG00000171502 "Collagen type XXIV alpha 1 chain" Q17RW2 1 85729233-86156943 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.0" "Cell line enhanced" "Detected in some" "ASC diff: 3.4;HSkMC: 3.1;Karpas-707: 6.0;NTERA-2: 3.1;RH-30: 4.4;U-266/70: 11.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 6.2" "Lineage enriched" "Detected in single" 10 "dendritic cells: 6.2" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" 12000 "unprognostic (3.00e-1)" "unprognostic (6.19e-2)" "unprognostic (2.21e-2)" "unprognostic (6.76e-3)" "unprognostic (1.82e-3)" "unprognostic (2.45e-2)" "unprognostic (2.44e-5)" "unprognostic (1.37e-1)" "unprognostic (4.08e-2)" "unprognostic (6.59e-2)" "unprognostic (3.89e-2)" "unprognostic (1.46e-1)" "unprognostic (3.48e-6)" "unprognostic (2.79e-5)" "unprognostic (5.07e-1)" "unprognostic (1.19e-1)" "unprognostic (9.90e-2)" 1.1 0.4 6.2 3.4 7.1 2.3 1.1 1.7 18.0 7.0 9.5 0.3 0.0 4.1 3.6 2.4 2.2 0.6 4.4 4.1 12.1 1.2 1.5 0.3 1.7 1.0 1.1 5.2 6.9 0.3 0.2 2.0 0.3 1.7 2.3 2.4 2.4 1.2 4.3 1.4 1.6 3.7 2.8 1.0 0.8 3.4 1.9 2.9 0.0 0.8 2.6 0.8 8.3 4.9 0.0 6.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.5 0.0 3.4 0.6 0.0 0.6 0.1 0.2 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 1.4 0.0 0.8 0.0 1.0 0.1 0.1 0.0 0.0 3.1 0.0 0.2 0.0 0.0 0.0 6.0 0.9 0.0 0.0 0.2 3.1 0.0 0.0 4.4 0.5 0.5 1.1 0.1 0.0 0.0 0.2 0.5 0.0 0.9 0.0 2.0 0.2 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 6.2 0.0 0.0 6.2 7.1 1.7 18.0 12.1 1.2 1.1 5.2 1.7 2.9 COL26A1 "EMI6, EMID2, Emu2" ENSG00000160963 "Collagen type XXVI alpha 1 chain" Q96A83 7 101362820-101559024 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.4;brain: 18.3" "Group enriched" "Detected in some" 4 "AF22: 20.6;BEWO: 16.5;HAP1: 7.3;Hep G2: 5.2;NTERA-2: 17.4" "Group enriched" "Detected in many" 6 "endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7" "Cell type enriched" "Detected in single" 63 "plasmacytoid DC: 11.4" "Lineage enriched" "Detected in single" 63 "dendritic cells: 11.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027059 Approved Approved Vesicles "Secreted to extracellular matrix" Vesicles "HPA027059: AB_1848142" "unprognostic (5.94e-3)" "unprognostic (2.16e-2)" "unprognostic (2.19e-2)" "unprognostic (4.67e-2)" "unprognostic (1.66e-1)" "unprognostic (3.35e-1)" "prognostic favourable (2.32e-5)" "unprognostic (1.48e-1)" "unprognostic (1.16e-1)" "unprognostic (2.85e-2)" "unprognostic (1.26e-3)" "unprognostic (1.78e-1)" "unprognostic (4.24e-3)" "unprognostic (3.60e-1)" "unprognostic (1.50e-1)" "unprognostic (7.48e-4)" "unprognostic (2.83e-3)" 0.0 4.1 2.5 0.3 7.0 0.3 0.2 0.4 18.3 0.1 0.0 0.2 0.0 0.1 0.5 0.3 0.0 0.2 0.3 0.1 3.3 3.1 4.8 0.6 0.9 0.0 8.1 0.2 3.1 6.7 0.0 0.5 0.6 3.7 0.0 0.0 0.2 1.1 0.0 0.1 0.1 0.1 0.3 0.4 0.2 0.8 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.6 20.6 1.3 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.8 0.0 0.1 3.2 0.0 0.0 7.3 0.0 0.0 0.7 0.9 0.0 0.0 5.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 17.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 COL27A1 "FLJ11895, KIAA1870, MGC11337" ENSG00000196739 "Collagen type XXVII alpha 1 chain" Q8IZC6 9 114155560-114312511 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.9;cervix, uterine: 41.9" "Cell line enhanced" "Detected in many" "BEWO: 29.6;Hep G2: 24.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 56.9" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 23 "cerebellum: 141.7" "HPA021884, HPA048471" Uncertain "Secreted to extracellular matrix" "HPA021884: , HPA048471: " "unprognostic (4.45e-2)" "unprognostic (3.27e-1)" "unprognostic (1.32e-1)" "unprognostic (5.00e-2)" "prognostic unfavourable (7.11e-4)" "unprognostic (4.13e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (6.25e-2)" "unprognostic (1.71e-1)" "unprognostic (1.09e-3)" "unprognostic (3.31e-1)" "unprognostic (3.41e-2)" "unprognostic (2.97e-2)" "unprognostic (9.48e-2)" "unprognostic (6.21e-3)" "unprognostic (3.50e-3)" 4.7 4.2 6.0 4.2 4.6 0.1 4.1 56.9 5.7 41.9 4.4 2.6 5.7 2.9 25.9 17.0 3.6 6.4 6.3 3.3 4.9 1.7 11.0 16.5 4.4 2.9 5.8 1.8 13.1 12.9 0.7 2.2 9.0 8.6 9.8 1.0 9.6 4.1 11.3 4.0 11.9 3.5 8.4 7.3 3.0 9.7 2.7 5.1 2.8 6.1 5.2 3.2 5.7 17.9 0.9 0.4 2.0 0.2 0.5 0.3 0.1 1.9 4.1 9.6 3.5 0.7 1.0 29.6 4.6 3.1 3.4 2.8 4.2 0.1 0.0 1.1 2.2 4.8 3.3 4.3 1.8 0.0 0.4 0.0 3.4 24.9 1.0 0.0 10.7 2.7 1.2 4.1 1.8 5.0 0.0 1.0 1.9 0.9 0.0 1.8 3.4 1.1 13.3 9.7 1.8 7.9 2.2 0.1 0.1 0.2 0.1 0.5 0.8 3.0 4.6 3.0 6.0 0.4 7.1 0.5 0.0 0.0 2.4 0.0 4.5 0.6 0.2 0.4 0.2 0.2 0.2 0.3 0.3 0.2 0.1 0.9 0.3 0.2 2.0 0.5 0.1 0.4 0.2 0.1 6.0 4.6 56.9 5.7 4.9 1.7 5.8 1.8 8.6 5.1 COL4A5 "ASLN, ATS" ENSG00000188153 "Collagen type IV alpha 5 chain" P29400 X 108439844-108697545 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Alport syndrome, Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2" "Cell line enhanced" "Detected in many" "HeLa: 28.6;HHSteC: 32.9;HUVEC TERT2: 30.9;TIME: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Secreted to extracellular matrix" "unprognostic (2.58e-2)" "unprognostic (2.57e-2)" "unprognostic (3.64e-2)" "unprognostic (3.98e-2)" "unprognostic (1.11e-1)" "unprognostic (1.61e-1)" "unprognostic (1.97e-2)" "unprognostic (7.27e-2)" "unprognostic (2.70e-1)" "unprognostic (2.20e-1)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" "prognostic unfavourable (2.41e-5)" "unprognostic (2.10e-3)" "unprognostic (1.70e-1)" "unprognostic (2.61e-2)" "unprognostic (1.06e-1)" 3.3 2.7 13.1 1.7 27.7 0.3 5.8 1.8 16.1 16.9 3.7 47.2 9.5 2.7 31.4 18.2 6.9 19.3 12.6 5.9 13.9 6.2 5.9 1.7 5.9 0.9 46.6 15.7 11.5 2.8 22.3 10.2 9.7 19.5 18.0 4.1 5.8 3.7 23.9 4.8 17.5 3.1 32.8 20.5 2.8 17.7 2.8 40.5 0.0 5.4 0.9 0.9 23.9 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 8.9 15.9 5.0 6.2 3.6 0.1 0.9 3.9 4.8 7.9 7.9 0.6 1.4 0.0 0.6 7.2 4.4 14.9 6.1 2.1 3.9 1.1 28.6 0.9 32.9 0.0 4.5 17.0 18.2 5.9 12.7 30.9 0.0 0.0 4.6 0.6 0.0 0.1 4.7 5.3 0.0 0.0 0.0 12.0 8.8 0.0 0.0 23.1 0.7 1.9 4.3 0.0 29.2 3.2 1.0 2.1 1.3 0.6 0.0 0.0 2.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 27.7 1.8 16.1 13.9 6.2 46.6 15.7 19.5 40.5 COL9A2 "EDM2, MED" ENSG00000049089 "Collagen type IX alpha 2 chain" Q14055 1 40300487-40317813 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Disease mutation, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.3;pituitary gland: 32.1;retina: 40.8" "Cell line enhanced" "Detected in some" "HDLM-2: 34.6;HMC-1: 33.4;THP-1: 37.4" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 6.4;myeloid DC: 2.7" "Group enriched" "Detected in many" 6 "dendritic cells: 2.7;granulocytes: 6.4" "Low region specificity" "Detected in all" "HPA056316, HPA075286" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" Vesicles Nucleoplasm "HPA056316: , HPA075286: " "unprognostic (1.42e-2)" "unprognostic (3.54e-2)" "unprognostic (8.94e-2)" "prognostic unfavourable (5.13e-4)" "unprognostic (4.46e-2)" "unprognostic (1.83e-3)" "unprognostic (2.06e-2)" "unprognostic (9.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.56e-3)" "unprognostic (2.26e-1)" "unprognostic (1.16e-3)" "unprognostic (4.28e-2)" "unprognostic (2.56e-1)" "unprognostic (5.89e-2)" "unprognostic (1.71e-2)" 0.7 2.3 17.2 2.6 19.5 7.6 3.1 2.3 12.1 10.0 3.6 32.0 17.4 4.6 3.9 1.5 0.7 3.7 6.5 1.0 20.8 14.5 4.3 0.6 2.8 4.2 29.8 10.5 0.6 1.7 28.3 32.1 0.9 16.3 8.8 2.6 40.8 13.7 21.3 0.3 2.0 3.3 1.3 35.3 3.2 12.8 0.8 19.7 0.2 4.3 0.9 2.5 4.0 0.5 0.7 2.7 6.4 0.7 0.4 0.3 0.1 4.2 0.1 0.6 0.3 0.9 0.5 2.9 0.0 0.0 0.2 0.5 0.1 2.4 1.2 3.7 0.1 0.7 0.0 0.0 0.1 34.6 0.5 0.7 0.3 9.7 0.6 0.3 33.4 1.8 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.9 0.4 0.7 0.8 0.4 0.8 0.0 2.4 0.0 5.1 0.5 0.8 0.0 4.3 0.4 5.4 37.4 0.0 0.0 4.4 0.0 0.1 0.5 0.0 1.1 0.3 4.4 0.2 0.0 0.2 6.4 0.0 0.5 0.0 0.5 0.2 0.0 2.7 0.7 0.1 0.0 1.1 0.4 0.7 0.3 0.3 0.1 17.2 19.5 2.3 10.8 20.8 14.5 29.8 10.5 16.3 19.7 COL9A3 "DJ885L7.4.1, EDM3, FLJ90759, IDD, MED" ENSG00000092758 "Collagen type IX alpha 3 chain" Q14050 20 62816244-62841159 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1" "Group enriched" "Detected in some" 6 "BEWO: 52.5;Hep G2: 20.7;SK-MEL-30: 17.2;WM-115: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040125, HPA058323" Supported Approved "Nucleoplasm,Intermediate filaments" "Secreted to extracellular matrix" Nucleoplasm "Intermediate filaments" "HPA040125: AB_10805604, HPA058323: " "unprognostic (1.14e-3)" "unprognostic (2.14e-2)" "unprognostic (3.93e-1)" "unprognostic (1.21e-3)" "unprognostic (4.25e-2)" "unprognostic (2.39e-2)" "unprognostic (2.33e-1)" "unprognostic (1.24e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-1)" "unprognostic (2.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.67e-1)" 2.2 2.0 11.2 2.3 16.3 1.2 1.5 1.5 8.9 1.7 3.4 26.4 1.6 2.3 1.8 1.5 1.6 1.2 1.4 2.1 14.9 9.8 1.4 1.3 1.3 1.4 18.4 8.1 1.6 5.4 1.1 5.3 1.9 12.4 1.7 1.3 37.2 38.9 3.4 1.5 1.8 2.5 1.4 25.0 1.2 1.8 6.4 15.2 0.0 18.1 1.4 1.2 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 52.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.4 20.7 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 2.3 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 17.2 0.0 1.9 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 16.3 1.5 8.0 14.9 9.8 18.4 8.1 12.4 15.2 COLGALT2 "C1orf17, GLT25D2, KIAA0584" ENSG00000198756 "Collagen beta(1-O)galactosyltransferase 2" Q8IYK4 1 183929854-184037729 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell line enhanced" "Detected in many" "Hep G2: 12.7;SK-MEL-30: 13.7;U-251 MG: 13.1;WM-115: 17.0" "Cancer enhanced" "Detected in many" "glioma: 11.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "basophil: 8.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031749, HPA031750" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" Nucleoplasm Vesicles "HPA031749: AB_10599298, HPA031750: AB_10611252" "unprognostic (5.44e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-5)" "unprognostic (2.08e-1)" "unprognostic (4.41e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (1.09e-2)" "unprognostic (2.52e-1)" "unprognostic (2.00e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (5.13e-9)" "unprognostic (1.53e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (3.80e-2)" 2.1 9.4 10.8 1.7 16.6 1.9 2.8 10.6 39.0 2.0 3.0 31.3 0.0 1.4 3.0 5.2 1.7 3.5 3.7 11.7 15.3 7.9 1.8 1.0 4.5 1.1 20.2 12.9 2.3 3.5 1.0 1.9 0.8 17.4 8.1 2.0 3.5 4.4 3.7 11.0 1.1 1.4 3.0 21.8 1.3 3.4 5.0 22.5 0.0 5.1 1.8 1.5 2.4 1.4 0.0 0.0 8.1 0.0 0.7 0.6 0.1 0.1 0.0 4.4 0.2 2.3 3.4 0.1 1.2 0.5 0.6 0.7 2.1 0.2 0.0 0.3 3.3 0.0 4.2 0.0 1.1 4.6 2.3 0.3 0.0 12.7 0.1 4.1 0.0 2.0 0.0 0.6 0.1 0.0 4.1 5.4 4.6 0.1 0.2 0.2 3.0 0.0 0.4 0.0 0.0 0.0 0.9 1.7 2.7 0.2 0.0 13.7 0.0 0.2 0.0 0.5 0.4 0.0 13.1 8.0 0.0 0.0 0.4 2.0 17.0 8.1 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 10.8 16.6 10.6 17.2 15.3 7.9 20.2 12.9 17.4 22.5 CORO2B "ClipinC, KIAA0925" ENSG00000103647 "Coronin 2B" Q9UQ03 15 68578969-68727806 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.5;fallopian tube: 27.4" "Cell line enhanced" "Detected in many" "ASC diff: 12.7;ASC TERT1: 27.4;HSkMC: 19.7;hTEC/SVTERT24-B: 16.0;U-87 MG: 27.3" "Group enriched" "Detected in many" 8 "glioma: 34.7;melanoma: 21.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 1.2;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 21 "B-cells: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017960 Enhanced Approved "Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" "HPA017960: AB_1847167" "unprognostic (1.35e-1)" "unprognostic (2.63e-2)" "unprognostic (2.81e-3)" "unprognostic (4.71e-3)" "unprognostic (3.28e-1)" "unprognostic (8.11e-5)" "unprognostic (4.77e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (1.81e-1)" "unprognostic (1.33e-3)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" "unprognostic (1.10e-2)" "unprognostic (5.83e-2)" "unprognostic (3.59e-2)" "unprognostic (1.87e-2)" 10.9 4.4 15.7 3.2 30.1 1.9 4.8 33.7 53.5 6.5 3.4 27.3 0.8 2.4 7.5 3.9 2.7 27.4 6.3 7.2 23.0 15.1 5.5 2.0 5.8 3.5 20.9 18.8 18.4 2.9 1.6 1.5 4.7 23.6 3.2 2.9 11.8 3.4 6.9 3.8 5.6 3.3 8.4 35.0 3.6 2.0 2.2 17.5 0.0 4.6 0.6 1.9 3.0 1.6 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 12.1 1.0 12.7 27.4 0.0 6.1 6.8 1.0 1.5 0.1 1.3 1.4 0.7 1.0 0.0 0.4 0.1 4.4 0.0 0.5 0.0 0.0 0.6 4.6 0.0 0.1 19.7 0.1 16.0 0.9 0.4 0.0 0.0 11.2 0.0 0.0 0.0 2.9 0.0 0.9 0.0 0.5 1.7 0.0 7.0 0.1 0.1 0.0 3.6 0.0 1.4 0.1 3.6 4.1 0.7 8.1 0.0 0.0 1.4 27.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 30.1 33.7 29.3 23.0 15.1 20.9 18.8 23.6 17.5 CORT MGC32686 ENSG00000241563 Cortistatin O00230 1 10449719-10451902 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 28.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 33 "amygdala: 13.7;basal ganglia: 5.1;cerebral cortex: 16.9;hippocampal formation: 11.6;olfactory region: 6.1" "Low region specificity" "Detected in many" "Secreted in brain" "unprognostic (1.25e-2)" "unprognostic (1.79e-2)" "unprognostic (1.65e-1)" "unprognostic (3.70e-3)" "unprognostic (8.87e-2)" "unprognostic (1.67e-2)" "unprognostic (1.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.05e-1)" "unprognostic (7.94e-3)" "unprognostic (7.08e-7)" "unprognostic (2.01e-1)" "unprognostic (9.01e-4)" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.14e-4)" 1.0 0.7 3.3 0.9 28.8 0.9 0.6 3.2 26.6 0.7 1.0 0.1 0.0 1.3 0.8 1.0 0.5 0.7 1.0 0.6 2.3 2.5 1.2 0.8 0.7 0.7 1.0 6.2 1.0 0.9 1.0 3.2 1.7 0.0 1.1 0.8 0.0 0.7 0.8 0.8 1.1 1.2 0.7 0.7 0.8 0.9 2.1 20.3 0.0 1.1 0.0 0.5 0.8 0.5 0.2 0.4 0.0 0.1 1.2 0.3 0.3 1.2 3.7 1.8 2.3 0.2 0.2 0.8 1.1 0.2 0.4 0.4 3.1 0.5 1.2 0.8 0.0 1.0 1.1 0.0 0.0 2.0 3.1 1.7 2.7 3.0 0.4 2.4 1.1 0.0 0.3 0.5 0.0 0.0 1.0 1.0 0.3 2.5 0.5 2.2 0.3 4.4 0.9 1.6 0.5 0.2 0.9 1.5 0.8 0.9 1.1 0.7 0.7 0.0 1.7 0.3 1.8 2.2 0.6 0.9 2.7 1.0 0.7 1.8 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.4 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.3 3.3 28.8 3.2 21.5 2.3 2.5 1.0 6.2 0.0 20.3 CPE ENSG00000109472 "Carboxypeptidase E" P16870 4 165361194-165498320 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 203.7" "Cell line enhanced" "Detected in many" "Hep G2: 49.9;SCLC-21H: 70.2;SiHa: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003819, CAB024907" Supported Approved Nucleoplasm,Vesicles,Centrosome "Intracellular and membrane" 470000 Centrosome "Nucleoplasm, Vesicles" "CAB024907: , HPA003819: " "unprognostic (1.84e-1)" "unprognostic (5.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.70e-2)" "unprognostic (2.51e-1)" "unprognostic (1.44e-2)" "unprognostic (1.65e-1)" "unprognostic (9.52e-2)" "unprognostic (2.91e-3)" "unprognostic (9.01e-2)" "unprognostic (4.84e-3)" "unprognostic (5.56e-3)" "prognostic unfavourable (2.60e-4)" "unprognostic (4.35e-3)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" "prognostic unfavourable (2.12e-4)" 27.7 33.8 123.1 4.4 135.5 0.9 21.5 82.9 203.7 10.7 9.6 31.6 5.3 5.0 13.3 94.3 16.4 15.7 14.0 19.6 116.9 56.3 12.0 6.3 11.0 7.6 56.9 70.7 23.4 35.5 33.9 40.0 2.2 53.0 66.5 8.8 13.2 12.0 20.1 11.0 5.5 6.2 18.5 40.5 2.8 19.2 30.4 53.3 0.9 40.7 4.3 7.7 6.3 9.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.3 9.0 1.7 7.2 0.8 0.4 0.0 3.6 1.3 2.9 0.0 0.0 0.0 2.6 0.0 0.2 3.4 0.7 0.8 0.0 13.2 0.0 3.7 49.9 0.5 0.0 0.0 17.6 3.7 0.0 0.0 0.0 0.0 0.3 1.8 2.5 0.0 0.4 5.7 2.0 0.0 0.0 0.1 0.1 0.5 70.2 23.2 103.0 12.9 0.0 7.7 0.3 0.0 2.8 7.2 0.2 0.2 3.9 0.0 0.3 2.6 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 123.1 135.5 82.9 82.2 116.9 56.3 56.9 70.7 53.0 53.3 CPEB3 KIAA0940 ENSG00000107864 "Cytoplasmic polyadenylation element binding protein 3" Q8NE35 10 92046692-92291087 "Predicted intracellular proteins" "Translation regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4;liver: 39.5" "Cell line enhanced" "Detected in many" "Karpas-707: 15.8;U-266/70: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059056 Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA059056: " "unprognostic (4.90e-2)" "unprognostic (2.12e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-1)" "unprognostic (2.95e-5)" "prognostic favourable (5.06e-5)" "unprognostic (4.09e-4)" "unprognostic (2.73e-1)" "unprognostic (2.40e-1)" "unprognostic (1.47e-2)" "unprognostic (2.42e-2)" "prognostic favourable (3.84e-9)" "unprognostic (3.33e-2)" "unprognostic (7.42e-2)" "unprognostic (1.36e-2)" "unprognostic (1.40e-1)" 3.1 6.1 11.9 3.0 10.9 2.9 5.0 33.4 24.6 4.0 3.8 4.4 5.5 4.8 3.3 6.8 6.0 3.3 3.4 7.0 10.7 11.5 7.0 39.5 3.6 3.0 10.3 15.1 5.8 5.4 6.6 8.6 2.8 16.4 6.5 4.2 3.0 10.2 8.0 23.4 5.3 4.6 3.4 4.6 4.1 4.5 20.5 7.0 0.3 9.3 5.4 3.4 3.3 4.5 1.8 0.9 6.5 1.5 0.5 0.7 0.5 1.1 0.3 0.4 2.6 0.7 0.7 1.1 1.1 0.8 1.6 1.3 0.8 2.6 1.4 1.3 0.5 3.3 1.1 0.9 0.9 1.6 1.4 1.8 1.8 0.9 2.0 0.9 1.9 0.6 2.0 1.0 3.1 1.5 1.3 15.8 0.6 0.9 1.2 1.0 0.2 1.2 1.5 2.3 2.7 1.6 0.5 2.0 0.6 1.0 3.0 1.9 3.8 2.0 1.2 0.8 0.8 0.6 1.0 8.8 2.3 1.5 0.4 3.0 0.2 6.5 1.1 2.2 0.7 1.4 0.5 1.8 0.4 0.7 0.9 0.5 0.4 0.4 1.3 0.5 1.5 0.6 0.3 0.5 11.9 10.9 33.4 24.6 10.7 11.5 10.3 15.1 16.4 7.0 CPLX1 CPX-I ENSG00000168993 "Complexin 1" O14810 4 784957-826198 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 98.8" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles Vesicles "HPA071191: , HPA074390: " "unprognostic (9.21e-3)" "prognostic unfavourable (4.20e-4)" "unprognostic (3.45e-2)" "unprognostic (4.68e-2)" "unprognostic (1.16e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" "unprognostic (2.26e-2)" "unprognostic (9.52e-3)" "unprognostic (2.01e-2)" "prognostic favourable (5.05e-4)" "unprognostic (1.10e-3)" "unprognostic (3.32e-1)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" "unprognostic (1.34e-1)" "unprognostic (7.77e-2)" 7.8 6.5 13.1 2.9 40.7 1.5 2.4 26.3 98.8 2.2 2.5 3.9 0.0 2.8 4.2 1.5 1.6 2.3 1.9 3.0 16.9 7.6 2.4 2.4 2.8 2.4 16.3 18.3 2.4 3.0 3.4 1.7 1.8 52.8 4.4 1.7 3.8 4.4 2.5 4.5 3.0 2.8 2.0 5.4 5.6 3.2 4.9 4.2 0.0 1.8 0.0 1.6 1.7 1.7 0.2 2.3 0.1 0.0 0.0 0.8 0.0 2.7 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 8.0 0.8 2.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.2 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.1 1.1 0.0 1.3 1.3 0.0 0.0 0.7 0.0 0.2 42.0 5.8 0.2 2.7 0.0 4.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 2.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 13.1 40.7 26.3 98.8 16.9 7.6 16.3 18.3 52.8 4.2 CPLX2 "CPX-2, DKFZp547D155" ENSG00000145920 "Complexin 2" Q6PUV4 5 175796310-175884020 "Predicted intracellular proteins" "Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 95.3;epididymis: 80.1" "Group enriched" "Detected in some" 22 "A549: 103.7;Hep G2: 62.5;SCLC-21H: 44.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles Vesicles "HPA071191: , HPA074390: " "unprognostic (1.36e-1)" "unprognostic (1.12e-1)" "unprognostic (2.81e-1)" "unprognostic (8.98e-2)" "unprognostic (1.23e-2)" "unprognostic (5.73e-2)" "unprognostic (5.16e-2)" "unprognostic (2.49e-3)" "unprognostic (6.22e-2)" "unprognostic (1.20e-2)" "unprognostic (2.06e-1)" "unprognostic (1.90e-5)" "unprognostic (6.88e-2)" "unprognostic (2.20e-1)" "unprognostic (7.32e-2)" "unprognostic (6.87e-2)" 1.7 23.3 72.6 2.0 32.7 1.4 1.3 79.0 95.3 1.3 2.6 2.6 0.3 2.7 1.3 80.1 1.4 1.4 1.4 1.3 68.3 16.3 1.4 1.3 2.1 1.3 37.2 26.3 1.3 7.9 1.3 11.3 1.3 17.9 1.4 2.2 0.2 1.3 1.4 1.3 1.4 2.5 1.6 4.0 1.3 5.1 3.1 3.7 0.0 1.4 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 103.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 44.1 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 72.6 32.7 79.0 66.6 68.3 16.3 37.2 26.3 17.9 3.7 CPLX3 CPX-III ENSG00000213578 "Complexin 3" Q8WVH0 15 74826547-74831802 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.8;lymphoid tissue: 31.8;prostate: 56.4;retina: 32.8" "Cell line enhanced" "Detected in some" "Daudi: 5.5;Karpas-707: 4.8;SK-BR-3: 2.7;U-266/84: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" CAB079003 Supported "CAB079003: " 0.4 2.5 6.4 0.5 7.4 0.4 0.4 20.8 19.6 0.5 0.5 3.3 0.0 0.4 0.4 0.5 0.5 0.4 0.4 13.4 6.4 0.8 0.4 0.4 0.4 0.5 0.6 7.9 0.4 0.4 0.4 1.7 0.4 8.2 56.4 0.4 32.8 9.8 0.4 0.4 0.5 0.6 0.4 1.0 31.8 4.6 2.2 1.2 0.0 0.4 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.5 0.0 0.0 0.1 0.2 0.1 0.0 5.5 0.1 0.0 0.2 0.1 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.2 0.2 0.0 0.0 0.0 4.8 0.0 0.1 0.0 0.9 0.1 0.3 0.2 0.0 0.4 0.0 0.1 2.1 0.1 0.0 2.7 1.1 1.6 0.0 0.0 0.1 0.1 0.5 0.0 1.3 3.1 2.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 7.4 20.8 19.6 6.4 0.8 0.6 7.9 8.2 1.2 CPNE2 CPN2 ENSG00000140848 "Copine 2" Q96FN4 16 57092537-57148367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041132 Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA041132: " "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.93e-3)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (2.10e-2)" "unprognostic (9.14e-2)" "unprognostic (2.10e-3)" "unprognostic (8.78e-3)" "unprognostic (2.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.53e-3)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" 14.1 3.9 8.4 4.6 15.1 22.8 11.4 7.9 15.4 16.4 12.0 40.6 1.1 2.0 8.8 3.1 6.4 12.0 5.6 5.9 10.6 11.6 4.8 4.3 15.5 8.2 20.8 9.8 5.1 3.3 3.7 4.9 11.5 12.9 5.1 11.9 4.6 3.7 7.4 4.9 4.0 6.6 10.5 13.5 6.0 3.7 15.3 20.1 0.2 5.8 2.2 3.2 6.4 8.3 0.0 2.1 4.0 4.2 0.5 1.2 0.9 8.2 16.0 24.8 13.7 4.5 4.3 4.1 9.1 14.3 20.8 14.6 4.5 9.7 5.0 8.3 13.7 13.1 9.7 5.4 11.3 6.1 5.7 2.0 6.4 3.7 8.1 1.6 0.2 4.1 6.1 8.1 4.0 30.5 5.5 0.1 5.2 3.8 2.4 24.3 5.6 3.4 31.0 7.8 4.1 13.8 3.2 0.5 10.1 11.5 2.5 6.9 2.7 33.2 21.5 19.0 10.4 4.7 11.7 1.2 1.0 11.1 12.3 7.2 13.3 0.0 4.2 1.9 0.7 1.2 0.7 0.0 0.4 1.2 2.1 0.0 0.3 0.6 4.0 0.5 0.4 0.1 0.5 0.9 8.4 15.1 7.9 15.4 10.6 11.6 20.8 9.8 12.9 20.1 CPNE4 "COPN4, CPN4" ENSG00000196353 "Copine 4" Q96A23 3 131533555-132285410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;prostate: 35.7" "Cell line enhanced" "Detected in some" "A549: 9.7;AF22: 9.1;Karpas-707: 2.7;RT4: 3.1" "Cancer enriched" "Detected in some" 6 "prostate cancer: 22.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 33 "granulocytes: 3.2" "Low region specificity" "Detected in many" "HPA032036, HPA078300" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA032036: AB_10600898, HPA078300: " "unprognostic (7.38e-2)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (1.22e-4)" "unprognostic (2.53e-2)" "unprognostic (1.41e-2)" "unprognostic (8.81e-3)" "unprognostic (3.40e-1)" "unprognostic (2.69e-2)" "unprognostic (1.57e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-2)" "unprognostic (9.10e-3)" "unprognostic (1.18e-2)" "unprognostic (1.76e-2)" "unprognostic (1.35e-1)" "unprognostic (2.51e-1)" 1.4 1.4 7.0 0.8 11.6 0.8 0.7 0.4 27.2 1.0 1.1 2.5 0.7 1.6 0.9 1.6 1.1 1.2 0.7 1.9 17.5 5.3 2.1 0.8 1.2 0.7 1.3 11.8 0.7 0.8 3.8 9.5 0.7 3.1 35.7 1.0 0.1 1.1 6.0 0.6 1.0 1.4 1.2 4.6 1.8 1.4 2.3 3.6 0.0 1.1 0.0 0.7 0.7 1.1 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 9.7 9.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 2.7 1.3 0.6 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.6 3.1 1.3 0.6 0.0 1.2 0.0 0.0 0.0 0.0 1.1 2.3 0.3 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.3 7.0 11.6 0.4 27.2 17.5 5.3 1.3 11.8 3.1 3.6 CPNE5 "COPN5, CPN5, KIAA1599" ENSG00000124772 "Copine 5" Q9HCH3 6 36740775-36840002 "Plasma proteins, Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.1;brain: 50.3;heart muscle: 28.6" "Group enriched" "Detected in some" 4 "Daudi: 32.3;HUVEC TERT2: 13.3;U-266/70: 11.1;U-266/84: 8.9;U-698: 15.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 50.3" "Group enriched" "Detected in some" 82 "memory B-cell: 27.1;naive B-cell: 12.9" "Lineage enriched" "Detected in single" 111 "B-cells: 27.1" "Region enhanced" "Detected in many" "basal ganglia: 100.1" "Region enhanced" "Detected in many" "basal ganglia: 166.9" HPA031369 Enhanced Approved Cytosol Cytosol "HPA031369: AB_10601801" "unprognostic (5.71e-3)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (2.73e-2)" "unprognostic (1.04e-1)" "prognostic favourable (2.87e-5)" "unprognostic (1.07e-1)" "unprognostic (3.07e-2)" "unprognostic (9.57e-2)" "unprognostic (1.21e-3)" "unprognostic (2.45e-1)" "unprognostic (4.10e-2)" "prognostic unfavourable (6.00e-5)" "unprognostic (1.68e-2)" "unprognostic (3.80e-1)" "unprognostic (2.00e-1)" "unprognostic (3.57e-1)" 1.8 1.1 8.1 12.5 50.3 1.1 1.7 1.9 49.4 1.8 4.2 1.3 0.0 3.9 3.7 1.0 1.8 11.3 1.7 28.6 3.7 4.9 1.3 0.5 1.5 14.3 3.6 12.8 2.3 1.0 0.8 3.6 1.3 3.3 2.9 3.6 4.1 2.0 2.2 0.5 1.0 2.9 3.6 3.0 7.1 3.4 11.8 6.2 0.1 1.4 0.0 20.3 5.5 1.9 27.1 0.1 0.2 0.1 0.0 0.1 2.2 0.5 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.1 32.3 0.3 0.4 0.3 0.1 0.2 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 13.3 0.1 0.9 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.5 0.0 0.5 3.0 0.2 0.4 0.0 1.3 11.1 8.9 15.2 0.2 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 27.1 0.1 0.0 0.0 12.9 0.0 0.0 0.2 0.0 0.1 0.1 0.0 2.2 8.1 50.3 1.9 20.4 3.7 4.9 3.6 12.8 3.3 6.2 CPNE6 ENSG00000100884 "Copine 6" O95741 14 24070837-24078100 "Plasma proteins, Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8;seminal vesicle: 20.8" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4;SK-MEL-30: 1.1;U-266/84: 4.1" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031636, HPA076665" Enhanced "HPA031636: AB_10601203, HPA076665: " "unprognostic (1.02e-2)" "unprognostic (3.26e-4)" "unprognostic (1.64e-1)" "unprognostic (5.66e-5)" "unprognostic (3.51e-3)" "unprognostic (2.53e-2)" "unprognostic (2.49e-2)" "unprognostic (1.09e-3)" "unprognostic (1.71e-1)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" "unprognostic (1.01e-2)" "unprognostic (5.79e-2)" "unprognostic (4.50e-2)" "unprognostic (2.71e-1)" 1.3 1.5 36.3 1.4 25.1 1.4 1.1 19.1 41.8 1.2 1.5 8.6 1.2 4.8 1.2 2.6 3.7 1.3 1.2 1.4 34.8 16.0 7.9 4.7 1.2 1.2 11.4 20.5 1.3 1.1 1.1 2.7 1.1 20.1 3.5 1.9 2.4 1.2 20.8 1.1 1.2 5.8 1.6 5.1 1.2 1.2 1.3 5.6 0.0 1.2 0.0 1.1 1.5 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 4.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 36.3 25.1 19.1 33.2 34.8 16.0 11.4 20.5 20.1 5.6 CPNE9 KIAA4217 ENSG00000144550 "Copine family member 9" Q8IYJ1 3 9703807-9729908 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 46.9" "Cell line enhanced" "Detected in some" "Daudi: 5.8;U-937: 5.2" "Cancer enhanced" "Detected in single" "testis cancer: 1.6" "Group enriched" "Detected in all" 4 "cerebellum: 26.6;cerebral cortex: 17.0;pons and medulla: 46.9" "Group enriched" "Detected in some" 7 "classical monocyte: 1.2;intermediate monocyte: 3.5;non-classical monocyte: 2.4;plasmacytoid DC: 1.4" "Group enriched" "Detected in many" 25 "dendritic cells: 1.4;monocytes: 3.5" "Low region specificity" "Detected in many" "unprognostic (2.96e-1)" "unprognostic (4.75e-2)" "unprognostic (1.34e-1)" "unprognostic (5.04e-3)" "unprognostic (1.10e-1)" "unprognostic (1.96e-1)" "unprognostic (2.13e-3)" "unprognostic (1.03e-2)" "unprognostic (3.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.20e-4)" "unprognostic (2.67e-2)" "unprognostic (5.44e-4)" "unprognostic (1.47e-2)" "unprognostic (8.59e-2)" "unprognostic (3.45e-1)" "unprognostic (7.48e-2)" 0.7 1.4 1.7 0.8 3.1 2.8 0.6 26.6 18.2 0.7 0.8 2.3 0.0 1.1 0.7 0.5 0.6 0.6 0.8 0.4 1.9 7.2 0.8 0.6 1.1 1.0 7.0 5.1 0.6 0.5 0.4 3.4 0.7 46.9 0.5 0.8 0.3 0.8 1.0 0.4 4.2 1.1 0.8 2.3 0.9 0.7 3.0 1.4 0.0 0.4 0.0 0.7 0.8 0.1 0.0 1.4 0.0 3.5 0.0 0.0 0.4 0.1 0.9 0.2 0.0 0.8 0.2 0.9 0.3 0.3 0.1 0.0 0.1 0.3 5.8 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.6 0.1 0.0 0.6 0.7 0.9 0.0 0.7 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.6 0.1 0.1 0.0 0.5 0.0 0.7 1.6 1.3 0.1 0.0 0.5 1.9 2.4 0.0 0.0 0.2 0.7 0.1 0.3 1.7 1.1 0.8 5.2 0.4 0.0 1.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.4 1.4 0.0 0.4 1.7 3.1 26.6 17.0 1.9 7.2 7.0 5.1 46.9 1.4 CPOX "CPO, CPX, HCP" ENSG00000080819 "Coproporphyrinogen oxidase" P36551 3 98521132-98593723 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.9" "Cell line enhanced" "Detected in all" "HEL: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015736, HPA054448" Enhanced Mitochondria 140000 Mitochondria "HPA015736: AB_1847194, HPA054448: " "unprognostic (2.14e-1)" "unprognostic (1.04e-1)" "unprognostic (4.07e-2)" "unprognostic (6.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (8.58e-3)" "unprognostic (7.14e-2)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.86e-2)" "prognostic unfavourable (1.04e-5)" "unprognostic (1.62e-1)" "unprognostic (2.67e-2)" "unprognostic (2.15e-2)" "unprognostic (2.57e-1)" 6.6 8.9 12.6 9.0 29.9 30.2 6.6 10.1 21.1 7.5 8.2 29.6 5.7 17.7 8.8 6.4 14.1 6.4 7.2 6.9 17.5 11.7 5.6 29.3 6.3 9.1 42.9 16.2 9.5 6.9 9.9 5.5 14.8 23.7 7.4 10.3 3.4 7.2 7.2 8.5 10.8 12.3 7.7 32.8 9.1 7.7 3.9 36.0 7.7 6.2 7.0 9.8 8.5 10.4 1.7 1.7 0.0 2.1 2.1 3.0 0.7 16.3 7.9 7.0 12.4 13.2 9.8 20.3 10.5 7.6 10.9 12.4 13.1 5.1 1.7 11.9 5.5 11.9 8.7 11.4 18.6 5.2 7.6 56.9 4.5 16.9 6.7 12.0 13.5 7.7 9.6 10.3 4.3 10.3 10.9 7.4 10.2 5.0 12.1 10.3 8.3 14.5 8.6 16.0 7.5 9.2 6.8 4.6 4.6 11.1 3.8 31.6 5.9 7.7 8.6 16.2 15.9 9.2 7.7 11.3 8.9 9.1 16.1 13.2 11.8 0.0 2.1 0.0 1.4 1.0 2.5 1.7 2.4 2.9 1.7 1.5 0.8 3.0 0.0 2.1 0.7 1.1 1.1 0.7 12.6 29.9 10.1 21.1 17.5 11.7 42.9 16.2 23.7 36.0 CPT1C "CPT1P, CPTIC, FLJ23809" ENSG00000169169 "Carnitine palmitoyltransferase 1C" Q8TCG5 19 49690898-49713731 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.0" "Cell line enhanced" "Detected in many" "AF22: 18.4;AN3-CA: 15.5;SH-SY5Y: 33.2;U-87 MG: 13.9" "Cancer enhanced" "Detected in many" "glioma: 9.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014529, HPA063621" Approved Approved Centrosome Centrosome "HPA014529: AB_1847206, HPA063621: " "unprognostic (1.09e-1)" "unprognostic (6.25e-2)" "unprognostic (1.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.73e-1)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.49e-1)" "prognostic favourable (1.84e-4)" "unprognostic (4.36e-1)" "unprognostic (1.92e-10)" "unprognostic (9.44e-4)" "unprognostic (3.35e-2)" "unprognostic (3.91e-1)" "unprognostic (4.72e-3)" 3.4 9.3 11.2 3.1 18.9 0.8 1.1 16.3 34.0 4.1 1.9 8.9 0.2 2.7 6.4 5.3 1.8 4.1 7.6 2.8 11.9 12.8 1.6 1.6 2.5 2.6 8.0 13.4 3.8 1.2 0.7 15.6 1.9 11.4 2.8 1.7 7.4 1.5 4.8 1.7 1.5 2.4 7.8 6.6 4.2 1.4 4.1 6.3 0.0 1.7 0.2 1.7 4.4 1.9 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 18.4 15.5 6.7 5.2 0.0 5.8 11.7 7.5 10.6 0.3 0.0 0.3 0.0 5.8 1.3 0.0 0.0 4.0 0.2 0.0 0.0 0.0 0.0 10.8 0.0 0.0 6.1 0.0 6.1 0.0 10.4 0.0 0.0 0.4 0.3 0.1 0.0 0.8 3.8 0.0 0.0 0.0 0.4 0.0 12.9 33.2 0.0 0.0 0.0 0.0 0.0 8.4 0.3 0.1 3.5 2.9 0.1 1.3 0.1 13.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 11.2 18.9 16.3 23.4 11.9 12.8 8.0 13.4 11.4 6.3 CR1L ENSG00000197721 "Complement C3b/C4b receptor 1 like" Q2VPA4 1 207645113-207738416 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.1;brain: 4.3" "Group enriched" "Detected in some" 8 "HEL: 3.0;HMC-1: 7.6;K-562: 3.7" "Cancer enhanced" "Detected in some" "testis cancer: 1.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA049348 Approved "Intracellular and membrane" "HPA049348: " "unprognostic (2.35e-2)" "unprognostic (8.27e-2)" "unprognostic (1.99e-1)" "unprognostic (8.89e-2)" "unprognostic (1.31e-2)" "unprognostic (5.50e-2)" "unprognostic (2.01e-1)" "unprognostic (7.45e-2)" "unprognostic (5.27e-2)" "unprognostic (8.21e-3)" "unprognostic (7.94e-2)" "unprognostic (3.02e-1)" "unprognostic (6.33e-2)" "unprognostic (2.02e-1)" "unprognostic (8.90e-2)" "unprognostic (1.31e-2)" "unprognostic (9.68e-2)" 0.4 0.3 0.2 1.3 2.5 6.1 0.2 0.2 4.0 0.7 0.3 0.9 0.9 0.1 0.2 0.1 0.2 1.3 0.1 0.2 0.8 0.2 3.2 0.8 2.8 1.3 1.0 1.7 0.9 0.2 0.1 0.2 2.6 1.1 0.3 0.2 0.0 0.9 1.0 0.2 0.2 0.6 0.1 4.3 1.0 0.2 0.2 3.3 0.0 0.3 0.0 0.8 0.2 0.2 0.4 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.2 4.0 0.8 0.2 1.0 1.7 1.1 3.3 CRABP1 "CRABP, CRABP-I, CRABPI, RBP5" ENSG00000166426 "Cellular retinoic acid binding protein 1" P29762 15 78340324-78348230 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.1;retina: 73.2;thyroid gland: 80.6" "Group enriched" "Detected in some" 8 "AF22: 143.3;NTERA-2: 42.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 117.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "myeloid DC: 1.2" "Lineage enriched" "Detected in single" 13 "dendritic cells: 1.2" "Group enriched" "Detected in many" 5 "amygdala: 6.6;basal ganglia: 20.9;hypothalamus: 15.5;olfactory region: 15.7;pons and medulla: 7.8" "Low region specificity" "Detected in some" HPA017203 Enhanced Supported "HPA017203: AB_1846512" "unprognostic (1.23e-1)" "unprognostic (3.76e-3)" "unprognostic (1.46e-1)" "prognostic unfavourable (4.72e-4)" "unprognostic (2.01e-1)" "unprognostic (4.35e-2)" "unprognostic (1.05e-1)" "unprognostic (1.35e-1)" "unprognostic (2.45e-2)" "unprognostic (9.79e-2)" "unprognostic (1.21e-1)" "unprognostic (2.79e-2)" "unprognostic (9.37e-2)" "unprognostic (2.17e-1)" "unprognostic (1.07e-1)" "unprognostic (2.69e-1)" 0.7 1.3 6.3 1.8 25.6 0.6 24.8 2.8 12.4 1.2 1.9 3.3 0.3 0.9 1.5 1.9 0.7 0.5 1.2 0.7 1.1 21.9 4.2 0.5 0.8 0.6 16.9 4.5 0.7 0.7 0.5 6.3 7.0 40.1 1.0 1.3 73.2 0.6 24.8 0.5 12.3 2.3 1.3 7.3 21.1 1.9 0.6 2.4 0.4 80.6 2.4 1.0 0.7 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.1 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 7.6 0.0 42.9 0.1 0.0 0.0 0.0 0.0 0.2 12.0 8.1 0.0 0.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 25.6 2.8 12.4 1.1 21.9 16.9 4.5 40.1 2.4 CRB1 "LCA8, RP12" ENSG00000134376 "Crumbs 1, cell polarity complex component" P82279 1 197268204-197478455 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Cell line enriched" "Detected in some" 8 "HeLa: 17.1" "Cancer enriched" "Detected in single" 12 "glioma: 2.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "basophil: 9.4" "Lineage enriched" "Detected in single" 22 "granulocytes: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA061250, HPA063127" Approved Uncertain Vesicles "Intracellular and membrane" Vesicles "HPA061250: , HPA063127: " "unprognostic (1.96e-1)" "unprognostic (5.38e-3)" "unprognostic (2.92e-3)" "unprognostic (1.50e-2)" "unprognostic (5.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.38e-1)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (1.48e-3)" "unprognostic (2.59e-1)" "unprognostic (2.01e-3)" "unprognostic (1.78e-3)" "unprognostic (1.56e-1)" "unprognostic (3.36e-2)" "unprognostic (2.96e-1)" 1.1 1.1 11.9 0.9 11.0 1.8 1.2 31.4 20.4 0.9 0.9 10.4 0.0 0.9 0.8 1.2 1.1 2.0 1.0 1.2 11.4 6.2 1.1 0.9 1.0 1.0 4.0 8.9 2.6 1.7 0.7 1.9 0.9 14.1 1.0 0.9 9.0 0.8 0.9 2.4 0.9 0.9 0.8 8.7 0.9 1.5 7.3 9.6 0.0 1.3 0.0 0.8 0.9 0.1 0.1 0.0 9.4 0.0 0.1 0.4 0.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 17.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.3 0.1 0.0 0.0 0.0 0.0 11.9 11.0 31.4 10.5 11.4 6.2 4.0 8.9 14.1 9.6 CRB2 "FLJ16786, FLJ38464" ENSG00000148204 "Crumbs 2, cell polarity complex component" Q5IJ48 9 123356170-123380324 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Gastrulation "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Cell line enriched" "Detected in some" 7 "AF22: 26.8" "Group enriched" "Detected in some" 7 "glioma: 9.4;ovarian cancer: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA043674 Approved Supported "Intracellular and membrane" 240000 "HPA043674: AB_10962974" "unprognostic (1.38e-2)" "unprognostic (2.39e-2)" "unprognostic (1.26e-1)" "unprognostic (2.83e-4)" "unprognostic (2.85e-2)" "unprognostic (1.14e-2)" "unprognostic (2.31e-1)" "unprognostic (3.69e-4)" "unprognostic (1.20e-1)" "unprognostic (7.28e-3)" "unprognostic (4.66e-3)" "unprognostic (3.09e-1)" "unprognostic (5.56e-5)" "unprognostic (1.31e-1)" "unprognostic (1.55e-1)" "unprognostic (4.38e-2)" "unprognostic (3.38e-1)" 1.3 0.6 6.8 1.9 8.7 1.3 1.0 3.0 16.2 0.5 2.4 21.5 0.0 0.9 2.4 0.9 0.7 3.4 0.5 0.6 9.7 3.7 5.7 0.5 0.6 2.4 7.3 17.4 0.9 0.5 0.5 1.3 0.7 7.4 0.6 1.7 5.1 0.6 0.6 0.5 1.0 1.0 1.3 9.5 1.8 1.1 1.1 7.7 0.0 0.6 0.0 2.3 0.7 0.2 0.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 26.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.0 0.0 3.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 6.8 8.7 3.0 8.2 9.7 3.7 7.3 17.4 7.4 7.7 CREB5 "CRE-BPA, H_GS165L15.1" ENSG00000146592 "CAMP responsive element binding protein 5" Q02930 7 28299321-28825894 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.3;brain: 38.0" "Cell line enhanced" "Detected in many" "HL-60: 31.6;Karpas-707: 13.2;U-2 OS: 13.9;U-2197: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 53.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 53.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050020, HPA061622" Approved "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Plasma membrane" Vesicles "HPA050020: , HPA061622: " "unprognostic (3.59e-2)" "unprognostic (3.80e-1)" "unprognostic (1.06e-1)" "unprognostic (6.46e-2)" "unprognostic (1.01e-1)" "unprognostic (4.90e-3)" "unprognostic (2.01e-3)" "unprognostic (2.87e-1)" "unprognostic (3.31e-1)" "unprognostic (1.04e-1)" "unprognostic (3.49e-1)" "unprognostic (2.67e-1)" "unprognostic (4.91e-3)" "unprognostic (6.61e-2)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" 20.0 3.6 12.1 15.4 19.5 11.5 9.0 10.4 17.8 4.6 5.6 38.0 0.9 2.8 16.3 6.9 7.7 4.7 23.1 10.4 16.7 8.7 6.6 4.6 9.5 6.1 17.9 12.1 2.4 7.0 1.5 2.8 19.5 18.3 3.1 4.3 1.1 6.5 3.0 6.2 5.5 4.2 9.8 14.6 12.6 3.2 2.3 22.7 0.0 3.8 7.0 2.5 5.5 5.0 0.3 4.8 53.3 7.8 0.0 0.0 1.5 0.0 0.3 3.9 0.2 0.2 5.6 0.1 0.3 0.8 2.3 3.5 2.2 1.4 9.7 0.7 0.9 0.4 0.1 3.3 7.4 0.0 2.6 10.5 2.0 0.2 0.2 31.6 0.4 0.7 0.7 10.0 10.8 1.5 1.2 13.2 0.8 0.0 0.0 0.0 4.8 3.9 0.2 3.6 0.2 4.8 1.0 0.4 2.8 0.1 0.2 1.1 0.1 0.7 0.4 4.6 13.9 15.2 4.4 0.8 2.2 0.1 5.1 0.2 7.8 0.0 7.8 0.0 0.0 2.7 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.0 53.3 0.0 0.8 0.0 0.0 1.5 12.1 19.5 10.4 15.6 16.7 8.7 17.9 12.1 18.3 22.7 CREG2 ENSG00000175874 "Cellular repressor of E1A stimulated genes 2" Q8IUH2 2 101345551-101387595 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 56.0" "Cell line enhanced" "Detected in some" "CACO-2: 4.1;CAPAN-2: 2.4;HaCaT: 10.7;HeLa: 4.1;PC-3: 4.3;RT4: 2.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "T-reg: 2.6" "Lineage enriched" "Detected in single" 5 "T-cells: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038224 Enhanced "Secreted in brain" "HPA038224: AB_10673167" "unprognostic (5.09e-2)" "unprognostic (3.78e-3)" "unprognostic (4.10e-3)" "unprognostic (8.15e-3)" "unprognostic (5.63e-3)" "unprognostic (9.68e-3)" "unprognostic (4.52e-8)" "unprognostic (3.86e-4)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (1.90e-2)" "unprognostic (7.69e-2)" "unprognostic (5.41e-3)" "unprognostic (4.44e-2)" "unprognostic (2.91e-1)" "unprognostic (8.26e-3)" "unprognostic (7.77e-2)" 0.8 0.9 12.6 0.8 13.8 0.9 0.8 0.2 56.0 0.9 0.8 1.0 0.0 0.9 0.8 0.8 0.8 1.1 0.9 0.9 17.2 4.4 0.9 0.8 0.8 0.8 3.3 16.6 0.9 0.8 0.8 0.2 0.9 7.2 0.8 0.9 0.0 0.8 0.8 0.8 0.8 0.9 0.8 1.2 0.8 0.8 0.9 0.5 0.0 0.8 0.0 0.8 0.8 0.6 0.2 0.3 0.5 0.0 0.0 2.6 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 2.4 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.6 0.2 0.0 0.4 0.1 0.0 0.0 0.1 0.1 4.3 0.0 0.0 0.0 0.0 2.9 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.3 2.6 0.0 12.6 13.8 0.2 29.7 17.2 4.4 3.3 16.6 7.2 0.5 CRHBP "CRF-BP, CRFBP" ENSG00000145708 "Corticotropin releasing hormone binding protein" P24387 5 76952713-76981158 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9;liver: 99.9" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 4.9;BJ hTERT+ SV40 Large T+ RasG12V: 4.8;HBF TERT88: 8.7;U-698: 9.5;U-87 MG: 5.2;WM-115: 4.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Region enhanced" "Detected in many" "hypothalamus: 24.9" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036234, HPA046120" Approved Supported "Secreted to blood" 43000000 "HPA036234: , HPA046120: AB_10959760" "unprognostic (1.41e-1)" "unprognostic (2.00e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.18e-1)" "unprognostic (1.65e-1)" "unprognostic (2.36e-3)" "unprognostic (4.44e-5)" "unprognostic (2.16e-1)" "unprognostic (7.08e-2)" "unprognostic (4.98e-4)" "unprognostic (1.09e-1)" "unprognostic (6.63e-5)" "unprognostic (2.76e-2)" "unprognostic (4.64e-1)" "unprognostic (1.74e-1)" "unprognostic (2.95e-2)" 8.4 5.6 3.5 0.4 5.4 1.2 2.6 0.0 7.8 1.6 0.3 3.2 1.8 0.4 1.2 0.7 0.2 0.9 0.5 3.2 4.0 24.9 16.1 99.9 0.3 0.4 2.7 5.4 0.8 0.2 0.4 0.0 18.1 1.8 0.6 0.3 1.5 0.6 1.9 0.5 0.2 0.3 0.8 2.2 13.9 0.3 0.5 1.2 0.0 1.9 0.9 0.4 0.5 0.2 0.0 0.0 1.2 0.1 0.0 0.2 0.8 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.1 4.9 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.0 0.0 0.0 9.5 5.2 0.0 4.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 3.5 5.4 0.0 7.8 4.0 24.9 2.7 5.4 1.8 1.2 CRHR1 "CRF-R, CRF1, CRHR" ENSG00000120088 "Corticotropin releasing hormone receptor 1" P34998 17 45784280-45835828 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 23.2;pituitary gland: 16.5" "Group enriched" "Detected in some" 4 "RT4: 7.9;SH-SY5Y: 4.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" CAB025251 Enhanced "Intracellular and membrane" "CAB025251: " "unprognostic (4.59e-2)" "unprognostic (1.43e-2)" "unprognostic (2.59e-7)" "unprognostic (1.76e-1)" "unprognostic (2.71e-1)" "unprognostic (3.94e-2)" "unprognostic (2.48e-1)" "unprognostic (4.55e-4)" "unprognostic (1.65e-2)" "unprognostic (2.21e-1)" "unprognostic (3.33e-4)" "unprognostic (2.07e-5)" "unprognostic (3.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" 0.8 0.6 14.7 0.5 5.1 0.5 1.5 23.2 11.5 1.4 0.6 1.1 0.0 0.8 2.7 1.1 0.5 1.6 0.7 0.5 3.2 2.2 0.6 0.5 0.6 0.5 1.8 5.2 0.6 0.5 0.6 16.5 0.6 2.9 1.3 0.6 1.9 1.2 2.5 0.6 1.4 1.0 1.2 1.0 0.5 0.5 1.0 2.8 0.0 0.9 0.0 0.5 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.6 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 5.1 23.2 11.5 3.2 2.2 1.8 5.2 2.9 2.8 CRHR2 "CRF-RB, CRF2, HM-CRF" ENSG00000106113 "Corticotropin releasing hormone receptor 2" Q13324 7 30651943-30700129 "G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;HeLa: 1.8;NTERA-2: 2.9;SCLC-21H: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" "unprognostic (7.14e-2)" "unprognostic (4.20e-1)" "unprognostic (1.68e-1)" "unprognostic (1.24e-3)" "unprognostic (5.69e-2)" "unprognostic (8.58e-2)" "unprognostic (6.00e-2)" "unprognostic (1.86e-4)" "unprognostic (2.01e-1)" "unprognostic (3.07e-1)" "unprognostic (5.90e-4)" "unprognostic (4.02e-2)" "unprognostic (8.29e-4)" "unprognostic (3.73e-3)" "unprognostic (2.84e-3)" "unprognostic (1.81e-1)" "unprognostic (3.84e-1)" 1.4 0.7 0.9 0.5 4.1 0.4 1.6 0.5 11.7 0.8 0.6 0.0 3.6 2.1 1.1 0.5 1.7 2.1 1.0 3.2 4.3 3.2 0.8 0.4 0.6 0.6 0.9 3.2 1.0 3.9 0.9 8.0 0.4 3.1 0.9 0.9 1.7 0.7 6.2 5.5 0.8 1.2 1.1 0.8 0.3 1.0 1.8 1.0 0.0 1.7 3.2 0.6 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 1.3 0.0 1.8 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.2 2.9 0.4 0.0 0.0 0.6 0.0 0.9 1.6 0.1 0.2 0.0 0.2 0.1 0.0 0.5 0.4 1.0 0.3 0.2 0.8 0.3 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.1 0.5 11.7 4.3 3.2 0.9 3.2 3.1 1.0 CRISPLD1 "Cocoacrisp, DKFZp762F133, LCRISP1" ENSG00000121005 "Cysteine rich secretory protein LCCL domain containing 1" Q9H336 8 74984515-75034558 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4" "Group enriched" "Detected in some" 5 "AF22: 51.1;SH-SY5Y: 27.6" "Cancer enhanced" "Detected in many" "glioma: 30.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 32 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 32 "dendritic cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024725 Uncertain "Secreted - unknown location" "HPA024725: AB_1847238" "unprognostic (2.16e-1)" "unprognostic (5.88e-2)" "unprognostic (4.01e-2)" "unprognostic (3.78e-2)" "unprognostic (3.85e-2)" "unprognostic (1.65e-1)" "unprognostic (2.09e-4)" "unprognostic (6.81e-2)" "unprognostic (1.58e-2)" "unprognostic (5.96e-2)" "unprognostic (2.35e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (7.39e-3)" "unprognostic (2.38e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" 3.2 1.0 5.3 1.7 24.7 1.0 22.4 0.7 8.2 5.4 3.8 15.9 0.0 0.5 7.1 4.0 4.0 5.9 7.8 8.4 10.2 6.4 1.6 1.6 2.2 1.8 7.8 4.7 4.7 1.8 12.1 1.9 5.7 34.4 20.0 1.2 3.1 15.1 2.2 0.7 3.2 1.7 5.4 29.6 1.4 1.7 3.2 9.3 6.0 12.9 1.6 1.1 2.4 1.9 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 51.1 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.7 0.3 0.0 0.0 7.3 0.0 0.0 4.2 0.0 0.0 0.0 1.9 0.0 1.9 0.0 1.1 0.0 0.4 2.8 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 5.2 1.8 0.0 7.0 0.0 0.0 0.0 0.3 27.6 0.0 0.0 2.9 3.9 2.3 0.0 1.4 7.7 0.0 0.2 0.9 0.3 0.0 1.7 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 5.3 24.7 0.7 8.2 10.2 6.4 7.8 4.7 34.4 9.3 CRMP1 "DPYSL1, DRP-1" ENSG00000072832 "Collapsin response mediator protein 1" Q14194 4 5748084-5893058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.1;pituitary gland: 23.0" "Cell line enhanced" "Detected in some" "AF22: 20.4;HAP1: 29.2;NTERA-2: 21.2;REH: 55.5;RH-30: 32.7;SCLC-21H: 42.4;SH-SY5Y: 26.8" "Cancer enhanced" "Detected in all" "glioma: 37.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "naive B-cell: 2.5" "Lineage enriched" "Detected in single" 25 "B-cells: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035640, CAB037313" Approved Supported Centrosome,Cytosol Centrosome Cytosol "CAB037313: AB_1078571, HPA035640: AB_10670838" "unprognostic (1.56e-1)" "unprognostic (7.22e-2)" "unprognostic (5.14e-2)" "unprognostic (8.08e-3)" "unprognostic (2.80e-1)" "unprognostic (2.22e-1)" "unprognostic (1.84e-2)" "unprognostic (1.20e-1)" "unprognostic (2.79e-1)" "unprognostic (9.71e-2)" "prognostic favourable (4.54e-4)" "unprognostic (2.26e-1)" "unprognostic (8.52e-3)" "unprognostic (1.21e-2)" "unprognostic (2.95e-2)" "unprognostic (1.68e-1)" "unprognostic (1.60e-3)" 1.8 8.2 24.2 2.5 21.7 0.7 1.0 32.0 63.1 3.3 2.0 5.9 0.1 1.5 11.7 0.7 2.7 4.3 4.3 2.6 22.2 23.9 2.4 0.9 4.2 1.8 9.9 18.1 6.9 4.8 0.9 23.0 4.6 12.3 3.0 1.9 4.6 2.6 3.1 1.0 3.3 2.5 11.6 4.7 1.4 3.5 2.8 4.5 0.0 2.4 0.9 1.3 2.9 1.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 20.4 0.7 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.4 29.2 0.0 0.0 0.5 0.2 0.0 1.0 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 21.2 0.6 55.5 32.7 4.9 0.0 0.0 42.4 26.8 0.0 0.1 0.3 0.2 0.0 1.7 1.0 7.1 0.6 0.6 3.7 0.5 0.0 2.5 0.2 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 21.7 32.0 34.2 22.2 23.9 9.9 18.1 12.3 4.5 CROCC2 ENSG00000226321 "Ciliary rootlet coiled-coil, rootletin family member 2" H7BZ55 2 240906330-240993311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;epididymis: 19.4;fallopian tube: 14.9" "Cell line enhanced" "Detected in some" "HDLM-2: 2.2;Hep G2: 1.2;HSkMC: 2.8;RPMI-8226: 7.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.5" "Group enriched" "Detected in many" 4 "basal ganglia: 5.0;hippocampal formation: 4.2;pons and medulla: 9.5" "Group enriched" "Detected in some" 18 "intermediate monocyte: 1.1;non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 26 "monocytes: 3.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA048678 Enhanced "HPA048678: " "unprognostic (4.33e-1)" "unprognostic (2.90e-1)" "unprognostic (2.24e-2)" "unprognostic (1.68e-3)" "unprognostic (7.92e-2)" "unprognostic (1.75e-4)" "unprognostic (2.84e-3)" "unprognostic (3.10e-2)" "unprognostic (8.28e-2)" "unprognostic (3.45e-2)" "unprognostic (6.56e-3)" "unprognostic (2.28e-2)" "unprognostic (1.15e-2)" "unprognostic (1.55e-1)" "unprognostic (6.05e-2)" "unprognostic (9.90e-3)" "unprognostic (7.19e-2)" 0.2 0.1 0.6 0.3 5.0 0.2 0.0 0.0 0.1 2.4 0.1 3.8 0.0 0.5 0.4 19.4 0.0 14.9 0.1 0.0 4.2 1.4 0.1 0.5 2.3 1.4 0.0 0.0 3.2 0.1 0.0 2.1 0.1 9.5 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.8 0.1 0.0 4.7 0.3 0.4 0.5 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.6 5.0 0.0 0.1 4.2 1.4 0.0 0.0 9.5 0.5 CRTAM CD355 ENSG00000109943 "Cytotoxic and regulatory T cell molecule" O95727 11 122838500-122872639 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 140.8" "Cell line enriched" "Detected in single" 34 "SCLC-21H: 17.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 24 "cerebellum: 140.8" "Cell type enhanced" "Detected in many" "NK-cell: 25.7" "Group enriched" "Detected in many" 5 "NK-cells: 25.7;T-cells: 16.7" "Region enriched" "Detected in single" 44 "cerebellum: 115.2" "Low region specificity" "Detected in all" 3200000 "unprognostic (3.51e-3)" "unprognostic (6.73e-4)" "unprognostic (1.33e-2)" "unprognostic (3.73e-3)" "unprognostic (2.40e-2)" "unprognostic (5.25e-4)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (5.27e-2)" "unprognostic (1.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.32e-1)" "unprognostic (1.83e-4)" "unprognostic (6.01e-2)" "unprognostic (4.26e-2)" "unprognostic (3.87e-2)" "unprognostic (6.59e-2)" 0.4 0.3 0.3 2.7 0.4 1.9 0.4 140.8 0.4 0.3 0.4 0.2 0.1 0.4 0.8 0.4 0.3 0.3 1.8 0.3 0.3 0.3 0.3 1.0 2.2 10.6 0.4 0.1 0.3 0.3 0.0 0.3 0.2 5.8 0.3 0.5 0.3 0.7 0.1 0.3 0.3 1.3 0.2 1.2 4.4 0.7 0.3 0.1 3.3 0.3 0.2 4.3 1.1 0.3 0.1 1.7 0.6 4.4 25.7 16.7 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.2 0.2 6.7 2.7 6.5 0.0 0.7 13.5 1.7 0.1 2.2 16.7 0.6 25.7 4.4 0.1 0.0 2.8 0.3 0.4 140.8 0.4 0.3 0.3 0.4 0.1 5.8 0.1 CRTC1 "FLJ14027, KIAA0616, MECT1, TORC1" ENSG00000105662 "CREB regulated transcription coactivator 1" Q6UUV9 19 18683677-18782333 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022035 Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" "Nucleoplasm, Nuclear bodies" "Plasma membrane, Cytosol" "HPA022035: AB_1847255" "unprognostic (5.95e-3)" "unprognostic (2.57e-1)" "unprognostic (9.94e-2)" "unprognostic (8.62e-3)" "unprognostic (9.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.04e-1)" "unprognostic (5.57e-2)" "unprognostic (2.27e-1)" "unprognostic (6.68e-2)" "prognostic favourable (1.80e-5)" "unprognostic (3.37e-2)" "prognostic favourable (3.83e-5)" "unprognostic (6.83e-3)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" "unprognostic (2.03e-2)" 8.6 7.7 26.0 7.4 38.8 3.2 3.8 40.7 30.1 5.0 4.4 6.5 4.3 6.5 6.8 5.6 3.1 10.5 5.5 5.6 17.7 7.8 6.6 4.5 5.7 6.3 6.4 18.1 6.7 10.0 8.4 11.3 6.4 6.0 7.0 2.6 5.1 8.8 9.4 12.4 5.5 6.2 4.3 4.8 8.1 8.0 7.5 10.2 1.9 7.4 1.1 3.7 4.6 3.5 4.1 3.8 1.8 3.4 1.1 3.0 1.3 4.3 8.0 5.8 9.3 5.4 4.6 16.5 4.8 3.2 4.6 4.5 5.4 5.7 6.1 10.2 4.6 4.7 1.7 3.0 1.1 2.7 13.9 5.1 7.1 8.8 5.2 7.0 14.5 7.4 2.9 4.0 1.2 2.6 4.0 5.6 2.6 16.0 4.5 8.1 7.5 11.8 7.2 2.5 6.7 2.9 7.8 10.7 9.6 5.4 5.2 5.8 5.8 4.3 4.6 5.3 8.1 9.6 5.5 3.8 3.0 4.0 6.1 7.6 4.0 1.5 3.4 1.8 1.7 1.3 1.8 2.3 2.7 3.0 3.0 4.1 2.3 1.8 1.7 1.1 1.9 3.8 1.8 1.3 26.0 38.8 40.7 30.1 17.7 7.8 6.4 18.1 6.0 10.2 CRYBA1 CRYB1 ENSG00000108255 "Crystallin beta A1" P05813 17 29246863-29254494 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.4;bone marrow: 1.4;brain: 2.8;lymphoid tissue: 1.5" "Group enriched" "Detected in some" 8 "AF22: 6.7;BEWO: 8.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebral cortex: 2.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA022016 Supported "HPA022016: " "unprognostic (2.89e-2)" "unprognostic (1.57e-1)" "unprognostic (8.75e-2)" "unprognostic (1.37e-1)" "unprognostic (9.62e-2)" "unprognostic (4.27e-3)" "unprognostic (2.08e-1)" "unprognostic (5.60e-2)" "unprognostic (2.52e-2)" "unprognostic (9.90e-2)" "unprognostic (5.85e-3)" "unprognostic (2.83e-1)" "unprognostic (2.09e-6)" "unprognostic (1.18e-1)" "unprognostic (1.86e-2)" "unprognostic (4.31e-2)" "unprognostic (6.84e-3)" 0.0 0.0 0.2 1.5 0.3 1.4 0.0 0.0 2.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.4 0.6 0.0 0.0 0.0 1.3 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.4 1.4 0.0 0.7 0.1 0.0 0.0 6.7 0.1 0.0 0.0 8.7 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.3 1.4 0.4 0.4 0.7 0.1 0.8 1.0 0.3 0.1 0.4 0.0 0.0 0.4 0.0 0.1 0.2 0.3 0.0 2.8 0.2 0.2 0.5 0.0 0.0 0.0 CRYGA "CRY-g-A, CRYG1, CRYG5" ENSG00000168582 "Crystallin gamma A" P11844 2 208160740-208163576 "Predicted intracellular proteins" "Eye lens protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.8" "Cell line enriched" "Detected in single" 5 "U-138 MG: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043386 Supported "HPA043386: " "unprognostic (1.49e-1)" 0.1 0.0 1.0 0.1 1.8 0.0 0.1 0.1 1.5 0.1 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.0 0.1 0.1 0.9 1.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 0.1 1.5 0.9 1.1 0.3 0.1 0.1 0.1 CRYGS CRYG8 ENSG00000213139 "Crystallin gamma S" P22914 3 186538441-186546702 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 15.1;cervix, uterine: 21.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035103, HPA063539" Supported Uncertain Cytosol Cytosol "HPA035103: AB_10696367, HPA063539: " "unprognostic (5.52e-4)" "unprognostic (1.29e-3)" "unprognostic (1.44e-2)" "unprognostic (5.45e-2)" "unprognostic (4.90e-2)" "unprognostic (5.85e-2)" "unprognostic (4.79e-2)" "unprognostic (1.73e-2)" "unprognostic (4.76e-2)" "unprognostic (1.12e-1)" "unprognostic (5.84e-3)" "unprognostic (1.51e-1)" "prognostic unfavourable (3.72e-9)" "unprognostic (1.10e-1)" "unprognostic (9.53e-2)" "unprognostic (3.67e-1)" "prognostic favourable (2.73e-4)" 1.6 1.9 3.6 1.8 2.7 4.0 3.4 15.1 3.3 21.8 1.8 3.5 1.6 1.7 2.7 3.8 1.6 1.3 1.6 1.6 4.1 4.1 2.2 1.8 2.6 4.2 4.2 1.6 2.2 1.8 1.9 1.6 1.6 3.0 1.6 3.7 5.8 1.8 2.9 1.6 3.0 1.8 2.3 3.2 3.6 2.4 1.8 1.6 6.0 1.6 3.2 3.3 1.6 1.6 0.3 0.6 0.2 0.2 0.0 2.1 0.1 1.0 2.0 3.7 3.1 3.6 5.6 0.5 0.5 1.2 1.3 2.5 0.4 1.5 3.8 4.1 2.7 3.2 1.7 2.8 5.5 3.2 4.9 5.0 1.4 1.9 1.4 2.9 3.4 5.9 3.8 1.2 2.1 4.2 1.0 2.2 3.0 1.2 2.6 1.5 0.2 1.6 4.3 0.8 1.8 1.5 2.3 1.7 1.6 2.6 2.5 1.0 2.0 1.7 4.5 1.4 1.1 1.6 2.7 4.6 2.3 5.3 1.9 1.9 2.7 0.0 0.2 0.0 1.4 0.0 2.1 0.3 1.9 0.8 0.4 0.1 0.2 0.4 0.2 0.0 0.0 0.6 0.2 0.1 3.6 2.7 15.1 3.3 4.1 4.1 4.2 1.6 3.0 1.6 CRYM DFNA40 ENSG00000103316 "Crystallin mu" Q14894 16 21238874-21303083 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.7;brain: 61.3;heart muscle: 45.9" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 30.5" "Cancer enhanced" "Detected in many" "prostate cancer: 14.6" "Region enhanced" "Detected in many" "basal ganglia: 61.3" "Cell type enriched" "Detected in single" 26 "plasmacytoid DC: 23.7" "Lineage enriched" "Detected in single" 26 "dendritic cells: 23.7" "Group enriched" "Detected in many" 12 "amygdala: 129.0;basal ganglia: 245.8;cerebral cortex: 127.4;hippocampal formation: 355.0" "Low region specificity" "Detected in all" "HPA019086, HPA030619" Enhanced Supported Cytosol 110000 Cytosol "HPA019086: AB_1847260, HPA030619: AB_2673551" "unprognostic (1.32e-1)" "unprognostic (2.93e-3)" "unprognostic (8.96e-2)" "unprognostic (1.44e-1)" "unprognostic (2.13e-1)" "unprognostic (4.62e-2)" "unprognostic (2.88e-1)" "unprognostic (5.75e-3)" "unprognostic (2.81e-1)" "unprognostic (7.37e-2)" "unprognostic (2.05e-2)" "unprognostic (5.95e-2)" "unprognostic (2.11e-3)" "unprognostic (7.79e-3)" "unprognostic (2.49e-2)" "unprognostic (1.87e-3)" "unprognostic (1.31e-1)" 1.4 0.5 7.6 0.5 61.3 0.5 1.0 15.6 21.2 1.8 2.2 0.0 0.0 0.7 0.8 0.3 2.3 0.5 2.3 45.9 6.5 2.1 17.8 4.2 2.7 0.5 1.0 15.5 0.5 0.8 0.6 3.3 0.3 0.1 10.5 2.6 1.0 4.8 0.3 4.0 1.4 1.0 2.0 0.9 0.5 0.6 1.6 1.2 0.0 0.5 0.0 1.5 8.3 0.8 0.9 23.7 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 1.6 0.0 0.0 0.0 0.4 7.0 0.0 0.7 0.0 0.0 0.7 0.2 0.0 0.3 0.5 0.0 0.0 0.1 0.2 0.1 0.0 0.3 3.2 0.0 0.0 0.0 0.2 30.5 0.0 1.2 1.7 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.2 2.6 0.0 0.0 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.3 7.6 61.3 15.6 20.7 6.5 2.1 1.0 15.5 0.1 1.2 CSAG1 "CSAGE, CT24.1" ENSG00000198930 "Chondrosarcoma associated gene 1" Q6PB30 X 152727484-152733735 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.2;lymphoid tissue: 3.3;testis: 6.3" "Cell line enhanced" "Detected in some" "HMC-1: 25.7;K-562: 16.4;PC-3: 23.3;SH-SY5Y: 14.5;U-266/70: 40.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.37e-1)" "unprognostic (4.66e-2)" "unprognostic (8.96e-3)" "unprognostic (4.48e-2)" "unprognostic (2.70e-1)" "unprognostic (2.83e-3)" "unprognostic (5.96e-2)" "unprognostic (4.21e-1)" "unprognostic (6.68e-3)" "unprognostic (3.15e-2)" "unprognostic (1.13e-1)" "unprognostic (4.07e-6)" "unprognostic (5.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-3)" "unprognostic (8.70e-3)" 0.2 0.2 3.3 1.1 4.2 0.2 0.2 1.6 4.1 0.2 0.3 1.5 0.0 0.2 0.8 0.2 0.2 0.4 0.2 0.2 3.2 1.8 0.3 0.4 0.3 3.3 3.0 0.9 0.2 0.2 0.2 0.0 0.3 2.0 0.4 0.3 0.0 0.5 0.5 0.2 0.5 0.6 0.7 1.3 0.5 0.4 6.3 2.7 0.1 0.9 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 1.2 0.0 0.0 0.0 25.7 0.0 0.1 0.0 0.0 0.0 16.4 0.2 0.0 0.0 0.1 0.0 0.0 23.3 0.0 0.0 0.1 0.0 0.0 2.6 14.5 0.0 8.6 6.8 0.4 0.0 0.1 1.6 0.3 8.3 2.7 40.8 0.6 0.0 0.3 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.2 1.6 4.1 3.2 1.8 3.0 0.9 2.0 2.7 CSMD1 "KIAA1890, PPP1R24" ENSG00000183117 "CUB and Sushi multiple domains 1" 8 2935353-4994972 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 29.5;testis: 9.0" "Cell line enhanced" "Detected in some" "K-562: 8.8;U-2 OS: 4.3;U-266/70: 4.2;U-266/84: 3.9;U-698: 3.6" "Cancer enhanced" "Detected in some" "testis cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074707 Approved Vesicles Vesicles "HPA074707: " "unprognostic (6.32e-2)" "unprognostic (4.23e-2)" "unprognostic (2.37e-1)" "unprognostic (1.67e-3)" "unprognostic (5.72e-2)" "unprognostic (4.26e-2)" "unprognostic (1.02e-2)" "unprognostic (4.66e-2)" "unprognostic (7.69e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-1)" "unprognostic (7.90e-2)" "unprognostic (1.01e-1)" "unprognostic (2.74e-2)" "unprognostic (5.09e-2)" "unprognostic (1.26e-2)" "unprognostic (1.11e-1)" 1.0 1.1 20.4 0.8 21.1 0.8 1.4 6.3 29.5 2.5 0.8 1.7 0.0 1.0 1.2 0.9 0.8 3.2 0.8 0.7 12.9 4.5 2.7 0.7 1.4 0.9 3.9 18.2 0.9 0.9 0.7 0.7 2.8 3.4 1.1 0.8 0.0 0.7 1.5 1.1 1.0 1.0 1.7 2.4 2.8 0.8 9.0 2.4 0.0 1.1 0.0 0.9 1.1 0.5 0.0 0.9 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.5 0.0 0.0 0.0 0.1 0.0 0.3 1.7 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.3 0.0 0.0 4.2 3.9 3.6 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 20.4 21.1 6.3 29.5 12.9 4.5 3.9 18.2 3.4 2.4 CSMD2 KIAA1884 ENSG00000121904 "CUB and Sushi multiple domains 2" Q7Z408 1 33513999-34165842 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8" "Cell line enhanced" "Detected in some" "BJ: 4.8;fHDF/TERT166: 5.8;HEL: 8.8;NTERA-2: 7.1;PC-3: 7.3;U-87 MG: 20.9" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008622 Uncertain "HPA008622: AB_1078579" "unprognostic (1.33e-2)" "unprognostic (2.98e-1)" "unprognostic (6.47e-2)" "unprognostic (2.14e-1)" "unprognostic (7.03e-2)" "unprognostic (2.77e-1)" "unprognostic (1.31e-3)" "unprognostic (5.90e-2)" "unprognostic (7.44e-2)" "unprognostic (5.36e-2)" "unprognostic (2.32e-2)" "unprognostic (2.97e-1)" "unprognostic (1.25e-5)" "unprognostic (1.03e-3)" "unprognostic (1.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.38e-2)" 2.1 2.3 9.0 2.0 10.6 0.7 0.9 5.9 15.8 1.2 1.1 6.2 1.6 1.7 1.4 1.3 1.1 0.9 6.6 1.5 10.4 7.5 1.0 0.9 1.0 1.9 4.7 9.3 0.9 1.9 0.8 0.8 0.9 10.4 1.4 1.4 2.7 0.9 1.8 0.8 1.6 1.4 2.5 7.4 1.5 1.2 3.4 5.2 0.0 1.3 0.0 2.9 2.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 7.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 2.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 10.6 5.9 15.8 10.4 7.5 4.7 9.3 10.4 5.2 CSMD3 ENSG00000164796 "CUB and Sushi multiple domains 3" Q7Z407 8 112222928-113437099 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 26.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 2.3;hTCEpi: 2.3;hTERT-HME1: 1.6;LHCN-M2: 3.3;RH-30: 2.1;SCLC-21H: 1.4;U-2 OS: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029007 Uncertain "HPA029007: AB_10601802" "unprognostic (2.26e-1)" "unprognostic (2.16e-2)" "unprognostic (2.83e-2)" "unprognostic (5.97e-2)" "unprognostic (3.44e-2)" "unprognostic (1.26e-2)" "unprognostic (3.54e-4)" "unprognostic (2.48e-1)" "unprognostic (2.54e-1)" "unprognostic (2.89e-2)" "unprognostic (2.33e-2)" "unprognostic (5.03e-10)" "unprognostic (1.95e-1)" "unprognostic (4.14e-3)" "unprognostic (1.91e-2)" "unprognostic (1.74e-3)" 1.0 1.0 26.6 1.0 21.9 1.0 1.0 6.0 18.3 1.6 1.1 2.2 0.0 1.1 1.1 1.1 1.0 2.3 1.0 1.0 14.2 6.7 1.1 1.0 1.1 1.0 3.0 15.8 1.0 1.0 1.0 5.7 1.0 10.9 2.1 1.2 0.0 1.0 2.1 1.0 1.0 1.2 1.1 3.6 2.4 1.3 5.0 7.0 0.0 1.0 0.0 1.0 1.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 2.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.3 0.0 1.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 21.9 6.0 18.3 14.2 6.7 3.0 15.8 10.9 7.0 CSPG5 NGC ENSG00000114646 "Chondroitin sulfate proteoglycan 5" O95196 3 47562239-47580792 "Predicted membrane proteins" "Differentiation, Growth regulation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 81.1" "Cell line enhanced" "Detected in many" "AF22: 26.2;HEK 293: 7.2" "Cancer enriched" "Detected in many" 19 "glioma: 48.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049529, HPA067818, HPA071779" Enhanced Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA049529: , HPA067818: , HPA071779: " "unprognostic (2.68e-1)" "unprognostic (2.11e-1)" "unprognostic (8.87e-2)" "unprognostic (3.12e-2)" "unprognostic (2.88e-1)" "unprognostic (7.66e-2)" "unprognostic (5.05e-4)" "unprognostic (1.40e-1)" "unprognostic (3.82e-1)" "prognostic favourable (2.14e-4)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (3.41e-4)" "unprognostic (8.08e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" 1.8 1.8 30.6 1.3 25.8 1.1 1.6 7.2 81.1 1.3 1.4 6.7 0.0 1.1 1.3 1.2 1.3 1.4 1.2 1.3 20.2 17.1 1.2 1.2 1.7 1.3 12.9 12.6 1.1 1.4 1.1 0.2 1.8 5.6 1.5 1.3 8.0 1.1 1.1 1.5 1.6 1.3 1.4 6.2 1.1 1.2 2.2 4.1 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 26.2 4.6 0.5 0.0 0.7 0.5 0.1 1.0 0.3 0.2 1.6 0.1 2.0 0.0 0.4 2.2 0.2 0.2 0.0 7.2 0.4 1.1 0.0 0.0 0.3 1.2 0.0 0.9 0.1 0.0 0.0 5.1 0.2 0.1 1.2 0.2 0.3 2.5 2.7 0.4 0.2 0.5 1.1 0.9 2.8 1.3 1.6 3.3 0.1 1.2 2.4 0.2 0.0 5.4 0.0 1.5 0.6 0.6 0.0 0.4 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 25.8 7.2 22.4 20.2 17.1 12.9 12.6 5.6 4.1 CSRNP3 "FAM130A2, FLJ32093, PPP1R73, TAIP-2" ENSG00000178662 "Cysteine and serine rich nuclear protein 3" Q8WYN3 2 165469647-165689407 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.7;pituitary gland: 21.1" "Cell line enhanced" "Detected in some" "AF22: 12.7;PC-3: 3.1;SCLC-21H: 9.3;SH-SY5Y: 7.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017905 Supported Uncertain Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA017905: AB_1857757" "unprognostic (2.85e-1)" "unprognostic (1.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.11e-1)" "unprognostic (1.27e-1)" "unprognostic (3.61e-1)" "unprognostic (8.87e-2)" "unprognostic (1.02e-2)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (4.87e-2)" "unprognostic (1.01e-1)" "unprognostic (1.82e-3)" "unprognostic (7.41e-2)" "unprognostic (5.36e-2)" "unprognostic (3.17e-1)" "unprognostic (1.08e-2)" 2.1 5.5 9.3 1.4 24.9 0.7 6.7 8.8 31.7 5.7 2.0 3.2 0.4 2.1 6.3 2.3 2.0 2.5 2.5 3.4 9.3 10.2 3.7 1.8 1.4 1.1 5.3 13.2 7.8 8.0 6.0 21.1 1.1 7.8 3.9 2.5 4.0 4.9 5.1 0.9 2.1 1.7 5.7 2.9 2.1 2.0 1.9 4.8 0.0 5.3 0.0 1.0 1.9 2.5 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.6 0.0 0.4 0.2 0.6 0.0 0.0 0.9 0.6 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.7 0.7 0.0 9.3 7.6 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.3 0.0 0.3 0.6 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.3 24.9 8.8 31.7 9.3 10.2 5.3 13.2 7.8 4.8 CTNNA2 "CAP-R, CT114" ENSG00000066032 "Catenin alpha 2" P26232 2 79185231-80648861 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Differentiation" "Developmental protein" "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.1;brain: 58.4;epididymis: 58.1" "Cell line enhanced" "Detected in some" "AF22: 8.2;Karpas-707: 9.4;NTERA-2: 7.7;SCLC-21H: 4.4;SH-SY5Y: 12.4" "Group enriched" "Detected in some" 7 "endometrial cancer: 3.9;glioma: 11.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 66 "basophil: 25.1" "Lineage enriched" "Detected in single" 252 "granulocytes: 25.1" "Low region specificity" "Detected in all" CAB037175 Enhanced "CAB037175: AB_476883" "unprognostic (9.15e-2)" "unprognostic (2.26e-2)" "unprognostic (2.66e-1)" "unprognostic (1.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.23e-1)" "unprognostic (3.31e-2)" "unprognostic (4.04e-1)" "unprognostic (3.17e-2)" "unprognostic (5.62e-2)" "unprognostic (7.96e-3)" "unprognostic (8.76e-2)" "unprognostic (2.27e-4)" "unprognostic (7.80e-2)" "unprognostic (8.44e-4)" "unprognostic (1.73e-4)" "unprognostic (2.83e-1)" 1.2 5.1 34.7 1.6 24.1 1.2 1.2 10.1 58.4 1.2 1.9 8.7 0.0 1.4 3.8 58.1 1.3 2.7 1.3 1.1 23.6 16.1 1.2 1.2 1.1 1.1 12.5 28.3 1.1 1.7 1.1 9.3 1.1 12.7 1.9 1.8 5.1 1.3 1.8 1.3 1.2 1.7 1.5 4.3 1.1 2.1 14.4 10.4 0.0 1.1 0.0 1.1 1.1 0.3 0.0 0.0 25.1 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.4 0.0 0.0 0.0 0.1 7.7 0.0 0.0 0.0 0.0 0.8 0.0 4.4 12.4 0.0 0.0 0.5 0.1 0.7 0.0 0.5 0.8 0.2 0.0 2.7 0.0 0.0 3.2 0.0 2.2 25.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 34.7 24.1 10.1 35.8 23.6 16.1 12.5 28.3 12.7 10.4 CTNNA3 "MGC26194, VR22" ENSG00000183230 "Catenin alpha 3" Q9UI47 10 65912518-67696169 "Disease related genes, Predicted intracellular proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 28.8;heart muscle: 27.5;liver: 12.9;skeletal muscle: 16.2;tongue: 7.9" "Cell line enhanced" "Detected in some" "Daudi: 4.0;Karpas-707: 2.5;NTERA-2: 3.0;RPMI-8226: 3.9;SCLC-21H: 2.6;U-266/70: 11.1" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.2;plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061818 Enhanced "HPA061818: " "unprognostic (2.19e-1)" "unprognostic (1.57e-1)" "unprognostic (8.64e-4)" "unprognostic (8.13e-3)" "unprognostic (6.43e-3)" "unprognostic (9.90e-2)" "unprognostic (2.60e-4)" "unprognostic (8.27e-2)" "unprognostic (5.10e-2)" "unprognostic (2.55e-1)" "unprognostic (9.09e-3)" "unprognostic (1.15e-1)" "unprognostic (2.67e-3)" "unprognostic (7.93e-5)" "unprognostic (6.43e-2)" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" 1.8 1.4 6.3 3.6 19.3 0.8 1.5 6.6 10.3 2.1 2.5 26.0 0.0 1.1 2.5 0.8 2.9 1.7 1.6 27.5 7.6 2.3 1.1 12.9 1.1 0.9 25.9 5.8 3.4 1.1 1.2 1.1 1.2 16.2 1.2 1.6 0.0 1.2 1.0 16.2 1.2 1.9 4.5 26.8 1.1 1.8 3.6 28.8 0.0 1.4 7.9 1.1 1.3 1.9 0.7 1.4 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.3 4.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.1 0.0 3.0 1.2 0.2 0.0 3.9 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.8 0.0 0.0 11.1 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.3 0.0 0.7 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.2 6.3 19.3 6.6 10.3 7.6 2.3 25.9 5.8 16.2 28.8 CTNND2 "GT24, NPRAP" ENSG00000169862 "Catenin delta 2" Q9UQB3 5 10971840-11904043 "Disease related genes, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 74.3" "Cell line enhanced" "Detected in some" "AF22: 17.7;MCF7: 8.0;SK-BR-3: 5.3;U-266/84: 15.1" "Cancer enriched" "Detected in many" 16 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015077, CAB037339" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" "Nucleoplasm, Golgi apparatus, Cell Junctions" "CAB037339: , HPA015077: " "unprognostic (7.32e-2)" "unprognostic (1.51e-3)" "unprognostic (2.23e-1)" "unprognostic (5.16e-2)" "unprognostic (5.66e-2)" "unprognostic (2.06e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-2)" "unprognostic (9.13e-2)" "unprognostic (9.86e-2)" "unprognostic (8.95e-3)" "unprognostic (2.66e-1)" "unprognostic (9.55e-4)" "unprognostic (5.87e-2)" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (4.76e-2)" 1.7 2.4 30.9 1.8 26.3 1.4 2.8 21.6 74.3 1.7 1.8 16.6 0.0 1.7 1.6 1.9 1.6 1.7 4.8 6.0 26.0 17.7 1.5 1.7 2.4 1.6 22.8 20.2 2.1 12.5 1.5 5.7 1.9 11.0 2.6 1.9 2.6 1.7 1.7 1.6 1.5 2.0 1.6 13.3 5.7 1.9 4.2 14.7 0.0 1.7 0.0 1.5 1.6 0.1 0.0 0.0 0.8 0.4 0.0 0.3 0.6 0.0 0.1 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.0 0.0 0.0 2.7 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 15.1 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.6 30.9 26.3 21.6 29.1 26.0 17.7 22.8 20.2 11.0 14.7 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924485-7926166 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 91.1" "Cell line enhanced" "Detected in many" "AN3-CA: 33.2;HEK 293: 23.1;NTERA-2: 25.2;REH: 19.1;SCLC-21H: 19.6;SH-SY5Y: 32.9" "Cancer enhanced" "Detected in all" "ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 2.1 4.8 47.7 2.5 91.1 1.6 2.1 0.0 74.2 5.2 6.1 5.0 3.6 2.6 17.5 5.1 2.4 16.4 1.8 1.6 49.4 16.8 3.1 1.5 3.0 1.6 15.7 20.1 2.7 2.1 2.3 6.5 2.0 4.0 5.5 2.1 0.0 2.1 16.5 1.6 2.8 2.1 7.1 1.5 2.0 2.2 6.1 8.3 0.0 1.8 0.0 1.6 2.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 2.7 7.1 33.2 0.0 0.1 1.6 2.9 0.8 1.4 0.8 0.8 1.7 0.0 5.6 0.7 12.1 1.6 0.3 0.0 1.0 23.1 0.2 1.9 0.5 0.3 0.5 0.6 0.0 0.9 0.5 0.3 1.8 7.0 0.1 0.1 13.4 6.1 4.5 25.2 11.7 19.1 0.0 2.1 5.1 0.5 19.6 32.9 1.7 0.9 3.0 7.3 0.2 2.8 0.7 11.7 1.3 1.6 0.2 0.3 1.5 2.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 91.1 0.0 63.8 49.4 16.8 15.7 20.1 4.0 8.3 CTXN2 ENSG00000233932 "Cortexin 2" P0C2S0 15 48178122-48203756 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "brain: 11.3;pituitary gland: 5.7;testis: 4.9" "Cell line enhanced" "Detected in single" "SCLC-21H: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053168 Uncertain "HPA053168: " "unprognostic (1.90e-1)" "unprognostic (3.85e-3)" "unprognostic (7.43e-2)" "unprognostic (2.18e-4)" "unprognostic (6.81e-3)" "unprognostic (1.72e-1)" "unprognostic (2.80e-1)" "unprognostic (4.61e-2)" 0.5 1.2 6.4 0.7 6.7 0.5 0.6 8.4 9.0 0.5 0.8 0.0 0.0 0.7 0.5 0.6 0.6 1.3 0.7 0.5 4.0 11.3 0.9 0.5 0.6 0.6 7.3 2.9 0.5 1.4 0.6 5.7 0.5 8.8 0.6 0.9 0.0 0.5 0.6 0.6 0.5 1.1 0.6 1.9 0.5 0.6 4.9 1.2 0.0 0.6 0.0 0.6 0.5 0.0 0.0 0.1 0.3 1.5 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 3.6 0.9 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 0.1 0.0 0.0 6.4 6.7 8.4 9.0 4.0 11.3 7.3 2.9 8.8 1.2 CTXN3 ENSG00000205279 "Cortexin 3" Q4LDR2 5 127649044-127658630 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 21.9;kidney: 58.1" "Group enriched" "Detected in some" 4 "AF22: 4.4;NTERA-2: 1.4" "Cancer enriched" "Detected in single" 8 "renal cancer: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 4 "olfactory region: 50.2" "unprognostic (7.32e-2)" "unprognostic (9.88e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-1)" "unprognostic (6.20e-3)" 0.6 0.6 2.2 0.5 9.4 0.5 0.6 0.2 19.1 0.6 0.6 0.7 0.0 0.5 0.6 0.5 0.6 0.6 0.6 0.6 7.9 4.8 58.1 0.6 0.6 0.6 12.6 4.6 0.5 0.5 0.5 5.9 0.5 21.9 0.9 0.6 0.0 0.7 0.6 9.1 0.5 0.5 0.5 0.5 0.5 0.6 0.6 1.0 0.0 0.5 0.3 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 9.4 0.2 19.1 7.9 4.8 12.6 4.6 21.9 1.0 CTXND1 LINC01314 ENSG00000259417 "Cortexin domain containing 1" 15 80195484-80252213 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 20.8;epididymis: 9.1;liver: 14.7" "Group enriched" "Detected in some" 6 "SK-MEL-30: 3.3;WM-115: 10.0" "Group enriched" "Detected in many" 7 "glioma: 3.4;liver cancer: 2.7;melanoma: 9.1;thyroid cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "hippocampal formation: 38.5" "unprognostic (4.15e-5)" "unprognostic (8.42e-2)" "unprognostic (6.08e-2)" "unprognostic (1.86e-3)" "unprognostic (5.59e-2)" "unprognostic (3.48e-1)" "unprognostic (1.90e-2)" "unprognostic (2.61e-1)" "unprognostic (2.41e-1)" "unprognostic (7.04e-2)" "unprognostic (3.90e-4)" "unprognostic (2.43e-1)" "unprognostic (1.72e-2)" "unprognostic (1.92e-3)" "unprognostic (1.06e-1)" "unprognostic (5.14e-3)" "unprognostic (1.34e-1)" 0.3 4.2 12.8 0.3 5.7 0.1 0.2 4.4 8.2 0.2 0.5 2.2 0.0 0.7 0.2 9.1 0.2 0.4 0.2 6.6 20.8 3.5 14.7 2.6 0.4 1.9 1.9 0.4 0.7 0.0 0.0 0.1 4.5 0.2 0.5 1.1 0.2 0.3 0.6 1.3 0.8 0.2 3.3 2.0 3.3 0.3 7.1 0.0 0.8 0.0 0.5 0.2 0.0 0.4 0.1 0.5 0.1 0.3 0.6 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.2 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 3.3 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.1 0.2 0.2 10.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.4 0.6 0.1 0.5 0.3 0.0 0.1 0.1 0.0 CUX2 "CDP2, CUTL2, KIAA0293" ENSG00000111249 "Cut like homeobox 2" O14529 12 111034024-111350554 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 9.9;brain: 13.2;liver: 21.5;prostate: 13.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 7.3;HDLM-2: 3.1;hTERT-HME1: 4.0;SCLC-21H: 7.4;SH-SY5Y: 15.9" "Cancer enhanced" "Detected in some" "prostate cancer: 11.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 100 "plasmacytoid DC: 9.9" "Lineage enriched" "Detected in single" 100 "dendritic cells: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.87e-2)" "unprognostic (6.98e-3)" "unprognostic (1.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (2.78e-2)" "unprognostic (1.22e-2)" "unprognostic (9.44e-2)" "unprognostic (2.33e-1)" "unprognostic (3.30e-2)" "unprognostic (7.83e-5)" "unprognostic (2.67e-1)" "unprognostic (3.54e-3)" "unprognostic (4.31e-2)" "unprognostic (9.03e-2)" "unprognostic (4.64e-2)" "unprognostic (1.90e-2)" 0.2 0.2 2.9 0.4 4.8 0.3 2.3 1.2 13.2 1.1 0.3 0.3 2.8 0.3 0.3 0.5 0.3 0.2 0.2 0.2 1.9 2.1 0.2 21.5 0.2 0.6 2.7 3.1 0.1 0.2 0.1 1.9 0.2 1.0 13.6 0.2 0.6 0.1 5.4 0.2 0.2 0.3 0.1 0.4 0.4 1.2 0.6 0.4 0.0 4.9 0.0 0.7 0.3 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 7.3 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.2 0.0 0.1 0.0 0.1 7.4 15.9 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 2.9 4.8 1.2 13.2 1.9 2.1 2.7 3.1 1.0 0.4 CX3CR1 "CCRL1, CMKBRL1, CMKDR1, GPR13, V28" ENSG00000168329 "C-X3-C motif chemokine receptor 1" P49238 3 39263494-39281735 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Age-related macular degeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 69.2;brain: 51.6" "Cell line enriched" "Detected in some" 20 "RPMI-8226: 112.1" "Cancer enhanced" "Detected in many" "glioma: 21.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 69.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032478, HPA046587" Approved "CAB032478: AB_638830, HPA046587: " "unprognostic (2.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.65e-1)" "unprognostic (2.42e-2)" "unprognostic (6.52e-2)" "unprognostic (3.01e-3)" "unprognostic (2.64e-1)" "unprognostic (1.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.57e-3)" "unprognostic (1.13e-2)" "unprognostic (1.04e-1)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (8.59e-2)" "unprognostic (7.71e-3)" "unprognostic (1.12e-1)" 2.3 3.8 14.9 6.0 17.3 0.9 4.8 2.5 34.1 2.7 1.2 51.6 0.0 1.2 2.7 4.2 1.4 5.9 2.5 2.2 12.4 11.9 2.5 1.9 9.0 1.8 21.8 7.4 1.8 1.8 5.2 2.5 4.3 21.8 3.7 1.2 3.5 6.4 7.0 5.2 2.4 1.2 3.3 33.5 10.3 1.5 1.8 16.3 0.8 2.4 0.7 4.7 2.8 1.3 0.1 15.7 3.5 69.2 6.5 46.5 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 112.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.5 0.0 1.2 15.9 0.2 46.5 43.3 0.5 0.1 10.4 25.2 15.7 0.1 3.7 22.7 3.5 6.5 69.2 1.1 0.2 29.8 14.9 17.3 2.5 19.9 12.4 11.9 21.8 7.4 21.8 16.3 CXorf57 "FLJ10178, FLJ14191" ENSG00000147231 "Chromosome X open reading frame 57" Q6NSI4 X 106611930-106679442 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;pituitary gland: 32.3" "Cell line enhanced" "Detected in many" "HEK 293: 22.2;Karpas-707: 11.4;RT4: 23.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "gdT-cell: 3.5;MAIT T-cell: 2.6;memory B-cell: 3.9;memory CD4 T-cell: 3.0;memory CD8 T-cell: 2.4;naive B-cell: 2.9;naive CD4 T-cell: 3.7;naive CD8 T-cell: 3.0;NK-cell: 2.1;T-reg: 1.1" "Group enriched" "Detected in many" 11 "B-cells: 3.9;NK-cells: 2.1;T-cells: 3.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA000896, HPA001374" Uncertain Approved "Intermediate filaments" "Intermediate filaments" "HPA000896: AB_1078880, HPA001374: " "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (2.67e-2)" "unprognostic (1.46e-3)" "unprognostic (4.85e-2)" "unprognostic (8.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-1)" "unprognostic (5.49e-2)" "unprognostic (3.81e-3)" "unprognostic (1.17e-1)" "unprognostic (4.20e-3)" "unprognostic (1.63e-1)" "unprognostic (2.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.23e-3)" 1.4 12.0 5.2 2.1 23.0 0.8 2.3 0.9 8.5 2.9 1.3 6.8 1.0 1.8 5.1 3.7 1.3 6.3 1.0 1.5 5.9 25.8 4.2 2.2 3.8 4.8 4.7 5.3 11.3 2.5 0.1 32.3 5.7 6.3 2.3 1.3 2.6 1.1 2.2 2.2 4.0 2.0 1.5 4.5 2.9 4.2 6.0 5.4 1.9 5.2 0.4 3.3 5.9 2.0 3.9 0.2 0.2 0.0 2.1 3.7 1.2 4.1 0.0 4.3 6.0 2.5 2.1 6.5 0.1 0.8 0.0 0.0 0.9 0.8 8.7 0.0 0.5 1.1 11.0 1.8 0.0 0.0 22.2 2.8 0.0 0.2 0.1 0.0 1.9 1.2 1.3 0.3 0.8 0.0 0.1 11.4 0.9 0.0 7.9 0.0 3.9 0.7 0.0 4.0 0.0 1.8 23.3 7.1 0.0 0.4 0.1 2.5 1.0 0.1 0.0 1.9 1.6 0.0 2.6 4.1 1.7 10.7 3.3 0.0 3.1 0.0 0.0 0.0 3.5 0.0 2.6 3.9 3.0 2.4 0.0 2.9 3.7 3.0 0.2 2.1 0.0 0.2 1.1 1.2 5.2 23.0 0.9 6.8 5.9 25.8 4.7 5.3 6.3 5.4 CXXC4 IDAX ENSG00000168772 "CXXC finger protein 4" 4 104468312-104494901 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.4;pituitary gland: 17.2" "Cell line enhanced" "Detected in some" "AF22: 7.1;AN3-CA: 9.8;Karpas-707: 9.1;RPMI-8226: 5.3;SCLC-21H: 12.3;U-266/70: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.9;memory CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036600, HPA036925" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA036600: AB_10673659, HPA036925: " "unprognostic (1.37e-2)" "unprognostic (1.12e-1)" "unprognostic (5.75e-2)" "unprognostic (5.86e-2)" "unprognostic (9.07e-3)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "unprognostic (9.69e-3)" "unprognostic (2.75e-1)" "unprognostic (2.45e-1)" "prognostic favourable (2.19e-4)" "unprognostic (1.82e-1)" "unprognostic (4.52e-3)" "unprognostic (5.69e-2)" "unprognostic (1.37e-1)" "unprognostic (2.38e-1)" "unprognostic (4.42e-3)" 2.2 4.3 10.3 0.9 12.0 0.6 4.3 17.5 19.4 2.4 2.5 7.4 0.8 5.4 1.9 5.3 1.0 6.7 1.5 5.3 9.9 14.4 1.7 2.7 2.3 0.7 7.9 9.9 5.6 5.8 3.2 17.2 1.4 10.2 2.1 2.9 7.9 7.5 2.1 1.3 0.8 5.5 1.8 5.3 1.4 4.3 4.9 13.3 0.0 7.1 0.1 0.7 1.6 1.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 7.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.5 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 2.6 0.0 2.5 0.1 0.0 0.0 5.3 0.0 0.1 12.3 2.2 0.0 0.6 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.1 10.0 2.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.1 1.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.0 17.5 19.4 9.9 14.4 7.9 9.9 10.2 13.3 CXXC5 "HSPC195, RINF, WID" ENSG00000171604 "CXXC finger protein 5" Q7LFL8 5 139647299-139683882 "Predicted intracellular proteins" Transcription "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 68.2" "Cell line enhanced" "Detected in many" "SK-BR-3: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "MAIT T-cell: 10.2;memory B-cell: 27.7;naive B-cell: 29.3;NK-cell: 21.8;plasmacytoid DC: 19.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036508, HPA058148" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036508: AB_10673620, HPA058148: " "unprognostic (3.08e-2)" "unprognostic (9.03e-2)" "prognostic favourable (2.40e-4)" "prognostic unfavourable (4.10e-7)" "unprognostic (2.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.11e-3)" "unprognostic (2.28e-2)" "unprognostic (2.12e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.79e-2)" "unprognostic (2.63e-2)" "unprognostic (8.02e-2)" "unprognostic (1.44e-1)" "unprognostic (7.26e-2)" "unprognostic (1.57e-1)" 12.3 9.5 22.4 9.3 19.9 22.2 9.2 68.2 38.8 17.5 10.2 39.3 5.1 6.0 9.9 18.0 10.1 18.1 11.4 15.8 23.9 16.7 25.6 33.8 9.0 15.5 30.9 21.7 5.4 24.9 18.2 18.6 10.4 25.4 8.1 7.9 14.2 30.0 11.7 39.7 9.8 9.1 8.4 36.7 18.1 11.4 19.0 27.5 20.5 12.5 7.7 13.5 9.6 9.9 29.3 19.1 0.7 2.1 21.8 10.2 3.4 9.3 7.9 8.8 3.3 12.3 16.9 3.4 6.1 9.4 2.6 5.3 17.4 9.6 12.4 27.4 16.4 10.8 1.8 4.7 1.3 1.3 3.0 18.5 7.0 12.2 5.3 4.0 0.6 6.0 1.0 4.5 1.3 0.7 17.2 2.0 19.3 24.5 4.4 13.1 10.6 2.2 8.0 17.9 18.9 20.2 6.8 28.0 28.8 2.2 56.6 4.6 30.9 19.3 3.8 22.0 4.3 10.4 5.5 7.4 15.5 23.4 33.1 1.4 12.1 0.3 2.1 0.1 3.2 0.4 10.2 27.7 0.3 2.3 1.8 29.3 0.2 0.9 0.7 21.8 0.1 19.1 0.4 3.4 22.4 19.9 68.2 38.8 23.9 16.7 30.9 21.7 25.4 27.5 CYFIP2 PIR121 ENSG00000055163 "Cytoplasmic FMR1 interacting protein 2" Q96F07 5 157266079-157395595 "Predicted intracellular proteins" "Apoptosis, Cell adhesion" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.8;brain: 44.2;kidney: 69.7" "Cell line enhanced" "Detected in many" "Daudi: 52.2;MOLT-4: 49.5;U-266/70: 38.6;U-698: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB055519, HPA068106, HPA071459" Uncertain Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" "Endoplasmic reticulum" "Plasma membrane, Cytosol" "CAB055519: , HPA068106: , HPA071459: " "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (7.07e-2)" "prognostic unfavourable (2.42e-6)" "unprognostic (3.76e-1)" "unprognostic (4.58e-2)" "unprognostic (1.14e-1)" "unprognostic (6.91e-3)" "unprognostic (3.97e-2)" "unprognostic (5.25e-2)" "prognostic favourable (1.18e-4)" "unprognostic (3.81e-2)" "prognostic favourable (3.21e-12)" "unprognostic (2.90e-1)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.49e-2)" 1.9 6.6 28.6 13.4 31.7 22.8 1.7 39.1 44.2 1.8 4.3 7.7 1.6 3.1 3.5 12.3 2.1 4.9 4.7 5.1 28.7 20.4 69.7 8.2 5.9 25.9 16.2 27.2 2.7 3.6 30.6 13.2 4.4 15.8 3.2 5.0 4.7 2.2 3.5 3.1 1.8 6.4 2.9 7.9 15.8 9.5 2.6 8.9 28.5 5.4 0.0 25.7 6.0 1.7 13.7 15.6 30.1 42.8 17.4 32.1 22.9 0.0 8.1 12.5 7.1 0.2 0.3 20.1 1.4 2.5 0.6 1.8 1.5 0.1 52.2 3.6 0.8 0.1 9.9 6.7 1.5 11.8 15.6 6.6 10.6 6.1 1.0 7.0 18.4 1.4 2.7 2.0 0.1 2.2 0.1 21.0 1.7 1.9 49.5 1.3 5.5 2.1 12.2 0.3 24.9 6.6 7.4 18.2 7.2 0.1 7.1 1.1 4.9 0.2 2.9 0.4 5.4 1.7 1.3 38.6 9.6 36.7 5.5 8.3 3.0 17.4 4.3 30.1 32.1 20.0 22.9 13.7 23.3 27.7 6.2 13.4 24.7 28.1 14.4 17.4 42.8 15.6 18.4 22.9 28.6 31.7 39.1 38.3 28.7 20.4 16.2 27.2 15.8 8.9 CYP26B1 P450RAI-2 ENSG00000003137 "Cytochrome P450 family 26 subfamily B member 1" Q9NR63 2 72129238-72148038 "Disease related genes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.4" "Cell line enhanced" "Detected in some" "ASC diff: 8.0;HaCaT: 11.8;RH-30: 15.2;U-2 OS: 16.9;U-2197: 7.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012567 Uncertain Approved Cytosol "Intracellular and membrane" Cytosol "HPA012567: AB_1847429" "unprognostic (1.70e-1)" "unprognostic (1.05e-1)" "unprognostic (8.76e-2)" "unprognostic (2.19e-4)" "unprognostic (3.46e-2)" "unprognostic (4.40e-1)" "unprognostic (2.17e-4)" "unprognostic (8.41e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (7.55e-3)" "unprognostic (1.52e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-1)" "unprognostic (1.55e-1)" "unprognostic (9.44e-3)" "unprognostic (2.04e-2)" 16.6 2.6 8.3 2.1 7.8 0.1 7.7 25.0 23.9 5.8 2.4 1.2 1.6 3.6 1.5 1.6 3.4 2.7 1.2 6.0 2.5 1.5 4.2 0.7 2.7 4.4 3.4 10.0 4.9 0.2 0.9 5.2 3.2 35.4 1.3 1.2 1.2 5.1 7.5 7.6 20.5 2.4 1.5 0.6 1.9 0.5 13.8 1.1 4.9 9.2 2.2 2.8 1.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.8 0.0 0.1 8.0 3.0 4.8 0.7 0.1 0.2 0.2 1.4 0.4 0.0 0.4 0.6 11.8 6.8 0.0 0.1 0.0 2.1 0.0 4.8 0.6 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.8 0.4 0.1 0.7 2.2 0.0 0.1 0.0 0.7 0.0 15.2 0.0 0.0 1.1 0.5 0.1 2.6 0.0 2.8 0.2 0.7 0.0 1.2 16.9 7.5 2.6 0.0 0.9 0.0 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 7.8 25.0 23.9 2.5 1.5 3.4 10.0 35.4 1.1 CYP46A1 CYP46 ENSG00000036530 "Cytochrome P450 family 46 subfamily A member 1" Q9Y6A2 14 99684304-99727301 "Enzymes, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 49.2" "Group enriched" "Detected in some" 4 "AF22: 4.3;U-937: 11.8" "Cancer enriched" "Detected in single" 5 "glioma: 1.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 23 "plasmacytoid DC: 7.0" "Lineage enriched" "Detected in single" 23 "dendritic cells: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (2.16e-1)" "unprognostic (4.30e-1)" "unprognostic (2.50e-5)" "unprognostic (9.48e-5)" "unprognostic (1.15e-1)" "unprognostic (5.92e-2)" "unprognostic (3.45e-2)" "unprognostic (1.06e-1)" "unprognostic (5.37e-2)" "unprognostic (4.01e-2)" "unprognostic (1.32e-5)" "unprognostic (5.21e-2)" "unprognostic (2.44e-4)" "unprognostic (5.97e-4)" "unprognostic (1.59e-1)" "unprognostic (1.15e-2)" "unprognostic (3.88e-3)" 3.0 3.3 13.8 1.3 47.3 1.0 1.2 2.6 49.2 1.4 1.1 3.7 0.0 1.2 1.9 2.0 1.1 1.6 1.4 6.2 15.7 9.9 2.0 1.5 1.3 1.6 7.1 10.0 2.1 2.3 2.7 5.3 1.0 3.8 1.8 1.1 0.6 2.5 1.7 2.0 1.1 1.0 1.9 3.1 1.0 1.0 2.1 6.1 0.4 1.8 0.0 1.1 1.1 0.1 0.0 7.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.3 1.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.2 0.6 0.2 0.0 0.1 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.1 1.8 0.0 0.1 0.0 1.0 0.0 0.3 0.0 0.0 0.2 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.0 0.0 0.0 13.8 47.3 2.6 21.5 15.7 9.9 7.1 10.0 3.8 6.1 DAAM2 KIAA0381 ENSG00000146122 "Dishevelled associated activator of morphogenesis 2" Q86T65 6 39792298-39904877 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 83.3" "Cell line enhanced" "Detected in some" "HSkMC: 25.6;LHCN-M2: 25.1;SK-MEL-30: 31.0;U-138 MG: 9.6;WM-115: 12.1" "Cancer enhanced" "Detected in all" "melanoma: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 29 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051300, HPA054630" Approved Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA051300: , HPA054630: " "unprognostic (7.53e-2)" "unprognostic (6.02e-3)" "unprognostic (4.49e-2)" "unprognostic (7.93e-2)" "unprognostic (8.24e-2)" "unprognostic (4.28e-2)" "unprognostic (2.43e-2)" "unprognostic (1.05e-3)" "unprognostic (1.33e-1)" "unprognostic (5.89e-2)" "unprognostic (2.17e-1)" "unprognostic (5.24e-2)" "prognostic unfavourable (2.79e-4)" "unprognostic (2.67e-2)" "unprognostic (8.54e-2)" "unprognostic (7.94e-2)" "unprognostic (8.54e-4)" 21.5 17.8 34.8 6.7 43.0 1.7 7.8 4.4 52.2 9.3 6.4 83.3 8.0 7.6 7.5 8.5 28.3 8.9 5.9 6.1 40.4 25.2 5.9 4.0 8.4 2.8 42.8 24.8 7.3 5.2 3.5 2.1 9.4 41.3 8.7 7.1 5.1 4.3 17.6 23.8 4.4 8.9 13.7 48.8 15.5 7.0 8.7 51.9 0.0 5.0 2.1 2.2 4.6 4.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.7 0.1 0.1 4.4 5.9 1.0 0.5 0.4 0.0 0.0 0.2 6.5 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 4.1 0.0 0.0 25.6 0.0 0.1 0.0 0.0 0.0 0.0 25.1 0.0 0.6 0.0 0.7 0.0 0.0 4.5 3.5 0.0 0.0 0.9 1.0 0.0 0.3 31.0 0.0 0.0 0.2 9.6 2.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 34.8 43.0 4.4 28.9 40.4 25.2 42.8 24.8 41.3 51.9 DAB1 ENSG00000173406 "DAB1, reelin adaptor protein" O75553 1 56994778-58546734 "Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4;intestine: 20.8" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 29.3;HeLa: 10.5;NTERA-2: 13.0;RT4: 17.3;WM-115: 14.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 31.4" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.5" "Group enriched" "Detected in many" 16 "granulocytes: 1.4;T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032329, HPA052033, HPA067495" Enhanced Enhanced Vesicles Vesicles "CAB032329: AB_638973, HPA052033: , HPA067495: " "unprognostic (7.88e-2)" "unprognostic (1.02e-1)" "unprognostic (8.54e-2)" "unprognostic (2.09e-4)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (7.30e-4)" "unprognostic (3.90e-1)" "unprognostic (3.07e-2)" "unprognostic (1.47e-2)" "unprognostic (2.06e-3)" "unprognostic (1.27e-1)" "unprognostic (2.00e-3)" "unprognostic (1.78e-1)" "unprognostic (2.01e-1)" "unprognostic (1.44e-2)" "unprognostic (5.67e-2)" 1.8 1.7 5.8 0.3 3.8 0.0 0.7 31.4 6.2 1.7 1.0 1.8 0.5 15.0 1.0 1.0 0.6 1.6 0.8 1.8 5.3 1.4 0.7 7.5 0.8 0.2 1.1 4.2 1.2 0.7 0.0 0.7 0.0 2.0 4.0 0.3 2.9 5.2 10.2 0.6 0.6 20.8 0.3 1.1 0.6 1.0 0.9 0.7 0.0 0.8 0.0 0.1 1.9 1.0 0.0 0.0 1.4 0.0 0.2 5.5 0.1 0.0 0.0 5.9 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 13.0 0.0 3.2 0.0 0.1 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 1.4 0.5 0.0 5.5 0.0 2.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.1 5.8 3.8 31.4 6.2 5.3 1.4 1.1 4.2 2.0 0.7 DAB2IP "AF9Q34, AIP1, DIP1/2, KIAA1743" ENSG00000136848 "DAB2 interacting protein" Q5VWQ8 9 121567057-121785530 "Disease related genes, Predicted intracellular proteins" "Angiogenesis, Apoptosis, Cell cycle, Growth regulation, Immunity, Inflammatory response, Innate immunity, Stress response, Unfolded protein response" "Developmental protein, GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.4" "Cell line enhanced" "Detected in many" "HaCaT: 34.2;HDLM-2: 25.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 81.4" "Cell type enriched" "Detected in single" 16 "MAIT T-cell: 2.8" "Lineage enriched" "Detected in single" 22 "T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.82e-2)" "unprognostic (2.79e-1)" "unprognostic (2.62e-2)" "unprognostic (4.99e-3)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.31e-1)" "unprognostic (1.07e-1)" "unprognostic (1.08e-1)" "unprognostic (1.49e-2)" "unprognostic (3.09e-1)" "unprognostic (1.87e-1)" "prognostic favourable (4.00e-15)" "unprognostic (1.00e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-2)" "unprognostic (2.81e-2)" 13.0 8.1 17.4 6.9 18.1 0.2 12.2 81.4 24.5 11.2 15.8 6.0 23.0 12.7 15.9 9.0 14.1 12.2 10.4 17.6 13.6 8.5 12.1 4.7 13.1 2.4 7.6 13.6 11.4 8.8 8.9 6.0 9.8 8.4 9.9 10.5 6.0 26.4 21.3 29.5 9.8 14.2 15.5 5.5 10.2 12.1 12.8 6.6 1.8 8.0 8.9 4.2 12.6 10.7 0.0 0.0 0.0 0.0 0.1 2.8 0.0 5.6 6.7 7.4 6.5 1.6 0.8 9.7 4.6 12.0 4.4 2.2 4.8 6.1 0.0 7.3 4.7 34.2 6.9 19.3 1.1 25.1 3.9 0.1 9.3 9.7 1.8 1.1 0.0 0.6 13.8 1.5 3.0 6.5 0.1 0.1 1.1 7.4 5.3 1.5 7.9 2.6 2.5 5.1 11.2 4.5 11.2 7.6 13.7 3.0 18.0 9.9 21.4 0.9 5.8 5.3 6.2 1.0 4.5 0.1 0.1 0.3 0.6 0.2 5.9 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 17.4 18.1 81.4 24.5 13.6 8.5 7.6 13.6 8.4 6.6 DACH2 ENSG00000126733 "Dachshund family transcription factor 2" Q96NX9 X 86148458-86832604 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 29.5;epididymis: 9.3;fallopian tube: 8.0" "Cell line enriched" "Detected in some" 7 "HAP1: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA000258, HPA001367" Approved Approved Nucleoplasm Nucleoplasm "HPA000258: AB_1078618, HPA001367: " "unprognostic (5.73e-3)" "unprognostic (3.22e-1)" "unprognostic (1.54e-6)" "unprognostic (3.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.34e-1)" "unprognostic (7.71e-2)" "unprognostic (6.48e-1)" "unprognostic (3.17e-2)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-2)" "unprognostic (1.28e-1)" "unprognostic (5.74e-3)" "unprognostic (5.01e-3)" "unprognostic (2.63e-2)" 0.9 0.9 7.9 0.6 29.5 0.6 0.6 0.2 17.8 1.0 0.8 0.3 0.0 1.2 1.2 9.3 0.7 8.0 0.6 0.6 13.5 10.8 2.4 0.6 0.9 0.6 3.4 10.4 1.4 1.1 0.7 1.3 0.6 11.8 1.5 0.7 1.6 0.7 0.8 0.6 0.7 1.3 0.8 0.7 0.6 1.4 0.7 1.7 0.0 0.7 0.0 0.6 1.4 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 29.5 0.2 16.8 13.5 10.8 3.4 10.4 11.8 1.7 DACT2 "bA503C24.7, C6orf116, DAPPER2" ENSG00000164488 "Dishevelled binding antagonist of beta catenin 2" Q5SW24 6 168292830-168319754 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 14.2;placenta: 54.8" "Cell line enhanced" "Detected in some" "A549: 6.4;CACO-2: 5.1;EFO-21: 2.9;Hep G2: 2.9;hTCEpi: 3.5;NTERA-2: 4.6;SCLC-21H: 5.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 14.1" "Region enriched" "Detected in many" 8 "basal ganglia: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA030251, HPA030252" Approved Supported "HPA030251: AB_10611108, HPA030252: AB_10601993" "unprognostic (5.22e-6)" "unprognostic (3.13e-2)" "unprognostic (1.04e-2)" "prognostic favourable (1.07e-5)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (1.64e-2)" "unprognostic (1.08e-1)" "unprognostic (4.04e-1)" "unprognostic (1.31e-1)" "unprognostic (7.05e-3)" "unprognostic (2.48e-1)" "prognostic favourable (5.76e-5)" "unprognostic (1.51e-2)" "unprognostic (1.66e-2)" "unprognostic (2.03e-4)" "unprognostic (4.23e-2)" 1.0 1.3 0.5 0.4 14.2 0.0 0.4 1.5 1.4 2.3 1.1 1.2 1.0 0.9 3.7 2.2 0.7 2.2 2.9 2.7 0.9 0.5 2.2 2.4 2.0 0.4 1.1 0.9 0.9 1.6 0.0 0.4 54.8 1.7 6.1 0.4 1.6 5.3 0.5 0.4 5.6 0.8 0.8 0.7 0.4 0.5 1.0 0.7 0.9 0.4 0.4 0.8 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.8 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 14.2 1.5 1.4 0.9 0.5 1.1 0.9 1.7 0.7 DAGLA "C11orf11, DAGLALPHA, KIAA0659, NSDDR" ENSG00000134780 "Diacylglycerol lipase alpha" Q9Y4D2 11 61680433-61747001 "Disease related genes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.0;T-47d: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;intermediate monocyte: 1.9;non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062497, CAB078793" Approved Supported "CAB078793: , HPA062497: " "unprognostic (2.53e-3)" "unprognostic (1.85e-1)" "unprognostic (1.26e-2)" "prognostic unfavourable (1.13e-7)" "unprognostic (1.23e-1)" "unprognostic (1.70e-1)" "unprognostic (1.14e-4)" "unprognostic (2.22e-2)" "unprognostic (2.29e-3)" "unprognostic (3.99e-3)" "unprognostic (1.55e-1)" "unprognostic (1.09e-1)" "unprognostic (1.11e-3)" "unprognostic (1.53e-1)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.14e-2)" 3.7 2.5 7.2 2.8 13.3 1.1 3.0 12.0 22.0 3.1 6.0 3.6 3.1 4.4 2.7 3.8 4.7 3.8 2.9 3.8 8.6 6.0 2.3 0.5 3.2 1.3 3.7 7.4 1.2 8.8 1.7 3.3 1.7 4.5 3.5 3.7 2.5 7.9 4.0 3.1 1.1 5.2 3.2 1.4 3.4 2.9 3.3 2.7 0.0 1.6 2.0 1.0 1.7 1.4 0.0 0.8 0.0 1.9 0.0 0.1 0.3 5.3 6.1 4.7 0.9 1.1 1.7 0.8 2.5 0.7 2.8 3.0 3.5 11.0 0.0 2.6 2.2 3.2 0.8 0.0 1.2 0.0 3.1 0.0 4.5 5.4 1.8 0.0 1.0 0.9 0.3 3.6 0.0 0.8 0.0 0.0 1.3 2.5 0.0 0.0 9.7 5.9 0.0 0.7 0.0 1.0 1.3 9.8 5.4 1.4 2.3 1.7 12.1 3.1 3.3 1.9 8.5 5.1 3.0 0.0 0.0 0.0 5.1 1.4 2.9 0.0 1.4 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.3 7.2 13.3 12.0 21.5 8.6 6.0 3.7 7.4 4.5 2.7 DAO DAMOX ENSG00000110887 "D-amino acid oxidase" P14920 12 108858932-108901043 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 39 "brain: 37.0;kidney: 39.0;liver: 64.2" "Cell line enhanced" "Detected in some" "AF22: 1.3;ASC TERT1: 1.3;BEWO: 1.5;Hep G2: 4.4;HL-60: 1.7;HMC-1: 1.3;RH-30: 1.2" "Cancer enriched" "Detected in some" 9 "liver cancer: 13.2" "Group enriched" "Detected in many" 5 "cerebellum: 37.0;pons and medulla: 31.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "cerebellum: 74.4;pons and medulla: 21.1" "Low region specificity" "Detected in many" "HPA038653, HPA038654" Enhanced "Intracellular and membrane" "HPA038653: AB_10673016, HPA038654: AB_10673285" "unprognostic (1.50e-1)" "unprognostic (5.61e-2)" "unprognostic (1.43e-1)" "unprognostic (2.91e-1)" "unprognostic (2.18e-1)" "unprognostic (2.99e-2)" "unprognostic (2.31e-3)" "unprognostic (8.02e-2)" "unprognostic (2.88e-2)" "unprognostic (9.59e-2)" "unprognostic (9.07e-2)" "unprognostic (7.13e-2)" "prognostic favourable (4.11e-4)" "unprognostic (3.44e-3)" "unprognostic (8.96e-2)" "unprognostic (2.67e-1)" "unprognostic (2.17e-1)" 0.3 0.2 0.0 0.2 2.7 0.2 0.2 37.0 0.7 0.2 0.9 11.5 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.9 39.0 64.2 0.3 0.2 6.4 0.5 0.2 0.3 0.2 0.0 0.2 31.2 0.2 1.1 0.0 0.2 0.2 0.2 0.2 0.2 0.3 35.9 0.2 0.2 0.2 0.4 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 37.0 0.5 0.8 0.9 6.4 0.5 31.2 0.4 DAW1 "FLJ25955, ODA16, WDR69" ENSG00000123977 "Dynein assembly factor with WD repeats 1" Q8N136 2 227871054-227924344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 14.9;fallopian tube: 24.4;testis: 49.9" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 14.9;U-2197: 28.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 25.4" HPA046118 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" Nucleoplasm "Nuclear bodies, Plasma membrane" "HPA046118: AB_10961428" "unprognostic (1.23e-1)" "unprognostic (1.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (4.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.63e-3)" "unprognostic (2.90e-2)" "unprognostic (9.92e-3)" "unprognostic (1.54e-5)" "unprognostic (1.52e-1)" "unprognostic (6.83e-3)" "unprognostic (1.70e-1)" "unprognostic (3.08e-1)" 0.4 0.1 2.5 0.3 14.9 0.4 0.5 0.0 1.8 0.7 0.3 3.1 0.0 0.1 0.3 3.1 0.6 24.4 0.4 0.4 3.9 3.0 0.3 0.5 2.4 0.3 0.3 2.7 1.3 0.1 0.7 0.2 0.8 14.3 0.2 0.2 0.0 0.3 0.2 2.6 0.3 0.2 0.2 0.3 0.3 0.2 49.9 1.1 0.0 0.2 0.0 0.3 0.3 0.0 0.5 0.5 1.2 0.5 0.2 0.8 0.0 0.6 0.0 0.1 0.0 0.2 0.9 0.4 0.5 0.3 0.6 0.4 3.6 0.3 0.2 0.0 0.1 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 1.3 0.0 0.7 0.5 14.9 0.0 0.2 0.2 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.1 0.3 1.5 0.1 1.4 28.1 0.0 0.0 0.1 0.2 2.7 0.0 0.2 1.2 0.0 0.2 0.2 0.5 0.8 0.3 0.4 0.4 0.0 0.5 0.6 0.3 0.0 0.2 0.5 0.5 0.6 0.0 2.5 14.9 0.0 1.8 3.9 3.0 0.3 2.7 14.3 1.1 DBH DBM ENSG00000123454 "Dopamine beta-hydroxylase" P09172 9 133636360-133659344 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adrenal gland: 86.6;brain: 36.2;liver: 35.6" "Cell line enriched" "Detected in single" 340 "SH-SY5Y: 201.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 45 "pons and medulla: 36.2" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.0" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Region enriched" "Detected in some" 6 "pons and medulla: 23.2" "Region enriched" "Detected in single" 37 "pons and medulla: 25.1" "HPA002130, HPA005960, HPA070789" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" 2000000000 Vesicles "Endoplasmic reticulum" "HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312" "unprognostic (1.93e-3)" "unprognostic (7.52e-3)" "unprognostic (8.53e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-3)" "unprognostic (3.38e-3)" "unprognostic (3.39e-3)" "unprognostic (3.97e-2)" "unprognostic (1.71e-1)" "unprognostic (8.99e-2)" "unprognostic (5.80e-2)" "unprognostic (7.69e-2)" "unprognostic (2.81e-7)" "unprognostic (9.31e-2)" "unprognostic (6.77e-2)" "unprognostic (1.49e-2)" "unprognostic (5.06e-3)" 0.7 86.6 0.1 0.3 0.1 0.0 0.0 0.1 0.8 0.3 0.0 1.9 0.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.5 35.6 0.3 0.6 0.0 0.0 0.1 1.3 0.0 0.6 0.4 36.2 0.8 0.0 1.0 0.2 5.9 0.0 0.0 0.2 0.0 1.4 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.2 201.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.0 0.0 36.2 0.0 DBNDD1 "FLJ12582, MGC3101" ENSG00000003249 "Dysbindin domain containing 1" Q9H9R9 16 90004865-90020128 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.6;skeletal muscle: 39.7" "Cell line enhanced" "Detected in many" "MCF7: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "naive B-cell: 14.4" "Lineage enriched" "Detected in many" 6 "B-cells: 14.4" HPA043018 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA043018: AB_10794921" "unprognostic (1.07e-1)" "unprognostic (8.40e-2)" "unprognostic (8.70e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-2)" "unprognostic (4.18e-2)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.07e-2)" "unprognostic (9.52e-2)" "unprognostic (1.54e-1)" "unprognostic (2.86e-2)" "prognostic favourable (2.75e-7)" "unprognostic (1.03e-1)" "unprognostic (5.67e-1)" "unprognostic (2.44e-2)" "unprognostic (2.00e-2)" 2.1 6.9 21.5 2.3 13.7 0.8 4.7 16.1 31.6 2.6 2.0 6.5 1.9 1.9 1.4 9.6 13.9 3.9 3.9 3.4 15.7 14.6 6.9 6.2 3.0 3.9 17.6 9.4 3.1 14.1 6.3 3.0 0.6 19.2 3.7 1.8 3.9 11.9 3.8 39.7 3.9 1.2 1.6 6.8 1.6 4.3 1.1 4.5 0.0 3.6 2.3 4.7 2.0 2.3 14.4 0.1 0.6 0.0 0.0 2.5 0.8 7.7 11.8 1.1 14.2 0.3 0.1 8.4 1.7 2.1 3.5 1.7 11.4 6.3 0.0 0.9 0.3 8.0 12.4 0.3 3.3 0.0 22.7 0.0 1.6 18.7 0.5 0.1 1.3 0.3 1.0 5.9 0.0 14.9 2.2 0.1 1.2 46.7 0.0 9.7 19.8 5.0 4.7 10.8 0.2 19.4 1.4 17.1 18.3 1.9 1.7 14.6 11.0 1.3 12.0 2.7 5.3 0.1 7.7 0.0 0.1 0.0 1.1 0.9 6.8 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.6 0.4 0.0 14.4 2.5 0.4 0.0 0.0 0.0 0.1 0.0 0.8 21.5 13.7 16.1 31.6 15.7 14.6 17.6 9.4 19.2 4.5 DBNDD2 "C20orf35, HSMNP1" ENSG00000244274 "Dysbindin domain containing 2" Q9BQY9 20 45406057-45410610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 160.5;skeletal muscle: 84.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "dendritic cells: 15.0;monocytes: 9.3;T-cells: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043991 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043991: AB_10966212" "unprognostic (6.33e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.79e-3)" "unprognostic (2.45e-1)" "unprognostic (1.62e-1)" "unprognostic (1.31e-3)" "unprognostic (8.24e-2)" "unprognostic (5.44e-2)" "unprognostic (3.06e-1)" "unprognostic (3.71e-2)" "unprognostic (2.47e-1)" "unprognostic (1.41e-3)" "unprognostic (2.52e-1)" "unprognostic (1.21e-1)" "unprognostic (2.52e-2)" "unprognostic (3.48e-1)" 12.2 7.8 56.5 9.9 64.9 2.1 15.3 21.3 88.8 11.0 26.4 132.3 5.0 16.6 14.9 13.6 18.3 17.7 10.2 68.4 85.1 47.3 5.9 2.5 13.9 5.8 98.2 31.5 6.5 6.7 18.4 5.0 13.2 51.8 14.2 28.4 3.1 9.0 29.1 84.2 10.4 19.4 31.0 160.5 5.0 13.3 3.0 70.7 2.7 4.8 10.5 8.2 16.8 8.2 0.3 15.0 0.3 9.3 0.6 7.9 3.5 21.4 3.8 3.1 21.7 2.0 0.9 4.3 12.6 13.8 10.6 7.2 10.4 29.4 0.3 2.2 12.4 31.8 21.2 1.1 6.5 0.1 12.5 17.9 16.6 9.4 12.7 0.9 27.3 0.3 3.6 4.0 3.7 7.2 1.2 0.4 0.8 27.2 1.5 1.3 4.0 22.9 0.0 0.3 0.2 30.2 0.4 7.1 3.6 4.4 2.4 27.2 29.8 5.5 11.6 0.4 21.1 14.0 13.8 0.3 0.4 0.1 1.5 0.1 3.1 0.0 8.4 0.0 7.9 9.3 2.9 0.1 6.9 5.8 6.0 0.3 6.4 6.0 0.3 0.6 5.0 15.0 5.8 3.5 56.5 64.9 21.3 62.5 85.1 47.3 98.2 31.5 51.8 70.7 DBX2 FLJ16139 ENSG00000185610 "Developing brain homeobox 2" Q6ZNG2 12 45014672-45051099 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.7" "Group enriched" "Detected in some" 4 "HEK 293: 1.2;HeLa: 1.6;SCLC-21H: 1.7" "Cancer enriched" "Detected in single" 32 "glioma: 4.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066053 Uncertain "HPA066053: " "unprognostic (1.13e-4)" "unprognostic (9.99e-2)" "unprognostic (7.82e-3)" "unprognostic (5.24e-2)" "unprognostic (5.62e-2)" "unprognostic (1.51e-1)" "unprognostic (9.22e-2)" "unprognostic (4.76e-2)" "unprognostic (1.64e-1)" "unprognostic (5.19e-1)" 2.0 0.5 4.4 0.5 3.6 0.5 1.8 1.2 10.7 0.9 0.5 5.1 0.2 0.4 0.5 0.4 0.6 0.6 0.7 0.9 4.4 4.6 1.1 0.4 0.5 0.5 5.9 3.1 0.4 0.4 0.5 0.0 0.4 10.3 0.7 0.5 0.0 0.8 0.7 0.7 2.1 0.4 0.5 10.3 0.4 0.5 2.9 1.8 0.0 0.7 1.3 0.6 0.6 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.4 3.6 1.2 4.6 4.4 4.6 5.9 3.1 10.3 1.8 DCC "IGDCC1, NTN1R1" ENSG00000187323 "DCC netrin 1 receptor" P43146 18 52340172-53535903 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 22.0;testis: 16.5" "Group enriched" "Detected in some" 4 "AF22: 15.1;U-266/70: 46.8;U-266/84: 22.0" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055376, HPA069552" Enhanced Supported "Golgi apparatus" 25000 "Golgi apparatus" "HPA055376: , HPA069552: " "unprognostic (1.96e-3)" "unprognostic (1.69e-2)" "unprognostic (3.13e-1)" "unprognostic (3.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.35e-3)" "unprognostic (2.59e-1)" "unprognostic (5.59e-2)" "unprognostic (2.00e-1)" "unprognostic (2.58e-1)" "unprognostic (8.22e-4)" "unprognostic (4.14e-2)" "unprognostic (1.27e-4)" "unprognostic (7.21e-2)" "unprognostic (1.84e-2)" "unprognostic (1.42e-1)" "unprognostic (2.69e-3)" 0.5 1.9 6.3 0.8 22.0 0.4 0.6 0.7 10.1 0.8 0.9 1.3 0.0 0.5 0.4 1.0 0.7 0.7 0.5 0.5 18.4 2.0 0.9 0.5 3.8 0.4 1.5 9.9 0.7 1.2 0.6 1.1 0.4 5.3 1.3 0.8 0.0 0.8 3.5 0.4 0.8 0.7 0.5 2.4 0.8 0.8 16.5 6.5 0.7 0.5 0.0 1.1 0.8 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 46.8 22.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 22.0 0.7 10.1 18.4 2.0 1.5 9.9 5.3 6.5 DCDC1 ENSG00000170959 "Doublecortin domain containing 1" P59894 11 30830369-31369810 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.2;pituitary gland: 26.7" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.8;U-266/70: 5.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "basal ganglia: 5.6;pons and medulla: 19.2" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "unprognostic (1.01e-2)" "unprognostic (1.57e-1)" "unprognostic (8.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.78e-2)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (5.68e-2)" "unprognostic (4.73e-1)" "unprognostic (3.17e-1)" "unprognostic (4.47e-3)" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-3)" "unprognostic (2.61e-1)" 0.6 0.6 1.0 0.1 5.6 0.2 1.0 0.4 1.0 1.3 0.5 2.7 3.3 0.1 1.3 13.3 0.4 9.9 4.3 0.5 1.9 1.6 3.4 6.4 4.8 0.2 0.6 0.2 4.2 2.4 3.9 26.7 0.2 19.2 0.6 0.2 2.8 0.7 2.0 0.4 0.5 0.4 0.2 0.6 0.4 0.5 11.5 1.1 0.0 2.8 0.0 0.2 0.5 1.3 0.0 0.0 1.4 0.0 0.0 0.9 0.0 0.2 1.1 0.8 0.6 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.4 0.1 0.1 1.0 0.4 0.5 0.0 0.1 1.4 0.0 0.1 0.3 0.7 0.0 0.3 0.3 0.0 0.3 0.1 0.2 0.1 0.2 0.0 1.4 0.0 0.0 0.3 0.0 2.8 0.0 0.8 0.1 1.4 0.0 0.1 0.2 0.0 0.1 0.5 0.7 1.1 0.2 5.4 0.3 0.2 1.2 0.0 0.3 1.4 0.0 0.0 0.4 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 5.6 0.4 1.0 1.9 1.6 0.6 0.2 19.2 1.1 DCLK1 "DCAMKL1, DCDC3A, DCLK, KIAA0369" ENSG00000133083 "Doublecortin like kinase 1" O15075 13 35768652-36131306 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 76.5" "Cell line enhanced" "Detected in some" "ASC diff: 17.3;ASC TERT1: 16.4;fHDF/TERT166: 13.3;HAP1: 10.3;HSkMC: 15.1;NTERA-2: 21.4" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012405, HPA015040, HPA015655" Enhanced Approved Nucleoplasm,Cytosol 11000 Nucleoplasm Cytosol "CAB012405: , HPA015040: , HPA015655: " "unprognostic (2.29e-1)" "unprognostic (2.56e-1)" "unprognostic (7.45e-2)" "unprognostic (1.30e-2)" "unprognostic (1.99e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" "unprognostic (3.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-1)" "unprognostic (7.72e-2)" "unprognostic (2.85e-1)" "prognostic unfavourable (4.42e-4)" "unprognostic (1.93e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-4)" 13.9 3.3 14.3 4.2 25.0 1.1 8.6 8.6 76.5 12.2 3.5 8.6 0.5 2.0 6.4 5.8 5.8 3.3 7.1 5.8 21.9 21.9 1.9 1.2 3.0 4.3 11.9 22.5 6.4 2.1 1.5 7.4 1.1 13.9 4.7 4.4 0.5 2.5 4.7 1.9 4.7 2.7 17.0 10.4 4.6 2.5 2.2 8.5 0.0 2.1 1.4 2.9 5.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.0 17.3 16.4 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 13.3 0.0 10.3 0.2 0.0 0.0 0.6 0.0 0.4 0.0 0.6 0.0 0.0 15.1 7.5 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 21.4 0.2 0.0 1.2 0.0 0.6 0.0 4.3 2.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.5 4.4 0.7 0.1 0.0 0.0 1.4 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 25.0 8.6 45.8 21.9 21.9 11.9 22.5 13.9 8.5 DCLK2 "DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428" ENSG00000170390 "Doublecortin like kinase 2" Q8N568 4 150078274-150257457 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 60.5" "Cell line enhanced" "Detected in many" "AF22: 18.2;BJ hTERT+: 19.0;fHDF/TERT166: 8.3" "Cancer enriched" "Detected in many" 17 "glioma: 53.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.5;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015770 Enhanced "HPA015770: AB_1847509" "unprognostic (7.37e-2)" "unprognostic (1.56e-3)" "unprognostic (9.30e-2)" "unprognostic (1.49e-2)" "unprognostic (4.06e-1)" "unprognostic (6.24e-3)" "unprognostic (1.90e-1)" "unprognostic (7.38e-3)" "unprognostic (2.18e-1)" "prognostic favourable (3.25e-4)" "prognostic favourable (2.48e-4)" "unprognostic (6.87e-2)" "unprognostic (3.93e-3)" "unprognostic (3.74e-3)" "unprognostic (4.53e-2)" "unprognostic (1.48e-1)" "unprognostic (1.45e-2)" 2.9 3.9 23.3 2.1 23.5 1.6 2.0 9.3 60.5 3.1 2.8 16.5 0.8 2.8 4.3 3.5 3.0 2.8 4.0 14.4 23.5 17.5 2.9 1.8 2.7 1.6 14.9 14.5 4.3 3.5 1.4 4.7 2.9 20.2 3.9 3.5 2.1 2.0 3.6 2.3 2.1 2.7 6.4 23.4 2.1 2.2 4.2 15.9 0.0 4.1 0.0 1.5 3.3 2.0 2.5 1.5 0.0 0.5 0.0 0.0 0.0 0.8 3.2 18.2 2.8 0.0 0.9 0.3 8.2 19.0 2.7 0.6 0.1 0.0 0.0 0.3 8.3 0.0 2.6 0.0 3.4 3.7 1.6 0.0 4.7 0.0 3.9 0.5 0.5 0.5 0.0 1.6 0.2 0.9 0.0 0.0 1.9 0.1 0.3 0.0 0.3 1.0 0.0 2.1 0.7 0.0 0.8 7.0 6.6 3.4 2.5 0.8 0.0 0.0 1.6 2.5 1.0 1.6 0.9 0.8 0.0 0.0 2.4 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 23.3 23.5 9.3 19.3 23.5 17.5 14.9 14.5 20.2 15.9 DCLK3 "DCAMKL3, DCDC3C, KIAA1765" ENSG00000163673 "Doublecortin like kinase 3" Q9C098 3 36712422-36764349 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.0;testis: 8.0" "Cell line enhanced" "Detected in some" "NTERA-2: 3.3;SCLC-21H: 3.2;SH-SY5Y: 2.6;U-2 OS: 1.8;U-2197: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Region enhanced" "Detected in many" "basal ganglia: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040685 Approved "HPA040685: " "unprognostic (9.09e-3)" "unprognostic (1.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.66e-2)" "unprognostic (2.41e-1)" "unprognostic (1.80e-1)" "unprognostic (1.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.96e-2)" "unprognostic (1.86e-2)" "unprognostic (2.05e-1)" "unprognostic (7.07e-2)" "unprognostic (6.11e-5)" "unprognostic (7.94e-3)" "unprognostic (5.80e-2)" "unprognostic (3.25e-3)" "unprognostic (1.36e-2)" 1.1 0.4 2.6 1.4 10.0 0.3 0.1 0.1 2.3 0.5 0.2 0.3 0.0 0.5 0.3 0.1 0.1 0.2 0.6 0.9 1.4 0.9 0.0 0.1 0.3 0.2 0.6 0.0 0.0 0.2 0.4 1.8 1.1 0.4 0.3 0.3 1.3 1.7 0.2 2.7 0.4 0.4 0.9 0.7 0.1 0.0 8.0 3.2 0.0 0.9 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 3.2 2.6 0.1 0.3 0.0 0.0 0.4 0.3 0.0 1.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 10.0 0.1 2.3 1.4 0.9 0.6 0.0 0.4 3.2 DCUN1D2 "C13orf17, FLJ10704, FLJ20092" ENSG00000150401 "Defective in cullin neddylation 1 domain containing 2" Q6PH85 13 113455819-113490952 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 24.0;heart muscle: 59.1;skeletal muscle: 65.6" "Cell line enhanced" "Detected in all" "SCLC-21H: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039349 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039349: AB_10673240" "unprognostic (3.09e-1)" "unprognostic (1.35e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (7.43e-2)" "unprognostic (7.68e-2)" "unprognostic (4.33e-2)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (2.02e-2)" "prognostic favourable (5.65e-5)" "unprognostic (1.21e-2)" "unprognostic (7.20e-2)" "unprognostic (3.57e-2)" "unprognostic (1.28e-1)" "unprognostic (3.69e-2)" "unprognostic (1.25e-2)" 4.9 4.5 6.2 6.0 7.0 7.8 4.6 24.0 13.3 4.1 4.3 6.5 3.4 3.1 6.2 6.6 4.7 4.0 4.9 59.1 5.9 7.2 4.3 4.0 3.8 4.6 7.2 5.9 5.5 4.5 3.5 7.1 5.2 9.7 3.9 4.5 6.2 4.5 4.5 65.6 9.1 5.4 5.2 8.5 4.9 4.3 5.6 6.1 5.3 3.3 7.5 4.9 3.8 3.7 3.5 2.7 10.9 2.2 2.8 4.1 1.8 6.7 4.2 7.1 5.4 5.2 4.6 5.5 5.3 6.5 5.0 5.7 15.0 4.1 4.9 1.7 6.1 9.8 7.6 4.0 7.2 3.2 12.8 8.3 19.2 4.1 2.7 12.6 6.2 6.8 6.7 5.6 4.5 4.2 4.6 4.7 4.8 4.8 8.6 20.8 4.5 6.6 9.0 11.7 6.5 3.7 4.5 31.6 7.0 4.1 14.2 3.9 8.1 5.9 7.0 6.6 9.0 5.0 7.6 14.0 5.9 9.8 15.0 5.6 4.4 10.9 1.9 3.6 3.1 1.7 4.1 3.5 2.8 1.9 2.7 1.9 3.0 1.6 1.5 2.8 2.2 0.3 2.9 1.8 6.2 7.0 24.0 13.3 5.9 7.2 7.2 5.9 9.7 6.1 DCX "DBCN, DC, LISX, SCLH, XLIS" ENSG00000077279 Doublecortin O43602 X 111293779-111412429 "Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Epilepsy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.1;testis: 6.4" "Group enriched" "Detected in some" 8 "SCLC-21H: 33.8;SH-SY5Y: 13.9" "Cancer enriched" "Detected in some" 5 "glioma: 5.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "olfactory region: 90.9" "Region enriched" "Detected in all" 4 "olfactory region: 130.1" HPA036121 Enhanced Supported Approved Cytosol Cytosol "HPA036121: " "unprognostic (1.36e-2)" "unprognostic (1.99e-1)" "unprognostic (7.36e-2)" "unprognostic (4.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (2.00e-2)" "unprognostic (7.18e-2)" "unprognostic (3.24e-2)" "unprognostic (2.33e-3)" "unprognostic (3.67e-1)" "unprognostic (4.90e-4)" "unprognostic (5.02e-3)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" 0.8 1.1 7.0 0.7 9.2 0.7 3.2 0.7 17.1 0.7 0.6 0.9 0.0 0.7 4.1 3.6 0.6 0.6 0.8 0.7 4.2 5.4 0.5 0.5 0.6 0.7 2.5 6.7 0.6 0.8 0.5 1.0 0.6 3.7 0.5 0.8 0.0 2.2 0.6 0.5 0.7 0.7 0.6 3.0 0.6 1.2 6.4 2.3 0.0 0.6 0.0 0.5 0.6 0.3 0.3 0.4 0.6 0.2 0.7 0.4 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 33.8 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.2 0.1 0.4 0.3 0.3 0.2 0.1 0.3 0.3 0.3 0.6 0.7 0.0 0.4 0.1 0.0 7.0 9.2 0.7 10.8 4.2 5.4 2.5 6.7 3.7 2.3 DDN KIAA0749 ENSG00000181418 Dendrin O94850 12 48995149-48999309 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 40.8;skeletal muscle: 73.8" "Cell line enhanced" "Detected in some" "HAP1: 10.3;RPMI-8226: 19.7;SCLC-21H: 10.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 33 "amygdala: 228.1;basal ganglia: 257.7;cerebral cortex: 232.0;hippocampal formation: 236.4;olfactory region: 128.1" HPA060952 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA060952: " "unprognostic (2.80e-2)" "unprognostic (3.19e-3)" "unprognostic (4.56e-2)" "unprognostic (8.10e-3)" "unprognostic (1.63e-1)" "unprognostic (1.79e-3)" "unprognostic (6.20e-5)" "unprognostic (8.61e-4)" "unprognostic (2.12e-1)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (5.08e-2)" "unprognostic (1.37e-6)" "unprognostic (1.72e-2)" "unprognostic (5.49e-2)" "unprognostic (1.61e-2)" "unprognostic (1.53e-2)" 0.7 0.7 40.5 0.8 40.8 1.3 0.7 0.0 38.5 0.7 0.7 0.2 0.0 0.7 0.7 3.8 1.0 0.7 0.7 0.9 30.5 2.0 4.8 0.7 0.7 0.9 2.9 9.3 0.7 0.8 0.8 0.0 0.7 0.0 1.6 0.7 0.0 0.7 0.7 73.8 0.8 0.8 0.7 0.0 0.8 0.8 0.8 1.2 0.0 0.7 0.0 0.8 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.3 0.3 0.2 0.6 0.0 0.0 0.1 0.1 0.1 0.1 0.2 4.4 0.4 0.0 0.2 0.0 1.5 10.3 0.0 0.1 0.5 4.7 2.3 0.5 1.0 0.0 5.3 0.2 0.0 0.1 0.1 0.0 0.1 0.0 3.5 0.2 0.1 5.2 5.8 0.1 1.4 4.8 0.3 19.7 0.0 0.1 10.3 1.0 0.2 0.5 0.2 0.2 0.7 0.1 0.2 0.5 0.2 0.0 1.2 2.3 4.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 40.5 40.8 0.0 31.9 30.5 2.0 2.9 9.3 0.0 1.2 DDX25 GRTH ENSG00000109832 "DEAD-box helicase 25" Q9UHL0 11 125903348-125943702 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport" "Developmental protein, Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.3;testis: 64.2" "Group enriched" "Detected in some" 4 "NTERA-2: 13.6;SCLC-21H: 11.0" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020137 Enhanced "HPA020137: AB_1847552" "unprognostic (5.78e-3)" "unprognostic (9.75e-3)" "unprognostic (7.93e-2)" "unprognostic (5.09e-3)" "unprognostic (1.11e-2)" "unprognostic (1.78e-2)" "unprognostic (1.54e-1)" "unprognostic (2.91e-3)" "unprognostic (6.24e-5)" "unprognostic (2.57e-1)" "unprognostic (2.44e-3)" "unprognostic (3.89e-1)" "unprognostic (3.44e-3)" "unprognostic (1.44e-1)" "unprognostic (1.76e-1)" "unprognostic (9.72e-2)" "unprognostic (1.69e-1)" 0.7 2.8 8.7 0.8 13.2 0.9 0.8 7.9 17.3 0.8 0.8 2.0 0.0 1.0 0.9 0.9 0.8 0.9 0.8 0.7 8.4 7.1 2.7 0.8 0.8 0.8 4.8 8.9 1.2 1.8 2.6 7.1 0.9 5.9 0.9 0.8 2.3 0.8 1.0 0.8 1.6 0.8 0.7 3.4 0.9 1.0 64.2 3.0 0.0 4.3 0.0 0.8 0.7 0.2 0.6 0.5 3.3 0.3 1.3 0.5 0.1 0.0 0.0 2.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.9 0.0 0.2 1.5 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.6 2.0 0.1 13.6 0.0 0.5 0.0 0.0 0.0 0.1 11.0 2.5 0.2 0.0 1.9 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.8 2.1 0.3 0.6 0.3 0.2 0.2 0.4 0.5 0.2 0.1 0.6 0.4 0.3 3.3 1.3 0.2 0.5 0.1 0.1 8.7 13.2 7.9 12.5 8.4 7.1 4.8 8.9 5.9 3.0 DEAF1 "NUDR, SPN, ZMYND5" ENSG00000177030 "DEAF1, transcription factor" O75398 11 644233-706715 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.1" "Cell line enhanced" "Detected in many" "HEK 293: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030302 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Intracellular and membrane" Nucleoplasm "Nucleoli fibrillar center" "HPA030302: " "unprognostic (1.32e-2)" "unprognostic (3.32e-2)" "unprognostic (3.58e-3)" "unprognostic (5.90e-2)" "prognostic unfavourable (9.70e-4)" "unprognostic (1.54e-2)" "prognostic unfavourable (1.75e-4)" "unprognostic (2.42e-2)" "unprognostic (2.65e-1)" "unprognostic (2.48e-1)" "unprognostic (2.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.39e-2)" "unprognostic (2.79e-1)" "unprognostic (3.03e-1)" "unprognostic (1.20e-1)" "unprognostic (5.15e-2)" 4.8 5.9 36.1 6.5 19.9 4.5 16.9 19.4 26.2 5.4 4.3 5.3 5.2 4.8 7.5 6.3 6.8 9.8 6.0 8.3 30.2 15.7 4.5 2.8 5.3 4.4 18.3 3.4 6.0 13.2 5.9 14.5 5.2 9.7 6.7 2.2 3.6 11.8 4.7 7.8 6.6 4.0 7.2 8.1 4.0 7.2 5.7 9.8 15.2 12.0 2.7 5.3 7.0 20.3 1.2 4.4 3.3 3.0 3.5 5.9 1.6 7.3 4.5 7.3 3.9 7.1 9.4 5.7 5.4 7.1 11.7 8.5 4.8 6.3 2.1 6.0 5.4 4.9 7.0 5.0 1.7 9.0 41.4 4.9 2.5 3.7 12.9 10.8 8.0 7.9 6.9 2.1 5.9 9.2 10.9 8.7 4.4 3.7 4.0 9.9 17.0 9.5 9.9 2.5 8.1 8.2 0.9 10.4 10.9 4.0 5.9 3.9 3.6 3.1 10.6 3.8 2.1 1.6 4.7 9.6 3.5 3.8 4.4 7.2 7.5 0.0 3.0 3.3 2.4 1.7 2.6 1.2 4.7 2.7 4.4 0.8 5.9 3.2 1.8 3.5 1.9 0.5 1.7 1.6 36.1 19.9 19.4 26.2 30.2 15.7 18.3 3.4 9.7 9.8 DGKB "DAGK2, DGK, DGK-BETA, KIAA0718" ENSG00000136267 "Diacylglycerol kinase beta" Q9Y6T7 7 14145049-14974777 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 37.7" "Cell line enhanced" "Detected in some" "AF22: 2.7;fHDF/TERT166: 5.5;hTEC/SVTERT24-B: 2.1;SCLC-21H: 2.8;SH-SY5Y: 2.1;U-266/70: 7.4" "Cancer enriched" "Detected in single" 11 "glioma: 1.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020321 Supported "HPA020321: " "unprognostic (9.89e-2)" "unprognostic (9.72e-5)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (4.32e-2)" "unprognostic (3.37e-1)" "unprognostic (7.34e-2)" "unprognostic (5.91e-2)" "unprognostic (6.19e-2)" "unprognostic (8.87e-2)" "unprognostic (2.72e-2)" "unprognostic (1.18e-1)" "unprognostic (5.98e-2)" "unprognostic (2.37e-3)" "unprognostic (6.13e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-4)" 1.1 5.2 11.5 1.1 37.7 0.8 0.8 1.3 34.0 4.9 1.6 1.4 0.0 0.9 6.1 0.9 1.6 2.7 1.3 1.4 10.5 4.3 2.6 1.1 0.8 0.8 2.2 11.3 0.8 0.9 0.8 1.8 0.7 4.8 1.1 1.7 0.0 0.9 0.9 1.2 0.9 1.2 3.1 3.5 0.8 0.8 0.9 7.9 0.0 0.9 0.0 0.8 1.5 0.6 0.7 0.6 1.3 0.3 0.6 0.5 0.1 0.1 0.0 2.7 0.1 0.0 0.2 0.1 0.0 1.2 0.0 0.3 0.2 0.0 0.1 0.0 5.5 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.0 2.8 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 7.4 0.0 0.0 0.1 0.1 0.1 0.7 0.3 0.3 0.5 0.2 0.4 0.3 0.5 0.2 0.1 0.7 0.5 0.4 1.3 0.6 0.2 0.6 0.2 0.1 11.5 37.7 1.3 19.1 10.5 4.3 2.2 11.3 4.8 7.9 DGKG DAGK3 ENSG00000058866 "Diacylglycerol kinase gamma" P49619 3 186105668-186362237 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.4" "Cell line enhanced" "Detected in some" "HDLM-2: 19.8;HL-60: 6.3;U-266/84: 7.5;U-87 MG: 12.5;U-937: 5.9" "Cancer enhanced" "Detected in some" "glioma: 2.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036577 Approved Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA036577: AB_10672358" "unprognostic (2.23e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-2)" "unprognostic (3.24e-5)" "unprognostic (2.70e-1)" "unprognostic (6.09e-4)" "unprognostic (1.21e-3)" "unprognostic (3.80e-2)" "unprognostic (5.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.94e-1)" "unprognostic (5.09e-2)" "unprognostic (8.05e-7)" "unprognostic (3.47e-3)" "unprognostic (7.19e-2)" "unprognostic (1.41e-1)" "unprognostic (9.16e-3)" 3.1 6.9 13.4 3.1 7.1 14.5 1.9 53.4 23.1 2.7 3.5 6.2 1.1 3.0 1.9 14.6 8.5 7.7 2.2 15.0 15.3 7.4 3.1 2.1 4.3 2.1 7.4 11.3 2.0 1.6 4.7 7.5 13.5 25.2 3.1 2.1 7.8 1.9 4.0 2.4 1.4 2.7 5.3 5.6 2.0 3.3 1.2 7.1 0.0 2.5 0.0 2.1 4.8 2.4 0.6 2.9 5.3 4.2 0.0 0.0 1.3 2.6 4.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 2.3 0.0 0.2 0.0 0.0 0.0 19.8 0.0 2.6 0.0 2.9 0.0 6.3 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.3 0.1 0.1 2.2 0.4 1.2 1.4 0.0 2.2 0.0 0.0 0.5 0.0 0.8 0.0 1.6 0.1 4.1 0.0 0.0 0.7 2.0 2.4 0.0 7.5 0.0 12.5 5.9 2.3 0.0 4.2 2.4 0.0 2.4 0.0 0.6 0.0 0.0 2.9 0.3 0.0 0.0 5.3 0.0 2.8 0.5 0.0 1.3 13.4 7.1 53.4 14.7 15.3 7.4 7.4 11.3 25.2 7.1 DGKI DGK-IOTA ENSG00000157680 "Diacylglycerol kinase iota" O75912 7 137381037-137847092 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8;thyroid gland: 32.1" "Cell line enhanced" "Detected in some" "BJ: 4.0;hTEC/SVTERT24-B: 4.1;SCLC-21H: 6.7;U-2197: 18.5;U-87 MG: 6.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" "unprognostic (6.66e-3)" "unprognostic (1.76e-1)" "unprognostic (6.08e-2)" "unprognostic (1.42e-1)" "unprognostic (9.62e-2)" "unprognostic (2.23e-1)" "unprognostic (1.09e-1)" "unprognostic (9.01e-2)" "unprognostic (8.74e-2)" "unprognostic (4.46e-2)" "unprognostic (5.98e-5)" "unprognostic (2.85e-3)" "unprognostic (1.85e-1)" "unprognostic (1.26e-2)" "unprognostic (1.73e-3)" 1.5 1.3 5.0 1.1 19.8 0.7 1.1 11.4 12.7 0.8 0.9 2.6 0.0 0.9 1.4 0.9 0.9 0.9 1.9 5.0 4.6 3.3 1.7 0.7 0.8 0.8 2.8 9.0 0.8 0.7 0.8 6.0 0.8 6.6 1.0 0.9 10.8 1.0 1.1 0.7 0.9 0.9 2.7 2.5 0.8 0.8 1.9 5.8 0.0 32.1 0.0 0.8 1.1 0.3 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.9 0.9 0.0 4.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.2 0.0 4.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 6.7 2.8 0.0 0.0 0.5 0.0 0.0 0.3 1.6 0.6 18.5 0.9 0.1 0.0 0.0 6.9 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 5.0 19.8 11.4 12.7 4.6 3.3 2.8 9.0 6.6 5.8 DGKK ENSG00000274588 "Diacylglycerol kinase kappa" Q5KSL6 X 50365409-50470738 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "adrenal gland: 9.8;brain: 29.6;pituitary gland: 33.5" "Cell line enriched" "Detected in some" 20 "Hep G2: 27.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 2.4;memory CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Region enhanced" "Detected in some" "hypothalamus: 12.9" "Group enriched" "Detected in many" 5 "basal ganglia: 3.5;hypothalamus: 1.8;midbrain: 4.3;pons and medulla: 1.1" "unprognostic (3.99e-1)" "unprognostic (1.18e-1)" "unprognostic (4.18e-3)" "unprognostic (1.23e-1)" "unprognostic (5.83e-3)" "unprognostic (9.58e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-2)" "unprognostic (2.06e-1)" "unprognostic (4.28e-3)" "unprognostic (3.89e-2)" "unprognostic (1.20e-1)" "unprognostic (9.49e-2)" "unprognostic (4.64e-3)" 0.1 9.8 0.0 0.0 29.6 0.2 0.3 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 33.5 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 DGKZ "DAGK5, DAGK6, DGK-ZETA, hDGKzeta" ENSG00000149091 "Diacylglycerol kinase zeta" Q13574 11 46332905-46380554 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051336 Enhanced Supported "Nuclear speckles" "Nuclear speckles" "HPA051336: " "unprognostic (2.85e-2)" "unprognostic (3.90e-2)" "unprognostic (2.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.40e-1)" "unprognostic (4.12e-2)" "unprognostic (3.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (2.49e-2)" "unprognostic (3.66e-3)" "unprognostic (8.18e-2)" "prognostic unfavourable (4.74e-5)" "unprognostic (1.48e-3)" "unprognostic (7.75e-2)" "unprognostic (3.61e-2)" "unprognostic (7.84e-3)" 8.6 6.7 34.5 11.8 27.4 28.0 6.8 22.6 50.7 7.5 7.4 8.5 2.5 21.0 6.1 4.3 7.1 6.3 6.7 16.0 48.0 9.2 5.3 3.3 8.3 20.7 9.4 26.7 5.0 17.3 7.0 18.6 8.4 7.5 5.9 4.2 4.8 24.1 7.0 42.8 8.3 23.2 5.6 7.2 15.6 9.9 5.0 7.5 14.2 4.1 9.1 9.9 7.6 5.0 0.9 12.3 11.2 11.8 7.7 7.5 8.1 11.7 10.5 7.1 10.7 3.8 4.2 33.2 9.2 6.9 9.8 8.6 12.5 5.5 15.1 6.7 9.5 13.7 8.6 13.3 3.5 15.1 20.0 9.9 7.7 9.1 6.8 18.6 19.9 5.7 6.3 5.3 7.3 10.7 13.8 9.4 6.9 31.0 17.9 29.2 20.8 16.2 21.4 12.4 6.4 3.0 11.6 49.0 8.3 10.5 35.3 7.2 25.4 23.5 12.0 12.9 14.0 20.3 16.5 6.2 7.0 12.4 17.6 16.9 11.9 11.2 11.8 5.8 7.5 6.1 4.5 0.4 4.7 6.3 12.3 0.9 4.9 5.0 9.8 7.7 5.9 5.9 4.5 8.1 34.5 27.4 22.6 50.7 48.0 9.2 9.4 26.7 7.5 7.5 DIRAS1 "Di-Ras1, GBTS1, RIG" ENSG00000176490 "DIRAS family GTPase 1" O95057 19 2714567-2721418 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 48.0;heart muscle: 52.0;parathyroid gland: 13.5" "Cell line enhanced" "Detected in many" "HMC-1: 22.4;REH: 24.2;SH-SY5Y: 14.4;THP-1: 16.9" "Cancer enhanced" "Detected in many" "glioma: 17.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 1.2;naive B-cell: 1.4" "Lineage enriched" "Detected in single" 15 "B-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (7.43e-2)" "unprognostic (1.13e-1)" "unprognostic (2.33e-2)" "unprognostic (1.66e-1)" "unprognostic (1.49e-1)" "unprognostic (4.19e-3)" "unprognostic (8.01e-3)" "unprognostic (2.68e-1)" "unprognostic (5.62e-2)" "unprognostic (3.60e-2)" "prognostic favourable (4.78e-4)" "unprognostic (3.00e-1)" "unprognostic (1.79e-3)" "unprognostic (5.47e-3)" "unprognostic (1.51e-1)" "unprognostic (1.03e-1)" "unprognostic (6.91e-4)" 1.3 2.9 12.8 1.7 20.1 1.2 2.0 20.6 48.0 3.4 1.7 3.0 0.1 1.7 6.9 2.8 5.2 2.8 1.3 52.0 14.8 8.5 2.5 0.7 1.0 1.2 10.0 16.2 1.8 6.1 13.5 8.2 1.0 19.1 3.1 1.6 2.4 6.0 2.3 1.4 1.6 1.8 6.8 2.9 2.2 2.6 4.2 1.3 0.0 1.0 1.8 1.3 1.6 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.6 12.3 0.4 1.7 0.0 4.1 1.4 0.2 0.0 0.7 0.2 0.0 0.5 10.9 0.0 5.1 0.0 0.0 0.0 8.0 0.2 0.4 0.4 0.5 0.0 22.4 0.7 2.6 0.0 0.1 0.0 7.2 3.6 1.4 1.8 0.1 0.2 7.7 1.7 24.2 0.0 5.8 0.0 0.0 1.6 14.4 0.1 0.5 7.7 0.5 16.9 0.0 2.8 3.5 0.1 1.3 8.5 5.9 4.4 6.1 0.2 12.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 20.1 20.6 48.0 14.8 8.5 10.0 16.2 19.1 1.3 DIRAS2 "Di-Ras2, DKFZp761C07121" ENSG00000165023 "DIRAS family GTPase 2" Q96HU8 9 90609832-90643105 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 65.3" "Cell line enhanced" "Detected in some" "AF22: 12.3;EFO-21: 3.6;SCLC-21H: 2.3" "Cancer enhanced" "Detected in many" "glioma: 5.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (1.20e-3)" "unprognostic (4.39e-2)" "unprognostic (1.35e-1)" "unprognostic (6.57e-2)" "unprognostic (4.27e-5)" "unprognostic (3.94e-2)" "unprognostic (4.37e-2)" "unprognostic (9.75e-3)" "unprognostic (9.85e-3)" "unprognostic (1.86e-1)" "unprognostic (5.70e-2)" "unprognostic (2.14e-1)" "unprognostic (5.39e-1)" "unprognostic (2.64e-3)" "unprognostic (2.05e-1)" 0.9 2.8 6.1 0.9 24.5 1.1 1.4 64.5 65.3 8.5 1.1 2.1 0.0 2.4 1.1 1.1 0.9 1.2 4.6 0.8 13.6 5.4 1.4 1.0 0.9 1.0 4.3 23.0 0.8 1.8 3.3 0.6 1.3 3.9 0.9 0.9 2.2 2.1 1.1 0.8 1.5 2.7 0.9 6.2 1.0 1.7 1.0 0.9 0.0 2.9 0.0 0.8 0.8 0.3 1.9 1.0 1.9 1.6 1.6 0.9 0.4 0.1 1.4 12.3 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 0.0 0.5 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.9 0.0 0.3 0.2 0.4 0.0 0.2 2.3 0.3 0.0 0.1 0.0 0.1 0.1 1.0 0.1 0.6 0.3 0.0 0.2 0.1 0.2 0.2 0.2 0.2 1.8 1.6 1.6 0.7 0.3 0.4 0.8 0.8 0.6 0.2 1.9 0.9 0.9 1.9 1.6 0.6 1.0 0.2 0.4 6.1 24.5 64.5 41.4 13.6 5.4 4.3 23.0 3.9 0.9 DIRAS3 "ARHI, NOEY2" ENSG00000162595 "DIRAS family GTPase 3" O95661 1 68045896-68051631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9;ovary: 33.2;pituitary gland: 35.2" "Cell line enhanced" "Detected in some" "HHSteC: 7.3;HSkMC: 15.3;TIME: 9.5;U-251 MG: 7.7;U-87 MG: 14.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 49.9" "Group enriched" "Detected in some" 18 "plasmacytoid DC: 2.1;T-reg: 1.8" "Group enriched" "Detected in many" 20 "dendritic cells: 2.1;T-cells: 1.8" "Low region specificity" "Detected in all" "HPA028483, HPA028557, HPA029384" Approved Approved "Nuclear membrane,Cytosol" "Nuclear membrane, Cytosol" "HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343" "prognostic favourable (9.21e-4)" "unprognostic (3.45e-1)" "unprognostic (3.17e-2)" "unprognostic (1.69e-2)" "unprognostic (1.15e-2)" "unprognostic (2.84e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (7.86e-2)" "unprognostic (8.35e-2)" "unprognostic (4.33e-1)" "prognostic favourable (9.21e-4)" "unprognostic (1.34e-1)" "unprognostic (4.99e-1)" "unprognostic (1.24e-2)" "unprognostic (5.07e-3)" 1.0 10.2 2.0 0.2 49.9 0.0 2.4 0.9 2.9 2.3 1.6 1.0 0.0 3.4 1.2 5.4 1.3 1.3 5.9 5.7 1.3 8.7 3.2 4.5 2.3 0.0 1.3 1.1 33.2 9.9 8.8 35.2 0.0 17.3 2.3 0.1 2.4 1.3 1.1 1.0 1.1 1.2 0.3 1.7 1.2 1.9 2.4 0.5 0.0 1.6 0.3 0.1 1.2 1.9 0.0 2.1 0.0 0.0 0.0 1.8 0.0 0.0 1.3 1.4 0.0 4.7 3.5 0.5 4.0 1.4 0.3 1.1 0.0 0.7 0.0 0.2 4.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.6 0.0 7.3 0.0 0.0 15.3 0.1 0.6 0.0 0.9 0.2 0.0 4.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.0 0.1 0.1 0.0 9.5 0.0 0.4 0.2 7.7 2.4 0.0 0.0 14.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.8 0.0 2.0 49.9 0.9 2.9 1.3 8.7 1.3 1.1 17.3 0.5 DIRC3 FLJ14199 ENSG00000231672 "Disrupted in renal carcinoma 3" 2 217284019-217756593 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.2;parathyroid gland: 5.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.8;HAP1: 1.1;SH-SY5Y: 1.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.29e-2)" "unprognostic (2.16e-1)" "unprognostic (3.15e-1)" "unprognostic (5.44e-6)" "unprognostic (3.39e-2)" "unprognostic (2.72e-1)" "unprognostic (9.31e-4)" "unprognostic (9.87e-2)" "unprognostic (2.14e-1)" "unprognostic (5.36e-3)" "unprognostic (2.95e-1)" "unprognostic (3.20e-2)" "unprognostic (4.88e-6)" "unprognostic (8.05e-3)" "unprognostic (1.51e-1)" "unprognostic (8.99e-2)" "unprognostic (4.83e-1)" 0.6 0.9 5.2 1.4 4.8 0.2 0.6 0.5 7.2 1.1 0.6 1.4 0.0 0.2 0.6 2.1 0.6 0.5 1.5 0.9 4.0 0.9 0.5 0.5 0.5 0.7 0.7 5.4 0.9 0.5 5.2 3.9 0.7 1.7 0.6 0.2 0.3 0.5 0.6 0.5 0.6 0.5 0.4 1.4 0.5 0.5 2.4 1.7 0.0 0.9 0.0 0.4 0.7 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 4.8 0.5 7.2 4.0 0.9 0.7 5.4 1.7 1.7 DISP2 "C15orf36, DISPB, HsT16908, KIAA1742, LINC00594" ENSG00000140323 "Dispatched RND transporter family member 2" A7MBM2 15 40358235-40378639 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 37.2" "Group enriched" "Detected in some" 5 "HaCaT: 8.0;SCLC-21H: 16.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059903 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA059903: " "unprognostic (3.43e-4)" "unprognostic (7.65e-3)" "unprognostic (4.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.90e-1)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (3.08e-2)" "unprognostic (1.98e-1)" "unprognostic (2.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" "unprognostic (4.47e-8)" "unprognostic (1.96e-1)" "unprognostic (3.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" 0.8 2.5 9.0 1.5 7.6 1.3 0.6 37.2 14.5 0.7 4.0 1.0 0.0 3.4 0.9 0.9 0.7 1.1 1.1 0.8 9.0 7.0 0.5 0.7 0.9 1.5 2.9 14.0 1.3 1.4 0.6 2.8 1.0 11.4 0.8 3.9 0.3 1.2 1.8 0.8 1.3 3.0 1.4 2.0 1.1 3.9 2.4 1.8 0.0 3.4 0.0 0.6 1.2 0.4 0.9 1.1 2.9 0.4 1.1 0.6 0.2 1.5 0.6 0.4 2.5 0.1 0.1 0.9 0.2 0.1 1.0 1.5 2.3 0.7 0.2 1.7 0.9 8.0 0.3 1.3 0.6 0.2 0.5 0.4 0.5 0.1 0.0 0.5 1.5 1.8 0.0 0.3 0.2 0.5 0.6 1.0 1.3 0.3 0.2 0.4 0.4 1.1 0.2 0.4 0.5 0.3 2.1 16.6 2.4 0.3 0.2 0.2 0.4 0.2 0.5 1.1 0.9 0.2 0.2 0.3 0.2 0.3 0.4 0.7 2.3 2.1 0.4 0.5 0.6 0.3 0.4 0.5 0.4 0.4 0.2 0.9 0.5 0.6 2.9 1.1 0.4 1.1 0.4 0.2 9.0 7.6 37.2 14.5 9.0 7.0 2.9 14.0 11.4 1.8 DISP3 "KIAA1337, PTCHD2" ENSG00000204624 "Dispatched RND transporter family member 3" Q9P2K9 1 11479166-11537584 "Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;testis: 7.5" "Cell line enhanced" "Detected in some" "AF22: 7.8;NTERA-2: 3.3;SCLC-21H: 3.2;SH-SY5Y: 10.8" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054579 Uncertain Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA054579: " "unprognostic (4.93e-2)" "unprognostic (2.23e-2)" "unprognostic (1.61e-1)" "unprognostic (9.55e-3)" "unprognostic (1.80e-1)" "unprognostic (2.73e-1)" "unprognostic (6.12e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.08e-1)" "unprognostic (4.34e-3)" "unprognostic (4.86e-2)" "unprognostic (3.80e-2)" "unprognostic (3.88e-1)" "unprognostic (7.06e-2)" "unprognostic (1.79e-4)" "unprognostic (1.34e-1)" 0.9 1.9 7.3 1.1 10.0 0.9 0.9 4.1 17.4 0.9 1.0 9.0 0.0 1.3 1.1 0.9 0.8 1.0 0.8 0.8 7.3 5.7 0.9 0.8 0.9 1.2 4.0 6.5 0.9 1.6 0.8 4.2 0.8 5.1 1.6 0.9 5.4 0.9 0.8 0.8 0.8 1.3 1.0 2.1 1.1 1.2 7.5 6.8 0.0 0.9 0.0 1.0 0.9 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 7.8 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.3 0.0 0.8 0.0 2.0 0.0 0.2 3.2 10.8 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 10.0 4.1 12.9 7.3 5.7 4.0 6.5 5.1 6.8 DIXDC1 "Dixin, KIAA1735" ENSG00000150764 "DIX domain containing 1" Q155Q3 11 111927144-112022584 "Predicted intracellular proteins" "Wnt signaling pathway" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.2" "Cell line enhanced" "Detected in many" "hTERT-HME1: 23.1;TIME: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "eosinophil: 8.6" "Lineage enriched" "Detected in single" 10 "granulocytes: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039658 Supported Cytosol Cytosol "HPA039658: AB_2676611" "unprognostic (1.93e-1)" "unprognostic (2.90e-2)" "unprognostic (8.93e-3)" "unprognostic (2.84e-1)" "unprognostic (2.98e-2)" "unprognostic (1.44e-1)" "unprognostic (2.37e-1)" "unprognostic (1.41e-1)" "unprognostic (7.23e-2)" "unprognostic (1.59e-1)" "unprognostic (7.85e-2)" "unprognostic (5.11e-2)" "prognostic favourable (6.89e-5)" "unprognostic (4.10e-2)" "unprognostic (2.11e-1)" "unprognostic (2.52e-2)" "prognostic unfavourable (4.19e-5)" 9.7 10.4 8.8 4.5 16.1 0.0 8.6 52.2 15.7 11.5 7.4 20.2 4.9 2.9 14.3 11.0 8.4 12.3 7.0 12.7 8.7 9.9 6.4 4.7 5.1 1.0 16.1 10.2 9.5 3.9 10.2 8.9 5.9 10.8 14.1 5.7 6.8 4.7 22.0 6.6 4.2 3.9 24.9 9.2 3.1 4.8 10.1 16.2 0.0 6.5 1.7 1.0 17.4 18.0 0.1 0.1 8.6 0.2 0.1 0.9 0.2 0.4 1.9 5.2 9.8 16.5 9.6 1.1 4.0 2.8 1.6 2.8 0.3 1.0 0.8 1.0 11.2 0.4 2.2 1.2 1.5 3.2 2.0 0.4 3.0 5.2 2.5 2.7 0.3 7.8 10.4 3.3 23.1 16.1 2.6 0.3 6.3 0.4 1.7 2.3 3.2 3.6 0.8 1.5 3.1 6.5 0.1 4.3 9.0 3.0 2.4 1.3 3.6 1.0 26.2 7.1 3.0 1.3 6.6 0.6 2.7 0.4 3.9 6.9 2.4 0.0 0.2 8.6 0.6 0.0 0.1 0.1 0.5 0.6 0.0 0.1 0.9 0.8 0.7 0.1 0.1 0.1 0.0 0.2 8.8 16.1 52.2 12.4 8.7 9.9 16.1 10.2 10.8 16.2 DKK3 "REIC, RIG" ENSG00000050165 "Dickkopf WNT signaling pathway inhibitor 3" Q9UBP4 11 11963106-12009769 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 94.7;heart muscle: 297.4" "Cell line enhanced" "Detected in many" "BJ: 60.0;BJ hTERT+: 92.8;fHDF/TERT166: 86.9;TIME: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 90 "T-cells: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011868, CAB024949" Approved Supported "Nuclear bodies,Vesicles,Cytosol" "Secreted in other tissues" 15000000 Vesicles "Nuclear bodies, Cytosol" "CAB024949: , HPA011868: AB_1847716" "unprognostic (4.24e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (7.84e-2)" "unprognostic (3.06e-3)" "unprognostic (6.58e-3)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-3)" "unprognostic (5.28e-2)" "unprognostic (4.51e-2)" "unprognostic (3.87e-2)" "prognostic unfavourable (6.31e-5)" "unprognostic (7.41e-3)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.02e-3)" 4.8 21.7 44.9 3.5 94.7 1.3 6.8 32.5 60.3 25.8 7.3 12.1 4.1 4.9 7.8 5.6 8.8 4.9 17.9 297.4 49.6 23.5 5.1 2.7 17.8 3.1 19.1 45.8 10.8 5.7 10.9 6.6 7.5 24.7 16.8 4.6 10.7 9.1 22.3 2.7 8.3 7.3 12.0 32.9 9.0 7.0 8.9 25.5 0.0 4.7 2.5 2.6 10.5 7.8 0.0 0.0 0.0 0.0 0.0 8.9 0.6 0.2 1.8 2.6 0.0 2.2 4.4 0.0 60.0 92.8 26.6 30.2 1.3 0.4 0.0 6.6 86.9 9.2 0.2 25.9 10.2 0.0 0.0 0.0 0.2 0.0 16.9 0.0 0.0 6.7 8.7 9.0 22.2 28.1 0.0 0.0 36.7 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 9.1 0.0 0.0 7.8 0.2 0.0 0.0 0.0 0.0 49.8 15.8 12.4 1.6 15.5 0.0 0.0 0.0 2.6 0.0 14.8 0.0 0.0 0.0 0.8 0.0 8.9 0.0 0.8 5.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 44.9 94.7 32.5 46.5 49.6 23.5 19.1 45.8 24.7 25.5 DLEU7 FLJ44882 ENSG00000186047 "Deleted in lymphocytic leukemia, 7" Q6UYE1 13 50711008-50843939 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 13.2" "Group enriched" "Detected in some" 8 "NTERA-2: 15.1;U-698: 6.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "intermediate monocyte: 1.5;naive B-cell: 1.3;neutrophil: 1.2;T-reg: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA053750 Uncertain "HPA053750: " "unprognostic (3.97e-2)" "unprognostic (2.53e-1)" "unprognostic (7.03e-2)" "unprognostic (9.31e-2)" "unprognostic (3.08e-1)" "unprognostic (1.08e-1)" "unprognostic (4.47e-3)" "unprognostic (1.09e-1)" "unprognostic (1.24e-1)" "unprognostic (8.75e-3)" "unprognostic (1.23e-1)" "unprognostic (1.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.59e-1)" "unprognostic (4.52e-2)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" 0.7 1.0 4.8 0.8 7.8 0.5 0.5 5.8 13.2 0.6 0.7 0.5 0.0 0.6 0.8 3.0 0.5 0.5 0.4 0.5 4.6 5.7 1.4 0.5 0.5 0.4 3.7 4.2 0.6 0.7 0.4 0.1 0.5 4.1 0.7 0.8 0.0 0.4 0.5 0.5 1.0 0.8 0.5 1.2 0.8 0.5 0.9 0.8 1.3 1.9 0.0 0.5 0.4 0.1 1.3 0.0 1.2 1.5 0.0 1.4 0.7 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 15.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.3 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 1.3 0.1 0.0 1.2 0.0 0.0 0.0 1.4 0.7 4.8 7.8 5.8 9.9 4.6 5.7 3.7 4.2 4.1 0.8 DLG2 "chapsyn-110, PPP1R58, PSD-93, PSD93" ENSG00000150672 "Discs large MAGUK scaffold protein 2" Q15700 11 83455012-85627922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.7" "Cell line enhanced" "Detected in some" "BEWO: 7.5;CACO-2: 4.6;NTERA-2: 5.1;SCLC-21H: 5.2;SH-SY5Y: 7.8;SK-BR-3: 4.6;T-47d: 19.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021307, HPA023896, CAB072341" Enhanced Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "CAB072341: , HPA021307: AB_1846625, HPA023896: " "unprognostic (2.61e-3)" "unprognostic (2.81e-2)" "unprognostic (4.05e-2)" "unprognostic (9.03e-2)" "unprognostic (3.25e-1)" "unprognostic (1.09e-1)" "unprognostic (9.44e-3)" "unprognostic (7.78e-2)" "unprognostic (4.32e-1)" "unprognostic (4.61e-2)" "unprognostic (9.28e-3)" "unprognostic (4.84e-1)" "unprognostic (7.66e-6)" "unprognostic (2.92e-2)" "unprognostic (2.41e-1)" "unprognostic (6.52e-2)" "unprognostic (8.89e-2)" 1.4 11.0 20.0 1.4 30.7 0.7 2.5 9.3 44.7 2.4 1.7 39.5 0.6 1.5 3.3 4.4 7.8 6.0 2.3 2.8 19.9 9.9 3.7 2.8 1.9 1.3 28.7 21.2 6.2 3.3 14.6 7.9 2.7 25.7 4.3 1.5 2.9 3.1 5.4 1.2 19.5 1.5 2.6 19.7 2.6 1.5 6.6 37.3 0.0 15.6 0.0 2.9 1.5 2.1 1.3 0.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.1 0.0 0.2 1.4 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.1 5.1 0.0 0.0 0.7 0.4 0.0 0.0 5.2 7.8 0.0 4.6 0.0 19.2 0.0 0.0 0.3 0.9 0.2 0.0 0.0 0.0 3.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.3 0.0 0.0 0.0 0.5 0.0 0.2 20.0 30.7 9.3 34.9 19.9 9.9 28.7 21.2 25.7 37.3 DLG4 "PSD-95, PSD95, SAP-90, SAP90" ENSG00000132535 "Discs large MAGUK scaffold protein 4" P78352 17 7189890-7219702 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 83.2" "Cell line enhanced" "Detected in many" "HMC-1: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.6;plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001999, CAB002000, HPA010122" Enhanced "Intracellular and membrane" "CAB001999: , CAB002000: , HPA010122: AB_1855169" "unprognostic (7.08e-2)" "unprognostic (1.06e-2)" "unprognostic (3.50e-3)" "unprognostic (2.48e-2)" "unprognostic (3.23e-2)" "unprognostic (1.80e-1)" "unprognostic (7.18e-3)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (2.72e-2)" "prognostic favourable (8.82e-6)" "unprognostic (3.45e-2)" "prognostic unfavourable (1.70e-4)" "unprognostic (3.12e-2)" "unprognostic (2.83e-2)" "unprognostic (3.68e-2)" "unprognostic (4.77e-3)" 5.5 16.0 58.3 7.5 73.3 4.1 4.5 47.4 83.2 9.7 4.1 5.4 4.3 4.7 13.8 5.0 5.0 9.2 10.7 8.9 58.7 24.2 3.3 3.1 6.0 4.2 14.4 53.9 12.8 4.6 11.5 15.1 8.7 14.8 7.3 3.8 3.1 6.3 12.5 3.6 4.0 4.4 10.7 11.3 7.8 5.7 10.1 17.0 1.7 5.8 0.0 3.5 7.0 4.2 0.0 1.6 0.0 0.9 0.0 1.6 0.6 0.2 7.7 19.3 6.5 7.4 10.9 0.5 10.2 8.8 7.6 7.3 0.3 3.2 1.4 4.5 8.7 0.7 1.1 4.0 3.7 10.1 1.9 5.7 13.8 0.9 6.2 0.1 32.3 12.1 0.5 6.4 6.6 8.9 2.3 5.2 11.4 0.2 4.4 3.5 2.8 0.5 8.0 0.8 0.7 5.5 0.2 7.9 6.3 0.2 0.4 1.2 4.6 3.6 11.0 18.3 8.9 3.7 5.3 0.8 0.5 0.7 13.8 3.7 5.6 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.3 0.1 0.0 0.0 0.1 1.6 0.0 0.6 58.3 73.3 47.4 71.2 58.7 24.2 14.4 53.9 14.8 17.0 DLGAP1 "DAP-1, GKAP, SAPAP1" ENSG00000170579 "DLG associated protein 1" O14490 18 3496032-4455335 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.9" "Cell line enhanced" "Detected in some" "Daudi: 14.3;HAP1: 5.1;U-2197: 4.5;U-87 MG: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.0" "Lineage enhanced" "Detected in single" "granulocytes: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.50e-3)" "unprognostic (7.82e-2)" "unprognostic (2.40e-1)" "unprognostic (1.98e-1)" "unprognostic (1.07e-2)" "unprognostic (3.63e-3)" "unprognostic (2.73e-2)" "unprognostic (1.97e-2)" "unprognostic (2.93e-3)" "unprognostic (5.49e-3)" "unprognostic (5.87e-4)" "unprognostic (2.18e-1)" "unprognostic (2.78e-3)" "unprognostic (3.10e-2)" "unprognostic (4.93e-3)" "unprognostic (8.93e-2)" "unprognostic (9.68e-2)" 1.0 5.1 18.3 1.0 22.6 0.8 2.4 25.9 55.9 1.4 1.0 1.3 4.1 0.9 1.6 9.0 1.0 7.1 4.8 1.2 17.2 4.7 1.4 0.9 1.4 1.0 4.2 20.8 2.7 1.0 0.8 2.0 1.4 6.1 3.8 1.0 0.0 2.4 11.4 0.9 1.0 0.9 1.1 2.2 1.3 0.9 4.3 1.6 0.0 1.3 0.0 0.9 0.9 0.7 0.5 0.0 2.0 0.0 0.0 0.1 0.2 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 14.3 0.0 0.3 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.4 0.0 1.2 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.7 0.0 1.9 1.2 1.7 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.4 0.0 0.2 3.3 0.0 1.3 0.9 0.0 2.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 18.3 22.6 25.9 40.3 17.2 4.7 4.2 20.8 6.1 1.6 DLGAP2 "C8orf68, DAP-2, ERICH1-AS1" ENSG00000198010 "DLG associated protein 2" Q9P1A6 8 737596-1708474 "Nuclear receptors, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 15.3;testis: 12.5" "Group enriched" "Detected in some" 13 "NTERA-2: 2.0;REH: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030320 Uncertain "HPA030320: AB_10600904" "unprognostic (8.86e-2)" "unprognostic (2.32e-1)" "unprognostic (5.32e-1)" "unprognostic (1.33e-1)" "unprognostic (5.42e-2)" "unprognostic (1.23e-3)" "unprognostic (1.07e-1)" "unprognostic (2.71e-2)" "unprognostic (5.01e-2)" "unprognostic (2.16e-2)" "unprognostic (1.90e-3)" "unprognostic (2.53e-1)" "unprognostic (1.04e-1)" "unprognostic (2.05e-3)" "unprognostic (1.96e-1)" "unprognostic (3.85e-1)" "unprognostic (3.81e-1)" 0.8 1.0 7.5 0.8 14.9 0.9 0.8 0.4 15.3 1.3 0.7 0.0 0.3 0.7 0.7 1.5 0.7 0.7 0.6 0.7 8.0 3.1 2.0 0.8 0.7 0.9 1.1 8.9 0.7 0.6 0.6 3.4 0.8 0.7 0.8 0.6 0.0 0.8 0.9 0.6 1.5 0.7 0.7 0.6 0.9 0.6 12.5 1.2 0.0 1.6 0.0 0.8 0.7 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 14.9 0.4 15.3 8.0 3.1 1.1 8.9 0.7 1.2 DLGAP3 "DAP3, SAPAP3" ENSG00000116544 "DLG associated protein 3" O95886 1 34865436-34929585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 28.7" "Cell line enhanced" "Detected in some" "Daudi: 9.3;NTERA-2: 5.1;SCLC-21H: 15.2" "Group enriched" "Detected in some" 5 "endometrial cancer: 1.0;glioma: 1.5;ovarian cancer: 1.9;testis cancer: 5.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 128.4;basal ganglia: 124.0;cerebral cortex: 122.6;hippocampal formation: 84.0;thalamus: 55.9" "Low region specificity" "Detected in all" HPA026445 Enhanced "HPA026445: AB_1847733" "unprognostic (8.63e-2)" "unprognostic (8.58e-2)" "unprognostic (1.48e-1)" "unprognostic (5.77e-7)" "unprognostic (4.01e-2)" "unprognostic (5.51e-2)" "unprognostic (2.95e-2)" "unprognostic (8.78e-2)" "unprognostic (2.66e-1)" "unprognostic (1.69e-1)" "unprognostic (1.27e-4)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (6.12e-2)" "unprognostic (1.47e-1)" "unprognostic (2.26e-1)" "unprognostic (2.21e-1)" 1.3 1.5 17.4 1.8 20.0 2.8 1.1 14.6 28.7 0.9 1.2 3.3 0.0 1.4 1.0 1.0 0.9 1.0 1.1 1.0 17.7 5.5 1.3 1.0 1.1 1.4 5.4 9.6 1.0 2.2 1.0 1.9 1.0 2.3 1.0 1.0 0.7 1.1 1.5 1.0 1.1 1.3 1.0 1.1 2.5 1.3 6.7 5.0 0.0 1.0 0.0 1.2 1.0 0.0 0.3 3.2 0.4 2.3 0.1 0.8 0.9 0.0 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 9.3 0.2 0.0 0.0 1.5 0.0 0.0 0.2 0.2 0.7 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.5 0.0 0.0 5.1 0.0 0.5 0.0 0.2 0.0 0.5 15.2 3.0 0.1 0.1 0.0 0.3 0.1 0.1 0.1 1.6 0.0 0.0 0.2 0.3 1.9 0.1 0.1 0.1 0.4 2.3 0.0 0.2 1.4 0.8 0.3 0.5 0.5 3.2 0.3 0.2 0.8 0.0 0.1 0.1 0.9 0.7 0.9 17.4 20.0 14.6 22.4 17.7 5.5 5.4 9.6 2.3 5.0 DLL3 SCDO1 ENSG00000090932 "Delta like canonical Notch ligand 3" Q9NYJ7 19 39498895-39508481 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 38.5" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 41.1" "Group enriched" "Detected in many" 11 "glioma: 29.2;melanoma: 15.5;testis cancer: 8.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4;naive CD8 T-cell: 3.3" "Group enriched" "Detected in many" 13 "B-cells: 5.4;T-cells: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA056533 Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA056533: " "unprognostic (2.52e-1)" "unprognostic (3.81e-1)" "unprognostic (3.13e-2)" "prognostic unfavourable (2.94e-4)" "unprognostic (9.85e-2)" "unprognostic (1.41e-2)" "unprognostic (1.65e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.82e-4)" "unprognostic (4.94e-2)" "unprognostic (5.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.97e-1)" 0.6 0.6 8.9 0.7 10.1 0.6 0.6 1.4 38.5 0.5 0.6 10.3 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.6 6.5 6.8 0.5 0.6 0.6 0.7 4.5 1.9 0.6 0.5 0.6 3.2 0.5 4.3 0.6 0.5 0.0 0.6 0.5 0.5 0.6 0.6 0.5 3.6 0.6 0.6 1.2 2.3 0.0 0.7 0.0 0.6 0.6 0.0 5.4 0.3 0.0 0.0 0.0 3.3 0.4 0.0 1.9 0.4 1.0 0.0 0.0 0.3 0.5 0.0 0.3 0.1 0.3 0.4 0.0 1.9 0.0 0.0 1.2 0.5 0.1 0.5 3.0 0.1 0.0 0.1 0.1 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.4 3.1 0.3 0.1 0.1 0.1 0.1 7.3 7.4 1.4 0.0 41.1 0.0 0.1 0.0 0.0 1.3 0.1 0.5 0.7 0.0 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.9 0.0 0.4 5.4 0.2 1.3 0.3 1.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.4 8.9 10.1 1.4 4.8 6.5 6.8 4.5 1.9 4.3 2.3 DLX1 ENSG00000144355 "Distal-less homeobox 1" P56177 2 172084740-172089677 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 4.7;brain: 17.3" "Cell line enhanced" "Detected in many" "AN3-CA: 47.6;WM-115: 14.1" "Cancer enhanced" "Detected in many" "prostate cancer: 11.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Group enriched" "Detected in many" 5 "basal ganglia: 29.8;olfactory region: 101.7" "Region enriched" "Detected in many" 5 "olfactory region: 106.7" HPA045884 Approved "HPA045884: AB_10960361" "unprognostic (2.14e-2)" "unprognostic (5.09e-2)" "unprognostic (3.92e-2)" "unprognostic (1.89e-3)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (7.92e-3)" "unprognostic (8.86e-2)" "unprognostic (2.80e-2)" "unprognostic (2.03e-1)" "unprognostic (5.74e-2)" "unprognostic (2.04e-1)" "unprognostic (7.40e-9)" "unprognostic (2.22e-1)" "unprognostic (9.19e-2)" "unprognostic (1.25e-1)" "unprognostic (5.91e-3)" 0.6 4.7 8.9 1.0 7.4 0.4 0.9 0.1 15.5 0.4 1.2 0.5 0.0 0.4 0.4 0.4 0.6 0.4 0.8 0.6 5.5 17.3 0.4 0.5 0.4 0.5 0.8 9.5 0.6 0.5 0.6 0.1 0.4 0.0 2.2 1.3 0.1 0.9 0.7 0.4 0.6 0.8 0.8 0.2 0.4 0.5 0.6 1.4 0.0 1.6 0.4 1.3 0.5 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.2 47.6 0.7 1.4 0.1 1.2 2.1 2.4 1.3 0.4 0.1 0.0 2.9 2.4 3.5 2.6 0.4 1.8 0.1 11.9 7.1 5.3 1.9 0.0 3.0 5.8 0.0 0.9 0.6 0.9 0.0 4.1 0.0 2.0 2.6 0.0 0.7 0.0 8.4 0.1 6.0 0.0 0.3 1.6 4.1 0.0 2.1 0.2 6.1 1.8 3.5 2.6 12.7 0.0 6.1 6.0 0.0 0.0 0.0 5.4 7.4 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 8.9 7.4 0.1 15.5 5.5 17.3 0.8 9.5 0.0 1.4 DLX2 TES-1 ENSG00000115844 "Distal-less homeobox 2" Q07687 2 172099439-172102900 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.9" "Group enriched" "Detected in some" 8 "AN3-CA: 38.7;HEK 293: 24.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 13.8;olfactory region: 36.1" "Region enriched" "Detected in many" 5 "olfactory region: 43.5" HPA056965 Approved "Nuclear speckles" "Nuclear speckles" "HPA056965: " "unprognostic (8.12e-2)" "unprognostic (3.56e-1)" "unprognostic (2.48e-2)" "unprognostic (1.28e-2)" "unprognostic (4.07e-1)" "unprognostic (2.13e-1)" "unprognostic (8.60e-3)" "unprognostic (3.03e-2)" "unprognostic (2.41e-1)" "unprognostic (8.74e-2)" "unprognostic (3.53e-2)" "unprognostic (3.01e-1)" "unprognostic (6.69e-10)" "unprognostic (9.38e-2)" "unprognostic (2.47e-1)" "unprognostic (2.41e-1)" "unprognostic (7.95e-3)" 0.7 3.2 4.5 0.7 5.4 1.2 1.2 0.1 10.9 0.4 0.7 1.1 0.0 0.6 0.5 0.4 0.4 0.5 0.7 0.7 4.3 7.5 0.5 0.6 0.5 0.4 0.4 4.1 0.4 0.4 0.4 0.2 0.6 0.0 1.0 0.6 0.0 1.7 0.7 0.4 1.9 1.2 0.5 0.1 0.4 0.5 2.5 3.4 1.4 1.5 1.5 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 38.7 0.2 0.1 1.1 2.0 0.4 0.3 0.1 0.2 0.0 0.0 1.2 0.9 2.0 1.2 0.1 0.1 0.0 24.6 0.6 4.0 0.9 0.1 0.2 0.1 0.0 1.8 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.0 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 1.4 0.0 1.0 0.6 2.3 0.3 0.1 0.1 2.7 0.0 1.5 0.2 0.0 0.0 0.2 2.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 5.4 0.1 10.9 4.3 7.5 0.4 4.1 0.0 3.4 DLX6 ENSG00000006377 "Distal-less homeobox 6" P56179 7 97005548-97011039 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.2;placenta: 11.3;testis: 10.4" "Cell line enhanced" "Detected in some" "AN3-CA: 7.5;BEWO: 24.9;HAP1: 11.2;SCLC-21H: 5.5;SH-SY5Y: 8.2" "Cancer enriched" "Detected in many" 8 "endometrial cancer: 12.5" "Region enhanced" "Detected in many" "basal ganglia: 23.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "olfactory region: 44.2" "HPA030608, HPA061460" Uncertain Approved "Nuclear bodies" "Nuclear bodies" "HPA030608: AB_10600867, HPA061460: " "unprognostic (7.50e-2)" "unprognostic (1.91e-1)" "unprognostic (5.19e-2)" "unprognostic (8.06e-2)" "unprognostic (8.16e-2)" "unprognostic (3.05e-1)" "unprognostic (4.32e-2)" "unprognostic (2.51e-1)" "unprognostic (2.86e-1)" "unprognostic (6.56e-2)" "unprognostic (8.09e-2)" "unprognostic (1.12e-7)" "unprognostic (5.60e-2)" "unprognostic (1.99e-1)" "unprognostic (5.58e-2)" "unprognostic (8.12e-2)" 0.9 0.4 1.8 0.3 23.2 0.9 0.4 0.3 6.1 5.7 0.6 0.5 0.0 0.4 7.0 2.4 0.3 1.5 0.3 0.5 3.9 2.6 0.4 0.3 0.3 1.0 0.5 2.8 0.9 0.3 0.4 0.4 11.3 0.0 0.7 0.3 0.0 1.7 2.5 0.5 1.6 0.3 0.9 0.3 0.5 0.4 10.4 4.2 0.1 0.7 0.0 0.8 0.9 0.6 0.4 0.6 1.5 0.7 0.5 0.7 0.3 0.0 0.0 0.0 7.5 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.5 0.0 1.4 11.2 0.0 0.0 0.0 2.9 0.0 4.2 5.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 1.6 5.5 8.2 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.8 0.6 1.1 0.5 0.6 0.2 0.3 0.5 0.4 0.4 0.3 0.3 0.4 0.7 0.6 1.5 0.5 0.7 0.6 0.5 0.3 1.8 23.2 0.3 6.1 3.9 2.6 0.5 2.8 0.0 4.2 DMRTA2 ENSG00000142700 "DMRT like family A2" Q96SC8 1 50417550-50423500 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0" "Cell line enhanced" "Detected in some" "BEWO: 4.1;HBEC3-KT: 4.2;RH-30: 15.3;SH-SY5Y: 3.2;SiHa: 3.1" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA043098, HPA062958" Uncertain Approved Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA043098: AB_10796684, HPA062958: " "unprognostic (1.60e-1)" "unprognostic (4.56e-3)" "unprognostic (2.62e-1)" "unprognostic (3.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.75e-2)" "unprognostic (1.15e-2)" "unprognostic (3.29e-1)" "unprognostic (6.89e-2)" "unprognostic (4.79e-1)" "unprognostic (7.47e-2)" "unprognostic (1.21e-3)" "unprognostic (7.08e-3)" "unprognostic (4.16e-2)" "unprognostic (7.85e-2)" "unprognostic (2.68e-3)" 0.2 0.1 0.4 0.1 1.5 0.2 0.2 0.4 2.1 0.3 0.3 8.5 0.0 0.4 0.2 0.1 3.8 0.2 0.1 0.1 1.2 0.7 0.2 0.2 0.2 0.2 1.2 0.0 0.2 0.1 0.4 5.4 0.2 2.1 0.2 0.3 0.0 0.5 0.2 0.3 0.1 0.2 0.1 2.0 0.3 0.2 4.0 3.7 0.3 0.2 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 1.2 4.2 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 3.2 3.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.4 1.8 1.2 0.7 1.2 0.0 2.1 3.7 DMRTC1 ENSG00000269502 "DMRT like family C1" Q5HYR2 X 72872025-72943814 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.0" "Cell line enhanced" "Detected in some" "AN3-CA: 1.7;Daudi: 3.7;NTERA-2: 1.2;U-266/70: 1.2;U-266/84: 1.4;U-698: 2.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.2" "Group enriched" "Detected in many" 17 "B-cells: 2.2;T-cells: 1.2" "HPA046874, HPA046992" Uncertain "HPA046874: , HPA046992: " "unprognostic (1.83e-1)" 0.0 1.3 0.0 0.0 0.0 4.0 0.6 0.1 0.0 1.1 0.0 0.1 2.1 0.2 0.0 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.6 0.7 0.0 1.1 2.0 0.8 0.0 2.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 1.4 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.5 0.0 2.2 0.7 1.2 0.0 0.0 0.0 0.0 0.4 0.1 DMRTC1B ENSG00000184911 "DMRT like family C1B" Q5HYR2 X 72777009-72848802 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.1;ovary: 12.1;pituitary gland: 12.1" "Cell line enhanced" "Detected in some" "HaCaT: 1.1;SK-BR-3: 1.1;U-138 MG: 1.0;U-266/70: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.8" "Group enriched" "Detected in many" 12 "B-cells: 2.1;T-cells: 2.8" "HPA046874, HPA046992" Uncertain "HPA046874: , HPA046992: " "unprognostic (2.00e-1)" "unprognostic (1.91e-2)" "unprognostic (1.54e-1)" "unprognostic (6.52e-2)" 0.3 4.6 11.0 1.7 15.1 0.1 0.7 4.5 14.3 1.7 0.6 2.2 1.4 0.5 2.2 9.6 0.3 3.3 0.6 0.2 8.6 14.2 1.6 0.2 1.1 1.4 4.9 9.1 12.1 5.2 1.5 12.1 0.2 2.2 3.8 0.8 2.4 1.0 1.9 0.2 0.5 0.5 0.6 2.2 1.3 1.2 7.1 2.9 0.7 3.9 0.2 2.1 0.3 0.2 2.1 0.0 0.0 0.0 0.2 2.8 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.4 0.0 2.1 2.1 2.8 0.0 0.2 0.0 0.0 0.0 0.2 11.0 15.1 4.5 11.4 8.6 14.2 4.9 9.1 2.2 2.9 DMTN "DMT, EPB49" ENSG00000158856 "Dematin actin binding protein" Q08495 8 22048995-22082527 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 88.6" "Cell line enhanced" "Detected in many" "A549: 19.9;HEL: 64.4;HMC-1: 19.5;RPTEC TERT1: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.1;MAIT T-cell: 2.1;memory CD4 T-cell: 4.7;memory CD8 T-cell: 2.0;naive CD4 T-cell: 2.0;naive CD8 T-cell: 2.0;neutrophil: 1.5;T-reg: 3.8" "Group enriched" "Detected in many" 7 "granulocytes: 1.5;T-cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024290 Uncertain 6700000 "HPA024290: AB_1847601" "unprognostic (6.74e-2)" "unprognostic (1.51e-1)" "unprognostic (3.48e-2)" "unprognostic (1.24e-3)" "prognostic unfavourable (7.92e-5)" "unprognostic (2.88e-1)" "unprognostic (3.85e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-2)" "unprognostic (2.25e-2)" "unprognostic (5.42e-2)" "unprognostic (1.97e-1)" "prognostic favourable (3.85e-9)" "unprognostic (3.14e-2)" "unprognostic (2.58e-1)" "unprognostic (1.86e-1)" "unprognostic (8.07e-2)" 15.0 14.7 49.7 2.8 60.0 51.1 5.8 24.9 88.6 5.2 9.6 5.2 4.3 4.5 5.9 7.3 9.1 14.8 6.5 31.7 36.6 28.0 18.4 5.8 8.5 1.7 19.2 39.9 1.8 13.4 20.4 23.5 3.7 31.8 9.4 7.4 6.0 10.2 10.4 27.2 10.2 5.4 6.9 6.0 4.5 8.0 3.1 9.0 0.0 16.1 3.1 1.9 3.9 3.0 0.0 0.4 1.5 0.1 0.0 4.7 11.4 12.4 19.9 0.1 0.4 0.3 0.1 1.6 1.3 1.2 4.3 1.3 8.6 7.7 0.1 13.0 0.2 4.3 0.6 0.7 1.9 0.1 3.8 64.4 1.5 18.0 0.4 0.0 19.5 0.2 8.7 0.0 0.0 4.3 6.0 0.6 0.0 5.4 1.5 0.1 0.5 1.8 0.0 0.1 0.8 25.8 3.5 4.6 6.5 2.1 0.2 0.9 3.2 0.6 7.5 0.0 6.7 0.1 6.8 0.0 0.0 0.2 0.1 0.0 4.5 0.0 0.1 0.2 2.1 0.0 2.1 0.0 4.7 2.0 0.1 0.0 2.0 2.0 1.5 0.0 0.0 0.4 3.8 11.4 49.7 60.0 24.9 88.6 36.6 28.0 19.2 39.9 31.8 9.0 DNAH10 FLJ43808 ENSG00000197653 "Dynein axonemal heavy chain 10" Q8IVF4 12 123762188-123936206 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.0;epididymis: 10.1;fallopian tube: 9.5;lung: 11.8;testis: 16.4" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3;ASC diff: 4.0;ASC TERT1: 1.7;U-87 MG: 1.7" "Cancer enhanced" "Detected in single" "testis cancer: 1.0" "Group enriched" "Detected in many" 4 "basal ganglia: 4.8;pons and medulla: 10.0" "Cell type enhanced" "Detected in some" "gdT-cell: 1.6;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 13 "T-cells: 1.6" HPA039066 Enhanced "HPA039066: AB_10673237" "unprognostic (1.37e-1)" "unprognostic (1.78e-1)" "unprognostic (6.08e-3)" "unprognostic (9.90e-3)" "unprognostic (2.16e-1)" "unprognostic (8.91e-2)" "unprognostic (3.39e-2)" "unprognostic (1.86e-1)" "unprognostic (5.59e-2)" "unprognostic (1.08e-2)" "unprognostic (7.28e-3)" "unprognostic (5.25e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-1)" "unprognostic (7.23e-2)" "unprognostic (1.22e-2)" "unprognostic (9.11e-3)" 0.4 0.2 0.7 0.2 4.8 3.1 0.3 1.2 0.6 1.9 0.7 3.9 0.5 0.5 0.6 10.1 0.2 9.5 0.2 0.2 1.4 1.7 0.4 0.2 11.8 0.2 0.5 0.0 6.2 0.2 0.1 0.2 0.4 10.0 1.1 0.2 0.0 0.2 0.2 0.1 0.2 1.1 0.2 1.5 0.3 0.2 16.4 0.3 0.0 0.5 0.0 0.2 0.4 0.9 0.1 0.0 0.1 0.0 0.0 1.6 0.2 0.0 0.0 0.1 2.3 4.0 1.7 0.6 1.0 0.3 0.0 0.2 0.0 0.5 0.1 0.2 1.2 0.5 0.0 0.0 0.0 0.4 0.8 0.6 0.0 0.0 0.4 0.0 1.1 1.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.8 0.0 0.2 0.3 1.2 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 4.8 1.2 0.5 1.4 1.7 0.5 0.0 10.0 0.3 DNAH10OS FLJ45278 ENSG00000250091 "Dynein axonemal heavy chain 10 opposite strand" P0CZ25 12 123926424-123934984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" HPA039786 Enhanced "HPA039786: AB_10795115" "unprognostic (1.62e-2)" "unprognostic (1.97e-2)" "unprognostic (8.74e-3)" "unprognostic (1.04e-2)" "unprognostic (7.76e-2)" "unprognostic (2.73e-1)" "unprognostic (8.78e-2)" "unprognostic (1.06e-1)" "unprognostic (3.69e-1)" "unprognostic (3.52e-2)" "unprognostic (3.12e-3)" "unprognostic (3.45e-1)" "unprognostic (8.63e-3)" "unprognostic (3.20e-2)" "unprognostic (4.49e-2)" "unprognostic (1.16e-2)" "unprognostic (1.15e-2)" 0.9 0.3 3.6 0.4 5.2 0.8 1.2 7.6 6.3 0.4 0.7 0.3 0.8 0.8 0.5 0.5 0.6 1.0 3.7 1.5 3.7 0.5 1.5 0.4 1.4 1.6 2.7 2.1 1.1 0.6 1.1 0.4 0.9 1.8 1.7 0.6 0.4 1.3 1.0 0.8 1.4 0.9 1.8 0.4 0.4 0.3 0.6 0.3 3.3 0.7 0.3 1.0 0.3 0.6 4.4 3.6 4.8 2.4 2.1 1.3 0.7 3.7 0.6 0.6 0.4 0.4 0.5 1.5 1.8 0.4 1.0 0.2 0.3 2.1 0.5 0.9 0.3 0.2 0.8 0.4 3.2 0.4 1.3 0.9 0.2 0.8 0.2 0.8 0.8 2.9 0.3 0.7 0.4 0.5 0.3 0.2 0.1 3.7 1.4 0.8 3.5 0.4 0.4 0.8 0.8 0.3 1.4 5.1 0.2 1.2 0.5 2.3 0.9 0.2 3.2 0.5 1.8 1.1 0.7 0.3 1.0 0.4 0.8 0.6 0.3 0.8 0.1 0.6 0.4 0.5 3.3 0.3 0.3 0.3 0.3 0.3 DNAH12 "DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19" ENSG00000174844 "Dynein axonemal heavy chain 12" Q6ZR08 3 57293699-57544344 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.0;fallopian tube: 16.7;lung: 17.5;testis: 17.6" "Cell line enhanced" "Detected in some" "CACO-2: 3.1;LHCN-M2: 2.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Region enriched" "Detected in many" 8 "pons and medulla: 23.0" "Cell type enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "HPA037493, HPA058203, HPA061365" Enhanced "HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: " "unprognostic (4.85e-2)" "unprognostic (1.29e-2)" "unprognostic (2.23e-1)" "unprognostic (2.18e-3)" "unprognostic (2.96e-2)" "unprognostic (2.17e-1)" "unprognostic (2.80e-2)" "unprognostic (1.51e-3)" "unprognostic (3.06e-2)" "unprognostic (3.21e-1)" "unprognostic (4.40e-2)" "unprognostic (5.90e-2)" "unprognostic (3.43e-5)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (2.53e-2)" "unprognostic (5.47e-2)" 0.2 0.3 0.6 0.1 3.0 0.1 0.4 0.2 0.5 1.3 0.2 5.3 0.0 0.1 1.4 11.6 0.2 16.7 0.5 0.1 2.9 0.8 0.2 0.3 17.5 0.2 0.4 0.0 7.6 3.1 0.1 8.9 0.1 23.0 0.2 0.2 0.0 0.3 0.2 0.2 0.3 0.2 0.2 0.4 0.2 0.2 17.6 1.0 0.0 0.3 0.0 0.1 0.2 0.2 0.5 0.5 0.0 0.0 1.2 0.9 0.1 0.3 0.7 0.0 0.0 0.9 0.3 0.1 0.0 0.2 0.3 0.0 3.1 0.3 0.1 0.0 0.4 0.4 0.0 0.3 0.2 0.7 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.6 0.1 0.4 0.2 0.2 0.1 2.1 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.9 0.1 0.0 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.5 0.2 0.0 0.0 1.2 0.0 0.5 0.0 0.1 0.6 3.0 0.2 0.3 2.9 0.8 0.4 0.0 23.0 1.0 DNAH6 "Dnahc6, DNHL1, FLJ37357, HL-2" ENSG00000115423 "Dynein axonemal heavy chain 6" Q9C0G6 2 84516455-84819589 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;fallopian tube: 15.3;pituitary gland: 17.4" "Cell line enhanced" "Detected in some" "AF22: 1.3;CACO-2: 1.5;SK-MEL-30: 2.9;U-266/70: 1.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "naive CD4 T-cell: 3.8;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 16 "T-cells: 3.8" "Low region specificity" "Detected in many" HPA036391 Enhanced "HPA036391: AB_10672220" "unprognostic (4.87e-2)" "unprognostic (4.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-2)" "unprognostic (1.42e-1)" "unprognostic (9.72e-2)" "unprognostic (1.67e-1)" "unprognostic (6.43e-2)" "unprognostic (6.06e-2)" "unprognostic (3.46e-1)" "unprognostic (8.11e-8)" "unprognostic (2.04e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.80e-2)" "unprognostic (5.97e-2)" 1.4 1.2 7.7 0.8 17.7 0.7 1.7 0.6 10.0 1.8 1.0 3.2 0.7 0.7 2.0 11.0 0.6 15.3 0.8 0.6 7.9 3.5 1.9 3.6 4.8 1.0 0.9 7.2 5.1 1.2 6.2 17.4 0.7 23.7 1.1 1.1 0.5 0.6 1.3 0.5 0.7 0.8 0.8 1.6 0.8 2.0 7.2 3.0 0.0 3.9 0.0 0.8 0.7 0.6 0.0 0.2 0.1 0.0 0.0 3.8 0.4 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.0 0.9 0.0 2.9 0.0 0.5 0.0 0.5 0.5 0.4 0.2 1.6 0.1 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 3.8 1.2 0.0 0.0 0.0 0.2 0.0 0.4 7.7 17.7 0.6 10.0 7.9 3.5 0.9 7.2 23.7 3.0 DNAH7 KIAA0944 ENSG00000118997 "Dynein axonemal heavy chain 7" Q8WXX0 2 195737703-196068812 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7;fallopian tube: 19.4;pituitary gland: 25.2" "Cell line enhanced" "Detected in some" "PC-3: 10.5;RPTEC TERT1: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "neutrophil: 2.0;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 7 "dendritic cells: 2.0;granulocytes: 2.0" "Low region specificity" "Detected in many" "HPA034724, HPA044070" Approved Supported Cytosol Cytosol "HPA034724: AB_10670977, HPA044070: " "unprognostic (1.71e-1)" "unprognostic (2.81e-2)" "unprognostic (2.65e-2)" "unprognostic (1.04e-2)" "unprognostic (3.56e-1)" "unprognostic (1.58e-2)" "unprognostic (6.74e-3)" "unprognostic (2.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (2.84e-2)" "unprognostic (1.71e-1)" "unprognostic (6.25e-3)" "unprognostic (2.24e-1)" "unprognostic (7.76e-2)" "unprognostic (2.52e-3)" "unprognostic (3.98e-2)" 1.0 2.6 6.8 1.4 9.9 0.7 1.9 0.6 6.4 3.3 1.9 4.6 4.3 0.9 2.2 12.9 1.1 19.4 1.9 1.4 7.1 5.8 4.5 1.2 9.5 0.9 3.4 3.5 3.9 4.2 3.6 25.2 0.9 21.7 1.9 1.6 1.8 1.8 2.5 0.6 0.9 1.9 1.2 2.1 0.8 1.5 18.3 2.3 0.0 5.9 0.0 1.0 1.3 0.5 0.3 2.0 2.0 0.0 0.1 0.2 0.2 0.6 2.4 0.5 0.2 1.3 0.9 0.1 0.2 1.4 0.5 0.5 0.5 1.7 0.0 0.7 0.5 0.1 0.0 0.3 0.4 0.0 1.4 0.0 2.9 0.7 0.2 0.1 0.2 0.3 0.4 2.1 0.4 0.0 0.6 3.3 0.9 2.4 0.0 0.1 0.5 10.5 0.1 0.6 0.8 4.9 0.3 1.1 1.9 0.6 0.4 0.2 0.9 0.2 0.0 1.3 0.4 2.0 0.6 2.6 2.3 0.0 2.9 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.1 2.0 0.1 0.0 2.0 0.0 0.2 6.8 9.9 0.6 6.4 7.1 5.8 3.4 3.5 21.7 2.3 DNAH9 "DNAH17L, Dnahc9, DNAL1, DYH9, HL-20, HL20, KIAA0357" ENSG00000007174 "Dynein axonemal heavy chain 9" Q9NYC9 17 11598431-11969748 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.8;fallopian tube: 41.2" "Cell line enhanced" "Detected in some" "HDLM-2: 7.2;Karpas-707: 1.6;NTERA-2: 2.3;SH-SY5Y: 1.9;WM-115: 4.5" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052641 Enhanced "HPA052641: " "unprognostic (4.16e-3)" "unprognostic (3.67e-2)" "unprognostic (9.31e-2)" "prognostic favourable (6.79e-5)" "unprognostic (8.37e-3)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (1.68e-1)" "unprognostic (1.26e-1)" "unprognostic (7.35e-2)" "unprognostic (1.97e-3)" "unprognostic (4.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.14e-1)" "unprognostic (3.63e-2)" "unprognostic (4.91e-3)" "unprognostic (5.31e-2)" 2.8 1.4 8.1 0.9 8.3 0.6 1.1 0.8 5.2 2.0 0.7 13.1 2.1 0.6 2.3 9.6 0.8 41.2 1.0 0.6 11.4 10.4 1.7 0.7 5.5 0.6 8.4 2.2 8.2 2.7 2.8 3.0 1.0 18.8 1.5 0.7 0.8 0.6 3.1 0.9 1.0 0.6 1.2 8.5 0.7 0.7 7.1 3.6 0.0 1.5 0.0 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 8.3 0.8 5.2 11.4 10.4 8.4 2.2 18.8 3.6 DNAI1 "CILD1, DIC1, PCD" ENSG00000122735 "Dynein axonemal intermediate chain 1" Q9UI46 9 34457414-34520989 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 14.6;fallopian tube: 32.2;pituitary gland: 36.4;testis: 47.0" "Cell line enhanced" "Detected in some" "AF22: 1.8;BEWO: 5.6;HDLM-2: 4.0;RPTEC TERT1: 2.1;SK-BR-3: 2.9;T-47d: 1.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA021649, HPA021843" Enhanced "HPA021649: AB_1847913, HPA021843: AB_1847914" "unprognostic (9.61e-2)" "unprognostic (5.16e-2)" "unprognostic (4.59e-2)" "unprognostic (1.44e-3)" "unprognostic (3.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.92e-1)" "unprognostic (6.39e-2)" "unprognostic (4.38e-1)" "unprognostic (1.51e-1)" "unprognostic (8.16e-3)" "unprognostic (8.14e-2)" "unprognostic (2.74e-2)" "unprognostic (3.77e-2)" "unprognostic (2.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.13e-1)" 0.4 0.4 2.3 0.4 8.0 0.4 0.9 0.3 3.1 2.2 0.4 3.6 0.0 0.4 1.3 6.8 0.4 32.2 0.5 0.4 2.7 3.3 0.9 0.5 4.3 0.4 1.0 0.2 3.5 1.2 1.9 36.4 0.4 14.6 0.5 0.4 1.3 0.4 0.5 0.4 0.4 0.4 0.4 0.6 0.4 0.6 47.0 1.5 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 1.8 0.7 0.2 0.0 5.6 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 2.1 0.0 0.4 0.3 0.0 2.9 0.8 1.9 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 8.0 0.3 3.1 2.7 3.3 1.0 0.2 14.6 1.5 DNAJC12 JDP1 ENSG00000108176 "DnaJ heat shock protein family (Hsp40) member C12" Q9UKB3 10 67796665-67838166 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.7;liver: 46.2" "Cell line enhanced" "Detected in many" "Daudi: 32.4;NB-4: 26.7;SCLC-21H: 26.7;U-698: 24.1" "Cancer enhanced" "Detected in many" "breast cancer: 22.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 10.5" "Lineage enriched" "Detected in single" 21 "dendritic cells: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036289 Enhanced "HPA036289: AB_10670794" "unprognostic (1.52e-2)" "unprognostic (3.65e-3)" "unprognostic (4.12e-2)" "unprognostic (2.28e-2)" "unprognostic (5.28e-2)" "unprognostic (6.59e-3)" "unprognostic (6.35e-2)" "unprognostic (3.46e-2)" "unprognostic (7.14e-2)" "unprognostic (5.05e-2)" "unprognostic (3.97e-2)" "unprognostic (7.31e-3)" "prognostic unfavourable (1.97e-10)" "unprognostic (7.35e-3)" "unprognostic (1.37e-1)" "unprognostic (5.81e-3)" "unprognostic (7.99e-2)" 1.3 31.4 14.7 1.9 21.6 1.3 22.3 34.7 16.8 4.9 6.5 6.6 1.9 2.6 5.5 4.6 1.2 2.5 4.1 3.4 11.3 18.6 19.7 46.2 1.5 0.8 13.4 10.1 11.2 14.7 9.3 22.5 0.5 13.7 3.0 10.2 1.0 6.4 4.9 6.9 0.5 3.6 4.5 10.4 1.1 5.5 5.1 12.6 0.6 0.9 1.1 0.9 1.9 1.2 0.2 10.5 0.0 0.0 0.0 0.4 0.0 0.0 11.6 1.8 0.3 2.7 2.1 0.0 0.0 0.7 0.4 2.4 0.2 0.0 32.4 4.9 0.0 0.0 0.3 0.3 0.1 1.5 13.3 7.6 10.2 3.0 2.9 14.5 0.1 7.1 2.8 1.2 0.7 4.1 14.0 0.4 1.1 0.6 0.7 26.7 0.5 13.2 0.3 1.1 16.9 0.3 0.0 26.7 15.1 0.1 5.2 0.4 0.2 0.1 0.0 1.3 0.3 0.3 0.3 3.1 0.3 24.1 2.4 17.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.2 0.2 0.4 0.0 0.0 0.0 10.5 0.0 0.0 14.7 21.6 34.7 13.6 11.3 18.6 13.4 10.1 13.7 12.6 DNAJC6 "KIAA0473, PARK19" ENSG00000116675 "DnaJ heat shock protein family (Hsp40) member C6" O75061 1 65248219-65415869 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Chaperone, Hydrolase, Protein phosphatase" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 91.4" "Cell line enhanced" "Detected in many" "HDLM-2: 20.9;HEL: 55.8;K-562: 21.7" "Cancer enhanced" "Detected in many" "glioma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031182, HPA054917" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA031182: AB_10611957, HPA054917: " "unprognostic (6.99e-2)" "unprognostic (2.00e-3)" "unprognostic (3.19e-1)" "unprognostic (7.94e-7)" "unprognostic (1.59e-1)" "unprognostic (7.61e-3)" "unprognostic (1.87e-4)" "unprognostic (2.98e-1)" "unprognostic (1.89e-1)" "unprognostic (4.14e-1)" "unprognostic (4.22e-3)" "unprognostic (1.53e-1)" "prognostic favourable (2.81e-4)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-1)" "unprognostic (8.67e-3)" 2.1 12.1 18.6 2.2 28.5 5.0 2.0 24.2 91.4 2.2 2.8 26.9 0.0 2.3 1.9 1.8 1.7 2.4 2.3 9.0 25.0 26.7 8.5 1.6 2.7 1.6 28.8 23.8 1.9 3.4 2.1 7.5 8.0 40.5 2.5 3.0 2.2 1.7 2.1 1.6 2.1 2.3 2.2 28.7 3.2 2.9 3.2 21.1 0.0 3.0 0.0 1.7 1.8 0.6 0.5 0.5 0.0 0.0 0.6 1.5 0.3 3.5 0.9 0.0 1.6 0.7 0.2 8.3 7.0 11.4 11.5 11.3 0.9 0.1 3.3 0.6 2.9 0.8 5.0 1.1 9.1 20.9 2.4 55.8 1.9 0.2 0.0 1.8 1.4 1.0 0.8 1.1 4.9 0.2 21.7 0.4 2.3 0.6 0.7 0.0 2.3 0.7 0.0 1.7 0.1 8.7 0.0 13.9 9.6 4.1 5.5 1.9 2.6 0.1 2.1 1.7 1.2 0.2 2.0 2.1 1.3 1.0 4.7 1.4 2.8 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.5 0.9 0.0 0.0 0.4 0.6 0.0 0.6 0.0 0.5 0.0 0.3 18.6 28.5 24.2 37.4 25.0 26.7 28.8 23.8 40.5 21.1 DND1 "MGC34750, RBMS4" ENSG00000256453 "DND microRNA-mediated repression inhibitor 1" Q8IYX4 5 140670794-140673586 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.2;testis: 12.0" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 6 "T-cells: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" 0.5 0.2 1.7 0.4 0.8 0.4 0.7 3.2 0.4 0.6 0.6 0.4 0.4 0.3 0.4 0.5 0.4 0.7 0.4 0.4 0.4 0.4 0.4 0.8 0.5 0.4 0.4 0.4 0.4 0.4 1.0 1.1 0.4 0.4 0.6 0.9 0.4 0.4 0.6 0.4 0.3 0.4 0.5 0.5 0.7 0.4 12.0 0.4 0.4 0.4 0.4 1.4 0.4 0.4 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.4 0.5 0.8 0.5 0.9 0.4 2.1 0.2 0.9 3.4 3.2 1.0 0.7 0.7 0.2 0.6 0.8 2.1 1.0 1.4 0.7 2.0 0.3 1.4 0.3 1.4 0.5 1.0 0.6 3.3 2.8 1.8 1.2 0.7 0.1 1.1 0.2 0.2 2.6 0.6 2.2 2.1 0.5 0.4 1.7 0.4 1.3 1.1 0.2 0.1 0.8 0.3 0.5 0.0 0.8 1.6 0.6 0.1 3.9 1.1 0.3 0.0 0.5 0.8 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.8 3.2 0.4 0.4 0.4 0.4 0.4 0.4 0.4 DNER "bet, UNQ26" ENSG00000187957 "Delta/notch like EGF repeat containing" Q8NFT8 2 229357629-229714558 "Cancer-related genes, Predicted membrane proteins" "Notch signaling pathway" "Activator, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 45.6;brain: 85.2;salivary gland: 46.1" "Group enriched" "Detected in some" 5 "hTERT-HME1: 39.4;U-138 MG: 66.4;U-87 MG: 39.3" "Cancer enriched" "Detected in many" 32 "glioma: 73.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017320 Enhanced 2700000 "HPA017320: AB_1847808" "unprognostic (4.39e-2)" "unprognostic (1.83e-1)" "unprognostic (3.25e-1)" "unprognostic (1.00e-3)" "unprognostic (8.73e-2)" "unprognostic (6.23e-2)" "prognostic unfavourable (1.05e-4)" "unprognostic (4.23e-3)" "unprognostic (2.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.60e-1)" "unprognostic (8.60e-2)" "prognostic unfavourable (3.42e-4)" "unprognostic (2.59e-2)" "unprognostic (7.32e-2)" "unprognostic (5.63e-2)" "unprognostic (5.13e-3)" 1.7 45.6 25.4 2.2 26.8 1.3 3.1 19.5 85.2 2.2 2.3 38.4 0.0 1.6 2.1 5.7 1.5 4.1 1.5 6.8 23.9 36.8 9.7 1.3 2.0 1.5 39.8 15.2 1.6 1.9 1.7 9.6 1.5 30.0 2.8 2.2 2.5 46.1 1.6 1.3 2.5 1.9 2.2 26.4 1.3 8.3 2.0 30.4 0.0 1.4 0.0 2.1 1.4 0.2 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.1 0.1 0.0 0.0 0.3 2.2 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.7 2.4 1.7 39.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 3.6 0.0 0.4 0.0 3.7 0.0 7.9 0.6 0.2 0.0 0.2 0.0 0.0 0.0 66.4 0.0 2.2 9.9 0.0 0.0 0.0 39.3 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 25.4 26.8 19.5 26.6 23.9 36.8 39.8 15.2 30.0 30.4 DNM1 DNM ENSG00000106976 "Dynamin 1" Q05193 9 128191655-128255248 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, Motor protein" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 133.5" "Cell line enhanced" "Detected in many" "A549: 48.8;U-87 MG: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005920, HPA049910, HPA061801" Enhanced Supported Nucleoplasm 440000 Nucleoplasm "CAB005920: , HPA049910: , HPA061801: " "unprognostic (3.25e-2)" "unprognostic (5.49e-2)" "unprognostic (1.34e-3)" "unprognostic (3.95e-2)" "unprognostic (4.57e-2)" "unprognostic (1.16e-1)" "unprognostic (3.60e-3)" "unprognostic (1.20e-1)" "unprognostic (5.53e-2)" "unprognostic (6.53e-2)" "unprognostic (6.62e-3)" "unprognostic (6.30e-1)" "unprognostic (9.58e-2)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (3.07e-3)" "unprognostic (1.10e-3)" 5.9 6.1 31.5 3.3 36.9 2.3 4.6 57.7 133.5 11.7 3.0 2.5 0.0 2.4 4.6 2.7 3.3 6.3 9.0 2.7 33.4 24.0 2.9 1.8 2.5 2.5 18.3 33.0 1.6 4.7 3.2 5.5 2.7 33.0 2.9 2.9 4.3 2.6 3.1 2.3 4.6 3.3 4.4 5.1 1.6 2.6 4.0 1.8 0.0 1.9 0.4 2.3 3.6 3.7 0.3 0.4 0.5 0.3 0.0 0.3 0.7 3.2 48.8 4.4 1.0 1.4 14.9 0.2 3.0 7.3 6.2 2.6 0.6 1.0 0.0 4.2 6.3 5.8 0.7 0.3 3.4 0.0 4.7 3.1 7.0 0.2 1.0 0.4 2.2 3.9 0.1 4.8 0.0 0.0 1.1 0.2 0.0 1.3 0.2 1.0 4.7 8.9 5.8 0.1 1.5 0.9 0.0 6.3 10.6 10.4 0.3 0.4 0.1 4.2 0.2 0.2 14.1 14.2 6.2 0.4 0.1 0.3 18.6 0.1 1.0 0.0 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.4 0.2 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.7 31.5 36.9 57.7 71.8 33.4 24.0 18.3 33.0 33.0 1.8 DNM3 KIAA0820 ENSG00000197959 "Dynamin 3" Q9UQ16 1 171841498-172418466 "Enzymes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Hydrolase, Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.3" "Cell line enhanced" "Detected in many" "HEL: 17.9;HMC-1: 8.3;RH-30: 8.1;RPTEC TERT1: 15.5;U-251 MG: 11.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 4.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064121 Approved "Golgi apparatus" "Golgi apparatus" "HPA064121: " "unprognostic (8.21e-2)" "unprognostic (6.80e-3)" "unprognostic (1.68e-1)" "unprognostic (1.41e-2)" "unprognostic (8.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.52e-3)" "unprognostic (6.46e-2)" "unprognostic (5.52e-2)" "unprognostic (2.96e-2)" "unprognostic (2.45e-2)" "unprognostic (3.37e-1)" "unprognostic (6.10e-4)" "unprognostic (1.60e-3)" "unprognostic (1.35e-1)" "unprognostic (2.22e-1)" "unprognostic (2.70e-3)" 5.0 19.3 14.1 2.3 28.3 2.6 3.4 41.4 39.7 6.8 2.7 26.8 0.0 1.9 5.9 3.1 3.0 6.0 5.1 3.0 14.3 16.3 5.8 1.4 7.5 2.5 19.6 17.7 4.6 2.6 3.5 10.3 1.6 47.3 3.6 2.7 2.9 3.7 3.6 2.5 4.0 2.4 5.7 16.4 3.6 5.3 5.4 22.1 0.0 3.4 0.0 2.2 4.3 3.6 0.7 0.7 1.1 0.4 1.0 4.0 3.8 0.6 2.0 1.6 0.3 1.2 0.8 0.0 0.4 1.0 0.8 1.0 0.0 2.9 0.0 6.2 0.9 0.2 1.2 2.3 0.7 0.8 2.3 17.9 3.0 0.0 0.1 0.3 8.3 0.6 0.4 0.9 0.5 0.4 0.0 0.2 0.3 0.0 1.1 0.1 4.7 1.4 1.1 8.1 0.0 15.5 0.1 3.2 0.6 2.1 0.6 0.2 0.0 0.7 0.2 2.3 3.1 1.9 11.1 3.1 0.5 0.1 2.2 0.9 0.8 0.0 0.4 0.0 0.7 0.0 0.9 0.7 1.0 0.5 0.7 0.0 1.2 1.5 1.1 1.0 0.3 0.0 4.0 3.8 14.1 28.3 41.4 31.6 14.3 16.3 19.6 17.7 47.3 22.1 DOC2A ENSG00000149927 "Double C2 domain alpha" Q14183 16 30005509-30023270 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.0;testis: 12.6" "Cell line enhanced" "Detected in many" "BEWO: 9.6;REH: 7.8;SCLC-21H: 26.1;U-937: 12.5" "Cancer enhanced" "Detected in many" "renal cancer: 5.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 13.5;cerebral cortex: 30.8;hippocampal formation: 24.4" HPA065676 Uncertain "Nucleoplasm,Nucleoli,Cell Junctions" "Cell Junctions" "Nucleoplasm, Nucleoli" "HPA065676: " "unprognostic (1.46e-3)" "unprognostic (3.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (4.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.66e-2)" "unprognostic (9.14e-2)" "unprognostic (3.90e-2)" "unprognostic (2.89e-2)" "unprognostic (1.28e-3)" "unprognostic (5.13e-2)" "unprognostic (8.29e-3)" "unprognostic (1.71e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" "unprognostic (2.61e-1)" 1.2 2.7 18.5 1.0 17.5 3.9 2.3 24.0 49.0 1.3 3.1 0.9 0.3 1.7 1.6 2.4 1.1 3.3 1.8 1.0 15.3 8.3 1.6 1.4 3.5 1.4 2.8 27.4 5.7 1.0 1.3 3.2 1.2 13.1 2.5 2.4 0.0 1.6 1.4 1.1 2.0 2.3 1.8 4.2 3.1 1.7 12.6 1.8 0.0 1.6 0.0 1.2 1.4 0.6 0.6 1.1 1.0 0.4 0.2 0.5 0.3 0.7 1.5 1.0 0.8 0.3 0.0 9.6 0.4 0.7 0.5 0.3 3.9 2.7 0.0 0.9 0.4 0.2 4.9 2.0 0.2 0.1 0.5 0.7 0.5 0.3 0.7 0.9 2.8 1.1 0.8 0.1 1.1 0.0 0.3 0.0 0.0 7.6 2.0 3.5 1.5 4.1 7.8 0.1 0.4 0.5 0.8 26.1 2.0 0.5 2.7 0.2 2.6 1.6 0.8 0.3 1.5 0.3 0.3 0.4 0.1 0.1 0.3 12.5 0.3 0.8 0.4 0.0 0.0 0.3 0.1 0.5 0.1 0.3 1.1 0.6 0.5 0.5 1.0 0.2 0.0 0.0 0.1 0.3 18.5 17.5 24.0 36.2 15.3 8.3 2.8 27.4 13.1 1.8 DOC2B DOC2BL ENSG00000272636 "Double C2 domain beta" 17 142789-181636 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.1" "Group enriched" "Detected in some" 8 "HAP1: 7.2;SH-SY5Y: 28.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043168 Uncertain "HPA043168: " "prognostic favourable (3.45e-4)" "unprognostic (2.28e-3)" "unprognostic (3.17e-1)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "prognostic favourable (8.68e-4)" "unprognostic (1.25e-1)" "unprognostic (3.61e-2)" "unprognostic (2.62e-1)" "unprognostic (8.78e-3)" "unprognostic (3.49e-2)" "unprognostic (2.18e-1)" "unprognostic (2.27e-3)" "unprognostic (2.06e-2)" "unprognostic (1.71e-1)" "unprognostic (1.27e-3)" "unprognostic (4.87e-3)" 11.1 7.7 9.1 4.6 10.6 11.0 4.5 23.1 12.6 2.6 1.9 0.2 0.2 1.0 2.8 1.1 8.1 4.8 2.2 2.8 15.5 2.8 0.3 2.6 2.8 0.4 9.9 0.5 6.7 0.9 1.1 3.2 6.6 2.2 2.3 7.6 0.4 2.4 2.1 2.2 2.3 4.1 4.2 2.8 1.7 0.2 2.1 0.0 0.7 5.7 8.4 2.2 10.5 0.8 1.1 1.8 1.1 0.7 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.3 0.5 0.7 0.4 0.5 0.3 0.3 0.2 0.8 0.3 0.3 1.6 0.7 1.1 1.1 0.3 0.1 DOCK10 "KIAA0694, ZIZ3" ENSG00000135905 "Dedicator of cytokinesis 10" Q96BY6 2 224765090-225042445 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.7;lymphoid tissue: 27.6" "Cell line enhanced" "Detected in many" "BJ: 20.0;HDLM-2: 22.7;TIME: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058106 Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA058106: " "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.03e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-3)" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (3.44e-2)" "unprognostic (3.80e-1)" "unprognostic (3.22e-3)" "unprognostic (3.39e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-1)" "unprognostic (7.72e-2)" 4.2 7.6 17.1 16.7 28.8 8.8 4.0 3.0 18.4 9.5 5.9 27.6 0.0 4.1 3.4 1.4 3.4 2.5 6.4 1.8 24.3 14.7 2.9 5.4 7.3 23.9 33.3 9.6 15.9 1.8 1.9 1.4 2.5 23.2 2.0 6.7 1.1 4.1 2.0 1.3 5.0 8.5 4.4 37.7 26.5 6.1 2.3 35.5 27.6 2.7 1.3 18.4 6.6 3.7 6.8 6.2 2.6 9.6 12.8 10.5 4.0 0.0 9.4 3.0 0.0 3.9 8.3 0.0 20.0 16.4 9.6 7.2 0.0 0.0 0.2 0.0 12.6 0.2 0.0 0.0 7.7 22.7 0.0 0.2 2.0 0.0 0.1 1.9 0.9 1.9 0.2 13.9 5.4 9.5 0.0 18.8 16.2 0.9 3.4 2.6 1.1 2.2 4.5 4.4 2.7 0.5 0.0 0.1 2.5 0.0 0.0 2.0 0.6 8.7 21.2 10.4 2.5 4.9 6.8 0.0 0.0 0.0 14.7 12.9 4.5 2.6 2.8 0.2 6.2 8.2 6.4 6.8 10.5 8.8 6.2 3.8 10.4 9.0 0.1 12.8 9.6 2.6 7.5 4.0 17.1 28.8 3.0 18.4 24.3 14.7 33.3 9.6 23.2 35.5 DOCK3 "KIAA0299, MOCA, PBP" ENSG00000088538 "Dedicator of cytokinesis 3" Q8IZD9 3 50675241-51384198 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell line enhanced" "Detected in some" "AN3-CA: 8.0;HAP1: 5.4;HEK 293: 5.5;HMC-1: 6.4;U-87 MG: 10.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037543, HPA037544" Enhanced Enhanced Cytosol Cytosol "HPA037543: AB_10672495, HPA037544: AB_10670383" "unprognostic (1.02e-1)" "unprognostic (1.11e-1)" "unprognostic (1.78e-3)" "unprognostic (6.35e-8)" "unprognostic (2.63e-1)" "unprognostic (3.02e-2)" "unprognostic (4.64e-2)" "unprognostic (3.67e-1)" "unprognostic (1.91e-1)" "unprognostic (7.99e-2)" "unprognostic (2.36e-3)" "unprognostic (1.34e-2)" "unprognostic (1.45e-2)" "unprognostic (5.83e-5)" "unprognostic (7.96e-2)" "unprognostic (6.19e-2)" "unprognostic (1.24e-1)" 1.6 5.5 15.3 1.7 19.8 1.6 1.7 24.2 38.9 1.7 2.3 11.6 1.9 1.7 2.1 2.7 4.2 2.2 1.9 4.6 11.5 9.8 1.9 1.3 1.8 1.8 9.1 17.6 1.7 2.0 15.8 9.2 1.5 13.1 3.8 1.9 1.8 3.2 5.0 4.3 4.0 1.7 3.1 8.5 1.8 1.7 9.0 10.7 0.0 17.4 0.0 1.9 2.0 0.7 0.7 0.7 0.2 2.0 0.6 1.3 0.0 0.1 0.2 0.2 8.0 0.0 0.0 3.5 0.1 0.2 0.4 0.3 0.2 0.5 0.0 0.7 2.5 0.5 5.4 0.0 0.1 4.6 5.5 0.1 1.3 0.1 0.1 0.2 6.4 0.1 0.2 0.3 0.0 0.1 0.0 0.1 0.6 0.3 0.0 0.0 2.6 2.5 0.0 0.8 0.0 0.4 0.7 4.9 0.0 0.4 4.5 0.1 0.1 0.0 0.5 0.3 2.2 0.3 2.8 0.3 0.0 0.0 10.6 1.0 0.1 0.0 0.1 0.2 0.5 0.4 0.5 0.4 0.4 0.2 0.1 0.7 1.3 0.5 0.2 0.6 2.0 0.7 0.1 0.0 15.3 19.8 24.2 25.3 11.5 9.8 9.1 17.6 13.1 10.7 DOK6 "DOK5L, HsT3226, MGC20785" ENSG00000206052 "Docking protein 6" Q6PKX4 18 69401055-69849087 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.4;Hep G2: 10.9;RPMI-8226: 10.6;SCLC-21H: 4.8;SH-SY5Y: 10.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041099, HPA063534" Approved Approved "Focal adhesion sites,Cytosol" "Focal adhesion sites, Cytosol" "HPA041099: , HPA063534: " "unprognostic (5.83e-2)" "unprognostic (1.39e-1)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (2.77e-2)" "unprognostic (2.59e-1)" "unprognostic (1.55e-1)" "unprognostic (1.90e-2)" "unprognostic (8.62e-2)" "unprognostic (5.99e-2)" "unprognostic (1.04e-2)" "unprognostic (4.60e-3)" "unprognostic (2.13e-4)" "unprognostic (2.30e-3)" "unprognostic (2.88e-2)" "unprognostic (4.49e-3)" "unprognostic (1.09e-3)" 2.1 1.6 21.3 1.6 11.3 0.6 1.3 6.8 22.1 3.8 1.5 0.9 0.3 1.0 3.0 1.4 1.7 1.7 5.8 10.2 19.2 9.2 8.7 4.4 4.2 1.2 13.7 13.1 4.2 0.7 3.4 1.1 9.9 14.0 3.5 1.3 5.5 1.7 4.2 0.6 1.2 1.3 6.6 2.7 1.8 1.3 2.8 2.7 0.0 4.1 0.0 1.2 5.2 6.6 0.0 0.0 0.0 0.0 0.9 0.9 0.4 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 10.4 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 10.9 0.3 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 10.6 0.0 0.0 4.8 10.9 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.6 0.0 1.5 0.3 0.0 0.0 3.1 0.0 3.2 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.2 0.4 0.0 0.0 0.1 0.5 0.0 0.9 0.0 0.0 0.3 0.4 21.3 11.3 6.8 17.1 19.2 9.2 13.7 13.1 14.0 2.7 DPF1 "BAF45b, NEUD4, neuro-d4" ENSG00000011332 "Double PHD fingers 1" Q92782 19 38211006-38229714 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 31.6" "Cell line enhanced" "Detected in many" "HAP1: 15.4;SCLC-21H: 18.2" "Cancer enhanced" "Detected in some" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049148 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "HPA049148: " "unprognostic (7.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.38e-2)" "unprognostic (4.11e-3)" "unprognostic (8.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-4)" "unprognostic (1.40e-2)" "unprognostic (2.72e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-3)" "unprognostic (2.87e-2)" "unprognostic (1.11e-16)" "unprognostic (2.56e-1)" "unprognostic (3.75e-1)" "unprognostic (6.96e-2)" "unprognostic (8.20e-4)" 1.1 1.5 11.8 1.5 15.7 1.0 0.9 6.4 31.6 0.8 1.0 0.9 0.0 0.9 1.0 0.8 0.8 1.0 1.0 1.0 12.4 7.7 0.8 0.8 1.0 1.1 4.5 11.3 0.9 0.9 0.9 1.3 1.1 2.0 0.9 0.9 0.0 1.2 0.8 1.1 1.2 1.0 1.3 2.1 1.1 0.8 2.5 1.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 3.4 2.9 12.5 9.1 0.9 0.6 1.2 3.7 2.1 6.3 5.4 2.1 0.3 5.7 2.5 2.8 2.2 15.4 2.1 2.8 5.4 3.0 1.9 1.4 0.8 0.3 1.4 1.6 0.7 0.0 3.8 1.2 1.1 4.2 0.3 6.0 4.8 3.0 0.3 2.2 3.5 5.7 6.3 1.2 0.6 1.0 18.2 6.3 4.2 0.4 0.8 1.9 0.3 1.4 9.2 2.9 2.2 3.3 2.3 7.5 7.6 4.8 2.0 3.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.8 15.7 6.4 19.6 12.4 7.7 4.5 11.3 2.0 1.2 DPF3 "BAF45c, cer-d4, Cerd4, FLJ14079" ENSG00000205683 "Double PHD fingers 3" Q92784 14 72619296-72894116 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.3;skeletal muscle: 28.4" "Cell line enhanced" "Detected in many" "BEWO: 13.4;BJ hTERT+ SV40 Large T+: 9.2;HEL: 22.8;Karpas-707: 9.3" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Region enriched" "Detected in all" 5 "cerebellum: 56.3" "Cell type enhanced" "Detected in some" "memory B-cell: 1.1;naive B-cell: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA066790, HPA070601" Enhanced Enhanced Nucleoplasm Nucleoplasm "HPA066790: , HPA070601: " "unprognostic (2.38e-2)" "unprognostic (2.96e-1)" "unprognostic (3.25e-1)" "unprognostic (1.56e-2)" "unprognostic (1.55e-1)" "unprognostic (9.98e-2)" "unprognostic (4.80e-2)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (3.54e-2)" "unprognostic (9.71e-3)" "unprognostic (1.02e-1)" "unprognostic (2.02e-1)" "unprognostic (3.85e-3)" "unprognostic (4.08e-2)" "unprognostic (4.80e-2)" "unprognostic (1.96e-1)" 0.7 2.2 6.2 1.1 10.3 3.2 0.8 56.3 7.6 0.9 2.7 8.4 0.0 0.8 0.8 0.5 1.2 0.7 1.0 16.8 6.4 2.5 2.2 4.3 0.8 1.5 8.9 4.5 17.8 0.7 8.4 0.9 0.9 10.4 0.7 2.4 3.4 0.8 0.7 28.4 1.1 1.7 1.2 10.1 1.4 1.1 6.6 10.7 0.0 0.8 6.3 1.8 0.8 0.7 1.9 0.0 0.0 0.3 0.4 0.8 0.2 1.5 0.0 1.2 0.1 0.2 2.2 13.4 4.0 3.8 9.2 3.5 0.0 0.1 0.2 0.2 1.2 0.1 1.3 0.6 5.6 0.2 0.4 22.8 0.1 0.0 0.3 0.1 0.4 0.6 0.2 2.1 1.5 2.9 2.0 9.3 2.9 0.1 1.9 0.2 0.0 1.3 5.0 0.6 0.3 1.6 0.0 0.9 0.5 0.0 0.1 0.0 0.0 0.0 6.4 4.5 0.0 1.6 0.5 3.3 0.8 0.3 0.4 0.8 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.2 6.2 10.3 56.3 7.6 6.4 2.5 8.9 4.5 10.4 10.7 DPP10 "DPL2, DPPY, DPRP3" ENSG00000175497 "Dipeptidyl peptidase like 10" Q8N608 2 114442299-115845752 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 15.6;brain: 30.3;pancreas: 23.4" "Cell line enhanced" "Detected in some" "AF22: 5.0;HAP1: 7.5;HMC-1: 5.3;NTERA-2: 4.5;RT4: 8.0;SCLC-21H: 11.9;SH-SY5Y: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048767 Uncertain "HPA048767: " "unprognostic (1.19e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" "unprognostic (1.77e-2)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (6.59e-2)" "unprognostic (2.92e-1)" "unprognostic (5.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-2)" "unprognostic (8.33e-2)" "unprognostic (7.61e-2)" "unprognostic (4.22e-2)" 0.7 15.6 13.4 1.1 15.9 0.9 0.9 1.9 30.3 1.3 3.6 7.9 0.0 2.4 1.4 0.8 0.8 0.9 1.9 0.8 17.5 9.9 1.1 0.9 1.0 0.7 7.1 21.3 0.9 23.4 0.7 1.5 1.8 10.8 0.8 4.6 0.0 1.0 0.8 0.7 0.9 2.4 1.9 12.7 0.7 1.5 2.1 10.3 0.0 1.6 0.0 0.8 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 8.0 11.9 4.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 15.9 1.9 30.3 17.5 9.9 7.1 21.3 10.8 10.3 DPP6 "DPL1, DPPX" ENSG00000130226 "Dipeptidyl peptidase like 6" P42658 7 153887097-154894285 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.7;endometrium 1: 24.5;thyroid gland: 24.1" "Cell line enriched" "Detected in some" 9 "NTERA-2: 11.0" "Cancer enriched" "Detected in some" 11 "glioma: 12.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050509 Enhanced Supported "HPA050509: " "unprognostic (1.29e-1)" "unprognostic (3.55e-2)" "unprognostic (5.68e-2)" "unprognostic (5.86e-2)" "unprognostic (1.53e-2)" "unprognostic (2.28e-1)" "unprognostic (2.73e-1)" "unprognostic (5.83e-4)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (7.45e-3)" "unprognostic (4.04e-3)" "unprognostic (2.94e-3)" "unprognostic (1.85e-4)" "unprognostic (1.05e-1)" "unprognostic (4.61e-3)" "unprognostic (6.11e-2)" 1.6 7.2 15.4 1.4 32.5 1.3 1.5 26.6 45.7 2.3 6.8 8.7 0.0 1.6 24.5 3.1 1.5 4.6 1.3 1.4 26.6 15.2 3.6 1.2 2.2 1.3 14.0 22.7 1.3 4.0 1.2 4.9 1.3 18.8 1.5 2.4 0.4 1.3 8.1 4.6 3.7 2.0 15.8 7.2 4.2 3.5 7.9 10.0 0.0 24.1 0.0 1.2 1.3 0.4 0.6 0.6 1.9 0.9 0.9 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 11.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.9 0.4 0.7 0.4 0.6 0.7 0.6 0.6 0.4 0.4 0.6 0.7 0.7 1.6 0.9 0.9 0.6 0.5 0.3 15.4 32.5 26.6 32.4 26.6 15.2 14.0 22.7 18.8 10.0 DPYSL2 "CRMP2, DHPRP2, DRP-2, DRP2" ENSG00000092964 "Dihydropyrimidinase like 2" Q16555 8 26514022-26658178 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 137.0" "Cell line enhanced" "Detected in many" "ASC diff: 60.4;Karpas-707: 62.2" "Cancer enhanced" "Detected in all" "glioma: 89.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 24.0;intermediate monocyte: 26.7;myeloid DC: 25.5;non-classical monocyte: 16.2;plasmacytoid DC: 15.1" "Group enriched" "Detected in many" 6 "dendritic cells: 25.5;monocytes: 26.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002381, CAB018719" Supported Supported "Plasma membrane,Cytosol" 3900000 Cytosol "Plasma membrane" "CAB018719: AB_2085366, HPA002381: AB_1847244" "unprognostic (2.88e-2)" "unprognostic (1.01e-2)" "unprognostic (9.51e-2)" "unprognostic (3.16e-3)" "unprognostic (8.23e-2)" "unprognostic (1.68e-2)" "unprognostic (1.51e-1)" "unprognostic (9.95e-3)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" "unprognostic (1.79e-2)" "unprognostic (4.13e-2)" "unprognostic (5.58e-2)" "unprognostic (9.32e-3)" "unprognostic (1.23e-1)" "unprognostic (3.27e-2)" "prognostic unfavourable (5.41e-5)" 31.6 21.7 53.5 13.4 48.1 3.0 21.3 51.8 137.0 14.6 12.2 54.7 3.9 7.1 14.2 8.1 12.0 14.7 18.0 27.2 52.9 48.6 12.1 11.2 45.3 9.9 56.5 45.4 25.8 7.5 5.1 7.2 25.6 46.9 9.8 12.4 8.2 6.5 10.3 10.9 10.2 9.7 19.9 70.1 19.0 8.5 7.5 44.9 5.8 7.7 5.2 12.3 14.0 13.1 3.2 25.5 0.6 26.7 4.0 4.6 8.8 4.7 22.7 22.4 11.9 60.4 27.9 2.2 9.2 21.4 8.8 11.5 8.8 6.8 7.0 6.7 28.7 4.6 23.5 9.2 8.4 15.8 2.0 7.9 8.6 12.4 38.7 1.7 3.2 34.5 13.3 24.0 14.0 17.6 0.2 62.2 8.8 3.0 13.5 1.7 17.5 4.4 18.0 9.0 4.6 14.7 5.4 10.2 21.5 11.2 0.1 6.0 1.7 3.2 31.7 20.0 8.1 16.5 4.0 8.8 9.0 5.5 28.9 10.4 10.1 0.4 24.0 0.2 3.5 26.7 1.2 3.2 3.1 2.3 25.5 1.7 1.6 2.1 0.6 4.0 16.2 15.1 4.6 8.8 53.5 48.1 51.8 68.4 52.9 48.6 56.5 45.4 46.9 44.9 DPYSL4 "DRP-4, ULIP4" ENSG00000151640 "Dihydropyrimidinase like 4" O14531 10 132186900-132205776 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0;heart muscle: 19.0" "Cell line enhanced" "Detected in many" "AF22: 23.2;AN3-CA: 30.4;SH-SY5Y: 31.6" "Cancer enhanced" "Detected in many" "glioma: 13.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049066 Approved Approved Vesicles,Mitochondria "Vesicles, Mitochondria" "HPA049066: " "unprognostic (6.27e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-1)" "unprognostic (1.81e-1)" "unprognostic (3.95e-1)" "unprognostic (5.99e-2)" "unprognostic (8.36e-5)" "unprognostic (1.72e-1)" "unprognostic (8.91e-2)" "unprognostic (1.08e-2)" "unprognostic (3.81e-2)" "unprognostic (6.36e-2)" "unprognostic (7.47e-6)" "unprognostic (3.04e-3)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "prognostic unfavourable (3.11e-4)" 1.5 4.4 11.8 2.0 12.3 1.1 1.5 8.9 32.0 1.7 1.4 6.5 0.2 1.1 6.4 2.2 1.4 1.4 2.1 19.0 13.6 9.6 1.0 1.0 1.5 1.4 9.0 9.1 3.0 1.9 1.0 5.0 1.3 6.0 4.8 1.0 4.6 1.5 4.2 2.5 1.6 1.2 2.7 8.1 2.5 1.8 6.7 4.8 0.0 1.0 0.0 1.3 1.4 0.4 0.7 0.0 0.0 0.6 1.1 2.5 0.8 0.0 6.5 23.2 30.4 0.0 0.2 0.0 1.9 0.2 1.2 0.3 0.0 0.2 0.0 0.8 1.0 0.0 4.5 4.4 0.1 0.0 0.8 0.0 0.0 2.4 4.1 0.0 4.6 2.1 2.1 0.7 0.1 2.3 0.0 0.2 3.3 1.9 0.0 0.0 4.0 2.2 0.0 0.0 3.6 0.0 0.4 3.6 31.6 0.7 0.0 4.0 0.1 0.0 3.8 5.8 9.7 0.0 5.4 0.0 1.5 0.0 9.7 0.0 0.6 0.0 0.1 0.0 1.4 0.6 0.0 0.0 1.1 0.1 0.0 0.7 2.5 0.7 0.0 1.1 0.5 0.0 0.0 0.8 11.8 12.3 8.9 18.7 13.6 9.6 9.0 9.1 6.0 4.8 DPYSL5 "CRAM, CRMP-5, CRMP5, Ulip6" ENSG00000157851 "Dihydropyrimidinase like 5" Q9BPU6 2 26847747-26950351 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.1" "Group enriched" "Detected in some" 4 "AF22: 41.0;HAP1: 34.1;SCLC-21H: 48.9;SH-SY5Y: 28.9" "Group enriched" "Detected in some" 15 "glioma: 17.7;testis cancer: 8.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034544, HPA072387" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034544: AB_10671228, HPA072387: " "unprognostic (1.07e-4)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (3.64e-6)" "unprognostic (3.94e-1)" "unprognostic (6.21e-2)" "unprognostic (6.12e-2)" "unprognostic (2.66e-1)" "unprognostic (1.54e-1)" "unprognostic (3.54e-2)" "unprognostic (1.35e-1)" "unprognostic (1.77e-2)" "unprognostic (5.67e-3)" "unprognostic (3.62e-2)" "unprognostic (1.08e-1)" "unprognostic (2.43e-1)" 1.2 4.7 6.1 1.6 18.4 1.1 1.1 7.8 36.6 1.4 1.6 43.5 0.0 1.7 1.2 1.1 1.3 1.2 1.1 1.1 10.3 11.3 1.2 1.1 1.1 1.1 24.3 8.8 1.1 1.1 1.1 2.8 1.2 21.9 1.3 1.5 1.6 1.1 1.1 1.2 1.2 1.7 1.6 47.1 1.1 1.1 10.3 19.7 0.0 1.1 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 41.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 0.0 0.0 34.1 0.0 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 48.9 28.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 18.4 7.8 11.8 10.3 11.3 24.3 8.8 21.9 19.7 DRAXIN "C1orf187, Draxin, FLJ34999, Neucrin" ENSG00000162490 "Dorsal inhibitory axon guidance protein" Q8NBI3 1 11691729-11725857 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.6;brain: 9.5" "Cell line enriched" "Detected in some" 5 "NTERA-2: 24.7" "Group enriched" "Detected in some" 6 "glioma: 5.1;testis cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 5.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA014302 Uncertain "Secreted in brain" "HPA014302: AB_1853084" "unprognostic (5.28e-2)" "unprognostic (2.73e-1)" "unprognostic (6.58e-2)" "unprognostic (4.95e-2)" "unprognostic (2.51e-1)" "unprognostic (1.85e-1)" "unprognostic (1.37e-2)" "unprognostic (1.84e-2)" "unprognostic (1.49e-1)" "unprognostic (1.17e-1)" "unprognostic (1.51e-2)" "unprognostic (7.47e-2)" "unprognostic (5.16e-6)" "unprognostic (4.65e-2)" "unprognostic (1.15e-1)" "unprognostic (8.52e-2)" "unprognostic (5.08e-1)" 0.7 0.4 9.5 1.0 4.4 2.8 1.4 4.1 4.7 0.3 0.4 4.9 0.0 0.6 1.0 0.8 0.6 0.7 0.6 0.4 8.9 0.9 0.5 0.2 1.2 1.0 2.7 3.0 0.5 0.7 0.4 0.2 0.4 2.4 0.4 0.5 0.0 3.6 0.7 0.6 1.3 0.7 0.3 1.9 0.9 0.4 1.5 2.5 0.0 0.7 0.8 0.5 0.4 0.2 1.2 0.6 5.6 1.1 0.9 1.9 0.5 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 1.8 0.3 24.7 0.0 5.4 0.2 0.0 0.0 0.0 1.6 0.7 0.0 0.0 0.1 0.0 0.1 0.2 0.1 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 5.6 1.1 0.7 1.9 0.6 0.7 0.6 0.5 1.1 0.3 1.2 0.8 1.0 2.9 0.9 0.7 0.6 0.8 0.5 9.5 4.4 4.1 4.2 8.9 0.9 2.7 3.0 2.4 2.5 DRC1 "C2orf39, CCDC164, CILD21, FLJ32660, MGC16372" ENSG00000157856 "Dynein regulatory complex subunit 1" Q96MC2 2 26401916-26456711 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.5;fallopian tube: 36.8;testis: 29.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.6;SCLC-21H: 1.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.3" "Region enriched" "Detected in many" 4 "pons and medulla: 20.5" "Cell type enriched" "Detected in single" 64 "neutrophil: 11.2" "Lineage enriched" "Detected in single" 64 "granulocytes: 11.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (2.28e-3)" "unprognostic (2.68e-2)" "unprognostic (5.36e-2)" "unprognostic (5.27e-3)" "unprognostic (3.41e-3)" "unprognostic (8.56e-3)" "unprognostic (7.02e-4)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (7.26e-2)" "unprognostic (1.97e-3)" "unprognostic (2.99e-1)" "unprognostic (3.06e-3)" "unprognostic (8.19e-2)" "unprognostic (9.91e-3)" "unprognostic (2.16e-1)" "unprognostic (1.30e-2)" 0.3 0.4 2.4 0.3 3.6 1.0 0.3 0.1 2.1 2.0 0.3 7.7 0.0 0.3 1.3 11.3 0.3 36.8 0.3 0.3 3.6 4.8 0.4 0.3 6.0 0.3 1.3 1.8 5.2 0.3 0.3 4.8 0.3 20.5 0.4 0.3 0.0 0.3 0.7 0.3 0.3 0.3 0.3 1.0 0.3 0.4 29.6 2.9 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 11.2 0.1 0.0 0.0 0.0 0.2 0.6 0.6 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.8 4.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 2.4 3.6 0.1 2.1 3.6 4.8 1.3 1.8 20.5 2.9 DRD1 ENSG00000184845 "Dopamine receptor D1" P21728 5 175440039-175444208 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 34.5" "Cell line enriched" "Detected in some" 5 "RT4: 23.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "basal ganglia: 147.4" "Region enriched" "Detected in many" 13 "basal ganglia: 95.6" HPA013393 Supported "HPA013393: AB_1847833" "unprognostic (2.74e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-3)" "unprognostic (1.28e-1)" "unprognostic (1.15e-6)" "unprognostic (6.69e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (8.60e-4)" "unprognostic (5.86e-2)" "unprognostic (5.43e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" 0.7 1.5 1.9 0.2 34.5 0.0 0.1 0.1 12.0 0.7 0.7 0.4 0.0 0.5 0.4 0.7 0.7 0.6 1.1 0.3 1.0 0.6 0.7 2.6 1.8 0.1 0.5 1.6 0.3 0.0 0.0 0.1 2.5 0.3 2.7 0.9 2.1 0.1 1.2 0.1 0.1 0.3 0.4 0.1 0.4 0.4 0.1 6.8 0.1 0.1 0.0 0.4 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 34.5 0.1 5.3 1.0 0.6 0.5 1.6 0.3 6.8 DRD2 ENSG00000149295 "Dopamine receptor D2" P14416 11 113409615-113475691 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 17.3;brain: 52.0;pituitary gland: 51.6" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 44.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 52.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 10 "basal ganglia: 183.8" "Group enriched" "Detected in many" 9 "basal ganglia: 126.7;midbrain: 41.7" "HPA015139, HPA015691" Supported Supported "HPA015139: , HPA015691: AB_1847834" "unprognostic (8.49e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-4)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (1.97e-2)" "unprognostic (5.89e-2)" "unprognostic (4.40e-2)" "unprognostic (8.33e-4)" "unprognostic (1.10e-1)" "unprognostic (6.65e-3)" "unprognostic (2.29e-1)" "unprognostic (1.71e-1)" "unprognostic (4.82e-2)" "unprognostic (8.49e-3)" 0.6 17.3 0.9 0.5 52.0 0.2 2.1 0.2 3.3 1.3 0.6 1.5 0.0 0.3 2.3 0.4 0.9 2.1 0.6 0.5 0.3 4.1 0.3 0.2 0.6 0.2 9.9 0.2 0.3 0.4 0.3 51.6 0.2 2.4 1.5 0.9 3.9 5.1 1.7 1.7 0.3 0.5 3.2 0.2 0.2 0.5 1.6 9.5 0.0 0.2 0.0 0.3 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.5 0.0 0.0 4.7 0.0 0.0 0.0 44.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.9 52.0 0.2 3.3 0.3 4.1 9.9 0.2 2.4 9.5 DRD3 ENSG00000151577 "Dopamine receptor D3" P35462 3 114128652-114199407 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.0;brain: 8.3;testis: 4.2" "Cell line enhanced" "Detected in single" "HAP1: 1.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.0;T-reg: 1.4" "Lineage enriched" "Detected in single" 6 "T-cells: 2.0" "Region enriched" "Detected in some" 5 "basal ganglia: 7.5" "Region enriched" "Detected in some" 12 "basal ganglia: 25.2" "unprognostic (2.32e-1)" 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 2.0 0.6 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 1.4 0.2 DRD5 "DRD1B, DRD1L2" ENSG00000169676 "Dopamine receptor D5" P21918 4 9781680-9784009 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Dystonia, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 8.4;lymphoid tissue: 3.5;stomach 1: 10.9" "Cell line enhanced" "Detected in some" "REH: 3.6;THP-1: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048930 Supported "HPA048930: " "unprognostic (2.03e-2)" "unprognostic (2.63e-1)" "unprognostic (9.73e-2)" "unprognostic (4.27e-2)" "unprognostic (4.44e-3)" "unprognostic (1.98e-2)" "unprognostic (1.32e-4)" "unprognostic (5.09e-4)" "unprognostic (6.51e-2)" "unprognostic (1.46e-1)" "unprognostic (7.36e-3)" 0.2 0.2 2.8 3.5 4.1 0.1 0.2 0.0 8.4 0.1 0.9 0.0 0.0 0.9 0.1 0.1 0.3 0.3 0.1 0.1 3.2 3.2 0.2 0.1 0.4 0.2 1.9 0.8 0.1 0.2 0.1 1.0 0.1 7.4 0.6 0.2 0.4 0.2 0.2 0.1 0.2 0.2 0.2 0.6 0.1 10.9 1.3 1.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 3.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.1 0.0 8.4 3.2 3.2 1.9 0.8 7.4 1.0 DRGX "DRG11, PRRXL1" ENSG00000165606 "Dorsal root ganglia homeobox" A6NNA5 10 49364181-49396016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "adrenal gland: 13.9;brain: 8.0" "Cell line enhanced" "Detected in some" "RH-30: 8.1;SH-SY5Y: 36.6;U-2197: 13.2" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low region specificity" "Detected in all" HPA043978 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA043978: AB_10961154" "unprognostic (1.42e-2)" "unprognostic (5.68e-2)" "unprognostic (3.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.74e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-2)" "unprognostic (3.74e-2)" "unprognostic (8.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.09e-2)" 0.2 13.9 0.0 0.4 0.2 0.3 0.1 0.4 3.3 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.5 0.1 2.0 0.6 0.0 0.0 0.0 0.9 0.0 4.8 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.3 0.0 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 3.3 0.2 0.3 2.0 0.6 4.8 0.0 DRP2 ENSG00000102385 "Dystrophin related protein 2" Q13474 X 101219769-101264497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.3" "Cell line enhanced" "Detected in some" "RH-30: 11.0;TIME: 18.5;U-87 MG: 4.5" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002949 Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles, Plasma membrane" "HPA002949: AB_1078706" "unprognostic (8.47e-4)" "unprognostic (3.56e-3)" "unprognostic (1.01e-2)" "unprognostic (5.58e-4)" "unprognostic (1.74e-2)" "unprognostic (2.47e-2)" "unprognostic (7.93e-3)" "unprognostic (2.94e-3)" "unprognostic (1.27e-2)" "unprognostic (5.46e-3)" "unprognostic (1.42e-1)" "unprognostic (4.61e-2)" "unprognostic (4.44e-16)" "unprognostic (3.71e-4)" "unprognostic (4.22e-1)" "unprognostic (9.03e-2)" "unprognostic (1.25e-1)" 1.1 1.5 9.3 1.2 17.2 1.1 0.8 0.4 20.3 1.7 2.8 1.2 0.0 1.1 2.5 2.7 1.3 1.0 1.3 0.9 5.8 4.2 0.7 0.6 0.8 0.8 4.6 10.1 4.4 0.6 0.6 2.4 0.7 2.6 4.1 1.8 0.5 0.7 3.1 0.7 0.8 1.2 2.2 3.1 0.7 0.7 1.6 2.2 0.9 0.6 0.0 0.8 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 2.3 0.1 0.1 0.2 0.1 0.4 0.1 0.3 1.0 0.0 0.4 0.3 0.3 0.1 0.0 0.3 0.0 0.7 0.1 0.2 0.2 0.5 0.0 0.2 0.1 0.4 1.5 0.0 0.7 0.0 1.4 0.0 0.9 1.6 0.0 1.3 0.5 0.1 0.1 0.3 11.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.1 18.5 0.2 0.7 0.2 0.4 0.0 0.1 0.0 4.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 9.3 17.2 0.4 20.3 5.8 4.2 4.6 10.1 2.6 2.2 DSCAM "CHD2-42, CHD2-52" ENSG00000171587 "DS cell adhesion molecule" O60469 21 40010999-40847139 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.2;pituitary gland: 9.1" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.4;MCF7: 12.0;NTERA-2: 3.3;SCLC-21H: 5.0;T-47d: 3.3" "Cancer enriched" "Detected in single" 14 "glioma: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019324 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA019324: " "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (7.59e-2)" "unprognostic (1.99e-2)" "unprognostic (9.98e-2)" "unprognostic (5.49e-4)" "unprognostic (1.78e-1)" "unprognostic (9.58e-2)" "unprognostic (7.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.85e-3)" "unprognostic (2.12e-2)" "unprognostic (2.00e-3)" "unprognostic (2.17e-2)" "unprognostic (2.29e-1)" "unprognostic (8.75e-2)" "unprognostic (5.46e-3)" 0.9 1.1 12.7 0.9 10.3 0.9 1.2 3.0 22.2 0.9 1.0 8.2 0.0 1.0 0.9 2.8 0.9 1.1 1.0 0.9 10.1 8.6 0.9 1.4 1.0 0.9 6.8 10.1 0.9 1.2 0.9 9.1 2.9 9.5 1.0 1.0 0.7 0.9 1.0 0.9 0.9 1.0 0.9 3.7 2.9 0.9 2.0 6.9 0.0 0.9 0.0 0.9 1.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.5 0.0 0.0 0.0 0.0 12.0 0.0 0.0 3.3 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.7 10.3 3.0 14.7 10.1 8.6 6.8 10.1 9.5 6.9 DSCAML1 KIAA1132 ENSG00000177103 "DS cell adhesion molecule like 1" Q8TD84 11 117427773-117817525 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Group enriched" "Detected in some" 4 "EFO-21: 9.0;RPTEC TERT1: 6.6;T-47d: 12.2" "Group enriched" "Detected in some" 5 "glioma: 1.9;ovarian cancer: 0.9;pancreatic cancer: 0.6;renal cancer: 2.5;thyroid cancer: 0.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "memory B-cell: 1.7;naive B-cell: 2.0;T-reg: 2.4" "Group enriched" "Detected in many" 22 "B-cells: 2.0;T-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035230 Uncertain "HPA035230: " "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" "unprognostic (1.07e-2)" "unprognostic (6.27e-5)" "unprognostic (8.48e-2)" "unprognostic (1.56e-2)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (7.96e-2)" "unprognostic (2.89e-2)" "unprognostic (2.39e-3)" "unprognostic (8.37e-2)" "prognostic favourable (8.37e-4)" "unprognostic (1.64e-1)" "unprognostic (1.86e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-2)" 1.5 1.7 10.4 1.3 14.5 1.1 1.3 3.4 19.5 1.7 2.2 26.0 0.0 1.8 4.2 2.2 1.3 4.3 3.5 2.1 12.0 5.8 5.6 1.2 2.0 1.4 14.9 11.1 9.9 2.6 1.0 5.0 1.0 12.1 1.7 2.3 10.8 3.6 1.5 2.1 1.0 1.9 2.9 12.2 3.3 1.9 4.2 17.4 0.0 1.5 0.0 1.7 1.7 0.9 2.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 9.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 6.6 0.0 1.1 0.2 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 10.4 14.5 3.4 14.4 12.0 5.8 14.9 11.1 12.1 17.4 DTHD1 FLJ16686 ENSG00000197057 "Death domain containing 1" Q6ZMT9 4 36281622-36345756 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.6;fallopian tube: 20.6;lung: 18.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 6.8" "Lineage enriched" "Detected in many" 6 "T-cells: 6.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "unprognostic (9.79e-6)" "unprognostic (4.04e-2)" "unprognostic (1.15e-2)" "unprognostic (5.54e-3)" "unprognostic (2.85e-1)" "unprognostic (5.45e-5)" "unprognostic (5.12e-3)" "unprognostic (9.11e-2)" "unprognostic (1.82e-2)" "unprognostic (7.59e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.05e-5)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.65e-2)" "unprognostic (7.12e-3)" 0.7 0.5 1.9 5.8 14.8 0.9 0.4 0.3 0.3 2.1 1.1 2.8 1.4 0.7 1.1 11.9 0.7 20.6 3.5 0.4 3.1 2.9 0.4 0.7 18.5 5.4 0.4 0.0 8.1 0.3 0.2 0.8 0.2 16.6 0.5 0.7 0.1 0.6 0.3 0.2 0.2 1.3 0.4 0.7 8.0 0.8 2.2 4.5 0.0 0.6 1.2 4.0 3.1 0.5 0.0 0.0 0.1 0.0 1.1 6.8 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.3 0.0 0.0 0.1 6.8 0.0 1.2 0.0 0.6 2.1 0.0 0.0 0.0 2.6 0.0 1.1 0.0 0.0 0.0 0.7 1.9 14.8 0.3 0.2 3.1 2.9 0.4 0.0 16.6 4.5 DTNA "D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3" ENSG00000134769 "Dystrobrevin alpha" Q9Y4J8 18 34493290-34891844 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2" "Cell line enhanced" "Detected in many" "MCF7: 17.5;NTERA-2: 19.5;SCLC-21H: 27.5;U-87 MG: 28.1" "Cancer enriched" "Detected in many" 9 "glioma: 28.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;T-cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015196, HPA071177" Enhanced Approved "Nucleoplasm,Cell Junctions,Intermediate filaments" "Nucleoplasm, Cell Junctions, Intermediate filaments" "CAB015196: AB_2261797, HPA071177: " "unprognostic (1.57e-1)" "unprognostic (4.57e-2)" "unprognostic (3.13e-3)" "unprognostic (7.82e-6)" "unprognostic (5.03e-1)" "unprognostic (2.43e-3)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (1.23e-1)" "unprognostic (6.27e-2)" "unprognostic (1.35e-4)" "unprognostic (6.89e-2)" "prognostic favourable (2.64e-7)" "unprognostic (6.08e-3)" "unprognostic (3.93e-2)" "unprognostic (1.12e-1)" "unprognostic (7.27e-5)" 9.3 5.3 51.5 4.0 47.6 1.6 7.3 37.7 69.1 4.5 5.4 38.7 0.9 3.4 4.3 13.9 13.9 7.6 7.1 82.8 42.3 46.5 2.7 2.5 4.8 2.3 44.7 21.0 5.4 12.3 1.4 6.1 3.6 51.0 14.6 5.6 3.4 5.7 15.9 90.2 1.8 3.9 15.2 106.3 3.9 3.6 4.7 39.5 0.0 9.3 6.5 2.4 12.8 1.7 1.4 7.0 0.4 1.3 1.0 6.7 1.7 0.2 0.1 7.5 0.0 4.8 13.4 1.2 2.0 7.3 0.3 0.9 1.7 0.0 0.0 4.4 0.8 0.6 0.9 3.9 0.7 0.0 5.2 0.0 0.4 3.5 3.9 0.1 0.1 10.2 0.8 6.3 2.2 3.2 1.1 0.9 2.1 17.5 0.1 0.0 19.5 4.0 0.0 3.7 11.9 0.3 0.1 27.5 3.2 0.0 0.7 2.0 10.7 2.6 0.1 8.7 4.7 0.1 2.7 0.6 0.9 0.4 28.1 0.0 3.7 0.4 1.3 0.0 1.4 0.0 1.9 1.4 2.7 1.9 7.0 1.1 2.8 2.0 0.1 1.0 0.0 0.2 6.7 1.7 51.5 47.6 37.7 35.7 42.3 46.5 44.7 21.0 51.0 39.5 DTNBP1 "BLOC1S8, DBND, Dysbindin, HPS7, My031" ENSG00000047579 "Dystrobrevin binding protein 1" Q96EV8 6 15522801-15663058 "Disease related genes, Predicted intracellular proteins" "Sensory transduction" "Albinism, Hermansky-Pudlak syndrome, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028053, HPA029615, HPA029616" Approved Enhanced Microtubules,Midbody Microtubules Midbody "HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413" "unprognostic (2.83e-1)" "prognostic favourable (2.82e-4)" "unprognostic (1.62e-1)" "unprognostic (1.20e-1)" "unprognostic (4.93e-2)" "unprognostic (1.29e-2)" "prognostic unfavourable (8.72e-4)" "prognostic favourable (6.34e-5)" "unprognostic (1.36e-1)" "unprognostic (4.28e-3)" "unprognostic (2.21e-3)" "unprognostic (2.08e-1)" "unprognostic (1.88e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.81e-3)" "unprognostic (1.09e-2)" 7.2 5.0 22.8 10.5 91.0 9.3 7.7 6.7 18.4 6.8 10.5 7.8 4.5 7.2 8.0 12.5 7.2 6.9 7.9 12.0 15.0 18.0 11.3 5.0 8.4 16.9 18.5 10.3 7.3 6.7 13.1 8.5 9.3 13.7 8.1 10.9 13.4 6.7 10.1 15.4 7.1 7.6 11.9 9.4 10.2 7.6 5.5 17.2 9.3 7.8 2.7 19.4 8.6 8.1 17.8 17.9 8.1 7.1 26.9 12.1 6.6 15.5 6.8 5.8 12.5 8.5 9.7 8.9 8.0 10.5 19.4 17.5 8.9 7.2 22.0 21.7 11.3 5.4 11.4 8.5 17.6 14.1 15.2 15.4 8.9 13.2 14.9 15.5 13.2 9.2 13.1 9.8 14.6 17.0 14.6 5.5 11.6 18.3 16.2 24.8 4.1 9.8 19.2 11.4 17.2 18.0 16.3 11.9 5.0 6.3 15.1 18.9 10.9 10.0 7.8 10.9 7.2 11.3 14.7 14.9 28.3 15.5 5.1 13.8 20.7 5.9 5.9 8.1 12.1 7.1 8.0 13.7 10.3 10.4 6.4 17.8 9.8 7.9 6.8 26.9 4.9 17.9 6.9 6.6 22.8 91.0 6.7 18.4 15.0 18.0 18.5 10.3 13.7 17.2 DTX4 "KIAA0937, RNF155" ENSG00000110042 "Deltex E3 ubiquitin ligase 4" Q9Y2E6 11 59171430-59208587 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.8" "Cell line enhanced" "Detected in many" "AF22: 13.3;BEWO: 27.0;CACO-2: 14.6;CAPAN-2: 15.5;RT4: 40.5" "Cancer enhanced" "Detected in all" "thyroid cancer: 63.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056760, HPA059294" Approved Approved Vesicles Vesicles "HPA056760: , HPA059294: " "unprognostic (3.23e-2)" "unprognostic (1.57e-1)" "unprognostic (1.10e-2)" "unprognostic (4.98e-2)" "unprognostic (4.97e-2)" "unprognostic (5.03e-1)" "unprognostic (2.92e-1)" "unprognostic (1.06e-1)" "unprognostic (3.75e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (3.04e-1)" "prognostic unfavourable (8.94e-4)" "unprognostic (5.51e-2)" "unprognostic (2.51e-1)" "prognostic favourable (5.81e-4)" "unprognostic (2.57e-3)" 7.0 2.2 8.9 7.6 12.8 8.2 7.9 14.0 16.5 8.9 17.7 29.8 1.4 16.7 4.3 2.3 3.7 6.5 9.5 2.1 10.7 10.9 6.5 23.9 17.7 5.2 15.3 8.8 16.3 5.9 1.7 3.3 15.3 24.8 5.6 18.4 7.7 16.0 3.7 1.5 4.2 14.3 3.6 42.8 5.0 12.2 1.9 9.1 0.8 12.4 2.3 6.7 19.8 14.7 3.3 6.1 3.1 1.0 0.1 0.1 0.2 2.0 2.3 13.3 0.2 3.8 0.2 27.0 0.2 1.1 0.1 0.1 14.6 15.5 4.8 0.9 0.3 6.9 4.1 5.0 0.0 0.3 0.2 0.0 2.6 4.7 1.0 0.4 0.9 0.6 8.4 0.0 0.2 0.0 0.0 0.5 0.6 1.1 0.2 0.0 6.8 0.6 1.6 11.7 0.5 1.1 40.5 0.0 0.0 10.3 2.7 0.3 2.0 0.2 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.5 0.1 1.2 1.0 1.5 1.0 0.7 0.1 1.0 0.0 2.2 0.1 0.0 1.4 3.3 0.0 0.0 3.1 0.1 0.5 6.1 0.0 0.2 8.9 12.8 14.0 16.5 10.7 10.9 15.3 8.8 24.8 9.1 DUSP8 "C11orf81, FLJ42958, HB5, HVH-5" ENSG00000184545 "Dual specificity phosphatase 8" Q13202 11 1554044-1571920 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2" "Cell line enhanced" "Detected in some" "MCF7: 6.1;SH-SY5Y: 5.4;U-251 MG: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020071 Approved Approved Cytosol Cytosol "HPA020071: AB_1847903" "unprognostic (2.29e-1)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (4.00e-2)" "unprognostic (1.35e-1)" "unprognostic (7.58e-3)" "unprognostic (6.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (4.04e-3)" "unprognostic (1.82e-1)" "prognostic favourable (2.75e-6)" "unprognostic (1.51e-1)" "unprognostic (1.57e-1)" "unprognostic (8.65e-2)" "unprognostic (6.30e-2)" 6.3 2.2 18.8 3.2 18.8 7.5 3.5 20.0 30.2 1.9 4.3 4.2 1.4 1.7 5.9 4.8 3.5 4.0 5.4 5.7 16.6 9.3 2.6 3.7 3.6 3.5 5.5 11.2 2.2 12.7 1.7 10.8 2.8 5.1 3.0 4.1 2.7 5.1 2.7 6.1 3.2 6.3 9.3 3.6 6.3 4.3 2.4 5.1 0.0 2.6 2.2 2.3 2.7 1.6 0.1 0.1 0.0 0.0 0.0 0.7 0.0 1.8 0.8 1.0 0.1 0.0 0.1 2.2 0.1 1.1 0.4 1.2 0.0 0.0 0.1 0.0 0.3 1.2 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.2 0.4 0.1 0.0 1.8 0.0 6.1 0.0 0.4 0.0 1.9 0.1 0.1 0.7 0.0 0.2 0.0 5.4 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 1.0 2.3 0.0 0.1 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 18.8 18.8 20.0 30.2 16.6 9.3 5.5 11.2 5.1 5.1 DYDC2 "bA36D19.6, MGC16186" ENSG00000133665 "DPY30 domain containing 2" Q96IM9 10 80344745-80368073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.3;fallopian tube: 56.4" "Cell line enhanced" "Detected in some" "AF22: 4.3;NTERA-2: 6.8;SCLC-21H: 5.9;SH-SY5Y: 4.0;U-2197: 4.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.2" "Group enriched" "Detected in many" 5 "amygdala: 6.3;basal ganglia: 9.1;hippocampal formation: 7.7;hypothalamus: 6.8;pons and medulla: 16.3" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038006, HPA038007" Enhanced "HPA038006: AB_10672734, HPA038007: AB_2675783" "unprognostic (1.60e-3)" "unprognostic (7.35e-2)" "unprognostic (1.89e-2)" "unprognostic (9.26e-3)" "unprognostic (8.85e-2)" "unprognostic (3.26e-1)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.55e-1)" "prognostic favourable (3.54e-4)" "unprognostic (1.87e-2)" "unprognostic (2.43e-1)" "unprognostic (2.34e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-4)" "unprognostic (9.86e-2)" "unprognostic (5.40e-2)" 0.2 0.2 6.3 0.2 9.1 0.6 0.4 0.1 1.7 1.6 0.3 3.0 0.1 0.3 1.3 10.0 0.5 56.4 0.4 0.2 7.7 6.8 0.3 0.3 3.6 0.2 0.2 0.4 4.3 0.6 0.2 0.1 0.4 16.3 0.3 0.2 0.1 0.3 0.3 0.3 0.3 0.2 0.2 0.6 0.2 0.4 5.2 0.7 0.1 0.3 0.1 0.2 0.2 0.1 0.6 0.6 2.4 0.3 1.2 0.4 0.0 0.2 0.1 4.3 0.1 0.5 0.0 0.1 0.0 0.6 0.4 0.1 0.4 0.7 0.1 0.9 0.1 0.2 0.3 0.1 0.1 0.2 0.6 0.3 0.2 1.5 0.0 0.0 0.4 0.2 1.0 0.0 0.1 0.0 0.2 0.3 0.2 0.3 0.7 0.0 6.8 0.0 1.8 0.5 1.5 0.0 0.1 5.9 4.0 0.2 0.0 0.6 0.0 2.7 0.1 0.1 0.3 4.3 0.0 0.1 0.1 0.3 0.3 0.0 0.0 2.4 0.3 0.1 0.3 0.1 0.4 0.3 0.3 0.2 0.0 0.6 0.3 0.4 0.5 1.2 0.2 0.6 0.0 0.0 6.3 9.1 0.1 1.6 7.7 6.8 0.2 0.4 16.3 0.7 DYNC1I1 "DNCI1, DNCIC1" ENSG00000158560 "Dynein cytoplasmic 1 intermediate chain 1" O14576 7 95772506-96110322 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.0" "Cell line enhanced" "Detected in many" "EFO-21: 14.2;SH-SY5Y: 10.5;U-266/84: 8.9;WM-115: 9.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 4.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061689 Enhanced "HPA061689: " "unprognostic (2.61e-1)" "unprognostic (4.58e-2)" "unprognostic (3.83e-2)" "prognostic favourable (3.79e-4)" "unprognostic (6.27e-2)" "unprognostic (2.11e-4)" "unprognostic (1.38e-1)" "unprognostic (1.94e-1)" "unprognostic (2.18e-2)" "unprognostic (1.85e-1)" "unprognostic (1.84e-3)" "unprognostic (5.86e-2)" "unprognostic (2.24e-4)" "unprognostic (2.25e-4)" "unprognostic (1.63e-1)" "unprognostic (7.81e-4)" "unprognostic (1.10e-2)" 3.1 16.5 15.6 2.9 20.3 2.3 3.6 34.3 62.0 3.1 7.9 5.2 1.2 2.8 3.8 7.3 5.3 2.6 3.5 21.6 29.2 23.1 3.6 1.6 2.3 2.1 25.8 26.5 10.7 3.6 2.0 17.2 2.2 27.3 10.3 4.9 9.5 2.7 11.3 4.2 4.0 2.5 17.1 18.8 2.8 3.3 3.9 7.4 0.0 3.6 0.0 1.9 10.5 3.6 0.8 2.7 4.7 1.1 2.1 1.0 0.6 0.4 0.3 0.2 1.3 0.2 0.1 0.5 0.2 0.0 0.7 0.2 1.7 1.1 0.5 14.2 1.9 0.6 4.9 0.3 0.3 0.1 1.1 3.4 0.5 0.0 0.2 0.4 4.6 0.2 0.3 0.3 0.6 0.3 0.6 0.5 2.2 3.1 0.4 0.6 0.9 2.9 0.8 0.4 1.9 1.8 1.6 1.9 10.5 0.1 0.2 2.2 1.0 0.8 0.4 4.1 2.9 2.2 2.2 7.3 8.9 0.4 4.7 0.5 9.1 1.5 1.1 0.6 1.0 0.6 0.5 0.7 0.5 0.4 0.2 0.8 0.7 0.6 4.7 2.1 0.3 2.7 0.6 0.6 15.6 20.3 34.3 30.4 29.2 23.1 25.8 26.5 27.3 7.4 ECE2 "KIAA0604, MGC2408" ENSG00000145194 "Endothelin converting enzyme 2" O60344 3 184276011-184293031 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "adrenal gland: 14.4;brain: 25.1;pancreas: 29.0;pituitary gland: 7.6" "Cell line enriched" "Detected in some" 8 "REH: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA043346 Uncertain "HPA043346: AB_10794181" "unprognostic (2.70e-2)" "unprognostic (1.44e-2)" "unprognostic (1.91e-2)" "prognostic unfavourable (8.41e-5)" "unprognostic (1.37e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (5.80e-4)" "unprognostic (1.47e-2)" "unprognostic (3.69e-1)" "unprognostic (2.65e-3)" "unprognostic (1.70e-2)" "unprognostic (5.95e-2)" "unprognostic (1.63e-9)" "unprognostic (3.66e-2)" "unprognostic (6.16e-2)" "unprognostic (2.19e-1)" "unprognostic (1.25e-2)" 0.7 14.4 9.1 0.9 17.1 0.7 0.7 17.6 10.5 0.7 1.1 2.2 0.0 0.8 0.7 1.6 0.8 0.9 0.7 1.5 4.6 25.1 0.7 0.7 0.7 0.7 10.3 3.0 0.7 29.0 0.7 7.6 0.7 7.5 1.6 0.9 1.4 1.1 1.1 0.7 0.7 0.8 0.9 2.9 0.7 1.0 0.8 3.3 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 17.1 17.6 5.2 4.6 25.1 10.3 3.0 7.5 3.3 ECEL1 "DINE, XCE" ENSG00000171551 "Endothelin converting enzyme like 1" O95672 2 232479827-232487828 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;ovary: 57.1" "Group enriched" "Detected in some" 6 "AN3-CA: 29.4;HeLa: 15.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.9" "Region enriched" "Detected in many" 5 "hypothalamus: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA067560, HPA069756, HPA077424" Approved Supported Approved "Nucleoplasm,Nuclear membrane,Nucleoli" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA067560: , HPA069756: , HPA077424: " "unprognostic (1.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.39e-1)" "unprognostic (4.62e-3)" "unprognostic (2.80e-1)" "unprognostic (9.96e-4)" "unprognostic (7.56e-3)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.49e-2)" "unprognostic (1.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.24e-5)" "unprognostic (3.09e-2)" "unprognostic (3.68e-1)" "unprognostic (7.84e-2)" "unprognostic (5.45e-2)" 0.9 2.6 0.5 0.9 4.0 0.2 0.4 0.7 1.2 0.3 0.4 0.5 0.1 0.3 0.6 4.9 0.3 1.7 1.0 1.1 0.1 28.6 1.0 0.7 0.2 1.2 0.3 0.1 57.1 0.6 0.3 8.9 0.4 5.5 0.3 0.2 11.5 0.3 1.2 1.8 0.3 0.3 1.1 4.5 2.0 0.3 0.8 1.6 0.1 0.5 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.0 0.0 2.6 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.0 0.7 1.2 0.1 28.6 0.3 0.1 5.5 1.6 ECT2L "ARHGEF32, C6orf91, FBXO49, LFDH" ENSG00000203734 "Epithelial cell transforming 2 like" Q008S8 6 138795926-138904070 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 8.1;epididymis: 7.7;fallopian tube: 18.5;lung: 12.2;ovary: 9.4" "Cell line enhanced" "Detected in some" "HEL: 2.7;SCLC-21H: 2.8" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "pons and medulla: 8.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA035488 Uncertain "HPA035488: AB_10672865" "unprognostic (2.88e-2)" "unprognostic (7.88e-2)" "unprognostic (2.52e-2)" "unprognostic (5.53e-3)" "unprognostic (3.48e-2)" "unprognostic (8.45e-3)" "unprognostic (9.42e-2)" "unprognostic (2.44e-2)" "unprognostic (1.18e-1)" "unprognostic (7.03e-2)" "unprognostic (5.90e-4)" "unprognostic (2.32e-1)" "unprognostic (5.21e-2)" "unprognostic (1.38e-2)" "unprognostic (7.27e-2)" "unprognostic (7.07e-3)" "unprognostic (2.65e-3)" 0.5 0.3 0.7 0.2 1.1 0.5 0.4 0.8 0.7 1.1 0.3 4.2 0.0 0.2 0.6 7.7 1.0 18.5 1.7 2.7 1.1 1.1 0.1 0.2 12.2 0.2 0.3 0.0 9.4 0.1 0.3 1.8 0.2 8.1 0.3 0.1 0.8 0.6 0.2 0.5 0.7 0.6 1.6 0.3 0.3 0.3 1.2 0.8 0.0 0.4 0.0 0.1 0.8 0.3 0.6 0.3 1.7 0.6 0.7 0.8 0.0 0.2 0.1 0.2 0.8 0.0 0.4 1.2 0.0 0.0 0.1 0.1 0.8 0.8 0.8 0.3 0.0 0.3 0.0 0.0 0.8 0.2 0.5 2.7 0.2 0.0 0.1 0.9 0.4 1.3 0.9 0.0 0.0 0.0 0.2 0.9 0.0 0.3 0.6 1.0 0.6 0.6 0.5 0.3 0.2 0.0 0.6 2.8 0.6 0.2 0.7 0.4 0.3 1.1 0.0 0.6 0.3 0.8 0.3 0.4 0.2 0.3 0.4 0.7 0.2 1.7 0.3 0.6 0.3 0.3 0.4 0.3 0.2 0.7 0.1 0.6 0.7 0.8 0.6 0.7 0.6 0.3 0.2 0.0 0.7 1.1 0.8 0.7 1.1 1.1 0.3 0.0 8.1 0.8 EDIL3 DEL1 ENSG00000164176 "EGF like repeats and discoidin domains 3" O43854 5 83940554-84384793 "Predicted secreted proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.3" "Cell line enhanced" "Detected in many" "HHSteC: 26.1;LHCN-M2: 42.9;TIME: 50.7;U-2 OS: 43.0;U-87 MG: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020415 Approved "Secreted to blood" "HPA020415: " "unprognostic (9.93e-3)" "unprognostic (2.38e-1)" "unprognostic (2.71e-2)" "unprognostic (8.63e-2)" "unprognostic (2.22e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (9.19e-2)" "unprognostic (6.64e-3)" "unprognostic (2.98e-1)" "unprognostic (1.56e-1)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.52e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (1.28e-3)" 7.9 12.6 29.3 7.2 45.3 0.2 3.6 5.5 46.2 10.9 20.1 77.0 0.3 9.3 15.6 26.2 9.9 4.9 19.2 10.8 42.6 24.7 6.5 1.1 11.7 0.5 67.3 22.5 6.1 2.0 0.9 2.1 2.6 37.1 8.1 21.8 5.0 2.5 13.5 1.2 5.5 14.3 14.4 85.3 1.8 10.6 1.4 61.6 0.0 2.4 0.1 2.1 7.7 5.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.9 0.0 0.0 1.2 0.0 3.2 4.3 0.0 5.3 0.0 0.0 0.0 4.9 0.0 0.2 2.4 0.0 2.3 0.0 15.3 0.0 26.1 0.2 0.0 6.7 0.6 15.6 2.2 5.4 0.0 0.0 42.9 0.0 0.0 0.0 2.2 10.0 0.0 10.5 0.0 7.2 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 50.7 15.7 43.0 0.5 13.9 0.4 0.0 0.0 29.0 0.0 4.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 29.3 45.3 5.5 30.1 42.6 24.7 67.3 22.5 37.1 61.6 EFCAB12 C3orf25 ENSG00000172771 "EF-hand calcium binding domain 12" Q6NXP0 3 129401321-129428651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.4;fallopian tube: 29.9;testis: 24.8" "Cell line enhanced" "Detected in some" "Hep G2: 4.6;RPTEC TERT1: 3.7;SCLC-21H: 2.9" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "basal ganglia: 14.9;pons and medulla: 24.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 14.2" "HPA037694, HPA057532" Uncertain Supported Approved "Nucleoplasm,Nuclear bodies,Midbody ring" Nucleoplasm "Nuclear bodies, Midbody ring" "HPA037694: AB_10672605, HPA057532: " "unprognostic (2.06e-3)" "unprognostic (1.87e-2)" "unprognostic (2.96e-2)" "unprognostic (4.34e-3)" "unprognostic (1.81e-1)" "unprognostic (7.59e-4)" "unprognostic (2.37e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-1)" "unprognostic (1.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.27e-1)" "unprognostic (1.57e-2)" "unprognostic (4.59e-2)" 0.7 0.6 2.2 0.7 14.9 1.5 0.9 1.7 3.0 2.0 0.6 7.8 0.0 0.5 1.8 10.1 0.6 29.9 1.5 0.7 4.2 4.3 1.2 2.1 3.6 0.8 0.5 3.5 6.1 1.0 3.1 15.2 0.7 24.4 4.1 0.6 1.5 0.6 0.9 0.5 0.5 0.5 0.6 1.0 0.7 1.0 24.8 1.6 0.0 2.4 0.0 0.9 0.5 0.1 1.4 0.0 1.3 0.4 0.3 0.6 0.0 0.4 2.2 0.7 2.2 0.4 0.1 0.4 0.0 0.2 0.3 0.1 0.8 1.2 0.4 0.4 0.0 0.3 0.0 0.4 0.3 0.6 0.5 0.5 0.6 4.6 0.3 0.3 0.9 0.5 0.0 0.5 0.0 0.0 1.3 0.9 0.0 0.3 0.1 1.6 0.3 0.1 0.8 0.0 0.5 3.7 0.0 2.9 0.1 0.0 0.0 0.1 0.8 0.3 0.0 0.0 0.5 1.0 0.2 1.4 1.8 2.1 0.5 0.7 0.2 0.0 0.4 0.8 0.1 0.0 0.3 0.3 0.0 0.6 0.0 1.4 0.3 0.2 1.3 0.3 0.0 0.0 0.2 0.0 2.2 14.9 1.7 3.0 4.2 4.3 0.5 3.5 24.4 1.6 EFHC2 "FLJ22843, MRX74" ENSG00000183690 "EF-hand domain containing 2" Q5JST6 X 44147882-44343672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.6;fallopian tube: 20.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.1;HEL: 5.3;HMC-1: 17.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "pons and medulla: 20.6" "Group enriched" "Detected in some" 5 "basophil: 14.1;NK-cell: 6.6" "Group enriched" "Detected in many" 5 "granulocytes: 14.1;NK-cells: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034492, HPA057359" Approved Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" "Nucleoplasm, Nucleoli fibrillar center" "Plasma membrane" "HPA034492: AB_10671227, HPA057359: " "unprognostic (1.93e-1)" "unprognostic (7.80e-3)" "unprognostic (7.35e-2)" "unprognostic (2.75e-1)" "unprognostic (6.83e-3)" "unprognostic (5.07e-2)" "unprognostic (4.29e-2)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "unprognostic (2.90e-2)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (7.89e-2)" "unprognostic (1.06e-1)" "unprognostic (6.13e-4)" "unprognostic (1.64e-3)" "unprognostic (4.97e-2)" 0.7 0.6 4.0 0.8 6.2 1.9 1.2 1.6 3.1 4.6 1.6 6.5 3.7 0.6 5.4 12.6 2.9 20.8 3.0 6.0 4.8 3.9 2.0 0.1 4.5 0.5 1.5 2.0 5.2 0.3 0.9 6.9 1.3 20.6 2.9 0.6 0.6 9.6 5.8 0.1 4.7 0.8 2.6 1.4 0.6 1.6 10.1 3.1 0.4 3.7 1.4 0.9 1.7 1.4 0.1 0.4 14.1 0.0 6.6 2.1 1.4 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 5.1 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.1 5.3 0.0 0.0 0.0 0.0 17.6 0.3 0.3 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 0.6 0.1 0.3 0.0 0.0 1.4 0.0 0.3 0.5 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 14.1 0.0 0.0 2.1 0.0 0.8 0.1 0.8 0.1 0.4 0.1 0.7 1.0 1.9 6.6 0.0 0.0 0.0 1.4 4.0 6.2 1.6 3.1 4.8 3.9 1.5 2.0 20.6 3.1 EFHD1 FLJ13612 ENSG00000115468 "EF-hand domain family member D1" Q9BUP0 2 232606057-232682781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.0;breast: 83.4;kidney: 75.9" "Cell line enhanced" "Detected in some" "BEWO: 29.7;RPTEC TERT1: 16.0;SK-BR-3: 70.9;T-47d: 55.5" "Cancer enhanced" "Detected in all" "breast cancer: 100.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.1" "Group enriched" "Detected in many" 5 "granulocytes: 6.1;T-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049331, HPA056959" Enhanced Supported "Nucleoli fibrillar center,Golgi apparatus" "Golgi apparatus" "Nucleoli fibrillar center" "HPA049331: , HPA056959: " "unprognostic (9.51e-3)" "unprognostic (2.21e-2)" "unprognostic (4.78e-3)" "unprognostic (3.25e-1)" "unprognostic (3.40e-1)" "unprognostic (9.70e-2)" "unprognostic (9.02e-2)" "unprognostic (1.13e-1)" "unprognostic (3.29e-3)" "unprognostic (1.21e-1)" "unprognostic (5.57e-2)" "unprognostic (9.99e-2)" "prognostic favourable (2.93e-7)" "unprognostic (2.00e-2)" "unprognostic (1.84e-1)" "unprognostic (2.51e-2)" "unprognostic (2.29e-3)" 16.1 4.0 32.0 2.3 71.3 1.1 83.4 4.1 39.1 37.2 3.9 85.0 0.8 2.7 22.2 16.5 5.1 16.7 6.0 13.5 42.0 24.5 75.9 24.2 4.0 2.3 85.0 25.2 32.1 39.3 4.8 3.5 55.2 43.2 8.0 3.4 12.9 10.1 13.8 13.5 5.9 3.8 10.3 66.0 20.7 3.7 7.3 80.1 0.0 6.8 3.6 1.8 5.0 9.3 0.8 0.7 6.1 0.7 0.3 1.6 0.3 0.0 0.8 1.3 0.3 0.5 0.0 29.7 6.2 0.4 0.5 0.4 0.2 0.1 0.0 0.4 2.6 0.0 4.4 0.0 0.0 0.1 2.1 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.1 0.1 0.5 0.1 0.0 1.9 0.0 0.1 1.7 0.1 16.0 0.1 0.0 0.7 2.1 70.9 4.2 55.5 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.1 1.9 0.7 0.4 0.7 0.3 1.2 0.8 1.0 1.0 0.3 0.3 1.6 1.6 6.1 0.3 0.2 0.7 0.3 0.3 32.0 71.3 4.1 35.5 42.0 24.5 85.0 25.2 43.2 80.1 EFNA3 "Ehk1-L, EPLG3, LERK3" ENSG00000143590 "Ephrin A3" P52797 1 155078872-155087538 "Predicted membrane proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.3;skin 1: 41.3" "Cell line enhanced" "Detected in many" "AN3-CA: 11.7;HAP1: 12.8;SCLC-21H: 19.0;SK-BR-3: 12.4;T-47d: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010494 Uncertain "CAB010494: AB_2097783" "unprognostic (3.75e-2)" "unprognostic (1.53e-2)" "unprognostic (1.56e-2)" "unprognostic (1.51e-2)" "unprognostic (3.88e-2)" "unprognostic (9.92e-2)" "prognostic unfavourable (2.46e-4)" "unprognostic (2.86e-2)" "unprognostic (3.56e-1)" "unprognostic (1.57e-1)" "unprognostic (5.14e-2)" "unprognostic (1.71e-1)" "prognostic unfavourable (9.66e-10)" "unprognostic (2.83e-3)" "unprognostic (6.38e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-3)" 1.0 1.3 5.9 1.1 15.5 0.7 5.8 1.7 17.3 4.7 3.9 0.8 0.0 1.5 1.3 4.4 13.3 1.3 1.1 0.8 6.4 5.6 0.7 1.1 1.0 1.0 2.2 8.6 1.5 1.3 1.6 5.6 1.2 12.2 1.8 4.1 0.4 4.0 1.0 1.1 41.3 1.5 1.2 1.3 1.1 1.3 2.2 1.7 0.0 0.9 8.9 3.8 1.1 9.0 3.1 3.4 2.0 1.8 6.5 3.5 1.1 4.1 1.0 1.8 11.7 2.0 1.0 1.4 0.2 0.3 0.5 0.7 0.7 1.8 3.2 1.9 0.4 7.0 12.8 2.6 0.4 1.9 2.8 0.4 0.4 0.9 0.2 0.5 2.4 0.6 3.1 0.2 0.7 1.0 2.0 2.0 0.4 5.4 0.6 1.7 1.2 3.3 4.1 1.0 10.5 1.4 0.1 19.0 5.8 0.7 12.4 0.3 17.7 0.6 0.3 1.3 3.7 0.5 0.3 4.0 1.7 0.8 2.2 1.6 0.1 0.0 1.4 2.0 2.1 1.8 2.1 2.6 1.7 1.1 3.4 3.1 2.5 1.2 0.1 6.5 0.8 2.6 3.5 1.1 5.9 15.5 1.7 17.3 6.4 5.6 2.2 8.6 12.2 1.7 EFNB3 "EPLG8, LERK-8" ENSG00000108947 "Ephrin B3" Q15768 17 7705202-7711378 "Cancer-related genes, Predicted membrane proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.6" "Cell line enhanced" "Detected in many" "AF22: 30.7;AN3-CA: 18.2;SH-SY5Y: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001623 Approved "HPA001623: AB_1848026" "unprognostic (5.17e-2)" "unprognostic (7.15e-2)" "unprognostic (6.08e-2)" "prognostic unfavourable (5.52e-4)" "unprognostic (3.27e-1)" "unprognostic (1.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.61e-1)" "unprognostic (2.64e-2)" "unprognostic (1.14e-1)" "prognostic favourable (8.21e-4)" "unprognostic (3.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.56e-2)" "unprognostic (3.00e-1)" "unprognostic (8.56e-2)" "unprognostic (2.20e-2)" 1.7 2.8 10.6 1.1 26.5 0.4 4.3 1.1 34.6 4.8 1.0 4.0 0.0 0.8 12.3 1.0 2.2 6.7 1.8 1.1 10.9 19.0 1.4 2.3 1.5 0.7 3.0 11.8 3.2 1.8 1.1 3.0 1.8 4.3 2.7 1.1 1.4 1.7 1.0 0.8 6.9 1.0 4.7 1.3 0.5 1.3 2.1 2.1 0.0 1.2 0.1 1.4 2.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 30.7 18.2 0.6 0.4 0.2 0.3 4.0 2.7 1.8 1.1 1.9 0.0 0.6 1.1 0.2 7.8 3.8 1.6 0.0 3.8 0.1 0.0 0.0 0.9 0.0 0.0 1.8 0.8 0.8 0.6 0.2 0.0 0.0 0.5 2.9 0.0 0.0 2.7 0.6 0.1 0.1 0.0 4.2 0.4 1.9 16.1 0.0 0.0 0.6 1.6 0.0 0.0 1.8 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.6 26.5 1.1 26.3 10.9 19.0 3.0 11.8 4.3 2.1 EFR3B "FLJ37871, KIAA0953" ENSG00000084710 "EFR3 homolog B" Q9Y2G0 2 25042130-25159137 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;retina: 21.1;skeletal muscle: 25.1" "Cell line enhanced" "Detected in many" "AN3-CA: 8.9;BEWO: 10.4;SH-SY5Y: 9.3;SK-BR-3: 15.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038089, HPA071831" Uncertain Supported "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane" "Actin filaments, Cytosol" "HPA038089: AB_10672618, HPA071831: " "unprognostic (9.31e-2)" "unprognostic (3.92e-1)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.24e-3)" "unprognostic (3.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.32e-2)" "unprognostic (4.49e-6)" "unprognostic (4.83e-2)" "unprognostic (4.43e-2)" "unprognostic (1.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" 1.9 3.2 13.1 1.7 22.9 1.3 1.3 15.5 30.5 1.4 1.7 9.4 0.0 1.4 1.8 8.4 1.3 1.8 1.5 6.9 11.4 8.7 1.4 1.1 4.4 1.3 8.7 13.5 1.4 1.3 2.4 4.1 3.2 29.9 1.5 1.8 21.1 1.1 2.0 25.1 1.7 1.3 2.6 7.8 4.3 2.2 3.5 9.0 0.0 4.5 0.2 1.1 1.4 0.7 1.0 0.6 4.4 0.5 1.0 0.7 0.1 0.1 7.0 8.2 8.9 0.5 0.1 10.4 0.8 0.2 0.4 0.1 5.6 0.3 0.1 0.5 1.2 0.5 6.5 0.0 0.1 1.3 1.6 1.3 0.3 0.5 0.0 0.1 0.7 0.1 0.0 2.0 0.1 0.2 0.1 0.4 0.2 0.8 0.2 0.4 1.6 5.6 0.6 7.9 0.2 0.1 0.2 3.5 9.3 1.0 15.6 5.0 0.8 0.1 0.5 0.5 2.4 3.6 1.7 0.6 0.7 0.1 6.4 0.1 1.7 4.4 0.4 1.1 0.7 0.3 0.5 0.6 0.4 0.6 0.3 1.0 0.4 0.7 1.7 1.0 0.5 0.6 0.2 0.1 13.1 22.9 15.5 22.7 11.4 8.7 8.7 13.5 29.9 9.0 EGFL8 "C6orf8, NG3" ENSG00000241404 "EGF like domain multiple 8" Q99944 6 32164583-32168281 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;Hep G2: 3.6;NB-4: 3.0;SK-MEL-30: 3.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061173 Uncertain Approved "Nuclear speckles,Vesicles" "Secreted - unknown location" Vesicles "Nuclear speckles" "HPA061173: " "unprognostic (7.13e-2)" "unprognostic (1.86e-1)" "unprognostic (6.79e-3)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (7.60e-4)" "unprognostic (3.42e-2)" "unprognostic (2.49e-1)" "unprognostic (6.42e-3)" "unprognostic (1.97e-1)" "unprognostic (7.60e-3)" "unprognostic (8.11e-3)" "unprognostic (1.07e-4)" "unprognostic (1.11e-1)" "unprognostic (6.79e-2)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" 4.5 6.3 7.3 2.6 7.6 4.5 5.0 6.3 9.4 7.1 6.7 8.4 8.7 4.7 6.4 5.5 4.3 4.8 8.4 4.8 8.2 4.4 4.3 1.8 4.3 2.0 25.7 3.9 14.4 2.9 1.3 2.9 9.2 14.1 6.0 2.7 14.7 3.9 5.3 3.8 12.9 5.8 3.0 11.9 3.5 3.9 2.3 7.0 0.2 3.1 8.3 2.0 5.2 6.8 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.6 0.3 1.3 3.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.2 0.0 2.0 1.3 0.4 0.0 0.0 1.9 0.0 0.9 3.6 1.1 0.0 0.7 0.0 0.3 0.3 0.0 0.7 0.3 0.0 0.0 1.7 0.9 3.0 0.0 0.0 1.1 0.1 0.0 0.2 0.6 0.5 1.2 0.0 0.1 3.7 1.4 2.2 0.0 0.8 1.7 0.0 0.1 0.0 0.1 0.1 0.1 1.1 1.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.3 7.6 6.3 9.4 8.2 4.4 25.7 3.9 14.1 7.0 EGR3 PILOT ENSG00000179388 "Early growth response 3" Q06889 8 22687659-22693302 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.5;HMC-1: 7.3;MCF7: 23.9;SK-MEL-30: 16.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 11.5;basal ganglia: 33.6;cerebral cortex: 35.0;hippocampal formation: 13.7;olfactory region: 12.8" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 10 "amygdala: 26.1;basal ganglia: 40.1;cerebral cortex: 47.9;hippocampal formation: 32.4;olfactory region: 18.2" "Group enriched" "Detected in many" 9 "amygdala: 29.0;basal ganglia: 68.2;cerebral cortex: 57.2;hippocampal formation: 56.6;olfactory region: 75.0" "HPA006206, CAB009373" Uncertain Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB009373: AB_2097202, HPA006206: AB_10602491" "prognostic favourable (1.83e-4)" "unprognostic (1.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "unprognostic (4.07e-2)" "unprognostic (1.00e-1)" "unprognostic (6.44e-2)" "prognostic favourable (4.78e-4)" "unprognostic (3.48e-2)" "unprognostic (5.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.11e-2)" "unprognostic (4.72e-2)" "unprognostic (2.35e-2)" "unprognostic (1.07e-2)" 20.7 17.7 11.5 12.3 33.6 5.6 7.1 0.8 35.0 7.4 3.3 11.1 0.2 0.9 3.8 1.0 4.0 14.6 20.6 8.5 13.7 2.0 3.0 2.0 4.1 7.3 1.9 12.8 10.6 2.9 12.8 5.0 1.2 3.6 10.3 2.2 2.6 2.3 4.0 1.6 28.4 3.6 8.3 1.6 2.8 5.3 4.1 2.1 5.5 5.8 1.3 5.8 12.3 2.5 0.8 0.0 2.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 1.4 4.5 0.1 0.4 0.5 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.3 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.3 0.4 0.2 0.2 0.0 0.1 0.2 0.1 0.0 23.9 0.0 0.2 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.4 0.0 16.0 1.1 0.0 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.0 0.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 11.5 33.6 0.8 35.0 13.7 2.0 1.9 12.8 3.6 2.1 EGR4 "NGFI-C, PAT133" ENSG00000135625 "Early growth response 4" Q05215 2 73290929-73293705 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 20.0" "Cell line enriched" "Detected in some" 6 "HMC-1: 5.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA028983 Enhanced "HPA028983: AB_10603665" "unprognostic (7.75e-2)" "unprognostic (1.17e-1)" "unprognostic (1.39e-4)" "unprognostic (2.43e-3)" "unprognostic (2.68e-2)" "unprognostic (8.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.03e-2)" "unprognostic (5.20e-2)" "unprognostic (4.00e-1)" "unprognostic (2.29e-4)" "unprognostic (2.41e-1)" "unprognostic (1.75e-2)" "unprognostic (3.20e-2)" "unprognostic (1.77e-1)" "unprognostic (1.21e-2)" "unprognostic (4.07e-3)" 1.1 0.8 4.9 1.0 15.9 0.9 0.6 17.2 20.0 0.6 0.6 1.2 0.0 0.5 0.6 0.5 0.6 0.6 0.6 0.6 8.8 1.9 0.6 0.6 0.6 0.6 0.3 4.4 0.6 0.5 0.6 2.3 0.6 0.0 0.7 0.6 0.0 0.5 0.5 0.6 0.6 0.6 0.6 0.3 0.6 0.7 4.9 2.6 0.0 0.5 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 15.9 17.2 20.0 8.8 1.9 0.3 4.4 0.0 2.6 EHD3 PAST3 ENSG00000013016 "EH domain containing 3" Q9NZN3 2 31234337-31269447 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.4;esophagus: 29.1" "Cell line enhanced" "Detected in many" "BJ: 25.1;BJ hTERT+: 62.1;HEL: 24.1;U-266/70: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 17.8;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 9 "B-cells: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA066751" Approved Approved "Plasma membrane" 41000000 "Plasma membrane" "HPA049890: , HPA049986: , HPA066751: " "unprognostic (3.44e-1)" "unprognostic (8.88e-2)" "unprognostic (2.21e-1)" "unprognostic (3.79e-2)" "unprognostic (3.70e-2)" "unprognostic (1.89e-1)" "unprognostic (5.49e-2)" "unprognostic (1.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.72e-2)" "unprognostic (9.92e-3)" "unprognostic (1.06e-1)" "prognostic unfavourable (1.02e-4)" "unprognostic (4.88e-3)" "unprognostic (9.41e-2)" "unprognostic (4.79e-3)" "unprognostic (4.92e-3)" 2.7 7.1 15.0 5.6 16.3 2.0 3.3 10.6 37.4 5.6 2.2 7.3 0.0 1.9 3.9 3.4 29.1 4.9 3.6 14.8 16.7 8.9 15.0 10.8 4.8 6.3 9.6 21.6 2.9 1.4 8.7 6.0 11.3 13.3 5.7 2.1 2.8 4.8 4.9 2.3 3.0 2.9 4.8 9.4 5.8 1.9 1.6 6.6 1.2 2.5 1.5 10.4 7.8 4.2 17.8 0.4 1.0 1.9 0.6 1.7 7.8 0.5 2.6 1.4 1.2 2.5 3.8 0.2 25.1 62.1 2.4 2.2 0.0 0.3 0.1 0.9 8.2 0.2 0.0 1.6 1.7 1.0 2.2 24.1 0.1 0.0 8.6 0.0 0.0 6.0 0.7 2.4 1.0 0.0 0.0 0.1 1.8 3.9 0.3 0.0 5.6 1.3 0.8 0.1 0.5 1.9 2.8 0.7 3.9 0.2 0.4 0.0 0.3 0.0 0.0 1.8 1.7 0.1 2.0 15.6 1.9 0.0 4.8 0.0 3.9 0.4 0.4 0.3 1.7 0.8 0.9 17.8 0.9 1.1 0.4 4.4 0.8 0.4 1.0 0.6 1.9 0.0 0.4 7.8 15.0 16.3 10.6 32.7 16.7 8.9 9.6 21.6 13.3 6.6 EID2B "EID-3, FLJ38944" ENSG00000176401 "EP300 interacting inhibitor of differentiation 2B" Q96D98 19 39530990-39532854 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 20.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064185 Approved "HPA064185: " "unprognostic (1.15e-1)" "unprognostic (8.53e-3)" "unprognostic (6.41e-3)" "unprognostic (1.08e-3)" "unprognostic (4.00e-1)" "unprognostic (7.08e-2)" "unprognostic (9.92e-4)" "unprognostic (2.45e-2)" "unprognostic (2.07e-1)" "unprognostic (3.29e-1)" "prognostic favourable (2.57e-4)" "unprognostic (6.80e-2)" "unprognostic (1.77e-1)" "unprognostic (1.02e-2)" "unprognostic (1.78e-1)" "unprognostic (2.77e-1)" "unprognostic (4.20e-2)" 3.7 7.9 9.6 4.1 20.7 2.5 3.4 17.3 16.3 3.7 3.4 4.5 2.1 2.9 7.1 6.2 2.8 6.3 2.9 6.2 8.6 14.6 3.7 1.3 3.7 6.1 6.6 12.6 11.4 3.2 3.4 10.4 2.6 9.1 4.4 2.4 5.6 3.1 4.7 3.9 2.1 2.7 3.6 4.9 5.4 3.1 7.7 5.1 3.6 7.7 1.2 3.3 2.9 2.7 5.2 3.5 5.4 3.0 6.8 10.3 3.1 2.5 5.3 6.0 6.6 3.9 3.7 1.4 3.9 3.1 6.6 6.1 0.8 1.6 5.2 2.3 2.4 0.8 3.0 2.7 4.9 7.9 8.2 2.3 5.9 3.1 3.4 2.2 4.2 3.6 2.0 3.7 1.9 2.9 2.5 7.3 3.2 2.3 4.4 4.0 1.6 2.9 5.8 5.7 2.5 3.2 0.8 8.3 5.2 7.9 0.3 3.1 0.7 1.3 2.0 4.9 8.8 4.7 5.1 5.4 7.5 3.6 2.7 5.4 2.6 0.6 2.7 5.4 4.5 2.8 4.2 5.2 5.3 6.4 3.5 5.2 10.3 6.7 0.9 6.8 3.0 3.4 3.3 3.1 9.6 20.7 17.3 14.3 8.6 14.6 6.6 12.6 9.1 5.1 EIF4E1B FLJ36951 ENSG00000175766 "Eukaryotic translation initiation factor 4E family member 1B" A6NMX2 5 176630682-176646641 "Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 8.9;epididymis: 5.6" "Cell line enriched" "Detected in some" 7 "T-47d: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA045045 Approved "HPA045045: " "unprognostic (6.54e-2)" "unprognostic (1.53e-2)" "unprognostic (7.44e-2)" "unprognostic (5.26e-2)" "unprognostic (1.86e-1)" 0.2 1.0 3.4 0.2 1.4 0.5 0.3 4.0 8.9 0.2 0.2 0.0 0.0 0.2 0.2 5.6 0.2 0.4 0.2 0.3 3.6 2.3 0.3 0.2 0.2 0.2 2.3 2.4 0.2 0.2 0.2 0.8 0.3 0.7 0.2 0.2 1.0 0.2 0.2 0.2 0.2 0.4 0.2 0.5 0.2 0.2 1.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.4 4.0 8.9 3.6 2.3 2.3 2.4 0.7 0.0 ELAVL2 "HEL-N1, HuB" ENSG00000107105 "ELAV like RNA binding protein 2" Q12926 9 23690104-23826337 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 30.7;testis: 45.3" "Cell line enhanced" "Detected in some" "A-431: 9.9;AF22: 15.2;SCLC-21H: 51.0" "Cancer enhanced" "Detected in many" "testis cancer: 7.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022222, HPA063001" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB022222: , HPA063001: " "unprognostic (3.51e-1)" "unprognostic (4.18e-2)" "unprognostic (2.05e-1)" "unprognostic (1.47e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-1)" "unprognostic (4.26e-2)" "unprognostic (8.94e-2)" "unprognostic (3.23e-1)" "unprognostic (1.01e-1)" "unprognostic (9.74e-4)" "unprognostic (3.98e-1)" "unprognostic (9.08e-4)" "unprognostic (8.30e-2)" "unprognostic (1.91e-2)" "unprognostic (2.12e-1)" "unprognostic (2.65e-1)" 1.0 2.4 8.7 1.0 13.4 1.4 1.1 18.3 27.5 1.0 1.3 0.7 0.0 1.0 1.5 1.4 1.1 1.0 1.1 1.0 8.1 19.2 1.4 0.8 1.1 1.0 16.3 18.9 2.1 0.8 1.2 2.5 0.9 30.7 1.2 1.5 0.5 1.0 1.0 1.0 1.5 1.1 1.1 5.0 1.0 1.0 45.3 1.1 0.0 1.2 0.0 1.0 1.6 0.3 1.8 1.1 5.1 0.9 1.4 1.3 0.1 9.9 0.1 15.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 4.1 6.4 0.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.3 0.3 3.9 0.0 4.6 0.1 0.3 0.5 2.1 0.0 0.0 0.0 4.0 4.8 0.0 5.5 0.0 0.0 0.0 51.0 4.8 0.1 0.1 0.1 0.2 0.7 0.0 0.1 3.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.5 2.7 0.9 1.6 0.5 0.6 0.6 1.0 0.5 0.4 0.4 1.8 1.1 1.3 5.1 1.4 0.5 1.1 0.6 0.1 8.7 13.4 18.3 27.5 8.1 19.2 16.3 18.9 30.7 1.1 ELAVL3 "DKFZp547J036, HUC, HUCL, MGC20653, PLE21" ENSG00000196361 "ELAV like RNA binding protein 3" Q14576 19 11451326-11481046 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 53.8" "Group enriched" "Detected in some" 8 "SCLC-21H: 39.6;SH-SY5Y: 22.8" "Cancer enriched" "Detected in some" 10 "glioma: 11.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.9;naive B-cell: 1.9" "Lineage enhanced" "Detected in single" "B-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013066 Enhanced "CAB013066: AB_221448" "unprognostic (1.47e-2)" "unprognostic (2.29e-2)" "unprognostic (1.70e-1)" "unprognostic (7.78e-3)" "unprognostic (8.76e-2)" "unprognostic (2.95e-3)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-2)" "unprognostic (2.44e-1)" "unprognostic (5.93e-3)" "unprognostic (1.86e-2)" "unprognostic (2.15e-3)" "unprognostic (2.26e-2)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (9.60e-3)" 1.0 2.4 14.0 1.5 13.2 1.0 1.0 45.2 53.8 1.0 1.3 12.2 0.0 1.2 1.1 1.6 1.2 1.0 1.0 1.1 17.3 13.0 1.1 1.1 1.1 1.0 14.3 18.3 1.0 1.0 1.0 1.3 1.0 9.5 1.6 1.2 0.1 1.0 1.2 4.0 1.0 1.2 1.2 21.9 1.1 1.2 1.5 5.1 0.0 1.0 0.0 1.0 1.0 0.0 1.9 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 39.6 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 1.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 14.0 13.2 45.2 35.2 17.3 13.0 14.3 18.3 9.5 5.1 ELAVL4 "HUD, PNEM" ENSG00000162374 "ELAV like RNA binding protein 4" P26378 1 50048014-50203786 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.1" "Cell line enriched" "Detected in some" 19 "SH-SY5Y: 52.5" "Group enriched" "Detected in some" 10 "glioma: 2.6;pancreatic cancer: 0.6;testis cancer: 0.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.4;non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 5 "monocytes: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004442, HPA043047" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB004442: AB_627765, HPA043047: " "unprognostic (1.25e-1)" "unprognostic (6.63e-3)" "unprognostic (4.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.28e-2)" "unprognostic (3.83e-4)" "unprognostic (4.52e-2)" "unprognostic (2.63e-1)" "unprognostic (2.75e-1)" "unprognostic (3.75e-3)" "unprognostic (7.91e-2)" "unprognostic (2.39e-3)" "unprognostic (7.83e-2)" "unprognostic (2.81e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-2)" 0.9 11.4 11.5 3.3 12.8 0.8 1.0 11.6 43.1 0.9 3.0 0.9 0.0 2.3 0.9 0.8 1.1 0.9 1.0 1.0 12.3 16.5 0.9 1.0 1.0 0.9 10.6 30.7 0.8 2.8 0.8 7.1 0.9 37.0 1.0 3.8 0.0 0.9 0.9 0.8 1.2 3.1 2.0 8.5 1.0 1.9 7.8 1.4 0.1 0.8 0.0 1.0 0.9 0.5 0.0 0.6 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.6 0.0 0.0 11.5 12.8 11.6 40.4 12.3 16.5 10.6 30.7 37.0 1.4 ELFN2 "dJ63G5.3, KIAA1904, LRRC62, PPP1R29" ENSG00000166897 "Extracellular leucine rich repeat and fibronectin type III domain containing 2" Q5R3F8 22 37367960-37427470 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 30.0" "Cell line enhanced" "Detected in some" "A-431: 8.7;CAPAN-2: 8.4;PC-3: 7.9;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000781 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000781: AB_1079280" "unprognostic (2.74e-1)" "unprognostic (6.81e-2)" "unprognostic (2.80e-2)" "unprognostic (1.31e-5)" "unprognostic (3.28e-1)" "unprognostic (2.51e-2)" "unprognostic (7.76e-2)" "unprognostic (4.25e-2)" "unprognostic (6.05e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (4.51e-1)" "prognostic unfavourable (7.21e-4)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" 1.0 2.1 26.8 0.9 10.9 0.9 0.9 0.7 30.0 0.9 0.9 1.9 0.0 0.9 0.9 0.9 0.9 1.0 1.9 0.8 16.2 8.7 1.2 0.8 2.0 1.0 6.7 15.0 0.8 1.1 0.8 0.1 0.8 5.8 2.2 0.9 0.9 0.9 0.9 0.9 1.5 0.9 0.8 3.8 0.9 1.1 4.2 3.9 0.1 0.8 0.0 0.9 0.9 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.7 3.7 0.0 0.0 0.0 0.7 0.0 3.9 2.1 0.9 0.0 1.4 8.4 0.2 5.2 2.8 6.1 0.4 0.8 0.1 0.2 0.0 0.0 3.9 0.0 0.2 0.0 0.1 0.7 0.1 0.3 1.2 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.2 7.9 0.1 0.0 8.4 16.4 0.0 0.7 0.0 3.6 4.6 0.0 0.0 0.1 0.4 0.0 18.6 0.1 2.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 10.9 0.7 16.8 16.2 8.7 6.7 15.0 5.8 3.9 ELMO1 "CED-12, CED12, ELMO-1, KIAA0281" ENSG00000155849 "Engulfment and cell motility 1" Q92556 7 36854361-37449249 "Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.3" "Cell line enhanced" "Detected in many" "Daudi: 29.1;Karpas-707: 28.2;U-266/70: 24.2;U-698: 34.8;U-937: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.77e-2)" "unprognostic (8.29e-3)" "unprognostic (1.55e-1)" "unprognostic (1.19e-2)" "unprognostic (3.69e-1)" "unprognostic (4.09e-2)" "unprognostic (3.01e-2)" "unprognostic (3.53e-3)" "unprognostic (1.34e-1)" "unprognostic (1.71e-1)" "prognostic favourable (4.62e-4)" "unprognostic (3.59e-1)" "prognostic unfavourable (3.27e-5)" "unprognostic (1.65e-2)" "unprognostic (3.42e-1)" "unprognostic (1.07e-2)" "unprognostic (3.16e-3)" 13.5 9.5 33.7 16.8 39.9 28.5 7.7 39.7 58.3 7.7 7.0 34.9 1.4 4.3 5.0 3.6 6.8 5.4 11.7 7.5 33.6 21.1 3.4 15.8 14.6 24.0 30.5 17.2 8.5 8.4 2.9 5.6 21.8 37.0 4.5 7.9 4.0 4.3 6.7 3.1 4.5 6.6 8.9 36.4 28.4 5.3 4.5 29.7 9.3 47.4 2.1 26.0 11.3 6.5 14.3 20.4 41.4 13.7 10.8 15.3 13.4 0.0 1.1 1.9 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 29.1 0.5 0.0 0.1 0.0 0.0 0.0 16.1 1.1 20.6 0.1 0.0 0.0 13.4 8.9 0.4 0.0 0.0 0.0 11.0 0.3 28.2 0.0 0.2 16.7 20.3 4.6 0.0 17.9 2.1 16.3 0.0 0.0 2.5 10.2 0.0 5.8 0.1 0.0 9.6 2.9 0.0 0.3 0.0 0.1 24.2 22.7 34.8 5.7 28.0 1.2 10.9 13.7 41.4 9.0 11.7 9.8 14.3 15.3 10.5 20.4 12.8 14.4 10.6 32.4 10.8 9.9 11.6 14.7 13.4 33.7 39.9 39.7 52.8 33.6 21.1 30.5 17.2 37.0 29.7 ELMOD1 DKFZp547C176 ENSG00000110675 "ELMO domain containing 1" Q8N336 11 107591091-107666779 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 51.1;pituitary gland: 20.8;skin 1: 34.7" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 11.6;RH-30: 26.5" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038435, HPA066479" Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038435: AB_10795575, HPA066479: " "unprognostic (2.74e-1)" "unprognostic (1.72e-4)" "unprognostic (2.58e-2)" "unprognostic (9.13e-2)" "unprognostic (3.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-1)" "unprognostic (6.59e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (6.29e-2)" "unprognostic (9.44e-2)" "unprognostic (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (3.15e-1)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" 1.5 4.2 10.7 1.5 41.1 1.3 4.1 12.8 51.1 1.5 1.4 1.7 0.0 1.4 1.6 1.3 1.2 3.6 1.2 4.8 13.8 14.3 4.7 1.3 1.6 1.3 8.7 15.2 1.2 1.2 1.2 20.8 1.2 14.8 2.1 1.3 1.4 1.3 1.2 2.8 34.7 1.3 1.4 6.6 1.2 1.2 2.9 3.9 0.0 1.3 0.0 1.2 1.1 0.1 0.9 0.7 2.4 0.9 1.8 0.5 0.2 0.0 0.0 4.4 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.2 0.4 2.1 0.3 0.4 0.0 1.8 0.1 0.0 0.0 1.2 0.1 0.0 0.4 0.1 0.0 0.0 11.6 0.0 0.1 0.8 0.0 0.0 0.1 0.5 1.7 0.0 26.5 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.6 0.1 0.0 0.0 3.5 0.0 2.0 1.6 0.9 0.6 0.4 0.6 0.4 0.5 0.5 0.2 0.2 0.9 0.4 0.5 2.4 1.8 0.6 0.7 0.4 0.2 10.7 41.1 12.8 26.9 13.8 14.3 8.7 15.2 14.8 3.9 ELOVL1 Ssc1 ENSG00000066322 "ELOVL fatty acid elongase 1" Q9BW60 1 43363397-43368074 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 101.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033426, HPA056557" Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB033426: AB_2099896, HPA056557: " "unprognostic (5.23e-2)" "prognostic unfavourable (3.63e-5)" "unprognostic (8.00e-2)" "unprognostic (8.45e-2)" "unprognostic (7.60e-2)" "unprognostic (7.40e-2)" "prognostic unfavourable (2.79e-7)" "unprognostic (4.74e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-1)" "prognostic unfavourable (8.51e-4)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" "unprognostic (1.73e-1)" "unprognostic (9.00e-2)" 21.2 15.6 16.2 15.3 25.3 18.3 24.1 6.8 32.5 16.1 23.6 101.5 11.7 20.7 14.1 13.0 46.6 15.1 17.3 11.5 30.3 18.3 26.6 23.8 22.9 22.7 51.4 14.1 9.3 18.3 16.7 8.4 20.9 45.6 21.6 20.1 8.6 20.6 21.6 6.8 54.0 21.7 20.7 99.5 17.2 22.8 8.4 37.2 7.2 23.9 15.6 21.7 20.4 22.6 30.9 61.1 46.9 54.8 30.5 32.3 48.8 23.5 26.6 5.2 10.2 35.2 33.1 16.1 27.9 35.3 35.7 28.8 23.6 41.5 16.3 21.8 43.8 27.2 18.2 34.4 21.9 20.9 12.3 21.2 18.4 17.0 30.6 18.2 22.6 25.3 39.2 42.2 46.6 35.6 14.6 12.4 40.8 17.4 4.2 15.3 7.6 27.5 9.6 13.7 19.9 45.0 28.8 6.3 6.6 16.5 59.1 23.6 27.7 18.2 29.5 30.3 19.1 36.6 35.4 6.2 6.7 7.8 29.4 18.7 27.2 29.0 54.8 46.9 32.3 50.6 28.6 30.9 30.7 31.4 61.1 25.5 20.1 28.1 38.2 30.5 48.1 42.9 31.4 48.8 16.2 25.3 6.8 32.5 30.3 18.3 51.4 14.1 45.6 37.2 ELOVL2 Ssc2 ENSG00000197977 "ELOVL fatty acid elongase 2" Q9NXB9 6 10980759-11044314 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.6;liver: 43.1;parathyroid gland: 19.9;placenta: 28.4" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 17.3;HAP1: 12.0;HBF TERT88: 16.8;Hep G2: 12.8;RH-30: 18.2" "Group enriched" "Detected in many" 8 "breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "prognostic favourable (6.73e-5)" "unprognostic (4.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.28e-5)" "unprognostic (4.06e-2)" "unprognostic (4.09e-3)" "unprognostic (1.89e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-1)" "unprognostic (2.56e-1)" "unprognostic (6.92e-3)" "unprognostic (1.78e-2)" "unprognostic (1.04e-12)" "unprognostic (9.98e-4)" "unprognostic (8.86e-2)" "unprognostic (3.41e-1)" "unprognostic (9.47e-2)" 1.4 1.3 10.7 1.7 11.5 0.6 4.7 5.8 12.2 0.6 0.6 8.8 0.0 0.7 0.9 2.5 0.8 0.6 1.1 3.1 6.4 4.8 0.7 43.1 0.7 0.9 7.1 7.1 0.7 2.6 19.9 2.8 28.4 8.0 5.0 0.6 5.9 1.1 0.9 1.3 0.7 0.8 1.1 18.6 0.5 0.6 9.3 4.0 0.0 2.0 0.0 1.3 1.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 11.5 0.0 0.0 0.0 6.5 0.2 0.6 10.1 17.3 0.0 0.0 0.0 0.0 0.6 0.0 12.0 0.0 16.8 0.0 10.3 0.1 0.2 12.8 0.5 0.2 2.7 0.1 0.0 7.8 0.0 0.0 0.6 0.0 0.2 0.0 6.5 0.1 2.1 9.8 9.1 18.2 0.0 0.0 0.1 4.5 5.2 0.0 0.0 4.1 2.1 5.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.7 11.5 5.8 10.9 6.4 4.8 7.1 7.1 8.0 4.0 EME2 "FLJ00151, SLX2B" ENSG00000197774 "Essential meiotic structure-specific endonuclease subunit 2" A4GXA9 16 1773207-1781708 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.9" "Cell line enhanced" "Detected in many" "HEK 293: 12.5;REH: 5.2;SCLC-21H: 5.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045770 Uncertain "HPA045770: " "unprognostic (2.67e-2)" "unprognostic (1.77e-1)" "unprognostic (2.07e-1)" "unprognostic (2.94e-1)" "unprognostic (5.83e-2)" "prognostic favourable (2.86e-4)" "unprognostic (4.83e-2)" "unprognostic (4.46e-2)" "unprognostic (9.67e-3)" "unprognostic (1.92e-1)" "unprognostic (2.42e-2)" "unprognostic (2.51e-2)" "prognostic unfavourable (6.76e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "prognostic favourable (6.32e-5)" 2.7 1.8 1.4 2.0 9.9 1.1 1.1 3.4 2.5 1.9 1.9 0.6 0.3 3.0 1.6 2.5 6.4 1.5 0.4 1.2 2.7 0.8 1.3 0.5 1.8 1.0 0.4 1.7 0.7 1.6 0.4 6.3 0.8 2.9 3.7 0.2 0.3 2.1 4.0 1.1 1.0 1.5 0.4 0.3 1.9 5.1 1.1 0.3 2.0 2.6 2.3 2.7 2.3 0.9 0.5 0.8 0.4 0.3 0.0 0.5 0.1 0.5 0.1 0.0 0.5 0.1 0.0 1.2 2.2 0.0 0.2 0.0 0.1 0.9 3.7 1.7 0.1 3.4 0.0 0.1 0.0 4.6 12.5 1.1 0.5 0.2 0.0 1.3 3.0 0.1 0.1 0.0 0.0 0.2 3.4 0.1 0.1 0.4 0.8 0.5 1.6 1.6 5.2 0.5 2.3 0.1 0.1 5.2 1.4 2.2 0.9 0.1 1.5 0.5 1.8 0.3 1.1 0.4 0.9 3.3 1.3 3.0 0.0 0.4 0.7 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.5 0.5 0.5 0.4 0.1 0.4 0.0 0.2 0.8 0.0 0.1 1.4 9.9 3.4 2.5 2.7 0.8 0.4 1.7 2.9 0.3 EML5 "EMAP-2, HuEMAP-2" ENSG00000165521 "Echinoderm microtubule associated protein like 5" Q05BV3 14 88612431-88792752 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0;ovary: 26.8" "Cell line enhanced" "Detected in many" "Karpas-707: 10.4;SH-SY5Y: 22.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054019, HPA055379" Uncertain "HPA054019: , HPA055379: " "unprognostic (2.28e-1)" "unprognostic (1.80e-1)" "unprognostic (2.49e-1)" "unprognostic (8.68e-2)" "unprognostic (1.15e-1)" "unprognostic (4.67e-4)" "unprognostic (3.42e-2)" "unprognostic (4.50e-2)" "unprognostic (1.63e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-3)" "unprognostic (1.36e-1)" "unprognostic (1.11e-4)" "unprognostic (1.21e-2)" "unprognostic (1.05e-1)" "unprognostic (3.82e-1)" "unprognostic (1.53e-3)" 0.8 9.1 5.1 1.5 9.0 0.8 1.4 23.0 5.0 0.8 1.6 1.9 0.1 1.2 1.7 0.7 1.6 1.7 1.1 0.9 5.8 2.6 1.9 1.1 1.2 1.5 1.6 4.7 26.8 2.2 6.0 13.7 0.7 3.8 7.6 0.7 4.5 1.6 0.7 0.6 1.3 1.4 1.8 1.6 1.5 1.6 4.9 2.1 0.9 3.9 0.8 1.1 1.2 0.9 0.9 0.3 0.0 0.2 0.0 2.4 0.4 2.0 1.3 1.9 1.8 0.0 0.0 3.9 1.9 0.3 0.2 0.1 0.6 1.7 1.0 0.8 0.0 4.6 3.6 0.1 0.1 3.1 2.8 1.4 1.3 1.1 0.0 2.8 0.4 0.0 0.1 0.0 0.0 0.0 1.4 10.4 0.0 2.5 3.5 1.1 1.6 2.1 2.3 2.0 1.0 0.1 4.0 5.3 22.3 2.5 4.5 1.5 2.0 1.4 0.8 2.1 0.4 0.3 2.7 4.8 1.3 4.3 0.9 1.2 0.8 0.0 0.0 0.0 0.2 0.2 2.4 0.9 0.5 0.2 0.3 0.5 0.6 0.4 0.0 0.0 0.2 0.0 0.0 0.4 5.1 9.0 23.0 5.0 5.8 2.6 1.6 4.7 3.8 2.1 EML6 FLJ42562 ENSG00000214595 "Echinoderm microtubule associated protein like 6" Q6ZMW3 2 54723499-54972025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.2;lymphoid tissue: 11.9" "Cell line enhanced" "Detected in some" "Daudi: 7.2;SCLC-21H: 20.1;U-698: 22.8" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "memory B-cell: 2.5" "Lineage enriched" "Detected in single" 26 "B-cells: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062808, HPA068759" Uncertain Approved Vesicles,Mitochondria Mitochondria Vesicles "HPA062808: , HPA068759: " "unprognostic (1.06e-1)" "unprognostic (6.89e-4)" "unprognostic (7.83e-2)" "unprognostic (9.96e-2)" "unprognostic (6.24e-2)" "unprognostic (3.26e-4)" "unprognostic (5.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-1)" "unprognostic (6.27e-2)" "unprognostic (6.85e-6)" "unprognostic (5.00e-1)" "unprognostic (5.81e-2)" "unprognostic (6.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (5.13e-3)" 0.1 3.3 1.8 4.0 2.8 0.0 0.2 7.2 4.2 0.0 0.6 0.6 0.0 1.3 0.3 0.4 0.1 0.0 1.9 2.1 1.3 0.2 0.1 7.9 1.5 0.0 0.5 3.0 3.4 1.4 0.4 0.8 0.1 0.4 0.6 0.8 1.8 0.3 0.5 2.7 0.4 1.5 3.1 11.9 0.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 1.1 0.7 0.2 1.5 0.1 0.2 0.2 0.2 0.6 0.2 7.2 0.1 0.4 0.2 1.0 0.3 0.3 0.7 0.3 0.4 0.5 2.7 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.0 1.1 0.0 0.7 1.4 0.2 0.3 1.1 0.6 0.5 0.6 0.0 0.7 20.1 2.7 0.3 0.0 0.0 0.0 0.0 0.2 0.3 1.6 0.4 0.4 4.9 1.2 22.8 1.2 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EMX1 ENSG00000135638 "Empty spiracles homeobox 1" Q04741 2 72916260-72936071 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.8;kidney: 27.4" "Cell line enhanced" "Detected in some" "BEWO: 3.6;CACO-2: 5.6;HEK 293: 12.5;HMC-1: 2.5;RPTEC TERT1: 2.2" "Cancer enhanced" "Detected in some" "renal cancer: 3.7" "Region enhanced" "Detected in many" "cerebral cortex: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 13 "amygdala: 3.8;cerebral cortex: 11.1;hippocampal formation: 8.6" "HPA006230, HPA006421" Approved Supported Nucleoli Nucleoli "HPA006230: , HPA006421: AB_1078739" "unprognostic (4.54e-2)" "unprognostic (5.59e-2)" "unprognostic (8.71e-2)" "unprognostic (2.22e-6)" "unprognostic (4.82e-2)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "unprognostic (2.99e-1)" "unprognostic (3.07e-1)" "prognostic favourable (1.54e-6)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.08e-3)" "unprognostic (5.02e-2)" 0.2 0.3 5.2 0.2 3.1 0.1 0.1 0.1 14.8 0.1 0.5 0.0 0.8 1.4 0.1 6.0 0.2 0.1 0.1 0.2 5.0 0.4 27.4 0.2 0.1 0.2 0.4 1.5 0.2 0.4 4.8 0.2 0.1 0.0 0.2 0.2 0.0 0.6 0.2 0.2 0.2 1.1 0.1 0.1 0.1 0.3 2.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.5 0.0 0.0 1.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 3.1 0.1 14.8 5.0 0.4 0.4 1.5 0.0 0.0 EN1 ENSG00000163064 "Engrailed homeobox 1" Q05925 2 118842171-118847678 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0" "Cell line enhanced" "Detected in some" "ASC diff: 14.1;ASC TERT1: 6.4;fHDF/TERT166: 11.1;HSkMC: 11.9;PC-3: 6.6;U-138 MG: 8.6;U-2197: 9.6" "Cancer enhanced" "Detected in many" "breast cancer: 5.6" "Group enriched" "Detected in some" 10 "midbrain: 11.4;pons and medulla: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "midbrain: 5.9" "Region enriched" "Detected in some" 5 "midbrain: 23.9" "CAB014884, HPA073141" Enhanced Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "CAB014884: , HPA073141: " "unprognostic (5.20e-2)" "unprognostic (1.61e-1)" "unprognostic (5.78e-2)" "unprognostic (4.84e-7)" "unprognostic (1.87e-3)" "unprognostic (1.90e-1)" "unprognostic (1.95e-3)" "unprognostic (1.16e-1)" "unprognostic (2.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.46e-1)" "unprognostic (3.38e-9)" "unprognostic (2.15e-2)" "unprognostic (1.88e-1)" "unprognostic (1.70e-1)" "unprognostic (9.30e-3)" 5.6 0.1 0.0 0.1 0.4 0.0 2.7 0.9 0.4 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 2.4 11.4 0.0 0.1 0.0 0.1 0.0 0.0 8.8 0.1 0.1 0.2 0.7 0.1 20.1 10.0 0.1 0.1 2.7 0.1 0.1 0.4 0.1 0.2 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.5 0.2 14.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.4 0.5 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 8.6 0.8 9.6 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 0.2 0.1 11.4 0.0 8.8 0.1 EN2 ENSG00000164778 "Engrailed homeobox 2" P19622 7 155458129-155464831 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 26.5" "Cell line enhanced" "Detected in some" "AF22: 26.9;AN3-CA: 9.9;HAP1: 5.8;HEK 293: 16.3;SK-MEL-30: 7.9" "Cancer enhanced" "Detected in many" "melanoma: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 8 "cerebellum: 31.1" "Region enriched" "Detected in some" 6 "cerebellum: 71.6" "HPA045646, HPA069809" Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA045646: , HPA069809: " "unprognostic (2.44e-3)" "unprognostic (1.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.99e-3)" "prognostic unfavourable (1.74e-6)" "unprognostic (2.54e-1)" "unprognostic (8.02e-2)" "unprognostic (7.00e-2)" "unprognostic (1.15e-1)" "unprognostic (9.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.94e-1)" "unprognostic (1.03e-13)" "unprognostic (4.91e-3)" "unprognostic (2.72e-1)" "unprognostic (2.24e-1)" "unprognostic (5.64e-3)" 0.3 0.2 0.1 0.0 0.1 0.0 0.1 26.5 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.3 1.3 1.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.4 26.9 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.0 0.0 5.8 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.2 3.4 0.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.2 0.0 0.0 1.9 0.0 7.9 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ENC1 "ENC-1, KLHL37, NRPB, PIG10, TP53I10" ENSG00000171617 "Ectodermal-neural cortex 1" O14682 5 74627406-74641424 "Cancer-related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 106.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 7 "amygdala: 39.7;basal ganglia: 42.7;cerebral cortex: 86.4;hippocampal formation: 44.1;olfactory region: 43.9" "Group enriched" "Detected in many" 6 "classical monocyte: 5.4;eosinophil: 3.4;gdT-cell: 2.3;intermediate monocyte: 4.8;memory CD8 T-cell: 3.0;myeloid DC: 2.4;naive CD8 T-cell: 2.5;neutrophil: 1.4;NK-cell: 2.8;non-classical monocyte: 1.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078061 Uncertain "Plasma membrane" "Plasma membrane" "HPA078061: " "prognostic unfavourable (3.88e-4)" "unprognostic (4.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.00e-3)" "unprognostic (1.05e-1)" "unprognostic (2.22e-3)" "unprognostic (1.36e-1)" "unprognostic (9.74e-2)" "unprognostic (1.24e-1)" "unprognostic (2.59e-1)" "unprognostic (4.98e-2)" "unprognostic (8.08e-2)" "prognostic unfavourable (2.95e-5)" "unprognostic (9.69e-2)" "unprognostic (3.08e-1)" "unprognostic (2.88e-1)" "unprognostic (5.65e-2)" 2.2 1.1 39.7 4.7 42.7 5.4 1.8 1.3 106.8 4.2 5.2 2.4 2.1 6.4 2.9 1.6 2.5 1.3 7.5 3.2 44.1 7.7 2.2 6.4 4.8 2.2 4.6 43.9 6.0 12.3 1.0 2.4 4.2 4.9 4.3 8.1 0.8 5.4 7.4 1.7 1.7 8.1 3.0 2.3 4.0 9.8 4.5 1.5 0.5 1.3 0.3 2.0 6.5 1.3 0.4 2.4 3.4 5.4 2.8 3.0 1.4 11.9 14.8 14.8 7.0 6.4 1.6 31.9 8.0 9.1 9.2 6.8 23.9 20.2 0.0 10.0 6.8 9.7 0.2 15.5 20.1 0.2 1.1 13.2 2.8 10.4 0.6 1.3 0.1 2.5 1.0 24.4 2.4 7.5 2.9 7.7 24.0 2.9 1.2 1.7 15.4 13.3 1.5 9.7 1.2 5.0 9.1 19.9 8.1 1.4 6.6 0.7 3.1 1.6 17.8 15.6 26.1 9.2 25.8 0.1 0.0 0.2 18.0 1.1 23.7 0.0 5.4 3.4 2.3 4.8 0.0 0.1 0.5 3.0 2.4 0.4 0.2 2.5 1.4 2.8 1.3 0.0 0.0 1.4 39.7 42.7 1.3 86.4 44.1 7.7 4.6 43.9 4.9 1.5 ENHO "C9orf165, UNQ470" ENSG00000168913 "Energy homeostasis associated" Q6UWT2 9 34521040-34523041 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 79.6" "Cell line enhanced" "Detected in some" "AN3-CA: 13.2;NTERA-2: 18.2;SCLC-21H: 9.3;SH-SY5Y: 8.8" "Cancer enhanced" "Detected in many" "glioma: 44.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "myeloid DC: 19.4" "Lineage enriched" "Detected in many" 7 "dendritic cells: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042575 Approved "Secreted to blood" 4236667 "HPA042575: AB_10794914" "unprognostic (2.63e-2)" "unprognostic (9.53e-3)" "unprognostic (2.46e-1)" "prognostic unfavourable (3.71e-4)" "unprognostic (1.30e-1)" "unprognostic (7.51e-2)" "unprognostic (9.93e-2)" "unprognostic (1.34e-2)" "unprognostic (5.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.78e-4)" "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.47e-2)" "unprognostic (1.87e-1)" "unprognostic (5.50e-2)" "unprognostic (8.76e-2)" 1.5 1.9 58.0 1.9 59.3 1.7 3.7 15.5 79.6 2.9 3.9 13.9 0.0 3.0 1.4 1.4 1.5 3.6 1.8 1.8 36.3 37.5 1.5 12.0 2.0 1.4 52.0 27.1 1.5 2.6 1.2 1.0 1.3 13.7 5.2 3.2 0.1 1.8 1.7 1.6 3.8 3.6 1.3 17.1 1.6 5.3 6.4 13.4 0.0 1.4 0.0 1.4 1.5 0.0 0.0 19.4 0.0 2.5 2.7 0.0 0.4 0.1 0.9 5.2 13.2 0.1 0.0 0.3 0.0 0.0 2.1 2.1 0.5 0.2 2.2 3.6 0.0 0.2 6.0 0.4 0.4 0.3 5.8 0.0 0.1 1.2 0.1 0.0 2.9 0.0 0.1 0.0 0.2 0.0 0.0 1.9 0.4 0.3 0.0 0.0 18.2 3.7 0.1 0.0 0.3 0.5 0.0 9.3 8.8 0.7 4.1 0.4 0.3 1.7 0.0 0.4 2.0 0.1 0.1 1.1 1.2 0.1 0.4 0.0 3.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 2.7 0.7 1.0 0.0 0.4 58.0 59.3 15.5 37.0 36.3 37.5 52.0 27.1 13.7 13.4 ENKUR "C10orf63, CFAP106, enkurin, MGC26778" ENSG00000151023 "Enkurin, TRPC channel interacting protein" Q8TC29 10 24981979-25062279 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.7;fallopian tube: 46.2" "Cell line enhanced" "Detected in some" "AN3-CA: 4.0;CAPAN-2: 7.0" "Cancer enhanced" "Detected in some" "glioma: 4.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037593, HPA037594, HPA061503" Enhanced "HPA037593: AB_10672387, HPA037594: AB_2675568, HPA061503: AB_2684543" "unprognostic (2.33e-3)" "unprognostic (4.86e-2)" "unprognostic (1.13e-2)" "unprognostic (6.52e-3)" "unprognostic (3.31e-2)" "unprognostic (2.91e-2)" "unprognostic (1.38e-2)" "unprognostic (7.35e-2)" "unprognostic (1.18e-1)" "unprognostic (8.69e-2)" "unprognostic (6.85e-2)" "unprognostic (3.17e-1)" "unprognostic (1.20e-6)" "unprognostic (3.94e-1)" "unprognostic (3.35e-2)" "unprognostic (3.45e-3)" "unprognostic (8.43e-3)" 0.7 1.1 8.4 1.2 13.4 1.0 0.7 1.1 10.6 2.2 0.9 6.2 0.0 2.0 2.5 7.0 0.7 46.2 1.0 0.8 8.8 10.8 1.2 2.4 6.7 0.7 9.2 3.5 6.5 0.6 0.8 10.4 1.4 18.7 0.7 0.8 0.0 0.8 0.7 0.9 0.8 4.6 0.9 6.5 1.0 0.9 8.4 8.6 0.0 1.2 0.0 0.8 0.7 0.0 0.0 0.4 4.1 0.3 0.0 0.0 9.9 0.4 1.2 1.2 4.0 0.1 0.3 0.1 0.4 0.0 0.0 0.0 0.7 7.0 0.7 1.0 0.2 0.5 0.0 0.7 0.1 0.4 0.4 0.8 0.9 0.4 0.1 0.0 0.2 0.0 0.0 0.4 0.6 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.3 1.0 2.3 0.4 0.2 0.2 0.6 0.0 0.2 0.4 1.2 0.6 1.0 0.0 0.1 0.0 2.1 0.2 0.1 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.1 0.0 0.1 0.4 0.0 9.9 8.4 13.4 1.1 5.2 8.8 10.8 9.2 3.5 18.7 8.6 ENO2 ENSG00000111674 "Enolase 2" P09104 12 6913745-6923698 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 119.2" "Cell line enhanced" "Detected in many" "U-87 MG: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5" "Group enriched" "Detected in many" 7 "B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000063, HPA068284, HPA068721, CAB073539, CAB079023" Enhanced Supported Supported "Plasma membrane,Cytosol" 89000000 "Plasma membrane, Cytosol" "CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: " "unprognostic (8.96e-2)" "unprognostic (8.28e-2)" "prognostic unfavourable (6.96e-4)" "unprognostic (1.28e-1)" "unprognostic (7.95e-3)" "unprognostic (1.39e-2)" "prognostic unfavourable (5.15e-4)" "unprognostic (1.48e-1)" "unprognostic (9.43e-2)" "unprognostic (1.58e-1)" "unprognostic (1.98e-1)" "unprognostic (2.02e-2)" "prognostic unfavourable (7.89e-11)" "unprognostic (7.61e-2)" "unprognostic (3.06e-1)" "unprognostic (8.10e-3)" "unprognostic (1.24e-1)" 4.2 20.7 31.2 8.3 48.0 4.0 4.9 115.2 119.2 7.6 7.9 10.9 2.6 4.9 11.7 6.3 5.9 9.4 8.0 10.3 30.2 39.2 3.5 2.0 10.1 10.5 29.6 47.4 3.7 4.1 19.1 15.5 4.8 47.7 8.0 7.4 28.6 3.1 15.3 2.1 5.8 6.0 15.2 15.7 5.8 6.4 3.2 13.3 1.7 14.2 0.3 10.3 7.1 5.0 5.6 1.0 6.2 0.2 0.4 10.8 4.5 14.0 8.9 3.2 0.1 4.8 5.2 0.2 10.9 7.0 16.2 25.0 1.7 1.1 19.8 1.8 4.7 2.1 33.7 3.0 24.6 39.6 3.1 27.3 9.1 11.8 3.5 1.6 32.9 2.6 0.1 11.9 2.4 3.4 1.8 0.2 10.8 1.9 12.8 1.7 17.1 5.0 14.2 2.7 4.3 7.9 1.9 25.9 18.2 2.8 0.2 18.6 0.9 0.8 4.3 14.2 15.0 19.1 14.1 14.5 14.5 2.9 81.3 0.0 2.9 1.3 0.0 0.1 8.2 0.0 9.7 5.6 10.8 9.6 0.0 3.3 7.1 7.4 6.2 0.4 0.2 1.0 5.5 4.5 31.2 48.0 115.2 91.3 30.2 39.2 29.6 47.4 47.7 13.3 ENO4 "AC023283.3, C10orf134" ENSG00000188316 "Enolase family member 4" A6NNW6 10 116849512-116911788 "Enzymes, Predicted intracellular proteins" Glycolysis Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1;epididymis: 12.6;fallopian tube: 13.6" "Cell line enhanced" "Detected in some" "HaCaT: 2.6;MCF7: 8.2;T-47d: 5.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037937, HPA037938" Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA037937: AB_10697089, HPA037938: " "unprognostic (2.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (6.55e-4)" "unprognostic (8.38e-5)" "unprognostic (1.88e-1)" "unprognostic (2.21e-1)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (3.74e-3)" "unprognostic (2.06e-1)" "unprognostic (2.20e-3)" "unprognostic (1.18e-1)" "unprognostic (9.77e-3)" "unprognostic (9.87e-5)" "unprognostic (1.08e-2)" 0.7 2.1 4.3 0.6 4.3 0.2 2.2 2.6 3.6 1.7 1.0 8.0 0.9 0.3 4.3 12.6 1.4 13.6 1.3 0.5 6.4 4.7 2.3 2.7 3.9 1.2 4.1 4.8 4.2 3.2 3.7 3.4 0.5 12.1 2.1 0.8 3.0 1.6 1.2 0.2 1.1 0.5 0.9 4.4 0.5 0.8 8.8 1.9 0.2 4.2 0.0 0.6 1.8 0.5 1.8 1.0 0.0 0.6 0.0 1.2 0.1 1.4 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.3 1.1 0.0 0.9 2.0 2.6 0.0 0.7 0.8 0.0 1.5 0.0 1.0 0.3 0.0 0.0 0.0 0.1 0.6 0.6 0.0 0.1 0.1 0.0 0.7 8.2 0.0 0.0 1.4 0.2 0.0 0.0 0.0 1.1 0.6 0.9 0.0 2.1 0.1 0.0 5.1 0.0 0.5 0.0 0.7 0.4 1.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 1.6 0.2 0.0 0.3 1.8 0.2 0.0 0.0 0.0 0.2 1.0 1.2 0.1 4.3 4.3 2.6 3.6 6.4 4.7 4.1 4.8 12.1 1.9 ENOPH1 "E1, MASA, mtnC" ENSG00000145293 "Enolase-phosphatase 1" Q9UHY7 4 82430562-82461091 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004985, HPA044607" Enhanced Approved "Nucleoplasm,Nuclear bodies" 140000 Nucleoplasm "Nuclear bodies" "CAB004985: AB_426046, HPA044607: AB_2679019" "unprognostic (6.64e-3)" "unprognostic (3.05e-1)" "unprognostic (6.77e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.68e-3)" "prognostic unfavourable (1.74e-5)" "unprognostic (9.99e-3)" "unprognostic (1.18e-1)" "unprognostic (2.17e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-1)" "unprognostic (9.30e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.52e-3)" "unprognostic (3.52e-2)" 10.2 15.4 43.4 12.1 37.1 14.3 16.3 22.9 38.8 13.8 12.7 34.7 5.1 12.2 10.5 23.3 13.5 10.4 9.0 11.1 44.2 34.9 20.8 13.3 11.1 16.0 47.5 26.4 12.9 14.6 17.8 11.7 17.7 31.0 17.2 15.3 8.9 11.4 11.9 9.8 13.1 11.0 11.1 66.2 12.8 13.2 6.1 29.4 14.2 18.0 8.2 18.6 10.7 9.5 13.0 14.1 4.3 10.4 14.4 20.2 12.2 18.8 12.5 22.4 13.9 13.7 13.5 24.6 22.0 14.7 20.1 18.0 22.7 21.1 37.5 23.1 16.6 10.2 29.6 27.8 36.4 22.6 13.8 22.7 12.2 30.2 22.3 37.6 19.7 13.0 29.6 21.0 24.9 20.3 29.3 20.7 26.2 24.3 41.4 22.4 20.6 10.1 29.6 34.4 20.4 32.8 18.7 31.8 19.4 12.5 37.8 27.9 17.1 18.2 14.9 25.0 18.5 24.7 28.9 23.8 20.4 46.8 16.1 23.4 33.5 3.4 8.7 4.3 14.4 10.4 18.0 13.0 17.3 16.5 12.7 11.0 20.2 16.2 0.7 14.4 8.8 14.1 18.4 12.2 43.4 37.1 22.9 38.4 44.2 34.9 47.5 26.4 31.0 29.4 ENPP2 "ATX, PD-IALPHA, PDNP2" ENSG00000136960 "Ectonucleotide pyrophosphatase/phosphodiesterase 2" Q13822 8 119557086-119673453 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 103.7;placenta: 79.0" "Cell line enhanced" "Detected in some" "AF22: 24.7;ASC diff: 33.8;ASC TERT1: 72.2;BJ hTERT+: 41.5;fHDF/TERT166: 26.8;HSkMC: 33.1" "Cancer enhanced" "Detected in all" "renal cancer: 46.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023700, HPA053652" Approved Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Intracellular and membrane" 1100000000 "Nucleoplasm, Golgi apparatus" "Actin filaments" "HPA023700: AB_1848170, HPA053652: " "unprognostic (1.17e-2)" "unprognostic (6.29e-2)" "unprognostic (3.63e-2)" "unprognostic (3.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-1)" "unprognostic (9.70e-3)" "unprognostic (7.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "prognostic favourable (2.07e-5)" "unprognostic (5.54e-2)" "unprognostic (3.14e-1)" "unprognostic (2.37e-1)" "unprognostic (5.18e-2)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" 29.9 15.4 24.0 18.2 42.0 0.7 26.2 4.4 33.3 19.6 8.1 103.7 1.7 20.8 44.8 6.4 2.9 18.7 12.7 3.6 39.8 21.5 24.9 8.9 13.5 31.0 71.5 20.9 5.3 5.2 0.9 4.1 79.0 59.7 8.5 10.6 67.6 3.4 9.2 3.0 5.4 12.1 28.9 102.4 17.3 8.3 9.7 63.9 3.6 3.7 0.8 26.1 13.4 5.7 0.2 3.8 26.8 0.1 0.2 1.8 0.3 0.0 0.0 24.7 0.0 33.8 72.2 0.0 22.7 41.5 9.8 9.4 0.0 0.0 0.0 0.3 26.8 0.0 0.5 0.0 6.9 1.8 0.7 0.0 0.0 0.6 15.1 0.0 0.1 33.1 0.2 20.0 1.0 0.1 0.0 4.0 0.5 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.4 23.9 0.1 0.2 0.0 0.0 16.8 0.1 0.5 26.8 0.1 5.2 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 1.8 0.6 0.3 0.2 0.0 3.8 0.0 0.3 24.0 42.0 4.4 33.3 39.8 21.5 71.5 20.9 59.7 63.9 ENPP6 MGC33971 ENSG00000164303 "Ectonucleotide pyrophosphatase/phosphodiesterase 6" Q6UWR7 4 184088706-184221230 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;kidney: 30.8" "Group enriched" "Detected in some" 7 "HDLM-2: 1.8;Karpas-707: 6.3;SH-SY5Y: 7.1;U-266/70: 5.8;U-266/84: 3.1" "Cancer enriched" "Detected in some" 5 "glioma: 3.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042740 Approved Approved "Golgi apparatus" "Intracellular and membrane" 68000 "Golgi apparatus" "HPA042740: AB_10793984" "unprognostic (4.81e-4)" "unprognostic (1.47e-1)" "unprognostic (3.54e-2)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.69e-3)" "unprognostic (3.07e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-1)" "unprognostic (7.60e-3)" "unprognostic (3.04e-2)" "unprognostic (1.72e-1)" "unprognostic (2.98e-2)" "unprognostic (2.82e-1)" "unprognostic (3.93e-3)" "unprognostic (2.01e-1)" 0.5 0.6 2.0 1.1 8.0 1.1 1.0 1.7 6.7 0.5 1.3 35.2 0.4 2.0 0.5 6.9 1.3 0.5 0.8 0.5 5.4 3.5 30.8 0.4 0.6 1.1 26.1 3.3 13.7 0.3 0.3 4.1 0.4 19.5 2.7 1.3 7.7 0.9 6.9 0.4 0.5 2.5 0.4 28.2 1.2 1.5 2.7 14.0 0.0 0.5 0.0 3.1 0.9 0.7 0.9 0.8 2.2 0.9 1.5 0.6 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.7 0.3 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 6.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.4 0.0 0.2 7.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 5.8 3.1 0.1 0.1 0.1 0.0 2.2 0.9 0.6 0.5 0.5 0.6 0.7 0.4 0.3 0.1 0.9 0.4 0.5 1.7 1.5 0.3 0.8 0.5 0.1 2.0 8.0 1.7 6.7 5.4 3.5 26.1 3.3 19.5 14.0 ENTPD2 "CD39L1, NTPDase-2" ENSG00000054179 "Ectonucleoside triphosphate diphosphohydrolase 2" Q9Y5L3 9 137048098-137054045 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.6" "Cell line enhanced" "Detected in some" "Hep G2: 16.6;hTCEpi: 9.2;MCF7: 11.5;SK-BR-3: 15.5;T-47d: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "eosinophil: 2.6" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017676 Approved "HPA017676: AB_1848179" "unprognostic (1.64e-1)" "unprognostic (3.35e-2)" "unprognostic (1.76e-1)" "unprognostic (3.33e-2)" "unprognostic (2.15e-3)" "unprognostic (1.07e-1)" "prognostic unfavourable (2.48e-5)" "unprognostic (2.71e-2)" "unprognostic (4.97e-2)" "unprognostic (3.23e-1)" "unprognostic (2.99e-1)" "unprognostic (1.89e-1)" "prognostic favourable (3.51e-6)" "prognostic favourable (1.38e-4)" "unprognostic (2.51e-1)" "unprognostic (8.43e-2)" "unprognostic (1.12e-3)" 1.7 1.6 18.8 1.5 10.1 0.6 7.0 4.0 10.4 9.8 9.1 21.9 1.7 17.6 2.8 4.4 3.3 9.4 10.7 2.7 22.6 9.6 4.5 1.0 1.0 0.5 6.1 12.8 0.8 2.6 1.2 3.1 3.9 11.9 11.2 5.8 2.5 6.2 2.9 3.0 9.3 11.1 1.9 7.5 0.5 9.5 6.8 11.7 0.0 0.7 2.6 1.0 0.9 3.5 0.0 0.0 2.6 0.1 0.0 0.0 0.0 4.4 1.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.8 1.3 0.0 1.0 0.0 3.6 0.3 2.6 0.0 0.0 0.1 0.0 0.5 16.6 0.0 0.0 0.2 0.0 9.2 0.0 2.4 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 2.5 0.0 0.8 1.7 2.0 0.4 2.5 0.1 0.2 15.5 0.0 16.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.8 10.1 4.0 9.8 22.6 9.6 6.1 12.8 11.9 11.7 EOMES TBR2 ENSG00000163508 Eomesodermin O95936 3 27715949-27722711 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.9;brain: 22.6;lymphoid tissue: 21.4" "Cell line enhanced" "Detected in some" "HDLM-2: 11.6;MCF7: 3.4;SCLC-21H: 6.5" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Region enriched" "Detected in some" 20 "cerebellum: 22.6" "Group enriched" "Detected in many" 7 "gdT-cell: 10.0;MAIT T-cell: 16.5;memory CD8 T-cell: 12.0;naive CD8 T-cell: 7.5;NK-cell: 17.9" "Group enriched" "Detected in many" 102 "NK-cells: 17.9;T-cells: 16.5" "Region enriched" "Detected in some" 8 "olfactory region: 95.2" "Group enriched" "Detected in some" 13 "cerebellum: 44.2;olfactory region: 21.9" "HPA028896, HPA077118" Uncertain Uncertain Vesicles Vesicles "HPA028896: AB_10601370, HPA077118: " "unprognostic (1.53e-4)" "unprognostic (5.95e-3)" "unprognostic (3.01e-2)" "unprognostic (1.60e-4)" "unprognostic (4.13e-2)" "unprognostic (9.63e-4)" "unprognostic (4.29e-4)" "unprognostic (3.14e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-2)" "unprognostic (9.96e-2)" "unprognostic (1.85e-1)" "prognostic unfavourable (9.45e-6)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (6.32e-3)" "unprognostic (1.49e-2)" 1.4 0.7 0.5 6.8 0.4 1.6 1.6 22.6 0.4 1.8 0.8 0.0 0.0 0.3 3.2 0.9 1.4 0.6 5.0 0.7 0.4 0.7 1.0 4.9 10.1 15.6 0.5 0.3 1.3 0.9 0.0 0.6 1.6 1.1 2.1 0.9 3.3 2.2 0.1 0.4 0.4 1.8 0.7 0.9 21.4 1.4 0.5 0.0 1.8 1.1 0.9 11.2 3.3 0.8 0.0 0.0 0.1 0.0 17.9 16.5 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 2.2 0.0 11.6 1.7 0.0 0.1 0.9 0.0 1.4 0.0 0.1 1.4 0.0 1.6 0.0 0.3 0.0 0.0 3.4 3.1 0.0 0.4 1.4 2.1 0.0 0.0 1.1 0.0 6.5 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 10.0 0.0 16.5 0.0 1.9 12.0 0.0 0.0 0.1 7.5 0.1 17.9 0.0 0.0 0.0 1.4 0.5 0.4 22.6 0.4 0.4 0.7 0.5 0.3 1.1 0.0 EPB41 "4.1R, EL1" ENSG00000159023 "Erythrocyte membrane protein band 4.1" P11171 1 28887091-29120046 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Actin-binding, Calmodulin-binding" "Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.7" "Cell line enhanced" "Detected in many" "HEL: 39.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 10 "cerebellum: 375.3" "HPA028076, HPA028096, HPA028412, HPA028414" Supported Supported "Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" 3400000 "Plasma membrane, Cell Junctions" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA028076: , HPA028096: , HPA028412: , HPA028414: AB_10601366" "unprognostic (2.16e-1)" "unprognostic (1.96e-1)" "unprognostic (8.92e-3)" "prognostic unfavourable (4.58e-4)" "unprognostic (5.00e-2)" "prognostic favourable (5.87e-4)" "unprognostic (5.01e-3)" "unprognostic (5.40e-3)" "unprognostic (2.52e-2)" "unprognostic (6.65e-2)" "unprognostic (7.81e-2)" "unprognostic (1.42e-2)" "prognostic unfavourable (1.75e-6)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 9.2 9.6 3.3 19.4 10.2 28.0 9.6 59.7 11.6 8.2 12.4 2.0 9.8 9.3 10.5 5.7 10.8 5.5 7.9 7.5 3.3 4.8 10.0 13.2 11.0 25.4 3.9 3.0 12.3 10.4 9.1 9.0 8.7 10.3 8.3 12.5 14.6 10.1 10.8 15.0 8.9 14.6 9.2 5.8 13.5 14.0 7.9 6.9 42.2 8.1 8.8 19.8 11.3 12.4 9.9 3.0 30.1 2.1 5.7 15.9 7.7 7.3 1.7 18.3 8.6 1.5 0.2 6.1 1.8 2.8 2.3 2.9 4.9 8.8 13.6 4.9 2.5 3.3 22.8 1.7 2.5 24.5 7.0 39.0 5.5 7.9 2.8 13.2 26.0 0.5 5.4 2.2 3.9 4.0 36.7 10.8 0.0 2.5 21.4 8.6 19.2 2.8 32.9 8.0 19.5 2.2 9.3 24.7 18.3 5.7 5.4 12.4 4.1 5.1 0.3 0.1 3.8 3.6 3.8 16.3 21.1 24.3 3.5 13.6 2.0 17.2 2.1 12.6 8.5 0.7 9.6 9.9 12.4 9.3 2.4 9.3 14.8 8.9 30.1 5.7 0.8 3.0 15.9 7.7 3.3 10.2 59.7 11.6 3.3 4.8 3.9 3.0 10.3 6.9 EPB41L3 "4.1B, DAL1, KIAA0987" ENSG00000082397 "Erythrocyte membrane protein band 4.1 like 3" Q9Y2J2 18 5392381-5630700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Actin-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.8" "Cell line enhanced" "Detected in many" "ASC diff: 17.6;ASC TERT1: 20.5;HUVEC TERT2: 18.5;SCLC-21H: 20.7;TIME: 50.8;U-2 OS: 18.5;U-2197: 18.0;U-251 MG: 21.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.7;non-classical monocyte: 11.6" "Lineage enriched" "Detected in many" 4 "monocytes: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028605 Enhanced Enhanced "Plasma membrane,Cell Junctions" 140000 "Plasma membrane, Cell Junctions" "HPA028605: AB_10611963" "unprognostic (3.58e-3)" "unprognostic (1.17e-2)" "unprognostic (3.61e-1)" "unprognostic (7.97e-2)" "unprognostic (1.88e-1)" "unprognostic (1.44e-2)" "unprognostic (2.60e-1)" "unprognostic (9.73e-2)" "unprognostic (3.40e-1)" "unprognostic (3.63e-3)" "unprognostic (1.07e-3)" "unprognostic (5.81e-2)" "unprognostic (5.96e-2)" "unprognostic (5.65e-3)" "unprognostic (8.99e-2)" "unprognostic (2.72e-2)" "unprognostic (6.59e-3)" 17.1 19.4 12.0 16.4 32.1 2.5 8.9 35.9 36.3 5.1 10.6 36.2 1.4 29.8 5.8 7.1 6.8 8.8 6.0 6.0 11.3 16.6 21.0 3.1 8.8 8.8 46.4 15.9 7.8 4.4 14.7 9.0 12.7 46.8 4.0 8.4 3.8 3.6 5.0 4.6 3.5 27.9 8.3 27.2 10.5 3.2 35.9 36.6 0.9 4.0 1.5 2.6 5.6 5.8 0.0 2.5 0.7 11.6 0.0 0.6 0.7 0.0 0.3 1.2 0.0 17.6 20.5 13.8 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.2 0.0 12.0 0.0 0.0 0.0 10.7 0.0 0.1 0.0 0.0 0.0 1.4 10.7 0.0 3.8 0.0 18.5 0.1 0.1 0.0 0.0 0.1 0.2 2.5 3.9 0.0 0.0 0.0 0.1 1.4 20.7 0.1 0.0 0.1 8.2 0.2 1.4 50.8 0.1 18.5 18.0 21.8 0.0 0.0 0.0 0.0 1.6 2.1 0.0 4.5 0.0 0.0 7.7 0.0 0.0 0.0 0.0 2.5 0.0 0.6 0.0 0.7 0.0 11.6 0.0 0.0 0.7 12.0 32.1 35.9 27.7 11.3 16.6 46.4 15.9 46.8 36.6 EPDR1 "EPDR, MERP-1, MERP1, UCC1" ENSG00000086289 "Ependymin related 1" Q9UM22 7 37683843-37951941 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6;skeletal muscle: 55.8" "Cell line enhanced" "Detected in many" "U-937: 36.6;WM-115: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.4" "Group enriched" "Detected in many" 9 "dendritic cells: 5.4;NK-cells: 1.9;T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB026298 Approved "Intracellular and membrane" "CAB026298: AB_425991" "unprognostic (1.99e-2)" "unprognostic (9.30e-2)" "unprognostic (4.44e-3)" "unprognostic (3.07e-2)" "unprognostic (1.38e-1)" "unprognostic (4.85e-2)" "prognostic unfavourable (6.97e-4)" "unprognostic (2.53e-2)" "unprognostic (2.75e-1)" "unprognostic (3.13e-1)" "unprognostic (7.23e-2)" "unprognostic (1.85e-1)" "unprognostic (4.88e-2)" "prognostic unfavourable (3.43e-4)" "unprognostic (4.13e-1)" "unprognostic (1.43e-2)" "prognostic unfavourable (1.00e-4)" 11.2 23.3 21.9 2.2 16.0 2.1 4.8 30.5 30.5 21.5 4.9 7.5 1.6 7.0 22.4 7.4 4.6 15.5 5.3 13.9 20.3 34.3 8.6 6.0 13.8 2.9 25.3 18.8 18.6 5.7 5.8 4.6 2.8 57.6 18.5 4.7 8.0 7.3 22.6 55.8 1.5 6.8 16.4 13.9 8.3 3.4 6.7 5.2 5.2 16.1 7.7 1.7 4.7 8.5 0.0 5.4 0.2 0.3 1.9 1.9 0.4 0.0 23.9 2.0 0.0 18.8 6.8 0.0 1.8 0.0 0.9 2.9 2.3 1.5 0.0 27.1 26.5 0.0 0.5 0.2 0.0 0.0 3.0 10.4 3.3 14.6 0.1 8.6 0.0 11.4 0.0 6.7 0.1 0.0 0.0 7.9 15.9 1.5 3.3 7.3 7.4 3.5 10.6 6.9 9.1 14.7 5.8 2.6 9.2 0.0 1.2 8.3 0.0 6.1 0.0 5.3 8.9 14.4 11.0 10.7 4.5 0.1 24.1 36.6 35.6 0.0 0.3 0.2 1.7 0.3 0.0 0.0 0.0 1.9 1.0 0.0 0.1 1.1 0.2 1.9 0.0 5.4 0.0 0.4 21.9 16.0 30.5 30.5 20.3 34.3 25.3 18.8 57.6 5.2 EPHA10 "FLJ16103, FLJ33655" ENSG00000183317 "EPH receptor A10" Q5JZY3 1 37713880-37765133 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.6;intestine: 12.6;testis: 24.8" "Cell line enhanced" "Detected in some" "BEWO: 5.1;HDLM-2: 19.2;SCLC-21H: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA027497 Uncertain "Intracellular and membrane" "HPA027497: AB_10601158" "unprognostic (9.27e-2)" "unprognostic (1.21e-1)" "unprognostic (2.94e-2)" "unprognostic (1.24e-6)" "unprognostic (1.06e-1)" "unprognostic (1.11e-2)" "unprognostic (5.39e-2)" "unprognostic (1.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.40e-1)" "unprognostic (7.06e-3)" "unprognostic (1.50e-1)" "unprognostic (8.81e-5)" "unprognostic (2.55e-2)" "unprognostic (2.97e-2)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 0.4 1.1 5.8 1.7 15.6 0.7 1.9 1.3 10.5 0.6 12.6 3.6 0.2 5.8 0.5 6.8 0.8 1.8 2.1 0.4 4.6 7.4 0.5 0.4 0.5 0.6 3.5 5.0 0.4 5.1 1.1 10.8 0.4 6.4 1.4 10.3 1.6 2.4 0.7 0.4 0.6 7.3 1.0 2.3 0.5 5.3 24.8 2.1 0.0 1.0 0.0 0.5 0.6 0.3 0.4 0.3 1.5 0.3 0.8 0.7 0.1 1.5 1.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.6 2.8 0.0 0.4 0.0 0.1 0.1 0.0 0.0 19.2 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 1.0 0.0 0.2 0.7 0.6 0.0 0.0 0.4 0.3 1.7 8.9 0.4 1.1 0.0 0.0 2.8 0.1 0.0 0.0 1.0 0.1 0.0 1.7 1.2 0.0 0.0 0.0 0.0 1.4 0.2 0.1 0.7 0.1 0.4 0.4 0.3 0.3 0.1 0.4 0.6 0.7 1.5 0.8 0.3 0.3 0.2 0.1 5.8 15.6 1.3 10.5 4.6 7.4 3.5 5.0 6.4 2.1 EPHA4 "Hek8, TYRO1" ENSG00000116106 "EPH receptor A4" P54764 2 221418027-221574202 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.6" "Cell line enhanced" "Detected in many" "AF22: 35.0;ASC diff: 15.5;CACO-2: 25.6;U-2197: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 3.0;gdT-cell: 3.4;MAIT T-cell: 3.4;memory B-cell: 2.5;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.3;naive B-cell: 1.8;naive CD4 T-cell: 1.9;NK-cell: 6.0;T-reg: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB028368 Enhanced 8400000 "CAB028368: AB_2099353" "unprognostic (1.28e-1)" "unprognostic (5.87e-2)" "unprognostic (2.28e-1)" "unprognostic (2.46e-2)" "unprognostic (5.99e-2)" "unprognostic (1.33e-1)" "unprognostic (7.05e-4)" "unprognostic (1.80e-2)" "unprognostic (2.40e-1)" "prognostic unfavourable (9.56e-4)" "unprognostic (1.12e-1)" "unprognostic (2.85e-2)" "prognostic favourable (5.67e-4)" "unprognostic (3.12e-2)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (8.66e-2)" 7.1 1.8 8.1 1.9 18.3 3.5 5.2 14.7 29.6 4.9 5.9 3.1 3.2 1.1 6.5 3.1 5.0 6.6 3.3 16.7 19.9 4.4 5.2 0.9 3.7 2.5 2.4 16.4 11.7 1.2 2.0 1.2 1.7 4.9 5.9 4.7 0.8 3.7 6.7 3.1 12.8 4.1 8.2 2.1 3.3 4.0 11.4 2.6 0.5 9.8 3.7 3.2 4.6 4.9 2.5 0.2 3.0 0.0 6.0 5.0 0.7 1.1 1.0 35.0 0.0 15.5 9.6 0.0 8.3 3.6 7.5 2.8 25.6 0.4 0.0 0.0 11.6 3.0 5.4 0.0 3.2 4.1 3.0 0.0 0.3 0.0 0.4 0.0 0.6 3.8 1.9 2.3 0.0 7.1 0.0 0.0 1.9 4.1 0.1 0.0 2.5 0.7 0.0 3.8 0.0 11.7 1.8 6.2 0.0 2.7 0.5 0.6 1.3 0.0 0.0 0.8 1.4 17.1 0.4 0.0 0.0 0.0 3.1 0.0 1.5 3.0 0.0 0.0 3.4 0.0 3.4 2.5 5.0 3.3 0.0 1.8 1.9 0.3 0.2 6.0 0.0 0.2 2.1 0.7 8.1 18.3 14.7 29.6 19.9 4.4 2.4 16.4 4.9 2.6 EPHA5 "CEK7, EHK1, Hek7, TYRO4" ENSG00000145242 "EPH receptor A5" P54756 4 65319563-65670495 "Enzymes, Predicted membrane proteins" Neurogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.5" "Cell line enhanced" "Detected in some" "PC-3: 7.0;TIME: 9.4;U-138 MG: 19.7;U-2197: 12.0;U-251 MG: 15.2" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.02e-2)" "unprognostic (4.22e-2)" "unprognostic (2.38e-1)" "unprognostic (4.89e-4)" "unprognostic (7.43e-4)" "unprognostic (1.60e-1)" "unprognostic (6.68e-3)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-2)" "unprognostic (9.25e-2)" "unprognostic (5.88e-3)" "unprognostic (2.55e-2)" "unprognostic (5.97e-4)" "unprognostic (3.81e-3)" 0.9 2.7 17.6 1.0 9.0 0.8 0.8 1.9 25.5 5.9 1.2 1.5 1.8 0.9 1.9 0.9 1.1 1.0 0.9 2.7 17.3 6.8 0.9 0.8 1.1 0.9 5.4 13.2 6.2 0.8 0.8 6.5 2.7 10.2 4.2 1.1 2.6 1.2 4.1 0.8 1.2 0.9 1.4 17.7 1.5 1.1 2.2 0.7 0.0 3.0 0.0 0.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.6 0.3 0.0 0.3 0.9 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.1 1.9 0.0 0.0 0.0 0.0 7.0 0.0 2.2 0.4 0.0 0.0 0.8 0.0 0.0 0.0 3.2 0.0 0.0 9.4 19.7 2.5 12.0 15.2 0.0 0.0 0.0 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 9.0 1.9 24.7 17.3 6.8 5.4 13.2 10.2 0.7 EPHA6 FLJ35246 ENSG00000080224 "EPH receptor A6" Q9UF33 3 96814581-97752460 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.9;ovary: 13.2;testis: 15.5" "Group enriched" "Detected in some" 6 "HEK 293: 8.0;U-266/70: 24.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA007397, HPA058047" Uncertain Enhanced Nucleoplasm Nucleoplasm "HPA007397: AB_2667821, HPA058047: " "unprognostic (9.87e-2)" "unprognostic (1.67e-2)" "unprognostic (3.42e-4)" "unprognostic (7.21e-5)" "unprognostic (8.51e-2)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (3.14e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (1.71e-4)" "unprognostic (1.93e-3)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (7.14e-3)" 0.8 0.5 8.7 0.5 9.8 0.3 0.8 27.9 9.9 2.2 5.8 1.1 0.3 0.6 2.2 1.0 2.1 4.2 2.1 1.1 15.4 1.3 1.3 0.5 0.5 0.4 1.1 6.8 13.2 1.4 0.7 0.6 0.5 5.7 2.5 1.8 0.2 0.6 1.7 0.4 0.5 1.1 3.2 0.8 0.4 1.7 15.5 2.8 0.0 4.3 0.0 0.5 2.1 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 8.0 0.0 2.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.5 0.0 0.1 0.0 2.1 0.0 0.8 24.3 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 9.8 27.9 9.9 15.4 1.3 1.1 6.8 5.7 2.8 EPHA8 "EEK, Hek3" ENSG00000070886 "EPH receptor A8" P29322 1 22563564-22603594 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 9.4;brain: 5.3;lymphoid tissue: 10.3;pancreas: 8.3;testis: 3.5" "Cell line enriched" "Detected in some" 12 "SCLC-21H: 36.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 25.0" "CAB009660, HPA031433" Uncertain "Intracellular and membrane" "CAB009660: AB_2099696, HPA031433: AB_10601371" "unprognostic (8.58e-2)" "unprognostic (8.59e-2)" "unprognostic (3.72e-1)" "unprognostic (1.15e-2)" "unprognostic (4.69e-4)" "unprognostic (3.58e-1)" "unprognostic (7.14e-2)" "unprognostic (1.52e-1)" "unprognostic (4.75e-2)" "unprognostic (9.80e-2)" "unprognostic (2.10e-1)" "unprognostic (9.84e-14)" "unprognostic (2.14e-3)" "unprognostic (1.69e-1)" "unprognostic (2.76e-1)" "unprognostic (8.68e-2)" 0.2 9.4 1.6 0.2 3.1 0.2 0.1 1.8 3.9 0.2 0.2 2.2 0.0 1.7 0.1 0.3 0.2 0.1 0.2 0.2 2.0 2.6 0.1 0.1 0.2 0.2 2.1 4.1 0.1 8.3 0.2 1.7 0.1 5.3 0.2 0.2 1.6 0.8 0.2 0.3 0.4 0.2 0.1 1.3 10.3 0.2 3.5 0.6 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 36.4 2.9 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 3.1 1.8 3.9 2.0 2.6 2.1 4.1 5.3 0.6 EPHB1 "EPHT2, Hek6" ENSG00000154928 "EPH receptor B1" P54762 3 134597801-135260467 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 74.7" "Group enriched" "Detected in some" 4 "HDLM-2: 33.9;HMC-1: 20.1;RPTEC TERT1: 9.2" "Cancer enriched" "Detected in many" 6 "glioma: 7.0" "Region enhanced" "Detected in all" "cerebellum: 74.7" "Group enriched" "Detected in some" 33 "neutrophil: 15.9;plasmacytoid DC: 15.4" "Group enriched" "Detected in many" 33 "dendritic cells: 15.4;granulocytes: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067740 Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" "Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA067740: " "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.52e-1)" "unprognostic (1.41e-6)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (8.15e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-2)" "unprognostic (1.78e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-4)" 2.0 1.5 9.0 1.8 16.6 1.5 5.5 74.7 23.6 3.6 3.4 3.4 3.1 2.8 4.1 2.0 3.8 2.8 3.3 1.1 9.4 5.3 2.3 2.9 1.0 3.3 2.8 7.0 1.7 1.1 0.6 3.8 0.9 7.1 3.3 1.4 1.9 3.9 5.1 7.4 6.0 1.7 1.7 6.0 3.4 1.3 16.7 6.0 0.0 11.6 2.9 3.3 4.5 2.6 0.0 15.4 15.9 0.0 0.0 0.4 0.1 0.0 0.0 4.7 0.0 0.1 0.0 0.1 3.5 0.0 0.2 0.0 0.0 0.0 0.6 1.0 1.8 0.0 3.1 0.0 0.6 33.9 0.4 2.5 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.5 0.1 0.1 0.1 1.3 0.0 0.0 0.5 0.1 9.2 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.6 2.0 0.3 4.2 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 15.4 0.0 0.1 9.0 16.6 74.7 19.0 9.4 5.3 2.8 7.0 7.1 6.0 EPHB6 HEP ENSG00000106123 "EPH receptor B6" 7 142855061-142871094 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.1;lymphoid tissue: 26.7;skin 1: 32.1" "Group enriched" "Detected in some" 6 "MOLT-4: 17.8;RT4: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035784 Approved "Nuclear speckles" "Intracellular and membrane" "Nuclear speckles" "HPA035784: " "unprognostic (1.90e-2)" "prognostic favourable (1.80e-4)" "unprognostic (7.08e-3)" "unprognostic (2.95e-2)" "prognostic unfavourable (4.10e-4)" "unprognostic (2.53e-3)" "unprognostic (3.15e-2)" "unprognostic (4.39e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.06e-3)" "unprognostic (3.18e-1)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (4.93e-2)" "unprognostic (3.16e-1)" "prognostic favourable (4.68e-5)" 3.3 1.7 7.4 3.0 30.1 3.3 2.6 3.1 29.3 9.0 1.5 0.8 3.4 0.9 3.0 4.5 7.5 6.4 2.8 1.4 5.4 4.2 1.7 1.3 2.4 3.6 3.3 14.4 3.9 7.8 0.8 1.1 2.9 1.7 6.8 0.9 1.5 4.7 8.1 1.8 32.1 1.6 2.0 1.4 2.6 3.3 3.8 3.6 26.7 6.6 2.5 3.3 5.1 6.5 4.1 0.9 1.0 1.3 0.0 3.1 1.4 0.1 0.0 0.0 0.4 1.9 1.0 0.0 0.2 0.4 0.1 0.0 0.5 1.3 0.0 0.0 0.1 4.4 0.2 0.0 0.0 1.0 0.1 0.3 0.0 0.2 0.6 4.2 0.1 0.3 0.0 1.1 0.0 0.2 0.6 0.0 0.0 0.0 17.8 3.2 3.0 1.3 0.4 0.0 0.0 0.0 33.8 0.0 0.0 1.2 0.8 0.0 2.8 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 1.3 0.5 0.1 1.0 0.6 4.1 2.5 1.4 0.9 1.0 3.1 1.5 1.0 0.0 0.4 0.1 1.9 1.4 7.4 30.1 3.1 29.3 5.4 4.2 3.3 14.4 1.7 3.6 EPHX4 "ABHD7, EPHXRP, FLJ90341" ENSG00000172031 "Epoxide hydrolase 4" Q8IUS5 1 92029982-92063536 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 13.3;brain: 20.7" "Cell line enhanced" "Detected in some" "A-431: 9.9;CAPAN-2: 8.6;EFO-21: 17.6;RPTEC TERT1: 24.4;U-251 MG: 7.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 13.3" "Lineage enriched" "Detected in single" 24 "T-cells: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035067 Uncertain Approved Vesicles Vesicles "HPA035067: AB_10601465" "unprognostic (1.27e-1)" "unprognostic (4.17e-2)" "unprognostic (6.76e-3)" "unprognostic (6.10e-8)" "prognostic unfavourable (9.43e-4)" "unprognostic (5.36e-3)" "unprognostic (2.72e-4)" "unprognostic (4.85e-2)" "unprognostic (9.44e-3)" "unprognostic (7.93e-2)" "prognostic unfavourable (2.00e-4)" "unprognostic (2.53e-1)" "unprognostic (6.36e-6)" "unprognostic (6.93e-3)" "unprognostic (1.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" 1.0 1.3 5.8 1.3 14.1 0.3 3.2 1.7 20.7 2.4 1.0 0.3 0.1 1.6 1.7 1.3 2.1 1.3 1.2 1.2 3.3 2.4 0.9 0.4 1.5 0.7 3.1 9.8 0.6 0.3 0.5 1.3 1.9 4.4 2.2 1.4 1.5 0.4 4.1 0.4 0.6 0.9 2.5 1.1 0.4 0.5 2.6 2.1 0.0 3.9 0.0 0.7 1.9 0.4 0.1 0.0 0.0 0.0 0.5 13.3 1.4 9.9 0.3 1.9 0.0 0.0 0.0 0.5 0.2 3.7 0.3 0.2 0.0 8.6 0.0 17.6 0.0 0.1 0.3 0.8 0.3 0.0 5.3 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.4 0.0 0.0 3.0 0.0 0.0 0.3 0.6 1.4 0.3 1.9 3.5 0.3 0.2 0.0 24.4 1.9 1.2 1.5 6.0 0.0 1.8 0.0 1.4 0.1 0.0 0.0 0.0 7.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.3 0.0 2.3 0.1 1.7 3.3 0.0 0.0 0.4 3.4 0.0 0.5 0.0 0.0 0.0 1.4 5.8 14.1 1.7 20.7 3.3 2.4 3.1 9.8 4.4 2.1 EPN2 "EHB21, KIAA1065" ENSG00000072134 "Epsin 2" O95208 17 19215615-19336715 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 19.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049809, HPA053360" Approved Supported Vesicles Vesicles "HPA049809: , HPA053360: " "unprognostic (1.38e-2)" "unprognostic (2.54e-2)" "unprognostic (2.58e-2)" "unprognostic (2.09e-1)" "unprognostic (1.94e-1)" "unprognostic (8.12e-3)" "unprognostic (6.73e-3)" "unprognostic (1.43e-1)" "unprognostic (8.89e-2)" "unprognostic (4.58e-3)" "unprognostic (3.42e-2)" "unprognostic (1.57e-1)" "prognostic favourable (9.13e-5)" "unprognostic (1.32e-1)" "unprognostic (9.40e-2)" "unprognostic (2.23e-2)" "prognostic unfavourable (8.15e-5)" 6.5 5.1 16.3 6.2 11.8 3.4 4.4 9.9 34.8 7.0 5.2 4.3 3.6 2.9 9.9 7.0 13.9 7.7 4.8 10.7 16.7 10.5 4.5 3.6 6.1 3.6 14.9 13.1 7.2 4.3 8.4 3.6 7.7 8.5 7.3 3.0 5.6 5.0 9.2 9.8 18.4 3.6 8.7 14.7 4.5 3.2 6.7 10.6 3.6 4.4 8.1 3.6 5.4 6.9 2.9 0.7 19.9 1.1 0.6 1.5 0.4 14.8 14.9 21.9 9.6 11.5 18.6 17.1 14.3 9.3 8.9 7.7 9.7 4.5 2.3 14.0 14.2 14.1 9.7 10.7 11.0 11.1 10.8 1.6 9.4 4.8 12.1 0.7 6.6 10.4 9.7 14.0 11.4 19.0 4.2 2.0 7.8 10.8 0.6 1.0 5.6 9.8 3.4 9.3 3.9 10.5 4.1 6.5 14.5 10.1 6.8 7.4 10.2 1.9 17.3 9.9 11.4 15.4 6.2 3.3 2.0 1.9 27.0 0.2 15.1 7.1 1.1 19.9 1.5 0.7 1.0 2.3 1.1 1.2 0.5 2.9 1.3 1.2 7.3 0.6 0.8 0.7 0.9 0.4 16.3 11.8 9.9 34.8 16.7 10.5 14.9 13.1 8.5 10.6 EPOP "C17orf96, LOC100170841, PRR28" ENSG00000273604 "Elongin BC and polycomb repressive complex 2 associated protein" A6NHQ4 17 38671703-38675421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5" "Cell line enhanced" "Detected in many" "AN3-CA: 15.7;Hep G2: 18.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 8 "T-cells: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055190, HPA056555" Enhanced Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA055190: , HPA056555: " "unprognostic (9.08e-2)" "unprognostic (3.71e-1)" "unprognostic (5.79e-2)" "unprognostic (6.75e-3)" "unprognostic (1.83e-1)" "unprognostic (1.84e-2)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (2.17e-2)" "unprognostic (2.63e-2)" "unprognostic (1.78e-10)" "unprognostic (8.97e-2)" "unprognostic (2.51e-1)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" 1.2 2.0 2.5 1.5 5.1 0.4 1.1 0.0 13.5 0.3 0.2 0.0 2.5 0.2 0.7 0.7 0.7 0.4 0.8 0.4 1.1 0.3 3.4 0.4 2.4 0.3 3.2 0.1 3.6 3.0 0.0 1.2 0.4 0.7 0.3 0.2 0.5 1.2 0.1 1.0 0.2 0.5 0.8 0.6 0.5 5.8 0.8 1.7 0.1 1.1 3.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 2.9 3.4 2.2 15.7 0.5 0.1 3.8 0.6 0.2 0.6 1.1 3.4 1.1 5.5 3.8 0.4 2.3 7.3 1.5 1.2 5.7 5.6 1.2 0.6 18.0 1.0 0.6 3.0 0.3 2.6 0.7 1.5 0.5 3.7 8.5 0.4 4.6 4.9 1.6 0.5 3.1 11.8 1.3 12.0 0.4 0.7 3.4 5.3 1.9 2.6 0.6 3.7 2.3 0.8 0.6 0.7 0.7 0.6 4.5 4.9 7.0 1.3 8.1 2.3 0.0 0.0 0.0 0.4 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 ERAS "HRAS2, HRASP" ENSG00000187682 "ES cell expressed Ras" Q7Z444 X 48826513-48830138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.5" "Cell line enhanced" "Detected in some" "CACO-2: 2.8;NB-4: 2.3;THP-1: 2.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "unprognostic (2.47e-2)" "unprognostic (1.28e-2)" "unprognostic (4.50e-2)" "unprognostic (3.93e-2)" "unprognostic (3.61e-1)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (1.20e-1)" "unprognostic (1.85e-1)" "unprognostic (1.87e-2)" "unprognostic (2.72e-4)" "unprognostic (9.40e-2)" "unprognostic (7.07e-3)" "unprognostic (1.22e-1)" "unprognostic (1.98e-1)" "unprognostic (1.08e-1)" "unprognostic (2.25e-2)" 0.1 0.2 1.7 0.0 1.7 0.7 0.0 4.2 2.7 0.2 0.2 0.0 1.0 0.3 0.1 0.4 0.1 0.0 1.1 5.5 0.5 1.1 0.4 0.0 1.2 0.7 0.0 0.9 1.4 0.2 0.2 0.0 0.7 1.1 0.6 1.0 0.4 0.6 1.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.2 0.3 0.2 0.0 0.5 0.5 0.0 0.0 0.3 0.0 2.8 0.5 0.0 0.1 0.0 0.2 0.5 1.6 0.4 0.0 0.5 0.0 0.8 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 2.3 0.8 1.0 0.4 0.3 0.0 0.3 0.1 0.1 0.4 0.0 0.3 0.6 0.0 2.1 0.0 0.0 0.8 0.5 0.0 0.6 0.6 0.4 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ERC2 "CAST, CAST1, ELKSL, KIAA0378, SPBC110, Spc110" ENSG00000187672 "ELKS/RAB6-interacting/CAST family member 2" O15083 3 55508308-56468363 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 30.5" "Cell line enhanced" "Detected in some" "HAP1: 3.7;HUVEC TERT2: 3.6;Karpas-707: 12.0;SH-SY5Y: 3.0;U-266/70: 8.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073739 Enhanced "HPA073739: " "unprognostic (2.13e-2)" "unprognostic (1.39e-1)" "unprognostic (9.10e-2)" "unprognostic (1.93e-2)" "unprognostic (2.62e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (4.50e-2)" "unprognostic (2.95e-2)" "unprognostic (1.22e-1)" "unprognostic (3.06e-2)" "unprognostic (2.69e-1)" "unprognostic (1.75e-2)" "unprognostic (1.46e-2)" "unprognostic (1.24e-2)" "unprognostic (4.49e-2)" "unprognostic (9.09e-2)" 0.9 1.6 13.4 1.0 9.5 0.9 1.1 11.5 30.5 1.0 1.0 0.7 1.3 1.0 1.2 0.9 1.0 1.0 1.1 2.2 9.4 5.3 1.4 0.9 1.1 0.9 3.8 12.6 2.9 1.3 0.9 7.4 1.3 8.8 1.5 1.0 1.1 1.0 3.1 0.9 0.9 1.1 1.1 2.3 0.9 1.2 1.5 1.5 0.0 1.3 0.0 0.9 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.6 0.0 12.0 0.0 1.5 0.0 0.0 2.6 0.3 0.0 0.2 0.0 2.7 0.0 1.4 3.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.3 8.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.4 9.5 11.5 16.8 9.4 5.3 3.8 12.6 8.8 1.5 ERICH3 "C1orf173, DKFZp547I048, RP11-653A5.1" ENSG00000178965 "Glutamate rich 3" Q5RHP9 1 74568111-74673738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.5;fallopian tube: 21.1;testis: 26.4" "Cell line enhanced" "Detected in some" "Karpas-707: 1.2;SCLC-21H: 3.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028655, HPA072916" Approved "HPA028655: AB_10961002, HPA072916: " "unprognostic (4.49e-4)" "unprognostic (1.02e-2)" "prognostic favourable (1.56e-5)" "unprognostic (1.71e-2)" "unprognostic (5.94e-2)" "unprognostic (6.83e-2)" "unprognostic (6.53e-2)" "unprognostic (4.76e-2)" "unprognostic (8.84e-2)" "unprognostic (1.49e-2)" "unprognostic (1.54e-1)" "unprognostic (1.74e-4)" "unprognostic (9.21e-3)" "unprognostic (2.25e-1)" "unprognostic (2.02e-1)" "unprognostic (8.90e-2)" 0.4 3.5 12.7 0.5 10.7 0.4 1.4 7.0 14.5 7.6 0.5 0.5 0.0 0.5 1.7 3.0 0.4 21.1 0.5 0.5 12.0 4.2 0.5 0.6 3.7 0.7 1.0 10.3 1.2 0.4 0.4 6.3 0.5 2.4 0.5 0.6 0.0 0.7 0.5 0.4 0.5 0.5 0.5 0.7 0.6 0.6 26.4 1.6 0.0 0.5 0.0 0.7 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.0 3.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 10.7 7.0 12.0 12.0 4.2 1.0 10.3 2.4 1.6 ERMN "ERMIN, JN, KIAA1189" ENSG00000136541 Ermin Q8TAM6 2 157318625-157327713 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 106.7" "Cell line enriched" "Detected in some" 6 "HAP1: 20.8" "Group enriched" "Detected in some" 12 "endometrial cancer: 2.2;glioma: 9.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038295, HPA038296" Enhanced Approved "Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "HPA038295: AB_10805353, HPA038296: AB_10796217" "unprognostic (7.89e-2)" "unprognostic (9.06e-3)" "unprognostic (2.71e-2)" "prognostic favourable (6.93e-6)" "unprognostic (1.06e-1)" "unprognostic (2.02e-2)" "unprognostic (9.14e-2)" "unprognostic (1.79e-1)" "unprognostic (4.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.07e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-3)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (9.97e-3)" "unprognostic (5.76e-2)" 1.6 1.4 29.1 2.9 50.5 9.7 1.6 2.7 106.7 1.4 1.8 52.4 0.0 1.8 1.6 1.5 1.7 1.4 1.9 1.6 40.9 21.4 1.5 1.5 2.0 3.1 75.1 18.4 1.5 1.6 1.4 0.1 1.4 54.5 1.5 1.9 4.3 2.4 1.5 1.7 1.9 1.9 1.6 100.9 2.5 2.2 1.7 69.5 0.0 1.6 0.0 2.7 1.7 0.1 1.7 1.3 3.9 1.6 2.4 2.1 0.7 0.1 0.3 0.3 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 1.2 0.0 1.9 0.3 20.8 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.2 2.8 0.4 0.2 0.7 2.3 0.3 0.5 0.0 0.4 0.5 0.0 1.0 0.4 0.6 0.0 0.1 0.0 0.7 1.2 0.0 0.2 0.1 0.2 0.6 3.4 1.9 0.5 1.8 0.9 1.0 2.6 1.6 1.1 2.1 1.2 1.0 0.7 0.8 0.6 0.6 1.7 1.5 1.6 3.9 2.4 1.0 1.3 0.9 0.7 29.1 50.5 2.7 27.9 40.9 21.4 75.1 18.4 54.5 69.5 ESPNL FLJ42568 ENSG00000144488 "Espin like" Q6ZVH7 2 238100157-238133287 "Predicted intracellular proteins" Hearing Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.9;pituitary gland: 8.2" "Cell line enhanced" "Detected in some" "AN3-CA: 3.6;Daudi: 5.0;fHDF/TERT166: 4.6;HHSteC: 5.3;THP-1: 3.6;U-87 MG: 4.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 5 "cerebellum: 9.9" "Cell type enriched" "Detected in single" 5 "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 16 "B-cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA055103 Uncertain "HPA055103: " "unprognostic (8.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.34e-2)" "unprognostic (1.18e-3)" "unprognostic (1.51e-2)" "unprognostic (2.12e-1)" "unprognostic (2.01e-2)" "unprognostic (3.20e-1)" "unprognostic (1.79e-1)" "unprognostic (2.18e-1)" "unprognostic (2.95e-1)" "unprognostic (2.24e-1)" "unprognostic (3.94e-6)" "unprognostic (3.49e-2)" "unprognostic (8.52e-2)" "unprognostic (1.08e-1)" "unprognostic (5.67e-2)" 0.6 0.5 0.3 6.0 0.3 0.0 0.6 9.9 0.6 1.2 1.1 0.6 0.3 1.4 1.5 0.3 0.8 2.8 0.3 1.3 0.3 0.0 1.1 3.5 0.7 2.6 0.3 0.3 4.0 1.3 0.0 8.2 0.3 2.0 1.5 0.2 0.6 2.0 3.5 0.3 0.1 4.9 1.6 0.3 3.8 0.8 0.4 0.8 0.3 2.0 0.3 2.8 0.4 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.7 1.4 0.6 1.9 1.0 1.6 1.8 0.0 0.0 5.0 2.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.9 1.8 5.3 0.0 1.1 1.9 0.0 0.2 0.0 0.0 1.7 0.0 2.0 0.0 0.0 2.2 0.3 0.0 1.6 0.2 0.7 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.2 4.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 9.9 0.6 0.3 0.0 0.3 0.3 2.0 0.8 ESRRG NR3B3 ENSG00000196482 "Estrogen related receptor gamma" P62508 1 216503246-217137755 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5;parathyroid gland: 37.2;placenta: 40.8" "Group enriched" "Detected in some" 4 "RPMI-8226: 15.1;SH-SY5Y: 28.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "pons and medulla: 49.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044678 Uncertain Approved Nucleoplasm Nucleoplasm "HPA044678: AB_10963215" "unprognostic (6.48e-2)" "unprognostic (1.11e-1)" "unprognostic (7.06e-2)" "unprognostic (7.32e-2)" "unprognostic (2.34e-1)" "unprognostic (5.48e-2)" "unprognostic (1.66e-1)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (2.88e-1)" "unprognostic (2.35e-1)" "unprognostic (1.79e-2)" "prognostic favourable (1.13e-11)" "unprognostic (3.04e-1)" "unprognostic (2.55e-1)" "unprognostic (3.65e-4)" "unprognostic (2.05e-1)" 0.5 5.1 2.8 0.4 3.3 0.2 2.9 6.9 10.3 1.4 0.7 0.7 2.2 4.0 0.5 1.5 1.4 2.1 0.8 8.3 3.2 2.6 22.0 0.8 0.7 0.4 6.8 1.7 0.8 4.4 37.2 9.9 40.8 49.5 2.6 0.4 10.7 11.0 2.4 6.3 1.5 3.7 0.9 2.6 1.0 22.2 1.0 1.5 0.0 4.6 7.2 0.4 1.0 0.7 0.4 0.2 1.5 0.0 0.2 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 15.1 2.3 1.7 5.4 28.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.1 0.1 1.5 0.2 0.0 0.2 0.0 0.0 2.8 3.3 6.9 10.3 3.2 2.6 6.8 1.7 49.5 1.5 ESYT3 "CHR3SYT, FAM62C" ENSG00000158220 "Extended synaptotagmin 3" A0FGR9 3 138434586-138481686 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;skin 1: 13.7" "Cell line enhanced" "Detected in some" "HAP1: 3.0;NTERA-2: 7.5;SCLC-21H: 8.1;SiHa: 3.3;SK-MEL-30: 4.0" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Region enriched" "Detected in all" 5 "cerebellum: 28.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 8.5" "Low region specificity" "Detected in all" HPA039200 Approved "HPA039200: AB_10805356" "unprognostic (4.48e-2)" "unprognostic (3.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.38e-4)" "unprognostic (2.23e-1)" "unprognostic (8.22e-2)" "unprognostic (3.55e-3)" "prognostic favourable (8.30e-4)" "unprognostic (3.38e-1)" "unprognostic (5.57e-2)" "unprognostic (6.19e-3)" "unprognostic (4.88e-3)" "unprognostic (3.16e-5)" "unprognostic (3.46e-1)" "unprognostic (1.12e-1)" "unprognostic (2.13e-1)" "unprognostic (6.43e-2)" 0.6 0.8 5.7 0.6 5.8 0.5 2.6 28.5 5.9 1.3 4.9 0.6 0.2 0.7 5.3 0.8 0.9 1.0 2.8 1.1 5.3 3.0 1.8 0.5 12.4 0.5 1.9 4.0 0.9 2.0 3.5 3.0 1.5 4.2 1.0 1.1 0.7 0.8 0.7 0.8 13.7 0.7 4.8 1.2 0.5 2.7 1.4 1.2 0.0 11.5 1.8 1.6 2.5 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 1.2 0.4 0.0 2.0 1.8 0.6 3.0 0.2 0.0 0.5 0.1 0.2 1.0 1.1 0.3 0.1 0.3 0.1 1.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.7 7.5 0.5 0.0 0.1 0.0 0.8 0.2 8.1 0.0 3.3 0.4 4.0 0.9 0.3 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.7 5.8 28.5 5.9 5.3 3.0 1.9 4.0 4.2 1.2 ETNPPL AGXT2L1 ENSG00000164089 "Ethanolamine-phosphate phospho-lyase" Q8TBG4 4 108742040-108763054 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 53.5;liver: 111.0" "Cell line enhanced" "Detected in some" "HeLa: 10.8;Hep G2: 4.2;NTERA-2: 2.2" "Group enriched" "Detected in some" 23 "glioma: 7.9;liver cancer: 21.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044546, HPA072938" Approved Approved Nucleoplasm Nucleoplasm "HPA044546: AB_10962867, HPA072938: " "unprognostic (5.20e-3)" "unprognostic (1.33e-1)" "unprognostic (3.93e-1)" "prognostic favourable (9.52e-5)" "unprognostic (5.93e-3)" "unprognostic (3.91e-2)" "unprognostic (2.82e-1)" "unprognostic (6.32e-2)" "unprognostic (2.70e-2)" "unprognostic (1.30e-1)" "unprognostic (3.40e-2)" "unprognostic (1.93e-1)" "unprognostic (1.59e-1)" "unprognostic (1.42e-2)" "unprognostic (9.48e-2)" 1.2 1.9 50.8 1.3 51.3 1.2 1.3 7.9 53.5 1.3 1.2 13.4 0.0 1.3 1.4 1.2 1.3 1.2 1.4 3.2 37.5 20.1 6.2 111.0 1.2 1.2 26.0 28.7 1.3 1.2 1.4 0.1 1.2 15.7 1.2 1.2 0.5 19.9 1.3 1.6 1.2 1.2 1.2 7.3 1.6 10.4 1.5 18.7 0.0 1.9 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.1 10.8 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 2.2 0.5 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.9 0.2 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 51.3 7.9 24.9 37.5 20.1 26.0 28.7 15.7 18.7 ETV1 ER81 ENSG00000006468 "ETS variant 1" P50549 7 13891228-13991425 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 90.0;salivary gland: 45.8" "Cell line enhanced" "Detected in many" "AN3-CA: 22.2;SCLC-21H: 26.3;U-87 MG: 51.9;WM-115: 25.6" "Cancer enhanced" "Detected in all" "glioma: 22.5" "Region enriched" "Detected in all" 8 "cerebellum: 90.0" "Cell type enriched" "Detected in single" 5 "T-reg: 3.1" "Lineage enriched" "Detected in single" 5 "T-cells: 3.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 418.9" "HPA068389, HPA077249" Supported Approved Nucleoplasm Nucleoplasm "HPA068389: , HPA077249: " "unprognostic (2.45e-1)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-2)" "unprognostic (2.13e-2)" "unprognostic (1.64e-7)" "unprognostic (7.08e-3)" "unprognostic (7.21e-2)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (3.02e-1)" "unprognostic (1.51e-3)" "unprognostic (2.21e-2)" "unprognostic (2.05e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-2)" 2.5 12.4 8.1 1.1 11.7 0.2 4.4 90.0 35.2 1.4 2.4 3.1 0.1 1.2 2.4 1.3 1.5 1.1 9.2 18.0 7.0 4.5 2.1 2.0 14.9 0.7 4.5 6.9 1.0 1.6 11.4 7.4 1.9 8.3 3.1 2.4 0.9 45.8 7.1 0.9 1.5 1.9 2.0 3.5 4.5 1.7 4.5 2.9 0.3 6.5 0.9 4.7 1.8 1.3 0.0 0.0 0.0 0.6 0.0 3.1 0.2 0.0 1.6 11.7 22.2 4.1 12.2 0.0 1.0 3.9 0.6 2.6 0.0 5.3 0.0 1.2 1.8 0.1 0.4 1.2 1.4 0.3 0.5 0.6 1.0 0.0 2.4 3.8 1.5 3.6 0.0 7.6 0.6 5.0 3.4 0.1 4.7 0.0 0.0 0.0 17.5 11.8 0.0 7.1 0.9 7.9 0.1 26.3 5.1 0.0 0.4 6.3 0.4 0.1 2.7 2.3 0.7 4.5 4.3 4.0 1.2 0.0 51.9 0.2 25.6 0.0 0.2 0.0 0.1 0.6 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 8.1 11.7 90.0 10.9 7.0 4.5 4.5 6.9 8.3 2.9 ETV3L FLJ16478 ENSG00000253831 "ETS variant 3 like" Q6ZN32 1 157092044-157099808 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.8;breast: 4.4;lymphoid tissue: 5.7" "Cell line enriched" "Detected in some" 17 "HDLM-2: 27.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 3.8;pons and medulla: 7.8" "Group enriched" "Detected in some" 13 "classical monocyte: 1.5;intermediate monocyte: 1.0" "Lineage enriched" "Detected in single" 15 "monocytes: 1.5" "Not detected" "Not detected" "unprognostic (7.39e-4)" "unprognostic (1.53e-1)" "unprognostic (3.22e-2)" "unprognostic (1.79e-5)" "unprognostic (2.25e-1)" "unprognostic (5.91e-2)" "unprognostic (1.57e-2)" "unprognostic (3.09e-4)" "unprognostic (1.88e-1)" "unprognostic (5.37e-2)" "unprognostic (3.37e-1)" 0.1 0.0 0.9 2.0 3.8 0.1 4.4 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.3 0.3 0.1 0.0 0.2 1.1 0.0 0.1 0.0 0.0 1.8 0.1 7.8 0.0 0.0 0.0 0.3 0.0 2.5 0.0 0.1 0.0 5.0 0.1 0.1 0.1 0.0 5.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 3.8 0.0 0.7 0.5 0.3 1.1 0.0 7.8 0.0 EVI2A "EVDA, EVI2" ENSG00000126860 "Ecotropic viral integration site 2A" P22794 17 31317560-31321884 "Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.7;brain: 74.0" "Cell line enhanced" "Detected in many" "HHSteC: 19.8;Karpas-707: 32.7;RPMI-8226: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA045033, HPA057051" Uncertain Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA045033: , HPA057051: " "unprognostic (7.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" "unprognostic (8.49e-2)" "unprognostic (4.89e-2)" "unprognostic (1.88e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (7.55e-4)" "unprognostic (1.90e-1)" "unprognostic (3.54e-2)" "unprognostic (3.15e-2)" "prognostic unfavourable (2.63e-6)" "unprognostic (7.64e-2)" "unprognostic (4.95e-2)" "unprognostic (5.87e-2)" "unprognostic (2.90e-2)" 6.4 4.7 26.8 25.8 36.0 15.1 4.7 3.8 30.0 5.2 6.2 16.5 0.0 6.3 2.2 1.6 3.5 2.1 10.6 2.6 42.5 21.8 2.2 5.3 12.5 27.4 64.7 13.9 1.6 1.6 1.0 1.6 11.6 33.7 2.4 8.2 0.0 3.0 2.0 1.2 1.5 6.8 4.1 74.0 20.4 6.9 1.2 59.7 32.1 2.0 0.6 22.6 14.2 2.2 8.6 17.9 51.7 26.5 8.9 19.2 23.9 0.0 0.0 0.0 0.0 1.6 10.4 0.0 1.3 2.2 1.7 6.0 0.0 0.4 8.8 0.0 1.7 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 19.8 10.2 11.1 12.8 0.0 2.4 6.8 0.6 0.3 32.7 12.9 0.1 7.3 11.2 0.0 0.0 7.6 1.3 50.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 11.1 4.2 7.2 0.2 0.3 4.7 14.8 0.0 9.9 5.8 7.4 5.9 1.3 26.5 1.0 11.3 12.7 13.7 8.6 16.1 13.1 17.9 4.2 19.2 16.8 51.7 8.9 9.6 5.9 17.1 23.9 26.8 36.0 3.8 24.0 42.5 21.8 64.7 13.9 33.7 59.7 EVI5 NB4S ENSG00000067208 "Ecotropic viral integration site 5" O60447 1 92508696-92792404 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027339 Approved "HPA027339: AB_1848308" "unprognostic (1.23e-1)" "unprognostic (2.84e-1)" "unprognostic (4.29e-3)" "unprognostic (1.65e-1)" "unprognostic (4.94e-2)" "unprognostic (1.06e-1)" "unprognostic (5.13e-3)" "unprognostic (7.43e-2)" "unprognostic (1.12e-1)" "unprognostic (9.11e-2)" "unprognostic (9.04e-3)" "unprognostic (2.25e-1)" "unprognostic (6.15e-2)" "unprognostic (8.30e-2)" "unprognostic (5.40e-1)" "unprognostic (6.38e-2)" "unprognostic (2.35e-2)" 4.5 8.5 27.5 3.4 13.4 1.6 3.6 5.1 35.7 5.4 4.1 2.3 1.7 3.4 5.6 3.9 3.2 4.4 5.0 6.0 12.5 5.5 4.2 14.5 5.9 2.1 5.6 23.1 3.5 4.4 8.8 4.5 10.4 3.7 4.6 4.6 1.7 4.2 5.0 3.1 4.0 3.3 6.1 5.7 3.3 5.3 8.0 2.4 1.7 5.6 1.7 2.4 4.2 3.9 2.3 2.2 6.0 4.8 0.2 0.2 0.7 3.8 4.2 6.7 6.5 11.0 13.9 6.3 8.9 13.6 6.1 7.1 7.4 1.0 1.7 12.5 10.1 4.4 6.3 6.5 11.0 0.1 2.4 3.1 4.4 4.4 10.8 2.1 3.6 8.7 5.4 10.5 6.4 13.1 5.4 2.8 10.1 1.9 0.2 2.5 1.9 3.5 1.6 16.1 2.2 4.7 11.2 2.5 5.2 10.4 5.4 11.9 2.7 5.0 8.5 6.8 5.0 9.0 5.7 4.1 2.4 2.8 4.5 3.6 5.6 1.3 4.8 4.4 0.2 3.3 0.1 2.0 0.2 0.0 2.2 2.3 0.1 0.1 6.0 0.2 4.7 1.5 0.1 0.7 27.5 13.4 5.1 35.7 12.5 5.5 5.6 23.1 3.7 2.4 EXPH5 SLAC2-B ENSG00000110723 "Exophilin 5" Q8NEV8 11 108505431-108593738 "Disease related genes, Predicted intracellular proteins" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 74.9;placenta: 45.1;skin 1: 23.1" "Cell line enhanced" "Detected in some" "HaCaT: 7.2;hTERT-HME1: 10.4;RT4: 18.2;SK-BR-3: 8.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 14 "cerebellum: 74.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebellum: 23.5;cerebral cortex: 6.7" "Region enriched" "Detected in many" 10 "cerebellum: 64.1" "unprognostic (1.34e-3)" "unprognostic (8.36e-2)" "unprognostic (1.18e-1)" "prognostic favourable (3.42e-6)" "unprognostic (2.91e-1)" "prognostic favourable (1.46e-4)" "unprognostic (4.57e-3)" "prognostic favourable (5.12e-4)" "unprognostic (1.26e-1)" "unprognostic (3.03e-1)" "unprognostic (5.56e-3)" "unprognostic (1.33e-1)" "prognostic favourable (2.43e-4)" "unprognostic (1.18e-2)" "unprognostic (2.57e-1)" "unprognostic (3.36e-1)" "unprognostic (4.51e-1)" 0.7 0.6 0.8 1.2 2.7 0.1 2.6 74.9 1.1 3.3 3.3 1.4 0.0 0.5 0.9 2.5 9.8 1.5 0.3 0.7 1.1 0.8 3.4 6.7 4.7 0.0 1.6 1.0 0.8 1.4 9.3 2.2 45.1 5.4 1.6 3.8 0.7 6.2 0.1 0.6 23.1 1.1 0.6 2.6 0.6 2.8 1.7 2.4 0.6 1.9 7.1 5.2 1.7 1.9 0.7 0.9 3.0 0.6 3.2 2.2 0.5 3.4 0.4 0.2 0.1 0.0 0.0 2.9 0.2 0.1 0.0 0.6 0.9 5.4 0.0 0.2 0.2 7.2 5.1 1.9 0.2 0.1 1.5 1.5 0.7 0.0 0.5 0.7 0.1 0.1 3.0 0.0 10.4 0.0 2.6 0.0 2.9 0.6 0.9 0.0 0.2 2.2 0.0 0.1 0.0 0.6 18.2 1.3 0.8 0.9 8.9 0.2 5.9 0.1 0.1 0.0 2.2 0.0 1.0 0.1 0.0 0.0 0.1 0.3 0.0 2.0 0.6 0.5 0.7 0.3 0.3 0.7 1.1 0.4 0.5 0.7 2.1 2.2 3.0 3.2 0.4 0.9 0.3 0.5 0.8 2.7 74.9 1.1 1.1 0.8 1.6 1.0 5.4 2.4 EXTL1 "EXTL, MGC70794" ENSG00000158008 "Exostosin like glycosyltransferase 1" Q92935 1 26019884-26036464 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 21.1;heart muscle: 6.0;skeletal muscle: 20.5" "Cell line enriched" "Detected in some" 10 "WM-115: 57.4" "Cancer enriched" "Detected in some" 13 "melanoma: 21.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA037749 Approved "Intracellular and membrane" 68000 "HPA037749: AB_10805350" "unprognostic (2.00e-1)" "unprognostic (1.10e-2)" "unprognostic (8.16e-3)" "unprognostic (1.47e-2)" "unprognostic (2.47e-2)" "unprognostic (6.14e-3)" "unprognostic (3.78e-2)" "unprognostic (1.99e-1)" "unprognostic (1.99e-1)" "unprognostic (6.70e-2)" "unprognostic (1.44e-2)" "unprognostic (3.46e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-3)" "unprognostic (2.27e-2)" "unprognostic (2.91e-1)" "unprognostic (1.35e-2)" 0.6 2.1 15.3 0.6 9.5 0.5 2.0 1.1 21.1 1.3 0.6 1.4 0.0 0.7 2.5 0.7 1.5 1.7 1.2 6.0 12.7 3.7 0.7 0.5 0.7 0.8 3.7 7.9 2.3 1.0 0.5 0.5 1.0 2.9 1.2 0.6 2.7 0.8 0.9 20.5 1.6 0.7 2.9 2.7 2.2 0.6 1.0 0.8 0.0 0.9 3.2 0.6 0.9 0.2 0.1 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 57.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.1 15.3 9.5 1.1 21.1 12.7 3.7 3.7 7.9 2.9 0.8 F5 ENSG00000198734 "Coagulation factor V" P12259 1 169514166-169586588 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.9;liver: 88.8;placenta: 32.2" "Cell line enriched" "Detected in some" 10 "Hep G2: 26.7" "Cancer enriched" "Detected in many" 7 "liver cancer: 69.6" "Region enriched" "Detected in many" 11 "pons and medulla: 27.9" "Cell type enhanced" "Detected in some" "eosinophil: 8.7;neutrophil: 8.0" "Group enriched" "Detected in many" 13 "granulocytes: 8.7;monocytes: 4.2;T-cells: 7.0" "Group enriched" "Detected in many" 5 "basal ganglia: 2.8;hippocampal formation: 7.4;pons and medulla: 4.6;thalamus: 5.8" "Group enriched" "Detected in many" 7 "amygdala: 59.9;basal ganglia: 33.8;cerebral cortex: 88.3;hippocampal formation: 79.2;olfactory region: 58.9" HPA002036 Approved "Golgi apparatus" "Secreted to blood" 7667000000 13000000000 "Golgi apparatus" "HPA002036: AB_1078787" "unprognostic (3.67e-2)" "unprognostic (2.77e-4)" "unprognostic (5.42e-2)" "unprognostic (2.56e-4)" "unprognostic (2.03e-1)" "unprognostic (2.39e-4)" "unprognostic (3.46e-3)" "unprognostic (9.25e-3)" "unprognostic (2.02e-1)" "unprognostic (8.99e-3)" "unprognostic (6.55e-3)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "prognostic unfavourable (3.39e-4)" "unprognostic (7.15e-2)" "unprognostic (3.41e-1)" "unprognostic (4.31e-1)" 1.1 0.4 0.4 1.4 0.5 1.5 0.8 1.0 0.4 0.4 0.4 6.7 0.0 0.5 0.4 2.2 0.4 1.6 14.1 13.9 2.5 0.5 1.2 88.8 1.1 1.1 1.4 0.1 0.4 1.3 0.1 2.0 32.2 27.9 1.0 0.4 17.8 4.4 0.1 0.4 1.3 0.5 0.5 2.6 1.9 2.2 0.7 1.1 0.0 0.7 0.2 2.6 1.5 0.4 0.0 0.5 8.7 4.2 0.0 7.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.2 8.7 0.0 0.2 0.0 0.0 1.7 0.2 0.5 0.0 0.3 0.0 8.0 0.0 0.0 0.0 7.0 1.1 0.4 0.5 1.0 0.4 2.5 0.5 1.4 0.1 27.9 1.1 FA2H "FAAH, FAXDC1, FLJ25287, SPG35" ENSG00000103089 "Fatty acid 2-hydroxylase" Q7L5A8 16 74712955-74774831 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.2;stomach 1: 45.5" "Cell line enhanced" "Detected in some" "A549: 20.2;CACO-2: 10.9;CAPAN-2: 11.2;HAP1: 26.2;RPTEC TERT1: 12.7;SK-BR-3: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 24 "memory B-cell: 3.0" "Lineage enriched" "Detected in single" 24 "B-cells: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056614, HPA077840" Approved Uncertain "Nuclear membrane" "Nuclear membrane" "HPA056614: , HPA077840: " "unprognostic (1.33e-1)" "unprognostic (4.97e-2)" "unprognostic (9.19e-2)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.85e-2)" "unprognostic (1.48e-2)" "unprognostic (2.47e-2)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "prognostic unfavourable (3.74e-4)" "unprognostic (6.01e-2)" "prognostic favourable (5.01e-6)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.83e-2)" "unprognostic (2.11e-3)" 0.7 0.7 11.8 3.4 27.7 0.7 2.6 2.8 25.3 2.0 16.2 62.4 0.0 8.1 0.7 2.2 3.7 1.8 14.3 0.7 22.3 11.0 3.7 0.7 1.5 0.9 40.5 16.5 0.6 6.8 7.1 0.8 1.0 28.5 1.9 15.4 0.0 8.4 1.0 0.6 3.5 11.3 1.4 78.2 0.8 45.5 2.4 44.6 2.6 2.0 0.0 4.7 3.8 1.2 3.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 20.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 10.9 11.2 0.0 0.1 0.0 1.9 26.2 0.3 0.0 0.0 0.8 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.4 0.0 0.5 1.3 0.0 0.0 0.8 12.7 8.2 3.5 0.0 0.0 15.5 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.8 27.7 2.8 16.1 22.3 11.0 40.5 16.5 28.5 44.6 FABP7 "B-FABP, BLBP" ENSG00000164434 "Fatty acid binding protein 7" O15540 6 122779475-122784074 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 62.7;breast: 26.8" "Group enriched" "Detected in some" 8 "AF22: 37.8;U-251 MG: 10.2;WM-115: 22.7" "Group enriched" "Detected in many" 6 "glioma: 139.3;renal cancer: 51.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Group enriched" "Detected in many" 5 "granulocytes: 3.1;NK-cells: 1.1" "Region enriched" "Detected in all" 6 "olfactory region: 1471.1" "Low region specificity" "Detected in all" "CAB025488, HPA028825, CAB058697" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "CAB025488: , CAB058697: , HPA028825: AB_10602130" "prognostic favourable (2.49e-4)" "unprognostic (1.56e-2)" "unprognostic (2.53e-3)" "unprognostic (5.80e-2)" "unprognostic (2.29e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (2.09e-2)" "unprognostic (3.42e-2)" "prognostic unfavourable (1.65e-6)" "unprognostic (9.83e-2)" "unprognostic (1.30e-2)" "unprognostic (2.50e-1)" "unprognostic (8.66e-2)" 2.1 1.3 34.8 1.1 15.5 1.3 26.8 51.6 62.7 1.1 1.5 13.0 0.0 1.2 1.2 1.3 1.6 1.2 1.2 1.2 32.0 16.4 1.6 1.4 1.1 1.1 11.4 30.3 1.1 1.1 1.0 2.1 1.3 11.2 1.3 1.2 5.7 7.0 3.7 6.7 10.5 1.1 1.1 8.1 1.1 1.3 1.2 6.9 0.0 1.1 0.0 1.1 1.4 0.0 0.4 0.2 3.1 0.3 1.1 0.4 0.0 0.0 0.0 37.8 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 10.2 0.0 0.0 0.0 0.4 0.0 22.7 3.1 0.3 0.1 0.3 0.1 0.3 0.2 0.3 0.4 0.1 0.4 0.3 0.3 0.5 1.1 0.2 0.2 0.1 0.0 34.8 15.5 51.6 27.3 32.0 16.4 11.4 30.3 11.2 6.9 FADS6 ENSG00000172782 "Fatty acid desaturase 6" 17 74877299-74893781 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.2;epididymis: 22.6;intestine: 20.0" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in some" "liver cancer: 2.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016802 Uncertain "HPA016802: " "unprognostic (2.41e-2)" "unprognostic (6.80e-3)" "unprognostic (2.64e-1)" "unprognostic (4.68e-3)" "unprognostic (4.73e-2)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (1.07e-1)" "unprognostic (6.41e-2)" "unprognostic (6.98e-4)" "unprognostic (3.38e-2)" "unprognostic (7.53e-2)" "unprognostic (1.14e-2)" "unprognostic (6.71e-2)" "unprognostic (2.27e-1)" "unprognostic (8.45e-2)" "unprognostic (1.79e-1)" 0.4 6.3 1.7 0.7 3.3 1.7 0.7 13.2 5.9 0.5 9.7 0.4 1.2 9.2 0.4 22.6 2.7 0.3 0.2 0.4 1.7 3.4 1.4 5.2 0.3 0.7 4.5 1.9 0.4 0.6 0.6 0.1 0.4 12.5 0.6 1.0 0.6 2.3 0.5 0.7 6.5 20.0 0.3 0.8 4.7 0.4 1.0 0.4 0.3 0.6 2.2 1.1 1.7 0.9 1.1 0.8 5.3 2.9 1.3 0.5 0.0 0.6 0.7 1.8 1.6 0.0 2.7 2.9 3.2 0.2 0.4 0.8 2.3 1.3 1.1 0.5 1.5 1.0 2.4 0.0 0.4 0.4 0.1 1.3 3.8 1.6 0.9 1.3 1.5 1.0 0.2 3.3 1.2 0.0 1.5 4.2 2.0 2.1 0.9 3.0 1.1 1.5 0.7 1.0 1.5 0.9 0.7 1.6 1.2 2.5 1.0 0.5 1.0 2.0 1.0 1.7 2.4 1.9 1.6 1.6 0.7 1.3 3.3 1.1 2.1 2.1 1.3 1.0 0.4 1.2 0.2 0.4 0.3 0.4 0.2 1.1 0.4 0.5 5.3 1.3 2.9 0.8 0.3 0.0 1.7 3.3 13.2 5.9 1.7 3.4 4.5 1.9 12.5 0.4 FAIM2 "KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2" ENSG00000135472 "Fas apoptotic inhibitory molecule 2" Q9BWQ8 12 49866896-49904217 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 138.5" "Cell line enhanced" "Detected in some" "HHSteC: 9.2;SH-SY5Y: 4.9;U-87 MG: 28.6" "Cancer enriched" "Detected in many" 8 "glioma: 21.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 1.7;T-reg: 6.2" "Lineage enriched" "Detected in single" 9 "T-cells: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018790, HPA048800" Enhanced Approved "Intermediate filaments" "Intermediate filaments" "HPA018790: AB_1852822, HPA048800: AB_2680526" "unprognostic (1.74e-1)" "unprognostic (5.98e-4)" "unprognostic (2.22e-1)" "unprognostic (9.75e-3)" "unprognostic (3.36e-2)" "unprognostic (2.61e-4)" "unprognostic (2.62e-1)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (1.75e-2)" "unprognostic (5.66e-2)" "unprognostic (1.30e-2)" "unprognostic (3.28e-6)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.47e-1)" "unprognostic (6.78e-4)" 3.9 27.2 35.6 4.1 57.5 1.4 2.5 42.4 138.5 3.2 4.7 29.1 0.2 2.7 4.2 6.4 3.9 5.8 7.5 7.4 38.8 51.0 2.0 1.5 2.5 3.5 35.9 33.7 2.6 2.8 14.7 7.8 1.5 65.6 8.8 3.5 3.9 3.0 7.1 2.0 1.8 4.0 8.7 36.9 2.5 2.6 12.1 20.5 0.0 1.7 0.0 3.1 4.7 2.0 0.0 0.0 0.0 0.4 0.6 6.2 0.2 0.0 0.3 0.4 0.5 2.0 1.3 0.1 0.5 2.6 0.5 0.3 0.3 0.0 0.0 0.1 3.6 0.2 1.2 0.0 0.3 0.0 0.0 2.0 0.0 0.0 9.2 0.1 0.0 0.8 0.2 2.0 0.0 0.0 1.1 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 4.9 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 28.6 0.0 0.2 0.0 0.1 0.0 1.7 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 6.2 0.2 35.6 57.5 42.4 99.5 38.8 51.0 35.9 33.7 65.6 20.5 FAM107A "DRR1, TU3A" ENSG00000168309 "Family with sequence similarity 107 member A" O95990 3 58564117-58627610 "Predicted intracellular proteins" "Cell cycle, Growth regulation, Stress response" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 149.7" "Group enriched" "Detected in some" 7 "ASC diff: 11.4;HUVEC TERT2: 34.8" "Cancer enriched" "Detected in many" 6 "glioma: 110.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055888 Enhanced Supported "Nuclear speckles" "Nuclear speckles" "HPA055888: " "unprognostic (1.20e-2)" "unprognostic (1.19e-3)" "unprognostic (1.47e-2)" "prognostic unfavourable (3.56e-4)" "unprognostic (3.11e-1)" "unprognostic (7.80e-3)" "prognostic favourable (3.38e-4)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (5.73e-2)" "unprognostic (7.82e-3)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (1.33e-2)" "unprognostic (2.82e-1)" "unprognostic (1.92e-1)" "unprognostic (7.95e-3)" 22.4 4.6 119.4 4.7 86.5 1.3 8.4 32.4 149.7 17.0 7.6 68.6 1.7 3.6 9.4 25.1 13.9 39.6 8.4 15.8 91.5 52.0 12.4 3.5 18.1 2.4 66.6 44.3 4.3 11.1 4.1 12.0 13.8 33.5 16.3 8.4 10.7 17.5 19.4 7.5 3.5 5.8 19.8 77.5 12.0 5.8 2.5 87.2 1.2 9.9 1.4 4.8 6.5 10.2 0.3 0.3 1.3 0.9 0.7 0.6 0.1 0.0 0.0 0.5 0.0 11.4 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 34.8 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 1.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 1.3 0.4 0.5 0.3 0.4 0.6 0.2 0.3 0.2 0.2 0.3 0.2 0.3 0.6 0.7 0.9 0.3 0.3 0.1 119.4 86.5 32.4 80.7 91.5 52.0 66.6 44.3 33.5 87.2 FAM124A FLJ30707 ENSG00000150510 "Family with sequence similarity 124 member A" Q86V42 13 51222334-51284241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.3" "Group enriched" "Detected in some" 4 "HAP1: 13.0;HUVEC TERT2: 7.7;NTERA-2: 25.5;SH-SY5Y: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048182 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA048182: " "unprognostic (3.94e-3)" "unprognostic (8.76e-2)" "unprognostic (8.05e-2)" "unprognostic (1.05e-2)" "unprognostic (3.34e-1)" "unprognostic (8.37e-2)" "unprognostic (2.59e-2)" "unprognostic (2.08e-3)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "unprognostic (2.43e-2)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (7.38e-3)" "unprognostic (4.51e-2)" "unprognostic (4.54e-3)" "unprognostic (1.05e-2)" 5.3 3.5 7.7 4.7 19.6 0.7 2.6 2.6 15.0 3.3 7.2 40.3 0.3 1.4 3.8 8.4 2.4 3.6 4.3 7.1 13.5 7.4 6.7 1.5 3.3 1.5 29.1 7.7 1.3 2.7 1.2 1.5 6.2 18.8 6.5 2.6 3.8 12.4 8.1 1.8 1.9 2.1 8.9 25.3 13.2 4.1 2.3 26.7 0.3 2.8 0.6 1.1 4.1 1.8 0.8 1.0 2.7 0.9 1.2 0.8 0.3 0.0 1.2 0.9 0.8 0.2 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.4 0.0 0.0 0.1 13.0 0.1 0.1 0.0 1.9 0.0 0.3 0.0 1.0 0.6 0.8 0.3 0.1 0.4 0.0 7.7 0.1 0.0 0.0 0.2 3.1 0.2 25.5 2.0 0.7 0.0 1.8 0.0 0.1 1.8 9.8 0.4 1.6 1.5 0.2 0.7 0.1 0.0 0.9 0.6 0.9 0.2 0.0 0.0 1.2 2.2 1.0 2.7 0.8 0.8 0.8 0.6 0.8 0.6 0.5 0.6 0.4 0.8 0.7 0.7 2.4 1.2 0.9 1.0 0.6 0.3 7.7 19.6 2.6 11.8 13.5 7.4 29.1 7.7 18.8 26.7 FAM131A "C3orf40, MGC21688" ENSG00000175182 "Family with sequence similarity 131 member A" Q6UXB0 3 184335926-184348421 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 31.7;basal ganglia: 23.9;cerebral cortex: 59.8;hippocampal formation: 86.5" HPA042800 Uncertain Approved Nucleoli "Secreted - unknown location" Nucleoli "HPA042800: AB_10797023" "unprognostic (1.02e-2)" "unprognostic (1.44e-1)" "unprognostic (2.41e-3)" "prognostic unfavourable (2.22e-4)" "unprognostic (2.88e-1)" "unprognostic (4.84e-2)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (7.54e-2)" "unprognostic (7.02e-2)" "unprognostic (6.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (1.28e-2)" 8.1 14.9 18.8 4.6 26.4 2.5 5.0 21.9 54.7 5.4 6.4 8.0 4.8 6.3 7.5 4.9 7.5 7.7 8.4 11.9 28.1 13.0 4.1 3.0 6.0 3.4 9.1 25.9 8.8 11.3 9.2 16.4 5.0 7.8 6.7 3.5 3.3 7.1 11.7 9.3 10.5 5.8 8.7 5.9 5.3 5.5 7.0 7.0 0.8 3.5 3.9 2.7 5.5 4.1 2.1 5.5 11.1 6.5 1.6 2.2 2.5 8.1 3.4 5.4 9.5 7.4 6.1 5.1 3.6 8.3 5.8 4.5 2.6 2.9 1.2 15.2 3.5 7.6 0.0 6.6 3.7 8.7 9.1 0.0 5.1 5.5 7.5 0.1 6.4 4.5 1.1 4.9 11.4 11.6 1.8 1.2 2.1 6.2 3.1 0.2 9.3 6.8 5.7 2.2 7.8 5.8 0.2 16.6 17.3 2.3 6.4 8.5 18.8 2.1 11.7 7.1 5.6 5.7 11.4 13.7 8.3 0.8 22.9 1.2 5.0 2.0 4.8 6.0 1.5 6.5 1.6 2.0 1.2 1.6 5.5 2.1 1.2 1.5 11.1 1.6 3.4 2.3 2.2 2.5 18.8 26.4 21.9 54.7 28.1 13.0 9.1 25.9 7.8 7.0 FAM131B KIAA0773 ENSG00000159784 "Family with sequence similarity 131 member B" Q86XD5 7 143353400-143362770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.1" "Cell line enhanced" "Detected in some" "CACO-2: 10.1;NTERA-2: 16.5;PC-3: 15.9;SCLC-21H: 16.2" "Cancer enriched" "Detected in many" 11 "glioma: 14.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021371, HPA029992" Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021371: AB_1852341, HPA029992: " "unprognostic (1.70e-1)" "unprognostic (7.26e-2)" "unprognostic (1.29e-1)" "unprognostic (5.61e-2)" "unprognostic (5.97e-2)" "unprognostic (2.54e-2)" "unprognostic (9.99e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (7.99e-5)" "unprognostic (1.31e-2)" "unprognostic (1.66e-1)" "unprognostic (1.02e-2)" "unprognostic (3.53e-2)" 1.5 2.1 10.0 2.0 12.4 0.9 1.2 37.2 47.1 2.7 2.0 15.1 0.0 1.7 4.4 1.0 1.7 1.6 1.4 1.1 9.1 6.8 1.1 0.9 1.5 1.3 14.6 12.3 1.0 0.9 6.4 0.4 0.9 13.8 1.0 2.2 0.0 0.9 1.0 7.7 0.8 2.1 5.6 18.6 1.1 1.4 1.2 11.3 0.0 0.9 0.0 1.1 1.2 0.5 0.0 0.2 0.0 0.5 0.1 2.1 0.2 0.0 0.1 4.9 0.0 4.0 5.1 0.0 0.2 1.2 0.8 0.2 10.1 0.0 0.0 0.0 0.3 0.2 2.0 0.4 0.7 2.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 5.6 0.0 0.0 0.0 0.9 0.0 0.0 0.7 0.0 0.0 0.3 16.5 15.9 0.0 0.0 0.0 0.0 0.0 16.2 0.5 0.2 1.1 0.0 0.0 0.0 0.7 0.3 1.6 0.1 0.0 0.0 0.0 0.0 0.1 3.2 0.1 0.0 0.3 0.0 2.1 0.5 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.2 0.0 0.0 0.2 10.0 12.4 37.2 25.0 9.1 6.8 14.6 12.3 13.8 11.3 FAM131C "C1orf117, FLJ36766" ENSG00000185519 "Family with sequence similarity 131 member C" Q96AQ9 1 16057769-16073632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.1" "Cell line enhanced" "Detected in some" "A549: 10.7;HEK 293: 6.9;PC-3: 7.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031046 Uncertain Approved "Nucleoli,Intermediate filaments,Cytosol" "Nucleoli, Intermediate filaments, Cytosol" "HPA031046: " "unprognostic (4.69e-3)" "unprognostic (4.98e-2)" "unprognostic (7.26e-2)" "unprognostic (2.46e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.63e-2)" "unprognostic (4.67e-4)" "unprognostic (2.82e-1)" "unprognostic (1.93e-2)" "unprognostic (1.75e-1)" "unprognostic (1.68e-1)" "prognostic favourable (9.33e-6)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.44e-1)" 0.7 7.8 5.6 0.6 4.0 0.5 1.1 41.1 9.1 1.1 1.0 7.7 0.0 0.7 1.0 1.4 1.2 1.1 1.4 5.2 5.0 6.5 10.4 2.2 0.6 0.5 10.7 3.8 1.2 7.1 2.0 5.6 0.7 8.7 0.8 0.6 0.8 6.3 1.6 0.6 3.2 0.8 0.9 17.7 0.6 1.6 1.3 4.9 0.0 1.7 0.0 1.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.2 10.7 0.4 0.6 0.0 0.0 0.0 1.0 0.9 1.2 2.7 0.2 2.3 0.0 0.4 0.5 1.2 1.4 0.3 0.3 0.0 6.9 0.0 2.4 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.9 0.7 0.0 0.0 0.1 2.2 0.0 0.0 0.4 7.9 0.0 0.0 4.5 0.8 0.0 1.5 3.1 0.4 1.3 0.3 0.3 0.0 1.7 0.2 3.8 0.0 0.0 1.7 0.1 0.0 3.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 4.0 41.1 7.1 5.0 6.5 10.7 3.8 8.7 4.9 FAM133A "CT115, FLJ37659, RP1-32F7.2" ENSG00000179083 "Family with sequence similarity 133 member A" Q8N9E0 X 93674013-93712274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.8;pituitary gland: 8.2;testis: 16.1" "Cell line enhanced" "Detected in some" "Karpas-707: 21.8;U-2197: 11.3;U-266/70: 17.0;U-266/84: 37.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Uncertain Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA066175: , HPA069513: " "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-3)" "unprognostic (4.45e-1)" "unprognostic (4.05e-2)" "unprognostic (3.86e-3)" "unprognostic (4.22e-2)" "unprognostic (8.76e-2)" "unprognostic (1.09e-2)" "unprognostic (7.42e-2)" "unprognostic (1.39e-2)" "unprognostic (7.12e-4)" "unprognostic (1.67e-3)" "unprognostic (2.13e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-3)" 0.5 3.0 4.7 0.4 14.8 0.3 0.8 2.3 7.7 1.7 0.5 0.5 0.0 0.4 1.0 0.8 0.4 1.1 0.7 2.2 2.5 4.5 0.4 0.4 0.5 0.4 2.3 4.4 1.4 0.4 0.4 8.2 0.4 3.7 0.4 0.5 0.2 0.4 0.5 0.3 0.6 0.5 0.8 4.5 0.5 0.4 16.1 2.6 0.0 0.9 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 21.8 0.0 0.0 0.0 0.0 0.5 5.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.4 0.5 11.3 0.4 17.0 37.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 14.8 2.3 7.3 2.5 4.5 2.3 4.4 3.7 2.6 FAM135B C8ORFK32 ENSG00000147724 "Family with sequence similarity 135 member B" Q49AJ0 8 138130023-138496822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.1;brain: 14.3;testis: 10.3" "Cell line enriched" "Detected in some" 11 "RH-30: 13.9" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023911, HPA023950, HPA024815" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376" "unprognostic (3.78e-1)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (6.64e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (8.26e-2)" "unprognostic (8.36e-3)" "unprognostic (4.54e-2)" "unprognostic (6.85e-4)" "unprognostic (9.92e-3)" "unprognostic (9.82e-3)" "unprognostic (4.47e-1)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (1.30e-1)" 0.6 8.1 12.1 0.9 6.8 0.6 0.7 13.9 14.3 0.7 2.7 1.3 0.0 1.4 0.6 0.9 0.7 0.7 0.7 0.8 9.3 4.5 1.4 0.8 0.7 0.6 4.6 5.6 0.6 1.9 0.6 3.6 0.6 5.2 1.3 2.3 0.7 0.7 1.4 0.6 0.6 1.4 0.8 2.5 0.6 2.5 10.3 3.5 0.0 0.6 0.0 0.6 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 13.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 6.8 13.9 12.3 9.3 4.5 4.6 5.6 5.2 3.5 FAM153A NY-REN-7 ENSG00000170074 "Family with sequence similarity 153 member A" Q9UHL3 5 177707981-177783398 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.6;lymphoid tissue: 8.9;testis: 15.2" "Cell line enhanced" "Detected in some" "A549: 2.5;Daudi: 1.0;K-562: 1.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 5.1;naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 13 "T-cells: 5.1" "HPA042585, HPA044022, HPA046691, HPA052337, HPA055498" Uncertain "HPA042585: , HPA044022: , HPA046691: , HPA052337: , HPA055498: " "unprognostic (5.92e-5)" "unprognostic (1.41e-1)" "unprognostic (5.94e-2)" "unprognostic (4.20e-3)" "unprognostic (1.58e-2)" "unprognostic (5.55e-3)" "unprognostic (1.70e-2)" "unprognostic (3.41e-2)" "unprognostic (1.44e-1)" "unprognostic (1.77e-2)" "unprognostic (4.75e-2)" "unprognostic (4.33e-2)" "unprognostic (1.30e-1)" "unprognostic (5.33e-3)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (2.11e-1)" 0.5 0.3 1.3 0.5 3.5 1.1 0.2 10.6 4.3 1.3 0.2 0.6 0.4 0.4 0.4 1.2 0.5 0.3 2.0 1.5 0.3 0.3 0.5 1.2 0.0 5.3 0.5 0.3 5.2 0.2 3.9 0.3 0.3 0.5 0.5 1.5 0.5 0.2 0.0 8.9 0.3 15.2 1.3 1.4 0.2 0.6 0.3 0.1 0.0 0.0 0.0 5.1 0.2 0.0 2.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.3 5.1 2.2 0.0 0.0 0.0 0.1 0.0 0.2 FAM153B ENSG00000182230 "Family with sequence similarity 153 member B" P0C7A2 5 176060689-176116015 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.2;ovary: 15.3;testis: 14.7" "Cell line enriched" "Detected in some" 4 "U-2 OS: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.1" "Low lineage specificity" "Detected in many" "HPA042585, HPA044022, HPA046691, HPA052337, HPA055498" Uncertain "HPA042585: , HPA044022: , HPA046691: , HPA052337: , HPA055498: " "unprognostic (1.08e-2)" "unprognostic (4.15e-2)" "unprognostic (1.92e-1)" "unprognostic (2.66e-2)" "unprognostic (2.45e-1)" "unprognostic (1.09e-3)" "unprognostic (1.66e-2)" "unprognostic (3.62e-3)" "unprognostic (3.59e-1)" "unprognostic (4.47e-2)" "unprognostic (3.19e-1)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (5.66e-2)" "unprognostic (2.62e-2)" "unprognostic (3.06e-1)" 2.1 2.1 8.1 1.7 5.6 1.4 0.4 16.2 11.1 1.5 0.4 0.4 0.4 0.3 0.7 2.8 0.4 4.5 2.6 1.5 7.9 2.6 0.6 0.4 1.3 3.5 0.4 2.6 15.3 1.2 0.3 7.1 0.4 1.4 2.7 0.6 0.6 0.6 0.9 0.5 0.7 0.6 0.4 1.0 8.5 0.5 14.7 1.8 0.4 1.2 0.4 1.9 0.4 0.4 0.5 2.6 0.7 0.3 0.3 3.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.3 0.1 0.3 0.0 0.5 0.5 0.4 0.4 0.0 0.4 3.1 3.0 0.5 0.3 0.1 2.6 0.0 0.3 8.1 5.6 16.2 11.1 7.9 2.6 0.4 2.6 1.4 1.8 FAM153C NY-REN-7-like ENSG00000204677 "Family with sequence similarity 153 member C" Q494X1 5 178006405-178055559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.5;pituitary gland: 11.8;testis: 21.9" "Cell line enhanced" "Detected in some" "Daudi: 2.4;Karpas-707: 3.0;MCF7: 2.7;U-2 OS: 3.9" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042585, HPA046691, HPA052337" Uncertain "HPA042585: , HPA046691: , HPA052337: " "unprognostic (5.81e-2)" "unprognostic (3.95e-1)" "unprognostic (1.38e-1)" "unprognostic (8.15e-2)" "unprognostic (2.14e-3)" "unprognostic (5.54e-2)" "unprognostic (1.99e-2)" "unprognostic (3.55e-2)" "unprognostic (2.06e-2)" "unprognostic (1.07e-1)" "unprognostic (3.86e-3)" "unprognostic (3.23e-1)" "unprognostic (6.05e-2)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" 0.9 1.1 1.2 0.5 3.9 0.7 0.0 22.5 5.1 0.0 0.0 0.1 0.3 2.0 0.5 0.4 0.1 0.0 2.3 0.7 0.0 0.1 1.0 1.2 0.0 2.0 3.6 0.0 11.8 0.0 2.8 0.0 0.6 1.1 0.1 2.1 0.3 0.0 0.0 1.4 0.0 21.9 1.9 0.5 0.0 0.1 1.1 3.0 0.7 0.0 1.8 3.2 0.7 0.0 1.0 0.0 0.0 0.1 0.0 0.4 0.0 0.9 0.3 0.0 0.0 0.4 2.4 0.4 0.0 0.3 0.5 0.0 0.0 0.6 1.4 0.0 0.3 0.0 1.0 0.0 0.5 0.0 0.0 0.1 1.0 0.2 0.4 3.0 0.3 2.7 0.3 0.0 0.3 0.0 1.2 2.1 0.5 0.0 0.7 1.9 0.0 0.2 0.3 0.0 0.4 2.3 0.0 0.0 3.9 0.3 0.0 1.7 0.0 1.4 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.1 0.9 0.3 0.1 0.0 1.1 3.2 1.9 0.0 1.8 0.0 3.0 2.2 0.7 FAM155A ENSG00000204442 "Family with sequence similarity 155 member A" B1AL88 13 107163510-107866735 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0;pituitary gland: 10.3" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 11.6;SCLC-21H: 7.1;SH-SY5Y: 16.1;U-138 MG: 5.0;U-87 MG: 10.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039453, HPA058768" Enhanced Approved Nucleoplasm,Vesicles,Centrosome "Nucleoplasm, Vesicles" Centrosome "HPA039453: AB_10795290, HPA058768: " "unprognostic (8.40e-2)" "unprognostic (9.98e-3)" "unprognostic (1.48e-1)" "unprognostic (3.38e-3)" "unprognostic (2.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.26e-1)" "unprognostic (9.06e-2)" "unprognostic (1.02e-5)" "unprognostic (5.56e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-2)" "unprognostic (3.69e-3)" 0.9 2.7 10.7 0.6 4.3 0.4 0.6 6.9 19.0 1.5 0.7 0.6 0.0 0.5 1.7 4.0 0.7 0.7 1.3 0.7 8.8 10.8 0.7 0.4 1.2 0.5 6.4 4.9 0.7 0.5 0.4 10.3 1.2 2.0 2.7 0.7 0.7 0.3 3.8 0.4 0.5 0.7 1.2 2.7 0.6 0.7 2.3 0.5 0.0 1.3 0.0 0.9 1.4 0.2 0.2 0.0 0.4 0.1 0.8 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.0 2.4 0.1 2.3 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.2 0.0 11.6 1.9 7.1 16.1 0.0 0.0 0.0 4.1 0.0 0.2 5.0 2.0 1.7 0.2 0.0 0.0 0.0 10.2 0.0 3.4 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.4 0.8 0.0 0.0 0.0 0.0 10.7 4.3 6.9 12.3 8.8 10.8 6.4 4.9 2.0 0.5 FAM163A "C1orf76, MGC16664, NDSP" ENSG00000143340 "Family with sequence similarity 163 member A" Q96GL9 1 179743163-179816198 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 19.2;lymphoid tissue: 25.5;pituitary gland: 24.2" "Cell line enriched" "Detected in some" 36 "SH-SY5Y: 50.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 9 "pons and medulla: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (8.74e-3)" "unprognostic (3.42e-2)" "unprognostic (1.32e-2)" "unprognostic (3.24e-1)" "unprognostic (2.62e-1)" "unprognostic (1.66e-1)" "unprognostic (5.67e-6)" "unprognostic (5.56e-2)" "unprognostic (1.52e-1)" "unprognostic (2.40e-2)" "unprognostic (3.81e-3)" "unprognostic (9.14e-2)" "unprognostic (7.75e-5)" "unprognostic (1.67e-2)" "unprognostic (2.83e-1)" "unprognostic (1.60e-1)" "unprognostic (4.98e-2)" 0.2 10.9 0.7 2.1 1.5 0.0 0.0 0.4 2.1 0.0 1.3 0.7 0.0 1.9 0.1 1.7 0.0 0.6 5.5 0.3 0.4 0.8 0.1 0.4 0.0 1.0 1.2 1.0 0.4 0.6 0.0 24.2 0.4 19.2 0.4 0.9 0.2 0.0 0.1 0.1 0.1 1.3 0.6 0.2 0.4 1.7 9.0 0.0 25.5 1.5 0.0 1.2 0.1 0.1 0.0 0.1 0.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 50.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.7 1.5 0.4 2.1 0.4 0.8 1.2 1.0 19.2 0.0 FAM163B C9orf166 ENSG00000196990 "Family with sequence similarity 163 member B" P0C2L3 9 133578415-133586197 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 41.7" "Cell line enriched" "Detected in some" 21 "SH-SY5Y: 39.0" "Cancer enriched" "Detected in some" 6 "glioma: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067336 Supported Approved "Nuclear bodies,Plasma membrane,Cytosol" "Nuclear bodies, Plasma membrane, Cytosol" "HPA067336: " "unprognostic (2.94e-2)" "unprognostic (6.87e-3)" "unprognostic (2.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.23e-2)" "unprognostic (9.05e-2)" "unprognostic (1.02e-2)" "unprognostic (3.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (5.75e-4)" "unprognostic (1.07e-1)" "unprognostic (9.54e-2)" "unprognostic (1.65e-1)" "unprognostic (4.73e-4)" 0.1 8.2 10.0 0.0 2.7 0.0 0.0 3.2 41.7 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.4 1.2 6.1 3.9 0.1 2.7 0.0 1.3 3.3 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.5 0.1 0.0 0.0 0.0 1.8 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM167A C8orf13 ENSG00000154319 "Family with sequence similarity 167 member A" Q96KS9 8 11421463-11474715 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.0;thyroid gland: 51.1" "Cell line enhanced" "Detected in many" "Daudi: 24.4;RPMI-8226: 25.8;SH-SY5Y: 19.6;U-698: 19.5;U-87 MG: 16.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023915, HPA030426" Approved Approved Mitochondria Mitochondria "HPA023915: AB_1845768, HPA030426: AB_10601318" "unprognostic (8.51e-3)" "unprognostic (2.43e-1)" "unprognostic (1.25e-3)" "prognostic unfavourable (5.96e-4)" "unprognostic (3.08e-2)" "unprognostic (4.62e-3)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (4.06e-2)" "unprognostic (7.17e-2)" "unprognostic (1.77e-2)" "unprognostic (7.13e-2)" "unprognostic (1.56e-1)" "unprognostic (4.30e-2)" "unprognostic (2.21e-2)" 0.8 1.6 13.8 1.8 11.2 1.3 2.0 7.1 20.0 1.1 1.4 12.6 0.0 1.1 0.9 1.3 1.4 2.0 1.8 0.9 13.8 7.6 6.6 0.8 10.5 2.8 8.6 11.8 0.8 2.8 0.8 12.3 2.5 12.2 2.1 1.4 0.5 3.3 5.7 0.8 11.8 1.3 0.8 7.0 1.9 2.7 3.2 7.6 0.8 51.1 0.3 3.5 1.3 1.0 4.0 1.3 0.1 1.8 0.9 0.1 0.1 2.0 1.3 2.7 0.2 0.2 1.1 0.0 7.3 7.0 4.4 1.9 0.0 0.6 24.4 0.4 7.8 0.7 0.0 1.7 5.3 10.5 0.3 0.0 0.0 0.0 9.3 0.0 0.0 1.3 1.1 2.3 14.4 0.0 0.1 0.9 2.6 0.7 0.0 0.0 0.7 0.0 0.1 0.0 25.8 2.2 0.2 11.6 19.6 0.3 2.1 0.9 0.8 0.0 12.4 0.4 0.7 11.3 0.1 7.8 5.6 19.5 16.1 0.0 0.7 0.1 0.2 0.0 0.0 1.8 0.1 4.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.9 1.7 1.3 0.0 0.1 13.8 11.2 7.1 12.5 13.8 7.6 8.6 11.8 12.2 7.6 FAM168A "KIAA0280, TCRP1" ENSG00000054965 "Family with sequence similarity 168 member A" Q92567 11 73400487-73598189 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037580 Enhanced Approved Nucleoplasm Nucleoplasm "HPA037580: AB_10672906" "unprognostic (2.65e-1)" "unprognostic (2.10e-1)" "unprognostic (1.15e-2)" "prognostic unfavourable (5.51e-4)" "unprognostic (4.60e-2)" "unprognostic (3.24e-2)" "unprognostic (3.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.64e-1)" "unprognostic (2.18e-2)" "unprognostic (3.07e-1)" "unprognostic (1.58e-1)" "prognostic favourable (6.41e-5)" "unprognostic (2.10e-1)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "prognostic unfavourable (9.70e-4)" 12.4 10.3 32.0 9.7 28.5 9.9 12.3 29.1 54.7 15.3 10.1 28.2 7.9 7.9 14.6 16.3 9.3 14.0 13.6 11.8 30.3 22.5 11.8 7.9 9.9 7.8 30.1 29.2 16.9 10.3 34.0 9.2 9.5 34.3 12.7 9.4 9.6 11.3 16.2 16.1 8.0 9.8 17.4 35.3 8.5 8.2 6.4 22.4 5.5 14.5 4.3 7.6 9.9 8.5 1.1 2.6 7.5 4.1 0.9 1.5 0.6 8.1 9.1 19.7 11.3 14.1 16.3 3.1 11.8 13.8 13.8 13.0 9.7 10.3 8.8 10.8 21.7 7.1 12.3 12.3 16.3 6.8 8.3 10.2 9.5 4.9 5.5 5.6 19.1 15.8 7.8 14.5 7.4 8.3 2.6 6.9 12.9 11.5 13.2 4.8 7.0 11.8 18.1 33.0 4.6 7.2 7.1 13.7 20.4 14.0 10.1 21.0 17.0 6.2 10.8 15.5 13.3 19.4 9.4 15.4 10.8 15.7 7.7 6.5 13.8 7.5 2.7 1.5 1.5 4.1 0.8 1.0 0.8 1.3 2.1 1.1 1.1 1.3 6.3 0.9 2.9 2.6 1.2 0.6 32.0 28.5 29.1 42.4 30.3 22.5 30.1 29.2 34.3 22.4 FAM169A "KIAA0888, SLAP75" ENSG00000198780 "Family with sequence similarity 169 member A" Q9Y6X4 5 74777574-74866951 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;epididymis: 23.6" "Cell line enhanced" "Detected in many" "BEWO: 23.1;Hep G2: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041574 Enhanced Supported "Nuclear membrane,Cytosol" "Nuclear membrane, Cytosol" "HPA041574: AB_10794382" "unprognostic (3.39e-1)" "unprognostic (2.25e-2)" "unprognostic (1.75e-4)" "unprognostic (5.87e-2)" "unprognostic (2.28e-2)" "unprognostic (1.46e-3)" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-2)" "unprognostic (2.72e-2)" "unprognostic (8.02e-2)" "unprognostic (3.51e-3)" "unprognostic (4.57e-1)" "unprognostic (4.72e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" 0.7 4.2 9.9 1.4 13.5 1.5 1.1 11.0 21.8 1.7 1.9 5.2 2.9 0.7 3.8 23.6 0.9 3.8 3.0 2.2 9.4 14.2 6.7 3.1 0.8 2.5 9.6 10.3 3.4 2.0 10.7 8.3 1.2 10.4 6.4 3.0 11.3 1.9 7.0 0.8 0.7 1.0 1.0 11.1 2.5 2.1 15.5 4.6 3.7 9.6 0.0 2.5 4.1 1.1 1.4 0.5 0.0 0.0 0.8 4.0 1.2 5.2 4.7 3.3 4.5 0.0 0.0 23.1 0.7 1.7 3.5 3.6 2.1 3.5 0.0 2.4 0.0 3.7 6.9 10.4 3.7 3.9 7.9 1.4 0.8 15.7 0.1 0.0 0.0 0.1 11.0 0.8 5.2 0.0 0.0 0.0 2.1 1.5 4.9 0.0 8.4 2.6 7.2 2.1 0.3 3.3 8.3 2.0 2.7 8.7 3.9 0.6 3.7 1.0 0.0 0.2 3.4 0.0 3.8 12.8 11.9 0.0 0.4 0.0 0.4 0.0 0.0 0.0 2.7 0.0 4.0 0.8 1.6 2.5 0.0 1.4 3.5 3.4 0.0 0.8 0.0 0.5 0.9 1.2 9.9 13.5 11.0 17.1 9.4 14.2 9.6 10.3 10.4 4.6 FAM171A1 "C10orf38, FLJ12884" ENSG00000148468 "Family with sequence similarity 171 member A1" Q5VUB5 10 15211643-15371062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.9" "Cell line enhanced" "Detected in many" "TIME: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.6;MAIT T-cell: 6.8;memory CD4 T-cell: 3.8;memory CD8 T-cell: 3.3;naive CD4 T-cell: 7.4;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 23 "T-cells: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051345 Approved Approved "Nucleoplasm,Plasma membrane" 96000 "Plasma membrane" Nucleoplasm "HPA051345: " "unprognostic (3.60e-2)" "unprognostic (7.15e-2)" "unprognostic (2.21e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (4.11e-2)" "unprognostic (9.84e-2)" "unprognostic (9.19e-2)" "unprognostic (2.28e-1)" "unprognostic (3.97e-2)" "unprognostic (3.09e-2)" "unprognostic (1.87e-1)" "prognostic favourable (2.71e-5)" "unprognostic (3.08e-1)" "unprognostic (1.86e-1)" "prognostic unfavourable (4.90e-6)" "unprognostic (3.28e-2)" 6.9 3.7 22.1 5.5 37.9 0.2 4.6 11.1 31.8 8.8 16.1 25.3 6.5 13.7 9.7 4.8 4.7 11.8 9.3 7.0 24.1 17.5 17.8 6.2 5.3 3.7 25.1 14.3 10.9 13.8 8.9 1.9 2.9 21.5 8.4 12.9 2.5 10.0 9.4 5.1 2.4 8.9 9.0 43.9 8.5 10.3 2.4 21.9 0.6 4.3 1.1 4.6 6.0 6.2 0.0 0.0 0.0 0.0 0.3 7.4 1.3 0.0 6.2 12.9 4.9 5.2 9.9 0.1 7.8 1.5 3.9 3.4 1.1 7.3 0.0 9.4 20.2 0.6 9.1 0.1 4.5 2.5 14.4 18.1 2.0 17.9 5.7 0.0 14.7 7.8 1.9 10.7 1.5 19.7 7.1 0.0 12.5 0.5 3.1 0.0 12.3 3.5 12.2 6.8 1.9 4.9 0.0 8.9 11.4 4.3 0.1 0.0 0.0 0.2 42.0 5.4 22.9 19.6 8.2 2.6 0.7 0.0 12.0 0.0 4.1 0.0 0.0 0.0 2.6 0.0 6.8 0.0 3.8 3.3 0.0 0.0 7.4 3.7 0.0 0.3 0.0 0.0 0.7 1.3 22.1 37.9 11.1 23.1 24.1 17.5 25.1 14.3 21.5 21.9 FAM171A2 MGC34829 ENSG00000161682 "Family with sequence similarity 171 member A2" A8MVW0 17 44353215-44363875 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5" "Cell line enhanced" "Detected in many" "HEK 293: 10.4;REH: 18.1;SCLC-21H: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019770 Uncertain "HPA019770: AB_1848383" "unprognostic (1.28e-2)" "unprognostic (2.07e-2)" "unprognostic (4.14e-3)" "unprognostic (8.47e-2)" "unprognostic (9.98e-2)" "unprognostic (1.92e-1)" "unprognostic (1.62e-4)" "unprognostic (5.76e-2)" "unprognostic (1.98e-2)" "unprognostic (1.01e-1)" "unprognostic (7.01e-3)" "unprognostic (3.00e-1)" "unprognostic (2.43e-3)" "unprognostic (1.06e-1)" "unprognostic (1.38e-1)" "unprognostic (2.36e-2)" "unprognostic (4.76e-2)" 3.1 3.3 10.3 1.2 12.8 1.0 1.0 13.9 26.5 6.4 1.2 1.7 1.1 1.1 4.1 7.9 2.1 5.4 2.6 1.3 8.6 8.8 1.7 1.0 1.4 1.3 3.7 13.2 5.5 1.1 2.3 7.3 1.8 4.6 2.2 0.9 3.1 1.5 3.2 1.1 2.0 1.2 1.6 1.7 1.4 1.2 1.3 2.2 0.0 2.6 0.0 1.2 1.5 1.9 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 1.8 5.5 7.6 0.9 1.1 3.8 2.0 0.3 1.7 2.2 0.2 0.1 2.4 4.8 0.5 0.1 1.9 0.5 0.2 2.0 10.4 0.7 0.1 1.0 0.6 0.1 0.4 1.3 0.2 0.6 0.0 2.6 1.6 0.0 0.6 6.2 5.6 0.9 8.1 3.9 18.1 3.6 1.4 0.3 0.4 13.0 9.7 0.7 0.1 0.8 2.1 1.3 1.7 2.5 4.9 4.2 0.7 0.8 0.2 0.9 0.2 0.9 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.8 13.9 26.5 8.6 8.8 3.7 13.2 4.6 2.2 FAM171B "FLJ34104, KIAA1946" ENSG00000144369 "Family with sequence similarity 171 member B" Q6P995 2 186693971-186765965 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.0" "Cell line enhanced" "Detected in many" "Karpas-707: 24.9;U-138 MG: 17.3" "Cancer enriched" "Detected in many" 5 "glioma: 15.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010639, HPA013434" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA010639: AB_1852447, HPA013434: AB_2262499" "unprognostic (2.52e-1)" "unprognostic (7.75e-3)" "unprognostic (1.27e-1)" "unprognostic (1.04e-2)" "unprognostic (4.03e-2)" "unprognostic (9.43e-2)" "unprognostic (6.78e-3)" "unprognostic (2.68e-1)" "unprognostic (1.88e-2)" "unprognostic (1.52e-1)" "unprognostic (4.24e-3)" "unprognostic (1.47e-1)" "prognostic unfavourable (9.51e-7)" "unprognostic (4.63e-3)" "unprognostic (1.52e-1)" "unprognostic (2.24e-3)" "prognostic unfavourable (5.03e-4)" 3.1 13.1 32.0 2.0 32.6 1.1 3.7 12.7 62.0 6.7 2.1 5.8 0.1 1.6 7.1 2.6 2.4 3.2 4.9 1.9 25.5 13.1 1.8 1.1 2.0 1.6 9.1 23.0 9.7 1.6 11.4 13.4 3.5 9.7 3.2 2.5 1.4 17.8 2.8 1.3 3.8 1.9 4.5 8.4 2.0 2.4 1.6 10.4 0.0 2.7 0.0 1.7 2.9 1.8 0.3 1.3 1.1 1.7 2.4 1.1 0.5 2.3 2.7 4.1 12.8 12.3 9.3 0.1 2.5 4.5 3.1 4.5 7.5 12.3 0.0 0.9 7.2 0.3 5.6 2.4 4.5 0.0 3.2 2.8 1.3 0.0 1.0 0.8 1.0 11.8 1.0 2.4 1.9 6.8 0.0 24.9 5.9 1.6 1.6 0.0 5.4 2.8 0.0 8.0 0.5 4.9 8.8 12.9 7.0 1.3 0.8 3.4 1.0 0.6 4.0 17.3 2.3 0.3 1.6 6.6 6.4 0.0 5.3 0.0 2.4 1.1 0.7 0.3 0.8 1.7 0.7 0.3 1.0 0.9 0.6 0.2 0.6 1.1 0.4 2.4 1.6 1.3 0.1 0.5 32.0 32.6 12.7 30.4 25.5 13.1 9.1 23.0 9.7 10.4 FAM181A C14orf152 ENSG00000140067 "Family with sequence similarity 181 member A" Q8N9Y4 14 93918894-93929608 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.3;testis: 19.2" "Cell line enriched" "Detected in some" 9 "AF22: 9.8" "Group enriched" "Detected in some" 6 "endometrial cancer: 3.1;glioma: 9.7;ovarian cancer: 5.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 31.1" HPA001603 Enhanced "HPA001603: AB_1078326" "unprognostic (8.19e-2)" "unprognostic (6.78e-2)" "unprognostic (1.28e-2)" "unprognostic (1.31e-1)" "unprognostic (2.05e-2)" "unprognostic (1.84e-2)" "unprognostic (6.27e-2)" "unprognostic (4.44e-2)" "unprognostic (5.37e-2)" 0.6 0.6 9.3 0.6 8.3 0.6 0.6 2.1 6.0 0.8 0.6 7.6 0.0 0.6 0.8 0.6 0.7 5.2 0.7 0.7 6.4 6.6 0.6 0.6 1.4 0.6 5.3 6.0 0.6 0.6 0.6 1.5 0.6 6.8 0.6 0.6 0.0 0.7 0.7 3.7 0.6 0.6 0.6 6.4 0.6 0.7 19.2 3.8 0.0 2.6 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 8.3 2.1 5.7 6.4 6.6 5.3 6.0 6.8 3.8 FAM181B "LOC220382, MGC33846" ENSG00000182103 "Family with sequence similarity 181 member B" A6NEQ2 11 82729941-82733864 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 29.6" "Cell line enhanced" "Detected in some" "RT4: 6.6;SH-SY5Y: 3.5;U-2 OS: 3.4" "Cancer enriched" "Detected in many" 19 "glioma: 29.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066861 Approved Approved "Nuclear membrane,Mitochondria" Mitochondria "Nuclear membrane" "HPA066861: " "unprognostic (2.84e-4)" "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "prognostic favourable (8.07e-4)" "unprognostic (6.71e-3)" "unprognostic (3.18e-2)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (1.90e-1)" "unprognostic (5.50e-2)" "unprognostic (6.27e-4)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (1.53e-2)" "unprognostic (2.56e-1)" "unprognostic (7.20e-3)" "unprognostic (7.20e-2)" 1.9 2.9 18.3 1.8 13.3 1.5 1.6 16.9 29.6 2.0 1.7 18.6 0.0 1.9 2.2 1.8 1.5 2.6 1.4 2.0 19.6 11.3 2.0 1.3 1.3 1.4 17.1 13.0 2.7 1.5 1.5 1.1 1.4 17.2 1.9 1.5 0.7 3.2 2.7 1.7 1.7 2.3 1.6 16.9 1.3 1.8 1.7 16.7 0.0 2.1 0.0 1.7 2.2 0.5 0.2 0.0 0.6 0.3 0.3 0.4 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.3 0.1 0.4 0.0 0.1 0.1 0.5 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.1 0.1 0.1 1.2 0.1 0.0 0.0 0.0 0.2 6.6 1.0 3.5 0.0 0.0 0.1 0.1 0.4 0.0 0.1 3.4 0.1 0.1 0.3 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.4 0.0 0.6 0.3 0.3 0.0 0.1 0.0 18.3 13.3 16.9 11.4 19.6 11.3 17.1 13.0 17.2 16.7 FAM182B ENSG00000175170 "Family with sequence similarity 182 member B" Q5T319 20 25763466-25868225 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.6;testis: 9.9" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 17.0" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA050100 Uncertain Approved Nucleoplasm Nucleoplasm "HPA050100: " "unprognostic (8.05e-2)" "unprognostic (1.48e-2)" "unprognostic (1.29e-2)" "unprognostic (3.63e-1)" "unprognostic (2.68e-1)" "unprognostic (1.50e-2)" "unprognostic (1.88e-4)" "unprognostic (1.61e-1)" "unprognostic (3.15e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-2)" "unprognostic (3.30e-1)" "unprognostic (2.47e-9)" "unprognostic (2.36e-1)" "unprognostic (4.40e-2)" "unprognostic (6.54e-2)" "unprognostic (3.18e-1)" 0.4 0.9 2.9 0.2 3.8 0.0 0.8 7.6 5.9 0.6 0.2 0.1 1.2 0.3 0.6 6.4 0.2 0.3 3.0 3.7 0.4 0.0 1.2 0.2 2.0 1.7 0.8 0.5 2.7 4.4 1.7 0.1 0.8 0.5 1.2 5.2 0.7 0.4 1.2 0.8 0.6 9.9 1.4 0.0 0.0 0.4 0.2 0.2 2.1 0.1 0.7 1.2 0.4 2.1 0.9 1.2 1.2 0.6 0.1 0.5 0.3 0.0 0.0 0.4 0.0 3.0 0.2 1.3 1.4 4.0 0.0 0.4 0.0 0.0 0.3 0.0 0.6 0.0 0.3 0.2 1.1 0.8 0.1 0.0 1.1 0.1 0.9 2.7 0.0 0.1 1.4 0.7 0.1 1.6 0.1 0.1 0.6 0.4 0.0 17.0 1.1 0.7 0.2 1.2 0.5 0.6 0.3 0.2 3.6 0.8 0.5 1.7 0.3 0.8 0.1 0.5 1.4 0.0 0.1 1.7 0.6 0.0 0.6 0.1 1.0 0.3 0.2 0.2 0.9 1.2 2.1 0.7 0.0 0.1 0.0 0.4 FAM183A "hCG23177, LOC440585" ENSG00000186973 "Family with sequence similarity 183 member A" A6NL82 1 43145153-43156396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 25.5;fallopian tube: 55.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.6;hTCEpi: 4.9;MCF7: 3.3;NTERA-2: 6.0;SCLC-21H: 5.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 19.3" "Region enhanced" "Detected in many" "pons and medulla: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043382, HPA049120" Approved "HPA043382: , HPA049120: " "unprognostic (6.66e-2)" "unprognostic (2.39e-1)" "unprognostic (9.56e-2)" "unprognostic (1.42e-3)" "unprognostic (6.79e-2)" "unprognostic (3.79e-2)" "unprognostic (1.44e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-2)" "unprognostic (1.27e-1)" "unprognostic (5.04e-3)" "unprognostic (1.04e-1)" "unprognostic (4.30e-2)" "unprognostic (1.27e-2)" "unprognostic (7.88e-2)" "unprognostic (1.18e-3)" "unprognostic (1.73e-2)" 0.1 0.1 3.6 0.1 9.8 0.1 0.8 0.0 0.5 2.6 0.3 6.5 0.0 0.2 1.3 16.5 0.5 55.8 0.2 0.1 4.6 4.7 0.3 0.2 14.5 0.2 0.1 0.2 10.1 0.3 1.0 5.5 0.5 25.5 1.4 0.3 0.0 0.9 0.3 0.1 5.5 0.1 0.3 0.6 0.2 0.2 6.7 1.7 0.0 0.2 0.0 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.5 0.0 0.6 0.6 0.7 1.2 6.6 0.0 0.8 0.5 0.8 0.0 0.4 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.5 0.0 0.1 0.0 0.0 3.3 0.0 0.0 6.0 0.0 0.0 0.0 0.0 2.6 1.2 5.1 0.0 0.0 0.3 0.0 1.5 0.0 1.0 0.0 0.7 0.2 0.1 2.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 9.8 0.0 0.5 4.6 4.7 0.1 0.2 25.5 1.7 FAM184B KIAA1276 ENSG00000047662 "Family with sequence similarity 184 member B" Q9ULE4 4 17629306-17781512 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.1;skeletal muscle: 11.1" "Cell line enhanced" "Detected in some" "SCLC-21H: 6.8;T-47d: 1.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044119, HPA048458" Enhanced "HPA044119: , HPA048458: " "unprognostic (1.20e-2)" "unprognostic (4.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (1.53e-1)" "unprognostic (9.64e-2)" "unprognostic (1.71e-2)" "unprognostic (5.13e-4)" "unprognostic (2.04e-2)" "unprognostic (7.46e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-1)" "unprognostic (2.28e-2)" "unprognostic (1.73e-1)" "unprognostic (1.16e-1)" "unprognostic (2.12e-1)" "unprognostic (1.54e-4)" 1.5 0.6 3.2 0.5 5.0 0.8 0.6 2.0 5.1 0.3 1.1 2.5 0.0 0.3 0.4 0.8 0.4 0.3 0.4 0.3 3.6 2.7 1.2 0.3 0.4 0.5 3.3 1.2 0.5 0.3 0.8 0.4 0.3 3.7 0.5 0.8 0.1 0.9 0.3 11.1 1.1 0.4 0.3 2.0 0.5 0.5 0.6 2.9 0.0 0.4 0.4 0.4 0.3 0.0 0.2 0.0 0.2 0.1 0.0 0.9 0.0 0.0 0.2 0.3 0.8 0.0 0.0 0.2 0.7 0.0 0.2 0.0 0.2 0.1 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.5 0.1 0.2 0.9 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.8 1.3 0.0 0.1 0.2 0.0 0.0 0.1 6.8 0.2 0.0 0.0 0.9 1.7 0.2 0.3 0.0 0.0 0.1 0.3 0.2 0.2 0.1 0.1 0.3 0.6 0.0 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.2 0.3 0.9 0.2 0.0 0.1 0.0 0.0 0.0 3.2 5.0 2.0 3.1 3.6 2.7 3.3 1.2 3.7 2.9 FAM189A1 "KIAA0574, TMEM228" ENSG00000104059 "Family with sequence similarity 189 member A1" O60320 15 29120254-29570723 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.3;parathyroid gland: 6.5" "Cell line enhanced" "Detected in some" "EFO-21: 6.2;HDLM-2: 15.2;REH: 3.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA009410, HPA010637" Uncertain Supported Nucleoplasm Nucleoplasm "HPA009410: AB_1852332, HPA010637: AB_1852333" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (5.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.71e-2)" "unprognostic (4.85e-3)" "unprognostic (2.21e-1)" "unprognostic (1.27e-1)" "unprognostic (3.39e-1)" "unprognostic (7.97e-2)" "unprognostic (5.00e-1)" "unprognostic (6.70e-3)" "unprognostic (2.39e-2)" "unprognostic (9.03e-2)" "unprognostic (2.50e-2)" "unprognostic (3.12e-1)" 0.8 1.5 12.8 0.6 7.9 0.4 0.6 4.2 9.5 0.4 4.0 1.5 0.0 1.0 1.1 0.8 0.6 1.5 0.5 0.7 15.3 4.7 1.7 0.5 1.5 0.5 3.5 3.4 0.4 3.3 6.5 0.0 0.7 4.0 0.8 3.0 0.0 1.1 0.5 0.4 0.8 3.2 1.0 0.7 1.3 0.6 2.3 0.3 0.0 1.9 0.0 1.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.2 15.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.5 0.0 0.0 0.5 0.0 3.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 12.8 7.9 4.2 9.5 15.3 4.7 3.5 3.4 4.0 0.3 FAM196A "C10orf141, FLJ45557, INSYN2" ENSG00000188916 "Family with sequence similarity 196 member A" Q6ZSG2 10 127135426-127196158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Group enriched" "Detected in some" 5 "SCLC-21H: 5.3;U-87 MG: 10.4" "Group enriched" "Detected in some" 13 "breast cancer: 3.4;glioma: 3.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 30 "dendritic cells: 3.0" "Low region specificity" "Detected in many" "HPA035898, HPA035899" Uncertain "HPA035898: AB_10964352, HPA035899: AB_10961723" "unprognostic (4.00e-2)" "unprognostic (9.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.66e-3)" "unprognostic (2.18e-1)" "unprognostic (4.70e-2)" "unprognostic (7.30e-2)" "unprognostic (3.62e-1)" "unprognostic (2.18e-2)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (5.47e-2)" "unprognostic (5.07e-2)" "unprognostic (2.86e-2)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-1)" 0.6 0.4 3.7 1.0 11.7 0.4 3.0 2.3 8.3 0.3 1.7 0.9 0.0 0.8 0.4 1.7 0.6 0.4 1.0 1.0 2.8 5.0 1.2 0.3 0.5 0.5 4.4 3.0 3.4 0.9 0.3 0.8 0.4 4.7 3.6 0.7 0.3 3.4 0.7 0.4 0.8 1.4 0.8 1.9 1.5 0.9 3.0 2.9 2.2 0.5 0.0 0.7 1.6 0.3 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.2 0.8 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.2 0.0 5.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.5 0.0 0.1 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.7 11.7 2.3 3.6 2.8 5.0 4.4 3.0 4.7 2.9 FAM196B C5orf57 ENSG00000204767 "Family with sequence similarity 196 member B" A6NMK8 5 169864264-169980740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5;breast: 14.4;salivary gland: 10.6" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 19.8;HUVEC TERT2: 12.6;U-138 MG: 32.9;U-251 MG: 11.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047227 Uncertain "HPA047227: " "unprognostic (5.30e-2)" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.16e-1)" "unprognostic (2.32e-1)" "unprognostic (1.92e-1)" "unprognostic (1.26e-3)" "unprognostic (2.31e-2)" "unprognostic (1.98e-2)" "unprognostic (3.31e-5)" "unprognostic (5.16e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-2)" "unprognostic (2.37e-1)" "unprognostic (6.38e-2)" "unprognostic (3.73e-3)" 1.4 1.5 3.8 1.3 8.8 1.1 14.4 2.3 10.4 0.6 0.6 13.5 0.0 0.5 0.8 0.5 0.6 0.6 1.1 0.8 4.9 3.6 1.4 0.7 0.7 0.6 6.7 3.5 4.6 0.6 0.5 3.3 0.6 5.2 2.1 0.6 6.7 10.6 0.6 0.5 1.0 0.5 1.1 7.9 3.0 0.5 0.7 5.9 0.0 2.3 0.0 0.5 0.8 0.4 0.3 0.1 0.9 0.4 0.0 0.4 0.0 0.1 0.2 0.7 0.0 5.2 1.9 0.0 3.5 1.8 3.0 2.3 0.0 0.0 0.0 7.9 19.8 0.0 0.1 6.1 5.8 0.0 0.0 0.0 1.3 0.0 1.0 0.0 0.0 0.7 0.0 4.1 3.7 12.6 0.0 0.0 7.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 32.9 0.3 0.9 11.1 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.4 0.9 0.0 0.2 0.0 0.0 0.0 3.8 8.8 2.3 8.3 4.9 3.6 6.7 3.5 5.2 5.9 FAM19A1 "TAFA-1, TAFA1" ENSG00000183662 "Family with sequence similarity 19 member A1, C-C motif chemokine like" Q7Z5A9 3 68004216-68545625 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 13.9;brain: 28.0" "Cell line enriched" "Detected in single" 9 "REH: 5.9" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 13.9;MAIT T-cell: 10.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 7.5;naive CD4 T-cell: 8.2;naive CD8 T-cell: 11.5;T-reg: 5.0" "Lineage enriched" "Detected in many" 6 "T-cells: 13.9" "Low region specificity" "Detected in many" HPA013407 Approved "Secreted in brain" "HPA013407: AB_1848386" "unprognostic (5.19e-2)" "unprognostic (4.64e-3)" "unprognostic (1.97e-2)" "unprognostic (1.86e-2)" "unprognostic (7.95e-2)" "unprognostic (6.40e-2)" "unprognostic (3.42e-3)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (2.41e-1)" "unprognostic (1.41e-2)" "unprognostic (7.87e-2)" "unprognostic (1.35e-3)" "unprognostic (2.11e-1)" "unprognostic (1.99e-1)" "unprognostic (3.50e-4)" "unprognostic (5.77e-2)" 0.7 2.0 10.6 0.8 9.0 0.4 0.5 0.4 28.0 0.5 0.7 0.1 0.3 2.3 0.8 2.0 0.5 0.5 1.4 0.5 18.4 4.8 0.8 0.8 0.5 1.2 4.4 10.4 0.4 0.4 0.4 0.6 0.4 25.2 2.6 0.6 0.0 0.6 6.2 0.6 0.4 0.5 0.9 1.3 0.9 0.5 0.7 0.2 0.0 0.6 0.0 0.7 0.7 0.3 0.0 0.0 0.2 0.1 2.1 13.9 2.6 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.9 0.0 10.7 0.0 11.5 7.5 0.0 0.0 8.2 11.5 0.2 2.1 0.0 0.0 5.0 2.6 10.6 9.0 0.4 24.4 18.4 4.8 4.4 10.4 25.2 0.2 FAM19A2 "TAFA-2, TAFA2" ENSG00000198673 "Family with sequence similarity 19 member A2, C-C motif chemokine like" Q8N3H0 12 61708259-62279150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.7;brain: 25.8" "Cell line enhanced" "Detected in some" "hTCEpi: 9.6;SCLC-21H: 3.7;WM-115: 8.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 17.7;neutrophil: 9.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (3.89e-3)" "unprognostic (9.33e-2)" "unprognostic (1.02e-1)" "unprognostic (1.37e-2)" "unprognostic (2.78e-1)" "unprognostic (4.83e-1)" "unprognostic (6.62e-2)" "unprognostic (4.16e-3)" "unprognostic (4.08e-1)" "unprognostic (1.80e-1)" "unprognostic (3.22e-5)" "unprognostic (1.05e-1)" "unprognostic (2.22e-2)" "unprognostic (3.31e-2)" "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (1.28e-1)" 1.7 1.7 16.7 1.3 10.1 3.8 1.5 1.3 25.8 3.1 1.7 1.1 0.0 1.8 1.9 1.0 0.9 1.3 1.2 0.7 13.1 7.0 0.9 0.8 0.9 1.4 5.8 12.7 4.3 1.8 0.9 5.7 4.9 9.9 2.4 1.5 0.2 1.2 11.1 0.6 1.3 1.3 1.0 2.1 1.8 1.2 5.3 0.0 0.0 1.0 0.0 0.7 1.5 2.5 0.4 0.4 17.7 1.9 0.4 2.8 0.4 0.2 0.0 1.9 0.4 1.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.3 0.8 0.0 0.3 0.3 0.3 0.6 0.4 1.3 2.9 0.0 0.3 1.3 2.2 0.1 9.6 0.0 0.0 0.0 1.8 1.1 0.0 0.0 2.4 0.5 0.8 0.0 0.5 0.0 0.0 0.0 0.0 3.7 0.3 0.8 0.0 0.6 0.4 0.4 0.1 0.4 1.1 0.2 0.5 0.8 0.8 0.5 0.0 0.6 8.0 17.7 1.9 3.8 0.3 0.6 0.1 0.4 0.8 0.4 0.2 0.2 0.7 0.2 9.2 0.4 0.2 0.4 2.8 0.4 16.7 10.1 1.3 25.8 13.1 7.0 5.8 12.7 9.9 0.0 FAM19A3 "TAFA-3, TAFA3" ENSG00000184599 "Family with sequence similarity 19 member A3, C-C motif chemokine like" Q7Z5A8 1 112720419-112727235 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "adrenal gland: 19.6;brain: 5.2;testis: 8.8" "Cell line enhanced" "Detected in some" "A-431: 2.7;BJ hTERT+: 9.3;HEL: 3.6;U-87 MG: 3.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA055927 Approved "Secreted in other tissues" "HPA055927: AB_2682972" "unprognostic (9.96e-2)" "unprognostic (4.30e-1)" "unprognostic (3.36e-2)" "unprognostic (5.63e-4)" "prognostic unfavourable (9.60e-4)" "unprognostic (1.66e-1)" "unprognostic (3.40e-2)" "unprognostic (1.13e-1)" "unprognostic (6.43e-2)" "unprognostic (1.32e-1)" "unprognostic (9.82e-2)" "unprognostic (2.51e-1)" "unprognostic (5.14e-6)" "unprognostic (2.10e-4)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-1)" 0.1 19.6 0.4 0.1 0.0 0.0 0.3 5.2 0.4 0.1 0.0 0.0 0.1 0.9 0.2 0.4 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.4 3.9 0.6 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.0 1.2 0.0 0.0 8.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.2 0.0 0.0 0.6 0.7 0.2 9.3 0.7 0.6 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.5 0.4 1.5 0.3 3.6 0.0 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.2 0.0 0.0 0.4 0.4 0.4 0.1 0.0 0.2 2.3 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.3 0.6 0.0 1.1 0.0 1.3 1.3 0.2 0.5 0.1 0.0 0.0 3.7 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM19A4 TAFA-4 ENSG00000163377 "Family with sequence similarity 19 member A4, C-C motif chemokine like" Q96LR4 3 68731766-68953297 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.0;brain: 10.9" "Cell line enriched" "Detected in some" 5 "NTERA-2: 13.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "thalamus: 14.7" "Low region specificity" "Detected in many" "Secreted in brain" "unprognostic (1.92e-1)" "unprognostic (9.97e-3)" "unprognostic (2.28e-1)" "unprognostic (8.19e-3)" "unprognostic (8.78e-2)" "unprognostic (2.00e-2)" "unprognostic (3.01e-2)" "unprognostic (1.22e-1)" "unprognostic (3.66e-2)" "unprognostic (8.06e-2)" "unprognostic (2.50e-1)" 0.5 26.0 2.3 0.9 7.3 0.5 0.6 0.4 7.5 0.5 0.7 10.8 0.0 0.6 0.5 0.5 1.1 0.6 2.7 0.5 2.9 4.2 0.7 0.5 0.6 0.6 10.9 1.8 1.0 0.5 0.5 1.8 1.8 8.7 2.2 0.6 5.0 0.7 1.1 0.5 0.5 0.5 1.0 10.4 0.6 8.3 2.1 8.2 0.0 0.6 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 7.3 0.4 7.5 2.9 4.2 10.9 1.8 8.7 8.2 FAM19A5 TAFA-5 ENSG00000219438 "Family with sequence similarity 19 member A5, C-C motif chemokine like" Q7Z5A7 22 48489460-48850912 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.2" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 13.5;HEK 293: 9.1;Hep G2: 20.8;NTERA-2: 11.7;U-2 OS: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025629 Approved "Secreted in brain" "CAB025629: " "unprognostic (2.86e-1)" "unprognostic (2.98e-1)" "unprognostic (3.42e-2)" "unprognostic (2.19e-1)" "unprognostic (3.57e-1)" "unprognostic (1.80e-1)" "unprognostic (2.82e-3)" "unprognostic (2.41e-2)" "unprognostic (6.80e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-2)" "unprognostic (1.26e-1)" "unprognostic (9.31e-3)" "unprognostic (2.64e-2)" "unprognostic (2.55e-2)" "unprognostic (1.06e-1)" "unprognostic (5.94e-2)" 1.9 2.5 22.7 1.7 18.7 0.7 2.7 19.1 40.2 12.2 1.8 8.5 0.1 2.0 8.1 6.9 1.1 3.4 3.4 1.4 23.6 22.8 1.9 3.0 2.2 1.2 18.1 12.9 8.3 2.4 0.8 1.9 0.8 8.7 4.0 1.0 0.7 7.3 5.7 1.5 1.9 2.6 1.8 9.9 1.1 3.7 2.5 7.3 1.3 1.1 0.0 1.0 2.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.8 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.5 0.0 0.9 0.0 0.0 0.0 9.1 0.0 0.1 20.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.2 11.7 0.0 0.5 0.0 5.0 0.0 0.0 5.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 16.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 18.7 19.1 21.9 23.6 22.8 18.1 12.9 8.7 7.3 FAM216B "C13orf30, FLJ40919" ENSG00000179813 "Family with sequence similarity 216 member B" Q8N7L0 13 42781550-42791549 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 21.0;epididymis: 18.2;fallopian tube: 51.3;lung: 28.5;ovary: 18.3" "Cell line enriched" "Detected in single" 12 "U-87 MG: 6.3" "Group enriched" "Detected in some" 10 "endometrial cancer: 4.4;lung cancer: 1.4;ovarian cancer: 0.9" "Group enriched" "Detected in many" 5 "basal ganglia: 9.5;pons and medulla: 21.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040118 Uncertain "HPA040118: AB_10674429" "unprognostic (1.03e-2)" "unprognostic (2.24e-1)" "prognostic favourable (9.77e-4)" "unprognostic (4.35e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (2.54e-2)" "unprognostic (5.44e-3)" "unprognostic (1.32e-1)" "unprognostic (2.27e-1)" "unprognostic (8.14e-3)" "unprognostic (1.37e-1)" "unprognostic (1.30e-2)" 0.3 0.2 1.7 0.9 9.5 0.2 0.2 0.1 0.6 3.0 0.3 8.0 0.0 0.3 1.3 18.2 0.2 51.3 0.4 10.0 3.1 3.2 0.2 0.2 28.5 2.2 0.1 0.0 18.3 0.3 0.2 2.0 0.2 21.0 0.2 0.5 0.0 0.7 0.2 0.2 0.2 1.5 0.2 0.5 0.3 0.3 1.0 1.7 0.0 0.2 0.0 3.9 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 9.5 0.1 0.6 3.1 3.2 0.1 0.0 21.0 1.7 FAM219A "bA573M23.5, C9orf25, FLJ39031" ENSG00000164970 "Family with sequence similarity 219 member A" Q8IW50 9 34398184-34458570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.9" "Cell line enhanced" "Detected in all" "HDLM-2: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019338, HPA052909" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA019338: AB_1845819, HPA052909: " "unprognostic (9.96e-3)" "unprognostic (2.16e-1)" "unprognostic (1.50e-2)" "unprognostic (1.23e-2)" "unprognostic (6.81e-2)" "unprognostic (4.07e-2)" "prognostic unfavourable (1.98e-5)" "unprognostic (2.71e-2)" "unprognostic (2.50e-1)" "unprognostic (2.95e-1)" "prognostic favourable (2.46e-4)" "unprognostic (3.46e-3)" "prognostic unfavourable (5.54e-5)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (3.34e-1)" "unprognostic (2.76e-1)" 13.6 10.3 27.8 10.9 27.0 4.9 7.1 26.3 56.9 7.5 6.3 23.3 3.7 7.2 13.2 8.6 6.3 6.5 7.6 17.5 25.4 27.6 6.1 5.0 11.0 7.8 30.8 31.0 10.7 8.4 9.4 10.6 16.3 34.0 9.2 6.6 5.4 7.1 9.7 28.6 12.3 6.7 15.0 25.2 9.8 7.2 6.9 25.6 2.9 7.2 4.0 6.6 6.5 6.4 0.5 0.6 3.8 0.7 0.7 1.5 0.3 12.4 4.8 11.4 6.5 10.7 4.1 11.2 7.6 5.7 6.6 8.4 3.3 2.9 2.7 7.8 7.3 5.2 9.0 4.8 6.6 43.0 5.2 1.1 6.2 3.6 6.0 2.7 6.4 4.3 4.9 9.8 5.5 10.8 2.7 13.8 5.1 2.5 4.2 3.8 7.4 7.2 5.4 1.9 2.4 4.7 2.7 3.6 11.6 6.5 4.8 3.8 2.4 2.7 12.8 7.3 5.7 15.1 10.4 3.6 5.2 2.4 20.9 6.3 12.8 2.3 0.6 3.8 1.5 0.4 0.8 0.5 0.8 0.4 0.5 0.4 0.6 0.8 2.0 0.7 0.7 0.6 1.4 0.3 27.8 27.0 26.3 40.8 25.4 27.6 30.8 31.0 34.0 25.6 FAM222A "C12orf34, FLJ14721" ENSG00000139438 "Family with sequence similarity 222 member A" Q5U5X8 12 109714228-109770507 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.9" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 50.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040181, HPA058774" Uncertain Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites,Mitochondria" "Nucleoplasm, Plasma membrane" "Focal adhesion sites, Mitochondria" "HPA040181: AB_10796448, HPA058774: " "unprognostic (8.59e-3)" "prognostic favourable (1.82e-5)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-2)" "unprognostic (1.03e-1)" "unprognostic (6.66e-2)" "unprognostic (8.17e-2)" "prognostic favourable (4.81e-4)" "unprognostic (1.15e-1)" "unprognostic (4.16e-2)" "prognostic favourable (8.59e-4)" "unprognostic (3.93e-2)" "unprognostic (2.77e-1)" "unprognostic (1.24e-1)" 1.8 16.0 7.3 2.3 17.4 2.0 3.0 15.1 25.5 1.6 3.3 37.9 0.0 10.0 1.5 2.7 2.1 1.4 2.6 4.4 11.7 9.6 7.7 2.7 1.8 1.7 23.2 7.9 7.8 6.9 1.5 13.1 1.3 15.1 2.3 3.0 10.3 7.3 2.1 2.8 4.7 5.1 1.8 27.8 6.3 8.0 17.4 23.0 0.0 1.4 0.0 2.1 1.4 2.4 0.2 0.6 0.9 0.2 0.0 0.2 0.0 0.8 1.3 0.7 1.6 0.4 0.0 0.5 0.2 0.1 0.7 0.1 11.7 0.2 0.1 1.0 0.3 0.5 0.8 0.0 0.2 7.5 1.7 1.4 0.3 2.6 0.1 1.1 1.5 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.1 4.7 0.3 1.5 1.3 2.3 0.9 3.4 0.5 1.5 0.6 8.3 50.2 1.0 1.6 3.3 1.9 1.2 0.1 0.2 1.4 0.6 1.0 1.3 1.6 1.0 0.1 0.8 1.6 0.0 0.2 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 7.3 17.4 15.1 13.7 11.7 9.6 23.2 7.9 15.1 23.0 FAM231C ENSG00000268674 "Family with sequence similarity 231 member C" "P0DMU3, P0DMU4, P0DMU5" Unmapped 35407-35916 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "blood: 1.6;brain: 5.6;parathyroid gland: 3.2;testis: 1.4" "Cell line enhanced" "Detected in single" "U-698: 1.4" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "HPA043267, HPA043292, HPA077864" Uncertain Approved "Intermediate filaments" "Intermediate filaments" "HPA043267: , HPA043292: , HPA077864: " 0.0 0.3 0.1 0.0 0.1 0.1 0.0 5.6 0.3 0.1 0.3 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.1 3.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 FAM234B KIAA1467 ENSG00000084444 "Family with sequence similarity 234 member B" A2RU67 12 13044284-13142521 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "breast cancer: 16.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010803, HPA010850" Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA010803: AB_1079200, HPA010850: " "unprognostic (1.85e-3)" "unprognostic (1.99e-1)" "unprognostic (1.93e-3)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (8.03e-3)" "unprognostic (3.34e-2)" "unprognostic (1.37e-1)" "unprognostic (9.55e-2)" "unprognostic (3.40e-2)" "unprognostic (3.62e-2)" "unprognostic (1.63e-1)" "unprognostic (1.85e-3)" "unprognostic (5.22e-2)" "unprognostic (1.06e-1)" "unprognostic (4.06e-3)" "unprognostic (7.62e-2)" 4.4 3.6 9.6 2.3 17.5 3.5 21.2 21.3 28.5 3.4 1.6 4.4 4.2 2.6 3.6 4.4 2.8 4.0 2.4 1.9 10.8 12.4 7.3 3.0 3.6 2.1 9.1 16.7 3.5 3.4 4.8 5.2 7.1 13.6 8.1 1.9 3.4 3.4 5.0 2.8 15.5 2.5 3.2 5.1 2.9 1.7 6.8 5.0 0.5 10.9 0.1 2.2 3.6 2.8 6.8 4.3 1.9 6.9 2.7 4.5 1.4 3.0 3.1 9.5 6.7 7.5 7.3 7.5 2.0 2.4 4.6 9.2 3.2 4.6 12.5 2.6 2.5 4.7 11.9 2.2 9.8 1.4 6.6 7.4 3.4 2.6 4.0 6.4 4.2 5.6 4.9 6.7 5.1 6.1 1.8 4.5 5.0 10.1 5.3 4.1 12.6 1.7 7.1 12.4 1.4 2.9 7.5 13.3 4.4 4.5 3.0 3.6 3.9 3.6 3.1 3.1 5.3 5.7 2.2 2.5 3.3 8.1 9.9 2.9 3.9 0.3 2.7 1.9 2.6 4.5 3.4 4.6 2.9 2.5 2.3 6.8 4.3 4.5 0.7 2.7 6.9 4.3 2.3 1.4 9.6 17.5 21.3 28.5 10.8 12.4 9.1 16.7 13.6 5.0 FAM237A ENSG00000235118 "Family with sequence similarity 237 member A" A0A1B0GTK4 2 206642412-206649011 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 7 "brain: 3.0;heart muscle: 1.1;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 2.0" "Low region specificity" "Detected in all" "unprognostic (3.02e-1)" 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM241B C10orf35 ENSG00000171224 "Family with sequence similarity 241 member B" Q96D05 10 69630251-69633599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5" "Cell line enhanced" "Detected in many" "EFO-21: 20.5;PC-3: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.2" "Lineage enriched" "Detected in single" 25 "T-cells: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034591 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Centrosome" Cytosol "HPA034591: AB_10670572" "unprognostic (1.12e-1)" "unprognostic (6.37e-2)" "unprognostic (3.13e-2)" "unprognostic (1.17e-1)" "unprognostic (7.17e-3)" "prognostic unfavourable (8.64e-4)" "prognostic unfavourable (1.03e-4)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.63e-1)" "unprognostic (3.37e-2)" "unprognostic (3.12e-2)" "unprognostic (5.23e-2)" "unprognostic (2.52e-1)" "prognostic favourable (9.72e-4)" 1.4 3.3 13.1 2.0 13.5 1.1 5.3 34.5 23.9 1.3 3.0 3.2 0.6 3.0 2.7 13.0 4.0 4.8 2.1 6.9 15.0 17.8 4.7 2.3 4.1 2.7 10.8 14.4 2.0 7.9 5.6 5.3 1.3 8.3 7.8 2.6 5.1 5.6 5.6 1.6 2.4 2.2 4.5 4.6 0.8 4.2 11.4 2.4 0.7 6.0 0.1 2.4 2.6 1.6 0.3 0.0 0.5 0.0 0.2 14.2 2.8 13.3 14.6 1.8 15.0 0.0 0.0 6.5 1.3 0.3 2.4 2.6 10.5 11.1 0.0 20.5 0.3 5.5 7.8 4.5 3.4 13.3 10.7 0.0 3.2 4.0 4.0 0.0 4.8 0.0 4.4 0.1 2.3 0.0 4.9 0.0 0.2 17.9 0.1 0.0 9.0 26.9 0.0 0.0 0.1 5.1 7.6 7.6 10.4 5.5 14.0 8.5 9.6 2.4 0.6 0.4 9.3 0.0 3.9 2.4 6.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 3.4 0.0 8.9 0.1 8.5 5.6 0.0 0.3 14.2 4.9 0.5 0.2 0.0 0.0 5.3 2.8 13.1 13.5 34.5 23.9 15.0 17.8 10.8 14.4 8.3 2.4 FAM43B FLJ44952 ENSG00000183114 "Family with sequence similarity 43 member B" Q6ZT52 1 20552439-20555010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 21.9;brain: 14.9;epididymis: 8.7" "Cell line enhanced" "Detected in some" "AN3-CA: 4.5;BJ hTERT+: 3.3;fHDF/TERT166: 6.5;Hep G2: 4.8;SCLC-21H: 5.9;SiHa: 11.0" "Cancer enhanced" "Detected in some" "glioma: 4.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050813 Approved Approved Cytosol Cytosol "HPA050813: " "unprognostic (1.51e-1)" "unprognostic (5.85e-2)" "unprognostic (2.80e-3)" "unprognostic (1.48e-1)" "unprognostic (5.97e-3)" "unprognostic (1.74e-1)" "unprognostic (8.33e-2)" "unprognostic (5.87e-4)" "unprognostic (1.86e-2)" "unprognostic (7.46e-2)" "unprognostic (8.85e-3)" "unprognostic (2.73e-1)" "unprognostic (1.78e-4)" "unprognostic (1.06e-2)" "unprognostic (6.05e-3)" "unprognostic (6.48e-2)" "unprognostic (2.12e-2)" 3.2 21.9 5.6 1.5 14.9 0.9 1.5 8.8 14.4 1.6 1.3 2.4 0.0 1.1 1.4 8.7 1.3 1.6 1.5 3.3 5.3 12.1 2.6 1.4 1.2 1.0 10.1 6.0 1.0 1.2 0.9 0.7 2.5 11.2 1.4 1.1 0.5 1.2 1.3 2.8 1.0 1.2 2.9 4.0 1.4 0.9 1.3 2.8 0.0 1.3 1.7 0.9 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 4.5 0.2 0.1 0.0 0.5 3.3 0.6 0.0 0.1 0.0 0.0 0.2 6.5 0.0 0.7 0.0 0.1 0.0 0.9 0.1 0.3 4.8 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.0 0.0 5.9 0.7 11.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 14.9 8.8 14.4 5.3 12.1 10.1 6.0 11.2 2.8 FAM49A "DKFZP566A1524, FLJ11080" ENSG00000197872 "Family with sequence similarity 49 member A" Q9H0Q0 2 16549459-16666331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.8;brain: 39.5" "Cell line enhanced" "Detected in many" "HMC-1: 22.7;HUVEC TERT2: 18.1;RH-30: 40.8;SK-BR-3: 12.0;TIME: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017847, HPA060398" Approved Approved Nucleoplasm Nucleoplasm "CAB017847: , HPA060398: " "unprognostic (3.45e-1)" "unprognostic (1.83e-2)" "unprognostic (6.50e-2)" "unprognostic (1.94e-3)" "unprognostic (1.88e-1)" "unprognostic (7.78e-2)" "unprognostic (8.61e-2)" "unprognostic (3.83e-2)" "unprognostic (2.61e-1)" "unprognostic (2.00e-2)" "unprognostic (5.74e-2)" "unprognostic (8.38e-2)" "prognostic unfavourable (1.83e-6)" "unprognostic (1.32e-2)" "unprognostic (3.43e-2)" "unprognostic (3.82e-2)" "prognostic unfavourable (4.46e-4)" 10.8 9.1 22.7 15.6 28.0 15.3 7.0 6.6 39.5 13.7 5.3 7.0 1.2 2.9 8.2 2.1 4.3 6.2 8.7 3.3 17.2 14.1 1.9 6.1 9.6 13.4 10.2 25.2 10.0 2.4 1.1 4.8 15.3 9.9 6.9 5.3 2.9 3.2 7.3 6.0 2.9 4.6 8.6 6.0 20.1 3.4 1.8 6.3 1.9 31.8 1.1 13.6 7.7 7.4 8.9 15.5 45.8 34.4 13.4 5.3 8.5 0.2 0.0 2.6 0.1 2.7 0.8 7.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 1.6 0.6 1.0 0.0 2.7 0.1 1.5 0.0 0.0 1.4 0.0 22.7 1.3 1.0 0.2 0.0 18.1 0.1 2.0 1.6 0.1 0.0 5.2 1.1 0.0 0.8 40.8 0.1 2.2 10.1 0.4 1.5 0.0 12.0 0.0 0.4 0.7 14.2 0.2 2.3 0.0 0.0 1.2 0.0 1.3 6.0 1.1 0.8 0.0 23.6 31.4 5.3 29.8 0.6 8.9 0.2 2.7 15.5 6.1 0.2 2.1 45.8 13.4 34.4 7.7 0.1 8.5 22.7 28.0 6.6 33.3 17.2 14.1 10.2 25.2 9.9 6.3 FAM57B DKFZP434I2117 ENSG00000149926 "Family with sequence similarity 57 member B" Q71RH2 16 30024427-30052978 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;retina: 20.8;testis: 51.7" "Cell line enhanced" "Detected in some" "NTERA-2: 8.0;SCLC-21H: 43.0;SH-SY5Y: 16.3" "Cancer enriched" "Detected in some" 5 "glioma: 2.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (9.31e-2)" "unprognostic (9.72e-4)" "unprognostic (7.78e-3)" "unprognostic (1.13e-1)" "unprognostic (8.06e-2)" "unprognostic (2.45e-1)" "unprognostic (1.54e-2)" "unprognostic (9.72e-2)" "unprognostic (2.60e-2)" "unprognostic (3.56e-2)" "unprognostic (1.12e-2)" "unprognostic (4.51e-2)" "unprognostic (2.40e-11)" "unprognostic (1.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.85e-2)" "unprognostic (1.09e-3)" 1.2 3.8 12.0 1.4 14.2 2.6 1.5 36.4 35.7 1.1 1.3 1.7 0.0 1.5 1.2 1.1 1.5 1.3 1.2 1.2 11.8 7.9 1.2 1.2 1.2 1.6 7.6 9.5 1.2 1.3 1.2 10.4 1.2 29.4 1.3 1.3 20.8 1.4 1.2 13.9 1.5 1.3 1.2 3.9 1.2 1.4 51.7 2.8 0.0 1.2 1.8 1.4 1.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.3 1.6 0.7 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 1.1 0.5 0.0 0.0 0.3 0.1 0.0 0.4 1.2 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.3 1.3 0.3 8.0 0.4 3.4 0.6 0.5 0.0 0.0 43.0 16.3 0.1 0.1 0.0 0.1 0.0 0.0 0.1 1.1 0.2 0.1 4.2 0.1 0.1 0.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 12.0 14.2 36.4 35.7 11.8 7.9 7.6 9.5 29.4 2.8 FAM69C C18orf51 ENSG00000187773 "Family with sequence similarity 69 member C" Q0P6D2 18 74434099-74457944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;heart muscle: 10.8" "Cell line enriched" "Detected in some" 9 "SK-MEL-30: 10.7" "Group enriched" "Detected in some" 18 "glioma: 11.1;melanoma: 6.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048928 Enhanced "HPA048928: " "unprognostic (6.35e-2)" "unprognostic (1.13e-2)" "unprognostic (8.09e-2)" "unprognostic (3.32e-2)" "unprognostic (4.08e-2)" "unprognostic (3.19e-1)" "unprognostic (1.43e-2)" "unprognostic (1.10e-1)" "unprognostic (3.31e-1)" "unprognostic (8.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.10e-2)" "unprognostic (1.91e-4)" "unprognostic (2.16e-1)" "unprognostic (6.73e-2)" "unprognostic (3.23e-2)" "unprognostic (4.40e-3)" 1.1 0.9 13.8 0.7 20.5 0.6 1.1 3.5 29.1 3.4 1.0 9.5 0.0 0.7 0.9 0.8 0.8 1.0 1.3 10.8 11.0 9.0 0.8 1.1 0.6 0.7 15.5 5.2 0.7 0.9 0.8 0.1 0.9 9.9 1.1 0.9 3.7 0.9 1.7 2.3 7.0 0.9 0.9 5.3 0.8 3.0 7.3 18.8 0.0 0.8 0.0 0.7 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 20.5 3.5 10.3 11.0 9.0 15.5 5.2 9.9 18.8 FAM81A MGC26690 ENSG00000157470 "Family with sequence similarity 81 member A" Q8TBF8 15 59372693-59523549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.2" "Cell line enriched" "Detected in many" 4 "Daudi: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.5;plasmacytoid DC: 12.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001847, HPA065797" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA001847: , HPA065797: " "unprognostic (3.43e-3)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.32e-3)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (1.43e-1)" "unprognostic (2.39e-1)" "unprognostic (8.90e-2)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (9.95e-3)" "unprognostic (1.08e-2)" "unprognostic (6.53e-2)" "unprognostic (3.76e-1)" "unprognostic (7.80e-2)" 1.0 0.8 13.7 3.1 14.0 0.4 1.8 1.2 32.2 8.4 5.2 3.2 0.7 3.0 3.3 5.7 1.0 7.8 2.1 1.9 16.1 8.7 8.7 0.8 1.1 5.7 5.6 17.7 1.1 2.5 0.6 3.3 1.1 3.7 3.1 6.6 1.2 3.3 2.2 0.9 1.5 1.8 1.7 4.3 1.8 3.1 2.2 1.9 0.0 2.7 0.0 6.6 0.9 1.1 2.6 12.5 0.4 0.6 0.1 0.0 0.3 5.7 8.4 0.6 0.1 0.2 0.1 3.4 0.3 0.0 0.5 1.6 1.0 1.0 36.7 0.2 0.1 4.4 4.7 1.4 1.1 0.4 2.4 0.0 5.6 0.3 0.0 3.1 0.7 0.0 0.9 0.2 0.4 0.0 0.0 0.0 0.5 1.9 0.0 0.1 0.5 3.0 0.8 8.5 0.9 1.9 2.1 1.7 0.5 3.3 0.1 5.4 1.4 1.9 0.2 1.4 4.3 1.6 6.2 0.0 0.0 0.4 1.4 1.2 3.8 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.5 2.6 0.0 0.0 0.4 0.1 0.0 12.5 0.0 0.3 13.7 14.0 1.2 32.2 16.1 8.7 5.6 17.7 3.7 1.9 FAM86B1 MGC16279 ENSG00000186523 "Family with sequence similarity 86 member B1" Q8N7N1 8 12182096-12194133 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Cell line enhanced" "Detected in many" "AN3-CA: 5.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041610, HPA055718" Uncertain Uncertain Vesicles Vesicles "HPA041610: , HPA055718: " "unprognostic (1.90e-2)" "unprognostic (8.67e-2)" "unprognostic (2.79e-1)" "unprognostic (3.74e-2)" "unprognostic (3.13e-3)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.74e-1)" "unprognostic (5.68e-2)" "unprognostic (1.91e-2)" "unprognostic (1.32e-1)" "unprognostic (6.69e-2)" "unprognostic (8.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.58e-1)" "unprognostic (7.02e-2)" "unprognostic (2.58e-2)" 0.9 2.0 3.2 1.0 6.9 1.2 0.7 4.8 7.5 0.8 0.5 2.2 4.0 1.3 1.2 2.8 1.3 1.1 3.3 4.1 1.3 0.1 1.2 0.7 2.8 5.0 0.9 2.0 5.4 0.3 2.6 0.0 2.4 1.0 2.0 3.0 0.7 0.1 2.3 1.4 0.3 0.6 2.6 0.0 0.8 1.1 0.2 0.6 0.9 0.1 0.0 0.8 0.2 0.5 2.8 0.0 5.7 0.0 0.7 2.4 4.6 0.3 1.0 0.7 1.6 1.3 1.0 0.2 0.2 4.8 0.9 0.8 0.8 0.5 0.7 0.2 0.7 0.8 3.0 1.9 2.1 0.3 0.4 0.5 1.3 0.2 1.6 1.6 0.2 2.6 0.0 1.3 1.8 0.4 1.5 0.9 0.7 0.3 1.3 4.7 0.9 0.9 0.5 0.6 2.1 0.0 0.0 1.0 0.9 3.9 1.6 0.6 1.3 0.6 0.8 0.1 0.7 0.8 0.1 0.7 0.1 0.0 0.7 0.2 0.8 0.5 0.3 0.0 0.6 0.7 0.9 0.0 0.0 0.6 0.4 0.2 FAM90A1 FLJ10408 ENSG00000171847 "Family with sequence similarity 90 member A1" Q86YD7 12 8221260-8227618 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.8" "Cell line enhanced" "Detected in some" "BEWO: 5.2;HDLM-2: 7.8;NTERA-2: 18.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "classical monocyte: 1.1;myeloid DC: 2.8;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 8 "dendritic cells: 2.8;monocytes: 1.1" "unprognostic (2.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.21e-2)" "prognostic unfavourable (3.92e-4)" "unprognostic (2.69e-3)" "unprognostic (1.94e-4)" "unprognostic (4.37e-3)" "unprognostic (4.43e-2)" "unprognostic (3.93e-2)" "unprognostic (3.97e-2)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (5.30e-5)" "unprognostic (1.50e-1)" "unprognostic (5.15e-2)" "unprognostic (2.04e-1)" "unprognostic (2.06e-2)" 0.2 2.5 2.1 1.2 4.1 0.1 0.3 4.1 9.8 0.3 0.2 0.6 1.9 1.4 1.0 1.6 2.9 2.0 2.3 2.7 0.5 0.0 1.4 0.8 2.2 5.8 2.5 0.0 3.3 0.4 1.7 0.0 2.8 0.6 0.4 2.3 0.3 0.2 1.8 0.7 0.4 2.1 3.1 0.1 0.6 0.5 0.1 2.8 0.0 1.1 0.1 0.2 0.2 0.0 0.0 0.7 1.3 0.2 0.0 5.2 0.4 0.4 0.1 0.0 0.0 2.1 0.3 0.9 0.1 0.0 3.4 0.0 0.0 7.8 0.4 0.5 0.0 0.1 0.0 0.1 0.0 0.5 1.2 0.3 0.2 0.2 2.8 0.4 0.0 1.1 0.1 2.8 18.7 0.0 0.2 0.1 0.0 1.2 0.4 0.2 0.4 0.0 0.0 0.1 0.0 0.8 0.0 0.8 0.0 0.2 0.1 0.3 2.8 0.0 2.0 2.4 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.1 0.2 2.0 0.0 0.2 FAM90A26 FAM90A26P ENSG00000229924 "Family with sequence similarity 90 member A26" 4 9170409-9176730 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.80e-2)" "unprognostic (3.76e-1)" "unprognostic (1.56e-1)" "unprognostic (1.37e-2)" "unprognostic (2.32e-3)" "unprognostic (1.08e-1)" "unprognostic (5.86e-2)" "unprognostic (4.41e-1)" 0.0 0.6 0.1 0.0 0.3 0.1 0.1 0.2 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.4 0.3 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.7 0.3 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM92B FLJ44299 ENSG00000153789 "Family with sequence similarity 92 member B" Q6ZTR7 16 85098358-85112508 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.2;fallopian tube: 50.7;lung: 13.8" "Cell line enhanced" "Detected in some" "SCLC-21H: 7.4;TIME: 2.2" "Group enriched" "Detected in some" 5 "endometrial cancer: 5.4;lung cancer: 1.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA041022 Enhanced "HPA041022: AB_10795500" "unprognostic (1.77e-4)" "unprognostic (7.44e-3)" "unprognostic (1.61e-1)" "unprognostic (2.11e-3)" "unprognostic (5.09e-3)" "unprognostic (1.14e-3)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (9.81e-2)" "unprognostic (3.70e-1)" "unprognostic (3.84e-2)" "unprognostic (2.05e-1)" "unprognostic (5.10e-13)" "unprognostic (2.76e-2)" "unprognostic (1.56e-1)" "unprognostic (2.47e-1)" "unprognostic (1.29e-1)" 0.1 0.9 2.0 0.7 8.3 0.3 0.3 0.7 0.6 2.0 0.5 6.3 0.0 0.9 0.9 10.8 0.1 50.7 0.2 0.1 2.7 5.0 0.1 0.1 13.8 0.3 0.0 0.0 8.8 0.1 0.1 13.5 0.1 14.2 0.2 0.4 0.0 0.3 0.2 0.1 0.3 0.5 0.1 0.4 0.6 0.3 0.7 1.8 0.0 0.1 0.0 1.2 1.3 0.0 1.2 0.2 0.9 0.3 2.5 0.4 0.2 0.4 0.0 0.5 0.3 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.4 0.3 0.6 0.3 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.2 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.6 0.0 0.1 0.5 0.2 0.1 0.5 0.2 0.3 0.4 7.4 0.9 0.0 0.1 0.2 0.7 0.7 2.2 0.6 0.5 0.1 0.2 0.2 0.2 0.4 0.4 0.2 1.6 0.1 0.2 0.1 0.4 0.3 0.2 1.2 0.2 0.1 0.2 0.3 0.2 0.2 0.9 2.5 0.1 0.2 0.0 0.2 2.0 8.3 0.7 0.6 2.7 5.0 0.0 0.0 14.2 1.8 FANCC "FA3, FAC, FACC" ENSG00000158169 "Fanconi anemia complementation group C" Q00597 9 95099054-95426796 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 29.7" "Cell line enhanced" "Detected in all" "RH-30: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 10.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017793, HPA030771" Approved Supported Nucleoplasm Nucleoplasm "CAB017793: , HPA030771: " "unprognostic (1.48e-2)" "unprognostic (4.33e-2)" "unprognostic (1.10e-1)" "unprognostic (2.63e-1)" "unprognostic (2.14e-1)" "unprognostic (1.32e-2)" "unprognostic (3.41e-3)" "unprognostic (1.26e-2)" "unprognostic (7.45e-3)" "unprognostic (1.37e-1)" "unprognostic (8.00e-3)" "unprognostic (3.19e-2)" "prognostic favourable (6.03e-6)" "unprognostic (2.35e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (5.71e-2)" 4.9 2.7 4.3 8.6 7.0 3.6 4.6 29.7 7.7 4.6 6.4 4.9 5.1 7.1 6.3 4.1 4.5 3.6 5.2 3.2 4.0 2.7 10.0 25.7 6.7 3.7 7.3 1.6 3.3 5.4 2.9 12.1 4.3 6.7 4.4 6.1 4.0 4.0 4.2 4.5 7.7 8.1 2.9 6.4 3.4 4.4 19.6 7.3 7.9 4.3 3.2 6.0 3.5 4.0 1.0 1.3 10.4 1.7 0.3 1.5 0.7 13.4 9.1 12.0 10.5 1.2 3.2 7.6 5.9 3.8 9.4 8.7 10.4 5.7 7.7 4.1 4.3 16.5 12.2 5.1 5.1 7.3 5.7 6.0 10.2 5.3 2.0 6.0 6.8 2.7 2.1 7.5 3.3 5.2 9.0 3.4 6.7 9.5 5.6 3.5 5.8 5.2 12.1 31.2 3.6 3.9 3.5 17.5 9.3 11.1 4.0 3.4 4.1 5.1 2.5 8.3 12.0 9.0 8.3 3.5 6.5 4.0 4.4 5.5 9.7 10.4 0.4 0.0 1.3 0.8 1.3 1.0 0.7 1.5 0.4 1.0 1.2 1.0 0.1 0.3 1.7 1.3 1.3 0.7 4.3 7.0 29.7 7.7 4.0 2.7 7.3 1.6 6.7 7.3 FAT2 "CDHF8, CDHR9, HFAT2, MEGF1" ENSG00000086570 "FAT atypical cadherin 2" Q9NYQ8 5 151504093-151568944 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 61.0;skin 1: 35.1" "Group enriched" "Detected in some" 9 "BEWO: 16.9;EFO-21: 10.1;HaCaT: 24.4;HBEC3-KT: 11.1;hTCEpi: 33.9" "Group enriched" "Detected in many" 6 "cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6" "Region enriched" "Detected in some" 34 "cerebellum: 61.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "cerebellum: 35.9" "Region enriched" "Detected in single" 67 "cerebellum: 442.8" CAB033680 Enhanced "CAB033680: AB_2100956" "unprognostic (8.06e-3)" "unprognostic (6.01e-2)" "unprognostic (3.47e-1)" "unprognostic (4.80e-3)" "unprognostic (1.33e-1)" "unprognostic (4.43e-1)" "unprognostic (9.78e-3)" "unprognostic (2.28e-1)" "unprognostic (8.25e-2)" "unprognostic (2.65e-1)" "unprognostic (2.96e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-7)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (6.77e-2)" "unprognostic (3.64e-3)" 0.4 0.0 0.4 0.4 1.7 0.0 2.2 61.0 0.4 2.4 0.4 0.4 0.4 0.0 0.4 1.0 11.8 0.5 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 1.3 0.4 0.0 0.4 0.4 0.9 0.9 0.0 0.4 3.8 3.2 0.4 35.1 0.4 0.4 0.4 0.4 0.0 2.7 0.4 0.4 0.4 0.4 1.9 1.0 4.9 0.2 0.6 0.1 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 16.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 24.4 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 1.7 61.0 0.4 0.4 0.0 0.4 0.4 0.9 0.4 FAT3 "CDHF15, CDHR10, KIAA1989" ENSG00000165323 "FAT atypical cadherin 3" Q8TDW7 11 92352096-92896470 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.5;seminal vesicle: 6.0" "Cell line enhanced" "Detected in some" "AF22: 8.0;fHDF/TERT166: 2.4;NTERA-2: 2.7;U-2 OS: 2.3;U-251 MG: 4.6" "Cancer enriched" "Detected in single" 6 "glioma: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026878 Uncertain "HPA026878: AB_1848430" "unprognostic (5.00e-2)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (4.76e-6)" "unprognostic (1.27e-1)" "unprognostic (1.79e-1)" "unprognostic (1.56e-1)" "unprognostic (9.32e-2)" "unprognostic (1.08e-1)" "unprognostic (3.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (5.79e-2)" "unprognostic (3.66e-4)" "unprognostic (8.83e-2)" "unprognostic (7.72e-2)" "unprognostic (2.25e-1)" 0.5 0.1 2.6 0.1 10.5 0.1 0.3 1.4 7.3 0.4 0.2 0.1 0.4 1.0 0.1 0.4 0.2 0.2 1.8 2.2 0.4 0.1 1.4 0.0 2.2 0.8 0.0 0.0 1.8 0.2 3.2 0.2 0.1 6.0 0.2 0.1 0.1 0.2 0.2 0.2 1.2 0.8 0.0 0.4 1.3 0.3 0.2 0.2 0.7 0.0 0.2 0.3 0.0 0.0 0.3 8.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.4 0.0 0.0 0.0 1.6 2.4 1.3 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.2 0.3 0.0 FAXDC2 "C5orf4, FLJ13758" ENSG00000170271 "Fatty acid hydroxylase domain containing 2" Q96IV6 5 154818491-154859252 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 77.9;parathyroid gland: 112.1" "Cell line enhanced" "Detected in many" "ASC diff: 21.6;ASC TERT1: 16.3;HSkMC: 14.5;SK-MEL-30: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (6.38e-3)" "unprognostic (2.88e-2)" "unprognostic (6.26e-2)" "unprognostic (5.11e-2)" "unprognostic (3.12e-2)" "unprognostic (2.70e-2)" "prognostic favourable (3.87e-5)" "unprognostic (8.29e-2)" "unprognostic (2.52e-2)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (3.42e-2)" "prognostic favourable (9.71e-10)" "unprognostic (1.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.07e-3)" "unprognostic (3.94e-1)" 15.9 15.7 14.5 2.9 25.1 12.2 12.9 7.7 31.6 11.9 19.9 77.9 6.7 4.1 14.9 23.7 7.7 16.8 12.7 13.7 19.8 12.3 11.2 55.3 15.3 3.4 29.0 15.3 25.8 6.7 112.1 6.6 5.7 35.9 12.6 8.1 25.6 16.7 14.1 5.0 10.1 7.2 16.9 38.7 5.6 9.0 8.8 33.6 0.0 29.7 5.6 3.1 11.4 8.3 1.9 1.4 6.7 1.2 4.3 0.9 8.8 1.0 0.8 3.1 6.2 21.6 16.3 2.5 2.1 6.3 0.9 3.9 0.8 7.9 1.1 1.4 3.8 0.8 0.0 1.0 0.8 0.7 0.9 12.0 2.0 4.7 3.3 1.6 1.1 14.5 4.1 2.1 0.5 4.8 7.1 0.4 5.3 0.3 1.0 2.4 1.4 0.2 1.0 2.0 0.4 1.5 0.9 0.3 5.3 1.0 0.5 13.6 0.4 0.4 1.7 2.2 1.3 0.9 0.6 1.0 0.6 0.7 2.9 0.9 1.3 4.4 1.2 2.2 0.7 0.9 0.6 0.7 0.8 0.7 1.4 1.9 0.7 0.9 6.7 4.3 0.7 1.1 0.4 8.8 14.5 25.1 7.7 31.6 19.8 12.3 29.0 15.3 35.9 33.6 FBLL1 LOC345630 ENSG00000188573 "Fibrillarin like 1" A6NHQ2 5 168529116-168530634 "Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9" "Group enriched" "Detected in some" 6 "SCLC-21H: 18.9;SH-SY5Y: 15.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049546 Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA049546: " "unprognostic (2.75e-3)" "unprognostic (2.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (1.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (4.41e-2)" "unprognostic (2.45e-1)" "unprognostic (3.80e-3)" "unprognostic (9.69e-2)" "unprognostic (6.55e-3)" "unprognostic (3.15e-1)" "unprognostic (6.18e-2)" "unprognostic (8.32e-2)" "unprognostic (1.22e-1)" 0.8 6.2 10.3 0.9 12.1 0.7 1.1 10.6 24.9 1.0 0.9 0.9 0.0 1.4 0.8 0.8 0.8 1.4 1.1 1.3 11.0 18.4 1.1 0.9 0.9 0.7 9.7 8.5 1.2 2.1 1.8 7.4 1.0 7.9 1.4 0.9 0.5 1.4 1.3 0.9 1.5 1.6 1.1 3.0 0.8 1.4 5.1 1.7 0.0 0.8 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.4 0.2 0.1 0.0 0.9 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.1 0.1 0.4 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 18.9 15.8 1.6 0.0 0.8 0.0 1.1 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.1 10.6 16.9 11.0 18.4 9.7 8.5 7.9 1.7 FBP2 ENSG00000130957 "Fructose-bisphosphatase 2" O00757 9 94558720-94593793 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 33.7;skeletal muscle: 134.7;tongue: 45.6" "Cell line enhanced" "Detected in some" "BEWO: 7.2;CACO-2: 3.7;HMC-1: 4.0;MCF7: 5.3;PC-3: 3.7;SiHa: 5.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 36 "pons and medulla: 33.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA012513, HPA055286, HPA077371" Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA012513: AB_1848446, HPA055286: , HPA077371: " "unprognostic (3.88e-2)" "unprognostic (3.54e-4)" "unprognostic (2.38e-1)" "unprognostic (6.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-2)" "unprognostic (9.40e-4)" "unprognostic (3.95e-3)" "unprognostic (5.11e-2)" "unprognostic (2.39e-2)" "unprognostic (4.69e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.48e-4)" 2.0 0.4 0.1 0.0 0.1 0.0 0.2 0.1 0.9 0.1 0.1 3.8 4.4 1.0 0.1 1.0 1.6 0.1 0.0 0.1 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 1.2 4.1 0.1 0.0 33.7 0.2 0.0 5.0 1.4 1.8 134.7 0.1 0.1 0.1 0.2 0.1 9.0 0.4 0.0 0.0 0.2 45.6 2.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.0 2.5 0.0 0.0 7.2 0.0 0.0 0.1 0.0 3.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.9 2.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 2.4 0.6 0.1 5.0 1.2 0.0 0.4 0.1 0.0 0.0 2.3 2.2 0.0 0.0 0.1 1.0 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.7 0.1 0.1 0.0 33.7 0.0 FBXL16 "C16orf22, Fbl16, MGC33974" ENSG00000127585 "F-box and leucine rich repeat protein 16" Q8N461 16 692498-705829 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 102.2" "Cell line enhanced" "Detected in many" "AN3-CA: 12.8;MCF7: 10.4;SCLC-21H: 21.5;SH-SY5Y: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.3" "Lineage enriched" "Detected in single" 9 "T-cells: 3.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 279.3;basal ganglia: 710.3;cerebral cortex: 403.7;hippocampal formation: 376.0" "HPA039504, HPA056354" Enhanced "HPA039504: AB_10794197, HPA056354: AB_2683105" "unprognostic (5.51e-2)" "unprognostic (3.39e-3)" "unprognostic (1.34e-1)" "prognostic unfavourable (6.24e-5)" "unprognostic (2.58e-2)" "unprognostic (4.79e-3)" "unprognostic (1.83e-1)" "unprognostic (1.19e-2)" "unprognostic (2.19e-1)" "unprognostic (1.75e-1)" "prognostic favourable (7.34e-5)" "unprognostic (1.62e-3)" "prognostic favourable (1.87e-4)" "unprognostic (1.90e-2)" "unprognostic (4.71e-2)" "unprognostic (2.33e-1)" "unprognostic (4.36e-2)" 1.7 5.7 53.5 2.0 75.8 1.6 1.8 17.7 102.2 1.6 1.8 2.5 0.1 2.2 1.6 1.6 1.7 1.8 1.6 1.6 44.9 10.2 2.1 1.6 1.7 1.8 10.2 25.8 1.6 3.6 2.6 3.8 1.6 5.1 1.9 1.6 0.0 5.5 2.4 1.6 2.2 1.9 1.5 2.5 2.0 2.8 5.0 11.9 0.0 2.0 0.0 1.7 1.6 0.0 0.3 0.0 0.0 0.0 0.0 3.3 0.3 0.4 0.6 0.2 12.8 0.1 0.1 0.4 0.4 0.1 2.3 0.1 1.2 0.1 0.2 3.5 0.0 2.3 1.0 1.3 0.1 6.4 0.3 0.0 3.0 0.5 0.0 1.3 0.2 0.0 2.0 0.0 1.2 0.0 0.6 3.2 0.0 10.4 0.3 0.0 0.6 4.1 0.0 0.0 7.2 0.1 0.0 21.5 16.0 2.2 0.4 0.2 1.1 0.0 0.0 0.1 4.4 0.0 1.6 0.6 3.7 1.6 1.8 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.3 1.5 0.2 0.0 0.0 3.3 0.7 0.0 0.0 0.0 0.0 1.2 0.3 53.5 75.8 17.7 56.5 44.9 10.2 10.2 25.8 5.1 11.9 FBXO2 "Fbg1, Fbs1, FBX2, Nfb42, OCP1" ENSG00000116661 "F-box protein 2" Q9UK22 1 11637018-11655785 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.7;pancreas: 52.5" "Cell line enhanced" "Detected in some" "CACO-2: 20.6;HBEC3-KT: 18.1;Hep G2: 43.2;SiHa: 81.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 1.4;T-cells: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005472 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA005472: " "unprognostic (2.02e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-1)" "unprognostic (8.13e-3)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.30e-2)" "unprognostic (1.18e-2)" "unprognostic (1.41e-1)" "unprognostic (5.44e-2)" "unprognostic (1.68e-2)" "prognostic favourable (3.45e-6)" "unprognostic (5.26e-2)" "unprognostic (5.21e-2)" "unprognostic (4.82e-2)" "unprognostic (1.64e-1)" 1.7 21.8 49.7 2.6 39.2 1.2 7.9 21.1 48.3 2.1 1.8 13.2 2.1 13.7 1.5 6.4 3.6 3.6 2.9 2.6 33.1 32.6 6.9 11.0 3.0 2.5 40.0 23.0 2.2 52.5 17.7 20.2 1.3 25.7 5.1 1.3 2.7 21.7 7.6 1.3 6.6 4.9 1.7 31.4 2.2 3.8 4.4 24.3 1.1 3.7 0.0 3.8 2.6 2.9 1.4 0.1 0.0 0.0 0.0 3.1 0.6 6.7 2.0 0.0 6.6 0.1 0.0 1.0 0.3 0.6 0.1 0.0 20.6 2.0 0.0 8.5 0.0 0.0 0.7 18.1 0.0 0.1 0.2 0.0 0.2 43.2 0.9 0.0 0.0 0.6 3.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.5 0.5 0.7 0.9 81.5 0.0 0.8 4.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.4 0.3 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.0 3.1 1.4 1.2 2.9 0.1 1.1 1.8 2.6 0.0 0.0 0.0 0.0 0.8 0.6 49.7 39.2 21.1 30.3 33.1 32.6 40.0 23.0 25.7 24.3 FBXO41 "Fbx41, KIAA1940" ENSG00000163013 "F-box protein 41" Q8TF61 2 73254682-73284431 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell line enhanced" "Detected in many" "Daudi: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055246, HPA058386" Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA055246: , HPA058386: " "unprognostic (1.15e-3)" "unprognostic (9.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavourable (5.76e-4)" "unprognostic (1.74e-2)" "unprognostic (5.85e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-1)" "unprognostic (7.97e-3)" "unprognostic (7.55e-2)" "unprognostic (9.13e-3)" "unprognostic (4.35e-2)" "prognostic unfavourable (1.08e-5)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-2)" 1.5 3.6 21.9 5.9 19.3 4.2 2.1 21.7 33.3 1.2 2.1 1.7 0.9 2.2 1.9 3.6 1.6 2.0 2.7 1.1 18.8 10.6 0.8 1.1 2.2 9.4 5.9 17.8 2.5 4.1 9.8 7.3 1.1 6.8 3.0 2.4 0.8 3.7 3.3 0.6 3.4 2.7 2.1 2.1 7.5 2.5 2.4 3.5 2.1 1.5 0.0 9.0 2.8 0.8 0.5 0.9 0.0 2.6 1.1 0.7 0.4 3.5 1.7 0.6 0.0 0.1 0.1 0.8 0.7 0.6 1.2 1.5 4.0 2.1 26.5 0.1 0.1 2.9 3.7 2.3 1.2 11.0 0.3 8.1 4.0 1.6 0.9 12.2 6.2 1.5 0.9 0.0 0.9 0.2 1.6 4.4 1.2 0.9 4.2 11.4 2.7 1.6 14.9 6.8 12.9 0.7 1.2 9.2 3.4 4.5 1.9 2.8 2.6 5.1 0.2 4.1 3.6 3.7 0.7 5.2 2.2 12.6 1.0 13.4 1.7 0.0 0.5 0.0 0.6 2.6 0.7 0.5 0.4 0.0 0.9 0.2 0.4 0.4 0.0 1.1 0.1 0.7 0.2 0.4 21.9 19.3 21.7 33.3 18.8 10.6 5.9 17.8 6.8 3.5 FBXO44 "FBG3, FBX30, Fbx44, Fbxo6a, MGC14140" ENSG00000132879 "F-box protein 44" Q9H4M3 1 11654375-11663327 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 61.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003363 Approved Approved Nucleoplasm Nucleoplasm "HPA003363: AB_1078831" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (9.59e-2)" "unprognostic (5.34e-2)" "unprognostic (2.82e-1)" "unprognostic (2.97e-2)" "unprognostic (2.44e-1)" "unprognostic (1.31e-2)" "unprognostic (3.32e-1)" "unprognostic (1.93e-1)" "prognostic favourable (2.63e-4)" "unprognostic (2.57e-2)" "prognostic favourable (6.29e-5)" "unprognostic (1.34e-2)" "unprognostic (5.45e-1)" "unprognostic (1.77e-1)" "unprognostic (3.02e-3)" 6.6 21.1 26.6 8.3 39.0 5.3 7.0 61.7 45.0 6.5 5.0 12.3 8.9 14.2 8.5 10.3 7.7 12.1 10.5 13.7 28.7 26.4 12.2 7.7 8.1 16.3 20.7 27.4 11.3 17.8 21.7 19.5 2.4 23.1 13.7 3.4 9.9 25.5 15.4 6.4 22.1 7.8 6.2 14.2 13.4 8.1 8.5 15.3 3.2 13.0 3.3 9.9 7.4 7.5 10.9 5.1 1.5 2.5 1.5 11.7 6.1 7.4 12.1 4.5 17.0 6.6 6.9 6.1 6.0 7.4 6.7 5.7 8.8 14.2 0.2 13.4 6.6 1.9 8.9 20.1 2.8 8.5 10.9 0.2 6.5 14.7 9.2 0.2 1.1 8.9 13.4 6.2 4.8 5.2 4.5 1.9 1.7 4.6 12.5 1.4 4.7 8.6 5.0 0.2 2.5 10.7 2.7 13.6 11.2 15.8 6.1 26.7 11.0 6.8 6.3 4.9 11.8 6.5 4.7 12.6 7.0 4.6 11.2 3.2 11.5 1.1 2.1 0.6 11.7 2.4 9.0 10.0 8.0 8.9 3.3 10.9 10.9 7.5 1.5 1.5 2.5 5.1 7.1 6.1 26.6 39.0 61.7 45.0 28.7 26.4 20.7 27.4 23.1 15.3 FBXW7 "AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10" ENSG00000109670 "F-box and WD repeat domain containing 7" Q969H0 4 152320544-152536063 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 60.1;skin 1: 45.0" "Cell line enhanced" "Detected in all" "U-266/70: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013793, CAB029987" Supported Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB013793: AB_2533451, CAB029987: AB_2246842" "unprognostic (3.32e-1)" "unprognostic (9.02e-2)" "unprognostic (1.84e-2)" "unprognostic (3.08e-2)" "unprognostic (3.87e-1)" "unprognostic (1.36e-3)" "unprognostic (4.37e-1)" "unprognostic (1.94e-1)" "unprognostic (8.28e-2)" "unprognostic (3.29e-1)" "unprognostic (5.32e-3)" "unprognostic (3.19e-2)" "prognostic unfavourable (1.52e-4)" "unprognostic (3.38e-2)" "unprognostic (1.41e-1)" "unprognostic (5.49e-3)" "unprognostic (2.17e-3)" 9.2 6.8 27.0 8.9 27.9 11.1 9.8 27.2 60.1 5.5 6.1 3.6 3.8 4.9 6.0 18.3 9.8 10.6 6.3 10.9 21.4 10.1 4.1 7.3 6.9 9.8 9.1 40.5 6.4 8.0 6.4 7.3 6.2 37.2 5.1 6.9 2.8 7.6 5.3 15.8 45.0 6.5 6.1 6.4 10.1 8.0 13.7 5.7 6.5 6.8 10.6 12.3 7.9 6.5 2.9 2.2 16.6 3.4 7.8 5.0 1.3 4.9 3.9 10.2 7.4 7.1 5.1 8.4 7.1 6.5 4.4 4.2 7.9 6.3 12.7 2.0 6.8 2.9 8.7 16.0 6.2 7.2 4.1 5.9 4.8 5.6 7.2 14.4 5.4 8.1 25.3 7.6 12.9 7.7 9.3 13.6 5.5 6.9 16.5 5.7 5.0 3.1 16.6 4.3 2.5 5.4 8.5 6.5 5.6 4.5 6.2 3.9 3.4 6.8 8.1 6.0 6.8 3.1 4.0 37.4 21.3 12.4 4.8 4.7 4.3 16.6 3.1 1.7 5.0 3.4 3.3 2.9 3.7 3.2 1.8 2.4 3.9 3.2 5.5 7.8 2.5 2.2 3.3 1.3 27.0 27.9 27.2 60.1 21.4 10.1 9.1 40.5 37.2 5.7 FCHO1 KIAA0290 ENSG00000130475 "FCH domain only 1" O14526 19 17747718-17788568 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4" "Cell line enhanced" "Detected in many" "Daudi: 27.9;RPMI-8226: 19.2;U-937: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041653, HPA062981" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041653: AB_10795641, HPA062981: " "unprognostic (3.02e-1)" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (4.54e-3)" "unprognostic (3.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (5.48e-3)" "unprognostic (1.72e-9)" "unprognostic (3.76e-3)" "unprognostic (1.18e-1)" "unprognostic (2.21e-1)" "unprognostic (9.77e-3)" 2.2 2.3 13.6 13.7 18.9 18.9 1.9 11.4 15.2 1.1 2.7 30.2 0.0 3.7 1.8 1.8 1.5 1.9 4.5 1.1 17.8 11.7 1.0 2.7 3.4 22.6 23.0 10.0 2.2 0.9 0.8 2.6 1.4 10.8 1.4 2.6 0.6 2.7 1.2 0.9 13.4 4.0 2.1 15.9 13.7 3.5 4.3 23.3 16.4 1.2 0.0 17.3 5.1 1.0 9.9 10.4 25.7 9.5 4.1 5.7 4.4 0.4 5.4 3.5 2.5 0.1 0.1 3.5 0.5 0.1 0.1 0.2 0.7 0.6 27.9 8.0 0.2 1.1 1.7 1.0 0.1 12.3 0.9 2.2 0.7 2.8 0.3 6.9 4.7 0.0 0.1 0.1 0.2 0.7 10.9 13.4 0.0 7.7 15.8 12.4 1.7 13.3 13.5 0.1 19.2 0.1 0.5 0.6 1.3 0.1 2.8 0.4 2.7 6.9 0.5 0.1 2.0 0.5 0.2 8.5 3.8 15.1 0.4 17.2 0.3 6.9 6.6 6.5 5.2 9.5 4.5 8.8 5.7 4.5 9.7 9.9 5.5 4.4 25.7 4.1 7.2 10.4 5.2 4.4 13.6 18.9 11.4 15.2 17.8 11.7 23.0 10.0 10.8 23.3 FERD3L "bHLHa31, N-TWIST, NATO3" ENSG00000146618 "Fer3 like bHLH transcription factor" Q96RJ6 7 19144782-19145421 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.7;pituitary gland: 2.4" "Cell line enriched" "Detected in single" 156 "SCLC-21H: 15.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "thalamus: 1.0" "Region enriched" "Detected in single" 19 "midbrain: 34.7" HPA043494 Uncertain "HPA043494: AB_10964193" 0.3 0.4 1.4 0.0 0.1 0.0 0.5 0.0 2.7 0.2 0.0 2.2 0.0 0.0 0.5 0.0 0.4 0.2 0.0 0.9 1.1 1.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.4 1.3 1.4 0.1 0.2 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 1.8 1.1 1.5 1.3 0.0 1.4 0.0 FEV Pet-1 ENSG00000163497 "FEV, ETS transcription factor" Q99581 2 218981087-218985657 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.9;intestine: 7.0;pituitary gland: 5.4;stomach 1: 6.1" "Group enriched" "Detected in some" 6 "HMC-1: 18.7;SH-SY5Y: 23.9" "Group enriched" "Detected in some" 10 "pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4" "Region enhanced" "Detected in many" "pons and medulla: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "midbrain: 2.3;pons and medulla: 0.9" "Group enriched" "Detected in some" 34 "midbrain: 7.3;pons and medulla: 3.9" HPA067679 Supported Supported "Nuclear speckles" "Nuclear speckles" "HPA067679: " "unprognostic (4.58e-1)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "prognostic favourable (4.85e-4)" "unprognostic (2.87e-1)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (2.15e-1)" 0.1 4.1 0.0 1.2 3.5 0.0 0.0 0.0 2.6 0.0 2.0 0.7 0.0 7.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.2 0.0 5.4 0.0 6.9 4.0 3.2 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.1 0.0 6.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 2.6 1.1 0.2 0.2 0.0 6.9 1.0 FEZ1 UNC-76 ENSG00000149557 "Fasciculation and elongation protein zeta 1" Q99689 11 125445745-125496317 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 123.4" "Cell line enhanced" "Detected in many" "AF22: 39.9;HBEC3-KT: 38.6;NTERA-2: 36.5;SCLC-21H: 39.0" "Cancer enriched" "Detected in all" 10 "glioma: 68.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 30.8;MAIT T-cell: 18.0;memory CD8 T-cell: 8.9;naive CD8 T-cell: 7.7" "Lineage enriched" "Detected in many" 14 "T-cells: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038490, HPA076844" Approved Supported Microtubules,Cytosol Microtubules Cytosol "HPA038490: AB_10672647, HPA076844: " "unprognostic (5.68e-2)" "prognostic unfavourable (9.06e-5)" "unprognostic (7.40e-2)" "unprognostic (3.73e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-1)" "unprognostic (2.06e-1)" "unprognostic (8.30e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-1)" "unprognostic (5.63e-2)" "prognostic unfavourable (2.16e-6)" "unprognostic (2.14e-2)" "unprognostic (2.68e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" 6.6 5.6 48.3 4.4 50.1 1.3 4.3 28.2 121.4 6.4 5.1 58.8 0.2 2.9 6.9 4.0 5.9 4.1 9.4 12.4 54.2 38.2 2.7 7.4 10.0 3.5 68.2 29.8 6.0 1.4 5.0 2.3 6.0 43.4 6.6 5.3 1.4 2.4 12.9 1.7 3.5 3.5 13.0 123.4 3.9 2.5 7.2 51.4 0.0 2.2 0.0 2.9 16.8 2.1 0.0 0.4 2.1 0.5 1.0 30.8 5.0 0.0 0.0 39.9 0.0 26.3 24.0 0.0 6.2 8.0 1.5 0.3 0.0 0.0 0.0 7.3 11.7 0.1 18.1 38.6 0.8 3.2 0.2 18.3 0.0 0.0 22.2 0.0 0.1 19.6 8.9 7.2 19.1 17.6 2.4 0.2 1.9 0.9 0.1 0.0 36.5 0.4 0.0 0.0 0.0 0.0 14.0 39.0 4.1 0.1 0.0 0.6 2.9 17.9 15.8 0.1 1.0 0.0 5.2 0.4 0.1 0.0 4.3 0.0 16.8 2.1 0.5 0.0 30.8 0.1 18.0 0.0 1.1 8.9 0.4 0.0 0.4 7.7 0.6 1.0 0.0 0.0 0.0 5.0 48.3 50.1 28.2 97.4 54.2 38.2 68.2 29.8 43.4 51.4 FEZF1 ZNF312B ENSG00000128610 "FEZ family zinc finger 1" A0PJY2 7 122301394-122310691 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 16.7;testis: 11.0" "Group enriched" "Detected in some" 10 "NTERA-2: 57.4;SCLC-21H: 25.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 16.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "hypothalamus: 13.7" "Region enriched" "Detected in single" 9 "hypothalamus: 6.9" "HPA064639, HPA073693" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064639: , HPA073693: " "unprognostic (8.48e-2)" "unprognostic (3.41e-2)" "unprognostic (3.64e-1)" "unprognostic (3.43e-2)" "unprognostic (4.17e-1)" "unprognostic (4.10e-2)" "unprognostic (2.64e-3)" "unprognostic (2.54e-1)" "unprognostic (1.34e-1)" "unprognostic (2.96e-2)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" 0.6 0.2 6.4 0.2 4.9 0.2 0.2 0.0 2.0 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 1.0 16.7 0.2 0.2 0.2 0.2 2.0 0.0 0.3 0.2 0.2 3.1 0.2 0.0 0.3 0.2 1.4 0.6 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.3 11.0 3.5 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 57.4 1.0 0.0 0.0 0.0 0.0 0.1 25.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.1 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 4.9 0.0 2.0 1.0 16.7 2.0 0.0 0.0 3.5 FEZF2 "FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312" ENSG00000153266 "FEZ family zinc finger 2" Q8TBJ5 3 62369681-62374324 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 22.0" "Group enriched" "Detected in some" 5 "AF22: 5.0;NTERA-2: 3.4;U-266/84: 2.3" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Group enriched" "Detected in many" 7 "amygdala: 12.2;basal ganglia: 6.4;cerebral cortex: 11.3;hippocampal formation: 22.0;olfactory region: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 15.6;cerebral cortex: 15.0;hippocampal formation: 26.2" "unprognostic (2.37e-1)" "unprognostic (1.74e-2)" "unprognostic (1.70e-1)" 0.7 0.5 12.2 0.4 6.4 0.4 0.5 0.0 18.0 0.4 1.4 1.8 0.0 0.4 0.5 0.4 0.4 0.5 0.5 0.5 22.0 1.8 0.7 0.5 0.5 0.4 1.1 10.0 0.5 0.4 0.4 0.7 0.5 0.0 0.6 0.4 1.1 0.5 0.5 0.8 0.6 0.5 0.4 0.0 0.8 0.9 0.5 0.3 3.3 0.5 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.6 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 6.4 0.0 11.3 22.0 1.8 1.1 10.0 0.0 0.3 FFAR1 "FFA1R, GPR40" ENSG00000126266 "Free fatty acid receptor 1" O14842 19 35351552-35353862 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.7;brain: 4.1;ovary: 4.8;pancreas: 9.6" "Cell line enhanced" "Detected in some" "Daudi: 2.8;U-698: 5.4;WM-115: 2.0" "Cancer enriched" "Detected in single" 13 "pancreatic cancer: 2.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "unprognostic (9.49e-2)" "unprognostic (2.08e-1)" "unprognostic (1.59e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" "unprognostic (4.51e-2)" "unprognostic (1.03e-2)" "unprognostic (4.46e-2)" "unprognostic (6.19e-2)" "unprognostic (9.56e-3)" 0.0 0.0 1.2 0.2 1.6 5.7 0.0 0.0 0.6 0.0 0.0 0.8 0.1 0.0 0.0 0.8 0.0 0.0 1.9 0.9 0.0 0.0 0.1 0.7 1.7 4.8 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 4.1 0.3 1.6 0.1 0.0 0.2 0.0 0.0 1.2 0.5 1.9 0.3 0.7 0.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 2.8 0.4 0.1 0.4 0.0 0.0 0.1 0.3 0.3 0.8 0.2 0.0 0.1 0.4 1.4 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.1 0.6 0.1 0.0 1.1 0.2 0.0 0.0 0.3 0.1 0.4 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 5.4 0.1 0.2 2.0 1.6 0.3 0.7 0.4 0.2 0.4 0.3 0.3 0.2 0.0 1.2 0.3 0.4 1.9 0.7 0.2 0.5 0.2 0.0 FGF1 "AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1" ENSG00000113578 "Fibroblast growth factor 1" P05230 5 142592178-142698070 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 65.0;heart muscle: 35.5;kidney: 41.5" "Cell line enhanced" "Detected in some" "BJ: 19.3;BJ hTERT+: 14.4;BJ hTERT+ SV40 Large T+: 16.0;BJ hTERT+ SV40 Large T+ RasG12V: 20.2;HBF TERT88: 28.8;hTEC/SVTERT24-B: 20.1;LHCN-M2: 13.4;U-2 OS: 14.4" "Cancer enriched" "Detected in many" 12 "glioma: 33.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003265, CAB017519" Enhanced Supported Nucleoplasm "Secreted in other tissues" Nucleoplasm "CAB017519: AB_629473, HPA003265: AB_1848522" "unprognostic (1.25e-2)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (3.41e-3)" "unprognostic (2.55e-2)" "unprognostic (3.52e-1)" "unprognostic (2.77e-1)" "unprognostic (2.39e-1)" "unprognostic (3.63e-1)" "unprognostic (1.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.54e-1)" "prognostic favourable (2.59e-5)" "unprognostic (3.72e-4)" "unprognostic (2.49e-1)" "prognostic favourable (3.45e-5)" "unprognostic (3.01e-4)" 7.3 3.5 44.2 2.0 43.1 1.5 9.7 10.5 59.9 1.8 1.7 65.0 0.0 1.6 3.1 8.7 2.3 2.1 2.7 35.5 47.4 33.0 41.5 2.0 2.9 1.4 62.6 13.8 1.5 1.4 3.4 1.6 2.3 36.3 2.2 1.8 0.8 5.8 2.6 2.3 2.0 1.7 2.6 57.7 5.5 1.1 2.2 48.6 0.0 4.9 0.8 2.2 1.7 0.4 1.2 1.0 1.8 0.6 0.1 2.3 0.2 2.3 0.1 0.1 0.7 0.5 1.5 0.8 19.3 14.4 16.0 20.2 0.1 0.1 0.5 1.4 6.6 0.3 0.0 1.5 28.8 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.2 0.7 0.5 20.1 1.2 0.0 0.0 0.7 13.4 0.3 0.0 0.4 0.6 0.6 0.1 0.6 0.2 0.6 0.1 0.5 1.0 0.0 0.4 0.2 0.0 0.1 0.4 2.6 14.4 0.3 9.1 0.3 0.1 0.1 3.6 0.1 0.7 0.3 0.3 1.8 2.3 0.1 1.8 0.4 0.8 0.9 0.2 1.2 0.9 1.9 1.7 0.1 0.6 1.0 0.5 0.2 44.2 43.1 10.5 22.6 47.4 33.0 62.6 13.8 36.3 48.6 FGF12 "FGF12B, FHF1" ENSG00000114279 "Fibroblast growth factor 12" P61328 3 192139395-192767764 "Disease related genes, Predicted intracellular proteins" "Growth factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 21.5;brain: 31.9;heart muscle: 75.7" "Cell line enhanced" "Detected in some" "AF22: 11.6;NTERA-2: 7.9;SCLC-21H: 18.6;U-251 MG: 11.1;WM-115: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071557 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA071557: " "unprognostic (1.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.26e-2)" "unprognostic (2.50e-5)" "unprognostic (1.75e-1)" "unprognostic (5.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (4.00e-2)" "unprognostic (9.19e-2)" "unprognostic (1.87e-7)" "unprognostic (2.41e-2)" "unprognostic (5.36e-2)" "unprognostic (5.59e-2)" "unprognostic (5.99e-2)" 1.2 21.5 8.8 0.7 15.8 0.6 1.0 17.7 31.9 0.9 0.9 1.9 0.0 1.0 1.2 0.7 1.5 1.5 0.9 75.7 6.8 4.1 2.0 0.9 1.2 0.7 5.1 15.8 1.1 4.9 0.7 2.9 0.8 22.3 1.3 0.8 1.1 3.6 4.2 1.1 0.7 0.7 1.0 2.7 6.8 0.9 1.7 2.8 0.0 1.4 0.0 0.7 0.8 0.8 1.1 0.3 1.2 0.4 0.5 0.4 0.1 0.0 0.8 11.6 0.0 0.0 0.0 0.0 0.0 0.1 1.1 1.4 0.0 0.1 0.6 5.6 0.2 0.1 0.0 0.0 1.3 0.1 0.1 2.4 4.9 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 3.2 0.0 0.0 7.9 0.2 0.0 0.1 0.0 3.6 1.3 18.6 0.0 0.0 0.4 0.0 0.8 0.1 0.3 4.8 2.5 0.0 11.1 0.1 1.8 0.0 1.0 0.0 13.4 1.2 0.2 0.5 0.2 0.3 0.4 1.1 0.2 0.2 0.1 0.5 0.4 0.3 0.6 0.5 0.4 0.3 0.3 0.1 8.8 15.8 17.7 31.9 6.8 4.1 5.1 15.8 22.3 2.8 FGF13 "FGF2, FHF2" ENSG00000129682 "Fibroblast growth factor 13" Q92913 X 138614731-139222777 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.7;parathyroid gland: 44.3;skeletal muscle: 37.0" "Cell line enhanced" "Detected in some" "AF22: 19.5;fHDF/TERT166: 16.8;HAP1: 17.8;RPMI-8226: 15.1;U-2197: 31.4;WM-115: 16.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 7.4" "Lineage enriched" "Detected in single" 8 "granulocytes: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002809 Supported Cytosol Cytosol "HPA002809: AB_1078855" "unprognostic (3.23e-1)" "unprognostic (3.13e-2)" "unprognostic (5.42e-2)" "unprognostic (1.42e-2)" "unprognostic (1.87e-1)" "unprognostic (2.87e-3)" "unprognostic (9.92e-3)" "unprognostic (2.97e-3)" "unprognostic (4.92e-2)" "unprognostic (5.90e-3)" "unprognostic (5.22e-3)" "unprognostic (6.79e-2)" "unprognostic (4.96e-4)" "unprognostic (4.36e-3)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" "unprognostic (7.48e-2)" 11.1 1.9 30.0 1.9 29.5 2.7 4.2 0.9 22.9 7.9 3.1 1.5 2.4 2.7 7.0 2.8 4.4 2.6 4.1 1.3 36.7 22.3 4.9 1.4 1.7 3.1 19.7 12.9 6.0 0.9 44.3 2.4 8.4 7.8 11.6 3.3 4.8 6.5 3.5 37.0 1.1 3.1 4.5 3.3 3.8 2.9 2.7 4.1 0.0 3.6 7.9 1.6 3.5 5.7 0.5 0.9 7.4 0.5 0.2 0.3 0.1 0.0 0.2 19.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 16.8 1.2 17.8 0.0 0.0 0.2 5.0 0.1 0.1 0.7 0.7 0.1 0.2 0.2 0.4 0.0 0.0 0.0 0.7 5.6 2.0 0.1 0.0 0.1 2.0 6.4 2.9 1.2 15.1 2.8 0.1 0.1 0.0 0.0 0.1 11.9 0.0 0.1 0.4 0.6 0.8 31.4 8.3 7.4 4.1 0.0 7.0 5.6 16.8 2.7 0.5 1.6 0.2 0.3 0.1 0.5 0.2 0.1 0.1 0.4 0.3 0.2 7.4 0.2 0.5 0.9 0.2 0.1 30.0 29.5 0.9 22.9 36.7 22.3 19.7 12.9 7.8 4.1 FGF14 "FHF4, SCA27" ENSG00000102466 "Fibroblast growth factor 14" Q92915 13 101710804-102402457 "Disease related genes, Predicted intracellular proteins" "Growth factor" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 46.4;cervix, uterine: 23.2;fallopian tube: 15.7" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 20.5" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Region enhanced" "Detected in all" "cerebellum: 46.4" "Group enriched" "Detected in some" 11 "memory CD4 T-cell: 1.0;T-reg: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049828 Approved "Nucleoli fibrillar center" "Nucleoli fibrillar center" "HPA049828: " "unprognostic (2.12e-1)" "unprognostic (1.57e-1)" "unprognostic (2.83e-2)" "unprognostic (2.27e-2)" "unprognostic (8.55e-2)" "unprognostic (1.28e-1)" "unprognostic (3.33e-1)" "unprognostic (1.81e-2)" "unprognostic (2.06e-1)" "unprognostic (8.22e-2)" "unprognostic (1.22e-1)" "unprognostic (2.45e-1)" "unprognostic (7.80e-3)" "unprognostic (2.20e-3)" "unprognostic (1.65e-1)" "unprognostic (3.86e-2)" "unprognostic (8.48e-2)" 1.6 4.4 6.0 0.8 12.1 0.4 0.8 46.4 13.6 23.2 0.9 1.0 0.1 1.2 0.8 1.5 2.4 15.7 1.1 3.5 4.5 10.4 1.3 2.1 3.0 0.6 2.3 4.5 0.5 1.5 0.5 4.6 0.6 6.5 0.7 1.1 0.0 1.2 1.4 0.7 1.2 0.8 0.8 1.8 0.6 3.2 3.5 3.6 0.0 0.7 0.0 0.5 0.7 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 4.8 20.5 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.3 0.3 0.0 0.3 0.0 0.0 4.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 6.0 12.1 46.4 11.4 4.5 10.4 2.3 4.5 6.5 3.6 FGF17 FGF-13 ENSG00000158815 "Fibroblast growth factor 17" O60258 8 22042398-22048809 "Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 31.3" "Cell line enhanced" "Detected in some" "HaCaT: 3.2;Hep G2: 2.3;MOLT-4: 2.2;RPMI-8226: 4.4" "Cancer enhanced" "Detected in some" "testis cancer: 3.9" "Region enriched" "Detected in many" 4 "cerebellum: 31.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 2.2" "Low region specificity" "Detected in some" HPA052600 Uncertain "Secreted in brain" "HPA052600: " "unprognostic (3.45e-2)" "unprognostic (1.64e-2)" "unprognostic (3.03e-2)" "unprognostic (1.34e-1)" "unprognostic (1.33e-2)" "unprognostic (3.51e-2)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (7.92e-5)" "unprognostic (6.85e-2)" "unprognostic (2.58e-4)" "unprognostic (6.55e-3)" "unprognostic (7.18e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-3)" 0.4 4.9 2.5 0.4 3.2 0.2 0.4 31.3 7.7 0.5 0.4 0.4 0.4 0.2 2.2 0.6 0.4 0.7 0.6 0.4 2.2 4.7 0.4 0.4 0.5 0.4 1.3 2.9 0.5 2.6 3.6 2.1 0.4 3.3 1.2 0.2 0.4 2.4 0.5 0.4 0.9 0.4 1.0 0.9 3.0 0.8 0.6 0.4 1.6 2.3 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.2 0.6 0.6 1.0 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.9 0.7 0.0 2.3 0.1 0.0 1.5 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.7 2.2 0.8 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.0 1.5 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.2 31.3 7.7 2.2 4.7 1.3 2.9 3.3 0.4 FGF20 ENSG00000078579 "Fibroblast growth factor 20" Q9NP95 8 16992169-17002181 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.0" "Group enriched" "Detected in some" 4 "BJ hTERT+: 3.3;CAPAN-2: 10.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "naive B-cell: 1.0" "Lineage enriched" "Detected in single" 11 "B-cells: 1.0" "Region enhanced" "Detected in some" "midbrain: 0.7" "Region enriched" "Detected in single" 5 "cerebellum: 3.4" "Secreted in other tissues" "unprognostic (1.93e-2)" "unprognostic (2.19e-1)" "unprognostic (5.57e-3)" "unprognostic (3.95e-2)" "unprognostic (1.59e-3)" "unprognostic (1.40e-2)" "unprognostic (1.94e-1)" "unprognostic (2.65e-2)" "unprognostic (9.32e-2)" "unprognostic (9.95e-2)" "unprognostic (3.92e-1)" "unprognostic (4.08e-2)" 0.2 2.0 1.9 0.2 1.6 0.0 1.1 9.0 3.7 3.9 0.1 4.0 0.1 0.4 0.1 2.5 0.1 0.8 1.2 0.3 2.3 2.1 0.1 0.1 0.1 0.5 2.9 2.4 2.5 0.2 0.0 0.9 0.5 2.7 0.6 0.2 0.8 3.8 0.6 0.1 0.0 0.2 0.1 4.2 3.6 2.2 0.8 1.1 0.1 0.5 0.1 1.6 0.6 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.4 0.0 1.2 3.3 0.5 1.6 0.0 10.4 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.6 9.0 3.7 2.3 2.1 2.9 2.4 2.7 1.1 FGF3 "HBGF-3, INT2" ENSG00000186895 "Fibroblast growth factor 3" P11487 11 69809969-69819024 "Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "brain: 16.6" "Cell line enriched" "Detected in single" 48 "CAPAN-2: 4.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 38 "cerebellum: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 2.7" "Not detected" "Not detected" HPA012692 Enhanced "Secreted in brain" "HPA012692: AB_1848526" "unprognostic (6.42e-3)" "unprognostic (7.82e-2)" "unprognostic (1.89e-1)" "unprognostic (3.61e-1)" "unprognostic (7.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 FGF4 "HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF" ENSG00000075388 "Fibroblast growth factor 4" P08620 11 69771016-69775403 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6;intestine: 1.6;testis: 2.4;tongue: 2.0" "Cell line enriched" "Detected in single" 93 "NTERA-2: 18.6" "Cancer enriched" "Detected in some" 5 "testis cancer: 13.9" "Group enriched" "Detected in some" 19 "midbrain: 2.6;pons and medulla: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA011209 Uncertain "Secreted in other tissues" "HPA011209: AB_1848527" "unprognostic (1.47e-2)" "unprognostic (6.22e-2)" "unprognostic (7.77e-2)" "unprognostic (8.56e-2)" 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 1.2 0.8 0.1 2.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.2 0.0 FGF5 ENSG00000138675 "Fibroblast growth factor 5" P12034 4 80266599-80336680 "Disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 38.2" "Cell line enhanced" "Detected in some" "BJ: 19.7;BJ hTERT+: 37.4;fHDF/TERT166: 26.9;HBF TERT88: 28.1;LHCN-M2: 25.2;U-138 MG: 34.9;U-251 MG: 16.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "cerebellum: 38.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB010313, HPA042442" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Secreted in brain" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010313: AB_2102677, HPA042442: " "unprognostic (6.44e-2)" "unprognostic (6.24e-3)" "unprognostic (8.49e-4)" "unprognostic (1.10e-1)" "unprognostic (2.91e-1)" "unprognostic (2.80e-3)" "unprognostic (6.87e-4)" "unprognostic (2.53e-1)" "unprognostic (1.69e-1)" "unprognostic (3.57e-3)" "unprognostic (1.17e-2)" "unprognostic (3.33e-16)" "unprognostic (3.02e-3)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" 0.1 0.1 0.1 1.7 0.1 0.5 0.1 38.2 1.3 0.1 3.1 0.0 0.0 0.4 0.4 0.1 1.3 0.1 9.2 0.3 1.6 0.2 2.3 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 1.3 0.1 4.1 0.2 0.1 0.0 0.1 0.0 0.5 0.4 2.8 2.4 0.3 0.1 0.8 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.7 1.7 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 1.9 7.1 0.0 19.7 37.4 5.2 3.8 0.0 0.0 0.0 0.0 26.9 0.0 0.0 6.9 28.1 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 2.0 0.0 15.3 7.3 1.7 0.0 0.1 25.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 6.4 34.9 1.4 1.7 16.7 0.0 0.0 0.0 2.0 0.0 0.7 1.7 0.3 0.3 0.4 0.2 0.5 0.2 0.3 0.4 0.2 0.7 0.5 0.5 0.9 0.2 0.2 0.7 0.2 0.0 0.1 0.1 38.2 1.3 1.6 0.2 0.2 0.2 4.1 0.1 FGF9 ENSG00000102678 "Fibroblast growth factor 9" P31371 13 21671383-21704498 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;kidney: 21.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.4;HEK 293: 2.4;RPMI-8226: 3.6;RPTEC TERT1: 5.5;SCLC-21H: 11.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "B-cells: 1.0;T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067007 Enhanced "Secreted in other tissues" "HPA067007: " "unprognostic (6.59e-3)" "unprognostic (9.09e-3)" "unprognostic (2.15e-2)" "unprognostic (9.24e-2)" "unprognostic (2.19e-1)" "unprognostic (2.37e-2)" "unprognostic (7.42e-4)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (3.86e-1)" "unprognostic (2.38e-3)" "unprognostic (7.93e-2)" "prognostic favourable (1.70e-6)" "unprognostic (5.38e-2)" "unprognostic (1.27e-1)" "unprognostic (3.49e-1)" "unprognostic (6.92e-2)" 3.1 7.3 2.1 1.0 4.4 0.8 0.7 17.7 7.3 3.8 2.1 0.3 0.5 1.8 3.7 0.9 0.9 1.0 1.2 5.5 3.7 2.6 21.7 0.5 2.6 0.6 2.6 2.5 2.3 1.8 0.5 12.0 0.7 12.6 1.1 3.1 2.4 1.2 1.6 1.4 0.5 4.0 4.0 2.5 0.6 2.2 1.5 0.3 0.0 0.6 0.0 0.5 3.0 1.4 1.0 0.0 0.0 0.2 0.0 1.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 2.4 0.0 1.6 0.9 0.0 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 3.6 5.5 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.6 0.7 1.4 1.7 0.0 1.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 2.1 4.4 17.7 7.3 3.7 2.6 2.6 2.5 12.6 0.3 FGFBP3 "C10orf13, MGC39320" ENSG00000174721 "Fibroblast growth factor binding protein 3" Q8TAT2 10 91906589-91909483 "Predicted secreted proteins" "Growth factor binding, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 20.6" "Cell line enriched" "Detected in some" 9 "AF22: 83.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA053943 Uncertain "Secreted in brain" "HPA053943: " "unprognostic (8.66e-2)" "unprognostic (6.00e-2)" "unprognostic (4.47e-2)" "unprognostic (2.88e-1)" "unprognostic (9.98e-3)" "unprognostic (7.76e-2)" "unprognostic (1.43e-1)" "unprognostic (1.96e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-1)" "unprognostic (3.39e-3)" "unprognostic (2.61e-1)" "unprognostic (3.90e-1)" "unprognostic (6.95e-2)" "unprognostic (2.85e-1)" "unprognostic (2.63e-1)" "unprognostic (6.76e-3)" 1.4 2.1 6.4 1.4 4.6 1.0 2.0 3.4 20.6 1.3 1.6 4.1 0.3 1.1 1.8 2.8 1.0 1.1 0.6 2.1 6.9 5.9 1.4 0.8 1.1 2.2 4.0 5.6 2.5 1.9 2.0 2.3 0.9 6.7 2.3 1.9 0.5 1.9 1.4 3.3 1.8 1.1 1.0 3.9 1.7 2.2 1.1 4.4 0.9 2.7 0.3 1.2 1.0 0.8 3.7 0.6 2.0 0.5 0.9 1.9 0.2 0.0 0.6 83.8 1.2 0.3 0.1 0.3 0.0 0.0 0.1 0.2 0.2 0.3 0.1 0.1 0.1 0.3 0.5 0.0 0.2 0.3 0.9 1.6 0.6 0.9 0.2 8.9 0.2 0.2 0.1 0.4 0.4 0.0 0.8 0.3 0.0 0.7 1.0 3.6 6.2 0.3 2.6 0.5 0.1 0.1 0.2 0.8 1.1 0.2 0.0 1.4 0.3 0.1 0.1 0.1 0.6 0.1 0.2 0.2 0.5 0.3 0.0 1.0 0.1 2.0 0.5 0.0 1.7 0.1 0.6 2.1 1.1 0.9 0.6 3.7 1.9 1.4 0.0 0.9 0.0 0.3 0.1 0.2 6.4 4.6 3.4 6.4 6.9 5.9 4.0 5.6 6.7 4.4 FGFR2 "BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25" ENSG00000066468 "Fibroblast growth factor receptor 2" P21802 10 121478334-121598458 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.8" "Cell line enhanced" "Detected in some" "AN3-CA: 57.8;BEWO: 19.4;CACO-2: 15.1;HaCaT: 17.4;HAP1: 18.7;NTERA-2: 18.5;T-47d: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 10.8;eosinophil: 4.6" "Lineage enriched" "Detected in single" 35 "granulocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010886, HPA035305" Uncertain Supported "Nucleoplasm,Vesicles,Cell Junctions" "Secreted - unknown location" 500000 "Cell Junctions" "Nucleoplasm, Vesicles" "CAB010886: AB_259379, HPA035305: AB_10672862" "unprognostic (5.53e-2)" "prognostic favourable (8.79e-4)" "unprognostic (1.08e-1)" "unprognostic (5.23e-2)" "unprognostic (1.73e-1)" "prognostic favourable (9.32e-4)" "unprognostic (1.53e-1)" "unprognostic (4.96e-3)" "unprognostic (1.74e-1)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "unprognostic (2.54e-1)" "unprognostic (6.93e-2)" "unprognostic (2.25e-1)" 2.1 8.8 16.4 3.0 30.3 0.0 9.9 15.8 21.3 6.8 14.1 55.7 5.6 4.2 22.0 6.6 10.2 12.5 12.5 1.4 20.6 11.1 11.4 16.1 13.1 1.0 41.2 13.3 7.4 12.8 25.5 2.5 6.2 30.2 11.7 8.7 16.4 23.8 24.3 0.4 45.4 4.7 18.3 74.8 0.5 9.3 2.9 32.1 0.8 23.4 1.6 3.4 6.9 8.5 0.1 0.1 10.8 0.1 0.1 0.3 0.0 2.2 0.1 9.0 57.8 0.0 0.0 19.4 0.1 0.0 0.0 0.0 15.1 0.3 0.0 4.1 0.9 17.4 18.7 4.0 0.0 0.0 4.0 0.0 0.0 0.3 0.4 0.0 3.8 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 18.5 0.0 0.0 0.0 2.2 5.6 4.9 0.1 0.1 0.1 10.6 0.0 15.5 0.0 0.0 0.1 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 10.8 0.1 4.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 16.4 30.3 15.8 21.3 20.6 11.1 41.2 13.3 30.2 32.1 FHAD1 KIAA1937 ENSG00000142621 "Forkhead associated phosphopeptide binding domain 1" B1AJZ9 1 15247272-15400283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.8;epididymis: 16.0;fallopian tube: 17.9;testis: 28.5" "Cell line enhanced" "Detected in some" "HDLM-2: 13.5;HMC-1: 38.9;K-562: 8.3;U-87 MG: 20.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 4 "pons and medulla: 13.8" "Cell type enhanced" "Detected in many" "gdT-cell: 3.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054284 Enhanced "HPA054284: " "unprognostic (3.18e-2)" "unprognostic (1.12e-3)" "unprognostic (2.36e-3)" "unprognostic (2.15e-2)" "unprognostic (5.55e-2)" "unprognostic (8.32e-2)" "unprognostic (2.46e-1)" "unprognostic (2.06e-2)" "unprognostic (1.04e-1)" "unprognostic (2.00e-1)" "unprognostic (1.72e-1)" "unprognostic (1.40e-1)" "unprognostic (1.17e-3)" "unprognostic (2.77e-1)" "unprognostic (3.59e-2)" "unprognostic (1.83e-1)" "unprognostic (1.04e-3)" 0.4 0.4 1.4 0.8 2.0 0.0 1.1 0.2 0.9 2.6 0.4 6.7 0.8 1.0 1.0 16.0 0.2 17.9 0.6 0.2 3.0 2.6 0.6 0.3 7.6 0.2 0.5 0.2 8.2 0.9 1.8 1.1 0.5 13.8 1.0 0.3 0.5 0.6 1.3 0.1 0.3 1.1 0.3 0.6 0.2 2.5 28.5 2.8 0.0 1.4 0.1 0.3 0.9 0.3 0.8 0.4 0.0 1.6 1.2 3.6 0.8 0.9 0.2 0.8 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.6 0.3 0.1 0.2 0.1 0.0 0.1 13.5 0.1 0.0 0.0 0.0 0.2 1.1 38.9 0.4 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.2 0.0 3.4 0.1 4.0 0.0 0.0 4.4 0.0 20.9 0.0 0.1 0.0 1.6 0.0 3.6 0.6 0.1 0.8 0.4 1.2 0.4 0.0 0.0 1.5 0.0 1.2 1.2 0.0 0.0 0.8 1.4 2.0 0.2 0.9 3.0 2.6 0.5 0.2 13.8 2.8 FIBCD1 FLJ14810 ENSG00000130720 "Fibrinogen C domain containing 1" Q8N539 9 130902438-130939286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;parathyroid gland: 10.7;testis: 9.5" "Cell line enhanced" "Detected in some" "MCF7: 21.9;RPTEC TERT1: 17.0;THP-1: 8.4;U-2 OS: 11.7;U-251 MG: 9.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 11 "hippocampal formation: 19.2" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 5.7" "Lineage enriched" "Detected in single" 11 "monocytes: 5.7" "Group enriched" "Detected in many" 4 "basal ganglia: 18.2;hippocampal formation: 75.0" "Region enriched" "Detected in many" 4 "hippocampal formation: 81.5" HPA055353 Approved Supported "Cell Junctions" "Cell Junctions" "HPA055353: " "unprognostic (1.18e-3)" "unprognostic (2.70e-1)" "unprognostic (4.69e-2)" "unprognostic (5.63e-2)" "unprognostic (9.11e-2)" "unprognostic (1.62e-1)" "unprognostic (4.16e-5)" "unprognostic (1.83e-3)" "unprognostic (3.14e-1)" "unprognostic (1.28e-1)" "unprognostic (2.05e-2)" "unprognostic (4.45e-2)" "unprognostic (1.42e-6)" "unprognostic (1.66e-1)" "unprognostic (5.53e-2)" "unprognostic (6.68e-3)" "unprognostic (2.77e-1)" 0.0 8.5 1.7 0.1 1.1 0.0 1.1 0.1 3.0 0.0 1.8 0.3 0.0 0.5 0.0 1.4 0.4 0.0 5.0 2.0 19.2 1.2 0.0 0.0 5.3 0.0 0.6 0.0 0.4 0.0 10.7 0.0 1.7 1.5 1.0 1.4 1.1 1.6 0.0 0.0 0.0 1.6 2.1 0.0 0.8 0.1 9.5 0.8 0.0 0.3 0.0 0.0 2.9 0.0 0.0 0.5 0.0 5.7 0.0 0.0 0.2 0.3 2.4 0.8 0.0 0.0 0.0 0.0 5.2 6.1 0.3 0.8 0.0 2.6 0.0 1.9 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.2 0.2 0.0 0.1 2.8 0.0 0.0 0.6 0.0 0.0 21.9 0.0 2.3 1.5 0.5 0.0 4.6 0.3 17.0 0.0 0.1 0.0 0.7 0.0 0.6 1.4 8.4 0.0 0.9 11.7 0.1 9.5 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.2 1.7 1.1 0.1 1.0 19.2 1.2 0.6 0.0 1.5 0.8 FJX1 "FLJ22416, FLJ25593" ENSG00000179431 "Four jointed box 1" Q86VR8 11 35618419-35620868 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4" "Cell line enhanced" "Detected in many" "U-251 MG: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059220 Uncertain Approved Vesicles "Intracellular and membrane" Vesicles "HPA059220: " "unprognostic (8.99e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-3)" "unprognostic (5.20e-2)" "unprognostic (5.72e-2)" "unprognostic (9.56e-3)" "unprognostic (5.16e-2)" "unprognostic (1.06e-2)" "unprognostic (1.74e-1)" "unprognostic (4.39e-3)" "unprognostic (5.28e-2)" "unprognostic (2.02e-1)" "prognostic unfavourable (9.24e-9)" "unprognostic (1.64e-2)" "unprognostic (9.64e-2)" "unprognostic (8.35e-2)" "prognostic unfavourable (6.56e-4)" 6.0 3.5 7.8 3.5 10.3 0.7 3.6 6.6 25.4 8.8 1.4 7.9 0.0 1.1 10.1 3.4 3.1 6.1 4.5 2.4 8.0 4.9 3.8 4.9 2.2 2.3 5.7 5.7 12.2 17.0 1.7 1.8 6.6 7.7 4.1 1.1 2.7 2.6 4.7 1.1 10.3 1.1 3.4 5.1 7.8 1.7 1.2 3.3 1.7 2.2 3.0 3.4 3.7 2.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 9.9 5.0 5.3 1.7 1.8 5.8 1.6 11.2 7.6 10.8 7.8 6.3 3.1 0.0 2.6 4.4 10.6 1.8 18.5 9.2 0.1 14.6 0.9 1.9 0.2 4.4 1.1 0.0 2.2 14.1 5.6 17.1 4.9 5.3 0.0 10.3 2.3 0.3 0.0 7.3 14.8 0.6 11.8 2.3 8.2 12.3 5.0 2.8 1.2 0.9 3.1 21.3 0.2 9.5 8.6 15.8 1.6 26.4 0.0 0.0 0.0 15.3 0.5 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 10.3 6.6 12.3 8.0 4.9 5.7 5.7 7.7 3.3 FKBP1B "FKBP12.6, FKBP1L, FKBP9, OTK4, PPIase" ENSG00000119782 "FK506 binding protein 1B" P68106 2 24049701-24063681 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.1;intestine: 24.9" "Cell line enhanced" "Detected in many" "Hep G2: 22.8;NTERA-2: 22.2;SH-SY5Y: 16.1;TIME: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 5.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045572, HPA051798" Uncertain Approved Vesicles Vesicles "HPA045572: , HPA051798: " "unprognostic (3.01e-3)" "unprognostic (3.35e-1)" "unprognostic (7.05e-2)" "unprognostic (9.89e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-2)" "unprognostic (9.19e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-1)" "unprognostic (9.55e-2)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (7.53e-2)" "unprognostic (3.43e-2)" "unprognostic (2.85e-2)" "unprognostic (1.45e-1)" 2.9 5.9 25.0 2.8 30.7 1.9 5.9 15.7 23.1 5.1 7.2 1.6 7.4 24.9 3.6 4.2 4.5 4.5 7.1 3.4 31.1 14.0 4.4 4.6 9.0 2.2 13.0 19.7 4.6 4.9 6.4 2.8 5.6 7.9 5.1 4.6 2.4 3.3 9.2 1.1 3.6 6.7 4.0 5.2 1.8 13.3 1.6 4.4 0.6 5.0 1.1 3.2 7.1 3.5 1.5 2.2 4.4 0.8 0.3 5.4 1.1 0.1 1.0 8.9 0.0 5.6 2.2 3.1 3.0 3.1 1.3 1.9 0.6 1.0 0.0 2.2 5.2 3.4 13.1 10.2 0.8 1.5 8.4 3.0 0.1 22.8 2.1 0.0 7.3 2.1 2.4 3.0 0.6 8.3 0.7 0.0 2.9 0.1 0.9 0.0 22.2 1.5 1.5 0.7 0.0 1.0 0.6 2.2 16.1 0.1 0.0 2.8 0.6 1.1 19.4 0.0 2.8 0.1 0.7 0.5 0.2 0.0 3.2 0.0 0.7 1.3 0.8 4.4 0.3 0.7 0.0 0.3 0.6 0.5 2.2 1.5 0.0 0.2 0.1 0.3 0.0 0.4 5.4 1.1 25.0 30.7 15.7 23.1 31.1 14.0 13.0 19.7 7.9 4.4 FLRT1 "MGC21624, SPG68" ENSG00000126500 "Fibronectin leucine rich transmembrane protein 1" Q9NZU1 11 64103188-64119173 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.6;brain: 13.0" "Cell line enhanced" "Detected in some" "Karpas-707: 4.4;SCLC-21H: 6.0;SH-SY5Y: 14.9;THP-1: 11.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054589 Uncertain "Intracellular and membrane" "HPA054589: " "unprognostic (5.13e-3)" "unprognostic (1.55e-1)" "unprognostic (1.63e-1)" "unprognostic (8.65e-2)" "unprognostic (2.89e-1)" "unprognostic (9.55e-2)" "unprognostic (2.61e-3)" "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (2.98e-1)" "unprognostic (4.64e-3)" "unprognostic (6.02e-2)" "unprognostic (1.79e-1)" "unprognostic (2.62e-2)" "unprognostic (5.62e-2)" "unprognostic (1.29e-3)" "unprognostic (4.37e-2)" 0.2 7.6 3.6 0.4 5.3 0.0 0.0 2.7 13.0 4.6 2.5 0.7 2.6 0.0 0.6 1.0 0.7 0.9 3.6 3.2 3.0 0.2 0.0 0.0 2.7 0.1 0.3 0.0 0.6 0.1 0.5 0.5 0.9 1.6 0.3 1.6 1.1 0.9 2.7 0.0 0.5 0.2 3.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 3.0 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.5 0.0 1.0 0.7 4.1 0.0 0.0 0.7 0.2 0.0 1.0 0.0 0.3 4.4 0.0 0.5 0.1 0.6 1.3 0.2 0.9 0.2 0.1 0.0 0.3 6.0 14.9 0.3 0.3 0.4 0.4 11.9 0.1 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.2 3.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FLT3 "CD135, FLK2, STK1" ENSG00000122025 "Fms related tyrosine kinase 3" P36888 13 28003274-28100592 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.9;brain: 19.3;lymphoid tissue: 15.0" "Group enriched" "Detected in some" 11 "REH: 27.8;THP-1: 17.1" "Cancer enhanced" "Detected in some" "breast cancer: 1.8" "Region enhanced" "Detected in many" "cerebellum: 19.3" "Group enriched" "Detected in some" 11 "myeloid DC: 29.9;plasmacytoid DC: 12.1" "Lineage enriched" "Detected in many" 16 "dendritic cells: 29.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047539 Approved "Endoplasmic reticulum" 180000 "Endoplasmic reticulum" "HPA047539: " "unprognostic (2.19e-3)" "unprognostic (3.16e-3)" "unprognostic (6.54e-3)" "unprognostic (9.96e-2)" "unprognostic (3.88e-1)" "unprognostic (3.96e-7)" "unprognostic (7.99e-3)" "unprognostic (1.65e-2)" "unprognostic (5.37e-2)" "unprognostic (1.01e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" "unprognostic (3.65e-1)" "unprognostic (3.91e-2)" "unprognostic (2.51e-1)" "unprognostic (2.22e-1)" 0.9 0.6 0.6 7.2 1.1 7.5 2.6 19.3 3.5 0.9 1.2 0.1 0.1 0.4 0.8 0.8 1.0 1.2 4.6 0.5 0.9 1.7 2.8 0.7 2.7 15.0 1.8 1.1 0.5 5.7 0.0 0.4 0.0 7.4 0.6 1.4 0.1 2.3 0.6 0.4 1.2 3.0 1.3 4.4 8.8 0.9 1.2 0.0 8.2 0.6 0.0 5.8 2.4 0.7 0.1 29.9 1.4 1.8 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.5 0.0 27.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 1.4 0.0 0.3 0.0 0.1 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.8 0.0 12.1 0.0 1.2 0.6 1.1 19.3 3.5 0.9 1.7 1.8 1.1 7.4 0.0 FMN2 ENSG00000155816 "Formin 2" Q9NZ56 1 240014348-240475189 "Disease related genes, Predicted intracellular proteins" "DNA damage, Protein transport, Stress response, Transport" "Actin-binding, Developmental protein" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 41.0;parathyroid gland: 26.6" "Cell line enhanced" "Detected in some" "BJ: 26.5;fHDF/TERT166: 26.1;LHCN-M2: 28.7;U-138 MG: 19.0;WM-115: 29.6" "Group enriched" "Detected in some" 8 "glioma: 5.9;testis cancer: 3.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA050649 Approved "Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" "HPA050649: " "unprognostic (1.55e-2)" "unprognostic (8.21e-2)" "unprognostic (4.01e-2)" "unprognostic (8.06e-2)" "unprognostic (2.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.97e-3)" "unprognostic (2.11e-2)" "unprognostic (2.93e-1)" "unprognostic (3.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.08e-1)" "unprognostic (1.11e-2)" "unprognostic (8.03e-3)" "unprognostic (9.78e-2)" "unprognostic (3.10e-2)" "unprognostic (1.40e-3)" 1.2 7.3 17.1 1.3 14.5 0.9 1.3 17.2 41.0 1.1 3.2 9.4 0.0 1.4 2.5 2.1 2.1 3.7 2.0 0.9 16.2 11.8 2.9 0.9 1.4 0.9 9.9 15.5 3.9 2.1 26.6 5.6 1.2 12.2 2.9 3.0 1.4 1.3 3.6 0.9 1.0 1.3 2.7 12.3 1.2 1.2 3.4 12.3 0.0 1.3 0.0 1.0 1.2 0.4 0.5 0.4 0.6 0.3 0.4 2.3 0.0 0.0 0.8 2.8 0.0 7.2 5.5 0.0 26.5 14.0 10.5 5.7 0.0 0.0 0.0 0.0 26.1 0.0 0.4 0.0 10.3 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.6 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.9 0.8 0.0 0.1 0.0 0.0 0.0 4.4 3.9 0.0 0.1 0.1 1.1 0.0 0.1 19.0 0.1 7.1 6.9 0.0 0.0 0.0 3.7 0.0 29.6 0.6 0.3 0.1 0.3 0.2 0.2 0.1 0.9 0.1 0.1 0.5 2.3 1.4 0.5 0.4 0.1 0.4 0.3 0.0 17.1 14.5 17.2 19.3 16.2 11.8 9.9 15.5 12.2 12.3 FMNL2 "FHOD2, KIAA1902" ENSG00000157827 "Formin like 2" Q96PY5 2 152335237-152649834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.1" "Cell line enhanced" "Detected in many" "BEWO: 56.7;hTERT-HME1: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.7;non-classical monocyte: 4.2" "Lineage enriched" "Detected in single" 5 "monocytes: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005464 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" Cytosol "Golgi apparatus, Plasma membrane" "HPA005464: AB_1848965" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (8.75e-3)" "unprognostic (3.06e-2)" "unprognostic (7.40e-2)" "unprognostic (9.45e-2)" "prognostic unfavourable (9.04e-4)" "unprognostic (1.34e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (2.54e-1)" "unprognostic (4.66e-2)" "unprognostic (5.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.58e-1)" "unprognostic (3.73e-2)" "unprognostic (1.58e-1)" 15.1 13.6 26.2 7.0 44.6 0.8 9.4 18.3 55.0 8.5 6.6 55.0 1.4 5.8 13.6 10.2 4.6 6.7 11.1 4.8 32.0 20.6 9.7 5.3 17.9 8.2 63.4 27.9 35.9 7.4 17.8 10.2 35.9 39.2 8.9 8.4 5.4 20.1 8.2 31.0 4.0 5.5 10.7 74.1 12.0 8.2 5.8 56.7 1.3 14.5 3.2 5.4 9.1 11.6 0.0 0.9 0.0 4.2 0.0 0.1 0.0 4.0 4.3 13.6 7.5 16.5 17.8 56.7 4.1 8.5 7.4 10.4 4.6 0.2 0.0 8.9 3.6 4.7 6.5 13.2 11.8 0.0 6.8 0.0 2.8 19.9 4.7 1.1 0.2 11.6 8.2 14.3 36.9 13.0 0.1 0.1 4.0 1.1 0.2 1.2 8.7 8.8 7.3 2.9 5.9 21.6 2.8 13.9 11.3 3.5 1.3 14.4 0.3 0.4 14.4 11.2 0.3 3.7 7.1 0.3 0.1 0.0 10.4 0.9 22.7 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.2 0.9 0.1 0.0 26.2 44.6 18.3 36.7 32.0 20.6 63.4 27.9 39.2 56.7 FNDC10 C1orf233 ENSG00000228594 "Fibronectin type III domain containing 10" F2Z333 1 1598012-1600096 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.9;brain: 17.2" "Cell line enhanced" "Detected in many" "HMC-1: 19.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 4.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (9.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-1)" "unprognostic (1.11e-1)" "unprognostic (3.22e-2)" "unprognostic (8.35e-2)" "unprognostic (7.32e-3)" "unprognostic (4.33e-2)" "unprognostic (3.33e-1)" "unprognostic (3.12e-1)" "unprognostic (2.72e-2)" "unprognostic (1.97e-1)" "prognostic favourable (1.11e-4)" "unprognostic (2.09e-2)" "unprognostic (1.50e-1)" "unprognostic (6.00e-2)" "unprognostic (5.76e-2)" 1.6 16.9 10.2 2.6 7.6 4.0 2.7 6.3 17.2 2.2 2.0 2.1 0.0 3.9 1.0 1.3 8.5 1.6 3.9 1.6 10.1 16.3 2.1 0.7 3.8 3.3 9.4 8.6 2.2 1.7 0.4 6.2 2.0 17.1 0.9 1.1 4.5 2.7 1.0 0.6 10.4 2.8 1.2 5.6 3.7 3.1 6.3 1.5 0.1 6.3 2.0 2.0 3.3 1.6 0.1 2.1 4.5 2.4 0.1 1.0 0.6 0.0 2.8 2.7 8.3 5.5 1.3 3.8 6.5 1.3 10.5 0.5 2.4 11.6 0.0 7.7 3.1 1.6 0.6 1.4 0.9 0.0 2.4 0.1 2.9 6.0 1.3 1.9 19.2 1.8 6.5 0.5 0.0 0.6 5.2 0.0 1.2 12.4 1.5 6.0 11.4 4.0 0.0 0.0 6.3 3.7 0.6 12.4 10.2 6.9 10.3 6.8 0.0 6.2 1.1 0.0 2.0 4.5 0.0 2.0 0.2 0.1 0.0 4.1 2.9 0.0 2.4 4.5 0.4 1.7 0.5 0.1 0.9 1.0 2.1 0.1 1.0 0.6 0.2 0.1 2.0 0.0 0.7 0.6 10.2 7.6 6.3 17.2 10.1 16.3 9.4 8.6 17.1 1.5 FNDC7 FLJ35838 ENSG00000143107 "Fibronectin type III domain containing 7" Q5VTL7 1 108712657-108742740 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.0;testis: 5.2" "Cell line enhanced" "Detected in some" "Karpas-707: 1.2;PC-3: 1.1;U-87 MG: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028079, HPA054297" Enhanced Approved "Nucleoplasm,Actin filaments" "Secreted in male reproductive system" "Actin filaments" Nucleoplasm "HPA028079: AB_10602501, HPA054297: " "unprognostic (2.35e-2)" "unprognostic (2.65e-2)" "unprognostic (3.74e-1)" "unprognostic (8.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-4)" "unprognostic (1.90e-10)" "unprognostic (1.59e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 0.1 0.1 0.6 0.1 0.8 0.6 0.1 0.4 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.7 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.8 0.1 3.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 5.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.5 0.6 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.5 0.0 0.9 0.0 0.0 0.1 0.2 0.1 0.6 0.2 0.3 0.0 0.0 1.2 0.5 0.0 0.1 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.5 0.3 0.3 0.1 0.4 0.2 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.4 1.1 1.7 0.7 0.1 0.1 3.0 0.1 FNDC9 "C5orf40, MGC27121" ENSG00000172568 "Fibronectin type III domain containing 9" Q8TBE3 5 157341600-157345721 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "adrenal gland: 9.4;brain: 24.0;pituitary gland: 10.0" "Cell line enhanced" "Detected in some" "Daudi: 1.7;HeLa: 1.8;Karpas-707: 3.0;U-266/70: 1.6" "Cancer enriched" "Detected in single" 16 "glioma: 0.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 5 "basal ganglia: 21.9;hypothalamus: 28.4" "Low region specificity" "Detected in all" HPA011115 Uncertain "HPA011115: AB_1079374" "unprognostic (2.35e-3)" "unprognostic (3.80e-2)" "unprognostic (2.93e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-3)" "unprognostic (3.40e-1)" "unprognostic (1.95e-1)" "unprognostic (1.68e-1)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (6.35e-6)" "unprognostic (3.63e-2)" "unprognostic (6.39e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" 0.6 9.4 3.9 1.5 21.1 2.0 0.6 9.1 24.0 0.5 1.1 0.0 0.0 0.6 0.6 0.9 0.5 0.6 0.6 0.7 1.9 22.0 0.7 0.6 0.5 0.9 1.3 3.8 0.5 0.5 0.5 10.0 0.6 5.8 0.6 1.2 0.0 0.5 0.6 0.6 0.6 0.8 0.8 1.3 0.6 0.6 0.5 0.4 0.0 0.6 0.0 0.5 0.6 0.0 0.5 0.3 0.8 0.8 0.0 1.9 0.1 0.0 0.2 0.4 0.4 0.0 0.0 0.4 1.0 0.0 0.2 0.0 0.2 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.0 0.3 0.3 1.6 0.0 1.0 0.3 0.0 0.1 0.0 0.0 0.8 1.9 0.2 0.1 0.0 0.6 1.3 0.0 0.5 0.8 1.5 0.2 0.0 0.8 0.3 0.0 0.1 3.9 21.1 9.1 13.3 1.9 22.0 1.3 3.8 5.8 0.4 FNTB FPTB ENSG00000257365 "Farnesyltransferase, CAAX box, beta" P49356 14 64986720-65062652 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 75.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062743 Uncertain Approved Centrosome Centrosome "HPA062743: " "unprognostic (2.79e-1)" "unprognostic (1.50e-2)" "unprognostic (1.54e-1)" "unprognostic (8.57e-3)" "unprognostic (1.88e-1)" "unprognostic (6.88e-2)" "prognostic unfavourable (6.03e-4)" "unprognostic (6.21e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-2)" "unprognostic (1.70e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-3)" "unprognostic (2.36e-2)" "unprognostic (3.60e-1)" "unprognostic (5.56e-2)" "unprognostic (1.11e-3)" 7.4 9.0 6.3 4.9 21.9 2.3 7.8 11.4 13.7 8.0 6.3 24.3 6.2 5.6 6.4 6.6 13.5 9.0 5.1 12.0 8.1 7.9 8.0 5.6 7.0 5.1 34.0 7.2 7.4 5.9 13.6 7.9 8.2 25.4 8.9 7.9 4.4 8.0 9.6 14.3 10.3 5.1 11.6 75.0 4.6 5.7 9.0 22.2 4.7 5.6 5.8 7.3 7.4 7.8 2.4 6.4 12.3 10.3 2.8 8.8 5.3 18.3 13.4 10.4 5.9 6.7 5.9 7.6 10.6 7.8 12.0 12.4 7.1 7.6 3.1 6.1 11.2 12.2 25.0 8.3 9.9 4.4 7.0 12.4 3.6 10.3 4.4 4.2 17.2 5.0 7.2 5.2 2.8 10.0 6.7 4.5 7.0 12.1 6.4 7.0 4.5 13.6 6.3 9.7 3.9 8.3 6.8 6.6 6.6 6.6 13.0 14.4 12.0 7.4 7.9 8.7 18.0 3.9 6.8 2.3 2.6 3.2 10.1 5.5 20.1 12.3 10.3 9.2 3.6 8.6 8.8 2.4 5.5 4.3 6.4 1.9 4.5 3.3 2.7 2.8 4.3 4.9 5.1 5.3 6.3 21.9 11.4 13.7 8.1 7.9 34.0 7.2 25.4 22.2 FO681492.1 ENSG00000277758 10 47750864-47763592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.2;brain: 6.7;lung: 10.6" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 36.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.2" "Low lineage specificity" "Detected in many" "HPA036971, HPA036972, HPA064559" Approved Approved "Golgi apparatus" "Golgi apparatus" "HPA036971: , HPA036972: , HPA064559: " "unprognostic (2.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-2)" "unprognostic (5.70e-2)" "unprognostic (4.59e-1)" "unprognostic (2.51e-1)" "unprognostic (2.06e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (2.69e-2)" "unprognostic (1.97e-1)" "unprognostic (3.49e-5)" "unprognostic (4.52e-2)" "unprognostic (5.13e-2)" "unprognostic (6.35e-2)" "unprognostic (1.11e-2)" 0.5 0.0 0.1 0.0 0.0 6.7 0.3 0.0 0.0 0.1 0.0 2.4 1.1 0.4 0.4 0.0 0.0 10.6 2.3 0.3 1.4 0.0 1.1 0.0 0.0 1.4 0.4 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.9 0.7 2.5 0.4 5.2 0.9 1.1 0.4 0.5 4.1 0.0 0.6 0.0 0.0 0.0 1.3 0.0 0.1 0.0 2.6 2.9 0.0 0.2 1.1 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.2 2.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 3.2 36.1 0.1 3.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.3 2.3 0.3 0.7 2.8 1.1 0.7 1.1 0.8 2.5 0.3 0.5 0.7 0.4 0.9 5.2 1.0 0.7 0.4 FOCAD "FLJ20375, KIAA1797" ENSG00000188352 Focadhesin Q5VW36 9 20658309-20995955 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 62.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "pons and medulla: 62.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055015 Uncertain Uncertain Mitochondria Mitochondria "HPA055015: " "unprognostic (3.05e-2)" "unprognostic (1.02e-1)" "prognostic favourable (3.25e-4)" "unprognostic (3.69e-3)" "unprognostic (4.14e-2)" "unprognostic (5.35e-2)" "prognostic unfavourable (4.41e-5)" "unprognostic (9.64e-2)" "unprognostic (7.38e-2)" "unprognostic (1.23e-1)" "unprognostic (5.26e-2)" "unprognostic (9.15e-2)" "prognostic favourable (3.09e-8)" "unprognostic (1.90e-1)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (1.41e-2)" 3.6 9.0 4.5 3.6 7.2 1.9 3.9 8.7 9.0 4.9 4.8 15.0 3.6 1.8 3.9 6.3 3.6 7.4 3.6 5.3 7.1 7.3 3.8 3.6 3.7 3.6 4.4 3.6 3.6 5.5 10.4 11.8 4.1 62.1 5.6 5.6 6.8 5.8 3.7 5.1 4.2 3.6 4.7 3.6 3.6 4.2 3.6 3.6 3.6 11.8 3.6 3.6 3.6 3.6 3.4 6.9 8.9 5.7 4.5 7.1 3.1 16.1 11.2 12.2 9.1 11.4 13.1 6.4 9.6 15.4 6.8 7.9 7.4 5.6 6.6 5.1 13.7 5.6 10.5 19.0 12.0 29.4 7.8 5.2 13.8 9.1 5.9 8.6 6.7 12.1 13.1 6.8 11.2 26.1 0.1 9.8 11.4 6.2 6.4 16.2 9.6 11.3 0.0 5.5 4.4 10.6 7.0 8.1 4.1 6.3 10.9 2.6 6.8 5.0 15.9 0.0 4.5 7.5 8.7 2.4 13.5 7.5 0.0 12.1 4.0 8.9 2.8 8.0 5.3 5.7 7.1 2.7 4.7 5.1 6.9 3.4 4.2 5.0 2.2 4.5 3.1 2.8 4.3 3.1 4.5 7.2 8.7 9.0 7.1 7.3 4.4 3.6 62.1 3.6 FOLH1 "FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA" ENSG00000086205 "Folate hydrolase 1" Q04609 11 49146635-49208670 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.7;intestine: 111.2;prostate: 33.8" "Cell line enhanced" "Detected in some" "HAP1: 5.3;RPMI-8226: 3.7;SK-BR-3: 4.4;TIME: 2.8;WM-115: 5.3" "Cancer enriched" "Detected in many" 27 "prostate cancer: 142.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001451, HPA010593" Enhanced "CAB001451: AB_563979, HPA010593: AB_1079685" "unprognostic (1.33e-1)" "unprognostic (1.19e-1)" "unprognostic (1.24e-1)" "prognostic favourable (5.24e-5)" "unprognostic (2.55e-1)" "unprognostic (8.31e-2)" "prognostic favourable (4.25e-4)" "unprognostic (1.32e-1)" "unprognostic (2.09e-2)" "unprognostic (2.67e-3)" "unprognostic (2.13e-2)" "unprognostic (2.72e-1)" "prognostic unfavourable (1.30e-6)" "unprognostic (4.81e-2)" "unprognostic (7.27e-2)" "unprognostic (4.74e-3)" "unprognostic (4.04e-1)" 1.2 1.0 10.4 0.9 16.4 0.8 2.5 1.4 12.7 1.4 67.6 37.7 0.0 111.2 1.3 0.8 1.2 2.1 5.0 0.7 16.9 8.7 6.1 15.7 1.1 0.9 19.0 9.1 1.0 0.7 0.7 0.4 0.7 17.7 33.8 0.8 0.6 20.7 0.8 0.6 1.2 61.1 1.0 33.0 1.5 1.0 0.9 16.2 0.0 1.0 0.0 0.8 1.2 0.5 0.9 0.1 0.3 0.8 1.4 1.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.6 0.0 0.2 5.3 0.5 0.0 1.2 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 1.0 0.0 0.3 0.3 3.7 0.0 0.0 0.4 1.6 0.0 4.4 1.0 1.0 0.0 2.8 0.2 2.7 0.4 0.3 0.1 0.5 0.1 0.0 0.9 5.3 0.1 0.8 0.3 0.9 0.6 0.2 0.6 1.2 0.5 0.0 0.9 0.7 0.3 0.2 1.4 0.5 0.1 0.4 0.0 10.4 16.4 1.4 12.7 16.9 8.7 19.0 9.1 17.7 16.2 FOLR1 FOLR ENSG00000110195 "Folate receptor 1" P15328 11 72189558-72196323 "Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" Transport Receptor Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 157.6;salivary gland: 101.2" "Group enriched" "Detected in some" 7 "HeLa: 81.7;RPTEC TERT1: 86.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 259.5" "Region enriched" "Detected in many" 20 "pons and medulla: 157.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0" "Low region specificity" "Detected in all" HPA077030 Approved "Nuclear membrane" "Secreted to blood" 81000 "Nuclear membrane" "HPA077030: " "unprognostic (3.30e-1)" "unprognostic (2.19e-1)" "unprognostic (6.55e-2)" "unprognostic (3.49e-2)" "unprognostic (7.67e-3)" "unprognostic (1.98e-2)" "prognostic unfavourable (2.50e-4)" "unprognostic (1.18e-2)" "unprognostic (8.13e-2)" "unprognostic (2.47e-2)" "unprognostic (2.58e-2)" "unprognostic (2.87e-3)" "unprognostic (1.67e-1)" "unprognostic (2.52e-1)" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (2.69e-1)" 0.0 0.7 1.3 0.2 1.7 0.0 6.6 0.6 3.5 31.4 0.1 21.4 2.8 0.0 1.0 3.5 1.6 46.7 1.0 0.2 7.9 1.8 38.8 0.2 47.0 0.0 0.8 0.4 8.9 1.8 0.4 3.5 24.5 157.6 1.5 0.0 17.0 101.2 4.0 0.1 0.9 0.1 0.0 0.7 0.0 7.4 0.4 0.2 0.0 12.7 2.6 3.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 7.6 7.7 0.0 7.9 0.1 0.1 0.4 0.3 0.0 0.0 0.2 0.1 81.7 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.6 0.0 86.8 0.0 0.0 0.5 0.2 1.2 0.0 11.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.3 1.7 0.6 3.5 7.9 1.8 0.8 0.4 157.6 0.2 FOXB1 "FKH5, HFKH-5" ENSG00000171956 "Forkhead box B1" Q99853 15 60004222-60061730 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 16.7" "Group enriched" "Detected in some" 4 "AF22: 7.0;HDLM-2: 15.2;HEK 293: 11.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Region enhanced" "Detected in many" "pons and medulla: 16.7" "Cell type enriched" "Detected in single" 4 "T-reg: 3.8" "Lineage enriched" "Detected in single" 38 "T-cells: 3.8" "Region enhanced" "Detected in some" "hypothalamus: 7.7" "Low region specificity" "Detected in many" HPA073369 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA073369: " "unprognostic (1.69e-1)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.40e-3)" "unprognostic (1.33e-3)" "unprognostic (1.17e-2)" "unprognostic (1.47e-2)" "unprognostic (5.32e-4)" "unprognostic (1.06e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-1)" "unprognostic (8.12e-9)" "unprognostic (8.74e-2)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" 0.0 0.0 0.3 0.5 4.1 0.2 0.2 0.6 0.0 0.1 0.1 0.6 0.0 0.0 0.6 0.0 0.2 0.9 0.1 0.2 0.1 6.2 0.0 0.1 0.1 1.8 6.5 0.0 0.0 0.4 0.0 0.0 1.9 16.7 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 8.4 0.1 1.8 2.6 3.7 0.0 0.1 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 2.6 0.0 7.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.2 11.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.3 4.1 0.6 0.0 0.1 6.2 6.5 0.0 16.7 3.7 FOXB2 bA159H20.4 ENSG00000204612 "Forkhead box B2" Q5VYV0 9 77019655-77020953 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "brain: 2.6" "Cell line enriched" "Detected in single" 8 "NTERA-2: 5.3" "Cancer enhanced" "Detected in single" "prostate cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 16 "hypothalamus: 1.4" "Group enriched" "Detected in many" 4 "basal ganglia: 3.1;hypothalamus: 6.4;midbrain: 2.0;pons and medulla: 2.0" HPA067947 Uncertain "HPA067947: " "unprognostic (2.02e-1)" "unprognostic (8.58e-2)" "unprognostic (2.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4 "FKHL9, FOXD4a, FREAC5" ENSG00000170122 "Forkhead box D4" Q12950 9 116231-118204 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.7;testis: 3.1" "Cell line enhanced" "Detected in many" "THP-1: 8.7" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" HPA012836 Uncertain Approved Nucleoplasm Nucleoplasm "HPA012836: AB_2105429" "unprognostic (8.27e-2)" "unprognostic (1.09e-2)" "unprognostic (2.38e-3)" "unprognostic (4.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-3)" "unprognostic (1.22e-1)" "unprognostic (4.20e-2)" "unprognostic (9.46e-2)" "unprognostic (2.52e-4)" "unprognostic (3.66e-4)" "unprognostic (7.06e-3)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "unprognostic (6.26e-2)" "unprognostic (1.02e-3)" 0.6 0.6 1.2 0.5 1.4 0.1 0.1 5.7 1.5 0.4 0.2 0.4 0.7 0.1 0.1 0.3 0.1 0.2 1.3 1.5 1.6 0.2 0.6 0.7 0.8 0.3 0.5 0.2 0.7 0.6 0.7 0.3 0.3 0.5 1.4 0.3 0.6 0.4 0.4 1.0 0.6 3.1 0.2 0.2 0.2 0.1 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.6 0.5 0.0 0.4 0.8 0.4 3.6 0.2 0.4 0.0 0.3 1.0 0.2 3.7 0.6 0.0 0.0 0.9 0.2 0.3 3.5 3.0 0.0 0.5 0.3 0.2 2.5 1.9 0.5 0.0 0.0 0.1 0.0 1.2 1.6 0.1 1.3 0.3 2.1 0.1 1.8 0.3 0.8 0.5 0.9 1.8 1.7 1.4 1.0 0.5 0.0 0.9 8.7 0.5 1.1 1.1 0.7 1.3 0.1 0.4 0.8 0.8 2.0 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L1 FOXD5 ENSG00000184492 "Forkhead box D4 like 1" Q9NU39 2 113498665-113501155 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.2;bone marrow: 3.0;brain: 3.3;lymphoid tissue: 1.2;testis: 3.1" "Cell line enhanced" "Detected in some" "RH-30: 5.2;THP-1: 3.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 22 "naive B-cell: 2.2" "Lineage enriched" "Detected in single" 22 "B-cells: 2.2" HPA012836 Uncertain Approved Nucleoplasm Nucleoplasm "HPA012836: AB_2105429" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" "unprognostic (3.02e-2)" "unprognostic (6.61e-2)" "unprognostic (3.22e-1)" "unprognostic (6.41e-4)" "unprognostic (2.54e-1)" "unprognostic (5.77e-3)" "unprognostic (5.93e-2)" "unprognostic (4.21e-2)" "unprognostic (9.54e-4)" "unprognostic (3.98e-2)" "unprognostic (1.18e-8)" "unprognostic (1.57e-2)" "unprognostic (4.14e-2)" "unprognostic (9.57e-2)" "unprognostic (5.91e-4)" 0.2 0.5 0.4 1.2 1.2 3.0 0.1 3.3 0.8 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.6 0.6 0.4 0.1 0.4 0.4 0.3 0.0 0.2 0.0 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.2 3.1 0.2 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.6 0.6 1.0 0.0 1.5 0.0 0.6 0.0 0.1 0.3 0.0 2.0 0.9 0.1 0.1 0.6 0.0 0.1 1.9 1.3 0.7 1.0 0.9 0.0 2.1 1.6 0.0 0.7 0.2 0.0 0.0 1.2 1.7 0.3 0.1 0.3 0.9 0.0 0.7 0.6 5.2 0.7 0.1 0.6 0.7 0.4 0.5 0.1 0.2 0.4 3.7 0.4 1.7 1.5 0.6 1.3 1.3 1.3 0.7 0.3 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L3 FOXD6 ENSG00000187559 "Forkhead box D4 like 3" Q6VB84 9 68302867-68304905 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.6;fallopian tube: 2.4;lymphoid tissue: 2.0" "Cell line enhanced" "Detected in some" "HDLM-2: 1.7;NB-4: 1.2;THP-1: 1.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 7 "B-cells: 1.0" HPA012836 Uncertain Approved Nucleoplasm Nucleoplasm "HPA012836: AB_2105429" "unprognostic (7.93e-4)" "unprognostic (8.71e-2)" "unprognostic (7.04e-2)" "unprognostic (4.75e-2)" 0.0 0.1 0.7 1.4 1.3 0.0 0.0 2.1 2.3 0.3 0.1 0.0 0.0 0.0 0.0 2.4 0.4 0.0 2.6 0.7 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 2.0 0.0 0.9 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.3 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.2 0.0 0.2 0.5 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.6 0.1 0.8 0.5 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L4 "bA460E7.2, FOXD4L2" ENSG00000184659 "Forkhead box D4 like 4" Q8WXT5 9 65736555-65738784 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.5" "Cell line enhanced" "Detected in some" "AN3-CA: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA012836 Uncertain Approved Nucleoplasm Nucleoplasm "HPA012836: AB_2105429" "unprognostic (6.92e-2)" "unprognostic (5.48e-2)" "unprognostic (5.19e-2)" "unprognostic (7.78e-2)" "unprognostic (7.93e-3)" "unprognostic (7.14e-2)" 0.4 0.6 0.3 1.0 1.2 0.0 0.2 1.5 1.3 0.7 0.2 0.0 0.2 0.0 0.2 0.2 0.1 0.4 1.0 0.7 0.2 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.2 0.2 0.2 0.1 0.4 0.1 0.4 0.0 0.4 0.1 0.2 0.5 0.1 0.5 0.0 0.2 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.5 1.4 0.0 0.2 0.3 0.7 0.0 0.0 0.2 1.0 0.0 0.5 0.2 0.2 0.0 0.2 0.0 0.0 0.2 1.1 0.2 0.5 0.0 0.2 0.2 0.7 0.3 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.0 0.5 0.2 0.0 0.1 0.3 0.2 0.0 0.0 0.3 0.7 1.0 0.4 0.0 0.2 0.7 0.0 0.1 0.5 0.0 0.4 1.0 0.5 0.7 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L5 bA15J10.2 ENSG00000204779 "Forkhead box D4 like 5" Q5VV16 9 65282101-65285209 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 2.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA012836 Uncertain Approved Nucleoplasm Nucleoplasm "HPA012836: AB_2105429" "unprognostic (8.26e-2)" "unprognostic (6.95e-3)" "unprognostic (1.58e-1)" "unprognostic (5.76e-2)" "unprognostic (2.57e-1)" 0.7 1.1 0.3 0.1 0.5 0.0 0.7 0.6 2.2 0.3 0.1 0.1 0.1 1.1 0.4 0.7 0.1 0.2 1.0 0.5 0.5 0.2 0.3 0.2 0.3 0.2 0.2 0.0 0.2 0.5 0.3 0.0 1.2 0.1 0.5 2.0 0.3 0.0 0.2 0.2 0.4 1.0 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.2 1.1 0.7 2.8 0.5 0.3 3.4 0.6 0.2 0.0 0.0 0.7 0.3 1.9 0.4 0.2 0.0 1.5 0.2 0.2 2.7 1.7 1.8 0.8 0.9 0.0 1.5 2.6 0.2 0.8 0.2 0.5 0.0 2.7 1.1 0.2 0.6 0.3 1.0 0.8 0.9 0.6 2.1 0.7 0.7 1.4 1.4 2.5 0.6 0.3 0.2 0.8 3.4 0.4 0.4 2.1 1.2 1.1 0.8 1.7 0.5 0.3 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L6 ENSG00000273514 "Forkhead box D4 like 6" Q3SYB3 9 41126430-41128463 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 1.8;lymphoid tissue: 1.5" "Cell line enhanced" "Detected in some" "HEK 293: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA012836 Uncertain Approved Nucleoplasm Nucleoplasm "HPA012836: AB_2105429" "unprognostic (2.41e-1)" "unprognostic (3.41e-1)" "unprognostic (3.61e-1)" 0.0 0.0 1.5 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.7 0.2 0.0 0.5 1.0 0.0 0.1 0.1 0.2 0.0 0.0 0.7 0.1 0.0 0.1 1.0 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.2 0.3 0.1 0.0 0.3 0.0 0.0 0.1 0.4 0.6 0.2 0.5 0.5 0.3 0.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.7 0.3 0.0 0.8 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXE3 "FKHL12, FREAC8" ENSG00000186790 "Forkhead box E3" Q13461 1 47416072-47418052 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Aortic aneurysm, Cataract, Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 2.9;lymphoid tissue: 4.6;testis: 2.9" "Cell line enhanced" "Detected in some" "NTERA-2: 3.0;SCLC-21H: 1.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.4" "Group enriched" "Detected in some" 5 "basal ganglia: 2.9;cerebellum: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.11e-1)" "unprognostic (1.31e-2)" "unprognostic (1.23e-3)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (6.24e-2)" "unprognostic (1.24e-2)" "unprognostic (8.21e-2)" "unprognostic (1.49e-1)" "unprognostic (2.34e-1)" "unprognostic (5.15e-2)" "unprognostic (1.04e-1)" "unprognostic (2.39e-7)" "unprognostic (2.41e-1)" "unprognostic (5.46e-2)" "unprognostic (3.60e-1)" 0.2 0.1 0.2 0.1 2.9 0.1 0.1 1.6 0.4 0.8 0.7 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 2.9 0.1 4.6 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.1 0.7 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.6 0.4 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 1.6 0.4 0.3 0.2 0.1 0.1 0.1 0.1 FOXG1 "BF1, FKH2, FKHL1, FKHL2, FKHL3, FKHL4, FOXG1A, FOXG1B, FOXG1C, HBF-3, HFK1, HFK2, HFK3, QIN" ENSG00000176165 "Forkhead box G1" P55316 14 28760330-28770277 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 32.4" "Cell line enhanced" "Detected in some" "HEK 293: 8.3;SCLC-21H: 21.6;U-138 MG: 13.3;U-251 MG: 13.3" "Cancer enriched" "Detected in some" 10 "glioma: 15.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "amygdala: 34.1;basal ganglia: 45.4;cerebral cortex: 40.1;hippocampal formation: 49.3;olfactory region: 31.7" "Group enriched" "Detected in many" 5 "amygdala: 84.2;basal ganglia: 118.5;cerebral cortex: 107.8;hippocampal formation: 165.6;olfactory region: 132.9" "unprognostic (2.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.92e-1)" "unprognostic (3.49e-1)" "unprognostic (1.17e-3)" "unprognostic (2.14e-2)" "unprognostic (1.27e-11)" "unprognostic (4.10e-2)" "unprognostic (1.08e-1)" "unprognostic (1.60e-2)" 0.8 0.8 15.0 0.8 22.4 0.8 0.8 0.0 32.4 0.8 0.8 8.3 0.0 0.8 0.8 0.8 1.2 0.8 0.8 0.8 16.7 2.2 0.8 0.8 0.8 1.5 1.0 14.2 1.3 0.8 0.9 2.1 0.8 0.0 0.8 0.8 0.0 0.8 0.8 0.8 0.8 0.8 0.8 0.0 0.8 0.8 5.4 7.8 0.0 0.8 0.0 0.9 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 3.4 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 1.3 13.3 0.0 0.0 0.0 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 15.0 22.4 0.0 18.8 16.7 2.2 1.0 14.2 0.0 7.8 FOXJ1 "FKHL13, HFH-4, HFH4" ENSG00000129654 "Forkhead box J1" Q92949 17 76136333-76141299 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.9;epididymis: 20.4;fallopian tube: 45.9" "Group enriched" "Detected in some" 9 "BEWO: 22.4;CAPAN-2: 18.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 73.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.6" "Lineage enriched" "Detected in single" 9 "T-cells: 2.6" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 55.6" HPA005714 Enhanced "HPA005714: AB_1078902" "prognostic favourable (9.39e-4)" "unprognostic (4.97e-3)" "unprognostic (1.22e-1)" "unprognostic (2.77e-3)" "unprognostic (1.19e-1)" "unprognostic (2.54e-3)" "unprognostic (1.71e-3)" "unprognostic (6.15e-2)" "unprognostic (1.00e-2)" "unprognostic (7.84e-3)" "unprognostic (1.43e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (2.03e-5)" "unprognostic (7.49e-2)" "unprognostic (1.94e-1)" "unprognostic (2.27e-1)" "unprognostic (1.91e-1)" 0.4 0.4 4.1 0.5 8.9 0.6 0.4 0.1 2.2 5.1 0.9 19.9 0.4 0.6 2.4 20.4 0.4 45.9 0.4 0.4 6.5 6.6 1.5 0.4 17.0 0.4 2.0 1.2 14.7 1.2 0.4 1.2 0.4 19.6 0.6 0.6 0.1 0.4 2.8 0.4 0.8 0.6 0.5 1.8 0.4 0.9 15.2 3.4 0.0 2.9 0.0 0.4 1.1 0.2 0.0 0.0 0.0 0.0 0.2 2.6 0.1 0.0 0.4 1.3 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 2.3 18.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.6 2.6 0.0 0.2 0.0 0.0 0.0 0.1 4.1 8.9 0.1 2.2 6.5 6.6 2.0 1.2 19.6 3.4 FP565260.3 ENSG00000277117 21 5022493-5040666 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell line enhanced" "Detected in many" "BEWO: 16.3;REH: 12.7;SiHa: 10.9" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 5.3" "Low lineage specificity" "Detected in many" HPA029179 Approved "Plasma membrane,Cytoplasmic bodies" "Plasma membrane, Cytoplasmic bodies" "HPA029179: " "unprognostic (3.34e-2)" "unprognostic (1.52e-1)" "unprognostic (2.82e-1)" "unprognostic (3.58e-4)" "unprognostic (6.66e-4)" "unprognostic (1.24e-2)" "unprognostic (1.12e-1)" "unprognostic (3.36e-1)" "unprognostic (2.46e-1)" "unprognostic (6.63e-2)" "unprognostic (1.14e-1)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (3.17e-1)" "unprognostic (3.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-1)" 1.5 0.2 0.6 3.4 4.5 2.4 1.9 0.4 7.0 2.6 2.0 9.2 0.6 4.3 0.8 1.7 1.4 2.1 2.6 2.9 2.2 2.5 2.3 1.2 4.5 4.2 3.1 0.2 1.8 0.0 0.0 1.9 4.3 1.3 1.6 0.1 1.3 1.0 0.7 3.1 2.8 0.7 2.6 2.3 4.1 0.5 3.6 0.0 1.0 1.9 5.7 1.6 1.2 5.3 0.9 0.0 3.0 0.0 1.1 0.8 0.2 0.6 0.0 1.1 0.3 0.7 16.3 1.3 1.0 0.2 0.0 3.9 0.7 8.7 2.6 0.0 3.1 1.0 1.2 0.2 0.2 0.8 0.0 0.5 2.1 0.2 6.7 6.4 0.1 1.7 0.9 0.8 0.9 1.0 0.3 0.1 2.2 0.0 4.0 0.6 5.3 12.7 0.4 8.9 0.4 5.5 0.7 0.0 10.9 9.7 0.1 2.9 9.0 0.3 0.0 2.5 0.0 0.2 6.0 6.1 5.7 6.9 3.8 1.5 0.0 0.6 0.0 0.0 3.0 0.3 2.9 0.5 0.2 0.7 5.3 0.1 0.5 0.0 0.0 0.6 0.9 1.1 0.8 FREM3 ENSG00000183090 "FRAS1 related extracellular matrix 3" P0C091 4 143577302-143700675 "Predicted secreted proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "brain: 5.0;lung: 1.8" "Cell line enriched" "Detected in single" 5 "TIME: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 3.3;hypothalamus: 3.2;thalamus: 4.8" "Low region specificity" "Detected in some" HPA041641 Uncertain "Secreted to extracellular matrix" "HPA041641: " "unprognostic (1.19e-2)" "unprognostic (4.09e-9)" "unprognostic (3.09e-3)" "unprognostic (2.74e-1)" "unprognostic (1.66e-1)" "unprognostic (4.74e-2)" "unprognostic (1.98e-1)" "unprognostic (1.91e-1)" "unprognostic (2.68e-1)" "unprognostic (2.17e-1)" "unprognostic (1.46e-1)" "unprognostic (2.30e-1)" "unprognostic (7.11e-3)" "unprognostic (3.24e-1)" 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 1.8 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRG2 FRG2A ENSG00000205097 "FSHD region gene 2" Q64ET8 4 190024351-190027257 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.0;brain: 2.8;skin 1: 3.8" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;HMC-1: 2.1;Karpas-707: 1.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 2.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.0" "HPA039264, HPA047769" Uncertain "HPA039264: , HPA047769: " 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.2 0.1 2.0 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.6 0.0 0.2 0.0 0.3 0.1 0.0 0.0 1.1 0.4 0.8 0.4 0.3 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.3 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.7 0.2 0.3 0.2 0.2 0.0 0.2 0.3 0.2 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.0 FRG2B ENSG00000225899 "FSHD region gene 2 family member B" Q96QU4 10 133623895-133626795 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.0;kidney: 1.9;pancreas: 1.2" "Cell line enriched" "Detected in single" 22 "HDLM-2: 13.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.1" "HPA039264, HPA047769" Uncertain "HPA039264: , HPA047769: " 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 FRMD5 MGC14161 ENSG00000171877 "FERM domain containing 5" Q7Z6J6 15 43870761-44195252 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 24.5;heart muscle: 48.9" "Cell line enhanced" "Detected in many" "hTERT-HME1: 11.8;HUVEC TERT2: 14.6;WM-115: 33.4" "Cancer enhanced" "Detected in many" "glioma: 6.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "B-cells: 1.6;T-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (9.54e-2)" "unprognostic (2.16e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (7.26e-7)" "unprognostic (3.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" "unprognostic (5.00e-3)" "prognostic unfavourable (5.89e-4)" "unprognostic (7.01e-2)" "unprognostic (2.92e-4)" "unprognostic (1.21e-1)" "unprognostic (7.31e-2)" "unprognostic (1.18e-1)" "unprognostic (3.31e-1)" 1.0 7.2 8.9 1.4 12.3 1.6 1.3 8.2 15.1 1.0 1.7 24.5 0.0 1.0 0.9 1.3 1.2 2.0 1.3 48.9 10.9 6.9 1.2 0.8 1.0 1.1 14.7 4.8 1.0 1.1 1.1 1.6 0.9 10.7 1.2 1.8 2.9 2.0 1.2 0.8 1.2 1.3 1.1 13.4 1.2 2.2 4.3 11.5 0.0 1.2 0.0 0.8 1.1 0.2 1.6 0.3 0.0 0.0 0.0 1.6 0.0 3.3 1.9 1.2 0.7 1.4 0.1 0.2 0.7 1.1 2.1 4.2 5.5 3.7 0.2 0.7 0.5 4.0 1.8 3.9 1.8 0.2 2.0 0.5 1.6 2.3 0.1 0.0 0.2 0.0 0.4 5.8 11.8 14.6 0.1 0.4 2.3 0.3 0.5 0.0 1.0 1.8 0.0 2.6 0.0 2.0 1.2 7.7 2.6 0.4 0.0 7.9 0.1 0.1 0.5 4.1 7.0 1.0 10.4 0.2 0.9 0.4 5.8 0.2 33.4 0.0 0.0 0.0 0.8 0.0 1.6 1.6 1.2 0.4 0.0 0.5 0.6 0.9 0.0 0.0 0.0 0.3 1.6 0.0 8.9 12.3 8.2 12.4 10.9 6.9 14.7 4.8 10.7 11.5 FRMPD2 "MGC35285, PDZD5C, PDZK5C" ENSG00000170324 "FERM and PDZ domain containing 2" Q68DX3 10 48153088-48274870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.2;epididymis: 7.9;fallopian tube: 11.1;heart muscle: 6.3;retina: 11.4" "Cell line enhanced" "Detected in some" "BEWO: 6.6;HBEC3-KT: 2.8;Hep G2: 1.5;SCLC-21H: 2.8;SK-BR-3: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 7.6" "unprognostic (1.53e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-4)" "unprognostic (7.59e-2)" "unprognostic (2.37e-1)" "unprognostic (2.06e-1)" "unprognostic (6.54e-3)" "unprognostic (1.85e-1)" "unprognostic (6.60e-2)" "unprognostic (1.12e-1)" "unprognostic (3.25e-12)" "unprognostic (3.48e-2)" "unprognostic (5.43e-2)" "unprognostic (1.54e-1)" "unprognostic (7.43e-5)" 0.4 0.4 5.6 0.4 12.0 0.4 2.1 7.3 4.1 1.4 0.6 12.7 0.0 0.4 0.9 7.9 0.4 11.1 0.4 6.3 6.4 4.0 1.1 0.4 1.5 0.4 3.1 1.3 0.8 0.7 0.4 0.5 0.7 14.2 1.8 1.0 11.4 0.5 0.6 0.4 0.4 0.5 0.4 2.4 0.4 0.4 1.5 6.5 0.0 2.3 0.0 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 2.8 0.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 12.0 7.3 1.7 6.4 4.0 3.1 1.3 14.2 6.5 FRMPD3 "KIAA1817, RP5-1070B1.1" ENSG00000147234 "FERM and PDZ domain containing 3" Q5JV73 X 107522450-107605251 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.6;ovary: 10.3;thyroid gland: 6.0" "Cell line enhanced" "Detected in some" "Daudi: 10.6;SCLC-21H: 3.3;U-698: 2.9;WM-115: 3.9" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Cell type enhanced" "Detected in some" "gdT-cell: 1.7;naive B-cell: 1.2" "Group enriched" "Detected in many" 15 "B-cells: 1.2;T-cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003164 Uncertain "HPA003164: AB_1078260" "unprognostic (1.27e-1)" "unprognostic (3.36e-1)" "unprognostic (5.44e-2)" "unprognostic (2.48e-4)" "unprognostic (1.69e-2)" "unprognostic (6.19e-2)" "unprognostic (2.43e-2)" "unprognostic (4.35e-2)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (7.29e-2)" "unprognostic (2.46e-1)" "unprognostic (1.83e-9)" "unprognostic (4.59e-2)" "unprognostic (7.88e-2)" "unprognostic (8.91e-3)" "unprognostic (1.26e-1)" 0.0 0.5 2.5 0.7 1.8 0.1 0.5 8.6 6.7 0.2 0.1 0.0 0.9 0.0 0.1 0.4 0.4 0.0 3.1 5.0 0.0 0.0 0.2 1.3 2.6 10.3 0.1 0.0 0.4 0.0 0.6 0.2 0.4 2.6 0.0 0.0 0.0 1.1 2.2 0.2 0.0 0.5 6.0 0.9 0.1 0.0 1.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 2.1 0.7 0.0 0.0 0.0 0.8 0.0 0.4 0.2 0.0 0.5 10.6 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.3 3.3 0.2 0.6 0.2 0.0 0.4 0.0 0.0 1.0 1.2 0.1 0.0 0.0 0.0 2.9 0.1 0.0 3.9 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.2 1.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 FRMPD4 "KIAA0316, PDZD10, PDZK10" ENSG00000169933 "FERM and PDZ domain containing 4" Q14CM0 X 12138466-12724523 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 16.4;parathyroid gland: 28.3" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 4.2;LHCN-M2: 5.9;U-2197: 9.3;U-266/70: 8.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.05e-1)" "unprognostic (3.70e-2)" "unprognostic (3.50e-2)" "unprognostic (2.68e-3)" "unprognostic (8.84e-2)" "unprognostic (1.05e-2)" "unprognostic (3.56e-2)" "unprognostic (2.09e-2)" "unprognostic (1.62e-2)" "unprognostic (6.32e-2)" "unprognostic (3.39e-1)" "unprognostic (1.62e-1)" "unprognostic (1.96e-1)" "unprognostic (2.25e-1)" 0.6 0.6 5.5 0.6 10.9 0.5 0.6 3.8 16.4 0.7 1.1 1.0 0.0 0.6 0.7 1.0 0.7 0.6 0.6 2.1 8.1 3.5 0.6 0.6 0.6 0.5 2.7 6.9 0.6 0.5 28.3 0.6 0.5 2.9 1.1 0.8 1.9 0.5 0.6 1.1 0.6 0.6 0.6 0.8 0.5 0.6 1.0 1.5 0.0 0.6 0.0 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.7 0.0 1.1 2.1 3.4 4.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.3 2.2 3.4 0.0 0.2 0.0 0.1 0.0 0.0 1.5 0.0 1.3 2.3 0.0 0.0 0.7 5.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 9.3 1.0 8.6 3.9 0.0 2.4 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 10.9 3.8 14.6 8.1 3.5 2.7 6.9 2.9 1.5 FRRS1L "C9orf4, CG-6" ENSG00000260230 "Ferric chelate reductase 1 like" Q9P0K9 9 109130293-109167295 "Disease related genes, Predicted membrane proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.0;ovary: 15.2" "Cell line enhanced" "Detected in some" "AF22: 3.7;SH-SY5Y: 9.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071086 Enhanced "HPA071086: " "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (2.21e-1)" "unprognostic (9.01e-2)" "unprognostic (3.10e-1)" "unprognostic (8.12e-2)" "unprognostic (1.84e-1)" "unprognostic (9.94e-2)" "unprognostic (1.51e-1)" "unprognostic (9.21e-4)" "unprognostic (7.35e-3)" "unprognostic (7.02e-2)" "unprognostic (5.78e-3)" "unprognostic (5.89e-2)" "unprognostic (2.85e-1)" "unprognostic (5.38e-3)" 0.9 10.9 10.2 1.1 26.6 1.2 1.1 19.3 38.0 2.4 1.2 2.3 0.1 1.3 2.7 4.4 3.2 2.2 2.0 2.0 10.5 12.5 0.8 0.9 1.0 1.0 6.1 13.1 15.2 1.5 4.4 6.0 0.8 6.6 4.9 1.2 3.0 1.1 3.0 0.9 1.1 1.4 2.5 3.5 1.0 1.1 1.7 3.4 0.0 1.0 0.0 0.9 0.9 0.3 1.3 0.8 2.7 1.6 1.3 0.8 0.3 0.1 0.5 3.7 0.2 0.2 0.2 0.4 0.1 0.0 0.1 0.3 0.2 0.3 0.2 0.1 0.0 0.2 0.1 0.1 0.2 0.2 0.2 0.5 0.4 0.2 0.0 0.1 0.3 0.5 0.0 0.2 0.0 0.0 0.1 0.5 0.2 0.1 0.2 0.7 1.6 0.1 0.3 0.1 0.2 0.1 0.3 1.5 9.1 0.0 0.2 0.0 0.2 0.3 0.4 0.2 0.4 0.2 0.1 0.3 0.1 0.1 0.1 0.2 0.2 2.6 0.9 0.6 0.6 1.2 0.5 0.8 0.6 0.5 0.3 1.3 0.8 0.7 2.7 1.3 1.6 0.8 0.4 0.3 10.2 26.6 19.3 25.8 10.5 12.5 6.1 13.1 6.6 3.4 FSCN1 "FLJ38511, p55, SNL" ENSG00000075618 "Fascin actin-bundling protein 1" Q16658 7 5592823-5606655 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.9" "Cell line enhanced" "Detected in many" "BEWO: 80.6;K-562: 67.5;NB-4: 76.7;PC-3: 67.5;SH-SY5Y: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000121, HPA005723, CAB035991, HPA050654" Enhanced Supported "Plasma membrane,Cytosol" 4500000 Cytosol "Plasma membrane" "CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: " "unprognostic (1.91e-1)" "unprognostic (2.03e-2)" "unprognostic (3.12e-2)" "unprognostic (5.00e-3)" "unprognostic (1.18e-1)" "prognostic unfavourable (5.76e-4)" "unprognostic (2.16e-3)" "prognostic unfavourable (2.28e-4)" "unprognostic (6.31e-2)" "unprognostic (1.25e-1)" "unprognostic (3.27e-3)" "unprognostic (1.54e-1)" "prognostic unfavourable (8.15e-7)" "unprognostic (1.21e-2)" "unprognostic (8.57e-2)" "unprognostic (1.05e-2)" "unprognostic (6.93e-3)" 26.3 13.3 23.7 29.6 30.1 6.3 8.1 5.5 56.9 9.9 5.5 35.1 0.0 5.4 11.7 2.3 22.3 5.9 8.9 10.6 27.7 16.8 5.5 7.1 11.3 15.2 26.9 23.6 21.8 5.1 2.3 7.0 29.4 20.1 4.1 3.0 8.1 11.0 3.9 7.8 17.3 6.6 7.0 29.6 39.3 7.6 15.9 28.3 9.3 8.5 15.9 11.4 14.7 12.3 0.2 5.4 1.0 1.9 0.0 0.1 1.4 7.8 18.3 12.2 43.7 4.7 9.1 80.6 18.9 8.4 3.2 3.5 12.7 2.0 0.1 23.2 8.3 30.0 7.0 30.4 0.2 9.0 3.8 0.5 19.4 59.7 2.5 0.0 1.5 5.6 9.0 6.1 5.0 15.9 67.5 0.1 4.2 0.8 0.2 76.7 31.9 67.5 17.8 2.9 0.3 4.7 0.7 9.8 64.8 15.9 0.2 0.6 0.4 4.8 32.3 22.5 39.6 13.0 19.4 0.1 0.1 0.0 14.5 0.0 42.2 0.0 1.9 0.1 0.0 0.5 0.0 0.2 0.1 0.0 5.4 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 1.4 23.7 30.1 5.5 41.3 27.7 16.8 26.9 23.6 20.1 28.3 FSD1 "MGC3213, MIR1" ENSG00000105255 "Fibronectin type III and SPRY domain containing 1" Q9BTV5 19 4304600-4323843 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 8.2;brain: 30.8;testis: 9.5" "Cell line enhanced" "Detected in many" "SCLC-21H: 27.5;SH-SY5Y: 28.6" "Group enriched" "Detected in many" 6 "glioma: 9.2;testis cancer: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.7;NK-cell: 8.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043141 Supported "HPA043141: AB_10797137" "unprognostic (8.31e-3)" "unprognostic (2.38e-1)" "unprognostic (6.85e-2)" "prognostic unfavourable (1.61e-4)" "unprognostic (3.29e-2)" "unprognostic (9.72e-4)" "unprognostic (1.33e-1)" "unprognostic (9.87e-2)" "unprognostic (1.00e-1)" "unprognostic (3.15e-1)" "unprognostic (8.16e-3)" "unprognostic (1.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.82e-1)" "unprognostic (3.92e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-1)" 1.5 2.3 15.5 2.2 9.9 1.8 0.9 15.7 30.8 2.1 1.6 3.2 0.0 2.7 1.0 1.1 1.1 1.0 1.6 0.9 15.8 14.3 1.0 1.2 1.1 2.9 11.4 13.0 1.2 0.9 0.9 1.1 2.3 9.5 1.1 1.1 0.0 0.9 1.2 0.9 1.1 1.8 1.7 5.7 1.5 1.4 9.5 7.8 1.6 0.9 0.0 1.7 1.1 0.2 0.0 2.0 0.0 0.0 8.2 5.7 0.8 0.0 3.2 9.1 4.7 0.0 0.9 3.8 3.7 1.5 12.5 9.6 7.4 0.2 11.6 3.3 2.6 0.7 8.3 6.1 3.9 7.3 12.2 3.1 2.5 0.2 5.1 0.0 0.7 2.1 0.0 7.2 0.4 6.5 0.4 0.0 0.5 8.7 5.2 0.0 11.7 6.2 0.0 4.3 0.0 0.0 0.2 27.5 28.6 1.0 0.4 0.8 0.1 0.1 7.4 1.9 8.9 3.5 3.4 6.7 8.4 2.8 4.7 0.0 4.8 0.0 0.0 0.0 0.7 0.0 5.7 0.0 0.2 0.0 0.0 0.0 1.1 0.4 0.0 8.2 0.0 2.0 0.6 0.8 15.5 9.9 15.7 21.5 15.8 14.3 11.4 13.0 9.5 7.8 FSTL4 KIAA1061 ENSG00000053108 "Follistatin like 4" Q6MZW2 5 133196455-133612564 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.5" "Cell line enhanced" "Detected in some" "SCLC-21H: 32.7;U-266/70: 11.7;U-266/84: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045920 Uncertain Approved "Nuclear membrane,Mitochondria" "Secreted to blood" Mitochondria "Nuclear membrane" "HPA045920: AB_10965844" "unprognostic (5.52e-2)" "unprognostic (2.54e-1)" "unprognostic (5.74e-2)" "unprognostic (8.14e-2)" "unprognostic (1.87e-1)" "unprognostic (3.97e-2)" "unprognostic (6.35e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" "unprognostic (4.74e-2)" "unprognostic (8.66e-2)" "unprognostic (3.73e-4)" "unprognostic (2.02e-2)" "unprognostic (9.91e-3)" "unprognostic (1.03e-2)" "unprognostic (4.25e-2)" 0.7 2.2 8.4 1.0 14.6 3.0 1.1 18.5 18.0 1.0 1.6 1.7 0.0 1.1 0.5 2.8 3.1 1.6 0.7 0.6 1.5 3.2 4.8 0.5 2.0 0.4 1.9 10.1 0.8 2.9 7.1 4.0 6.4 2.6 2.9 1.9 1.4 1.4 0.1 1.5 5.3 1.2 0.3 1.0 0.5 2.3 2.8 4.7 0.0 1.3 0.0 1.7 10.2 1.6 2.8 1.2 3.4 1.1 0.8 2.3 1.2 4.3 7.5 0.8 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 6.7 0.9 0.3 6.1 0.0 0.1 0.9 0.2 0.0 0.4 0.3 0.3 7.3 0.6 0.0 0.0 0.4 0.1 1.1 0.0 0.0 0.0 3.4 4.0 0.0 7.1 0.8 0.3 8.0 0.8 0.3 0.7 7.6 0.0 8.3 32.7 0.7 1.6 1.4 0.1 2.8 0.3 0.2 0.3 1.3 0.4 0.2 11.7 11.7 0.3 0.1 0.0 0.2 3.4 1.1 0.6 1.2 0.4 2.3 2.8 1.7 1.2 0.6 2.6 2.1 1.3 2.4 0.8 0.7 1.2 1.6 1.2 8.4 14.6 18.5 18.0 1.5 3.2 1.9 10.1 2.6 4.7 FSTL5 "DKFZp566D234, KIAA1263" ENSG00000168843 "Follistatin like 5" Q8N475 4 161383897-162164035 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 106.9" "Cell line enriched" "Detected in some" 5 "Karpas-707: 39.8" "Cancer enriched" "Detected in single" 6 "melanoma: 1.7" "Region enriched" "Detected in all" 6 "cerebellum: 106.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" "unprognostic (4.90e-2)" "unprognostic (4.46e-1)" "unprognostic (1.52e-2)" "unprognostic (2.03e-1)" "unprognostic (3.66e-2)" "unprognostic (2.99e-2)" "unprognostic (3.00e-1)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (1.61e-1)" "unprognostic (1.08e-10)" "unprognostic (8.45e-4)" "unprognostic (1.53e-1)" "unprognostic (1.52e-1)" "unprognostic (6.60e-3)" 0.5 12.1 3.5 0.6 6.9 0.5 0.5 106.9 19.9 0.5 0.6 0.6 0.0 0.5 0.5 1.7 0.5 0.6 0.5 0.5 3.2 5.9 0.6 0.5 0.5 0.5 3.0 3.0 0.5 1.0 0.5 1.1 0.7 18.2 0.5 0.8 7.1 0.5 0.6 0.5 0.8 0.6 0.6 3.1 0.5 0.5 1.5 2.9 0.0 0.6 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 5.7 0.0 39.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 5.7 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 8.6 0.0 3.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 6.9 106.9 6.9 3.2 5.9 3.0 3.0 18.2 2.9 FUT9 Fuc-TIX ENSG00000172461 "Fucosyltransferase 9" Q9Y231 6 96015984-96215612 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 37.7;stomach 1: 35.4" "Cell line enhanced" "Detected in some" "MCF7: 4.1;RT4: 9.4;SCLC-21H: 9.6;SK-BR-3: 5.4" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070923 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA070923: " "unprognostic (1.60e-1)" "unprognostic (2.48e-1)" "unprognostic (5.99e-3)" "unprognostic (1.33e-1)" "unprognostic (2.40e-1)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (6.43e-3)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" 1.1 1.7 18.5 1.1 22.5 1.1 1.9 37.7 28.6 1.1 1.1 10.7 0.0 4.1 1.4 1.2 1.1 1.4 1.1 1.1 20.0 6.2 1.2 1.1 1.1 1.1 10.2 24.0 1.1 8.0 1.1 0.9 1.7 13.8 1.5 1.2 0.0 1.1 1.5 1.2 1.1 1.1 1.1 10.2 1.1 35.4 1.1 16.5 0.0 1.2 0.0 1.1 2.2 0.4 0.3 0.2 1.5 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 9.4 9.6 0.2 0.0 5.4 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.8 0.2 0.0 0.2 0.0 0.0 18.5 22.5 37.7 28.6 20.0 6.2 10.2 24.0 13.8 16.5 FXYD6 ENSG00000137726 "FXYD domain containing ion transport regulator 6" Q9H0Q3 11 117836976-117877486 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 142.8" "Cell line enhanced" "Detected in some" "AF22: 37.1;HAP1: 24.5;RH-30: 15.4;SCLC-21H: 56.2;SH-SY5Y: 32.1" "Cancer enriched" "Detected in all" 6 "glioma: 71.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "classical monocyte: 21.9" "Lineage enriched" "Detected in many" 6 "monocytes: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041334, HPA042284" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041334: AB_10970752, HPA042284: " "unprognostic (2.18e-3)" "unprognostic (2.70e-2)" "unprognostic (1.60e-2)" "prognostic unfavourable (1.05e-5)" "unprognostic (3.31e-2)" "unprognostic (1.15e-1)" "prognostic favourable (5.87e-4)" "unprognostic (4.51e-2)" "unprognostic (3.78e-2)" "unprognostic (1.07e-2)" "prognostic favourable (5.97e-4)" "unprognostic (3.44e-2)" "prognostic favourable (4.38e-5)" "unprognostic (4.64e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.60e-4)" 12.9 38.7 41.2 9.5 46.2 3.1 8.1 49.1 142.8 24.3 52.0 30.2 9.2 7.6 54.8 19.0 9.8 26.7 29.0 25.6 35.4 51.6 12.3 10.4 21.5 8.5 18.4 59.5 82.8 9.5 3.5 28.5 5.6 20.2 35.6 11.7 11.9 9.8 22.9 11.0 3.9 16.3 58.5 12.8 42.8 17.6 23.2 18.5 2.9 15.9 6.4 5.9 38.1 13.9 0.0 3.6 0.5 21.9 0.0 0.3 5.1 0.0 0.2 37.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 24.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 1.6 0.1 7.4 0.0 0.0 15.4 0.2 0.9 0.0 56.2 32.1 0.0 0.1 1.2 0.6 0.6 0.0 0.0 9.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 21.9 0.0 0.0 5.3 0.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 5.1 41.2 46.2 49.1 78.8 35.4 51.6 18.4 59.5 20.2 18.5 FXYD7 ENSG00000221946 "FXYD domain containing ion transport regulator 7" P58549 19 35143250-35154301 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "blood: 24.4;brain: 76.1" "Cell line enhanced" "Detected in some" "HAP1: 3.1;HMC-1: 9.6;Karpas-707: 3.3;NTERA-2: 2.8;WM-115: 5.5" "Cancer enhanced" "Detected in some" "glioma: 4.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 24.4" "Group enriched" "Detected in many" 22 "B-cells: 8.1;NK-cells: 24.4;T-cells: 12.9" "Low region specificity" "Detected in all" HPA026916 Approved "HPA026916: AB_1849217" "unprognostic (1.25e-3)" "unprognostic (8.73e-3)" "unprognostic (4.64e-2)" "unprognostic (6.95e-4)" "unprognostic (8.47e-2)" "unprognostic (1.73e-2)" "unprognostic (2.13e-2)" "unprognostic (1.91e-1)" "unprognostic (1.90e-1)" "unprognostic (3.08e-2)" "unprognostic (5.70e-2)" "unprognostic (1.16e-1)" "unprognostic (6.90e-5)" "unprognostic (1.51e-2)" "unprognostic (3.32e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" 1.5 1.7 46.9 2.8 31.6 1.8 1.6 3.0 76.1 1.7 1.5 4.7 0.0 1.9 1.9 1.2 1.7 1.8 1.7 1.5 41.9 20.1 1.3 1.4 1.6 3.7 19.8 26.2 1.8 1.5 1.2 0.1 1.4 10.1 1.4 1.5 0.0 1.8 1.6 2.9 1.9 1.7 1.5 8.7 3.2 1.7 1.7 1.6 0.0 1.4 0.0 2.8 1.8 0.4 8.1 0.6 0.3 0.0 24.4 12.9 2.4 1.1 0.3 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.3 0.0 0.6 1.0 0.2 0.0 0.4 3.1 0.0 0.4 0.5 0.2 0.4 0.8 0.0 0.2 0.0 9.6 0.9 0.0 0.0 0.0 0.1 0.8 3.3 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.2 0.2 0.0 0.7 0.0 0.0 0.5 0.3 1.3 0.2 0.0 0.1 0.0 0.0 0.8 0.2 5.5 0.0 0.0 0.0 8.1 0.0 5.0 8.1 12.9 9.2 0.0 7.3 4.2 7.2 0.3 24.4 0.0 0.6 3.6 2.4 46.9 31.6 3.0 76.1 41.9 20.1 19.8 26.2 10.1 1.6 GAB1 ENSG00000109458 "GRB2 associated binding protein 1" Q13480 4 143336762-143474568 "Predicted intracellular proteins, RAS pathway related proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.0" "Cell line enhanced" "Detected in many" "REH: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034333, HPA066404" Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoli fibrillar center" "CAB034333: AB_2107855, HPA066404: " "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.32e-3)" "unprognostic (1.66e-1)" "unprognostic (4.71e-2)" "unprognostic (1.79e-2)" "unprognostic (4.17e-2)" "unprognostic (1.23e-1)" "unprognostic (1.35e-2)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.20e-1)" "prognostic favourable (3.91e-5)" "unprognostic (4.99e-2)" "unprognostic (2.70e-1)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" 9.2 8.4 15.0 7.3 33.3 8.8 9.7 5.8 22.0 10.1 17.0 64.0 10.2 10.4 17.7 13.1 18.2 8.6 11.1 26.2 19.5 11.4 12.9 7.9 15.6 5.0 35.7 19.0 18.1 7.0 17.2 6.3 18.0 30.5 7.8 20.3 15.4 11.7 13.9 11.2 11.1 10.4 15.9 32.3 6.2 11.0 7.9 41.7 1.0 7.8 6.0 7.3 9.9 11.9 3.1 3.4 5.9 2.3 7.4 0.4 0.4 3.3 0.7 8.7 6.3 4.4 4.3 11.4 2.3 7.8 2.8 5.0 6.5 5.7 0.1 0.7 3.3 1.9 8.3 2.7 3.2 0.4 2.0 6.1 1.9 3.0 3.0 0.8 1.2 5.2 4.9 3.4 2.3 3.7 2.0 11.2 1.9 4.9 0.5 0.0 2.5 2.7 37.3 4.3 4.3 4.4 4.1 2.0 6.2 1.6 6.8 2.9 4.4 0.8 2.8 3.6 2.9 1.7 1.7 18.1 8.8 13.4 2.4 2.4 2.9 5.9 0.6 0.7 0.0 0.8 0.4 1.3 0.1 0.0 0.8 3.1 0.0 0.0 4.0 7.4 2.3 3.4 0.0 0.4 15.0 33.3 5.8 22.0 19.5 11.4 35.7 19.0 30.5 41.7 GAB2 KIAA0571 ENSG00000033327 "GRB2 associated binding protein 2" Q9UQC2 11 78215297-78418348 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.1" "Cell line enhanced" "Detected in many" "SH-SY5Y: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.4;neutrophil: 16.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 16.3" "HPA000271, HPA001368, CAB022159" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB022159: , HPA000271: AB_1078925, HPA001368: " "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (3.56e-3)" "unprognostic (1.99e-3)" "unprognostic (1.04e-2)" "unprognostic (4.69e-2)" "unprognostic (4.47e-2)" "unprognostic (1.08e-1)" "unprognostic (6.54e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (1.74e-1)" "prognostic favourable (9.32e-5)" "unprognostic (6.95e-2)" "unprognostic (4.35e-1)" "unprognostic (3.99e-2)" "unprognostic (1.67e-2)" 15.5 8.4 31.1 12.0 26.9 32.9 11.6 5.7 21.5 10.2 8.9 49.1 1.6 13.7 16.8 4.6 8.2 13.5 9.1 13.6 30.4 21.3 5.2 4.5 16.1 6.8 31.5 14.8 20.0 5.9 10.4 7.0 14.6 24.7 6.5 10.9 6.6 5.4 7.3 5.2 8.8 10.1 17.1 35.4 11.8 7.4 5.5 26.0 9.4 6.5 3.0 5.6 9.3 12.3 0.5 1.7 16.3 3.4 0.0 0.1 0.7 1.7 1.5 4.4 0.5 6.4 2.8 19.4 2.7 3.3 2.0 1.6 11.4 0.9 0.5 12.4 3.8 2.8 10.3 0.2 2.6 17.2 1.1 6.9 2.7 2.0 3.2 2.6 1.4 3.0 0.9 7.7 1.2 11.5 18.1 0.6 3.3 0.7 1.3 6.5 1.4 2.1 13.0 4.2 0.2 3.6 6.5 3.8 31.0 0.7 1.4 7.1 6.5 7.5 9.4 0.9 2.2 7.5 0.6 4.8 0.7 0.3 0.7 4.1 8.2 9.4 2.4 0.7 0.0 1.4 0.0 0.5 0.0 0.0 0.8 0.3 0.0 0.0 16.3 0.0 3.4 1.7 0.1 0.7 31.1 26.9 5.7 19.3 30.4 21.3 31.5 14.8 24.7 26.0 GABBR1 "GPRC3A, hGB1a" ENSG00000204681 "Gamma-aminobutyric acid type B receptor subunit 1" Q9UBS5 6 29555629-29633976 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.8" "Cell line enhanced" "Detected in many" "AN3-CA: 8.0;HEL: 7.7;U-2 OS: 8.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8;plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050483, HPA058459" Uncertain Approved Centrosome "Intracellular and membrane" Centrosome "HPA050483: , HPA058459: " "unprognostic (1.01e-1)" "unprognostic (2.07e-3)" "unprognostic (3.22e-3)" "unprognostic (2.93e-3)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (7.95e-4)" "unprognostic (5.44e-2)" "unprognostic (4.24e-2)" "unprognostic (1.14e-1)" "prognostic favourable (2.54e-5)" "unprognostic (1.23e-3)" "prognostic unfavourable (3.77e-10)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.87e-2)" "unprognostic (2.55e-2)" 14.0 7.4 33.6 7.0 47.2 8.2 4.2 29.1 53.8 6.9 5.6 17.3 3.0 2.3 18.1 1.9 2.9 7.9 4.1 4.6 24.8 21.4 2.9 2.0 6.9 6.6 15.6 33.7 7.8 5.1 1.8 5.8 5.0 22.3 12.8 3.2 4.4 13.0 13.3 8.5 18.3 6.1 5.5 14.9 24.2 6.1 4.3 15.4 0.0 3.9 0.1 5.2 4.0 5.9 1.8 1.7 0.0 0.5 0.0 0.4 0.3 2.9 0.0 1.9 8.0 0.9 2.1 2.1 2.0 0.8 1.8 0.5 2.3 0.1 1.4 2.0 0.0 2.4 0.9 0.0 0.0 7.2 3.4 7.7 3.4 0.0 1.2 0.3 4.0 0.0 0.0 1.6 0.0 1.0 6.6 0.0 0.3 1.9 0.7 0.1 0.6 1.1 3.5 0.7 0.1 0.3 0.0 0.5 1.3 0.5 0.0 3.3 1.5 1.1 4.5 3.2 8.3 0.3 3.7 7.0 0.7 0.0 1.8 3.5 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.3 1.8 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.3 33.6 47.2 29.1 53.8 24.8 21.4 15.6 33.7 22.3 15.4 GABBR2 "GABABR2, GPR51, GPRC3B, HG20" ENSG00000136928 "Gamma-aminobutyric acid type B receptor subunit 2" O75899 9 98288082-98709197 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 52.7" "Cell line enhanced" "Detected in some" "BJ: 10.9;fHDF/TERT166: 5.4;HUVEC TERT2: 22.5;U-138 MG: 8.8" "Group enriched" "Detected in many" 10 "glioma: 7.2;thyroid cancer: 11.6;urothelial cancer: 3.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013820, HPA031684, CAB079065" Enhanced Approved "CAB079065: , HPA013820: AB_1849364, HPA031684: " "unprognostic (2.00e-1)" "unprognostic (7.56e-2)" "unprognostic (3.75e-1)" "unprognostic (3.09e-5)" "unprognostic (2.52e-1)" "unprognostic (1.16e-1)" "unprognostic (2.81e-2)" "unprognostic (1.42e-1)" "unprognostic (2.66e-1)" "unprognostic (4.43e-2)" "unprognostic (1.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.76e-2)" "unprognostic (3.52e-2)" "unprognostic (1.91e-1)" "unprognostic (2.68e-2)" "unprognostic (3.45e-2)" 0.9 4.4 13.6 1.0 14.6 0.8 0.9 19.7 52.7 0.8 0.9 2.1 0.0 0.8 1.1 1.1 0.9 0.8 0.9 0.9 14.6 11.1 0.9 0.9 1.0 0.9 7.6 17.6 0.8 0.8 0.9 0.3 0.9 10.3 0.9 0.8 0.6 0.9 0.9 3.2 0.9 0.8 1.0 2.2 0.9 1.0 1.3 0.2 0.0 2.3 0.0 1.1 1.5 0.1 0.7 0.7 1.7 1.1 1.7 1.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 1.0 10.9 2.2 2.3 4.2 0.0 0.1 0.0 0.7 5.4 0.0 0.1 0.2 0.8 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.8 0.2 22.5 0.2 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.6 3.1 0.0 0.0 2.8 0.0 0.0 0.1 1.0 8.8 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 1.7 0.4 0.8 0.6 0.7 1.0 0.7 0.7 0.7 0.4 0.6 0.8 0.9 1.2 1.7 1.1 0.7 1.0 0.4 13.6 14.6 19.7 35.0 14.6 11.1 7.6 17.6 10.3 0.2 GABRA1 EJM5 ENSG00000022355 "Gamma-aminobutyric acid type A receptor alpha1 subunit" P14867 5 161847063-161899981 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 58.6" "Cell line enhanced" "Detected in some" "HEL: 3.6;SCLC-21H: 1.1;U-2 OS: 1.5;U-87 MG: 2.3;WM-115: 1.2" "Cancer enriched" "Detected in single" 5 "glioma: 1.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022502, HPA055746" Enhanced Supported "CAB022502: , HPA055746: " "unprognostic (2.58e-2)" "unprognostic (4.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.31e-1)" "unprognostic (2.43e-1)" 1.0 2.6 8.5 1.0 21.9 1.0 1.0 35.2 58.6 1.0 1.0 1.8 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 10.5 8.8 1.0 1.0 1.0 1.0 6.7 22.0 1.0 1.0 1.0 0.1 1.0 7.4 1.2 1.0 0.2 1.0 1.1 1.0 1.0 1.0 1.0 1.3 1.1 1.5 1.1 0.0 0.0 1.0 0.0 1.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.6 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 21.9 35.2 49.8 10.5 8.8 6.7 22.0 7.4 0.0 GABRA2 ENSG00000151834 "Gamma-aminobutyric acid type A receptor alpha2 subunit" P47869 4 46248427-46475230 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 52.6" "Cell line enhanced" "Detected in some" "U-2 OS: 9.4;U-87 MG: 4.4;WM-115: 5.0" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079061 Supported "Intracellular and membrane" "CAB079061: " "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (2.45e-4)" "unprognostic (6.87e-3)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.09e-1)" "unprognostic (6.90e-3)" "unprognostic (8.83e-2)" "unprognostic (2.22e-5)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 2.2 1.3 38.5 1.4 34.4 1.2 1.9 10.4 52.6 1.7 4.5 4.9 0.0 2.0 1.4 11.7 1.7 1.0 1.6 1.0 38.9 7.7 8.8 1.4 1.0 1.4 3.7 31.0 1.9 1.0 0.9 0.6 1.5 10.5 1.0 3.5 0.0 1.2 1.9 1.0 1.3 7.7 1.3 6.9 2.3 1.6 1.5 7.1 0.0 1.1 0.0 1.4 1.2 0.8 0.2 0.3 1.0 0.1 0.1 0.1 0.0 0.5 0.5 0.1 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 2.1 0.6 0.2 0.5 0.0 0.8 0.0 0.0 0.1 0.5 0.5 0.1 0.7 0.2 0.8 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.8 0.2 0.0 0.4 0.0 0.3 0.9 0.1 0.0 0.6 0.4 0.1 0.6 0.2 0.0 0.1 0.3 0.0 0.3 0.4 0.1 0.5 9.4 0.5 0.1 0.7 1.2 0.2 4.4 0.4 5.0 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.1 0.3 0.0 0.0 38.5 34.4 10.4 31.4 38.9 7.7 3.7 31.0 10.5 7.1 GABRA3 ENSG00000011677 "Gamma-aminobutyric acid type A receptor alpha3 subunit" P34903 X 152166234-152451358 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 30.1" "Cell line enhanced" "Detected in some" "HMC-1: 7.8;Karpas-707: 13.2;PC-3: 7.6;U-2 OS: 6.5;U-266/70: 7.1;U-266/84: 11.7;U-87 MG: 7.7" "Cancer enriched" "Detected in many" 7 "testis cancer: 16.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA000839 Approved Supported "HPA000839: AB_1078929" "unprognostic (9.63e-3)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (1.18e-2)" "unprognostic (7.07e-2)" "unprognostic (5.42e-2)" "unprognostic (2.34e-6)" "unprognostic (1.24e-1)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" "unprognostic (2.63e-2)" "unprognostic (1.73e-1)" "unprognostic (7.29e-6)" "unprognostic (7.42e-3)" "unprognostic (6.20e-2)" "unprognostic (8.13e-2)" 0.7 0.7 7.7 0.6 15.2 0.7 0.7 1.3 30.1 2.2 0.8 3.3 0.0 0.8 1.2 0.8 1.3 0.7 0.7 0.7 10.9 15.9 0.7 0.7 0.7 0.7 4.7 10.5 0.6 0.7 0.6 0.9 5.2 6.2 0.8 0.8 0.4 0.7 1.8 0.8 1.1 0.9 0.8 2.1 0.7 0.7 1.8 1.1 0.0 0.7 0.0 0.9 1.8 0.4 0.0 0.1 1.5 0.3 0.3 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 1.3 13.2 0.0 0.0 0.0 0.0 2.4 7.6 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 4.9 0.4 0.1 1.2 0.0 5.0 6.5 0.3 1.4 7.1 11.7 0.0 7.7 0.0 4.9 1.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.1 0.2 0.0 7.7 15.2 1.3 28.4 10.9 15.9 4.7 10.5 6.2 1.1 GABRA4 ENSG00000109158 "Gamma-aminobutyric acid type A receptor alpha4 subunit" P48169 4 46918900-46994407 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 16.1" "Cell line enriched" "Detected in single" 173 "REH: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.78e-2)" "unprognostic (6.57e-3)" "unprognostic (2.46e-1)" "unprognostic (2.23e-1)" "unprognostic (3.17e-1)" "unprognostic (1.11e-1)" "unprognostic (6.91e-2)" 0.0 0.1 2.7 0.1 8.9 0.0 0.0 0.3 16.1 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.1 4.0 1.9 1.4 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 GABRA5 ENSG00000186297 "Gamma-aminobutyric acid type A receptor alpha5 subunit" P31644 15 26866363-26949207 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 52.6" "Group enriched" "Detected in some" 12 "A549: 25.8;HAP1: 8.9;NTERA-2: 10.7;U-2 OS: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA077031, CAB079022" Supported Supported "Plasma membrane" "Plasma membrane" "CAB079022: , HPA077031: " "unprognostic (6.33e-2)" "unprognostic (8.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (9.50e-3)" "unprognostic (2.57e-1)" "unprognostic (7.63e-2)" "unprognostic (8.50e-2)" "unprognostic (1.44e-2)" 0.8 0.8 12.0 0.8 48.2 0.8 0.8 0.1 52.6 0.8 0.8 0.8 0.0 0.8 0.8 0.7 2.5 0.8 1.5 0.9 20.9 6.0 0.9 0.8 0.8 0.8 2.3 15.2 0.7 0.7 0.7 0.1 0.8 1.0 1.0 0.7 0.0 0.7 0.9 0.7 0.8 0.7 1.4 0.3 0.8 1.1 1.4 2.0 1.3 0.9 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 8.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 48.2 0.1 26.0 20.9 6.0 2.3 15.2 1.0 2.0 GABRA6 ENSG00000145863 "Gamma-aminobutyric acid type A receptor alpha6 subunit" Q16445 5 161547063-161702593 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "brain: 96.4" "Group enriched" "Detected in some" 9 "AF22: 1.0;PC-3: 1.4;TIME: 1.0;U-266/70: 2.4" "Not detected" "Not detected" "Region enriched" "Detected in some" 36 "cerebellum: 96.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 40 "cerebellum: 1204.9" "Region enriched" "Detected in single" 44 "cerebellum: 189.6" CAB022462 Approved "CAB022462: " "unprognostic (3.79e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 0.1 0.0 0.0 0.0 0.0 2.6 0.0 GABRB1 ENSG00000163288 "Gamma-aminobutyric acid type A receptor beta1 subunit" P18505 4 46993723-47426444 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 34.5;pituitary gland: 14.7" "Cell line enhanced" "Detected in some" "CACO-2: 2.3;REH: 4.1;SCLC-21H: 1.1;U-87 MG: 6.7" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051297 Uncertain "HPA051297: " "unprognostic (3.11e-2)" "unprognostic (7.56e-3)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-1)" "unprognostic (4.98e-3)" "unprognostic (8.16e-3)" "unprognostic (6.22e-2)" "unprognostic (2.72e-2)" "unprognostic (2.34e-1)" 1.0 1.3 19.9 1.0 34.5 0.9 1.0 14.7 27.9 1.0 1.2 2.7 0.0 1.6 1.2 1.0 1.0 1.2 1.2 6.0 16.3 4.2 1.8 1.1 1.1 0.9 2.8 18.5 1.1 0.9 0.9 14.7 1.3 5.6 1.0 1.2 0.0 0.9 0.9 0.9 0.9 1.3 1.0 3.4 1.0 1.0 1.1 6.7 0.0 1.3 0.0 0.9 0.9 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.6 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 34.5 14.7 16.6 16.3 4.2 2.8 18.5 5.6 6.7 GABRB2 ENSG00000145864 "Gamma-aminobutyric acid type A receptor beta2 subunit" P47870 5 161288429-161549044 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 48.7" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 22.8" "Cancer enriched" "Detected in some" 20 "thyroid cancer: 10.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001964, HPA067632" Enhanced "CAB001964: , HPA067632: " "unprognostic (5.46e-2)" "unprognostic (1.03e-1)" "unprognostic (3.29e-1)" "unprognostic (2.26e-6)" "unprognostic (2.33e-2)" "unprognostic (6.65e-2)" "unprognostic (3.58e-2)" "unprognostic (1.82e-1)" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (2.24e-4)" "unprognostic (1.22e-1)" "unprognostic (1.33e-2)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.04e-2)" 1.2 3.6 7.7 0.8 19.2 0.7 0.9 48.7 45.4 1.3 1.5 0.9 0.0 2.0 0.9 5.8 0.8 1.2 0.8 0.9 8.1 4.6 2.8 0.7 1.8 0.8 3.7 16.3 0.9 0.9 0.8 0.5 1.0 4.3 0.9 2.2 0.1 1.3 1.5 0.8 0.8 1.4 0.9 1.1 3.4 1.2 1.5 1.8 0.0 1.3 0.0 0.8 0.8 0.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.2 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.7 19.2 48.7 34.1 8.1 4.6 3.7 16.3 4.3 1.8 GABRB3 ENSG00000166206 "Gamma-aminobutyric acid type A receptor beta3 subunit" P28472 15 26543546-26939539 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.6" "Cell line enhanced" "Detected in some" "A549: 31.9;HAP1: 13.1;NTERA-2: 22.9;SCLC-21H: 21.2;SH-SY5Y: 8.0;U-2 OS: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.72e-1)" "unprognostic (4.91e-2)" "unprognostic (3.20e-2)" "unprognostic (4.25e-2)" "unprognostic (1.66e-1)" "unprognostic (7.07e-2)" "unprognostic (1.00e-1)" "unprognostic (8.87e-2)" "unprognostic (1.02e-1)" "unprognostic (2.44e-1)" "unprognostic (1.44e-2)" "unprognostic (3.62e-1)" "unprognostic (3.56e-3)" "unprognostic (2.99e-2)" "unprognostic (1.49e-1)" "unprognostic (3.33e-2)" "unprognostic (4.05e-1)" 1.2 6.2 16.8 1.1 22.6 0.7 1.5 12.7 48.6 3.0 1.8 1.6 0.1 1.4 2.4 1.6 1.9 3.0 13.9 7.4 14.3 11.7 7.8 1.5 1.5 0.7 4.6 13.7 2.5 5.2 1.2 12.2 0.7 3.7 5.7 1.6 3.2 1.2 1.9 0.7 1.3 1.2 2.0 2.5 1.2 6.0 4.4 3.4 0.0 9.1 0.0 0.9 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 31.9 5.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 13.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.6 1.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.2 0.0 22.9 1.6 0.0 0.0 0.0 2.3 0.0 21.2 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 16.8 22.6 12.7 25.7 14.3 11.7 4.6 13.7 3.7 3.4 GABRD ENSG00000187730 "Gamma-aminobutyric acid type A receptor delta subunit" O14764 1 2019298-2030758 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 87.0" "Cell line enhanced" "Detected in some" "EFO-21: 2.8;HMC-1: 2.5;MCF7: 8.2;NB-4: 5.2;SH-SY5Y: 3.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 87.0" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044371 Enhanced Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA044371: " "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-8)" "unprognostic (6.34e-3)" "unprognostic (2.66e-3)" "unprognostic (1.04e-2)" "unprognostic (3.44e-3)" "unprognostic (2.14e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.99e-1)" "prognostic unfavourable (4.12e-8)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "unprognostic (5.16e-2)" 1.2 3.4 8.8 0.9 16.8 1.0 1.0 87.0 40.0 1.0 1.2 1.7 0.0 0.9 1.3 1.2 1.3 1.0 1.5 1.7 6.0 1.7 1.1 0.9 1.4 1.3 3.3 11.1 0.9 0.9 1.4 0.7 1.2 17.1 1.0 1.0 0.0 1.1 0.9 1.3 1.4 1.0 1.4 1.4 1.0 1.0 3.3 1.5 0.0 1.6 0.0 1.0 1.2 0.1 0.0 1.2 0.2 0.1 0.0 0.0 0.8 0.0 0.7 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 5.2 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.1 0.0 0.0 1.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.8 8.8 16.8 87.0 40.0 6.0 1.7 3.3 11.1 17.1 1.5 GABRG1 ENSG00000163285 "Gamma-aminobutyric acid type A receptor gamma1 subunit" Q8N1C3 4 46035769-46124081 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 35.7" "Cell line enhanced" "Detected in some" "Karpas-707: 1.3;THP-1: 2.6;U-2 OS: 1.8;U-266/70: 5.3" "Cancer enriched" "Detected in single" 8 "glioma: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035622 Approved "HPA035622: AB_10603669" "unprognostic (2.50e-1)" "unprognostic (2.20e-1)" "unprognostic (6.06e-2)" "unprognostic (1.46e-2)" "unprognostic (7.39e-4)" "unprognostic (1.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.99e-1)" 1.5 1.5 20.3 1.2 25.9 1.2 1.3 26.4 35.7 1.3 1.3 12.2 0.0 1.4 1.4 1.3 1.3 1.7 1.3 1.2 26.0 14.6 1.4 1.4 1.2 1.3 10.2 14.0 3.9 1.2 1.3 1.6 1.2 17.9 1.2 1.3 0.0 1.2 1.3 1.2 1.2 1.4 1.4 17.8 1.4 1.3 1.8 17.8 0.0 1.5 0.0 1.2 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.6 0.0 0.3 1.8 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 25.9 26.4 18.5 26.0 14.6 10.2 14.0 17.9 17.8 GABRG2 ENSG00000113327 "Gamma-aminobutyric acid type A receptor gamma2 subunit" P18507 5 162000057-162162977 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.1" "Cell line enhanced" "Detected in many" "CACO-2: 10.7;Karpas-707: 8.5;RPMI-8226: 10.3;U-266/70: 17.9;U-266/84: 14.1" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.3" "Group enriched" "Detected in many" 5 "B-cells: 2.9;granulocytes: 7.3;T-cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079060 Supported "CAB079060: " "unprognostic (2.88e-2)" "unprognostic (1.56e-2)" "unprognostic (6.31e-3)" "unprognostic (3.07e-3)" "unprognostic (1.52e-1)" 1.1 5.7 9.7 1.2 28.8 3.3 0.9 21.7 47.1 0.7 1.5 1.1 0.0 2.2 1.2 1.3 1.3 1.3 3.8 1.6 10.6 19.6 1.0 1.2 1.9 1.2 7.5 19.1 1.5 1.0 0.8 5.3 2.9 17.6 1.0 1.3 0.6 1.3 0.8 1.2 3.3 1.9 1.6 2.6 1.2 3.3 1.7 1.8 0.0 1.8 0.0 1.3 1.5 0.3 2.9 0.7 7.3 0.3 0.9 3.2 0.2 3.6 1.7 2.0 0.3 0.0 0.0 2.1 0.6 0.0 0.0 0.0 10.7 4.7 0.7 5.3 0.0 1.6 1.2 0.0 0.0 0.8 1.1 0.0 2.1 1.3 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 1.8 8.5 0.0 2.5 0.4 0.1 6.1 2.9 0.4 0.1 10.3 0.0 3.4 0.9 0.8 0.3 0.6 3.4 5.7 5.7 0.2 0.3 4.5 0.3 0.5 17.9 14.1 0.5 0.2 0.4 0.4 7.3 0.3 0.6 0.4 0.3 2.7 2.9 0.7 0.6 0.0 2.5 3.2 0.7 1.6 0.9 0.2 0.7 0.6 0.2 9.7 28.8 21.7 38.1 10.6 19.6 7.5 19.1 17.6 1.8 GABRG3 ENSG00000182256 "Gamma-aminobutyric acid type A receptor gamma3 subunit" Q99928 15 26971282-27541991 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.3;prostate: 13.5;testis: 16.6" "Cell line enhanced" "Detected in some" "K-562: 4.9;PC-3: 6.3;SK-MEL-30: 4.1;U-2 OS: 2.9;U-266/70: 3.8;U-87 MG: 16.8" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054010 Supported "HPA054010: " "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-2)" "unprognostic (3.50e-2)" "unprognostic (2.61e-1)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (4.41e-1)" "unprognostic (1.43e-5)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" "unprognostic (2.03e-2)" "unprognostic (1.83e-1)" 0.5 1.3 2.2 0.8 10.4 0.5 1.2 3.1 15.3 2.2 0.5 0.8 0.0 0.4 0.7 4.4 0.5 1.3 0.5 0.4 3.0 5.8 1.0 0.6 0.5 1.5 1.0 7.8 0.5 0.4 0.4 6.4 0.5 2.7 13.5 0.5 4.0 1.5 3.4 0.5 0.9 0.4 0.6 0.8 2.3 0.4 16.6 0.5 0.3 3.3 0.0 1.9 0.4 0.7 0.8 0.3 0.9 0.4 0.3 0.3 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.4 0.4 6.3 0.0 0.0 1.1 0.0 0.0 0.1 1.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 3.8 0.0 0.0 16.8 0.1 0.0 0.4 0.4 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.0 0.8 0.3 0.1 0.9 0.3 0.1 0.3 0.1 0.0 2.2 10.4 3.1 15.3 3.0 5.8 1.0 7.8 2.7 0.5 GABRQ THETA ENSG00000268089 "Gamma-aminobutyric acid type A receptor theta subunit" Q9UN88 X 152638183-152657534 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 28.9;cervix, uterine: 16.2" "Group enriched" "Detected in some" 7 "HeLa: 8.8;SiHa: 8.6;U-87 MG: 28.2" "Cancer enhanced" "Detected in many" "testis cancer: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "hypothalamus: 61.6" "Region enhanced" "Detected in many" "midbrain: 24.9" "unprognostic (3.68e-3)" "unprognostic (7.78e-2)" "unprognostic (9.16e-2)" "unprognostic (1.17e-4)" "unprognostic (3.38e-1)" "unprognostic (1.41e-1)" "unprognostic (1.45e-4)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (1.41e-1)" "unprognostic (3.73e-1)" "unprognostic (3.76e-2)" "unprognostic (3.10e-5)" "unprognostic (3.43e-3)" "unprognostic (1.84e-1)" "unprognostic (6.42e-2)" "unprognostic (7.70e-2)" 0.2 4.4 10.5 0.2 5.7 0.1 0.1 0.0 7.5 16.2 0.2 1.5 1.0 0.2 2.6 0.5 1.1 0.3 0.1 0.2 23.4 0.2 0.1 0.1 0.2 0.0 13.6 0.1 0.1 0.1 0.0 0.3 28.9 0.9 0.2 0.0 0.1 1.7 0.1 0.7 0.5 1.6 7.2 0.2 0.1 4.7 1.0 0.0 0.3 1.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.2 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 2.2 0.0 0.0 0.0 0.0 1.2 8.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAD1 GAD ENSG00000128683 "Glutamate decarboxylase 1" Q99259 2 170813213-170861151 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Decarboxylase, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 53.9" "Cell line enhanced" "Detected in many" "HaCaT: 10.5;HEL: 34.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "olfactory region: 888.9" "CAB004415, HPA031949, HPA058412, CAB078176" Enhanced Supported Approved Vesicles Vesicles "CAB004415: AB_627650, CAB078176: , HPA031949: , HPA058412: " "unprognostic (1.28e-1)" "prognostic favourable (7.31e-4)" "unprognostic (1.87e-2)" "prognostic favourable (8.61e-4)" "unprognostic (1.12e-1)" "unprognostic (3.05e-1)" "unprognostic (4.97e-7)" "unprognostic (1.51e-1)" "unprognostic (7.72e-2)" "unprognostic (4.27e-4)" "unprognostic (6.75e-2)" "unprognostic (9.18e-3)" "unprognostic (6.90e-5)" "unprognostic (2.93e-2)" "unprognostic (6.57e-2)" "unprognostic (1.56e-2)" "unprognostic (3.08e-3)" 1.2 2.0 14.5 0.9 28.1 3.7 1.0 10.6 53.9 1.8 1.0 3.1 0.0 1.0 2.6 5.5 1.2 1.1 1.0 1.0 10.8 24.4 6.0 1.0 1.1 1.1 8.6 17.5 1.1 1.1 9.5 2.8 1.4 6.0 1.8 1.0 1.3 1.0 1.3 0.9 1.0 1.1 1.0 2.6 1.0 1.0 4.0 3.4 0.0 1.1 0.0 1.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.3 0.0 3.7 0.0 0.0 0.0 0.2 0.0 1.4 0.9 2.5 3.5 0.0 0.5 0.2 10.5 1.2 0.3 0.8 1.4 7.2 34.2 3.0 0.1 0.0 0.1 0.6 0.0 3.1 0.0 1.2 0.0 8.8 0.1 0.4 0.8 0.0 0.0 4.2 3.7 0.5 2.5 0.2 4.6 4.9 3.6 1.1 6.5 0.0 1.8 0.1 0.0 0.0 6.4 0.9 1.3 3.7 0.0 0.0 0.0 6.2 1.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 28.1 10.6 36.7 10.8 24.4 8.6 17.5 6.0 3.4 GAD2 GAD65 ENSG00000136750 "Glutamate decarboxylase 2" Q05329 10 26216307-26304558 "Enzymes, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 66.2" "Group enriched" "Detected in some" 12 "MOLT-4: 5.0;SCLC-21H: 11.4" "Group enriched" "Detected in some" 21 "glioma: 0.7;pancreatic cancer: 3.0;testis cancer: 1.2" "Region enhanced" "Detected in all" "basal ganglia: 66.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044637, CAB078177" Enhanced "CAB078177: , HPA044637: AB_10794053" "unprognostic (8.67e-2)" "unprognostic (1.11e-1)" "unprognostic (4.93e-2)" "unprognostic (2.52e-5)" "unprognostic (5.44e-2)" "unprognostic (8.08e-2)" 1.0 0.9 6.3 0.9 66.2 1.0 0.9 5.6 28.7 0.9 0.9 1.4 0.0 1.2 0.9 1.1 0.9 0.9 0.9 0.9 5.2 13.2 1.0 0.9 0.9 0.9 5.4 10.0 0.9 12.9 0.9 0.4 0.9 6.8 1.2 1.0 0.0 0.9 0.9 0.9 1.3 1.1 0.9 1.3 0.9 1.2 1.7 8.1 0.0 0.9 0.0 0.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.3 66.2 5.6 18.2 5.2 13.2 5.4 10.0 6.8 8.1 GAL3ST1 CST ENSG00000128242 "Galactose-3-O-sulfotransferase 1" Q99999 22 30554635-30574587 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2" "Cell line enhanced" "Detected in some" "A549: 22.6;CACO-2: 6.2;EFO-21: 12.3;K-562: 5.2" "Cancer enriched" "Detected in many" 6 "renal cancer: 38.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001220 Approved Approved Vesicles "Intracellular and membrane" Vesicles "HPA001220: AB_1078933" "unprognostic (2.69e-2)" "unprognostic (3.12e-4)" "unprognostic (5.93e-2)" "unprognostic (1.08e-2)" "unprognostic (2.32e-1)" "unprognostic (6.50e-3)" "unprognostic (1.53e-2)" "unprognostic (2.23e-1)" "unprognostic (2.89e-1)" "unprognostic (5.18e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "prognostic unfavourable (1.79e-4)" "unprognostic (2.33e-1)" "unprognostic (4.23e-2)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" 0.8 0.6 8.4 0.7 9.6 1.2 0.8 1.4 12.3 1.4 11.3 25.8 0.0 24.2 1.3 2.3 0.8 2.2 13.4 0.5 12.1 8.3 13.3 1.6 1.5 0.9 14.0 2.6 1.2 2.9 0.6 0.5 1.3 12.4 1.2 2.8 0.3 1.0 1.9 1.9 2.1 25.1 0.7 28.7 0.7 7.2 2.5 7.8 0.0 0.6 0.0 0.4 1.0 0.7 2.3 2.8 2.3 0.7 0.3 0.8 0.0 0.1 22.6 0.4 0.2 0.0 0.0 1.7 0.0 0.1 0.0 0.0 6.2 3.1 0.3 12.3 0.0 0.2 0.0 0.0 0.0 0.2 0.8 0.3 0.2 4.1 0.5 0.1 0.3 0.2 0.0 0.1 0.1 0.0 5.2 0.6 0.0 0.1 0.3 0.8 3.2 0.3 0.2 0.1 0.6 0.9 0.1 0.3 1.5 0.0 0.4 0.2 0.1 0.1 0.6 0.2 0.1 0.2 0.0 2.0 1.2 0.3 0.1 0.1 0.2 0.9 0.7 0.1 0.4 0.5 0.7 1.8 0.7 0.8 0.2 2.3 0.5 0.8 2.3 0.3 0.3 2.8 0.1 0.0 8.4 9.6 1.4 10.3 12.1 8.3 14.0 2.6 12.4 7.8 GAL3ST3 GAL3ST2 ENSG00000175229 "Galactose-3-O-sulfotransferase 3" Q96A11 11 66041952-66049180 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.4;retina: 14.2;thyroid gland: 28.0" "Group enriched" "Detected in some" 5 "NTERA-2: 12.3;SH-SY5Y: 10.0" "Cancer enhanced" "Detected in many" "thyroid cancer: 10.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "naive CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 4 "T-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" "prognostic unfavourable (6.53e-6)" "unprognostic (1.24e-1)" "unprognostic (3.30e-1)" "unprognostic (1.57e-2)" "unprognostic (2.62e-1)" "unprognostic (6.08e-2)" "unprognostic (2.01e-3)" "unprognostic (7.26e-2)" "unprognostic (2.07e-2)" "unprognostic (1.40e-1)" "unprognostic (5.29e-1)" 0.8 0.7 6.3 0.7 15.4 0.7 0.7 7.5 14.5 5.4 0.8 2.4 0.3 0.8 8.0 1.0 0.8 2.5 0.8 5.9 6.1 4.3 4.0 0.7 0.7 0.9 2.9 5.0 0.9 1.5 1.9 3.5 0.7 3.7 2.2 0.7 14.2 0.8 5.9 1.3 1.0 0.8 9.7 1.2 0.7 0.7 2.6 2.0 0.0 28.0 0.0 0.8 0.7 0.2 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 12.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 10.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.3 15.4 7.5 14.5 6.1 4.3 2.9 5.0 3.7 2.0 GALNT13 "GalNAc-T13, KIAA1918" ENSG00000144278 "Polypeptide N-acetylgalactosaminyltransferase 13" Q8IUC8 2 153871913-154453849 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell line enhanced" "Detected in some" "SH-SY5Y: 27.7;U-251 MG: 7.2;WM-115: 20.7" "Cancer enriched" "Detected in some" 5 "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060775 Approved "HPA060775: " "unprognostic (1.97e-1)" "unprognostic (3.43e-3)" "unprognostic (2.47e-2)" "unprognostic (1.00e-3)" "unprognostic (4.21e-3)" "unprognostic (7.73e-3)" "unprognostic (6.50e-2)" "unprognostic (8.17e-2)" "unprognostic (3.57e-1)" "unprognostic (9.15e-2)" "unprognostic (3.83e-2)" "unprognostic (3.09e-2)" "unprognostic (5.17e-2)" "unprognostic (2.05e-5)" "unprognostic (8.61e-3)" "unprognostic (1.52e-1)" "unprognostic (2.05e-1)" 3.0 7.7 8.5 0.7 6.2 0.6 1.4 39.0 29.1 3.1 0.9 7.9 0.6 0.7 3.1 2.3 0.7 1.0 1.1 0.6 7.8 8.9 0.6 0.4 3.4 0.4 8.3 3.1 1.1 1.0 0.5 3.1 1.0 10.5 3.6 1.0 1.1 10.9 2.6 1.7 0.8 0.8 2.0 10.4 0.5 1.1 1.3 4.3 0.0 0.4 0.0 0.5 1.5 0.2 0.2 0.6 2.2 0.9 0.2 0.8 0.0 0.0 3.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 1.7 0.0 3.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.1 4.6 4.3 0.0 0.2 0.6 0.0 0.0 4.7 27.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 7.2 0.3 0.0 0.0 4.5 0.0 20.7 0.0 0.9 2.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.8 0.1 0.2 0.0 0.6 0.4 0.0 8.5 6.2 39.0 7.4 7.8 8.9 8.3 3.1 10.5 4.3 GALNT15 "GALNT7, GALNTL2, pp-GalNAc-T15" ENSG00000131386 "Polypeptide N-acetylgalactosaminyltransferase 15" Q8N3T1 3 16174649-16231992 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 66.7;brain: 52.3" "Group enriched" "Detected in some" 5 "ASC diff: 43.8;ASC TERT1: 43.2;HSkMC: 32.9" "Cancer enriched" "Detected in many" 5 "glioma: 21.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebellum: 10.7;pons and medulla: 6.7" "Low region specificity" "Detected in all" HPA017076 Uncertain Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" 25000 "Golgi apparatus" Cytosol "HPA017076: AB_1849458" "unprognostic (3.87e-1)" "unprognostic (4.84e-4)" "unprognostic (6.39e-2)" "unprognostic (8.77e-3)" "unprognostic (2.77e-1)" "unprognostic (2.52e-1)" "unprognostic (7.40e-4)" "unprognostic (4.24e-1)" "unprognostic (2.24e-1)" "unprognostic (8.28e-6)" "unprognostic (5.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.66e-2)" "unprognostic (1.37e-3)" "unprognostic (1.88e-1)" "unprognostic (8.51e-2)" "unprognostic (1.78e-3)" 66.7 5.3 7.6 2.6 17.4 1.1 22.8 2.3 31.5 3.9 8.6 28.1 1.1 2.8 3.5 3.3 11.4 5.3 5.2 7.3 14.8 6.6 8.3 2.8 3.1 3.4 38.9 8.4 8.4 3.2 1.6 1.0 35.5 24.8 4.9 3.8 1.3 8.0 4.1 17.3 11.6 5.3 10.5 52.3 12.8 4.6 8.1 19.9 0.0 6.3 1.6 1.5 16.6 23.5 0.6 0.9 0.9 0.3 0.3 0.4 0.3 0.0 0.0 0.0 0.0 43.8 43.2 0.0 0.9 0.7 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 32.9 0.0 0.4 0.5 0.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 7.7 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.2 0.3 0.2 0.2 0.1 0.4 0.2 0.3 0.0 0.6 0.4 0.2 0.9 0.3 0.3 0.9 0.3 0.3 7.6 17.4 2.3 13.6 14.8 6.6 38.9 8.4 24.8 19.9 GALNT17 "GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17" ENSG00000185274 "Polypeptide N-acetylgalactosaminyltransferase 17" Q6IS24 7 71132169-71713600 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.9" "Cell line enhanced" "Detected in some" "AF22: 9.5;NTERA-2: 7.2;RPMI-8226: 7.9;SK-BR-3: 30.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA013624, HPA047986" Approved Uncertain "Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "Nucleoli, Nuclear bodies" "HPA013624: AB_1858787, HPA047986: " "unprognostic (2.79e-2)" "unprognostic (6.83e-2)" "unprognostic (5.54e-2)" "unprognostic (3.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.62e-1)" "unprognostic (6.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.00e-1)" "prognostic favourable (4.60e-4)" "unprognostic (2.00e-1)" "unprognostic (4.73e-1)" "unprognostic (1.96e-2)" "unprognostic (9.63e-3)" "prognostic favourable (3.91e-4)" "unprognostic (1.92e-1)" "unprognostic (7.94e-3)" 1.8 7.8 8.2 2.1 13.9 0.5 1.2 25.7 42.9 2.3 4.9 1.7 1.9 0.8 7.9 4.6 8.9 4.4 2.7 19.4 13.2 4.6 2.3 0.6 3.5 0.5 2.1 12.0 22.3 9.4 0.6 4.1 0.7 4.5 9.1 1.4 1.2 1.7 8.3 1.9 0.8 1.5 12.3 1.2 3.3 1.1 3.8 0.8 0.3 9.4 0.0 1.8 10.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 7.9 0.0 0.0 0.5 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 13.9 25.7 22.5 13.2 4.6 2.1 12.0 4.5 0.8 GALNT5 GalNAc-T5 ENSG00000136542 "Polypeptide N-acetylgalactosaminyltransferase 5" Q7Z7M9 2 157257598-157314211 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2" "Cell line enhanced" "Detected in some" "A-431: 23.1;BJ: 15.2;BJ hTERT+: 27.2;fHDF/TERT166: 31.7;HaCaT: 27.1;K-562: 15.7;LHCN-M2: 27.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "cerebellum: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008963, HPA009035" Approved Approved "Nucleoli,Golgi apparatus,Vesicles,Cytosol" 630000 "Nucleoli, Golgi apparatus, Cytosol" Vesicles "HPA008963: AB_1078942, HPA009035: AB_1078943" "unprognostic (6.34e-3)" "unprognostic (9.31e-2)" "unprognostic (2.11e-2)" "unprognostic (9.89e-2)" "unprognostic (3.19e-2)" "unprognostic (2.46e-2)" "unprognostic (4.63e-3)" "unprognostic (1.88e-1)" "unprognostic (1.09e-1)" "unprognostic (6.93e-2)" "unprognostic (4.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-2)" "unprognostic (6.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-3)" 0.4 0.2 0.2 1.5 0.2 0.5 1.1 28.2 0.2 7.5 12.0 0.7 0.0 2.3 0.5 0.5 9.0 0.2 17.1 0.9 0.4 0.2 0.3 0.2 15.5 0.0 0.2 0.0 0.3 1.5 0.0 6.8 0.1 4.4 1.6 16.1 0.3 18.9 0.2 0.2 0.5 8.4 0.8 0.3 0.3 15.2 0.5 0.0 0.1 0.3 12.2 11.7 2.3 6.6 0.2 0.1 0.2 0.1 0.1 0.5 0.0 23.1 2.5 0.0 0.0 1.0 8.1 0.0 15.2 27.2 0.2 0.6 1.0 13.4 0.0 0.0 31.7 27.1 0.4 5.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.5 0.0 15.7 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.1 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.5 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.2 0.2 28.2 0.2 0.4 0.2 0.2 0.0 4.4 0.0 GALNT8 GALNAC-T8 ENSG00000130035 "Polypeptide N-acetylgalactosaminyltransferase 8" "Q9NY28, P17658" 12 4720341-4851927 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Glycosyltransferase, Ion channel, Potassium channel, Transferase, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 12.7;intestine: 33.2;testis: 18.5" "Group enriched" "Detected in some" 4 "Karpas-707: 26.3;NTERA-2: 9.3;U-266/84: 7.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA012638, HPA073461" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" "Golgi apparatus, Vesicles" "HPA012638: AB_2294503, HPA073461: " "unprognostic (2.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.13e-2)" "unprognostic (1.75e-2)" "unprognostic (6.24e-2)" "unprognostic (2.87e-1)" "unprognostic (2.59e-2)" "unprognostic (3.79e-1)" "unprognostic (2.72e-1)" "unprognostic (5.76e-2)" "unprognostic (8.06e-5)" "unprognostic (1.16e-2)" "unprognostic (6.67e-5)" "unprognostic (5.18e-2)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-2)" 1.1 2.2 5.3 2.2 6.5 0.5 3.1 1.4 12.7 1.0 15.5 9.4 0.0 7.2 0.9 0.4 0.7 1.2 1.1 3.7 8.0 1.7 1.2 0.8 0.9 1.0 5.7 9.6 1.6 0.9 0.2 3.7 0.5 6.0 1.1 33.2 0.1 1.0 0.9 0.7 0.9 14.7 2.1 3.5 1.2 1.3 18.5 11.5 0.0 0.8 0.5 0.9 1.2 0.9 1.0 0.7 0.1 0.1 0.9 3.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 26.3 0.0 0.0 0.2 0.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.3 7.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.3 0.7 1.2 0.0 1.0 0.0 0.1 0.1 0.9 0.0 0.7 3.0 0.0 5.3 6.5 1.4 12.7 8.0 1.7 5.7 9.6 6.0 11.5 GALNT9 GALNAC-T9 ENSG00000182870 "Polypeptide N-acetylgalactosaminyltransferase 9" Q9HCQ5 12 132196372-132329349 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 52.4" "Cell line enriched" "Detected in some" 5 "U-87 MG: 26.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 2.6;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 9 "B-cells: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075016 Approved Vesicles Vesicles "HPA075016: " "unprognostic (1.13e-1)" "unprognostic (3.47e-2)" "unprognostic (1.47e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (6.53e-2)" "unprognostic (2.65e-1)" "unprognostic (1.32e-2)" "unprognostic (2.03e-1)" "unprognostic (1.64e-3)" "unprognostic (2.85e-1)" "unprognostic (6.62e-2)" "unprognostic (5.17e-2)" "unprognostic (1.89e-1)" "unprognostic (1.71e-1)" "unprognostic (3.89e-2)" "unprognostic (5.69e-2)" 2.6 2.2 9.3 1.0 6.7 0.6 0.5 52.4 27.9 1.1 0.8 0.8 0.0 1.1 1.8 7.7 0.5 1.9 0.7 0.6 12.9 6.8 3.2 0.5 0.9 1.3 4.3 10.8 1.3 0.4 1.9 2.7 0.5 6.9 1.0 0.6 0.3 1.2 1.7 0.5 0.9 1.0 0.6 1.7 1.2 0.7 0.9 1.1 0.0 6.1 0.0 0.4 0.7 0.1 2.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 26.3 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 2.6 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.3 6.7 52.4 20.2 12.9 6.8 4.3 10.8 6.9 1.1 GALNTL6 "GalNAc-T6L, GALNT17" ENSG00000174473 "Polypeptide N-acetylgalactosaminyltransferase like 6" Q49A17 4 171812254-173041559 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 7.3;testis: 6.4" "Cell line enhanced" "Detected in some" "Karpas-707: 2.3;SCLC-21H: 2.4;SK-MEL-30: 1.9;U-266/70: 2.8;WM-115: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 4.5;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 8 "B-cells: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031019 Uncertain "Intracellular and membrane" "HPA031019: AB_10601653" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (2.01e-2)" "unprognostic (5.73e-2)" "unprognostic (7.50e-2)" "unprognostic (8.32e-2)" "unprognostic (3.25e-1)" "unprognostic (9.55e-2)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (2.06e-1)" "unprognostic (2.80e-1)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.11e-2)" "unprognostic (4.84e-3)" "unprognostic (1.73e-2)" 0.2 0.7 3.9 1.2 8.3 1.1 0.7 1.0 9.5 3.3 1.0 0.6 0.0 0.7 0.3 0.3 0.2 0.3 0.5 0.5 3.6 4.1 0.3 0.5 0.5 1.3 7.6 2.4 0.1 0.5 0.1 0.0 0.1 1.8 2.2 0.7 1.3 0.3 0.2 0.5 0.6 1.2 0.3 0.5 7.3 2.9 6.4 1.2 0.0 0.5 1.1 0.4 0.5 0.6 4.5 0.5 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.5 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.7 1.2 0.0 1.3 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.7 2.3 0.2 1.1 0.3 0.6 1.4 0.0 0.0 0.1 0.0 0.0 0.0 2.4 1.0 0.0 0.5 1.9 0.0 0.3 0.0 0.0 0.1 0.0 0.1 2.8 0.0 0.0 0.3 0.1 1.7 0.0 0.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 8.3 1.0 5.9 3.6 4.1 7.6 2.4 1.8 1.2 GALP ENSG00000197487 "Galanin like peptide" Q9UBC7 19 56176020-56185775 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Hormone, Neuropeptide" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 4.4;liver: 4.1" "Cell line enhanced" "Detected in some" "Daudi: 1.1;EFO-21: 1.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Region enhanced" "Detected in many" "pons and medulla: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hippocampal formation: 29.0" HPA053938 Uncertain "Secreted in brain" "HPA053938: " "unprognostic (8.51e-3)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (7.02e-2)" 0.0 0.2 1.2 0.0 1.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 4.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.1 1.1 0.7 0.4 0.0 4.4 0.0 GALR1 "GALNR, GALNR1" ENSG00000166573 "Galanin receptor 1" P47211 18 77250549-77277896 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.3;brain: 3.5;pituitary gland: 4.9" "Low cell line specificity" "Detected in some" "Cancer enriched" "Detected in single" 6 "glioma: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in some" "hypothalamus: 6.1" "Low region specificity" "Detected in many" "unprognostic (1.65e-1)" "unprognostic (1.56e-2)" "unprognostic (2.85e-1)" "unprognostic (3.00e-1)" "unprognostic (2.11e-1)" "unprognostic (2.77e-3)" "unprognostic (1.31e-2)" "unprognostic (5.34e-3)" "unprognostic (7.33e-3)" "unprognostic (9.49e-2)" "unprognostic (2.18e-1)" 1.1 5.3 1.2 0.3 0.8 0.7 0.5 0.0 3.5 0.0 0.3 0.4 0.2 0.5 0.0 0.3 0.1 0.1 0.7 2.0 0.1 0.5 0.0 0.1 0.8 0.1 0.5 0.0 4.9 0.0 0.8 0.5 0.5 0.7 0.1 0.4 0.5 0.1 0.9 0.0 0.3 0.4 0.3 0.0 0.0 0.1 0.4 0.4 1.6 0.2 0.5 0.3 0.0 0.2 0.4 0.6 0.8 0.5 1.2 0.6 0.2 0.5 0.1 0.1 0.8 1.1 0.8 0.2 0.4 0.4 0.3 0.2 0.1 1.1 0.6 1.1 0.8 0.5 0.3 0.5 0.8 0.8 0.4 0.3 0.3 0.3 0.4 1.6 0.1 0.9 0.4 0.9 0.6 0.5 0.5 0.4 0.4 0.2 0.6 1.5 0.5 0.2 0.4 0.4 0.5 0.4 0.6 0.6 0.7 1.1 0.1 0.6 0.3 0.4 0.8 0.3 0.4 1.0 0.2 0.3 0.3 0.2 0.3 0.3 0.3 0.2 0.1 0.4 0.2 0.2 1.6 0.5 0.2 0.4 0.1 0.0 GALR3 ENSG00000128310 "Galanin receptor 3" O60755 22 37823382-37825495 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.0;skeletal muscle: 2.5" "Cell line enhanced" "Detected in some" "AN3-CA: 1.9;HEK 293: 2.3;Hep G2: 2.9;REH: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "unprognostic (4.45e-2)" "unprognostic (1.45e-2)" "unprognostic (4.60e-3)" "unprognostic (7.07e-2)" "unprognostic (7.63e-2)" "unprognostic (8.17e-2)" "unprognostic (4.18e-2)" "unprognostic (2.16e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (2.07e-1)" "unprognostic (1.66e-2)" "unprognostic (7.37e-2)" "unprognostic (8.35e-2)" "unprognostic (4.45e-2)" 0.0 0.0 0.6 0.0 1.3 0.7 0.0 2.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.0 0.0 0.9 0.0 0.0 0.2 0.4 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.1 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.9 0.4 0.0 0.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 2.9 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.2 0.0 1.0 0.4 0.3 1.9 0.0 0.0 0.0 0.0 0.4 0.3 1.1 0.0 0.1 0.9 1.3 0.0 0.1 0.4 0.3 0.0 0.3 0.4 0.3 0.1 0.6 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAP43 "B-50, PP46" ENSG00000172020 "Growth associated protein 43" P17677 3 115623324-115721490 "Plasma proteins, Predicted intracellular proteins, Transporters" "Differentiation, Growth regulation, Neurogenesis" "Calmodulin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 132.7" "Cell line enhanced" "Detected in some" "AF22: 16.4;NTERA-2: 34.8;SCLC-21H: 22.4;SH-SY5Y: 16.8;U-87 MG: 7.8" "Cancer enriched" "Detected in many" 43 "glioma: 245.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "naive CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004417, HPA013392, HPA015600, CAB078783" Enhanced Supported Enhanced "Plasma membrane" "Plasma membrane" "CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.15e-2)" "unprognostic (5.72e-5)" "unprognostic (7.44e-3)" "unprognostic (2.19e-2)" "unprognostic (3.97e-3)" "unprognostic (3.15e-3)" "unprognostic (6.08e-4)" "unprognostic (3.33e-1)" "unprognostic (2.17e-2)" "unprognostic (1.62e-1)" "unprognostic (5.35e-8)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (1.29e-3)" 1.8 5.0 48.8 5.2 38.3 1.4 1.9 31.2 132.7 1.6 4.1 4.3 0.0 2.7 1.5 1.5 1.9 1.5 3.8 3.6 29.0 56.6 1.4 1.4 1.5 1.5 30.6 42.2 1.4 1.8 1.4 1.5 2.2 25.7 1.7 4.0 0.8 2.2 1.5 1.4 1.4 4.3 3.6 6.1 1.4 1.5 1.6 5.7 0.0 1.5 0.0 1.6 1.7 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 22.4 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 48.8 38.3 31.2 75.7 29.0 56.6 30.6 42.2 25.7 5.7 GAREM2 "FAM59B, FLJ00375, GAREML, KIAA2038" ENSG00000157833 "GRB2 associated regulator of MAPK1 subtype 2" Q75VX8 2 26173091-26189663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 21.2;parathyroid gland: 17.0" "Cell line enhanced" "Detected in many" "HAP1: 15.1;SH-SY5Y: 9.4;U-2 OS: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071575 Approved Cytosol Cytosol "HPA071575: " "unprognostic (1.70e-2)" "unprognostic (5.62e-2)" "unprognostic (7.61e-4)" "unprognostic (1.56e-2)" "unprognostic (8.27e-2)" "unprognostic (2.19e-1)" "unprognostic (2.90e-2)" "unprognostic (1.99e-1)" "unprognostic (2.12e-2)" "unprognostic (2.65e-1)" "unprognostic (1.33e-1)" "unprognostic (3.94e-2)" "unprognostic (1.15e-3)" "unprognostic (1.35e-1)" "unprognostic (3.22e-1)" "unprognostic (1.46e-2)" "unprognostic (1.04e-1)" 3.2 1.6 19.9 1.8 13.9 0.9 1.5 8.2 21.2 2.5 3.0 11.7 0.7 1.2 3.0 1.7 2.6 2.4 2.8 2.0 17.9 11.0 1.8 0.5 1.1 2.2 13.1 8.9 4.1 4.4 17.0 1.4 1.5 16.5 1.7 2.9 0.9 1.8 3.5 3.7 2.4 1.1 3.6 15.9 1.6 1.5 2.6 13.9 0.0 2.6 0.0 2.0 2.1 1.2 0.8 2.5 1.6 0.6 0.4 1.9 0.3 2.6 4.0 4.8 0.4 0.8 1.7 0.4 1.4 0.0 0.4 0.4 7.5 0.9 0.0 1.9 3.0 0.1 15.1 0.0 0.6 1.6 5.6 1.3 1.3 0.5 5.9 0.1 0.3 2.3 0.7 2.3 0.2 1.8 6.9 0.1 2.8 0.0 0.4 0.5 5.1 1.1 1.5 0.0 0.0 2.4 0.8 1.0 9.4 3.3 0.3 2.8 0.2 7.9 0.8 2.1 12.9 3.8 0.1 0.3 0.0 1.6 0.1 0.0 2.7 0.4 0.6 0.2 1.2 0.2 0.5 0.5 1.9 1.4 0.5 0.8 1.5 0.5 1.6 0.4 0.5 2.5 0.4 0.3 19.9 13.9 8.2 14.1 17.9 11.0 13.1 8.9 16.5 13.9 GARNL3 "bA356B19.1, DKFZp761J1523" ENSG00000136895 "GTPase activating Rap/RanGAP domain like 3" Q5VVW2 9 127224265-127393660 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell line enhanced" "Detected in many" "RPMI-8226: 5.9;SH-SY5Y: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 4 "dendritic cells: 3.8;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028757, HPA074886" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA028757: AB_2294383, HPA074886: " "unprognostic (3.15e-2)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (3.40e-2)" "unprognostic (3.12e-2)" "unprognostic (1.19e-3)" "unprognostic (5.58e-3)" "unprognostic (3.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (6.88e-4)" "unprognostic (2.22e-1)" "unprognostic (3.23e-7)" "unprognostic (6.39e-2)" "unprognostic (6.60e-2)" "unprognostic (7.04e-3)" "unprognostic (1.78e-5)" 4.2 8.4 11.4 2.5 13.5 0.4 6.4 33.3 19.6 9.1 3.6 12.9 3.8 3.0 10.6 6.6 7.0 8.5 5.8 16.3 7.5 9.6 3.4 3.0 3.8 2.0 7.8 10.7 6.6 3.5 15.7 3.1 2.3 12.9 9.0 3.1 4.3 7.0 6.4 2.2 4.3 2.7 10.1 7.2 2.4 2.9 4.0 9.4 0.0 8.6 1.5 2.1 7.9 4.8 0.5 3.8 0.0 0.5 0.0 1.3 0.2 0.8 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.6 0.3 1.8 1.9 0.6 0.0 1.7 0.1 0.9 3.3 0.0 0.3 0.0 1.4 0.0 2.9 1.9 0.8 0.7 0.3 0.2 2.6 0.0 0.0 1.3 1.4 1.1 0.1 1.0 0.0 0.6 0.7 2.7 0.2 2.0 5.9 3.2 4.1 2.1 6.5 1.3 4.7 0.5 1.6 0.1 0.0 0.4 1.9 0.0 0.6 4.1 3.9 2.0 0.9 1.0 0.8 0.0 0.5 0.0 1.2 0.1 0.3 0.2 0.1 1.3 0.5 0.5 0.8 0.0 0.0 0.0 0.0 3.8 0.6 0.2 11.4 13.5 33.3 19.6 7.5 9.6 7.8 10.7 12.9 9.4 GAS7 "KIAA0394, MGC1348" ENSG00000007237 "Growth arrest specific 7" O60861 17 9910609-10198551 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.2" "Cell line enriched" "Detected in some" 9 "WM-115: 107.7" "Cancer enhanced" "Detected in all" "melanoma: 54.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 17.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004838, HPA064678" Enhanced Approved "Plasma membrane,Actin filaments,Focal adhesion sites" "Plasma membrane" "Actin filaments, Focal adhesion sites" "HPA004838: AB_2667263, HPA064678: " "unprognostic (1.68e-2)" "unprognostic (2.84e-3)" "unprognostic (1.80e-1)" "unprognostic (1.28e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-2)" "unprognostic (7.32e-2)" "unprognostic (7.16e-2)" "unprognostic (2.88e-1)" "unprognostic (1.50e-2)" "unprognostic (2.48e-1)" "unprognostic (1.79e-1)" "unprognostic (1.94e-3)" "unprognostic (6.48e-2)" "unprognostic (8.78e-2)" "unprognostic (3.08e-2)" "prognostic unfavourable (6.89e-4)" 19.1 6.5 22.1 15.4 40.3 18.7 10.8 86.2 64.7 22.6 9.3 33.4 1.7 5.2 9.7 4.4 17.0 12.6 11.5 23.1 25.8 15.0 1.5 2.1 9.9 5.9 28.1 25.0 5.9 2.8 1.4 1.7 11.0 14.2 3.7 8.7 7.7 4.0 8.2 3.9 21.2 7.4 16.3 33.8 10.0 4.2 11.8 22.2 2.7 2.5 2.7 7.2 11.7 7.8 0.4 3.6 11.0 17.6 2.8 2.1 4.4 0.0 0.1 0.1 0.2 3.4 4.8 0.0 0.1 0.0 0.5 0.2 0.0 0.0 1.3 0.3 1.3 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.1 1.1 0.3 9.9 0.9 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 10.4 3.1 0.5 0.0 2.7 0.0 9.6 0.0 0.0 0.0 0.6 0.0 0.0 12.4 0.5 4.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 7.0 107.7 0.4 17.6 10.8 2.1 4.7 0.7 0.3 0.2 1.0 3.6 0.4 0.2 1.0 11.0 2.8 3.1 0.6 0.0 4.4 22.1 40.3 86.2 38.8 25.8 15.0 28.1 25.0 14.2 22.2 GBX1 ENSG00000164900 "Gastrulation brain homeobox 1" Q14549 7 151148589-151174745 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 6.0;skeletal muscle: 16.6;testis: 9.0" "Cell line enhanced" "Detected in some" "HAP1: 1.8;HEK 293: 1.9;HMC-1: 5.6;PC-3: 1.1" "Cancer enhanced" "Detected in single" "cervical cancer: 1.0" "Region enhanced" "Detected in single" "basal ganglia: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 3.4" "Low region specificity" "Detected in many" HPA055783 Uncertain "HPA055783: " "unprognostic (4.24e-2)" "unprognostic (3.87e-2)" "unprognostic (3.58e-2)" "unprognostic (2.40e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.91e-1)" "unprognostic (3.14e-1)" 1.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.5 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 6.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.5 0.0 0.2 0.0 0.0 0.7 0.0 GBX2 ENSG00000168505 "Gastrulation brain homeobox 2" P52951 2 236165236-236168369 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 11.9" "Cell line enhanced" "Detected in some" "AF22: 31.8;BEWO: 5.5;PC-3: 9.3;TIME: 5.0" "Group enriched" "Detected in some" 6 "glioma: 1.7;testis cancer: 6.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 0.7;thalamus: 1.4" "Region enhanced" "Detected in many" "thalamus: 6.3" HPA067809 Approved Nucleoplasm Nucleoplasm "HPA067809: " "unprognostic (5.30e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.91e-1)" "unprognostic (8.13e-2)" "unprognostic (6.99e-2)" "unprognostic (3.55e-4)" "unprognostic (8.69e-7)" "unprognostic (2.08e-1)" "unprognostic (1.01e-2)" "unprognostic (5.47e-2)" "unprognostic (9.39e-4)" 0.1 0.1 0.3 0.4 5.8 0.1 0.1 11.9 3.6 0.1 0.2 4.2 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.4 0.6 3.8 0.2 0.3 0.1 0.1 1.2 0.3 0.1 0.1 0.1 0.2 1.4 6.3 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.2 0.3 4.6 0.1 0.1 1.3 2.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 31.8 1.2 0.0 0.0 5.5 0.4 0.0 0.8 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.2 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.1 0.0 0.4 0.7 0.0 0.2 0.8 9.3 0.0 3.4 0.0 0.3 0.0 0.4 0.2 1.0 0.0 0.3 0.0 0.0 5.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.8 11.9 0.0 0.6 3.8 1.2 0.3 6.3 2.8 GCA GCL ENSG00000115271 Grancalcin P28676 2 162318840-162371595 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 112.7;bone marrow: 116.0;brain: 30.2;lymphoid tissue: 51.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 41.1;neutrophil: 112.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 112.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035033, HPA035034" Enhanced Supported "Plasma membrane,Cytosol" 890000 Cytosol "Plasma membrane" "HPA035033: AB_10669854, HPA035034: AB_10669900" "unprognostic (9.62e-2)" "unprognostic (9.76e-2)" "unprognostic (3.33e-1)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (2.33e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-2)" "unprognostic (2.49e-2)" "unprognostic (1.20e-1)" "unprognostic (9.78e-2)" "unprognostic (6.56e-2)" "unprognostic (5.80e-2)" "unprognostic (3.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.32e-2)" 13.1 6.8 13.4 24.8 21.3 116.0 7.8 6.9 15.8 6.0 7.7 15.3 3.2 8.2 4.6 11.0 5.0 7.2 9.7 11.2 15.9 13.0 8.5 7.6 15.6 51.8 26.0 9.7 4.4 11.5 4.8 8.1 10.6 24.6 5.7 8.6 3.7 6.9 4.9 2.2 3.7 7.8 7.7 30.2 50.0 10.3 10.7 20.8 5.8 7.4 2.5 10.3 10.0 6.3 3.1 8.9 112.7 18.2 0.3 1.3 8.4 1.3 2.1 5.8 0.0 1.4 1.2 0.2 2.1 6.1 3.4 6.2 4.8 16.3 1.9 15.0 0.1 0.8 2.2 6.9 4.2 9.1 9.2 17.1 1.5 9.1 1.7 21.4 5.0 1.5 2.4 3.1 0.7 0.4 0.3 6.6 0.2 16.8 0.4 12.4 3.7 8.3 7.4 1.4 9.6 17.9 9.6 3.8 6.5 2.8 12.6 10.6 8.6 9.6 0.4 0.8 6.2 9.7 3.2 6.3 11.7 0.3 5.3 8.4 4.0 4.4 18.2 41.1 0.4 10.7 0.5 3.0 0.6 0.6 8.9 3.1 1.1 0.7 112.7 0.3 8.0 2.2 1.3 8.4 13.4 21.3 6.9 15.8 15.9 13.0 26.0 9.7 24.6 20.8 GCSAML "C1orf150, FLJ44728" ENSG00000169224 "Germinal center associated signaling and motility like" Q5JQS6 1 247507058-247577690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 48.3;brain: 17.6" "Group enriched" "Detected in some" 73 "HEL: 27.8;HMC-1: 110.6" "Cancer enriched" "Detected in single" 13 "prostate cancer: 1.9" "Region enriched" "Detected in some" 10 "cerebellum: 17.6" "Cell type enriched" "Detected in single" 439 "basophil: 48.3" "Lineage enriched" "Detected in single" 439 "granulocytes: 48.3" "Not detected" "Not detected" "HPA027507, HPA027510" Uncertain Approved Cytosol Cytosol "HPA027507: AB_10600756, HPA027510: " "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (4.07e-3)" "unprognostic (3.48e-2)" "unprognostic (1.72e-1)" "unprognostic (2.76e-4)" "unprognostic (3.21e-1)" "unprognostic (6.14e-2)" "unprognostic (5.42e-2)" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.81e-1)" "unprognostic (9.51e-3)" "unprognostic (3.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.24e-1)" "unprognostic (1.40e-2)" 3.7 0.3 0.4 1.1 0.4 2.4 1.6 17.6 0.4 3.8 2.1 0.2 0.0 2.2 2.4 2.2 1.9 0.6 2.7 1.3 0.4 0.5 0.5 0.4 5.6 1.1 0.5 0.0 0.3 0.5 0.1 0.4 0.3 1.7 9.5 2.4 0.4 1.0 0.9 0.5 1.2 2.5 6.6 0.9 0.5 1.4 5.3 0.0 1.4 0.4 2.4 1.5 3.4 9.4 0.1 0.0 48.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 110.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 48.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 17.6 0.4 0.4 0.5 0.5 0.0 1.7 0.0 GDA ENSG00000119125 "Guanine deaminase" Q9Y2T3 9 72114595-72257193 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;intestine: 54.5;liver: 27.6" "Cell line enhanced" "Detected in some" "A-431: 12.7;BJ hTERT+: 9.2;EFO-21: 50.3;HeLa: 17.6;hTCEpi: 23.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "amygdala: 39.7;basal ganglia: 31.5;cerebral cortex: 63.2;hippocampal formation: 79.5;olfactory region: 28.4" "HPA019352, HPA024099, HPA030387" Enhanced Approved Nucleoplasm 1300000 Nucleoplasm "HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351" "unprognostic (2.64e-2)" "unprognostic (7.10e-2)" "unprognostic (2.83e-2)" "unprognostic (2.92e-1)" "unprognostic (4.35e-2)" "unprognostic (8.45e-2)" "unprognostic (2.00e-1)" "unprognostic (5.60e-2)" "unprognostic (3.26e-1)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (5.56e-2)" "prognostic favourable (2.66e-5)" "unprognostic (2.23e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (8.30e-4)" 0.5 1.7 26.7 1.8 27.7 0.5 0.5 0.4 33.8 1.0 20.6 0.9 7.7 47.4 2.4 0.6 0.5 4.7 13.1 0.5 25.7 15.0 21.4 27.6 0.5 0.5 2.9 27.4 0.4 1.7 10.8 1.7 10.3 0.8 0.4 5.5 0.0 0.4 4.1 1.1 1.6 54.5 0.5 0.6 0.5 2.0 1.0 0.2 0.0 0.4 1.0 2.6 3.4 0.5 1.4 0.5 3.0 0.7 1.0 1.0 0.1 12.7 1.6 0.0 0.0 0.0 0.0 0.3 0.0 9.2 0.0 0.0 1.1 7.1 0.0 50.3 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.2 0.0 3.4 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.4 2.9 0.0 0.2 0.9 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 3.0 0.7 0.3 1.0 0.6 0.3 0.6 0.5 0.4 0.3 1.4 0.7 0.7 1.9 1.0 0.4 0.5 0.5 0.1 26.7 27.7 0.4 33.8 25.7 15.0 2.9 27.4 0.8 0.2 GDAP1 "CMT2K, CMT4, CMT4A" ENSG00000104381 "Ganglioside induced differentiation associated protein 1" Q8TB36 8 74321130-74488872 "Disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.3" "Cell line enhanced" "Detected in many" "SH-SY5Y: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014266, HPA024334" Enhanced Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA014266: AB_1849581, HPA024334: AB_1849583" "unprognostic (3.19e-2)" "unprognostic (1.52e-3)" "unprognostic (2.72e-1)" "prognostic unfavourable (1.82e-4)" "unprognostic (3.31e-1)" "unprognostic (4.36e-2)" "unprognostic (1.72e-2)" "prognostic favourable (2.68e-4)" "unprognostic (3.88e-1)" "unprognostic (4.17e-1)" "unprognostic (9.44e-3)" "unprognostic (2.44e-1)" "unprognostic (5.40e-2)" "unprognostic (3.29e-1)" "unprognostic (6.99e-2)" "prognostic unfavourable (4.54e-4)" "unprognostic (2.73e-1)" 2.8 11.2 19.2 3.8 25.9 2.1 5.6 24.9 48.3 3.2 2.9 7.6 1.1 3.2 5.4 5.7 5.3 3.7 3.4 2.8 17.6 21.4 5.3 2.0 3.2 3.7 16.5 19.2 8.2 10.8 12.3 16.4 2.3 23.3 5.6 3.6 3.7 2.9 5.4 2.6 2.1 3.0 3.9 14.6 2.9 3.2 5.4 9.6 0.7 7.5 0.5 3.4 3.8 1.8 2.7 1.7 2.8 7.2 1.9 4.6 1.4 2.3 7.7 11.9 2.7 1.0 0.9 1.1 1.0 5.6 6.0 6.9 4.0 2.7 9.1 1.4 1.3 3.9 6.4 3.9 11.8 7.9 2.0 4.8 4.3 7.8 1.3 3.9 9.8 2.8 1.3 2.9 6.1 0.7 2.3 0.1 3.6 2.9 7.9 0.6 13.7 10.5 4.0 5.6 1.7 2.0 7.2 11.7 28.7 7.0 2.6 5.9 11.8 1.3 0.1 8.8 4.1 2.0 2.8 6.0 5.6 4.4 4.0 0.2 9.2 0.0 1.7 2.8 1.5 4.3 1.8 2.7 1.6 1.9 1.7 1.9 1.3 1.6 0.0 1.9 7.2 0.0 4.6 1.4 19.2 25.9 24.9 25.8 17.6 21.4 16.5 19.2 23.3 9.6 GDAP1L1 ENSG00000124194 "Ganglioside induced differentiation associated protein 1 like 1" Q96MZ0 20 44247099-44280917 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.4" "Group enriched" "Detected in some" 5 "NTERA-2: 9.6;SCLC-21H: 23.6;SH-SY5Y: 11.6" "Cancer enriched" "Detected in single" 14 "glioma: 6.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054182, HPA063265" Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA054182: , HPA063265: " "unprognostic (6.58e-3)" "unprognostic (2.58e-1)" "unprognostic (2.30e-1)" "unprognostic (2.23e-4)" "unprognostic (3.69e-1)" "unprognostic (5.15e-1)" "unprognostic (6.45e-2)" "unprognostic (7.69e-2)" "unprognostic (1.53e-1)" "unprognostic (5.07e-1)" "unprognostic (4.74e-3)" "unprognostic (2.41e-1)" "unprognostic (3.81e-5)" "unprognostic (8.57e-2)" "unprognostic (1.87e-1)" "unprognostic (3.21e-2)" "unprognostic (1.13e-1)" 1.1 3.9 18.9 1.3 14.9 1.2 1.1 17.8 47.4 1.2 1.2 1.4 0.0 1.0 1.5 1.1 1.1 1.2 1.1 1.3 13.1 14.3 1.1 1.0 1.0 1.0 9.1 12.2 3.0 1.8 2.4 7.1 1.0 10.6 1.1 1.1 0.9 1.0 1.1 1.1 1.5 1.3 1.2 2.6 1.0 1.9 2.8 1.6 0.0 1.1 0.0 1.0 1.1 0.0 0.1 0.0 0.7 0.1 0.5 0.8 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 23.6 11.6 0.0 0.1 1.0 0.0 3.0 0.0 0.9 0.5 0.2 0.0 0.0 0.1 0.6 0.8 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.7 0.5 0.1 0.0 0.0 0.0 18.9 14.9 17.8 25.7 13.1 14.3 9.1 12.2 10.6 1.6 GDF1 ENSG00000130283 "Growth differentiation factor 1" P27539 19 18868545-18896096 "Disease related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 36.4;skeletal muscle: 15.5" "Cell line enhanced" "Detected in some" "AN3-CA: 3.4;EFO-21: 5.2;HEK 293: 6.3;NB-4: 8.2;NTERA-2: 4.2;SCLC-21H: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" 2.2 2.1 25.6 2.2 28.6 1.9 1.9 11.7 32.1 2.0 2.0 36.4 0.0 1.9 2.0 1.9 2.0 2.0 2.0 2.1 24.6 18.0 2.0 1.9 1.9 1.9 26.2 18.3 2.4 2.0 2.0 1.1 1.9 30.4 2.2 1.9 1.4 2.1 2.0 15.5 1.9 2.0 2.0 33.7 1.9 2.0 4.9 19.8 0.0 2.0 0.0 1.9 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 3.4 0.0 0.0 0.3 0.2 0.0 0.3 0.3 0.8 0.0 0.0 5.2 0.0 0.1 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.7 0.0 8.2 4.2 0.1 0.0 0.0 0.1 0.0 0.0 3.5 2.2 0.0 0.0 1.5 0.6 2.5 0.0 0.0 1.0 0.8 0.5 0.3 0.0 0.0 0.1 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 28.6 11.7 32.1 24.6 18.0 26.2 18.3 30.4 19.8 GDI1 "FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4" ENSG00000203879 "GDP dissociation inhibitor 1" P31150 X 154436913-154443467 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 122.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012979, HPA049290, HPA057668" Enhanced Approved Vesicles 70000000 Vesicles "CAB012979: AB_2533970, HPA049290: , HPA057668: " "prognostic unfavourable (6.84e-4)" "unprognostic (1.13e-2)" "prognostic unfavourable (3.83e-5)" "unprognostic (3.53e-1)" "unprognostic (1.22e-1)" "unprognostic (1.92e-3)" "unprognostic (1.31e-3)" "unprognostic (1.36e-1)" "unprognostic (1.46e-2)" "unprognostic (1.30e-1)" "unprognostic (2.98e-3)" "unprognostic (3.86e-2)" "unprognostic (3.88e-3)" "unprognostic (1.70e-1)" "unprognostic (8.12e-2)" "unprognostic (1.92e-2)" "unprognostic (1.72e-1)" 19.8 27.1 51.7 16.2 65.3 10.5 12.0 61.3 122.3 16.7 13.6 46.2 6.5 11.5 20.1 15.7 14.4 23.0 15.2 25.7 53.7 54.3 13.7 10.3 16.9 15.1 45.1 49.6 27.7 16.2 18.8 26.9 19.0 65.3 19.6 13.9 13.8 13.6 24.0 14.3 17.2 13.1 25.6 46.4 17.1 13.5 12.9 31.3 6.8 12.7 6.2 15.7 13.9 11.8 7.6 8.3 20.6 13.4 5.6 13.0 4.9 20.3 18.9 42.7 35.2 17.5 20.7 13.4 29.5 19.8 31.1 32.5 11.0 10.8 16.3 30.9 29.9 16.1 37.4 18.0 21.6 29.4 18.4 5.1 27.7 7.3 25.8 4.9 18.6 21.2 22.3 36.0 22.1 20.0 6.2 25.9 36.9 20.6 15.6 12.4 11.3 34.5 15.6 11.1 9.3 21.7 9.6 59.1 45.7 14.2 18.5 22.4 11.0 8.9 22.6 28.7 24.9 29.7 43.1 36.7 38.9 25.9 31.2 11.1 35.2 14.9 5.7 17.2 8.9 8.6 13.0 7.3 9.6 8.6 4.7 7.6 7.6 7.5 20.6 5.6 13.4 8.3 10.8 4.9 51.7 65.3 61.3 96.6 53.7 54.3 45.1 49.6 65.3 31.3 GDNF "ATF1, ATF2, HFB1-GDNF" ENSG00000168621 "Glial cell derived neurotrophic factor" P39905 5 37812677-37839686 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes, Disease mutation, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;skeletal muscle: 12.4" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 24.6;U-87 MG: 7.4;WM-115: 27.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 14.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in single" "basal ganglia: 2.5" "Low region specificity" "Detected in many" "CAB005210, HPA070283" Supported Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "CAB005210: AB_2247684, HPA070283: " "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (3.54e-2)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (5.33e-2)" "unprognostic (1.92e-1)" "unprognostic (3.71e-2)" "unprognostic (2.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.10e-1)" "unprognostic (1.16e-4)" "unprognostic (2.04e-1)" "unprognostic (8.86e-2)" "unprognostic (1.05e-1)" "unprognostic (4.42e-2)" 1.9 0.3 0.6 1.9 2.3 0.0 0.4 14.1 1.3 0.8 9.4 0.4 0.4 1.6 1.7 3.4 1.0 0.9 0.9 0.9 0.6 0.4 1.0 0.7 0.4 0.4 0.6 1.2 4.5 0.4 0.0 0.4 6.3 1.4 1.6 3.1 1.1 0.4 6.3 12.4 1.4 2.5 2.5 0.5 0.4 1.9 3.9 2.4 0.4 0.4 1.5 0.4 0.6 1.1 0.8 0.4 1.2 0.3 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 3.3 2.1 0.6 0.9 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.2 0.3 0.1 0.0 0.0 1.0 0.1 24.6 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.1 0.2 0.0 0.1 0.1 1.6 0.0 0.0 0.0 3.3 0.0 0.8 3.8 2.3 0.0 0.0 7.4 0.0 27.0 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.8 0.2 0.4 1.2 0.9 0.2 0.4 0.1 0.0 0.6 2.3 14.1 1.3 0.6 0.4 0.6 1.2 1.4 2.4 GDPD1 "FLJ37451, GDE4" ENSG00000153982 "Glycerophosphodiester phosphodiesterase domain containing 1" Q8N9F7 17 59220467-59275967 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3" "Cell line enhanced" "Detected in many" "HEL: 22.2;K-562: 12.6;SCLC-21H: 14.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (8.33e-2)" "unprognostic (6.63e-3)" "unprognostic (2.68e-2)" "unprognostic (5.98e-3)" "unprognostic (7.12e-2)" "unprognostic (5.35e-2)" "unprognostic (4.85e-6)" "prognostic favourable (2.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.36e-2)" "unprognostic (1.24e-3)" "unprognostic (2.73e-1)" "unprognostic (1.15e-1)" "unprognostic (2.25e-3)" "unprognostic (4.72e-2)" "unprognostic (1.32e-2)" "unprognostic (6.28e-3)" 1.5 3.6 9.4 1.8 13.1 2.3 3.5 16.6 22.3 2.5 3.9 9.2 0.9 10.7 2.8 1.9 1.7 3.2 3.8 2.2 10.6 13.2 4.2 2.0 4.3 1.7 9.3 10.3 2.2 2.3 14.8 3.1 9.2 15.1 4.4 3.1 2.0 4.1 3.0 2.6 2.8 7.8 2.9 7.1 2.8 10.4 13.0 8.9 3.2 5.5 0.3 2.0 3.6 1.7 1.5 2.9 4.5 3.0 3.0 3.5 1.0 0.8 1.3 4.7 3.5 0.6 0.5 3.6 0.5 1.9 0.7 3.5 0.0 1.7 2.1 5.1 0.1 0.7 8.0 0.9 2.0 4.0 8.3 22.2 0.5 3.1 1.8 1.3 4.3 0.7 4.8 2.0 0.5 2.5 12.6 1.3 0.8 0.8 3.8 0.3 1.0 1.2 2.7 0.4 2.0 2.4 1.4 14.1 4.2 1.4 0.4 5.3 3.9 1.3 2.9 0.2 1.6 0.1 0.5 4.3 3.1 0.8 1.2 1.5 2.0 4.5 1.9 0.8 2.2 3.0 1.7 0.7 2.2 3.2 0.9 1.5 3.0 3.5 2.0 3.0 2.3 2.9 1.2 1.0 9.4 13.1 16.6 17.7 10.6 13.2 9.3 10.3 15.1 8.9 GFAP FLJ45472 ENSG00000131095 "Glial fibrillary acidic protein" P14136 17 44903161-44916937 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "brain: 595.5" "Cell line enhanced" "Detected in many" "U-87 MG: 9.5" "Cancer enriched" "Detected in some" 368 "glioma: 2468.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.8" "Group enriched" "Detected in many" 5 "granulocytes: 9.8;NK-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000039, HPA056030, HPA063513" Enhanced Supported Supported "Intermediate filaments" 220000000 "Intermediate filaments" "CAB000039: AB_10013382, HPA056030: , HPA063513: " "unprognostic (1.79e-2)" "unprognostic (2.74e-1)" "unprognostic (9.83e-2)" "unprognostic (2.12e-5)" "unprognostic (4.08e-1)" "unprognostic (5.09e-1)" "unprognostic (1.26e-1)" "unprognostic (6.53e-2)" "unprognostic (6.57e-3)" "unprognostic (7.35e-2)" "unprognostic (5.86e-2)" "unprognostic (1.24e-1)" "unprognostic (7.63e-2)" "unprognostic (2.75e-5)" "unprognostic (1.49e-1)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" 3.0 2.9 122.2 3.2 105.4 5.8 3.0 33.9 595.5 2.7 3.0 171.0 0.0 2.8 2.9 3.0 3.6 3.2 3.1 4.0 143.0 175.1 3.0 2.8 3.0 3.1 227.0 67.3 3.0 3.0 3.4 1.3 2.8 212.7 3.0 2.9 0.0 3.1 2.9 3.2 3.3 2.8 2.9 482.0 3.0 3.0 2.9 119.0 0.0 3.0 0.0 2.9 3.4 0.0 1.1 0.8 9.8 1.2 2.9 0.8 0.3 1.7 1.1 2.0 3.8 0.0 0.8 0.5 1.7 2.0 2.4 2.0 2.1 2.4 3.5 3.1 0.9 4.3 2.2 0.7 3.0 4.3 1.9 2.8 2.9 1.4 0.1 0.8 4.2 0.2 1.3 1.7 0.0 0.0 1.3 8.3 0.6 2.2 2.9 4.1 2.7 5.2 1.2 1.2 2.8 1.1 1.5 2.7 2.9 0.5 3.4 0.3 2.2 2.2 1.2 2.1 1.6 1.9 2.5 1.2 2.3 2.7 9.5 3.4 3.3 1.9 1.2 0.5 0.5 1.1 0.4 0.4 0.5 0.7 0.3 1.1 0.6 0.8 9.8 2.9 0.7 0.8 0.4 0.3 122.2 105.4 33.9 69.4 143.0 175.1 227.0 67.3 212.7 119.0 GFRA2 "GDNFRB, NTNRA, RETL2, TRNR2" ENSG00000168546 "GDNF family receptor alpha 2" O00451 8 21690403-21812357 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;thyroid gland: 17.4" "Cell line enhanced" "Detected in some" "HEL: 8.8;HMC-1: 20.2;WM-115: 3.7" "Cancer enriched" "Detected in some" 5 "thyroid cancer: 6.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 10.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.1;monocytes: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024704, CAB032791" Uncertain Uncertain Vesicles "Intracellular and membrane" 3300000 Vesicles "CAB032791: AB_2110428, HPA024704: AB_1849629" "unprognostic (4.24e-2)" "unprognostic (1.11e-2)" "unprognostic (4.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.93e-2)" "unprognostic (1.08e-2)" "unprognostic (7.48e-4)" "unprognostic (2.87e-1)" "unprognostic (6.11e-2)" "unprognostic (4.40e-3)" "unprognostic (2.11e-3)" "unprognostic (7.82e-2)" "unprognostic (1.50e-4)" "unprognostic (8.45e-4)" "unprognostic (1.74e-1)" "unprognostic (4.68e-2)" "unprognostic (9.63e-3)" 4.2 3.4 2.6 3.4 6.7 1.2 1.4 2.1 19.2 4.9 3.6 0.7 2.6 3.4 1.3 4.0 3.0 4.3 1.2 3.2 6.8 8.9 1.1 1.9 2.2 4.3 4.3 7.1 1.0 0.9 0.2 2.0 11.5 3.2 1.3 2.0 3.7 2.0 4.9 0.4 1.2 3.2 3.5 1.9 12.2 2.2 6.7 0.2 1.0 17.4 0.0 1.5 2.4 2.6 0.1 3.1 0.9 10.9 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 2.4 0.9 0.0 10.9 0.0 0.0 0.0 0.0 3.1 0.1 0.2 0.0 0.5 0.0 1.4 0.0 0.0 0.9 2.6 6.7 2.1 19.2 6.8 8.9 4.3 7.1 3.2 0.2 GFRA4 ENSG00000125861 "GDNF family receptor alpha 4" Q9GZZ7 20 3659292-3663399 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.8;thyroid gland: 4.9" "Cell line enhanced" "Detected in single" "MOLT-4: 1.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Intracellular and membrane" "unprognostic (3.50e-2)" "unprognostic (2.36e-1)" 0.0 0.0 1.7 0.0 0.6 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GFY Goofy ENSG00000261949 "Golgi associated olfactory signaling regulator" I3L273 19 49423749-49428818 "Predicted membrane proteins" "Olfaction, Sensory transduction" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "brain: 2.1;testis: 4.0" "Group enriched" "Detected in some" 5 "HEK 293: 3.8;SCLC-21H: 9.0;T-47d: 2.4;U-266/84: 5.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 14 "olfactory region: 1.8" "Region enriched" "Detected in some" 7 "cerebellum: 14.5" "unprognostic (8.04e-2)" "unprognostic (8.21e-2)" "unprognostic (1.16e-1)" "unprognostic (2.43e-1)" "unprognostic (4.50e-2)" "unprognostic (8.99e-2)" "unprognostic (8.85e-2)" "unprognostic (1.42e-1)" "unprognostic (1.82e-1)" "unprognostic (9.62e-3)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.9 0.0 2.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GHRH GHRF ENSG00000118702 "Growth hormone releasing hormone" P01286 20 37251082-37261835 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 37.3" "Group enriched" "Detected in some" 7 "NTERA-2: 3.5;U-266/84: 12.4" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 8.5" "Region enriched" "Detected in some" 15 "hypothalamus: 37.3" "Cell type enhanced" "Detected in single" "eosinophil: 2.7" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 9 "hypothalamus: 38.7" "Low region specificity" "Detected in many" "Secreted in other tissues" "unprognostic (4.78e-2)" "unprognostic (2.57e-2)" "unprognostic (1.58e-1)" "unprognostic (3.10e-1)" 0.1 2.7 0.3 0.1 2.4 0.0 0.6 0.1 1.0 0.1 4.0 0.1 0.1 8.1 0.1 0.1 0.7 0.0 0.1 6.5 0.1 37.3 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 7.7 0.1 0.1 0.1 1.9 0.1 0.1 7.5 0.4 0.1 0.1 0.1 0.1 0.0 0.7 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.1 1.0 0.1 37.3 0.1 0.8 0.1 0.1 GIPR ENSG00000010310 "Gastric inhibitory polypeptide receptor" P48546 19 45668244-45683724 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3;stomach 1: 26.1" "Cell line enhanced" "Detected in some" "HDLM-2: 7.9;HMC-1: 17.9;SCLC-21H: 11.9;U-266/70: 14.7" "Cancer enriched" "Detected in many" 5 "pancreatic cancer: 4.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" CAB022710 Uncertain "CAB022710: " "unprognostic (2.40e-2)" "unprognostic (9.03e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-2)" "unprognostic (2.65e-1)" "unprognostic (3.70e-4)" "unprognostic (1.82e-2)" "unprognostic (2.94e-2)" "unprognostic (1.42e-1)" "unprognostic (1.72e-2)" "unprognostic (4.85e-3)" "unprognostic (2.78e-1)" "unprognostic (1.72e-2)" "unprognostic (1.19e-1)" "unprognostic (1.37e-1)" "unprognostic (3.37e-2)" "unprognostic (2.59e-2)" 8.0 0.4 2.3 4.5 8.4 2.4 6.6 1.8 10.5 2.9 4.5 9.4 0.1 4.3 0.7 1.5 1.8 10.0 1.8 12.3 3.7 2.6 1.7 0.5 4.8 3.6 21.3 1.4 1.0 8.5 9.0 2.0 0.4 6.3 5.3 5.8 2.6 5.8 0.6 0.4 3.3 3.6 0.5 4.6 4.1 26.1 0.4 16.2 0.2 1.8 0.8 4.4 3.0 3.3 2.3 1.2 2.5 0.8 4.1 2.3 0.7 0.7 0.4 1.2 0.7 0.5 0.0 0.2 0.9 0.7 0.1 0.7 0.4 3.4 1.5 0.5 0.6 1.8 0.3 0.1 0.1 7.9 0.3 1.4 0.8 0.3 0.1 0.4 17.9 0.0 0.3 0.2 0.2 0.1 3.6 1.9 0.0 0.2 0.1 1.1 0.1 0.9 0.5 0.3 3.5 0.4 0.9 11.9 1.1 0.1 0.8 0.1 1.7 2.5 0.3 0.0 0.5 0.3 0.3 14.7 0.2 0.3 0.5 1.4 0.3 2.5 0.7 2.0 2.3 0.8 0.8 0.9 0.9 1.6 0.9 2.3 1.1 1.8 2.2 4.1 0.5 1.2 1.8 0.7 2.3 8.4 1.8 10.5 3.7 2.6 21.3 1.4 6.3 16.2 GJB1 "CMTX, CMTX1, CX32" ENSG00000169562 "Gap junction protein beta 1" P08034 X 71215194-71225516 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.4;liver: 114.4;pancreas: 37.1" "Group enriched" "Detected in some" 6 "Hep G2: 45.7;SK-MEL-30: 50.6" "Cancer enhanced" "Detected in many" "liver cancer: 163.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012994 Uncertain "CAB012994: AB_2533228" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (8.78e-2)" "unprognostic (2.71e-3)" "unprognostic (2.70e-1)" "unprognostic (4.11e-1)" "unprognostic (2.92e-1)" "unprognostic (3.68e-1)" "unprognostic (2.63e-2)" "unprognostic (2.22e-2)" "unprognostic (7.36e-3)" "unprognostic (1.80e-1)" "prognostic favourable (2.85e-6)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (7.79e-2)" "unprognostic (4.97e-2)" 0.4 0.4 7.2 2.5 9.3 0.3 2.6 1.9 14.4 3.3 12.0 46.3 2.5 14.6 0.9 8.1 0.5 9.5 19.8 0.4 13.4 8.0 14.8 114.4 1.2 0.4 22.4 5.6 0.4 37.1 0.3 0.4 0.4 23.0 4.3 8.3 0.5 19.6 8.7 0.4 0.6 11.7 1.0 52.4 0.4 5.7 3.1 12.1 0.0 0.4 0.0 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 9.3 1.9 14.4 13.4 8.0 22.4 5.6 23.0 12.1 GJC2 "CX46.6, CX47, GJA12, SPG44" ENSG00000198835 "Gap junction protein gamma 2" Q5T442 1 228149852-228159826 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 34.3" "Cell line enhanced" "Detected in some" "EFO-21: 9.7;SCLC-21H: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069619 Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA069619: " "unprognostic (2.67e-1)" "unprognostic (1.81e-2)" "unprognostic (6.42e-2)" "unprognostic (8.19e-3)" "unprognostic (4.24e-1)" "unprognostic (1.57e-1)" "unprognostic (6.94e-2)" "unprognostic (2.56e-1)" "unprognostic (4.99e-2)" "unprognostic (7.09e-2)" "unprognostic (7.88e-3)" "unprognostic (9.67e-2)" "unprognostic (6.09e-3)" "unprognostic (2.53e-2)" "unprognostic (7.36e-2)" "unprognostic (1.54e-1)" "unprognostic (2.02e-1)" 2.4 1.9 4.6 1.2 10.0 0.5 2.0 2.2 14.8 2.8 2.6 34.3 0.0 0.6 4.5 2.0 1.7 4.8 1.4 1.6 9.3 5.3 0.6 0.5 3.1 1.2 27.2 5.6 3.4 0.9 2.9 0.6 1.2 18.3 2.1 0.8 0.0 1.5 4.0 1.5 2.4 1.2 3.8 32.6 1.9 1.2 1.0 15.7 0.0 0.9 0.0 0.7 1.3 1.8 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.2 0.5 1.3 0.7 1.8 1.4 0.4 0.6 0.7 0.9 1.2 0.2 9.7 2.6 0.9 0.3 0.3 0.3 0.3 1.5 0.3 2.4 2.1 2.5 0.0 0.0 0.4 0.2 0.8 0.5 0.2 1.0 0.3 0.4 0.5 1.8 0.6 0.6 1.9 0.4 0.3 0.1 0.8 0.0 5.1 3.0 0.4 0.1 0.3 0.1 0.3 4.5 1.3 3.7 4.4 1.5 0.3 0.6 0.2 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 4.6 10.0 2.2 10.4 9.3 5.3 27.2 5.6 18.3 15.7 GJD4 "CX40.1, FLJ90023" ENSG00000177291 "Gap junction protein delta 4" Q96KN9 10 35605410-35608935 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.4;brain: 3.5" "Cell line enhanced" "Detected in many" "RH-30: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 5.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.4" "Not detected" "Not detected" HPA038266 Uncertain "HPA038266: AB_10672741" "unprognostic (2.05e-1)" "unprognostic (2.58e-1)" "unprognostic (5.74e-6)" "unprognostic (2.00e-1)" "unprognostic (8.96e-2)" "unprognostic (3.92e-2)" "unprognostic (8.49e-2)" "unprognostic (7.70e-2)" "unprognostic (1.67e-2)" "unprognostic (2.44e-1)" "unprognostic (1.19e-10)" "unprognostic (3.06e-1)" "unprognostic (1.43e-1)" "unprognostic (2.27e-1)" "unprognostic (1.31e-1)" 0.2 0.2 0.7 0.2 1.0 2.5 0.2 0.2 3.5 0.5 0.2 0.2 0.2 1.0 0.7 0.2 0.3 0.2 1.3 0.3 0.6 1.3 0.2 0.3 0.2 0.4 0.8 0.2 0.2 0.4 0.3 0.5 0.4 0.2 0.3 0.3 0.2 0.8 0.2 1.5 2.6 0.8 0.2 0.3 0.4 0.8 0.9 0.2 0.2 0.9 0.2 0.2 0.4 0.2 0.7 0.9 5.4 0.6 0.6 0.8 0.2 0.9 0.9 0.5 1.5 0.2 0.0 1.4 0.2 0.0 0.0 0.3 0.7 1.4 1.0 0.5 0.1 1.5 0.1 0.3 0.3 1.1 0.8 0.9 0.4 0.6 0.0 0.2 0.8 0.3 0.3 0.3 0.1 0.2 1.8 1.9 0.2 1.3 1.3 1.0 0.9 2.4 0.8 5.8 0.4 0.1 1.6 1.2 0.8 0.8 0.6 1.3 1.0 1.3 1.4 1.0 2.0 0.8 0.6 1.0 0.6 0.3 0.9 0.8 1.0 1.8 0.6 0.7 0.5 0.2 0.4 0.6 0.5 0.4 0.4 0.7 0.8 0.7 5.4 0.6 0.2 0.9 0.2 0.2 0.7 1.0 0.2 3.3 0.6 1.3 0.8 0.2 0.2 0.2 GLB1L3 FLJ90231 ENSG00000166105 "Galactosidase beta 1 like 3" Q8NCI6 11 134274245-134319564 "Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 18.5;seminal vesicle: 10.8" "Cell line enhanced" "Detected in some" "HDLM-2: 2.8;HEK 293: 8.0;MOLT-4: 2.9;NTERA-2: 4.9;PC-3: 6.6;SCLC-21H: 10.5" "Cancer enhanced" "Detected in some" "prostate cancer: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "gdT-cell: 2.3;memory CD4 T-cell: 5.7;memory CD8 T-cell: 3.5;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6;T-reg: 2.4" "Lineage enriched" "Detected in single" 57 "T-cells: 5.7" "Not detected" "Not detected" HPA039916 Uncertain "HPA039916: " "unprognostic (1.64e-3)" "unprognostic (7.80e-3)" "unprognostic (5.12e-2)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (8.69e-3)" "prognostic favourable (1.97e-4)" "unprognostic (6.58e-3)" "unprognostic (3.81e-1)" "unprognostic (6.95e-3)" "unprognostic (9.73e-2)" "unprognostic (1.52e-5)" "unprognostic (1.39e-1)" "unprognostic (6.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.07e-1)" 0.5 2.7 4.0 1.2 19.1 0.6 1.2 10.3 14.4 0.8 1.2 0.0 0.0 0.5 3.8 0.4 0.5 0.4 0.5 0.4 2.7 2.6 1.3 0.4 0.5 2.1 1.4 6.1 0.4 0.6 0.4 1.1 0.5 5.8 18.5 0.5 1.0 3.4 10.8 0.5 5.4 0.5 0.5 0.6 0.6 0.6 2.4 1.4 0.0 3.4 0.0 0.8 0.9 1.2 0.0 0.0 0.0 0.0 0.0 5.7 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.3 0.0 2.8 8.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 4.9 6.6 0.0 0.0 0.0 0.0 0.0 10.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 5.7 3.5 0.0 0.0 4.8 3.6 0.0 0.0 0.0 0.0 2.4 1.0 4.0 19.1 10.3 14.4 2.7 2.6 1.4 6.1 5.8 1.4 GLCE "HSEPI, KIAA0836" ENSG00000138604 "Glucuronic acid epimerase" O94923 15 69160584-69272217 "Enzymes, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 49.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 58.4" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 4.0;monocytes: 4.4;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040481, HPA048216" Uncertain Approved Mitochondria "Intracellular and membrane" 78000 Mitochondria "HPA040481: , HPA048216: " "unprognostic (1.30e-1)" "unprognostic (2.39e-1)" "unprognostic (1.20e-3)" "unprognostic (7.77e-2)" "unprognostic (1.58e-1)" "unprognostic (5.55e-3)" "unprognostic (1.00e-1)" "unprognostic (2.84e-1)" "unprognostic (1.48e-1)" "unprognostic (2.56e-1)" "unprognostic (7.47e-2)" "unprognostic (1.41e-1)" "unprognostic (2.40e-2)" "unprognostic (1.53e-1)" "unprognostic (6.00e-2)" "unprognostic (5.23e-1)" "unprognostic (4.07e-2)" 8.3 12.2 6.5 4.9 14.2 0.6 8.8 58.4 12.1 8.4 12.1 12.4 7.8 13.5 6.3 6.9 10.2 5.9 7.2 5.5 5.8 8.5 13.3 16.0 8.4 5.3 9.4 8.1 12.9 5.9 9.0 12.0 12.6 14.4 5.7 14.0 10.8 11.7 8.9 4.1 9.8 11.2 6.8 10.2 4.0 8.8 6.1 7.6 5.4 4.1 8.4 5.8 6.3 5.6 0.6 4.0 0.1 4.4 0.5 4.0 1.9 3.9 3.5 2.3 4.1 8.0 7.7 0.8 7.3 9.7 5.6 10.8 2.9 9.8 2.3 3.6 5.9 5.8 5.0 4.7 11.6 0.9 5.6 3.9 6.6 2.9 7.8 1.7 8.1 5.2 3.3 7.0 8.0 49.9 1.5 2.5 10.6 2.3 1.0 2.9 1.1 2.4 2.3 9.6 2.9 5.2 4.1 7.6 1.6 7.4 4.6 15.4 3.3 2.4 17.3 5.5 6.8 6.0 6.4 1.0 1.5 0.5 5.5 2.8 7.9 0.0 4.4 0.1 0.7 3.4 1.2 0.6 1.8 0.8 3.6 0.5 1.2 1.5 0.1 0.5 4.4 4.0 4.0 1.9 6.5 14.2 58.4 12.1 5.8 8.5 9.4 8.1 14.4 7.6 GLDN "CLOM, COLM, colmedin, CRG-L2, UNC-112" ENSG00000186417 Gliomedin Q6ZMI3 15 51341629-51408013 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.3" "Cell line enhanced" "Detected in some" "HHSteC: 5.7;MCF7: 2.6;U-266/70: 6.8;U-266/84: 5.5" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059441 Uncertain "Secreted to extracellular matrix" 190000 "HPA059441: " "unprognostic (5.04e-2)" "unprognostic (2.57e-2)" "unprognostic (5.15e-5)" "unprognostic (3.21e-3)" "unprognostic (2.82e-2)" "unprognostic (2.33e-1)" "unprognostic (2.07e-4)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (3.30e-2)" "unprognostic (3.15e-1)" "unprognostic (2.14e-2)" "unprognostic (9.89e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-1)" "unprognostic (3.80e-3)" "unprognostic (1.37e-1)" 16.6 3.3 8.1 2.9 22.8 1.5 5.2 1.8 22.7 2.3 5.7 42.8 0.0 0.9 0.9 1.4 1.2 1.5 5.5 7.7 14.2 8.3 0.9 0.7 10.4 0.7 43.3 10.1 0.7 1.1 1.1 0.6 16.0 20.1 1.6 10.3 1.3 1.1 1.6 1.0 4.5 1.0 1.4 26.8 2.6 3.8 0.7 25.4 0.0 0.8 0.8 0.8 2.4 1.0 0.1 1.9 1.0 0.8 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.3 0.1 1.4 0.0 0.0 0.1 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 5.7 0.0 0.1 2.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.6 0.3 0.0 0.2 1.7 0.1 0.0 0.0 0.0 2.2 0.4 0.1 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 6.8 5.5 0.0 0.8 0.0 0.0 1.0 0.2 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.4 0.1 0.8 1.9 0.1 0.0 8.1 22.8 1.8 12.4 14.2 8.3 43.3 10.1 20.1 25.4 GLRA1 STHE ENSG00000145888 "Glycine receptor alpha 1" P23415 5 151822513-151924842 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 31.7" "Cell line enhanced" "Detected in single" "HeLa: 1.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 10 "pons and medulla: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "hypothalamus: 11.0;midbrain: 18.1;pons and medulla: 27.6" "Region enhanced" "Detected in many" "pons and medulla: 54.9" "HPA016502, CAB079042" Uncertain Supported "CAB079042: , HPA016502: AB_1849819" "unprognostic (3.17e-1)" "unprognostic (2.47e-1)" "unprognostic (3.85e-7)" "unprognostic (8.24e-2)" "unprognostic (9.45e-3)" 0.3 3.2 1.2 0.1 0.7 0.2 0.1 3.2 0.9 0.1 0.2 0.0 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.3 0.1 2.7 0.2 0.1 0.1 0.1 2.7 0.0 0.1 2.2 0.1 0.1 0.2 31.7 0.1 0.1 1.6 0.1 0.1 0.6 0.1 0.1 0.1 12.6 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 3.2 0.9 0.1 2.7 2.7 0.0 31.7 0.0 GLRA2 GLR ENSG00000101958 "Glycine receptor alpha 2" P23416 X 14529298-14731812 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "brain: 21.0;intestine: 11.1" "Cell line enriched" "Detected in single" 33 "AN3-CA: 19.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB070422 Approved "CAB070422: AB_11153055" "unprognostic (2.52e-1)" "unprognostic (3.13e-1)" "unprognostic (5.52e-2)" "unprognostic (1.90e-1)" "unprognostic (5.74e-2)" "unprognostic (1.81e-2)" "unprognostic (3.39e-1)" "unprognostic (5.82e-2)" "unprognostic (7.95e-3)" "unprognostic (1.13e-1)" "unprognostic (2.76e-1)" "unprognostic (6.69e-2)" 0.4 0.5 14.5 0.7 13.2 0.7 0.5 21.0 10.8 0.4 4.1 0.1 0.0 0.7 0.5 0.5 0.4 0.8 0.7 0.4 3.6 13.9 0.5 0.5 0.4 0.5 1.6 8.4 0.9 0.5 0.4 0.5 0.8 10.1 0.4 11.1 1.1 0.8 0.5 0.5 0.8 0.9 0.7 6.5 0.5 0.5 0.9 0.8 0.0 0.5 0.0 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 19.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 13.2 21.0 10.4 3.6 13.9 1.6 8.4 10.1 0.8 GLRA3 ENSG00000145451 "Glycine receptor alpha 3" O75311 4 174636914-174829314 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 15.2;breast: 6.1;pituitary gland: 12.5" "Group enriched" "Detected in some" 5 "HEL: 2.6;Karpas-707: 6.2;U-698: 2.2" "Cancer enhanced" "Detected in single" "breast cancer: 1.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (2.75e-3)" "unprognostic (3.14e-1)" "unprognostic (1.78e-2)" "unprognostic (1.36e-1)" "unprognostic (9.02e-2)" "unprognostic (3.82e-2)" "unprognostic (2.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.12e-2)" "unprognostic (4.26e-2)" "unprognostic (1.64e-5)" "unprognostic (4.61e-4)" "unprognostic (2.24e-1)" "unprognostic (1.15e-2)" 0.5 2.6 13.3 0.6 7.3 0.6 6.1 0.7 15.2 0.5 0.5 0.3 0.0 0.5 0.7 0.5 0.5 0.4 0.6 0.4 2.7 7.4 0.5 0.4 0.5 0.9 4.6 8.7 0.4 1.4 0.5 12.5 0.5 4.4 0.5 0.5 0.0 0.5 0.5 0.4 0.7 0.5 0.8 2.1 0.6 0.5 1.7 0.0 0.0 0.5 0.0 0.9 0.4 0.2 2.7 0.1 1.1 0.0 0.3 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.6 0.0 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 2.2 0.1 0.1 0.1 0.6 0.0 0.4 0.1 0.0 0.5 2.7 0.2 0.1 0.0 0.5 0.2 0.2 1.1 0.3 0.0 0.1 0.1 0.0 13.3 7.3 0.7 14.5 2.7 7.4 4.6 8.7 4.4 0.0 GLRA4 ENSG00000188828 "Glycine receptor alpha 4" Q5JXX5 X 103707224-103728655 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.5;endometrium 1: 5.1;smooth muscle: 6.7" "Cell line enriched" "Detected in single" 13 "SCLC-21H: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044759 Uncertain "HPA044759: AB_10795885" "unprognostic (4.96e-2)" "unprognostic (2.09e-2)" "unprognostic (3.95e-1)" "unprognostic (2.24e-1)" "unprognostic (1.28e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (4.94e-7)" "unprognostic (4.49e-1)" "unprognostic (1.94e-1)" "unprognostic (1.87e-1)" 0.0 0.0 0.9 0.1 1.5 0.0 0.3 2.8 3.5 1.9 1.4 0.9 0.0 2.2 5.1 0.1 0.2 0.6 0.1 0.1 1.5 1.8 0.0 0.0 0.0 0.0 0.5 1.0 1.2 0.0 2.4 0.2 0.0 1.2 0.5 1.8 0.0 0.0 0.4 0.1 0.3 2.3 6.7 1.5 0.0 0.1 1.4 0.0 2.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 1.5 2.8 3.5 1.5 1.8 0.5 1.0 1.2 0.0 GLRB ENSG00000109738 "Glycine receptor beta" P48167 4 157076057-157172090 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.1;parathyroid gland: 37.0" "Cell line enhanced" "Detected in many" "AN3-CA: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 18 "dendritic cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052363 Approved "HPA052363: " "unprognostic (7.36e-2)" "unprognostic (6.53e-2)" "unprognostic (1.44e-1)" "unprognostic (2.59e-3)" "unprognostic (5.65e-2)" "unprognostic (1.18e-1)" "unprognostic (9.47e-2)" "unprognostic (1.52e-1)" "unprognostic (1.19e-2)" "unprognostic (2.99e-2)" "unprognostic (6.81e-2)" "unprognostic (1.48e-1)" "prognostic favourable (4.89e-4)" "unprognostic (4.32e-3)" "unprognostic (1.85e-1)" "unprognostic (5.61e-2)" "unprognostic (1.66e-2)" 4.5 7.2 12.6 1.5 20.9 0.7 10.3 15.9 43.1 9.4 2.3 2.8 0.1 1.1 3.3 5.4 1.5 7.4 3.5 9.9 18.3 17.3 4.1 1.6 3.4 0.8 11.1 21.3 1.8 14.2 37.0 6.7 2.9 16.5 6.5 1.4 0.7 16.7 5.2 3.3 1.5 1.2 4.0 6.1 0.6 2.2 1.9 4.5 0.0 1.5 0.5 0.7 1.9 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 5.0 2.2 6.1 18.5 12.0 4.9 0.0 10.1 6.5 5.0 9.4 0.0 15.7 0.0 2.4 10.2 0.0 4.6 1.6 9.4 0.0 6.1 3.1 2.4 0.2 5.5 3.9 0.0 4.3 1.4 8.7 1.3 4.4 0.0 0.0 9.0 0.0 0.4 0.0 0.4 1.3 0.0 8.4 0.0 13.4 0.9 6.7 4.1 0.0 4.8 0.8 4.4 1.0 6.6 3.0 8.8 5.0 9.8 0.0 0.0 0.0 7.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 12.6 20.9 15.9 43.1 18.3 17.3 11.1 21.3 16.5 4.5 GMFB GMF ENSG00000197045 "Glia maturation factor beta" P60983 14 54474484-54489196 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Approved Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" 1000000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (7.93e-2)" "unprognostic (7.69e-3)" "unprognostic (4.81e-3)" "unprognostic (2.99e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "prognostic unfavourable (2.21e-4)" "unprognostic (1.48e-2)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "prognostic favourable (9.48e-5)" "unprognostic (1.80e-1)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (9.09e-2)" 14.2 13.2 37.9 12.9 26.7 14.2 15.3 25.1 41.6 11.8 19.8 23.9 6.1 19.1 11.6 8.5 9.3 8.4 9.7 9.6 36.7 30.1 19.9 14.7 13.8 13.3 36.9 28.3 9.8 7.3 10.1 13.6 17.9 25.6 9.0 20.7 6.6 7.0 8.0 4.1 7.8 17.5 10.5 54.4 10.1 10.7 6.2 21.7 6.4 12.8 6.1 13.5 10.0 7.4 9.1 12.8 16.4 14.5 9.0 8.8 6.8 30.4 12.3 24.7 18.0 26.7 33.4 18.5 31.2 23.0 22.7 28.4 14.2 27.0 28.0 14.8 30.7 11.3 24.9 21.6 36.0 10.1 8.6 14.0 13.9 13.1 22.8 19.5 12.3 25.3 20.3 19.7 19.5 20.4 10.2 9.9 35.9 15.1 11.9 7.6 15.9 13.1 12.1 29.0 8.1 29.0 29.0 14.7 22.8 21.7 18.5 23.6 20.4 15.5 16.1 33.0 25.1 16.7 19.3 3.5 6.2 17.5 27.8 12.1 20.8 8.7 11.0 9.2 6.1 13.5 8.5 7.6 7.2 6.0 12.8 9.1 7.8 8.2 16.4 9.0 14.5 5.2 8.8 6.8 37.9 26.7 25.1 33.5 36.7 30.1 36.9 28.3 25.6 21.7 GNAL ENSG00000141404 "G protein subunit alpha L" P38405 18 11688956-11885685 "Disease related genes, Predicted intracellular proteins" Transducer "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.7" "Cell line enhanced" "Detected in many" "Daudi: 18.0;HeLa: 18.5;U-2 OS: 9.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "basal ganglia: 82.7" "Group enriched" "Detected in some" 4 "basophil: 1.1;gdT-cell: 4.2;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.2;neutrophil: 1.7" "Group enriched" "Detected in many" 5 "granulocytes: 1.7;T-cells: 4.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 13 "basal ganglia: 183.9" "CAB015464, HPA051160" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB015464: AB_831819, HPA051160: " "unprognostic (2.29e-3)" "unprognostic (7.43e-2)" "unprognostic (8.14e-3)" "unprognostic (3.41e-5)" "unprognostic (4.71e-2)" "unprognostic (9.58e-3)" "unprognostic (9.93e-3)" "unprognostic (1.87e-1)" "unprognostic (2.36e-1)" "unprognostic (7.17e-2)" "unprognostic (1.82e-3)" "unprognostic (6.05e-2)" "unprognostic (1.23e-3)" "unprognostic (1.09e-1)" "unprognostic (3.85e-2)" "unprognostic (4.26e-2)" "unprognostic (7.03e-2)" 7.2 1.5 17.8 3.0 82.7 0.7 4.2 2.7 18.1 8.0 3.7 3.2 3.3 1.6 6.7 2.4 8.2 4.1 4.6 2.2 7.1 7.6 4.2 1.3 2.5 5.1 6.6 5.3 3.2 1.3 1.0 20.7 2.9 8.8 9.9 3.7 2.1 4.6 18.1 18.3 7.0 2.0 9.9 3.3 1.8 2.1 6.2 11.3 0.9 8.0 1.4 5.7 9.5 7.7 0.4 0.2 1.7 0.2 0.5 4.2 1.4 0.5 5.9 7.3 0.5 0.6 0.1 0.8 0.1 0.2 0.5 0.0 6.4 1.1 18.0 1.2 0.1 0.3 6.8 5.7 0.0 3.8 6.2 0.1 18.5 3.6 0.0 0.2 0.4 0.8 8.6 0.0 0.1 0.0 1.6 0.2 0.2 0.2 0.2 0.5 6.0 0.1 0.1 1.0 0.2 0.4 0.2 6.7 0.1 8.5 0.4 2.1 0.2 0.2 1.0 0.7 9.5 0.3 1.8 0.3 0.1 0.1 0.3 0.2 0.2 1.1 0.2 0.4 4.2 0.1 0.1 0.4 0.5 2.9 0.0 0.3 0.2 2.2 1.7 0.5 0.1 0.2 0.1 1.4 17.8 82.7 2.7 12.7 7.1 7.6 6.6 5.3 8.8 11.3 GNAO1 G-ALPHA-o ENSG00000087258 "G protein subunit alpha o1" P09471 16 56191347-56357457 "Disease related genes, Predicted intracellular proteins" Transducer "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 102.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 16.6;BJ hTERT+ SV40 Large T+: 11.1;SCLC-21H: 33.9" "Cancer enriched" "Detected in many" 5 "glioma: 11.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.7" "Lineage enriched" "Detected in single" 14 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008387, HPA040878" Enhanced "CAB008387: AB_591430, HPA040878: " "unprognostic (1.50e-1)" "unprognostic (1.36e-3)" "unprognostic (8.12e-2)" "unprognostic (1.63e-1)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (6.87e-2)" "unprognostic (1.68e-4)" "unprognostic (3.08e-1)" "unprognostic (1.74e-1)" "prognostic favourable (5.93e-4)" "unprognostic (1.71e-1)" "unprognostic (6.86e-3)" "unprognostic (6.28e-2)" "unprognostic (1.21e-1)" "unprognostic (6.00e-1)" "unprognostic (9.70e-5)" 4.6 9.4 42.6 4.7 50.8 1.8 2.3 40.6 102.5 3.4 9.9 24.4 9.1 4.7 5.2 4.6 4.5 4.3 4.2 12.8 37.9 34.8 2.3 7.7 2.6 2.7 28.1 38.5 2.6 5.4 1.9 10.2 2.2 25.2 6.9 6.7 3.1 2.7 18.2 3.5 2.7 5.3 11.2 20.5 2.9 6.2 10.2 32.5 0.0 2.5 0.0 2.7 5.9 0.9 0.0 0.1 0.0 0.0 0.0 1.7 1.0 4.0 0.0 0.3 0.0 0.0 0.0 0.5 4.2 16.6 11.1 5.3 0.2 0.0 0.0 0.1 0.0 0.3 2.6 0.0 7.4 0.1 0.5 0.0 1.1 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 6.2 0.0 0.0 3.9 0.0 0.0 0.0 33.9 6.7 6.8 0.1 0.4 0.1 0.0 0.0 0.1 3.9 0.0 1.9 0.4 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.7 0.5 0.1 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 1.0 42.6 50.8 40.6 45.7 37.9 34.8 28.1 38.5 25.2 32.5 GNAZ ENSG00000128266 "G protein subunit alpha z" P19086 22 23070361-23125037 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 24.7;SH-SY5Y: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003011 Enhanced Approved Vesicles 6900000 Vesicles "HPA003011: AB_1078918" "unprognostic (7.61e-2)" "unprognostic (1.63e-2)" "unprognostic (3.13e-2)" "prognostic unfavourable (4.85e-4)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (3.45e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-3)" "unprognostic (1.68e-2)" "unprognostic (9.69e-2)" "unprognostic (2.29e-1)" "unprognostic (6.63e-2)" "unprognostic (2.82e-1)" "unprognostic (1.30e-1)" 8.8 6.9 15.4 3.2 13.4 1.8 3.2 17.8 34.4 2.2 6.0 11.1 6.9 2.3 6.2 3.7 5.9 6.9 12.1 2.0 17.7 14.7 2.2 0.6 1.7 2.2 16.4 13.0 9.9 2.2 4.7 11.1 0.9 13.5 7.8 2.3 6.8 2.4 19.5 1.9 1.2 2.4 12.9 19.0 5.1 5.3 4.3 7.7 0.0 1.9 0.0 1.7 3.6 1.5 1.3 0.1 1.7 1.4 0.2 0.6 5.3 0.0 1.2 4.2 8.8 0.0 0.0 0.2 5.7 11.2 5.5 3.7 0.0 0.0 10.7 0.4 0.5 0.2 5.2 0.2 4.0 1.4 4.3 0.7 6.3 7.8 0.3 0.0 0.9 0.0 0.2 0.1 0.3 0.1 0.1 3.4 0.1 3.8 0.0 0.0 2.5 3.4 0.0 4.2 1.7 0.1 0.1 24.7 15.3 1.2 2.7 1.1 1.2 0.1 0.0 4.6 5.3 1.2 0.1 4.2 7.2 5.6 2.3 0.3 1.7 1.7 0.3 0.5 0.2 0.0 0.0 0.3 0.0 0.0 0.1 1.3 0.0 0.6 0.9 0.2 1.4 0.0 0.0 5.3 15.4 13.4 17.8 19.4 17.7 14.7 16.4 13.0 13.5 7.7 GNG13 "G(gamma)13, h2-35" ENSG00000127588 "G protein subunit gamma 13" Q9P2W3 16 798041-800733 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 78.6;retina: 22.9" "Cell line enhanced" "Detected in many" "CACO-2: 11.0;HEK 293: 9.7;HeLa: 5.8;MCF7: 13.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 7 "cerebellum: 78.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in all" "cerebellum: 1054.1" "Group enriched" "Detected in many" 6 "cerebellum: 43.5;olfactory region: 18.2" HPA046272 Enhanced "HPA046272: AB_10960062" "unprognostic (1.84e-1)" "unprognostic (2.75e-1)" "unprognostic (3.78e-2)" "unprognostic (2.48e-1)" "unprognostic (2.57e-2)" "unprognostic (5.41e-2)" "unprognostic (8.47e-2)" "unprognostic (9.16e-3)" "unprognostic (4.04e-2)" "unprognostic (1.78e-1)" "unprognostic (6.77e-2)" "unprognostic (7.12e-2)" "unprognostic (1.55e-1)" "unprognostic (3.38e-1)" 0.2 0.2 1.8 0.7 3.3 0.9 0.3 78.6 11.3 0.2 2.9 3.4 0.0 5.4 0.2 0.7 0.2 0.2 0.3 0.2 1.1 1.6 0.2 0.2 0.3 0.6 1.3 2.7 0.3 0.2 0.2 0.3 0.4 2.7 0.4 0.6 22.9 0.2 0.2 0.2 0.5 5.1 0.4 1.9 0.4 0.8 1.5 0.2 0.2 0.3 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.5 1.1 0.0 0.0 0.9 1.0 0.0 0.0 0.0 11.0 0.3 1.2 0.3 0.0 1.7 0.0 0.0 0.0 1.3 9.7 1.4 5.8 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.0 13.6 1.3 0.8 1.3 1.1 3.0 3.1 0.7 0.0 1.6 1.0 0.9 1.0 0.4 0.2 0.8 0.1 0.0 1.4 1.4 1.9 0.3 0.5 2.4 4.4 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.3 78.6 11.3 1.1 1.6 1.3 2.7 2.7 0.2 GNG2 ENSG00000186469 "G protein subunit gamma 2" P59768 14 51826195-51979342 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 68.4;brain: 50.5;testis: 55.7" "Cell line enhanced" "Detected in many" "AF22: 20.5;fHDF/TERT166: 36.3;MOLT-4: 28.2;SH-SY5Y: 23.9;WM-115: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003534, CAB018380" Uncertain Supported Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "CAB018380: AB_631547, HPA003534: AB_1079004" "unprognostic (6.11e-2)" "unprognostic (5.78e-3)" "unprognostic (2.06e-3)" "unprognostic (6.55e-2)" "unprognostic (1.33e-1)" "unprognostic (4.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (5.72e-2)" "unprognostic (1.24e-1)" "prognostic favourable (1.64e-4)" "unprognostic (8.47e-2)" "prognostic unfavourable (3.90e-6)" "unprognostic (9.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (3.59e-2)" 22.0 10.4 50.5 17.4 18.5 25.0 11.7 4.9 46.1 5.9 13.0 5.2 1.6 6.8 5.7 4.7 6.5 3.5 7.9 6.6 30.9 50.3 4.0 5.6 8.5 19.4 10.7 20.7 7.1 3.3 1.6 12.2 8.6 8.9 6.6 9.1 8.3 4.5 4.4 2.3 3.5 9.9 8.8 8.5 41.2 7.3 55.7 2.5 39.6 3.9 4.3 19.5 8.5 4.0 8.0 13.9 68.4 34.9 5.0 36.5 27.6 0.0 0.8 20.5 12.8 3.1 4.1 0.3 3.3 4.2 1.6 1.3 1.6 0.0 0.0 0.4 36.3 0.0 2.7 0.0 1.1 9.2 0.3 0.0 0.2 0.0 1.6 1.8 0.1 6.8 0.0 1.6 0.1 0.0 0.0 1.7 10.4 0.0 28.2 3.0 10.9 2.5 10.0 1.6 0.5 1.7 0.0 3.0 23.9 0.0 0.0 8.8 0.0 0.0 0.0 5.0 0.8 0.1 2.5 0.0 0.0 1.4 4.1 10.0 65.4 68.4 13.5 36.0 36.5 23.3 24.6 8.0 20.3 29.7 13.9 7.3 12.9 22.8 39.9 5.0 34.9 6.0 28.8 27.6 50.5 18.5 4.9 44.2 30.9 50.3 10.7 20.7 8.9 2.5 GNG3 ENSG00000162188 "G protein subunit gamma 3" P63215 11 62707658-62709201 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 136.6" "Group enriched" "Detected in some" 7 "Karpas-707: 38.2;SCLC-21H: 75.6" "Cancer enriched" "Detected in some" 14 "glioma: 12.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 30 "memory B-cell: 13.4;naive B-cell: 11.8" "Lineage enriched" "Detected in single" 32 "B-cells: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.43e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-1)" "unprognostic (4.68e-4)" "unprognostic (2.73e-2)" "unprognostic (7.60e-2)" "unprognostic (1.77e-2)" "unprognostic (1.69e-1)" "unprognostic (6.03e-3)" "unprognostic (3.04e-1)" "unprognostic (2.33e-3)" "unprognostic (1.50e-1)" "unprognostic (5.37e-5)" "unprognostic (3.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.00e-1)" "unprognostic (1.00e-1)" 1.7 11.8 51.6 2.9 47.6 2.3 1.7 41.0 136.6 1.7 3.5 6.0 0.0 2.5 1.8 2.3 1.8 1.8 1.9 1.8 45.3 39.6 1.9 1.9 1.7 1.9 39.8 36.0 1.9 2.0 2.2 6.7 1.8 43.7 1.8 3.5 1.5 2.0 2.2 2.0 1.9 3.2 2.5 7.4 1.8 2.0 5.7 4.8 0.0 2.0 0.0 1.8 1.6 0.0 13.4 0.0 0.4 0.2 0.2 0.1 0.3 0.1 0.2 1.8 0.1 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.6 0.3 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.2 0.1 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 38.2 0.0 0.3 0.0 1.0 8.4 0.0 0.4 0.3 0.2 0.1 0.6 75.6 0.6 0.2 0.2 0.0 0.4 0.1 0.1 0.4 0.7 0.2 0.1 0.2 0.5 0.2 0.4 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 13.4 0.1 0.1 0.0 11.8 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 51.6 47.6 41.0 83.2 45.3 39.6 39.8 36.0 43.7 4.8 GNG4 ENSG00000168243 "G protein subunit gamma 4" P50150 1 235547687-235650754 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1;ovary: 25.1;pituitary gland: 18.8" "Cell line enhanced" "Detected in some" "NTERA-2: 28.3;SCLC-21H: 30.0;SH-SY5Y: 42.2;U-2197: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 6 "olfactory region: 574.6" "Region enhanced" "Detected in all" "olfactory region: 427.7" "unprognostic (1.50e-3)" "unprognostic (8.33e-3)" "unprognostic (7.14e-2)" "unprognostic (1.56e-2)" "unprognostic (2.48e-1)" "unprognostic (4.94e-2)" "unprognostic (2.22e-2)" "unprognostic (3.10e-2)" "unprognostic (3.47e-2)" "unprognostic (3.49e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (2.56e-9)" "unprognostic (1.22e-1)" "unprognostic (1.62e-1)" "unprognostic (1.68e-3)" "unprognostic (5.01e-3)" 1.9 9.4 16.8 2.0 21.5 0.9 1.1 8.6 24.1 1.8 3.4 6.5 0.5 2.5 8.3 1.1 8.4 1.6 1.2 0.9 10.2 20.8 1.3 0.8 0.9 4.7 6.3 7.7 25.1 4.5 0.8 18.8 4.2 11.2 17.1 3.0 1.7 1.4 1.4 0.8 1.1 4.8 5.8 7.1 0.9 3.6 2.1 2.8 3.1 0.9 0.0 3.9 1.2 1.1 1.3 0.8 3.8 0.6 1.0 0.8 0.3 6.6 0.4 5.0 0.0 0.0 0.2 0.4 0.0 0.0 0.6 0.8 0.0 0.3 0.0 0.0 2.0 0.7 5.3 0.2 1.2 3.5 1.9 0.0 0.1 2.5 0.1 0.0 2.3 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.3 0.2 28.3 0.0 0.0 2.6 0.1 0.0 0.2 30.0 42.2 0.2 0.1 0.6 0.0 0.9 0.0 0.3 0.9 12.6 0.9 0.9 0.0 0.0 0.9 0.0 8.3 3.8 0.6 0.6 0.5 0.5 0.4 1.0 0.8 0.5 0.2 1.3 0.6 0.6 2.3 1.0 0.5 0.8 0.6 0.3 16.8 21.5 8.6 21.7 10.2 20.8 6.3 7.7 11.2 2.8 GNG7 FLJ00058 ENSG00000176533 "G protein subunit gamma 7" O60262 19 2511219-2702709 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 115.9" "Cell line enhanced" "Detected in some" "Daudi: 10.3;REH: 30.3;SK-MEL-30: 14.0;U-266/70: 29.2;U-266/84: 13.4" "Cancer enhanced" "Detected in all" "glioma: 21.9" "Region enriched" "Detected in all" 5 "basal ganglia: 115.9" "Group enriched" "Detected in many" 4 "memory B-cell: 23.9;naive B-cell: 20.5;plasmacytoid DC: 19.9" "Group enriched" "Detected in many" 4 "B-cells: 23.9;dendritic cells: 19.9" "Region enriched" "Detected in many" 6 "basal ganglia: 1142.7" "Region enriched" "Detected in all" 6 "basal ganglia: 484.6" HPA057790 Supported Supported "HPA057790: " "unprognostic (3.97e-3)" "unprognostic (1.16e-4)" "unprognostic (4.92e-2)" "unprognostic (2.72e-1)" "unprognostic (2.79e-1)" "unprognostic (8.42e-4)" "prognostic favourable (3.05e-4)" "prognostic favourable (1.35e-5)" "unprognostic (1.27e-2)" "unprognostic (4.95e-2)" "prognostic favourable (3.71e-4)" "unprognostic (1.27e-1)" "prognostic favourable (0.00e+0)" "unprognostic (6.96e-2)" "unprognostic (1.46e-1)" "unprognostic (6.36e-2)" "unprognostic (4.96e-2)" 3.1 4.8 19.8 4.5 115.9 5.4 4.1 9.7 28.2 2.6 3.8 23.4 0.8 4.7 4.8 4.9 11.1 6.5 3.3 22.5 20.3 11.4 6.0 2.2 3.0 8.0 20.0 10.0 10.0 7.2 5.4 4.6 1.4 20.9 7.1 3.0 12.2 22.8 5.7 2.9 1.7 4.9 3.4 28.5 11.0 5.8 5.5 22.0 0.1 3.7 0.4 8.2 3.4 1.4 23.9 19.9 5.0 0.6 0.0 0.5 1.3 0.1 0.0 1.5 3.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 10.3 0.5 0.1 0.1 1.6 0.0 0.0 0.0 1.4 0.2 0.0 1.2 0.7 0.0 6.1 0.2 0.2 0.0 0.1 0.0 0.1 6.7 0.0 1.0 0.2 0.6 1.2 0.6 30.3 0.0 2.7 0.1 0.0 0.0 4.4 0.0 0.0 14.0 0.2 2.6 0.0 0.0 1.5 0.1 0.1 29.2 13.4 2.2 0.1 3.2 7.7 1.1 0.6 3.2 0.1 0.2 0.4 23.9 0.2 0.1 2.5 20.5 0.5 0.3 5.0 0.0 0.0 19.9 0.0 1.3 19.8 115.9 9.7 20.0 20.3 11.4 20.0 10.0 20.9 22.0 GNG8 ENSG00000167414 "G protein subunit gamma 8" Q9UK08 19 46634076-46634685 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 21.5;blood: 12.7;brain: 13.0" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 158.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 6.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 12.7" "Group enriched" "Detected in many" 4 "B-cells: 12.7;T-cells: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (7.23e-4)" "unprognostic (4.96e-6)" "unprognostic (9.00e-2)" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "prognostic favourable (2.14e-5)" "unprognostic (1.94e-1)" "unprognostic (1.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.80e-1)" "unprognostic (9.60e-2)" "unprognostic (9.83e-2)" "unprognostic (5.90e-8)" "unprognostic (2.67e-2)" "unprognostic (1.70e-1)" "unprognostic (4.22e-2)" "unprognostic (4.41e-1)" 0.6 21.5 4.5 4.7 4.9 0.5 0.6 4.1 5.9 2.5 3.2 1.1 0.6 1.5 2.2 0.6 0.6 1.0 0.6 8.4 9.2 13.0 1.2 0.6 1.0 3.4 5.3 2.8 1.2 0.6 0.0 5.8 0.6 3.1 0.7 1.8 1.1 0.6 1.5 0.6 0.0 2.3 2.7 4.4 2.3 0.7 0.8 3.3 1.2 0.6 0.6 5.4 0.9 0.9 12.7 0.0 2.0 0.1 0.0 5.2 4.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 36.2 158.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 12.7 2.4 1.2 2.0 0.0 0.0 0.0 5.2 4.6 4.5 4.9 4.1 4.3 9.2 13.0 5.3 2.8 3.1 3.3 GNRH1 "GNRH, GRH, LHRH" ENSG00000147437 "Gonadotropin releasing hormone 1" P01148 8 25419260-25424654 "Disease related genes, Predicted secreted proteins" Hormone "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5" "Cell line enhanced" "Detected in many" "SCLC-21H: 21.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "basal ganglia: 23.5;cerebellum: 6.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 20.8;hypothalamus: 14.2;olfactory region: 8.3" "Group enriched" "Detected in some" 30 "basal ganglia: 21.7;hypothalamus: 66.0" HPA027532 Supported "Secreted to blood" "HPA027532: AB_10612111" "unprognostic (6.49e-3)" "unprognostic (7.62e-2)" "unprognostic (2.90e-1)" "unprognostic (5.06e-2)" "unprognostic (1.35e-1)" "unprognostic (3.53e-4)" "unprognostic (7.80e-3)" "unprognostic (2.97e-2)" "unprognostic (1.39e-1)" "unprognostic (7.99e-2)" "unprognostic (3.45e-1)" "unprognostic (1.44e-1)" "prognostic unfavourable (8.08e-9)" "unprognostic (7.98e-3)" "unprognostic (5.11e-2)" "unprognostic (3.49e-1)" "unprognostic (3.68e-2)" 2.0 1.3 1.7 1.7 23.5 3.6 5.0 6.9 2.3 2.4 2.6 2.1 1.7 2.6 2.5 6.7 2.3 1.9 2.8 2.3 1.7 3.7 2.3 1.7 2.7 2.8 1.7 1.7 4.3 2.8 0.8 2.0 1.9 1.7 3.6 2.5 1.7 3.3 2.4 4.0 12.6 2.9 1.7 1.7 3.1 1.5 1.7 3.2 1.7 1.8 1.7 2.3 1.7 3.9 0.9 1.1 1.7 0.3 0.2 1.9 0.1 1.0 1.7 4.5 2.4 1.6 5.3 2.0 4.0 1.6 1.2 1.9 1.7 1.2 1.3 0.9 2.3 4.0 1.3 0.3 2.9 1.8 2.3 1.4 5.9 1.7 1.3 0.2 1.5 3.1 2.4 0.9 0.8 1.0 1.6 1.3 2.0 0.7 1.4 3.1 1.6 0.5 0.9 0.6 0.6 1.2 0.7 21.0 0.8 1.1 0.8 1.4 0.8 1.9 3.7 3.5 1.7 4.0 1.5 0.2 0.2 1.9 1.7 1.1 1.5 0.0 0.0 0.0 1.9 0.1 0.8 0.3 0.2 0.6 0.1 0.9 0.4 0.3 1.7 0.2 0.3 1.1 1.6 0.1 1.7 23.5 6.9 2.3 1.7 3.7 1.7 1.7 1.7 3.2 GOLGA7B "bA451M19.3, bA459F3.4, C10orf132, C10orf133" ENSG00000155265 "Golgin A7 family member B" Q2TAP0 10 97850239-97871580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 39.6;epididymis: 35.9;skin 1: 21.4" "Cell line enhanced" "Detected in some" "A-431: 5.0;HDLM-2: 5.4;SK-MEL-30: 21.4;U-87 MG: 3.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 24 "T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046878 Uncertain "HPA046878: " "unprognostic (7.90e-2)" "unprognostic (1.70e-3)" "unprognostic (7.10e-3)" "unprognostic (1.06e-2)" "unprognostic (8.97e-2)" "unprognostic (1.54e-1)" "unprognostic (6.20e-4)" "unprognostic (1.95e-1)" "unprognostic (4.45e-1)" "unprognostic (2.49e-1)" "unprognostic (8.89e-2)" "unprognostic (4.13e-2)" "unprognostic (1.15e-7)" "unprognostic (2.12e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-3)" "unprognostic (5.90e-3)" 2.5 4.5 16.4 2.1 12.0 1.3 2.5 39.6 24.1 1.3 1.5 4.4 1.3 3.2 1.3 35.9 2.3 1.1 1.5 3.4 19.8 12.8 1.0 1.1 1.7 2.8 11.1 20.4 1.0 6.6 1.0 6.7 1.3 10.7 1.3 1.8 0.6 1.4 1.7 4.9 21.4 3.8 1.2 5.4 1.5 2.3 1.7 6.2 0.0 1.4 0.5 2.5 1.2 1.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 5.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 2.0 0.0 0.1 0.0 1.9 0.0 0.4 0.0 5.4 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.3 0.0 1.8 0.1 0.1 0.3 0.8 1.5 0.0 1.0 21.4 2.1 0.1 0.1 0.1 0.0 0.0 0.2 1.7 0.7 0.0 3.9 2.2 2.4 0.0 0.0 0.0 0.7 0.0 0.3 0.0 2.3 1.9 0.0 0.0 1.5 1.4 0.0 0.0 0.0 0.0 1.2 0.3 16.4 12.0 39.6 24.1 19.8 12.8 11.1 20.4 10.7 6.2 GP1BB "CD42c, GPIbbeta" ENSG00000203618 "Glycoprotein Ib platelet beta subunit" P13224 22 19722945-19724771 "CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.7;brain: 19.6" "Cell line enhanced" "Detected in some" "HEK 293: 5.6;K-562: 10.1;NB-4: 8.4;REH: 10.2;SH-SY5Y: 4.9;U-2 OS: 10.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 6.3;neutrophil: 11.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" 110000000 0.9 0.5 16.7 1.2 19.6 0.5 0.5 7.3 9.0 0.5 1.7 1.2 0.7 0.5 1.8 0.5 0.7 2.9 15.0 4.1 0.5 0.9 0.6 0.6 2.7 0.5 0.5 0.5 2.5 0.6 1.3 0.7 1.9 0.5 1.2 10.4 0.5 1.0 0.2 1.8 1.9 0.5 0.7 0.7 0.5 0.2 0.1 1.7 11.0 1.2 0.1 0.3 61.7 0.0 0.9 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 1.7 5.6 2.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 10.1 0.1 0.1 0.4 0.4 8.4 0.4 3.1 10.2 0.0 0.1 0.0 0.0 3.7 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.0 6.3 1.2 1.1 0.2 0.3 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.1 11.0 0.1 0.0 1.7 0.3 61.7 GPC5 ENSG00000179399 "Glypican 5" P78333 13 91398607-92873682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;kidney: 14.8;testis: 11.3" "Group enriched" "Detected in some" 11 "CACO-2: 30.6;HeLa: 17.5" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040152, HPA044081" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA040152: , HPA044081: " "unprognostic (4.99e-3)" "unprognostic (2.20e-2)" "unprognostic (1.00e-1)" "unprognostic (9.93e-5)" "prognostic unfavourable (4.37e-4)" "unprognostic (4.46e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (9.49e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-5)" "unprognostic (2.19e-2)" "unprognostic (1.82e-6)" "unprognostic (3.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.11e-1)" "unprognostic (6.69e-3)" 0.8 3.8 11.8 1.1 18.3 0.8 0.7 3.1 18.9 0.6 1.5 2.9 0.1 0.7 0.6 0.9 0.6 0.8 1.6 2.3 11.8 6.0 14.8 2.9 6.5 1.0 7.3 5.6 1.5 0.8 0.6 7.7 1.4 19.4 0.9 1.5 0.0 0.8 1.5 0.6 0.7 0.8 0.8 4.4 0.7 0.9 11.3 6.6 0.0 2.7 0.0 0.7 0.6 0.3 0.5 0.4 0.3 1.8 2.0 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 17.5 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.3 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.1 1.2 0.4 0.2 0.0 0.5 0.3 2.0 1.8 0.0 0.0 0.2 11.8 18.3 3.1 8.6 11.8 6.0 7.3 5.6 19.4 6.6 GPIHBP1 "GPI-HBP1, LOC338328" ENSG00000277494 "Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1" Q8IV16 8 143213193-143217170 "Disease related genes, Predicted intracellular proteins" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.6;brain: 18.5" "Cell line enriched" "Detected in some" 5 "Karpas-707: 8.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA066302 Enhanced "Intracellular and membrane" "HPA066302: " "unprognostic (2.05e-1)" "unprognostic (3.11e-2)" "unprognostic (1.71e-3)" "unprognostic (2.43e-3)" "unprognostic (1.58e-1)" "unprognostic (9.50e-2)" "unprognostic (1.75e-3)" "unprognostic (8.01e-2)" "unprognostic (2.04e-1)" "unprognostic (1.30e-1)" "unprognostic (9.31e-2)" "unprognostic (8.69e-2)" "unprognostic (5.06e-3)" "unprognostic (9.65e-3)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (2.85e-3)" 47.6 2.2 0.0 0.3 11.5 0.1 9.0 0.6 7.5 1.6 1.7 17.9 0.0 0.4 1.6 0.2 2.0 2.2 3.7 8.3 2.1 2.6 0.7 13.0 1.3 18.5 2.9 1.9 0.6 0.3 0.0 4.0 9.7 0.7 0.4 1.1 0.5 1.1 16.0 1.6 0.3 1.5 12.8 4.2 0.4 1.4 10.2 0.0 0.6 0.4 0.7 1.5 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPM6A GPM6 ENSG00000150625 "Glycoprotein M6A" P51674 4 175632934-176002664 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 249.7" "Group enriched" "Detected in some" 10 "AF22: 26.2;Daudi: 21.8;HAP1: 9.0;U-251 MG: 25.9" "Cancer enriched" "Detected in many" 107 "glioma: 110.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 22.2;naive B-cell: 9.1" "Lineage enriched" "Detected in many" 12 "B-cells: 22.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017338 Supported "HPA017338: AB_1849933" "unprognostic (1.36e-4)" "unprognostic (3.35e-3)" "unprognostic (2.96e-2)" "unprognostic (1.34e-2)" "unprognostic (9.45e-2)" "unprognostic (1.34e-1)" "unprognostic (3.82e-5)" "unprognostic (2.24e-1)" "unprognostic (9.13e-3)" "unprognostic (1.06e-1)" "unprognostic (3.69e-2)" "unprognostic (7.73e-2)" "unprognostic (2.24e-2)" "unprognostic (3.53e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-3)" "unprognostic (2.60e-3)" 2.4 3.1 81.8 2.0 51.1 1.8 2.5 83.3 249.7 4.1 4.1 15.9 0.0 2.2 4.3 2.7 2.3 4.4 3.1 2.3 54.4 31.2 4.3 6.2 8.8 2.4 23.5 39.4 6.5 2.2 2.0 1.0 1.7 13.1 3.7 3.8 6.3 1.9 4.2 1.8 1.9 2.3 5.5 9.6 6.9 2.0 2.1 17.0 0.0 5.9 0.0 2.0 2.4 0.5 22.2 1.7 0.3 0.1 0.0 0.0 0.4 0.1 0.4 26.2 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.3 21.8 0.1 0.1 0.4 9.0 0.7 0.0 0.1 2.1 0.2 1.7 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.5 0.8 0.3 0.6 0.3 0.1 0.1 0.1 0.0 1.1 0.2 0.2 0.1 0.4 0.1 0.3 0.0 0.1 0.5 0.3 0.3 25.9 0.8 0.0 1.3 0.9 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.1 9.1 0.0 0.0 0.1 0.0 0.1 1.7 0.0 0.4 81.8 51.1 83.3 79.7 54.4 31.2 23.5 39.4 13.1 17.0 GPM6B "M6B, MGC17150, MGC54284" ENSG00000046653 "Glycoprotein M6B" Q13491 X 13771031-13938638 "Predicted membrane proteins" "Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 219.5" "Cell line enhanced" "Detected in some" "AF22: 41.9;AN3-CA: 41.6;ASC TERT1: 21.3;HSkMC: 31.4;SK-MEL-30: 41.3" "Group enriched" "Detected in many" 14 "glioma: 192.5;melanoma: 41.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 222 "plasmacytoid DC: 33.4" "Lineage enriched" "Detected in single" 240 "dendritic cells: 33.4" "Low region specificity" "Detected in all" HPA002913 Approved "HPA002913: AB_2263553" "unprognostic (1.56e-2)" "unprognostic (3.42e-1)" "unprognostic (1.83e-1)" "unprognostic (3.70e-2)" "unprognostic (8.55e-2)" "unprognostic (2.75e-3)" "unprognostic (2.12e-2)" "unprognostic (1.92e-2)" "unprognostic (4.27e-2)" "prognostic favourable (2.67e-4)" "unprognostic (1.79e-2)" "unprognostic (4.78e-2)" "unprognostic (2.38e-3)" "unprognostic (8.34e-2)" "unprognostic (2.12e-1)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" 4.6 5.5 68.4 3.9 55.1 2.0 12.4 24.1 219.5 10.2 5.7 68.7 1.1 3.6 4.3 6.7 6.4 4.2 3.9 5.9 62.6 33.1 4.5 2.0 6.7 2.6 68.9 47.3 3.1 2.9 1.9 2.6 2.1 44.1 9.9 4.9 3.2 7.4 16.9 2.1 7.1 4.3 3.8 109.4 7.2 3.3 3.0 64.8 0.0 3.5 0.0 2.3 3.3 2.7 0.1 33.4 0.1 0.0 0.1 0.1 0.2 0.1 0.1 41.9 41.6 11.9 21.3 0.1 0.2 1.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 2.1 0.2 0.0 0.1 6.8 0.1 2.8 0.1 0.4 0.1 0.2 31.4 0.2 0.0 0.5 0.0 0.1 1.9 0.4 0.1 0.8 0.1 13.1 0.7 0.5 3.8 6.3 0.0 0.1 2.1 1.2 0.2 1.2 41.3 0.2 0.9 0.0 0.2 0.3 0.1 0.5 0.1 0.0 0.0 0.3 0.0 3.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 33.4 0.0 0.2 68.4 55.1 24.1 43.1 62.6 33.1 68.9 47.3 44.1 64.8 GPR101 ENSG00000165370 "G protein-coupled receptor 101" Q96P66 X 137030148-137031674 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "brain: 11.1" "Cell line enriched" "Detected in single" 4 "HEK 293: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 44.7" "Low region specificity" "Detected in many" HPA001084 Uncertain "HPA001084: AB_1078920" 0.0 0.0 0.0 0.0 11.1 0.1 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR12 "GPCR21, PPP1R84" ENSG00000132975 "G protein-coupled receptor 12" P47775 13 26755200-26760785 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 29.4;salivary gland: 7.7" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 17.7" "Group enriched" "Detected in some" 7 "breast cancer: 0.5;glioma: 0.8;ovarian cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "basophil: 2.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050972 Uncertain "HPA050972: " "unprognostic (2.37e-2)" "unprognostic (9.64e-3)" "unprognostic (3.75e-1)" "unprognostic (3.30e-1)" "unprognostic (1.40e-2)" "unprognostic (4.65e-2)" "unprognostic (1.42e-1)" "unprognostic (7.35e-2)" "unprognostic (5.53e-2)" "unprognostic (3.83e-2)" "unprognostic (2.40e-1)" 1.1 0.7 4.9 0.5 29.4 0.9 4.6 17.7 14.6 1.4 0.7 1.6 0.0 0.7 0.6 0.5 0.8 2.5 0.7 0.7 5.6 2.6 0.6 0.5 0.7 0.6 2.2 4.8 0.6 0.5 0.5 0.7 1.6 1.1 0.6 0.7 1.9 7.7 0.6 0.9 4.4 0.9 0.9 0.7 0.8 0.7 0.8 6.6 0.0 0.6 0.0 0.6 0.6 0.0 0.3 0.2 2.4 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.3 0.1 0.5 0.1 0.1 0.2 0.0 0.1 4.9 29.4 17.7 8.4 5.6 2.6 2.2 4.8 1.1 6.6 GPR137C "DKFZp762F0713, TM7SF1L2" ENSG00000180998 "G protein-coupled receptor 137C" Q8N3F9 14 52553148-52637713 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.1;epididymis: 16.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 3.9;T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003640, HPA030763" Uncertain Approved Vesicles Vesicles "HPA003640: , HPA030763: AB_10602352" "unprognostic (1.39e-1)" "unprognostic (1.45e-1)" "unprognostic (1.23e-1)" "unprognostic (6.84e-2)" "unprognostic (8.50e-3)" "unprognostic (7.34e-3)" "unprognostic (5.95e-3)" "unprognostic (2.32e-2)" "unprognostic (4.41e-2)" "unprognostic (8.42e-4)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" "unprognostic (7.88e-2)" "unprognostic (4.08e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.60e-1)" 1.4 2.2 7.1 1.0 11.0 3.3 1.9 31.1 20.2 1.4 1.2 7.5 0.2 2.0 2.5 16.6 1.7 1.2 2.8 2.4 5.9 10.6 1.2 1.3 1.7 2.1 6.3 7.5 1.6 0.7 2.3 1.8 1.8 13.3 1.6 1.5 3.2 1.7 1.5 1.3 1.8 1.2 1.5 7.0 2.5 1.4 6.5 8.3 0.0 2.1 0.0 1.2 2.1 0.7 0.7 0.5 2.4 0.5 3.9 4.1 0.8 0.8 0.3 8.1 7.4 2.3 0.7 3.2 3.4 2.3 3.5 8.6 1.5 1.6 0.8 2.5 2.8 1.9 2.7 0.5 5.3 1.2 1.8 0.9 2.3 0.9 0.3 0.5 1.9 0.4 0.0 3.3 0.2 1.8 1.2 3.5 5.1 3.9 0.3 1.1 2.0 4.7 1.8 5.1 0.3 1.0 5.7 8.3 10.4 1.7 0.5 0.2 5.1 0.0 0.3 8.1 8.7 5.9 2.8 0.8 2.0 1.8 2.0 0.4 2.4 1.2 0.5 0.5 3.1 0.1 4.1 0.3 2.0 3.9 0.2 0.7 1.5 1.8 2.4 3.9 0.4 0.5 1.4 0.8 7.1 11.0 31.1 14.1 5.9 10.6 6.3 7.5 13.3 8.3 GPR139 PGR3 ENSG00000180269 "G protein-coupled receptor 139" Q6DWJ6 16 20031485-20073917 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 2.8;endometrium 1: 2.1;smooth muscle: 1.0" "Cell line enriched" "Detected in single" 10 "NTERA-2: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA046596 Uncertain "HPA046596: " "unprognostic (2.94e-1)" 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR141 PGR13 ENSG00000187037 "G protein-coupled receptor 141" Q7Z602 7 37683796-37833788 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 27.6;brain: 18.1" "Cell line enhanced" "Detected in some" "HEL: 7.6;HMC-1: 30.1;NTERA-2: 16.2;U-937: 12.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 11.4;eosinophil: 8.1;gdT-cell: 4.8;memory CD8 T-cell: 4.5;myeloid DC: 5.8;naive CD8 T-cell: 3.3;neutrophil: 10.7" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (4.91e-2)" "unprognostic (3.44e-1)" "unprognostic (3.26e-4)" "unprognostic (4.70e-3)" "unprognostic (8.67e-2)" "unprognostic (2.00e-2)" "unprognostic (3.01e-1)" "unprognostic (2.51e-2)" "unprognostic (7.93e-3)" "unprognostic (1.44e-1)" "unprognostic (1.51e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-3)" "unprognostic (1.39e-2)" "unprognostic (4.14e-2)" "unprognostic (1.79e-1)" "unprognostic (1.60e-1)" 1.7 0.9 2.5 4.4 3.3 27.6 0.9 1.0 3.2 1.9 1.4 0.6 0.0 1.0 1.9 2.0 1.8 1.5 3.7 1.7 3.2 1.4 1.2 1.3 4.3 10.0 5.3 0.7 0.6 1.5 0.3 1.0 2.8 5.8 2.0 2.0 2.7 1.7 0.5 0.6 1.2 1.8 1.8 18.1 10.0 1.2 1.5 5.1 2.9 1.1 1.0 2.1 4.8 2.3 0.0 5.8 10.7 11.4 0.6 4.8 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.6 0.0 0.0 0.1 30.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 12.7 0.0 0.0 11.4 8.1 4.8 0.9 0.0 0.0 1.2 4.5 5.8 0.0 0.5 3.3 10.7 0.6 0.1 0.2 0.0 3.4 2.5 3.3 1.0 3.2 3.2 1.4 5.3 0.7 5.8 5.1 GPR142 PGR2 ENSG00000257008 "G protein-coupled receptor 142" Q7Z601 17 74367407-74372622 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.3;lymphoid tissue: 1.3" "Cell line enhanced" "Detected in single" "U-937: 1.1" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031392 Uncertain Uncertain "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cytosol" "Cell Junctions" "HPA031392: AB_10601935" "unprognostic (6.81e-2)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (6.54e-5)" "unprognostic (4.16e-2)" "unprognostic (4.85e-7)" "unprognostic (3.95e-2)" "unprognostic (7.72e-4)" "unprognostic (1.93e-1)" "unprognostic (1.68e-3)" 0.2 0.0 0.0 1.3 0.1 0.0 0.1 1.3 0.2 0.3 0.1 0.8 0.6 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.2 0.0 0.1 0.8 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR148 PGR6 ENSG00000173302 "G protein-coupled receptor 148" Q8TDV2 2 130729070-130730336 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 2.6;pancreas: 1.1;pituitary gland: 2.2;stomach 1: 3.5" "Group enriched" "Detected in some" 11 "CACO-2: 2.5;SCLC-21H: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA060527 Uncertain "HPA060527: " "unprognostic (7.16e-4)" "unprognostic (3.38e-1)" 0.0 0.2 0.1 0.0 0.4 0.0 0.0 2.6 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR149 "IEDA, PGR10, R35" ENSG00000174948 "G protein-coupled receptor 149" Q86SP6 3 154337672-154429715 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "brain: 23.5;pituitary gland: 6.5;seminal vesicle: 8.7" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basal ganglia: 23.5;pons and medulla: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 15.0" "Low region specificity" "Detected in all" HPA018020 Uncertain "HPA018020: AB_1849334" 0.2 0.3 0.2 0.2 23.5 0.2 0.2 0.0 0.8 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.9 0.2 0.2 0.2 0.2 0.8 0.0 0.2 0.2 0.2 6.5 0.2 6.5 0.3 0.3 0.4 0.2 8.7 0.2 0.3 0.3 0.2 0.6 0.2 0.5 1.1 2.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 23.5 0.0 0.8 0.2 1.9 0.8 0.0 6.5 2.1 GPR150 PGR11 ENSG00000178015 "G protein-coupled receptor 150" Q8NGU9 5 95620078-95622142 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.5;pancreas: 13.4" "Cell line enhanced" "Detected in some" "ASC diff: 3.8;SiHa: 3.1;TIME: 6.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.3;memory CD4 T-cell: 2.5;NK-cell: 2.1" "Group enriched" "Detected in many" 12 "NK-cells: 2.1;T-cells: 2.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA026635 Uncertain "HPA026635: AB_1849266" "unprognostic (3.03e-2)" "unprognostic (6.88e-3)" "unprognostic (1.01e-1)" "unprognostic (1.01e-2)" "unprognostic (5.95e-2)" "unprognostic (5.34e-4)" "unprognostic (1.98e-2)" "unprognostic (6.36e-2)" "unprognostic (3.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.94e-3)" "unprognostic (1.88e-2)" "unprognostic (1.76e-1)" "unprognostic (3.23e-2)" "unprognostic (4.42e-2)" "unprognostic (3.55e-2)" "unprognostic (1.26e-1)" 1.5 0.7 4.3 0.4 2.6 0.4 1.2 0.4 11.5 0.6 0.9 0.3 0.4 0.5 0.4 0.6 0.3 0.5 0.5 0.5 2.3 1.3 0.3 0.4 1.2 1.0 0.6 8.0 0.3 13.4 3.8 1.0 0.6 0.2 0.7 0.7 1.4 0.3 1.1 0.4 1.0 0.6 0.4 0.2 0.8 2.1 0.6 0.0 0.0 0.3 0.0 0.7 0.6 0.3 0.2 0.0 0.0 0.0 2.1 2.5 0.2 0.0 0.0 0.1 0.0 3.8 1.7 0.1 1.2 0.3 0.1 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 1.4 0.0 0.1 0.3 0.0 0.5 0.0 0.6 0.0 2.0 1.4 0.0 1.2 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.1 2.0 1.2 3.1 0.0 0.6 0.0 0.9 6.7 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.5 0.0 2.3 0.2 2.5 0.0 0.0 0.0 1.0 0.2 0.0 2.1 0.0 0.0 0.0 0.2 4.3 2.6 0.4 11.5 2.3 1.3 0.6 8.0 0.2 0.0 GPR151 "GALR4, PGR7" ENSG00000173250 "G protein-coupled receptor 151" Q8TDV0 5 146513103-146516190 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 1.5;brain: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in single" 19 "thalamus: 36.8" "Region enriched" "Detected in single" 7 "thalamus: 4.6" HPA065728 Supported "HPA065728: " "unprognostic (2.09e-1)" "unprognostic (2.30e-1)" "unprognostic (1.14e-1)" "unprognostic (1.32e-2)" 0.0 0.1 0.4 0.0 0.5 0.1 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.4 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 GPR155 "DEP.7, DEPDC3, FLJ31819, PGR22" ENSG00000163328 "G protein-coupled receptor 155" Q7Z3F1 2 174431571-174487094 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5;stomach 1: 43.2" "Cell line enhanced" "Detected in many" "U-266/70: 16.0;WM-115: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036159, HPA057384" Approved Approved "Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" "HPA036159: AB_10671835, HPA057384: " "unprognostic (3.91e-2)" "unprognostic (7.93e-2)" "unprognostic (3.14e-2)" "unprognostic (4.11e-4)" "unprognostic (5.03e-2)" "unprognostic (2.48e-1)" "unprognostic (8.49e-2)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (4.82e-2)" "unprognostic (2.59e-2)" "unprognostic (9.90e-2)" "unprognostic (1.82e-2)" "unprognostic (4.54e-2)" 4.5 10.1 9.3 6.6 34.5 2.6 3.0 15.1 17.3 3.2 11.4 6.1 2.2 4.0 2.6 13.1 6.7 2.5 5.9 6.8 15.5 9.4 19.8 7.3 3.3 5.9 7.7 11.5 3.0 16.9 8.0 3.2 4.7 27.4 8.0 4.2 4.9 3.7 8.8 5.1 13.4 5.1 7.8 6.9 5.3 43.2 2.6 9.9 1.6 8.3 0.8 3.8 6.6 3.6 1.5 0.8 9.6 6.8 4.7 7.0 1.9 0.7 0.4 1.0 2.4 5.6 3.1 0.6 4.2 1.4 0.7 2.4 0.3 0.3 2.4 1.3 2.9 0.4 1.4 1.3 2.3 0.9 1.6 2.5 1.4 0.2 1.0 0.9 1.3 4.5 3.6 2.1 0.7 1.1 0.4 6.0 4.7 0.7 1.7 1.1 0.5 1.7 2.0 6.1 1.1 2.4 1.5 6.5 5.5 1.3 1.0 2.1 0.4 0.4 3.0 3.1 1.2 4.4 0.6 16.0 2.3 0.4 3.5 0.8 10.5 1.5 2.9 0.1 2.4 5.4 2.2 1.3 4.4 4.0 0.8 1.5 3.5 5.4 9.6 4.7 6.8 0.5 7.0 1.9 9.3 34.5 15.1 16.2 15.5 9.4 7.7 11.5 27.4 9.9 GPR158 KIAA1136 ENSG00000151025 "G protein-coupled receptor 158" Q5T848 10 25175062-25602226 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.4;seminal vesicle: 11.2" "Group enriched" "Detected in some" 5 "HEL: 20.7;T-47d: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013185 Uncertain Approved Cytosol Cytosol "HPA013185: AB_2113957" "unprognostic (4.43e-2)" "unprognostic (3.14e-2)" "unprognostic (7.42e-2)" "unprognostic (2.66e-5)" "unprognostic (5.67e-2)" "unprognostic (9.37e-2)" "unprognostic (4.73e-2)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (4.37e-2)" "unprognostic (8.09e-3)" "unprognostic (1.72e-1)" "unprognostic (2.60e-6)" "unprognostic (8.36e-2)" "unprognostic (1.78e-1)" "unprognostic (1.21e-3)" "unprognostic (3.90e-1)" 0.9 2.4 3.6 1.0 16.2 0.8 0.8 28.4 25.2 0.8 1.1 1.6 6.1 0.9 0.8 1.0 0.8 0.8 0.8 0.8 1.9 2.8 0.8 0.9 0.9 0.8 2.4 4.8 0.8 0.9 1.5 8.9 1.5 14.9 1.2 1.1 1.4 0.8 11.2 0.8 0.8 1.2 0.8 4.0 0.9 1.1 1.9 2.9 0.0 1.0 0.0 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 20.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.4 0.0 0.0 0.1 0.5 0.0 0.3 0.2 0.0 0.0 1.2 0.0 0.5 1.1 1.9 5.7 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 16.2 28.4 11.6 1.9 2.8 2.4 4.8 14.9 2.9 GPR162 "A-2, GRCA" ENSG00000250510 "G protein-coupled receptor 162" Q16538 12 6821545-6829972 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.6" "Cell line enhanced" "Detected in many" "AF22: 13.3;AN3-CA: 15.8;NTERA-2: 14.9;SH-SY5Y: 10.2;U-2 OS: 12.6" "Cancer enriched" "Detected in many" 6 "glioma: 16.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.3;intermediate monocyte: 3.7;neutrophil: 14.7" "Group enriched" "Detected in many" 6 "granulocytes: 14.7;monocytes: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055135 Enhanced Approved "Centriolar satellite" "Intracellular and membrane" "Centriolar satellite" "HPA055135: " "unprognostic (4.76e-2)" "unprognostic (8.00e-2)" "unprognostic (8.24e-3)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (2.38e-1)" "unprognostic (4.78e-2)" "unprognostic (2.25e-2)" "unprognostic (5.83e-3)" "unprognostic (1.18e-1)" "prognostic favourable (4.29e-5)" "unprognostic (3.82e-3)" "prognostic unfavourable (1.37e-6)" "unprognostic (3.10e-3)" "unprognostic (1.77e-1)" "unprognostic (3.22e-1)" "unprognostic (3.64e-2)" 2.7 6.7 19.6 4.2 13.2 1.5 2.4 41.3 47.6 2.1 3.4 4.7 0.8 3.1 3.8 2.8 1.9 16.9 5.7 4.2 25.9 18.4 1.4 3.7 6.0 1.7 9.9 17.7 2.0 1.7 5.3 8.4 4.3 10.2 2.1 3.0 3.6 1.3 2.1 1.6 1.7 4.2 5.7 5.3 2.8 2.0 1.2 3.6 0.1 1.1 0.0 1.1 2.4 0.5 0.0 1.8 14.7 6.3 0.0 0.0 1.7 0.0 3.0 13.3 15.8 1.5 1.0 0.0 1.0 3.5 3.0 1.8 0.3 0.0 0.0 0.1 1.9 0.1 2.1 0.0 1.5 0.0 0.9 1.5 0.1 0.0 2.3 0.3 0.0 2.4 0.0 4.6 0.2 8.1 0.7 0.1 1.1 0.0 0.4 1.1 14.9 0.1 0.0 1.7 2.7 1.0 0.0 1.1 10.2 0.0 0.0 0.4 0.1 3.9 5.4 2.1 12.6 1.1 1.8 0.0 0.9 0.0 2.2 2.7 0.2 0.0 6.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 14.7 0.0 1.3 1.6 0.0 1.7 19.6 13.2 41.3 32.4 25.9 18.4 9.9 17.7 10.2 3.6 GPR17 ENSG00000144230 "G protein-coupled receptor 17" Q13304 2 127645864-127652639 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 43.8" "Cell line enhanced" "Detected in some" "HeLa: 4.5;REH: 7.5;TIME: 7.4;U-2 OS: 3.1;U-2197: 3.5;U-251 MG: 4.4" "Cancer enriched" "Detected in some" 32 "glioma: 16.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "naive B-cell: 4.0" "Lineage enriched" "Detected in single" 11 "B-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029766 Enhanced Supported Approved Vesicles Vesicles "HPA029766: AB_10612114" "unprognostic (8.10e-2)" "unprognostic (1.73e-1)" "unprognostic (2.61e-1)" "unprognostic (1.42e-2)" "unprognostic (1.54e-1)" "unprognostic (5.19e-2)" "unprognostic (2.77e-5)" "unprognostic (8.40e-3)" "unprognostic (2.92e-1)" "unprognostic (3.25e-2)" "unprognostic (1.61e-3)" "unprognostic (6.60e-2)" "unprognostic (2.11e-3)" "unprognostic (3.33e-2)" "unprognostic (2.19e-1)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" 7.0 2.2 23.7 6.8 21.3 0.8 5.4 4.1 25.6 2.4 16.4 43.8 0.0 3.3 11.2 3.3 5.0 4.0 4.3 12.5 20.6 1.2 2.3 1.6 9.3 2.4 9.1 9.9 1.4 4.6 0.5 0.4 2.7 18.8 3.9 0.8 0.1 1.7 0.5 13.1 6.7 3.8 0.5 6.3 12.6 5.0 1.8 22.6 0.0 2.8 0.0 0.5 6.1 3.9 4.0 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.3 0.6 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.5 0.8 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 0.0 0.0 0.6 0.2 0.1 0.2 7.5 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.3 0.0 7.4 0.0 3.1 3.5 4.4 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.7 21.3 4.1 25.6 20.6 1.2 9.1 9.9 18.8 22.6 GPR173 SREB3 ENSG00000184194 "G protein-coupled receptor 173" Q9NS66 X 53049091-53080615 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2" "Cell line enhanced" "Detected in many" "HAP1: 10.3" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003905 Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA003905: AB_1078922" "unprognostic (2.68e-1)" "unprognostic (2.33e-1)" "unprognostic (4.95e-3)" "prognostic unfavourable (2.88e-6)" "unprognostic (3.87e-2)" "unprognostic (8.58e-2)" "unprognostic (2.73e-1)" "unprognostic (1.47e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-2)" "prognostic favourable (2.33e-5)" "unprognostic (1.03e-1)" "prognostic unfavourable (2.47e-4)" "unprognostic (1.08e-4)" "unprognostic (2.83e-1)" "unprognostic (3.92e-2)" "unprognostic (6.95e-2)" 2.5 5.2 8.2 3.0 9.4 2.2 3.1 15.4 23.2 4.2 2.8 11.6 0.8 1.8 6.4 5.0 2.4 7.7 3.3 4.2 7.9 10.0 2.4 1.1 2.8 2.1 7.3 11.2 15.0 1.3 1.3 14.6 4.5 9.7 3.2 2.6 6.4 2.0 5.4 4.6 3.9 2.1 4.5 6.5 4.0 2.1 2.4 9.6 0.7 3.1 0.1 1.5 3.3 2.8 0.9 0.7 5.7 0.4 1.8 0.7 0.0 0.0 0.0 8.2 0.5 4.7 2.8 0.0 1.3 3.0 2.2 2.6 0.8 0.1 0.2 2.0 2.8 0.7 10.3 0.0 1.9 0.6 1.0 0.5 8.4 0.3 6.8 0.5 0.1 6.6 0.0 3.3 4.7 3.5 0.0 5.7 3.2 4.2 0.0 0.0 6.3 3.6 0.1 2.5 0.3 0.5 0.4 5.9 8.3 0.0 0.4 0.0 1.1 0.1 6.5 3.6 5.2 2.3 1.1 0.2 0.3 0.7 2.5 0.0 2.0 5.7 0.2 0.3 0.7 0.1 0.5 0.3 0.2 0.1 0.1 0.9 0.5 0.4 1.2 1.8 0.4 0.7 0.0 0.0 8.2 9.4 15.4 15.1 7.9 10.0 7.3 11.2 9.7 9.6 GPR176 Gm1012 ENSG00000166073 "G protein-coupled receptor 176" Q14439 15 39799032-39920892 "G-protein coupled receptors, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 68.5;fHDF/TERT166: 46.2;U-138 MG: 30.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "eosinophil: 2.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039943, HPA039979" Approved "HPA039943: AB_10697711, HPA039979: " "unprognostic (4.02e-2)" "unprognostic (2.65e-1)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (4.24e-1)" "unprognostic (1.04e-2)" "unprognostic (2.75e-2)" "unprognostic (1.38e-3)" "unprognostic (9.32e-2)" "unprognostic (3.23e-2)" "unprognostic (2.74e-2)" "unprognostic (2.33e-2)" "prognostic unfavourable (9.38e-7)" "prognostic unfavourable (6.84e-5)" "unprognostic (2.23e-1)" "unprognostic (1.95e-1)" "unprognostic (3.26e-2)" 9.8 9.6 9.7 5.9 18.4 0.5 8.9 22.6 16.0 8.0 2.9 2.5 1.3 2.8 5.6 3.1 2.9 3.8 10.5 5.4 8.4 12.7 4.7 2.8 5.4 8.0 7.2 7.4 2.5 2.3 3.3 4.1 3.6 11.3 10.9 3.5 3.2 2.5 5.7 3.1 3.0 2.5 6.9 3.0 5.6 2.5 9.9 2.0 1.2 5.1 3.1 8.0 9.5 4.5 0.0 0.5 2.8 0.0 0.0 0.0 0.0 12.4 0.6 0.8 0.1 9.0 16.4 0.0 26.5 68.5 16.3 25.3 0.9 2.0 0.1 2.4 46.2 0.3 2.0 2.1 24.5 0.4 3.1 1.9 2.0 0.0 10.1 0.0 0.1 12.4 0.2 14.6 12.1 6.1 0.3 0.2 22.4 0.5 0.0 0.0 0.8 2.5 0.7 8.2 0.1 0.4 0.1 3.3 13.0 6.8 0.0 1.0 2.5 0.1 7.7 30.1 8.7 1.8 9.7 0.3 1.0 0.0 6.2 0.0 11.7 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.7 18.4 22.6 14.3 8.4 12.7 7.2 7.4 11.3 2.0 GPR179 "CSNB1E, GPR158L1" ENSG00000277399 "G protein-coupled receptor 179" 17 38325530-38343847 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.0;retina: 7.5" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;U-266/84: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA017885 Uncertain "HPA017885: AB_2279357" "unprognostic (1.65e-1)" "unprognostic (2.27e-1)" "unprognostic (1.24e-4)" "unprognostic (8.89e-3)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "unprognostic (3.04e-2)" "unprognostic (4.76e-2)" "unprognostic (2.34e-2)" "unprognostic (6.57e-3)" "unprognostic (5.31e-2)" "unprognostic (5.09e-10)" "unprognostic (6.18e-2)" "unprognostic (2.31e-1)" "unprognostic (1.62e-2)" "unprognostic (3.41e-4)" 0.2 0.6 1.6 0.0 3.0 0.0 0.2 0.8 1.9 0.1 0.1 0.2 0.0 0.3 0.2 1.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.4 0.3 0.0 7.5 0.6 0.3 1.5 0.0 0.3 0.1 0.6 0.0 0.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 1.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 GPR19 ENSG00000183150 "G protein-coupled receptor 19" Q15760 12 12660891-12696207 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 9.2;brain: 13.3;pituitary gland: 9.8;testis: 9.8" "Cell line enhanced" "Detected in many" "HDLM-2: 23.2;NTERA-2: 24.1;WM-115: 12.3" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 9.2" "Group enriched" "Detected in many" 16 "granulocytes: 4.2;T-cells: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013955 Uncertain "HPA013955: AB_1849287" "unprognostic (1.92e-1)" "unprognostic (3.38e-2)" "unprognostic (1.72e-1)" "unprognostic (8.62e-5)" "unprognostic (1.60e-1)" "unprognostic (3.21e-1)" "unprognostic (8.25e-4)" "unprognostic (1.37e-1)" "unprognostic (1.73e-1)" "unprognostic (6.90e-2)" "unprognostic (1.45e-1)" "unprognostic (1.70e-2)" "unprognostic (2.67e-12)" "unprognostic (5.19e-2)" "unprognostic (1.38e-1)" "unprognostic (7.60e-2)" "unprognostic (1.60e-1)" 1.0 2.4 7.5 4.8 13.3 2.3 1.2 11.5 13.0 0.8 1.5 2.8 0.0 1.1 0.7 0.7 1.5 1.0 1.1 0.7 8.5 8.4 0.7 0.8 0.8 4.3 5.6 6.3 0.5 1.1 1.0 9.8 1.1 3.7 0.5 1.9 0.4 0.6 0.6 0.4 2.2 1.1 1.1 6.7 1.7 1.3 9.8 3.6 0.3 0.7 0.0 5.8 1.3 0.2 0.3 0.0 4.2 0.0 0.4 9.2 0.5 0.9 0.3 10.0 0.2 0.0 0.0 4.3 0.9 1.0 1.8 1.5 3.9 6.0 4.0 1.5 0.7 0.8 1.6 0.2 2.9 23.2 0.2 0.9 0.4 0.6 0.0 1.0 0.4 0.0 0.0 1.9 1.1 0.3 0.1 8.3 0.3 1.4 0.3 0.5 24.1 1.8 2.6 1.5 0.1 0.1 0.8 3.3 3.0 0.4 0.9 7.7 0.5 1.0 0.0 0.5 4.5 0.8 2.3 4.6 4.0 7.7 1.9 2.8 12.3 0.0 0.0 0.0 1.8 0.0 1.4 0.3 3.8 2.1 0.0 0.1 0.7 1.4 4.2 0.4 0.0 0.0 9.2 0.5 7.5 13.3 11.5 10.6 8.5 8.4 5.6 6.3 3.7 3.6 GPR21 ENSG00000188394 "G protein-coupled receptor 21" Q99679 9 123034527-123035696 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 4.6" "Cell line enriched" "Detected in some" 8 "HBEC3-KT: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA041651 Uncertain "HPA041651: AB_10794673" "unprognostic (9.22e-3)" "unprognostic (1.46e-1)" 3.6 0.0 1.1 1.7 2.2 0.2 1.1 0.1 4.6 2.1 0.4 0.0 2.7 1.0 1.9 0.9 0.8 0.5 0.7 0.4 0.3 0.0 0.5 1.9 0.3 1.4 0.0 0.2 0.0 1.5 0.1 0.6 0.1 0.7 0.4 0.6 0.3 1.7 0.4 0.9 0.5 0.0 1.0 0.9 1.3 2.0 0.9 0.0 0.1 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 8.2 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 GPR22 ENSG00000172209 "G protein-coupled receptor 22" Q99680 7 107470018-107475659 "G-protein coupled receptors, Predicted membrane proteins" "Cilium biogenesis/degradation" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 31.5;heart muscle: 18.7" "Cell line enriched" "Detected in single" 55 "SH-SY5Y: 7.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (4.23e-2)" "unprognostic (1.25e-2)" "unprognostic (1.19e-1)" "unprognostic (5.52e-2)" "unprognostic (7.73e-2)" "unprognostic (1.00e-1)" "unprognostic (4.27e-3)" "unprognostic (1.62e-1)" "unprognostic (8.76e-3)" "unprognostic (5.48e-2)" "unprognostic (1.25e-1)" "unprognostic (5.85e-4)" "unprognostic (1.55e-1)" "unprognostic (7.53e-3)" "unprognostic (2.27e-3)" "unprognostic (2.04e-1)" 0.6 2.7 10.9 0.6 4.4 0.7 0.6 15.5 31.5 6.3 0.6 0.0 0.0 0.6 4.1 0.6 0.6 0.6 0.6 18.7 19.4 2.0 1.0 0.6 0.6 0.6 1.8 13.0 0.6 0.6 0.6 0.3 0.6 6.0 0.6 0.6 0.0 0.6 0.8 0.6 0.6 0.6 1.0 0.7 0.6 0.6 0.6 1.1 0.0 0.6 0.0 0.6 0.6 1.7 1.0 0.2 0.3 0.3 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.2 0.3 0.9 0.4 0.5 0.0 1.0 0.4 1.0 0.3 0.2 0.2 0.2 0.4 0.0 10.9 4.4 15.5 31.5 19.4 2.0 1.8 13.0 6.0 1.1 GPR26 ENSG00000154478 "G protein-coupled receptor 26" Q8NDV2 10 123666355-123694607 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "brain: 8.6" "Cell line enriched" "Detected in single" 16 "SCLC-21H: 5.3" "Cancer enriched" "Detected in single" 13 "breast cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062736 Enhanced "HPA062736: " "unprognostic (4.15e-2)" "unprognostic (5.75e-2)" "unprognostic (3.42e-1)" "unprognostic (2.12e-1)" "unprognostic (9.09e-2)" "unprognostic (9.98e-2)" "unprognostic (2.12e-2)" "unprognostic (1.16e-2)" "unprognostic (1.12e-1)" 0.0 0.0 1.0 0.1 0.2 0.1 0.0 0.0 8.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.6 2.4 0.0 0.3 0.0 0.1 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 GPR27 SREB1 ENSG00000170837 "G protein-coupled receptor 27" Q9NS67 3 71754050-71756496 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2;parathyroid gland: 29.6" "Cell line enhanced" "Detected in some" "EFO-21: 12.8;HL-60: 12.2;MCF7: 10.5;NTERA-2: 21.1;RPTEC TERT1: 10.1;SH-SY5Y: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "eosinophil: 3.7;neutrophil: 10.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029395 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA029395: AB_10602907" "prognostic favourable (5.63e-4)" "unprognostic (2.99e-1)" "unprognostic (3.23e-2)" "unprognostic (3.22e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-2)" "unprognostic (2.17e-2)" "unprognostic (1.18e-2)" "unprognostic (3.22e-1)" "prognostic favourable (1.21e-6)" "unprognostic (2.97e-3)" "unprognostic (4.97e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.71e-2)" "unprognostic (1.45e-2)" "unprognostic (6.79e-2)" 1.7 4.5 14.9 1.7 23.2 14.5 4.3 4.4 15.4 3.4 1.0 5.8 1.7 0.6 5.5 3.3 2.7 7.7 1.2 3.5 12.8 12.4 3.2 0.9 2.4 5.5 10.6 8.8 5.0 2.6 29.6 5.1 2.0 5.9 5.7 0.7 3.3 1.7 5.1 1.8 1.9 0.7 3.3 16.8 3.7 2.4 4.2 3.6 0.0 6.8 1.2 0.5 2.1 2.8 0.0 0.2 10.5 0.8 0.0 0.4 0.1 0.0 0.8 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 12.8 0.0 0.0 3.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 12.2 0.7 0.0 2.2 0.0 0.9 0.0 0.0 0.0 0.0 10.5 0.8 0.2 21.1 0.0 0.0 0.0 0.0 10.1 5.7 2.2 8.0 2.8 0.0 0.0 7.4 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 3.7 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 10.5 0.0 0.1 0.0 0.0 0.1 14.9 23.2 4.4 9.9 12.8 12.4 10.6 8.8 5.9 3.6 GPR3 ACCA ENSG00000181773 "G protein-coupled receptor 3" P46089 1 27392644-27395814 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9" "Cell line enhanced" "Detected in many" "U-2197: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB006254 Uncertain "CAB006254: AB_425462" "unprognostic (4.42e-2)" "unprognostic (2.22e-1)" "unprognostic (4.05e-2)" "unprognostic (1.55e-2)" "unprognostic (1.38e-2)" "unprognostic (1.27e-1)" "unprognostic (7.30e-3)" "unprognostic (6.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.09e-1)" "unprognostic (5.94e-2)" "unprognostic (1.97e-1)" "unprognostic (1.46e-1)" "unprognostic (8.17e-2)" "unprognostic (2.07e-2)" "unprognostic (6.54e-2)" "unprognostic (1.03e-2)" 3.5 1.5 4.0 2.8 7.5 3.2 1.5 5.5 12.3 1.2 1.1 2.1 0.2 1.0 2.3 0.5 2.0 1.1 2.9 7.1 5.0 6.3 1.9 2.0 2.7 1.0 4.4 1.7 1.2 2.6 2.8 6.1 1.8 13.9 1.8 1.1 1.1 0.7 1.0 0.6 0.6 0.9 2.5 6.5 0.7 1.3 0.8 0.5 0.0 3.0 0.8 0.7 1.6 0.5 0.7 0.4 0.0 0.1 0.0 0.1 0.0 1.6 0.8 4.7 5.3 0.2 0.6 0.6 3.0 3.5 4.7 3.5 1.4 1.0 0.3 0.7 1.4 1.1 1.2 3.7 3.6 0.1 0.2 1.3 0.2 2.9 0.6 2.9 4.0 0.7 0.0 6.6 1.4 1.5 3.7 5.2 5.7 2.3 0.6 4.2 6.9 7.5 7.9 3.7 2.2 1.9 0.4 0.9 2.3 1.5 0.6 5.6 0.1 0.6 0.9 3.6 6.4 20.6 3.6 0.6 3.6 0.4 5.3 1.0 6.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.0 7.5 5.5 12.3 5.0 6.3 4.4 1.7 13.9 0.5 GPR37 "EDNRBL, hET(B)R-LP, PAELR" ENSG00000170775 "G protein-coupled receptor 37" O15354 7 124745997-124765627 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 62.4" "Cell line enhanced" "Detected in many" "AF22: 9.4;fHDF/TERT166: 21.9;hTCEpi: 9.7;SK-BR-3: 8.5;TIME: 15.3" "Cancer enhanced" "Detected in many" "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042903, HPA068009" Approved Approved "Nuclear membrane,Cytosol" 48000 "Nuclear membrane, Cytosol" "HPA042903: , HPA068009: " "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-2)" "unprognostic (7.29e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavourable (6.00e-5)" "unprognostic (6.19e-2)" "prognostic favourable (7.26e-4)" "unprognostic (6.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.16e-2)" "unprognostic (6.12e-3)" "unprognostic (2.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.71e-4)" 1.6 1.0 14.5 1.1 19.6 0.9 1.7 2.3 52.6 1.5 1.4 62.4 0.0 1.0 2.1 1.4 7.8 2.1 1.4 0.9 23.9 11.3 1.2 8.8 1.3 1.1 33.5 12.3 1.0 3.0 0.8 0.3 10.0 23.3 1.8 1.5 3.5 1.6 1.8 1.1 4.1 1.3 3.0 49.4 4.3 1.2 15.5 26.5 0.0 0.9 0.0 0.9 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 9.4 0.0 0.0 0.0 2.7 0.5 2.5 2.4 0.6 0.4 0.8 0.0 0.0 21.9 0.2 2.7 0.0 0.5 0.4 1.2 0.1 5.9 0.0 2.8 0.0 0.4 0.0 9.7 0.0 0.1 4.5 0.0 4.3 0.0 0.5 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.1 2.2 3.3 0.0 8.5 3.2 2.2 0.0 15.3 2.0 0.7 0.0 0.0 1.3 0.0 0.0 1.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 19.6 2.3 19.6 23.9 11.3 33.5 12.3 23.3 26.5 GPR37L1 ETBR-LP-2 ENSG00000170075 "G protein-coupled receptor 37 like 1" O60883 1 202122858-202133592 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 44.0" "Group enriched" "Detected in some" 4 "HaCaT: 2.8;MCF7: 3.2;T-47d: 8.7" "Cancer enriched" "Detected in some" 57 "glioma: 36.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064454 Enhanced "HPA064454: " "unprognostic (2.12e-2)" "unprognostic (1.83e-1)" "unprognostic (2.96e-1)" "unprognostic (1.61e-3)" "unprognostic (4.52e-1)" "unprognostic (8.20e-2)" "unprognostic (2.26e-4)" "unprognostic (5.83e-2)" "unprognostic (3.46e-3)" "unprognostic (2.07e-1)" "unprognostic (1.83e-1)" "unprognostic (3.28e-2)" "unprognostic (4.86e-3)" "unprognostic (1.14e-1)" "unprognostic (4.58e-2)" "unprognostic (1.18e-3)" "unprognostic (3.49e-1)" 1.6 2.0 20.5 1.6 25.2 1.9 1.6 13.2 44.0 2.0 2.4 33.4 0.0 1.9 1.8 1.8 1.7 1.8 1.7 1.6 22.3 12.6 1.5 1.6 1.6 1.5 17.7 22.1 1.7 1.5 1.5 0.4 1.6 23.8 1.7 1.9 0.9 1.9 2.3 1.7 1.8 2.1 1.7 11.1 1.6 1.6 1.9 15.7 0.0 1.8 0.0 1.5 1.6 0.2 0.9 0.9 1.8 0.9 0.6 1.4 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.1 0.0 2.8 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.1 1.2 0.0 8.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.0 0.8 0.7 0.5 0.9 0.7 0.6 0.3 0.2 0.6 0.9 0.7 0.5 1.8 0.6 0.4 0.9 1.4 0.2 20.5 25.2 13.2 39.3 22.3 12.6 17.7 22.1 23.8 15.7 GPR45 "PSP24, PSP24A" ENSG00000135973 "G protein-coupled receptor 45" Q9Y5Y3 2 105241743-105243049 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 5.7" "Group enriched" "Detected in some" 11 "BEWO: 3.1;U-2 OS: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055940 Uncertain "HPA055940: " "unprognostic (3.80e-3)" "unprognostic (5.92e-2)" "unprognostic (2.19e-3)" "unprognostic (4.71e-1)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (6.87e-2)" "unprognostic (2.21e-1)" "unprognostic (1.13e-1)" "unprognostic (3.96e-1)" "unprognostic (1.61e-3)" "unprognostic (1.11e-2)" "unprognostic (3.13e-4)" "unprognostic (2.25e-1)" "unprognostic (2.76e-1)" "unprognostic (1.39e-1)" "unprognostic (3.99e-2)" 0.1 0.1 1.4 0.1 2.3 0.0 0.1 0.0 5.7 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 1.4 3.1 0.1 0.0 0.0 0.3 1.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.1 0.2 0.4 0.4 0.0 0.4 0.2 0.2 1.2 0.3 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 9.6 0.0 0.1 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR52 ENSG00000203737 "G protein-coupled receptor 52" Q9Y2T5 1 174448111-174449198 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "brain: 28.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.0;Daudi: 1.4;Karpas-707: 2.5" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "basal ganglia: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.93e-1)" "unprognostic (1.15e-1)" "unprognostic (8.60e-2)" "unprognostic (2.61e-2)" "unprognostic (3.65e-1)" "unprognostic (2.27e-1)" "unprognostic (4.49e-1)" 0.3 0.3 0.8 0.2 28.0 2.2 0.1 0.2 7.4 0.1 0.2 0.1 0.0 0.1 0.4 0.4 0.2 0.2 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.1 0.9 0.4 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.6 0.2 0.6 0.0 0.2 0.3 0.4 5.0 0.0 0.1 0.0 0.8 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.2 0.0 0.0 0.2 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.5 0.0 0.0 0.4 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.4 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.7 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 28.0 0.2 3.2 0.2 0.7 0.2 0.1 0.0 5.0 GPR55 ENSG00000135898 "G protein-coupled receptor 55" Q9Y2T6 2 230907318-230961066 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.8;intestine: 8.2;lymphoid tissue: 13.2;testis: 7.7" "Cell line enriched" "Detected in some" 5 "Karpas-707: 26.4" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 6 "basal ganglia: 7.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (9.88e-4)" "unprognostic (2.60e-2)" "unprognostic (2.27e-1)" "unprognostic (4.24e-3)" "unprognostic (5.93e-2)" "unprognostic (1.12e-4)" "unprognostic (3.79e-1)" "unprognostic (2.98e-2)" "unprognostic (1.08e-1)" "unprognostic (2.34e-1)" "unprognostic (4.37e-2)" "unprognostic (3.18e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.42e-2)" "unprognostic (4.26e-1)" 0.4 0.1 0.4 6.9 7.8 0.2 0.7 0.1 1.2 0.6 4.8 0.7 0.1 2.1 0.9 0.5 0.8 0.2 1.6 0.1 0.5 0.7 0.9 0.1 0.8 8.8 0.2 0.1 0.1 0.1 0.1 0.5 0.1 0.3 1.2 1.5 0.1 1.9 2.1 0.1 0.6 8.2 0.1 0.3 6.6 0.9 7.7 0.1 7.0 0.4 1.2 13.2 2.2 0.4 3.0 1.9 0.5 0.2 2.2 3.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.6 26.4 0.0 0.0 0.2 0.7 0.5 0.8 0.0 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 4.8 0.0 1.8 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.1 0.0 0.0 0.1 0.3 1.2 1.2 0.9 0.4 3.0 0.5 2.3 0.5 2.2 0.2 1.9 3.1 4.6 0.4 7.8 0.1 1.2 0.5 0.7 0.2 0.1 0.3 0.1 GPR6 ENSG00000146360 "G protein-coupled receptor 6" P46095 6 109978256-109980718 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "brain: 42.5" "Cell line enriched" "Detected in single" 22 "SCLC-21H: 4.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "basal ganglia: 42.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 11 "basal ganglia: 81.5" "unprognostic (1.14e-2)" "unprognostic (1.59e-2)" "unprognostic (7.10e-3)" 0.4 0.5 3.5 0.4 42.5 0.5 0.4 0.0 6.5 0.4 0.4 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.3 1.8 0.4 0.4 0.4 0.4 0.1 0.8 0.4 0.4 0.4 2.2 0.4 0.0 0.4 0.4 0.0 0.5 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.8 0.5 4.6 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 42.5 0.0 4.0 1.3 1.8 0.1 0.8 0.0 4.6 GPR61 BALGR ENSG00000156097 "G protein-coupled receptor 61" Q9BZJ8 1 109539872-109548406 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;pituitary gland: 6.3;retina: 6.3" "Cell line enhanced" "Detected in some" "Karpas-707: 1.1;U-266/70: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.1;naive CD8 T-cell: 1.0" "Group enriched" "Detected in many" 11 "granulocytes: 1.1;T-cells: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007326, HPA026088" Approved "HPA007326: AB_1849308, HPA026088: AB_10602323" "unprognostic (1.70e-1)" "unprognostic (1.61e-1)" "unprognostic (1.91e-1)" "unprognostic (2.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.70e-2)" "unprognostic (7.51e-2)" "unprognostic (3.63e-3)" "unprognostic (2.94e-2)" "unprognostic (4.50e-2)" "unprognostic (1.46e-4)" "unprognostic (3.27e-1)" "unprognostic (4.08e-4)" "unprognostic (1.33e-1)" "unprognostic (1.07e-1)" "unprognostic (6.72e-2)" "unprognostic (3.85e-2)" 0.5 4.0 4.9 0.7 8.2 0.7 0.5 6.4 10.6 0.5 0.6 0.2 0.0 0.8 0.8 0.6 0.7 0.5 0.7 0.9 5.4 3.9 0.6 0.6 0.5 0.8 1.7 8.3 0.6 0.5 0.5 6.3 0.6 4.9 0.6 0.5 6.3 0.7 0.5 2.3 0.8 1.0 0.5 1.2 0.6 0.6 1.7 1.2 0.0 3.6 0.0 0.5 0.7 0.3 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.4 0.2 0.3 0.2 0.2 0.3 0.3 0.0 0.0 0.1 0.6 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.2 0.4 0.5 0.0 2.4 0.4 0.2 0.0 0.3 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.0 0.1 0.0 4.9 8.2 6.4 10.6 5.4 3.9 1.7 8.3 4.9 1.2 GPR62 ENSG00000180929 "G protein-coupled receptor 62" Q9BZJ7 3 51955314-51957504 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 24.2" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 6.4" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (9.56e-3)" "unprognostic (3.32e-3)" "unprognostic (2.21e-1)" "unprognostic (6.38e-2)" "unprognostic (7.98e-2)" "unprognostic (1.66e-2)" "unprognostic (9.02e-2)" "unprognostic (6.49e-2)" "unprognostic (2.03e-2)" "unprognostic (6.17e-2)" "unprognostic (3.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.82e-5)" "unprognostic (3.64e-2)" "unprognostic (2.45e-1)" "unprognostic (1.16e-2)" "unprognostic (1.77e-2)" 1.0 1.3 5.6 0.6 12.5 0.6 0.8 1.4 16.2 0.8 0.7 24.2 0.0 0.7 1.1 1.4 0.8 1.1 1.0 1.3 9.7 5.3 1.2 1.0 0.7 0.7 17.8 5.4 2.1 0.8 1.3 0.4 0.7 10.6 0.9 0.7 0.0 1.1 1.0 1.3 0.8 0.7 0.8 18.6 0.8 1.0 0.8 14.5 0.0 0.9 0.0 0.7 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.2 0.2 0.2 0.0 0.0 0.1 6.4 1.2 1.0 0.0 1.1 0.0 0.0 0.0 0.1 1.0 0.2 0.1 0.6 0.2 0.0 0.4 0.9 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 12.5 1.4 8.5 9.7 5.3 17.8 5.4 10.6 14.5 GPR75 WI-31133 ENSG00000119737 "G protein-coupled receptor 75" O95800 2 53852913-53859989 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in many" "glioma: 4.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.88e-1)" "unprognostic (2.39e-2)" "unprognostic (2.77e-1)" "unprognostic (4.44e-2)" "unprognostic (5.96e-2)" "unprognostic (5.27e-3)" "unprognostic (8.31e-3)" "unprognostic (2.59e-3)" "unprognostic (4.71e-2)" "unprognostic (2.20e-1)" "unprognostic (3.07e-4)" "unprognostic (1.10e-1)" "unprognostic (3.97e-3)" "unprognostic (8.23e-2)" "unprognostic (1.94e-1)" "unprognostic (3.38e-1)" "unprognostic (5.75e-2)" 2.9 3.6 19.6 2.6 20.7 2.9 4.8 16.6 23.0 2.7 1.6 18.9 0.1 1.3 3.5 2.2 2.3 3.3 3.2 1.5 20.1 5.7 1.4 6.0 2.1 2.5 9.0 15.2 4.7 2.7 9.0 7.3 1.5 17.3 3.8 1.9 5.3 3.4 3.4 2.1 2.2 1.8 3.8 10.7 3.3 2.5 2.0 15.6 0.0 4.6 0.0 2.0 2.1 1.5 1.4 1.0 1.4 0.2 0.1 0.8 0.0 2.6 2.9 4.2 3.8 1.5 0.9 5.5 2.2 1.4 2.6 2.4 7.3 1.1 5.5 1.9 3.0 4.0 4.8 4.0 4.1 4.8 3.2 6.5 4.0 4.0 0.9 3.6 4.6 1.9 1.3 6.5 1.2 2.1 3.8 1.6 2.2 2.0 1.7 2.8 5.4 3.3 2.7 3.8 1.0 1.4 4.0 2.4 3.6 1.9 1.5 1.0 1.4 1.2 5.4 4.4 4.4 3.6 6.1 1.3 0.8 1.8 4.1 3.7 3.1 0.0 0.2 0.0 0.5 0.0 0.4 0.7 0.0 0.8 0.2 1.4 0.6 0.1 1.4 0.1 0.0 1.0 0.0 0.0 19.6 20.7 16.6 19.3 20.1 5.7 9.0 15.2 17.3 15.6 GPR75-ASB3 ENSG00000270898 "GPR75-ASB3 readthrough" 2 53670293-53860160 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.4" "Cell line enhanced" "Detected in some" "K-562: 3.9;RH-30: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA003940 Uncertain "HPA003940: AB_1845067" "unprognostic (4.77e-4)" "unprognostic (1.49e-1)" "unprognostic (1.89e-2)" "unprognostic (1.10e-1)" "unprognostic (2.25e-1)" "unprognostic (3.68e-2)" "unprognostic (9.02e-3)" "unprognostic (1.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.34e-1)" "unprognostic (1.37e-2)" "unprognostic (1.53e-3)" "unprognostic (1.07e-2)" "unprognostic (9.17e-2)" "unprognostic (4.42e-2)" "unprognostic (3.47e-1)" "unprognostic (1.91e-1)" 1.3 1.1 12.7 1.1 13.4 1.1 1.3 10.7 12.5 1.7 1.4 12.2 0.0 1.1 1.5 1.1 1.1 1.7 1.1 1.8 13.0 2.2 1.1 1.4 1.2 1.5 5.5 9.7 3.0 1.1 1.1 4.3 1.4 11.1 1.1 1.1 3.0 1.3 1.5 1.1 1.1 1.1 1.1 6.6 3.0 1.4 1.3 10.0 0.0 1.3 0.0 1.1 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.3 0.0 0.0 2.4 0.8 0.0 0.0 0.0 1.8 0.0 0.3 0.6 0.0 1.8 0.0 0.0 0.6 0.7 2.7 2.7 0.0 1.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 3.9 0.3 0.0 1.4 0.0 0.2 0.8 2.7 2.8 3.3 0.9 0.0 0.0 0.0 1.6 0.9 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.0 1.9 1.0 0.1 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 13.4 10.7 12.5 13.0 2.2 5.5 9.7 11.1 10.0 GPR83 GPR72 ENSG00000123901 "G protein-coupled receptor 83" Q9NYM4 11 94377311-94401419 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 20.0;thyroid gland: 9.3" "Cell line enhanced" "Detected in some" "CACO-2: 5.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 61.1" "Low region specificity" "Detected in all" "unprognostic (6.74e-2)" "unprognostic (7.78e-3)" "unprognostic (8.58e-2)" "unprognostic (2.60e-1)" "unprognostic (1.82e-1)" "unprognostic (2.88e-1)" "unprognostic (6.36e-3)" "unprognostic (6.89e-2)" "unprognostic (6.03e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (6.17e-2)" "unprognostic (1.47e-12)" "unprognostic (3.16e-1)" "unprognostic (1.64e-1)" "unprognostic (1.33e-2)" "unprognostic (8.28e-3)" 0.6 2.6 3.3 0.8 6.1 2.0 0.6 20.0 11.7 0.8 0.7 0.9 0.0 0.7 0.8 1.2 0.5 0.8 0.8 1.2 19.8 6.7 1.2 1.2 0.7 1.1 1.0 3.7 0.7 0.7 0.5 0.6 0.5 1.7 0.5 0.6 0.3 0.6 0.6 1.3 1.4 0.8 0.6 1.8 1.1 0.8 1.1 1.0 0.0 9.3 0.0 0.7 0.5 0.3 0.7 0.5 2.6 0.6 1.6 0.6 0.2 0.3 0.4 0.8 1.1 0.0 0.2 0.9 0.7 0.1 0.1 0.2 5.6 1.0 1.1 0.5 0.1 1.2 0.3 0.2 0.1 0.8 0.5 1.2 1.2 0.7 0.0 1.6 2.9 0.1 0.5 0.4 0.2 0.0 1.1 1.3 0.1 0.8 0.4 2.4 1.1 0.7 1.0 0.2 0.8 0.1 0.9 0.7 0.7 0.5 0.8 0.2 0.9 0.1 0.4 0.8 1.3 0.8 0.8 1.2 1.5 0.5 0.5 1.0 1.1 2.6 0.6 0.5 0.5 0.3 0.4 0.4 0.5 0.6 0.2 0.7 0.4 0.4 1.4 1.6 0.6 0.5 0.3 0.2 3.3 6.1 20.0 11.7 19.8 6.7 1.0 3.7 1.7 1.0 GPR85 SREB2 ENSG00000164604 "G protein-coupled receptor 85" P60893 7 113078331-113087778 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 15.0;skeletal muscle: 30.4" "Cell line enriched" "Detected in many" 5 "HEL: 48.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.80e-2)" "unprognostic (1.93e-2)" "unprognostic (6.98e-3)" "unprognostic (3.92e-2)" "unprognostic (2.68e-2)" "unprognostic (2.41e-2)" "unprognostic (9.90e-2)" "unprognostic (1.94e-1)" "unprognostic (6.09e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" "unprognostic (1.68e-1)" "unprognostic (1.34e-5)" "unprognostic (5.89e-3)" "unprognostic (9.99e-2)" "unprognostic (1.69e-1)" "unprognostic (1.23e-2)" 2.1 1.1 8.9 1.2 15.0 1.9 0.9 12.2 11.2 0.7 0.9 2.4 0.0 0.9 1.2 1.1 1.1 1.9 4.4 2.4 11.8 9.2 0.7 4.5 2.5 1.6 10.8 7.7 0.5 1.6 2.0 4.0 5.3 6.2 1.2 0.8 0.9 2.8 0.8 30.4 0.9 1.0 1.2 8.1 3.1 1.0 3.4 4.3 0.0 0.9 0.0 1.0 1.4 0.3 1.3 1.0 3.0 2.1 1.5 1.1 0.5 0.1 0.1 0.3 0.3 1.0 1.5 0.3 1.3 1.9 2.7 3.7 0.1 0.5 0.1 0.3 1.1 0.2 0.2 1.2 5.7 0.2 0.1 48.3 0.5 0.1 0.5 9.0 0.5 1.9 0.2 4.6 0.1 0.1 0.2 0.5 3.0 0.2 0.9 5.7 0.6 0.3 0.2 0.6 0.2 0.0 0.8 1.4 1.1 0.1 0.6 0.4 0.3 2.1 0.3 3.3 0.5 0.9 1.2 1.1 0.1 0.5 3.9 3.5 1.2 3.0 1.2 1.0 1.0 1.4 1.0 0.9 0.8 0.6 0.6 1.3 1.1 1.0 2.1 1.5 2.1 1.0 0.9 0.5 8.9 15.0 12.2 10.8 11.8 9.2 10.8 7.7 6.2 4.3 GPR88 ENSG00000181656 "G protein-coupled receptor 88" Q9GZN0 1 100538137-100542018 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Mental retardation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 62.7" "Group enriched" "Detected in some" 8 "HSkMC: 4.8;SCLC-21H: 5.9" "Cancer enriched" "Detected in some" 9 "liver cancer: 12.0" "Group enriched" "Detected in many" 7 "basal ganglia: 62.7;thalamus: 32.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 11 "basal ganglia: 643.5" "Region enriched" "Detected in some" 35 "basal ganglia: 223.4" HPA007488 Approved "HPA007488: " "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (8.30e-2)" "unprognostic (8.37e-3)" "unprognostic (5.41e-1)" "unprognostic (5.63e-2)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "unprognostic (1.03e-2)" "unprognostic (7.76e-2)" "unprognostic (8.23e-3)" "unprognostic (2.45e-1)" "unprognostic (3.93e-4)" "unprognostic (1.85e-2)" "unprognostic (5.56e-2)" "unprognostic (4.41e-1)" "unprognostic (1.35e-2)" 0.7 0.6 1.2 0.5 62.7 0.2 10.9 0.0 6.8 0.1 0.3 0.8 0.0 0.6 0.2 0.2 0.2 0.1 0.2 0.4 0.9 0.8 0.3 13.1 0.2 0.3 0.7 1.1 3.8 0.1 4.6 0.5 0.2 7.0 0.6 0.5 0.3 0.7 0.1 0.3 0.1 0.5 0.3 0.5 13.7 0.4 0.2 32.8 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 62.7 0.0 6.8 0.9 0.8 0.7 1.1 7.0 32.8 GPRASP1 "GASP, GASP1" ENSG00000198932 "G protein-coupled receptor associated sorting protein 1" Q5JY77 X 102651366-102659083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.0" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 6.7;REH: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.2" "Group enriched" "Detected in many" 5 "B-cells: 1.4;T-cells: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000161, HPA031061" Uncertain Supported Cytosol Cytosol "HPA000161: AB_2247872, HPA031061: " "unprognostic (3.92e-3)" "unprognostic (1.10e-1)" "unprognostic (2.07e-4)" "unprognostic (1.42e-1)" "unprognostic (3.32e-2)" "unprognostic (1.71e-3)" "unprognostic (3.57e-1)" "unprognostic (2.33e-2)" "unprognostic (1.58e-1)" "unprognostic (2.82e-1)" "prognostic favourable (1.77e-5)" "unprognostic (3.34e-1)" "unprognostic (2.48e-1)" "unprognostic (1.93e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (7.38e-4)" "unprognostic (1.23e-2)" 3.5 16.6 19.0 3.7 34.3 2.5 4.0 28.2 37.0 8.9 7.2 4.3 1.6 1.9 18.2 8.1 3.3 8.7 5.5 10.6 19.9 18.3 5.2 1.4 3.8 6.2 7.9 30.3 29.9 3.0 22.4 16.1 2.2 20.6 12.0 3.5 4.0 5.1 13.4 4.0 2.2 4.1 11.7 6.6 6.8 3.5 2.9 5.6 0.9 11.9 0.8 5.4 6.3 6.3 1.4 0.6 0.0 0.0 0.3 5.2 1.0 0.4 0.8 2.6 1.6 2.6 2.6 1.5 2.7 0.2 4.0 6.7 0.3 0.5 0.0 0.6 5.5 0.7 0.8 0.1 5.8 0.0 0.3 0.2 0.7 0.7 2.1 0.3 0.3 3.4 1.0 4.9 0.4 0.4 0.5 0.2 6.3 0.6 5.2 0.2 1.8 0.8 8.0 2.5 0.0 0.4 0.6 2.5 4.1 0.9 0.4 0.7 0.3 1.3 0.7 1.3 1.6 0.8 0.4 0.4 0.6 0.0 0.6 0.4 1.7 0.0 0.0 0.0 1.3 0.0 2.9 0.6 2.4 1.0 0.0 1.4 5.2 4.8 0.0 0.3 0.0 0.6 1.8 1.0 19.0 34.3 28.2 37.0 19.9 18.3 7.9 30.3 20.6 5.6 GPRASP2 "FLJ37327, GASP2" ENSG00000158301 "G protein-coupled receptor associated sorting protein 2" Q96D09 X 102712176-102717733 "Predicted intracellular proteins" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 4.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;NK-cells: 2.1;T-cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017438 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA017438: AB_1849504" "unprognostic (8.74e-3)" "unprognostic (1.99e-1)" "unprognostic (2.47e-2)" "unprognostic (5.14e-3)" "unprognostic (4.60e-2)" "unprognostic (5.06e-2)" "unprognostic (1.12e-1)" "unprognostic (1.89e-2)" "unprognostic (2.99e-1)" "unprognostic (1.06e-1)" "prognostic favourable (5.71e-4)" "unprognostic (1.42e-1)" "prognostic favourable (4.60e-6)" "unprognostic (1.19e-2)" "unprognostic (9.03e-2)" "unprognostic (8.05e-2)" "prognostic unfavourable (6.63e-5)" 3.7 12.2 13.8 1.5 22.6 0.2 6.1 16.9 30.0 7.7 3.7 3.4 1.7 1.3 13.8 7.4 3.3 8.8 4.0 10.9 15.8 22.3 8.1 5.2 3.9 1.2 8.7 22.5 24.8 7.1 13.3 11.5 2.8 18.7 10.2 2.5 3.6 6.6 9.8 5.2 4.4 1.8 8.3 7.2 3.0 2.2 3.6 4.1 0.8 12.0 1.3 1.3 3.6 3.8 0.4 1.6 0.0 0.6 2.1 4.7 1.2 0.4 5.0 13.5 10.4 4.3 5.1 1.0 7.7 6.9 6.6 12.9 1.7 2.3 0.0 2.6 7.9 1.8 16.1 4.1 8.4 0.0 6.2 0.7 1.5 0.4 3.1 1.2 1.0 5.3 4.4 7.3 0.3 4.7 1.9 0.5 7.9 2.3 3.5 0.5 6.7 7.0 4.7 2.2 0.0 4.1 1.8 3.0 9.3 7.7 1.5 1.0 4.3 2.6 4.1 4.7 9.9 9.5 7.3 0.2 0.3 0.0 6.3 0.8 2.6 0.0 0.4 0.0 0.9 0.6 0.8 0.4 1.1 1.3 0.8 0.4 4.7 1.9 0.0 2.1 0.2 1.6 1.6 1.2 13.8 22.6 16.9 30.0 15.8 22.3 8.7 22.5 18.7 4.1 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 108.0" "Cell line enhanced" "Detected in many" "EFO-21: 38.4;HHSteC: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavourable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favourable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 12.6 4.4 45.2 3.2 55.9 1.0 7.3 22.8 108.0 5.4 2.9 95.1 4.9 4.0 7.1 9.3 5.5 12.7 9.2 22.3 47.8 28.7 12.1 2.7 3.9 4.6 63.1 34.9 13.7 12.7 9.5 3.8 9.3 38.6 6.3 2.3 3.8 20.8 11.5 35.1 2.5 3.3 5.1 61.6 2.2 22.7 19.6 63.1 0.0 7.2 2.6 2.7 6.2 3.0 0.0 0.0 0.0 1.5 0.0 6.5 1.3 0.4 12.3 12.3 2.2 12.7 0.8 2.2 0.1 3.1 1.2 0.8 11.3 0.4 0.0 38.4 0.4 0.6 9.0 0.0 0.7 0.0 3.3 0.0 0.0 0.0 26.2 0.0 0.0 1.1 0.0 2.1 0.0 6.0 2.5 0.2 2.8 0.6 0.0 0.0 13.4 5.8 3.5 0.0 0.0 0.4 5.7 9.5 0.8 1.4 0.8 11.0 0.0 0.2 1.1 0.0 1.4 6.0 0.3 0.1 0.0 0.0 0.6 0.1 0.7 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 1.3 45.2 55.9 22.8 40.5 47.8 28.7 63.1 34.9 38.6 63.1 GPRIN1 "GRIN1, KIAA1893" ENSG00000169258 "G protein regulated inducer of neurite outgrowth 1" Q7Z2K8 5 176595802-176610133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 28.2" "Cell line enhanced" "Detected in many" "HDLM-2: 27.3;SCLC-21H: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036478, HPA070892" Enhanced Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA036478: , HPA070892: " "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.41e-2)" "unprognostic (5.66e-2)" "unprognostic (6.54e-3)" "unprognostic (3.06e-1)" "unprognostic (4.76e-6)" "prognostic unfavourable (6.83e-6)" "unprognostic (1.11e-1)" "unprognostic (1.45e-1)" "unprognostic (2.59e-3)" "unprognostic (1.56e-3)" "prognostic unfavourable (2.79e-7)" "unprognostic (4.24e-3)" "unprognostic (5.60e-2)" "unprognostic (2.21e-1)" "unprognostic (3.32e-3)" 1.3 3.2 16.9 1.8 6.4 0.9 0.9 16.9 28.2 1.1 1.6 0.2 0.0 6.4 1.3 0.6 1.1 0.7 1.1 0.7 11.1 11.1 0.7 0.7 1.1 1.7 3.6 11.4 0.5 1.5 0.7 5.8 1.0 4.4 0.7 1.3 0.7 0.7 0.6 0.7 1.5 4.0 1.7 1.9 0.9 1.9 2.2 0.7 0.0 0.8 0.0 2.3 0.9 0.1 0.9 0.0 0.0 0.0 0.5 0.3 0.0 3.6 3.9 4.9 7.1 1.1 2.4 4.2 4.9 2.5 3.8 4.9 4.7 2.4 8.3 10.0 2.6 3.2 3.1 3.4 3.3 27.3 2.1 0.1 2.1 1.6 0.4 0.2 2.1 1.1 2.6 4.1 0.6 2.7 4.3 12.1 3.1 9.5 0.8 0.0 5.0 7.7 15.4 5.5 4.9 4.3 3.8 30.3 17.4 5.6 1.6 8.5 3.7 3.1 3.3 7.1 8.2 2.7 7.1 0.2 1.0 2.3 6.1 0.4 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.9 6.4 16.9 14.3 11.1 11.1 3.6 11.4 4.4 0.7 GPRIN3 "FLJ42625, GRIN3" ENSG00000185477 "GPRIN family member 3" Q6ZVF9 4 89236386-89308010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.0" "Cell line enhanced" "Detected in some" "Karpas-707: 46.0;RPMI-8226: 11.8;SCLC-21H: 12.3;U-266/70: 7.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 41.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "basal ganglia: 53.1" "HPA043148, HPA057666, HPA059092" Enhanced Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA043148: , HPA057666: , HPA059092: " "unprognostic (9.05e-2)" "unprognostic (4.92e-2)" "prognostic favourable (7.22e-5)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.07e-3)" "unprognostic (3.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.34e-3)" "unprognostic (3.13e-1)" "prognostic favourable (8.33e-4)" "unprognostic (1.91e-1)" "unprognostic (5.35e-2)" "unprognostic (3.93e-1)" "unprognostic (7.82e-4)" 7.0 1.8 4.0 11.5 9.1 8.9 3.2 41.0 5.0 3.5 7.2 2.8 0.0 8.4 2.3 1.7 1.8 2.1 5.6 5.4 3.6 4.1 5.5 2.8 11.2 12.7 4.1 3.1 4.8 7.0 1.1 12.4 1.4 6.5 2.1 9.8 6.4 2.9 1.0 2.1 1.6 7.0 2.0 6.0 12.9 4.7 1.1 6.2 5.3 2.9 1.4 10.5 4.5 2.4 0.3 1.5 0.1 2.2 2.9 6.6 1.4 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 11.8 0.1 0.0 12.3 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.1 5.5 0.0 0.2 0.0 0.0 0.1 0.5 0.0 4.8 1.7 6.6 0.3 4.7 3.7 1.5 0.1 1.9 1.9 0.1 2.9 2.2 0.0 5.3 1.4 4.0 9.1 41.0 5.0 3.6 4.1 4.1 3.1 6.5 6.2 GRAMD1B "KIAA1201, LINC01059" ENSG00000023171 "GRAM domain containing 1B" Q3KR37 11 123358428-123627774 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.7;brain: 55.2;intestine: 21.7" "Group enriched" "Detected in many" 4 "A549: 21.8;HDLM-2: 57.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008557 Approved Approved "Nucleoplasm,Nucleoli,Intermediate filaments" Nucleoli "Nucleoplasm, Intermediate filaments" "HPA008557: AB_1079197" "unprognostic (1.86e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.74e-3)" "unprognostic (8.15e-2)" "unprognostic (4.28e-2)" "unprognostic (2.69e-3)" "unprognostic (4.12e-3)" "unprognostic (1.40e-1)" "unprognostic (2.90e-2)" "unprognostic (9.60e-2)" "unprognostic (8.06e-2)" "prognostic unfavourable (4.30e-7)" "unprognostic (1.39e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" 1.4 67.7 15.5 3.1 16.0 11.8 1.1 55.2 25.0 1.2 3.1 5.1 5.9 21.7 1.2 6.6 0.9 2.9 8.1 4.3 13.6 7.5 10.4 1.3 1.9 3.6 6.8 15.1 7.6 2.0 0.6 6.7 5.0 14.4 1.1 1.2 11.9 1.3 2.5 1.8 0.8 15.6 1.3 4.1 2.7 7.8 10.6 5.1 3.4 3.7 0.0 2.7 1.5 0.8 0.1 11.5 0.6 2.0 2.6 2.7 0.7 0.0 21.8 1.2 0.0 0.1 0.2 3.6 7.2 5.2 1.6 0.6 0.9 0.1 1.3 3.8 3.6 0.0 2.3 0.0 1.7 57.6 2.0 0.0 9.8 0.2 0.0 7.5 0.0 0.4 0.0 2.8 0.0 0.6 0.0 0.0 1.3 0.1 1.2 2.5 2.8 8.2 3.9 3.5 2.3 0.1 0.0 7.2 5.9 1.7 0.1 0.0 0.2 4.2 4.3 8.7 1.4 1.5 0.3 0.0 0.0 0.0 1.8 7.9 0.4 0.0 2.0 0.6 0.7 1.0 0.4 0.0 2.7 2.1 3.0 0.1 0.3 0.3 0.2 2.6 1.0 11.5 1.1 0.7 15.5 16.0 55.2 25.0 13.6 7.5 6.8 15.1 14.4 5.1 GRIA1 "GluA1, GLUR1, GLURA" ENSG00000155511 "Glutamate ionotropic receptor AMPA type subunit 1" P42261 5 153489615-153813869 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 52.6" "Cell line enhanced" "Detected in some" "AF22: 13.4;ASC diff: 4.1;BJ: 6.4;LHCN-M2: 9.4;U-266/70: 6.8" "Cancer enriched" "Detected in some" 15 "glioma: 9.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001965, HPA035202" Enhanced "CAB001965: , HPA035202: " "unprognostic (2.51e-1)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (4.20e-2)" "unprognostic (6.95e-2)" "unprognostic (2.43e-1)" "unprognostic (2.61e-1)" "unprognostic (1.18e-2)" "unprognostic (2.04e-1)" "unprognostic (2.35e-2)" "unprognostic (5.14e-4)" "unprognostic (7.97e-2)" "unprognostic (2.96e-2)" "unprognostic (1.01e-1)" "unprognostic (1.70e-1)" "unprognostic (2.80e-1)" "unprognostic (7.61e-2)" 1.8 1.6 44.9 1.2 23.1 1.0 1.5 23.6 52.6 1.4 1.2 3.7 0.0 1.3 1.2 2.0 1.2 1.2 1.1 2.0 50.4 13.4 1.1 1.1 9.5 1.0 4.8 20.0 1.3 1.4 1.2 0.5 1.1 4.6 1.1 1.2 0.7 1.1 1.7 1.1 1.1 1.3 2.3 2.3 1.1 1.2 2.1 5.2 0.0 1.1 0.0 1.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 4.1 2.8 0.0 6.4 3.3 0.4 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 9.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 23.1 23.6 24.3 50.4 13.4 4.8 20.0 4.6 5.2 GRIA2 "GluA2, GLUR2, GLURB" ENSG00000120251 "Glutamate ionotropic receptor AMPA type subunit 2" P42262 4 157204182-157366075 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.9" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 19.4" "Group enriched" "Detected in some" 10 "breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008441 Enhanced "HPA008441: AB_1078983" "unprognostic (1.36e-1)" "unprognostic (9.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (3.87e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-3)" "unprognostic (7.40e-2)" "unprognostic (2.91e-5)" "unprognostic (2.42e-1)" "unprognostic (1.31e-1)" "unprognostic (1.82e-1)" "unprognostic (6.55e-2)" 1.2 6.5 36.9 1.3 39.1 1.1 2.0 22.1 95.9 8.2 1.3 5.6 0.0 1.2 13.5 9.8 1.2 9.6 1.2 1.2 30.1 15.7 1.5 1.1 1.4 1.2 10.0 30.6 1.7 2.2 1.2 10.5 1.2 7.1 1.8 1.2 0.1 2.1 3.0 1.2 1.1 1.2 6.1 6.9 1.3 1.5 2.1 8.8 0.0 1.2 0.0 1.2 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.4 2.7 0.0 0.0 0.0 0.9 0.0 0.0 1.1 0.1 0.0 0.0 0.6 0.0 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 39.1 22.1 41.2 30.1 15.7 10.0 30.6 7.1 8.8 GRIA3 "GluA3, GLUR3, GLURC, MRX94" ENSG00000125675 "Glutamate ionotropic receptor AMPA type subunit 3" P42263 X 123184153-123490915 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.8" "Cell line enhanced" "Detected in some" "BJ: 14.1;BJ hTERT+: 20.4;fHDF/TERT166: 26.9;U-2197: 9.0" "Cancer enriched" "Detected in some" 11 "glioma: 10.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058659, HPA073344" Enhanced "Intracellular and membrane" "HPA058659: , HPA073344: " "unprognostic (2.14e-2)" "unprognostic (6.00e-2)" "unprognostic (2.02e-2)" "unprognostic (2.94e-3)" "unprognostic (5.09e-2)" "unprognostic (4.29e-4)" "unprognostic (2.42e-1)" "unprognostic (6.74e-2)" "unprognostic (1.44e-1)" "unprognostic (2.36e-1)" "unprognostic (1.65e-3)" "unprognostic (1.31e-1)" "unprognostic (3.78e-3)" "unprognostic (8.05e-3)" "unprognostic (6.40e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" 1.5 10.7 31.4 1.0 27.4 0.7 2.3 3.5 40.8 9.1 1.3 3.7 0.1 0.9 3.0 4.9 1.1 2.0 1.9 2.7 26.1 8.1 3.4 9.3 1.0 1.1 10.2 21.2 5.6 2.6 0.6 0.6 1.1 4.9 2.1 1.5 0.7 0.9 3.0 0.9 1.2 1.0 2.9 8.4 0.7 3.0 1.4 7.8 0.0 0.8 0.0 1.5 1.3 1.8 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 14.1 20.4 0.2 0.5 0.0 0.0 0.0 0.0 26.9 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 9.0 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 27.4 3.5 27.5 26.1 8.1 10.2 21.2 4.9 7.8 GRIA4 "GluA4, GLUR4, GLURD" ENSG00000152578 "Glutamate ionotropic receptor AMPA type subunit 4" P48058 11 105609994-105982092 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 55.4" "Cell line enhanced" "Detected in some" "AF22: 15.5;NTERA-2: 5.1;RPMI-8226: 3.0;SCLC-21H: 5.6" "Group enriched" "Detected in some" 18 "glioma: 5.9;renal cancer: 1.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "unprognostic (4.09e-4)" "unprognostic (4.45e-3)" "unprognostic (1.92e-3)" "unprognostic (4.14e-4)" "unprognostic (1.40e-2)" "unprognostic (3.73e-4)" "unprognostic (1.62e-1)" "unprognostic (3.89e-1)" "unprognostic (2.04e-1)" "unprognostic (1.53e-1)" "unprognostic (1.70e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (3.35e-2)" "unprognostic (1.28e-1)" 1.1 7.4 11.4 1.5 13.1 0.9 4.5 55.4 52.9 2.6 1.8 8.1 0.0 0.9 1.5 2.9 1.0 2.2 1.2 0.9 9.3 16.0 1.4 0.9 1.0 1.6 12.1 17.4 1.3 1.6 0.9 2.2 1.3 24.8 1.2 2.0 2.8 4.1 1.5 1.0 1.5 4.5 1.0 11.5 0.9 6.6 1.1 6.9 0.0 1.0 0.0 1.3 1.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.1 0.2 0.0 0.0 3.0 0.0 0.0 5.6 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.1 55.4 23.3 9.3 16.0 12.1 17.4 24.8 6.9 GRID1 "GluD1, KIAA1220" ENSG00000182771 "Glutamate ionotropic receptor delta type subunit 1" Q9ULK0 10 85599555-86366493 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.9" "Cell line enhanced" "Detected in some" "Daudi: 6.2;HEL: 6.1;SH-SY5Y: 2.4" "Group enriched" "Detected in many" 5 "glioma: 3.6;thyroid cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "basophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (7.60e-2)" "unprognostic (2.75e-2)" "unprognostic (5.92e-2)" "unprognostic (4.31e-2)" "unprognostic (4.24e-1)" "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (4.21e-2)" "unprognostic (5.09e-2)" "unprognostic (1.49e-3)" "unprognostic (8.30e-2)" "unprognostic (8.26e-2)" "unprognostic (4.58e-9)" "unprognostic (3.15e-3)" "unprognostic (5.91e-2)" "unprognostic (2.21e-1)" "unprognostic (8.65e-3)" 2.5 4.2 8.8 1.0 13.0 0.8 1.6 3.1 15.7 4.5 1.4 20.9 0.0 1.7 2.6 3.4 1.3 4.8 1.6 1.3 8.8 6.9 1.0 1.3 2.1 1.7 19.6 8.7 1.4 1.2 1.1 0.9 3.1 9.9 2.1 1.3 1.0 1.1 4.4 1.4 2.1 1.7 2.4 6.4 0.9 1.2 2.8 14.2 0.0 7.0 0.0 1.5 1.2 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.8 6.2 0.2 0.0 0.0 0.8 0.0 0.0 0.3 1.4 6.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.8 13.0 3.1 14.3 8.8 6.9 19.6 8.7 9.9 14.2 GRID2 "GluD2, GluR-delta-2" ENSG00000152208 "Glutamate ionotropic receptor delta type subunit 2" O43424 4 92303622-93810157 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 45.1;testis: 38.2" "Group enriched" "Detected in some" 4 "U-2 OS: 12.6;U-266/70: 5.6" "Cancer enriched" "Detected in single" 7 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 130.6" "HPA056253, HPA058538" Enhanced "HPA056253: , HPA058538: " "unprognostic (2.78e-1)" "unprognostic (1.29e-4)" "unprognostic (7.23e-3)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (3.50e-2)" "unprognostic (3.34e-1)" "unprognostic (6.92e-2)" "unprognostic (7.96e-3)" "unprognostic (4.36e-2)" "unprognostic (9.31e-2)" "unprognostic (7.38e-3)" 0.6 3.5 8.0 0.6 13.6 0.6 0.6 45.1 7.0 1.1 0.7 2.8 0.0 0.8 0.7 0.9 0.6 0.9 0.6 0.7 6.2 3.4 0.8 0.6 0.7 0.6 7.6 6.4 3.7 0.6 0.6 0.3 0.6 7.2 0.6 0.7 0.6 0.6 0.9 0.6 0.6 0.8 0.6 9.0 0.7 0.6 38.2 7.9 0.0 0.7 0.0 0.6 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 5.6 0.0 0.6 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 13.6 45.1 7.0 6.2 3.4 7.6 6.4 7.2 7.9 GRID2IP ENSG00000215045 "Grid2 interacting protein" A4D2P6 7 6497462-6551436 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 23.6" "Cell line enriched" "Detected in some" 4 "REH: 8.7" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 23.6" "Cell type enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebellum: 25.2;thalamus: 7.9" "Group enriched" "Detected in many" 5 "cerebellum: 14.3;midbrain: 10.0;pons and medulla: 9.7;thalamus: 14.7" HPA045381 Approved "Plasma membrane" "Plasma membrane" "HPA045381: AB_10962495" "unprognostic (1.77e-1)" "unprognostic (2.64e-1)" "unprognostic (3.39e-4)" "unprognostic (1.19e-3)" "unprognostic (5.52e-2)" "unprognostic (2.50e-2)" "unprognostic (2.82e-1)" "unprognostic (2.37e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-3)" "unprognostic (1.64e-1)" "unprognostic (3.40e-2)" "unprognostic (3.38e-2)" "unprognostic (5.54e-2)" "unprognostic (8.08e-2)" "unprognostic (1.87e-1)" "unprognostic (3.17e-1)" 0.2 1.7 0.8 0.6 3.6 1.1 1.1 23.6 6.6 0.6 1.4 6.5 0.0 1.8 0.4 0.1 1.2 1.1 0.6 0.3 1.6 1.6 0.7 0.3 1.2 0.5 0.7 1.2 0.9 1.8 3.9 3.0 0.2 5.5 2.3 0.7 0.3 2.1 1.6 0.2 3.4 1.6 0.0 1.5 1.4 2.2 1.2 6.8 2.5 1.6 0.0 0.6 0.9 0.8 0.7 0.2 0.0 0.2 1.1 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.7 0.0 0.2 0.0 8.7 0.3 0.2 0.1 0.3 0.1 1.1 0.0 0.8 0.0 2.0 0.2 0.1 0.0 0.9 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.6 0.4 0.0 0.0 1.1 0.2 0.2 0.0 0.1 0.8 3.6 23.6 6.6 1.6 1.6 0.7 1.2 5.5 6.8 GRIK1 "GluK1, GLUR5" ENSG00000171189 "Glutamate ionotropic receptor kainate type subunit 1" P39086 21 29536933-29940033 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 23.7;brain: 44.2;retina: 12.0" "Cell line enhanced" "Detected in some" "Daudi: 4.4" "Group enriched" "Detected in some" 7 "glioma: 4.5;prostate cancer: 0.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014623 Uncertain "HPA014623: AB_1850305" "unprognostic (1.39e-1)" "unprognostic (6.54e-2)" "unprognostic (1.32e-1)" "unprognostic (1.04e-2)" "unprognostic (1.03e-3)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (2.12e-3)" "unprognostic (1.25e-1)" "unprognostic (8.77e-2)" "unprognostic (4.89e-3)" "unprognostic (1.20e-3)" "unprognostic (1.47e-8)" "unprognostic (2.09e-1)" "unprognostic (2.68e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-3)" 0.8 23.7 9.8 0.9 10.2 0.7 4.1 6.6 18.3 1.2 1.2 2.9 0.0 0.7 0.7 4.3 1.2 0.7 0.8 0.6 10.0 13.4 0.6 0.8 0.8 0.9 7.1 7.6 1.1 0.6 0.6 0.3 1.3 44.2 5.3 1.5 12.0 0.7 0.8 0.8 2.1 1.3 0.8 2.6 0.8 0.7 1.4 2.7 0.0 0.7 0.0 0.6 1.0 0.6 0.4 0.3 1.6 1.1 0.2 0.4 0.0 0.2 0.4 0.8 0.3 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.7 4.4 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.4 1.3 1.0 0.2 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.0 0.0 0.4 1.0 1.0 0.3 0.2 1.1 0.3 0.0 0.4 0.1 0.3 0.1 1.0 0.1 0.5 1.0 0.4 0.6 0.9 0.2 0.2 0.5 0.9 0.2 0.7 0.7 1.7 0.0 1.1 0.6 0.1 0.8 0.0 0.2 0.1 0.0 0.3 0.4 0.3 0.1 1.6 0.2 0.5 0.1 0.4 0.0 9.8 10.2 6.6 18.3 10.0 13.4 7.1 7.6 44.2 2.7 GRIK2 "GluK2, GLUR6, MRT6" ENSG00000164418 "Glutamate ionotropic receptor kainate type subunit 2" Q13002 6 101398788-102070083 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6" "Cell line enhanced" "Detected in some" "BJ: 11.4;BJ hTERT+: 19.0;fHDF/TERT166: 14.2;SiHa: 7.7;WM-115: 17.4" "Cancer enhanced" "Detected in some" "glioma: 3.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014395, HPA014623, CAB022463" Approved "Intracellular and membrane" "CAB022463: , HPA014395: AB_1850303, HPA014623: AB_1850305" "unprognostic (1.43e-3)" "unprognostic (1.26e-2)" "unprognostic (3.99e-2)" "unprognostic (3.20e-1)" "unprognostic (1.92e-1)" "unprognostic (3.48e-2)" "unprognostic (2.57e-1)" "unprognostic (4.32e-2)" "unprognostic (8.46e-2)" "unprognostic (9.19e-2)" "unprognostic (4.01e-2)" "unprognostic (1.36e-1)" "unprognostic (1.34e-5)" "unprognostic (1.94e-3)" "unprognostic (7.78e-2)" "unprognostic (1.09e-2)" "unprognostic (8.68e-4)" 0.8 3.9 16.1 1.1 22.5 1.0 0.8 40.6 22.8 3.1 1.2 1.6 0.0 1.4 1.2 2.5 1.2 0.9 1.5 7.6 9.1 11.4 1.9 0.6 0.7 0.6 4.1 17.0 1.1 5.2 0.5 13.0 4.3 8.5 2.1 1.2 0.4 2.0 2.6 1.8 3.8 1.5 0.9 2.7 1.1 0.8 1.8 5.3 0.0 6.3 0.0 0.4 1.1 0.9 1.4 1.2 2.7 0.7 1.2 0.9 0.4 0.0 0.1 2.4 0.2 2.6 0.1 0.0 11.4 19.0 0.6 0.4 0.0 0.2 0.1 0.0 14.2 3.9 7.4 0.0 0.2 0.0 0.0 1.2 6.5 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.3 4.2 0.0 0.0 0.1 2.1 0.1 0.0 0.3 0.0 0.5 0.0 2.5 5.0 7.7 0.0 0.4 0.0 0.7 0.0 1.6 0.3 0.1 0.9 0.0 0.0 0.0 1.1 0.0 17.4 2.5 0.7 0.7 0.6 0.7 0.4 0.7 0.6 0.4 0.2 1.4 0.8 0.9 2.7 1.2 0.7 1.2 0.3 0.4 16.1 22.5 40.6 21.9 9.1 11.4 4.1 17.0 8.5 5.3 GRIK3 "GluK3, GLUR7" ENSG00000163873 "Glutamate ionotropic receptor kainate type subunit 3" Q13003 1 36795527-37034129 "Plasma proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;pituitary gland: 13.1" "Cell line enriched" "Detected in some" 4 "T-47d: 29.1" "Cancer enhanced" "Detected in some" "glioma: 13.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (4.20e-2)" "unprognostic (1.90e-1)" "unprognostic (7.66e-2)" "unprognostic (9.26e-3)" "unprognostic (2.87e-1)" "unprognostic (1.60e-1)" "unprognostic (1.45e-1)" "unprognostic (2.60e-3)" "unprognostic (9.06e-2)" "unprognostic (1.04e-1)" "unprognostic (3.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.28e-2)" "unprognostic (3.53e-3)" "unprognostic (2.06e-1)" "unprognostic (9.37e-2)" "unprognostic (2.08e-2)" 1.7 4.6 5.4 1.8 9.4 0.6 5.4 5.7 24.7 2.1 8.4 3.3 1.5 2.1 0.8 4.5 3.1 1.2 2.2 1.9 3.8 9.6 0.8 0.7 0.9 0.9 9.1 10.4 1.3 1.6 1.5 13.1 0.6 13.1 1.9 3.3 9.0 2.2 5.8 0.7 1.1 2.9 1.8 3.6 1.0 2.1 2.0 2.7 0.0 1.0 0.2 1.4 1.1 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 9.4 5.7 14.2 3.8 9.6 9.1 10.4 13.1 2.7 GRIK4 "GluK4, GRIK, KA1" ENSG00000149403 "Glutamate ionotropic receptor kainate type subunit 4" Q16099 11 120511700-120988904 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.3;ovary: 8.5" "Group enriched" "Detected in some" 4 "HDLM-2: 6.2;HEL: 19.2;T-47d: 5.0" "Cancer enriched" "Detected in some" 5 "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074453 Enhanced "HPA074453: " "unprognostic (9.63e-2)" "unprognostic (4.96e-2)" "unprognostic (1.58e-1)" "unprognostic (2.49e-1)" "unprognostic (2.37e-1)" "unprognostic (6.64e-4)" "unprognostic (1.48e-2)" "unprognostic (7.26e-2)" "unprognostic (3.16e-1)" "unprognostic (2.38e-1)" "unprognostic (4.53e-2)" "unprognostic (2.50e-1)" "unprognostic (4.84e-11)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (4.47e-3)" "unprognostic (2.58e-2)" 1.0 5.4 11.3 1.0 9.0 0.8 1.3 3.9 19.3 1.2 1.1 9.4 0.0 1.2 1.1 0.9 1.2 1.7 1.1 1.6 13.9 7.2 1.0 0.8 3.1 1.0 8.7 11.0 8.5 0.8 0.8 2.6 1.5 12.3 1.5 1.1 0.0 1.1 1.0 1.0 1.3 1.2 1.0 6.3 1.4 0.9 2.0 8.2 0.0 6.3 0.0 1.0 1.2 0.4 0.0 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 6.2 0.6 19.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 5.0 0.0 0.2 0.0 0.2 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 11.3 9.0 3.9 14.0 13.9 7.2 8.7 11.0 12.3 8.2 GRIK5 "GluK5, GRIK2, KA2" ENSG00000105737 "Glutamate ionotropic receptor kainate type subunit 5" Q16478 19 41998321-42069498 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Cell line enhanced" "Detected in some" "HEL: 9.1;NTERA-2: 9.0;REH: 24.8;SCLC-21H: 7.1;SH-SY5Y: 15.8" "Cancer enhanced" "Detected in many" "glioma: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "eosinophil: 1.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074001 Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA074001: " "unprognostic (4.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.30e-3)" "unprognostic (6.68e-3)" "unprognostic (4.28e-2)" "unprognostic (3.86e-1)" "unprognostic (5.82e-1)" "unprognostic (2.23e-1)" "unprognostic (3.89e-2)" "unprognostic (1.73e-2)" "prognostic favourable (7.23e-4)" "unprognostic (8.43e-2)" "prognostic unfavourable (9.32e-4)" "unprognostic (6.47e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-2)" "unprognostic (6.12e-2)" 1.7 5.4 9.6 2.3 12.2 3.4 2.4 17.2 23.9 2.7 6.9 4.9 1.3 1.2 3.8 2.7 2.4 4.5 2.6 5.6 21.7 8.9 3.8 0.3 0.6 2.6 5.0 5.3 5.3 3.5 17.8 9.1 0.3 5.5 4.5 1.6 5.8 0.7 8.9 1.0 1.1 1.4 6.7 7.6 1.8 2.7 13.6 3.5 1.0 10.3 0.3 1.0 2.2 2.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.2 9.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 9.0 0.0 24.8 0.0 0.1 4.1 0.0 7.1 15.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 12.2 17.2 12.7 21.7 8.9 5.0 5.3 5.5 3.5 GRIN1 "GluN1, NMDAR1" ENSG00000176884 "Glutamate ionotropic receptor NMDA type subunit 1" Q05586 9 137138390-137168762 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 38 "brain: 97.5" "Cell line enhanced" "Detected in some" "REH: 3.0;RPMI-8226: 4.3;SCLC-21H: 9.8;SH-SY5Y: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067773 Enhanced "HPA067773: " "unprognostic (3.58e-2)" "unprognostic (4.51e-1)" "unprognostic (2.68e-2)" "unprognostic (5.48e-4)" "unprognostic (5.20e-2)" "unprognostic (1.25e-1)" "unprognostic (2.34e-2)" "unprognostic (2.81e-2)" "unprognostic (6.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.21e-3)" "unprognostic (4.47e-2)" "unprognostic (1.44e-1)" "unprognostic (3.56e-3)" "unprognostic (4.72e-2)" 1.7 2.0 23.6 2.0 47.5 1.7 1.8 28.1 97.5 1.8 2.0 3.2 0.0 2.2 1.7 1.8 1.7 1.7 1.7 1.7 29.1 26.4 1.8 1.7 1.8 1.8 15.4 37.9 1.7 1.8 1.8 0.0 1.7 22.0 2.2 1.8 0.7 2.5 1.8 1.7 1.8 2.2 1.8 4.7 1.8 1.8 1.9 6.3 0.0 1.7 0.0 1.8 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.4 1.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 1.5 0.1 0.0 0.2 0.2 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.9 0.0 0.0 0.1 0.0 3.0 0.0 4.3 0.0 0.0 9.8 6.8 0.1 0.5 0.0 2.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 23.6 47.5 28.1 87.9 29.1 26.4 15.4 37.9 22.0 6.3 GRIN2A "GluN2A, NMDAR2A" ENSG00000183454 "Glutamate ionotropic receptor NMDA type subunit 2A" Q12879 16 9753404-10182754 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 25.2" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 7.7;RPMI-8226: 2.9;U-138 MG: 8.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB022725 Enhanced "CAB022725: " "unprognostic (6.43e-2)" "unprognostic (2.47e-1)" "unprognostic (5.97e-2)" "unprognostic (3.21e-2)" "unprognostic (3.13e-2)" "unprognostic (1.59e-2)" "unprognostic (1.62e-1)" "unprognostic (2.10e-1)" "unprognostic (2.08e-1)" "unprognostic (5.39e-2)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "unprognostic (3.75e-3)" "unprognostic (4.79e-3)" "unprognostic (2.05e-1)" "unprognostic (3.92e-3)" "unprognostic (3.33e-2)" 0.9 1.0 5.4 0.5 5.9 0.4 0.6 8.5 25.2 0.6 0.7 1.5 0.0 0.9 0.8 4.5 2.1 4.1 0.5 4.0 8.0 1.9 0.9 0.4 1.0 0.5 1.7 10.3 0.5 0.6 0.4 0.3 0.4 1.4 0.5 0.7 1.4 0.7 1.0 0.5 1.2 0.7 0.9 1.2 0.4 1.1 5.2 0.8 0.0 0.8 0.0 0.7 0.6 0.5 0.6 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 1.8 0.5 1.4 0.0 0.1 0.0 0.0 7.7 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.8 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 5.4 5.9 8.5 17.9 8.0 1.9 1.7 10.3 1.4 0.8 GRIN2B "GluN2B, NMDAR2B" ENSG00000273079 "Glutamate ionotropic receptor NMDA type subunit 2B" Q13224 12 13437942-13981957 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "brain: 36.5" "Cell line enhanced" "Detected in some" "A549: 1.4;AF22: 3.3;CACO-2: 3.8;Daudi: 1.5;NTERA-2: 4.8;RPTEC TERT1: 4.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 19.5;basal ganglia: 26.0;cerebral cortex: 36.5;hippocampal formation: 19.6;olfactory region: 15.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA069762 Approved "HPA069762: " "unprognostic (2.01e-2)" "unprognostic (4.07e-2)" "unprognostic (7.89e-2)" "unprognostic (3.77e-3)" "unprognostic (3.39e-3)" "unprognostic (9.36e-2)" "unprognostic (5.92e-2)" "unprognostic (1.77e-2)" "unprognostic (6.85e-2)" "unprognostic (2.24e-1)" "unprognostic (4.68e-2)" "unprognostic (4.12e-2)" "unprognostic (4.48e-5)" "unprognostic (2.43e-1)" "unprognostic (8.76e-2)" "unprognostic (1.63e-1)" "unprognostic (2.37e-1)" 1.9 0.9 19.5 0.8 26.0 0.8 0.9 0.9 36.5 0.8 1.9 1.9 0.0 0.8 0.8 0.8 0.9 0.8 0.8 0.8 19.6 3.5 1.0 1.6 0.8 1.4 1.8 15.0 0.9 0.8 0.8 0.4 0.9 2.6 0.8 1.2 0.0 0.8 0.8 0.8 0.8 1.8 0.8 0.8 0.9 1.0 1.5 3.6 0.0 0.8 0.0 1.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 26.0 0.9 36.5 19.6 3.5 1.8 15.0 2.6 3.6 GRIN2C "GluN2C, NMDAR2C" ENSG00000161509 "Glutamate ionotropic receptor NMDA type subunit 2C" Q14957 17 74842023-74861504 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 43.6;heart muscle: 13.2;salivary gland: 14.2;thyroid gland: 12.4" "Cell line enhanced" "Detected in some" "BEWO: 11.1;RPMI-8226: 3.9;SCLC-21H: 5.0" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.3" "Region enriched" "Detected in many" 5 "cerebellum: 43.6" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 13 "cerebellum: 65.6" "unprognostic (7.21e-3)" "unprognostic (4.68e-2)" "unprognostic (9.38e-3)" "unprognostic (2.24e-5)" "unprognostic (3.42e-1)" "unprognostic (1.53e-2)" "unprognostic (1.84e-1)" "unprognostic (1.82e-2)" "unprognostic (1.78e-1)" "unprognostic (2.95e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-3)" "unprognostic (4.20e-2)" "unprognostic (1.49e-1)" "unprognostic (1.51e-2)" "unprognostic (1.14e-1)" 1.0 1.4 7.8 0.5 9.1 1.0 0.5 43.6 8.9 0.5 0.5 2.4 0.0 0.5 0.5 0.5 0.4 0.6 0.6 13.2 4.5 1.4 0.3 0.2 0.3 0.3 3.2 4.5 0.4 0.2 0.5 0.0 2.7 4.2 0.3 0.4 0.3 14.2 0.5 0.6 0.4 0.6 0.5 1.0 0.4 0.3 2.7 0.9 0.0 12.4 0.0 0.3 0.4 0.0 0.2 1.3 0.3 0.1 0.2 0.7 0.0 0.0 0.4 0.4 0.1 0.1 0.0 11.1 0.0 0.0 0.0 0.0 1.3 0.2 0.5 0.1 0.0 0.4 0.1 0.0 0.0 1.0 0.3 0.2 0.2 0.3 0.0 0.8 0.9 0.0 0.0 0.3 0.0 0.0 0.4 0.3 0.0 1.7 0.1 0.1 0.1 0.1 0.3 0.9 3.9 0.0 0.3 5.0 0.3 2.1 0.2 0.8 0.7 0.1 0.2 0.4 2.0 0.4 0.1 1.1 0.1 0.2 0.4 0.6 0.2 0.1 0.1 0.3 0.7 0.1 0.1 0.0 0.1 0.3 0.1 0.2 0.3 0.2 0.3 0.2 0.0 1.3 0.2 0.0 7.8 9.1 43.6 6.3 4.5 1.4 3.2 4.5 4.2 0.9 GRIN2D "EB11, GluN2D, NMDAR2D, NR2D" ENSG00000105464 "Glutamate ionotropic receptor NMDA type subunit 2D" O15399 19 48394875-48444931 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.9" "Cell line enhanced" "Detected in many" "A549: 12.7;EFO-21: 8.8;HMC-1: 21.6;NB-4: 12.7;SK-BR-3: 11.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "classical monocyte: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009006 Approved "CAB009006: AB_2279191" "unprognostic (9.96e-2)" "unprognostic (6.98e-2)" "unprognostic (1.17e-1)" "unprognostic (5.08e-3)" "unprognostic (1.46e-1)" "unprognostic (4.17e-1)" "unprognostic (1.43e-4)" "unprognostic (7.84e-2)" "unprognostic (2.72e-1)" "unprognostic (2.23e-3)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (6.66e-13)" "unprognostic (2.15e-2)" "unprognostic (1.92e-2)" "unprognostic (1.26e-3)" "unprognostic (1.14e-1)" 0.5 0.1 4.1 1.1 1.7 0.1 0.1 2.0 5.0 0.1 0.6 1.8 0.0 0.1 0.0 0.2 1.1 0.3 2.4 6.9 0.0 0.0 0.4 0.3 3.1 0.0 0.0 1.4 0.0 3.2 0.8 0.0 0.5 0.1 0.1 1.0 2.8 0.4 1.1 0.4 0.7 1.6 1.0 0.1 0.5 0.1 0.0 0.8 0.0 1.2 0.0 0.0 0.0 1.0 12.7 0.3 0.0 1.0 2.7 7.5 1.5 0.0 0.4 0.1 0.9 7.4 0.3 8.8 0.8 0.1 0.1 0.1 0.2 1.3 0.3 3.8 0.2 1.6 1.4 0.3 21.6 1.0 0.0 0.7 0.0 0.3 7.1 0.4 0.0 2.2 0.0 12.7 0.4 0.2 0.0 0.0 0.1 0.2 0.0 1.3 1.2 0.5 11.3 0.1 0.0 4.8 4.2 0.0 0.1 0.0 0.0 2.0 2.3 0.0 0.0 1.4 0.1 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 GRIN3A GluN3A ENSG00000198785 "Glutamate ionotropic receptor NMDA type subunit 3A" Q8TCU5 9 101569353-101738580 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 17.3" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 6.3" "Cancer enriched" "Detected in single" 7 "prostate cancer: 3.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "intermediate monocyte: 3.3;non-classical monocyte: 2.5" "Lineage enriched" "Detected in single" 7 "monocytes: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.29e-1)" "unprognostic (7.10e-3)" "unprognostic (3.01e-5)" "unprognostic (3.39e-2)" "unprognostic (6.32e-2)" "unprognostic (7.06e-4)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (7.56e-2)" "unprognostic (7.34e-3)" "unprognostic (1.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (1.42e-1)" "unprognostic (4.87e-1)" "unprognostic (9.41e-2)" 0.6 0.6 7.4 0.8 4.2 0.5 0.7 0.4 17.3 4.1 1.0 2.6 0.0 0.6 1.0 1.0 0.5 0.6 0.5 1.2 6.8 6.4 0.6 0.6 0.7 1.1 3.8 12.4 2.4 0.5 0.4 0.4 0.4 4.6 1.8 0.8 2.7 0.6 2.6 0.7 1.0 0.7 0.7 3.0 1.8 0.6 1.0 2.3 0.0 0.5 0.0 0.8 0.5 0.6 0.0 0.4 0.1 3.3 0.0 0.4 0.2 0.0 0.2 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.2 0.0 0.2 0.5 0.0 0.0 0.6 0.1 0.0 0.1 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.3 0.7 0.5 0.3 0.4 0.1 0.0 0.3 6.3 0.6 0.2 0.2 0.2 0.2 0.3 0.3 0.4 0.1 0.7 0.2 0.6 1.0 0.3 0.7 0.3 1.2 0.0 0.6 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 2.5 0.0 0.4 0.2 7.4 4.2 0.4 13.4 6.8 6.4 3.8 12.4 4.6 2.3 GRM1 "GPRC1A, mGlu1, MGLUR1, PPP1R85" ENSG00000152822 "Glutamate metabotropic receptor 1" Q13255 6 146027646-146437598 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 39.9" "Cell line enhanced" "Detected in some" "AF22: 1.6;HeLa: 1.4;Karpas-707: 1.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 39.9" "Cell type enriched" "Detected in single" 4 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015701 Approved Supported Approved Vesicles Vesicles "HPA015701: AB_1853917" "unprognostic (1.04e-2)" "unprognostic (7.33e-2)" "unprognostic (3.73e-3)" "unprognostic (9.77e-3)" "unprognostic (6.75e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-2)" "unprognostic (4.31e-2)" "unprognostic (2.93e-2)" "unprognostic (9.48e-3)" "unprognostic (7.92e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (3.50e-2)" "unprognostic (8.33e-3)" "unprognostic (9.76e-2)" 0.5 0.5 6.6 0.4 6.0 0.4 0.5 39.9 13.0 0.5 0.5 0.9 0.0 0.4 0.5 0.7 0.5 0.7 0.5 7.7 6.0 2.7 2.7 0.5 0.6 0.5 2.6 4.1 0.5 0.5 0.4 0.2 0.5 3.6 0.5 0.4 2.6 0.5 0.8 0.4 0.5 0.5 0.5 1.0 0.6 0.5 1.3 0.9 0.0 0.8 0.0 0.4 0.5 0.1 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.1 1.6 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.4 1.4 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 1.5 0.1 0.0 0.0 0.4 0.2 0.8 0.0 0.0 0.0 0.1 0.0 1.1 0.6 0.1 0.1 0.5 0.0 0.5 0.1 0.1 0.1 0.7 0.2 0.2 0.1 0.1 0.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 6.6 6.0 39.9 10.5 6.0 2.7 2.6 4.1 3.6 0.9 GRM2 "GPRC1B, mGlu2, MGLUR2" ENSG00000164082 "Glutamate metabotropic receptor 2" Q14416 3 51707070-51718613 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 13.2" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 11.7" "Cancer enhanced" "Detected in single" "testis cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027868, HPA065166" Approved Supported "HPA027868: , HPA065166: " "unprognostic (1.01e-1)" "unprognostic (8.61e-4)" "unprognostic (7.66e-2)" "unprognostic (7.29e-3)" "unprognostic (1.98e-1)" "unprognostic (3.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.27e-1)" "unprognostic (1.39e-2)" "unprognostic (2.05e-1)" "unprognostic (4.45e-1)" "unprognostic (1.74e-1)" "unprognostic (1.37e-2)" "unprognostic (1.35e-1)" "unprognostic (1.82e-1)" "unprognostic (2.93e-2)" "unprognostic (1.19e-2)" 0.8 0.6 4.6 0.8 6.3 1.6 0.7 3.8 13.2 0.6 0.6 0.4 0.0 0.6 0.8 0.4 0.5 0.5 0.4 0.9 3.0 3.1 0.5 0.5 0.6 0.7 1.2 7.0 0.5 0.4 0.4 0.4 0.6 8.3 0.7 0.5 0.6 0.8 0.6 1.8 1.3 0.5 0.6 0.5 1.1 0.5 1.3 0.2 0.0 0.5 0.0 0.5 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 6.3 3.8 13.2 3.0 3.1 1.2 7.0 8.3 0.2 GRM3 "GPRC1C, mGlu3, MGLUR3" ENSG00000198822 "Glutamate metabotropic receptor 3" Q14832 7 86643914-86864884 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 24 "brain: 53.3" "Cell line enriched" "Detected in some" 6 "AF22: 28.0" "Cancer enriched" "Detected in single" 7 "glioma: 2.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (2.05e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-1)" "unprognostic (2.70e-3)" "unprognostic (3.16e-1)" "unprognostic (1.07e-3)" "unprognostic (6.99e-3)" "unprognostic (2.98e-1)" "unprognostic (2.71e-1)" "unprognostic (9.13e-3)" "unprognostic (1.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.91e-3)" "unprognostic (4.00e-2)" "unprognostic (9.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.12e-2)" 1.2 2.2 10.6 1.2 22.5 1.2 1.2 4.6 53.3 1.3 1.3 23.9 0.0 1.3 1.3 1.2 1.2 1.2 1.3 1.3 12.6 5.6 1.4 1.2 1.3 1.2 18.9 13.0 1.2 1.2 1.2 0.2 1.2 11.5 1.7 1.2 0.0 1.3 1.3 2.1 1.2 1.2 1.2 12.0 1.8 1.3 2.2 22.1 0.0 1.2 0.0 1.2 1.4 0.1 0.5 0.1 0.5 0.0 0.1 0.3 0.1 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 10.6 22.5 4.6 20.2 12.6 5.6 18.9 13.0 11.5 22.1 GRM4 "GPRC1D, mGlu4, MGLUR4" ENSG00000124493 "Glutamate metabotropic receptor 4" Q14833 6 34018645-34155622 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "brain: 101.6" "Group enriched" "Detected in some" 8 "BEWO: 6.4;SCLC-21H: 25.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Region enriched" "Detected in many" 21 "cerebellum: 101.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in all" "cerebellum: 83.5" "Region enriched" "Detected in many" 4 "cerebellum: 252.6" CAB022096 Enhanced "CAB022096: " "unprognostic (1.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (7.00e-2)" "unprognostic (4.03e-2)" "unprognostic (8.36e-2)" "unprognostic (9.05e-3)" "unprognostic (3.56e-1)" "unprognostic (9.45e-2)" "unprognostic (2.08e-2)" "unprognostic (6.21e-3)" "unprognostic (2.44e-1)" "unprognostic (2.15e-11)" "unprognostic (5.32e-2)" "unprognostic (9.16e-2)" "unprognostic (6.57e-2)" "unprognostic (3.07e-1)" 0.2 0.1 0.4 0.3 4.9 0.2 0.2 101.6 7.2 0.6 0.1 0.3 0.1 0.5 0.5 0.1 0.1 0.3 0.1 0.1 0.5 0.9 0.2 0.3 0.3 0.2 0.3 0.4 0.2 3.5 0.1 0.0 0.3 4.3 0.3 0.2 0.1 0.1 0.2 0.3 0.6 0.8 0.7 1.1 0.1 0.2 1.6 0.5 0.0 0.3 0.0 0.7 0.4 0.0 0.2 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 25.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.9 101.6 1.0 0.5 0.9 0.3 0.4 4.3 0.5 GRM5 "GPRC1E, mGlu5, MGLUR5, PPP1R86" ENSG00000168959 "Glutamate metabotropic receptor 5" P41594 11 88504576-89065945 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 27.7" "Cell line enhanced" "Detected in some" "Hep G2: 2.2;U-266/70: 1.5;U-937: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (1.94e-1)" "unprognostic (9.62e-2)" "unprognostic (9.57e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (2.62e-1)" "unprognostic (1.26e-1)" "unprognostic (7.16e-2)" "unprognostic (8.15e-4)" "unprognostic (3.43e-2)" 0.5 0.5 11.4 0.5 11.0 0.6 0.5 2.6 27.7 0.6 0.5 1.0 0.0 0.5 0.5 0.5 0.5 0.7 0.7 0.5 6.0 3.2 0.7 0.5 0.7 0.5 2.1 10.0 0.5 0.5 0.5 0.8 0.6 1.5 0.5 0.5 0.0 0.5 0.5 0.6 1.1 0.5 0.5 1.2 0.6 0.5 3.1 1.5 0.0 0.5 0.0 0.5 0.5 0.2 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.7 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.2 0.0 0.0 1.5 0.0 0.2 0.1 1.1 0.8 1.6 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.4 11.0 2.6 13.2 6.0 3.2 2.1 10.0 1.5 1.5 GRM7 "GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87" ENSG00000196277 "Glutamate metabotropic receptor 7" Q14831 3 6770001-7741533 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.8;parathyroid gland: 11.3" "Cell line enriched" "Detected in single" 11 "SH-SY5Y: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015964 Uncertain Cytosol Cytosol "HPA015964: " "unprognostic (2.04e-2)" "unprognostic (7.03e-3)" "unprognostic (1.43e-1)" "unprognostic (9.37e-2)" "unprognostic (8.48e-3)" "unprognostic (2.58e-1)" "unprognostic (7.30e-2)" "unprognostic (3.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.46e-2)" "unprognostic (2.54e-1)" "unprognostic (6.84e-6)" "unprognostic (1.45e-1)" "unprognostic (2.82e-2)" "unprognostic (5.43e-2)" "unprognostic (2.59e-2)" 0.9 5.3 8.1 0.6 10.5 0.6 0.9 1.6 15.8 2.9 0.8 2.1 0.0 0.9 3.1 0.5 0.6 1.0 0.7 0.6 11.1 9.3 0.5 0.7 0.8 0.5 2.3 10.1 0.8 0.7 11.3 0.6 0.9 4.3 1.2 0.8 0.8 2.1 1.4 0.5 0.6 0.6 5.9 2.8 0.8 0.6 2.8 4.1 0.0 0.7 0.0 0.7 1.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 10.5 1.6 15.8 11.1 9.3 2.3 10.1 4.3 4.1 GRM8 "GLUR8, GPRC1H, mGlu8, MGLUR8" ENSG00000179603 "Glutamate metabotropic receptor 8" O00222 7 126438598-127253294 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.5;liver: 8.0" "Cell line enhanced" "Detected in some" "HAP1: 5.4;HEK 293: 2.8;NTERA-2: 7.1;RH-30: 4.2;SCLC-21H: 6.4;SH-SY5Y: 3.4" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051481 Uncertain "HPA051481: " "unprognostic (4.57e-3)" "unprognostic (5.10e-4)" "unprognostic (1.21e-1)" "unprognostic (2.09e-2)" "unprognostic (1.83e-1)" "unprognostic (5.54e-2)" "unprognostic (2.06e-4)" "unprognostic (1.79e-1)" "unprognostic (8.90e-2)" "unprognostic (1.31e-2)" "unprognostic (1.68e-1)" "unprognostic (1.69e-1)" "unprognostic (3.12e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (1.32e-2)" "unprognostic (1.12e-2)" 0.2 1.5 2.0 2.0 4.6 0.1 0.2 1.1 6.4 0.3 4.5 4.0 0.0 0.3 0.3 0.3 0.2 0.5 3.5 5.5 2.6 4.0 1.9 8.0 0.7 0.2 2.9 2.6 2.3 1.4 0.2 0.7 0.2 14.5 0.4 5.0 3.5 0.2 0.2 0.1 0.3 0.2 0.5 1.2 0.2 0.8 3.8 1.5 0.0 2.4 0.0 0.3 1.4 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.2 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 7.1 0.1 0.0 4.2 0.1 0.2 0.0 6.4 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.7 2.3 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.6 1.1 5.4 2.6 4.0 2.9 2.6 14.5 1.5 GSG1L "KTSR5831, MGC18079, PRO19651" ENSG00000169181 "GSG1 like" Q6UXU4 16 27787535-28063509 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 14.6;heart muscle: 19.3" "Group enriched" "Detected in some" 7 "HMC-1: 13.3;THP-1: 4.9" "Cancer enriched" "Detected in some" 7 "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014479 Enhanced "HPA014479: AB_2247974" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (2.38e-1)" "unprognostic (7.06e-4)" "unprognostic (2.30e-1)" "unprognostic (1.10e-1)" "unprognostic (2.05e-2)" "unprognostic (6.68e-2)" "unprognostic (5.02e-2)" "unprognostic (1.25e-1)" "unprognostic (2.50e-1)" "unprognostic (6.66e-2)" "unprognostic (1.55e-1)" "unprognostic (3.13e-1)" "unprognostic (6.35e-2)" "unprognostic (9.77e-2)" 0.7 0.8 8.7 0.6 14.6 0.7 0.6 1.8 13.3 0.8 1.1 2.7 0.0 1.1 1.1 1.0 0.6 3.4 0.5 19.3 6.0 6.8 1.1 1.1 0.9 0.6 10.0 3.3 0.4 0.7 0.4 0.2 2.0 6.5 0.8 0.7 1.2 0.8 0.6 1.0 1.8 1.2 0.5 3.5 0.9 2.5 2.2 3.3 0.0 1.0 0.0 0.5 0.5 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.3 0.0 0.3 0.2 0.2 0.2 0.3 0.3 0.1 0.0 0.0 13.3 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.5 0.8 0.1 0.3 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.1 0.6 0.1 4.9 1.2 0.0 0.8 0.0 0.2 1.0 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 8.7 14.6 1.8 10.7 6.0 6.8 10.0 3.3 6.5 3.3 GSG1L2 ENSG00000214978 "GSG1 like 2" A8MUP6 17 9802386-9822071 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 36 "brain: 4.8;retina: 3.3;testis: 2.6" "Cell line enhanced" "Detected in single" "HeLa: 2.7" "Cancer enriched" "Detected in single" 95 "renal cancer: 4.7" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.7;olfactory region: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 4.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 1.7 0.3 0.0 0.0 2.6 0.0 0.0 GSX1 "Gsh-1, GSH1" ENSG00000169840 "GS homeobox 1" Q9H4S2 13 27792643-27794768 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "brain: 7.1" "Cell line enhanced" "Detected in some" "AF22: 1.0;THP-1: 1.5" "Cancer enriched" "Detected in single" 29 "glioma: 3.9" "Region enhanced" "Detected in many" "hypothalamus: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "unprognostic (1.62e-1)" 0.1 0.1 1.6 0.1 3.2 0.1 0.1 0.9 4.0 0.1 0.1 2.5 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.7 7.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.9 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.9 1.5 0.7 7.1 0.2 0.0 0.1 0.0 GSX2 Gsh2 ENSG00000180613 "GS homeobox 2" Q9BZM3 4 54099523-54102505 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.8;retina: 16.7" "Group enriched" "Detected in some" 5 "HAP1: 3.0;RPTEC TERT1: 1.8" "Cancer enriched" "Detected in single" 15 "glioma: 2.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.3" "Low region specificity" "Detected in many" "unprognostic (4.48e-2)" "unprognostic (1.05e-1)" "unprognostic (7.01e-2)" "unprognostic (1.89e-1)" 0.0 0.0 3.3 0.4 4.8 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.7 0.1 0.0 0.0 0.4 1.0 0.8 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 16.7 0.0 0.0 0.0 1.7 0.3 0.0 0.7 0.2 0.1 2.2 0.5 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.3 4.8 0.0 0.9 0.7 0.7 1.0 0.8 0.5 0.5 GYG2 GN-2 ENSG00000056998 "Glycogenin 2" O15488 X 2828788-2882820 "Enzymes, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 76.7;brain: 21.2;breast: 30.4" "Cell line enhanced" "Detected in many" "AF22: 17.7;BEWO: 12.8;CACO-2: 13.1;Hep G2: 14.2;NTERA-2: 17.4;SK-MEL-30: 37.7" "Cancer enhanced" "Detected in all" "melanoma: 42.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005495, HPA064686" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA005495: AB_1079035, HPA064686: " "unprognostic (4.45e-2)" "unprognostic (4.21e-2)" "unprognostic (6.41e-3)" "unprognostic (8.50e-2)" "unprognostic (2.07e-3)" "unprognostic (5.16e-1)" "unprognostic (1.74e-2)" "unprognostic (1.18e-1)" "unprognostic (7.43e-3)" "unprognostic (6.74e-2)" "prognostic favourable (3.01e-5)" "unprognostic (9.76e-2)" "unprognostic (6.10e-5)" "unprognostic (1.78e-1)" "unprognostic (5.05e-3)" "unprognostic (5.41e-2)" "unprognostic (6.60e-2)" 76.7 1.4 4.6 1.3 4.6 0.5 30.4 2.1 3.7 2.1 3.5 8.2 0.7 1.2 4.2 0.9 1.0 3.6 1.7 1.7 3.9 2.9 1.4 9.9 0.7 0.7 5.5 2.9 1.9 3.2 0.4 0.5 1.6 12.9 2.7 2.0 4.2 2.8 4.4 0.5 1.2 1.3 2.8 21.2 0.5 2.2 0.8 5.1 0.0 1.3 0.5 0.6 2.9 1.4 1.0 0.6 0.6 0.4 1.2 0.7 0.0 0.0 5.4 17.7 0.0 10.6 0.0 12.8 0.5 3.1 3.1 3.9 13.1 0.3 0.0 1.4 2.2 0.0 10.0 0.2 3.0 0.1 2.8 0.0 0.2 14.2 3.1 0.0 4.3 3.8 0.1 0.3 0.0 0.0 0.1 0.0 3.2 0.8 0.0 0.4 17.4 0.1 2.9 5.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 37.7 1.7 10.7 0.0 0.0 3.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.7 0.5 0.4 0.3 0.1 1.0 0.3 0.2 0.6 1.2 0.4 0.6 0.4 0.0 4.6 4.6 2.1 3.7 3.9 2.9 5.5 2.9 12.9 5.1 H3.Y ENSG00000269466 "Histone cluster 2, H3c pseudogene" 5 17654870-17655847 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 1.4;epididymis: 1.3;testis: 1.0" "Cell line enriched" "Detected in single" 14 "U-2 OS: 6.1" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA042570 Uncertain "HPA042570: " "unprognostic (1.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 HABP4 "IHABP4, SERBP1L" ENSG00000130956 "Hyaluronan binding protein 4" Q5JVS0 9 96450201-96491336 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.1;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055969 Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA055969: " "unprognostic (1.67e-1)" "unprognostic (7.99e-2)" "unprognostic (2.12e-3)" "unprognostic (2.40e-1)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.36e-2)" "unprognostic (3.63e-2)" "unprognostic (3.49e-1)" "unprognostic (2.42e-2)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "prognostic favourable (1.10e-7)" "unprognostic (2.25e-1)" "unprognostic (1.40e-1)" "unprognostic (4.93e-2)" "unprognostic (3.62e-2)" 13.2 11.9 31.2 6.1 44.8 1.7 6.5 14.1 40.6 7.9 5.5 12.4 1.5 3.0 8.2 6.8 7.2 5.3 8.1 19.1 26.1 24.9 23.5 5.7 6.1 6.8 27.1 20.5 11.7 4.8 13.8 7.4 3.4 31.6 8.3 4.2 8.4 4.1 10.6 9.4 6.1 3.3 10.6 19.4 5.0 5.0 21.8 13.0 0.4 11.2 2.2 4.9 7.6 6.5 4.1 0.1 0.3 0.8 1.0 4.0 0.7 7.4 8.5 10.8 11.6 24.1 20.6 7.7 10.1 11.3 7.6 8.4 12.7 12.5 3.8 5.0 15.1 5.5 9.0 1.9 6.2 4.6 5.4 1.5 4.0 21.1 12.2 0.3 1.6 8.3 3.5 8.7 6.9 5.4 1.7 11.3 13.7 7.6 0.1 2.3 5.0 8.3 3.9 9.5 0.1 13.0 3.3 6.9 4.7 5.4 3.3 16.1 2.3 1.6 9.2 10.6 2.4 19.3 8.5 7.1 7.0 1.6 8.4 3.0 15.5 0.0 0.1 0.0 1.4 0.3 1.4 4.1 4.0 3.2 0.0 1.7 2.8 2.8 0.3 1.0 0.8 0.1 3.0 0.7 31.2 44.8 14.1 33.8 26.1 24.9 27.1 20.5 31.6 13.0 HAGHL MGC2605 ENSG00000103253 "Hydroxyacylglutathione hydrolase like" Q6PII5 16 726936-735525 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.7" "Cell line enhanced" "Detected in many" "RPMI-8226: 29.4;U-266/70: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074402 Approved "HPA074402: " "unprognostic (6.74e-2)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.49e-1)" "unprognostic (4.56e-2)" "unprognostic (5.62e-3)" "unprognostic (9.52e-2)" "unprognostic (2.16e-1)" "unprognostic (1.83e-2)" "unprognostic (6.37e-2)" "unprognostic (1.77e-1)" "prognostic favourable (1.18e-5)" "unprognostic (1.92e-2)" "unprognostic (5.36e-1)" "unprognostic (3.41e-2)" "unprognostic (2.41e-1)" 2.7 8.7 10.0 6.2 19.7 4.5 1.2 13.0 15.5 1.7 2.1 9.4 2.5 2.9 3.7 2.7 1.1 7.9 2.6 5.3 10.6 10.9 4.9 1.4 4.0 8.3 15.9 6.7 1.4 2.4 5.8 8.1 2.3 10.7 2.6 0.9 4.5 9.6 4.0 1.3 2.7 4.5 1.1 13.9 8.4 5.8 3.5 9.1 2.9 0.9 1.6 3.8 1.8 1.0 13.1 3.7 1.3 1.5 8.5 7.2 3.1 2.1 2.3 0.5 3.0 0.5 1.1 2.3 1.9 1.3 0.4 0.5 1.0 3.0 4.8 2.9 0.1 2.9 0.5 0.7 0.0 14.0 2.0 1.5 5.3 1.8 3.6 6.0 4.5 2.1 0.7 0.0 1.0 0.3 2.8 4.3 0.6 14.4 0.1 8.4 3.3 5.0 3.1 1.4 29.4 1.2 0.7 11.1 6.6 1.0 8.6 9.1 5.4 10.5 1.9 2.3 3.6 0.8 1.2 31.5 4.0 6.6 3.7 6.0 4.2 0.0 1.5 1.3 6.2 0.5 7.2 13.1 4.1 6.8 1.9 3.5 1.2 4.6 0.0 8.5 0.2 3.7 4.7 3.1 10.0 19.7 13.0 14.1 10.6 10.9 15.9 6.7 10.7 9.1 HAP1 "HAP2, hHLP1, HIP5, HLP" ENSG00000173805 "Huntingtin associated protein 1" P54257 17 41717742-41734644 "Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;stomach 1: 23.3" "Cell line enriched" "Detected in some" 7 "REH: 45.1" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA076992 Enhanced Supported Nucleoli,Cytosol Cytosol Nucleoli "HPA076992: " "unprognostic (2.84e-3)" "unprognostic (3.74e-3)" "unprognostic (2.42e-2)" "unprognostic (2.30e-1)" "unprognostic (7.53e-2)" "unprognostic (4.90e-2)" "unprognostic (1.64e-1)" "unprognostic (1.32e-1)" "unprognostic (6.11e-2)" "unprognostic (8.76e-2)" "prognostic favourable (4.26e-4)" "unprognostic (1.38e-1)" "unprognostic (2.46e-2)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-2)" "unprognostic (9.29e-2)" 0.7 3.2 11.7 1.1 16.2 0.8 2.0 5.6 13.1 4.8 1.3 3.8 2.2 5.2 4.6 3.5 0.9 2.8 3.1 0.6 10.1 30.5 1.1 1.2 1.4 0.9 6.6 6.6 1.0 2.2 0.5 6.8 3.1 15.5 1.6 1.4 0.4 3.4 3.0 1.0 1.6 2.5 1.7 8.3 3.3 23.3 3.4 2.2 0.0 7.2 0.0 1.0 0.9 1.2 1.2 0.8 2.6 0.6 1.5 1.0 0.1 0.1 1.5 0.7 1.5 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.9 0.1 0.1 0.5 0.1 6.2 3.2 0.2 0.0 0.0 1.6 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.8 0.4 45.1 0.0 1.7 0.3 0.5 0.2 0.0 0.3 0.2 0.0 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.6 0.6 0.5 0.6 0.3 0.4 0.5 0.5 0.6 0.2 1.2 0.8 1.0 2.6 1.5 0.6 0.8 0.8 0.1 11.7 16.2 5.6 9.3 10.1 30.5 6.6 6.6 15.5 2.2 HAPLN2 BRAL1 ENSG00000132702 "Hyaluronan and proteoglycan link protein 2" Q9GZV7 1 156619294-156625725 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 39 "brain: 108.1" "Cell line enhanced" "Detected in some" "SH-SY5Y: 1.1;U-266/70: 4.5;U-87 MG: 1.3" "Cancer enriched" "Detected in some" 10 "glioma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045765 Enhanced "Secreted in brain" "HPA045765: AB_10964781" "unprognostic (3.19e-3)" "unprognostic (1.06e-1)" "unprognostic (1.02e-2)" "unprognostic (3.41e-1)" "unprognostic (1.88e-1)" "unprognostic (2.44e-1)" "unprognostic (1.92e-1)" "unprognostic (2.04e-3)" "unprognostic (1.31e-1)" "unprognostic (8.25e-2)" "unprognostic (5.54e-3)" "unprognostic (2.72e-2)" "unprognostic (2.70e-2)" "unprognostic (1.08e-1)" "unprognostic (2.25e-1)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 1.5 1.5 11.0 1.3 21.1 1.3 1.3 4.4 45.3 1.3 1.3 43.6 0.0 2.7 1.6 1.3 1.3 1.4 1.3 1.3 21.2 13.9 1.4 1.3 1.4 1.3 49.3 9.3 1.3 1.3 1.6 0.0 1.3 43.1 1.9 1.3 0.0 1.4 1.5 1.9 1.6 1.7 1.3 108.1 1.3 1.3 1.7 31.5 0.0 1.3 0.0 1.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 4.5 0.1 0.2 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 21.1 4.4 15.1 21.2 13.9 49.3 9.3 43.1 31.5 HAPLN4 "BRAL2, KIAA1926" ENSG00000187664 "Hyaluronan and proteoglycan link protein 4" Q86UW8 19 19255641-19262796 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 38.5;intestine: 24.3" "Cell line enhanced" "Detected in some" "NB-4: 5.6;NTERA-2: 14.6;SCLC-21H: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055856 Enhanced "Secreted in brain" "HPA055856: " "unprognostic (3.36e-4)" 0.5 1.9 3.0 0.4 7.5 0.4 0.7 8.9 38.5 2.4 0.6 1.6 0.0 19.6 1.6 0.5 0.4 0.7 0.6 0.5 8.9 9.4 0.5 7.5 0.6 0.4 7.8 2.7 1.4 1.3 0.4 0.2 0.7 26.4 1.1 0.6 0.4 0.5 0.8 0.4 0.4 24.3 0.6 3.8 0.4 0.8 0.5 0.0 0.0 0.4 0.0 0.4 0.5 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 5.6 14.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 7.5 8.9 38.5 8.9 9.4 7.8 2.7 26.4 0.0 HBE1 HBE ENSG00000213931 "Hemoglobin subunit epsilon 1" P02100 11 5268345-5505652 "Plasma proteins, Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.7;liver: 6.7" "Cell line enriched" "Detected in some" 15 "K-562: 461.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043234 Approved "HPA043234: " "unprognostic (7.59e-2)" "unprognostic (6.70e-2)" "unprognostic (3.76e-2)" "unprognostic (4.25e-1)" "unprognostic (1.64e-1)" "unprognostic (9.03e-2)" "unprognostic (2.28e-1)" "unprognostic (1.26e-1)" "unprognostic (7.32e-2)" "unprognostic (1.02e-3)" "unprognostic (2.14e-1)" "unprognostic (5.80e-2)" "unprognostic (7.34e-2)" 1.8 1.1 1.1 0.4 1.0 1.3 0.9 1.0 1.9 0.7 0.4 0.4 0.4 0.1 0.6 2.0 0.4 1.0 0.6 0.4 1.4 0.8 0.9 6.7 0.6 0.4 7.7 5.1 1.9 0.5 0.1 0.6 3.6 3.2 1.1 0.3 0.4 0.7 0.6 1.5 0.6 0.4 1.2 0.5 1.0 0.4 2.2 0.4 1.6 0.6 0.4 0.4 0.4 0.7 0.0 0.0 2.1 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 461.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.7 1.1 1.0 1.0 1.9 1.4 0.8 7.7 5.1 3.2 0.4 HBQ1 HBQ ENSG00000086506 "Hemoglobin subunit theta 1" P09105 16 180453-181181 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 8.0;bone marrow: 29.4;brain: 12.2;vagina: 10.7" "Group enriched" "Detected in some" 7 "HEL: 13.1;Hep G2: 9.1;K-562: 32.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 6 "granulocytes: 2.5;T-cells: 2.3" "Low region specificity" "Detected in all" HPA062473 Enhanced Approved "Lipid droplets" 47000 "Lipid droplets" "HPA062473: " "unprognostic (4.24e-1)" "unprognostic (3.38e-1)" "unprognostic (2.11e-2)" "unprognostic (2.20e-2)" "unprognostic (1.30e-1)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.75e-2)" "unprognostic (2.33e-1)" "unprognostic (8.92e-2)" "unprognostic (2.02e-3)" "unprognostic (8.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.02e-1)" "unprognostic (5.55e-1)" 0.5 0.6 12.2 0.5 10.0 29.4 0.5 0.6 6.3 0.5 0.5 0.2 0.0 0.6 0.5 0.5 0.5 0.5 0.5 0.9 5.6 4.0 0.5 0.5 2.1 0.5 2.2 3.7 0.6 0.5 0.5 0.5 2.6 2.4 0.6 0.5 0.0 0.8 0.5 0.9 0.5 0.5 0.5 0.7 2.8 0.5 1.3 0.3 0.0 0.5 0.0 0.5 0.6 10.7 0.4 0.2 2.5 0.0 0.0 2.3 8.0 0.0 0.7 0.2 2.4 0.0 0.0 0.4 0.1 0.0 0.0 0.1 2.2 0.0 0.0 0.3 0.0 0.1 0.9 0.0 0.0 0.0 0.0 13.1 0.5 9.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 32.4 0.0 0.0 0.1 1.4 0.0 1.8 0.1 0.1 0.0 0.2 0.4 0.0 0.3 1.8 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 2.3 0.4 0.7 1.6 0.1 0.0 0.5 1.2 2.5 0.0 0.0 0.2 0.0 8.0 12.2 10.0 0.6 6.3 5.6 4.0 2.2 3.7 2.4 0.3 HCN1 "BCNG-1, BCNG1, HAC-2" ENSG00000164588 "Hyperpolarization activated cyclic nucleotide gated potassium channel 1" O60741 5 45254950-45696498 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.4;retina: 16.1" "Cell line enhanced" "Detected in some" "NTERA-2: 1.6;WM-115: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019195 Enhanced "HPA019195: " "unprognostic (1.30e-1)" "unprognostic (3.62e-1)" "unprognostic (1.64e-1)" "unprognostic (9.24e-3)" "unprognostic (6.82e-2)" "unprognostic (1.10e-1)" "unprognostic (9.63e-3)" "unprognostic (4.11e-3)" "unprognostic (6.78e-2)" "unprognostic (1.16e-2)" "unprognostic (7.42e-2)" "unprognostic (3.68e-3)" 1.0 2.8 6.0 1.0 13.0 1.3 1.2 9.8 26.4 0.9 1.0 0.5 0.0 0.9 1.1 0.9 1.1 1.0 1.0 4.6 8.1 4.5 0.9 1.0 1.0 1.0 2.6 11.1 1.1 1.7 0.9 4.0 0.9 9.2 1.0 1.0 16.1 1.0 0.9 3.6 1.6 1.1 0.9 1.2 1.1 1.1 1.2 0.0 0.0 1.1 0.0 0.9 0.9 0.3 0.6 0.2 0.6 0.2 0.3 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.3 0.1 0.3 1.6 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.2 0.3 4.6 0.5 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.6 0.2 0.3 0.6 0.3 0.1 0.2 0.0 0.0 6.0 13.0 9.8 26.4 8.1 4.5 2.6 11.1 9.2 0.0 HCN2 "BCNG-2, BCNG2, HAC-1" ENSG00000099822 "Hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2" Q9UL51 19 589893-617159 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 38.1;heart muscle: 16.8" "Cell line enhanced" "Detected in many" "A549: 17.6;MCF7: 16.4;U-138 MG: 12.3;U-87 MG: 25.4" "Group enriched" "Detected in many" 6 "glioma: 8.7;melanoma: 5.7;renal cancer: 2.8;testis cancer: 4.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (8.69e-2)" "unprognostic (3.97e-3)" "unprognostic (3.31e-4)" "unprognostic (1.44e-1)" "unprognostic (2.44e-1)" "unprognostic (3.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" "unprognostic (5.32e-2)" "unprognostic (1.19e-3)" "unprognostic (8.00e-2)" "prognostic unfavourable (6.99e-5)" "unprognostic (1.07e-1)" "unprognostic (1.41e-1)" "unprognostic (5.53e-4)" "unprognostic (9.72e-3)" 1.1 4.8 12.0 1.4 29.1 1.5 1.0 8.5 38.1 1.1 1.2 8.2 0.0 1.2 1.0 1.3 2.2 1.0 1.1 16.8 18.3 11.7 1.5 1.1 1.1 1.5 22.0 6.6 1.0 1.5 1.2 3.0 1.1 11.4 1.2 1.1 0.6 1.4 1.2 1.1 1.7 1.2 1.2 24.5 1.3 1.3 3.7 7.3 0.0 1.1 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 17.6 0.2 0.6 1.9 1.3 0.6 1.2 1.4 0.5 0.1 2.5 0.1 0.0 3.9 1.7 0.1 0.4 0.1 0.0 2.9 7.5 0.0 9.4 0.2 1.4 0.2 3.4 3.4 0.3 0.1 0.0 0.1 1.0 0.1 1.3 16.4 0.0 0.0 0.8 0.5 0.1 0.1 0.4 0.3 0.5 6.8 3.5 4.3 0.0 1.3 3.5 0.6 1.6 12.3 1.8 0.2 4.8 0.3 0.2 0.1 25.4 0.8 3.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 12.0 29.1 8.5 19.6 18.3 11.7 22.0 6.6 11.4 7.3 HCN3 KIAA1535 ENSG00000143630 "Hyperpolarization activated cyclic nucleotide gated potassium channel 3" Q9P1Z3 1 155277583-155289848 "Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026584 Approved "HPA026584: AB_1850534" "unprognostic (1.04e-1)" "unprognostic (6.22e-2)" "unprognostic (7.17e-2)" "unprognostic (1.34e-1)" "unprognostic (3.17e-1)" "unprognostic (1.48e-3)" "unprognostic (1.63e-1)" "unprognostic (5.97e-2)" "unprognostic (4.44e-2)" "unprognostic (1.84e-2)" "unprognostic (4.36e-3)" "unprognostic (1.33e-1)" "prognostic unfavourable (7.49e-4)" "unprognostic (2.55e-2)" "unprognostic (1.85e-1)" "unprognostic (5.90e-2)" "prognostic favourable (6.93e-4)" 1.6 3.5 4.5 2.0 7.5 1.5 2.1 20.3 9.5 3.6 4.4 3.3 3.6 7.7 4.5 2.1 3.9 2.2 3.0 1.6 4.0 8.2 4.4 10.2 1.9 2.3 4.1 8.5 4.7 4.7 6.4 12.6 2.4 9.5 2.7 5.0 4.0 4.4 3.6 1.1 9.2 6.6 2.8 3.0 1.9 3.2 1.7 2.1 1.6 2.6 1.3 3.0 2.3 3.6 0.3 0.0 0.0 0.1 0.0 0.6 0.0 1.6 1.8 7.8 3.1 1.2 1.5 1.9 1.3 1.1 1.6 1.9 2.7 5.4 1.5 1.0 0.9 6.8 2.2 1.0 0.8 2.1 2.7 0.6 5.0 1.8 0.5 0.6 1.6 0.9 1.0 1.1 0.2 0.3 3.6 4.3 1.9 2.2 1.1 0.6 2.6 2.1 3.9 1.9 2.8 2.1 1.7 6.4 4.5 1.2 1.6 0.5 2.8 1.3 0.1 1.9 1.6 3.9 1.2 1.4 0.6 1.3 1.4 1.1 1.7 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 7.5 20.3 9.5 4.0 8.2 4.1 8.5 9.5 2.1 HCN4 ENSG00000138622 "Hyperpolarization activated cyclic nucleotide gated potassium channel 4" Q9Y3Q4 15 73319859-73369264 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Brugada syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 4.3;heart muscle: 12.5;testis: 9.6" "Cell line enhanced" "Detected in some" "AF22: 2.5;CACO-2: 3.1;HDLM-2: 2.1;NTERA-2: 9.4;U-2 OS: 4.1" "Group enriched" "Detected in some" 8 "testis cancer: 3.1;thyroid cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073174 Approved "HPA073174: " "unprognostic (2.21e-1)" "unprognostic (1.39e-1)" "unprognostic (2.18e-2)" "unprognostic (3.14e-2)" "unprognostic (5.30e-3)" "unprognostic (1.92e-2)" "unprognostic (2.19e-1)" "unprognostic (3.50e-2)" "unprognostic (2.37e-1)" "unprognostic (6.56e-2)" "unprognostic (1.13e-3)" "unprognostic (1.13e-1)" "unprognostic (6.05e-5)" "unprognostic (5.56e-2)" "unprognostic (4.60e-2)" "unprognostic (1.51e-2)" "unprognostic (7.95e-2)" 0.2 1.3 4.3 0.2 1.1 0.1 0.1 0.9 3.4 0.2 0.4 2.1 0.0 1.2 0.1 0.2 0.1 0.3 0.2 12.5 0.6 2.0 0.4 0.1 0.3 0.1 1.8 0.9 0.1 0.2 0.1 2.1 0.1 3.9 0.6 0.3 0.2 0.1 1.0 0.1 0.2 0.4 0.2 0.7 0.1 0.6 9.6 1.9 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 1.5 0.0 0.2 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.1 0.9 3.4 0.6 2.0 1.8 0.9 3.9 1.9 HCRT "OX, PPOX" ENSG00000161610 "Hypocretin neuropeptide precursor" O43612 17 42184060-42185452 "Disease related genes, Predicted secreted proteins" Neuropeptide "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "brain: 84.3" "Cell line enhanced" "Detected in some" "HDLM-2: 1.9;Karpas-707: 1.0;RPMI-8226: 3.6" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.7;granulocytes: 2.3;T-cells: 2.2" "Region enriched" "Detected in some" 5 "hypothalamus: 110.5" "Region enriched" "Detected in single" 56 "hypothalamus: 152.0" "HPA064801, CAB079778" Enhanced Supported "Secreted to blood" "CAB079778: , HPA064801: " "unprognostic (3.34e-2)" "unprognostic (7.76e-5)" "unprognostic (3.21e-2)" "unprognostic (3.01e-2)" "unprognostic (2.20e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" 0.9 0.0 0.0 1.1 0.2 0.9 0.0 0.0 0.7 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 84.3 0.4 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 2.7 0.4 2.3 0.5 0.4 2.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.8 0.8 0.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 0.7 0.8 0.2 0.0 0.1 0.0 2.3 0.5 0.0 1.2 0.4 2.2 1.5 0.9 1.6 0.4 2.7 1.4 1.3 0.1 0.4 0.2 0.3 0.5 0.1 HCRTR1 OX1R ENSG00000121764 "Hypocretin receptor 1" O43613 1 31617686-31632518 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.0" "Cell line enhanced" "Detected in some" "HeLa: 1.7;HUVEC TERT2: 2.9;TIME: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014018 Approved "HPA014018: AB_1854810" "unprognostic (2.96e-2)" "unprognostic (2.34e-2)" "unprognostic (7.86e-3)" "unprognostic (3.72e-3)" "unprognostic (2.42e-1)" "unprognostic (3.45e-3)" "unprognostic (2.54e-5)" "unprognostic (3.58e-2)" "unprognostic (4.17e-2)" "unprognostic (1.19e-1)" "unprognostic (2.28e-1)" "unprognostic (2.93e-1)" "unprognostic (3.77e-3)" "unprognostic (2.16e-2)" "unprognostic (1.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" 3.3 4.3 0.9 0.3 1.4 1.6 2.7 0.7 4.5 0.1 0.3 0.0 0.0 0.2 0.6 0.3 0.7 0.5 0.8 1.8 0.8 4.6 0.5 0.1 0.2 0.6 1.1 0.0 0.5 0.3 0.0 1.7 2.3 8.0 0.5 0.2 0.7 0.5 0.0 2.4 1.1 0.5 0.0 0.5 0.6 0.4 0.4 0.0 0.0 2.9 0.8 0.2 0.6 0.1 1.1 0.2 0.0 0.2 0.2 0.5 0.1 0.4 0.0 0.3 0.1 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.6 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.7 0.0 0.0 1.0 0.4 0.0 0.0 0.5 0.0 2.9 0.4 0.2 0.0 0.5 0.1 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.7 0.1 0.4 0.3 0.2 0.0 0.2 0.0 1.6 0.1 0.2 0.3 0.4 0.5 0.1 0.2 0.0 0.6 1.0 0.0 0.2 0.0 0.5 0.2 0.0 0.1 0.2 0.0 0.1 1.1 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.1 0.9 1.4 0.7 4.5 0.8 4.6 1.1 0.0 8.0 0.0 HCRTR2 OX2R ENSG00000137252 "Hypocretin receptor 2" O43614 6 55106460-55282620 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 17.4" "Cell line enriched" "Detected in single" 6 "AF22: 4.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "pons and medulla: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054516 Enhanced "HPA054516: " "unprognostic (4.86e-1)" "unprognostic (2.69e-2)" "unprognostic (1.86e-2)" "unprognostic (2.32e-1)" "unprognostic (7.45e-2)" "unprognostic (7.39e-2)" 0.1 0.2 1.7 0.0 1.3 0.0 0.1 0.6 2.2 0.1 0.1 0.3 0.0 0.0 0.1 0.5 0.0 0.1 0.1 1.1 0.9 4.2 3.7 0.1 0.4 0.1 2.6 1.7 1.7 0.0 0.0 0.3 2.2 17.4 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 1.3 0.6 2.2 0.9 4.2 2.6 1.7 17.4 0.0 HDC ENSG00000140287 "Histidine decarboxylase" P19113 15 50241947-50266026 "Enzymes, Predicted intracellular proteins" "Catecholamine biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 83.5;brain: 36.0;epididymis: 36.9" "Group enriched" "Detected in some" 4 "HEL: 59.8;HMC-1: 143.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 52 "hypothalamus: 36.0" "Cell type enriched" "Detected in single" 835 "basophil: 83.5" "Lineage enriched" "Detected in single" 835 "granulocytes: 83.5" "Region enriched" "Detected in many" 5 "hypothalamus: 51.5" "Low region specificity" "Detected in all" HPA038891 Enhanced Approved "Nuclear bodies" "Nuclear bodies" "HPA038891: AB_10673231" "unprognostic (4.97e-2)" "unprognostic (7.42e-2)" "unprognostic (1.43e-4)" "unprognostic (1.08e-1)" "unprognostic (6.16e-2)" "unprognostic (3.93e-7)" "unprognostic (4.18e-5)" "unprognostic (8.79e-3)" "unprognostic (1.48e-1)" "unprognostic (8.46e-2)" "unprognostic (4.60e-2)" "unprognostic (1.05e-1)" "unprognostic (2.53e-1)" "unprognostic (7.20e-2)" "unprognostic (9.78e-2)" "unprognostic (2.15e-1)" "unprognostic (1.50e-1)" 1.7 0.2 0.2 5.1 0.4 2.4 1.1 0.2 0.3 2.7 1.9 0.2 1.2 2.1 3.1 36.9 2.7 0.6 6.6 2.1 0.2 36.0 0.6 0.8 4.9 2.3 0.6 0.1 0.4 0.5 0.3 0.7 0.2 0.3 2.2 1.9 3.0 0.9 1.3 1.8 1.8 2.4 5.4 0.2 0.4 6.9 2.4 0.2 0.4 0.3 0.4 1.7 1.8 2.7 0.0 0.0 83.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 59.8 0.0 0.0 0.0 0.1 143.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.2 0.3 0.2 36.0 0.6 0.1 0.3 0.2 HDX "CXorf43, FLJ30678" ENSG00000165259 "Highly divergent homeobox" Q7Z353 X 84317874-84502479 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1" "Cell line enhanced" "Detected in many" "AF22: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047189 Uncertain Approved Cytosol Cytosol "HPA047189: AB_10965463" "unprognostic (7.26e-2)" "unprognostic (3.53e-2)" "unprognostic (1.64e-2)" "unprognostic (1.51e-5)" "unprognostic (3.23e-4)" "unprognostic (5.52e-2)" "unprognostic (1.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (6.40e-6)" "unprognostic (1.14e-1)" "unprognostic (7.20e-2)" "unprognostic (3.86e-3)" "unprognostic (2.34e-1)" "unprognostic (1.30e-2)" "unprognostic (3.66e-2)" 5.1 7.4 8.3 3.3 7.9 0.6 6.4 23.1 10.2 8.2 4.6 2.6 3.5 1.8 7.4 5.3 4.2 6.3 5.5 4.8 5.5 4.6 4.3 4.5 4.4 2.3 6.5 7.0 8.0 2.2 5.5 16.4 1.4 6.6 6.0 4.5 2.0 4.5 6.2 1.7 1.9 2.9 6.6 5.7 4.2 3.2 4.0 7.1 0.4 5.7 2.7 2.7 5.2 8.3 2.7 6.1 0.0 6.9 1.4 1.4 1.1 0.0 2.2 9.0 0.0 5.4 4.7 0.0 3.0 4.0 6.9 7.9 0.4 1.2 0.0 0.6 3.0 0.5 0.1 1.1 5.4 0.0 0.6 0.0 1.7 0.0 5.0 0.0 0.0 3.3 0.1 4.5 3.0 7.0 0.0 0.0 6.9 0.1 0.0 0.0 6.7 3.0 0.0 7.7 0.1 3.3 1.5 0.3 5.2 0.0 0.2 0.0 0.4 0.0 7.4 3.8 2.7 1.3 2.7 0.2 0.0 0.0 1.8 0.0 1.6 0.0 4.3 0.0 1.4 6.9 0.2 2.7 0.4 0.3 6.1 1.0 1.2 0.7 0.0 1.4 5.9 0.6 0.2 1.1 8.3 7.9 23.1 10.2 5.5 4.6 6.5 7.0 6.6 7.1 HECTD4 "C12orf51, FLJ34154, KIAA0614" ENSG00000173064 "HECT domain E3 ubiquitin protein ligase 4" 12 112160188-112382439 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 43.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041062, HPA045473" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA041062: , HPA045473: " "unprognostic (9.27e-2)" "unprognostic (2.35e-1)" "unprognostic (6.50e-2)" "unprognostic (1.33e-1)" "unprognostic (3.38e-1)" "prognostic favourable (2.97e-4)" "unprognostic (3.52e-2)" "unprognostic (2.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.21e-2)" "unprognostic (4.95e-2)" "unprognostic (1.06e-1)" "unprognostic (2.89e-2)" "unprognostic (2.81e-2)" "unprognostic (1.89e-1)" "unprognostic (1.58e-2)" "unprognostic (4.51e-3)" 6.8 7.1 11.3 6.3 16.3 26.6 7.7 43.3 22.7 8.9 9.0 14.0 10.8 5.4 11.1 10.0 10.0 9.0 6.5 6.6 10.1 10.3 7.4 6.3 7.3 8.1 11.4 13.7 10.9 10.1 13.8 14.0 8.0 17.2 12.3 7.4 9.4 8.7 9.6 12.9 16.6 7.0 8.8 13.0 7.4 8.8 14.6 12.7 8.3 12.8 5.0 7.7 8.3 9.0 2.9 2.4 2.8 1.2 1.0 1.8 0.7 5.6 10.6 8.5 7.5 11.6 7.9 4.9 4.1 3.9 5.3 4.5 10.3 1.9 5.9 3.8 6.7 5.7 11.1 5.4 4.0 7.6 10.0 8.4 11.2 5.7 4.1 5.9 8.2 6.5 6.6 8.2 5.4 8.1 10.4 4.6 5.1 6.2 7.0 12.5 4.0 7.9 9.5 4.3 3.8 4.3 8.9 13.9 9.5 9.6 9.4 3.6 7.1 8.4 11.7 6.3 4.6 6.5 5.5 15.7 5.9 6.6 5.1 3.9 3.9 2.8 1.2 0.6 1.8 0.5 1.2 1.1 0.6 0.9 0.8 2.9 1.0 0.9 1.4 1.0 1.1 2.4 0.1 0.7 11.3 16.3 43.3 22.7 10.1 10.3 11.4 13.7 17.2 12.7 HECW1 "KIAA0322, NEDL1" ENSG00000002746 "HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1" Q76N89 7 43112599-43566001 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.0;kidney: 15.4" "Cell line enhanced" "Detected in some" "A549: 5.5;U-266/70: 15.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 7.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007203, HPA007593, HPA007609" Approved Supported Cytosol Cytosol "HPA007203: , HPA007593: AB_1852305, HPA007609: AB_2117518" "unprognostic (1.40e-1)" "unprognostic (2.85e-3)" "unprognostic (2.57e-1)" "unprognostic (4.39e-1)" "unprognostic (2.43e-2)" "unprognostic (2.80e-2)" "unprognostic (8.65e-4)" "unprognostic (6.93e-2)" "unprognostic (7.30e-2)" "unprognostic (7.31e-2)" "unprognostic (3.43e-2)" "unprognostic (2.67e-2)" "unprognostic (1.43e-3)" "unprognostic (1.64e-2)" "unprognostic (5.23e-3)" "unprognostic (1.89e-2)" "unprognostic (2.42e-2)" 0.7 0.5 10.3 0.8 12.1 1.4 0.8 13.6 24.0 0.6 0.8 1.1 0.0 0.4 0.8 1.7 2.6 0.5 4.0 0.4 3.9 4.1 15.4 0.6 0.6 1.3 3.8 15.5 1.0 0.4 1.7 0.4 0.6 10.2 3.2 0.5 0.6 1.0 0.8 1.8 2.1 0.6 0.7 1.4 0.6 1.0 3.7 1.6 0.0 1.5 0.0 0.8 1.2 0.6 2.4 1.6 7.0 1.7 1.6 0.7 0.1 0.1 5.5 0.6 0.8 0.0 0.0 0.0 1.6 2.8 0.1 0.6 0.0 0.0 0.2 3.0 2.7 0.4 0.0 0.0 0.2 0.2 0.9 0.0 0.4 0.2 0.2 1.3 0.0 1.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 2.3 0.9 0.5 0.0 0.0 0.0 0.1 0.2 0.7 0.5 0.1 0.0 0.4 0.0 0.0 0.8 1.1 1.3 0.4 15.6 0.5 0.0 3.5 0.4 0.0 6.4 1.7 1.1 0.7 1.0 0.5 1.0 0.7 0.3 0.2 2.4 0.6 0.7 7.0 1.6 0.9 1.6 0.2 0.1 10.3 12.1 13.6 24.0 3.9 4.1 3.8 15.5 10.2 1.6 HEPACAM "FLJ25530, GLIALCAM, hepaCAM" ENSG00000165478 "Hepatic and glial cell adhesion molecule" Q14CZ8 11 124919193-124936412 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Cell cycle, Growth arrest, Growth regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "adipose tissue: 17.3;brain: 64.7;liver: 19.6" "Cell line enriched" "Detected in single" 31 "Hep G2: 24.3" "Cancer enriched" "Detected in some" 12 "glioma: 29.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017613, CAB025486" Enhanced Approved Vesicles Vesicles "CAB025486: , HPA017613: AB_1850595" "unprognostic (3.22e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-1)" "unprognostic (6.41e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (2.25e-1)" "unprognostic (7.58e-2)" "unprognostic (1.33e-2)" "unprognostic (1.06e-6)" "unprognostic (2.62e-1)" "unprognostic (3.21e-1)" 17.3 1.8 25.6 1.7 25.7 1.5 2.6 8.5 64.7 1.6 1.8 55.4 0.0 1.6 1.6 1.7 1.6 1.6 1.6 1.7 31.0 10.8 1.6 19.6 1.6 1.7 30.3 22.4 1.5 1.6 1.5 0.6 1.5 27.9 1.6 1.8 0.0 1.7 2.1 1.6 1.6 1.6 1.6 21.5 1.5 1.6 1.7 35.5 0.0 1.6 0.0 2.3 1.5 0.3 1.5 1.2 3.0 1.4 2.0 1.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 1.1 1.2 1.1 1.2 1.5 1.5 1.4 1.0 1.2 1.3 1.7 1.5 1.3 2.0 1.4 1.0 1.1 1.5 25.6 25.7 8.5 29.7 31.0 10.8 30.3 22.4 27.9 35.5 HEPN1 ENSG00000221932 "Hepatocellular carcinoma, down-regulated 1" Q6WQI6 11 124919244-124920677 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 43.3" "Cell line enriched" "Detected in single" 335 "Hep G2: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043768, HPA063054" Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA043768: , HPA063054: " 8.4 0.5 22.0 0.4 20.4 0.3 0.3 4.2 43.3 0.3 0.4 0.3 0.4 0.3 0.4 0.3 0.3 0.5 17.9 11.0 0.4 4.5 0.3 0.5 19.3 0.4 0.3 0.3 0.0 0.3 0.3 0.3 0.5 0.3 0.5 0.3 0.5 0.3 19.4 0.3 0.4 0.4 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HES5 bHLHb38 ENSG00000197921 "Hes family bHLH transcription factor 5" Q5TA89 1 2528745-2530245 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.7" "Cell line enhanced" "Detected in some" "AF22: 2.6;HaCaT: 5.0;HAP1: 1.1;SCLC-21H: 1.0" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065458, HPA076164" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" Nucleoplasm "Nuclear speckles, Cytosol" "HPA065458: , HPA076164: " "unprognostic (2.04e-3)" "unprognostic (2.83e-2)" "unprognostic (4.26e-2)" "unprognostic (2.75e-3)" "unprognostic (5.26e-3)" "unprognostic (1.60e-4)" "unprognostic (1.76e-4)" "unprognostic (1.60e-1)" "unprognostic (5.30e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (4.67e-1)" "unprognostic (9.95e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (3.89e-2)" "unprognostic (1.72e-1)" 1.1 0.9 11.1 1.1 12.7 1.4 2.8 3.5 16.7 1.0 1.9 1.2 0.4 1.2 1.9 2.7 1.6 1.1 1.2 2.3 9.7 11.2 1.0 1.0 1.4 1.1 4.1 15.8 1.0 0.9 1.0 2.4 2.2 1.6 1.3 1.4 6.3 1.2 1.1 1.6 6.2 1.2 0.9 0.9 1.0 1.2 2.0 1.9 0.0 1.1 1.9 1.4 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 12.7 3.5 16.7 9.7 11.2 4.1 15.8 1.6 1.9 HES6 bHLHb41 ENSG00000144485 "Hes family bHLH transcription factor 6" Q96HZ4 2 238238267-238240662 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell line enhanced" "Detected in many" "NB-4: 50.4;SCLC-21H: 33.4;SK-MEL-30: 48.2;U-937: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 8.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061763 Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" "Nucleoli, Nuclear bodies" "Nucleoplasm, Cytosol" "HPA061763: " "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (2.40e-3)" "unprognostic (7.46e-3)" "unprognostic (1.17e-1)" "prognostic unfavourable (2.79e-4)" "prognostic favourable (9.18e-5)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-2)" "unprognostic (4.35e-1)" "unprognostic (6.30e-2)" "unprognostic (5.13e-2)" "unprognostic (8.50e-2)" "unprognostic (6.66e-2)" "unprognostic (3.49e-2)" 2.1 5.2 15.4 3.4 10.6 10.5 3.0 7.3 47.4 3.7 12.2 17.1 0.8 18.1 6.3 1.5 1.6 14.3 5.7 1.7 17.5 9.1 1.9 2.5 2.2 3.3 11.4 12.3 1.3 13.9 5.3 23.6 1.7 14.3 2.0 9.6 1.5 3.8 1.7 8.2 1.7 12.9 3.3 18.8 4.6 5.2 9.4 11.7 0.4 5.5 1.7 2.8 1.3 1.0 0.3 1.4 8.0 0.3 0.1 1.0 0.2 1.2 1.4 6.4 7.2 0.4 0.2 4.1 0.4 0.4 0.6 0.9 1.1 0.8 0.0 1.0 0.1 0.8 6.5 0.4 0.2 2.8 7.8 1.4 1.0 13.1 1.0 10.5 8.8 0.6 4.0 0.9 1.3 0.4 13.3 0.1 0.4 3.2 1.6 50.4 10.2 1.1 7.1 16.2 3.0 0.8 0.6 33.4 14.6 1.9 2.9 48.2 2.5 22.4 0.6 0.6 1.3 3.5 3.7 3.0 0.5 2.2 2.2 25.7 1.1 0.1 0.3 8.0 1.0 0.2 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.3 1.4 0.7 0.2 15.4 10.6 7.3 39.3 17.5 9.1 11.4 12.3 14.3 11.7 HES7 bHLHb37 ENSG00000179111 "Hes family bHLH transcription factor 7" Q9BYE0 17 8120590-8124092 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.3;salivary gland: 10.5" "Cell line enhanced" "Detected in some" "A-431: 6.6;Daudi: 7.0;HAP1: 9.0;HDLM-2: 7.1;HeLa: 13.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "cerebellum: 0.8" HPA072105 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA072105: " "unprognostic (1.98e-1)" "unprognostic (7.91e-3)" "unprognostic (1.16e-3)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (4.99e-2)" "unprognostic (2.84e-1)" "unprognostic (5.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (1.22e-5)" "unprognostic (2.99e-2)" "unprognostic (4.79e-2)" "unprognostic (2.69e-2)" "unprognostic (1.55e-1)" 0.4 0.4 1.0 0.3 1.0 0.2 0.5 9.3 2.4 1.4 0.3 0.6 0.2 0.0 2.0 0.2 0.7 0.6 0.6 1.3 1.5 0.5 1.1 0.2 0.9 0.6 1.0 0.2 1.5 0.5 0.0 0.4 3.6 2.1 0.6 0.2 0.9 10.5 2.5 1.1 0.6 0.3 0.4 1.5 0.3 0.2 2.3 0.2 0.2 0.8 0.2 0.5 1.3 0.9 0.2 0.1 0.0 0.1 0.3 0.2 0.1 6.6 0.5 0.5 2.2 0.2 0.3 0.3 0.3 0.5 0.8 2.4 0.1 0.4 7.0 0.1 0.0 0.7 9.0 0.6 0.0 7.1 4.3 0.3 13.4 0.1 0.8 0.7 0.9 0.2 1.2 1.9 5.1 0.1 0.2 3.2 0.1 0.1 0.1 0.3 0.2 1.7 0.7 0.4 1.2 0.2 0.0 0.3 3.2 0.4 0.0 0.4 0.1 0.0 0.6 0.0 1.5 1.5 2.3 4.4 0.9 0.4 0.7 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 1.0 1.0 9.3 2.4 1.5 0.5 1.0 0.2 2.1 0.2 HEY1 "bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1" ENSG00000164683 "Hes related family bHLH transcription factor with YRPW motif 1" Q9Y5J3 8 79764010-79767863 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.6" "Cell line enhanced" "Detected in many" "HEK 293: 48.4;PC-3: 11.0;SK-MEL-30: 33.1;WM-115: 11.3" "Cancer enhanced" "Detected in all" "glioma: 43.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "neutrophil: 9.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055599, HPA063472" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Cytosol" "Nuclear membrane" "HPA055599: AB_2682858, HPA063472: " "unprognostic (1.15e-1)" "unprognostic (5.06e-2)" "unprognostic (5.13e-3)" "unprognostic (2.12e-1)" "unprognostic (1.86e-3)" "unprognostic (8.47e-2)" "unprognostic (4.21e-3)" "unprognostic (9.56e-2)" "unprognostic (1.72e-1)" "unprognostic (7.22e-2)" "unprognostic (1.25e-2)" "unprognostic (6.71e-3)" "unprognostic (5.92e-3)" "unprognostic (5.77e-2)" "unprognostic (8.53e-2)" "unprognostic (1.74e-2)" "unprognostic (1.00e-1)" 13.3 3.8 13.7 3.6 22.9 1.8 8.8 11.2 60.6 8.9 4.4 10.7 0.0 3.3 3.8 2.4 4.6 3.9 5.7 13.4 11.3 11.6 3.8 2.9 16.4 3.3 11.9 9.3 2.6 4.3 3.0 9.9 20.3 12.5 4.5 3.9 10.3 4.5 3.0 10.3 3.5 3.2 4.4 9.1 2.8 3.6 3.9 10.5 1.3 5.0 3.7 3.7 5.2 2.5 0.0 0.0 9.9 1.7 0.0 0.3 0.1 0.6 0.0 0.4 3.4 0.3 0.2 8.8 0.8 0.8 0.1 0.1 0.1 0.0 1.6 0.8 0.3 2.2 1.8 0.1 0.2 0.1 48.4 0.0 1.5 0.8 0.5 0.0 0.3 0.4 1.4 0.0 6.1 1.6 3.1 1.4 0.5 0.1 0.0 0.2 0.1 11.0 0.0 1.8 1.4 0.1 1.5 2.0 5.6 0.0 1.0 33.1 0.0 0.0 1.1 0.2 0.9 0.0 0.6 1.2 0.2 0.0 1.2 0.0 11.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.9 0.0 1.7 0.0 0.0 0.1 13.7 22.9 11.2 12.3 11.3 11.6 11.9 9.3 12.5 10.5 HFM1 "FLJ36760, FLJ39011, MER3, SEC63D1" ENSG00000162669 "HFM1, ATP dependent DNA helicase homolog" A2PYH4 1 91260766-91404869 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Meiosis "Helicase, Hydrolase" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3;testis: 19.9" "Cell line enhanced" "Detected in some" "AF22: 9.1;AN3-CA: 4.8;K-562: 4.9;SCLC-21H: 3.1;SH-SY5Y: 3.8;U-266/70: 4.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035036, HPA035557" Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA035036: , HPA035557: AB_10696507" "unprognostic (1.35e-2)" "unprognostic (9.39e-2)" "unprognostic (1.17e-1)" "unprognostic (2.83e-4)" "unprognostic (2.05e-2)" "unprognostic (1.52e-1)" "unprognostic (7.43e-3)" "unprognostic (1.79e-1)" "unprognostic (7.75e-2)" "unprognostic (7.97e-2)" "unprognostic (1.76e-4)" "unprognostic (2.81e-2)" "unprognostic (1.06e-2)" "unprognostic (2.89e-3)" "unprognostic (2.78e-2)" "unprognostic (1.77e-4)" "unprognostic (9.59e-2)" 0.8 0.7 2.6 0.3 4.1 0.4 0.8 11.3 4.4 1.7 0.9 1.5 2.7 0.6 3.7 2.5 0.4 1.2 0.6 1.0 2.3 0.9 1.3 0.4 0.5 1.6 0.7 1.4 6.4 1.2 0.1 7.8 0.9 3.9 1.1 0.7 2.7 1.0 2.0 2.3 0.4 0.5 1.7 4.7 0.7 0.6 19.9 1.5 0.0 2.7 0.5 0.4 0.7 2.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.1 4.8 0.0 0.2 0.1 0.5 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 1.0 0.0 0.1 0.2 1.1 0.0 0.5 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.6 0.2 2.4 0.0 0.3 1.4 0.1 0.0 0.0 3.1 3.8 0.0 0.0 1.2 0.0 0.8 0.1 0.0 1.0 0.9 0.1 4.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 4.1 11.3 4.4 2.3 0.9 0.7 1.4 3.9 1.5 HHATL "C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3" ENSG00000010282 "Hedgehog acyltransferase like" Q9HCP6 3 42692663-42702827 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "brain: 57.1;heart muscle: 184.7;skeletal muscle: 93.6" "Cell line enhanced" "Detected in some" "ASC diff: 1.1;HSkMC: 1.3;Karpas-707: 1.1;NTERA-2: 1.4;RPMI-8226: 4.1;THP-1: 1.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 25.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018174 Enhanced "HPA018174: AB_2116671" "unprognostic (1.72e-2)" "unprognostic (1.56e-1)" "unprognostic (5.20e-2)" "unprognostic (9.71e-2)" "unprognostic (7.94e-3)" "unprognostic (3.79e-2)" "unprognostic (8.80e-2)" "unprognostic (2.47e-1)" "unprognostic (5.98e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (9.68e-2)" "unprognostic (1.01e-1)" "unprognostic (2.89e-1)" "unprognostic (3.14e-1)" 1.5 1.6 12.9 1.3 29.0 1.3 1.9 2.3 15.2 1.5 1.4 36.5 0.0 1.3 1.7 1.5 2.7 2.0 1.5 184.7 14.5 8.9 1.4 1.3 1.5 1.4 51.6 10.5 1.4 1.8 1.4 0.9 1.4 25.9 1.9 1.4 5.4 4.7 1.4 93.6 1.6 1.4 1.4 57.1 1.4 1.3 1.7 39.9 0.0 9.3 7.2 1.4 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.3 0.0 1.4 0.0 0.5 0.0 4.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.5 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 29.0 2.3 15.2 14.5 8.9 51.6 10.5 25.9 39.9 HHIP "FLJ20992, HIP" ENSG00000164161 "Hedgehog interacting protein" Q96QV1 4 144646021-144745271 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.5;lung: 29.7" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 68.2;TIME: 78.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012616 Uncertain Approved Nucleoplasm "Secreted in other tissues" Nucleoplasm "HPA012616: AB_1850687" "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (7.12e-3)" "unprognostic (8.18e-2)" "unprognostic (2.43e-2)" "unprognostic (1.02e-1)" "unprognostic (3.60e-1)" "unprognostic (1.95e-2)" "unprognostic (4.20e-1)" "unprognostic (1.90e-2)" "unprognostic (1.89e-1)" "unprognostic (9.66e-3)" "unprognostic (7.13e-3)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (2.38e-1)" 4.0 5.2 9.9 1.7 22.2 2.3 1.1 2.3 16.0 3.4 6.5 31.5 0.0 5.5 4.1 8.1 1.0 1.2 3.0 1.1 16.0 6.3 2.4 12.7 29.7 1.0 21.6 9.9 2.2 4.8 1.0 1.1 1.0 17.5 9.8 6.8 4.4 1.3 6.2 1.3 1.1 8.2 1.3 12.3 1.0 11.2 3.7 26.5 2.3 1.6 0.0 1.0 7.1 1.0 0.1 2.6 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.6 68.2 0.0 0.0 1.0 0.0 9.6 0.0 0.9 0.6 0.1 13.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.7 0.0 0.8 0.0 0.5 0.4 0.0 2.0 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 2.6 0.0 0.0 9.9 22.2 2.3 16.0 16.0 6.3 21.6 9.9 17.5 26.5 HHIPL1 KIAA1822 ENSG00000182218 "HHIP like 1" Q96JK4 14 99645110-99680569 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 14.1" "Cell line enhanced" "Detected in some" "EFO-21: 5.2;fHDF/TERT166: 8.9;SiHa: 6.0;THP-1: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" 59000 "unprognostic (6.16e-2)" "unprognostic (3.44e-2)" "unprognostic (3.43e-2)" "unprognostic (1.59e-2)" "unprognostic (1.30e-1)" "unprognostic (2.31e-1)" "unprognostic (2.75e-2)" "unprognostic (4.70e-3)" "unprognostic (6.68e-2)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "unprognostic (1.35e-3)" "unprognostic (8.49e-6)" "unprognostic (2.52e-2)" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (7.12e-6)" 3.8 1.6 9.8 4.0 12.7 1.1 2.1 5.1 14.1 3.2 2.7 2.5 2.9 2.2 4.8 2.6 3.3 2.7 6.2 3.6 7.3 4.9 1.3 1.6 2.0 4.5 4.8 6.8 2.4 1.2 1.1 1.6 2.5 5.4 4.4 1.7 4.4 2.4 3.8 2.5 1.9 2.2 6.3 3.2 3.3 2.1 1.7 2.7 0.0 1.1 1.6 2.4 2.5 1.8 0.1 0.0 1.2 0.1 0.0 0.1 0.0 0.1 0.4 0.7 0.2 0.2 0.0 2.8 2.6 0.6 0.5 0.2 0.2 0.8 0.2 5.2 8.9 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.3 0.0 2.8 0.0 0.1 1.6 0.3 2.1 0.3 2.4 0.1 0.2 1.5 0.4 0.0 0.4 2.1 0.1 0.8 0.0 0.3 0.1 0.1 0.3 1.1 6.0 0.1 0.0 0.1 6.3 1.6 0.1 0.1 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.6 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 1.2 0.0 0.1 0.0 0.0 0.0 9.8 12.7 5.1 10.8 7.3 4.9 4.8 6.8 5.4 2.7 HID1 "C17orf28, DMC1, HID-1" ENSG00000167861 "HID1 domain containing" Q8IV36 17 74950743-74973166 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.3" "Cell line enhanced" "Detected in some" "MCF7: 34.7;SH-SY5Y: 18.0;SK-BR-3: 53.2;T-47d: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.8" "Group enriched" "Detected in many" 34 "B-cells: 1.5;dendritic cells: 5.8;T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031406 Approved Supported "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA031406: " "unprognostic (7.41e-2)" "unprognostic (1.96e-1)" "unprognostic (2.69e-1)" "unprognostic (2.22e-3)" "unprognostic (4.47e-3)" "unprognostic (6.79e-3)" "unprognostic (4.00e-2)" "unprognostic (1.11e-1)" "unprognostic (2.78e-1)" "unprognostic (3.90e-1)" "unprognostic (1.54e-3)" "unprognostic (1.37e-1)" "prognostic favourable (3.13e-5)" "unprognostic (1.17e-1)" "unprognostic (2.83e-1)" "unprognostic (1.09e-1)" "prognostic favourable (1.34e-4)" 5.4 3.8 10.1 3.9 21.2 1.3 8.9 62.3 22.2 12.2 9.2 19.9 21.3 21.9 7.1 17.3 2.4 11.3 16.7 5.4 12.8 13.3 4.7 2.0 7.5 3.0 21.3 12.2 1.3 49.4 9.0 16.9 11.4 15.8 19.7 10.4 4.1 46.7 20.0 2.6 2.9 15.3 4.0 10.5 6.4 31.2 2.6 17.1 0.7 8.5 1.4 3.7 7.4 3.8 1.5 5.8 0.0 0.0 0.0 2.8 1.3 1.5 3.4 0.4 4.8 0.0 0.0 0.8 0.0 0.2 0.3 0.3 3.1 1.8 0.0 0.3 0.0 1.6 4.4 0.3 0.2 0.0 3.5 0.0 0.1 3.0 0.8 0.0 0.3 0.0 1.8 0.0 0.7 7.9 0.2 1.2 0.0 34.7 0.2 0.0 0.1 2.1 0.0 0.0 6.5 4.5 13.5 6.5 18.0 0.0 53.2 0.0 31.4 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 1.5 2.3 1.8 0.0 0.4 2.5 2.8 0.0 0.0 0.0 5.8 0.0 1.3 10.1 21.2 62.3 22.2 12.8 13.3 21.3 12.2 15.8 17.1 HILPDA "C7orf68, FLJ21076, HIG-2, HIG2" ENSG00000135245 "Hypoxia inducible lipid droplet associated" Q9Y5L2 7 128455849-128458418 "Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4;esophagus: 71.4" "Cell line enhanced" "Detected in all" "SK-BR-3: 44.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010515 Approved Supported "Nucleoplasm,Lipid droplets" "Intracellular and membrane" "Lipid droplets" Nucleoplasm "HPA010515: AB_1850710" "unprognostic (1.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (2.27e-1)" "unprognostic (2.10e-2)" "unprognostic (2.70e-2)" "prognostic unfavourable (4.30e-11)" "unprognostic (9.20e-3)" "unprognostic (4.07e-3)" "unprognostic (2.49e-1)" "unprognostic (4.06e-3)" "unprognostic (2.15e-2)" "prognostic unfavourable (2.05e-7)" "unprognostic (2.23e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-2)" "unprognostic (1.27e-1)" 24.5 5.2 25.3 5.5 34.2 14.1 16.2 8.6 53.9 15.7 14.4 6.4 2.8 4.7 9.1 6.3 71.4 7.9 7.2 16.7 25.1 8.5 10.4 10.3 13.2 4.9 22.4 3.1 22.9 5.0 3.0 4.2 25.7 46.5 7.0 6.2 2.8 7.7 6.1 5.2 14.4 4.4 6.9 66.4 3.0 6.4 10.1 21.1 1.7 5.6 6.9 6.0 60.5 18.6 9.2 5.9 31.7 3.6 6.9 3.3 2.0 11.0 23.2 12.7 13.8 17.4 6.4 23.9 4.0 5.0 8.5 9.4 5.8 10.1 7.5 3.2 6.0 7.1 7.1 8.6 10.9 4.1 6.5 4.6 4.9 5.2 3.9 7.2 6.3 10.6 7.5 6.7 4.5 6.9 6.6 3.1 8.4 13.5 21.7 13.2 15.7 10.3 16.4 5.9 11.7 4.7 16.4 12.2 11.2 6.3 44.1 7.8 35.9 7.1 5.0 10.9 5.4 8.2 5.0 3.1 2.2 9.6 20.6 11.2 9.4 9.2 3.5 31.7 2.3 3.6 3.3 7.8 2.9 2.8 3.4 9.2 3.0 2.9 1.4 6.9 2.7 5.9 1.9 2.0 25.3 34.2 8.6 53.9 25.1 8.5 22.4 3.1 46.5 21.1 HIPK2 ENSG00000064393 "Homeodomain interacting protein kinase 2" Q9H2X6 7 139561570-139777778 "Enzymes, Plasma proteins, Predicted membrane proteins" "Apoptosis, DNA damage, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.1" "Cell line enhanced" "Detected in many" "HDLM-2: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 17.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007611 Supported Supported Nucleoplasm Nucleoplasm "HPA007611: AB_1850730" "unprognostic (1.35e-3)" "unprognostic (1.49e-2)" "unprognostic (1.65e-1)" "unprognostic (7.65e-2)" "unprognostic (5.50e-2)" "unprognostic (9.44e-2)" "unprognostic (2.76e-1)" "unprognostic (4.66e-2)" "unprognostic (1.44e-1)" "unprognostic (2.76e-2)" "unprognostic (3.42e-3)" "unprognostic (4.58e-2)" "prognostic favourable (9.99e-4)" "unprognostic (1.38e-1)" "unprognostic (7.82e-2)" "unprognostic (3.93e-3)" "unprognostic (1.03e-2)" 19.6 9.8 58.8 7.4 53.6 14.4 12.6 8.5 39.8 5.5 7.4 54.5 5.2 8.2 4.7 5.2 10.2 9.9 5.5 30.5 60.0 39.9 28.2 17.5 8.6 5.3 66.1 16.4 6.6 12.3 17.2 7.6 10.8 26.4 10.7 5.8 9.4 11.5 7.1 21.6 3.2 6.2 4.8 56.2 7.3 15.4 2.6 38.6 1.7 10.4 2.8 4.9 6.8 7.4 0.6 0.5 17.8 2.9 0.2 1.4 0.5 4.1 18.2 8.4 5.2 20.7 14.8 1.0 2.2 2.2 2.5 2.6 1.3 2.2 0.0 5.3 4.2 0.2 3.8 5.9 6.4 42.0 1.6 18.7 3.0 6.5 11.6 5.1 5.1 22.6 3.9 11.7 17.6 6.3 10.8 5.2 19.5 3.1 6.4 3.7 2.1 12.5 7.7 4.6 0.5 11.6 0.7 5.1 4.7 5.1 0.1 2.6 2.9 2.1 21.2 8.9 4.3 10.3 11.1 25.4 15.1 3.7 18.3 2.7 4.8 17.8 1.1 2.7 0.2 0.9 0.3 0.6 0.5 0.1 0.5 0.3 1.4 0.4 1.5 0.2 2.9 0.2 0.0 0.5 58.8 53.6 8.5 25.2 60.0 39.9 66.1 16.4 26.4 38.6 HIST1H4K "dJ160A22.1, H4/d, H4F2iii, H4FD" ENSG00000273542 "Histone cluster 1 H4 family member k" P62805 6 27831216-27831527 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.4;lung: 2.9;lymphoid tissue: 3.1" "Group enriched" "Detected in some" 5 "HHSteC: 2.8;LHCN-M2: 2.8;RT4: 1.6;U-87 MG: 1.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA042201 Supported 30000000 "HPA042201: " "unprognostic (3.19e-1)" "unprognostic (9.09e-3)" "unprognostic (1.16e-1)" "unprognostic (4.84e-3)" "unprognostic (9.63e-2)" "unprognostic (9.13e-2)" "unprognostic (1.48e-1)" "unprognostic (4.80e-2)" "unprognostic (1.09e-1)" "unprognostic (2.58e-1)" "unprognostic (7.39e-2)" "unprognostic (5.79e-2)" "unprognostic (3.13e-2)" "unprognostic (2.79e-1)" "unprognostic (3.45e-1)" "unprognostic (4.16e-2)" "unprognostic (1.02e-1)" 0.7 0.0 1.0 3.1 3.4 0.0 0.0 0.7 2.0 0.4 0.6 0.3 0.0 0.0 0.0 0.5 2.1 0.0 1.3 0.0 0.3 0.1 0.0 2.9 2.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 1.6 0.0 0.7 1.1 0.0 0.9 0.0 2.1 0.5 2.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 HIST2H3C "H3, H3.2, H3/m, H3F2, H3FM, MGC9629" ENSG00000203811 "Histone cluster 2 H3 family member c" Q71DI3 1 149839538-149841193 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.8;brain: 5.1;prostate: 3.6" "Cell line enhanced" "Detected in many" "HEK 293: 5.5;SiHa: 8.3;U-266/70: 7.3;U-266/84: 7.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "HPA042570, CAB069990" Approved "CAB069990: AB_10804539, HPA042570: " "unprognostic (1.78e-1)" "unprognostic (2.25e-1)" "unprognostic (2.42e-1)" "unprognostic (1.36e-2)" 0.4 0.5 0.7 0.4 1.4 3.8 0.0 5.1 2.9 0.1 0.3 0.8 0.2 0.0 0.4 1.0 0.0 1.4 0.7 0.2 0.1 0.6 0.3 0.5 0.3 0.0 1.9 0.0 0.1 0.3 3.6 0.0 0.9 0.0 0.2 0.5 0.6 0.0 0.4 0.4 1.1 1.4 0.1 0.0 0.4 0.6 0.4 0.6 1.6 0.2 0.2 0.1 0.2 0.5 3.2 0.6 0.4 0.1 0.0 1.1 0.5 0.1 0.7 0.1 0.5 0.6 0.3 0.5 0.0 2.6 0.0 0.1 0.2 0.8 5.5 0.5 2.5 0.1 0.0 0.4 1.5 0.0 0.0 0.1 0.2 0.1 2.5 3.1 0.1 2.2 1.5 2.0 1.7 1.3 1.3 0.3 1.5 0.0 0.3 4.9 1.1 8.3 2.3 0.4 1.4 1.8 0.0 0.6 4.7 0.3 0.4 7.3 7.2 1.7 0.5 0.6 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.1 1.6 0.2 0.2 0.6 0.0 0.2 HIST3H2A MGC3165 ENSG00000181218 "Histone cluster 3 H2A" Q7L7L0 1 228456979-228457873 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.8;lymphoid tissue: 62.3" "Cell line enhanced" "Detected in many" "HEK 293: 18.4;U-266/70: 18.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 35.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041189 Supported "HPA041189: " "unprognostic (3.65e-3)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (2.71e-1)" "prognostic favourable (3.73e-4)" "unprognostic (1.84e-3)" "unprognostic (2.49e-2)" "unprognostic (4.51e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-2)" "unprognostic (3.20e-2)" "unprognostic (1.96e-1)" "unprognostic (6.67e-3)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (7.76e-2)" 2.5 20.5 4.3 7.0 8.3 11.1 5.8 35.8 8.1 9.9 3.8 2.4 2.0 7.7 5.0 4.4 7.0 4.2 3.8 4.9 5.4 4.6 1.6 1.0 2.5 5.1 5.6 5.3 8.3 4.5 3.5 5.0 3.4 6.5 7.0 2.8 13.9 6.6 3.9 1.0 6.4 4.2 1.5 5.2 6.6 4.7 3.5 4.8 62.3 1.9 5.6 9.3 2.9 9.3 3.4 3.4 5.1 7.1 6.8 11.7 4.3 3.5 1.9 2.5 3.4 2.1 2.1 3.0 1.7 1.7 5.1 3.6 1.8 2.9 1.6 2.1 0.4 8.7 1.8 0.8 1.2 2.5 18.4 2.5 2.5 0.0 4.9 1.7 5.1 4.7 5.2 0.9 2.2 2.1 8.8 0.0 0.0 5.0 2.3 0.0 3.8 4.7 0.0 0.0 13.3 0.8 2.1 15.5 10.9 6.2 5.5 11.9 9.8 1.3 0.8 0.0 0.0 6.8 1.5 18.5 13.1 0.0 1.8 1.8 1.3 5.1 1.7 0.0 7.1 3.1 5.1 3.4 6.8 5.3 3.4 2.0 5.3 5.2 0.7 6.8 7.1 0.6 11.7 4.3 4.3 8.3 35.8 5.9 5.4 4.6 5.6 5.3 6.5 4.8 HIVEP3 "FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C" ENSG00000127124 "Human immunodeficiency virus type I enhancer binding protein 3" Q5T1R4 1 41506365-42035925 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3;lymphoid tissue: 16.6" "Cell line enhanced" "Detected in many" "HDLM-2: 17.5;hTEC/SVTERT24-B: 9.1;Karpas-707: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005728 Approved Supported Nucleoplasm Nucleoplasm "HPA005728: AB_10612117" "unprognostic (2.87e-3)" "unprognostic (2.38e-2)" "unprognostic (4.65e-2)" "unprognostic (2.56e-1)" "unprognostic (1.55e-2)" "unprognostic (6.50e-2)" "unprognostic (2.70e-3)" "unprognostic (3.73e-1)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "unprognostic (2.07e-8)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (1.13e-2)" "unprognostic (3.21e-1)" 4.2 1.5 7.5 5.4 5.7 3.8 3.6 20.3 11.7 1.2 1.4 5.1 0.0 1.2 1.1 1.1 3.2 1.3 2.0 2.1 6.1 3.0 1.4 1.2 4.6 4.1 4.8 4.7 1.6 2.4 2.3 8.3 1.8 6.5 2.2 1.5 0.5 3.7 1.1 1.6 11.7 1.3 2.2 5.0 2.9 1.9 1.4 5.1 16.6 2.9 1.8 5.4 1.9 1.6 1.0 1.5 0.1 3.7 0.2 2.1 1.1 1.8 0.6 0.2 1.7 2.2 1.0 0.0 0.9 0.2 2.3 4.0 0.1 0.3 3.8 0.6 0.9 2.5 0.4 0.4 3.0 17.5 0.5 0.2 0.8 0.0 0.4 0.3 0.3 5.5 0.4 9.1 1.0 0.5 0.0 10.6 1.7 1.1 2.8 0.7 0.5 2.2 1.8 2.7 2.0 1.4 0.3 2.0 0.6 2.5 0.6 0.5 0.8 3.2 3.2 2.0 2.1 0.6 4.3 3.2 1.3 2.5 7.9 0.2 7.1 0.1 1.7 0.0 2.1 3.7 0.5 0.6 0.9 1.0 1.5 1.0 0.2 0.8 0.1 0.2 3.1 0.3 0.3 1.1 7.5 5.7 20.3 11.7 6.1 3.0 4.8 4.7 6.5 5.1 HMGCLL1 "bA418P12.1, DKFZP434G1411" ENSG00000146151 "3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1" Q8TB92 6 55434369-55579214 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.4;pituitary gland: 14.8" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 11.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.74e-3)" "unprognostic (1.54e-2)" "unprognostic (4.08e-3)" "unprognostic (6.11e-2)" "unprognostic (1.41e-1)" "unprognostic (9.54e-3)" "unprognostic (8.97e-3)" "unprognostic (2.12e-2)" "unprognostic (9.27e-3)" "unprognostic (4.11e-2)" "unprognostic (1.18e-4)" "unprognostic (3.13e-3)" "unprognostic (7.57e-2)" "unprognostic (2.55e-1)" "unprognostic (1.52e-1)" 2.2 7.7 7.7 0.9 14.5 0.5 3.4 10.1 18.4 2.2 1.7 3.1 0.3 0.8 0.8 0.6 2.5 1.5 1.8 4.1 8.7 12.6 2.2 1.8 5.7 1.1 9.1 10.0 1.3 3.6 0.8 14.8 12.5 14.6 7.0 2.2 4.8 2.1 2.9 2.4 0.6 2.4 1.6 10.1 0.6 2.9 5.5 3.3 0.0 0.9 0.0 1.0 2.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 14.5 10.1 12.6 8.7 12.6 9.1 10.0 14.6 3.3 HMSD "ACC-6, ACC6, C18orf53" ENSG00000221887 "Histocompatibility minor serpin domain containing" "A8MTL9, P0C7T4" 18 63949301-63981774 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 26.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 7.7;HDLM-2: 18.1;Karpas-707: 7.1" "Cancer enhanced" "Detected in single" "cervical cancer: 1.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 5.0" "Lineage enriched" "Detected in single" 18 "dendritic cells: 5.0" "Secreted to blood" "unprognostic (5.83e-3)" "unprognostic (1.40e-1)" "unprognostic (1.40e-2)" "unprognostic (5.42e-3)" "unprognostic (6.20e-2)" "unprognostic (1.16e-2)" "unprognostic (4.91e-2)" "unprognostic (3.80e-1)" "unprognostic (1.41e-2)" "unprognostic (5.19e-3)" "unprognostic (8.67e-2)" "unprognostic (1.44e-1)" "unprognostic (7.14e-6)" "unprognostic (1.22e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-3)" "unprognostic (3.55e-1)" 1.7 1.9 3.9 3.4 8.4 0.5 1.5 0.6 4.8 0.4 0.8 11.3 0.0 0.7 0.3 0.2 1.3 0.8 0.4 1.0 5.8 4.2 0.3 1.9 3.0 5.9 15.1 1.0 1.2 0.9 0.2 0.3 0.3 12.1 0.3 2.1 0.0 0.6 0.5 0.5 2.9 1.0 0.4 26.1 2.1 1.5 2.1 11.2 1.4 0.8 0.2 4.9 0.5 1.3 0.2 5.0 0.0 0.0 0.0 0.0 0.2 3.2 0.0 0.0 0.0 3.3 7.7 0.0 0.6 2.1 0.3 4.1 0.0 0.8 0.0 0.0 0.9 3.3 1.3 0.2 2.6 18.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 4.2 0.0 2.8 0.1 0.0 0.0 7.1 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.2 1.3 0.0 0.0 3.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.2 3.9 8.4 0.6 3.7 5.8 4.2 15.1 1.0 12.1 11.2 HMX1 "H6, NKX5-3" ENSG00000215612 "H6 family homeobox 1" Q9NP08 4 8846076-8871817 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cataract, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.0;retina: 17.4" "Cell line enhanced" "Detected in some" "AN3-CA: 11.8;EFO-21: 7.0;HEK 293: 12.8;SH-SY5Y: 4.8" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (6.11e-2)" "unprognostic (1.63e-2)" "unprognostic (2.97e-1)" "unprognostic (6.35e-2)" "unprognostic (7.94e-2)" "unprognostic (9.36e-2)" "unprognostic (1.97e-1)" 0.5 1.0 3.9 0.4 3.6 0.3 0.3 0.8 5.0 0.3 0.3 1.1 0.0 0.8 0.3 0.3 0.3 0.3 0.3 0.3 3.1 3.5 0.3 0.3 0.3 0.3 3.6 0.1 0.3 0.3 0.3 0.4 0.3 2.7 0.3 0.4 17.4 0.5 0.3 0.5 0.6 0.3 0.3 1.8 0.3 0.4 3.5 1.6 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 3.6 0.8 2.8 3.1 3.5 3.6 0.1 2.7 1.6 HMX2 NKX5-2 ENSG00000188816 "H6 family homeobox 2" A2RU54 10 123148122-123150672 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.0;brain: 5.1;kidney: 5.5" "Cell line enriched" "Detected in some" 13 "REH: 28.3" "Cancer enhanced" "Detected in single" "cervical cancer: 0.9" "Group enriched" "Detected in some" 41 "hypothalamus: 5.1;pons and medulla: 3.0" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.0" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Region enhanced" "Detected in single" "hypothalamus: 0.6" "Group enriched" "Detected in some" 4 "basal ganglia: 1.1;hypothalamus: 4.0" "CAB013268, CAB022752" Approved "CAB013268: , CAB022752: " "unprognostic (3.98e-2)" "unprognostic (1.00e-3)" "unprognostic (1.44e-1)" "unprognostic (7.18e-2)" "unprognostic (2.73e-2)" "unprognostic (7.64e-2)" "unprognostic (3.29e-1)" "unprognostic (2.10e-3)" "unprognostic (5.29e-1)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.1 1.2 0.0 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.3 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 3.0 0.0 HMX3 NKX5-1 ENSG00000188620 "H6 family homeobox 3" A6NHT5 10 123135962-123137741 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;intestine: 5.7" "Cell line enhanced" "Detected in some" "EFO-21: 3.4;HEL: 5.4;HeLa: 5.0;K-562: 17.9;NB-4: 6.1;SiHa: 5.0" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 11 "hypothalamus: 6.8;pons and medulla: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 1.3" "Group enriched" "Detected in some" 5 "basal ganglia: 2.3;hypothalamus: 8.0" HPA069659 Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA069659: " "unprognostic (1.79e-1)" "unprognostic (9.65e-2)" "unprognostic (6.07e-2)" 1.9 0.1 0.0 1.5 0.1 0.0 0.0 0.0 0.4 0.1 3.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.8 0.9 0.0 0.4 0.2 0.0 0.0 0.9 0.7 0.0 1.3 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 2.0 0.0 0.0 0.8 0.7 5.4 5.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 6.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.0 0.0 0.0 0.0 2.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 6.8 0.0 0.0 2.2 0.0 HOMER1 "HOMER-1B, SYN47, Ves-1" ENSG00000152413 "Homer scaffolding protein 1" Q86YM7 5 79372636-79514217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.9;skeletal muscle: 28.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004437, HPA036521, HPA036522" Enhanced Supported Approved Cytosol Cytosol "CAB004437: AB_627742, HPA036521: AB_2675170, HPA036522: AB_2675171" "unprognostic (2.80e-1)" "unprognostic (5.30e-2)" "unprognostic (4.00e-2)" "unprognostic (5.79e-2)" "unprognostic (8.83e-2)" "unprognostic (6.40e-2)" "unprognostic (2.00e-3)" "unprognostic (2.41e-3)" "unprognostic (2.22e-1)" "unprognostic (3.79e-1)" "unprognostic (3.07e-3)" "unprognostic (3.98e-1)" "unprognostic (7.35e-2)" "unprognostic (9.30e-2)" "unprognostic (1.72e-1)" "unprognostic (2.83e-2)" "unprognostic (2.86e-3)" 3.0 1.6 11.3 2.4 19.7 0.6 2.7 8.4 28.9 4.4 1.6 1.2 0.0 1.0 6.8 4.5 4.7 2.5 6.9 19.1 8.5 4.2 5.9 2.0 5.1 1.3 2.9 13.3 4.7 2.4 4.5 3.6 5.3 5.3 2.0 1.3 2.1 1.9 2.1 28.0 2.6 1.2 4.7 2.2 1.1 2.1 5.1 3.5 1.7 14.4 4.8 1.7 5.0 2.2 2.0 0.6 0.2 0.0 0.4 2.3 0.5 8.4 5.9 8.8 14.0 3.4 2.2 20.4 5.4 4.3 5.5 5.9 9.2 6.0 0.1 16.5 4.6 4.6 10.9 14.6 9.5 1.2 8.6 10.2 2.5 9.1 5.5 4.7 3.3 3.6 9.5 4.9 13.8 2.5 12.4 5.6 7.1 11.9 20.0 3.3 14.9 5.0 13.1 14.5 12.9 5.8 13.2 9.0 5.4 10.2 7.3 5.4 10.0 4.2 0.4 4.1 10.3 4.9 9.5 2.7 6.1 5.0 11.6 1.9 7.8 0.0 0.0 0.1 2.3 0.0 1.3 2.0 0.9 0.7 0.0 1.6 0.5 1.7 0.2 0.4 0.0 0.6 0.0 0.5 11.3 19.7 8.4 18.8 8.5 4.2 2.9 13.3 5.3 3.5 HOXA2 HOX1K ENSG00000105996 "Homeobox A2" O43364 7 27100354-27102811 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1" "Cell line enhanced" "Detected in some" "AN3-CA: 16.5;HaCaT: 6.8;RPTEC TERT1: 5.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 44 "pons and medulla: 15.7" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Region enriched" "Detected in single" 35 "pons and medulla: 6.1" "Region enriched" "Detected in single" 27 "pons and medulla: 7.7" HPA078220 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA078220: " "unprognostic (7.30e-2)" "unprognostic (4.90e-4)" "unprognostic (2.81e-1)" "unprognostic (7.43e-4)" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (1.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.85e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (1.58e-2)" "unprognostic (4.98e-9)" "unprognostic (1.34e-1)" "unprognostic (1.33e-1)" "unprognostic (9.36e-2)" "unprognostic (1.28e-2)" 2.7 1.6 0.3 1.9 0.1 0.0 2.6 0.1 0.2 1.4 4.5 0.2 8.7 1.5 3.4 9.7 8.3 6.3 4.9 1.8 0.1 0.0 4.2 0.7 4.7 1.9 0.3 0.1 3.8 0.4 9.6 0.1 0.1 15.7 2.8 3.5 0.1 0.1 4.1 1.2 2.7 4.3 2.4 18.1 2.9 3.7 0.8 0.1 3.8 2.2 2.9 3.3 3.2 3.5 0.0 0.0 1.8 0.3 0.0 0.1 0.0 1.2 0.8 4.2 16.5 0.0 0.0 0.0 0.2 0.1 0.0 0.1 2.1 4.0 0.2 1.9 0.2 6.8 0.2 0.0 0.0 0.0 2.4 0.0 0.1 0.3 1.9 0.1 0.3 1.0 0.0 3.5 3.3 2.7 0.1 0.0 0.1 0.0 0.0 0.3 0.0 1.0 1.0 0.7 0.0 5.4 0.7 1.2 0.0 0.2 0.0 1.1 0.0 0.0 2.7 0.0 0.2 1.2 0.6 0.0 0.0 0.1 0.1 0.6 2.9 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.0 0.3 0.1 15.7 0.1 HOXB5 "HOX2, HOX2A" ENSG00000120075 "Homeobox B5" P09067 17 48591257-48593961 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6" "Cell line enhanced" "Detected in many" "HEK 293: 21.1;RPTEC TERT1: 15.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 28.1" "Region enriched" "Detected in single" 33 "pons and medulla: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 90 "pons and medulla: 24.0" "Region enriched" "Detected in single" 100 "pons and medulla: 14.7" "HPA043851, HPA074454" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA043851: , HPA074454: " "unprognostic (6.50e-2)" "unprognostic (1.63e-1)" "unprognostic (4.22e-2)" "prognostic favourable (6.28e-4)" "unprognostic (6.48e-3)" "unprognostic (7.12e-2)" "unprognostic (8.14e-2)" "prognostic unfavourable (4.61e-4)" "unprognostic (2.47e-1)" "unprognostic (1.47e-3)" "unprognostic (5.10e-2)" "unprognostic (9.64e-2)" "unprognostic (7.61e-3)" "unprognostic (8.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "prognostic favourable (8.59e-5)" 3.4 3.1 0.2 2.1 0.2 0.0 5.0 0.2 0.7 5.4 10.5 0.2 25.9 1.5 2.2 18.5 0.6 7.2 0.2 0.7 0.2 0.0 16.0 0.4 5.2 0.8 0.2 0.2 1.9 0.5 0.9 0.2 1.2 25.4 1.3 4.7 0.2 0.6 27.6 0.2 0.5 9.5 1.6 22.5 2.0 4.3 0.7 0.2 0.2 0.7 0.2 0.2 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.7 0.0 2.4 2.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.1 2.6 0.0 0.2 0.0 0.0 0.0 21.1 0.9 5.4 0.0 4.1 0.0 1.2 1.3 0.0 2.8 0.0 1.4 1.6 0.0 3.2 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 15.7 1.6 0.0 0.0 0.1 0.0 2.3 0.4 0.0 5.2 0.7 2.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 25.4 0.2 HOXB8 "HOX2, HOX2D" ENSG00000120068 "Homeobox B8" P17481 17 48611377-48614939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6" "Cell line enhanced" "Detected in some" "EFO-21: 20.6;HDLM-2: 9.2;HEK 293: 21.2;LHCN-M2: 10.8;RPTEC TERT1: 22.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 33.3" "Region enriched" "Detected in single" 82 "pons and medulla: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 48 "pons and medulla: 6.8" "Low region specificity" "Detected in many" HPA075905 Supported Nucleoplasm Nucleoplasm "HPA075905: " "unprognostic (4.44e-1)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (2.13e-1)" "unprognostic (1.94e-2)" "unprognostic (9.07e-5)" "unprognostic (6.63e-3)" "unprognostic (1.40e-3)" "unprognostic (6.00e-2)" "unprognostic (5.66e-3)" "unprognostic (2.93e-2)" "unprognostic (1.14e-2)" "prognostic favourable (1.30e-7)" "unprognostic (1.77e-2)" "unprognostic (6.64e-2)" "unprognostic (4.57e-2)" "unprognostic (2.88e-3)" 3.5 4.3 0.0 1.6 0.0 0.0 2.5 0.0 0.0 7.7 2.1 0.0 45.4 0.0 2.1 39.2 0.0 0.9 0.0 0.0 0.0 0.0 16.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.4 0.2 0.2 8.2 1.9 0.8 0.0 0.1 34.6 0.2 0.4 4.0 1.1 49.3 0.0 4.3 2.8 0.0 0.1 0.1 0.0 0.0 5.0 6.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.1 3.2 0.0 0.4 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 20.6 3.2 0.0 0.0 0.0 0.0 9.2 21.2 0.5 0.0 0.0 0.2 0.0 3.1 0.6 0.0 0.0 0.0 1.3 6.1 0.0 10.8 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 22.5 0.5 0.0 0.0 0.3 0.0 3.0 0.2 0.0 5.1 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 HOXC4 "HOX3, HOX3E" ENSG00000198353 "Homeobox C4" P09017 12 54016931-54056030 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.7;ovary: 31.6" "Cell line enhanced" "Detected in many" "HDLM-2: 17.8;HEK 293: 19.6;SH-SY5Y: 16.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 27 "pons and medulla: 29.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 24 "pons and medulla: 9.9" "Region enriched" "Detected in single" 13 "pons and medulla: 3.7" HPA053910 Supported Nucleoplasm Nucleoplasm "HPA053910: " "unprognostic (2.78e-2)" "unprognostic (8.51e-2)" "unprognostic (2.96e-6)" "unprognostic (3.30e-2)" "unprognostic (6.27e-2)" "unprognostic (1.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.63e-3)" "unprognostic (6.42e-2)" "unprognostic (1.42e-1)" "unprognostic (8.83e-3)" "unprognostic (4.37e-2)" "unprognostic (7.81e-2)" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (2.11e-4)" "unprognostic (9.82e-2)" 16.2 4.4 0.7 3.2 0.7 0.0 17.9 0.7 0.7 1.3 2.3 0.6 1.4 0.9 11.5 17.8 6.0 20.9 1.0 1.0 0.7 0.7 15.4 0.8 0.9 3.2 1.1 0.0 31.6 0.7 0.0 0.7 5.8 29.7 2.4 0.0 0.3 0.7 1.3 8.1 4.2 9.2 4.4 10.5 1.2 2.6 8.3 0.9 0.0 1.0 0.0 1.8 2.1 3.4 1.1 0.5 0.0 0.0 0.0 1.1 0.0 3.0 3.1 0.0 13.8 5.8 3.0 0.0 1.4 1.4 1.4 1.0 0.1 2.6 12.0 0.1 10.6 2.7 0.2 0.3 0.8 17.8 19.6 0.1 1.4 0.0 0.6 1.4 0.4 7.6 1.4 8.3 1.4 0.2 0.6 0.0 5.3 0.1 1.6 0.3 0.1 0.0 3.9 4.4 0.0 5.9 0.0 0.0 16.7 2.1 0.7 7.8 10.4 0.7 0.0 7.3 4.2 0.5 7.4 3.2 3.4 6.2 0.4 1.3 7.6 0.0 0.0 0.0 0.8 0.0 0.8 1.1 0.0 0.8 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.5 0.6 0.0 0.7 0.7 0.7 0.7 0.7 0.7 1.1 0.0 29.7 0.9 HOXC5 "HOX3, HOX3D" ENSG00000172789 "Homeobox C5" Q00444 12 54032853-54035358 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.8;ovary: 13.4" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;ASC TERT1: 6.1;HSkMC: 5.7;SH-SY5Y: 9.1" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Region enriched" "Detected in single" 14 "pons and medulla: 8.8" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;naive CD8 T-cell: 1.9" "Lineage enriched" "Detected in single" 59 "T-cells: 5.9" "Region enriched" "Detected in single" 40 "pons and medulla: 4.8" "Region enriched" "Detected in single" 7 "pons and medulla: 1.0" HPA026794 Uncertain Supported "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA026794: AB_10612118" "unprognostic (1.57e-1)" "unprognostic (7.73e-3)" "unprognostic (1.70e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-3)" "unprognostic (2.87e-3)" "unprognostic (6.89e-2)" "unprognostic (9.53e-3)" "unprognostic (1.86e-2)" "unprognostic (2.69e-2)" "unprognostic (2.01e-3)" "unprognostic (1.17e-2)" "unprognostic (7.53e-3)" "unprognostic (2.19e-3)" "unprognostic (1.08e-2)" 1.8 1.6 0.2 1.0 0.2 0.0 1.8 0.2 0.6 0.2 1.6 0.2 0.2 0.3 0.5 5.3 1.7 8.0 1.5 0.2 0.2 0.0 1.5 0.2 0.2 0.3 0.4 0.2 13.4 0.2 0.0 0.2 1.4 8.8 0.2 0.0 0.8 0.2 0.2 4.2 2.1 4.6 2.5 2.6 0.2 3.9 2.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.9 2.1 0.0 8.3 5.0 6.1 0.0 0.5 0.4 0.9 0.7 3.5 0.4 0.0 0.6 2.5 1.3 0.1 0.0 0.3 2.6 2.9 0.0 1.0 0.1 0.2 0.0 0.1 5.7 0.6 4.1 0.4 0.0 0.0 0.0 1.8 1.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 9.1 0.6 0.2 4.3 1.7 0.1 0.0 1.4 0.9 3.1 0.3 0.0 0.0 0.0 0.2 0.1 3.2 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.6 0.2 0.0 0.4 0.2 8.8 0.2 HOXD1 "HOX4, HOX4G" ENSG00000128645 "Homeobox D1" Q9GZZ0 2 176188579-176190907 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9;epididymis: 14.1;seminal vesicle: 20.4" "Cell line enhanced" "Detected in some" "EFO-21: 5.7;Hep G2: 5.9;RPTEC TERT1: 18.3;RT4: 14.1;SCLC-21H: 4.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 6.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "pons and medulla: 1.2" "Low region specificity" "Detected in many" "HPA040062, HPA056900" Enhanced Nucleoplasm Nucleoplasm "HPA040062: , HPA056900: " "unprognostic (8.78e-2)" "unprognostic (9.97e-2)" "unprognostic (7.11e-3)" "unprognostic (1.06e-3)" "unprognostic (2.70e-1)" "unprognostic (3.19e-2)" "unprognostic (7.33e-2)" "unprognostic (4.10e-2)" "unprognostic (2.85e-1)" "unprognostic (2.44e-1)" "unprognostic (9.64e-2)" "unprognostic (4.02e-1)" "unprognostic (1.54e-5)" "unprognostic (4.33e-3)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" 2.4 0.6 1.5 1.1 3.5 0.3 2.0 0.6 3.9 0.5 5.2 18.8 11.8 0.7 0.8 14.1 0.9 8.8 1.4 0.3 4.1 2.2 6.8 0.2 5.7 0.9 9.8 1.3 1.2 0.5 0.2 0.2 0.3 15.5 1.7 3.7 0.3 1.0 20.4 0.3 1.2 4.4 0.9 18.9 1.5 0.7 2.2 6.3 0.0 0.4 0.0 0.5 4.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 5.7 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 5.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 18.3 14.1 4.9 0.8 0.0 0.0 0.9 0.0 0.0 3.3 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.5 0.6 3.2 4.1 2.2 9.8 1.3 15.5 6.3 HOXD12 HOX4H ENSG00000170178 "Homeobox D12" P35452 2 176099730-176101193 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.3;intestine: 3.5;seminal vesicle: 4.8;vagina: 3.7" "Group enriched" "Detected in some" 4 "REH: 7.1;SCLC-21H: 2.0" "Not detected" "Not detected" "Region enriched" "Detected in single" 41 "basal ganglia: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059444 Uncertain "HPA059444: " "unprognostic (1.00e-1)" "unprognostic (2.40e-3)" "unprognostic (1.32e-2)" "unprognostic (3.53e-2)" "unprognostic (1.71e-2)" "unprognostic (1.36e-2)" "unprognostic (7.11e-2)" "unprognostic (4.54e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-2)" 0.1 0.0 0.1 0.1 4.3 0.0 0.1 0.1 0.1 1.4 3.5 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.8 3.4 0.1 0.1 4.8 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.6 0.0 0.1 0.2 1.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 1.1 0.5 0.1 7.1 0.0 0.0 0.0 0.1 2.0 0.2 0.6 0.0 0.9 0.9 0.0 0.0 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 HPCA ENSG00000121905 Hippocalcin P84074 1 32885994-32898441 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 46 "brain: 118.9" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 10.0" "Cancer enriched" "Detected in many" 9 "glioma: 8.0" "Group enriched" "Detected in many" 5 "basal ganglia: 118.9;cerebral cortex: 40.4;hippocampal formation: 42.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basal ganglia: 1321.6;hippocampal formation: 1344.5" "CAB012340, HPA043245" Enhanced "CAB012340: AB_2120209, HPA043245: " "unprognostic (4.60e-2)" "unprognostic (5.96e-3)" "unprognostic (2.16e-3)" "unprognostic (1.19e-3)" "unprognostic (6.72e-3)" "unprognostic (5.18e-2)" "unprognostic (9.08e-3)" "unprognostic (6.71e-3)" "unprognostic (1.18e-1)" "unprognostic (1.33e-1)" "unprognostic (2.32e-3)" "unprognostic (1.98e-2)" "unprognostic (2.36e-2)" "unprognostic (1.12e-2)" "unprognostic (6.42e-2)" "unprognostic (3.09e-2)" "unprognostic (2.85e-3)" 1.2 1.5 13.5 1.2 118.9 1.1 1.2 4.8 82.2 1.4 1.5 2.2 0.0 1.2 1.4 1.2 1.1 1.4 1.3 1.2 42.5 2.8 1.3 1.1 1.1 1.2 3.7 14.5 1.5 1.2 1.1 0.0 1.2 0.0 1.3 1.5 0.6 1.3 1.3 1.1 1.2 1.4 1.3 0.8 1.2 1.2 2.5 12.2 0.0 1.3 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.6 1.4 0.3 0.4 0.0 0.1 0.1 0.3 0.8 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.6 0.0 0.0 10.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 1.0 0.8 0.0 0.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 13.5 118.9 4.8 40.4 42.5 2.8 3.7 14.5 0.0 12.2 HPCAL1 "BDR1, HLP2, VILIP-3" ENSG00000115756 "Hippocalcin like 1" P37235 2 10302889-10427617 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 103.3" "Cell line enhanced" "Detected in all" "HDLM-2: 62.1;PC-3: 68.4;U-87 MG: 67.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043245 Approved 35000 "HPA043245: " "unprognostic (3.22e-1)" "unprognostic (2.37e-1)" "unprognostic (1.98e-2)" "unprognostic (1.11e-1)" "prognostic unfavourable (4.11e-5)" "unprognostic (2.73e-1)" "unprognostic (6.76e-3)" "unprognostic (5.26e-2)" "unprognostic (7.36e-3)" "unprognostic (4.16e-2)" "unprognostic (1.04e-1)" "unprognostic (3.28e-1)" "prognostic unfavourable (4.39e-6)" "unprognostic (4.06e-1)" "unprognostic (3.64e-2)" "unprognostic (1.04e-1)" "unprognostic (2.55e-1)" 11.8 20.7 30.5 13.8 17.7 7.5 19.7 103.3 42.2 9.8 16.8 8.6 5.4 20.5 22.6 10.3 4.8 12.1 9.7 10.9 18.0 41.0 16.3 13.4 31.9 14.4 17.9 31.1 6.1 26.5 2.9 15.3 14.8 17.6 5.7 12.8 14.0 10.6 5.9 6.2 6.1 35.3 17.1 14.5 14.6 28.1 13.2 6.0 10.0 10.2 3.8 10.0 6.7 8.3 13.6 21.0 33.8 23.9 11.0 24.3 12.4 9.8 17.2 1.2 5.0 2.8 7.2 12.0 8.0 21.8 11.6 12.8 6.0 25.2 3.8 9.5 5.9 3.6 3.2 11.0 5.2 62.1 5.5 8.5 19.3 13.1 12.5 5.2 17.3 3.9 5.1 27.7 8.6 15.3 7.9 25.5 20.7 13.4 4.3 32.0 6.5 68.4 5.7 4.8 16.7 16.7 2.8 4.5 30.5 8.4 10.2 19.4 3.2 13.9 18.3 14.6 4.5 15.4 13.4 7.7 8.3 1.9 67.4 12.9 34.1 10.8 23.9 28.5 11.1 19.0 12.5 13.6 19.9 14.3 21.0 11.3 24.3 15.5 33.8 11.0 16.6 7.6 15.9 12.4 30.5 17.7 103.3 42.2 18.0 41.0 17.9 31.1 17.6 6.0 HPCAL4 "DKFZp761G122, HLP4" ENSG00000116983 "Hippocalcin like 4" Q9UM19 1 39678648-39691689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 80.4" "Cell line enhanced" "Detected in some" "Karpas-707: 3.9;SH-SY5Y: 13.1;SK-MEL-30: 4.1;U-2 OS: 2.8;U-266/70: 3.4;U-266/84: 4.2" "Group enriched" "Detected in some" 11 "glioma: 5.4;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 5.6;naive CD4 T-cell: 5.0" "Lineage enriched" "Detected in single" 33 "T-cells: 5.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 336.7;basal ganglia: 201.9;cerebral cortex: 348.1;hippocampal formation: 324.0;olfactory region: 266.4" HPA053808 Approved Cytosol Cytosol "HPA053808: " "unprognostic (2.62e-1)" "unprognostic (2.37e-1)" "unprognostic (2.13e-2)" "unprognostic (8.56e-4)" "unprognostic (4.73e-3)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (4.89e-3)" "unprognostic (1.27e-1)" "unprognostic (3.18e-2)" "unprognostic (4.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.62e-3)" "unprognostic (3.78e-3)" "unprognostic (2.77e-2)" "unprognostic (3.97e-2)" "unprognostic (2.63e-1)" 1.2 10.2 35.8 1.8 46.0 1.5 1.2 31.1 80.4 1.2 1.2 3.7 0.0 1.3 1.2 1.5 5.5 1.2 1.3 1.4 28.3 17.0 3.5 1.2 1.7 1.9 7.5 32.7 3.7 4.7 1.2 0.4 1.2 6.8 1.4 1.3 0.0 1.2 1.3 2.1 1.2 1.3 1.2 4.4 1.4 1.3 4.1 3.0 0.0 1.2 0.0 1.8 1.3 0.0 0.0 0.1 0.0 0.0 0.0 5.6 1.8 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.0 0.3 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.6 0.0 1.2 13.1 0.4 0.0 4.1 0.0 0.1 0.0 0.0 2.8 0.0 0.0 3.4 4.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.4 0.0 5.6 1.0 0.1 0.0 5.0 1.8 0.0 0.0 0.0 0.0 3.8 1.8 35.8 46.0 31.1 40.4 28.3 17.0 7.5 32.7 6.8 3.0 HRH3 GPCR97 ENSG00000101180 "Histamine receptor H3" Q9Y5N1 20 62214970-62220267 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "brain: 50.1" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 18.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "unprognostic (1.56e-1)" "unprognostic (3.22e-1)" "unprognostic (4.15e-2)" "unprognostic (1.79e-1)" "unprognostic (2.77e-2)" "unprognostic (1.62e-2)" "unprognostic (7.30e-2)" "unprognostic (3.17e-4)" "unprognostic (2.40e-1)" "unprognostic (3.66e-3)" "unprognostic (3.30e-1)" "unprognostic (3.59e-2)" 1.0 2.3 5.7 0.8 50.1 0.9 0.9 16.7 20.6 0.8 0.9 2.8 0.0 1.0 0.8 0.8 0.9 0.8 0.8 0.8 5.1 16.5 0.9 0.9 0.9 0.9 2.7 8.7 0.8 0.8 0.8 0.7 0.8 2.6 1.4 0.9 0.0 1.1 0.8 0.8 1.6 0.9 0.9 1.0 0.8 0.9 1.6 10.5 0.0 0.8 0.0 0.9 2.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.9 0.0 0.0 0.0 1.2 0.0 0.1 18.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.7 50.1 16.7 15.1 5.1 16.5 2.7 8.7 2.6 10.5 HRK DP5 ENSG00000135116 "Harakiri, BCL2 interacting protein" O00198 12 116856144-116881441 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.3;lymphoid tissue: 12.9;thyroid gland: 8.1" "Cell line enhanced" "Detected in some" "Daudi: 7.6;SCLC-21H: 6.5;SH-SY5Y: 5.6;SK-MEL-30: 14.9;U-698: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "eosinophil: 2.2;memory B-cell: 6.7;naive B-cell: 5.5" "Group enriched" "Detected in many" 45 "B-cells: 6.7;granulocytes: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB025973 Uncertain "CAB025973: " "unprognostic (9.38e-2)" "unprognostic (6.19e-2)" "unprognostic (1.14e-1)" "unprognostic (1.93e-3)" "unprognostic (2.54e-1)" "unprognostic (7.30e-2)" "unprognostic (1.82e-1)" "unprognostic (1.67e-2)" "unprognostic (1.10e-1)" "unprognostic (8.44e-3)" "unprognostic (1.28e-1)" "unprognostic (1.46e-1)" "unprognostic (7.24e-3)" "unprognostic (5.21e-2)" "unprognostic (2.49e-1)" "unprognostic (1.66e-1)" "unprognostic (9.42e-2)" 0.5 1.9 10.1 1.2 3.2 1.7 2.9 0.5 17.3 0.4 0.6 1.3 0.0 0.4 0.5 0.4 0.5 1.4 0.4 0.6 12.1 3.6 0.4 0.3 0.6 1.9 1.8 4.1 0.4 0.6 0.3 5.0 0.4 2.6 0.4 0.7 0.0 1.0 0.3 1.3 0.6 0.5 0.4 1.1 0.8 0.4 1.4 0.6 12.9 8.1 0.0 1.8 0.4 0.2 6.7 0.0 2.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.3 0.0 3.1 1.7 0.0 0.0 0.0 3.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.7 0.1 0.7 0.0 1.0 0.1 0.0 6.5 5.6 0.4 0.0 14.9 0.4 0.1 0.0 0.0 1.3 0.2 0.0 0.7 0.3 25.8 0.0 0.3 0.0 0.1 0.0 2.2 0.0 0.0 0.0 6.7 0.0 0.0 0.0 5.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 10.1 3.2 0.5 8.5 12.1 3.6 1.8 4.1 2.6 0.6 HS3ST1 3OST1 ENSG00000002587 "Heparan sulfate-glucosamine 3-sulfotransferase 1" O14792 4 11393150-11429765 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4;gallbladder: 31.9;ovary: 30.3" "Cell line enhanced" "Detected in some" "A-431: 4.4;CAPAN-2: 14.0;HaCaT: 4.2;RPTEC TERT1: 12.4;RT4: 10.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 8 "cerebellum: 27.4;cerebral cortex: 9.0" "Group enriched" "Detected in some" 39 "memory B-cell: 7.3;naive B-cell: 15.8;plasmacytoid DC: 22.3" "Group enriched" "Detected in many" 99 "B-cells: 15.8;dendritic cells: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002237 Approved Approved Vesicles "Intracellular and membrane" Vesicles "HPA002237: AB_1079085" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (4.01e-2)" "prognostic favourable (7.73e-4)" "unprognostic (3.32e-2)" "unprognostic (8.90e-3)" "unprognostic (4.21e-1)" "unprognostic (2.08e-1)" "unprognostic (2.22e-1)" "unprognostic (1.32e-1)" "unprognostic (1.77e-2)" "unprognostic (1.08e-1)" "prognostic favourable (5.99e-8)" "unprognostic (9.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.57e-1)" "prognostic favourable (8.67e-4)" 2.3 2.9 1.6 2.8 2.2 2.8 2.0 27.4 9.0 3.3 2.7 1.1 3.6 3.5 4.3 5.0 10.2 4.3 31.9 2.2 1.7 1.8 10.4 0.9 3.4 2.1 1.9 1.5 30.3 1.1 0.7 8.9 1.0 2.4 3.2 1.7 1.7 3.7 2.4 0.7 0.8 2.9 1.7 2.2 3.0 7.0 3.0 0.3 3.8 1.8 7.0 7.4 7.3 2.4 15.8 22.3 0.1 0.1 0.0 0.1 0.6 4.4 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.0 0.0 0.4 0.0 4.2 0.0 2.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.9 1.1 1.0 0.0 0.0 12.4 10.1 3.7 0.0 0.0 0.1 0.5 0.0 0.0 2.0 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.1 7.3 0.0 0.0 0.3 15.8 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.6 1.6 2.2 27.4 9.0 1.7 1.8 1.9 1.5 2.4 0.3 HS3ST2 3OST2 ENSG00000122254 "Heparan sulfate-glucosamine 3-sulfotransferase 2" Q9Y278 16 22814177-22916338 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 12.7;brain: 38.2;lung: 13.4" "Group enriched" "Detected in some" 5 "HaCaT: 10.2;SH-SY5Y: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017736 Approved "HPA017736: AB_1851095" "unprognostic (4.09e-2)" "unprognostic (2.90e-3)" "unprognostic (5.97e-3)" "unprognostic (3.46e-3)" "prognostic unfavourable (1.57e-4)" "unprognostic (2.00e-1)" "unprognostic (1.05e-1)" "unprognostic (2.17e-3)" "unprognostic (1.83e-1)" "unprognostic (2.75e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "prognostic favourable (1.35e-4)" "unprognostic (4.89e-2)" "unprognostic (1.16e-1)" "unprognostic (1.35e-1)" "unprognostic (3.00e-2)" 12.7 1.7 3.8 1.1 6.5 1.1 2.4 0.5 38.2 2.0 1.4 0.3 0.3 1.0 1.0 1.0 1.2 1.0 1.1 3.8 7.8 4.3 1.0 2.2 13.4 2.1 2.2 8.4 4.5 1.0 1.0 0.4 1.2 1.5 2.0 1.4 5.0 2.9 1.1 1.0 2.0 1.0 1.2 1.0 1.1 1.1 1.1 0.0 0.0 1.8 0.4 1.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 6.5 0.5 19.1 7.8 4.3 2.2 8.4 1.5 0.0 HS3ST4 3OST4 ENSG00000182601 "Heparan sulfate-glucosamine 3-sulfotransferase 4" Q9Y661 16 25692026-26137688 "Enzymes, Predicted membrane proteins" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 23.9" "Group enriched" "Detected in some" 4 "NTERA-2: 5.4;SCLC-21H: 2.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (1.09e-2)" "unprognostic (1.87e-1)" "unprognostic (2.95e-1)" "unprognostic (2.24e-1)" "unprognostic (1.43e-3)" "unprognostic (1.27e-1)" "unprognostic (3.84e-1)" "unprognostic (8.81e-3)" "unprognostic (6.71e-2)" "unprognostic (2.39e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-2)" "unprognostic (3.67e-2)" 0.7 0.8 6.9 0.6 9.3 0.6 5.1 6.8 23.9 1.1 0.6 2.6 0.0 0.6 0.7 1.3 0.9 0.7 0.6 0.6 11.5 10.0 0.7 0.6 0.6 0.6 5.9 10.8 0.7 0.6 0.6 0.1 0.6 14.3 2.0 0.6 0.3 0.8 0.6 0.6 0.7 0.6 0.6 2.2 3.7 1.1 1.3 1.5 0.0 0.6 0.0 0.8 1.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 9.3 6.8 13.4 11.5 10.0 5.9 10.8 14.3 1.5 HS3ST5 3-OST-5 ENSG00000249853 "Heparan sulfate-glucosamine 3-sulfotransferase 5" Q8IZT8 6 114055586-114343045 "Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.1;seminal vesicle: 9.4;skeletal muscle: 10.1" "Cell line enhanced" "Detected in some" "PC-3: 4.9;RT4: 9.0;SCLC-21H: 17.5;U-266/70: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA021823, HPA064677" Approved "HPA021823: AB_1851100, HPA064677: AB_2685318" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" "unprognostic (2.81e-2)" "unprognostic (1.04e-2)" "unprognostic (1.72e-2)" "unprognostic (3.00e-2)" "unprognostic (7.98e-4)" "unprognostic (5.39e-2)" "unprognostic (6.29e-2)" "unprognostic (1.61e-1)" "unprognostic (1.91e-1)" "unprognostic (5.72e-2)" "unprognostic (3.28e-2)" "unprognostic (3.01e-1)" "unprognostic (3.48e-1)" "unprognostic (1.53e-2)" 0.5 1.9 3.3 0.9 13.1 1.3 0.5 0.6 11.9 0.8 1.0 9.1 3.5 0.7 0.8 0.5 0.6 0.6 0.7 0.5 4.2 3.5 0.9 0.5 1.1 0.5 6.1 2.7 0.6 1.3 0.5 0.3 0.6 7.8 0.7 0.9 0.6 0.7 9.4 10.1 1.3 1.2 0.9 7.5 0.5 1.2 0.9 8.0 0.0 0.6 0.0 0.5 2.5 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 4.9 0.0 1.0 0.0 0.0 9.0 17.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 4.4 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.3 13.1 0.6 5.7 4.2 3.5 6.1 2.7 7.8 8.0 HS6ST2 ENSG00000171004 "Heparan sulfate 6-O-sulfotransferase 2" Q96MM7 X 132626016-132961395 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5;kidney: 17.3;ovary: 18.2" "Cell line enhanced" "Detected in some" "HEK 293: 19.3;HeLa: 13.1;RH-30: 28.0;RT4: 13.9;SH-SY5Y: 34.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 29.5" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Lineage enhanced" "Detected in single" "NK-cells: 1.8" "Low region specificity" "Detected in all" "HPA034625, HPA034626" Uncertain Uncertain Nucleoplasm Nucleoplasm "HPA034625: AB_10612119, HPA034626: " "unprognostic (7.62e-3)" "unprognostic (4.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.41e-1)" "unprognostic (3.24e-1)" "unprognostic (5.54e-2)" "unprognostic (1.44e-1)" "unprognostic (1.71e-2)" "unprognostic (1.14e-2)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-1)" "unprognostic (8.39e-5)" "unprognostic (1.36e-3)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "prognostic favourable (6.03e-4)" 0.4 3.2 6.5 0.9 29.5 0.1 2.6 3.0 6.7 1.0 0.8 0.8 0.6 0.3 4.5 3.2 5.0 2.5 0.5 0.4 4.1 9.1 17.3 0.2 1.0 0.3 3.5 0.9 18.2 6.5 0.1 1.3 9.9 3.3 5.4 1.2 0.0 1.1 1.6 6.7 0.3 0.2 2.0 3.3 0.2 1.1 7.9 0.7 0.7 0.6 1.7 2.7 2.3 0.6 0.0 0.0 0.0 0.0 1.8 0.6 0.0 4.3 0.0 6.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.0 0.0 0.0 6.4 0.0 0.2 9.1 0.0 0.0 0.0 19.3 0.0 13.1 0.0 0.0 0.0 0.0 0.3 8.5 0.0 0.0 0.4 0.0 0.0 0.0 3.1 0.1 0.0 4.9 0.2 0.0 28.0 0.0 5.6 13.9 0.7 34.9 6.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.0 9.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.5 29.5 3.0 5.8 4.1 9.1 3.5 0.9 3.3 0.7 HS6ST3 ENSG00000185352 "Heparan sulfate 6-O-sulfotransferase 3" Q8IZP7 13 96090839-96839562 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.7" "Cell line enriched" "Detected in some" 6 "RT4: 19.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078257 Approved "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments" "Intracellular and membrane" 9800 "Nucleoplasm, Nuclear membrane" "Plasma membrane, Actin filaments" "HPA078257: " "unprognostic (2.34e-2)" "unprognostic (1.90e-2)" "unprognostic (2.82e-2)" "unprognostic (1.72e-2)" "unprognostic (4.88e-2)" "unprognostic (2.78e-2)" "unprognostic (1.55e-1)" "unprognostic (3.67e-3)" "unprognostic (8.11e-3)" "unprognostic (1.19e-1)" "prognostic favourable (6.12e-5)" "unprognostic (1.54e-4)" "unprognostic (2.24e-1)" "unprognostic (1.57e-3)" "unprognostic (9.89e-2)" 0.9 4.5 1.5 0.0 1.9 0.0 0.0 0.4 18.7 1.9 0.0 0.2 2.1 2.2 0.2 0.1 0.0 0.2 3.2 2.7 0.7 0.0 0.0 0.0 0.9 0.0 2.1 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.0 1.6 0.4 0.0 0.7 0.1 2.4 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 19.2 1.0 0.8 0.1 0.1 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSD11B1L "SCDR10, SDR26C2" ENSG00000167733 "Hydroxysteroid 11-beta dehydrogenase 1 like" Q7Z5J1 19 5680604-5688523 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 34.4" "Cell line enhanced" "Detected in many" "SH-SY5Y: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049078 Supported Vesicles "Secreted in brain" Vesicles "HPA049078: " "unprognostic (2.34e-2)" "unprognostic (1.10e-1)" "unprognostic (4.73e-3)" "unprognostic (5.26e-2)" "unprognostic (9.37e-2)" "prognostic favourable (4.38e-4)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (1.18e-3)" "unprognostic (1.43e-1)" "unprognostic (3.33e-2)" "unprognostic (1.75e-1)" "unprognostic (5.77e-2)" "unprognostic (4.52e-1)" "unprognostic (1.73e-2)" 3.9 8.8 34.4 2.1 19.2 4.7 5.0 10.3 29.7 3.9 2.9 5.4 3.7 2.6 3.6 8.5 2.2 7.6 4.8 3.8 25.4 16.1 6.7 3.5 4.4 2.3 11.7 20.4 6.1 6.2 5.8 8.5 2.5 10.7 4.0 1.9 3.2 9.1 6.9 15.0 6.9 2.9 2.7 6.0 2.6 3.3 4.3 7.5 0.0 6.6 1.3 1.8 2.5 2.2 2.5 4.8 2.5 5.8 1.4 4.5 1.7 3.0 2.9 10.7 2.0 5.1 5.5 2.2 2.3 4.6 1.1 4.7 1.3 3.0 0.7 5.1 2.0 1.5 1.3 1.7 1.0 2.5 3.3 2.0 2.6 1.9 3.5 0.8 7.3 5.4 3.7 1.7 1.5 1.7 1.9 2.9 4.3 0.4 1.8 2.1 2.9 3.4 3.4 0.4 2.6 8.9 0.7 2.9 17.8 0.5 1.5 11.4 2.5 0.7 2.9 2.7 4.8 4.5 1.8 7.2 2.3 0.8 7.4 1.1 2.1 1.7 2.5 0.2 1.2 5.8 1.6 1.2 3.2 3.6 2.3 2.5 4.5 3.9 2.5 1.4 2.9 4.8 0.9 1.7 34.4 19.2 10.3 29.7 25.4 16.1 11.7 20.4 10.7 7.5 HSPA12A "FLJ13874, KIAA0417" ENSG00000165868 "Heat shock protein family A (Hsp70) member 12A" O43301 10 116671192-116850236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "basophil: 3.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011273, HPA073244" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA011273: AB_1851190, HPA073244: " "unprognostic (7.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.27e-1)" "unprognostic (1.07e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-2)" "unprognostic (1.44e-1)" "unprognostic (7.31e-3)" "unprognostic (5.79e-2)" "unprognostic (1.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.62e-1)" "prognostic unfavourable (3.61e-7)" "unprognostic (2.85e-2)" "unprognostic (1.66e-1)" "unprognostic (3.75e-1)" "unprognostic (5.55e-4)" 21.2 24.9 15.4 4.0 21.8 1.1 7.5 10.2 47.7 7.6 6.3 6.8 3.3 2.1 9.4 8.0 5.3 9.1 5.9 6.4 17.1 15.5 23.5 1.9 2.8 2.0 17.1 17.8 23.5 3.0 4.0 17.2 4.2 23.3 4.1 4.9 7.4 3.6 9.1 4.9 9.5 2.9 8.6 8.2 3.6 2.8 8.2 8.6 0.0 6.8 1.2 1.6 4.1 6.6 0.0 0.0 3.1 0.0 0.0 0.4 0.0 2.3 8.9 0.9 7.8 9.0 6.5 0.4 4.5 9.0 2.2 1.2 8.3 0.1 0.0 2.4 5.5 5.9 5.8 0.7 7.4 0.0 3.1 0.0 3.1 8.7 1.2 0.0 0.7 2.7 3.6 6.7 0.6 0.0 0.0 0.0 1.2 1.5 0.0 0.0 0.7 0.0 0.0 2.7 0.1 33.9 0.1 2.0 11.7 2.6 2.2 3.1 1.7 0.0 0.0 2.1 3.6 11.9 4.4 0.1 0.0 0.0 3.6 0.0 1.5 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 21.8 10.2 32.4 17.1 15.5 17.1 17.8 23.3 8.6 HSPA2 ENSG00000126803 "Heat shock protein family A (Hsp70) member 2" P54652 14 64535905-64546173 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0;skeletal muscle: 90.5" "Cell line enhanced" "Detected in many" "A549: 24.6;BEWO: 38.4;BJ hTERT+: 32.8;SCLC-21H: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000798, HPA052504" Enhanced Supported Approved Nucleoplasm,Vesicles 77000000 Vesicles Nucleoplasm "HPA000798: AB_1079090, HPA052504: " "prognostic favourable (1.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (1.08e-2)" "unprognostic (3.78e-2)" "unprognostic (2.90e-2)" "unprognostic (7.11e-2)" "prognostic unfavourable (9.11e-4)" "unprognostic (1.31e-1)" "unprognostic (3.14e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" 5.2 3.3 21.1 5.2 45.3 1.5 5.2 3.7 37.6 3.3 23.3 87.0 0.1 4.4 13.8 12.8 25.2 7.2 4.2 22.8 33.2 18.7 26.6 2.6 4.5 3.2 71.0 20.6 2.4 3.8 7.5 4.3 37.6 37.7 3.8 6.9 3.5 10.2 4.0 90.5 14.8 7.8 17.9 83.8 8.5 5.7 58.8 65.2 0.0 2.3 8.2 3.9 12.4 4.0 0.7 0.3 2.4 0.6 0.9 3.7 0.5 9.6 24.6 3.8 0.0 2.7 0.2 38.4 13.9 32.8 5.6 9.2 0.9 17.4 2.4 5.6 15.1 11.0 0.0 0.7 3.4 1.3 1.9 0.0 1.4 0.0 2.7 0.0 3.3 1.2 0.5 0.8 0.0 0.3 0.0 2.0 2.7 4.3 0.1 0.1 2.8 3.0 1.9 0.0 0.0 8.6 1.5 34.1 1.9 0.6 1.2 0.0 0.9 1.0 0.5 0.1 0.0 1.2 0.0 2.5 0.0 0.0 3.1 0.0 3.7 0.9 0.2 0.1 1.8 0.4 0.1 0.7 1.7 0.8 0.0 0.5 0.6 0.6 2.4 0.9 0.6 0.3 3.7 0.5 21.1 45.3 3.7 28.3 33.2 18.7 71.0 20.6 37.7 65.2 HTR1A "5-HT1A, ADRB2RL1, ADRBRL1" ENSG00000178394 "5-hydroxytryptamine receptor 1A" P08908 5 63960356-63962507 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 21.5;ovary: 10.4" "Group enriched" "Detected in some" 32 "NTERA-2: 5.3;SCLC-21H: 4.3" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 14.7;cerebral cortex: 10.7;hippocampal formation: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA018073 Uncertain "HPA018073: AB_1856704" "unprognostic (1.81e-1)" 0.2 0.4 14.7 0.2 1.0 0.2 0.2 0.1 10.7 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.5 21.5 2.4 0.2 0.2 0.3 0.2 0.7 2.7 10.4 0.2 0.2 0.1 0.2 0.9 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.6 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 1.0 0.1 10.7 21.5 2.4 0.7 2.7 0.9 0.0 HTR1B "5-HT1B, 5-HT1DB, HTR1D2, S12" ENSG00000135312 "5-hydroxytryptamine receptor 1B" P28222 6 77461753-77463773 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;placenta: 14.2;stomach 1: 10.2" "Group enriched" "Detected in some" 15 "HUVEC TERT2: 40.8;TIME: 18.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "basal ganglia: 11.8" "Cell type enriched" "Detected in single" 17 "basophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" "Region enriched" "Detected in many" 4 "basal ganglia: 34.5" HPA028808 Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA028808: " "unprognostic (3.86e-2)" "unprognostic (3.56e-1)" "unprognostic (7.68e-2)" "unprognostic (2.58e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.11e-1)" "unprognostic (8.96e-2)" "unprognostic (4.03e-1)" "unprognostic (1.77e-2)" "unprognostic (1.24e-1)" "unprognostic (1.10e-3)" "unprognostic (3.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" 2.2 1.5 1.3 1.1 11.8 0.3 2.4 0.4 3.7 2.9 0.6 0.1 0.0 0.6 1.1 1.0 1.4 0.8 2.8 0.4 1.0 2.1 0.9 0.3 1.1 0.3 1.2 0.9 1.1 0.5 0.3 0.5 14.2 3.0 1.6 0.4 0.3 1.3 1.2 0.9 0.5 0.4 4.1 0.6 0.4 10.2 1.5 0.6 0.0 0.5 0.0 0.3 2.6 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.4 1.0 40.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 11.8 0.4 3.7 1.0 2.1 1.2 0.9 3.0 0.6 HTR1D "5-HT1D, HT1DA, HTRL, RDC4" ENSG00000179546 "5-hydroxytryptamine receptor 1D" P28221 1 23191895-23194729 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;intestine: 12.2" "Cell line enhanced" "Detected in some" "A549: 8.7;CAPAN-2: 6.3;SiHa: 5.9;TIME: 22.0;U-2 OS: 7.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in some" "basal ganglia: 7.6" "Low region specificity" "Detected in many" "unprognostic (1.73e-2)" "unprognostic (8.69e-3)" "unprognostic (8.86e-3)" "unprognostic (2.03e-1)" "unprognostic (2.65e-2)" "unprognostic (5.97e-4)" "prognostic unfavourable (1.86e-4)" "unprognostic (3.87e-3)" "unprognostic (8.88e-2)" "unprognostic (4.00e-2)" "prognostic unfavourable (5.30e-4)" "unprognostic (3.17e-2)" "unprognostic (3.28e-6)" "unprognostic (9.14e-2)" "unprognostic (2.27e-1)" "unprognostic (2.45e-1)" "unprognostic (8.02e-3)" 0.0 0.0 0.3 0.0 3.9 0.1 0.0 0.0 0.2 0.0 0.1 12.2 0.0 0.0 0.0 0.5 1.9 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 10.4 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.5 0.0 1.0 0.7 2.2 1.2 1.2 0.9 0.2 2.6 8.7 0.0 0.0 0.0 0.2 0.8 0.0 0.6 0.3 0.3 0.6 6.3 0.0 2.6 0.3 1.9 1.7 0.0 0.4 0.0 0.7 0.0 5.1 0.1 0.3 0.0 0.0 0.1 0.1 1.1 0.4 5.2 0.0 0.0 0.2 1.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.2 0.0 2.2 0.0 5.9 0.4 0.1 0.1 0.0 22.0 0.0 7.4 0.1 2.1 0.0 0.0 0.1 0.0 0.0 0.1 1.7 1.2 0.5 0.6 0.8 0.4 1.0 0.9 0.6 0.4 1.0 0.6 0.6 2.2 1.2 1.0 0.7 0.4 0.2 HTR1E 5-HT1E ENSG00000168830 "5-hydroxytryptamine receptor 1E" P28566 6 86937306-87016683 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.4;ovary: 13.3" "Group enriched" "Detected in some" 22 "PC-3: 2.9;SH-SY5Y: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA004931 Approved "HPA004931: AB_1856706" "unprognostic (2.25e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (4.52e-2)" "unprognostic (1.25e-1)" 0.5 0.6 8.9 0.6 13.3 0.5 0.5 5.4 16.4 1.6 0.5 0.0 0.0 0.5 5.1 1.1 0.6 0.5 0.8 0.5 4.1 2.8 0.5 0.5 0.5 0.5 1.8 11.4 13.3 0.8 0.5 0.3 0.5 2.2 1.1 0.5 0.0 0.5 1.2 0.5 0.5 0.5 2.9 0.6 0.5 3.6 1.4 1.5 0.0 2.7 0.0 0.5 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 13.3 5.4 16.4 4.1 2.8 1.8 11.4 2.2 1.5 HTR2A "5-HT2A, HTR2" ENSG00000102468 "5-hydroxytryptamine receptor 2A" P28223 13 46831550-46897076 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "Behavior, Host-virus interaction" "G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 30.4" "Cell line enhanced" "Detected in some" "ASC diff: 3.7;ASC TERT1: 9.1;BEWO: 2.8;HEL: 2.8;U-138 MG: 4.6;U-2 OS: 2.9;U-87 MG: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "neutrophil: 1.2;plasmacytoid DC: 1.2" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014011 Enhanced "HPA014011: AB_1856709" "unprognostic (8.01e-2)" "unprognostic (2.71e-2)" "unprognostic (9.49e-2)" "unprognostic (7.40e-2)" "unprognostic (2.78e-1)" "unprognostic (1.99e-1)" "unprognostic (2.70e-2)" "unprognostic (4.31e-2)" "unprognostic (5.27e-2)" "unprognostic (3.97e-2)" "unprognostic (2.61e-1)" "unprognostic (2.90e-1)" "unprognostic (9.94e-5)" "unprognostic (4.78e-3)" "unprognostic (2.54e-1)" "unprognostic (2.91e-2)" "unprognostic (8.28e-2)" 1.9 1.0 9.5 1.7 13.5 0.6 1.3 0.6 30.4 1.6 1.2 1.2 0.0 1.1 1.6 0.6 1.4 1.1 2.9 1.5 3.8 5.1 0.7 0.6 1.0 0.6 3.3 13.3 1.0 0.6 0.6 0.5 0.6 1.8 0.9 1.6 2.0 0.6 1.5 0.9 0.7 1.1 4.4 1.2 0.6 1.0 1.5 0.7 0.0 0.7 0.0 0.8 1.9 1.5 0.1 1.2 1.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 3.7 9.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.0 0.1 4.6 2.9 0.0 0.2 0.1 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 1.2 0.0 1.5 9.5 13.5 0.6 26.4 3.8 5.1 3.3 13.3 1.8 0.7 HTR2C "5-HT2C, 5HTR2C, HTR1C" ENSG00000147246 "5-hydroxytryptamine receptor 2C" P28335 X 114584078-114910061 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "brain: 45.3" "Group enriched" "Detected in some" 4 "EFO-21: 4.9;RPMI-8226: 2.4;U-266/70: 8.7;U-266/84: 7.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Region enhanced" "Detected in many" "basal ganglia: 45.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (2.14e-1)" "unprognostic (6.09e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (2.89e-2)" "unprognostic (3.42e-2)" "unprognostic (9.22e-4)" "unprognostic (1.37e-1)" "unprognostic (6.84e-2)" 0.5 0.5 2.4 0.4 45.3 0.5 0.5 0.0 9.4 2.3 0.4 8.5 0.0 0.4 0.5 0.6 0.4 0.4 0.5 0.4 2.4 9.8 0.5 0.5 0.5 0.4 2.0 1.2 0.4 0.4 0.4 0.3 1.0 29.7 0.9 0.4 0.8 0.4 1.1 0.4 0.4 0.4 0.4 1.7 0.4 0.4 0.6 2.4 0.0 0.4 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 1.3 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.9 0.0 0.0 8.7 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.4 45.3 0.0 4.6 2.4 9.8 2.0 1.2 29.7 2.4 HTR3B 5-HT3B ENSG00000149305 "5-hydroxytryptamine receptor 3B" O95264 11 113904677-113946565 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.7" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "cerebral cortex: 8.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in single" "hypothalamus: 0.4" "Low region specificity" "Detected in many" HPA039559 Approved "HPA039559: AB_10672779" "unprognostic (1.60e-2)" "unprognostic (8.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.28e-1)" "unprognostic (1.71e-1)" "unprognostic (2.46e-1)" 0.2 0.2 1.0 0.8 2.1 2.4 0.2 0.4 8.7 0.3 0.4 0.2 0.0 0.3 0.5 1.6 2.6 0.2 0.2 0.2 1.2 0.7 1.0 0.2 0.2 0.5 0.8 1.4 0.3 0.3 0.1 0.2 0.2 0.0 0.2 0.5 0.0 0.5 0.1 0.5 1.2 0.5 0.1 0.7 0.5 0.3 1.5 0.0 0.0 0.5 0.0 0.5 0.3 0.6 1.6 1.3 2.9 0.9 1.9 0.9 0.1 0.4 1.4 0.8 0.7 1.6 0.9 1.2 0.1 0.2 0.2 0.2 0.9 0.9 1.9 0.5 0.5 0.5 0.6 0.6 0.8 0.5 0.7 0.6 1.9 1.8 0.3 1.5 1.4 1.1 0.5 0.2 0.0 0.2 0.7 1.5 0.3 0.2 0.9 1.6 0.4 0.2 0.8 1.4 0.9 0.9 0.7 0.7 2.7 0.5 1.6 1.1 0.6 0.4 1.8 1.4 1.1 1.4 1.0 1.1 0.7 1.3 0.9 0.5 0.8 1.6 0.9 0.3 0.9 0.5 0.7 1.3 0.8 0.6 0.5 1.6 0.9 0.9 2.9 1.9 0.3 1.3 0.7 0.1 1.0 2.1 0.4 8.7 1.2 0.7 0.8 1.4 0.0 0.0 HTR4 5-HT4 ENSG00000164270 "5-hydroxytryptamine receptor 4" Q13639 5 148451032-148677235 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 18.1;heart muscle: 7.2;intestine: 14.6;pituitary gland: 5.9" "Cell line enriched" "Detected in single" 5 "Karpas-707: 2.6" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 18.1" "Cell type enriched" "Detected in single" 8 "T-reg: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040591 Enhanced "HPA040591: " "unprognostic (1.12e-1)" "unprognostic (4.60e-2)" "unprognostic (7.74e-2)" "unprognostic (2.37e-1)" "unprognostic (5.02e-2)" "unprognostic (3.77e-2)" "unprognostic (4.68e-2)" "unprognostic (1.10e-2)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (3.40e-2)" "unprognostic (2.25e-1)" "unprognostic (4.49e-2)" "unprognostic (8.83e-5)" 0.4 1.4 1.9 1.1 18.1 0.1 0.2 0.1 3.2 0.6 4.3 0.0 0.0 8.0 0.3 0.1 0.3 0.4 1.5 7.2 5.2 0.6 0.1 0.2 0.3 0.2 0.5 1.3 0.2 0.1 0.1 5.9 0.1 0.1 0.1 4.9 0.0 0.2 0.2 0.2 0.2 14.6 1.1 0.3 0.2 0.2 0.2 2.4 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 1.9 18.1 0.1 3.2 5.2 0.6 0.5 1.3 0.1 2.4 HTR5A 5-HT5A ENSG00000157219 "5-hydroxytryptamine receptor 5A" P47898 7 155070324-155085749 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 15.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB017467 Approved "CAB017467: AB_2122566" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.4 0.4 2.6 0.4 3.9 0.4 0.4 15.4 15.0 0.4 0.4 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 2.6 5.9 0.4 0.4 0.4 0.4 2.3 2.5 0.4 0.4 0.4 0.1 0.4 2.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.8 0.4 0.4 1.4 0.3 3.3 0.4 0.0 0.4 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 3.9 15.4 9.8 2.6 5.9 2.3 2.5 2.4 0.3 HTR6 "5-HT6, 5-HT6R" ENSG00000158748 "5-hydroxytryptamine receptor 6" P50406 1 19665287-19679562 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 24.6" "Cell line enhanced" "Detected in some" "MCF7: 1.2;NTERA-2: 2.4;SH-SY5Y: 6.5" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Group enriched" "Detected in many" 5 "basal ganglia: 24.6;cerebral cortex: 6.6" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 9.5" HPA068165 Uncertain "HPA068165: " "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (7.19e-3)" "unprognostic (3.84e-5)" "unprognostic (1.38e-4)" "unprognostic (2.69e-2)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (5.33e-3)" "unprognostic (8.63e-2)" "unprognostic (5.47e-4)" "unprognostic (1.28e-1)" "unprognostic (2.49e-1)" "unprognostic (6.13e-3)" "unprognostic (2.02e-1)" 0.4 0.5 1.2 1.4 24.6 0.4 0.4 0.2 6.6 0.6 0.4 0.0 0.0 0.6 0.6 0.5 0.5 0.6 0.5 0.4 1.4 1.0 0.3 0.3 0.3 1.4 0.5 2.2 0.3 0.3 0.3 0.4 0.3 0.4 0.4 0.3 0.0 0.5 0.3 0.3 0.8 0.5 0.5 0.2 0.4 0.5 0.8 3.2 0.0 0.3 0.0 2.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 1.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.2 24.6 0.2 6.6 1.4 1.0 0.5 2.2 0.4 3.2 HYAL3 "LUCA-3, LUCA14, Minna14" ENSG00000186792 "Hyaluronoglucosaminidase 3" O43820 3 50292831-50299468 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 26.9;bone marrow: 48.8;brain: 12.5;testis: 31.1" "Cell line enhanced" "Detected in many" "HEL: 21.9;HMC-1: 39.3;THP-1: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 12.1;eosinophil: 26.9" "Lineage enriched" "Detected in all" 6 "granulocytes: 26.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049402 Uncertain "Secreted to blood" "HPA049402: " "unprognostic (1.21e-3)" "unprognostic (2.55e-2)" "unprognostic (5.45e-2)" "unprognostic (8.19e-2)" "unprognostic (3.07e-1)" "unprognostic (1.65e-2)" "unprognostic (7.98e-3)" "unprognostic (7.36e-2)" "unprognostic (1.58e-1)" "unprognostic (3.41e-2)" "unprognostic (5.40e-2)" "unprognostic (5.71e-2)" "unprognostic (2.61e-1)" "unprognostic (8.09e-2)" "unprognostic (1.28e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (2.12e-5)" 3.5 4.2 6.3 3.1 8.8 48.8 3.3 11.4 12.5 4.2 3.6 3.8 6.1 3.8 2.7 5.1 5.6 3.7 5.4 3.4 6.4 5.6 2.9 7.0 3.2 4.2 5.3 5.6 4.3 3.7 2.6 3.1 3.6 11.1 4.9 2.9 3.7 6.7 5.6 3.9 3.0 4.1 4.6 3.4 2.8 6.6 31.1 2.7 3.0 3.3 5.1 3.7 4.8 3.8 1.1 4.2 26.9 2.1 1.0 2.2 1.2 2.2 2.5 1.4 1.6 3.0 1.6 0.9 2.4 2.2 3.1 2.3 3.4 2.3 1.9 1.2 2.8 2.4 2.6 5.7 1.1 4.5 1.3 21.9 6.7 2.8 2.1 2.3 39.3 3.2 4.4 3.1 2.0 3.1 1.6 2.4 1.4 1.3 0.9 13.9 1.1 6.4 0.9 1.9 3.5 3.7 0.9 1.8 2.1 3.5 2.8 1.9 1.9 40.4 4.2 2.6 1.9 8.4 1.4 1.1 2.5 1.5 2.3 8.4 2.2 12.1 2.1 26.9 0.7 1.1 1.2 0.9 2.2 1.0 4.2 1.1 0.6 0.8 0.7 1.0 0.7 1.1 1.3 1.2 6.3 8.8 11.4 12.5 6.4 5.6 5.3 5.6 11.1 2.7 HYDIN "CILD5, DKFZp434D0513, KIAA1864, PPP1R31" ENSG00000157423 "HYDIN, axonemal central pair apparatus protein" Q4G0P3 16 70807378-71230722 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5;pituitary gland: 23.6;testis: 19.1" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 5.2;SiHa: 10.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA067155, HPA074129" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA067155: , HPA074129: " "unprognostic (8.90e-2)" "unprognostic (1.04e-2)" "unprognostic (8.65e-2)" "unprognostic (4.88e-4)" "unprognostic (4.25e-3)" "unprognostic (1.81e-1)" "unprognostic (3.87e-2)" "unprognostic (2.45e-1)" "unprognostic (3.95e-1)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (2.52e-5)" "unprognostic (2.13e-3)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (3.97e-2)" 0.8 0.9 6.3 1.2 13.9 1.7 1.5 2.9 4.2 2.1 1.2 13.3 4.4 1.0 2.4 18.4 0.9 14.5 1.9 1.0 6.9 4.3 3.5 1.8 7.1 1.1 2.3 4.1 7.2 1.6 9.0 23.6 0.7 21.5 1.4 0.8 3.9 0.9 1.5 0.8 1.7 1.1 1.0 3.1 1.5 1.1 19.1 3.8 0.0 3.2 0.0 0.6 1.2 0.8 0.9 1.1 3.7 1.3 0.7 1.2 0.2 0.1 0.1 2.1 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.9 0.3 0.2 0.3 0.3 0.7 0.3 0.2 1.6 0.4 0.5 0.1 0.1 0.2 0.4 0.5 0.2 0.4 0.5 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.7 0.8 1.3 0.7 0.2 0.2 0.8 5.2 0.7 2.4 0.5 10.9 0.3 0.4 0.7 0.0 0.3 0.3 0.8 0.1 0.3 1.8 0.1 1.0 0.9 0.2 0.6 1.5 1.0 0.8 1.2 0.9 1.2 0.6 1.0 1.1 0.3 0.9 0.9 0.8 3.7 0.7 1.3 1.1 0.6 0.2 6.3 13.9 2.9 4.2 6.9 4.3 2.3 4.1 21.5 3.8 IBSP "BSP, BSP-II, SP-II" ENSG00000029559 "Integrin binding sialoprotein" P21815 4 87799581-87812435 "Cancer-related genes, Predicted secreted proteins" "Biomineralization, Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.5;cervix, uterine: 4.0;pituitary gland: 6.2" "Cell line enriched" "Detected in some" 6 "U-138 MG: 12.6" "Cancer enhanced" "Detected in many" "glioma: 12.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 0.9" "Not detected" "Not detected" "Secreted in other tissues" "unprognostic (2.53e-2)" "unprognostic (3.55e-2)" "unprognostic (1.49e-2)" "unprognostic (3.93e-1)" "unprognostic (3.75e-2)" "unprognostic (9.48e-3)" "unprognostic (1.03e-3)" "unprognostic (4.07e-2)" "unprognostic (1.12e-2)" "unprognostic (2.39e-1)" "unprognostic (2.02e-3)" "unprognostic (5.81e-11)" "unprognostic (6.20e-2)" "unprognostic (1.96e-1)" "unprognostic (1.30e-3)" "unprognostic (2.11e-1)" 0.2 0.0 1.9 0.6 0.4 1.0 0.1 2.0 4.5 4.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.8 1.3 1.0 0.1 0.0 0.0 0.2 0.1 0.9 0.0 0.0 0.2 0.8 6.2 1.1 2.6 0.4 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 2.0 1.5 1.0 0.1 0.9 0.0 2.6 0.0 ICAM5 "TLCN, TLN" ENSG00000105376 "Intercellular adhesion molecule 5" Q9UMF0 19 10289981-10296778 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 32.6" "Cell line enhanced" "Detected in some" "HEL: 13.2;K-562: 10.5;RPMI-8226: 12.0;U-266/70: 14.5;U-87 MG: 8.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.8" "Group enriched" "Detected in many" 15 "amygdala: 22.5;basal ganglia: 24.3;cerebral cortex: 32.6;hippocampal formation: 23.0;olfactory region: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "amygdala: 111.1;basal ganglia: 75.7;cerebral cortex: 76.7;hippocampal formation: 105.7;olfactory region: 63.4" "Group enriched" "Detected in many" 14 "amygdala: 58.8;basal ganglia: 55.2;cerebral cortex: 67.5;hippocampal formation: 103.7;olfactory region: 57.5" "HPA008943, HPA009083, CAB025178" Enhanced 2400000 "CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094" "unprognostic (7.76e-2)" "unprognostic (1.91e-1)" "unprognostic (1.66e-2)" "unprognostic (4.24e-2)" "unprognostic (8.23e-3)" "unprognostic (2.58e-1)" "unprognostic (8.12e-2)" "unprognostic (9.99e-3)" "unprognostic (2.58e-1)" "unprognostic (2.44e-2)" "unprognostic (3.90e-3)" "unprognostic (9.89e-3)" "unprognostic (5.29e-5)" "unprognostic (6.47e-2)" "unprognostic (4.86e-2)" "unprognostic (5.44e-3)" "unprognostic (6.28e-3)" 0.8 0.9 22.5 0.8 24.3 2.0 0.9 0.0 32.6 0.8 0.8 1.0 0.0 0.8 0.8 0.8 0.8 0.9 0.8 1.0 23.0 1.4 1.1 0.8 3.6 1.2 0.9 15.9 1.4 0.8 0.8 0.1 1.1 0.0 0.9 0.8 0.0 0.8 0.9 0.8 0.8 1.0 0.8 0.1 1.0 1.0 1.9 1.6 0.0 0.8 0.0 0.9 0.8 0.3 0.0 0.0 0.4 0.0 0.0 0.4 0.0 2.8 0.0 0.0 6.1 0.0 0.0 0.1 4.3 0.7 0.1 0.4 0.0 0.1 4.6 1.9 0.0 5.3 0.2 0.0 0.0 0.1 0.9 13.2 4.2 0.4 0.1 0.0 2.6 0.0 0.5 0.1 0.0 0.0 10.5 0.1 0.0 0.6 0.0 1.8 0.0 4.3 0.1 0.0 12.0 0.2 0.0 0.8 0.1 1.9 0.1 0.3 2.2 0.0 0.0 1.3 0.0 0.6 0.0 14.5 2.3 2.6 8.6 0.0 1.3 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 24.3 0.0 32.6 23.0 1.4 0.9 15.9 0.0 1.6 IDS SIDS ENSG00000010404 "Iduronate 2-sulfatase" P22304 X 149476990-149521096 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA078003 Approved "Intracellular and membrane" 8900000 "HPA078003: " "unprognostic (9.88e-2)" "unprognostic (1.10e-2)" "unprognostic (6.59e-2)" "unprognostic (1.45e-3)" "unprognostic (2.83e-2)" "unprognostic (4.52e-3)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" "unprognostic (2.35e-2)" "unprognostic (1.20e-1)" "unprognostic (1.71e-2)" "unprognostic (1.42e-1)" "unprognostic (9.76e-3)" "unprognostic (3.61e-2)" "unprognostic (1.91e-1)" "unprognostic (1.01e-1)" "unprognostic (1.87e-1)" 11.6 20.4 92.9 12.1 81.5 16.0 12.0 30.4 107.9 13.1 9.3 15.0 8.1 9.1 17.8 29.5 11.3 14.8 12.3 16.2 83.6 42.7 10.5 7.0 17.9 12.5 36.7 51.8 22.6 10.6 19.5 17.8 7.4 33.0 14.0 10.7 7.7 9.1 19.5 8.9 12.9 11.6 14.1 21.0 14.1 10.6 3.8 14.7 1.9 13.2 4.9 14.7 11.4 8.6 8.7 11.7 63.4 16.6 8.5 18.2 13.3 14.3 16.3 7.2 4.2 7.9 14.1 3.0 8.3 21.8 7.7 14.8 3.3 10.8 34.5 22.2 12.3 8.4 6.9 13.0 10.0 12.4 5.9 3.7 5.3 1.9 6.1 5.9 33.3 7.7 7.0 16.7 11.0 12.2 1.7 25.2 11.4 18.3 5.9 3.1 5.6 11.2 3.9 6.5 6.6 9.9 3.6 9.6 22.2 3.2 7.4 10.2 2.3 2.6 14.3 10.2 10.4 16.5 22.4 17.7 13.9 25.2 45.9 14.2 7.2 23.9 13.8 39.6 18.2 14.9 13.5 8.7 11.2 13.6 11.7 6.6 7.5 11.3 63.4 8.5 16.6 8.8 16.9 13.3 92.9 81.5 30.4 90.7 83.6 42.7 36.7 51.8 33.0 14.7 IFNA1 "IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA@, IFNA13" ENSG00000197919 "Interferon alpha 1" P01562 9 21440454-21441316 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Antiviral defense" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.3;urinary bladder: 2.1" "Cell line enhanced" "Detected in some" "A549: 1.7;BJ: 1.0;HeLa: 6.6;NB-4: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "cerebellum: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" 10000 "HPA047557: " "unprognostic (3.14e-1)" "unprognostic (1.55e-1)" "unprognostic (9.75e-2)" "unprognostic (5.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 IFNA13 ENSG00000233816 "Interferon alpha 13" P01562 9 21367424-21368962 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Antiviral defense" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 2.1;epididymis: 3.7" "Cell line enhanced" "Detected in some" "A549: 2.7;HeLa: 1.6;NB-4: 3.5;TIME: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" "HPA047557: " 0.0 0.0 1.1 0.0 2.1 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.1 3.7 0.0 0.1 0.0 0.0 1.5 0.6 0.4 0.0 0.2 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 IFNA2 "IFN-alphaA, IFNA" ENSG00000188379 "Interferon alpha 2" P01563 9 21384254-21385388 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.6;brain: 1.3;lymphoid tissue: 1.1" "Cell line enriched" "Detected in single" 11 "HeLa: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 17 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" HPA047557 Uncertain "Secreted to blood" 253150 "HPA047557: " 0.1 0.0 0.8 0.1 1.3 0.8 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 1.0 0.4 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.4 1.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.3 0.4 1.0 0.4 0.6 0.1 0.1 0.1 IFNA21 IFN-alphaI ENSG00000137080 "Interferon alpha 21" P01568 9 21165637-21166660 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.2;brain: 2.1;lymphoid tissue: 1.4" "Cell line enhanced" "Detected in single" "NB-4: 1.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" HPA047557 Uncertain "Secreted to blood" "HPA047557: " 0.0 0.4 0.3 0.3 0.9 0.0 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.3 1.3 0.0 0.0 0.1 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA6 IFN-alphaK ENSG00000120235 "Interferon alpha 6" P05013 9 21349835-21351378 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" "HPA047557: " 0.0 0.0 1.2 0.0 2.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA8 IFN-alphaB ENSG00000120242 "Interferon alpha 8" P32881 9 21409147-21410185 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.0" "Cell line enriched" "Detected in single" 9 "HeLa: 3.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" "HPA047557: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 IFNK ENSG00000147896 "Interferon kappa" Q9P0W0 9 27524314-27526498 "Predicted intracellular proteins, Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.9;skin 1: 1.7" "Cell line enhanced" "Detected in single" "HaCaT: 1.7" "Group enriched" "Detected in some" 6 "cervical cancer: 0.5;head and neck cancer: 0.6;urothelial cancer: 0.5" "Region enhanced" "Detected in single" "pons and medulla: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" "unprognostic (5.58e-3)" "unprognostic (4.64e-3)" "unprognostic (1.06e-1)" 0.1 0.0 0.1 0.1 0.5 0.7 0.1 0.5 0.1 1.0 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.8 0.1 0.0 0.1 0.1 1.9 0.1 0.0 0.1 0.3 0.1 0.1 1.7 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.1 0.1 0.0 0.1 0.1 1.9 0.1 IFNL3 "IL-28B, IL28B, IL28C" ENSG00000197110 "Interferon lambda 3" Q8IZI9 19 39243553-39245129 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.1;salivary gland: 1.0;skin 1: 1.4;testis: 1.5" "Group enriched" "Detected in some" 5 "AN3-CA: 1.1;CACO-2: 3.5;HDLM-2: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" 1700 "unprognostic (2.67e-1)" "unprognostic (9.19e-2)" "unprognostic (4.17e-1)" "unprognostic (6.86e-2)" "unprognostic (1.89e-2)" "unprognostic (1.66e-1)" 0.1 0.0 0.5 0.0 0.3 0.2 0.0 1.1 0.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 IGDCC3 "HsT18880, PUNC" ENSG00000174498 "Immunoglobulin superfamily DCC subclass member 3" Q8IVU1 15 65327127-65378040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;parathyroid gland: 16.6;placenta: 12.2" "Group enriched" "Detected in some" 5 "AF22: 42.5;CACO-2: 10.7;Hep G2: 33.7" "Cancer enhanced" "Detected in many" "testis cancer: 5.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015713 Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA015713: " "unprognostic (7.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.24e-2)" "unprognostic (7.25e-3)" "unprognostic (6.67e-2)" "unprognostic (7.35e-3)" "unprognostic (3.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-2)" "unprognostic (4.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.77e-5)" "unprognostic (4.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-2)" 0.2 0.6 3.5 0.4 2.1 0.2 1.7 10.8 4.6 1.0 0.5 3.3 0.0 0.3 1.6 0.4 0.2 1.4 0.4 0.4 3.2 2.6 0.6 0.2 0.3 0.2 2.5 1.7 1.7 0.3 16.6 2.9 12.2 2.6 0.5 0.3 0.6 0.2 0.5 0.5 0.4 0.3 0.6 2.2 0.3 0.4 4.7 2.7 3.7 1.7 0.0 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 2.1 10.8 4.6 3.2 2.6 2.5 1.7 2.6 2.7 IGFBPL1 bA113O24.1 ENSG00000137142 "Insulin like growth factor binding protein like 1" Q8WX77 9 38408994-38424447 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2" "Group enriched" "Detected in some" 6 "AF22: 68.0;NTERA-2: 18.7;RH-30: 19.5;SCLC-21H: 70.0;SH-SY5Y: 67.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basal ganglia: 12.5;olfactory region: 16.2" "Low region specificity" "Detected in many" HPA051354 Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" "Nucleoplasm, Vesicles" "HPA051354: " "unprognostic (5.63e-2)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.30e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.94e-1)" "unprognostic (3.92e-2)" "unprognostic (1.59e-2)" "unprognostic (6.67e-2)" 1.6 2.6 3.8 1.1 11.0 0.3 0.4 4.7 4.7 0.7 1.0 1.0 0.0 1.9 2.1 0.5 0.7 1.0 1.9 3.7 3.3 2.3 0.7 0.6 1.2 0.4 1.4 1.5 0.5 1.6 0.4 7.4 1.1 1.8 1.6 0.7 0.2 0.5 2.9 0.3 0.3 1.2 2.1 0.6 0.4 2.5 3.3 1.5 2.6 27.2 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 68.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.1 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 18.7 0.1 0.0 19.5 0.1 0.0 0.0 70.0 67.9 1.1 0.0 0.0 0.3 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 11.0 4.7 4.7 3.3 2.3 1.4 1.5 1.8 1.5 IGFL4 ENSG00000204869 "IGF like family member 4" Q6B9Z1 19 46039748-46077118 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 8.5;skin 1: 13.9" "Cell line enhanced" "Detected in some" "A549: 7.7;HaCaT: 6.9;RH-30: 3.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA047655 Approved Approved Cytosol "Secreted - unknown location" Cytosol "HPA047655: " "unprognostic (1.22e-2)" "unprognostic (3.37e-2)" "unprognostic (2.57e-1)" "unprognostic (7.96e-2)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (2.39e-1)" "unprognostic (8.25e-2)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (1.09e-2)" "unprognostic (3.59e-4)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (3.38e-1)" "unprognostic (2.85e-1)" 0.1 0.8 4.4 0.3 4.4 0.2 0.3 3.9 8.5 0.2 0.3 0.0 0.0 0.9 1.0 2.9 1.9 0.4 1.1 1.9 2.8 2.8 0.3 0.4 0.7 0.9 1.2 6.0 2.0 0.2 3.3 4.5 0.2 2.1 0.9 0.5 4.6 1.1 0.0 0.5 13.9 0.7 0.1 1.6 0.5 0.7 0.8 0.5 0.0 1.5 0.6 0.2 1.2 0.2 0.3 1.6 1.3 0.7 0.2 0.5 0.1 0.1 7.7 0.2 0.6 0.0 1.3 0.5 0.0 0.0 0.0 0.0 1.7 0.3 1.1 0.1 0.1 6.9 0.0 0.0 0.0 0.8 1.2 0.0 0.9 1.9 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.9 0.1 0.6 0.3 0.4 0.1 3.3 1.6 0.0 0.4 0.5 0.5 0.0 0.2 2.0 0.5 1.4 0.7 0.9 1.6 0.5 0.5 1.0 0.5 0.2 0.2 1.0 2.1 1.3 0.7 0.7 0.5 0.3 0.3 0.3 0.2 0.1 0.1 0.3 0.1 0.4 0.9 0.2 0.1 1.6 0.4 0.1 4.4 4.4 3.9 8.5 2.8 2.8 1.2 6.0 2.1 0.5 IGLON5 LOC402665 ENSG00000142549 "IgLON family member 5" A6NGN9 19 51311848-51330354 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 33.6;testis: 11.5" "Cell line enhanced" "Detected in some" "HMC-1: 24.9;NTERA-2: 11.2;SH-SY5Y: 16.2;U-2 OS: 4.7" "Cancer enhanced" "Detected in many" "testis cancer: 12.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA041994 Approved "Secreted in brain" "HPA041994: AB_10794641" "unprognostic (2.09e-1)" "unprognostic (5.76e-2)" "unprognostic (1.80e-2)" "unprognostic (8.87e-3)" "unprognostic (2.33e-1)" "unprognostic (2.66e-1)" "unprognostic (3.47e-4)" "unprognostic (6.38e-5)" "unprognostic (4.54e-2)" "unprognostic (7.89e-3)" "unprognostic (1.59e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (5.62e-7)" "unprognostic (1.77e-2)" "unprognostic (9.28e-2)" "unprognostic (1.36e-2)" "unprognostic (1.86e-3)" 2.0 4.6 9.6 1.1 6.0 1.9 0.7 33.6 16.5 0.6 0.8 0.8 0.0 0.9 0.8 2.2 2.8 0.7 1.0 1.2 9.5 13.7 0.6 2.3 0.6 0.6 11.1 8.4 1.5 1.1 0.5 0.5 1.3 29.3 1.1 0.7 3.0 1.1 2.4 0.6 1.5 1.1 0.8 10.9 0.7 0.7 11.5 2.6 0.0 0.6 0.0 0.6 1.1 0.4 0.0 0.9 1.4 0.3 0.2 0.3 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 11.2 0.0 0.0 0.0 2.4 0.0 0.1 0.1 16.2 0.0 0.0 0.0 0.1 1.5 0.0 0.0 4.7 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.4 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.9 0.0 0.0 9.6 6.0 33.6 10.7 9.5 13.7 11.1 8.4 29.3 2.6 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;ovary: 21.1;testis: 39.9" "Cell line enhanced" "Detected in some" "A549: 5.9;HEL: 4.3;SK-MEL-30: 25.6;U-266/70: 8.9;U-266/84: 10.4" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 1.1 10.5 12.5 1.4 14.6 0.9 1.2 3.4 23.9 1.3 2.6 27.8 0.0 1.1 1.6 2.3 2.0 1.6 1.9 2.2 12.3 6.0 10.6 0.9 1.0 1.0 25.2 8.9 21.1 5.1 3.8 1.4 1.1 15.3 1.3 1.8 7.0 1.4 2.0 2.9 2.6 1.6 1.5 20.5 1.0 1.4 39.9 20.7 0.0 5.0 0.0 1.1 1.1 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 5.9 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 2.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 25.6 0.5 0.1 0.0 0.0 1.0 0.0 0.0 8.9 10.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.5 14.6 3.4 13.6 12.3 6.0 25.2 8.9 15.3 20.7 IGSF21 "MGC15730, RP11-121A23.1" ENSG00000117154 "Immunoglobin superfamily member 21" Q96ID5 1 18107746-18378483 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.5;lymphoid tissue: 16.5" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 19.9" "Group enriched" "Detected in many" 5 "breast cancer: 4.1;glioma: 8.6;prostate cancer: 3.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" 7900 "unprognostic (1.87e-1)" "unprognostic (1.73e-1)" "unprognostic (1.50e-3)" "unprognostic (7.06e-2)" "unprognostic (3.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "unprognostic (1.66e-2)" "unprognostic (7.87e-2)" "unprognostic (2.77e-3)" "unprognostic (4.34e-2)" "unprognostic (2.33e-1)" "unprognostic (7.85e-4)" "unprognostic (3.76e-5)" "unprognostic (2.10e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-2)" 3.1 9.0 14.1 1.7 12.3 1.6 6.0 48.5 32.7 3.0 1.8 7.2 0.0 0.9 1.9 1.8 2.6 1.8 2.4 1.8 21.1 10.4 1.7 1.7 2.5 1.3 10.9 13.9 2.0 4.1 1.8 1.1 3.3 10.1 4.5 1.5 5.5 1.9 3.0 1.4 1.5 1.2 2.7 6.5 16.5 1.6 1.8 4.5 0.0 1.4 0.0 2.1 4.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 12.3 48.5 27.4 21.1 10.4 10.9 13.9 10.1 4.5 IGSF8 "CD316, CD81P3, EWI2, PGRL" ENSG00000162729 "Immunoglobulin superfamily member 8" Q969P0 1 160091340-160098943 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.2" "Cell line enhanced" "Detected in all" "SK-MEL-30: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011917, HPA075970" Approved Supported Vesicles 190000 Vesicles "HPA011917: AB_1851536, HPA075970: " "unprognostic (4.08e-1)" "prognostic unfavourable (7.32e-4)" "unprognostic (1.30e-2)" "unprognostic (9.31e-2)" "unprognostic (1.46e-1)" "unprognostic (1.20e-1)" "unprognostic (1.71e-1)" "unprognostic (1.01e-3)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.31e-1)" "unprognostic (2.60e-2)" "unprognostic (2.35e-1)" "unprognostic (3.74e-3)" "unprognostic (1.75e-3)" 9.9 10.4 25.2 9.0 30.3 2.4 11.1 40.9 54.2 9.6 11.8 53.5 6.4 18.2 8.6 16.6 7.0 13.9 8.5 11.6 32.4 24.1 10.4 19.3 10.1 10.3 32.2 29.9 15.1 19.1 9.0 8.7 7.8 25.9 13.8 7.4 11.2 21.0 14.0 6.0 34.0 14.4 5.1 42.6 10.6 9.8 11.5 25.3 6.2 10.0 5.9 6.2 6.0 6.9 14.3 5.6 1.2 4.0 4.7 15.6 6.4 8.8 5.3 6.9 17.6 4.1 2.6 14.6 4.3 5.7 9.3 8.7 6.0 6.1 13.0 16.3 6.3 17.0 2.8 6.4 1.3 15.5 5.0 1.6 5.9 10.3 6.8 4.4 14.5 3.1 13.0 6.0 1.9 1.9 2.2 7.5 2.1 8.4 11.0 10.3 14.6 8.5 6.3 3.5 9.4 8.5 9.2 2.9 12.6 5.0 16.2 58.0 11.5 5.7 1.9 4.1 8.9 7.4 3.5 20.6 22.8 5.8 14.5 1.7 10.7 0.0 2.9 1.2 13.3 4.0 11.7 12.2 11.0 15.4 3.3 14.3 14.8 15.6 0.8 4.7 2.4 5.6 14.9 6.4 25.2 30.3 40.9 54.2 32.4 24.1 32.2 29.9 25.9 25.3 IGSF9B KIAA1030 ENSG00000080854 "Immunoglobulin superfamily member 9B" Q9UPX0 11 133908564-133956985 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.7" "Cell line enhanced" "Detected in some" "SCLC-21H: 17.9;SH-SY5Y: 9.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 39.7" "Cell type enriched" "Detected in single" 9 "T-reg: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010744, HPA010802" Uncertain Approved Cytosol Cytosol "HPA010744: , HPA010802: AB_1079194" "unprognostic (9.04e-4)" "unprognostic (1.74e-2)" "unprognostic (7.52e-3)" "unprognostic (4.38e-4)" "unprognostic (8.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" "unprognostic (1.38e-1)" "unprognostic (8.10e-2)" "unprognostic (2.81e-1)" "unprognostic (2.99e-4)" "unprognostic (3.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-1)" "unprognostic (9.14e-4)" "unprognostic (3.12e-3)" 2.2 2.1 4.9 3.7 6.8 0.7 1.2 39.7 12.4 7.4 6.8 2.4 4.6 1.1 7.7 4.3 5.9 7.6 4.9 13.4 2.9 3.1 1.1 0.5 1.8 1.6 2.1 4.0 2.4 2.1 1.5 6.2 1.3 3.8 4.2 2.4 6.1 2.1 6.4 5.0 2.4 2.4 12.8 1.6 1.8 3.7 5.0 2.3 0.0 4.9 2.6 1.2 5.2 3.1 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.3 1.2 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.0 0.0 2.6 1.6 0.8 0.5 3.2 2.6 0.0 0.1 2.9 2.5 0.0 0.0 0.0 0.2 0.7 3.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.8 0.4 0.3 2.0 0.1 0.0 0.0 0.0 0.3 0.0 17.9 9.1 0.1 0.2 0.0 1.8 0.0 0.0 1.3 1.4 1.1 0.8 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.2 4.9 6.8 39.7 9.7 2.9 3.1 2.1 4.0 3.8 2.3 IL11 "AGIF, IL-11" ENSG00000095752 "Interleukin 11" P20809 19 55364389-55370463 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell line enhanced" "Detected in some" "BJ: 17.9;BJ hTERT+: 20.3;hTEC/SVTERT24-B: 16.6;U-251 MG: 64.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebellum: 9.2;hypothalamus: 3.7;pons and medulla: 2.7" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "Secreted to blood" 18300 "unprognostic (6.60e-3)" "unprognostic (7.23e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (3.32e-3)" "unprognostic (6.33e-2)" "unprognostic (1.04e-2)" "unprognostic (7.84e-5)" "unprognostic (2.47e-1)" "unprognostic (2.52e-1)" "prognostic unfavourable (7.50e-4)" "unprognostic (4.83e-2)" "unprognostic (4.07e-8)" "unprognostic (1.23e-1)" "unprognostic (1.41e-1)" "unprognostic (3.82e-3)" "unprognostic (3.08e-2)" 1.1 0.1 0.6 7.7 0.9 1.5 0.6 9.2 1.0 0.6 0.6 1.8 0.6 0.3 6.1 0.6 2.3 0.0 5.9 0.6 0.6 3.7 3.4 0.6 0.9 0.6 1.2 0.6 0.6 0.6 0.0 5.3 2.3 2.7 3.7 0.2 0.6 0.6 1.1 0.6 2.5 0.6 0.6 0.6 0.6 2.8 1.4 0.6 0.6 0.6 0.6 0.6 2.3 0.6 0.7 0.3 2.8 0.3 0.8 0.4 0.0 0.7 0.4 0.1 0.3 0.0 0.0 0.1 17.9 20.3 9.5 12.5 0.3 0.4 0.2 0.8 1.6 0.9 0.1 0.4 12.7 0.7 0.5 0.0 1.1 1.2 0.9 0.0 0.1 0.1 0.4 16.6 0.1 0.0 0.1 0.5 1.1 0.4 0.0 0.1 0.3 1.5 0.0 6.0 0.0 0.1 0.1 0.9 0.6 2.2 0.3 0.4 0.2 0.1 0.2 5.6 6.8 0.0 64.4 0.3 0.7 0.1 12.2 0.1 2.9 1.4 0.3 0.5 0.3 0.2 0.2 0.7 0.3 0.1 0.1 0.7 0.3 0.4 2.8 0.8 0.1 0.3 0.2 0.0 0.6 0.9 9.2 0.8 0.6 3.7 1.2 0.6 2.7 0.6 IL17D "FLJ30846, IL-17D, IL-22, IL-27, IL27" ENSG00000172458 "Interleukin 17D" Q8TAD2 13 20702127-20723098 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 36.1;skeletal muscle: 65.7" "Cell line enhanced" "Detected in many" "TIME: 18.2" "Group enriched" "Detected in many" 9 "glioma: 10.8;melanoma: 3.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD8 T-cell: 1.0;NK-cell: 1.9" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" 25000 "unprognostic (1.76e-2)" "unprognostic (2.05e-1)" "unprognostic (1.38e-2)" "unprognostic (2.23e-1)" "unprognostic (4.26e-2)" "unprognostic (3.86e-2)" "unprognostic (5.96e-2)" "unprognostic (1.37e-2)" "unprognostic (4.00e-2)" "unprognostic (3.28e-2)" "unprognostic (1.35e-3)" "unprognostic (1.43e-1)" "unprognostic (1.33e-3)" "unprognostic (1.68e-1)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (5.97e-2)" 2.5 3.2 22.4 1.3 24.6 0.6 2.1 9.5 36.1 3.6 1.9 16.1 0.2 5.6 2.9 1.1 5.5 1.4 3.2 3.9 16.5 13.9 0.8 0.5 3.5 1.0 16.7 9.4 5.3 3.7 0.7 0.6 1.4 11.0 3.1 0.7 2.2 1.8 1.4 65.7 2.0 3.5 1.2 14.6 0.7 1.4 1.9 10.9 0.0 2.5 1.1 0.6 2.6 1.6 0.3 0.0 0.1 0.1 1.9 1.0 0.1 10.7 1.5 2.4 5.2 5.7 3.2 12.5 3.0 0.8 0.3 0.6 5.0 5.9 7.3 0.6 0.3 5.7 1.0 0.1 0.1 2.6 8.3 0.5 0.5 6.0 0.7 7.9 1.6 4.4 0.1 0.4 0.0 3.4 2.9 0.0 2.0 10.4 8.8 6.5 7.3 1.8 11.6 5.9 0.8 0.1 9.4 14.2 4.6 1.7 2.6 11.8 6.5 6.8 18.2 1.2 2.1 0.9 3.7 1.3 1.1 1.9 2.8 3.8 5.3 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.2 1.0 0.0 0.2 0.1 0.0 0.1 1.9 0.0 0.0 0.0 0.1 22.4 24.6 9.5 15.2 16.5 13.9 16.7 9.4 11.0 10.9 IL1RAPL1 "IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2" ENSG00000169306 "Interleukin 1 receptor accessory protein like 1" Q9NZN1 X 28587399-29956723 "Disease related genes, Plasma proteins, Predicted membrane proteins" Receptor "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 26.7" "Cell line enhanced" "Detected in some" "LHCN-M2: 1.5;SK-MEL-30: 2.0;U-2 OS: 1.9;WM-115: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (2.51e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (3.75e-3)" "unprognostic (1.17e-1)" "unprognostic (3.98e-1)" "unprognostic (2.25e-2)" "unprognostic (4.45e-2)" "unprognostic (1.29e-1)" "unprognostic (5.85e-2)" "unprognostic (3.95e-2)" "unprognostic (8.02e-2)" "unprognostic (1.08e-2)" "unprognostic (5.74e-4)" "unprognostic (2.29e-1)" "unprognostic (5.22e-2)" "unprognostic (3.58e-3)" 1.5 1.0 12.9 1.0 21.8 0.9 1.5 6.9 17.2 1.2 1.5 15.0 0.0 1.1 1.2 1.5 1.7 1.0 1.5 2.7 10.9 3.3 1.1 1.8 1.1 1.1 21.7 10.1 2.3 1.2 1.0 1.5 1.6 12.3 2.1 1.5 0.0 1.2 2.1 2.2 0.9 1.7 1.2 9.9 0.9 1.4 1.6 26.7 0.0 1.7 0.0 1.0 2.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.6 0.4 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.3 0.0 1.1 0.1 0.0 1.5 0.0 0.0 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 21.8 6.9 17.2 10.9 3.3 21.7 10.1 12.3 26.7 IL1RAPL2 "IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1" ENSG00000189108 "Interleukin 1 receptor accessory protein like 2" Q9NP60 X 104566315-105767829 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 8.0;parathyroid gland: 8.9" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.7;hTERT-HME1: 10.8;NTERA-2: 2.0;RT4: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036128, HPA036129" Uncertain "HPA036128: AB_10669983, HPA036129: AB_2674957" "unprognostic (1.62e-1)" "unprognostic (1.50e-1)" "unprognostic (1.66e-2)" "unprognostic (3.09e-1)" "unprognostic (1.48e-4)" "unprognostic (9.32e-3)" "unprognostic (1.67e-1)" "unprognostic (6.80e-5)" "unprognostic (1.78e-2)" "unprognostic (2.79e-3)" "unprognostic (5.91e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.84e-2)" 0.2 4.2 1.5 0.0 5.0 0.0 1.2 1.1 8.0 0.4 0.6 0.0 0.8 0.4 0.1 0.2 0.2 0.4 1.9 0.5 0.4 0.8 0.4 2.8 0.1 0.0 1.1 2.2 0.9 0.2 8.9 0.1 1.1 2.2 0.4 0.1 0.0 0.8 1.1 0.1 0.3 0.2 0.4 0.3 0.1 0.4 1.9 0.5 0.0 0.2 0.0 0.1 2.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.8 0.0 0.0 0.0 0.4 0.4 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 3.7 0.7 0.2 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.0 1.1 8.0 0.4 0.8 1.1 2.2 2.2 0.5 IL27 "IL-27, IL-27A, IL27A, IL27p28, IL30, MGC71873, p28" ENSG00000197272 "Interleukin 27" Q8NEV9 16 28499362-28512051 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Antiviral protein, Cytokine" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.3;brain: 6.5;liver: 21.2" "Cell line enriched" "Detected in some" 11 "BEWO: 19.9" "Cancer enriched" "Detected in some" 8 "liver cancer: 4.3" "Region enhanced" "Detected in many" "hippocampal formation: 6.5" "Cell type enhanced" "Detected in many" "classical monocyte: 6.2;intermediate monocyte: 6.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" CAB024722 Approved "Secreted to blood" 520900 "CAB024722: " "unprognostic (4.79e-3)" "unprognostic (2.66e-3)" "unprognostic (4.72e-2)" "unprognostic (1.52e-1)" "unprognostic (2.09e-1)" "unprognostic (6.55e-3)" "prognostic favourable (1.30e-4)" "unprognostic (3.76e-2)" "unprognostic (8.23e-3)" "unprognostic (1.29e-2)" "unprognostic (6.07e-3)" "unprognostic (4.57e-2)" "unprognostic (2.41e-7)" "unprognostic (6.44e-2)" "unprognostic (1.04e-3)" "unprognostic (2.13e-1)" "unprognostic (2.83e-2)" 0.8 0.2 0.1 1.4 0.9 0.9 0.1 0.1 1.0 0.2 0.2 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.0 0.1 6.5 0.1 0.1 21.2 0.6 0.4 0.2 0.0 0.0 0.1 0.0 0.1 0.8 2.2 0.2 0.0 0.4 0.1 0.0 0.6 0.1 0.1 0.2 1.4 2.9 0.1 0.5 1.2 1.9 0.4 0.0 0.0 0.2 0.0 0.3 1.1 3.5 6.3 2.7 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 6.2 1.3 0.1 6.3 0.2 0.3 0.0 0.1 1.1 0.0 0.0 0.0 3.5 2.7 0.2 0.0 0.4 1.5 0.1 0.9 0.1 1.0 6.5 0.1 0.2 0.0 2.2 1.2 IL31RA "CRL, CRL3, GLM-R, Glmr, IL-31RA" ENSG00000164509 "Interleukin 31 receptor A" Q8NI17 5 55851379-55922853 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;tongue: 6.4" "Cell line enhanced" "Detected in some" "HBEC3-KT: 8.9;HHSteC: 7.7;hTERT-HME1: 10.8;U-2 OS: 16.0;U-87 MG: 18.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 6 "amygdala: 10.3" "Group enriched" "Detected in some" 5 "classical monocyte: 2.2;myeloid DC: 1.2" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;monocytes: 2.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.5;hippocampal formation: 1.1" "HPA051532, HPA068114" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA051532: , HPA068114: " "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.13e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-3)" "unprognostic (7.34e-2)" "unprognostic (3.54e-1)" "unprognostic (5.38e-2)" "unprognostic (2.95e-3)" "unprognostic (7.75e-5)" "unprognostic (5.55e-2)" "unprognostic (2.65e-6)" "unprognostic (7.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.02e-1)" "unprognostic (1.76e-2)" 0.3 0.1 10.3 1.0 0.1 5.3 0.2 0.1 0.4 0.2 1.5 0.0 0.0 0.4 1.2 1.8 1.7 0.1 0.2 0.4 1.6 0.2 0.3 0.3 0.5 0.1 0.1 0.0 0.5 0.7 0.0 0.7 0.7 0.0 1.0 0.4 0.4 1.3 0.2 2.6 2.5 0.8 1.8 0.1 0.3 0.5 5.9 0.0 1.4 0.5 6.4 0.5 0.5 2.2 0.0 1.2 0.2 2.2 0.0 0.1 0.4 0.1 1.1 0.0 0.0 0.0 0.4 0.5 0.1 0.5 0.2 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 8.9 1.8 0.0 0.1 0.0 0.0 0.0 7.7 0.0 0.0 6.0 3.0 4.3 10.8 3.3 0.0 0.4 1.4 0.0 0.0 1.4 0.0 6.0 0.0 1.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.5 0.5 16.0 0.0 1.0 0.0 0.0 0.0 18.5 0.0 2.5 0.1 2.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 10.3 0.1 0.1 0.4 1.6 0.2 0.1 0.0 0.0 0.0 IL9 "HP40, IL-9, P40" ENSG00000145839 "Interleukin 9" P15248 5 135892246-135895827 "Cancer-related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.0;skin 1: 2.1" "Cell line enriched" "Detected in single" 267 "HDLM-2: 30.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted to blood" 11049 0.1 0.2 0.3 0.0 2.2 0.0 0.0 0.3 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 2.1 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 2.2 0.3 1.1 0.7 0.2 2.1 0.0 0.0 0.0 ILDR2 C1orf32 ENSG00000143195 "Immunoglobulin like domain containing receptor 2" Q71H61 1 166895711-166975482 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;testis: 18.0" "Cell line enhanced" "Detected in some" "AF22: 9.8;MOLT-4: 5.1;U-2 OS: 12.6;U-251 MG: 6.6" "Cancer enhanced" "Detected in some" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012545, HPA012815" Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA012545: AB_2126894, HPA012815: " "unprognostic (9.14e-2)" "unprognostic (5.05e-2)" "unprognostic (8.27e-2)" "unprognostic (2.16e-1)" "unprognostic (5.89e-2)" "unprognostic (5.33e-2)" "unprognostic (2.89e-5)" "unprognostic (2.09e-1)" "unprognostic (8.55e-2)" "unprognostic (4.51e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (9.17e-2)" "unprognostic (5.87e-3)" "unprognostic (4.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 0.8 1.1 9.8 0.9 6.4 1.4 0.5 2.1 14.6 0.7 2.9 3.6 0.1 0.7 0.9 1.4 0.9 0.8 1.3 3.1 7.2 7.7 6.3 1.3 1.4 1.0 2.7 8.0 0.8 0.7 0.5 3.3 0.8 3.1 2.3 1.2 2.8 0.8 2.8 0.8 0.7 0.8 2.0 2.3 0.7 0.7 18.0 3.1 1.9 0.9 0.0 1.1 0.9 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.5 0.0 0.0 9.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 1.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 2.3 1.9 0.0 0.0 0.2 0.0 3.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 5.1 0.0 3.4 0.0 0.0 0.3 0.7 0.7 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 12.6 0.0 6.6 2.3 0.0 0.5 1.4 1.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.5 9.8 6.4 2.1 11.4 7.2 7.7 2.7 8.0 3.1 3.1 INA "NEF5, NF-66" ENSG00000148798 "Internexin neuronal intermediate filament protein alpha" Q16352 10 103277163-103290351 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 65.4" "Cell line enhanced" "Detected in some" "NTERA-2: 20.6;SCLC-21H: 40.5;SH-SY5Y: 23.0;SiHa: 27.4" "Cancer enhanced" "Detected in many" "testis cancer: 18.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002059, HPA007572, HPA008057" Enhanced Supported Approved "Intermediate filaments" "Intermediate filaments" "CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833" "unprognostic (1.77e-1)" "unprognostic (2.50e-2)" "unprognostic (9.54e-2)" "unprognostic (5.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.45e-3)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.98e-1)" "unprognostic (8.09e-3)" "unprognostic (3.07e-2)" "unprognostic (1.78e-3)" "unprognostic (1.66e-1)" "unprognostic (1.90e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" 1.5 15.7 16.6 2.6 21.3 1.3 1.3 26.9 65.2 1.3 2.7 2.3 0.0 2.0 1.3 1.4 1.9 1.3 1.5 1.3 13.2 34.0 1.3 1.4 1.5 1.4 27.2 17.7 1.3 3.6 1.3 12.8 1.5 65.4 1.5 2.8 5.5 1.3 1.4 1.3 2.2 2.5 2.2 7.9 1.3 2.6 4.1 3.3 0.0 1.5 0.0 1.5 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 4.6 0.0 0.0 0.0 7.5 5.1 1.2 1.2 0.1 0.0 0.0 0.0 2.1 0.3 0.7 4.2 0.0 0.3 9.2 1.9 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 20.6 0.0 0.0 0.0 0.0 3.2 0.0 40.5 23.0 27.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 1.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 21.3 26.9 42.0 13.2 34.0 27.2 17.7 65.4 3.3 INPP5F "hSac2, KIAA0966, SAC2" ENSG00000198825 "Inositol polyphosphate-5-phosphatase F" Q9Y2H2 10 119726097-119829278 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.7" "Cell line enhanced" "Detected in many" "AF22: 36.0;SH-SY5Y: 28.5;SK-MEL-30: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042605 Supported Vesicles Vesicles "HPA042605: AB_10793886" "unprognostic (2.65e-2)" "unprognostic (3.23e-1)" "unprognostic (3.42e-2)" "unprognostic (5.84e-2)" "unprognostic (1.87e-2)" "unprognostic (1.57e-3)" "unprognostic (2.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.09e-2)" "unprognostic (2.09e-1)" "unprognostic (6.46e-2)" "unprognostic (7.78e-2)" "unprognostic (1.02e-1)" "unprognostic (9.91e-2)" "unprognostic (2.96e-2)" "unprognostic (6.21e-2)" 4.6 12.3 17.5 5.9 50.4 3.2 5.7 37.0 52.9 10.9 5.0 5.5 2.2 3.1 11.8 18.0 4.5 4.2 5.5 4.1 24.6 53.1 7.3 2.0 4.2 7.6 23.7 29.1 9.8 4.6 8.9 34.0 8.2 69.7 8.3 6.1 3.4 7.1 8.4 7.5 10.4 3.8 10.8 19.2 4.1 3.8 10.1 7.3 1.4 8.4 1.4 9.3 5.3 4.5 12.2 7.4 1.5 4.5 3.8 6.7 2.2 4.6 3.3 36.0 5.2 3.9 4.0 3.1 6.5 3.6 3.1 3.0 4.8 5.9 3.0 2.5 8.1 5.2 3.9 3.8 4.7 1.9 3.6 2.0 1.6 4.8 5.5 1.3 6.7 4.8 3.5 6.1 6.1 10.4 1.8 4.8 7.3 2.6 1.8 5.4 3.4 4.1 2.4 6.4 0.8 5.2 2.4 2.6 28.5 7.2 2.2 54.3 1.5 1.4 6.9 3.1 4.1 4.0 6.3 5.4 2.4 1.4 3.9 4.6 12.6 1.1 4.0 1.5 1.3 3.5 1.6 8.1 2.8 1.9 7.4 12.2 3.2 1.4 1.0 3.8 4.5 1.8 6.7 2.2 17.5 50.4 37.0 50.5 24.6 53.1 23.7 29.1 69.7 7.3 INSM1 "IA-1, IA1" ENSG00000173404 "INSM transcriptional repressor 1" Q01101 20 20368121-20370949 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 13.2;brain: 15.5;pituitary gland: 29.2" "Cell line enriched" "Detected in some" 20 "SCLC-21H: 91.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 13 "dendritic cells: 1.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "unprognostic (1.86e-2)" "unprognostic (5.25e-4)" "unprognostic (7.59e-2)" "unprognostic (3.49e-2)" "unprognostic (1.07e-1)" "unprognostic (1.07e-3)" "unprognostic (4.34e-2)" "unprognostic (2.89e-2)" "unprognostic (1.40e-1)" "unprognostic (2.38e-3)" "unprognostic (1.33e-1)" "unprognostic (1.52e-1)" "unprognostic (2.77e-1)" "unprognostic (1.33e-1)" "unprognostic (5.23e-1)" "unprognostic (1.22e-1)" 0.4 13.2 2.4 1.2 4.6 0.2 0.5 15.5 3.8 0.1 6.2 2.8 0.2 5.5 0.1 0.1 0.1 0.1 0.2 0.1 3.4 4.4 0.2 0.1 0.3 1.1 1.8 1.4 0.1 5.5 0.1 29.2 0.1 1.0 0.6 3.6 0.0 0.1 0.6 0.1 0.3 3.7 0.2 0.4 0.5 10.4 0.7 1.4 8.3 0.2 0.0 0.7 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 4.5 0.0 0.0 91.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.4 4.6 15.5 3.8 3.4 4.4 1.8 1.4 1.0 1.4 INSM2 "IA-6, Mlt1" ENSG00000168348 "INSM transcriptional repressor 2" Q96T92 14 35534042-35537054 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.3;brain: 5.2;salivary gland: 1.6;testis: 2.9" "Cell line enriched" "Detected in single" 134 "SH-SY5Y: 49.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 1.3" "Low region specificity" "Detected in some" "HPA044885, HPA051925" Uncertain Approved Nucleoplasm Nucleoplasm "HPA044885: AB_10794779, HPA051925: " "unprognostic (9.88e-2)" "unprognostic (8.74e-2)" "unprognostic (2.35e-1)" "unprognostic (1.08e-3)" "unprognostic (3.29e-3)" "unprognostic (1.72e-1)" "unprognostic (2.51e-1)" "unprognostic (2.26e-3)" "unprognostic (2.60e-3)" "unprognostic (7.51e-2)" "unprognostic (1.75e-2)" "unprognostic (2.36e-3)" "unprognostic (5.00e-1)" 0.3 2.3 1.0 0.5 2.8 0.2 0.3 0.5 5.2 0.2 0.2 1.0 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.8 5.0 0.2 0.2 0.3 0.2 1.9 1.2 0.2 0.2 0.2 0.1 0.2 2.7 0.2 0.2 0.7 1.6 0.2 0.2 0.4 0.2 0.2 0.4 0.2 0.2 2.9 0.2 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 49.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.8 0.5 4.6 0.8 5.0 1.9 1.2 2.7 0.2 INSRR IRR ENSG00000027644 "Insulin receptor related receptor" P14616 1 156840063-156859018 "Enzymes, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.5;brain: 5.9;kidney: 8.3" "Group enriched" "Detected in some" 7 "SCLC-21H: 5.4;SH-SY5Y: 18.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA025285 Uncertain "HPA025285: AB_1851814" "unprognostic (1.19e-1)" "unprognostic (7.69e-2)" "unprognostic (2.42e-2)" "unprognostic (6.76e-4)" "unprognostic (1.51e-1)" "unprognostic (9.07e-3)" "unprognostic (5.57e-2)" "unprognostic (1.75e-1)" "unprognostic (6.17e-2)" "unprognostic (5.57e-2)" "unprognostic (2.20e-2)" "unprognostic (7.00e-2)" "unprognostic (4.22e-5)" "unprognostic (2.82e-1)" "unprognostic (9.55e-2)" "unprognostic (2.75e-3)" "unprognostic (3.66e-2)" 0.9 5.5 0.0 0.3 5.9 0.1 0.8 1.9 1.4 1.9 0.1 0.0 0.0 0.1 2.7 0.1 0.1 0.6 0.3 1.9 0.5 1.3 8.3 0.1 0.1 0.4 0.8 0.6 0.3 0.9 0.1 1.7 0.4 5.6 2.7 0.1 2.1 0.6 0.5 0.4 0.1 0.2 0.3 0.0 0.2 3.0 4.2 0.4 0.3 0.3 0.0 0.8 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.4 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 1.9 1.4 0.5 1.3 0.8 0.6 5.6 0.4 IP6K3 "IHPK3, INSP6K3" ENSG00000161896 "Inositol hexakisphosphate kinase 3" Q96PC2 6 33721670-33746905 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.5;skeletal muscle: 87.9" "Cell line enhanced" "Detected in some" "HHSteC: 15.8;HSkMC: 5.7;LHCN-M2: 25.1;RH-30: 11.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA053644 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA053644: " "unprognostic (3.23e-2)" "unprognostic (2.87e-1)" "unprognostic (2.07e-5)" "unprognostic (1.07e-3)" "unprognostic (2.20e-1)" "unprognostic (5.10e-3)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "unprognostic (2.47e-2)" "unprognostic (1.24e-2)" "unprognostic (2.94e-3)" "prognostic unfavourable (6.09e-4)" "unprognostic (1.63e-2)" "unprognostic (2.01e-1)" "unprognostic (2.66e-3)" "unprognostic (1.33e-1)" 2.2 1.0 2.1 0.8 13.0 0.5 0.9 0.6 6.2 1.2 2.2 11.8 1.4 0.8 1.6 1.4 5.2 1.3 0.6 10.0 3.2 1.3 4.7 7.7 2.0 0.6 22.5 1.1 0.6 0.7 0.5 0.5 3.8 7.7 2.8 1.0 1.2 1.4 1.8 87.9 0.5 1.1 1.8 9.2 1.4 0.9 0.6 15.2 0.0 9.9 8.1 0.5 1.5 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.5 0.1 0.2 0.2 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 5.7 0.8 0.1 0.4 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.1 0.0 0.0 11.1 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 13.0 0.6 6.2 3.2 1.3 22.5 1.1 7.7 15.2 IPCEF1 "KIAA0403, PIP3-E" ENSG00000074706 "Interaction protein for cytohesin exchange factors 1" Q8WWN9 6 154154496-154356792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9" "Group enriched" "Detected in some" 5 "HMC-1: 19.3;THP-1: 9.8;U-937: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA028708, HPA028710" Enhanced Approved "Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies" "Nuclear speckles, Plasma membrane" "Nucleoli, Cytoplasmic bodies" "HPA028708: AB_10601916, HPA028710: " "unprognostic (1.23e-2)" "unprognostic (8.93e-3)" "unprognostic (4.18e-2)" "unprognostic (5.63e-3)" "unprognostic (2.05e-1)" "unprognostic (6.55e-3)" "unprognostic (1.30e-3)" "unprognostic (2.57e-2)" "unprognostic (3.87e-1)" "unprognostic (5.84e-2)" "unprognostic (3.27e-2)" "unprognostic (4.87e-2)" "unprognostic (5.01e-2)" "unprognostic (8.64e-2)" "unprognostic (5.45e-2)" "unprognostic (1.42e-2)" "unprognostic (1.51e-4)" 1.3 0.7 5.3 6.9 12.9 15.2 1.9 20.0 26.4 3.4 1.6 5.5 0.0 1.1 1.7 1.8 1.9 2.5 3.2 1.0 3.8 4.6 3.4 2.4 2.0 12.4 3.9 14.1 1.3 1.4 0.4 1.3 2.0 5.5 1.3 1.6 0.0 1.4 0.8 0.7 1.2 2.9 1.3 4.2 6.4 2.6 1.5 4.9 10.0 36.9 0.0 11.7 2.4 1.1 0.0 7.1 30.1 6.3 6.0 13.5 5.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 19.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.1 1.0 0.4 0.2 0.2 0.5 0.9 2.1 0.3 0.3 0.0 0.1 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.2 0.0 1.4 6.3 30.1 6.1 2.8 13.1 0.0 7.7 5.8 7.1 0.0 13.5 7.9 19.3 6.0 3.4 0.2 9.9 5.3 5.3 12.9 20.0 26.4 3.8 4.6 3.9 14.1 5.5 4.9 IQCJ ENSG00000214216 "IQ motif containing J" Q1A5X6 3 158962928-159266307 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 19.5" "Cell line enriched" "Detected in single" 21 "Daudi: 10.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052835 Uncertain "HPA052835: " "unprognostic (1.99e-2)" 0.5 0.5 19.5 0.5 10.0 0.5 1.6 0.4 14.5 0.5 0.5 0.1 0.0 0.5 0.5 0.5 0.8 0.5 0.7 1.0 9.4 0.6 0.6 0.5 0.5 0.9 0.9 7.4 0.6 0.5 0.5 3.6 0.5 6.8 0.5 0.5 0.0 0.5 0.9 0.5 0.5 0.5 0.5 0.5 0.5 0.5 4.8 1.5 0.0 0.5 0.0 0.6 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 10.0 0.4 14.5 9.4 0.6 0.9 7.4 6.8 1.5 IQCJ-SCHIP1 ENSG00000283154 "IQCJ-SCHIP1 readthrough" B3KU38 3 158962235-159897366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0" "Low cell line specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "HPA003243, HPA003445" Approved Approved Cytosol Cytosol "HPA003243: AB_1079877, HPA003445: AB_1079875" 5.3 2.1 11.1 4.1 12.4 0.5 2.4 1.5 30.0 1.9 3.8 17.8 0.3 1.7 5.6 2.8 7.3 1.4 5.8 16.4 7.7 7.6 6.3 6.8 0.6 18.8 10.6 0.8 0.9 0.2 1.3 10.9 13.1 6.3 3.0 0.4 0.6 10.0 1.8 0.8 1.7 11.8 7.3 1.2 1.0 1.7 15.1 0.0 0.6 0.1 0.4 5.9 0.9 0.0 1.0 0.1 0.0 0.9 0.2 0.2 28.4 5.0 9.8 11.6 2.3 2.2 8.5 24.5 5.8 20.3 13.9 18.3 7.0 1.4 15.9 8.1 11.6 3.8 8.3 16.7 23.6 9.3 0.0 10.9 0.9 2.6 1.3 0.1 2.2 7.1 9.0 10.7 15.0 0.0 0.1 9.3 1.2 0.1 0.0 8.2 10.7 3.3 19.8 0.0 19.5 1.5 1.9 9.2 13.2 5.6 7.0 3.3 0.2 12.5 11.7 16.3 7.8 33.3 0.1 0.1 0.1 6.5 4.0 30.9 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.1 0.9 0.0 1.0 0.0 0.2 IQSEC2 "KIAA0522, MRX1, MRX18, MRX78" ENSG00000124313 "IQ motif and Sec7 domain 2" Q5JU85 X 53225828-53321350 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.2" "Cell line enhanced" "Detected in many" "A549: 27.2;U-87 MG: 20.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 10.0;plasmacytoid DC: 10.2" "Group enriched" "Detected in many" 15 "dendritic cells: 10.2;monocytes: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003973 Approved Vesicles Vesicles "HPA003973: AB_2280343" "unprognostic (1.85e-1)" "unprognostic (7.77e-2)" "unprognostic (2.61e-2)" "unprognostic (1.32e-1)" "unprognostic (4.66e-3)" "unprognostic (6.02e-2)" "unprognostic (2.80e-1)" "unprognostic (3.78e-2)" "unprognostic (2.82e-1)" "unprognostic (9.05e-2)" "unprognostic (1.57e-1)" "unprognostic (2.59e-1)" "prognostic unfavourable (2.00e-4)" "unprognostic (1.56e-2)" "unprognostic (1.75e-1)" "unprognostic (4.30e-2)" "prognostic favourable (2.38e-4)" 8.1 10.0 16.6 4.3 22.0 1.5 4.7 32.1 34.2 7.0 6.9 3.7 4.9 9.9 4.7 3.5 4.9 8.5 4.9 6.0 19.4 9.0 10.8 1.3 6.5 2.0 6.7 12.7 4.7 5.4 8.1 6.1 2.9 13.4 6.4 5.6 2.8 5.1 7.8 25.6 5.7 10.7 5.9 4.4 3.5 5.5 4.2 5.2 0.2 5.3 4.3 2.6 4.7 4.1 0.2 10.2 0.6 10.0 0.0 0.1 2.2 2.6 27.2 1.0 2.5 3.8 8.4 3.0 4.4 7.7 3.3 6.3 0.7 10.1 0.1 7.2 10.3 3.7 0.9 4.3 2.5 2.7 4.7 3.0 11.9 0.7 8.3 0.1 1.6 6.0 6.6 9.4 5.2 4.6 9.4 3.1 7.1 6.3 0.0 0.5 8.5 11.9 2.0 2.1 3.2 5.1 5.7 1.1 1.0 10.3 6.4 4.1 9.0 1.3 5.3 3.3 6.3 1.8 2.0 0.9 0.1 0.1 20.3 1.9 1.7 0.1 10.0 0.5 0.0 3.6 0.1 0.2 0.0 0.1 5.2 0.1 0.1 0.1 0.6 0.0 1.8 10.2 0.0 2.2 16.6 22.0 32.1 34.2 19.4 9.0 6.7 12.7 13.4 5.2 IQSEC3 "KIAA1110, MGC30156" ENSG00000120645 "IQ motif and Sec7 domain 3" Q9UPP2 12 66765-178460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8" "Cell line enhanced" "Detected in some" "HEL: 9.4;U-266/70: 12.7;U-266/84: 3.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039025 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA039025: AB_10672768" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.26e-2)" "unprognostic (4.24e-3)" "unprognostic (4.32e-2)" "unprognostic (1.28e-1)" "unprognostic (4.44e-2)" "unprognostic (5.14e-2)" "unprognostic (3.91e-1)" "unprognostic (8.82e-3)" "unprognostic (2.83e-3)" "unprognostic (7.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-2)" "unprognostic (1.36e-2)" 5.6 1.3 5.6 0.7 4.2 0.8 0.4 19.8 15.5 1.6 0.4 0.5 0.0 0.5 2.0 0.5 0.4 5.2 2.2 1.9 6.5 5.1 2.4 0.2 2.9 0.5 3.7 4.7 2.1 1.2 0.0 2.2 1.3 5.0 1.5 0.2 0.4 0.2 4.5 1.3 0.2 0.7 1.9 1.4 0.3 0.6 1.2 0.8 0.0 0.3 0.0 0.2 1.3 0.6 0.0 2.1 0.0 0.0 0.5 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 12.7 3.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 1.2 0.0 0.5 0.0 2.1 0.0 0.4 5.6 4.2 19.8 12.4 6.5 5.1 3.7 4.7 5.0 0.8 IRX1 IRX-5 ENSG00000170549 "Iroquois homeobox 1" P78414 5 3596054-3601403 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.1;breast: 36.0;salivary gland: 20.9" "Group enriched" "Detected in some" 4 "AF22: 7.0;REH: 28.3;U-251 MG: 11.5" "Group enriched" "Detected in many" 6 "breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043160 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA043160: AB_10794771" "unprognostic (1.52e-2)" "unprognostic (1.26e-2)" "unprognostic (2.27e-1)" "unprognostic (3.73e-2)" "unprognostic (4.30e-3)" "unprognostic (2.70e-1)" "unprognostic (2.02e-2)" "unprognostic (2.03e-2)" "unprognostic (9.78e-4)" "unprognostic (5.11e-2)" "unprognostic (2.78e-2)" "unprognostic (3.58e-2)" 5.3 0.4 2.6 0.4 2.1 1.4 36.0 6.6 1.5 0.4 0.4 2.0 6.0 0.4 0.4 1.7 0.8 0.4 0.4 1.0 3.1 3.2 13.9 0.4 8.0 0.6 4.2 1.0 0.4 0.7 0.4 0.7 0.4 16.1 0.5 0.4 2.8 20.9 1.5 0.4 6.8 0.4 0.4 5.1 0.4 0.4 0.5 1.6 3.0 0.5 0.5 0.9 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.4 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 28.3 0.0 0.0 2.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.1 6.6 0.2 3.1 3.2 4.2 1.0 16.1 1.6 IRX2 ENSG00000170561 "Iroquois homeobox 2" Q9BZI1 5 2745845-2751662 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6" "Cell line enhanced" "Detected in many" "AF22: 39.8;BEWO: 23.9;HaCaT: 13.5;hTCEpi: 26.2;SK-BR-3: 16.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3" "Low region specificity" "Detected in all" "HPA050895, HPA054669" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA050895: AB_2616458, HPA054669: " "unprognostic (9.79e-2)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (5.50e-3)" "unprognostic (8.12e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-1)" "unprognostic (7.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.07e-1)" "prognostic favourable (8.84e-4)" "unprognostic (2.62e-2)" "unprognostic (3.98e-7)" "unprognostic (4.40e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (8.97e-2)" 2.4 0.1 0.8 0.1 2.8 0.1 27.9 8.4 1.7 0.4 0.7 0.7 4.4 0.1 0.1 2.5 3.1 0.2 0.1 2.1 1.9 1.7 14.3 0.1 32.8 0.3 3.9 0.2 0.1 1.9 2.7 1.4 9.0 36.9 3.9 0.3 1.8 26.6 1.4 0.3 17.7 0.1 0.1 4.8 0.1 8.7 3.1 2.2 0.0 1.4 3.1 3.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 39.8 0.0 2.2 1.5 23.9 2.3 1.3 2.0 1.5 4.7 0.0 0.0 0.0 4.4 13.5 0.0 9.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 26.2 0.9 8.1 0.0 0.0 0.0 1.4 7.7 0.0 0.0 4.4 0.0 0.0 2.5 0.0 8.9 0.0 1.5 0.0 7.8 16.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.8 8.4 0.5 1.9 1.7 3.9 0.2 36.9 2.2 ISLR2 KIAA1465 ENSG00000167178 "Immunoglobulin superfamily containing leucine rich repeat 2" Q6UXK2 15 74100311-74138540 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;testis: 11.6" "Group enriched" "Detected in some" 12 "SCLC-21H: 26.9;SH-SY5Y: 40.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012930, HPA067333" Uncertain 66000 "HPA012930: , HPA067333: " "unprognostic (1.31e-2)" "unprognostic (3.27e-3)" "unprognostic (1.44e-2)" "unprognostic (8.65e-3)" "unprognostic (1.53e-3)" "unprognostic (7.73e-2)" "unprognostic (6.64e-2)" "unprognostic (1.46e-2)" "unprognostic (9.19e-3)" "unprognostic (1.72e-1)" "unprognostic (2.94e-2)" "unprognostic (2.46e-1)" "unprognostic (2.44e-4)" "unprognostic (1.31e-2)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" 1.6 2.1 7.5 1.0 16.8 0.4 1.5 2.0 25.9 2.4 1.2 0.1 0.0 1.1 3.9 0.6 1.2 2.0 1.6 6.3 3.5 4.8 0.5 0.5 1.2 2.6 0.7 7.2 0.6 1.3 1.3 0.6 0.6 1.7 0.7 0.9 3.0 0.9 1.1 3.0 1.0 2.0 1.8 0.3 1.5 1.0 11.6 3.4 0.0 0.7 2.1 0.6 0.9 0.4 1.1 0.9 2.5 0.7 0.5 0.4 0.2 0.0 0.1 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 26.9 40.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 1.5 0.7 0.2 0.4 0.3 0.2 0.5 0.3 0.2 0.2 1.1 0.4 0.4 2.5 0.5 0.4 0.9 0.2 0.2 7.5 16.8 2.0 20.3 3.5 4.8 0.7 7.2 1.7 3.4 ITM2C "BRI3, BRICD2C, E25, hRPC.1050_D_4, ITM3" ENSG00000135916 "Integral membrane protein 2C" Q9NQX7 2 230864639-230879248 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 187.0;brain: 138.3;intestine: 158.6" "Cell line enhanced" "Detected in many" "EFO-21: 77.1;NB-4: 83.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "plasmacytoid DC: 187.0" "Lineage enriched" "Detected in many" 9 "dendritic cells: 187.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.50e-3)" "unprognostic (1.46e-1)" "unprognostic (2.60e-2)" "prognostic unfavourable (1.81e-4)" "unprognostic (3.74e-1)" "unprognostic (6.03e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-2)" "unprognostic (4.44e-2)" "unprognostic (3.45e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (2.08e-1)" "unprognostic (4.92e-2)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (2.52e-2)" 9.7 21.5 113.6 23.9 138.3 21.7 6.6 15.9 122.4 18.2 158.6 41.9 3.9 18.4 19.4 9.9 20.2 12.7 12.7 11.5 81.8 96.8 29.5 7.7 8.2 15.9 97.3 63.4 19.7 18.5 23.1 39.6 24.8 51.4 24.7 124.0 26.1 17.1 27.4 5.1 4.3 41.7 22.5 68.1 18.1 18.3 4.4 44.3 29.6 12.7 1.9 16.4 27.5 10.8 14.9 187.0 21.1 0.2 3.6 4.5 3.6 4.7 9.6 31.8 25.0 4.0 2.3 10.2 25.0 28.1 13.7 21.6 12.8 6.8 0.0 77.1 18.0 2.4 19.1 3.6 8.6 47.2 15.7 6.3 5.1 16.3 14.5 11.3 27.1 19.7 3.6 12.3 1.2 0.5 6.0 16.1 5.1 7.5 8.3 83.1 38.7 8.7 12.3 5.3 67.6 18.2 28.4 1.7 49.1 12.3 1.5 28.9 2.4 65.6 0.4 5.9 17.1 10.3 7.1 0.1 1.2 0.6 18.6 10.0 49.0 4.6 0.2 21.1 1.0 0.1 2.7 14.9 3.2 2.6 5.2 6.9 3.2 2.5 0.5 3.6 0.0 187.0 4.5 3.6 113.6 138.3 15.9 93.6 81.8 96.8 97.3 63.4 51.4 44.3 ITPKA "IP3-3KA, IP3KA" ENSG00000137825 "Inositol-trisphosphate 3-kinase A" P23677 15 41493393-41503551 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 28.8;intestine: 19.8;stomach 1: 10.7" "Cell line enhanced" "Detected in many" "Hep G2: 22.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 12.3;basal ganglia: 21.2;cerebral cortex: 28.8;hippocampal formation: 10.4;olfactory region: 8.2" "Cell type enriched" "Detected in single" 8 "MAIT T-cell: 4.7" "Lineage enriched" "Detected in single" 13 "T-cells: 4.7" "Group enriched" "Detected in many" 13 "amygdala: 120.1;basal ganglia: 97.6;cerebellum: 62.9;cerebral cortex: 164.4;hippocampal formation: 162.9" "Group enriched" "Detected in many" 7 "amygdala: 12.1;basal ganglia: 40.8;cerebral cortex: 32.2;hippocampal formation: 28.6" HPA040454 Enhanced Approved Approved Vesicles Vesicles "HPA040454: AB_10672897" "unprognostic (5.91e-2)" "unprognostic (2.16e-3)" "unprognostic (4.19e-1)" "unprognostic (3.57e-3)" "prognostic unfavourable (6.77e-4)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.58e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (2.06e-1)" "prognostic unfavourable (3.76e-9)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-3)" "unprognostic (2.10e-2)" 0.4 3.0 12.3 1.1 21.2 0.8 0.4 3.0 28.8 0.6 8.5 0.3 0.0 19.8 0.6 0.5 0.4 0.6 0.6 0.7 10.4 0.9 0.4 0.8 0.4 0.4 1.6 8.2 0.6 2.5 1.7 0.0 0.7 0.3 0.8 3.4 0.0 2.1 0.8 1.4 0.4 19.7 0.7 0.2 0.4 10.7 3.5 0.6 0.0 0.4 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.3 4.7 0.0 4.8 1.3 0.2 5.6 0.0 1.8 10.2 3.0 2.4 2.0 2.1 11.2 0.2 0.0 2.5 0.2 0.5 2.4 0.2 0.1 4.5 3.0 6.8 3.0 22.7 9.2 2.3 0.3 0.1 0.1 1.9 0.6 0.1 8.6 1.3 0.7 3.2 0.2 4.4 0.6 4.0 1.1 1.0 0.4 0.2 0.3 0.5 1.1 2.2 0.0 0.2 0.6 3.4 0.2 4.9 5.1 5.5 8.1 0.7 7.1 0.0 9.1 9.0 1.6 0.0 0.0 0.0 0.3 0.0 4.7 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.3 21.2 3.0 28.8 10.4 0.9 1.6 8.2 0.3 0.6 ITPKB "IP3-3KB, IP3KB" ENSG00000143772 "Inositol-trisphosphate 3-kinase B" P27987 1 226631690-226739323 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 28.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030273, HPA072923" Enhanced Approved Nucleoplasm Nucleoplasm "HPA030273: AB_10601127, HPA072923: " "unprognostic (4.54e-2)" "unprognostic (3.85e-2)" "unprognostic (8.41e-3)" "unprognostic (9.37e-3)" "unprognostic (1.53e-1)" "prognostic favourable (1.72e-5)" "unprognostic (1.24e-1)" "prognostic favourable (6.65e-4)" "unprognostic (2.29e-1)" "unprognostic (9.57e-2)" "unprognostic (1.41e-2)" "unprognostic (1.75e-2)" "unprognostic (3.23e-3)" "unprognostic (2.90e-2)" "unprognostic (7.46e-2)" "unprognostic (6.54e-3)" "unprognostic (7.87e-2)" 23.8 4.2 34.7 13.0 35.1 14.8 15.2 11.1 33.6 14.3 19.7 32.4 8.5 6.0 27.1 15.6 12.6 15.3 8.9 7.8 27.9 24.8 9.7 3.2 13.4 22.7 50.4 16.3 8.8 4.8 10.1 4.2 13.5 40.0 13.1 6.3 20.8 24.9 21.3 9.8 10.5 12.5 32.6 63.1 19.0 12.4 3.2 34.0 20.0 5.9 4.3 17.1 19.6 8.5 3.1 0.9 7.7 3.5 3.0 7.9 2.6 2.8 3.0 4.9 5.6 3.8 2.5 1.3 0.7 3.3 1.5 3.6 0.5 3.5 12.8 4.6 0.7 4.1 6.2 2.5 0.7 1.7 4.2 5.7 3.3 0.0 1.5 5.3 10.2 2.8 3.6 1.7 1.6 10.5 0.0 1.8 0.2 2.6 9.7 7.1 10.6 4.9 3.8 8.8 2.8 11.3 4.5 2.9 3.7 2.3 1.7 28.1 7.2 6.0 7.3 2.0 1.5 1.8 4.5 0.1 4.6 15.7 0.5 4.8 7.4 1.2 1.4 7.7 4.4 2.1 3.9 1.9 5.3 4.5 0.9 3.1 7.9 5.7 5.4 3.0 3.5 0.8 3.0 2.6 34.7 35.1 11.1 27.9 27.9 24.8 50.4 16.3 40.0 34.0 JAKMIP1 "FLJ31564, Gababrbp, JAMIP1, MARLIN1" ENSG00000152969 "Janus kinase and microtubule interacting protein 1" Q96N16 4 6026199-6200591 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.5;brain: 37.4" "Cell line enhanced" "Detected in some" "Daudi: 9.7;HDLM-2: 5.4;MOLT-4: 27.0;SCLC-21H: 12.1;U-266/70: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 21 "gdT-cell: 14.9;MAIT T-cell: 6.5;memory CD4 T-cell: 6.7;memory CD8 T-cell: 13.0;naive CD8 T-cell: 6.2;T-reg: 19.5" "Lineage enriched" "Detected in single" 37 "T-cells: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044570 Uncertain "HPA044570: AB_2678995" "unprognostic (4.79e-2)" "unprognostic (3.46e-3)" "unprognostic (4.90e-2)" "unprognostic (1.73e-2)" "unprognostic (5.34e-2)" "unprognostic (3.86e-3)" "unprognostic (6.16e-2)" "unprognostic (6.69e-3)" "unprognostic (4.25e-4)" "unprognostic (7.14e-2)" "unprognostic (4.57e-3)" "unprognostic (1.13e-1)" "unprognostic (3.70e-8)" "unprognostic (1.85e-2)" "unprognostic (3.15e-1)" "unprognostic (4.23e-2)" "unprognostic (2.96e-3)" 1.3 8.5 15.7 2.3 35.0 2.6 1.0 2.5 37.4 1.0 1.5 2.7 0.0 1.2 1.1 1.0 1.1 1.0 1.7 1.0 15.6 14.7 1.0 1.1 1.9 4.7 10.8 13.3 1.6 1.6 1.0 3.8 1.0 7.2 7.4 1.3 0.1 2.0 1.1 1.0 1.0 1.7 1.3 4.3 2.9 1.7 5.9 7.6 0.0 1.4 0.0 1.8 2.3 0.1 0.1 0.0 0.0 0.0 0.5 19.5 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 27.0 0.0 2.2 1.6 1.4 0.0 0.7 0.0 0.0 12.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 6.5 0.1 6.7 13.0 0.0 0.1 0.5 6.2 0.0 0.5 0.0 0.0 19.5 2.5 15.7 35.0 2.5 21.2 15.6 14.7 10.8 13.3 7.2 7.6 JAKMIP2 "JAMIP2, KIAA0555" ENSG00000176049 "Janus kinase and microtubule interacting protein 2" Q96AA8 5 147585439-147782848 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0" "Cell line enhanced" "Detected in some" "AF22: 10.9;Karpas-707: 25.8;RH-30: 26.1;SCLC-21H: 12.3;SH-SY5Y: 8.5" "Cancer enriched" "Detected in some" 6 "glioma: 4.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 8.9;MAIT T-cell: 6.3;memory CD4 T-cell: 3.5;memory CD8 T-cell: 6.4;naive CD8 T-cell: 5.6;NK-cell: 7.4" "Group enriched" "Detected in many" 6 "NK-cells: 7.4;T-cells: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046929, HPA065023" Approved Supported "Golgi apparatus" "Golgi apparatus" "HPA046929: , HPA065023: " "unprognostic (3.69e-2)" "unprognostic (4.22e-3)" "unprognostic (9.92e-2)" "unprognostic (3.58e-2)" "unprognostic (1.63e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.71e-2)" "unprognostic (1.09e-1)" "unprognostic (3.69e-1)" "unprognostic (2.21e-4)" "unprognostic (1.28e-1)" "unprognostic (5.20e-8)" "unprognostic (1.54e-3)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 1.3 6.5 12.0 2.5 10.4 1.7 1.1 44.0 35.0 1.8 1.7 8.7 0.0 1.6 2.6 1.4 3.1 1.1 3.2 1.2 12.4 10.0 1.3 5.1 4.2 2.3 11.4 9.0 1.2 2.2 0.9 14.8 1.0 10.2 1.7 1.9 1.0 1.4 1.6 1.0 1.3 1.9 3.4 10.8 2.1 1.9 5.3 16.5 8.7 1.0 0.0 2.3 1.6 0.3 0.8 1.2 0.7 0.2 7.4 8.9 1.6 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.7 1.0 0.0 0.0 0.2 0.0 3.1 1.3 0.0 0.0 0.0 0.0 0.0 25.8 0.0 0.0 2.6 0.0 6.2 0.1 1.0 26.1 8.3 0.0 0.0 12.3 8.5 0.0 0.1 0.0 0.0 0.0 0.0 1.9 2.2 0.0 0.5 1.8 1.0 2.5 4.9 0.0 0.0 0.0 0.0 0.4 8.9 0.0 6.3 0.8 3.5 6.4 0.2 0.4 0.9 5.6 0.7 7.4 0.2 1.2 1.5 1.6 12.0 10.4 44.0 16.4 12.4 10.0 11.4 9.0 10.2 16.5 JAKMIP3 "bA140A10.5, C10orf14, C10orf39, FLJ37857, KIAA4091, NECC2" ENSG00000188385 "Janus kinase and microtubule interacting protein 3" Q5VZ66 10 132104671-132184809 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.8" "Cell line enhanced" "Detected in some" "A549: 4.5;RPMI-8226: 2.5;U-266/84: 10.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022872 Uncertain "HPA022872: AB_2249331" "unprognostic (1.75e-1)" "unprognostic (1.76e-2)" "unprognostic (4.55e-3)" "unprognostic (8.90e-2)" "unprognostic (2.72e-1)" "unprognostic (9.39e-2)" "unprognostic (2.31e-3)" "unprognostic (1.40e-1)" "unprognostic (2.22e-1)" "unprognostic (1.80e-1)" "unprognostic (5.28e-5)" "unprognostic (1.55e-2)" "unprognostic (5.71e-6)" "unprognostic (1.43e-1)" "unprognostic (2.11e-1)" "unprognostic (7.19e-4)" "unprognostic (1.59e-2)" 0.2 1.8 2.7 0.0 2.8 0.1 0.6 5.2 8.8 0.3 0.1 0.0 1.2 0.6 0.5 0.9 0.6 1.0 4.2 4.1 0.0 0.0 0.2 0.0 5.2 3.5 0.6 0.0 2.8 0.0 3.3 0.2 0.4 1.6 1.5 0.2 0.1 1.0 7.0 0.1 0.5 1.1 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.2 2.1 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.1 1.7 0.2 1.8 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.1 1.3 0.1 0.0 0.0 2.5 0.0 0.1 0.9 0.3 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.1 0.0 0.3 10.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 JAM3 "JAM-C, JAMC" ENSG00000166086 "Junctional adhesion molecule 3" Q9BX67 11 134068925-134152001 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 77.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 29.1;RH-30: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 8.2" "Group enriched" "Detected in many" 7 "B-cells: 8.2;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003417, HPA050434" Approved Enhanced "Golgi apparatus" "Secreted to blood" 570000 "Golgi apparatus" "HPA003417: AB_1851981, HPA050434: " "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (3.24e-1)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (3.73e-4)" "unprognostic (3.23e-3)" "unprognostic (2.17e-1)" "unprognostic (1.06e-3)" "prognostic unfavourable (2.68e-4)" 14.0 14.9 17.6 7.9 34.1 2.2 9.9 7.0 28.7 15.5 23.4 77.0 6.9 5.9 25.0 12.9 16.3 11.9 17.8 21.4 26.1 16.9 6.7 3.0 13.7 6.2 40.3 17.4 32.0 4.4 14.5 19.5 68.8 29.6 26.2 9.7 17.5 9.4 32.5 4.1 9.1 11.7 29.7 34.8 8.7 12.0 24.8 34.1 5.1 7.6 4.6 5.6 22.7 22.6 8.2 0.2 0.8 0.1 0.1 4.0 2.9 0.2 0.4 28.0 14.4 26.2 19.4 23.5 11.9 14.1 4.5 4.4 0.3 0.2 0.3 12.3 15.5 0.4 20.2 0.2 8.5 0.2 10.0 0.8 0.1 1.8 7.8 0.5 12.4 13.2 0.0 3.1 2.8 29.1 0.3 0.2 19.2 0.3 8.6 1.0 6.6 1.2 0.2 38.3 0.1 0.2 0.1 18.9 10.6 0.1 0.3 0.4 0.3 0.3 0.2 8.4 6.1 13.1 8.1 0.1 0.1 0.2 9.3 1.1 16.0 0.4 0.1 0.3 2.2 0.0 2.6 8.2 2.8 1.6 0.2 4.8 4.0 2.6 0.8 0.1 0.0 0.2 0.1 2.9 17.6 34.1 7.0 28.7 26.1 16.9 40.3 17.4 29.6 34.1 JPH3 "CAGL237, HDL2, JP-3, JP3, TNRC22" ENSG00000154118 "Junctophilin 3" Q8WXH2 16 87601835-87698156 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 44.2" "Cell line enhanced" "Detected in some" "MCF7: 6.4;NTERA-2: 5.7;SH-SY5Y: 7.3;SiHa: 4.7;U-2 OS: 23.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076304 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA076304: " "unprognostic (8.97e-3)" "unprognostic (3.17e-2)" "unprognostic (1.57e-3)" "unprognostic (4.82e-3)" "unprognostic (3.43e-1)" "unprognostic (9.12e-2)" "unprognostic (1.68e-2)" "unprognostic (8.10e-2)" "unprognostic (5.53e-2)" "unprognostic (1.48e-1)" "unprognostic (5.61e-3)" "unprognostic (2.80e-2)" "unprognostic (1.28e-4)" "unprognostic (3.01e-2)" "unprognostic (2.09e-1)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" 1.3 3.6 27.2 1.6 24.1 1.1 1.2 18.9 44.2 1.5 1.4 1.2 0.0 1.4 1.3 1.2 2.4 1.4 1.2 1.2 30.9 14.6 1.2 1.2 1.2 1.2 8.3 12.2 1.1 1.5 1.2 4.4 1.2 6.4 1.3 1.3 0.8 1.2 1.7 1.1 1.2 1.7 1.3 3.3 1.2 1.5 1.8 3.5 0.0 1.2 0.0 1.2 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.4 0.0 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.5 7.3 4.7 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 27.2 24.1 18.9 30.3 30.9 14.6 8.3 12.2 6.4 3.5 JPH4 "JPHL1, KIAA1831" ENSG00000092051 "Junctophilin 4" Q96JJ6 14 23568035-23578800 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.7;seminal vesicle: 37.8" "Group enriched" "Detected in some" 6 "SCLC-21H: 9.9;SH-SY5Y: 24.6;U-2 OS: 18.6" "Cancer enhanced" "Detected in some" "glioma: 6.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.4;myeloid DC: 5.9" "Group enriched" "Detected in many" 14 "dendritic cells: 5.9;monocytes: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013492 Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB013492: " "unprognostic (3.30e-2)" "unprognostic (1.91e-3)" "unprognostic (5.05e-3)" "unprognostic (7.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.84e-1)" "unprognostic (3.77e-3)" "unprognostic (5.98e-4)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (3.89e-3)" "unprognostic (1.15e-2)" "unprognostic (3.15e-2)" "unprognostic (2.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.13e-2)" "unprognostic (4.96e-3)" 1.9 12.3 33.6 2.0 43.8 1.3 1.6 45.3 63.7 3.4 1.9 2.1 8.0 1.8 17.1 6.2 1.5 5.1 1.6 1.3 32.3 16.8 2.7 1.3 3.4 2.0 8.3 27.6 6.2 1.5 3.1 23.2 1.6 9.8 11.6 1.7 0.8 1.2 37.8 1.2 1.6 2.2 13.9 4.2 2.9 1.7 2.2 10.9 0.0 1.3 0.0 1.7 1.7 1.8 0.0 5.9 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.5 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 9.9 24.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 33.6 43.8 45.3 42.6 32.3 16.8 8.3 27.6 9.8 10.9 KALRN "ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD" ENSG00000160145 "Kalirin RhoGEF kinase" O60229 3 124080023-124726325 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;retina: 31.2" "Cell line enhanced" "Detected in many" "CACO-2: 32.1;HEL: 19.6;SH-SY5Y: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.3" "Lineage enriched" "Detected in single" 5 "T-cells: 4.3" "Low region specificity" "Detected in many" "HPA011913, CAB026456" Approved Approved Nucleoplasm,Cytosol 110000 "Nucleoplasm, Cytosol" "CAB026456: , HPA011913: AB_1850494" "unprognostic (2.54e-2)" "unprognostic (3.43e-1)" "unprognostic (2.08e-1)" "unprognostic (3.12e-4)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (3.41e-2)" "unprognostic (8.58e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "unprognostic (2.26e-3)" "unprognostic (5.58e-2)" "unprognostic (2.67e-1)" "unprognostic (3.70e-2)" "unprognostic (2.81e-3)" 5.5 4.3 12.7 2.4 14.1 0.6 4.2 1.8 35.2 4.0 3.8 3.7 0.5 2.7 5.6 2.3 9.6 4.2 3.1 12.1 17.6 3.9 2.6 7.3 2.9 1.1 4.1 15.8 2.3 11.9 2.5 14.4 6.8 9.4 3.1 2.1 31.2 2.2 5.4 23.5 1.5 7.2 6.4 3.6 8.0 11.5 2.2 2.4 0.0 5.3 6.7 3.1 2.9 4.1 0.1 0.0 0.9 0.0 0.1 4.3 1.2 0.3 0.6 3.6 0.7 0.5 0.1 4.6 1.4 0.8 1.4 0.6 32.1 2.5 0.1 0.4 3.6 0.2 0.8 0.0 1.1 0.0 0.3 19.6 0.3 4.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.6 4.5 0.1 0.4 2.3 0.0 0.0 2.0 3.1 1.0 1.6 0.0 0.1 0.3 1.2 9.2 0.4 0.3 0.3 0.7 0.1 8.1 4.1 1.6 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.8 0.3 0.0 0.0 2.4 0.7 0.9 0.1 0.0 0.0 4.3 1.2 12.7 14.1 1.8 35.2 17.6 3.9 4.1 15.8 9.4 2.4 KANK4 "ANKRD38, KIAA0172" ENSG00000132854 "KN motif and ankyrin repeat domains 4" Q5T7N3 1 62236979-62319414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4" "Cell line enhanced" "Detected in some" "BEWO: 26.0;CACO-2: 3.7;Hep G2: 10.9;SCLC-21H: 5.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014030 Uncertain Uncertain Microtubules,Cytosol Cytosol Microtubules "HPA014030: AB_2128155" "unprognostic (1.66e-2)" "unprognostic (1.90e-3)" "unprognostic (2.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-2)" "unprognostic (6.31e-2)" "unprognostic (1.66e-2)" "unprognostic (3.58e-2)" "unprognostic (1.54e-1)" "unprognostic (3.85e-3)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (9.06e-2)" "unprognostic (1.97e-1)" "unprognostic (3.31e-2)" "unprognostic (7.74e-6)" 10.6 0.7 0.9 1.0 3.1 0.1 3.1 0.5 2.2 0.6 1.2 8.9 1.0 0.4 0.3 1.0 0.4 0.7 0.6 0.6 1.9 2.7 1.7 3.6 2.9 0.1 11.1 0.1 0.4 18.4 20.4 0.4 14.4 23.2 1.8 1.2 2.6 10.4 0.8 0.5 0.8 0.6 0.2 13.4 0.8 2.4 1.0 4.9 0.1 0.7 0.8 0.2 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 26.0 0.1 0.0 0.1 0.0 3.7 0.0 0.0 0.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 10.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.8 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 3.1 0.5 2.2 1.9 2.7 11.1 0.1 23.2 4.9 KANTR "LINC01155, Spasm" ENSG00000232593 "KDM5C adjacent transcript" X 53094145-53170914 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "unprognostic (2.89e-1)" "unprognostic (1.66e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (5.52e-2)" "unprognostic (2.18e-2)" "unprognostic (7.30e-2)" "unprognostic (4.79e-2)" "unprognostic (2.30e-3)" "unprognostic (2.54e-2)" "unprognostic (2.10e-2)" "unprognostic (1.46e-2)" "unprognostic (3.47e-6)" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "unprognostic (2.78e-3)" "unprognostic (1.81e-3)" 1.5 2.4 4.9 1.5 5.9 5.7 2.2 11.9 11.7 2.3 1.6 3.0 2.5 1.5 2.6 2.9 1.5 2.0 1.6 1.5 3.4 1.6 1.5 1.7 1.5 3.9 4.5 2.4 1.4 2.0 6.8 2.2 4.0 2.1 1.7 2.1 2.0 2.6 1.5 2.0 1.5 2.1 2.8 1.6 1.5 2.4 4.4 1.1 1.8 0.0 1.5 1.6 2.5 0.6 0.6 1.6 0.8 0.0 0.4 0.0 0.7 0.2 0.8 0.7 0.9 0.9 0.7 0.1 0.2 1.3 0.8 0.2 0.4 0.8 0.5 0.3 0.4 1.4 0.4 2.0 0.2 0.2 0.3 0.2 0.3 1.5 1.4 1.0 1.1 0.5 2.6 1.2 1.0 1.2 1.0 0.2 0.4 1.2 1.6 1.2 0.9 0.6 0.7 0.4 0.3 1.4 2.9 1.3 0.6 0.3 0.1 0.5 0.2 0.6 0.7 1.7 2.4 0.3 0.8 0.9 1.2 0.0 1.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.8 0.6 0.0 0.0 KBTBD11 "KIAA0711, KLHDC7C" ENSG00000176595 "Kelch repeat and BTB domain containing 11" O94819 8 1973878-2006936 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.4" "Cell line enhanced" "Detected in some" "HDLM-2: 10.2;NB-4: 7.4;SCLC-21H: 8.9;THP-1: 14.4;U-937: 20.4" "Cancer enhanced" "Detected in many" "renal cancer: 14.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.6" "Group enriched" "Detected in many" 4 "granulocytes: 4.6;monocytes: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051159 Uncertain Approved "Intermediate filaments" "Intermediate filaments" "HPA051159: " "unprognostic (1.19e-1)" "unprognostic (2.27e-1)" "unprognostic (1.20e-3)" "unprognostic (2.70e-2)" "unprognostic (2.03e-1)" "unprognostic (6.84e-2)" "unprognostic (2.76e-4)" "unprognostic (2.50e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.75e-2)" "unprognostic (9.53e-2)" "unprognostic (3.52e-2)" "unprognostic (1.75e-1)" "unprognostic (1.04e-2)" 3.2 6.8 17.6 2.6 17.7 8.7 1.8 16.3 22.4 4.5 8.2 10.9 0.0 10.9 1.6 1.7 1.7 3.8 3.8 2.1 16.1 10.8 13.9 6.7 2.3 3.1 13.2 16.7 1.9 3.2 5.1 2.0 0.8 11.4 5.0 6.6 3.1 2.1 2.9 1.8 1.0 12.7 1.7 12.4 6.4 1.9 1.6 9.3 4.7 2.4 0.0 2.0 1.4 0.7 0.0 0.4 4.6 1.4 0.0 0.6 0.4 1.5 1.0 4.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.9 0.4 0.1 0.3 0.0 2.1 0.0 0.0 10.2 1.2 0.0 0.0 0.0 1.0 4.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.7 4.5 7.4 1.0 0.0 1.3 0.0 0.0 2.2 0.3 8.9 4.5 0.0 0.0 0.1 0.1 14.4 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.1 20.4 0.7 0.7 1.4 4.6 0.0 0.6 0.2 0.0 0.2 0.1 0.4 0.0 0.6 0.3 0.9 0.0 0.3 0.0 0.5 0.4 17.6 17.7 16.3 21.9 16.1 10.8 13.2 16.7 11.4 9.3 KCNA1 "AEMK, HUK1, Kv1.1, MBK1, RBK1" ENSG00000111262 "Potassium voltage-gated channel subfamily A member 1" Q09470 12 4909893-4918256 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 24.1" "Group enriched" "Detected in some" 11 "LHCN-M2: 2.3;NTERA-2: 2.0;SCLC-21H: 3.8;U-2 OS: 3.7" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "basal ganglia: 13.7;cerebellum: 23.8;cerebral cortex: 21.1;pons and medulla: 24.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074471 Approved "HPA074471: " "unprognostic (6.39e-3)" "unprognostic (2.64e-1)" "unprognostic (1.09e-1)" "unprognostic (8.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.79e-2)" "unprognostic (4.69e-3)" "unprognostic (2.48e-1)" "unprognostic (8.77e-5)" "unprognostic (6.30e-2)" "unprognostic (1.08e-4)" 0.8 0.7 1.5 0.7 13.7 0.7 1.3 23.8 21.1 1.6 0.9 0.9 0.0 0.9 1.0 0.7 0.7 0.7 0.9 0.7 4.6 1.1 0.7 0.7 0.8 0.7 2.2 3.5 0.7 0.7 4.0 0.6 0.7 24.1 0.7 0.9 0.0 1.9 0.8 0.7 0.8 0.8 1.1 1.1 0.7 1.0 0.7 1.4 0.2 2.0 0.0 0.7 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 13.7 23.8 21.1 4.6 1.1 2.2 3.5 24.1 1.4 KCNA2 "HK4, Kv1.2" ENSG00000177301 "Potassium voltage-gated channel subfamily A member 2" P16389 1 110519837-110631474 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 28.0" "Cell line enhanced" "Detected in some" "Karpas-707: 10.6;SCLC-21H: 2.7;U-2 OS: 2.4;U-266/70: 3.5;U-266/84: 5.3;WM-115: 2.9" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.1" "Lineage enriched" "Detected in single" 8 "T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB001976 Enhanced "CAB001976: " "unprognostic (1.84e-2)" "unprognostic (9.70e-3)" "unprognostic (1.97e-1)" "unprognostic (2.98e-1)" "unprognostic (7.17e-3)" "unprognostic (6.68e-3)" "unprognostic (5.05e-3)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (4.50e-3)" "unprognostic (3.08e-3)" "unprognostic (2.93e-4)" "unprognostic (2.15e-1)" "unprognostic (3.55e-1)" "unprognostic (6.41e-2)" "unprognostic (2.83e-1)" 3.2 1.4 7.1 2.2 13.1 0.8 1.2 17.2 28.0 1.2 1.6 3.1 0.0 1.4 1.0 1.3 1.7 1.1 1.6 1.6 7.2 6.1 0.9 0.9 1.0 1.9 7.2 14.5 1.1 1.9 0.8 1.4 0.7 21.1 1.8 2.0 1.4 1.8 2.4 2.1 1.6 1.6 1.6 2.8 1.3 1.3 2.5 3.8 0.3 5.3 0.0 3.5 1.4 0.5 0.5 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 1.4 0.0 0.0 2.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 2.4 0.0 0.0 3.5 5.3 0.2 0.1 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.3 0.5 1.8 1.3 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 4.1 0.1 7.1 13.1 17.2 26.3 7.2 6.1 7.2 14.5 21.1 3.8 KCNA4 "HK1, HPCN2, KCNA4L, Kv1.4" ENSG00000182255 "Potassium voltage-gated channel subfamily A member 4" P22459 11 30009741-30017023 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Cataract, Disease mutation, Dystonia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 16.5;brain: 39.0" "Cell line enhanced" "Detected in some" "U-2 OS: 1.6;WM-115: 2.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 39.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001977, HPA016422" Approved "CAB001977: , HPA016422: AB_1855574" "unprognostic (1.12e-2)" "unprognostic (1.80e-2)" "unprognostic (1.31e-2)" "unprognostic (2.73e-2)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (2.24e-1)" "unprognostic (1.15e-2)" "unprognostic (6.71e-2)" "unprognostic (1.17e-1)" 2.2 16.5 9.8 0.6 39.0 0.6 0.6 0.2 12.2 0.6 0.6 0.8 1.8 0.7 1.1 0.9 0.6 0.8 0.6 5.9 6.1 2.7 1.2 0.6 2.4 0.6 1.6 6.2 0.6 0.6 0.6 2.8 1.2 10.5 0.6 0.6 0.0 0.6 1.7 0.6 0.8 0.6 0.8 0.6 0.6 1.0 0.7 5.9 0.0 0.6 0.0 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 0.6 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 39.0 0.2 12.2 6.1 2.7 1.6 6.2 10.5 5.9 KCNA6 "HBK2, Kv1.6, PPP1R96" ENSG00000151079 "Potassium voltage-gated channel subfamily A member 6" P17658 12 4809176-4813412 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.6" "Cell line enhanced" "Detected in some" "Daudi: 3.9;TIME: 1.2;U-698: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" 0.7 0.8 3.8 2.7 4.7 0.8 2.0 0.7 9.6 1.0 0.7 6.8 0.0 2.2 0.8 0.6 0.8 0.8 0.6 0.7 5.8 0.7 0.8 0.9 0.9 2.1 3.9 7.2 0.9 0.8 0.6 2.0 0.7 4.3 0.8 0.6 0.0 0.8 0.6 1.2 0.7 0.8 0.7 1.7 1.5 0.8 2.0 8.4 0.0 0.8 0.0 0.6 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.0 0.0 3.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 4.7 0.7 9.6 5.8 0.7 3.9 7.2 4.3 8.4 KCNAB1 "AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3" ENSG00000169282 "Potassium voltage-gated channel subfamily A member regulatory beta subunit 1" Q14722 3 156037701-156539138 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.1;thyroid gland: 25.7" "Cell line enhanced" "Detected in many" "HEL: 5.8;hTEC/SVTERT24-B: 9.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 300.5" "Low region specificity" "Detected in all" "HPA036110, HPA044550" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" Vesicles "Nucleoplasm, Plasma membrane" "HPA036110: , HPA044550: AB_10797032" "unprognostic (1.52e-1)" "unprognostic (3.73e-1)" "unprognostic (1.33e-1)" "unprognostic (2.98e-4)" "unprognostic (1.24e-2)" "unprognostic (1.64e-1)" "unprognostic (1.81e-1)" "unprognostic (2.83e-2)" "unprognostic (8.51e-2)" "unprognostic (3.72e-2)" "unprognostic (5.87e-2)" "unprognostic (9.70e-2)" "unprognostic (2.17e-3)" "unprognostic (2.60e-1)" "unprognostic (1.95e-1)" "unprognostic (1.06e-1)" "unprognostic (4.00e-1)" 12.6 5.9 7.5 1.1 41.1 1.4 3.5 10.7 16.4 5.7 2.9 4.6 2.5 1.6 3.4 11.9 2.1 2.7 2.7 4.8 12.3 4.3 1.8 2.3 3.1 0.9 3.7 10.3 2.8 3.7 1.8 1.2 1.3 3.0 21.1 1.8 7.2 3.4 17.9 1.7 1.3 1.9 2.6 2.6 4.3 1.3 2.7 12.3 0.0 25.7 1.0 0.5 2.0 3.0 1.0 4.3 2.4 1.2 0.9 2.7 0.4 0.8 0.8 1.2 0.3 0.1 0.0 2.5 2.2 0.0 0.0 0.2 1.7 0.2 0.6 1.1 0.0 0.5 0.0 0.0 0.0 0.6 1.7 5.8 1.0 2.6 0.0 1.6 0.5 0.0 0.0 9.1 0.0 3.6 0.2 0.5 0.4 0.2 0.5 1.0 1.8 0.4 0.9 1.2 4.6 0.0 0.4 1.3 1.4 0.5 1.1 1.1 1.4 0.9 3.7 1.5 0.9 2.4 1.9 3.2 0.7 0.7 4.5 1.9 1.6 2.4 0.6 0.2 1.5 0.7 2.7 0.9 1.4 1.3 0.9 1.0 1.2 1.3 0.1 0.9 1.2 4.3 1.7 0.4 7.5 41.1 10.7 16.4 12.3 4.3 3.7 10.3 3.0 12.3 KCNAB2 "AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B" ENSG00000069424 "Potassium voltage-gated channel subfamily A regulatory beta subunit 2" Q13303 1 5991466-6101193 "Plasma proteins, Predicted intracellular proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 57.5;brain: 54.3" "Cell line enhanced" "Detected in many" "HL-60: 67.1;U-937: 71.5" "Cancer enriched" "Detected in all" 7 "melanoma: 29.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB001975 Enhanced "CAB001975: " "unprognostic (6.60e-2)" "unprognostic (2.33e-2)" "unprognostic (3.97e-3)" "unprognostic (2.30e-2)" "unprognostic (1.76e-2)" "unprognostic (8.18e-3)" "unprognostic (4.30e-2)" "unprognostic (1.05e-1)" "unprognostic (4.85e-2)" "unprognostic (1.58e-2)" "unprognostic (7.71e-3)" "unprognostic (8.83e-3)" "prognostic unfavourable (3.50e-5)" "unprognostic (2.88e-2)" "unprognostic (3.10e-2)" "unprognostic (2.35e-1)" "unprognostic (5.24e-2)" 6.9 4.8 37.8 21.5 34.7 57.5 2.7 13.5 54.3 2.7 4.2 4.2 0.5 3.7 3.4 2.1 4.1 6.2 8.1 8.1 44.6 13.1 10.9 3.8 13.9 31.2 16.1 24.7 3.2 2.2 1.3 6.1 4.5 28.7 2.7 4.1 10.8 3.1 2.5 4.0 9.0 7.4 5.0 5.8 21.9 5.3 3.1 4.7 13.9 2.4 0.5 17.0 9.0 1.7 6.8 19.6 11.4 21.1 9.2 19.8 22.8 2.5 7.0 0.6 0.8 0.3 1.2 2.3 1.3 8.5 1.4 1.7 2.5 1.1 14.9 4.3 0.9 0.9 0.5 0.1 0.8 17.3 2.3 18.2 7.0 4.2 1.3 67.1 0.5 1.3 0.3 0.9 1.7 1.1 0.5 28.2 0.7 2.2 12.9 28.9 0.4 3.1 2.6 2.1 17.6 0.2 0.0 4.3 1.5 1.0 1.2 22.1 1.0 25.9 0.2 0.3 2.5 2.5 1.4 21.4 25.0 21.1 2.6 71.5 0.5 2.1 21.1 11.4 19.8 17.6 18.7 6.0 13.0 19.1 19.6 6.8 13.8 14.5 9.0 9.2 15.4 8.1 13.6 22.8 37.8 34.7 13.5 54.3 44.6 13.1 16.1 24.7 28.7 4.7 KCNAB3 "AKR6A9, KCNA3B" ENSG00000170049 "Potassium voltage-gated channel subfamily A regulatory beta subunit 3" O43448 17 7921859-7929803 "Predicted intracellular proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 36.1;endometrium 1: 17.2" "Cell line enhanced" "Detected in many" "REH: 14.9;SH-SY5Y: 8.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 5 "cerebellum: 36.1;cerebral cortex: 31.6" "Cell type enhanced" "Detected in some" "myeloid DC: 1.5;plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077993 Approved Mitochondria Mitochondria "HPA077993: " "unprognostic (3.02e-2)" "unprognostic (5.59e-2)" "unprognostic (6.95e-2)" "unprognostic (2.62e-2)" "unprognostic (6.13e-2)" "unprognostic (5.84e-4)" "unprognostic (2.19e-1)" "unprognostic (5.72e-2)" "unprognostic (8.50e-2)" "unprognostic (8.55e-2)" "unprognostic (3.27e-4)" "unprognostic (7.47e-3)" "unprognostic (3.03e-6)" "unprognostic (2.12e-1)" "unprognostic (5.00e-2)" "unprognostic (4.97e-2)" "unprognostic (9.54e-3)" 1.4 0.7 4.2 2.7 5.2 5.5 1.2 36.1 31.6 1.8 1.4 0.8 0.0 1.3 17.2 2.2 0.8 3.5 2.1 0.7 4.7 2.9 1.7 1.1 1.5 3.8 2.4 6.3 2.1 1.0 0.8 4.9 1.6 5.9 2.3 2.0 3.8 1.3 1.4 1.0 3.3 1.9 11.4 5.2 2.6 2.2 1.7 1.9 0.8 1.6 0.0 3.3 1.0 1.0 0.1 1.7 0.5 0.2 0.0 0.7 0.1 1.3 1.1 5.5 1.4 0.6 1.4 1.9 4.9 3.1 4.2 4.8 0.7 0.3 2.2 0.3 0.8 0.4 1.5 0.7 6.0 1.8 2.3 0.7 0.9 0.0 5.1 0.2 3.0 2.1 1.6 4.5 0.2 0.3 0.5 0.3 0.7 1.0 0.8 2.6 0.8 0.7 14.9 1.5 0.6 0.5 1.7 0.3 8.0 0.4 0.0 0.9 1.4 0.1 0.3 0.7 2.8 1.1 0.4 1.1 1.2 1.2 2.1 2.9 1.0 0.0 0.2 0.0 0.5 0.0 0.7 0.0 0.0 0.0 1.5 0.1 0.2 0.2 0.5 0.0 0.0 1.7 0.0 0.1 4.2 5.2 36.1 31.6 4.7 2.9 2.4 6.3 5.9 1.9 KCNB1 Kv2.1 ENSG00000158445 "Potassium voltage-gated channel subfamily B member 1" Q14721 20 49293394-49484297 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Exocytosis, Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;retina: 22.4" "Cell line enhanced" "Detected in some" "ASC diff: 3.5;CACO-2: 5.0;hTCEpi: 3.1;U-2 OS: 4.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001979, HPA042434" Enhanced "CAB001979: , HPA042434: " "unprognostic (4.51e-1)" "unprognostic (1.72e-1)" "unprognostic (6.54e-3)" "unprognostic (4.87e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-1)" "unprognostic (8.09e-2)" "unprognostic (6.22e-2)" "unprognostic (5.31e-1)" "unprognostic (8.32e-2)" "unprognostic (1.87e-3)" "unprognostic (1.37e-1)" "unprognostic (1.31e-2)" "unprognostic (2.07e-3)" "unprognostic (8.17e-2)" "unprognostic (9.35e-2)" "unprognostic (5.25e-4)" 16.9 3.6 11.4 1.3 14.6 0.8 2.4 8.1 25.9 2.3 5.1 1.8 0.7 1.2 6.8 2.3 3.9 9.0 1.9 1.9 6.6 5.3 1.3 3.5 1.2 0.8 3.3 12.5 1.2 1.2 0.9 2.5 1.0 2.5 4.8 1.9 22.4 1.7 6.5 6.2 1.1 1.8 9.6 1.2 1.2 3.9 1.5 2.4 0.0 1.0 0.1 0.8 4.0 0.9 0.4 0.3 1.2 0.2 0.3 0.7 0.0 0.0 0.1 0.8 0.0 3.5 0.3 0.1 0.0 0.4 0.4 0.0 5.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.2 0.0 0.1 0.0 0.0 2.5 0.0 0.6 3.1 0.0 0.1 0.0 0.0 1.9 1.1 0.3 0.0 2.3 0.1 0.9 0.0 0.9 0.0 0.0 0.0 2.3 1.8 1.6 2.3 0.0 1.6 0.0 0.0 2.2 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.0 0.1 0.1 0.3 0.2 0.0 0.4 0.7 0.2 1.2 0.3 0.1 0.3 0.1 0.0 11.4 14.6 8.1 25.9 6.6 5.3 3.3 12.5 2.5 2.4 KCNB2 Kv2.2 ENSG00000182674 "Potassium voltage-gated channel subfamily B member 2" Q92953 8 72537391-72938349 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2" "Group enriched" "Detected in some" 5 "HaCaT: 3.2;HDLM-2: 3.0;HEK 293: 7.4;SCLC-21H: 6.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065970 Approved "Nucleoli,Plasma membrane,Midbody" "Plasma membrane" "Nucleoli, Midbody" "HPA065970: " "unprognostic (9.87e-3)" "unprognostic (1.71e-1)" "unprognostic (7.57e-2)" "unprognostic (1.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (2.72e-1)" "unprognostic (6.93e-5)" "unprognostic (5.53e-3)" "unprognostic (3.30e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-2)" "unprognostic (3.26e-1)" 0.8 1.9 3.8 0.6 5.3 0.4 0.7 0.3 9.7 0.5 0.7 0.0 0.0 1.2 0.4 0.4 1.1 2.1 0.5 0.4 7.1 3.1 0.5 0.4 0.6 0.5 0.9 7.8 0.4 2.4 0.4 9.2 0.5 3.2 0.7 0.7 4.2 0.5 0.5 0.4 0.4 1.6 0.5 1.6 8.6 2.4 1.7 0.4 0.9 0.4 0.0 0.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 5.3 0.3 9.7 7.1 3.1 0.9 7.8 3.2 0.4 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.5" "Cell line enhanced" "Detected in some" "RH-30: 7.4;SCLC-21H: 7.0;SH-SY5Y: 4.3" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Region enhanced" "Detected in all" "cerebellum: 67.5" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: , HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.7 2.3 8.2 1.0 10.0 2.9 0.9 67.5 33.3 3.0 1.0 1.0 0.0 1.4 1.5 0.6 1.1 0.9 1.3 0.6 5.6 4.9 0.9 1.1 1.0 1.2 3.3 12.6 1.1 0.9 0.6 1.4 0.7 19.5 1.2 0.8 0.7 1.2 0.7 1.7 1.8 1.2 0.8 1.9 1.0 1.3 2.9 2.0 0.0 1.5 0.0 0.8 2.4 0.5 1.7 0.8 5.8 0.8 0.7 1.1 0.3 0.4 0.1 3.0 1.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.2 0.0 1.1 1.8 0.0 0.3 0.3 2.1 0.6 2.9 0.2 0.3 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.5 1.4 0.0 0.5 0.5 1.1 1.5 0.0 0.7 7.4 0.9 0.0 0.4 7.0 4.3 0.4 0.4 0.0 0.6 0.5 0.1 0.2 2.3 0.3 0.3 0.5 0.6 1.0 0.5 0.3 0.9 5.8 0.7 1.1 1.1 0.7 0.7 0.7 0.9 0.5 0.2 1.7 0.7 0.8 3.8 0.7 0.8 0.8 0.4 0.3 8.2 10.0 67.5 33.3 5.6 4.9 3.3 12.6 19.5 2.0 KCNC2 Kv3.2 ENSG00000166006 "Potassium voltage-gated channel subfamily C member 2" Q96PR1 12 75040077-75209868 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 39.3" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" "Group enriched" "Detected in some" 8 "breast cancer: 1.5;prostate cancer: 4.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019664, CAB022571" Uncertain Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "CAB022571: , HPA019664: AB_1855578" "unprognostic (2.01e-1)" "unprognostic (1.14e-1)" "unprognostic (2.68e-1)" "unprognostic (5.58e-3)" "unprognostic (4.46e-2)" "unprognostic (3.39e-2)" 0.7 0.7 8.7 0.7 12.9 0.7 3.3 0.4 39.3 0.7 0.8 1.9 0.0 0.7 0.9 0.9 0.7 0.7 0.7 0.7 7.4 10.4 0.7 0.9 0.7 0.7 4.7 13.5 0.7 0.7 0.7 6.0 0.7 19.1 4.4 0.8 1.3 1.1 0.7 0.7 0.7 0.8 0.7 1.0 0.7 0.7 1.0 0.6 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.7 12.9 0.4 27.3 7.4 10.4 4.7 13.5 19.1 0.6 KCNC3 "Kv3.3, SCA13" ENSG00000131398 "Potassium voltage-gated channel subfamily C member 3" Q14003 19 50311937-50333515 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;parathyroid gland: 31.1;thyroid gland: 23.9" "Cell line enhanced" "Detected in some" "CACO-2: 8.7;CAPAN-2: 7.6;HDLM-2: 7.9;HMC-1: 20.9;K-562: 7.7;SK-BR-3: 14.2;T-47d: 13.5;U-2 OS: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018041 Approved "HPA018041: AB_1855579" "unprognostic (8.05e-2)" "unprognostic (2.34e-2)" "unprognostic (3.01e-4)" "unprognostic (4.41e-2)" "unprognostic (3.84e-2)" "unprognostic (1.91e-2)" "unprognostic (2.79e-2)" "unprognostic (1.12e-2)" "unprognostic (1.46e-1)" "unprognostic (1.59e-1)" "unprognostic (3.94e-3)" "unprognostic (2.10e-5)" "prognostic unfavourable (1.23e-4)" "unprognostic (1.68e-2)" "unprognostic (1.45e-1)" "unprognostic (2.85e-2)" "unprognostic (1.19e-1)" 1.4 2.2 7.2 5.4 9.4 1.4 2.3 32.1 31.2 3.1 1.1 3.4 3.0 1.8 4.5 5.8 1.1 12.8 1.4 1.7 6.9 4.2 10.6 2.5 4.5 4.7 4.0 6.6 0.6 3.7 31.1 9.7 2.4 15.6 2.4 1.4 3.0 2.3 15.1 1.2 2.1 1.8 1.7 3.8 6.5 2.1 2.4 2.9 1.1 23.9 0.0 3.4 1.8 1.0 0.4 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 4.1 0.0 0.0 0.0 0.0 8.7 7.6 0.7 1.0 0.0 1.1 0.2 0.0 0.0 7.9 1.8 0.0 0.0 1.7 0.0 0.0 20.9 0.1 0.0 0.0 0.0 0.1 7.7 0.0 0.0 2.7 0.1 0.0 1.1 3.3 0.0 0.1 0.0 0.5 0.2 0.0 1.4 1.6 14.2 0.0 13.5 2.1 0.1 0.0 9.3 0.0 0.0 0.0 0.1 0.4 0.3 1.7 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 7.2 9.4 32.1 31.2 6.9 4.2 4.0 6.6 15.6 2.9 KCND1 Kv4.1 ENSG00000102057 "Potassium voltage-gated channel subfamily D member 1" Q9NSA2 X 48961378-48971569 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell line enhanced" "Detected in many" "HSkMC: 13.6;NB-4: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000524, HPA001066" Approved Uncertain Nucleoplasm Nucleoplasm "HPA000524: , HPA001066: AB_1079662" "unprognostic (6.00e-2)" "unprognostic (2.58e-1)" "unprognostic (1.01e-4)" "unprognostic (2.19e-4)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" "unprognostic (2.79e-1)" "unprognostic (8.13e-3)" "unprognostic (1.13e-2)" "unprognostic (2.41e-3)" "prognostic favourable (2.66e-6)" "unprognostic (2.61e-1)" "unprognostic (4.30e-11)" "unprognostic (3.13e-2)" "unprognostic (3.49e-1)" "unprognostic (7.64e-2)" "unprognostic (2.22e-3)" 4.9 2.4 4.2 3.4 4.7 6.0 2.2 16.8 7.8 5.1 2.2 6.3 1.9 2.0 5.0 3.8 1.4 7.4 6.3 2.9 6.9 2.5 2.5 1.8 3.0 3.1 3.1 3.5 4.6 1.4 1.8 3.0 2.5 10.4 3.3 2.1 2.6 1.2 6.0 0.7 1.6 2.6 6.6 6.5 4.2 2.5 3.0 2.7 1.1 2.3 0.5 3.6 3.0 3.0 0.6 1.3 1.4 0.1 0.0 0.8 0.1 0.4 2.0 0.8 4.8 6.6 5.2 1.6 1.0 4.2 2.9 1.9 1.3 0.6 1.6 3.5 3.2 0.6 0.8 0.4 2.8 2.7 3.2 1.5 2.0 0.1 2.4 0.4 3.0 13.6 1.8 5.3 0.6 1.0 1.1 3.7 2.1 3.6 0.4 10.8 2.6 0.7 1.3 0.9 1.6 3.2 1.5 0.5 2.2 0.9 0.0 2.2 2.1 1.6 2.5 0.6 2.7 0.6 0.2 3.0 3.9 3.9 1.8 3.9 2.1 0.0 0.1 0.0 0.5 0.0 0.3 0.6 0.2 0.8 0.0 0.1 0.2 0.0 1.4 0.0 0.0 1.3 0.0 0.1 4.2 4.7 16.8 7.8 6.9 2.5 3.1 3.5 10.4 2.7 KCND2 "KIAA1044, Kv4.2, RK5" ENSG00000184408 "Potassium voltage-gated channel subfamily D member 2" Q9NZV8 7 120273668-120750331 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 41.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.4;HSkMC: 4.0;NTERA-2: 3.1;RT4: 3.2;SCLC-21H: 16.2" "Cancer enhanced" "Detected in many" "glioma: 6.2" "Region enhanced" "Detected in all" "cerebellum: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029068 Enhanced "HPA029068: AB_10601436" "unprognostic (4.22e-1)" "unprognostic (2.79e-4)" "unprognostic (3.79e-2)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.91e-2)" "unprognostic (4.98e-3)" "unprognostic (9.07e-3)" "unprognostic (1.03e-1)" "unprognostic (1.14e-1)" "unprognostic (9.77e-3)" "unprognostic (1.51e-1)" "unprognostic (4.51e-4)" "unprognostic (4.07e-5)" "unprognostic (2.71e-2)" "unprognostic (2.92e-2)" "unprognostic (1.83e-3)" 2.9 1.0 3.9 1.0 6.7 0.3 1.9 41.1 20.6 2.4 0.7 1.5 0.0 0.7 5.6 0.5 0.5 1.7 7.0 0.5 3.7 5.4 0.3 0.4 0.6 0.5 4.2 3.6 5.9 0.6 2.5 6.6 0.8 12.1 0.5 0.6 0.0 0.7 1.7 0.5 0.3 0.5 3.7 3.7 0.3 0.5 2.9 4.5 0.0 0.8 1.1 0.3 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 6.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.6 0.0 0.0 4.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 3.2 16.2 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 6.7 41.1 5.3 3.7 5.4 4.2 3.6 12.1 4.5 KCND3 "KSHIVB, Kv4.3, SCA19, SCA22" ENSG00000171385 "Potassium voltage-gated channel subfamily D member 3" Q9UK17 1 111770662-111989155 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Brugada syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029452 Approved "HPA029452: AB_10602239" "unprognostic (1.11e-2)" "unprognostic (1.73e-3)" "unprognostic (1.71e-1)" "unprognostic (2.60e-2)" "unprognostic (1.37e-1)" "unprognostic (2.42e-1)" "unprognostic (1.41e-1)" "unprognostic (9.48e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-2)" "unprognostic (1.40e-1)" "unprognostic (7.44e-2)" "unprognostic (3.64e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-3)" "unprognostic (6.64e-3)" 3.3 0.8 6.8 3.1 6.9 0.0 2.1 25.9 11.9 1.3 2.5 1.3 1.3 0.3 4.1 9.6 3.2 3.4 4.2 5.5 5.6 5.6 1.3 11.6 1.3 1.3 8.9 5.7 1.3 2.2 4.1 1.5 1.3 1.6 9.2 1.6 1.9 1.3 10.0 2.8 5.1 1.3 7.7 1.3 2.0 1.7 1.3 1.3 1.3 1.3 2.3 1.3 3.7 1.3 0.5 0.4 1.2 0.3 0.9 0.3 0.7 0.0 0.0 0.3 0.0 0.5 0.1 0.1 0.4 0.0 0.0 0.0 0.8 0.1 0.0 1.6 0.6 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.3 16.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.5 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.3 0.4 0.5 0.3 0.2 1.2 0.9 0.3 0.3 0.1 0.7 6.8 6.9 25.9 9.3 5.6 5.6 8.9 5.7 1.6 1.3 KCNE5 KCNE1L ENSG00000176076 "Potassium voltage-gated channel subfamily E regulatory subunit 5" Q9UJ90 X 109623700-109625172 "Disease related genes, Predicted membrane proteins" "Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5" "Cell line enhanced" "Detected in some" "HMC-1: 4.1;hTEC/SVTERT24-B: 5.4" "Group enriched" "Detected in some" 8 "glioma: 7.9;testis cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 5.6" "Group enriched" "Detected in many" 4 "dendritic cells: 5.6;monocytes: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042316 Uncertain Cytosol Cytosol "HPA042316: AB_10795397" "unprognostic (5.33e-2)" "unprognostic (2.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (2.14e-3)" "unprognostic (3.27e-2)" "unprognostic (9.46e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-3)" "unprognostic (7.83e-2)" "unprognostic (5.64e-6)" "unprognostic (5.10e-2)" "unprognostic (9.06e-2)" "unprognostic (1.36e-1)" "unprognostic (5.37e-3)" 4.8 1.1 6.4 1.3 11.3 6.8 1.2 6.0 6.6 1.0 0.6 8.2 0.0 0.7 0.8 1.3 1.2 0.5 2.4 2.2 8.9 8.1 0.7 0.7 0.8 0.8 14.3 1.6 1.7 0.4 0.4 0.2 2.5 29.5 1.9 0.5 0.1 0.6 2.3 3.2 1.1 0.8 0.9 7.3 1.4 0.6 1.2 0.3 8.5 0.6 2.6 0.8 0.8 0.2 0.0 5.6 0.0 1.7 0.1 0.8 0.3 0.9 0.0 0.2 0.4 0.1 0.1 0.1 1.9 0.4 0.7 0.7 0.1 0.4 0.4 0.0 0.4 0.8 0.0 2.2 0.9 0.2 0.4 2.6 2.6 1.8 0.1 0.0 4.1 0.6 1.4 5.4 1.3 0.4 0.0 0.1 0.5 0.0 0.8 3.3 0.0 0.1 0.2 0.1 0.1 0.7 0.1 0.2 0.4 1.2 0.0 1.1 0.0 2.5 1.2 1.8 0.9 1.0 2.4 0.5 0.6 0.3 1.2 1.2 0.5 0.0 0.7 0.0 0.8 1.7 0.0 0.0 0.1 0.1 5.6 0.0 0.0 0.1 0.0 0.1 0.1 1.2 0.0 0.3 6.4 11.3 6.0 6.5 8.9 8.1 14.3 1.6 29.5 0.3 KCNF1 "IK8, KCNF, kH1, Kv5.1" ENSG00000162975 "Potassium voltage-gated channel modifier subfamily F member 1" Q9H3M0 2 10911937-10914225 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 36.9" "Cell line enhanced" "Detected in some" "A549: 16.5;MCF7: 5.8;T-47d: 7.2" "Cancer enriched" "Detected in many" 7 "glioma: 27.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 70.7;basal ganglia: 55.9;cerebral cortex: 78.2;hippocampal formation: 69.5;olfactory region: 141.1" "Low region specificity" "Detected in all" "HPA014738, HPA062278" Enhanced Approved "Golgi apparatus" "Golgi apparatus" "HPA014738: AB_1852114, HPA062278: " "unprognostic (2.54e-1)" "unprognostic (6.06e-3)" "unprognostic (1.37e-1)" "unprognostic (3.07e-2)" "unprognostic (4.39e-2)" "unprognostic (7.41e-4)" "unprognostic (1.54e-3)" "unprognostic (4.83e-5)" "unprognostic (1.57e-1)" "unprognostic (6.95e-2)" "unprognostic (1.60e-2)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (3.10e-4)" "unprognostic (2.37e-1)" "unprognostic (4.28e-2)" "unprognostic (4.08e-2)" 0.9 0.9 11.5 1.0 25.5 0.8 1.2 0.8 36.9 0.9 1.2 2.4 0.0 1.2 1.9 0.8 1.6 1.1 1.0 1.1 13.1 4.7 1.1 0.9 1.0 1.0 3.1 10.5 0.9 2.2 0.8 0.2 0.9 3.6 1.0 1.2 0.0 0.8 1.4 0.8 0.8 1.1 1.0 1.0 1.5 1.1 1.0 3.1 0.5 0.8 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 16.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.0 0.0 2.5 1.7 0.0 0.1 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 7.2 0.8 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 11.5 25.5 0.8 28.5 13.1 4.7 3.1 10.5 3.6 3.1 KCNG2 "KCNF2, Kv6.2" ENSG00000178342 "Potassium voltage-gated channel modifier subfamily G member 2" Q9UJ96 18 79863668-79900184 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 5.3" "Cell line enhanced" "Detected in some" "NB-4: 3.5;U-2 OS: 1.1;U-937: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 4 "hippocampal formation: 31.7" HPA048628 Enhanced "HPA048628: " "unprognostic (1.07e-2)" "unprognostic (1.34e-2)" "unprognostic (8.39e-2)" "unprognostic (4.41e-1)" "unprognostic (1.99e-1)" "unprognostic (9.69e-2)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (2.40e-1)" "unprognostic (3.78e-1)" "unprognostic (3.61e-3)" "unprognostic (1.09e-1)" "unprognostic (3.18e-5)" "unprognostic (1.05e-1)" "unprognostic (7.72e-2)" "unprognostic (4.08e-2)" "unprognostic (3.63e-2)" 0.2 0.1 1.5 0.8 2.2 0.6 0.0 0.1 2.4 0.0 0.3 1.1 0.3 0.0 0.1 0.0 0.0 0.0 5.3 1.0 0.9 0.1 0.2 0.4 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.2 0.3 0.3 1.2 0.0 0.0 0.5 0.0 0.6 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.7 0.3 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.7 0.1 0.1 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 KCNG3 Kv6.3 ENSG00000171126 "Potassium voltage-gated channel modifier subfamily G member 3" Q8TAE7 2 42442017-42494097 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.4" "Group enriched" "Detected in some" 4 "HAP1: 5.0;HMC-1: 17.3;NTERA-2: 11.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 6 "amygdala: 9.0;basal ganglia: 11.4;cerebral cortex: 7.1;hippocampal formation: 4.4;olfactory region: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "amygdala: 3.9;basal ganglia: 4.7;cerebral cortex: 5.3;hippocampal formation: 6.6;midbrain: 3.0" HPA041625 Approved "Cytoplasmic bodies" "Cytoplasmic bodies" "HPA041625: " "unprognostic (1.56e-1)" "unprognostic (4.22e-3)" "unprognostic (2.48e-1)" "unprognostic (7.67e-3)" "unprognostic (7.95e-2)" "unprognostic (9.14e-3)" "unprognostic (4.83e-3)" "unprognostic (6.59e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-1)" "unprognostic (2.56e-1)" "unprognostic (2.17e-1)" "unprognostic (1.67e-2)" "unprognostic (2.76e-1)" "unprognostic (6.47e-2)" "unprognostic (1.23e-1)" 0.4 5.2 9.0 2.5 11.4 0.3 0.5 0.2 7.1 0.8 2.3 0.1 1.6 0.4 1.6 0.7 0.4 0.5 0.7 0.3 4.4 0.9 1.2 0.3 1.2 0.4 1.2 3.6 0.9 2.9 0.3 1.8 0.3 0.5 1.2 1.3 0.6 0.3 1.7 0.3 0.6 0.5 0.6 0.3 0.4 0.3 3.3 1.1 4.9 0.3 0.0 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 5.0 0.0 0.0 0.0 2.7 0.0 0.5 0.9 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.0 11.0 0.8 0.0 0.0 0.0 0.0 0.0 1.6 0.7 1.0 1.6 0.5 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 11.4 0.2 7.1 4.4 0.9 1.2 3.6 0.5 1.1 KCNH1 "eag, eag1, h-eag, Kv10.1" ENSG00000143473 "Potassium voltage-gated channel subfamily H member 1" O95259 1 210676823-211134180 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 20.2" "Cell line enhanced" "Detected in some" "LHCN-M2: 4.2;RH-30: 7.1;RPTEC TERT1: 4.1;SH-SY5Y: 9.0;SK-MEL-30: 8.5;T-47d: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014551, HPA019445" Enhanced Supported Vesicles Vesicles "HPA014551: , HPA019445: AB_1852118" "unprognostic (9.12e-2)" "unprognostic (4.82e-3)" "unprognostic (2.63e-1)" "unprognostic (6.70e-2)" "unprognostic (3.56e-1)" "unprognostic (3.63e-2)" "unprognostic (1.73e-1)" "unprognostic (9.36e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.77e-2)" "unprognostic (1.42e-3)" "unprognostic (1.17e-1)" "unprognostic (8.89e-2)" "unprognostic (1.36e-1)" "unprognostic (9.70e-2)" 0.9 2.3 6.3 1.3 13.3 0.7 0.6 19.1 20.2 1.0 1.3 3.3 0.2 1.2 1.5 1.0 0.9 1.2 1.0 0.7 3.8 1.7 1.0 0.7 0.7 0.7 1.1 7.5 0.8 0.9 0.9 0.8 1.1 1.7 1.3 1.3 0.0 0.8 0.9 0.7 0.9 1.0 1.0 2.1 0.6 1.5 2.4 1.5 0.0 0.8 0.0 0.7 0.9 0.7 0.1 0.7 0.7 0.1 0.1 0.3 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.1 0.6 0.1 1.4 1.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.1 0.0 0.0 7.1 0.0 4.1 0.0 0.3 9.0 1.6 0.1 8.5 6.3 0.0 0.0 1.1 0.1 1.3 0.8 0.0 0.0 0.0 0.2 0.0 0.5 0.7 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.7 0.1 0.0 6.3 13.3 19.1 20.2 3.8 1.7 1.1 7.5 1.7 1.5 KCNH3 "BEC1, elk2, Kv12.2" ENSG00000135519 "Potassium voltage-gated channel subfamily H member 3" Q9ULD8 12 49539157-49558308 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7" "Cell line enhanced" "Detected in some" "A549: 9.4;AN3-CA: 4.4;HMC-1: 4.5;RPTEC TERT1: 11.6;U-2 OS: 12.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.6" "Lineage enriched" "Detected in single" 5 "T-cells: 3.6" "Group enriched" "Detected in many" 11 "amygdala: 60.0;basal ganglia: 42.5;cerebral cortex: 73.6;hippocampal formation: 46.6;olfactory region: 50.0" "Low region specificity" "Detected in many" HPA051088 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA051088: " "unprognostic (5.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-4)" "unprognostic (8.24e-3)" "unprognostic (7.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.66e-1)" "unprognostic (9.91e-3)" "unprognostic (5.28e-2)" "unprognostic (6.39e-5)" "unprognostic (1.68e-1)" "unprognostic (1.07e-4)" "unprognostic (5.52e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" 0.9 3.8 24.3 1.5 18.5 1.4 1.0 5.8 30.7 0.9 0.8 0.5 0.0 0.9 1.3 0.9 0.7 8.7 1.7 1.2 22.0 3.0 1.6 0.7 1.2 1.9 1.9 13.0 0.8 1.4 6.3 9.3 0.8 0.0 1.2 0.7 0.0 1.1 1.6 0.8 1.1 1.0 1.0 0.6 1.4 1.4 2.6 2.1 0.0 1.7 0.0 1.4 0.9 0.0 0.0 0.1 0.6 0.8 0.4 3.6 0.5 1.0 9.4 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.6 0.0 2.2 0.7 0.2 0.0 0.1 0.4 0.0 0.5 0.1 0.1 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.1 0.1 0.1 0.0 0.0 0.6 11.6 0.0 1.8 0.3 0.3 0.0 0.3 1.0 0.2 0.1 0.0 12.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.7 0.0 3.6 0.0 0.3 1.1 0.1 0.0 1.1 2.6 0.6 0.4 0.1 0.0 0.4 0.5 24.3 18.5 5.8 30.7 22.0 3.0 1.9 13.0 0.0 2.1 KCNH4 "elk1, Kv12.3" ENSG00000089558 "Potassium voltage-gated channel subfamily H member 4" Q9UQ05 17 42156891-42181278 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.2" "Cell line enhanced" "Detected in some" "HDLM-2: 6.2;K-562: 5.8;RPMI-8226: 11.1;RT4: 4.2;U-266/70: 6.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (3.07e-3)" "unprognostic (1.02e-2)" "unprognostic (4.02e-2)" "unprognostic (1.70e-1)" "unprognostic (9.30e-2)" "unprognostic (2.08e-3)" "unprognostic (4.59e-3)" "unprognostic (1.56e-1)" "unprognostic (2.41e-1)" "unprognostic (9.92e-2)" "unprognostic (4.77e-3)" "unprognostic (1.58e-1)" "unprognostic (1.36e-6)" "unprognostic (9.52e-2)" "unprognostic (2.66e-1)" "unprognostic (6.47e-2)" "unprognostic (1.72e-3)" 1.2 1.0 0.7 2.4 11.2 0.7 0.3 0.0 7.9 0.7 0.3 0.1 0.0 0.7 0.2 0.1 0.1 0.4 0.5 0.7 0.4 0.9 0.2 0.2 0.3 1.0 0.3 1.0 0.2 0.3 0.0 0.4 0.3 0.0 0.5 0.3 0.0 0.8 0.5 0.2 0.4 0.5 0.3 0.1 0.8 0.6 0.9 2.6 0.0 0.2 0.0 1.1 3.1 0.1 0.4 0.6 0.6 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 1.4 0.0 0.0 1.1 0.0 0.0 0.0 6.2 0.5 0.9 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 5.8 1.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 11.1 0.0 4.2 2.5 1.4 0.4 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.0 0.8 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.7 11.2 0.0 7.9 0.4 0.9 0.3 1.0 0.0 2.6 KCNH5 "eag2, H-EAG2, Kv10.2" ENSG00000140015 "Potassium voltage-gated channel subfamily H member 5" Q8NCM2 14 62699454-63102037 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.6;brain: 9.2;retina: 5.7" "Group enriched" "Detected in some" 5 "HeLa: 9.9;RT4: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030487, HPA072351" Uncertain Approved Nucleoplasm,Centrosome,Cytosol Centrosome "Nucleoplasm, Cytosol" "HPA030487: AB_10609995, HPA072351: " "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-2)" "unprognostic (8.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" 0.9 4.6 1.7 0.5 3.6 0.3 0.4 0.2 9.2 0.3 0.4 0.4 0.0 0.3 0.4 0.5 0.3 0.3 0.3 0.3 1.3 3.0 0.4 0.3 0.3 0.3 1.2 4.2 0.3 0.3 0.3 1.5 1.2 6.5 0.7 0.3 5.7 0.3 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 1.7 0.0 0.0 0.3 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.6 0.2 9.2 1.3 3.0 1.2 4.2 6.5 0.0 KCNH7 "erg3, HERG3, Kv11.3" ENSG00000184611 "Potassium voltage-gated channel subfamily H member 7" Q9NS40 2 162371407-162838730 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.0;pituitary gland: 5.4" "Group enriched" "Detected in some" 13 "SCLC-21H: 10.5;SK-BR-3: 9.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 1.5;neutrophil: 3.0" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA018039 Uncertain "HPA018039: AB_1852125" "unprognostic (1.80e-1)" "unprognostic (2.68e-1)" "unprognostic (2.66e-1)" "unprognostic (5.55e-2)" "unprognostic (3.05e-2)" "unprognostic (5.51e-2)" "unprognostic (8.12e-3)" "unprognostic (7.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (3.52e-2)" "unprognostic (7.55e-3)" "unprognostic (2.76e-3)" "unprognostic (2.13e-1)" "unprognostic (4.71e-2)" "unprognostic (1.68e-2)" 0.4 1.0 4.4 0.9 6.8 0.8 0.4 6.0 11.0 0.4 0.4 0.0 0.7 0.7 0.4 0.6 0.4 0.5 0.4 1.0 2.6 1.8 0.6 2.7 0.5 0.5 0.7 4.6 0.4 1.0 0.3 5.4 0.6 3.1 0.4 0.3 0.4 0.4 1.5 0.3 0.4 0.5 0.4 0.7 1.1 2.5 1.6 0.3 0.0 0.4 0.0 0.3 0.4 0.4 0.1 0.1 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 10.5 0.7 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 4.4 6.8 6.0 11.0 2.6 1.8 0.7 4.6 3.1 0.3 KCNH8 "elk3, Kv12.1" ENSG00000183960 "Potassium voltage-gated channel subfamily H member 8" Q96L42 3 19148454-19535646 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.3;pituitary gland: 16.1" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 5 "B-cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA016586, HPA077537, HPA077773" Approved Supported "Plasma membrane" "Plasma membrane" "HPA016586: AB_1852127, HPA077537: , HPA077773: " "unprognostic (6.68e-3)" "unprognostic (1.68e-1)" "unprognostic (2.99e-2)" "unprognostic (8.56e-6)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.88e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (1.69e-1)" "unprognostic (5.04e-3)" "unprognostic (2.90e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (3.89e-2)" "unprognostic (8.71e-5)" "unprognostic (1.72e-1)" 0.6 7.0 8.4 1.6 22.0 1.4 2.4 1.3 11.4 1.3 1.9 31.3 0.0 2.2 1.2 1.2 0.7 1.4 2.2 1.0 11.8 5.7 0.7 0.7 0.8 3.2 16.4 10.2 0.7 2.7 0.8 16.1 0.6 15.0 2.2 2.5 0.1 3.3 1.4 0.6 1.9 1.8 1.1 9.9 2.6 5.9 4.0 18.1 0.0 1.1 0.0 3.2 0.9 0.5 4.5 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 8.4 22.0 1.3 11.4 11.8 5.7 16.4 10.2 15.0 18.1 KCNIP1 KCHIP1 ENSG00000182132 "Potassium voltage-gated channel interacting protein 1" Q9NZI2 5 170353487-170736632 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2;epididymis: 27.8" "Cell line enriched" "Detected in some" 23 "RPTEC TERT1: 35.9" "Cancer enriched" "Detected in some" 18 "glioma: 22.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022864, HPA066717" Uncertain Approved Vesicles Vesicles "HPA022864: AB_1858712, HPA066717: " "unprognostic (7.75e-5)" "unprognostic (2.66e-2)" "unprognostic (6.78e-2)" "unprognostic (3.22e-4)" "unprognostic (4.51e-2)" "unprognostic (3.49e-1)" "unprognostic (1.25e-2)" "unprognostic (2.69e-1)" "unprognostic (5.46e-2)" "unprognostic (6.62e-3)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (2.55e-1)" "unprognostic (2.58e-2)" "unprognostic (1.63e-1)" "unprognostic (2.39e-1)" "unprognostic (6.05e-2)" 1.1 5.9 20.6 1.2 27.9 0.6 1.9 6.4 31.2 4.0 1.0 6.0 5.2 0.9 2.7 27.8 1.0 2.8 2.9 1.2 11.7 20.5 4.9 0.8 1.9 1.2 12.9 7.3 0.9 2.4 5.1 0.7 2.1 11.1 2.3 1.3 0.8 1.3 7.9 0.8 0.7 1.1 2.1 6.9 2.2 1.1 5.2 5.3 0.0 1.2 0.0 1.2 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 35.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 27.9 6.4 14.6 11.7 20.5 12.9 7.3 11.1 5.3 KCNIP2 KCHIP2 ENSG00000120049 "Potassium voltage-gated channel interacting protein 2" Q9NS61 10 101825974-101843920 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 86.5;brain: 54.5;heart muscle: 74.8" "Cell line enhanced" "Detected in many" "HEL: 19.7;HMC-1: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 1.9;intermediate monocyte: 1.2;memory B-cell: 2.9;naive B-cell: 4.6" "Group enriched" "Detected in many" 5 "B-cells: 4.6;granulocytes: 1.9;monocytes: 1.2" "Group enriched" "Detected in many" 5 "amygdala: 96.2;basal ganglia: 204.2;cerebral cortex: 97.2;hippocampal formation: 151.4;olfactory region: 172.7" "Low region specificity" "Detected in all" HPA066717 Approved Vesicles Vesicles "HPA066717: " "unprognostic (5.92e-2)" "unprognostic (2.16e-1)" "unprognostic (3.48e-3)" "unprognostic (5.77e-4)" "unprognostic (1.34e-1)" "unprognostic (1.31e-3)" "unprognostic (8.80e-2)" "unprognostic (9.11e-3)" "unprognostic (1.14e-1)" "unprognostic (5.34e-2)" "unprognostic (3.18e-2)" "unprognostic (7.20e-2)" "unprognostic (1.49e-9)" "unprognostic (9.85e-2)" "unprognostic (1.81e-1)" "unprognostic (3.27e-1)" "unprognostic (8.37e-4)" 86.5 3.5 15.5 2.0 54.5 0.9 10.4 8.3 26.1 1.8 2.4 2.6 0.0 1.4 2.3 2.4 1.2 2.2 1.9 74.8 19.6 5.0 1.0 1.0 1.4 3.7 4.2 11.3 5.7 1.6 1.2 3.3 1.8 4.3 1.6 2.7 1.7 4.6 2.1 3.8 3.0 1.6 1.8 2.1 2.8 1.6 4.1 9.8 0.0 1.3 0.8 3.9 1.6 0.7 4.6 0.5 1.9 1.2 0.0 0.4 0.4 1.6 2.4 2.5 3.1 1.0 1.1 0.6 1.1 1.0 0.6 0.9 3.6 3.2 1.6 0.9 0.7 1.7 0.8 0.4 0.6 2.2 1.9 19.7 2.4 1.8 0.9 1.3 12.2 2.6 1.7 1.0 1.3 1.0 5.7 1.7 0.9 1.1 0.7 3.8 0.7 0.6 0.9 0.2 1.2 0.9 1.0 7.2 1.1 0.8 0.5 2.3 2.0 0.8 2.1 1.3 2.1 0.5 1.1 1.7 1.7 1.6 1.4 5.0 0.2 0.0 0.1 1.9 0.1 1.2 0.4 2.9 0.3 0.0 0.4 4.6 0.0 0.1 0.0 0.0 0.5 0.5 0.3 0.4 15.5 54.5 8.3 26.1 19.6 5.0 4.2 11.3 4.3 9.8 KCNIP3 "CSEN, DREAM, KCHIP3" ENSG00000115041 "Potassium voltage-gated channel interacting protein 3" Q9Y2W7 2 95297304-95386083 "Predicted intracellular proteins, Transporters" "Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport" "Ion channel, Potassium channel, Repressor, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.8;parathyroid gland: 32.5" "Cell line enhanced" "Detected in many" "A-431: 9.1;BJ hTERT+: 12.4;RPTEC TERT1: 24.4;U-138 MG: 11.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066717, HPA069797" Enhanced Approved Vesicles "Intracellular and membrane" Vesicles "HPA066717: , HPA069797: " "unprognostic (1.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.33e-3)" "prognostic unfavourable (1.58e-5)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" "unprognostic (2.23e-1)" "unprognostic (2.96e-1)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (2.32e-1)" "unprognostic (4.09e-1)" "unprognostic (1.44e-3)" "unprognostic (8.90e-2)" "unprognostic (6.51e-2)" "unprognostic (7.33e-2)" "unprognostic (1.04e-1)" 4.2 1.8 19.8 1.5 20.1 0.7 2.8 3.7 39.8 6.0 4.6 12.9 0.6 2.1 5.8 4.9 3.5 5.3 2.4 3.4 16.7 7.8 4.6 1.2 1.5 1.1 9.1 19.5 8.8 2.5 32.5 5.6 6.5 8.2 5.7 1.8 1.4 6.9 18.6 2.2 3.9 1.9 6.4 6.3 2.2 2.9 9.2 15.9 5.4 19.5 0.0 1.3 4.5 5.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.1 0.0 0.6 4.2 3.7 3.0 0.0 4.3 12.4 7.0 6.5 0.0 0.0 0.0 0.4 5.6 0.1 2.7 0.7 3.0 0.0 1.0 0.0 1.1 0.0 1.5 0.0 0.0 2.1 2.5 1.5 7.0 0.0 0.0 0.0 0.6 5.3 0.0 0.0 0.1 2.5 0.0 0.0 0.0 24.4 0.0 0.5 0.1 0.2 0.2 4.7 0.2 0.0 0.2 11.4 2.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 20.1 3.7 39.8 16.7 7.8 9.1 19.5 8.2 15.9 KCNIP4 "CALP, KCHIP4, MGC44947" ENSG00000185774 "Potassium voltage-gated channel interacting protein 4" Q6PIL6 4 20728616-21948799 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 9.9;SCLC-21H: 7.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022862, HPA066717" Supported Approved Vesicles Vesicles "HPA022862: AB_1852654, HPA066717: " "unprognostic (8.08e-2)" "unprognostic (1.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (9.26e-2)" "unprognostic (1.49e-1)" "unprognostic (2.53e-1)" "unprognostic (2.99e-2)" "unprognostic (1.18e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (3.11e-1)" "unprognostic (1.03e-2)" "unprognostic (2.69e-1)" "unprognostic (4.59e-2)" "unprognostic (2.10e-2)" 1.1 3.6 15.8 2.2 28.3 1.0 0.9 22.4 38.9 15.0 4.2 1.8 0.0 2.4 9.6 1.1 5.6 3.9 2.6 1.8 11.9 16.2 7.8 0.7 1.1 1.1 11.6 19.3 1.9 1.0 0.5 5.1 1.8 16.9 1.0 5.2 3.5 1.4 0.8 1.3 2.3 5.5 7.8 3.9 1.1 1.3 1.3 3.5 0.0 8.9 0.0 0.5 2.7 1.1 0.3 0.7 0.0 0.7 0.8 0.7 0.3 1.7 1.5 2.1 2.1 0.0 0.0 1.1 1.3 0.0 0.0 0.0 1.9 1.6 3.3 1.4 0.5 0.9 0.0 0.1 0.0 0.4 2.3 1.2 2.5 1.1 0.0 3.2 0.5 0.0 0.7 0.0 1.4 0.6 2.0 1.1 0.0 0.6 2.7 1.9 2.8 1.4 0.8 4.1 1.3 9.9 0.9 7.7 4.6 1.4 1.7 2.1 0.9 1.2 2.1 1.1 1.5 2.3 3.1 1.0 0.1 1.2 3.6 2.7 1.7 0.0 0.3 0.0 0.2 0.7 0.7 0.2 0.1 0.2 0.7 0.3 0.5 0.5 0.0 0.8 0.5 0.3 0.2 0.3 15.8 28.3 22.4 33.0 11.9 16.2 11.6 19.3 16.9 3.5 KCNJ10 "Kir1.2, Kir4.1" ENSG00000177807 "Potassium voltage-gated channel subfamily J member 10" P78508 1 159998651-160070483 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Deafness, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 74.1;kidney: 28.1" "Cell line enhanced" "Detected in some" "Hep G2: 11.4;SK-MEL-30: 3.6;U-266/70: 3.7" "Cancer enriched" "Detected in some" 6 "glioma: 27.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.5" "Group enriched" "Detected in many" 6 "NK-cells: 1.7;T-cells: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078302 Enhanced "HPA078302: " "unprognostic (2.64e-2)" "unprognostic (3.54e-3)" "unprognostic (6.19e-2)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (6.98e-4)" "unprognostic (1.96e-1)" "unprognostic (7.13e-2)" "unprognostic (3.43e-1)" "unprognostic (1.28e-3)" "unprognostic (5.80e-4)" "unprognostic (9.52e-2)" "unprognostic (2.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (3.77e-1)" "unprognostic (6.70e-3)" 1.4 1.5 23.6 3.0 28.1 1.3 1.3 10.5 74.1 1.4 1.7 37.9 0.0 1.5 1.3 1.3 1.4 1.3 1.3 1.3 21.8 13.2 28.1 3.1 1.3 7.1 28.1 15.1 1.3 1.3 1.3 0.3 1.3 25.5 1.3 1.5 0.5 1.5 1.5 1.2 1.6 1.7 1.3 42.9 10.3 2.0 1.8 25.5 0.0 1.5 0.0 2.9 1.5 0.1 0.0 0.0 0.0 0.3 1.7 2.5 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.3 0.0 0.2 1.7 0.2 0.0 0.4 0.3 0.0 0.2 0.0 0.2 0.1 0.1 11.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.0 2.1 0.1 0.0 0.0 0.2 0.4 0.0 0.3 3.6 0.1 0.5 0.1 0.1 0.3 0.9 0.0 3.7 1.7 0.0 0.2 0.2 1.7 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.8 0.0 1.7 0.3 0.0 2.5 0.2 23.6 28.1 10.5 22.2 21.8 13.2 28.1 15.1 25.5 25.5 KCNJ12 "hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v" ENSG00000184185 "Potassium voltage-gated channel subfamily J member 12" Q14500 17 21376197-21419872 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 39.4;skeletal muscle: 47.8" "Cell line enhanced" "Detected in some" "EFO-21: 3.7;HeLa: 6.2;PC-3: 6.5;SCLC-21H: 7.6;SiHa: 3.8;U-2197: 6.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 39.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA027021 Approved Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (3.81e-3)" "unprognostic (2.69e-2)" "unprognostic (8.60e-2)" "prognostic unfavourable (7.84e-5)" "unprognostic (2.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (4.91e-2)" "unprognostic (8.12e-2)" "unprognostic (1.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-1)" "unprognostic (5.90e-2)" "unprognostic (9.70e-3)" 1.2 1.3 1.9 0.9 2.9 0.7 0.9 39.4 5.8 1.2 0.8 1.1 0.5 0.5 0.8 1.4 1.5 2.1 0.7 5.1 0.9 1.4 1.2 0.5 1.3 0.4 1.3 3.4 0.7 0.5 10.6 0.7 0.7 4.0 0.9 0.6 1.7 0.6 0.9 47.8 6.0 0.6 1.0 0.9 1.3 0.9 1.3 0.9 0.0 1.0 7.5 1.1 0.8 1.5 0.0 0.9 0.0 0.5 0.0 0.1 0.0 0.0 1.1 0.4 2.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 3.7 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 6.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.5 0.1 0.1 0.0 1.5 6.5 0.0 1.0 1.7 0.0 0.0 7.6 0.4 3.8 0.0 1.6 0.0 0.0 2.9 0.0 0.5 6.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 1.9 2.9 39.4 5.8 0.9 1.4 1.3 3.4 4.0 0.9 KCNJ13 "Kir1.4, Kir7.1, LCA16" ENSG00000115474 "Potassium voltage-gated channel subfamily J member 13" O60928 2 232766464-232776568 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Cataract, Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 22.9;intestine: 49.5;retina: 70.3" "Cell line enhanced" "Detected in some" "BEWO: 1.8;CACO-2: 2.7;U-2197: 4.7" "Cancer enriched" "Detected in some" 5 "melanoma: 5.9" "Region enriched" "Detected in some" 7 "pons and medulla: 22.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "unprognostic (4.29e-2)" "unprognostic (2.00e-1)" "unprognostic (2.69e-1)" "unprognostic (9.03e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-2)" "unprognostic (2.26e-1)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.41e-1)" "unprognostic (4.90e-2)" "unprognostic (1.86e-2)" "unprognostic (2.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.82e-2)" "unprognostic (1.11e-2)" 0.2 0.2 0.5 0.0 0.7 0.1 0.3 0.4 0.9 0.2 10.1 7.0 1.3 4.3 0.2 0.3 0.2 0.1 1.6 0.2 3.2 0.5 1.9 0.3 0.2 0.0 0.4 0.4 0.3 0.4 8.5 0.3 0.0 22.9 0.3 0.0 70.3 0.3 1.6 0.2 1.8 49.5 0.0 0.6 0.2 1.1 0.5 0.1 0.0 3.8 0.0 0.0 0.3 0.3 1.1 0.8 5.4 1.1 1.1 2.7 0.1 0.1 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.5 0.0 0.3 0.2 0.9 0.0 0.0 0.4 0.0 0.6 0.0 0.1 0.0 0.3 1.1 0.2 0.3 0.0 0.1 0.0 4.7 0.4 1.4 0.1 0.8 0.8 0.4 0.0 5.4 1.1 0.9 1.0 0.2 1.2 0.8 1.8 0.7 0.4 1.1 2.1 1.1 0.8 1.1 1.0 0.8 2.7 0.1 0.5 0.7 0.4 0.9 3.2 0.5 0.4 0.4 22.9 0.1 KCNJ2 "IRK1, Kir2.1, LQT7" ENSG00000123700 "Potassium voltage-gated channel subfamily J member 2" P63252 17 70168673-70180048 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Atrial fibrillation, Disease mutation, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;parathyroid gland: 34.8" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 5.1;REH: 6.0;RH-30: 24.2;U-138 MG: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 20.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 20.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA029109 Approved "HPA029109: AB_10602913" "unprognostic (1.32e-1)" "unprognostic (1.24e-1)" "unprognostic (1.18e-1)" "unprognostic (6.22e-2)" "unprognostic (3.50e-1)" "unprognostic (6.36e-3)" "unprognostic (1.22e-2)" "unprognostic (3.14e-1)" "unprognostic (1.09e-1)" "unprognostic (1.62e-1)" "unprognostic (3.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.74e-3)" "unprognostic (6.15e-3)" "unprognostic (9.60e-3)" "unprognostic (4.89e-2)" "unprognostic (5.49e-3)" 3.0 1.5 6.2 6.3 17.9 2.5 6.6 1.3 12.8 1.8 5.0 23.7 5.1 1.6 1.5 1.2 4.7 8.4 2.2 11.4 6.4 4.4 1.7 1.9 3.9 4.4 22.4 8.5 1.4 1.0 34.8 1.6 9.0 11.7 2.6 4.3 3.1 2.7 2.9 10.3 6.0 2.1 1.6 14.9 10.4 2.0 0.9 18.2 0.5 1.9 6.0 2.2 2.6 3.3 0.1 0.7 20.8 4.7 0.0 0.0 0.4 0.0 0.7 1.5 0.0 1.6 0.4 0.0 0.5 3.7 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.4 0.1 0.2 0.1 0.0 0.2 0.0 0.5 0.0 4.6 0.0 0.0 1.7 0.1 2.3 0.2 5.1 0.0 0.0 1.5 0.0 0.5 0.0 0.1 0.1 6.0 24.2 0.0 0.6 0.0 0.3 0.7 0.4 0.1 0.0 0.2 0.4 0.1 8.9 0.1 0.0 1.9 0.0 0.0 0.1 1.9 0.0 1.2 1.8 2.5 3.6 0.0 4.7 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 20.8 0.0 4.6 0.1 0.0 0.4 6.2 17.9 1.3 12.8 6.4 4.4 22.4 8.5 11.7 18.2 KCNJ3 "GIRK1, KGA, Kir3.1" ENSG00000162989 "Potassium voltage-gated channel subfamily J member 3" P48549 2 154698299-154858352 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;parathyroid gland: 22.1" "Cell line enhanced" "Detected in some" "BJ: 5.3;SH-SY5Y: 3.3" "Group enriched" "Detected in many" 5 "breast cancer: 12.2;renal cancer: 4.4" "Region enhanced" "Detected in many" "cerebellum: 33.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024231 Uncertain "HPA024231: AB_1855558" "unprognostic (1.45e-1)" "unprognostic (9.42e-2)" "unprognostic (2.66e-2)" "unprognostic (4.49e-4)" "unprognostic (8.89e-2)" "unprognostic (6.81e-2)" "unprognostic (7.24e-3)" "unprognostic (1.15e-2)" "unprognostic (4.25e-3)" "unprognostic (3.72e-3)" "unprognostic (3.33e-1)" "unprognostic (8.90e-3)" "unprognostic (3.75e-2)" "unprognostic (5.59e-1)" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" 0.3 1.0 4.5 0.0 3.4 0.0 0.2 33.8 13.6 1.3 1.5 1.4 0.3 7.9 0.2 0.9 0.1 0.4 0.9 10.8 8.4 4.0 8.0 2.3 0.2 0.4 1.8 4.9 0.2 1.5 22.1 9.0 0.0 3.0 5.1 0.6 1.0 0.1 9.2 3.5 0.2 6.7 0.1 1.5 0.4 0.5 0.2 0.9 0.0 0.2 0.0 0.0 0.5 0.6 1.2 0.9 3.3 1.1 1.8 1.0 0.4 0.2 0.3 0.0 0.1 0.2 0.1 0.4 5.3 0.2 0.0 0.2 0.1 0.3 0.3 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.2 0.4 0.4 0.1 0.1 0.0 0.2 0.2 0.1 0.2 0.1 0.0 0.2 0.2 0.0 0.8 0.0 0.7 0.5 0.5 0.1 0.0 0.4 0.2 0.3 1.7 3.3 0.1 0.5 0.2 0.4 0.1 0.0 0.3 0.4 0.4 0.3 0.3 0.2 0.1 1.2 0.2 0.5 3.3 0.7 0.9 0.7 0.8 0.9 1.0 0.9 0.6 0.6 1.2 1.0 0.9 1.9 1.8 1.1 0.9 0.7 0.4 4.5 3.4 33.8 12.0 8.4 4.0 1.8 4.9 3.0 0.9 KCNJ4 "HIR, hIRK2, HRK1, IRK3, Kir2.3" ENSG00000168135 "Potassium voltage-gated channel subfamily J member 4" P48050 22 38426327-38455199 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 22 "brain: 25.9;heart muscle: 16.9" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 15.8" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "amygdala: 105.8;basal ganglia: 143.6;cerebral cortex: 111.8;hippocampal formation: 85.7;olfactory region: 150.7" "Group enriched" "Detected in many" 14 "amygdala: 32.2;basal ganglia: 63.2;cerebral cortex: 71.1;hippocampal formation: 59.7;olfactory region: 117.2" "unprognostic (4.76e-2)" "unprognostic (2.60e-3)" "unprognostic (2.21e-3)" "unprognostic (1.65e-1)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (9.68e-3)" "unprognostic (3.12e-1)" "unprognostic (8.96e-2)" "unprognostic (2.07e-1)" "unprognostic (3.15e-3)" "unprognostic (1.28e-3)" "unprognostic (1.05e-1)" "unprognostic (5.41e-2)" 0.1 0.2 9.9 0.1 17.9 0.1 0.1 0.0 25.9 0.1 0.1 0.3 0.1 0.1 0.1 0.7 0.8 16.9 9.4 1.7 0.2 0.4 0.1 0.1 0.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 1.1 0.0 0.5 0.0 2.3 0.0 0.1 0.0 0.0 15.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.4 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 KCNJ6 "BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2" ENSG00000157542 "Potassium voltage-gated channel subfamily J member 6" P48051 21 37607376-38121345 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Congenital generalized lipodystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.0;pituitary gland: 12.2" "Cell line enriched" "Detected in some" 7 "LHCN-M2: 25.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basophil: 4.2;eosinophil: 3.6;neutrophil: 2.0" "Lineage enriched" "Detected in single" 12 "granulocytes: 4.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.43e-1)" "unprognostic (1.96e-1)" "unprognostic (7.71e-2)" "unprognostic (1.26e-3)" "unprognostic (6.75e-2)" "unprognostic (3.59e-1)" "unprognostic (1.33e-1)" "unprognostic (1.25e-1)" "unprognostic (3.68e-1)" "unprognostic (8.76e-2)" "unprognostic (1.64e-2)" "unprognostic (3.49e-1)" "unprognostic (1.96e-10)" "unprognostic (2.42e-1)" "unprognostic (1.46e-1)" "unprognostic (9.87e-2)" "unprognostic (1.21e-1)" 2.0 1.2 7.7 0.9 8.4 1.0 1.1 24.0 15.6 0.9 1.4 0.8 0.0 1.1 1.4 0.6 0.7 0.7 0.8 1.2 14.6 1.1 1.2 0.9 1.0 1.4 1.3 10.8 0.8 2.7 0.7 12.2 7.4 13.5 1.5 0.9 0.0 0.8 0.6 2.2 1.1 1.1 0.5 1.5 1.6 2.7 2.0 0.4 0.0 0.8 0.0 0.6 0.8 0.8 0.3 0.3 4.2 0.3 0.3 0.2 0.0 0.0 0.0 0.6 0.3 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.7 1.4 0.0 2.9 0.1 25.0 0.1 0.0 0.0 0.2 2.4 0.0 0.1 0.8 3.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.3 0.0 0.0 0.1 3.7 1.0 0.0 0.0 0.0 0.0 4.2 0.3 3.6 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.2 2.0 0.3 0.2 0.3 0.1 0.0 7.7 8.4 24.0 15.6 14.6 1.1 1.3 10.8 13.5 0.4 KCNJ9 "GIRK3, Kir3.3" ENSG00000162728 "Potassium voltage-gated channel subfamily J member 9" Q92806 1 160081570-160090563 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 27 "brain: 52.0" "Group enriched" "Detected in some" 5 "SCLC-21H: 2.3;SH-SY5Y: 2.7;U-266/70: 2.8" "Cancer enriched" "Detected in single" 35 "glioma: 2.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070478 Enhanced "HPA070478: " "unprognostic (2.35e-1)" "unprognostic (6.53e-2)" "unprognostic (2.17e-2)" "unprognostic (4.73e-1)" "unprognostic (1.05e-1)" "unprognostic (7.29e-3)" "unprognostic (1.66e-1)" "unprognostic (3.33e-2)" "unprognostic (2.64e-1)" "unprognostic (3.29e-1)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-2)" "unprognostic (2.66e-1)" "unprognostic (1.34e-1)" "unprognostic (2.44e-1)" "unprognostic (5.24e-2)" 1.4 1.9 15.6 1.4 15.3 1.4 1.4 32.1 52.0 1.4 1.4 11.9 0.0 1.4 1.4 1.4 1.4 1.4 1.4 1.4 18.4 11.1 1.5 1.4 1.4 1.4 18.3 20.6 1.4 1.4 1.4 0.7 1.4 7.4 1.4 1.4 0.0 1.4 1.4 1.4 1.4 1.5 1.4 11.4 1.4 1.5 1.7 11.6 0.0 1.4 0.0 1.4 1.4 0.0 0.8 0.0 0.0 0.3 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 2.3 2.7 0.0 0.1 0.3 0.0 0.1 0.3 0.0 0.0 0.5 0.0 2.8 0.2 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.5 0.3 1.1 0.4 0.2 1.1 0.0 0.8 0.6 0.1 0.0 0.5 0.0 0.0 0.0 0.0 15.6 15.3 32.1 27.2 18.4 11.1 18.3 20.6 7.4 11.6 KCNK1 "DPK, K2p1.1, TWIK-1" ENSG00000135750 "Potassium two pore domain channel subfamily K member 1" O00180 1 233614004-233672512 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3" "Cell line enhanced" "Detected in many" "HeLa: 20.6;SCLC-21H: 19.4;U-266/70: 44.7;U-266/84: 40.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 75.3" "Cell type enriched" "Detected in single" 98 "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in single" 98 "dendritic cells: 9.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 236.2" "HPA016049, CAB022588" Approved Approved Vesicles Vesicles "CAB022588: , HPA016049: AB_1855571" "unprognostic (7.06e-3)" "unprognostic (1.76e-1)" "unprognostic (4.64e-2)" "unprognostic (7.46e-2)" "unprognostic (9.15e-2)" "unprognostic (1.27e-1)" "prognostic favourable (3.84e-4)" "unprognostic (4.32e-2)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "prognostic unfavourable (7.29e-4)" "unprognostic (1.10e-1)" "prognostic unfavourable (8.69e-8)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" 1.9 3.3 15.2 2.2 12.7 0.3 4.5 75.3 22.8 5.5 11.5 7.9 5.1 12.5 4.5 22.9 12.0 8.4 9.3 20.8 10.3 5.2 7.2 10.8 3.4 0.8 8.9 11.1 3.8 4.4 2.5 11.3 5.0 22.3 4.6 10.6 2.6 7.2 9.3 0.5 8.7 9.6 3.2 12.3 0.8 28.0 0.7 7.8 0.0 5.6 1.6 3.2 4.3 6.5 0.0 9.7 0.0 0.0 0.0 0.0 0.0 10.1 5.5 0.0 0.0 0.0 0.0 15.5 2.7 0.0 0.0 0.0 0.0 16.7 0.0 6.5 2.0 14.7 2.8 4.8 0.0 0.0 4.8 0.0 20.6 0.0 0.1 0.0 0.5 1.2 5.2 0.0 3.8 0.0 2.3 4.4 0.0 3.7 3.6 0.0 3.3 12.5 0.0 0.8 1.1 4.9 8.5 19.4 3.8 10.1 4.5 0.0 1.3 0.0 0.0 0.0 8.2 0.0 0.3 44.7 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 15.2 12.7 75.3 17.1 10.3 5.2 8.9 11.1 22.3 7.8 KCNK10 "K2p10.1, PPP1R97, TREK-2, TREK2" ENSG00000100433 "Potassium two pore domain channel subfamily K member 10" P57789 14 88180103-88326907 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 12.2;brain: 14.1;intestine: 11.6" "Cell line enhanced" "Detected in some" "AF22: 2.5;NTERA-2: 1.7;REH: 4.2;SCLC-21H: 7.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 67 "plasmacytoid DC: 12.2" "Lineage enriched" "Detected in single" 123 "dendritic cells: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030462 Approved "HPA030462: AB_10601919" "unprognostic (9.52e-3)" "unprognostic (1.17e-1)" "unprognostic (1.94e-2)" "unprognostic (1.08e-1)" "unprognostic (8.20e-2)" "unprognostic (1.45e-1)" "unprognostic (1.18e-1)" "unprognostic (2.25e-1)" "unprognostic (4.58e-1)" "unprognostic (1.23e-2)" "unprognostic (2.70e-1)" "unprognostic (2.45e-1)" "unprognostic (6.97e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (1.29e-1)" "unprognostic (4.26e-3)" 0.4 1.1 7.4 1.2 6.9 0.9 0.5 14.1 11.2 0.4 3.2 5.6 0.0 11.6 0.3 0.3 2.2 0.4 0.5 0.4 7.2 4.5 5.7 0.4 0.6 0.7 5.0 5.7 0.4 3.5 0.4 0.9 0.3 6.4 0.5 2.1 0.0 0.5 0.3 0.4 0.4 5.7 0.5 5.0 0.6 6.7 1.3 2.3 0.0 0.4 0.5 1.3 0.5 0.4 0.0 12.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.7 0.2 4.2 0.1 0.0 0.1 0.1 7.7 0.3 0.1 0.1 0.0 0.0 1.0 0.1 0.1 1.4 0.2 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.1 7.4 6.9 14.1 11.2 7.2 4.5 5.0 5.7 6.4 2.3 KCNK12 "K2p12.1, THIK-2, THIK2" ENSG00000184261 "Potassium two pore domain channel subfamily K member 12" Q9HB15 2 47516581-47570939 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 22.7" "Group enriched" "Detected in some" 6 "REH: 21.6;SCLC-21H: 8.5" "Cancer enriched" "Detected in single" 12 "testis cancer: 2.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (6.10e-2)" "unprognostic (1.24e-1)" "unprognostic (6.02e-3)" "unprognostic (3.29e-2)" "unprognostic (2.50e-1)" "unprognostic (3.77e-2)" "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (2.54e-2)" "unprognostic (2.14e-1)" "unprognostic (6.55e-3)" "unprognostic (2.12e-1)" "unprognostic (1.12e-6)" "unprognostic (1.36e-1)" "unprognostic (1.34e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-1)" 1.1 1.7 9.8 5.1 4.6 1.0 0.9 22.7 16.1 0.8 1.1 2.4 0.0 1.0 1.0 1.0 1.0 0.9 0.9 0.9 5.6 3.4 1.0 0.8 1.0 1.6 7.2 4.0 1.2 0.8 0.9 5.5 1.7 8.1 1.0 0.9 0.6 0.9 0.8 1.2 1.0 0.9 0.9 10.1 1.1 1.2 1.5 2.1 0.0 1.0 0.0 1.5 1.0 0.3 0.7 0.1 0.2 0.0 0.4 1.8 0.2 0.0 0.1 0.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.2 0.5 21.6 0.0 1.6 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.7 1.0 1.8 0.1 0.2 1.1 1.0 0.2 0.4 0.0 0.0 1.1 0.2 9.8 4.6 22.7 16.1 5.6 3.4 7.2 4.0 8.1 2.1 KCNK13 "K2p13.1, THIK-1, THIK1" ENSG00000152315 "Potassium two pore domain channel subfamily K member 13" Q9HB14 14 90061765-90185857 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.3;parathyroid gland: 14.3;testis: 13.2" "Cell line enhanced" "Detected in some" "MCF7: 2.3;RT4: 5.1;SCLC-21H: 2.2;SK-BR-3: 2.2;U-2 OS: 2.5;U-266/84: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8" "Group enriched" "Detected in many" 7 "dendritic cells: 3.8;monocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003514 Approved Approved "Nuclear speckles,Cell Junctions" "Nuclear speckles, Cell Junctions" "HPA003514: " "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (6.17e-2)" "unprognostic (6.31e-2)" "unprognostic (2.56e-1)" "unprognostic (5.55e-2)" "unprognostic (3.56e-2)" "unprognostic (3.98e-2)" "unprognostic (2.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-2)" "unprognostic (1.97e-1)" "unprognostic (2.04e-2)" "unprognostic (6.32e-2)" "unprognostic (1.46e-1)" "unprognostic (5.65e-2)" 0.8 1.1 2.9 2.2 3.5 0.1 0.4 0.2 4.2 0.4 0.6 4.0 0.0 0.6 0.3 1.5 0.3 0.4 0.5 2.7 2.9 2.4 4.8 0.7 0.7 1.6 6.3 1.4 0.4 2.7 14.3 0.6 1.2 3.6 0.4 0.7 0.1 1.1 0.7 0.1 0.1 0.7 0.4 8.3 1.1 0.5 13.2 5.4 0.7 2.7 0.0 0.6 0.8 0.1 0.0 3.8 0.0 1.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.9 1.2 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.9 1.2 0.0 0.0 0.0 0.5 5.1 2.2 0.7 0.0 2.2 1.4 0.0 1.9 0.0 0.0 2.5 0.0 0.8 0.7 2.2 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 2.9 3.5 0.2 4.2 2.9 2.4 6.3 1.4 3.6 5.4 KCNK18 "K2p18.1, TRESK, TRESK-2, TRESK2, TRIK" ENSG00000186795 "Potassium two pore domain channel subfamily K member 18" Q7Z418 10 117197489-117210299 "Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 1.5;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA044739 Uncertain "HPA044739: AB_10795008" 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK4 "K2p4.1, TRAAK" ENSG00000182450 "Potassium two pore domain channel subfamily K member 4" Q9NYG8 11 64291302-64300031 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 12.3" "Cell line enhanced" "Detected in some" "BEWO: 2.1;MCF7: 1.5;SH-SY5Y: 2.9;U-2197: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.85e-1)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (2.84e-1)" 0.7 0.5 12.2 0.5 11.6 0.5 0.5 1.0 12.3 1.6 0.6 0.3 0.0 0.6 1.2 0.5 0.5 0.6 0.6 0.6 10.2 3.1 0.7 0.5 0.6 0.6 1.5 4.0 0.5 0.5 0.5 0.0 2.0 2.7 0.9 0.5 1.1 0.5 0.8 0.5 0.5 0.7 0.5 0.3 0.6 0.6 0.9 0.1 0.0 0.6 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.2 0.0 1.5 0.0 0.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 1.2 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 11.6 1.0 12.3 10.2 3.1 1.5 4.0 2.7 0.1 KCNK9 "K2p9.1, TASK-3, TASK3" ENSG00000169427 "Potassium two pore domain channel subfamily K member 9" Q9NPC2 8 139600838-139703056 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 9.4;brain: 15.4" "Group enriched" "Detected in some" 7 "PC-3: 6.5;SCLC-21H: 2.8;SH-SY5Y: 2.1" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 15.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075842 Approved "Plasma membrane" "Plasma membrane" "HPA075842: " "unprognostic (1.84e-2)" "unprognostic (2.57e-1)" "unprognostic (1.58e-1)" "unprognostic (8.96e-8)" "unprognostic (1.91e-1)" "unprognostic (8.17e-3)" "unprognostic (2.19e-3)" "unprognostic (1.65e-1)" "unprognostic (3.87e-1)" "unprognostic (1.69e-1)" "unprognostic (1.00e-2)" "unprognostic (3.21e-1)" "unprognostic (5.12e-6)" "unprognostic (2.94e-2)" "unprognostic (1.64e-1)" "unprognostic (9.99e-3)" "unprognostic (1.76e-1)" 0.2 9.4 0.5 0.5 1.0 0.1 0.1 15.4 7.7 1.3 0.5 0.0 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.2 1.6 1.4 0.1 0.1 0.1 0.1 0.7 1.7 0.1 0.1 0.1 1.1 0.2 6.6 0.1 0.2 0.2 0.1 0.1 1.4 0.1 0.1 0.6 0.6 0.1 0.3 0.5 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 2.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.0 15.4 3.7 1.6 1.4 0.7 1.7 6.6 0.0 KCNMB4 ENSG00000135643 "Potassium calcium-activated channel subfamily M regulatory beta subunit 4" Q86W47 12 70366276-70434292 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 24.4;brain: 37.7" "Cell line enhanced" "Detected in many" "NTERA-2: 9.0;RH-30: 9.7;RT4: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA072287 Enhanced Approved Approved Cytosol Cytosol "HPA072287: " "unprognostic (3.90e-1)" "unprognostic (1.72e-2)" "unprognostic (2.69e-2)" "unprognostic (2.62e-2)" "unprognostic (6.98e-2)" "unprognostic (1.13e-3)" "unprognostic (1.85e-1)" "unprognostic (2.48e-2)" "unprognostic (3.50e-1)" "unprognostic (2.95e-2)" "unprognostic (3.75e-1)" "unprognostic (2.47e-2)" "unprognostic (2.19e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (1.05e-2)" 4.4 24.4 19.8 2.6 24.6 1.3 2.6 13.8 37.7 3.5 5.0 28.4 1.0 2.5 3.2 2.8 2.6 3.3 3.2 5.9 25.9 10.4 5.8 1.8 4.6 2.8 28.6 19.3 5.4 1.5 1.3 1.4 4.9 11.6 2.9 2.9 2.0 3.8 4.5 4.2 4.9 3.0 2.8 15.2 2.8 1.8 3.8 26.0 0.8 3.3 0.0 2.6 2.4 2.1 1.7 0.6 0.3 0.3 0.2 2.8 0.5 0.0 0.4 5.7 3.2 0.3 0.3 0.6 0.7 1.0 0.3 0.9 0.2 2.1 2.8 0.3 0.0 0.1 6.2 0.9 0.2 1.3 3.5 1.4 1.3 3.2 0.0 0.1 0.1 1.7 0.1 0.0 0.0 0.2 0.0 0.0 1.1 0.8 2.0 0.5 9.0 6.5 2.9 9.7 0.2 0.3 10.6 2.8 3.5 0.9 1.1 0.1 3.2 0.1 0.1 0.4 1.5 0.1 0.4 2.0 0.0 2.8 0.5 0.0 0.9 0.3 0.3 0.0 0.3 0.3 0.3 0.6 0.6 0.6 0.6 1.7 2.2 2.8 0.3 0.2 0.1 0.2 0.6 0.5 19.8 24.6 13.8 19.1 25.9 10.4 28.6 19.3 11.6 26.0 KCNN1 "hSK1, KCa2.1" ENSG00000105642 "Potassium calcium-activated channel subfamily N member 1" Q92952 19 17951293-18000080 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 12 "brain: 32.5" "Cell line enriched" "Detected in some" 12 "REH: 57.4" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065938 Approved "Actin filaments,Cytosol" "Actin filaments, Cytosol" "HPA065938: " "unprognostic (7.55e-2)" "unprognostic (4.03e-2)" "unprognostic (1.82e-1)" "unprognostic (7.80e-2)" "unprognostic (1.90e-1)" "unprognostic (8.94e-5)" "unprognostic (3.92e-3)" "unprognostic (1.01e-1)" "unprognostic (8.42e-2)" "unprognostic (3.59e-1)" "unprognostic (2.71e-3)" "unprognostic (3.38e-1)" "unprognostic (5.21e-3)" "unprognostic (2.70e-2)" "unprognostic (1.14e-1)" "unprognostic (7.24e-3)" "unprognostic (3.24e-1)" 0.8 0.9 25.8 1.5 11.3 0.9 0.8 3.3 27.0 1.6 1.0 0.5 0.1 1.0 1.7 1.0 1.0 0.9 1.0 1.3 32.5 3.3 0.9 0.8 0.8 1.0 5.0 8.7 2.6 0.9 0.7 0.2 0.8 4.1 1.2 0.8 0.0 1.5 1.3 1.0 0.9 1.2 0.9 1.2 0.9 0.9 2.8 1.6 0.0 0.9 0.0 1.0 0.9 0.0 0.2 0.2 2.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.1 0.1 0.9 1.8 0.1 0.0 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 57.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.1 0.0 0.2 0.0 0.0 25.8 11.3 3.3 22.4 32.5 3.3 5.0 8.7 4.1 1.6 KCNN2 "hSK2, KCa2.2" ENSG00000080709 "Potassium calcium-activated channel subfamily N member 2" Q9H2S1 5 114360945-114496500 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 25.3;brain: 23.1;liver: 33.2" "Group enriched" "Detected in some" 5 "BJ: 14.7;NTERA-2: 5.6;SK-MEL-30: 10.4;THP-1: 18.3;U-937: 6.5" "Group enriched" "Detected in some" 7 "glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038221 Uncertain Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA038221: AB_10673044" "unprognostic (9.22e-3)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (4.61e-1)" "unprognostic (3.16e-1)" "unprognostic (4.25e-1)" 0.8 25.3 12.6 0.8 7.3 0.6 1.1 21.7 15.0 1.7 1.2 9.5 0.0 0.9 3.9 0.9 0.8 1.0 1.0 7.7 23.1 3.6 4.8 33.2 2.5 0.9 4.5 16.9 1.4 3.8 1.0 16.0 0.6 9.1 11.7 1.3 4.2 1.1 5.4 9.9 2.1 0.9 2.8 8.4 1.1 1.1 3.8 6.5 0.0 0.9 0.0 0.8 2.4 1.1 0.3 0.3 0.8 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 14.7 2.2 0.3 0.1 0.0 0.2 0.0 0.5 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.2 5.6 0.0 0.1 0.0 0.7 0.2 0.1 1.8 0.0 0.0 0.1 10.4 0.2 18.3 0.2 0.0 0.4 1.6 0.0 0.1 0.0 0.1 1.8 6.5 0.5 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.3 0.1 0.3 0.8 0.1 0.3 0.3 0.1 0.0 12.6 7.3 21.7 15.0 23.1 3.6 4.5 16.9 9.1 6.5 KCNN3 "hSK3, KCa2.3, SKCA3" ENSG00000143603 "Potassium calcium-activated channel subfamily N member 3" Q9UGI6 1 154697455-154870280 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.7" "Cell line enhanced" "Detected in some" "Daudi: 17.7;HMC-1: 12.3;Karpas-707: 30.3;RPMI-8226: 8.2;U-266/70: 29.2;U-698: 9.8" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.8;memory B-cell: 4.8" "Group enriched" "Detected in many" 9 "B-cells: 4.8;granulocytes: 5.8;monocytes: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057127 Enhanced Approved Nucleoplasm Nucleoplasm "HPA057127: " "unprognostic (2.09e-1)" "unprognostic (2.91e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (7.22e-2)" "unprognostic (4.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (9.51e-2)" "unprognostic (4.07e-3)" "unprognostic (4.89e-2)" "prognostic unfavourable (1.97e-4)" "unprognostic (1.71e-2)" "unprognostic (1.54e-1)" "unprognostic (6.93e-2)" "unprognostic (1.80e-2)" 1.7 2.5 20.6 6.5 21.7 1.0 1.8 5.7 26.7 9.3 9.1 12.4 1.1 5.4 12.6 1.7 3.5 10.3 3.1 4.0 21.6 8.0 3.5 1.0 3.1 5.8 12.0 10.9 2.1 1.0 1.5 2.6 0.7 13.3 3.4 4.6 0.1 2.7 2.7 8.5 1.1 3.9 10.6 8.1 5.0 4.4 1.3 15.5 0.2 3.7 3.5 9.2 8.3 4.9 4.8 0.4 5.8 2.7 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.2 0.0 0.1 0.0 0.4 0.0 30.3 0.3 0.0 0.1 0.0 0.3 1.1 0.0 7.5 8.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 29.2 3.8 9.8 0.3 0.0 2.8 5.8 0.0 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.4 20.6 21.7 5.7 10.3 21.6 8.0 12.0 10.9 13.3 15.5 KCNQ2 "BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2" ENSG00000075043 "Potassium voltage-gated channel subfamily Q member 2" O43526 20 63400210-63472677 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.8" "Cell line enhanced" "Detected in some" "AF22: 8.3;AN3-CA: 13.7;NTERA-2: 7.6;SCLC-21H: 26.9;SH-SY5Y: 47.2" "Cancer enriched" "Detected in some" 9 "glioma: 8.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.2;T-reg: 1.5" "Lineage enriched" "Detected in single" 22 "T-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016642, HPA057112" Enhanced Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA016642: AB_1855555, HPA057112: " "unprognostic (2.35e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-4)" "unprognostic (8.21e-6)" "unprognostic (6.18e-2)" "unprognostic (7.58e-2)" "unprognostic (6.06e-2)" "unprognostic (3.16e-1)" "unprognostic (1.73e-1)" "unprognostic (1.92e-1)" "unprognostic (9.96e-2)" "unprognostic (9.39e-2)" "unprognostic (1.43e-5)" "unprognostic (4.36e-2)" "unprognostic (1.02e-1)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" 1.2 10.0 18.7 1.3 21.4 1.2 1.2 24.1 50.8 1.2 1.3 2.4 0.0 1.3 1.2 1.3 1.2 1.7 1.7 1.2 15.4 10.0 1.2 1.2 1.2 1.2 8.4 14.1 1.2 1.9 1.2 9.2 1.2 8.9 2.8 1.2 0.0 1.2 1.2 1.2 1.2 1.3 1.2 2.6 1.2 1.3 6.9 4.2 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 8.3 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 26.9 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 1.5 0.0 18.7 21.4 24.1 31.2 15.4 10.0 8.4 14.1 8.9 4.2 KCNQ3 "EBN2, Kv7.3" ENSG00000184156 "Potassium voltage-gated channel subfamily Q member 3" O43525 8 132120858-132481019 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 29.5" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.8;hTERT-HME1: 10.2;RPMI-8226: 4.1;U-2 OS: 6.7;U-87 MG: 5.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (2.90e-1)" "unprognostic (1.26e-3)" "unprognostic (1.45e-2)" "unprognostic (3.65e-5)" "unprognostic (2.32e-1)" "unprognostic (4.60e-2)" "unprognostic (5.57e-6)" "unprognostic (5.82e-2)" "unprognostic (7.32e-2)" "unprognostic (6.09e-2)" "unprognostic (7.09e-2)" "unprognostic (3.22e-1)" "unprognostic (2.71e-4)" "unprognostic (1.14e-3)" "unprognostic (3.52e-1)" "unprognostic (7.92e-2)" "unprognostic (2.50e-2)" 1.8 3.3 10.6 1.5 13.1 0.7 1.4 0.9 29.5 1.4 1.0 1.7 0.0 1.0 1.0 0.9 0.8 1.2 1.3 1.8 8.0 7.3 1.8 0.7 2.0 0.9 7.4 11.5 0.8 1.2 1.2 1.4 1.0 6.5 1.4 1.0 0.0 1.0 1.8 0.7 1.3 1.7 1.6 2.1 1.3 0.9 1.0 4.7 0.0 1.2 0.0 1.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.5 1.6 0.0 0.5 1.6 0.0 0.0 0.0 1.6 0.0 1.8 2.3 0.0 0.0 3.8 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 2.7 10.2 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.7 0.3 0.0 0.0 4.1 2.4 0.0 1.9 1.7 0.7 0.0 0.0 0.0 1.5 0.0 0.0 6.7 0.2 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 13.1 0.9 13.3 8.0 7.3 7.4 11.5 6.5 4.7 KCNQ5 Kv7.5 ENSG00000185760 "Potassium voltage-gated channel subfamily Q member 5" Q9NR82 6 72621792-73198851 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 6.6;brain: 23.0;skeletal muscle: 26.1;thyroid gland: 6.9" "Cell line enhanced" "Detected in many" "BJ: 20.1;HL-60: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA016655 Enhanced Approved Vesicles Vesicles "HPA016655: AB_1855557" "unprognostic (4.91e-2)" "unprognostic (1.42e-1)" "unprognostic (4.96e-2)" "unprognostic (3.78e-2)" "unprognostic (2.69e-1)" "unprognostic (2.18e-2)" "unprognostic (3.57e-2)" "unprognostic (1.43e-1)" "unprognostic (6.09e-2)" "unprognostic (8.55e-2)" "unprognostic (7.96e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (1.08e-2)" "unprognostic (2.62e-1)" "unprognostic (8.16e-2)" "unprognostic (1.39e-3)" 0.7 2.8 4.2 3.0 14.9 6.6 1.1 0.6 19.6 0.6 0.9 0.0 0.0 0.8 0.7 0.6 1.7 1.0 0.9 0.6 6.9 2.7 0.6 0.8 0.8 3.4 3.0 7.5 0.7 0.6 0.6 0.5 1.0 23.0 2.4 0.9 2.2 2.1 1.9 26.1 0.6 0.9 1.7 0.9 2.0 0.8 2.0 0.7 1.6 6.9 0.4 3.1 1.2 0.7 2.7 0.5 1.2 0.0 2.2 1.7 0.2 2.5 0.6 0.0 0.1 0.0 0.9 0.0 20.1 3.0 3.0 2.6 0.0 0.0 12.0 0.0 6.8 0.4 0.1 1.2 3.6 0.1 4.2 13.1 0.0 0.0 0.5 17.6 0.0 0.2 0.5 8.6 9.0 0.0 0.7 8.3 5.9 0.1 0.0 7.5 0.7 4.2 0.0 0.6 8.2 1.1 0.0 3.4 1.6 0.0 0.0 8.2 2.5 1.3 0.0 12.5 5.5 0.0 13.3 8.7 0.2 5.5 0.1 8.5 0.7 1.2 0.0 0.0 0.2 0.0 1.1 2.7 0.5 1.5 0.5 1.4 1.7 1.2 0.0 2.2 0.0 0.0 0.0 0.2 4.2 14.9 0.6 19.6 6.9 2.7 3.0 7.5 23.0 0.7 KCNS1 Kv9.1 ENSG00000124134 "Potassium voltage-gated channel modifier subfamily S member 1" Q96KK3 20 45092310-45101112 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 27.0" "Cell line enhanced" "Detected in some" "HBF TERT88: 3.1;HHSteC: 4.8;hTEC/SVTERT24-B: 2.6;THP-1: 4.0;U-87 MG: 6.8" "Cancer enhanced" "Detected in many" "cervical cancer: 6.1" "Region enhanced" "Detected in many" "cerebral cortex: 27.0" "Cell type enhanced" "Detected in single" "neutrophil: 2.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (2.46e-2)" "unprognostic (2.95e-3)" "unprognostic (2.03e-1)" "unprognostic (3.11e-4)" "unprognostic (8.91e-3)" "unprognostic (6.01e-3)" "unprognostic (7.47e-2)" "unprognostic (8.94e-2)" "unprognostic (4.37e-2)" "prognostic unfavourable (6.45e-4)" "unprognostic (6.74e-2)" "unprognostic (4.65e-2)" "unprognostic (6.35e-2)" "unprognostic (5.62e-2)" "unprognostic (3.06e-2)" "unprognostic (1.15e-1)" "unprognostic (1.39e-1)" 0.3 0.8 1.4 0.2 4.6 0.4 0.7 0.4 27.0 0.6 0.3 0.0 5.9 0.2 0.2 0.2 0.4 0.3 5.2 0.4 2.1 1.1 0.5 0.3 0.7 0.3 1.0 7.2 0.2 0.3 0.1 0.4 0.3 0.0 0.9 0.2 0.0 3.4 7.0 0.2 2.6 0.3 0.2 0.4 0.3 0.3 2.0 0.0 0.0 0.3 0.0 0.5 0.4 0.6 0.6 0.2 2.5 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.1 0.5 0.0 0.3 0.3 1.0 0.9 0.1 0.4 1.4 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.2 0.9 0.0 2.6 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.3 1.8 0.0 2.0 0.0 4.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 6.8 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.5 0.2 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 1.4 4.6 0.4 27.0 2.1 1.1 1.0 7.2 0.0 0.0 KCNS2 Kv9.2 ENSG00000156486 "Potassium voltage-gated channel modifier subfamily S member 2" Q9ULS6 8 98427022-98432848 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.9" "Group enriched" "Detected in some" 6 "HSkMC: 3.9;SCLC-21H: 11.6" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051417 Uncertain "HPA051417: " "unprognostic (7.83e-2)" "unprognostic (9.39e-3)" "unprognostic (5.25e-2)" "unprognostic (2.87e-1)" "unprognostic (1.38e-2)" "unprognostic (2.59e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-2)" "unprognostic (4.27e-2)" "unprognostic (4.58e-2)" "unprognostic (1.47e-1)" "unprognostic (5.30e-5)" "unprognostic (2.43e-2)" "unprognostic (1.42e-2)" "unprognostic (2.31e-1)" "unprognostic (1.30e-1)" "unprognostic (1.27e-3)" 1.6 1.4 2.9 0.6 6.6 0.3 0.7 0.7 20.9 2.0 1.0 0.1 0.5 0.4 1.3 1.7 0.9 1.0 1.5 0.4 1.9 2.8 0.7 0.3 0.7 0.4 0.8 6.4 1.9 0.8 0.8 1.2 4.4 3.4 0.9 0.9 0.1 0.3 3.3 0.2 0.3 0.7 0.6 0.9 0.3 1.5 1.0 0.4 0.0 0.5 0.0 0.3 2.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 1.3 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 6.6 0.7 20.9 1.9 2.8 0.8 6.4 3.4 0.4 KCNT1 "KCa4.1, KIAA1422, SLACK, Slo2.2" ENSG00000107147 "Potassium sodium-activated channel subfamily T member 1" Q5JUK3 9 135702185-135795508 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.7;skeletal muscle: 19.5" "Cell line enhanced" "Detected in some" "RH-30: 2.0;RPMI-8226: 4.5;SCLC-21H: 6.8;SH-SY5Y: 1.4" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059880 Uncertain "HPA059880: " "unprognostic (1.50e-3)" "unprognostic (1.72e-2)" "unprognostic (2.07e-3)" "unprognostic (2.98e-13)" "unprognostic (9.26e-2)" "unprognostic (7.73e-2)" "unprognostic (9.60e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (1.30e-3)" "unprognostic (9.89e-2)" "unprognostic (6.20e-2)" "unprognostic (4.89e-7)" "unprognostic (9.15e-2)" "unprognostic (2.70e-1)" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" 1.4 0.8 7.3 1.0 12.4 1.0 0.7 29.7 29.3 0.7 0.9 0.2 0.0 1.0 0.8 0.9 1.2 0.9 1.1 1.8 5.3 4.2 0.7 0.7 0.9 0.8 1.8 12.0 7.3 0.8 0.7 4.7 1.2 6.1 0.8 0.8 0.0 0.7 0.8 19.5 0.8 0.8 0.8 2.1 9.6 1.4 1.9 3.1 0.0 0.8 0.0 0.7 1.1 0.1 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 2.0 4.5 0.0 0.0 6.8 1.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 7.3 12.4 29.7 29.3 5.3 4.2 1.8 12.0 6.1 3.1 KCNV1 Kv8.1 ENSG00000164794 "Potassium voltage-gated channel modifier subfamily V member 1" Q6PIU1 8 109963645-109975847 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 22.4" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in single" "renal cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (1.41e-1)" "unprognostic (1.81e-2)" "unprognostic (5.01e-4)" "unprognostic (2.30e-1)" "unprognostic (3.76e-2)" "unprognostic (1.13e-2)" "unprognostic (3.89e-2)" "unprognostic (2.27e-1)" "unprognostic (4.17e-2)" 0.5 0.5 10.6 0.6 10.2 1.1 0.6 0.2 22.4 0.4 1.1 0.0 0.0 0.5 0.6 1.2 0.5 0.4 0.5 0.5 3.9 1.6 0.6 0.5 0.5 0.7 0.9 8.2 0.8 1.0 0.4 0.7 0.6 0.9 0.7 0.9 0.0 0.6 0.5 0.5 1.1 0.8 0.4 0.4 0.6 0.5 0.7 0.0 0.0 0.9 0.0 0.5 0.4 0.2 0.8 0.6 2.5 0.9 0.6 0.5 0.1 2.0 2.6 1.9 0.8 0.3 0.3 0.7 0.6 0.0 0.4 0.4 0.5 0.8 0.7 0.6 0.1 2.1 0.7 0.3 0.5 1.0 0.3 1.2 2.0 0.5 0.1 1.1 1.5 0.3 0.4 0.6 0.5 0.4 1.0 2.6 0.3 0.6 0.8 1.2 0.9 1.2 0.2 1.0 0.3 3.4 1.0 1.5 0.7 0.4 0.4 0.6 1.0 0.5 1.3 2.3 1.9 1.5 0.6 0.9 0.5 0.4 1.0 0.9 0.9 2.5 0.8 0.3 0.5 0.9 0.4 0.6 0.5 0.5 0.5 0.8 0.5 0.5 1.1 0.6 0.8 0.6 0.3 0.1 10.6 10.2 0.2 19.5 3.9 1.6 0.9 8.2 0.9 0.0 KCTD16 KIAA1317 ENSG00000183775 "Potassium channel tetramerization domain containing 16" Q68DU8 5 144170832-144485686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 25.1" "Cell line enhanced" "Detected in some" "SCLC-21H: 6.9;TIME: 13.1;U-87 MG: 3.0" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Group enriched" "Detected in many" 5 "amygdala: 11.4;basal ganglia: 14.5;cerebral cortex: 25.1;hippocampal formation: 14.5;olfactory region: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044590, HPA050154" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA044590: AB_2679008, HPA050154: AB_2681034" "unprognostic (7.22e-2)" "unprognostic (3.63e-1)" "unprognostic (2.54e-2)" "unprognostic (6.81e-5)" "unprognostic (9.88e-2)" "unprognostic (1.21e-1)" "unprognostic (7.74e-3)" "unprognostic (3.23e-2)" "unprognostic (1.94e-2)" "unprognostic (9.57e-2)" "unprognostic (9.38e-3)" "unprognostic (6.20e-3)" "unprognostic (2.52e-8)" "unprognostic (1.55e-3)" "unprognostic (2.34e-1)" "unprognostic (5.80e-3)" "unprognostic (1.22e-2)" 1.0 2.0 11.4 0.7 14.5 0.6 0.9 0.7 25.1 1.5 0.8 0.4 0.0 1.0 0.9 1.5 0.8 1.2 1.4 0.9 14.5 3.2 2.9 0.8 2.4 0.7 1.7 12.0 1.0 5.2 0.8 1.7 0.9 1.3 0.8 0.7 0.0 0.7 1.1 0.6 0.7 1.2 0.9 1.6 0.7 0.8 4.4 2.4 0.0 2.2 0.0 0.7 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.1 0.6 0.0 1.9 1.6 0.6 0.8 0.4 0.0 0.0 0.6 0.5 0.0 0.0 0.3 0.8 0.2 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.4 0.1 1.1 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 6.9 0.3 0.1 0.0 0.1 0.0 0.0 13.1 1.0 0.7 0.2 0.0 0.2 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 14.5 0.7 25.1 14.5 3.2 1.7 12.0 1.3 2.4 KCTD17 FLJ12242 ENSG00000100379 "Potassium channel tetramerization domain containing 17" Q8N5Z5 22 37051736-37063390 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Ubl conjugation pathway" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018459 Uncertain "HPA018459: AB_1852169" "unprognostic (1.09e-2)" "unprognostic (2.33e-1)" "unprognostic (1.09e-1)" "unprognostic (1.61e-2)" "unprognostic (5.38e-2)" "unprognostic (3.09e-3)" "prognostic unfavourable (3.59e-5)" "unprognostic (1.89e-1)" "unprognostic (4.90e-2)" "unprognostic (2.19e-1)" "prognostic favourable (4.22e-5)" "unprognostic (8.62e-2)" "prognostic unfavourable (5.13e-12)" "unprognostic (2.32e-1)" "unprognostic (1.57e-1)" "unprognostic (2.32e-1)" "unprognostic (6.94e-2)" 6.1 11.8 21.7 9.6 59.0 2.5 4.2 7.0 36.3 6.2 8.3 9.2 2.7 3.8 9.6 2.6 7.7 5.9 8.9 17.1 23.1 12.9 2.3 2.1 7.1 9.6 12.6 14.7 10.8 3.0 4.0 14.5 9.5 10.5 5.1 5.8 2.3 1.8 10.3 1.9 16.9 4.3 10.0 6.8 6.8 4.4 18.7 16.0 4.1 2.8 2.3 7.1 8.7 7.9 2.9 2.7 0.0 2.9 3.8 2.8 1.0 8.2 10.9 17.3 12.8 8.3 8.3 0.7 8.7 8.4 14.2 12.3 2.3 2.5 6.4 6.0 11.0 2.2 5.4 10.1 6.0 12.4 14.4 2.7 2.9 2.6 12.4 0.0 3.3 9.7 5.0 14.5 3.2 18.1 0.6 7.1 8.9 6.7 5.6 0.1 11.0 9.4 10.3 4.5 1.9 3.6 2.1 14.5 18.0 8.0 7.7 3.9 2.0 2.2 10.4 18.5 17.3 8.7 6.3 9.7 2.8 1.0 16.3 3.8 10.0 0.0 2.3 0.0 2.7 2.9 2.6 2.9 2.0 2.8 2.7 1.5 2.5 2.0 0.0 3.8 1.3 0.6 2.8 1.0 21.7 59.0 7.0 25.4 23.1 12.9 12.6 14.7 10.5 16.0 KCTD2 KIAA0176 ENSG00000180901 "Potassium channel tetramerization domain containing 2" Q14681 17 75032575-75065889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.1" "Cell line enhanced" "Detected in many" "HEK 293: 10.4;K-562: 9.0;U-266/70: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.62e-1)" "unprognostic (1.83e-1)" "unprognostic (2.66e-1)" "unprognostic (1.00e-3)" "unprognostic (1.73e-2)" "unprognostic (8.50e-2)" "prognostic unfavourable (1.83e-4)" "unprognostic (5.43e-2)" "unprognostic (3.34e-1)" "unprognostic (6.58e-2)" "prognostic favourable (1.25e-5)" "unprognostic (7.19e-2)" "unprognostic (9.57e-3)" "unprognostic (2.13e-1)" "unprognostic (6.10e-2)" "unprognostic (1.16e-2)" "unprognostic (1.60e-1)" 13.9 3.2 5.5 1.8 6.1 3.6 2.3 26.1 20.8 3.3 7.2 6.9 1.5 2.3 4.3 1.8 2.9 3.6 1.8 5.0 4.4 4.0 9.6 3.2 3.7 1.8 5.2 7.0 4.1 1.8 1.8 3.8 3.9 6.6 5.3 1.9 3.6 2.8 4.1 11.3 3.6 2.5 2.1 5.9 5.0 5.6 5.0 4.3 0.4 4.5 1.9 1.8 5.4 2.5 0.0 0.0 0.5 0.0 1.7 0.5 0.4 3.8 0.0 0.1 0.9 0.4 1.1 2.7 7.8 0.9 0.0 0.9 0.0 0.0 6.9 7.5 1.4 2.3 0.0 0.0 0.0 5.8 10.4 0.0 1.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 7.6 0.4 1.2 7.3 7.2 0.3 1.7 0.0 0.1 1.0 4.7 2.1 0.1 1.4 0.0 0.5 0.0 0.1 5.7 0.0 6.2 10.4 4.9 2.4 1.3 1.0 0.0 0.0 0.0 0.5 0.4 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 5.5 6.1 26.1 11.9 4.4 4.0 5.2 7.0 6.6 4.3 KCTD4 bA321C24.3 ENSG00000180332 "Potassium channel tetramerization domain containing 4" Q8WVF5 13 45192853-45194717 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 45.5" "Cell line enhanced" "Detected in some" "hTERT-HME1: 4.7;RPTEC TERT1: 9.5;U-138 MG: 11.5;U-87 MG: 22.8" "Group enriched" "Detected in some" 5 "glioma: 1.2;renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040734 Uncertain Approved "Centriolar satellite" "Centriolar satellite" "HPA040734: AB_10963227" "unprognostic (1.36e-1)" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.19e-2)" "unprognostic (1.70e-1)" "unprognostic (4.68e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-3)" "unprognostic (1.63e-1)" "unprognostic (1.73e-1)" "unprognostic (2.15e-1)" "unprognostic (2.98e-2)" 0.5 0.6 33.1 0.6 45.5 0.7 1.5 0.2 22.0 0.7 1.1 1.5 0.0 0.9 0.5 0.6 0.5 0.5 1.8 0.9 9.8 4.0 0.9 0.5 0.5 0.5 3.6 4.8 0.5 0.9 0.5 1.1 0.9 3.9 0.5 0.9 1.8 1.5 0.8 0.5 6.4 1.0 1.8 2.7 0.5 0.5 0.5 7.0 0.0 0.5 0.0 0.5 0.5 0.0 0.0 0.0 0.5 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 2.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.5 0.0 0.0 2.4 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.7 0.6 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 33.1 45.5 0.2 9.3 9.8 4.0 3.6 4.8 3.9 7.0 KCTD8 ENSG00000183783 "Potassium channel tetramerization domain containing 8" Q6ZWB6 4 44173909-44448807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.5" "Cell line enhanced" "Detected in some" "HAP1: 4.0;NTERA-2: 2.8;PC-3: 1.7;SCLC-21H: 10.6;U-2 OS: 3.2" "Cancer enhanced" "Detected in some" "glioma: 0.9;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA031562 Enhanced Approved Vesicles Vesicles "HPA031562: AB_10602609" "unprognostic (1.49e-2)" "unprognostic (7.70e-3)" "unprognostic (1.53e-1)" "unprognostic (4.15e-1)" "unprognostic (1.77e-2)" "unprognostic (1.48e-1)" "unprognostic (7.85e-2)" "unprognostic (2.62e-3)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (2.57e-3)" "unprognostic (8.72e-2)" "unprognostic (3.55e-2)" "unprognostic (2.44e-1)" 2.0 1.4 5.4 0.9 12.2 0.7 0.9 19.5 18.9 2.2 1.0 8.5 3.5 0.8 4.2 1.3 0.8 1.1 1.5 1.1 4.8 5.2 2.8 0.7 1.0 0.7 8.9 4.0 4.3 2.4 0.7 0.2 0.7 6.8 1.5 1.1 2.3 1.7 3.1 2.6 0.8 0.9 2.3 8.0 0.7 2.6 3.8 8.3 0.0 8.6 0.4 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.7 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 12.2 19.5 8.5 4.8 5.2 8.9 4.0 6.8 8.3 KHDC1L RP11-257K9.7 ENSG00000256980 "KH domain containing 1 like" Q5JSQ8 6 73223544-73225770 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 8.9;lymphoid tissue: 4.1;testis: 7.7" "Cell line enriched" "Detected in some" 4 "BEWO: 33.0" "Cancer enriched" "Detected in some" 9 "testis cancer: 33.6" "Region enriched" "Detected in some" 5 "basal ganglia: 8.9" "Cell type enriched" "Detected in single" 13 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "unprognostic (1.18e-1)" "unprognostic (6.11e-5)" "unprognostic (3.06e-2)" "unprognostic (1.93e-1)" "unprognostic (3.07e-2)" "unprognostic (9.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.99e-2)" "unprognostic (1.48e-1)" "unprognostic (4.01e-2)" "unprognostic (1.31e-2)" "unprognostic (4.13e-1)" "unprognostic (6.63e-2)" "unprognostic (3.17e-3)" 0.3 0.2 1.1 0.3 8.9 0.5 0.3 1.6 1.4 0.3 0.3 0.3 0.3 0.2 0.5 0.3 0.3 0.0 0.3 0.3 0.5 0.4 0.3 0.3 2.1 0.3 0.7 0.3 0.4 0.3 0.0 1.4 2.0 0.3 0.4 0.0 0.3 0.3 0.4 0.3 0.1 0.3 0.3 0.3 0.3 0.0 7.7 0.3 4.1 0.3 0.3 1.5 0.3 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.1 0.0 0.3 0.0 0.0 33.0 0.1 0.2 0.2 0.1 0.2 0.1 0.3 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 8.9 1.6 0.7 0.5 0.4 0.7 0.3 0.3 0.3 KHDC3L "C6orf221, ECAT1" ENSG00000203908 "KH domain containing 3 like, subcortical maternal complex member" Q587J8 6 73362677-73364171 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 4.1;epididymis: 1.5;lung: 3.0;lymphoid tissue: 4.4;testis: 4.9" "Cell line enhanced" "Detected in some" "HDLM-2: 1.0;HMC-1: 1.5;NTERA-2: 2.1" "Cancer enriched" "Detected in single" 3155 "testis cancer: 254.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA043699 Uncertain "HPA043699: AB_10960564" "unprognostic (1.39e-2)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (4.36e-1)" 0.2 0.5 1.2 0.2 2.1 0.0 0.2 4.1 0.9 0.2 0.2 0.2 0.2 0.1 0.2 1.5 0.3 0.1 0.2 0.2 2.1 0.6 0.2 0.2 3.0 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.6 0.3 4.9 0.2 4.4 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 2.1 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.8 0.2 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.1 4.1 0.9 2.1 0.6 0.4 0.2 0.2 0.2 KHDRBS2 "MGC26664, SLM-1, SLM1" ENSG00000112232 "KH RNA binding domain containing, signal transduction associated 2" Q5VWX1 6 61679960-62286227 "Predicted intracellular proteins" "mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.4;thyroid gland: 16.9" "Cell line enhanced" "Detected in some" "AF22: 12.5;NTERA-2: 3.2;THP-1: 2.6" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "memory B-cell: 6.8;naive B-cell: 10.4;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 13 "B-cells: 10.4;dendritic cells: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA000500, HPA029392" Supported "HPA000500: AB_1079184, HPA029392: AB_10600816" "unprognostic (6.98e-2)" "unprognostic (1.21e-1)" "unprognostic (3.06e-2)" "unprognostic (1.37e-1)" "unprognostic (1.80e-3)" "unprognostic (4.35e-1)" "unprognostic (2.80e-1)" "unprognostic (1.25e-4)" "unprognostic (1.45e-2)" "unprognostic (2.19e-5)" "unprognostic (5.52e-2)" "unprognostic (4.54e-2)" "unprognostic (6.24e-3)" "unprognostic (1.15e-1)" 1.1 3.0 6.4 4.7 18.4 1.6 0.8 0.9 16.9 0.9 1.6 1.2 0.0 1.0 3.2 0.8 0.9 0.9 1.0 0.9 6.7 8.1 1.9 0.8 9.7 2.4 4.0 14.6 1.2 0.8 0.7 7.3 2.4 3.9 1.0 1.4 1.3 1.2 1.3 1.2 0.7 2.2 1.3 2.2 3.8 1.0 1.0 1.6 0.0 16.9 0.0 2.9 0.9 0.5 10.4 2.6 0.0 0.5 0.1 0.0 0.3 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.2 0.0 6.8 0.0 0.0 0.1 10.4 0.0 0.0 0.0 0.1 0.3 2.6 0.0 0.3 6.4 18.4 0.9 16.9 6.7 8.1 4.0 14.6 3.9 1.6 KHDRBS3 "Etle, etoile, SALP, SLM-2, SLM2, T-STAR" ENSG00000131773 "KH RNA binding domain containing, signal transduction associated 3" O75525 8 135457457-135656722 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4;testis: 79.1" "Cell line enhanced" "Detected in many" "REH: 30.9;RPTEC TERT1: 27.8;WM-115: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "eosinophil: 4.1" "Lineage enriched" "Detected in single" 25 "granulocytes: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000275, HPA000500, HPA000981" Enhanced Supported Nucleoplasm Nucleoplasm "HPA000275: AB_1079183, HPA000500: AB_1079184, HPA000981: AB_2666164" "unprognostic (1.36e-1)" "unprognostic (1.61e-1)" "unprognostic (1.98e-1)" "unprognostic (6.55e-3)" "unprognostic (2.75e-1)" "unprognostic (2.43e-1)" "unprognostic (1.31e-3)" "unprognostic (9.36e-2)" "unprognostic (2.00e-2)" "unprognostic (2.66e-1)" "unprognostic (1.91e-2)" "unprognostic (1.21e-1)" "prognostic favourable (7.16e-6)" "unprognostic (6.63e-2)" "unprognostic (7.85e-2)" "unprognostic (1.07e-1)" "unprognostic (1.33e-3)" 8.0 9.6 16.4 3.3 16.6 1.7 5.8 7.1 34.4 10.3 5.3 8.0 0.9 2.7 4.3 13.4 3.9 4.2 6.8 5.6 16.7 9.8 11.0 7.0 4.5 1.9 11.1 21.7 5.8 5.4 3.5 4.2 1.6 8.7 5.2 5.4 2.6 6.4 7.6 14.7 3.1 3.6 5.1 12.5 1.9 3.7 79.1 7.9 0.9 3.1 1.5 2.7 6.8 4.5 0.1 0.0 4.1 0.0 0.0 0.1 0.0 0.1 0.6 11.3 0.6 2.4 4.5 4.5 7.4 10.3 7.0 3.6 3.9 1.6 0.0 4.0 7.0 0.9 7.0 7.5 9.6 1.5 12.2 0.0 4.2 8.0 1.9 2.0 25.7 1.0 1.0 3.8 5.9 5.7 0.9 18.6 12.5 2.6 0.7 0.4 2.3 12.3 30.9 15.4 7.9 27.8 0.2 14.5 12.3 0.5 1.6 8.0 0.5 0.6 0.4 8.8 15.1 0.1 15.9 6.6 0.0 0.0 5.3 0.0 30.8 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 16.6 7.1 34.4 16.7 9.8 11.1 21.7 8.7 7.9 KIAA0319 NMIG ENSG00000137261 KIAA0319 Q5VV43 6 24544104-24646155 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 23.5" "Cell line enhanced" "Detected in some" "A-431: 3.6;A549: 4.1;HDLM-2: 4.8;SCLC-21H: 7.8;U-266/84: 6.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 1.4;neutrophil: 5.0" "Group enriched" "Detected in many" 32 "B-cells: 1.4;granulocytes: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015607, HPA076313" Enhanced Supported Approved Vesicles "Secreted in brain" Vesicles "HPA015607: AB_1852299, HPA076313: " "unprognostic (1.64e-1)" "unprognostic (2.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (1.77e-1)" "unprognostic (1.72e-2)" "unprognostic (4.65e-2)" "unprognostic (9.70e-2)" "unprognostic (2.21e-5)" "unprognostic (7.88e-4)" "unprognostic (9.53e-4)" "unprognostic (1.44e-6)" "unprognostic (1.20e-1)" "unprognostic (6.97e-2)" "unprognostic (3.13e-1)" "unprognostic (3.41e-2)" 0.9 1.9 9.9 1.3 10.2 0.9 1.1 10.7 23.5 0.9 1.6 4.0 0.0 0.9 0.9 0.9 0.8 4.8 1.4 0.8 9.7 7.7 0.9 0.8 2.2 0.9 5.8 12.1 0.8 3.0 0.8 3.8 1.1 10.2 1.7 1.7 0.0 0.8 0.9 0.8 2.4 1.1 1.1 1.4 1.1 3.2 3.5 2.3 0.0 0.8 0.0 1.1 0.9 0.1 1.4 0.0 5.0 0.0 0.0 0.0 0.0 3.6 4.1 0.2 2.6 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 1.5 1.1 2.0 0.0 1.7 0.7 0.0 0.0 4.8 1.8 0.0 3.5 0.2 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.0 0.5 0.3 0.2 0.0 0.8 0.1 0.2 7.8 0.5 0.1 2.2 0.0 0.8 0.0 0.0 0.0 0.6 0.4 0.7 0.6 6.3 0.3 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 9.9 10.2 10.7 14.9 9.7 7.7 5.8 12.1 10.2 2.3 KIAA0513 ENSG00000135709 KIAA0513 O60268 16 85027751-85094230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 15.9;monocytes: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012866, HPA014431" Enhanced Uncertain Nucleoplasm,Cytosol 8400 "Nucleoplasm, Cytosol" "HPA012866: AB_1852321, HPA014431: AB_1852322" "unprognostic (1.98e-2)" "unprognostic (2.47e-2)" "unprognostic (2.35e-1)" "unprognostic (1.69e-2)" "unprognostic (1.49e-2)" "unprognostic (9.37e-3)" "unprognostic (2.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.38e-1)" "unprognostic (4.85e-2)" "prognostic favourable (1.72e-5)" "unprognostic (7.52e-2)" "unprognostic (1.94e-3)" "unprognostic (7.88e-2)" "unprognostic (4.00e-1)" "unprognostic (2.33e-2)" "unprognostic (2.34e-1)" 5.2 11.0 20.8 8.8 30.8 14.3 2.8 57.6 57.6 6.9 8.1 4.6 1.8 4.7 3.3 3.1 7.6 2.3 4.9 4.5 19.7 14.9 3.0 1.9 6.7 5.2 11.3 27.6 2.9 13.0 4.1 14.8 4.0 17.6 6.2 6.1 2.9 8.3 5.2 5.6 9.9 6.0 5.6 6.9 7.4 10.1 5.7 4.6 0.5 2.8 1.0 6.2 8.3 3.5 0.0 3.6 15.9 13.6 0.7 0.9 3.1 5.6 6.1 4.1 5.9 7.8 5.8 1.0 5.7 9.1 8.2 4.8 2.7 2.7 2.0 2.5 6.8 5.0 3.8 9.0 5.1 4.2 3.1 3.6 1.9 1.5 3.7 0.4 5.2 10.7 4.8 9.4 1.2 4.3 15.8 4.7 7.2 8.8 0.7 1.5 4.0 4.9 0.6 5.3 1.2 7.6 4.1 12.2 1.9 6.7 11.1 2.7 9.0 1.1 8.7 5.1 3.8 7.7 2.0 7.4 1.3 4.0 6.7 2.8 5.4 11.0 7.2 10.6 0.9 8.3 0.3 0.0 0.6 0.6 2.6 0.0 0.6 0.6 15.9 0.7 13.6 3.6 0.2 3.1 20.8 30.8 57.6 45.9 19.7 14.9 11.3 27.6 17.6 4.6 KIAA0930 "bK268H5.C22.1, C22orf9" ENSG00000100364 KIAA0930 Q6ICG6 22 45190338-45240769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.8" "Cell line enhanced" "Detected in many" "THP-1: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 9.1;eosinophil: 6.5;intermediate monocyte: 11.1;myeloid DC: 9.8;non-classical monocyte: 12.9;plasmacytoid DC: 8.2" "Group enriched" "Detected in all" 4 "dendritic cells: 9.8;granulocytes: 6.5;monocytes: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038091 Uncertain Approved "Nuclear membrane,Mitochondria" "Nuclear membrane, Mitochondria" "HPA038091: AB_10675627" "unprognostic (4.16e-2)" "unprognostic (1.27e-2)" "unprognostic (1.99e-1)" "prognostic favourable (9.22e-5)" "unprognostic (3.16e-2)" "unprognostic (2.44e-1)" "prognostic unfavourable (6.90e-8)" "unprognostic (2.80e-1)" "unprognostic (2.03e-1)" "unprognostic (3.58e-2)" "unprognostic (2.23e-1)" "unprognostic (4.44e-1)" "prognostic unfavourable (8.95e-7)" "unprognostic (6.89e-3)" "unprognostic (5.32e-2)" "unprognostic (5.58e-2)" "unprognostic (1.15e-1)" 13.4 18.0 51.3 17.1 50.0 14.4 12.9 9.9 41.3 15.3 11.6 52.8 10.3 9.6 8.3 28.4 14.2 10.0 10.7 6.6 50.2 39.9 5.9 12.7 12.5 16.6 48.2 36.8 6.7 8.2 10.2 5.6 7.9 28.9 9.5 7.6 4.9 8.6 18.1 15.6 34.2 12.9 10.3 29.3 15.4 8.5 10.1 50.0 6.5 5.2 6.7 14.3 14.1 9.6 1.8 9.8 6.5 12.9 1.5 2.2 2.6 12.1 7.9 4.9 9.7 16.8 8.0 4.9 6.7 6.8 7.2 6.2 7.3 6.7 8.2 10.1 10.6 13.7 7.4 29.9 2.8 8.7 11.7 0.0 9.8 8.4 6.7 21.7 5.0 4.5 15.2 7.0 11.8 6.8 2.8 13.5 4.4 14.0 9.6 20.2 4.8 6.7 11.8 3.3 26.8 10.9 7.5 4.1 7.3 10.7 14.7 18.5 7.1 81.3 9.1 7.5 13.2 10.1 3.8 11.5 7.7 7.8 8.7 33.1 7.6 0.9 9.1 6.5 2.0 11.1 1.3 1.8 0.8 2.2 9.8 1.6 0.8 1.4 2.2 1.5 12.9 8.2 1.5 2.6 51.3 50.0 9.9 41.3 50.2 39.9 48.2 36.8 28.9 50.0 KIAA1024 ENSG00000169330 KIAA1024 Q9UPX6 15 79432516-79472290 "Predicted membrane proteins" Angiogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 16.8;brain: 10.8" "Cell line enhanced" "Detected in many" "U-138 MG: 14.1" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in many" 5 "cerebellum: 10.8;pons and medulla: 8.5" "Group enriched" "Detected in some" 12 "eosinophil: 2.5;non-classical monocyte: 1.9" "Group enriched" "Detected in many" 12 "granulocytes: 2.5;monocytes: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011545 Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA011545: AB_1852361" "unprognostic (5.45e-5)" "unprognostic (3.26e-1)" "unprognostic (4.56e-3)" "unprognostic (2.12e-2)" "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (4.49e-2)" "unprognostic (5.66e-2)" "unprognostic (2.90e-1)" "unprognostic (3.16e-1)" "unprognostic (1.96e-1)" "unprognostic (4.45e-2)" "unprognostic (6.66e-13)" "unprognostic (7.08e-2)" "unprognostic (2.73e-2)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" 0.1 16.8 0.8 0.2 0.6 0.7 0.5 10.8 2.0 0.6 0.2 0.4 0.1 0.0 0.4 0.5 0.5 0.1 0.6 0.1 0.5 1.4 0.2 0.1 0.1 0.6 1.2 1.5 0.2 3.5 0.0 0.7 0.5 8.5 1.2 0.3 0.7 4.2 0.2 0.6 0.2 0.2 0.2 1.7 0.3 0.2 1.1 1.0 0.1 0.2 0.1 0.4 0.2 0.1 0.1 0.1 2.5 1.9 0.0 0.1 0.0 0.4 0.3 0.6 0.8 1.8 1.6 0.7 0.8 1.5 0.7 0.8 0.0 0.4 1.1 0.2 1.3 0.3 1.5 0.1 0.5 1.3 1.7 3.0 0.7 0.0 1.0 4.0 1.5 0.7 0.3 1.2 0.2 0.8 0.2 0.0 0.2 0.0 0.6 1.4 0.7 0.7 0.6 0.1 0.6 0.2 0.0 3.0 1.6 0.3 2.6 1.5 0.3 2.0 0.5 14.1 0.5 0.0 2.9 1.8 2.1 0.5 1.4 2.2 1.7 0.0 0.0 2.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.8 0.6 10.8 2.0 0.5 1.4 1.2 1.5 8.5 1.0 KIAA1211L "C2orf55, MGC42367" ENSG00000196872 "KIAA1211 like" Q6NV74 2 98793846-98936259 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4;epididymis: 27.7" "Cell line enhanced" "Detected in some" "BEWO: 21.9;HDLM-2: 31.3;Karpas-707: 9.2;SiHa: 8.9;SK-BR-3: 11.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 6 "amygdala: 19.0;basal ganglia: 23.7;cerebral cortex: 27.4;hippocampal formation: 12.9;olfactory region: 18.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 15 "amygdala: 29.7;basal ganglia: 59.8;cerebral cortex: 52.5;hippocampal formation: 81.9;olfactory region: 36.3" "HPA051082, HPA061678" Enhanced Approved "Microtubules,Cytokinetic bridge,Centrosome" "Microtubules, Centrosome" "Cytokinetic bridge" "HPA051082: , HPA061678: " "unprognostic (3.56e-3)" "unprognostic (1.23e-3)" "unprognostic (5.88e-2)" "unprognostic (6.43e-2)" "unprognostic (1.34e-1)" "unprognostic (1.24e-1)" "unprognostic (3.67e-3)" "unprognostic (2.12e-1)" "unprognostic (5.10e-2)" "unprognostic (7.65e-2)" "unprognostic (3.23e-2)" "unprognostic (3.61e-2)" "prognostic favourable (1.13e-5)" "unprognostic (1.22e-1)" "unprognostic (3.34e-1)" "prognostic favourable (1.33e-5)" "unprognostic (2.22e-2)" 2.7 0.8 19.0 1.3 23.7 0.5 3.5 2.4 27.4 4.6 5.0 0.8 3.5 6.7 1.5 27.7 9.1 19.3 2.5 1.4 12.9 1.9 2.5 0.4 3.9 0.6 2.7 18.3 1.4 3.7 9.6 4.3 4.0 0.1 1.6 4.0 0.0 9.0 4.3 1.3 4.3 6.1 2.1 1.2 1.0 6.8 3.6 3.6 0.0 4.3 3.3 2.5 2.4 3.2 0.0 0.7 1.4 0.3 0.2 0.9 0.0 4.2 0.2 0.1 1.7 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.2 2.5 0.0 5.5 0.0 3.8 0.1 0.2 0.0 31.3 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.1 1.2 0.0 0.6 1.3 0.0 9.2 0.0 8.4 0.1 0.6 0.0 0.4 0.0 0.0 0.4 1.7 3.4 3.1 0.5 8.9 11.9 0.0 4.6 0.7 5.4 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.1 0.0 1.4 0.2 0.0 0.7 0.0 0.0 19.0 23.7 2.4 27.4 12.9 1.9 2.7 18.3 0.1 3.6 KIAA1324L "EIG121L, FLJ31340" ENSG00000164659 "KIAA1324 like" A8MWY0 7 86876906-87059699 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.9" "Cell line enhanced" "Detected in many" "AF22: 15.4;hTERT-HME1: 18.0;HUVEC TERT2: 15.0;K-562: 23.0;SCLC-21H: 19.2;SH-SY5Y: 14.4;TIME: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.8" "Group enriched" "Detected in many" 5 "B-cells: 2.7;NK-cells: 4.8;T-cells: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044527, HPA076093" Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA044527: AB_10963793, HPA076093: " "unprognostic (2.78e-2)" "unprognostic (9.37e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-4)" "unprognostic (3.79e-1)" "unprognostic (4.00e-2)" "unprognostic (1.33e-3)" "unprognostic (1.89e-1)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (6.82e-2)" "unprognostic (8.82e-3)" "unprognostic (3.86e-3)" "unprognostic (1.25e-1)" "unprognostic (4.32e-1)" "unprognostic (1.37e-1)" 11.1 4.5 7.7 2.3 17.3 1.0 6.5 15.6 15.8 4.0 5.0 28.9 1.2 1.8 4.3 1.0 4.5 3.9 5.0 5.5 10.8 8.7 2.9 1.5 24.4 3.8 22.4 10.4 2.7 5.5 11.7 13.5 9.0 22.7 7.6 6.5 2.4 3.6 6.3 3.5 3.4 2.7 6.4 23.5 6.4 4.1 3.6 21.7 0.0 6.1 1.0 4.0 5.9 2.8 2.7 0.9 0.4 0.0 4.8 5.8 0.7 0.9 0.0 15.4 0.0 0.2 0.0 4.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 3.9 0.3 0.0 1.7 0.0 0.0 3.7 0.3 11.8 4.1 1.3 0.1 0.1 1.5 1.3 0.0 0.0 18.0 15.0 23.0 0.4 1.7 4.7 0.3 0.0 8.4 3.9 0.0 1.0 2.4 1.6 6.9 19.2 14.4 4.1 5.4 1.7 1.6 0.3 17.7 0.2 6.1 0.1 0.0 8.5 5.0 0.1 4.5 0.0 0.2 0.0 0.0 0.4 0.7 0.0 5.8 0.9 2.1 1.3 0.4 2.7 2.2 1.2 0.0 4.8 0.0 0.9 0.7 0.7 7.7 17.3 15.6 15.8 10.8 8.7 22.4 10.4 22.7 21.7 KIAA1549L "C11orf41, C11orf69, G2, MGC34830" ENSG00000110427 "KIAA1549 like" Q6ZVL6 11 33376466-33674102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 30.4;parathyroid gland: 64.4" "Cell line enhanced" "Detected in many" "TIME: 22.7;U-138 MG: 30.0;WM-115: 20.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010132, HPA051594" Approved Nucleoplasm,Vesicles 27000 Nucleoplasm Vesicles "HPA010132: AB_1078313, HPA051594: " "unprognostic (3.02e-1)" "unprognostic (1.18e-1)" "unprognostic (2.70e-2)" "unprognostic (1.34e-5)" "unprognostic (2.63e-1)" "unprognostic (7.92e-2)" "unprognostic (2.89e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-2)" "unprognostic (2.59e-4)" "unprognostic (8.88e-2)" "unprognostic (1.44e-1)" "unprognostic (3.62e-3)" "unprognostic (1.08e-3)" "unprognostic (8.46e-2)" "unprognostic (4.04e-1)" "unprognostic (1.09e-1)" 0.8 0.9 8.2 0.7 20.5 0.6 1.2 6.2 30.4 0.7 0.7 1.7 0.0 0.6 0.7 0.6 0.9 0.6 0.8 0.6 5.3 2.4 0.9 0.6 0.6 0.7 1.6 17.1 0.7 0.8 64.4 1.0 1.4 2.3 0.7 0.7 0.0 0.7 0.6 0.6 1.9 0.6 0.7 1.1 0.6 0.7 1.3 1.6 0.0 0.6 0.0 1.1 0.9 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 3.3 0.1 0.5 3.7 0.0 13.1 7.7 2.1 1.2 0.0 0.3 10.1 0.1 11.6 0.7 0.4 3.8 3.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.2 5.7 9.3 0.0 9.6 8.2 0.0 0.1 0.0 0.7 4.8 0.0 0.8 0.0 0.0 5.0 1.1 1.2 0.1 0.0 3.1 0.0 0.0 22.7 30.0 6.3 0.7 10.5 0.0 0.0 0.0 7.9 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.2 20.5 6.2 30.4 5.3 2.4 1.6 17.1 2.3 1.6 KIAA1614 ENSG00000135835 KIAA1614 Q5VZ46 1 180913154-180951614 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 58.8;retina: 23.8" "Cell line enhanced" "Detected in many" "RH-30: 12.0;SH-SY5Y: 30.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 58.8" "Cell type enhanced" "Detected in some" "basophil: 4.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.4" "Low region specificity" "Detected in all" "HPA028227, HPA061684" Approved Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA028227: AB_10601765, HPA061684: " "unprognostic (3.23e-1)" "unprognostic (3.60e-2)" "unprognostic (3.17e-2)" "unprognostic (2.15e-2)" "unprognostic (1.05e-1)" "unprognostic (3.55e-2)" "unprognostic (8.76e-3)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.15e-2)" "unprognostic (1.57e-1)" "unprognostic (8.61e-5)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.36e-2)" "unprognostic (1.35e-2)" 4.6 1.5 2.4 1.4 2.6 0.1 2.2 58.8 11.3 4.5 4.6 1.8 0.8 3.0 5.2 1.6 4.6 3.5 3.1 7.5 2.7 1.4 3.0 0.4 3.2 1.1 1.5 3.8 6.3 2.1 0.0 1.3 3.6 3.3 3.5 0.5 23.8 4.6 2.8 2.1 3.0 2.5 4.1 1.4 2.6 2.2 1.2 2.5 0.4 7.6 0.9 0.4 4.3 5.1 0.5 0.5 4.4 0.5 0.5 0.6 0.3 1.1 0.5 0.9 2.0 3.0 7.3 3.2 2.2 2.6 1.1 0.6 1.0 1.1 0.5 2.1 2.7 2.1 0.2 0.0 0.3 0.6 0.9 1.6 0.4 1.4 4.1 1.0 1.1 3.5 0.1 0.1 0.0 1.5 1.3 0.7 0.9 0.9 1.3 0.4 2.2 0.3 0.7 12.0 1.6 1.7 1.0 8.3 30.4 0.6 0.8 4.8 0.8 1.4 3.4 2.3 1.7 2.7 0.8 1.5 2.0 1.0 0.3 0.8 1.5 4.4 0.5 1.2 0.3 0.3 0.4 0.5 0.3 0.3 0.5 0.4 0.6 0.4 0.7 0.5 0.1 0.5 0.2 0.3 2.4 2.6 58.8 11.3 2.7 1.4 1.5 3.8 3.3 2.5 KIAA1755 RP5-1054A22.3 ENSG00000149633 KIAA1755 Q5JYT7 20 38210488-38260772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2" "Cell line enhanced" "Detected in some" "AF22: 39.9;ASC diff: 6.1;ASC TERT1: 9.2;WM-115: 10.1" "Cancer enhanced" "Detected in many" "melanoma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051064 Approved Approved "Nucleoli,Golgi apparatus,Vesicles" Nucleoli "Golgi apparatus, Vesicles" "HPA051064: " "unprognostic (3.98e-3)" "unprognostic (2.20e-2)" "unprognostic (3.79e-1)" "unprognostic (3.01e-3)" "unprognostic (1.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (4.50e-2)" "unprognostic (2.70e-1)" "unprognostic (3.88e-2)" "unprognostic (1.69e-1)" "unprognostic (2.42e-8)" "unprognostic (1.41e-2)" "unprognostic (2.78e-2)" "unprognostic (1.25e-2)" "unprognostic (5.53e-3)" 6.1 2.5 13.6 5.8 27.3 0.7 3.8 4.8 22.1 13.2 8.1 47.2 3.1 2.7 15.5 7.2 5.6 10.0 16.9 11.5 13.9 8.4 4.6 1.7 2.7 4.9 22.7 13.7 14.7 1.5 0.3 3.1 0.4 24.5 7.3 4.7 8.8 6.1 8.2 1.3 1.6 4.5 15.8 20.4 2.8 4.1 2.9 29.2 0.0 2.6 1.6 4.9 6.8 5.4 0.3 0.5 0.9 0.4 0.4 0.7 0.0 1.5 0.1 39.9 0.0 6.1 9.2 0.0 3.9 2.2 0.0 0.0 0.2 1.1 0.0 0.2 1.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.1 0.0 10.1 0.9 0.4 0.1 0.7 0.2 0.5 0.1 0.5 0.6 0.1 0.3 0.4 0.4 0.7 0.4 0.1 0.5 0.0 0.0 13.6 27.3 4.8 15.7 13.9 8.4 22.7 13.7 24.5 29.2 KIAA2012 ENSG00000182329 KIAA2012 Q0VF49 2 202073289-202205203 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.0;fallopian tube: 19.2" "Cell line enhanced" "Detected in some" "AF22: 1.6;BJ hTERT+: 1.2;CAPAN-2: 1.8;SCLC-21H: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077834 Enhanced "HPA077834: " "unprognostic (1.91e-2)" "unprognostic (3.17e-1)" "unprognostic (2.56e-1)" "unprognostic (5.35e-2)" "unprognostic (2.85e-2)" "unprognostic (3.22e-2)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "unprognostic (7.35e-2)" "unprognostic (6.31e-2)" "unprognostic (7.81e-2)" "unprognostic (6.94e-5)" "unprognostic (1.60e-1)" "unprognostic (9.44e-2)" "unprognostic (3.37e-1)" "unprognostic (9.95e-3)" 0.3 0.5 6.2 0.4 10.0 0.3 0.4 0.6 8.4 1.2 0.4 5.1 0.0 0.5 0.5 2.5 0.4 19.2 0.4 0.4 6.7 3.5 0.4 2.5 2.0 0.4 0.2 4.4 3.8 0.4 0.3 2.8 0.4 6.5 0.4 0.5 0.0 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 2.6 1.0 0.0 0.4 0.0 0.3 0.4 0.1 0.6 0.5 0.9 0.6 0.5 0.8 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.1 0.7 1.2 0.1 0.0 0.4 1.8 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.1 0.9 0.3 0.6 0.2 0.2 0.5 0.5 0.2 0.6 0.8 0.4 0.3 0.5 0.5 0.5 0.0 0.0 6.2 10.0 0.6 8.4 6.7 3.5 0.2 4.4 6.5 1.0 KIF13B "GAKIN, KIAA0639" ENSG00000197892 "Kinesin family member 13B" Q9NQT8 8 29067279-29263124 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 40.5;parathyroid gland: 107.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025023, HPA049655" Enhanced "HPA025023: AB_1852471, HPA049655: AB_2732555" "unprognostic (1.37e-1)" "unprognostic (4.31e-1)" "prognostic favourable (8.92e-4)" "unprognostic (1.35e-3)" "unprognostic (2.27e-1)" "prognostic favourable (6.26e-4)" "unprognostic (1.04e-1)" "unprognostic (1.66e-1)" "unprognostic (1.21e-2)" "unprognostic (9.69e-2)" "prognostic unfavourable (4.77e-4)" "unprognostic (9.76e-2)" "prognostic favourable (0.00e+0)" "unprognostic (1.19e-1)" "unprognostic (1.81e-1)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" 7.4 10.5 12.3 8.2 21.5 4.8 8.7 3.2 13.8 8.6 15.1 40.5 15.4 13.6 6.1 9.1 6.9 7.1 10.5 4.6 16.5 10.4 16.3 12.5 7.6 4.3 25.9 7.1 7.2 9.7 107.1 10.2 4.4 22.0 10.0 12.2 4.9 12.9 8.9 3.9 15.2 18.0 7.3 29.3 7.7 15.6 6.1 25.1 4.2 8.4 5.1 7.9 9.4 5.9 2.9 5.4 4.1 3.8 2.0 4.1 1.0 9.0 9.8 3.5 2.9 5.7 3.4 5.1 0.5 2.2 3.0 4.8 6.1 5.2 1.9 5.3 0.6 6.1 2.8 1.6 3.8 2.8 2.7 4.7 1.4 6.1 5.6 1.3 14.8 3.9 3.0 6.6 2.8 12.9 6.1 7.2 9.6 2.8 7.0 2.2 1.7 1.7 4.0 8.0 3.5 13.0 9.8 1.0 6.9 1.8 6.1 8.5 4.5 2.7 17.0 2.1 5.9 0.6 4.0 5.3 7.8 3.2 12.6 2.5 9.9 0.3 3.8 4.1 4.1 2.9 2.0 2.9 1.6 2.4 1.2 2.0 1.3 1.7 2.0 2.0 1.4 5.4 1.5 1.0 12.3 21.5 3.2 13.8 16.5 10.4 25.9 7.1 22.0 25.1 KIF17 "KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3" ENSG00000117245 "Kinesin family member 17" Q9P2E2 1 20664014-20718017 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.2;testis: 19.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.7;hTERT-HME1: 8.2;U-2 OS: 4.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA032085 Enhanced Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA032085: AB_10669917" "unprognostic (4.15e-3)" "unprognostic (8.60e-3)" "unprognostic (6.43e-2)" "unprognostic (1.12e-2)" "unprognostic (7.68e-2)" "unprognostic (3.70e-1)" "unprognostic (1.07e-2)" "unprognostic (1.04e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (7.34e-3)" "unprognostic (8.73e-2)" "unprognostic (3.63e-3)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.20e-2)" 0.1 0.4 2.4 0.2 5.2 0.1 0.1 0.0 3.9 0.4 0.2 0.4 0.0 0.3 0.4 0.8 0.1 3.1 0.2 0.2 1.8 3.5 0.2 0.1 0.4 0.1 0.4 0.7 0.6 0.1 0.2 1.5 0.7 0.5 0.4 0.1 0.0 0.1 0.8 0.1 0.1 0.2 0.9 0.3 0.1 0.1 19.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.5 0.9 0.0 0.0 0.1 0.2 2.7 3.7 1.5 0.9 0.4 1.0 0.0 1.2 1.9 0.0 1.3 0.9 1.1 0.0 0.3 0.0 0.0 0.4 1.6 0.0 0.0 0.3 0.8 1.0 8.2 0.0 0.6 0.0 1.8 0.1 0.0 0.0 2.5 1.7 0.0 0.1 0.0 0.6 0.0 0.6 1.5 0.4 0.0 0.3 0.0 0.0 0.0 0.6 4.9 0.5 0.3 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 5.2 0.0 3.6 1.8 3.5 0.4 0.7 0.5 0.0 KIF19 "FLJ37300, KIF19A" ENSG00000196169 "Kinesin family member 19" Q2TAC6 17 74326210-74355820 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9;fallopian tube: 25.2" "Cell line enriched" "Detected in single" 11 "SCLC-21H: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 5.5" "Lineage enriched" "Detected in single" 55 "T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043638, HPA073303" Enhanced Approved "Plasma membrane,Actin filaments,Centrosome" "Plasma membrane" "Actin filaments, Centrosome" "HPA043638: AB_10962579, HPA073303: " "unprognostic (1.59e-3)" "unprognostic (1.05e-1)" "unprognostic (1.00e-1)" "unprognostic (5.37e-3)" "unprognostic (9.64e-2)" "unprognostic (1.64e-1)" "unprognostic (2.70e-2)" "unprognostic (2.81e-1)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (1.05e-3)" "unprognostic (1.14e-1)" "unprognostic (1.59e-9)" "unprognostic (5.16e-5)" "unprognostic (2.72e-1)" "unprognostic (1.67e-2)" "unprognostic (1.53e-1)" 1.6 0.9 9.3 1.6 29.5 1.1 1.1 25.8 14.1 2.1 3.1 17.4 0.0 6.6 1.1 1.1 1.1 25.2 1.6 1.1 11.9 6.6 0.9 1.6 3.1 1.0 25.0 4.2 1.1 3.0 0.9 0.3 0.8 6.5 0.9 2.1 0.8 2.5 1.3 1.0 0.8 5.2 1.6 6.2 11.6 2.2 1.2 29.9 0.0 2.3 0.0 1.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 5.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 9.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.6 0.0 0.9 1.6 0.0 0.0 0.7 2.4 0.0 0.0 0.0 0.0 0.0 0.7 9.3 29.5 25.8 14.1 11.9 6.6 25.0 4.2 6.5 29.9 KIF1A "ATSV, C2orf20, SPG30, UNC104" ENSG00000130294 "Kinesin family member 1A" Q12756 2 240713764-240820308 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 144.1" "Cell line enhanced" "Detected in some" "AN3-CA: 18.8;HAP1: 33.3;K-562: 29.1;SCLC-21H: 89.7;SH-SY5Y: 14.4" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Low region specificity" "Detected in all" HPA005442 Approved "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA005442: AB_1079210" "unprognostic (1.19e-1)" "unprognostic (2.17e-3)" "unprognostic (7.31e-2)" "prognostic unfavourable (4.97e-4)" "unprognostic (1.65e-1)" "unprognostic (4.74e-3)" "unprognostic (2.32e-2)" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (3.09e-2)" "unprognostic (2.06e-2)" "unprognostic (2.60e-1)" "unprognostic (2.54e-1)" "unprognostic (3.83e-2)" "unprognostic (1.96e-1)" "unprognostic (1.74e-3)" "unprognostic (3.90e-2)" 2.1 15.2 47.0 2.9 37.0 2.0 2.0 28.4 144.1 1.9 2.7 35.8 0.0 2.9 2.3 3.1 2.0 2.3 2.1 8.2 40.9 28.4 2.1 2.3 2.1 2.0 35.1 46.8 3.5 31.3 2.0 15.7 2.0 38.7 6.4 2.6 8.6 2.0 2.2 1.9 2.8 2.9 2.3 35.0 2.2 5.0 10.0 30.9 0.0 2.9 0.0 1.9 2.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.5 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 1.0 0.0 0.0 33.3 0.0 0.0 2.6 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 29.1 0.1 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 89.7 14.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 47.0 37.0 28.4 62.2 40.9 28.4 35.1 46.8 38.7 30.9 KIF21A "FEOM1, FLJ20052" ENSG00000139116 "Kinesin family member 21A" Q7Z4S6 12 39293228-39443390 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.5" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 8.4;MAIT T-cell: 4.1;memory CD4 T-cell: 5.2;memory CD8 T-cell: 8.5;naive CD8 T-cell: 5.9;NK-cell: 3.1;T-reg: 2.3" "Group enriched" "Detected in many" 8 "NK-cells: 3.1;T-cells: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022079, HPA058432" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "CAB022079: , HPA058432: " "unprognostic (1.08e-3)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (7.67e-2)" "unprognostic (1.13e-1)" "unprognostic (3.09e-1)" "unprognostic (2.24e-3)" "unprognostic (7.77e-2)" "unprognostic (3.17e-2)" "unprognostic (4.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.73e-2)" "prognostic favourable (8.07e-8)" "unprognostic (4.05e-2)" "unprognostic (1.66e-1)" "unprognostic (2.14e-1)" "unprognostic (2.34e-2)" 3.4 10.1 17.7 3.1 18.5 0.8 5.1 22.1 36.7 8.4 9.2 7.7 2.9 7.1 7.7 4.7 16.0 26.8 5.1 13.4 18.0 28.7 20.9 15.6 4.8 2.2 26.4 18.0 3.2 10.1 17.4 12.3 6.4 41.5 9.3 10.6 5.9 16.4 3.5 8.0 8.5 7.9 7.2 29.2 5.0 9.6 9.5 9.6 0.0 7.1 2.5 4.1 3.6 6.0 0.7 0.0 0.1 0.0 3.1 8.5 1.1 5.8 7.5 10.5 4.5 2.0 1.0 8.4 1.4 0.7 1.9 1.3 13.5 7.3 0.0 4.7 0.6 5.1 6.0 3.6 1.8 11.4 4.8 0.0 13.1 12.3 1.5 9.7 0.0 0.6 8.1 2.4 11.8 2.5 11.0 12.1 1.5 3.5 1.2 0.0 14.1 6.5 0.0 0.0 6.7 7.4 9.7 14.4 62.6 5.7 9.1 3.4 10.5 1.2 1.7 1.1 4.6 0.3 4.1 5.5 1.8 0.0 2.7 1.4 0.9 0.0 0.0 0.0 8.4 0.0 4.1 0.7 5.2 8.5 0.0 0.0 1.3 5.9 0.1 3.1 0.0 0.0 2.3 1.1 17.7 18.5 22.1 31.6 18.0 28.7 26.4 18.0 41.5 9.6 KIF21B "DKFZP434J212, KIAA0449" ENSG00000116852 "Kinesin family member 21B" O75037 1 200969390-201023700 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.3;brain: 20.4" "Cell line enhanced" "Detected in many" "Daudi: 16.4;HMC-1: 17.5;Karpas-707: 20.7;RPMI-8226: 17.6;U-266/70: 37.8;U-266/84: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027249, HPA027274" Approved Approved "Plasma membrane,Mitotic spindle,Cytosol" "Plasma membrane" "Mitotic spindle, Cytosol" "HPA027249: AB_10602241, HPA027274: AB_1852483" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (2.15e-1)" "unprognostic (2.28e-1)" "unprognostic (3.92e-3)" "unprognostic (1.32e-2)" "unprognostic (1.80e-1)" "unprognostic (2.18e-1)" "unprognostic (3.03e-1)" "unprognostic (1.54e-3)" "unprognostic (7.14e-2)" "unprognostic (1.41e-4)" "unprognostic (5.98e-3)" "unprognostic (2.64e-1)" "unprognostic (6.81e-2)" "unprognostic (5.81e-4)" 2.2 1.6 19.8 10.0 12.9 34.3 1.5 3.7 20.4 1.5 2.8 6.0 1.0 2.7 1.4 1.0 1.5 1.4 2.9 1.5 15.1 12.5 1.4 1.7 4.3 15.7 8.3 12.7 1.4 1.5 11.3 0.9 1.6 7.1 1.2 2.6 8.6 2.1 1.7 0.9 1.3 6.1 1.5 4.3 11.5 3.2 11.1 4.9 10.8 1.2 0.0 9.1 3.7 1.1 0.9 0.2 8.0 0.5 2.4 1.7 0.6 0.5 0.6 4.9 0.2 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.1 16.4 0.2 0.0 0.1 0.5 0.1 0.1 0.8 0.1 3.9 0.1 0.1 0.4 12.0 17.5 0.4 1.7 0.1 0.3 0.6 1.8 20.7 0.0 0.0 9.5 4.3 2.1 0.0 3.3 0.0 17.6 0.1 0.0 3.4 0.4 0.2 0.2 0.2 0.0 3.6 1.1 0.0 1.5 0.0 0.1 37.8 17.5 8.2 1.7 5.2 0.1 8.0 0.1 1.0 1.6 0.4 1.7 0.9 1.2 1.7 0.1 0.7 1.0 1.1 2.0 2.4 0.5 0.2 1.0 0.6 19.8 12.9 3.7 20.0 15.1 12.5 8.3 12.7 7.1 4.9 KIF25 KNSL3 ENSG00000125337 "Kinesin family member 25" Q9UIL4 6 167996241-168045089 "Predicted intracellular proteins" "Motor protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 6.2;brain: 9.9" "Cell line enhanced" "Detected in some" "CACO-2: 2.1;HDLM-2: 5.1;HMC-1: 2.7;SiHa: 2.2;U-266/84: 3.1;U-937: 3.0;WM-115: 2.2" "Cancer enhanced" "Detected in some" "testis cancer: 1.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" HPA046153 Uncertain "HPA046153: AB_10960550" "unprognostic (1.11e-1)" "unprognostic (9.32e-3)" "unprognostic (1.39e-1)" "unprognostic (6.65e-2)" "unprognostic (1.60e-1)" "unprognostic (4.46e-3)" "unprognostic (1.66e-3)" "unprognostic (2.27e-2)" "unprognostic (1.19e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-3)" "unprognostic (2.45e-1)" "unprognostic (7.08e-5)" "unprognostic (1.55e-2)" "unprognostic (5.09e-2)" "unprognostic (1.15e-1)" "unprognostic (1.77e-3)" 6.2 0.0 2.0 0.2 3.1 0.1 1.3 9.9 2.7 0.2 0.3 0.2 0.1 0.9 0.0 0.6 1.5 1.9 2.7 2.3 0.0 0.3 0.3 0.9 3.5 2.0 0.0 0.0 0.0 1.9 0.8 1.1 1.0 0.1 3.1 2.0 0.2 0.2 3.1 0.8 0.3 1.6 0.0 0.3 1.6 0.0 0.7 0.3 1.7 0.3 0.1 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.5 0.0 0.0 0.0 2.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 1.7 5.1 0.8 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 0.0 0.2 0.5 0.1 0.5 1.5 0.1 0.0 0.8 0.2 0.5 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.1 3.1 0.1 0.1 3.0 2.2 1.7 0.3 0.9 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.2 1.4 0.1 0.2 0.3 0.1 0.1 KIF3A "FLA10, KLP-20" ENSG00000131437 "Kinesin family member 3A" Q9Y496 5 132692628-132737638 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 27.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037085 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" "Nucleoplasm, Intermediate filaments, Cytosol" "CAB037085: AB_477147" "unprognostic (8.22e-3)" "unprognostic (2.58e-1)" "unprognostic (2.29e-3)" "unprognostic (3.59e-2)" "unprognostic (2.51e-1)" "unprognostic (3.80e-1)" "unprognostic (8.21e-4)" "unprognostic (1.30e-1)" "unprognostic (4.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-2)" "unprognostic (7.64e-2)" "unprognostic (6.08e-3)" "unprognostic (8.62e-2)" "unprognostic (1.92e-1)" "unprognostic (1.17e-1)" "unprognostic (1.23e-1)" 3.4 9.9 19.6 5.0 21.0 2.5 6.6 23.8 54.5 6.2 3.6 8.1 3.2 3.5 6.5 7.1 4.5 8.7 5.3 7.0 28.0 22.9 7.6 2.5 5.7 4.8 18.7 25.5 6.9 4.0 15.8 18.5 4.3 37.7 6.6 3.8 3.8 3.8 6.6 3.5 5.1 3.0 5.7 15.0 3.8 4.9 23.9 11.1 3.5 6.9 0.1 4.7 5.3 3.5 3.4 0.7 27.1 1.1 2.4 4.3 1.1 7.1 8.8 7.9 14.2 5.3 5.3 6.3 6.0 4.7 5.7 8.0 8.6 5.8 19.5 8.3 6.9 4.6 6.1 11.8 11.8 5.8 7.2 2.8 4.4 3.2 5.2 3.6 7.7 4.0 6.1 8.2 9.1 7.0 2.9 11.3 6.9 5.1 22.9 2.7 3.9 3.3 6.4 6.3 2.3 5.6 6.1 24.5 7.7 8.9 2.9 9.0 9.0 1.1 7.4 7.1 12.4 5.2 7.2 8.2 11.9 11.2 8.7 2.9 7.8 27.1 0.4 1.1 3.9 0.8 4.1 3.4 4.0 3.6 0.7 2.1 3.9 4.3 0.3 2.4 1.1 0.7 3.0 1.1 19.6 21.0 23.8 32.3 28.0 22.9 18.7 25.5 37.7 11.1 KIF3C ENSG00000084731 "Kinesin family member 3C" O14782 2 25926596-25982749 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 72.9" "Cell line enhanced" "Detected in many" "SH-SY5Y: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035755 Approved "Nuclear membrane,Nuclear bodies,Intermediate filaments" "Nuclear bodies, Intermediate filaments" "Nuclear membrane" "HPA035755: AB_10602242" "unprognostic (3.95e-1)" "unprognostic (1.40e-2)" "unprognostic (7.85e-2)" "prognostic unfavourable (1.32e-5)" "unprognostic (2.75e-1)" "unprognostic (4.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.53e-2)" "prognostic favourable (1.22e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-2)" "unprognostic (1.55e-1)" "prognostic unfavourable (7.57e-4)" "unprognostic (3.90e-2)" "unprognostic (3.54e-1)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" 3.0 7.3 22.8 2.9 21.2 2.2 2.6 22.7 72.9 3.6 2.4 3.8 0.0 2.1 3.9 2.6 3.0 3.3 4.1 3.0 21.6 18.9 2.0 1.6 2.6 2.0 17.5 20.3 7.3 2.3 4.5 4.8 2.8 22.8 3.3 2.6 1.9 1.9 4.6 2.4 2.3 2.7 4.8 6.2 2.2 2.0 3.0 5.2 0.5 2.5 0.0 2.0 3.5 1.5 0.1 0.3 2.4 0.2 0.7 2.0 1.3 13.0 19.8 10.6 8.1 6.2 7.2 8.5 6.8 3.4 4.1 4.7 3.5 2.0 0.0 5.7 6.2 1.4 8.0 4.1 2.8 2.2 3.8 4.7 1.5 7.1 3.7 1.2 4.1 5.2 1.2 12.9 2.6 13.6 1.7 1.7 4.3 0.9 3.3 1.6 10.8 5.8 5.3 5.2 0.8 9.4 3.2 12.9 29.1 2.7 1.2 14.3 0.4 1.6 10.7 7.2 7.4 3.2 6.6 0.4 2.3 1.5 16.3 6.4 6.1 0.0 0.2 0.0 0.4 0.0 1.1 0.0 1.6 1.5 0.3 0.1 0.5 0.6 2.4 0.7 0.0 0.2 2.0 1.3 22.8 21.2 22.7 40.0 21.6 18.9 17.5 20.3 22.8 5.2 KIF5A "D12S1889, MY050, NKHC, SPG10" ENSG00000155980 "Kinesin family member 5A" Q12840 12 57549998-57586632 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 138.6" "Cell line enhanced" "Detected in some" "HDLM-2: 20.0;K-562: 8.4;NTERA-2: 10.3;SCLC-21H: 21.3;U-87 MG: 7.9" "Cancer enriched" "Detected in some" 5 "glioma: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004469, HPA073448" Enhanced Approved "Nucleoplasm,Mitotic spindle,Cytosol" "Nucleoplasm, Cytosol" "Mitotic spindle" "HPA004469: AB_1079212, HPA073448: " "unprognostic (7.94e-2)" "unprognostic (4.95e-3)" "unprognostic (3.87e-1)" "unprognostic (3.34e-3)" "unprognostic (7.12e-2)" "unprognostic (4.22e-2)" "unprognostic (3.22e-5)" "unprognostic (2.82e-1)" "unprognostic (2.01e-1)" "unprognostic (1.52e-2)" "prognostic favourable (5.23e-4)" "unprognostic (7.61e-2)" "unprognostic (2.26e-4)" "unprognostic (4.75e-2)" "unprognostic (1.46e-1)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" 1.8 7.6 85.4 3.0 47.6 1.9 1.9 15.2 138.6 2.1 2.8 4.0 0.0 2.4 3.4 2.1 1.9 2.0 1.9 1.7 52.4 18.3 2.0 1.7 1.8 1.8 12.9 43.6 1.8 2.3 6.0 2.5 1.7 21.6 1.9 2.8 0.6 2.0 2.0 1.7 1.7 3.0 2.8 9.0 1.8 2.1 4.4 12.9 0.0 2.8 0.0 1.8 1.8 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.7 3.2 0.0 0.0 0.1 0.2 0.7 1.3 1.7 0.0 0.0 1.6 0.0 0.6 0.1 2.0 0.0 1.0 20.0 1.4 0.1 0.1 1.6 0.6 0.0 0.1 0.2 0.1 1.0 0.0 0.2 8.4 4.4 0.0 0.0 0.3 0.0 10.3 0.0 0.0 0.0 0.0 0.2 0.0 21.3 4.8 0.0 0.2 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.9 2.8 3.4 0.3 7.9 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.4 0.8 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.3 0.0 85.4 47.6 15.2 112.0 52.4 18.3 12.9 43.6 21.6 12.9 KIF5C ENSG00000168280 "Kinesin family member 5C" O60282 2 148875250-149026759 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Transport "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 95.8" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 65.3" "Cancer enhanced" "Detected in many" "prostate cancer: 19.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 5.9" "Lineage enriched" "Detected in single" 7 "T-cells: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035210, HPA062272" Enhanced Approved Vesicles Vesicles "HPA035210: AB_10671931, HPA062272: " "unprognostic (1.95e-1)" "unprognostic (2.39e-1)" "unprognostic (2.54e-1)" "unprognostic (4.70e-4)" "unprognostic (1.89e-1)" "unprognostic (3.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.90e-2)" "unprognostic (2.86e-1)" "unprognostic (1.41e-2)" "unprognostic (6.61e-3)" "unprognostic (1.56e-1)" "unprognostic (6.55e-6)" "unprognostic (8.34e-3)" "unprognostic (3.69e-1)" "unprognostic (3.63e-2)" "unprognostic (4.46e-2)" 1.8 10.5 32.0 2.3 31.8 1.3 1.6 33.8 95.8 2.2 2.5 21.7 0.0 1.6 1.8 11.0 1.4 1.6 1.7 1.6 25.4 13.7 1.6 1.2 1.5 1.8 15.8 25.5 3.3 2.5 1.5 12.6 1.3 27.1 21.9 3.2 0.4 1.4 7.5 1.3 1.4 2.3 2.0 20.1 1.6 2.4 13.5 18.3 0.0 3.6 0.0 1.7 2.4 1.0 0.8 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 12.6 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.6 0.0 0.1 0.0 7.3 0.0 1.4 3.7 1.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 12.7 3.9 0.0 0.1 0.0 0.0 2.7 65.3 15.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 1.1 0.0 1.8 1.2 0.2 0.0 4.6 0.2 0.4 0.0 0.0 0.0 0.3 0.0 5.9 0.5 1.1 1.4 0.0 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.7 0.0 32.0 31.8 33.8 40.3 25.4 13.7 15.8 25.5 27.1 18.3 KIF6 "C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317" ENSG00000164627 "Kinesin family member 6" Q6ZMV9 6 39329990-39725405 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 18.8;fallopian tube: 9.9;pituitary gland: 5.6;testis: 12.6" "Cell line enhanced" "Detected in some" "RPMI-8226: 10.4;SCLC-21H: 14.6;SK-MEL-30: 5.9;U-2197: 3.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038811, HPA058624" Enhanced Approved Centrosome Centrosome "HPA038811: AB_10795140, HPA058624: " "unprognostic (4.94e-2)" "unprognostic (3.38e-2)" "unprognostic (3.68e-1)" "unprognostic (1.02e-2)" "unprognostic (1.55e-1)" "unprognostic (8.25e-4)" "unprognostic (3.12e-3)" "unprognostic (1.00e-1)" "unprognostic (3.06e-1)" "unprognostic (3.48e-2)" "unprognostic (9.12e-4)" "unprognostic (1.08e-1)" "unprognostic (3.07e-2)" "unprognostic (3.10e-2)" "unprognostic (5.09e-2)" "unprognostic (3.92e-2)" "unprognostic (1.99e-1)" 1.3 1.4 5.1 0.7 9.1 0.9 1.9 2.2 11.4 1.4 1.0 18.8 0.1 1.7 1.0 2.6 1.3 9.9 1.6 1.3 7.3 7.1 1.4 1.3 2.4 1.2 11.8 3.2 1.8 1.6 1.2 5.6 1.2 8.6 1.1 0.9 1.7 1.0 0.9 1.6 1.2 1.1 0.8 10.6 0.9 0.9 12.6 7.8 0.0 2.0 0.0 0.9 0.7 0.4 1.2 2.7 2.5 0.6 1.3 0.7 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.1 1.2 0.3 0.7 0.1 0.1 0.1 0.1 1.2 0.2 0.1 0.1 0.3 0.0 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.6 10.4 0.3 0.1 14.6 0.2 0.0 0.1 5.9 0.1 0.1 0.2 0.1 0.2 3.4 0.8 0.2 0.0 0.0 0.8 0.1 1.8 1.9 0.6 0.4 0.5 0.3 0.5 0.7 0.5 0.4 0.2 1.2 0.6 0.7 2.5 1.3 0.4 2.7 0.3 0.1 5.1 9.1 2.2 5.4 7.3 7.1 11.8 3.2 8.6 7.8 KIFC2 ENSG00000167702 "Kinesin family member C2" Q96AC6 8 144466043-144474202 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 36.2;skin 1: 48.2" "Cell line enhanced" "Detected in many" "T-47d: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029264 Approved Supported Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA029264: AB_10609999" "unprognostic (2.03e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-3)" "unprognostic (4.12e-3)" "unprognostic (4.28e-2)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-2)" "unprognostic (2.12e-1)" "unprognostic (9.95e-2)" "unprognostic (2.39e-2)" "unprognostic (4.48e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (2.05e-1)" "unprognostic (8.13e-2)" "unprognostic (2.71e-2)" 4.2 5.1 18.7 4.2 28.4 4.5 3.4 36.2 35.0 3.1 6.3 2.3 6.6 8.8 2.7 5.2 7.0 2.9 4.4 2.2 13.5 7.2 4.7 2.8 3.8 4.8 4.4 16.8 2.1 7.9 9.8 7.9 2.5 8.3 7.2 4.8 2.2 7.5 6.5 2.3 48.2 7.9 2.1 2.6 8.1 8.7 5.2 6.6 1.6 4.1 1.3 3.5 5.0 4.9 0.8 0.1 0.1 0.1 0.0 0.8 0.1 7.9 6.8 3.3 7.2 4.8 2.9 7.8 4.8 3.4 2.6 2.6 2.7 9.9 8.3 2.7 2.7 16.3 3.3 4.3 1.1 8.4 2.9 5.0 16.7 3.5 6.2 1.3 14.8 3.7 15.5 2.6 3.4 1.7 5.4 8.7 1.9 13.6 6.0 4.2 0.5 10.1 15.1 0.2 4.9 10.8 12.5 10.4 9.5 3.4 10.6 3.8 27.9 2.7 4.6 5.1 15.4 5.4 4.8 4.3 2.0 2.3 9.9 7.0 2.8 0.0 0.1 0.0 0.5 0.0 0.8 0.0 0.3 0.6 0.1 0.8 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.1 18.7 28.4 36.2 35.0 13.5 7.2 4.4 16.8 8.3 6.6 KIR3DX1 "FLJ00060, LENG12" ENSG00000104970 "Killer cell immunoglobulin like receptor, three Ig domains X1" 19 54532692-54545771 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.9;heart muscle: 3.6;lymphoid tissue: 4.6" "Cell line enriched" "Detected in some" 6 "U-266/84: 9.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA052110 Uncertain "Secreted - unknown location" "HPA052110: " "unprognostic (5.85e-3)" "unprognostic (4.13e-3)" "unprognostic (8.47e-2)" "unprognostic (8.90e-2)" "unprognostic (1.42e-1)" "unprognostic (4.46e-4)" "unprognostic (1.09e-1)" "unprognostic (7.51e-2)" "unprognostic (4.99e-4)" "unprognostic (1.22e-4)" "unprognostic (1.36e-1)" "unprognostic (6.40e-2)" "unprognostic (8.73e-9)" "unprognostic (1.09e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (6.20e-3)" 1.9 0.0 0.0 1.3 0.6 2.2 0.3 0.0 1.2 0.6 0.2 3.9 0.0 0.0 1.0 0.0 0.5 0.1 0.4 3.6 0.1 0.1 0.2 2.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.2 0.0 0.0 0.0 0.9 0.1 0.1 0.5 0.6 4.6 0.0 0.5 0.1 0.0 0.2 0.0 2.7 0.0 0.0 0.4 0.3 1.7 0.2 1.2 1.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 9.7 0.0 0.0 0.8 0.0 1.7 0.2 0.0 1.1 0.2 0.2 0.2 0.2 0.2 0.0 0.4 0.1 0.2 0.6 1.2 0.0 0.3 0.3 0.0 KIRREL3 "KIAA1867, KIRRE, NEPH2" ENSG00000149571 "Kirre like nephrin family adhesion molecule 3" Q8IZU9 11 126423359-127003460 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 10.9;brain: 28.2" "Cell line enhanced" "Detected in some" "BJ: 18.7;BJ hTERT+: 11.0;BJ hTERT+ SV40 Large T+: 7.0;BJ hTERT+ SV40 Large T+ RasG12V: 7.4;fHDF/TERT166: 13.4;U-138 MG: 8.6;U-251 MG: 10.2" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 10.9" "Lineage enriched" "Detected in single" 12 "dendritic cells: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053324 Enhanced "Intracellular and membrane" "HPA053324: " "unprognostic (1.92e-1)" "unprognostic (5.29e-2)" "unprognostic (1.06e-1)" "unprognostic (4.72e-2)" "unprognostic (2.50e-2)" "unprognostic (1.09e-1)" "unprognostic (4.49e-3)" "unprognostic (6.23e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (7.05e-3)" "unprognostic (3.81e-2)" "unprognostic (4.06e-6)" "unprognostic (9.91e-3)" "unprognostic (1.15e-1)" "unprognostic (2.76e-2)" "unprognostic (2.92e-1)" 1.2 4.0 12.3 1.9 20.0 1.4 1.0 13.2 28.2 1.5 2.2 23.6 0.0 1.7 1.1 1.0 1.7 1.1 1.4 2.3 9.1 7.2 1.1 1.0 1.0 2.1 7.2 11.7 1.3 1.4 0.9 0.1 1.6 9.9 1.0 1.8 0.6 3.5 3.4 1.0 1.1 1.7 1.9 8.9 2.6 1.5 1.2 12.1 0.0 1.0 0.0 1.9 1.1 0.2 0.0 10.9 0.9 0.0 0.0 0.0 0.0 0.3 2.2 0.1 0.0 0.0 0.1 0.1 18.7 11.0 7.0 7.4 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 4.4 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.8 0.0 0.0 4.4 0.1 0.3 0.0 0.0 0.9 0.0 0.1 2.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 8.6 6.0 3.4 10.2 0.0 0.0 0.0 0.0 0.0 4.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 12.3 20.0 13.2 17.4 9.1 7.2 7.2 11.7 9.9 12.1 KISS1R "AXOR12, GPR54, HOT7T175" ENSG00000116014 "KISS1 receptor" Q969F8 19 917287-921015 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;lymphoid tissue: 12.4" "Cell line enhanced" "Detected in some" "K-562: 10.5;RPMI-8226: 25.7;SCLC-21H: 5.4;SH-SY5Y: 14.4" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;neutrophil: 1.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007156, HPA071913" Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA007156: , HPA071913: " "unprognostic (1.54e-1)" "unprognostic (3.01e-2)" "unprognostic (9.42e-2)" "unprognostic (2.15e-1)" "unprognostic (8.46e-3)" "unprognostic (9.23e-2)" "unprognostic (1.65e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (7.17e-2)" "prognostic unfavourable (3.33e-6)" "unprognostic (1.87e-1)" "unprognostic (8.09e-3)" "unprognostic (1.05e-1)" "unprognostic (2.05e-2)" 0.2 0.2 2.1 2.1 4.1 0.2 0.3 0.1 4.7 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.1 0.2 0.1 0.1 1.0 6.8 1.4 0.1 0.3 12.4 1.1 0.1 0.4 3.6 0.1 2.0 1.0 0.8 0.2 0.2 0.3 0.3 0.1 0.1 0.1 0.7 0.5 1.0 2.4 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.5 0.1 0.6 0.0 1.8 0.0 0.0 2.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 2.8 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.2 0.1 0.0 0.4 0.3 0.7 0.0 25.7 0.0 0.0 5.4 14.4 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.7 0.0 0.0 0.1 2.0 0.6 1.8 0.0 0.0 0.0 0.1 0.0 2.1 4.1 0.1 1.5 1.0 6.8 1.1 0.1 0.8 0.1 KLC1 "hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A" ENSG00000126214 "Kinesin light chain 1" Q07866 14 103561896-103714249 "Predicted intracellular proteins" "Host-virus interaction" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 117.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB009798, HPA044617, HPA052450" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009798: AB_2280879, HPA044617: , HPA052450: " "unprognostic (6.93e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (7.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-3)" "unprognostic (2.67e-2)" "unprognostic (9.21e-2)" "unprognostic (5.62e-2)" "prognostic favourable (6.75e-4)" "unprognostic (6.84e-3)" "prognostic unfavourable (7.17e-4)" "unprognostic (6.58e-2)" "unprognostic (8.69e-2)" "unprognostic (4.05e-1)" "unprognostic (1.49e-1)" 19.5 20.4 61.3 15.7 45.6 17.6 16.6 103.0 117.9 15.2 14.8 22.4 11.5 10.5 21.1 18.7 19.7 16.0 15.7 27.1 61.0 65.1 8.6 8.9 20.0 15.9 66.2 47.9 19.8 14.8 25.2 17.0 17.9 50.7 16.3 14.1 14.1 16.9 19.7 28.2 22.4 12.8 23.1 56.0 18.3 13.8 14.3 23.2 7.9 13.8 13.0 18.1 15.7 14.9 7.3 10.4 12.4 8.6 4.1 10.9 3.1 16.3 22.0 42.5 23.1 28.7 31.4 19.5 38.5 31.6 36.2 24.8 18.8 17.9 21.7 20.1 41.5 27.3 25.9 20.3 34.4 26.1 13.0 12.1 26.0 19.0 32.7 23.7 24.1 22.8 33.1 27.3 33.3 31.1 18.0 24.9 31.5 27.5 15.9 20.9 13.6 40.6 15.3 17.8 10.7 22.5 36.3 50.1 28.0 31.3 15.9 25.4 14.0 11.7 45.2 26.9 13.3 36.8 21.3 20.0 13.9 24.1 30.8 13.7 28.8 7.6 5.8 12.4 10.3 6.0 9.5 6.4 9.3 10.9 6.8 7.3 7.9 7.2 7.0 4.1 8.6 10.4 8.4 3.1 61.3 45.6 103.0 90.3 61.0 65.1 66.2 47.9 50.7 23.2 KLC2 FLJ12387 ENSG00000174996 "Kinesin light chain 2" Q9H0B6 11 66257294-66267860 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040416, HPA040434" Approved Supported "Nucleoplasm,Plasma membrane,Mitochondria,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Mitochondria" "HPA040416: AB_10795524, HPA040434: AB_10795367" "unprognostic (1.29e-1)" "unprognostic (4.95e-3)" "unprognostic (2.99e-1)" "unprognostic (3.24e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (3.16e-4)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (6.27e-3)" "unprognostic (1.60e-1)" "unprognostic (3.49e-2)" "unprognostic (1.64e-3)" "unprognostic (4.57e-3)" "unprognostic (1.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.72e-2)" "unprognostic (8.08e-2)" 7.5 12.5 15.9 7.9 20.7 2.9 6.6 51.7 49.4 7.4 7.8 7.5 6.5 8.5 11.3 6.0 8.8 9.0 8.0 15.3 20.0 17.4 6.7 2.4 6.6 7.5 13.8 26.0 11.3 11.2 15.4 15.4 6.4 29.0 13.6 4.4 8.2 8.4 15.5 23.8 9.3 7.7 10.1 8.6 6.6 9.8 17.4 10.0 13.5 6.3 4.5 5.6 8.8 8.5 4.7 4.1 0.8 0.4 2.3 6.2 1.5 20.2 24.8 12.1 7.2 7.3 5.9 9.4 14.3 10.3 14.7 11.4 13.5 6.1 9.1 13.8 10.6 17.1 12.4 13.9 4.9 14.6 15.6 1.8 19.6 9.1 14.2 4.0 9.7 5.9 18.4 17.2 14.1 6.8 9.8 12.4 11.7 28.5 22.9 6.1 11.9 20.6 8.8 6.3 12.4 11.5 11.4 33.0 16.0 10.4 9.4 17.1 15.5 2.8 11.2 24.2 21.7 29.2 18.8 12.9 10.8 4.9 17.1 2.8 9.7 0.0 0.4 0.8 4.6 0.1 6.2 3.6 2.2 3.1 0.6 4.7 2.2 2.7 0.7 2.3 0.3 4.1 0.6 1.5 15.9 20.7 51.7 49.4 20.0 17.4 13.8 26.0 29.0 10.0 KLHL1 "FLJ30047, KIAA1490, MRP2" ENSG00000150361 "Kelch like family member 1" Q9NR64 13 69700594-70108493 "Predicted intracellular proteins" Actin-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "brain: 17.6" "Cell line enriched" "Detected in single" 14 "HeLa: 7.2" "Cancer enriched" "Detected in single" 7 "breast cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021196 Uncertain "HPA021196: AB_1852567" "unprognostic (5.81e-2)" "unprognostic (7.40e-3)" "unprognostic (2.43e-1)" "unprognostic (1.41e-1)" 0.3 1.4 2.0 0.5 5.0 0.3 0.3 3.5 6.9 0.3 0.5 0.0 0.0 0.4 0.3 0.3 0.4 0.3 0.3 0.3 1.8 7.6 0.8 0.3 0.3 0.3 17.6 2.3 0.3 0.7 0.5 1.9 0.3 16.2 2.1 0.4 1.0 0.3 0.4 0.3 0.3 0.6 0.4 5.3 0.3 0.7 1.5 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.0 3.5 4.2 1.8 7.6 17.6 2.3 16.2 0.0 KLHL2 MAV ENSG00000109466 "Kelch like family member 2" O95198 4 165207618-165323156 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 10.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051637 Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA051637: " "unprognostic (1.14e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (8.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.56e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (4.42e-2)" "unprognostic (2.06e-1)" "unprognostic (4.67e-1)" "unprognostic (4.88e-2)" "prognostic favourable (3.77e-4)" "unprognostic (4.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-2)" "unprognostic (1.81e-1)" 10.5 11.2 25.1 10.4 36.0 16.4 12.1 9.7 41.6 6.1 5.8 19.6 4.0 5.0 7.0 13.4 15.8 8.9 9.5 5.0 37.2 17.7 13.3 23.8 10.6 9.4 25.7 14.7 3.8 6.6 5.3 18.4 6.9 15.1 7.8 6.5 4.0 16.3 9.7 3.2 4.7 5.6 9.6 25.7 11.1 7.4 5.4 25.0 1.6 11.3 3.4 8.4 10.9 7.2 1.3 1.2 10.8 1.9 0.3 1.6 0.6 8.6 7.9 5.5 5.7 8.5 7.7 5.9 11.7 9.2 6.1 6.6 4.8 6.5 9.0 2.9 5.9 6.0 8.9 6.2 7.9 14.6 3.4 7.5 7.1 7.4 7.5 7.7 10.9 6.4 17.7 5.5 20.8 14.6 3.3 18.9 9.4 3.3 0.2 2.4 3.4 3.6 3.0 4.1 2.7 11.1 8.3 28.4 4.7 7.4 2.7 7.1 1.8 8.7 20.1 4.8 10.0 5.5 7.9 12.3 8.5 7.1 5.9 5.5 9.4 1.9 1.4 1.9 0.8 1.4 0.5 0.4 0.6 0.5 1.2 1.3 1.4 1.6 10.8 0.3 1.9 0.7 0.7 0.6 25.1 36.0 9.7 24.7 37.2 17.7 25.7 14.7 15.1 25.0 KLHL3 KIAA1129 ENSG00000146021 "Kelch like family member 3" Q9UH77 5 137617500-137736090 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 64.2" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 6.3;RT4: 6.6;TIME: 14.6;U-266/70: 8.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 64.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051291 Approved "HPA051291: " "unprognostic (4.31e-2)" "unprognostic (5.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (6.17e-2)" "unprognostic (1.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.41e-1)" "unprognostic (6.39e-3)" "unprognostic (3.28e-1)" "unprognostic (9.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.71e-1)" "unprognostic (5.20e-3)" "unprognostic (1.50e-4)" 4.1 5.8 9.1 3.2 11.9 1.2 2.7 64.2 12.0 5.3 2.1 0.8 1.7 2.6 5.0 2.7 2.2 5.1 5.8 14.7 6.2 4.2 10.2 1.8 2.8 5.2 4.7 9.3 9.0 2.2 1.3 5.9 3.3 5.0 2.3 2.4 10.4 1.6 2.2 2.2 3.1 1.9 3.6 4.2 3.5 5.1 5.5 1.7 3.7 12.1 1.3 4.0 3.0 3.4 0.1 1.2 1.6 0.0 2.2 3.2 0.6 0.4 0.3 1.5 0.0 0.9 1.2 1.0 0.3 0.4 0.2 0.2 0.5 5.8 1.4 3.1 0.0 0.2 0.3 2.6 0.2 1.4 0.7 0.6 1.0 0.0 0.3 0.0 1.1 1.1 0.2 0.7 0.0 6.3 0.3 1.2 0.2 0.0 3.1 0.9 2.7 0.9 2.5 0.0 0.0 1.0 6.6 1.8 1.0 0.4 0.0 0.5 0.0 0.5 14.6 0.4 0.4 0.0 0.4 8.8 4.9 0.0 5.6 0.1 0.7 0.0 0.0 1.6 0.7 0.0 0.8 0.0 3.0 1.1 0.1 0.1 3.2 1.8 0.0 2.2 0.0 1.2 1.3 0.6 9.1 11.9 64.2 12.0 6.2 4.2 4.7 9.3 5.0 1.7 KLHL32 "BKLHD5, KIAA1900" ENSG00000186231 "Kelch like family member 32" Q96NJ5 6 96924620-97140754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 47.1;fallopian tube: 12.8" "Cell line enhanced" "Detected in some" "Daudi: 6.0;HDLM-2: 8.1;RPMI-8226: 3.7;SCLC-21H: 3.5;U-266/70: 4.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.2;T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039150 Enhanced "HPA039150: " "unprognostic (1.75e-1)" "unprognostic (7.99e-2)" "unprognostic (6.66e-3)" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (5.22e-2)" "unprognostic (5.00e-1)" "unprognostic (3.12e-3)" "unprognostic (5.88e-3)" "unprognostic (1.01e-1)" "unprognostic (1.51e-5)" "unprognostic (5.82e-2)" "unprognostic (6.04e-2)" "unprognostic (7.01e-2)" "unprognostic (1.86e-2)" "unprognostic (7.48e-2)" "unprognostic (4.49e-4)" 1.0 2.6 14.2 1.5 47.1 1.1 1.5 8.8 36.9 1.5 2.0 19.4 0.0 2.3 1.3 1.8 1.0 12.8 1.5 2.1 16.2 11.1 4.3 2.0 2.2 1.6 31.0 14.7 2.7 3.2 2.6 3.0 1.0 22.0 1.2 2.5 0.1 1.8 1.3 2.9 1.1 2.9 1.2 30.6 1.4 1.7 3.7 32.2 0.0 2.3 0.0 1.6 1.1 0.5 2.2 0.1 0.1 0.0 0.7 5.5 1.5 0.0 0.0 0.7 0.0 0.5 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.5 6.0 0.2 0.0 0.2 0.6 0.2 0.0 8.1 1.3 0.4 0.1 0.2 0.2 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.9 3.0 0.0 0.0 1.5 0.4 0.4 0.3 0.2 0.0 3.7 0.0 0.0 3.5 1.2 0.0 0.0 0.8 0.2 0.2 0.4 0.0 0.1 0.0 0.0 4.3 0.7 2.4 0.2 0.3 0.4 0.0 0.0 0.0 0.9 0.0 2.1 2.2 3.6 1.3 0.1 1.5 4.2 5.5 0.1 0.7 0.0 0.0 2.5 1.5 14.2 47.1 8.8 36.9 16.2 11.1 31.0 14.7 22.0 32.2 KLHL35 FLJ33790 ENSG00000149243 "Kelch like family member 35" Q6PF15 11 75422394-75430629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;testis: 11.2" "Cell line enhanced" "Detected in some" "CACO-2: 13.9;HMC-1: 9.3;PC-3: 8.0;SiHa: 16.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.4" "Group enriched" "Detected in many" 4 "granulocytes: 5.4;T-cells: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039864, HPA070736" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Centrosome" "Nucleoplasm, Centrosome" "Nucleoli fibrillar center" "HPA039864: AB_10794204, HPA070736: " "unprognostic (3.53e-2)" "prognostic favourable (4.63e-4)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "unprognostic (6.88e-2)" "unprognostic (4.15e-3)" "unprognostic (4.98e-2)" "unprognostic (3.92e-2)" "unprognostic (6.52e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (4.39e-2)" "unprognostic (8.68e-3)" "unprognostic (1.59e-1)" "unprognostic (1.05e-1)" "unprognostic (3.11e-2)" "unprognostic (1.28e-1)" 1.1 3.4 4.5 0.7 14.1 0.7 3.5 1.8 8.2 3.2 1.0 3.0 0.2 0.7 0.5 1.0 1.0 2.0 1.1 1.1 3.7 6.2 0.6 0.6 2.7 0.7 3.1 3.3 0.5 4.5 0.5 0.8 0.8 6.2 0.7 0.6 0.7 1.3 1.0 0.9 1.2 0.5 1.1 4.3 1.0 2.3 11.2 2.4 0.0 1.4 0.0 0.7 0.7 0.2 0.2 0.8 5.4 0.3 0.0 2.1 1.2 0.0 0.3 0.1 0.0 0.2 1.2 0.0 0.8 0.0 0.8 0.1 13.9 1.2 0.0 3.9 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.7 3.5 9.3 0.2 0.2 0.0 0.0 0.3 0.0 0.0 1.0 0.6 0.3 0.1 0.1 8.0 0.0 0.0 0.8 0.6 0.1 1.0 0.9 16.4 3.1 0.0 3.1 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 2.1 0.0 0.5 0.0 1.2 0.7 0.8 0.2 0.3 0.5 0.1 0.0 0.3 0.0 0.0 1.2 4.5 14.1 1.8 7.1 3.7 6.2 3.1 3.3 6.2 2.4 KLHL4 "DKELCHL, KHL4, KIAA1687" ENSG00000102271 "Kelch like family member 4" Q9C0H6 X 87517749-87670050 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 34.4;brain: 16.3" "Cell line enhanced" "Detected in some" "AF22: 9.7;HHSteC: 8.2;HUVEC TERT2: 20.6;NTERA-2: 15.6;RH-30: 8.4;TIME: 22.6" "Cancer enriched" "Detected in some" 8 "glioma: 9.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.1;T-reg: 2.0" "Lineage enriched" "Detected in single" 10 "T-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029192 Approved Supported "Microtubules,Centriolar satellite" Microtubules "Centriolar satellite" "HPA029192: AB_10602341" "unprognostic (6.70e-2)" "unprognostic (2.20e-1)" "unprognostic (8.74e-2)" "unprognostic (2.84e-3)" "unprognostic (1.48e-2)" "unprognostic (5.90e-2)" "unprognostic (1.71e-2)" "unprognostic (1.89e-2)" "unprognostic (5.21e-2)" "unprognostic (2.63e-1)" "unprognostic (5.98e-2)" "unprognostic (1.30e-1)" "prognostic unfavourable (8.08e-5)" "unprognostic (2.40e-4)" "unprognostic (1.05e-1)" "unprognostic (5.87e-2)" "unprognostic (7.25e-4)" 2.3 34.4 6.8 1.0 12.1 0.5 1.9 1.1 11.2 2.4 1.0 16.3 0.9 0.7 4.8 1.4 1.3 3.7 2.5 1.5 7.0 4.0 2.1 1.4 1.8 1.0 15.9 7.4 11.7 0.9 0.6 0.6 0.6 11.9 1.1 1.1 0.0 0.5 2.8 0.8 0.6 0.9 8.0 12.7 2.4 0.9 9.7 16.2 0.0 1.4 0.2 0.7 1.9 0.7 0.0 0.0 0.2 0.0 0.0 2.0 0.2 0.0 2.9 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.2 0.0 2.0 0.0 8.2 0.1 0.0 1.3 3.9 4.2 1.0 20.6 0.1 1.7 5.6 0.0 0.0 0.0 15.6 4.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 22.6 0.0 4.8 0.0 0.3 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.2 6.8 12.1 1.1 11.2 7.0 4.0 15.9 7.4 11.9 16.2 KLK6 "Bssp, Klk7, neurosin, PRSS18, PRSS9" ENSG00000167755 "Kallikrein related peptidase 6" Q92876 19 50958631-50969673 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6;esophagus: 48.9" "Group enriched" "Detected in some" 14 "A-431: 68.4;CAPAN-2: 163.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 131.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 175.6" "Group enriched" "Detected in many" 8 "midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4" HPA051837 Supported "Nucleoplasm,Nuclear membrane,Cytokinetic bridge" "Secreted in other tissues" 6800000 Nucleoplasm "Nuclear membrane, Cytokinetic bridge" "HPA051837: " "unprognostic (7.30e-2)" "unprognostic (3.32e-1)" "unprognostic (6.58e-2)" "prognostic unfavourable (1.38e-5)" "unprognostic (1.10e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (8.85e-4)" "unprognostic (3.02e-1)" "unprognostic (2.46e-1)" "prognostic unfavourable (7.82e-4)" "unprognostic (4.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (9.07e-2)" "prognostic unfavourable (1.27e-4)" 0.9 0.9 9.7 0.9 23.5 0.9 6.5 3.3 42.2 10.0 1.0 82.0 0.0 1.1 2.0 1.2 48.9 24.6 3.8 0.9 20.1 11.8 9.0 0.9 0.9 0.9 46.1 14.9 0.9 0.9 0.9 0.2 0.9 44.3 1.0 0.9 0.0 5.9 2.8 0.9 2.9 0.9 1.0 97.6 5.1 1.0 1.5 32.6 0.0 0.9 15.7 28.1 0.9 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.1 163.7 0.0 1.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.1 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 23.5 3.3 23.1 20.1 11.8 46.1 14.9 44.3 32.6 KLRC2 "CD159c, NKG2-C" ENSG00000205809 "Killer cell lectin like receptor C2" P26717 12 10426854-10442300 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.8;brain: 16.2" "Cell line enhanced" "Detected in some" "HEL: 6.1;HeLa: 19.0;HSkMC: 4.6;U-87 MG: 3.1" "Cancer enriched" "Detected in single" 8 "glioma: 3.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 10.7;NK-cell: 32.8" "Group enriched" "Detected in many" 92 "NK-cells: 32.8;T-cells: 10.7" HPA058052 Approved "Plasma membrane" "Plasma membrane" "HPA058052: " "unprognostic (9.05e-4)" "unprognostic (2.54e-2)" "unprognostic (3.77e-2)" "unprognostic (2.51e-3)" "unprognostic (2.83e-1)" "unprognostic (9.49e-4)" "unprognostic (1.27e-1)" "unprognostic (8.74e-2)" "unprognostic (2.88e-1)" "unprognostic (4.00e-3)" "unprognostic (2.88e-2)" "unprognostic (9.16e-3)" "unprognostic (1.55e-9)" "unprognostic (8.10e-2)" "unprognostic (2.34e-1)" "unprognostic (8.93e-2)" "unprognostic (5.31e-3)" 0.5 0.2 8.2 0.6 4.6 2.8 1.1 1.2 16.2 0.4 1.9 2.3 0.1 1.0 1.4 1.0 0.8 0.6 1.7 0.2 6.1 5.4 0.1 1.1 1.4 1.5 6.2 2.6 1.5 0.1 0.0 0.1 0.6 3.7 0.3 1.3 0.1 0.5 0.3 0.1 0.2 1.8 0.1 4.1 8.1 3.2 0.5 1.7 2.2 0.2 0.1 2.0 1.2 0.1 0.0 0.0 0.2 0.0 32.8 10.7 1.7 0.0 1.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 6.1 19.0 0.3 0.0 0.6 0.0 4.6 0.1 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.2 0.2 0.4 0.0 0.0 0.0 0.0 0.6 3.1 0.1 0.1 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 4.7 0.0 0.0 0.0 3.7 0.2 32.8 0.0 0.0 0.0 1.7 8.2 4.6 1.2 3.6 6.1 5.4 6.2 2.6 3.7 1.7 KLRC3 NKG2-E ENSG00000205810 "Killer cell lectin like receptor C3" Q07444 12 10412312-10420595 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 28.5;brain: 9.7;lymphoid tissue: 6.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.5;HEL: 2.2;HeLa: 11.8;HSkMC: 2.2;U-698: 3.2" "Cancer enriched" "Detected in single" 9 "glioma: 0.6" "Cell type enriched" "Detected in some" 5 "NK-cell: 28.5" "Lineage enriched" "Detected in many" 5 "NK-cells: 28.5" "HPA039910, HPA062570" Approved Uncertain Vesicles Vesicles "HPA039910: , HPA062570: " "unprognostic (8.92e-4)" "unprognostic (4.47e-2)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.07e-3)" "unprognostic (2.48e-1)" "unprognostic (3.22e-1)" "unprognostic (9.12e-2)" "unprognostic (3.52e-3)" "unprognostic (3.09e-1)" "unprognostic (1.08e-1)" "unprognostic (3.15e-1)" 0.1 0.0 4.6 0.2 2.4 2.5 0.0 0.2 9.7 0.0 0.6 1.2 0.7 0.0 0.1 0.3 0.9 0.0 3.7 2.9 0.0 0.6 0.8 2.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.0 2.1 6.9 0.7 0.1 0.1 1.0 0.1 0.0 0.0 0.0 0.3 0.0 28.5 5.6 1.5 0.0 0.0 0.2 0.7 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.2 11.8 0.1 0.0 0.3 0.0 2.2 0.0 0.0 0.2 0.0 0.4 0.2 0.5 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 4.4 0.3 28.5 0.0 0.0 0.0 1.5 KNCN "FLJ32011, KINO, L5" ENSG00000162456 Kinocilin A6PVL3 1 46545644-46551527 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.9;pituitary gland: 1.0;testis: 2.5" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA046357 Uncertain "HPA046357: AB_10961149" "unprognostic (6.99e-3)" "unprognostic (2.28e-2)" "unprognostic (2.80e-2)" 0.0 0.5 0.4 0.0 0.1 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KNDC1 "bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND" ENSG00000171798 "Kinase non-catalytic C-lobe domain containing 1" Q76NI1 10 133160447-133226412 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.2" "Cell line enhanced" "Detected in some" "AN3-CA: 4.2;EFO-21: 3.0;MCF7: 2.7;NTERA-2: 3.7;RPMI-8226: 5.2;U-2 OS: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "intermediate monocyte: 1.4;non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 10 "monocytes: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039624 Uncertain "Intracellular and membrane" "HPA039624: AB_10671045" "unprognostic (2.32e-1)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (1.59e-3)" "unprognostic (1.96e-2)" "unprognostic (2.76e-1)" "unprognostic (5.61e-2)" "unprognostic (2.75e-2)" "unprognostic (6.77e-2)" "unprognostic (1.15e-1)" "unprognostic (6.80e-3)" "unprognostic (2.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.53e-1)" "unprognostic (1.94e-1)" "unprognostic (9.41e-2)" 1.1 11.4 14.7 1.2 13.2 1.0 1.2 23.9 26.2 2.1 1.1 5.4 0.0 1.1 3.9 2.7 1.0 14.6 1.5 1.2 11.3 12.1 1.5 5.5 4.2 1.1 8.3 13.2 10.9 2.1 1.0 13.2 1.9 8.5 2.0 1.1 0.7 2.5 3.2 1.2 1.2 1.2 1.9 3.2 1.7 1.4 2.8 3.5 0.0 2.4 0.0 1.1 1.1 0.3 0.3 0.0 0.0 3.1 0.0 0.0 0.1 0.6 0.9 0.5 4.2 0.0 0.1 0.0 0.6 0.3 0.0 0.0 1.5 0.6 0.0 3.0 0.3 0.6 0.1 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 3.7 0.0 0.0 0.1 5.2 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 14.7 13.2 23.9 25.2 11.3 12.1 8.3 13.2 8.5 3.5 KRT222 "KA21, KRT222P, MGC45562" ENSG00000213424 "Keratin 222" Q8N1A0 17 40654665-40665181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 15.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA054586, HPA068724, HPA069774" Enhanced Approved "Vesicles,Lipid droplets" "Vesicles, Lipid droplets" "HPA054586: AB_2682532, HPA068724: , HPA069774: " "unprognostic (2.72e-2)" "unprognostic (4.08e-2)" "unprognostic (1.92e-1)" "unprognostic (2.43e-1)" "unprognostic (1.26e-2)" "unprognostic (3.50e-1)" "unprognostic (1.27e-1)" "unprognostic (6.12e-2)" "unprognostic (5.59e-1)" "unprognostic (2.04e-1)" "unprognostic (1.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-1)" "unprognostic (1.00e-1)" "unprognostic (1.79e-1)" "unprognostic (7.41e-2)" 3.8 5.0 9.6 0.7 18.3 0.6 1.3 15.6 21.7 2.3 1.8 0.2 0.9 1.2 1.9 11.8 1.2 1.2 8.3 1.0 10.0 10.0 1.3 9.4 1.4 1.1 8.6 13.4 0.9 1.7 1.6 5.2 0.6 14.3 3.2 2.3 0.8 0.7 4.6 0.6 0.8 2.3 3.1 3.3 3.4 1.0 1.4 3.3 0.0 1.2 0.3 1.1 2.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 18.3 15.6 21.7 10.0 10.0 8.6 13.4 14.3 3.3 KRT31 "Ha-1, KRTHA1" ENSG00000094796 "Keratin 31" Q15323 17 41393724-41397592 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 21.2;skin 1: 72.1" "Cell line enhanced" "Detected in single" "HBEC3-KT: 1.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 22 "cerebellum: 21.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049550, HPA055194" Enhanced 560000000 "HPA049550: , HPA055194: " "unprognostic (3.92e-2)" "unprognostic (3.50e-1)" "unprognostic (3.30e-1)" "unprognostic (5.51e-2)" "unprognostic (7.71e-2)" "unprognostic (4.60e-1)" "unprognostic (6.98e-2)" "unprognostic (1.84e-1)" "unprognostic (4.07e-1)" "unprognostic (4.26e-2)" "unprognostic (1.65e-1)" 1.5 0.0 0.0 0.0 0.2 0.0 1.0 21.2 1.2 0.6 0.0 0.6 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.5 0.0 5.5 72.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 21.2 0.9 0.0 0.0 0.0 0.7 0.8 0.0 KRTAP5-1 "KRN1L, KRTAP5.1" ENSG00000205869 "Keratin associated protein 5-1" Q6L8H4 11 1584342-1585283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 11.5" "Cell line enhanced" "Detected in some" "MCF7: 3.3;SCLC-21H: 5.0;TIME: 1.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.68e-1)" "unprognostic (2.97e-1)" "prognostic unfavourable (2.37e-4)" "unprognostic (1.04e-1)" "unprognostic (8.08e-2)" "unprognostic (3.36e-3)" "unprognostic (2.41e-1)" "unprognostic (7.87e-2)" "unprognostic (1.43e-1)" "unprognostic (6.71e-2)" "unprognostic (9.66e-2)" "unprognostic (2.75e-2)" "unprognostic (6.32e-3)" "unprognostic (3.88e-2)" "unprognostic (1.25e-1)" "unprognostic (2.71e-2)" "unprognostic (3.10e-1)" 0.4 0.8 0.6 0.2 1.7 0.3 0.1 11.5 1.3 0.1 0.6 0.5 0.5 0.1 0.1 0.2 0.3 1.2 0.6 0.8 0.4 0.2 0.5 0.5 0.2 0.1 3.9 0.1 3.6 0.2 0.2 0.1 1.9 0.1 0.8 1.8 1.2 0.1 0.2 0.7 1.0 0.3 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.5 0.0 0.7 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-2 "KRTAP5-8, KRTAP5.2" ENSG00000205867 "Keratin associated protein 5-2" Q701N4 11 1597177-1598294 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 6.3;pancreas: 5.2;skin 1: 10.2" "Group enriched" "Detected in some" 11 "HDLM-2: 1.6;MCF7: 5.8;SCLC-21H: 6.7;SH-SY5Y: 2.9;SK-BR-3: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 1.1;memory CD8 T-cell: 1.0" "Group enriched" "Detected in many" 11 "B-cells: 1.1;T-cells: 1.0" "unprognostic (6.31e-2)" 0.0 0.8 0.8 0.2 1.3 0.0 0.0 5.4 6.3 0.0 0.6 1.2 0.2 0.9 0.0 0.0 1.5 0.3 0.7 1.4 0.0 0.0 0.3 0.1 0.4 0.0 5.2 0.0 0.4 0.0 0.0 0.0 1.6 0.0 0.1 10.2 1.5 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 2.9 0.0 1.8 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 KSR2 FLJ25965 ENSG00000171435 "Kinase suppressor of ras 2" Q6VAB6 12 117453012-117968983 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 27.4;pituitary gland: 24.6" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 7.2;SCLC-21H: 5.3;TIME: 10.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035536 Enhanced "HPA035536: AB_10673485" "unprognostic (1.74e-2)" "unprognostic (4.21e-2)" "unprognostic (2.38e-1)" "unprognostic (2.29e-2)" "unprognostic (9.11e-2)" "unprognostic (8.42e-2)" "unprognostic (6.91e-3)" "unprognostic (1.10e-2)" "unprognostic (5.78e-2)" "unprognostic (5.80e-2)" "unprognostic (2.05e-4)" "unprognostic (1.19e-1)" "unprognostic (9.28e-3)" "unprognostic (5.02e-2)" "unprognostic (5.68e-2)" "unprognostic (8.14e-3)" "unprognostic (5.74e-2)" 0.9 5.0 13.2 1.1 13.8 1.1 1.7 27.4 17.2 1.0 1.9 1.3 2.2 1.0 0.8 2.6 0.9 1.7 1.0 0.8 12.9 4.8 3.5 0.8 1.2 1.6 2.2 10.8 0.8 3.0 0.9 24.6 0.9 7.7 1.3 2.3 0.2 1.2 3.4 0.9 1.0 1.0 0.9 2.9 1.0 1.7 3.2 3.0 0.0 3.8 0.0 1.5 2.3 0.5 0.1 0.2 0.8 0.1 0.2 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 1.5 0.1 0.0 0.5 1.2 0.0 0.0 0.1 0.7 1.4 5.3 0.1 0.0 0.0 0.0 1.1 0.0 10.8 0.0 0.8 0.0 0.2 0.9 1.5 0.0 0.4 0.0 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.2 0.1 0.2 0.0 0.0 13.2 13.8 27.4 17.2 12.9 4.8 2.2 10.8 7.7 3.0 L1CAM "CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1" ENSG00000198910 "L1 cell adhesion molecule" P32004 X 153861514-153886174 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 29.6;brain: 54.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 72.2;BJ hTERT+ SV40 Large T+ RasG12V: 39.7;HeLa: 52.1;RPTEC TERT1: 42.4" "Cancer enhanced" "Detected in many" "melanoma: 34.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 1.0;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 7 "B-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010896 Enhanced Approved "Nucleoplasm,Plasma membrane" 59000000 Nucleoplasm "Plasma membrane" "CAB010896: AB_609903" "unprognostic (1.33e-3)" "unprognostic (3.43e-2)" "unprognostic (2.75e-1)" "prognostic unfavourable (8.51e-10)" "unprognostic (2.04e-2)" "prognostic unfavourable (3.81e-4)" "unprognostic (9.44e-2)" "prognostic unfavourable (2.36e-6)" "unprognostic (1.13e-1)" "unprognostic (9.12e-2)" "unprognostic (8.52e-3)" "unprognostic (8.02e-2)" "prognostic unfavourable (1.17e-4)" "unprognostic (3.07e-1)" "unprognostic (6.31e-2)" "unprognostic (1.69e-1)" "unprognostic (7.47e-3)" 4.4 29.6 19.9 8.0 21.9 1.2 1.7 54.5 43.6 2.8 16.3 1.5 2.0 4.9 1.7 3.0 5.3 2.6 3.2 5.2 11.2 20.6 12.3 1.3 1.3 3.7 7.3 22.4 1.4 3.0 1.0 6.1 1.4 19.3 3.5 5.7 6.2 5.9 10.8 1.6 9.9 7.6 6.1 3.5 1.7 4.8 1.5 3.4 0.0 1.2 1.3 2.6 2.3 3.9 2.2 0.0 0.0 0.0 0.0 0.3 0.2 17.6 1.3 5.4 0.0 0.0 0.0 2.3 25.0 72.2 24.2 39.7 7.1 0.1 0.0 23.9 0.1 0.7 0.6 0.4 12.7 0.0 0.1 0.0 52.1 1.1 0.0 0.0 4.0 0.1 0.3 3.6 2.5 0.0 0.0 0.0 0.1 23.9 0.0 0.5 1.2 0.9 0.0 31.7 0.1 42.4 0.3 15.9 10.4 14.0 12.5 10.2 1.3 0.3 0.0 0.0 10.6 1.1 11.9 0.2 0.3 0.1 0.1 0.2 20.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.9 21.9 54.5 30.2 11.2 20.6 7.3 22.4 19.3 3.4 L34079.1 ENSG00000268361 19 43554692-43593036 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.0;brain: 4.3" "Group enriched" "Detected in some" 6 "HaCaT: 1.5;SK-BR-3: 1.7;U-266/70: 3.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 30 "basophil: 3.0" "Lineage enriched" "Detected in single" 30 "granulocytes: 3.0" 0.2 0.8 0.1 0.7 0.2 0.0 0.2 4.3 0.5 0.3 0.4 0.0 0.6 0.0 1.4 0.4 0.0 0.3 0.4 0.2 0.0 0.0 0.2 0.0 0.3 1.5 0.0 2.3 0.2 0.3 0.0 0.0 0.0 0.0 1.7 1.1 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 LACC1 "C13orf31, FAMIN, FLJ38725" ENSG00000179630 "Laccase domain containing 1" Q8IV20 13 43879284-43893932 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.0" "Cell line enhanced" "Detected in many" "HMC-1: 15.5;TIME: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 9.6" "Low lineage specificity" "Detected in many" "CAB034228, HPA040150, HPA044211" Uncertain "CAB034228: AB_1564163, HPA040150: AB_10963540, HPA044211: AB_10961258" "unprognostic (2.48e-1)" "unprognostic (3.27e-2)" "unprognostic (4.54e-2)" "unprognostic (3.31e-3)" "unprognostic (1.17e-2)" "unprognostic (3.90e-2)" "unprognostic (6.41e-3)" "unprognostic (4.43e-2)" "unprognostic (3.03e-3)" "unprognostic (1.78e-2)" "unprognostic (6.06e-3)" "unprognostic (2.02e-1)" "unprognostic (3.93e-2)" "unprognostic (3.30e-1)" "unprognostic (9.36e-3)" "unprognostic (2.22e-1)" "unprognostic (1.18e-1)" 6.6 7.1 13.1 11.0 28.2 1.5 5.1 2.1 12.2 4.8 9.8 12.2 2.7 10.0 4.4 4.7 7.1 4.6 9.9 9.6 18.5 10.5 7.6 8.2 7.8 7.3 31.0 9.1 4.5 4.7 9.8 6.2 6.4 10.9 5.7 13.2 2.2 6.1 4.6 2.5 4.6 14.2 7.8 16.5 8.3 6.6 9.2 21.5 4.8 3.6 4.3 7.6 12.2 4.4 1.7 3.5 4.1 9.6 0.5 1.2 1.3 1.9 1.0 0.5 0.0 1.1 4.7 4.0 4.2 10.9 1.2 1.6 2.2 4.4 3.9 1.0 5.8 2.8 0.1 1.1 1.9 2.7 0.7 5.0 1.0 0.7 5.1 1.2 15.5 7.1 3.4 4.4 4.9 2.5 0.0 2.8 2.7 0.9 0.1 1.5 0.4 0.9 0.9 0.0 2.1 3.1 2.3 0.7 1.0 1.4 0.5 2.1 0.6 2.5 48.8 1.5 0.4 7.9 0.0 0.0 0.0 1.0 4.1 1.4 3.3 1.3 4.1 4.1 1.0 6.8 1.2 1.2 0.9 0.9 3.5 1.7 0.3 0.5 0.2 0.5 9.6 0.8 1.2 1.3 13.1 28.2 2.1 12.2 18.5 10.5 31.0 9.1 10.9 21.5 LAMP5 "BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46" ENSG00000125869 "Lysosomal associated membrane protein family member 5" Q9UJQ1 20 9514358-9530524 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.1;brain: 105.2" "Cell line enhanced" "Detected in some" "Karpas-707: 92.7;SH-SY5Y: 17.0;THP-1: 32.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "basal ganglia: 105.2" "Cell type enriched" "Detected in some" 15 "plasmacytoid DC: 42.1" "Lineage enriched" "Detected in many" 30 "dendritic cells: 42.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA004802, HPA070765" Enhanced Uncertain "Mitotic spindle,Centriolar satellite,Cytosol" Cytosol "Mitotic spindle, Centriolar satellite" "HPA004802: AB_10603682, HPA070765: " "unprognostic (2.78e-2)" "unprognostic (3.90e-3)" "unprognostic (5.73e-4)" "unprognostic (5.47e-2)" "unprognostic (7.89e-2)" "unprognostic (2.67e-1)" "unprognostic (3.80e-3)" "unprognostic (1.45e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "prognostic unfavourable (6.46e-6)" "unprognostic (5.12e-3)" "unprognostic (3.74e-2)" "unprognostic (1.08e-2)" "unprognostic (4.49e-3)" 0.5 4.1 21.6 1.5 105.2 2.0 1.0 2.3 28.6 9.1 1.3 0.6 1.8 1.3 4.6 6.0 0.6 9.7 2.9 0.6 18.7 4.1 0.9 0.5 1.1 4.8 4.5 7.7 21.2 1.3 0.3 2.0 0.4 23.2 2.3 1.4 2.6 1.4 3.6 0.3 0.5 1.4 3.8 6.7 1.4 1.6 1.1 4.8 0.0 1.1 0.0 4.7 1.2 0.6 1.4 42.1 0.9 0.5 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 92.7 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.9 0.5 0.0 0.0 0.1 0.0 1.4 0.0 0.0 2.8 0.1 0.0 0.0 0.1 0.0 0.0 42.1 0.0 0.7 21.6 105.2 2.3 19.1 18.7 4.1 4.5 7.7 23.2 4.8 LANCL1 "GPR69A, p40" ENSG00000115365 "LanC like 1" O43813 2 210431249-210477652 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 73.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034994 Approved Uncertain Microtubules 13000 Microtubules "HPA034994: AB_10601936" "unprognostic (2.34e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (2.67e-2)" "unprognostic (2.02e-2)" "unprognostic (1.20e-1)" "unprognostic (6.10e-2)" "unprognostic (9.76e-2)" "unprognostic (2.82e-2)" "unprognostic (2.08e-1)" "unprognostic (2.13e-3)" "unprognostic (1.23e-1)" "unprognostic (9.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.06e-1)" 10.7 11.5 26.2 5.7 43.8 6.6 14.0 24.0 48.7 10.3 8.5 66.1 3.5 8.6 12.2 8.4 12.4 10.0 9.4 16.6 36.6 23.0 16.1 9.5 8.5 10.0 43.5 21.5 14.0 9.9 34.9 9.4 8.9 47.3 14.3 9.5 6.6 7.8 14.1 10.4 17.3 8.2 13.9 73.1 8.9 7.3 21.2 37.1 8.7 10.1 5.9 10.9 9.1 7.1 8.6 8.0 6.1 7.4 7.5 13.0 6.0 10.1 11.5 18.5 18.7 21.1 29.9 12.9 15.5 20.1 14.3 18.9 12.8 11.7 8.7 20.4 17.6 10.5 12.0 25.1 24.3 10.0 12.9 15.3 40.0 22.5 17.6 19.3 5.5 21.5 20.7 18.8 15.4 20.7 19.0 14.2 18.5 8.9 26.0 10.7 12.3 8.0 11.8 25.8 12.8 26.4 10.0 17.6 24.5 18.1 39.0 20.3 13.3 10.4 21.0 25.4 17.1 13.2 16.2 8.8 16.5 12.2 23.8 15.1 29.2 5.8 2.4 6.1 12.1 5.1 11.8 7.8 10.8 12.1 8.0 8.6 11.5 13.0 0.9 7.5 7.4 7.1 11.1 6.0 26.2 43.8 24.0 48.7 36.6 23.0 43.5 21.5 47.3 37.1 LANCL2 "GPR69B, TASP" ENSG00000132434 "LanC like 2" Q9NS86 7 55365448-55433742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell line enriched" "Detected in all" 7 "A-431: 57.1" "Cancer enhanced" "Detected in all" "glioma: 52.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019711, HPA029535" Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA019711: AB_1852699, HPA029535: AB_10602342" "unprognostic (1.11e-1)" "unprognostic (6.89e-2)" "unprognostic (7.28e-2)" "unprognostic (1.28e-2)" "unprognostic (1.20e-1)" "unprognostic (1.76e-2)" "unprognostic (1.01e-1)" "unprognostic (1.31e-1)" "unprognostic (2.56e-1)" "prognostic favourable (1.89e-4)" "unprognostic (1.35e-3)" "unprognostic (5.58e-2)" "prognostic favourable (1.03e-6)" "unprognostic (4.58e-3)" "unprognostic (1.04e-2)" "unprognostic (3.94e-1)" "unprognostic (1.45e-1)" 3.1 4.9 20.4 2.3 17.0 3.1 5.9 9.9 28.5 6.1 4.6 19.8 1.8 5.0 9.6 5.3 3.5 5.6 3.8 3.9 17.2 11.3 6.0 4.8 3.0 4.0 12.9 21.1 9.6 3.4 10.4 4.2 3.9 10.1 5.9 4.7 2.4 3.3 6.9 5.7 5.3 4.2 7.0 10.8 2.8 3.5 5.7 13.1 3.3 6.6 0.3 2.7 2.8 2.7 2.7 4.7 0.7 4.5 3.6 6.0 2.6 57.1 2.0 4.0 2.7 1.2 2.1 2.2 2.6 3.1 4.0 3.4 2.0 1.6 4.0 2.4 3.7 2.6 2.1 1.4 2.5 1.7 4.2 1.4 1.6 2.0 2.2 4.4 2.7 3.8 1.5 3.0 1.0 2.0 2.5 2.6 3.7 1.7 1.1 2.0 7.7 2.5 1.7 1.8 2.0 2.6 4.5 7.0 6.7 3.7 5.6 1.5 2.3 4.7 3.3 2.5 3.5 4.8 5.0 2.5 3.0 4.3 2.0 1.0 4.8 0.4 3.6 0.7 2.6 4.5 4.5 2.7 3.4 3.9 4.7 2.6 3.1 2.7 0.5 3.6 3.0 3.7 6.0 2.6 20.4 17.0 9.9 28.5 17.2 11.3 12.9 21.1 10.1 13.1 LBHD2 ENSG00000283071 "LBH domain containing 2" 14 103084210-103090027 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.9;brain: 1.6;testis: 2.7" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;HeLa: 2.2;Hep G2: 1.1;K-562: 1.0;PC-3: 1.5;RT4: 1.2;SiHa: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 134.1" 1.9 0.0 1.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.3 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LBX1 "HPX6, LBX1H" ENSG00000138136 "Ladybird homeobox 1" P52954 10 101226195-101229794 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 76 "brain: 11.8;skeletal muscle: 25.0" "Group enriched" "Detected in some" 5 "HEK 293: 4.9;RH-30: 6.2;SCLC-21H: 13.3" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "cerebellum: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "cerebellum: 1.8;pons and medulla: 3.2" "Group enriched" "Detected in some" 20 "cerebellum: 2.9;pons and medulla: 2.8" "HPA002016, HPA002086" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA002016: , HPA002086: AB_1079242" "unprognostic (4.13e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" "unprognostic (2.29e-1)" "unprognostic (7.28e-3)" "unprognostic (3.31e-1)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 6.2 0.0 0.0 0.0 13.3 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.8 0.8 0.0 0.0 0.0 0.0 1.7 0.0 LCAT ENSG00000213398 "Lecithin-cholesterol acyltransferase" P04180 16 67939750-67944131 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Transferase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "brain: 64.4;liver: 154.2" "Cell line enhanced" "Detected in many" "BEWO: 35.1;Hep G2: 27.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 64.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044767 Approved Nucleoplasm "Secreted to blood" 6470000000 9500000000 Nucleoplasm "HPA044767: AB_2756312" "unprognostic (3.34e-2)" "unprognostic (3.56e-2)" "prognostic unfavourable (8.50e-4)" "unprognostic (5.43e-3)" "unprognostic (1.25e-2)" "unprognostic (2.16e-1)" "prognostic favourable (4.21e-8)" "unprognostic (6.42e-2)" "unprognostic (4.26e-1)" "unprognostic (4.12e-1)" "unprognostic (1.50e-2)" "unprognostic (7.21e-2)" "prognostic unfavourable (1.71e-4)" "unprognostic (9.93e-2)" "unprognostic (1.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.90e-3)" 4.4 3.6 6.3 2.2 3.7 0.9 4.3 64.4 9.6 4.5 4.4 7.3 1.4 1.3 5.3 3.0 1.8 3.5 3.5 4.5 8.4 1.8 3.9 154.2 5.6 1.9 5.5 6.3 4.7 2.5 5.9 2.7 5.5 9.2 6.4 1.3 1.8 2.4 6.2 3.4 9.9 2.4 3.8 7.5 3.9 2.3 2.2 6.1 1.4 7.6 1.6 1.4 2.6 4.5 1.8 0.8 5.0 1.1 1.3 1.4 0.1 2.4 4.0 5.9 6.7 5.2 7.3 35.1 9.8 4.2 6.6 4.7 13.1 3.0 1.3 1.8 14.1 8.7 1.4 13.4 4.1 0.6 3.6 1.7 8.7 27.3 7.1 0.3 4.7 12.6 12.8 13.7 4.8 4.8 3.7 0.5 4.7 4.0 1.6 4.2 3.9 2.2 1.7 6.5 1.4 1.8 4.3 0.2 3.0 14.8 0.7 1.6 8.4 2.6 9.2 8.6 13.4 9.4 3.5 8.1 2.1 3.7 4.1 1.1 7.4 2.4 1.1 5.0 0.9 0.1 1.3 1.2 0.7 0.8 0.2 1.8 1.4 0.4 2.8 1.3 0.5 0.8 0.0 0.1 6.3 3.7 64.4 9.6 8.4 1.8 5.5 6.3 9.2 6.1 LCN15 "PRO6093, UNQ2541" ENSG00000177984 "Lipocalin 15" Q6UWW0 9 136759634-136766255 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 4.9;ductus deferens: 12.0;intestine: 16.5;seminal vesicle: 5.3" "Cell line enriched" "Detected in some" 7 "Hep G2: 19.2" "Cancer enriched" "Detected in some" 19 "colorectal cancer: 23.0" "Group enriched" "Detected in some" 6 "amygdala: 2.4;cerebral cortex: 4.9;hippocampal formation: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA060584 Enhanced "Secreted in other tissues" "HPA060584: " "unprognostic (5.24e-1)" "unprognostic (2.61e-1)" "unprognostic (2.14e-1)" "unprognostic (3.67e-1)" "unprognostic (3.45e-2)" "unprognostic (3.28e-2)" "unprognostic (2.39e-1)" "unprognostic (1.83e-1)" 0.1 0.0 2.4 0.1 0.4 0.0 0.1 0.1 4.9 0.1 12.8 0.1 12.0 16.5 0.1 2.0 0.1 0.0 0.1 1.9 1.7 0.1 0.1 0.1 2.0 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 2.6 0.1 0.1 5.3 1.3 0.0 5.2 0.1 0.7 0.3 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.4 0.1 4.9 1.7 0.1 0.5 0.1 0.1 0.1 LCNL1 FLJ45224 ENSG00000214402 "Lipocalin like 1" Q6ZST4 9 136981904-136986410 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.1;seminal vesicle: 3.7;testis: 2.5" "Cell line enhanced" "Detected in some" "BEWO: 1.9;fHDF/TERT166: 1.4;HSkMC: 1.0;TIME: 1.3" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "unprognostic (1.39e-1)" "unprognostic (4.60e-3)" "unprognostic (1.08e-3)" "unprognostic (5.14e-2)" "unprognostic (3.39e-1)" "unprognostic (2.03e-5)" "unprognostic (6.46e-2)" "unprognostic (6.67e-2)" "unprognostic (7.79e-2)" "unprognostic (9.51e-2)" "unprognostic (2.16e-1)" "unprognostic (9.82e-2)" "unprognostic (1.34e-9)" "unprognostic (4.31e-2)" "unprognostic (1.97e-1)" "unprognostic (1.28e-1)" "unprognostic (1.93e-1)" 0.1 0.0 2.2 0.0 1.8 0.0 0.1 0.4 1.9 1.0 0.1 0.0 0.3 1.6 0.0 0.4 0.2 0.5 2.0 1.3 0.3 0.0 0.2 0.7 3.1 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 3.7 1.0 0.0 0.2 0.1 2.6 0.3 0.1 2.5 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 LCTL "FLJ33279, KLG, KLPH" ENSG00000188501 "Lactase like" Q6UWM7 15 66547179-66565979 "Cancer-related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.4" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;NTERA-2: 5.9;U-2 OS: 16.6;U-251 MG: 7.0" "Group enriched" "Detected in some" 5 "glioma: 1.5;melanoma: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA071640 Approved "Endoplasmic reticulum,Plasma membrane" "Plasma membrane" "Endoplasmic reticulum" "HPA071640: " "unprognostic (4.60e-2)" "unprognostic (5.46e-2)" "unprognostic (8.70e-2)" "unprognostic (1.56e-2)" "unprognostic (3.22e-3)" "unprognostic (3.53e-2)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (4.51e-3)" "unprognostic (4.44e-16)" "unprognostic (6.06e-2)" "unprognostic (3.39e-1)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" 0.4 0.7 6.0 0.9 4.3 3.1 0.4 0.7 3.1 0.4 0.5 3.1 0.0 1.4 0.8 0.9 0.7 0.3 1.0 0.4 3.3 1.2 0.4 0.4 0.4 1.0 5.3 3.1 0.6 0.7 0.2 0.4 0.3 4.9 0.4 0.3 1.1 0.6 0.3 3.0 2.6 0.7 0.4 10.4 0.8 0.7 1.5 2.3 0.0 0.5 0.0 0.2 0.3 0.3 0.9 0.6 3.9 0.7 1.0 0.5 0.2 0.3 0.3 3.2 0.3 0.1 0.1 0.8 0.8 0.0 0.1 0.4 0.4 0.4 0.5 6.4 0.2 0.7 0.0 0.0 0.2 0.2 0.2 0.7 1.0 1.6 0.0 0.2 0.4 0.4 0.0 0.3 0.0 0.0 0.4 0.4 0.2 0.1 0.3 0.4 5.9 0.1 0.2 3.5 0.3 0.0 0.4 0.4 0.3 0.1 0.3 1.8 0.4 0.5 0.4 1.7 16.6 0.6 7.0 0.2 0.2 0.2 2.2 0.7 3.0 1.6 0.7 0.5 0.5 0.4 0.3 0.4 0.5 0.3 0.2 0.9 0.5 0.4 3.9 1.0 0.4 0.6 0.5 0.2 6.0 4.3 0.7 2.7 3.3 1.2 5.3 3.1 4.9 2.3 LDLRAD3 LRAD3 ENSG00000179241 "Low density lipoprotein receptor class A domain containing 3" Q86YD5 11 35943981-36232136 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.5" "Cell line enhanced" "Detected in many" "hTCEpi: 28.1;RH-30: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.1;non-classical monocyte: 7.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038251 Approved Approved "Cell Junctions" "Cell Junctions" "HPA038251: AB_10675790" "unprognostic (1.59e-3)" "prognostic unfavourable (2.24e-4)" "unprognostic (3.25e-2)" "unprognostic (4.08e-3)" "unprognostic (1.81e-1)" "unprognostic (1.93e-1)" "unprognostic (2.29e-2)" "prognostic unfavourable (9.34e-6)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (1.68e-2)" "unprognostic (6.93e-2)" "prognostic unfavourable (5.05e-8)" "unprognostic (3.32e-2)" "unprognostic (9.21e-3)" "unprognostic (9.33e-2)" "prognostic unfavourable (2.14e-5)" 12.0 5.0 9.5 6.0 13.7 2.0 23.4 32.5 17.9 9.3 2.8 20.7 1.7 2.9 8.2 4.7 8.8 5.0 6.5 3.6 10.8 7.2 3.0 2.6 3.3 4.4 18.0 4.0 15.0 5.1 1.5 9.2 3.4 18.1 14.8 3.2 5.3 23.9 6.0 5.5 17.0 3.3 7.2 24.4 2.9 3.4 4.8 13.5 0.1 3.0 2.6 4.8 5.3 6.5 0.0 4.1 1.9 7.7 0.0 0.0 2.0 4.8 4.6 14.2 8.6 11.3 12.5 10.8 2.8 2.5 6.3 5.6 3.4 3.0 0.0 2.1 3.0 2.4 4.3 6.2 8.8 0.4 9.2 15.5 3.0 1.0 15.0 3.3 1.9 14.9 28.1 2.8 24.9 10.5 4.0 0.5 11.6 2.7 0.0 0.7 5.8 8.0 0.0 26.5 1.5 1.1 0.7 4.8 11.0 4.8 5.3 15.6 7.3 4.5 10.6 7.6 6.8 0.6 9.2 0.3 0.0 0.0 3.8 4.1 13.5 1.9 6.1 0.6 0.0 6.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 0.0 7.7 0.3 0.0 2.0 9.5 13.7 32.5 9.1 10.8 7.2 18.0 4.0 18.1 13.5 LDLRAD4 C18orf1 ENSG00000168675 "Low density lipoprotein receptor class A domain containing 4" O15165 18 13217498-13652755 "Predicted intracellular proteins, Predicted membrane proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.4;lymphoid tissue: 49.2" "Cell line enhanced" "Detected in many" "HEL: 15.5;MOLT-4: 47.4;REH: 14.3;U-698: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047633, HPA065246" Approved Supported Vesicles Vesicles "HPA047633: , HPA065246: " "unprognostic (2.52e-1)" "unprognostic (4.31e-3)" "unprognostic (5.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.64e-1)" "unprognostic (3.94e-3)" "unprognostic (9.73e-2)" "unprognostic (2.26e-2)" "unprognostic (2.21e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-1)" "unprognostic (3.64e-1)" "prognostic unfavourable (4.58e-4)" "unprognostic (2.51e-2)" "unprognostic (4.38e-2)" "unprognostic (6.58e-2)" "unprognostic (8.18e-2)" 8.3 6.6 9.6 11.5 22.0 11.9 7.5 10.3 22.9 8.6 6.1 45.4 4.3 9.8 12.9 5.2 5.6 11.0 7.8 17.8 14.6 10.7 3.9 10.4 5.9 11.6 19.9 12.5 3.6 6.2 4.6 8.3 8.0 23.5 10.4 3.3 3.7 4.8 8.3 19.0 4.8 10.9 7.5 30.7 8.9 7.6 8.9 21.2 49.2 5.2 2.5 8.5 7.9 6.7 8.2 8.2 17.2 11.0 12.5 14.5 6.2 0.1 0.2 0.9 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.5 0.2 0.0 0.0 0.0 7.7 0.8 15.5 3.2 0.2 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.0 1.2 47.4 0.6 1.2 5.4 14.3 0.1 0.6 0.0 0.8 1.1 1.6 0.2 1.0 0.0 2.1 4.7 1.4 0.8 5.5 0.1 1.0 2.2 0.2 11.9 0.0 3.5 3.1 12.7 10.3 3.4 10.2 10.3 8.9 7.2 9.7 8.8 5.1 8.2 14.5 12.6 17.2 12.5 11.0 8.2 5.2 6.2 9.6 22.0 10.3 20.6 14.6 10.7 19.9 12.5 23.5 21.2 LDLRAP1 "ARH, ARH2, DKFZp586D0624, FHCB1, FHCB2, MGC34705" ENSG00000157978 "Low density lipoprotein receptor adaptor protein 1" Q5SW96 1 25543580-25568886 "Disease related genes, Predicted intracellular proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Atherosclerosis, Disease mutation, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 60.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 36.7" "Group enriched" "Detected in all" 7 "NK-cells: 11.3;T-cells: 36.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB003705, HPA050358" Uncertain Approved Microtubules Microtubules "CAB003705: AB_425923, HPA050358: " "unprognostic (2.52e-2)" "unprognostic (5.39e-3)" "unprognostic (7.49e-3)" "unprognostic (4.12e-2)" "unprognostic (1.40e-1)" "unprognostic (1.18e-2)" "unprognostic (1.70e-2)" "unprognostic (7.27e-3)" "unprognostic (4.79e-1)" "unprognostic (1.18e-1)" "unprognostic (1.20e-3)" "unprognostic (9.96e-2)" "unprognostic (6.49e-2)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (2.74e-2)" "unprognostic (4.24e-1)" 5.9 10.9 5.4 11.0 16.7 4.7 8.1 60.6 10.4 6.4 11.7 31.8 9.7 7.2 5.9 6.2 10.5 6.2 6.3 6.0 9.3 5.7 8.3 14.0 10.2 21.3 23.4 6.9 6.7 26.1 8.5 11.1 15.8 16.4 11.4 10.8 9.9 22.6 7.6 7.4 13.6 8.8 6.8 34.3 31.1 8.7 3.2 15.8 2.8 11.0 8.0 13.8 6.2 8.3 3.5 2.9 1.0 2.1 11.3 36.7 15.0 13.2 5.2 7.5 7.9 4.7 5.5 6.1 8.4 8.3 13.0 9.1 2.1 11.0 2.9 6.2 11.5 14.1 5.1 8.6 6.6 3.5 7.9 4.7 6.2 4.0 7.5 5.3 7.1 5.9 12.3 10.4 3.9 11.1 6.5 29.2 4.3 7.7 0.1 9.2 9.5 5.6 0.7 8.5 23.8 4.8 2.8 3.7 2.1 11.7 18.8 13.3 8.5 9.2 6.6 5.7 8.4 10.8 5.8 28.1 32.6 8.4 19.3 4.5 6.9 0.0 2.1 0.0 7.7 1.7 9.1 3.5 18.2 14.3 2.9 1.8 36.7 29.4 1.0 11.3 1.7 0.4 14.9 15.0 5.4 16.7 60.6 10.4 9.3 5.7 23.4 6.9 16.4 15.8 LENEP LEP503 ENSG00000163352 "Lens epithelial protein" Q9Y5L5 1 154993586-154994315 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.0" "Cell line enhanced" "Detected in some" "A549: 1.7;BEWO: 1.0;Daudi: 1.1;HaCaT: 1.6;HAP1: 1.6;Karpas-707: 1.2;MCF7: 1.1;PC-3: 1.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 1.7;hippocampal formation: 3.0;pons and medulla: 2.5" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "unprognostic (1.03e-1)" "unprognostic (3.60e-2)" "unprognostic (4.71e-2)" "unprognostic (1.16e-1)" "unprognostic (2.04e-2)" "unprognostic (9.50e-3)" "unprognostic (2.72e-2)" "unprognostic (4.25e-2)" "unprognostic (2.34e-1)" "unprognostic (1.79e-1)" "unprognostic (9.51e-2)" "unprognostic (8.04e-2)" "unprognostic (1.32e-5)" "unprognostic (5.26e-2)" "unprognostic (4.50e-3)" "unprognostic (1.00e-1)" "unprognostic (9.08e-2)" 0.1 0.4 1.7 0.1 0.2 0.0 0.2 0.4 0.2 0.8 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 3.0 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.7 0.3 0.0 0.3 0.2 2.5 0.6 0.3 0.1 1.9 0.1 0.5 1.4 1.3 0.1 1.8 0.1 0.3 0.3 0.1 0.1 1.6 0.1 0.1 0.1 0.2 0.2 0.8 0.0 0.1 0.0 1.0 0.0 0.9 1.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 1.2 0.0 1.1 0.0 0.0 0.5 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.8 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.2 0.4 0.2 3.0 0.2 0.1 0.1 2.5 0.1 LGI1 "EPITEMPIN, EPT, ETL1, IB1099" ENSG00000108231 "Leucine rich glioma inactivated 1" O95970 10 93757809-93806272 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 45.1" "Group enriched" "Detected in some" 5 "AF22: 13.2;NTERA-2: 8.9" "Group enriched" "Detected in some" 7 "glioma: 1.8;testis cancer: 0.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" "unprognostic (1.26e-1)" "unprognostic (4.68e-2)" "unprognostic (2.45e-2)" "unprognostic (1.01e-1)" "unprognostic (8.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "unprognostic (1.24e-3)" "unprognostic (1.85e-1)" "unprognostic (4.07e-3)" "unprognostic (8.71e-2)" "unprognostic (2.21e-1)" "unprognostic (5.93e-2)" "unprognostic (4.65e-1)" 1.4 4.5 15.3 1.4 30.6 1.1 1.5 18.1 45.1 1.4 4.4 7.3 0.0 1.3 1.3 1.2 7.2 1.2 2.6 1.5 16.3 10.1 1.2 5.4 1.2 1.2 9.6 17.3 1.3 1.5 1.1 6.5 1.1 35.6 2.2 5.2 10.9 1.1 1.9 9.2 1.2 2.3 2.1 7.3 1.1 2.4 1.5 10.4 0.0 1.2 0.0 1.3 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 30.6 18.1 20.7 16.3 10.1 9.6 17.3 35.6 10.4 LGI3 ENSG00000168481 "Leucine rich repeat LGI family member 3" Q8N145 8 22146825-22157084 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9" "Cell line enhanced" "Detected in some" "A549: 3.2;SCLC-21H: 4.5;SK-MEL-30: 4.5;U-2 OS: 2.5;WM-115: 2.9" "Cancer enhanced" "Detected in many" "melanoma: 14.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024826 Approved Cytosol "Secreted in brain" Cytosol "HPA024826: AB_10601131" "unprognostic (4.41e-2)" "unprognostic (1.78e-1)" "unprognostic (3.28e-1)" "unprognostic (8.11e-3)" "unprognostic (1.14e-1)" "unprognostic (7.45e-2)" "unprognostic (3.38e-1)" "unprognostic (2.43e-2)" "unprognostic (9.64e-2)" "unprognostic (1.64e-2)" "unprognostic (6.25e-3)" "unprognostic (1.26e-2)" "unprognostic (5.59e-5)" "unprognostic (1.36e-2)" "unprognostic (9.41e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 1.2 4.8 13.1 1.1 26.4 1.1 1.2 7.7 52.2 2.6 1.2 35.5 0.0 1.4 1.5 1.3 6.1 2.0 1.1 1.5 20.7 15.7 1.1 1.0 17.7 1.0 24.2 10.4 1.1 1.5 0.9 0.7 1.0 24.9 2.3 1.1 4.6 1.2 4.2 1.0 16.3 1.4 1.7 29.8 1.1 1.3 1.4 14.8 0.0 14.9 0.0 1.3 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.2 0.0 1.0 0.8 0.3 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.3 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 4.5 0.6 0.0 0.0 4.5 0.5 0.0 0.0 0.0 2.5 0.4 0.0 0.0 0.0 0.0 1.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 26.4 7.7 32.1 20.7 15.7 24.2 10.4 24.9 14.8 LGI4 ENSG00000153902 "Leucine rich repeat LGI family member 4" Q8N135 19 35124513-35142451 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.3;skeletal muscle: 59.4" "Cell line enriched" "Detected in single" 30 "WM-115: 25.7" "Group enriched" "Detected in many" 6 "glioma: 4.5;melanoma: 11.5;renal cancer: 13.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042116, HPA043556" Approved Approved "Golgi apparatus" "Secreted in brain" "Golgi apparatus" "HPA042116: , HPA043556: " "unprognostic (3.79e-1)" "unprognostic (6.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-2)" "unprognostic (3.71e-2)" "unprognostic (2.12e-2)" "unprognostic (4.26e-2)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-1)" "unprognostic (3.80e-3)" "prognostic unfavourable (2.84e-7)" "unprognostic (1.71e-2)" "unprognostic (4.47e-1)" "unprognostic (7.73e-2)" "unprognostic (7.13e-2)" 35.6 10.7 31.7 7.9 18.5 2.0 9.9 16.3 36.5 22.3 26.9 17.1 6.3 7.4 13.2 8.9 9.0 12.2 9.4 12.2 23.3 7.9 3.4 4.7 5.3 4.5 15.4 31.5 5.8 4.5 4.4 1.0 7.6 26.0 10.4 8.1 8.7 8.7 24.7 59.4 5.9 11.7 9.6 50.3 3.5 8.5 3.1 15.1 0.0 5.6 4.8 2.4 9.6 24.4 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 25.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 31.7 18.5 16.3 36.5 23.3 7.9 15.4 31.5 26.0 15.1 LGR5 "FEX, GPR49, GPR67, HG38" ENSG00000139292 "Leucine rich repeat containing G protein-coupled receptor 5" O75473 12 71439770-71586310 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.3;fallopian tube: 19.9;placenta: 21.6;skeletal muscle: 26.6" "Group enriched" "Detected in some" 5 "Hep G2: 15.8;SH-SY5Y: 46.7" "Group enriched" "Detected in many" 7 "colorectal cancer: 16.8;endometrial cancer: 26.8;ovarian cancer: 9.8;stomach cancer: 6.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 10 "B-cells: 1.1" "Region enriched" "Detected in some" 8 "olfactory region: 41.8" "Low region specificity" "Detected in many" HPA012530 Approved "HPA012530: AB_1849329" "unprognostic (5.19e-2)" "unprognostic (3.79e-1)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.49e-3)" "unprognostic (1.52e-1)" "prognostic favourable (5.09e-4)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (3.71e-1)" "unprognostic (8.10e-2)" "unprognostic (2.01e-5)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (2.28e-2)" "unprognostic (6.25e-3)" 2.3 2.2 3.5 0.8 18.1 0.4 2.1 0.9 9.5 2.2 4.2 24.5 0.0 6.1 4.9 1.7 0.6 19.9 0.8 0.8 5.0 3.4 0.9 1.4 1.4 0.4 32.3 5.1 1.5 0.6 1.0 2.0 21.6 10.8 1.8 4.6 0.9 3.1 9.0 26.6 4.0 6.5 0.7 15.0 0.6 2.9 0.7 25.7 0.0 0.9 0.9 2.1 0.7 1.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 5.2 0.0 0.4 15.8 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.7 1.0 0.0 0.0 0.0 6.3 0.1 46.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 18.1 0.9 9.5 5.0 3.4 32.3 5.1 10.8 25.7 LHCGR "HHG, LCGR, LGR2, LHR, ULG5" ENSG00000138039 "Luteinizing hormone/choriogonadotropin receptor" P22888 2 48686775-48755730 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;testis: 18.8" "Group enriched" "Detected in some" 5 "AF22: 2.8;HSkMC: 1.0;NTERA-2: 1.6" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" CAB009814 Uncertain "CAB009814: AB_2135467" "unprognostic (8.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (3.14e-2)" "unprognostic (2.97e-2)" "unprognostic (2.24e-2)" "unprognostic (5.22e-2)" 3.6 2.9 0.3 1.4 6.1 0.0 1.6 0.3 0.4 0.2 0.5 0.2 0.0 0.2 0.4 0.3 2.1 0.2 1.8 0.6 0.7 0.4 0.9 0.1 0.4 0.1 2.6 0.0 5.0 0.1 0.0 2.7 0.1 1.4 0.4 0.2 0.3 1.0 0.1 0.2 0.6 0.3 1.0 10.3 0.1 0.6 18.8 0.0 0.4 2.2 0.1 0.1 0.4 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 6.1 0.3 0.4 0.7 0.4 2.6 0.0 1.4 0.0 LHFPL1 ENSG00000182508 "LHFPL tetraspan subfamily member 1" Q86WI0 X 112630648-112680054 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 13.7;pituitary gland: 15.9;salivary gland: 8.2" "Cell line enhanced" "Detected in some" "MOLT-4: 1.4;NTERA-2: 2.5;REH: 1.5;SK-MEL-30: 7.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Region enriched" "Detected in many" 5 "olfactory region: 6.1" HPA003029 Uncertain "HPA003029: AB_1079248" "unprognostic (2.23e-2)" "unprognostic (2.78e-3)" "unprognostic (2.49e-1)" "unprognostic (1.36e-1)" "unprognostic (2.65e-1)" "unprognostic (1.54e-1)" "unprognostic (5.31e-3)" "unprognostic (1.29e-1)" "unprognostic (4.41e-3)" "unprognostic (5.19e-5)" "unprognostic (1.33e-1)" "unprognostic (7.63e-3)" "unprognostic (4.83e-2)" "unprognostic (1.21e-1)" "unprognostic (6.98e-2)" "unprognostic (1.92e-1)" 0.2 0.6 3.1 0.4 13.7 0.1 2.0 0.1 3.8 1.5 0.3 0.6 0.9 0.3 0.6 0.9 0.5 1.3 0.2 2.2 2.8 2.5 0.6 0.2 0.2 0.4 4.5 1.5 1.1 0.1 0.3 15.9 0.5 3.8 1.2 0.4 0.0 8.2 3.3 0.5 0.3 0.5 0.3 0.5 0.4 0.2 0.4 1.6 0.3 6.1 0.1 0.5 0.5 0.2 0.7 0.0 0.0 0.0 0.8 2.6 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 2.5 0.0 1.5 0.3 0.9 0.1 0.4 0.2 0.2 0.0 0.0 7.0 0.0 0.0 0.0 0.2 0.3 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.2 0.7 1.0 2.6 0.0 0.6 0.2 0.8 0.0 0.8 0.0 0.0 0.1 0.4 3.1 13.7 0.1 2.7 2.8 2.5 4.5 1.5 3.8 1.6 LHFPL3 LHFPL4 ENSG00000187416 "LHFPL tetraspan subfamily member 3" Q86UP9 7 104328656-104907232 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "brain: 36.5" "Cell line enhanced" "Detected in some" "K-562: 2.2;SCLC-21H: 4.0;SH-SY5Y: 5.3;SK-BR-3: 4.5;SK-MEL-30: 2.3" "Cancer enriched" "Detected in some" 12 "glioma: 27.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069691 Approved Vesicles Vesicles "HPA069691: " "unprognostic (1.20e-2)" "unprognostic (6.91e-2)" "unprognostic (4.59e-3)" "unprognostic (5.03e-2)" "unprognostic (2.27e-2)" "unprognostic (2.22e-1)" "unprognostic (1.07e-1)" "unprognostic (6.96e-2)" "unprognostic (5.81e-2)" "unprognostic (5.99e-3)" "unprognostic (8.50e-3)" "unprognostic (3.07e-1)" "unprognostic (1.33e-1)" 0.5 0.6 6.4 0.6 7.7 0.5 0.5 2.3 36.5 4.3 0.8 6.1 0.0 2.0 0.7 0.5 0.5 0.9 0.5 0.5 4.9 5.6 1.4 0.5 2.2 0.5 4.8 4.2 0.7 1.5 0.5 0.1 0.5 5.6 0.7 0.6 3.8 0.5 0.5 0.5 0.7 1.4 0.5 6.0 0.9 0.8 0.7 6.7 0.0 0.5 0.0 0.6 0.5 0.2 0.5 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 4.0 5.3 0.0 4.5 2.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 7.7 2.3 7.1 4.9 5.6 4.8 4.2 5.6 6.7 LHFPL4 ENSG00000156959 "LHFPL tetraspan subfamily member 4" Q7Z7J7 3 9498361-9553802 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 29.1;pituitary gland: 9.0" "Cell line enhanced" "Detected in some" "NTERA-2: 4.6;SCLC-21H: 10.7;SH-SY5Y: 13.4;U-266/84: 11.2;WM-115: 4.1" "Group enriched" "Detected in some" 13 "glioma: 6.8;pancreatic cancer: 1.3;testis cancer: 5.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041421 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA041421: AB_10796673" "unprognostic (6.81e-2)" "unprognostic (3.65e-2)" "unprognostic (4.50e-1)" "unprognostic (6.62e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.65e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (3.77e-1)" "unprognostic (1.90e-2)" "unprognostic (6.78e-2)" "unprognostic (2.99e-1)" "unprognostic (3.03e-3)" "unprognostic (8.21e-2)" 0.9 4.9 8.0 1.0 11.4 0.9 0.9 16.0 29.1 0.9 1.4 1.5 0.0 1.2 0.9 0.8 0.9 0.9 0.9 0.8 8.4 8.5 0.9 0.8 1.0 0.8 4.2 8.6 0.8 1.8 1.2 9.0 0.8 9.2 0.9 1.4 1.7 0.9 0.9 0.8 0.9 1.3 0.9 4.2 0.8 1.3 1.6 1.8 0.0 0.9 0.0 0.8 0.8 0.1 0.0 1.2 0.6 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 10.7 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.0 0.0 11.2 0.0 0.5 0.0 4.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.0 0.0 8.0 11.4 16.0 15.6 8.4 8.5 4.2 8.6 9.2 1.8 LHFPL5 "DFNB67, dJ510O8.8, MGC33835, Tmhs" ENSG00000197753 "LHFPL tetraspan subfamily member 5" Q8TAF8 6 35805293-35833874 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 7.4;brain: 6.7;epididymis: 12.0;pancreas: 12.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055110 Uncertain "HPA055110: AB_2682697" "unprognostic (2.35e-1)" "unprognostic (6.45e-2)" "unprognostic (2.41e-2)" "unprognostic (1.22e-3)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (4.89e-3)" "unprognostic (2.96e-3)" "unprognostic (2.46e-2)" "unprognostic (1.47e-8)" "unprognostic (5.53e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" "unprognostic (1.41e-1)" 0.5 0.5 3.9 1.2 4.1 7.4 0.5 0.4 5.8 0.4 0.4 0.2 0.0 0.9 0.9 12.0 0.3 0.3 0.7 0.3 3.5 2.8 0.4 0.4 0.3 1.5 1.2 6.7 0.6 12.3 0.0 2.2 0.6 2.0 0.6 0.3 0.2 1.1 0.1 0.6 2.3 0.8 0.1 0.6 1.0 0.5 0.8 0.0 0.0 0.8 0.0 0.4 0.3 0.4 1.0 0.3 1.0 0.8 0.5 0.9 0.0 1.5 1.9 3.5 2.1 0.6 1.7 3.2 2.5 0.9 0.4 1.1 2.1 2.2 3.5 1.9 1.3 1.9 0.6 1.4 0.9 1.8 2.9 3.8 5.5 1.9 0.1 1.6 2.6 1.4 0.7 0.7 1.0 0.5 2.0 7.1 2.0 1.2 2.3 1.8 2.3 1.5 2.0 1.5 1.0 1.1 3.3 3.3 2.2 1.6 1.8 1.1 2.9 1.3 3.6 2.4 2.1 3.2 1.0 4.0 3.3 2.8 1.1 2.4 1.5 1.0 0.3 0.2 0.9 0.6 0.5 0.5 0.5 0.3 0.0 1.0 0.6 0.8 0.9 0.5 0.8 0.3 0.4 0.0 3.9 4.1 0.4 5.8 3.5 2.8 1.2 6.7 2.0 0.0 LHPP HDHD2B ENSG00000107902 "Phospholysine phosphohistidine inorganic pyrophosphate phosphatase" Q9H008 10 124461834-124617888 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 106.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009163, HPA009269" Enhanced Supported "Nuclear speckles,Cytosol" 880000 "Nuclear speckles, Cytosol" "HPA009163: AB_1079250, HPA009269: AB_1079249" "unprognostic (3.46e-2)" "unprognostic (1.23e-2)" "unprognostic (4.78e-2)" "unprognostic (3.89e-1)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (5.77e-3)" "unprognostic (2.02e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-1)" "unprognostic (6.42e-2)" "unprognostic (5.55e-2)" "unprognostic (1.79e-3)" "unprognostic (2.52e-1)" "unprognostic (2.10e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" 9.6 14.2 37.3 6.0 34.0 6.9 7.9 11.9 34.2 12.3 13.6 29.7 8.2 17.9 7.5 11.0 12.7 8.1 8.3 9.8 43.0 31.5 18.6 33.8 6.6 8.2 62.7 19.3 5.5 12.2 6.6 5.6 7.2 20.5 6.9 6.7 6.7 13.3 10.6 6.5 8.9 15.7 8.1 106.0 8.2 12.4 14.2 19.5 7.1 20.5 3.6 11.2 8.7 5.7 24.7 20.0 13.3 16.1 3.9 17.2 12.9 14.7 7.3 3.0 7.5 11.6 9.5 7.9 5.4 11.1 3.4 6.3 1.3 13.7 14.6 12.6 8.1 16.0 0.9 2.8 3.6 3.2 10.5 10.6 2.3 6.7 11.8 2.1 17.3 7.0 12.5 3.4 8.2 5.4 5.2 5.8 4.2 14.6 7.0 6.8 5.3 4.1 7.5 3.3 18.6 7.4 1.9 1.6 9.0 3.8 13.9 4.9 10.5 0.3 2.5 5.3 7.9 4.4 1.4 4.9 1.5 4.7 4.9 4.1 1.2 4.6 16.1 13.3 9.5 13.5 12.4 23.7 11.1 10.1 20.0 24.7 13.7 9.6 2.7 3.9 14.9 7.5 17.2 12.9 37.3 34.0 11.9 25.0 43.0 31.5 62.7 19.3 20.5 19.5 LHX1 "LIM-1, LIM1" ENSG00000273706 "LIM homeobox 1" P48742 17 36936785-36944612 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 15.0;kidney: 5.7;seminal vesicle: 7.1" "Cell line enhanced" "Detected in some" "HAP1: 6.2;HMC-1: 2.6;WM-115: 11.4" "Cancer enhanced" "Detected in some" "ovarian cancer: 8.1" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Region enhanced" "Detected in many" "cerebellum: 21.5" "Region enriched" "Detected in many" 4 "cerebellum: 20.4" "HPA044307, HPA073521, HPA074382" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA044307: , HPA073521: , HPA074382: " "unprognostic (3.86e-5)" "unprognostic (1.64e-1)" "prognostic unfavourable (3.63e-5)" "unprognostic (3.85e-2)" "unprognostic (1.06e-4)" "unprognostic (2.67e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (4.20e-3)" "unprognostic (1.74e-5)" "unprognostic (1.33e-1)" "unprognostic (8.62e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 15.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 6.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.9 0.0 1.5 0.0 0.0 0.0 0.1 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 LHX2 "hLhx2, LH-2" ENSG00000106689 "LIM homeobox 2" P50458 9 124001670-124033301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 44.7;retina: 17.0" "Cell line enhanced" "Detected in many" "AN3-CA: 15.8;HAP1: 15.7;HeLa: 10.9;NTERA-2: 19.6;U-138 MG: 10.3" "Group enriched" "Detected in many" 5 "cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5" "Group enriched" "Detected in many" 6 "amygdala: 30.7;basal ganglia: 20.5;cerebral cortex: 26.6;hippocampal formation: 23.6;olfactory region: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 41.7;basal ganglia: 25.3;cerebral cortex: 46.8;hippocampal formation: 47.4;olfactory region: 19.7" "Group enriched" "Detected in many" 6 "amygdala: 55.6;basal ganglia: 46.4;cerebral cortex: 70.9;hippocampal formation: 73.5;olfactory region: 35.5" HPA000838 Supported Approved Nucleoplasm Nucleoplasm "HPA000838: " "unprognostic (3.60e-3)" "prognostic favourable (9.52e-4)" "unprognostic (3.52e-1)" "unprognostic (9.97e-2)" "unprognostic (1.29e-1)" "unprognostic (1.12e-2)" "unprognostic (6.37e-3)" "unprognostic (1.07e-1)" "unprognostic (4.59e-2)" "unprognostic (3.24e-1)" "unprognostic (2.96e-1)" "unprognostic (1.32e-2)" "unprognostic (4.66e-15)" "unprognostic (1.72e-1)" "unprognostic (2.92e-1)" "unprognostic (2.46e-2)" "unprognostic (1.77e-1)" 0.9 1.0 30.7 1.1 20.5 0.9 1.1 0.0 44.7 0.8 0.9 4.7 0.0 1.0 0.8 0.8 0.8 0.8 1.0 0.8 23.6 2.4 0.8 6.1 0.9 1.1 1.5 16.1 1.1 0.8 0.8 4.6 5.1 0.0 0.8 1.1 17.0 1.1 0.8 0.8 2.2 0.9 0.8 0.2 0.9 0.9 4.0 4.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 4.9 0.1 15.8 0.0 0.2 1.6 0.4 0.2 1.2 0.1 4.9 0.0 0.1 2.1 0.9 0.1 15.7 0.0 0.6 0.0 3.4 0.0 10.9 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 7.9 0.0 0.1 19.6 4.6 4.2 0.0 0.0 0.0 0.0 6.4 0.0 4.0 0.0 0.0 5.6 2.0 0.0 10.3 0.4 2.9 0.7 0.2 3.2 0.0 0.6 2.2 1.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 30.7 20.5 0.0 26.6 23.6 2.4 1.5 16.1 0.0 4.2 LHX5 ENSG00000089116 "LIM homeobox 5" Q9H2C1 12 113462034-113472280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.0;stomach 1: 2.1;testis: 2.3" "Cell line enhanced" "Detected in some" "BEWO: 1.6;HMC-1: 4.5;K-562: 1.2;SiHa: 3.2;U-2 OS: 1.4" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 5 "cerebellum: 4.8;hypothalamus: 6.7;pons and medulla: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (5.20e-2)" "unprognostic (4.04e-3)" "unprognostic (1.73e-1)" "unprognostic (1.21e-1)" "unprognostic (2.19e-2)" "unprognostic (1.06e-2)" "unprognostic (1.95e-1)" "unprognostic (4.56e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (5.10e-2)" "unprognostic (7.54e-3)" 0.0 0.1 0.0 0.0 0.3 0.0 0.0 4.8 4.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 2.1 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 6.7 1.2 0.0 9.0 0.0 LHX6 LHX6.1 ENSG00000106852 "LIM homeobox 6" Q9UPM6 9 122202577-122229626 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4" "Cell line enhanced" "Detected in many" "CACO-2: 11.5;K-562: 8.3;NB-4: 15.7;PC-3: 10.9;U-87 MG: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 11.3;basal ganglia: 16.2;cerebral cortex: 8.5;hippocampal formation: 9.5;hypothalamus: 10.7" "Group enriched" "Detected in many" 7 "amygdala: 13.1;basal ganglia: 12.2;cerebral cortex: 13.3;hippocampal formation: 13.4;hypothalamus: 4.9" "HPA047854, HPA058319" Approved Uncertain "Nucleoli fibrillar center,Plasma membrane" "Nucleoli fibrillar center" "Plasma membrane" "HPA047854: , HPA058319: " "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (8.06e-2)" "unprognostic (6.18e-2)" "unprognostic (7.72e-2)" "unprognostic (4.49e-2)" "unprognostic (5.83e-2)" "unprognostic (3.47e-1)" "unprognostic (5.94e-3)" "unprognostic (2.15e-1)" "unprognostic (2.98e-2)" "unprognostic (9.14e-2)" "unprognostic (5.64e-6)" "unprognostic (1.77e-3)" "unprognostic (1.96e-1)" "unprognostic (1.08e-1)" "unprognostic (3.51e-2)" 14.4 1.2 7.3 4.2 11.5 0.5 10.6 0.4 17.4 3.6 3.0 0.9 0.9 2.6 3.8 2.5 4.1 2.6 6.1 6.4 12.3 3.5 1.9 0.9 5.2 2.2 2.0 12.4 2.1 1.1 2.3 0.3 6.0 1.1 2.4 3.2 1.4 2.3 2.3 4.3 2.5 3.1 7.4 1.5 0.6 2.3 7.8 2.2 0.0 3.2 4.6 2.5 5.3 7.3 0.0 0.0 0.0 0.1 0.0 0.5 0.1 2.3 0.0 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 11.5 2.9 0.0 2.6 0.0 0.0 1.2 3.2 0.0 0.0 1.9 0.1 0.8 0.5 0.0 2.1 0.6 0.0 0.8 0.0 0.2 4.2 8.3 0.0 0.0 2.4 0.0 15.7 2.5 10.9 0.0 5.5 0.0 1.9 0.0 1.7 0.4 2.9 0.9 3.0 2.4 0.0 0.7 0.8 1.2 0.0 0.2 0.3 0.1 0.2 8.7 3.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 7.3 11.5 0.4 17.4 12.3 3.5 2.0 12.4 1.1 2.2 LHX8 Lhx7 ENSG00000162624 "LIM homeobox 8" Q68G74 1 75128434-75161533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9" "Group enriched" "Detected in some" 6 "SCLC-21H: 23.3;U-266/70: 7.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 9.5;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 9.9" "Group enriched" "Detected in some" 32 "basal ganglia: 15.3;hypothalamus: 4.4" HPA071806 Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA071806: " "unprognostic (2.28e-2)" "unprognostic (6.23e-2)" "unprognostic (3.85e-3)" "unprognostic (1.52e-9)" "unprognostic (1.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.0 3.9 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.3 0.0 0.5 4.9 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.2 0.0 0.0 7.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.5 0.0 1.1 0.0 0.6 0.0 3.3 LILRA4 "CD85g, ILT7" ENSG00000239961 "Leukocyte immunoglobulin like receptor A4" P59901 19 54333185-54339150 "CD markers, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "blood: 49.7;brain: 12.5;lymphoid tissue: 16.8" "Cell line enriched" "Detected in single" 30 "RPMI-8226: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 21 "plasmacytoid DC: 49.7" "Lineage enriched" "Detected in many" 21 "dendritic cells: 49.7" HPA049418 Approved "HPA049418: " "unprognostic (5.11e-2)" "unprognostic (1.21e-4)" "unprognostic (2.65e-2)" "unprognostic (5.94e-2)" "unprognostic (1.44e-1)" "unprognostic (1.19e-3)" "unprognostic (7.62e-2)" "unprognostic (1.36e-3)" "unprognostic (1.08e-1)" "unprognostic (9.46e-2)" "unprognostic (4.90e-2)" "unprognostic (9.30e-2)" "unprognostic (8.28e-7)" "unprognostic (2.12e-2)" "unprognostic (1.17e-3)" "unprognostic (4.53e-1)" "unprognostic (5.86e-2)" 0.7 0.4 2.1 2.3 2.5 0.6 0.7 1.1 4.3 0.4 0.9 12.5 0.0 0.7 0.4 0.4 0.6 0.4 0.8 0.4 3.5 1.4 0.4 0.7 1.4 5.3 12.2 1.2 0.4 0.4 0.4 0.3 0.4 7.6 0.5 0.5 0.0 0.7 0.5 0.4 0.6 2.0 0.6 7.4 16.8 0.5 0.5 6.7 2.3 0.4 0.0 10.1 0.7 0.2 2.4 49.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.1 0.0 49.7 0.0 0.1 2.1 2.5 1.1 4.3 3.5 1.4 12.2 1.2 7.6 6.7 LIMK1 LIMK ENSG00000106683 "LIM domain kinase 1" P53667 7 74082933-74122525 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.2" "Cell line enhanced" "Detected in all" "U-87 MG: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028064, HPA028516" Approved Supported "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA028064: AB_10600111, HPA028516: AB_10601751" "unprognostic (1.45e-2)" "unprognostic (2.75e-1)" "prognostic unfavourable (4.95e-5)" "unprognostic (2.77e-2)" "unprognostic (1.40e-3)" "unprognostic (3.35e-2)" "prognostic unfavourable (7.79e-6)" "unprognostic (1.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-1)" "unprognostic (3.32e-2)" "unprognostic (3.16e-2)" "prognostic unfavourable (6.63e-8)" "unprognostic (4.14e-2)" "unprognostic (7.00e-2)" "unprognostic (3.84e-2)" "unprognostic (5.79e-2)" 8.8 8.6 31.6 18.2 18.6 6.3 7.4 14.3 44.1 11.5 6.6 7.1 6.6 6.9 7.3 5.3 6.4 6.0 10.8 6.3 26.8 32.9 5.2 2.6 12.5 22.0 33.4 22.2 12.1 8.1 4.0 7.2 8.0 45.2 6.1 4.7 4.8 18.1 9.6 10.9 6.8 7.2 7.6 10.8 18.4 7.8 10.4 6.5 4.3 7.5 3.7 18.1 14.1 7.2 4.6 8.6 3.8 7.7 6.9 2.4 3.1 17.2 13.5 10.3 17.1 13.6 18.5 7.5 10.7 10.3 8.7 9.7 7.8 17.0 10.7 4.8 13.1 10.4 3.8 6.6 3.3 18.5 6.7 7.9 4.6 8.9 15.6 6.0 29.0 18.2 5.9 7.0 3.7 12.9 5.3 3.4 10.8 15.1 5.1 10.8 19.5 8.4 7.5 16.0 6.7 9.6 3.7 4.1 9.4 6.9 16.5 8.6 5.2 5.4 15.3 13.9 12.9 35.7 17.1 3.9 4.3 19.5 51.4 4.4 9.4 0.1 6.5 3.8 2.4 7.7 1.8 4.6 0.6 1.5 8.6 2.4 0.2 0.7 0.7 6.9 4.7 0.8 0.4 3.1 31.6 18.6 14.3 44.1 26.8 32.9 33.4 22.2 45.2 6.5 LIN7A "LIN-7A, MALS-1, TIP-33, VELI1" ENSG00000111052 "Lin-7 homolog A, crumbs cell polarity complex component" O14910 12 80792520-80937925 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.5" "Cell line enhanced" "Detected in many" "ASC diff: 12.6;ASC TERT1: 18.8;HAP1: 14.4;HDLM-2: 16.4;HL-60: 16.0;NB-4: 15.0" "Cancer enhanced" "Detected in many" "renal cancer: 8.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 10.1;eosinophil: 9.6;neutrophil: 18.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071562 Approved "HPA071562: " "unprognostic (7.11e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-1)" "unprognostic (2.02e-1)" "unprognostic (2.52e-3)" "unprognostic (3.04e-2)" "unprognostic (8.24e-2)" "unprognostic (4.24e-2)" "unprognostic (1.46e-2)" "unprognostic (8.83e-2)" "unprognostic (2.27e-2)" "unprognostic (2.41e-1)" "prognostic favourable (1.63e-11)" "unprognostic (5.01e-5)" "unprognostic (7.79e-2)" "unprognostic (1.41e-1)" "unprognostic (1.69e-2)" 6.5 5.0 12.8 3.8 13.1 32.9 8.5 56.5 18.2 7.2 2.4 1.1 1.4 1.4 12.1 1.6 2.1 3.1 6.1 7.7 10.6 7.4 12.5 23.9 6.6 6.6 6.4 11.3 5.5 1.3 1.4 28.9 7.6 7.0 2.5 1.6 4.5 1.8 1.9 1.5 1.2 2.6 7.2 2.7 5.3 1.7 8.9 3.0 0.0 6.5 0.7 2.4 4.2 6.7 0.0 0.0 18.9 3.4 0.0 0.1 0.8 0.0 0.3 2.9 0.0 12.6 18.8 0.0 7.3 3.3 2.9 0.6 5.5 0.0 0.0 0.0 2.7 0.0 14.4 0.0 0.9 16.4 4.4 0.0 0.1 8.6 1.5 16.0 0.1 4.6 0.0 0.3 0.3 2.3 0.0 0.0 1.3 0.2 0.0 15.0 2.7 0.0 0.0 10.8 0.0 1.7 2.3 5.9 0.0 0.0 0.0 0.0 0.6 8.7 0.0 2.3 0.9 1.2 0.0 2.5 0.0 0.0 0.2 0.0 0.1 10.1 3.4 9.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.1 0.0 0.1 0.8 12.8 13.1 56.5 18.2 10.6 7.4 6.4 11.3 7.0 3.0 LINC00672 ENSG00000263874 "Long intergenic non-protein coding RNA 672" 17 38925168-38929384 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 16.8" "Cell line enhanced" "Detected in many" "NTERA-2: 11.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "unprognostic (3.28e-1)" "unprognostic (9.28e-2)" "unprognostic (6.62e-2)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (2.06e-1)" "unprognostic (4.15e-2)" "unprognostic (8.81e-2)" "unprognostic (7.08e-2)" "unprognostic (2.02e-2)" "unprognostic (4.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.68e-6)" "unprognostic (7.29e-2)" "unprognostic (6.58e-2)" "unprognostic (3.44e-2)" "unprognostic (2.59e-4)" 0.7 2.5 4.6 1.0 9.6 3.5 0.9 5.1 16.8 0.4 1.1 4.0 0.0 1.0 2.5 3.1 0.7 1.5 1.8 1.1 5.0 0.3 0.2 1.4 1.4 2.8 7.5 2.7 0.3 0.4 0.4 1.0 7.1 1.5 1.7 2.1 0.6 3.1 0.6 2.3 1.8 2.3 3.5 1.9 1.6 0.3 3.7 0.0 0.2 0.0 0.9 0.8 0.0 1.3 1.0 4.0 1.2 1.4 2.8 0.5 0.7 1.0 2.1 1.4 1.2 1.5 0.3 0.9 0.7 0.2 0.6 0.4 3.8 0.7 0.7 1.3 2.0 0.0 0.5 0.7 0.4 0.6 1.1 1.1 0.1 0.7 1.4 2.6 1.5 0.8 0.7 0.3 0.3 0.2 0.8 0.5 0.7 0.7 1.5 11.5 0.0 3.2 0.2 1.0 1.2 0.9 0.2 4.4 1.2 1.2 0.7 1.4 1.3 2.2 0.6 0.9 0.8 0.4 1.1 1.6 0.8 1.1 1.5 0.4 1.6 1.2 1.9 1.1 0.5 0.5 0.7 0.8 0.8 0.5 1.3 0.9 2.8 4.0 1.4 0.7 1.0 0.7 0.5 LINC02210-CRHR1 ENSG00000263715 "LINC02210-CRHR1 readthrough" 17 45620344-45835826 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Cell line enriched" "Detected in single" 18 "U-2 OS: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.9 0.9 0.8 0.9 2.6 0.9 0.9 2.1 7.3 1.4 0.9 1.8 1.0 0.9 4.0 0.9 0.9 1.6 0.9 0.9 7.5 0.9 0.9 0.9 0.9 0.0 2.7 0.9 2.2 0.9 2.1 1.0 4.2 1.2 0.9 0.9 3.3 0.9 1.2 0.9 0.9 1.4 0.0 0.9 0.9 2.6 0.4 1.1 0.9 0.9 1.3 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LINGO1 "FLJ14594, LERN1, LRRN6A" ENSG00000169783 "Leucine rich repeat and Ig domain containing 1" Q96FE5 15 77613027-77820900 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 67.2" "Cell line enhanced" "Detected in some" "AF22: 13.2;AN3-CA: 11.0;HAP1: 16.6;HEK 293: 11.7;MCF7: 7.1;NTERA-2: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074653 Enhanced Approved "Plasma membrane" 8400 "Plasma membrane" "HPA074653: " "unprognostic (1.06e-1)" "unprognostic (7.07e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-2)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.84e-2)" "unprognostic (3.77e-2)" "unprognostic (3.40e-1)" "unprognostic (1.10e-1)" "unprognostic (7.36e-2)" "unprognostic (2.74e-2)" "prognostic unfavourable (3.23e-7)" "unprognostic (2.07e-1)" "unprognostic (7.06e-2)" "unprognostic (2.85e-1)" "unprognostic (2.59e-2)" 3.0 1.6 27.4 1.7 21.8 0.8 1.3 9.1 67.2 3.8 2.0 5.9 0.0 2.0 3.3 2.7 1.4 3.1 2.5 9.7 29.8 12.2 2.2 1.1 1.1 1.3 10.3 21.8 1.7 2.7 1.1 0.5 6.1 6.8 1.7 1.5 1.8 3.4 2.5 1.0 3.0 1.5 4.5 6.8 3.3 2.0 3.7 3.9 0.0 1.7 0.0 1.1 3.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 13.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 16.6 0.0 0.0 0.0 11.7 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.7 0.1 0.0 7.1 0.0 0.0 31.3 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.7 0.0 1.3 2.8 0.2 0.2 1.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 21.8 9.1 47.5 29.8 12.2 10.3 21.8 6.8 3.9 LINGO3 "LERN2, LRRN6B" ENSG00000220008 "Leucine rich repeat and Ig domain containing 3" P0C6S8 19 2289784-2292024 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.9;brain: 15.7;lymphoid tissue: 7.1" "Cell line enriched" "Detected in some" 4 "HMC-1: 19.2" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Cell type enhanced" "Detected in some" "eosinophil: 6.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 6.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "basal ganglia: 34.0;cerebellum: 34.4;hippocampal formation: 11.5" "HPA043781, HPA059558" Enhanced Approved Mitochondria Mitochondria "HPA043781: , HPA059558: " "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (7.16e-3)" "unprognostic (3.10e-1)" "unprognostic (1.59e-1)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (7.45e-3)" "unprognostic (1.11e-2)" "unprognostic (3.19e-2)" "unprognostic (4.03e-4)" "unprognostic (2.35e-2)" "unprognostic (1.36e-2)" "unprognostic (1.79e-1)" "unprognostic (5.74e-2)" "unprognostic (1.05e-1)" "unprognostic (4.14e-2)" 0.1 0.2 2.2 3.1 15.7 2.8 0.0 4.6 2.9 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.2 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 1.2 0.0 0.4 7.1 1.2 0.1 0.0 0.0 0.0 0.0 1.0 0.1 6.9 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 2.1 19.2 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 2.5 0.2 0.1 1.8 0.0 4.7 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 1.9 0.1 6.9 0.4 0.0 0.4 0.5 0.0 0.2 0.1 1.0 0.1 0.0 2.9 0.3 0.1 0.0 0.6 0.0 LINGO4 LRRN6D ENSG00000213171 "Leucine rich repeat and Ig domain containing 4" Q6UY18 1 151800264-151806154 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 5.4;skeletal muscle: 17.7" "Group enriched" "Detected in some" 4 "HDLM-2: 4.0;Karpas-707: 1.1;SH-SY5Y: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA060781 Uncertain "HPA060781: " "unprognostic (2.71e-2)" "unprognostic (1.98e-1)" "unprognostic (1.33e-3)" "unprognostic (1.96e-1)" "unprognostic (8.65e-2)" "unprognostic (3.16e-2)" "unprognostic (1.49e-5)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (2.39e-1)" "unprognostic (1.94e-4)" "unprognostic (6.92e-2)" "unprognostic (3.94e-4)" "unprognostic (3.84e-1)" "unprognostic (1.65e-1)" "unprognostic (7.06e-2)" "unprognostic (5.60e-2)" 0.0 2.5 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.8 0.0 0.3 0.0 0.1 0.3 0.7 0.1 0.1 0.0 0.0 0.3 0.4 1.2 0.0 0.8 0.0 0.4 0.1 17.7 0.3 0.0 0.0 0.3 0.0 0.3 0.4 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LIX1 "C5orf11, Lft" ENSG00000145721 "Limb and CNS expressed 1" Q8N485 5 97091867-97142872 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 35.9" "Cell line enriched" "Detected in some" 12 "RPTEC TERT1: 26.8" "Cancer enhanced" "Detected in many" "glioma: 13.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive B-cell: 5.9" "Lineage enriched" "Detected in single" 9 "B-cells: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058426 Uncertain Approved "Vesicles,Cytokinetic bridge,Cytosol" Cytosol "Vesicles, Cytokinetic bridge" "HPA058426: " "unprognostic (3.18e-1)" "unprognostic (4.53e-2)" "unprognostic (9.46e-2)" "prognostic unfavourable (2.48e-4)" "unprognostic (8.96e-2)" "unprognostic (6.60e-2)" "unprognostic (1.34e-1)" "unprognostic (4.70e-1)" "unprognostic (7.63e-2)" "unprognostic (1.58e-2)" "unprognostic (3.52e-1)" "unprognostic (2.01e-1)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (1.26e-1)" "unprognostic (9.61e-2)" 1.0 1.2 14.9 1.3 16.9 1.4 1.1 6.1 35.9 1.0 1.3 19.2 1.0 1.2 1.2 1.2 1.0 1.2 1.1 1.1 24.6 10.7 4.9 1.0 1.1 1.6 11.7 13.2 1.0 1.0 1.0 1.2 1.4 12.4 3.0 1.4 3.3 1.1 8.3 1.1 1.1 1.2 1.2 10.1 1.2 1.2 1.1 13.0 0.0 6.5 0.0 1.0 1.0 0.2 5.9 0.1 0.6 0.1 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.2 1.2 0.1 0.0 0.0 5.9 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 14.9 16.9 6.1 11.9 24.6 10.7 11.7 13.2 12.4 13.0 LLGL1 "DLG4, HUGL, HUGL-1, Lgl1, LLGL, Mgl1" ENSG00000131899 "LLGL1, scribble cell polarity complex component" Q15334 17 18225587-18244875 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 53.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022924, HPA023569" Enhanced "HPA022924: AB_1852926, HPA023569: AB_1852928" "unprognostic (1.15e-1)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" "unprognostic (1.88e-2)" "unprognostic (2.94e-1)" "unprognostic (1.90e-2)" "prognostic unfavourable (2.72e-4)" "unprognostic (7.71e-2)" "unprognostic (3.06e-1)" "unprognostic (7.18e-2)" "unprognostic (3.27e-3)" "unprognostic (8.99e-3)" "unprognostic (1.40e-1)" "unprognostic (6.02e-2)" "unprognostic (2.35e-1)" "unprognostic (1.31e-2)" "unprognostic (2.40e-2)" 5.6 10.0 15.0 5.1 21.2 3.5 3.7 7.3 24.1 6.0 3.7 53.5 3.1 3.6 8.1 4.6 10.3 8.0 6.1 6.0 18.4 11.9 3.4 1.4 4.5 5.7 30.4 12.5 10.6 5.1 3.8 4.4 8.2 17.3 5.2 2.4 3.0 6.6 6.5 8.5 8.8 4.2 5.6 32.5 6.1 4.3 6.8 24.2 3.9 3.9 2.9 4.5 6.9 4.8 0.6 0.2 1.0 0.5 1.2 1.6 0.2 11.4 7.5 18.9 18.3 7.3 6.7 7.8 5.1 8.2 10.1 9.1 16.8 2.2 6.9 8.9 4.4 10.6 5.6 6.7 3.0 11.5 15.0 3.2 5.5 5.9 3.5 1.2 7.3 8.3 3.7 5.1 2.4 6.4 2.3 1.5 3.9 8.1 8.2 1.9 8.0 4.2 10.5 13.5 3.8 3.0 4.3 5.0 10.7 6.2 2.9 4.8 3.5 2.0 8.9 8.0 10.3 10.6 7.9 2.4 1.6 2.2 15.9 3.0 7.0 1.0 0.3 0.0 0.4 0.5 0.3 0.5 0.4 0.3 0.1 0.6 0.3 0.1 1.0 1.2 0.1 0.2 1.6 0.2 15.0 21.2 7.3 17.2 18.4 11.9 30.4 12.5 17.3 24.2 LMAN1L "ERGIC-53L, ERGL" ENSG00000140506 "Lectin, mannose binding 1 like" Q9HAT1 15 74812716-74825758 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "brain: 45.5;heart muscle: 18.0;lymphoid tissue: 13.5;prostate: 37.0;salivary gland: 17.3" "Cell line enhanced" "Detected in some" "BEWO: 2.7;Daudi: 3.7;HEK 293: 2.3;SCLC-21H: 2.4;SK-BR-3: 2.4" "Cancer enriched" "Detected in single" 45 "prostate cancer: 2.2" "Region enriched" "Detected in some" 22 "cerebellum: 45.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (4.51e-1)" "unprognostic (2.44e-1)" "unprognostic (4.26e-2)" "unprognostic (3.09e-1)" 0.1 1.1 0.2 4.8 0.2 0.0 0.1 45.5 0.9 0.3 0.1 0.1 0.1 0.0 0.1 0.3 0.4 0.0 0.5 18.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.1 2.0 37.0 0.0 0.1 17.3 0.1 0.1 0.0 0.2 0.1 0.3 13.5 2.5 0.7 0.1 0.1 0.1 0.3 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.4 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.1 0.8 0.3 0.0 1.1 0.0 0.5 2.4 0.1 0.0 2.4 0.2 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.6 1.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 45.5 0.9 0.1 0.0 0.1 0.3 2.0 0.1 LMF1 "C16orf26, FLJ12681, FLJ22302, JFP11, TMEM112, TMEM112A" ENSG00000103227 "Lipase maturation factor 1" Q96S06 16 853634-981318 "Disease related genes, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (5.42e-2)" "unprognostic (7.56e-2)" "unprognostic (1.02e-2)" "unprognostic (1.16e-3)" "unprognostic (5.58e-3)" "unprognostic (1.20e-2)" "unprognostic (5.24e-3)" "unprognostic (1.41e-2)" "unprognostic (6.22e-2)" "unprognostic (3.02e-2)" "unprognostic (1.36e-1)" "unprognostic (4.01e-3)" "prognostic favourable (7.95e-8)" "unprognostic (2.00e-1)" "unprognostic (1.26e-1)" "unprognostic (1.45e-1)" "unprognostic (2.03e-3)" 8.5 12.5 40.0 6.4 66.1 6.6 8.8 7.3 37.2 7.2 6.4 30.0 5.3 7.2 8.1 22.9 7.3 9.3 7.6 6.8 27.4 10.5 8.6 12.4 7.3 6.7 23.6 23.9 9.5 33.2 23.5 8.0 5.8 23.5 11.1 5.7 8.6 22.5 9.5 6.5 10.6 7.5 8.2 31.4 9.5 10.1 5.8 42.1 3.0 13.6 3.2 6.2 8.7 7.8 3.6 10.1 2.5 7.2 8.2 9.0 4.8 0.7 8.8 6.3 11.3 8.0 8.2 2.7 4.3 14.1 1.5 2.8 1.8 11.8 1.9 6.7 11.2 3.3 2.3 0.0 0.9 5.8 3.2 0.6 0.5 2.1 4.1 1.6 2.3 4.7 0.0 0.3 3.7 3.4 1.4 7.7 5.2 10.1 3.3 0.9 3.2 4.9 3.4 6.3 12.3 5.7 2.0 0.0 3.4 2.1 2.4 7.9 5.4 5.3 3.5 0.9 1.4 3.5 0.6 9.4 1.3 2.7 2.4 1.7 7.1 2.5 6.4 1.4 9.0 7.2 5.2 3.6 5.1 6.2 10.1 3.2 5.2 4.1 0.3 8.2 4.3 9.5 4.8 4.8 40.0 66.1 7.3 37.2 27.4 10.5 23.6 23.9 23.5 42.1 LMLN2 ENSG00000283654 "Leishmanolysin like peptidase 2" 14 23099065-23104992 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.9" "Cell line enriched" "Detected in single" 12 "HSkMC: 7.6" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" 0.3 0.5 0.0 0.4 2.5 1.2 0.3 1.1 2.0 0.2 0.7 3.7 0.0 0.4 0.4 1.4 0.2 0.2 1.4 0.1 0.0 0.0 0.0 0.1 1.0 0.9 1.1 0.7 0.0 0.7 0.0 0.0 3.9 0.3 0.7 0.9 0.4 0.0 0.1 1.3 0.6 1.7 0.9 0.6 0.1 1.1 0.7 0.0 1.4 0.0 1.0 0.1 0.0 0.7 0.3 1.0 0.5 0.4 0.7 0.2 0.2 0.2 0.6 0.5 0.0 0.2 0.3 0.2 0.2 0.0 0.2 0.4 0.2 0.4 0.1 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.2 0.6 0.3 0.3 0.1 0.2 7.6 0.1 0.1 0.0 0.3 0.1 0.3 0.0 0.2 0.2 0.1 0.2 0.1 0.3 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.2 0.2 0.2 0.0 0.2 0.5 0.1 0.2 0.2 0.2 0.1 0.0 0.1 0.2 0.0 0.8 0.5 0.2 0.7 0.1 0.3 0.0 0.1 0.3 0.2 0.7 0.5 0.3 1.0 0.4 0.0 0.3 0.1 0.2 LMNTD1 "FLJ36004, IFLTD1, Pas1c1" ENSG00000152936 "Lamin tail domain containing 1" Q8N9Z9 12 25409307-25648579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.4;RT4: 6.6;SH-SY5Y: 6.7;U-2197: 23.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038640 Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA038640: " "unprognostic (8.92e-3)" "unprognostic (3.21e-1)" "unprognostic (2.41e-1)" "unprognostic (1.19e-2)" "unprognostic (9.57e-2)" "unprognostic (1.68e-1)" "unprognostic (6.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.89e-2)" 0.4 0.3 4.3 0.7 6.7 0.4 1.1 3.3 1.6 1.4 3.9 7.1 0.0 1.5 0.8 6.0 0.3 19.0 0.9 0.5 8.5 2.8 0.8 0.2 4.1 0.4 1.1 3.0 4.0 0.7 0.1 21.3 0.3 13.4 0.4 3.8 1.3 0.2 0.3 0.2 0.6 0.6 1.2 4.1 0.6 0.6 15.0 6.5 0.0 1.1 0.0 0.2 0.4 0.3 2.6 2.2 2.7 0.9 0.7 1.6 0.6 0.3 0.3 0.1 0.2 0.2 1.5 2.3 3.1 5.4 1.2 0.2 0.0 0.3 0.2 0.1 0.0 0.0 0.2 0.1 0.3 0.9 0.1 0.9 0.8 1.9 0.3 0.1 0.1 0.5 0.2 1.6 0.4 0.1 1.9 0.3 0.0 0.4 0.0 0.3 1.6 0.5 0.4 0.2 0.2 0.2 6.6 0.1 6.7 0.2 0.4 3.8 0.3 1.5 0.3 0.2 0.9 23.5 0.2 0.8 1.3 1.6 0.3 1.5 2.5 1.9 0.9 0.6 1.4 0.3 0.5 2.1 1.0 1.3 0.4 2.6 1.4 1.6 2.7 0.7 0.4 2.2 0.5 0.6 4.3 6.7 3.3 1.6 8.5 2.8 1.1 3.0 13.4 6.5 LMO3 "DAT1, RBTNL2, Rhom-3" ENSG00000048540 "LIM domain only 3" Q8TAP4 12 16548373-16610594 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.5" "Group enriched" "Detected in some" 8 "ASC diff: 69.0;LHCN-M2: 31.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (1.67e-2)" "unprognostic (2.84e-1)" "unprognostic (1.54e-2)" "prognostic unfavourable (1.10e-7)" "unprognostic (3.62e-2)" "unprognostic (5.44e-2)" "unprognostic (6.56e-3)" "unprognostic (4.91e-2)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (7.11e-2)" "unprognostic (1.17e-1)" "unprognostic (1.39e-5)" "unprognostic (4.41e-2)" "unprognostic (1.61e-1)" "unprognostic (2.13e-3)" "unprognostic (4.83e-2)" 15.9 8.3 38.1 3.1 43.9 1.2 8.2 5.2 87.5 13.1 22.6 5.8 6.4 2.0 8.7 3.4 3.1 2.1 6.3 3.6 20.8 9.4 4.0 1.3 30.0 1.3 14.5 27.6 9.6 29.6 2.1 7.9 2.1 12.9 11.2 9.9 0.9 4.1 25.7 1.2 1.3 4.3 16.9 4.2 1.4 2.6 1.7 8.6 0.3 30.4 0.0 1.2 15.9 6.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.9 0.4 5.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.1 43.9 5.2 42.5 20.8 9.4 14.5 27.6 12.9 8.6 LMO4 ENSG00000143013 "LIM domain only 4" P61968 1 87328468-87348923 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.4" "Cell line enhanced" "Detected in many" "AN3-CA: 102.8;T-47d: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022345, HPA045877, HPA061638" Approved Supported "Nucleoplasm,Midbody ring" Nucleoplasm "Midbody ring" "CAB022345: , HPA045877: , HPA061638: " "unprognostic (5.39e-2)" "unprognostic (4.62e-3)" "unprognostic (2.67e-2)" "unprognostic (4.33e-3)" "unprognostic (1.37e-1)" "unprognostic (2.05e-2)" "prognostic unfavourable (5.25e-4)" "unprognostic (3.97e-3)" "unprognostic (7.44e-2)" "prognostic favourable (1.47e-4)" "unprognostic (3.46e-2)" "unprognostic (6.82e-2)" "unprognostic (1.14e-2)" "unprognostic (2.86e-2)" "unprognostic (2.87e-2)" "prognostic favourable (1.42e-4)" "unprognostic (1.70e-1)" 19.3 7.5 39.8 11.7 36.4 8.0 13.9 10.3 102.4 22.7 16.2 9.8 10.9 11.5 19.4 18.1 22.2 13.7 21.0 17.2 62.3 18.0 12.8 14.5 16.6 11.5 21.0 50.9 18.4 10.4 11.6 13.3 27.5 13.0 26.0 14.3 11.2 36.2 37.9 18.4 17.1 21.1 15.3 16.5 15.8 38.6 12.0 11.0 4.4 14.2 12.5 36.3 15.4 21.4 7.8 7.2 18.9 8.2 15.3 6.9 3.6 9.2 7.3 5.7 102.8 17.5 20.8 14.4 8.4 6.7 7.9 8.9 17.8 5.9 21.7 10.7 9.8 7.7 2.2 5.8 7.9 11.5 5.6 19.8 15.8 5.4 16.8 10.6 26.8 10.8 13.5 12.3 7.1 5.3 4.4 19.3 4.2 3.7 0.3 6.9 20.8 6.8 12.3 7.9 4.7 9.8 35.5 4.7 0.3 33.8 5.0 24.9 65.4 29.3 3.4 37.3 7.0 8.9 27.4 17.6 11.6 4.9 4.6 2.3 5.3 18.9 6.8 13.0 6.0 8.2 6.9 7.8 5.4 6.1 5.0 4.4 1.4 3.5 10.9 15.3 7.7 7.2 1.4 3.6 39.8 36.4 10.3 102.4 62.3 18.0 21.0 50.9 13.0 11.0 LMTK3 "KIAA1883, LMR3, PPP1R101, TYKLM3" ENSG00000142235 "Lemur tyrosine kinase 3" Q96Q04 19 48485271-48513189 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.1" "Cell line enhanced" "Detected in many" "HMC-1: 8.4;SK-BR-3: 10.0;U-266/70: 9.3;U-266/84: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040203, HPA077070" Enhanced Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA040203: AB_10671690, HPA077070: " "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (5.37e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-1)" "unprognostic (1.71e-2)" "unprognostic (5.67e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-3)" "unprognostic (5.71e-2)" "unprognostic (1.47e-1)" "prognostic favourable (3.18e-8)" "unprognostic (1.38e-1)" "unprognostic (3.22e-2)" "unprognostic (3.24e-1)" "unprognostic (6.11e-2)" 1.3 4.4 19.8 2.3 28.6 2.0 2.0 20.0 38.1 2.0 1.5 6.0 0.2 6.2 1.4 1.5 2.3 1.6 1.9 1.7 17.2 11.1 2.5 1.3 3.2 2.2 6.5 23.8 1.3 2.1 8.5 6.1 2.1 12.5 3.5 1.2 1.6 5.2 3.1 1.2 2.4 4.0 1.2 6.6 1.8 2.9 1.5 10.3 0.0 2.3 0.0 2.2 1.6 1.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 4.5 3.0 0.3 0.0 0.0 0.0 4.4 0.0 0.2 0.0 0.1 2.2 3.6 1.6 1.2 0.0 2.1 0.3 1.6 0.0 0.0 1.2 0.2 0.3 0.7 0.0 0.0 8.4 0.2 0.9 0.0 0.0 0.1 1.4 2.8 0.0 3.0 0.6 0.8 1.1 0.9 3.8 0.0 1.3 1.1 0.7 0.7 2.8 0.1 10.0 0.0 3.8 0.2 0.1 0.0 0.8 0.1 0.0 9.3 7.5 0.4 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 19.8 28.6 20.0 38.1 17.2 11.1 6.5 23.8 12.5 10.3 LMX1A "LMX1, LMX1.1" ENSG00000162761 "LIM homeobox transcription factor 1 alpha" Q8TE12 1 165201867-165356715 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.3;pituitary gland: 8.0" "Cell line enriched" "Detected in single" 12 "SCLC-21H: 4.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028051, HPA030088" Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA028051: AB_10599731, HPA030088: AB_10601106" "unprognostic (1.73e-1)" "unprognostic (9.57e-2)" "unprognostic (7.58e-2)" "unprognostic (1.59e-1)" "unprognostic (2.17e-1)" "unprognostic (2.82e-1)" "unprognostic (2.63e-1)" "unprognostic (3.22e-2)" "unprognostic (2.10e-3)" "unprognostic (1.51e-1)" "unprognostic (9.82e-3)" 2.2 0.0 0.0 2.0 0.0 0.0 1.2 2.6 0.5 0.5 1.7 3.4 3.1 4.0 0.1 1.3 1.1 0.5 0.2 0.2 0.9 1.5 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.1 8.0 0.0 7.3 0.2 2.1 0.5 1.5 0.3 1.4 0.3 2.2 0.9 0.1 0.0 0.2 4.3 0.3 0.0 0.3 3.5 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.5 0.9 1.5 2.2 0.0 7.3 0.3 LONRF2 "FLJ45273, RNF192" ENSG00000170500 "LON peptidase N-terminal domain and ring finger 2" Q1L5Z9 2 100273291-100322733 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9;epididymis: 32.6" "Cell line enhanced" "Detected in some" "A549: 6.5;HAP1: 6.4;HEK 293: 6.9;HMC-1: 5.7;PC-3: 5.9;SCLC-21H: 14.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 15.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057366 Approved Supported Nucleoplasm Nucleoplasm "HPA057366: " "unprognostic (9.81e-2)" "unprognostic (4.97e-2)" "unprognostic (2.68e-2)" "unprognostic (3.20e-2)" "unprognostic (7.10e-2)" "unprognostic (7.72e-2)" "unprognostic (9.50e-2)" "unprognostic (9.86e-3)" "unprognostic (6.33e-2)" "unprognostic (1.32e-1)" "prognostic favourable (6.42e-5)" "unprognostic (1.14e-1)" "unprognostic (6.06e-2)" "unprognostic (3.45e-2)" "unprognostic (2.50e-2)" "unprognostic (2.66e-3)" "unprognostic (6.34e-2)" 1.6 23.0 8.4 0.6 32.9 0.2 2.2 21.1 15.4 5.1 1.7 1.3 2.3 0.5 19.0 32.6 2.0 17.8 1.7 4.3 5.6 9.9 1.3 0.7 1.5 0.5 3.9 7.0 10.5 4.4 9.6 7.8 0.6 6.4 3.2 0.7 1.6 1.5 3.2 4.6 0.4 0.5 19.8 4.5 0.5 1.5 1.8 4.3 0.4 3.5 0.8 0.4 1.4 1.3 0.7 0.5 1.7 0.4 0.7 0.5 0.1 0.0 6.5 2.0 2.4 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 1.2 0.0 1.1 0.0 0.0 6.4 0.0 0.0 0.5 6.9 0.0 0.4 0.0 0.2 0.1 5.7 0.0 0.0 0.3 0.0 0.0 3.7 0.1 0.0 4.2 0.0 0.3 0.4 5.9 0.0 0.0 0.0 1.6 0.2 14.1 3.8 0.0 0.0 1.0 3.5 0.1 0.1 0.1 0.8 0.0 0.4 0.0 0.0 0.0 2.8 0.0 0.3 1.1 0.4 0.4 0.3 0.3 0.3 0.4 0.3 0.3 0.2 0.7 0.4 0.5 1.7 0.7 0.3 0.5 0.2 0.1 8.4 32.9 21.1 9.7 5.6 9.9 3.9 7.0 6.4 4.3 LPAR1 "edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1" ENSG00000198121 "Lysophosphatidic acid receptor 1" Q92633 9 110873263-111038458 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4" "Cell line enhanced" "Detected in many" "ASC diff: 96.2;ASC TERT1: 56.2;BJ hTERT+: 68.0;HSkMC: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.5;eosinophil: 15.6" "Group enriched" "Detected in many" 6 "granulocytes: 15.6;monocytes: 7.5" "Low region specificity" "Detected in all" HPA050667 Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA050667: " "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (4.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.17e-2)" "unprognostic (2.10e-1)" "unprognostic (1.40e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (4.29e-3)" "unprognostic (2.12e-2)" "unprognostic (5.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.97e-3)" "unprognostic (1.65e-1)" 16.3 9.5 55.8 12.0 56.2 0.3 14.8 4.7 30.9 43.7 12.3 71.4 3.4 9.4 12.1 12.3 10.6 10.1 9.8 8.5 55.6 30.6 5.7 1.9 7.3 10.5 59.4 17.0 8.9 4.6 1.1 2.3 25.7 29.1 9.4 12.8 3.5 5.6 17.2 3.3 6.9 10.2 14.0 69.8 9.5 6.5 4.8 49.4 0.1 6.2 3.2 11.3 15.4 17.8 0.0 1.9 15.6 7.5 1.8 0.0 1.6 1.8 3.5 4.9 0.0 96.2 56.2 0.0 24.0 68.0 16.8 7.6 0.4 0.2 0.0 0.0 24.8 7.2 0.0 18.7 13.9 0.0 0.6 0.0 0.2 0.0 26.0 0.0 0.0 40.8 1.1 8.3 15.8 0.3 0.0 0.0 12.9 0.0 0.0 0.0 0.9 19.4 0.0 3.6 0.0 3.8 3.2 0.1 1.1 0.4 0.0 0.0 1.6 0.0 0.0 8.0 0.2 5.7 0.0 0.2 0.0 0.0 1.2 0.0 8.7 0.9 7.5 15.6 0.0 2.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.6 1.8 1.1 0.1 0.0 1.6 55.8 56.2 4.7 29.5 55.6 30.6 59.4 17.0 29.1 49.4 LPAR4 "GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9" ENSG00000147145 "Lysophosphatidic acid receptor 4" Q99677 X 78747709-78757094 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8;ovary: 10.0" "Cell line enhanced" "Detected in some" "AF22: 10.1;NTERA-2: 16.4;RH-30: 6.9;U-937: 3.9" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "basophil: 7.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046563, HPA054951, HPA055571" Uncertain Supported "Nuclear bodies,Vesicles,Plasma membrane" "Plasma membrane" "Nuclear bodies, Vesicles" "HPA046563: , HPA054951: , HPA055571: " "unprognostic (1.62e-1)" "unprognostic (3.53e-1)" "unprognostic (1.58e-1)" "unprognostic (5.81e-4)" "unprognostic (3.12e-2)" "unprognostic (4.85e-3)" "unprognostic (2.81e-1)" "unprognostic (2.57e-1)" "unprognostic (6.75e-2)" "unprognostic (6.73e-2)" "unprognostic (8.91e-2)" "unprognostic (4.86e-4)" "unprognostic (2.99e-5)" "unprognostic (9.27e-3)" "unprognostic (1.00e-1)" "unprognostic (3.58e-2)" "unprognostic (6.03e-3)" 1.5 0.2 6.0 1.0 2.1 0.6 2.0 4.9 3.7 1.8 0.9 7.4 0.7 0.2 2.9 0.8 1.8 1.1 2.1 1.9 15.8 1.4 0.3 0.3 0.3 0.2 2.4 4.0 10.0 0.7 0.1 0.7 0.2 3.6 0.6 1.2 0.5 1.0 1.6 0.2 1.6 0.9 1.3 3.8 0.4 1.5 0.8 5.6 0.0 0.6 0.8 1.2 1.4 0.9 0.0 0.5 7.4 0.0 0.0 0.0 0.1 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.6 1.1 1.4 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 2.3 0.0 0.4 1.8 16.4 0.2 0.8 6.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.2 0.0 0.6 1.4 0.0 0.7 0.7 3.9 1.6 7.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 6.0 2.1 4.9 3.5 15.8 1.4 2.4 4.0 3.6 5.6 LPAR5 "GPR92, GPR93, KPG_010, LPA5" ENSG00000184574 "Lysophosphatidic acid receptor 5" Q9H1C0 12 6618835-6636447 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 28.4;brain: 20.3;esophagus: 21.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.5;HEL: 13.7;HMC-1: 19.9;K-562: 10.2;U-698: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 28.4;T-cells: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013170 Approved "HPA013170: AB_1849314" "unprognostic (1.94e-1)" "unprognostic (6.43e-2)" "unprognostic (1.78e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (1.37e-1)" "unprognostic (5.95e-2)" "unprognostic (3.45e-1)" "unprognostic (1.41e-2)" "unprognostic (3.62e-3)" "unprognostic (2.07e-1)" "unprognostic (6.27e-2)" "unprognostic (7.99e-3)" "unprognostic (5.43e-1)" "prognostic favourable (6.56e-5)" "unprognostic (7.43e-2)" 2.1 3.2 11.2 5.6 12.4 1.1 1.6 1.3 8.9 5.8 10.2 20.3 0.5 11.2 0.7 3.2 21.1 2.0 1.9 3.6 10.9 4.0 1.3 1.5 2.1 9.2 9.3 4.0 0.9 0.8 0.9 1.4 7.2 9.2 1.7 9.7 1.7 6.3 1.6 0.3 6.8 9.3 1.3 11.7 10.6 8.3 1.7 13.6 2.2 2.0 1.1 13.5 3.4 9.0 28.4 5.5 2.5 1.8 1.3 23.9 6.5 4.0 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 7.5 3.2 1.0 0.0 5.2 0.0 2.2 0.0 0.0 0.0 13.7 0.4 0.3 0.0 0.0 19.9 0.0 2.5 0.1 1.1 0.0 10.2 0.0 0.0 0.3 0.4 4.3 0.0 0.7 3.5 0.0 0.0 0.0 2.4 0.1 0.1 2.0 0.0 0.0 0.0 1.6 0.1 0.0 3.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 2.5 0.1 0.0 23.9 1.0 18.0 28.4 4.0 14.1 5.5 27.8 4.0 8.9 0.2 1.3 1.8 0.3 5.4 6.5 11.2 12.4 1.3 8.9 10.9 4.0 9.3 4.0 9.2 13.6 LRFN1 "KIAA1484, SALM2" ENSG00000128011 "Leucine rich repeat and fibronectin type III domain containing 1" Q9P244 19 39306568-39315336 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.5" "Cell line enhanced" "Detected in many" "CACO-2: 14.6;HEK 293: 17.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (4.92e-3)" "unprognostic (2.00e-1)" "unprognostic (6.36e-4)" "prognostic unfavourable (3.31e-5)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (1.87e-2)" "unprognostic (6.75e-2)" "unprognostic (4.25e-1)" "prognostic unfavourable (3.13e-4)" "unprognostic (1.45e-3)" "unprognostic (1.08e-1)" "unprognostic (0.00e+0)" "unprognostic (1.89e-3)" "unprognostic (2.10e-2)" "unprognostic (1.31e-3)" "unprognostic (1.78e-1)" 1.6 0.3 5.5 1.3 3.4 1.1 0.6 9.5 9.0 0.4 0.6 1.0 1.2 1.4 0.2 0.6 0.3 0.2 5.2 6.6 0.3 0.5 0.9 1.0 2.9 0.3 2.0 0.2 0.1 0.5 1.1 0.4 2.0 0.3 0.2 1.4 1.5 0.7 1.0 3.8 0.7 0.6 0.3 0.6 0.2 0.0 0.3 0.4 3.2 0.8 1.8 1.0 0.0 1.0 4.7 0.1 4.0 0.0 0.0 5.0 0.1 0.0 0.2 0.1 14.6 0.6 0.4 1.9 0.0 0.2 1.9 0.1 0.1 0.4 17.9 0.7 0.7 0.6 0.1 0.3 3.8 0.3 0.2 0.1 0.0 0.1 7.4 0.4 0.0 2.4 1.9 2.3 2.0 4.9 6.3 0.0 1.5 0.0 0.2 1.4 7.2 1.6 3.1 1.2 1.5 1.5 0.3 1.7 5.8 1.4 0.1 0.7 0.2 1.7 0.1 0.9 0.5 1.7 0.3 3.2 1.0 0.2 0.9 0.1 0.4 1.0 0.0 0.3 0.5 0.7 2.6 1.8 0.8 0.4 0.3 0.0 LRFN2 "FIGLER2, KIAA1246, SALM1" ENSG00000156564 "Leucine rich repeat and fibronectin type III domain containing 2" Q9ULH4 6 40391586-40587465 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 21.7" "Group enriched" "Detected in some" 5 "REH: 3.4;SH-SY5Y: 10.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 1.8;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;T-cells: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA076660 Enhanced Supported Vesicles Vesicles "HPA076660: " "unprognostic (1.93e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (4.58e-4)" "unprognostic (3.10e-1)" "unprognostic (1.21e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-3)" "unprognostic (4.94e-2)" "unprognostic (1.80e-1)" "unprognostic (9.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (1.64e-1)" "unprognostic (2.98e-1)" "unprognostic (1.16e-1)" "unprognostic (2.66e-4)" 0.5 1.4 5.9 0.5 7.6 1.3 0.6 4.5 21.7 0.5 0.8 0.0 0.0 0.5 0.6 0.4 1.8 0.6 0.6 0.4 5.0 5.2 0.5 0.4 0.4 0.5 2.3 7.4 2.1 0.7 0.4 0.6 0.5 0.9 0.5 0.7 2.7 0.4 0.4 0.4 0.5 0.5 0.5 0.8 3.1 0.7 2.5 0.5 0.0 0.7 0.0 0.6 0.5 0.2 0.0 1.3 0.0 0.0 0.3 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 3.4 0.0 0.0 0.0 0.3 1.4 10.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.4 0.0 0.3 0.0 1.3 0.0 0.2 5.9 7.6 4.5 21.7 5.0 5.2 2.3 7.4 0.9 0.5 LRFN5 "C14orf146, FIGLER8, SALM5" ENSG00000165379 "Leucine rich repeat and fibronectin type III domain containing 5" Q96NI6 14 41607570-41904549 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;parathyroid gland: 38.4" "Cell line enhanced" "Detected in some" "AN3-CA: 17.3;HSkMC: 3.5;RPTEC TERT1: 5.9;SCLC-21H: 9.1;U-138 MG: 11.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001177 Uncertain "Intracellular and membrane" "HPA001177: AB_1079274" "unprognostic (5.23e-3)" "unprognostic (1.37e-1)" "unprognostic (5.10e-1)" "unprognostic (6.24e-2)" "unprognostic (2.39e-1)" "unprognostic (3.54e-1)" "unprognostic (1.31e-1)" "unprognostic (6.38e-3)" "unprognostic (2.61e-2)" "unprognostic (5.78e-2)" "unprognostic (2.70e-2)" "unprognostic (9.27e-2)" "unprognostic (6.02e-3)" "unprognostic (3.79e-3)" "unprognostic (1.98e-1)" "unprognostic (6.07e-3)" "unprognostic (2.92e-3)" 1.5 3.3 7.9 1.7 9.3 0.5 2.4 3.1 19.1 13.7 2.2 0.8 1.3 0.8 3.8 1.5 1.2 5.0 1.9 0.9 12.2 9.5 0.9 0.6 1.2 0.6 4.3 11.9 2.7 0.9 38.4 1.0 1.8 8.7 3.7 1.9 0.9 0.8 9.3 0.8 1.0 0.9 9.3 1.6 1.2 1.0 1.7 1.2 0.0 1.0 0.0 0.8 7.8 6.3 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.8 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.1 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.9 9.3 3.1 19.1 12.2 9.5 4.3 11.9 8.7 1.2 LRGUK "CFAP246, FLJ32786" ENSG00000155530 "Leucine rich repeats and guanylate kinase domain containing" Q96M69 7 134127299-134264591 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.5;pituitary gland: 11.5;testis: 22.4" "Cell line enhanced" "Detected in some" "NTERA-2: 5.0;SH-SY5Y: 4.8;SK-MEL-30: 5.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029505, HPA029506" Uncertain "HPA029505: AB_10599606, HPA029506: AB_10601752" "unprognostic (4.08e-3)" "unprognostic (1.87e-1)" "unprognostic (6.94e-2)" "unprognostic (1.01e-2)" "unprognostic (2.31e-2)" "unprognostic (2.64e-2)" "unprognostic (7.85e-4)" "unprognostic (6.92e-2)" "unprognostic (2.43e-1)" "unprognostic (4.28e-2)" "unprognostic (5.57e-3)" "unprognostic (1.10e-1)" "unprognostic (1.27e-3)" "unprognostic (2.22e-3)" "unprognostic (3.83e-2)" "unprognostic (3.01e-3)" "unprognostic (2.10e-2)" 0.7 0.6 2.3 0.6 6.4 1.3 1.2 0.5 1.4 1.2 0.5 4.1 0.3 0.5 1.5 4.0 0.4 9.1 0.7 0.4 2.4 1.2 1.2 0.9 3.4 0.4 0.3 0.6 2.4 1.9 0.4 11.5 0.4 12.5 1.6 0.7 2.2 1.3 0.5 0.2 1.2 0.5 0.5 1.6 1.3 0.6 22.4 0.9 0.0 2.2 0.0 0.6 0.5 0.4 0.5 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.4 0.7 1.1 0.1 0.3 0.3 0.0 0.1 0.5 0.4 0.0 0.9 0.2 0.3 0.1 0.3 0.4 0.1 0.8 0.5 0.5 0.1 0.3 0.2 0.1 0.2 0.5 0.3 0.7 0.9 0.0 0.2 0.2 0.8 0.8 0.2 0.3 0.6 5.0 1.2 0.7 0.1 0.0 0.8 0.4 1.6 4.8 1.5 0.0 5.0 0.2 1.1 0.0 0.3 0.5 0.3 0.6 1.1 1.7 1.5 1.3 0.2 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 6.4 0.5 1.4 2.4 1.2 0.3 0.6 12.5 0.9 LRP1B "LRP-DIT, LRPDIT" ENSG00000168702 "LDL receptor related protein 1B" Q9NZR2 2 140231423-142131701 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7;thyroid gland: 14.9" "Cell line enhanced" "Detected in some" "ASC diff: 4.2;HEK 293: 4.4;HeLa: 2.3;HSkMC: 2.1;U-138 MG: 4.9;U-87 MG: 2.5" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "myeloid DC: 1.4;plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.4" "Low region specificity" "Detected in all" "HPA069094, HPA074788" Approved Approved Vesicles 63000 Vesicles "HPA069094: , HPA074788: " "unprognostic (5.31e-4)" "unprognostic (3.68e-2)" "unprognostic (2.61e-1)" "unprognostic (7.36e-4)" "unprognostic (5.19e-2)" "unprognostic (1.26e-1)" "unprognostic (2.00e-2)" "unprognostic (3.49e-1)" "unprognostic (3.75e-1)" "unprognostic (7.02e-3)" "unprognostic (1.64e-3)" "unprognostic (1.05e-1)" "unprognostic (2.94e-3)" "unprognostic (4.85e-3)" "unprognostic (1.52e-1)" "unprognostic (1.66e-2)" "unprognostic (1.36e-1)" 4.8 4.5 17.6 1.3 14.1 1.2 2.6 23.2 25.7 1.4 1.3 6.5 0.0 1.2 1.3 6.8 1.3 1.9 1.4 1.6 18.3 9.3 2.2 1.6 1.4 1.2 10.8 16.7 3.0 1.2 1.1 12.7 1.2 12.8 3.5 1.3 0.1 2.5 3.8 10.5 1.7 1.3 1.3 8.2 1.2 1.5 1.9 10.6 0.0 14.9 0.0 1.3 1.2 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 4.2 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.9 0.2 0.2 0.6 4.4 0.0 2.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.2 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 17.6 14.1 23.2 21.3 18.3 9.3 10.8 16.7 12.8 10.6 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856868-46918642 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;skin 1: 33.0" "Cell line enhanced" "Detected in many" "AF22: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 1.2 1.9 16.0 1.3 20.3 0.5 2.1 7.3 23.7 3.0 5.4 11.6 0.6 3.9 2.1 1.3 2.4 2.0 2.5 7.2 20.4 5.8 1.2 0.7 3.4 0.5 9.6 12.6 5.4 2.7 9.3 3.3 3.1 14.5 2.7 4.1 1.3 2.1 3.0 4.4 33.0 5.3 2.0 9.7 4.2 9.6 1.6 19.0 0.0 2.9 1.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.6 17.3 5.2 10.8 2.9 4.0 0.7 1.5 2.3 2.6 2.2 0.0 0.0 1.1 8.9 3.1 9.6 5.9 1.8 0.0 8.1 0.8 3.0 5.3 2.3 0.1 1.5 3.7 3.4 3.6 0.9 2.0 0.7 0.0 1.3 0.6 0.1 0.2 9.4 0.7 1.2 5.9 0.0 0.2 2.2 0.0 11.4 0.9 0.0 2.8 0.2 0.4 0.1 4.7 2.9 5.3 1.6 0.0 0.0 0.3 3.5 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 20.3 7.3 17.3 20.4 5.8 9.6 12.6 14.5 19.0 LRRC10B ENSG00000204950 "Leucine rich repeat containing 10B" A6NIK2 11 61508800-61511018 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8" "Group enriched" "Detected in some" 5 "AF22: 11.9;RH-30: 12.8;SCLC-21H: 6.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "basal ganglia: 202.0" "Group enriched" "Detected in many" 5 "basal ganglia: 39.3;hippocampal formation: 35.0" HPA047619 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA047619: " "unprognostic (9.95e-2)" "unprognostic (2.67e-2)" "unprognostic (4.92e-2)" "unprognostic (1.26e-2)" "unprognostic (2.11e-1)" "unprognostic (1.32e-1)" "unprognostic (6.10e-2)" "unprognostic (9.22e-2)" "unprognostic (4.88e-3)" "unprognostic (1.62e-1)" "unprognostic (9.21e-3)" "unprognostic (2.52e-2)" "unprognostic (5.27e-4)" "unprognostic (5.07e-2)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (6.63e-2)" 2.4 1.6 4.8 0.9 27.8 0.5 1.9 0.2 5.8 3.4 1.6 1.2 1.0 0.9 2.2 3.7 1.1 36.2 0.8 1.2 5.2 1.9 0.9 0.6 3.7 0.5 1.1 4.3 3.0 1.5 2.1 14.8 1.2 1.2 0.9 1.0 0.0 1.1 1.2 0.7 0.5 0.9 2.5 0.2 0.6 1.0 2.4 8.3 0.9 0.8 0.2 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.0 12.8 0.0 0.0 0.0 6.7 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 27.8 0.2 5.8 5.2 1.9 1.1 4.3 1.2 8.3 LRRC24 LRRC14OS ENSG00000254402 "Leucine rich repeat containing 24" Q50LG9 8 144522377-144527032 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.9" "Cell line enhanced" "Detected in some" "MCF7: 4.1;SCLC-21H: 4.4;SH-SY5Y: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028171, HPA052250" Enhanced Approved Vesicles Vesicles "HPA028171: , HPA052250: " "unprognostic (1.75e-1)" "unprognostic (5.76e-2)" "unprognostic (2.33e-3)" "unprognostic (3.63e-2)" 2.5 4.0 5.1 1.4 9.3 1.7 1.5 12.3 16.9 2.3 2.1 1.6 0.6 2.0 2.5 1.7 1.7 2.8 1.3 1.5 4.5 7.9 2.2 1.6 2.0 1.4 4.5 8.4 4.5 3.2 9.3 8.4 1.5 5.9 11.4 1.1 10.3 2.8 3.2 2.3 1.7 2.0 1.6 2.1 2.2 1.9 1.5 1.3 0.6 1.6 1.0 1.1 1.4 1.6 0.0 0.5 0.0 0.1 0.1 0.5 0.0 0.3 0.8 0.6 1.5 0.8 0.5 1.8 0.5 0.6 0.6 0.6 0.2 1.6 0.8 3.4 0.2 0.1 0.0 0.0 0.1 1.2 2.2 0.5 1.0 0.3 0.6 0.0 1.0 0.7 0.4 0.5 0.1 0.3 0.9 0.1 0.1 4.1 1.2 1.6 0.1 0.8 1.8 0.1 0.6 0.1 0.5 4.4 12.2 0.4 0.1 0.4 3.7 1.3 0.0 0.1 1.2 0.4 0.2 1.0 0.1 0.1 0.6 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 9.3 12.3 16.9 4.5 7.9 4.5 8.4 5.9 1.3 LRRC37B ENSG00000185158 "Leucine rich repeat containing 37B" Q96QE4 17 32007872-32053504 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 2.8;NK-cells: 6.4;T-cells: 4.9" HPA015135 Approved Approved Cytosol Cytosol "HPA015135: AB_1853309" "unprognostic (5.46e-3)" "unprognostic (2.56e-2)" "unprognostic (5.08e-2)" "unprognostic (5.30e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-1)" "unprognostic (3.60e-2)" "unprognostic (9.65e-3)" "unprognostic (5.06e-2)" "unprognostic (3.19e-2)" "unprognostic (1.72e-4)" "unprognostic (6.99e-2)" "unprognostic (5.72e-3)" "unprognostic (6.94e-2)" "unprognostic (3.35e-2)" "unprognostic (4.97e-2)" "unprognostic (1.36e-3)" 4.7 5.0 13.7 4.8 15.0 28.5 6.4 35.5 14.4 5.9 5.2 7.2 5.0 4.5 8.3 6.5 4.6 8.2 4.8 2.7 10.7 8.5 3.7 3.0 6.7 5.5 8.6 10.2 12.1 4.3 7.4 13.8 4.6 8.9 5.3 6.4 6.1 6.5 4.2 3.5 11.7 6.3 7.2 8.5 7.6 6.6 24.5 10.3 8.3 4.4 1.8 5.8 5.3 10.2 0.8 1.1 2.8 0.5 6.4 4.9 0.5 2.0 3.9 12.4 7.0 3.1 3.9 3.8 1.8 7.0 5.4 7.0 5.4 2.0 5.6 4.0 4.2 2.8 7.3 1.5 4.3 1.6 6.2 2.6 5.7 2.0 4.6 9.9 4.7 4.1 4.6 5.0 12.6 4.6 6.0 5.4 2.0 1.9 17.3 15.4 3.7 2.6 12.3 2.9 4.5 3.1 5.2 2.3 3.9 4.7 3.1 6.4 8.1 16.1 3.8 3.8 2.6 8.5 4.6 5.4 7.6 5.5 2.7 10.1 2.7 0.0 0.4 2.8 1.1 0.5 2.1 0.2 2.2 3.0 0.8 0.8 3.0 0.8 1.1 6.4 0.2 1.1 4.9 0.5 13.7 15.0 35.5 14.4 10.7 8.5 8.6 10.2 8.9 10.3 LRRC3B LRP15 ENSG00000179796 "Leucine rich repeat containing 3B" Q96PB8 3 26622806-26710776 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 21.3;skeletal muscle: 17.4;testis: 12.0" "Group enriched" "Detected in some" 4 "NTERA-2: 5.4;REH: 2.5;THP-1: 3.2" "Group enriched" "Detected in some" 9 "endometrial cancer: 0.7;glioma: 2.6;ovarian cancer: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015568 Approved "HPA015568: AB_1853282" "unprognostic (1.22e-2)" "unprognostic (2.94e-1)" "unprognostic (1.87e-1)" "unprognostic (7.42e-2)" "unprognostic (8.82e-4)" "unprognostic (2.84e-2)" "unprognostic (1.55e-1)" "unprognostic (2.77e-1)" "unprognostic (1.91e-4)" "unprognostic (3.31e-2)" "unprognostic (2.63e-1)" "unprognostic (1.60e-1)" "unprognostic (2.82e-1)" 0.8 0.9 15.5 0.7 13.6 0.6 1.6 18.5 21.3 0.8 1.2 2.2 0.0 0.8 2.3 0.7 1.5 1.6 0.7 1.4 9.5 7.3 0.8 0.8 0.8 0.6 8.7 5.6 2.9 0.6 0.7 0.8 0.7 5.7 0.8 1.9 3.0 1.9 1.1 17.4 0.7 1.2 2.0 4.9 0.8 1.5 12.0 1.7 0.0 0.7 0.1 0.7 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.4 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.5 13.6 18.5 10.1 9.5 7.3 8.7 5.6 5.7 1.7 LRRC4 NAG14 ENSG00000128594 "Leucine rich repeat containing 4" Q9HBW1 7 128027071-128032107 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2" "Group enriched" "Detected in some" 6 "AF22: 10.5;NTERA-2: 23.3;REH: 21.4;SCLC-21H: 11.9;SH-SY5Y: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 14.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051100 Approved "Golgi apparatus" 1100000 "Golgi apparatus" "HPA051100: " "unprognostic (7.98e-2)" "unprognostic (6.15e-3)" "unprognostic (2.85e-2)" "prognostic favourable (8.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.34e-3)" "unprognostic (3.43e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (7.63e-2)" "unprognostic (3.23e-2)" "unprognostic (1.72e-1)" "prognostic favourable (6.98e-4)" "unprognostic (4.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-1)" "unprognostic (5.84e-3)" 2.6 7.7 11.6 2.9 13.1 10.0 0.8 22.3 33.2 2.3 1.1 3.2 0.7 0.9 3.4 0.5 4.0 7.3 3.4 2.0 10.1 6.6 4.6 2.2 6.3 1.9 5.1 15.5 5.5 0.6 8.6 1.5 4.7 3.1 0.9 0.8 1.7 1.5 3.5 1.0 0.5 1.0 1.9 3.4 4.7 1.5 6.3 2.9 0.8 0.8 3.6 2.4 1.5 2.0 0.0 0.0 14.3 0.6 0.0 0.1 0.1 0.0 0.1 10.5 0.0 0.4 0.0 0.0 0.6 0.0 0.9 0.3 0.0 0.0 0.0 0.7 0.9 1.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.0 1.2 0.0 0.1 0.0 23.3 0.0 21.4 0.0 0.2 0.1 0.0 11.9 7.4 0.0 0.0 0.9 0.0 2.3 0.3 0.7 0.1 0.1 0.5 0.0 0.0 0.0 0.1 0.0 1.5 0.5 0.3 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.3 0.0 0.6 0.0 0.0 0.1 11.6 13.1 22.3 28.4 10.1 6.6 5.1 15.5 3.1 2.9 LRRC4B "DKFZp761A179, HSM, LRIG4" ENSG00000131409 "Leucine rich repeat containing 4B" Q9NT99 19 50516892-50568045 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.9" "Cell line enhanced" "Detected in some" "HMC-1: 21.7;SH-SY5Y: 18.9;U-2 OS: 17.8;WM-115: 6.7" "Group enriched" "Detected in many" 9 "glioma: 36.5;testis cancer: 9.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058986 Uncertain 2300000 "HPA058986: " "unprognostic (1.52e-2)" "unprognostic (1.14e-1)" "unprognostic (4.46e-2)" "unprognostic (4.48e-2)" "unprognostic (3.56e-1)" "unprognostic (5.39e-4)" "unprognostic (2.70e-2)" "unprognostic (1.11e-1)" "unprognostic (5.28e-2)" "unprognostic (4.61e-3)" "unprognostic (1.11e-3)" "unprognostic (3.41e-1)" "unprognostic (3.15e-5)" "unprognostic (4.29e-2)" "unprognostic (2.61e-1)" "unprognostic (3.64e-1)" "unprognostic (2.17e-1)" 3.0 8.8 28.7 2.3 24.6 1.2 1.3 21.7 52.9 13.4 2.3 4.0 0.0 2.3 9.4 1.4 3.3 3.6 2.8 2.5 23.4 22.9 1.7 1.7 3.6 2.7 17.8 20.6 2.8 1.7 1.3 8.8 6.9 12.8 2.2 1.4 2.2 2.3 2.8 1.7 1.7 3.2 3.1 15.0 1.9 2.4 2.3 8.5 0.0 1.8 0.0 1.9 3.2 3.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 3.5 0.3 0.0 0.6 0.1 0.0 5.6 0.0 5.9 0.0 0.1 0.0 0.0 0.0 18.9 0.0 0.0 3.7 0.0 0.1 0.0 0.0 17.8 0.0 0.0 0.4 0.0 0.0 0.1 0.2 6.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 28.7 24.6 21.7 31.9 23.4 22.9 17.8 20.6 12.8 8.5 LRRC4C "KIAA1580, NGL-1" ENSG00000148948 "Leucine rich repeat containing 4C" Q9HCJ2 11 40114203-41459773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 31.5" "Group enriched" "Detected in some" 6 "AF22: 16.9;U-2 OS: 18.6" "Cancer enhanced" "Detected in some" "glioma: 3.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "naive B-cell: 1.7" "Lineage enriched" "Detected in single" 18 "B-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054800, HPA075816" Approved Approved Cytosol Cytosol "HPA054800: , HPA075816: " "unprognostic (4.86e-3)" "unprognostic (3.43e-2)" "unprognostic (7.62e-3)" "unprognostic (4.87e-3)" "unprognostic (6.48e-2)" "unprognostic (1.42e-1)" "unprognostic (2.84e-1)" "unprognostic (4.64e-2)" "unprognostic (1.93e-1)" "unprognostic (2.22e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-1)" "unprognostic (4.90e-13)" "unprognostic (5.05e-4)" "unprognostic (5.21e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-3)" 1.6 5.7 20.2 1.6 23.7 0.5 2.6 3.6 31.5 5.3 1.9 3.3 0.0 1.1 2.3 1.0 1.2 1.3 1.8 2.6 16.7 8.7 0.9 2.1 1.6 1.4 7.5 10.3 1.6 1.0 4.3 3.2 0.5 8.7 1.5 1.6 1.3 1.4 3.0 0.7 0.7 1.3 2.4 6.0 1.3 0.9 0.9 7.9 0.0 4.0 0.0 1.6 1.1 1.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 23.7 3.6 16.4 16.7 8.7 7.5 10.3 8.7 7.9 LRRC53 ENSG00000162621 "Leucine rich repeat containing 53" A6NM62 1 74469878-74512614 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "brain: 2.9" "Cell line enriched" "Detected in single" 17 "SCLC-21H: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA054062 Uncertain "HPA054062: " "unprognostic (3.67e-1)" 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.6 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.5 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 LRRC55 FLJ45686 ENSG00000183908 "Leucine rich repeat containing 55" Q6ZSA7 11 57181747-57191717 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 9.2;lymphoid tissue: 24.4" "Cell line enriched" "Detected in some" 4 "AF22: 20.5" "Group enriched" "Detected in some" 9 "glioma: 9.0;ovarian cancer: 2.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" "Low region specificity" "Detected in many" HPA014053 Uncertain "HPA014053: AB_2137630" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (3.68e-2)" "unprognostic (3.03e-2)" "unprognostic (2.78e-3)" "unprognostic (2.29e-3)" "unprognostic (2.30e-1)" "unprognostic (1.43e-1)" "unprognostic (2.26e-2)" "unprognostic (3.39e-1)" "unprognostic (9.43e-2)" "unprognostic (2.11e-2)" "unprognostic (3.32e-2)" "unprognostic (7.17e-4)" "unprognostic (6.66e-2)" "unprognostic (3.59e-1)" "unprognostic (3.79e-2)" 0.8 1.0 2.2 3.4 2.3 0.0 0.1 0.8 9.2 0.1 0.9 0.4 0.1 0.6 3.1 0.1 1.2 0.7 0.6 0.5 2.7 7.3 0.6 2.5 1.5 24.4 6.9 0.5 0.6 0.4 0.0 0.1 2.9 1.7 0.1 1.0 0.1 3.4 0.1 0.6 0.1 0.9 2.2 7.3 2.6 0.1 0.2 0.1 2.2 0.2 2.1 1.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.2 2.3 0.8 3.7 2.7 7.3 6.9 0.5 1.7 0.1 LRRC63 RP11-139H14.4 ENSG00000173988 "Leucine rich repeat containing 63" 13 46211943-46277366 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 16.3;epididymis: 7.2" "Cell line enhanced" "Detected in some" "HDLM-2: 4.6;MOLT-4: 2.1;THP-1: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.7" "Low lineage specificity" "Detected in single" "HPA039318, HPA039763" Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA039318: AB_10796224, HPA039763: AB_10795408" "unprognostic (3.40e-2)" "unprognostic (2.81e-1)" "unprognostic (5.33e-1)" "unprognostic (2.12e-3)" "unprognostic (1.96e-1)" "unprognostic (3.99e-1)" "unprognostic (1.06e-2)" "unprognostic (7.28e-2)" "unprognostic (3.05e-2)" "unprognostic (1.11e-1)" "unprognostic (5.39e-2)" "unprognostic (7.61e-2)" "unprognostic (1.18e-6)" "unprognostic (1.27e-1)" "unprognostic (2.98e-1)" "unprognostic (4.57e-2)" "unprognostic (7.31e-2)" 0.6 1.3 1.5 1.0 9.9 1.0 0.7 0.7 5.0 1.2 0.7 11.9 0.0 0.6 0.5 7.2 0.5 1.3 0.4 0.5 3.0 1.8 0.8 0.7 1.1 1.3 16.3 2.3 0.5 0.5 0.7 0.5 0.7 10.0 1.1 0.7 0.7 0.7 0.8 0.5 0.6 0.6 0.4 15.9 0.8 0.8 6.2 10.0 3.6 0.6 0.0 0.4 0.8 0.5 0.0 0.9 0.2 0.1 0.0 1.8 0.5 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.4 4.6 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.2 0.0 2.4 0.0 0.1 0.0 0.0 0.5 1.0 0.4 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.4 0.4 0.1 0.0 1.8 1.7 0.2 0.0 0.0 0.9 0.0 0.5 1.5 9.9 0.7 5.0 3.0 1.8 16.3 2.3 10.0 10.0 LRRC7 "densin-180, KIAA1365" ENSG00000033122 "Leucine rich repeat containing 7" Q96NW7 1 69568398-70151945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 29.1" "Group enriched" "Detected in some" 6 "HaCaT: 10.3;HEL: 30.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3" "Group enriched" "Detected in many" 14 "granulocytes: 1.4;T-cells: 1.7" "Low region specificity" "Detected in many" HPA005625 Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA005625: AB_1853340" "unprognostic (2.81e-2)" "unprognostic (1.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.98e-3)" "unprognostic (2.47e-1)" "unprognostic (1.73e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (4.84e-3)" "unprognostic (2.92e-2)" "unprognostic (1.06e-3)" "unprognostic (1.46e-1)" "unprognostic (5.64e-6)" "unprognostic (1.31e-2)" "unprognostic (1.74e-2)" "unprognostic (5.13e-3)" "unprognostic (2.08e-3)" 1.0 1.3 20.2 1.0 29.1 1.0 0.8 0.5 21.9 1.2 1.9 5.0 0.0 1.0 1.2 1.0 1.3 0.8 3.2 2.8 15.4 5.8 2.8 1.2 0.8 0.9 4.4 17.6 1.0 2.7 0.7 0.4 1.2 2.4 1.5 2.4 0.2 0.9 1.1 2.8 1.1 1.3 1.2 2.5 0.8 0.8 5.8 7.6 0.0 6.7 0.0 0.8 0.9 0.5 0.0 0.1 1.4 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 3.3 0.0 10.3 0.2 0.0 0.0 0.0 0.5 30.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 20.2 29.1 0.5 19.2 15.4 5.8 4.4 17.6 2.4 7.6 LRRC71 "C1orf92, FLJ32884" ENSG00000160838 "Leucine rich repeat containing 71" Q8N4P6 1 156920650-156933094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;fallopian tube: 16.9;testis: 26.4" "Cell line enhanced" "Detected in some" "HBEC3-KT: 8.2;PC-3: 3.7;TIME: 3.3;U-2 OS: 1.6" "Cancer enriched" "Detected in single" 7 "endometrial cancer: 3.3" "Region enhanced" "Detected in many" "pons and medulla: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "unprognostic (8.91e-2)" "unprognostic (4.21e-2)" "unprognostic (6.13e-2)" "unprognostic (1.95e-3)" "unprognostic (5.43e-2)" "unprognostic (3.98e-2)" "unprognostic (1.28e-1)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (8.02e-2)" "unprognostic (5.07e-3)" "unprognostic (5.18e-1)" "unprognostic (1.68e-7)" "unprognostic (2.29e-1)" "unprognostic (5.18e-2)" "unprognostic (1.23e-1)" "unprognostic (1.56e-2)" 0.3 0.8 1.1 0.1 4.0 0.1 0.1 0.0 0.3 1.1 0.1 5.6 0.0 0.1 0.5 5.6 0.1 16.9 0.1 0.1 1.7 1.8 0.1 0.1 3.0 0.1 0.2 0.4 3.6 0.1 0.1 0.0 0.3 9.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 26.4 1.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 4.0 0.0 0.3 1.7 1.8 0.2 0.4 9.5 1.2 LRRC73 "C6orf154, dJ337H4.2" ENSG00000204052 "Leucine rich repeat containing 73" Q5JTD7 6 43506969-43510686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5;testis: 31.6" "Cell line enhanced" "Detected in some" "AN3-CA: 6.2;MCF7: 6.2;T-47d: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046698 Enhanced Approved Cytosol Cytosol "HPA046698: AB_10959526" "unprognostic (3.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.13e-1)" "unprognostic (4.42e-3)" "unprognostic (1.04e-2)" "unprognostic (3.52e-1)" "unprognostic (6.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.25e-1)" "unprognostic (1.01e-1)" "unprognostic (2.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.81e-1)" "unprognostic (2.72e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-3)" "unprognostic (1.89e-2)" 1.2 6.1 10.4 0.9 19.4 0.8 1.1 2.3 23.5 1.4 1.3 2.3 0.9 2.1 1.4 1.5 1.0 11.3 1.8 1.8 8.9 5.2 3.0 1.2 1.6 0.9 3.1 12.1 2.0 2.8 7.5 4.1 1.2 6.2 1.9 1.1 0.6 1.4 2.1 1.0 1.1 1.2 1.5 1.1 1.2 1.8 31.6 1.8 0.0 1.6 0.0 0.9 1.4 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.9 6.2 1.0 3.2 0.2 0.2 1.8 0.5 0.3 0.0 0.3 0.2 0.1 1.1 2.4 0.7 0.7 0.0 0.1 1.0 0.0 0.4 0.2 1.0 0.0 0.1 0.5 1.2 2.0 0.3 0.2 0.4 0.6 1.1 6.2 0.0 0.1 0.1 0.8 0.0 0.0 0.1 1.6 0.0 2.3 2.7 0.6 0.4 0.2 6.3 0.0 0.3 0.5 0.6 2.3 0.2 0.6 0.4 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 19.4 2.3 23.5 8.9 5.2 3.1 12.1 6.2 1.8 LRRC74B ENSG00000187905 "Leucine rich repeat containing 74B" Q6ZQY2 22 21045960-21064168 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 17.1;epididymis: 5.6;fallopian tube: 11.4" "Cell line enhanced" "Detected in some" "U-138 MG: 1.6;U-87 MG: 3.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "pons and medulla: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049947 Uncertain "HPA049947: " "unprognostic (3.43e-2)" "unprognostic (1.76e-1)" "unprognostic (3.28e-4)" "unprognostic (1.06e-1)" "unprognostic (6.44e-3)" "unprognostic (2.23e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (1.64e-2)" "unprognostic (1.18e-1)" "unprognostic (7.57e-9)" "unprognostic (4.20e-1)" "unprognostic (1.23e-1)" "unprognostic (2.10e-2)" "unprognostic (4.92e-2)" 0.2 0.2 2.1 0.2 2.3 0.2 0.2 0.4 1.6 1.5 0.2 3.7 0.0 0.4 0.3 5.6 0.2 11.4 0.2 0.2 1.5 1.2 0.2 0.2 1.9 0.2 0.1 0.7 1.9 0.2 0.2 0.9 0.2 17.1 0.2 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.5 0.2 0.2 3.6 0.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.3 0.4 1.6 1.5 1.2 0.1 0.7 17.1 0.3 LRRC8B "KIAA0231, TA-LRRP" ENSG00000197147 "Leucine rich repeat containing 8 VRAC subunit B" Q6P9F7 1 89524836-89597864 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8" "Cell line enhanced" "Detected in many" "HAP1: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017950 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA017950: AB_1853346" "unprognostic (2.50e-2)" "unprognostic (3.93e-2)" "prognostic favourable (7.15e-4)" "prognostic unfavourable (9.99e-4)" "unprognostic (1.22e-1)" "unprognostic (5.24e-2)" "unprognostic (3.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-2)" "unprognostic (1.72e-1)" "unprognostic (8.80e-3)" "unprognostic (2.30e-2)" "unprognostic (1.85e-1)" "unprognostic (4.17e-2)" "unprognostic (2.06e-1)" 8.1 18.0 13.0 4.4 19.3 3.0 6.6 2.5 27.8 3.8 5.6 15.4 0.5 7.4 2.6 6.9 5.0 4.3 6.2 3.3 15.3 6.5 4.9 4.8 5.8 4.9 8.8 17.1 2.6 8.5 12.4 5.1 2.4 8.3 5.6 6.8 4.4 5.0 1.6 5.9 6.9 4.9 3.6 16.2 4.3 6.4 17.4 8.2 3.1 6.1 2.7 5.9 3.3 3.3 3.0 2.4 1.5 2.2 0.9 3.7 1.6 8.4 3.2 2.4 8.3 12.0 7.2 9.6 0.2 2.4 1.1 1.5 5.1 5.1 0.7 3.4 1.2 4.4 21.9 1.9 1.4 4.1 4.4 16.3 2.2 4.4 1.2 7.8 11.6 4.0 7.0 0.9 3.6 11.7 18.2 5.6 1.3 4.5 3.9 3.7 13.6 4.8 8.6 1.1 3.0 2.7 10.5 6.9 11.0 4.6 11.2 7.9 6.8 3.7 3.8 0.9 5.6 2.6 2.6 4.2 3.3 4.1 1.3 1.9 2.0 1.4 2.2 1.5 1.1 1.1 1.7 3.0 2.1 1.7 2.4 2.3 3.7 2.9 0.7 0.9 1.2 2.1 3.4 1.6 13.0 19.3 2.5 27.5 15.3 6.5 8.8 17.1 8.3 8.2 LRRC8D "FLJ10470, LRRC5" ENSG00000171492 "Leucine rich repeat containing 8 VRAC subunit D" Q7L1W4 1 89821014-89936611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014745 Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA014745: AB_1853348" "unprognostic (2.92e-3)" "unprognostic (9.50e-2)" "unprognostic (1.06e-3)" "prognostic unfavourable (3.21e-5)" "unprognostic (4.98e-2)" "unprognostic (7.03e-2)" "unprognostic (7.71e-3)" "unprognostic (7.74e-2)" "unprognostic (9.67e-2)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" "unprognostic (2.77e-1)" "unprognostic (4.91e-2)" "unprognostic (9.52e-3)" "unprognostic (1.23e-1)" "unprognostic (2.65e-2)" "unprognostic (9.61e-2)" 4.4 26.3 15.7 11.0 24.0 9.6 9.7 8.8 21.3 9.7 13.1 46.2 4.3 14.1 7.7 8.1 6.7 5.9 6.0 5.5 24.5 16.9 19.8 17.6 7.1 17.0 34.7 20.3 4.6 9.6 6.8 16.2 7.5 24.5 4.3 14.0 7.5 17.8 4.6 7.8 5.0 13.6 8.6 38.5 16.8 8.3 7.5 31.6 11.8 12.1 4.3 14.8 8.9 3.4 5.8 7.8 3.0 8.8 10.5 14.3 8.4 24.3 15.9 6.5 15.4 11.7 9.9 22.1 16.7 25.3 9.5 12.0 6.8 6.2 19.3 19.1 27.7 32.1 14.9 20.0 12.1 15.0 8.3 22.6 14.4 14.4 22.9 25.7 7.1 6.2 16.7 8.1 17.7 16.1 12.3 6.1 10.3 7.3 10.6 16.7 11.3 14.6 14.5 9.5 13.8 24.0 8.7 12.2 8.5 20.8 21.6 46.2 5.1 25.6 7.1 10.2 3.5 20.8 12.6 7.5 12.7 11.6 3.9 32.6 9.0 0.0 7.1 1.2 6.2 8.8 10.3 5.8 14.3 7.4 6.8 5.3 13.8 10.2 3.0 10.5 6.6 7.8 13.8 8.4 15.7 24.0 8.8 21.3 24.5 16.9 34.7 20.3 24.5 31.6 LRRC9 FLJ46156 ENSG00000131951 "Leucine rich repeat containing 9" Q6ZRR7 14 59919713-60063559 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 16.4;pituitary gland: 13.9;testis: 14.3" "Cell line enhanced" "Detected in some" "AF22: 1.3;CACO-2: 2.0;NTERA-2: 4.2;SCLC-21H: 1.9;SH-SY5Y: 1.3;U-2 OS: 1.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 7.3;pons and medulla: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040965, HPA041381" Uncertain "HPA040965: , HPA041381: " "unprognostic (1.01e-2)" "unprognostic (2.00e-1)" "unprognostic (4.45e-2)" "unprognostic (2.12e-3)" "unprognostic (2.80e-1)" "unprognostic (2.95e-3)" "unprognostic (1.93e-1)" "unprognostic (3.11e-2)" "unprognostic (1.91e-2)" "unprognostic (4.82e-2)" "unprognostic (3.45e-3)" "unprognostic (6.06e-2)" "unprognostic (2.62e-3)" "unprognostic (8.54e-3)" "unprognostic (8.30e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-2)" 0.6 0.4 0.6 0.1 7.3 0.2 0.1 0.2 1.1 0.3 0.1 3.2 0.0 0.1 0.2 1.4 0.1 3.4 0.1 0.1 1.4 1.2 0.2 0.2 0.1 0.1 0.5 1.3 1.0 0.2 4.8 13.9 0.1 16.4 1.3 0.1 0.0 0.1 0.2 0.1 0.1 0.7 0.1 0.9 0.1 0.2 14.3 2.2 0.0 0.1 0.0 0.1 0.2 0.1 0.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 7.3 0.2 1.1 1.4 1.2 0.5 1.3 16.4 2.2 LRRIQ1 "FLJ12303, KIAA1801" ENSG00000133640 "Leucine rich repeats and IQ motif containing 1" Q96JM4 12 85036314-85263224 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5;pituitary gland: 24.9;testis: 20.1" "Cell line enhanced" "Detected in many" "AF22: 3.8;RPTEC TERT1: 6.5;SH-SY5Y: 4.3;U-138 MG: 3.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046162 Uncertain "HPA046162: AB_10963055" "unprognostic (3.55e-2)" "unprognostic (7.81e-2)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (1.01e-2)" "unprognostic (9.69e-2)" "unprognostic (4.81e-2)" "unprognostic (4.05e-3)" "unprognostic (1.52e-1)" "unprognostic (1.22e-1)" "unprognostic (1.97e-2)" "unprognostic (6.98e-2)" "unprognostic (1.25e-3)" "unprognostic (3.35e-2)" "unprognostic (6.10e-3)" "unprognostic (1.64e-1)" 0.4 1.2 2.4 0.5 8.2 0.3 1.5 0.4 3.1 2.0 0.5 2.2 2.0 0.2 1.9 8.2 0.3 13.4 0.9 0.5 4.7 3.7 5.3 0.3 4.6 0.3 1.0 3.4 4.7 0.7 3.1 24.9 0.3 21.5 1.8 0.3 1.0 0.6 1.0 0.2 0.3 0.3 1.0 1.0 0.4 0.6 20.1 3.4 0.0 2.8 0.2 0.3 0.3 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.8 0.0 1.0 2.0 0.4 0.6 0.6 1.7 0.4 0.0 0.1 0.0 0.2 0.4 0.1 1.4 1.7 0.4 0.0 2.5 0.6 0.2 0.0 0.0 0.0 0.0 1.0 2.7 1.3 1.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.0 2.4 0.0 0.6 0.0 6.5 0.0 2.4 4.3 0.2 0.2 0.2 1.9 0.0 0.0 3.6 1.0 1.4 0.2 0.0 1.1 0.0 2.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 8.2 0.4 3.1 4.7 3.7 1.0 3.4 21.5 3.4 LRRN1 FIGLER3 ENSG00000175928 "Leucine rich repeat neuronal 1" Q6UXK5 3 3799437-3847703 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.5" "Cell line enhanced" "Detected in some" "AF22: 53.7;CAPAN-2: 19.0;HAP1: 16.0;NTERA-2: 31.9;U-266/84: 11.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 2.1;memory B-cell: 1.0;neutrophil: 2.6" "Group enriched" "Detected in many" 8 "B-cells: 1.0;granulocytes: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011071 Enhanced 1400000 "HPA011071: AB_1853355" "unprognostic (1.27e-2)" "unprognostic (4.87e-1)" "unprognostic (1.32e-2)" "unprognostic (3.30e-3)" "unprognostic (2.01e-2)" "unprognostic (3.02e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-2)" "unprognostic (3.34e-1)" "unprognostic (2.96e-1)" "unprognostic (2.85e-2)" "unprognostic (2.70e-1)" "unprognostic (1.39e-3)" "unprognostic (1.86e-3)" "unprognostic (1.67e-1)" "unprognostic (1.75e-1)" "unprognostic (7.25e-2)" 1.4 0.8 12.5 1.1 19.0 2.4 7.6 13.8 32.5 7.1 0.9 5.0 0.3 1.9 4.7 2.5 1.9 2.9 4.6 0.7 11.1 9.4 1.3 0.7 2.1 0.9 8.5 6.1 10.0 3.8 14.2 2.7 0.9 22.2 7.7 1.0 11.5 8.9 8.2 9.2 2.2 2.6 3.2 8.3 1.8 1.8 10.3 10.7 8.7 4.8 0.7 1.7 10.6 1.5 1.0 0.0 2.6 0.0 0.1 0.2 0.0 0.0 0.0 53.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 16.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.5 0.0 31.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 6.5 0.0 0.6 5.6 11.1 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 1.0 0.0 0.2 0.0 0.3 0.0 0.1 2.6 0.1 0.0 0.0 0.0 0.0 12.5 19.0 13.8 10.3 11.1 9.4 8.5 6.1 22.2 10.7 LRRN2 "FIGLER7, GAC1, LRANK1, LRRN5" ENSG00000170382 "Leucine rich repeat neuronal 2" O75325 1 204617170-204685733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3" "Cell line enhanced" "Detected in some" "HEL: 7.1;NTERA-2: 14.2;RPMI-8226: 22.1;T-47d: 7.9" "Group enriched" "Detected in many" 6 "breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029124 Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA029124: AB_10601545" "unprognostic (2.16e-2)" "unprognostic (1.93e-1)" "unprognostic (1.35e-1)" "prognostic unfavourable (2.59e-7)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (2.89e-2)" "unprognostic (1.21e-1)" "unprognostic (4.63e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (1.68e-2)" "unprognostic (1.43e-2)" "unprognostic (7.33e-2)" "unprognostic (1.88e-1)" "unprognostic (1.59e-3)" 4.9 6.6 11.8 3.7 16.5 2.4 3.3 9.7 20.3 1.9 7.9 5.3 1.0 1.9 3.9 0.8 2.4 10.2 6.1 6.0 11.7 12.8 7.3 0.7 2.5 2.9 6.3 13.8 3.3 1.4 19.1 9.7 1.3 8.1 1.6 7.5 12.2 2.8 3.7 2.2 0.7 3.3 9.9 3.1 6.3 1.4 3.8 6.1 3.2 2.8 0.0 1.3 2.1 1.5 0.4 0.1 1.7 0.3 0.7 0.8 0.2 0.0 3.3 2.7 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.1 7.1 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 1.1 0.0 14.2 0.1 0.2 0.0 22.1 0.0 0.1 1.9 0.3 4.3 0.1 0.0 7.9 0.0 0.0 0.0 3.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.2 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.4 0.1 0.2 0.7 0.7 0.0 0.1 0.8 0.2 11.8 16.5 9.7 15.7 11.7 12.8 6.3 13.8 8.1 6.1 LRRN3 "FIGLER5, FLJ11129, NLRR3" ENSG00000173114 "Leucine rich repeat neuronal 3" Q9H3W5 7 111091006-111125454 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.5;brain: 23.8" "Cell line enhanced" "Detected in some" "AF22: 14.6;BJ: 8.2;BJ hTERT+: 18.0;SH-SY5Y: 26.2;T-47d: 14.3" "Group enriched" "Detected in many" 7 "glioma: 17.5;thyroid cancer: 4.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4" "Lineage enriched" "Detected in single" 98 "T-cells: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043820, HPA046792" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043820: , HPA046792: " "unprognostic (4.93e-2)" "unprognostic (4.55e-2)" "unprognostic (5.92e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-2)" "unprognostic (4.78e-3)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.84e-2)" "unprognostic (4.85e-3)" "unprognostic (1.08e-2)" "unprognostic (3.29e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (7.23e-2)" 7.8 26.5 12.7 1.6 21.2 1.1 2.1 20.0 23.8 3.6 1.4 1.9 0.8 1.0 1.0 3.1 1.9 1.3 1.6 9.0 10.4 10.7 0.9 2.7 8.7 3.6 7.7 13.0 7.9 1.5 0.7 4.9 6.7 9.0 4.7 1.6 0.8 1.9 6.4 4.0 0.8 2.1 1.0 2.9 2.0 0.9 16.4 6.3 8.8 22.3 0.0 4.4 1.6 1.3 0.2 0.0 0.1 0.0 0.0 20.3 4.0 0.0 0.0 14.6 1.7 6.8 2.9 0.0 8.2 18.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 7.1 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 26.2 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 1.2 0.0 0.0 20.3 18.4 0.1 0.0 0.0 0.0 0.2 4.0 12.7 21.2 20.0 23.8 10.4 10.7 7.7 13.0 9.0 6.3 LRRTM1 FLJ32082 ENSG00000162951 "Leucine rich repeat transmembrane neuronal 1" Q86UE6 2 80288351-80304749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.8;salivary gland: 19.8" "Cell line enhanced" "Detected in some" "AF22: 2.1;CAPAN-2: 3.2;NTERA-2: 2.1;SH-SY5Y: 4.6;U-266/70: 1.6" "Group enriched" "Detected in many" 11 "endometrial cancer: 8.8;ovarian cancer: 16.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062660 Approved "HPA062660: " "unprognostic (2.47e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (5.63e-2)" "unprognostic (6.67e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-1)" "unprognostic (8.16e-2)" "unprognostic (6.03e-3)" "unprognostic (7.10e-4)" "unprognostic (3.16e-2)" "unprognostic (1.90e-1)" "unprognostic (4.96e-4)" 0.7 2.2 8.1 1.0 17.8 0.5 0.6 0.5 17.6 1.5 2.2 2.7 0.1 1.7 1.7 1.2 1.1 2.8 0.9 1.3 10.7 6.3 0.9 0.7 0.7 0.5 2.5 7.8 0.9 0.5 0.5 1.3 0.5 1.8 0.9 1.1 1.7 19.8 2.8 0.5 0.7 1.9 1.1 2.1 0.5 0.9 0.7 2.4 0.0 2.9 0.0 0.6 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 17.8 0.5 17.6 10.7 6.3 2.5 7.8 1.8 2.4 LRRTM2 KIAA0416 ENSG00000146006 "Leucine rich repeat transmembrane neuronal 2" O43300 5 138868923-138875368 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 33.1" "Group enriched" "Detected in some" 7 "HDLM-2: 17.8;SCLC-21H: 5.8" "Cancer enriched" "Detected in single" 11 "glioma: 4.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.77e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-1)" "unprognostic (2.85e-1)" "unprognostic (3.58e-1)" "unprognostic (8.72e-2)" "unprognostic (4.31e-2)" "unprognostic (4.48e-1)" "unprognostic (4.47e-2)" "unprognostic (8.54e-2)" "unprognostic (1.13e-2)" "unprognostic (3.13e-2)" "unprognostic (2.86e-2)" "unprognostic (8.11e-2)" "unprognostic (1.08e-1)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" 2.3 4.1 11.0 1.1 15.7 1.1 1.5 15.6 33.1 1.3 1.4 5.1 0.0 1.3 1.1 1.0 1.0 1.1 1.4 1.1 9.7 9.1 1.2 1.3 1.1 1.2 5.4 17.7 1.2 1.4 0.9 0.7 4.5 8.4 1.0 1.4 1.0 1.0 0.9 1.1 1.2 1.5 1.4 5.8 1.9 1.0 0.9 9.9 0.0 1.1 0.0 1.0 1.2 0.3 0.5 0.0 1.0 0.8 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.1 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 17.8 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 1.5 0.0 0.8 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 11.0 15.7 15.6 20.8 9.7 9.1 5.4 17.7 8.4 9.9 LRRTM3 ENSG00000198739 "Leucine rich repeat transmembrane neuronal 3" Q86VH5 10 66926006-67099830 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 7.3;brain: 29.1;ovary: 8.0;pituitary gland: 26.6" "Cell line enhanced" "Detected in some" "AF22: 3.7;Daudi: 2.2;HAP1: 10.6;NTERA-2: 2.3;RPMI-8226: 1.8" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA070444, HPA078598" Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA070444: , HPA078598: " "unprognostic (1.21e-2)" "unprognostic (4.85e-2)" "unprognostic (1.12e-1)" "unprognostic (4.02e-2)" "unprognostic (1.15e-4)" "unprognostic (8.11e-2)" "unprognostic (4.77e-1)" 0.9 7.3 12.9 1.0 18.7 0.9 0.9 19.7 29.1 1.7 0.9 3.2 0.0 1.0 1.2 0.9 1.4 0.9 0.9 0.9 7.0 6.5 1.0 0.9 1.4 0.9 3.7 16.0 8.0 3.7 0.9 26.6 0.9 4.5 1.2 0.9 0.0 1.0 1.2 1.0 0.9 1.1 1.0 2.8 0.9 0.9 1.9 5.9 0.0 0.9 0.0 0.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.3 0.4 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 18.7 19.7 21.3 7.0 6.5 3.7 16.0 4.5 5.9 LRRTM4 FLJ12568 ENSG00000176204 "Leucine rich repeat transmembrane neuronal 4" Q86VH4 2 76747719-77593319 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4" "Cell line enriched" "Detected in some" 10 "Karpas-707: 53.1" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.00e-1)" "unprognostic (4.40e-2)" "unprognostic (3.13e-1)" "unprognostic (4.72e-4)" "unprognostic (7.20e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-2)" "unprognostic (9.15e-2)" "unprognostic (3.93e-1)" "unprognostic (5.84e-2)" "unprognostic (4.22e-2)" "unprognostic (1.40e-1)" "unprognostic (2.64e-1)" "unprognostic (5.77e-3)" "unprognostic (3.54e-2)" "unprognostic (7.99e-2)" 1.2 1.5 13.7 1.2 15.7 4.5 0.8 1.8 25.4 1.0 1.5 1.6 0.8 2.1 1.3 3.7 2.4 1.2 2.3 1.3 8.9 8.0 0.9 3.4 1.9 1.9 4.1 16.4 2.4 1.2 0.2 7.9 2.3 5.5 1.7 1.2 1.0 1.9 3.1 2.8 2.1 1.2 0.8 3.1 1.5 1.8 1.2 5.1 0.0 2.2 0.0 0.8 1.6 1.6 0.0 0.4 3.3 0.6 0.9 1.2 0.2 0.8 1.2 0.4 0.5 0.1 0.0 0.8 0.1 0.0 0.0 0.0 1.1 0.3 0.4 1.2 0.5 0.4 0.0 0.0 0.1 0.3 1.1 0.2 1.9 1.7 0.2 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.3 53.1 0.1 1.1 0.2 0.5 5.4 0.5 0.7 0.0 1.1 0.0 2.2 2.0 0.6 0.3 0.4 0.5 0.8 0.4 0.0 1.6 2.0 0.2 0.2 0.3 1.2 0.1 1.1 0.1 1.5 0.0 0.6 0.9 0.3 0.4 0.1 0.0 1.0 0.9 0.0 0.0 1.2 0.7 3.3 0.9 0.3 0.4 0.4 0.2 13.7 15.7 1.8 25.4 8.9 8.0 4.1 16.4 5.5 5.1 LRTM2 ENSG00000166159 "Leucine rich repeats and transmembrane domains 2" Q8N967 12 1820267-1836752 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "brain: 18.7" "Group enriched" "Detected in some" 8 "HEL: 9.0;SCLC-21H: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA055094, HPA062745" Uncertain Approved Cytosol Cytosol "HPA055094: , HPA062745: " "unprognostic (1.84e-3)" "unprognostic (4.83e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (5.49e-2)" "unprognostic (1.60e-1)" "unprognostic (1.34e-3)" "unprognostic (2.25e-1)" "unprognostic (1.24e-1)" "unprognostic (6.20e-4)" "unprognostic (2.21e-1)" "unprognostic (8.02e-2)" 0.7 0.7 5.1 0.7 12.3 0.7 0.7 0.8 18.7 0.7 0.7 1.7 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 3.3 5.0 0.7 0.7 0.7 0.7 1.7 10.5 0.7 0.7 0.7 0.1 0.7 4.7 0.7 0.7 0.1 0.7 0.8 0.7 0.7 0.7 0.7 1.7 0.7 0.8 0.9 4.3 0.0 0.7 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.3 0.8 18.7 3.3 5.0 1.7 10.5 4.7 4.3 LSAMP "IGLON3, LAMP" ENSG00000185565 "Limbic system-associated membrane protein" Q13449 3 115802363-117139389 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.4" "Cell line enhanced" "Detected in some" "AF22: 6.8;SH-SY5Y: 13.9;WM-115: 33.8" "Cancer enhanced" "Detected in many" "glioma: 13.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054051, HPA076122" Enhanced Cytosol 200000000 Cytosol "HPA054051: , HPA076122: " "unprognostic (4.18e-2)" "unprognostic (2.54e-1)" "unprognostic (9.97e-3)" "unprognostic (6.03e-2)" "unprognostic (9.63e-2)" "unprognostic (4.15e-3)" "unprognostic (6.81e-2)" "unprognostic (2.70e-2)" "unprognostic (5.71e-2)" "unprognostic (6.82e-3)" "unprognostic (1.26e-1)" "unprognostic (6.03e-2)" "unprognostic (1.92e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (5.23e-5)" "unprognostic (1.31e-2)" 2.3 12.7 21.9 4.3 23.7 1.1 1.6 43.4 48.4 17.8 5.5 16.6 0.0 1.9 4.4 2.8 3.4 2.9 11.3 2.1 23.7 18.8 2.5 1.0 8.5 4.0 17.6 21.5 4.8 11.1 0.6 3.1 1.2 18.3 21.1 3.5 1.2 1.7 6.2 0.7 4.6 1.9 3.3 13.1 1.7 3.2 3.9 21.3 0.0 4.2 0.0 5.2 7.3 3.4 1.6 0.4 3.0 0.8 0.3 1.0 0.3 0.2 2.2 6.8 0.2 0.7 2.1 0.7 0.6 0.3 0.2 0.7 0.2 0.4 0.5 0.2 3.5 0.1 0.1 0.1 0.3 0.5 0.1 0.2 0.7 0.3 0.1 0.5 0.3 1.7 0.0 0.8 0.1 0.0 0.3 2.3 0.0 0.2 0.7 0.6 2.6 0.8 0.2 0.1 0.1 1.7 1.6 1.6 13.9 0.0 0.1 2.1 0.2 0.8 0.1 1.5 1.3 1.7 0.4 1.4 1.8 0.2 0.4 0.2 33.8 3.0 0.8 1.4 0.9 0.5 1.0 0.7 0.6 0.5 0.2 1.6 1.0 0.7 2.8 0.3 0.6 0.4 0.5 0.3 21.9 23.7 43.4 23.7 23.7 18.8 17.6 21.5 18.3 21.3 LUZP2 ENSG00000187398 "Leucine zipper protein 2" Q86TE4 11 24496970-25082631 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.1;brain: 32.7" "Group enriched" "Detected in some" 4 "HaCaT: 14.3;HAP1: 7.1" "Group enriched" "Detected in some" 7 "glioma: 3.5;prostate cancer: 4.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039007, HPA046161" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in brain" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039007: , HPA046161: " "unprognostic (4.49e-2)" "unprognostic (2.74e-2)" "unprognostic (8.63e-2)" "unprognostic (3.50e-1)" "unprognostic (5.22e-3)" "unprognostic (3.38e-1)" "unprognostic (4.88e-2)" "unprognostic (5.67e-4)" "unprognostic (2.40e-1)" "unprognostic (5.66e-2)" "unprognostic (6.16e-3)" "unprognostic (4.09e-2)" "unprognostic (5.18e-3)" "unprognostic (9.41e-3)" "unprognostic (4.18e-2)" "unprognostic (2.17e-1)" "unprognostic (9.64e-2)" 1.2 11.1 14.5 0.9 10.8 0.9 1.6 2.6 32.7 0.9 2.1 5.9 0.0 0.9 1.0 0.8 0.9 0.8 1.0 1.0 10.3 13.8 1.0 2.3 1.1 0.8 13.7 5.6 0.8 0.8 0.7 1.9 0.8 26.7 4.5 1.7 0.0 1.0 0.9 0.8 0.9 1.1 1.2 30.0 0.9 0.9 1.6 14.5 0.0 0.8 0.9 0.8 1.6 0.3 0.5 0.4 1.9 0.3 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 14.3 7.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.2 0.2 0.0 1.5 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.5 0.3 0.4 0.2 0.1 0.2 0.2 0.1 0.3 0.1 0.5 0.3 0.2 1.9 0.3 0.2 0.4 0.1 0.0 14.5 10.8 2.6 9.3 10.3 13.8 13.7 5.6 26.7 14.5 LY6G5C "C6orf20, G5c, NG33" ENSG00000204428 "Lymphocyte antigen 6 family member G5C" Q5SRR4 6 31676684-31684040 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6" "Cell line enhanced" "Detected in some" "ASC diff: 3.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038690 Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" Nucleoplasm Cytosol "HPA038690: AB_10673286" "unprognostic (1.51e-2)" "unprognostic (7.26e-2)" "unprognostic (7.19e-2)" "prognostic favourable (1.07e-4)" "unprognostic (4.83e-1)" "unprognostic (6.91e-2)" "unprognostic (1.33e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-2)" "unprognostic (5.63e-2)" "unprognostic (3.74e-5)" "unprognostic (5.84e-2)" "unprognostic (3.78e-4)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.88e-2)" "unprognostic (1.39e-2)" 0.4 0.0 0.5 2.1 2.5 1.1 0.3 4.6 3.8 0.0 0.0 0.2 0.3 0.4 0.0 0.5 2.0 0.8 0.4 0.7 0.0 0.9 0.5 1.2 0.3 0.4 2.5 0.0 1.0 0.4 0.1 0.0 0.2 0.0 1.3 0.3 0.3 0.0 0.4 0.8 1.2 2.1 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.4 2.1 3.1 0.1 0.1 0.1 0.3 0.3 0.8 0.0 2.4 1.5 0.1 0.1 0.6 0.0 0.0 0.9 2.7 1.4 1.1 0.0 0.5 0.0 0.3 1.2 0.0 0.0 0.7 1.7 0.0 0.0 1.5 0.1 0.0 2.3 0.4 0.1 0.0 1.0 0.4 0.8 0.1 0.5 0.3 0.2 0.9 0.0 0.5 0.1 1.8 0.0 0.2 1.0 1.8 0.1 0.4 0.5 0.5 2.3 1.5 0.6 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 LY6G6E "C6orf22, G6e" ENSG00000255552 "Lymphocyte antigen 6 family member G6E" 6 31711771-31714065 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0" "Cell line enriched" "Detected in single" 111 "HEL: 22.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" HPA056234 Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA056234: " "unprognostic (1.77e-1)" "unprognostic (1.58e-2)" "unprognostic (2.25e-1)" "unprognostic (6.88e-2)" 0.3 0.0 2.9 0.0 0.5 4.3 0.0 0.0 5.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.3 0.2 1.7 0.1 0.0 0.3 3.9 0.0 0.0 0.0 0.6 0.0 0.2 0.2 0.6 0.7 0.2 0.0 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.6 2.2 0.0 0.1 0.2 0.4 0.4 0.8 1.1 0.4 0.1 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.4 0.4 0.4 0.7 0.4 0.0 0.2 0.3 0.4 1.1 0.1 0.3 0.8 0.7 1.0 2.9 0.5 0.0 5.2 1.7 0.1 0.0 0.0 0.7 0.0 LY6H NMLY6 ENSG00000176956 "Lymphocyte antigen 6 family member H" O94772 8 143157914-143160711 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 58.2" "Cell line enhanced" "Detected in some" "MOLT-4: 6.7;NTERA-2: 1.3;SCLC-21H: 3.8" "Cancer enhanced" "Detected in many" "glioma: 9.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077218 Enhanced "Intracellular and membrane" "HPA077218: " "unprognostic (8.76e-2)" "unprognostic (2.76e-1)" "unprognostic (1.41e-2)" "unprognostic (9.45e-4)" "unprognostic (3.34e-3)" "unprognostic (1.82e-1)" "unprognostic (1.71e-4)" "unprognostic (2.26e-2)" "unprognostic (1.56e-1)" "unprognostic (5.07e-3)" "unprognostic (3.76e-3)" "unprognostic (5.97e-2)" "unprognostic (2.20e-5)" "unprognostic (6.43e-3)" "unprognostic (1.54e-1)" "unprognostic (8.98e-2)" "unprognostic (9.89e-3)" 1.4 1.4 46.7 1.6 26.3 1.3 1.3 0.0 42.8 1.3 2.8 3.2 0.0 5.6 1.5 1.4 1.5 2.6 1.4 1.2 58.2 53.4 1.3 1.2 1.4 1.4 10.9 32.5 1.2 1.3 1.2 8.4 1.3 7.1 1.3 1.3 0.0 1.3 1.4 1.4 1.2 2.2 1.8 4.0 1.2 4.3 2.3 1.9 0.0 1.3 0.0 1.2 1.4 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.7 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 46.7 26.3 0.0 36.9 58.2 53.4 10.9 32.5 7.1 1.9 LYNX1 SLURP2 ENSG00000180155 "Ly6/neurotoxin 1" P0DP58 8 142771197-142777810 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.2" "Cell line enhanced" "Detected in many" "BJ: 8.5;fHDF/TERT166: 10.7;HHSteC: 9.0;HSkMC: 8.2;SK-BR-3: 6.6;T-47d: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "intermediate monocyte: 5.7;non-classical monocyte: 15.0" "Lineage enriched" "Detected in single" 16 "monocytes: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (8.67e-2)" "unprognostic (6.96e-2)" "unprognostic (1.31e-2)" "unprognostic (2.79e-3)" "unprognostic (1.04e-3)" "unprognostic (5.13e-3)" "unprognostic (1.33e-1)" "unprognostic (5.55e-3)" "unprognostic (1.12e-1)" "unprognostic (3.61e-3)" "unprognostic (7.21e-2)" "unprognostic (1.03e-2)" "prognostic favourable (2.82e-4)" "unprognostic (2.02e-2)" "unprognostic (2.28e-1)" "unprognostic (1.64e-2)" "unprognostic (1.85e-1)" 6.5 15.5 15.0 2.2 26.7 0.3 5.7 18.8 55.2 7.2 7.2 13.3 0.9 2.5 7.2 3.3 13.4 7.6 5.5 37.7 32.8 4.8 5.3 16.4 5.0 1.2 7.9 24.4 7.1 6.2 23.4 6.0 1.9 38.5 8.1 1.7 6.1 10.9 9.0 3.5 14.3 3.0 7.2 8.9 8.5 5.1 2.1 10.2 0.0 5.2 1.3 1.4 7.1 8.8 0.0 0.9 0.0 15.0 0.0 0.3 0.3 0.1 5.9 0.3 0.0 2.4 0.3 0.1 8.5 0.7 1.2 1.5 0.3 1.4 0.0 4.1 10.7 1.6 0.2 0.0 0.3 0.0 0.2 0.0 0.2 1.4 9.0 0.0 4.2 8.2 1.4 2.5 0.0 0.9 0.0 0.3 0.9 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 3.3 0.0 0.8 4.5 0.6 6.6 0.0 7.6 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.0 0.2 5.7 0.1 0.0 0.0 0.0 0.9 0.0 0.3 0.1 0.0 0.0 15.0 0.0 0.0 0.3 15.0 26.7 18.8 55.2 32.8 4.8 7.9 24.4 38.5 10.2 LYNX1-SLURP2 ENSG00000284505 "LYNX1-SLURP2 readthrough" 8 142764334-142778224 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.1;esophagus: 13.6" "Cell line enhanced" "Detected in some" "A549: 2.2;BJ: 3.6;EFO-21: 2.9;HaCaT: 2.6;SH-SY5Y: 1.7;TIME: 1.6" "Group enriched" "Detected in some" 5 "intermediate monocyte: 2.7;non-classical monocyte: 4.1" "Lineage enriched" "Detected in single" 6 "monocytes: 4.1" "Intracellular and membrane" 3.8 2.4 3.7 0.8 4.1 0.3 1.1 1.2 13.1 1.1 1.4 2.1 0.0 1.1 1.9 1.4 13.6 2.1 1.2 7.0 3.0 1.6 6.5 1.1 0.6 2.3 4.2 1.6 1.0 1.2 0.0 0.7 6.7 3.6 0.9 1.9 2.0 5.0 2.0 8.6 1.5 3.5 1.2 1.5 1.2 0.8 1.4 0.0 0.5 0.5 1.1 4.2 0.8 0.0 0.2 0.0 4.1 0.0 0.6 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.1 0.4 0.3 0.0 0.0 2.9 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.4 0.2 0.0 1.1 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.7 0.1 0.0 0.0 0.1 0.2 0.0 0.6 0.2 0.0 0.0 4.1 0.0 0.0 0.1 LYPD1 "LYPDC1, MGC29643" ENSG00000150551 "LY6/PLAUR domain containing 1" Q8N2G4 2 132644853-132671579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;fallopian tube: 74.6" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 17.1;HUVEC TERT2: 14.5;SK-MEL-30: 14.9;U-251 MG: 31.1;WM-115: 62.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 57.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 10.9" "Lineage enriched" "Detected in single" 36 "granulocytes: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Intracellular and membrane" "unprognostic (9.25e-2)" "unprognostic (7.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.07e-2)" "unprognostic (6.40e-3)" "unprognostic (5.60e-2)" "unprognostic (8.36e-3)" "unprognostic (1.05e-2)" "unprognostic (6.70e-2)" "unprognostic (2.86e-2)" "unprognostic (1.51e-2)" "unprognostic (1.43e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" 1.5 2.5 16.4 1.7 27.8 1.2 1.4 3.8 16.8 1.3 2.5 4.6 0.0 1.4 2.5 1.8 1.4 74.6 3.6 1.8 18.9 19.0 3.2 1.6 1.4 3.5 16.9 5.4 8.4 3.5 2.0 12.4 1.2 11.8 1.4 1.4 5.4 21.7 1.4 1.2 1.5 1.4 1.8 7.0 1.3 1.4 1.5 3.4 1.2 1.3 1.1 2.5 1.4 0.0 0.3 0.0 10.9 0.0 0.0 0.0 0.0 0.2 4.7 5.3 0.0 0.0 0.0 0.0 1.0 0.6 2.4 0.5 0.4 0.6 0.0 9.9 1.9 5.1 0.0 0.0 1.2 0.0 1.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 14.5 0.0 0.0 0.0 0.3 0.0 0.0 5.2 2.0 0.0 0.0 0.0 7.0 0.1 0.7 1.2 0.6 0.0 14.9 0.0 0.1 0.7 0.3 7.4 3.1 31.1 0.0 0.0 0.0 6.1 0.0 62.7 1.3 0.0 10.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 27.8 3.8 11.0 18.9 19.0 16.9 5.4 11.8 3.4 LZTS1 FEZ1 ENSG00000061337 "Leucine zipper tumor suppressor 1" Q9Y250 8 20246165-20303963 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 19.0;parathyroid gland: 64.9" "Cell line enhanced" "Detected in some" "SK-MEL-30: 35.9;U-698: 11.0;WM-115: 24.3" "Cancer enhanced" "Detected in all" "melanoma: 59.2" "Group enriched" "Detected in many" 5 "amygdala: 13.3;basal ganglia: 19.0;cerebral cortex: 19.0;hippocampal formation: 8.9;olfactory region: 8.8" "Cell type enhanced" "Detected in single" "gdT-cell: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 5 "amygdala: 47.8;basal ganglia: 76.8;cerebral cortex: 46.2;hippocampal formation: 41.3;olfactory region: 26.1" "Group enriched" "Detected in many" 10 "amygdala: 28.4;basal ganglia: 66.4;cerebral cortex: 45.3;hippocampal formation: 38.6;olfactory region: 47.4" "HPA006294, HPA022046" Approved Approved "Nucleoli,Plasma membrane" "Plasma membrane" Nucleoli "HPA006294: AB_1079288, HPA022046: AB_1853455" "unprognostic (7.76e-2)" "unprognostic (1.02e-1)" "unprognostic (3.49e-3)" "prognostic unfavourable (3.03e-4)" "unprognostic (6.27e-2)" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (5.76e-2)" "unprognostic (1.41e-2)" "unprognostic (9.06e-3)" "unprognostic (6.81e-2)" "unprognostic (3.63e-2)" "prognostic unfavourable (9.28e-6)" "unprognostic (3.35e-2)" "unprognostic (2.71e-1)" "unprognostic (1.11e-1)" "unprognostic (6.82e-3)" 2.4 2.1 13.3 1.8 19.0 0.8 1.9 0.6 19.0 1.6 1.1 2.2 0.4 1.1 2.2 1.5 3.5 1.4 3.5 2.3 8.9 2.6 1.9 1.1 4.0 1.5 2.5 8.8 1.7 1.6 64.9 1.4 5.8 1.9 1.7 1.1 10.3 1.3 1.7 1.6 4.2 1.2 2.7 0.8 1.1 1.3 6.6 1.5 0.3 2.0 0.9 1.1 1.9 1.0 0.2 0.1 0.7 0.1 0.1 2.2 0.5 0.0 0.0 4.7 4.0 0.0 0.0 0.5 2.3 0.0 2.0 1.8 0.1 0.0 5.2 1.7 1.4 0.1 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.0 0.8 0.0 0.0 0.0 0.0 6.9 0.0 9.0 0.0 5.9 0.0 0.0 7.5 0.0 1.3 0.2 7.2 6.2 0.0 0.0 35.9 0.0 0.2 0.0 2.5 1.7 0.0 0.7 0.0 0.0 11.0 0.0 0.5 24.3 0.2 0.1 0.0 2.2 0.0 0.8 0.0 0.7 0.4 0.0 0.2 0.2 0.3 0.7 0.1 0.0 0.1 0.0 0.5 13.3 19.0 0.6 19.0 8.9 2.6 2.5 8.8 1.9 1.5 LZTS3 "KIAA0552, ProSAPiP1" ENSG00000088899 "Leucine zipper tumor suppressor family member 3" O60299 20 3162617-3173592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.9;salivary gland: 36.2" "Cell line enhanced" "Detected in many" "CACO-2: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031008, HPA031009" Approved Approved Vesicles Vesicles "HPA031008: AB_10601610, HPA031009: AB_10670162" "unprognostic (4.09e-2)" "unprognostic (4.10e-2)" "unprognostic (1.55e-2)" "prognostic unfavourable (7.26e-4)" "unprognostic (1.15e-1)" "unprognostic (6.19e-3)" "unprognostic (2.14e-1)" "prognostic favourable (7.98e-4)" "unprognostic (3.31e-1)" "unprognostic (1.08e-1)" "unprognostic (4.57e-2)" "unprognostic (9.69e-3)" "prognostic favourable (5.92e-8)" "unprognostic (4.63e-2)" "unprognostic (1.85e-1)" "unprognostic (8.47e-2)" "unprognostic (1.38e-1)" 2.4 5.3 17.6 1.4 31.1 1.7 3.5 51.9 45.7 11.5 2.4 4.2 2.1 8.6 4.6 3.7 1.7 6.4 6.8 5.4 16.4 10.7 11.9 2.7 5.6 1.2 7.1 17.4 9.0 17.0 11.8 4.1 2.2 10.5 5.0 2.2 7.4 36.2 7.9 5.1 1.4 6.5 2.7 4.5 1.7 7.7 1.9 6.0 0.0 7.1 0.4 1.0 2.6 1.5 0.2 0.8 0.0 0.0 0.0 0.9 0.0 2.7 2.6 3.7 4.1 5.2 1.5 2.6 2.8 6.0 4.7 7.0 15.0 7.9 4.7 1.5 5.4 1.3 2.0 2.9 3.6 0.1 2.7 0.2 0.5 12.3 11.8 0.2 1.3 1.9 6.5 6.6 2.5 0.7 2.7 1.5 2.3 1.2 0.3 0.6 8.4 2.6 1.2 1.2 5.0 5.9 1.0 14.8 4.5 2.3 3.2 2.2 7.6 0.1 4.2 5.1 9.6 2.0 0.8 3.0 0.4 1.4 2.5 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.8 0.5 0.0 17.6 31.1 51.9 45.7 16.4 10.7 7.1 17.4 10.5 6.0 MAB21L1 CAGR1 ENSG00000180660 "Mab-21 like 1" Q13394 13 35474182-35477209 "Predicted intracellular proteins" "Developmental protein, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 24.0;skeletal muscle: 8.5" "Cell line enhanced" "Detected in some" "BJ: 13.5;BJ hTERT+: 11.0;BJ hTERT+ SV40 Large T+: 15.5;BJ hTERT+ SV40 Large T+ RasG12V: 8.8;HBF TERT88: 16.9;SH-SY5Y: 50.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "cerebellum: 45.8;midbrain: 22.3;pons and medulla: 12.9" "Low region specificity" "Detected in all" "HPA049324, HPA059864" Approved Nucleoplasm Nucleoplasm "HPA049324: , HPA059864: " "unprognostic (4.44e-2)" "unprognostic (2.82e-2)" "unprognostic (2.79e-3)" "unprognostic (3.87e-4)" "unprognostic (5.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.71e-1)" "unprognostic (4.12e-3)" "unprognostic (1.64e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (3.19e-2)" "unprognostic (6.93e-3)" "unprognostic (1.14e-1)" "unprognostic (3.72e-1)" "unprognostic (2.86e-1)" 2.9 6.4 0.3 0.5 0.0 0.0 6.3 24.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.8 0.6 1.1 0.0 0.0 0.0 0.0 1.8 0.5 3.7 0.2 8.5 1.2 1.1 0.0 0.8 0.0 0.3 0.0 0.6 0.2 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13.5 11.0 15.5 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 16.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 1.3 50.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAB21L2 ENSG00000181541 "Mab-21 like 2" Q9Y586 4 150581922-150584693 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.2;intestine: 59.8;smooth muscle: 15.2" "Group enriched" "Detected in some" 17 "HHSteC: 7.0;SH-SY5Y: 17.7" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.3" "Region enriched" "Detected in some" 18 "pons and medulla: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049324, HPA059864" Enhanced Nucleoplasm Nucleoplasm "HPA049324: , HPA059864: " "unprognostic (1.12e-1)" "unprognostic (3.67e-2)" "unprognostic (4.03e-2)" "unprognostic (2.63e-1)" "unprognostic (2.32e-1)" "unprognostic (3.85e-2)" "unprognostic (8.99e-2)" "unprognostic (2.76e-2)" "unprognostic (2.75e-1)" "unprognostic (6.60e-2)" "unprognostic (4.78e-3)" "unprognostic (1.18e-1)" "unprognostic (6.81e-2)" "unprognostic (1.68e-1)" 0.6 3.1 0.2 8.6 0.4 0.0 0.1 0.2 0.2 0.2 59.8 0.1 0.0 6.8 0.1 0.9 0.9 0.2 0.5 0.7 0.2 0.6 0.1 0.5 0.1 0.6 1.0 0.0 0.1 0.2 0.0 0.3 0.0 19.2 0.2 8.1 9.0 2.2 0.0 0.3 0.2 14.7 15.2 4.5 0.1 0.3 0.1 0.0 0.2 1.4 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 17.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.6 1.0 0.0 19.2 0.0 MACROD2 "C20orf133, dJ631M13.5" ENSG00000172264 "MACRO domain containing 2" A1Z1Q3 20 13995369-16053197 "Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.5" "Cell line enhanced" "Detected in many" "EFO-21: 14.5;Karpas-707: 17.9;RT4: 7.9;SCLC-21H: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 7.4;naive B-cell: 14.1;neutrophil: 3.8" "Group enriched" "Detected in many" 5 "B-cells: 14.1;granulocytes: 3.8" "Low region specificity" "Detected in all" HPA049076 Enhanced Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA049076: " "unprognostic (1.70e-1)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (5.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.63e-3)" "unprognostic (1.24e-1)" "unprognostic (2.32e-2)" "unprognostic (3.02e-1)" "unprognostic (2.96e-2)" "unprognostic (4.02e-1)" "unprognostic (7.83e-2)" "unprognostic (4.15e-5)" "unprognostic (9.80e-2)" "unprognostic (9.91e-3)" "unprognostic (3.23e-1)" "unprognostic (2.02e-2)" 2.8 5.1 15.2 3.0 47.5 2.0 4.2 20.8 13.6 6.4 2.7 3.7 2.0 1.4 12.1 3.9 2.3 10.3 4.1 1.9 10.5 8.2 5.6 2.7 15.7 5.5 7.6 8.9 4.5 4.2 5.4 12.0 1.8 10.5 7.1 2.1 4.0 2.4 14.9 3.1 3.9 1.8 5.8 6.9 6.9 3.4 7.9 9.9 0.0 4.1 0.1 7.2 10.6 3.1 14.1 0.5 3.8 1.8 0.3 0.6 0.5 1.0 0.6 2.7 0.9 0.9 0.8 0.5 0.5 2.0 1.1 0.6 1.0 0.7 1.9 14.5 1.4 1.4 0.4 0.6 1.8 0.9 0.8 1.1 1.1 1.8 3.5 0.3 0.3 1.6 1.1 0.0 0.8 1.1 1.3 17.9 3.0 0.4 0.5 0.7 0.9 0.4 1.1 0.5 3.4 2.1 7.9 9.9 4.3 1.5 0.1 0.7 1.0 1.6 0.8 1.5 3.0 0.2 0.1 1.5 0.4 1.8 0.9 1.0 1.8 0.3 0.6 0.6 0.4 1.3 0.4 7.4 0.3 0.4 0.5 14.1 0.4 0.6 3.8 0.3 1.8 0.2 0.2 0.5 15.2 47.5 20.8 12.8 10.5 8.2 7.6 8.9 10.5 9.9 MADD "DENN, KIAA0358, RAB3GEP" ENSG00000110514 "MAP kinase activating death domain" Q8WXG6 11 47269161-47330031 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038568 Uncertain Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038568: AB_10795030" "unprognostic (3.16e-1)" "unprognostic (1.81e-1)" "unprognostic (8.51e-3)" "prognostic favourable (6.62e-5)" "unprognostic (1.27e-1)" "unprognostic (6.36e-3)" "unprognostic (4.82e-3)" "unprognostic (1.16e-1)" "unprognostic (1.91e-1)" "unprognostic (3.78e-2)" "prognostic favourable (5.69e-5)" "unprognostic (1.53e-1)" "unprognostic (3.55e-1)" "unprognostic (8.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.76e-1)" "prognostic favourable (8.25e-4)" 7.7 18.2 18.3 11.5 27.6 16.9 8.7 66.3 46.5 9.2 10.8 15.5 13.1 8.6 9.4 8.9 6.9 9.4 8.6 13.8 20.2 18.4 9.8 7.7 11.0 13.2 15.5 19.8 14.0 12.2 18.8 26.7 11.2 20.7 12.5 12.0 16.0 10.2 14.0 16.1 14.0 9.8 10.5 11.3 12.3 13.2 19.4 11.0 14.6 8.4 6.0 12.2 11.0 7.8 3.5 4.1 20.8 5.8 4.5 5.7 4.4 6.3 13.3 14.6 13.0 10.0 7.0 3.3 9.0 12.1 11.5 12.5 9.7 6.0 13.6 2.9 9.9 12.7 11.8 6.3 10.0 15.0 12.0 24.1 24.7 8.3 7.2 16.3 33.2 6.7 6.8 6.0 7.6 10.5 15.4 10.0 10.1 9.0 7.7 17.6 8.7 9.2 10.6 23.5 8.9 5.9 30.6 23.1 15.1 11.6 13.7 7.9 10.8 12.4 8.9 10.8 6.8 15.3 6.0 11.9 12.3 7.7 10.0 11.6 10.1 20.8 2.6 4.8 4.8 4.6 4.2 3.5 3.4 4.0 4.1 3.3 4.0 3.1 0.7 4.5 5.8 2.2 5.7 4.4 18.3 27.6 66.3 44.6 20.2 18.4 15.5 19.8 20.7 11.0 MAG "GMA, S-MAG, SIGLEC-4A, SIGLEC4A" ENSG00000105695 "Myelin associated glycoprotein" P20916 19 35292125-35313804 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 113.6" "Cell line enriched" "Detected in some" 22 "WM-115: 28.1" "Cancer enriched" "Detected in some" 7 "glioma: 20.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 15 "dendritic cells: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009345, HPA012499" Enhanced "CAB009345: AB_670104, HPA012499: AB_1854238" "unprognostic (2.70e-3)" "unprognostic (2.70e-2)" "unprognostic (8.06e-3)" "unprognostic (1.23e-1)" "unprognostic (6.93e-2)" "unprognostic (3.74e-1)" "unprognostic (1.50e-1)" "unprognostic (2.39e-1)" "unprognostic (1.06e-1)" "unprognostic (2.00e-1)" "unprognostic (5.62e-2)" "unprognostic (5.18e-4)" "unprognostic (6.29e-2)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.66e-1)" 1.5 2.3 19.5 1.4 29.9 1.4 1.5 3.6 90.8 1.5 1.4 97.0 0.0 1.4 1.6 1.4 1.5 5.1 1.4 1.4 36.7 19.1 1.5 1.6 1.7 1.5 48.9 18.0 21.8 1.4 1.4 0.1 1.7 38.0 1.5 1.4 0.0 1.4 1.7 1.4 1.4 1.5 1.4 113.6 1.6 1.4 1.7 38.1 0.0 1.8 0.0 1.5 1.4 0.1 0.4 6.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 6.4 0.0 0.1 19.5 29.9 3.6 38.5 36.7 19.1 48.9 18.0 38.0 38.1 MAGEA12 "CT1.12, MAGE12" ENSG00000213401 "MAGE family member A12" P43365 X 152733779-152737669 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "brain: 4.1;testis: 8.3" "Cell line enhanced" "Detected in some" "HMC-1: 21.7;K-562: 31.6;PC-3: 15.4;SH-SY5Y: 18.1;U-2 OS: 33.0;U-266/70: 26.0" "Cancer enhanced" "Detected in many" "melanoma: 10.8" "Region enhanced" "Detected in some" "cerebral cortex: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.47e-2)" "unprognostic (4.54e-1)" "prognostic unfavourable (3.22e-4)" "unprognostic (1.82e-1)" "unprognostic (3.25e-1)" "unprognostic (1.60e-3)" "unprognostic (8.57e-4)" "unprognostic (4.61e-2)" "unprognostic (1.78e-1)" "unprognostic (4.06e-2)" 0.2 0.0 0.7 0.0 1.1 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.4 0.0 0.0 1.2 18.1 0.0 9.0 4.7 0.2 0.0 0.1 0.0 33.0 4.7 2.3 26.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.1 4.1 0.5 0.4 1.1 0.0 0.0 0.0 MAGEC3 "CT7.2, HCA2, MAGE-C3" ENSG00000165509 "MAGE family member C3" Q8TD91 X 141838316-141897832 "Cancer-related genes, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.9;epididymis: 3.0;testis: 3.1" "Group enriched" "Detected in some" 4 "U-2197: 1.9;U-266/70: 2.9;U-266/84: 6.3" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA052067 Approved "HPA052067: " "unprognostic (3.45e-1)" "unprognostic (2.39e-1)" "unprognostic (4.01e-1)" "unprognostic (2.95e-1)" "unprognostic (2.10e-2)" "unprognostic (3.45e-2)" "unprognostic (2.35e-11)" "unprognostic (3.21e-2)" "unprognostic (4.29e-2)" 0.1 0.1 1.6 0.0 2.5 0.1 0.5 0.5 2.5 0.2 0.0 0.0 0.2 3.0 0.1 0.4 0.2 0.0 3.3 2.0 0.1 0.1 0.2 0.0 2.8 0.4 0.0 0.0 0.7 0.0 0.3 0.0 0.5 0.3 0.0 0.1 0.2 0.3 4.9 1.1 0.1 3.1 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.9 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 1.9 0.3 2.9 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGED4 "KIAA1859, MAGE-E1, MAGE1, MGC3210" ENSG00000154545 "MAGE family member D4" Q96JG8 X 52184823-52192268 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.1;pituitary gland: 7.5" "Cell line enhanced" "Detected in some" "A549: 4.7;ASC TERT1: 4.4;Hep G2: 12.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 3.1" "Group enriched" "Detected in many" 21 "B-cells: 3.1;dendritic cells: 1.3;T-cells: 1.6" HPA003554 Uncertain "HPA003554: AB_1853497" "unprognostic (7.71e-2)" "unprognostic (8.21e-2)" "unprognostic (4.07e-4)" "unprognostic (6.15e-2)" 1.3 2.1 5.5 1.3 6.1 0.4 3.1 0.8 4.6 2.0 1.0 2.4 0.0 0.4 1.9 0.4 0.4 0.4 1.9 1.6 5.1 4.8 1.1 0.6 0.4 0.4 3.7 5.5 1.2 1.0 0.4 7.5 1.7 3.7 1.2 1.2 0.3 1.1 1.4 0.9 0.4 0.4 2.0 5.2 0.8 0.5 0.6 1.2 0.0 0.4 0.0 0.4 0.4 0.4 3.1 1.3 0.0 0.0 0.0 1.6 0.3 0.0 4.7 0.8 0.8 0.0 4.4 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.9 0.0 0.0 12.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.9 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 1.6 0.0 3.1 0.5 0.2 0.0 0.0 0.0 1.3 1.5 0.3 5.5 6.1 0.8 4.6 5.1 4.8 3.7 5.5 3.7 1.2 MAGED4B ENSG00000187243 "MAGE family member D4B" Q96JG8 X 52061827-52069248 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3" "Cell line enhanced" "Detected in many" "AF22: 24.3;NTERA-2: 19.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive B-cell: 8.1" "Group enriched" "Detected in many" 30 "B-cells: 8.1;dendritic cells: 5.4;T-cells: 5.0" HPA003554 Approved "HPA003554: AB_1853497" "unprognostic (7.75e-2)" "unprognostic (2.19e-1)" "unprognostic (2.37e-2)" "unprognostic (7.01e-6)" "unprognostic (6.45e-2)" 0.5 2.8 7.4 1.6 13.5 0.0 1.2 1.9 19.3 5.5 1.4 1.2 7.2 0.5 0.4 3.1 2.9 0.1 5.2 18.1 0.2 0.0 0.3 0.5 5.6 5.7 2.5 0.0 7.2 2.3 3.6 0.7 2.9 1.6 0.0 0.5 1.9 3.8 6.9 0.3 2.4 0.3 1.7 0.5 1.6 1.0 8.1 5.4 0.0 0.0 0.2 5.0 0.8 0.0 1.0 24.3 8.0 6.9 5.3 8.1 13.7 9.6 3.6 7.1 0.0 1.7 0.0 2.8 15.2 0.0 9.9 0.0 2.1 0.0 1.6 0.0 0.0 11.1 5.5 0.0 3.2 11.9 0.0 7.7 0.2 6.8 0.0 0.1 6.3 1.0 2.6 0.0 19.9 0.7 0.0 14.3 0.0 2.6 0.0 1.0 15.1 0.0 0.0 1.9 0.0 0.0 0.9 6.7 10.1 0.0 0.0 0.0 0.0 0.5 8.8 0.0 11.8 0.0 0.0 0.0 0.2 0.0 0.5 2.7 2.4 1.3 0.0 8.1 0.0 0.5 0.0 0.2 0.0 5.4 5.0 0.8 MAGEE1 "DAMAGE, KIAA1587" ENSG00000198934 "MAGE family member E1" Q9HCI5 X 76427724-76431353 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.9" "Cell line enhanced" "Detected in many" "AN3-CA: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 17 "B-cells: 1.0;NK-cells: 1.5;T-cells: 2.4" "Low region specificity" "Detected in all" HPA003047 Approved Approved "Cytokinetic bridge,Cytosol" Cytosol "Cytokinetic bridge" "HPA003047: AB_1079298" "unprognostic (9.30e-2)" "unprognostic (2.14e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-3)" "unprognostic (1.76e-1)" "unprognostic (3.94e-2)" "unprognostic (5.61e-3)" "unprognostic (8.72e-3)" "unprognostic (2.41e-3)" "unprognostic (1.43e-1)" "prognostic favourable (3.95e-4)" "unprognostic (7.91e-2)" "prognostic favourable (6.86e-6)" "unprognostic (4.60e-3)" "unprognostic (2.71e-1)" "unprognostic (6.03e-3)" "unprognostic (5.99e-3)" 2.6 5.8 13.8 3.0 23.5 1.1 3.3 18.7 33.9 4.7 1.9 3.2 0.5 1.5 5.4 3.5 2.3 4.8 2.3 3.9 18.9 20.3 4.1 1.1 2.6 4.1 10.2 22.0 8.4 4.1 15.1 5.1 0.8 19.8 5.9 2.1 2.3 3.4 7.4 2.2 3.3 2.0 4.8 5.4 4.5 2.6 1.3 4.9 1.1 4.0 0.1 3.6 2.4 1.8 1.0 0.0 0.0 0.0 1.5 2.4 0.4 0.2 4.7 4.8 9.2 3.4 2.0 4.3 3.5 3.5 3.0 1.7 1.0 0.7 1.0 1.8 3.1 3.6 7.1 6.6 2.5 2.3 0.1 0.0 0.0 3.0 0.7 1.8 0.6 1.5 3.0 0.8 0.8 1.1 0.3 0.0 4.5 0.6 5.1 0.2 5.8 7.1 4.0 3.6 0.0 3.9 0.0 0.0 2.5 0.0 0.5 0.7 2.2 0.1 0.6 4.5 5.8 4.8 0.0 0.0 0.0 0.8 1.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 1.8 0.8 1.1 2.3 0.0 1.0 1.4 1.3 0.0 1.5 0.0 0.0 0.0 0.4 13.8 23.5 18.7 33.9 18.9 20.3 10.2 22.0 19.8 4.9 MAGEE2 HCA3 ENSG00000186675 "MAGE family member E2" Q8TD90 X 75782988-75785236 "Predicted intracellular proteins" "Tumor antigen" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 8.8" "Cell line enhanced" "Detected in single" "U-2 OS: 1.1" "Cancer enriched" "Detected in single" 9 "glioma: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030625 Uncertain "HPA030625: AB_10601863" "unprognostic (5.92e-2)" "unprognostic (9.33e-2)" "unprognostic (2.24e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-2)" "unprognostic (2.05e-2)" "unprognostic (3.01e-3)" "unprognostic (5.79e-3)" "unprognostic (3.47e-2)" "unprognostic (6.43e-2)" 0.5 3.6 2.6 0.5 6.4 0.3 0.7 8.1 8.8 0.9 1.0 0.3 0.0 0.8 1.2 1.2 0.8 0.6 1.0 0.8 2.5 6.7 1.0 0.4 0.9 0.3 2.0 3.8 1.6 0.3 0.3 1.9 0.3 4.1 1.1 1.4 0.4 0.8 1.1 0.3 0.9 1.1 1.3 2.0 0.4 0.4 0.5 0.9 0.0 0.5 0.0 0.4 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 6.4 8.1 7.2 2.5 6.7 2.0 3.8 4.1 0.9 MAGEL2 "NDNL1, nM15" ENSG00000254585 "MAGE family member L2" Q9UJ55 15 23643544-23647841 "Disease related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" Repressor "Autism spectrum disorder, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.6;pituitary gland: 13.0" "Group enriched" "Detected in some" 5 "AF22: 7.7;NTERA-2: 4.7;U-2 OS: 2.5" "Cancer enhanced" "Detected in some" "testis cancer: 4.3" "Group enriched" "Detected in many" 5 "basal ganglia: 20.6;cerebral cortex: 6.4;hypothalamus: 19.4;pons and medulla: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 20.7" "Low region specificity" "Detected in all" "unprognostic (3.18e-1)" "unprognostic (2.63e-1)" "unprognostic (2.21e-1)" "unprognostic (7.47e-3)" "unprognostic (1.65e-2)" "unprognostic (3.80e-1)" "unprognostic (1.17e-1)" "unprognostic (5.38e-3)" "unprognostic (3.51e-3)" "unprognostic (8.61e-2)" "unprognostic (1.31e-2)" "unprognostic (9.55e-2)" "unprognostic (2.96e-9)" "unprognostic (1.66e-4)" "unprognostic (3.30e-2)" "unprognostic (2.06e-4)" "unprognostic (1.79e-2)" 1.5 1.3 3.0 0.9 20.6 0.3 0.7 0.3 6.8 6.7 0.5 1.0 0.2 0.3 4.9 1.2 0.5 1.6 1.2 0.6 2.9 19.4 0.5 0.4 0.5 0.4 2.1 1.6 7.2 2.2 0.3 13.0 4.3 8.9 1.0 0.4 2.5 0.6 1.9 0.5 0.7 0.6 2.2 0.9 1.0 0.5 4.2 1.4 0.0 2.5 0.0 0.4 1.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 4.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 20.6 0.3 6.4 2.9 19.4 2.1 1.6 8.9 1.4 MAGI2 "ACVRIP1, AIP1, ARIP1, KIAA0705, MAGI-2" ENSG00000187391 "Membrane associated guanylate kinase, WW and PDZ domain containing 2" Q86UL8 7 78017057-79453574 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.7;parathyroid gland: 31.8" "Cell line enriched" "Detected in some" 4 "Karpas-707: 42.0" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013650 Approved "HPA013650: AB_1853501" "unprognostic (4.32e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-4)" "unprognostic (5.04e-2)" "unprognostic (3.33e-1)" "unprognostic (6.57e-2)" "unprognostic (1.03e-1)" "unprognostic (2.17e-1)" "unprognostic (8.80e-3)" "unprognostic (1.64e-2)" "unprognostic (5.06e-2)" "prognostic favourable (1.08e-4)" "unprognostic (4.34e-4)" "unprognostic (2.17e-1)" "unprognostic (2.23e-2)" "unprognostic (3.01e-2)" 5.4 8.3 21.0 2.2 20.5 1.8 3.9 43.7 36.8 5.5 3.2 17.7 2.5 3.1 5.6 5.6 3.6 4.8 4.6 3.9 21.8 12.7 7.6 2.5 4.4 1.6 13.6 19.5 11.5 5.1 31.8 7.7 2.3 16.5 11.9 3.0 3.5 2.8 11.6 2.9 2.3 3.2 4.1 15.1 3.1 2.9 5.1 24.4 0.0 9.0 0.0 1.4 4.1 2.9 2.0 1.4 3.8 0.9 1.0 0.9 0.2 0.0 0.3 10.1 0.2 2.1 3.3 0.1 1.8 3.3 0.4 0.5 0.0 0.1 0.0 0.0 1.1 0.1 0.6 0.0 0.5 0.5 0.4 0.1 0.2 0.5 3.1 0.2 0.5 2.5 0.1 0.2 0.1 0.4 0.3 42.0 0.9 0.4 0.1 0.2 2.2 0.1 0.1 0.1 0.7 0.1 0.1 1.5 2.6 0.4 0.1 0.9 0.2 0.3 0.5 1.5 0.5 4.1 0.2 0.2 0.0 0.1 0.9 0.1 0.6 2.7 0.7 0.8 0.9 0.6 0.6 1.1 0.6 0.5 0.4 2.0 0.6 0.8 3.8 1.0 0.9 1.4 0.6 0.2 21.0 20.5 43.7 34.5 21.8 12.7 13.6 19.5 16.5 24.4 MAMDC4 "AEGP, DKFZp434M1411" ENSG00000177943 "MAM domain containing 4" Q6UXC1 9 136850943-136860799 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;liver: 48.9" "Cell line enhanced" "Detected in many" "BEWO: 18.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 10 "cerebellum: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB026377, HPA059977" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB026377: , HPA059977: " "unprognostic (2.79e-1)" "unprognostic (7.90e-2)" "unprognostic (4.09e-3)" "unprognostic (6.86e-2)" "unprognostic (8.33e-2)" "unprognostic (2.66e-4)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "unprognostic (1.31e-1)" "unprognostic (7.37e-2)" "prognostic favourable (1.88e-6)" "unprognostic (8.22e-3)" "unprognostic (1.58e-2)" "unprognostic (1.22e-3)" "unprognostic (9.22e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" 2.0 1.6 1.2 1.9 1.5 1.4 1.2 14.9 1.2 1.2 2.3 1.2 1.2 5.0 1.2 1.2 1.2 1.7 1.2 1.6 1.2 0.4 2.6 48.9 1.2 2.5 1.2 1.2 1.2 3.4 0.5 7.2 1.2 1.2 3.2 0.9 1.2 3.5 1.4 1.7 1.5 6.1 1.2 1.2 5.1 2.3 6.5 1.2 1.2 5.1 1.2 1.2 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 1.5 2.5 1.4 2.8 0.6 0.1 18.5 2.7 0.3 0.3 0.6 2.0 1.6 1.3 0.6 0.7 2.2 0.3 1.3 0.0 2.0 0.9 0.8 5.2 2.2 1.2 0.1 4.8 0.8 1.7 1.4 0.6 0.6 2.6 1.2 0.2 4.1 0.9 3.6 1.4 0.7 1.6 0.4 2.4 0.9 1.3 1.6 2.0 0.5 1.2 1.1 4.3 0.8 0.8 7.5 4.7 1.5 0.4 3.1 1.6 0.4 1.7 1.9 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 14.9 1.2 1.2 0.4 1.2 1.2 1.2 1.2 MAN2A1 "GOLIM7, MANA2" ENSG00000112893 "Mannosidase alpha class 2A member 1" Q16706 5 109689366-109869625 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022377, HPA026896" Enhanced Supported "Golgi apparatus" 70000000 "Golgi apparatus" "CAB022377: , HPA026896: AB_1853512" "unprognostic (1.62e-2)" "unprognostic (4.06e-2)" "unprognostic (1.25e-2)" "unprognostic (6.96e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-1)" "unprognostic (5.80e-2)" "unprognostic (4.20e-2)" "unprognostic (3.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.73e-2)" "unprognostic (1.23e-1)" "unprognostic (6.77e-3)" "unprognostic (2.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.11e-3)" "unprognostic (5.31e-3)" 7.6 17.5 10.9 7.7 21.8 5.7 7.4 1.9 13.2 8.4 11.2 46.8 2.4 17.2 9.2 1.8 7.7 6.2 10.6 4.2 11.7 4.8 9.5 20.7 8.5 7.8 29.9 10.4 7.5 16.7 20.1 3.4 8.7 19.8 4.7 11.9 5.6 9.0 6.0 8.7 7.0 14.4 11.2 23.1 6.9 8.9 7.5 30.6 15.0 9.0 1.8 7.8 10.9 6.2 3.3 2.7 5.8 6.7 0.9 5.5 1.6 7.2 6.7 8.4 3.6 16.1 14.2 31.4 16.1 26.6 9.2 16.6 7.9 11.7 5.2 10.4 20.9 8.6 4.5 16.7 20.1 5.6 3.4 10.6 5.0 7.2 9.1 4.8 5.8 12.1 6.9 14.7 19.5 18.1 2.8 30.5 21.6 3.6 9.0 1.3 6.0 2.4 3.5 13.1 23.0 7.3 11.5 1.2 1.1 7.6 6.8 4.6 6.7 4.2 19.3 18.2 8.0 9.8 10.4 16.3 21.1 4.4 14.0 6.2 10.1 5.8 2.9 0.9 3.0 3.8 1.9 3.3 4.5 4.9 2.7 2.9 5.5 4.8 2.1 0.9 6.7 2.5 4.1 1.6 10.9 21.8 1.9 13.2 11.7 4.8 29.9 10.4 19.8 30.6 MANEAL FLJ31434 ENSG00000185090 "Mannosidase endo-alpha like" Q5VSG8 1 37793802-37801137 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7" "Cell line enhanced" "Detected in many" "SCLC-21H: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.6" "Lineage enriched" "Detected in single" 6 "T-cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063423 Approved "Golgi apparatus" "Intracellular and membrane" 24000 "Golgi apparatus" "HPA063423: " "unprognostic (8.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (7.92e-2)" "prognostic favourable (5.28e-4)" "prognostic unfavourable (3.32e-4)" "unprognostic (3.02e-1)" "unprognostic (1.03e-2)" "unprognostic (7.67e-2)" "unprognostic (6.27e-3)" "unprognostic (1.08e-1)" "unprognostic (1.17e-3)" "unprognostic (8.29e-3)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (2.26e-1)" 1.6 9.5 12.3 2.6 15.2 0.4 6.4 11.2 21.7 4.1 7.6 6.6 2.4 4.5 2.6 8.8 4.8 3.8 2.4 1.5 12.0 20.3 3.8 11.4 3.9 1.5 10.4 9.6 1.8 12.8 6.2 16.2 1.3 15.4 5.6 8.2 4.1 4.4 3.8 4.6 5.2 4.4 3.1 6.2 1.9 6.3 3.5 3.8 0.8 7.3 1.8 2.4 2.7 2.1 0.6 0.3 0.1 0.4 0.0 3.6 0.6 8.0 10.3 1.8 19.9 2.6 0.9 18.0 1.5 9.0 7.8 3.3 17.0 19.1 13.4 6.7 1.0 1.8 3.8 2.0 2.8 15.8 8.1 9.9 9.3 13.6 0.2 14.1 8.2 0.3 10.7 0.4 0.3 0.2 5.7 10.7 1.2 15.8 3.9 0.0 6.3 10.9 6.1 13.7 15.6 4.5 21.4 49.4 14.9 21.6 0.7 8.0 9.5 1.5 1.2 11.0 6.7 10.6 13.8 15.4 14.6 4.4 1.8 4.6 8.1 0.0 0.0 0.0 1.5 0.1 3.6 0.6 0.7 0.8 0.0 0.6 0.0 1.2 0.1 0.0 0.4 0.3 0.6 0.6 12.3 15.2 11.2 21.7 12.0 20.3 10.4 9.6 15.4 3.8 MANSC4 ENSG00000205693 "MANSC domain containing 4" A6NHS7 12 27762738-27771276 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 3.3;testis: 5.9" "Cell line enhanced" "Detected in some" "HaCaT: 2.2;HUVEC TERT2: 5.1;PC-3: 2.6;U-2 OS: 1.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 13 "T-cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039454, HPA039682" Uncertain "HPA039454: , HPA039682: AB_10805483" "unprognostic (1.13e-1)" "unprognostic (4.74e-2)" "unprognostic (2.34e-2)" "unprognostic (2.75e-2)" "unprognostic (6.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (2.25e-4)" "unprognostic (1.96e-1)" "unprognostic (2.49e-2)" "unprognostic (2.87e-3)" "unprognostic (2.50e-3)" "unprognostic (7.15e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-2)" "unprognostic (1.21e-1)" "unprognostic (2.10e-2)" 0.1 0.0 0.2 0.6 0.5 0.1 0.5 3.3 0.2 0.2 0.0 0.2 0.5 0.0 0.0 0.2 0.0 0.0 0.2 1.2 0.7 0.0 0.8 1.9 0.1 0.7 0.6 0.0 2.0 2.0 0.2 0.0 0.0 0.4 0.0 0.3 0.2 0.0 0.2 0.1 0.1 5.9 0.2 1.4 0.1 0.2 0.1 0.0 0.0 0.0 0.1 1.7 0.2 0.1 0.8 0.0 0.1 0.7 0.2 0.8 0.4 0.0 0.0 0.3 1.7 0.3 0.1 0.0 0.2 2.2 0.0 0.0 0.0 0.1 0.2 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 5.1 0.3 0.1 0.0 0.0 0.1 0.0 0.4 2.6 0.2 0.1 0.0 0.0 1.1 0.1 0.0 0.2 0.7 0.0 0.4 1.0 1.2 0.2 1.8 0.4 0.2 0.5 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 MAP1A MAP1L ENSG00000166963 "Microtubule associated protein 1A" P78559 15 43510958-43531620 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 103.6" "Cell line enhanced" "Detected in many" "ASC diff: 21.4;BJ hTERT+: 21.1;fHDF/TERT166: 31.5;hTEC/SVTERT24-B: 20.0;U-87 MG: 42.4" "Cancer enhanced" "Detected in many" "glioma: 18.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 74 "plasmacytoid DC: 12.3" "Lineage enriched" "Detected in single" 74 "dendritic cells: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039063, HPA039064, HPA066488" Enhanced Approved Cytosol Cytosol "HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: " "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-2)" "unprognostic (1.86e-3)" "unprognostic (4.45e-2)" "unprognostic (3.58e-2)" "unprognostic (5.66e-2)" "unprognostic (1.12e-1)" "unprognostic (2.65e-2)" "unprognostic (1.13e-3)" "unprognostic (8.36e-3)" "unprognostic (3.45e-3)" "prognostic unfavourable (6.59e-5)" "unprognostic (5.83e-2)" "unprognostic (2.53e-1)" "prognostic unfavourable (1.09e-5)" "prognostic unfavourable (1.66e-5)" 5.2 7.9 43.6 5.4 42.8 2.5 4.3 24.5 103.6 10.5 5.4 18.3 1.0 3.0 5.6 4.3 4.8 9.1 5.9 14.8 40.9 30.2 2.8 1.9 3.4 2.7 34.7 31.3 7.1 2.7 4.1 4.4 4.4 56.2 6.7 5.3 3.1 2.5 9.6 4.5 3.1 3.2 14.5 21.4 2.6 2.7 5.4 12.6 6.5 3.7 0.1 2.7 6.3 2.8 0.0 12.3 0.0 0.0 0.0 0.1 0.2 0.1 0.8 3.8 2.2 21.4 14.7 0.0 12.2 21.1 3.6 3.5 1.4 0.0 0.0 5.3 31.5 0.1 5.1 0.0 2.1 1.8 0.5 4.7 1.2 0.1 2.0 0.1 2.0 11.0 0.0 20.0 0.1 2.7 7.8 0.1 14.6 0.1 8.6 0.2 2.8 0.3 2.3 11.1 0.0 0.0 0.0 12.0 3.6 0.4 0.0 0.1 0.7 0.2 0.5 11.7 3.9 3.9 0.1 0.0 0.5 1.7 42.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.1 0.2 43.6 42.8 24.5 63.1 40.9 30.2 34.7 31.3 56.2 12.6 MAP1B "MAP5, PPP1R102" ENSG00000131711 "Microtubule associated protein 1B" P46821 5 72107234-72209570 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 102.5" "Cell line enhanced" "Detected in many" "TIME: 64.1" "Cancer enriched" "Detected in all" 5 "glioma: 48.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009792, HPA022275" Enhanced Supported Enhanced Cytosol 140000 Cytosol "CAB009792: AB_2137420, HPA022275: AB_1853944" "unprognostic (9.96e-2)" "unprognostic (3.97e-2)" "unprognostic (1.57e-2)" "unprognostic (3.70e-1)" "unprognostic (4.67e-3)" "unprognostic (2.98e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (1.42e-1)" "unprognostic (7.00e-2)" "unprognostic (4.78e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-2)" "unprognostic (1.13e-2)" "unprognostic (1.90e-1)" "unprognostic (1.75e-2)" "prognostic unfavourable (8.22e-5)" 20.3 18.1 27.5 10.2 39.6 1.6 9.3 52.3 101.9 15.3 6.1 21.6 3.5 3.2 9.2 9.8 12.8 7.7 10.7 17.1 37.6 40.7 4.4 3.3 3.7 3.2 42.4 42.5 7.8 4.5 3.0 7.0 9.5 102.5 19.0 6.2 9.4 7.6 24.0 3.6 10.2 3.9 22.9 45.7 2.4 7.2 11.0 11.3 0.0 5.7 0.1 2.6 13.4 5.9 0.2 0.4 0.6 0.0 0.0 0.3 2.1 0.3 12.1 30.5 11.0 19.0 33.3 0.0 6.5 5.0 6.6 7.9 0.1 0.4 0.0 15.7 24.1 0.1 16.6 0.6 10.0 0.0 2.4 1.3 4.3 3.9 10.1 0.0 1.0 33.4 2.1 26.6 9.9 20.6 1.9 0.0 11.2 0.1 0.0 0.0 8.2 3.9 0.1 3.6 0.0 0.5 0.0 19.7 13.6 6.4 0.0 3.3 0.0 1.2 64.1 21.0 9.9 15.3 29.4 1.4 0.0 0.0 22.7 0.0 16.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.1 0.2 0.6 0.0 0.0 0.4 0.2 2.1 27.5 39.6 52.3 59.1 37.6 40.7 42.4 42.5 102.5 11.3 MAP2 "MAP2A, MAP2B, MAP2C" ENSG00000078018 "Microtubule associated protein 2" P11137 2 209424058-209734118 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 122.3" "Cell line enhanced" "Detected in some" "AF22: 74.6;NTERA-2: 26.7;SCLC-21H: 37.5;SH-SY5Y: 21.0" "Cancer enhanced" "Detected in many" "glioma: 30.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 2.6;naive B-cell: 3.4" "Lineage enriched" "Detected in single" 15 "B-cells: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001984, HPA008273, HPA012828" Enhanced Supported "CAB001984: , HPA008273: AB_1853945, HPA012828: AB_1853946" "unprognostic (2.47e-2)" "unprognostic (2.81e-1)" "unprognostic (2.58e-2)" "prognostic unfavourable (1.98e-6)" "unprognostic (2.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.13e-2)" "unprognostic (6.06e-2)" "unprognostic (1.31e-1)" "unprognostic (9.84e-2)" "unprognostic (1.09e-2)" "unprognostic (1.60e-1)" "unprognostic (1.23e-1)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (7.28e-2)" "unprognostic (4.10e-5)" 4.6 9.2 62.1 2.1 63.1 1.5 4.9 24.7 122.3 4.4 2.5 3.8 0.0 2.0 2.9 4.0 5.6 2.8 6.3 6.2 73.6 53.8 3.9 3.7 9.3 2.4 31.0 48.8 6.4 8.2 12.5 14.7 1.9 35.4 6.5 2.5 7.6 4.9 4.7 2.2 12.1 2.0 3.2 19.9 2.4 2.6 5.4 11.4 0.0 12.2 0.4 2.9 2.8 1.5 3.4 0.1 0.0 0.0 0.0 0.2 0.3 0.6 0.1 74.6 0.0 1.0 0.5 0.0 0.4 0.5 0.1 0.5 0.0 4.0 0.0 0.4 0.9 1.0 5.7 0.4 0.2 0.0 0.3 0.2 2.3 0.0 9.4 0.0 0.0 0.8 2.4 0.0 1.4 1.9 0.0 0.7 0.0 0.2 0.0 0.0 26.7 0.1 0.0 0.1 0.0 0.9 0.0 37.5 21.0 1.5 0.2 0.9 2.0 0.0 0.0 0.0 0.4 0.0 1.0 0.5 0.0 0.0 3.9 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 62.1 63.1 24.7 79.6 73.6 53.8 31.0 48.8 35.4 11.4 MAP3K10 "MEKK10, MLK2, MST" ENSG00000130758 "Mitogen-activated protein kinase kinase kinase 10" Q02779 19 40191744-40215575 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007039 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" "Nucleoplasm, Actin filaments, Cytosol" "HPA007039: AB_1079357" "unprognostic (2.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-3)" "unprognostic (2.03e-2)" "unprognostic (2.04e-1)" "prognostic favourable (8.69e-4)" "unprognostic (4.50e-3)" "unprognostic (1.80e-1)" "unprognostic (3.94e-2)" "unprognostic (6.13e-2)" "unprognostic (1.34e-3)" "unprognostic (4.62e-3)" "unprognostic (6.88e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-2)" "unprognostic (4.77e-3)" "prognostic favourable (2.13e-4)" 7.7 7.0 29.6 4.7 22.8 3.7 2.2 14.3 32.0 3.3 3.4 5.3 1.8 4.4 4.5 1.8 3.7 3.1 4.0 8.2 28.2 11.2 4.7 2.1 4.2 4.6 11.5 9.4 4.3 8.1 4.7 5.2 3.7 9.0 4.6 2.0 2.4 6.9 4.8 22.9 5.6 5.0 4.0 5.3 6.7 6.2 6.6 7.1 2.3 3.3 2.6 2.4 3.8 5.4 0.8 0.0 0.0 0.2 0.0 0.9 0.0 6.2 7.5 2.3 5.5 2.2 1.3 6.5 4.4 2.2 2.0 2.1 1.7 1.8 5.7 4.6 1.5 2.0 0.9 2.2 0.3 10.9 7.1 1.5 3.2 1.7 4.2 1.2 3.7 1.2 5.4 2.2 1.5 1.9 5.4 9.8 0.6 3.7 4.7 2.3 2.8 4.9 5.9 2.5 3.4 1.8 4.0 7.8 11.3 5.1 1.8 10.3 2.5 2.3 3.1 5.3 5.1 7.8 8.4 13.0 7.5 2.5 6.2 2.4 7.7 0.0 0.1 0.0 0.4 0.2 0.0 0.8 0.2 0.9 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 29.6 22.8 14.3 28.7 28.2 11.2 11.5 9.4 9.0 7.1 MAP3K12 "DLK, MEKK12, MUK, ZPK, ZPKP1" ENSG00000139625 "Mitogen-activated protein kinase kinase kinase 12" Q12852 12 53479669-53500063 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.3" "Cell line enhanced" "Detected in many" "ASC diff: 28.4;HHSteC: 27.1;HSkMC: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039936, HPA071996" Enhanced Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA039936: AB_10795239, HPA071996: " "unprognostic (4.01e-1)" "unprognostic (3.30e-1)" "unprognostic (8.89e-3)" "unprognostic (6.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-1)" "unprognostic (6.97e-2)" "unprognostic (3.61e-2)" "unprognostic (2.39e-1)" "unprognostic (2.70e-1)" "prognostic favourable (1.51e-4)" "unprognostic (8.50e-3)" "prognostic unfavourable (5.43e-10)" "unprognostic (1.65e-2)" "unprognostic (2.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.18e-1)" 8.0 8.7 12.3 5.8 16.0 3.0 5.1 40.3 20.6 14.1 6.1 7.0 7.8 3.6 15.1 5.8 4.6 11.5 16.1 4.2 9.4 7.7 4.5 1.4 8.8 4.5 6.4 14.7 13.7 1.8 3.0 12.7 7.3 10.8 5.9 4.6 9.5 2.4 13.5 1.2 4.5 4.1 16.9 5.3 5.3 3.9 6.5 7.4 2.7 4.3 1.4 3.2 11.3 6.4 0.3 0.6 3.4 1.7 0.6 2.8 0.5 0.2 7.5 4.7 7.3 28.4 15.2 0.6 5.1 9.6 5.6 5.6 0.1 0.9 1.7 2.9 5.4 0.0 2.1 3.4 2.2 2.5 2.6 1.8 3.8 0.0 27.1 0.0 1.9 27.0 2.4 7.6 4.0 8.7 0.0 8.1 5.3 3.3 1.8 0.4 1.6 2.8 2.6 3.2 0.4 2.8 0.0 4.7 6.4 2.7 3.5 7.2 2.4 4.7 6.4 5.4 5.8 2.4 1.3 3.3 3.7 0.0 8.7 3.3 5.2 0.0 1.7 0.0 1.5 1.3 2.8 0.3 2.1 2.3 0.6 0.0 0.9 1.2 3.4 0.6 0.4 0.3 0.4 0.5 12.3 16.0 40.3 20.6 9.4 7.7 6.4 14.7 10.8 7.4 MAP3K15 "ASK3, bA723P2.3, FLJ16518" ENSG00000180815 "Mitogen-activated protein kinase kinase kinase 15" Q6ZN16 X 19360056-19515261 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 17.3;brain: 13.2" "Cell line enhanced" "Detected in some" "A549: 3.4;HAP1: 8.6;HEK 293: 7.2;HEL: 2.9;REH: 4.4" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 6 "pons and medulla: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA004006 Approved Vesicles Vesicles "HPA004006: AB_1079358" "unprognostic (2.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.21e-2)" "unprognostic (6.56e-8)" "unprognostic (3.47e-2)" "unprognostic (1.42e-2)" "unprognostic (2.19e-3)" "unprognostic (2.35e-2)" "unprognostic (1.46e-1)" "unprognostic (4.87e-2)" "unprognostic (1.30e-2)" "unprognostic (8.95e-2)" "unprognostic (2.77e-3)" "unprognostic (4.00e-1)" "unprognostic (2.37e-1)" "unprognostic (3.98e-2)" "unprognostic (8.20e-2)" 0.1 17.3 0.5 0.4 0.3 0.5 0.1 2.3 0.1 0.1 0.1 5.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.5 3.6 0.1 0.5 0.0 0.1 0.0 1.3 4.1 0.4 5.7 0.0 13.2 0.1 0.0 4.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 2.6 0.1 2.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 8.6 0.0 0.0 1.4 7.2 2.9 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 2.2 2.2 0.9 4.4 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 2.3 0.1 0.4 0.5 0.1 0.0 13.2 0.0 MAP3K19 "FLJ23074, RCK, YSK4" ENSG00000176601 "Mitogen-activated protein kinase kinase kinase 19" Q56UN5 2 134964491-135047468 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.3;fallopian tube: 23.9" "Group enriched" "Detected in some" 5 "RPMI-8226: 4.0;U-266/70: 2.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8" "Region enhanced" "Detected in many" "pons and medulla: 18.3" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.5" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 20.2" HPA011388 Uncertain Cytosol Cytosol "HPA011388: AB_1848822" "unprognostic (7.12e-3)" "unprognostic (6.55e-3)" "unprognostic (6.96e-2)" "unprognostic (3.90e-3)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (1.96e-1)" "unprognostic (9.38e-2)" "unprognostic (1.09e-1)" "unprognostic (4.33e-1)" "unprognostic (2.02e-2)" "unprognostic (1.32e-1)" "unprognostic (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (2.83e-4)" 0.1 0.2 1.7 0.2 6.2 0.1 0.1 0.0 0.5 1.1 0.2 7.3 0.0 0.2 1.0 6.7 0.2 23.9 0.1 0.1 2.9 3.8 0.2 0.2 5.6 0.2 0.5 1.5 7.3 0.1 0.1 1.0 0.1 18.3 0.3 0.2 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.5 0.2 0.2 7.6 3.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 4.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.7 6.2 0.0 0.5 2.9 3.8 0.5 1.5 18.3 3.1 MAP3K9 "MEKK9, MLK1, PRKE1" ENSG00000006432 "Mitogen-activated protein kinase kinase kinase 9" P80192 14 70722526-70809534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.1" "Cell line enhanced" "Detected in many" "A-431: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000942 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" "Nucleoplasm, Nucleoli" "HPA000942: AB_1079360" "unprognostic (1.20e-1)" "unprognostic (3.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.16e-3)" "unprognostic (2.45e-2)" "unprognostic (3.75e-5)" "unprognostic (2.58e-1)" "unprognostic (4.20e-2)" "unprognostic (4.38e-2)" "unprognostic (1.53e-2)" "unprognostic (2.48e-2)" "unprognostic (4.23e-6)" "unprognostic (5.71e-3)" "unprognostic (6.86e-3)" "unprognostic (1.79e-1)" "unprognostic (2.35e-1)" 0.5 2.2 5.8 2.0 9.2 1.4 2.8 20.1 16.5 2.4 3.1 1.8 0.4 3.0 1.1 3.4 10.1 2.2 1.5 1.2 5.7 7.1 3.1 2.4 3.9 2.6 5.9 5.9 1.4 4.3 6.8 4.7 2.8 12.8 2.0 3.1 3.1 3.2 1.3 1.9 7.8 2.9 0.7 1.6 1.9 3.4 10.1 1.8 0.6 5.3 3.2 6.8 2.0 3.9 2.3 0.5 1.3 0.2 1.1 1.4 0.3 17.7 8.2 1.6 2.0 0.0 0.0 5.5 0.3 0.2 1.7 1.5 5.9 6.8 3.6 2.4 0.1 8.4 5.2 10.0 1.8 2.4 1.5 0.2 2.9 3.9 0.2 0.4 0.8 0.1 5.5 1.2 10.4 0.0 1.3 0.8 0.4 7.1 2.8 0.4 3.5 3.8 1.0 3.1 0.7 3.9 8.2 11.3 2.4 5.1 6.1 1.0 5.5 0.6 0.0 0.0 7.2 0.0 2.8 1.9 4.3 1.9 2.7 0.3 1.0 0.5 0.2 0.8 0.6 0.1 0.1 1.0 0.6 1.0 0.0 2.3 1.0 0.7 1.3 1.1 0.2 0.5 1.4 0.3 5.8 9.2 20.1 16.5 5.7 7.1 5.9 5.9 12.8 1.8 MAP4 ENSG00000047849 "Microtubule associated protein 4" P27816 3 47850690-48089272 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 131.5;skeletal muscle: 197.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038149, HPA038150" Enhanced Enhanced "Plasma membrane,Microtubules,Cytosol" 120000 "Plasma membrane, Microtubules, Cytosol" "HPA038149: AB_10672471, HPA038150: AB_10672505" "unprognostic (2.51e-1)" "unprognostic (4.48e-1)" "unprognostic (2.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.36e-1)" "unprognostic (4.57e-1)" "prognostic unfavourable (1.82e-4)" "unprognostic (6.82e-2)" "unprognostic (1.46e-2)" "unprognostic (5.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.30e-2)" "unprognostic (2.25e-2)" "unprognostic (8.89e-2)" "unprognostic (6.45e-2)" "unprognostic (1.88e-1)" "unprognostic (1.21e-3)" 39.3 14.8 60.5 18.2 50.9 6.3 16.4 29.3 56.0 26.9 26.4 80.8 15.8 13.6 25.8 27.4 27.0 24.6 20.1 110.2 63.7 57.5 20.8 13.8 22.7 12.4 86.8 26.1 26.8 18.9 14.6 9.3 24.0 59.5 21.8 18.8 25.2 14.0 34.9 197.9 25.1 15.2 35.0 131.5 18.3 16.2 21.2 41.8 7.3 15.4 31.3 14.2 24.3 18.1 9.9 8.9 6.3 19.7 10.7 13.4 6.7 21.9 17.6 22.1 16.7 32.6 58.2 9.3 41.2 45.0 34.9 39.2 14.8 13.8 18.6 9.6 62.1 14.7 28.2 37.3 39.2 26.8 11.9 12.6 19.7 19.1 44.3 8.7 10.2 48.6 46.7 42.3 51.9 45.7 16.2 21.6 27.4 12.4 12.3 10.6 13.3 36.5 6.6 20.8 23.1 22.3 18.4 8.8 13.7 31.6 12.8 21.8 9.4 8.1 61.7 33.0 25.5 34.4 26.3 15.2 11.8 8.8 42.4 10.7 31.2 6.3 5.3 2.8 13.4 9.0 6.5 9.9 9.0 10.9 5.7 9.4 4.3 6.7 2.2 10.7 19.7 8.9 10.2 6.7 60.5 50.9 29.3 51.8 63.7 57.5 86.8 26.1 59.5 41.8 MAP4K4 "FLH21957, HGK, NIK" ENSG00000071054 "Mitogen-activated protein kinase kinase kinase kinase 4" O95819 2 101696850-101894689 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 81.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008476 Uncertain "HPA008476: AB_1079362" "unprognostic (6.40e-2)" "unprognostic (1.09e-2)" "unprognostic (4.01e-1)" "unprognostic (1.89e-1)" "unprognostic (1.88e-1)" "unprognostic (1.87e-2)" "unprognostic (2.83e-2)" "prognostic unfavourable (1.57e-4)" "unprognostic (4.29e-2)" "unprognostic (9.79e-2)" "unprognostic (2.22e-3)" "unprognostic (8.65e-2)" "prognostic unfavourable (3.62e-6)" "unprognostic (6.67e-3)" "unprognostic (8.98e-2)" "unprognostic (3.15e-1)" "unprognostic (7.14e-3)" 27.0 5.0 68.3 21.1 56.3 32.1 35.2 14.5 50.4 13.2 7.8 47.5 2.1 5.4 14.6 6.7 18.5 8.6 18.0 22.2 70.5 40.5 6.3 16.8 13.2 25.8 65.3 21.5 12.6 8.3 9.5 4.3 25.1 40.2 7.6 9.6 6.1 7.7 5.7 16.1 8.7 6.5 14.8 81.2 11.7 11.0 20.3 49.1 13.2 8.3 6.6 29.6 13.5 16.3 4.6 6.3 14.4 3.4 1.1 3.7 1.5 18.8 14.3 30.7 14.6 29.1 52.3 38.6 24.0 19.8 21.5 17.8 23.7 25.1 27.5 20.9 35.9 7.8 9.7 21.1 21.5 36.8 6.6 20.6 10.8 61.8 24.6 9.8 0.9 46.9 9.7 53.0 23.7 55.8 13.3 0.0 56.4 10.3 22.7 6.1 15.6 22.8 27.5 21.0 0.1 14.3 6.6 12.0 20.0 16.5 0.0 17.9 3.9 17.8 70.1 42.7 18.3 12.3 28.5 0.0 0.0 16.7 27.5 12.5 31.2 6.9 3.3 0.0 2.4 3.4 1.8 3.5 3.3 1.7 1.1 4.6 2.5 2.7 14.4 1.1 3.0 6.3 3.7 1.5 68.3 56.3 14.5 38.9 70.5 40.5 65.3 21.5 40.2 49.1 MAP6 "FLJ41346, KIAA1878, MAP6-N, STOP" ENSG00000171533 "Microtubule associated protein 6" Q96JE9 11 75586918-75669120 "Predicted intracellular proteins" Transport Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.9" "Group enriched" "Detected in some" 6 "AF22: 19.0;CACO-2: 18.6;HDLM-2: 10.3;SCLC-21H: 31.6;SH-SY5Y: 16.1" "Cancer enhanced" "Detected in many" "glioma: 9.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 24 "B-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015442, CAB022600, HPA039061, HPA039062" Enhanced Uncertain "Plasma membrane" "Plasma membrane" "CAB015442: AB_2140997, CAB022600: , HPA039061: , HPA039062: " "unprognostic (3.04e-2)" "unprognostic (6.18e-2)" "unprognostic (3.15e-2)" "unprognostic (9.07e-2)" "unprognostic (7.54e-2)" "unprognostic (4.49e-2)" "unprognostic (8.29e-2)" "unprognostic (2.51e-2)" "unprognostic (5.99e-2)" "unprognostic (7.99e-2)" "prognostic favourable (3.41e-4)" "prognostic favourable (9.15e-4)" "unprognostic (2.43e-2)" "unprognostic (3.96e-3)" "unprognostic (8.09e-3)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" 3.0 16.6 23.7 2.1 26.4 0.6 2.6 14.9 35.9 6.9 6.4 10.0 6.1 1.9 10.0 18.6 4.2 34.6 5.8 5.4 21.3 26.6 7.3 1.3 6.5 1.1 17.0 19.9 7.1 3.4 28.7 24.9 1.8 33.2 12.9 3.6 7.5 2.9 18.7 1.1 2.4 2.0 11.5 13.7 1.7 3.6 12.4 9.9 0.0 6.2 0.0 1.0 2.6 3.1 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 19.0 0.0 0.0 0.0 0.0 1.8 0.1 0.1 0.0 18.6 0.0 0.3 0.7 3.1 0.0 1.7 0.2 0.0 10.3 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.4 0.0 0.0 0.0 0.0 0.2 31.6 16.1 2.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.7 26.4 14.9 29.1 21.3 26.6 17.0 19.9 33.2 9.9 MAP6D1 "FLJ12748, SL21" ENSG00000180834 "MAP6 domain containing 1" Q9H9H5 3 183815876-183825594 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 48.1;skeletal muscle: 33.5" "Cell line enriched" "Detected in many" 5 "T-47d: 38.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 2.7" "Lineage enriched" "Detected in single" 5 "T-cells: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037991 Enhanced Supported Approved Cytosol Cytosol "HPA037991: AB_10672503" "unprognostic (9.23e-3)" "unprognostic (2.70e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-3)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-1)" "unprognostic (2.42e-1)" "unprognostic (1.28e-2)" "unprognostic (5.36e-2)" "prognostic unfavourable (3.37e-4)" "unprognostic (8.81e-12)" "unprognostic (1.08e-1)" "unprognostic (2.96e-3)" "unprognostic (1.86e-1)" "unprognostic (5.72e-2)" 1.1 1.2 11.8 1.5 16.0 1.1 2.0 30.9 32.1 1.5 1.4 48.1 0.0 1.9 1.4 2.0 1.1 1.5 1.3 1.9 18.8 9.2 1.2 1.3 1.4 1.7 24.7 8.7 1.7 6.0 1.8 0.5 1.3 18.4 2.7 1.4 0.0 1.6 2.0 33.5 4.6 1.5 1.4 37.7 1.5 1.2 1.3 20.4 2.2 1.1 0.0 1.4 1.1 0.2 0.5 0.3 0.2 0.2 0.0 2.7 0.3 1.8 1.3 2.1 0.4 0.5 0.7 1.6 2.3 0.4 4.5 3.0 1.8 0.1 0.2 3.0 3.5 1.4 4.4 1.1 3.0 1.3 6.6 0.2 0.0 0.0 1.3 2.4 0.8 0.3 0.3 1.1 0.4 0.9 0.3 0.0 0.6 8.2 5.7 3.3 2.0 3.8 2.8 3.3 0.0 0.2 0.0 7.0 1.3 1.7 1.3 2.4 38.9 2.3 0.4 1.0 1.6 1.6 3.5 1.4 0.8 1.1 0.3 0.4 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.5 2.7 0.3 0.0 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.3 11.8 16.0 30.9 19.9 18.8 9.2 24.7 8.7 18.4 20.4 MAP7 E-MAP-115 ENSG00000135525 "Microtubule associated protein 7" Q14244 6 136342281-136550819 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.4" "Cell line enhanced" "Detected in many" "CACO-2: 21.7;HeLa: 25.9;MCF7: 31.8;RT4: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029712, HPA029713" Enhanced Supported Microtubules,Cytosol "Microtubules, Cytosol" "HPA029712: AB_10600303, HPA029713: AB_10601339" "unprognostic (8.68e-3)" "prognostic unfavourable (9.70e-5)" "unprognostic (2.33e-3)" "unprognostic (4.35e-3)" "unprognostic (6.95e-2)" "unprognostic (3.35e-1)" "prognostic favourable (9.22e-4)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.72e-1)" "unprognostic (4.61e-2)" "unprognostic (3.33e-1)" "prognostic favourable (5.07e-7)" "unprognostic (1.62e-3)" "unprognostic (7.84e-2)" "unprognostic (3.62e-1)" "unprognostic (6.51e-2)" 2.2 6.8 24.1 3.6 41.3 3.4 10.4 36.9 29.3 5.2 18.5 49.8 6.0 21.8 2.1 15.7 11.9 7.9 6.5 1.5 30.7 18.3 25.3 13.3 5.5 1.3 47.6 16.5 1.5 19.0 18.9 13.8 5.3 26.2 15.8 18.0 6.6 14.0 8.2 1.1 13.0 19.7 2.1 55.4 1.5 14.4 17.1 52.7 0.4 12.6 4.3 3.9 6.3 6.0 1.6 5.9 13.0 2.8 0.7 0.6 0.7 9.1 14.3 0.1 0.0 0.1 0.0 15.2 0.2 0.4 0.1 0.2 21.7 9.7 0.0 2.0 0.3 14.1 4.1 12.7 0.2 0.0 9.1 9.6 25.9 0.1 0.1 9.3 1.1 0.0 11.9 0.0 0.9 0.1 6.5 0.2 0.0 31.8 0.1 0.9 1.9 2.1 0.0 0.3 1.7 8.9 25.0 9.2 1.9 10.1 19.3 0.2 7.6 0.9 0.2 0.0 0.7 0.1 0.6 1.7 2.2 0.0 0.2 3.7 0.2 3.0 2.6 0.0 0.0 1.7 0.3 1.6 0.6 0.0 5.9 1.2 0.1 0.0 13.0 0.7 2.8 0.0 0.2 0.7 24.1 41.3 36.9 29.3 30.7 18.3 47.6 16.5 26.2 52.7 MAP7D2 FLJ14503 ENSG00000184368 "MAP7 domain containing 2" Q96T17 X 20006713-20116917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;epididymis: 38.7" "Cell line enhanced" "Detected in some" "A549: 8.6;CACO-2: 12.4;HEK 293: 17.0;HeLa: 14.7;Hep G2: 7.3;SCLC-21H: 19.6;SiHa: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "basophil: 5.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051508, HPA059537" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051508: , HPA059537: " "unprognostic (1.51e-1)" "unprognostic (9.19e-2)" "unprognostic (3.76e-1)" "unprognostic (1.45e-5)" "unprognostic (5.65e-2)" "unprognostic (9.77e-3)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (7.77e-3)" "unprognostic (3.58e-4)" "unprognostic (2.21e-2)" "prognostic unfavourable (7.27e-5)" "unprognostic (9.12e-3)" "unprognostic (3.60e-2)" "unprognostic (2.54e-3)" "unprognostic (3.19e-1)" 0.7 3.6 11.1 0.9 18.5 1.3 1.0 12.9 30.8 0.7 1.3 0.8 0.7 1.3 1.2 38.7 0.9 3.0 1.1 0.9 16.5 10.3 4.1 0.7 0.9 0.8 10.4 15.0 0.8 1.7 0.7 3.0 8.1 24.2 1.5 1.5 0.8 0.8 2.8 1.0 1.5 1.8 1.0 7.1 0.7 8.9 9.7 2.1 0.0 0.6 0.0 0.9 0.7 0.5 0.0 0.8 5.5 0.1 0.0 0.3 0.0 0.0 8.6 0.8 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.1 12.4 0.3 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.6 17.0 0.0 14.7 7.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.2 0.0 0.0 1.0 0.0 19.6 3.3 8.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.9 0.0 0.9 5.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 11.1 18.5 12.9 21.7 16.5 10.3 10.4 15.0 24.2 2.1 MAP9 "ASAP, FLJ21159" ENSG00000164114 "Microtubule associated protein 9" Q49MG5 4 155342658-155376970 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.3;parathyroid gland: 43.5" "Cell line enhanced" "Detected in many" "SH-SY5Y: 25.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (8.00e-2)" "unprognostic (1.60e-1)" "unprognostic (6.53e-2)" "unprognostic (6.11e-2)" "unprognostic (2.11e-1)" "unprognostic (5.50e-2)" "unprognostic (2.12e-1)" "unprognostic (3.01e-1)" "unprognostic (7.58e-2)" "unprognostic (2.98e-1)" "unprognostic (1.23e-1)" "unprognostic (1.47e-1)" "unprognostic (4.39e-2)" "unprognostic (2.48e-2)" "unprognostic (1.04e-1)" "unprognostic (4.05e-2)" "unprognostic (9.54e-2)" 3.5 5.1 8.9 3.3 16.3 1.6 3.9 7.5 19.0 5.4 3.8 2.2 7.2 1.1 6.5 6.7 2.8 8.3 6.8 5.7 8.9 13.3 8.4 0.9 4.3 2.7 11.2 10.3 5.5 4.8 43.5 25.7 4.4 31.3 10.9 1.8 3.3 2.5 8.0 0.6 0.8 1.9 5.1 7.6 2.1 5.2 10.2 4.8 1.6 12.9 0.4 2.2 3.7 2.4 6.7 4.1 0.2 0.6 1.3 4.6 0.9 0.0 6.0 6.6 5.6 7.0 8.5 1.3 6.5 6.0 4.0 3.4 0.0 0.0 4.3 8.8 4.8 0.0 6.8 7.0 6.5 0.0 5.6 2.7 0.0 0.0 5.2 0.0 0.0 7.1 3.9 5.5 3.4 0.0 0.0 0.0 4.4 2.7 5.0 0.0 5.0 7.8 0.0 0.0 0.1 13.2 5.1 9.0 25.5 0.0 11.4 0.3 9.3 0.0 0.9 5.3 9.7 0.1 4.8 5.3 0.0 4.7 15.4 0.0 8.5 0.0 0.0 0.0 4.6 0.6 3.7 5.1 2.6 4.1 0.1 6.7 2.4 3.1 0.2 1.3 0.0 4.1 1.5 0.9 8.9 16.3 7.5 19.0 8.9 13.3 11.2 10.3 31.3 4.8 MAPK1 "ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2" ENSG00000100030 "Mitogen-activated protein kinase 1" P28482 22 21754500-21867680 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 80.3" "Cell line enhanced" "Detected in all" "K-562: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003995, CAB004229, HPA005700, HPA030069" Approved 250000 "CAB004229: AB_627547, HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035" "unprognostic (9.41e-3)" "unprognostic (2.68e-1)" "unprognostic (2.50e-3)" "unprognostic (4.17e-1)" "unprognostic (4.44e-3)" "unprognostic (1.72e-1)" "prognostic unfavourable (4.95e-4)" "unprognostic (2.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.58e-1)" "unprognostic (8.43e-3)" "unprognostic (1.04e-1)" "unprognostic (1.35e-2)" "unprognostic (2.08e-1)" "unprognostic (1.94e-1)" "unprognostic (1.41e-1)" "unprognostic (6.49e-2)" 16.1 21.1 32.9 18.3 80.3 20.2 13.6 31.0 54.5 18.6 18.5 23.2 9.6 13.7 17.4 10.6 25.7 16.9 14.9 22.8 32.4 23.4 21.7 16.4 19.9 16.6 18.4 23.6 16.0 19.8 27.4 10.9 17.2 27.6 16.4 19.9 14.2 15.8 17.8 28.2 17.5 15.1 22.8 20.4 19.8 17.2 24.2 21.5 19.5 23.0 11.1 21.4 17.7 15.3 2.5 3.2 13.5 4.9 7.0 13.7 2.5 19.3 12.2 15.7 9.0 18.7 18.9 6.0 21.4 20.0 19.2 18.6 9.7 10.3 10.7 10.6 28.6 18.4 18.5 17.1 25.1 43.1 17.3 19.4 11.5 11.4 15.4 27.3 20.1 14.0 13.7 23.2 21.5 26.2 79.5 12.2 23.4 7.9 17.6 6.0 5.9 12.1 19.4 39.0 2.9 11.0 15.9 12.9 7.1 23.1 14.0 12.5 10.5 9.2 22.9 16.1 21.0 18.4 13.6 11.7 14.3 16.7 15.2 13.3 17.4 1.0 4.0 5.8 13.7 4.6 3.9 2.0 2.9 4.9 3.2 2.5 2.8 5.1 13.5 7.0 4.9 3.2 2.7 2.5 32.9 80.3 31.0 54.5 32.4 23.4 18.4 23.6 27.6 21.5 MAPK10 "JNK3, p493F12, p54bSAPK, PRKM10" ENSG00000109339 "Mitogen-activated protein kinase 10" P53779 4 85990007-86594625 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.3" "Cell line enriched" "Detected in many" 6 "AF22: 58.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022625 Approved "CAB022625: " "unprognostic (2.46e-2)" "unprognostic (4.36e-2)" "unprognostic (1.13e-1)" "unprognostic (4.05e-2)" "unprognostic (5.17e-2)" "unprognostic (2.03e-1)" "unprognostic (4.59e-2)" "unprognostic (4.82e-2)" "unprognostic (3.81e-2)" "unprognostic (4.45e-2)" "unprognostic (1.18e-3)" "unprognostic (3.02e-2)" "prognostic favourable (3.11e-4)" "unprognostic (1.92e-2)" "unprognostic (1.44e-1)" "unprognostic (6.22e-3)" "prognostic favourable (5.57e-4)" 17.2 11.9 31.6 3.7 34.5 9.7 6.2 26.1 58.3 11.4 4.0 12.6 8.1 3.2 11.0 14.2 7.4 11.9 10.4 5.1 36.0 28.6 15.0 2.7 6.5 3.9 31.5 36.4 11.3 5.6 10.9 31.5 3.4 37.9 16.6 4.3 5.4 3.4 18.9 2.0 3.5 3.9 11.4 23.1 5.3 4.3 18.2 15.8 0.0 15.3 0.4 3.6 11.1 10.2 3.7 3.0 6.9 1.8 3.3 3.6 2.3 1.0 1.9 58.9 1.8 1.6 1.3 2.2 1.2 1.1 1.0 0.4 1.1 1.7 2.6 2.0 0.7 3.6 0.6 1.5 1.7 3.7 1.6 2.1 2.3 1.9 1.4 0.9 1.2 1.6 0.7 1.4 1.9 1.2 1.9 9.7 0.6 1.5 1.7 1.1 3.4 1.2 1.8 1.5 0.9 4.2 6.2 3.6 3.2 1.2 4.8 0.8 3.5 1.2 2.7 2.6 2.6 1.1 1.0 3.2 1.9 1.6 3.7 1.3 1.4 6.9 1.8 3.3 2.3 1.6 2.4 3.7 1.9 2.5 1.6 3.3 2.7 3.6 6.2 3.3 1.5 3.0 2.7 2.3 31.6 34.5 26.1 58.3 36.0 28.6 31.5 36.4 37.9 15.8 MAPK15 "ERK7, ERK8" ENSG00000181085 "Mitogen-activated protein kinase 15" Q8TD08 8 143716259-143722458 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;epididymis: 27.6;fallopian tube: 29.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.1;HeLa: 14.0;MCF7: 13.6;T-47d: 12.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002704 Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA002704: AB_1079307" "unprognostic (9.11e-2)" "unprognostic (1.38e-1)" "unprognostic (8.04e-3)" "unprognostic (2.94e-1)" "unprognostic (2.54e-2)" "unprognostic (1.14e-2)" "unprognostic (1.22e-1)" "unprognostic (6.09e-2)" "unprognostic (2.59e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-1)" "unprognostic (9.51e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (5.78e-1)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" 0.6 0.1 3.6 0.3 8.1 0.1 1.1 0.2 2.1 4.5 0.4 8.7 5.2 0.5 2.2 27.6 1.3 29.5 0.4 1.1 5.4 4.6 3.9 0.2 7.4 0.5 0.2 1.5 4.7 2.0 9.1 4.2 0.6 26.9 0.9 0.4 1.6 3.0 2.4 0.2 4.9 0.7 0.5 0.4 0.5 0.9 7.3 2.4 0.1 8.4 0.5 0.4 0.5 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.7 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.2 7.1 0.0 1.3 0.0 5.3 0.0 0.2 0.0 1.1 1.6 0.0 14.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 13.6 0.0 0.0 2.0 1.1 0.0 2.9 0.3 0.9 1.3 3.9 3.9 0.0 2.8 0.0 12.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.1 0.2 2.1 5.4 4.6 0.2 1.5 26.9 2.4 MAPK4 "Erk3-related, Erk4, PRKM4" ENSG00000141639 "Mitogen-activated protein kinase 4" P31152 18 50560078-50731824 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5" "Cell line enhanced" "Detected in some" "HAP1: 3.0;HeLa: 4.4;NTERA-2: 3.0;SCLC-21H: 15.4;SH-SY5Y: 3.7" "Group enriched" "Detected in many" 5 "glioma: 15.2;melanoma: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007461 Approved "Nucleoplasm,Golgi apparatus,Midbody" "Nucleoplasm, Golgi apparatus" Midbody "HPA007461: AB_1079308" "unprognostic (4.12e-2)" "unprognostic (3.24e-2)" "unprognostic (3.60e-1)" "unprognostic (1.42e-3)" "unprognostic (5.17e-2)" "unprognostic (1.84e-2)" "unprognostic (6.32e-2)" "unprognostic (2.08e-2)" "unprognostic (8.24e-2)" "unprognostic (1.61e-1)" "unprognostic (4.38e-3)" "unprognostic (2.16e-1)" "unprognostic (3.44e-7)" "unprognostic (1.96e-4)" "unprognostic (5.99e-4)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" 1.9 26.4 16.9 1.1 33.4 0.9 1.8 15.9 23.9 1.4 2.6 9.5 3.8 1.6 1.8 4.5 3.5 1.5 3.0 16.9 13.0 14.3 4.5 7.0 3.5 0.9 17.1 9.1 4.2 2.5 43.5 8.3 3.7 20.5 5.3 1.8 4.1 1.8 12.4 1.7 1.0 1.9 5.2 11.8 1.1 1.3 3.5 12.4 1.7 7.8 0.0 0.9 2.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 1.5 1.4 4.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.1 15.4 3.7 0.0 1.1 2.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 33.4 15.9 14.5 13.0 14.3 17.1 9.1 20.5 12.4 MAPK8IP1 "IB1, JIP-1, JIP1, PRKM8IP" ENSG00000121653 "Mitogen-activated protein kinase 8 interacting protein 1" Q9UQF2 11 45885651-45906465 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 73.5" "Cell line enhanced" "Detected in many" "SCLC-21H: 38.6" "Cancer enhanced" "Detected in all" "glioma: 51.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058921, HPA070332" Enhanced "Plasma membrane" "Plasma membrane" "HPA058921: , HPA070332: " "unprognostic (3.96e-2)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (6.88e-2)" "unprognostic (5.59e-2)" "unprognostic (2.82e-1)" "unprognostic (8.25e-3)" "unprognostic (3.42e-3)" "unprognostic (1.27e-2)" "unprognostic (9.54e-2)" "unprognostic (3.22e-3)" "unprognostic (2.20e-2)" "prognostic favourable (1.23e-11)" "unprognostic (7.19e-2)" "unprognostic (4.01e-2)" "unprognostic (4.46e-2)" "unprognostic (1.80e-3)" 3.0 12.8 33.3 2.1 29.6 1.4 2.7 24.9 73.5 3.1 1.9 4.6 0.1 1.6 4.9 3.1 2.1 6.6 3.0 2.9 38.1 22.3 5.1 2.7 2.6 1.0 28.0 18.9 4.4 26.4 14.7 24.8 1.6 23.5 4.9 1.5 4.5 4.8 5.0 1.7 1.7 2.0 4.4 44.4 1.7 3.8 10.8 4.8 0.0 3.9 0.5 0.9 2.0 0.4 0.4 0.4 2.1 0.9 2.6 0.2 0.0 0.0 3.5 4.7 13.1 1.8 0.9 0.1 2.5 2.2 5.0 3.6 3.0 0.5 0.2 1.2 2.9 2.8 5.0 2.3 2.2 1.9 6.5 0.0 4.4 2.0 1.6 0.2 2.2 1.2 0.5 3.2 0.6 1.1 5.4 0.8 1.4 1.8 0.1 0.3 12.5 5.2 0.3 7.7 0.1 2.3 0.0 38.6 14.4 4.1 3.4 4.7 5.5 0.2 1.0 6.4 9.8 9.5 4.5 0.5 0.6 0.2 4.0 0.1 1.9 2.1 0.9 0.0 0.2 0.2 0.1 0.2 0.0 0.1 0.0 0.4 0.1 0.2 1.8 2.6 0.0 0.4 0.1 0.0 33.3 29.6 24.9 41.7 38.1 22.3 28.0 18.9 23.5 4.8 MAPK8IP2 "IB2, JIP2, PRKM8IPL" ENSG00000008735 "Mitogen-activated protein kinase 8 interacting protein 2" Q13387 22 50600685-50613981 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 48.9" "Cell line enhanced" "Detected in many" "HEK 293: 8.7;SCLC-21H: 17.5;SH-SY5Y: 15.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034780 Uncertain "HPA034780: AB_10670283" "unprognostic (7.82e-2)" "unprognostic (7.62e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (5.80e-2)" "unprognostic (6.72e-2)" "unprognostic (1.18e-1)" "unprognostic (2.90e-1)" "unprognostic (5.23e-2)" "unprognostic (9.19e-2)" "unprognostic (8.57e-3)" "unprognostic (8.78e-3)" "unprognostic (6.33e-3)" "unprognostic (6.77e-2)" "unprognostic (1.72e-1)" "unprognostic (5.29e-2)" "unprognostic (4.75e-2)" 1.9 8.4 12.2 0.9 14.5 0.6 1.9 13.4 48.9 3.0 2.0 2.1 0.0 1.3 1.6 0.8 2.3 1.7 0.7 2.0 12.0 1.3 2.0 1.8 1.8 0.7 1.4 19.0 4.7 3.1 2.4 4.1 1.2 20.1 1.9 0.9 0.9 4.3 1.1 1.7 1.6 2.0 1.0 3.1 2.1 2.4 3.5 3.8 0.0 2.2 0.0 0.7 3.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 4.4 4.0 0.5 0.0 4.6 0.0 0.1 1.4 0.7 2.6 0.8 0.6 1.2 0.1 0.0 5.6 0.0 0.0 0.2 8.7 0.0 0.2 1.6 0.5 0.0 0.9 0.2 5.6 0.0 0.2 0.0 1.3 2.1 0.0 0.2 0.0 0.0 2.9 2.4 0.8 0.5 0.0 0.0 0.0 17.5 15.8 4.7 5.1 0.2 1.1 0.0 0.0 0.1 0.2 0.4 0.0 1.1 2.8 0.3 0.3 0.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 14.5 13.4 29.7 12.0 1.3 1.4 19.0 20.1 3.8 MAPK8IP3 "JIP3, JSAP1, KIAA1066, syd" ENSG00000138834 "Mitogen-activated protein kinase 8 interacting protein 3" Q9UPT6 16 1706183-1770317 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005580, HPA041785, HPA069311" Approved Approved Vesicles Vesicles "CAB005580: AB_627840, HPA041785: , HPA069311: " "unprognostic (1.49e-1)" "unprognostic (2.22e-1)" "unprognostic (8.28e-3)" "unprognostic (8.32e-2)" "unprognostic (3.90e-1)" "unprognostic (6.83e-3)" "unprognostic (3.66e-2)" "unprognostic (2.41e-2)" "unprognostic (1.55e-1)" "unprognostic (8.67e-2)" "unprognostic (1.57e-2)" "unprognostic (6.91e-3)" "prognostic unfavourable (5.25e-5)" "unprognostic (2.84e-1)" "unprognostic (1.85e-1)" "unprognostic (2.45e-1)" "prognostic favourable (3.95e-4)" 9.6 13.8 29.3 14.0 35.7 24.7 6.7 54.9 56.8 8.4 7.7 25.8 5.7 14.9 10.4 5.4 5.5 7.2 9.2 15.1 24.4 19.4 9.1 7.5 8.5 16.4 20.3 35.7 14.6 21.8 12.0 21.3 9.8 32.9 11.1 5.1 8.8 18.1 9.5 12.8 25.1 13.8 8.0 15.3 20.6 13.8 11.1 22.0 4.6 10.0 2.4 7.7 9.8 7.6 1.5 1.6 2.4 1.3 0.0 1.4 0.4 3.7 7.3 7.7 6.9 3.8 6.5 6.0 6.3 2.4 3.1 2.8 10.1 12.6 4.4 4.0 3.9 7.2 1.9 4.2 1.0 6.9 8.5 5.8 16.6 7.7 5.2 3.7 10.3 12.9 5.6 4.6 2.2 4.2 4.9 8.5 3.3 9.5 5.8 16.5 5.1 4.1 25.7 3.8 7.4 3.9 5.0 16.1 12.8 7.6 7.1 3.0 3.8 5.3 13.0 13.4 7.5 5.7 5.0 19.1 3.3 5.7 3.5 3.9 6.6 0.0 1.3 2.4 1.4 0.3 0.8 1.5 0.3 0.5 0.4 1.4 0.4 0.4 1.1 0.0 0.3 1.6 0.8 0.4 29.3 35.7 54.9 53.1 24.4 19.4 20.3 35.7 32.9 22.0 MAPK9 "JNK2, p54a, PRKM9, SAPK" ENSG00000050748 "Mitogen-activated protein kinase 9" P45984 5 180233143-180292099 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.7" "Cell line enhanced" "Detected in all" "HDLM-2: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "basophil: 13.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB008910 Approved "CAB008910: " "unprognostic (5.04e-3)" "unprognostic (2.06e-2)" "prognostic favourable (1.11e-4)" "unprognostic (8.53e-2)" "unprognostic (1.75e-1)" "unprognostic (5.06e-3)" "unprognostic (6.83e-3)" "unprognostic (3.16e-1)" "unprognostic (4.93e-2)" "unprognostic (3.76e-1)" "unprognostic (5.97e-2)" "unprognostic (1.36e-1)" "unprognostic (1.50e-1)" "unprognostic (2.13e-1)" "unprognostic (2.29e-1)" "unprognostic (9.38e-3)" "unprognostic (2.40e-1)" 10.3 12.4 22.9 9.6 31.8 10.3 11.4 48.7 41.4 10.8 12.4 10.6 4.7 10.1 8.7 9.5 8.7 8.8 7.8 14.0 24.3 25.0 12.2 9.7 10.8 10.0 22.0 21.0 8.5 25.9 16.3 8.8 10.9 29.4 11.7 15.3 7.0 9.9 13.1 20.5 6.3 10.4 11.4 16.8 8.6 12.3 9.4 10.3 7.1 15.4 5.1 11.3 9.9 7.3 1.4 1.4 13.2 2.4 1.3 3.1 0.3 17.0 14.1 12.5 15.6 12.4 13.9 26.9 16.4 14.6 13.9 13.9 18.5 12.2 18.3 28.4 17.4 13.1 12.8 27.6 16.3 68.7 12.4 7.6 15.7 13.1 9.4 15.7 13.3 10.2 12.4 13.4 13.0 16.4 8.4 13.3 18.8 22.4 15.6 6.6 8.7 8.4 15.2 21.3 8.7 10.5 16.4 14.4 10.2 19.3 18.8 13.1 19.1 13.7 11.7 16.6 16.8 23.4 24.5 9.6 11.3 12.5 17.6 14.7 11.0 13.2 0.6 2.5 2.0 1.3 2.0 1.0 1.5 1.8 1.0 1.4 1.0 1.2 0.9 1.3 2.4 1.4 3.1 0.3 22.9 31.8 48.7 41.4 24.3 25.0 22.0 21.0 29.4 10.3 MAPKBP1 KIAA0596 ENSG00000137802 "Mitogen-activated protein kinase binding protein 1" O60336 15 41774434-41827855 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030832, HPA030833" Approved Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA030832: AB_10601869, HPA030833: " "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (6.56e-2)" "prognostic favourable (1.47e-4)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (9.84e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavourable (6.80e-4)" "unprognostic (1.08e-3)" "unprognostic (6.03e-3)" "unprognostic (7.94e-2)" "unprognostic (1.68e-1)" "unprognostic (8.98e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" 4.7 6.0 10.6 5.0 13.8 4.4 5.7 48.1 13.9 6.1 5.7 8.8 4.4 10.6 9.3 5.4 12.5 8.0 5.3 4.2 8.6 6.7 3.9 2.3 4.7 4.0 8.6 9.2 15.4 4.3 5.8 9.5 6.1 9.3 5.9 4.3 7.0 5.1 7.1 4.9 26.3 10.5 10.2 6.8 5.7 5.4 19.5 10.7 4.4 8.7 5.2 7.4 8.4 6.6 1.9 1.9 4.3 2.1 2.2 3.3 1.6 4.9 2.6 7.0 6.6 7.8 7.7 4.7 7.0 17.5 6.3 4.7 5.1 1.8 1.2 5.8 5.6 11.8 6.8 19.4 4.6 4.4 2.0 4.9 8.0 1.7 3.3 3.1 10.2 3.9 15.6 10.0 18.3 9.2 3.0 2.3 8.9 1.0 2.6 2.8 0.8 5.3 2.8 5.0 0.5 3.7 5.5 7.9 4.5 4.1 4.1 3.0 4.9 2.5 7.3 9.1 4.4 8.8 6.8 5.1 8.4 2.9 6.1 4.3 7.6 4.3 1.3 1.1 3.3 0.7 2.4 1.9 1.9 1.4 1.9 1.8 2.4 2.0 0.7 2.2 2.1 0.7 0.8 1.6 10.6 13.8 48.1 13.9 8.6 6.7 8.6 9.2 9.3 10.7 MAPRE2 "EB1, EB2, RP1" ENSG00000166974 "Microtubule associated protein RP/EB family member 2" Q15555 18 34976928-35143470 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016738, HPA016739" Enhanced Uncertain Nucleoplasm 24000000 Nucleoplasm "HPA016738: AB_1853571, HPA016739: AB_1853570" "unprognostic (2.01e-1)" "unprognostic (3.48e-1)" "unprognostic (2.55e-2)" "unprognostic (5.30e-3)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-2)" "unprognostic (8.53e-2)" "unprognostic (1.09e-2)" "unprognostic (2.29e-1)" "unprognostic (2.93e-2)" "unprognostic (5.40e-2)" "unprognostic (2.22e-3)" "unprognostic (5.83e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (3.99e-3)" 12.3 33.8 38.9 15.3 35.5 10.4 9.6 34.6 61.8 11.6 13.4 30.4 3.1 8.3 8.1 11.3 10.1 6.5 22.7 47.9 43.7 29.8 10.6 18.5 15.1 18.4 39.0 43.3 14.8 7.3 7.6 8.6 15.7 32.1 9.4 14.0 8.7 10.5 10.2 24.6 12.8 10.7 14.4 71.4 14.6 16.7 3.8 22.1 31.9 12.3 8.6 17.5 15.7 8.4 27.4 23.1 25.1 22.8 34.0 32.8 32.8 0.2 8.7 9.8 5.1 5.9 5.5 0.7 6.2 14.8 7.4 12.8 0.6 3.3 28.5 7.2 13.5 11.7 7.6 5.0 13.7 16.6 7.1 28.9 9.4 16.6 4.3 15.9 24.3 6.6 1.3 10.3 3.6 41.4 8.9 12.8 9.7 0.5 33.5 5.3 7.5 1.7 13.5 11.9 6.5 3.9 0.1 12.2 8.1 4.6 0.2 5.1 1.0 9.3 6.9 8.2 4.6 4.8 4.1 6.7 15.9 16.7 14.1 21.3 12.7 25.1 14.7 22.2 32.8 18.2 25.4 27.4 23.2 29.8 16.0 25.9 26.8 32.6 10.6 34.0 22.8 23.1 23.5 32.8 38.9 35.5 34.6 41.2 43.7 29.8 39.0 43.3 32.1 22.1 MAPRE3 "EB3, RP3" ENSG00000084764 "Microtubule associated protein RP/EB family member 3" Q9UPY8 2 26970612-27027196 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 77.1;skeletal muscle: 62.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 7.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009263 Uncertain Supported Cytosol Cytosol "HPA009263: AB_1078716" "unprognostic (1.24e-1)" "unprognostic (1.10e-1)" "unprognostic (8.31e-2)" "unprognostic (2.94e-2)" "unprognostic (1.04e-2)" "unprognostic (3.40e-2)" "unprognostic (2.22e-2)" "unprognostic (1.35e-3)" "unprognostic (1.75e-2)" "unprognostic (3.49e-1)" "unprognostic (4.77e-3)" "unprognostic (2.37e-1)" "unprognostic (1.22e-2)" "unprognostic (3.84e-2)" "unprognostic (3.43e-1)" "unprognostic (2.48e-1)" "unprognostic (2.30e-1)" 14.4 17.3 38.5 5.7 46.6 1.7 10.0 39.5 77.1 7.3 9.7 13.4 6.5 5.8 12.0 8.4 7.3 30.2 9.6 22.2 34.6 40.9 9.3 11.3 9.2 4.5 27.7 46.0 22.1 9.6 17.9 25.9 8.2 32.8 12.0 7.8 8.8 7.7 11.8 62.3 17.2 4.5 9.9 15.7 5.7 10.3 25.4 15.9 0.5 9.8 6.3 5.2 6.6 6.0 1.4 1.7 7.0 3.2 1.0 1.5 1.3 10.4 8.1 7.5 13.0 13.7 7.7 2.1 8.2 6.6 7.0 7.2 2.9 13.9 0.0 8.0 10.2 5.4 4.1 8.7 4.1 8.6 10.1 1.5 4.4 0.7 12.6 1.2 20.1 6.3 15.7 3.5 6.6 1.7 10.0 8.2 4.2 4.7 0.0 0.5 3.2 13.0 0.0 0.2 1.1 4.8 6.9 19.0 9.4 5.7 4.2 5.7 4.4 0.7 1.7 6.2 6.3 8.7 7.2 6.3 2.2 0.0 22.2 0.8 12.2 0.2 2.8 0.5 1.5 2.9 1.0 1.4 0.8 0.5 1.7 0.7 1.3 0.3 7.0 1.0 3.2 0.0 0.2 1.3 38.5 46.6 39.5 57.3 34.6 40.9 27.7 46.0 32.8 15.9 MAPT "DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau" ENSG00000186868 "Microtubule associated protein tau" P10636 17 45894382-46028334 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Alzheimer disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 89.9;skeletal muscle: 43.7" "Cell line enhanced" "Detected in some" "HDLM-2: 27.3;SCLC-21H: 9.8;T-47d: 12.4" "Group enriched" "Detected in many" 11 "breast cancer: 9.5;glioma: 13.3;prostate cancer: 3.0;renal cancer: 4.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000151, HPA048895, HPA069524, HPA069570, CAB072344" Enhanced Supported "Nuclear speckles,Plasma membrane" "Plasma membrane" "Nuclear speckles" "CAB000151: , CAB072344: , HPA048895: , HPA069524: , HPA069570: " "unprognostic (1.78e-3)" "unprognostic (7.51e-2)" "unprognostic (3.71e-2)" "unprognostic (8.40e-5)" "unprognostic (1.40e-1)" "unprognostic (1.31e-2)" "unprognostic (4.06e-5)" "unprognostic (6.04e-2)" "unprognostic (2.19e-2)" "unprognostic (3.49e-2)" "unprognostic (3.88e-3)" "unprognostic (2.65e-1)" "unprognostic (1.72e-3)" "unprognostic (6.53e-2)" "unprognostic (3.43e-1)" "unprognostic (1.85e-2)" "unprognostic (5.47e-2)" 3.8 7.1 28.9 2.4 31.2 2.1 8.8 40.1 89.9 2.4 2.7 21.4 1.7 2.5 2.6 2.3 6.4 2.5 2.8 6.5 28.7 29.7 15.3 2.2 2.4 2.3 22.6 35.2 2.3 2.8 8.5 8.8 5.2 29.1 5.1 2.5 2.2 8.1 5.3 43.7 4.6 2.8 2.5 13.6 2.2 2.3 6.5 27.7 0.0 2.3 3.1 2.3 3.2 0.8 0.0 0.0 0.3 0.1 0.5 1.7 0.1 0.8 0.3 0.2 2.6 0.0 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.3 0.1 0.0 27.3 1.4 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.2 1.3 0.0 4.1 0.5 0.1 0.0 1.1 0.0 2.2 2.7 0.0 3.5 9.8 4.6 1.0 0.0 0.9 12.4 0.0 0.0 0.2 0.3 0.6 0.1 0.5 0.1 0.0 0.2 0.5 0.3 0.0 0.1 0.3 0.8 0.0 0.6 0.0 0.4 1.2 0.0 0.0 0.9 0.9 0.0 0.5 0.1 0.0 1.7 0.1 28.9 31.2 40.1 46.3 28.7 29.7 22.6 35.2 29.1 27.7 MARCH1 "FLJ20668, MARCH-I, RNF171" ENSG00000145416 "Membrane associated ring-CH-type finger 1" Q8TCQ1 4 163524298-164384050 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.4;lymphoid tissue: 32.4" "Cell line enhanced" "Detected in many" "Daudi: 9.4;U-266/70: 9.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 95 "classical monocyte: 16.8;eosinophil: 9.9;intermediate monocyte: 17.0;memory B-cell: 18.5;myeloid DC: 18.1;naive B-cell: 15.7;non-classical monocyte: 17.2;plasmacytoid DC: 6.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014600 Uncertain Supported Mitochondria Mitochondria "HPA014600: AB_1853573" "unprognostic (7.29e-2)" "unprognostic (5.82e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" "unprognostic (8.25e-2)" "unprognostic (2.98e-2)" "unprognostic (4.79e-3)" "unprognostic (9.00e-2)" "unprognostic (3.00e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-1)" "unprognostic (2.20e-1)" "unprognostic (1.24e-1)" "unprognostic (7.00e-2)" "unprognostic (2.48e-2)" "unprognostic (2.70e-1)" "unprognostic (2.91e-2)" 7.7 4.2 11.6 20.5 19.7 3.9 4.0 3.1 14.5 3.7 3.9 8.5 0.1 4.4 3.9 4.6 3.6 4.2 5.9 2.6 12.6 10.1 3.0 4.5 8.3 28.5 17.3 6.3 4.2 4.1 1.5 4.1 10.2 13.5 3.5 5.1 2.4 4.6 1.8 1.6 4.9 9.0 6.5 24.4 32.4 4.1 2.3 17.9 2.6 3.2 1.4 24.6 9.0 4.2 18.5 18.1 9.9 17.2 0.1 0.0 6.6 0.8 0.7 2.9 1.7 0.0 0.0 1.8 1.2 0.1 0.0 0.0 1.6 3.3 9.4 3.5 0.0 1.4 0.0 0.0 0.0 1.0 1.0 6.7 3.7 0.6 0.0 4.1 2.2 0.0 0.0 0.0 0.2 0.0 2.5 4.9 3.3 1.0 2.3 2.6 3.6 1.3 2.6 0.5 0.7 0.1 1.5 1.5 1.3 0.9 1.4 0.5 4.0 0.7 3.1 1.1 2.0 0.7 2.3 9.7 3.2 2.6 1.3 2.1 1.5 0.0 16.8 9.9 0.0 17.0 0.0 18.5 0.0 0.0 18.1 15.7 0.0 0.0 0.1 0.1 17.2 6.8 0.0 6.6 11.6 19.7 3.1 12.5 12.6 10.1 17.3 6.3 13.5 17.9 MARCH4 "KIAA1399, MARCH-IV, RNF174" ENSG00000144583 "Membrane associated ring-CH-type finger 4" Q9P2E8 2 216257865-216372027 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 16.6;pituitary gland: 13.1" "Cell line enhanced" "Detected in many" "BJ: 33.3;fHDF/TERT166: 21.2;TIME: 15.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014348 Approved "HPA014348: AB_1853578" "unprognostic (4.84e-2)" "unprognostic (1.02e-4)" "unprognostic (1.63e-1)" "unprognostic (5.42e-2)" "unprognostic (3.31e-2)" "unprognostic (1.88e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-2)" "unprognostic (1.24e-2)" "unprognostic (6.49e-2)" "unprognostic (5.55e-3)" "unprognostic (1.07e-1)" "unprognostic (6.81e-5)" "unprognostic (4.82e-2)" "unprognostic (2.06e-1)" "unprognostic (1.23e-1)" "unprognostic (1.09e-3)" 0.7 2.9 7.0 0.7 11.9 0.7 0.6 1.0 16.6 0.6 1.1 0.3 0.0 1.5 0.7 0.7 0.6 2.5 0.6 0.6 5.8 5.6 0.6 0.6 0.8 0.6 2.0 4.8 0.6 1.5 0.6 13.1 3.1 3.4 0.7 1.2 0.1 0.6 0.6 0.6 0.7 1.4 0.6 1.6 0.6 5.1 0.7 1.1 0.0 0.6 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.0 5.5 1.2 0.0 0.0 0.1 0.8 0.0 33.3 11.4 7.2 2.5 0.0 0.5 0.0 5.2 21.2 0.0 0.0 13.1 7.1 0.0 0.0 2.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 6.5 9.9 9.3 0.0 0.0 11.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.9 0.0 0.0 0.0 0.0 0.0 15.6 11.2 11.6 0.0 8.9 0.0 0.0 0.0 2.5 0.0 7.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.0 11.9 1.0 16.6 5.8 5.6 2.0 4.8 3.4 1.1 MARCKSL1 "F52, MacMARCKS, MLP, MLP1" ENSG00000175130 "MARCKS like 1" P49006 1 32333832-32336379 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 166.5" "Cell line enhanced" "Detected in many" "AF22: 106.6;NTERA-2: 102.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "eosinophil: 54.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 54.9" "Low region specificity" "Detected in all" "CAB020787, HPA030528" Enhanced Supported "Nucleoplasm,Actin filaments,Cytosol" 120000 Cytosol "Nucleoplasm, Actin filaments" "CAB020787: , HPA030528: " "unprognostic (8.08e-2)" "unprognostic (1.28e-1)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (3.16e-3)" "prognostic unfavourable (1.78e-6)" "unprognostic (3.65e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-3)" "unprognostic (2.91e-1)" "unprognostic (1.76e-2)" "prognostic unfavourable (1.20e-4)" "unprognostic (1.50e-1)" "unprognostic (8.16e-3)" "unprognostic (1.08e-1)" "unprognostic (3.22e-2)" 9.9 12.7 59.9 22.1 45.4 10.9 27.7 22.0 58.0 22.3 27.5 126.3 5.3 15.9 25.8 42.3 3.6 15.9 24.9 10.7 64.2 47.2 6.4 9.7 9.0 41.5 83.6 35.4 74.1 4.8 1.3 4.9 11.0 56.6 22.5 30.7 5.2 19.9 14.2 2.0 5.3 13.9 11.3 166.5 12.5 34.8 30.3 52.3 41.4 29.0 2.2 49.2 17.0 5.5 6.4 2.2 54.9 6.7 0.2 3.9 1.2 8.2 7.5 106.6 43.5 2.4 0.8 19.0 3.5 2.1 10.4 6.9 17.7 6.1 18.7 13.1 2.3 4.4 34.4 0.3 7.7 0.4 25.4 1.0 2.9 39.1 7.3 4.8 0.1 12.2 1.4 7.8 0.2 30.4 28.7 0.2 13.9 19.7 60.7 20.6 102.8 17.4 76.0 11.4 8.9 15.6 16.5 66.1 62.9 18.3 20.3 57.6 14.1 8.6 8.9 4.4 25.9 0.4 6.6 2.9 0.2 49.1 0.5 7.4 23.3 0.7 1.0 54.9 0.9 5.4 0.3 4.6 1.9 1.2 1.5 6.4 3.9 1.6 4.4 0.2 6.7 2.2 1.0 1.2 59.9 45.4 22.0 54.9 64.2 47.2 83.6 35.4 56.6 52.3 MAS1 ENSG00000130368 "MAS1 proto-oncogene, G protein-coupled receptor" P04201 6 159906690-159916530 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.5;cervix, uterine: 1.9" "Cell line enriched" "Detected in some" 8 "HMC-1: 13.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 25 "amygdala: 40.1;basal ganglia: 26.8;cerebral cortex: 31.9;hippocampal formation: 71.0" "Group enriched" "Detected in many" 7 "amygdala: 8.6;cerebral cortex: 13.2;hippocampal formation: 26.9" "unprognostic (3.31e-1)" "unprognostic (2.25e-3)" "unprognostic (2.91e-1)" "unprognostic (2.22e-3)" "unprognostic (8.15e-3)" "unprognostic (7.05e-2)" "unprognostic (1.88e-1)" "unprognostic (5.53e-2)" "unprognostic (6.52e-2)" "unprognostic (1.48e-5)" "unprognostic (1.69e-1)" "unprognostic (7.67e-2)" "unprognostic (6.28e-1)" 0.1 0.0 0.9 0.0 0.0 0.8 0.0 0.0 4.5 1.9 0.0 0.0 0.3 0.7 0.0 0.3 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.2 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.0 0.5 0.3 1.5 0.2 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 13.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 1.5 0.1 1.5 0.2 0.3 0.2 0.1 0.2 0.3 0.2 0.2 0.1 0.5 0.3 0.3 1.5 0.3 0.1 0.3 0.1 0.1 MAST1 "KIAA0973, SAST" ENSG00000105613 "Microtubule associated serine/threonine kinase 1" Q9Y2H9 19 12833951-12874951 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 51.0" "Cell line enhanced" "Detected in many" "AN3-CA: 14.8;SCLC-21H: 26.2;SH-SY5Y: 13.0;U-266/70: 10.7" "Cancer enhanced" "Detected in many" "glioma: 3.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 3.6;T-reg: 2.0" "Lineage enriched" "Detected in single" 8 "T-cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028181, HPA073106" Enhanced Approved Vesicles Vesicles "HPA028181: AB_10603872, HPA073106: " "unprognostic (6.32e-2)" "unprognostic (3.66e-2)" "unprognostic (3.93e-2)" "unprognostic (2.83e-5)" "unprognostic (1.72e-1)" "unprognostic (4.19e-2)" "unprognostic (2.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "unprognostic (8.89e-3)" "unprognostic (3.43e-2)" "unprognostic (3.84e-3)" "unprognostic (1.19e-1)" "unprognostic (7.04e-2)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" 1.2 5.2 20.4 1.7 13.6 1.6 1.5 51.0 40.1 1.1 1.5 1.4 0.0 1.7 1.3 1.2 1.3 1.2 1.6 1.3 16.1 16.3 1.2 1.3 1.2 1.3 8.8 19.5 1.5 1.6 1.2 10.4 1.2 19.9 1.2 1.3 1.6 1.3 1.2 1.2 4.1 1.6 1.3 4.2 1.2 1.5 3.9 2.7 0.0 1.2 0.0 1.3 1.2 0.2 0.4 0.0 0.0 0.2 0.0 3.6 0.1 2.2 1.0 0.9 14.8 0.0 0.0 1.2 0.1 0.1 0.2 0.6 0.5 0.9 3.6 1.6 0.0 0.0 4.3 0.0 0.0 2.5 2.9 0.3 3.6 1.6 0.0 0.7 0.7 0.3 0.0 0.5 0.5 0.0 3.1 1.9 0.0 0.5 1.5 0.4 4.4 4.5 9.8 2.9 5.1 0.2 0.1 26.2 13.0 0.5 0.9 2.6 2.4 1.3 0.0 1.8 2.8 2.0 0.4 10.7 8.5 2.1 3.3 2.0 0.1 0.0 0.2 0.0 0.0 0.2 3.6 0.1 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 2.0 0.1 20.4 13.6 51.0 34.3 16.1 16.3 8.8 19.5 19.9 2.7 MAST3 KIAA0561 ENSG00000099308 "Microtubule associated serine/threonine kinase 3" O60307 19 18097793-18151692 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 72.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035061, HPA035062" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA035061: AB_10670585, HPA035062: AB_10671508" "unprognostic (5.94e-3)" "unprognostic (4.75e-2)" "unprognostic (1.70e-1)" "unprognostic (1.02e-1)" "unprognostic (3.38e-1)" "prognostic favourable (2.97e-4)" "unprognostic (1.93e-1)" "unprognostic (4.63e-2)" "unprognostic (1.43e-1)" "unprognostic (3.21e-1)" "prognostic favourable (7.01e-4)" "unprognostic (2.58e-1)" "unprognostic (1.64e-3)" "unprognostic (1.02e-2)" "unprognostic (3.61e-1)" "unprognostic (1.58e-3)" "unprognostic (1.26e-3)" 4.6 3.5 20.7 8.3 36.1 12.3 1.8 1.1 72.5 3.8 5.3 19.0 0.2 9.1 3.6 4.9 2.2 4.9 3.1 2.1 19.7 9.3 3.6 6.4 4.6 9.9 13.0 33.6 4.6 14.3 7.1 7.7 2.6 13.0 2.7 4.4 0.7 4.6 4.2 2.6 6.9 8.8 3.0 7.9 11.4 3.9 2.1 12.5 1.8 2.4 0.3 9.4 3.3 2.4 4.4 10.3 23.2 9.7 5.8 8.4 3.1 3.3 4.9 2.3 10.0 6.8 5.5 5.4 3.4 2.2 2.4 3.4 4.9 4.6 8.6 5.1 3.4 1.8 3.3 1.9 1.7 7.3 4.1 3.9 5.2 7.8 5.7 2.1 13.2 6.2 5.7 3.6 1.4 1.0 4.0 5.7 2.7 5.9 4.4 6.9 2.4 6.1 11.9 1.9 6.3 1.8 1.5 3.7 6.1 4.7 2.8 2.0 3.1 4.9 3.9 3.1 3.3 12.9 1.4 6.2 8.3 7.9 6.7 11.1 2.8 0.1 4.5 9.4 8.4 5.6 6.2 4.1 4.7 3.3 2.1 4.4 3.7 6.4 23.2 5.8 9.7 10.3 5.0 3.1 20.7 36.1 1.1 72.5 19.7 9.3 13.0 33.6 13.0 12.5 MATK "CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101" ENSG00000007264 "Megakaryocyte-associated tyrosine kinase" P42679 19 3777970-3802129 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.3;bone marrow: 19.1;brain: 27.4" "Cell line enhanced" "Detected in some" "HL-60: 40.7;HMC-1: 12.5;K-562: 18.1;MCF7: 13.2;NB-4: 28.4;SCLC-21H: 12.4;THP-1: 10.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 19.4;NK-cell: 29.3" "Group enriched" "Detected in many" 54 "NK-cells: 29.3;T-cells: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004847, HPA066547" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol" Microtubules "Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol" "HPA004847: AB_1079316, HPA066547: " "prognostic favourable (5.27e-4)" "unprognostic (1.28e-2)" "unprognostic (1.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.36e-1)" "unprognostic (3.39e-2)" "unprognostic (9.50e-2)" "unprognostic (1.23e-1)" "unprognostic (7.91e-2)" "unprognostic (3.19e-3)" "unprognostic (2.07e-2)" "unprognostic (4.51e-2)" "unprognostic (1.16e-2)" "unprognostic (7.59e-2)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (2.33e-2)" 11.2 1.6 22.1 6.8 18.1 19.1 2.2 1.5 27.4 1.5 2.3 1.7 0.0 7.0 1.2 0.4 1.1 4.7 5.1 1.7 25.1 10.0 1.1 2.8 7.3 9.6 7.0 11.0 1.0 1.6 0.1 1.4 1.4 6.1 1.2 1.4 0.6 3.8 1.0 0.8 1.6 6.7 1.1 2.8 14.8 4.1 2.1 1.3 3.5 0.9 0.0 4.5 2.4 0.7 0.4 0.3 0.4 0.0 29.3 19.4 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 4.1 5.4 0.1 0.0 0.0 7.0 4.5 0.5 1.1 0.0 40.7 12.5 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 13.2 0.1 28.4 3.3 0.1 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 10.7 1.3 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 13.2 0.0 2.5 12.2 0.3 0.4 1.2 7.1 0.4 29.3 0.0 0.1 0.1 2.7 22.1 18.1 1.5 27.4 25.1 10.0 7.0 11.0 6.1 1.3 MBP ENSG00000197971 "Myelin basic protein" P02686 18 76978827-77133683 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autoimmune encephalomyelitis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 43 "brain: 1297.7" "Cell line enhanced" "Detected in many" "HL-60: 28.4;SK-MEL-30: 59.1" "Group enriched" "Detected in all" 9 "glioma: 47.5;melanoma: 20.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002300, HPA049222, HPA064368" Enhanced Supported Approved "Plasma membrane" "Plasma membrane" "CAB002300: AB_563893, HPA049222: , HPA064368: " "unprognostic (9.36e-2)" "unprognostic (7.60e-2)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" "unprognostic (6.93e-2)" "unprognostic (2.81e-1)" "unprognostic (1.14e-1)" "unprognostic (3.31e-1)" "unprognostic (9.87e-2)" "unprognostic (2.90e-2)" "unprognostic (5.25e-2)" "unprognostic (1.95e-1)" "prognostic favourable (4.48e-12)" "unprognostic (2.90e-1)" "unprognostic (5.99e-2)" "unprognostic (1.33e-1)" "unprognostic (6.03e-2)" 4.0 3.4 271.6 6.1 244.9 10.1 4.5 28.7 418.9 5.6 5.5 487.7 0.0 5.9 4.4 3.6 6.4 9.0 5.7 6.8 355.0 247.6 6.2 5.9 6.2 7.1 645.5 43.4 3.7 6.8 16.4 0.7 2.7 242.9 4.5 5.6 0.4 5.0 4.9 29.9 7.9 6.2 3.8 1297.7 7.6 5.1 2.9 224.3 0.0 6.8 0.0 7.7 6.0 0.6 3.4 6.8 23.7 4.7 15.4 17.1 5.6 7.4 6.5 0.0 0.2 11.0 16.4 2.6 0.1 0.2 0.2 0.1 0.9 11.5 4.6 1.3 0.5 14.7 1.1 6.5 0.2 17.8 1.6 2.9 1.1 1.5 6.9 28.4 19.8 2.3 5.5 5.9 9.1 1.9 0.0 1.0 0.0 0.9 1.1 14.6 0.6 5.2 0.4 0.1 10.2 10.4 10.1 0.5 0.1 0.9 0.0 59.1 0.2 17.4 0.0 0.0 0.1 0.0 0.8 0.0 0.1 4.9 1.7 18.0 0.7 11.0 4.7 17.8 13.2 4.6 8.0 3.4 9.4 17.1 5.3 3.3 5.7 10.5 23.7 15.4 4.4 6.8 7.9 5.6 271.6 244.9 28.7 127.7 355.0 247.6 645.5 43.4 242.9 224.3 MC3R MC3 ENSG00000124089 "Melanocortin 3 receptor" P41968 20 56248732-56249815 "G-protein coupled receptors, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 6.4" "Cell line enriched" "Detected in single" 24 "hTERT-HME1: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basal ganglia: 4.8;hypothalamus: 3.3;thalamus: 2.6" HPA074739 Uncertain "HPA074739: " 0.0 0.4 0.1 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MC4R ENSG00000166603 "Melanocortin 4 receptor" P32245 18 60371110-60372775 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.8;fallopian tube: 10.3" "Cell line enriched" "Detected in single" 69 "fHDF/TERT166: 45.9" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA016719 Uncertain "HPA016719: AB_1853617" "unprognostic (2.29e-1)" "unprognostic (5.31e-3)" "unprognostic (5.78e-2)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (3.33e-1)" "unprognostic (2.54e-1)" "unprognostic (1.48e-1)" "unprognostic (2.49e-2)" "unprognostic (2.30e-1)" "unprognostic (2.59e-1)" 0.4 1.1 4.0 0.3 9.8 0.2 0.9 0.7 6.4 0.5 0.5 0.3 0.0 0.6 0.4 1.3 0.4 10.3 0.4 0.4 3.0 7.8 0.4 0.2 0.3 0.4 1.1 7.6 0.6 0.2 0.2 0.3 0.2 3.3 0.4 0.5 0.1 2.5 0.5 0.2 0.3 0.4 0.2 0.8 0.8 0.6 0.6 5.1 0.0 0.2 0.0 1.4 0.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 9.8 0.7 6.4 3.0 7.8 1.1 7.6 3.3 5.1 MCF2 "ARHGEF21, DBL" ENSG00000101977 "MCF.2 cell line derived transforming sequence" P10911 X 139581770-139708227 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 30.7;brain: 23.1;seminal vesicle: 18.8;testis: 18.2" "Cell line enriched" "Detected in some" 11 "U-251 MG: 28.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (2.42e-1)" "unprognostic (2.18e-2)" "unprognostic (1.46e-2)" "unprognostic (5.11e-4)" "unprognostic (8.95e-2)" "unprognostic (3.99e-2)" "unprognostic (1.24e-1)" "unprognostic (2.28e-1)" "unprognostic (1.80e-1)" "unprognostic (1.28e-1)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (2.33e-3)" "unprognostic (3.68e-2)" "unprognostic (2.92e-2)" "unprognostic (4.62e-4)" "unprognostic (4.02e-2)" 0.7 30.7 5.2 0.8 8.1 1.0 0.5 3.3 12.4 0.5 0.5 0.9 12.5 0.5 0.5 13.4 0.5 1.2 1.1 1.4 7.1 11.3 2.0 0.6 0.5 1.0 8.9 5.7 11.5 0.7 0.5 3.3 0.5 23.1 1.8 0.5 2.8 1.3 18.8 0.6 0.6 0.5 0.5 6.3 1.3 0.6 18.2 2.4 0.0 1.6 0.0 0.6 0.6 0.1 0.1 0.3 0.6 0.1 1.0 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 2.4 0.0 0.4 0.4 1.9 0.0 0.1 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 28.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.2 0.6 1.0 0.0 0.3 0.0 0.0 5.2 8.1 3.3 12.4 7.1 11.3 8.9 5.7 23.1 2.4 MCF2L "ARHGEF14, DBS, KIAA0362, OST" ENSG00000126217 "MCF.2 cell line derived transforming sequence like" O15068 13 112894378-113099739 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 77.5" "Cell line enhanced" "Detected in many" "SCLC-21H: 30.3;SH-SY5Y: 13.5;SK-BR-3: 20.1;WM-115: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 6 "B-cells: 2.3;granulocytes: 1.8;T-cells: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (1.56e-1)" "unprognostic (2.53e-2)" "unprognostic (8.86e-3)" "prognostic favourable (6.01e-4)" "unprognostic (9.07e-2)" "unprognostic (3.91e-2)" "unprognostic (7.07e-2)" "unprognostic (3.02e-2)" "unprognostic (1.94e-1)" "unprognostic (2.11e-1)" "prognostic favourable (4.36e-5)" "unprognostic (1.17e-1)" "prognostic favourable (9.14e-6)" "unprognostic (2.04e-2)" "unprognostic (1.28e-1)" "unprognostic (2.24e-1)" "prognostic favourable (2.63e-5)" 24.2 6.4 21.2 4.6 37.5 0.8 10.9 77.5 37.2 9.4 13.2 20.9 2.6 8.7 7.3 4.3 11.0 6.9 10.4 19.0 20.1 15.7 10.3 3.7 7.0 4.9 49.0 11.5 2.4 14.7 7.7 20.7 6.7 28.6 11.2 10.9 5.7 24.5 7.2 11.4 19.0 12.4 5.7 23.0 2.9 13.7 1.4 46.2 0.3 11.5 4.0 4.7 8.8 12.0 2.3 0.2 1.8 0.1 0.3 2.1 2.0 0.0 0.7 7.0 2.2 0.2 0.4 1.0 0.0 0.0 0.0 0.0 1.7 1.0 0.0 1.7 0.6 0.1 1.7 0.0 0.0 0.0 3.5 1.9 0.0 4.1 0.2 0.1 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 6.5 2.5 0.2 1.1 1.9 0.0 0.1 6.8 3.6 2.8 10.6 30.3 13.5 0.0 20.1 0.0 11.9 0.0 0.2 0.0 5.9 2.4 0.0 3.3 0.1 1.0 11.1 0.4 27.2 0.2 0.1 0.3 0.5 0.1 0.6 0.5 0.6 0.7 0.0 2.3 2.1 0.7 1.8 0.3 0.1 0.2 0.2 2.0 21.2 37.5 77.5 37.2 20.1 15.7 49.0 11.5 28.6 46.2 MCF2L2 "ARHGEF22, KIAA0861" ENSG00000053524 "MCF.2 cell line derived transforming sequence-like 2" Q86YR7 3 183178043-183428778 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.4;brain: 23.7" "Cell line enhanced" "Detected in many" "HDLM-2: 9.2;Karpas-707: 8.1;REH: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "T-reg: 4.6" "Lineage enriched" "Detected in single" 8 "T-cells: 4.6" "Low region specificity" "Detected in all" "HPA038946, HPA038947" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038946: AB_10670914, HPA038947: AB_10672655" "unprognostic (2.17e-2)" "unprognostic (4.42e-1)" "unprognostic (3.08e-1)" "unprognostic (1.95e-3)" "unprognostic (1.98e-1)" "unprognostic (2.87e-2)" "unprognostic (3.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (5.08e-2)" "unprognostic (4.80e-4)" "unprognostic (1.32e-1)" "unprognostic (8.75e-6)" "unprognostic (1.09e-1)" "unprognostic (5.47e-2)" "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" 0.9 16.4 12.8 1.4 14.9 1.1 1.1 11.3 23.7 1.3 1.4 3.6 0.0 0.9 1.3 1.3 1.3 1.0 1.5 1.1 12.2 7.6 1.4 0.8 1.2 1.7 5.6 13.0 1.2 1.2 10.5 8.9 0.8 7.3 2.1 1.4 7.5 0.8 1.6 1.4 1.0 1.2 1.4 4.5 5.3 1.2 5.5 4.3 0.0 0.9 0.0 2.1 1.6 0.4 0.1 0.0 0.6 0.0 0.1 4.6 0.2 0.1 0.6 0.2 1.7 0.1 0.2 0.4 0.0 0.1 0.3 0.0 1.2 0.2 1.5 0.2 0.1 0.0 0.3 0.2 0.1 9.2 1.4 3.9 0.3 0.0 0.3 1.2 0.8 0.3 0.0 0.0 0.6 0.7 1.2 8.1 0.4 1.2 1.2 0.8 1.3 1.6 5.3 0.0 1.5 0.4 0.1 2.5 0.9 1.0 0.0 2.0 0.5 0.8 0.6 0.0 0.9 0.1 0.1 3.2 3.4 1.7 0.8 1.4 0.1 0.1 0.0 0.1 0.4 0.0 1.0 0.0 1.0 0.6 0.0 0.1 0.0 0.9 0.6 0.1 0.0 0.0 4.6 0.2 12.8 14.9 11.3 23.7 12.2 7.6 5.6 13.0 7.3 4.3 MCHR1 "GPR24, MCH1R, SLC1" ENSG00000128285 "Melanin concentrating hormone receptor 1" Q99705 22 40678750-40682814 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell line enhanced" "Detected in some" "MOLT-4: 1.8;NTERA-2: 3.3;RH-30: 4.5;T-47d: 3.8;U-87 MG: 4.3" "Group enriched" "Detected in some" 7 "glioma: 4.9;liver cancer: 1.5;melanoma: 3.1;renal cancer: 2.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (3.37e-2)" "unprognostic (1.37e-2)" "unprognostic (2.45e-3)" "unprognostic (2.68e-1)" "unprognostic (2.84e-3)" "unprognostic (4.92e-3)" "unprognostic (4.51e-3)" "unprognostic (1.19e-2)" "unprognostic (1.58e-2)" "unprognostic (9.35e-4)" "unprognostic (3.05e-1)" "unprognostic (2.26e-1)" "prognostic unfavourable (1.49e-6)" "unprognostic (3.07e-2)" "unprognostic (5.40e-2)" "unprognostic (2.42e-1)" "unprognostic (3.91e-2)" 0.7 0.8 3.4 1.1 4.7 0.4 0.4 1.0 14.4 1.2 0.5 0.2 0.0 0.7 4.8 1.5 0.4 1.2 0.4 3.1 4.6 7.3 0.4 2.6 0.5 0.8 3.4 4.9 5.1 0.5 0.3 2.8 0.6 2.5 0.4 0.5 0.8 0.4 0.5 0.5 1.7 0.5 2.4 1.2 0.4 0.5 0.6 0.1 0.0 0.3 0.0 0.7 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.8 0.0 3.3 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.8 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.3 0.1 0.1 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.7 1.0 11.6 4.6 7.3 3.4 4.9 2.5 0.1 MCHR2 "GPR145, MCH2, MCH2R, SLT" ENSG00000152034 "Melanin concentrating hormone receptor 2" Q969V1 6 99919910-99994247 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "brain: 14.9;testis: 5.5" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;HMC-1: 1.9;U-266/70: 1.8" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 6.3;cerebral cortex: 14.9;olfactory region: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 0.9" "unprognostic (5.76e-2)" 0.2 0.2 1.9 0.3 6.3 0.3 0.2 0.2 14.9 0.2 0.5 0.0 0.0 0.3 0.2 0.2 0.4 0.2 0.2 0.2 0.7 0.6 0.2 0.2 0.2 0.3 0.5 4.4 0.3 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.0 0.2 0.2 0.2 0.3 0.5 0.2 0.2 0.2 0.3 5.5 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.3 0.2 0.6 0.2 0.5 0.3 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.4 0.0 0.1 0.2 0.1 0.0 0.2 0.0 2.0 0.2 0.1 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.1 0.2 0.1 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.4 0.1 0.1 0.2 0.2 1.8 0.9 0.3 0.0 0.1 0.0 0.6 0.2 0.2 0.2 0.0 0.1 0.1 0.2 0.3 0.0 0.3 0.1 0.1 0.3 0.5 0.0 0.2 0.2 0.1 1.9 6.3 0.2 14.9 0.7 0.6 0.5 4.4 0.0 0.0 MCTP1 FLJ22344 ENSG00000175471 "Multiple C2 and transmembrane domain containing 1" Q6DN14 5 94703741-95284575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 49.2;brain: 42.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 20.7;Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 41 "basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 52 "dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019018 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA019018: AB_1853665" "unprognostic (1.20e-2)" "unprognostic (6.70e-4)" "unprognostic (1.77e-2)" "unprognostic (1.03e-2)" "unprognostic (1.16e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (2.47e-2)" "unprognostic (1.86e-1)" "unprognostic (6.99e-2)" "unprognostic (5.31e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-6)" "unprognostic (5.38e-2)" "unprognostic (3.65e-2)" "unprognostic (2.89e-3)" "unprognostic (4.43e-2)" 49.2 2.7 6.5 11.4 42.4 36.9 18.3 18.3 16.5 6.9 7.2 0.3 4.4 5.0 11.1 9.2 6.5 4.1 16.7 4.6 8.5 7.4 3.0 3.8 11.3 5.5 4.1 3.8 3.3 3.4 3.1 5.2 7.1 3.9 5.9 7.3 1.0 4.3 2.7 5.1 4.5 4.8 10.9 5.7 8.2 5.3 4.0 8.1 5.5 5.0 21.2 4.3 17.3 12.6 0.3 10.1 18.7 19.2 0.2 0.2 3.3 0.1 2.0 1.3 0.0 19.9 8.0 0.0 0.1 9.8 0.9 3.2 0.0 5.2 7.2 7.7 0.0 0.0 0.1 0.1 1.1 0.0 1.4 4.3 4.8 0.0 2.6 8.9 5.8 2.9 0.0 3.6 13.1 20.7 0.1 28.3 7.4 0.2 0.5 6.8 1.6 8.2 0.3 0.0 28.0 21.3 11.3 4.0 0.2 0.6 0.0 14.6 0.0 8.4 0.1 3.6 5.6 0.1 1.6 2.0 0.0 0.0 16.9 14.9 3.5 11.5 12.9 5.8 0.0 19.2 0.0 0.3 0.0 0.1 10.1 0.1 0.2 0.0 18.7 0.2 17.6 5.3 0.0 3.3 6.5 42.4 18.3 12.2 8.5 7.4 4.1 3.8 3.9 8.1 MDFIC2 ENSG00000242120 "MyoD family inhibitor domain containing 2" A0A1B0GVS7 3 70196894-70312726 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.5;salivary gland: 1.1" "Cell line enriched" "Detected in single" 5 "HeLa: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MDGA1 "GPIM, MAMDC3" ENSG00000112139 "MAM domain containing glycosylphosphatidylinositol anchor 1" Q8NFP4 6 37630679-37699306 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 94.7" "Cell line enhanced" "Detected in many" "ASC diff: 13.8;HaCaT: 8.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 17 "cerebellum: 94.7" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 3.1" "Group enriched" "Detected in many" 22 "B-cells: 1.1;T-cells: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031235, HPA050382" Approved Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" 490000 "Plasma membrane" "Golgi apparatus" "HPA031235: AB_10603017, HPA050382: " "unprognostic (4.67e-2)" "unprognostic (6.97e-3)" "unprognostic (3.24e-1)" "unprognostic (5.69e-4)" "unprognostic (2.75e-2)" "unprognostic (2.41e-1)" "unprognostic (1.45e-2)" "unprognostic (2.00e-1)" "unprognostic (2.02e-2)" "unprognostic (1.45e-1)" "unprognostic (2.16e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-5)" "unprognostic (9.19e-3)" "unprognostic (5.28e-3)" "unprognostic (3.80e-3)" "unprognostic (4.60e-2)" 1.5 3.7 3.4 3.1 2.4 0.0 1.0 94.7 5.1 3.0 1.3 1.5 1.0 0.0 3.0 1.5 1.8 2.1 3.4 1.2 5.0 2.0 0.8 0.5 3.5 3.4 1.7 2.4 8.4 2.6 6.6 2.6 0.5 5.4 1.5 1.1 3.4 0.7 1.2 0.9 6.7 1.5 2.6 4.1 3.9 1.2 1.4 1.3 0.6 1.1 1.7 2.7 1.1 3.1 1.1 0.0 0.0 0.0 0.0 3.1 0.4 0.1 3.8 6.9 2.6 13.8 5.6 3.0 2.7 2.7 3.5 3.9 0.7 0.0 0.9 0.6 1.7 8.9 0.5 0.0 1.1 6.9 4.0 0.0 0.5 0.0 0.6 0.0 0.9 1.0 0.1 1.4 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.5 0.0 0.4 7.4 2.4 0.0 0.8 4.2 6.3 0.0 1.5 0.4 3.3 3.2 0.6 0.5 3.7 1.2 1.3 5.0 0.0 0.1 0.0 5.9 1.1 2.4 0.0 0.0 0.0 1.4 0.0 0.4 1.1 1.2 0.8 0.0 1.0 3.1 0.8 0.0 0.0 0.0 0.0 1.8 0.4 3.4 2.4 94.7 2.7 5.0 2.0 1.7 2.4 5.4 1.3 MDGA2 MAMDC1 ENSG00000139915 "MAM domain containing glycosylphosphatidylinositol anchor 2" Q7Z553 14 46840092-47674954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 8.6;testis: 7.9" "Cell line enhanced" "Detected in some" "AF22: 7.9;T-47d: 3.9;U-138 MG: 8.6;U-2 OS: 6.2;U-87 MG: 3.4;WM-115: 5.3" "Cancer enhanced" "Detected in single" "melanoma: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003084 Uncertain "HPA003084: AB_1079302" "unprognostic (3.27e-1)" "unprognostic (5.38e-2)" "unprognostic (9.13e-2)" "unprognostic (8.92e-3)" "unprognostic (6.36e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.49e-3)" "unprognostic (3.62e-3)" "unprognostic (3.06e-2)" "unprognostic (5.89e-1)" 0.2 0.3 1.4 0.0 1.5 0.0 0.2 0.4 8.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.3 2.2 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 3.3 0.0 0.5 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.9 0.0 0.0 8.6 6.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 MED12L "KIAA1635, TNRC11L, TRALP, TRALPUSH" ENSG00000144893 "Mediator complex subunit 12 like" Q86YW9 3 151085697-151437072 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1" "Cell line enhanced" "Detected in some" "BEWO: 16.0;HEL: 17.3;MOLT-4: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036807 Enhanced Approved Nucleoli Nucleoli "HPA036807: AB_10670242" "unprognostic (1.01e-2)" "unprognostic (5.82e-2)" "unprognostic (5.12e-2)" "unprognostic (8.14e-4)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (1.23e-2)" "unprognostic (5.90e-3)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" "unprognostic (1.38e-3)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (4.36e-3)" "unprognostic (3.84e-1)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" 2.8 5.2 6.4 1.2 11.1 5.5 0.5 4.9 23.1 1.6 0.6 4.4 0.0 2.2 0.9 3.0 0.9 0.6 1.8 1.7 5.5 5.1 0.4 0.4 0.7 4.4 5.8 2.6 1.0 1.7 0.5 5.4 2.0 3.9 1.2 0.3 1.9 1.7 0.7 0.5 0.4 1.6 0.6 6.1 2.1 0.8 6.1 5.7 0.6 1.0 0.0 1.5 1.3 0.8 1.0 5.1 3.1 2.8 0.1 0.4 0.8 0.7 0.3 2.5 0.2 0.1 0.0 16.0 0.0 0.2 0.6 0.7 0.9 0.3 0.0 0.2 0.1 0.1 3.3 0.2 0.7 0.0 1.6 17.3 0.1 0.1 0.0 0.5 6.1 0.0 0.1 0.1 0.1 0.0 0.0 2.7 0.0 2.6 8.0 0.0 2.9 0.5 0.1 0.9 0.4 0.2 2.5 4.2 0.6 0.4 0.2 0.0 0.9 0.1 0.0 0.0 1.9 0.0 1.3 5.1 0.0 6.1 0.2 1.5 0.9 3.1 0.3 0.0 0.1 2.8 0.4 0.1 0.1 0.2 1.6 1.0 0.0 0.0 0.3 0.1 0.8 5.1 0.0 0.8 6.4 11.1 4.9 6.9 5.5 5.1 5.8 2.6 3.9 5.7 MEGF10 KIAA1780 ENSG00000145794 "Multiple EGF like domains 10" Q96KG7 5 127290831-127465737 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Myogenesis, Phagocytosis" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Group enriched" "Detected in some" 5 "AF22: 21.1;RH-30: 25.8" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Intracellular and membrane" 27000000 "unprognostic (7.02e-2)" "unprognostic (4.50e-2)" "unprognostic (1.02e-1)" "unprognostic (2.26e-3)" "unprognostic (8.91e-3)" "unprognostic (1.59e-2)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (1.52e-1)" "unprognostic (1.41e-1)" "unprognostic (1.76e-4)" "unprognostic (5.28e-3)" "unprognostic (2.59e-1)" "unprognostic (9.36e-4)" "unprognostic (1.17e-1)" 1.3 5.1 9.8 1.2 12.9 0.9 2.8 3.3 24.6 1.8 1.4 25.8 0.0 1.2 2.8 2.0 1.2 1.2 1.1 1.5 11.6 5.6 1.1 1.8 1.0 1.0 21.7 10.4 1.2 0.9 0.9 2.4 1.2 12.2 2.8 1.5 2.4 5.0 3.7 7.3 1.1 1.3 1.6 14.8 1.2 1.0 1.9 23.1 0.0 1.1 2.0 1.5 1.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.6 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 2.3 0.0 0.0 25.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 9.8 12.9 3.3 10.8 11.6 5.6 21.7 10.4 12.2 23.1 MEGF11 "DKFZp434L121, KIAA1781" ENSG00000157890 "Multiple EGF like domains 11" A6BM72 15 65895079-66253747 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 34.7;fallopian tube: 16.3" "Cell line enhanced" "Detected in some" "AN3-CA: 4.5;HEK 293: 3.6;RPTEC TERT1: 12.4;SCLC-21H: 9.7" "Cancer enhanced" "Detected in some" "glioma: 2.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in many" 4 "cerebellum: 39.2" "Region enriched" "Detected in all" 7 "cerebellum: 62.2" "unprognostic (2.97e-2)" "unprognostic (1.23e-1)" "unprognostic (7.95e-2)" "unprognostic (1.84e-2)" "unprognostic (9.02e-3)" "unprognostic (6.45e-3)" "unprognostic (1.51e-1)" "unprognostic (4.08e-2)" "unprognostic (2.92e-1)" "unprognostic (1.23e-1)" "unprognostic (6.79e-3)" "unprognostic (6.81e-3)" "unprognostic (5.71e-5)" "unprognostic (7.94e-2)" "unprognostic (9.78e-3)" "unprognostic (2.03e-1)" "unprognostic (4.89e-2)" 0.6 0.8 8.7 0.9 5.4 1.3 0.6 34.7 17.1 0.6 0.7 5.3 0.0 0.6 0.8 2.3 0.7 16.3 0.7 0.6 11.6 5.7 4.6 0.6 1.6 0.9 6.5 2.5 0.7 1.0 0.5 1.5 0.6 9.2 0.7 0.6 3.4 0.6 0.8 0.6 3.2 0.7 0.6 9.2 0.9 1.0 2.6 5.5 0.0 0.7 0.0 0.7 0.6 0.2 0.3 0.1 0.5 0.2 0.0 1.5 0.0 0.0 0.1 0.5 4.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.7 0.0 0.1 0.3 0.0 0.1 0.2 3.6 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.1 0.0 1.5 0.0 0.1 12.4 0.3 9.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.3 0.3 0.0 0.0 0.1 0.4 1.5 0.5 0.0 0.0 0.1 0.1 0.0 8.7 5.4 34.7 4.7 11.6 5.7 6.5 2.5 9.2 5.5 MEIS3 "DKFZp547H236, MRG2" ENSG00000105419 "Meis homeobox 3" Q99687 19 47403124-47419523 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 35.3;endometrium 1: 28.8" "Cell line enhanced" "Detected in many" "AF22: 27.9;HMC-1: 24.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046699 Uncertain Approved Nucleoplasm Nucleoplasm "HPA046699: AB_2616456" "unprognostic (3.27e-3)" "unprognostic (2.98e-1)" "unprognostic (2.13e-2)" "unprognostic (4.49e-1)" "unprognostic (3.16e-1)" "unprognostic (4.67e-2)" "unprognostic (2.12e-2)" "unprognostic (5.93e-3)" "unprognostic (1.21e-1)" "unprognostic (2.73e-2)" "unprognostic (1.58e-2)" "unprognostic (9.76e-2)" "prognostic unfavourable (1.78e-6)" "unprognostic (9.29e-3)" "unprognostic (9.21e-3)" "unprognostic (4.36e-2)" "unprognostic (3.80e-3)" 5.6 3.9 35.3 4.7 10.6 0.0 5.0 11.0 25.3 8.4 4.7 2.4 3.8 3.5 28.8 2.2 6.0 14.2 6.0 3.7 23.2 11.6 1.5 1.1 3.1 1.2 2.6 14.6 7.4 1.7 1.1 4.9 7.4 3.8 7.0 2.1 4.1 3.6 6.4 1.4 1.6 3.8 22.5 1.7 2.4 2.6 3.3 2.0 0.5 3.4 1.6 1.4 6.1 4.7 0.0 0.2 0.5 0.7 0.0 0.1 0.4 0.3 11.9 27.9 0.1 15.2 13.1 0.4 12.4 19.1 9.7 17.2 1.0 1.9 0.0 1.4 20.4 1.4 2.9 3.4 3.3 18.6 4.2 0.0 4.3 0.1 9.8 0.2 24.2 9.6 0.7 3.8 2.0 0.0 0.2 2.8 1.1 11.3 0.0 0.1 8.1 0.7 0.0 2.0 0.3 0.6 0.8 1.1 22.6 10.7 0.9 5.1 0.6 3.5 0.0 7.5 18.9 5.4 1.6 0.0 0.0 0.0 20.9 1.1 14.9 0.1 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.1 0.4 35.3 10.6 11.0 25.3 23.2 11.6 2.6 14.6 3.8 2.0 MEPE ENSG00000152595 "Matrix extracellular phosphoglycoprotein" Q9NQ76 4 87821411-87846817 "Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "brain: 34.2" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 34.2;cerebral cortex: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "amygdala: 1.3" "HPA038003, HPA038004" Uncertain "Secreted to extracellular matrix" 24000000 "HPA038003: , HPA038004: AB_10670537" "unprognostic (2.88e-1)" "unprognostic (8.15e-2)" "unprognostic (3.62e-1)" "unprognostic (1.91e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.14e-2)" "unprognostic (1.98e-1)" "unprognostic (2.41e-1)" "unprognostic (5.64e-4)" 0.2 0.2 34.2 0.2 5.2 0.3 0.5 0.0 10.0 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.2 2.4 1.7 0.3 0.2 0.3 0.2 0.5 5.4 0.2 0.2 0.2 0.1 0.3 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 5.2 0.0 10.0 2.4 1.7 0.5 5.4 0.0 0.0 METRN "C16orf23, MGC2601" ENSG00000103260 "Meteorin, glial cell differentiation regulator" Q9UJH8 16 715115-719655 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.9" "Cell line enhanced" "Detected in many" "MCF7: 52.2;PC-3: 40.4" "Cancer enhanced" "Detected in all" "glioma: 69.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 549.1" "Low region specificity" "Detected in many" HPA051164 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted in brain" "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA051164: " "unprognostic (1.60e-2)" "unprognostic (3.49e-1)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (7.49e-2)" "unprognostic (1.82e-1)" "unprognostic (2.59e-1)" "unprognostic (8.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.12e-2)" "unprognostic (3.32e-1)" "unprognostic (5.03e-3)" "unprognostic (3.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.09e-1)" "unprognostic (2.17e-2)" 7.7 14.9 44.7 5.1 58.9 2.6 4.6 14.2 45.4 4.1 7.0 24.1 19.8 5.6 5.3 7.8 3.1 27.4 6.4 12.4 39.6 31.6 10.5 8.5 6.0 4.2 45.7 15.1 2.7 43.1 5.2 15.1 5.3 15.3 7.4 2.5 9.2 27.3 16.8 21.5 3.9 5.9 4.4 39.5 5.4 8.3 4.6 19.0 2.5 6.6 3.4 3.0 3.9 5.0 3.2 0.9 0.8 1.0 1.7 2.9 0.5 2.6 22.1 4.3 22.0 7.7 4.3 7.0 5.2 2.6 2.1 1.3 3.2 6.5 0.4 12.3 3.7 9.7 0.6 5.1 0.3 1.4 9.7 0.8 4.0 16.6 4.7 1.8 2.8 10.4 5.6 0.6 1.3 0.7 1.5 0.5 1.5 52.2 0.7 6.4 1.6 40.4 7.1 5.0 7.1 5.4 0.7 6.9 8.7 2.1 5.8 26.8 8.7 3.7 2.4 6.0 11.4 6.9 4.5 3.3 0.9 0.4 9.4 1.4 14.1 0.0 0.3 0.8 2.9 1.0 1.7 3.2 1.5 2.7 0.2 0.5 0.9 1.9 0.0 1.7 1.0 0.9 2.8 0.5 44.7 58.9 14.2 27.4 39.6 31.6 45.7 15.1 15.3 19.0 MFRP "C1QTNF5, FLJ30570, NNO2, rd6" ENSG00000235718 "Membrane frizzled-related protein" Q9BY79 11 119338942-119346673 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Microphthalmia, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 40 "brain: 54.9;retina: 112.9" "Cell line enhanced" "Detected in single" "NB-4: 2.0" "Not detected" "Not detected" "Region enriched" "Detected in some" 10 "pons and medulla: 54.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 3.5;hippocampal formation: 13.2;pons and medulla: 10.8;thalamus: 8.9" "Low region specificity" "Detected in some" 0.9 0.3 0.6 0.0 0.4 0.1 0.1 0.2 2.8 0.2 0.1 14.6 0.0 0.2 0.3 0.0 0.1 0.2 0.1 0.2 5.5 0.5 0.2 0.1 0.3 0.2 0.8 0.0 0.1 0.1 2.0 0.5 0.6 54.9 0.1 0.0 112.9 0.1 0.1 0.5 0.1 0.2 0.4 0.4 0.3 0.2 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.4 0.2 2.8 5.5 0.5 0.8 0.0 54.9 0.0 MFSD2B ENSG00000205639 "Major facilitator superfamily domain containing 2B" A6NFX1 2 24010081-24063321 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 17.4;brain: 7.5;placenta: 7.5" "Group enriched" "Detected in some" 14 "HEL: 12.8;K-562: 5.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 16 "basal ganglia: 7.5" "Cell type enriched" "Detected in some" 4 "basophil: 5.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044145 Enhanced "HPA044145: " "unprognostic (5.67e-2)" "unprognostic (1.25e-3)" "unprognostic (1.84e-1)" "unprognostic (5.35e-5)" "unprognostic (2.82e-1)" "unprognostic (1.74e-1)" "unprognostic (4.26e-2)" "unprognostic (7.47e-2)" "unprognostic (2.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.21e-3)" "unprognostic (1.90e-2)" "unprognostic (6.87e-6)" "unprognostic (7.76e-2)" "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.72e-1)" 0.2 0.1 0.1 0.6 7.5 17.4 0.2 0.1 0.3 0.3 0.4 0.0 1.1 0.3 0.5 0.3 0.1 0.2 0.2 0.5 0.1 0.4 0.1 0.4 3.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 7.5 0.3 1.2 0.2 0.2 1.0 0.1 0.5 0.2 0.2 0.1 0.3 2.3 0.2 2.0 0.0 0.1 0.1 0.0 0.4 0.8 1.8 0.0 0.2 5.5 0.0 0.2 0.0 3.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.2 5.5 0.0 0.6 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.0 3.4 0.1 7.5 0.1 0.3 0.1 0.4 0.3 0.0 0.3 0.0 MFSD4A "DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064" ENSG00000174514 "Major facilitator superfamily domain containing 4A" Q8N468 1 205568885-205602918 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9;kidney: 37.6;stomach 1: 60.0" "Cell line enhanced" "Detected in some" "HaCaT: 2.0;HAP1: 2.7;HMC-1: 4.5;SCLC-21H: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 17.1;cerebellum: 24.8;cerebral cortex: 56.2;hippocampal formation: 32.0" "unprognostic (7.15e-4)" "prognostic favourable (7.54e-4)" "unprognostic (5.60e-2)" "unprognostic (1.38e-1)" "unprognostic (2.09e-1)" "unprognostic (1.56e-2)" "unprognostic (1.25e-1)" "prognostic favourable (4.59e-4)" "unprognostic (2.73e-2)" "unprognostic (1.65e-2)" "unprognostic (3.20e-2)" "unprognostic (6.97e-3)" "prognostic favourable (2.27e-13)" "unprognostic (1.58e-1)" "unprognostic (4.44e-2)" "unprognostic (5.75e-3)" "unprognostic (8.78e-2)" 1.7 0.6 17.3 0.8 10.6 0.3 2.1 18.8 24.9 4.9 7.3 1.3 0.0 1.2 0.8 5.2 1.0 1.6 11.1 0.8 11.9 4.3 37.6 0.5 3.8 0.5 3.6 13.3 0.6 1.0 0.4 3.2 3.5 8.4 1.1 9.5 2.4 8.6 0.6 0.6 3.3 1.1 0.7 2.8 0.6 60.0 0.5 0.2 0.0 0.7 0.8 2.8 0.9 0.8 1.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.2 0.8 0.0 0.8 0.0 2.0 2.7 0.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 4.5 0.2 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.2 0.5 4.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.6 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.3 0.1 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 17.3 10.6 18.8 24.9 11.9 4.3 3.6 13.3 8.4 0.2 MGAT3 GNT-III ENSG00000128268 "Mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase" Q09327 22 39457344-39492194 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0;intestine: 27.1" "Cell line enhanced" "Detected in some" "BEWO: 28.7;HMC-1: 24.8;U-266/70: 32.2;U-266/84: 13.0;U-698: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.5;eosinophil: 3.3;memory B-cell: 1.7;naive B-cell: 1.2" "Group enriched" "Detected in many" 9 "B-cells: 1.7;granulocytes: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017598 Approved "Intracellular and membrane" 78000 "HPA017598: AB_1853853" "unprognostic (1.41e-3)" "unprognostic (5.98e-3)" "unprognostic (4.79e-2)" "unprognostic (2.96e-1)" "unprognostic (2.76e-1)" "unprognostic (5.71e-3)" "unprognostic (8.92e-2)" "unprognostic (2.17e-1)" "unprognostic (4.35e-3)" "unprognostic (6.77e-2)" "unprognostic (8.12e-3)" "unprognostic (8.74e-2)" "prognostic unfavourable (5.04e-8)" "unprognostic (6.73e-2)" "unprognostic (1.46e-1)" "unprognostic (5.89e-2)" "unprognostic (4.92e-2)" 5.3 1.2 17.1 3.9 18.7 9.2 3.6 29.0 24.6 7.1 11.9 8.9 0.0 21.1 3.4 1.2 1.4 4.0 7.9 3.0 18.1 14.9 3.3 0.4 14.9 7.2 13.1 13.4 1.0 3.1 0.9 1.4 10.5 10.7 1.0 4.9 1.7 2.1 1.4 1.6 2.5 27.1 3.2 10.4 3.3 7.8 4.9 9.0 0.2 1.1 0.0 8.9 3.0 2.7 1.7 0.1 3.5 0.2 0.0 0.2 0.1 0.1 0.1 4.7 0.4 0.0 0.0 28.7 0.2 0.3 0.2 0.0 6.3 1.6 9.9 3.5 0.0 0.5 2.4 0.0 0.0 0.0 0.2 8.0 0.0 0.0 0.1 0.0 24.8 0.0 0.0 0.0 0.0 0.0 6.5 1.2 0.0 0.1 0.2 0.6 1.4 0.0 0.5 0.0 1.6 0.2 0.2 2.6 1.9 0.0 0.0 0.0 0.3 0.4 0.0 0.0 3.7 0.0 0.0 32.2 13.0 13.9 0.0 0.0 0.7 3.5 0.1 3.3 0.1 0.2 0.1 1.7 0.0 0.0 0.1 1.2 0.2 0.2 0.4 0.0 0.0 0.0 0.1 0.1 17.1 18.7 29.0 24.6 18.1 14.9 13.1 13.4 10.7 9.0 MGAT4C HGNT-IV-H ENSG00000182050 "MGAT4 family member C" Q9UBM8 12 85955666-86838904 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0" "Group enriched" "Detected in some" 13 "NTERA-2: 10.9;SCLC-21H: 4.8" "Cancer enriched" "Detected in single" 19 "thyroid cancer: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016418 Approved "HPA016418: AB_1853854" "unprognostic (5.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.32e-4)" "unprognostic (1.07e-1)" "unprognostic (9.64e-2)" "unprognostic (5.94e-3)" "unprognostic (1.88e-1)" "unprognostic (8.05e-2)" "unprognostic (1.89e-1)" "unprognostic (6.32e-3)" "unprognostic (3.51e-2)" "unprognostic (6.85e-10)" "unprognostic (3.15e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" "unprognostic (4.74e-3)" 1.0 3.0 5.5 1.0 12.3 1.1 0.9 4.9 12.8 1.3 1.2 2.5 0.4 0.9 1.0 10.9 1.1 1.1 1.2 3.6 9.4 3.9 1.0 0.9 1.0 0.9 3.0 9.3 0.9 0.9 0.9 25.9 0.8 10.6 1.1 1.2 0.0 0.9 2.4 0.8 1.0 1.0 1.0 4.3 0.9 1.0 7.8 5.1 0.0 18.0 0.0 0.8 0.9 0.6 0.5 0.3 0.8 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.0 10.9 0.1 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.1 0.8 0.2 0.1 0.3 0.2 0.0 5.5 12.3 4.9 12.8 9.4 3.9 3.0 9.3 10.6 5.1 MGAT5B "FLJ25132, GnT-IX, GnT-VB" ENSG00000167889 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B" Q3V5L5 17 76868456-76950393 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 28.1" "Cell line enhanced" "Detected in many" "A549: 21.6;SCLC-21H: 11.1;U-138 MG: 13.1;U-2 OS: 14.2" "Group enriched" "Detected in many" 5 "glioma: 2.6;melanoma: 7.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011082 Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" "Nucleoplasm, Mitotic spindle" "Cytokinetic bridge" "HPA011082: " "unprognostic (6.37e-2)" "unprognostic (9.16e-3)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (5.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.28e-3)" "unprognostic (1.52e-3)" "unprognostic (5.30e-2)" "unprognostic (3.89e-2)" "unprognostic (1.68e-1)" "unprognostic (5.67e-2)" "unprognostic (1.46e-7)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.04e-1)" "unprognostic (3.01e-1)" 1.1 1.2 9.3 1.1 13.4 1.0 0.9 4.4 28.1 1.0 0.9 1.1 0.0 0.8 1.1 0.7 0.9 1.0 0.9 0.8 5.5 2.8 0.9 0.7 1.0 0.9 2.3 8.1 1.2 0.8 1.0 0.6 1.1 2.6 0.8 0.8 1.1 0.8 0.8 0.7 0.9 0.9 0.8 0.7 1.4 1.0 2.3 1.7 0.0 0.8 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 21.6 4.4 2.2 0.0 0.0 2.3 0.3 0.9 7.9 4.7 0.0 0.5 0.0 1.7 1.0 0.1 1.0 0.2 2.1 0.0 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.2 1.4 0.1 0.0 0.0 1.0 0.0 0.0 1.2 2.2 3.0 3.8 4.5 6.2 0.0 11.1 4.2 3.8 1.7 3.4 0.1 0.1 4.0 13.1 14.2 0.2 4.1 0.0 0.0 0.5 0.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 13.4 4.4 27.4 5.5 2.8 2.3 8.1 2.6 1.7 MIA CD-RAP ENSG00000261857 "Melanoma inhibitory activity" Q16674 19 40771648-40777490 "Cancer-related genes, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 16.1;breast: 28.7;pituitary gland: 33.5;salivary gland: 22.7;stomach 1: 28.9" "Group enriched" "Detected in some" 35 "AN3-CA: 21.3;CAPAN-2: 17.8;SK-MEL-30: 62.1;WM-115: 58.8" "Cancer enriched" "Detected in many" 5 "melanoma: 58.6" "Region enriched" "Detected in some" 8 "midbrain: 16.1" "Cell type enhanced" "Detected in some" "basophil: 1.6;neutrophil: 3.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.0" HPA042369 Approved "Secreted to blood" 8273333 "HPA042369: AB_10794420" "prognostic favourable (2.08e-4)" "unprognostic (1.30e-1)" "unprognostic (3.15e-1)" "unprognostic (9.02e-3)" "unprognostic (2.27e-1)" "unprognostic (1.11e-1)" "unprognostic (6.37e-3)" "unprognostic (3.67e-2)" "unprognostic (1.61e-1)" "unprognostic (9.37e-2)" "unprognostic (1.17e-1)" "unprognostic (3.19e-1)" "unprognostic (3.29e-8)" "unprognostic (5.88e-2)" "unprognostic (2.44e-1)" "unprognostic (2.20e-1)" "unprognostic (2.56e-1)" 0.7 1.5 0.6 3.5 0.6 1.4 28.7 0.9 0.4 3.7 6.1 0.5 2.2 0.8 2.8 3.2 4.0 1.0 3.2 4.1 0.4 0.4 0.9 0.8 1.4 0.7 16.1 0.4 2.6 0.4 0.0 33.5 0.9 2.1 2.2 1.9 6.0 22.7 1.7 0.8 4.5 2.2 3.4 3.1 2.4 28.9 1.0 0.4 0.5 1.1 5.9 4.4 2.0 1.5 0.7 0.0 3.0 0.1 0.0 0.3 0.1 0.0 0.1 0.2 21.3 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.1 17.8 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 62.1 0.1 0.2 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.2 0.0 0.1 58.8 1.6 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.1 0.0 0.0 0.1 0.6 0.6 0.9 0.4 0.4 0.4 16.1 0.4 2.1 0.4 MICAL2 KIAA0750 ENSG00000133816 "Microtubule associated monooxygenase, calponin and LIM domain containing 2" "O94851, Q6ZW33" 11 12094008-12359144 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 138.4" "Cell line enhanced" "Detected in many" "U-138 MG: 39.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebellum: 138.4;cerebral cortex: 39.8" "Cell type enhanced" "Detected in many" "neutrophil: 12.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030437, HPA039895, HPA040438" Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Cytosol" "Nucleoplasm, Plasma membrane" "HPA030437: AB_10601873, HPA039895: , HPA040438: AB_10672896" "unprognostic (2.68e-2)" "unprognostic (1.77e-2)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "prognostic unfavourable (6.88e-4)" "unprognostic (2.20e-2)" "unprognostic (3.60e-2)" "unprognostic (9.32e-2)" "unprognostic (2.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-2)" "unprognostic (6.47e-2)" "prognostic unfavourable (3.63e-5)" "unprognostic (4.61e-2)" "unprognostic (1.97e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 4.1 3.3 15.4 7.3 15.1 6.8 2.9 138.4 39.8 6.6 14.7 2.7 2.9 7.2 14.7 7.7 11.5 5.4 11.1 24.8 22.0 6.9 2.9 3.9 12.8 2.3 5.6 17.9 3.9 4.4 0.7 2.4 5.0 5.5 3.3 15.1 2.8 2.9 8.4 14.6 9.3 10.8 22.7 7.6 2.6 5.9 24.6 0.6 0.0 4.5 1.9 2.2 7.8 3.2 0.2 5.5 12.2 6.7 3.7 3.5 2.1 11.6 6.2 0.2 1.4 1.6 2.9 7.4 18.6 21.1 7.3 11.4 13.0 8.4 0.3 4.0 13.0 8.2 2.2 30.0 18.2 13.5 1.5 11.0 1.2 0.9 14.1 2.0 1.4 5.2 5.3 32.2 31.5 16.6 19.3 0.5 11.7 0.7 0.1 1.0 0.4 5.8 0.1 7.4 7.8 1.5 14.7 6.1 0.5 6.1 17.1 1.2 1.7 0.6 29.7 39.8 15.0 6.5 16.2 0.4 0.9 0.4 24.2 2.9 0.8 0.1 6.7 0.5 2.8 1.7 3.5 0.2 1.7 1.7 5.5 0.2 0.2 0.9 12.2 3.7 0.5 1.0 2.1 2.1 15.4 15.1 138.4 39.8 22.0 6.9 5.6 17.9 5.5 0.6 MICU3 "DKFZp313A0139, EFHA2" ENSG00000155970 "Mitochondrial calcium uptake family member 3" Q86XE3 8 17027238-17122644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 11.9;HBF TERT88: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024048, HPA024771, HPA024779" Uncertain "HPA024048: AB_1848021, HPA024771: AB_1848022, HPA024779: AB_1848023" "unprognostic (2.99e-2)" "unprognostic (7.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.80e-2)" "unprognostic (1.19e-1)" "unprognostic (7.49e-2)" "unprognostic (2.25e-2)" "unprognostic (9.01e-5)" "unprognostic (9.82e-2)" "unprognostic (2.80e-1)" "unprognostic (1.11e-3)" "unprognostic (8.45e-2)" "unprognostic (2.32e-2)" "unprognostic (3.03e-3)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (4.65e-2)" 9.1 11.7 13.7 3.3 18.7 1.4 7.0 34.1 32.3 8.6 4.1 7.7 1.9 2.0 10.4 7.0 5.1 5.4 6.0 6.6 15.4 12.0 7.3 14.8 5.5 4.1 10.5 15.1 12.9 4.6 13.9 13.3 22.1 19.8 9.5 3.5 5.8 5.2 7.5 5.4 2.4 2.7 9.1 10.2 6.9 3.5 7.9 6.3 1.8 7.9 1.3 3.2 6.1 7.5 1.4 0.0 0.1 0.0 0.8 0.9 0.0 0.0 1.1 5.6 2.1 4.3 6.5 1.4 8.3 11.9 6.4 5.2 0.0 0.2 0.1 1.7 4.3 0.0 2.5 1.7 12.1 0.0 1.5 0.0 0.0 2.0 7.5 0.0 0.3 4.9 0.0 5.4 5.5 2.4 0.3 1.6 6.0 0.0 0.7 1.0 4.0 1.4 0.0 2.6 0.0 4.4 0.0 9.2 4.4 0.0 0.0 3.3 0.0 0.0 3.1 2.8 1.1 0.4 1.5 1.6 1.2 2.8 5.2 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.8 0.2 0.4 0.0 0.0 1.4 0.9 0.7 0.0 0.8 0.0 0.0 0.0 0.0 13.7 18.7 34.1 24.3 15.4 12.0 10.5 15.1 19.8 6.3 MID1IP1 "FLJ10386, G12-like, MIG12, STRAIT11499, THRSPL" ENSG00000165175 "MID1 interacting protein 1" Q9NPA3 X 38801432-38806537 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.2;skeletal muscle: 86.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 3.7;eosinophil: 14.0;neutrophil: 8.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038816 Uncertain "HPA038816: AB_10670908" "unprognostic (5.35e-2)" "unprognostic (1.75e-1)" "unprognostic (1.24e-1)" "unprognostic (2.51e-2)" "unprognostic (1.07e-1)" "unprognostic (8.08e-2)" "prognostic unfavourable (2.20e-4)" "unprognostic (2.62e-2)" "unprognostic (3.10e-1)" "unprognostic (1.26e-2)" "unprognostic (2.88e-1)" "unprognostic (2.31e-3)" "prognostic favourable (1.15e-4)" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (1.18e-2)" "prognostic favourable (8.06e-4)" 20.3 9.3 26.9 9.4 59.5 58.4 8.9 5.4 33.3 5.0 9.3 33.7 7.2 11.6 5.5 5.9 7.7 8.7 5.6 6.7 29.1 21.0 8.9 13.9 21.9 7.2 69.2 12.3 13.1 30.6 3.6 3.6 6.5 42.3 8.7 4.3 5.1 7.7 10.3 86.1 6.2 8.7 7.0 31.6 5.8 19.7 9.7 62.9 3.0 4.0 7.1 4.7 9.4 10.5 0.7 1.3 14.0 1.8 0.8 1.5 0.8 18.1 16.8 4.5 3.5 21.4 10.1 4.9 10.3 7.1 2.2 4.2 5.5 13.9 17.7 9.1 3.2 17.1 14.7 12.0 1.4 12.1 5.8 15.1 14.6 4.4 16.3 7.0 11.6 14.8 9.7 8.6 7.5 2.2 13.9 19.3 3.1 15.0 12.2 19.1 15.6 29.9 33.7 5.6 34.8 5.7 9.0 10.9 13.1 5.4 10.6 26.5 8.8 21.5 3.1 6.4 7.2 8.0 7.5 49.5 19.0 16.2 19.5 11.5 7.0 3.7 1.8 14.0 1.0 1.3 1.1 0.5 1.5 1.0 1.3 0.7 1.4 1.3 8.2 0.8 1.8 1.3 0.5 0.8 26.9 59.5 5.4 33.3 29.1 21.0 69.2 12.3 42.3 62.9 MINDY4B "C3orf76, FAM188B2" ENSG00000214237 "MINDY family member 4B" 3 150871045-150905439 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.5;endometrium 1: 2.8" "Cell line enhanced" "Detected in some" "NTERA-2: 1.7;T-47d: 3.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.3" "Low region specificity" "Detected in single" "unprognostic (1.91e-4)" "unprognostic (6.32e-3)" "unprognostic (6.09e-3)" "unprognostic (3.14e-1)" "unprognostic (3.96e-1)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "unprognostic (2.07e-3)" "unprognostic (3.36e-1)" "unprognostic (8.66e-3)" "unprognostic (1.43e-1)" "unprognostic (2.22e-1)" "unprognostic (4.70e-1)" "unprognostic (2.54e-1)" "unprognostic (4.77e-1)" "unprognostic (2.16e-1)" 0.0 0.9 0.0 0.0 7.5 0.2 0.0 0.0 0.6 0.0 0.0 0.2 2.8 0.0 0.4 0.7 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 MKRN2OS "C3orf83, MKRN2-AS1" ENSG00000225526 "MKRN2 opposite strand" H3BPM6 3 12514934-12561059 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.1;epididymis: 8.8" "Cell line enhanced" "Detected in some" "A-431: 3.4;CAPAN-2: 16.4;HBEC3-KT: 4.2;MCF7: 3.7;RT4: 6.8;T-47d: 3.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA065586, HPA065753" Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA065586: , HPA065753: " "unprognostic (2.53e-2)" "unprognostic (1.01e-2)" "unprognostic (3.89e-3)" "unprognostic (2.03e-3)" "unprognostic (3.81e-1)" "unprognostic (8.45e-2)" "unprognostic (2.24e-1)" "unprognostic (2.29e-1)" "unprognostic (5.26e-2)" "unprognostic (3.86e-2)" "unprognostic (1.58e-2)" "unprognostic (4.29e-3)" "unprognostic (2.53e-5)" "unprognostic (1.02e-1)" "unprognostic (2.48e-1)" "unprognostic (8.50e-3)" "unprognostic (3.17e-3)" 0.0 0.0 0.0 0.0 0.6 0.0 0.9 10.1 0.5 1.4 3.7 7.0 0.2 8.8 5.5 1.5 1.7 1.4 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.1 5.1 1.1 1.9 0.0 0.6 4.3 5.8 1.5 0.3 2.0 6.6 0.0 0.0 0.0 4.5 0.0 0.1 0.3 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 16.4 0.0 0.4 0.0 0.7 0.0 4.2 0.0 0.0 1.1 0.0 0.3 0.3 0.0 0.2 0.3 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.1 0.1 0.1 0.0 0.0 0.0 0.2 2.6 6.8 0.3 0.0 0.0 1.0 0.0 3.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MKRN3 "D15S9, MGC88288, RNF63, ZFP127, ZNF127" ENSG00000179455 "Makorin ring finger protein 3" Q13064 15 23565678-23630075 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell line enhanced" "Detected in many" "K-562: 17.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.7" "Lineage enriched" "Detected in many" 4 "T-cells: 5.7" "Low region specificity" "Detected in many" HPA029494 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA029494: AB_10603873" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (4.26e-1)" "unprognostic (1.86e-3)" "unprognostic (1.04e-3)" "unprognostic (1.15e-2)" "unprognostic (6.27e-4)" "unprognostic (1.51e-1)" "unprognostic (8.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.97e-3)" "unprognostic (2.86e-1)" "unprognostic (1.05e-4)" "unprognostic (5.37e-2)" "unprognostic (1.52e-1)" "unprognostic (8.91e-2)" "unprognostic (9.78e-2)" 1.0 0.7 5.1 1.2 10.4 4.0 1.2 1.0 11.1 0.5 1.1 8.4 0.0 1.3 1.3 3.2 5.6 0.9 0.8 0.8 6.4 3.4 1.1 0.7 1.0 1.9 14.4 3.0 1.2 1.7 0.5 3.8 8.5 5.1 1.2 0.8 3.1 5.2 1.0 1.4 1.2 1.9 0.8 8.2 1.5 0.9 5.7 13.3 5.0 0.9 1.1 1.7 0.7 0.6 1.0 0.9 1.3 0.5 0.4 5.7 0.7 4.7 3.4 3.0 3.1 0.0 0.0 7.1 0.3 0.0 2.9 2.0 8.5 0.0 0.2 0.1 0.0 8.2 1.3 0.0 0.7 0.0 0.3 6.8 9.1 0.3 0.2 8.0 6.1 0.1 0.0 6.0 0.0 0.0 17.5 7.5 0.8 0.0 8.4 3.5 0.0 10.4 6.0 1.1 4.2 0.0 0.1 0.7 2.4 0.0 3.4 0.0 2.7 2.4 0.1 8.0 6.7 0.4 5.6 9.4 11.5 5.6 4.7 0.1 0.1 1.3 0.5 0.4 1.8 0.2 1.0 1.0 0.6 1.4 0.2 0.9 2.0 5.7 1.3 0.4 0.3 0.9 0.4 0.7 5.1 10.4 1.0 6.8 6.4 3.4 14.4 3.0 5.1 13.3 MLC1 "KIAA0027, LVM, MLC, VL" ENSG00000100427 "Megalencephalic leukoencephalopathy with subcortical cysts 1" Q15049 22 50059391-50085902 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.0;brain: 95.3" "Cell line enhanced" "Detected in some" "HL-60: 45.7;NB-4: 42.4;THP-1: 80.2;U-266/70: 28.0;U-266/84: 23.9" "Cancer enriched" "Detected in some" 69 "glioma: 122.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 15.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003040 Enhanced "HPA003040: AB_1079387" "unprognostic (2.68e-2)" "unprognostic (5.46e-6)" "unprognostic (5.41e-3)" "unprognostic (1.51e-1)" "unprognostic (1.47e-1)" "unprognostic (2.42e-3)" "unprognostic (9.54e-3)" "unprognostic (7.21e-2)" "unprognostic (2.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.31e-1)" "unprognostic (1.51e-3)" "unprognostic (8.39e-4)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (3.66e-2)" "unprognostic (2.92e-1)" 1.6 1.4 42.3 1.9 45.4 27.0 1.4 17.6 95.3 2.5 1.5 25.9 0.0 1.8 1.5 2.3 1.4 2.8 2.1 1.6 30.9 19.6 1.4 1.6 2.3 1.6 22.5 28.9 1.4 1.4 1.4 0.1 3.2 18.4 2.9 1.4 0.0 1.5 2.6 1.4 2.2 1.5 1.6 18.9 2.8 1.5 2.8 17.3 0.0 1.4 0.0 1.8 1.8 2.6 0.1 0.7 0.1 7.1 15.8 3.3 2.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 45.7 14.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 42.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.2 0.0 0.0 0.0 0.0 0.0 28.0 23.9 0.0 0.0 7.0 0.4 0.0 0.7 0.0 3.3 5.7 0.1 0.1 0.2 1.4 0.7 0.0 0.1 1.6 0.1 15.8 7.1 0.1 0.1 2.7 42.3 45.4 17.6 29.8 30.9 19.6 22.5 28.9 18.4 17.3 MLLT11 AF1Q ENSG00000213190 "MLLT11, transcription factor 7 cofactor" Q13015 1 151057758-151068497 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.1" "Cell line enhanced" "Detected in many" "AF22: 38.4;EFO-21: 29.2;SH-SY5Y: 42.1;U-698: 35.8" "Cancer enhanced" "Detected in all" "glioma: 29.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000540 Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA000540: " "unprognostic (2.96e-2)" "unprognostic (1.98e-2)" "unprognostic (1.08e-2)" "prognostic unfavourable (4.26e-5)" "unprognostic (1.69e-1)" "unprognostic (1.96e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "prognostic unfavourable (4.25e-12)" "unprognostic (5.66e-3)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (3.94e-3)" 1.9 7.5 13.6 3.4 9.1 1.1 1.2 16.3 42.1 1.9 2.1 5.1 1.2 0.8 3.7 1.2 1.3 0.8 11.1 11.8 11.3 16.4 1.2 1.2 5.3 2.3 10.3 1.2 4.2 1.3 8.4 1.8 1.2 3.2 1.3 1.1 1.2 1.5 1.2 2.6 1.0 2.0 4.2 5.8 2.1 0.9 1.2 1.2 2.0 1.2 1.2 2.6 3.2 1.2 2.4 1.0 6.5 1.0 4.2 9.2 2.8 1.2 5.2 38.4 6.0 0.6 1.0 0.6 2.4 2.6 2.3 4.2 0.5 2.5 1.9 29.2 1.8 1.5 9.2 2.2 1.3 11.2 2.5 5.0 3.8 0.1 1.2 0.3 0.8 1.7 0.3 12.7 0.5 16.9 5.3 0.9 7.4 0.4 17.6 3.3 16.7 0.8 16.8 5.1 0.1 4.3 1.1 23.1 42.1 0.2 0.4 1.2 1.4 0.6 11.8 5.0 5.5 1.8 4.3 0.9 0.8 35.8 12.4 0.3 9.3 1.6 0.6 1.6 5.9 0.7 2.7 2.4 3.9 6.0 0.8 2.1 5.3 9.2 6.5 4.2 1.0 1.0 3.6 2.8 13.6 9.1 16.3 21.0 11.3 16.4 10.3 1.2 3.2 1.2 MMD "MMA, PAQR11" ENSG00000108960 "Monocyte to macrophage differentiation associated" Q15546 17 55392613-55421992 "Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 61.1;brain: 40.5;breast: 46.0" "Cell line enhanced" "Detected in many" "ASC diff: 32.1;HSkMC: 58.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026978 Approved Vesicles Vesicles "HPA026978: " "unprognostic (1.33e-1)" "unprognostic (2.92e-2)" "prognostic favourable (3.52e-5)" "prognostic unfavourable (3.88e-4)" "unprognostic (2.48e-1)" "unprognostic (4.16e-2)" "prognostic unfavourable (6.39e-5)" "unprognostic (8.07e-3)" "unprognostic (6.67e-2)" "unprognostic (2.15e-1)" "unprognostic (1.30e-1)" "unprognostic (1.06e-3)" "prognostic unfavourable (2.85e-4)" "unprognostic (3.71e-3)" "unprognostic (7.93e-2)" "prognostic unfavourable (8.62e-4)" "unprognostic (1.12e-2)" 61.1 6.6 33.4 7.1 40.5 5.3 46.0 2.0 23.7 2.6 5.6 4.1 1.7 5.0 3.2 4.9 3.6 1.8 4.7 5.0 26.9 7.5 3.2 6.0 4.7 9.0 11.2 5.1 1.5 1.6 0.9 2.1 13.4 4.6 3.2 6.5 3.2 2.2 4.1 2.5 2.5 4.7 5.4 6.5 8.7 2.4 7.8 5.0 1.4 3.3 1.2 5.6 5.7 4.1 4.1 3.6 9.6 1.6 2.2 4.2 15.9 5.0 12.9 19.1 3.7 32.1 25.4 9.4 3.1 1.4 2.0 2.9 2.0 15.0 7.2 9.3 1.1 0.3 5.2 4.0 4.2 9.5 1.9 2.7 0.7 23.4 8.6 2.5 0.7 58.1 1.3 2.9 3.2 2.5 0.9 5.8 4.2 0.7 7.1 1.9 5.2 3.3 2.9 12.4 2.7 5.5 1.4 1.7 18.2 1.1 2.0 2.9 4.3 4.6 2.3 5.3 6.4 4.2 3.5 2.6 1.2 10.2 7.6 2.1 4.2 9.6 1.3 1.5 1.4 1.6 4.2 3.6 1.6 2.9 3.6 4.1 2.7 2.9 3.8 2.2 1.5 1.1 1.7 15.9 33.4 40.5 2.0 16.9 26.9 7.5 11.2 5.1 4.6 5.0 MMD2 PAQR10 ENSG00000136297 "Monocyte to macrophage differentiation associated 2" Q8IY49 7 4905989-4959213 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 38.5;testis: 10.1" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.9;SH-SY5Y: 1.9;U-87 MG: 1.0" "Cancer enriched" "Detected in single" 59 "glioma: 3.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (2.32e-1)" "unprognostic (1.53e-2)" "unprognostic (5.03e-2)" "unprognostic (2.03e-1)" 0.9 1.2 10.6 0.9 16.2 0.8 0.8 2.4 38.5 0.9 0.9 4.0 0.0 0.9 0.8 0.9 0.9 0.8 0.9 0.8 7.4 6.5 0.9 0.8 0.8 0.9 7.4 6.8 1.0 0.8 0.8 1.9 0.8 7.9 0.9 0.9 1.4 1.0 1.0 0.8 0.8 1.0 0.9 16.7 0.8 0.9 10.1 3.7 0.0 0.9 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.6 16.2 2.4 9.8 7.4 6.5 7.4 6.8 7.9 3.7 MMP16 "C8orf57, DKFZp761D112, MT3-MMP" ENSG00000156103 "Matrix metallopeptidase 16" P51512 8 88032009-88328025 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.9" "Cell line enhanced" "Detected in many" "AN3-CA: 20.0;HUVEC TERT2: 8.7;SH-SY5Y: 11.1;U-138 MG: 9.5;WM-115: 19.5" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023693 Uncertain Approved Vesicles,Cytosol "Secreted to extracellular matrix" Cytosol Vesicles "HPA023693: AB_1854025" "unprognostic (2.58e-1)" "unprognostic (2.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.31e-2)" "unprognostic (2.39e-3)" "unprognostic (1.45e-3)" "unprognostic (2.46e-1)" "unprognostic (2.61e-1)" "unprognostic (9.42e-2)" "unprognostic (2.92e-1)" "unprognostic (2.09e-8)" "unprognostic (6.90e-3)" "unprognostic (1.16e-1)" "unprognostic (3.62e-1)" "unprognostic (2.19e-3)" 2.4 1.3 11.0 1.4 6.8 0.5 4.9 8.3 15.9 5.3 2.2 2.9 0.7 0.8 4.9 2.1 1.7 2.1 7.3 2.7 8.7 6.9 0.8 0.9 1.0 1.0 5.5 9.1 3.3 2.1 1.5 1.7 3.0 6.3 3.2 1.7 0.6 1.2 2.4 0.7 1.1 1.3 4.0 4.6 1.5 1.4 1.5 5.5 0.0 3.2 0.7 1.0 2.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.4 20.0 0.7 1.4 0.0 7.3 1.0 2.1 1.2 0.0 0.0 0.0 0.0 3.3 0.0 3.9 0.0 2.5 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.3 1.0 0.0 3.0 0.9 8.7 0.0 0.7 1.1 0.0 0.0 0.0 1.1 2.0 0.2 0.4 0.0 0.4 0.0 0.1 11.1 0.0 0.0 0.1 0.8 0.0 4.8 9.5 5.4 0.1 2.7 0.0 0.0 0.0 3.8 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 6.8 8.3 14.1 8.7 6.9 5.5 9.1 6.3 5.5 MMP17 MT4-MMP ENSG00000198598 "Matrix metallopeptidase 17" Q9ULZ9 12 131828393-131851783 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.3" "Group enriched" "Detected in many" 4 "REH: 16.9;SK-MEL-30: 41.2;WM-115: 60.9" "Cancer enriched" "Detected in many" 10 "melanoma: 29.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 2.2;intermediate monocyte: 2.1;memory B-cell: 1.4;myeloid DC: 1.2;naive B-cell: 1.7;non-classical monocyte: 2.7" "Group enriched" "Detected in many" 9 "B-cells: 1.7;dendritic cells: 1.2;monocytes: 2.7" "Group enriched" "Detected in many" 5 "amygdala: 51.6;basal ganglia: 52.2;cerebral cortex: 70.8;hippocampal formation: 73.1;hypothalamus: 21.6" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" "unprognostic (9.11e-2)" "unprognostic (1.27e-2)" "unprognostic (1.69e-2)" "unprognostic (3.71e-3)" "unprognostic (5.62e-2)" "unprognostic (1.85e-2)" "unprognostic (8.90e-3)" "unprognostic (2.14e-2)" "unprognostic (2.60e-1)" "unprognostic (2.66e-4)" "unprognostic (7.68e-2)" "unprognostic (5.88e-2)" "unprognostic (9.26e-10)" "unprognostic (1.15e-2)" "unprognostic (2.65e-1)" "unprognostic (1.21e-3)" "unprognostic (2.81e-2)" 4.6 2.0 12.6 3.0 23.3 6.2 2.5 1.4 21.5 5.6 3.0 3.1 0.0 1.4 4.2 0.9 2.1 2.1 7.0 1.1 22.5 10.1 0.5 0.5 1.8 5.5 3.7 7.6 9.0 5.0 3.1 0.7 1.1 2.2 1.6 0.8 1.6 8.5 2.5 1.6 9.7 1.9 1.7 1.6 4.8 1.4 2.9 3.5 0.0 0.8 1.5 1.6 2.8 2.8 1.7 1.2 0.2 2.7 0.1 0.0 1.1 0.1 5.1 0.2 0.4 4.2 1.7 0.0 2.7 6.6 2.5 2.6 0.0 1.5 0.0 2.1 4.1 2.3 2.1 2.5 0.5 0.0 0.3 0.9 1.9 0.0 5.2 0.0 3.7 2.6 0.7 3.6 0.9 3.4 1.0 0.1 3.3 4.6 0.1 3.9 2.3 3.1 16.9 0.0 1.9 0.0 0.0 2.2 0.7 0.3 0.9 41.2 4.8 9.8 2.6 0.7 0.6 3.7 0.3 0.0 0.0 0.0 1.3 0.5 60.9 0.1 2.2 0.0 0.0 2.1 0.0 1.4 0.0 0.0 1.2 1.7 0.0 0.0 0.2 0.1 2.7 0.0 0.0 1.1 12.6 23.3 1.4 17.9 22.5 10.1 3.7 7.6 2.2 3.5 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226654-35277000 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.5" "Cell line enhanced" "Detected in some" "A549: 19.6;CACO-2: 29.9;EFO-21: 8.8;RPTEC TERT1: 13.5;U-2 OS: 10.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 38.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 91.3" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favourable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 1.6 1.3 4.0 0.4 7.8 0.6 0.4 38.5 8.9 0.7 0.3 1.3 0.2 2.8 1.6 0.9 0.2 2.8 0.6 1.0 2.7 3.2 8.6 0.9 6.1 0.3 1.8 1.5 0.9 8.0 0.0 3.8 0.6 1.7 2.2 0.1 0.5 0.4 6.0 0.2 1.5 1.7 2.5 0.9 0.6 0.7 0.4 1.4 0.2 0.8 0.2 0.2 0.5 0.2 0.8 0.4 2.2 0.8 0.6 1.2 0.3 0.3 19.6 0.0 0.1 0.1 0.0 0.6 1.1 1.2 2.1 1.1 29.9 5.3 0.0 8.8 1.3 0.3 4.6 0.0 0.9 0.1 0.2 1.0 0.5 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 7.5 1.3 0.0 0.1 0.0 13.5 0.1 7.8 5.4 1.4 0.5 0.2 0.3 0.1 0.3 4.2 10.1 1.0 0.4 0.1 0.1 0.0 0.9 0.1 0.6 1.0 0.6 0.1 1.0 0.7 1.2 0.6 0.7 0.8 0.4 0.8 0.6 0.6 2.2 0.6 0.8 0.2 0.0 0.3 4.0 7.8 38.5 5.3 2.7 3.2 1.8 1.5 1.7 1.4 MNS1 "FLJ11222, SPATA40" ENSG00000138587 "Meiosis specific nuclear structural 1" Q8NEH6 15 56421544-56465137 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;testis: 36.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039975, HPA040382" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA039975: AB_10793858, HPA040382: AB_10794740" "unprognostic (7.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.19e-1)" "unprognostic (5.07e-2)" "unprognostic (2.25e-1)" "unprognostic (6.62e-2)" "unprognostic (1.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.13e-2)" "unprognostic (2.05e-2)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-3)" "unprognostic (8.20e-3)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.71e-2)" 1.6 1.4 3.2 2.7 4.9 3.2 2.6 35.2 6.7 4.3 2.0 2.1 0.6 2.0 3.2 5.4 2.4 17.6 2.9 2.1 4.1 4.0 7.9 1.8 2.9 1.2 2.1 4.9 4.0 2.1 0.8 10.7 1.4 11.4 3.8 1.9 1.1 1.8 1.7 1.2 1.3 1.8 1.9 3.2 1.3 1.9 36.4 2.4 3.3 2.6 1.4 1.1 1.6 2.2 0.1 0.8 0.0 0.4 0.0 0.0 0.0 19.0 4.5 2.4 7.0 2.0 4.3 0.4 4.6 2.7 5.5 11.8 6.3 9.2 10.7 5.9 1.9 7.5 2.9 2.6 11.3 0.0 1.2 13.7 5.0 1.1 0.7 4.7 1.5 1.7 0.1 11.1 1.6 1.0 3.0 0.0 4.6 2.5 0.1 5.8 0.7 2.6 8.9 14.0 0.1 5.4 3.7 18.4 5.6 7.7 2.3 8.1 5.6 7.2 0.4 7.5 8.6 7.2 11.3 2.2 7.0 0.2 8.4 11.0 8.6 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 3.2 4.9 35.2 6.7 4.1 4.0 2.1 4.9 11.4 2.4 MOAP1 "MAP-1, PNMA4" ENSG00000165943 "Modulator of apoptosis 1" Q96BY2 14 93182196-93184928 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000939 Enhanced Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA000939: AB_1079402" "unprognostic (9.40e-3)" "unprognostic (1.26e-1)" "unprognostic (1.57e-1)" "unprognostic (7.52e-2)" "unprognostic (1.21e-1)" "unprognostic (8.75e-2)" "unprognostic (1.01e-1)" "prognostic favourable (7.37e-9)" "unprognostic (1.98e-1)" "unprognostic (6.52e-2)" "unprognostic (1.05e-3)" "unprognostic (1.58e-2)" "prognostic favourable (3.15e-6)" "unprognostic (6.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (9.27e-2)" 6.9 14.5 21.9 5.7 30.0 15.9 8.6 30.5 69.5 12.8 10.1 7.1 7.7 7.1 9.3 12.0 8.0 11.1 8.2 23.9 24.2 35.9 14.2 9.0 9.7 7.9 22.9 27.8 8.6 9.0 25.0 12.0 7.1 27.8 15.0 7.4 10.1 8.2 14.9 13.9 5.2 7.0 10.1 11.2 7.8 8.3 4.4 7.8 5.9 10.6 3.6 7.5 8.4 3.8 6.3 4.2 16.4 4.4 8.8 14.3 7.5 3.8 3.0 7.3 9.8 6.3 2.4 4.9 4.5 5.2 4.7 5.3 3.2 3.8 11.6 8.3 5.2 6.0 5.2 4.5 5.2 5.3 6.6 6.5 6.1 4.3 8.2 5.8 11.8 4.3 6.8 2.8 5.7 5.7 2.3 7.1 5.3 15.9 9.1 5.5 3.3 3.9 5.6 9.9 7.0 11.9 10.9 16.8 14.6 4.6 6.5 18.4 10.0 4.3 6.2 1.8 2.9 4.2 2.2 13.4 13.7 7.0 4.8 3.7 3.2 16.4 4.0 10.3 11.3 4.4 12.6 6.0 10.5 11.5 4.2 6.3 14.3 12.2 3.7 8.8 4.4 4.0 9.8 7.5 21.9 30.0 30.5 69.5 24.2 35.9 22.9 27.8 27.8 7.8 MOB3B "C9orf35, FLJ13204, MOB1D, MOBKL2B" ENSG00000120162 "MOB kinase activator 3B" Q86TA1 9 27325209-27529781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2;ovary: 29.9" "Cell line enhanced" "Detected in many" "BEWO: 10.0;HAP1: 10.2;K-562: 29.2;SK-BR-3: 12.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.8;myeloid DC: 4.6;naive B-cell: 5.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057744 Uncertain "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (6.96e-3)" "unprognostic (9.60e-2)" "unprognostic (5.10e-3)" "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.02e-1)" "unprognostic (1.87e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (7.57e-3)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "prognostic favourable (2.33e-10)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (1.02e-4)" "unprognostic (7.99e-2)" 6.0 2.3 6.2 4.2 18.0 1.0 7.0 5.0 13.9 7.8 13.2 32.6 2.8 19.0 10.9 6.1 4.3 9.4 5.8 2.0 9.8 6.4 8.6 1.9 7.5 4.2 19.7 6.2 29.9 4.5 0.9 1.8 5.3 17.2 2.8 14.9 5.7 3.9 3.8 8.5 7.1 16.6 7.5 33.2 8.6 6.2 3.7 17.5 0.6 7.0 2.9 6.2 4.0 5.2 5.9 4.6 0.0 1.4 0.0 0.1 0.5 2.0 1.5 4.7 0.0 1.2 0.1 10.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 2.0 0.0 6.6 10.2 8.0 0.0 4.6 1.6 2.9 6.2 0.0 0.0 0.0 0.6 2.1 8.5 0.0 1.5 0.0 29.2 0.1 0.0 0.0 0.0 0.0 6.0 0.5 1.9 0.4 0.0 2.8 3.9 0.0 1.5 1.6 12.3 2.8 0.8 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.9 0.0 0.0 1.4 0.0 4.8 0.0 0.0 4.6 5.9 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.5 6.2 18.0 5.0 12.0 9.8 6.4 19.7 6.2 17.2 17.5 MOBP ENSG00000168314 "Myelin-associated oligodendrocyte basic protein" Q13875 3 39467198-39529479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 32 "brain: 194.3" "Cell line enriched" "Detected in single" 52 "HAP1: 20.2" "Cancer enriched" "Detected in single" 63 "glioma: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA035152 Supported Supported "Cytoplasmic bodies" "Cytoplasmic bodies" "HPA035152: AB_10603020" "unprognostic (1.76e-2)" "unprognostic (2.34e-1)" "unprognostic (3.53e-2)" "unprognostic (7.35e-2)" "unprognostic (5.67e-2)" "unprognostic (3.60e-2)" "unprognostic (7.47e-2)" "unprognostic (2.82e-1)" "unprognostic (7.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.01e-1)" "unprognostic (2.07e-1)" "unprognostic (2.04e-5)" "unprognostic (2.28e-1)" "unprognostic (8.98e-2)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" 1.7 1.8 35.0 1.7 58.5 1.7 1.7 3.8 101.8 1.7 2.3 102.1 0.0 1.6 1.8 1.7 1.7 2.7 1.7 1.7 51.4 33.4 1.7 1.6 2.3 1.6 84.8 14.7 2.1 1.6 6.0 0.0 1.6 68.2 1.6 1.8 0.0 1.6 1.7 1.8 1.7 1.7 1.8 194.3 1.6 1.7 5.0 64.2 0.0 1.7 0.0 1.6 1.7 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 35.0 58.5 3.8 29.1 51.4 33.4 84.8 14.7 68.2 64.2 MOG "BTN6, BTNL11" ENSG00000204655 "Myelin oligodendrocyte glycoprotein" Q16653 6 29656981-29672372 "Disease related genes, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 47 "brain: 106.4" "Group enriched" "Detected in some" 7 "BEWO: 3.4;HEK 293: 2.1" "Cancer enriched" "Detected in single" 45 "glioma: 15.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021873 Enhanced "HPA021873: AB_1854055" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (7.87e-2)" "unprognostic (3.00e-4)" "unprognostic (4.89e-2)" "unprognostic (4.90e-2)" 1.9 1.7 22.1 1.7 35.1 1.7 1.7 3.1 30.0 1.7 1.9 79.5 0.0 1.7 1.7 1.7 1.7 1.7 1.7 1.7 40.2 19.6 2.0 1.7 1.8 1.7 49.2 17.1 2.0 1.7 1.7 0.0 1.8 39.8 1.8 2.1 0.0 1.7 2.2 1.7 1.7 2.0 1.7 106.4 1.7 1.7 2.0 46.4 0.0 1.7 0.0 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 22.1 35.1 3.1 30.0 40.2 19.6 49.2 17.1 39.8 46.4 MPP2 "DKFZp761D0712, DLG2" ENSG00000108852 "Membrane palmitoylated protein 2" Q14168 17 43875357-43909711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.3;epididymis: 31.0;parathyroid gland: 31.1" "Cell line enhanced" "Detected in many" "T-47d: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.9" "Lineage enriched" "Detected in single" 14 "T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026486 Approved Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA026486: AB_1854085" "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (1.30e-5)" "prognostic unfavourable (1.87e-4)" "unprognostic (4.37e-2)" "unprognostic (2.86e-2)" "unprognostic (7.95e-3)" "unprognostic (2.34e-1)" "unprognostic (1.25e-1)" "unprognostic (3.69e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.72e-2)" "unprognostic (4.93e-2)" "unprognostic (1.85e-1)" "unprognostic (7.23e-2)" "unprognostic (6.89e-4)" 2.1 5.0 12.1 2.1 11.8 1.1 3.1 19.5 26.3 3.5 5.1 19.8 2.7 1.9 4.6 31.0 4.1 3.3 3.0 9.0 13.8 14.2 2.0 0.9 2.0 1.2 15.3 14.4 2.8 4.4 31.1 8.4 3.4 11.5 7.1 2.0 6.5 2.3 10.7 1.7 2.0 2.0 6.5 20.3 1.3 2.5 13.8 12.3 0.0 4.5 0.0 1.4 3.6 2.8 0.1 0.0 0.0 0.1 0.0 1.9 0.7 4.9 7.3 7.8 11.3 1.1 0.7 4.3 1.7 0.2 6.8 6.5 2.5 3.3 7.1 4.0 1.7 2.0 10.5 4.1 5.3 0.0 8.1 0.6 6.7 0.1 0.2 0.0 2.1 1.1 0.3 4.9 0.0 0.4 2.7 0.0 2.0 1.9 1.0 0.5 14.0 4.5 5.0 11.2 0.5 0.1 0.1 8.4 7.8 2.1 0.7 2.9 17.2 3.4 0.1 7.6 9.6 2.9 3.1 2.4 4.9 0.0 11.4 4.8 1.4 0.0 0.1 0.0 1.4 0.0 0.2 0.0 0.5 1.2 0.0 0.1 1.6 1.9 0.0 0.0 0.0 0.0 0.1 0.7 12.1 11.8 19.5 22.5 13.8 14.2 15.3 14.4 11.5 12.3 MPP3 DLG3 ENSG00000161647 "Membrane palmitoylated protein 3" Q13368 17 43800799-43833170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.7" "Cell line enhanced" "Detected in many" "hTERT-HME1: 6.4;SCLC-21H: 13.0;T-47d: 6.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 46.7;pons and medulla: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021818, HPA024742" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021818: AB_1854086, HPA024742: AB_1854087" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (2.30e-2)" "unprognostic (2.23e-5)" "unprognostic (4.59e-3)" "unprognostic (5.63e-2)" "unprognostic (5.07e-6)" "unprognostic (2.01e-1)" "unprognostic (1.03e-2)" "unprognostic (3.43e-2)" "unprognostic (1.77e-1)" "unprognostic (1.84e-3)" "unprognostic (8.02e-11)" "unprognostic (9.98e-3)" "unprognostic (1.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.75e-2)" 5.1 2.0 4.8 2.1 2.9 0.6 5.1 46.7 5.2 3.3 1.7 2.2 4.5 1.4 3.5 4.0 3.0 2.7 5.4 12.3 2.7 5.0 2.1 1.2 7.4 1.3 3.0 1.5 1.7 5.9 3.0 2.6 2.1 13.0 3.0 1.1 1.7 1.6 4.3 1.5 2.4 1.3 3.5 2.5 2.2 4.3 3.7 1.1 0.0 1.7 0.9 1.4 1.6 4.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.6 3.0 0.8 0.7 1.8 1.4 0.0 1.5 0.6 1.2 0.7 1.2 1.9 0.0 0.6 1.3 1.5 1.2 2.3 1.7 0.0 1.5 1.5 3.7 0.7 0.1 0.0 0.1 0.9 3.1 2.1 6.4 1.5 0.9 0.0 0.6 0.9 0.0 0.0 0.8 1.2 0.0 1.0 0.4 4.3 0.6 13.0 3.4 0.7 2.8 0.5 6.9 1.5 1.4 3.4 3.2 0.9 3.0 0.9 0.4 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.8 2.9 46.7 3.3 2.7 5.0 3.0 1.5 13.0 1.1 MPPED1 "239AB, C22orf1, FAM1A" ENSG00000186732 "Metallophosphoesterase domain containing 1" O15442 22 43411196-43507848 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "brain: 33.0;liver: 11.0" "Group enriched" "Detected in some" 5 "HaCaT: 11.6;SCLC-21H: 4.8" "Cancer enhanced" "Detected in some" "liver cancer: 1.6" "Group enriched" "Detected in many" 4 "amygdala: 9.3;basal ganglia: 11.0;cerebral cortex: 32.1;hippocampal formation: 16.2;olfactory region: 17.4" "Cell type enhanced" "Detected in some" "eosinophil: 1.3;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 16 "dendritic cells: 1.8;granulocytes: 1.3" "Group enriched" "Detected in many" 5 "amygdala: 108.6;basal ganglia: 66.9;cerebral cortex: 165.8;hippocampal formation: 190.7" "Group enriched" "Detected in many" 6 "cerebral cortex: 131.1;hippocampal formation: 116.7" "unprognostic (1.15e-1)" "unprognostic (4.29e-1)" "unprognostic (8.17e-2)" "unprognostic (4.81e-2)" "unprognostic (9.62e-2)" "unprognostic (1.03e-1)" "unprognostic (7.47e-2)" "unprognostic (2.04e-1)" "unprognostic (3.19e-1)" "unprognostic (4.46e-4)" "unprognostic (1.09e-1)" "unprognostic (4.32e-3)" "unprognostic (1.30e-1)" "unprognostic (2.87e-1)" "unprognostic (6.92e-3)" 0.5 0.8 9.3 0.6 11.0 0.5 0.8 0.5 33.0 0.6 0.6 0.8 0.0 0.7 1.2 1.2 0.5 0.7 0.5 0.7 16.2 2.2 0.6 11.0 0.5 0.6 3.8 17.4 1.9 0.5 0.5 0.9 0.5 0.7 1.2 0.6 0.0 0.6 0.6 0.5 1.4 0.7 0.6 2.9 0.6 0.9 2.1 0.1 0.0 0.5 0.0 0.6 0.6 0.1 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 9.3 11.0 0.5 32.1 16.2 2.2 3.8 17.4 0.7 0.1 MPZ "CMT1, CMT1B, CMT2I, CMT2J, HMSNIB" ENSG00000158887 "Myelin protein zero" P25189 1 161304735-161309972 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 118.7;retina: 60.6" "Cell line enriched" "Detected in some" 5 "WM-115: 66.6" "Cancer enriched" "Detected in many" 11 "melanoma: 83.9" "Region enriched" "Detected in many" 4 "midbrain: 118.7" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.9" "Group enriched" "Detected in some" 5 "olfactory region: 3.6;pons and medulla: 1.4" "Region enriched" "Detected in single" 57 "midbrain: 262.7" HPA068925 Enhanced "HPA068925: " "unprognostic (6.77e-2)" "unprognostic (2.98e-1)" "unprognostic (9.27e-2)" "unprognostic (1.46e-1)" "unprognostic (3.35e-2)" "unprognostic (1.78e-1)" "unprognostic (1.49e-2)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (1.33e-1)" "unprognostic (7.88e-3)" "unprognostic (1.51e-1)" "unprognostic (6.62e-8)" "unprognostic (6.75e-2)" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (8.32e-2)" 14.3 12.6 2.2 3.4 2.9 1.3 4.7 6.0 2.2 4.5 6.1 2.6 9.9 2.6 1.7 7.5 8.7 1.5 4.3 7.2 2.4 4.3 3.2 7.9 3.1 1.3 118.7 0.7 1.9 2.2 0.5 7.4 0.8 28.4 7.3 5.0 60.6 6.4 15.6 4.2 2.3 6.3 5.6 40.9 6.8 2.1 2.7 0.8 0.2 2.8 26.3 3.0 9.3 3.3 0.1 0.0 1.9 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.9 0.4 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.7 0.5 0.1 0.0 0.6 0.2 0.0 0.3 0.0 0.3 0.1 12.3 0.4 1.4 1.2 1.4 0.0 2.0 0.1 0.9 3.1 0.0 1.4 0.0 0.2 2.4 0.5 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 0.0 0.0 6.3 0.0 3.0 0.9 0.1 0.1 0.8 0.0 0.3 0.3 0.3 1.6 5.6 66.6 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.2 0.1 2.2 2.9 6.0 2.2 2.4 4.3 118.7 0.7 28.4 0.8 MRAP2 "bA51G5.2, C6orf117" ENSG00000135324 "Melanocortin 2 receptor accessory protein 2" Q96G30 6 84033756-84090881 "Disease related genes, Predicted membrane proteins" Obesity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0" "Group enriched" "Detected in some" 6 "K-562: 42.4;SCLC-21H: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Lineage enhanced" "Detected in single" "B-cells: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (3.82e-4)" "unprognostic (7.11e-2)" "unprognostic (2.35e-1)" "prognostic favourable (1.66e-4)" "unprognostic (8.80e-3)" "unprognostic (3.15e-1)" "unprognostic (9.85e-2)" "unprognostic (7.43e-2)" "unprognostic (2.76e-1)" "unprognostic (2.05e-3)" "unprognostic (1.41e-2)" "unprognostic (4.47e-1)" "unprognostic (6.02e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (4.50e-3)" "unprognostic (9.12e-2)" 1.4 9.6 7.8 1.5 11.6 0.2 2.1 14.5 19.0 3.6 6.8 3.5 4.2 4.7 3.5 1.5 2.0 10.8 3.5 1.2 5.2 16.3 4.6 0.4 1.2 0.6 5.8 14.5 6.4 5.4 0.2 3.7 0.3 8.4 8.2 6.6 4.7 7.4 10.3 1.5 2.5 5.0 1.5 3.0 8.0 10.0 3.2 1.9 0.1 0.8 2.0 2.1 1.2 2.1 2.3 0.1 0.6 0.0 0.0 0.1 0.1 0.0 1.2 0.4 0.0 0.1 0.7 0.0 0.4 0.0 0.7 0.1 0.5 0.0 0.1 0.0 4.5 0.0 0.8 0.1 0.0 0.3 0.4 1.4 0.1 0.1 0.0 0.3 0.1 0.2 0.6 0.0 0.0 2.8 42.4 0.0 0.2 0.0 0.0 0.0 1.0 0.2 0.0 2.4 0.0 2.6 0.7 14.8 5.0 0.1 0.0 0.7 0.1 1.2 0.2 0.2 0.2 2.4 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 2.3 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.1 7.8 11.6 14.5 19.0 5.2 16.3 5.8 14.5 8.4 1.9 MRGPRE "GPR167, mrgE" ENSG00000184350 "MAS related GPR family member E" Q86SM8 11 3227698-3232386 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 34.9" "Group enriched" "Detected in some" 6 "NB-4: 2.6;RPMI-8226: 4.9;SCLC-21H: 8.0" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Region enriched" "Detected in many" 14 "pons and medulla: 34.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA046556 Uncertain "HPA046556: AB_10961404" "unprognostic (1.18e-1)" "unprognostic (7.52e-4)" "unprognostic (1.04e-1)" "unprognostic (9.09e-2)" "unprognostic (6.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.27e-1)" "unprognostic (1.83e-1)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" 0.1 0.8 0.1 0.1 0.3 2.1 0.8 1.5 2.0 3.5 0.8 0.0 0.0 0.0 2.0 0.7 0.6 1.7 0.5 1.1 0.6 2.3 0.1 0.0 0.3 0.0 2.5 0.0 0.1 0.3 0.0 0.5 1.8 34.9 1.1 0.0 3.9 1.6 1.3 0.1 0.3 0.3 0.5 1.5 1.9 0.1 0.2 0.1 0.0 0.9 0.2 0.0 0.6 1.6 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.9 0.0 0.0 8.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.1 0.3 1.5 2.0 0.6 2.3 2.5 0.0 34.9 0.1 MRLN "Linc-RAM, LINC00948, M1, MLN, MUSER1" ENSG00000227877 Myoregulin P0DMT0 10 59736692-59756041 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.1;skeletal muscle: 59.2;tongue: 22.0" "Cell line enriched" "Detected in some" 10 "RH-30: 22.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in single" 11 "cerebellum: 24.2" "Low region specificity" "Detected in many" "unprognostic (2.32e-2)" "unprognostic (1.52e-1)" "unprognostic (2.27e-1)" "unprognostic (4.54e-1)" "unprognostic (3.17e-3)" "unprognostic (9.77e-2)" "unprognostic (1.09e-2)" "unprognostic (8.49e-2)" "unprognostic (1.23e-1)" "unprognostic (2.79e-2)" "unprognostic (1.12e-2)" "unprognostic (6.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.46e-1)" 0.8 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 2.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 4.4 0.0 0.9 0.4 0.0 1.2 0.1 0.0 59.2 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.9 22.0 0.7 0.0 0.0 2.5 1.7 4.2 1.4 1.7 2.4 0.4 0.0 0.8 0.4 0.9 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.7 0.5 1.1 0.2 0.0 0.6 0.0 0.0 0.0 0.4 0.7 0.2 1.9 0.3 0.1 0.0 1.0 1.8 0.0 0.6 0.0 0.0 0.1 1.3 0.0 2.1 0.0 0.9 0.2 1.5 0.5 22.2 0.0 0.0 0.1 0.6 0.2 0.3 0.1 0.1 0.4 0.7 0.0 0.3 0.8 0.8 0.6 1.1 0.1 0.1 0.4 0.3 0.0 4.2 1.4 1.6 2.4 1.0 1.7 2.0 1.7 1.5 1.2 2.5 1.2 2.1 4.2 1.7 1.0 1.7 1.5 0.4 MRO "B29, C18orf3, FLJ30140" ENSG00000134042 Maestro Q9BYG7 18 50795120-50825402 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 17.5;kidney: 24.3;testis: 30.9" "Group enriched" "Detected in some" 4 "ASC diff: 4.5;ASC TERT1: 13.7" "Cancer enriched" "Detected in some" 7 "glioma: 6.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022011 Approved "HPA022011: AB_2670880" "unprognostic (9.21e-5)" "unprognostic (5.22e-2)" "unprognostic (7.87e-3)" "unprognostic (1.45e-2)" "unprognostic (2.47e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-2)" "unprognostic (5.11e-2)" "unprognostic (3.45e-2)" "unprognostic (2.15e-2)" "unprognostic (1.32e-1)" "unprognostic (4.71e-1)" "unprognostic (5.15e-3)" "unprognostic (1.14e-1)" "unprognostic (3.99e-3)" "unprognostic (6.06e-4)" 2.7 3.2 12.2 0.9 13.9 0.6 1.0 4.5 17.5 0.7 0.7 13.9 1.0 8.3 0.5 4.1 0.9 0.7 1.7 4.4 15.4 5.9 24.3 7.7 0.7 0.7 9.1 10.3 3.8 2.2 3.8 1.3 1.2 11.1 0.7 0.6 1.6 0.7 2.7 2.4 0.5 5.3 0.7 10.7 2.5 1.8 30.9 12.4 0.0 6.6 0.0 0.5 0.8 0.6 0.8 0.9 2.1 1.2 0.5 0.4 0.0 0.0 0.0 0.1 0.3 4.5 13.7 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.4 2.1 0.1 0.0 0.3 0.0 0.0 0.4 0.6 0.1 0.4 0.2 0.4 0.1 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.2 1.0 0.5 0.2 0.3 0.9 0.3 0.4 0.3 0.3 0.1 0.8 0.4 0.4 2.1 0.5 1.2 0.9 0.2 0.0 12.2 13.9 4.5 11.2 15.4 5.9 9.1 10.3 11.1 12.4 MSANTD1 "C4orf44, LOC345222" ENSG00000188981 "Myb/SANT DNA binding domain containing 1" Q6ZTZ1 4 3244369-3271738 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.7;testis: 6.3" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Lineage enhanced" "Detected in single" "T-cells: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (7.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.03e-3)" "unprognostic (1.28e-1)" "unprognostic (2.59e-1)" "unprognostic (1.16e-3)" "unprognostic (2.04e-2)" "unprognostic (4.67e-2)" "unprognostic (3.99e-1)" "unprognostic (5.50e-2)" "unprognostic (2.34e-3)" "unprognostic (6.36e-4)" "unprognostic (1.06e-1)" "unprognostic (3.47e-2)" "unprognostic (8.57e-2)" "unprognostic (5.96e-2)" "unprognostic (1.24e-1)" 0.7 0.8 3.3 1.0 9.4 1.0 0.7 2.0 9.7 0.5 0.7 1.3 0.0 0.8 0.7 1.6 0.5 0.6 0.5 0.5 6.9 4.7 1.0 0.5 1.3 0.8 0.8 5.8 0.8 1.5 0.5 1.4 0.7 1.4 1.0 0.5 0.3 1.5 0.8 2.4 0.8 0.8 0.6 0.4 1.3 1.1 6.3 1.0 0.0 1.2 0.0 0.7 0.3 0.4 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.3 0.5 1.7 0.4 0.1 0.7 0.3 0.2 0.1 0.4 0.9 0.8 0.7 0.6 0.3 0.4 0.3 0.1 0.3 0.5 0.4 0.8 1.2 1.2 0.0 0.1 2.2 0.7 0.5 0.3 0.5 0.3 0.4 1.0 0.0 0.7 0.6 2.0 1.4 1.5 0.4 0.1 0.5 0.2 0.8 2.3 0.5 0.3 0.1 0.5 0.6 0.3 0.5 0.7 1.4 0.9 0.9 1.6 1.3 0.4 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 9.4 2.0 9.7 6.9 4.7 0.8 5.8 1.4 1.0 MSANTD3-TMEFF1 C9orf30-TMEFF1 ENSG00000251349 "MSANTD3-TMEFF1 readthrough" 9 100442271-100577636 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 21.4" "Cell line enhanced" "Detected in many" "AF22: 42.0;NTERA-2: 21.2;SCLC-21H: 22.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (8.53e-3)" "unprognostic (1.95e-3)" "unprognostic (5.92e-2)" "unprognostic (5.32e-2)" "unprognostic (8.87e-2)" "unprognostic (3.00e-1)" "unprognostic (3.39e-4)" "unprognostic (6.34e-2)" "unprognostic (2.19e-1)" "unprognostic (8.88e-3)" "unprognostic (1.46e-1)" "unprognostic (9.55e-3)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.02e-3)" 0.6 0.6 7.7 1.1 4.9 0.0 0.5 7.1 21.4 2.3 0.8 0.0 3.5 1.0 0.6 0.6 1.1 0.7 5.5 3.9 0.4 0.0 0.5 0.0 2.9 1.2 0.0 0.1 0.0 1.1 1.1 0.6 0.0 2.0 0.3 0.0 0.3 2.8 3.5 0.0 0.2 3.3 3.7 0.2 0.9 0.1 0.2 1.0 1.0 0.0 0.0 1.0 0.7 1.1 1.9 42.0 3.4 5.2 2.9 7.0 4.5 3.2 3.4 3.6 0.2 1.3 0.8 2.2 4.1 0.7 13.2 1.3 7.8 3.2 2.5 0.3 1.4 0.6 2.6 0.8 0.7 1.3 1.1 3.3 3.9 8.5 0.8 0.5 6.8 0.8 5.1 0.7 21.2 1.8 6.3 17.8 0.1 3.3 0.4 22.6 10.6 1.4 0.9 2.2 0.5 2.6 3.0 3.6 3.7 4.2 4.1 2.0 4.4 3.9 5.5 0.5 3.4 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.4 0.3 1.0 0.2 0.3 0.5 1.0 0.0 0.0 0.0 0.0 0.7 MSGN1 pMesogenin1 ENSG00000151379 "Mesogenin 1" A6NI15 2 17816496-17817101 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 2.2;esophagus: 2.9;tongue: 2.1" "Cell line enhanced" "Detected in some" "hTCEpi: 1.3;REH: 1.1;RH-30: 1.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebral cortex: 2.0;hippocampal formation: 2.2" "Cell type enriched" "Detected in single" 14 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.63e-2)" "unprognostic (3.25e-2)" "unprognostic (1.66e-1)" 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.0 2.0 0.3 0.2 0.0 0.0 0.0 0.0 1.0 2.9 0.6 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.1 0.1 0.0 1.3 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.1 0.4 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.1 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 2.0 2.2 0.1 0.0 0.0 0.4 0.0 MSLNL "C16orf37, MPFL" ENSG00000162006 Mesothelin-like Q96KJ4 16 769428-783370 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 2.4;epididymis: 4.1" "Group enriched" "Detected in some" 6 "CAPAN-2: 14.5;HeLa: 8.5" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.93e-1)" "unprognostic (1.51e-1)" "unprognostic (1.40e-3)" "unprognostic (5.26e-4)" "unprognostic (3.50e-2)" "unprognostic (4.49e-2)" "unprognostic (2.38e-2)" "unprognostic (1.54e-1)" "unprognostic (3.73e-3)" "unprognostic (6.50e-2)" "unprognostic (2.09e-1)" "unprognostic (5.36e-2)" "unprognostic (2.16e-1)" 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.1 2.4 0.0 0.0 0.2 0.3 4.1 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 14.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MSMP "PC-3, PSMP" ENSG00000215183 "Microseminoprotein, prostate associated" Q1L6U9 9 35752990-35756613 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;pituitary gland: 6.0;placenta: 5.7" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 34.3;PC-3: 43.7" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.9" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA055174 Uncertain Supported Vesicles,Cytosol "Secreted in male reproductive system" Vesicles Cytosol "HPA055174: " 0.5 0.0 1.2 1.1 0.6 0.0 0.8 0.0 0.7 0.2 0.8 0.6 0.0 0.0 0.1 0.0 0.0 0.5 1.9 0.0 0.1 0.1 0.4 0.0 0.4 0.9 3.9 0.0 0.0 0.0 0.0 6.0 5.7 0.8 0.7 0.5 0.0 0.0 0.3 1.3 0.5 1.5 0.3 2.2 0.0 0.1 0.6 0.0 0.0 1.3 0.0 0.2 0.1 0.1 0.0 0.1 3.2 0.3 1.2 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.2 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.7 1.1 0.0 1.2 0.3 0.1 0.3 0.4 1.2 0.6 0.0 0.6 0.1 0.1 3.9 0.0 0.8 0.0 MSRA ENSG00000175806 "Methionine sulfoxide reductase A" Q9UJ68 8 10054268-10428891 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.4" "Cell line enhanced" "Detected in many" "HMC-1: 15.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 78.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Group enriched" "Detected in many" 4 "dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023804, HPA053069" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Intracellular and membrane" 25000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA023804: AB_1853826, HPA053069: " "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" "unprognostic (1.45e-3)" "unprognostic (1.00e-2)" "unprognostic (4.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.49e-2)" "unprognostic (6.40e-2)" "unprognostic (9.69e-2)" "unprognostic (1.08e-1)" "unprognostic (1.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.07e-3)" "unprognostic (6.43e-3)" "unprognostic (4.02e-1)" "unprognostic (6.36e-3)" "unprognostic (3.07e-1)" 7.0 8.1 8.0 5.2 7.5 36.1 5.9 78.4 13.7 3.6 5.9 4.3 2.2 5.9 4.8 3.7 5.5 4.2 4.4 8.5 8.9 5.5 32.4 22.9 5.7 6.8 6.8 9.5 4.2 10.2 2.9 3.4 4.6 8.1 3.4 4.0 3.9 6.0 5.0 4.7 3.8 12.7 4.9 6.7 7.2 4.9 8.5 5.5 3.5 4.4 2.6 3.8 3.9 2.7 1.1 2.3 9.0 3.2 1.1 0.8 0.3 0.1 1.1 1.8 5.4 1.6 1.8 0.6 3.3 0.7 0.5 2.2 0.7 2.7 0.0 0.8 3.0 2.9 0.5 0.2 1.7 0.4 0.0 0.5 1.7 2.5 5.3 1.0 15.2 0.5 3.9 0.4 0.0 0.9 0.5 0.3 5.9 0.2 0.0 0.3 0.8 1.0 1.8 1.7 2.3 1.3 1.3 3.1 2.0 5.4 0.2 0.7 2.8 3.3 3.2 2.2 2.6 0.5 1.6 0.2 0.1 0.9 5.9 1.0 4.1 0.8 3.2 9.0 0.7 2.2 0.6 1.1 0.8 0.5 2.3 0.4 0.6 0.5 3.8 1.1 1.6 0.3 0.5 0.3 8.0 7.5 78.4 13.7 8.9 5.5 6.8 9.5 8.1 5.5 MT1M "MT1, MT1K" ENSG00000205364 "Metallothionein 1M" Q8N339 16 56632233-56633986 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 78.0;brain: 80.1;liver: 85.1" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.3" "unprognostic (1.83e-2)" "unprognostic (2.49e-1)" "unprognostic (2.10e-2)" "unprognostic (3.10e-2)" "unprognostic (4.19e-3)" "unprognostic (7.73e-2)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "prognostic unfavourable (2.13e-4)" "unprognostic (4.67e-2)" "unprognostic (3.10e-1)" "unprognostic (3.55e-1)" "unprognostic (3.68e-2)" "unprognostic (1.25e-1)" "unprognostic (3.50e-2)" "unprognostic (1.34e-2)" "unprognostic (4.71e-2)" 78.0 10.3 16.5 12.7 80.1 1.6 25.5 4.7 31.0 5.1 33.7 6.1 0.4 8.1 2.8 4.9 20.5 16.9 12.4 9.5 39.3 13.6 38.9 85.1 17.5 15.7 28.7 9.6 4.4 40.8 2.5 1.4 2.2 54.5 11.6 35.3 3.5 5.0 3.7 16.6 7.4 35.6 12.6 37.1 3.5 13.1 2.0 13.1 0.0 12.2 3.2 2.2 5.4 5.1 0.1 0.0 2.3 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.5 4.8 0.1 0.3 1.7 0.4 0.4 0.0 0.2 0.0 1.9 1.2 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 4.5 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 32.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.2 0.0 0.4 0.3 0.1 0.0 0.3 0.5 0.0 0.1 0.0 0.2 2.3 0.0 0.1 0.0 0.4 0.0 16.5 80.1 4.7 31.0 39.3 13.6 28.7 9.6 54.5 13.1 MT3 GIF ENSG00000087250 "Metallothionein 3" P25713 16 56589074-56591088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 243.8" "Group enriched" "Detected in some" 5 "RPMI-8226: 5.2;SCLC-21H: 9.0;U-87 MG: 15.2" "Cancer enriched" "Detected in many" 58 "glioma: 392.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive CD8 T-cell: 8.0" "Lineage enriched" "Detected in single" 81 "T-cells: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004011, CAB017779" Enhanced "CAB017779: , HPA004011: AB_1854158" "unprognostic (6.63e-3)" "unprognostic (1.40e-1)" "unprognostic (1.25e-1)" "unprognostic (4.34e-2)" "unprognostic (8.11e-2)" "unprognostic (1.02e-1)" "unprognostic (3.49e-3)" "unprognostic (2.45e-2)" "unprognostic (7.99e-2)" "unprognostic (1.66e-1)" "unprognostic (8.30e-2)" "unprognostic (1.70e-1)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.55e-1)" "unprognostic (2.03e-1)" "unprognostic (9.26e-2)" 2.7 19.8 168.7 2.6 140.5 2.3 2.4 42.2 243.8 2.5 3.6 20.2 0.0 2.4 2.4 2.3 3.2 2.5 2.4 3.8 107.2 80.5 3.1 2.3 2.5 2.5 129.1 53.2 2.6 2.3 2.3 1.1 2.7 37.0 2.6 3.1 0.0 17.4 2.5 2.8 2.5 2.8 2.4 53.7 2.4 2.4 5.9 48.6 0.0 2.4 0.0 5.9 2.4 0.2 0.0 0.0 0.0 0.0 0.0 8.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 5.2 0.0 0.0 9.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 1.7 8.0 0.0 0.0 0.0 0.0 0.0 0.9 168.7 140.5 42.2 102.1 107.2 80.5 129.1 53.2 37.0 48.6 MTCL1 "CCDC165, KIAA0802, SOGA2" ENSG00000168502 "Microtubule crosslinking factor 1" Q9Y4B5 18 8705661-8832778 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 61.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 61.5" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 63.6" HPA046245 Uncertain "HPA046245: AB_10962580" "unprognostic (2.64e-1)" "prognostic unfavourable (6.45e-4)" "unprognostic (2.35e-1)" "unprognostic (2.27e-2)" "unprognostic (1.70e-1)" "unprognostic (1.01e-1)" "unprognostic (4.41e-4)" "unprognostic (1.30e-2)" "unprognostic (7.19e-2)" "unprognostic (9.95e-2)" "unprognostic (2.51e-1)" "unprognostic (1.79e-2)" "prognostic unfavourable (5.19e-4)" "unprognostic (2.82e-1)" "unprognostic (3.67e-1)" "unprognostic (7.17e-3)" "unprognostic (1.08e-2)" 1.4 1.2 1.8 3.2 3.4 0.4 1.4 61.5 10.0 5.5 8.5 2.4 4.1 2.3 3.4 2.0 3.8 1.3 12.5 3.8 1.7 2.4 1.4 1.3 1.4 0.9 2.4 3.8 1.3 3.4 4.8 2.7 3.0 5.2 1.7 2.3 8.4 1.5 4.4 2.4 1.6 2.7 7.0 3.3 1.1 4.9 8.2 1.2 1.4 1.1 1.1 0.6 9.9 4.8 0.6 1.1 0.0 0.0 0.0 0.0 0.0 8.8 19.0 9.5 5.5 4.3 8.0 0.3 12.4 9.2 10.3 7.4 5.5 3.1 5.5 7.1 8.6 1.3 3.0 5.0 4.7 1.1 2.4 2.7 5.0 4.9 6.1 0.1 4.0 4.7 3.8 5.8 4.0 8.0 0.6 9.7 4.7 2.6 0.3 1.3 4.3 8.3 7.4 6.9 2.0 14.7 16.0 21.8 4.9 5.7 1.6 1.5 0.5 0.3 15.2 18.9 9.9 15.1 12.7 1.9 1.4 2.7 4.7 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.8 3.4 61.5 10.0 1.7 2.4 2.4 3.8 5.2 1.2 MTMR10 FLJ20313 ENSG00000166912 "Myotubularin related protein 10" Q9NXD2 15 30938941-30991607 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.0" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006081 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA006081: " "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-1)" "unprognostic (7.36e-2)" "unprognostic (4.43e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" "unprognostic (6.43e-2)" "unprognostic (2.54e-1)" "prognostic favourable (7.77e-12)" "unprognostic (9.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-1)" 13.9 7.3 19.9 7.8 22.8 12.0 16.3 8.4 19.3 10.0 8.4 32.9 4.2 9.6 7.4 8.1 17.1 6.4 7.5 10.2 22.5 13.3 25.9 19.2 10.6 9.6 30.9 11.9 9.5 9.8 14.8 4.3 32.7 29.4 9.2 8.5 9.5 11.1 10.0 24.3 7.6 8.9 8.3 84.0 10.7 10.0 6.6 24.9 8.9 11.7 6.0 8.3 9.5 7.2 3.4 3.8 14.1 6.9 1.4 1.6 1.6 5.3 6.1 5.6 3.1 12.6 6.9 4.1 7.8 16.5 6.6 6.5 3.9 1.9 2.2 10.7 10.4 8.0 4.4 4.7 6.3 8.1 1.2 2.8 4.0 5.8 7.4 5.4 5.7 9.2 3.8 4.2 4.7 16.3 3.1 6.4 6.0 1.6 5.7 1.5 2.8 2.5 4.3 4.9 12.8 24.7 8.6 2.1 5.3 3.8 4.5 1.6 2.9 10.2 7.8 7.7 4.8 4.0 4.8 5.8 4.9 5.9 4.5 2.0 8.6 3.3 3.2 3.0 0.8 4.2 0.8 2.1 0.9 0.6 3.2 3.4 1.6 1.3 14.1 1.4 6.9 3.8 1.3 1.6 19.9 22.8 8.4 19.3 22.5 13.3 30.9 11.9 29.4 24.9 MTMR7 ENSG00000003987 "Myotubularin related protein 7" Q9Y216 8 17298030-17413528 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;parathyroid gland: 17.9" "Cell line enhanced" "Detected in some" "NTERA-2: 5.3;SCLC-21H: 14.0;SH-SY5Y: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA075682 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA075682: " "unprognostic (1.01e-1)" "unprognostic (6.10e-2)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (1.31e-2)" "unprognostic (4.15e-2)" "unprognostic (1.41e-2)" "unprognostic (1.92e-1)" "unprognostic (2.45e-1)" "unprognostic (2.07e-4)" "unprognostic (1.46e-2)" "unprognostic (1.97e-7)" "unprognostic (1.12e-1)" "unprognostic (1.42e-1)" "unprognostic (4.17e-2)" "unprognostic (2.66e-3)" 1.4 4.9 10.9 1.9 16.7 3.4 0.9 16.2 25.8 1.2 1.3 16.0 0.0 2.0 1.8 0.8 1.5 1.5 1.6 1.7 7.5 7.8 2.4 2.2 1.4 1.7 9.2 9.5 3.5 2.6 17.9 10.3 1.8 19.5 1.2 1.3 4.7 1.4 1.1 2.1 2.6 1.9 1.1 11.2 1.4 1.8 2.9 9.4 0.0 6.5 0.0 0.8 1.4 0.7 0.7 0.2 0.8 0.2 0.3 1.4 0.1 0.7 0.6 1.1 1.0 0.0 0.0 0.9 1.8 0.0 0.0 0.0 0.9 0.2 0.8 0.5 0.0 0.4 4.1 0.0 0.0 0.1 3.0 1.2 1.6 0.5 1.0 0.7 0.9 0.2 0.0 0.0 0.0 0.2 0.6 0.7 0.0 0.6 1.3 1.7 5.3 0.5 0.4 1.8 0.5 0.0 3.3 14.0 8.1 0.6 0.8 0.9 0.4 0.9 1.5 0.9 0.5 2.0 1.1 0.4 0.4 0.6 2.6 1.3 0.7 0.0 0.1 0.7 0.2 0.2 0.1 0.7 0.1 0.2 0.1 0.0 0.5 0.3 0.8 0.3 0.2 0.2 1.4 0.1 10.9 16.7 16.2 15.2 7.5 7.8 9.2 9.5 19.5 9.4 MTNR1A MEL-1A-R ENSG00000168412 "Melatonin receptor 1A" P48039 4 186533655-186555567 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.8;intestine: 3.1;kidney: 5.7;testis: 2.5" "Cell line enhanced" "Detected in some" "A549: 2.7;EFO-21: 2.0;HEK 293: 2.0;NTERA-2: 1.8;SCLC-21H: 1.5;SH-SY5Y: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "unprognostic (7.99e-2)" "unprognostic (2.27e-1)" "unprognostic (2.16e-1)" "unprognostic (3.67e-1)" "unprognostic (2.14e-1)" "unprognostic (9.88e-2)" "unprognostic (9.20e-2)" "unprognostic (8.81e-2)" 0.0 0.0 0.1 1.2 0.1 0.0 0.0 3.8 0.2 0.0 3.1 0.3 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.1 5.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.5 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTNR1B ENSG00000134640 "Melatonin receptor 1B" P49286 11 92969720-92985066 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.0;lymphoid tissue: 1.9;placenta: 4.5;testis: 2.0" "Group enriched" "Detected in some" 8 "AF22: 1.1;U-138 MG: 1.4;WM-115: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "midbrain: 0.8;pons and medulla: 1.2" HPA074024 Supported "HPA074024: " "unprognostic (3.61e-1)" "unprognostic (1.43e-1)" 0.1 0.0 0.3 0.0 3.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTSS1L "ABBA, ABBA-1, LOC92154" ENSG00000132613 "MTSS1L, I-BAR domain containing" Q765P7 16 70661204-70686066 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 105.5" "Cell line enhanced" "Detected in many" "Hep G2: 61.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "MAIT T-cell: 2.4;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 7 "dendritic cells: 2.3;T-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048531, HPA066469" Approved Supported "Focal adhesion sites" "Focal adhesion sites" "HPA048531: , HPA066469: AB_2685671" "prognostic unfavourable (2.85e-4)" "unprognostic (8.85e-2)" "unprognostic (7.01e-2)" "unprognostic (5.99e-2)" "unprognostic (3.21e-1)" "unprognostic (2.98e-1)" "unprognostic (1.86e-1)" "unprognostic (1.82e-1)" "unprognostic (5.30e-2)" "unprognostic (1.31e-1)" "unprognostic (5.59e-3)" "unprognostic (3.88e-1)" "unprognostic (2.92e-3)" "unprognostic (9.87e-2)" "unprognostic (9.92e-2)" "unprognostic (6.74e-2)" "unprognostic (2.25e-2)" 17.2 13.4 61.9 11.1 47.6 4.9 6.4 68.3 105.5 22.5 15.5 59.5 4.1 8.1 29.5 4.1 27.4 17.5 15.8 16.8 70.3 45.6 6.8 21.7 12.9 5.5 50.2 38.7 14.5 7.9 7.7 5.2 19.0 40.7 15.5 5.2 11.8 16.1 21.6 37.2 15.8 7.8 31.6 53.5 19.2 6.7 6.2 53.3 8.2 4.5 5.2 4.8 20.8 10.0 0.3 2.3 0.2 0.1 0.0 2.4 0.4 13.6 32.8 8.2 8.5 6.8 6.8 31.2 20.6 25.7 17.7 14.7 13.2 8.8 0.1 7.4 32.2 28.6 8.9 9.0 6.8 0.2 11.9 4.7 28.0 61.0 60.7 7.0 0.2 28.1 19.6 8.2 28.5 5.8 17.8 0.3 15.6 33.8 6.7 36.1 7.2 6.9 14.4 15.4 0.0 15.5 20.5 19.4 13.0 44.0 19.2 5.7 14.7 13.8 8.7 13.8 15.7 12.5 12.8 5.0 1.2 0.2 12.5 0.2 4.7 0.0 0.1 0.2 0.1 0.0 2.4 0.2 0.0 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.4 61.9 47.6 68.3 52.3 70.3 45.6 50.2 38.7 40.7 53.3 MTURN "C7orf41, Ells1, FLJ25903" ENSG00000180354 "Maturin, neural progenitor differentiation regulator homolog" Q8N3F0 7 30134810-30162762 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 189.2" "Cell line enhanced" "Detected in many" "ASC diff: 22.6;HEL: 39.3;SCLC-21H: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 9.9" "Group enriched" "Detected in many" 4 "granulocytes: 9.9;NK-cells: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029507 Enhanced Approved Cytosol Cytosol "HPA029507: AB_10601149" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (3.70e-1)" "unprognostic (7.14e-2)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-3)" "unprognostic (9.80e-2)" "unprognostic (1.94e-1)" "unprognostic (1.11e-3)" "unprognostic (8.11e-3)" "prognostic favourable (7.64e-13)" "unprognostic (9.50e-2)" "unprognostic (7.64e-2)" "unprognostic (4.64e-1)" "unprognostic (3.26e-1)" 35.9 5.7 113.5 4.8 86.7 9.3 14.2 21.7 100.8 12.9 5.2 97.0 3.3 3.0 7.9 45.6 9.6 8.2 5.3 11.2 122.8 79.5 24.7 2.3 10.1 2.8 162.4 26.2 16.5 6.2 9.7 2.7 4.0 54.2 9.2 5.3 2.9 14.9 12.0 14.3 7.8 3.4 8.5 189.2 4.1 10.0 4.5 49.4 0.0 6.7 2.4 3.0 6.0 6.5 0.7 1.4 9.9 0.4 3.0 0.8 2.4 5.0 0.9 3.0 3.1 22.6 15.4 2.7 2.5 2.9 0.8 1.2 0.4 2.0 0.3 2.0 5.4 0.9 6.7 9.6 2.7 2.1 5.4 39.3 6.2 2.7 1.7 1.9 13.0 7.6 4.5 2.5 4.6 1.3 2.4 2.1 5.7 1.9 2.2 0.9 2.0 3.1 0.2 6.9 8.4 10.1 2.0 29.0 7.7 1.5 7.9 7.9 5.6 3.0 6.3 3.3 3.6 6.9 3.4 3.5 5.0 0.4 4.4 4.2 1.6 9.9 0.4 4.8 0.5 0.2 0.1 0.7 0.3 0.2 0.6 0.5 0.2 0.5 3.1 3.0 0.0 1.4 0.8 2.4 113.5 86.7 21.7 51.7 122.8 79.5 162.4 26.2 54.2 49.4 MVB12B "C9orf28, FAM125B, FLJ00001" ENSG00000196814 "Multivesicular body subunit 12B" Q9H7P6 9 126326849-126507041 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.2" "Cell line enhanced" "Detected in many" "AF22: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 1.5;gdT-cell: 3.1;MAIT T-cell: 5.7;memory CD4 T-cell: 1.4;memory CD8 T-cell: 5.0;myeloid DC: 2.0;naive CD8 T-cell: 2.2" "Group enriched" "Detected in many" 7 "dendritic cells: 2.0;monocytes: 1.5;T-cells: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043683, HPA049383" Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA043683: , HPA049383: " "unprognostic (3.50e-1)" "unprognostic (1.12e-1)" "unprognostic (6.82e-2)" "unprognostic (9.59e-3)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-2)" "unprognostic (4.45e-3)" "unprognostic (4.33e-1)" "unprognostic (1.05e-1)" "prognostic favourable (7.89e-4)" "unprognostic (2.82e-1)" "unprognostic (1.66e-3)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (5.79e-2)" "unprognostic (1.12e-3)" 5.6 5.5 15.2 4.3 21.2 10.7 5.0 7.3 22.9 6.3 6.1 52.0 2.4 3.7 5.9 3.3 4.3 10.2 3.9 4.6 22.8 15.3 3.4 4.0 17.7 5.9 31.1 9.8 6.6 3.3 8.8 5.3 14.8 28.2 5.9 6.4 5.8 3.1 9.0 21.4 3.3 4.2 6.6 62.2 10.3 4.0 5.4 28.8 4.8 5.7 1.5 2.6 6.9 3.2 0.4 2.0 0.2 1.5 0.1 5.7 1.4 2.9 4.1 22.2 12.2 0.8 0.2 13.2 2.5 2.0 4.5 0.9 3.4 0.1 0.0 1.5 2.3 1.3 6.8 1.2 2.8 4.9 4.3 1.1 0.7 15.1 1.8 1.9 0.9 1.7 2.3 0.9 0.0 3.4 0.0 0.0 3.3 2.4 3.2 6.2 4.8 5.5 4.7 12.1 0.0 0.2 12.2 5.6 10.3 4.1 3.0 2.5 2.9 11.9 5.0 5.1 3.8 2.8 5.1 0.0 0.0 1.2 1.4 8.8 2.7 0.0 1.5 0.2 3.1 0.4 5.7 0.2 1.4 5.0 2.0 0.4 0.3 2.2 0.1 0.1 0.4 0.1 0.0 1.4 15.2 21.2 7.3 15.9 22.8 15.3 31.1 9.8 28.2 28.8 MYH15 KIAA1000 ENSG00000144821 "Myosin heavy chain 15" Q9Y2K3 3 108380369-108529322 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6" "Cell line enhanced" "Detected in some" "Karpas-707: 4.4;PC-3: 9.5;SH-SY5Y: 3.4;U-87 MG: 3.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 1.4;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 13 "B-cells: 1.4;dendritic cells: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034871 Uncertain "HPA034871: AB_10669996" "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.31e-3)" "unprognostic (2.62e-1)" "unprognostic (1.70e-1)" "unprognostic (2.96e-1)" "unprognostic (7.84e-3)" "unprognostic (7.32e-2)" "unprognostic (1.89e-2)" "unprognostic (5.67e-2)" "unprognostic (6.67e-2)" "unprognostic (4.42e-2)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (8.41e-2)" "unprognostic (3.57e-2)" 0.1 0.9 2.9 0.3 2.4 0.1 0.1 1.1 4.6 0.3 1.4 1.5 0.0 1.1 0.0 0.5 0.8 1.3 2.8 2.3 0.0 0.0 1.1 0.2 3.3 0.0 0.1 0.0 1.5 0.0 0.7 1.0 0.0 0.0 0.7 1.2 2.3 0.0 3.3 0.6 0.5 1.4 0.3 0.1 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.8 1.8 0.2 0.5 0.1 0.7 0.0 0.2 0.0 0.1 0.2 0.0 1.5 0.1 0.1 0.2 0.0 0.0 0.3 2.5 0.0 0.1 0.0 0.5 0.3 0.5 0.0 4.4 2.3 0.0 0.0 0.0 0.1 9.5 0.2 0.1 0.0 0.0 0.0 0.5 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.9 1.0 0.0 1.0 2.4 0.4 0.1 3.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 MYMK "TMEM226, TMEM8C" ENSG00000187616 "Myomaker, myoblast fusion factor" A6NI61 9 133514586-133528612 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Myogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.3;epididymis: 3.1;skeletal muscle: 8.0" "Group enriched" "Detected in some" 34 "HSkMC: 18.0;RH-30: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051846, HPA055785" Uncertain "HPA051846: , HPA055785: " "unprognostic (9.17e-3)" "unprognostic (8.63e-2)" "unprognostic (3.76e-1)" "unprognostic (1.13e-1)" "unprognostic (1.03e-1)" "unprognostic (5.37e-1)" "unprognostic (9.32e-2)" "unprognostic (1.91e-1)" 0.6 0.2 0.5 0.0 3.3 0.2 0.0 0.7 2.6 0.0 0.0 0.8 0.0 0.0 0.0 3.1 0.6 0.1 0.0 0.3 1.0 0.4 1.7 0.2 0.3 0.0 0.9 2.1 0.0 0.0 0.0 0.1 2.0 1.6 0.6 0.0 0.0 0.2 0.0 8.0 0.2 0.0 0.0 0.4 0.1 0.0 1.5 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.3 0.7 2.6 1.0 0.4 0.9 2.1 1.6 0.4 MYO16 "KIAA0865, Myo16b, MYR8, NYAP3, PPP1R107" ENSG00000041515 "Myosin XVI" Q9Y6X6 13 108596152-109208007 "Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell line enhanced" "Detected in some" "AF22: 1.5;SH-SY5Y: 6.5;U-2197: 3.9" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 10 "T-cells: 1.3" "Group enriched" "Detected in all" 4 "basal ganglia: 21.9;olfactory region: 88.9" "Low region specificity" "Detected in all" "HPA040110, HPA058769, HPA071948" Uncertain Approved Vesicles Vesicles "HPA040110: AB_10796339, HPA058769: , HPA071948: " "unprognostic (7.55e-3)" "unprognostic (7.74e-3)" "unprognostic (4.52e-4)" "unprognostic (5.12e-3)" "unprognostic (1.38e-1)" "unprognostic (5.81e-2)" "unprognostic (1.20e-2)" "unprognostic (2.16e-1)" "unprognostic (2.53e-1)" "unprognostic (6.50e-2)" "unprognostic (9.01e-3)" "unprognostic (5.29e-2)" "unprognostic (4.68e-4)" "unprognostic (4.26e-2)" "unprognostic (3.21e-2)" "unprognostic (7.06e-2)" "unprognostic (2.34e-2)" 3.4 2.2 4.0 0.9 3.7 0.4 0.8 2.4 9.2 0.9 0.6 1.5 0.0 0.6 0.5 0.5 1.0 0.5 0.5 2.4 7.5 3.2 0.6 4.8 0.8 0.9 1.8 4.5 0.5 0.7 0.3 5.7 0.6 5.7 1.1 0.6 0.7 0.6 2.0 0.4 0.7 0.5 1.4 5.1 0.5 0.6 3.0 0.0 0.0 0.5 0.0 1.1 0.5 1.2 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.9 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 3.7 2.4 9.2 7.5 3.2 1.8 4.5 5.7 0.0 MYO5A "GS1, MYH12, MYO5, MYR12" ENSG00000197535 "Myosin VA" Q9Y4I1 15 52307283-52529050 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5;parathyroid gland: 47.6" "Cell line enhanced" "Detected in many" "Karpas-707: 58.9;RPMI-8226: 39.9" "Cancer enhanced" "Detected in all" "melanoma: 25.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001356 Enhanced Approved "Focal adhesion sites,Centriolar satellite" "Focal adhesion sites, Centriolar satellite" "HPA001356: AB_1079441" "unprognostic (1.54e-1)" "unprognostic (1.78e-1)" "unprognostic (6.95e-2)" "unprognostic (2.29e-2)" "unprognostic (1.97e-2)" "unprognostic (3.91e-2)" "unprognostic (2.30e-2)" "unprognostic (6.65e-2)" "unprognostic (7.89e-2)" "unprognostic (4.74e-2)" "unprognostic (9.36e-3)" "unprognostic (1.71e-1)" "unprognostic (5.63e-3)" "unprognostic (3.79e-3)" "unprognostic (1.24e-1)" "unprognostic (7.16e-2)" "prognostic unfavourable (4.22e-4)" 8.4 7.1 16.6 9.5 27.5 15.7 5.5 27.4 34.5 6.2 4.4 7.8 0.4 3.3 4.2 3.2 5.0 3.6 7.3 4.6 15.9 15.4 4.6 2.7 7.3 11.2 15.6 17.6 5.4 4.3 47.6 10.5 5.2 29.3 4.5 5.2 9.9 4.0 3.4 4.1 10.4 3.9 7.7 10.1 7.3 4.1 4.6 7.1 3.1 6.8 2.7 10.3 7.3 4.2 2.3 5.2 6.3 4.4 0.7 4.5 1.9 5.4 9.6 5.1 6.1 5.2 6.4 5.5 9.9 9.0 5.3 4.2 0.9 2.2 5.2 2.6 11.8 4.5 11.7 10.2 6.6 29.4 2.7 4.8 2.5 1.1 2.7 2.5 4.7 4.2 6.4 7.8 15.5 30.8 0.1 58.9 10.2 9.6 2.2 0.3 2.3 7.7 4.1 8.2 39.9 4.4 3.9 3.8 2.2 9.2 7.6 18.0 4.0 2.8 14.7 10.7 4.6 5.0 9.6 6.1 13.5 6.3 11.7 7.3 15.4 0.9 4.4 5.4 2.9 3.6 4.5 2.3 2.9 1.9 5.2 1.6 0.5 1.0 6.3 0.7 2.6 3.1 4.1 1.9 16.6 27.5 27.4 34.5 15.9 15.4 15.6 17.6 29.3 7.1 MYRF "C11orf9, MRF, Ndt80, pqn-47" ENSG00000124920 "Myelin regulatory factor" Q9Y2G1 11 61752642-61788518 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.7;stomach 1: 57.2" "Cell line enhanced" "Detected in some" "A549: 18.3;CACO-2: 30.5;CAPAN-2: 17.6;EFO-21: 23.9;Hep G2: 12.9;HHSteC: 13.7;U-2 OS: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018310 Approved Nucleoplasm,Cytosol 550000 Nucleoplasm Cytosol "HPA018310: AB_1845534" "unprognostic (3.51e-2)" "unprognostic (3.34e-1)" "unprognostic (1.56e-1)" "unprognostic (5.39e-2)" "unprognostic (1.54e-1)" "unprognostic (3.65e-2)" "unprognostic (1.34e-1)" "unprognostic (9.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "prognostic unfavourable (2.01e-4)" "unprognostic (8.91e-3)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" 4.6 1.3 16.4 2.1 42.9 1.4 1.5 3.3 38.5 3.7 4.3 96.7 0.0 12.8 6.9 1.6 2.0 8.0 22.4 1.5 29.2 13.9 4.5 5.8 15.8 1.2 54.3 19.9 5.8 19.7 1.2 0.2 2.6 35.7 1.2 4.0 11.6 1.7 1.6 1.0 1.4 11.4 5.4 53.8 1.3 57.2 3.0 51.4 0.0 1.2 0.0 1.2 1.3 0.3 0.0 0.0 0.2 0.3 0.5 2.1 0.5 1.3 18.3 3.3 1.0 0.0 0.0 0.1 0.1 0.0 0.7 0.8 30.5 17.6 0.6 23.9 0.0 0.8 1.0 0.1 1.3 0.1 0.3 0.1 0.4 12.9 13.7 0.0 0.3 0.3 0.2 0.4 0.0 0.1 5.6 0.2 0.1 0.3 0.0 0.6 0.9 2.4 0.0 0.1 1.2 8.1 0.1 0.1 0.6 0.1 1.3 0.3 0.4 0.1 0.6 0.2 10.6 0.2 0.3 0.3 0.1 0.1 0.1 1.2 0.2 0.0 0.0 0.2 2.1 0.3 1.2 0.0 0.7 1.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.5 16.4 42.9 3.3 29.3 29.2 13.9 54.3 19.9 35.7 51.4 MYRIP "DKFZp586F1018, exophilin-8, MyRIP, SLAC2-C, SLAC2C" ENSG00000170011 "Myosin VIIA and Rab interacting protein" Q8NFW9 3 39808914-40260321 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0;retina: 36.3" "Cell line enhanced" "Detected in some" "HAP1: 4.4;HUVEC TERT2: 16.6;REH: 3.9;SCLC-21H: 3.5;SH-SY5Y: 10.3;T-47d: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006433 Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "HPA006433: AB_10603023" "unprognostic (1.87e-2)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.89e-2)" "unprognostic (2.36e-1)" "unprognostic (6.03e-2)" "unprognostic (2.57e-3)" "unprognostic (1.34e-3)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (1.91e-1)" "prognostic favourable (3.96e-8)" "unprognostic (7.12e-2)" "unprognostic (2.40e-1)" "unprognostic (8.92e-2)" "unprognostic (6.16e-2)" 4.8 2.0 31.0 2.2 7.8 0.5 3.4 23.7 19.4 9.0 4.2 3.9 1.3 2.9 6.0 3.8 2.4 3.3 4.3 2.8 13.9 9.6 2.7 16.7 1.7 2.6 8.5 11.0 5.3 13.1 2.1 8.4 0.6 10.8 3.4 4.4 36.3 16.0 1.8 2.7 1.8 2.8 3.9 5.5 10.2 7.7 1.7 4.2 0.0 2.1 1.6 2.9 2.8 2.7 0.8 0.1 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.0 16.6 0.0 0.1 0.2 0.1 0.0 0.0 1.1 0.1 3.9 0.0 0.0 0.4 2.1 3.5 10.3 0.0 0.0 0.0 4.1 0.0 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 31.0 7.8 23.7 18.4 13.9 9.6 8.5 11.0 10.8 4.2 MYT1 "MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A" ENSG00000196132 "Myelin transcription factor 1" Q01538 20 64102394-64242253 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 69.5" "Cell line enhanced" "Detected in some" "HAP1: 4.7;REH: 13.0;SCLC-21H: 16.2;SH-SY5Y: 4.2" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Region enriched" "Detected in all" 13 "cerebellum: 69.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006303 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006303: AB_1079446" "unprognostic (1.09e-1)" "unprognostic (4.65e-2)" "unprognostic (3.68e-2)" "unprognostic (2.05e-7)" "unprognostic (1.28e-1)" "unprognostic (8.34e-2)" "unprognostic (1.20e-1)" "unprognostic (7.10e-2)" "unprognostic (9.33e-3)" "unprognostic (2.28e-2)" "unprognostic (8.45e-4)" "unprognostic (9.73e-2)" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (9.68e-2)" "unprognostic (2.91e-3)" "unprognostic (1.23e-1)" 0.4 7.4 4.3 0.5 5.0 2.4 0.4 69.5 11.0 0.3 0.7 2.7 0.0 0.9 0.4 0.5 0.3 0.6 0.5 0.8 4.2 5.3 0.6 0.4 0.4 0.4 3.7 2.2 0.4 4.7 0.4 3.7 0.4 5.1 0.6 0.6 3.7 0.3 0.4 0.3 0.4 0.6 0.4 2.0 0.5 1.0 2.1 4.8 0.0 1.4 0.0 0.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.6 0.0 0.0 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 1.4 0.0 0.7 0.2 13.0 0.0 0.0 0.0 0.0 16.2 4.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 4.3 5.0 69.5 3.1 4.2 5.3 3.7 2.2 5.1 4.8 MYT1L "KIAA1106, NZF1, ZC2H2C2, ZC2HC4B" ENSG00000186487 "Myelin transcription factor 1 like" Q9UL68 2 1789113-2331348 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Autism spectrum disorder, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.2" "Group enriched" "Detected in some" 9 "SCLC-21H: 11.0;SH-SY5Y: 8.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.3;naive CD8 T-cell: 1.6" "Group enriched" "Detected in many" 8 "granulocytes: 2.3;T-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060245 Approved Vesicles Vesicles "HPA060245: " "unprognostic (9.90e-3)" "unprognostic (3.74e-1)" "unprognostic (1.30e-1)" "unprognostic (9.61e-3)" "unprognostic (7.17e-2)" "unprognostic (3.73e-2)" "unprognostic (2.44e-1)" "unprognostic (2.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.93e-2)" "unprognostic (2.46e-1)" "unprognostic (7.96e-2)" "unprognostic (1.21e-2)" "unprognostic (1.04e-2)" 1.2 3.4 11.0 1.4 20.0 1.1 1.1 19.5 50.2 1.1 1.2 0.5 0.0 1.1 1.2 1.1 1.3 1.1 1.1 1.1 15.6 10.3 1.1 1.1 1.1 1.2 5.1 14.5 1.1 1.5 1.0 10.7 1.1 6.8 1.3 1.3 0.4 1.1 1.1 1.1 1.1 1.2 1.1 1.5 1.0 1.1 4.6 2.0 0.0 1.1 0.0 1.1 1.1 0.0 0.0 0.2 2.3 0.0 0.0 1.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.6 0.1 0.0 0.0 11.0 8.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.2 0.0 0.6 11.0 20.0 19.5 26.7 15.6 10.3 5.1 14.5 6.8 2.0 MZT1 "C13orf37, FLJ21869, LOC440145, MGC150539, MOZART1, RP11-11C5.2" ENSG00000204899 "Mitotic spindle organizing protein 1" Q08AG7 13 72708357-72727687 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063299, HPA066715" Approved "HPA063299: , HPA066715: " "unprognostic (1.52e-1)" "unprognostic (3.38e-2)" "unprognostic (1.48e-1)" "unprognostic (4.89e-1)" "unprognostic (2.46e-1)" "unprognostic (2.38e-3)" "prognostic unfavourable (3.22e-5)" "unprognostic (2.65e-2)" "unprognostic (6.88e-2)" "unprognostic (5.28e-2)" "unprognostic (7.09e-2)" "unprognostic (3.18e-2)" "prognostic unfavourable (1.01e-5)" "unprognostic (9.01e-3)" "unprognostic (5.23e-1)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" 7.5 14.1 19.8 9.7 44.6 19.9 10.6 26.9 24.1 8.3 7.6 4.4 7.3 7.2 7.6 8.5 8.9 5.4 5.4 10.3 17.3 16.6 10.1 4.6 8.6 14.1 11.3 14.8 6.8 6.1 5.3 7.2 9.3 9.2 9.5 9.1 5.3 8.0 10.7 15.5 8.4 6.4 7.0 9.1 8.1 7.9 5.3 8.2 12.1 10.9 7.8 11.2 9.2 6.2 9.6 7.5 13.8 8.6 9.0 11.5 4.8 30.4 4.9 17.4 12.8 3.6 6.0 14.3 24.7 10.3 15.7 18.1 9.1 20.1 21.1 19.0 9.8 9.9 17.3 9.2 28.5 25.2 17.6 27.3 10.4 13.8 5.0 45.7 22.4 3.3 9.4 9.4 19.7 15.8 15.0 16.6 30.8 5.4 23.1 25.6 13.2 9.3 16.5 19.9 10.4 14.0 7.6 20.5 18.8 10.5 15.6 14.9 11.7 22.8 10.7 13.9 15.8 19.5 29.8 15.3 23.5 16.6 32.5 28.0 28.3 13.8 4.7 9.9 6.2 8.3 7.7 9.6 8.4 7.7 5.8 8.5 11.1 8.8 2.4 9.0 8.6 7.5 11.5 4.8 19.8 44.6 26.9 24.1 17.3 16.6 11.3 14.8 9.2 8.2 NACAD KIAA0363 ENSG00000136274 "NAC alpha domain containing" O15069 7 45080438-45088914 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.0" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 6.5;SCLC-21H: 21.5;SH-SY5Y: 14.9" "Group enriched" "Detected in many" 7 "glioma: 12.1;testis cancer: 16.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;non-classical monocyte: 1.8" "Group enriched" "Detected in many" 12 "monocytes: 1.8;T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020981 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA020981: " "unprognostic (5.54e-6)" "unprognostic (1.89e-1)" "unprognostic (8.55e-4)" "unprognostic (7.06e-3)" "prognostic unfavourable (1.38e-4)" "unprognostic (1.61e-1)" "unprognostic (6.91e-2)" "unprognostic (1.16e-1)" "unprognostic (4.17e-2)" "unprognostic (3.17e-2)" "unprognostic (8.17e-3)" "unprognostic (2.76e-2)" "unprognostic (7.72e-3)" "unprognostic (2.72e-3)" "unprognostic (9.22e-2)" "unprognostic (1.54e-1)" "unprognostic (2.87e-2)" 4.7 8.9 11.5 2.7 19.4 1.1 2.1 16.7 45.0 4.8 3.5 43.1 0.1 2.1 6.9 2.3 3.9 4.8 3.7 5.1 16.7 15.9 2.2 1.2 3.0 1.9 30.2 12.9 10.4 2.4 3.2 11.7 3.8 26.7 4.7 2.3 1.1 3.2 5.7 2.0 2.1 2.7 7.4 30.8 2.7 2.5 4.5 21.5 0.0 1.4 0.0 1.5 3.2 2.3 0.1 0.0 0.0 1.8 0.0 1.4 0.1 0.0 0.0 2.1 0.0 1.3 0.6 0.0 2.3 2.9 6.5 4.1 0.2 0.1 0.0 1.9 4.2 0.2 1.8 1.6 2.3 0.0 0.6 0.0 1.4 0.0 1.6 0.0 0.0 1.4 0.0 2.8 0.3 2.0 0.0 2.9 1.6 0.0 0.0 0.0 1.9 1.8 0.0 0.8 0.0 0.2 0.0 21.5 14.9 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.2 0.4 1.5 0.8 0.0 1.2 0.0 4.4 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.1 11.5 19.4 16.7 24.1 16.7 15.9 30.2 12.9 26.7 21.5 NALCN "bA430M15.1, CanIon, VGCNL1" ENSG00000102452 "Sodium leak channel, non-selective" Q8IZF0 13 101053776-101416492 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.8;HaCaT: 11.7;HHSteC: 12.7;TIME: 15.3;U-87 MG: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031889, HPA031890, HPA031958" Approved "HPA031889: AB_10669638, HPA031890: AB_10696056, HPA031958: AB_10601039" "unprognostic (4.66e-1)" "unprognostic (6.55e-3)" "unprognostic (1.86e-3)" "unprognostic (6.78e-3)" "unprognostic (1.16e-1)" "unprognostic (1.37e-3)" "unprognostic (8.11e-2)" "unprognostic (2.60e-1)" "unprognostic (7.72e-2)" "unprognostic (5.92e-2)" "unprognostic (1.25e-1)" "unprognostic (2.18e-1)" "unprognostic (1.58e-5)" "unprognostic (1.77e-3)" "unprognostic (5.44e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" 1.5 8.3 9.8 1.4 18.3 1.6 5.2 13.4 29.4 3.6 1.3 18.6 0.0 1.1 1.5 3.4 1.1 2.6 4.6 6.0 10.8 11.4 1.2 2.3 2.7 1.0 11.0 13.1 5.6 2.1 4.2 13.0 5.6 17.0 1.3 1.7 4.3 1.6 2.5 1.0 1.6 1.4 1.3 12.7 1.3 1.8 2.0 14.1 0.0 4.8 0.0 0.8 1.6 0.6 1.4 0.8 5.4 0.5 0.9 0.9 0.3 0.1 6.6 1.3 0.2 0.6 0.3 0.1 0.7 0.6 1.6 0.4 0.1 7.8 0.0 0.4 3.1 11.7 0.0 1.8 4.2 0.0 0.8 0.4 3.8 0.1 12.7 0.2 0.2 0.2 0.5 1.4 3.9 6.9 0.1 0.4 5.0 0.0 0.1 0.0 0.3 1.4 0.0 0.0 0.0 3.9 1.6 1.0 0.2 0.1 0.1 0.6 0.2 0.1 15.3 0.4 0.1 0.3 1.5 0.0 0.1 0.0 9.6 0.0 0.3 5.4 0.5 0.8 0.9 0.3 0.4 0.7 0.5 0.5 0.1 1.4 0.6 0.5 1.8 0.9 0.2 0.8 0.4 0.3 9.8 18.3 13.4 18.2 10.8 11.4 11.0 13.1 17.0 14.1 NANOS3 "NANOS1L, NOS3, ZC2HC12C" ENSG00000187556 "Nanos C2HC-type zinc finger 3" P60323 19 13862063-13880757 "Predicted intracellular proteins" "Differentiation, Oogenesis, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1;testis: 9.4" "Cell line enhanced" "Detected in some" "HDLM-2: 1.9;MCF7: 3.2;MOLT-4: 1.8;REH: 2.9;RPMI-8226: 2.2;SH-SY5Y: 2.6" "Cancer enriched" "Detected in many" 34 "testis cancer: 132.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA062989 Enhanced "HPA062989: " "unprognostic (9.42e-3)" "unprognostic (3.17e-2)" "unprognostic (1.58e-1)" "unprognostic (8.58e-2)" "unprognostic (2.69e-1)" "unprognostic (6.89e-3)" "unprognostic (3.23e-3)" "unprognostic (4.97e-3)" "unprognostic (1.65e-1)" "unprognostic (1.39e-1)" "unprognostic (5.29e-3)" "unprognostic (5.17e-2)" "unprognostic (4.60e-2)" "unprognostic (3.12e-1)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (2.06e-1)" 0.3 0.0 1.7 0.3 0.4 0.0 0.3 5.1 4.4 0.3 0.3 0.3 0.3 2.2 0.3 0.3 0.3 0.0 0.3 0.3 1.3 1.7 0.3 0.3 1.1 0.3 0.8 0.3 0.3 0.5 0.0 0.4 0.4 0.3 0.3 0.0 0.3 0.3 0.4 0.3 0.4 1.3 0.3 0.3 0.4 0.5 9.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.5 0.0 0.0 0.0 1.9 0.6 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.8 1.4 0.3 0.0 2.9 0.0 2.2 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.2 0.0 0.3 0.0 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 5.1 4.4 1.3 1.7 0.8 0.3 0.3 0.3 NAP1L2 "BPX, MGC26243" ENSG00000186462 "Nucleosome assembly protein 1 like 2" Q9ULW6 X 73212299-73214848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 49.8" "Cell line enhanced" "Detected in some" "EFO-21: 12.0;Karpas-707: 10.0;NTERA-2: 12.8;U-2 OS: 7.5;U-2197: 10.4;U-266/84: 20.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054050, HPA057065" Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA054050: , HPA057065: " "unprognostic (1.12e-1)" "unprognostic (6.64e-5)" "unprognostic (4.22e-2)" "unprognostic (9.64e-4)" "unprognostic (1.78e-1)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (8.51e-3)" "unprognostic (1.76e-2)" "unprognostic (2.66e-1)" "prognostic favourable (5.41e-4)" "unprognostic (1.53e-2)" "unprognostic (1.54e-2)" "unprognostic (6.95e-4)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.45e-2)" 2.3 5.8 15.7 2.2 20.0 0.9 3.2 37.5 49.8 4.5 2.8 2.0 0.2 1.3 4.9 8.0 2.8 4.2 2.5 7.2 21.0 22.8 8.0 1.3 2.5 2.9 15.7 28.7 8.6 2.6 10.5 10.2 0.5 20.5 10.4 3.1 2.6 3.1 5.9 1.1 4.9 1.7 4.6 8.3 3.9 2.0 2.2 4.9 0.0 8.0 0.0 1.8 2.6 2.5 0.9 0.0 0.0 0.0 1.2 3.6 1.4 0.0 3.3 0.1 6.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 12.0 0.0 0.7 2.4 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.6 0.3 0.9 0.1 1.7 0.2 0.2 10.0 0.0 1.2 3.9 0.0 12.8 5.9 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.1 0.0 7.5 10.4 0.8 4.7 20.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.4 0.9 3.4 2.3 0.0 0.1 1.6 3.6 0.0 1.2 0.0 0.0 2.6 1.4 15.7 20.0 37.5 42.1 21.0 22.8 15.7 28.7 20.5 4.9 NAP1L3 "MB20, MGC26312, NPL3" ENSG00000186310 "Nucleosome assembly protein 1 like 3" Q99457 X 93670930-93673568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.2" "Cell line enhanced" "Detected in some" "AF22: 10.2;HAP1: 9.9;NTERA-2: 18.1;RH-30: 8.0;U-2 OS: 8.3;U-2197: 12.1" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.9" "Group enriched" "Detected in many" 24 "NK-cells: 4.5;T-cells: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026075 Approved Vesicles Vesicles "HPA026075: AB_1854301" "unprognostic (7.18e-2)" "unprognostic (1.81e-2)" "unprognostic (9.26e-2)" "unprognostic (4.83e-4)" "unprognostic (3.06e-1)" "unprognostic (1.28e-2)" "unprognostic (5.10e-2)" "unprognostic (1.76e-1)" "unprognostic (3.31e-2)" "unprognostic (9.29e-2)" "unprognostic (2.75e-3)" "unprognostic (5.01e-2)" "unprognostic (2.75e-3)" "unprognostic (5.78e-3)" "unprognostic (1.19e-1)" "unprognostic (1.75e-1)" "unprognostic (5.23e-4)" 2.3 10.4 24.4 2.4 25.7 1.2 2.4 44.9 60.2 16.0 2.4 5.3 0.0 1.6 9.5 4.7 1.5 8.1 4.4 8.4 22.0 42.3 2.9 1.4 1.8 2.1 18.5 31.0 13.1 1.5 1.1 7.9 1.6 20.9 3.9 2.3 2.4 1.6 4.6 0.8 1.7 2.0 6.5 13.1 3.6 1.4 11.9 7.0 0.0 4.6 0.0 1.5 3.3 1.2 0.0 0.0 0.2 0.0 4.5 6.9 1.6 0.0 0.1 10.2 7.4 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.6 0.0 9.9 0.0 0.0 0.0 0.2 4.7 0.0 0.1 0.5 0.0 0.3 4.7 0.0 0.5 4.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 18.1 4.2 0.0 8.0 0.0 0.3 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.5 0.0 5.7 8.3 12.1 0.5 7.7 3.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 1.1 0.0 4.3 1.6 0.0 0.0 6.9 4.8 0.2 4.5 0.0 0.0 1.3 1.6 24.4 25.7 44.9 60.2 22.0 42.3 18.5 31.0 20.9 7.0 NAP1L5 DRLM ENSG00000177432 "Nucleosome assembly protein 1 like 5" Q96NT1 4 88695915-88697829 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.4" "Cell line enhanced" "Detected in many" "SH-SY5Y: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058227 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA058227: " "unprognostic (1.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.61e-2)" "unprognostic (1.96e-2)" "unprognostic (5.62e-2)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (8.54e-3)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (2.57e-2)" "unprognostic (1.39e-1)" 7.3 21.8 24.5 3.6 23.3 4.9 4.9 25.8 53.4 6.2 3.1 4.2 2.1 1.9 6.4 10.5 4.1 4.9 5.4 5.6 23.9 52.8 6.1 5.0 3.1 3.0 28.4 33.6 8.2 2.8 7.9 12.9 4.7 35.6 6.7 3.1 3.6 2.5 8.7 1.8 1.7 2.4 6.4 11.5 3.5 2.8 4.9 5.4 0.5 9.3 1.3 2.4 5.2 2.0 0.7 0.9 0.6 0.8 1.5 3.9 1.0 0.0 1.0 7.1 4.3 10.5 6.7 0.0 7.7 4.7 3.9 6.2 0.0 0.9 0.0 3.1 4.4 1.4 12.7 3.0 7.1 2.4 0.0 13.3 4.6 1.1 9.1 6.8 8.8 10.6 1.0 4.6 0.7 6.9 3.7 0.0 11.5 0.1 8.3 0.5 2.9 0.0 4.5 2.0 0.8 2.6 3.2 9.6 29.0 0.0 1.3 5.6 0.0 1.9 5.0 4.5 1.1 2.8 3.8 2.0 0.0 0.0 9.6 0.0 3.5 0.0 0.2 0.4 3.9 0.4 2.6 0.0 1.9 3.0 0.9 0.7 3.5 3.3 0.6 1.5 0.8 0.7 1.7 1.0 24.5 23.3 25.8 41.9 23.9 52.8 28.4 33.6 35.6 5.4 NAPB "SNAP-BETA, SNAPB" ENSG00000125814 "NSF attachment protein beta" Q9H115 20 23374519-23421519 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 110.9" "Cell line enhanced" "Detected in all" "SCLC-21H: 24.0;U-937: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037225, CAB037227, HPA046149, HPA050196" Supported Uncertain Cytosol Cytosol "CAB037225: AB_477555, CAB037227: AB_477554, HPA046149: , HPA050196: " "unprognostic (3.89e-1)" "unprognostic (2.71e-1)" "unprognostic (5.95e-2)" "unprognostic (1.05e-1)" "unprognostic (2.54e-2)" "unprognostic (3.92e-2)" "unprognostic (1.32e-3)" "unprognostic (1.25e-1)" "unprognostic (4.71e-2)" "unprognostic (6.37e-2)" "unprognostic (4.46e-3)" "unprognostic (7.52e-3)" "prognostic unfavourable (1.14e-4)" "unprognostic (1.42e-1)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (4.60e-2)" 3.2 15.5 32.7 3.8 32.7 6.0 4.4 46.0 110.9 4.0 4.0 4.4 2.6 3.8 4.7 6.3 3.7 4.6 3.8 3.7 30.5 32.0 4.4 3.8 3.9 4.0 26.1 40.1 6.4 3.4 6.1 4.6 5.9 50.2 4.0 5.0 6.1 4.0 4.6 3.4 5.0 5.5 4.5 9.7 4.5 4.3 5.3 4.0 0.7 5.1 0.1 3.4 3.6 2.3 2.4 1.9 6.0 2.1 1.5 5.1 2.1 4.2 2.7 4.5 4.7 5.1 4.7 6.4 5.5 3.0 4.4 3.9 3.2 3.8 6.2 6.5 3.2 5.4 5.8 3.7 5.4 2.0 4.3 6.8 3.6 7.6 6.0 5.0 4.0 4.7 4.9 3.1 4.0 3.3 5.7 8.2 7.0 2.8 5.1 4.6 1.9 5.0 3.4 3.6 4.6 5.8 4.6 24.0 7.6 3.1 3.1 5.1 3.2 3.1 3.8 4.3 3.2 4.7 3.9 6.0 4.7 2.8 2.2 23.9 4.2 6.0 1.2 0.0 5.1 1.3 1.5 1.7 2.0 2.4 1.9 2.4 2.0 3.3 1.5 1.5 2.1 1.5 2.5 2.1 32.7 32.7 46.0 57.7 30.5 32.0 26.1 40.1 50.2 4.0 NAPG ENSG00000134265 "NSF attachment protein gamma" Q99747 18 10525905-10552761 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008208, HPA011389" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA008208: AB_1854305, HPA011389: AB_1854306" "unprognostic (1.23e-1)" "unprognostic (7.64e-3)" "unprognostic (6.96e-2)" "unprognostic (1.53e-1)" "unprognostic (9.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.28e-1)" "unprognostic (4.59e-2)" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (1.46e-3)" "unprognostic (5.85e-2)" "prognostic favourable (8.14e-4)" "unprognostic (3.81e-2)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (6.96e-2)" 11.0 14.0 20.5 9.1 31.2 6.1 12.1 24.0 40.2 11.6 11.6 17.8 4.9 9.3 11.0 12.7 12.3 11.3 13.5 19.3 26.3 20.8 16.9 13.3 9.6 8.7 24.1 21.4 7.6 12.4 12.8 10.5 13.7 54.1 14.3 14.1 10.1 10.7 11.6 9.0 8.8 10.3 12.5 25.2 8.5 13.4 7.1 11.9 6.9 14.8 8.2 10.6 12.6 8.7 8.4 4.7 15.2 7.1 6.6 7.1 3.6 5.7 3.4 6.1 5.2 17.5 12.0 8.9 12.3 17.7 12.0 15.4 7.6 8.8 7.7 9.9 16.8 5.7 8.0 11.1 17.3 6.6 4.9 5.6 6.0 7.8 16.8 15.5 10.6 12.6 12.9 13.8 10.3 11.3 9.1 18.3 17.5 8.0 11.9 6.6 4.7 5.2 5.3 10.1 12.8 14.1 13.6 24.3 6.4 10.0 10.6 14.1 4.9 10.3 12.6 19.1 9.2 17.4 12.9 11.8 12.1 8.5 12.8 10.9 8.7 11.3 5.7 15.2 6.5 7.1 5.8 8.4 5.2 6.3 4.2 4.1 7.1 6.1 9.7 6.6 6.9 4.7 5.1 3.6 20.5 31.2 24.0 40.2 26.3 20.8 24.1 21.4 54.1 11.9 NAT16 "C7orf52, FLJ39237" ENSG00000167011 "N-acetyltransferase 16 (putative)" Q8N8M0 7 101170493-101180276 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6" "Cell line enhanced" "Detected in some" "RPMI-8226: 4.5;SH-SY5Y: 6.8;SK-MEL-30: 5.0;U-2 OS: 5.9;U-87 MG: 3.4" "Cancer enhanced" "Detected in some" "melanoma: 2.1" "Group enriched" "Detected in many" 4 "amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA021918 Uncertain Approved Nucleoplasm Nucleoplasm "HPA021918: AB_1848922" "unprognostic (4.32e-2)" "unprognostic (1.75e-1)" "unprognostic (2.69e-3)" "unprognostic (4.58e-3)" "unprognostic (2.93e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" "unprognostic (1.40e-2)" "unprognostic (2.25e-3)" "unprognostic (2.35e-2)" "unprognostic (4.23e-2)" "unprognostic (2.62e-2)" "unprognostic (5.53e-5)" "unprognostic (7.65e-2)" "unprognostic (2.48e-1)" "unprognostic (5.02e-5)" "unprognostic (1.59e-1)" 0.2 0.4 3.1 0.2 9.1 0.7 0.1 0.4 8.2 0.1 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.1 0.1 0.9 4.8 0.1 0.5 0.1 0.2 0.7 0.6 0.1 6.0 0.2 5.8 0.1 0.8 0.2 0.3 0.5 0.3 0.1 0.3 0.4 0.2 0.2 0.4 0.3 1.2 0.4 1.2 0.0 4.6 0.0 0.0 0.1 0.0 1.2 0.7 2.2 0.6 1.3 0.8 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.1 0.0 0.0 1.3 0.5 0.5 0.1 0.1 0.8 0.6 0.2 0.1 4.5 0.0 0.4 0.1 6.8 0.0 0.3 5.0 0.3 0.0 0.0 0.4 5.9 0.5 0.1 0.1 0.0 0.1 3.4 0.0 1.6 0.4 0.6 0.3 0.3 0.4 0.3 0.2 0.2 0.1 0.2 1.2 0.8 0.4 2.2 1.3 0.3 0.7 0.3 0.0 3.1 9.1 0.4 2.9 0.9 4.8 0.7 0.6 0.8 1.2 NAT8L "FLJ37478, Hcml3" ENSG00000185818 "N-acetyltransferase 8 like" Q8N9F0 4 2059512-2069089 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 45.9;brain: 45.9;testis: 11.8" "Cell line enhanced" "Detected in many" "NB-4: 14.4;SCLC-21H: 18.6;SK-MEL-30: 14.8" "Group enriched" "Detected in many" 6 "endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 3.8" "Lineage enriched" "Detected in single" 28 "dendritic cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040677 Approved Mitochondria Mitochondria "HPA040677: AB_10794745" "unprognostic (1.32e-2)" "unprognostic (8.62e-2)" "unprognostic (3.02e-3)" "prognostic unfavourable (1.01e-5)" "unprognostic (2.56e-1)" "unprognostic (2.63e-4)" "unprognostic (6.58e-2)" "unprognostic (1.79e-1)" "unprognostic (2.90e-2)" "unprognostic (4.54e-1)" "unprognostic (3.70e-2)" "unprognostic (7.06e-2)" "unprognostic (1.78e-3)" "unprognostic (7.24e-3)" "unprognostic (1.14e-2)" "unprognostic (2.10e-2)" "unprognostic (1.35e-2)" 45.9 2.0 23.5 1.3 28.3 1.2 7.9 16.4 45.9 1.2 1.5 7.4 0.3 1.3 1.6 2.8 1.3 2.4 1.3 2.1 20.8 12.9 8.2 1.2 1.2 1.4 16.4 12.6 1.4 3.9 1.2 5.6 1.3 12.8 2.4 1.3 1.2 3.8 3.2 7.3 2.4 1.5 1.4 6.5 1.5 1.6 11.8 8.2 0.0 1.6 0.0 1.2 1.2 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 6.5 3.6 7.2 0.7 0.0 4.1 0.1 0.0 0.2 0.0 2.9 0.2 0.0 1.3 0.0 0.1 8.0 0.0 0.1 0.0 9.4 0.1 1.4 4.6 1.2 9.9 4.9 0.0 0.1 0.0 0.0 0.0 7.7 0.0 0.2 4.3 0.1 14.4 10.1 2.9 0.5 1.7 0.2 0.1 0.3 18.6 6.2 4.7 0.0 14.8 0.5 5.8 0.0 0.0 2.4 0.1 3.8 0.0 0.0 0.1 0.0 4.2 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 23.5 28.3 16.4 32.7 20.8 12.9 16.4 12.6 12.8 8.2 NAV3 "KIAA0938, POMFIL1" ENSG00000067798 "Neuron navigator 3" Q8IVL0 12 77324641-78213008 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.2;ovary: 29.6" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 23.4;THP-1: 20.5;U-138 MG: 15.7;WM-115: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 3.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA032111, HPA061392" Approved Approved "Nuclear membrane,Cytosol" "Nuclear membrane" Cytosol "HPA032111: AB_10603881, HPA061392: " "unprognostic (3.51e-1)" "unprognostic (6.72e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (8.98e-2)" "unprognostic (2.14e-1)" "unprognostic (2.78e-1)" "unprognostic (3.25e-2)" "unprognostic (3.03e-2)" "unprognostic (2.06e-2)" "unprognostic (2.99e-1)" "unprognostic (1.90e-1)" "unprognostic (5.68e-7)" "unprognostic (6.86e-3)" "unprognostic (1.23e-1)" "unprognostic (1.58e-2)" "unprognostic (2.29e-3)" 6.2 8.5 17.8 2.4 14.2 1.5 7.1 14.7 25.2 2.8 2.1 9.7 2.6 1.2 4.1 5.8 3.8 3.6 8.6 3.7 14.2 7.5 1.4 2.3 3.8 1.6 7.8 13.0 29.6 1.4 2.2 9.3 4.3 7.1 4.5 2.0 12.3 2.2 5.1 2.6 4.1 1.3 4.6 10.6 12.7 1.6 5.0 8.3 0.0 1.7 0.0 1.4 3.9 2.3 0.3 0.1 3.8 0.2 0.1 0.0 0.0 1.8 4.3 0.3 0.1 4.5 9.3 0.1 13.1 10.3 5.4 2.8 1.2 0.3 0.1 1.0 10.5 1.4 3.8 2.0 9.6 0.0 0.0 0.0 1.8 0.1 3.5 0.0 0.1 3.4 0.0 23.4 5.9 8.0 0.0 0.0 13.2 0.1 0.0 5.9 1.5 1.2 0.6 1.1 0.0 0.9 0.0 0.3 0.0 0.9 0.1 1.8 0.0 20.5 6.9 15.7 4.4 6.7 9.0 0.7 0.0 0.4 4.7 0.2 19.4 1.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.8 0.1 0.2 0.1 0.0 0.0 17.8 14.2 14.7 20.5 14.2 7.5 7.8 13.0 7.1 8.3 NCALD ENSG00000104490 "Neurocalcin delta" P61601 8 101686543-102124907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 57.2;salivary gland: 48.5" "Group enriched" "Detected in some" 4 "AF22: 43.5;HDLM-2: 53.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 32.8" "Group enriched" "Detected in many" 13 "NK-cells: 32.8;T-cells: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043245 Approved "HPA043245: " "unprognostic (3.49e-1)" "unprognostic (1.55e-1)" "unprognostic (4.85e-2)" "unprognostic (4.97e-2)" "unprognostic (5.48e-3)" "unprognostic (2.60e-3)" "unprognostic (1.25e-1)" "unprognostic (5.63e-3)" "unprognostic (1.54e-1)" "unprognostic (2.48e-1)" "prognostic favourable (5.30e-4)" "unprognostic (2.79e-1)" "unprognostic (6.24e-2)" "unprognostic (9.16e-3)" "unprognostic (1.55e-1)" "unprognostic (7.87e-2)" "unprognostic (1.00e-2)" 9.6 3.4 21.2 5.6 26.8 0.7 21.2 2.7 57.2 6.9 8.8 7.3 1.3 2.7 3.7 2.0 6.1 18.6 5.8 5.1 25.1 16.4 7.0 7.0 9.4 5.6 7.2 18.4 18.2 4.3 0.6 6.6 4.6 7.8 5.9 4.2 20.8 48.5 7.4 6.4 7.3 4.6 5.7 4.4 3.6 5.7 3.4 2.8 0.3 2.6 3.1 4.9 5.4 2.1 0.3 1.9 0.5 0.1 32.8 17.1 4.6 2.1 3.1 43.5 0.2 0.3 7.6 0.0 0.7 0.1 0.0 0.0 0.0 0.0 2.7 0.9 3.2 0.0 0.3 0.0 0.0 53.7 0.3 0.2 0.0 0.1 0.0 1.8 0.3 1.4 0.0 0.1 0.0 0.0 0.0 6.3 0.2 0.0 0.3 0.7 0.5 0.0 1.0 0.0 0.0 7.1 0.1 0.2 4.2 0.0 1.0 1.8 0.3 1.5 0.0 0.6 0.1 0.0 0.1 11.8 1.7 0.0 0.1 0.0 0.7 0.1 0.1 0.1 17.1 0.1 15.4 0.3 6.6 10.1 1.9 0.2 1.6 8.5 0.5 32.8 0.1 0.1 6.5 4.6 21.2 26.8 2.7 57.2 25.1 16.4 7.2 18.4 7.8 2.8 NCAM1 "CD56, NCAM" ENSG00000149294 "Neural cell adhesion molecule 1" P13591 11 112961247-113278436 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 110.6;heart muscle: 67.7" "Cell line enhanced" "Detected in some" "HEL: 19.1;RH-30: 43.1;SCLC-21H: 35.1;SH-SY5Y: 17.2;U-138 MG: 24.0;WM-115: 25.4" "Cancer enriched" "Detected in many" 8 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 14 "NK-cell: 27.2" "Lineage enriched" "Detected in many" 14 "NK-cells: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000142, CAB018071, HPA039835" Enhanced Enhanced "Plasma membrane,Cytosol" "Intracellular and membrane" 2800000000 "Plasma membrane" Cytosol "CAB000142: , CAB018071: AB_627129, HPA039835: " "unprognostic (7.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.77e-2)" "unprognostic (2.18e-2)" "unprognostic (2.91e-1)" "unprognostic (1.74e-3)" "unprognostic (2.82e-1)" "unprognostic (4.42e-3)" "unprognostic (2.13e-1)" "unprognostic (1.63e-2)" "prognostic favourable (9.11e-6)" "unprognostic (8.13e-2)" "prognostic unfavourable (8.20e-4)" "unprognostic (2.97e-2)" "unprognostic (2.24e-1)" "unprognostic (3.75e-2)" "unprognostic (5.82e-5)" 3.5 36.4 22.7 3.0 35.7 1.8 2.1 20.2 110.6 13.3 9.0 55.8 0.3 3.4 24.7 3.0 4.8 8.3 3.6 67.7 22.5 19.2 2.3 2.6 2.0 1.7 45.0 27.1 21.9 2.3 1.1 9.1 1.4 38.8 8.4 4.6 5.5 2.5 10.9 14.6 1.8 5.3 25.6 27.6 3.4 6.7 2.9 39.2 0.0 16.9 0.7 1.7 7.0 6.5 0.0 0.0 0.4 0.1 27.2 2.0 0.9 0.0 0.0 6.7 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.4 0.1 0.1 0.9 6.0 6.3 0.1 0.0 0.0 0.0 0.1 3.8 19.1 0.0 0.0 0.7 0.0 3.1 4.1 0.0 0.0 6.1 0.0 0.0 0.3 6.7 0.0 0.0 1.6 0.5 0.1 0.0 43.1 3.1 0.0 0.0 35.1 17.2 0.0 0.1 0.0 0.0 0.2 0.0 24.0 11.2 0.1 10.0 0.0 0.1 0.0 2.7 9.0 25.4 0.0 0.1 0.0 2.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.4 27.2 0.0 0.0 0.1 0.9 22.7 35.7 20.2 41.6 22.5 19.2 45.0 27.1 38.8 39.2 NCAM2 "MGC51008, NCAM21" ENSG00000154654 "Neural cell adhesion molecule 2" O15394 21 20998315-21543329 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 15.9;brain: 52.7" "Cell line enriched" "Detected in some" 4 "T-47d: 44.1" "Cancer enhanced" "Detected in some" "glioma: 5.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030900, HPA030901" Enhanced Supported Supported "Nuclear bodies,Plasma membrane" 100000000 "Nuclear bodies, Plasma membrane" "HPA030900: AB_10602037, HPA030901: " "unprognostic (9.70e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (2.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.81e-1)" "unprognostic (1.37e-2)" "unprognostic (3.01e-2)" "unprognostic (5.90e-2)" "unprognostic (1.62e-1)" "unprognostic (1.31e-1)" "unprognostic (5.61e-1)" "unprognostic (3.07e-4)" "unprognostic (2.47e-4)" "unprognostic (1.62e-1)" "unprognostic (8.05e-2)" "unprognostic (1.35e-3)" 2.0 15.9 25.8 2.0 22.3 1.1 3.1 7.0 52.7 3.3 2.1 14.7 0.0 1.3 2.3 1.8 1.7 1.8 2.6 3.1 18.7 13.9 1.3 9.1 4.4 1.2 21.6 19.4 1.4 1.3 1.1 1.0 1.7 17.9 2.2 2.4 0.5 1.8 2.3 1.5 2.0 1.9 2.7 17.3 2.0 1.3 8.3 26.6 0.0 1.5 0.0 1.3 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.6 0.0 1.1 0.0 0.0 5.6 0.0 1.7 0.0 0.0 5.1 1.1 0.1 7.1 0.1 0.0 0.2 0.0 0.5 0.0 2.1 0.0 0.0 0.0 2.6 0.0 0.3 0.3 44.1 3.3 0.0 0.6 0.4 0.0 0.0 0.3 0.0 0.0 1.2 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 22.3 7.0 22.4 18.7 13.9 21.6 19.4 17.9 26.6 NCAN CSPG3 ENSG00000130287 Neurocan O14594 19 19211973-19252233 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 48 "brain: 88.4" "Cell line enhanced" "Detected in some" "AF22: 2.9;SCLC-21H: 6.3;SH-SY5Y: 4.4" "Cancer enriched" "Detected in some" 57 "glioma: 71.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036814 Enhanced "Secreted in brain" 340000 "HPA036814: AB_10673666" "unprognostic (1.02e-2)" "unprognostic (2.84e-3)" "unprognostic (1.92e-1)" "unprognostic (1.56e-2)" "unprognostic (2.35e-2)" "unprognostic (1.65e-2)" "unprognostic (1.70e-2)" "unprognostic (1.03e-3)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "unprognostic (4.58e-3)" "unprognostic (4.38e-2)" "unprognostic (9.09e-6)" "unprognostic (1.10e-2)" "unprognostic (2.79e-2)" "unprognostic (2.91e-1)" "unprognostic (2.58e-2)" 1.1 1.2 21.2 1.1 23.2 1.1 1.1 5.4 88.4 1.1 1.1 12.9 0.0 1.1 1.1 1.1 1.1 1.1 1.1 1.1 16.8 8.3 1.1 1.2 1.1 1.1 7.8 15.2 1.1 1.1 1.1 0.1 1.1 12.3 1.1 1.1 0.0 1.2 1.1 1.1 1.1 1.1 1.1 4.0 1.1 1.1 1.8 5.6 0.0 1.1 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 6.3 4.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 23.2 5.4 22.8 16.8 8.3 7.8 15.2 12.3 5.6 NCDN "NCDN-1, NCDN-2" ENSG00000020129 Neurochondrin Q9UBB6 1 35557473-35567274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 144.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023676 Enhanced Supported Supported Cytosol Cytosol "HPA023676: AB_1854325" "unprognostic (1.15e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (2.39e-1)" "prognostic unfavourable (1.91e-5)" "unprognostic (4.66e-2)" "unprognostic (1.41e-1)" "unprognostic (4.36e-2)" "prognostic favourable (3.73e-4)" "unprognostic (5.91e-3)" "unprognostic (5.34e-3)" "unprognostic (5.88e-3)" "unprognostic (2.87e-1)" "unprognostic (3.24e-2)" "unprognostic (2.23e-2)" 5.2 11.3 33.4 6.0 144.3 3.4 3.6 28.7 104.9 9.9 3.5 8.7 1.2 3.9 6.2 4.8 4.5 8.1 6.5 12.0 45.4 25.0 4.0 2.5 4.5 5.9 15.8 32.3 9.2 6.1 6.2 5.5 4.7 26.4 7.1 2.9 3.6 6.7 8.0 5.3 5.6 3.2 6.5 10.7 5.0 4.7 5.8 15.6 0.8 6.5 0.6 4.6 6.0 2.4 5.9 2.7 0.8 4.5 3.0 6.5 5.5 8.7 10.6 8.9 14.0 12.9 16.0 6.1 11.6 12.1 12.2 9.8 10.6 13.0 10.0 11.3 10.7 13.5 8.7 14.1 4.5 9.7 18.0 12.4 15.6 5.4 17.9 11.2 14.3 15.3 11.8 21.6 8.7 6.5 13.4 16.0 9.9 15.7 10.2 7.2 39.9 18.7 8.4 4.9 12.9 8.2 9.8 11.1 16.0 13.2 12.2 16.3 11.7 7.4 8.8 15.6 11.2 11.4 15.8 22.6 15.9 7.4 19.4 18.0 14.2 0.0 4.5 0.8 3.1 2.6 3.8 5.9 4.8 4.8 2.7 2.7 6.5 5.3 0.7 3.0 4.2 1.6 2.7 5.5 33.4 144.3 28.7 61.4 45.4 25.0 15.8 32.3 26.4 15.6 NCEH1 "AADACL1, KIAA1363, NCEH" ENSG00000144959 "Neutral cholesterol ester hydrolase 1" Q6PIU2 3 172630249-172711218 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 69.4;LHCN-M2: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 15.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026888, HPA043873" Enhanced Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA026888: AB_10601557, HPA043873: " "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (5.74e-2)" "unprognostic (1.27e-1)" "unprognostic (6.88e-3)" "unprognostic (5.41e-2)" "unprognostic (3.29e-2)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (1.87e-2)" "prognostic unfavourable (8.25e-5)" "unprognostic (5.29e-2)" "unprognostic (2.96e-2)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (2.81e-2)" "unprognostic (2.28e-1)" 17.0 14.8 6.5 7.1 23.8 6.0 5.1 14.3 30.1 4.1 9.8 2.3 1.4 3.5 3.9 2.9 4.4 3.5 6.0 14.6 13.2 9.6 18.8 4.2 17.0 11.2 6.6 11.4 2.5 4.0 6.3 4.2 5.7 17.7 6.0 10.7 4.3 8.2 4.2 6.6 2.7 4.1 2.9 5.0 9.1 10.9 2.0 4.0 1.9 3.9 3.1 9.3 5.1 3.4 3.0 10.6 4.8 15.1 2.8 2.3 4.8 22.8 13.3 0.4 0.7 0.8 0.8 1.9 17.2 11.5 11.4 6.7 3.3 69.4 1.9 26.0 10.4 4.6 0.4 8.4 26.7 6.4 1.0 1.3 2.1 2.5 0.9 3.4 4.8 0.4 0.8 7.8 11.8 7.6 0.3 1.6 32.4 1.9 0.5 1.2 0.6 10.9 0.5 1.3 2.3 20.4 3.1 0.3 0.1 10.4 11.0 2.3 3.7 1.6 20.7 17.6 2.6 8.2 31.2 2.0 3.7 1.6 13.1 3.3 13.3 4.8 15.1 0.5 2.3 9.6 1.5 3.0 1.5 1.6 10.6 1.9 1.5 1.8 0.5 2.8 6.2 0.6 1.3 4.8 6.5 23.8 14.3 30.1 13.2 9.6 6.6 11.4 17.7 4.0 NCKIPSD "AF3P21, DIP1, ORF1, SPIN90, WASLBP, WISH" ENSG00000213672 "NCK interacting protein with SH3 domain" Q9NZQ3 3 48673844-48686364 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 39.6;parathyroid gland: 123.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019267, HPA050005" Enhanced "Plasma membrane" 42000 "Plasma membrane" "CAB019267: , HPA050005: " "unprognostic (1.55e-2)" "unprognostic (2.02e-1)" "unprognostic (2.15e-1)" "unprognostic (1.79e-1)" "unprognostic (9.64e-3)" "unprognostic (5.50e-3)" "prognostic unfavourable (8.57e-4)" "unprognostic (1.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (2.40e-2)" "unprognostic (1.23e-1)" "prognostic favourable (1.20e-5)" "unprognostic (1.60e-2)" "unprognostic (1.55e-1)" "unprognostic (3.73e-2)" "unprognostic (2.09e-2)" 11.7 11.9 14.4 4.9 18.5 4.4 7.8 17.9 39.6 7.0 7.9 10.3 3.5 7.3 7.8 8.6 7.8 9.6 9.3 17.8 12.9 16.0 8.7 6.8 7.4 5.9 11.1 17.8 17.7 8.5 123.9 10.0 8.0 16.9 8.1 7.4 9.6 8.9 11.7 6.4 9.8 7.3 8.7 9.2 5.7 6.2 8.4 10.9 2.9 7.7 1.9 5.4 7.7 6.5 4.9 8.5 1.0 5.3 4.8 6.4 4.7 11.6 10.2 10.5 10.7 14.3 8.7 14.6 11.7 13.1 13.0 16.6 15.1 7.1 8.6 6.4 6.9 7.9 13.3 15.5 7.5 9.6 16.3 15.4 38.1 11.9 12.5 10.4 17.4 8.3 13.5 18.0 11.3 7.3 5.2 11.5 10.4 8.6 9.4 8.8 12.1 18.2 4.8 4.8 14.4 7.1 12.0 11.0 8.9 12.2 11.5 9.8 10.2 12.7 4.1 11.3 12.7 13.3 15.4 10.4 7.6 9.6 12.8 13.9 17.2 1.0 4.6 0.2 3.5 5.3 2.6 4.9 4.2 4.1 5.8 2.6 6.4 4.1 0.3 4.8 2.8 8.5 4.6 4.7 14.4 18.5 17.9 39.6 12.9 16.0 11.1 17.8 16.9 10.9 NCR3LG1 "B7-H6, DKFZp686O24166" ENSG00000188211 "Natural killer cell cytotoxicity receptor 3 ligand 1" Q68D85 11 17351726-17377341 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9;parathyroid gland: 15.4" "Cell line enhanced" "Detected in many" "HL-60: 28.8;K-562: 16.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.5" "Lineage enriched" "Detected in single" 4 "T-cells: 2.5" HPA024137 Uncertain 7300 "HPA024137: AB_1859534" "unprognostic (1.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.52e-2)" "unprognostic (1.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.05e-1)" "unprognostic (7.03e-5)" "unprognostic (6.24e-2)" "unprognostic (1.09e-1)" "unprognostic (3.59e-1)" "unprognostic (2.62e-1)" "unprognostic (2.36e-1)" "prognostic favourable (4.21e-12)" "unprognostic (7.88e-3)" "unprognostic (1.72e-1)" "unprognostic (3.52e-3)" "unprognostic (1.36e-1)" 2.4 1.4 1.6 2.2 9.4 3.1 1.4 14.9 14.1 1.7 6.2 1.1 0.0 8.1 2.1 1.1 2.0 3.5 2.4 2.4 1.9 2.9 5.0 1.3 2.7 1.1 1.5 5.3 3.2 2.2 15.4 7.9 0.9 4.3 1.5 9.6 3.6 2.0 1.4 1.2 2.0 10.1 2.1 1.2 1.3 2.4 4.2 0.4 0.4 4.9 1.0 1.4 1.6 2.1 0.0 0.3 0.0 0.6 0.0 2.5 0.1 2.1 0.7 4.9 0.7 1.7 4.7 0.3 1.5 2.9 2.1 5.1 3.9 0.8 12.2 0.2 1.7 2.2 8.0 2.0 1.7 2.1 13.3 11.1 5.1 3.9 7.2 28.8 0.5 3.8 1.0 3.0 7.3 2.3 16.3 0.0 0.7 0.2 2.7 2.5 0.2 1.2 0.9 2.6 0.1 1.7 0.7 5.3 2.0 1.7 0.4 1.5 1.2 6.4 3.3 0.4 0.7 1.2 0.8 1.3 2.4 14.1 2.2 9.7 1.0 0.0 0.6 0.0 0.6 0.3 2.5 0.0 0.1 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.1 1.6 9.4 14.9 14.1 1.9 2.9 1.5 5.3 4.3 0.4 NCS1 "FREQ, NCS-1" ENSG00000107130 "Neuronal calcium sensor 1" P62166 9 130172578-130237304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 76.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018587, HPA019713" Enhanced Supported Enhanced "Plasma membrane" "Plasma membrane" "CAB018587: AB_649907, HPA019713: AB_1854404" "prognostic unfavourable (5.40e-4)" "unprognostic (1.57e-1)" "unprognostic (4.64e-3)" "prognostic unfavourable (8.69e-4)" "unprognostic (1.29e-1)" "unprognostic (9.23e-2)" "prognostic unfavourable (1.11e-4)" "unprognostic (1.61e-3)" "unprognostic (4.27e-1)" "unprognostic (1.21e-2)" "unprognostic (8.45e-2)" "unprognostic (1.58e-1)" "unprognostic (3.71e-3)" "unprognostic (8.59e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (8.25e-4)" "unprognostic (1.65e-1)" 5.8 12.6 76.8 7.9 56.6 4.6 2.8 18.6 66.2 7.7 20.1 6.4 5.0 3.6 12.6 4.1 24.9 13.5 8.7 4.6 74.3 25.7 8.7 1.6 2.5 1.6 20.6 28.1 4.6 3.5 1.5 2.7 1.6 17.7 14.9 6.8 4.2 5.3 41.6 0.9 10.0 4.3 34.3 6.8 1.1 5.1 2.2 7.1 0.0 20.1 0.7 2.7 16.4 4.6 0.0 0.0 0.0 0.0 0.0 1.2 0.1 7.7 15.8 8.2 16.4 5.1 11.6 3.9 20.0 9.3 15.4 10.3 7.5 4.0 0.0 7.3 25.2 14.0 13.3 17.5 6.9 22.9 4.0 0.0 10.5 8.0 7.9 0.6 9.7 13.4 8.9 17.4 11.0 14.5 5.6 0.1 22.2 22.2 1.4 7.7 12.5 6.7 0.0 25.9 5.3 15.0 4.9 21.7 20.4 12.3 5.9 11.8 11.0 4.9 11.4 29.9 24.3 23.9 25.6 0.0 0.0 0.0 34.9 2.2 32.2 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 76.8 56.6 18.6 59.9 74.3 25.7 20.6 28.1 17.7 7.1 NDRG3 ENSG00000101079 "NDRG family member 3" Q9UGV2 20 36651766-36746078 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.1" "Cell line enhanced" "Detected in all" "SK-BR-3: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017851, HPA018256" Approved "HPA017851: AB_1854340, HPA018256: AB_1854341" "unprognostic (4.59e-2)" "unprognostic (9.38e-3)" "unprognostic (6.73e-2)" "unprognostic (1.34e-2)" "unprognostic (2.80e-1)" "unprognostic (9.27e-2)" "prognostic unfavourable (4.35e-4)" "unprognostic (1.56e-1)" "unprognostic (1.30e-2)" "unprognostic (5.42e-3)" "unprognostic (2.48e-3)" "unprognostic (3.52e-1)" "unprognostic (9.57e-2)" "unprognostic (2.66e-2)" "unprognostic (3.39e-1)" "unprognostic (3.98e-2)" "unprognostic (1.61e-1)" 6.4 16.6 24.6 6.7 31.9 3.6 9.5 62.1 59.7 12.2 8.9 11.3 6.4 9.6 11.7 8.5 8.8 10.1 8.0 15.5 26.2 22.2 9.6 4.0 8.5 8.4 20.3 19.8 14.8 6.6 18.5 14.3 5.8 62.1 29.5 11.3 11.3 8.4 9.4 9.3 8.7 8.3 12.8 15.6 8.9 6.9 33.1 12.6 4.3 8.0 5.2 10.6 8.0 6.8 10.5 8.7 11.3 8.5 21.2 14.7 7.9 17.7 10.1 13.2 7.8 14.0 15.4 4.3 7.5 9.1 12.8 12.7 19.4 9.3 9.1 8.8 15.2 16.7 17.0 26.4 14.6 6.8 12.6 25.3 14.3 21.5 7.4 6.6 8.0 14.4 15.3 10.9 3.2 16.1 9.8 19.6 11.3 6.6 9.0 9.2 3.9 17.7 7.9 20.8 6.6 15.1 8.3 11.8 10.1 11.6 51.5 11.2 23.9 5.8 7.0 12.5 8.2 5.0 9.3 9.2 7.6 5.8 23.4 11.5 6.6 5.1 5.4 11.3 13.9 7.4 14.6 10.5 14.7 13.2 8.7 7.6 12.6 13.0 8.5 21.2 8.5 4.4 14.0 7.9 24.6 31.9 62.1 59.7 26.2 22.2 20.3 19.8 62.1 12.6 NDRG4 "KIAA1180, SMAP-8" ENSG00000103034 "NDRG family member 4" Q9ULP0 16 58462846-58513628 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 59.2;brain: 134.1;heart muscle: 112.6" "Cell line enhanced" "Detected in many" "EFO-21: 19.0;HUVEC TERT2: 12.1;SCLC-21H: 28.7" "Cancer enriched" "Detected in many" 6 "glioma: 23.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015313, HPA017587" Enhanced Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA015313: AB_1854343, HPA017587: AB_1854344" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" "unprognostic (9.03e-3)" "unprognostic (1.59e-2)" "unprognostic (3.97e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (6.07e-2)" "unprognostic (1.02e-1)" "unprognostic (4.84e-3)" "unprognostic (5.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.22e-2)" "unprognostic (8.51e-2)" "unprognostic (4.45e-2)" "unprognostic (7.17e-2)" 3.6 59.2 28.7 2.9 49.4 1.6 2.3 65.4 134.1 3.8 3.5 11.0 15.6 3.4 10.2 5.1 10.0 3.9 3.4 112.6 30.5 32.0 2.3 1.9 6.5 3.4 33.7 35.4 2.1 2.6 10.8 11.6 2.6 81.2 2.1 3.2 8.7 2.9 18.2 5.3 3.9 3.2 8.7 11.7 11.7 2.6 19.9 7.4 0.0 2.6 0.3 3.5 2.7 8.0 1.5 0.1 0.2 0.0 0.1 0.9 0.2 0.1 9.6 9.2 1.8 0.2 1.7 0.7 3.0 4.7 1.4 0.9 3.6 2.5 0.2 19.0 2.3 0.8 0.7 0.5 1.3 0.0 1.9 0.4 1.6 2.6 2.6 0.1 0.1 2.1 0.2 0.9 0.0 12.1 0.1 0.1 1.3 2.4 0.9 0.1 0.8 7.1 0.2 2.5 0.2 0.4 6.0 28.7 10.8 0.3 0.8 0.1 0.3 0.1 4.3 1.2 3.6 0.3 0.4 0.5 0.2 3.1 6.6 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.2 28.7 49.4 65.4 63.4 30.5 32.0 33.7 35.4 81.2 7.4 NDST3 HSST3 ENSG00000164100 "N-deacetylase and N-sulfotransferase 3" O95803 4 118033618-118258648 "Enzymes, Predicted intracellular proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 22.2;lymphoid tissue: 6.8;pituitary gland: 7.6" "Cell line enriched" "Detected in single" 19 "MOLT-4: 18.7" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 17.0;cerebellum: 22.2;cerebral cortex: 5.7" "Cell type enhanced" "Detected in some" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056189 Uncertain "HPA056189: " "unprognostic (1.95e-2)" "unprognostic (7.58e-2)" "unprognostic (4.34e-3)" "unprognostic (2.55e-7)" "unprognostic (4.05e-2)" "unprognostic (2.18e-2)" "unprognostic (2.86e-3)" "unprognostic (2.32e-2)" "unprognostic (1.87e-1)" "unprognostic (1.46e-2)" "unprognostic (7.43e-2)" "unprognostic (1.99e-2)" "unprognostic (1.09e-3)" "unprognostic (1.37e-1)" "unprognostic (4.39e-3)" "unprognostic (6.83e-2)" "unprognostic (8.85e-2)" 0.3 2.0 3.2 0.3 17.0 0.6 0.3 22.2 6.9 2.1 0.4 0.0 0.0 0.3 0.4 0.2 0.3 1.3 0.4 0.3 2.3 2.0 0.9 4.6 0.4 0.6 0.9 1.7 0.6 0.2 0.2 7.6 0.4 1.7 0.5 0.4 1.3 0.2 1.2 0.3 0.4 0.4 0.4 0.6 6.8 1.0 0.5 2.4 6.8 0.6 0.0 0.4 0.3 0.3 0.3 0.4 1.3 0.2 0.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.9 1.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.3 0.4 0.1 0.4 0.0 0.0 3.2 17.0 22.2 5.7 2.3 2.0 0.9 1.7 1.7 2.4 NDST4 ENSG00000138653 "N-deacetylase and N-sulfotransferase 4" Q9H3R1 4 114827763-115113876 "Enzymes, Predicted intracellular proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 34.6" "Cell line enriched" "Detected in some" 4 "RH-30: 17.6" "Not detected" "Not detected" "Region enriched" "Detected in many" 17 "pons and medulla: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA011129 Uncertain "HPA011129: AB_1079460" "unprognostic (5.58e-2)" "unprognostic (5.90e-2)" "unprognostic (4.82e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-1)" "unprognostic (1.11e-1)" "unprognostic (1.94e-1)" "unprognostic (6.55e-2)" 0.1 0.0 1.3 0.0 1.7 0.0 0.1 0.2 3.4 1.4 0.3 0.3 0.3 0.1 1.5 0.0 0.1 0.1 0.3 0.1 0.7 1.9 0.1 0.0 0.1 0.0 1.3 1.4 5.7 0.1 0.0 0.6 0.0 34.6 1.5 0.1 0.0 0.5 0.6 0.1 0.2 0.1 1.6 1.0 2.5 1.1 0.7 0.0 0.0 0.1 0.1 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 0.2 1.7 0.7 1.9 1.3 1.4 34.6 0.0 NECAB1 EFCBP1 ENSG00000123119 "N-terminal EF-hand calcium binding protein 1" Q8N987 8 90791550-90959408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 56.4" "Cell line enhanced" "Detected in many" "HEL: 6.1;MOLT-4: 6.4;U-266/70: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210" Enhanced Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB068208: , CAB068209: , CAB068210: , HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815" "unprognostic (8.09e-3)" "unprognostic (3.78e-1)" "unprognostic (8.17e-3)" "unprognostic (5.96e-5)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-3)" "unprognostic (8.38e-2)" "unprognostic (1.78e-3)" "unprognostic (2.60e-1)" "unprognostic (2.25e-2)" "unprognostic (2.57e-2)" "unprognostic (2.19e-3)" "unprognostic (4.45e-3)" "unprognostic (1.68e-2)" "unprognostic (2.42e-3)" "unprognostic (5.39e-3)" 2.7 4.9 19.7 2.0 27.3 3.2 1.5 0.5 56.4 1.4 3.7 12.1 0.3 1.7 4.1 4.4 3.6 1.6 3.1 10.9 19.5 9.8 3.4 1.1 6.8 1.4 16.0 30.7 3.8 1.3 1.9 1.9 2.8 10.8 2.6 1.1 4.1 2.5 2.0 1.3 1.9 1.8 1.3 18.7 2.4 2.1 5.2 17.4 0.0 2.9 0.0 1.0 4.2 1.2 0.5 1.8 0.3 0.0 0.7 0.9 0.2 0.2 0.1 2.3 0.4 0.0 0.1 0.1 2.5 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.0 1.0 0.0 0.1 0.0 4.7 6.1 2.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 4.1 4.4 0.0 4.9 6.4 3.1 0.9 0.1 0.0 4.0 0.0 0.0 0.0 4.1 4.4 0.1 0.0 2.1 0.0 0.2 1.5 3.9 3.8 0.0 1.6 6.1 3.7 3.2 3.8 0.0 1.8 0.0 0.0 0.1 0.6 0.0 0.4 0.2 0.4 0.6 0.1 0.5 0.6 0.9 0.3 0.7 0.0 1.8 0.9 0.2 19.7 27.3 0.5 37.1 19.5 9.8 16.0 30.7 10.8 17.4 NECAB2 EFCBP2 ENSG00000103154 "N-terminal EF-hand calcium binding protein 2" Q7Z6G3 16 83968632-84002776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 30.6;brain: 42.5;kidney: 12.4;liver: 15.1" "Cell line enhanced" "Detected in some" "AF22: 7.5;SCLC-21H: 28.6;U-87 MG: 10.1" "Cancer enhanced" "Detected in many" "liver cancer: 7.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 68 "neutrophil: 30.6" "Lineage enriched" "Detected in single" 68 "granulocytes: 30.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA013998, HPA014144, CAB068211" Enhanced Supported "CAB068211: , HPA013998: AB_1848016, HPA014144: AB_1848017" "unprognostic (5.27e-2)" "unprognostic (1.14e-1)" "unprognostic (5.50e-2)" "unprognostic (3.48e-5)" "unprognostic (3.45e-2)" "unprognostic (4.20e-2)" "unprognostic (6.74e-2)" "unprognostic (8.79e-2)" "unprognostic (4.15e-1)" "unprognostic (2.59e-1)" "unprognostic (5.75e-3)" "unprognostic (2.14e-2)" "prognostic unfavourable (1.58e-4)" "unprognostic (8.89e-3)" "unprognostic (3.48e-1)" "unprognostic (8.61e-3)" "unprognostic (3.75e-2)" 1.8 1.1 34.1 1.3 42.5 1.3 0.9 0.2 35.2 0.7 1.1 2.2 0.0 1.9 2.2 0.9 0.7 0.7 1.3 1.0 9.5 21.7 12.4 15.1 1.0 0.8 5.0 14.0 0.7 2.1 1.6 3.3 0.9 7.4 0.8 0.9 0.1 0.6 0.8 0.5 0.7 1.7 1.2 1.9 1.1 2.8 5.4 5.9 0.0 0.8 0.0 0.5 1.1 0.0 0.0 0.0 30.6 0.4 0.0 0.0 0.0 0.1 3.7 7.5 0.0 0.0 1.0 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.0 1.2 0.1 0.0 1.3 0.0 0.0 0.0 2.1 0.0 0.0 0.3 0.1 0.0 1.2 0.4 0.1 0.2 0.2 0.1 0.1 0.1 0.0 4.3 0.0 0.0 3.9 0.5 0.0 0.0 0.4 0.0 0.0 28.6 1.2 0.0 0.1 2.2 3.8 1.3 0.2 0.1 2.2 0.3 0.0 0.1 0.0 0.0 10.1 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 34.1 42.5 0.2 21.2 9.5 21.7 5.0 14.0 7.4 5.9 NECAP1 DKFZP566B183 ENSG00000089818 "NECAP endocytosis associated 1" Q8NC96 12 8076939-8097859 "Disease related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053980, HPA063300" Uncertain Approved Vesicles,Cytosol Vesicles Cytosol "HPA053980: , HPA063300: " "unprognostic (1.73e-2)" "unprognostic (6.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-3)" "unprognostic (1.03e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (5.79e-3)" "unprognostic (5.72e-3)" "unprognostic (1.03e-1)" "unprognostic (1.72e-2)" "unprognostic (1.89e-2)" "unprognostic (2.64e-1)" "unprognostic (2.06e-1)" "unprognostic (5.94e-2)" 7.5 19.1 25.5 9.2 34.1 6.5 10.5 45.9 53.2 11.9 13.1 9.6 5.1 12.1 8.4 8.1 9.3 12.0 7.8 9.4 27.6 36.8 12.5 11.1 8.5 6.0 19.2 22.1 13.1 17.4 16.3 17.9 11.6 32.5 12.7 13.3 11.1 10.9 10.1 5.0 5.9 11.8 9.0 9.6 7.0 12.0 10.0 7.5 5.3 9.6 4.4 8.0 8.9 5.8 7.0 8.9 25.4 14.3 6.8 12.0 8.5 10.7 9.7 7.1 9.7 16.3 12.4 15.8 23.1 14.0 19.4 19.5 21.0 12.3 5.5 4.0 11.0 7.5 18.8 12.1 16.6 14.7 14.8 6.0 12.5 10.5 14.8 5.6 17.6 15.8 14.7 21.3 26.6 14.0 13.8 8.1 20.5 13.1 9.4 1.8 19.1 9.0 3.7 17.0 5.1 13.4 16.2 11.3 8.8 11.4 16.3 9.0 5.5 4.9 13.6 9.4 18.9 11.0 15.9 5.4 9.4 11.1 16.4 6.2 13.7 18.5 11.5 25.4 8.4 11.5 9.4 6.6 7.9 8.6 8.9 7.0 9.5 8.8 18.8 6.8 14.3 4.8 12.0 8.5 25.5 34.1 45.9 47.0 27.6 36.8 19.2 22.1 32.5 7.5 NEFH ENSG00000100285 "Neurofilament heavy" P12036 22 29480230-29491390 "Disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 87.6;prostate: 116.0" "Cell line enriched" "Detected in some" 5 "SiHa: 61.9" "Group enriched" "Detected in many" 7 "prostate cancer: 130.0;testis cancer: 31.8" "Region enhanced" "Detected in many" "pons and medulla: 87.6" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.4" "Lineage enriched" "Detected in many" 5 "monocytes: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007786, HPA061615" Enhanced "CAB007786: AB_598179, HPA061615: " "prognostic favourable (2.33e-6)" "unprognostic (6.17e-3)" "unprognostic (9.74e-2)" "unprognostic (3.20e-2)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (2.63e-4)" "unprognostic (2.95e-2)" "unprognostic (1.68e-1)" "unprognostic (6.42e-2)" "unprognostic (5.85e-2)" "unprognostic (6.64e-3)" "unprognostic (1.57e-3)" "unprognostic (1.54e-1)" "unprognostic (2.59e-1)" "unprognostic (1.31e-2)" "unprognostic (1.47e-1)" 1.0 8.4 3.3 1.4 5.4 1.0 1.4 7.1 31.6 0.9 0.9 2.2 0.0 0.9 1.0 1.1 0.8 0.8 0.9 0.8 8.3 17.1 1.2 0.9 0.9 1.1 34.8 2.3 10.0 0.8 0.8 3.9 1.0 87.6 116.0 1.0 4.0 1.1 1.0 0.8 0.8 1.0 1.2 17.9 1.2 0.8 3.6 0.1 0.0 0.8 0.0 1.2 0.8 0.0 0.2 1.1 0.0 7.4 0.4 1.6 1.2 0.0 0.0 0.8 0.2 0.0 0.1 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 2.9 11.7 0.0 8.6 0.0 0.5 0.0 3.6 1.2 0.0 0.1 0.0 0.4 9.1 0.0 4.0 0.0 3.9 0.4 6.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 6.8 61.9 0.0 0.0 0.0 3.3 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.8 4.8 1.6 0.2 0.9 0.7 1.1 0.1 0.3 1.0 0.0 0.4 7.4 0.3 0.4 1.2 3.3 5.4 7.1 31.6 8.3 17.1 34.8 2.3 87.6 0.1 NEFL "CMT1F, CMT2E, NF68, NFL, PPP1R110" ENSG00000277586 "Neurofilament light" P07196 8 24950955-24957110 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.1" "Group enriched" "Detected in some" 5 "HEK 293: 112.2;PC-3: 30.1" "Cancer enhanced" "Detected in many" "renal cancer: 24.0" "Cell type enriched" "Detected in some" 5 "memory CD4 T-cell: 13.7" "Lineage enriched" "Detected in single" 138 "T-cells: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014850, HPA015021" Enhanced Supported Approved "Nuclear speckles,Intermediate filaments" "Nuclear speckles" "Intermediate filaments" "HPA014850: AB_1854397, HPA015021: " "unprognostic (7.63e-2)" "unprognostic (1.36e-2)" "unprognostic (9.53e-2)" "unprognostic (6.81e-2)" "unprognostic (2.82e-2)" "unprognostic (6.69e-2)" "unprognostic (3.69e-2)" "unprognostic (3.78e-3)" "unprognostic (3.06e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic unfavourable (4.91e-4)" "unprognostic (5.76e-3)" "unprognostic (7.88e-2)" "unprognostic (3.97e-3)" "unprognostic (3.17e-3)" 0.7 12.0 10.3 1.4 20.1 0.6 0.6 2.3 92.1 1.8 1.8 3.0 0.0 1.0 0.7 0.8 3.8 0.7 0.6 0.6 14.1 3.5 0.6 0.6 0.7 0.0 23.8 0.7 0.7 0.6 0.0 0.6 95.1 1.6 1.5 5.0 0.6 9.5 0.6 0.7 1.7 1.2 18.0 0.7 1.1 1.6 2.1 0.0 1.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 13.7 2.1 0.0 0.1 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 112.2 0.0 0.0 0.0 4.9 0.0 0.1 1.8 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.8 30.1 0.0 0.0 0.0 6.9 1.0 6.2 6.4 2.6 0.0 0.4 0.0 0.0 0.0 0.6 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.7 1.5 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.2 2.1 NEFM "NEF3, NF-M, NFM" ENSG00000104722 "Neurofilament medium" P07197 8 24913012-24919098 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 144.7" "Cell line enriched" "Detected in some" 23 "HEK 293: 286.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "MAIT T-cell: 1.0;memory CD4 T-cell: 1.0;naive CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010900, CAB012976, HPA022845, HPA023138" Enhanced Enhanced "Intermediate filaments" "Intermediate filaments" "CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398" "unprognostic (1.41e-2)" "unprognostic (1.83e-1)" "unprognostic (2.59e-2)" "unprognostic (9.38e-2)" "unprognostic (5.17e-2)" "unprognostic (6.32e-3)" "unprognostic (6.10e-3)" "unprognostic (2.57e-1)" "unprognostic (8.55e-3)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (4.76e-2)" "unprognostic (2.61e-2)" 1.5 18.9 20.3 2.0 24.2 1.3 1.3 10.9 87.6 9.7 2.0 5.6 0.0 1.3 3.8 1.3 4.7 1.3 1.4 1.3 36.1 25.0 2.2 1.2 1.3 1.3 52.2 22.4 2.0 2.5 1.2 3.3 1.4 144.7 2.5 1.9 3.4 1.3 26.9 1.9 1.3 1.5 3.3 26.7 1.3 1.5 12.4 4.9 0.0 1.3 0.0 1.6 1.3 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 286.0 0.0 0.0 0.0 6.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.3 24.2 10.9 71.9 36.1 25.0 52.2 22.4 144.7 4.9 NEGR1 "IGLON4, KILON, MGC46680, Ntra" ENSG00000172260 "Neuronal growth regulator 1" Q7Z3B1 1 71395940-72282734 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.5" "Cell line enhanced" "Detected in many" "ASC diff: 15.8;TIME: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.1;plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011894 Uncertain Approved "Vesicles,Actin filaments,Cytosol" 390000000 "Vesicles, Actin filaments, Cytosol" "HPA011894: AB_1854363" "unprognostic (2.60e-1)" "unprognostic (1.89e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (7.99e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.94e-2)" "unprognostic (8.15e-2)" "unprognostic (8.73e-2)" "unprognostic (3.38e-2)" "unprognostic (1.36e-1)" "unprognostic (3.31e-5)" "unprognostic (5.89e-3)" "unprognostic (1.31e-1)" "unprognostic (1.43e-3)" "unprognostic (2.11e-4)" 17.5 7.8 18.1 7.6 16.3 2.2 7.3 24.1 41.5 8.0 14.7 2.6 2.4 3.8 7.1 5.9 13.6 5.9 13.5 10.7 11.2 14.8 8.8 1.1 5.4 2.4 8.7 26.3 8.4 6.0 1.5 4.6 4.1 5.9 9.9 10.3 3.2 3.6 7.6 5.9 5.5 6.3 25.5 10.2 1.5 7.6 4.4 3.0 0.3 3.8 1.5 1.6 20.1 9.1 0.5 3.3 1.1 0.4 0.4 0.4 0.1 0.2 0.1 0.4 0.2 15.8 12.5 0.1 11.0 4.1 6.1 7.4 0.1 0.1 0.2 0.1 12.1 0.3 0.0 0.0 13.2 0.2 0.1 0.1 2.2 0.1 1.3 0.2 0.3 6.0 0.0 5.1 0.9 7.1 0.1 0.5 11.2 0.1 0.1 0.2 1.8 6.3 7.6 11.8 0.2 1.0 0.2 0.8 1.0 3.8 0.1 0.1 0.1 0.2 16.1 1.3 13.4 0.6 13.6 0.3 0.2 0.1 3.0 7.3 4.7 1.1 0.4 0.3 0.4 0.2 0.3 0.3 0.3 0.3 3.1 0.5 0.3 0.3 0.8 0.4 0.4 3.3 0.2 0.1 18.1 16.3 24.1 31.8 11.2 14.8 8.7 26.3 5.9 3.0 NEK5 ENSG00000197168 "NIMA related kinase 5" Q6P3R8 13 52033611-52129078 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 11.8;fallopian tube: 12.7;testis: 15.7" "Cell line enhanced" "Detected in some" "T-47d: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035565, HPA041399" Enhanced "HPA035565: AB_10672095, HPA041399: " "unprognostic (4.14e-2)" "unprognostic (1.49e-1)" "unprognostic (1.89e-1)" "unprognostic (5.80e-3)" "unprognostic (2.80e-2)" "unprognostic (2.47e-1)" "unprognostic (3.57e-2)" "unprognostic (6.50e-2)" "unprognostic (8.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.37e-2)" "unprognostic (2.94e-1)" "unprognostic (2.06e-3)" "unprognostic (1.83e-3)" "unprognostic (1.10e-1)" "unprognostic (1.19e-3)" "unprognostic (9.44e-3)" 0.6 0.3 3.2 1.4 3.2 0.7 0.9 0.4 2.6 0.9 0.4 5.4 0.3 0.5 2.5 3.0 0.4 12.7 0.5 1.3 3.2 1.6 0.9 0.3 4.9 0.5 0.7 1.3 2.8 0.5 0.9 5.3 0.8 11.8 1.5 0.4 0.3 0.5 0.3 0.6 0.5 0.4 0.5 0.9 0.4 0.3 15.7 2.1 0.0 0.7 0.0 0.3 0.4 0.4 0.9 1.1 2.5 0.5 0.6 0.4 0.0 0.5 0.6 0.4 2.2 0.3 1.4 2.8 0.0 0.0 0.0 0.3 0.2 1.4 0.7 0.2 0.0 0.5 0.3 0.5 0.1 0.2 0.4 0.8 0.8 0.5 0.4 1.4 1.7 0.4 1.1 0.2 0.8 0.3 1.5 1.0 0.0 1.7 0.7 1.1 0.6 0.8 0.3 0.2 0.0 2.4 0.6 0.8 1.1 0.5 0.0 1.2 4.2 1.7 0.6 0.2 0.3 0.2 0.3 0.4 0.2 0.4 0.1 0.3 0.4 2.5 0.5 0.1 0.3 0.3 0.4 0.5 0.2 0.2 0.1 0.9 0.3 0.3 0.9 0.6 0.1 1.1 0.2 0.0 3.2 3.2 0.4 2.6 3.2 1.6 0.7 1.3 11.8 2.1 NELL1 "FLJ45906, IDH3GL" ENSG00000165973 "Neural EGFL like 1" Q92832 11 20669551-21575681 "Predicted secreted proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6;kidney: 24.2" "Cell line enhanced" "Detected in some" "HAP1: 8.9;RH-30: 1.5;SH-SY5Y: 4.1;U-2 OS: 2.3;WM-115: 2.6" "Cancer enhanced" "Detected in many" "melanoma: 5.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051535 Approved "Secreted in other tissues" 120000 "HPA051535: " "unprognostic (1.73e-1)" "unprognostic (1.31e-1)" "unprognostic (7.29e-2)" "unprognostic (5.35e-4)" "unprognostic (3.78e-4)" "unprognostic (1.67e-2)" "unprognostic (3.91e-1)" "unprognostic (4.38e-2)" "unprognostic (4.65e-2)" "unprognostic (1.57e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "unprognostic (7.27e-3)" "unprognostic (4.23e-2)" "unprognostic (1.83e-1)" "unprognostic (2.29e-1)" 0.6 0.6 5.5 0.6 10.3 0.4 0.5 1.8 19.6 0.9 0.8 0.5 0.1 0.5 0.9 2.8 1.3 0.6 1.0 0.4 8.8 6.9 24.2 0.4 1.1 0.4 2.0 13.3 0.6 0.4 0.5 4.5 0.4 4.1 7.9 1.0 0.0 1.1 4.2 0.4 0.9 0.6 0.7 0.9 0.6 1.3 1.8 0.5 0.0 0.4 0.0 1.3 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.3 1.2 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 10.3 1.8 18.7 8.8 6.9 2.0 13.3 4.1 0.5 NELL2 NRP2 ENSG00000184613 "Neural EGFL like 2" Q99435 12 44508275-44921848 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.8;brain: 73.3;fallopian tube: 35.1" "Cell line enhanced" "Detected in some" "AF22: 40.9;NTERA-2: 16.1;SCLC-21H: 29.7;U-266/70: 10.9;U-266/84: 10.8;U-698: 14.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 33.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 24.5;naive CD8 T-cell: 36.8" "Lineage enriched" "Detected in many" 11 "T-cells: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035714, HPA035715" Uncertain Approved Vesicles "Secreted to blood" 4700000 Vesicles "HPA035714: , HPA035715: AB_10669602" "unprognostic (4.25e-3)" "unprognostic (4.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (7.18e-2)" "unprognostic (5.85e-2)" "unprognostic (2.59e-2)" "unprognostic (4.85e-2)" "unprognostic (2.80e-1)" "prognostic favourable (5.56e-4)" "unprognostic (1.19e-1)" "unprognostic (1.71e-5)" "unprognostic (8.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.60e-3)" "unprognostic (3.75e-2)" 2.0 10.5 22.4 6.1 24.8 4.2 1.6 15.7 73.3 14.9 2.9 3.6 0.0 15.3 1.9 0.8 1.3 35.1 1.7 0.8 40.2 20.4 1.2 1.1 3.4 11.2 6.6 27.0 1.0 1.1 0.6 18.4 0.8 7.5 18.8 1.8 9.3 1.5 1.8 0.7 5.0 8.6 2.2 2.6 3.8 2.1 2.2 2.4 0.4 4.4 0.0 9.1 2.3 2.0 0.0 0.0 0.1 0.0 3.3 36.8 8.5 0.1 0.0 40.9 1.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.1 4.9 0.0 0.1 9.7 0.0 0.0 0.0 10.6 0.1 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 16.1 5.3 0.0 4.9 0.0 0.0 0.0 29.7 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.1 1.5 0.0 0.7 10.9 10.8 14.7 0.1 0.1 0.2 0.0 0.0 0.0 1.6 0.0 8.5 0.0 10.3 18.1 0.0 0.0 24.5 36.8 0.1 3.3 0.0 0.0 0.1 8.5 22.4 24.8 15.7 50.4 40.2 20.4 6.6 27.0 7.5 2.4 NETO1 "BCTL1, BTCL1" ENSG00000166342 "Neuropilin and tolloid like 1" Q8TDF5 18 72742314-72868146 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 47.9" "Cell line enhanced" "Detected in some" "MOLT-4: 14.8;REH: 14.5;RPMI-8226: 23.2;RT4: 15.4;SCLC-21H: 20.5;U-2 OS: 7.5" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 27 "memory B-cell: 1.6;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 38 "B-cells: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA064630 Approved "Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" "HPA064630: " "unprognostic (4.02e-2)" "unprognostic (4.08e-3)" "unprognostic (2.75e-1)" "unprognostic (1.55e-2)" "unprognostic (6.04e-2)" "unprognostic (1.35e-5)" "unprognostic (4.05e-1)" "unprognostic (4.73e-2)" "unprognostic (3.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.63e-2)" "unprognostic (1.20e-1)" "unprognostic (1.73e-2)" "unprognostic (3.70e-2)" "unprognostic (3.35e-2)" "unprognostic (1.59e-1)" "unprognostic (9.13e-3)" 2.0 0.8 9.1 1.3 18.3 1.0 1.7 0.4 47.9 0.9 0.9 0.7 0.0 0.8 0.9 0.9 1.0 0.8 0.9 1.4 15.9 3.9 1.0 0.8 0.9 3.8 3.0 15.1 0.8 0.8 1.0 0.3 0.8 5.0 0.9 1.1 3.9 1.1 0.8 0.8 1.2 0.8 0.8 1.1 4.0 0.9 2.0 2.8 0.8 2.3 0.0 2.7 1.2 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.8 0.0 6.7 0.0 14.5 0.0 23.2 3.6 15.4 20.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 18.3 0.4 22.8 15.9 3.9 3.0 15.1 5.0 2.8 NETO2 "FLJ10430, NEOT2" ENSG00000171208 "Neuropilin and tolloid like 2" Q8NC67 16 47077703-47143997 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.6;lymphoid tissue: 23.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013180 Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA013180: AB_1854383" "unprognostic (2.67e-2)" "unprognostic (3.46e-2)" "unprognostic (3.90e-1)" "unprognostic (1.51e-3)" "unprognostic (2.25e-1)" "unprognostic (5.26e-3)" "unprognostic (1.10e-2)" "unprognostic (5.73e-2)" "unprognostic (1.92e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (3.98e-1)" "prognostic unfavourable (5.53e-6)" "unprognostic (3.48e-2)" "unprognostic (1.66e-1)" "unprognostic (6.79e-2)" "unprognostic (1.32e-1)" 3.3 6.7 6.9 6.9 23.6 2.4 3.4 11.8 15.8 1.8 9.5 2.1 0.6 1.9 2.8 0.9 5.6 1.1 5.5 2.4 8.3 5.9 2.5 0.9 5.3 6.6 4.9 7.1 2.0 9.8 11.6 1.4 3.8 13.5 1.4 2.8 10.1 2.6 1.6 4.5 1.7 2.7 1.9 2.5 23.8 1.9 8.6 4.7 1.9 10.0 3.1 6.8 4.2 2.5 1.0 2.1 0.9 3.3 0.3 2.2 0.7 24.7 27.6 40.0 0.1 5.9 34.5 6.6 24.6 3.9 21.9 11.9 5.7 15.9 6.1 15.2 5.2 11.1 25.5 24.5 27.0 0.0 16.4 4.9 9.8 6.1 7.3 15.8 13.1 20.7 16.4 8.8 12.4 14.5 7.3 7.6 14.0 6.7 9.0 8.6 19.2 20.3 0.0 7.8 12.4 15.4 5.3 26.3 19.1 32.5 2.5 3.6 0.5 11.6 7.0 0.0 0.0 0.0 0.1 8.2 6.7 13.6 17.8 11.2 17.6 0.9 3.3 0.1 0.1 1.6 1.3 1.0 1.3 0.1 2.1 0.4 0.0 0.1 0.9 0.3 1.5 0.2 2.2 0.7 6.9 23.6 11.8 15.8 8.3 5.9 4.9 7.1 13.5 4.7 NEUROD1 "BETA2, BHF-1, bHLHa3, MODY6, NeuroD" ENSG00000162992 "Neuronal differentiation 1" Q13562 2 181673088-181680876 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 101.9" "Cell line enriched" "Detected in some" 72 "SCLC-21H: 79.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.3" "Region enriched" "Detected in many" 16 "cerebellum: 101.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in many" 14 "cerebellum: 242.4" "Region enriched" "Detected in some" 20 "cerebellum: 447.6" "HPA003278, CAB022450" Approved "CAB022450: , HPA003278: AB_1845331" "unprognostic (1.29e-1)" "prognostic favourable (1.34e-4)" "unprognostic (6.92e-3)" "unprognostic (1.27e-1)" 0.2 0.2 6.3 0.2 0.8 0.1 0.2 101.9 5.6 0.2 3.1 0.0 0.0 8.9 0.2 0.1 0.2 0.2 0.0 0.2 4.7 0.4 0.2 0.2 0.2 0.0 0.4 1.2 0.2 13.3 0.0 0.8 0.0 3.9 0.2 1.9 14.4 0.2 0.0 0.2 0.2 5.8 0.0 1.4 0.2 7.6 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.2 1.1 1.0 3.5 1.8 1.4 1.5 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.6 1.0 0.8 1.1 1.5 1.1 1.1 0.8 0.8 1.0 1.3 1.4 1.8 1.4 1.8 1.0 1.0 0.7 6.3 0.8 101.9 2.5 4.7 0.4 0.4 1.2 3.9 0.0 NEUROD2 "bHLHa1, NDRF" ENSG00000171532 "Neuronal differentiation 2" Q15784 17 39603536-39609777 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "brain: 51.4" "Cell line enriched" "Detected in single" 239 "SCLC-21H: 23.9" "Cancer enhanced" "Detected in some" "cervical cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 13 "amygdala: 28.0;cerebellum: 127.9;cerebral cortex: 45.1;hippocampal formation: 107.5" "unprognostic (5.70e-2)" "unprognostic (3.85e-2)" "unprognostic (2.87e-1)" "unprognostic (3.51e-3)" "unprognostic (2.44e-2)" "unprognostic (3.04e-1)" "unprognostic (4.69e-1)" "unprognostic (1.72e-1)" "unprognostic (2.16e-1)" "unprognostic (3.96e-1)" "unprognostic (6.15e-2)" "unprognostic (4.09e-2)" "unprognostic (3.21e-6)" "unprognostic (4.20e-1)" "unprognostic (2.66e-1)" "unprognostic (2.52e-2)" "unprognostic (2.57e-3)" 0.7 0.7 10.9 0.7 8.3 0.7 0.7 51.4 22.1 0.7 0.7 0.2 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 18.8 0.6 0.7 0.7 0.7 0.7 1.1 18.3 0.7 0.7 0.7 0.2 0.7 12.3 0.7 0.7 0.0 0.7 0.7 0.7 0.8 0.7 0.7 1.1 0.7 0.9 0.7 0.0 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 8.3 51.4 18.8 18.8 0.6 1.1 18.3 12.3 0.0 NEUROD6 "Atoh2, bHLHa2, Math-2, Nex1, NEX1M" ENSG00000164600 "Neuronal differentiation 6" Q96NK8 7 31337461-31340894 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "brain: 30.6" "Cell line enriched" "Detected in single" 116 "SCLC-21H: 11.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 8.3;basal ganglia: 10.7;cerebral cortex: 25.5;hippocampal formation: 30.6;olfactory region: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebral cortex: 99.2;hippocampal formation: 246.6" "Group enriched" "Detected in some" 10 "cerebral cortex: 26.0;hippocampal formation: 108.7" HPA074530 Enhanced "HPA074530: " "unprognostic (3.68e-2)" 0.5 0.5 8.3 0.5 10.7 0.5 0.5 3.9 25.5 0.5 0.5 0.7 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 30.6 0.5 0.5 0.5 0.5 0.5 1.3 17.4 0.5 0.5 0.5 0.1 0.5 0.4 0.5 0.5 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.4 0.5 0.5 0.5 0.0 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 10.7 3.9 25.5 30.6 0.5 1.3 17.4 0.4 0.0 NEUROG1 "AKA, bHLHa6, Math4C, NEUROD3, ngn1" ENSG00000181965 "Neurogenin 1" Q92886 5 135534282-135535949 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 2.1;retina: 7.7;testis: 2.3" "Group enriched" "Detected in some" 9 "AF22: 1.2;SCLC-21H: 1.1;THP-1: 2.4" "Cancer enriched" "Detected in single" 12 "testis cancer: 1.1" "Region enhanced" "Detected in single" "midbrain: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 2.1 0.0 0.4 0.0 NEUROG2 "Atoh4, bHLHa8, Math4A, ngn-2, NGN2" ENSG00000178403 "Neurogenin 2" Q9H2A3 4 112513516-112516172 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.1;testis: 5.1" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 67.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Region enriched" "Detected in single" 18 "hippocampal formation: 17.3" CAB012342 Uncertain "CAB012342: " "unprognostic (1.09e-1)" "unprognostic (2.52e-2)" "unprognostic (7.51e-2)" "unprognostic (4.10e-1)" "unprognostic (1.62e-1)" "unprognostic (7.75e-2)" "unprognostic (1.04e-1)" "unprognostic (1.13e-3)" "unprognostic (1.02e-1)" "unprognostic (3.30e-1)" 0.4 0.1 3.0 0.0 3.6 0.1 1.2 4.1 1.6 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 3.9 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.2 0.1 0.2 0.1 0.6 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 67.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.6 4.1 0.8 3.9 0.1 0.0 0.0 0.9 0.0 NEUROG3 "Atoh5, bHLHa7, Math4B, ngn3" ENSG00000122859 "Neurogenin 3" Q9Y4Z2 10 69571698-69573238 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.5;intestine: 8.4" "Cell line enriched" "Detected in some" 5 "THP-1: 15.0" "Cancer enhanced" "Detected in some" "stomach cancer: 1.4" "Region enriched" "Detected in single" 20 "hippocampal formation: 7.5" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;memory B-cell: 1.1" "Group enriched" "Detected in many" 7 "B-cells: 1.1;T-cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA039785 Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA039785: AB_10795114" "unprognostic (1.22e-2)" "unprognostic (7.33e-2)" "unprognostic (3.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (5.85e-5)" "unprognostic (4.58e-2)" "unprognostic (4.19e-1)" 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 7.6 0.0 0.0 8.0 0.0 0.0 0.9 0.0 1.8 0.0 7.5 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.1 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.3 7.5 0.1 0.1 0.0 0.0 0.0 NEXMIF "KIAA2022, KIDLIA, MRX98, XPN" ENSG00000050030 "Neurite extension and migration factor" Q5QGS0 X 74732856-74925485 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2;parathyroid gland: 9.0" "Group enriched" "Detected in some" 9 "HAP1: 6.5;Karpas-707: 10.5;SiHa: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000407 Uncertain Supported "Nucleoplasm,Midbody,Mitotic spindle,Cytosol" Nucleoplasm "Midbody, Mitotic spindle, Cytosol" "HPA000407: " "unprognostic (1.04e-3)" "unprognostic (6.07e-5)" "unprognostic (1.81e-2)" "unprognostic (2.07e-5)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (3.71e-1)" "unprognostic (1.79e-2)" "unprognostic (1.64e-3)" "unprognostic (8.25e-2)" "unprognostic (7.58e-3)" "unprognostic (1.37e-2)" "unprognostic (3.80e-2)" "unprognostic (2.79e-4)" "unprognostic (6.94e-4)" 0.6 3.0 5.4 0.7 6.2 0.4 1.3 10.2 9.4 1.7 1.9 0.7 1.0 0.6 1.7 0.9 1.8 1.3 0.5 0.3 5.0 6.2 2.4 0.2 0.9 0.5 1.8 5.0 1.7 4.4 9.0 7.5 0.5 1.9 3.2 1.1 1.1 2.5 2.5 0.4 1.8 1.1 2.6 1.2 0.6 1.6 0.9 1.5 0.0 1.5 0.0 0.5 0.7 2.8 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.2 0.3 0.1 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 9.3 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 6.2 10.2 6.8 5.0 6.2 1.8 5.0 1.9 1.5 NFASC "FLJ46866, KIAA0756, NF, NRCAML" ENSG00000163531 Neurofascin O94856 1 204828651-205022822 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.6" "Cell line enhanced" "Detected in some" "BJ: 13.2;BJ hTERT+ SV40 Large T+: 9.6;fHDF/TERT166: 23.9;SCLC-21H: 11.2;U-138 MG: 31.0;U-87 MG: 15.3" "Cancer enhanced" "Detected in many" "glioma: 8.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008832 Enhanced 2100000 "HPA008832: AB_1854411" "unprognostic (1.71e-1)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (3.39e-2)" "unprognostic (6.65e-2)" "unprognostic (1.18e-2)" "unprognostic (3.71e-3)" "unprognostic (3.37e-1)" "unprognostic (6.34e-3)" "unprognostic (2.79e-1)" "prognostic favourable (3.21e-5)" "unprognostic (3.76e-1)" "prognostic unfavourable (2.93e-5)" "unprognostic (1.56e-3)" "unprognostic (1.91e-1)" "unprognostic (6.90e-2)" "unprognostic (5.26e-3)" 4.9 8.7 21.1 3.9 25.9 0.6 3.8 22.3 37.3 4.6 7.8 49.6 1.1 5.1 9.1 10.4 11.3 12.0 6.6 17.4 19.5 10.8 10.7 2.4 5.7 2.6 27.9 25.2 11.9 6.4 1.6 11.7 11.2 28.7 8.7 6.8 8.1 2.6 18.4 3.3 4.2 5.6 15.3 17.5 6.8 5.3 2.0 34.0 0.0 3.0 0.2 3.4 8.9 7.9 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.5 0.0 0.2 0.4 0.0 13.2 0.0 9.6 2.9 0.0 0.0 0.0 0.0 23.9 6.3 0.2 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 6.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 1.0 0.0 0.0 0.0 11.2 0.6 0.0 0.6 0.0 0.1 0.0 0.0 31.0 6.7 0.0 0.0 0.0 0.0 0.0 15.3 0.0 7.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 25.9 22.3 35.0 19.5 10.8 27.9 25.2 28.7 34.0 NGB ENSG00000165553 Neuroglobin Q9NPG2 14 77265483-77271312 "Predicted intracellular proteins, Transporters" "Apoptosis, Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 15.6;brain: 34.5;pancreas: 9.9" "Group enriched" "Detected in some" 29 "RPMI-8226: 7.6;SCLC-21H: 15.7" "Cancer enhanced" "Detected in some" "cervical cancer: 2.0" "Region enhanced" "Detected in many" "hypothalamus: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042615, HPA058596" Enhanced "HPA042615: , HPA058596: " "unprognostic (1.02e-1)" "unprognostic (3.55e-2)" "unprognostic (8.86e-2)" "unprognostic (1.03e-1)" "unprognostic (9.29e-2)" "unprognostic (3.14e-1)" "unprognostic (4.08e-2)" "unprognostic (6.65e-2)" "unprognostic (6.58e-2)" "unprognostic (3.37e-4)" "unprognostic (1.80e-1)" "unprognostic (3.12e-1)" 0.4 15.6 4.2 0.7 4.8 0.3 0.3 1.2 14.2 0.3 2.1 0.5 0.9 0.7 0.3 0.5 0.6 2.9 0.3 0.3 1.7 34.5 0.3 0.3 0.3 0.3 2.0 6.4 0.3 9.9 0.3 7.0 0.3 8.0 0.3 1.3 0.0 0.3 0.3 0.3 0.3 0.9 0.5 1.4 0.3 0.3 0.7 0.9 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 7.6 0.0 0.0 15.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 4.8 1.2 14.2 1.7 34.5 2.0 6.4 8.0 0.9 NGEF ARHGEF27 ENSG00000066248 "Neuronal guanine nucleotide exchange factor" Q8N5V2 2 232878686-233013272 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.1;brain: 55.6;intestine: 23.2" "Cell line enhanced" "Detected in many" "A-431: 25.0;HDLM-2: 21.1;PC-3: 27.5;T-47d: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 177.2;basal ganglia: 332.1;cerebral cortex: 231.3;hippocampal formation: 147.2" "Low region specificity" "Detected in many" HPA008160 Approved Uncertain "Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane, Cytosol" "HPA008160: AB_1854450" "unprognostic (3.92e-1)" "unprognostic (1.78e-1)" "unprognostic (4.12e-3)" "unprognostic (1.66e-1)" "unprognostic (5.25e-2)" "unprognostic (5.46e-2)" "unprognostic (1.15e-1)" "unprognostic (2.39e-3)" "unprognostic (5.41e-3)" "unprognostic (2.58e-1)" "unprognostic (6.94e-3)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (2.31e-1)" "unprognostic (1.10e-1)" "unprognostic (2.80e-2)" "unprognostic (2.74e-1)" 0.8 29.1 15.8 1.4 55.6 0.3 1.4 0.8 53.8 1.4 7.9 1.6 0.0 23.2 2.8 2.6 5.3 3.1 2.0 0.9 7.0 5.1 4.2 9.7 0.6 0.3 3.2 26.7 1.5 1.8 7.9 0.9 0.4 5.4 1.3 6.1 0.0 0.8 0.7 0.7 16.5 16.6 4.0 1.4 0.5 6.2 2.3 12.0 0.0 0.8 1.0 0.4 0.9 1.6 0.0 0.5 0.5 0.3 0.0 0.0 0.0 25.0 7.3 0.2 0.1 0.1 4.1 0.4 0.4 0.0 0.2 0.0 0.3 2.5 0.0 7.5 5.1 3.3 5.6 1.4 0.2 21.1 1.8 0.0 10.2 7.8 0.1 0.0 0.1 0.0 0.1 1.7 0.3 0.9 0.1 0.1 0.2 1.8 0.0 0.0 0.6 27.5 0.0 0.0 0.0 0.5 0.6 0.9 0.2 3.1 1.6 0.0 15.5 0.2 0.0 0.2 2.3 0.1 0.5 0.2 0.1 0.0 1.8 0.0 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 15.8 55.6 0.8 53.8 7.0 5.1 3.2 26.7 5.4 12.0 NHLH1 "bHLHa35, HEN1, NSCL, NSCL1" ENSG00000171786 "Nescient helix-loop-helix 1" Q02575 1 160367067-160372848 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 10.8;skin 1: 4.2" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 24.2" "Group enriched" "Detected in some" 6 "glioma: 2.4;testis cancer: 0.8;urothelial cancer: 0.5" "Region enhanced" "Detected in many" "cerebellum: 10.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hippocampal formation: 1.1" "Region enriched" "Detected in some" 12 "cerebellum: 37.9" HPA017943 Approved "Golgi apparatus" "Golgi apparatus" "HPA017943: AB_2732421" "unprognostic (6.95e-2)" "unprognostic (3.02e-1)" "unprognostic (3.81e-1)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-2)" "unprognostic (2.24e-1)" "unprognostic (1.75e-2)" "unprognostic (7.06e-2)" "unprognostic (1.96e-2)" "unprognostic (4.21e-8)" "unprognostic (4.09e-2)" "unprognostic (2.82e-1)" "unprognostic (1.38e-2)" "unprognostic (1.36e-1)" 1.0 0.5 0.9 1.1 4.1 0.4 0.3 10.8 2.0 0.3 0.8 0.3 0.3 0.4 0.3 0.5 0.3 0.2 0.4 0.3 3.2 2.2 0.3 0.3 0.3 0.5 0.8 0.3 0.3 0.5 0.2 0.4 0.3 2.3 0.3 0.3 0.6 1.3 0.3 0.6 4.2 0.6 0.5 2.5 1.0 0.4 0.8 0.3 0.3 0.3 0.3 0.4 0.4 0.3 0.1 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.1 2.4 0.0 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.2 1.0 0.5 0.2 0.5 0.0 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.1 0.1 0.0 0.0 24.2 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 1.7 0.6 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 4.1 10.8 1.6 3.2 2.2 0.8 0.3 2.3 0.3 NHLH2 "bHLHa34, HEN2, NSCL2" ENSG00000177551 "Nescient helix-loop-helix 2" Q02577 1 115836377-115843917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 16.6;skin 1: 10.5" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 35.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055238 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA055238: " "unprognostic (2.20e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.17e-1)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.11e-2)" "unprognostic (5.26e-2)" "unprognostic (9.55e-2)" "unprognostic (2.80e-3)" "unprognostic (1.53e-1)" "unprognostic (3.09e-1)" "unprognostic (2.25e-1)" 0.2 0.2 3.4 0.2 0.9 0.2 0.6 16.6 2.4 0.3 0.3 0.4 0.5 0.3 0.2 1.4 2.5 0.2 0.3 0.2 7.1 9.1 0.2 0.2 0.9 0.2 4.1 1.5 0.2 0.2 0.2 0.1 0.5 16.3 0.7 0.4 1.0 0.4 0.7 0.6 10.5 0.3 0.2 3.1 0.2 1.0 1.6 0.6 0.0 0.2 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.9 16.6 2.4 7.1 9.1 4.1 1.5 16.3 0.6 NHSL2 ENSG00000204131 "NHS like 2" Q5HYW2 X 71910818-72161750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1" "Group enriched" "Detected in some" 4 "AF22: 16.5;EFO-21: 19.5;HUVEC TERT2: 18.0;TIME: 10.4;U-937: 13.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;granulocytes: 13.5;monocytes: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049771 Uncertain Approved "Plasma membrane,Cell Junctions" "Cell Junctions" "Plasma membrane" "HPA049771: " "unprognostic (9.71e-3)" "unprognostic (1.96e-1)" "unprognostic (1.92e-1)" "unprognostic (4.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.50e-2)" "unprognostic (2.88e-2)" "unprognostic (5.72e-4)" "unprognostic (5.46e-2)" "unprognostic (3.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.91e-1)" "unprognostic (1.61e-2)" "unprognostic (4.27e-3)" "unprognostic (9.99e-2)" "unprognostic (7.76e-2)" "unprognostic (4.37e-4)" 7.8 2.3 11.0 4.8 22.5 3.4 5.2 27.1 9.4 6.6 5.5 1.5 0.9 1.3 8.7 2.7 5.5 3.8 7.4 3.6 4.9 3.2 2.0 1.6 5.5 1.3 2.2 4.9 3.1 1.6 3.1 6.1 3.7 4.3 6.4 3.3 6.2 2.6 8.7 2.8 2.3 2.6 11.7 2.4 4.5 3.4 9.6 2.7 0.3 5.3 4.6 1.6 6.3 4.4 0.0 3.5 13.5 5.7 0.9 1.8 1.7 0.2 0.4 16.5 0.0 0.2 0.7 0.1 0.5 3.0 0.1 0.2 0.1 0.0 0.1 19.5 1.6 0.0 1.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.9 0.3 0.0 0.6 0.0 18.0 0.0 2.7 0.1 0.1 0.1 1.3 3.1 0.0 0.0 0.9 0.0 0.1 1.8 0.4 3.8 0.0 0.0 0.0 0.0 1.1 10.4 0.0 1.0 1.3 0.0 0.0 0.0 0.1 0.7 13.1 0.0 4.1 5.7 11.8 1.8 3.9 1.7 0.0 1.0 1.6 3.5 0.0 0.1 0.2 13.5 0.9 3.0 0.0 0.1 1.7 11.0 22.5 27.1 9.4 4.9 3.2 2.2 4.9 4.3 2.7 NIM1K "MGC42105, NIM1" ENSG00000177453 "NIM1 serine/threonine protein kinase" Q8IY84 5 43192071-43280850 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 23.7;pituitary gland: 9.7" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 4.4;HDLM-2: 4.8;PC-3: 5.5;U-87 MG: 6.0" "Cancer enriched" "Detected in some" 11 "glioma: 6.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 10 "dendritic cells: 1.2;T-cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007695 Uncertain Approved Cytosol Cytosol "HPA007695: " "unprognostic (7.97e-2)" "unprognostic (9.79e-2)" "unprognostic (8.74e-2)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.17e-1)" "unprognostic (2.40e-1)" "unprognostic (4.35e-2)" "unprognostic (1.35e-1)" "unprognostic (4.28e-2)" "unprognostic (8.84e-4)" "unprognostic (1.25e-1)" "unprognostic (1.55e-5)" "unprognostic (2.18e-1)" "unprognostic (2.66e-1)" "unprognostic (6.46e-3)" "unprognostic (4.98e-3)" 1.4 3.5 9.4 1.6 10.9 0.9 1.3 4.9 23.7 1.6 1.4 6.3 0.0 1.1 1.2 1.6 1.6 1.4 1.5 1.8 8.7 7.7 1.4 1.2 3.6 1.2 5.6 5.8 1.2 1.5 1.2 9.7 1.8 6.4 1.4 1.7 1.7 2.3 2.4 2.0 1.8 1.2 1.3 4.9 1.0 3.0 1.4 8.1 0.0 2.7 0.0 1.0 1.1 0.8 0.1 1.2 0.0 0.0 0.2 3.2 0.0 0.2 0.6 0.1 0.1 0.9 0.5 0.0 1.0 3.1 1.1 4.4 0.1 0.0 0.4 0.6 0.8 0.3 0.6 0.0 2.7 4.8 0.3 0.1 0.6 0.2 1.6 0.2 0.6 1.9 0.1 0.5 0.0 0.0 0.2 0.3 0.9 0.2 0.3 0.2 0.0 5.5 0.2 0.3 0.5 0.1 0.7 0.9 0.1 1.7 0.5 0.3 0.4 1.5 0.0 0.9 0.8 0.7 0.7 1.6 0.4 0.3 6.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 1.2 3.2 0.0 9.4 10.9 4.9 11.6 8.7 7.7 5.6 5.8 6.4 8.1 NINJ2 ENSG00000171840 "Ninjurin 2" Q9NZG7 12 564296-663779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.7;brain: 43.6" "Cell line enhanced" "Detected in some" "HEL: 40.5;MOLT-4: 68.4;THP-1: 14.4;U-698: 13.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA058980 Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA058980: " "unprognostic (1.16e-1)" "unprognostic (2.19e-1)" "unprognostic (9.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.37e-1)" "prognostic favourable (5.31e-4)" "unprognostic (5.72e-3)" "unprognostic (1.90e-3)" "unprognostic (4.60e-2)" "unprognostic (4.98e-3)" "unprognostic (5.88e-2)" "unprognostic (5.12e-2)" "unprognostic (2.68e-2)" "unprognostic (9.05e-2)" "unprognostic (1.03e-2)" "unprognostic (3.51e-3)" "unprognostic (1.23e-1)" 11.8 1.4 9.8 9.2 14.1 27.8 9.2 2.4 18.5 7.3 5.0 43.6 1.6 4.6 2.9 3.3 8.4 3.8 4.7 7.9 16.4 8.7 1.4 13.8 31.3 10.8 21.8 10.2 0.8 1.8 0.9 1.1 3.9 17.2 2.7 4.5 2.9 4.5 2.8 20.1 6.7 3.9 4.8 26.4 8.8 3.6 3.9 21.1 3.6 2.6 2.2 9.2 9.0 3.9 5.6 14.9 34.2 17.7 5.7 44.7 9.1 0.4 0.1 0.0 0.4 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.8 3.2 0.0 0.1 1.6 0.0 0.0 0.0 0.0 2.2 0.0 40.5 9.7 0.4 0.0 1.1 1.6 0.6 0.0 0.0 0.0 0.8 2.3 6.9 0.0 0.0 68.4 2.2 0.7 0.0 1.8 0.0 0.2 0.7 0.0 0.0 0.0 7.6 0.0 0.0 0.0 14.4 0.2 0.0 0.4 2.6 0.0 0.0 1.0 13.0 0.1 7.5 0.0 2.0 17.7 14.1 10.5 13.7 3.1 5.6 11.8 11.1 14.9 4.5 2.6 5.5 34.2 5.7 11.2 7.8 44.7 9.1 9.8 14.1 2.4 18.5 16.4 8.7 21.8 10.2 17.2 21.1 NIPA1 "MGC35570, SLC57A1, SPG6" ENSG00000170113 "Non imprinted in Prader-Willi/Angelman syndrome 1" Q7RTP0 15 22773063-22829791 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 9.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.1" "Low region specificity" "Detected in all" HPA023269 Uncertain "HPA023269: AB_1854485" "unprognostic (1.64e-2)" "unprognostic (7.60e-2)" "unprognostic (2.61e-2)" "unprognostic (2.13e-1)" "unprognostic (2.83e-1)" "unprognostic (1.79e-1)" "unprognostic (3.31e-2)" "unprognostic (2.13e-2)" "unprognostic (2.77e-1)" "unprognostic (2.42e-2)" "unprognostic (6.25e-2)" "unprognostic (6.32e-2)" "unprognostic (6.95e-2)" "unprognostic (8.80e-2)" "unprognostic (1.62e-1)" "unprognostic (8.42e-3)" "unprognostic (8.66e-2)" 3.4 4.9 15.2 4.1 18.1 1.3 3.4 8.3 27.0 4.6 4.6 20.7 1.3 7.3 2.7 2.6 4.5 3.1 5.5 2.9 18.7 15.7 7.3 4.7 5.3 5.4 26.9 11.8 1.6 7.6 12.3 2.9 4.0 24.8 7.9 5.0 2.2 3.9 4.2 2.4 5.6 7.2 2.9 36.7 4.5 7.4 4.9 15.1 2.6 8.5 0.4 6.0 3.6 2.6 2.0 9.1 0.6 0.2 0.6 1.7 0.8 9.7 11.4 3.5 8.2 4.6 3.8 2.9 11.4 8.3 5.7 4.7 8.7 4.8 4.4 9.6 4.8 6.6 10.6 3.1 6.7 26.2 6.9 6.8 7.0 7.3 5.5 0.1 13.8 1.3 10.3 3.7 6.4 5.4 5.4 7.7 3.2 3.6 3.7 6.1 4.0 13.0 8.3 5.0 3.5 8.8 9.7 10.1 10.3 9.1 1.0 10.7 7.8 8.9 9.8 16.0 9.4 6.6 17.8 8.6 8.6 8.4 8.4 0.0 10.6 0.6 0.2 0.3 1.1 0.1 1.2 1.8 1.7 1.2 1.4 2.0 0.8 0.6 0.5 0.6 0.1 9.1 1.3 0.8 15.2 18.1 8.3 19.7 18.7 15.7 26.9 11.8 24.8 15.1 NIPAL3 "DJ462O23.2, NPAL3" ENSG00000001461 "NIPA like domain containing 3" Q6P499 1 24415794-24472976 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.4" "Cell line enhanced" "Detected in many" "BJ: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039978 Approved Approved Nucleoplasm Nucleoplasm "HPA039978: AB_10697712" "unprognostic (9.36e-2)" "unprognostic (7.63e-2)" "unprognostic (2.88e-2)" "unprognostic (1.19e-2)" "unprognostic (5.96e-2)" "unprognostic (5.38e-2)" "unprognostic (3.72e-3)" "unprognostic (3.60e-2)" "unprognostic (2.43e-1)" "unprognostic (6.66e-2)" "unprognostic (2.79e-1)" "unprognostic (3.14e-1)" "prognostic favourable (3.03e-7)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic favourable (3.95e-4)" "unprognostic (2.85e-1)" 5.3 5.1 21.4 5.2 21.8 4.9 8.3 41.2 29.4 6.9 8.9 42.4 5.6 7.1 4.2 7.4 10.3 10.4 6.3 9.2 25.5 21.3 9.4 2.3 9.2 7.1 32.9 14.7 5.5 11.3 14.0 6.5 2.8 31.5 38.4 9.3 7.1 9.9 5.7 3.5 7.7 8.5 8.1 34.8 4.8 9.6 3.1 22.5 5.8 20.7 2.3 7.9 7.8 5.4 12.9 8.4 8.9 3.6 9.2 26.0 9.7 12.6 5.1 0.5 1.6 7.7 8.7 1.8 41.0 29.4 15.0 11.1 1.7 14.5 5.9 13.2 22.7 12.4 5.0 15.2 14.8 12.0 15.7 6.5 8.5 2.0 7.2 5.7 5.9 8.6 14.2 10.0 30.3 5.1 3.8 3.7 9.0 2.8 4.6 2.4 3.1 14.4 2.2 0.0 6.7 15.9 4.1 19.1 1.8 5.5 7.8 11.0 10.7 4.4 7.3 13.5 2.9 4.5 9.0 11.7 9.5 2.1 9.0 10.4 12.0 8.9 3.6 4.7 10.8 3.4 10.7 12.9 18.2 14.0 6.5 10.9 26.0 16.1 1.6 9.2 2.3 8.4 17.6 9.7 21.4 21.8 41.2 24.6 25.5 21.3 32.9 14.7 31.5 22.5 NIPAL4 ICHYN ENSG00000172548 "NIPA like domain containing 4" Q0D2K0 5 157460019-157474717 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" Receptor "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;skin 1: 38.1" "Group enriched" "Detected in some" 11 "hTCEpi: 13.8;RT4: 45.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 33 "memory B-cell: 2.6;naive B-cell: 8.7" "Lineage enriched" "Detected in single" 51 "B-cells: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038259 Approved "HPA038259: AB_10672510" "unprognostic (6.74e-4)" "unprognostic (9.54e-2)" "unprognostic (2.63e-2)" "unprognostic (1.49e-1)" "unprognostic (2.61e-1)" "unprognostic (6.56e-2)" "unprognostic (3.55e-2)" "unprognostic (5.20e-2)" "unprognostic (2.53e-1)" "unprognostic (2.99e-2)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (5.28e-9)" "unprognostic (3.12e-2)" "unprognostic (8.66e-3)" "unprognostic (1.18e-2)" "prognostic favourable (6.82e-4)" 0.6 0.5 1.5 2.5 7.1 3.3 3.0 0.4 7.7 3.6 2.1 25.9 0.0 0.8 1.7 0.6 10.6 0.5 1.0 1.0 3.1 1.7 0.5 0.5 0.5 0.9 8.0 2.5 0.5 0.5 0.5 0.4 1.1 10.9 2.6 1.1 0.0 1.2 1.9 0.6 38.1 0.7 5.8 11.9 0.7 1.9 0.6 6.9 0.0 0.8 15.8 6.0 10.7 7.7 8.7 0.0 0.1 0.0 0.0 0.1 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.2 2.7 0.1 1.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 13.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 45.8 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.1 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 7.1 0.4 7.7 3.1 1.7 8.0 2.5 10.9 6.9 NKAIN1 "FAM77C, FLJ12650" ENSG00000084628 "Sodium/potassium transporting ATPase interacting 1" Q4KMZ8 1 31179745-31239554 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 15.5;brain: 23.2;skeletal muscle: 26.2" "Cell line enhanced" "Detected in some" "AF22: 10.2;AN3-CA: 16.8;NTERA-2: 43.3;SCLC-21H: 12.9;SH-SY5Y: 20.6" "Group enriched" "Detected in many" 5 "breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006873 Uncertain "HPA006873: AB_1848410" "unprognostic (1.58e-2)" "unprognostic (7.99e-2)" "unprognostic (8.54e-2)" "unprognostic (6.11e-5)" "unprognostic (6.59e-2)" "unprognostic (1.24e-1)" "unprognostic (4.30e-4)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (2.78e-2)" "unprognostic (2.01e-2)" "unprognostic (8.07e-2)" "unprognostic (6.31e-9)" "unprognostic (1.00e-2)" "unprognostic (8.83e-3)" "unprognostic (1.62e-4)" "unprognostic (5.50e-2)" 0.7 15.5 4.2 0.8 13.3 0.5 1.2 23.2 11.8 0.6 0.7 10.7 0.0 0.7 1.5 5.8 1.4 0.8 0.6 0.6 6.3 4.3 0.6 0.5 0.5 0.5 4.7 7.2 0.6 0.7 0.7 0.3 0.9 18.2 2.2 0.7 0.0 0.7 1.1 26.2 1.9 0.7 0.8 3.3 0.5 0.6 0.9 9.0 0.0 0.5 0.1 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.2 16.8 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 43.3 0.4 0.0 0.1 0.0 0.0 1.5 12.9 20.6 0.4 0.1 1.1 4.5 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.3 23.2 9.5 6.3 4.3 4.7 7.2 18.2 9.0 NKAIN2 "FAM77B, TCBA1" ENSG00000188580 "Sodium/potassium transporting ATPase interacting 2" Q5VXU1 6 123804141-124825657 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 43.2" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.8;HEK 293: 6.4;HEL: 8.0;Karpas-707: 13.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 4.3" "Lineage enriched" "Detected in single" 44 "granulocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045860 Approved Cytosol Cytosol "HPA045860: AB_10983192" "unprognostic (3.09e-2)" "unprognostic (1.06e-2)" "unprognostic (2.33e-2)" "unprognostic (4.53e-3)" "unprognostic (5.67e-2)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.19e-1)" "unprognostic (5.41e-3)" "unprognostic (2.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.95e-3)" "unprognostic (3.63e-3)" "unprognostic (1.77e-1)" "unprognostic (1.66e-1)" "unprognostic (1.63e-1)" 2.2 1.6 12.9 1.1 12.1 1.9 1.3 17.3 43.2 1.4 1.7 24.9 0.0 1.1 1.2 1.6 1.4 1.4 1.3 2.6 17.5 8.8 1.3 1.2 1.3 1.3 18.1 10.9 1.2 1.0 1.0 1.1 1.2 18.0 1.4 1.3 0.5 1.1 1.3 4.8 1.1 1.5 1.5 42.9 1.1 1.0 1.6 16.1 0.0 1.2 0.5 1.3 1.5 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.0 0.0 0.0 0.5 0.0 0.0 1.6 0.2 0.0 0.5 0.0 0.0 13.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 12.1 17.3 15.3 17.5 8.8 18.1 10.9 18.0 16.1 NKAIN3 "FAM77D, FLJ39630" ENSG00000185942 "Sodium/potassium transporting ATPase interacting 3" Q8N8D7 8 62248591-62999652 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.4;HeLa: 1.9;PC-3: 2.5;REH: 2.5;RT4: 1.6;SCLC-21H: 4.9" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018833 Enhanced "HPA018833: " "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (1.12e-2)" "unprognostic (1.83e-1)" "unprognostic (3.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.81e-3)" "unprognostic (4.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.22e-2)" "unprognostic (3.15e-2)" "unprognostic (1.58e-1)" 0.8 3.4 13.7 1.2 15.5 0.8 1.0 0.6 9.7 1.3 1.4 6.9 0.0 0.7 1.7 0.7 0.8 1.1 0.8 1.1 15.1 1.6 0.8 0.9 0.7 0.8 2.3 7.5 0.9 0.7 0.7 0.8 1.0 7.3 1.0 0.8 0.3 5.9 1.4 2.2 0.7 2.3 0.7 7.3 0.9 0.9 1.9 7.1 0.0 0.8 0.0 0.7 2.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 2.5 0.0 0.0 0.0 1.6 4.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 15.5 0.6 9.7 15.1 1.6 2.3 7.5 7.3 7.1 NKAIN4 "bA261N11.2, C20orf58, FAM77A" ENSG00000101198 "Sodium/potassium transporting ATPase interacting 4" Q8IVV8 20 63240784-63272694 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 51.7" "Cell line enhanced" "Detected in some" "AF22: 4.9;BEWO: 16.6;MOLT-4: 26.9;REH: 4.8;SK-MEL-30: 6.0" "Cancer enriched" "Detected in many" 6 "glioma: 45.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "amygdala: 3.2;cerebral cortex: 3.9;hippocampal formation: 2.5" HPA029876 Approved "HPA029876: AB_10602038" "unprognostic (1.26e-1)" "unprognostic (4.27e-1)" "unprognostic (6.07e-5)" "prognostic unfavourable (3.14e-4)" "unprognostic (6.65e-2)" "unprognostic (2.59e-1)" "unprognostic (7.07e-3)" "unprognostic (1.94e-1)" "unprognostic (3.62e-2)" "unprognostic (2.69e-2)" "unprognostic (1.83e-2)" "unprognostic (1.27e-1)" "unprognostic (2.12e-2)" "unprognostic (1.44e-4)" "unprognostic (5.66e-2)" "unprognostic (6.74e-2)" "unprognostic (4.01e-1)" 1.1 1.9 21.7 1.2 23.0 1.0 1.0 5.7 51.7 1.3 1.1 9.9 0.0 1.2 1.4 1.3 0.9 1.3 1.0 0.9 15.5 15.5 10.9 0.9 0.9 0.9 18.5 11.8 0.9 1.0 0.9 0.4 3.9 6.2 1.0 1.0 1.0 0.9 1.1 0.9 1.4 1.1 1.0 9.1 1.0 1.1 2.7 7.1 0.0 1.2 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.9 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.7 0.5 0.0 2.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 26.9 0.0 3.3 0.0 4.8 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.1 6.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 23.0 5.7 13.2 15.5 15.5 18.5 11.8 6.2 7.1 NKRF "ITBA4, NRF" ENSG00000186416 "NFKB repressing factor" O15226 X 119588337-119605895 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001476 Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA001476: AB_1079488" "unprognostic (6.12e-3)" "unprognostic (7.58e-2)" "unprognostic (8.10e-2)" "unprognostic (2.39e-1)" "unprognostic (9.92e-2)" "unprognostic (4.74e-3)" "prognostic unfavourable (4.92e-5)" "unprognostic (2.47e-1)" "unprognostic (1.20e-1)" "unprognostic (2.65e-1)" "unprognostic (1.33e-2)" "unprognostic (9.56e-3)" "unprognostic (2.62e-2)" "unprognostic (5.06e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-3)" "unprognostic (3.08e-3)" 3.8 7.9 14.5 6.2 24.3 7.6 6.5 11.4 34.9 4.9 4.0 4.4 1.1 4.7 4.8 5.6 5.6 5.2 4.1 3.8 15.4 14.0 6.9 6.9 4.1 9.7 8.1 24.6 7.4 3.9 8.3 6.5 7.5 25.7 4.9 4.5 2.9 4.6 4.3 4.8 6.4 4.4 4.7 6.0 6.4 4.0 1.9 3.5 7.4 5.4 1.4 9.7 5.2 4.8 3.8 2.7 2.8 2.2 1.3 5.5 1.7 10.8 11.1 6.6 7.6 5.7 5.8 10.0 6.6 5.4 9.0 9.7 11.8 9.4 19.4 11.7 5.7 12.8 27.4 10.2 11.0 9.7 18.7 10.2 13.2 7.8 5.4 19.7 7.9 6.1 8.4 10.4 12.2 9.1 11.0 8.2 8.0 16.8 12.6 15.8 14.6 12.5 9.9 9.4 19.9 11.9 8.1 10.8 9.0 9.3 14.5 9.8 6.1 12.0 7.4 5.8 6.2 12.2 16.6 6.7 8.1 20.5 5.9 22.2 6.4 2.8 1.3 1.5 3.3 2.2 3.1 3.7 3.6 3.7 1.3 3.8 5.5 4.8 0.2 1.3 1.1 2.7 4.3 1.7 14.5 24.3 11.4 34.9 15.4 14.0 8.1 24.6 25.7 3.5 NKX1-2 "bB238F13.2, C10orf121" ENSG00000229544 "NK1 homeobox 2" Q9UD57 10 124445239-124450184 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.7;intestine: 2.9;skin 1: 2.2" "Cell line enhanced" "Detected in some" "HaCaT: 6.9;HEK 293: 2.7;hTCEpi: 6.7;NTERA-2: 13.3;SCLC-21H: 5.8" "Cancer enhanced" "Detected in some" "testis cancer: 3.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029367 Uncertain "HPA029367: " "unprognostic (2.43e-1)" "unprognostic (7.85e-3)" "unprognostic (6.81e-5)" "unprognostic (1.55e-2)" "unprognostic (3.61e-2)" "unprognostic (5.40e-2)" "unprognostic (7.28e-2)" "unprognostic (2.20e-1)" "unprognostic (3.73e-2)" "unprognostic (2.69e-1)" "unprognostic (1.71e-1)" "unprognostic (8.68e-2)" 0.0 0.0 0.7 0.0 2.0 0.0 0.9 0.2 2.9 0.4 0.0 1.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.4 0.0 0.7 3.7 0.3 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 1.2 0.0 0.0 2.2 2.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 6.9 0.6 0.9 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.0 0.2 2.9 0.6 0.3 0.7 3.7 2.2 0.0 NKX2-2 "NKX2.2, NKX2B" ENSG00000125820 "NK2 homeobox 2" O95096 20 21511010-21514026 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 30.6;pancreas: 12.1" "Cell line enhanced" "Detected in some" "HAP1: 4.4;T-47d: 5.2;U-138 MG: 18.5;U-2 OS: 3.8;WM-115: 7.4" "Group enriched" "Detected in many" 5 "glioma: 9.5;pancreatic cancer: 7.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003468 Approved "HPA003468: AB_1079490" "unprognostic (5.13e-3)" "unprognostic (5.54e-2)" "unprognostic (3.10e-1)" "unprognostic (2.29e-1)" "unprognostic (1.75e-2)" "unprognostic (2.93e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (3.29e-1)" 0.6 0.6 6.5 0.7 8.1 0.7 0.6 3.4 15.5 0.6 1.4 19.1 0.0 6.2 0.6 0.6 0.6 0.6 0.6 0.6 7.8 6.9 0.6 0.6 0.6 0.7 14.2 6.4 0.6 12.1 1.0 4.6 0.6 10.9 0.7 1.4 0.0 0.6 0.6 0.6 0.8 2.5 0.6 30.6 0.6 7.0 0.6 9.4 0.0 0.6 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 4.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.3 0.0 18.5 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.1 3.4 7.6 7.8 6.9 14.2 6.4 10.9 9.4 NKX2-4 "NKX2.4, NKX2D" ENSG00000125816 "NK2 homeobox 4" Q9H2Z4 20 21395367-21398028 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.5;pituitary gland: 1.2;testis: 5.2" "Cell line enhanced" "Detected in some" "HAP1: 3.6;HEK 293: 7.6;SCLC-21H: 5.0;SK-MEL-30: 5.8;WM-115: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 22 "hypothalamus: 3.1" "Region enriched" "Detected in single" 24 "hypothalamus: 1.4" HPA074996 Approved "Nuclear bodies" "Nuclear bodies" "HPA074996: " "unprognostic (3.77e-1)" "unprognostic (2.15e-1)" "unprognostic (1.68e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 5.0 0.0 0.0 0.0 5.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX2-8 "Nkx2-9, NKX2.8, NKX2H" ENSG00000136327 "NK2 homeobox 8" O15522 14 36580579-36582607 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.6;lung: 7.7;testis: 22.9" "Cell line enhanced" "Detected in some" "EFO-21: 1.9;HaCaT: 9.7;HEK 293: 2.3;PC-3: 5.7;SiHa: 2.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons and medulla: 2.3" "Low region specificity" "Detected in some" HPA062879 Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA062879: " "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.37e-3)" "unprognostic (2.27e-1)" "unprognostic (3.45e-4)" "unprognostic (2.36e-1)" "unprognostic (8.34e-2)" "unprognostic (7.80e-2)" "unprognostic (3.66e-1)" "unprognostic (3.11e-1)" "unprognostic (8.39e-3)" "unprognostic (4.60e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" 0.3 0.3 0.2 0.4 0.7 0.3 0.3 0.0 1.2 0.3 0.3 2.0 0.0 0.3 0.3 0.3 5.3 0.3 0.3 0.3 0.3 2.0 0.3 0.3 7.7 0.3 2.0 0.0 0.3 0.3 1.5 2.1 0.3 5.7 0.4 0.3 0.0 2.0 0.3 0.3 1.1 0.3 0.3 9.6 0.3 0.3 22.9 0.5 0.0 4.2 1.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 9.7 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.5 1.4 0.0 2.3 0.4 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 1.2 0.3 2.0 2.0 0.0 5.7 0.5 NKX6-2 "GTX, NKX6.1, NKX6B" ENSG00000148826 "NK6 homeobox 2" Q9C056 10 132783179-132786052 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 25 "brain: 50.0;stomach 1: 31.7" "Cell line enhanced" "Detected in single" "NTERA-2: 1.2" "Cancer enriched" "Detected in some" 5 "glioma: 3.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "unprognostic (1.92e-1)" "unprognostic (4.39e-2)" "unprognostic (2.26e-1)" "unprognostic (2.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.57e-1)" "unprognostic (1.62e-1)" 1.0 1.0 14.8 1.0 21.7 1.0 1.0 2.2 18.7 1.0 1.0 25.9 0.0 1.0 1.0 1.0 1.1 1.0 1.0 1.0 25.6 13.2 1.0 1.0 1.0 1.0 34.7 6.3 1.0 1.1 1.0 0.0 1.0 18.1 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0 1.0 50.0 1.0 31.7 1.6 26.8 0.0 1.0 0.0 1.0 1.0 0.1 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.8 21.7 2.2 12.7 25.6 13.2 34.7 6.3 18.1 26.8 NKX6-3 FLJ25169 ENSG00000165066 "NK6 homeobox 3" A6NJ46 8 41645178-41650669 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 13.8;intestine: 10.8;stomach 1: 33.7" "Group enriched" "Detected in some" 7 "Daudi: 10.8;THP-1: 4.9" "Group enriched" "Detected in some" 6 "endometrial cancer: 0.9;pancreatic cancer: 3.1;stomach cancer: 3.9;testis cancer: 1.6" "Region enriched" "Detected in some" 10 "cerebellum: 13.8" "Cell type enriched" "Detected in single" 17 "naive B-cell: 1.7" "Lineage enriched" "Detected in single" 17 "B-cells: 1.7" "unprognostic (1.87e-1)" "unprognostic (9.91e-3)" "unprognostic (4.04e-1)" "unprognostic (5.73e-2)" "unprognostic (1.98e-1)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (1.13e-1)" "unprognostic (2.17e-2)" "unprognostic (1.92e-1)" "unprognostic (1.78e-1)" 0.2 0.0 0.4 0.2 0.5 0.0 0.2 13.8 1.3 0.2 4.6 0.2 0.2 10.8 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.2 0.2 0.2 0.8 2.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 33.7 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 13.8 1.3 0.2 0.2 0.2 0.2 0.2 0.2 NLGN1 KIAA1070 ENSG00000169760 "Neuroligin 1" Q8N2Q7 3 173396284-174286644 "Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 15.9;HUVEC TERT2: 15.5;RH-30: 16.6;WM-115: 16.9" "Group enriched" "Detected in some" 9 "glioma: 3.8;melanoma: 2.2;renal cancer: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006572, HPA006680" Approved Uncertain "Nuclear bodies,Plasma membrane" 40000 "Plasma membrane" "Nuclear bodies" "HPA006572: , HPA006680: AB_1854400" "unprognostic (2.81e-1)" "unprognostic (9.86e-2)" "unprognostic (3.08e-5)" "unprognostic (7.52e-5)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (6.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.78e-1)" "unprognostic (8.07e-2)" "unprognostic (3.21e-3)" "unprognostic (1.86e-2)" "unprognostic (1.97e-1)" "unprognostic (4.08e-2)" "unprognostic (8.81e-2)" "unprognostic (2.41e-3)" "unprognostic (5.37e-2)" 3.9 2.4 13.4 1.4 9.4 0.6 1.6 20.2 26.9 6.3 3.2 5.6 0.0 1.0 4.3 5.0 4.8 5.9 3.3 5.7 8.8 9.1 5.6 0.6 1.2 1.0 6.3 7.8 2.8 2.0 0.6 6.9 1.4 6.8 4.4 2.2 4.3 0.9 5.9 0.7 1.0 1.6 8.2 4.6 0.7 2.0 11.1 8.9 0.0 2.2 0.4 0.8 5.1 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 7.6 8.1 0.0 3.2 8.0 0.4 0.5 0.0 0.3 0.0 0.1 15.9 0.0 2.3 0.0 0.8 0.0 3.7 1.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 15.5 0.0 1.0 0.1 0.0 0.0 0.0 4.5 1.1 0.0 16.6 3.8 3.0 0.0 1.6 1.0 0.0 0.0 7.7 0.4 0.0 1.9 8.6 0.8 6.2 7.0 7.4 0.0 0.0 2.9 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 9.4 20.2 10.9 8.8 9.1 6.3 7.8 6.8 8.9 NLGN2 KIAA1366 ENSG00000169992 "Neuroligin 2" Q8NFZ4 17 7404874-7419860 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.0" "Cell line enhanced" "Detected in many" "AF22: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Low region specificity" "Detected in all" "HPA055321, HPA069278" Enhanced Approved Mitochondria Mitochondria "HPA055321: , HPA069278: " "unprognostic (1.31e-1)" "unprognostic (1.87e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-3)" "unprognostic (2.92e-1)" "unprognostic (1.56e-1)" "unprognostic (6.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.58e-3)" "unprognostic (1.23e-2)" "prognostic unfavourable (3.44e-4)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (5.50e-3)" "unprognostic (1.81e-2)" 13.0 10.9 31.3 9.9 45.3 2.4 7.4 32.7 47.0 16.9 11.3 18.3 9.5 4.4 25.3 16.4 9.0 13.8 15.5 6.6 28.8 16.0 5.7 3.3 6.2 6.1 13.9 27.5 24.3 7.4 20.7 8.3 8.5 21.3 11.6 5.9 11.2 6.5 19.2 6.3 8.7 5.4 24.3 19.4 7.5 5.9 4.8 15.9 0.0 4.8 1.7 5.0 9.8 11.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 4.2 6.0 26.4 15.2 8.1 11.3 0.6 7.1 11.2 12.1 11.1 1.3 1.5 0.0 3.5 9.8 2.4 4.9 2.9 6.5 6.4 4.9 1.8 5.4 1.0 4.1 1.8 6.5 9.1 2.4 9.9 1.6 4.1 1.7 3.4 5.0 4.0 0.8 1.8 4.5 2.8 7.6 3.2 0.8 3.5 0.9 0.4 10.6 3.3 1.5 1.8 4.3 0.2 5.6 10.4 13.3 6.5 3.4 4.0 1.3 0.7 10.8 1.7 3.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 31.3 45.3 32.7 37.2 28.8 16.0 13.9 27.5 21.3 15.9 NLGN3 "ASPGX1, AUTSX1, HNL3, KIAA1480" ENSG00000196338 "Neuroligin 3" Q9NZ94 X 71144831-71171201 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Asperger syndrome, Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.9" "Cell line enhanced" "Detected in some" "AF22: 10.9;NTERA-2: 7.9;SH-SY5Y: 4.3" "Cancer enriched" "Detected in many" 19 "glioma: 37.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003183, HPA004066" Enhanced Supported "Golgi apparatus,Cell Junctions" "Intracellular and membrane" "Golgi apparatus, Cell Junctions" "HPA003183: AB_1079469, HPA004066: " "unprognostic (4.06e-2)" "unprognostic (1.77e-1)" "unprognostic (1.59e-2)" "unprognostic (2.38e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-1)" "unprognostic (6.52e-2)" "unprognostic (1.63e-1)" "unprognostic (7.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (6.18e-2)" "unprognostic (4.27e-9)" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (2.22e-5)" "unprognostic (9.01e-2)" 1.4 8.9 16.3 1.6 19.4 2.2 1.3 11.5 45.9 3.2 1.6 30.0 0.1 1.1 4.2 8.1 1.5 6.0 2.4 2.1 15.7 9.7 1.2 0.9 1.3 1.2 12.7 13.1 6.1 1.2 1.4 1.1 1.5 15.2 7.9 1.4 1.6 1.6 16.0 0.8 1.6 1.6 2.9 12.9 1.4 1.5 3.8 12.3 0.0 1.0 0.0 1.1 1.5 1.3 0.2 0.1 3.3 0.3 0.3 0.5 0.0 0.1 0.8 10.9 0.3 2.6 1.1 1.9 0.3 0.1 0.0 0.2 0.1 0.5 0.8 0.8 0.1 0.2 0.4 0.0 0.2 0.7 1.3 0.5 0.5 0.1 0.0 0.2 0.9 0.6 0.1 0.3 0.0 0.1 0.7 2.1 0.1 0.6 0.7 1.7 7.9 0.0 0.9 0.4 0.5 0.0 1.2 2.7 4.3 0.3 0.0 0.9 0.0 0.5 0.3 0.2 1.3 0.4 0.0 1.7 1.5 0.6 0.3 0.4 0.6 0.3 0.3 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.5 0.1 3.3 0.3 0.0 0.1 0.1 0.0 16.3 19.4 11.5 23.1 15.7 9.7 12.7 13.1 15.2 12.3 NLGN4Y KIAA0951 ENSG00000165246 "Neuroligin 4, Y-linked" Q8NFZ3 Y 14522573-14845650 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.8;seminal vesicle: 15.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 19.6;fHDF/TERT166: 15.0;HDLM-2: 17.5;hTCEpi: 13.1;U-138 MG: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.0;memory CD4 T-cell: 1.7" "Group enriched" "Detected in many" 12 "B-cells: 3.0;T-cells: 1.7" HPA001651 Approved "Intracellular and membrane" "HPA001651: AB_1079470" "unprognostic (2.31e-1)" "unprognostic (9.19e-2)" "unprognostic (2.84e-5)" "unprognostic (7.85e-2)" "unprognostic (6.46e-2)" "unprognostic (8.80e-3)" "unprognostic (7.71e-2)" "unprognostic (6.26e-2)" "unprognostic (5.89e-2)" "unprognostic (7.20e-3)" "unprognostic (1.88e-1)" "unprognostic (5.65e-2)" 1.4 1.9 4.7 1.4 18.7 0.4 1.3 11.2 23.8 0.4 2.5 11.2 2.4 1.2 0.4 4.0 4.3 0.4 4.8 0.8 4.9 5.7 2.0 4.4 1.3 2.7 3.7 0.0 0.5 3.3 0.4 2.9 0.9 12.6 12.6 3.1 7.2 2.2 15.3 0.6 1.3 2.0 3.7 3.5 1.1 1.5 1.3 0.0 2.5 2.6 4.0 2.5 6.0 0.0 3.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.3 19.6 1.2 1.6 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 3.1 17.5 0.0 0.0 0.0 2.9 2.1 0.0 0.0 6.8 13.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 1.2 0.0 4.0 0.0 0.0 1.3 0.0 4.7 7.5 2.6 0.0 0.0 0.0 0.0 0.0 0.4 5.6 14.4 0.0 0.0 3.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.0 1.7 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 4.7 18.7 11.2 23.8 4.9 5.7 3.7 0.0 12.6 0.0 NLRP4 "CLR19.5, CT58, FLJ32126, NALP4, PAN2, PYPAF4, RNH2" ENSG00000160505 "NLR family pyrin domain containing 4" Q96MN2 19 55836578-55881854 "Predicted intracellular proteins" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 9.4;lymphoid tissue: 9.0;testis: 12.1" "Cell line enriched" "Detected in some" 8 "Daudi: 41.8" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 5 "B-cells: 2.4" HPA062128 Approved Mitochondria Mitochondria "HPA062128: " "unprognostic (2.48e-1)" "unprognostic (7.01e-2)" "unprognostic (4.21e-2)" "unprognostic (1.34e-2)" "unprognostic (3.11e-1)" "unprognostic (1.81e-1)" "unprognostic (2.36e-3)" "unprognostic (3.72e-2)" "unprognostic (2.36e-1)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" 0.2 0.2 1.9 1.0 1.8 0.0 0.2 0.2 2.9 0.2 0.2 2.7 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.2 1.0 0.3 0.2 0.2 0.2 2.8 5.1 0.6 0.4 0.2 0.1 0.3 0.0 2.9 0.2 0.1 0.0 0.8 0.0 0.2 0.2 0.3 0.1 9.4 0.3 0.2 12.1 2.2 0.0 0.2 0.4 9.0 0.2 0.2 2.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 41.8 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 1.8 0.2 2.9 1.0 0.3 5.1 0.6 2.9 2.2 NMB "MGC17211, MGC2277, MGC3936" ENSG00000197696 "Neuromedin B" P08949 15 84655129-84658563 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 37.2;brain: 28.5;breast: 59.9" "Cell line enhanced" "Detected in many" "A-431: 27.5" "Cancer enhanced" "Detected in all" "glioma: 93.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 16 "olfactory region: 206.6" "Group enriched" "Detected in many" 6 "olfactory region: 80.6;pons and medulla: 17.5" CAB019302 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted to blood" "Nucleoplasm, Vesicles" "Plasma membrane" "CAB019302: " "unprognostic (2.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-3)" "unprognostic (3.79e-1)" "prognostic favourable (3.43e-4)" "unprognostic (3.81e-1)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (2.17e-1)" "unprognostic (4.36e-1)" "unprognostic (7.24e-2)" "unprognostic (2.10e-1)" "prognostic unfavourable (2.25e-4)" "unprognostic (7.92e-3)" "unprognostic (1.45e-1)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" 37.2 8.0 4.6 2.8 7.5 3.3 59.9 2.4 28.5 4.0 6.5 13.7 1.0 2.3 3.1 3.2 2.5 5.0 4.5 7.0 7.0 12.2 4.4 1.9 3.8 3.6 6.6 3.5 3.4 3.3 2.7 4.2 1.4 5.6 1.9 2.1 2.6 4.6 1.8 2.0 1.8 1.4 2.9 9.9 2.0 2.5 6.4 4.8 2.2 8.9 4.9 1.9 4.7 8.5 7.0 10.4 5.9 0.8 1.3 6.4 2.6 27.5 10.5 1.9 0.4 5.5 2.4 0.2 1.7 3.3 3.7 5.1 3.7 7.6 1.2 4.4 4.4 4.9 10.6 2.1 2.1 10.3 13.3 4.2 4.1 17.1 1.4 2.8 4.6 2.5 0.8 5.8 2.2 5.4 0.0 0.4 2.0 16.1 2.6 9.3 7.8 3.0 8.3 0.0 12.2 3.5 2.2 1.0 12.0 2.7 1.6 12.5 1.8 11.0 1.3 0.7 3.7 3.5 2.6 0.2 3.0 2.6 8.5 15.9 4.4 0.0 0.8 5.9 6.3 0.6 2.3 4.9 5.0 6.4 3.5 7.0 4.8 3.6 1.2 1.3 0.3 10.4 5.6 2.6 4.6 7.5 2.4 8.5 7.0 12.2 6.6 3.5 5.6 4.8 NMBR "BB1, BB1R" ENSG00000135577 "Neuromedin B receptor" P28336 6 142058330-142088799 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.5;fallopian tube: 3.3;testis: 5.1" "Cell line enhanced" "Detected in some" "AN3-CA: 2.9;RPTEC TERT1: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026665 Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA026665: AB_1854527" "unprognostic (6.24e-2)" "unprognostic (3.05e-1)" "unprognostic (2.77e-2)" "unprognostic (7.88e-2)" "unprognostic (3.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.63e-2)" "unprognostic (1.54e-1)" "unprognostic (3.95e-1)" "unprognostic (7.94e-3)" "unprognostic (3.44e-1)" "unprognostic (2.11e-1)" "unprognostic (8.45e-2)" 0.1 0.0 0.6 0.0 2.5 0.0 0.4 0.0 0.8 0.5 0.0 0.0 0.2 0.3 0.6 3.3 0.0 0.0 0.5 1.6 0.2 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.8 0.1 0.2 5.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.9 0.9 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.5 0.0 0.4 0.0 0.2 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NMNAT2 "C1orf15, KIAA0479, PNAT2" ENSG00000157064 "Nicotinamide nucleotide adenylyltransferase 2" Q9BZQ4 1 183248237-183418602 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.9" "Cell line enhanced" "Detected in many" "HSkMC: 12.7;SCLC-21H: 37.1;U-2197: 21.7;U-87 MG: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061714 Enhanced "HPA061714: " "unprognostic (3.70e-1)" "unprognostic (7.98e-3)" "unprognostic (8.83e-2)" "unprognostic (4.16e-2)" "unprognostic (8.95e-2)" "unprognostic (9.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.35e-1)" "unprognostic (7.92e-2)" "unprognostic (8.09e-2)" "unprognostic (1.33e-2)" "unprognostic (3.20e-1)" "unprognostic (2.73e-3)" "unprognostic (2.90e-3)" "unprognostic (1.87e-1)" "unprognostic (7.51e-2)" "unprognostic (1.02e-1)" 9.6 7.7 26.2 1.9 34.5 1.0 2.9 53.9 53.5 3.6 2.2 2.0 0.0 1.5 2.5 2.7 1.9 3.8 4.1 19.6 20.6 15.1 1.5 1.1 1.8 1.7 8.6 28.3 1.5 2.9 1.3 17.4 2.0 15.6 1.3 2.1 0.5 1.5 4.1 1.3 1.7 2.0 2.7 4.1 1.2 2.1 8.7 6.3 0.0 7.2 0.0 1.7 1.9 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.2 2.5 0.0 1.5 6.1 2.2 1.6 4.0 0.8 0.2 1.2 2.4 0.0 6.8 0.3 1.0 0.1 0.0 1.6 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 12.7 0.5 1.0 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.2 4.4 2.4 0.0 0.1 0.0 2.8 2.0 37.1 2.8 0.3 0.1 0.0 0.3 0.6 1.3 1.2 0.4 21.7 1.4 0.3 0.0 0.0 16.9 0.1 0.1 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 26.2 34.5 53.9 34.7 20.6 15.1 8.6 28.3 15.6 6.3 NMS ENSG00000204640 "Neuromedin S" Q5H8A3 2 100470482-100483280 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 3.2;testis: 2.9" "Group enriched" "Detected in some" 10 "HL-60: 12.3;HMC-1: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basal ganglia: 2.6;hypothalamus: 6.3;pons and medulla: 1.4" "Secreted in brain" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NMUR2 NMU2R ENSG00000132911 "Neuromedin U receptor 2" Q9GZQ4 5 152391532-152433368 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.9;stomach 1: 5.0;testis: 8.0" "Cell line enriched" "Detected in some" 8 "EFO-21: 14.5" "Group enriched" "Detected in some" 5 "colorectal cancer: 0.5;endometrial cancer: 0.6;pancreatic cancer: 1.8;stomach cancer: 2.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 2.0" "Low region specificity" "Detected in all" "HPA027800, HPA045836" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA027800: , HPA045836: AB_10968856" "unprognostic (1.82e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-1)" "unprognostic (9.29e-2)" "unprognostic (5.87e-2)" "unprognostic (6.44e-3)" "unprognostic (3.13e-1)" "unprognostic (6.47e-2)" "unprognostic (5.63e-2)" "unprognostic (8.20e-3)" "unprognostic (8.90e-5)" "unprognostic (1.48e-2)" "unprognostic (9.24e-2)" "unprognostic (9.56e-2)" "unprognostic (2.29e-1)" 0.1 0.5 0.6 0.7 1.0 0.0 0.1 0.2 1.2 0.4 0.2 0.7 1.1 0.6 0.9 0.2 0.4 0.1 0.6 1.4 0.9 2.8 2.0 0.1 2.9 0.1 4.3 0.4 0.1 0.0 0.0 0.7 0.5 1.6 0.2 0.4 0.0 0.0 0.2 0.8 0.0 0.3 0.2 8.9 0.0 5.0 8.0 1.4 0.9 2.5 0.0 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 14.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.2 1.2 0.9 2.8 4.3 0.4 1.6 1.4 NNAT Peg5 ENSG00000053438 Neuronatin Q16517 20 37521215-37523693 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "brain: 117.2;pituitary gland: 165.1;placenta: 69.1" "Cell line enriched" "Detected in some" 22 "SH-SY5Y: 124.5" "Group enriched" "Detected in many" 16 "glioma: 87.5;testis cancer: 55.0;urothelial cancer: 37.4" "Region enhanced" "Detected in all" "basal ganglia: 117.2" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "unprognostic (1.18e-2)" "unprognostic (7.41e-3)" "unprognostic (1.85e-2)" "unprognostic (1.04e-2)" "prognostic unfavourable (9.66e-4)" "unprognostic (7.08e-2)" "unprognostic (1.42e-1)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (7.52e-2)" "unprognostic (4.94e-2)" "unprognostic (1.64e-2)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.96e-1)" "unprognostic (1.15e-3)" "unprognostic (5.90e-2)" 17.0 11.6 35.4 2.6 117.2 2.3 3.5 4.9 68.4 2.3 7.0 11.1 0.0 3.4 4.6 2.5 2.6 2.8 4.2 1.7 35.0 21.4 1.4 1.1 1.7 1.9 4.9 14.0 1.3 1.6 1.0 165.1 69.1 7.9 2.4 3.9 1.5 3.4 1.5 8.0 3.8 3.2 4.4 2.1 1.8 2.1 2.9 3.8 0.2 1.5 0.0 1.1 3.3 0.6 0.7 0.7 0.3 0.3 0.0 1.0 0.0 0.3 0.2 2.2 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.5 0.1 0.1 0.5 0.0 0.0 0.0 5.5 0.0 0.3 0.0 0.1 0.9 0.1 0.1 0.2 0.0 0.6 0.0 0.0 3.1 0.2 124.5 0.1 0.7 0.0 0.2 0.0 0.1 0.9 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 1.0 0.3 0.0 0.0 0.7 0.0 0.0 35.4 117.2 4.9 41.0 35.0 21.4 4.9 14.0 7.9 3.8 NODAL ENSG00000156574 "Nodal growth differentiation factor" Q96S42 10 70432315-70447951 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Developmental protein, Growth factor" "Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.0;skeletal muscle: 5.1;testis: 5.2" "Cell line enhanced" "Detected in some" "CACO-2: 5.2;SH-SY5Y: 3.9;U-698: 3.3" "Cancer enriched" "Detected in some" 10 "testis cancer: 20.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045201 Uncertain "Secreted to blood" "HPA045201: AB_2679252" "unprognostic (3.07e-2)" "unprognostic (2.10e-1)" "unprognostic (1.51e-2)" "unprognostic (2.41e-1)" "unprognostic (1.70e-1)" "unprognostic (4.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.65e-1)" "unprognostic (5.66e-3)" "unprognostic (3.12e-2)" "unprognostic (8.77e-2)" "unprognostic (1.61e-1)" "unprognostic (1.63e-5)" "unprognostic (4.37e-1)" "unprognostic (6.98e-2)" "unprognostic (1.19e-1)" "unprognostic (2.02e-1)" 1.2 0.1 1.1 0.3 2.4 2.0 0.9 2.4 5.0 0.9 0.5 3.8 0.3 0.8 0.7 0.3 1.4 0.4 1.0 0.7 1.2 1.0 0.3 0.3 1.0 0.7 1.5 0.3 0.9 0.3 0.0 0.3 0.9 2.9 0.8 0.0 0.3 0.5 0.3 5.1 3.5 0.6 0.3 0.4 0.9 0.9 5.2 0.3 0.8 0.3 0.3 0.3 0.7 0.7 1.2 0.4 1.1 0.6 0.0 2.2 0.3 1.0 0.6 2.2 2.5 0.0 0.0 0.3 0.1 0.0 0.4 0.0 5.2 0.6 1.7 0.1 0.0 0.2 0.0 1.9 0.0 1.4 0.2 0.0 0.1 0.4 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.7 0.0 0.7 0.2 0.7 1.4 0.1 0.6 0.7 1.4 0.0 0.3 0.4 3.9 1.1 0.5 0.0 1.1 0.5 0.0 0.0 0.7 0.3 0.3 1.2 2.8 3.3 0.0 0.5 0.3 0.0 0.6 0.0 0.2 0.5 0.7 0.2 1.2 2.2 0.4 1.2 0.8 0.6 1.1 0.0 0.4 0.0 0.2 0.3 1.1 2.4 2.4 5.0 1.2 1.0 1.5 0.3 2.9 0.3 NOL4 "CT125, HRIHFB2255, NOLP" ENSG00000101746 "Nucleolar protein 4" O94818 18 33851100-34224952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 12.5;testis: 14.5" "Cell line enhanced" "Detected in some" "SCLC-21H: 28.2;SH-SY5Y: 7.5;U-698: 6.1" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046740 Supported Nucleoplasm Nucleoplasm "HPA046740: AB_10960527" "unprognostic (7.86e-2)" "unprognostic (1.58e-1)" "unprognostic (3.61e-1)" "unprognostic (5.43e-7)" "unprognostic (5.76e-2)" "unprognostic (1.56e-2)" "unprognostic (7.19e-2)" "unprognostic (3.45e-1)" "unprognostic (1.12e-2)" "unprognostic (4.78e-2)" "unprognostic (3.52e-2)" "unprognostic (1.23e-1)" "unprognostic (1.39e-1)" "unprognostic (7.77e-2)" "unprognostic (7.71e-2)" 0.0 2.4 3.3 0.0 6.2 0.0 0.0 8.9 12.5 0.7 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.8 5.3 1.0 2.8 0.2 0.2 1.2 0.0 2.0 0.0 3.2 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 14.5 2.1 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.5 0.1 0.0 0.0 0.0 28.2 7.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 NOS1 "nNOS, NOS" ENSG00000089250 "Nitric oxide synthase 1" P29475 12 117208142-117452170 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Oxidoreductase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 13.4;skeletal muscle: 36.3" "Cell line enhanced" "Detected in some" "HaCaT: 6.2;RH-30: 12.8;RPTEC TERT1: 8.0;U-2 OS: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002167, HPA058312, HPA069509" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB002167: AB_564073, HPA058312: , HPA069509: " "unprognostic (1.63e-1)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (6.64e-3)" "unprognostic (4.91e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-1)" "unprognostic (9.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-1)" "unprognostic (7.56e-2)" "unprognostic (1.01e-1)" "unprognostic (3.73e-2)" "unprognostic (1.34e-1)" "unprognostic (5.97e-4)" "unprognostic (1.87e-1)" 0.5 0.6 3.8 3.5 13.4 0.7 0.6 4.4 4.8 0.7 2.0 1.1 0.0 0.5 0.6 0.7 1.3 0.8 0.5 0.5 2.8 4.4 1.9 0.5 1.4 0.6 2.4 1.6 0.5 1.9 0.4 0.8 0.4 5.9 1.6 0.9 0.6 3.8 0.6 36.3 2.2 0.6 0.8 1.2 0.5 0.5 0.9 3.0 0.0 0.6 0.0 0.5 0.9 0.6 0.9 0.6 2.1 0.5 0.8 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 6.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 1.4 0.0 12.8 0.1 8.0 0.0 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.5 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 2.1 0.5 0.5 0.5 0.4 0.4 0.7 0.4 0.3 0.2 0.9 0.5 0.5 1.9 0.8 0.5 0.6 0.3 0.0 3.8 13.4 4.4 4.8 2.8 4.4 2.4 1.6 5.9 3.0 NOS1AP "CAPON, KIAA0464" ENSG00000198929 "Nitric oxide synthase 1 adaptor protein" O75052 1 162069774-162370475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.1" "Cell line enhanced" "Detected in many" "A-431: 6.7;HEL: 8.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB018582, HPA030066, HPA055561" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB018582: AB_2251417, HPA030066: , HPA055561: " "unprognostic (7.04e-3)" "unprognostic (2.20e-1)" "unprognostic (1.79e-2)" "unprognostic (3.93e-2)" "unprognostic (1.58e-2)" "unprognostic (4.75e-2)" "unprognostic (2.07e-1)" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.54e-1)" "unprognostic (3.48e-1)" "unprognostic (1.71e-1)" "unprognostic (2.15e-5)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (5.08e-3)" 2.1 7.9 10.2 1.6 7.0 4.8 6.2 23.1 34.1 2.4 3.7 3.1 7.1 2.7 2.4 1.7 2.2 2.6 7.4 2.3 19.0 10.1 2.9 7.6 2.3 1.4 6.5 13.0 1.6 3.5 2.0 2.7 2.2 5.5 2.5 3.9 2.7 4.6 9.7 1.7 2.4 3.1 2.1 4.4 1.3 3.8 4.0 3.1 0.0 1.6 0.2 1.8 1.8 2.2 0.0 0.1 1.1 0.5 0.0 0.3 0.1 6.7 0.0 3.2 1.8 0.1 0.0 0.5 0.6 0.7 0.9 0.8 1.5 1.7 0.0 4.3 0.2 5.1 1.0 0.2 0.3 0.1 3.1 8.1 1.1 1.7 0.0 0.0 0.1 0.3 0.2 0.0 0.2 1.7 0.6 0.1 0.1 3.5 0.6 0.0 2.3 3.0 0.1 1.2 0.2 1.5 2.3 2.6 1.8 1.5 0.3 1.2 1.9 0.4 0.7 0.1 0.8 0.0 1.2 4.6 0.0 0.0 1.0 0.1 0.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 10.2 7.0 23.1 21.1 19.0 10.1 6.5 13.0 5.5 3.1 NOVA1 ENSG00000139910 "NOVA alternative splicing regulator 1" P51513 14 26443093-26597754 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Cell line enhanced" "Detected in many" "AF22: 25.6;ASC diff: 13.9;HAP1: 12.5" "Cancer enriched" "Detected in many" 5 "glioma: 14.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 2.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004155 Uncertain Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA004155: AB_1079497" "unprognostic (1.46e-1)" "unprognostic (4.43e-3)" "unprognostic (6.55e-3)" "unprognostic (4.00e-2)" "unprognostic (6.69e-3)" "unprognostic (4.29e-2)" "unprognostic (3.74e-3)" "unprognostic (2.41e-1)" "unprognostic (5.21e-1)" "unprognostic (4.32e-2)" "unprognostic (5.04e-4)" "unprognostic (2.40e-1)" "unprognostic (1.93e-3)" "unprognostic (9.27e-4)" "unprognostic (9.20e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-4)" 17.8 6.7 17.5 3.4 17.4 1.3 32.9 54.7 49.2 12.2 6.3 13.3 5.0 2.5 9.4 6.9 4.0 6.2 6.2 3.0 17.1 25.1 7.0 2.2 2.7 4.4 19.2 17.8 6.3 2.7 4.4 14.1 1.3 26.4 5.4 6.5 4.0 2.8 17.5 6.9 3.1 3.4 9.9 22.5 2.1 3.3 10.3 14.9 0.0 4.1 2.7 5.2 5.6 9.4 0.3 0.3 0.6 0.4 2.2 0.5 0.0 0.0 6.0 25.6 0.0 13.9 7.5 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.4 0.4 0.1 12.5 0.1 0.0 0.0 1.0 0.0 0.0 0.2 5.2 0.0 1.2 9.3 0.0 1.9 1.9 5.4 0.0 0.0 4.1 0.0 5.2 0.1 7.5 6.1 0.7 8.5 0.1 3.5 4.9 8.1 4.7 0.0 0.0 0.0 0.7 0.0 0.0 3.6 4.1 3.1 0.7 0.0 0.0 0.0 5.0 0.0 3.7 0.6 0.0 0.2 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.3 0.2 0.5 0.6 2.2 0.4 0.3 0.4 0.0 17.5 17.4 54.7 26.9 17.1 25.1 19.2 17.8 26.4 14.9 NOVA2 "ANOVA, NOVA3" ENSG00000104967 "NOVA alternative splicing regulator 2" Q9UNW9 19 45933734-45973546 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.5" "Cell line enhanced" "Detected in some" "AF22: 8.1;HDLM-2: 8.6;HUVEC TERT2: 13.9;TIME: 20.7;U-2 OS: 5.1" "Cancer enhanced" "Detected in many" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045607 Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "HPA045607: AB_10962628" "unprognostic (9.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.68e-2)" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (3.04e-3)" "unprognostic (1.46e-1)" "unprognostic (6.21e-2)" "unprognostic (2.36e-1)" "unprognostic (3.02e-3)" "unprognostic (6.42e-5)" "unprognostic (1.16e-1)" "prognostic unfavourable (3.04e-4)" "unprognostic (5.05e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-1)" "unprognostic (8.31e-2)" 11.8 4.5 23.9 2.7 22.7 1.3 5.7 13.0 33.5 3.9 2.5 7.2 0.0 2.5 5.6 2.7 2.4 3.6 4.2 5.8 17.1 10.9 3.2 2.7 9.4 2.2 7.1 17.3 2.0 2.5 3.3 5.7 9.7 11.1 2.6 2.4 2.5 2.4 3.1 5.5 2.7 2.0 5.7 5.5 2.4 2.5 4.3 8.7 0.0 4.5 0.4 1.8 3.9 3.5 0.0 0.0 0.4 0.1 0.4 0.1 0.0 0.0 0.1 8.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 8.6 0.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 1.7 4.6 0.0 0.0 0.0 0.0 0.0 20.7 0.0 5.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 23.9 22.7 13.0 29.3 17.1 10.9 7.1 17.3 11.1 8.7 NOXO1 "P41NOXA, P41NOXB, P41NOXC, SH3PXD5, SNX28" ENSG00000196408 "NADPH oxidase organizer 1" Q8NFA2 16 1978917-1984192 "FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.0;intestine: 10.5;lymphoid tissue: 10.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.6;HaCaT: 3.8;MOLT-4: 3.3;SCLC-21H: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA071540 Enhanced "HPA071540: " "unprognostic (3.74e-1)" "unprognostic (1.10e-1)" "unprognostic (1.73e-2)" 0.5 0.0 1.1 10.6 3.1 0.3 0.5 7.0 2.0 0.9 10.5 0.5 0.5 4.6 0.5 1.5 2.2 0.2 2.8 0.5 1.0 0.9 0.5 2.2 1.0 0.5 0.6 0.5 0.5 0.5 0.3 0.8 0.5 0.5 0.5 8.6 0.5 4.9 0.5 0.5 0.6 4.2 0.6 0.5 0.5 0.3 4.8 0.5 1.4 0.5 0.5 4.1 1.1 0.5 0.7 0.2 1.3 0.0 0.0 0.3 0.0 0.4 1.0 1.1 0.3 0.6 0.0 0.0 0.1 0.3 0.9 0.5 0.8 6.6 0.6 0.5 0.0 3.8 0.0 0.3 0.0 1.2 0.0 0.0 1.9 0.0 0.1 0.0 0.6 1.1 0.2 1.0 0.4 0.0 0.3 0.0 0.0 0.3 3.3 0.1 0.0 0.0 0.5 1.0 0.1 0.8 0.0 3.5 0.0 1.4 1.3 0.2 2.6 1.0 0.0 0.7 0.1 0.0 1.6 0.2 0.6 1.5 0.6 0.1 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 1.1 3.1 7.0 2.0 1.0 0.9 0.6 0.5 0.5 0.5 NPAS1 "bHLHe11, MOP5, PASD5" ENSG00000130751 "Neuronal PAS domain protein 1" Q99742 19 47019820-47045775 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.2;skin 1: 10.5;stomach 1: 8.0" "Cell line enhanced" "Detected in many" "BJ: 8.7;Daudi: 8.9;HEK 293: 9.8;HMC-1: 8.1;NB-4: 15.6;U-266/84: 9.5" "Cancer enhanced" "Detected in many" "testis cancer: 5.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 2.2" "Lineage enhanced" "Detected in single" "B-cells: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA043364, HPA072259" Approved Approved Nucleoplasm Nucleoplasm "HPA043364: , HPA072259: " "unprognostic (2.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.32e-4)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-3)" "unprognostic (2.21e-2)" "unprognostic (1.09e-1)" "unprognostic (3.75e-1)" "unprognostic (5.91e-2)" "unprognostic (2.64e-1)" "unprognostic (2.14e-8)" "unprognostic (8.82e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (4.20e-2)" 0.6 0.6 9.5 1.3 4.1 0.9 1.3 0.4 14.2 0.4 0.9 0.4 0.0 0.5 0.6 0.4 0.8 1.2 0.5 0.9 9.0 5.2 1.2 0.8 0.9 1.7 3.0 4.1 0.4 1.5 0.7 1.1 0.8 5.1 0.6 0.5 3.4 0.7 0.5 0.5 10.5 0.4 0.7 0.8 3.9 8.0 0.8 0.2 0.0 0.6 0.0 1.3 0.5 0.4 2.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 2.1 0.2 0.4 0.2 0.1 0.0 8.7 0.2 0.1 0.4 0.6 0.5 8.9 2.0 7.0 0.2 1.8 0.2 0.1 0.6 9.8 0.7 0.8 2.1 0.0 4.7 8.1 0.8 0.3 0.0 0.1 0.2 3.0 0.7 1.1 0.7 0.3 15.6 2.1 1.5 0.8 0.3 0.7 0.5 0.5 0.7 0.6 0.7 0.3 2.0 1.9 1.5 0.1 0.1 0.9 0.1 0.2 4.9 9.5 1.9 1.1 0.9 6.4 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 9.5 4.1 0.4 14.2 9.0 5.2 3.0 4.1 5.1 0.2 NPAS3 "bHLHe12, MOP6, PASD6" ENSG00000151322 "Neuronal PAS domain protein 3" Q8IXF0 14 32934933-33804176 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.8" "Group enriched" "Detected in some" 11 "AF22: 8.8;U-266/70: 21.8;U-266/84: 6.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 6.4;glioma: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002892, HPA075337" Enhanced Supported Nucleoplasm Nucleoplasm "HPA002892: AB_1079403, HPA075337: " "unprognostic (6.02e-3)" "unprognostic (2.37e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-2)" "unprognostic (3.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-2)" "unprognostic (5.65e-2)" "unprognostic (2.74e-1)" "unprognostic (3.12e-3)" "unprognostic (5.29e-3)" "unprognostic (1.38e-1)" "unprognostic (3.18e-3)" "unprognostic (2.65e-3)" "unprognostic (1.50e-1)" "unprognostic (2.69e-3)" "unprognostic (3.27e-1)" 1.8 2.4 17.4 1.4 14.4 1.0 2.7 8.5 29.8 14.0 1.8 15.8 0.7 1.5 9.1 2.6 1.6 8.5 2.2 1.6 18.7 10.3 2.4 1.3 1.3 1.3 11.7 13.0 6.4 2.2 2.5 1.6 2.0 16.2 2.5 1.7 0.8 2.7 3.6 2.0 1.4 1.6 2.2 13.8 3.1 2.8 3.5 16.3 0.0 4.4 0.0 1.5 1.1 1.4 0.0 0.6 0.1 0.2 0.0 0.2 0.0 0.0 0.0 8.8 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 21.8 6.2 0.0 0.3 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.6 0.0 0.0 17.4 14.4 8.5 15.3 18.7 10.3 11.7 13.0 16.2 16.3 NPAS4 "bHLHe79, Le-PAS, NXF, PASD10" ENSG00000174576 "Neuronal PAS domain protein 4" Q8IUM7 11 66421004-66426707 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 18.7;pituitary gland: 19.5" "Cell line enhanced" "Detected in some" "AF22: 1.6;BJ: 1.4;HMC-1: 1.2;Karpas-707: 4.4;SCLC-21H: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 4.3;basal ganglia: 3.2;cerebral cortex: 8.0;hippocampal formation: 7.1;olfactory region: 5.3" "Low region specificity" "Detected in all" HPA039255 Uncertain "HPA039255: AB_10674282" "unprognostic (7.81e-2)" "unprognostic (9.93e-2)" "unprognostic (1.55e-2)" "unprognostic (1.24e-1)" "unprognostic (2.51e-1)" "unprognostic (1.78e-3)" "unprognostic (4.97e-1)" "unprognostic (7.84e-2)" "unprognostic (1.85e-2)" "unprognostic (3.29e-2)" "unprognostic (3.96e-2)" "unprognostic (1.12e-3)" "unprognostic (1.58e-1)" "unprognostic (1.37e-1)" "unprognostic (4.24e-1)" "unprognostic (3.21e-2)" 1.1 1.1 1.4 1.7 12.7 0.2 0.5 18.7 12.6 1.1 1.6 1.0 2.4 0.7 4.4 2.0 1.3 0.9 0.8 0.4 4.3 3.1 0.3 0.3 0.4 0.2 0.2 1.5 0.6 1.3 0.7 19.5 0.3 2.9 2.1 0.6 1.5 0.5 2.9 0.3 0.2 0.8 4.0 0.4 0.5 0.9 0.7 0.0 0.0 0.2 0.0 0.2 1.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.4 0.2 0.6 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 12.7 18.7 12.6 4.3 3.1 0.2 1.5 2.9 0.0 NPB "PPL7, PPNPB" ENSG00000183979 "Neuropeptide B" Q8NG41 17 81900745-81902905 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.2" "Cell line enhanced" "Detected in some" "HDLM-2: 4.2;PC-3: 5.6;RH-30: 4.3;SH-SY5Y: 4.6;U-2 OS: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 2.1;MAIT T-cell: 2.2" "Group enriched" "Detected in many" 14 "granulocytes: 2.1;T-cells: 2.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 9.3;basal ganglia: 16.6;cerebral cortex: 7.3;hippocampal formation: 12.3;hypothalamus: 5.9" "Secreted in other tissues" "unprognostic (2.44e-2)" "unprognostic (6.21e-2)" "unprognostic (2.90e-1)" "unprognostic (3.47e-3)" "unprognostic (9.42e-2)" "unprognostic (1.46e-1)" "unprognostic (3.31e-1)" "unprognostic (1.92e-1)" "unprognostic (3.55e-2)" "unprognostic (5.40e-2)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (6.06e-2)" "unprognostic (3.71e-1)" "unprognostic (4.32e-1)" 1.5 0.6 4.7 5.2 5.1 1.1 2.2 3.4 6.9 2.3 1.3 3.8 0.1 0.4 2.8 2.4 0.6 2.1 0.8 1.0 2.7 10.3 1.3 1.2 1.1 4.4 6.1 2.7 2.4 0.9 1.1 0.7 8.0 4.5 1.4 1.2 1.9 0.8 1.8 1.6 2.5 1.3 1.9 13.2 2.8 1.0 2.0 1.4 1.9 0.7 0.0 3.7 0.8 2.5 0.1 0.0 2.1 0.0 0.0 2.2 0.0 0.7 2.1 1.5 0.4 0.3 0.4 1.3 0.6 0.4 0.4 0.0 1.0 0.2 0.4 0.2 0.3 0.0 0.9 0.3 0.6 4.2 0.2 0.8 0.1 0.0 0.2 0.1 0.6 0.0 1.7 0.6 0.5 0.1 1.3 0.2 0.2 0.4 0.1 1.1 0.5 5.6 0.4 4.3 0.0 0.3 1.1 0.9 4.6 0.4 0.6 0.9 0.1 0.1 0.5 0.8 5.3 0.2 0.6 0.5 0.5 0.0 0.1 1.3 0.4 0.2 0.0 2.1 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 4.7 5.1 3.4 6.9 2.7 10.3 6.1 2.7 4.5 1.4 NPBWR1 GPR7 ENSG00000183729 "Neuropeptides B and W receptor 1" P48145 8 52938431-52941117 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.1;brain: 2.8;liver: 2.6" "Group enriched" "Detected in some" 5 "A549: 2.2;HaCaT: 2.9;SiHa: 4.5" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 9 "classical monocyte: 1.6;eosinophil: 3.1" "Group enriched" "Detected in many" 9 "granulocytes: 3.1;monocytes: 1.6" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 10.5" "unprognostic (2.33e-1)" "unprognostic (1.01e-1)" "unprognostic (7.86e-2)" "unprognostic (2.67e-2)" "unprognostic (2.05e-1)" "unprognostic (1.02e-2)" "unprognostic (2.21e-1)" "unprognostic (3.89e-3)" "unprognostic (2.18e-1)" "unprognostic (8.55e-2)" "unprognostic (2.84e-1)" "unprognostic (6.76e-2)" "unprognostic (4.71e-2)" "unprognostic (2.26e-1)" "unprognostic (4.90e-2)" "unprognostic (2.68e-1)" "unprognostic (1.23e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.3 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.3 0.1 0.0 0.0 3.1 1.6 0.0 0.2 0.8 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.5 0.3 0.0 4.5 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.8 NPBWR2 GPR8 ENSG00000125522 "Neuropeptides B and W receptor 2" P48146 20 64105820-64107171 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "cerebral cortex: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "unprognostic (1.44e-1)" 0.2 2.4 0.3 0.3 1.8 0.3 0.2 0.4 14.8 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.2 2.3 0.2 0.2 0.2 1.6 0.2 0.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.4 14.8 0.2 0.5 0.2 2.3 0.1 0.0 NPC1 SLC65A1 ENSG00000141458 "NPC intracellular cholesterol transporter 1" O15118 18 23506184-23586898 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.6" "Cell line enhanced" "Detected in all" "hTERT-HME1: 70.3;U-87 MG: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 32.7" "Group enriched" "Detected in all" 4 "dendritic cells: 32.7;T-cells: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026618, CAB070132, HPA077445" Approved Supported Nucleoplasm,Vesicles 27000 "Nucleoplasm, Vesicles" "CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: " "unprognostic (1.74e-1)" "unprognostic (1.53e-3)" "unprognostic (2.67e-1)" "unprognostic (1.25e-1)" "unprognostic (3.20e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (2.26e-6)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (7.36e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-3)" "unprognostic (2.78e-2)" "unprognostic (1.89e-1)" "unprognostic (2.73e-2)" "unprognostic (1.38e-1)" "unprognostic (2.08e-3)" 13.4 38.8 17.4 11.2 30.9 26.4 15.8 7.1 25.1 10.1 8.7 65.6 3.4 10.2 11.1 11.7 12.8 8.2 11.2 7.1 23.4 14.3 9.9 10.3 17.8 13.0 46.0 15.4 12.0 7.9 51.8 9.9 18.9 27.7 9.7 8.9 12.0 25.4 10.1 13.7 17.0 12.2 10.9 41.4 11.5 12.0 9.5 38.4 7.0 8.3 5.3 10.7 10.8 10.8 3.6 32.7 3.8 5.8 4.6 14.5 4.1 5.3 10.6 4.5 7.4 14.9 11.6 10.5 9.3 20.2 9.9 21.4 7.1 7.8 4.5 7.2 13.4 15.0 5.8 15.9 8.8 3.5 4.6 1.6 9.6 16.0 21.4 6.1 7.3 11.1 15.8 20.8 70.3 9.7 4.8 12.0 11.0 8.1 2.5 3.6 3.2 9.6 3.6 7.2 11.2 23.0 13.3 1.9 3.7 11.1 16.1 13.7 4.0 4.8 12.5 21.0 4.1 8.3 8.0 7.5 23.1 3.1 46.2 5.4 9.4 1.8 4.1 3.8 14.5 3.8 9.8 2.4 5.9 9.9 1.7 3.6 2.7 7.3 3.7 4.6 5.8 32.7 7.7 4.1 17.4 30.9 7.1 25.1 23.4 14.3 46.0 15.4 27.7 38.4 NPFFR1 "GPR147, NPFF1R1, OT7T022" ENSG00000148734 "Neuropeptide FF receptor 1" Q9GZQ6 10 70247329-70283676 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 34.9" "Cell line enhanced" "Detected in some" "U-2 OS: 4.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Group enriched" "Detected in all" 5 "basal ganglia: 10.2;cerebellum: 34.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basal ganglia: 16.1;hypothalamus: 7.3" "Low region specificity" "Detected in many" HPA037521 Uncertain "HPA037521: " "unprognostic (1.73e-3)" "unprognostic (7.29e-4)" "unprognostic (2.12e-1)" "unprognostic (3.50e-2)" "unprognostic (2.07e-1)" "unprognostic (8.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.48e-1)" "unprognostic (4.14e-2)" "unprognostic (3.51e-1)" "unprognostic (9.62e-2)" "unprognostic (6.78e-2)" "unprognostic (5.84e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" 0.6 0.5 1.9 1.8 10.2 1.3 0.9 34.9 2.6 0.9 0.6 2.6 0.0 0.8 1.0 1.2 0.4 1.6 0.6 0.4 2.7 4.1 0.5 0.5 1.3 2.5 2.2 4.1 0.8 0.3 0.9 0.4 0.4 4.7 0.6 0.8 5.4 0.4 1.1 1.0 1.0 0.8 0.4 4.0 1.0 1.4 4.7 2.0 0.0 0.6 0.0 1.4 0.6 0.7 1.0 1.2 2.4 2.2 1.3 0.6 2.6 1.1 0.7 0.9 0.7 0.8 1.2 0.7 0.3 0.4 0.3 0.3 1.3 2.3 0.8 0.7 1.0 1.0 2.2 1.2 0.7 0.7 0.8 1.0 1.0 1.0 0.8 0.8 1.3 0.7 1.0 0.5 0.8 0.9 0.9 0.9 0.5 0.9 0.7 0.9 0.7 0.3 0.9 0.8 0.5 0.8 0.8 0.8 0.8 0.8 1.1 0.4 0.5 0.6 1.0 0.9 4.7 0.8 1.0 0.7 0.8 0.5 0.6 0.9 0.7 2.4 2.2 0.4 0.5 0.7 0.5 0.5 0.5 0.4 1.2 1.0 0.6 0.6 1.9 1.3 0.4 0.9 0.4 2.6 1.9 10.2 34.9 2.6 2.7 4.1 2.2 4.1 4.7 2.0 NPIPA1 "morpheus, NPIP" ENSG00000183426 "Nuclear pore complex interacting protein family member A1" Q9UND3 16 14922802-14952060 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.1" "Cell line enhanced" "Detected in many" "HHSteC: 33.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 16 "B-cells: 2.3;granulocytes: 1.7;T-cells: 1.3" HPA053611 Supported Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (2.77e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-2)" "unprognostic (2.29e-2)" "unprognostic (9.21e-2)" "unprognostic (1.65e-2)" "unprognostic (5.12e-2)" "unprognostic (1.08e-1)" "unprognostic (8.82e-3)" "unprognostic (3.65e-2)" "unprognostic (1.74e-7)" "unprognostic (2.28e-1)" "unprognostic (8.76e-2)" "unprognostic (1.73e-2)" "unprognostic (2.66e-5)" 5.1 6.0 5.9 3.8 4.9 4.2 4.8 33.1 8.3 5.0 5.8 1.8 15.6 0.0 3.0 16.3 2.7 4.6 7.0 6.2 6.6 3.0 4.3 5.4 3.7 25.2 4.7 1.1 13.6 3.0 7.8 3.3 2.5 11.7 7.9 16.3 3.0 12.4 3.8 5.0 3.2 6.5 6.1 4.1 5.0 4.0 2.3 0.0 1.7 0.1 0.1 1.3 0.7 0.1 5.2 24.1 9.3 0.0 0.4 4.2 9.2 6.4 8.5 7.6 3.6 5.7 1.5 13.2 12.7 4.2 11.1 1.2 8.7 4.7 4.2 0.0 8.1 19.2 33.5 11.5 2.7 18.6 18.2 7.0 12.8 4.1 1.2 6.4 9.6 11.1 0.0 6.1 0.2 0.2 4.5 0.1 2.1 13.6 11.1 1.0 9.2 4.9 0.6 10.4 1.9 10.1 0.8 11.3 0.5 0.2 2.9 3.8 2.7 3.0 0.4 0.7 5.7 1.7 0.0 0.0 0.8 0.0 1.3 2.3 0.3 1.2 0.0 1.3 0.6 0.4 0.0 0.1 0.1 0.0 0.7 0.7 NPIPA2 ENSG00000254852 "Nuclear pore complex interacting protein family member A2" E9PIF3 16 14748066-14765413 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 11.8" "Cell line enhanced" "Detected in some" "BEWO: 12.0;NB-4: 4.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " 1.6 1.2 1.3 1.1 1.5 0.9 1.8 11.8 3.8 0.6 3.2 0.6 1.7 2.7 1.1 2.4 0.8 1.3 1.8 1.5 0.6 0.5 1.6 0.9 1.0 2.6 1.2 2.3 4.1 1.1 2.2 2.6 3.1 1.0 4.2 4.1 1.0 0.8 1.3 0.9 1.6 5.9 1.2 0.8 3.3 1.5 1.6 0.0 0.1 0.1 0.0 0.5 0.0 0.4 0.4 0.3 0.0 0.4 0.3 12.0 1.0 0.5 0.1 0.3 0.4 1.7 0.0 1.1 0.9 1.4 0.3 0.0 0.1 0.9 0.7 0.8 0.9 0.2 0.4 0.2 2.8 0.1 1.6 1.6 1.2 0.3 0.8 0.8 0.2 2.3 1.3 4.1 0.8 0.5 1.3 0.8 0.2 0.7 0.6 1.1 0.6 0.4 0.7 1.7 0.0 1.0 0.9 0.4 0.3 0.0 0.5 0.4 0.3 0.3 1.4 0.6 1.0 0.1 0.1 0.0 0.5 0.0 0.3 0.7 0.5 0.1 0.0 1.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 NPIPA3 ENSG00000224712 "Nuclear pore complex interacting protein family member A3" F8WFD2 16 14708944-14726338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 13.2" "Cell line enhanced" "Detected in some" "HSkMC: 5.0;NB-4: 11.2;SK-MEL-30: 16.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (1.44e-1)" "unprognostic (7.83e-3)" "unprognostic (8.12e-3)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" "unprognostic (5.69e-3)" "unprognostic (3.11e-2)" "unprognostic (4.58e-3)" "unprognostic (4.87e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (1.67e-3)" "unprognostic (1.20e-3)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" "unprognostic (1.71e-2)" 1.3 1.4 1.8 2.3 1.3 1.9 1.2 13.2 5.0 0.8 2.9 0.5 2.4 2.2 1.1 2.8 6.4 1.0 2.2 1.8 1.1 0.8 1.2 1.0 1.1 2.8 1.5 7.2 4.1 1.3 2.3 2.6 1.9 2.9 5.3 3.2 3.4 1.2 1.0 1.0 1.3 1.8 1.4 1.0 1.9 1.6 0.1 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.6 0.1 0.3 0.0 0.1 1.5 0.5 0.0 0.4 0.4 0.0 2.1 3.5 0.2 1.3 0.1 0.1 2.3 0.3 0.1 0.0 0.4 0.7 0.4 0.2 0.1 0.5 5.0 0.7 1.3 0.2 0.1 0.1 0.3 0.3 1.2 0.0 11.2 0.9 0.0 0.1 0.0 0.0 3.1 1.0 0.5 0.5 0.0 0.2 16.1 0.2 0.0 0.5 0.6 0.1 0.0 0.1 0.0 0.2 0.1 1.9 0.1 2.0 1.6 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPA5 ENSG00000183793 "Nuclear pore complex interacting protein family member A5" E9PKD4 16 15363624-15381047 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 25.3" "Cell line enhanced" "Detected in many" "THP-1: 15.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (4.19e-4)" "unprognostic (5.85e-2)" "unprognostic (5.92e-2)" "unprognostic (7.85e-2)" "unprognostic (6.58e-2)" "unprognostic (9.02e-3)" "unprognostic (1.57e-2)" "unprognostic (4.34e-3)" "unprognostic (1.85e-1)" "unprognostic (2.85e-1)" "unprognostic (9.18e-2)" "unprognostic (4.02e-2)" 2.0 2.7 4.9 0.8 4.0 3.2 3.3 25.3 6.6 3.2 4.5 2.4 8.0 8.4 4.0 5.8 4.8 4.2 5.5 5.7 1.9 2.5 4.5 2.4 3.6 5.5 4.0 7.6 8.9 1.0 3.3 2.4 1.6 2.5 4.6 13.9 2.1 2.6 2.5 2.7 2.3 8.8 2.9 1.0 2.8 2.5 0.8 0.3 0.1 0.1 1.1 0.7 0.1 0.9 1.4 4.9 0.7 9.2 9.7 0.7 1.9 4.6 6.4 6.5 2.0 0.8 2.0 0.5 4.9 2.0 1.7 4.9 3.3 3.9 1.9 2.6 5.8 9.7 1.3 0.6 3.6 1.9 8.4 2.5 3.4 3.3 2.7 1.5 6.1 1.0 2.0 3.2 6.8 0.9 0.7 0.7 0.6 5.4 1.9 0.0 0.7 5.4 2.4 6.0 2.4 15.5 7.7 0.0 2.5 7.5 0.4 4.3 6.0 7.2 0.9 3.7 1.3 0.1 0.1 0.0 0.1 0.0 0.7 0.8 0.4 0.2 0.3 0.4 0.2 0.1 0.0 1.1 0.1 0.1 0.1 0.1 NPIPA8 LCR16a9 ENSG00000214940 "Nuclear pore complex interacting protein family member A8" P0DM63 16 18317942-18336736 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 14.1" "Cell line enhanced" "Detected in some" "Daudi: 17.8;EFO-21: 17.8;HMC-1: 66.0;SCLC-21H: 16.1;THP-1: 17.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (1.68e-1)" "unprognostic (3.60e-2)" "unprognostic (2.81e-1)" 2.6 7.9 2.0 1.3 2.8 3.9 2.3 14.1 10.8 1.4 5.5 0.0 0.6 0.0 0.9 5.1 0.0 2.6 3.4 1.9 1.1 1.0 2.4 1.5 0.5 6.0 1.1 7.6 6.6 4.8 2.3 1.3 1.5 6.5 1.5 4.6 1.7 0.0 0.2 4.4 1.4 2.1 1.6 0.0 3.8 0.5 1.8 0.5 1.7 0.6 0.1 1.1 0.3 0.0 0.6 0.0 0.1 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.1 3.1 17.8 17.8 0.1 0.0 7.0 2.1 0.0 0.0 0.0 0.0 0.5 0.5 3.0 0.0 66.0 0.1 0.0 0.0 0.0 1.3 6.9 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.7 10.9 0.5 0.0 0.0 16.1 5.1 0.0 0.1 0.1 0.0 17.8 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 5.7 4.9 0.4 0.0 0.6 0.0 0.6 0.0 1.1 1.8 0.5 0.2 0.3 0.2 0.7 0.4 1.7 0.1 0.0 0.5 0.0 0.3 NPM2 ENSG00000158806 "Nucleophosmin/nucleoplasmin 2" Q86SE8 8 22024125-22036897 "Predicted intracellular proteins" Fertilization "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6;parathyroid gland: 40.2;thyroid gland: 23.2" "Cell line enhanced" "Detected in some" "HaCaT: 13.1;HEL: 10.6;Hep G2: 23.4;THP-1: 8.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 10.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.1" "Group enriched" "Detected in many" 6 "granulocytes: 4.1;T-cells: 2.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA041070 Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA041070: " "unprognostic (1.40e-2)" "unprognostic (3.30e-2)" "unprognostic (3.11e-2)" "unprognostic (2.49e-2)" "unprognostic (1.55e-1)" "unprognostic (2.06e-1)" "unprognostic (1.61e-1)" "unprognostic (3.03e-2)" "unprognostic (5.30e-3)" "unprognostic (1.01e-1)" "prognostic favourable (9.02e-4)" "unprognostic (2.23e-1)" "prognostic favourable (3.18e-6)" "unprognostic (8.05e-3)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" "unprognostic (1.30e-1)" 0.8 15.6 14.4 0.5 11.4 1.3 2.3 20.4 27.6 1.9 1.4 0.8 0.3 2.4 4.9 1.3 1.4 2.8 2.2 1.5 13.0 13.8 2.9 1.3 2.0 1.0 14.9 15.7 0.8 7.4 40.2 7.8 0.9 7.2 4.7 1.4 3.7 3.1 1.8 0.8 2.0 1.4 4.0 3.0 7.5 2.0 3.1 2.4 0.1 23.2 0.0 0.8 1.4 0.8 0.4 0.0 4.1 0.0 0.0 2.2 0.1 2.8 0.4 0.1 0.2 0.7 0.0 1.2 0.3 0.4 1.8 3.7 1.2 2.7 0.0 0.9 0.0 13.1 0.3 0.0 1.1 0.1 0.3 10.6 0.7 23.4 2.4 1.4 1.0 0.4 1.8 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.1 2.8 0.5 0.3 0.2 1.0 0.6 4.4 0.0 2.8 0.2 0.0 0.0 3.5 0.5 8.3 0.0 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.9 0.0 2.2 0.0 0.9 2.1 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 1.4 0.1 14.4 11.4 20.4 27.6 13.0 13.8 14.9 15.7 7.2 2.4 NPR2 "AMDM, ANPb, ANPRB, GUCY2B, NPRB" ENSG00000159899 "Natriuretic peptide receptor 2" P20594 9 35792154-35809732 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "cGMP biosynthesis, Osteogenesis" "Lyase, Receptor" "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.7" "Cell line enhanced" "Detected in many" "ASC diff: 27.2;ASC TERT1: 20.3;BJ hTERT+: 16.6;HSkMC: 20.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.1" "Group enriched" "Detected in many" 6 "dendritic cells: 3.1;T-cells: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.93e-2)" "unprognostic (8.22e-3)" "unprognostic (9.25e-3)" "unprognostic (3.59e-2)" "unprognostic (6.13e-2)" "unprognostic (2.63e-2)" "unprognostic (1.41e-1)" "unprognostic (1.56e-1)" "unprognostic (1.56e-1)" "unprognostic (2.40e-1)" "unprognostic (3.06e-1)" "unprognostic (1.49e-1)" "unprognostic (3.99e-2)" "unprognostic (6.99e-3)" "unprognostic (7.10e-2)" "unprognostic (3.24e-1)" "unprognostic (7.86e-2)" 9.0 4.8 3.8 1.9 6.4 0.0 7.2 32.7 11.2 29.2 7.8 1.8 4.4 1.8 22.6 9.8 5.3 7.6 5.7 7.6 3.7 4.2 3.7 8.4 4.7 2.3 2.5 5.1 8.0 1.3 2.7 7.9 7.1 11.8 8.3 4.0 8.3 3.3 9.5 7.7 6.2 3.7 17.1 3.9 2.6 4.5 5.5 4.0 0.9 3.2 2.4 2.0 6.2 8.9 0.4 3.1 0.0 0.0 0.1 2.1 0.1 0.0 1.6 1.9 0.0 27.2 20.3 1.2 7.5 16.6 6.1 6.6 4.0 2.7 1.1 2.0 14.7 0.7 2.3 0.2 5.5 1.2 0.7 1.0 1.7 1.9 14.8 0.1 0.0 20.1 1.1 6.8 0.5 10.0 0.5 0.1 11.4 0.5 0.3 0.4 2.5 2.8 1.3 0.1 0.5 0.9 0.8 0.5 0.6 0.2 0.0 0.3 0.1 0.0 6.4 6.5 5.0 2.1 0.7 0.2 0.3 2.9 8.3 0.3 3.6 0.0 0.0 0.0 1.1 0.0 0.0 0.4 1.2 0.6 0.0 0.0 0.5 0.4 0.0 0.1 0.0 3.1 2.1 0.1 3.8 6.4 32.7 11.2 3.7 4.2 2.5 5.1 11.8 4.0 NPS ENSG00000214285 "Neuropeptide S" P0C0P6 10 127549369-127552639 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "brain: 1.9" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 8 "head and neck cancer: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "midbrain: 6.5;pons and medulla: 5.3" "Region enriched" "Detected in single" 8 "cerebral cortex: 5.8" CAB020139 Uncertain "Secreted - unknown location" "CAB020139: AB_776718" "unprognostic (2.83e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPSR1 "GPR154, GPRA, PGR14" ENSG00000187258 "Neuropeptide S receptor 1" Q6W5P4 7 34658239-34878332 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.5;retina: 9.1;stomach 1: 3.7" "Group enriched" "Detected in some" 5 "HAP1: 4.6;SCLC-21H: 2.5" "Cancer enhanced" "Detected in some" "stomach cancer: 2.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 4 "midbrain: 9.6" "unprognostic (3.56e-1)" "unprognostic (9.34e-2)" "unprognostic (7.55e-2)" "unprognostic (1.80e-1)" "unprognostic (2.00e-2)" "unprognostic (9.35e-2)" "unprognostic (6.34e-3)" "unprognostic (2.85e-1)" "unprognostic (1.36e-2)" "unprognostic (2.08e-2)" 0.0 0.2 0.5 1.0 0.1 0.0 0.0 3.5 1.0 0.1 0.9 1.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 3.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.6 9.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 3.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 3.5 1.0 0.6 3.2 0.6 0.0 1.1 0.0 NPTX1 ENSG00000171246 "Neuronal pentraxin 1" Q15818 17 80467148-80477843 "Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 68.9" "Cell line enhanced" "Detected in some" "HAP1: 12.1;HeLa: 9.5;SiHa: 15.4;U-138 MG: 33.0;WM-115: 45.3" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "NK-cell: 1.5" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 74.8;cerebellum: 228.3;cerebral cortex: 119.6;hippocampal formation: 173.6" HPA077062 Enhanced "Secreted in brain" 1000000 "HPA077062: " "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-2)" "unprognostic (6.95e-2)" "unprognostic (4.16e-3)" "unprognostic (2.43e-2)" "unprognostic (1.48e-2)" "unprognostic (3.63e-1)" "unprognostic (1.31e-2)" "unprognostic (2.07e-1)" "unprognostic (1.81e-2)" "unprognostic (9.63e-3)" "unprognostic (1.05e-6)" "unprognostic (1.41e-4)" "unprognostic (1.35e-1)" "unprognostic (8.86e-6)" "unprognostic (2.71e-3)" 1.0 3.4 28.8 1.4 14.7 0.8 1.1 68.9 62.5 0.8 9.1 0.2 0.0 1.3 1.3 2.5 1.4 1.4 1.7 0.7 15.5 3.0 0.8 0.7 1.0 1.4 1.0 18.2 0.7 0.7 0.7 0.8 1.6 4.6 1.3 2.5 0.6 0.7 2.9 1.0 3.2 1.5 1.4 1.9 2.3 1.5 1.3 0.0 0.9 0.7 0.0 0.7 0.9 0.2 0.0 0.0 0.0 0.0 1.5 0.3 0.1 0.0 0.7 0.2 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 12.1 0.0 0.0 0.0 7.5 0.0 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.5 0.0 0.0 3.1 0.0 0.0 8.2 0.0 15.4 0.0 0.0 0.0 0.2 0.1 33.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 45.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 28.8 14.7 68.9 29.9 15.5 3.0 1.0 18.2 4.6 0.0 NPTX2 ENSG00000106236 "Neuronal pentraxin 2" P47972 7 98617297-98629868 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7" "Cell line enriched" "Detected in some" 12 "LHCN-M2: 125.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020801, HPA049799, HPA058320" Enhanced Approved "Golgi apparatus,Actin filaments,Centrosome" "Secreted to blood" 2488000 320000 "Golgi apparatus, Actin filaments" Centrosome "CAB020801: , HPA049799: , HPA058320: " "unprognostic (1.18e-1)" "unprognostic (9.61e-2)" "unprognostic (1.56e-2)" "prognostic unfavourable (5.46e-5)" "unprognostic (1.91e-3)" "unprognostic (9.20e-2)" "unprognostic (2.42e-2)" "unprognostic (6.04e-3)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (7.64e-2)" "unprognostic (2.35e-1)" "prognostic unfavourable (5.46e-9)" "unprognostic (1.06e-2)" "unprognostic (1.21e-1)" "unprognostic (5.33e-2)" "unprognostic (3.69e-2)" 4.3 24.0 7.1 2.3 8.4 1.0 1.4 0.2 45.6 8.2 3.8 3.2 0.1 1.1 1.8 3.9 2.2 1.5 1.6 3.2 9.2 11.0 0.9 0.9 0.8 0.7 9.4 2.2 1.5 19.5 0.8 71.6 0.8 7.0 2.1 1.4 1.3 1.5 2.2 2.9 4.0 1.3 2.9 2.9 6.1 1.9 20.7 5.0 0.0 1.6 0.1 0.9 1.4 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.4 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 125.7 0.0 0.9 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 10.8 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 7.1 8.4 0.2 24.6 9.2 11.0 9.4 2.2 7.0 5.0 NPTXR ENSG00000221890 "Neuronal pentraxin receptor" O95502 22 38818452-38843982 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 73.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.8;SiHa: 11.0;U-87 MG: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA001079 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 280000 "Plasma membrane, Cytosol" Nucleoplasm "HPA001079: AB_1078414" "unprognostic (6.29e-2)" "prognostic favourable (3.93e-4)" "unprognostic (6.82e-3)" "prognostic unfavourable (2.85e-4)" "unprognostic (9.55e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (1.52e-3)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.49e-2)" "unprognostic (9.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.77e-2)" 2.3 3.8 39.1 1.8 17.5 0.8 1.9 16.2 73.6 5.8 2.6 4.3 0.5 1.5 5.6 3.3 2.7 6.1 2.0 10.5 57.4 15.2 1.3 0.8 1.7 1.6 5.6 20.7 6.2 3.6 5.9 2.0 0.9 4.5 6.2 1.7 1.0 3.2 5.6 0.9 1.2 1.4 5.7 3.3 2.1 2.0 1.6 4.0 0.0 2.5 0.0 1.6 2.5 1.9 0.3 0.2 0.6 0.2 0.6 2.3 0.4 0.4 2.9 0.1 0.8 5.9 0.6 0.0 1.9 0.4 3.8 1.3 2.9 0.6 0.0 3.4 0.5 0.4 0.8 0.1 1.2 0.2 1.0 0.0 0.1 4.4 0.6 0.0 0.1 1.9 0.1 3.4 0.0 0.1 3.5 0.1 0.1 4.4 0.0 0.2 3.5 1.0 0.7 0.0 6.9 0.9 7.9 14.8 0.9 11.0 0.0 0.3 4.7 1.1 0.2 6.8 4.2 0.0 0.3 1.0 0.0 0.0 42.5 8.6 3.5 0.5 0.2 0.1 1.8 0.0 1.3 0.1 1.0 2.3 0.0 0.3 1.5 1.2 0.6 0.6 0.1 0.2 0.0 0.4 39.1 17.5 16.2 49.0 57.4 15.2 5.6 20.7 4.5 4.0 NPVF "C7orf9, RFRP" ENSG00000105954 "Neuropeptide VF precursor" Q9HCQ7 7 25224570-25228486 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "brain: 9.5;lymphoid tissue: 2.9;retina: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 95 "hypothalamus: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 17 "hypothalamus: 7.2" "Region enriched" "Detected in some" 4 "hypothalamus: 3.8" HPA041733 Enhanced "Secreted in other tissues" "HPA041733: AB_10794524" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 NPY PYY4 ENSG00000122585 "Neuropeptide Y" P01303 7 24284163-24291865 "Plasma proteins, Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 50.5;brain: 63.6;prostate: 131.2" "Cell line enriched" "Detected in some" 36 "SH-SY5Y: 121.1" "Cancer enriched" "Detected in many" 187 "prostate cancer: 1214.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016733, CAB034368, HPA036636, HPA044572, HPA056798" Supported Supported Enhanced "Golgi apparatus" "Secreted to blood" 30733800 "Golgi apparatus" "CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: , HPA056798: " "unprognostic (2.00e-1)" "prognostic unfavourable (5.78e-4)" "unprognostic (4.15e-1)" "unprognostic (3.76e-2)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "unprognostic (6.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.78e-1)" "unprognostic (2.52e-1)" 1.6 50.5 27.2 5.5 63.6 2.8 1.0 0.1 55.9 1.0 1.8 2.8 1.4 4.7 1.1 1.1 2.5 1.0 1.4 1.0 11.9 20.6 1.1 1.0 1.1 1.0 2.6 18.3 1.0 4.0 1.0 0.5 1.0 1.9 131.2 1.7 0.0 1.0 14.7 1.0 1.0 5.0 1.4 1.4 1.0 1.7 1.3 13.9 0.0 1.1 0.0 1.0 3.9 4.5 0.5 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 3.4 0.0 0.1 0.0 0.0 0.1 121.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 27.2 63.6 0.1 31.2 11.9 20.6 2.6 18.3 1.9 13.9 NPY2R ENSG00000185149 "Neuropeptide Y receptor Y2" P49146 4 155208629-155217078 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.2;breast: 4.1" "Cell line enhanced" "Detected in some" "A549: 2.5;ASC diff: 3.5;HSkMC: 1.7;SH-SY5Y: 12.6" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 13.5;basal ganglia: 13.1;hippocampal formation: 51.2;hypothalamus: 27.7" "Region enriched" "Detected in many" 5 "hippocampal formation: 19.7" "unprognostic (7.14e-2)" "unprognostic (4.36e-3)" "unprognostic (7.08e-2)" "unprognostic (5.50e-2)" "unprognostic (9.35e-2)" 0.8 1.1 3.4 1.3 6.9 0.1 4.1 0.1 8.6 0.4 2.7 1.8 0.0 1.1 0.2 0.4 0.2 0.5 0.2 0.7 7.3 5.5 0.3 0.1 0.2 0.2 0.8 0.0 0.4 0.1 0.1 0.2 0.2 7.8 0.5 2.8 0.2 2.0 0.2 0.1 0.5 1.5 0.6 10.2 0.6 0.3 2.5 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 3.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 6.9 0.1 8.6 7.3 5.5 0.8 0.0 7.8 0.0 NPY5R NPYR5 ENSG00000164129 "Neuropeptide Y receptor Y5" Q15761 4 163343939-163351934 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.2;lymphoid tissue: 13.6" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;RPTEC TERT1: 3.5;T-47d: 1.3" "Cancer enhanced" "Detected in single" "breast cancer: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (4.63e-6)" "unprognostic (3.00e-1)" "unprognostic (2.79e-1)" "unprognostic (2.13e-1)" "unprognostic (1.24e-1)" "unprognostic (3.74e-2)" "unprognostic (3.94e-2)" "unprognostic (5.40e-2)" "unprognostic (4.30e-2)" "unprognostic (3.99e-2)" "unprognostic (1.76e-1)" "unprognostic (3.94e-1)" 10.6 5.7 3.6 1.6 12.2 0.1 3.2 0.3 6.2 1.5 0.7 0.1 0.3 0.2 2.2 1.9 0.6 1.4 1.0 1.3 4.5 3.1 7.8 1.8 0.7 6.6 1.3 4.6 0.5 1.8 0.8 0.6 4.9 2.3 0.5 0.6 1.1 6.1 1.7 0.4 1.4 0.3 1.5 4.2 13.6 0.5 9.1 2.2 0.0 1.3 0.4 0.3 0.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 12.2 0.3 6.2 4.5 3.1 1.3 4.6 2.3 2.2 NR2E1 "TLL, TLX, XTLL" ENSG00000112333 "Nuclear receptor subfamily 2 group E member 1" Q9Y466 6 108166058-108188809 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 19.0" "Cell line enhanced" "Detected in some" "BEWO: 6.3;HEK 293: 2.2;RH-30: 1.6;U-251 MG: 8.1" "Cancer enriched" "Detected in single" 14 "glioma: 6.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 11 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036954, HPA055642" Uncertain Approved "Nuclear bodies" "Nuclear bodies" "HPA036954: AB_10670958, HPA055642: " "unprognostic (3.43e-1)" "unprognostic (1.41e-1)" "unprognostic (1.77e-1)" "unprognostic (9.60e-2)" "unprognostic (6.27e-2)" "unprognostic (6.00e-1)" "unprognostic (1.78e-2)" "unprognostic (7.31e-2)" "unprognostic (8.64e-2)" "unprognostic (9.59e-8)" "unprognostic (2.87e-1)" "unprognostic (2.49e-1)" "unprognostic (3.07e-1)" 0.6 1.1 14.5 0.6 16.0 0.8 0.8 0.0 19.0 0.6 0.6 2.8 0.0 0.7 0.6 0.6 0.6 0.6 0.6 0.7 10.8 4.3 0.9 0.6 0.6 0.7 3.5 7.5 0.7 0.7 0.8 0.1 0.7 0.0 0.6 0.6 3.3 1.0 0.6 0.7 0.9 0.6 0.6 0.0 0.7 0.7 0.8 4.1 0.0 0.7 0.0 0.6 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 14.5 16.0 0.0 10.0 10.8 4.3 3.5 7.5 0.0 4.1 NRBP2 DKFZp434P086 ENSG00000185189 "Nuclear receptor binding protein 2" Q9NSY0 8 143833594-143840974 "Enzymes, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB020944, HPA029051, HPA029052" Approved Approved Cytosol Cytosol "CAB020944: , HPA029051: , HPA029052: AB_10602714" "unprognostic (1.84e-1)" "unprognostic (4.66e-2)" "unprognostic (2.54e-2)" "unprognostic (1.53e-3)" "unprognostic (1.01e-1)" "unprognostic (2.00e-2)" "unprognostic (4.03e-1)" "unprognostic (2.86e-1)" "unprognostic (3.97e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (2.47e-2)" "prognostic unfavourable (2.01e-5)" "unprognostic (3.86e-2)" "unprognostic (3.98e-1)" "unprognostic (4.56e-2)" "unprognostic (2.04e-1)" 18.5 10.7 21.6 6.8 21.1 1.9 10.0 17.5 32.6 7.6 13.3 47.5 8.7 8.8 11.2 10.0 9.9 14.6 11.3 15.2 23.5 14.9 14.0 18.9 14.9 4.9 30.9 23.6 10.7 10.4 8.4 8.8 6.1 30.2 17.8 6.9 10.1 22.1 15.5 7.6 23.0 9.3 12.3 54.1 7.5 10.1 6.1 27.5 1.0 9.0 3.6 3.8 8.2 7.8 0.5 0.0 0.0 0.4 0.0 1.5 0.3 5.8 7.3 6.7 8.2 10.4 16.1 1.5 12.0 5.2 4.3 6.4 1.7 5.5 0.6 3.2 14.3 9.5 3.9 4.2 1.7 7.1 2.9 1.1 19.4 3.0 10.7 0.0 2.8 20.6 9.9 2.2 2.2 6.0 3.7 7.8 9.2 2.5 0.5 0.3 2.5 4.1 2.0 6.2 2.7 5.9 2.0 2.4 4.9 15.3 7.8 6.0 11.2 0.4 13.9 2.6 7.9 12.4 3.8 4.3 0.2 0.1 13.8 2.4 3.5 0.0 0.4 0.0 0.2 0.2 1.5 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 21.6 21.1 17.5 21.4 23.5 14.9 30.9 23.6 30.2 27.5 NRCAM "Bravo, KIAA0343" ENSG00000091129 "Neuronal cell adhesion molecule" Q92823 7 108147623-108456717 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.0" "Cell line enhanced" "Detected in some" "A549: 26.0;AF22: 25.2;EFO-21: 47.1;HMC-1: 50.3;SH-SY5Y: 31.0" "Cancer enriched" "Detected in all" 7 "glioma: 57.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD8 T-cell: 5.5" "Lineage enriched" "Detected in single" 15 "T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012606 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" 70000000 Nucleoplasm "Vesicles, Plasma membrane" "HPA012606: AB_1854636" "unprognostic (2.66e-1)" "unprognostic (2.65e-1)" "unprognostic (2.52e-3)" "unprognostic (2.18e-2)" "unprognostic (4.08e-3)" "unprognostic (1.01e-2)" "unprognostic (4.47e-3)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "unprognostic (4.81e-2)" "unprognostic (9.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.22e-2)" "unprognostic (9.70e-3)" "unprognostic (6.42e-2)" "unprognostic (6.51e-3)" "unprognostic (3.28e-2)" 2.5 28.7 24.5 2.3 23.7 1.2 1.6 16.6 82.0 5.0 1.6 10.5 9.5 1.5 2.6 26.6 1.5 3.7 6.3 1.1 19.1 15.9 5.8 1.3 2.7 1.6 11.8 21.2 2.1 21.5 1.2 14.6 6.4 21.7 1.6 1.6 0.7 2.4 12.1 1.0 1.6 1.5 1.6 10.8 4.2 2.3 2.2 9.9 0.0 4.0 0.0 2.9 1.5 0.8 0.1 0.0 0.3 0.0 0.0 5.5 0.6 0.0 26.0 25.2 0.0 3.1 0.6 0.5 0.1 0.1 0.2 0.4 10.5 0.0 0.0 47.1 0.2 0.1 0.5 0.4 0.2 0.0 3.3 0.0 0.2 0.2 0.0 0.2 50.3 4.2 0.0 0.0 0.1 16.2 0.0 0.2 0.4 9.7 0.1 0.0 3.4 0.0 0.0 7.4 8.5 5.8 0.0 4.9 31.0 0.3 0.0 0.5 0.0 0.0 17.2 1.1 0.2 0.0 4.2 0.0 0.1 0.2 0.1 0.0 14.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.0 0.6 24.5 23.7 16.6 34.7 19.1 15.9 11.8 21.2 21.7 9.9 NREP "C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17" ENSG00000134986 "Neuronal regeneration related protein" Q16612 5 111662621-111997464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 149.5" "Cell line enhanced" "Detected in many" "AF22: 71.1;SH-SY5Y: 77.0" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 149.5" "Group enriched" "Detected in many" 5 "myeloid DC: 16.0;NK-cell: 4.1;plasmacytoid DC: 16.2" "Low lineage specificity" "Detected in many" HPA000545 Approved Approved Vesicles Vesicles "HPA000545: AB_1845721" "unprognostic (2.85e-2)" "unprognostic (1.00e-2)" "unprognostic (2.30e-1)" "unprognostic (1.48e-3)" "unprognostic (4.37e-1)" "unprognostic (2.26e-1)" "unprognostic (8.16e-3)" "unprognostic (1.58e-1)" "unprognostic (6.45e-3)" "unprognostic (1.32e-1)" "unprognostic (3.76e-2)" "unprognostic (2.02e-1)" "unprognostic (4.44e-2)" "prognostic unfavourable (3.09e-4)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (5.76e-3)" 4.2 14.4 14.1 5.0 21.9 7.1 6.4 149.5 45.5 8.2 8.5 6.7 4.3 3.5 21.7 4.1 5.2 4.6 16.0 17.2 15.7 10.5 11.7 11.7 6.3 3.3 11.0 21.5 10.4 2.9 1.7 5.0 28.2 27.8 13.1 5.9 16.1 8.3 18.2 39.6 4.7 3.9 13.1 8.0 8.3 5.6 3.0 4.3 34.1 4.7 8.6 3.8 7.4 6.4 0.9 16.2 0.0 2.6 4.1 1.1 1.4 0.1 1.1 71.1 15.1 3.4 8.0 3.3 23.7 14.0 22.5 37.3 0.1 0.4 11.7 7.4 11.4 0.0 14.7 0.8 11.7 4.7 2.1 9.1 6.0 12.5 4.7 12.1 0.1 7.7 3.7 21.8 7.5 25.4 0.1 1.2 23.3 0.2 47.9 8.5 40.2 5.5 51.6 28.7 3.1 8.6 0.2 16.2 77.0 5.2 0.3 0.5 2.9 33.5 5.0 27.4 9.2 13.4 2.5 5.7 4.6 14.7 6.0 25.6 5.3 0.0 2.6 0.0 0.0 1.3 0.0 0.9 0.1 0.1 16.0 0.8 0.8 1.1 0.0 4.1 0.6 16.2 0.0 1.4 14.1 21.9 149.5 45.5 15.7 10.5 11.0 21.5 27.8 4.3 NRG1 "GGF, HGL, HRG, NDF, NRG1-IT2" ENSG00000157168 "Neuregulin 1" Q02297 8 31639386-32767959 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.3" "Cell line enhanced" "Detected in many" "A549: 38.9;BJ: 26.6;fHDF/TERT166: 29.8;HBF TERT88: 26.2;hTEC/SVTERT24-B: 27.9;hTERT-HME1: 29.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "classical monocyte: 22.8" "Lineage enriched" "Detected in many" 5 "monocytes: 22.8" "Low region specificity" "Detected in all" HPA010964 Uncertain Approved Nucleoplasm "Secreted to blood" Nucleoplasm "HPA010964: AB_1854641" "unprognostic (5.76e-3)" "unprognostic (8.60e-2)" "unprognostic (1.96e-4)" "unprognostic (2.67e-1)" "unprognostic (1.94e-4)" "unprognostic (4.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.72e-2)" "unprognostic (2.98e-1)" "unprognostic (5.65e-2)" "unprognostic (7.99e-2)" "unprognostic (8.49e-2)" "unprognostic (4.47e-2)" "unprognostic (1.31e-1)" "unprognostic (2.88e-1)" "unprognostic (5.40e-2)" "unprognostic (7.83e-2)" 0.7 2.1 4.6 5.0 3.3 1.2 8.8 14.8 8.1 10.6 4.2 0.3 2.1 3.5 2.5 1.1 3.7 2.0 4.8 2.2 4.7 15.4 11.5 23.6 5.7 0.6 6.2 3.5 2.9 0.9 0.8 23.9 0.2 28.3 3.2 5.4 3.6 2.5 1.6 0.2 4.3 5.7 1.1 2.5 1.7 3.1 6.4 0.8 0.2 13.8 7.2 2.2 7.2 3.5 0.0 4.9 0.8 22.8 0.0 0.0 4.6 0.1 38.9 0.7 0.0 0.3 0.8 0.0 26.6 18.9 22.1 16.9 0.0 0.8 0.0 4.9 29.8 21.0 0.2 10.6 26.2 0.0 0.2 0.5 0.5 0.5 0.1 0.0 0.0 0.3 1.1 27.9 29.3 12.7 0.0 0.1 7.9 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 16.3 1.1 1.1 1.3 2.0 0.0 0.0 0.0 0.0 9.2 15.4 4.7 24.5 14.8 0.0 0.0 0.2 7.9 0.0 1.8 0.0 22.8 0.2 0.0 2.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.6 4.6 3.3 14.8 8.1 4.7 15.4 6.2 3.5 28.3 0.8 NRG2 "Don-1, HRG2, NTAK" ENSG00000158458 "Neuregulin 2" O14511 5 139846779-140043299 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.3" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;Karpas-707: 5.5;PC-3: 14.5;RPTEC TERT1: 7.4;SCLC-21H: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Lineage enriched" "Detected in single" 4 "T-cells: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038935, HPA047973" Approved Supported Nucleoplasm,Nucleoli "Secreted to blood" Nucleoplasm Nucleoli "HPA038935: AB_10672833, HPA047973: " "unprognostic (8.66e-4)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (6.04e-2)" "unprognostic (3.22e-1)" "unprognostic (2.96e-2)" "unprognostic (8.66e-3)" "unprognostic (1.11e-1)" "unprognostic (3.99e-1)" "unprognostic (1.88e-1)" "unprognostic (4.26e-3)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (3.64e-3)" "unprognostic (9.54e-2)" "unprognostic (2.23e-2)" "unprognostic (2.07e-2)" 4.5 4.5 4.0 1.4 7.0 0.6 4.4 27.3 5.1 13.1 2.3 3.8 2.6 1.0 3.0 2.9 3.7 7.6 7.6 1.5 4.2 3.5 1.3 0.6 1.2 2.1 5.2 3.4 15.9 3.2 15.8 7.7 1.1 4.1 4.5 0.9 2.9 13.6 4.7 6.0 5.0 1.0 5.1 3.6 3.3 1.1 2.7 4.9 0.0 0.8 1.0 1.5 4.8 3.7 0.4 0.1 0.0 0.1 0.0 2.1 0.1 0.0 1.9 0.2 8.3 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.0 0.4 0.0 2.4 0.4 0.2 0.1 4.7 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.5 0.2 0.0 5.5 0.0 0.4 0.0 0.0 0.1 14.5 0.1 0.0 0.0 7.4 1.7 5.5 3.3 0.0 3.2 3.3 0.0 0.0 0.2 2.5 0.4 0.0 1.6 1.1 0.0 0.0 3.6 0.0 0.7 0.0 0.0 0.0 2.1 0.1 0.5 0.1 0.2 0.4 0.0 0.4 0.4 1.2 0.0 0.0 0.0 0.1 0.0 0.1 4.0 7.0 27.3 5.1 4.2 3.5 5.2 3.4 4.1 4.9 NRG3 ENSG00000185737 "Neuregulin 3" P56975 10 81875314-82987179 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6" "Cell line enhanced" "Detected in some" "AF22: 1.5;HEK 293: 3.3;HUVEC TERT2: 1.6;SK-MEL-30: 7.2;U-2 OS: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075789 Uncertain Vesicles "Secreted in brain" Vesicles "HPA075789: " "unprognostic (6.15e-3)" "unprognostic (2.43e-2)" "unprognostic (1.65e-5)" "unprognostic (1.89e-1)" "unprognostic (7.03e-4)" "unprognostic (1.85e-2)" "unprognostic (1.06e-1)" "unprognostic (7.05e-2)" "unprognostic (9.33e-2)" "unprognostic (1.82e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-2)" "unprognostic (3.31e-4)" "unprognostic (1.04e-1)" "unprognostic (7.68e-3)" "unprognostic (7.27e-4)" 0.9 1.5 15.6 1.2 8.2 0.6 2.8 1.9 30.6 0.8 0.9 4.8 0.0 0.8 0.7 0.7 0.9 8.0 5.3 0.9 14.5 6.2 1.2 1.5 1.6 0.8 4.9 8.0 0.7 0.9 0.7 1.6 1.2 6.5 0.9 0.9 3.1 5.0 1.1 0.7 0.8 0.9 0.9 5.6 0.8 0.8 3.3 6.0 0.0 0.9 0.0 0.8 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 8.2 1.9 12.8 14.5 6.2 4.9 8.0 6.5 6.0 NRGN RC3 ENSG00000154146 Neurogranin Q92686 11 124739846-124747210 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 223.3" "Cell line enhanced" "Detected in many" "HEL: 48.3;PC-3: 39.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 7 "amygdala: 79.5;basal ganglia: 172.6;cerebral cortex: 220.7;hippocampal formation: 63.6;olfactory region: 71.9" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 2.5;granulocytes: 3.8;monocytes: 5.0" "Group enriched" "Detected in many" 9 "amygdala: 797.3;basal ganglia: 614.3;cerebral cortex: 1197.5;hippocampal formation: 705.6" "Group enriched" "Detected in all" 5 "basal ganglia: 2514.3;cerebral cortex: 5912.4;hippocampal formation: 3143.5" "CAB006908, HPA038171" Enhanced 10000000 "CAB006908: , HPA038171: " "unprognostic (1.37e-1)" "unprognostic (8.24e-3)" "unprognostic (3.95e-2)" "unprognostic (1.45e-2)" "unprognostic (3.49e-2)" "unprognostic (5.33e-3)" "unprognostic (1.02e-2)" "unprognostic (9.16e-2)" "unprognostic (2.87e-2)" "unprognostic (3.72e-3)" "unprognostic (4.14e-3)" "unprognostic (5.20e-2)" "prognostic unfavourable (1.52e-5)" "unprognostic (8.29e-2)" "unprognostic (2.12e-1)" "unprognostic (4.06e-2)" "unprognostic (4.03e-2)" 4.3 2.8 79.5 4.0 172.6 11.8 1.7 0.3 223.3 2.8 2.7 3.2 0.0 2.1 3.5 2.5 2.5 4.6 3.3 3.8 63.6 13.3 3.7 1.8 14.9 2.6 9.5 71.9 2.8 1.9 1.5 0.5 3.5 4.6 2.0 2.0 0.0 1.9 2.4 2.5 1.9 2.6 3.2 1.8 8.5 2.6 2.3 17.5 0.0 2.5 0.0 2.0 2.9 0.7 0.6 2.5 3.8 5.0 0.2 0.3 9.4 4.1 3.5 14.9 16.6 0.2 0.0 0.5 2.0 1.2 1.9 1.2 2.4 6.5 11.8 7.2 0.4 1.3 2.9 5.0 0.8 1.9 7.9 48.3 1.6 1.4 0.0 1.2 15.3 0.1 0.0 1.5 0.3 9.5 2.6 4.8 1.5 15.9 0.0 0.6 5.1 39.1 6.7 7.0 1.1 1.0 2.9 2.6 5.3 2.7 9.0 0.5 8.3 12.9 9.8 7.1 5.2 2.9 5.2 1.1 0.1 0.1 5.0 12.5 8.7 1.6 5.0 1.1 0.2 2.8 0.3 0.4 0.3 0.1 2.5 0.6 0.3 0.2 3.8 0.2 1.7 0.7 0.1 9.4 79.5 172.6 0.3 220.7 63.6 13.3 9.5 71.9 4.6 17.5 NRIP2 DKFZP761G1913 ENSG00000053702 "Nuclear receptor interacting protein 2" Q9BQI9 12 2825348-2835544 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 48.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039197, HPA039860" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039197: AB_10673416, HPA039860: AB_10794203" "unprognostic (3.28e-3)" "unprognostic (3.83e-1)" "prognostic unfavourable (8.05e-4)" "unprognostic (2.10e-2)" "unprognostic (8.11e-2)" "unprognostic (4.26e-3)" "unprognostic (5.66e-2)" "unprognostic (4.42e-3)" "unprognostic (2.89e-1)" "unprognostic (4.39e-2)" "prognostic favourable (8.69e-5)" "unprognostic (7.15e-2)" "unprognostic (2.82e-2)" "unprognostic (7.55e-2)" "unprognostic (5.23e-2)" "unprognostic (1.00e-1)" "unprognostic (8.97e-2)" 5.4 5.1 5.8 3.9 20.1 4.3 3.9 48.5 20.9 6.0 4.2 13.5 1.1 2.9 9.8 9.9 3.0 5.9 7.4 6.2 9.7 7.3 9.2 1.6 2.0 4.6 27.6 5.6 11.7 2.5 0.5 2.6 3.3 11.9 3.2 3.8 4.6 4.3 6.6 5.4 3.2 4.1 6.4 7.2 8.0 3.3 2.6 27.7 0.7 5.9 3.0 3.0 3.8 6.3 2.1 0.8 5.9 1.1 1.1 2.3 0.3 0.8 1.7 2.9 1.7 0.0 0.0 3.7 2.1 0.0 0.0 0.0 4.4 2.2 2.3 0.6 0.0 1.7 0.0 0.0 0.0 1.6 2.6 3.7 4.6 0.5 0.0 4.5 2.8 0.1 0.0 0.0 0.0 0.0 2.1 5.4 0.0 1.8 2.8 2.4 3.0 0.8 1.7 3.1 1.4 0.0 3.0 2.3 3.4 1.6 2.4 0.5 1.7 0.8 2.3 1.2 1.5 1.8 3.1 0.9 0.2 3.5 3.0 2.2 1.5 5.9 1.1 0.4 1.7 0.7 0.9 2.1 1.3 1.5 0.7 2.0 2.3 1.0 0.5 1.1 0.4 0.8 0.5 0.3 5.8 20.1 48.5 20.9 9.7 7.3 27.6 5.6 11.9 27.7 NRIP3 C11orf14 ENSG00000175352 "Nuclear receptor interacting protein 3" Q9NQ35 11 8980576-9004049 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 11.5;blood: 13.8;bone marrow: 12.7;brain: 28.4;testis: 30.3" "Cell line enhanced" "Detected in many" "HMC-1: 25.8;SiHa: 16.7;U-87 MG: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "basophil: 13.8" "Lineage enriched" "Detected in many" 13 "granulocytes: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058827, HPA072961" Approved Approved Cytosol Cytosol "HPA058827: , HPA072961: " "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "unprognostic (8.84e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-1)" "unprognostic (2.68e-1)" "unprognostic (2.03e-4)" "unprognostic (1.25e-1)" "unprognostic (1.88e-1)" "unprognostic (3.63e-2)" "unprognostic (1.04e-2)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "unprognostic (1.13e-1)" "unprognostic (1.41e-1)" "unprognostic (5.88e-3)" "unprognostic (1.30e-1)" 2.9 11.5 10.0 2.0 19.7 12.7 4.8 27.6 24.7 1.9 1.0 3.1 0.0 1.0 3.9 3.8 1.4 2.1 2.2 1.4 28.4 9.6 1.2 0.7 1.3 1.3 10.5 6.8 0.8 0.8 2.4 0.7 1.3 11.0 1.2 1.2 3.3 1.1 1.4 0.6 0.9 1.0 2.8 4.5 1.0 1.6 30.3 0.8 0.0 1.4 0.0 1.1 1.0 0.3 0.1 0.2 13.8 0.3 0.1 1.0 0.2 0.0 0.4 0.9 0.1 0.3 1.4 0.0 10.0 3.9 8.1 8.5 1.5 0.8 0.0 1.5 2.9 0.1 2.7 0.2 14.1 0.7 4.0 1.0 0.5 0.1 0.6 12.5 25.8 1.8 0.1 8.3 0.1 6.5 1.9 0.1 7.4 0.0 0.6 4.0 3.2 0.0 0.0 1.4 0.0 0.1 0.6 2.7 0.8 16.7 0.4 2.5 1.7 1.2 8.1 12.4 5.9 0.7 0.0 0.0 0.0 0.0 24.1 1.5 6.0 13.8 0.1 2.0 0.1 0.3 0.2 0.1 0.5 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 1.0 0.2 10.0 19.7 27.6 19.6 28.4 9.6 10.5 6.8 11.0 0.8 NRN1 NRN ENSG00000124785 "Neuritin 1" Q9NPD7 6 5997999-6007605 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 32.1;brain: 59.3" "Cell line enhanced" "Detected in many" "ASC diff: 37.7;ASC TERT1: 29.3;fHDF/TERT166: 37.9;REH: 49.8" "Cancer enhanced" "Detected in all" "glioma: 38.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "MAIT T-cell: 5.7;neutrophil: 5.6" "Group enriched" "Detected in many" 8 "granulocytes: 5.6;T-cells: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (6.24e-2)" "unprognostic (2.47e-2)" "unprognostic (1.35e-2)" "unprognostic (1.22e-1)" "unprognostic (1.26e-2)" "unprognostic (5.57e-2)" "unprognostic (4.70e-3)" "unprognostic (2.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-1)" "unprognostic (1.67e-2)" "unprognostic (3.35e-1)" "prognostic unfavourable (4.79e-5)" "unprognostic (1.26e-1)" "unprognostic (2.04e-1)" "unprognostic (2.90e-1)" "unprognostic (4.37e-3)" 32.1 3.7 38.8 4.0 21.5 0.7 16.8 53.3 59.3 6.1 5.8 3.5 1.1 2.6 5.9 2.9 5.4 6.2 6.9 9.9 40.2 9.8 3.2 3.1 9.3 5.3 10.0 22.1 2.5 1.9 1.9 3.5 25.5 23.4 3.2 3.4 4.1 3.7 5.2 10.0 7.8 3.4 6.8 5.6 9.3 3.2 0.8 1.8 0.0 3.0 2.8 2.5 7.8 5.7 0.7 0.5 5.6 0.4 0.0 5.7 0.2 4.2 0.2 0.4 0.1 37.7 29.3 5.8 0.7 0.0 3.1 4.3 0.0 0.0 0.0 0.6 37.9 0.1 11.2 0.0 3.1 7.0 5.7 3.6 0.2 0.0 0.0 14.7 11.7 4.6 0.0 2.8 0.0 15.1 0.1 0.2 11.1 1.0 22.4 0.7 0.1 0.0 49.8 12.7 0.1 0.0 0.1 6.7 2.4 0.0 0.2 3.6 0.1 4.4 3.1 15.2 0.5 5.8 9.4 0.0 0.5 0.3 23.0 0.3 2.3 1.0 0.3 0.0 0.3 0.4 5.7 0.7 0.4 0.7 0.0 0.0 0.0 0.1 5.6 0.0 0.3 0.5 0.2 0.2 38.8 21.5 53.3 58.3 40.2 9.8 10.0 22.1 23.4 1.8 NRSN1 "p24, VMP" ENSG00000152954 "Neurensin 1" Q8IZ57 6 24126122-24154900 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 67.2" "Cell line enhanced" "Detected in some" "SCLC-21H: 14.3;SH-SY5Y: 11.4" "Cancer enriched" "Detected in single" 17 "glioma: 3.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019681, HPA061006" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA019681: , HPA061006: " "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (8.00e-3)" "unprognostic (8.01e-3)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (7.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.40e-3)" "unprognostic (1.45e-1)" "unprognostic (1.57e-1)" 1.3 6.9 21.5 1.7 27.7 1.7 1.3 5.3 67.2 1.3 1.7 2.1 0.0 1.7 1.5 1.4 1.4 1.3 1.5 1.4 15.3 25.0 1.5 1.4 1.4 1.5 12.4 25.4 1.3 2.6 1.4 12.9 1.3 27.4 1.4 1.7 0.3 1.5 1.3 3.3 1.5 1.6 1.6 6.7 1.5 1.9 1.6 5.0 0.0 1.4 0.0 1.3 1.3 0.1 0.5 0.2 1.8 0.2 0.1 0.3 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.6 0.1 1.6 0.0 0.3 0.1 0.0 0.1 1.6 0.6 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 1.9 1.2 0.1 0.2 0.3 0.9 0.7 2.5 0.5 0.2 0.5 0.0 0.0 14.3 11.4 0.0 0.1 0.9 1.7 3.4 0.2 0.4 0.6 0.1 0.4 0.8 2.2 0.9 0.7 0.0 1.3 1.8 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.3 1.0 0.1 0.2 0.2 0.0 0.0 21.5 27.7 5.3 34.1 15.3 25.0 12.4 25.4 27.4 5.0 NRSN2 "C20orf98, dJ1103G7.6" ENSG00000125841 "Neurensin 2" Q9GZP1 20 346782-359660 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015967 Approved Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA015967: AB_1854647" "unprognostic (5.67e-2)" "unprognostic (3.47e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (4.05e-2)" "unprognostic (4.48e-2)" "unprognostic (1.48e-1)" "unprognostic (4.96e-2)" "unprognostic (5.92e-2)" "prognostic favourable (1.61e-4)" "unprognostic (6.96e-2)" "unprognostic (1.96e-3)" "unprognostic (2.94e-2)" "unprognostic (1.96e-1)" "unprognostic (7.85e-3)" "unprognostic (1.73e-3)" 8.4 18.6 34.3 6.0 39.3 0.9 7.2 22.7 70.9 12.8 6.6 11.0 4.9 3.5 12.5 16.0 6.1 13.4 9.3 13.5 31.1 24.9 10.1 1.8 8.7 4.1 17.1 28.5 18.3 10.5 26.5 16.3 10.1 27.8 12.2 6.1 12.8 13.3 16.5 1.4 5.0 3.8 16.3 8.7 5.7 5.3 12.8 6.8 1.3 14.9 2.5 4.2 9.4 4.8 9.4 4.8 1.5 1.1 3.4 3.9 1.5 18.7 22.9 13.8 13.0 18.3 20.5 5.4 12.5 24.2 22.7 22.9 12.6 0.4 0.0 4.4 23.1 8.3 11.1 1.9 14.5 0.1 11.2 6.8 10.9 23.8 18.5 0.2 1.1 23.2 1.5 16.2 2.7 15.6 13.4 12.2 19.9 3.3 0.3 5.8 10.6 11.8 10.7 7.7 0.9 22.7 0.1 28.2 20.3 14.9 4.4 21.4 18.3 7.0 10.4 24.4 12.9 0.9 15.2 2.2 0.4 5.1 3.2 0.2 12.8 0.0 1.1 1.5 3.8 0.3 1.1 7.2 1.1 3.9 2.1 9.4 1.6 2.7 0.0 3.4 0.4 4.8 0.9 1.5 34.3 39.3 22.7 70.9 31.1 24.9 17.1 28.5 27.8 6.8 NRXN1 "Hs.22998, KIAA0578" ENSG00000179915 "Neurexin 1" "P58400, Q9ULB1" 2 49918505-51225575 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Angiogenesis, Cell adhesion" "Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 81.9" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 28.3" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071400 Supported "Plasma membrane" "Intracellular and membrane" 620000 "Plasma membrane" "HPA071400: " "unprognostic (7.01e-2)" "unprognostic (9.96e-2)" "unprognostic (7.68e-2)" "unprognostic (1.74e-4)" "unprognostic (2.46e-1)" "unprognostic (8.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.85e-1)" "unprognostic (8.19e-2)" "unprognostic (6.37e-4)" "unprognostic (2.85e-2)" "unprognostic (6.68e-7)" "unprognostic (3.40e-2)" "unprognostic (1.75e-1)" "unprognostic (5.57e-2)" "unprognostic (1.99e-3)" 2.1 3.2 22.4 2.1 20.3 1.4 1.7 56.5 81.9 2.8 5.1 3.0 0.5 2.1 2.1 3.7 3.0 1.4 2.2 3.8 16.9 13.8 1.5 1.6 1.5 1.4 8.3 25.9 2.1 2.3 1.3 4.8 1.1 12.6 2.5 3.8 2.0 3.5 9.3 1.3 2.0 3.1 2.1 6.5 1.3 2.3 6.5 4.7 0.0 1.4 0.0 1.4 2.0 1.6 0.0 0.0 4.4 0.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.2 0.0 0.0 28.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 2.4 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.3 0.0 0.0 0.0 0.0 22.4 20.3 56.5 33.2 16.9 13.8 8.3 25.9 12.6 4.7 NRXN2 ENSG00000110076 "Neurexin 2" "P58401, Q9P2S2" 11 64606174-64723188 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 101.5" "Cell line enhanced" "Detected in some" "REH: 27.8;SCLC-21H: 13.9;U-2 OS: 16.2;U-87 MG: 11.4" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 2.0;non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 6 "monocytes: 2.0" "Low region specificity" "Detected in all" "unprognostic (3.87e-2)" "unprognostic (1.54e-4)" "unprognostic (2.60e-2)" "unprognostic (1.96e-1)" "unprognostic (8.07e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (5.08e-2)" "unprognostic (3.23e-1)" "unprognostic (5.93e-3)" "unprognostic (3.40e-1)" "unprognostic (9.97e-3)" "unprognostic (2.39e-2)" "unprognostic (6.99e-2)" "unprognostic (4.27e-4)" "unprognostic (5.46e-3)" 3.4 7.5 33.3 4.1 26.3 2.5 2.3 68.8 101.5 7.3 4.6 6.5 1.0 3.1 11.7 3.3 2.5 6.4 4.4 2.9 28.8 23.5 3.8 2.4 2.5 3.0 15.2 32.8 6.3 2.5 2.2 1.3 2.8 14.0 4.5 2.7 3.5 3.2 5.6 2.5 2.2 3.0 4.7 12.4 3.5 2.4 11.6 8.7 0.0 2.9 0.0 2.5 2.4 2.5 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.2 0.2 1.5 0.0 1.9 0.0 0.0 0.2 0.2 3.8 0.0 0.0 0.0 0.0 0.3 0.7 0.0 2.7 0.0 0.0 0.0 5.4 1.8 0.0 0.4 0.2 4.6 0.0 27.8 0.8 1.1 0.0 0.0 13.9 6.4 0.0 0.0 0.0 0.0 0.0 0.2 0.7 16.2 0.3 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 33.3 26.3 68.8 41.2 28.8 23.5 15.2 32.8 14.0 8.7 NRXN3 "C14orf60, KIAA0743" ENSG00000021645 "Neurexin 3" "Q9HDB5, Q9Y4C0" 14 78170373-79868290 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 8.2;RT4: 20.3;SK-BR-3: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.2" "Low region specificity" "Detected in all" HPA002727 Approved 520000 "HPA002727: AB_1079468" "unprognostic (7.96e-2)" "unprognostic (5.70e-4)" "unprognostic (8.18e-3)" "unprognostic (2.19e-2)" "unprognostic (2.31e-4)" "unprognostic (9.56e-2)" "unprognostic (2.80e-1)" "unprognostic (2.99e-3)" "unprognostic (1.12e-2)" "unprognostic (7.91e-2)" "unprognostic (2.40e-2)" "unprognostic (2.61e-1)" "prognostic favourable (1.83e-7)" "unprognostic (4.81e-2)" "unprognostic (2.61e-1)" "unprognostic (3.61e-2)" "unprognostic (2.91e-1)" 1.8 7.5 15.1 4.1 24.7 1.1 2.8 75.3 36.9 6.3 12.3 2.6 7.3 3.6 4.7 2.8 6.7 3.9 3.9 2.3 12.7 9.4 2.3 1.3 4.0 1.3 11.9 20.2 1.4 4.5 1.7 9.2 2.3 14.7 9.5 6.0 7.8 4.1 15.7 1.1 2.9 5.6 25.5 8.6 7.4 6.9 7.5 4.3 0.0 1.2 0.0 1.2 8.1 2.1 0.5 0.3 2.2 0.4 0.4 0.2 0.1 0.0 0.0 6.3 0.0 0.1 0.2 0.0 2.5 1.8 8.2 6.2 2.1 0.0 0.1 0.0 0.2 2.4 0.0 0.2 5.7 2.3 5.1 0.0 0.2 0.0 0.6 0.0 0.0 1.5 0.2 3.6 1.2 2.1 0.0 0.1 0.1 0.0 0.2 0.2 1.4 0.0 0.2 0.0 0.0 4.4 20.3 1.0 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.1 5.4 0.0 2.6 0.0 0.0 0.0 1.5 0.3 4.5 2.2 0.4 0.5 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.5 0.2 0.2 1.6 0.4 0.2 0.3 0.1 0.1 15.1 24.7 75.3 36.9 12.7 9.4 11.9 20.2 14.7 4.3 NSF "SEC18, SKD2" ENSG00000073969 "N-ethylmaleimide sensitive factor, vesicle fusing ATPase" P46459 17 46590669-46757464 "Enzymes, Predicted intracellular proteins, Transporters" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003154, CAB009324, HPA071089" Enhanced Enhanced Cytosol 6900 Cytosol "CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: " "unprognostic (5.70e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-3)" "unprognostic (1.98e-1)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.95e-2)" "unprognostic (5.48e-2)" "unprognostic (2.37e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-2)" "unprognostic (3.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.74e-1)" 1.9 3.6 11.2 2.7 19.1 1.6 2.6 14.1 35.4 2.5 4.0 1.4 1.9 2.7 3.9 2.2 2.8 1.5 13.9 14.4 3.4 2.5 2.2 3.1 12.6 1.3 3.5 6.5 5.5 2.6 2.8 5.5 2.4 2.1 4.3 2.4 3.2 2.2 3.1 1.6 3.0 3.1 3.6 3.4 3.3 1.0 7.2 15.5 10.4 13.3 6.7 11.1 8.8 6.1 13.6 9.1 0.6 5.4 7.6 7.4 8.4 9.8 8.1 7.9 9.3 0.0 15.0 15.1 18.6 1.1 10.2 3.1 13.3 5.3 13.3 0.5 9.8 12.7 8.0 0.4 3.3 6.9 4.3 16.4 6.8 12.7 10.0 8.2 17.9 12.0 10.0 3.9 5.1 16.2 7.2 8.8 14.0 9.2 12.8 8.4 9.5 12.4 0.0 5.9 15.5 18.6 10.3 22.9 8.1 12.1 12.5 17.6 10.1 8.8 6.4 8.1 16.1 10.4 13.3 7.8 8.2 12.1 8.9 6.8 8.2 10.5 15.5 7.2 6.9 8.1 6.0 6.7 12.1 6.2 11.1 8.8 NSG1 "D4S234E, NEEP21, P21" ENSG00000168824 "Neuronal vesicle trafficking associated 1" P42857 4 4348140-4419058 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.8;pituitary gland: 49.1;skin 1: 70.0" "Cell line enhanced" "Detected in some" "HAP1: 22.9;SCLC-21H: 46.6;SH-SY5Y: 22.7;SK-MEL-30: 21.8;TIME: 55.1;U-698: 19.8" "Cancer enhanced" "Detected in many" "melanoma: 61.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 25.5" "Lineage enriched" "Detected in single" 58 "T-cells: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.21e-3)" "unprognostic (2.33e-1)" "unprognostic (5.29e-3)" "unprognostic (7.60e-2)" "unprognostic (8.06e-2)" "unprognostic (1.49e-1)" "unprognostic (1.32e-3)" "unprognostic (3.47e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-3)" "prognostic favourable (9.49e-4)" "unprognostic (2.50e-1)" "unprognostic (6.85e-2)" "unprognostic (4.21e-2)" "unprognostic (7.33e-2)" "unprognostic (2.85e-1)" "unprognostic (7.41e-2)" 1.4 16.1 8.9 2.8 44.8 1.0 4.2 32.2 32.0 4.7 5.1 3.1 0.4 4.4 5.3 2.6 17.2 12.7 1.3 3.8 6.0 31.9 1.3 0.7 1.4 2.3 15.8 19.2 29.5 1.6 0.5 49.1 20.9 38.8 14.4 4.8 7.6 4.5 12.5 1.0 70.0 3.8 4.7 6.2 1.8 5.3 9.8 4.4 3.7 0.8 4.3 2.6 10.2 8.3 0.0 0.0 0.4 0.0 0.3 25.5 6.9 0.0 0.0 0.2 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 2.8 0.1 0.6 22.9 1.4 0.1 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.3 0.0 0.6 3.9 0.0 0.0 0.3 0.0 1.7 0.1 2.7 0.1 0.0 0.0 0.1 0.0 1.2 46.6 22.7 0.1 0.0 21.8 0.2 0.0 55.1 0.0 3.6 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.1 0.0 0.0 0.0 19.2 0.0 25.5 0.0 18.0 15.6 0.0 0.0 4.7 12.0 0.4 0.3 0.0 0.0 1.7 6.9 8.9 44.8 32.2 32.0 6.0 31.9 15.8 19.2 38.8 4.4 NSG2 "CALY3, HMP19, Nsg2" ENSG00000170091 "Neuronal vesicle trafficking associated 2" Q9Y328 5 174045604-174243501 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 120.8" "Group enriched" "Detected in some" 58 "SCLC-21H: 21.3;SH-SY5Y: 34.3" "Cancer enriched" "Detected in some" 8 "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046531, HPA056191" Enhanced Enhanced "Golgi apparatus" "Golgi apparatus" "HPA046531: , HPA056191: " "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (3.27e-1)" "unprognostic (3.36e-5)" "unprognostic (1.93e-1)" "unprognostic (2.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.07e-1)" "unprognostic (3.29e-1)" "unprognostic (1.76e-1)" "unprognostic (3.86e-3)" "unprognostic (8.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.02e-2)" "unprognostic (5.20e-2)" "unprognostic (9.31e-4)" "unprognostic (1.55e-1)" 1.7 23.1 31.6 3.0 92.4 1.4 1.4 19.7 120.8 1.4 3.6 5.0 0.0 2.8 1.4 1.7 1.5 1.4 1.6 1.6 27.3 40.2 1.6 1.4 1.6 1.4 20.2 27.6 1.4 2.0 1.4 0.9 1.4 22.5 1.4 4.1 0.8 1.4 1.5 1.4 1.4 3.8 2.5 4.6 1.4 3.3 5.0 11.7 0.0 1.8 0.0 1.4 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 92.4 19.7 49.8 27.3 40.2 20.2 27.6 22.5 11.7 NSMF NELF ENSG00000165802 "NMDA receptor synaptonuclear signaling and neuronal migration factor" Q6X4W1 9 137447573-137459334 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 96.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 12.1;non-classical monocyte: 10.5" "Group enriched" "Detected in many" 5 "dendritic cells: 6.0;granulocytes: 3.1;monocytes: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044316 Enhanced Supported Nucleoplasm Nucleoplasm "HPA044316: AB_10964877" "unprognostic (1.48e-1)" "unprognostic (4.03e-2)" "unprognostic (5.40e-2)" "unprognostic (3.92e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-1)" "unprognostic (7.96e-2)" "unprognostic (3.26e-2)" "unprognostic (2.38e-3)" "unprognostic (2.34e-3)" "prognostic favourable (1.85e-6)" "unprognostic (1.97e-2)" "unprognostic (4.14e-2)" "unprognostic (4.61e-2)" "unprognostic (3.97e-2)" 8.8 8.8 61.7 6.9 34.4 6.1 5.3 6.4 67.3 6.0 8.1 18.2 2.1 16.9 8.6 6.6 6.6 7.2 5.7 5.0 96.4 21.8 15.3 6.2 5.2 6.9 20.4 30.2 5.0 14.7 10.8 13.7 4.2 12.1 9.0 6.3 5.4 11.5 8.7 4.0 9.7 13.7 8.2 9.6 6.8 9.6 7.8 15.0 2.4 5.1 1.3 5.8 6.4 3.8 0.2 6.0 3.1 12.1 0.0 1.5 1.4 7.7 6.3 11.2 16.7 26.4 12.5 9.7 7.5 10.0 7.2 5.6 16.8 4.7 9.7 10.2 11.0 23.7 16.5 10.1 4.3 12.7 17.8 7.5 14.9 22.3 14.3 5.1 17.3 14.2 19.3 8.4 19.7 7.6 17.3 1.6 9.6 18.0 0.2 22.3 14.3 17.0 4.7 17.8 21.6 5.0 3.9 47.2 38.5 18.0 10.0 11.3 7.1 10.7 19.1 12.8 10.5 31.0 12.7 3.4 5.3 14.8 7.3 6.9 11.7 1.5 2.0 3.1 1.5 12.1 0.2 0.2 0.5 0.9 6.0 0.1 0.6 0.7 0.3 0.0 10.5 0.2 0.7 1.4 61.7 34.4 6.4 62.9 96.4 21.8 20.4 30.2 12.1 15.0 NTF3 NGF2 ENSG00000185652 "Neurotrophin 3" P20783 12 5432112-5521536 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.0;BJ hTERT+ SV40 Large T+: 11.9;BJ hTERT+ SV40 Large T+ RasG12V: 15.8;HBF TERT88: 14.7;RT4: 6.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 16 "cerebellum: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 4.1;basal ganglia: 7.4;cerebellum: 12.3;hippocampal formation: 12.3" "Low region specificity" "Detected in all" HPA032001 Uncertain Approved Vesicles "Secreted in other tissues" Vesicles "HPA032001: " "unprognostic (3.04e-2)" "unprognostic (7.46e-2)" "unprognostic (7.33e-3)" "unprognostic (4.66e-3)" "unprognostic (8.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.36e-3)" "unprognostic (7.68e-2)" "unprognostic (1.35e-1)" "unprognostic (2.14e-1)" "unprognostic (1.86e-1)" "unprognostic (2.20e-1)" "unprognostic (7.77e-4)" "unprognostic (4.02e-3)" "unprognostic (1.92e-1)" "unprognostic (8.06e-3)" "unprognostic (4.51e-3)" 4.9 2.7 0.5 2.4 0.5 0.0 5.4 29.2 0.6 12.9 4.7 0.3 5.6 2.7 9.2 6.8 5.0 2.2 5.3 4.1 1.7 0.2 4.3 10.4 2.5 1.0 0.7 0.2 16.8 0.4 0.1 1.3 2.7 1.2 8.9 1.5 8.9 4.6 3.7 3.6 3.7 6.6 11.5 0.4 8.5 3.0 3.5 0.0 0.2 1.2 3.9 2.0 10.4 9.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 5.4 0.0 0.0 0.0 0.0 3.4 9.0 11.9 15.8 0.1 0.2 0.0 5.4 5.6 1.9 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.5 3.7 6.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 29.2 0.6 1.7 0.2 0.7 0.2 1.2 0.0 NTM "CEPU-1, HNT, IGLON2, NTRI" ENSG00000182667 Neurotrimin Q9P121 11 131370478-132336822 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.2" "Cell line enhanced" "Detected in many" "LHCN-M2: 37.7;U-138 MG: 15.0;U-2 OS: 26.0;WM-115: 51.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 157 "plasmacytoid DC: 15.6" "Lineage enriched" "Detected in single" 157 "dendritic cells: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB024875 Enhanced "Intracellular and membrane" 58000000 "CAB024875: " "unprognostic (1.52e-2)" "unprognostic (4.38e-3)" "unprognostic (1.61e-2)" "unprognostic (1.89e-1)" "unprognostic (4.25e-1)" "unprognostic (1.07e-1)" "unprognostic (9.99e-3)" "unprognostic (9.61e-2)" "unprognostic (1.26e-2)" "unprognostic (2.52e-2)" "unprognostic (4.29e-2)" "unprognostic (1.79e-2)" "prognostic unfavourable (1.10e-8)" "unprognostic (4.60e-3)" "unprognostic (1.37e-1)" "unprognostic (2.94e-1)" "unprognostic (9.31e-3)" 14.0 5.0 22.5 2.7 22.5 0.9 3.5 39.0 63.0 2.4 4.7 31.2 0.0 3.0 2.0 1.4 9.0 1.7 9.1 15.9 23.4 13.7 1.6 1.1 22.6 1.2 29.3 20.8 0.9 1.7 7.5 0.6 1.4 29.6 1.6 4.2 8.7 3.3 3.4 1.5 5.9 4.1 4.6 66.2 1.3 1.8 1.4 29.1 0.0 1.5 0.3 1.2 3.8 1.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 7.1 0.0 11.1 5.9 3.6 2.1 0.0 0.0 0.0 0.0 6.1 0.1 0.0 13.3 3.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 11.8 14.1 2.3 0.0 0.1 37.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 6.4 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 2.4 15.0 26.0 0.7 9.4 0.0 0.0 0.0 0.0 0.0 51.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 22.5 22.5 39.0 25.8 23.4 13.7 29.3 20.8 29.6 29.1 NTN3 NTN2L ENSG00000162068 "Netrin 3" O00634 16 2471499-2474145 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.3" "Cell line enhanced" "Detected in some" "REH: 8.0;SCLC-21H: 10.3;SH-SY5Y: 5.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050817 Uncertain "Secreted in brain" "HPA050817: " "unprognostic (2.60e-2)" "unprognostic (1.95e-2)" "unprognostic (1.79e-1)" "unprognostic (9.17e-2)" "unprognostic (6.44e-2)" "unprognostic (2.23e-2)" "unprognostic (9.62e-3)" "unprognostic (2.11e-1)" "unprognostic (4.55e-2)" "unprognostic (6.95e-2)" "unprognostic (5.58e-2)" "unprognostic (2.34e-1)" "unprognostic (1.35e-2)" "unprognostic (3.26e-2)" "unprognostic (6.68e-2)" "unprognostic (2.39e-2)" "unprognostic (6.61e-2)" 1.2 0.7 5.8 0.5 6.0 0.8 0.5 1.4 3.8 1.8 0.6 1.6 0.0 0.3 1.9 0.5 0.4 0.8 0.6 0.8 6.3 2.4 0.6 1.5 0.5 0.7 1.8 3.0 0.3 2.1 0.3 1.3 0.5 4.7 0.6 0.3 1.3 1.0 0.9 1.0 0.3 0.9 0.3 2.3 1.1 0.5 3.1 3.3 2.5 0.8 0.0 0.4 0.4 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.2 0.5 0.1 0.0 0.3 0.1 0.0 0.0 1.2 1.2 0.1 2.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 1.2 0.3 0.1 8.0 0.1 0.2 0.0 0.0 10.3 5.7 0.0 0.0 0.1 0.1 0.0 0.0 0.3 1.5 0.1 0.1 0.5 0.4 0.7 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 6.0 1.4 3.8 6.3 2.4 1.8 3.0 4.7 3.3 NTNG1 "KIAA0976, Lmnt1" ENSG00000162631 "Netrin G1" Q9Y2I2 1 107140007-107483458 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 28.2;fHDF/TERT166: 13.7;RPTEC TERT1: 15.3;U-138 MG: 12.9;U-251 MG: 9.3;U-87 MG: 14.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065954 Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA065954: " "unprognostic (1.79e-1)" "unprognostic (4.63e-2)" "unprognostic (1.67e-2)" "unprognostic (9.38e-5)" "unprognostic (1.93e-3)" "unprognostic (9.87e-3)" "unprognostic (3.34e-1)" "unprognostic (8.38e-3)" "unprognostic (1.03e-1)" "unprognostic (2.02e-1)" "unprognostic (5.68e-2)" "unprognostic (2.05e-2)" "unprognostic (3.10e-4)" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (1.93e-5)" 4.2 11.0 6.8 1.3 6.4 0.9 1.1 7.3 12.8 7.0 2.9 9.6 0.3 0.8 2.2 0.9 1.2 1.3 2.1 0.9 9.8 16.4 13.0 0.8 9.2 1.7 5.0 5.3 1.9 1.1 0.7 7.4 3.2 10.0 9.0 1.7 6.4 2.8 12.1 1.1 1.9 1.7 7.5 7.4 1.3 1.4 1.7 6.1 0.0 0.8 0.0 2.0 5.3 3.0 4.4 0.8 1.4 0.7 0.8 0.6 0.3 0.0 0.0 1.6 0.0 2.8 28.2 0.0 7.7 1.1 0.6 0.6 0.0 0.0 0.0 0.3 13.7 0.0 0.0 0.8 1.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 8.0 0.2 2.0 1.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 3.5 0.0 1.9 0.0 15.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 12.9 2.5 4.7 9.3 0.0 0.0 0.0 14.4 0.0 1.4 1.4 0.3 0.4 0.3 0.4 0.5 4.4 0.4 0.3 0.4 1.0 0.6 0.5 0.9 0.8 0.7 0.8 0.4 0.3 6.8 6.4 7.3 12.3 9.8 16.4 5.0 5.3 10.0 6.1 NTNG2 "KIAA1857, Lmnt2, NTNG1" ENSG00000196358 "Netrin G2" Q96CW9 9 132161676-132244534 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.9;brain: 32.0" "Cell line enhanced" "Detected in some" "HL-60: 4.7;HMC-1: 11.9;NB-4: 27.0;U-937: 7.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "neutrophil: 4.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA065089, HPA071290" Approved Approved "Plasma membrane,Cytokinetic bridge,Midbody ring" "Intracellular and membrane" "Plasma membrane" "Cytokinetic bridge, Midbody ring" "HPA065089: , HPA071290: " "unprognostic (5.01e-2)" "unprognostic (2.95e-2)" "unprognostic (4.12e-2)" "unprognostic (1.01e-1)" "unprognostic (3.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.73e-2)" "unprognostic (2.87e-1)" "unprognostic (4.86e-2)" "unprognostic (1.47e-1)" "unprognostic (2.62e-2)" "prognostic favourable (6.06e-4)" "unprognostic (9.30e-12)" "unprognostic (1.66e-1)" "unprognostic (3.23e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" 1.2 1.4 11.9 1.6 10.9 38.9 0.6 4.4 32.0 1.0 0.8 11.5 0.2 1.8 0.7 0.9 0.8 0.7 1.4 4.6 11.4 3.1 0.8 0.8 2.0 1.9 4.4 7.4 0.6 1.8 11.9 1.0 1.1 11.7 7.4 0.7 10.7 1.3 1.8 0.9 0.8 1.1 0.8 5.3 2.8 1.2 1.8 2.8 0.0 0.7 0.0 1.0 1.1 0.9 0.1 0.1 4.0 0.2 0.0 0.4 0.0 0.0 0.3 0.2 0.4 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.6 4.7 11.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.2 27.0 1.0 0.1 0.3 0.3 0.1 0.0 0.0 3.3 3.0 0.1 0.0 0.0 0.0 0.4 0.1 0.6 2.1 2.6 0.1 0.1 0.0 0.0 0.9 7.0 0.7 0.6 0.2 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.0 0.0 0.1 0.1 0.1 0.0 11.9 10.9 4.4 32.0 11.4 3.1 4.4 7.4 11.7 2.8 NTRK1 "MTC, TRK, TRKA" ENSG00000198400 "Neurotrophic receptor tyrosine kinase 1" P04629 1 156815640-156881850 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 15.8;blood: 32.3;brain: 28.3" "Cell line enriched" "Detected in some" 4 "HMC-1: 41.1" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Region enriched" "Detected in many" 5 "pons and medulla: 28.3" "Cell type enriched" "Detected in single" 127 "basophil: 32.3" "Lineage enriched" "Detected in single" 323 "granulocytes: 32.3" "Region enhanced" "Detected in some" "basal ganglia: 8.2" "Low region specificity" "Detected in all" "CAB004606, HPA035799, HPA076570" Approved Approved Vesicles,Cytosol 140000 "Vesicles, Cytosol" "CAB004606: AB_628397, HPA035799: , HPA076570: " "unprognostic (5.89e-3)" "unprognostic (7.56e-2)" "unprognostic (2.74e-2)" "unprognostic (5.99e-3)" "unprognostic (7.26e-2)" "unprognostic (1.43e-3)" "unprognostic (1.56e-1)" "unprognostic (7.42e-3)" "unprognostic (7.63e-2)" "unprognostic (1.35e-1)" "unprognostic (6.73e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-11)" "unprognostic (2.18e-3)" "unprognostic (3.79e-2)" "unprognostic (1.07e-1)" "unprognostic (4.89e-1)" 1.0 15.8 0.5 0.8 6.0 0.9 0.4 0.0 0.7 0.9 1.1 0.1 0.0 0.8 1.6 2.0 0.7 0.6 2.1 1.5 0.0 1.2 2.9 0.2 1.9 0.3 2.1 0.6 0.3 0.3 0.3 1.1 0.5 28.3 2.2 0.2 3.1 1.2 0.5 0.7 0.2 0.4 1.1 1.2 0.2 1.0 2.4 1.5 0.4 0.3 0.0 0.4 0.7 0.8 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.6 0.0 6.6 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 2.1 0.7 0.0 0.0 0.0 1.1 0.0 0.6 1.2 0.0 0.1 0.0 0.0 0.7 9.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 32.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.0 0.0 0.6 0.0 1.2 2.1 0.6 28.3 1.5 NTRK2 TRKB ENSG00000148053 "Neurotrophic receptor tyrosine kinase 2" Q16620 9 84668551-85027070 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Epilepsy, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 133.8;thyroid gland: 63.4" "Cell line enhanced" "Detected in some" "AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.6;SH-SY5Y: 13.3" "Group enriched" "Detected in many" 5 "glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007637, CAB010346" Enhanced Approved Cytosol 13000000 Cytosol "CAB010346: AB_2155274, HPA007637: AB_1080385" "unprognostic (2.75e-3)" "unprognostic (3.48e-2)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-2)" "unprognostic (1.29e-2)" "unprognostic (9.16e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (4.25e-2)" "unprognostic (2.18e-2)" "unprognostic (2.66e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-3)" 19.8 2.7 66.1 2.0 56.7 1.2 33.2 15.1 133.8 6.4 4.4 27.4 0.0 1.4 3.0 3.3 5.6 3.7 18.7 5.8 61.0 30.7 12.5 2.1 6.3 2.7 32.4 41.4 6.6 18.9 1.6 3.0 2.1 34.1 3.8 3.1 2.0 8.6 11.9 2.0 7.2 1.6 3.0 22.1 6.5 1.4 2.4 34.1 0.0 63.4 2.6 3.4 3.5 3.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.6 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.6 0.8 0.9 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 66.1 56.7 15.1 45.6 61.0 30.7 32.4 41.4 34.1 34.1 NTRK3 TRKC ENSG00000140538 "Neurotrophic receptor tyrosine kinase 3" Q16288 15 87859751-88256768 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8" "Cell line enriched" "Detected in some" 8 "U-138 MG: 47.4" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009233, HPA027484, HPA048065" Approved Supported "Nuclear membrane,Nucleoli" 11000000 Nucleoli "Nuclear membrane" "CAB009233: AB_632555, HPA027484: , HPA048065: " "unprognostic (1.27e-3)" "unprognostic (1.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.04e-2)" "unprognostic (1.65e-1)" "unprognostic (3.34e-1)" "unprognostic (3.18e-2)" "unprognostic (2.23e-2)" "unprognostic (2.34e-1)" "unprognostic (3.91e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-3)" "unprognostic (6.45e-3)" "unprognostic (1.06e-2)" "unprognostic (1.26e-2)" "unprognostic (2.49e-3)" 20.8 7.4 22.0 2.5 28.1 1.5 6.2 30.4 41.8 7.0 4.0 8.4 1.3 2.0 12.4 6.7 3.4 9.5 3.9 5.5 22.0 11.1 5.1 2.0 5.7 3.1 11.2 18.7 5.1 2.9 1.6 7.9 2.8 14.7 6.8 4.7 8.0 11.5 8.7 1.9 2.9 2.5 7.7 13.7 4.1 3.0 13.8 13.7 0.0 2.5 0.7 4.3 7.1 4.8 0.7 0.4 1.3 0.5 0.5 0.8 0.0 0.0 5.9 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.9 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.1 1.2 0.5 0.4 0.3 0.1 0.2 0.4 0.3 0.3 0.1 0.7 0.4 0.4 1.3 0.5 0.1 0.4 0.8 0.0 22.0 28.1 30.4 28.9 22.0 11.1 11.2 18.7 14.7 13.7 NTSR1 NTR ENSG00000101188 "Neurotensin receptor 1" P30989 20 62708837-62762771 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.0;intestine: 15.1" "Cell line enriched" "Detected in some" 5 "PC-3: 35.0" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050299 Supported "Plasma membrane" "Plasma membrane" "HPA050299: " "unprognostic (4.14e-2)" "unprognostic (2.02e-2)" "unprognostic (2.75e-2)" "unprognostic (8.87e-4)" "unprognostic (9.27e-3)" "unprognostic (1.45e-1)" "unprognostic (4.17e-2)" "unprognostic (2.80e-3)" "unprognostic (7.16e-2)" "unprognostic (3.10e-3)" "unprognostic (3.55e-2)" "unprognostic (2.53e-1)" "unprognostic (1.27e-2)" "unprognostic (1.25e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (2.49e-1)" 0.3 0.1 3.7 2.5 3.6 3.8 0.1 0.1 7.0 0.1 15.1 0.0 0.0 0.4 0.2 0.1 0.1 0.1 1.4 0.1 2.0 1.1 0.6 0.2 0.3 0.3 3.3 1.0 0.4 0.1 0.2 0.3 0.2 1.4 0.2 0.5 1.2 0.3 0.1 0.2 0.2 1.5 0.8 0.8 0.6 0.5 0.5 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.3 0.0 0.3 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.2 6.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 1.6 0.1 1.5 0.2 35.0 1.0 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.7 3.6 0.1 7.0 2.0 1.1 3.3 1.0 1.4 0.0 NTSR2 NTR2 ENSG00000169006 "Neurotensin receptor 2" O95665 2 11658178-11670164 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 33.4" "Cell line enhanced" "Detected in some" "HEK 293: 1.0;NTERA-2: 1.8" "Cancer enriched" "Detected in single" 15 "glioma: 6.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (5.40e-2)" "unprognostic (2.30e-2)" "unprognostic (2.36e-2)" "unprognostic (5.32e-2)" "unprognostic (2.23e-1)" "unprognostic (1.80e-1)" "unprognostic (2.75e-1)" "unprognostic (4.98e-1)" "unprognostic (1.64e-1)" 1.3 1.8 22.3 1.1 30.7 1.1 1.1 2.1 33.4 1.1 1.1 11.9 0.0 1.1 1.1 1.2 1.1 1.1 1.1 1.1 13.4 15.6 1.1 1.1 1.1 1.1 26.8 13.8 2.8 1.7 1.1 0.0 1.1 10.6 1.1 1.1 0.0 1.1 1.1 1.2 1.1 1.1 1.1 4.3 1.1 1.1 1.5 8.7 0.0 1.1 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 30.7 2.1 14.5 13.4 15.6 26.8 13.8 10.6 8.7 NUAK1 "ARK5, KIAA0537, NuaK1" ENSG00000074590 "NUAK family kinase 1" O60285 12 106063340-106140033 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.3;parathyroid gland: 18.6" "Cell line enhanced" "Detected in many" "AF22: 23.0;EFO-21: 23.0;Karpas-707: 16.8;RH-30: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057143 Approved "Nucleoplasm,Nucleoli fibrillar center,Microtubules" "Nucleoli fibrillar center" "Nucleoplasm, Microtubules" "HPA057143: " "unprognostic (4.20e-2)" "unprognostic (8.42e-2)" "unprognostic (3.71e-2)" "prognostic unfavourable (9.83e-4)" "unprognostic (4.13e-2)" "unprognostic (2.34e-1)" "unprognostic (1.43e-1)" "unprognostic (4.80e-2)" "unprognostic (9.91e-2)" "unprognostic (4.06e-3)" "unprognostic (3.29e-1)" "unprognostic (1.31e-1)" "unprognostic (1.93e-3)" "prognostic unfavourable (4.27e-4)" "unprognostic (2.31e-1)" "unprognostic (8.70e-2)" "unprognostic (4.47e-2)" 8.2 1.8 4.2 2.0 13.0 0.0 5.5 9.9 20.1 4.6 1.7 24.3 1.1 1.0 5.8 1.6 1.9 3.6 2.7 11.3 5.1 3.3 2.5 2.4 4.9 1.5 8.7 8.4 3.2 1.2 18.6 1.9 2.5 7.6 3.6 2.2 2.3 1.8 3.7 9.4 11.6 1.5 6.3 5.5 1.1 1.5 1.3 9.3 1.1 1.8 1.1 1.4 3.4 3.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 4.9 3.4 23.0 0.2 9.2 1.0 10.6 5.7 3.9 4.4 3.3 1.7 0.8 0.0 23.0 10.3 4.8 4.8 4.6 2.0 0.0 1.3 0.0 3.6 1.8 1.9 0.0 0.0 4.7 3.1 2.5 0.8 8.3 0.0 16.8 3.1 0.5 0.1 0.2 4.5 1.4 0.0 33.0 4.0 2.5 5.9 2.7 0.1 2.6 0.7 0.2 1.2 0.1 6.2 3.8 12.8 1.4 6.8 0.0 0.0 0.3 1.1 0.0 3.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.0 9.9 17.5 5.1 3.3 8.7 8.4 7.6 9.3 NUDT11 "DIPP3b, FLJ10628, hDIPP3beta" ENSG00000196368 "Nudix hydrolase 11" Q96G61 X 51490011-51496596 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1;testis: 35.5" "Cell line enhanced" "Detected in many" "HAP1: 33.1;NTERA-2: 20.6" "Cancer enhanced" "Detected in many" "testis cancer: 17.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 3.7;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD8 T-cell: 3.1;NK-cell: 1.9" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 3.7" "HPA047027, HPA057684" Approved Approved Cytosol Cytosol "HPA047027: , HPA057684: " "unprognostic (2.01e-1)" "unprognostic (2.57e-1)" "unprognostic (8.21e-2)" "unprognostic (1.93e-3)" "unprognostic (6.61e-2)" "unprognostic (1.13e-3)" "unprognostic (5.52e-3)" "unprognostic (1.25e-1)" "unprognostic (2.25e-2)" "unprognostic (2.18e-1)" "unprognostic (8.41e-2)" "unprognostic (1.33e-1)" "unprognostic (7.80e-12)" "unprognostic (4.34e-4)" "unprognostic (1.17e-2)" "unprognostic (2.78e-1)" "unprognostic (3.94e-4)" 1.2 5.4 11.2 1.4 21.9 1.6 2.8 7.4 26.1 3.8 2.6 0.8 4.4 1.7 5.9 4.3 1.9 1.6 2.2 0.8 7.0 17.9 0.9 0.6 0.8 1.1 5.3 12.7 10.0 3.8 0.5 2.8 0.6 5.3 10.1 1.4 0.5 1.3 11.9 0.6 1.7 1.5 5.0 1.8 0.9 0.9 35.5 1.1 3.6 1.0 0.2 1.1 1.7 1.6 0.5 0.4 0.0 0.2 1.9 3.7 1.0 0.0 0.5 10.0 0.0 8.6 11.0 0.0 4.6 1.3 0.2 0.2 0.0 0.0 0.0 0.2 5.6 0.7 33.1 11.3 0.1 0.0 2.2 0.0 0.0 0.0 4.1 0.0 2.2 6.7 4.5 3.0 11.0 7.8 0.0 0.0 9.3 0.2 12.5 0.0 20.6 8.4 0.0 7.0 0.0 2.0 0.0 0.0 6.5 2.0 0.0 1.8 0.0 0.0 4.5 2.3 10.9 0.6 0.0 4.3 2.0 7.0 1.5 0.0 0.9 0.0 0.0 0.0 3.7 0.0 1.4 0.5 1.2 1.9 0.4 0.3 0.2 3.1 0.0 1.9 0.2 0.2 0.0 1.0 11.2 21.9 7.4 14.9 7.0 17.9 5.3 12.7 5.3 1.1 NWD1 ENSG00000188039 "NACHT and WD repeat domain containing 1" Q149M9 19 16719976-16817963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;fallopian tube: 14.1" "Group enriched" "Detected in some" 12 "MCF7: 3.3;U-937: 7.7" "Cancer enriched" "Detected in many" 6 "prostate cancer: 9.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (5.29e-3)" "unprognostic (3.08e-2)" "unprognostic (3.05e-2)" "prognostic favourable (2.55e-4)" "unprognostic (2.49e-1)" "unprognostic (4.20e-4)" "unprognostic (6.54e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (1.60e-1)" "unprognostic (7.94e-2)" "unprognostic (1.76e-1)" "unprognostic (9.20e-2)" "unprognostic (1.31e-1)" "unprognostic (5.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.25e-1)" 0.6 0.7 6.9 0.6 8.1 0.8 1.0 0.9 5.9 1.7 0.9 11.3 0.5 0.7 1.1 6.5 0.6 14.1 0.8 0.7 10.9 4.2 1.0 0.7 1.8 0.7 3.9 7.8 0.7 4.3 0.6 1.3 0.7 27.8 10.6 0.9 10.3 2.7 3.9 0.8 0.6 0.7 0.8 2.2 0.6 1.0 1.4 4.6 0.0 1.6 0.0 0.6 0.8 0.5 0.5 0.1 1.3 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.5 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 1.3 0.5 0.0 0.1 0.0 0.1 6.9 8.1 0.9 5.9 10.9 4.2 3.9 7.8 27.8 4.6 NWD2 KIAA1239 ENSG00000174145 "NACHT and WD repeat domain containing 2" Q9ULI1 4 37244220-37449465 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.8;breast: 20.0" "Cell line enhanced" "Detected in single" "AF22: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046911 Uncertain "HPA046911: " "unprognostic (1.14e-2)" "unprognostic (3.12e-2)" "unprognostic (2.53e-1)" "unprognostic (5.47e-2)" "unprognostic (9.42e-2)" "unprognostic (2.55e-1)" "unprognostic (5.15e-2)" "unprognostic (1.63e-2)" "unprognostic (7.47e-2)" "unprognostic (1.00e-1)" "unprognostic (7.00e-2)" "unprognostic (1.98e-1)" "unprognostic (1.86e-2)" "unprognostic (7.65e-2)" "unprognostic (4.36e-2)" "unprognostic (1.26e-2)" 4.9 0.3 2.1 0.3 2.9 0.2 20.0 1.0 11.8 0.3 1.6 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.3 0.2 2.3 3.2 0.2 0.5 0.2 0.3 0.7 2.0 0.2 0.7 0.3 0.3 0.3 2.0 0.2 0.8 0.0 0.4 0.2 0.2 0.7 0.4 0.4 0.3 0.2 0.3 0.6 0.0 0.4 2.7 0.0 0.3 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.9 1.0 8.9 2.3 3.2 0.7 2.0 2.0 0.0 NXPH1 ENSG00000122584 "Neurexophilin 1" P58417 7 8433955-8752963 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "adrenal gland: 41.1;brain: 30.1" "Group enriched" "Detected in some" 6 "Karpas-707: 15.1;WM-115: 4.7" "Group enriched" "Detected in some" 62 "breast cancer: 2.3;glioma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" "unprognostic (2.84e-2)" "unprognostic (1.30e-1)" "unprognostic (3.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.39e-2)" "unprognostic (1.46e-4)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (5.32e-1)" "unprognostic (9.46e-2)" 0.8 41.1 9.6 0.7 9.8 0.7 1.1 3.6 30.1 0.7 0.7 3.0 0.0 0.7 0.7 0.7 0.7 0.7 0.8 0.7 6.5 13.9 0.7 0.7 0.7 0.7 6.2 7.1 0.7 0.7 0.7 1.9 0.7 6.8 0.7 0.7 0.0 1.0 0.7 0.7 0.7 0.7 0.7 3.3 0.7 0.7 0.9 1.9 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 1.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 9.8 3.6 11.5 6.5 13.9 6.2 7.1 6.8 1.9 NXPH2 NPH2 ENSG00000144227 "Neurexophilin 2" O95156 2 138670772-138780348 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 15 "brain: 23.0;kidney: 8.0;ovary: 19.3" "Cell line enhanced" "Detected in some" "AF22: 6.2;SCLC-21H: 2.4;SiHa: 6.0;U-2 OS: 9.9;U-251 MG: 3.2" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 4 "pons and medulla: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034759 Approved "Secreted in brain" "HPA034759: AB_10669732" "unprognostic (5.83e-2)" "unprognostic (8.83e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-1)" "unprognostic (1.80e-1)" 0.4 0.5 3.1 0.6 3.7 0.2 0.4 0.8 6.0 0.6 0.3 0.0 0.0 0.2 1.1 0.5 0.2 0.6 0.2 0.2 1.9 1.5 8.0 0.3 0.3 0.2 2.4 2.0 19.3 0.2 0.4 0.4 0.4 23.0 0.3 0.3 0.5 0.2 1.1 0.2 0.2 0.4 0.3 0.7 0.2 0.2 0.4 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 2.4 1.6 6.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.7 0.8 5.6 1.9 1.5 2.4 2.0 23.0 0.8 NXPH4 NPH4 ENSG00000182379 "Neurexophilin 4" O95158 12 57216795-57226449 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1;skin 1: 17.7" "Cell line enhanced" "Detected in many" "AN3-CA: 34.4;RH-30: 28.2;RPMI-8226: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.9" "Lineage enriched" "Detected in single" 19 "B-cells: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in brain" "unprognostic (1.08e-2)" "unprognostic (4.84e-2)" "unprognostic (2.70e-3)" "prognostic unfavourable (6.21e-4)" "prognostic unfavourable (5.42e-4)" "unprognostic (1.16e-1)" "prognostic unfavourable (2.57e-4)" "unprognostic (3.07e-1)" "unprognostic (1.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (6.77e-2)" "prognostic unfavourable (7.68e-6)" "unprognostic (7.83e-2)" "unprognostic (2.73e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-3)" 2.8 1.4 2.6 0.8 3.8 0.9 1.9 18.1 9.4 1.9 0.4 0.0 0.0 0.3 0.3 0.7 2.5 0.4 0.4 4.6 1.6 3.7 0.7 1.1 0.4 1.1 2.6 6.2 0.3 1.6 0.7 0.7 4.8 10.9 8.2 0.3 2.7 3.2 0.4 0.6 17.7 0.4 0.5 3.4 0.8 0.4 1.3 0.0 0.0 1.0 0.7 1.7 0.5 2.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.6 0.1 34.4 4.0 1.0 3.2 2.2 5.1 0.9 1.2 2.2 0.4 8.5 3.5 2.2 7.2 4.6 1.0 0.3 1.4 9.2 0.0 0.3 0.1 3.4 0.3 1.1 0.9 1.8 0.9 1.4 0.0 0.3 9.0 0.7 8.0 0.0 0.0 0.3 6.0 0.4 28.2 18.5 0.0 1.4 5.6 0.3 4.9 10.1 9.8 10.0 0.2 0.0 2.5 8.2 1.0 2.5 4.9 0.9 3.0 1.6 4.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.8 18.1 5.7 1.6 3.7 2.6 6.2 10.9 0.0 NYAP1 "C7orf51, FLJ37538, KIAA1486L" ENSG00000166924 "Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1" Q6ZVC0 7 100483927-100494799 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.8" "Cell line enhanced" "Detected in some" "AF22: 4.4;HUVEC TERT2: 5.6;SH-SY5Y: 13.6" "Cancer enhanced" "Detected in some" "glioma: 4.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022251 Uncertain Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA022251: AB_1848915" "unprognostic (6.59e-4)" "unprognostic (2.67e-2)" "unprognostic (1.82e-2)" "unprognostic (2.51e-4)" "unprognostic (2.89e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-2)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.20e-1)" "unprognostic (3.06e-2)" "unprognostic (4.31e-1)" "unprognostic (8.65e-2)" 3.1 6.3 11.8 1.6 15.2 1.3 1.4 15.4 32.8 1.8 1.6 3.8 0.0 1.6 2.8 1.3 1.5 1.9 1.6 1.2 13.2 12.8 1.9 1.1 1.3 1.4 7.4 13.4 5.7 2.1 1.1 10.2 1.7 11.4 2.9 1.4 1.0 2.3 3.2 1.2 1.9 1.8 2.1 3.9 1.6 2.3 9.0 4.4 0.0 1.2 0.0 1.2 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.4 2.0 2.9 1.9 0.4 0.1 1.4 0.2 0.6 0.6 0.3 0.0 1.5 0.4 0.2 0.9 0.2 0.1 1.9 0.3 0.2 0.4 0.2 2.1 0.0 1.2 1.9 0.0 0.6 0.7 5.6 0.7 0.1 0.1 0.5 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.1 0.0 1.3 13.6 0.5 0.3 1.3 0.2 0.0 2.0 0.0 2.8 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 15.2 15.4 20.6 13.2 12.8 7.4 13.4 11.4 4.4 NYAP2 KIAA1486 ENSG00000144460 "Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2" Q9P242 2 225399710-225654018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.9;pituitary gland: 13.5" "Cell line enhanced" "Detected in some" "HeLa: 1.9;SH-SY5Y: 2.0;SiHa: 6.1;U-2 OS: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045531 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA045531: AB_10960749" "unprognostic (2.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.24e-1)" "unprognostic (2.63e-1)" "unprognostic (2.35e-1)" "unprognostic (6.13e-3)" "unprognostic (3.33e-1)" "unprognostic (2.08e-1)" "unprognostic (1.32e-8)" "unprognostic (9.83e-2)" "unprognostic (2.92e-1)" "unprognostic (6.46e-2)" "unprognostic (1.27e-1)" 0.8 1.1 10.8 1.0 16.4 1.4 0.7 17.9 11.9 0.6 0.7 0.8 0.0 1.0 0.7 0.7 1.2 0.6 0.8 0.7 8.5 2.5 0.7 0.7 1.9 1.1 2.6 8.5 0.6 0.8 0.6 13.5 0.7 2.5 0.7 0.8 0.0 0.7 0.6 2.6 1.2 0.9 0.6 2.7 0.9 0.8 1.0 2.9 0.0 0.6 0.0 0.8 1.2 0.6 0.5 0.5 2.1 0.3 0.2 0.4 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 2.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.1 0.3 0.2 0.3 0.2 0.4 0.3 0.2 0.1 0.0 0.5 0.3 0.4 1.2 0.2 0.2 0.5 0.1 0.1 10.8 16.4 17.9 11.9 8.5 2.5 2.6 8.5 2.5 2.9 OC90 PLA2L ENSG00000253117 "Otoconin 90" Q02509 8 132024220-132059380 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.5;lymphoid tissue: 1.1;placenta: 1.3;retina: 2.9" "Cell line enriched" "Detected in single" 46 "SK-MEL-30: 4.6" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" "unprognostic (1.92e-1)" "unprognostic (2.93e-1)" 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.2 0.7 1.5 0.0 0.0 0.0 OCM OCM1 ENSG00000122543 Oncomodulin P0CE72 7 5879827-5886362 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.7;brain: 9.5;lymphoid tissue: 5.5" "Cell line enhanced" "Detected in some" "MCF7: 2.1;PC-3: 1.9;THP-1: 1.4;U-937: 2.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.7" "Low lineage specificity" "Detected in many" HPA046422 Uncertain "HPA046422: " "unprognostic (1.79e-2)" "unprognostic (2.55e-2)" "unprognostic (3.97e-1)" "unprognostic (1.50e-1)" "unprognostic (5.39e-2)" "unprognostic (1.31e-2)" "unprognostic (2.30e-2)" "unprognostic (7.62e-3)" "unprognostic (2.47e-1)" "unprognostic (1.52e-1)" "unprognostic (1.92e-3)" "unprognostic (6.13e-2)" "unprognostic (2.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.02e-1)" "unprognostic (3.23e-1)" "unprognostic (3.90e-4)" 0.1 0.5 9.5 0.7 1.7 1.8 1.6 3.1 1.4 0.2 0.5 0.0 0.2 2.7 0.3 0.3 0.5 0.0 2.0 1.8 0.3 0.1 0.1 5.5 0.9 0.5 0.3 0.0 0.2 0.0 0.2 0.6 0.9 0.8 0.0 2.0 0.7 0.2 0.8 1.4 0.1 2.3 0.6 2.3 0.3 0.1 2.1 0.1 2.0 0.8 0.0 5.7 1.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.8 0.4 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.5 0.1 0.0 1.4 0.0 0.0 0.2 0.4 0.4 0.3 0.3 0.1 0.0 2.1 0.0 0.0 0.8 2.0 1.1 0.5 0.4 0.9 2.8 0.8 0.1 2.1 3.7 1.0 1.6 0.0 0.4 0.0 5.7 1.3 OGFRL1 dJ331H24.1 ENSG00000119900 "Opioid growth factor receptor like 1" Q5TC84 6 71288803-71308950 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 12.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027122 Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA027122: AB_2156775" "unprognostic (8.44e-3)" "unprognostic (1.41e-2)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (4.24e-3)" "prognostic unfavourable (3.62e-4)" "unprognostic (9.62e-3)" "unprognostic (2.30e-2)" "unprognostic (2.49e-1)" "unprognostic (4.22e-2)" "unprognostic (2.11e-1)" "unprognostic (1.39e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (3.25e-2)" "unprognostic (5.58e-3)" 16.9 8.7 20.2 11.3 26.8 16.9 36.0 22.3 33.3 6.7 7.2 29.1 2.8 2.9 8.3 10.7 24.5 5.2 8.3 5.8 30.2 17.6 5.7 4.8 8.5 9.6 27.7 18.3 5.4 6.0 5.8 10.0 9.9 37.8 6.7 4.3 3.3 31.8 10.3 4.1 14.6 5.7 24.1 52.2 11.7 5.4 2.4 29.1 3.2 4.8 4.3 17.8 5.4 9.4 0.7 2.4 12.8 3.0 0.5 0.5 0.6 3.8 1.1 4.0 0.0 11.0 10.1 1.5 17.1 10.6 6.9 7.0 1.4 0.7 23.3 23.5 7.3 1.9 3.1 11.7 24.6 4.9 2.5 5.1 4.1 0.6 9.0 2.4 1.8 10.2 10.2 5.1 16.1 5.5 0.3 1.8 23.7 3.2 0.0 3.8 1.6 0.9 1.6 12.4 5.3 16.0 0.3 13.9 6.3 5.0 3.1 1.1 5.4 18.9 8.4 17.0 8.6 1.8 5.6 2.5 0.1 3.0 5.7 16.2 2.9 3.1 3.0 0.1 0.5 2.0 0.5 0.4 0.4 0.5 2.4 0.7 0.1 0.3 12.8 0.5 1.4 0.9 0.2 0.6 20.2 26.8 22.3 27.4 30.2 17.6 27.7 18.3 37.8 29.1 OLFM1 "AMY, NOE1, NOELIN, OlfA" ENSG00000130558 "Olfactomedin 1" Q99784 9 135075422-135121179 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 159.5" "Cell line enhanced" "Detected in some" "HeLa: 25.2;MCF7: 21.2;NTERA-2: 28.3;SCLC-21H: 40.8;SiHa: 33.8;T-47d: 52.4;U-2197: 22.8" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 38 "classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 51 "dendritic cells: 5.1;monocytes: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057444 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in brain" 130000000 Nucleoli "Nucleoplasm, Cytosol" "HPA057444: " "unprognostic (6.77e-2)" "prognostic favourable (7.14e-4)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "prognostic unfavourable (6.58e-4)" "unprognostic (3.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.69e-3)" "unprognostic (2.67e-1)" "unprognostic (6.04e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (9.46e-3)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (6.20e-2)" "unprognostic (7.53e-4)" 7.7 10.0 80.5 5.0 41.5 0.9 4.7 30.9 159.5 7.4 5.4 4.6 0.7 2.5 6.9 26.4 5.0 4.4 3.8 3.9 77.2 19.1 3.4 2.4 4.7 5.2 18.8 36.5 6.2 5.1 3.6 9.9 1.1 13.5 4.8 5.7 0.9 2.6 7.5 6.1 4.5 3.5 6.9 6.1 5.8 3.9 2.8 2.8 0.3 2.7 0.8 7.1 4.1 6.2 0.0 5.1 0.0 5.0 0.0 0.0 0.6 0.0 1.5 3.1 0.0 0.4 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.3 0.6 0.6 0.0 0.0 3.6 0.2 0.0 25.2 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 21.2 0.1 0.0 28.3 0.0 0.0 0.0 11.9 0.0 0.0 40.8 5.4 33.8 0.1 2.1 52.4 0.0 0.0 2.0 4.5 22.8 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 3.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 80.5 41.5 30.9 119.7 77.2 19.1 18.8 36.5 13.5 2.8 OLFM2 "NOE2, OlfC" ENSG00000105088 "Olfactomedin 2" O95897 19 9853718-9936552 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.4;skin 1: 60.2" "Cell line enhanced" "Detected in many" "AN3-CA: 15.4;ASC diff: 14.6;BJ hTERT+: 11.1;SH-SY5Y: 14.8;U-2 OS: 17.8;WM-115: 15.4" "Cancer enhanced" "Detected in all" "glioma: 96.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 24.9" "Group enriched" "Detected in many" 27 "granulocytes: 24.9;T-cells: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049961, HPA057771" Uncertain Approved Nucleoplasm "Secreted in other tissues" 2300000 Nucleoplasm "HPA049961: , HPA057771: " "unprognostic (1.42e-2)" "unprognostic (3.93e-2)" "prognostic unfavourable (3.05e-4)" "unprognostic (1.99e-2)" "unprognostic (5.91e-2)" "unprognostic (3.39e-2)" "unprognostic (8.78e-2)" "unprognostic (4.47e-2)" "unprognostic (8.04e-2)" "unprognostic (4.03e-2)" "unprognostic (1.41e-3)" "unprognostic (2.77e-2)" "prognostic unfavourable (2.21e-4)" "unprognostic (6.23e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" 20.9 12.2 37.2 2.7 39.7 0.8 5.8 9.1 51.4 4.5 1.9 11.6 0.3 2.1 7.9 3.8 3.9 6.6 4.9 3.9 26.2 21.6 1.8 23.5 3.2 5.0 19.6 17.9 3.5 7.9 1.1 4.4 5.2 15.4 5.2 1.4 3.2 7.1 10.3 1.7 60.2 2.0 5.1 9.0 2.2 1.4 5.2 4.6 16.0 8.4 1.1 3.7 2.6 3.2 0.0 0.0 24.9 0.0 0.6 8.9 1.7 0.0 2.2 1.8 15.4 14.6 9.0 1.0 3.3 11.1 0.7 0.9 0.1 1.4 0.0 1.4 2.5 0.9 5.9 1.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.0 2.6 4.7 0.9 0.1 0.1 0.0 0.1 0.2 0.0 4.8 0.1 0.1 9.6 0.0 0.0 0.0 0.0 0.0 0.5 0.1 14.8 0.5 0.0 3.0 0.5 0.0 0.1 6.5 17.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 15.4 9.6 0.0 24.9 3.5 0.0 3.8 0.0 4.1 3.1 0.0 0.0 8.0 5.1 0.3 0.6 0.0 0.0 8.9 1.7 37.2 39.7 9.1 38.0 26.2 21.6 19.6 17.9 15.4 4.6 OLFM3 NOE3 ENSG00000118733 "Olfactomedin 3" Q96PB7 1 101802574-101997030 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.0" "Group enriched" "Detected in some" 11 "AF22: 9.3;HAP1: 6.4;HEL: 5.7;SCLC-21H: 3.7;SH-SY5Y: 3.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050297 Uncertain Vesicles "Secreted in brain" Vesicles "HPA050297: " "unprognostic (4.19e-1)" "unprognostic (4.19e-4)" "unprognostic (1.26e-1)" "unprognostic (4.61e-2)" "unprognostic (2.93e-1)" "unprognostic (1.47e-2)" "unprognostic (3.58e-4)" "unprognostic (2.48e-1)" "unprognostic (5.68e-2)" 0.7 3.2 5.0 1.4 13.7 0.7 0.8 24.2 30.0 0.9 1.8 0.4 0.0 1.0 0.9 1.2 0.7 0.8 0.8 0.7 4.8 7.4 1.5 0.8 0.7 0.7 6.0 11.9 0.8 0.7 0.7 2.4 0.8 16.6 0.7 1.7 0.3 0.8 0.7 0.7 0.7 2.1 1.3 1.5 0.9 1.0 0.9 0.7 0.0 1.2 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.0 3.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 13.7 24.2 26.7 4.8 7.4 6.0 11.9 16.6 0.7 OLIG1 "BHLHB6, bHLHe21" ENSG00000184221 "Oligodendrocyte transcription factor 1" Q8TAK6 21 33070144-33072420 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 95.6" "Group enriched" "Detected in some" 6 "NB-4: 23.8;RPMI-8226: 12.4;THP-1: 15.6;U-937: 17.8" "Cancer enriched" "Detected in some" 18 "glioma: 116.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 6.3;eosinophil: 22.0" "Lineage enriched" "Detected in many" 14 "granulocytes: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (4.13e-2)" "unprognostic (6.46e-2)" "unprognostic (4.06e-1)" "unprognostic (3.58e-1)" "unprognostic (9.01e-3)" "unprognostic (2.40e-1)" "unprognostic (7.93e-2)" "unprognostic (1.50e-1)" "unprognostic (3.82e-3)" "unprognostic (5.19e-2)" "unprognostic (8.17e-2)" "unprognostic (2.51e-1)" "unprognostic (4.05e-2)" "unprognostic (5.96e-3)" "unprognostic (3.20e-2)" "unprognostic (1.17e-1)" 1.8 1.8 44.6 1.9 51.6 2.5 1.9 7.3 95.6 1.8 1.8 58.3 0.0 1.9 1.8 1.8 1.8 1.8 1.8 1.8 42.7 30.4 3.1 1.8 1.9 1.8 40.7 22.7 1.8 1.9 1.8 0.1 1.8 35.5 1.8 1.8 0.0 1.9 1.8 3.0 1.8 2.0 1.8 41.4 2.3 2.0 2.2 35.7 0.0 1.8 0.0 1.8 1.9 0.0 0.0 0.2 22.0 1.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 1.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 23.8 0.1 0.0 0.0 0.1 12.4 0.0 0.0 0.8 0.0 0.0 0.0 2.9 0.1 15.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 17.8 1.0 6.3 1.6 22.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.4 0.1 0.0 0.3 44.6 51.6 7.3 35.2 42.7 30.4 40.7 22.7 35.5 35.7 OLIG2 "BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17" ENSG00000205927 "Oligodendrocyte transcription factor 2" Q13516 21 33025845-33029196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 66.2" "Cell line enhanced" "Detected in some" "HMC-1: 29.3;NB-4: 21.2;THP-1: 18.4;WM-115: 6.0" "Cancer enriched" "Detected in some" 52 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 15.4" "Lineage enriched" "Detected in single" 154 "granulocytes: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003254, CAB019381" Enhanced Uncertain "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "CAB019381: , HPA003254: AB_1854795" "unprognostic (5.14e-1)" "unprognostic (4.56e-1)" "unprognostic (1.44e-2)" "unprognostic (8.27e-2)" "unprognostic (3.24e-2)" "unprognostic (4.34e-2)" "unprognostic (4.81e-2)" "unprognostic (5.41e-2)" "unprognostic (1.39e-1)" "unprognostic (5.78e-5)" "unprognostic (2.76e-1)" 1.3 1.3 24.1 1.4 19.1 1.4 1.3 4.2 66.2 1.3 1.3 41.4 0.0 1.7 1.3 1.3 1.3 1.3 1.3 1.3 23.6 15.6 1.3 1.3 1.3 1.3 20.9 15.5 1.3 1.3 1.3 0.0 1.3 17.1 1.3 1.3 0.0 1.3 1.3 1.3 1.3 1.5 1.3 16.8 1.3 1.4 1.3 16.6 0.0 1.3 0.0 1.3 1.4 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.6 4.2 0.0 0.0 0.0 0.8 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.2 1.9 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 6.0 1.8 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 19.1 4.2 27.6 23.6 15.6 20.9 15.5 17.1 16.6 OLIG3 "Bhlhb7, bHLHe20" ENSG00000177468 "Oligodendrocyte transcription factor 3" Q7RTU3 6 137492202-137494250 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.7;esophagus: 1.4;placenta: 1.8" "Group enriched" "Detected in some" 4 "AF22: 2.9;NTERA-2: 4.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "pons and medulla: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA018303, CAB024865" Uncertain "CAB024865: , HPA018303: AB_1854796" "unprognostic (1.07e-3)" "unprognostic (1.44e-1)" "unprognostic (2.77e-1)" "unprognostic (2.03e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 1.8 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.7 0.0 OLR1 "CLEC8A, LOX-1, SCARE1" ENSG00000173391 "Oxidized low density lipoprotein receptor 1" P78380 12 10158301-10172138 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Inflammatory response" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;lung: 46.8;placenta: 53.4" "Cell line enhanced" "Detected in some" "CACO-2: 32.0;HaCaT: 16.8;HHSteC: 33.8;hTCEpi: 15.5;SiHa: 64.4;SK-BR-3: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.9" "Group enriched" "Detected in many" 6 "dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5" "Low region specificity" "Detected in all" HPA050798 Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" "Nucleoplasm, Plasma membrane" Vesicles "HPA050798: AB_2756318" "unprognostic (2.30e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "prognostic unfavourable (8.24e-5)" "unprognostic (6.34e-2)" "unprognostic (6.07e-3)" "unprognostic (5.40e-2)" "unprognostic (2.64e-1)" "unprognostic (1.97e-2)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (4.94e-3)" "unprognostic (3.47e-2)" "unprognostic (1.48e-2)" "unprognostic (1.42e-1)" 2.0 1.9 6.0 14.1 10.3 10.6 2.0 1.3 10.2 1.9 0.5 21.3 0.0 0.8 1.0 0.9 0.5 1.2 3.9 1.1 8.5 6.7 6.9 1.8 46.8 0.5 16.4 4.4 0.4 1.6 2.8 1.9 53.4 12.3 1.4 0.7 0.2 2.0 0.7 0.4 0.5 0.8 1.2 28.5 0.6 1.4 2.8 10.5 0.0 1.5 0.0 0.6 4.3 0.4 0.5 5.9 3.3 1.5 0.3 0.3 1.1 1.8 0.1 0.0 0.1 0.0 0.0 4.4 3.1 0.5 1.9 0.7 32.0 0.0 0.3 0.0 4.1 16.8 0.0 0.1 1.3 0.0 0.0 0.0 1.6 0.0 33.8 0.0 0.0 0.2 15.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 64.4 25.6 0.0 7.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 1.5 2.7 0.2 0.2 0.3 0.3 0.3 0.2 5.9 0.5 0.3 0.3 3.3 0.3 0.4 0.8 0.2 1.1 6.0 10.3 1.3 7.4 8.5 6.7 16.4 4.4 12.3 10.5 OMG OMGP ENSG00000126861 "Oligodendrocyte myelin glycoprotein" P23515 17 31272013-31297539 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 40 "brain: 89.6" "Cell line enhanced" "Detected in some" "HAP1: 3.5;U-87 MG: 1.4" "Group enriched" "Detected in some" 7 "endometrial cancer: 3.5;glioma: 9.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008206, HPA012693" Enhanced "Intracellular and membrane" "HPA008206: AB_1854240, HPA012693: AB_1854239" "unprognostic (8.05e-4)" "unprognostic (2.11e-2)" "unprognostic (1.27e-1)" "unprognostic (3.03e-3)" "unprognostic (1.85e-1)" "unprognostic (4.16e-2)" "unprognostic (1.63e-1)" "unprognostic (3.81e-2)" "unprognostic (9.54e-2)" "unprognostic (8.60e-2)" "unprognostic (7.03e-2)" "unprognostic (1.52e-1)" "unprognostic (3.96e-13)" "unprognostic (7.80e-3)" "unprognostic (6.00e-2)" "unprognostic (3.24e-1)" "unprognostic (2.42e-2)" 1.6 1.8 25.2 1.6 25.4 2.2 1.6 10.2 89.6 1.6 1.7 20.3 0.0 1.7 1.6 1.6 1.6 1.6 1.6 1.6 26.8 20.6 1.6 1.6 1.6 1.6 30.8 23.2 1.6 1.6 1.6 0.1 1.6 36.8 1.6 1.7 1.4 1.6 1.6 1.7 1.6 1.7 1.6 23.0 1.7 1.6 1.6 39.6 0.0 1.6 0.0 1.6 1.6 0.0 0.0 0.1 1.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.2 0.2 3.5 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.6 1.4 0.0 0.7 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 25.2 25.4 10.2 34.1 26.8 20.6 30.8 23.2 36.8 39.6 ONECUT2 OC-2 ENSG00000119547 "One cut homeobox 2" O95948 18 57435685-57491297 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.6;gallbladder: 60.7;intestine: 18.0" "Cell line enhanced" "Detected in some" "HDLM-2: 18.2;HeLa: 11.6;RT4: 6.2;SCLC-21H: 9.5" "Group enriched" "Detected in many" 7 "liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4" "Region enhanced" "Detected in many" "basal ganglia: 18.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "basal ganglia: 10.6;cerebellum: 9.9;cerebral cortex: 6.6;hippocampal formation: 4.3;hypothalamus: 4.3" HPA057058 Enhanced Supported "Nucleoplasm,Actin filaments" Nucleoplasm "Actin filaments" "HPA057058: " "unprognostic (3.02e-2)" "unprognostic (5.36e-2)" "unprognostic (9.06e-3)" "unprognostic (3.79e-5)" "unprognostic (1.13e-2)" "unprognostic (4.48e-4)" "unprognostic (2.10e-2)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (4.56e-3)" "unprognostic (8.66e-3)" "unprognostic (1.16e-2)" "unprognostic (5.34e-4)" "unprognostic (3.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.13e-1)" "unprognostic (3.21e-1)" 0.3 0.4 0.3 0.3 18.6 0.2 0.3 3.0 3.7 0.2 16.5 0.0 0.0 15.0 0.3 0.3 0.3 0.2 60.7 0.2 0.5 0.9 0.3 12.8 0.3 0.3 0.5 0.9 0.3 4.3 3.2 5.1 0.2 1.1 0.3 0.3 0.7 0.3 0.3 0.3 0.3 18.0 0.3 0.3 0.3 0.5 0.6 6.6 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.1 2.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 3.2 0.0 0.1 18.2 2.9 0.7 11.6 2.7 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 3.5 0.6 0.0 0.4 1.7 0.0 0.1 0.7 0.0 1.1 0.0 1.6 6.2 9.5 1.6 0.1 0.0 0.2 0.4 0.6 0.0 1.0 1.2 0.2 0.2 0.3 2.7 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.6 3.0 3.7 0.5 0.9 0.5 0.9 1.1 6.6 OPALIN "HTMP10, TMEM10, TMP10" ENSG00000197430 "Oligodendrocytic myelin paranodal and inner loop protein" Q96PE5 10 96343216-96359365 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 43 "brain: 69.7" "Group enriched" "Detected in some" 11 "MOLT-4: 2.2;REH: 4.5" "Cancer enriched" "Detected in single" 36 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014372 Supported "HPA014372: AB_2158172" "unprognostic (1.18e-1)" 1.5 1.5 35.0 1.5 42.1 1.6 1.5 2.8 69.7 1.5 1.5 52.5 0.0 1.5 1.5 1.5 1.5 1.5 1.5 1.5 40.1 15.1 1.5 1.5 1.5 1.5 19.9 17.8 1.5 1.5 1.5 0.0 1.5 13.8 1.5 1.5 0.0 1.5 1.5 1.5 1.5 1.5 1.5 17.8 1.5 1.5 1.5 29.5 0.0 1.5 0.0 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 42.1 2.8 33.4 40.1 15.1 19.9 17.8 13.8 29.5 OPCML "IGLON1, OBCAM, OPCM" ENSG00000183715 "Opioid binding protein/cell adhesion molecule like" Q14982 11 132414977-133532519 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 49.9" "Cell line enriched" "Detected in some" 5 "BJ: 14.0" "Group enriched" "Detected in some" 10 "glioma: 3.7;renal cancer: 0.7;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" 6300000 "unprognostic (1.59e-1)" "unprognostic (2.26e-2)" "unprognostic (3.70e-2)" "unprognostic (3.31e-4)" "unprognostic (8.23e-2)" "unprognostic (3.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (8.46e-3)" "unprognostic (2.59e-2)" "unprognostic (2.80e-1)" "unprognostic (4.73e-2)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" "unprognostic (1.76e-1)" "unprognostic (9.71e-2)" "unprognostic (2.19e-1)" 1.2 1.5 10.5 1.1 22.3 0.9 1.0 31.4 49.9 1.6 1.1 3.9 0.0 1.1 1.7 1.1 1.5 1.6 1.3 1.4 14.7 8.9 2.9 1.0 1.0 1.0 4.2 21.2 1.3 1.0 7.0 1.1 0.9 4.0 1.1 1.2 4.8 1.2 1.8 1.0 1.1 1.1 1.7 2.6 1.8 1.2 1.5 6.6 0.0 1.2 0.0 1.0 1.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 14.0 0.1 2.1 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 2.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.5 22.3 31.4 35.6 14.7 8.9 4.2 21.2 4.0 6.6 OPN4 "melanopsin, MOP" ENSG00000122375 "Opsin 4" Q9UHM6 10 86654557-86666848 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Biological rhythms, Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.2;skeletal muscle: 14.6" "Cell line enhanced" "Detected in single" "PC-3: 1.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 21.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039147 Approved "HPA039147: AB_10673304" "unprognostic (3.67e-3)" "unprognostic (1.40e-2)" "unprognostic (3.02e-2)" "unprognostic (1.62e-1)" "unprognostic (7.03e-3)" "unprognostic (2.89e-2)" "unprognostic (3.26e-1)" "unprognostic (9.54e-2)" "unprognostic (5.68e-2)" "unprognostic (8.88e-3)" "unprognostic (1.93e-6)" "unprognostic (4.10e-2)" "unprognostic (5.58e-2)" "unprognostic (6.76e-2)" 3.5 0.3 5.4 0.4 21.2 0.2 1.1 0.0 5.1 0.6 0.9 0.0 0.0 0.5 0.4 0.4 0.6 0.4 0.5 3.1 3.0 0.1 0.3 0.2 0.3 0.2 0.2 3.3 0.3 0.4 3.6 0.6 0.5 0.0 0.2 0.7 1.2 1.6 0.2 14.6 1.2 1.1 0.5 0.0 0.3 0.5 0.5 2.0 0.0 1.4 2.7 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 21.2 0.0 3.5 3.0 0.1 0.2 3.3 0.0 2.0 OPRD1 ENSG00000116329 "Opioid receptor delta 1" P41143 1 28812142-28871267 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.7" "Group enriched" "Detected in some" 12 "RH-30: 14.5;SCLC-21H: 5.7;SH-SY5Y: 5.8;WM-115: 19.3" "Cancer enhanced" "Detected in single" "melanoma: 1.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070831 Approved "HPA070831: " "unprognostic (1.44e-1)" "unprognostic (4.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.89e-2)" "unprognostic (2.68e-1)" "unprognostic (5.84e-3)" "unprognostic (6.28e-3)" "unprognostic (5.92e-2)" "unprognostic (1.82e-2)" "unprognostic (5.95e-3)" "unprognostic (4.28e-3)" "unprognostic (2.98e-1)" "unprognostic (1.52e-7)" "unprognostic (1.44e-2)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (2.18e-3)" 0.4 2.4 5.5 0.6 3.9 1.9 0.4 0.4 8.7 0.4 0.6 0.0 0.0 0.5 0.4 0.4 0.4 0.4 0.6 0.4 3.0 1.3 0.4 0.4 0.5 0.7 0.6 5.9 0.5 1.3 0.2 0.5 0.5 4.7 0.4 0.5 0.1 1.0 0.2 3.2 1.0 0.6 0.4 0.4 0.7 0.8 0.8 0.2 0.0 0.6 0.0 0.2 0.4 0.4 1.2 1.1 3.1 0.5 1.1 0.7 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.2 0.9 0.0 0.0 14.5 0.1 0.0 0.0 5.7 5.8 0.0 0.1 0.9 0.1 0.1 0.0 0.1 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.3 19.3 3.1 0.5 0.6 0.6 0.3 0.4 0.6 0.6 0.5 0.1 1.2 0.6 0.7 2.5 1.1 0.3 1.1 0.3 0.1 5.5 3.9 0.4 8.7 3.0 1.3 0.6 5.9 4.7 0.2 OPRK1 "KOR, OPRK" ENSG00000082556 "Opioid receptor kappa 1" P41145 8 53225716-53251697 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.0;prostate: 6.7" "Cell line enriched" "Detected in some" 5 "U-937: 21.6" "Cancer enhanced" "Detected in some" "prostate cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067549 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA067549: " "unprognostic (1.01e-1)" "unprognostic (1.17e-2)" "unprognostic (8.70e-3)" "unprognostic (3.73e-2)" "unprognostic (6.74e-2)" "unprognostic (2.22e-3)" "unprognostic (8.09e-2)" "unprognostic (9.71e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" "unprognostic (3.35e-2)" "unprognostic (9.54e-4)" "unprognostic (1.61e-1)" 0.7 0.7 15.9 0.3 18.0 0.4 0.3 2.2 8.8 0.4 0.4 0.3 0.0 0.4 0.4 0.6 0.5 0.7 0.4 0.8 4.5 6.2 0.3 0.5 0.8 0.4 1.7 5.8 0.4 0.3 0.4 0.8 2.8 3.1 6.7 0.4 0.0 0.3 0.4 3.8 0.4 0.5 0.5 0.5 0.6 0.3 2.8 1.6 0.2 0.9 0.0 0.3 0.3 0.1 0.2 0.8 1.2 0.2 0.1 0.4 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 21.6 0.1 1.2 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.8 0.0 0.0 15.9 18.0 2.2 8.8 4.5 6.2 1.7 5.8 3.1 1.6 OPRL1 "KOR-3, NOCIR, NOPr, OOR, ORL1" ENSG00000125510 "Opioid related nociceptin receptor 1" P41146 20 64080173-64100643 "G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.9;brain: 17.5" "Cell line enhanced" "Detected in some" "REH: 6.0;SCLC-21H: 10.3;U-937: 11.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 3.7;eosinophil: 5.6;intermediate monocyte: 5.6;myeloid DC: 4.9;neutrophil: 4.9;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 8 "dendritic cells: 4.9;granulocytes: 5.6;monocytes: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (9.03e-3)" "unprognostic (4.78e-2)" "unprognostic (4.35e-3)" "unprognostic (3.74e-1)" "unprognostic (4.13e-2)" "unprognostic (9.63e-2)" "unprognostic (2.13e-4)" "unprognostic (1.53e-1)" "unprognostic (1.67e-1)" "unprognostic (2.91e-1)" "unprognostic (2.66e-4)" "unprognostic (1.47e-1)" "unprognostic (1.12e-4)" "unprognostic (1.99e-2)" "unprognostic (4.17e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-3)" 2.1 2.6 4.7 2.9 9.4 3.6 1.5 6.0 17.5 1.7 0.8 3.6 0.7 1.1 1.7 1.4 0.9 1.4 1.8 0.9 4.5 8.9 1.6 1.1 2.5 6.3 3.9 0.9 1.1 4.2 0.8 1.5 2.4 4.0 1.3 0.8 0.2 5.0 1.2 0.7 0.7 1.4 1.1 2.7 8.2 0.9 9.2 1.5 1.9 0.8 0.3 5.2 1.6 1.3 0.9 4.9 5.6 11.9 0.0 0.4 1.8 0.0 0.8 1.1 4.4 3.2 1.0 0.6 0.2 0.3 0.1 0.4 0.2 1.0 1.7 0.6 0.8 0.0 0.1 0.0 0.0 1.0 0.0 1.5 0.0 0.3 0.1 4.3 0.8 1.1 0.2 0.0 0.1 1.7 0.3 1.4 0.0 0.1 0.4 2.4 0.3 1.8 6.0 0.0 0.2 0.0 0.0 10.3 3.5 0.0 0.0 0.0 0.3 4.2 0.4 0.4 0.2 0.0 0.0 0.1 0.8 2.9 0.6 11.4 0.4 0.0 3.7 5.6 0.2 5.6 0.4 0.7 0.3 0.1 4.9 0.9 0.2 0.0 4.9 0.0 11.9 0.5 0.4 1.8 4.7 9.4 6.0 11.9 4.5 8.9 3.9 0.9 4.0 1.5 OPRM1 MOR1 ENSG00000112038 "Opioid receptor mu 1" P35372 6 154010496-154246867 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 37.9" "Cell line enriched" "Detected in single" 24 "SH-SY5Y: 12.8" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 37.9" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014509, HPA067435" Enhanced Supported "HPA014509: AB_1854801, HPA067435: " "unprognostic (7.34e-2)" "unprognostic (6.91e-2)" 0.5 3.4 7.0 0.6 17.5 1.8 0.9 37.9 7.6 0.5 0.6 0.8 0.0 0.6 0.7 1.4 3.7 0.5 1.0 0.5 2.6 2.3 0.5 0.5 0.5 0.9 0.6 9.3 0.8 0.7 0.4 0.6 0.5 5.2 0.7 0.4 0.0 0.6 0.2 0.9 1.8 0.5 0.3 1.9 0.6 1.0 8.0 0.5 0.0 1.0 0.0 0.3 0.5 0.5 0.5 0.2 2.1 0.1 0.1 0.7 0.0 0.1 0.0 0.2 0.4 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.2 0.4 0.4 0.1 0.0 0.3 0.3 0.2 0.1 0.2 0.1 0.1 0.4 0.1 0.0 0.3 0.5 0.1 0.5 0.0 0.1 0.1 0.1 0.3 0.3 0.2 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.3 12.8 0.0 0.0 0.3 0.3 0.1 0.3 0.4 0.1 0.3 0.1 0.4 0.2 0.1 0.3 0.1 0.0 0.2 0.1 0.6 0.6 0.0 0.7 0.2 0.3 0.5 0.1 0.5 0.4 0.1 2.1 0.1 0.0 0.2 0.3 0.0 7.0 17.5 37.9 7.6 2.6 2.3 0.6 9.3 5.2 0.5 OR13J1 ENSG00000168828 "Olfactory receptor family 13 subfamily J member 1" Q8NGT2 9 35869263-35870601 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.2;skeletal muscle: 1.4" "Cell line enriched" "Detected in single" 4 "AN3-CA: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (6.58e-2)" "unprognostic (2.89e-2)" "unprognostic (1.82e-1)" "unprognostic (2.49e-1)" "unprognostic (9.58e-2)" "unprognostic (7.73e-2)" "unprognostic (1.45e-1)" "unprognostic (2.09e-3)" "unprognostic (1.68e-1)" "unprognostic (4.07e-1)" 0.1 0.2 1.2 0.2 1.6 0.0 0.0 0.9 2.2 0.0 0.1 0.4 0.1 0.0 0.4 0.1 0.2 0.6 1.7 0.8 0.1 0.1 0.0 0.2 0.6 0.4 0.0 0.0 0.4 0.1 0.3 0.1 1.1 0.0 1.4 0.5 0.0 0.0 0.8 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14I1 "OR5BU1, OR5BU1P" ENSG00000189181 "Olfactory receptor family 14 subfamily I member 1" A6ND48 1 248681369-248682304 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 7.4" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.68e-1)" "unprognostic (1.63e-1)" 0.0 0.0 1.2 0.0 1.9 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1F1 "Olfmf, OR16-36, OR16-37, OR16-88, OR16-89, OR16-90, OR1F10, OR1F13P, OR1F4, OR1F5, OR1F6, OR1F7, OR1F8, OR1F9, OR3-145" ENSG00000168124 "Olfactory receptor family 1 subfamily F member 1" O43749 16 3204247-3205188 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.2;brain: 7.4;testis: 2.8" "Cell line enhanced" "Detected in some" "THP-1: 3.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "eosinophil: 2.2;memory CD4 T-cell: 1.1;naive CD4 T-cell: 1.2" "Group enriched" "Detected in many" 18 "granulocytes: 2.2;T-cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (3.72e-1)" "unprognostic (2.99e-2)" "unprognostic (1.22e-1)" "unprognostic (4.94e-2)" "unprognostic (4.88e-1)" "unprognostic (4.16e-1)" "unprognostic (1.26e-1)" 0.0 0.0 0.5 0.2 1.8 0.4 0.0 7.4 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.7 2.2 1.3 0.2 0.0 0.0 0.3 1.1 0.2 1.0 0.8 2.3 0.0 0.0 0.0 0.6 0.3 0.0 1.8 0.6 0.9 0.0 1.3 1.2 0.6 0.3 0.3 0.0 1.4 0.0 0.0 0.7 1.7 1.0 0.3 0.0 0.5 0.4 0.0 0.0 1.4 0.0 0.0 1.1 0.7 2.3 0.0 0.0 1.6 0.0 0.0 1.1 0.0 3.4 2.1 0.0 1.1 0.3 0.3 0.4 0.0 0.0 1.4 1.3 0.3 0.0 0.0 2.2 0.3 0.0 0.0 0.0 1.1 0.2 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.7 OR2H2 hs6M1-12 ENSG00000204657 "Olfactory receptor family 2 subfamily H member 2" O95918 6 29585121-29590500 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 3.3;epididymis: 11.7;testis: 4.8" "Cell line enhanced" "Detected in some" "AF22: 2.3;NTERA-2: 3.5;TIME: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.95e-1)" "unprognostic (3.76e-1)" "unprognostic (2.33e-2)" "unprognostic (2.42e-1)" "unprognostic (2.34e-1)" "unprognostic (3.11e-1)" "unprognostic (2.76e-1)" "unprognostic (3.20e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" 0.2 0.1 1.5 0.3 3.3 1.5 0.1 2.2 0.9 0.1 0.1 0.0 0.2 11.7 0.1 0.1 0.1 0.3 1.2 0.9 0.1 0.1 0.2 0.4 0.6 0.2 0.0 0.0 0.7 0.1 0.2 0.1 0.1 0.9 0.1 0.4 0.1 0.1 0.2 0.4 0.2 4.8 0.2 0.2 0.1 0.1 0.4 0.2 0.8 0.1 0.1 0.3 0.0 0.4 0.0 2.3 0.3 0.0 0.0 0.4 0.2 0.1 0.0 0.2 0.0 0.2 0.5 0.1 0.4 0.3 0.2 0.0 0.0 0.2 0.7 0.9 0.7 0.6 0.1 0.6 1.0 0.1 0.1 0.0 0.2 0.3 0.4 0.7 0.2 0.1 0.0 0.2 3.5 0.2 0.4 0.3 0.0 0.0 0.2 0.7 0.2 0.3 0.2 0.0 0.2 0.2 1.9 0.4 0.9 0.3 0.2 1.0 0.2 0.4 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.0 OR2K2 "HSHTPCRH06, HTPCRH06, OR2AR1P" ENSG00000171133 "Olfactory receptor family 2 subfamily K member 2" Q8NGT1 9 111327483-111330183 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.2;skeletal muscle: 1.6;testis: 1.7" "Cell line enhanced" "Detected in some" "HSkMC: 1.7;Karpas-707: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA024261 Uncertain "HPA024261: AB_1854786" "unprognostic (1.03e-1)" 0.0 0.2 0.3 0.0 0.4 0.4 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.9 0.8 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.7 0.0 0.2 3.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.5 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2L13 OR2L14 ENSG00000196071 "Olfactory receptor family 2 subfamily L member 13" Q8N349 1 248095184-248101103 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.2;brain: 7.3" "Group enriched" "Detected in some" 8 "ASC diff: 1.3;WM-115: 3.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 13 "B-cells: 1.0;granulocytes: 3.2;T-cells: 1.5" "unprognostic (1.39e-2)" "unprognostic (1.53e-1)" "unprognostic (9.89e-2)" "unprognostic (3.66e-1)" "unprognostic (7.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.14e-1)" 0.0 2.0 2.1 0.0 2.4 0.2 0.6 0.7 7.3 0.1 0.1 0.0 0.0 1.2 0.0 1.0 0.0 0.0 2.5 3.2 0.0 0.0 0.0 0.2 3.5 0.2 0.0 0.0 0.2 0.1 1.8 0.1 0.0 0.6 0.0 0.0 0.0 0.1 4.5 1.1 0.0 1.2 0.9 0.1 0.1 0.0 1.0 0.1 3.2 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.2 3.2 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.6 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.3 OR2L2 "HSHTPCRH07, HTPCRH07, OR2L12, OR2L4P" ENSG00000203663 "Olfactory receptor family 2 subfamily L member 2" Q8NH16 1 248030070-248042305 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.1;testis: 3.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "unprognostic (3.37e-2)" "unprognostic (2.16e-2)" "unprognostic (3.88e-2)" "unprognostic (2.96e-2)" 0.3 0.4 1.1 0.4 1.1 2.7 0.0 0.4 0.9 0.1 0.1 0.9 0.2 0.1 0.3 0.1 0.4 0.0 1.6 1.2 0.2 1.7 0.2 0.3 1.7 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.0 2.2 0.6 1.0 0.0 4.1 0.7 0.9 3.3 0.2 0.0 0.0 0.0 1.7 0.8 2.7 0.8 1.2 1.0 0.2 1.0 0.6 0.8 1.0 0.2 0.1 2.2 0.5 0.0 0.0 0.0 0.6 1.2 1.2 1.2 0.1 0.8 0.0 0.0 0.3 1.2 0.3 1.0 1.8 0.7 0.0 0.7 1.2 0.0 0.1 0.1 0.0 0.1 0.5 2.8 0.1 0.6 0.4 1.4 1.2 1.3 1.1 1.4 0.8 0.2 1.6 1.3 2.1 1.3 0.7 0.5 0.9 0.7 1.4 0.9 1.9 1.9 1.3 2.2 1.3 1.1 1.3 0.9 1.3 2.5 0.8 0.6 1.0 0.4 0.8 0.7 0.6 0.5 0.2 1.7 0.8 0.9 2.7 1.2 0.6 0.8 0.4 0.2 OR2T4 OR2T4Q ENSG00000196944 "Olfactory receptor family 2 subfamily T member 4" Q8NH00 1 248361581-248362627 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 1.0;cervix, uterine: 1.1;prostate: 1.2" "Cell line enhanced" "Detected in single" "BJ hTERT+: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR3A2 "OLFRA04, OR17-228, OR228" ENSG00000221882 "Olfactory receptor family 3 subfamily A member 2" P47893 17 3276942-3386317 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 3.6;brain: 8.6;lymphoid tissue: 6.5;pituitary gland: 5.5;testis: 10.9" "Cell line enriched" "Detected in some" 6 "HDLM-2: 15.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "unprognostic (7.58e-2)" "unprognostic (5.10e-2)" "unprognostic (6.89e-2)" "unprognostic (1.12e-1)" "unprognostic (1.32e-1)" 0.5 0.5 2.2 0.5 8.6 0.5 0.6 0.4 2.8 0.6 0.4 1.2 0.0 0.4 0.5 1.5 0.4 0.3 0.2 0.4 2.5 1.2 0.5 0.3 0.8 6.5 1.4 0.6 1.0 0.4 0.2 5.5 1.0 2.7 0.7 0.4 1.3 0.3 0.5 0.8 0.6 0.5 0.4 1.9 0.9 0.4 10.9 2.1 2.3 0.3 0.0 0.7 0.6 0.4 3.0 3.4 3.6 0.6 0.7 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 0.6 0.7 0.9 0.3 1.6 3.0 1.2 0.3 0.8 0.8 1.2 1.8 1.6 0.7 0.4 3.4 0.5 0.8 2.2 8.6 0.4 2.8 2.5 1.2 1.4 0.6 2.7 2.1 OR51Q1 ENSG00000167360 "Olfactory receptor family 51 subfamily Q member 1 (gene/pseudogene)" Q8NH59 11 5422111-5423206 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;epididymis: 2.0" "Cell line enriched" "Detected in single" 30 "RT4: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "olfactory region: 4.5" HPA044998 Uncertain "HPA044998: AB_10794780" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.2 0.0 0.0 0.0 2.0 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5J2 ENSG00000174957 "Olfactory receptor family 5 subfamily J member 2" Q8NH18 11 56176618-56177556 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "brain: 1.3" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059466 Uncertain "HPA059466: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B3 "OR6B3P, OR6B3Q" ENSG00000178586 "Olfactory receptor family 6 subfamily B member 3" Q8NGW1 2 240045077-240047027 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 6 "brain: 1.6;epididymis: 6.5;testis: 2.3" "Cell line enhanced" "Detected in single" "HaCaT: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047529 Uncertain "HPA047529: " 0.1 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7A5 HTPCR2 ENSG00000188269 "Olfactory receptor family 7 subfamily A member 5" Q15622 19 14824251-14835285 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.4;pituitary gland: 33.6" "Low cell line specificity" "Detected in some" "Cancer enriched" "Detected in single" 8 "melanoma: 2.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA053823 Uncertain "HPA053823: " "unprognostic (3.26e-4)" "unprognostic (1.44e-1)" "unprognostic (7.46e-2)" "unprognostic (6.19e-3)" "unprognostic (4.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (6.78e-2)" "unprognostic (2.01e-7)" "unprognostic (6.45e-2)" "unprognostic (9.64e-2)" "unprognostic (6.44e-2)" "unprognostic (2.47e-3)" 0.3 0.7 1.7 0.4 7.3 1.0 2.0 0.4 3.8 0.7 0.5 4.7 3.2 0.5 0.4 10.1 0.5 0.5 0.5 0.3 4.4 2.1 0.6 0.8 0.6 0.5 16.4 1.3 0.4 0.8 6.9 33.6 0.4 10.9 1.5 0.6 7.0 0.9 2.6 0.5 2.2 0.7 0.3 6.1 0.5 6.4 5.0 16.4 0.0 0.5 0.0 0.3 0.4 0.9 1.0 0.7 1.3 0.3 0.4 0.5 0.0 0.5 0.6 0.4 0.6 0.1 0.1 0.7 0.2 0.2 0.0 0.1 0.5 0.7 0.6 0.3 0.0 0.5 0.2 0.1 0.0 0.3 0.3 0.5 1.7 0.6 0.1 1.1 0.3 1.8 0.7 0.4 0.2 0.2 0.4 1.0 0.0 0.6 0.3 0.5 1.1 0.2 0.6 0.1 0.6 0.0 1.5 0.4 0.4 0.6 0.2 1.8 0.1 0.1 0.7 0.4 0.5 0.5 0.3 1.0 0.3 0.5 0.4 0.6 0.7 1.1 0.3 0.3 0.5 0.2 0.3 0.4 0.3 0.2 0.1 1.0 0.4 0.5 1.3 0.4 0.2 0.7 0.1 0.0 1.7 7.3 0.4 3.8 4.4 2.1 16.4 1.3 10.9 16.4 OR7C1 "OR19-5, OR7C4" ENSG00000127530 "Olfactory receptor family 7 subfamily C member 1" O76099 19 14789260-14835376 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.6;pituitary gland: 34.0" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in single" 9 "melanoma: 1.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 4 "granulocytes: 4.8;monocytes: 1.5" HPA047127 Uncertain "HPA047127: " "unprognostic (7.68e-4)" "unprognostic (1.31e-1)" "unprognostic (2.13e-1)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.39e-1)" "unprognostic (4.30e-2)" "unprognostic (6.11e-4)" "unprognostic (1.90e-1)" "unprognostic (6.80e-2)" "unprognostic (6.91e-2)" 0.5 3.3 1.4 0.7 7.4 1.9 1.5 0.5 3.9 0.7 0.5 4.7 3.2 0.7 0.5 5.9 0.5 0.5 0.6 0.5 3.2 0.9 0.6 0.6 0.5 0.8 16.6 1.4 0.5 0.5 7.3 34.0 0.5 11.0 3.0 0.4 7.1 1.1 2.9 3.6 3.1 0.7 0.3 3.8 0.7 0.6 6.3 16.6 0.0 1.0 0.0 0.4 0.5 1.0 0.7 0.5 4.8 1.5 0.5 0.4 0.2 0.8 1.1 0.8 2.2 0.7 0.5 1.1 0.5 0.3 0.6 0.8 1.1 1.8 1.3 1.5 0.6 1.0 0.3 0.5 0.8 0.7 0.6 1.0 2.1 0.6 0.5 0.9 1.4 0.8 0.3 0.4 0.4 0.3 0.7 3.0 0.3 0.5 0.6 1.4 1.1 1.0 0.8 0.4 0.6 0.7 1.3 1.6 1.0 0.6 0.7 1.0 0.6 1.5 0.9 1.0 2.2 1.1 0.7 1.3 0.7 1.0 0.9 0.8 0.7 2.9 0.9 1.7 0.3 0.8 0.3 0.4 0.3 0.2 0.4 0.7 0.3 0.4 4.8 0.5 1.5 0.5 0.2 0.2 1.4 7.4 0.5 3.9 3.2 0.9 16.6 1.4 11.0 16.6 OR9A2 ENSG00000179468 "Olfactory receptor family 9 subfamily A member 2" Q8NGT5 7 143026158-143027195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OSTN ENSG00000188729 Osteocrin P61366 3 191199241-191265615 "Predicted secreted proteins" Differentiation "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.8;brain: 7.9;prostate: 8.0" "Cell line enriched" "Detected in some" 24 "U-2197: 29.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "memory B-cell: 7.8" "Lineage enriched" "Detected in single" 10 "B-cells: 7.8" "Region enriched" "Detected in single" 4 "cerebellum: 1.2" "Low region specificity" "Detected in all" "CAB024997, CAB025649, HPA030878" Uncertain "Secreted in other tissues" "CAB024997: , CAB025649: , HPA030878: " "unprognostic (2.35e-2)" "unprognostic (9.12e-2)" "unprognostic (6.30e-2)" "unprognostic (2.34e-1)" "unprognostic (2.51e-1)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (8.11e-3)" "unprognostic (2.90e-1)" "unprognostic (1.45e-1)" 0.9 0.4 1.9 1.6 2.1 0.0 0.6 0.2 7.9 7.1 0.4 0.0 0.0 0.0 0.2 4.4 0.1 1.9 1.9 1.5 1.8 1.9 0.5 1.6 1.0 1.3 1.5 2.4 0.5 0.1 0.0 0.3 1.1 0.4 8.0 0.1 0.0 0.4 0.2 2.3 3.4 0.3 2.3 1.1 0.5 0.6 1.1 0.0 0.0 0.6 0.7 0.0 3.7 1.0 7.8 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 1.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 1.9 2.1 0.2 7.9 1.8 1.9 1.5 2.4 0.4 0.0 OTOF "DFNB6, DFNB9, FER1L2" ENSG00000115155 Otoferlin Q9HC10 2 26457203-26558698 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Hearing "Deafness, Disease mutation, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "bone marrow: 13.8;brain: 26.8" "Cell line enriched" "Detected in some" 17 "HDLM-2: 26.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "basal ganglia: 26.8" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;memory CD8 T-cell: 1.6" "Lineage enhanced" "Detected in single" "T-cells: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012410 Approved "HPA012410: AB_1854836" "unprognostic (4.01e-3)" "unprognostic (7.85e-2)" "unprognostic (8.95e-2)" "unprognostic (7.20e-5)" "unprognostic (1.82e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (6.61e-2)" "unprognostic (1.78e-2)" "unprognostic (1.26e-1)" "unprognostic (2.97e-3)" "unprognostic (4.85e-14)" "unprognostic (1.33e-2)" "unprognostic (5.19e-1)" "unprognostic (9.65e-2)" "unprognostic (8.96e-5)" 0.5 0.7 5.5 0.8 26.8 13.8 0.2 0.4 2.2 0.3 0.4 0.3 0.0 1.1 0.2 0.1 0.4 0.3 0.9 0.2 1.6 2.0 0.1 0.2 0.6 0.5 0.6 0.7 0.2 0.1 0.1 0.0 0.2 1.1 0.3 0.3 0.0 0.3 0.2 0.7 0.2 0.7 0.4 0.7 1.2 0.5 1.4 2.6 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.6 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 5.5 26.8 0.4 2.2 1.6 2.0 0.6 0.7 1.1 2.6 OTOL1 "C1QTNF15, C1QTNF16" ENSG00000182447 "Otolin 1" A6NHN0 3 161496808-161503942 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 8 "brain: 3.7" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.1" HPA041030 Uncertain "Secreted in other tissues" "HPA041030: AB_10795000" 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTOR "FDP, MIAL, MIAL1" ENSG00000125879 Otoraplin Q9NRC9 20 16748358-16770062 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;stomach 1: 1.2" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA024335 Uncertain "Secreted in other tissues" "HPA024335: AB_1854838" "unprognostic (8.50e-3)" "unprognostic (9.56e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-1)" "unprognostic (1.72e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 16.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTP ENSG00000171540 "Orthopedia homeobox" Q5XKR4 5 77628712-77639688 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 16.2" "Cell line enhanced" "Detected in some" "HDLM-2: 3.2;SCLC-21H: 1.5;THP-1: 1.5" "Cancer enriched" "Detected in single" 6 "glioma: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "hypothalamus: 23.4" "Region enhanced" "Detected in some" "hypothalamus: 24.0" HPA059342 Enhanced Supported "HPA059342: " "unprognostic (1.00e-1)" "unprognostic (2.40e-2)" "unprognostic (6.25e-2)" "unprognostic (8.06e-3)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (7.77e-2)" "unprognostic (2.39e-2)" "unprognostic (9.66e-2)" "unprognostic (4.64e-2)" "unprognostic (7.76e-14)" "unprognostic (3.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.49e-3)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.2 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTUD7A "C15orf16, CEZANNE2, OTUD7" ENSG00000169918 "OTU deubiquitinase 7A" Q8TE49 15 31475398-31870789 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044554 Uncertain Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA044554: AB_10794895" "unprognostic (3.61e-2)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.25e-3)" "unprognostic (1.29e-1)" "unprognostic (1.03e-4)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (3.24e-3)" "unprognostic (1.34e-1)" "unprognostic (1.79e-11)" "unprognostic (6.78e-2)" "unprognostic (2.76e-1)" "unprognostic (8.27e-2)" "unprognostic (1.79e-1)" 2.6 2.0 12.4 1.7 13.9 5.9 1.5 13.2 17.0 1.8 3.4 16.0 0.0 1.5 1.9 1.9 1.9 2.0 2.3 2.1 10.0 4.6 2.3 1.0 1.5 3.5 20.4 7.1 2.0 2.5 4.6 1.7 0.9 10.5 1.2 3.1 0.7 1.6 2.0 1.8 3.2 2.1 2.9 9.1 2.2 2.3 8.2 17.4 0.0 2.3 0.0 2.4 1.9 1.3 0.1 3.2 0.3 1.4 0.1 0.7 0.4 3.6 4.1 4.5 6.0 0.4 1.3 3.2 2.5 1.3 3.9 1.9 2.5 3.2 2.9 2.2 0.9 4.6 4.8 2.0 3.2 5.9 6.6 3.7 8.3 2.0 0.3 4.0 5.7 0.0 0.2 3.8 4.3 3.5 6.0 5.4 1.8 2.9 3.1 3.9 2.0 2.0 5.6 3.0 1.4 1.6 3.9 10.9 6.0 3.4 3.0 1.0 2.5 4.3 2.3 5.3 5.2 3.0 6.2 3.3 2.4 3.0 2.9 5.8 4.5 0.0 0.4 0.3 0.6 0.5 0.3 0.0 0.3 0.7 0.2 0.1 0.2 0.2 0.0 0.1 1.4 3.2 0.0 0.4 12.4 13.9 13.2 13.8 10.0 4.6 20.4 7.1 10.5 17.4 OTX2 ENSG00000165588 "Orthodenticle homeobox 2" P32243 14 56799905-56810479 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "brain: 27.7;retina: 78.2" "Group enriched" "Detected in some" 545 "HAP1: 62.7;NTERA-2: 52.5" "Cancer enriched" "Detected in single" 27 "testis cancer: 11.6" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;pons and medulla: 27.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA000633, HPA001123" Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA000633: AB_1079538, HPA001123: " "unprognostic (3.82e-1)" "unprognostic (2.56e-2)" "unprognostic (9.28e-2)" 0.2 0.2 0.0 0.2 0.3 0.2 0.2 20.4 0.3 0.2 0.2 3.7 0.0 0.2 0.2 1.0 0.2 0.2 0.2 0.2 1.8 2.7 0.2 0.2 0.2 0.5 4.7 0.0 0.5 0.2 0.2 2.8 0.2 27.7 0.3 0.2 78.2 0.2 1.3 0.2 0.5 0.2 0.2 0.2 0.4 0.2 3.1 2.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 20.4 0.3 1.8 2.7 4.7 0.0 27.7 2.3 OXT "OT, OT-NPI, OXT-NPI" ENSG00000101405 "Oxytocin/neurophysin I prepropeptide" P01178 20 3071620-3072517 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 232.0" "Group enriched" "Detected in some" 4 "CACO-2: 5.1;HL-60: 1.3;HMC-1: 3.7;PC-3: 2.6" "Cancer enriched" "Detected in some" 5 "testis cancer: 12.1" "Region enriched" "Detected in some" 59 "hypothalamus: 232.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in some" 5 "hypothalamus: 210.0" "Group enriched" "Detected in some" 878 "basal ganglia: 840.1;hypothalamus: 2453.1" HPA071892 Supported Supported "Secreted to blood" 1501000 "HPA071892: " "unprognostic (7.45e-3)" "unprognostic (1.99e-2)" "unprognostic (2.66e-2)" "unprognostic (2.28e-1)" "unprognostic (2.62e-1)" "unprognostic (3.82e-2)" "unprognostic (8.22e-2)" "unprognostic (8.36e-2)" "unprognostic (6.02e-2)" "unprognostic (3.05e-2)" "unprognostic (6.65e-2)" "unprognostic (6.18e-1)" "unprognostic (3.81e-1)" "unprognostic (3.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.10e-1)" 5.0 0.2 0.0 0.1 3.9 0.2 0.2 0.0 0.3 0.1 0.0 0.4 0.0 2.6 0.0 3.8 0.0 0.0 0.0 0.0 0.1 232.0 1.6 24.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 1.8 0.6 0.2 0.2 0.0 0.0 0.4 0.2 0.2 0.2 2.4 0.0 0.0 0.2 0.2 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 1.5 6.3 0.4 0.4 3.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 6.3 0.8 0.4 1.0 3.7 1.7 1.1 0.9 3.6 3.2 3.6 1.1 0.4 0.0 1.5 2.4 0.9 0.0 3.9 0.0 0.3 0.1 232.0 0.0 0.0 0.2 0.0 P2RX7 "MGC20089, P2X7" ENSG00000089041 "Purinergic receptor P2X 7" Q99572 12 121132819-121188032 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Cell line enhanced" "Detected in some" "Karpas-707: 23.0;RPMI-8226: 13.5;SK-MEL-30: 22.8;U-266/70: 12.6;U-266/84: 11.0" "Cancer enhanced" "Detected in all" "melanoma: 19.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 4.2;monocytes: 7.5;T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034968, HPA042013, HPA044141" Approved "HPA034968: AB_10673105, HPA042013: , HPA044141: " "unprognostic (1.05e-1)" "unprognostic (4.90e-2)" "unprognostic (8.87e-2)" "unprognostic (6.54e-3)" "unprognostic (4.49e-2)" "unprognostic (1.55e-2)" "unprognostic (8.82e-2)" "unprognostic (9.11e-2)" "unprognostic (1.05e-2)" "unprognostic (1.08e-1)" "unprognostic (2.42e-1)" "unprognostic (6.62e-2)" "prognostic unfavourable (2.92e-4)" "unprognostic (1.91e-1)" "unprognostic (3.59e-2)" "unprognostic (5.55e-2)" "unprognostic (1.65e-1)" 2.4 3.1 13.7 5.7 25.2 2.9 2.4 7.8 23.3 4.6 3.0 26.5 0.1 1.7 4.8 1.8 1.7 2.9 4.1 1.5 14.8 5.9 1.2 5.3 7.4 6.0 30.5 9.4 10.2 1.2 2.4 2.0 3.4 14.5 2.3 2.8 3.1 2.8 2.2 0.8 15.1 1.7 5.1 16.3 6.5 1.8 1.6 26.1 0.4 1.4 0.5 4.0 3.1 3.3 0.6 4.2 0.5 7.5 1.0 2.3 1.3 0.0 0.0 0.0 0.6 0.7 0.3 0.4 0.0 1.0 0.4 1.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 1.0 0.1 0.3 0.0 0.0 0.5 0.9 6.7 0.6 0.0 1.1 0.0 1.1 0.0 23.0 0.0 0.0 0.1 2.5 0.0 0.2 2.1 5.1 13.5 0.0 0.0 0.3 1.3 0.1 0.0 22.8 0.3 4.4 0.0 0.4 0.1 0.0 0.1 12.6 11.0 0.1 1.4 6.6 3.5 0.4 4.8 0.0 2.3 7.5 0.8 0.6 1.1 1.0 4.2 0.4 1.0 1.0 0.5 1.0 5.1 0.8 2.3 1.3 13.7 25.2 7.8 23.3 14.8 5.9 30.5 9.4 14.5 26.1 P2RY1 "P2Y1, SARCC" ENSG00000169860 "Purinergic receptor P2Y1" P47900 3 152834693-152841439 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;placenta: 24.7" "Cell line enriched" "Detected in some" 5 "HEL: 29.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 29.1" "Group enriched" "Detected in some" 5 "basophil: 7.0;non-classical monocyte: 4.1" "Group enriched" "Detected in many" 6 "granulocytes: 7.0;monocytes: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015577 Enhanced "HPA015577: AB_1854882" "unprognostic (3.30e-1)" "unprognostic (4.52e-2)" "unprognostic (2.68e-2)" "unprognostic (4.76e-2)" "unprognostic (9.70e-2)" "unprognostic (1.40e-3)" "unprognostic (3.32e-2)" "unprognostic (2.53e-1)" "unprognostic (5.14e-1)" "unprognostic (2.58e-1)" "unprognostic (4.68e-2)" "unprognostic (2.70e-1)" "prognostic unfavourable (2.04e-7)" "unprognostic (1.36e-1)" "unprognostic (8.98e-2)" "unprognostic (7.33e-2)" "unprognostic (3.20e-2)" 2.9 1.7 4.7 5.9 29.1 4.8 2.0 3.1 6.3 6.7 8.7 4.9 0.6 3.3 8.5 0.8 19.4 2.3 2.2 2.9 8.4 2.3 1.1 1.6 10.4 2.1 1.8 6.1 9.6 3.6 0.5 2.3 24.7 2.4 8.0 6.9 2.6 5.6 2.6 7.1 8.8 6.1 4.8 3.8 2.4 1.7 1.3 3.3 3.0 1.5 9.9 3.5 3.0 9.5 0.0 0.9 7.0 4.1 0.0 0.0 0.2 0.0 0.5 4.7 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.4 5.8 0.0 0.0 0.5 0.0 1.0 2.6 0.8 0.2 0.0 2.3 29.6 0.0 0.0 0.0 3.4 2.7 0.4 5.8 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.5 0.1 4.3 3.6 0.0 0.1 0.8 0.0 2.0 0.7 0.0 0.0 0.0 0.6 0.0 1.5 0.0 0.5 1.2 0.0 2.5 0.0 0.0 0.0 3.0 0.0 3.4 7.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.1 0.9 0.0 0.2 4.7 29.1 3.1 6.3 8.4 2.3 1.8 6.1 2.4 3.3 P2RY12 "HORK3, P2Y12, SP1999" ENSG00000169313 "Purinergic receptor P2Y12" Q9H244 3 151337380-151384812 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.0" "Cell line enhanced" "Detected in some" "HSkMC: 1.7;Karpas-707: 1.1;REH: 1.9" "Cancer enriched" "Detected in many" 14 "glioma: 17.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 12.4" "Group enriched" "Detected in many" 13 "dendritic cells: 5.0;monocytes: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013796, HPA014518" Enhanced "HPA013796: AB_1854884, HPA014518: " "unprognostic (2.39e-2)" "unprognostic (1.60e-3)" "unprognostic (5.93e-2)" "unprognostic (1.77e-1)" "unprognostic (2.41e-2)" "unprognostic (2.52e-2)" "unprognostic (8.09e-2)" "unprognostic (1.72e-3)" "unprognostic (6.46e-2)" "unprognostic (8.64e-4)" "unprognostic (4.84e-2)" "unprognostic (5.96e-2)" "unprognostic (2.03e-1)" "unprognostic (8.92e-2)" "unprognostic (1.65e-1)" "unprognostic (3.52e-2)" "unprognostic (4.04e-1)" 7.4 4.3 15.3 2.2 14.2 0.8 4.3 2.3 46.0 2.0 2.0 13.4 0.0 1.6 1.1 1.1 1.7 3.2 2.7 1.8 14.3 11.6 1.1 2.7 2.9 9.2 21.1 10.0 2.2 0.9 2.0 0.9 2.7 16.8 1.4 1.8 0.2 3.1 2.9 0.6 0.8 3.1 2.1 24.9 5.3 1.5 0.6 18.8 0.0 0.9 0.0 8.6 1.9 0.9 0.6 5.0 0.3 12.4 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.3 0.3 0.0 2.9 0.0 0.0 12.4 0.0 0.6 0.0 0.0 5.0 0.6 0.0 0.0 0.3 0.0 3.3 0.5 0.0 2.0 15.3 14.2 2.3 14.6 14.3 11.6 21.1 10.0 16.8 18.8 PABPC1L2A RBM32A ENSG00000186288 "Poly(A) binding protein cytoplasmic 1 like 2A" Q5JQF8 X 73077276-73079512 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.6;prostate: 5.2" "Cell line enhanced" "Detected in some" "HeLa: 8.9;NTERA-2: 3.3;SK-MEL-30: 1.8" "Cancer enriched" "Detected in single" 15 "prostate cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA041573 Approved "HPA041573: " "unprognostic (4.30e-2)" "unprognostic (2.19e-1)" "unprognostic (3.22e-1)" 0.1 3.5 3.3 0.2 5.0 0.0 0.1 7.1 9.6 0.1 0.2 0.4 0.1 1.4 0.0 0.2 0.2 0.0 3.5 9.2 0.2 0.1 0.1 0.0 2.9 0.4 0.1 0.0 1.2 0.0 5.2 0.1 0.8 0.6 0.1 0.1 0.2 0.0 2.4 0.7 0.1 3.2 0.3 0.1 0.2 0.0 0.2 0.1 0.7 0.2 0.8 0.1 0.3 0.0 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.1 0.1 0.9 0.1 0.0 0.0 0.0 0.0 8.9 0.4 0.0 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.4 0.1 1.8 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.7 0.3 0.1 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.8 0.2 0.1 0.0 0.3 PABPC1L2B RBM32B ENSG00000184388 "Poly(A) binding protein cytoplasmic 1 like 2B" Q5JQF8 X 73003517-73005713 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 12.2;prostate: 6.6" "Group enriched" "Detected in some" 30 "HAP1: 2.7;NTERA-2: 5.6;U-2 OS: 1.8" "Cancer enriched" "Detected in single" 23 "prostate cancer: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA041573 Approved "HPA041573: " "unprognostic (1.73e-1)" "unprognostic (2.26e-1)" "unprognostic (3.31e-1)" 0.1 1.6 3.3 0.1 4.9 0.1 0.1 6.4 12.2 0.1 0.1 0.4 0.1 0.5 0.1 0.1 0.1 0.1 3.5 10.2 0.1 0.1 0.1 0.1 3.3 0.1 0.1 0.1 1.0 0.1 6.6 0.1 0.8 0.5 0.1 0.1 0.1 0.1 2.1 0.2 0.1 1.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PABPN1L ePABP2 ENSG00000205022 "Poly(A) binding protein nuclear 1 like, cytoplasmic" A6NDY0 16 88863333-88866660 "Predicted intracellular proteins" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 3.6;bone marrow: 3.0;brain: 5.3" "Cell line enhanced" "Detected in some" "MCF7: 4.9;NB-4: 3.4;SCLC-21H: 9.3;T-47d: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "cerebellum: 3.6" HPA043415 Uncertain "HPA043415: AB_10981610" "unprognostic (2.19e-1)" "unprognostic (1.50e-2)" "unprognostic (1.40e-3)" "unprognostic (8.96e-3)" "unprognostic (1.57e-1)" "unprognostic (3.19e-1)" 0.5 3.6 0.0 0.2 1.1 3.0 0.1 5.3 0.5 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.1 0.0 0.3 0.2 1.1 0.0 0.1 1.8 0.0 0.3 0.0 0.8 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 1.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 4.9 0.6 3.4 0.0 0.0 0.2 0.4 0.3 0.0 0.0 9.3 0.2 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 PACS2 "KIAA0602, PACS1L" ENSG00000179364 "Phosphofurin acidic cluster sorting protein 2" Q86VP3 14 105300563-105398147 "Predicted intracellular proteins, Transporters" "Apoptosis, Host-virus interaction" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.7;skeletal muscle: 63.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077892 Approved Mitochondria Mitochondria "HPA077892: " "unprognostic (4.31e-2)" "unprognostic (2.61e-1)" "unprognostic (4.53e-2)" "unprognostic (1.24e-1)" "unprognostic (3.09e-2)" "unprognostic (4.08e-2)" "prognostic unfavourable (3.11e-5)" "unprognostic (1.18e-2)" "unprognostic (1.37e-1)" "unprognostic (1.90e-1)" "prognostic favourable (2.95e-4)" "unprognostic (1.49e-1)" "prognostic favourable (1.56e-4)" "unprognostic (2.08e-1)" "unprognostic (3.80e-1)" "unprognostic (2.58e-1)" "unprognostic (1.30e-1)" 15.3 10.8 18.8 7.7 25.5 6.1 13.3 20.5 29.8 8.0 7.7 41.7 6.5 8.4 10.0 8.1 8.9 9.6 8.7 15.1 23.9 18.0 6.8 3.7 9.3 6.1 36.8 13.9 11.8 21.3 10.3 8.1 6.9 26.3 7.6 5.5 6.7 11.8 9.8 63.8 7.2 9.1 8.1 65.7 10.9 7.4 13.4 26.8 2.7 7.1 7.0 4.4 8.3 7.3 0.6 5.4 0.3 4.0 2.1 2.0 0.9 9.1 12.7 11.9 11.2 12.0 11.6 14.2 7.0 8.1 6.0 5.3 5.5 17.4 10.0 11.9 10.6 10.6 7.3 10.0 4.3 12.5 6.0 4.5 5.0 8.1 15.8 3.7 8.3 13.5 9.6 4.2 9.8 10.9 2.8 9.3 5.2 28.7 6.3 5.0 4.6 10.5 14.1 7.2 6.3 5.1 21.1 26.9 14.3 6.7 6.0 10.4 15.2 6.9 16.4 8.9 4.1 14.0 6.9 12.4 8.0 3.7 13.6 6.8 8.6 0.0 1.6 0.2 0.9 2.7 1.7 0.2 0.8 1.0 2.7 0.6 0.3 1.0 0.3 2.1 4.0 5.4 2.0 0.9 18.8 25.5 20.5 18.9 23.9 18.0 36.8 13.9 26.3 26.8 PACSIN1 SDPI ENSG00000124507 "Protein kinase C and casein kinase substrate in neurons 1" Q9BY11 6 34466061-34535231 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 81.7" "Cell line enhanced" "Detected in some" "MCF7: 9.7;RPMI-8226: 11.3;T-47d: 18.0;U-266/84: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 15.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009929, HPA028852, HPA055491" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: " "unprognostic (3.33e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (2.97e-1)" "unprognostic (1.72e-2)" "unprognostic (2.47e-3)" "unprognostic (2.14e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (6.63e-2)" "unprognostic (3.95e-4)" "unprognostic (9.12e-2)" "unprognostic (3.02e-2)" "unprognostic (4.18e-2)" "unprognostic (9.90e-2)" "unprognostic (5.50e-2)" "unprognostic (9.33e-2)" 1.5 2.1 42.5 2.4 33.8 2.0 1.4 29.3 81.7 1.5 1.7 2.1 0.0 1.8 1.9 1.5 1.4 2.0 1.7 4.7 32.8 21.9 1.6 1.4 1.5 4.4 14.6 32.9 1.7 6.1 1.4 1.2 1.4 31.6 1.8 1.6 5.5 1.6 1.7 1.5 1.4 1.8 1.5 3.7 2.5 2.4 1.9 4.1 0.0 1.4 0.0 3.4 2.0 0.0 0.0 15.0 0.0 0.0 3.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 3.7 0.7 0.0 0.1 1.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 9.7 0.5 0.0 2.4 0.0 0.1 0.0 11.3 0.0 0.3 3.6 0.2 0.0 1.8 0.0 18.0 1.9 0.0 0.0 0.3 0.0 0.0 3.0 13.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 15.0 0.0 0.1 42.5 33.8 29.3 56.3 32.8 21.9 14.6 32.9 31.6 4.1 PADI2 "KIAA0994, PDI2" ENSG00000117115 "Peptidyl arginine deiminase 2" Q9Y2J8 1 17066761-17119435 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 76.7;skeletal muscle: 126.4" "Cell line enhanced" "Detected in some" "A549: 6.8;RPTEC TERT1: 19.9;SK-BR-3: 30.4;T-47d: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 15.1;neutrophil: 37.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047735 Enhanced "HPA047735: " "unprognostic (2.61e-2)" "unprognostic (3.60e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (2.33e-2)" "unprognostic (2.44e-1)" "unprognostic (1.49e-1)" "unprognostic (3.74e-3)" "unprognostic (2.78e-3)" "unprognostic (3.28e-3)" "unprognostic (1.29e-1)" "unprognostic (3.07e-1)" "unprognostic (2.87e-1)" "unprognostic (3.64e-2)" "unprognostic (3.15e-1)" "unprognostic (2.27e-1)" "unprognostic (5.91e-3)" 2.1 1.4 16.2 5.0 25.1 10.9 19.2 3.3 25.6 2.7 41.4 76.7 1.3 1.6 1.4 1.3 3.8 2.3 1.8 1.1 21.9 15.6 5.5 1.3 2.2 1.4 36.8 13.6 1.1 1.7 1.3 1.5 1.6 45.6 2.3 43.4 4.6 21.1 1.8 126.4 2.8 3.6 3.9 69.6 4.2 2.1 1.3 26.0 0.0 1.2 14.8 1.6 2.1 0.7 0.0 4.2 37.2 5.1 0.0 0.0 1.7 0.0 6.8 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.1 2.9 0.1 0.9 0.3 0.9 0.2 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.2 0.3 0.8 0.9 0.0 0.0 0.0 0.2 19.9 0.0 1.2 0.1 0.0 30.4 0.0 8.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.4 5.1 15.1 0.0 0.3 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 37.2 0.0 0.1 0.1 0.0 1.7 16.2 25.1 3.3 22.0 21.9 15.6 36.8 13.6 45.6 26.0 PAIP2B KIAA1155 ENSG00000124374 "Poly(A) binding protein interacting protein 2B" Q9ULR5 2 71182739-71227083 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.9;pancreas: 47.8;skeletal muscle: 39.4" "Cell line enhanced" "Detected in many" "RH-30: 9.1;RPMI-8226: 13.0;SCLC-21H: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046784, HPA072371" Approved Approved Cytosol Cytosol "HPA046784: , HPA072371: " "unprognostic (8.70e-2)" "unprognostic (8.20e-2)" "unprognostic (2.55e-1)" "prognostic unfavourable (8.17e-5)" "unprognostic (4.56e-2)" "unprognostic (1.34e-1)" "unprognostic (9.67e-3)" "unprognostic (1.51e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.25e-2)" "unprognostic (2.76e-1)" "prognostic favourable (6.96e-12)" "unprognostic (1.63e-2)" "unprognostic (3.87e-1)" "unprognostic (1.21e-2)" "unprognostic (4.61e-2)" 2.8 2.4 36.3 2.3 28.8 1.8 4.8 11.9 15.7 3.3 4.2 50.9 5.1 4.0 3.5 2.5 6.2 7.4 1.8 17.8 39.5 25.1 9.9 16.6 3.3 2.5 47.7 9.7 11.6 47.8 6.4 2.1 1.4 21.9 5.2 4.2 2.7 29.9 5.6 39.4 15.1 3.2 3.4 44.9 2.7 6.7 2.7 24.6 0.6 11.1 3.5 4.7 2.7 2.3 5.8 4.5 1.0 0.9 1.5 4.6 1.2 2.1 0.5 0.9 3.1 0.3 0.5 3.9 0.3 0.1 0.3 0.1 0.8 0.9 2.7 0.6 0.0 1.7 5.2 3.1 1.0 1.4 4.3 2.6 0.3 0.1 1.4 0.7 0.2 0.6 2.9 0.1 3.2 0.5 4.5 2.6 0.1 2.6 0.8 1.4 2.3 2.0 0.0 9.1 13.0 1.6 1.4 20.2 1.2 2.2 1.5 0.9 6.5 0.1 0.1 0.2 1.7 1.7 0.9 5.3 4.4 3.3 0.2 1.0 0.5 1.0 0.7 1.0 2.0 0.9 2.6 4.9 2.8 2.0 0.8 5.8 4.6 4.0 0.5 1.5 0.8 4.5 1.1 1.2 36.3 28.8 11.9 15.7 39.5 25.1 47.7 9.7 21.9 24.6 PAK1 ENSG00000149269 "P21 (RAC1) activated kinase 1" Q13153 11 77321707-77474635 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Exocytosis" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 70.0;brain: 71.4" "Cell line enhanced" "Detected in many" "U-266/70: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 29.3;eosinophil: 45.0;intermediate monocyte: 28.7;myeloid DC: 42.3;neutrophil: 70.0;non-classical monocyte: 30.4" "Group enriched" "Detected in all" 11 "dendritic cells: 42.3;granulocytes: 70.0;monocytes: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003565, CAB005312" Enhanced Supported Supported "Plasma membrane,Cytosol" 200000 "Plasma membrane, Cytosol" "CAB005312: AB_2160720, HPA003565: AB_1854935" "unprognostic (1.15e-2)" "unprognostic (3.23e-2)" "prognostic favourable (5.87e-4)" "unprognostic (1.30e-1)" "prognostic unfavourable (1.15e-4)" "unprognostic (6.62e-2)" "unprognostic (8.19e-3)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (1.22e-3)" "unprognostic (1.86e-2)" "unprognostic (2.76e-1)" "unprognostic (1.02e-1)" "unprognostic (6.91e-2)" "unprognostic (1.57e-1)" "unprognostic (4.00e-3)" "unprognostic (1.52e-2)" 5.4 6.0 30.5 13.8 39.5 22.9 7.8 49.1 71.4 9.8 18.2 8.4 2.3 18.2 9.1 13.3 9.9 9.8 13.2 5.3 19.0 16.9 11.3 6.0 6.9 7.5 12.8 40.6 10.4 9.2 11.8 10.8 11.9 39.2 12.2 20.2 5.4 10.4 8.8 34.0 6.7 18.9 11.6 7.8 11.7 17.1 11.1 6.6 7.6 17.7 3.9 9.4 10.5 10.4 2.7 42.3 70.0 30.4 4.3 2.4 12.2 11.8 8.0 17.4 7.8 7.1 11.9 13.9 13.6 9.7 12.9 15.2 11.4 15.9 10.6 5.0 11.7 6.1 12.1 14.4 20.4 12.2 9.8 11.2 5.4 0.7 4.7 18.9 16.6 8.8 8.7 15.1 22.5 3.0 7.4 18.7 23.4 0.8 12.0 8.7 25.7 6.9 18.5 22.5 0.4 3.3 9.9 7.5 7.4 7.3 3.1 5.7 13.9 8.6 0.2 8.6 14.9 45.9 11.3 51.4 26.4 7.0 7.2 12.6 9.3 0.3 29.3 45.0 1.9 28.7 1.5 2.7 1.4 1.8 42.3 1.9 1.3 2.4 70.0 4.3 30.4 3.6 1.1 12.2 30.5 39.5 49.1 71.4 19.0 16.9 12.8 40.6 39.2 6.6 PAK3 "bPAK, hPAK3, MRX30, MRX47" ENSG00000077264 "P21 (RAC1) activated kinase 3" O75914 X 110944285-111227361 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 26.2;pancreas: 46.5;pituitary gland: 37.2" "Cell line enhanced" "Detected in some" "EFO-21: 9.7;HAP1: 8.7;HDLM-2: 10.9;NTERA-2: 8.5;SCLC-21H: 11.1;SH-SY5Y: 6.9;U-2197: 6.7;U-251 MG: 11.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "MAIT T-cell: 4.3" "Lineage enriched" "Detected in single" 7 "T-cells: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044791, HPA060219" Approved Approved Cytosol Cytosol "HPA044791: , HPA060219: " "unprognostic (1.80e-2)" "unprognostic (1.54e-1)" "unprognostic (1.80e-2)" "unprognostic (3.27e-4)" "unprognostic (2.46e-1)" "unprognostic (5.63e-3)" "unprognostic (7.29e-2)" "unprognostic (3.23e-2)" "unprognostic (1.27e-2)" "unprognostic (3.01e-1)" "unprognostic (6.80e-3)" "unprognostic (1.66e-1)" "unprognostic (1.89e-4)" "unprognostic (5.71e-3)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" 2.0 6.8 17.6 2.5 17.5 1.0 6.4 1.8 24.6 3.7 1.6 0.9 9.1 1.0 6.8 7.6 1.7 3.7 2.6 1.2 26.2 20.8 1.6 1.1 1.8 2.5 7.9 21.9 7.9 46.5 0.9 37.2 1.6 12.9 4.8 1.7 1.4 3.0 7.1 2.4 2.0 1.4 6.1 5.8 2.9 3.0 3.6 1.9 0.0 7.7 0.0 1.7 2.0 1.5 0.1 0.1 0.6 0.1 0.2 4.3 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.2 0.3 0.9 0.0 0.0 0.0 0.0 9.7 1.0 0.0 8.7 0.5 1.2 10.9 0.3 0.0 1.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 2.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 8.5 1.9 0.1 4.0 0.0 0.8 0.0 11.1 6.9 0.0 0.4 0.0 0.0 0.0 0.0 0.6 4.3 6.7 11.6 0.0 0.1 0.1 1.2 0.0 0.1 0.6 0.1 0.1 0.1 0.0 4.3 0.0 0.7 0.4 0.0 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.3 0.0 17.6 17.5 1.8 18.5 26.2 20.8 7.9 21.9 12.9 1.9 PAK5 "KIAA1264, PAK7" ENSG00000101349 "P21 (RAC1) activated kinase 5" Q9P286 20 9537389-9839041 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 30.3" "Group enriched" "Detected in some" 9 "SCLC-21H: 10.0;SH-SY5Y: 3.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020444 Approved Approved Nucleoplasm Nucleoplasm "HPA020444: AB_1854947" "unprognostic (5.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.05e-1)" "unprognostic (8.63e-2)" "unprognostic (3.21e-1)" "unprognostic (3.04e-1)" "unprognostic (2.25e-4)" "unprognostic (3.76e-1)" "unprognostic (2.56e-2)" "unprognostic (3.83e-1)" "unprognostic (3.35e-2)" "unprognostic (6.04e-2)" "unprognostic (4.58e-1)" 0.5 5.2 5.7 0.6 11.7 0.5 1.6 30.3 19.6 0.8 0.6 0.8 0.0 0.7 1.0 2.2 1.0 0.7 3.4 0.6 4.0 3.3 1.0 2.3 0.7 0.6 1.6 8.8 0.6 3.5 0.5 2.0 0.6 5.3 1.6 0.6 0.6 1.2 1.6 0.6 1.6 0.6 0.6 1.2 0.6 1.2 1.0 1.7 0.0 0.6 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 10.0 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 5.7 11.7 30.3 13.6 4.0 3.3 1.6 8.8 5.3 1.7 PALM KIAA0270 ENSG00000099864 Paralemmin O75781 19 708939-748329 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 47.6;brain: 56.5" "Cell line enhanced" "Detected in many" "AN3-CA: 16.2;EFO-21: 15.0;REH: 26.6;SH-SY5Y: 17.1;U-2197: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "non-classical monocyte: 4.7" "Lineage enriched" "Detected in single" 35 "monocytes: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041713, HPA049578" Approved Enhanced "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA041713: AB_10794305, HPA049578: AB_2680822" "unprognostic (9.08e-3)" "unprognostic (2.97e-2)" "unprognostic (2.11e-2)" "unprognostic (3.53e-3)" "unprognostic (1.61e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-1)" "unprognostic (8.39e-2)" "unprognostic (7.62e-2)" "unprognostic (1.36e-2)" "prognostic favourable (9.81e-4)" "unprognostic (2.74e-2)" "prognostic favourable (5.44e-4)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (6.00e-2)" 47.6 11.8 49.1 5.1 39.9 2.2 11.3 13.3 56.5 22.7 8.2 12.4 4.2 9.2 10.7 6.7 5.8 17.7 7.2 9.6 37.7 18.9 21.9 3.5 9.0 2.2 19.2 28.1 21.2 2.1 1.2 10.2 17.6 11.9 12.2 2.7 6.1 5.9 18.6 7.0 6.9 7.5 9.0 14.7 10.5 3.6 8.2 12.5 0.0 3.3 3.3 1.9 5.0 8.4 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 4.3 8.4 16.2 1.3 0.1 1.2 1.1 0.0 1.1 0.3 1.0 0.0 0.0 15.0 0.1 1.5 4.2 0.0 0.2 0.0 8.3 0.0 3.4 5.3 5.9 0.0 0.1 3.8 0.0 0.7 0.0 0.6 2.9 0.0 1.1 8.5 0.6 5.0 3.4 2.4 26.6 0.0 0.1 0.4 0.0 0.9 17.1 4.3 0.0 0.1 1.5 4.0 0.0 0.0 8.8 14.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 49.1 39.9 13.3 44.4 37.7 18.9 19.2 28.1 11.9 12.5 PALM2 ENSG00000243444 "Paralemmin 2" Q8IXS6 9 109640788-109946703 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;liver: 19.7" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 5.8;RH-30: 20.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA074153, HPA076866" Approved "Plasma membrane" "Plasma membrane" "HPA074153: , HPA076866: " "unprognostic (7.68e-2)" "unprognostic (1.21e-1)" "unprognostic (1.44e-2)" "unprognostic (1.17e-3)" "unprognostic (3.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.51e-2)" "unprognostic (2.77e-2)" "unprognostic (2.36e-2)" "unprognostic (3.35e-1)" "unprognostic (7.62e-2)" "unprognostic (1.09e-1)" "unprognostic (5.59e-2)" "unprognostic (2.50e-2)" "unprognostic (2.02e-1)" "unprognostic (1.74e-6)" "unprognostic (8.39e-2)" 14.8 6.1 8.1 2.0 11.1 1.2 6.7 1.7 17.9 4.3 2.4 9.1 0.0 1.8 4.9 1.7 2.4 3.8 3.0 7.6 6.3 1.8 2.7 19.7 4.8 1.5 5.0 9.7 2.3 2.2 1.4 1.6 3.1 8.4 2.4 2.4 0.0 3.2 1.4 2.5 3.1 2.0 2.2 4.9 1.5 2.2 2.7 8.7 0.0 4.3 0.0 1.4 2.8 2.6 0.5 0.1 1.1 0.2 0.3 0.1 0.0 0.1 0.5 0.5 0.0 0.4 0.9 0.2 0.4 1.2 0.7 1.7 0.3 0.7 0.1 0.1 1.8 1.7 0.0 0.6 1.2 0.1 0.9 0.0 2.4 0.2 0.0 0.0 0.1 2.0 0.8 5.8 0.9 0.0 0.0 0.0 2.4 0.5 0.0 0.0 3.4 1.3 0.0 20.4 0.4 2.8 0.4 3.8 0.0 5.0 0.2 1.6 2.0 0.4 0.2 2.0 2.9 0.1 1.6 0.1 0.7 0.1 1.6 0.0 2.4 0.3 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.1 0.0 1.1 0.3 0.1 0.1 0.0 0.0 8.1 11.1 1.7 12.7 6.3 1.8 5.0 9.7 8.4 8.7 PANX2 "hPANX2, PX2" ENSG00000073150 "Pannexin 2" Q96RD6 22 50170731-50180294 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Cell line enhanced" "Detected in many" "EFO-21: 8.9;HDLM-2: 13.7;Hep G2: 16.0;MCF7: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.2" "Group enriched" "Detected in many" 36 "dendritic cells: 1.8;granulocytes: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004624, HPA039117" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA004624: , HPA039117: AB_10805354" "unprognostic (1.00e-1)" "unprognostic (7.25e-2)" "unprognostic (2.72e-2)" "unprognostic (1.05e-1)" "unprognostic (3.01e-3)" "unprognostic (2.11e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (1.56e-1)" "unprognostic (4.43e-2)" "unprognostic (3.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-9)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.00e-1)" "unprognostic (4.08e-1)" 1.6 2.6 10.3 2.6 9.2 5.3 1.4 22.4 31.4 1.8 1.1 1.2 10.5 1.1 2.4 2.7 3.8 4.9 2.3 1.1 14.2 8.8 3.4 7.8 2.4 1.2 15.9 7.9 3.5 3.0 1.0 4.1 1.6 23.9 3.8 1.0 1.5 5.5 6.2 1.5 2.6 1.2 1.2 4.5 2.7 1.4 2.6 2.4 0.0 3.8 0.2 1.5 1.8 0.9 0.0 1.8 5.2 0.0 0.0 0.0 0.0 0.8 1.8 0.3 1.9 0.0 0.2 4.2 2.2 2.2 0.5 0.3 0.4 6.7 0.0 8.9 0.2 0.4 1.1 0.8 0.1 13.7 1.2 0.3 2.8 16.0 0.7 0.1 1.0 0.1 0.9 0.6 0.0 0.5 1.1 0.0 0.2 8.8 0.0 0.8 3.3 3.6 0.8 0.0 3.3 0.0 1.3 8.4 0.8 1.4 0.1 5.1 0.5 0.6 3.8 0.4 3.6 5.8 4.1 1.5 0.1 0.5 0.2 0.0 6.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 1.8 0.0 0.0 10.3 9.2 22.4 31.4 14.2 8.8 15.9 7.9 23.9 2.4 PANX3 Px3 ENSG00000154143 "Pannexin 3" Q96QZ0 11 124611490-124620356 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.8;testis: 2.3" "Cell line enhanced" "Detected in some" "BEWO: 1.3;MCF7: 2.5;U-266/70: 2.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.80e-2)" "unprognostic (3.10e-1)" 0.1 0.4 0.1 0.1 1.8 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.2 0.0 0.1 1.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 2.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.5 0.2 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 2.8 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.1 0.5 0.1 0.7 0.1 0.1 0.1 0.1 PAQR4 FLJ30002 ENSG00000162073 "Progestin and adipoQ receptor family member 4" Q8N4S7 16 2969245-2973489 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.4;parathyroid gland: 32.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "non-classical monocyte: 6.7" "Lineage enriched" "Detected in single" 8 "monocytes: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068394 Approved Vesicles Vesicles "HPA068394: " "unprognostic (1.93e-1)" "unprognostic (2.75e-1)" "unprognostic (6.73e-2)" "unprognostic (1.30e-3)" "unprognostic (8.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavourable (6.86e-4)" "unprognostic (2.62e-2)" "unprognostic (7.59e-2)" "unprognostic (9.65e-3)" "unprognostic (5.21e-2)" "unprognostic (8.59e-2)" "prognostic unfavourable (3.01e-6)" "prognostic favourable (1.70e-4)" "unprognostic (1.36e-1)" "unprognostic (3.79e-2)" "unprognostic (6.06e-3)" 3.1 3.2 14.1 5.2 19.2 10.3 2.3 8.0 26.3 2.4 4.8 49.6 1.3 4.9 1.8 1.0 4.2 3.0 5.5 4.2 24.1 11.7 1.7 1.6 3.9 6.3 30.6 11.1 0.4 6.6 32.8 0.9 2.2 19.1 9.6 4.5 16.8 17.0 1.3 12.3 12.3 4.9 2.8 54.4 3.2 7.4 1.6 20.3 3.6 1.5 3.5 7.8 2.1 1.7 0.5 0.9 0.1 6.7 0.0 0.4 0.5 12.7 10.9 12.3 17.8 2.0 3.7 4.1 4.8 5.9 9.0 8.6 6.5 13.7 12.8 6.6 5.6 18.0 12.8 7.6 3.7 13.5 5.6 3.9 21.3 8.9 0.2 8.3 14.2 0.9 4.0 4.9 1.2 5.9 7.6 34.7 7.7 25.6 11.9 8.9 10.4 7.5 23.9 16.2 41.2 6.1 4.4 28.4 13.2 18.0 17.5 13.1 18.7 12.9 3.6 15.8 9.7 7.3 6.8 15.2 10.5 17.0 7.0 11.3 17.3 0.0 1.0 0.1 0.4 0.5 0.0 0.5 0.2 0.1 0.9 0.1 0.0 0.3 0.1 0.0 6.7 0.5 0.1 0.5 14.1 19.2 8.0 21.2 24.1 11.7 30.6 11.1 19.1 20.3 PAQR6 "FLJ22672, PRdelta" ENSG00000160781 "Progestin and adipoQ receptor family member 6" Q6TCH4 1 156243321-156248117 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 138.1" "Cell line enhanced" "Detected in many" "U-266/70: 20.7" "Cancer enriched" "Detected in all" 6 "glioma: 34.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "NK-cell: 10.5" "Lineage enriched" "Detected in many" 6 "NK-cells: 10.5" HPA073505 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA073505: " "unprognostic (1.64e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (1.60e-5)" "unprognostic (7.42e-2)" "unprognostic (5.52e-2)" "unprognostic (4.50e-3)" "unprognostic (4.75e-1)" "unprognostic (2.25e-1)" "unprognostic (2.57e-1)" "unprognostic (3.13e-1)" "unprognostic (4.25e-3)" "prognostic unfavourable (1.99e-4)" "prognostic unfavourable (1.58e-8)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" "unprognostic (8.82e-2)" "prognostic favourable (1.86e-4)" 2.1 3.6 42.5 2.2 38.0 7.6 2.2 8.7 71.6 2.0 2.7 102.9 0.0 2.8 2.3 2.9 2.5 2.2 2.9 2.0 48.1 37.6 2.0 2.1 2.1 2.1 82.7 16.1 1.6 1.6 2.4 1.2 2.2 72.5 3.5 2.3 0.0 3.2 3.0 2.1 11.5 3.0 2.0 138.1 2.3 3.1 2.5 46.0 0.0 2.0 0.0 2.0 2.5 0.3 0.8 1.6 0.0 0.0 10.5 1.2 0.1 1.7 2.0 3.3 3.4 0.6 0.5 8.1 0.2 0.5 0.0 0.2 0.9 6.3 3.2 1.5 0.5 5.7 0.0 0.7 0.4 1.9 2.7 2.0 1.7 0.9 0.3 0.6 5.3 1.6 2.6 2.4 2.4 0.2 1.5 9.4 0.5 6.7 0.2 1.0 3.7 0.9 1.4 0.7 1.5 2.3 10.6 2.8 5.7 0.7 0.7 3.8 10.7 1.1 0.5 1.0 5.3 1.7 0.5 20.7 4.5 2.0 0.2 7.4 0.9 0.0 0.0 0.0 0.4 0.0 1.2 0.8 0.6 0.2 0.0 0.1 0.0 0.0 0.0 10.5 0.0 1.6 0.1 0.1 42.5 38.0 8.7 34.4 48.1 37.6 82.7 16.1 72.5 46.0 PAQR8 "C6orf33, LMPB1, MPRB" ENSG00000170915 "Progestin and adipoQ receptor family member 8" Q8TEZ7 6 52361421-52407777 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.2" "Cell line enhanced" "Detected in many" "Hep G2: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064625 Supported "Golgi apparatus,Plasma membrane" "Plasma membrane" "Golgi apparatus" "HPA064625: " "prognostic favourable (4.61e-4)" "unprognostic (7.39e-3)" "unprognostic (2.77e-3)" "unprognostic (8.23e-2)" "unprognostic (4.33e-1)" "unprognostic (4.08e-3)" "unprognostic (2.66e-2)" "unprognostic (5.67e-2)" "unprognostic (6.37e-2)" "unprognostic (4.30e-3)" "unprognostic (2.10e-1)" "unprognostic (5.55e-2)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (2.12e-1)" "unprognostic (3.14e-2)" "prognostic favourable (6.40e-4)" 2.4 3.5 25.6 6.6 32.4 1.3 2.2 14.9 31.0 4.2 28.9 35.5 14.2 14.5 4.4 6.7 13.7 5.4 4.9 2.9 27.3 17.5 5.3 1.5 5.8 7.2 48.5 15.8 19.5 2.5 3.7 1.8 5.5 28.2 3.8 28.1 1.9 1.9 28.5 1.1 2.7 25.1 5.2 69.2 4.8 24.1 3.1 36.5 3.1 2.6 0.4 6.0 7.3 3.3 1.0 6.0 2.0 2.6 7.0 16.3 3.2 0.6 0.6 7.0 3.0 4.3 7.0 4.8 2.1 7.9 1.3 2.9 2.6 2.4 0.7 0.8 1.4 0.3 0.9 3.4 2.1 9.4 1.2 4.2 0.6 26.5 1.2 1.1 0.6 1.9 0.4 0.9 5.0 7.5 0.9 4.2 5.4 0.9 2.7 3.8 3.6 0.3 7.3 1.1 1.7 8.2 2.0 2.7 5.7 0.5 0.2 8.0 0.2 9.4 3.1 2.7 1.1 0.8 1.2 1.2 1.6 1.0 2.5 10.9 14.0 2.0 2.6 1.3 2.5 0.5 3.8 0.9 7.6 5.2 6.0 1.0 16.3 7.6 0.5 7.0 0.5 3.0 4.7 3.2 25.6 32.4 14.9 22.8 27.3 17.5 48.5 15.8 28.2 36.5 PAQR9 FLJ41938 ENSG00000188582 "Progestin and adipoQ receptor family member 9" Q6ZVX9 3 142949164-142963682 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.1;heart muscle: 12.1;liver: 18.6;testis: 20.8" "Cell line enhanced" "Detected in some" "A549: 5.3;AF22: 3.3;HEL: 3.6;NTERA-2: 4.0;U-266/70: 9.9;U-266/84: 5.4" "Cancer enriched" "Detected in single" 15 "liver cancer: 5.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052798 Uncertain "HPA052798: " "unprognostic (4.13e-2)" "unprognostic (2.54e-1)" "unprognostic (2.81e-1)" "unprognostic (3.09e-2)" "unprognostic (1.21e-2)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (3.56e-2)" "unprognostic (1.23e-2)" "unprognostic (1.09e-1)" "unprognostic (6.91e-2)" 0.4 0.6 2.5 0.3 7.0 7.0 0.3 0.5 10.1 0.3 0.3 0.6 0.0 0.3 0.3 0.3 0.3 0.3 0.4 12.1 3.3 1.7 0.3 18.6 0.3 0.3 0.7 3.1 0.3 0.5 0.3 1.4 0.8 6.0 0.4 0.3 2.7 0.3 0.3 5.9 0.3 0.3 0.3 1.0 0.3 0.3 20.8 0.3 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.3 3.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 4.0 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 0.4 9.9 5.4 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 7.0 0.5 10.1 3.3 1.7 0.7 3.1 6.0 0.3 PARD6A "PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40" ENSG00000102981 "Par-6 family cell polarity regulator alpha" Q9NPB6 16 67660946-67662778 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.8;pancreas: 31.0" "Cell line enhanced" "Detected in many" "REH: 17.6;RPMI-8226: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009733, HPA041551" Approved Supported "Cell Junctions,Actin filaments,Cytosol" "Cell Junctions, Actin filaments" Cytosol "CAB009733: AB_2159676, HPA041551: " "prognostic favourable (5.40e-4)" "unprognostic (6.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.33e-2)" "unprognostic (7.63e-2)" "unprognostic (4.08e-3)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (6.59e-2)" "unprognostic (2.09e-1)" "unprognostic (1.98e-3)" "unprognostic (9.13e-2)" "prognostic favourable (3.08e-7)" "unprognostic (9.22e-3)" "unprognostic (6.69e-2)" "unprognostic (1.25e-1)" "unprognostic (1.39e-2)" 2.7 6.1 11.7 3.5 12.4 2.1 2.8 26.8 16.1 2.0 3.0 2.2 3.7 2.0 2.4 3.6 2.7 2.5 3.1 2.3 13.8 7.2 5.5 3.1 3.5 4.0 7.9 5.7 3.3 31.0 5.3 13.9 1.5 7.4 2.7 2.0 1.4 3.8 4.6 7.0 1.5 2.5 2.7 3.7 3.7 3.2 16.9 3.4 2.5 2.3 1.4 3.4 2.9 3.1 11.4 5.3 3.7 1.0 1.2 8.5 2.1 5.6 6.1 1.7 14.9 1.2 0.2 3.1 0.1 0.7 2.2 2.1 3.0 2.4 9.5 2.9 0.1 4.5 3.4 0.7 0.5 4.4 3.2 3.8 2.8 3.5 1.6 1.6 9.0 0.1 0.3 2.1 0.8 1.1 0.3 2.2 0.4 5.5 9.7 2.0 2.0 4.0 17.6 1.1 15.3 5.9 3.3 14.5 7.8 0.9 2.1 2.3 13.1 0.6 0.9 0.2 0.5 1.4 2.9 2.3 7.4 8.4 1.7 3.4 0.6 2.1 1.0 0.4 4.5 0.5 8.5 11.4 6.4 5.9 1.2 7.4 3.2 2.4 3.7 1.2 0.1 5.3 6.1 2.1 11.7 12.4 26.8 16.1 13.8 7.2 7.9 5.7 7.4 3.4 PASK "KIAA0135, PASKIN, STK37" ENSG00000115687 "PAS domain containing serine/threonine kinase" Q96RG2 2 241106099-241150264 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 24.1;testis: 22.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 24.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA016450, HPA021079" Uncertain Supported Cytosol Cytosol "HPA016450: AB_1854992, HPA021079: AB_1854993" "unprognostic (1.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.84e-1)" "unprognostic (1.41e-2)" "unprognostic (1.14e-1)" "unprognostic (8.99e-6)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.60e-3)" "unprognostic (1.58e-2)" "unprognostic (1.02e-2)" "unprognostic (6.35e-2)" "unprognostic (7.12e-2)" "unprognostic (1.52e-3)" "unprognostic (1.68e-1)" "unprognostic (6.44e-2)" "unprognostic (4.38e-3)" 1.5 1.1 2.4 10.3 24.1 8.9 3.1 6.3 5.2 2.2 2.1 2.2 2.1 3.8 2.9 6.7 3.1 7.2 3.3 1.1 2.9 2.7 3.7 1.3 3.0 14.5 1.3 1.6 1.9 3.3 4.4 4.9 1.1 3.6 12.1 2.8 4.7 2.7 1.8 2.0 4.9 3.9 1.4 1.6 4.4 3.4 22.0 7.2 9.0 4.8 1.9 9.9 2.7 1.9 7.1 1.1 4.8 1.0 2.7 6.0 3.0 4.9 6.7 9.1 11.5 0.7 1.4 12.1 4.8 1.5 4.4 6.2 5.4 5.0 2.6 1.0 1.1 12.5 10.3 4.1 3.2 10.4 9.7 7.1 12.4 9.6 0.5 9.7 11.2 0.6 3.3 4.6 1.3 3.1 9.2 3.5 3.1 5.6 11.5 10.2 10.1 4.1 18.3 9.2 3.2 1.7 11.2 16.1 4.9 2.8 5.5 2.1 4.6 7.0 4.1 6.1 5.5 7.7 6.4 4.8 4.8 12.2 3.8 7.3 5.6 4.8 1.0 0.7 1.7 0.6 1.5 7.1 5.9 5.3 1.1 6.6 3.7 3.9 1.3 2.7 1.0 0.7 6.0 3.0 2.4 24.1 6.3 5.2 2.9 2.7 1.3 1.6 3.6 7.2 PATJ "Cipp, INADL" ENSG00000132849 "PATJ, crumbs cell polarity complex component" Q8NI35 1 61742406-62178675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4" "Cell line enhanced" "Detected in many" "A-431: 19.3;BEWO: 16.4;RPTEC TERT1: 16.9;RT4: 18.1;SK-BR-3: 16.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 66.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA066352, HPA066960, HPA069079" Approved Enhanced "Cell Junctions,Centriolar satellite" "Cell Junctions, Centriolar satellite" "HPA066352: , HPA066960: , HPA069079: " "unprognostic (1.81e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-2)" "unprognostic (2.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-1)" "unprognostic (7.96e-2)" "unprognostic (7.60e-2)" "unprognostic (1.88e-1)" "unprognostic (9.90e-2)" "unprognostic (3.39e-3)" "unprognostic (2.99e-2)" "prognostic favourable (1.47e-5)" "unprognostic (3.05e-3)" "unprognostic (6.72e-3)" "unprognostic (2.21e-2)" "unprognostic (2.43e-1)" 2.6 4.6 3.4 6.3 4.4 1.9 11.6 66.4 3.2 5.7 9.6 2.0 17.9 5.5 4.4 17.7 11.6 5.3 10.3 27.8 2.3 5.1 19.8 7.7 12.5 6.1 4.6 2.0 4.7 17.9 15.2 21.4 2.8 14.2 8.4 7.0 4.4 24.8 24.3 25.4 13.9 15.7 5.2 15.8 2.2 6.3 2.7 3.0 1.3 17.0 11.1 9.6 7.4 7.5 1.8 0.3 9.9 0.2 3.2 4.1 0.8 19.3 3.9 1.3 1.7 0.7 1.9 16.4 1.1 1.5 1.2 1.6 6.7 7.3 0.1 5.2 2.4 11.6 2.8 10.2 2.1 1.9 4.8 0.1 5.6 6.0 1.7 0.0 0.1 0.7 10.9 2.0 4.6 0.6 0.0 0.0 1.0 6.8 0.0 0.0 6.7 1.0 0.0 1.5 2.7 16.9 18.1 3.4 1.1 4.9 16.1 4.2 12.8 0.2 0.1 1.0 2.5 0.1 2.2 0.8 1.4 2.5 0.9 0.0 0.2 0.4 0.1 9.9 1.9 0.1 3.5 1.8 3.1 2.6 0.1 1.5 4.1 2.6 0.9 3.2 0.2 0.3 2.7 0.8 3.4 4.4 66.4 3.2 2.3 5.1 4.6 2.0 14.2 3.0 PAX3 "HUP2, WS1" ENSG00000135903 "Paired box 3" P23760 2 222199888-222298996 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Deafness, Disease mutation, Proto-oncogene, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.1;retina: 39.6" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 7.5;BJ hTERT+ SV40 Large T+ RasG12V: 8.9;HBF TERT88: 6.6;RH-30: 12.9;SK-MEL-30: 22.7" "Cancer enriched" "Detected in some" 24 "melanoma: 20.3" "Group enriched" "Detected in some" 6 "cerebellum: 19.1;pons and medulla: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "cerebellum: 3.9;midbrain: 1.6;pons and medulla: 1.4" "Group enriched" "Detected in many" 5 "cerebellum: 10.0;midbrain: 11.7;pons and medulla: 3.5" "HPA063659, HPA069000" Uncertain Enhanced Nucleoplasm Nucleoplasm "HPA063659: , HPA069000: " "unprognostic (2.57e-2)" "unprognostic (1.48e-2)" "unprognostic (1.27e-2)" "unprognostic (1.65e-1)" "unprognostic (2.61e-2)" "unprognostic (3.70e-1)" "unprognostic (6.18e-2)" "unprognostic (1.41e-1)" "unprognostic (2.26e-1)" "unprognostic (9.70e-2)" 0.8 0.1 0.0 0.1 0.8 0.1 2.9 19.1 0.2 0.3 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.2 2.2 0.0 0.1 0.2 0.1 0.0 0.1 7.8 0.4 0.1 39.6 7.9 0.2 8.6 7.9 0.1 0.1 4.2 0.1 0.2 2.9 0.8 0.0 0.1 3.9 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 5.1 5.1 7.5 8.9 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 6.6 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.3 0.1 0.0 0.0 12.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.8 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.8 19.1 0.1 0.0 0.2 2.2 0.0 7.8 0.8 PAX6 "AN, AN2, D11S812E, WAGR" ENSG00000007372 "Paired box 6" P26367 11 31784779-31818062 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.3;retina: 29.4" "Cell line enhanced" "Detected in some" "AF22: 11.6;AN3-CA: 15.0;HEK 293: 14.1;HeLa: 11.0;U-251 MG: 12.3" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Region enriched" "Detected in all" 5 "cerebellum: 78.3" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 5 "cerebellum: 61.0;olfactory region: 41.2" "Low region specificity" "Detected in all" "HPA030775, CAB034143" Enhanced Supported Enhanced Nucleoplasm Nucleoplasm "CAB034143: AB_1127044, HPA030775: AB_10601243" "unprognostic (2.89e-1)" "unprognostic (2.98e-2)" "unprognostic (8.34e-2)" "unprognostic (3.85e-2)" "unprognostic (4.42e-2)" "unprognostic (7.82e-2)" "unprognostic (2.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.24e-3)" "unprognostic (1.68e-1)" "unprognostic (1.20e-2)" "unprognostic (3.91e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" 0.8 2.0 12.6 0.8 10.4 1.1 1.0 78.3 23.5 0.8 1.1 9.3 0.0 3.5 0.8 1.8 0.8 0.8 0.8 0.8 16.0 3.7 0.9 0.9 0.7 0.9 3.9 9.1 0.8 15.8 0.8 4.6 0.8 10.8 0.8 1.4 29.4 0.8 0.9 1.9 1.6 2.0 0.8 16.1 0.8 19.4 2.8 9.8 0.0 0.8 0.0 1.0 1.1 0.3 0.2 0.2 1.6 0.4 0.4 0.5 0.1 0.0 0.2 11.6 15.0 3.7 5.0 4.5 0.0 0.0 0.1 0.0 0.9 2.7 0.1 4.8 1.6 0.3 1.3 0.0 0.2 0.0 14.1 6.6 11.0 6.2 0.0 0.3 0.0 0.0 0.5 0.1 0.3 0.0 5.3 0.0 0.2 0.0 2.7 0.4 0.2 7.6 0.0 5.5 0.1 0.6 0.4 0.5 0.0 0.3 0.1 0.0 3.4 0.0 0.0 3.9 0.3 0.0 12.3 0.0 0.1 0.0 6.2 0.0 0.0 1.6 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.2 0.2 0.2 0.3 1.0 0.4 0.4 0.2 0.1 0.1 12.6 10.4 78.3 12.2 16.0 3.7 3.9 9.1 10.8 9.8 PBOV1 "UC28, UROC28" ENSG00000254440 "Prostate and breast cancer overexpressed 1" Q9GZY1 6 138215986-138218491 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.5;bone marrow: 1.9;brain: 1.9" "Cell line enhanced" "Detected in single" "MCF7: 1.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" HPA063021 Uncertain "HPA063021: " "unprognostic (3.32e-3)" "unprognostic (8.23e-2)" "unprognostic (9.35e-2)" "unprognostic (1.22e-1)" "unprognostic (4.77e-2)" "unprognostic (2.51e-1)" "unprognostic (1.35e-4)" 0.0 0.0 0.2 0.0 0.3 1.9 0.2 1.9 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.3 0.2 1.1 0.1 0.1 0.0 0.1 0.0 0.8 0.7 0.3 0.0 0.5 0.0 0.5 0.0 0.2 0.5 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.8 0.4 2.5 0.4 1.1 0.4 0.1 0.0 0.5 0.1 0.8 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.8 0.3 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.2 1.0 0.4 0.8 0.4 0.0 0.3 0.1 0.3 0.0 0.4 0.3 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.9 0.1 0.0 0.4 0.1 0.0 2.5 0.4 0.3 0.2 0.2 0.1 0.4 0.2 0.3 0.1 0.8 0.4 0.4 2.0 1.1 0.2 0.4 0.1 0.1 PCBP3 "FLJ44028, PCBP3-OT1, PCBP3OT" ENSG00000183570 "Poly(rC) binding protein 3" P57721 21 45643694-45942454 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.5;HDLM-2: 26.6;HSkMC: 20.4;SH-SY5Y: 23.1;U-87 MG: 12.3;U-937: 14.8" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 5 "cerebellum: 47.4;pons and medulla: 23.0" "Cell type enhanced" "Detected in many" "eosinophil: 5.9" "Group enriched" "Detected in many" 6 "B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6" "Region enriched" "Detected in all" 5 "olfactory region: 280.8" "Region enhanced" "Detected in all" "olfactory region: 184.8" HPA030247 Approved Approved Nucleoplasm,Vesicles,Mitochondria "Nucleoplasm, Mitochondria" Vesicles "HPA030247: AB_10601244" "unprognostic (3.88e-2)" "unprognostic (1.19e-1)" "unprognostic (2.01e-4)" "unprognostic (9.89e-4)" "unprognostic (2.74e-1)" "unprognostic (1.40e-1)" "unprognostic (4.10e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-2)" "unprognostic (1.64e-3)" "unprognostic (1.12e-3)" "unprognostic (1.97e-2)" "unprognostic (1.96e-6)" "unprognostic (8.67e-2)" "unprognostic (2.32e-2)" "unprognostic (8.04e-2)" "unprognostic (1.97e-2)" 6.5 11.7 6.0 11.2 6.7 12.3 6.3 47.4 12.6 3.8 7.9 7.0 2.2 3.1 9.3 12.4 1.4 3.2 4.4 2.7 6.5 7.3 2.2 1.1 1.8 5.0 6.9 3.7 3.4 3.5 0.6 14.8 2.3 23.0 1.5 3.0 20.2 1.7 1.9 1.1 1.6 4.8 12.3 7.3 11.6 3.4 20.5 6.1 22.6 0.8 0.0 4.6 2.3 1.8 2.9 0.0 5.9 0.4 0.6 1.6 0.5 0.0 0.0 0.2 0.0 6.7 14.5 0.0 0.8 0.2 1.5 0.6 0.0 0.0 0.0 0.3 3.9 0.0 0.8 0.0 0.2 26.6 0.0 0.0 0.0 0.0 6.9 0.0 0.0 20.4 0.1 0.2 0.4 0.0 0.0 0.1 0.9 0.3 7.6 1.5 0.4 1.3 0.0 0.0 1.1 0.0 0.0 2.5 23.1 0.5 0.0 0.0 0.0 4.1 0.0 0.0 0.0 6.0 0.0 0.3 1.4 0.0 12.3 14.8 0.5 4.4 0.4 5.9 1.6 0.3 0.3 2.9 0.9 0.0 0.0 1.9 1.5 0.2 1.4 0.6 0.2 0.0 0.8 0.5 6.0 6.7 47.4 6.0 6.5 7.3 6.9 3.7 23.0 6.1 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149315-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0;placenta: 31.1;seminal vesicle: 23.6" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 15.8;MOLT-4: 13.2;TIME: 31.4;U-138 MG: 8.5;U-251 MG: 7.2" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: " "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 1.9 7.6 17.9 1.5 35.5 1.2 1.3 1.7 48.0 3.3 1.5 23.2 4.5 1.3 3.1 1.9 1.6 2.6 1.9 1.8 17.5 12.6 3.7 1.3 2.0 1.2 13.2 16.3 4.1 1.4 1.2 1.7 31.1 13.6 14.7 1.5 1.3 1.8 23.6 1.2 1.3 1.7 2.0 6.8 1.2 1.3 2.9 19.2 0.9 1.5 0.0 1.2 3.6 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 5.1 0.0 0.1 0.0 0.0 4.9 2.7 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.2 0.0 2.4 0.0 13.2 0.0 0.0 0.1 0.3 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 31.4 8.5 0.0 0.0 7.2 0.0 0.0 0.0 0.5 0.0 4.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.9 35.5 1.7 27.7 17.5 12.6 13.2 16.3 13.6 19.2 PCDH11X "PCDH-X, PCDH11, PCDHX, PPP1R119" ENSG00000102290 "Protocadherin 11 X-linked" Q9BZA7 X 91779261-92623230 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 7.0;ovary: 12.6;parathyroid gland: 5.2" "Group enriched" "Detected in some" 5 "AF22: 4.2;AN3-CA: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA077495 Approved "HPA077495: " "unprognostic (4.22e-3)" "unprognostic (1.16e-1)" "unprognostic (1.39e-4)" "unprognostic (1.18e-1)" "unprognostic (8.20e-3)" "unprognostic (6.32e-2)" "unprognostic (9.10e-2)" "unprognostic (6.19e-2)" "unprognostic (4.58e-1)" "unprognostic (1.58e-1)" "unprognostic (2.45e-2)" "unprognostic (3.86e-1)" 0.0 0.3 2.6 0.1 7.0 0.0 0.2 0.0 4.8 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 4.2 0.0 0.0 0.0 0.2 1.3 12.6 0.0 5.2 0.3 1.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDH11Y "PCDH22, PCDHY" ENSG00000099715 "Protocadherin 11 Y-linked" Q9BZA8 Y 5000226-5742224 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.9;seminal vesicle: 9.1" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;RPMI-8226: 2.4;U-266/70: 2.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 21.9" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "unprognostic (9.26e-2)" "unprognostic (1.84e-1)" "unprognostic (7.64e-3)" "unprognostic (2.36e-2)" "unprognostic (3.55e-2)" 0.2 0.3 4.5 5.4 3.1 0.3 0.1 0.0 21.9 0.2 0.4 1.1 2.7 0.2 0.2 0.3 0.5 0.1 0.3 0.5 4.2 5.6 0.2 0.2 0.3 0.4 1.8 0.0 0.5 0.2 0.2 0.2 1.8 0.7 0.5 0.9 0.9 0.3 9.1 0.2 0.4 0.6 0.2 0.4 0.6 0.4 0.4 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.5 0.4 2.0 0.3 0.8 0.3 0.6 0.0 0.2 0.4 0.4 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.2 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.2 0.1 0.7 1.4 0.2 0.2 0.0 2.4 0.3 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.8 0.3 0.1 0.2 0.0 0.1 2.3 0.0 0.2 0.3 0.2 0.1 0.8 0.3 0.2 0.2 0.1 0.1 0.3 0.1 0.2 0.1 0.5 0.2 0.3 2.0 0.8 0.1 0.4 0.1 0.6 4.5 3.1 0.0 21.9 4.2 5.6 1.8 0.0 0.7 0.0 PCDH17 "PCDH68, PCH68" ENSG00000118946 "Protocadherin 17" O14917 13 57631810-57729311 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;lymphoid tissue: 32.7" "Cell line enhanced" "Detected in some" "AF22: 15.8;HEK 293: 9.9;U-87 MG: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026817 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" 31000 Cytosol "Vesicles, Plasma membrane" "HPA026817: AB_1855044" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-1)" "unprognostic (6.52e-2)" "unprognostic (6.98e-3)" "unprognostic (1.95e-2)" "unprognostic (8.26e-4)" "unprognostic (3.56e-1)" "unprognostic (2.38e-2)" "unprognostic (2.82e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "prognostic unfavourable (3.31e-5)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.40e-2)" 2.0 2.4 8.0 2.1 11.2 0.3 0.9 4.6 18.2 2.9 1.2 6.2 0.3 1.1 2.6 1.3 1.7 2.5 3.6 2.3 6.5 12.1 1.6 1.4 13.5 0.9 7.4 4.8 0.8 6.2 2.0 1.0 4.7 4.4 1.2 1.2 1.1 1.0 1.1 1.8 0.6 0.7 2.6 4.4 32.7 1.8 8.9 7.7 0.0 3.4 0.4 0.8 3.4 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.7 0.0 0.0 1.8 0.0 0.0 0.0 9.9 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.4 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 0.0 1.0 0.0 0.0 0.0 6.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 11.2 4.6 7.8 6.5 12.1 7.4 4.8 4.4 7.7 PCDH19 "EFMR, EIEE9, KIAA1313" ENSG00000165194 "Protocadherin 19" Q8TAB3 X 100291644-100410273 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 27.1" "Cell line enriched" "Detected in some" 6 "AF22: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027533 Approved Approved Cytosol Cytosol "HPA027533: AB_10602043" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (5.04e-2)" "unprognostic (2.13e-1)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (4.77e-2)" "unprognostic (3.64e-2)" "unprognostic (1.36e-2)" "unprognostic (2.53e-1)" "unprognostic (2.79e-1)" "unprognostic (9.77e-3)" "unprognostic (2.82e-3)" "unprognostic (1.53e-1)" "unprognostic (1.80e-4)" "unprognostic (1.37e-1)" 4.9 1.1 19.8 1.3 10.5 0.7 3.7 1.0 22.5 5.5 4.0 1.9 0.0 1.2 3.8 1.3 2.9 2.2 2.0 1.6 27.1 12.8 1.4 0.9 1.0 1.3 3.7 14.2 3.6 1.1 1.2 2.1 1.0 7.3 1.4 5.5 6.4 2.1 1.6 2.4 3.3 1.8 3.1 3.7 0.8 2.0 2.3 1.0 0.0 1.1 0.7 0.9 2.3 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 19.6 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 3.4 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 10.5 1.0 22.5 27.1 12.8 3.7 14.2 7.3 1.0 PCDH20 "FLJ22218, PCDH13" ENSG00000280165 "Protocadherin 20" Q8N6Y1 13 61409685-61415522 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;smooth muscle: 12.7" "Cell line enriched" "Detected in some" 14 "RPTEC TERT1: 33.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062669 Approved "Vesicles,Cytokinetic bridge" Vesicles "Cytokinetic bridge" "HPA062669: " "unprognostic (2.40e-1)" "unprognostic (1.80e-1)" "unprognostic (2.45e-1)" "unprognostic (7.83e-2)" "unprognostic (6.79e-4)" "unprognostic (2.32e-2)" "unprognostic (1.56e-1)" "unprognostic (5.34e-4)" "unprognostic (6.96e-2)" "unprognostic (1.67e-1)" "unprognostic (3.12e-1)" 0.3 1.6 6.7 0.4 5.8 0.0 1.3 0.0 13.1 3.5 4.5 0.0 0.2 1.2 4.3 4.3 1.8 0.2 0.9 4.8 13.4 1.2 1.8 4.7 0.0 8.8 3.8 0.3 0.1 0.0 0.7 1.3 6.9 1.5 2.5 0.0 0.7 1.5 0.1 0.5 1.4 12.7 8.4 1.6 1.5 0.4 6.3 0.0 0.3 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 33.8 0.0 0.5 1.2 0.0 2.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDH8 "ARCADLIN, PAPC" ENSG00000136099 "Protocadherin 8" O95206 13 52842889-52848641 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 20.6" "Cell line enriched" "Detected in some" 4 "AF22: 22.5" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010509 Uncertain Uncertain "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA010509: AB_10601384" "unprognostic (3.50e-3)" "unprognostic (6.48e-2)" "unprognostic (1.40e-1)" "unprognostic (9.11e-4)" "unprognostic (2.12e-2)" "unprognostic (1.97e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-1)" "unprognostic (3.59e-1)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" 0.8 0.9 11.5 1.1 18.6 0.8 0.8 0.4 20.6 0.9 1.0 1.1 0.0 0.9 1.0 0.8 0.8 0.8 0.8 0.8 18.2 4.8 0.8 0.8 0.9 0.8 3.6 8.4 0.8 0.8 0.8 1.4 0.8 0.8 1.7 0.9 0.8 0.8 0.8 1.4 0.8 1.1 0.9 0.9 0.8 1.2 2.3 2.5 0.0 1.4 0.0 0.8 0.9 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 1.6 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 18.6 0.4 20.6 18.2 4.8 3.6 8.4 0.8 2.5 PCDH9 ENSG00000184226 "Protocadherin 9" Q9HC56 13 66302834-67230445 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 16.5;brain: 47.0" "Cell line enhanced" "Detected in many" "AF22: 12.4;LHCN-M2: 20.3;TIME: 23.6;U-698: 31.0" "Cancer enriched" "Detected in single" 8 "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive B-cell: 16.5" "Lineage enriched" "Detected in many" 7 "B-cells: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015581 Approved Nucleoplasm,Centrosome 1300000 "Nucleoplasm, Centrosome" "HPA015581: AB_1855048" "unprognostic (1.77e-1)" "unprognostic (8.36e-2)" "unprognostic (9.12e-3)" "unprognostic (4.42e-5)" "unprognostic (7.54e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-1)" "unprognostic (1.38e-1)" "unprognostic (2.35e-1)" "unprognostic (8.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.14e-1)" "unprognostic (8.47e-4)" "unprognostic (6.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.35e-4)" 4.5 3.2 18.4 1.1 24.7 4.1 1.5 6.7 47.0 1.8 1.3 7.8 0.0 0.9 1.0 2.1 1.0 1.1 2.4 5.7 15.0 10.0 3.5 2.3 2.3 1.4 21.4 11.0 1.4 2.0 0.7 1.3 0.7 16.6 2.5 1.3 0.0 1.0 5.6 2.0 0.9 1.0 1.2 11.0 1.6 1.7 1.6 18.9 0.7 1.8 0.0 1.4 1.1 0.6 16.5 1.0 2.5 0.0 0.7 0.1 0.2 0.0 9.3 12.4 0.0 3.3 2.6 0.0 1.8 0.1 1.3 0.5 0.0 0.0 2.7 0.0 1.4 0.0 1.0 0.3 0.6 0.0 4.9 0.1 0.1 0.0 3.2 0.3 0.1 6.1 0.3 1.5 2.5 1.0 0.3 0.1 20.3 0.7 5.6 0.0 0.1 1.2 8.5 0.4 0.0 0.2 0.0 1.6 0.6 0.0 0.1 0.1 0.0 0.0 23.6 0.7 0.6 2.9 0.9 3.6 0.0 31.0 5.3 0.0 2.4 2.5 0.0 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 16.5 0.1 0.1 0.1 0.7 0.0 1.0 0.0 0.2 18.4 24.7 6.7 24.6 15.0 10.0 21.4 11.0 16.6 18.9 PCDHA1 ENSG00000204970 "Protocadherin alpha 1" Q9Y5I3 5 140786136-141012347 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.1;testis: 3.1" "Cell line enriched" "Detected in some" 7 "T-47d: 14.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035969 Enhanced Approved "Plasma membrane" "Secreted - unknown location" "Plasma membrane" "HPA035969: AB_10673492" "unprognostic (2.76e-5)" "unprognostic (1.19e-1)" "unprognostic (3.74e-2)" "unprognostic (1.09e-4)" "unprognostic (7.38e-2)" "unprognostic (2.86e-2)" "unprognostic (2.26e-3)" "unprognostic (1.25e-2)" "unprognostic (1.91e-2)" "unprognostic (1.81e-1)" "unprognostic (9.01e-5)" "unprognostic (2.46e-2)" "unprognostic (1.91e-1)" "unprognostic (7.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.77e-3)" "unprognostic (1.29e-1)" 0.2 1.5 4.6 0.2 4.4 0.1 0.2 3.3 7.1 0.2 0.3 0.7 0.5 0.1 0.2 0.2 0.4 0.1 5.0 3.7 0.6 0.1 0.2 0.3 3.4 0.2 0.2 1.0 1.4 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.6 0.2 3.4 0.2 0.3 3.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 1.4 1.0 0.0 0.2 1.8 14.1 0.5 0.0 1.5 1.0 0.7 0.1 0.0 0.1 0.0 0.4 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA10 "CNR8, CNRN8, CNRS8, CRNR8, PCDH-ALPHA10" ENSG00000250120 "Protocadherin alpha 10" Q9Y5I2 5 140855883-141012344 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3" "Cell line enriched" "Detected in some" 10 "EFO-21: 19.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Secreted - unknown location" "unprognostic (4.24e-2)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (4.70e-2)" "unprognostic (4.19e-1)" "unprognostic (2.36e-1)" "unprognostic (6.46e-2)" "unprognostic (8.24e-2)" "unprognostic (8.10e-2)" "unprognostic (5.28e-2)" "unprognostic (2.65e-1)" "unprognostic (6.14e-3)" "unprognostic (1.93e-2)" "unprognostic (3.57e-3)" "unprognostic (5.21e-2)" "unprognostic (3.03e-1)" "unprognostic (1.10e-1)" 2.1 1.7 6.1 1.1 6.6 0.6 2.4 8.0 20.3 3.0 0.9 4.9 0.9 1.1 4.5 6.3 0.5 2.7 3.1 0.8 7.1 2.7 4.3 0.6 2.1 0.7 7.2 3.6 2.8 7.8 0.8 11.2 0.5 6.1 1.6 0.9 1.9 3.2 1.0 0.5 0.7 1.8 4.0 6.9 0.7 1.1 1.9 8.2 0.0 5.0 0.0 0.5 0.7 0.7 0.6 0.4 1.5 0.3 0.6 0.3 0.0 0.0 0.2 0.4 2.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.3 1.5 0.8 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.1 0.3 0.3 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.6 0.2 0.3 1.5 0.6 0.2 0.4 0.1 0.0 6.1 6.6 8.0 6.9 7.1 2.7 7.2 3.6 6.1 8.2 PCDHA11 "CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11" ENSG00000249158 "Protocadherin alpha 11" Q9Y5I1 5 140868183-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.3;parathyroid gland: 4.7" "Cell line enhanced" "Detected in some" "AN3-CA: 16.5;EFO-21: 8.6;MCF7: 4.4;T-47d: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077160 Approved "Vesicles,Cell Junctions,Cytoplasmic bodies" "Vesicles, Cell Junctions" "Cytoplasmic bodies" "HPA077160: " "unprognostic (1.54e-2)" "unprognostic (1.83e-3)" "unprognostic (2.75e-1)" "unprognostic (2.59e-1)" "unprognostic (6.98e-3)" "unprognostic (1.36e-1)" "unprognostic (9.28e-3)" "unprognostic (2.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (3.13e-4)" "unprognostic (9.91e-5)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (3.26e-2)" 0.1 0.6 1.0 0.1 1.6 0.0 0.2 7.0 9.3 1.3 0.0 0.0 0.6 0.1 0.0 0.2 1.0 0.0 0.8 1.0 1.2 0.0 0.8 0.0 0.3 0.0 3.3 4.7 1.6 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.9 16.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 8.6 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.1 0.0 4.4 0.0 0.0 3.6 3.1 0.0 0.0 0.0 0.4 1.9 0.8 2.2 0.0 1.8 0.4 5.8 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA12 PCDH-ALPHA12 ENSG00000251664 "Protocadherin alpha 12" Q9UN75 5 140875302-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6" "Cell line enhanced" "Detected in some" "A549: 10.0;AN3-CA: 4.0;hTCEpi: 6.2;PC-3: 7.6;RT4: 7.5;SH-SY5Y: 4.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 14.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA035812 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA035812: " "unprognostic (3.95e-2)" "unprognostic (7.74e-2)" "unprognostic (7.55e-2)" "unprognostic (3.87e-2)" "unprognostic (2.74e-2)" "unprognostic (2.24e-2)" "unprognostic (2.08e-2)" "unprognostic (4.29e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-4)" "unprognostic (3.18e-4)" "unprognostic (1.11e-1)" "unprognostic (3.21e-3)" "unprognostic (6.97e-2)" 1.0 1.7 0.9 0.3 1.2 0.0 0.9 14.6 3.7 3.5 0.4 1.1 0.0 0.1 1.0 0.5 0.2 1.9 4.3 0.3 1.0 0.7 3.8 1.7 5.7 0.2 0.5 0.8 0.3 2.4 0.9 4.6 0.0 2.3 0.4 0.1 1.5 5.7 0.3 0.1 0.2 0.2 0.6 0.8 0.2 0.3 2.1 0.2 0.0 3.4 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 2.4 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.4 7.6 0.0 0.0 0.0 0.3 7.5 0.3 4.3 0.0 0.9 0.1 1.6 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.2 14.6 3.7 1.0 0.7 0.5 0.8 2.3 0.2 PCDHA13 "CNR5, CNRN5, CNRS5, CRNR5, PCDH-ALPHA13" ENSG00000239389 "Protocadherin alpha 13" Q9Y5I0 5 140882208-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 5.6;parathyroid gland: 12.2" "Group enriched" "Detected in some" 5 "AN3-CA: 2.7;PC-3: 8.8;WM-115: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.07e-1)" "unprognostic (5.25e-2)" "unprognostic (5.58e-2)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (1.01e-2)" "unprognostic (1.14e-1)" "unprognostic (8.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.48e-2)" "unprognostic (2.64e-3)" "unprognostic (5.53e-2)" "unprognostic (1.36e-1)" 1.0 0.9 2.1 0.6 2.3 0.2 0.6 5.6 5.3 1.0 0.2 2.3 0.0 0.3 0.8 1.2 0.2 0.5 2.4 0.3 1.7 1.6 0.7 1.2 0.8 0.6 1.1 3.8 0.2 1.9 12.2 1.2 0.2 1.0 0.6 0.2 2.7 1.0 0.2 0.3 0.2 0.2 0.5 1.1 0.3 0.3 1.6 1.0 0.0 1.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 8.8 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.3 5.6 5.3 1.7 1.6 1.1 3.8 1.0 1.0 PCDHA2 ENSG00000204969 "Protocadherin alpha 2" Q9Y5H9 5 140794852-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.3" "Cell line enhanced" "Detected in some" "AF22: 9.5;SH-SY5Y: 2.7;T-47d: 2.6;WM-115: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA035653 Uncertain "HPA035653: AB_10670969" "unprognostic (3.54e-2)" "unprognostic (5.87e-2)" "unprognostic (3.27e-2)" "unprognostic (8.39e-3)" "unprognostic (4.61e-2)" "unprognostic (4.16e-3)" "unprognostic (1.23e-1)" "unprognostic (4.30e-2)" "unprognostic (3.35e-3)" "unprognostic (5.64e-6)" "unprognostic (2.17e-2)" "unprognostic (7.20e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-3)" "unprognostic (3.42e-1)" 1.1 1.4 3.7 0.3 4.4 0.2 1.7 7.3 4.5 1.1 0.5 1.2 0.0 0.8 3.5 0.2 0.2 1.1 1.6 0.8 3.8 1.6 1.5 0.2 0.9 0.5 2.8 4.9 1.9 1.7 0.5 4.1 0.2 3.1 1.2 0.3 0.1 0.8 0.2 0.6 0.7 0.9 1.0 1.3 0.6 1.0 2.5 3.8 0.0 0.6 0.0 0.2 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 9.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 1.4 2.7 0.0 0.6 0.4 2.6 0.0 0.2 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 4.4 7.3 4.5 3.8 1.6 2.8 4.9 3.1 3.8 PCDHA3 PCDH-ALPHA3 ENSG00000255408 "Protocadherin alpha 3" Q9Y5H8 5 140801028-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.3;pituitary gland: 9.9" "Cell line enhanced" "Detected in some" "A549: 2.7;AF22: 2.3;SH-SY5Y: 2.3;T-47d: 14.0;WM-115: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (5.21e-2)" "unprognostic (2.77e-2)" "unprognostic (7.20e-3)" "unprognostic (2.69e-1)" "unprognostic (1.62e-1)" "unprognostic (7.83e-2)" "unprognostic (2.72e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-2)" "unprognostic (7.10e-2)" "unprognostic (5.68e-3)" "unprognostic (3.09e-3)" "unprognostic (1.72e-2)" "unprognostic (7.25e-3)" "unprognostic (8.41e-2)" "unprognostic (5.66e-3)" "unprognostic (2.67e-2)" 2.0 3.8 3.1 0.7 5.0 0.2 2.2 10.3 5.8 2.6 1.4 2.6 0.3 1.0 5.9 1.4 0.9 2.3 2.6 0.9 2.8 3.1 3.4 0.6 2.6 0.9 3.7 2.5 4.9 4.8 0.6 9.9 0.4 3.7 2.2 1.0 1.3 1.0 1.8 0.6 0.6 1.4 2.1 6.4 0.9 1.1 2.9 4.8 0.0 2.6 0.4 0.4 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 1.1 2.3 0.0 0.3 1.0 14.0 0.0 0.5 0.1 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.0 10.3 5.6 2.8 3.1 3.7 2.5 3.7 4.8 PCDHA4 "CNR1, CNRN1, CRNR1, PCDH-ALPHA4" ENSG00000204967 "Protocadherin alpha 4" Q9UN74 5 140806929-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1" "Cell line enhanced" "Detected in some" "A549: 8.9;AF22: 8.7;EFO-21: 7.6;T-47d: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043180, HPA073478" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "HPA043180: AB_10806381, HPA073478: " "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (2.85e-1)" "unprognostic (5.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.14e-2)" "unprognostic (2.56e-1)" "unprognostic (7.90e-3)" "unprognostic (7.14e-3)" "unprognostic (7.00e-2)" "unprognostic (5.06e-3)" "unprognostic (6.94e-5)" "unprognostic (5.01e-3)" "unprognostic (6.21e-2)" "unprognostic (3.98e-1)" "unprognostic (6.29e-3)" "unprognostic (4.79e-2)" 0.9 0.8 5.1 0.9 6.5 3.2 1.7 12.1 8.7 2.1 1.1 1.6 0.4 0.9 2.3 2.0 0.6 1.6 5.1 1.2 4.5 3.2 2.0 0.6 1.7 1.5 1.9 2.1 1.1 4.1 1.0 1.4 0.7 3.9 1.8 1.1 0.4 1.1 1.3 1.1 2.0 0.9 1.1 3.0 1.1 1.0 1.4 2.4 0.0 1.3 0.1 0.7 1.3 0.8 1.5 1.3 2.0 0.7 0.8 1.1 0.0 0.2 8.9 8.7 0.4 0.1 0.3 0.3 0.2 0.1 0.1 0.1 0.2 1.8 0.3 7.6 0.2 0.3 0.0 0.1 0.2 0.2 0.1 0.3 0.6 0.3 0.1 0.3 0.5 0.4 2.3 0.2 0.4 0.5 0.2 1.2 0.3 0.2 0.2 0.3 2.5 1.2 0.2 0.2 0.3 0.3 0.4 0.4 3.7 0.1 1.9 0.8 7.6 0.3 0.9 1.9 1.2 0.7 0.2 0.5 0.2 0.2 0.3 0.4 0.8 1.8 0.7 0.7 1.1 0.4 0.8 0.8 0.8 0.7 0.3 1.5 0.8 1.1 2.0 0.8 0.7 1.3 0.6 0.0 5.1 6.5 12.1 6.6 4.5 3.2 1.9 2.1 3.9 2.4 PCDHA5 "CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5" ENSG00000204965 "Protocadherin alpha 5" Q9Y5H7 5 140821604-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 13.6" "Cell line enhanced" "Detected in some" "A549: 2.6;EFO-21: 7.3;T-47d: 7.5;WM-115: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" HPA044557 Approved Approved "Nuclear speckles,Plasma membrane,Mitochondria" "Plasma membrane" "Nuclear speckles, Mitochondria" "HPA044557: AB_10970597" "unprognostic (4.95e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-1)" "unprognostic (8.81e-4)" "unprognostic (5.10e-2)" "unprognostic (6.25e-3)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (2.46e-2)" "unprognostic (4.49e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-4)" "unprognostic (9.30e-4)" "unprognostic (1.07e-1)" "unprognostic (1.39e-1)" "unprognostic (8.17e-5)" "unprognostic (2.11e-1)" 0.9 1.2 3.4 0.5 3.6 0.6 0.6 13.6 10.2 0.6 0.6 0.4 0.0 0.5 1.2 0.5 0.4 0.5 1.1 0.3 1.6 2.0 1.1 0.4 0.7 0.4 1.3 5.1 0.6 1.2 0.4 2.5 0.4 2.3 0.6 0.5 0.0 0.4 0.4 0.4 0.5 0.5 0.7 1.1 0.4 0.7 0.9 0.1 0.0 0.5 0.0 0.3 0.5 0.2 0.6 0.6 1.6 0.5 0.3 0.3 0.2 0.0 2.6 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 7.5 0.1 0.1 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.5 0.5 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.6 0.3 0.3 1.6 0.3 0.4 0.6 0.2 0.2 3.4 3.6 13.6 7.2 1.6 2.0 1.3 5.1 2.3 0.1 PCDHA6 "CNR2, CNRS2, CRNR2, PCDH-ALPHA6" ENSG00000081842 "Protocadherin alpha 6" Q9UN73 5 140827958-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.7;pituitary gland: 11.2" "Cell line enhanced" "Detected in some" "AF22: 2.9;EFO-21: 12.4;U-2 OS: 5.2;WM-115: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059326, HPA078110" Enhanced Approved Vesicles "Intracellular and membrane" Vesicles "HPA059326: , HPA078110: " "unprognostic (1.15e-1)" "unprognostic (7.00e-2)" "unprognostic (5.07e-1)" "unprognostic (2.79e-1)" "unprognostic (4.39e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-4)" "unprognostic (4.23e-3)" "unprognostic (8.38e-2)" "unprognostic (2.55e-1)" "unprognostic (1.23e-3)" "unprognostic (3.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.66e-3)" "unprognostic (2.56e-1)" "unprognostic (5.66e-3)" "unprognostic (3.55e-2)" 1.1 1.8 2.9 0.8 7.1 0.4 1.6 10.2 10.7 1.9 0.7 2.3 0.0 1.2 2.9 2.3 0.4 1.6 1.6 0.5 3.8 3.8 2.3 0.4 1.1 0.7 4.6 4.1 2.1 3.7 4.7 11.2 0.4 3.6 1.3 0.7 1.6 0.7 0.5 0.4 0.6 1.3 1.4 3.4 0.8 0.7 1.4 3.2 0.0 0.9 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 2.1 1.3 0.6 0.0 1.9 0.0 5.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.1 10.2 9.6 3.8 3.8 4.6 4.1 3.6 3.2 PCDHA7 "CNR4, CNRS4, CRNR4" ENSG00000204963 "Protocadherin alpha 7" Q9UN72 5 140834248-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 10.1;testis: 2.9" "Cell line enhanced" "Detected in some" "NTERA-2: 3.2;SCLC-21H: 2.0;SK-BR-3: 2.8;SK-MEL-30: 3.6;U-2 OS: 2.4;WM-115: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.99e-1)" "unprognostic (8.54e-2)" "unprognostic (2.67e-1)" "unprognostic (5.28e-2)" "unprognostic (3.05e-1)" "unprognostic (7.08e-2)" "unprognostic (9.29e-3)" "unprognostic (4.11e-3)" "unprognostic (7.20e-2)" "unprognostic (3.18e-3)" "unprognostic (3.12e-4)" "unprognostic (9.54e-4)" "unprognostic (6.86e-5)" "unprognostic (5.34e-4)" "unprognostic (2.88e-1)" "unprognostic (3.72e-1)" "unprognostic (1.14e-1)" 0.9 1.1 0.9 0.6 2.3 0.2 1.0 10.1 6.8 0.6 0.8 3.2 0.0 1.2 1.3 0.9 0.2 0.6 1.5 0.6 1.8 1.1 0.8 0.3 1.0 0.5 2.2 1.8 1.4 1.1 0.7 1.4 0.4 4.3 0.6 0.6 0.3 1.1 0.4 0.2 0.5 1.0 1.3 3.7 0.3 0.9 2.9 0.4 0.0 0.7 0.0 0.3 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.9 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 2.8 3.6 0.9 0.0 0.5 0.5 2.4 0.6 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.3 10.1 6.8 1.8 1.1 2.2 1.8 4.3 0.4 PCDHA8 ENSG00000204962 "Protocadherin alpha 8" Q9Y5H6 5 140841187-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 6.2" "Group enriched" "Detected in some" 6 "AN3-CA: 17.8;SCLC-21H: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA044585 Uncertain "HPA044585: AB_10793953" "unprognostic (1.11e-2)" "unprognostic (1.15e-2)" "unprognostic (1.35e-1)" "unprognostic (1.95e-1)" "unprognostic (4.20e-2)" "unprognostic (9.67e-2)" "unprognostic (8.58e-3)" "unprognostic (7.87e-4)" "unprognostic (5.62e-3)" "unprognostic (2.22e-2)" "unprognostic (5.48e-1)" "unprognostic (1.20e-2)" 0.2 1.6 1.0 0.2 2.3 0.2 0.2 6.2 4.7 0.4 0.4 1.4 0.0 0.3 0.8 0.2 0.3 0.3 0.4 0.2 1.2 1.2 0.5 0.3 0.4 0.3 1.0 3.6 0.7 0.9 0.2 1.8 0.3 2.8 0.3 0.5 0.7 0.5 0.2 0.2 0.2 0.4 0.7 1.1 0.2 0.2 1.7 1.3 0.0 0.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 17.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 5.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.3 6.2 4.7 1.2 1.2 1.0 3.6 2.8 1.3 PCDHA9 "KIAA0345, PCDH-ALPHA9" ENSG00000204961 "Protocadherin alpha 9" Q9Y5H5 5 140847463-141012344 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 1.8;brain: 3.1;pancreas: 3.4;testis: 3.5" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 11.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "unprognostic (1.53e-3)" "unprognostic (1.13e-1)" "unprognostic (7.54e-4)" "unprognostic (1.28e-2)" "unprognostic (4.65e-2)" "unprognostic (1.48e-1)" "unprognostic (5.20e-3)" "unprognostic (6.49e-3)" "unprognostic (1.31e-4)" "unprognostic (1.82e-1)" "unprognostic (8.79e-2)" "unprognostic (6.77e-2)" "unprognostic (1.19e-1)" 0.2 0.4 0.4 0.1 0.5 0.6 0.0 3.1 1.8 0.4 0.0 0.0 0.3 0.4 0.0 0.1 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.3 0.2 3.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.9 0.1 0.0 3.5 0.2 0.0 0.0 0.0 0.9 0.5 1.8 0.4 0.7 0.5 0.2 0.0 0.1 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 11.3 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.3 0.4 0.4 0.5 0.3 0.4 0.4 0.3 0.4 0.2 0.9 0.4 0.5 1.8 0.7 0.4 0.5 0.2 0.2 PCDHAC2 PCDH-ALPHA-C2 ENSG00000243232 "Protocadherin alpha subfamily C, 2" Q9Y5I4 5 140966235-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 14.1;parathyroid gland: 52.5" "Cell line enriched" "Detected in some" 4 "AN3-CA: 36.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA076190 Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA076190: " "unprognostic (1.47e-1)" "unprognostic (3.58e-3)" "unprognostic (2.59e-1)" "unprognostic (5.31e-4)" "unprognostic (3.89e-1)" "unprognostic (1.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-1)" "unprognostic (2.13e-2)" "unprognostic (2.45e-1)" "unprognostic (1.41e-1)" "unprognostic (2.30e-1)" "unprognostic (4.46e-4)" "unprognostic (9.90e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-3)" 1.1 1.7 5.7 1.0 9.2 0.5 0.7 13.6 14.1 1.5 0.9 2.3 0.0 0.7 1.2 0.6 0.6 0.8 3.2 1.2 4.5 5.2 0.9 1.3 2.5 2.2 2.9 6.4 0.7 0.9 52.5 3.1 2.2 3.8 0.9 0.9 2.7 1.1 0.7 0.6 0.6 0.7 1.4 2.0 2.1 1.0 2.4 1.7 0.0 1.6 0.0 1.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.7 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.7 3.9 0.0 0.0 0.1 0.0 8.2 0.0 0.5 0.0 0.0 0.1 5.3 0.0 1.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.4 1.3 0.0 0.0 0.0 1.3 0.0 1.6 6.4 0.0 0.0 0.0 1.4 0.2 0.0 0.7 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.2 13.6 14.1 4.5 5.2 2.9 6.4 3.8 1.7 PCDHB9 "PCDH-BETA9, PCDH3H" ENSG00000177839 "Protocadherin beta 9" Q9Y5E1 5 141187127-141191541 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.9" "Cell line enhanced" "Detected in some" "ASC diff: 10.5;ASC TERT1: 9.8;SH-SY5Y: 14.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA013445 Uncertain "HPA013445: AB_1855054" "unprognostic (1.85e-2)" "unprognostic (3.27e-2)" "unprognostic (2.73e-1)" "unprognostic (8.97e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.12e-1)" "unprognostic (6.78e-3)" "unprognostic (1.34e-2)" "unprognostic (4.46e-2)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (1.86e-4)" "unprognostic (1.71e-1)" "unprognostic (9.80e-2)" "unprognostic (1.17e-1)" "unprognostic (8.01e-2)" 1.9 1.9 5.3 0.3 4.1 0.3 1.6 1.8 10.9 3.6 1.0 3.2 0.0 0.2 2.8 4.7 0.9 2.3 1.6 2.0 5.9 0.9 0.2 1.4 0.2 1.2 3.1 4.7 1.7 2.1 6.6 1.1 4.1 1.1 0.6 1.2 1.4 0.8 0.7 0.9 1.0 2.6 4.6 0.6 0.5 1.2 2.5 0.0 0.8 0.3 0.2 0.7 1.0 0.5 0.2 1.9 0.2 0.9 1.3 0.0 0.0 0.0 0.9 6.0 10.5 9.8 0.2 0.1 3.5 0.4 0.5 0.0 1.0 0.4 4.0 0.1 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.9 0.0 0.0 0.0 0.0 2.6 2.9 0.9 0.5 0.7 0.3 0.4 2.7 5.5 0.0 0.5 0.1 2.1 14.5 0.6 0.1 1.0 2.8 0.2 0.9 5.9 0.5 4.9 1.2 0.1 0.0 0.0 3.2 0.2 2.2 1.1 0.2 0.5 0.2 0.1 0.1 0.2 0.4 1.3 0.0 0.5 0.3 0.3 1.9 0.9 0.1 0.2 0.2 0.0 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 "Protocadherin gamma subfamily A, 1" Q9Y5H4 5 141330571-141512981 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Cell line enhanced" "Detected in many" "LHCN-M2: 6.9;T-47d: 11.3;WM-115: 5.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008755, HPA010580, HPA036547" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA036547: AB_10669798" "unprognostic (9.50e-4)" "unprognostic (2.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.42e-3)" "unprognostic (3.39e-1)" "unprognostic (3.97e-2)" "unprognostic (2.42e-1)" "unprognostic (5.61e-3)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-3)" "unprognostic (4.76e-2)" "unprognostic (1.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-3)" 1.4 1.3 2.7 0.9 11.7 1.0 1.1 6.8 7.9 1.4 1.2 2.7 0.5 1.0 2.8 3.9 1.3 1.1 0.8 3.9 3.5 2.8 1.2 0.5 1.2 1.0 2.5 2.5 2.9 2.5 2.8 6.1 2.3 5.4 1.5 0.9 2.4 1.1 1.0 1.7 1.5 0.6 1.8 2.4 1.1 0.8 2.7 1.1 0.0 1.3 0.6 0.7 1.2 0.9 1.2 0.9 2.7 0.5 0.8 1.0 0.2 0.1 0.4 0.5 1.9 1.2 2.0 0.3 1.7 1.1 0.5 1.0 0.4 0.2 0.5 2.8 1.0 0.2 0.2 0.3 1.1 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.2 1.7 0.5 0.0 0.7 0.1 0.2 0.8 6.9 0.1 0.2 0.8 0.3 0.3 3.0 2.6 0.3 0.3 0.3 1.7 2.1 0.2 0.9 1.7 11.3 0.4 0.8 3.2 0.7 1.6 0.4 0.3 1.0 0.2 3.8 0.2 5.1 2.7 0.5 0.5 0.7 0.4 0.4 0.7 0.7 0.5 0.2 1.2 1.0 0.8 1.1 0.8 0.5 0.9 0.6 0.2 2.7 11.7 6.8 6.1 3.5 2.8 2.5 2.5 5.4 1.1 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 "Protocadherin gamma subfamily A, 10" Q9Y5H3 5 141412987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 33.7" "Cell line enhanced" "Detected in many" "AF22: 12.0;HSkMC: 13.5;T-47d: 16.0;U-2197: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077276" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA077276: " "unprognostic (2.92e-1)" "unprognostic (2.17e-4)" "unprognostic (1.63e-1)" "unprognostic (3.33e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-2)" "unprognostic (9.99e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.64e-3)" "unprognostic (2.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.06e-1)" "unprognostic (8.83e-3)" 5.2 4.2 7.9 1.6 11.4 1.2 2.7 2.4 33.7 3.6 2.9 9.8 1.2 2.4 3.0 2.4 4.3 3.6 3.7 2.3 9.1 4.4 2.0 6.5 3.5 1.7 5.1 7.2 3.6 1.9 1.4 2.4 7.4 5.3 3.6 2.6 4.9 4.1 4.6 2.0 4.7 2.9 3.1 6.7 2.5 4.7 2.0 6.5 0.0 4.9 1.5 3.3 2.5 3.5 0.9 1.1 1.5 0.7 0.8 1.0 0.2 0.0 0.0 12.0 6.1 5.3 2.3 5.7 2.0 0.1 2.9 4.7 0.2 0.7 0.6 7.9 2.9 0.3 2.8 1.9 2.3 0.7 0.0 0.0 0.3 0.0 2.1 1.2 0.2 13.5 0.3 2.0 0.8 1.1 0.0 0.1 7.3 0.0 0.1 0.3 1.1 0.1 0.1 1.0 0.0 2.0 0.0 1.6 0.6 0.3 0.0 0.3 16.0 1.5 2.6 5.5 0.3 9.4 0.1 0.2 0.9 0.1 2.8 0.0 0.3 1.5 0.3 0.3 1.0 0.4 1.0 0.6 0.4 0.6 0.1 0.9 0.4 0.9 0.9 0.8 0.7 1.1 0.3 0.2 7.9 11.4 2.4 8.5 9.1 4.4 5.1 7.2 5.3 6.5 PCDHGA11 PCDH-GAMMA-A11 ENSG00000253873 "Protocadherin gamma subfamily A, 11" Q9Y5H2 5 141421047-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell line enhanced" "Detected in many" "ASC diff: 14.9;ASC TERT1: 16.1;HSkMC: 11.5;REH: 9.6;SK-MEL-30: 12.4;WM-115: 25.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.13e-2)" "unprognostic (1.78e-3)" "unprognostic (9.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.68e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.16e-3)" "unprognostic (1.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.97e-1)" "unprognostic (2.22e-1)" "unprognostic (3.03e-2)" "unprognostic (3.74e-2)" "unprognostic (3.54e-1)" "unprognostic (4.34e-3)" "unprognostic (1.89e-1)" 3.4 2.5 7.4 2.8 9.4 0.5 2.1 4.1 8.5 2.4 2.5 8.5 0.0 1.2 2.6 1.7 3.1 2.1 2.1 3.4 11.6 1.9 1.9 1.2 2.3 1.8 4.5 5.2 3.8 2.3 1.3 1.9 8.3 5.0 2.5 1.5 3.3 2.8 3.4 2.8 6.6 1.2 3.3 4.9 1.6 1.8 2.2 7.1 0.1 3.4 0.6 1.7 1.7 2.2 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.4 14.9 16.1 0.5 3.2 6.2 2.5 4.0 0.0 0.1 0.3 5.4 3.2 2.1 0.1 0.3 4.0 0.1 1.4 0.0 0.0 0.0 2.5 0.2 0.0 11.5 0.1 4.4 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 9.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.3 1.8 4.5 0.5 0.1 0.4 0.0 0.0 0.2 0.0 0.1 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 7.4 9.4 4.1 8.5 11.6 1.9 4.5 5.2 5.0 7.1 PCDHGA12 "CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12" ENSG00000253159 "Protocadherin gamma subfamily A, 12" O60330 5 141430589-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9" "Cell line enhanced" "Detected in some" "BJ: 7.6;BJ hTERT+: 12.6;fHDF/TERT166: 18.7;HHSteC: 6.1;HSkMC: 14.0;TIME: 6.0" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Low lineage specificity" "Detected in many" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.17e-3)" "unprognostic (2.71e-2)" "unprognostic (1.04e-2)" "unprognostic (2.67e-1)" "unprognostic (2.74e-1)" "unprognostic (5.06e-2)" "unprognostic (1.99e-1)" "unprognostic (9.01e-3)" "unprognostic (1.19e-1)" "unprognostic (4.65e-4)" "unprognostic (2.98e-1)" "unprognostic (3.02e-1)" "unprognostic (1.28e-4)" "unprognostic (8.30e-3)" "unprognostic (1.57e-1)" "unprognostic (2.42e-1)" "unprognostic (6.85e-3)" 5.1 12.7 14.8 2.8 18.9 0.7 2.4 4.7 13.8 4.9 1.8 8.6 0.6 1.4 5.4 2.3 3.5 2.7 11.3 6.5 15.7 5.6 3.1 2.8 6.5 1.6 4.7 7.3 6.2 3.6 2.0 2.7 6.5 8.4 3.5 1.7 3.4 1.7 4.9 1.9 5.1 1.5 5.3 8.4 3.7 2.2 1.6 12.4 0.4 3.0 0.6 1.7 4.5 3.6 3.7 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.6 1.2 0.1 7.6 12.6 0.0 0.0 0.0 0.0 0.4 0.0 18.7 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.0 14.0 0.0 3.7 0.0 4.4 0.0 0.0 2.6 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 6.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 14.8 18.9 4.7 10.4 15.7 5.6 4.7 7.3 8.4 12.4 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.1" "Group enriched" "Detected in some" 7 "ASC diff: 18.4;ASC TERT1: 7.3" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 4.0 2.7 6.1 1.8 9.1 0.9 3.9 19.1 9.6 9.0 2.7 7.7 4.1 1.0 7.6 3.2 3.3 4.7 4.5 4.9 6.9 4.0 1.5 1.2 3.3 1.3 3.2 3.8 6.6 1.7 3.3 3.7 2.7 4.6 5.6 1.6 4.1 2.5 4.0 1.5 3.0 1.5 4.3 6.3 1.4 1.7 1.7 3.7 0.0 1.8 0.9 1.0 2.5 4.2 0.9 0.8 1.6 0.6 1.9 0.7 0.2 0.0 0.4 0.3 0.1 18.4 7.3 0.0 0.8 0.1 0.1 0.3 0.0 0.0 0.8 0.3 0.3 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 1.8 0.2 0.0 0.0 0.6 0.1 0.6 0.7 0.3 0.5 0.7 0.1 0.3 0.9 0.6 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.3 1.6 0.0 1.0 0.6 0.2 1.0 0.7 0.1 1.0 0.1 0.3 0.2 0.7 1.5 0.6 0.6 0.7 0.3 0.3 0.6 0.6 0.4 0.1 0.9 0.7 0.7 1.6 1.9 0.2 0.8 0.4 0.2 6.1 9.1 19.1 9.6 6.9 4.0 3.2 3.8 4.6 3.7 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 "Protocadherin gamma subfamily A, 6" Q9Y5G7 5 141373914-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6" "Cell line enhanced" "Detected in some" "SCLC-21H: 11.0;T-47d: 6.4;WM-115: 13.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (4.49e-2)" "unprognostic (8.91e-3)" "unprognostic (5.45e-2)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (3.86e-3)" "unprognostic (2.02e-2)" "unprognostic (5.26e-2)" "unprognostic (7.44e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-3)" 4.1 3.8 6.1 2.3 8.4 0.8 2.9 19.6 10.8 7.9 3.4 8.3 2.9 1.0 6.9 4.7 2.6 4.3 3.6 3.7 5.0 4.3 2.8 1.7 3.3 1.4 2.9 4.7 9.7 2.5 2.5 4.5 6.9 3.3 4.0 1.6 5.8 4.1 5.3 2.1 4.7 1.5 6.1 2.8 2.8 1.7 2.2 2.9 0.2 3.8 1.2 1.5 4.6 3.6 1.3 0.7 2.8 0.6 0.5 0.8 0.2 0.1 0.3 3.1 0.5 1.5 5.3 0.1 2.3 0.8 1.2 1.2 0.0 0.2 2.1 3.0 3.6 0.5 0.1 0.5 0.8 0.0 0.3 0.0 0.3 0.3 0.8 0.1 0.1 5.7 0.4 0.3 0.1 1.8 0.3 1.3 0.4 0.5 0.7 1.8 0.3 0.1 1.5 0.4 0.0 0.4 0.1 11.0 0.9 0.1 0.3 0.7 6.4 0.1 5.4 0.9 0.4 0.8 0.8 0.4 1.8 0.4 0.9 0.7 13.7 1.8 0.6 0.3 0.8 0.3 0.3 0.8 0.6 0.2 0.1 1.3 0.3 0.5 2.8 0.5 0.3 0.7 0.5 0.2 6.1 8.4 19.6 10.8 5.0 4.3 2.9 4.7 3.3 2.9 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ hTERT+: 17.3;SH-SY5Y: 15.5;T-47d: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 1.7 2.0 3.1 1.3 9.0 0.6 2.1 5.3 14.9 3.5 3.0 7.1 2.1 1.0 4.2 4.1 2.2 3.3 1.9 3.0 5.1 3.3 3.2 1.9 2.2 1.0 5.1 6.6 4.7 2.5 4.6 3.4 4.8 5.4 3.7 1.5 5.8 2.6 3.3 1.6 3.8 1.2 3.0 6.3 1.3 1.4 2.1 5.1 0.0 6.6 1.5 1.0 2.4 2.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 1.9 0.0 5.8 9.9 0.0 2.6 17.3 3.5 5.2 0.0 0.0 0.4 4.3 0.5 0.1 0.0 0.1 2.9 0.0 0.3 0.0 0.4 0.1 1.0 0.0 0.0 4.3 0.1 0.0 0.6 1.4 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 15.5 0.0 0.1 0.1 6.8 0.0 5.2 0.1 0.1 2.5 0.0 0.1 1.5 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.0 5.3 7.7 5.1 3.3 5.1 6.6 5.4 5.1 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 "Protocadherin gamma subfamily B, 1" Q9Y5G3 5 141350102-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 32.2;pituitary gland: 13.7" "Cell line enhanced" "Detected in some" "ASC diff: 14.9;ASC TERT1: 7.7;T-47d: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076182" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody" "Vesicles, Plasma membrane" "Nucleoplasm, Focal adhesion sites, Midbody" "HPA008755: AB_1079577, HPA010580: , HPA076182: " "unprognostic (1.53e-2)" "unprognostic (1.94e-3)" "unprognostic (3.21e-1)" "unprognostic (4.38e-3)" "unprognostic (2.98e-1)" "unprognostic (8.36e-3)" "unprognostic (2.37e-1)" "unprognostic (9.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.78e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-2)" "unprognostic (1.93e-1)" "unprognostic (7.63e-3)" 2.3 2.7 8.2 1.4 7.5 1.0 2.1 4.3 32.2 2.5 1.4 9.4 0.1 1.2 3.7 2.0 1.7 1.9 2.1 2.2 7.6 5.7 2.1 1.3 2.4 1.2 5.5 5.0 4.1 2.8 1.4 13.7 1.6 7.0 2.5 1.4 2.6 1.7 3.1 1.1 1.4 1.3 3.0 6.9 1.4 1.2 1.5 5.6 0.0 2.5 0.0 1.2 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 2.1 1.8 0.0 14.9 7.7 0.1 1.4 3.6 0.5 0.8 0.2 0.5 0.5 4.7 0.5 0.6 0.4 0.2 0.5 0.0 0.9 0.0 0.2 1.3 0.2 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.2 0.2 3.3 1.9 0.4 0.3 0.2 0.0 0.0 2.8 0.1 0.0 0.0 1.1 0.8 0.0 0.9 0.1 9.6 0.0 1.1 0.2 1.6 1.2 0.0 0.0 2.6 0.3 2.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.5 4.3 9.6 7.6 5.7 5.5 5.0 7.0 5.6 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 "Protocadherin gamma subfamily B, 6" Q9Y5F9 5 141408021-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell line enhanced" "Detected in some" "AF22: 18.2;EFO-21: 6.2;HSkMC: 4.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (2.63e-1)" "unprognostic (7.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-2)" "unprognostic (3.51e-1)" "unprognostic (1.11e-1)" "unprognostic (4.77e-2)" "unprognostic (9.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.27e-1)" "unprognostic (1.21e-2)" "unprognostic (7.71e-4)" 6.7 7.2 8.8 2.6 9.9 1.6 4.4 6.1 26.6 5.8 4.1 10.1 0.3 1.8 7.2 5.7 3.0 5.1 4.4 4.6 8.9 5.7 3.2 9.4 4.4 2.2 6.9 4.4 13.3 5.2 16.1 4.7 6.8 5.9 4.0 2.3 9.0 5.3 5.9 5.7 4.7 2.2 4.8 4.1 4.0 2.5 2.1 6.7 0.3 6.1 1.9 2.1 4.2 5.1 0.8 0.5 3.2 0.4 0.5 0.9 0.2 0.0 0.1 18.2 0.1 0.6 0.7 0.9 1.6 0.0 0.4 1.0 0.2 0.2 1.5 6.2 1.0 0.3 0.0 0.3 1.2 0.0 0.3 0.0 0.2 0.1 1.5 0.1 0.1 4.2 2.0 0.9 0.1 0.6 0.1 0.3 0.1 0.3 0.1 1.2 0.8 0.0 0.2 0.1 0.1 2.9 0.2 0.2 0.3 0.0 0.1 0.1 1.4 0.4 2.9 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.8 1.1 0.4 0.2 0.9 0.3 0.2 0.6 0.4 0.2 0.1 0.8 0.4 0.3 3.2 0.5 0.3 0.5 0.2 0.2 8.8 9.9 6.1 7.9 8.9 5.7 6.9 4.4 5.9 6.7 PCDHGC3 "PC-43, PC43, PCDH-GAMMA-C3, PCDH2" ENSG00000240184 "Protocadherin gamma subfamily C, 3" Q9UN70 5 141475947-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 99.3" "Cell line enhanced" "Detected in many" "ASC diff: 43.0;ASC TERT1: 41.2;HSkMC: 40.4;U-138 MG: 51.8;WM-115: 77.2" "Group enriched" "Detected in all" 6 "glioma: 55.0;melanoma: 20.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "plasmacytoid DC: 15.2" "Lineage enriched" "Detected in single" 22 "dendritic cells: 15.2" "HPA008755, HPA010580, HPA077289" Approved Approved "Plasma membrane" 74000 "Plasma membrane" "HPA008755: AB_1079577, HPA010580: , HPA077289: " "unprognostic (2.52e-1)" "unprognostic (4.83e-3)" "unprognostic (1.17e-1)" "unprognostic (6.76e-2)" "unprognostic (3.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "prognostic unfavourable (6.19e-4)" "unprognostic (2.03e-1)" "unprognostic (2.22e-1)" "prognostic unfavourable (8.18e-4)" "unprognostic (3.72e-2)" "unprognostic (5.66e-2)" "unprognostic (9.55e-2)" "prognostic unfavourable (6.00e-4)" 14.9 15.0 52.8 7.0 49.0 0.5 11.2 30.1 99.3 28.0 8.7 38.9 2.4 3.8 20.6 27.6 12.8 15.7 14.6 11.0 40.2 25.2 7.1 8.0 20.9 4.2 32.0 24.9 16.6 4.4 18.8 7.9 17.7 25.8 17.1 10.2 17.3 8.4 20.1 5.8 18.3 5.6 19.8 28.1 5.3 6.6 4.8 24.1 0.9 5.4 6.4 7.1 8.6 11.1 0.6 15.2 0.0 0.0 0.0 0.1 0.0 2.7 1.6 10.7 2.8 43.0 41.2 0.1 14.0 37.5 7.0 7.5 0.0 2.7 9.3 9.1 24.4 10.2 1.4 4.4 6.7 0.0 4.2 0.0 0.2 0.2 13.3 0.1 0.3 40.4 6.7 10.4 8.6 4.6 0.0 0.3 17.5 5.1 0.2 1.0 0.4 0.0 6.3 21.7 0.0 3.7 3.0 3.5 15.2 3.7 0.1 23.0 8.7 13.0 5.6 51.8 2.7 10.1 15.1 0.0 0.1 0.1 12.4 0.0 77.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 15.2 0.0 0.0 52.8 49.0 30.1 38.9 40.2 25.2 32.0 24.9 25.8 24.1 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 23.6" "Cell line enhanced" "Detected in some" "REH: 9.7;SCLC-21H: 8.2;SH-SY5Y: 15.9" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.7 2.9 5.7 0.7 9.5 0.5 0.8 23.6 21.9 1.0 1.1 2.3 0.0 0.6 0.9 1.2 0.8 1.0 1.0 1.3 4.1 10.1 0.6 0.6 1.0 0.9 3.3 4.5 0.8 1.2 0.8 1.3 0.8 8.6 0.8 0.8 1.9 1.0 0.7 1.2 1.5 0.7 0.9 2.3 0.8 0.7 1.5 0.8 0.0 0.7 0.0 1.0 0.6 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.2 0.2 0.8 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.3 0.9 0.9 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.0 1.5 0.0 9.7 0.6 0.0 0.0 0.1 8.2 15.9 0.1 0.0 0.2 0.1 0.3 0.1 0.9 0.1 0.2 0.7 0.2 0.0 0.2 0.6 0.1 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.5 23.6 15.6 4.1 10.1 3.3 4.5 8.6 0.8 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489121-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 43.7" "Cell line enhanced" "Detected in some" "U-138 MG: 16.3;U-251 MG: 7.0;U-87 MG: 10.0" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4" "HPA008755, HPA010580, HPA076140" Supported Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 1.0 1.1 7.4 1.1 34.5 0.9 1.1 3.0 43.7 1.1 1.0 2.8 0.0 0.9 1.4 1.3 1.0 1.2 1.2 2.8 11.8 2.8 0.9 0.9 1.1 0.9 2.2 10.0 1.1 1.0 1.0 1.1 1.0 2.3 1.3 1.0 0.0 0.9 1.6 1.6 1.5 0.9 2.0 0.8 1.0 1.0 1.3 1.1 0.0 1.0 0.0 1.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.7 0.2 0.8 0.6 0.5 0.6 0.0 0.0 0.5 1.6 2.4 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.9 0.8 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.2 0.1 16.3 0.2 0.2 7.0 0.0 0.0 0.0 10.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 34.5 3.0 39.2 11.8 2.8 2.2 10.0 2.3 1.1 PCLO "ACZ, DKFZp779G1236, KIAA0559" ENSG00000186472 "Piccolo presynaptic cytomatrix protein" Q9Y6V0 7 82754013-83162930 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.3" "Group enriched" "Detected in some" 28 "REH: 61.0;U-2 OS: 70.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015858, HPA029579, CAB079012" Approved Supported Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles, Plasma membrane" "CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044" "unprognostic (1.32e-2)" "unprognostic (1.99e-1)" "unprognostic (9.33e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (4.49e-3)" "unprognostic (6.14e-2)" "unprognostic (4.61e-2)" "unprognostic (1.82e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-1)" "unprognostic (4.79e-6)" "unprognostic (5.15e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-5)" "unprognostic (6.62e-5)" 3.1 7.9 8.8 0.8 26.3 0.4 4.7 50.3 19.4 3.2 3.9 1.6 0.4 2.9 1.0 7.3 2.3 2.0 1.9 2.2 9.8 5.7 8.2 0.6 1.8 0.6 4.6 12.6 1.9 4.0 11.4 19.2 1.0 9.1 4.9 3.5 3.6 2.5 5.0 0.6 2.6 2.4 0.7 5.3 1.1 2.9 4.5 4.4 0.0 8.4 0.0 0.8 1.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.1 1.3 0.5 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.4 0.0 2.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 1.1 61.0 1.0 0.0 0.4 0.2 1.1 0.8 0.0 0.6 0.1 0.7 0.1 0.0 0.0 70.0 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.8 26.3 50.3 19.4 9.8 5.7 4.6 12.6 9.1 4.4 PCNX2 "FLJ11383, KIAA0435, PCNXL2" ENSG00000135749 "Pecanex homolog 2" A6NKB5 1 232983435-233295713 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 29.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013815, HPA014427" Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA013815: AB_2236561, HPA014427: AB_1855081" "unprognostic (3.15e-1)" "unprognostic (5.61e-3)" "unprognostic (1.92e-2)" "unprognostic (1.44e-2)" "unprognostic (2.54e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-2)" "unprognostic (1.71e-1)" "unprognostic (4.25e-2)" "unprognostic (3.79e-1)" "unprognostic (2.40e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (2.27e-5)" "unprognostic (1.12e-1)" "unprognostic (2.92e-2)" "unprognostic (1.49e-2)" "unprognostic (1.29e-1)" 4.7 4.7 11.4 7.5 16.8 4.2 7.7 29.6 23.1 4.9 3.9 6.3 4.2 3.4 6.6 14.0 5.2 9.0 8.1 2.3 11.9 8.2 5.4 1.2 4.7 9.4 8.0 13.1 11.4 5.2 8.6 18.6 2.4 14.3 6.2 4.8 6.0 6.0 8.1 5.6 6.3 5.6 5.2 5.8 5.3 5.8 5.5 5.5 4.0 7.9 3.4 8.8 6.0 5.7 1.5 1.8 0.9 0.9 0.8 3.1 1.1 3.8 9.2 5.1 0.1 8.3 9.0 1.5 2.3 6.7 2.4 4.2 3.0 4.6 8.0 5.4 6.2 6.3 2.2 6.6 5.7 6.7 6.8 0.1 4.7 0.0 3.7 2.6 1.6 6.9 5.8 4.7 18.9 4.5 0.0 4.3 2.3 2.3 7.3 0.2 16.3 5.6 0.1 1.3 1.1 4.3 5.9 8.7 7.2 3.4 1.4 1.4 3.4 0.7 1.7 6.7 4.3 7.6 7.5 5.2 5.3 0.1 6.1 2.9 7.7 0.9 0.9 0.4 3.1 0.5 2.4 1.5 2.5 2.9 1.8 1.3 1.1 2.1 0.7 0.8 0.7 0.6 2.7 1.1 11.4 16.8 29.6 23.1 11.9 8.2 8.0 13.1 14.3 5.5 PCP2 "GPSM4, MGC41903" ENSG00000174788 "Purkinje cell protein 2" Q8IVA1 19 7631611-7633748 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 45.5;retina: 20.2;testis: 80.7" "Cell line enhanced" "Detected in some" "HMC-1: 8.9;Karpas-707: 4.5;NB-4: 18.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 14 "cerebellum: 45.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in some" 43 "cerebellum: 2422.3" "Region enriched" "Detected in single" 19 "cerebellum: 135.0" HPA057428 Approved "Nuclear speckles,Vesicles" "Nuclear speckles" Vesicles "HPA057428: " "prognostic favourable (7.93e-4)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.43e-2)" "unprognostic (1.49e-1)" "unprognostic (1.79e-4)" "unprognostic (1.19e-1)" "unprognostic (4.88e-5)" "unprognostic (1.11e-1)" "unprognostic (6.23e-2)" "unprognostic (9.15e-3)" "unprognostic (6.01e-2)" "unprognostic (1.36e-2)" "unprognostic (8.17e-2)" "unprognostic (1.18e-1)" "unprognostic (8.70e-2)" "prognostic favourable (2.76e-5)" 0.5 0.4 0.5 0.5 0.5 1.9 3.3 45.5 0.6 1.0 0.5 0.5 0.5 0.6 0.5 2.0 0.5 1.3 1.2 0.5 0.5 0.0 2.5 1.0 1.2 1.4 0.5 0.5 0.5 1.6 0.3 0.5 0.5 3.2 2.0 0.0 20.2 10.6 1.0 0.5 4.2 0.5 0.5 1.9 1.1 0.9 80.7 0.5 0.5 1.9 0.5 0.6 0.5 0.5 1.0 1.7 2.6 0.3 0.7 1.2 5.2 1.8 0.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 1.6 0.7 1.1 0.0 1.3 0.0 0.2 0.0 0.8 0.6 2.7 2.5 0.1 0.0 0.3 8.9 0.0 0.6 0.0 0.0 0.0 0.2 4.5 0.0 0.3 0.3 18.0 0.4 0.0 0.8 0.2 0.7 0.9 0.1 0.1 0.0 1.4 1.5 0.0 3.9 3.3 0.2 0.0 0.6 0.4 0.1 1.6 0.6 0.2 0.0 2.1 0.0 0.0 0.3 0.0 0.9 0.1 1.2 0.4 0.5 0.5 0.5 1.0 0.8 1.0 2.6 0.7 0.0 1.7 0.2 5.2 0.5 0.5 45.5 0.6 0.5 0.0 0.5 0.5 3.2 0.5 PCP4 PEP-19 ENSG00000183036 "Purkinje cell protein 4" P48539 21 39867317-39929397 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 177.9;seminal vesicle: 234.5" "Cell line enhanced" "Detected in some" "RPMI-8226: 56.4;SK-BR-3: 9.5;T-47d: 17.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "basal ganglia: 177.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005792 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA005792: AB_1855086" "unprognostic (6.82e-2)" "prognostic favourable (9.76e-4)" "unprognostic (5.26e-2)" "unprognostic (1.56e-1)" "unprognostic (4.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (3.95e-3)" "unprognostic (2.63e-1)" "prognostic favourable (1.85e-7)" "unprognostic (9.00e-2)" "unprognostic (2.99e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" 2.1 11.0 5.6 1.4 177.9 1.0 2.6 15.8 15.8 39.3 10.6 11.4 50.8 1.9 11.4 65.7 38.4 2.9 1.7 1.7 8.3 14.0 9.7 1.0 1.1 1.0 11.6 3.7 1.2 2.1 3.4 1.0 1.3 20.0 60.9 6.9 49.0 1.7 234.5 1.0 1.4 1.5 93.5 3.7 1.5 1.1 1.2 37.5 0.0 39.2 0.0 1.2 65.6 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.5 0.0 0.0 0.0 56.4 0.0 0.0 0.1 0.1 0.0 9.5 0.0 17.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 177.9 15.8 15.8 8.3 14.0 11.6 3.7 20.0 37.5 PCP4L1 IQM1 ENSG00000248485 "Purkinje cell protein 4 like 1" A6NKN8 1 161258727-161285450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.7;urinary bladder: 33.2" "Group enriched" "Detected in some" 6 "RT4: 15.7;T-47d: 10.3" "Group enriched" "Detected in many" 6 "cervical cancer: 12.4;head and neck cancer: 5.1;lung cancer: 13.6;testis cancer: 18.9;urothelial cancer: 21.8" "Group enriched" "Detected in all" 5 "basal ganglia: 67.7;cerebral cortex: 17.9;pons and medulla: 30.8" "Cell type enhanced" "Detected in single" "T-reg: 3.1" "Lineage enhanced" "Detected in single" "T-cells: 3.1" "Low region specificity" "Detected in all" HPA052833 Enhanced Supported Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA052833: " "unprognostic (1.81e-2)" "unprognostic (9.39e-2)" "unprognostic (5.25e-2)" "unprognostic (2.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.87e-2)" "unprognostic (2.51e-1)" "prognostic favourable (8.10e-5)" "unprognostic (2.39e-1)" "unprognostic (1.92e-1)" "unprognostic (4.93e-2)" "unprognostic (7.37e-2)" "unprognostic (3.63e-5)" "unprognostic (4.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (6.15e-2)" 3.2 1.0 5.7 1.3 67.7 0.6 2.2 4.4 28.9 4.3 4.3 1.4 1.5 2.2 2.2 3.3 16.5 2.1 3.9 1.3 3.9 6.3 1.0 4.3 5.0 0.7 7.8 4.6 2.6 0.5 0.6 21.9 0.9 30.8 5.5 3.2 5.9 1.2 17.8 1.0 2.8 3.3 6.8 7.5 0.8 1.2 2.3 5.3 0.0 1.0 0.0 3.0 33.2 4.1 0.0 0.7 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 2.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.1 0.0 15.7 2.2 0.0 0.0 0.3 0.0 10.3 0.4 0.2 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 5.7 67.7 4.4 17.9 3.9 6.3 7.8 4.6 30.8 5.3 PCSK1 "NEC1, PC1, PC3, SPC3" ENSG00000175426 "Proprotein convertase subtilisin/kexin type 1" P29120 5 96390415-96434143 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.6" "Group enriched" "Detected in some" 6 "SCLC-21H: 18.5;U-138 MG: 15.8;U-87 MG: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Lineage enhanced" "Detected in single" "granulocytes: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA048564 Approved "Secreted in other tissues" "HPA048564: " "unprognostic (1.86e-2)" "unprognostic (2.13e-2)" "unprognostic (4.66e-3)" "unprognostic (8.20e-5)" "prognostic unfavourable (9.13e-5)" "unprognostic (8.47e-4)" "unprognostic (1.46e-1)" "unprognostic (5.84e-3)" "unprognostic (4.71e-1)" "unprognostic (3.07e-3)" "unprognostic (1.89e-3)" "unprognostic (1.01e-1)" "unprognostic (7.90e-6)" "unprognostic (5.25e-2)" "unprognostic (9.96e-2)" "unprognostic (1.33e-3)" "unprognostic (9.37e-3)" 2.3 8.5 1.3 6.0 10.1 0.5 1.3 0.5 36.6 1.2 3.3 0.5 0.0 6.7 0.5 8.8 0.4 0.4 0.6 1.0 2.8 27.1 0.5 0.4 0.8 0.4 3.1 14.0 0.6 9.8 0.3 10.9 0.4 7.5 0.5 3.3 0.1 2.8 0.5 0.5 1.7 4.6 1.0 1.3 0.5 8.4 0.5 0.4 0.0 1.9 0.0 0.3 0.9 0.6 0.0 0.0 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.1 0.0 0.0 0.0 0.0 1.7 0.8 0.3 0.1 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.0 2.7 0.0 0.0 0.0 0.0 0.9 15.8 0.5 0.2 0.1 0.0 0.0 0.1 13.1 0.0 0.3 1.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 10.1 0.5 36.6 2.8 27.1 3.1 14.0 7.5 0.4 PCSK1N "BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII" ENSG00000102109 "Proprotein convertase subtilisin/kexin type 1 inhibitor" Q9UHG2 X 48831094-48835633 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.9;kidney: 72.9;pituitary gland: 127.7" "Cell line enhanced" "Detected in some" "HEK 293: 19.6;PC-3: 49.6;SCLC-21H: 19.7;SH-SY5Y: 18.2;SiHa: 17.2;U-266/84: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 3.0;memory CD4 T-cell: 6.5;memory CD8 T-cell: 6.3;naive CD4 T-cell: 2.7;naive CD8 T-cell: 8.2;T-reg: 2.1" "Lineage enriched" "Detected in single" 77 "T-cells: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003925, HPA064734" Enhanced Supported Approved Vesicles "Secreted to blood" 5300000 Vesicles "HPA003925: AB_1079582, HPA064734: AB_2685339" "unprognostic (2.44e-3)" "unprognostic (5.86e-2)" "unprognostic (1.94e-1)" "prognostic unfavourable (1.15e-4)" "unprognostic (3.36e-1)" "unprognostic (4.76e-3)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (1.50e-3)" "unprognostic (2.79e-3)" "prognostic favourable (1.36e-4)" "unprognostic (3.34e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" 4.1 27.5 49.1 2.6 72.7 2.1 2.2 15.6 70.3 3.2 9.8 10.8 1.5 12.4 4.4 10.9 2.1 2.3 2.8 2.7 38.5 74.9 72.9 2.1 2.6 2.2 33.5 29.0 2.2 20.0 12.4 127.7 2.3 32.9 4.6 2.7 6.6 2.8 3.1 2.2 2.8 8.5 2.7 18.3 2.4 26.0 3.8 9.8 0.0 2.2 0.0 2.1 2.1 0.5 0.1 0.0 0.0 0.0 0.0 8.2 0.8 0.0 1.8 0.0 5.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.5 0.0 0.2 0.0 0.3 0.0 0.0 19.6 0.0 0.0 2.9 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 2.7 49.6 0.0 0.0 0.1 0.4 0.0 19.7 18.2 17.2 0.0 1.4 0.0 0.0 0.0 0.0 7.6 0.0 1.6 4.5 22.9 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.1 0.0 3.0 0.0 6.5 6.3 0.0 0.1 2.7 8.2 0.0 0.0 0.0 0.0 2.1 0.8 49.1 72.7 15.6 70.3 38.5 74.9 33.5 29.0 32.9 9.8 PCSK6 "PACE4, SPC4" ENSG00000140479 "Proprotein convertase subtilisin/kexin type 6" P29122 15 101297142-101525202 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.3;liver: 76.0;lymphoid tissue: 37.4" "Cell line enhanced" "Detected in many" "BEWO: 26.1;CACO-2: 18.3;HEK 293: 27.5;Hep G2: 24.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004774 Uncertain "Secreted to extracellular matrix" 38000 "HPA004774: AB_1079583" "prognostic favourable (9.99e-4)" "unprognostic (1.09e-1)" "unprognostic (4.37e-2)" "unprognostic (2.46e-2)" "unprognostic (9.83e-2)" "unprognostic (8.14e-2)" "unprognostic (2.20e-3)" "unprognostic (8.56e-2)" "unprognostic (2.16e-1)" "unprognostic (2.39e-2)" "unprognostic (3.85e-3)" "unprognostic (2.01e-1)" "prognostic unfavourable (7.06e-7)" "unprognostic (2.02e-1)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-2)" 3.0 1.5 5.1 1.5 25.1 0.9 6.1 4.5 11.5 1.5 8.4 41.9 0.0 3.6 1.4 2.5 4.8 1.9 1.9 10.1 8.9 5.7 1.7 76.0 2.3 4.6 38.8 8.4 4.0 1.7 0.5 3.1 16.5 29.0 1.9 8.2 0.7 1.5 0.7 3.5 4.0 4.8 1.9 69.3 37.4 5.3 6.6 24.5 3.7 1.4 3.5 1.3 1.6 1.6 2.6 0.7 1.9 2.4 7.5 1.4 2.5 8.6 7.0 1.3 0.9 0.1 0.1 26.1 0.5 1.3 0.0 0.1 18.3 4.0 0.2 1.2 0.2 5.9 7.0 0.7 0.1 1.2 27.5 15.0 3.6 24.6 0.8 2.1 0.3 0.4 4.8 0.1 0.2 0.0 11.5 0.2 0.0 4.2 0.1 1.9 3.7 3.0 0.2 0.2 1.9 2.3 12.2 3.5 3.8 12.1 0.9 3.9 1.0 9.5 0.1 0.1 0.7 0.2 0.0 0.3 0.3 0.3 0.1 0.3 3.4 1.3 0.6 1.9 0.6 0.8 0.7 1.1 1.0 0.5 0.2 2.6 1.4 1.3 1.1 7.5 2.4 0.7 0.2 2.5 5.1 25.1 4.5 10.4 8.9 5.7 38.8 8.4 29.0 24.5 PCYT1B "CCT-beta, CTB" ENSG00000102230 "Phosphate cytidylyltransferase 1, choline, beta" Q9Y5K3 X 24558087-24672677 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9;testis: 15.6" "Cell line enhanced" "Detected in some" "AF22: 8.2;CACO-2: 17.6;HEL: 21.6;Hep G2: 9.0;NTERA-2: 9.3;SCLC-21H: 6.4" "Cancer enhanced" "Detected in some" "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.7;neutrophil: 2.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006367 Uncertain "HPA006367: AB_1079585" "unprognostic (4.49e-1)" "unprognostic (2.20e-1)" "unprognostic (1.16e-1)" "unprognostic (7.39e-2)" "unprognostic (9.88e-2)" "unprognostic (6.83e-2)" "unprognostic (5.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.61e-2)" "unprognostic (1.67e-1)" "unprognostic (1.65e-2)" "unprognostic (5.64e-2)" "unprognostic (2.63e-6)" "unprognostic (2.62e-4)" "unprognostic (4.56e-2)" "unprognostic (1.75e-2)" "unprognostic (1.96e-4)" 0.8 1.1 12.0 1.1 11.4 2.0 1.0 3.1 23.9 1.6 1.1 13.7 2.3 1.3 3.2 1.7 2.8 5.7 1.7 4.2 10.0 6.0 1.0 0.6 2.1 0.6 7.8 10.5 4.0 3.1 0.7 1.4 3.6 10.7 2.3 1.3 2.1 1.0 6.4 0.7 0.7 1.1 6.1 10.3 1.0 0.9 15.6 8.7 0.0 0.6 0.0 0.7 0.9 0.4 0.4 0.5 2.7 0.5 0.6 0.2 1.4 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 17.6 0.0 0.0 4.6 0.0 0.9 3.8 0.0 0.0 0.0 0.1 21.6 0.0 9.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.5 9.3 0.0 0.0 1.1 0.0 0.0 0.0 6.4 5.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.0 4.2 0.6 0.2 2.7 0.3 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.4 0.2 0.2 2.2 0.6 0.5 0.5 0.2 1.4 12.0 11.4 3.1 11.3 10.0 6.0 7.8 10.5 10.7 8.7 PDE10A ENSG00000112541 "Phosphodiesterase 10A" Q9Y233 6 165327287-165986603 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Allosteric enzyme, Hydrolase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.8" "Cell line enhanced" "Detected in some" "LHCN-M2: 13.7;RH-30: 8.0;RT4: 8.4;SH-SY5Y: 8.4;TIME: 14.2;U-2 OS: 7.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 36.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 11 "basal ganglia: 307.0" "Group enriched" "Detected in all" 4 "basal ganglia: 155.2;cerebellum: 80.7" "CAB045998, HPA047200" Supported "CAB045998: AB_2162589, HPA047200: " "unprognostic (1.02e-1)" "unprognostic (3.63e-2)" "unprognostic (3.58e-2)" "unprognostic (2.91e-1)" "unprognostic (1.20e-1)" "unprognostic (1.25e-1)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (9.36e-2)" "unprognostic (6.03e-2)" "unprognostic (3.79e-2)" "unprognostic (9.24e-2)" "prognostic unfavourable (4.44e-7)" "unprognostic (3.59e-3)" "unprognostic (2.37e-2)" "unprognostic (3.44e-2)" "unprognostic (5.90e-3)" 3.1 1.9 1.7 1.0 36.8 0.0 3.4 4.5 6.9 2.2 1.0 1.1 4.3 0.8 2.9 7.5 0.7 3.1 3.2 3.6 2.6 2.1 8.8 0.9 4.3 1.4 2.7 1.1 3.4 0.8 1.2 2.5 5.3 1.7 2.6 0.5 0.6 0.7 4.9 0.9 0.6 0.8 4.3 1.1 2.5 1.2 8.7 16.0 0.0 12.2 1.0 0.8 7.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.7 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 3.3 0.0 7.6 0.0 0.5 0.0 0.0 0.1 0.0 0.6 0.0 7.4 0.0 0.0 13.7 0.1 1.1 0.0 1.5 5.5 1.7 8.0 0.0 7.2 8.4 2.2 8.4 0.0 0.0 0.4 0.0 0.0 14.2 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 36.8 4.5 6.9 2.6 2.1 2.7 1.1 1.7 16.0 PDE1A ENSG00000115252 "Phosphodiesterase 1A" P54750 2 182140036-182523192 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.0;kidney: 37.1" "Group enriched" "Detected in some" 5 "ASC diff: 22.3;HHSteC: 13.2;HSkMC: 28.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 6 "amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8" "Low region specificity" "Detected in many" HPA022151 Approved Approved Nucleoplasm Nucleoplasm "HPA022151: AB_1855118" "unprognostic (3.63e-1)" "unprognostic (7.21e-2)" "unprognostic (1.32e-1)" "unprognostic (8.61e-2)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (3.84e-1)" "unprognostic (3.82e-1)" "unprognostic (1.02e-1)" "unprognostic (5.38e-2)" "unprognostic (2.78e-1)" "unprognostic (2.86e-1)" "unprognostic (5.55e-3)" "unprognostic (2.50e-3)" "unprognostic (5.96e-2)" "unprognostic (1.37e-1)" "unprognostic (1.40e-3)" 7.6 3.9 13.8 3.6 11.5 0.5 4.1 66.0 25.3 11.5 8.8 6.2 1.7 2.6 7.3 6.7 4.7 7.4 18.2 11.8 12.6 4.1 37.1 3.2 3.1 1.8 7.1 15.7 9.2 2.0 1.3 2.3 1.3 6.9 3.8 5.6 3.0 1.8 4.8 2.4 2.1 4.6 11.8 10.1 2.6 4.6 24.6 9.0 0.0 35.1 2.6 1.1 8.3 9.0 0.0 1.4 0.8 0.2 0.0 0.0 0.0 0.0 0.1 2.2 0.0 22.3 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 3.1 0.0 13.2 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 4.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 3.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 13.8 11.5 66.0 25.3 12.6 4.1 7.1 15.7 6.9 9.0 PDE1B PDES1B ENSG00000123360 "Phosphodiesterase 1B" Q01064 12 54549350-54579239 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 52.6" "Cell line enhanced" "Detected in some" "HDLM-2: 11.3;HL-60: 6.3;HMC-1: 12.1;NB-4: 8.0;THP-1: 7.7;U-937: 6.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 52.6" "Cell type enriched" "Detected in single" 4 "naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 4 "T-cells: 1.6" "Region enriched" "Detected in all" 6 "basal ganglia: 895.2" "Region enriched" "Detected in all" 7 "basal ganglia: 253.8" HPA018492 Enhanced "HPA018492: AB_1855119" "unprognostic (2.90e-1)" "unprognostic (1.51e-1)" "unprognostic (7.67e-4)" "unprognostic (5.63e-3)" "unprognostic (7.02e-2)" "unprognostic (7.51e-2)" "unprognostic (1.97e-1)" "unprognostic (9.39e-2)" "unprognostic (1.14e-1)" "unprognostic (5.11e-2)" "unprognostic (3.84e-3)" "unprognostic (2.70e-2)" "prognostic unfavourable (4.77e-6)" "unprognostic (6.64e-4)" "unprognostic (2.14e-1)" "unprognostic (3.09e-1)" "unprognostic (2.83e-2)" 12.3 1.4 9.9 4.6 52.6 5.6 2.7 3.1 19.4 2.6 3.7 1.4 0.0 1.2 3.9 2.5 1.7 2.4 2.9 1.9 3.7 3.8 1.3 1.6 2.9 1.6 3.0 9.3 12.5 0.6 11.0 0.5 0.5 5.8 1.0 1.7 0.5 1.3 2.1 0.7 1.0 2.6 4.9 1.2 4.8 2.5 1.1 7.7 0.0 2.7 0.0 1.1 2.8 1.1 0.2 0.3 0.1 0.3 0.1 1.6 0.4 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.1 0.0 0.0 1.8 0.0 0.0 11.3 0.3 4.6 0.0 0.0 0.0 6.3 12.1 0.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.7 8.0 3.3 0.0 2.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 2.4 0.0 6.4 1.2 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 1.6 0.0 0.1 0.1 0.0 0.0 0.0 0.4 9.9 52.6 3.1 19.4 3.7 3.8 3.0 9.3 5.8 7.7 PDE1C Hcam3 ENSG00000154678 "Phosphodiesterase 1C" Q14123 7 31751179-32299329 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.6;heart muscle: 56.2" "Cell line enhanced" "Detected in some" "BJ: 15.0;fHDF/TERT166: 48.3;U-251 MG: 26.1;WM-115: 34.5" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052375 Approved Nucleoplasm Nucleoplasm "HPA052375: " "unprognostic (1.29e-2)" "unprognostic (2.20e-5)" "unprognostic (1.68e-2)" "unprognostic (1.20e-3)" "unprognostic (2.29e-1)" "unprognostic (5.65e-2)" "unprognostic (4.06e-3)" "unprognostic (2.75e-1)" "unprognostic (6.79e-3)" "unprognostic (6.49e-2)" "unprognostic (3.88e-5)" "unprognostic (7.03e-2)" "unprognostic (3.09e-3)" "unprognostic (5.76e-2)" "unprognostic (5.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.06e-3)" 2.9 2.7 10.6 3.2 27.7 0.9 5.1 2.4 17.1 1.2 2.7 30.1 0.0 2.3 3.1 6.8 7.4 8.4 2.4 56.2 14.8 7.5 4.0 1.0 5.0 1.4 31.1 12.0 4.9 2.7 1.3 1.3 4.0 16.3 2.9 2.7 7.9 2.6 4.2 1.4 0.9 2.8 10.4 17.1 1.4 3.8 4.2 33.6 0.0 3.9 0.2 1.0 7.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 5.2 0.0 0.2 0.1 0.0 15.0 6.1 7.1 5.8 0.0 0.0 0.0 0.0 48.3 0.4 0.0 0.0 9.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 10.8 0.6 0.0 1.4 0.0 2.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 7.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.0 2.9 0.1 26.1 0.0 0.0 0.0 0.7 0.1 34.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 27.7 2.4 17.1 14.8 7.5 31.1 12.0 16.3 33.6 PDE2A ENSG00000186642 "Phosphodiesterase 2A" O00408 11 72576141-72674591 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.0;lymphoid tissue: 65.4" "Cell line enriched" "Detected in some" 8 "HeLa: 105.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 30.4;basal ganglia: 34.2;cerebral cortex: 48.0;hippocampal formation: 18.0;olfactory region: 27.0" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.7;T-cells: 9.6" "Group enriched" "Detected in many" 5 "amygdala: 111.5;basal ganglia: 166.3;cerebral cortex: 98.9;hippocampal formation: 120.9" "CAB009752, HPA031192" Enhanced Supported Cytosol Cytosol "CAB009752: AB_2268159, HPA031192: " "unprognostic (1.92e-1)" "unprognostic (1.52e-3)" "unprognostic (4.58e-2)" "unprognostic (1.49e-1)" "unprognostic (1.26e-1)" "unprognostic (2.50e-1)" "prognostic favourable (1.76e-6)" "unprognostic (3.06e-2)" "unprognostic (1.35e-1)" "unprognostic (3.01e-3)" "unprognostic (3.13e-3)" "unprognostic (1.50e-2)" "unprognostic (1.77e-2)" "unprognostic (2.85e-3)" "unprognostic (6.31e-2)" "unprognostic (7.72e-2)" "unprognostic (7.96e-4)" 27.8 18.4 30.4 3.0 34.2 2.5 25.4 1.0 48.0 8.9 7.7 3.8 1.9 3.5 9.4 4.9 10.2 11.6 12.0 11.3 18.0 6.1 7.0 10.4 5.1 3.8 3.8 27.0 3.4 2.4 4.4 3.4 6.6 6.7 4.8 5.2 3.0 2.3 6.3 6.6 4.8 4.2 10.3 2.1 65.4 4.2 2.9 7.4 0.1 7.0 3.9 2.2 8.3 11.2 3.7 1.2 0.2 1.0 0.1 9.6 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 2.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 105.0 0.1 0.2 0.0 1.6 0.0 0.2 0.5 4.3 2.3 0.1 0.1 0.0 0.0 0.0 0.0 1.5 2.9 0.0 0.0 0.2 0.0 0.0 9.4 0.5 0.0 0.0 0.4 0.0 0.0 13.4 0.0 2.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.8 0.0 9.6 1.0 5.6 3.7 5.7 5.6 1.2 2.5 3.7 3.0 0.2 0.1 0.5 0.0 2.3 1.9 30.4 34.2 1.0 48.0 18.0 6.1 3.8 27.0 6.7 7.4 PDE4A DPDE2 ENSG00000065989 "Phosphodiesterase 4A" P27815 19 10416773-10469631 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.5;testis: 31.8" "Cell line enhanced" "Detected in many" "HMC-1: 21.6;NB-4: 24.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017632, HPA043310, HPA076091" Uncertain Supported "Plasma membrane" "Plasma membrane" "CAB017632: AB_1127109, HPA043310: , HPA076091: " "unprognostic (1.29e-2)" "unprognostic (3.98e-2)" "unprognostic (8.91e-2)" "unprognostic (1.82e-1)" "unprognostic (7.00e-2)" "unprognostic (6.84e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-2)" "unprognostic (6.90e-2)" "unprognostic (2.41e-1)" "unprognostic (2.27e-2)" "unprognostic (1.64e-2)" "unprognostic (2.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.15e-1)" 6.4 2.5 9.0 4.2 13.9 3.4 6.3 15.0 38.5 8.4 4.3 3.2 0.4 2.0 4.4 1.1 3.1 4.8 5.0 4.1 12.4 6.9 2.8 1.9 7.7 2.0 5.3 19.4 1.7 9.8 17.3 2.3 4.9 34.7 3.7 3.0 3.1 7.1 4.0 26.1 2.2 2.7 4.7 3.6 4.1 6.1 31.8 4.5 0.0 5.4 1.0 1.9 4.6 3.5 0.2 3.3 5.9 4.4 5.3 2.0 1.3 0.0 1.4 0.3 3.9 11.4 6.8 2.2 3.2 6.5 0.4 1.1 3.4 3.1 1.4 9.6 8.4 0.3 2.2 0.4 0.2 3.7 3.2 13.4 4.7 3.7 7.4 2.2 21.6 5.0 0.4 3.6 0.0 3.1 10.5 3.2 2.3 0.9 1.3 24.9 1.7 2.8 8.8 2.2 11.5 0.5 0.8 2.5 0.9 0.2 0.1 3.5 0.5 4.4 6.5 4.9 6.3 3.3 2.0 6.4 0.5 7.1 2.1 0.1 3.9 5.9 2.6 5.1 1.5 4.4 0.8 0.2 0.5 2.0 3.3 0.1 0.1 0.7 0.2 5.3 4.4 0.2 1.2 1.3 9.0 13.9 15.0 38.5 12.4 6.9 5.3 19.4 34.7 4.5 PDE6B "CSNB3, CSNBAD2, PDEB, rd1, RP40" ENSG00000133256 "Phosphodiesterase 6B" P35913 4 625584-670782 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Congenital stationary night blindness, Disease mutation, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2;retina: 64.2" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;MOLT-4: 20.5;REH: 11.1;SCLC-21H: 14.0;SH-SY5Y: 8.2;U-266/84: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA054148, HPA059929" Enhanced Approved Cytosol Cytosol "HPA054148: , HPA059929: " "unprognostic (2.43e-2)" "unprognostic (1.33e-4)" "unprognostic (2.45e-4)" "unprognostic (7.18e-3)" "unprognostic (1.88e-2)" "unprognostic (5.04e-3)" "unprognostic (7.32e-3)" "prognostic favourable (5.34e-4)" "unprognostic (9.70e-2)" "unprognostic (1.14e-1)" "unprognostic (1.37e-2)" "unprognostic (2.33e-2)" "unprognostic (4.09e-2)" "unprognostic (1.67e-2)" "unprognostic (2.26e-1)" "unprognostic (2.41e-3)" "unprognostic (1.85e-1)" 1.6 1.9 12.1 4.6 19.1 6.7 3.8 2.3 13.2 2.3 1.3 30.2 1.5 0.8 2.5 3.9 1.4 9.6 3.2 5.2 18.1 10.2 4.6 0.7 4.2 12.0 29.6 9.8 2.6 1.4 9.1 3.2 2.6 14.5 2.5 1.0 64.2 3.5 2.9 0.7 1.8 2.2 2.1 20.2 8.7 2.5 3.6 22.4 4.3 11.4 0.2 8.3 4.1 1.1 16.5 14.1 11.2 5.8 10.2 13.1 7.1 0.0 0.2 0.8 0.4 0.2 0.3 0.2 0.0 0.0 0.5 1.4 0.0 0.1 0.2 8.0 0.2 0.1 1.7 0.4 0.0 0.1 0.0 0.6 0.2 0.0 4.1 0.1 0.3 0.5 0.1 2.4 0.0 0.7 0.1 0.6 0.0 0.2 20.5 0.2 6.5 0.2 11.1 0.2 0.4 1.4 0.9 14.0 8.2 0.0 0.3 0.1 0.4 0.0 0.2 0.1 0.8 0.1 0.3 5.4 15.2 0.2 0.2 0.2 0.1 11.2 4.2 0.6 11.5 5.8 10.5 10.0 7.7 7.9 6.6 16.5 12.2 13.1 1.1 10.2 5.6 14.1 11.4 7.1 12.1 19.1 2.3 10.0 18.1 10.2 29.6 9.8 14.5 22.4 PDP1 "PDH, PDP, PPM2A, PPM2C" ENSG00000164951 "Pyruvate dehyrogenase phosphatase catalytic subunit 1" Q9P0J1 8 93857807-93926066 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 33.2;TIME: 33.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018483, HPA019081, HPA021152" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635" "prognostic unfavourable (8.61e-5)" "unprognostic (4.62e-1)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.46e-2)" "unprognostic (1.38e-1)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (3.25e-1)" "prognostic favourable (8.42e-9)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (5.04e-2)" "unprognostic (1.67e-1)" 5.1 32.3 11.0 4.6 38.9 5.9 7.9 7.5 62.2 7.5 4.3 4.7 1.6 3.3 7.7 8.6 8.0 6.1 9.6 22.9 10.1 8.0 6.3 2.2 6.0 5.6 5.1 32.5 9.7 9.3 20.6 4.2 6.6 4.4 5.2 6.2 4.4 6.6 4.7 31.8 3.2 5.5 5.5 3.4 5.8 5.5 12.9 4.8 4.1 9.3 7.0 5.8 7.7 5.1 11.0 12.7 7.8 21.5 2.8 19.5 8.8 8.9 4.4 9.6 4.0 8.0 14.6 3.2 7.0 7.8 8.3 9.8 4.6 33.2 5.0 23.7 11.2 19.9 4.1 5.9 12.3 0.5 2.0 2.3 5.5 1.6 9.1 1.1 3.3 9.4 11.8 14.1 22.6 18.7 0.8 8.2 10.1 2.1 6.9 3.6 4.4 5.7 1.7 5.7 0.9 5.7 6.2 0.8 4.2 4.6 0.5 21.6 1.5 1.4 33.2 10.1 6.5 23.6 8.3 4.6 1.9 4.2 12.9 4.2 8.9 3.1 15.4 7.8 5.6 14.3 5.3 9.3 9.1 7.2 12.7 11.0 5.5 4.8 1.8 2.8 21.5 2.1 19.5 8.8 11.0 38.9 7.5 62.2 10.1 8.0 5.1 32.5 4.4 4.8 PDXP "CIN, dJ37E16.5, FLJ32703" ENSG00000241360 "Pyridoxal phosphatase" Q96GD0 22 37658727-37666934 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.4;liver: 34.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 12.9" "Lineage enriched" "Detected in many" 8 "dendritic cells: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000531 Approved 17000 "HPA000531: " "unprognostic (6.29e-2)" "unprognostic (7.89e-3)" "unprognostic (1.00e-1)" "unprognostic (2.89e-1)" "unprognostic (2.15e-2)" "unprognostic (3.25e-2)" "unprognostic (2.81e-1)" "unprognostic (4.44e-2)" "unprognostic (2.54e-1)" "unprognostic (1.46e-1)" "unprognostic (1.57e-3)" "unprognostic (2.76e-2)" "unprognostic (1.77e-1)" "unprognostic (3.03e-3)" "unprognostic (2.04e-1)" "unprognostic (4.66e-2)" "unprognostic (2.38e-1)" 2.4 14.8 43.5 1.7 32.0 3.0 2.5 24.9 55.4 1.7 8.3 5.3 0.8 15.4 3.7 4.1 1.0 3.4 2.7 12.9 38.1 27.7 10.2 34.7 1.3 3.9 16.4 15.8 3.5 8.4 6.1 7.9 1.0 13.6 3.3 7.6 3.8 7.1 4.2 5.7 0.9 15.8 4.8 9.1 2.6 3.3 10.4 4.6 4.2 3.4 1.0 5.4 2.2 0.7 1.5 12.9 0.5 0.4 0.8 0.9 0.1 2.8 6.7 14.0 12.2 4.4 1.1 1.7 6.6 3.1 12.0 9.4 2.5 0.2 18.2 6.8 3.2 1.4 18.9 0.1 10.3 5.5 37.5 3.1 9.6 13.6 2.8 12.4 15.3 0.4 1.2 5.8 8.6 5.5 11.1 11.0 10.7 2.3 25.4 20.8 7.1 16.5 19.8 10.1 13.4 5.2 0.3 32.6 20.6 6.3 5.3 11.6 1.3 9.9 3.2 10.4 13.0 11.0 13.2 11.4 14.5 19.4 9.8 4.0 13.1 0.0 0.3 0.5 0.9 0.4 0.1 1.5 0.3 0.6 0.6 1.4 0.3 0.1 0.4 0.8 0.2 12.9 0.3 0.1 43.5 32.0 24.9 50.6 38.1 27.7 16.4 15.8 13.6 4.6 PDYN "ADCA, PENKB, SCA23" ENSG00000101327 Prodynorphin P01213 20 1978757-1994285 "Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters" "Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 55.9" "Cell line enhanced" "Detected in some" "AF22: 1.5;NTERA-2: 2.8;THP-1: 2.6" "Group enriched" "Detected in some" 29 "glioma: 2.6;ovarian cancer: 1.6" "Region enriched" "Detected in many" 4 "basal ganglia: 55.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 150.7;hypothalamus: 70.9" "Region enhanced" "Detected in many" "basal ganglia: 131.1" "HPA053342, CAB079777" Enhanced Supported "Secreted in brain" "CAB079777: , HPA053342: " "unprognostic (7.00e-2)" "unprognostic (1.07e-1)" "unprognostic (1.40e-1)" "unprognostic (3.73e-2)" 0.4 0.4 13.2 0.4 55.9 0.4 0.4 0.0 40.3 0.4 0.4 1.2 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 5.0 3.9 0.4 0.4 0.4 0.4 0.7 3.7 0.4 0.4 0.4 0.0 0.4 0.2 0.4 0.4 0.0 0.4 0.4 0.4 0.6 0.4 0.4 2.2 0.4 0.4 3.2 1.1 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 55.9 0.0 3.8 5.0 3.9 0.7 3.7 0.2 1.1 PDZD2 "KIAA0300, PDZK3" ENSG00000133401 "PDZ domain containing 2" O15018 5 31639410-32110931 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.8" "Cell line enhanced" "Detected in some" "BEWO: 8.9;SiHa: 12.4;SK-BR-3: 11.5;T-47d: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020784, HPA036503, HPA036504, HPA064387, HPA076072" Uncertain Approved "Plasma membrane,Cytosol" "Intracellular and membrane" Cytosol "Plasma membrane" "CAB020784: , HPA036503: , HPA036504: , HPA064387: , HPA076072: " "unprognostic (3.65e-2)" "unprognostic (4.06e-2)" "unprognostic (6.63e-2)" "unprognostic (5.42e-5)" "unprognostic (2.39e-1)" "unprognostic (9.67e-3)" "unprognostic (2.55e-1)" "unprognostic (6.49e-2)" "unprognostic (3.38e-2)" "unprognostic (2.45e-2)" "unprognostic (1.71e-2)" "unprognostic (1.93e-1)" "unprognostic (2.33e-3)" "unprognostic (4.13e-2)" "unprognostic (6.92e-2)" "unprognostic (7.67e-2)" "unprognostic (1.79e-1)" 16.3 1.3 7.8 1.0 28.8 0.3 5.6 3.6 18.1 2.9 1.9 5.1 2.4 0.8 3.0 7.4 6.1 2.8 1.2 19.6 6.6 4.8 9.5 0.4 10.0 0.5 5.4 8.8 16.7 1.5 0.8 2.6 11.9 11.5 2.0 1.1 4.3 2.3 2.5 2.6 11.1 1.1 2.9 3.2 0.5 2.0 6.2 6.1 0.3 1.3 0.7 2.0 1.1 2.9 0.4 0.7 0.7 0.6 0.2 1.0 0.0 0.1 0.0 3.4 0.1 0.0 0.0 8.9 0.0 0.0 0.6 0.6 0.0 0.0 0.0 5.0 0.0 4.7 1.8 1.0 0.0 0.0 0.4 0.0 2.7 0.0 0.0 0.0 2.7 0.3 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.8 0.0 0.0 0.0 3.9 0.1 0.1 0.8 12.4 11.5 0.0 6.0 0.0 0.0 0.0 2.4 0.0 0.5 0.0 0.0 2.9 0.0 0.0 1.2 0.4 0.5 0.4 0.5 0.1 1.0 0.1 0.3 0.1 0.1 0.4 0.1 0.1 0.7 0.2 0.6 0.7 0.0 0.0 7.8 28.8 3.6 18.1 6.6 4.8 5.4 8.8 11.5 6.1 PDZD4 "FLJ34125, KIAA1444, LNX5, LU1, PDZK4, PDZRN4L" ENSG00000067840 "PDZ domain containing 4" Q76G19 X 153802166-153830565 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 71.6" "Cell line enhanced" "Detected in some" "AF22: 15.8;NTERA-2: 8.0;RH-30: 11.3;SCLC-21H: 19.2;SH-SY5Y: 18.7;U-2 OS: 9.4" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.5" "Group enriched" "Detected in many" 25 "NK-cells: 1.5;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003878 Enhanced "HPA003878: AB_2162807" "unprognostic (9.18e-3)" "unprognostic (1.25e-1)" "unprognostic (1.11e-4)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (1.85e-2)" "unprognostic (1.92e-3)" "unprognostic (2.17e-1)" "unprognostic (2.32e-3)" "unprognostic (5.90e-2)" "prognostic favourable (2.96e-5)" "unprognostic (2.27e-1)" "unprognostic (2.54e-4)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.83e-2)" "unprognostic (2.87e-2)" 3.3 5.8 42.8 2.6 36.7 2.5 2.0 40.1 71.6 2.3 3.5 5.1 0.4 2.5 4.4 2.2 3.3 7.9 2.8 3.3 40.8 14.8 1.6 1.7 3.0 2.6 9.9 24.9 1.7 2.6 1.5 7.4 1.2 9.0 4.5 2.3 1.8 4.3 10.5 3.6 4.8 3.3 5.0 7.0 7.0 2.3 3.4 6.4 0.0 1.6 0.0 1.6 2.4 1.4 0.0 0.0 0.0 0.0 1.5 3.5 0.6 0.0 1.0 15.8 4.1 0.0 0.1 0.0 0.4 0.0 0.5 0.5 0.4 0.0 0.0 0.2 0.0 0.1 2.8 0.0 0.1 0.0 0.5 0.0 1.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.1 0.1 0.5 8.0 0.2 0.0 11.3 0.0 0.0 0.0 19.2 18.7 0.8 0.0 5.6 1.8 0.1 0.0 0.0 9.4 0.2 1.1 0.0 0.0 0.0 0.1 0.0 5.0 0.0 0.0 0.0 3.5 0.0 0.8 0.0 1.5 2.0 0.0 0.0 0.1 0.9 0.0 1.5 0.0 0.0 0.0 0.6 42.8 36.7 40.1 49.2 40.8 14.8 9.9 24.9 9.0 6.4 PDZD7 "bA108L7.8, DFNB57, FLJ23209, PDZK7" ENSG00000186862 "PDZ domain containing 7" Q9H5P4 10 101007683-101032295 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;intestine: 25.3" "Cell line enhanced" "Detected in many" "SCLC-21H: 11.9;THP-1: 17.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074542 Supported Nucleoplasm Nucleoplasm "HPA074542: " "unprognostic (1.46e-1)" "unprognostic (2.85e-3)" "unprognostic (3.96e-2)" "unprognostic (2.10e-1)" "unprognostic (2.15e-2)" "unprognostic (2.83e-2)" "unprognostic (1.38e-2)" "unprognostic (5.31e-2)" "unprognostic (2.52e-2)" "unprognostic (2.95e-2)" "unprognostic (2.45e-1)" "unprognostic (1.87e-3)" "unprognostic (3.54e-3)" "unprognostic (3.89e-1)" "unprognostic (1.79e-1)" "unprognostic (3.51e-2)" "unprognostic (2.80e-1)" 2.4 2.3 7.0 1.7 10.7 2.4 0.9 15.9 11.6 0.8 3.4 2.4 0.0 17.4 2.5 1.9 1.0 1.1 3.0 1.2 6.3 7.8 2.2 0.7 1.9 1.6 12.5 8.3 1.4 1.7 3.8 6.2 1.8 17.7 1.5 0.7 1.1 2.1 1.2 1.4 3.8 25.3 2.0 9.1 2.6 1.9 2.1 4.8 0.0 2.2 0.0 0.6 1.3 1.0 1.3 0.7 6.9 2.1 2.3 1.5 0.6 7.3 1.0 0.5 0.8 0.9 0.2 2.5 1.3 0.7 0.0 0.4 1.7 1.9 3.6 3.5 0.3 2.3 0.2 0.7 0.0 1.0 2.4 0.2 3.5 2.3 0.6 0.6 3.3 0.4 0.3 0.2 0.2 0.3 0.6 0.9 0.1 1.8 0.5 1.4 0.6 2.6 1.6 1.0 0.4 1.8 0.8 11.9 5.5 0.8 0.4 1.2 2.5 17.4 0.5 1.2 2.6 1.4 1.1 1.5 0.1 0.3 6.5 1.3 0.7 2.9 2.1 1.5 1.0 1.3 1.0 1.1 0.9 1.3 0.4 1.3 1.5 0.8 6.9 2.3 0.8 0.7 0.6 0.6 7.0 10.7 15.9 11.6 6.3 7.8 12.5 8.3 17.7 4.8 PEA15 "HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15" ENSG00000162734 "Proliferation and apoptosis adaptor protein 15" Q15121 1 160205337-160215376 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 199.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 30.6" "Group enriched" "Detected in all" 6 "B-cells: 7.6;dendritic cells: 22.1;monocytes: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028356, HPA070820" Enhanced Approved Nucleoplasm,Cytosol 240000 "Nucleoplasm, Cytosol" "HPA028356: AB_10602814, HPA070820: " "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (1.64e-2)" "unprognostic (1.99e-3)" "unprognostic (6.10e-2)" "unprognostic (4.57e-1)" "unprognostic (1.25e-1)" "unprognostic (6.31e-2)" "unprognostic (4.07e-2)" "prognostic unfavourable (6.53e-7)" "unprognostic (2.60e-2)" "unprognostic (1.39e-1)" "unprognostic (2.82e-3)" "unprognostic (1.24e-1)" 45.3 20.4 105.3 28.7 83.6 3.8 25.3 30.5 173.1 25.1 15.5 68.1 5.0 8.0 21.5 21.8 22.6 19.2 22.1 53.9 70.5 81.3 14.8 10.4 23.8 16.6 106.5 67.0 19.7 9.7 14.9 10.2 25.1 74.1 24.4 15.3 18.2 12.3 31.1 10.2 16.9 8.8 47.4 199.4 23.8 10.0 17.5 53.7 1.6 12.6 6.0 22.9 22.4 17.5 7.6 22.1 1.8 30.6 3.1 3.5 5.4 16.7 5.8 24.3 10.5 45.1 25.3 8.1 72.8 63.6 60.6 42.6 12.8 9.1 7.8 26.4 90.8 18.3 9.0 22.8 47.4 4.2 5.0 6.4 4.1 3.2 55.7 2.1 7.9 21.2 12.9 33.3 42.5 45.5 6.6 14.3 81.0 8.3 2.5 5.0 16.1 16.8 4.2 25.6 5.3 22.0 8.8 4.8 12.9 38.6 26.4 22.2 16.2 15.1 60.6 40.3 31.6 30.0 31.2 11.3 6.9 14.8 37.1 4.1 57.0 0.3 15.3 1.8 3.5 30.6 2.7 7.6 2.6 2.8 22.1 5.0 1.6 1.8 0.7 3.1 13.9 9.7 2.9 5.4 105.3 83.6 30.5 78.2 70.5 81.3 106.5 67.0 74.1 53.7 PEG10 "HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1" ENSG00000242265 "Paternally expressed 10" Q86TG7 7 94656325-94669695 "Predicted intracellular proteins" "Apoptosis, Differentiation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4" "Cell line enhanced" "Detected in many" "AF22: 93.1;HAP1: 120.8;Hep G2: 93.1;SCLC-21H: 59.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 143.8" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 130.3" "Low region specificity" "Detected in all" "HPA021324, HPA029915, HPA051038" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA021324: AB_1855181, HPA029915: , HPA051038: " "unprognostic (1.03e-1)" "unprognostic (2.98e-2)" "unprognostic (1.38e-1)" "prognostic unfavourable (8.15e-4)" "unprognostic (1.06e-1)" "unprognostic (5.70e-3)" "unprognostic (9.70e-3)" "unprognostic (2.61e-3)" "unprognostic (5.43e-2)" "unprognostic (1.68e-2)" "unprognostic (1.99e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-2)" "unprognostic (5.48e-2)" "unprognostic (6.01e-2)" "unprognostic (2.40e-2)" 2.3 67.5 32.0 2.1 143.8 1.4 10.6 25.6 16.8 4.2 2.1 7.4 0.0 1.5 3.3 1.9 2.0 5.1 2.4 1.8 21.0 47.0 4.0 2.0 7.3 2.9 13.1 21.3 27.0 5.4 2.3 102.6 171.4 27.4 2.2 1.9 1.8 4.3 2.2 1.9 1.4 1.6 2.6 14.4 1.8 2.1 19.8 11.1 1.5 5.4 0.0 2.3 1.8 1.0 2.6 0.0 0.0 0.0 2.7 0.7 0.2 2.6 13.1 93.1 39.3 1.9 3.5 5.4 7.1 4.2 5.1 7.0 21.8 4.3 0.2 0.2 8.2 0.8 120.8 5.0 7.2 0.3 12.7 0.0 15.0 93.1 1.4 14.8 0.0 7.8 1.6 12.7 8.9 3.0 0.0 29.1 10.0 0.6 0.0 0.0 42.6 8.4 5.6 29.8 7.8 23.4 9.7 59.1 3.4 0.0 2.0 7.0 12.6 0.0 0.0 4.1 0.2 0.5 5.4 7.8 5.2 11.6 9.3 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.7 0.0 2.6 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.2 32.0 143.8 25.6 14.4 21.0 47.0 13.1 21.3 27.4 11.1 PEG3 "KIAA0287, ZKSCAN22, ZNF904, ZSCAN24" ENSG00000198300 "Paternally expressed 3" Q9GZU2 19 56810083-56840728 "Predicted intracellular proteins, Transcription factors" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.0;ovary: 106.4;placenta: 49.8" "Group enriched" "Detected in some" 5 "BEWO: 31.4;Hep G2: 63.9;RH-30: 21.9" "Cancer enhanced" "Detected in many" "testis cancer: 9.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 1.3;plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.3" "Low region specificity" "Detected in all" HPA026070 Approved Supported Nucleoplasm Nucleoplasm "HPA026070: AB_10603328" "unprognostic (1.38e-2)" "unprognostic (1.90e-2)" "unprognostic (1.20e-1)" "unprognostic (7.12e-2)" "unprognostic (1.58e-1)" "unprognostic (4.84e-2)" "unprognostic (4.84e-2)" "unprognostic (4.44e-2)" "unprognostic (9.16e-2)" "unprognostic (1.21e-1)" "unprognostic (1.82e-3)" "unprognostic (9.92e-2)" "unprognostic (2.48e-5)" "unprognostic (6.92e-3)" "unprognostic (2.19e-1)" "prognostic unfavourable (1.56e-4)" "unprognostic (6.68e-3)" 2.0 29.8 10.1 1.0 51.0 0.5 4.5 9.8 22.4 4.1 2.4 5.9 0.0 0.7 9.1 2.6 1.7 5.8 1.2 2.3 9.7 9.6 1.8 2.1 1.7 0.7 3.5 16.0 106.4 1.9 7.3 24.6 49.8 21.3 1.8 1.2 0.4 2.3 2.5 1.7 1.8 1.7 4.1 4.8 1.6 2.0 12.3 7.3 0.0 2.7 0.0 2.7 2.6 2.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.9 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.1 0.0 21.9 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 10.1 51.0 9.8 22.4 9.7 9.6 3.5 16.0 21.3 7.3 PENK ENSG00000181195 Proenkephalin P01210 8 56436674-56446734 "Plasma proteins, Predicted secreted proteins, Transporters" "Endorphin, Neuropeptide, Opioid peptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 124.3;brain: 171.5" "Cell line enhanced" "Detected in some" "ASC diff: 16.2;ASC TERT1: 9.7;BJ: 9.0;THP-1: 8.4" "Cancer enhanced" "Detected in many" "lung cancer: 4.5" "Region enriched" "Detected in many" 12 "basal ganglia: 171.5" "Cell type enhanced" "Detected in some" "naive B-cell: 3.1" "Group enriched" "Detected in many" 19 "B-cells: 3.1;dendritic cells: 1.2;monocytes: 1.2" "Region enriched" "Detected in all" 7 "basal ganglia: 3244.3" "Region enriched" "Detected in many" 7 "basal ganglia: 1049.6" "HPA013138, CAB016390" Enhanced "Secreted in other tissues" 35000 "CAB016390: AB_2161515, HPA013138: AB_1855191" "unprognostic (6.89e-2)" "unprognostic (1.21e-1)" "unprognostic (2.71e-2)" "unprognostic (1.17e-3)" "unprognostic (1.56e-2)" "unprognostic (3.58e-3)" "unprognostic (1.31e-2)" "unprognostic (3.60e-1)" "unprognostic (6.34e-2)" "unprognostic (5.73e-2)" "unprognostic (3.47e-2)" "unprognostic (4.24e-2)" "unprognostic (1.73e-3)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (3.98e-3)" 2.5 124.3 2.8 1.7 171.5 0.3 0.9 3.9 7.8 14.3 2.2 0.9 0.1 0.6 3.0 0.9 0.9 2.6 4.0 9.1 1.2 9.1 0.3 0.2 1.0 0.3 2.5 0.4 8.2 0.6 0.2 1.5 1.1 8.4 11.7 0.9 2.2 0.9 8.1 1.1 0.5 0.9 1.7 7.0 0.3 1.1 29.9 14.7 0.0 0.6 0.3 0.3 0.5 0.6 3.1 1.2 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 16.2 9.7 0.0 9.0 2.9 1.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 3.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 2.8 171.5 3.9 7.8 1.2 9.1 2.5 0.4 8.4 14.7 PEX5L "PEX5R, PXR2, TRIP8b" ENSG00000114757 "Peroxisomal biogenesis factor 5 like" Q8IYB4 3 179794958-180037053 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 41.9;parathyroid gland: 60.1" "Group enriched" "Detected in some" 4 "HDLM-2: 5.6;MOLT-4: 19.8;RPMI-8226: 15.8;SCLC-21H: 9.7;U-266/70: 12.7" "Cancer enhanced" "Detected in some" "glioma: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058026 Enhanced "HPA058026: " "unprognostic (5.21e-2)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (1.36e-2)" "unprognostic (2.93e-1)" "unprognostic (1.82e-3)" "unprognostic (2.68e-2)" "unprognostic (1.52e-2)" "unprognostic (2.10e-1)" "unprognostic (3.33e-4)" "unprognostic (9.67e-5)" "unprognostic (3.84e-1)" "unprognostic (2.66e-10)" "unprognostic (2.27e-3)" "unprognostic (1.45e-2)" "unprognostic (1.69e-2)" "unprognostic (4.03e-3)" 1.3 1.4 17.0 1.3 26.6 1.2 1.2 1.8 41.9 1.3 1.2 24.5 0.0 1.3 1.2 1.5 1.3 1.4 1.2 1.3 16.9 8.1 1.3 1.2 1.3 1.2 38.4 18.9 2.9 10.6 60.1 5.3 1.1 24.1 1.4 1.2 0.0 1.3 1.2 1.4 1.2 1.3 1.1 32.3 1.2 1.3 5.4 36.5 0.0 1.3 0.0 1.2 1.2 0.4 0.8 0.4 0.8 0.1 0.4 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 5.6 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.1 0.0 0.0 1.0 0.0 0.0 2.9 0.0 0.0 19.8 0.0 1.2 0.2 0.1 0.0 15.8 0.0 0.0 9.7 0.5 0.0 0.0 0.0 0.0 1.5 0.0 2.0 0.1 0.0 0.5 12.7 0.4 0.0 0.3 0.1 0.5 0.6 0.1 0.2 0.6 0.1 0.5 0.0 0.1 0.0 0.0 0.8 0.2 0.3 0.8 0.4 0.1 0.4 0.0 0.0 17.0 26.6 1.8 26.0 16.9 8.1 38.4 18.9 24.1 36.5 PFN2 ENSG00000070087 "Profilin 2" P35080 3 149964904-150050788 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 89.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035611, CAB037073" Enhanced "CAB037073: AB_1079600, HPA035611: AB_10672870" "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.07e-3)" "prognostic unfavourable (2.93e-4)" "unprognostic (1.77e-2)" "prognostic unfavourable (3.42e-4)" "prognostic unfavourable (2.19e-7)" "unprognostic (4.11e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-2)" "unprognostic (2.96e-3)" "unprognostic (4.86e-3)" "unprognostic (6.82e-2)" "unprognostic (1.25e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.99e-1)" 9.2 13.9 59.1 6.7 49.6 1.3 12.8 35.1 89.7 14.5 10.3 22.8 11.6 8.8 21.4 54.1 9.0 33.8 12.5 15.4 64.8 39.9 39.8 8.7 6.6 2.6 36.1 44.6 21.8 11.7 15.7 12.9 7.4 33.6 23.4 10.0 11.7 15.8 23.9 75.0 2.9 11.7 20.5 30.5 5.5 8.5 9.4 15.9 2.3 34.4 9.1 3.7 15.2 6.8 2.7 0.3 1.5 0.3 1.6 9.7 3.1 76.8 26.8 64.6 26.4 14.4 49.4 17.3 24.7 37.6 39.1 45.5 10.0 62.2 0.0 52.3 54.0 0.8 26.8 35.1 56.8 2.4 15.9 0.9 14.6 28.6 19.3 4.3 1.2 31.0 29.8 38.3 50.0 22.7 0.2 3.1 40.5 28.5 3.7 0.2 28.2 35.6 4.3 48.0 0.3 28.8 39.3 35.2 36.3 12.2 5.9 33.2 9.4 0.6 16.4 18.6 26.2 31.0 31.8 4.1 0.3 2.0 40.4 0.2 22.7 1.2 0.3 0.5 2.9 0.1 6.0 2.7 6.3 5.3 0.1 1.5 9.7 5.7 1.5 1.6 0.1 0.3 1.6 3.1 59.1 49.6 35.1 87.5 64.8 39.9 36.1 44.6 33.6 15.9 PGBD5 "DKFZp761A0620, FLJ11413" ENSG00000177614 "PiggyBac transposable element derived 5" Q8N414 1 230314482-230426371 "Disease related genes, Predicted intracellular proteins" Transposition "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.0;cervix, uterine: 21.9;pancreas: 21.6" "Cell line enhanced" "Detected in some" "Daudi: 17.7;NTERA-2: 18.1;RH-30: 9.8;SCLC-21H: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065010 Approved Nucleoplasm Nucleoplasm "HPA065010: " "unprognostic (2.00e-2)" "unprognostic (4.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.61e-2)" "prognostic unfavourable (8.78e-5)" "unprognostic (1.44e-2)" "unprognostic (4.66e-2)" "unprognostic (4.91e-2)" "unprognostic (3.97e-1)" "unprognostic (1.15e-1)" "unprognostic (7.48e-3)" "unprognostic (2.57e-1)" "unprognostic (3.29e-2)" "unprognostic (6.69e-2)" "unprognostic (2.12e-1)" "unprognostic (3.13e-3)" "unprognostic (2.51e-1)" 0.8 10.8 16.0 0.8 14.1 0.6 0.7 17.9 27.0 21.9 1.5 6.0 0.1 1.0 5.8 0.5 1.8 5.6 2.2 13.3 20.0 8.0 1.5 2.8 1.8 0.9 7.1 8.9 0.9 21.6 0.9 4.0 2.6 8.0 1.4 1.3 1.0 3.2 1.2 2.8 0.9 1.0 3.0 5.0 2.6 1.6 5.8 4.6 0.5 6.0 0.6 5.1 1.6 1.5 0.8 0.6 1.5 0.6 0.6 0.6 0.2 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 4.0 0.0 17.7 1.7 0.0 3.3 1.4 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.1 3.6 18.1 0.1 0.0 9.8 2.8 2.1 0.0 25.0 4.7 0.6 0.0 0.2 0.2 6.1 0.0 0.0 1.5 0.0 1.4 7.6 5.7 0.0 0.0 1.5 0.2 1.5 0.6 1.2 0.6 0.6 0.5 0.4 0.5 0.4 0.4 0.8 0.6 0.6 1.2 0.6 0.6 0.6 0.4 0.2 16.0 14.1 17.9 23.8 20.0 8.0 7.1 8.9 8.0 4.6 PGM2L1 "BM32A, FLJ32029" ENSG00000165434 "Phosphoglucomutase 2 like 1" Q6PCE3 11 74330318-74398473 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 48.6" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 13.1;LHCN-M2: 15.7;RH-30: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056995, HPA060948" Enhanced Approved Mitochondria 64000 Mitochondria "HPA056995: , HPA060948: " "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" "unprognostic (7.28e-3)" "unprognostic (8.91e-2)" "unprognostic (6.16e-2)" "unprognostic (1.55e-1)" "unprognostic (7.16e-6)" "unprognostic (1.43e-1)" "unprognostic (1.95e-1)" "unprognostic (5.97e-3)" "unprognostic (1.70e-2)" "unprognostic (2.98e-1)" "unprognostic (9.33e-3)" "unprognostic (3.71e-1)" "unprognostic (1.97e-1)" "unprognostic (3.04e-1)" "unprognostic (1.03e-2)" 3.0 4.0 30.6 4.9 19.8 4.0 3.2 6.3 48.6 6.1 4.5 1.3 1.0 2.3 6.1 1.9 2.1 4.7 4.8 1.6 30.1 15.1 2.5 2.1 2.7 4.0 9.7 20.4 1.7 4.4 1.4 4.5 2.1 11.7 3.8 5.1 2.9 3.2 2.5 7.1 1.7 2.6 5.6 2.6 2.5 3.4 2.3 0.3 10.0 4.1 1.3 4.0 5.2 2.6 2.4 1.7 2.5 0.6 3.0 7.5 1.1 2.0 2.9 11.5 2.1 3.5 1.5 0.3 2.7 2.1 2.4 2.6 1.0 5.4 0.2 6.8 1.8 1.0 2.3 0.5 2.3 0.8 1.2 1.6 1.6 0.9 0.4 1.9 2.6 0.8 0.5 5.4 1.0 13.1 2.1 1.4 15.7 0.3 7.4 1.6 2.3 2.6 2.3 15.0 0.1 6.2 0.4 0.5 2.3 4.4 1.0 2.0 0.2 0.3 10.9 5.3 5.0 2.1 2.8 1.9 2.8 0.2 0.5 2.6 1.2 2.5 0.6 1.1 2.1 0.6 2.8 2.4 3.5 2.3 0.5 1.8 3.3 1.9 0.7 3.0 0.3 1.7 7.5 1.1 30.6 19.8 6.3 24.4 30.1 15.1 9.7 20.4 11.7 0.3 PHACTR1 "dJ257A7.2, KIAA1733, RPEL1" ENSG00000112137 "Phosphatase and actin regulator 1" Q9C0D0 6 12716805-13290484 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.9;brain: 80.3" "Cell line enhanced" "Detected in many" "HMC-1: 16.4;SK-MEL-30: 15.4;U-266/70: 40.3;U-266/84: 26.2" "Cancer enhanced" "Detected in many" "melanoma: 10.2" "Region enhanced" "Detected in all" "basal ganglia: 80.3" "Group enriched" "Detected in many" 13 "memory B-cell: 7.2;myeloid DC: 7.7;naive B-cell: 20.9;neutrophil: 10.1;plasmacytoid DC: 25.9" "Group enriched" "Detected in many" 17 "B-cells: 20.9;dendritic cells: 25.9;granulocytes: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029755, HPA029756, HPA029757" Enhanced Uncertain "Plasma membrane" "Plasma membrane" "HPA029755: AB_10600089, HPA029756: AB_10601852, HPA029757: AB_10669870" "unprognostic (7.86e-2)" "unprognostic (7.49e-2)" "unprognostic (2.74e-2)" "unprognostic (2.80e-1)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (7.72e-2)" "unprognostic (4.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-4)" "unprognostic (1.53e-1)" "prognostic unfavourable (5.48e-6)" "unprognostic (1.31e-1)" "unprognostic (1.43e-1)" "unprognostic (5.00e-2)" "unprognostic (1.16e-1)" 3.5 1.6 11.6 7.2 80.3 22.6 1.6 4.9 31.4 1.4 1.4 1.3 0.3 2.0 1.3 2.6 1.5 1.9 4.2 9.2 10.9 4.4 3.9 1.9 9.0 8.7 2.7 16.6 1.8 4.2 0.5 6.0 1.7 2.2 1.4 1.5 0.6 1.4 0.7 1.2 2.6 2.9 1.7 2.6 6.5 2.0 2.2 7.2 0.4 1.3 0.0 13.4 3.4 1.4 20.9 25.9 10.1 1.1 0.4 0.2 1.1 0.0 0.1 1.1 0.2 0.0 0.0 3.2 0.3 1.2 1.2 2.1 0.0 0.0 0.2 0.4 0.1 0.1 0.0 0.0 1.5 4.1 0.3 8.2 0.1 0.1 0.1 7.7 16.4 0.4 0.0 0.0 0.1 1.5 3.8 7.0 1.1 0.0 0.1 6.0 1.1 0.0 3.9 2.1 0.7 0.9 0.1 4.9 1.4 0.0 3.1 15.4 9.4 1.8 1.6 0.1 0.3 0.0 0.0 40.3 26.2 6.8 0.6 2.2 6.2 0.1 1.1 0.6 0.1 0.9 0.0 7.2 0.1 0.0 7.7 20.9 0.1 0.2 10.1 0.4 0.3 25.9 0.0 1.1 11.6 80.3 4.9 31.4 10.9 4.4 2.7 16.6 2.2 7.2 PHACTR3 "C20orf101, PPP1R123" ENSG00000087495 "Phosphatase and actin regulator 3" Q96KR7 20 59577509-59847711 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 56.1" "Cell line enriched" "Detected in some" 4 "THP-1: 51.8" "Group enriched" "Detected in some" 5 "glioma: 3.8;lung cancer: 1.6;pancreatic cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 2.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051834, HPA054847" Enhanced Nucleoplasm Nucleoplasm "HPA051834: , HPA054847: " "unprognostic (7.14e-2)" "unprognostic (1.22e-1)" "unprognostic (3.72e-2)" "unprognostic (1.43e-7)" "unprognostic (1.99e-1)" "unprognostic (2.87e-2)" "unprognostic (5.83e-3)" "unprognostic (8.92e-2)" "unprognostic (5.02e-2)" "unprognostic (2.30e-2)" "unprognostic (7.71e-2)" "unprognostic (7.22e-2)" "unprognostic (1.74e-2)" "unprognostic (1.66e-1)" "unprognostic (5.43e-2)" "unprognostic (2.53e-3)" "unprognostic (1.32e-1)" 1.6 2.7 31.3 1.8 29.2 2.0 1.4 15.9 56.1 1.5 1.9 20.0 0.0 2.1 1.3 2.0 2.8 1.4 3.3 3.0 27.3 14.6 2.0 2.1 5.3 1.4 28.3 19.4 6.9 1.5 1.4 0.5 1.9 21.3 1.4 1.8 0.0 1.3 1.3 1.4 2.6 2.1 1.5 25.4 8.0 1.8 1.8 29.8 0.0 1.4 0.0 1.4 1.6 0.0 0.0 2.5 0.1 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.8 0.0 0.0 0.0 10.1 0.0 0.7 2.7 0.0 0.0 0.0 0.0 51.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 31.3 29.2 15.9 34.1 27.3 14.6 28.3 19.4 21.3 29.8 PHF24 KIAA1045 ENSG00000122733 "PHD finger protein 24" Q9UPV7 9 34957608-34982544 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 43.0;testis: 15.9" "Group enriched" "Detected in some" 6 "NTERA-2: 3.7;WM-115: 4.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 45 "neutrophil: 5.4" "Lineage enriched" "Detected in single" 45 "granulocytes: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020974 Approved "HPA020974: AB_1852364" "unprognostic (5.54e-3)" "unprognostic (1.21e-1)" "unprognostic (9.00e-2)" "unprognostic (2.44e-1)" "unprognostic (1.00e-2)" "unprognostic (6.30e-2)" "unprognostic (3.66e-2)" "unprognostic (1.78e-2)" "unprognostic (7.06e-2)" "unprognostic (2.97e-1)" "unprognostic (4.80e-4)" "unprognostic (1.24e-1)" "unprognostic (4.58e-6)" "unprognostic (1.87e-2)" "unprognostic (1.41e-1)" "unprognostic (9.23e-2)" "unprognostic (2.30e-1)" 1.2 1.0 14.9 1.2 13.3 0.7 1.1 6.1 43.0 1.1 0.9 1.5 0.0 0.9 1.1 1.0 1.1 1.3 1.0 0.8 12.3 7.5 0.8 0.8 0.9 1.7 6.5 15.6 0.8 0.7 1.0 0.0 0.7 9.0 0.8 1.0 0.6 0.8 0.8 0.8 1.8 0.9 1.2 1.9 0.9 0.8 15.9 0.0 0.0 0.8 0.0 1.6 0.9 0.1 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 14.9 13.3 6.1 26.8 12.3 7.5 6.5 15.6 9.0 0.0 PHLDB1 "FLJ00141, KIAA0638, LL5a" ENSG00000019144 "Pleckstrin homology like domain family B member 1" Q86UU1 11 118606440-118658038 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0" "Cell line enhanced" "Detected in many" "ASC diff: 38.5;ASC TERT1: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037959, HPA038448, HPA061506" Approved Approved "Nucleoplasm,Mitotic spindle" Nucleoplasm "Mitotic spindle" "HPA037959: AB_10673651, HPA038448: AB_10697390, HPA061506: " "unprognostic (7.81e-2)" "unprognostic (8.32e-3)" "unprognostic (1.13e-1)" "unprognostic (9.36e-3)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" "unprognostic (4.37e-3)" "unprognostic (1.22e-1)" "unprognostic (3.21e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.57e-1)" "prognostic unfavourable (6.36e-6)" "unprognostic (7.09e-2)" "unprognostic (2.42e-2)" "unprognostic (3.69e-2)" "unprognostic (1.44e-1)" 40.5 7.4 19.6 9.5 52.2 0.9 19.0 4.6 30.8 25.0 10.7 87.0 3.6 8.1 22.0 9.6 8.2 18.7 18.5 20.8 22.4 11.8 9.6 2.8 13.7 4.0 47.0 19.9 21.4 18.9 4.9 4.5 20.8 26.9 9.4 5.9 8.0 7.1 14.6 10.0 9.2 8.8 16.0 27.6 10.2 7.9 7.0 51.0 0.0 10.7 5.4 2.3 10.8 11.6 0.5 0.4 2.1 0.3 1.9 0.7 0.1 1.6 2.6 10.3 5.0 38.5 39.1 3.6 7.6 9.4 4.5 2.6 3.9 11.2 0.0 14.5 15.4 6.5 2.3 15.7 0.7 0.2 1.5 2.9 1.9 1.8 10.0 0.0 5.6 20.4 3.4 6.3 4.4 12.9 2.5 0.1 5.8 1.1 0.0 0.1 3.6 1.3 0.4 2.6 0.2 4.5 2.4 2.3 5.1 19.5 1.7 5.4 7.1 0.9 15.7 9.3 8.5 4.7 6.0 0.0 0.0 0.0 2.7 0.5 10.5 0.5 0.3 0.4 0.2 0.0 0.3 0.2 0.3 0.7 0.0 0.5 0.7 0.5 2.1 1.9 0.2 0.4 0.2 0.1 19.6 52.2 4.6 30.8 22.4 11.8 47.0 19.9 26.9 51.0 PHLPP1 "KIAA0606, PHLPP, PLEKHE1, PPM3A, SCOP" ENSG00000081913 "PH domain and leucine rich repeat protein phosphatase 1" O60346 18 62715450-62980433 "Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protein phosphatase" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "neutrophil: 7.7;T-reg: 2.4" "Group enriched" "Detected in many" 7 "granulocytes: 7.7;T-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020200 Uncertain "Intracellular and membrane" "HPA020200: " "unprognostic (1.38e-1)" "unprognostic (3.61e-2)" "unprognostic (2.26e-1)" "unprognostic (1.18e-1)" "unprognostic (1.89e-1)" "unprognostic (3.07e-2)" "unprognostic (5.57e-2)" "unprognostic (5.24e-1)" "unprognostic (1.63e-1)" "unprognostic (3.10e-1)" "unprognostic (2.95e-1)" "unprognostic (6.03e-2)" "prognostic favourable (5.35e-8)" "unprognostic (1.52e-1)" "unprognostic (3.49e-2)" "unprognostic (8.13e-2)" "unprognostic (8.25e-2)" 5.8 10.6 22.1 2.3 34.1 7.4 7.4 8.3 29.6 4.3 6.0 48.0 0.9 6.2 4.4 2.5 6.1 4.0 4.9 3.0 22.4 12.3 4.0 18.5 3.4 3.0 44.4 13.8 5.5 8.0 9.6 5.6 6.3 20.6 5.0 6.7 4.4 11.2 4.5 3.9 9.1 5.5 4.0 18.6 2.0 5.6 11.5 44.8 2.3 5.6 1.6 4.1 5.6 3.2 0.6 0.7 7.7 0.2 0.6 2.4 0.1 8.9 3.4 13.8 4.6 2.3 2.0 10.8 2.7 2.4 5.4 5.5 7.3 5.4 6.0 1.6 4.0 11.0 7.1 4.2 6.9 18.6 5.9 2.0 3.7 13.4 3.3 3.0 1.0 2.1 2.8 5.7 5.3 3.8 5.1 12.2 5.1 2.0 2.2 2.6 5.6 3.3 21.4 7.8 7.2 3.0 11.6 6.4 2.6 2.9 6.7 5.5 2.9 8.8 4.8 4.4 2.1 2.6 6.2 1.4 0.7 7.1 2.6 3.5 3.3 0.0 0.2 0.1 0.7 0.0 0.0 0.6 0.1 0.0 0.7 0.2 0.4 0.1 7.7 0.6 0.2 0.3 2.4 0.1 22.1 34.1 8.3 21.1 22.4 12.3 44.4 13.8 20.6 44.8 PHOX2A "ARIX, CFEOM2, FEOM2, PMX2A" ENSG00000165462 "Paired like homeobox 2a" O14813 11 72239077-72245664 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7" "Cell line enriched" "Detected in single" 228 "SH-SY5Y: 112.7" "Cancer enriched" "Detected in some" 9 "ovarian cancer: 9.3" "Region enriched" "Detected in single" 96 "pons and medulla: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "pons and medulla: 0.8" "Low region specificity" "Detected in some" "HPA053810, HPA065621, HPA078004" Enhanced Enhanced "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" Nucleoplasm "Nuclear membrane, Vesicles, Cytosol" "HPA053810: , HPA065621: , HPA078004: " "unprognostic (5.84e-2)" "unprognostic (8.51e-2)" "unprognostic (5.07e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "unprognostic (9.92e-4)" "unprognostic (3.03e-2)" 0.4 24.6 0.0 9.7 0.0 0.0 0.0 0.0 0.1 0.2 3.3 0.5 0.0 0.4 0.1 0.0 1.4 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 12.1 0.9 0.7 1.7 0.7 3.7 0.0 0.0 3.2 0.3 2.1 0.1 1.6 5.2 0.0 0.0 0.0 0.0 0.0 2.6 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 112.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.1 0.0 PHOX2B "NBPhox, Phox2b, PMX2B" ENSG00000109132 "Paired like homeobox 2b" Q99453 4 41744082-41748970 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 14.5;brain: 24.8" "Cell line enriched" "Detected in single" 91 "SH-SY5Y: 52.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 99 "pons and medulla: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 17 "pons and medulla: 5.9" "Region enriched" "Detected in single" 38 "pons and medulla: 2.0" "HPA074325, HPA074941" Enhanced Enhanced Nucleoplasm Nucleoplasm "HPA074325: , HPA074941: " "unprognostic (1.01e-1)" "unprognostic (2.47e-1)" "unprognostic (5.27e-2)" 0.0 14.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 24.8 0.2 1.4 0.8 0.0 0.0 0.0 0.0 3.2 0.5 0.4 0.0 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 52.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.8 0.0 PHYHIP "DYRK1AP3, KIAA0273, PAHX-AP" ENSG00000168490 "Phytanoyl-CoA 2-hydroxylase interacting protein" Q92561 8 22219704-22232341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.4;skin 1: 37.9" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.7;SH-SY5Y: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "amygdala: 111.3;basal ganglia: 281.7;cerebellum: 369.4;cerebral cortex: 248.5;hippocampal formation: 314.4" HPA069318 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA069318: " "unprognostic (1.19e-2)" "unprognostic (2.33e-2)" "unprognostic (3.06e-2)" "unprognostic (9.22e-3)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (2.80e-1)" "unprognostic (3.01e-2)" "unprognostic (7.44e-3)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (4.44e-5)" "unprognostic (8.62e-4)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (4.09e-3)" 5.4 18.6 25.0 2.3 71.8 1.3 3.5 58.9 89.4 3.2 2.1 3.0 0.0 2.2 6.0 3.4 7.1 9.8 6.2 2.9 31.2 12.3 2.2 1.4 1.8 1.4 7.3 40.3 2.3 2.2 1.3 5.5 3.0 21.1 3.6 1.7 0.0 1.4 5.9 1.7 37.9 2.4 7.2 3.5 3.6 1.6 5.8 10.4 0.0 2.0 0.0 1.4 7.8 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.3 0.4 0.0 0.3 0.8 1.1 0.3 1.2 0.4 0.4 0.1 1.9 0.0 2.1 0.6 3.7 0.0 0.6 0.1 0.0 0.2 0.0 3.9 1.4 1.6 0.0 0.0 0.9 0.0 0.8 0.0 2.5 0.2 1.3 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.2 12.7 0.0 0.0 4.3 4.9 2.9 0.0 3.3 0.0 0.3 1.1 0.0 2.1 1.5 0.7 1.0 0.2 0.0 2.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 71.8 58.9 82.9 31.2 12.3 7.3 40.3 21.1 10.4 PHYHIPL "Em:AC025038.1, KIAA1796" ENSG00000165443 "Phytanoyl-CoA 2-hydroxylase interacting protein like" Q96FC7 10 59176590-59247774 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.3" "Cell line enhanced" "Detected in some" "CACO-2: 3.8;Hep G2: 24.3;SCLC-21H: 4.4;SH-SY5Y: 14.5;SK-BR-3: 6.1" "Group enriched" "Detected in many" 5 "glioma: 21.1;renal cancer: 8.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038746 Uncertain Approved Cytosol Cytosol "HPA038746: AB_10673293" "unprognostic (6.34e-3)" "unprognostic (2.40e-1)" "unprognostic (1.04e-1)" "unprognostic (3.76e-3)" "unprognostic (7.06e-2)" "unprognostic (3.37e-1)" "unprognostic (5.63e-2)" "unprognostic (3.78e-2)" "unprognostic (1.06e-1)" "unprognostic (4.00e-3)" "unprognostic (2.67e-3)" "unprognostic (2.02e-1)" "prognostic favourable (1.60e-7)" "unprognostic (1.29e-3)" "unprognostic (1.30e-1)" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" 1.9 23.1 22.2 2.0 22.4 1.6 1.8 17.6 70.3 2.1 2.1 25.4 0.4 11.2 2.5 3.8 2.0 2.5 1.8 1.7 20.8 21.4 14.8 2.7 1.7 1.6 28.0 25.0 2.5 5.6 1.6 4.4 10.6 24.8 4.4 2.0 7.6 2.2 4.9 1.6 1.6 11.5 1.7 27.4 1.6 2.2 8.9 31.0 0.0 1.6 0.0 1.6 1.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 14.5 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 22.4 17.6 32.6 20.8 21.4 28.0 25.0 24.8 31.0 PI4KA "PI4K-ALPHA, pi4K230, PIK4CA" ENSG00000241973 "Phosphatidylinositol 4-kinase alpha" P42356 22 20707691-20859417 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.0" "Cell line enhanced" "Detected in all" "K-562: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009092, HPA075515" Approved Approved "Nucleoplasm,Plasma membrane" 18000 Nucleoplasm "Plasma membrane" "CAB009092: AB_2164033, HPA075515: " "unprognostic (8.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.21e-1)" "unprognostic (5.01e-3)" "unprognostic (3.19e-2)" "prognostic favourable (5.24e-4)" "unprognostic (2.08e-1)" "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.29e-1)" "prognostic favourable (7.22e-5)" "unprognostic (1.37e-1)" "unprognostic (1.33e-1)" "unprognostic (2.35e-1)" "unprognostic (1.50e-1)" 7.7 9.2 28.8 10.5 34.2 12.5 6.5 14.1 48.0 9.7 8.8 10.1 4.9 9.1 9.7 6.1 8.3 8.4 8.0 8.5 30.4 19.2 9.0 12.6 9.0 11.2 19.0 25.9 10.2 8.6 25.6 12.5 10.4 19.3 9.8 8.9 10.8 6.8 10.6 7.1 6.6 10.0 13.2 6.8 10.2 9.9 13.1 8.2 17.9 9.9 2.9 10.2 8.4 4.8 5.0 12.5 7.6 5.5 9.1 7.7 2.9 9.7 8.2 7.3 10.9 20.8 12.6 10.4 8.9 13.5 13.1 12.8 6.4 4.2 18.4 5.3 17.8 8.6 13.8 8.5 8.0 15.6 21.2 18.9 11.2 7.3 10.4 18.7 15.2 11.2 5.4 11.1 6.2 10.6 51.5 15.6 10.1 13.5 16.3 6.4 5.7 8.5 16.4 15.9 3.4 7.3 15.6 17.9 13.1 11.6 13.5 9.2 11.4 8.6 10.7 23.9 12.4 8.8 7.4 12.0 12.2 14.6 15.8 13.5 9.9 3.1 5.5 7.3 5.1 5.4 4.9 4.6 5.6 6.1 3.6 5.0 5.7 7.7 7.6 9.1 4.6 12.5 5.8 2.9 28.8 34.2 14.1 48.0 30.4 19.2 19.0 25.9 19.3 8.2 PIANP "C12orf53, DKFZp547D2210, PANP" ENSG00000139200 "PILR alpha associated neural protein" Q8IYJ0 12 6693792-6700800 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.0;HAP1: 8.0;NTERA-2: 16.9;SH-SY5Y: 15.9;U-2 OS: 8.9" "Cancer enhanced" "Detected in many" "glioma: 14.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 7 "T-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010631 Enhanced Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA010631: AB_10603680" "unprognostic (1.82e-1)" "unprognostic (9.21e-3)" "unprognostic (1.62e-2)" "unprognostic (7.65e-2)" "unprognostic (1.34e-1)" "unprognostic (3.03e-2)" "unprognostic (6.58e-2)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (6.41e-3)" "unprognostic (1.92e-2)" "unprognostic (3.89e-1)" "unprognostic (3.30e-3)" "unprognostic (3.26e-3)" "unprognostic (1.16e-1)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" 1.5 8.3 28.0 2.2 55.7 1.2 1.5 27.4 52.8 7.2 2.7 2.6 0.5 1.9 11.6 4.1 1.8 2.2 3.3 1.5 19.5 26.2 1.5 1.1 1.5 2.4 11.0 20.9 1.8 1.7 1.2 4.0 1.5 9.0 3.4 2.0 1.7 2.2 8.7 1.3 1.7 2.2 8.1 4.6 1.6 2.1 4.4 8.3 0.0 1.4 0.0 1.7 1.8 2.5 0.3 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.4 6.0 1.2 0.2 0.3 0.2 1.6 8.0 4.2 3.8 0.1 0.2 0.1 0.0 2.8 0.2 8.0 0.2 2.0 0.2 1.0 0.3 0.2 0.0 0.2 0.3 0.3 1.0 0.0 1.7 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 16.9 0.0 1.1 0.0 0.1 0.1 0.1 2.2 15.9 0.0 0.1 0.0 0.0 0.0 0.0 4.3 8.9 4.5 1.1 0.2 0.0 0.3 5.9 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.7 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.0 55.7 27.4 27.8 19.5 26.2 11.0 20.9 9.0 8.3 PIEZO2 "C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771" ENSG00000154864 "Piezo type mechanosensitive ion channel component 2" Q9H5I5 18 10666483-11148762 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Cell line enhanced" "Detected in some" "AF22: 9.4;BJ hTERT+ SV40 Large T+: 10.5;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HeLa: 23.4;U-266/70: 14.9;U-698: 9.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA015986, HPA031974, HPA031975, HPA040616" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA015986: AB_1848395, HPA031974: AB_10603675, HPA031975: , HPA040616: " "unprognostic (1.36e-1)" "unprognostic (1.92e-1)" "unprognostic (9.21e-2)" "unprognostic (2.53e-2)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.87e-2)" "unprognostic (4.34e-3)" "unprognostic (6.55e-2)" "unprognostic (3.89e-2)" "unprognostic (6.06e-2)" "unprognostic (2.23e-1)" "prognostic unfavourable (9.57e-7)" "unprognostic (1.12e-3)" "unprognostic (1.09e-1)" "unprognostic (9.04e-2)" "unprognostic (1.83e-2)" 0.9 0.3 3.1 0.9 2.3 0.0 1.9 0.1 3.6 0.9 3.3 0.0 0.3 1.6 5.8 0.8 5.9 0.0 5.2 2.1 0.9 4.5 7.4 0.5 5.8 0.6 1.7 0.0 0.6 0.0 3.4 1.3 0.0 3.3 0.0 0.8 0.9 1.9 10.3 2.7 1.4 0.9 1.3 0.2 4.6 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.1 9.4 0.0 0.0 0.0 0.0 0.5 2.7 10.5 14.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 6.7 0.0 0.3 0.0 23.4 5.5 3.3 0.0 0.0 0.0 0.1 2.7 0.7 3.2 0.0 0.2 1.6 0.0 0.1 0.0 2.9 0.0 0.0 0.0 4.1 0.0 3.2 8.1 0.0 0.1 0.0 0.5 0.0 2.7 0.0 0.0 3.8 0.2 0.5 14.9 0.1 9.7 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIFO "C1orf88, FLJ23853, pitchfork" ENSG00000173947 "Primary cilia formation" Q8TCI5 1 111346288-111353013 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.9;fallopian tube: 96.8" "Cell line enhanced" "Detected in some" "hTCEpi: 5.1;RPTEC TERT1: 7.0;RT4: 8.2;T-47d: 5.8;U-87 MG: 5.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "pons and medulla: 55.9" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.3" "Group enriched" "Detected in many" 25 "B-cells: 1.6;T-cells: 3.3" "Low region specificity" "Detected in many" "unprognostic (3.18e-3)" "unprognostic (3.23e-2)" "unprognostic (7.33e-2)" "unprognostic (3.03e-3)" "unprognostic (6.00e-2)" "unprognostic (7.43e-4)" "unprognostic (8.78e-7)" "unprognostic (6.43e-3)" "unprognostic (7.28e-2)" "unprognostic (9.07e-3)" "prognostic favourable (2.48e-4)" "unprognostic (3.32e-2)" "prognostic favourable (1.44e-4)" "unprognostic (6.03e-3)" "unprognostic (4.73e-2)" "unprognostic (6.37e-2)" "unprognostic (6.83e-2)" 1.1 2.0 6.6 1.2 10.1 0.8 3.8 0.7 3.9 4.4 3.0 15.9 3.5 1.1 4.9 15.5 2.8 96.8 2.7 6.4 8.6 8.6 5.4 0.8 10.8 0.9 5.0 6.5 9.2 4.2 5.1 13.8 4.3 55.9 7.5 1.4 4.2 2.2 4.3 0.9 1.6 1.1 3.4 4.2 1.0 2.6 26.5 5.4 0.4 8.8 0.1 1.1 5.4 0.6 1.6 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.1 0.7 0.9 0.9 1.0 1.6 0.0 1.9 0.4 0.0 1.5 1.6 0.0 0.4 0.0 0.0 1.4 0.3 0.0 2.1 0.3 0.0 0.2 1.3 0.8 0.0 0.0 1.0 5.1 0.0 0.0 0.0 0.3 0.2 2.9 0.1 0.8 0.1 3.0 0.0 0.0 0.0 0.0 7.0 8.2 3.5 0.4 0.0 0.2 0.2 5.8 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.4 0.5 5.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 3.3 1.6 0.9 1.0 0.0 0.9 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.3 6.6 10.1 0.7 3.9 8.6 8.6 5.0 6.5 55.9 5.4 PIH1D3 "CXorf41, MGC35261, NYSAR97" ENSG00000080572 "PIH1 domain containing 3" Q9NQM4 X 107206632-107244243 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.0;fallopian tube: 16.2;lung: 7.0;testis: 13.9" "Cell line enhanced" "Detected in single" "WM-115: 1.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Region enhanced" "Detected in many" "pons and medulla: 8.0" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in single" "midbrain: 4.6" HPA072496 Enhanced "HPA072496: " "unprognostic (8.66e-2)" "unprognostic (2.75e-3)" "unprognostic (7.73e-4)" "unprognostic (3.37e-1)" "unprognostic (8.61e-2)" "unprognostic (4.27e-1)" "unprognostic (3.37e-2)" "unprognostic (1.77e-2)" 0.0 0.1 0.9 0.0 4.0 0.2 0.0 0.0 0.1 1.3 0.0 1.9 1.0 0.1 0.5 4.5 0.1 16.2 0.1 0.1 1.6 1.5 0.2 0.0 7.0 0.1 0.0 0.0 4.8 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 13.9 1.3 0.1 0.4 0.0 0.1 0.0 0.0 0.5 0.3 2.1 0.3 0.6 0.2 0.2 0.3 0.9 0.1 0.0 0.4 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.8 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.5 0.0 0.1 0.4 0.1 0.0 0.0 0.5 0.5 0.6 0.3 0.3 0.2 0.9 0.1 0.0 0.8 0.3 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.3 1.7 2.1 0.3 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.5 0.1 0.2 1.2 0.6 0.2 0.3 0.1 0.2 0.9 4.0 0.0 0.0 1.6 1.5 0.0 0.0 8.0 1.3 PIP4K2A "PIP5K2A, PIP5KIIA, PIP5KIIalpha" ENSG00000150867 "Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha" P48426 10 22534849-22714555 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 92.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065440, HPA068771" Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" 8800000 "Golgi apparatus" "Plasma membrane, Cytosol" "HPA065440: , HPA068771: " "unprognostic (1.11e-1)" "unprognostic (2.71e-3)" "unprognostic (1.57e-3)" "unprognostic (4.20e-3)" "unprognostic (1.55e-1)" "unprognostic (8.80e-3)" "unprognostic (1.56e-3)" "unprognostic (7.32e-2)" "unprognostic (1.68e-1)" "unprognostic (7.08e-2)" "unprognostic (1.29e-1)" "unprognostic (1.21e-1)" "prognostic unfavourable (1.46e-4)" "unprognostic (1.52e-3)" "unprognostic (2.51e-1)" "unprognostic (1.38e-1)" "unprognostic (7.92e-3)" 13.0 7.3 43.8 20.3 63.8 17.3 6.9 6.6 41.4 13.2 7.8 75.5 1.0 5.9 9.9 5.6 9.2 7.2 15.1 5.9 56.0 31.7 7.6 8.3 11.5 33.4 65.7 22.9 4.3 4.9 29.5 4.2 10.5 36.5 4.4 9.0 5.7 3.9 6.3 2.6 4.0 8.1 14.4 92.0 26.6 8.4 5.4 59.8 10.1 5.9 1.0 38.5 11.5 5.8 14.7 12.0 26.3 16.6 38.4 46.7 39.3 8.7 8.7 10.1 3.2 16.3 22.2 7.7 16.4 17.5 8.9 11.0 8.1 14.2 18.5 6.0 32.9 3.1 8.8 4.6 9.0 40.9 9.1 34.7 6.4 17.9 28.9 6.6 27.3 11.1 4.1 12.1 11.7 13.1 19.3 36.1 16.4 3.6 26.6 6.0 4.1 6.2 10.7 14.5 25.1 13.2 1.7 1.8 4.3 5.2 2.7 26.1 2.3 11.6 15.8 6.9 10.1 12.7 10.0 23.0 13.0 13.5 18.6 20.2 5.3 16.1 8.8 26.3 34.5 15.6 46.7 14.7 27.5 40.0 11.6 8.6 18.6 34.9 10.9 38.4 16.6 12.0 19.6 39.3 43.8 63.8 6.6 30.3 56.0 31.7 65.7 22.9 36.5 59.8 PIRT ENSG00000233670 "Phosphoinositide interacting regulator of transient receptor potential channels" P0C851 17 10822475-10838445 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.3;brain: 24.8;intestine: 7.5" "Cell line enhanced" "Detected in single" "HMC-1: 1.4" "Cancer enriched" "Detected in single" 40 "glioma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA042337 Uncertain Uncertain "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA042337: AB_10794795" "unprognostic (2.95e-1)" "unprognostic (2.19e-2)" "unprognostic (7.57e-2)" "unprognostic (6.58e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (2.85e-3)" 0.4 7.3 9.9 3.2 14.0 0.3 0.3 5.6 5.2 0.4 6.3 10.8 0.0 2.9 0.4 0.4 0.8 0.9 0.7 0.3 13.1 11.6 0.3 0.3 0.4 0.3 12.5 2.3 0.4 0.3 0.3 0.1 0.3 24.8 0.4 7.5 0.0 0.4 0.4 0.4 0.4 5.2 2.5 19.9 0.3 4.9 0.5 12.8 0.0 0.3 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 14.0 5.6 5.2 13.1 11.6 12.5 2.3 24.8 12.8 PITPNM3 "ACKR6, CORD5, NIR1, RDGBA3" ENSG00000091622 "PITPNM family member 3" Q9BZ71 17 6451264-6556494 "Disease related genes, Predicted intracellular proteins" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0;lymphoid tissue: 43.3;ovary: 24.2" "Cell line enhanced" "Detected in some" "HaCaT: 11.1;HeLa: 8.6;hTCEpi: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 58 "neutrophil: 5.8" "Lineage enriched" "Detected in single" 58 "granulocytes: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022432, HPA059005" Enhanced Approved "Plasma membrane" "Plasma membrane" "HPA022432: AB_2670936, HPA059005: AB_2683876" "unprognostic (2.97e-2)" "unprognostic (8.60e-3)" "unprognostic (1.45e-2)" "unprognostic (1.52e-1)" "unprognostic (2.69e-2)" "prognostic favourable (3.67e-6)" "unprognostic (1.25e-2)" "unprognostic (6.86e-2)" "unprognostic (3.66e-2)" "unprognostic (3.01e-2)" "unprognostic (2.99e-3)" "unprognostic (3.58e-2)" "unprognostic (2.41e-1)" "unprognostic (9.60e-2)" "unprognostic (1.61e-1)" "unprognostic (3.55e-1)" "unprognostic (2.63e-1)" 1.1 2.4 17.9 1.2 18.8 0.5 1.7 18.7 23.0 2.4 4.5 0.7 3.4 1.5 1.9 3.4 9.4 4.3 3.8 0.8 7.2 5.2 1.5 1.6 3.1 0.6 2.9 11.9 24.2 0.9 1.9 0.7 0.6 2.5 2.7 3.6 2.3 1.9 8.3 1.1 14.3 1.4 3.8 0.9 43.3 3.2 2.4 1.5 0.0 2.4 0.7 2.1 1.3 2.5 0.0 0.0 5.8 0.0 0.0 0.0 0.0 5.4 0.5 0.4 0.2 0.0 0.1 0.4 0.4 0.1 0.5 0.3 0.3 3.9 0.1 2.1 0.1 11.1 0.2 2.3 0.2 0.2 0.4 0.1 8.6 0.1 0.6 0.2 0.3 0.1 32.3 0.6 1.8 0.3 0.1 0.0 0.3 0.5 0.0 0.1 0.6 1.6 0.1 1.2 0.0 0.8 0.1 0.3 0.3 5.0 2.4 0.1 0.8 0.0 0.2 0.3 2.1 0.4 1.3 0.3 0.1 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 17.9 18.8 18.7 23.0 7.2 5.2 2.9 11.9 2.5 1.5 PKD1 "PBP, Pc-1, TRPP1" ENSG00000008710 "Polycystin 1, transient receptor potential channel interacting" P98161 16 2088710-2135898 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB046448 Approved 120000 "CAB046448: AB_2163360" "unprognostic (1.95e-1)" "unprognostic (1.52e-1)" "prognostic unfavourable (7.43e-4)" "unprognostic (1.35e-1)" "unprognostic (1.79e-1)" "prognostic favourable (3.35e-4)" "unprognostic (1.98e-2)" "unprognostic (1.02e-2)" "unprognostic (1.81e-1)" "unprognostic (1.22e-2)" "prognostic favourable (3.38e-5)" "unprognostic (7.86e-2)" "unprognostic (4.07e-1)" "unprognostic (3.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.78e-2)" "unprognostic (2.81e-1)" 4.5 4.6 2.6 2.3 3.6 1.5 1.4 45.3 7.9 2.8 5.1 1.8 5.4 0.7 2.6 3.4 1.8 7.1 3.5 4.2 0.7 0.6 2.2 1.3 1.9 6.8 3.3 1.2 11.3 1.7 3.7 0.4 4.3 5.4 18.0 7.8 2.8 3.3 1.5 2.7 2.6 2.2 1.0 0.3 3.1 1.8 0.1 0.1 0.0 0.1 0.0 0.4 0.7 3.0 6.5 3.6 8.2 6.3 6.8 7.1 10.5 4.4 3.0 3.1 5.8 2.3 4.6 6.7 5.4 7.7 1.0 1.6 1.1 5.3 5.2 2.8 16.6 2.3 12.5 3.9 5.9 6.3 5.3 5.7 3.5 2.3 4.0 4.6 1.9 4.9 5.5 11.8 3.2 4.9 15.6 5.9 6.8 1.5 2.1 15.1 16.9 9.5 6.4 6.5 5.2 13.3 5.4 9.7 7.9 7.2 7.6 6.8 3.0 5.1 5.4 3.6 6.1 0.0 0.1 0.0 0.4 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.7 PKD2L1 "PCL, PKD2L, PKDL, TRPP3" ENSG00000107593 "Polycystin 2 like 1, transient receptor potential cation channel" Q9P0L9 10 100288154-100330486 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.2;lymphoid tissue: 12.0" "Cell line enhanced" "Detected in some" "Karpas-707: 1.6;NB-4: 1.7;PC-3: 1.9;RT4: 1.0;SK-MEL-30: 1.6;U-266/70: 1.0;U-266/84: 2.7;U-937: 1.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 2.7;intermediate monocyte: 3.0;non-classical monocyte: 2.3" "Lineage enriched" "Detected in single" 5 "monocytes: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" CAB022621 Uncertain "CAB022621: " "unprognostic (2.67e-1)" "unprognostic (3.66e-7)" "unprognostic (8.07e-3)" "unprognostic (4.38e-2)" "unprognostic (4.70e-2)" "unprognostic (5.31e-2)" "unprognostic (2.19e-1)" "unprognostic (2.85e-2)" "unprognostic (2.01e-1)" "unprognostic (9.25e-2)" "unprognostic (1.55e-1)" "unprognostic (9.37e-2)" "unprognostic (1.49e-4)" "unprognostic (3.00e-1)" "unprognostic (2.05e-2)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" 0.3 0.3 0.4 0.6 3.7 1.3 1.4 0.1 6.2 0.1 1.5 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 2.0 0.3 0.5 2.7 4.0 2.3 0.5 4.0 0.2 0.2 0.0 0.2 0.7 1.3 0.4 2.2 1.0 0.3 0.0 0.1 0.1 0.8 0.0 1.5 12.0 0.1 2.3 0.0 0.3 0.1 0.0 2.9 0.4 0.1 0.2 0.3 0.6 3.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.7 0.0 1.9 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.7 0.0 0.0 1.3 0.0 0.0 2.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.6 0.0 2.3 0.0 0.0 0.4 0.4 3.7 0.1 6.2 2.0 0.3 0.5 4.0 1.3 0.0 PKIB PRKACN2 ENSG00000135549 "CAMP-dependent protein kinase inhibitor beta" Q9C010 6 122471917-122726373 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 91.6;placenta: 140.9" "Cell line enhanced" "Detected in some" "AF22: 19.9;BEWO: 17.4;MCF7: 22.5;PC-3: 31.7;RPTEC TERT1: 51.7;SCLC-21H: 44.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "cerebellum: 91.6" "Cell type enriched" "Detected in some" 11 "myeloid DC: 22.3" "Lineage enriched" "Detected in many" 11 "dendritic cells: 22.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "cerebellum: 92.0;olfactory region: 58.4" HPA030156 Approved "HPA030156: AB_10602816" "unprognostic (1.59e-2)" "unprognostic (1.82e-1)" "unprognostic (1.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.39e-1)" "unprognostic (9.45e-2)" "prognostic unfavourable (4.72e-7)" "unprognostic (1.94e-2)" "unprognostic (5.88e-2)" "unprognostic (3.91e-2)" "unprognostic (1.26e-1)" "unprognostic (3.58e-2)" "prognostic favourable (2.47e-7)" "unprognostic (1.82e-1)" "unprognostic (1.37e-1)" "unprognostic (2.57e-1)" "unprognostic (1.48e-1)" 0.8 2.0 3.3 7.3 3.7 0.0 8.8 91.6 2.3 1.8 33.0 1.0 1.0 5.4 0.9 1.2 1.6 1.8 2.3 0.5 2.8 4.5 0.9 2.6 2.0 0.9 6.1 2.2 0.5 2.3 18.9 22.3 140.9 17.7 2.0 23.6 5.6 2.8 1.2 0.5 3.1 12.0 1.2 2.8 0.8 12.2 1.2 0.7 1.6 1.0 1.3 2.5 1.8 0.7 0.1 22.3 0.0 1.9 1.4 0.5 0.5 0.0 0.7 19.9 0.1 0.1 0.0 17.4 0.0 0.2 0.0 0.3 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.1 1.0 0.3 1.1 0.4 0.0 0.0 3.4 0.1 0.3 0.3 4.3 0.1 5.8 0.1 0.0 22.5 0.0 0.1 8.2 31.7 0.1 3.0 0.1 51.7 2.8 44.1 0.0 0.0 4.7 0.5 3.3 0.4 1.7 0.0 13.4 0.0 1.6 0.0 0.0 0.0 13.1 0.4 0.1 0.0 0.4 0.0 0.0 1.9 0.5 0.0 0.0 0.0 22.3 0.1 0.3 0.1 0.0 1.4 0.1 0.3 0.2 0.5 3.3 3.7 91.6 2.3 2.8 4.5 6.1 2.2 17.7 0.7 PKP4 p0071 ENSG00000144283 "Plakophilin 4" Q99569 2 158456964-158682879 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 111.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037334, HPA066647, HPA070648" Approved Enhanced "Plasma membrane,Cell Junctions" "Cell Junctions" "Plasma membrane" "CAB037334: , HPA066647: , HPA070648: " "unprognostic (2.76e-1)" "unprognostic (5.26e-2)" "unprognostic (1.48e-2)" "prognostic favourable (5.80e-4)" "unprognostic (2.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.02e-3)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (9.53e-2)" "unprognostic (1.82e-2)" "unprognostic (9.69e-2)" "prognostic favourable (3.29e-7)" "unprognostic (2.23e-1)" "unprognostic (9.80e-2)" "unprognostic (1.33e-3)" "unprognostic (2.28e-3)" 7.3 3.9 42.7 3.7 42.1 4.2 15.5 14.5 26.6 19.8 7.1 49.9 6.9 7.1 8.3 8.9 10.7 11.8 8.9 12.1 47.7 31.2 34.2 9.7 7.3 3.0 66.9 14.7 8.3 8.7 12.2 6.6 3.4 28.4 7.8 8.1 10.4 19.3 13.1 4.0 9.4 6.4 8.5 111.7 3.2 7.7 5.6 31.6 3.3 18.2 2.4 5.5 9.1 6.9 0.1 0.7 1.0 5.3 0.0 2.1 0.5 16.5 9.2 12.7 14.4 5.9 6.4 12.1 13.8 7.4 20.8 18.1 30.9 15.7 10.6 10.3 16.0 13.4 16.4 13.8 34.9 15.9 8.4 10.0 10.4 25.2 9.9 15.8 2.2 2.8 13.3 14.3 21.9 10.5 13.6 16.9 15.8 18.3 6.9 6.8 13.5 7.0 9.2 19.0 9.1 30.8 12.0 22.2 3.9 9.6 14.4 11.3 17.1 14.5 4.8 12.5 14.0 9.2 17.3 9.7 8.1 7.8 7.3 8.7 12.1 0.0 1.0 0.0 0.4 0.3 0.7 0.0 1.5 0.6 0.4 0.1 1.2 0.4 1.0 0.0 5.3 0.7 2.1 0.5 42.7 42.1 14.5 26.6 47.7 31.2 66.9 14.7 28.4 31.6 PLA2G4C cPLA2-gamma ENSG00000105499 "Phospholipase A2 group IVC" Q9UP65 19 48047843-48110817 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.8;skeletal muscle: 45.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 8.0;HHSteC: 13.1;TIME: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 7.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA043083 Approved Approved Cytosol Cytosol "HPA043083: AB_10795714" "unprognostic (1.27e-1)" "unprognostic (3.88e-2)" "unprognostic (4.18e-2)" "unprognostic (2.82e-2)" "unprognostic (7.37e-2)" "unprognostic (1.62e-2)" "unprognostic (1.33e-1)" "unprognostic (6.53e-2)" "unprognostic (8.30e-2)" "unprognostic (1.94e-1)" "unprognostic (5.11e-3)" "unprognostic (1.90e-1)" "unprognostic (4.66e-2)" "unprognostic (9.45e-2)" "unprognostic (2.28e-3)" "unprognostic (1.87e-1)" "unprognostic (9.01e-2)" 4.0 11.7 8.9 4.2 23.2 0.4 3.0 12.9 14.5 3.4 3.5 23.4 2.0 5.1 6.8 5.2 3.6 4.3 4.6 18.5 10.0 10.0 4.4 3.8 5.9 7.2 31.8 8.5 2.0 4.1 14.8 4.6 4.1 16.9 5.7 2.9 5.4 3.1 6.7 45.0 4.9 6.7 8.1 18.6 8.1 2.4 2.4 17.1 0.7 3.3 7.5 4.3 4.9 2.1 5.4 2.0 0.0 7.9 1.5 0.8 2.0 0.6 1.1 0.0 0.3 5.1 3.0 0.1 1.3 8.0 1.2 3.4 0.0 2.1 0.0 1.7 3.2 0.2 0.0 0.2 1.9 0.8 0.1 0.0 0.3 1.1 13.1 0.0 1.7 0.6 0.3 0.5 5.3 5.0 0.0 7.2 1.9 2.0 0.0 0.1 0.1 0.1 0.1 1.8 0.6 2.4 0.3 0.7 0.1 1.4 2.5 6.2 0.7 1.8 18.3 2.2 0.7 2.5 0.9 0.4 1.3 0.2 1.6 0.0 4.3 0.0 3.2 0.0 0.2 7.9 0.6 5.4 0.8 0.0 2.0 1.6 0.0 0.0 0.0 1.5 2.0 1.4 0.2 2.0 8.9 23.2 12.9 14.5 10.0 10.0 31.8 8.5 16.9 17.1 PLCB4 ENSG00000101333 "Phospholipase C beta 4" Q15147 20 9068763-9481242 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.9;retina: 40.2;salivary gland: 39.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.0;hTERT-HME1: 18.6;LHCN-M2: 30.6;RPTEC TERT1: 39.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.5" "Group enriched" "Detected in all" 4 "cerebellum: 44.9;pons and medulla: 11.9" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 6.6" "Lineage enriched" "Detected in single" 20 "dendritic cells: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007951 Approved Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "HPA007951: " "unprognostic (3.88e-2)" "unprognostic (3.62e-1)" "unprognostic (1.19e-2)" "prognostic favourable (2.11e-4)" "unprognostic (1.44e-2)" "unprognostic (9.72e-3)" "unprognostic (3.32e-3)" "unprognostic (2.57e-2)" "unprognostic (7.75e-2)" "unprognostic (4.23e-2)" "unprognostic (5.21e-3)" "unprognostic (1.35e-1)" "unprognostic (4.64e-3)" "unprognostic (7.12e-2)" "unprognostic (1.37e-1)" "unprognostic (2.22e-1)" "unprognostic (4.45e-2)" 5.5 5.0 2.1 4.5 4.6 0.2 5.6 44.9 5.2 6.0 13.1 2.7 2.4 1.6 12.3 16.2 6.9 10.9 6.2 12.4 2.3 6.6 2.3 0.9 4.4 1.0 4.0 3.3 2.9 1.3 0.5 15.1 4.4 11.9 6.9 12.6 40.2 39.8 7.1 2.5 4.3 3.1 12.3 3.1 1.1 9.7 2.1 2.4 4.3 21.9 4.4 2.0 7.1 8.8 0.0 6.6 0.0 0.0 0.3 0.0 0.0 0.0 6.1 3.0 0.0 0.0 0.1 0.0 13.3 3.8 4.0 2.5 1.1 0.9 0.0 0.2 38.0 0.0 0.9 2.9 6.0 0.0 1.8 1.6 2.2 0.0 0.5 0.0 0.0 0.9 1.2 5.1 18.6 0.0 1.5 0.1 30.6 1.9 0.0 0.0 3.2 3.8 0.0 0.0 0.2 39.1 2.8 10.2 7.0 0.0 9.2 5.6 7.8 0.0 0.1 4.3 0.3 0.4 5.2 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.6 0.0 0.0 2.1 4.6 44.9 5.2 2.3 6.6 4.0 3.3 11.9 2.4 PLCH1 "DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3" ENSG00000114805 "Phospholipase C eta 1" Q4KWH8 3 155375580-155745067 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7;testis: 15.8" "Cell line enhanced" "Detected in some" "A549: 8.2;AF22: 26.6;NTERA-2: 14.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036176, HPA057978" Uncertain Enhanced Vesicles Vesicles "HPA036176: AB_10671837, HPA057978: " "unprognostic (1.08e-2)" "unprognostic (3.68e-1)" "unprognostic (2.17e-2)" "unprognostic (1.55e-2)" "unprognostic (3.50e-4)" "unprognostic (6.41e-2)" "unprognostic (2.94e-5)" "unprognostic (5.04e-2)" "unprognostic (2.41e-1)" "unprognostic (2.24e-3)" "unprognostic (4.84e-2)" "unprognostic (1.76e-2)" "prognostic favourable (3.03e-5)" "unprognostic (3.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-2)" 0.3 0.3 3.9 0.7 14.1 0.5 3.9 7.4 14.7 2.1 3.9 5.7 4.1 3.9 1.4 12.9 0.5 12.4 2.4 2.5 4.5 3.6 2.1 0.4 6.1 0.3 3.4 7.3 0.5 2.5 0.8 3.2 0.8 6.5 0.8 3.9 5.6 2.3 3.4 0.6 0.5 3.9 0.5 1.9 0.3 5.8 15.8 2.9 0.0 8.9 0.0 0.4 1.3 0.4 0.1 0.3 0.7 0.0 0.0 1.2 0.9 0.0 8.2 26.6 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.5 6.6 0.0 0.5 0.0 0.0 4.7 0.0 0.0 0.0 2.4 6.6 0.0 0.9 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 1.5 6.1 14.1 1.1 0.6 0.0 0.0 1.6 0.1 2.5 0.6 0.0 6.4 0.0 2.8 0.0 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.9 3.9 14.1 7.4 14.7 4.5 3.6 3.4 7.3 6.5 2.9 PLCH2 "KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1" ENSG00000149527 "Phospholipase C eta 2" O75038 1 2425980-2505530 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0;retina: 28.6;skin 1: 36.6" "Group enriched" "Detected in some" 4 "HBEC3-KT: 49.5;hTCEpi: 23.3;hTERT-HME1: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 9 "NK-cells: 2.9;T-cells: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072705 Enhanced "HPA072705: " "unprognostic (2.06e-3)" "unprognostic (1.30e-2)" "unprognostic (1.09e-3)" "unprognostic (3.84e-3)" "unprognostic (1.99e-1)" "unprognostic (1.59e-2)" "unprognostic (7.39e-2)" "unprognostic (7.70e-2)" "unprognostic (7.58e-2)" "unprognostic (9.28e-2)" "unprognostic (2.26e-1)" "unprognostic (5.95e-2)" "unprognostic (6.61e-3)" "unprognostic (8.43e-2)" "unprognostic (1.07e-1)" "unprognostic (8.64e-2)" "unprognostic (5.80e-2)" 0.5 1.2 6.4 2.9 9.1 1.4 3.1 32.0 25.1 3.2 0.9 1.6 0.5 1.6 0.3 1.7 9.7 2.5 2.4 0.3 20.2 2.7 0.8 0.8 1.2 4.0 2.6 8.4 0.2 1.7 0.1 3.0 0.4 2.6 6.7 0.7 28.6 8.6 4.9 0.2 36.6 2.0 0.2 6.4 4.0 1.7 0.8 2.0 0.2 1.2 0.2 4.9 8.3 6.4 0.3 0.1 0.0 0.0 2.9 2.4 0.9 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 6.9 0.0 49.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 13.9 0.0 0.0 1.2 0.1 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 2.7 5.6 1.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.9 0.3 1.5 1.4 0.0 0.3 1.1 0.7 0.0 2.9 0.0 0.1 2.1 0.9 6.4 9.1 32.0 25.1 20.2 2.7 2.6 8.4 2.6 2.0 PLCL1 "PLC-L, PLCE, PLCL, PPP1R127, PRIP" ENSG00000115896 "Phospholipase C like 1 (inactive)" Q15111 2 197804702-198572581 "FDA approved drug targets, Predicted intracellular proteins" Transducer "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.9" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 8.6;K-562: 14.4;Karpas-707: 10.9;MOLT-4: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.1" "Lineage enriched" "Detected in single" 6 "T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031849 Enhanced "HPA031849: AB_10602192" "unprognostic (7.77e-3)" "unprognostic (2.57e-1)" "unprognostic (2.09e-1)" "unprognostic (5.18e-3)" "unprognostic (4.40e-2)" "unprognostic (7.14e-2)" "unprognostic (2.05e-1)" "unprognostic (4.42e-3)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" "unprognostic (3.02e-2)" "unprognostic (7.42e-2)" "prognostic favourable (3.91e-7)" "unprognostic (1.07e-4)" "unprognostic (6.74e-2)" "unprognostic (1.68e-1)" "unprognostic (3.20e-2)" 4.4 5.2 11.1 3.3 26.0 2.2 4.4 3.4 16.3 5.3 4.5 21.2 3.4 1.3 15.4 3.9 4.3 4.1 3.7 32.8 14.9 10.9 32.8 1.3 3.9 4.4 34.9 8.8 8.1 2.2 20.7 3.0 8.4 19.9 11.8 2.1 4.8 2.9 8.2 28.4 1.8 2.5 6.7 23.0 2.5 3.1 2.3 26.9 22.1 4.0 3.2 3.2 5.3 2.9 0.0 0.1 0.6 0.1 0.0 4.1 0.2 0.0 0.0 0.1 0.0 1.7 0.4 0.0 0.4 0.2 0.1 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 1.5 0.0 0.2 0.2 1.9 4.2 0.0 0.0 0.0 8.6 14.4 10.9 0.1 0.4 10.0 0.0 0.1 0.0 0.0 0.0 4.4 0.2 0.0 1.7 0.9 1.8 0.0 2.5 0.3 0.0 0.7 0.2 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 2.5 0.0 1.8 0.0 0.1 0.0 1.3 0.4 0.6 0.0 0.1 0.0 4.1 0.2 11.1 26.0 3.4 16.3 14.9 10.9 34.9 8.8 19.9 26.9 PLCL2 "KIAA1092, PLCE2" ENSG00000154822 "Phospholipase C like 2" Q9UPR0 3 16802651-17090594 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 15.4;Daudi: 16.8;HAP1: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047616, HPA061728" Enhanced "HPA047616: , HPA061728: " "unprognostic (2.95e-2)" "unprognostic (8.09e-2)" "unprognostic (3.96e-2)" "unprognostic (6.35e-2)" "unprognostic (1.59e-1)" "unprognostic (3.83e-3)" "unprognostic (1.83e-1)" "unprognostic (9.31e-2)" "unprognostic (3.22e-2)" "unprognostic (8.72e-2)" "unprognostic (5.93e-3)" "unprognostic (1.29e-2)" "prognostic favourable (2.98e-10)" "unprognostic (2.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.70e-1)" "unprognostic (9.97e-2)" 6.7 9.2 5.6 9.0 7.9 9.6 5.3 32.0 9.2 5.1 5.1 2.0 1.7 7.0 7.3 6.9 1.5 4.8 5.2 11.3 4.9 3.4 8.1 5.8 4.3 12.3 3.0 7.4 14.1 4.7 0.5 7.8 5.5 8.0 2.7 6.2 3.1 3.6 1.5 22.7 2.1 7.6 4.5 3.8 13.0 5.6 3.2 3.4 7.3 4.0 1.0 8.0 3.4 3.1 2.4 1.6 3.0 1.8 10.0 4.9 1.7 0.0 1.3 1.7 0.0 6.7 15.4 1.4 1.2 3.5 0.6 1.4 0.0 1.3 16.8 0.0 1.1 0.0 17.3 0.6 1.3 8.0 3.6 0.0 1.9 0.0 0.2 2.6 1.9 2.4 0.1 4.9 0.0 3.0 3.9 6.6 0.0 0.0 2.9 0.3 3.5 1.8 6.4 0.0 9.1 0.0 0.2 5.7 2.5 0.7 2.1 0.5 0.0 2.7 3.1 0.9 1.2 0.7 2.8 6.3 0.0 10.9 0.9 3.5 0.6 1.2 1.4 2.8 3.6 1.5 4.5 2.2 3.4 4.9 1.6 2.4 3.3 3.7 3.0 10.0 1.8 0.9 2.4 1.7 5.6 7.9 32.0 9.2 4.9 3.4 3.0 7.4 8.0 3.4 PLCXD1 FLJ11323 ENSG00000182378 "Phosphatidylinositol specific phospholipase C X domain containing 1" Q9NUJ7 X 276322-303356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.3" "Cell line enhanced" "Detected in many" "HEL: 53.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 42.3;cerebellum: 24.6;cerebral cortex: 19.1;pons and medulla: 29.2" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA007721 Approved Approved Cytosol Cytosol "HPA007721: AB_1079630" "unprognostic (2.73e-2)" "unprognostic (5.67e-2)" "unprognostic (4.57e-2)" "prognostic unfavourable (8.10e-4)" "unprognostic (3.80e-2)" "prognostic favourable (2.50e-4)" "unprognostic (1.47e-3)" "unprognostic (7.92e-2)" "unprognostic (1.72e-2)" "unprognostic (4.80e-2)" "unprognostic (7.25e-2)" "unprognostic (1.11e-3)" "prognostic unfavourable (7.82e-14)" "unprognostic (6.01e-2)" "unprognostic (1.95e-1)" "unprognostic (3.59e-2)" "unprognostic (1.78e-1)" 7.4 1.5 6.5 5.3 42.3 18.8 8.7 24.6 19.1 8.9 3.7 2.1 2.1 5.3 9.1 2.1 11.4 3.5 5.3 2.8 7.1 4.2 3.1 5.4 3.5 10.0 4.8 3.6 19.3 4.3 2.3 5.5 12.5 29.2 3.5 3.5 2.1 7.0 2.4 4.5 11.6 5.9 2.1 22.2 10.5 17.3 3.6 6.7 2.1 5.1 2.1 5.4 4.7 7.9 5.8 2.9 6.3 11.9 1.8 4.1 2.7 8.7 33.4 8.1 12.1 1.7 1.3 6.4 7.9 0.9 4.2 4.1 13.5 9.5 11.2 5.5 3.4 2.7 2.0 5.2 2.2 6.7 14.9 53.0 10.8 18.0 5.2 5.4 20.9 6.9 0.7 15.6 1.6 3.2 13.8 6.1 3.0 2.7 16.3 8.0 17.2 6.5 9.3 4.4 16.4 1.3 4.1 8.7 4.6 8.0 4.8 7.3 9.1 7.5 2.3 5.6 9.0 6.1 8.6 2.1 5.5 26.0 3.7 14.4 6.0 4.3 3.8 6.3 2.8 8.1 3.9 2.3 2.2 3.4 2.9 5.8 2.8 2.7 4.9 1.8 11.9 2.7 4.1 2.7 6.5 42.3 24.6 19.1 7.1 4.2 4.8 3.6 29.2 6.7 PLCXD3 ENSG00000182836 "Phosphatidylinositol specific phospholipase C X domain containing 3" Q63HM9 5 41306954-41510628 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.4;heart muscle: 36.6;ovary: 27.6" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.2;PC-3: 5.5;SH-SY5Y: 25.7;TIME: 13.4" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "cerebellum: 33.4" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Lineage enriched" "Detected in single" 15 "granulocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046849 Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA046849: " "unprognostic (1.71e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" "unprognostic (7.04e-3)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (4.90e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-2)" "unprognostic (3.12e-1)" "unprognostic (6.38e-3)" "unprognostic (2.57e-1)" "unprognostic (2.73e-2)" "unprognostic (2.15e-3)" "unprognostic (5.91e-5)" "unprognostic (5.11e-2)" "unprognostic (6.75e-2)" 7.0 15.3 6.9 1.2 4.5 0.8 4.5 33.4 6.5 4.5 1.4 2.0 1.4 1.3 1.6 1.7 1.4 2.5 3.4 36.6 4.8 8.1 7.3 2.2 2.0 7.9 4.2 4.2 27.6 4.8 1.3 13.7 0.8 9.0 1.9 1.5 0.5 1.2 2.0 0.9 0.9 1.7 2.1 5.8 0.9 5.9 1.1 2.1 0.0 1.4 0.0 1.0 1.4 6.1 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 1.3 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.3 25.7 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 6.9 4.5 33.4 5.5 4.8 8.1 4.2 4.2 9.0 2.1 PLD5 FLJ40773 ENSG00000180287 "Phospholipase D family member 5" Q8N7P1 1 242082986-242524696 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 54.8;retina: 37.7" "Cell line enhanced" "Detected in some" "A549: 3.9;AF22: 13.7;HDLM-2: 6.8;SH-SY5Y: 3.8;U-2 OS: 4.7" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Region enriched" "Detected in all" 4 "cerebellum: 54.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028389, HPA050367" Approved Vesicles,Mitochondria,Cytosol Mitochondria "Vesicles, Cytosol" "HPA028389: AB_10602145, HPA050367: " "unprognostic (5.20e-2)" "unprognostic (1.05e-1)" "unprognostic (9.14e-2)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (8.77e-2)" "unprognostic (4.36e-1)" "unprognostic (1.95e-1)" "unprognostic (2.08e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-5)" "unprognostic (2.79e-2)" "unprognostic (4.46e-1)" "unprognostic (3.44e-3)" "unprognostic (2.18e-1)" 1.1 5.4 5.0 0.4 3.7 0.4 1.6 54.8 7.6 2.2 0.8 7.7 0.0 0.4 3.5 0.9 1.6 1.8 0.8 0.8 4.4 4.6 1.5 0.5 0.8 3.3 5.4 2.5 6.6 3.1 1.4 7.2 1.5 12.7 2.7 0.6 37.7 2.2 9.3 0.8 0.6 0.5 2.9 6.0 2.2 0.8 4.2 6.2 0.0 1.0 0.0 1.5 0.4 1.0 0.4 0.2 1.0 0.2 0.3 0.4 0.0 0.0 3.9 13.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 6.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.5 2.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.2 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.4 0.3 0.4 1.0 0.3 0.2 0.2 0.2 0.0 5.0 3.7 54.8 5.5 4.4 4.6 5.4 2.5 12.7 6.2 PLEKHA6 "KIAA0969, PEPP3" ENSG00000143850 "Pleckstrin homology domain containing A6" Q9Y2H5 1 204218851-204377665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.1" "Cell line enhanced" "Detected in many" "A-431: 20.6;BEWO: 33.5;CAPAN-2: 28.0;RT4: 23.2;SK-BR-3: 20.7;T-47d: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028152 Enhanced Approved "Vesicles,Cell Junctions" "Cell Junctions" Vesicles "HPA028152: AB_10601048" "unprognostic (9.81e-3)" "unprognostic (3.05e-1)" "unprognostic (1.59e-2)" "unprognostic (3.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (1.38e-2)" "unprognostic (9.01e-2)" "unprognostic (3.32e-1)" "unprognostic (9.60e-3)" "unprognostic (1.53e-1)" "unprognostic (5.02e-3)" "unprognostic (1.23e-1)" "unprognostic (8.22e-2)" "unprognostic (5.17e-2)" "prognostic favourable (3.57e-4)" 2.4 4.6 18.2 4.1 27.8 0.4 10.6 60.1 34.5 3.4 23.2 13.4 1.4 18.2 2.6 10.0 13.0 7.4 9.8 11.8 14.2 11.4 20.9 13.9 2.4 0.6 11.5 23.3 2.8 7.6 3.7 17.6 6.3 18.9 9.4 21.9 21.7 5.2 11.2 2.6 2.0 20.8 4.8 19.0 1.9 29.1 2.7 14.2 0.0 2.2 1.3 1.9 7.3 6.1 0.9 1.4 0.1 0.2 0.0 0.4 0.0 20.6 13.0 8.2 0.0 0.1 0.2 33.5 0.7 2.3 0.0 0.1 6.2 28.0 0.1 6.2 0.4 2.3 0.1 2.2 0.1 0.0 1.3 0.0 5.1 8.8 1.2 0.0 0.0 0.3 6.9 0.0 1.8 3.7 0.0 0.0 8.5 9.2 0.0 0.0 2.6 15.9 0.0 0.0 0.0 8.3 23.2 1.7 17.2 9.4 20.7 0.1 19.7 0.1 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 18.2 27.8 60.1 34.5 14.2 11.4 11.5 23.3 18.9 14.2 PLEKHB1 "KPL1, PHR1, PHRET1" ENSG00000021300 "Pleckstrin homology domain containing B1" Q9UF11 11 73646178-73662819 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 220.2" "Cell line enhanced" "Detected in many" "EFO-21: 10.4;Hep G2: 38.0;U-266/84: 14.5" "Cancer enhanced" "Detected in all" "glioma: 59.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 33.1" "Lineage enriched" "Detected in many" 5 "T-cells: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.20e-1)" "unprognostic (5.07e-1)" "unprognostic (2.91e-1)" "unprognostic (9.72e-2)" "unprognostic (2.16e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-2)" "unprognostic (1.41e-3)" "unprognostic (3.01e-1)" "unprognostic (3.94e-2)" "prognostic favourable (6.02e-4)" "unprognostic (3.59e-1)" "prognostic favourable (1.99e-6)" "unprognostic (2.64e-1)" "unprognostic (7.23e-2)" "unprognostic (4.47e-1)" "unprognostic (7.44e-2)" 2.0 4.3 87.5 4.3 85.7 1.6 5.8 18.4 144.2 4.2 5.9 120.2 0.4 6.3 2.5 8.3 3.3 12.5 5.8 7.0 89.2 72.8 6.5 1.7 8.0 4.8 143.1 48.7 1.9 11.4 45.4 12.9 1.5 70.1 5.1 5.3 27.8 25.9 5.4 4.8 1.3 7.0 2.5 220.2 2.9 10.1 5.6 69.5 0.0 14.5 0.0 4.4 2.3 0.7 6.9 0.3 0.4 0.1 1.5 33.1 9.9 0.3 1.0 2.4 1.9 1.0 0.3 0.1 0.1 0.0 0.1 0.1 4.2 8.1 0.0 10.4 0.2 0.2 1.3 0.2 0.2 5.4 6.4 0.0 0.4 38.0 0.6 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 5.4 0.1 3.1 2.6 0.1 1.6 0.5 1.9 0.0 1.2 0.4 0.7 6.1 1.4 0.0 0.1 0.6 2.8 0.5 0.0 0.0 1.2 0.1 0.7 9.1 14.5 5.4 1.4 0.0 0.3 0.0 0.1 0.4 6.5 0.0 15.9 6.9 16.1 11.8 0.2 2.9 33.1 18.4 0.3 1.5 0.0 0.3 9.3 9.9 87.5 85.7 18.4 47.9 89.2 72.8 143.1 48.7 70.1 69.5 PLEKHD1 UPF0639 ENSG00000175985 "Pleckstrin homology and coiled-coil domain containing D1" A6NEE1 14 69484692-69531551 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.4;brain: 16.0" "Cell line enhanced" "Detected in some" "SK-BR-3: 6.2;T-47d: 5.9;U-266/70: 2.8" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "cerebellum: 16.0" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 7.4" "Lineage enriched" "Detected in single" 12 "dendritic cells: 7.4" "Region enhanced" "Detected in many" "cerebellum: 33.7" "Low region specificity" "Detected in all" HPA051875 Uncertain "HPA051875: " "unprognostic (8.73e-2)" "unprognostic (4.64e-3)" "unprognostic (3.73e-2)" "unprognostic (4.03e-2)" "unprognostic (7.58e-2)" "unprognostic (3.15e-3)" "unprognostic (1.44e-1)" "unprognostic (1.64e-3)" "unprognostic (3.28e-1)" "unprognostic (1.83e-1)" "unprognostic (4.56e-3)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (8.08e-2)" "unprognostic (2.28e-1)" "unprognostic (2.74e-2)" "unprognostic (1.42e-2)" 0.3 0.3 0.4 0.1 1.5 1.1 1.4 16.0 2.2 0.5 0.2 0.5 2.5 0.3 0.2 4.2 0.2 0.2 0.2 0.3 0.6 0.5 1.8 0.1 0.4 2.0 0.8 0.1 0.2 0.5 4.5 0.6 0.1 1.4 0.2 0.0 4.1 3.9 4.0 0.2 2.0 0.2 0.1 0.6 0.4 0.3 1.8 0.4 0.8 4.0 0.1 0.5 0.2 0.2 0.2 7.4 0.6 0.1 0.1 0.1 0.0 0.3 0.3 0.5 0.9 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.7 0.5 0.5 0.1 0.5 0.8 0.1 0.1 0.5 0.4 0.1 0.4 0.1 0.1 0.5 0.7 0.1 0.3 0.0 0.1 0.0 0.2 1.2 0.1 0.9 0.4 0.4 0.7 0.1 0.3 0.1 0.2 0.5 0.5 0.8 1.9 0.2 6.2 0.1 5.9 0.2 0.2 0.3 0.8 0.4 0.3 2.8 0.6 0.3 0.2 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.6 0.1 0.1 7.4 0.1 0.0 0.4 1.5 16.0 2.2 0.6 0.5 0.8 0.1 1.4 0.4 PLEKHG5 "GEF720, KIAA0720, Syx, Tech" ENSG00000171680 "Pleckstrin homology and RhoGEF domain containing G5" O94827 1 6466092-6520061 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.8;skin 1: 60.0" "Cell line enhanced" "Detected in many" "TIME: 17.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 18.7;basal ganglia: 13.2;cerebral cortex: 26.7;hippocampal formation: 40.2" "Low region specificity" "Detected in all" HPA049570 Uncertain Approved Nucleoplasm Nucleoplasm "HPA049570: " "unprognostic (5.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.47e-1)" "unprognostic (2.81e-1)" "unprognostic (1.50e-3)" "unprognostic (5.10e-2)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (4.40e-2)" "unprognostic (1.02e-2)" "unprognostic (4.85e-1)" "unprognostic (2.70e-2)" "unprognostic (1.28e-3)" "unprognostic (4.85e-1)" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (4.85e-2)" 10.6 9.7 8.7 2.9 6.3 0.7 4.1 59.8 11.6 3.9 3.0 1.2 2.5 3.3 3.8 4.5 7.1 3.9 6.5 5.4 7.7 2.9 2.3 0.8 3.6 2.7 1.8 6.7 2.6 3.1 4.0 15.2 7.6 4.4 3.4 2.8 4.9 4.2 5.3 3.4 60.0 4.3 2.7 1.8 16.9 2.6 2.6 1.4 0.0 2.4 6.5 4.8 2.3 4.4 0.5 0.6 2.1 0.5 0.3 1.0 0.4 3.9 1.1 8.0 4.7 0.8 2.7 1.4 5.4 3.0 1.7 1.0 2.3 7.9 0.1 12.4 1.7 13.6 0.9 11.9 0.8 7.8 1.5 0.0 5.5 1.4 1.2 0.0 0.7 2.9 6.4 5.8 6.8 12.1 0.0 1.0 0.4 3.4 0.1 15.4 2.5 12.0 0.0 1.0 1.0 4.3 1.3 5.2 14.7 0.6 4.1 0.3 5.3 0.1 17.3 4.1 3.0 0.0 3.3 0.1 0.0 0.9 4.5 0.0 0.3 1.8 0.5 0.3 0.4 0.4 1.0 0.2 0.8 0.7 0.1 0.5 0.5 0.6 2.1 0.3 0.2 0.6 0.2 0.4 8.7 6.3 59.8 11.6 7.7 2.9 1.8 6.7 4.4 1.4 PLEKHH1 KIAA1200 ENSG00000054690 "Pleckstrin homology, MyTH4 and FERM domain containing H1" Q9ULM0 14 67533301-67589612 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.0;thyroid gland: 30.2" "Cell line enhanced" "Detected in many" "AN3-CA: 9.9;BEWO: 9.6;RT4: 9.7;SK-MEL-30: 12.0;T-47d: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047707, HPA051964" Uncertain Approved Centrosome Centrosome "HPA047707: , HPA051964: " "unprognostic (2.47e-2)" "unprognostic (9.57e-2)" "unprognostic (3.94e-2)" "prognostic favourable (8.03e-5)" "unprognostic (4.74e-1)" "unprognostic (9.15e-3)" "unprognostic (8.43e-5)" "unprognostic (1.54e-2)" "unprognostic (2.28e-1)" "unprognostic (4.14e-2)" "unprognostic (3.72e-2)" "unprognostic (1.85e-1)" "prognostic favourable (4.03e-7)" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "prognostic favourable (2.26e-4)" 1.3 4.5 9.7 1.6 33.7 0.5 2.9 8.6 26.8 3.5 6.8 61.0 2.5 11.6 1.9 8.9 1.6 3.8 2.5 1.1 16.2 8.7 2.7 0.8 1.2 0.6 35.8 16.6 0.6 7.7 10.3 3.3 2.0 26.9 10.7 7.0 5.1 20.3 2.9 1.1 4.1 9.0 1.3 38.1 1.3 6.6 2.3 34.4 0.0 30.2 0.0 0.7 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 1.2 2.0 9.9 0.2 0.0 9.6 0.0 0.0 0.1 0.1 3.1 1.5 0.0 1.6 0.0 2.2 3.5 0.8 0.1 0.3 3.4 0.0 1.6 1.9 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 3.7 0.0 0.0 7.1 0.0 0.2 3.0 0.6 0.1 0.3 1.4 1.1 9.7 2.7 2.5 0.8 1.8 12.0 9.5 2.0 0.0 0.8 3.6 0.9 0.6 0.0 0.0 0.0 0.5 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 33.7 8.6 18.1 16.2 8.7 35.8 16.6 26.9 34.4 PLK5 "PLK5P, SgK384ps" ENSG00000185988 "Polo like kinase 5" Q496M5 19 1524074-1536046 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 50.1" "Cell line enhanced" "Detected in some" "Daudi: 5.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in all" 6 "cerebellum: 50.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA035024 Enhanced "HPA035024: " "unprognostic (4.32e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (7.69e-2)" "unprognostic (1.11e-2)" "unprognostic (1.33e-1)" "unprognostic (2.69e-1)" "unprognostic (8.38e-2)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" "unprognostic (3.36e-2)" "unprognostic (9.94e-3)" "unprognostic (2.18e-3)" "unprognostic (3.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.54e-2)" "unprognostic (4.01e-4)" 0.4 0.7 8.3 0.4 4.8 1.7 0.8 50.1 7.9 5.9 0.4 1.6 0.3 0.5 6.4 6.2 1.6 2.7 0.4 0.3 3.2 1.7 0.3 0.3 0.3 0.4 1.1 1.9 0.8 0.6 0.5 0.5 0.3 2.9 0.9 0.4 8.4 0.6 3.2 0.5 1.0 0.7 2.8 0.8 0.4 0.2 7.4 1.8 0.0 0.4 0.0 0.3 0.2 2.9 1.2 1.2 4.4 0.9 1.0 1.1 0.1 0.2 0.9 0.8 1.2 0.4 0.9 1.0 0.2 0.5 0.5 0.4 0.5 1.0 5.0 0.3 0.5 1.2 0.8 0.5 0.2 0.5 0.6 1.0 1.3 0.8 0.1 0.2 1.1 1.0 0.3 0.8 0.2 0.3 0.8 1.7 0.8 1.0 0.4 1.0 1.4 0.9 1.0 0.3 0.4 0.6 0.1 0.5 0.7 0.7 0.4 0.3 1.5 0.7 0.0 0.9 1.0 1.2 0.2 1.5 0.4 0.6 0.4 0.7 0.5 1.6 0.9 2.2 0.8 0.5 0.5 0.7 0.8 0.5 0.2 1.2 1.1 0.6 4.4 1.0 0.6 1.2 1.0 0.1 8.3 4.8 50.1 7.9 3.2 1.7 1.1 1.9 2.9 1.8 PLLP "PMLP, TM4SF11" ENSG00000102934 Plasmolipin Q9Y342 16 57248547-57284687 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 92.3" "Cell line enhanced" "Detected in many" "EFO-21: 14.0;Hep G2: 38.7;RPTEC TERT1: 16.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "naive CD4 T-cell: 15.1;naive CD8 T-cell: 5.7" "Lineage enriched" "Detected in many" 8 "T-cells: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041862 Enhanced "HPA041862: " "unprognostic (7.96e-2)" "unprognostic (2.07e-3)" "unprognostic (3.86e-2)" "prognostic favourable (2.80e-4)" "unprognostic (3.19e-1)" "unprognostic (1.42e-1)" "unprognostic (9.56e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (5.64e-2)" "unprognostic (6.99e-3)" "unprognostic (2.83e-2)" "prognostic favourable (6.21e-9)" "unprognostic (2.06e-2)" "unprognostic (9.06e-3)" "unprognostic (3.86e-1)" "unprognostic (3.32e-2)" 3.5 2.3 35.9 1.8 46.1 1.8 7.8 5.6 45.6 15.6 12.0 92.3 13.1 20.2 4.3 2.0 10.1 14.3 16.8 2.8 52.5 26.8 19.2 3.6 22.1 1.8 42.3 25.0 1.4 28.4 4.7 1.1 2.1 32.3 3.2 8.1 3.5 25.3 18.7 2.6 25.5 19.5 2.0 46.2 6.1 42.8 3.0 40.3 0.0 7.0 1.4 3.3 6.9 5.8 1.2 0.5 1.9 1.1 0.6 15.1 2.2 0.8 2.8 3.6 0.7 0.0 0.0 1.8 0.5 0.1 0.2 0.1 7.8 3.4 0.3 14.0 0.0 2.6 1.7 2.4 0.0 0.8 1.4 3.5 1.5 38.7 0.5 0.3 1.0 0.1 0.6 0.0 0.3 4.0 0.6 1.0 0.0 1.0 0.4 0.9 3.0 1.2 0.4 0.7 0.7 16.5 8.4 0.8 1.4 0.9 1.1 1.6 5.8 1.2 3.0 0.7 0.8 0.5 0.6 0.7 0.8 0.5 0.8 0.2 2.4 1.3 1.1 0.6 0.8 0.5 0.6 0.7 2.1 0.6 0.2 1.2 15.1 5.7 1.9 0.6 0.4 0.5 0.6 2.2 35.9 46.1 5.6 41.1 52.5 26.8 42.3 25.0 32.3 40.3 PLP1 "GPM6C, PLP, SPG2" ENSG00000123560 "Proteolipid protein 1" P60201 X 103773718-103792619 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "brain: 463.6" "Group enriched" "Detected in some" 5 "SK-MEL-30: 66.3;WM-115: 39.6" "Group enriched" "Detected in many" 22 "glioma: 160.5;melanoma: 75.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "plasmacytoid DC: 2.3" "Lineage enriched" "Detected in single" 9 "dendritic cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004128 Enhanced "HPA004128: AB_1079635" "unprognostic (5.72e-2)" "unprognostic (1.77e-2)" "unprognostic (2.27e-2)" "unprognostic (4.09e-3)" "unprognostic (1.32e-1)" "unprognostic (3.95e-2)" "unprognostic (2.57e-2)" "unprognostic (1.02e-1)" "unprognostic (5.92e-2)" "unprognostic (2.28e-2)" "unprognostic (1.21e-1)" "unprognostic (1.62e-5)" "unprognostic (4.91e-2)" "unprognostic (1.86e-1)" "unprognostic (3.46e-2)" "unprognostic (1.16e-2)" 3.6 5.6 90.6 2.8 109.9 1.9 3.1 8.9 463.6 3.9 5.7 208.1 0.0 3.3 3.6 3.5 4.2 2.5 4.0 5.0 143.8 73.8 2.1 2.1 2.1 2.0 174.8 42.2 3.0 2.2 17.9 0.3 1.9 124.4 3.6 5.4 0.0 3.4 9.3 2.2 7.3 5.1 7.0 453.8 2.0 2.8 9.2 145.2 0.0 2.0 0.0 2.0 2.7 0.8 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 39.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 90.6 109.9 8.9 68.1 143.8 73.8 174.8 42.2 124.4 145.2 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120456954-120589855 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5;kidney: 12.6" "Cell line enhanced" "Detected in some" "BJ: 15.1;fHDF/TERT166: 10.7;TIME: 12.0;U-138 MG: 9.6;U-251 MG: 46.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA045188: " "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.6 1.7 11.4 1.2 13.6 4.9 3.1 11.6 18.2 3.4 1.2 12.1 1.0 0.7 1.7 2.7 0.9 1.2 11.3 0.7 15.9 17.4 12.6 2.8 0.5 0.6 15.5 6.0 0.6 0.6 0.4 0.5 0.6 26.5 3.0 0.8 0.0 2.0 6.1 0.4 1.7 0.8 1.5 19.1 0.5 1.2 11.1 12.5 0.0 1.5 0.0 0.5 0.8 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 1.1 2.3 1.4 0.1 1.3 0.0 0.0 10.7 0.1 0.9 0.2 1.2 1.4 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 1.1 0.0 8.7 0.9 2.1 0.9 0.0 0.0 0.0 0.9 2.7 0.0 0.0 0.0 4.4 0.0 0.8 0.2 0.7 0.0 0.7 1.9 0.0 12.0 9.6 5.3 0.5 46.4 0.0 0.0 0.0 8.9 0.0 2.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.6 11.6 10.0 15.9 17.4 15.5 6.0 26.5 12.5 PLPPR1 "FLJ20300, LPPR1, MGC26189, PRG-3" ENSG00000148123 "Phospholipid phosphatase related 1" Q8TBJ4 9 101028709-101325135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 38.5;kidney: 24.4" "Group enriched" "Detected in some" 4 "Hep G2: 5.6;SCLC-21H: 10.3" "Group enriched" "Detected in some" 5 "glioma: 11.1;liver cancer: 5.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014760, HPA014968, HPA014979" Supported Supported Nucleoplasm Nucleoplasm "HPA014760: , HPA014968: AB_1855702, HPA014979: " "unprognostic (1.08e-2)" "unprognostic (2.79e-1)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (7.33e-2)" "unprognostic (3.41e-1)" "prognostic favourable (1.37e-4)" "unprognostic (2.09e-1)" "unprognostic (1.14e-1)" "unprognostic (9.86e-4)" "unprognostic (1.44e-1)" "unprognostic (1.65e-6)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (4.83e-2)" 0.8 0.9 12.6 0.7 38.5 0.7 1.4 1.7 24.4 1.0 0.9 7.6 0.0 0.8 0.8 5.2 0.8 1.0 0.9 0.8 12.7 7.0 24.4 5.0 2.8 0.7 7.5 5.5 0.7 1.1 0.7 0.1 0.8 5.3 1.0 1.0 0.1 1.1 0.8 0.8 0.8 0.8 0.8 10.2 0.7 0.9 1.5 9.3 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.9 10.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 38.5 1.7 6.4 12.7 7.0 7.5 5.5 5.3 9.3 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821977 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6" "Group enriched" "Detected in some" 6 "NB-4: 23.5;THP-1: 49.8" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: , HPA057034: " "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.7 0.7 20.5 1.2 30.0 18.2 2.1 0.1 21.3 0.9 0.7 0.7 0.0 0.7 1.3 0.7 0.7 12.6 1.1 0.7 14.4 13.1 0.7 0.7 2.6 0.9 3.9 14.9 1.0 0.7 0.7 0.1 0.8 4.7 0.9 0.7 0.1 0.7 0.8 0.9 0.8 1.0 0.7 1.1 0.9 0.9 3.0 3.1 0.0 0.7 0.0 0.7 0.8 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 4.8 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.4 0.0 0.1 0.9 0.0 0.0 0.0 2.0 0.0 0.6 0.0 0.2 1.6 0.1 0.6 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.4 0.0 23.5 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.2 0.1 0.0 0.0 2.1 49.8 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 3.8 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 30.0 0.1 21.3 14.4 13.1 3.9 14.9 4.7 3.1 PLPPR4 "KIAA0455, LPPR4, PHP1, PRG-1" ENSG00000117600 "Phospholipid phosphatase related 4" Q7Z2D5 1 99263953-99309590 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 55.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 19.8;BJ hTERT+ SV40 Large T+ RasG12V: 7.7;fHDF/TERT166: 6.7;SH-SY5Y: 14.9;U-138 MG: 7.5;U-87 MG: 12.6" "Cancer enhanced" "Detected in many" "glioma: 7.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "non-classical monocyte: 2.1" "Lineage enriched" "Detected in single" 22 "monocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (4.32e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-2)" "unprognostic (1.67e-2)" "unprognostic (2.95e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-2)" "unprognostic (9.09e-2)" "unprognostic (9.70e-3)" "unprognostic (3.36e-2)" "unprognostic (2.21e-1)" "unprognostic (7.25e-12)" "unprognostic (1.67e-5)" "unprognostic (3.47e-1)" "unprognostic (1.34e-2)" "unprognostic (1.16e-3)" 3.0 1.7 25.1 1.2 25.8 0.8 1.8 2.0 55.3 4.6 1.5 2.6 0.0 1.2 1.7 1.7 3.2 1.3 6.0 1.4 39.2 10.8 1.4 0.8 3.5 1.5 5.2 16.7 0.8 1.5 1.7 9.0 1.9 6.1 1.1 1.9 0.6 1.4 1.3 1.2 4.6 1.5 2.1 2.2 1.3 1.1 5.2 2.7 0.0 1.5 0.4 1.7 7.0 1.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 3.8 19.8 4.4 7.7 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 14.9 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.1 0.0 0.0 0.0 12.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 25.1 25.8 2.0 33.8 39.2 10.8 5.2 16.7 6.1 2.7 PLPPR5 "LPPR5, PAP2, PAP2D, PRG5" ENSG00000117598 "Phospholipid phosphatase related 5" Q32ZL2 1 98890245-99005032 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 18.6;testis: 5.5" "Group enriched" "Detected in some" 7 "PC-3: 12.0;SH-SY5Y: 21.5" "Group enriched" "Detected in some" 13 "glioma: 2.7;renal cancer: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018072, HPA059085" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA018072: AB_1854958, HPA059085: " "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.07e-1)" "prognostic unfavourable (6.22e-4)" "unprognostic (1.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" 0.5 1.8 7.8 0.7 8.7 0.5 0.5 0.8 18.6 1.4 0.6 2.1 0.0 0.7 0.7 0.5 0.6 0.5 0.6 0.5 8.0 6.6 0.7 0.5 0.7 0.5 2.5 4.5 0.6 1.6 0.5 0.3 0.5 3.6 0.6 0.8 1.8 0.5 1.0 0.9 0.6 0.7 0.6 1.0 0.5 0.7 5.5 1.8 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 12.0 0.0 0.0 0.0 0.5 0.1 0.4 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 8.7 0.8 11.6 8.0 6.6 2.5 4.5 3.6 1.8 PLSCR5 ENSG00000231213 "Phospholipid scramblase family member 5" A0PG75 3 146576555-146606216 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.8;intestine: 1.8;parathyroid gland: 5.6" "Cell line enhanced" "Detected in single" "HSkMC: 1.3" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047249 Uncertain "HPA047249: " 0.1 0.0 0.5 0.1 1.8 0.0 0.1 0.1 0.3 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.2 0.1 0.4 0.1 0.1 0.1 5.6 0.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 1.8 0.1 0.1 0.1 0.0 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.1 0.3 0.1 0.5 0.4 0.1 0.1 0.1 PLXNB1 "KIAA0407, PLXN5, SEP" ENSG00000164050 "Plexin B1" O43157 3 48403854-48430051 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040586 Enhanced "Intracellular and membrane" 55000000 "HPA040586: AB_10794034" "unprognostic (1.31e-3)" "unprognostic (7.09e-2)" "unprognostic (9.63e-2)" "unprognostic (8.13e-2)" "unprognostic (3.65e-1)" "prognostic favourable (5.03e-4)" "unprognostic (1.06e-1)" "unprognostic (4.29e-2)" "unprognostic (3.45e-2)" "unprognostic (1.01e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-2)" "prognostic favourable (2.77e-5)" "unprognostic (4.01e-2)" "unprognostic (1.61e-1)" "unprognostic (6.98e-2)" "prognostic favourable (7.60e-4)" 5.8 3.6 23.1 3.7 34.0 1.4 7.5 11.5 25.6 8.4 9.0 47.4 7.2 10.6 10.8 6.7 14.3 25.0 11.3 7.8 26.3 7.4 17.1 14.8 10.8 2.0 48.7 19.3 11.1 24.9 9.1 9.9 7.6 28.9 12.5 6.2 8.8 11.5 18.7 1.0 21.0 9.9 8.5 22.6 6.3 10.1 3.2 34.7 1.4 19.9 3.6 3.0 11.3 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.9 9.1 5.4 3.4 2.7 18.7 2.5 1.4 1.4 0.9 6.0 11.2 0.0 9.1 1.7 8.8 1.9 19.8 0.3 5.0 0.4 0.0 9.5 11.3 5.0 3.9 1.7 4.9 17.4 0.3 4.1 2.3 0.7 0.4 1.4 5.0 0.7 3.4 16.2 1.1 4.4 1.9 0.6 8.6 13.1 4.7 10.1 3.1 18.9 2.8 10.1 3.3 4.5 1.5 4.4 2.1 2.8 0.1 0.0 0.1 0.3 1.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 34.0 11.5 25.6 26.3 7.4 48.7 19.3 28.9 34.7 PLXNB3 "PLEXB3, PLEXR, PLXN6" ENSG00000198753 "Plexin B3" Q9ULL4 X 153764196-153779346 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.3;salivary gland: 28.9" "Cell line enhanced" "Detected in many" "WM-115: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.7" "Lineage enhanced" "Detected in single" "dendritic cells: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048046 Enhanced 17000 "HPA048046: " "prognostic unfavourable (6.13e-4)" "unprognostic (2.60e-1)" "unprognostic (9.10e-4)" "unprognostic (2.30e-2)" "unprognostic (1.45e-1)" "unprognostic (8.53e-2)" "unprognostic (1.15e-3)" "unprognostic (1.29e-1)" "unprognostic (1.23e-1)" "unprognostic (2.17e-1)" "unprognostic (2.66e-1)" "unprognostic (8.76e-2)" "unprognostic (0.00e+0)" "unprognostic (3.68e-2)" "unprognostic (1.14e-1)" "unprognostic (9.73e-3)" "unprognostic (1.98e-2)" 3.7 17.4 15.5 2.9 34.9 1.5 4.5 16.1 46.3 3.5 14.8 45.8 1.8 3.3 8.1 5.3 6.4 3.8 6.1 3.1 19.9 9.4 1.3 1.3 2.1 1.4 39.7 17.3 1.3 5.6 1.1 0.6 1.4 18.4 9.0 3.2 2.8 28.9 10.7 1.4 11.3 3.4 8.9 25.6 1.3 4.4 7.2 40.2 0.0 1.3 0.2 1.2 6.8 3.8 0.1 2.7 0.0 0.0 0.7 0.0 0.7 4.8 0.5 0.6 0.4 0.6 0.4 0.3 4.5 0.9 0.6 1.6 0.0 0.1 0.0 2.9 1.2 0.5 0.0 3.8 0.5 0.1 0.0 3.0 5.4 3.4 1.3 0.0 0.3 1.0 2.8 2.8 1.8 1.8 0.2 1.7 1.2 3.9 0.0 0.7 0.1 7.5 1.4 0.5 0.0 0.7 2.2 1.3 4.1 0.2 4.2 10.1 5.6 0.0 7.9 4.7 2.4 3.7 5.6 1.6 0.4 0.1 10.2 0.2 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 2.7 0.0 0.7 15.5 34.9 16.1 20.8 19.9 9.4 39.7 17.3 18.4 40.2 PMCH MCH ENSG00000183395 "Pro-melanin concentrating hormone" P20382 12 102196459-102197845 "Predicted secreted proteins" "Differentiation, Spermatogenesis" "Developmental protein, Hormone, Neuropeptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 124.8" "Cell line enriched" "Detected in some" 8 "HDLM-2: 30.6" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.8" "Region enriched" "Detected in some" 27 "hypothalamus: 124.8" "Cell type enriched" "Detected in some" 8 "T-reg: 11.3" "Lineage enriched" "Detected in single" 81 "T-cells: 11.3" "Group enriched" "Detected in some" 131 "hypothalamus: 737.6;thalamus: 373.6" "Region enriched" "Detected in single" 30 "hypothalamus: 98.6" "HPA046055, HPA061884" Enhanced Supported "Secreted to blood" 274240 "HPA046055: AB_2679517, HPA061884: AB_2684632" "unprognostic (3.23e-3)" "unprognostic (8.04e-2)" "unprognostic (3.96e-4)" "unprognostic (2.09e-2)" "unprognostic (1.75e-1)" "unprognostic (7.73e-2)" "unprognostic (4.31e-3)" "unprognostic (1.43e-2)" "unprognostic (3.18e-3)" "unprognostic (4.51e-2)" "unprognostic (1.21e-1)" "unprognostic (2.16e-6)" "unprognostic (1.17e-2)" "unprognostic (1.93e-1)" "unprognostic (5.10e-2)" "unprognostic (3.53e-2)" 0.1 0.0 0.3 2.1 2.0 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 1.1 1.0 0.0 0.2 0.6 0.8 124.8 0.1 0.1 0.2 6.4 0.4 0.1 0.1 0.1 0.0 1.4 0.2 4.5 0.2 0.0 0.1 0.2 0.1 0.1 0.9 0.1 0.1 0.9 1.1 2.0 0.2 0.7 1.0 0.1 0.1 1.7 0.2 0.1 0.0 0.0 0.0 0.0 0.1 11.3 0.0 0.3 0.1 0.3 0.3 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.0 30.6 0.1 0.5 0.6 0.3 0.0 1.0 0.4 0.0 0.0 0.0 0.0 3.7 0.7 0.1 0.0 0.0 0.6 1.0 0.5 1.2 0.3 0.6 1.2 0.0 0.2 0.3 0.4 0.4 0.6 0.1 0.2 0.1 0.4 0.4 0.4 0.1 0.5 0.1 0.5 0.4 0.4 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.3 0.0 0.3 2.0 0.1 0.1 0.8 124.8 0.4 0.1 4.5 0.7 PMP2 "FABP8, M-FABP, MP2" ENSG00000147588 "Peripheral myelin protein 2" P02689 8 81440326-81447523 "Predicted intracellular proteins" Transport "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 30 "brain: 124.8" "Cell line enhanced" "Detected in some" "HaCaT: 1.0;Karpas-707: 1.3;U-87 MG: 1.6;WM-115: 5.3" "Cancer enriched" "Detected in some" 59 "glioma: 239.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 26 "midbrain: 78.0;pons and medulla: 111.5" "unprognostic (5.87e-2)" "unprognostic (5.81e-2)" "unprognostic (1.12e-2)" "unprognostic (1.95e-1)" "unprognostic (8.03e-3)" "unprognostic (1.10e-2)" "unprognostic (8.45e-2)" "unprognostic (4.43e-2)" "unprognostic (7.21e-2)" "unprognostic (4.41e-1)" "unprognostic (3.27e-3)" 2.7 2.5 39.2 2.4 36.9 1.5 1.6 13.4 124.8 2.5 2.2 14.5 0.0 1.8 1.6 2.8 2.0 1.7 2.2 2.4 30.4 31.2 1.6 1.6 1.5 1.5 48.3 18.3 1.7 1.8 1.5 0.0 1.5 66.6 2.0 2.0 0.0 2.2 4.2 1.7 1.7 1.9 1.7 106.3 1.5 1.6 1.6 45.8 0.0 1.5 0.0 1.5 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 36.9 13.4 27.8 30.4 31.2 48.3 18.3 66.6 45.8 PNCK "CaMK1b, MGC45419" ENSG00000130822 "Pregnancy up-regulated nonubiquitous CaM kinase" Q6P2M8 X 153669730-153689010 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.4;seminal vesicle: 38.5" "Cell line enriched" "Detected in some" 8 "AN3-CA: 26.5" "Cancer enhanced" "Detected in many" "renal cancer: 15.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007458 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA007458: AB_1079644" "unprognostic (1.56e-1)" "unprognostic (2.56e-1)" "unprognostic (1.16e-2)" "unprognostic (5.95e-3)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-2)" "unprognostic (3.60e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (1.04e-6)" "unprognostic (2.86e-3)" "unprognostic (1.43e-1)" "unprognostic (2.66e-1)" "unprognostic (6.26e-3)" 1.6 1.8 21.4 2.2 35.4 0.6 0.9 3.7 24.9 0.9 21.9 0.9 6.9 3.8 4.2 3.1 14.5 2.9 2.9 3.8 19.5 17.0 1.0 0.5 0.7 0.6 6.1 15.5 0.7 0.5 1.4 0.3 2.4 3.8 12.6 4.2 0.4 0.7 38.5 2.2 1.4 5.2 15.3 2.6 0.7 5.5 4.7 1.7 0.0 0.5 0.0 0.7 10.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 26.5 0.0 0.0 2.8 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.4 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.1 0.0 0.1 2.1 0.2 0.3 0.0 0.2 1.1 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 35.4 3.7 23.2 19.5 17.0 6.1 15.5 3.8 1.7 PNMA2 "MA2, RGAG2" ENSG00000240694 "PNMA family member 2" Q9UL42 8 26504686-26514092 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 82.6" "Cell line enhanced" "Detected in many" "AF22: 27.8;HAP1: 17.2;HUVEC TERT2: 16.4;NTERA-2: 15.3;SH-SY5Y: 20.0;U-87 MG: 16.1" "Cancer enhanced" "Detected in many" "glioma: 28.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 3.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001936 Enhanced "HPA001936: AB_1079647" "unprognostic (1.25e-2)" "unprognostic (1.27e-2)" "unprognostic (6.39e-2)" "unprognostic (1.43e-6)" "unprognostic (1.18e-1)" "unprognostic (1.37e-1)" "unprognostic (8.76e-2)" "prognostic favourable (1.81e-4)" "unprognostic (4.66e-2)" "unprognostic (1.34e-2)" "unprognostic (1.46e-2)" "unprognostic (1.52e-1)" "unprognostic (9.98e-2)" "prognostic unfavourable (6.23e-4)" "unprognostic (5.12e-2)" "unprognostic (4.58e-5)" "unprognostic (9.00e-3)" 2.6 9.5 24.4 1.9 33.2 1.3 2.5 5.9 82.6 4.1 1.9 4.3 0.0 1.7 1.8 1.9 1.5 3.0 4.0 2.9 21.6 36.7 3.0 1.7 6.1 1.4 14.5 26.8 1.4 4.0 2.1 5.1 1.5 16.6 1.7 1.8 1.7 1.2 1.8 1.4 1.6 1.9 2.5 7.0 1.4 3.4 2.3 4.6 0.0 3.1 0.0 1.3 2.6 0.4 0.9 0.4 3.0 0.3 0.4 0.5 0.1 0.0 5.1 27.8 0.3 5.5 1.1 0.0 1.4 7.5 3.4 1.1 0.2 3.7 0.0 1.0 0.5 0.1 17.2 0.0 2.6 0.0 3.1 0.0 3.8 0.0 0.4 0.0 0.2 1.9 0.0 14.8 0.1 16.4 0.0 0.0 2.1 0.1 8.1 0.0 15.3 0.0 0.0 5.6 0.0 8.3 1.8 13.6 20.0 0.0 0.0 0.8 0.1 0.5 8.1 0.3 5.7 7.1 1.1 2.6 1.9 0.0 16.1 0.0 0.4 3.0 0.3 0.2 0.4 0.1 0.2 0.3 0.2 0.2 0.1 0.9 0.3 0.5 0.9 0.4 0.2 0.4 0.2 0.1 24.4 33.2 5.9 42.3 21.6 36.7 14.5 26.8 16.6 4.6 PNMA3 "MA3, MA5, MGC132756, MGC132758" ENSG00000183837 "PNMA family member 3" Q9UL41 X 153056409-153060467 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 17.4;epididymis: 35.5" "Cell line enhanced" "Detected in some" "HMC-1: 1.8;NTERA-2: 8.0;SCLC-21H: 2.6;SH-SY5Y: 2.0;THP-1: 2.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047920 Approved "HPA047920: " "unprognostic (1.66e-2)" "unprognostic (8.97e-3)" "unprognostic (8.70e-2)" "prognostic unfavourable (4.14e-5)" "unprognostic (9.43e-2)" "unprognostic (3.10e-3)" "unprognostic (1.16e-1)" "unprognostic (3.77e-4)" "unprognostic (2.84e-2)" "unprognostic (6.20e-2)" "unprognostic (7.62e-4)" "unprognostic (1.93e-1)" "unprognostic (5.92e-3)" "unprognostic (2.93e-3)" "unprognostic (7.25e-2)" "unprognostic (7.84e-2)" "unprognostic (2.07e-2)" 0.4 1.4 4.8 0.8 6.8 0.4 0.3 3.0 17.4 0.5 0.3 0.2 0.0 0.4 0.5 35.5 0.3 1.2 0.4 1.4 4.9 1.0 0.3 0.3 1.4 0.0 13.7 0.6 0.5 0.4 0.7 0.3 11.2 0.5 0.3 0.7 0.4 0.6 0.3 0.6 0.5 0.3 1.3 0.8 0.3 5.9 0.0 0.0 0.9 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 8.0 0.0 0.1 0.0 0.3 0.0 0.0 2.6 2.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 PNMA5 KIAA1934 ENSG00000198883 "PNMA family member 5" Q96PV4 X 152988824-152994127 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "brain: 21.6;testis: 16.8" "Group enriched" "Detected in some" 573 "HMC-1: 62.0;U-266/70: 97.6;U-266/84: 58.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "HPA044690, HPA073946" Enhanced "HPA044690: , HPA073946: " "unprognostic (5.25e-2)" "unprognostic (1.03e-2)" "prognostic unfavourable (2.25e-4)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (9.98e-3)" "unprognostic (3.55e-2)" "prognostic favourable (3.16e-4)" "unprognostic (1.15e-1)" "unprognostic (1.16e-3)" "unprognostic (2.66e-2)" "unprognostic (1.11e-1)" "unprognostic (4.76e-9)" "unprognostic (1.00e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (1.41e-2)" 0.4 0.3 8.2 0.5 21.6 0.4 0.3 0.0 11.6 0.3 0.4 0.3 0.0 0.5 0.4 0.5 0.4 0.4 0.4 0.4 3.9 19.1 0.4 0.4 0.4 0.6 1.0 6.6 0.3 0.3 0.3 0.6 0.7 2.4 0.3 0.4 0.0 0.4 0.4 0.3 1.2 0.4 0.4 0.5 1.1 0.7 16.8 0.0 0.0 0.4 0.0 0.5 0.5 0.0 0.8 0.7 0.1 1.2 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.6 58.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.8 0.0 0.8 0.6 0.0 0.7 0.0 0.2 0.0 0.1 0.0 1.2 0.4 0.6 0.2 8.2 21.6 0.0 11.6 3.9 19.1 1.0 6.6 2.4 0.0 PNMA6A "MGC15827, PNMA6C" ENSG00000235961 "PNMA family member 6A" P0CW24 X 153072482-153075018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3" "Cell line enhanced" "Detected in some" "HHSteC: 7.9;HMC-1: 6.8;SK-MEL-30: 6.6;U-2 OS: 15.2;U-266/70: 5.8;U-698: 8.2" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 28 "granulocytes: 5.3" "HPA045007, HPA052115" Uncertain Uncertain Nucleoli,Mitochondria Mitochondria Nucleoli "HPA045007: , HPA052115: " "unprognostic (2.14e-2)" "unprognostic (2.35e-1)" "unprognostic (2.33e-2)" "unprognostic (4.12e-3)" "unprognostic (4.39e-2)" "unprognostic (3.44e-2)" "unprognostic (9.27e-3)" "unprognostic (2.15e-1)" "unprognostic (1.85e-1)" "unprognostic (2.46e-1)" "unprognostic (7.76e-4)" "unprognostic (5.75e-3)" "prognostic favourable (1.93e-5)" "unprognostic (4.61e-2)" "unprognostic (3.04e-1)" "unprognostic (4.04e-3)" "unprognostic (3.22e-2)" 1.3 2.0 7.2 0.1 6.2 0.2 0.3 7.0 16.3 3.7 0.2 0.5 1.8 7.0 0.1 1.5 0.9 2.1 6.5 11.0 6.2 7.9 0.1 0.2 5.5 3.1 0.7 0.4 3.9 0.1 0.1 0.1 0.9 0.7 0.0 0.3 0.3 0.6 1.6 0.5 0.5 0.8 1.8 0.2 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.1 0.0 0.0 5.3 0.1 1.6 0.0 0.0 0.0 0.9 0.2 0.3 0.0 0.0 0.5 0.0 1.8 0.4 0.0 2.9 0.0 0.0 0.0 0.6 0.0 0.3 0.2 7.9 3.2 6.8 1.2 0.0 0.1 0.0 0.2 1.3 0.0 0.1 0.4 1.1 0.0 3.4 0.0 0.0 0.0 0.0 0.3 0.0 3.3 1.9 0.4 0.0 6.6 0.0 4.1 0.0 0.0 15.2 0.0 0.0 5.8 4.3 8.2 0.0 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 PNMA6F PNMA6BL ENSG00000225110 "PNMA family member 6F" A0A0J9YX94 X 153317681-153321822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adrenal gland: 2.5;brain: 8.4" "Cell line enriched" "Detected in single" 6 "AN3-CA: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (6.52e-2)" "unprognostic (7.19e-2)" 0.0 2.5 1.7 0.1 6.5 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 6.6 0.2 0.1 0.9 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNMA8A "FLJ10781, KIAA1183L, PNMAL1" ENSG00000182013 "PNMA family member 8A" Q86V59 19 46466491-46471563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.0" "Cell line enhanced" "Detected in many" "HAP1: 17.7;K-562: 18.7;LHCN-M2: 19.4;SH-SY5Y: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012956 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA012956: AB_1844328" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.98e-2)" "unprognostic (9.35e-3)" "unprognostic (1.01e-1)" "unprognostic (6.90e-3)" "unprognostic (1.76e-3)" "unprognostic (9.56e-2)" "unprognostic (1.78e-2)" "unprognostic (2.85e-2)" "unprognostic (1.82e-1)" "unprognostic (6.48e-3)" 1.2 17.4 18.6 1.2 26.4 1.1 3.9 24.8 61.0 2.9 1.6 5.1 1.2 1.2 9.7 12.7 1.5 16.7 4.3 10.7 16.6 29.9 7.2 0.9 1.8 0.8 14.1 25.7 13.5 5.0 3.8 14.5 2.4 19.5 7.1 1.1 5.4 4.4 8.1 1.2 1.5 1.3 5.9 8.9 0.9 1.4 16.1 4.4 4.3 11.7 0.0 1.0 1.9 0.7 1.1 1.1 3.0 0.5 0.8 2.6 0.3 0.0 7.4 10.7 10.6 3.1 7.1 1.9 0.7 0.1 1.3 0.6 0.1 0.8 0.0 10.0 0.5 0.1 17.7 2.8 0.9 0.0 6.6 0.0 0.2 0.2 5.2 0.1 0.1 1.8 3.5 4.5 0.0 1.0 18.7 0.1 19.4 0.0 0.1 0.1 9.0 0.0 0.0 11.7 0.0 4.5 0.0 8.7 17.1 0.0 0.2 0.0 0.1 0.2 0.6 0.0 0.1 0.1 3.6 0.0 0.0 0.1 0.1 0.0 1.1 3.0 0.5 0.3 0.3 0.3 0.2 1.1 0.3 0.9 0.1 0.7 0.4 2.6 1.3 0.8 0.1 1.1 0.2 0.3 18.6 26.4 24.8 37.2 16.6 29.9 14.1 25.7 19.5 4.4 PNMA8B "KIAA1183, PNMAL2" ENSG00000204851 "PNMA family member 8B" Q9ULN7 19 46486906-46496498 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 10.3;brain: 22.5" "Cell line enhanced" "Detected in some" "AF22: 3.7;AN3-CA: 4.7;fHDF/TERT166: 1.6;NTERA-2: 1.9;SH-SY5Y: 3.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.8" "Lineage enriched" "Detected in single" 5 "T-cells: 1.8" "Low region specificity" "Detected in all" HPA054810 Enhanced "HPA054810: " "unprognostic (1.31e-2)" "unprognostic (2.81e-2)" "unprognostic (3.27e-2)" "unprognostic (1.34e-1)" "unprognostic (5.97e-2)" "unprognostic (3.38e-3)" "unprognostic (2.90e-1)" "unprognostic (1.35e-1)" "unprognostic (4.15e-1)" "unprognostic (4.19e-3)" "unprognostic (4.26e-4)" "unprognostic (7.30e-2)" "unprognostic (5.57e-3)" "unprognostic (1.84e-2)" "unprognostic (1.07e-1)" "unprognostic (3.38e-1)" "unprognostic (1.32e-2)" 2.3 10.3 9.1 0.3 6.7 0.0 0.5 2.5 22.5 0.8 0.3 0.3 0.6 0.5 0.4 0.7 0.9 1.2 9.0 15.6 0.4 0.2 0.6 0.3 6.4 3.9 0.8 0.1 1.8 0.3 1.0 0.1 1.4 1.0 0.4 1.6 0.5 0.5 2.8 1.6 0.4 0.6 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.3 1.8 0.3 0.0 0.0 3.7 4.7 1.1 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.0 0.4 3.9 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.0 0.0 1.8 0.4 0.0 0.3 0.0 0.0 0.1 0.3 PNMA8C ENSG00000277531 "PNMA family member 8C" A0A1B0GUJ8 19 46424697-46428951 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 23.5" "Group enriched" "Detected in some" 6 "AF22: 2.6;HMC-1: 5.5;SH-SY5Y: 8.3" "Cancer enriched" "Detected in some" 11 "glioma: 7.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "unprognostic (3.25e-2)" "unprognostic (2.38e-1)" "unprognostic (3.89e-2)" "unprognostic (4.91e-3)" "unprognostic (2.58e-1)" "unprognostic (4.61e-3)" "unprognostic (1.16e-2)" "unprognostic (1.69e-1)" "unprognostic (4.49e-2)" "unprognostic (2.39e-2)" "unprognostic (2.92e-2)" 0.4 2.1 5.3 0.5 8.1 0.6 0.6 2.1 23.5 0.4 0.5 3.3 0.0 0.4 0.4 3.7 0.4 2.3 0.7 0.6 4.8 0.4 0.3 0.6 0.3 1.9 11.5 0.6 0.4 0.7 4.6 0.3 7.0 0.9 0.4 0.0 0.4 1.0 1.3 0.5 0.5 0.5 1.8 0.4 0.4 1.2 1.6 0.0 0.4 0.0 0.3 0.4 0.0 1.1 1.4 2.7 0.5 1.7 0.6 0.1 0.0 0.0 2.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 2.7 0.4 0.4 0.4 0.3 0.3 0.4 0.4 0.3 0.2 1.1 0.5 0.6 2.3 1.7 0.5 1.4 0.2 0.1 PNOC "N/OFQ, NOP, PPNOC" ENSG00000168081 Prepronociceptin Q13519 8 28316986-28343355 "Predicted intracellular proteins, Predicted secreted proteins" "Neuropeptide, Neurotransmitter, Opioid peptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 47.9;brain: 22.6;lymphoid tissue: 18.1" "Group enriched" "Detected in some" 6 "Daudi: 24.0;Karpas-707: 18.9;RPMI-8226: 7.0;U-698: 14.5" "Cancer enriched" "Detected in many" 8 "ovarian cancer: 32.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 17 "memory B-cell: 46.6;naive B-cell: 47.9;plasmacytoid DC: 33.7" "Group enriched" "Detected in many" 17 "B-cells: 47.9;dendritic cells: 33.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044507, HPA056724" Enhanced "Secreted to blood" 12325 "HPA044507: AB_10795043, HPA056724: AB_2683216" "unprognostic (1.11e-1)" "unprognostic (1.77e-3)" "unprognostic (3.53e-2)" "prognostic unfavourable (2.94e-6)" "unprognostic (3.71e-2)" "unprognostic (5.16e-5)" "unprognostic (1.03e-1)" "unprognostic (1.50e-1)" "unprognostic (7.81e-4)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (9.99e-3)" "unprognostic (7.57e-9)" "unprognostic (2.19e-2)" "unprognostic (5.45e-1)" "unprognostic (3.44e-1)" "unprognostic (1.40e-1)" 0.4 0.6 4.0 7.2 7.4 2.0 0.5 0.9 22.6 0.3 2.3 1.0 0.0 3.3 0.2 0.0 1.2 13.5 0.9 0.3 3.1 8.4 1.2 0.4 0.9 18.1 5.9 3.2 2.2 0.2 0.1 0.2 0.0 7.5 0.3 1.3 0.0 2.5 0.1 0.2 0.2 6.5 0.4 4.3 16.9 2.4 0.7 0.0 0.6 0.6 0.0 18.1 5.2 0.4 47.9 33.7 0.4 2.4 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.6 2.6 14.5 0.1 0.1 0.0 0.0 2.4 0.4 0.0 1.5 0.0 46.6 0.0 0.0 0.2 47.9 0.0 0.0 0.2 0.2 0.6 33.7 0.1 2.4 4.0 7.4 0.9 15.7 3.1 8.4 5.9 3.2 7.5 0.0 PNPLA5 "dJ388M5.4, GS2L" ENSG00000100341 "Patatin like phospholipase domain containing 5" Q7Z6Z6 22 43879678-43892013 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.6;epididymis: 6.2;skin 1: 4.6" "Group enriched" "Detected in some" 5 "NTERA-2: 3.9;RPMI-8226: 7.1;SCLC-21H: 2.4" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA050409, HPA054211" Uncertain "HPA050409: , HPA054211: " "unprognostic (6.69e-5)" "unprognostic (3.53e-1)" "unprognostic (1.28e-1)" "unprognostic (1.27e-2)" "unprognostic (3.33e-3)" "unprognostic (1.05e-1)" "unprognostic (1.50e-1)" "unprognostic (4.31e-2)" 0.0 0.1 0.5 0.2 5.6 1.0 0.9 0.1 2.4 0.1 0.0 0.1 0.3 6.2 0.0 0.6 0.5 0.0 0.8 0.9 0.0 1.7 0.1 0.1 0.4 0.0 0.0 0.0 1.3 0.1 0.2 0.0 0.1 0.1 0.0 4.6 0.0 0.1 0.1 0.2 0.1 0.4 0.5 0.0 0.0 0.0 0.7 1.0 2.2 0.5 0.2 0.7 0.0 0.2 0.0 0.1 0.3 0.1 0.4 0.2 0.1 0.3 0.1 0.8 0.3 0.4 0.1 0.4 0.2 0.4 0.2 0.5 0.1 0.7 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.2 0.3 0.4 0.3 0.1 0.3 3.9 0.1 0.2 0.2 7.1 0.1 0.0 2.4 0.2 0.5 0.1 0.0 0.3 0.1 0.2 0.6 0.2 0.3 0.1 0.3 0.1 0.2 0.4 0.2 0.1 2.2 0.5 0.1 0.7 0.3 0.5 0.4 0.6 0.6 0.1 0.7 0.4 0.6 1.6 0.2 0.5 1.0 0.6 0.0 PODXL2 "endoglycan, PODLX2" ENSG00000114631 "Podocalyxin like 2" Q9NZ53 3 127629181-127672809 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.8" "Cell line enhanced" "Detected in many" "RPMI-8226: 32.0;SCLC-21H: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024934, HPA042265" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "CAB024934: , HPA042265: " "unprognostic (2.07e-2)" "unprognostic (2.34e-1)" "unprognostic (7.02e-2)" "unprognostic (1.07e-2)" "unprognostic (9.74e-2)" "unprognostic (1.79e-2)" "unprognostic (8.97e-3)" "unprognostic (1.81e-1)" "unprognostic (3.89e-1)" "unprognostic (2.67e-1)" "unprognostic (4.05e-3)" "unprognostic (3.48e-1)" "unprognostic (2.91e-1)" "unprognostic (1.90e-1)" "unprognostic (2.67e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-3)" 3.0 16.1 19.1 2.6 19.7 1.8 8.1 31.4 42.8 3.0 8.3 9.0 1.6 6.6 4.5 2.5 2.8 4.3 4.4 2.5 22.2 37.3 4.5 1.6 2.1 2.2 21.3 17.5 10.8 12.0 1.2 20.9 1.3 31.5 12.0 7.6 8.7 21.4 2.4 2.8 4.6 6.1 2.0 17.0 2.1 12.2 16.4 7.7 0.6 4.1 1.6 2.7 2.1 0.9 1.6 2.6 0.1 0.8 0.2 2.7 0.7 0.1 3.8 10.6 25.1 0.0 0.0 15.7 1.2 0.0 2.2 0.4 7.9 0.4 9.3 9.5 0.1 0.0 8.6 0.0 0.2 0.0 17.7 0.1 8.8 7.9 0.3 21.0 21.6 0.4 1.8 0.0 0.0 0.6 12.2 0.0 0.8 4.7 0.1 0.0 15.9 18.7 0.0 0.3 32.0 3.1 1.0 47.6 26.8 11.3 24.4 20.7 6.2 10.7 0.1 0.0 4.9 0.4 7.4 0.0 0.0 7.3 0.2 13.7 7.0 0.0 0.2 0.0 0.8 0.8 1.1 1.6 2.7 0.7 0.0 1.3 1.3 0.6 0.1 0.2 0.0 2.6 1.7 0.7 19.1 19.7 31.4 33.8 22.2 37.3 21.3 17.5 31.5 7.7 POLB ENSG00000070501 "DNA polymerase beta" P06746 8 42338454-42371808 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 73.6" "Cell line enhanced" "Detected in all" "HMC-1: 79.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 73.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011616, HPA049104" Enhanced Uncertain Vesicles Vesicles "CAB011616: AB_731977, HPA049104: " "unprognostic (1.67e-1)" "unprognostic (2.68e-3)" "unprognostic (2.43e-1)" "prognostic unfavourable (1.46e-4)" "unprognostic (8.49e-2)" "unprognostic (2.64e-2)" "unprognostic (4.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.31e-2)" "unprognostic (1.99e-1)" "unprognostic (4.57e-2)" "unprognostic (4.77e-1)" "prognostic unfavourable (2.15e-5)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (4.22e-2)" "prognostic favourable (5.65e-4)" 5.5 8.6 10.1 9.5 10.7 21.9 13.5 73.6 16.6 7.0 5.5 5.8 6.0 4.9 6.2 11.2 12.4 6.3 11.3 16.3 9.8 9.6 7.2 15.8 9.1 11.8 8.4 10.3 10.3 7.7 10.3 11.6 5.0 10.9 11.4 6.3 6.8 22.1 6.9 36.6 10.8 4.9 6.6 10.0 8.1 6.4 29.5 5.4 9.7 7.7 17.2 10.1 11.5 9.2 4.9 33.8 25.1 9.4 7.9 7.2 4.2 10.8 6.5 11.3 22.5 6.3 6.0 9.5 6.9 8.0 11.5 10.6 9.1 12.7 9.8 8.8 4.4 5.5 9.4 8.1 14.2 6.4 10.2 7.1 5.4 12.3 9.7 5.0 79.7 5.3 9.6 8.5 10.0 8.7 15.5 6.3 11.1 6.4 20.7 14.2 15.2 7.5 11.9 11.4 8.4 21.6 8.8 6.4 11.7 8.2 5.5 20.9 14.7 8.6 4.8 5.5 7.7 13.7 6.7 9.2 15.3 13.9 5.5 10.7 14.3 12.5 5.9 17.3 4.9 7.2 5.5 4.9 5.2 5.3 6.1 4.5 5.8 5.4 25.1 7.9 9.4 33.8 7.2 4.2 10.1 10.7 73.6 16.6 9.8 9.6 8.4 10.3 10.9 5.4 POLR2J2 RPB11b1 ENSG00000228049 "RNA polymerase II subunit J2" Q9GZM3 7 102665368-102671629 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.6" "Cell line enhanced" "Detected in many" "MOLT-4: 17.7;RT4: 12.8;U-2 OS: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA046970 Approved Nucleoplasm Nucleoplasm "HPA046970: " 3.8 3.9 12.0 9.5 10.0 5.4 6.6 10.6 32.6 7.2 4.6 6.5 3.4 7.9 6.9 6.5 4.8 4.6 7.4 4.3 12.5 5.5 5.8 6.1 6.1 7.8 10.1 7.7 9.0 3.7 3.2 6.1 5.7 7.8 4.6 5.2 4.5 11.2 3.4 11.9 9.9 10.3 9.8 9.3 7.5 6.6 3.5 6.2 4.2 5.8 1.3 11.0 4.7 5.1 7.9 6.0 11.3 4.0 2.9 6.5 1.3 2.4 2.1 1.5 1.8 3.3 4.7 3.0 2.8 0.6 1.7 1.7 1.6 5.0 2.6 0.5 1.8 2.4 1.1 0.7 4.2 1.8 2.9 1.4 3.0 1.0 1.5 6.0 2.7 0.9 0.5 1.2 2.4 0.6 2.6 6.5 1.2 0.9 17.7 1.8 1.1 0.6 2.3 0.4 2.3 1.0 12.8 1.4 1.7 2.3 1.3 1.0 0.8 1.0 1.0 3.8 12.5 0.6 2.1 2.9 2.0 2.3 1.6 2.6 1.3 11.3 4.0 2.9 5.9 2.3 3.9 5.5 6.0 4.2 1.9 7.9 6.5 5.0 3.2 2.9 3.6 6.0 3.5 1.3 12.0 10.0 10.6 32.6 12.5 5.5 10.1 7.7 7.8 6.2 POLR3G "RPC32, RPC7" ENSG00000113356 "RNA polymerase III subunit G" O15318 5 90471748-90514553 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 20.2" "Cell line enhanced" "Detected in all" "WM-115: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010109, HPA052658" Enhanced Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB010109: AB_2165718, HPA052658: " "unprognostic (4.31e-1)" "unprognostic (5.35e-2)" "unprognostic (2.62e-2)" "unprognostic (3.55e-3)" "unprognostic (1.18e-1)" "unprognostic (3.42e-2)" "unprognostic (4.19e-6)" "unprognostic (2.17e-3)" "unprognostic (1.91e-1)" "unprognostic (1.93e-2)" "unprognostic (3.52e-2)" "unprognostic (9.71e-2)" "unprognostic (1.21e-14)" "unprognostic (3.86e-2)" "unprognostic (3.19e-2)" "unprognostic (1.53e-2)" "unprognostic (8.17e-5)" 2.7 1.6 7.1 3.6 10.2 4.4 3.8 7.2 7.2 3.7 2.6 6.7 1.4 2.8 2.7 8.4 7.3 2.7 2.4 2.7 7.7 7.7 1.7 4.0 2.9 8.1 10.3 6.1 4.1 4.1 11.1 3.9 3.1 20.2 2.9 3.1 2.6 4.2 1.5 4.4 7.4 2.3 4.2 16.0 3.3 2.1 8.0 8.1 1.0 5.9 8.5 3.2 4.4 4.7 3.9 2.1 6.8 2.8 5.4 3.2 0.8 10.5 6.1 7.2 1.9 2.2 4.1 3.3 5.3 1.7 8.4 6.9 3.5 7.9 29.0 1.8 2.2 4.4 9.0 8.5 30.3 13.3 8.1 10.6 2.9 5.4 3.8 7.4 2.7 2.7 3.9 14.1 10.7 10.4 15.1 2.6 3.0 5.2 7.7 4.7 34.4 27.3 6.9 3.2 16.3 2.5 1.0 9.2 2.5 2.1 4.0 14.6 2.2 2.1 12.4 4.6 8.9 6.5 19.9 6.6 17.2 21.3 10.2 9.9 36.7 6.8 0.6 0.3 3.2 0.8 1.6 3.9 1.1 2.0 0.9 2.4 2.4 2.6 1.6 5.4 2.8 2.1 0.5 0.8 7.1 10.2 7.2 7.2 7.7 7.7 10.3 6.1 20.2 8.1 POU2F1 "OCT1, OTF1" ENSG00000143190 "POU class 2 homeobox 1" P14859 1 167220829-167427345 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002608, HPA058559, HPA064323" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB002608: , HPA058559: , HPA064323: " "unprognostic (1.74e-1)" "unprognostic (9.33e-2)" "unprognostic (1.28e-2)" "unprognostic (1.40e-3)" "unprognostic (5.78e-3)" "unprognostic (4.26e-2)" "unprognostic (5.67e-6)" "unprognostic (4.47e-2)" "unprognostic (5.14e-1)" "unprognostic (7.94e-3)" "unprognostic (1.95e-2)" "unprognostic (1.28e-1)" "prognostic unfavourable (2.98e-5)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.17e-2)" 6.9 5.7 15.5 7.3 11.9 12.6 7.2 36.4 13.8 7.7 6.6 9.5 5.2 4.1 7.5 8.4 5.3 6.5 4.3 5.1 14.5 6.7 7.0 5.8 6.6 8.2 7.7 10.8 8.1 6.1 15.5 8.3 9.6 7.1 6.7 6.8 12.0 5.5 6.5 10.5 8.8 6.6 5.5 6.3 9.3 6.1 10.1 10.9 7.4 6.9 4.9 9.7 7.6 6.2 7.5 5.9 8.6 5.9 1.4 4.4 2.2 6.3 5.1 13.3 4.0 1.6 1.6 5.4 0.8 1.4 1.6 1.6 7.4 3.7 7.2 3.4 1.3 4.9 8.1 2.4 2.3 2.9 3.1 5.0 3.5 6.0 1.0 5.5 3.4 1.1 1.4 1.8 3.3 2.1 5.4 4.1 2.1 3.3 5.0 3.6 15.5 2.0 7.3 4.8 3.2 2.8 3.6 8.1 6.1 4.9 3.6 3.3 4.1 6.8 3.4 3.0 4.9 1.8 3.1 4.0 1.8 16.6 1.4 3.4 3.9 8.6 2.3 2.8 4.4 2.7 3.3 7.5 2.3 2.0 2.5 6.8 3.2 2.4 3.3 1.4 5.9 5.9 2.1 2.2 15.5 11.9 36.4 13.8 14.5 6.7 7.7 10.8 7.1 10.9 POU2F2 "OCT2, OTF2" ENSG00000028277 "POU class 2 homeobox 2" P09086 19 42086110-42196585 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 33.1;brain: 12.0;intestine: 10.8;lymphoid tissue: 43.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.1;Daudi: 38.2;hTEC/SVTERT24-B: 15.0;U-266/70: 26.6;U-266/84: 25.7;U-698: 30.3;U-87 MG: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 33.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002513, HPA049056, HPA062096, HPA064404" Enhanced Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB002513: AB_442118, HPA049056: , HPA062096: , HPA064404: " "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-2)" "unprognostic (8.89e-2)" "unprognostic (6.77e-2)" "unprognostic (1.44e-2)" "unprognostic (1.62e-2)" "unprognostic (3.34e-1)" "unprognostic (8.39e-2)" "unprognostic (2.09e-1)" "unprognostic (1.52e-1)" "unprognostic (8.56e-2)" "prognostic unfavourable (7.57e-11)" "unprognostic (2.31e-1)" "unprognostic (1.76e-1)" "unprognostic (2.61e-2)" "unprognostic (1.54e-1)" 1.9 2.0 5.6 43.1 7.4 4.8 1.2 12.0 5.7 0.9 3.2 2.5 0.0 2.1 0.9 1.7 1.4 1.5 2.3 4.8 5.7 5.9 1.6 1.4 3.1 31.4 6.8 1.5 0.7 1.6 0.4 2.1 2.5 6.6 2.5 2.1 1.4 2.1 2.3 0.7 1.2 10.8 1.9 6.5 22.7 3.1 6.0 6.2 1.9 1.3 0.6 30.0 4.3 1.0 13.9 8.0 1.7 33.1 0.6 2.7 4.5 0.3 0.5 0.6 0.0 0.0 1.0 0.1 2.8 18.1 1.8 3.5 0.1 0.5 38.2 1.0 1.0 0.3 0.2 2.9 8.2 0.1 0.1 0.9 0.1 0.0 0.2 0.3 0.7 0.8 0.5 15.0 1.0 1.1 0.4 8.8 0.4 0.2 0.1 2.0 0.1 0.2 0.4 0.0 0.1 0.0 0.2 0.6 0.3 0.1 0.2 0.2 0.0 4.8 1.4 7.8 0.8 0.0 0.3 26.6 25.7 30.3 14.6 0.9 1.0 1.0 10.7 0.1 1.2 19.3 1.1 11.0 1.8 1.6 8.0 13.9 0.9 1.3 1.7 0.6 33.1 1.3 2.7 4.5 5.6 7.4 12.0 5.7 5.7 5.9 6.8 1.5 6.6 6.2 POU3F1 "OCT6, OTF6, SCIP" ENSG00000185668 "POU class 3 homeobox 1" Q03052 1 38044611-38046794 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 10.5;skin 1: 31.0" "Cell line enhanced" "Detected in some" "AF22: 10.8;HDLM-2: 18.8;NTERA-2: 5.2;SCLC-21H: 3.7;SK-MEL-30: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 7.0;cerebral cortex: 3.5;hippocampal formation: 9.7" "HPA055980, HPA073824" Enhanced Nucleoplasm Nucleoplasm "HPA055980: , HPA073824: " "unprognostic (9.99e-2)" "unprognostic (1.63e-1)" "unprognostic (1.69e-1)" "unprognostic (1.43e-2)" "unprognostic (7.46e-3)" "unprognostic (1.96e-2)" "unprognostic (1.33e-2)" "unprognostic (2.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.40e-1)" "unprognostic (4.61e-4)" "unprognostic (2.79e-2)" "unprognostic (1.97e-1)" "unprognostic (3.61e-2)" "unprognostic (2.67e-3)" 0.8 2.1 4.0 0.9 10.5 0.7 0.8 1.2 6.8 0.6 0.7 1.1 0.0 0.6 0.7 0.8 3.4 0.7 0.7 0.7 7.7 0.9 0.7 0.6 0.6 1.7 3.9 2.9 0.7 0.8 0.6 0.0 0.6 1.4 3.6 0.6 1.6 0.6 0.7 1.3 31.0 0.7 2.5 0.6 0.7 0.7 1.5 2.6 0.0 0.7 1.3 1.7 1.5 0.4 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 10.8 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 18.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.1 0.0 0.0 0.1 0.0 0.7 3.7 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 10.5 1.2 6.8 7.7 0.9 3.9 2.9 1.4 2.6 POU3F2 "BRN2, OCT7, OTF7, POUF3" ENSG00000184486 "POU class 3 homeobox 2" P20265 6 98834592-98839470 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "brain: 28.0" "Cell line enhanced" "Detected in some" "AF22: 51.0;SK-MEL-30: 7.0;U-251 MG: 15.6;WM-115: 13.5" "Cancer enriched" "Detected in some" 11 "glioma: 16.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047081, HPA056261" Approved Supported Nucleoplasm Nucleoplasm "HPA047081: , HPA056261: " "unprognostic (5.94e-4)" "unprognostic (7.80e-2)" "unprognostic (3.07e-3)" "unprognostic (1.83e-1)" "unprognostic (3.57e-1)" "unprognostic (1.38e-1)" "unprognostic (1.17e-3)" "unprognostic (1.84e-1)" "unprognostic (1.16e-1)" "unprognostic (1.60e-1)" "unprognostic (1.63e-3)" "unprognostic (4.77e-1)" "unprognostic (9.38e-11)" "unprognostic (4.77e-2)" "unprognostic (2.84e-2)" "unprognostic (8.47e-3)" "unprognostic (4.04e-1)" 0.9 1.0 9.0 0.9 10.8 0.9 0.9 3.4 28.0 0.9 0.9 10.3 0.0 0.9 0.9 0.9 0.9 0.9 0.9 0.9 9.8 7.1 0.9 0.9 0.9 0.9 10.7 6.8 0.9 0.9 0.9 0.0 0.9 9.7 0.9 0.9 0.0 0.9 0.9 0.9 1.0 0.9 0.9 8.4 0.9 0.9 1.2 9.0 0.0 0.9 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 51.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.0 0.2 2.2 1.6 0.4 0.0 0.0 0.0 2.8 1.4 0.0 0.0 7.0 0.4 0.0 0.0 0.3 0.0 0.1 15.6 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.0 10.8 3.4 12.5 9.8 7.1 10.7 6.8 9.7 9.0 POU3F3 "BRN1, OTF8" ENSG00000198914 "POU class 3 homeobox 3" P20264 2 104855511-104858574 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "brain: 18.9;epididymis: 27.2;kidney: 23.7;seminal vesicle: 12.1" "Group enriched" "Detected in some" 6 "AF22: 27.0;AN3-CA: 25.8;HEK 293: 10.0;RPTEC TERT1: 30.6;SH-SY5Y: 8.5" "Group enriched" "Detected in some" 6 "glioma: 21.5;renal cancer: 24.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052792, HPA056039, HPA067151" Enhanced Enhanced Nucleoplasm Nucleoplasm "HPA052792: , HPA056039: , HPA067151: AB_2685790" "unprognostic (3.05e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (4.26e-5)" "unprognostic (9.66e-2)" "unprognostic (1.97e-1)" "unprognostic (4.69e-1)" "unprognostic (1.16e-1)" "unprognostic (7.28e-2)" "unprognostic (1.15e-3)" "unprognostic (7.15e-2)" 0.2 0.2 9.0 0.1 8.6 0.0 0.1 4.3 18.9 0.0 0.3 0.0 0.0 27.2 0.0 0.0 0.0 0.0 9.9 6.0 23.7 0.0 0.0 0.1 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.5 0.0 0.0 10.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.9 0.2 0.3 0.2 0.0 0.0 0.0 27.0 25.8 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 3.2 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 2.8 0.6 0.0 30.6 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.0 POU3F4 "BRN4, DFN3, DFNX2, OTF9" ENSG00000196767 "POU class 3 homeobox 4" P49335 X 83508261-83512127 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "brain: 39.0" "Cell line enriched" "Detected in single" 145 "AF22: 14.7" "Cancer enriched" "Detected in single" 21 "glioma: 5.6" "Region enriched" "Detected in all" 6 "basal ganglia: 39.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062295 Supported Nucleoplasm Nucleoplasm "HPA062295: " "unprognostic (5.73e-2)" "unprognostic (2.00e-1)" 0.5 0.5 3.3 0.5 39.0 0.6 0.5 5.0 15.2 0.5 0.7 2.4 0.0 0.5 0.5 0.5 0.5 0.5 1.3 0.5 2.8 1.6 2.5 0.5 0.5 0.5 2.4 3.7 1.1 0.5 0.5 0.1 0.5 2.4 0.5 0.6 0.0 0.5 0.5 0.5 0.5 0.5 0.6 1.7 0.5 0.5 0.5 6.6 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 39.0 5.0 4.2 2.8 1.6 2.4 3.7 2.4 6.6 POU4F1 "BRN3A, RDC-1" ENSG00000152192 "POU class 4 homeobox 1" Q01851 13 78598362-78603560 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 25.3" "Cell line enhanced" "Detected in some" "HEK 293: 10.9;HEL: 11.5;REH: 8.1;RH-30: 13.9;SCLC-21H: 13.3;U-266/70: 12.5" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 23 "pons and medulla: 25.3" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.1" "Group enriched" "Detected in some" 14 "midbrain: 3.0;pons and medulla: 2.2;thalamus: 2.4" "Group enriched" "Detected in some" 25 "midbrain: 3.1;pons and medulla: 7.4;thalamus: 2.5" HPA068024 Enhanced Approved "HPA068024: " "unprognostic (6.70e-2)" "unprognostic (2.38e-1)" "unprognostic (1.27e-4)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (6.30e-2)" "unprognostic (6.00e-2)" "unprognostic (1.70e-2)" "unprognostic (9.17e-2)" "unprognostic (8.98e-2)" "unprognostic (9.95e-2)" "unprognostic (1.53e-1)" "unprognostic (4.75e-3)" 0.1 0.0 1.1 2.3 1.0 1.2 1.0 0.2 0.4 0.1 0.1 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.2 1.0 1.0 0.0 0.5 0.1 2.3 0.7 0.0 0.0 0.1 0.1 0.0 0.9 25.3 0.0 0.3 6.3 0.2 0.0 1.8 0.4 0.3 0.0 2.5 0.3 0.3 4.4 0.4 2.7 0.0 0.2 3.5 0.3 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 10.9 11.5 0.0 1.4 0.0 5.7 3.4 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.5 0.0 0.8 1.0 0.0 0.0 8.1 13.9 0.0 0.0 0.0 13.3 0.1 0.0 0.0 0.5 0.0 1.1 0.1 0.0 0.0 0.2 0.0 12.5 3.7 0.0 0.0 6.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.1 1.0 0.2 0.4 1.0 1.0 0.7 0.0 25.3 0.4 POU4F2 "Brn-3b, BRN3B" ENSG00000151615 "POU class 4 homeobox 2" Q12837 4 146638893-146642474 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "brain: 5.7;testis: 5.0" "Cell line enhanced" "Detected in some" "AF22: 1.6;SCLC-21H: 6.3;THP-1: 1.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 29 "midbrain: 1.8;pons and medulla: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "midbrain: 5.2" "Group enriched" "Detected in some" 14 "midbrain: 4.7;pons and medulla: 1.3;thalamus: 1.8" "unprognostic (4.18e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 5.7 0.0 POU4F3 "BRN3C, DFNA15, DFNA42, DFNA52" ENSG00000091010 "POU class 4 homeobox 3" Q15319 5 146338839-146341722 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.8" "Cell line enhanced" "Detected in some" "NB-4: 1.9" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Region enhanced" "Detected in single" "cerebellum: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA038215 Uncertain Supported Nucleoplasm Nucleoplasm "HPA038215: AB_10697245" "unprognostic (8.41e-3)" "unprognostic (9.46e-2)" "unprognostic (1.84e-1)" "unprognostic (6.26e-4)" "unprognostic (1.86e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-1)" "unprognostic (9.54e-2)" "unprognostic (1.61e-1)" "unprognostic (2.09e-3)" "unprognostic (1.20e-3)" "unprognostic (1.24e-3)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (8.84e-2)" "unprognostic (7.82e-2)" 0.6 0.1 0.4 0.4 0.6 1.0 0.4 2.8 0.9 0.3 0.2 0.2 0.2 0.1 0.6 0.7 0.2 0.4 0.3 0.2 0.7 0.4 0.3 0.2 0.3 0.2 0.7 0.2 0.6 0.2 0.0 0.2 1.8 0.2 0.2 0.2 0.2 1.1 0.4 0.2 0.8 0.2 0.8 2.4 0.6 0.2 0.4 0.2 1.5 0.5 0.2 0.2 0.6 0.2 0.7 0.4 0.0 0.0 0.0 0.4 0.0 0.2 1.0 0.2 0.4 0.2 0.3 0.0 0.0 0.0 0.2 0.4 0.9 0.2 0.3 0.2 0.3 0.5 0.3 0.0 0.9 0.4 0.5 0.0 0.1 0.0 0.1 0.1 0.8 0.4 1.6 0.4 0.1 0.3 0.2 0.5 0.1 0.1 0.4 1.9 0.1 0.3 0.8 0.0 0.1 0.4 0.5 1.8 1.6 0.6 0.5 0.1 0.4 0.1 0.0 0.0 1.9 0.0 0.6 0.6 0.8 0.7 0.0 0.6 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.8 0.2 0.7 0.4 0.7 0.2 0.2 0.2 POU6F2 RPF-1 ENSG00000106536 "POU class 6 homeobox 2" P78424 7 38977998-39493095 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.2;pancreas: 12.3" "Cell line enhanced" "Detected in some" "EFO-21: 4.4;Karpas-707: 3.3;NTERA-2: 4.2;SK-BR-3: 3.4;T-47d: 7.5;U-266/70: 8.4;U-266/84: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "unprognostic (6.89e-2)" "unprognostic (1.04e-1)" "unprognostic (2.48e-1)" "unprognostic (1.80e-4)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "unprognostic (8.68e-2)" "unprognostic (3.36e-1)" "unprognostic (1.01e-1)" "unprognostic (1.96e-1)" "unprognostic (7.22e-3)" "unprognostic (2.32e-1)" "unprognostic (1.60e-2)" "unprognostic (5.00e-3)" "unprognostic (4.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" 0.9 0.3 2.9 0.4 6.2 0.8 1.0 0.4 13.2 1.2 0.4 0.6 0.0 0.6 0.3 0.3 0.7 0.3 2.4 1.9 3.1 2.1 0.5 2.9 0.5 0.3 2.0 11.2 1.0 12.3 0.3 0.9 3.6 2.3 0.4 0.4 1.5 0.5 0.5 0.3 0.5 0.4 0.3 0.8 0.4 0.4 2.0 1.0 0.0 0.4 0.0 0.4 3.0 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.3 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.1 0.0 0.3 2.7 0.0 0.0 3.4 0.0 7.5 0.0 0.0 0.0 0.8 0.0 0.0 8.4 10.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 6.2 0.4 13.2 3.1 2.1 2.0 11.2 2.3 1.0 PPEF1 "PPEF, PPP7CA" ENSG00000086717 "Protein phosphatase with EF-hand domain 1" O14829 X 18675909-18827921 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;testis: 20.2" "Cell line enhanced" "Detected in some" "A549: 3.5;HeLa: 5.1;SH-SY5Y: 2.9;SK-MEL-30: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034577 Uncertain "Plasma membrane,Cytokinetic bridge" "Plasma membrane" "Cytokinetic bridge" "HPA034577: AB_10602817" "unprognostic (4.13e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-2)" "unprognostic (9.85e-2)" "unprognostic (3.84e-2)" "unprognostic (5.00e-2)" "unprognostic (2.38e-1)" "unprognostic (3.43e-2)" "unprognostic (4.96e-3)" "unprognostic (9.29e-2)" "unprognostic (1.70e-1)" "unprognostic (2.89e-1)" "unprognostic (1.10e-11)" "unprognostic (5.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "unprognostic (1.19e-2)" 0.1 0.5 3.1 0.2 6.4 1.4 3.9 0.2 10.6 0.2 0.2 0.1 0.0 0.1 0.3 0.9 0.2 0.2 0.3 0.3 1.9 1.0 0.3 0.1 0.4 0.3 1.7 6.9 0.2 0.2 0.1 0.7 1.0 0.2 0.5 0.1 0.0 0.3 0.6 0.1 0.7 0.1 0.2 10.5 0.3 0.1 20.2 0.0 0.1 0.4 0.0 0.3 0.4 0.1 0.2 1.3 0.0 0.9 0.0 0.0 0.2 0.0 3.5 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 1.2 0.0 5.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.3 2.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.1 6.4 0.2 10.6 1.9 1.0 1.7 6.9 0.2 0.0 PPFIA2 ENSG00000139220 "PTPRF interacting protein alpha 2" O75334 12 81257975-81759553 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 48.8" "Group enriched" "Detected in some" 8 "HAP1: 24.7;SCLC-21H: 8.5" "Cancer enhanced" "Detected in some" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 27 "basophil: 2.6" "Lineage enriched" "Detected in single" 27 "granulocytes: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (4.31e-2)" "unprognostic (2.72e-1)" "unprognostic (1.82e-2)" "unprognostic (6.78e-5)" "unprognostic (4.69e-3)" "unprognostic (2.13e-1)" "unprognostic (6.67e-2)" "unprognostic (7.10e-2)" "unprognostic (8.92e-2)" "unprognostic (3.97e-2)" "unprognostic (3.76e-1)" "unprognostic (9.84e-2)" "unprognostic (3.27e-3)" "unprognostic (2.45e-2)" "unprognostic (4.88e-2)" "unprognostic (4.49e-3)" "unprognostic (1.06e-3)" 2.6 8.3 23.0 1.4 17.7 0.9 1.8 7.2 48.8 6.0 2.3 10.5 0.0 1.4 3.2 1.8 1.8 2.4 3.2 1.2 19.2 10.6 2.0 1.3 1.9 1.1 10.1 20.9 2.2 1.7 1.0 4.5 1.0 8.6 2.7 2.7 2.5 1.2 5.5 1.0 1.9 1.7 3.7 7.7 1.2 2.0 8.2 9.7 0.0 1.3 0.0 1.1 2.4 2.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.1 0.0 1.2 0.0 8.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.6 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 17.7 7.2 38.3 19.2 10.6 10.1 20.9 8.6 9.7 PPFIA3 "KIAA0654, LPNA3, MGC126567, MGC126569" ENSG00000177380 "PTPRF interacting protein alpha 3" O75145 19 49119389-49151026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 22.1;pituitary gland: 14.9;skin 1: 25.3" "Cell line enhanced" "Detected in many" "PC-3: 23.0;SK-BR-3: 18.8;U-266/70: 13.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 6 "T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043567, HPA050340" Enhanced Uncertain "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center, Vesicles" "HPA043567: , HPA050340: " "prognostic unfavourable (3.09e-4)" "unprognostic (4.70e-2)" "unprognostic (5.14e-3)" "prognostic favourable (8.65e-4)" "unprognostic (3.46e-1)" "prognostic favourable (6.46e-7)" "prognostic unfavourable (2.24e-5)" "unprognostic (1.27e-1)" "unprognostic (8.36e-2)" "unprognostic (9.41e-3)" "unprognostic (5.21e-3)" "unprognostic (8.52e-2)" "unprognostic (1.00e-2)" "unprognostic (1.22e-2)" "unprognostic (1.52e-1)" "unprognostic (3.92e-2)" "unprognostic (1.32e-1)" 1.6 3.9 13.9 1.6 9.3 0.9 2.2 22.1 20.8 1.2 4.3 1.6 1.7 5.1 1.6 1.1 4.4 1.3 1.4 1.4 12.8 12.2 1.1 1.6 1.8 1.6 7.4 13.7 1.0 4.9 4.1 14.9 1.1 7.3 3.4 2.0 1.6 2.7 1.6 1.7 25.3 4.6 1.2 2.4 1.3 2.3 2.1 1.8 0.0 1.8 1.2 2.2 1.1 1.9 0.0 0.0 0.0 0.0 0.2 1.1 0.3 1.9 2.0 2.0 5.1 0.0 0.0 3.9 0.2 0.2 1.0 1.4 1.4 0.8 4.5 2.7 0.2 1.0 3.1 0.4 0.2 4.8 6.8 2.8 1.8 1.0 0.2 1.1 7.3 0.2 1.1 0.6 0.3 0.0 5.4 7.1 0.1 8.7 1.4 1.9 0.9 23.0 4.6 4.0 2.2 0.3 1.0 4.2 5.8 0.8 18.8 2.0 10.4 2.7 0.4 1.1 4.0 0.7 0.1 13.3 10.9 3.3 1.1 4.5 2.6 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.4 0.0 0.0 1.1 0.2 0.0 0.2 0.0 0.0 0.0 0.3 13.9 9.3 22.1 19.8 12.8 12.2 7.4 13.7 7.3 1.8 PPFIA4 ENSG00000143847 "PTPRF interacting protein alpha 4" O75335 1 203026498-203078740 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 72.6;heart muscle: 26.2;skeletal muscle: 20.4" "Cell line enhanced" "Detected in many" "A-431: 7.7;LHCN-M2: 6.5;RH-30: 13.7;U-266/70: 8.6;U-87 MG: 12.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "cerebellum: 72.6;cerebral cortex: 21.1" "Cell type enhanced" "Detected in some" "myeloid DC: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053419, HPA054132" Enhanced "HPA053419: , HPA054132: " "unprognostic (2.83e-1)" "unprognostic (2.34e-3)" "unprognostic (3.38e-5)" "unprognostic (3.19e-1)" "unprognostic (6.58e-2)" "unprognostic (5.36e-2)" "unprognostic (7.49e-8)" "unprognostic (4.65e-1)" "unprognostic (6.01e-4)" "unprognostic (1.29e-1)" "unprognostic (7.70e-2)" "unprognostic (2.60e-2)" "prognostic unfavourable (1.73e-8)" "unprognostic (6.82e-3)" "unprognostic (9.96e-2)" "unprognostic (1.11e-1)" "unprognostic (4.28e-2)" 0.6 1.3 9.2 1.0 10.9 1.6 0.9 72.6 21.1 1.8 1.0 1.4 0.0 1.1 1.7 3.5 1.3 1.2 2.6 26.2 6.6 5.0 1.9 0.6 1.2 0.8 3.0 10.8 0.9 0.6 1.3 0.7 3.9 11.4 1.5 0.8 0.6 1.4 1.3 20.4 2.9 1.3 2.0 2.0 2.2 0.8 3.3 2.3 0.0 0.9 0.4 0.8 0.9 0.9 0.0 1.4 1.3 0.9 0.0 0.6 0.0 7.7 0.0 0.1 1.9 0.0 0.3 0.4 0.4 0.9 0.7 3.3 0.4 0.3 0.4 1.6 1.7 0.9 0.6 1.5 1.5 0.0 0.6 0.1 0.0 0.0 0.1 0.0 1.0 2.5 0.1 0.4 0.0 0.0 0.1 0.3 6.5 1.1 0.5 1.0 0.9 0.3 1.3 13.7 2.2 0.0 0.0 2.6 3.3 0.8 0.2 1.1 0.2 0.6 0.0 4.9 3.0 0.1 0.0 8.6 0.2 0.1 12.6 0.7 0.5 0.0 0.9 1.3 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.6 0.0 9.2 10.9 72.6 21.1 6.6 5.0 3.0 10.8 11.4 2.3 PPIAL4D ENSG00000256374 "Peptidylprolyl isomerase A like 4D" F5H284 1 145241630-145242124 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 4 "blood: 5.4;brain: 3.9" "Cell line enhanced" "Detected in some" "CACO-2: 2.1;NB-4: 1.9;SK-MEL-30: 1.7;THP-1: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA058345 Uncertain "HPA058345: " "unprognostic (9.32e-2)" "unprognostic (1.33e-1)" "unprognostic (3.05e-2)" 0.0 0.0 0.5 0.0 0.7 0.0 0.0 3.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.2 1.0 0.0 0.0 0.2 0.0 0.0 0.0 4.5 3.8 0.7 3.7 1.8 4.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.0 0.9 0.0 0.9 0.4 0.0 0.0 0.0 1.7 0.6 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.7 1.4 0.3 1.2 3.7 1.4 4.5 2.7 1.7 3.6 3.1 2.8 3.5 0.0 1.8 1.8 3.8 4.1 5.4 PPIAL4G ENSG00000236334 "Peptidylprolyl isomerase A like 4G" P0DN37 1 148479824-148483679 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 6.9;skeletal muscle: 6.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA058345 Uncertain "HPA058345: " "unprognostic (2.17e-3)" "unprognostic (3.63e-1)" "unprognostic (4.83e-1)" "unprognostic (2.26e-1)" "unprognostic (2.37e-1)" "unprognostic (2.11e-1)" "unprognostic (3.95e-1)" "unprognostic (2.67e-2)" "unprognostic (1.79e-1)" 0.2 0.1 1.3 0.7 1.8 1.3 0.3 6.9 1.2 0.1 0.2 0.5 0.4 1.0 0.3 0.1 0.3 0.2 0.9 1.1 0.1 0.2 0.2 1.1 0.5 0.4 0.0 0.1 0.3 0.1 0.2 0.3 0.4 0.0 6.8 0.8 0.7 0.0 0.4 2.7 0.5 0.5 0.4 0.3 0.0 0.0 2.2 0.6 2.4 0.8 2.4 3.2 0.2 0.8 1.1 0.5 1.7 0.2 0.3 1.3 0.3 0.3 0.1 0.1 1.3 0.9 1.2 0.8 0.3 1.0 0.1 0.2 0.2 0.5 0.6 1.2 2.4 1.0 0.1 1.5 1.1 0.2 1.8 0.1 0.3 0.2 0.7 1.8 0.0 0.9 0.8 2.5 1.1 0.3 0.6 0.3 0.8 0.3 1.3 0.7 0.9 1.0 0.7 0.4 1.1 1.3 0.8 0.9 0.9 1.4 0.7 1.4 1.2 1.0 0.7 1.0 0.9 2.2 0.4 1.0 3.2 0.4 2.4 0.9 1.5 1.7 0.3 2.2 1.6 2.8 2.4 2.4 0.8 0.6 0.5 0.2 PPIP5K1 "HISPPD2A, IPS1, KIAA0377, VIP1" ENSG00000168781 "Diphosphoinositol pentakisphosphate kinase 1" Q6PFW1 15 43533462-43590253 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039380 Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039380: AB_10673528" "unprognostic (8.72e-2)" "unprognostic (6.49e-2)" "unprognostic (1.90e-2)" "unprognostic (1.12e-1)" "unprognostic (2.38e-1)" "unprognostic (2.78e-1)" "unprognostic (8.18e-2)" "unprognostic (5.78e-2)" "unprognostic (2.59e-3)" "prognostic unfavourable (8.57e-4)" "unprognostic (6.67e-2)" "unprognostic (2.85e-3)" "prognostic favourable (7.14e-8)" "unprognostic (2.67e-2)" "unprognostic (3.35e-2)" "unprognostic (5.92e-3)" "unprognostic (7.95e-3)" 1.7 5.2 3.4 1.8 6.4 1.1 3.4 28.4 7.0 2.8 6.1 9.1 2.2 5.6 3.7 3.1 2.5 2.1 3.6 5.0 2.5 1.4 1.4 2.0 3.3 3.0 2.9 13.4 7.6 0.9 3.4 6.5 4.7 2.7 6.3 7.2 8.8 2.3 2.8 2.3 5.3 4.5 5.0 3.0 3.3 2.7 5.3 3.2 4.3 2.8 3.5 3.8 3.0 8.5 5.6 4.9 9.1 3.0 1.9 8.5 4.2 5.4 6.1 9.0 6.5 8.1 8.0 6.5 5.8 23.2 9.6 18.5 6.2 7.8 7.6 12.0 17.0 3.5 6.9 13.6 12.5 3.4 16.3 7.4 11.5 6.5 8.6 11.9 4.5 6.6 4.5 7.7 2.4 6.1 9.8 5.0 4.0 6.7 15.4 14.9 4.6 11.0 10.5 4.2 19.3 11.5 2.8 5.4 6.4 6.7 10.3 2.6 3.2 9.9 10.1 15.7 5.1 4.3 1.4 0.0 2.7 2.8 3.8 5.3 3.3 3.6 3.2 3.6 2.7 2.5 1.0 3.5 2.1 2.4 0.8 3.0 PPM1E "CaMKP-N, KIAA1072, POPX1, PP2CH" ENSG00000175175 "Protein phosphatase, Mg2+/Mn2+ dependent 1E" Q8WY54 17 58755869-58985176 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 10.7;brain: 36.5;testis: 13.1" "Cell line enhanced" "Detected in some" "AF22: 10.0;HAP1: 16.2;MOLT-4: 7.6;SCLC-21H: 7.5;SH-SY5Y: 15.5;THP-1: 6.9" "Cancer enhanced" "Detected in some" "prostate cancer: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 2.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018462, HPA019263" Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA018462: AB_1855623, HPA019263: AB_1855624" "unprognostic (2.50e-2)" "unprognostic (5.75e-2)" "unprognostic (8.12e-2)" "unprognostic (2.99e-2)" "unprognostic (5.30e-1)" "unprognostic (8.19e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (3.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.80e-5)" "unprognostic (4.97e-2)" "unprognostic (1.23e-7)" "unprognostic (1.05e-4)" "unprognostic (1.64e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" 0.7 10.7 15.0 0.8 7.5 0.7 0.7 11.9 23.3 1.0 0.7 3.6 0.0 0.8 1.1 2.2 0.7 3.3 0.8 2.3 36.5 5.4 1.9 2.4 1.0 0.9 3.2 9.2 1.0 1.7 0.8 3.4 0.6 10.5 3.2 0.7 3.5 0.8 0.7 0.6 0.7 1.0 1.3 2.7 0.8 1.4 13.1 2.0 0.0 0.8 0.0 1.0 0.6 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.5 0.0 0.0 0.7 0.0 0.0 0.8 1.1 0.0 0.0 6.3 0.1 0.1 0.0 16.2 0.0 0.4 0.1 4.8 0.0 0.1 0.0 1.1 0.5 2.1 0.3 1.3 0.0 0.0 0.0 1.6 0.0 0.0 2.8 7.6 0.0 2.8 0.8 0.0 1.3 0.0 0.0 0.0 7.5 15.5 0.2 0.0 1.0 0.0 6.9 0.0 0.0 1.9 0.0 2.3 0.0 0.1 4.3 0.2 0.0 2.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 7.5 11.9 14.0 36.5 5.4 3.2 9.2 10.5 2.0 PPM1H "ARHCL1, FLJ13253, KIAA1157, NERPP-2C" ENSG00000111110 "Protein phosphatase, Mg2+/Mn2+ dependent 1H" Q9ULR3 12 62643982-62935037 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.1;parathyroid gland: 36.6" "Cell line enhanced" "Detected in many" "CACO-2: 35.1;HMC-1: 28.3;SK-BR-3: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.3" "Group enriched" "Detected in many" 11 "dendritic cells: 2.3;granulocytes: 5.3;monocytes: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020694, HPA044244, HPA058777" Approved Supported Nucleoplasm Nucleoplasm "CAB020694: , HPA044244: , HPA058777: " "unprognostic (3.41e-2)" "unprognostic (1.94e-1)" "unprognostic (9.51e-2)" "unprognostic (8.61e-3)" "unprognostic (1.44e-1)" "unprognostic (1.23e-1)" "unprognostic (1.86e-2)" "unprognostic (5.85e-2)" "unprognostic (3.17e-1)" "unprognostic (1.78e-2)" "unprognostic (5.53e-3)" "unprognostic (2.19e-1)" "prognostic favourable (2.72e-5)" "unprognostic (3.90e-2)" "unprognostic (1.73e-1)" "unprognostic (8.04e-3)" "unprognostic (1.14e-1)" 2.6 2.1 10.6 1.6 12.4 3.1 5.7 37.1 16.3 8.5 2.8 14.0 12.4 3.6 6.9 7.7 1.1 7.5 9.1 2.2 13.0 12.2 11.7 3.9 3.2 1.5 14.3 9.0 9.4 4.9 36.6 13.3 7.1 8.5 15.0 3.6 7.7 10.2 11.6 1.5 1.2 2.1 2.2 8.9 1.3 6.2 1.4 15.0 0.5 3.8 0.1 2.1 3.4 1.2 0.0 2.3 5.3 1.7 0.2 0.0 0.3 0.5 5.4 1.0 0.0 0.2 0.0 11.9 1.3 1.3 0.8 0.2 35.1 2.5 0.0 1.2 0.6 0.7 3.8 0.1 0.5 0.1 1.9 6.6 1.0 7.9 0.0 2.0 28.3 0.0 0.1 0.0 0.3 0.1 1.7 0.0 0.6 4.0 0.6 0.9 7.1 2.6 0.9 2.5 9.8 8.1 12.4 3.1 0.0 2.2 16.0 5.2 8.7 1.1 0.1 0.2 0.7 0.1 0.4 1.4 9.0 1.8 0.1 0.0 0.5 5.3 1.7 3.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.2 0.2 1.4 0.0 0.0 0.3 10.6 12.4 37.1 16.3 13.0 12.2 14.3 9.0 8.5 15.0 PPP1R16B "ANKRD4, KIAA0823, TIMAP" ENSG00000101445 "Protein phosphatase 1 regulatory subunit 16B" Q96T49 20 38805705-38923024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.4;lymphoid tissue: 35.0" "Cell line enhanced" "Detected in some" "Daudi: 22.2;HMC-1: 24.0;HUVEC TERT2: 14.1;U-266/70: 39.0;U-266/84: 15.6;U-698: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049571 Supported "Nuclear speckles,Plasma membrane" "Plasma membrane" "Nuclear speckles" "HPA049571: " "unprognostic (2.62e-2)" "prognostic favourable (2.11e-4)" "unprognostic (2.67e-3)" "unprognostic (3.35e-3)" "unprognostic (2.19e-1)" "prognostic favourable (7.87e-5)" "unprognostic (1.13e-1)" "unprognostic (4.17e-2)" "unprognostic (4.31e-2)" "unprognostic (6.28e-2)" "unprognostic (4.09e-3)" "unprognostic (4.77e-2)" "unprognostic (3.45e-2)" "unprognostic (8.53e-2)" "unprognostic (3.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.90e-2)" 11.2 3.2 26.3 15.9 44.4 13.0 4.4 19.7 35.1 3.6 4.5 25.6 0.0 3.6 3.5 1.9 3.3 5.8 5.3 4.9 25.5 9.1 24.4 2.6 7.3 30.1 15.0 18.8 1.6 1.5 1.2 1.8 3.7 10.9 2.1 5.1 1.6 2.3 2.3 3.4 1.8 9.2 6.8 18.6 14.4 4.9 1.2 15.1 5.1 3.2 0.5 35.0 7.5 3.7 8.4 4.9 3.5 1.3 3.9 5.2 1.6 0.0 0.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.2 0.3 0.0 0.0 0.4 0.0 0.0 0.5 0.1 1.7 0.0 0.0 0.0 0.1 24.0 0.0 0.0 0.0 0.0 14.1 0.3 4.7 0.0 0.0 2.8 3.7 3.1 0.0 1.9 0.0 0.0 0.0 0.0 7.1 8.0 0.0 0.0 0.0 0.0 1.2 2.1 0.0 0.3 0.0 0.0 39.0 15.6 15.3 0.0 0.0 0.0 0.0 0.3 3.5 5.2 0.7 2.8 8.4 3.7 5.1 1.1 5.4 2.2 3.0 0.0 3.9 1.3 4.9 3.7 1.6 26.3 44.4 19.7 35.1 25.5 9.1 15.0 18.8 10.9 15.1 PPP1R17 "C7orf16, GSBS" ENSG00000106341 "Protein phosphatase 1 regulatory subunit 17" O96001 7 31686715-31708455 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 10.5;blood: 24.5;brain: 29.7" "Group enriched" "Detected in some" 197 "NTERA-2: 15.3;SCLC-21H: 46.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in many" 6 "cerebellum: 29.7;hypothalamus: 8.5" "Cell type enriched" "Detected in some" 4 "non-classical monocyte: 24.5" "Lineage enriched" "Detected in many" 19 "monocytes: 24.5" "Region enriched" "Detected in some" 32 "cerebellum: 483.2" "Region enriched" "Detected in many" 4 "cerebellum: 339.5" "HPA047819, HPA073123" Enhanced "HPA047819: , HPA073123: " "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "unprognostic (6.56e-2)" "unprognostic (5.55e-2)" "unprognostic (2.33e-1)" 0.6 10.5 0.9 0.6 1.3 0.8 0.1 29.7 4.6 0.1 0.1 1.7 0.0 0.1 0.8 0.3 0.1 0.1 0.1 0.4 0.6 8.5 0.1 0.2 1.1 0.1 1.1 0.9 0.1 0.1 0.1 2.9 0.1 2.6 0.3 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.4 1.0 0.3 0.3 1.7 3.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 1.2 0.0 24.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.8 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.4 0.9 1.3 29.7 3.3 0.6 8.5 1.1 0.9 2.6 3.0 PPP1R1B "DARPP-32, FLJ20940" ENSG00000131771 "Protein phosphatase 1 regulatory inhibitor subunit 1B" Q9UD71 17 39626740-39636626 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 173.9;salivary gland: 105.3" "Cell line enhanced" "Detected in some" "ASC diff: 5.5;CAPAN-2: 8.7;HSkMC: 23.1;SCLC-21H: 19.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "basal ganglia: 173.9" "Cell type enriched" "Detected in single" 37 "eosinophil: 3.6" "Lineage enriched" "Detected in single" 37 "granulocytes: 3.6" "Region enriched" "Detected in many" 8 "basal ganglia: 1113.7" "Region enriched" "Detected in all" 21 "basal ganglia: 1698.9" "CAB004026, HPA048630, HPA061142" Approved Approved "CAB004026: AB_2169007, HPA048630: , HPA061142: " "unprognostic (2.71e-1)" "unprognostic (4.09e-2)" "unprognostic (6.91e-3)" "unprognostic (2.42e-1)" "unprognostic (3.01e-1)" "unprognostic (7.69e-2)" "unprognostic (6.00e-3)" "unprognostic (2.76e-2)" "unprognostic (1.75e-2)" "unprognostic (6.13e-2)" "unprognostic (6.07e-2)" "unprognostic (2.04e-1)" "unprognostic (1.27e-1)" "unprognostic (2.67e-2)" "unprognostic (2.50e-2)" "unprognostic (2.52e-3)" "unprognostic (1.55e-1)" 26.2 10.0 25.6 5.8 173.9 0.6 23.3 14.6 24.1 7.4 64.1 16.2 39.4 25.7 1.8 2.2 1.9 9.4 4.6 0.7 17.3 11.2 2.0 0.5 5.1 0.5 21.9 22.2 2.6 19.1 0.6 1.7 0.5 17.9 19.9 63.3 6.9 105.3 49.6 0.5 5.7 20.9 4.1 12.4 0.5 13.6 4.6 40.0 0.0 0.5 0.3 0.8 3.6 1.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 3.3 0.1 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.6 0.0 0.0 0.4 0.0 0.0 19.3 0.4 0.0 1.0 0.0 0.4 0.7 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 173.9 14.6 24.1 17.3 11.2 21.9 22.2 17.9 40.0 PPP1R1C Inhibitor-1-like ENSG00000150722 "Protein phosphatase 1 regulatory inhibitor subunit 1C" Q8WVI7 2 181954241-182131398 "Predicted intracellular proteins" "Cell cycle, Cell division" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 7.5;heart muscle: 27.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;HAP1: 1.2;MOLT-4: 2.1;SiHa: 1.3;U-266/70: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA055043 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Nucleoplasm "Nucleoli, Golgi apparatus" "HPA055043: " "unprognostic (1.70e-1)" "unprognostic (3.15e-1)" "unprognostic (4.54e-3)" "unprognostic (1.08e-2)" "unprognostic (1.36e-1)" "unprognostic (1.01e-1)" "unprognostic (2.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.57e-2)" "unprognostic (6.59e-3)" "unprognostic (1.13e-1)" "unprognostic (7.98e-2)" "unprognostic (3.70e-2)" "unprognostic (1.00e-3)" "unprognostic (7.68e-2)" "unprognostic (3.07e-2)" "unprognostic (9.75e-3)" 0.2 0.1 0.7 0.1 3.5 0.1 0.2 3.5 1.8 0.1 0.2 3.0 0.0 0.2 0.2 0.1 0.3 0.2 0.5 27.8 1.5 1.1 0.2 1.2 0.3 0.2 0.8 0.6 0.1 0.6 0.1 0.4 0.2 7.5 1.4 0.2 0.5 0.5 0.2 4.3 0.2 0.7 0.1 2.5 0.2 0.4 0.6 1.3 0.0 0.2 3.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.3 0.2 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.5 3.5 1.8 1.5 1.1 0.8 0.6 7.5 1.3 PPP1R42 "dtr, LRRC67, TLLR" ENSG00000178125 "Protein phosphatase 1 regulatory subunit 42" Q7Z4L9 8 66964099-67056604 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 11.2;fallopian tube: 10.2;testis: 20.2" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.2;RPTEC TERT1: 1.7;SCLC-21H: 1.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA024313, HPA027983, HPA028628" Uncertain "HPA024313: AB_1853053, HPA027983: AB_10599300, HPA028628: AB_2250064" "unprognostic (8.03e-3)" "unprognostic (5.45e-2)" "unprognostic (4.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.92e-1)" "unprognostic (5.42e-2)" "unprognostic (1.99e-2)" "unprognostic (1.03e-1)" "unprognostic (3.61e-3)" "unprognostic (6.86e-2)" "unprognostic (8.58e-3)" "unprognostic (1.44e-1)" "unprognostic (1.12e-1)" "unprognostic (8.07e-2)" "unprognostic (2.33e-1)" 0.3 0.5 2.3 0.3 5.7 0.3 0.3 0.3 2.3 0.9 0.3 3.5 0.0 0.3 0.6 8.0 0.3 10.2 0.4 0.4 3.1 1.4 1.1 0.3 4.1 0.3 0.6 0.8 2.6 0.5 1.0 6.7 0.3 11.2 0.3 0.3 0.8 0.3 1.5 0.3 0.3 0.3 0.4 2.0 0.3 0.3 20.2 1.8 0.0 1.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 5.7 0.3 2.3 3.1 1.4 0.6 0.8 11.2 1.8 PPP2R2B "B55beta, PR52B, PR55-BETA, SCA12" ENSG00000156475 "Protein phosphatase 2 regulatory subunit Bbeta" Q00005 5 146581146-147084784 "Disease related genes, Predicted intracellular proteins" Apoptosis "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 73.2" "Cell line enriched" "Detected in some" 4 "HDLM-2: 46.4" "Cancer enriched" "Detected in some" 8 "glioma: 7.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 15.1;MAIT T-cell: 13.8;memory CD4 T-cell: 7.1;memory CD8 T-cell: 16.1;naive CD8 T-cell: 12.0;NK-cell: 9.5;T-reg: 8.0" "Group enriched" "Detected in many" 33 "NK-cells: 9.5;T-cells: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038118, HPA042122, HPA042770" Approved Approved Cytosol Cytosol "HPA038118: AB_10697238, HPA042122: , HPA042770: " "unprognostic (4.54e-5)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.80e-4)" "unprognostic (2.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.76e-1)" "unprognostic (1.84e-2)" "unprognostic (2.68e-1)" "unprognostic (3.20e-2)" "unprognostic (9.73e-4)" "unprognostic (4.51e-2)" "unprognostic (1.49e-8)" "unprognostic (2.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.48e-5)" "unprognostic (1.14e-4)" 2.0 9.7 30.8 2.5 35.2 2.9 1.8 10.2 73.2 1.6 2.7 26.0 0.0 3.0 1.7 1.8 2.9 14.5 2.9 2.9 26.4 20.9 4.7 2.4 2.5 4.3 25.5 22.4 1.6 2.9 16.0 6.4 2.6 27.5 2.7 2.8 4.6 2.0 2.9 1.5 4.9 2.3 3.5 18.6 2.9 2.2 15.7 29.3 0.0 4.2 0.0 2.4 6.8 1.1 0.0 0.0 0.3 0.0 9.5 16.1 4.1 0.4 0.4 2.4 1.0 0.1 0.1 0.2 0.5 0.2 1.1 1.5 1.3 4.7 0.2 0.1 0.0 10.0 0.8 1.0 1.1 46.4 0.2 0.6 2.7 0.5 0.1 0.0 0.2 0.1 0.6 0.0 0.2 0.1 0.6 0.5 0.7 0.3 0.0 0.0 6.1 1.0 0.7 0.1 0.1 4.1 10.7 1.9 0.2 0.3 0.0 0.2 0.4 0.1 0.3 0.2 0.7 2.5 0.4 0.3 0.2 0.0 1.7 4.2 1.3 0.2 0.0 0.0 15.1 0.0 13.8 0.0 7.1 16.1 0.0 0.0 1.3 12.0 0.3 9.5 0.0 0.0 8.0 4.1 30.8 35.2 10.2 34.1 26.4 20.9 25.5 22.4 27.5 29.3 PPP2R2C "B55gamma, IMYPNO, MGC33570, PR52, PR55G" ENSG00000074211 "Protein phosphatase 2 regulatory subunit Bgamma" Q9Y2T4 4 6320578-6563600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.4" "Cell line enhanced" "Detected in some" "A-431: 15.4;A549: 22.7;CAPAN-2: 15.2;MCF7: 18.7;PC-3: 21.5;SCLC-21H: 20.8;U-2 OS: 12.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042122, HPA042770, HPA060473" Approved Enhanced Cytosol Cytosol "HPA042122: , HPA042770: , HPA060473: " "unprognostic (9.39e-2)" "unprognostic (7.10e-2)" "unprognostic (9.12e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-1)" "unprognostic (5.91e-2)" "unprognostic (2.70e-4)" "prognostic unfavourable (4.94e-4)" "unprognostic (1.77e-1)" "unprognostic (3.90e-1)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (1.36e-13)" "unprognostic (2.52e-1)" "unprognostic (3.92e-2)" "unprognostic (2.66e-3)" "unprognostic (9.90e-3)" 1.5 6.6 28.2 1.6 33.9 1.1 2.4 17.0 78.4 11.8 1.5 13.8 0.5 1.7 25.3 7.0 25.2 10.5 1.4 1.9 25.8 19.5 1.2 1.1 1.1 1.3 25.6 19.3 1.3 1.7 1.1 5.9 1.1 19.1 5.5 1.4 0.4 1.4 14.4 1.7 28.8 2.0 11.8 32.0 1.3 1.9 4.7 13.5 0.0 1.1 3.9 3.6 1.5 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.4 22.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 9.9 0.0 7.1 11.1 0.3 0.0 0.0 1.3 0.0 1.5 1.7 0.3 0.0 0.0 3.3 5.9 0.0 0.0 0.0 0.0 0.0 3.0 18.7 0.0 0.0 1.1 21.5 0.0 0.0 0.6 0.0 0.0 20.8 4.0 0.7 0.0 0.0 9.6 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 33.9 17.0 40.2 25.8 19.5 25.6 19.3 19.1 13.5 PPP2R5B "B56B, B56beta, FLJ35411, PR61B" ENSG00000068971 "Protein phosphatase 2 regulatory subunit B'beta" Q15173 11 64917553-64934473 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "eosinophil: 11.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036607 Approved "HPA036607: AB_10670235" "unprognostic (2.20e-2)" "unprognostic (7.31e-2)" "unprognostic (7.11e-2)" "unprognostic (1.45e-1)" "unprognostic (1.15e-1)" "unprognostic (2.54e-1)" "prognostic unfavourable (3.24e-5)" "unprognostic (1.98e-1)" "unprognostic (1.68e-1)" "unprognostic (3.33e-2)" "unprognostic (9.37e-3)" "unprognostic (8.00e-2)" "unprognostic (1.35e-1)" "unprognostic (1.45e-1)" "unprognostic (2.66e-1)" "unprognostic (1.40e-1)" "unprognostic (2.12e-2)" 11.0 11.7 18.9 8.5 36.7 12.1 6.6 51.9 41.3 7.5 10.0 16.3 8.3 7.5 8.9 11.7 7.8 6.2 16.1 13.7 19.0 24.5 9.1 5.6 11.4 8.4 20.2 23.1 6.3 15.1 17.8 11.6 9.8 27.5 8.7 8.6 10.5 8.7 15.7 13.7 12.3 8.7 14.2 15.2 14.0 7.2 3.4 13.3 2.9 9.0 4.4 8.0 8.9 6.0 1.1 0.6 11.0 1.7 0.9 1.0 0.3 7.4 3.7 4.9 11.4 10.3 7.7 0.7 8.4 7.7 12.0 9.7 2.7 5.7 1.8 5.9 9.9 5.0 4.6 7.2 6.8 10.9 3.3 2.1 6.6 1.8 9.9 0.9 9.8 4.8 12.5 13.0 14.8 9.5 4.1 4.7 8.9 3.0 1.2 3.3 1.5 10.7 2.2 1.4 4.2 9.0 3.4 12.8 12.0 5.1 3.8 7.6 4.3 1.8 9.5 15.4 5.1 16.5 3.1 5.8 4.6 1.5 19.3 1.3 7.0 1.2 0.9 11.0 1.0 1.4 0.7 0.9 0.5 0.9 0.6 1.1 0.5 0.6 0.4 0.9 1.7 0.5 1.0 0.3 18.9 36.7 51.9 41.3 19.0 24.5 20.2 23.1 27.5 13.3 PPP3CA "CALN, CALNA, CNA1, PPP2B" ENSG00000138814 "Protein phosphatase 3 catalytic subunit alpha" Q08209 4 101023409-101348278 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.8" "Low cell line specificity" "Detected in all" "Cancer enriched" "Detected in all" 7 "prostate cancer: 98.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012778, CAB018581" Enhanced Enhanced Nucleoplasm,Cytosol 35000 Nucleoplasm Cytosol "CAB018581: AB_2168324, HPA012778: AB_1855660" "unprognostic (6.66e-2)" "unprognostic (1.96e-1)" "unprognostic (3.40e-1)" "unprognostic (1.36e-1)" "unprognostic (1.56e-1)" "unprognostic (7.81e-2)" "unprognostic (1.77e-2)" "unprognostic (1.08e-1)" "unprognostic (7.87e-2)" "unprognostic (3.49e-3)" "prognostic unfavourable (3.82e-4)" "unprognostic (3.38e-2)" "unprognostic (2.51e-2)" "unprognostic (5.12e-2)" "unprognostic (1.98e-1)" "unprognostic (1.84e-2)" "unprognostic (5.74e-2)" 12.2 9.2 22.7 7.4 71.8 7.7 10.6 42.1 52.4 9.4 9.5 4.8 9.8 5.8 6.2 6.9 7.4 7.2 6.8 4.3 36.0 13.5 5.8 8.4 10.0 6.7 10.1 22.1 9.6 4.7 7.0 4.2 6.6 11.9 34.6 8.4 2.6 10.4 21.1 23.7 11.4 6.4 7.9 7.5 6.9 11.0 5.3 13.0 3.8 6.8 6.8 8.9 8.4 6.8 27.7 18.3 44.3 14.9 22.3 15.5 6.6 19.4 13.8 3.8 7.4 21.6 16.4 7.4 21.4 19.7 8.7 9.2 7.9 24.3 9.2 9.0 19.3 9.7 13.9 28.5 14.8 22.6 6.4 14.7 19.7 10.2 15.8 23.5 7.5 16.9 15.0 18.9 21.7 16.3 5.7 25.5 13.9 23.3 4.9 17.7 6.4 8.9 9.0 34.9 10.7 8.4 15.4 30.3 11.5 17.7 15.2 10.2 13.6 13.4 18.9 20.6 23.4 18.8 14.1 11.9 12.2 16.4 11.4 13.3 5.5 24.6 11.8 24.8 13.6 11.4 15.5 27.7 12.9 13.1 9.9 23.4 6.2 12.3 44.3 22.3 14.9 18.3 8.6 6.6 22.7 71.8 42.1 51.5 36.0 13.5 10.1 22.1 11.9 13.0 PPP3R1 "CALNB1, CNB, CNB1" ENSG00000221823 "Protein phosphatase 3 regulatory subunit B, alpha" P63098 2 68178857-68256237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005610, HPA047157" Approved Approved "Plasma membrane,Cytosol" 43000 "Plasma membrane, Cytosol" "CAB005610: AB_325975, HPA047157: " "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.55e-1)" "prognostic unfavourable (9.08e-6)" "unprognostic (5.90e-2)" "unprognostic (1.86e-1)" "prognostic unfavourable (5.37e-4)" "unprognostic (3.59e-1)" "unprognostic (3.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (1.74e-1)" "prognostic unfavourable (1.70e-5)" "unprognostic (5.24e-3)" "unprognostic (5.35e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-1)" 25.8 20.1 43.3 15.9 66.2 32.3 25.7 47.9 78.2 14.8 14.0 7.7 6.9 13.1 16.6 14.2 15.7 10.5 14.7 10.2 56.2 28.7 11.3 29.6 15.5 18.8 23.7 45.1 13.6 9.8 9.4 8.9 18.5 25.4 14.3 14.8 6.8 12.1 16.6 41.7 17.1 12.0 18.5 21.6 16.5 12.6 10.4 16.5 12.7 12.6 7.7 20.1 14.4 13.3 1.0 1.8 6.4 1.4 0.9 1.4 0.9 17.4 14.9 20.2 13.9 14.0 16.2 20.6 25.5 21.7 28.7 25.4 21.5 15.9 24.4 8.8 17.2 11.9 21.3 18.4 35.1 17.2 15.2 79.3 12.2 19.8 27.6 31.1 26.8 16.3 16.7 22.3 22.9 19.2 19.1 27.9 20.9 15.1 26.3 27.4 23.7 12.7 19.2 26.7 38.9 17.8 18.7 26.7 18.8 14.6 20.8 18.3 9.8 14.5 20.2 24.8 22.8 18.7 21.9 15.8 17.4 36.2 18.1 32.7 15.5 3.2 1.2 2.9 0.7 0.8 1.4 0.5 0.8 0.5 1.3 1.0 0.9 1.4 6.4 0.9 1.4 1.8 0.9 0.9 43.3 66.2 47.9 78.2 56.2 28.7 23.7 45.1 25.4 16.5 PPP4R4 "CFAP14, KIAA1622, PP4R4" ENSG00000119698 "Protein phosphatase 4 regulatory subunit 4" Q6NUP7 14 94146128-94279735 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3;testis: 14.0" "Group enriched" "Detected in some" 4 "RH-30: 16.3;T-47d: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041866, HPA050321" Approved Supported Cytosol Cytosol "HPA041866: AB_10804120, HPA050321: " "unprognostic (2.65e-3)" "unprognostic (3.06e-1)" "unprognostic (9.07e-2)" "unprognostic (9.49e-3)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (2.45e-1)" "unprognostic (1.25e-1)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (1.72e-2)" "unprognostic (8.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.35e-2)" "unprognostic (1.77e-1)" "unprognostic (6.24e-2)" 1.0 1.7 15.2 1.3 15.5 1.1 3.5 4.9 21.3 6.9 1.0 1.9 0.1 1.0 2.1 4.0 1.4 4.0 1.5 1.1 11.1 6.9 1.3 3.0 3.1 1.2 4.7 9.8 11.5 1.6 1.1 7.1 1.7 8.0 1.4 1.1 2.3 1.2 1.8 1.0 2.0 1.0 1.3 5.2 1.0 2.1 14.0 4.1 0.0 1.3 0.0 1.8 1.2 1.3 0.3 0.0 1.1 0.0 0.0 0.3 0.0 0.7 0.0 1.7 0.9 0.4 0.0 0.5 0.2 1.5 1.0 0.4 0.1 0.5 0.9 0.0 0.0 0.0 4.0 4.1 0.4 0.2 0.4 0.0 0.0 1.0 0.2 0.0 0.3 0.0 0.4 0.0 3.8 0.0 0.0 0.1 0.4 0.5 0.0 0.1 1.0 0.9 0.1 16.3 0.0 0.2 0.9 0.2 0.1 0.0 0.0 0.1 17.3 0.0 0.0 3.1 1.7 0.1 0.1 0.8 0.1 0.3 1.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 15.2 15.5 4.9 13.2 11.1 6.9 4.7 9.8 8.0 4.1 PRAG1 "DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223" ENSG00000275342 "PEAK1 related, kinase-activating pseudokinase 1" Q86YV5 8 8317736-8386498 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.4" "Cell line enhanced" "Detected in many" "A549: 28.1;NTERA-2: 18.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012066 Uncertain "HPA012066: AB_1847706" "unprognostic (7.04e-3)" "unprognostic (7.90e-2)" "unprognostic (2.32e-1)" "unprognostic (2.95e-2)" "unprognostic (1.60e-1)" "unprognostic (2.92e-1)" "unprognostic (1.05e-1)" "unprognostic (4.78e-3)" "unprognostic (2.64e-3)" "unprognostic (5.19e-2)" "unprognostic (4.95e-2)" "unprognostic (1.78e-1)" "prognostic favourable (4.81e-4)" "unprognostic (5.27e-2)" "unprognostic (1.23e-1)" "unprognostic (5.04e-2)" "unprognostic (5.22e-3)" 7.6 0.2 6.4 8.8 4.9 0.1 5.4 30.4 7.0 2.4 5.7 1.8 3.2 9.8 0.8 1.7 2.6 5.0 4.0 1.8 2.1 1.3 0.9 4.3 9.1 0.0 1.4 1.7 1.0 2.2 0.0 5.4 1.2 1.5 3.4 0.0 1.7 5.7 5.6 2.8 9.4 0.9 1.4 5.7 3.9 0.7 1.2 1.8 15.4 4.7 6.2 1.5 0.2 3.1 4.6 2.2 1.6 1.3 3.9 0.4 3.4 28.1 3.2 0.4 0.0 0.2 8.0 7.1 1.5 2.8 1.2 13.9 8.2 5.6 4.9 3.4 12.2 0.5 8.6 0.6 0.2 0.9 0.0 3.4 7.8 3.1 0.8 8.9 0.7 5.6 0.4 1.3 5.8 0.0 0.0 2.1 4.7 0.7 2.6 18.2 7.2 3.6 3.4 1.3 4.1 9.8 1.6 1.0 2.7 7.9 2.8 6.1 3.5 7.7 0.3 7.5 0.0 1.7 0.4 0.6 7.7 1.8 1.9 4.2 0.0 0.5 2.2 1.2 0.1 0.9 3.1 1.5 0.4 0.7 2.6 3.9 3.2 0.0 1.3 1.6 4.6 0.2 0.4 PRAM1 PML-RAR ENSG00000133246 "PML-RARA regulated adaptor molecule 1" Q96QH2 19 8490056-8503112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.8;bone marrow: 70.7;brain: 25.1" "Cell line enhanced" "Detected in some" "HL-60: 9.1;NB-4: 7.2;THP-1: 15.8;U-937: 50.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 23.6;intermediate monocyte: 28.1;myeloid DC: 16.1;neutrophil: 14.9;non-classical monocyte: 30.8" "Group enriched" "Detected in many" 7 "dendritic cells: 16.1;granulocytes: 14.9;monocytes: 30.8" "Low region specificity" "Detected in all" "HPA045236, HPA050161" Approved Approved "Golgi apparatus" "Golgi apparatus" "HPA045236: , HPA050161: " "unprognostic (1.68e-2)" "unprognostic (3.79e-3)" "unprognostic (1.15e-2)" "unprognostic (3.91e-3)" "unprognostic (1.25e-1)" "unprognostic (6.54e-3)" "unprognostic (3.36e-1)" "unprognostic (1.74e-3)" "unprognostic (1.48e-2)" "unprognostic (1.26e-1)" "unprognostic (1.28e-2)" "unprognostic (1.28e-1)" "prognostic unfavourable (8.08e-4)" "unprognostic (1.73e-1)" "unprognostic (2.15e-3)" "unprognostic (2.72e-1)" "unprognostic (6.12e-3)" 4.0 1.5 7.1 9.2 15.5 70.7 1.3 2.7 8.3 2.7 1.2 14.4 0.0 3.0 1.7 1.2 1.4 2.3 2.4 1.5 6.8 3.7 1.3 2.4 12.3 10.2 10.9 3.5 1.7 1.5 1.2 2.1 1.6 10.1 3.7 1.3 1.5 1.5 1.2 1.2 1.9 3.1 2.5 25.1 12.8 1.7 1.3 12.0 1.8 2.0 0.0 1.2 2.3 1.4 0.0 16.1 14.9 30.8 3.1 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 50.6 0.0 0.8 23.6 0.8 0.0 28.1 0.1 0.0 0.0 0.0 16.1 0.0 0.0 0.1 14.9 3.1 30.8 0.9 0.0 8.9 7.1 15.5 2.7 8.3 6.8 3.7 10.9 3.5 10.1 12.0 PRDM12 ENSG00000130711 "PR/SET domain 12" Q9H4Q4 9 130664594-130682981 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 3.7" "Cell line enriched" "Detected in single" 20 "RH-30: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "basal ganglia: 11.2" "Group enriched" "Detected in some" 33 "basal ganglia: 6.1;hypothalamus: 2.0" HPA043143 Uncertain Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA043143: AB_10806379" "unprognostic (3.25e-2)" "unprognostic (2.32e-1)" "unprognostic (3.40e-1)" "unprognostic (1.81e-4)" "unprognostic (7.90e-2)" "unprognostic (4.75e-3)" "unprognostic (2.48e-3)" "unprognostic (4.18e-2)" "unprognostic (4.61e-1)" "unprognostic (2.70e-1)" "unprognostic (6.43e-2)" "unprognostic (7.58e-2)" "unprognostic (4.03e-3)" "unprognostic (3.01e-2)" "unprognostic (4.79e-2)" "unprognostic (6.30e-4)" "unprognostic (1.40e-1)" 0.1 0.7 1.0 0.3 1.5 0.0 0.1 1.1 2.2 0.0 0.1 0.3 0.0 0.9 0.0 0.0 0.0 0.0 1.0 3.7 0.0 0.2 0.0 0.0 0.5 0.0 0.8 0.1 0.2 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.4 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.1 0.0 0.2 0.3 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.9 0.0 0.8 0.0 0.1 0.0 19.0 0.5 0.0 0.0 0.9 0.3 0.4 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 PRDM8 KMT8D ENSG00000152784 "PR/SET domain 8" Q9NQV8 4 80183879-80204329 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0;prostate: 30.9;seminal vesicle: 34.0" "Cell line enhanced" "Detected in many" "LHCN-M2: 17.9;NB-4: 20.1;SCLC-21H: 43.4" "Cancer enhanced" "Detected in many" "prostate cancer: 4.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 31.4" "Group enriched" "Detected in many" 4 "amygdala: 15.7;cerebral cortex: 21.5;hippocampal formation: 24.7" HPA057253 Approved "Nuclear bodies" "Nuclear bodies" "HPA057253: " "unprognostic (2.33e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (2.67e-1)" "unprognostic (1.15e-1)" "unprognostic (1.68e-1)" "unprognostic (1.65e-1)" "unprognostic (7.95e-2)" "unprognostic (1.19e-1)" "unprognostic (1.76e-1)" "unprognostic (2.34e-1)" "unprognostic (2.80e-2)" "unprognostic (1.89e-11)" "unprognostic (4.64e-2)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-1)" 3.6 3.5 17.6 6.3 10.1 4.4 3.3 3.6 31.0 9.3 8.2 10.9 1.8 2.1 8.2 3.0 2.8 3.7 2.7 1.9 30.9 6.0 1.4 0.9 2.0 6.1 12.3 18.1 5.5 1.1 0.8 4.5 5.6 7.5 30.9 2.6 4.3 1.5 34.0 3.0 2.1 4.4 8.6 15.2 2.5 4.4 1.9 9.0 0.0 1.1 0.0 3.5 9.0 8.2 2.2 0.5 2.1 0.0 0.7 2.4 0.4 0.9 0.0 0.3 0.0 0.9 3.2 0.0 2.4 8.8 1.2 1.4 0.0 0.9 0.0 0.0 3.0 0.3 0.0 1.0 5.3 3.7 0.8 0.3 0.0 0.0 1.8 3.7 1.1 2.0 0.0 4.8 1.4 0.1 0.0 1.6 17.9 0.0 1.7 20.1 0.0 7.3 0.6 0.0 0.0 0.5 0.1 43.4 6.0 0.1 0.0 0.0 0.0 1.9 3.7 3.1 0.4 2.3 0.1 0.7 0.0 0.0 7.8 1.7 0.4 0.0 0.0 0.0 1.6 0.0 2.4 0.3 2.1 2.0 0.3 2.2 1.3 0.7 2.1 0.7 0.0 0.5 0.9 0.4 17.6 10.1 3.6 31.0 30.9 6.0 12.3 18.1 7.5 9.0 PREPL KIAA0436 ENSG00000138078 "Prolyl endopeptidase like" Q4J6C6 2 44316281-44361862 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063238 Approved "HPA063238: " "unprognostic (5.60e-3)" "unprognostic (9.81e-2)" "unprognostic (4.51e-2)" "unprognostic (4.65e-3)" "unprognostic (2.22e-1)" "unprognostic (8.53e-2)" "unprognostic (5.98e-3)" "unprognostic (4.38e-3)" "unprognostic (2.27e-1)" "unprognostic (2.72e-2)" "unprognostic (1.52e-2)" "unprognostic (4.67e-2)" "unprognostic (2.33e-2)" "unprognostic (3.79e-1)" "unprognostic (1.87e-1)" "unprognostic (1.76e-1)" "unprognostic (1.75e-1)" 11.5 24.5 32.6 8.2 78.4 2.5 15.0 57.3 75.8 18.1 11.3 18.7 6.0 12.0 22.1 34.2 10.9 16.4 13.4 28.2 51.8 50.2 30.4 9.9 11.4 7.6 28.5 44.0 24.3 11.6 34.9 33.2 9.9 69.4 18.1 14.1 13.0 11.7 16.5 13.7 10.2 12.6 16.3 31.3 10.5 12.1 12.6 21.5 5.2 28.9 7.1 8.2 10.7 10.3 8.8 6.3 4.7 4.8 11.1 12.5 5.8 18.3 14.1 16.3 20.7 26.5 27.8 12.5 20.7 15.7 14.9 12.9 15.3 13.0 23.6 28.7 21.5 15.9 23.5 15.0 28.7 21.6 16.6 16.5 11.3 11.6 19.2 15.6 15.2 17.9 30.0 28.7 23.3 14.3 20.2 34.3 19.9 9.8 17.1 7.6 15.7 16.1 13.5 19.9 16.8 28.5 10.7 28.1 21.8 13.5 14.2 29.9 19.0 12.4 15.0 26.5 15.0 20.7 14.0 18.9 12.4 15.5 31.0 18.6 19.5 4.7 4.5 3.4 8.5 4.8 12.2 8.8 8.1 9.2 6.3 7.4 12.5 9.7 1.3 11.1 4.1 3.1 8.7 5.8 32.6 78.4 57.3 75.8 51.8 50.2 28.5 44.0 69.4 21.5 PREX1 "KIAA1415, P-REX1" ENSG00000124126 "Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1" Q8TCU6 20 48624252-48827883 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.7;brain: 35.5" "Cell line enhanced" "Detected in many" "MCF7: 43.2;SK-BR-3: 45.3;T-47d: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001927 Supported Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA001927: AB_1079674" "unprognostic (8.07e-2)" "unprognostic (3.16e-2)" "unprognostic (2.15e-2)" "unprognostic (2.55e-1)" "unprognostic (7.47e-2)" "prognostic favourable (8.56e-4)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (5.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.70e-2)" "unprognostic (5.86e-3)" "unprognostic (6.84e-2)" "unprognostic (2.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" 10.8 8.1 20.5 25.1 24.9 32.7 12.4 11.4 25.0 9.6 5.1 35.5 0.2 4.6 3.2 2.7 4.8 3.7 9.5 4.9 21.8 15.5 4.1 4.0 17.7 28.3 26.2 12.1 2.2 3.9 5.2 5.8 8.4 17.4 3.9 4.6 7.7 4.0 2.8 4.6 2.7 8.6 5.6 27.6 28.7 6.1 4.5 23.9 2.8 6.7 1.0 15.1 10.3 2.5 2.0 2.1 11.7 2.7 2.1 9.3 2.2 0.6 1.6 22.0 0.0 0.3 1.6 7.7 0.7 0.9 3.1 0.8 0.1 0.0 4.4 14.0 1.9 0.2 1.1 0.0 2.1 1.0 0.5 0.6 2.5 0.0 1.3 2.3 14.4 1.8 0.0 7.2 0.0 19.0 0.0 0.1 4.1 43.2 0.0 6.8 0.8 1.8 6.4 6.4 2.6 0.1 0.0 4.6 0.7 4.0 45.3 5.0 40.5 18.5 21.2 1.2 4.5 0.0 1.2 0.2 0.9 5.4 20.6 4.8 6.7 5.2 2.3 2.5 5.0 2.7 3.0 2.0 2.7 4.2 2.1 1.7 0.4 1.5 11.7 2.1 2.3 1.7 9.3 2.2 20.5 24.9 11.4 17.7 21.8 15.5 26.2 12.1 17.4 23.9 PRKACB PKACb ENSG00000142875 "Protein kinase cAMP-activated catalytic subunit beta" P22694 1 84078062-84238498 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 85.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010363, HPA029754, HPA071185" Approved Approved Cytosol 1500000 Cytosol "CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: " "unprognostic (9.38e-2)" "unprognostic (1.18e-1)" "unprognostic (6.37e-2)" "unprognostic (1.39e-1)" "unprognostic (1.58e-1)" "unprognostic (1.98e-1)" "prognostic unfavourable (9.49e-4)" "unprognostic (1.28e-1)" "unprognostic (3.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.31e-1)" "unprognostic (4.62e-2)" "prognostic favourable (1.89e-6)" "unprognostic (1.22e-1)" "unprognostic (3.28e-1)" "unprognostic (1.12e-2)" "unprognostic (2.48e-1)" 7.0 21.5 40.0 10.5 57.0 6.2 8.0 54.7 85.5 9.4 23.6 16.9 3.9 4.8 8.7 17.6 8.1 5.2 11.5 10.1 43.1 52.1 10.6 9.0 6.9 16.2 38.3 33.5 8.3 11.9 12.2 18.3 5.1 35.5 13.8 22.6 4.9 32.9 12.7 3.2 2.6 6.3 12.6 47.7 14.6 14.2 3.6 25.9 25.5 11.1 1.8 15.3 13.5 4.6 13.5 7.1 17.1 5.4 25.9 27.6 22.0 3.1 6.2 9.9 11.9 11.5 10.1 4.6 15.4 11.7 7.8 7.4 0.1 2.8 16.3 10.6 12.0 2.1 4.6 5.0 8.4 15.9 2.5 35.9 8.5 1.2 11.3 14.2 0.8 6.0 2.2 7.6 4.3 36.1 1.1 9.4 12.8 0.5 18.4 7.5 9.8 4.4 14.3 15.5 9.9 19.1 11.1 3.2 12.7 8.5 3.3 9.4 3.0 3.0 32.0 10.9 8.5 11.1 11.6 7.0 8.4 16.5 5.2 15.1 13.6 17.1 2.7 5.8 23.3 3.6 18.7 13.5 17.3 20.6 7.1 10.2 26.4 27.6 1.5 25.9 5.4 4.1 15.9 22.0 40.0 57.0 54.7 58.2 43.1 52.1 38.3 33.5 35.5 25.9 PRKAR1B ENSG00000188191 "Protein kinase cAMP-dependent type I regulatory subunit beta" P31321 7 549197-727650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 83.6" "Cell line enhanced" "Detected in many" "NTERA-2: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026719 Approved "HPA026719: AB_1855419" "unprognostic (4.90e-2)" "unprognostic (4.92e-2)" "unprognostic (2.69e-1)" "unprognostic (4.34e-2)" "unprognostic (1.74e-3)" "unprognostic (1.02e-3)" "unprognostic (3.28e-2)" "unprognostic (4.24e-2)" "unprognostic (1.73e-1)" "unprognostic (1.41e-2)" "unprognostic (2.01e-3)" "unprognostic (1.95e-1)" "unprognostic (3.38e-3)" "unprognostic (5.18e-2)" "unprognostic (2.64e-1)" "unprognostic (9.23e-2)" "unprognostic (2.00e-1)" 5.0 6.8 33.6 4.3 30.4 4.5 4.0 24.0 83.6 4.8 5.7 3.4 1.6 7.2 7.2 2.7 4.2 6.2 4.6 7.7 35.5 42.8 5.4 3.8 5.5 5.2 22.5 29.2 12.9 4.1 5.6 7.0 3.5 29.7 6.0 4.2 2.5 3.9 5.5 3.8 3.0 7.6 5.3 9.1 8.2 3.8 4.8 3.7 2.5 2.9 1.4 3.3 3.5 2.6 7.0 5.5 1.5 2.6 3.5 12.8 10.3 24.8 17.2 2.6 6.3 1.7 1.5 7.3 5.0 2.3 3.2 1.8 30.7 5.5 18.9 3.5 2.2 18.4 8.6 9.5 1.3 3.9 6.2 1.2 11.1 20.2 3.2 11.9 3.0 4.2 3.0 2.1 6.1 3.4 18.0 3.8 2.8 23.9 14.4 7.8 40.3 6.8 9.3 0.5 8.4 8.0 6.5 33.7 25.5 12.7 12.6 9.9 6.5 4.5 4.1 1.4 3.2 1.9 10.1 2.4 6.8 12.3 2.6 9.3 18.8 1.5 2.0 0.0 4.6 2.6 6.9 6.2 7.9 7.1 2.4 7.0 12.8 11.7 0.8 3.5 0.9 5.5 5.2 10.3 33.6 30.4 24.0 68.6 35.5 42.8 22.5 29.2 29.7 3.7 PRKCB "PKCB, PRKCB1, PRKCB2" ENSG00000166501 "Protein kinase C beta" P05771 16 23835946-24220611 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 57.2;lymphoid tissue: 31.2" "Cell line enhanced" "Detected in some" "HEL: 40.8;HMC-1: 40.9;K-562: 58.1;THP-1: 18.4;U-937: 16.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003843, HPA048321, HPA054203" Approved Supported Nucleoplasm,Cytosol 3400000 Nucleoplasm Cytosol "CAB003843: AB_562197, HPA048321: , HPA054203: " "unprognostic (1.53e-3)" "unprognostic (4.53e-4)" "unprognostic (2.52e-3)" "unprognostic (3.07e-2)" "unprognostic (1.72e-1)" "unprognostic (7.13e-3)" "unprognostic (2.06e-1)" "unprognostic (1.67e-3)" "unprognostic (3.19e-2)" "unprognostic (1.79e-1)" "unprognostic (7.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.17e-3)" "unprognostic (2.08e-1)" "unprognostic (2.12e-2)" "unprognostic (3.28e-1)" "unprognostic (4.95e-2)" 4.0 1.9 13.9 20.8 55.6 20.4 1.8 14.1 57.2 4.1 4.7 4.4 0.6 4.9 3.5 1.2 3.2 2.6 3.9 1.5 23.4 7.8 1.8 3.7 5.4 31.0 11.0 20.4 1.2 1.4 0.9 1.4 2.5 8.3 6.2 4.4 3.5 1.9 8.4 1.2 4.6 9.1 5.8 7.3 31.2 3.8 6.4 6.4 24.1 3.9 0.0 27.7 7.6 1.7 23.6 18.5 21.8 14.6 20.1 19.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.8 40.8 1.9 0.0 0.0 5.9 40.9 0.0 0.1 0.0 0.0 0.0 58.1 0.1 0.0 0.0 12.9 12.9 0.3 0.0 12.3 0.1 2.3 0.1 3.6 7.1 0.0 0.0 0.0 0.6 0.0 18.4 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 16.4 0.0 17.5 7.6 14.4 14.5 10.7 6.7 23.6 9.5 17.2 6.2 22.1 7.8 19.0 21.8 20.1 14.6 18.5 6.7 7.5 13.9 55.6 14.1 57.2 23.4 7.8 11.0 20.4 8.3 6.4 PRKCE ENSG00000171132 "Protein kinase C epsilon" Q02156 2 45651345-46187990 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.5" "Cell line enhanced" "Detected in many" "REH: 19.1;TIME: 19.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 5.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001948, HPA044496, HPA054252" Enhanced Supported Approved Vesicles Vesicles "CAB001948: , HPA044496: , HPA054252: " "unprognostic (1.10e-1)" "unprognostic (1.78e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (2.42e-4)" "unprognostic (9.61e-2)" "unprognostic (5.70e-2)" "unprognostic (1.51e-1)" "prognostic favourable (9.62e-4)" "unprognostic (3.05e-1)" "unprognostic (6.72e-2)" "unprognostic (7.49e-3)" "unprognostic (9.99e-2)" "prognostic favourable (2.63e-7)" "unprognostic (1.21e-1)" "unprognostic (7.11e-2)" "unprognostic (6.43e-3)" "unprognostic (2.23e-2)" 5.5 7.4 15.3 7.2 14.2 9.3 8.1 28.8 36.5 6.6 5.5 3.8 5.9 3.6 5.6 4.6 4.7 7.6 4.7 7.7 22.5 10.0 12.8 15.5 17.5 6.9 6.0 15.0 4.1 4.2 16.3 6.0 10.4 9.1 3.6 4.7 3.7 3.6 8.6 7.2 3.0 3.7 6.2 4.4 4.9 4.4 7.2 3.7 1.5 6.5 1.2 5.4 5.0 6.5 5.5 2.2 1.7 1.4 0.9 1.3 0.6 5.3 2.0 2.8 2.8 4.3 5.1 2.3 3.8 6.8 3.2 3.4 0.5 5.3 8.1 3.6 3.9 1.3 1.8 2.0 4.5 4.8 3.4 0.0 1.4 1.1 4.9 0.6 2.9 4.5 2.2 4.7 3.4 11.6 1.1 1.9 3.6 2.7 2.6 0.3 1.0 1.0 19.1 13.5 8.6 2.9 3.7 2.0 4.3 1.7 5.7 12.3 4.6 1.9 19.2 6.2 6.5 4.5 3.7 0.0 0.0 6.8 5.1 4.5 6.2 0.0 1.2 1.7 1.0 0.4 1.1 3.6 0.7 0.7 2.2 5.5 1.3 0.4 0.4 0.9 1.4 0.9 0.0 0.6 15.3 14.2 28.8 33.2 22.5 10.0 6.0 15.0 9.1 3.7 PRKCG "MGC57564, PKCC, PKCG, SCA14" ENSG00000126583 "Protein kinase C gamma" P05129 19 53879190-53907652 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 49.9" "Cell line enhanced" "Detected in some" "A549: 5.8;HAP1: 2.7;SH-SY5Y: 4.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB013051, HPA047870, HPA054560" Enhanced "CAB013051: AB_2533015, HPA047870: , HPA054560: " "unprognostic (7.14e-2)" "unprognostic (5.42e-2)" "unprognostic (1.85e-1)" "unprognostic (3.86e-2)" "unprognostic (1.41e-1)" "unprognostic (5.38e-2)" "unprognostic (5.96e-2)" "unprognostic (4.46e-2)" "unprognostic (2.09e-1)" "unprognostic (2.64e-2)" "unprognostic (7.48e-3)" "unprognostic (2.68e-1)" "unprognostic (2.22e-7)" "unprognostic (2.41e-2)" "unprognostic (2.61e-1)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" 1.0 0.9 28.0 1.1 49.9 2.2 0.9 12.1 39.2 0.9 1.3 1.6 0.0 1.5 1.0 0.9 1.0 1.4 1.0 0.9 49.7 4.4 0.9 0.9 1.0 0.9 2.9 20.8 0.9 3.5 2.1 0.2 0.9 0.7 0.9 1.2 0.0 0.9 1.0 1.0 0.9 1.3 1.1 1.4 0.9 1.8 4.4 2.1 1.3 0.9 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 5.8 1.3 0.0 0.0 0.2 0.1 0.7 0.4 0.1 0.0 1.5 1.5 0.3 1.7 0.0 0.5 2.7 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.1 0.0 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.1 1.0 0.5 1.0 0.6 0.1 1.1 0.0 0.0 4.0 1.6 0.2 0.0 1.9 0.0 1.0 0.0 2.0 0.0 0.0 1.7 0.4 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 49.9 12.1 28.5 49.7 4.4 2.9 20.8 0.7 2.1 PRKCZ PKC2 ENSG00000067606 "Protein kinase C zeta" Q05513 1 2050470-2185395 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.6;placenta: 93.0" "Cell line enhanced" "Detected in many" "BEWO: 23.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 15.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021851 Enhanced Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA021851: AB_1855433" "unprognostic (1.25e-2)" "unprognostic (2.61e-1)" "unprognostic (5.10e-2)" "unprognostic (1.14e-2)" "unprognostic (2.08e-1)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (5.13e-2)" "unprognostic (1.18e-1)" "unprognostic (3.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" "prognostic favourable (1.64e-9)" "unprognostic (3.57e-2)" "unprognostic (3.27e-2)" "unprognostic (1.39e-1)" "unprognostic (7.85e-2)" 1.2 7.8 15.9 3.0 31.8 1.4 3.9 39.8 43.6 3.2 8.6 17.1 2.3 20.0 1.7 5.5 10.1 6.5 3.1 6.4 15.5 6.4 11.3 6.8 22.3 5.0 12.2 23.6 1.9 8.5 9.8 12.0 93.0 27.3 5.8 7.5 2.6 7.0 3.0 0.4 8.8 18.4 1.2 8.4 6.9 6.1 17.5 13.5 0.6 14.1 0.9 5.0 4.0 4.6 0.4 0.3 15.0 0.3 0.8 2.6 0.3 7.5 4.8 1.7 8.9 0.0 0.0 23.5 0.5 0.2 5.6 0.3 12.1 16.4 0.0 14.9 1.9 13.2 10.1 12.5 4.0 0.5 11.2 0.0 7.7 16.1 1.6 0.0 5.8 0.3 7.5 0.0 4.3 0.0 3.3 0.1 0.1 9.2 0.4 0.0 3.4 11.7 0.0 0.0 2.6 9.6 7.9 12.3 9.9 6.1 13.7 2.6 9.6 2.0 0.0 0.0 7.1 0.1 0.0 3.5 0.6 0.1 0.6 0.1 8.5 0.3 0.0 15.0 0.6 0.3 2.6 0.3 1.0 0.6 0.0 0.4 0.8 0.4 1.2 0.8 0.0 0.3 0.8 0.3 15.9 31.8 39.8 43.6 15.5 6.4 12.2 23.6 27.3 13.5 PRLH PRH ENSG00000071677 "Prolactin releasing hormone" P81277 2 237566574-237567175 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.1;heart muscle: 4.5" "Cell line enhanced" "Detected in some" "A549: 5.9;MCF7: 4.3;RPMI-8226: 3.6;SK-BR-3: 1.8;T-47d: 2.0;U-87 MG: 2.4" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 58 "hypothalamus: 13.4;pons and medulla: 22.5" "Region enriched" "Detected in single" 13 "pons and medulla: 5.1" HPA014976 Approved "Secreted - unknown location" "HPA014976: " "unprognostic (8.28e-4)" "unprognostic (3.22e-2)" "unprognostic (5.42e-2)" 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.5 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 1.8 0.3 2.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRLHR "GPR10, PrRPR" ENSG00000119973 "Prolactin releasing hormone receptor" P49683 10 118589989-118595699 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 11.3;brain: 10.6;cervix, uterine: 8.3;pituitary gland: 11.8;smooth muscle: 8.1" "Cell line enriched" "Detected in single" 9 "SH-SY5Y: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA039361 Enhanced "HPA039361: AB_10673527" "unprognostic (1.83e-1)" "unprognostic (2.62e-3)" "unprognostic (1.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" 0.2 11.3 1.4 0.2 3.0 0.2 0.1 3.2 5.1 8.3 0.2 0.8 0.0 0.3 5.4 0.2 0.2 0.4 0.2 0.1 0.6 4.0 0.1 0.2 0.2 0.1 3.4 0.9 0.1 0.5 0.1 11.8 0.1 10.6 0.3 0.2 0.1 0.2 1.4 0.2 0.2 0.2 8.1 0.5 0.2 0.5 0.2 1.0 0.0 0.2 0.0 0.1 0.1 5.4 0.5 0.4 1.3 0.3 0.7 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 3.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.5 0.3 0.2 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.5 0.3 0.2 1.3 0.7 0.3 0.4 0.0 0.0 1.4 3.0 3.2 1.9 0.6 4.0 3.4 0.9 10.6 1.0 PRLR ENSG00000113494 "Prolactin receptor" P16471 5 35048756-35230589 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.3;placenta: 45.7;seminal vesicle: 42.7" "Cell line enriched" "Detected in some" 18 "T-47d: 91.5" "Cancer enriched" "Detected in many" 9 "breast cancer: 20.6" "Region enriched" "Detected in many" 7 "pons and medulla: 54.3" "Group enriched" "Detected in some" 4 "classical monocyte: 2.7;intermediate monocyte: 2.8" "Lineage enriched" "Detected in single" 11 "monocytes: 2.8" "Low region specificity" "Detected in some" "Intracellular and membrane" "unprognostic (3.81e-2)" "unprognostic (2.41e-1)" "unprognostic (2.37e-2)" "unprognostic (6.04e-2)" "unprognostic (5.05e-2)" "unprognostic (8.21e-2)" "unprognostic (3.99e-2)" "unprognostic (7.94e-2)" "unprognostic (4.89e-2)" "unprognostic (1.67e-3)" "unprognostic (4.84e-4)" "unprognostic (2.50e-3)" "unprognostic (4.15e-3)" "unprognostic (1.89e-1)" "unprognostic (1.12e-1)" "unprognostic (9.84e-5)" "unprognostic (1.24e-1)" 0.5 13.3 1.8 0.2 5.6 0.3 13.3 0.4 1.4 23.5 5.3 10.7 36.6 3.5 25.1 10.0 1.1 2.1 2.0 0.6 7.6 2.4 17.8 5.9 0.6 0.0 0.6 0.2 3.2 4.3 11.5 15.7 45.7 54.3 3.2 3.0 0.5 1.8 42.7 0.4 2.6 10.1 6.4 0.7 0.4 3.3 2.0 0.4 0.1 0.5 0.5 0.0 1.4 6.2 0.0 0.2 0.1 2.8 0.0 0.0 0.3 0.0 0.0 0.1 0.7 0.0 0.7 0.1 0.4 0.3 0.8 0.2 0.1 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.0 91.5 0.7 0.0 0.5 0.5 0.1 0.3 0.0 0.0 0.0 0.9 0.0 0.2 0.1 2.7 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 1.8 5.6 0.4 1.4 7.6 2.4 0.6 0.2 54.3 0.4 PRMT8 "HRMT1L3, HRMT1L4" ENSG00000111218 "Protein arginine methyltransferase 8" Q9NR22 12 3381349-3593973 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 24.8" "Cell line enriched" "Detected in some" 10 "hTERT-HME1: 32.9" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039747, HPA069769" Enhanced "HPA039747: AB_10697554, HPA069769: " "unprognostic (3.09e-1)" "unprognostic (9.47e-2)" "unprognostic (5.59e-1)" "unprognostic (3.34e-3)" "unprognostic (4.80e-3)" "unprognostic (9.41e-2)" "unprognostic (3.41e-5)" "unprognostic (5.99e-1)" "unprognostic (1.93e-1)" "unprognostic (1.50e-2)" "unprognostic (7.06e-2)" "unprognostic (2.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.64e-1)" "unprognostic (6.02e-2)" "unprognostic (5.49e-2)" 0.6 0.6 4.6 0.6 18.3 0.6 0.7 8.7 24.8 0.8 0.7 0.2 0.1 0.7 0.7 0.6 0.6 3.1 0.6 2.3 4.0 2.1 1.2 0.6 2.2 0.6 3.5 10.0 0.7 1.8 0.6 0.0 0.6 1.4 0.6 0.7 0.0 0.6 0.7 0.6 0.6 0.6 0.6 0.4 0.6 0.7 3.0 1.8 1.0 0.6 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 18.3 8.7 14.6 4.0 2.1 3.5 10.0 1.4 1.8 PROKR2 "dJ680N4.3, GPR73b, GPR73L1, GPRg2, KAL3, PKR2" ENSG00000101292 "Prokineticin receptor 2" Q8NFJ6 20 5302040-5314369 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.7;brain: 5.9" "Cell line enhanced" "Detected in some" "HaCaT: 1.6;NTERA-2: 3.2;SCLC-21H: 1.1;SH-SY5Y: 6.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory CD8 T-cell: 1.6;neutrophil: 1.1" "Group enriched" "Detected in many" 8 "granulocytes: 1.1;T-cells: 1.6" "Region enhanced" "Detected in many" "olfactory region: 20.9" "Low region specificity" "Detected in all" HPA047281 Uncertain "HPA047281: AB_10960057" "unprognostic (1.36e-1)" "unprognostic (1.69e-1)" 0.0 0.0 0.4 0.0 0.5 3.7 0.1 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.5 0.4 0.0 0.0 0.0 1.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 1.4 0.1 0.0 0.1 0.0 0.3 0.3 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 1.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 1.1 0.1 0.0 0.0 0.0 0.0 PRPH "NEF4, PRPH1" ENSG00000135406 Peripherin P41219 12 49293252-49298686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.9;testis: 30.4" "Cell line enriched" "Detected in some" 5 "AN3-CA: 89.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 23 "pons and medulla: 44.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "hypothalamus: 22.7;pons and medulla: 36.8" "Low region specificity" "Detected in all" "CAB002437, HPA039277, HPA063887" Enhanced "CAB002437: AB_563956, HPA039277: AB_2676424, HPA063887: AB_2685142" "unprognostic (1.73e-2)" "unprognostic (3.03e-1)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (7.88e-4)" "unprognostic (5.04e-3)" "unprognostic (1.88e-2)" "unprognostic (6.29e-2)" "unprognostic (1.87e-1)" "unprognostic (2.10e-1)" "unprognostic (7.38e-2)" "unprognostic (1.24e-1)" "unprognostic (4.25e-3)" "unprognostic (3.63e-2)" "unprognostic (5.73e-2)" "unprognostic (4.86e-3)" "unprognostic (6.36e-5)" 2.2 20.0 0.7 13.4 1.6 0.1 1.2 0.5 2.3 3.9 16.0 0.6 1.0 5.6 0.9 1.4 3.1 2.5 2.7 3.2 1.9 0.9 0.3 0.1 0.7 0.4 0.9 0.0 0.5 1.1 0.3 2.5 0.5 44.9 5.0 2.7 12.1 1.0 4.9 0.6 0.7 11.4 2.5 5.9 0.9 4.8 30.4 0.4 0.1 0.3 0.9 0.2 5.8 7.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.0 89.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.5 0.1 0.0 0.3 19.3 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.7 1.6 0.5 0.5 1.9 0.9 0.9 0.0 44.9 0.4 PRR18 MGC35308 ENSG00000176381 "Proline rich 18" Q8N4B5 6 166305300-166308448 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 35.7" "Group enriched" "Detected in some" 7 "SCLC-21H: 9.1;SH-SY5Y: 5.3" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077250 Enhanced "HPA077250: " "unprognostic (2.91e-1)" "unprognostic (7.18e-2)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (1.44e-1)" "unprognostic (9.65e-2)" "unprognostic (5.60e-3)" "unprognostic (1.25e-1)" "unprognostic (1.10e-1)" "unprognostic (3.16e-2)" "unprognostic (2.44e-3)" "unprognostic (4.79e-3)" "unprognostic (2.43e-1)" "unprognostic (3.35e-3)" "unprognostic (9.49e-2)" "unprognostic (9.58e-2)" "unprognostic (1.07e-1)" 1.3 0.9 12.4 0.9 17.3 0.9 0.9 1.7 34.8 1.1 0.9 35.7 0.0 1.4 0.9 0.9 0.9 4.4 0.9 0.9 18.6 9.0 1.0 6.4 1.1 0.9 23.1 7.0 1.0 1.1 3.3 0.4 0.9 11.0 1.3 0.9 0.0 1.0 1.1 0.9 0.9 1.0 0.9 21.7 0.9 1.2 0.9 18.9 0.0 1.1 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 9.1 5.3 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 17.3 1.7 14.9 18.6 9.0 23.1 7.0 11.0 18.9 PRR35 C16orf11 ENSG00000161992 "Proline rich 35" P0CG20 16 560422-565528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "brain: 51.1" "Cell line enhanced" "Detected in some" "HEK 293: 2.3;HMC-1: 1.0;K-562: 2.1;NTERA-2: 1.0;RT4: 1.3;U-2 OS: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in some" 27 "cerebellum: 51.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 4.8" "Region enhanced" "Detected in single" "cerebellum: 0.9" HPA069297 Uncertain "HPA069297: " "unprognostic (6.96e-2)" "unprognostic (3.08e-2)" "unprognostic (5.25e-1)" "unprognostic (8.11e-2)" "unprognostic (2.56e-1)" "unprognostic (3.38e-2)" "unprognostic (1.17e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 51.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.8 0.0 0.0 1.1 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.0 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.1 0.2 0.0 0.0 0.0 0.0 1.8 0.0 PRR36 ENSG00000183248 "Proline rich 36" Q9H6K5 19 7868719-7874379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.5;pituitary gland: 6.5" "Cell line enhanced" "Detected in some" "REH: 21.8;SCLC-21H: 6.3;SH-SY5Y: 14.2;T-47d: 7.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062741 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA062741: " "unprognostic (3.15e-2)" "unprognostic (1.02e-1)" "unprognostic (6.23e-2)" "unprognostic (5.61e-2)" "unprognostic (1.72e-1)" "unprognostic (1.20e-2)" "unprognostic (9.62e-2)" "unprognostic (3.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.15e-3)" "unprognostic (1.75e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-3)" "unprognostic (7.89e-2)" "prognostic favourable (7.74e-4)" "unprognostic (3.56e-1)" "unprognostic (8.52e-3)" 0.4 2.0 11.8 0.5 11.4 0.3 1.5 12.0 20.5 0.7 0.4 0.8 0.0 0.8 1.2 0.8 0.3 1.1 0.5 0.3 8.0 1.1 0.4 1.3 0.4 0.0 10.6 0.9 3.2 1.6 6.5 0.3 5.5 2.5 0.4 0.5 3.0 1.0 0.3 0.8 0.4 0.4 0.7 0.4 1.4 0.7 1.2 0.0 1.0 0.0 0.3 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.7 5.2 4.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 2.3 0.0 1.5 0.0 0.1 4.0 0.0 0.0 0.0 5.0 0.0 0.2 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.3 0.2 0.2 2.0 0.4 21.8 0.0 0.2 2.9 4.2 6.3 14.2 0.0 0.2 0.0 7.1 0.0 0.0 0.0 2.6 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 PRR5L "FLJ14213, PROTOR-2" ENSG00000135362 "Proline rich 5 like" Q6MZQ0 11 36296288-36465204 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.1;intestine: 25.7;lymphoid tissue: 26.1" "Cell line enhanced" "Detected in many" "HeLa: 16.3;HMC-1: 27.1;hTERT-HME1: 28.2;SiHa: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070174 Approved "Cytokinetic bridge,Cytosol" "Cytokinetic bridge, Cytosol" "HPA070174: " "unprognostic (6.76e-2)" "unprognostic (1.61e-1)" "unprognostic (3.48e-2)" "prognostic favourable (7.30e-5)" "unprognostic (2.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.63e-1)" "unprognostic (7.45e-2)" "unprognostic (3.61e-1)" "unprognostic (1.46e-2)" "unprognostic (3.03e-3)" "unprognostic (2.12e-1)" "prognostic unfavourable (7.71e-8)" "prognostic unfavourable (4.86e-4)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (2.98e-2)" 2.9 1.5 4.2 8.1 15.5 3.1 2.4 1.7 9.5 9.5 25.7 34.1 1.1 2.5 2.6 1.6 1.4 4.9 5.3 1.6 7.2 5.1 3.8 2.3 10.4 6.2 24.9 3.8 11.4 2.0 1.0 2.7 2.8 16.6 2.3 21.4 3.3 6.3 1.6 0.7 1.6 9.3 4.8 22.8 26.1 2.6 1.2 19.7 1.1 3.0 0.2 2.6 3.6 3.6 1.1 4.2 16.9 12.3 4.6 20.1 7.2 0.0 2.8 4.9 0.1 0.7 0.0 0.0 5.9 4.6 12.6 13.0 0.0 0.0 0.0 1.9 7.3 0.2 0.9 3.0 6.1 2.3 1.7 0.6 16.3 0.0 1.6 0.0 27.1 2.0 4.3 1.2 28.2 5.2 0.0 0.0 6.4 1.5 0.3 0.0 0.3 1.1 1.7 0.5 0.5 12.8 3.0 0.0 0.2 18.6 0.0 1.1 0.0 0.2 3.6 10.7 3.3 0.0 7.4 0.1 0.0 0.0 4.6 0.6 3.2 16.9 1.1 13.3 20.1 11.8 4.6 0.0 7.2 16.8 1.3 1.1 1.6 10.8 6.5 4.6 12.3 4.2 0.0 7.2 4.2 15.5 1.7 9.5 7.2 5.1 24.9 3.8 16.6 19.7 PRR7 MGC10772 ENSG00000131188 "Proline rich 7, synaptic" Q8TB68 5 177446445-177456286 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell line enhanced" "Detected in many" "PC-3: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA046636 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA046636: " "unprognostic (3.69e-1)" "unprognostic (9.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (4.08e-2)" "unprognostic (7.94e-3)" "prognostic unfavourable (1.50e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (4.75e-2)" "unprognostic (5.86e-2)" "unprognostic (2.76e-2)" "prognostic unfavourable (1.98e-4)" "unprognostic (8.84e-3)" "unprognostic (2.22e-1)" "unprognostic (3.76e-2)" "unprognostic (1.69e-1)" 1.9 2.4 12.5 3.2 22.0 15.1 1.7 4.1 28.5 1.1 2.9 9.8 0.0 2.9 1.7 1.3 1.9 3.2 1.9 1.1 14.1 7.6 1.5 2.2 2.0 3.6 4.8 8.4 1.2 4.0 2.6 6.2 1.3 6.2 2.0 1.4 4.7 5.2 1.5 1.7 8.8 2.6 1.2 4.4 4.9 4.6 3.2 4.6 1.2 1.2 0.8 2.3 1.5 0.9 3.2 3.0 10.8 0.6 2.0 7.3 1.5 7.1 2.8 0.8 5.6 0.0 0.4 2.4 3.4 0.6 1.0 1.3 0.6 3.8 6.9 8.9 0.5 6.0 0.4 3.0 0.4 6.0 8.9 2.1 2.6 2.1 0.6 4.1 5.0 0.6 1.3 0.4 0.2 0.4 1.0 4.9 0.9 9.6 3.4 10.6 1.3 17.1 9.8 2.6 6.9 1.2 0.5 13.9 9.9 1.3 3.3 15.9 3.0 0.6 2.6 5.7 9.5 5.0 8.1 2.7 1.5 3.3 5.5 6.7 4.1 2.4 0.1 10.8 3.0 0.5 7.3 2.1 3.4 5.1 0.1 3.2 3.2 4.1 4.8 2.0 0.6 3.0 2.5 1.5 12.5 22.0 4.1 28.5 14.1 7.6 4.8 8.4 6.2 4.6 PRRG1 PRGP1 ENSG00000130962 "Proline rich and Gla domain 1" O14668 X 37349275-37457295 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078129 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA078129: " "unprognostic (8.82e-2)" "prognostic unfavourable (4.65e-4)" "unprognostic (8.34e-2)" "unprognostic (2.08e-3)" "unprognostic (1.92e-1)" "unprognostic (5.11e-3)" "unprognostic (2.24e-2)" "unprognostic (7.23e-3)" "unprognostic (1.01e-2)" "unprognostic (1.74e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (8.21e-2)" "prognostic favourable (2.05e-7)" "unprognostic (1.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.48e-1)" 11.6 5.5 12.0 3.1 22.0 0.7 5.8 2.6 18.7 6.7 5.7 35.9 4.6 4.1 6.2 2.5 5.9 4.0 12.4 8.5 17.9 10.7 14.9 10.7 6.3 2.5 31.0 9.9 6.2 2.6 1.2 2.3 10.6 21.3 5.1 6.0 3.0 3.9 11.6 19.3 3.1 4.3 7.5 43.4 4.0 3.4 2.4 23.7 0.0 11.6 2.9 1.6 5.9 4.5 0.6 0.2 2.6 1.7 0.2 0.4 0.1 14.7 3.4 2.7 2.7 9.2 7.5 1.2 6.2 8.4 2.3 4.0 8.1 9.5 0.0 10.9 4.9 4.8 7.4 4.7 3.9 0.0 2.4 2.6 3.5 2.7 11.3 0.0 3.4 11.6 4.0 4.4 3.7 11.7 1.2 0.0 7.8 1.1 0.0 0.0 3.3 7.0 0.0 6.1 0.0 38.6 0.7 0.0 0.0 4.6 7.3 2.8 0.0 1.6 8.3 3.5 2.1 6.8 1.9 0.0 0.0 0.0 3.5 0.0 3.3 2.6 1.7 0.1 0.2 0.5 0.2 0.6 0.1 0.3 0.1 0.4 0.2 0.4 0.8 0.2 0.2 0.2 0.2 0.1 12.0 22.0 2.6 13.9 17.9 10.7 31.0 9.9 21.3 23.7 PRRG3 TMG3 ENSG00000130032 "Proline rich and Gla domain 3" Q9BZD7 X 151695124-151705924 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.4;epididymis: 10.3" "Cell line enhanced" "Detected in some" "HeLa: 2.7;HMC-1: 2.2;NTERA-2: 4.1;U-2197: 2.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060566 Uncertain "HPA060566: " "unprognostic (1.85e-1)" "unprognostic (1.21e-1)" "unprognostic (7.71e-2)" "unprognostic (1.77e-2)" "unprognostic (4.42e-4)" "unprognostic (7.24e-2)" "unprognostic (2.29e-2)" "unprognostic (1.28e-1)" "unprognostic (2.06e-2)" "unprognostic (5.11e-2)" "unprognostic (3.01e-2)" "unprognostic (2.26e-1)" "unprognostic (1.98e-2)" "unprognostic (7.69e-2)" "unprognostic (4.64e-2)" "unprognostic (1.57e-1)" "unprognostic (1.84e-2)" 3.1 0.2 5.6 1.2 12.4 0.4 2.0 1.0 10.2 9.2 1.1 1.0 0.1 0.3 3.0 10.3 4.0 1.0 3.3 1.6 5.3 11.6 0.4 0.1 2.0 0.2 3.2 5.3 3.9 0.1 0.4 1.3 1.3 5.3 1.1 1.0 1.4 1.3 0.4 3.3 2.5 0.5 2.4 1.2 2.6 0.6 0.6 0.7 0.1 0.7 0.6 0.4 1.4 2.4 1.2 1.4 3.8 1.8 2.4 1.4 1.0 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.2 0.0 0.0 0.0 1.2 0.4 0.3 0.2 0.0 0.4 0.1 0.2 0.0 0.1 0.0 0.1 2.7 0.4 0.2 0.3 2.2 0.3 0.0 0.1 0.2 0.0 0.1 0.5 0.2 0.3 0.1 0.5 4.1 0.1 0.2 0.0 0.1 0.1 0.5 1.0 0.4 0.0 0.3 0.1 0.2 0.2 0.1 0.5 0.5 2.3 0.1 0.1 1.4 0.1 0.3 0.2 0.1 3.8 1.3 1.3 1.2 1.2 1.4 1.1 0.9 0.9 1.0 1.2 1.3 1.1 3.1 2.4 1.8 1.4 1.1 1.0 5.6 12.4 1.0 10.2 5.3 11.6 3.2 5.3 5.3 0.7 PRRT1 "C6orf31, IFITMD7, NG5" ENSG00000204314 "Proline rich transmembrane protein 1" Q99946 6 32148359-32153083 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 41.1" "Group enriched" "Detected in some" 4 "HEK 293: 1.5;SK-MEL-30: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055149, HPA059099" Enhanced "HPA055149: , HPA059099: " "unprognostic (1.40e-2)" "unprognostic (1.35e-1)" "unprognostic (2.10e-3)" "unprognostic (3.87e-3)" "unprognostic (2.89e-1)" "unprognostic (4.74e-2)" "unprognostic (5.51e-3)" "unprognostic (5.93e-2)" "unprognostic (1.49e-1)" "unprognostic (1.58e-2)" "unprognostic (8.08e-5)" "unprognostic (2.99e-1)" "unprognostic (2.22e-2)" "unprognostic (8.59e-2)" "unprognostic (9.40e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-2)" 2.6 4.8 23.9 2.4 25.3 2.2 2.2 35.8 41.1 2.5 2.5 4.9 0.0 2.6 2.6 2.1 2.1 2.4 2.3 2.3 24.4 10.5 2.4 2.2 2.2 2.2 4.9 27.1 6.1 2.4 2.3 3.2 2.5 11.7 2.8 2.3 1.8 2.3 2.7 2.4 2.4 2.4 2.3 3.0 2.4 2.9 2.6 7.7 0.0 2.2 0.0 2.1 2.2 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.8 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.1 0.5 0.7 0.1 0.0 5.5 0.2 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 23.9 25.3 35.8 41.1 24.4 10.5 4.9 27.1 11.7 7.7 PRRT2 "DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC" ENSG00000167371 "Proline rich transmembrane protein 2" Q7Z6L0 16 29811382-29815892 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Dystonia, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 86.7" "Cell line enhanced" "Detected in many" "AF22: 19.9;REH: 15.2;U-138 MG: 13.7" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 7.3" "Lineage enriched" "Detected in single" 11 "NK-cells: 7.3" "HPA014447, HPA019203" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA014447: AB_1855786, HPA019203: " "unprognostic (7.60e-3)" "unprognostic (3.00e-1)" "unprognostic (8.32e-3)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (1.19e-3)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "unprognostic (9.30e-2)" "unprognostic (1.93e-1)" "unprognostic (4.45e-2)" "unprognostic (3.26e-2)" "unprognostic (3.43e-8)" "unprognostic (1.22e-1)" "unprognostic (1.17e-1)" "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" 3.7 7.2 27.2 2.8 40.5 0.8 2.1 86.7 53.6 10.1 6.0 6.0 3.1 6.2 20.7 8.3 4.4 10.2 10.3 5.3 18.9 13.0 2.1 0.9 5.7 3.5 5.5 33.2 35.7 2.4 8.6 17.6 7.1 18.0 16.2 2.6 5.2 4.6 14.4 4.3 3.1 6.8 10.3 7.4 1.8 7.3 9.9 10.2 0.0 2.8 0.3 1.6 5.1 10.7 0.2 0.0 0.5 0.2 7.3 0.6 0.3 0.3 1.2 19.9 7.4 1.0 3.8 0.5 2.4 4.0 0.8 0.9 1.1 2.3 0.2 0.5 3.3 2.0 2.7 0.4 0.3 5.3 1.6 1.3 8.9 0.8 0.2 0.0 0.3 3.4 0.1 1.4 0.1 1.0 0.2 1.6 0.6 3.3 0.5 0.6 5.7 1.0 15.2 1.1 0.4 0.1 0.7 4.3 4.5 0.2 2.9 0.4 7.4 0.1 1.1 13.7 4.8 0.8 1.3 3.4 0.4 0.1 5.4 0.1 0.5 0.5 0.0 0.1 0.2 0.1 0.3 0.1 0.6 0.4 0.0 0.2 0.4 0.2 0.2 7.3 0.2 0.0 0.1 0.3 27.2 40.5 86.7 53.6 18.9 13.0 5.5 33.2 18.0 10.2 PRRT3 FLJ33674 ENSG00000163704 "Proline rich transmembrane protein 3" Q5FWE3 3 9945542-9952394 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9" "Cell line enhanced" "Detected in many" "ASC diff: 12.5;MCF7: 15.8;SK-BR-3: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035127, HPA035128, HPA069859" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 18000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA035127: AB_10602822, HPA035128: , HPA069859: " "unprognostic (1.55e-1)" "unprognostic (8.41e-2)" "unprognostic (3.42e-1)" "unprognostic (2.38e-3)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.15e-4)" "unprognostic (2.27e-3)" "unprognostic (1.37e-2)" "unprognostic (2.76e-2)" "unprognostic (2.20e-3)" "unprognostic (3.60e-1)" "unprognostic (1.01e-4)" "unprognostic (2.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (2.09e-1)" 1.4 2.9 8.4 1.8 11.9 2.1 2.0 13.4 26.0 2.4 1.4 4.2 0.0 1.0 2.0 2.2 1.7 10.8 1.9 1.6 5.9 3.2 1.5 0.9 1.4 1.8 2.7 8.3 2.9 2.9 24.7 6.9 0.8 11.4 4.0 0.8 1.8 2.0 2.9 1.5 2.5 1.2 1.7 2.3 1.5 1.5 3.9 3.2 1.2 3.4 0.0 2.0 2.1 1.8 1.8 1.5 0.9 0.6 1.7 3.8 1.0 0.2 0.7 2.5 3.3 12.5 1.7 0.8 1.2 2.4 1.4 3.3 0.2 2.4 1.3 0.3 2.9 0.2 0.9 3.1 0.6 6.7 1.4 0.5 1.3 0.0 1.2 0.3 1.2 3.2 0.2 1.2 0.5 0.6 0.7 3.3 1.8 15.8 3.0 0.2 6.1 1.5 1.8 0.3 1.3 0.7 0.2 4.8 3.2 1.2 23.8 0.4 6.4 0.2 0.6 0.3 3.4 0.6 0.9 4.3 4.4 0.4 7.9 0.2 0.9 0.9 0.6 0.5 3.3 0.3 3.7 1.6 3.4 3.3 0.2 1.8 3.8 3.5 0.8 1.7 0.4 1.5 0.6 1.0 8.4 11.9 13.4 26.0 5.9 3.2 2.7 8.3 11.4 3.2 PRSS48 ESSPL ENSG00000189099 "Serine protease 48" Q7RTY5 4 151277171-151291453 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.0;skin 1: 1.9;testis: 4.1" "Cell line enhanced" "Detected in some" "HHSteC: 1.4;LHCN-M2: 1.3;PC-3: 1.5;RT4: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053801 Uncertain "Secreted in male reproductive system" "HPA053801: " "unprognostic (9.68e-2)" "unprognostic (1.35e-2)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.76e-2)" "unprognostic (4.10e-2)" 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.0 0.5 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 PRSS51 ENSG00000253649 "Serine protease 51" A0A1B0GVH4 8 10482878-10547585 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "brain: 1.4;breast: 3.4;liver: 1.5;testis: 2.3" "Cell line enhanced" "Detected in some" "AN3-CA: 1.7;CAPAN-2: 1.6;T-47d: 1.9;U-2 OS: 5.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" "unprognostic (2.52e-1)" "unprognostic (3.00e-1)" "unprognostic (3.10e-1)" "unprognostic (1.90e-1)" "unprognostic (1.06e-1)" "unprognostic (2.22e-2)" "unprognostic (2.72e-1)" "unprognostic (7.48e-2)" "unprognostic (1.64e-1)" "unprognostic (7.94e-2)" "unprognostic (1.02e-1)" "unprognostic (6.33e-3)" "unprognostic (2.71e-3)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.4 3.4 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 PRSS56 ENSG00000237412 "Serine protease 56" P0CW18 2 232520463-232525716 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.4;retina: 8.6;skeletal muscle: 16.2" "Cell line enriched" "Detected in single" 5 "Daudi: 4.6" "Cancer enhanced" "Detected in many" "urothelial cancer: 4.7" "Region enhanced" "Detected in many" "hypothalamus: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "basal ganglia: 1.6;olfactory region: 5.2" "Region enhanced" "Detected in many" "olfactory region: 32.6" "unprognostic (3.26e-1)" "unprognostic (1.98e-2)" "unprognostic (1.31e-1)" "unprognostic (3.73e-3)" "unprognostic (2.28e-1)" "unprognostic (7.15e-2)" "unprognostic (4.64e-2)" "unprognostic (1.20e-1)" 0.1 0.1 0.3 0.1 1.8 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.2 4.4 0.1 0.1 0.1 0.1 2.2 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.2 0.1 8.6 0.1 0.1 16.2 0.1 0.1 0.1 0.8 0.2 0.1 2.6 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.1 1.0 0.2 4.4 2.2 0.1 0.1 0.1 PRTFDC1 HHGP ENSG00000099256 "Phosphoribosyl transferase domain containing 1" Q9NRG1 10 24848607-24952604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0" "Cell line enhanced" "Detected in many" "CACO-2: 29.6;CAPAN-2: 37.3;HEL: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "NK-cell: 7.9" "Lineage enriched" "Detected in many" 7 "NK-cells: 7.9" HPA021458 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA021458: AB_1855793" "unprognostic (2.61e-1)" "unprognostic (3.47e-1)" "unprognostic (3.69e-1)" "prognostic unfavourable (2.66e-4)" "unprognostic (9.49e-3)" "unprognostic (2.03e-1)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (2.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic unfavourable (9.27e-5)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (7.66e-3)" "unprognostic (1.94e-2)" 4.1 18.3 18.1 3.3 18.2 0.6 6.1 6.1 24.0 8.1 7.7 29.0 2.4 13.9 12.9 6.1 4.5 5.9 11.8 8.6 16.8 13.0 4.0 2.2 3.4 2.8 18.1 12.6 17.1 3.6 10.2 11.0 2.3 16.2 6.5 9.2 6.0 7.2 6.9 0.9 1.4 13.2 8.0 22.5 2.3 13.8 1.7 20.7 2.3 3.7 1.1 2.4 6.0 4.6 0.0 0.3 0.1 0.0 7.9 1.1 1.7 7.4 16.2 12.1 4.9 2.0 10.1 0.0 7.9 6.0 5.7 7.8 29.6 37.3 0.0 1.2 9.3 4.2 13.7 0.0 8.9 0.0 0.5 21.7 3.0 0.0 6.0 0.0 0.0 2.9 0.1 3.1 0.0 8.9 7.0 4.2 2.7 0.2 3.3 0.0 8.3 0.3 3.7 0.0 0.0 5.1 0.2 8.7 0.4 7.6 0.0 0.0 0.4 1.7 4.8 2.5 6.4 9.2 4.7 0.4 0.0 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.4 0.5 0.3 0.0 0.1 0.3 0.1 7.9 0.0 0.2 0.0 1.7 18.1 18.2 6.1 15.8 16.8 13.0 18.1 12.6 16.2 20.7 PRX KIAA1620 ENSG00000105227 Periaxin Q9BXM0 19 40393768-40413366 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 42.1;lung: 31.7;retina: 20.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "midbrain: 42.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Region enriched" "Detected in single" 21 "midbrain: 24.7" HPA001868 Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" "Golgi apparatus, Vesicles, Plasma membrane" "HPA001868: AB_2172440" "unprognostic (1.29e-2)" "unprognostic (3.04e-1)" "unprognostic (2.72e-2)" "unprognostic (9.72e-3)" "unprognostic (2.92e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (3.54e-2)" "unprognostic (5.82e-2)" "unprognostic (3.23e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-2)" "unprognostic (2.03e-3)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (9.97e-2)" 3.4 4.4 4.8 1.0 4.1 1.1 2.7 2.2 5.4 3.0 2.3 1.8 2.8 1.2 3.8 2.0 2.2 3.2 2.4 2.9 4.0 2.2 4.3 0.6 31.7 1.3 42.1 3.7 7.5 5.4 7.3 1.1 6.0 10.3 3.2 0.8 20.6 3.9 4.4 5.4 2.2 1.5 3.3 11.0 1.7 2.4 1.6 3.6 0.0 7.2 6.7 0.9 3.1 2.0 0.3 0.4 0.0 0.3 0.1 1.2 0.2 2.4 2.7 3.3 4.2 2.7 7.0 4.1 2.0 2.3 2.9 2.1 2.3 2.7 0.8 2.6 1.9 1.3 1.1 0.9 1.0 1.2 1.4 0.5 0.9 0.7 3.2 0.2 3.6 4.9 4.9 1.9 1.6 1.5 3.0 0.8 1.5 3.2 1.1 0.8 0.7 2.5 4.8 2.7 2.4 0.5 1.3 0.3 1.5 3.9 3.3 3.0 4.9 1.2 2.2 5.9 4.6 2.3 1.2 8.4 7.3 1.1 1.8 1.3 1.3 0.0 0.3 0.0 0.6 0.2 0.2 0.0 0.4 0.6 0.0 0.3 0.3 1.2 0.0 0.1 0.0 0.4 0.3 0.2 4.8 4.1 2.2 5.4 4.0 2.2 42.1 3.7 10.3 3.6 PSD "EFA6, EFA6A, KIAA2011, PSD1, TYL" ENSG00000059915 "Pleckstrin and Sec7 domain containing" A5PKW4 10 102402617-102421539 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.8" "Cell line enhanced" "Detected in some" "HSkMC: 10.1;MOLT-4: 5.4;SCLC-21H: 9.4;SH-SY5Y: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059237 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA059237: " "unprognostic (2.43e-1)" "unprognostic (1.74e-1)" "unprognostic (5.62e-3)" "unprognostic (1.53e-1)" "unprognostic (3.16e-2)" "unprognostic (2.90e-2)" "unprognostic (7.73e-3)" "unprognostic (1.75e-1)" "unprognostic (9.59e-2)" "unprognostic (7.59e-2)" "unprognostic (2.24e-3)" "unprognostic (4.71e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (8.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" 1.2 9.8 48.7 4.3 59.4 1.6 1.5 8.0 66.8 6.7 21.5 1.7 0.0 6.7 23.9 2.4 3.2 11.1 9.4 1.9 48.7 12.2 1.5 1.4 1.7 1.8 7.6 26.7 5.6 4.7 2.5 13.6 1.8 4.2 6.2 4.4 3.7 1.5 2.2 1.2 2.1 5.8 20.7 1.8 1.5 4.8 4.6 7.0 0.0 1.2 0.0 1.5 11.7 3.0 0.8 0.0 1.1 0.2 0.9 1.3 0.0 0.3 0.1 3.8 3.4 1.4 0.8 0.3 0.3 0.0 0.1 0.0 2.6 0.4 0.3 2.4 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.1 2.1 0.0 0.1 10.1 0.3 0.6 0.1 0.0 0.5 0.9 0.0 2.0 5.4 0.3 0.5 0.0 1.4 0.0 0.1 0.0 0.2 9.4 8.3 0.1 0.1 0.2 0.6 0.5 0.0 2.8 4.6 0.2 0.0 2.4 0.3 0.1 0.3 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.2 0.2 0.3 0.0 0.8 0.3 1.3 1.1 0.9 0.0 0.0 0.0 0.0 48.7 59.4 8.0 41.2 48.7 12.2 7.6 26.7 4.2 7.0 PSD2 "DKFZp761B0514, EFA6C" ENSG00000146005 "Pleckstrin and Sec7 domain containing 2" Q9BQI7 5 139795821-139844466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "brain: 52.4" "Cell line enhanced" "Detected in some" "HEL: 3.5;SCLC-21H: 2.1;SH-SY5Y: 3.6;U-2 OS: 1.7" "Cancer enriched" "Detected in single" 43 "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.76e-2)" "unprognostic (1.90e-1)" "unprognostic (1.34e-3)" "unprognostic (2.48e-3)" "unprognostic (1.34e-2)" "unprognostic (5.01e-2)" "unprognostic (1.22e-2)" "unprognostic (6.55e-2)" "unprognostic (2.42e-1)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (4.02e-1)" "unprognostic (4.16e-3)" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (3.07e-1)" "unprognostic (2.12e-3)" 1.3 1.7 21.1 1.3 28.9 1.3 1.7 12.6 52.4 1.9 1.3 15.2 0.0 1.4 1.4 3.6 1.3 1.6 1.3 1.4 16.1 15.2 1.3 1.3 1.3 1.3 18.9 14.4 1.3 1.6 1.3 0.2 1.3 24.7 1.4 1.3 0.0 3.5 1.7 1.4 1.3 1.3 1.4 12.8 1.4 1.3 2.2 17.0 0.0 1.3 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.2 0.9 0.1 0.2 0.0 0.0 0.2 0.3 0.9 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.1 0.4 0.1 0.0 0.4 0.0 0.1 0.0 0.1 2.1 3.6 0.0 0.7 0.1 0.0 0.2 0.0 0.2 1.7 0.0 0.0 1.0 0.0 1.5 1.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 28.9 12.6 17.5 16.1 15.2 18.9 14.4 24.7 17.0 PSD3 "DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942" ENSG00000156011 "Pleckstrin and Sec7 domain containing 3" Q9NYI0 8 18527301-19084730 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.6;LHCN-M2: 22.4;U-87 MG: 24.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002455 Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA002455: " "unprognostic (3.87e-2)" "unprognostic (2.52e-2)" "prognostic favourable (7.55e-4)" "prognostic unfavourable (5.76e-5)" "unprognostic (2.56e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.84e-2)" "unprognostic (7.27e-2)" "unprognostic (3.39e-1)" "unprognostic (2.50e-3)" "unprognostic (2.13e-1)" "unprognostic (7.18e-3)" "unprognostic (3.71e-2)" "unprognostic (8.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.45e-1)" 2.3 15.5 18.3 2.7 40.5 1.3 5.2 51.6 50.7 11.3 5.7 13.4 2.5 4.2 7.8 3.6 4.8 2.6 6.5 21.8 23.2 9.3 2.1 15.6 4.1 2.2 10.0 27.6 16.0 8.3 9.5 9.6 5.6 10.7 3.7 6.5 5.4 3.2 5.5 1.3 3.9 4.3 5.2 7.4 8.4 8.0 12.7 11.4 0.0 5.4 1.4 3.1 6.1 3.3 3.1 0.6 2.3 1.3 1.9 2.0 0.7 5.0 2.6 11.9 0.0 4.3 26.6 0.6 2.7 4.2 2.4 5.1 1.5 2.0 3.0 1.7 10.9 0.4 3.4 4.7 4.7 0.0 3.1 0.2 2.1 0.2 7.8 0.0 0.1 7.0 3.0 13.5 2.4 3.2 0.3 2.4 22.4 1.7 0.0 0.5 2.3 7.0 2.3 10.4 1.3 6.2 6.5 5.1 5.7 1.1 0.5 1.8 0.0 1.2 13.1 7.6 5.3 17.9 2.3 0.2 0.3 6.9 24.0 1.2 2.6 2.3 1.3 1.3 1.0 0.8 1.3 1.6 1.0 0.6 0.5 3.1 0.5 0.6 1.5 1.9 1.1 0.6 2.0 0.7 18.3 40.5 51.6 50.7 23.2 9.3 10.0 27.6 10.7 11.4 PSRC1 DDA3 ENSG00000134222 "Proline and serine rich coiled-coil 1" Q6PGN9 1 109279556-109283186 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "glioma: 50.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 12.3" "Group enriched" "Detected in many" 10 "dendritic cells: 5.4;granulocytes: 7.3;monocytes: 12.3" "Group enriched" "Detected in some" 6 "amygdala: 3.5;cerebral cortex: 7.5;hippocampal formation: 6.3" "Low region specificity" "Detected in all" "HPA049315, HPA056561" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA049315: , HPA056561: " "unprognostic (1.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.42e-3)" "unprognostic (6.78e-3)" "unprognostic (2.17e-1)" "unprognostic (4.76e-2)" "prognostic unfavourable (1.36e-9)" "unprognostic (3.51e-2)" "unprognostic (6.21e-2)" "unprognostic (4.88e-3)" "unprognostic (1.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (9.43e-2)" "unprognostic (2.08e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" 1.7 2.4 17.1 4.3 21.6 8.3 3.0 3.8 27.3 2.0 4.0 31.2 0.3 5.1 3.0 3.4 6.3 3.2 3.7 2.0 25.9 11.2 1.7 2.6 2.2 4.0 29.8 12.9 3.6 1.4 0.8 1.7 4.8 16.8 4.0 3.3 4.5 2.9 5.9 1.0 6.1 5.3 4.7 30.6 2.3 2.4 8.6 20.7 5.5 2.0 0.4 5.0 2.6 2.3 0.0 5.4 7.3 12.3 0.2 0.7 3.2 18.4 9.5 39.1 18.9 1.5 3.1 10.7 14.7 11.9 20.1 19.3 14.7 7.7 9.4 5.4 7.2 13.3 21.1 12.0 16.9 3.6 10.1 5.9 12.8 12.0 1.8 6.2 6.7 3.5 1.1 7.9 5.6 9.8 13.3 4.3 16.0 16.8 9.5 4.2 16.2 10.9 14.7 37.7 3.1 6.7 4.8 16.5 9.5 8.3 12.7 15.0 7.6 6.0 5.0 12.4 20.6 8.7 24.1 3.4 2.2 3.2 10.0 15.0 34.5 0.0 12.3 1.8 0.7 4.8 0.5 0.0 0.7 0.2 5.4 0.0 0.4 0.4 7.3 0.2 2.6 0.0 0.7 3.2 17.1 21.6 3.8 16.4 25.9 11.2 29.8 12.9 16.8 20.7 PTCHD1 FLJ30296 ENSG00000165186 "Patched domain containing 1" Q96NR3 X 23334016-23404372 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Autism, Autism spectrum disorder" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.8" "Cell line enhanced" "Detected in some" "HEK 293: 3.3;RT4: 3.1;WM-115: 10.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 27.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046110 Uncertain "HPA046110: " "unprognostic (1.50e-2)" "unprognostic (1.36e-2)" "unprognostic (7.43e-3)" "unprognostic (1.14e-2)" "unprognostic (1.15e-1)" "unprognostic (1.90e-1)" "unprognostic (1.14e-4)" "unprognostic (2.13e-1)" "unprognostic (1.48e-1)" "unprognostic (2.78e-1)" "unprognostic (2.13e-1)" "unprognostic (3.50e-1)" "unprognostic (3.19e-2)" "unprognostic (3.68e-4)" "unprognostic (5.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" 1.6 2.3 6.6 0.9 5.5 0.7 6.0 27.8 8.9 6.2 8.4 1.0 3.5 1.4 5.1 2.1 4.5 0.9 0.8 0.8 5.3 2.7 0.8 0.6 1.2 0.6 3.1 5.8 0.8 0.8 0.5 1.7 0.5 6.5 4.4 2.9 0.0 1.8 11.7 1.1 0.8 1.8 10.2 2.6 1.4 3.4 1.1 3.8 0.0 1.0 0.0 0.6 5.4 2.9 0.7 0.4 1.2 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.3 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 1.2 0.4 0.0 1.4 0.0 0.0 3.1 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 10.4 1.2 0.3 0.4 0.3 0.2 0.2 0.3 0.3 0.2 0.1 0.7 0.3 0.3 1.0 0.3 0.2 0.4 0.1 0.0 6.6 5.5 27.8 6.5 5.3 2.7 3.1 5.8 6.5 3.8 PTCHD4 "C6orf138, dJ402H5.2, FLJ41841, PTCH53" ENSG00000244694 "Patched domain containing 4" Q6ZW05 6 47878028-48068689 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3" "Cell line enhanced" "Detected in some" "AF22: 10.8;BEWO: 14.4;Hep G2: 24.0;LHCN-M2: 11.4;TIME: 12.1;WM-115: 10.5" "Group enriched" "Detected in some" 6 "melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041276 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041276: AB_10796570" "unprognostic (1.35e-4)" "unprognostic (1.66e-2)" "unprognostic (3.25e-1)" "unprognostic (3.11e-3)" "unprognostic (1.07e-2)" "unprognostic (1.57e-3)" "unprognostic (7.94e-2)" "unprognostic (3.59e-3)" "unprognostic (2.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic favourable (1.49e-6)" "unprognostic (5.03e-4)" "unprognostic (9.84e-2)" "unprognostic (1.57e-2)" "unprognostic (5.56e-3)" 2.1 0.7 4.6 0.1 7.4 0.2 1.3 2.7 11.3 3.8 1.2 0.3 0.0 0.6 1.7 3.7 1.9 3.2 1.4 1.4 2.2 1.3 2.2 2.1 3.1 0.2 1.4 5.5 1.1 1.1 0.4 3.9 1.9 1.8 2.3 1.2 1.6 2.1 6.4 0.6 0.3 0.4 1.9 1.3 0.2 0.5 0.9 0.8 0.0 3.6 0.0 0.3 2.8 1.3 0.4 0.4 0.8 0.2 0.1 0.2 0.0 0.0 0.0 10.8 0.0 1.8 5.3 14.4 1.6 3.4 0.1 0.4 0.0 0.7 0.0 0.0 0.9 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.3 24.0 0.5 0.0 0.0 7.9 7.7 0.0 0.1 1.6 0.0 0.0 11.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 2.5 0.6 0.0 0.0 0.0 0.0 0.0 12.1 2.6 1.7 0.0 0.2 0.0 0.0 0.0 3.6 0.0 10.5 0.8 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.1 0.2 0.4 0.0 0.0 4.6 7.4 2.7 11.3 2.2 1.3 1.4 5.5 1.8 0.8 PTH2 TIP39 ENSG00000142538 "Parathyroid hormone 2" Q96A98 19 49422414-49423441 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "blood: 2.4;brain: 4.1;testis: 1.7" "Cell line enhanced" "Detected in some" "Hep G2: 1.3;REH: 3.7;SCLC-21H: 3.2;U-266/84: 1.1;U-937: 1.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 18 "B-cells: 2.4" "Region enriched" "Detected in single" 10 "olfactory region: 3.5" "Region enriched" "Detected in many" 4 "cerebellum: 36.9" "Secreted in brain" "unprognostic (3.41e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 3.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 1.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PTH2R PTHR2 ENSG00000144407 "Parathyroid hormone 2 receptor" P49190 2 208359714-208854503 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 8.6;brain: 8.9;salivary gland: 8.2" "Cell line enhanced" "Detected in some" "EFO-21: 11.4;HEL: 16.2;HL-60: 4.0;SH-SY5Y: 6.7" "Cancer enhanced" "Detected in many" "renal cancer: 6.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010655 Approved "HPA010655: " "unprognostic (4.76e-3)" "unprognostic (1.39e-3)" "unprognostic (1.64e-1)" "unprognostic (5.78e-2)" "unprognostic (3.77e-1)" "unprognostic (8.28e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (3.45e-2)" "unprognostic (2.14e-2)" "unprognostic (1.70e-1)" "unprognostic (1.09e-3)" "unprognostic (2.54e-3)" "unprognostic (6.87e-2)" "unprognostic (1.30e-2)" "unprognostic (1.37e-2)" 2.5 0.9 6.0 0.6 3.5 8.6 2.1 0.2 8.6 0.2 0.2 0.0 0.0 0.0 1.6 4.9 0.2 0.2 0.2 0.2 8.9 4.3 0.5 1.4 0.3 0.3 0.5 4.3 0.1 1.4 0.0 1.0 2.7 0.1 1.2 0.1 0.0 8.2 1.4 0.1 0.3 0.2 1.2 0.4 0.4 0.1 1.7 0.0 0.0 0.2 0.1 0.2 0.2 0.2 1.4 0.6 0.9 1.3 0.0 0.8 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.7 1.3 0.8 1.4 0.0 0.0 0.0 1.0 0.4 0.0 0.9 0.0 0.9 0.6 0.0 0.4 6.0 3.5 0.2 8.6 8.9 4.3 0.5 4.3 0.1 0.0 PTK2B "CADTK, CAKB, FAK2, PTK, PYK2, RAFTK" ENSG00000120899 "Protein tyrosine kinase 2 beta" Q14289 8 27311482-27459391 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 46.7;brain: 65.2" "Cell line enhanced" "Detected in many" "Daudi: 37.0;REH: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 202.9;basal ganglia: 236.9;cerebral cortex: 189.7;hippocampal formation: 443.3;olfactory region: 185.5" "Low region specificity" "Detected in many" "CAB003850, HPA026091, HPA026276" Approved Supported "Plasma membrane,Cytosol" 84000 "Plasma membrane, Cytosol" "CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234" "unprognostic (2.36e-2)" "prognostic favourable (3.32e-4)" "unprognostic (1.06e-1)" "unprognostic (7.36e-3)" "unprognostic (3.72e-2)" "unprognostic (3.11e-2)" "unprognostic (2.70e-2)" "unprognostic (2.13e-2)" "unprognostic (3.23e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-2)" "unprognostic (3.32e-1)" "unprognostic (2.40e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "prognostic favourable (5.11e-4)" "unprognostic (3.33e-3)" 7.2 4.7 20.4 24.3 30.0 46.7 4.9 65.2 48.3 5.4 14.5 7.8 5.0 16.6 4.3 4.7 7.9 6.8 6.4 4.7 30.5 7.0 6.8 5.0 11.5 35.6 4.3 25.4 2.4 5.4 5.2 5.3 4.1 3.9 10.1 11.9 8.3 12.6 6.7 2.2 15.1 18.4 5.5 4.8 32.0 10.8 4.3 3.7 37.8 5.6 2.9 35.4 13.0 6.0 26.9 18.7 24.0 25.8 14.7 19.0 21.5 10.9 3.0 0.8 0.9 23.5 1.7 6.4 0.8 0.5 0.6 0.8 2.9 6.3 37.0 1.2 1.7 10.1 0.3 9.2 0.3 2.5 0.2 7.6 2.9 0.5 4.8 8.2 13.8 12.7 13.8 0.8 5.3 0.3 8.9 25.7 0.6 1.1 14.0 16.5 0.6 0.8 41.0 0.2 25.3 2.6 8.6 5.8 1.0 3.9 2.7 1.4 3.3 21.2 5.2 0.4 0.8 0.7 0.3 20.7 8.9 20.0 1.6 17.8 0.7 22.3 23.7 18.0 19.0 22.4 12.5 25.5 9.6 13.3 18.7 26.9 12.1 14.2 24.0 14.7 25.8 6.2 9.5 21.5 20.4 30.0 65.2 48.3 30.5 7.0 4.3 25.4 3.9 3.7 PTPDC1 "FLJ37312, PTP9Q22" ENSG00000158079 "Protein tyrosine phosphatase domain containing 1" A2A3K4 9 94030794-94109856 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0" "Group enriched" "Detected in many" 5 "B-cells: 1.1;T-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016747, HPA026832" Uncertain Enhanced Nucleoplasm Nucleoplasm "HPA016747: AB_1855908, HPA026832: AB_10602917" "unprognostic (3.99e-2)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (4.91e-2)" "unprognostic (1.94e-1)" "unprognostic (3.64e-2)" "unprognostic (1.90e-3)" "unprognostic (4.71e-1)" "unprognostic (2.43e-1)" "unprognostic (2.56e-1)" "unprognostic (3.49e-2)" "unprognostic (3.55e-2)" "unprognostic (2.48e-2)" "unprognostic (2.45e-2)" "unprognostic (2.17e-1)" "unprognostic (1.28e-1)" "unprognostic (2.61e-2)" 7.0 12.0 7.6 4.4 32.3 1.5 6.4 4.7 16.4 4.7 4.9 25.3 1.4 3.1 6.2 4.9 4.4 4.4 4.7 10.0 12.1 6.9 5.1 2.4 6.8 3.7 13.9 8.9 6.3 12.2 6.8 8.9 3.7 19.9 5.6 5.9 4.1 4.3 4.4 7.0 6.2 3.6 8.3 20.5 3.0 7.1 15.0 13.0 1.6 5.1 1.3 3.9 4.9 3.6 1.1 0.3 0.0 0.2 0.0 2.0 0.1 6.2 2.7 4.9 6.3 6.1 8.5 6.6 4.5 3.2 4.7 3.9 2.6 5.2 5.2 3.1 3.5 4.9 5.0 2.9 4.6 7.0 1.4 1.2 7.2 2.8 8.0 1.4 4.0 8.4 10.5 7.0 9.8 4.9 3.0 0.0 8.7 3.3 5.2 2.2 3.5 5.1 5.7 9.8 0.0 2.6 1.5 4.3 5.5 6.2 5.9 9.7 3.2 2.5 6.9 6.2 3.8 9.5 5.5 7.7 8.4 0.7 4.6 2.6 8.6 0.0 0.2 0.0 0.1 0.0 0.1 0.4 1.1 0.0 0.3 1.1 2.0 0.7 0.0 0.0 0.2 0.2 0.0 0.1 7.6 32.3 4.7 16.4 12.1 6.9 13.9 8.9 19.9 13.0 PTPN5 "PTPSTEP, STEP, STEP61" ENSG00000110786 "Protein tyrosine phosphatase, non-receptor type 5" P54829 11 18727928-18792721 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "brain: 70.0" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HMC-1: 3.6;NTERA-2: 5.7" "Group enriched" "Detected in some" 6 "glioma: 1.6;testis cancer: 2.0" "Region enhanced" "Detected in many" "basal ganglia: 70.0" "Cell type enriched" "Detected in single" 9 "basophil: 1.5" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031014, HPA072091" Supported Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA031014: AB_10669550, HPA072091: " "unprognostic (1.23e-1)" "unprognostic (2.91e-2)" "unprognostic (8.93e-3)" "unprognostic (1.09e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-2)" "unprognostic (5.83e-3)" "unprognostic (3.59e-1)" "unprognostic (4.91e-2)" "unprognostic (2.59e-1)" "unprognostic (2.00e-1)" "unprognostic (3.58e-1)" "unprognostic (8.44e-4)" "unprognostic (4.21e-3)" "unprognostic (3.90e-2)" "unprognostic (9.39e-2)" "unprognostic (8.49e-2)" 2.5 1.6 16.3 1.1 70.0 1.1 1.2 0.9 47.5 1.5 1.1 0.4 0.0 1.1 1.2 1.0 1.3 1.7 1.4 4.3 9.1 8.6 1.1 0.9 2.7 1.1 3.5 16.0 2.5 1.2 1.5 0.5 0.9 6.1 1.6 1.4 0.0 1.3 1.7 1.8 1.0 1.4 1.4 2.1 1.3 1.3 3.4 9.3 0.0 1.2 0.0 1.0 1.5 0.3 0.1 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.0 3.6 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 5.7 0.3 0.0 0.1 0.1 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.3 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 70.0 0.9 25.1 9.1 8.6 3.5 16.0 6.1 9.3 PTPRD "HPTP, PTPD" ENSG00000153707 "Protein tyrosine phosphatase, receptor type D" P23468 9 8314246-10612723 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;parathyroid gland: 37.5" "Cell line enhanced" "Detected in some" "AF22: 23.0;HAP1: 5.0;HSkMC: 7.8;NTERA-2: 5.6;RH-30: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054829 Uncertain Approved Nucleoplasm,Vesicles "Intracellular and membrane" 2500000 Vesicles Nucleoplasm "HPA054829: " "unprognostic (4.74e-1)" "unprognostic (4.79e-2)" "unprognostic (1.44e-2)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (9.90e-2)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (1.91e-2)" "unprognostic (2.13e-2)" "unprognostic (7.52e-3)" "unprognostic (2.62e-1)" "prognostic favourable (7.45e-6)" "unprognostic (3.56e-4)" "unprognostic (7.59e-2)" "unprognostic (4.84e-2)" "unprognostic (3.08e-3)" 2.6 1.7 19.7 1.5 19.2 1.1 1.1 27.9 32.1 5.6 5.4 21.7 0.2 4.0 3.6 1.8 1.5 3.6 2.6 3.0 18.0 13.5 11.4 4.2 3.4 0.9 17.9 22.3 12.7 1.7 37.5 4.4 9.4 15.1 3.3 5.3 1.9 1.1 2.0 1.0 1.2 4.6 2.8 29.7 1.4 1.7 2.5 18.5 0.0 3.2 0.0 1.0 2.7 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 23.0 0.0 0.3 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 2.6 4.7 0.6 0.0 0.0 0.0 0.2 7.8 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 2.7 0.0 5.6 1.4 2.8 8.5 0.0 2.1 0.0 3.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.7 19.2 27.9 32.1 18.0 13.5 17.9 22.3 15.1 18.5 PTPRN "IA-2, ICA512" ENSG00000054356 "Protein tyrosine phosphatase, receptor type N" Q16849 2 219289623-219309648 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Receptor "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.6;pancreas: 28.9;pituitary gland: 43.4" "Group enriched" "Detected in some" 8 "U-2 OS: 19.8;U-87 MG: 73.7" "Group enriched" "Detected in some" 12 "glioma: 5.3;pancreatic cancer: 18.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007152, HPA007179" Enhanced Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA007152: , HPA007179: AB_1079714" "unprognostic (1.43e-1)" "unprognostic (1.33e-4)" "unprognostic (2.91e-3)" "unprognostic (5.83e-3)" "prognostic unfavourable (1.45e-7)" "unprognostic (3.64e-2)" "unprognostic (1.24e-4)" "unprognostic (1.58e-3)" "unprognostic (1.02e-1)" "unprognostic (6.20e-4)" "unprognostic (1.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.28e-10)" "unprognostic (1.43e-2)" "unprognostic (2.49e-1)" "unprognostic (1.10e-2)" "unprognostic (8.61e-2)" 1.7 22.3 19.3 4.7 35.7 1.7 1.3 17.3 89.6 1.2 2.4 2.5 0.0 2.5 1.5 1.2 1.5 1.3 1.5 1.4 21.6 40.1 1.5 1.2 1.4 1.3 14.4 19.8 1.3 28.9 1.2 43.4 1.4 22.0 1.4 1.9 3.1 1.2 1.3 1.2 2.0 2.5 2.4 3.5 1.3 6.0 1.4 2.1 0.0 1.5 0.0 1.2 2.7 0.0 0.1 0.3 0.2 0.0 0.0 0.6 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.1 2.5 0.0 6.1 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 4.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.2 73.7 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.6 3.7 19.3 35.7 17.3 54.0 21.6 40.1 14.4 19.8 22.0 2.1 PTPRN2 "IA-2beta, ICAAR, KIAA0387, phogrin" ENSG00000155093 "Protein tyrosine phosphatase, receptor type N2" Q92932 7 157539056-158587788 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Protein phosphatase, Receptor" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6;pancreas: 51.3" "Cell line enhanced" "Detected in some" "AF22: 15.3;HDLM-2: 21.5;NB-4: 22.1;SCLC-21H: 12.2;SH-SY5Y: 12.4;THP-1: 10.8;U-87 MG: 15.1" "Cancer enhanced" "Detected in all" "prostate cancer: 40.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006900, HPA007255, HPA026656" Enhanced Approved Vesicles Vesicles "HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912" "unprognostic (2.42e-1)" "unprognostic (4.17e-2)" "unprognostic (7.82e-2)" "unprognostic (2.69e-2)" "prognostic unfavourable (9.37e-5)" "unprognostic (7.12e-3)" "unprognostic (1.04e-1)" "unprognostic (4.55e-2)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-2)" "unprognostic (1.39e-1)" "prognostic favourable (8.68e-4)" "unprognostic (2.60e-2)" "unprognostic (1.48e-1)" "unprognostic (1.43e-3)" "unprognostic (6.16e-2)" 2.1 10.5 20.1 1.7 33.9 1.0 1.1 6.2 40.6 1.7 4.6 2.9 0.0 5.1 2.0 2.9 1.5 6.9 4.7 1.9 18.2 21.3 2.0 1.2 3.1 2.1 11.3 22.3 5.8 51.3 0.5 20.0 1.5 10.3 10.2 3.7 1.5 3.4 2.6 0.8 0.7 4.2 1.6 5.3 7.7 24.2 2.2 5.2 0.0 5.6 0.3 1.7 2.8 0.6 3.4 1.3 14.8 1.1 1.5 3.5 1.1 0.0 0.2 15.3 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.6 0.2 0.0 0.4 0.0 0.0 21.5 0.2 0.0 0.0 2.5 0.6 0.0 0.0 1.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.2 6.3 22.1 3.0 0.7 0.0 0.7 0.1 0.0 0.0 12.2 12.4 0.0 0.0 0.0 0.0 10.8 3.2 5.0 1.9 0.0 0.3 0.1 0.0 0.0 15.1 9.0 3.6 8.7 1.1 1.6 0.9 0.1 0.3 2.3 1.5 1.1 1.3 3.4 1.4 0.9 14.8 1.5 0.0 0.2 3.5 1.1 20.1 33.9 6.2 40.6 18.2 21.3 11.3 22.3 10.3 5.2 PTPRO "GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2" ENSG00000151490 "Protein tyrosine phosphatase, receptor type O" Q16827 12 15322397-15597399 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1;intestine: 28.5;kidney: 21.6" "Cell line enhanced" "Detected in some" "NTERA-2: 9.3;SCLC-21H: 5.7;SH-SY5Y: 11.2;THP-1: 4.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 8.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 5.2;intermediate monocyte: 10.5;memory B-cell: 8.3;myeloid DC: 7.4;naive B-cell: 7.0;naive CD4 T-cell: 2.9;non-classical monocyte: 10.5;plasmacytoid DC: 9.5" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "olfactory region: 215.3" "Low region specificity" "Detected in many" HPA034525 Enhanced "Intracellular and membrane" "HPA034525: AB_10669785" "unprognostic (3.68e-2)" "unprognostic (3.49e-1)" "unprognostic (9.64e-2)" "unprognostic (1.25e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-1)" "unprognostic (5.93e-3)" "unprognostic (5.37e-2)" "unprognostic (2.03e-1)" "unprognostic (3.72e-2)" "unprognostic (2.00e-1)" "unprognostic (5.43e-2)" "unprognostic (4.89e-2)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 3.3 1.2 16.2 3.1 26.1 0.6 1.1 1.0 15.3 1.7 10.4 1.5 0.0 2.0 4.5 2.1 0.8 1.2 1.6 0.7 11.3 10.6 21.6 1.6 6.7 3.2 4.8 8.8 0.7 0.6 0.6 3.8 4.4 4.0 0.7 28.5 1.1 0.8 1.1 0.5 0.7 1.9 7.1 2.6 3.6 1.0 0.9 3.5 0.0 0.5 0.0 3.5 1.7 0.5 8.3 9.5 0.0 10.5 0.1 2.9 2.7 0.0 0.1 0.5 0.4 0.6 0.1 0.2 0.0 0.0 0.9 2.2 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.3 0.1 0.2 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.7 9.3 0.1 0.0 0.0 0.1 0.2 0.3 5.7 11.2 1.3 0.0 0.1 0.1 4.6 0.0 0.1 0.4 0.0 0.4 1.4 0.1 0.4 0.1 0.3 1.7 0.0 5.2 0.0 0.0 10.5 0.0 8.3 1.7 0.4 7.4 7.0 2.9 1.3 0.0 0.1 10.5 9.5 1.3 2.7 16.2 26.1 1.0 15.3 11.3 10.6 4.8 8.8 4.0 3.5 PTPRQ DFNB84 ENSG00000139304 "Protein tyrosine phosphatase, receptor type Q" 12 80402178-80680271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6;urinary bladder: 19.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.2;BJ: 6.1;HBF TERT88: 4.3;RH-30: 4.8;RT4: 5.3;U-2197: 5.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 24 "basal ganglia: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053245 Uncertain Approved Cytosol Cytosol "HPA053245: " "unprognostic (9.10e-2)" "unprognostic (1.63e-1)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (1.37e-1)" "unprognostic (1.93e-2)" "unprognostic (1.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-2)" "unprognostic (1.78e-1)" "unprognostic (4.47e-11)" "unprognostic (8.51e-3)" "unprognostic (1.47e-1)" "unprognostic (1.73e-2)" "unprognostic (2.66e-2)" 4.6 0.2 0.3 1.0 12.6 0.0 5.2 0.2 0.3 1.7 1.3 0.0 1.6 0.0 0.5 4.7 1.6 4.1 0.5 1.3 0.4 0.5 6.5 0.2 5.4 2.1 0.2 0.0 0.9 0.6 0.0 1.1 6.4 0.0 6.5 0.0 0.0 0.4 0.5 0.5 0.3 0.2 4.0 0.2 0.2 0.2 5.8 0.0 0.0 3.9 0.0 0.6 19.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.2 0.0 6.1 1.3 1.9 1.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.9 0.0 0.8 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 5.3 0.0 0.0 3.0 0.1 0.0 0.3 0.0 0.0 0.5 0.1 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.6 0.2 0.3 0.4 0.5 0.2 0.0 0.0 0.0 PTPRR "EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ" ENSG00000153233 "Protein tyrosine phosphatase, receptor type R" Q15256 12 70638073-70920843 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 56.1" "Group enriched" "Detected in some" 5 "HDLM-2: 14.0;RT4: 26.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 56.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 5 "cerebellum: 100.5" "Low region specificity" "Detected in all" "CAB011461, HPA011851, HPA071067" Uncertain Supported "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions, Cytosol" "CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: " "unprognostic (4.98e-2)" "unprognostic (1.91e-2)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "unprognostic (3.63e-3)" "unprognostic (3.48e-5)" "unprognostic (5.44e-3)" "unprognostic (1.77e-3)" "unprognostic (1.13e-1)" "unprognostic (9.01e-2)" "unprognostic (1.37e-3)" "unprognostic (8.06e-2)" "unprognostic (1.10e-2)" "unprognostic (1.92e-2)" "unprognostic (4.78e-2)" "unprognostic (2.72e-1)" "prognostic favourable (1.40e-5)" 0.4 3.8 18.8 1.6 11.3 0.3 0.4 56.1 20.9 0.5 11.2 0.1 0.0 5.1 8.4 0.3 0.4 0.5 1.9 0.4 8.6 4.9 0.4 0.4 0.4 0.4 1.3 13.2 0.4 0.6 0.3 0.9 0.7 3.3 0.5 7.8 0.8 0.4 2.1 0.4 0.4 11.3 4.9 3.1 0.4 4.4 0.4 1.4 0.0 0.4 0.0 0.3 4.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.3 0.0 0.5 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 26.7 0.1 4.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.8 11.3 56.1 20.9 8.6 4.9 1.3 13.2 3.3 1.4 PTPRT "KIAA0283, RPTPrho" ENSG00000196090 "Protein tyrosine phosphatase, receptor type T" O14522 20 42072752-43189970 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 23.5;fallopian tube: 17.0" "Cell line enhanced" "Detected in some" "BEWO: 4.5;RPMI-8226: 1.2;SCLC-21H: 2.9;U-266/70: 1.0" "Cancer enhanced" "Detected in many" "breast cancer: 5.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017336, CAB069423" Approved "CAB069423: AB_1622602, HPA017336: AB_1855943" "unprognostic (7.17e-3)" "unprognostic (1.02e-1)" "unprognostic (5.61e-3)" "unprognostic (1.08e-2)" "unprognostic (5.95e-2)" "unprognostic (3.71e-2)" "unprognostic (1.97e-1)" "unprognostic (1.31e-2)" "unprognostic (6.93e-2)" "unprognostic (2.00e-1)" "unprognostic (1.37e-6)" "unprognostic (3.16e-1)" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" 0.6 0.8 5.0 0.6 11.1 0.5 4.6 1.6 23.5 1.6 0.7 0.9 0.0 1.2 0.5 1.8 0.5 17.0 0.7 0.8 4.7 6.5 0.6 0.9 2.1 1.0 2.2 12.6 0.5 0.9 0.5 4.1 4.6 5.1 0.8 0.6 0.5 2.0 4.6 0.5 0.8 1.0 0.5 1.4 0.7 1.8 2.8 0.9 4.9 0.5 0.0 1.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 11.1 1.6 22.6 4.7 6.5 2.2 12.6 5.1 0.9 PTPRZ1 "phosphacan, PTP18, PTPRZ, PTPZ, RPTPB" ENSG00000106278 "Protein tyrosine phosphatase, receptor type Z1" P23471 7 121873089-122062036 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 118.1" "Group enriched" "Detected in some" 9 "AF22: 92.1;NTERA-2: 25.6;WM-115: 40.3" "Cancer enriched" "Detected in many" 14 "glioma: 175.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015103 Enhanced Approved Vesicles,Cytosol "Secreted in brain" 950000 Cytosol Vesicles "HPA015103: AB_1855946" "unprognostic (8.49e-4)" "unprognostic (3.96e-3)" "unprognostic (4.11e-2)" "unprognostic (1.37e-1)" "unprognostic (9.18e-2)" "unprognostic (2.41e-2)" "unprognostic (8.30e-3)" "unprognostic (3.78e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (9.17e-4)" "unprognostic (1.83e-1)" "unprognostic (8.72e-6)" "unprognostic (2.00e-1)" "unprognostic (2.16e-1)" "unprognostic (8.77e-2)" "prognostic unfavourable (9.36e-4)" 2.0 2.5 33.1 2.3 44.1 1.5 4.0 15.4 118.1 2.4 2.2 19.3 0.0 1.9 1.6 2.0 7.0 1.7 1.9 2.0 39.6 15.9 1.6 1.6 2.1 1.5 18.6 17.8 2.0 3.3 1.5 1.6 1.6 67.6 2.1 2.3 0.8 2.4 2.0 1.5 19.3 1.9 2.4 76.6 2.1 9.8 1.7 23.6 0.0 1.5 1.8 3.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 1.1 0.0 0.1 0.0 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 44.1 15.4 39.6 39.6 15.9 18.6 17.8 67.6 23.6 PURG "PURG-A, PURG-B" ENSG00000172733 "Purine rich element binding protein G" Q9UJV8 8 30995802-31033715 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7" "Cell line enhanced" "Detected in some" "AF22: 8.8;HEK 293: 4.4;HUVEC TERT2: 4.3;NTERA-2: 6.9;SH-SY5Y: 8.3" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047746 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Plasma membrane" Nucleoli "HPA047746: " "unprognostic (3.37e-1)" "unprognostic (2.15e-1)" "unprognostic (6.69e-2)" "unprognostic (7.33e-3)" "unprognostic (3.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.51e-3)" "unprognostic (1.10e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (4.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.27e-1)" "unprognostic (1.83e-2)" "unprognostic (5.30e-2)" 1.3 1.9 11.0 1.2 10.3 0.6 0.9 14.7 13.5 2.4 1.0 2.4 0.5 1.0 5.6 2.6 1.5 1.6 3.0 1.6 9.4 6.2 1.7 0.7 1.4 1.3 4.9 7.3 1.6 0.7 0.6 3.9 1.5 6.2 1.9 1.1 1.7 1.6 2.6 1.0 0.9 1.0 5.0 4.5 2.5 1.3 8.1 6.4 0.0 0.8 0.0 1.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.2 0.1 0.0 0.0 0.2 0.4 0.7 1.8 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 1.1 0.0 4.4 1.6 0.0 0.2 0.0 0.0 0.2 1.3 0.0 1.3 0.0 4.3 0.4 0.5 0.2 0.0 0.9 0.0 6.9 0.3 2.2 1.2 0.0 0.0 0.0 1.2 8.3 0.0 0.0 0.0 0.0 0.0 2.7 3.0 3.7 0.0 0.4 0.3 0.0 0.2 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.3 14.7 8.9 9.4 6.2 4.9 7.3 6.2 6.4 PVALB D22S749 ENSG00000100362 Parvalbumin P20472 22 36800684-36819479 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 125.0;parathyroid gland: 137.5" "Cell line enriched" "Detected in single" 198 "RPMI-8226: 130.9" "Group enriched" "Detected in many" 10 "breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3" "Region enhanced" "Detected in all" "cerebellum: 125.0" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.4" "Region enriched" "Detected in many" 5 "cerebellum: 2377.5" "Low region specificity" "Detected in many" "CAB002515, HPA048536" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" Nucleoplasm "Nucleoli, Cell Junctions" "CAB002515: AB_563948, HPA048536: " "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "unprognostic (9.75e-2)" "unprognostic (1.79e-3)" "unprognostic (7.80e-2)" "unprognostic (2.49e-2)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (2.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-1)" "unprognostic (5.21e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-1)" "unprognostic (1.65e-2)" "unprognostic (8.99e-3)" 0.9 0.8 1.2 0.9 3.9 0.8 4.3 125.0 47.2 0.8 0.8 6.6 0.0 0.8 1.1 0.9 0.8 0.8 0.9 0.8 4.5 9.4 16.7 1.8 1.2 1.2 28.6 2.5 0.8 0.8 137.5 0.2 1.2 22.9 0.9 0.9 27.3 1.2 1.0 5.0 0.8 0.8 0.9 12.6 1.2 0.9 1.1 1.2 0.0 0.9 0.0 1.4 1.2 1.0 0.0 0.5 3.4 0.4 0.0 0.3 12.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 130.9 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.5 0.3 12.2 1.2 3.9 125.0 47.2 4.5 9.4 28.6 2.5 22.9 1.2 PVALEF AATK-AS1 ENSG00000225180 "Parvalbumin like EF-hand containing" 17 81165507-81183164 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "adipose tissue: 1.2;brain: 1.1" "Cell line enhanced" "Detected in some" "MCF7: 2.3;REH: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.35e-2)" "unprognostic (2.55e-1)" "unprognostic (4.40e-1)" "unprognostic (2.30e-1)" "unprognostic (3.26e-1)" "unprognostic (1.09e-1)" 1.2 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.9 0.0 1.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PWWP2A KIAA1935 ENSG00000170234 "PWWP domain containing 2A" Q96N64 5 160061801-160119423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046733, HPA058233" Supported "Nucleoplasm,Focal adhesion sites" Nucleoplasm "Focal adhesion sites" "HPA046733: , HPA058233: " "unprognostic (1.03e-1)" "unprognostic (2.67e-1)" "unprognostic (5.13e-2)" "unprognostic (1.85e-1)" "unprognostic (1.18e-2)" "unprognostic (7.86e-3)" "unprognostic (1.40e-3)" "unprognostic (6.24e-2)" "unprognostic (2.42e-2)" "unprognostic (7.08e-2)" "unprognostic (7.25e-2)" "unprognostic (8.24e-3)" "prognostic unfavourable (3.70e-4)" "unprognostic (2.23e-1)" "unprognostic (3.88e-2)" "unprognostic (1.08e-1)" "prognostic favourable (3.51e-4)" 8.4 9.3 9.5 12.7 22.3 11.9 9.1 52.7 16.0 14.4 13.6 19.9 5.3 9.6 10.8 7.2 8.7 9.5 8.1 7.4 15.9 8.8 10.3 8.6 9.8 12.0 25.2 8.9 10.5 10.5 10.6 15.1 11.2 17.0 11.9 14.7 10.3 8.8 8.4 7.0 14.7 10.6 9.3 13.8 12.5 11.8 6.3 21.3 18.6 9.8 5.8 11.4 10.7 10.1 6.0 2.9 6.0 4.4 1.1 4.9 0.9 10.6 5.1 13.4 11.4 14.9 11.7 18.9 8.5 7.0 7.6 7.8 16.6 20.8 17.2 13.1 6.5 7.7 11.6 13.3 12.6 17.8 12.9 12.3 9.5 8.5 11.4 12.4 9.4 8.3 6.7 15.3 11.7 12.2 9.4 11.2 12.9 8.9 10.6 12.1 15.7 6.7 16.7 11.9 11.0 9.3 7.6 15.8 11.0 14.4 14.5 15.4 11.2 13.8 16.2 13.3 9.2 9.9 16.5 12.8 11.5 15.3 8.8 12.6 13.1 6.0 4.4 2.4 2.8 2.0 2.2 6.0 3.0 3.3 2.9 3.7 4.9 2.7 5.0 1.1 2.6 2.7 2.5 0.9 9.5 22.3 52.7 16.0 15.9 8.8 25.2 8.9 17.0 21.3 PXK "FLJ20335, Slob" ENSG00000168297 "PX domain containing serine/threonine kinase like" Q7Z7A4 3 58332880-58426126 "Enzymes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 81.1" "Cell line enhanced" "Detected in many" "U-937: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024068 Approved Supported "Plasma membrane,Centriolar satellite,Cytosol" "Plasma membrane, Cytosol" "Centriolar satellite" "HPA024068: AB_1855967" "unprognostic (2.98e-2)" "unprognostic (3.29e-1)" "unprognostic (2.71e-3)" "unprognostic (1.61e-1)" "unprognostic (2.40e-1)" "unprognostic (6.62e-3)" "unprognostic (5.03e-3)" "prognostic favourable (5.68e-4)" "unprognostic (3.90e-1)" "unprognostic (8.09e-2)" "unprognostic (3.48e-2)" "unprognostic (1.21e-1)" "unprognostic (1.38e-3)" "unprognostic (2.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.86e-2)" 9.3 9.4 20.7 17.0 51.4 33.6 7.6 22.6 31.4 28.9 8.9 81.1 2.4 6.3 14.2 5.3 6.6 8.0 9.6 7.5 33.7 19.9 10.4 5.7 8.2 23.8 68.6 23.4 11.1 8.5 13.7 6.1 17.5 43.9 6.0 6.4 4.4 8.8 7.7 7.6 7.5 7.7 11.8 55.9 13.5 8.3 6.7 56.6 3.7 40.3 2.5 26.1 9.8 13.1 31.3 18.8 31.8 22.5 8.7 11.2 13.4 4.2 2.5 1.9 3.5 26.6 23.6 5.6 6.9 14.6 6.6 9.3 1.2 0.9 22.6 1.6 11.6 1.3 6.0 4.3 7.0 5.6 3.8 3.9 3.0 1.7 31.0 33.5 6.9 20.2 10.5 8.3 14.4 5.8 4.7 7.4 11.8 1.6 7.3 34.6 2.3 6.3 12.6 3.3 4.0 4.2 2.4 1.7 1.2 4.7 3.3 5.4 11.4 34.7 5.9 8.3 3.4 15.7 7.2 5.8 5.7 22.5 12.0 47.6 3.4 14.6 20.1 29.4 11.2 16.2 9.9 29.0 8.1 9.4 18.8 31.3 7.1 8.4 31.8 8.7 22.5 13.5 8.7 13.4 20.7 51.4 22.6 31.4 33.7 19.9 68.6 23.4 43.9 56.6 PYDC1 "ASC2, POP1" ENSG00000169900 "Pyrin domain containing 1" Q8WXC3 16 31215962-31217359 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.4;skin 1: 10.1" "Group enriched" "Detected in some" 7 "SCLC-21H: 2.4;T-47d: 2.5;U-266/70: 1.3" "Cancer enriched" "Detected in some" 8 "breast cancer: 8.0" "Cell type enhanced" "Detected in single" "memory B-cell: 1.0" "Low lineage specificity" "Detected in single" "unprognostic (9.72e-3)" "unprognostic (1.00e-2)" "unprognostic (2.05e-2)" "unprognostic (1.61e-1)" "unprognostic (1.32e-2)" "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" "unprognostic (2.62e-1)" "unprognostic (5.34e-2)" "unprognostic (3.15e-2)" "unprognostic (2.60e-10)" "unprognostic (3.62e-1)" "unprognostic (1.74e-1)" "unprognostic (1.70e-1)" "unprognostic (9.47e-2)" 0.1 0.1 7.7 0.2 9.0 0.2 1.0 12.4 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.5 2.4 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 3.0 10.1 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.0 0.1 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 QDPR "DHPR, PKU2, SDR33C1" ENSG00000151552 "Quinoid dihydropteridine reductase" P09417 4 17460261-17512234 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Oxidoreductase "Disease mutation, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 114.1;liver: 64.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058951, HPA065649" Enhanced Approved Mitochondria 1800000 Mitochondria "HPA058951: AB_2683861, HPA065649: AB_2685526" "unprognostic (1.30e-2)" "unprognostic (4.29e-1)" "unprognostic (8.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" "unprognostic (3.29e-3)" "unprognostic (3.80e-3)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "unprognostic (6.82e-3)" "unprognostic (2.07e-1)" "prognostic favourable (7.84e-6)" "unprognostic (1.58e-1)" "unprognostic (2.60e-1)" "unprognostic (9.01e-2)" "unprognostic (3.19e-1)" 22.5 25.9 67.8 3.4 111.9 4.4 7.4 16.0 54.1 5.7 7.5 56.3 2.6 9.1 5.5 12.5 5.2 6.4 6.3 15.0 80.7 58.2 36.1 64.8 8.0 3.7 114.1 36.7 6.7 10.3 13.7 6.2 4.1 82.5 10.3 5.9 2.6 12.4 7.5 34.2 4.6 8.1 6.4 93.6 4.8 9.1 4.1 94.7 0.7 7.7 2.8 4.4 4.5 2.6 7.5 42.5 1.0 21.9 9.9 15.0 12.3 11.3 22.3 8.8 12.3 21.4 10.9 15.6 16.3 6.9 15.2 13.4 17.8 15.1 4.2 10.5 9.0 6.5 12.5 18.4 9.5 12.9 2.5 11.5 11.6 42.1 12.9 15.0 1.0 13.5 11.7 9.6 13.1 7.6 12.4 9.7 16.3 5.9 22.3 24.1 15.0 15.1 9.3 6.8 16.9 15.7 6.3 16.7 21.4 10.8 1.8 46.3 4.9 5.8 13.2 8.8 15.8 8.7 12.9 15.1 23.5 29.6 17.6 13.3 14.6 0.0 14.4 1.0 12.3 21.9 11.1 7.5 13.3 12.8 18.0 6.2 15.0 12.9 0.4 9.9 16.3 42.5 6.9 12.3 67.8 111.9 16.0 54.1 80.7 58.2 114.1 36.7 82.5 94.7 QKI QK3 ENSG00000112531 "QKI, KH domain containing RNA binding" Q96PU8 6 163414000-163578596 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, mRNA transport, Translation regulation, Transport" "Developmental protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 100.3" "Cell line enhanced" "Detected in all" "AF22: 64.0" "Cancer enriched" "Detected in all" 6 "glioma: 42.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019123, CAB022602" Enhanced Supported Supported Nucleoplasm Nucleoplasm "CAB022602: , HPA019123: AB_1855980" "unprognostic (2.42e-1)" "unprognostic (5.81e-2)" "unprognostic (1.31e-1)" "unprognostic (1.06e-2)" "unprognostic (8.57e-2)" "unprognostic (1.65e-1)" "prognostic unfavourable (1.27e-4)" "unprognostic (1.34e-1)" "unprognostic (7.06e-2)" "unprognostic (1.76e-3)" "unprognostic (1.08e-1)" "unprognostic (5.15e-2)" "prognostic unfavourable (2.31e-5)" "prognostic unfavourable (3.69e-4)" "unprognostic (1.16e-1)" "unprognostic (3.86e-1)" "unprognostic (4.09e-2)" 32.4 12.4 37.5 16.2 63.5 27.1 14.6 15.1 100.3 14.9 12.2 83.9 3.7 4.0 14.7 4.9 16.0 12.3 15.7 64.0 43.7 18.1 11.1 18.4 24.9 11.4 72.5 31.9 18.4 7.6 7.8 4.7 23.4 46.5 7.9 8.4 7.1 10.2 11.1 59.9 12.4 7.1 21.1 68.8 16.9 8.9 20.5 74.3 5.0 10.4 10.8 11.4 15.8 17.7 1.7 7.3 10.8 8.4 7.4 3.8 1.3 4.2 18.0 64.0 21.3 19.4 21.6 14.9 11.6 27.5 19.1 23.1 12.2 3.9 5.2 9.7 29.1 6.4 33.9 12.1 31.0 10.4 10.9 20.4 9.9 13.6 23.7 10.8 6.3 25.2 5.0 20.4 32.5 26.3 29.8 12.3 12.3 8.1 7.2 2.3 8.2 9.1 11.1 39.9 10.3 10.5 13.5 1.2 7.4 12.4 6.8 5.1 2.6 17.7 26.7 13.2 11.2 14.2 21.3 7.8 9.5 6.3 11.4 9.6 31.0 3.4 8.4 3.8 2.3 5.4 3.8 1.4 1.6 2.0 4.3 1.7 1.5 2.5 10.8 7.4 5.5 7.3 1.1 1.3 37.5 63.5 15.1 41.4 43.7 18.1 72.5 31.9 46.5 74.3 QRFPR GPR103 ENSG00000186867 "Pyroglutamylated RFamide peptide receptor" Q96P65 4 121329312-121381059 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 6.9;heart muscle: 4.6" "Cell line enhanced" "Detected in some" "HL-60: 5.2;hTERT-HME1: 7.1;RPTEC TERT1: 4.5;SCLC-21H: 2.9;U-2 OS: 7.7;WM-115: 4.3" "Cancer enriched" "Detected in some" 6 "renal cancer: 5.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA014300, HPA050236" Approved "HPA014300: AB_1849251, HPA050236: " "unprognostic (1.24e-2)" "unprognostic (2.30e-1)" "unprognostic (1.93e-2)" "unprognostic (3.21e-1)" "unprognostic (2.77e-1)" "unprognostic (3.21e-4)" "unprognostic (2.71e-1)" "unprognostic (5.77e-3)" "unprognostic (5.37e-2)" "unprognostic (6.33e-2)" "unprognostic (2.12e-1)" "prognostic favourable (3.09e-4)" "unprognostic (3.09e-1)" "unprognostic (2.57e-1)" "unprognostic (1.61e-1)" 1.6 1.2 0.7 0.3 1.9 0.0 0.5 0.1 2.0 0.3 0.2 0.3 0.0 0.0 0.2 1.1 0.8 0.1 1.1 4.6 1.3 6.9 3.2 0.2 0.1 0.0 0.8 0.8 0.4 0.0 1.0 0.8 0.2 4.9 0.6 0.1 3.3 0.0 2.3 0.1 0.0 0.4 0.2 2.6 0.0 1.3 0.7 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 4.5 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.7 0.0 0.0 0.1 1.8 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.9 0.1 2.0 1.3 6.9 0.8 0.8 4.9 0.0 R3HDM1 "KIAA0029, R3HDM" ENSG00000048991 "R3H domain containing 1" Q15032 2 135531455-135725270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030936 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA030936: AB_10670835" "unprognostic (1.93e-1)" "unprognostic (4.32e-2)" "unprognostic (8.16e-3)" "unprognostic (1.10e-3)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (2.00e-3)" "prognostic unfavourable (8.02e-4)" "unprognostic (3.51e-2)" "unprognostic (9.52e-2)" "unprognostic (5.51e-2)" "unprognostic (5.76e-2)" "prognostic unfavourable (5.83e-7)" "unprognostic (1.16e-2)" "unprognostic (7.23e-2)" "unprognostic (4.32e-3)" "unprognostic (2.47e-1)" 6.5 6.4 23.2 8.3 27.8 13.4 5.3 22.2 57.6 6.7 7.5 4.5 2.4 4.5 6.9 6.6 6.2 5.5 6.3 5.3 17.9 15.5 6.0 6.2 5.0 11.0 11.5 32.7 5.3 8.4 20.1 13.2 4.2 7.7 5.4 10.3 4.3 4.3 6.1 13.5 5.3 5.6 8.6 7.9 6.6 5.4 14.3 7.6 14.2 8.7 3.6 13.2 8.4 4.3 6.5 12.7 3.5 8.4 9.6 9.6 5.0 20.5 12.6 17.9 20.7 9.6 13.2 10.6 12.9 13.5 13.0 14.3 22.6 14.3 32.7 10.3 18.3 9.3 23.4 24.0 22.9 20.5 11.7 26.3 16.1 22.5 11.6 22.4 17.1 12.4 10.7 22.9 29.5 20.9 27.2 28.1 14.9 21.2 38.8 15.4 13.8 14.9 23.2 12.4 19.5 12.9 18.2 18.3 14.2 20.8 8.5 9.3 11.4 12.0 15.2 12.1 12.1 15.2 16.2 22.5 30.8 30.7 13.6 18.4 15.4 3.5 7.8 3.0 6.1 8.4 5.8 6.5 6.6 9.1 11.2 4.4 6.4 7.2 1.0 9.6 7.1 12.7 9.6 5.0 23.2 27.8 22.2 57.6 17.9 15.5 11.5 32.7 7.7 7.6 R3HDML dJ881L22.3 ENSG00000101074 "R3H domain containing like" Q9H3Y0 20 44336986-44351235 "Predicted secreted proteins" "Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.4;intestine: 5.9" "Cell line enhanced" "Detected in some" "AF22: 1.9;CACO-2: 3.9;U-2 OS: 2.9" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA070264 Enhanced "Secreted - unknown location" "HPA070264: " "unprognostic (1.89e-1)" "unprognostic (2.23e-1)" "unprognostic (9.86e-2)" "unprognostic (9.12e-2)" "unprognostic (6.06e-3)" "unprognostic (2.64e-1)" "unprognostic (6.32e-2)" "unprognostic (4.95e-3)" 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.1 0.0 1.5 5.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.4 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.8 1.4 0.1 0.0 0.0 0.0 0.3 0.5 0.9 0.0 0.2 0.2 0.0 0.0 0.3 1.9 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 3.9 0.9 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.5 0.2 1.3 0.9 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.4 0.2 0.0 0.4 0.2 0.0 0.0 0.4 2.9 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.6 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.5 0.0 0.0 RAB11FIP4 "FLJ00131, KIAA1821, MGC11316, RAB11-FIP4" ENSG00000131242 "RAB11 family interacting protein 4" Q86YS3 17 31391624-31538217 "Predicted intracellular proteins" "Host-virus interaction, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.9;brain: 39.3" "Cell line enhanced" "Detected in many" "BEWO: 30.6;Daudi: 16.8;Hep G2: 18.5;HMC-1: 19.7;RT4: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 32.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021595 Approved "HPA021595: " "unprognostic (2.11e-1)" "unprognostic (1.48e-1)" "prognostic favourable (2.70e-4)" "unprognostic (6.03e-3)" "unprognostic (4.29e-2)" "unprognostic (4.15e-2)" "unprognostic (1.11e-1)" "unprognostic (1.35e-3)" "unprognostic (2.71e-1)" "unprognostic (3.20e-1)" "unprognostic (1.16e-1)" "unprognostic (1.49e-1)" "prognostic favourable (7.74e-8)" "prognostic favourable (1.22e-4)" "unprognostic (3.00e-1)" "unprognostic (2.00e-2)" "unprognostic (4.13e-3)" 1.2 1.5 25.7 7.1 30.2 12.4 4.3 16.6 39.3 2.9 8.7 22.0 4.8 11.9 1.5 11.0 4.4 7.4 3.3 2.7 28.8 19.7 6.9 3.1 5.5 10.1 29.7 16.9 2.7 16.2 5.6 2.7 9.5 14.9 2.7 7.1 1.6 6.8 4.4 0.8 7.5 13.2 1.2 26.6 6.6 12.2 25.4 16.3 2.0 4.6 0.4 9.7 4.3 1.8 4.4 2.4 32.9 6.5 2.5 6.4 3.3 5.6 0.6 0.6 1.5 0.2 0.0 30.6 0.1 0.0 0.3 0.4 9.5 0.9 16.8 2.2 0.1 4.8 5.7 2.7 0.2 3.4 5.1 0.0 0.2 18.5 0.1 1.2 19.7 0.1 2.8 0.4 1.2 0.0 1.2 0.4 0.0 4.4 1.2 0.3 5.0 0.1 0.4 0.0 3.2 1.1 17.4 9.1 6.4 1.3 8.2 7.0 12.1 0.5 0.0 0.3 3.1 0.0 0.2 3.1 2.5 1.6 0.1 1.7 1.2 1.9 3.6 32.9 6.4 5.1 4.1 2.6 3.4 4.7 2.4 4.4 3.6 4.2 17.7 2.5 6.5 0.5 4.0 3.3 25.7 30.2 16.6 32.1 28.8 19.7 29.7 16.9 14.9 16.3 RAB15 ENSG00000139998 "RAB15, member RAS oncogene family" P59190 14 64945814-64973226 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.4" "Cell line enhanced" "Detected in many" "HAP1: 37.4;RH-30: 44.7;RT4: 32.7;SK-BR-3: 34.3" "Cancer enhanced" "Detected in all" "testis cancer: 83.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041177 Uncertain Approved "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "HPA041177: AB_10794547" "unprognostic (9.80e-2)" "unprognostic (1.42e-2)" "unprognostic (1.53e-1)" "unprognostic (4.94e-2)" "unprognostic (6.29e-2)" "unprognostic (3.45e-1)" "prognostic unfavourable (4.68e-4)" "unprognostic (7.14e-2)" "unprognostic (3.12e-1)" "unprognostic (4.25e-2)" "unprognostic (2.79e-2)" "unprognostic (2.02e-1)" "unprognostic (1.98e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-2)" "unprognostic (2.82e-2)" 2.3 4.0 16.7 4.2 19.2 0.6 6.3 40.4 32.9 5.7 9.9 2.2 3.2 9.1 2.4 4.5 1.8 1.9 4.7 14.1 21.2 10.8 7.5 11.4 4.3 2.6 7.8 12.6 1.4 5.6 16.2 4.0 11.9 10.2 4.3 15.4 1.9 27.2 3.8 3.9 2.8 9.6 8.6 4.2 1.2 5.3 1.0 2.5 2.4 2.9 0.6 2.2 13.4 1.8 0.0 5.2 0.0 0.1 0.8 0.7 0.1 3.0 16.2 6.0 5.9 1.3 1.9 16.8 1.9 2.7 4.0 3.5 7.6 8.2 0.1 1.1 4.7 3.1 37.4 0.3 2.8 1.0 1.8 3.5 0.3 6.6 0.2 0.1 2.2 1.3 0.7 1.7 0.3 12.4 0.1 0.5 7.0 17.3 4.2 3.1 13.4 2.3 5.2 44.7 0.2 4.6 32.7 19.3 3.7 0.9 34.3 4.3 9.7 3.3 3.1 3.4 14.8 1.6 2.4 0.1 0.1 1.6 0.7 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.1 5.2 0.3 0.1 16.7 19.2 40.4 32.9 21.2 10.8 7.8 12.6 10.2 2.5 RAB26 ENSG00000167964 "RAB26, member RAS oncogene family" Q9ULW5 16 2140803-2154165 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;liver: 21.9;pancreas: 24.6;salivary gland: 17.7" "Cell line enhanced" "Detected in many" "A549: 13.6;HeLa: 14.9;MCF7: 8.9;SCLC-21H: 18.9;SK-BR-3: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075624 Uncertain "Vesicles,Plasma membrane,Centrosome" "Intracellular and membrane" "Vesicles, Plasma membrane" Centrosome "HPA075624: " "unprognostic (1.01e-2)" "prognostic favourable (8.20e-5)" "unprognostic (7.25e-2)" "unprognostic (1.52e-1)" "unprognostic (7.34e-2)" "unprognostic (9.41e-3)" "unprognostic (2.81e-2)" "unprognostic (5.10e-2)" "unprognostic (1.82e-2)" "unprognostic (3.55e-2)" "unprognostic (3.75e-2)" "unprognostic (2.14e-1)" "unprognostic (6.48e-2)" "unprognostic (5.68e-2)" "unprognostic (1.23e-1)" "unprognostic (7.16e-2)" "unprognostic (2.92e-3)" 0.6 1.0 13.6 0.4 19.9 0.5 0.9 30.5 13.5 2.0 4.1 0.5 1.5 5.7 0.4 2.3 1.2 0.9 1.1 1.2 18.0 6.2 0.7 21.9 0.6 0.6 5.6 9.1 0.6 24.6 3.1 9.2 0.3 2.5 2.2 5.4 0.7 17.7 1.6 1.1 1.2 6.0 0.4 1.9 0.6 5.3 0.6 3.2 0.0 1.2 0.0 1.1 0.9 0.0 0.8 0.2 0.0 0.1 0.0 1.1 0.7 1.1 13.6 0.0 3.5 0.2 0.1 0.1 0.6 1.1 0.5 0.9 0.4 2.7 0.2 0.9 0.8 2.2 0.7 0.2 0.0 1.5 1.4 0.5 14.9 1.2 0.6 0.0 0.4 0.5 0.1 0.1 0.2 0.3 0.3 0.0 1.6 8.9 0.0 0.6 0.8 1.2 1.1 1.1 2.3 5.2 0.9 18.9 3.7 0.3 17.1 0.6 5.6 0.2 0.6 0.0 2.5 0.2 0.2 2.0 0.1 0.2 0.3 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.1 0.0 0.8 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.7 13.6 19.9 30.5 13.5 18.0 6.2 5.6 9.1 2.5 3.2 RAB27B ENSG00000041353 "RAB27B, member RAS oncogene family" O00194 18 54717860-54895516 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0;stomach 1: 36.6" "Cell line enhanced" "Detected in many" "HEL: 20.5;hTCEpi: 15.6;hTERT-HME1: 19.0;U-87 MG: 55.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 4.6;NK-cell: 5.0" "Group enriched" "Detected in many" 4 "NK-cells: 5.0;T-cells: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017712, HPA019849" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" 37000000 "Golgi apparatus, Plasma membrane" Cytosol "CAB017712: , HPA019849: AB_1856000" "unprognostic (1.59e-1)" "unprognostic (5.20e-2)" "unprognostic (9.89e-3)" "unprognostic (7.51e-2)" "unprognostic (8.89e-2)" "unprognostic (1.84e-2)" "unprognostic (1.52e-1)" "unprognostic (2.73e-3)" "unprognostic (6.82e-2)" "unprognostic (8.12e-2)" "prognostic unfavourable (2.13e-4)" "unprognostic (1.39e-2)" "unprognostic (1.20e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (5.75e-1)" "unprognostic (1.29e-1)" 1.1 2.4 13.8 2.3 11.3 1.0 10.8 0.8 30.0 4.5 4.4 0.3 0.0 4.5 1.1 0.7 17.0 1.3 9.8 0.9 12.0 7.9 0.8 1.4 6.2 0.7 4.6 18.4 0.7 5.3 1.3 3.6 2.4 8.6 18.0 4.8 0.0 12.8 3.3 0.6 13.2 4.3 1.1 2.1 1.8 36.6 4.8 0.4 0.1 0.7 13.9 5.9 6.8 7.1 0.0 0.0 1.1 0.0 5.0 4.6 3.4 2.5 7.3 0.2 0.0 0.5 6.7 0.0 0.5 4.4 0.6 0.4 0.0 2.8 0.4 0.0 1.2 4.8 0.0 2.9 0.1 0.0 0.1 20.5 1.7 0.0 0.8 1.1 2.2 5.3 15.6 8.6 19.0 0.2 0.0 1.3 5.4 2.5 0.0 2.4 0.1 4.9 0.0 0.0 0.1 1.3 9.4 0.0 3.5 0.7 4.4 0.0 2.7 0.1 0.1 6.4 0.2 3.3 0.6 0.1 0.0 0.0 55.6 11.6 0.3 1.1 0.0 0.2 4.6 0.0 1.1 0.0 1.5 2.3 0.0 0.0 0.6 2.3 0.5 5.0 0.0 0.0 0.0 3.4 13.8 11.3 0.8 30.0 12.0 7.9 4.6 18.4 8.6 0.4 RAB33A RabS10 ENSG00000134594 "RAB33A, member RAS oncogene family" Q14088 X 130171649-130184870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.3;brain: 32.4" "Cell line enhanced" "Detected in some" "HMC-1: 31.6;Karpas-707: 35.9;U-266/70: 26.3;U-937: 14.9" "Group enriched" "Detected in many" 6 "glioma: 10.7;melanoma: 2.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059737 Uncertain Uncertain Vesicles Vesicles "HPA059737: " "unprognostic (5.40e-2)" "unprognostic (6.64e-3)" "unprognostic (3.48e-2)" "unprognostic (8.47e-3)" "unprognostic (4.88e-2)" "unprognostic (1.17e-2)" "unprognostic (2.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.12e-2)" "unprognostic (4.16e-2)" "unprognostic (3.03e-2)" "unprognostic (8.28e-2)" "unprognostic (7.00e-6)" "unprognostic (2.51e-1)" "unprognostic (6.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.61e-1)" 1.8 2.3 12.5 4.9 11.6 6.8 1.6 15.8 32.4 2.0 1.7 20.8 0.0 1.6 2.1 1.4 1.4 2.2 3.5 10.3 15.9 9.9 1.1 1.5 1.9 11.9 13.0 12.6 2.5 0.8 3.2 1.6 2.3 10.1 1.1 1.9 0.6 1.5 1.0 0.8 1.0 1.9 1.6 21.5 3.3 2.3 1.5 17.3 1.2 1.0 0.0 13.1 3.3 0.6 7.1 3.3 27.3 1.7 5.7 22.9 5.9 0.0 0.0 2.1 0.0 0.9 0.2 0.0 0.2 0.6 0.5 0.9 0.0 0.2 1.6 0.0 0.1 0.0 2.5 0.0 0.5 8.2 0.0 9.4 0.0 0.0 8.8 7.6 31.6 0.3 0.0 0.1 0.3 0.2 0.0 35.9 0.0 0.0 3.5 2.7 0.3 0.3 0.0 0.0 0.4 0.0 0.0 6.9 5.7 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.1 0.0 26.3 7.8 0.0 1.1 14.9 0.0 9.4 0.4 27.3 11.2 0.2 7.0 7.1 10.1 11.1 3.3 2.6 9.8 13.9 1.3 5.7 1.7 0.3 22.9 5.9 12.5 11.6 15.8 18.5 15.9 9.9 13.0 12.6 10.1 17.3 RAB37 ENSG00000172794 "RAB37, member RAS oncogene family" Q96AX2 17 74670578-74747335 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.0;brain: 52.1" "Cell line enhanced" "Detected in some" "HEL: 22.3;HMC-1: 24.4;U-266/70: 35.6;U-937: 15.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 52.1" "Cell type enhanced" "Detected in many" "basophil: 47.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" 1100000 "unprognostic (2.10e-2)" "unprognostic (7.04e-4)" "unprognostic (5.95e-2)" "unprognostic (9.80e-4)" "unprognostic (3.49e-1)" "unprognostic (7.04e-5)" "unprognostic (1.74e-1)" "unprognostic (1.48e-2)" "unprognostic (7.62e-3)" "unprognostic (9.47e-3)" "unprognostic (3.05e-2)" "unprognostic (2.02e-2)" "prognostic unfavourable (8.80e-6)" "unprognostic (7.30e-2)" "prognostic unfavourable (9.27e-4)" "unprognostic (7.80e-2)" "unprognostic (4.01e-2)" 1.3 1.2 1.3 7.5 2.1 15.5 1.0 52.1 9.8 1.5 3.9 0.3 0.0 2.6 1.2 1.0 1.3 1.5 3.5 1.4 4.1 2.8 1.4 9.3 4.8 12.8 2.6 2.7 0.8 1.0 0.0 1.0 1.1 14.7 3.5 3.8 2.1 2.2 0.9 0.9 1.2 6.5 1.6 1.6 11.3 4.6 0.8 0.0 15.8 1.0 1.0 10.9 4.2 2.0 3.4 1.8 47.0 10.8 11.1 12.7 9.8 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.1 0.0 1.7 24.4 0.2 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.1 6.4 5.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.1 4.6 0.0 0.0 0.1 0.0 0.0 35.6 1.4 0.5 0.0 15.0 0.0 47.0 3.1 43.0 12.7 6.6 3.2 3.4 5.6 9.1 1.8 3.4 3.3 7.4 14.5 11.1 10.8 0.3 9.2 9.8 1.3 2.1 52.1 9.8 4.1 2.8 2.6 2.7 14.7 0.0 RAB39A RAB39 ENSG00000179331 "RAB39A, member RAS oncogene family" Q14964 11 107928503-107963482 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3;pituitary gland: 10.0" "Cell line enhanced" "Detected in some" "NTERA-2: 6.7;RPMI-8226: 11.9;SCLC-21H: 21.8;SH-SY5Y: 13.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 3.3;intermediate monocyte: 5.0;memory B-cell: 1.4;myeloid DC: 2.4;naive B-cell: 1.3;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 7 "B-cells: 1.4;dendritic cells: 2.4;monocytes: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042505 Uncertain "HPA042505: " "unprognostic (1.45e-1)" "unprognostic (1.48e-2)" "unprognostic (1.83e-1)" "unprognostic (3.40e-2)" "unprognostic (4.99e-1)" "unprognostic (4.30e-2)" "unprognostic (4.26e-3)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (7.36e-2)" "unprognostic (4.22e-3)" "unprognostic (2.24e-2)" "unprognostic (1.41e-3)" "unprognostic (1.11e-1)" "unprognostic (1.36e-1)" "unprognostic (5.02e-2)" "unprognostic (2.43e-1)" 2.3 2.8 5.3 7.3 5.1 1.7 1.2 16.3 11.0 1.0 1.6 4.1 0.0 1.5 0.8 0.5 1.0 1.3 2.3 1.1 5.9 5.2 1.7 1.9 2.5 5.0 3.7 3.0 0.9 1.1 0.5 10.0 3.4 10.2 1.0 2.3 0.9 1.3 0.6 0.8 1.0 2.1 2.0 4.1 7.3 1.8 2.3 4.9 3.3 1.0 0.0 3.7 3.5 0.9 1.4 2.4 0.4 5.0 0.1 0.2 0.9 0.0 1.4 5.7 0.1 0.0 0.0 0.7 0.0 0.0 0.6 0.4 0.0 0.0 0.3 0.1 0.0 0.0 5.7 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.3 5.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 6.7 0.2 0.0 3.1 11.9 0.0 0.0 21.8 13.5 0.0 0.0 0.3 0.3 2.3 0.0 0.1 1.5 0.0 1.0 0.1 3.1 0.0 0.3 1.3 3.2 0.2 3.3 0.1 0.1 5.0 0.1 1.4 0.1 0.0 2.4 1.3 0.2 0.2 0.4 0.1 3.5 0.3 0.0 0.9 5.3 5.1 16.3 7.1 5.9 5.2 3.7 3.0 10.2 4.9 RAB39B "MRX72, WSN" ENSG00000155961 "RAB39B, member RAS oncogene family" Q96DA2 X 155258241-155264589 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Autism spectrum disorder, Disease mutation, Mental retardation, Parkinson disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Cell line enhanced" "Detected in some" "Daudi: 15.7;Karpas-707: 20.8;U-266/70: 20.9;U-266/84: 14.5" "Cancer enhanced" "Detected in many" "glioma: 6.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001114, HPA042505" Approved "HPA001114: AB_1079732, HPA042505: " "prognostic favourable (8.95e-4)" "unprognostic (1.20e-3)" "unprognostic (3.52e-2)" "unprognostic (7.10e-5)" "unprognostic (1.77e-1)" "unprognostic (7.47e-4)" "unprognostic (2.19e-1)" "unprognostic (6.00e-4)" "unprognostic (1.78e-1)" "unprognostic (5.64e-2)" "unprognostic (3.87e-4)" "unprognostic (5.41e-2)" "unprognostic (1.72e-1)" "unprognostic (7.21e-2)" "unprognostic (4.94e-2)" "unprognostic (6.35e-2)" "unprognostic (3.24e-1)" 0.9 3.8 9.4 4.8 12.1 1.7 1.7 14.2 21.5 1.3 1.7 5.8 1.8 1.5 1.0 11.6 1.1 1.4 1.6 1.1 10.4 11.0 1.8 1.0 1.5 8.5 10.1 9.6 1.2 4.7 7.7 10.8 0.9 11.9 3.9 1.6 1.0 1.2 2.8 0.6 0.6 2.0 0.9 9.5 5.3 2.6 2.0 7.3 4.5 4.6 0.0 9.9 2.4 0.7 4.9 5.4 3.3 0.5 3.5 8.7 3.8 0.0 0.2 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.7 0.7 0.0 0.0 0.0 0.1 0.0 6.6 0.3 1.3 0.0 0.0 1.0 0.0 2.8 0.1 0.0 0.2 4.6 0.0 0.0 20.8 0.1 1.1 5.7 0.0 4.0 0.3 0.0 0.0 1.2 0.0 0.0 7.9 6.1 0.0 0.0 3.6 0.2 0.1 0.0 0.4 1.3 0.0 0.6 20.9 14.5 3.6 3.7 0.0 0.0 1.0 0.4 2.5 5.7 0.3 5.9 4.9 7.7 7.4 5.4 3.4 8.1 8.7 3.3 3.5 0.5 1.4 5.6 3.8 9.4 12.1 14.2 15.8 10.4 11.0 10.1 9.6 11.9 7.3 RAB3A ENSG00000105649 "RAB3A, member RAS oncogene family" P20336 19 18196784-18204074 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 114.7" "Cell line enhanced" "Detected in many" "PC-3: 13.5;SCLC-21H: 24.7;SH-SY5Y: 11.8;U-2197: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003160, CAB009949, CAB078998" Enhanced Supported Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731" "unprognostic (1.82e-1)" "unprognostic (2.22e-1)" "unprognostic (6.80e-3)" "prognostic unfavourable (3.17e-4)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (1.36e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (1.13e-1)" "prognostic favourable (6.14e-7)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (6.14e-2)" 2.3 13.0 32.3 2.6 50.5 2.0 2.0 39.1 114.7 2.8 3.1 6.3 0.0 3.6 2.7 2.6 2.4 3.2 2.8 17.0 40.8 32.7 4.1 2.2 2.5 2.4 31.5 35.6 8.0 2.3 5.0 7.5 2.4 38.2 3.8 2.8 5.8 4.2 4.4 7.5 2.5 3.0 2.9 7.0 2.5 2.5 2.2 4.8 0.0 2.9 0.1 2.1 2.9 0.7 4.6 6.0 5.1 3.0 0.7 4.2 2.6 0.9 1.0 2.3 3.2 3.8 1.0 1.4 2.0 1.2 1.4 1.9 0.9 0.5 3.3 2.2 1.6 2.7 10.7 1.3 0.7 0.7 3.4 1.3 3.9 3.7 0.9 2.2 4.1 3.1 1.3 0.8 0.4 0.4 0.7 1.1 1.3 3.2 5.0 0.6 1.9 13.5 3.5 0.2 2.8 1.5 0.5 24.7 11.8 1.0 4.3 2.3 0.9 0.4 0.4 1.2 0.9 17.1 1.1 2.1 4.5 0.8 3.2 1.7 1.1 0.0 3.0 3.8 3.0 2.2 4.0 4.6 3.2 3.0 6.0 2.2 4.1 4.2 5.1 0.7 2.7 5.5 1.8 2.6 32.3 50.5 39.1 95.0 40.8 32.7 31.5 35.6 38.2 4.8 RAB3B ENSG00000169213 "RAB3B, member RAS oncogene family" P20337 1 51907956-51990764 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;placenta: 37.6;prostate: 20.0" "Cell line enhanced" "Detected in many" "BJ: 43.7;BJ hTERT+: 16.9;fHDF/TERT166: 15.8;TIME: 33.9" "Group enriched" "Detected in many" 6 "prostate cancer: 19.4;testis cancer: 6.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003159, CAB023293" Enhanced Approved "Cell Junctions" "Cell Junctions" "CAB023293: , HPA003159: AB_1856005" "unprognostic (1.10e-1)" "unprognostic (2.20e-3)" "unprognostic (5.43e-3)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (1.38e-2)" "unprognostic (1.20e-2)" "unprognostic (8.77e-3)" "unprognostic (2.79e-1)" "unprognostic (2.81e-1)" "unprognostic (2.42e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-2)" "unprognostic (2.02e-3)" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.15e-2)" 0.4 5.8 16.6 1.4 8.5 0.8 1.8 2.0 13.8 0.4 3.1 0.9 0.0 1.6 0.5 0.8 0.5 0.7 2.7 0.4 9.9 15.8 1.4 1.3 0.5 0.5 4.5 9.3 3.2 2.1 0.4 13.7 37.6 18.2 20.0 4.4 0.1 0.8 0.6 1.0 3.7 1.9 0.9 1.4 0.5 2.7 0.8 1.3 0.0 0.5 0.0 0.6 0.6 0.4 1.1 0.8 2.1 0.5 0.5 0.4 0.0 0.6 2.9 0.4 0.4 0.1 0.8 0.0 43.7 16.9 8.8 4.3 3.5 1.3 0.2 0.7 15.8 0.0 5.4 4.5 15.0 0.0 0.4 0.0 0.2 1.1 0.7 0.0 0.0 0.4 0.1 14.6 3.3 2.7 0.1 0.1 9.7 0.1 0.0 0.0 7.0 0.4 0.1 0.0 0.0 1.4 0.2 1.5 0.4 0.0 0.1 0.0 0.0 0.1 33.9 8.6 3.2 0.1 14.2 0.0 0.2 0.1 7.8 0.0 0.3 1.1 0.5 0.3 0.4 0.3 0.3 0.6 0.3 0.4 0.1 1.1 0.4 0.4 2.1 0.5 0.5 0.8 0.2 0.0 16.6 8.5 2.0 13.8 9.9 15.8 4.5 9.3 18.2 1.3 RAB3C ENSG00000152932 "RAB3C, member RAS oncogene family" Q96E17 5 58582221-58859394 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adrenal gland: 13.6;brain: 47.4;pituitary gland: 14.1" "Cell line enhanced" "Detected in some" "AF22: 2.4;HEL: 3.4;SCLC-21H: 14.3;SH-SY5Y: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA003160, HPA048156" Enhanced Approved Cytosol Cytosol "HPA003160: AB_1079731, HPA048156: " "unprognostic (1.30e-1)" "unprognostic (3.35e-2)" "unprognostic (9.94e-2)" "unprognostic (2.23e-2)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (8.73e-3)" "unprognostic (3.40e-2)" "unprognostic (6.90e-2)" "unprognostic (7.58e-2)" "unprognostic (9.52e-4)" "unprognostic (1.51e-3)" "unprognostic (3.70e-5)" "unprognostic (4.70e-2)" "unprognostic (1.05e-1)" "unprognostic (9.65e-2)" "unprognostic (3.61e-3)" 2.5 13.6 19.8 2.5 36.1 1.1 1.3 7.7 47.4 1.3 1.8 2.1 0.0 3.1 2.1 1.0 1.3 1.3 1.9 1.1 22.9 23.6 1.2 1.2 1.2 1.3 14.5 23.6 1.2 3.3 1.4 14.1 1.2 25.6 1.1 2.1 0.0 1.1 1.1 1.1 1.1 3.3 2.0 3.2 1.0 2.3 1.3 4.1 0.0 1.1 0.0 1.4 1.7 0.4 0.3 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.7 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 14.3 5.2 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 19.8 36.1 7.7 32.4 22.9 23.6 14.5 23.6 25.6 4.1 RAB40B "RAR, SEC4L" ENSG00000141542 "RAB40B, member RAS oncogene family" Q12829 17 82654973-82698728 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.4" "Cell line enhanced" "Detected in many" "HEK 293: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.0" "Low lineage specificity" "Detected in all" HPA076172 Approved Vesicles Vesicles "HPA076172: " "unprognostic (2.21e-2)" "unprognostic (7.50e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-1)" "unprognostic (6.03e-2)" "unprognostic (2.34e-2)" "prognostic favourable (9.77e-4)" "unprognostic (1.74e-1)" "unprognostic (3.28e-2)" "unprognostic (1.36e-1)" "unprognostic (3.14e-2)" "prognostic favourable (2.95e-6)" "unprognostic (1.81e-2)" "unprognostic (1.38e-1)" "unprognostic (2.13e-2)" "unprognostic (9.83e-3)" 6.3 7.5 29.7 2.1 43.4 1.0 6.5 9.3 34.2 6.2 12.5 38.3 1.5 7.3 6.5 15.0 5.0 5.8 5.3 13.4 25.8 13.7 15.9 6.4 5.3 2.1 21.3 17.0 8.6 5.0 5.3 5.9 3.3 19.8 8.7 7.9 2.2 8.0 5.9 29.6 8.5 5.3 4.4 28.7 4.0 16.7 3.0 23.2 0.0 4.3 3.9 2.5 4.6 3.4 3.5 10.0 2.1 4.5 2.8 2.6 1.0 4.9 8.1 2.5 7.4 6.3 7.9 3.7 5.5 1.5 3.5 1.1 2.7 1.3 0.6 11.0 5.5 9.0 4.7 4.4 3.1 0.4 23.3 1.9 8.4 7.4 3.1 0.6 2.2 6.7 7.2 2.0 1.5 3.2 5.7 0.7 4.7 6.6 1.9 4.3 0.5 10.7 4.6 6.4 4.2 12.2 9.2 13.7 8.6 3.9 3.5 7.4 7.6 4.0 6.5 9.8 3.0 10.2 4.4 3.9 3.1 7.0 2.3 1.3 1.7 2.1 0.7 0.1 1.6 1.9 2.2 3.5 2.0 2.6 1.2 1.3 2.5 1.3 0.3 2.8 4.5 10.0 2.6 1.0 29.7 43.4 9.3 26.8 25.8 13.7 21.3 17.0 19.8 23.2 RAB41 ENSG00000147127 "RAB41, member RAS oncogene family" Q5JT25 X 70282093-70285002 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.4;testis: 7.3" "Cell line enhanced" "Detected in many" "U-2197: 6.9;U-87 MG: 8.7" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA001510 Uncertain "HPA001510: AB_1079733" "unprognostic (1.32e-1)" "unprognostic (1.39e-1)" "unprognostic (3.36e-3)" "unprognostic (4.25e-3)" "unprognostic (1.18e-1)" "unprognostic (3.46e-2)" "unprognostic (6.33e-3)" "unprognostic (1.85e-3)" "unprognostic (1.38e-1)" "unprognostic (2.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.04e-3)" "unprognostic (7.63e-2)" "unprognostic (2.39e-1)" "unprognostic (9.78e-3)" "unprognostic (8.42e-2)" "unprognostic (9.89e-2)" 0.2 1.6 2.4 0.9 2.7 0.5 0.0 1.3 6.4 0.0 0.3 0.5 0.3 0.0 0.4 0.1 0.9 0.9 1.8 2.1 0.4 0.0 0.5 0.7 2.6 1.6 0.0 0.0 0.2 0.2 0.3 0.0 1.9 0.0 0.7 2.5 1.3 0.0 1.8 0.8 0.2 7.3 1.4 0.0 1.0 0.0 1.5 1.6 0.1 0.9 0.0 2.0 0.4 1.0 1.0 2.4 0.9 0.0 0.0 0.9 0.9 0.0 0.0 0.0 1.1 0.9 1.1 2.0 0.0 1.1 0.0 0.0 0.0 1.4 2.5 0.2 2.1 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 1.0 2.2 0.0 0.6 1.5 1.0 1.6 3.1 0.6 1.8 1.5 0.0 0.8 1.6 2.9 1.0 0.6 2.7 0.7 2.5 2.9 1.2 1.3 6.9 1.5 1.3 1.8 1.4 8.7 2.1 2.0 0.0 0.4 0.1 0.7 0.9 2.0 1.5 0.6 0.6 1.6 1.5 1.2 1.0 0.0 0.0 0.3 0.4 1.1 0.4 RAB6B ENSG00000154917 "RAB6B, member RAS oncogene family" Q9NRW1 3 133824239-133895836 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 86.5;parathyroid gland: 33.1" "Cell line enriched" "Detected in many" 4 "HEL: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 10.5" "Lineage enriched" "Detected in single" 54 "T-cells: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017713, HPA059131" Uncertain Approved "Golgi apparatus" 11000000 "Golgi apparatus" "CAB017713: , HPA059131: " "unprognostic (2.87e-2)" "unprognostic (6.33e-3)" "unprognostic (4.53e-3)" "prognostic unfavourable (9.01e-4)" "unprognostic (3.61e-1)" "unprognostic (5.14e-2)" "unprognostic (1.73e-4)" "unprognostic (3.12e-2)" "unprognostic (4.26e-2)" "unprognostic (4.80e-2)" "prognostic favourable (3.97e-6)" "unprognostic (9.00e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-2)" "unprognostic (8.10e-2)" "unprognostic (9.53e-2)" "unprognostic (6.05e-3)" 5.3 8.4 38.2 2.6 26.1 7.0 2.3 18.4 86.5 2.8 3.1 4.1 2.7 2.5 2.6 2.3 3.6 11.5 2.9 14.4 29.2 29.1 3.6 1.1 2.1 2.8 25.6 43.6 2.2 3.8 33.1 4.4 2.0 26.9 2.7 2.3 3.4 6.8 5.0 2.4 1.5 1.9 6.1 12.1 4.6 4.3 3.5 7.0 0.0 4.3 0.0 2.2 1.6 1.0 0.1 0.1 0.0 0.0 0.1 10.5 1.1 0.0 0.9 1.8 4.6 3.2 3.3 0.1 1.0 1.9 2.2 0.2 0.4 0.4 0.0 2.0 0.7 0.1 4.2 0.1 1.1 0.0 3.3 69.2 1.0 0.1 0.4 0.4 2.7 0.9 0.9 0.3 0.0 0.9 16.2 0.2 0.3 1.6 0.2 6.3 5.7 0.7 0.0 0.1 0.7 1.2 0.3 15.0 3.3 1.4 1.3 8.1 5.1 2.9 1.1 2.1 5.0 0.9 1.7 1.7 0.4 0.1 0.2 0.1 1.7 0.0 0.0 0.0 1.0 0.0 10.5 0.1 0.2 2.5 0.1 0.1 0.2 0.6 0.0 0.1 0.0 0.1 0.1 1.1 38.2 26.1 18.4 54.0 29.2 29.1 25.6 43.6 26.9 7.0 RAC3 ENSG00000169750 "Rac family small GTPase 3" P60763 17 82031624-82034204 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.9" "Cell line enhanced" "Detected in many" "CACO-2: 52.4;HEK 293: 63.3;NB-4: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.5;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 15 "dendritic cells: 1.5;T-cells: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047820 Uncertain "HPA047820: " "unprognostic (3.48e-2)" "unprognostic (2.26e-1)" "unprognostic (2.66e-1)" "prognostic unfavourable (6.21e-5)" "unprognostic (1.62e-1)" "unprognostic (1.39e-1)" "unprognostic (1.43e-2)" "unprognostic (3.36e-2)" "unprognostic (1.57e-1)" "unprognostic (6.62e-2)" "unprognostic (1.22e-2)" "unprognostic (3.67e-1)" "unprognostic (4.39e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "prognostic unfavourable (4.69e-4)" "unprognostic (1.25e-3)" 10.2 5.8 13.2 2.2 7.7 8.0 14.5 33.9 27.8 3.5 2.9 3.3 12.8 4.3 1.8 14.7 5.0 3.5 3.8 2.4 11.6 20.7 6.3 9.1 3.0 2.1 13.7 12.7 2.3 5.6 10.7 11.2 6.9 16.8 9.0 2.0 4.2 18.4 7.8 0.5 9.2 3.6 1.8 6.7 0.8 7.1 23.0 3.4 0.3 5.5 3.5 2.0 2.5 3.2 0.0 1.5 0.0 0.0 0.0 1.5 0.0 2.4 3.4 10.8 14.7 2.3 4.4 11.9 1.7 1.6 6.1 5.2 52.4 4.9 1.3 2.7 1.1 3.6 10.2 4.1 1.0 0.8 63.3 14.6 4.3 3.7 11.3 6.2 2.8 6.6 3.1 0.8 2.9 14.0 23.1 7.0 2.4 7.9 1.6 34.8 14.5 6.3 10.7 1.0 6.2 4.6 1.1 26.2 26.0 0.9 13.3 12.2 13.5 9.3 4.9 2.5 2.3 1.3 2.6 3.4 2.2 0.9 1.5 3.9 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 1.1 0.0 13.2 7.7 33.9 27.8 11.6 20.7 13.7 12.7 16.8 3.4 RADIL "FLJ10324, KIAA1849, RASIP2" ENSG00000157927 "Rap associating with DIL domain" Q96JH8 7 4797055-4883719 "Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9;testis: 18.5" "Cell line enhanced" "Detected in some" "AN3-CA: 7.6;HEK 293: 5.9;NTERA-2: 6.6;SCLC-21H: 9.3;SH-SY5Y: 20.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051776 Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA051776: " "unprognostic (6.77e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.80e-2)" "unprognostic (1.80e-2)" "unprognostic (1.21e-1)" "unprognostic (9.74e-4)" "unprognostic (4.63e-2)" "unprognostic (3.48e-1)" "unprognostic (2.83e-2)" "unprognostic (7.89e-4)" "unprognostic (5.32e-2)" "unprognostic (1.49e-4)" "unprognostic (5.10e-3)" "unprognostic (2.46e-1)" "unprognostic (3.33e-3)" "unprognostic (4.28e-3)" 7.5 2.4 4.3 0.8 4.6 0.5 3.7 29.9 9.9 5.9 3.3 3.3 0.7 0.8 6.1 1.4 1.7 6.4 2.1 7.8 4.1 4.0 1.1 0.7 7.5 0.6 3.4 4.4 1.6 2.5 1.5 3.3 7.2 7.5 2.1 1.1 2.7 1.1 4.3 4.5 1.2 1.8 3.1 4.3 1.0 1.4 18.5 4.0 0.0 2.8 0.6 0.7 2.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.7 7.6 0.2 1.8 0.0 0.9 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.8 0.0 2.9 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 4.0 0.0 0.4 2.1 0.0 0.0 6.6 1.3 4.9 0.2 0.0 0.0 0.0 9.3 20.1 0.1 0.0 0.0 3.0 0.6 0.0 0.0 0.0 5.4 1.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 4.6 29.9 9.9 4.1 4.0 3.4 4.4 7.5 4.0 RALYL HNRPCL3 ENSG00000184672 "RALY RNA binding protein like" Q86SE5 8 84182787-84921844 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 25.6;brain: 54.9;kidney: 23.5" "Cell line enriched" "Detected in some" 5 "AF22: 9.5" "Cancer enhanced" "Detected in single" "glioma: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055868, HPA059112" Enhanced Approved Nucleoplasm Nucleoplasm "HPA055868: , HPA059112: " "unprognostic (1.13e-5)" "unprognostic (1.62e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (5.04e-2)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (4.82e-5)" "unprognostic (2.74e-2)" "unprognostic (2.52e-1)" 1.1 25.6 14.0 1.1 23.0 1.2 1.1 54.9 38.2 0.9 1.3 1.1 0.0 1.4 1.1 1.8 0.9 1.7 7.1 3.7 14.9 22.6 23.5 1.3 1.1 1.0 14.7 20.0 1.0 3.7 1.0 7.6 2.4 9.8 1.2 1.5 0.4 1.1 3.4 1.1 1.2 1.8 1.1 4.6 3.8 1.6 1.4 3.5 0.0 1.1 0.0 1.0 1.0 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.2 0.0 9.5 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.9 1.1 0.1 0.0 0.1 0.1 0.3 0.3 0.1 0.1 0.6 0.1 0.2 0.1 0.5 0.4 0.0 0.3 0.5 0.0 0.0 0.0 0.4 0.4 0.4 0.0 1.0 0.0 0.0 0.0 1.8 0.3 0.2 0.5 0.2 0.2 0.0 0.9 0.4 0.2 0.4 0.2 0.5 0.5 0.2 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 14.0 23.0 54.9 23.0 14.9 22.6 14.7 20.0 9.8 3.5 RANBP3L FLJ25422 ENSG00000164188 "RAN binding protein 3 like" Q86VV4 5 36248434-36302114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;kidney: 33.8" "Cell line enriched" "Detected in some" 5 "ASC diff: 16.6" "Cancer enhanced" "Detected in some" "prostate cancer: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037471, HPA037472, HPA061526" Approved Uncertain Nucleoplasm Nucleoplasm "HPA037471: AB_10671756, HPA037472: , HPA061526: AB_2684552" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-3)" "unprognostic (5.52e-3)" "unprognostic (2.85e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-2)" "unprognostic (9.56e-2)" "unprognostic (2.66e-1)" "unprognostic (2.81e-1)" "unprognostic (1.28e-1)" "unprognostic (3.76e-4)" "unprognostic (1.68e-2)" "unprognostic (9.13e-2)" "unprognostic (8.87e-3)" "unprognostic (5.71e-2)" 4.6 2.8 25.7 1.0 27.5 0.8 10.7 8.5 24.5 2.4 1.1 5.6 0.6 1.0 1.4 3.1 1.4 2.3 3.0 2.5 30.3 5.6 33.8 12.2 3.2 1.1 8.2 16.5 3.4 1.2 1.1 5.3 7.0 12.2 18.6 1.3 1.0 1.5 4.7 0.9 0.9 1.0 6.6 21.4 1.0 2.7 6.4 18.4 0.0 3.6 0.0 1.5 8.2 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 16.6 0.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.1 0.0 3.4 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 27.5 8.5 21.2 30.3 5.6 8.2 16.5 12.2 18.4 RAP1GAP "KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII" ENSG00000076864 "RAP1 GTPase activating protein" P47736 1 21596215-21669363 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.3;thyroid gland: 72.5" "Cell line enhanced" "Detected in many" "A549: 24.0;Hep G2: 11.2;K-562: 14.8;SCLC-21H: 27.8;SK-BR-3: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 286.1" "HPA001922, CAB003851" Enhanced Supported Approved Cytosol Cytosol "CAB003851: AB_562338, HPA001922: AB_1079743" "unprognostic (1.17e-2)" "unprognostic (4.33e-2)" "unprognostic (7.84e-2)" "unprognostic (2.45e-2)" "unprognostic (4.52e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (5.85e-4)" "unprognostic (8.33e-2)" "unprognostic (1.52e-2)" "unprognostic (2.35e-1)" "unprognostic (3.43e-2)" "unprognostic (1.35e-2)" "prognostic favourable (1.12e-6)" "unprognostic (1.11e-1)" "unprognostic (9.85e-3)" "unprognostic (4.86e-3)" "unprognostic (3.64e-2)" 0.9 38.2 30.2 1.9 89.3 1.1 3.1 27.1 40.1 4.7 10.5 5.7 0.0 6.9 1.7 1.8 2.9 3.0 13.4 2.7 17.8 12.9 33.2 10.3 7.8 1.2 8.6 20.6 1.6 49.3 7.1 8.2 5.8 14.6 7.4 9.4 2.4 43.9 1.2 0.7 2.1 11.6 1.1 3.2 0.9 28.4 2.1 14.2 0.0 72.5 0.9 1.6 2.5 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.3 3.1 24.0 0.2 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.2 3.3 0.0 2.4 0.1 4.1 2.3 0.1 0.0 0.5 1.2 1.1 2.3 11.2 0.4 0.0 3.5 0.1 1.6 0.0 0.0 0.0 14.8 0.6 0.0 7.9 3.8 0.3 1.5 3.7 2.2 0.6 0.5 5.5 1.7 27.8 5.0 4.0 14.5 4.6 1.4 2.7 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 30.2 89.3 27.1 30.4 17.8 12.9 8.6 20.6 14.6 14.2 RAP1GAP2 "GARNL4, KIAA1039" ENSG00000132359 "RAP1 GTPase activating protein 2" Q684P5 17 2755705-3037739 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.5;pancreas: 26.0" "Cell line enhanced" "Detected in many" "SH-SY5Y: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022148, HPA022896" Approved Supported "Nuclear membrane,Cytosol" 110000 "Nuclear membrane, Cytosol" "HPA022148: AB_1849474, HPA022896: AB_1849476" "unprognostic (1.85e-3)" "unprognostic (1.02e-2)" "unprognostic (8.92e-2)" "unprognostic (5.39e-1)" "unprognostic (4.04e-2)" "unprognostic (3.92e-1)" "unprognostic (6.52e-5)" "unprognostic (1.18e-2)" "unprognostic (2.91e-1)" "unprognostic (2.22e-1)" "unprognostic (1.66e-2)" "unprognostic (9.64e-2)" "prognostic favourable (1.36e-6)" "unprognostic (3.44e-2)" "unprognostic (6.38e-2)" "unprognostic (9.33e-2)" "unprognostic (7.50e-2)" 1.2 4.6 6.7 2.9 13.5 16.8 3.1 27.5 22.9 2.7 5.3 2.2 0.0 5.9 3.7 1.0 2.5 5.8 2.7 9.9 6.5 6.3 3.9 0.7 3.4 3.4 4.3 16.4 3.3 26.0 4.5 8.0 3.3 15.8 2.6 5.6 2.6 9.0 3.5 0.8 2.7 5.5 2.3 4.3 3.2 15.4 2.3 3.1 1.6 2.1 0.3 3.0 1.6 2.2 0.5 3.0 7.2 6.3 2.9 5.2 2.0 4.4 5.6 1.1 4.6 0.0 0.0 9.2 6.0 2.8 0.8 0.7 12.3 2.0 1.6 1.7 0.7 6.2 3.6 11.3 0.2 0.0 3.9 2.0 7.8 5.5 1.1 0.4 2.2 0.2 9.8 3.2 8.1 0.1 11.6 0.8 0.0 5.0 1.6 1.1 6.7 5.4 7.4 4.0 4.3 3.4 2.3 12.5 30.3 8.7 9.1 3.9 4.5 1.3 1.3 5.3 8.4 0.9 5.0 0.0 0.0 0.6 0.3 3.8 8.6 1.5 2.3 3.3 5.2 4.7 2.0 0.5 1.7 3.7 1.8 0.4 0.3 1.9 7.2 2.9 6.3 3.0 1.6 2.0 6.7 13.5 27.5 22.9 6.5 6.3 4.3 16.4 15.8 3.1 RAP2A "K-REV, RAP2" ENSG00000125249 "RAP2A, member of RAS oncogene family" P10114 13 97434222-97469128 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 39.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018552 Uncertain "CAB018552: AB_2177305" "unprognostic (2.40e-1)" "unprognostic (7.72e-2)" "unprognostic (1.94e-1)" "unprognostic (4.34e-2)" "unprognostic (2.04e-2)" "unprognostic (2.35e-2)" "prognostic unfavourable (1.55e-4)" "unprognostic (1.20e-2)" "unprognostic (2.06e-2)" "unprognostic (2.10e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-2)" "prognostic unfavourable (8.06e-4)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.53e-1)" 12.0 7.4 25.2 8.6 20.6 3.0 9.9 11.4 39.7 10.9 8.6 16.5 2.2 6.7 7.7 4.1 13.8 6.1 11.0 9.4 24.3 20.4 12.2 7.4 11.6 17.8 22.4 24.6 6.1 4.2 4.9 7.1 21.2 13.7 5.8 9.8 4.1 5.1 6.7 8.0 6.1 6.8 10.5 30.6 12.0 5.4 3.8 13.3 8.9 5.8 7.4 10.6 10.7 6.5 1.3 3.7 0.9 4.2 1.0 4.7 0.8 11.0 3.1 12.0 8.6 20.0 11.9 4.7 8.2 5.4 8.1 9.1 5.9 6.5 8.4 5.3 13.5 8.6 10.2 8.2 10.7 15.7 5.3 9.2 12.4 8.7 14.4 8.0 5.9 18.3 10.8 8.0 11.1 17.4 3.1 16.3 10.7 4.0 5.5 12.6 6.9 4.8 7.2 13.0 5.5 7.9 3.7 13.8 23.5 5.8 14.0 12.0 11.2 4.1 12.9 8.0 7.9 7.8 7.8 11.7 9.2 4.7 22.1 9.7 12.8 0.0 0.8 0.9 4.7 3.3 2.1 1.3 1.9 3.4 2.2 0.7 1.2 3.7 0.3 1.0 4.2 3.7 3.0 0.8 25.2 20.6 11.4 33.4 24.3 20.4 22.4 24.6 13.7 13.3 RAPGEF4 "cAMP-GEFII, CGEF2" ENSG00000091428 "Rap guanine nucleotide exchange factor 4" Q8WZA2 2 172735274-173052893 "Predicted intracellular proteins" Exocytosis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.6;brain: 70.9" "Cell line enhanced" "Detected in some" "Karpas-707: 17.6;SCLC-21H: 6.8;U-266/70: 9.0;U-266/84: 17.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 68.3;basal ganglia: 31.5;cerebral cortex: 55.3;hippocampal formation: 70.9;olfactory region: 23.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004388, HPA028968" Approved Approved "Focal adhesion sites" "Focal adhesion sites" "CAB004388: AB_670916, HPA028968: " "unprognostic (1.87e-1)" "unprognostic (4.22e-2)" "unprognostic (1.31e-1)" "unprognostic (2.98e-3)" "unprognostic (4.53e-2)" "unprognostic (1.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.80e-1)" "unprognostic (1.16e-1)" "unprognostic (3.23e-1)" "prognostic favourable (1.32e-4)" "unprognostic (6.32e-2)" "unprognostic (1.46e-3)" "unprognostic (1.97e-2)" "unprognostic (6.18e-2)" "unprognostic (5.70e-2)" "unprognostic (2.93e-1)" 3.3 29.6 68.3 1.6 31.5 0.6 5.2 10.9 55.3 4.9 1.5 5.4 1.0 2.1 6.6 2.7 2.3 2.9 3.7 5.7 70.9 10.2 3.8 24.6 5.4 1.7 10.0 23.8 9.7 2.0 3.2 2.4 2.3 8.6 3.5 1.7 11.3 1.7 2.9 1.4 10.6 1.8 4.3 2.9 0.9 5.4 3.7 11.5 0.0 4.3 0.9 1.8 4.2 1.2 0.4 0.6 1.4 0.6 0.6 0.7 0.1 0.1 0.1 2.6 0.4 0.0 0.2 0.1 0.9 0.5 0.1 0.2 0.0 3.0 0.0 0.2 0.0 0.5 2.2 0.6 0.3 0.1 4.7 0.4 2.2 0.0 0.0 2.9 0.7 0.0 0.7 0.0 0.0 2.8 0.0 17.6 0.1 0.0 0.2 0.2 0.3 0.3 0.0 0.6 0.0 0.0 5.2 6.8 2.5 0.1 0.0 0.9 0.1 0.1 0.8 0.1 0.3 0.0 0.2 9.0 17.6 0.0 0.3 0.1 0.1 1.4 0.4 0.4 0.3 0.4 0.6 0.4 0.4 0.3 0.3 0.4 0.6 0.7 1.0 0.6 0.6 0.6 0.3 0.1 68.3 31.5 10.9 55.3 70.9 10.2 10.0 23.8 8.6 11.5 RAPGEF5 "GFR, KIAA0277, MR-GEF" ENSG00000136237 "Rap guanine nucleotide exchange factor 5" Q92565 7 22118238-22357144 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 67.0;parathyroid gland: 258.2" "Cell line enhanced" "Detected in many" "Daudi: 11.6;HUVEC TERT2: 24.6;SCLC-21H: 19.0;TIME: 13.9;U-698: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057821, HPA076772" Uncertain Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" Nucleoplasm "Nuclear bodies" "HPA057821: , HPA076772: " "unprognostic (1.00e-1)" "unprognostic (1.57e-1)" "unprognostic (3.17e-2)" "prognostic unfavourable (9.44e-4)" "unprognostic (5.22e-2)" "prognostic favourable (3.52e-5)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" "unprognostic (1.31e-1)" "unprognostic (3.76e-2)" "unprognostic (6.36e-3)" "unprognostic (6.57e-2)" "unprognostic (2.55e-1)" "unprognostic (8.26e-3)" 10.8 5.8 12.6 3.6 22.6 1.8 6.2 5.2 25.1 4.5 4.6 47.6 0.6 3.9 4.4 3.1 6.1 4.2 7.0 6.7 21.3 10.1 7.3 8.5 14.1 5.7 41.8 13.3 3.7 7.9 258.2 3.3 23.2 31.5 2.8 5.2 0.9 3.4 3.4 2.7 4.4 4.1 5.6 67.0 17.1 3.7 3.5 29.5 3.9 5.4 1.8 4.9 3.9 4.9 0.7 0.0 0.0 0.0 0.0 0.2 0.4 1.5 0.0 2.5 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 2.9 0.7 11.6 0.6 0.1 7.2 1.5 1.0 0.0 0.0 2.3 0.1 0.0 2.9 0.0 0.0 0.0 0.3 1.3 0.7 0.4 24.6 2.6 0.1 0.0 0.6 1.6 0.0 2.0 2.3 2.8 0.0 3.9 2.3 1.0 19.0 5.0 0.2 3.3 0.0 1.6 0.0 13.9 0.0 0.6 0.2 0.6 6.4 1.3 20.7 0.3 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 12.6 22.6 5.2 25.1 21.3 10.1 41.8 13.3 31.5 29.5 RASD2 "MGC:4834, Rhes, TEM2" ENSG00000100302 "RASD family member 2" Q96D21 22 35540868-35554001 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.0;seminal vesicle: 25.2" "Cell line enhanced" "Detected in some" "hTCEpi: 4.0;SK-BR-3: 9.2;U-2 OS: 5.3;U-87 MG: 6.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 71.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 8 "basal ganglia: 527.8" "Region enriched" "Detected in all" 8 "basal ganglia: 265.8" HPA005839 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA005839: AB_1079745" "unprognostic (1.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.33e-2)" "unprognostic (7.00e-2)" "unprognostic (1.43e-1)" "unprognostic (7.07e-3)" "unprognostic (9.76e-2)" "unprognostic (5.49e-2)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.00e-3)" "prognostic unfavourable (2.22e-5)" "unprognostic (3.75e-2)" "unprognostic (1.61e-1)" "unprognostic (8.42e-3)" "unprognostic (6.22e-2)" 1.6 7.9 8.6 2.5 71.0 3.4 1.3 1.8 23.5 1.1 8.3 2.2 3.2 2.5 3.5 16.4 5.2 6.2 2.5 2.8 4.1 5.0 0.8 0.5 1.5 0.6 3.4 8.0 0.8 1.0 0.9 1.0 0.4 2.1 9.6 4.4 3.5 4.0 25.2 13.6 0.8 3.4 7.5 2.2 0.4 1.8 0.6 15.3 0.0 1.4 0.1 1.4 3.8 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 3.5 0.0 0.6 0.0 0.0 0.1 0.9 0.3 1.4 1.1 0.2 0.7 0.0 0.2 3.0 0.2 0.2 0.0 1.3 0.0 0.9 0.0 0.2 0.0 1.7 0.0 0.1 0.2 4.0 2.7 0.4 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.2 0.4 1.5 0.0 1.1 0.0 0.0 2.4 0.4 2.6 9.2 0.0 0.7 0.3 0.1 2.2 5.3 0.2 1.0 2.3 0.7 0.0 6.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.6 71.0 1.8 23.5 4.1 5.0 3.4 8.0 2.1 15.3 RASGEF1A "CG4853, FLJ37817" ENSG00000198915 "RasGEF domain family member 1A" Q8N9B8 10 43194535-43266919 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.6;brain: 18.3" "Cell line enhanced" "Detected in some" "K-562: 13.0;SCLC-21H: 12.6;SK-BR-3: 11.4;T-47d: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035593 Enhanced Approved "Golgi apparatus" "Golgi apparatus" "HPA035593: AB_10602083" "prognostic favourable (1.86e-5)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "prognostic unfavourable (4.28e-4)" "unprognostic (1.86e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (5.73e-2)" "unprognostic (8.53e-2)" "unprognostic (9.00e-2)" "unprognostic (2.86e-1)" "unprognostic (3.52e-1)" "prognostic unfavourable (4.11e-7)" "unprognostic (2.88e-2)" "unprognostic (2.32e-1)" "unprognostic (1.89e-2)" "unprognostic (3.83e-2)" 1.1 2.3 13.1 1.6 16.2 16.6 4.4 11.0 18.3 2.1 0.9 4.0 0.0 1.2 1.6 0.7 1.5 3.4 3.0 1.5 12.3 10.6 1.4 0.4 1.8 6.0 7.2 8.7 1.8 4.8 10.7 3.3 1.1 7.2 1.7 0.7 2.3 4.6 2.6 1.1 0.9 0.8 1.7 3.5 3.5 1.0 3.1 4.1 0.0 1.2 0.2 4.6 2.2 1.9 2.1 5.8 10.4 0.6 7.1 3.6 1.1 7.4 6.4 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 0.0 0.2 4.1 6.5 7.0 0.6 0.1 1.0 6.1 0.0 0.0 5.0 0.0 0.1 0.3 3.1 0.0 2.4 1.6 7.0 0.6 0.0 0.0 13.0 0.0 0.0 1.5 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.5 3.5 12.6 0.0 0.0 11.4 0.1 12.5 0.1 0.0 0.0 2.9 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 6.6 3.6 0.6 1.3 0.2 0.9 2.6 3.3 2.1 0.3 1.8 10.4 7.1 0.4 5.8 0.0 1.1 13.1 16.2 11.0 17.8 12.3 10.6 7.2 8.7 7.2 4.1 RASGEF1C FLJ35841 ENSG00000146090 "RasGEF domain family member 1C" Q8N431 5 180100791-180209153 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 27.4;testis: 7.1" "Cell line enhanced" "Detected in some" "BEWO: 3.6;HEK 293: 2.7;MCF7: 3.8;SCLC-21H: 12.4;U-2 OS: 3.8" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028242 Uncertain Approved Mitochondria Mitochondria "HPA028242: AB_10602294" "unprognostic (2.21e-1)" "unprognostic (2.18e-1)" "unprognostic (2.23e-1)" "unprognostic (4.75e-4)" "unprognostic (4.65e-2)" "unprognostic (4.04e-2)" "unprognostic (3.84e-2)" "unprognostic (1.02e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "unprognostic (2.35e-2)" "unprognostic (2.34e-1)" "unprognostic (1.65e-4)" "unprognostic (5.89e-2)" "unprognostic (8.25e-3)" "unprognostic (3.70e-1)" "unprognostic (1.77e-2)" 1.1 1.1 7.0 1.1 5.4 0.6 1.4 27.4 22.0 1.4 2.3 9.2 0.0 0.8 0.6 0.8 1.2 1.7 1.2 1.5 4.5 2.8 0.6 0.6 0.6 0.6 5.1 4.9 0.8 0.9 0.8 0.2 0.8 7.7 0.8 1.1 0.4 3.0 2.7 0.7 1.1 1.4 1.0 8.3 0.7 0.8 7.1 4.7 0.0 2.1 0.0 0.6 0.8 0.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 3.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.6 0.0 0.0 0.3 0.2 0.0 0.0 0.0 3.8 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 7.0 5.4 27.4 11.1 4.5 2.8 5.1 4.9 7.7 4.7 RASGRF1 "CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187" ENSG00000058335 "Ras protein specific guanine nucleotide releasing factor 1" Q13972 15 78959947-79090773 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 34.3;lung: 13.0" "Cell line enhanced" "Detected in some" "A-431: 7.7;BEWO: 7.5;Karpas-707: 10.0;RPMI-8226: 12.0;U-2 OS: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.9" "Lineage enhanced" "Detected in single" "B-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010413, HPA041965" Approved Supported "Golgi apparatus" "Golgi apparatus" "CAB010413: AB_2238127, HPA041965: AB_10793939" "unprognostic (2.57e-3)" "unprognostic (3.08e-2)" "unprognostic (3.14e-2)" "prognostic favourable (6.14e-6)" "unprognostic (1.90e-1)" "unprognostic (1.15e-3)" "unprognostic (5.37e-2)" "unprognostic (6.16e-2)" "unprognostic (7.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.00e-1)" "unprognostic (2.03e-1)" "unprognostic (4.02e-6)" "unprognostic (2.35e-1)" "unprognostic (8.02e-2)" "unprognostic (3.81e-2)" "unprognostic (8.81e-2)" 1.0 1.1 7.6 2.3 12.2 0.8 1.1 34.3 33.0 1.9 1.1 11.5 0.0 1.1 1.6 1.1 1.0 1.5 1.0 0.9 12.8 8.6 1.3 0.9 13.0 2.8 8.9 12.0 2.3 4.5 0.9 0.8 1.2 19.2 1.7 1.2 0.4 0.9 1.2 0.8 0.9 1.2 1.0 16.9 1.8 1.1 1.2 5.8 0.0 0.8 0.0 3.1 1.7 0.3 1.9 0.2 0.0 0.0 0.0 0.6 0.1 7.7 0.1 0.1 0.0 0.0 0.0 7.5 0.0 0.4 0.4 1.1 0.0 1.4 0.4 0.2 0.0 0.7 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.1 0.0 0.1 0.1 0.0 0.0 10.0 1.0 0.0 0.0 1.3 0.0 0.0 0.0 1.8 12.0 0.0 0.3 0.8 0.0 0.0 0.1 1.5 0.0 1.6 0.0 0.0 14.7 0.0 0.2 0.0 3.4 2.7 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 7.6 12.2 34.3 33.0 12.8 8.6 8.9 12.0 19.2 5.8 RASGRF2 "GRF2, Ras-GRF2" ENSG00000113319 "Ras protein specific guanine nucleotide releasing factor 2" O14827 5 80960672-81230156 "Predicted intracellular proteins, RAS pathway related proteins" "Calmodulin-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 23.8;ovary: 24.6" "Cell line enhanced" "Detected in some" "BEWO: 23.8;CACO-2: 14.4;EFO-21: 7.5;Hep G2: 19.1;HHSteC: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.8;MAIT T-cell: 7.7;memory CD4 T-cell: 3.8;memory CD8 T-cell: 2.2;naive CD4 T-cell: 6.4;naive CD8 T-cell: 4.3" "Lineage enriched" "Detected in single" 78 "T-cells: 7.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 41.1;cerebral cortex: 118.3;hippocampal formation: 72.9;olfactory region: 58.3" HPA018679 Uncertain Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA018679: AB_1856089" "unprognostic (1.32e-1)" "unprognostic (6.96e-2)" "unprognostic (7.27e-2)" "unprognostic (7.80e-2)" "unprognostic (3.62e-1)" "unprognostic (1.00e-1)" "unprognostic (5.76e-3)" "unprognostic (2.58e-1)" "unprognostic (4.02e-1)" "unprognostic (8.51e-2)" "unprognostic (8.13e-2)" "unprognostic (1.34e-1)" "unprognostic (1.47e-3)" "unprognostic (1.37e-3)" "unprognostic (2.13e-2)" "unprognostic (5.01e-2)" "unprognostic (1.12e-1)" 13.3 1.6 11.6 4.3 14.0 1.5 5.4 1.5 23.8 3.8 2.7 18.7 1.5 2.7 3.9 1.6 2.1 2.6 7.1 4.3 11.1 6.6 6.6 1.0 3.8 4.5 8.5 5.5 24.6 1.4 6.8 3.4 13.2 8.9 5.3 2.3 17.1 1.9 2.4 3.1 1.5 2.9 3.8 15.2 3.0 2.3 2.9 5.6 0.0 4.3 1.1 3.9 4.1 2.4 0.0 0.0 0.0 0.0 0.0 7.7 1.5 0.0 1.3 0.3 0.1 0.0 0.0 23.8 0.4 5.7 0.2 0.3 14.4 0.0 0.2 7.5 0.0 0.4 0.0 0.0 0.8 0.3 2.4 0.1 0.1 19.1 13.2 0.0 0.0 0.6 0.0 5.5 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.1 2.8 0.0 0.1 2.8 0.0 0.9 0.0 0.2 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 2.8 0.0 7.7 0.0 3.8 2.2 0.0 0.0 6.4 4.3 0.0 0.0 0.0 0.0 0.8 1.5 11.6 14.0 1.5 23.8 11.1 6.6 8.5 5.5 8.9 5.6 RASGRP1 "CalDAG-GEFII, RASGRP" ENSG00000172575 "RAS guanyl releasing protein 1" O95267 15 38488103-38565575 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.1;lymphoid tissue: 55.8" "Cell line enhanced" "Detected in some" "HDLM-2: 28.8;MOLT-4: 27.2;REH: 7.6;U-698: 7.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039389 Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA039389: " "unprognostic (3.44e-3)" "unprognostic (1.86e-2)" "unprognostic (1.17e-2)" "unprognostic (3.43e-3)" "unprognostic (1.82e-2)" "unprognostic (3.33e-3)" "unprognostic (9.63e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" "unprognostic (4.50e-1)" "unprognostic (3.01e-2)" "unprognostic (2.54e-1)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (9.30e-2)" 1.7 1.0 5.7 9.9 17.0 7.8 1.9 33.1 18.5 1.4 1.6 0.8 0.0 2.5 1.6 1.6 6.7 4.7 2.7 1.6 6.1 3.2 5.9 1.2 4.2 20.0 3.0 6.2 0.8 2.0 0.3 1.2 4.9 22.3 1.0 2.3 1.4 2.5 1.0 0.8 7.3 3.7 0.7 1.6 8.6 4.8 2.2 1.1 55.8 1.2 1.6 16.3 4.3 2.4 1.2 0.0 0.8 0.0 2.4 10.4 1.4 0.0 0.2 0.5 0.1 0.0 0.0 0.0 2.2 0.7 1.1 0.9 2.4 0.0 6.1 0.5 0.1 0.1 1.3 0.0 1.0 28.8 1.2 0.4 0.2 0.0 0.3 0.2 0.4 0.0 0.1 0.6 0.0 0.0 0.2 1.9 0.0 0.9 27.2 0.0 0.4 0.0 7.6 0.1 0.0 1.1 0.0 2.6 0.9 1.4 0.1 0.1 0.6 0.0 0.1 0.2 0.9 3.1 0.4 4.8 2.3 7.3 0.1 0.0 0.3 0.0 0.0 0.8 5.7 0.0 4.2 1.2 6.4 5.7 0.0 0.7 6.0 6.0 0.3 2.4 0.0 0.0 10.4 1.4 5.7 17.0 33.1 11.7 6.1 3.2 3.0 6.2 22.3 1.1 RASGRP3 "CalDAG-GEFIII, GRP3, KIAA0846" ENSG00000152689 "RAS guanyl releasing protein 3" Q8IV61 2 33436324-33564750 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.4;skeletal muscle: 28.7" "Group enriched" "Detected in some" 6 "Daudi: 29.3;HEL: 30.9;U-266/70: 48.4;U-266/84: 18.4;U-698: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 11.4;memory B-cell: 10.4;naive B-cell: 13.4" "Group enriched" "Detected in many" 16 "B-cells: 13.4;granulocytes: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058937 Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA058937: " "unprognostic (2.64e-1)" "unprognostic (9.50e-2)" "unprognostic (1.45e-1)" "unprognostic (5.76e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (3.90e-1)" "unprognostic (7.57e-2)" "unprognostic (2.39e-2)" "unprognostic (4.35e-2)" "unprognostic (2.43e-1)" "unprognostic (1.48e-1)" "unprognostic (9.96e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.87e-1)" "unprognostic (5.82e-2)" 7.8 2.6 9.4 13.6 13.3 3.2 4.9 2.0 9.6 3.1 3.5 35.0 0.0 5.7 2.6 1.3 2.0 2.1 5.0 24.3 13.4 8.8 5.1 4.1 5.8 19.8 25.2 5.5 1.6 3.7 9.3 3.1 8.2 19.9 2.1 5.3 6.7 5.4 1.7 28.7 2.3 4.5 3.7 42.4 10.1 5.4 1.3 26.3 1.9 6.7 5.0 25.0 5.4 2.1 13.4 0.2 11.4 0.1 0.2 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.2 1.5 4.4 0.8 0.2 29.3 0.1 0.2 0.0 0.0 0.0 0.4 3.0 0.3 30.9 0.2 0.0 0.4 0.1 4.2 0.0 0.0 0.0 0.0 1.7 0.1 1.6 0.6 0.0 0.2 2.3 0.1 0.0 0.0 1.4 0.0 0.3 1.8 0.2 0.0 0.0 0.1 1.4 0.0 0.1 0.5 0.1 0.1 0.1 0.2 48.4 18.4 12.9 0.0 0.1 0.1 11.4 0.0 0.0 0.3 0.0 0.4 10.4 0.5 0.5 0.2 13.4 0.7 0.2 0.0 0.2 0.1 0.0 0.7 0.9 9.4 13.3 2.0 9.6 13.4 8.8 25.2 5.5 19.9 26.3 RASL10A RRP22 ENSG00000100276 "RAS like family 10 member A" Q92737 22 29312933-29319679 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 35.2" "Cell line enhanced" "Detected in some" "HEK 293: 3.6;NB-4: 5.6;U-2 OS: 2.5;U-266/70: 6.2" "Cancer enhanced" "Detected in some" "testis cancer: 3.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 34.5;basal ganglia: 16.7;cerebral cortex: 33.9;hippocampal formation: 29.1" "Region enhanced" "Detected in many" "cerebral cortex: 43.6" HPA056169 Approved "HPA056169: " "unprognostic (1.94e-1)" "unprognostic (2.51e-4)" "unprognostic (3.78e-2)" "unprognostic (1.75e-1)" "unprognostic (2.94e-2)" "unprognostic (2.74e-1)" "unprognostic (1.16e-1)" "unprognostic (7.99e-2)" "unprognostic (9.42e-2)" "unprognostic (1.61e-2)" "unprognostic (5.00e-4)" "unprognostic (2.44e-1)" "unprognostic (7.00e-4)" "unprognostic (3.12e-1)" "unprognostic (1.19e-1)" "unprognostic (6.61e-2)" "unprognostic (3.61e-3)" 1.2 1.5 19.7 1.3 11.8 1.0 3.9 1.4 35.2 1.0 1.1 1.1 0.0 1.4 1.0 1.1 0.9 1.0 1.0 1.2 12.7 7.9 1.1 1.4 1.1 1.0 5.9 11.3 0.9 0.8 0.8 2.3 1.2 2.8 1.2 1.0 0.0 1.0 1.0 1.5 1.1 1.3 1.0 2.0 1.1 1.2 1.3 1.8 0.0 0.9 0.1 1.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.5 0.4 0.0 0.0 0.2 3.6 0.3 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.5 1.2 0.0 0.9 0.0 5.6 1.4 0.0 0.0 0.5 0.0 0.3 0.4 0.7 0.1 0.0 0.4 0.1 1.1 0.5 0.2 0.0 2.5 0.0 0.4 6.2 2.2 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 19.7 11.8 1.4 22.4 12.7 7.9 5.9 11.3 2.8 1.8 RASSF2 "CENP-34, KIAA0168" ENSG00000101265 "Ras association domain family member 2" P50749 20 4780023-4823645 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 106.1" "Cell line enhanced" "Detected in many" "AN3-CA: 19.2;BEWO: 20.1;Daudi: 20.5;HL-60: 24.1;NB-4: 31.2;U-937: 38.4" "Cancer enhanced" "Detected in all" "glioma: 48.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051200 Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" Nucleoplasm "Golgi apparatus, Plasma membrane, Cytosol" "HPA051200: " "unprognostic (6.51e-2)" "unprognostic (3.67e-3)" "unprognostic (5.31e-2)" "unprognostic (1.47e-2)" "unprognostic (3.15e-1)" "unprognostic (1.46e-3)" "unprognostic (2.80e-1)" "unprognostic (7.01e-2)" "unprognostic (1.38e-2)" "unprognostic (2.41e-2)" "unprognostic (4.93e-2)" "unprognostic (3.90e-1)" "prognostic unfavourable (7.82e-4)" "unprognostic (3.51e-2)" "unprognostic (1.35e-1)" "unprognostic (3.49e-1)" "unprognostic (6.46e-2)" 8.3 5.1 26.5 21.5 26.9 38.6 3.6 10.2 45.8 14.9 4.1 59.5 0.1 2.7 13.0 11.6 5.2 9.8 7.8 2.4 33.2 22.4 2.0 3.0 10.1 26.2 54.7 8.7 3.5 1.7 0.7 2.6 4.5 39.7 3.9 5.0 19.8 2.0 4.8 1.2 2.2 5.7 18.6 106.1 14.9 3.3 9.9 27.3 4.7 2.5 0.6 34.2 10.7 2.7 7.9 14.1 42.1 17.9 2.4 4.7 10.6 0.0 4.8 11.9 19.2 0.1 0.0 20.1 1.1 3.3 0.2 0.0 1.1 0.0 20.5 1.9 1.0 0.0 1.7 0.0 0.3 7.3 0.7 13.4 0.0 0.2 0.0 24.1 13.7 0.0 0.0 0.4 0.0 7.8 0.0 8.1 0.0 0.0 3.5 31.2 2.6 0.3 5.5 1.3 7.8 0.0 9.5 0.1 0.9 0.0 0.3 0.6 0.0 15.4 0.2 0.5 2.6 0.2 1.5 0.1 1.9 12.6 0.1 38.4 0.1 21.1 17.9 29.5 2.4 15.4 4.7 7.9 3.9 3.3 14.1 5.3 2.6 2.1 42.1 2.4 16.8 9.4 3.4 10.6 26.5 26.9 10.2 19.3 33.2 22.4 54.7 8.7 39.7 27.3 RBFOX1 "A2BP1, FOX-1, HRNBP1" ENSG00000078328 "RNA binding fox-1 homolog 1" Q9NWB1 16 5239802-7713338 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6" "Cell line enriched" "Detected in some" 15 "RH-30: 24.5" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040809, HPA066746" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA040809: AB_10796228, HPA066746: " "unprognostic (3.75e-3)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (5.19e-3)" "unprognostic (8.82e-5)" "unprognostic (5.02e-1)" "unprognostic (3.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.43e-2)" "unprognostic (3.24e-2)" "unprognostic (2.23e-1)" "unprognostic (5.00e-2)" "unprognostic (2.28e-1)" 1.2 2.4 19.9 1.5 33.0 1.6 1.3 31.5 57.2 1.4 1.9 1.9 0.0 1.3 1.3 5.0 2.0 2.2 1.3 17.6 16.4 6.7 1.5 1.3 1.2 1.2 3.7 21.7 1.4 1.3 1.2 0.5 1.3 13.5 2.6 1.7 0.0 1.7 4.9 67.6 1.5 1.4 1.2 3.5 1.2 1.4 1.7 5.6 0.0 1.3 9.7 1.2 1.5 0.3 1.7 0.7 3.1 0.7 1.2 1.4 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 1.4 0.0 0.0 24.5 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 2.4 0.6 2.0 1.1 0.3 0.7 1.0 0.9 0.8 0.3 1.7 1.4 1.0 3.1 1.2 0.7 0.7 1.0 0.0 19.9 33.0 31.5 34.3 16.4 6.7 3.7 21.7 13.5 5.6 RBFOX3 "FOX-3, HRNBP3, NeuN" ENSG00000167281 "RNA binding fox-1 homolog 3" A6NFN3 17 79089345-79516148 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.4;seminal vesicle: 21.5" "Group enriched" "Detected in some" 6 "A549: 12.9;NTERA-2: 11.7;SCLC-21H: 18.7;U-2 OS: 8.8" "Cancer enhanced" "Detected in some" "prostate cancer: 1.1" "Region enhanced" "Detected in all" "cerebellum: 60.4" "Cell type enhanced" "Detected in single" "gdT-cell: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030790, CAB078782" Enhanced Supported Supported Nucleoplasm Nucleoplasm "CAB078782: , HPA030790: AB_10602305" "unprognostic (2.84e-1)" "unprognostic (1.88e-1)" "unprognostic (4.10e-2)" "unprognostic (9.23e-3)" "unprognostic (8.85e-2)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (1.09e-1)" "unprognostic (7.72e-2)" "unprognostic (1.50e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (3.22e-15)" "unprognostic (8.92e-3)" "unprognostic (1.92e-1)" "unprognostic (1.61e-1)" "unprognostic (1.88e-1)" 0.5 1.0 10.2 0.6 23.5 0.6 0.2 60.4 33.2 0.5 15.2 0.3 0.2 1.5 9.3 3.0 8.3 1.0 0.3 0.3 8.6 3.3 0.4 0.2 0.3 0.4 1.8 3.5 0.3 0.5 0.2 0.9 0.3 5.5 13.2 2.2 0.2 0.2 21.5 0.3 0.3 1.3 8.1 2.3 0.4 0.5 7.2 5.6 0.2 0.3 0.2 0.2 15.2 1.0 0.7 0.2 0.0 0.7 0.0 1.4 0.2 0.0 12.9 0.2 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 11.7 0.2 0.2 0.5 0.0 0.0 0.0 18.7 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.8 0.5 0.0 0.7 0.0 0.3 0.4 0.3 0.0 0.0 0.7 0.0 1.4 0.3 0.0 0.7 0.1 0.4 0.2 0.7 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.2 10.2 23.5 60.4 19.5 8.6 3.3 1.8 3.5 5.5 5.6 RBM11 ENSG00000185272 "RNA binding motif protein 11" P57052 21 14216130-14228372 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 20.6;epididymis: 55.3" "Cell line enhanced" "Detected in some" "HEL: 3.7;NTERA-2: 2.9;REH: 2.8;SK-BR-3: 3.1;U-266/70: 2.9;WM-115: 2.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.1" "Lineage enriched" "Detected in single" 11 "T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045885 Supported Nucleoplasm Nucleoplasm "HPA045885: AB_10963937" "unprognostic (1.95e-2)" "unprognostic (1.35e-1)" "unprognostic (3.57e-1)" "unprognostic (5.44e-4)" "unprognostic (2.18e-1)" "unprognostic (7.97e-2)" "unprognostic (3.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.41e-1)" "unprognostic (3.23e-2)" "unprognostic (9.92e-4)" "unprognostic (5.74e-2)" "unprognostic (1.16e-4)" "unprognostic (3.45e-2)" "unprognostic (4.81e-2)" "unprognostic (2.69e-1)" "unprognostic (9.24e-3)" 1.2 1.8 5.0 1.4 5.8 1.5 1.5 2.3 7.3 1.0 1.2 1.9 0.6 1.3 1.8 55.3 1.6 2.1 1.2 1.3 5.9 6.1 1.4 1.0 1.2 1.3 6.1 4.3 3.5 1.4 2.2 5.4 1.1 9.7 1.6 1.1 2.8 1.5 2.2 1.0 1.1 1.0 1.4 20.6 1.5 1.3 2.5 6.1 0.0 2.4 0.0 1.2 1.1 0.9 0.3 0.0 0.0 0.1 0.0 4.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 1.6 1.1 0.0 2.9 0.0 2.8 0.0 0.0 0.7 1.1 0.3 0.0 0.4 3.1 0.0 0.6 0.6 0.0 0.0 1.1 0.0 0.0 2.9 0.0 0.4 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.6 0.0 0.0 0.3 4.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 5.8 2.3 7.3 5.9 6.1 6.1 4.3 9.7 6.1 RCAN3 DSCR1L2 ENSG00000117602 "RCAN family member 3" Q9UKA8 1 24502351-24541040 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 37.0" "Group enriched" "Detected in many" 4 "MAIT T-cell: 5.6;memory CD4 T-cell: 14.0;memory CD8 T-cell: 5.0;naive CD4 T-cell: 19.2;naive CD8 T-cell: 9.9;T-reg: 19.2" "Lineage enriched" "Detected in many" 7 "T-cells: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034533, HPA064289" Enhanced Approved "Nucleoli fibrillar center,Nuclear speckles" "Nuclear speckles" "Nucleoli fibrillar center" "HPA034533: AB_10601481, HPA064289: " "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (4.01e-2)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "unprognostic (4.20e-3)" "unprognostic (3.41e-3)" "unprognostic (3.66e-2)" "unprognostic (6.42e-2)" "unprognostic (2.47e-1)" "unprognostic (1.72e-3)" "unprognostic (7.44e-2)" "unprognostic (3.52e-3)" "unprognostic (9.83e-2)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "unprognostic (4.71e-2)" 3.2 1.5 2.7 15.8 4.0 4.7 7.6 37.0 3.7 3.9 5.0 7.6 3.2 5.2 3.2 7.7 12.6 11.2 6.5 3.1 3.3 7.8 5.3 2.1 8.1 27.2 5.5 1.9 2.0 15.0 5.5 15.0 7.0 7.6 27.7 5.2 6.1 17.4 4.8 1.6 10.0 6.7 2.6 7.9 7.9 13.2 2.6 2.9 17.2 11.7 8.6 23.2 6.0 6.3 2.8 1.5 1.4 0.9 1.9 19.2 4.2 10.3 8.1 0.1 2.5 2.2 5.2 9.5 7.0 3.8 5.6 5.3 2.3 13.8 7.7 6.4 11.8 9.8 7.3 8.9 6.1 7.4 4.4 0.8 2.1 7.1 1.4 2.5 6.8 1.8 6.7 1.9 2.9 1.2 1.1 0.3 2.5 3.4 6.7 4.0 10.9 6.0 2.7 0.1 0.2 4.2 8.9 22.2 5.5 5.6 7.3 21.7 7.6 5.3 8.1 6.7 8.0 0.4 4.8 10.5 12.6 9.9 2.8 10.6 7.7 1.4 0.9 1.1 0.7 0.5 5.6 2.6 14.0 5.0 1.5 2.8 19.2 9.9 0.3 1.9 0.2 1.1 19.2 4.2 2.7 4.0 37.0 3.7 3.3 7.8 5.5 1.9 7.6 2.9 RCOR2 ENSG00000167771 "REST corepressor 2" Q8IZ40 11 63911221-63916844 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.6" "Cell line enhanced" "Detected in some" "AF22: 17.7;NTERA-2: 22.8;SCLC-21H: 35.8;SH-SY5Y: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021638 Uncertain Approved Nucleoplasm,Vesicles,Midbody Nucleoplasm "Vesicles, Midbody" "HPA021638: AB_10960885" "unprognostic (1.96e-2)" "unprognostic (1.15e-1)" "unprognostic (4.10e-2)" "unprognostic (1.98e-3)" "unprognostic (3.10e-2)" "unprognostic (5.86e-2)" "unprognostic (2.33e-4)" "unprognostic (8.64e-2)" "unprognostic (1.46e-1)" "unprognostic (4.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-3)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.51e-1)" "unprognostic (9.93e-2)" "unprognostic (6.06e-3)" 0.8 1.4 3.3 0.7 8.0 0.3 0.7 9.3 16.6 3.0 1.4 3.4 0.0 2.0 3.5 2.6 1.2 3.7 1.6 5.9 4.0 2.6 0.7 0.4 1.0 0.3 2.4 3.8 5.2 1.4 3.2 5.0 1.8 1.8 1.7 1.7 3.3 2.3 1.7 3.1 0.6 1.6 2.5 2.2 0.5 1.2 7.0 2.5 4.1 0.6 0.6 0.3 2.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 17.7 1.2 0.2 1.5 5.3 0.1 0.3 0.2 0.6 0.6 0.1 0.1 0.2 0.4 0.2 7.7 0.0 0.2 0.2 0.9 0.2 0.1 5.6 3.0 0.0 0.1 1.8 0.0 0.3 0.0 0.1 0.9 0.0 0.0 1.5 1.6 6.2 22.8 0.0 5.7 1.0 0.5 0.0 0.0 35.8 23.9 0.1 1.6 0.8 1.3 2.1 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 8.0 9.3 11.0 4.0 2.6 2.4 3.8 1.8 2.5 REEP2 "C5orf19, SGC32445, SPG72, Yip2d" ENSG00000132563 "Receptor accessory protein 2" Q9BRK0 5 138439017-138446969 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.9" "Cell line enhanced" "Detected in many" "AN3-CA: 41.4;SCLC-21H: 17.3;SH-SY5Y: 19.6;U-87 MG: 15.6" "Cancer enriched" "Detected in many" 9 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 21 "dendritic cells: 1.0;T-cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031813, HPA076571" Enhanced "HPA031813: , HPA076571: " "prognostic favourable (7.83e-5)" "unprognostic (1.11e-2)" "unprognostic (3.97e-6)" "unprognostic (3.70e-3)" "prognostic unfavourable (6.65e-4)" "unprognostic (5.43e-2)" "unprognostic (1.62e-2)" "unprognostic (1.04e-1)" "prognostic favourable (9.31e-4)" "unprognostic (5.93e-2)" "unprognostic (3.70e-3)" "unprognostic (9.78e-2)" "unprognostic (6.54e-3)" "unprognostic (7.54e-2)" "unprognostic (1.47e-3)" "unprognostic (6.19e-3)" "unprognostic (1.13e-3)" 5.2 10.9 27.2 3.4 27.2 1.2 2.0 37.0 58.9 3.0 4.4 5.9 0.4 2.8 3.7 2.6 5.6 2.8 3.6 10.5 29.3 32.1 1.6 1.0 1.5 1.4 27.9 19.6 3.5 2.9 2.8 13.9 1.6 25.8 6.1 3.3 7.9 2.1 9.9 15.6 2.0 3.1 13.6 9.7 1.2 2.2 4.5 6.3 0.0 1.4 0.5 1.5 4.1 1.1 0.0 1.0 0.0 0.0 0.0 3.2 0.3 0.2 3.1 11.9 41.4 1.8 4.6 0.0 3.6 1.6 4.9 5.6 2.2 0.4 0.0 0.6 4.4 0.2 11.2 2.3 3.8 1.2 9.9 0.0 0.8 5.4 4.4 0.0 0.0 1.5 0.1 2.8 0.2 0.9 0.0 3.0 1.6 1.8 1.0 0.7 7.3 0.1 4.0 1.1 0.0 0.9 0.0 17.3 19.6 1.2 0.0 3.0 1.1 0.4 0.1 2.8 2.9 2.6 6.6 7.7 4.8 0.3 15.6 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 3.2 0.3 27.2 27.2 37.0 35.6 29.3 32.1 27.9 19.6 25.8 6.3 RELL2 "C5orf16, FLJ90583" ENSG00000164620 "RELT like 2" Q8NC24 5 141636950-141641077 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6;parathyroid gland: 27.6" "Cell line enhanced" "Detected in many" "HMC-1: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077928 Uncertain Vesicles Vesicles "HPA077928: " "unprognostic (3.27e-2)" "unprognostic (8.46e-2)" "unprognostic (2.12e-1)" "unprognostic (4.95e-3)" "unprognostic (1.91e-3)" "unprognostic (7.12e-2)" "unprognostic (1.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.69e-2)" "unprognostic (2.12e-2)" "unprognostic (6.76e-4)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (7.85e-2)" "unprognostic (8.74e-3)" "unprognostic (4.31e-2)" "unprognostic (6.58e-2)" 2.0 4.5 6.9 2.4 12.3 2.2 2.3 12.5 27.6 1.4 2.3 2.3 0.0 2.5 1.3 1.8 2.7 1.2 2.4 1.6 10.8 14.5 3.3 1.8 2.7 4.7 17.8 8.4 1.1 2.2 27.6 9.4 7.4 24.9 2.2 2.1 1.7 3.7 1.8 1.0 4.2 1.8 2.2 3.8 5.4 2.3 4.6 2.5 4.6 2.8 1.7 5.0 2.9 0.9 2.5 7.8 1.2 3.5 0.1 5.4 1.9 0.9 3.0 3.0 5.7 2.4 0.7 1.4 2.6 4.8 8.4 12.5 11.3 1.1 0.1 1.2 3.9 4.6 2.8 10.9 2.2 2.7 1.8 6.9 6.5 5.6 3.9 2.2 20.0 1.6 6.8 7.8 5.7 2.3 2.4 3.6 1.9 1.4 4.0 0.8 3.5 1.5 0.2 0.6 4.7 2.7 2.7 5.0 5.5 2.3 11.0 1.8 3.8 5.2 2.0 6.5 2.9 5.1 4.4 2.1 5.7 16.2 3.5 9.6 4.1 0.0 1.4 0.0 3.0 3.5 1.1 2.5 3.2 3.0 2.3 1.5 2.9 1.6 1.2 0.1 2.5 7.8 5.4 1.9 6.9 12.3 12.5 27.6 10.8 14.5 17.8 8.4 24.9 2.5 RELN "PRO1598, RL" ENSG00000189056 Reelin P78509 7 103471784-103989516 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Developmental protein, Hydrolase, Protease, Serine protease" "Disease mutation, Epilepsy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 73.4;liver: 35.8" "Cell line enhanced" "Detected in some" "Hep G2: 33.6;PC-3: 6.8;SCLC-21H: 8.2;SH-SY5Y: 8.9;TIME: 19.5" "Cancer enhanced" "Detected in many" "liver cancer: 5.7" "Region enriched" "Detected in many" 11 "cerebellum: 73.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046512 Approved "Plasma membrane,Focal adhesion sites" "Secreted to extracellular matrix" 59000000 "Focal adhesion sites" "Plasma membrane" "HPA046512: " "unprognostic (1.42e-1)" "unprognostic (2.93e-3)" "unprognostic (4.31e-2)" "unprognostic (1.29e-4)" "unprognostic (1.30e-1)" "unprognostic (6.95e-2)" "unprognostic (1.85e-1)" "unprognostic (8.35e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-2)" "unprognostic (3.31e-3)" "unprognostic (3.86e-1)" "unprognostic (2.02e-2)" "unprognostic (1.43e-2)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.06e-2)" 2.7 5.9 5.7 1.2 5.3 0.5 6.3 73.4 6.7 2.9 2.1 0.8 0.0 1.1 1.0 3.0 1.7 4.4 1.9 3.2 5.7 5.3 1.2 35.8 1.6 7.9 1.8 2.5 1.3 1.0 0.3 0.8 0.4 5.1 1.2 2.1 10.6 1.1 2.1 0.4 1.1 1.9 2.4 3.2 1.1 0.8 1.5 0.0 0.0 2.6 1.7 0.9 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.2 0.0 0.1 0.0 0.0 2.4 0.0 33.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 1.4 0.0 0.0 0.0 8.2 8.9 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 5.3 73.4 6.7 5.7 5.3 1.8 2.5 5.1 0.0 REM2 FLJ38964 ENSG00000139890 "RRAD and GEM like GTPase 2" Q8IYK8 14 22883165-22887686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.4;brain: 23.9" "Cell line enhanced" "Detected in some" "AF22: 7.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 8 "basal ganglia: 23.9" "Cell type enriched" "Detected in some" 4 "neutrophil: 7.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 7.5" "Region enhanced" "Detected in many" "basal ganglia: 40.1" "Low region specificity" "Detected in all" "unprognostic (4.56e-3)" "unprognostic (1.89e-2)" "unprognostic (1.47e-1)" "unprognostic (3.95e-1)" "unprognostic (1.49e-1)" "unprognostic (9.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-2)" "unprognostic (1.54e-1)" "unprognostic (1.66e-3)" "unprognostic (1.49e-5)" "unprognostic (9.40e-2)" "unprognostic (4.63e-5)" "unprognostic (3.56e-1)" "unprognostic (2.72e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-2)" 0.6 1.0 0.4 1.6 23.9 15.4 0.6 2.7 2.5 0.5 0.7 0.9 0.4 0.7 0.9 0.9 0.4 2.4 0.7 0.4 1.2 1.5 0.7 0.4 1.6 1.6 0.4 1.1 1.3 1.0 5.7 5.4 0.4 1.5 1.0 0.4 0.4 1.0 0.7 0.7 1.5 1.4 0.6 0.9 5.2 1.0 3.8 2.9 0.6 0.7 0.4 1.0 0.6 0.4 1.7 0.4 7.5 0.7 0.0 1.0 0.2 1.6 0.8 7.2 0.3 0.7 1.0 1.1 0.1 0.5 0.1 0.6 0.8 2.4 0.6 0.3 0.1 3.0 0.1 0.2 0.6 1.1 1.7 0.3 2.9 0.0 0.6 0.3 0.5 0.4 0.2 0.2 0.1 0.3 0.2 3.0 0.4 2.3 0.0 0.7 0.4 1.3 0.1 0.2 0.7 0.3 0.2 0.9 3.4 0.6 1.1 1.2 1.3 0.6 0.0 0.0 1.6 0.1 0.2 2.9 1.1 1.8 0.3 0.1 0.0 0.4 0.0 0.8 0.2 0.0 0.7 1.1 0.5 0.6 0.0 1.7 1.0 1.0 7.5 0.0 0.7 0.4 0.4 0.2 0.4 23.9 2.7 2.5 1.2 1.5 0.4 1.1 1.5 2.9 RESP18 ENSG00000182698 "Regulated endocrine specific protein 18" Q5W5W9 2 219327409-219333177 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "brain: 28.7" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.1" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "basal ganglia: 28.7" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.57e-2)" "unprognostic (2.12e-1)" 0.4 0.4 2.6 0.4 28.7 0.4 0.5 0.1 7.5 0.4 0.4 0.3 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.1 4.0 0.4 0.4 0.4 0.4 3.6 1.0 0.4 0.4 0.4 0.0 0.4 2.3 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.6 2.4 2.5 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 28.7 0.1 1.8 3.1 4.0 3.6 1.0 2.3 2.5 RFFL "CARP-2, CARP2, fring, rififylin, RNF189, RNF34L" ENSG00000092871 "Ring finger and FYVE like domain containing E3 ubiquitin protein ligase" Q8WZ73 17 35005990-35089319 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell line enhanced" "Detected in all" "HDLM-2: 40.5;Karpas-707: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB008096, HPA017910, HPA019492" Approved Approved Vesicles Vesicles "CAB008096: AB_2178607, HPA017910: AB_1856189, HPA019492: AB_1856190" "unprognostic (2.59e-1)" "unprognostic (2.87e-1)" "prognostic favourable (4.92e-4)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" "unprognostic (1.79e-1)" "unprognostic (5.73e-3)" "unprognostic (4.34e-3)" "unprognostic (2.31e-1)" "unprognostic (9.26e-3)" "unprognostic (2.39e-1)" "unprognostic (2.63e-1)" "prognostic unfavourable (2.43e-5)" "unprognostic (1.44e-1)" "unprognostic (1.97e-1)" "unprognostic (8.68e-2)" "unprognostic (1.36e-1)" 5.8 6.1 11.1 9.9 22.9 22.1 6.7 4.4 15.7 6.7 14.6 56.8 5.9 14.8 6.9 5.3 21.6 5.4 11.5 5.8 14.4 10.5 15.4 25.0 6.8 8.9 32.1 7.3 5.2 10.1 8.3 4.9 6.5 30.7 10.7 12.6 4.5 9.6 7.0 12.2 5.2 11.9 7.3 32.1 9.9 13.4 15.7 27.5 13.1 23.0 5.4 15.0 10.2 9.2 4.2 5.2 26.8 7.6 6.7 14.5 7.1 7.7 14.8 3.9 5.5 6.5 9.2 2.1 5.1 8.4 5.3 6.4 5.0 15.5 2.3 6.5 6.5 11.0 6.1 9.9 7.4 40.5 4.2 12.1 3.9 12.3 5.5 7.8 7.3 6.2 5.9 7.9 14.1 5.2 5.7 37.8 4.7 2.5 1.7 7.0 4.6 8.8 5.4 6.3 13.7 7.8 15.6 4.3 5.4 3.2 3.4 3.2 5.2 8.6 10.1 3.1 5.5 3.0 8.3 14.1 11.8 3.6 12.1 5.5 2.8 11.3 7.6 16.3 8.8 4.6 10.6 4.2 9.9 8.3 5.2 4.1 8.5 7.5 26.8 6.7 4.1 0.6 14.5 7.1 11.1 22.9 4.4 15.7 14.4 10.5 32.1 7.3 30.7 27.5 RFPL1 RNF78 ENSG00000128250 "Ret finger protein like 1" O75677 22 29438583-29442455 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 20.4" "Cell line enhanced" "Detected in some" "HDLM-2: 10.9;HMC-1: 4.2;Karpas-707: 4.5;SH-SY5Y: 5.7;SiHa: 2.7;THP-1: 5.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA048320: , HPA072380: " "unprognostic (4.54e-1)" "unprognostic (6.63e-8)" "unprognostic (3.14e-3)" "unprognostic (1.89e-1)" 0.0 3.3 0.2 0.1 0.7 0.0 0.0 0.4 20.4 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 1.9 0.0 0.1 0.4 2.8 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 4.5 0.0 0.0 0.0 0.4 1.6 0.9 0.0 1.8 0.0 1.2 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.9 0.7 0.0 1.0 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 5.7 2.7 0.0 0.0 0.0 5.2 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.2 1.2 0.8 0.0 0.6 1.0 0.9 1.6 0.1 1.1 0.0 0.0 1.8 0.0 1.2 0.5 RFPL2 RNF79 ENSG00000128253 "Ret finger protein like 2" O75678 22 32190435-32203477 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 7.9;prostate: 10.8" "Cell line enhanced" "Detected in some" "A549: 2.4;REH: 1.0;SCLC-21H: 1.8;SK-MEL-30: 1.2" "Cancer enriched" "Detected in single" 15 "prostate cancer: 5.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "HPA046608, HPA048320, HPA072380" Approved Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA046608: , HPA048320: , HPA072380: " "unprognostic (3.81e-2)" "unprognostic (4.05e-2)" "unprognostic (8.29e-2)" "unprognostic (9.66e-3)" "unprognostic (2.54e-1)" "unprognostic (9.90e-2)" "unprognostic (2.59e-1)" "unprognostic (6.02e-3)" "unprognostic (2.22e-2)" "unprognostic (3.44e-2)" "unprognostic (8.64e-3)" "prognostic favourable (4.16e-4)" "unprognostic (2.04e-4)" "unprognostic (6.02e-2)" "unprognostic (3.28e-2)" "unprognostic (5.62e-7)" "unprognostic (3.50e-2)" 0.1 0.3 2.3 0.2 3.9 1.1 0.1 2.7 7.9 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 3.1 5.6 0.2 0.5 0.1 0.4 1.9 0.1 0.1 0.1 0.0 0.1 10.8 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.5 0.0 0.8 0.0 1.2 0.2 0.0 2.4 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.2 1.8 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.1 0.8 0.0 1.2 1.2 0.5 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 RFTN2 "C2orf11, FLJ30574, Raftlin-2" ENSG00000162944 "Raftlin family member 2" Q52LD8 2 197568224-197676045 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.5" "Cell line enhanced" "Detected in some" "AF22: 16.9;ASC diff: 11.7;ASC TERT1: 6.4;HSkMC: 6.4;WM-115: 7.4" "Group enriched" "Detected in many" 6 "glioma: 10.2;melanoma: 2.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035232 Approved "HPA035232: AB_10601495" "unprognostic (1.15e-1)" "unprognostic (3.52e-1)" "unprognostic (2.07e-2)" "unprognostic (1.00e-1)" "prognostic favourable (8.05e-4)" "unprognostic (1.89e-2)" "unprognostic (1.81e-1)" "unprognostic (3.09e-2)" "unprognostic (2.16e-2)" "unprognostic (6.04e-2)" "unprognostic (1.39e-1)" "unprognostic (1.05e-1)" "unprognostic (8.44e-3)" "unprognostic (2.56e-2)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (6.77e-2)" 10.6 6.3 22.3 2.6 31.5 0.9 3.6 11.7 29.5 4.4 2.4 20.3 0.5 1.5 5.7 1.5 3.0 2.8 5.6 4.0 25.3 9.5 3.1 1.5 3.0 3.0 39.5 13.2 11.4 3.0 1.1 1.2 7.4 25.8 2.3 2.5 2.2 3.7 2.1 2.8 2.7 2.1 3.4 37.9 2.8 2.2 4.3 38.4 0.0 2.8 0.2 1.9 5.0 2.8 0.9 0.6 2.3 0.4 0.7 2.2 0.2 0.1 0.0 16.9 0.4 11.7 6.4 0.7 0.2 0.9 0.0 0.8 0.4 0.4 0.4 0.4 1.3 0.6 0.0 0.0 0.0 0.7 0.1 0.2 1.0 0.0 1.6 0.3 0.3 6.4 0.4 0.1 0.0 1.8 0.1 0.2 0.4 0.8 0.1 0.1 0.8 0.6 0.1 0.5 0.2 0.0 0.2 0.5 0.1 0.0 0.1 1.9 0.1 0.1 3.7 1.3 0.3 0.1 0.2 0.5 0.8 0.2 1.2 0.1 7.4 1.3 0.4 0.4 1.1 0.3 2.2 0.5 1.3 0.6 0.1 0.9 1.1 1.8 2.3 0.7 0.4 0.6 1.0 0.2 22.3 31.5 11.7 21.4 25.3 9.5 39.5 13.2 25.8 38.4 RFX3 ENSG00000080298 "Regulatory factor X3" P48380 9 3218297-3526004 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.1;testis: 36.5" "Cell line enhanced" "Detected in many" "AF22: 21.9;HDLM-2: 12.9;SCLC-21H: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035689 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA035689: AB_10671224" "prognostic favourable (1.47e-4)" "unprognostic (8.78e-2)" "unprognostic (1.18e-1)" "unprognostic (5.52e-2)" "unprognostic (2.27e-2)" "unprognostic (1.50e-1)" "unprognostic (8.26e-3)" "unprognostic (3.06e-2)" "unprognostic (1.68e-1)" "unprognostic (6.49e-2)" "unprognostic (7.58e-3)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-1)" "unprognostic (2.52e-1)" "unprognostic (8.89e-3)" 5.2 4.6 17.9 7.6 14.9 11.4 6.7 35.1 19.5 6.9 4.7 6.9 5.0 5.0 6.8 6.3 3.8 22.0 5.2 4.0 12.8 7.5 5.0 4.1 7.2 6.7 6.0 11.9 7.0 5.4 9.0 21.7 5.8 9.9 6.1 5.6 4.2 4.7 4.6 5.7 4.4 5.0 4.0 12.5 5.7 6.6 36.5 11.0 12.7 5.7 2.9 7.5 4.5 7.8 8.3 4.6 8.9 4.8 5.3 9.3 3.2 1.9 2.7 21.9 5.3 0.9 1.0 2.2 0.8 2.3 1.9 1.4 0.8 2.5 3.1 0.9 1.1 1.1 5.3 2.2 3.3 12.9 1.4 5.9 2.9 1.8 1.1 1.2 0.8 1.3 1.0 2.3 3.7 3.2 1.1 3.2 2.0 1.5 3.7 4.3 5.8 1.1 3.9 1.5 0.8 3.0 1.6 11.8 5.2 1.3 0.6 2.0 1.1 3.1 2.0 1.4 3.2 0.7 1.3 1.1 0.5 6.3 1.5 1.4 1.4 3.5 3.2 6.2 8.8 4.8 5.4 6.3 8.1 7.2 3.1 8.3 5.7 7.0 8.9 5.3 1.4 4.6 9.3 3.2 17.9 14.9 35.1 19.5 12.8 7.5 6.0 11.9 9.9 11.0 RFX4 ENSG00000111783 "Regulatory factor X4" Q33E94 12 106582907-106762803 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 43.9;testis: 70.5" "Cell line enriched" "Detected in some" 14 "AF22: 32.5" "Cancer enriched" "Detected in single" 54 "glioma: 15.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;NK-cell: 1.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050527 Enhanced Approved Nucleoplasm Nucleoplasm "HPA050527: " "unprognostic (3.67e-1)" "unprognostic (4.86e-2)" "unprognostic (1.76e-3)" "unprognostic (1.60e-2)" "unprognostic (1.09e-1)" "unprognostic (6.97e-2)" "unprognostic (7.97e-2)" "unprognostic (3.04e-1)" "unprognostic (6.80e-2)" "unprognostic (2.72e-3)" "unprognostic (1.66e-3)" "unprognostic (1.15e-2)" "unprognostic (1.30e-2)" "unprognostic (5.46e-2)" 1.3 1.2 13.8 1.2 14.5 1.2 1.2 7.6 20.6 1.2 1.2 21.0 0.0 1.2 1.2 1.3 1.2 1.3 1.3 1.3 15.7 9.9 1.3 1.2 1.3 1.3 12.0 8.6 1.2 1.4 1.2 8.0 1.2 20.6 1.4 1.2 0.0 1.2 1.3 1.2 1.2 1.3 1.2 43.9 1.2 1.3 70.5 13.7 0.0 1.4 0.0 1.2 1.2 0.1 0.5 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.2 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 13.8 14.5 7.6 13.6 15.7 9.9 12.0 8.6 20.6 13.7 RFX7 "FLJ12994, RFXDC2" ENSG00000181827 "Regulatory factor X7" Q2KHR2 15 56087280-56243266 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035462 Supported Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA035462: AB_10602152" "unprognostic (2.36e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-1)" "unprognostic (4.72e-2)" "unprognostic (2.73e-2)" "unprognostic (9.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.10e-2)" "unprognostic (2.78e-2)" "unprognostic (2.60e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (1.12e-5)" "unprognostic (2.24e-1)" "unprognostic (5.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" 6.6 6.6 4.2 4.1 7.1 6.7 5.0 28.2 11.7 4.4 3.5 8.6 3.0 4.3 4.4 4.9 5.1 4.1 3.1 4.2 4.7 3.6 4.4 4.2 4.1 7.1 4.5 8.3 4.7 6.3 7.1 10.6 4.1 8.1 3.9 3.9 2.7 5.3 7.1 13.7 9.8 4.6 4.1 6.4 6.0 4.1 6.0 6.8 15.4 4.2 3.7 7.2 4.9 4.8 1.3 1.5 4.6 0.8 1.4 2.6 0.5 3.9 6.1 14.6 11.1 6.3 7.2 3.8 2.9 4.1 3.9 6.2 4.3 2.9 11.2 4.8 4.3 10.2 8.8 5.6 5.3 5.9 3.5 13.1 8.3 9.3 6.5 10.6 2.3 5.9 13.3 3.5 8.8 7.1 6.1 5.8 6.6 4.6 8.9 4.3 6.9 2.3 9.9 9.4 10.1 5.7 10.2 8.1 10.2 3.7 4.3 5.2 3.3 8.6 5.8 10.7 5.4 2.7 6.3 5.5 5.2 12.6 3.8 11.4 4.7 4.6 0.5 0.9 1.2 0.8 1.6 1.2 1.8 1.9 0.9 1.3 1.0 1.3 0.0 1.4 0.4 1.5 2.6 0.5 4.2 7.1 28.2 11.7 4.7 3.6 4.5 8.3 8.1 6.8 RGMA "RGM, RGMa" ENSG00000182175 "Repulsive guidance molecule BMP co-receptor a" Q96B86 15 93035273-93089204 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.0;skeletal muscle: 85.5" "Cell line enhanced" "Detected in some" "AF22: 30.4;BEWO: 8.9;MOLT-4: 9.0;NTERA-2: 13.6" "Cancer enriched" "Detected in many" 6 "glioma: 26.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012343, HPA039880, HPA044222" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" 1400000 Nucleoplasm Cytosol "CAB012343: AB_777667, HPA039880: , HPA044222: " "unprognostic (3.21e-2)" "unprognostic (1.59e-1)" "unprognostic (8.85e-2)" "unprognostic (3.96e-3)" "unprognostic (5.73e-2)" "unprognostic (4.72e-3)" "unprognostic (2.53e-2)" "prognostic favourable (2.78e-4)" "unprognostic (2.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "unprognostic (6.25e-2)" "unprognostic (3.59e-4)" "unprognostic (8.11e-2)" "unprognostic (2.92e-2)" "unprognostic (1.73e-1)" "unprognostic (7.98e-5)" 12.2 3.3 17.4 17.6 24.7 1.8 9.3 11.0 59.0 21.0 22.2 22.2 0.9 9.1 21.8 9.4 23.1 12.1 9.5 7.7 19.3 16.2 2.3 1.6 2.8 3.1 23.0 12.8 16.6 9.1 1.9 2.1 2.5 30.9 5.5 6.5 2.3 16.2 7.0 85.5 4.9 12.3 46.9 36.8 2.2 26.6 15.8 23.1 0.2 2.9 12.2 5.6 4.1 8.8 1.3 0.7 1.7 1.0 0.7 0.5 0.2 1.2 0.2 30.4 0.5 6.4 3.6 8.9 0.2 0.0 0.0 0.0 0.3 0.4 0.1 0.1 0.2 2.0 5.0 0.1 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 0.1 3.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 9.0 0.1 13.6 0.0 7.9 7.0 0.0 0.0 0.3 3.2 1.8 0.3 0.1 0.0 2.4 1.6 0.0 0.0 6.6 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.8 1.4 0.7 0.6 0.4 1.0 0.3 0.6 0.5 0.5 0.1 1.3 0.4 0.5 1.7 0.7 0.4 0.7 0.3 0.2 17.4 24.7 11.0 21.3 19.3 16.2 23.0 12.8 30.9 23.1 RGS1 "1R20, BL34, IER1, IR20" ENSG00000090104 "Regulator of G protein signaling 1" Q08116 1 192575727-192580031 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 124.8" "Cell line enriched" "Detected in some" 4 "U-266/70: 141.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 16.7;T-reg: 14.5" "Group enriched" "Detected in many" 5 "granulocytes: 16.7;T-cells: 14.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA074572 Approved "HPA074572: " "unprognostic (3.68e-3)" "unprognostic (1.14e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-1)" "unprognostic (4.37e-1)" "unprognostic (3.87e-3)" "unprognostic (6.61e-2)" "unprognostic (1.38e-1)" "unprognostic (3.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-2)" "unprognostic (2.70e-1)" "prognostic unfavourable (4.91e-5)" "prognostic unfavourable (9.57e-4)" "unprognostic (4.01e-2)" "unprognostic (9.90e-2)" "unprognostic (4.56e-2)" 46.1 25.9 8.9 46.3 12.0 37.9 19.3 1.9 11.0 15.8 17.5 12.2 2.6 6.8 5.5 5.0 19.0 6.2 32.5 8.4 16.2 19.4 5.9 16.4 39.8 36.5 32.9 4.9 5.1 5.1 2.7 11.4 5.9 43.7 12.8 33.3 5.9 15.6 4.1 4.5 4.6 22.5 23.7 124.8 20.1 9.8 7.9 20.0 24.8 6.3 12.6 24.0 40.3 10.5 0.0 3.3 16.7 0.1 0.5 14.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.6 2.9 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 141.5 0.5 0.4 0.0 0.0 0.0 0.0 0.0 16.7 0.6 0.1 1.3 0.0 3.7 3.2 0.4 0.0 0.3 2.9 0.1 0.5 0.0 3.3 14.5 0.4 8.9 12.0 1.9 11.0 16.2 19.4 32.9 4.9 43.7 20.0 RGS11 ENSG00000076344 "Regulator of G protein signaling 11" O94810 16 268301-275980 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.0" "Cell line enhanced" "Detected in some" "ASC diff: 3.8;ASC TERT1: 4.1;fHDF/TERT166: 3.6;HHSteC: 5.7;SCLC-21H: 5.5;SH-SY5Y: 4.3;T-47d: 4.7;U-2197: 3.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041692, HPA043039" Uncertain "HPA041692: , HPA043039: " "unprognostic (8.39e-2)" "unprognostic (1.97e-1)" "unprognostic (5.46e-2)" "unprognostic (4.55e-3)" "unprognostic (1.46e-1)" "unprognostic (8.50e-2)" "unprognostic (7.48e-2)" "unprognostic (2.02e-1)" "unprognostic (2.93e-1)" "unprognostic (6.56e-2)" "prognostic favourable (1.24e-4)" "unprognostic (1.70e-1)" "unprognostic (1.48e-3)" "unprognostic (6.91e-3)" "unprognostic (2.27e-1)" "unprognostic (1.20e-1)" "unprognostic (1.04e-1)" 10.9 7.6 10.7 2.0 8.4 0.5 1.9 50.0 19.8 2.4 5.0 14.1 5.3 10.5 2.0 2.9 5.1 2.5 3.4 16.7 11.0 12.7 1.4 0.8 4.3 1.1 9.3 8.3 0.8 17.7 2.1 15.6 4.7 9.7 6.1 1.6 10.4 5.6 5.0 1.7 1.9 7.4 2.5 13.3 2.0 7.9 0.9 7.4 0.0 0.8 0.8 0.6 3.1 2.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.8 4.1 0.0 1.2 0.1 0.0 0.0 0.5 0.1 0.0 2.7 3.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 1.5 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 5.5 4.3 2.5 0.3 0.8 4.7 0.1 3.0 0.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 8.4 50.0 14.8 11.0 12.7 9.3 8.3 9.7 7.4 RGS12 ENSG00000159788 "Regulator of G protein signaling 12" O14924 4 3293028-3439913 "Plasma proteins, Predicted intracellular proteins" Transcription "GTPase activation, Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054646, HPA067421" Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA054646: , HPA067421: " "unprognostic (2.08e-1)" "unprognostic (1.71e-3)" "unprognostic (7.50e-2)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "prognostic favourable (7.03e-4)" "unprognostic (3.43e-2)" "unprognostic (1.93e-1)" "unprognostic (1.76e-1)" "unprognostic (9.02e-2)" "unprognostic (1.70e-2)" "unprognostic (2.13e-1)" "prognostic favourable (8.43e-4)" "unprognostic (2.54e-1)" "unprognostic (2.60e-1)" "unprognostic (5.92e-2)" "unprognostic (1.11e-2)" 4.7 4.4 20.7 4.1 22.0 2.3 4.4 10.2 37.2 5.4 2.9 10.2 1.5 5.3 6.4 5.6 13.5 7.5 4.4 4.7 13.4 5.6 4.4 6.7 6.5 3.4 12.3 16.3 8.9 3.1 3.1 6.1 4.1 9.4 6.8 2.2 3.1 6.5 5.7 6.8 20.6 4.6 3.0 18.9 4.1 3.2 5.5 9.9 4.3 3.8 3.4 3.6 5.5 7.9 1.0 1.5 1.6 3.9 0.4 1.3 0.7 3.9 5.0 10.1 7.3 3.4 2.7 4.2 4.3 3.4 4.4 3.3 4.0 2.4 0.9 2.7 3.7 3.9 2.0 13.6 1.4 0.1 1.6 0.4 2.8 9.8 3.1 0.3 5.6 2.3 9.3 2.3 3.1 9.7 4.6 0.2 4.0 3.4 0.7 10.6 4.8 4.8 10.0 3.9 3.2 2.3 11.8 11.4 11.8 2.7 1.9 9.0 4.6 6.7 7.3 8.6 5.6 1.7 4.5 5.0 3.9 2.2 5.1 5.9 6.1 1.0 1.2 0.3 0.9 3.9 0.3 0.2 0.8 0.5 1.5 1.0 1.3 0.5 1.6 0.4 3.7 0.8 0.6 0.7 20.7 22.0 10.2 37.2 13.4 5.6 12.3 16.3 9.4 9.9 RGS14 ENSG00000169220 "Regulator of G protein signaling 14" O43566 5 177357837-177372601 "Predicted intracellular proteins" "Cell cycle, Cell division" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.9;brain: 76.1" "Cell line enhanced" "Detected in many" "HDLM-2: 39.8;HMC-1: 35.6;NB-4: 15.7;RPMI-8226: 20.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 76.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 11 "amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5" "Group enriched" "Detected in all" 5 "amygdala: 38.0;basal ganglia: 118.5;cerebral cortex: 32.0;hippocampal formation: 90.8" "HPA046847, HPA061819" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments" Nucleoplasm "Vesicles, Plasma membrane, Intermediate filaments" "HPA046847: , HPA061819: " "unprognostic (6.05e-3)" "unprognostic (1.65e-2)" "unprognostic (8.57e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (6.97e-4)" "unprognostic (7.27e-2)" "prognostic unfavourable (1.84e-6)" "unprognostic (1.95e-2)" "unprognostic (4.34e-2)" "unprognostic (2.04e-3)" "unprognostic (2.71e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-2)" "unprognostic (2.78e-2)" 1.9 1.5 7.7 12.5 76.1 17.5 1.3 0.4 8.8 1.7 2.6 1.9 0.6 5.1 1.3 1.4 3.2 6.6 3.4 0.7 17.1 1.9 2.1 6.9 4.3 15.5 2.5 3.6 0.8 1.5 0.1 0.9 1.0 0.8 1.2 0.5 0.7 5.2 1.8 1.6 3.5 5.7 1.2 0.7 12.8 3.7 0.7 4.4 24.2 4.3 1.7 12.9 4.9 1.6 9.2 12.2 43.9 12.3 6.5 20.7 12.4 1.8 0.4 0.7 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.2 1.1 3.7 4.7 2.6 0.0 3.8 0.0 1.2 0.0 39.8 0.1 7.4 0.1 1.5 0.2 5.7 35.6 0.6 0.3 0.2 0.2 0.2 1.2 9.6 0.0 0.1 7.6 15.7 0.6 1.0 3.5 0.0 20.5 0.4 0.1 0.1 0.7 0.0 0.1 3.0 1.3 9.0 0.3 0.0 0.7 0.0 3.4 5.1 2.4 2.0 0.6 10.8 0.8 18.6 12.3 43.9 20.5 11.4 20.7 9.2 19.1 18.7 12.2 8.0 16.0 14.3 43.0 6.5 11.6 5.4 18.2 12.4 7.7 76.1 0.4 8.8 17.1 1.9 2.5 3.6 0.8 4.4 RGS17 "RGS-17, RGSZ2" ENSG00000091844 "Regulator of G protein signaling 17" Q9UGC6 6 153004459-153131249 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell line enhanced" "Detected in many" "ASC TERT1: 13.0;hTERT-HME1: 14.0;LHCN-M2: 13.9;RH-30: 10.0;U-87 MG: 11.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022276, HPA056493" Approved Approved Vesicles Vesicles "HPA022276: AB_10794628, HPA056493: " "unprognostic (2.77e-2)" "unprognostic (6.81e-2)" "unprognostic (3.11e-1)" "unprognostic (1.99e-1)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (1.03e-3)" "unprognostic (3.12e-1)" "unprognostic (3.79e-2)" "unprognostic (7.95e-3)" "unprognostic (1.92e-1)" "unprognostic (5.33e-2)" "unprognostic (5.96e-12)" "unprognostic (2.70e-2)" "unprognostic (2.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" 3.0 1.3 14.2 1.5 12.5 3.3 1.4 16.8 10.1 7.1 1.5 1.2 0.0 1.7 2.2 1.1 3.2 1.3 5.9 1.0 8.1 7.3 0.9 0.6 1.4 1.6 3.2 7.8 2.7 4.4 0.3 7.2 0.6 7.9 5.2 2.0 0.2 1.5 1.6 0.6 1.9 1.8 1.4 4.1 1.2 4.3 3.3 3.0 0.3 8.9 0.0 0.6 3.7 1.5 0.5 0.4 1.4 0.3 2.1 1.6 0.2 0.0 4.3 3.2 0.1 1.5 13.0 0.1 0.3 1.4 1.0 2.7 0.0 0.3 0.2 0.3 0.7 0.2 3.0 3.2 1.5 0.2 0.3 0.5 0.3 0.1 3.5 0.2 1.5 5.5 0.0 5.5 14.0 6.4 0.1 0.2 13.9 2.3 0.1 0.3 2.2 3.5 0.1 10.0 0.1 4.0 1.3 2.2 5.9 0.1 0.0 0.0 0.0 0.2 3.2 2.2 2.7 2.7 3.9 0.2 0.0 0.1 11.8 0.1 3.0 1.4 0.3 0.4 1.6 0.2 0.2 0.2 0.9 0.6 0.2 0.5 0.3 0.9 1.1 2.1 0.3 0.4 0.2 0.2 14.2 12.5 16.8 10.1 8.1 7.3 3.2 7.8 7.9 3.0 RGS20 "RGSZ1, ZGAP1" ENSG00000147509 "Regulator of G protein signaling 20" O76081 8 53851808-53959303 "Plasma proteins, Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 20.0" "Cell line enhanced" "Detected in many" "AF22: 12.5;SK-MEL-30: 19.0;U-87 MG: 18.9" "Cancer enhanced" "Detected in many" "melanoma: 12.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070193 Enhanced "HPA070193: " "unprognostic (2.14e-2)" "unprognostic (2.87e-2)" "unprognostic (1.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.48e-1)" "unprognostic (4.97e-2)" "unprognostic (1.91e-5)" "unprognostic (5.03e-5)" "unprognostic (2.15e-1)" "unprognostic (1.57e-2)" "unprognostic (8.86e-3)" "unprognostic (5.28e-2)" "unprognostic (2.75e-8)" "unprognostic (3.71e-3)" "unprognostic (9.78e-3)" "unprognostic (8.32e-2)" "unprognostic (1.69e-2)" 0.7 0.6 12.4 0.7 20.0 0.6 1.0 3.8 17.6 0.9 0.6 1.3 0.0 0.6 0.8 0.6 1.8 0.6 0.6 0.6 6.2 2.2 0.6 0.6 0.7 0.6 1.9 5.6 0.8 0.6 0.6 0.0 3.8 1.4 0.6 0.6 4.7 0.7 0.6 0.6 3.1 0.6 0.6 1.5 0.6 0.6 0.9 2.9 0.0 4.1 1.4 1.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 6.4 12.5 0.2 0.4 1.5 0.0 5.0 2.9 4.4 2.6 0.0 5.6 0.0 0.2 1.4 6.7 0.2 8.1 2.9 0.0 0.9 1.5 1.0 1.1 2.0 0.0 0.6 0.3 5.3 3.5 10.5 1.7 0.4 0.0 7.2 0.0 0.0 0.3 0.2 2.5 0.0 0.4 0.0 8.5 0.6 7.8 0.7 0.4 0.0 19.0 0.0 0.0 5.4 1.1 0.0 9.3 3.7 1.5 0.0 0.0 18.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 20.0 3.8 8.2 6.2 2.2 1.9 5.6 1.4 2.9 RGS4 SCZD9 ENSG00000117152 "Regulator of G protein signaling 4" P49798 1 163068775-163076802 "Disease related genes, Predicted intracellular proteins" "Signal transduction inhibitor" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 88.0" "Cell line enhanced" "Detected in many" "LHCN-M2: 37.4;SH-SY5Y: 74.4;TIME: 151.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030802 Approved "Intermediate filaments" "Intermediate filaments" "HPA030802: AB_10602295" "unprognostic (1.03e-1)" "unprognostic (1.84e-1)" "unprognostic (3.02e-2)" "unprognostic (6.84e-2)" "prognostic unfavourable (2.62e-4)" "unprognostic (8.26e-2)" "unprognostic (1.27e-1)" "unprognostic (5.34e-3)" "unprognostic (1.82e-1)" "unprognostic (6.45e-2)" "unprognostic (2.12e-2)" "unprognostic (8.47e-2)" "prognostic unfavourable (3.97e-4)" "prognostic unfavourable (1.92e-4)" "unprognostic (1.00e-1)" "unprognostic (8.33e-2)" "unprognostic (2.30e-2)" 2.9 20.9 9.1 2.1 45.3 0.5 1.4 1.1 88.0 4.0 1.7 1.0 0.0 2.9 4.8 1.4 6.3 4.9 11.2 4.7 13.9 10.1 1.5 2.6 2.1 2.3 12.1 36.2 1.1 2.7 1.2 6.2 1.3 16.0 3.3 1.8 1.0 0.9 3.9 0.7 0.6 1.6 3.0 1.9 1.5 3.7 2.1 2.1 0.0 1.5 0.2 0.7 2.8 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 3.7 19.2 0.0 12.9 14.1 1.9 5.0 0.0 0.0 0.0 5.7 8.3 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.1 0.0 20.4 2.5 19.7 0.0 0.0 37.4 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 74.4 0.0 0.0 0.0 0.0 0.0 151.8 15.4 0.7 3.0 21.5 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.1 45.3 1.1 78.8 13.9 10.1 12.1 36.2 16.0 2.1 RGS6 ENSG00000182732 "Regulator of G protein signaling 6" P49758 14 71932439-72566529 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8" "Group enriched" "Detected in some" 7 "HEL: 8.1;Karpas-707: 29.3" "Group enriched" "Detected in some" 7 "glioma: 3.1;thyroid cancer: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.6;T-reg: 1.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003067 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA003067: AB_1079807" "unprognostic (7.18e-2)" "unprognostic (7.78e-2)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (5.61e-2)" "unprognostic (3.80e-2)" "unprognostic (1.24e-4)" "unprognostic (7.83e-2)" "unprognostic (2.03e-1)" "unprognostic (8.17e-2)" "unprognostic (1.30e-1)" "unprognostic (2.06e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-2)" "unprognostic (8.06e-3)" "unprognostic (2.10e-1)" "unprognostic (3.68e-2)" 6.9 0.8 8.6 1.1 11.1 2.0 4.9 4.0 18.0 7.9 1.8 2.8 0.3 0.8 2.7 4.2 1.0 3.6 1.9 15.7 3.7 7.5 3.3 0.6 1.7 0.5 15.4 9.3 2.3 0.6 10.9 2.6 4.6 20.8 0.7 1.8 1.3 1.3 2.5 1.7 1.4 1.4 2.2 5.2 1.5 0.8 13.9 2.4 0.0 8.5 0.3 1.0 1.1 1.3 0.5 0.4 1.6 0.2 0.6 1.2 4.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 29.3 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.6 0.0 0.4 1.2 4.1 8.6 11.1 4.0 18.0 3.7 7.5 15.4 9.3 20.8 2.4 RGS7 ENSG00000182901 "Regulator of G protein signaling 7" P49802 1 240775515-241357230 "Plasma proteins, Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.5;brain: 38.1" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 7.0;HaCaT: 6.8;hTERT-HME1: 8.3;RH-30: 7.3;SH-SY5Y: 6.4;U-2 OS: 7.3;U-251 MG: 7.9" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017561 Enhanced Supported Mitochondria,Cytosol Cytosol Mitochondria "CAB017561: AB_2285043" "unprognostic (6.48e-2)" "unprognostic (4.30e-2)" "unprognostic (4.67e-2)" "unprognostic (6.65e-2)" "unprognostic (7.84e-3)" "unprognostic (4.09e-2)" "unprognostic (1.49e-2)" "unprognostic (3.61e-1)" "unprognostic (1.42e-2)" "unprognostic (2.51e-4)" "unprognostic (3.54e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-1)" "unprognostic (2.64e-2)" "unprognostic (2.28e-1)" 0.7 11.5 9.1 0.8 18.3 0.7 0.9 27.6 38.1 0.9 0.8 1.6 1.7 1.0 1.0 0.8 0.9 0.7 1.3 0.7 11.5 8.3 4.2 0.8 0.9 1.1 3.6 8.9 1.3 1.4 0.7 2.8 0.7 4.7 0.8 0.9 1.3 0.7 1.4 0.7 0.9 0.9 0.7 1.4 1.0 4.6 7.8 1.8 0.0 0.7 0.0 1.0 0.7 0.1 0.7 3.6 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.3 0.9 0.0 2.7 5.2 7.0 0.5 0.0 0.0 0.0 0.4 3.6 6.8 0.0 0.1 3.5 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.3 0.5 0.0 0.0 2.2 0.0 0.0 0.0 3.8 0.2 0.0 7.3 0.0 0.0 0.0 5.9 6.4 0.4 0.3 0.3 0.0 0.0 2.8 0.0 7.3 0.4 7.9 0.0 4.2 0.0 1.1 0.0 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 9.1 18.3 27.6 20.7 11.5 8.3 3.6 8.9 4.7 1.8 RGS7BP R7BP ENSG00000186479 "Regulator of G protein signaling 7 binding protein" Q6MZT1 5 64506257-64612312 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.1" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 15.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039600 Approved Uncertain "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane, Cytosol" "Actin filaments" "HPA039600: " "unprognostic (2.93e-1)" "unprognostic (3.39e-1)" "unprognostic (7.35e-2)" "unprognostic (4.77e-2)" "unprognostic (7.57e-2)" "unprognostic (8.59e-2)" "unprognostic (5.22e-2)" "unprognostic (8.81e-3)" "unprognostic (1.86e-2)" "unprognostic (7.64e-2)" "unprognostic (5.49e-3)" "unprognostic (1.83e-1)" "unprognostic (1.65e-3)" "unprognostic (3.39e-3)" "unprognostic (2.06e-3)" "unprognostic (6.46e-2)" "unprognostic (8.50e-3)" 2.8 4.7 10.2 1.1 22.6 0.4 1.1 10.4 31.1 6.0 1.3 1.5 0.5 1.6 3.7 5.7 2.7 10.9 2.7 3.7 10.8 4.3 3.3 1.7 2.2 0.8 4.0 16.0 3.8 0.8 0.7 1.7 0.4 8.2 7.8 1.4 1.8 2.7 10.9 0.7 1.0 1.7 2.3 1.9 1.3 1.5 1.5 6.7 0.0 1.0 0.0 0.6 2.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 22.6 10.4 25.1 10.8 4.3 4.0 16.0 8.2 6.7 RGS8 "MGC119067, MGC119068, MGC119069" ENSG00000135824 "Regulator of G protein signaling 8" P57771 1 182641816-182684576 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 29.8;thyroid gland: 15.0" "Cell line enhanced" "Detected in some" "AF22: 6.5;Daudi: 2.3;SCLC-21H: 18.1;U-698: 3.7" "Group enriched" "Detected in some" 13 "glioma: 0.6;testis cancer: 0.8;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in all" "cerebellum: 477.3" "Low region specificity" "Detected in all" HPA076764 Enhanced "HPA076764: " "unprognostic (6.75e-2)" "unprognostic (2.62e-1)" "unprognostic (1.03e-1)" "unprognostic (9.29e-5)" "unprognostic (2.60e-1)" "unprognostic (2.37e-1)" "unprognostic (9.29e-3)" "unprognostic (1.16e-1)" "unprognostic (3.78e-1)" "unprognostic (2.40e-1)" "unprognostic (3.23e-2)" "unprognostic (7.08e-2)" "unprognostic (2.98e-2)" "unprognostic (6.37e-2)" "unprognostic (1.02e-1)" 0.3 2.6 2.0 0.4 23.3 0.3 0.3 3.7 7.5 0.3 0.3 2.7 0.0 0.5 0.3 0.4 0.5 0.3 0.5 0.3 1.4 3.3 0.4 0.4 0.4 0.6 3.9 2.0 1.2 0.3 0.3 0.5 0.3 29.8 0.3 0.4 1.3 0.6 0.3 0.3 0.3 0.3 0.6 2.6 0.3 0.4 5.7 7.1 0.0 15.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 3.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 23.3 3.7 3.5 1.4 3.3 3.9 2.0 29.8 7.1 RGS9 "MGC111763, MGC26458, PERRS, RGS9L" ENSG00000108370 "Regulator of G protein signaling 9" O75916 17 65100812-65227703 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.3" "Group enriched" "Detected in some" 8 "HDLM-2: 22.9;HEL: 9.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "basal ganglia: 47.3" "Group enriched" "Detected in many" 6 "gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7" "Group enriched" "Detected in many" 74 "NK-cells: 3.7;T-cells: 11.0" "Region enriched" "Detected in many" 9 "basal ganglia: 222.4" "Region enriched" "Detected in many" 9 "basal ganglia: 79.8" "HPA013550, HPA014137" Enhanced Supported Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA013550: , HPA014137: " "unprognostic (4.43e-3)" "unprognostic (7.49e-3)" "unprognostic (5.12e-2)" "unprognostic (3.09e-5)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.20e-1)" "unprognostic (4.88e-2)" "prognostic favourable (1.35e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-2)" "unprognostic (4.94e-2)" "unprognostic (3.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.49e-1)" 1.1 1.9 3.3 4.4 47.3 1.0 2.3 4.1 8.9 3.4 5.2 7.2 2.7 3.3 4.2 7.2 4.1 9.5 3.9 1.3 5.4 7.4 2.0 5.0 5.9 5.3 3.5 3.7 6.7 3.7 7.3 7.9 3.0 4.5 8.6 3.4 24.1 3.2 9.2 1.6 1.5 3.6 4.0 3.4 4.3 3.7 1.7 6.6 0.4 4.2 0.5 7.5 5.1 2.4 0.0 0.0 0.0 0.0 3.7 11.0 1.4 0.2 0.0 1.0 0.1 0.1 0.2 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.7 1.6 0.0 0.1 0.0 0.1 0.2 22.9 0.5 9.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 2.8 0.0 1.0 7.4 0.0 0.0 0.0 3.6 0.0 3.7 0.0 0.0 0.0 1.4 3.3 47.3 4.1 4.5 5.4 7.4 3.5 3.7 4.5 6.6 RHBDL1 "RHBDL, RRP" ENSG00000103269 "Rhomboid like 1" O75783 16 675666-678268 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3" "Cell line enhanced" "Detected in many" "HeLa: 9.1;MCF7: 9.6;U-266/70: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 3.4" "Group enriched" "Detected in many" 20 "B-cells: 2.2;NK-cells: 1.3;T-cells: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030359, HPA030360, HPA046593" Uncertain Approved Nucleoplasm Nucleoplasm "HPA030359: , HPA030360: , HPA046593: " "prognostic favourable (8.12e-4)" "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.45e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-2)" "unprognostic (3.27e-2)" "unprognostic (1.94e-1)" "unprognostic (2.78e-1)" "unprognostic (6.60e-3)" "unprognostic (2.74e-2)" "unprognostic (3.97e-2)" "unprognostic (5.63e-3)" "unprognostic (5.89e-2)" "unprognostic (1.27e-1)" "unprognostic (8.30e-3)" "unprognostic (1.49e-2)" 1.7 6.3 10.0 1.1 8.3 2.3 0.7 21.3 14.5 1.3 2.2 1.3 2.2 5.8 1.3 1.7 1.1 1.0 1.2 2.4 8.4 9.9 3.9 1.2 0.8 1.1 5.5 7.2 0.9 6.2 2.2 4.4 1.1 4.6 1.5 1.1 1.5 6.1 2.6 0.8 3.1 5.9 0.7 2.2 0.6 4.5 2.2 1.9 0.7 0.6 0.6 0.5 0.8 0.5 2.2 0.1 0.0 0.0 1.3 3.4 0.7 1.7 2.3 1.3 2.0 1.0 2.6 6.7 0.8 1.2 0.4 0.1 4.7 1.3 0.7 1.6 0.5 1.2 0.1 0.4 0.0 1.7 8.5 1.0 9.1 1.9 0.9 1.7 1.3 1.8 3.2 0.3 0.0 0.1 1.3 1.3 0.1 9.6 0.4 4.6 1.2 0.7 8.1 1.2 1.7 0.1 1.6 1.6 2.2 1.0 0.5 2.2 3.5 4.8 0.5 2.8 2.6 0.9 0.6 11.7 1.6 2.3 1.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.4 0.3 0.0 0.5 0.5 0.2 0.0 1.3 0.0 0.1 1.2 0.7 10.0 8.3 21.3 14.5 8.4 9.9 5.5 7.2 4.6 1.9 RHBDL3 "RHBDL4, VRHO" ENSG00000141314 "Rhomboid like 3" P58872 17 32266176-32324661 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7" "Cell line enhanced" "Detected in some" "A549: 5.9;AF22: 5.9;AN3-CA: 4.7;HDLM-2: 8.1;NTERA-2: 8.8;U-2 OS: 6.2" "Cancer enhanced" "Detected in some" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA059607 Uncertain "HPA059607: " "unprognostic (7.70e-2)" "unprognostic (3.71e-2)" "unprognostic (2.36e-2)" "unprognostic (6.95e-2)" "unprognostic (2.91e-1)" "unprognostic (2.83e-2)" "unprognostic (2.22e-1)" "unprognostic (1.93e-1)" "unprognostic (1.85e-3)" "unprognostic (1.13e-1)" "unprognostic (1.82e-3)" "unprognostic (1.75e-2)" "unprognostic (4.19e-2)" "unprognostic (2.18e-3)" "unprognostic (2.11e-1)" "unprognostic (1.23e-1)" "unprognostic (8.87e-2)" 1.0 8.2 6.8 1.2 7.4 0.7 1.1 11.3 23.7 1.4 1.2 2.9 3.3 0.9 2.0 1.9 1.3 4.4 0.9 9.7 10.1 6.6 0.8 0.6 0.7 0.7 9.1 4.6 3.4 1.1 0.6 1.9 1.0 6.7 2.1 1.4 3.9 1.0 5.6 0.6 0.9 0.9 1.8 3.6 0.6 0.9 2.5 4.0 0.0 0.6 0.0 0.8 1.9 1.1 0.8 0.0 0.0 0.0 0.0 0.3 0.3 0.0 5.9 5.9 4.7 0.9 0.0 0.1 0.3 0.6 1.9 2.0 0.1 0.0 0.0 0.4 0.7 0.1 1.6 0.0 0.5 8.1 2.3 1.0 4.0 0.3 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.5 0.1 0.2 0.0 8.8 0.0 1.0 0.0 0.0 0.0 3.2 0.1 1.6 0.8 0.1 0.1 0.4 0.1 0.0 0.0 6.2 0.3 3.0 0.0 0.0 0.0 0.3 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 6.8 7.4 11.3 15.6 10.1 6.6 9.1 4.6 6.7 4.0 RHBG SLC42A2 ENSG00000132677 "Rh family B glycoprotein (gene/pseudogene)" Q9H310 1 156369212-156385219 "Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 23.2;kidney: 16.9;ovary: 5.9" "Group enriched" "Detected in some" 65 "CACO-2: 4.7;Hep G2: 5.6;RT4: 9.7" "Group enriched" "Detected in some" 5 "liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1" "Region enriched" "Detected in some" 15 "cerebellum: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042726, HPA048489" Enhanced Approved Nucleoplasm Nucleoplasm "HPA042726: , HPA048489: " "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" "unprognostic (4.55e-3)" "unprognostic (5.04e-2)" "unprognostic (2.95e-2)" "unprognostic (3.76e-3)" "unprognostic (2.00e-1)" "unprognostic (1.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.45e-1)" "unprognostic (3.72e-1)" "unprognostic (3.63e-2)" "unprognostic (4.91e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-3)" "prognostic favourable (8.06e-4)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 23.2 0.1 0.3 0.3 0.0 1.0 0.0 0.1 0.0 2.2 0.0 0.0 0.1 0.1 0.1 16.9 3.3 0.1 0.0 0.1 0.1 5.9 0.2 0.0 0.1 0.0 1.5 0.1 0.0 0.0 0.1 0.4 0.1 1.0 0.3 0.0 0.1 0.1 0.1 1.2 0.0 0.0 0.1 1.1 1.2 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 23.2 0.1 0.1 0.1 0.1 0.1 1.5 0.0 RHEBL1 "FLJ25797, MGC34869, RHEB2" ENSG00000167550 "RHEB like 1" Q8TAI7 12 49064685-49070025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.6;brain: 9.5" "Cell line enhanced" "Detected in many" "HDLM-2: 16.3;U-266/84: 32.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.1;granulocytes: 10.6;T-cells: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA053111, HPA061001" Uncertain Uncertain Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA053111: , HPA061001: " "unprognostic (2.94e-1)" "unprognostic (1.11e-3)" "unprognostic (2.36e-2)" "unprognostic (9.81e-3)" "unprognostic (8.76e-2)" "unprognostic (2.03e-2)" "unprognostic (3.03e-5)" "unprognostic (9.13e-2)" "unprognostic (9.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.98e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-10)" "unprognostic (4.67e-2)" "unprognostic (1.11e-1)" "unprognostic (7.66e-2)" "unprognostic (2.07e-1)" 1.6 0.6 3.6 2.7 2.0 4.0 2.3 4.0 9.5 0.8 1.1 0.4 1.3 1.1 3.3 2.5 0.9 5.5 1.0 1.4 2.2 2.7 0.9 0.7 2.6 6.8 2.0 5.1 1.0 0.6 0.2 0.7 1.4 1.9 0.5 1.8 0.4 1.0 1.3 0.6 5.6 1.8 1.0 1.2 5.2 1.2 3.0 0.9 2.5 0.8 0.0 3.9 1.0 4.1 3.1 0.9 10.6 1.6 1.3 10.1 1.2 0.9 1.9 1.2 2.8 0.7 0.1 1.1 0.9 2.7 5.0 5.6 1.8 1.6 2.8 0.8 0.2 0.7 0.8 1.0 2.2 16.3 0.1 2.7 1.4 0.9 0.6 1.0 5.7 0.3 0.4 2.5 0.8 1.9 3.4 7.9 1.9 0.8 1.2 6.6 1.8 2.8 2.6 1.7 4.3 0.4 0.1 0.6 1.7 0.7 0.7 4.4 0.3 1.8 1.0 1.5 2.6 3.0 0.9 9.6 32.6 1.6 1.3 4.0 0.6 10.6 0.3 0.7 7.3 1.6 10.1 1.9 3.1 3.9 0.7 3.1 1.0 3.8 0.6 1.3 1.4 0.9 6.1 1.2 3.6 2.0 4.0 9.5 2.2 2.7 2.0 5.1 1.9 0.9 RHOU "ARHU, CDC42L1, DJ646B12.2, fJ646B12.2, FLJ10616, hG28K, WRCH-1, WRCH1" ENSG00000116574 "Ras homolog family member U" Q7L0Q8 1 228735077-228746669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.8" "Cell line enhanced" "Detected in many" "BEWO: 41.0;MOLT-4: 18.0;RT4: 17.4;THP-1: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049592 Approved "HPA049592: " "unprognostic (7.90e-2)" "unprognostic (1.18e-2)" "unprognostic (1.76e-2)" "unprognostic (8.26e-3)" "unprognostic (3.26e-2)" "unprognostic (2.57e-1)" "unprognostic (3.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.47e-2)" "unprognostic (2.00e-1)" "unprognostic (1.53e-1)" "unprognostic (6.21e-2)" "prognostic favourable (3.56e-5)" "unprognostic (4.20e-1)" "unprognostic (1.69e-1)" "unprognostic (1.52e-1)" "unprognostic (1.87e-2)" 15.3 8.7 21.4 6.0 27.8 7.6 15.9 3.2 23.4 15.9 15.2 58.8 11.0 24.0 9.0 8.5 6.9 16.4 25.5 8.0 28.2 13.8 3.9 26.6 8.4 5.7 32.1 16.5 16.5 19.1 21.1 4.7 17.9 24.5 13.4 10.9 9.5 12.1 12.1 21.0 3.9 26.2 9.3 37.3 10.4 14.5 8.8 30.5 1.1 12.6 1.7 1.7 12.7 8.9 0.0 1.6 1.3 1.8 0.5 3.1 0.5 0.4 1.0 3.2 0.2 0.7 0.4 41.0 0.2 0.3 0.2 0.1 4.3 6.0 0.0 2.4 0.5 0.2 1.2 0.0 0.2 6.3 2.3 0.0 0.3 1.3 4.6 3.1 0.3 0.2 0.3 0.1 0.2 0.0 0.0 0.0 0.2 1.0 18.0 3.3 1.0 0.4 0.1 1.0 0.5 0.1 17.4 1.2 3.6 0.3 2.7 0.0 0.0 11.9 0.3 0.0 0.5 0.0 0.0 0.9 4.0 0.0 0.0 8.1 2.1 0.0 1.2 1.3 1.6 1.8 3.1 0.0 1.2 2.2 1.6 0.0 0.2 0.9 0.1 0.5 0.7 1.5 0.0 0.5 21.4 27.8 3.2 23.4 28.2 13.8 32.1 16.5 24.5 30.5 RHOXF1 "OTEX, PEPP1" ENSG00000101883 "Rhox homeobox family member 1" Q8NHV9 X 120109053-120115937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 8.1;brain: 9.2;testis: 27.8" "Cell line enhanced" "Detected in some" "HDLM-2: 3.1;HEK 293: 3.8;NB-4: 2.7" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 9.2" "Cell type enriched" "Detected in some" 6 "T-reg: 8.1" "Lineage enriched" "Detected in single" 30 "T-cells: 8.1" HPA056506 Approved "HPA056506: " "unprognostic (5.03e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (2.31e-2)" "unprognostic (8.65e-2)" "unprognostic (1.07e-3)" "unprognostic (2.46e-1)" "unprognostic (3.15e-1)" "unprognostic (3.89e-1)" "unprognostic (2.15e-1)" "unprognostic (7.50e-4)" "unprognostic (1.97e-1)" "unprognostic (5.85e-4)" "unprognostic (3.00e-1)" "unprognostic (7.96e-2)" "unprognostic (2.26e-1)" "unprognostic (1.73e-3)" 2.8 0.5 0.9 0.5 1.1 0.3 0.9 9.2 1.7 0.5 0.7 0.5 0.5 0.2 0.5 0.5 0.5 1.5 0.5 0.5 0.8 2.4 0.8 0.5 0.5 0.6 0.8 0.5 2.2 0.5 0.8 0.9 1.1 0.5 0.5 0.1 0.5 0.8 0.6 0.5 2.4 0.5 0.5 0.5 0.5 0.2 27.8 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 3.1 3.8 0.4 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.2 8.1 0.0 0.9 1.1 9.2 1.7 0.8 2.4 0.8 0.5 0.5 0.5 RIBC1 FLJ32783 ENSG00000158423 "RIB43A domain with coiled-coils 1" Q8N443 X 53422690-53431120 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 12.7;fallopian tube: 24.5;testis: 37.6" "Cell line enhanced" "Detected in many" "HeLa: 8.4;T-47d: 11.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 12.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA001150 Approved "Nuclear bodies" "Nuclear bodies" "HPA001150: " "unprognostic (1.08e-2)" "prognostic favourable (1.90e-5)" "unprognostic (1.25e-1)" "prognostic favourable (9.66e-4)" "unprognostic (1.11e-1)" "unprognostic (2.39e-3)" "unprognostic (9.88e-2)" "unprognostic (3.97e-4)" "unprognostic (2.25e-2)" "unprognostic (7.89e-3)" "unprognostic (3.79e-2)" "unprognostic (4.99e-2)" "unprognostic (1.78e-1)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" 0.6 2.9 2.0 1.3 3.7 0.4 1.3 0.5 1.4 1.8 0.7 5.3 0.8 0.7 2.1 5.4 1.1 24.5 1.4 1.1 2.5 3.0 2.3 0.3 2.9 0.6 1.3 1.4 5.5 1.6 1.9 5.0 0.5 12.7 1.1 0.4 2.4 1.9 1.5 0.5 1.0 0.7 0.5 1.4 0.6 0.7 37.6 1.2 0.3 3.1 0.2 0.5 0.8 0.5 1.5 1.0 2.9 1.5 3.7 2.3 1.1 1.9 5.2 2.0 1.4 0.7 1.3 1.2 0.5 0.3 1.1 1.0 2.0 3.2 1.9 3.6 0.2 3.6 0.5 1.1 1.5 1.1 3.3 1.1 8.4 0.9 0.3 1.1 2.0 0.4 0.4 3.1 0.7 0.9 0.8 2.3 0.7 1.3 2.2 1.0 2.5 1.4 1.6 1.4 1.5 3.1 1.0 4.5 0.8 5.1 1.9 1.2 11.6 0.5 0.6 0.6 2.6 1.5 0.7 2.4 1.6 1.1 2.1 0.4 0.9 0.0 0.7 0.0 0.3 1.2 2.3 0.2 0.9 1.9 1.0 1.5 0.4 0.4 2.9 3.7 1.5 0.8 1.9 1.1 2.0 3.7 0.5 1.4 2.5 3.0 1.3 1.4 12.7 1.2 RIBC2 "C22orf11, DKFZp566F0546, FLJ25720" ENSG00000128408 "RIB43A domain with coiled-coils 2" 22 45413691-45432496 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.9;fallopian tube: 10.9;testis: 35.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 7.8;MCF7: 9.0;SiHa: 13.2" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 2.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Region enhanced" "Detected in many" "midbrain: 8.5" HPA003210 Approved "HPA003210: AB_1078347" "unprognostic (2.55e-1)" "prognostic favourable (7.08e-8)" "unprognostic (3.58e-1)" "unprognostic (1.53e-2)" "unprognostic (1.24e-1)" "unprognostic (1.71e-2)" "unprognostic (1.30e-3)" "unprognostic (9.51e-3)" "unprognostic (7.21e-3)" "unprognostic (7.34e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (9.95e-5)" "unprognostic (1.41e-1)" "unprognostic (5.32e-2)" "unprognostic (7.91e-2)" "unprognostic (1.13e-1)" 0.0 0.1 0.7 0.6 6.5 1.9 0.2 0.0 3.2 1.0 0.5 3.1 0.0 0.3 0.6 2.2 0.6 10.9 0.9 0.0 2.4 0.0 0.0 1.0 0.4 0.0 1.0 1.5 0.1 2.2 8.7 0.4 10.9 0.7 0.2 0.3 0.0 0.1 0.0 0.9 0.5 0.1 0.0 0.1 0.5 35.3 1.9 1.8 0.5 0.0 0.9 0.2 0.0 0.6 2.0 0.2 0.7 0.0 1.4 0.2 5.8 4.1 0.6 0.0 0.0 0.0 0.6 7.7 0.7 1.5 2.2 4.2 7.8 0.0 1.9 0.7 6.9 0.0 0.0 1.2 0.0 0.2 0.0 5.8 0.2 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.5 9.0 3.9 2.0 0.9 2.3 4.4 0.0 0.0 2.2 0.8 4.0 0.0 13.2 2.7 0.0 4.9 2.8 0.4 0.0 0.0 4.7 0.0 2.3 2.3 0.0 0.0 1.2 3.6 0.0 0.7 0.2 0.0 0.0 0.0 0.6 0.3 1.3 2.0 0.1 0.0 0.5 0.0 0.0 0.0 1.0 1.4 0.2 RILPL1 FLJ39378 ENSG00000188026 "Rab interacting lysosomal protein like 1" Q5EBL4 12 123470054-123533718 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 21.1;heart muscle: 43.8;skeletal muscle: 66.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041314 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA041314: AB_10795587" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (3.71e-2)" "unprognostic (5.36e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-3)" "unprognostic (1.94e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (2.30e-2)" "unprognostic (8.30e-2)" "unprognostic (4.25e-2)" "unprognostic (2.98e-1)" "unprognostic (2.32e-1)" "unprognostic (6.07e-3)" "unprognostic (2.81e-1)" 6.1 5.7 9.9 3.5 12.3 3.0 3.7 5.2 11.3 4.8 4.7 12.6 4.4 2.1 6.6 5.0 4.8 5.0 4.3 43.8 9.6 7.5 3.8 3.0 5.5 2.3 21.1 5.8 7.2 3.2 5.7 3.6 7.1 11.1 6.2 2.2 4.9 8.0 7.8 66.2 6.2 2.7 9.8 14.4 3.8 3.0 2.9 15.1 0.3 8.2 9.7 1.9 4.7 5.3 1.6 1.2 4.6 1.2 1.2 2.0 0.7 6.0 8.5 7.7 6.0 8.7 8.2 8.1 10.9 6.1 6.0 5.3 5.3 1.4 0.3 5.5 10.6 6.6 5.7 5.2 2.4 6.1 10.4 0.8 5.5 7.7 15.2 0.3 2.3 9.3 10.4 6.7 9.7 6.0 4.8 0.4 6.0 10.0 0.7 1.9 5.6 9.0 1.0 4.2 0.3 4.2 6.3 1.2 7.2 5.8 5.1 13.0 6.8 0.2 12.0 7.8 3.9 11.3 6.9 1.3 0.6 0.2 8.0 0.1 4.9 1.4 1.0 0.7 0.9 0.5 0.8 0.9 1.0 0.8 0.3 1.6 2.0 1.6 4.6 1.2 1.2 1.2 0.9 0.7 9.9 12.3 5.2 9.9 9.6 7.5 21.1 5.8 11.1 15.1 RIMBP2 "KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2" ENSG00000060709 "RIMS binding protein 2" O15034 12 130396137-130716281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;parathyroid gland: 49.1;pituitary gland: 42.7" "Group enriched" "Detected in some" 6 "SCLC-21H: 17.2;SH-SY5Y: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive B-cell: 2.7" "Lineage enriched" "Detected in single" 28 "B-cells: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041494, HPA044114" Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA041494: , HPA044114: " "unprognostic (4.15e-4)" "unprognostic (9.77e-3)" "unprognostic (1.20e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-3)" "unprognostic (3.63e-1)" "unprognostic (1.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (6.82e-3)" "prognostic favourable (4.16e-4)" "unprognostic (2.86e-1)" "unprognostic (6.41e-3)" "unprognostic (5.27e-2)" "unprognostic (2.07e-1)" "unprognostic (1.03e-1)" "unprognostic (4.73e-2)" 0.9 11.9 14.1 1.1 13.0 0.6 0.6 1.1 24.7 6.1 1.5 1.6 0.0 2.5 2.5 2.4 0.8 6.6 1.1 0.4 15.3 11.0 2.8 0.6 0.7 0.5 5.6 12.9 2.1 2.3 49.1 42.7 0.4 4.9 1.3 1.8 4.1 0.6 1.4 0.5 2.4 2.3 2.3 5.6 1.1 5.2 2.3 1.6 0.0 0.9 0.0 0.5 0.8 0.7 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.2 4.1 0.0 0.0 17.2 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 13.0 1.1 24.7 15.3 11.0 5.6 12.9 4.9 1.6 RIMKLA "FAM80A, MGC47816, NAAGS-II, RP11-157D18.1" ENSG00000177181 "Ribosomal modification protein rimK like family member A" Q8IXN7 1 42380795-42422578 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.1" "Cell line enhanced" "Detected in some" "AN3-CA: 7.8;Karpas-707: 9.0;SCLC-21H: 11.8;U-266/70: 8.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027826 Uncertain Uncertain "Nucleoli fibrillar center" "Nucleoli fibrillar center" "HPA027826: AB_10603992" "unprognostic (4.04e-2)" "unprognostic (1.61e-1)" "unprognostic (3.68e-3)" "unprognostic (9.84e-2)" "unprognostic (2.49e-2)" "unprognostic (1.06e-1)" "unprognostic (2.63e-3)" "prognostic favourable (1.43e-4)" "unprognostic (8.89e-2)" "unprognostic (3.76e-1)" "unprognostic (9.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.22e-3)" "unprognostic (3.99e-2)" "unprognostic (7.07e-2)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" 0.9 1.2 6.2 1.5 10.4 0.8 1.3 7.8 18.4 1.0 7.9 1.7 0.0 1.4 1.0 0.8 1.0 0.9 1.8 8.5 7.5 5.9 2.5 0.7 5.4 0.8 7.9 8.5 0.7 2.5 6.6 2.0 1.3 20.1 2.2 9.0 3.3 1.1 1.2 1.4 1.1 1.3 2.4 3.6 1.1 2.1 2.3 1.2 0.0 2.2 0.0 0.8 1.1 0.4 0.3 1.6 1.3 0.2 0.4 2.0 0.1 0.0 0.8 0.1 7.8 0.1 0.0 1.4 0.0 0.0 0.2 0.5 0.4 0.2 0.0 1.6 0.0 0.0 4.6 0.0 0.4 4.1 3.0 0.3 0.1 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.3 2.1 0.0 3.9 5.5 0.0 0.3 0.4 0.6 2.0 11.8 5.0 0.4 0.3 0.1 0.4 2.0 0.0 0.0 0.4 0.0 0.7 8.2 4.6 5.4 0.1 0.0 0.0 1.1 0.2 1.3 0.2 0.2 2.0 0.2 0.1 1.0 0.0 0.3 0.1 0.2 1.0 0.4 0.1 1.6 0.1 0.1 6.2 10.4 7.8 18.4 7.5 5.9 7.9 8.5 20.1 1.2 RIMS1 "CORD7, KIAA0340, RAB3IP2, RIM, RIM1" ENSG00000079841 "Regulating synaptic membrane exocytosis 1" Q86UR5 6 71886703-72403143 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 83.1" "Cell line enhanced" "Detected in some" "Daudi: 4.8;EFO-21: 8.7;LHCN-M2: 9.6;RPTEC TERT1: 14.8;SH-SY5Y: 10.4;TIME: 5.1;U-138 MG: 5.0" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Region enriched" "Detected in all" 6 "cerebellum: 83.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076565 Enhanced "HPA076565: " "unprognostic (1.34e-3)" "unprognostic (3.47e-1)" "unprognostic (1.48e-1)" "unprognostic (1.63e-3)" "unprognostic (6.62e-2)" "unprognostic (1.16e-1)" "unprognostic (1.73e-2)" "unprognostic (8.57e-2)" "unprognostic (2.85e-1)" "unprognostic (7.76e-4)" "unprognostic (2.42e-2)" "unprognostic (2.29e-1)" "unprognostic (7.91e-2)" "unprognostic (2.76e-1)" "unprognostic (5.74e-2)" "unprognostic (1.07e-2)" 0.5 2.3 10.5 1.5 9.8 0.4 1.2 83.1 27.7 0.9 0.6 0.5 0.0 1.5 0.8 0.5 3.7 0.5 6.2 0.6 9.3 3.6 0.5 0.4 0.7 0.5 2.8 11.7 0.5 0.8 5.0 4.6 0.4 7.2 4.9 0.6 0.2 1.9 0.9 0.6 0.4 0.8 1.4 1.5 0.4 1.4 5.9 2.7 0.0 0.5 0.0 0.4 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.2 1.3 0.0 0.1 0.0 0.0 4.8 8.7 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.3 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.4 14.8 0.0 0.4 10.4 0.0 0.0 0.0 0.6 0.0 5.1 5.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 9.8 83.1 12.9 9.3 3.6 2.8 11.7 7.2 2.7 RIMS2 "KIAA0751, OBOE, RAB3IP3, RIM2" ENSG00000176406 "Regulating synaptic membrane exocytosis 2" Q9UQ26 8 103500748-104256094 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 51.1;brain: 28.7" "Cell line enhanced" "Detected in some" "AF22: 6.0;Daudi: 11.7;RT4: 8.4;SCLC-21H: 20.7;U-2 OS: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046538, HPA066498, CAB079049" Enhanced Supported Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB079049: , HPA046538: , HPA066498: " "unprognostic (2.98e-2)" "unprognostic (7.14e-2)" "unprognostic (4.47e-2)" "unprognostic (5.51e-2)" "unprognostic (2.82e-1)" "unprognostic (7.09e-3)" "unprognostic (2.02e-2)" "unprognostic (1.16e-2)" "unprognostic (7.61e-2)" "unprognostic (8.01e-3)" "unprognostic (1.40e-2)" "unprognostic (6.34e-2)" "unprognostic (1.67e-5)" "unprognostic (8.12e-4)" "unprognostic (1.04e-1)" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" 0.9 51.1 15.8 1.0 21.8 1.1 1.8 14.5 28.7 8.5 0.9 0.5 0.9 1.2 1.4 1.7 1.0 6.3 1.7 0.9 10.3 4.9 1.1 0.9 1.0 1.1 3.1 17.5 2.8 1.6 0.9 12.4 1.1 8.6 2.8 1.0 5.8 1.0 1.8 1.0 1.0 1.4 2.0 4.0 0.9 1.7 3.9 8.7 0.0 2.9 0.0 1.0 1.5 1.6 0.7 0.7 2.9 0.6 1.6 0.6 0.2 3.7 0.0 6.0 0.0 0.0 0.0 0.0 0.4 0.3 1.1 1.4 0.1 0.3 11.7 0.1 0.0 0.3 1.8 0.7 1.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.9 0.0 0.1 0.5 0.0 0.5 0.8 0.0 4.6 0.6 0.0 0.0 0.0 0.0 8.4 20.7 5.0 0.0 0.1 0.5 0.3 0.2 0.0 0.0 5.5 0.1 0.1 1.5 0.0 0.1 0.4 0.2 0.2 2.7 0.6 0.6 0.6 0.3 0.4 0.4 0.3 0.4 0.1 0.7 0.3 0.5 2.9 1.6 0.4 0.7 0.3 0.2 15.8 21.8 14.5 28.7 10.3 4.9 3.1 17.5 8.6 8.7 RIMS3 "NIM3, RIM3" ENSG00000117016 "Regulating synaptic membrane exocytosis 3" Q9UJD0 1 40620679-40665657 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.7" "Cell line enhanced" "Detected in many" "Daudi: 37.0;SH-SY5Y: 17.5;U-87 MG: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 1.8;plasmacytoid DC: 4.6" "Group enriched" "Detected in many" 9 "dendritic cells: 4.6;T-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055285 Approved Nucleoli,Mitochondria Mitochondria Nucleoli "HPA055285: " "unprognostic (3.51e-3)" "unprognostic (7.18e-3)" "unprognostic (4.44e-3)" "unprognostic (1.44e-4)" "unprognostic (3.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.44e-5)" "unprognostic (2.41e-1)" "unprognostic (1.53e-1)" "unprognostic (2.87e-1)" "unprognostic (2.54e-1)" "unprognostic (7.93e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.25e-2)" "unprognostic (3.11e-2)" "unprognostic (2.19e-2)" 1.3 7.2 13.6 2.2 19.2 3.7 3.1 21.5 47.7 1.4 3.4 3.4 0.0 1.1 3.0 2.2 2.9 2.1 1.3 1.5 7.8 17.4 1.4 0.7 3.1 2.0 7.4 22.3 2.5 1.1 4.0 0.5 3.8 4.9 3.2 3.8 2.0 2.0 4.1 0.6 2.7 1.7 4.8 3.4 1.7 2.5 3.1 4.4 0.7 2.8 0.0 2.8 1.7 1.0 0.1 4.6 0.1 0.3 0.1 1.8 0.1 1.9 0.7 2.8 3.0 0.1 0.0 0.4 0.0 0.0 0.5 0.6 0.3 0.6 37.0 0.0 0.0 0.3 1.9 0.3 0.3 6.4 0.9 2.1 0.2 1.0 0.1 0.3 1.7 0.0 1.5 0.1 0.1 0.1 1.8 1.4 0.0 3.3 5.4 0.2 1.8 0.2 2.5 2.6 6.8 0.5 0.5 9.9 17.5 0.4 1.8 1.2 0.4 10.3 0.0 0.3 3.0 0.0 0.5 0.3 2.7 8.1 16.1 0.6 0.3 0.1 0.0 0.0 0.1 0.0 1.8 0.0 0.5 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.3 4.6 0.4 0.1 13.6 19.2 21.5 47.7 7.8 17.4 7.4 22.3 4.9 4.4 RIMS4 "C20orf190, dJ781B1.3" ENSG00000101098 "Regulating synaptic membrane exocytosis 4" Q9H426 20 44751808-44810338 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.8;testis: 14.6" "Cell line enhanced" "Detected in some" "HAP1: 12.8;MCF7: 8.6;SCLC-21H: 26.5;SH-SY5Y: 13.6;SiHa: 9.2;U-2 OS: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060928 Approved Approved Nucleoplasm Nucleoplasm "HPA060928: " "unprognostic (1.54e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" "unprognostic (9.46e-2)" "unprognostic (2.97e-1)" "unprognostic (1.90e-2)" "unprognostic (4.63e-3)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (4.21e-3)" "unprognostic (1.70e-1)" "unprognostic (8.60e-3)" "unprognostic (3.37e-2)" "unprognostic (1.28e-1)" "unprognostic (7.66e-3)" "unprognostic (2.94e-2)" 1.0 2.1 13.8 0.8 23.3 0.4 1.2 9.6 23.8 11.8 1.2 0.2 0.0 0.6 3.2 2.2 1.3 11.9 1.4 0.6 14.1 7.5 0.6 0.5 1.7 0.6 4.9 8.8 9.5 0.6 0.5 6.0 0.6 4.1 3.2 1.2 1.0 2.0 1.8 1.8 0.5 0.7 4.3 1.3 0.5 2.3 14.6 2.6 0.0 7.5 0.9 1.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.0 0.0 12.8 0.1 0.0 0.0 5.4 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 26.5 13.6 9.2 0.0 0.1 4.0 0.4 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 23.3 9.6 19.0 14.1 7.5 4.9 8.8 4.1 2.6 RIPPLY2 "C6orf159, dJ237I15.1" ENSG00000203877 "Ripply transcriptional repressor 2" Q5TAB7 6 83853266-83857515 "Disease related genes, Predicted intracellular proteins" "Developmental protein" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.4" "Cell line enhanced" "Detected in some" "HEL: 4.9;SCLC-21H: 21.8;SH-SY5Y: 14.9" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047454 Uncertain "HPA047454: " "unprognostic (2.09e-1)" "unprognostic (7.43e-2)" "unprognostic (2.51e-1)" "unprognostic (1.20e-3)" "unprognostic (2.69e-3)" "unprognostic (3.66e-1)" "unprognostic (6.94e-3)" "unprognostic (2.30e-1)" "unprognostic (1.72e-1)" "unprognostic (1.74e-1)" 1.5 4.3 11.6 1.3 14.7 0.8 1.1 20.9 23.4 1.6 1.5 2.1 0.0 1.3 2.6 0.8 1.3 1.5 1.5 1.4 11.2 9.8 0.9 0.8 0.9 0.8 8.8 6.9 1.9 3.5 0.8 6.2 0.9 5.3 2.3 1.3 0.4 1.2 1.9 1.5 1.0 1.5 1.5 6.3 0.9 2.5 2.4 6.9 0.0 1.3 0.0 0.8 2.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.0 0.0 0.0 1.2 0.0 0.0 0.9 21.8 14.9 1.0 0.1 0.1 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 14.7 20.9 17.0 11.2 9.8 8.8 6.9 5.3 6.9 RIT2 "RIBA, RIN" ENSG00000152214 "Ras like without CAAX 2" Q99578 18 42743227-43115691 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 55.9" "Cell line enhanced" "Detected in some" "CACO-2: 1.1;NTERA-2: 1.4;SH-SY5Y: 1.9" "Cancer enriched" "Detected in single" 49 "glioma: 4.7" "Region enhanced" "Detected in many" "cerebellum: 55.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA072174 Enhanced "HPA072174: " "unprognostic (1.37e-2)" "unprognostic (4.15e-1)" "unprognostic (2.14e-1)" 0.7 5.2 3.7 0.9 15.0 0.6 0.8 55.9 24.1 1.0 0.7 0.1 0.0 0.8 0.6 0.6 0.6 0.7 0.7 0.6 5.1 11.7 0.6 0.7 0.6 0.7 3.6 5.9 0.8 0.6 0.6 0.4 0.8 6.1 0.7 0.9 0.0 0.6 0.8 0.6 0.6 0.7 0.8 2.1 0.6 0.6 1.1 0.8 0.0 0.7 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.4 1.9 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 15.0 55.9 11.0 5.1 11.7 3.6 5.9 6.1 0.8 RLN2 "bA12D24.1.1, bA12D24.1.2, H2, RLXH2" ENSG00000107014 "Relaxin 2" P04090 9 5299868-5304969 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 44.0" "Cell line enhanced" "Detected in some" "Daudi: 5.1;HEL: 19.7;T-47d: 5.7;U-266/84: 9.0" "Cancer enhanced" "Detected in some" "prostate cancer: 6.7" "Region enriched" "Detected in single" 64 "basal ganglia: 44.0" "Group enriched" "Detected in many" 39 "gdT-cell: 2.1;MAIT T-cell: 6.5;memory B-cell: 2.8;memory CD4 T-cell: 4.3;memory CD8 T-cell: 3.5;naive B-cell: 2.1;naive CD4 T-cell: 6.2;naive CD8 T-cell: 4.6;NK-cell: 4.9;T-reg: 2.0" "Group enriched" "Detected in many" 47 "B-cells: 2.8;NK-cells: 4.9;T-cells: 6.5" "Secreted to blood" 24440 "unprognostic (1.63e-3)" "unprognostic (1.26e-1)" "unprognostic (2.09e-3)" "unprognostic (2.84e-1)" "unprognostic (2.03e-2)" "unprognostic (9.99e-2)" "unprognostic (1.48e-1)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (2.50e-3)" "unprognostic (9.18e-2)" "unprognostic (1.74e-6)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (1.88e-2)" "unprognostic (8.41e-4)" 0.6 0.0 0.6 1.6 44.0 0.0 3.2 0.6 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 7.5 0.6 0.6 0.6 0.6 2.0 0.6 0.7 3.5 0.6 0.6 0.6 0.9 5.2 5.8 0.7 0.6 6.2 0.3 0.6 0.6 0.7 0.6 0.4 0.8 0.6 0.6 1.4 0.4 4.2 0.6 0.6 0.9 0.6 3.0 0.6 0.6 2.8 0.0 0.0 0.0 4.9 6.5 1.4 2.8 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.9 0.3 1.5 5.1 0.4 0.0 0.9 0.0 2.6 0.7 4.0 1.9 19.7 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.1 0.2 0.5 0.0 0.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.5 2.6 2.9 0.0 0.6 0.1 5.7 0.1 0.2 0.0 0.5 0.0 0.1 1.3 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 6.5 2.8 4.3 3.5 0.0 2.1 6.2 4.6 0.0 4.9 0.0 0.0 2.0 1.4 0.6 44.0 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 RND1 "ARHS, Rho6, RHOS" ENSG00000172602 "Rho family GTPase 1" Q92730 12 48857145-48865898 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;liver: 50.6" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 38.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077800 Supported "Vesicles,Plasma membrane,Actin filaments" "Vesicles, Plasma membrane, Actin filaments" "HPA077800: " "unprognostic (5.60e-2)" "unprognostic (3.21e-2)" "unprognostic (2.23e-1)" "unprognostic (1.16e-1)" "unprognostic (6.90e-2)" "unprognostic (1.32e-3)" "unprognostic (3.59e-2)" "unprognostic (7.43e-2)" "unprognostic (2.21e-3)" "unprognostic (2.97e-1)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (8.38e-3)" "unprognostic (6.18e-2)" "unprognostic (6.60e-2)" "unprognostic (3.35e-3)" 2.9 1.3 9.9 2.6 15.0 2.0 2.8 2.6 21.8 1.4 2.8 1.4 0.2 2.6 4.4 1.5 1.8 1.1 13.3 2.5 7.4 7.6 1.8 50.6 12.3 1.4 7.1 8.6 0.9 2.0 3.2 3.2 1.6 8.6 3.7 2.3 1.0 4.0 1.5 0.6 0.6 2.3 2.6 5.6 0.9 6.1 0.8 2.3 0.0 5.5 2.1 2.4 6.9 2.0 1.7 1.7 0.0 0.0 0.5 1.6 0.2 0.6 4.2 2.1 1.1 0.4 0.0 0.3 0.0 0.2 0.6 0.7 2.6 0.9 3.2 0.8 0.0 0.0 1.7 0.1 0.4 1.0 1.0 0.4 0.0 1.6 0.2 0.9 0.6 0.0 0.1 0.3 0.4 1.1 0.1 3.3 0.0 5.4 0.4 0.2 5.0 0.2 1.0 0.2 1.5 0.6 0.8 0.0 0.5 0.1 38.6 0.1 3.8 0.1 0.2 0.0 0.4 0.0 0.5 1.7 2.8 5.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.6 1.7 0.2 0.1 1.7 1.1 0.7 0.1 0.0 0.5 0.0 0.0 0.4 0.2 9.9 15.0 2.6 20.4 7.4 7.6 7.1 8.6 8.6 2.3 RND2 "ARHN, Rho7, RhoN" ENSG00000108830 "Rho family GTPase 2" P52198 17 43025241-43032036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6;testis: 22.9" "Cell line enhanced" "Detected in some" "AF22: 10.5;AN3-CA: 13.4;HAP1: 10.4;NTERA-2: 14.9;SH-SY5Y: 9.1" "Group enriched" "Detected in many" 5 "glioma: 44.4;testis cancer: 11.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077757 Approved "HPA077757: " "unprognostic (2.19e-2)" "unprognostic (5.70e-2)" "unprognostic (1.65e-2)" "unprognostic (1.53e-1)" "unprognostic (2.02e-1)" "unprognostic (6.52e-2)" "unprognostic (2.44e-3)" "unprognostic (4.55e-2)" "unprognostic (7.44e-2)" "unprognostic (3.79e-1)" "unprognostic (1.22e-4)" "unprognostic (7.85e-2)" "unprognostic (8.17e-2)" "unprognostic (6.13e-3)" "unprognostic (9.92e-2)" "unprognostic (7.52e-2)" "unprognostic (5.57e-2)" 1.5 5.3 13.1 1.2 25.2 1.1 2.3 7.1 33.6 1.9 1.5 8.5 1.0 1.3 4.2 4.6 2.4 3.3 2.0 2.1 11.1 33.9 1.9 5.7 1.5 1.1 40.6 5.8 6.5 1.6 8.2 3.9 1.1 30.9 3.5 1.4 3.3 1.8 6.4 1.5 2.9 1.3 4.3 28.7 1.1 1.3 22.9 10.1 0.0 10.1 0.8 1.3 1.6 2.2 1.5 0.5 2.3 0.4 1.0 0.8 0.2 0.0 0.3 10.5 13.4 0.8 0.5 0.2 0.4 0.6 1.8 1.4 1.6 0.1 0.1 2.5 1.3 0.1 10.4 0.2 1.5 0.0 5.4 0.0 0.1 0.2 0.8 0.1 0.1 0.7 0.1 2.1 0.1 0.1 2.5 0.1 0.0 0.4 4.0 0.1 14.9 0.1 0.7 0.0 0.1 0.2 0.0 2.9 9.1 0.0 0.2 0.1 2.0 0.0 0.1 0.3 0.4 0.1 0.0 0.9 2.7 0.2 1.7 0.0 0.1 2.3 0.4 0.5 0.8 0.3 0.4 1.5 0.7 0.4 0.1 0.8 0.7 0.5 1.3 1.0 0.2 0.5 0.2 0.2 13.1 25.2 7.1 9.0 11.1 33.9 40.6 5.8 30.9 10.1 RNF112 "BFP, ZNF179" ENSG00000128482 "Ring finger protein 112" Q9ULX5 17 19411125-19417276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;fHDF/TERT166: 4.7;SCLC-21H: 4.7;SH-SY5Y: 8.2;U-87 MG: 26.9" "Cancer enriched" "Detected in some" 8 "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015970 Supported Approved "Nuclear speckles" "Nuclear speckles" "HPA015970: AB_1859103" "unprognostic (1.16e-1)" "unprognostic (3.74e-1)" "unprognostic (8.43e-5)" "unprognostic (3.65e-2)" "unprognostic (2.96e-2)" "unprognostic (6.02e-2)" "unprognostic (1.27e-1)" "unprognostic (2.88e-1)" "unprognostic (4.26e-1)" "unprognostic (5.02e-2)" "unprognostic (3.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.31e-9)" "unprognostic (1.32e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" "unprognostic (4.24e-1)" 2.5 8.1 11.3 2.3 15.9 0.6 1.8 47.5 29.1 1.2 3.6 1.4 0.0 2.9 2.0 6.9 1.1 1.5 4.4 2.3 12.4 8.2 1.2 0.7 1.7 1.4 3.9 14.1 1.3 0.8 0.5 1.9 1.1 3.1 10.2 4.4 1.6 1.3 3.5 2.1 1.9 3.6 3.5 2.9 1.7 2.1 2.0 3.7 0.0 0.9 0.0 0.8 2.8 1.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 4.1 0.1 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.0 1.7 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.1 0.1 0.1 0.0 0.0 4.7 8.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 26.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 15.9 47.5 15.9 12.4 8.2 3.9 14.1 3.1 3.7 RNF144A "hUIP4, KIAA0161, RNF144, UBCE7IP4" ENSG00000151692 "Ring finger protein 144A" P50876 2 6917392-7068286 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.5" "Cell line enhanced" "Detected in many" "HMC-1: 50.4;SH-SY5Y: 15.3;SK-MEL-30: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.7" "Group enriched" "Detected in many" 7 "granulocytes: 8.7;T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049939 Approved Approved Vesicles Vesicles "HPA049939: " "unprognostic (1.78e-1)" "unprognostic (2.53e-3)" "unprognostic (8.37e-2)" "prognostic unfavourable (6.00e-4)" "unprognostic (6.57e-2)" "prognostic favourable (6.96e-4)" "unprognostic (7.04e-6)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "unprognostic (5.64e-1)" "unprognostic (9.11e-2)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "prognostic unfavourable (7.32e-5)" "unprognostic (1.30e-2)" "unprognostic (3.01e-1)" "unprognostic (1.82e-3)" 12.9 28.8 13.3 4.2 21.2 12.1 11.1 45.5 20.7 17.3 5.2 28.7 9.0 3.0 26.0 8.3 4.7 8.4 7.5 8.0 15.6 11.6 7.5 1.8 5.7 7.9 26.5 12.2 20.0 29.7 21.5 12.5 6.2 13.2 8.7 5.7 5.9 4.0 7.4 8.7 5.7 4.1 12.2 21.8 21.1 2.8 5.0 27.1 3.4 3.2 1.2 5.8 5.8 6.5 0.1 0.2 8.7 0.1 0.8 4.1 0.6 0.3 2.2 11.7 2.4 2.6 5.5 9.0 0.0 0.0 0.4 1.1 0.0 0.2 1.1 1.3 0.1 0.2 3.8 0.0 0.0 0.6 1.0 14.9 0.1 4.4 0.1 0.2 50.4 8.7 0.0 0.8 0.0 0.0 6.4 0.2 0.0 1.8 7.6 0.6 4.3 5.3 5.9 8.5 0.9 0.3 3.9 3.9 15.3 0.2 1.5 15.1 0.6 0.9 0.0 1.5 4.0 4.1 1.7 4.1 1.3 0.0 5.8 3.3 5.5 1.5 0.1 8.7 2.1 0.0 3.0 0.1 2.1 1.5 0.2 0.1 4.1 2.8 0.4 0.8 0.0 0.0 0.8 0.6 13.3 21.2 45.5 20.3 15.6 11.6 26.5 12.2 13.2 27.1 RNF157 KIAA1917 ENSG00000141576 "Ring finger protein 157" Q96PX1 17 76142453-76240373 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.5;skeletal muscle: 52.2;testis: 24.7" "Cell line enhanced" "Detected in many" "HDLM-2: 41.3;U-266/70: 21.9;U-266/84: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.5;T-cells: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021854, HPA021991, HPA023922" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202" "unprognostic (4.21e-1)" "unprognostic (4.62e-2)" "unprognostic (1.55e-2)" "unprognostic (2.63e-3)" "unprognostic (4.93e-2)" "unprognostic (5.06e-2)" "unprognostic (2.07e-3)" "unprognostic (4.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (1.04e-3)" "unprognostic (4.02e-1)" "unprognostic (8.26e-2)" "unprognostic (8.69e-3)" "unprognostic (2.28e-1)" "unprognostic (2.75e-2)" "unprognostic (1.38e-1)" 10.5 3.5 21.0 3.4 19.4 2.3 2.5 10.7 36.5 1.5 7.6 8.0 0.4 8.2 1.9 3.6 1.5 2.4 1.8 3.6 26.4 15.5 5.1 1.4 1.4 4.5 19.7 12.0 1.4 3.6 8.8 2.7 2.1 25.3 1.8 6.6 6.8 1.9 2.0 52.2 1.5 7.3 2.2 11.3 3.0 2.4 24.7 5.9 0.0 3.8 1.5 2.8 1.5 0.5 0.7 0.4 2.5 0.3 1.1 8.5 1.4 0.1 3.4 12.4 4.5 4.0 2.0 5.7 0.1 3.9 0.8 0.4 1.4 1.3 0.0 1.8 0.3 0.1 10.9 0.0 0.7 41.3 3.7 0.0 1.2 1.9 0.6 0.5 4.7 1.1 0.0 1.5 0.0 0.1 6.4 0.1 1.5 3.3 1.8 0.3 2.0 8.8 0.0 0.1 0.0 1.5 1.3 2.2 10.2 2.2 0.0 4.9 0.3 2.1 0.0 0.8 1.0 6.1 3.9 21.9 17.6 0.0 0.3 0.0 6.3 2.5 0.3 0.4 2.3 0.2 4.9 0.3 5.1 4.0 0.2 0.7 8.5 5.5 1.7 1.1 0.3 0.4 2.1 1.4 21.0 19.4 10.7 36.5 26.4 15.5 19.7 12.0 25.3 5.9 RNF165 "ARKL2, RNF111L2" ENSG00000141622 "Ring finger protein 165" Q6ZSG1 18 46326809-46463140 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6" "Cell line enhanced" "Detected in some" "AF22: 12.5;HaCaT: 6.8;HeLa: 6.7;RPMI-8226: 6.5;SCLC-21H: 12.9;SH-SY5Y: 14.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "MAIT T-cell: 1.1;NK-cell: 3.9;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 4 "dendritic cells: 1.5;NK-cells: 3.9;T-cells: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041615, HPA047798" Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA041615: , HPA047798: " "unprognostic (6.46e-3)" "unprognostic (7.25e-2)" "unprognostic (4.55e-2)" "unprognostic (1.24e-5)" "unprognostic (3.43e-1)" "unprognostic (4.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.04e-3)" "unprognostic (1.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.87e-5)" "unprognostic (3.53e-3)" "unprognostic (1.90e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" 1.9 1.7 9.9 1.0 9.5 0.9 2.1 28.6 13.8 1.0 0.8 1.7 1.7 0.4 1.0 8.4 2.7 3.0 1.0 2.5 6.1 4.4 2.3 8.3 1.0 0.9 2.2 7.2 0.5 1.0 13.1 4.8 0.8 2.0 3.6 0.6 2.7 1.4 3.9 3.6 3.5 1.0 0.7 1.7 5.3 0.7 1.3 1.0 1.7 8.8 1.2 1.3 1.2 1.0 0.0 1.5 0.5 0.0 3.9 1.1 0.0 1.5 0.1 12.5 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 6.8 0.5 1.0 0.0 0.0 1.0 0.1 6.7 0.0 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.3 1.0 1.7 1.2 2.4 0.5 6.5 0.8 2.1 12.9 14.7 2.3 0.0 0.0 0.3 0.5 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 4.0 0.4 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.9 0.0 1.5 0.0 0.0 9.9 9.5 28.6 13.8 6.1 4.4 2.2 7.2 2.0 1.0 RNF175 FLJ34190 ENSG00000145428 "Ring finger protein 175" Q8N4F7 4 153710125-153760235 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.3" "Cell line enhanced" "Detected in some" "AF22: 7.7;HSkMC: 5.1;REH: 6.5;SH-SY5Y: 6.5;THP-1: 15.8;U-87 MG: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 26 "classical monocyte: 2.4;intermediate monocyte: 1.7;myeloid DC: 1.7;naive CD4 T-cell: 4.0;neutrophil: 4.5;non-classical monocyte: 3.6;T-reg: 1.1" "Low lineage specificity" "Detected in many" HPA035837 Uncertain "HPA035837: AB_10601609" "unprognostic (3.23e-2)" "unprognostic (4.12e-2)" "unprognostic (3.34e-1)" "unprognostic (1.48e-2)" "prognostic unfavourable (3.11e-4)" "unprognostic (9.00e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-4)" "unprognostic (1.17e-1)" "unprognostic (2.96e-3)" "unprognostic (6.30e-3)" "unprognostic (1.42e-1)" "unprognostic (3.63e-4)" "unprognostic (7.25e-3)" "unprognostic (3.27e-1)" "unprognostic (1.28e-1)" "unprognostic (7.66e-2)" 2.7 4.8 8.6 5.4 14.3 9.5 1.3 9.3 17.3 5.4 0.8 1.4 0.8 0.8 0.8 2.0 1.5 0.6 2.2 4.4 9.0 12.1 0.6 0.5 2.2 2.2 6.4 9.8 0.5 1.1 0.4 3.0 0.6 13.0 4.7 0.6 0.6 3.4 6.7 0.5 1.6 0.9 0.6 2.5 3.4 0.8 2.8 1.8 0.0 0.6 0.3 1.3 1.8 1.5 0.0 1.7 4.5 3.6 0.0 4.0 1.2 0.1 0.0 7.7 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.6 0.0 6.5 0.0 0.3 0.0 0.1 0.0 6.5 0.0 0.0 0.2 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.9 0.0 0.0 2.4 0.0 0.0 1.7 0.0 0.0 0.1 0.0 1.7 0.0 4.0 0.1 4.5 0.0 3.6 0.0 1.1 1.2 8.6 14.3 9.3 17.3 9.0 12.1 6.4 9.8 13.0 1.8 RNF182 MGC33993 ENSG00000180537 "Ring finger protein 182" Q8N6D2 6 13924446-13980302 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.9;brain: 17.6" "Cell line enhanced" "Detected in many" "HeLa: 36.3;RPTEC TERT1: 29.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012309 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA012309: AB_1856349" "unprognostic (1.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic unfavourable (4.66e-5)" "unprognostic (6.16e-2)" "unprognostic (2.08e-1)" "unprognostic (9.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.71e-2)" "unprognostic (4.21e-1)" "unprognostic (6.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (9.33e-5)" "unprognostic (6.66e-3)" "unprognostic (1.33e-3)" "unprognostic (1.26e-1)" 1.2 0.7 7.6 0.6 6.2 12.9 1.2 16.6 17.6 1.2 0.7 7.5 2.0 0.8 1.6 2.5 1.0 2.7 0.9 1.0 11.0 7.3 2.6 0.5 5.7 0.8 6.8 8.5 1.1 3.6 0.5 2.0 2.9 14.3 0.9 0.6 2.2 1.9 4.7 0.9 0.8 1.1 1.0 5.1 0.5 0.6 7.0 2.9 0.0 3.0 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.7 5.2 0.0 1.8 2.2 0.3 2.6 3.6 7.4 7.1 0.1 0.0 0.0 0.0 2.8 0.0 6.1 0.0 13.5 0.0 2.0 0.1 36.3 0.0 0.0 0.0 0.0 1.2 0.0 11.3 0.1 0.1 0.2 0.0 5.1 0.0 0.0 0.9 2.9 10.1 1.5 1.2 0.4 29.1 0.0 6.3 6.0 0.2 0.0 10.2 0.0 1.0 2.7 9.0 1.9 0.1 6.0 0.0 0.0 0.0 6.1 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.2 16.6 12.1 11.0 7.3 6.8 8.5 14.3 2.9 RNF208 DKFZP761H1710 ENSG00000212864 "Ring finger protein 208" Q9H0X6 9 137220247-137221581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4" "Cell line enhanced" "Detected in many" "Hep G2: 12.1;MCF7: 29.0;REH: 23.4;RPMI-8226: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021256, HPA021429" Uncertain Enhanced Nucleoplasm Nucleoplasm "HPA021256: AB_1844331, HPA021429: AB_2180654" "unprognostic (2.97e-1)" "unprognostic (7.37e-2)" "unprognostic (1.46e-2)" "unprognostic (6.33e-3)" "unprognostic (9.99e-2)" "unprognostic (2.10e-3)" "unprognostic (3.52e-3)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.95e-2)" "unprognostic (8.42e-3)" "unprognostic (1.60e-1)" "prognostic favourable (1.12e-8)" "unprognostic (3.41e-1)" "unprognostic (1.69e-1)" "unprognostic (7.66e-2)" "unprognostic (3.40e-2)" 3.7 7.1 17.3 1.2 13.3 0.7 4.3 10.1 27.4 1.9 1.7 1.5 1.2 2.0 1.7 2.7 4.6 3.4 1.2 6.2 18.1 10.8 3.7 8.1 1.8 3.4 9.4 4.6 1.5 8.8 5.7 3.0 1.2 3.5 4.0 0.6 1.8 11.4 5.5 13.2 6.6 2.4 1.2 3.3 1.8 3.4 3.1 2.1 1.2 2.1 3.2 1.2 2.1 1.3 0.6 0.0 0.8 0.7 0.0 1.2 0.8 0.7 1.5 1.0 1.7 0.7 0.1 3.1 0.4 0.6 0.7 0.7 4.4 2.8 0.4 2.2 0.5 2.3 2.5 0.1 0.1 1.0 0.9 3.1 5.1 12.1 2.3 0.6 1.0 0.5 0.8 0.7 0.3 0.7 4.3 0.2 0.3 29.0 1.5 1.4 1.3 3.2 23.4 0.2 12.9 0.8 0.1 2.9 10.4 0.3 0.9 0.6 10.5 2.2 0.3 0.5 0.6 1.0 0.0 0.4 0.4 0.1 1.4 0.2 0.5 0.0 0.4 0.2 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.8 17.3 13.3 10.1 27.4 18.1 10.8 9.4 4.6 3.5 2.1 RNF220 "C1orf164, FLJ10597" ENSG00000187147 "Ring finger protein 220" Q5VTB9 1 44405194-44651724 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.4" "Cell line enhanced" "Detected in all" "U-937: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027577, HPA027578" Uncertain Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA027577: , HPA027578: AB_10601482" "unprognostic (3.12e-2)" "unprognostic (1.24e-1)" "unprognostic (3.49e-2)" "unprognostic (2.56e-1)" "unprognostic (2.94e-2)" "unprognostic (6.96e-3)" "prognostic unfavourable (2.35e-6)" "unprognostic (1.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.13e-1)" "unprognostic (2.14e-3)" "unprognostic (2.96e-2)" "prognostic unfavourable (5.12e-4)" "unprognostic (1.51e-2)" "unprognostic (1.98e-1)" "unprognostic (1.37e-3)" "unprognostic (6.46e-2)" 9.8 7.4 20.9 9.6 38.5 12.7 6.7 12.6 40.1 5.4 9.2 40.7 2.7 10.7 8.0 8.8 6.0 9.3 4.5 9.2 33.4 20.9 7.4 5.1 7.4 7.6 49.8 19.8 9.5 8.1 7.0 5.7 8.7 25.8 7.7 5.9 4.2 9.3 7.1 28.4 8.7 8.8 8.0 57.4 7.9 7.6 7.0 49.6 5.0 7.3 4.6 8.0 7.9 5.6 3.6 6.6 2.8 2.3 1.9 4.3 1.4 5.9 2.8 12.3 4.2 4.8 4.4 9.3 7.1 6.5 5.5 8.1 4.9 5.9 11.6 6.3 5.6 3.9 13.8 5.8 7.5 14.4 12.2 16.0 8.9 8.3 7.8 11.3 8.2 4.8 13.3 6.1 9.8 3.1 11.7 5.8 3.4 4.1 11.1 8.6 13.4 6.5 9.4 7.3 8.3 3.5 3.7 5.6 6.9 6.0 4.2 8.6 3.1 20.0 4.8 5.8 6.2 5.4 13.1 13.2 12.7 8.4 4.8 36.5 3.5 2.4 2.3 2.8 3.2 1.8 2.4 2.4 1.0 4.3 3.4 3.6 1.9 1.7 1.5 1.9 1.3 6.6 3.2 1.4 20.9 38.5 12.6 30.8 33.4 20.9 49.8 19.8 25.8 49.6 RNFT2 "FLJ14627, TMEM118" ENSG00000135119 "Ring finger protein, transmembrane 2" Q96EX2 12 116738178-116853631 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.0" "Cell line enhanced" "Detected in many" "AN3-CA: 15.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064161 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064161: " "unprognostic (1.56e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (3.59e-1)" "unprognostic (3.98e-1)" "unprognostic (3.10e-2)" "unprognostic (8.14e-5)" "unprognostic (8.62e-2)" "unprognostic (6.28e-3)" "unprognostic (2.58e-1)" "unprognostic (9.25e-3)" "unprognostic (2.75e-1)" "unprognostic (7.61e-3)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.36e-3)" "unprognostic (4.01e-4)" 1.7 3.2 8.8 2.6 15.1 3.5 1.4 13.6 21.0 1.5 1.6 6.6 0.0 2.0 1.5 4.3 1.5 1.5 1.6 1.4 9.9 12.1 2.0 1.0 1.5 4.1 9.7 9.8 1.7 1.4 2.6 7.5 2.9 19.0 1.2 1.7 3.6 2.6 1.2 2.1 2.7 1.8 1.4 6.2 2.9 1.9 7.0 3.4 2.5 2.1 0.0 4.4 1.2 0.4 4.3 2.2 4.0 1.1 2.8 3.1 0.9 1.5 9.0 4.7 15.3 0.2 0.0 7.9 0.6 0.7 1.9 1.7 3.6 1.7 7.9 2.2 0.1 1.9 10.0 0.7 1.8 7.5 5.0 1.5 7.3 4.8 2.0 0.6 4.6 0.2 0.2 3.1 1.0 0.3 6.0 2.9 0.2 7.6 7.7 1.9 4.7 1.8 5.0 2.7 4.1 3.7 1.8 7.3 6.6 2.2 1.2 2.2 7.2 1.7 0.5 1.3 5.2 3.1 3.1 3.6 12.0 8.3 5.7 0.8 1.0 4.0 1.1 1.3 2.0 0.7 0.6 4.3 1.8 1.4 0.6 3.3 2.9 3.1 3.4 2.8 0.8 2.2 1.1 0.9 8.8 15.1 13.6 20.9 9.9 12.1 9.7 9.8 19.0 3.4 ROBO2 KIAA1568 ENSG00000185008 "Roundabout guidance receptor 2" Q9HCK4 3 75906695-77649964 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1" "Group enriched" "Detected in some" 5 "BJ hTERT+: 14.9;HEL: 40.7" "Cancer enhanced" "Detected in many" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013371 Approved Approved "Nucleoplasm,Centriolar satellite" 660000 "Nucleoplasm, Centriolar satellite" "HPA013371: AB_1856391" "unprognostic (1.14e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.82e-2)" "unprognostic (5.93e-3)" "unprognostic (3.87e-1)" "unprognostic (2.83e-3)" "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (2.90e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (9.65e-3)" 1.1 3.3 6.4 0.8 13.8 0.3 1.1 19.0 26.1 3.6 1.3 2.2 0.0 0.9 2.9 0.8 6.2 0.4 3.1 1.0 6.3 6.5 2.5 1.8 12.3 1.8 9.6 5.5 9.4 2.2 6.8 2.1 6.4 9.9 1.9 0.8 4.8 2.1 7.8 0.4 3.0 1.2 1.9 7.8 3.6 1.1 4.5 3.6 3.6 0.4 4.2 3.0 2.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.9 4.2 0.0 0.1 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 4.8 40.7 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 2.6 4.6 0.0 0.0 0.5 6.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 13.8 19.0 11.3 6.3 6.5 9.6 5.5 9.9 3.6 ROGDI FLJ22386 ENSG00000067836 "Rogdi homolog" Q9GZN7 16 4796968-4802950 "Disease related genes, Predicted intracellular proteins" "Amelogenesis imperfecta, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 21.6;intermediate monocyte: 15.8;myeloid DC: 17.3;non-classical monocyte: 15.0;plasmacytoid DC: 8.1" "Group enriched" "Detected in many" 8 "dendritic cells: 17.3;monocytes: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041000 Uncertain "HPA041000: AB_10794077" "unprognostic (1.74e-3)" "unprognostic (1.98e-3)" "unprognostic (1.25e-1)" "unprognostic (1.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.95e-1)" "unprognostic (3.13e-1)" "unprognostic (3.79e-3)" "unprognostic (3.22e-2)" "unprognostic (1.21e-1)" "prognostic favourable (9.71e-4)" "unprognostic (5.24e-2)" "prognostic favourable (2.67e-5)" "unprognostic (1.71e-1)" "unprognostic (7.16e-2)" "unprognostic (2.17e-1)" "unprognostic (3.08e-2)" 6.0 9.4 17.1 7.5 23.2 30.7 4.1 23.9 34.1 3.3 10.5 45.4 4.4 22.4 4.5 3.3 8.2 5.1 9.0 13.6 21.0 14.2 10.2 13.3 8.6 4.0 22.7 17.4 3.0 12.8 5.5 12.0 4.4 26.4 10.2 4.1 12.3 14.8 7.1 27.1 4.1 14.9 4.5 20.1 8.7 18.9 4.8 21.5 1.7 2.6 4.1 5.2 6.4 4.2 0.8 17.3 2.3 21.6 1.7 1.9 9.5 4.8 5.8 1.2 12.3 2.6 0.8 13.9 4.8 0.6 1.0 0.5 3.1 6.3 2.9 5.3 5.8 9.0 3.8 4.8 1.1 2.1 5.6 2.0 10.4 7.8 4.5 3.4 2.4 0.9 2.6 3.7 2.1 5.7 2.1 1.3 5.7 23.3 4.0 13.3 3.7 6.7 9.1 10.2 11.1 7.1 5.9 19.2 7.7 19.0 12.5 2.1 12.5 7.7 9.3 2.3 6.3 16.1 2.0 5.9 8.1 1.9 2.5 11.0 0.8 2.0 21.6 2.3 0.7 15.8 1.9 0.8 1.4 1.6 17.3 0.8 1.5 1.5 1.6 1.7 15.0 8.1 1.8 9.5 17.1 23.2 23.9 34.1 21.0 14.2 22.7 17.4 26.4 21.5 RORB "NR1F2, ROR-BETA, RZRB" ENSG00000198963 "RAR related orphan receptor B" Q92753 9 74497365-74693177 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding, Receptor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.5;cervix, uterine: 20.8" "Cell line enhanced" "Detected in some" "HHSteC: 19.9;HSkMC: 10.9;MOLT-4: 5.6;SH-SY5Y: 11.7" "Group enriched" "Detected in some" 5 "glioma: 2.1;prostate cancer: 2.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008393 Uncertain Approved Nucleoplasm Nucleoplasm "HPA008393: AB_1079830" "unprognostic (6.89e-3)" "unprognostic (4.06e-3)" "unprognostic (1.38e-1)" "unprognostic (3.97e-1)" "unprognostic (1.34e-1)" "unprognostic (1.05e-3)" "unprognostic (1.28e-1)" "unprognostic (1.18e-2)" "unprognostic (1.07e-1)" "unprognostic (3.07e-1)" "unprognostic (3.52e-1)" "unprognostic (5.46e-2)" "unprognostic (8.81e-8)" "unprognostic (5.97e-3)" "unprognostic (2.17e-2)" "unprognostic (2.26e-2)" "unprognostic (4.00e-2)" 3.1 7.9 8.3 1.2 11.1 1.0 1.4 1.8 35.5 20.8 1.3 2.1 2.2 1.1 8.9 0.9 1.7 1.5 4.5 3.9 5.6 7.0 2.0 1.0 2.0 0.9 4.1 18.7 1.4 1.1 1.1 4.0 10.6 6.1 10.5 1.6 18.7 1.2 11.7 0.9 1.3 1.1 1.7 6.7 1.0 1.6 2.0 3.7 2.2 1.5 0.0 1.5 2.3 2.2 0.2 0.2 1.8 0.2 0.6 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.9 0.0 0.6 10.9 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 5.6 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.2 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.4 2.7 0.0 1.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.6 1.8 0.6 0.1 0.2 0.0 0.0 8.3 11.1 1.8 35.5 5.6 7.0 4.1 18.7 6.1 3.7 RPEL1 ENSG00000235376 "Ribulose-5-phosphate-3-epimerase like 1" Q2QD12 10 103245887-103248016 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;brain: 1.2;pituitary gland: 1.2" "Cell line enhanced" "Detected in some" "HeLa: 1.1;NB-4: 1.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: , HPA036499: AB_10670109" "unprognostic (7.52e-2)" "unprognostic (1.69e-1)" "unprognostic (4.78e-2)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (1.83e-1)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.91e-2)" "unprognostic (6.59e-2)" "unprognostic (4.34e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (1.62e-1)" "unprognostic (6.72e-2)" "unprognostic (5.06e-2)" 0.0 0.1 0.1 1.0 0.3 0.1 0.1 1.2 0.2 0.0 0.0 0.3 0.4 0.4 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.8 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.4 1.0 0.3 0.7 1.4 0.6 0.2 0.5 0.5 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.4 0.7 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.3 1.1 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 1.0 0.7 0.0 0.0 0.1 0.3 0.5 0.2 0.3 0.1 0.3 0.4 0.2 0.1 0.4 0.0 0.1 0.9 0.1 0.2 0.3 0.1 0.3 0.7 0.4 0.1 0.3 0.7 0.2 0.5 0.7 0.5 0.4 0.4 0.3 1.0 0.4 0.5 0.6 0.0 1.4 0.4 0.3 0.4 0.2 RPH3A "exophilin-1, KIAA0985, rabphilin" ENSG00000089169 "Rabphilin 3A" Q9Y2J0 12 112570380-112898881 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.9;brain: 51.2" "Cell line enhanced" "Detected in many" "RPMI-8226: 8.1;SH-SY5Y: 18.6" "Cancer enriched" "Detected in some" 5 "glioma: 4.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 9.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002475 Enhanced "HPA002475: AB_1079837" "unprognostic (5.50e-2)" "unprognostic (3.19e-1)" "unprognostic (3.72e-3)" "unprognostic (5.90e-2)" "unprognostic (7.72e-3)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (6.39e-2)" "unprognostic (6.75e-2)" "unprognostic (3.73e-2)" "unprognostic (1.42e-1)" "unprognostic (5.85e-2)" "unprognostic (3.92e-2)" "unprognostic (2.08e-2)" "unprognostic (2.70e-2)" "unprognostic (7.46e-2)" 0.9 3.5 15.5 1.6 27.4 15.9 1.2 32.9 51.2 0.7 1.2 3.6 0.0 1.2 1.6 2.7 1.3 1.1 2.2 1.0 14.0 13.2 1.0 1.2 1.0 3.2 6.4 19.9 1.4 2.5 0.9 0.2 1.5 9.9 1.2 1.6 0.2 1.3 0.9 1.0 2.5 1.4 1.6 5.0 1.9 1.0 1.6 5.9 0.0 1.8 0.0 2.1 1.7 0.2 1.8 0.9 3.5 9.2 0.9 0.8 2.3 0.9 0.9 0.9 1.6 0.3 0.6 2.7 0.0 0.5 0.5 0.0 0.6 1.3 1.3 0.5 0.0 2.3 0.4 0.6 1.2 0.4 1.3 2.3 3.3 2.2 0.5 1.4 2.1 0.6 0.2 1.4 1.7 0.0 0.1 3.5 2.0 1.4 0.6 1.7 1.3 1.2 0.0 1.0 8.1 0.0 1.8 1.6 18.6 0.2 0.1 0.1 0.8 0.1 0.1 1.8 1.4 1.7 1.0 1.7 0.3 1.3 1.2 0.8 0.6 1.3 9.2 0.5 0.7 4.2 0.4 0.8 0.4 0.6 0.9 1.8 0.5 0.8 3.5 0.9 5.7 0.5 0.1 2.3 15.5 27.4 32.9 51.2 14.0 13.2 6.4 19.9 9.9 5.9 RPRM "FLJ90327, REPRIMO" ENSG00000177519 "Reprimo, TP53 dependent G2 arrest mediator homolog" Q9NS64 2 153477338-153478808 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.9" "Group enriched" "Detected in some" 5 "HEK 293: 17.9;MCF7: 20.0;NTERA-2: 14.3;SCLC-21H: 5.3;SH-SY5Y: 6.0" "Group enriched" "Detected in many" 8 "glioma: 6.7;testis cancer: 28.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 19 "T-reg: 1.9" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (6.66e-2)" "unprognostic (2.69e-1)" "unprognostic (1.08e-1)" "unprognostic (1.72e-2)" "unprognostic (2.48e-2)" "unprognostic (1.11e-1)" "unprognostic (1.62e-2)" "unprognostic (5.19e-1)" "unprognostic (5.51e-2)" "unprognostic (3.09e-3)" "unprognostic (2.58e-1)" "unprognostic (6.19e-2)" "unprognostic (6.38e-4)" "unprognostic (5.21e-2)" "unprognostic (1.25e-2)" "unprognostic (8.61e-2)" 2.8 14.6 21.9 0.7 5.3 0.5 0.6 0.4 17.7 14.2 9.6 1.3 4.2 0.6 17.6 7.3 1.2 4.8 0.5 0.6 4.0 11.2 1.2 0.5 1.3 0.6 1.6 4.2 10.5 0.5 0.5 11.5 0.6 3.8 11.0 1.0 4.2 14.3 9.2 0.6 0.9 0.9 15.8 1.5 1.5 5.3 1.6 1.5 0.0 1.6 0.0 0.6 1.7 1.9 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 17.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 20.0 0.0 0.0 14.3 0.8 0.0 0.0 0.0 0.0 0.1 5.3 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 21.9 5.3 0.4 10.5 4.0 11.2 1.6 4.2 3.8 1.5 RPRML MGC43894 ENSG00000179673 "Reprimo like" Q8N4K4 17 46978156-46979248 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 27.0" "Cell line enhanced" "Detected in some" "AF22: 2.6;Daudi: 15.8;HEK 293: 4.9;NTERA-2: 2.5;SCLC-21H: 2.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Group enriched" "Detected in many" 13 "amygdala: 44.0;basal ganglia: 29.6;cerebral cortex: 41.6;hippocampal formation: 38.9;olfactory region: 24.9" "Region enhanced" "Detected in many" "basal ganglia: 311.4" HPA062668 Uncertain "HPA062668: " "unprognostic (7.79e-4)" "unprognostic (1.66e-2)" "unprognostic (8.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.31e-1)" "unprognostic (8.93e-4)" "unprognostic (2.78e-2)" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" 0.8 0.6 6.6 0.6 27.0 0.6 0.8 3.6 16.5 0.6 0.8 0.0 0.0 0.8 0.6 2.5 0.6 0.7 0.6 0.6 4.9 1.3 0.7 0.6 0.6 0.6 0.8 10.1 0.6 0.6 0.6 0.1 0.6 0.0 0.8 0.6 0.4 0.7 0.6 3.9 1.0 0.8 0.6 0.0 0.7 1.3 0.7 2.7 0.0 0.6 0.0 0.6 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.5 0.6 0.9 0.3 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 27.0 3.6 11.6 4.9 1.3 0.8 10.1 0.0 2.7 RPS6KL1 MGC11287 ENSG00000198208 "Ribosomal protein S6 kinase like 1" Q9Y6S9 14 74903954-74923396 "Enzymes, Predicted intracellular proteins" "Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1" "Cell line enhanced" "Detected in many" "HMC-1: 12.8;SCLC-21H: 24.5;SK-BR-3: 14.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 2.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.0;plasmacytoid DC: 5.4" "Group enriched" "Detected in many" 26 "B-cells: 2.0;dendritic cells: 5.4;T-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027451, HPA027794" Approved Approved Nucleoplasm Nucleoplasm "HPA027451: AB_10599304, HPA027794: AB_10602098" "unprognostic (2.71e-2)" "unprognostic (9.33e-3)" "unprognostic (3.36e-1)" "unprognostic (1.13e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.49e-4)" "unprognostic (2.06e-1)" "unprognostic (1.54e-1)" "unprognostic (4.09e-3)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.03e-2)" "unprognostic (7.52e-2)" 4.2 7.5 14.7 2.3 13.6 4.2 5.7 18.2 29.1 2.1 4.8 9.0 2.2 3.8 5.1 8.8 5.3 2.5 3.7 10.2 14.3 13.7 2.3 2.1 2.5 2.5 11.1 15.3 1.5 6.7 4.0 10.6 1.4 8.4 2.8 5.6 5.9 3.2 5.4 12.7 1.2 2.8 6.9 8.8 1.7 2.0 11.4 6.8 0.0 3.8 1.2 2.5 1.9 0.8 2.0 5.4 0.1 0.0 0.0 2.0 0.1 2.3 0.3 0.9 3.7 0.1 0.0 4.4 0.4 0.2 1.8 0.5 5.5 1.6 0.0 3.4 0.7 0.3 1.8 0.3 2.3 0.0 0.8 1.9 0.7 4.1 4.6 2.2 12.8 0.3 3.2 2.0 0.0 5.8 2.6 0.7 0.1 7.5 0.0 0.7 0.8 3.6 1.8 0.0 7.1 1.8 0.0 24.5 3.0 0.2 14.1 2.3 1.3 1.5 3.9 0.1 0.2 3.0 0.0 9.9 5.2 5.2 1.3 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 2.0 0.4 0.1 0.0 0.4 1.9 2.0 0.1 0.0 0.0 5.4 0.0 0.1 14.7 13.6 18.2 18.2 14.3 13.7 11.1 15.3 8.4 6.8 RSPH1 "CILD24, FLJ32753, RSP44, RSPH10A, TSGA2" ENSG00000160188 "Radial spoke head 1 homolog" Q8WYR4 21 42472486-42496354 "Disease related genes, Predicted intracellular proteins" Meiosis "Ciliopathy, Disease mutation, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.4;fallopian tube: 85.5" "Cell line enhanced" "Detected in some" "HEL: 5.4;MCF7: 10.8;RPTEC TERT1: 16.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 6.7" "Lineage enriched" "Detected in single" 11 "dendritic cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016816, HPA017382" Enhanced Supported Centrosome Centrosome "HPA016816: AB_1858393, HPA017382: AB_1858392" "unprognostic (1.76e-3)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.12e-3)" "unprognostic (5.48e-2)" "unprognostic (2.43e-1)" "unprognostic (7.59e-3)" "unprognostic (1.97e-1)" "unprognostic (2.53e-1)" "unprognostic (1.46e-1)" "unprognostic (4.37e-3)" "unprognostic (2.77e-1)" "unprognostic (1.10e-2)" "unprognostic (8.41e-2)" "unprognostic (2.58e-2)" "unprognostic (5.22e-3)" "unprognostic (1.99e-1)" 0.6 2.5 11.5 0.9 16.4 0.7 1.7 1.2 4.7 4.5 2.6 15.9 3.1 4.5 3.6 22.5 1.0 85.5 3.8 0.6 11.6 15.0 3.8 0.8 17.4 0.7 4.8 4.5 12.9 2.2 4.8 21.4 0.6 38.4 2.2 2.5 1.0 0.9 2.4 0.9 2.4 4.1 1.1 4.6 0.6 3.4 21.9 7.7 0.2 4.8 0.0 0.7 1.5 0.2 0.6 6.7 0.5 0.3 0.0 0.3 0.3 1.6 1.2 0.1 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 3.5 0.1 0.6 0.0 2.0 0.0 0.5 0.0 0.2 0.1 5.4 0.5 0.0 0.0 0.1 0.2 0.3 1.0 0.0 0.1 0.0 0.0 0.3 0.0 10.8 0.1 0.2 0.3 0.5 0.0 0.4 0.0 16.2 1.3 2.5 1.0 2.6 3.9 0.3 4.4 0.4 0.2 0.0 0.1 0.1 0.0 0.5 2.5 0.1 0.1 0.0 0.0 0.1 0.3 0.5 0.3 0.2 0.1 0.4 0.3 0.3 0.3 0.6 0.3 0.2 0.2 0.0 0.1 6.7 0.2 0.3 11.5 16.4 1.2 4.7 11.6 15.0 4.8 4.5 38.4 7.7 RSPH4A "CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B" ENSG00000111834 "Radial spoke head 4 homolog A" Q5TD94 6 116616479-116632985 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8;fallopian tube: 35.9;pituitary gland: 16.7" "Cell line enhanced" "Detected in some" "RPMI-8226: 7.4;U-266/84: 5.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.6" "Group enriched" "Detected in many" 4 "basal ganglia: 9.4;pons and medulla: 19.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031196, HPA031197, HPA031198" Enhanced Approved Nucleoplasm Nucleoplasm "HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025" "unprognostic (9.83e-4)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" "unprognostic (9.69e-3)" "unprognostic (9.37e-2)" "unprognostic (1.13e-3)" "unprognostic (4.52e-1)" "unprognostic (1.07e-1)" "unprognostic (1.06e-1)" "unprognostic (5.08e-2)" "unprognostic (9.56e-5)" "unprognostic (2.87e-1)" "unprognostic (2.69e-4)" "unprognostic (1.96e-2)" "unprognostic (2.51e-1)" "unprognostic (3.55e-2)" "unprognostic (5.21e-2)" 0.5 0.7 1.8 0.5 9.4 0.9 0.7 1.2 0.9 2.2 0.4 10.2 0.4 0.5 1.9 13.3 0.4 35.9 0.8 0.5 3.0 3.3 0.7 0.4 11.1 0.5 0.5 1.1 13.7 0.6 2.8 16.7 0.3 19.8 0.6 0.4 0.2 0.4 0.5 1.0 0.6 0.4 0.6 0.7 1.0 0.8 6.6 1.8 0.0 1.0 0.0 0.5 0.4 0.1 0.8 0.1 1.3 0.2 0.2 1.0 0.0 0.1 0.2 1.4 3.2 0.1 0.1 0.3 0.4 0.8 0.6 0.8 0.7 1.1 1.0 0.3 0.1 0.2 0.3 0.6 0.6 0.8 1.1 0.4 0.5 1.2 0.0 0.8 1.1 0.4 0.2 1.0 0.2 0.0 0.2 0.1 0.6 0.2 0.6 0.1 0.5 0.1 0.8 1.6 7.4 3.1 0.4 2.8 1.2 0.2 0.2 0.4 0.5 0.6 0.5 0.4 0.7 0.5 0.5 0.5 5.4 0.4 0.1 0.4 0.5 1.3 0.2 0.8 1.0 0.1 0.1 0.4 0.3 0.0 0.0 0.8 0.2 0.5 0.0 0.2 0.1 0.1 0.0 0.0 1.8 9.4 1.2 0.7 3.0 3.3 0.5 1.1 19.8 1.8 RSPO2 MGC35555 ENSG00000147655 "R-spondin 2" Q6UXX9 8 107899316-108083648 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" "Developmental protein, Heparin-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.0;placenta: 20.1" "Cell line enhanced" "Detected in some" "HEK 293: 3.5;HEL: 3.3;NTERA-2: 2.0;U-138 MG: 3.5;U-266/70: 10.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 1.6" "Lineage enriched" "Detected in single" 17 "monocytes: 1.6" "Group enriched" "Detected in some" 7 "amygdala: 8.2;cerebral cortex: 18.2;hippocampal formation: 23.2" "Group enriched" "Detected in many" 5 "amygdala: 23.3;cerebral cortex: 18.0;hippocampal formation: 24.1;midbrain: 33.2" "HPA024764, CAB025900, HPA053068" Uncertain "Secreted in other tissues" "CAB025900: , HPA024764: AB_10603236, HPA053068: " "unprognostic (1.10e-2)" "unprognostic (2.18e-1)" "unprognostic (3.97e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.19e-1)" "unprognostic (8.33e-3)" "unprognostic (1.82e-1)" "unprognostic (9.48e-2)" "unprognostic (1.31e-1)" "unprognostic (1.40e-1)" "unprognostic (8.45e-2)" "unprognostic (1.95e-2)" "unprognostic (1.17e-2)" 0.4 0.5 3.9 1.4 6.3 0.5 0.2 1.9 27.0 3.6 12.0 4.2 3.6 5.1 0.3 3.6 8.9 0.2 4.8 0.5 5.8 10.5 0.2 1.1 9.3 0.2 15.7 5.4 1.1 0.2 0.2 2.8 20.1 2.0 11.6 10.1 15.5 0.2 3.4 0.3 0.3 5.8 0.7 1.3 0.2 8.3 2.0 1.7 0.0 0.2 0.0 0.2 2.2 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 1.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.2 0.1 0.0 10.4 0.0 0.0 1.0 0.4 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 6.3 1.9 27.0 5.8 10.5 15.7 5.4 2.0 1.7 RSPO4 "C20orf182, dJ824F16.3" ENSG00000101282 "R-spondin 4" Q2I0M5 20 958452-1002264 "Disease related genes, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" Heparin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.5;lung: 12.0" "Cell line enhanced" "Detected in some" "BEWO: 4.3;EFO-21: 3.2;fHDF/TERT166: 3.4;NTERA-2: 8.9;SK-BR-3: 6.1;U-2 OS: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "basal ganglia: 0.5" HPA048887 Uncertain "Secreted in other tissues" "HPA048887: " "unprognostic (2.36e-1)" "unprognostic (3.60e-3)" "unprognostic (2.88e-2)" "prognostic unfavourable (2.98e-6)" "unprognostic (8.93e-2)" "unprognostic (1.14e-3)" "unprognostic (1.05e-2)" "unprognostic (1.47e-1)" "unprognostic (6.50e-2)" "unprognostic (2.02e-2)" "unprognostic (5.26e-3)" "unprognostic (2.96e-1)" "unprognostic (5.68e-9)" "unprognostic (6.65e-3)" "unprognostic (4.41e-2)" "unprognostic (6.18e-3)" "unprognostic (2.22e-2)" 1.0 0.8 2.0 1.7 6.2 0.2 1.7 0.5 2.4 2.0 0.3 1.6 0.0 0.7 0.3 4.2 2.3 3.1 1.5 1.1 2.8 9.0 0.3 0.5 12.0 0.4 4.5 0.8 0.4 0.4 0.4 1.7 0.9 17.5 0.6 0.3 3.7 0.3 0.9 0.2 3.1 0.4 1.8 2.0 0.3 0.5 3.4 1.4 0.0 5.4 0.6 1.3 0.4 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.6 0.0 0.1 0.0 0.0 0.0 1.1 3.2 3.4 0.1 0.0 0.2 0.5 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 6.1 0.0 0.1 0.1 0.0 0.0 10.5 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.2 0.5 1.6 2.8 9.0 4.5 0.8 17.5 1.4 RTBDN FLJ36353 ENSG00000132026 Retbindin Q9BSG5 19 12825478-12835428 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 17.3;pituitary gland: 25.8;retina: 57.0" "Cell line enhanced" "Detected in some" "SCLC-21H: 8.0;SH-SY5Y: 5.3;U-266/84: 20.6;U-87 MG: 4.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 1.7;neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA052511 Approved "Endoplasmic reticulum" "Secreted in other tissues" "Endoplasmic reticulum" "HPA052511: " "unprognostic (4.55e-4)" "unprognostic (3.94e-3)" "unprognostic (2.18e-1)" "unprognostic (1.54e-4)" "unprognostic (3.33e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" "unprognostic (2.45e-2)" "unprognostic (2.02e-2)" "unprognostic (3.55e-1)" "unprognostic (6.48e-2)" "unprognostic (7.04e-3)" "unprognostic (7.66e-9)" "unprognostic (3.55e-2)" "unprognostic (1.00e-1)" "unprognostic (7.05e-2)" "unprognostic (2.24e-2)" 0.3 6.9 10.2 0.5 3.4 0.9 0.3 2.7 17.3 0.2 0.9 0.4 0.0 1.0 0.3 1.5 0.3 0.3 0.4 0.3 7.3 5.1 0.2 0.4 0.5 0.4 2.8 2.8 0.3 2.5 0.2 25.8 0.3 4.0 0.4 0.9 57.0 0.3 0.3 0.3 0.5 1.0 0.6 1.0 0.4 2.5 3.5 0.0 7.0 0.4 0.0 0.4 0.3 0.0 0.3 0.2 1.8 0.2 0.4 0.2 0.0 0.9 0.1 0.1 0.6 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.3 0.1 0.8 0.9 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.0 0.4 0.8 0.0 0.1 2.3 0.0 0.0 0.4 0.2 0.0 1.2 2.6 0.0 0.1 0.0 0.0 0.9 1.1 0.7 0.1 1.0 0.0 0.0 8.0 5.3 0.1 0.1 0.4 2.7 0.7 0.0 0.8 1.0 0.7 0.1 1.2 20.6 3.9 4.7 0.0 0.0 1.7 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.2 1.8 0.4 0.2 0.2 0.1 0.0 10.2 3.4 2.7 8.6 7.3 5.1 2.8 2.8 4.0 0.0 RTL1 "HUR1, Mar1, MART1, PEG11, SIRH2" ENSG00000254656 "Retrotransposon Gag like 1" A6NKG5 14 100880655-100884847 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 5.0;brain: 7.6;placenta: 8.3" "Cell line enriched" "Detected in some" 31 "SH-SY5Y: 118.2" "Cancer enhanced" "Detected in some" "melanoma: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 2.1" "HPA066979, HPA077601" Enhanced Approved Cytosol Cytosol "HPA066979: , HPA077601: " "unprognostic (1.61e-1)" "unprognostic (3.30e-1)" "unprognostic (1.26e-1)" "unprognostic (1.42e-3)" "unprognostic (2.10e-1)" 0.0 5.0 0.2 0.0 0.9 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 1.8 1.3 0.1 0.0 0.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTN1 NSP ENSG00000139970 "Reticulon 1" Q16799 14 59595976-59870966 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 144.6" "Group enriched" "Detected in some" 4 "HEL: 22.7;SCLC-21H: 28.1;SH-SY5Y: 45.0" "Cancer enhanced" "Detected in many" "glioma: 19.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9" "Group enriched" "Detected in many" 15 "dendritic cells: 7.9;monocytes: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002745, HPA040945, HPA044249" Enhanced Supported "Nuclear bodies,Endoplasmic reticulum" 140000 "Endoplasmic reticulum" "Nuclear bodies" "CAB002745: , HPA040945: , HPA044249: " "unprognostic (9.40e-3)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (4.24e-2)" "unprognostic (3.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (2.79e-1)" "prognostic favourable (3.69e-4)" "unprognostic (5.79e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.75e-1)" "unprognostic (6.71e-2)" "unprognostic (1.62e-2)" 6.3 8.3 27.4 6.1 46.3 1.6 3.0 98.5 144.6 2.6 2.9 11.0 0.0 2.7 2.1 1.6 2.3 8.6 4.4 1.9 32.3 50.7 2.3 1.9 4.8 2.7 21.3 45.9 1.7 3.6 19.2 10.3 2.7 35.1 5.0 3.0 1.2 2.3 2.6 1.6 2.3 3.4 2.7 12.1 10.6 3.6 2.6 10.5 0.0 2.7 0.0 2.3 2.5 0.9 0.0 7.9 0.4 4.6 0.0 0.0 1.0 0.0 0.0 0.3 0.3 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.8 22.7 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.2 0.1 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 28.1 45.0 5.5 0.0 0.0 0.0 0.0 0.0 3.8 1.1 0.0 2.0 0.0 0.0 0.0 7.5 1.6 0.2 0.0 4.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 1.0 27.4 46.3 98.5 94.7 32.3 50.7 21.3 45.9 35.1 10.5 RTN3 "ASYIP, HAP, NSPL2, NSPLII, RTN3-A1" ENSG00000133318 "Reticulon 3" O95197 11 63681446-63759891 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, ER-Golgi transport, Host-virus interaction, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 122.2;brain: 149.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 122.2" "Group enriched" "Detected in all" 6 "granulocytes: 122.2;monocytes: 42.2" "Low region specificity" "Detected in all" "HPA015649, HPA015650" Enhanced Supported "Endoplasmic reticulum" 620000 "Endoplasmic reticulum" "HPA015649: AB_1856498, HPA015650: AB_1856499" "unprognostic (8.11e-3)" "unprognostic (8.51e-2)" "unprognostic (3.61e-2)" "unprognostic (7.88e-3)" "unprognostic (1.41e-1)" "unprognostic (1.74e-2)" "prognostic unfavourable (1.30e-6)" "unprognostic (5.49e-2)" "unprognostic (1.25e-1)" "unprognostic (1.07e-2)" "unprognostic (2.70e-2)" "unprognostic (1.07e-1)" "prognostic favourable (9.87e-4)" "unprognostic (1.60e-2)" "unprognostic (2.54e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-2)" 43.6 19.6 72.2 11.9 71.6 22.3 21.5 55.9 149.6 21.7 20.0 50.2 9.3 12.3 14.8 19.7 12.4 21.0 13.1 12.8 78.3 72.9 22.0 19.9 17.7 7.3 72.6 53.5 11.9 20.7 36.4 14.0 14.1 109.9 12.9 18.8 12.7 30.4 18.9 10.8 22.6 14.6 18.6 66.0 9.2 12.8 10.3 39.2 6.8 40.9 5.1 10.7 13.1 8.9 3.3 14.7 122.2 42.2 4.6 7.4 28.1 30.9 22.9 27.6 26.3 51.2 36.4 11.0 28.2 30.1 25.0 26.8 19.9 68.8 36.7 48.2 42.2 32.0 39.5 13.9 33.0 29.5 21.1 46.9 33.6 13.9 42.6 41.7 37.9 24.0 41.2 30.3 33.9 33.7 26.5 59.6 21.9 25.4 22.0 46.4 32.2 26.0 29.3 19.3 67.6 49.2 17.6 58.7 34.0 45.7 50.4 52.6 55.6 34.4 31.3 14.9 20.2 51.7 21.5 38.0 32.7 29.4 57.4 34.7 15.7 40.1 42.2 52.8 4.9 21.1 5.3 3.3 5.0 4.9 14.7 2.3 3.7 4.0 122.2 4.6 25.1 8.8 7.4 28.1 72.2 71.6 55.9 118.2 78.3 72.9 72.6 53.5 109.9 39.2 RTN4R NOGOR ENSG00000040608 "Reticulon 4 receptor" Q9BZR6 22 20241415-20283246 "Disease related genes, Predicted membrane proteins" Receptor "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 12.0;brain: 33.2" "Cell line enhanced" "Detected in many" "NB-4: 20.0;REH: 28.2;SCLC-21H: 17.2;SK-MEL-30: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 12.0" "Lineage enriched" "Detected in many" 9 "T-cells: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB012443 Supported "Plasma membrane,Actin filaments,Focal adhesion sites" 1300000 "Plasma membrane, Focal adhesion sites" "Actin filaments" "CAB012443: " "unprognostic (1.28e-1)" "unprognostic (1.28e-2)" "unprognostic (8.29e-2)" "unprognostic (6.58e-2)" "unprognostic (3.49e-1)" "prognostic unfavourable (7.73e-4)" "unprognostic (2.19e-1)" "unprognostic (1.56e-1)" "unprognostic (3.44e-1)" "unprognostic (8.90e-3)" "unprognostic (1.21e-2)" "unprognostic (9.89e-2)" "unprognostic (1.80e-2)" "unprognostic (1.34e-2)" "unprognostic (1.30e-1)" "unprognostic (5.02e-2)" "unprognostic (3.07e-1)" 0.8 1.1 10.9 1.2 7.0 1.3 0.7 33.2 24.6 0.8 1.7 1.2 0.3 3.9 4.9 0.5 0.9 1.3 0.6 1.4 8.8 3.1 0.9 4.0 1.7 1.1 1.4 6.8 1.1 2.7 0.6 1.6 1.1 4.9 1.2 0.6 0.7 1.3 1.2 0.8 5.2 1.8 0.7 2.8 5.9 2.3 1.1 0.5 0.1 1.1 0.4 0.7 0.7 0.7 0.1 1.3 0.0 0.0 0.7 12.0 1.7 4.1 2.0 1.2 3.0 0.0 0.0 0.6 0.4 0.0 0.3 0.1 3.2 1.1 0.2 1.4 0.0 6.8 0.7 1.7 0.0 0.1 7.3 0.1 1.8 0.4 0.7 0.1 0.2 0.0 2.2 0.0 0.2 0.0 0.2 0.2 0.0 5.8 2.1 20.0 4.7 3.6 28.2 0.0 0.2 0.2 1.7 17.2 2.8 2.0 1.4 13.4 1.6 0.5 0.0 0.2 8.1 0.0 0.1 0.0 0.5 0.5 0.2 4.1 0.0 0.0 0.0 0.0 5.1 0.0 12.0 0.0 4.5 5.1 0.2 0.1 2.7 5.7 0.0 0.7 0.0 1.3 3.1 1.7 10.9 7.0 33.2 20.1 8.8 3.1 1.4 6.8 4.9 0.5 RTN4RL1 "DKFZp547J144, NgR3, NGRH2" ENSG00000185924 "Reticulon 4 receptor like 1" Q86UN2 17 1934677-2025345 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.6;HaCaT: 10.6;hTCEpi: 10.1;T-47d: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044428 Uncertain "Intracellular and membrane" "HPA044428: AB_10963229" "unprognostic (5.23e-1)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" "unprognostic (2.12e-1)" "unprognostic (2.93e-2)" "unprognostic (7.25e-2)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (8.97e-3)" "unprognostic (6.21e-2)" "unprognostic (2.55e-3)" "unprognostic (6.32e-3)" "prognostic unfavourable (7.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.05e-1)" "unprognostic (7.01e-2)" "unprognostic (3.15e-2)" 8.3 5.0 6.8 1.2 8.0 0.6 7.0 4.6 19.3 3.4 1.3 0.6 7.2 0.8 1.9 1.0 1.4 3.6 2.9 2.7 9.6 2.7 2.6 3.2 3.9 0.8 1.3 7.9 1.6 3.8 2.0 6.5 1.3 0.7 6.1 0.8 8.4 9.8 5.3 3.9 11.3 1.2 1.2 1.0 2.7 1.2 1.3 0.1 0.0 1.5 0.8 0.9 1.4 3.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.4 1.6 1.8 2.5 2.1 0.3 0.0 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.1 10.6 10.6 4.6 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.1 0.0 3.6 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.3 0.3 0.7 0.3 1.1 0.0 0.0 2.2 0.1 0.3 0.8 1.7 13.2 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 8.0 4.6 19.3 9.6 2.7 1.3 7.9 0.7 0.1 RTN4RL2 "NgR2, NGRH1" ENSG00000186907 "Reticulon 4 receptor like 2" Q86UN3 11 57460549-57477534 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 44.3;liver: 38.1;thyroid gland: 24.9" "Cell line enhanced" "Detected in many" "HMC-1: 16.9;Karpas-707: 25.6;REH: 15.4;RPMI-8226: 49.3" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 11 "amygdala: 17.7;basal ganglia: 17.9;cerebral cortex: 44.3;hippocampal formation: 12.4;olfactory region: 17.6" "Group enriched" "Detected in some" 4 "classical monocyte: 1.0;intermediate monocyte: 2.5;MAIT T-cell: 1.1;myeloid DC: 3.4" "Group enriched" "Detected in many" 24 "dendritic cells: 3.4;monocytes: 2.5;T-cells: 1.1" "Group enriched" "Detected in many" 4 "amygdala: 23.2;basal ganglia: 10.6;cerebral cortex: 29.8;hippocampal formation: 23.6" "Low region specificity" "Detected in many" "Intracellular and membrane" 25000000 "unprognostic (6.27e-3)" "unprognostic (2.02e-2)" "unprognostic (4.57e-2)" "unprognostic (8.40e-2)" "unprognostic (8.51e-2)" "unprognostic (7.64e-2)" "unprognostic (6.83e-2)" "unprognostic (3.72e-2)" "unprognostic (7.27e-2)" "unprognostic (2.41e-1)" "unprognostic (1.09e-2)" "unprognostic (3.28e-1)" "prognostic unfavourable (3.05e-7)" "unprognostic (3.53e-2)" "unprognostic (1.40e-1)" "unprognostic (5.16e-3)" "unprognostic (2.18e-2)" 2.7 0.9 17.7 0.9 17.9 1.4 2.4 1.6 44.3 1.5 1.0 1.0 0.0 1.8 1.5 0.8 1.2 1.2 3.8 2.1 12.4 1.5 2.0 38.1 1.9 1.0 2.0 17.6 1.0 2.8 5.4 2.5 2.7 1.0 1.9 0.7 1.9 2.8 1.0 2.3 5.3 1.2 1.4 0.7 1.3 1.9 1.5 0.1 1.0 24.9 0.5 1.0 1.3 1.2 0.0 3.4 0.0 2.5 0.0 1.1 0.0 2.6 3.8 2.9 4.9 1.2 1.7 0.3 0.0 1.0 0.1 1.0 0.5 0.5 0.1 0.1 0.1 0.0 4.5 0.0 0.0 0.6 1.8 0.7 0.3 2.6 1.7 0.6 16.9 4.6 0.5 0.4 0.4 0.0 0.6 25.6 0.0 0.5 0.1 1.9 5.0 2.9 15.4 2.0 49.3 0.0 0.0 5.4 0.4 0.4 0.2 2.8 3.2 0.7 0.0 0.2 8.9 1.2 0.9 1.5 3.2 0.5 6.4 2.7 2.1 0.0 1.0 0.0 0.2 2.5 1.1 0.0 0.3 0.0 3.4 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 17.7 17.9 1.6 44.3 12.4 1.5 2.0 17.6 1.0 0.1 RTP1 "MGC35450, Z3CXXC1" ENSG00000175077 "Receptor transporter protein 1" P59025 3 187197486-187201465 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.5;testis: 1.9" "Cell line enriched" "Detected in single" 25 "T-47d: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (2.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.29e-1)" "unprognostic (1.91e-1)" "unprognostic (2.63e-1)" "unprognostic (2.89e-1)" 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 1.3 4.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.8 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTP5 "C2orf85, CXXC11, FLJ33590, Z3CXXC5" ENSG00000188011 "Receptor transporter protein 5 (putative)" Q14D33 2 241869600-241873823 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 44.8" "Group enriched" "Detected in some" 29 "MOLT-4: 3.6;SCLC-21H: 7.2" "Cancer enriched" "Detected in single" 10 "glioma: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA050902 Enhanced "HPA050902: " "unprognostic (3.26e-2)" "unprognostic (5.38e-4)" "unprognostic (2.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.01e-1)" "unprognostic (9.40e-4)" "unprognostic (8.68e-3)" "unprognostic (2.04e-1)" "unprognostic (6.34e-4)" "unprognostic (3.30e-1)" "unprognostic (9.01e-3)" "unprognostic (3.91e-1)" "unprognostic (9.08e-8)" "unprognostic (1.81e-1)" "unprognostic (1.77e-1)" "unprognostic (2.68e-2)" "unprognostic (3.72e-2)" 0.8 0.8 27.9 1.1 44.8 1.9 0.7 0.2 13.5 0.7 0.7 2.1 0.0 0.9 0.7 0.7 0.7 0.7 0.8 0.8 32.9 24.9 0.7 0.7 0.8 2.4 3.1 4.8 0.7 0.9 0.7 0.0 0.7 7.3 0.7 0.7 0.0 0.9 0.7 0.7 0.7 0.7 0.7 2.1 1.1 0.8 0.7 1.5 0.0 0.7 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 44.8 0.2 12.7 32.9 24.9 3.1 4.8 7.3 1.5 RUFY3 "KIAA0871, RIPx, Singar1, ZFYVE30" ENSG00000018189 "RUN and FYVE domain containing 3" Q7L099 4 70704204-70807315 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 80.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022952, HPA022970" Enhanced Supported Cytosol Cytosol "HPA022952: , HPA022970: AB_1856307" "unprognostic (4.33e-2)" "unprognostic (1.60e-2)" "unprognostic (1.30e-1)" "unprognostic (3.96e-3)" "unprognostic (1.38e-1)" "prognostic favourable (1.28e-4)" "prognostic unfavourable (8.95e-4)" "unprognostic (1.69e-2)" "unprognostic (2.00e-1)" "unprognostic (3.50e-2)" "prognostic favourable (8.02e-5)" "unprognostic (7.90e-3)" "unprognostic (1.31e-3)" "unprognostic (1.26e-1)" "unprognostic (1.21e-2)" "unprognostic (7.45e-3)" "unprognostic (5.41e-1)" 10.9 24.5 39.1 11.8 53.4 6.9 12.5 36.4 66.3 12.3 8.7 24.1 6.7 8.1 20.6 16.3 15.3 9.3 12.7 8.9 64.5 34.4 15.5 13.6 14.8 13.6 37.0 51.3 25.5 9.8 8.5 61.4 12.0 54.2 13.8 11.4 12.8 10.1 11.5 15.4 29.9 9.9 15.1 80.2 16.0 12.8 25.3 32.5 7.1 31.6 5.9 11.5 9.3 12.3 3.5 6.0 0.0 3.1 2.2 2.8 1.0 3.7 2.6 31.0 7.3 15.0 17.5 12.4 12.1 4.6 3.9 4.5 4.4 9.2 14.9 5.0 10.0 3.8 4.7 5.3 6.3 8.1 6.0 3.2 3.6 4.9 8.5 3.7 1.9 12.3 8.4 5.3 6.2 8.4 8.8 15.4 8.7 4.6 23.0 3.9 7.4 3.3 5.7 9.7 6.8 7.7 3.6 29.0 14.3 4.4 7.8 7.3 5.3 1.8 7.1 13.5 9.4 4.0 2.8 17.2 7.8 15.9 14.0 2.7 2.7 0.0 3.1 0.0 2.2 3.0 2.8 3.5 1.5 2.0 6.0 3.1 1.5 1.6 0.0 2.2 2.8 4.8 1.0 1.0 39.1 53.4 36.4 66.3 64.5 34.4 37.0 51.3 54.2 32.5 RUNDC3A "RAP2IP, RPIP8" ENSG00000108309 "RUN domain containing 3A" Q59EK9 17 44308413-44318671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 92.6" "Group enriched" "Detected in some" 6 "SCLC-21H: 34.1;SH-SY5Y: 21.8" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 4 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023548, HPA070733" Enhanced Supported Approved Vesicles Vesicles "HPA023548: AB_1856069, HPA070733: AB_2732162" "unprognostic (3.66e-2)" "unprognostic (3.77e-2)" "unprognostic (3.50e-3)" "unprognostic (1.58e-3)" "unprognostic (3.04e-1)" "unprognostic (2.02e-1)" "unprognostic (3.87e-3)" "unprognostic (2.29e-1)" "unprognostic (4.63e-2)" "unprognostic (3.43e-2)" "unprognostic (1.42e-3)" "unprognostic (1.34e-1)" "unprognostic (8.87e-3)" "unprognostic (1.07e-2)" "unprognostic (5.17e-2)" "unprognostic (9.39e-2)" "unprognostic (1.84e-1)" 1.4 12.9 40.5 1.6 28.5 2.8 1.5 33.0 92.6 1.3 1.8 4.8 0.0 2.2 1.6 1.5 1.5 1.5 1.6 1.8 40.9 20.6 1.7 1.3 1.5 1.4 22.0 23.2 1.7 4.3 2.4 16.1 2.5 15.6 1.5 1.8 1.6 1.4 1.6 1.3 4.1 2.2 1.8 8.0 1.5 3.3 5.2 4.4 0.0 2.4 0.0 1.4 1.5 0.0 0.3 0.1 0.0 0.2 0.1 1.3 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.2 0.2 0.0 0.0 0.5 0.1 0.0 34.1 21.8 0.2 0.0 0.2 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.3 1.3 0.3 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 40.5 28.5 33.0 49.2 40.9 20.6 22.0 23.2 15.6 4.4 RUNDC3B "RPIB9, RPIP9" ENSG00000105784 "RUN domain containing 3B" Q96NL0 7 87627548-87832296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 13.2;brain: 16.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.9;SCLC-21H: 6.5;SH-SY5Y: 3.0;U-266/70: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1;memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056968, HPA057155" Uncertain "HPA056968: , HPA057155: " "unprognostic (2.49e-1)" "unprognostic (1.99e-1)" "unprognostic (2.12e-1)" "unprognostic (1.83e-1)" "unprognostic (2.20e-2)" "unprognostic (1.77e-3)" "unprognostic (1.19e-2)" "unprognostic (4.16e-2)" "unprognostic (2.56e-1)" "unprognostic (1.19e-1)" "unprognostic (9.42e-5)" "unprognostic (4.44e-1)" "prognostic favourable (2.62e-6)" "unprognostic (1.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.32e-1)" "unprognostic (9.55e-2)" 1.1 13.2 3.6 0.8 9.4 0.1 1.4 16.4 7.9 2.7 3.7 1.0 1.0 4.7 3.4 1.2 1.0 2.0 1.7 1.4 2.8 5.1 3.3 9.7 0.8 0.4 2.8 4.8 2.3 0.5 0.5 2.0 0.2 7.9 1.1 2.7 0.7 0.9 0.8 1.1 0.9 5.2 3.8 2.2 0.4 0.6 3.1 1.0 0.0 0.6 0.1 0.5 1.6 1.1 0.1 0.0 0.4 0.0 0.0 2.1 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 2.9 0.4 0.2 0.3 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 2.4 0.1 1.5 1.0 0.1 1.2 0.4 0.0 0.7 0.0 0.4 1.2 1.2 0.0 0.0 1.3 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.2 6.5 3.0 0.0 0.2 0.1 0.1 0.0 0.4 2.5 0.0 0.1 0.0 3.9 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.4 2.1 0.0 0.8 0.1 0.0 1.7 0.0 0.1 0.3 1.2 0.3 0.0 0.0 0.0 0.0 0.1 3.6 9.4 16.4 6.5 2.8 5.1 2.8 4.8 7.9 1.0 RUNX1T1 "AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2" ENSG00000079102 "RUNX1 translocation partner 1" Q06455 8 91954967-92103286 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 57.8" "Cell line enhanced" "Detected in many" "Daudi: 12.9;fHDF/TERT166: 11.0;HEL: 23.7;HSkMC: 9.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 57.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049852, HPA070951" Approved Supported Nucleoplasm Nucleoplasm "HPA049852: , HPA070951: " "unprognostic (2.37e-1)" "unprognostic (1.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.62e-1)" "unprognostic (3.37e-4)" "unprognostic (2.29e-4)" "unprognostic (5.56e-3)" "unprognostic (1.24e-2)" "unprognostic (1.62e-2)" "unprognostic (2.11e-2)" "unprognostic (2.37e-1)" "unprognostic (5.70e-4)" "unprognostic (8.98e-3)" "unprognostic (6.78e-2)" "unprognostic (1.51e-1)" "unprognostic (7.80e-3)" 9.6 4.6 7.7 4.5 11.5 0.4 6.9 57.8 13.0 14.0 7.8 1.1 2.0 2.0 11.8 5.9 4.1 7.7 7.8 12.3 5.8 4.0 2.5 1.3 6.0 2.0 3.6 9.6 7.7 1.8 1.7 8.6 8.7 4.2 4.2 4.0 5.3 4.7 4.1 5.5 3.6 3.6 10.3 3.0 2.9 4.2 5.6 3.7 0.0 5.2 3.3 1.8 5.7 5.9 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.3 3.5 5.1 0.0 5.1 7.8 3.4 5.3 0.0 0.0 12.9 0.0 11.0 0.0 2.7 0.3 2.3 0.0 2.1 23.7 0.0 0.0 1.4 0.0 0.0 9.5 0.0 5.7 0.2 7.3 0.1 0.0 0.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 7.7 4.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.6 0.0 2.6 0.0 4.1 0.5 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 7.7 11.5 57.8 13.0 5.8 4.0 3.6 9.6 4.2 3.7 RXFP1 "LGR7, RXFPR1" ENSG00000171509 "Relaxin/insulin like family peptide receptor 1" Q9HBX9 4 158315311-158653372 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.7;placenta: 12.2" "Group enriched" "Detected in some" 4 "EFO-21: 23.6;HEL: 7.8;RPTEC TERT1: 10.9" "Cancer enriched" "Detected in single" 9 "endometrial cancer: 3.9" "Group enriched" "Detected in many" 6 "basal ganglia: 10.4;cerebral cortex: 18.5;olfactory region: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA027067 Approved "HPA027067: AB_10602127" "unprognostic (3.07e-3)" "unprognostic (3.02e-3)" "unprognostic (1.05e-1)" "unprognostic (2.53e-3)" "unprognostic (2.97e-2)" "unprognostic (4.15e-3)" "unprognostic (6.13e-2)" "unprognostic (6.18e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-6)" "unprognostic (8.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.33e-4)" "unprognostic (3.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.31e-1)" "unprognostic (6.22e-3)" 0.5 6.5 2.1 0.5 10.4 0.2 0.4 0.4 19.7 4.0 0.5 0.0 1.1 0.3 9.0 1.6 0.5 1.3 1.2 0.4 2.0 1.7 2.9 2.1 5.1 0.7 0.8 12.4 0.8 0.6 0.2 0.6 12.2 0.0 1.0 0.3 0.6 0.4 4.2 0.4 0.4 0.9 1.3 0.4 0.6 0.6 0.6 0.0 0.0 2.4 0.0 0.6 0.5 2.2 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.1 10.4 0.4 18.5 2.0 1.7 0.8 12.4 0.0 0.0 RXFP2 "GPR106, GREAT, INSL3R, LGR8, RXFPR2" ENSG00000133105 "Relaxin/insulin like family peptide receptor 2" Q8WXD0 13 31739542-31803388 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.3;epididymis: 28.4" "Group enriched" "Detected in some" 6 "U-2197: 2.1;U-87 MG: 4.0" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "basal ganglia: 8.3" "Cell type enriched" "Detected in single" 11 "classical monocyte: 5.0" "Lineage enriched" "Detected in single" 23 "monocytes: 5.0" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 7 "basal ganglia: 2.0" "unprognostic (1.77e-2)" 0.5 3.3 1.5 0.1 8.3 2.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.9 28.4 0.0 1.5 0.1 0.5 0.6 0.5 0.3 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.6 0.0 0.2 0.0 3.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 5.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 5.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.5 8.3 0.0 0.5 0.6 0.5 0.0 0.0 0.5 0.0 RXFP3 "GPCR135, RLN3R1, RXFPR3, SALPR" ENSG00000182631 "Relaxin/insulin like family peptide receptor 3" Q9NSD7 5 33936386-33938237 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 3.1;brain: 1.1;pancreas: 1.7;pituitary gland: 1.1" "Cell line enhanced" "Detected in single" "RPTEC TERT1: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027833 Uncertain "HPA027833: AB_1849247" "unprognostic (1.93e-2)" "unprognostic (3.66e-1)" "unprognostic (2.89e-1)" "unprognostic (2.86e-1)" "unprognostic (9.68e-2)" "unprognostic (1.72e-1)" "unprognostic (8.67e-3)" 0.0 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RXRG NR2B3 ENSG00000143171 "Retinoid X receptor gamma" P48443 1 165400917-165445355 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;pituitary gland: 29.8;retina: 13.5;skeletal muscle: 44.8" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 28.3" "Group enriched" "Detected in many" 13 "melanoma: 25.7;thyroid cancer: 34.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "basal ganglia: 89.8" "Low region specificity" "Detected in all" "CAB002615, HPA012933" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB002615: , HPA012933: " "unprognostic (2.29e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.66e-1)" "unprognostic (4.29e-2)" "unprognostic (6.19e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-2)" "unprognostic (9.13e-2)" "unprognostic (6.86e-2)" "unprognostic (2.95e-2)" "unprognostic (5.41e-3)" "unprognostic (2.52e-2)" "unprognostic (6.12e-3)" "unprognostic (1.18e-1)" "prognostic favourable (9.40e-5)" "unprognostic (5.03e-2)" 1.9 3.9 5.4 1.0 14.9 0.6 1.0 0.3 5.9 4.0 2.5 5.3 0.6 1.3 1.8 1.3 1.7 3.6 1.2 5.8 7.5 8.9 0.7 0.8 3.4 0.8 4.1 4.3 1.7 2.7 0.8 29.8 1.3 14.1 1.1 2.7 13.5 1.9 2.1 44.8 2.9 2.0 1.8 8.9 1.0 1.1 1.5 5.4 0.0 1.1 2.5 0.6 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 14.9 0.3 5.9 7.5 8.9 4.1 4.3 14.1 5.4 S100B S100beta ENSG00000160307 "S100 calcium binding protein B" P04271 21 46598962-46605208 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 342.0" "Group enriched" "Detected in some" 7 "SK-MEL-30: 81.0;WM-115: 159.2" "Group enriched" "Detected in all" 58 "glioma: 463.5;melanoma: 495.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 78.0" "Lineage enriched" "Detected in many" 7 "T-cells: 78.0" "Low region specificity" "Detected in all" "CAB000073, HPA015768, CAB078196" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol 120000 "Nucleoplasm, Cytosol" Vesicles "CAB000073: AB_10013383, CAB078196: , HPA015768: AB_1856538" "unprognostic (5.67e-3)" "unprognostic (6.39e-3)" "unprognostic (2.08e-3)" "unprognostic (2.08e-2)" "unprognostic (4.54e-3)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.57e-3)" "unprognostic (6.70e-2)" "unprognostic (4.41e-7)" "unprognostic (3.55e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" 67.7 14.0 60.9 5.6 51.0 2.0 13.2 39.4 151.2 5.2 9.1 101.0 3.0 4.7 1.5 7.6 8.6 2.1 8.3 6.6 74.6 65.4 1.5 1.6 2.9 9.8 152.0 36.5 2.4 3.0 1.1 3.1 1.4 90.3 3.0 8.3 7.4 10.1 15.3 1.3 5.7 7.5 4.3 342.0 5.7 4.3 1.5 46.4 0.0 1.3 1.8 10.8 8.2 1.6 0.1 3.4 0.7 1.9 11.0 78.0 10.6 0.1 0.0 17.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 81.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 1.0 159.2 0.0 0.1 0.0 78.0 1.8 22.4 0.0 0.2 14.5 3.4 0.1 0.6 33.3 0.7 11.0 1.9 0.8 0.0 10.6 60.9 51.0 39.4 37.6 74.6 65.4 152.0 36.5 90.3 46.4 S1PR5 "Edg-8, EDG8" ENSG00000180739 "Sphingosine-1-phosphate receptor 5" Q9H228 19 10512742-10517931 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 62.0;brain: 37.8;skin 1: 25.4" "Cell line enhanced" "Detected in some" "HaCaT: 21.5;HBEC3-KT: 8.3;RT4: 14.0;T-47d: 8.9;U-2 OS: 8.0" "Group enriched" "Detected in many" 5 "cervical cancer: 11.7;head and neck cancer: 8.0;lung cancer: 3.7;urothelial cancer: 6.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 62.0;MAIT T-cell: 38.0;memory CD8 T-cell: 29.2;naive CD8 T-cell: 23.2" "Lineage enriched" "Detected in many" 8 "T-cells: 62.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029683 Enhanced "HPA029683: AB_10603237" "unprognostic (9.07e-3)" "unprognostic (1.27e-1)" "unprognostic (1.28e-2)" "unprognostic (5.55e-4)" "unprognostic (4.21e-1)" "unprognostic (4.85e-2)" "unprognostic (9.30e-2)" "unprognostic (1.55e-1)" "unprognostic (3.48e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (6.71e-7)" "unprognostic (2.46e-2)" "unprognostic (2.90e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-1)" 1.4 1.0 10.0 1.6 17.4 21.0 1.1 1.9 15.1 2.7 1.0 37.8 0.0 0.9 1.1 6.9 6.5 1.0 1.0 0.9 15.7 8.0 1.1 2.7 3.0 1.7 28.8 9.3 0.7 0.8 0.6 0.2 2.8 13.9 2.0 0.8 0.7 1.3 1.4 1.4 25.4 1.0 0.9 26.2 11.6 0.9 0.9 21.0 0.0 0.8 0.2 3.3 3.1 5.0 0.1 0.1 0.8 0.1 8.1 62.0 10.2 1.4 2.2 0.4 0.0 0.0 0.1 0.1 0.5 0.3 0.6 0.4 0.2 0.1 0.0 5.9 0.2 21.5 1.4 8.3 1.6 0.0 1.4 0.2 1.7 0.0 0.0 0.0 0.1 0.0 3.9 2.3 0.4 0.0 0.1 0.0 0.0 2.7 0.8 0.0 3.4 0.4 0.0 1.6 0.0 0.0 14.0 0.0 0.0 3.5 0.0 0.4 8.9 2.5 0.0 1.1 8.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.2 62.0 0.0 38.0 0.1 7.8 29.2 0.1 0.1 2.4 23.2 0.8 8.1 0.1 0.1 0.1 10.2 10.0 17.4 1.9 15.1 15.7 8.0 28.8 9.3 13.9 21.0 SALL1 "Hsal1, TBS, ZNF794" ENSG00000103449 "Spalt like transcription factor 1" Q9NSC2 16 51135975-51151367 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.9;kidney: 26.8;liver: 32.0" "Cell line enhanced" "Detected in some" "AF22: 14.8;BJ hTERT+: 12.7;NTERA-2: 24.1;RPTEC TERT1: 20.4;U-87 MG: 23.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 5 "olfactory region: 64.6" "Low region specificity" "Detected in many" "HPA049829, HPA074673" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol" Nucleoplasm "Nucleoli, Nuclear speckles, Cytosol" "HPA049829: , HPA074673: " "unprognostic (9.91e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-6)" "prognostic favourable (1.28e-4)" "unprognostic (2.55e-1)" "unprognostic (1.17e-1)" "unprognostic (1.96e-2)" "unprognostic (4.41e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (1.48e-1)" "unprognostic (3.96e-1)" "prognostic favourable (1.91e-7)" "unprognostic (1.86e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-2)" "unprognostic (1.76e-1)" 0.8 0.7 12.2 1.2 14.5 0.7 0.9 1.7 18.9 16.1 3.1 31.9 0.0 1.6 17.8 1.5 0.8 10.4 1.1 1.2 13.6 5.5 26.8 32.0 0.6 0.6 21.8 9.1 5.2 1.6 0.9 4.3 4.3 17.6 1.3 3.2 0.0 0.9 2.3 0.6 0.7 1.4 9.4 19.7 0.7 3.0 2.2 19.4 0.0 23.7 0.0 0.6 2.2 4.8 1.0 1.9 2.3 3.1 0.1 1.1 1.1 0.0 0.8 14.8 0.1 0.4 0.3 0.0 4.9 12.7 0.3 0.7 0.0 0.0 0.0 5.7 6.9 0.0 9.2 0.0 0.4 0.0 5.6 0.0 0.0 8.9 0.3 0.0 4.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 1.8 0.9 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 23.5 0.0 4.9 0.6 3.1 2.3 0.7 2.0 0.7 1.0 1.0 0.9 1.9 0.8 0.6 0.6 1.8 0.1 1.5 1.9 1.1 1.1 12.2 14.5 1.7 10.3 13.6 5.5 21.8 9.1 17.6 19.4 SALL2 "Hsal2, KIAA0360, ZNF795" ENSG00000165821 "Spalt like transcription factor 2" Q9Y467 14 21521081-21537216 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9;parathyroid gland: 36.0" "Cell line enhanced" "Detected in many" "AF22: 46.1;NTERA-2: 34.8;SCLC-21H: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;T-cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004162 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA004162: " "unprognostic (5.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.21e-2)" "prognostic unfavourable (3.97e-4)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (4.58e-3)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "prognostic favourable (1.23e-4)" "unprognostic (7.98e-2)" "unprognostic (2.09e-1)" "unprognostic (5.28e-3)" "unprognostic (2.03e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" 2.6 4.7 11.5 1.6 12.7 0.5 5.3 30.9 21.9 7.5 4.5 10.4 2.9 2.3 10.5 6.0 3.5 11.6 4.0 3.7 11.7 8.9 4.2 1.7 4.8 1.9 7.4 9.3 19.5 3.7 36.0 10.9 1.5 13.5 5.8 2.4 4.3 3.3 10.0 2.1 2.2 3.1 10.5 9.5 2.1 3.2 1.9 11.4 3.7 12.0 0.1 1.9 4.6 4.8 0.3 1.7 0.0 0.0 0.5 3.8 0.6 0.0 0.8 46.1 11.5 0.8 0.7 0.0 1.0 1.4 3.6 3.0 0.8 0.6 0.0 1.0 1.3 0.1 11.2 1.2 4.3 0.7 6.4 0.0 0.4 1.0 1.4 0.0 0.0 3.1 0.3 1.5 0.0 0.9 7.5 0.0 2.9 0.8 7.1 0.0 34.8 0.2 6.7 1.1 0.0 3.3 4.8 15.7 8.8 0.0 0.2 0.1 4.6 0.1 0.0 0.5 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 1.0 0.1 1.5 1.2 0.2 0.3 1.8 3.8 0.0 0.5 0.0 1.7 1.6 0.6 11.5 12.7 30.9 14.3 11.7 8.9 7.4 9.3 13.5 11.4 SALL3 ZNF796 ENSG00000256463 "Spalt like transcription factor 3" Q9BXA9 18 78980275-79002677 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.6;vagina: 6.6" "Group enriched" "Detected in some" 30 "HAP1: 6.7;HEK 293: 3.9;NTERA-2: 13.6" "Cancer enriched" "Detected in some" 6 "glioma: 6.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "olfactory region: 15.4" "Low region specificity" "Detected in many" HPA016656 Uncertain "HPA016656: AB_1856546" "unprognostic (3.96e-2)" "unprognostic (3.41e-3)" "unprognostic (8.16e-2)" "unprognostic (1.87e-2)" "unprognostic (2.37e-1)" "unprognostic (4.23e-1)" "unprognostic (2.12e-1)" "unprognostic (1.11e-1)" "unprognostic (3.22e-1)" "unprognostic (5.86e-3)" 0.7 0.7 7.3 0.7 7.6 0.7 0.7 0.3 11.6 0.9 0.7 8.3 0.0 0.7 0.7 2.1 0.7 0.7 0.7 1.2 7.1 5.4 4.4 0.7 0.7 0.7 5.7 3.3 0.7 0.7 0.7 1.1 0.8 6.8 6.0 0.7 0.2 0.7 1.2 0.7 0.7 0.7 0.7 8.8 0.7 0.7 2.4 4.6 0.0 0.9 0.0 0.7 0.8 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 7.6 0.3 6.6 7.1 5.4 5.7 3.3 6.8 4.6 SAMD10 C20orf136 ENSG00000130590 "Sterile alpha motif domain containing 10" Q9BYL1 20 63974113-63980008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;T-cells: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040973 Approved Approved Nucleoplasm Nucleoplasm "HPA040973: AB_10794258" "unprognostic (5.89e-3)" "unprognostic (1.16e-3)" "unprognostic (6.27e-2)" "unprognostic (3.19e-1)" "unprognostic (2.28e-1)" "unprognostic (2.84e-3)" "prognostic unfavourable (4.60e-4)" "unprognostic (2.69e-2)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.96e-2)" "unprognostic (1.08e-1)" "unprognostic (5.83e-2)" "unprognostic (4.97e-3)" "unprognostic (4.20e-1)" "unprognostic (1.28e-1)" "unprognostic (6.94e-3)" 2.4 2.8 6.4 6.1 14.5 3.4 5.4 25.7 10.4 2.3 4.4 1.6 9.2 7.3 1.4 3.0 10.3 4.7 8.8 3.2 5.5 5.0 6.5 4.4 3.6 10.1 3.5 3.5 0.5 5.6 5.3 3.3 3.3 3.2 4.8 3.7 2.7 9.7 6.5 1.7 9.3 6.8 1.5 1.9 5.7 10.2 3.2 2.4 5.7 3.1 2.7 12.3 5.4 4.2 2.9 1.0 0.6 0.4 1.0 6.2 1.6 5.9 0.0 2.0 0.2 0.5 0.6 0.1 1.9 1.5 3.9 1.8 5.7 11.4 0.4 4.0 0.9 8.0 1.9 2.4 2.0 11.9 4.0 1.9 5.9 8.5 0.8 9.8 16.0 0.5 4.3 2.1 0.3 1.8 4.7 4.9 0.7 4.5 4.4 9.2 3.2 9.1 6.3 0.1 10.4 6.4 10.3 2.2 4.6 1.3 11.1 2.4 7.5 4.9 1.7 1.2 2.8 0.0 0.3 1.0 0.7 3.3 3.8 8.0 1.1 0.0 0.2 0.6 4.9 0.2 2.7 2.9 3.3 2.9 0.6 1.3 5.6 6.2 0.0 1.0 0.4 1.0 2.5 1.6 6.4 14.5 25.7 10.4 5.5 5.0 3.5 3.5 3.2 2.4 SAMD14 FLJ36890 ENSG00000167100 "Sterile alpha motif domain containing 14" Q8IZD0 17 50110040-50129882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 45.8" "Cell line enhanced" "Detected in some" "HDLM-2: 10.6;HEL: 6.7;HMC-1: 22.7;SH-SY5Y: 10.7" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051916 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA051916: " "unprognostic (2.33e-2)" "unprognostic (6.05e-2)" "unprognostic (2.85e-1)" "unprognostic (2.10e-1)" "unprognostic (3.24e-1)" "unprognostic (2.31e-1)" "unprognostic (8.84e-3)" "unprognostic (6.77e-2)" "unprognostic (1.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-2)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (7.48e-4)" 2.8 3.8 18.3 3.9 19.5 2.0 1.0 45.8 18.5 2.4 2.2 3.1 1.1 2.0 3.2 4.3 1.6 1.3 2.2 1.5 15.4 10.3 2.9 1.7 5.4 2.2 7.9 16.1 1.7 1.5 2.9 2.1 3.9 10.9 3.9 1.8 4.3 1.3 4.0 6.1 1.6 2.6 2.8 6.8 3.0 3.2 4.6 6.9 0.0 1.3 0.0 3.2 2.2 0.9 0.0 0.0 2.3 0.0 0.3 0.0 0.4 0.0 0.1 3.9 0.0 1.0 0.2 0.0 2.5 0.9 0.0 0.0 0.5 0.0 0.1 3.6 1.0 0.1 0.2 0.0 0.1 10.6 0.1 6.7 0.2 0.0 0.6 0.0 22.7 0.3 0.0 0.0 0.0 0.6 0.2 0.3 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 3.6 10.7 0.0 0.0 0.0 0.2 0.1 0.1 0.4 1.4 0.2 0.0 0.2 0.0 0.0 1.9 0.0 0.8 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 18.3 19.5 45.8 18.5 15.4 10.3 7.9 16.1 10.9 6.9 SAPCD2 "C9orf140, p42.3" ENSG00000186193 "Suppressor APC domain containing 2" Q86UD0 9 137062124-137070588 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell line enhanced" "Detected in many" "MCF7: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044154 Approved Supported Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA044154: AB_10959464" "unprognostic (3.68e-2)" "unprognostic (9.85e-2)" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.80e-2)" "unprognostic (1.27e-1)" "unprognostic (5.42e-8)" "prognostic unfavourable (5.88e-4)" "unprognostic (8.33e-2)" "unprognostic (7.47e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (9.83e-7)" "unprognostic (4.37e-3)" "unprognostic (4.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.35e-2)" 1.0 0.4 11.5 10.5 7.0 3.3 2.6 1.4 14.4 2.5 6.2 10.1 0.0 7.6 1.0 0.4 7.8 0.8 5.4 0.4 9.6 7.5 1.2 0.4 2.7 4.7 8.0 3.8 0.3 0.8 0.3 0.4 1.8 5.4 5.4 3.5 0.0 7.3 0.4 0.4 5.4 7.7 1.0 7.0 2.7 4.6 1.5 2.7 9.2 0.6 3.5 10.0 1.0 1.9 0.5 0.8 0.5 1.7 0.0 0.4 0.4 16.4 8.9 3.5 10.5 0.1 0.2 19.0 2.7 1.8 2.9 1.3 16.9 7.6 17.2 8.9 1.3 23.5 11.1 3.1 0.6 11.9 12.8 7.5 9.9 18.9 0.0 8.5 13.1 0.0 0.5 1.0 1.9 4.7 10.4 7.8 0.8 38.9 2.4 23.1 6.6 20.4 26.4 13.5 19.2 3.6 4.8 18.5 10.9 10.5 29.4 4.0 23.7 16.3 3.0 2.6 9.1 8.0 13.4 2.7 7.8 8.3 6.2 10.2 8.4 0.2 1.7 0.0 0.0 0.5 0.4 0.5 0.3 0.0 0.8 0.2 0.1 0.0 0.5 0.0 0.8 0.2 0.3 0.4 11.5 7.0 1.4 6.1 9.6 7.5 8.0 3.8 5.4 2.7 SATB2 "FLJ21474, KIAA1034" ENSG00000119042 "SATB homeobox 2" Q9UPW6 2 199269500-199471266 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.1;intestine: 33.2;lymphoid tissue: 11.0" "Cell line enhanced" "Detected in many" "HEL: 19.4;K-562: 21.2;THP-1: 28.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 10.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "amygdala: 7.9;cerebral cortex: 29.7;hippocampal formation: 19.7" "Group enriched" "Detected in many" 10 "cerebral cortex: 52.6;hippocampal formation: 45.2" "HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231" Enhanced Supported Nucleoplasm Nucleoplasm "CAB023669: AB_1129287, CAB062562: , CAB067751: , CAB068229: , CAB068230: , CAB068231: , HPA001042: AB_10601711, HPA029543: AB_10959737" "unprognostic (1.77e-2)" "unprognostic (1.90e-1)" "unprognostic (8.53e-3)" "unprognostic (4.77e-2)" "unprognostic (1.07e-1)" "unprognostic (9.39e-3)" "unprognostic (1.80e-1)" "unprognostic (5.54e-3)" "unprognostic (8.26e-2)" "unprognostic (3.75e-1)" "unprognostic (2.04e-2)" "unprognostic (1.13e-1)" "prognostic favourable (5.37e-8)" "unprognostic (1.14e-1)" "unprognostic (2.84e-1)" "unprognostic (7.95e-6)" "unprognostic (1.08e-3)" 2.4 5.0 4.5 11.0 10.0 0.5 2.0 0.5 26.1 2.3 27.9 0.4 0.4 1.4 1.7 1.1 0.9 1.1 1.4 0.7 5.6 1.6 3.6 2.8 0.8 0.6 2.3 15.5 1.9 3.4 3.1 1.1 0.8 4.6 1.9 33.2 0.1 1.5 2.6 2.1 1.7 5.0 2.9 4.9 0.7 1.0 2.4 0.0 0.0 1.6 2.4 1.0 1.6 3.1 0.2 0.0 0.0 0.7 0.0 0.5 0.1 1.2 0.8 8.7 4.0 4.2 5.1 0.6 3.0 4.4 2.2 2.9 0.1 2.8 0.4 0.1 6.5 0.2 6.9 1.8 3.5 4.4 6.0 19.4 1.6 2.3 0.9 8.8 8.6 2.4 3.2 4.3 2.8 0.2 21.2 0.0 6.3 0.4 0.4 11.0 1.6 1.4 0.8 3.0 0.1 3.3 0.3 1.9 0.0 1.5 0.0 4.5 1.8 28.9 3.0 15.9 3.0 5.0 8.0 1.3 4.1 12.7 11.0 7.1 12.5 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 4.5 10.0 0.5 26.1 5.6 1.6 2.3 15.5 4.6 0.0 SATL1 ENSG00000184788 "Spermidine/spermine N1-acetyl transferase like 1" Q86VE3 X 85092287-85243961 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.7;brain: 5.4;pituitary gland: 7.2;testis: 4.8" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HAP1: 3.4;HEL: 1.1;RH-30: 1.5;SH-SY5Y: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA060369 Uncertain "HPA060369: " "unprognostic (1.77e-1)" "unprognostic (2.06e-1)" "unprognostic (4.69e-3)" "unprognostic (7.88e-2)" 0.3 2.7 2.9 0.4 2.6 0.4 0.4 5.4 4.6 0.4 0.4 0.2 0.0 0.3 0.4 0.3 0.3 0.4 0.3 0.5 2.2 2.0 1.1 0.4 0.3 0.3 1.1 2.7 0.4 0.3 0.3 7.2 0.4 2.2 0.5 0.4 0.0 0.4 0.3 0.7 0.6 0.3 0.3 1.4 0.4 0.3 4.8 0.4 0.0 0.4 0.2 0.3 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 3.4 0.0 0.0 0.0 0.6 1.1 0.1 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.0 1.5 0.0 0.0 0.1 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 2.6 5.4 4.6 2.2 2.0 1.1 2.7 2.2 0.4 SBK1 Sbk ENSG00000188322 "SH3 domain binding kinase 1" Q52WX2 16 28292519-28323849 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 31.1;lymphoid tissue: 22.1;skeletal muscle: 39.6" "Cell line enhanced" "Detected in some" "AF22: 15.0;AN3-CA: 10.8;NTERA-2: 15.4;REH: 16.3;SCLC-21H: 23.8;SH-SY5Y: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.3;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.4;naive CD8 T-cell: 3.0;NK-cell: 1.4;T-reg: 1.4" "Group enriched" "Detected in many" 10 "NK-cells: 1.4;T-cells: 4.3" "Region enriched" "Detected in all" 5 "cerebellum: 306.7" "unprognostic (5.15e-2)" "prognostic favourable (6.88e-4)" "unprognostic (2.08e-1)" "unprognostic (6.22e-2)" "unprognostic (1.81e-1)" "unprognostic (1.71e-2)" "unprognostic (5.71e-3)" "unprognostic (3.66e-3)" "unprognostic (1.17e-1)" "unprognostic (1.62e-2)" "unprognostic (2.87e-2)" "unprognostic (6.38e-2)" "unprognostic (1.19e-3)" "unprognostic (3.99e-2)" "unprognostic (3.50e-2)" "unprognostic (7.91e-2)" "unprognostic (5.03e-3)" 0.9 2.0 8.0 1.8 7.3 2.0 1.7 31.1 17.5 1.7 1.2 1.5 0.0 1.1 1.9 1.3 1.5 1.6 1.0 1.8 9.9 5.6 1.6 0.9 1.8 2.7 6.0 4.0 1.1 2.7 4.2 4.1 0.8 8.3 2.6 1.2 1.4 3.8 1.0 39.6 1.4 1.1 0.9 3.1 2.8 1.6 2.3 3.1 22.1 2.6 0.0 1.7 1.2 0.3 0.2 0.2 0.2 0.1 1.4 4.3 0.4 0.1 0.2 15.0 10.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.0 0.3 4.5 0.1 0.0 1.5 0.5 0.0 0.1 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 1.8 6.9 0.1 15.4 0.1 16.3 0.8 0.1 0.1 0.9 23.8 22.4 0.3 1.4 0.2 1.7 0.0 0.4 0.0 2.3 0.2 0.1 0.2 0.0 0.2 0.1 0.2 0.8 0.2 0.1 0.1 4.3 0.0 1.4 0.0 1.2 2.4 0.0 0.2 1.4 3.0 0.1 1.4 0.1 0.2 1.4 0.4 8.0 7.3 31.1 17.5 9.9 5.6 6.0 4.0 8.3 3.1 SCAMP5 MGC24969 ENSG00000198794 "Secretory carrier membrane protein 5" Q8TAC9 15 74957219-75021496 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 39.4;SH-SY5Y: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 24 "plasmacytoid DC: 20.0" "Lineage enriched" "Detected in single" 24 "dendritic cells: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046645 Enhanced "HPA046645: AB_2679734" "unprognostic (1.37e-1)" "unprognostic (3.30e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-2)" "unprognostic (2.74e-1)" "unprognostic (4.46e-2)" "unprognostic (2.56e-1)" "unprognostic (4.13e-1)" "unprognostic (2.34e-1)" "unprognostic (8.37e-2)" "prognostic favourable (5.67e-5)" "unprognostic (9.82e-2)" "prognostic favourable (1.34e-6)" "unprognostic (7.27e-2)" "unprognostic (3.01e-1)" "unprognostic (1.69e-1)" "unprognostic (3.31e-2)" 2.1 11.1 29.2 2.5 35.7 1.7 2.1 57.5 87.0 1.5 3.3 7.5 0.0 20.6 3.3 2.4 1.3 3.1 3.3 2.8 32.4 32.1 8.9 2.6 1.9 4.0 23.9 27.8 3.6 16.7 27.0 7.4 3.8 31.1 2.6 3.1 10.7 4.1 1.9 0.8 1.6 14.7 2.1 11.9 3.6 8.2 5.6 5.6 0.0 3.8 0.0 5.3 5.5 0.7 0.2 20.0 0.8 0.1 0.3 0.2 0.2 0.6 8.0 1.7 5.5 0.1 0.1 0.2 0.2 0.2 1.8 0.6 2.1 4.0 11.9 3.8 0.4 0.5 6.8 0.4 0.6 1.8 0.8 1.5 0.8 10.9 1.2 0.3 5.1 0.6 0.9 0.4 0.1 0.7 0.1 9.8 0.4 6.4 0.4 4.3 5.9 3.1 0.2 1.4 2.8 0.4 3.7 39.4 22.0 8.7 6.0 11.9 3.4 14.5 0.5 0.5 3.8 0.8 0.5 0.9 0.9 1.1 1.4 9.2 2.1 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.8 0.3 0.1 20.0 0.0 0.2 29.2 35.7 57.5 64.8 32.4 32.1 23.9 27.8 31.1 5.6 SCART1 CD163c-alpha ENSG00000214279 "Scavenger receptor family member expressed on T cells 1" Q4G0T1 10 133453928-133523558 "Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.6" "Group enriched" "Detected in some" 5 "HMC-1: 7.1;NB-4: 6.5;THP-1: 2.1;U-266/84: 7.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA043101 Supported "HPA043101: AB_10797026" "unprognostic (4.32e-2)" "unprognostic (2.15e-2)" "unprognostic (1.13e-2)" "unprognostic (2.40e-2)" "unprognostic (7.42e-2)" "unprognostic (8.20e-4)" "unprognostic (1.29e-3)" "unprognostic (4.28e-3)" "unprognostic (2.63e-2)" "unprognostic (1.68e-1)" "unprognostic (2.91e-1)" "unprognostic (2.24e-2)" "unprognostic (6.24e-5)" "unprognostic (8.53e-2)" "unprognostic (1.25e-1)" "unprognostic (5.03e-2)" "unprognostic (1.94e-1)" 0.3 0.2 0.0 0.3 0.5 1.6 0.0 0.4 4.8 0.1 0.3 0.2 0.0 1.3 0.9 0.0 0.4 0.0 0.9 0.0 5.6 0.7 0.2 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.3 0.3 0.0 0.2 0.8 0.4 0.2 0.2 0.7 1.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.1 0.2 0.2 0.0 0.4 0.3 0.8 0.4 0.2 1.2 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.2 0.0 0.3 0.4 0.8 0.1 0.0 0.0 0.2 7.1 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.1 0.3 0.3 6.5 0.2 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.1 0.0 0.1 0.4 0.0 0.4 0.5 7.1 1.1 0.0 0.0 0.3 0.8 0.2 0.3 0.3 0.1 1.2 0.3 0.4 0.6 0.1 0.4 0.3 0.4 0.2 0.2 0.4 0.3 0.1 0.0 SCD "FADS5, SCDOS" ENSG00000099194 "Stearoyl-CoA desaturase" O00767 10 100347124-100364834 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8" "Cell line enhanced" "Detected in many" "ASC diff: 199.5;CAPAN-2: 138.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012107, HPA063921" Approved Enhanced "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA012107: AB_1856610, HPA063921: " "unprognostic (2.10e-1)" "unprognostic (2.62e-3)" "unprognostic (7.86e-2)" "unprognostic (5.19e-2)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (1.13e-1)" "unprognostic (3.88e-2)" "unprognostic (6.53e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "prognostic unfavourable (7.56e-5)" "unprognostic (7.18e-2)" "unprognostic (3.27e-1)" "unprognostic (4.73e-2)" "prognostic unfavourable (7.79e-5)" 245.0 21.3 59.8 11.4 32.7 5.5 94.0 12.7 83.9 5.3 10.8 63.6 0.1 21.4 3.7 7.0 13.4 1.7 18.3 109.2 61.5 43.4 5.0 130.8 32.2 23.1 65.1 23.6 12.7 6.1 7.7 1.5 5.3 34.5 24.4 10.1 4.5 24.9 3.7 2.4 3.4 6.1 4.6 130.0 4.2 5.9 12.2 35.4 1.4 2.0 6.9 5.4 3.7 5.0 2.0 5.3 0.2 3.3 2.9 5.1 2.1 30.4 28.0 59.8 40.9 199.5 115.1 12.2 3.2 72.1 7.8 41.8 24.1 138.2 12.8 2.6 7.6 54.4 32.9 116.8 6.9 4.3 13.6 7.2 17.8 48.2 38.6 10.0 7.8 62.6 35.4 30.4 53.6 14.8 20.0 39.2 3.1 47.6 11.3 12.0 20.7 8.1 5.3 22.1 40.2 34.2 34.1 3.7 14.4 6.4 30.5 62.7 34.2 21.6 5.9 0.7 9.3 0.7 6.7 11.0 5.8 19.8 14.3 31.3 5.0 0.0 1.5 0.0 3.0 3.3 5.1 1.3 1.2 1.6 5.3 2.0 1.0 2.9 0.2 2.9 0.0 3.0 0.0 2.1 59.8 32.7 12.7 27.9 61.5 43.4 65.1 23.6 34.5 35.4 SCD5 "ACOD4, FADS4, FLJ21032, HSCD5, SCD4" ENSG00000145284 "Stearoyl-CoA desaturase 5" Q86SK9 4 82629539-82798857 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 69.1;brain: 137.3;epididymis: 44.5;ovary: 42.7" "Cell line enhanced" "Detected in many" "BJ: 27.1;RPTEC TERT1: 35.8" "Group enriched" "Detected in all" 6 "glioma: 152.4;thyroid cancer: 38.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042380 Uncertain "HPA042380: AB_10794797" "unprognostic (3.23e-2)" "unprognostic (3.84e-2)" "unprognostic (2.86e-1)" "unprognostic (6.98e-2)" "unprognostic (1.58e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (3.82e-2)" "unprognostic (6.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.04e-1)" "unprognostic (2.37e-2)" "prognostic favourable (2.32e-5)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.88e-3)" "unprognostic (2.92e-2)" 3.0 69.1 61.2 2.7 48.6 2.5 3.0 33.5 137.3 5.9 3.0 50.4 1.8 3.0 6.7 44.5 3.7 9.3 5.1 3.5 49.6 43.4 15.4 2.3 7.5 2.3 58.2 36.3 42.7 18.1 2.2 6.9 4.4 42.0 6.9 3.0 6.3 5.6 12.4 1.7 4.8 3.7 6.2 57.1 3.0 4.3 14.8 43.4 1.2 16.4 0.0 3.0 3.8 2.0 0.9 1.3 3.0 1.2 2.0 7.2 1.8 4.4 2.8 14.5 7.4 8.0 5.2 0.3 27.1 13.4 11.9 9.2 0.3 0.7 8.8 9.5 5.6 7.9 4.2 3.0 15.0 1.7 1.9 0.4 3.5 0.4 1.2 3.9 2.9 4.1 12.2 2.4 2.1 19.0 0.6 1.1 6.2 1.7 16.0 0.9 1.1 1.9 13.7 8.6 6.9 35.8 4.4 8.1 4.6 4.5 0.4 2.6 0.6 2.0 23.3 12.8 7.5 4.8 7.3 2.5 1.0 0.9 6.2 4.1 3.6 3.0 1.2 0.4 7.2 0.5 4.6 0.5 1.7 4.3 0.5 0.9 1.5 5.1 2.0 2.0 0.9 1.3 0.4 1.8 61.2 48.6 33.5 41.2 49.6 43.4 58.2 36.3 42.0 43.4 SCG2 "CHGC, SgII, SN" ENSG00000171951 "Secretogranin II" P13521 2 223596940-223602503 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 26.2;HSkMC: 22.4;SCLC-21H: 22.8;SH-SY5Y: 9.9;WM-115: 16.7" "Group enriched" "Detected in many" 8 "glioma: 70.0;pancreatic cancer: 52.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011893, HPA075062" Enhanced Supported Approved "Golgi apparatus,Vesicles" "Secreted to blood" 54000 "Golgi apparatus" Vesicles "HPA011893: AB_1856656, HPA075062: AB_2732277" "unprognostic (2.93e-2)" "unprognostic (1.44e-2)" "unprognostic (1.23e-3)" "unprognostic (6.82e-4)" "unprognostic (2.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.77e-3)" "unprognostic (6.73e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "prognostic favourable (5.58e-4)" "unprognostic (1.34e-1)" "prognostic unfavourable (7.01e-10)" "unprognostic (2.47e-3)" "unprognostic (4.02e-1)" "unprognostic (1.57e-2)" "unprognostic (1.90e-3)" 3.5 133.0 13.3 11.0 94.1 0.9 0.9 5.6 55.9 1.4 5.4 5.8 0.0 17.3 2.1 0.9 1.0 0.8 2.2 1.4 10.5 79.4 1.0 0.8 1.9 0.9 21.7 11.0 1.3 10.7 1.1 76.5 1.1 57.7 2.1 5.5 1.5 0.9 1.3 0.8 1.0 8.0 5.2 10.3 0.8 8.0 0.9 5.0 0.0 3.1 0.0 0.8 1.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.9 4.1 1.1 26.2 0.1 0.2 0.9 1.9 4.9 0.2 0.4 0.0 0.4 0.3 0.1 0.1 0.0 2.5 0.0 0.2 0.0 0.3 0.0 0.3 0.3 2.2 22.4 0.1 2.7 0.9 0.0 0.1 0.2 2.4 0.1 0.0 0.1 3.5 0.0 0.0 0.1 0.0 0.3 0.0 22.8 9.9 0.0 0.2 1.1 0.0 0.0 0.0 2.6 1.0 0.1 1.7 0.0 0.0 0.1 0.7 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 13.3 94.1 5.6 23.0 10.5 79.4 21.7 11.0 57.7 5.0 SCG3 "FLJ90833, SgIII" ENSG00000104112 "Secretogranin III" Q8WXD2 15 51681353-51721031 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 118.3" "Group enriched" "Detected in some" 7 "NTERA-2: 20.0;SCLC-21H: 47.9;SH-SY5Y: 22.6" "Group enriched" "Detected in many" 7 "glioma: 41.0;pancreatic cancer: 15.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006880, CAB033274, HPA053715" Enhanced Supported Supported Vesicles "Secreted in brain" 4800000 Vesicles "CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: " "unprognostic (1.38e-2)" "unprognostic (2.42e-1)" "unprognostic (1.40e-1)" "unprognostic (5.24e-5)" "unprognostic (1.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.74e-1)" "unprognostic (9.93e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (8.17e-2)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.78e-1)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" 1.7 12.9 29.6 2.1 25.4 1.7 1.7 33.4 118.3 1.5 2.4 6.5 0.0 2.9 1.5 1.6 1.6 1.6 1.6 1.5 22.6 23.5 1.5 1.5 1.8 1.7 13.6 37.7 1.5 11.5 1.4 23.7 1.5 27.1 1.6 2.8 1.3 1.5 1.4 1.5 1.8 2.6 1.7 13.2 1.5 8.7 2.9 7.3 0.0 2.1 0.0 1.5 1.6 0.1 0.9 1.2 1.9 0.5 0.3 0.8 0.2 0.0 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 20.0 0.0 0.1 0.0 0.1 0.0 0.2 47.9 22.6 0.1 0.1 0.0 0.0 1.4 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.3 0.1 4.3 0.4 0.4 0.6 0.8 0.2 0.5 0.9 0.6 0.4 0.4 0.7 0.5 0.6 1.9 0.3 0.5 1.2 0.2 0.2 29.6 25.4 33.4 40.6 22.6 23.5 13.6 37.7 27.1 7.3 SCG5 "7B2, SGNE1, SgV" ENSG00000166922 "Secretogranin V" P05408 15 32641676-32697098 "Predicted secreted proteins" Transport "Chaperone, Neuropeptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.1;pancreas: 63.5;parathyroid gland: 60.1;pituitary gland: 74.6" "Cell line enhanced" "Detected in some" "HHSteC: 14.7;HSkMC: 18.2;NTERA-2: 8.2;SCLC-21H: 16.8;SH-SY5Y: 19.5;U-87 MG: 25.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 82.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 2.8;naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 28 "T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013136, HPA074618" Enhanced "Secreted to blood" 22000 "HPA013136: AB_1856657, HPA074618: AB_2732262" "unprognostic (1.71e-1)" "unprognostic (9.87e-2)" "unprognostic (7.94e-2)" "unprognostic (1.30e-2)" "unprognostic (3.59e-3)" "prognostic unfavourable (9.64e-4)" "unprognostic (2.69e-1)" "unprognostic (1.27e-3)" "unprognostic (4.69e-2)" "unprognostic (1.97e-1)" "unprognostic (5.62e-3)" "unprognostic (3.92e-1)" "prognostic unfavourable (4.51e-9)" "unprognostic (3.57e-2)" "unprognostic (8.13e-2)" "unprognostic (3.08e-3)" "unprognostic (8.88e-2)" 1.2 30.7 24.0 2.2 47.2 0.9 2.5 36.4 71.1 1.0 4.4 13.0 0.0 9.0 3.4 21.8 1.0 2.4 3.4 1.0 30.5 36.9 1.2 2.2 2.5 1.3 25.2 23.1 2.0 63.5 60.1 74.6 0.9 30.5 3.2 5.5 15.4 0.7 1.2 0.7 1.3 3.3 3.9 24.1 1.0 21.0 3.0 9.5 0.0 1.8 0.0 0.9 2.5 0.5 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.2 0.1 0.0 0.1 0.3 2.5 0.0 2.2 0.2 0.2 0.2 0.0 0.0 0.2 1.0 0.2 0.6 0.3 0.1 0.6 0.3 0.1 0.3 0.0 0.0 14.7 0.1 0.4 18.2 0.1 0.4 0.2 0.3 0.1 0.3 0.4 0.0 0.1 0.1 8.2 0.4 0.0 0.2 0.3 0.2 0.0 16.8 19.5 0.1 0.0 0.1 0.0 0.2 0.0 2.8 1.9 0.1 0.2 0.3 1.1 0.2 25.5 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 24.0 47.2 36.4 50.8 30.5 36.9 25.2 23.1 30.5 9.5 SCGN "CALBL, DJ501N12.8, SECRET, SEGN" ENSG00000079689 "Secretagogin, EF-hand calcium binding protein" O76038 6 25652201-25701783 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3;pancreas: 39.7;pituitary gland: 47.9" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 23.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 38.2" "Group enriched" "Detected in many" 11 "cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 16 "olfactory region: 100.5" "Region enriched" "Detected in some" 9 "olfactory region: 282.4" "CAB004005, HPA006641, CAB044060, CAB062563, CAB068232" Enhanced Supported Supported Cytosol "Intracellular and membrane" Cytosol "CAB004005: , CAB044060: , CAB062563: , CAB068232: , HPA006641: AB_1079874" "unprognostic (8.15e-2)" "unprognostic (4.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.25e-2)" "unprognostic (4.70e-1)" "unprognostic (1.78e-2)" "unprognostic (2.01e-1)" "unprognostic (5.14e-2)" "unprognostic (5.41e-2)" "unprognostic (9.45e-2)" "unprognostic (1.19e-1)" 1.5 2.1 0.7 6.0 0.8 0.1 2.0 22.3 1.5 0.4 10.5 0.5 0.9 7.2 0.1 0.3 0.3 0.0 0.5 5.0 6.2 22.0 3.8 2.5 0.4 0.1 0.5 1.2 0.2 39.7 0.0 47.9 1.8 1.4 1.1 11.7 1.8 3.7 3.0 0.1 0.3 8.0 0.7 1.0 0.1 12.5 0.6 0.1 0.5 1.1 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 23.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 22.3 1.5 6.2 22.0 0.5 1.2 1.4 0.1 SCHIP1 SCHIP-1 ENSG00000151967 "Schwannomin interacting protein 1" P0DPB3 3 159839861-159897360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5" "Cell line enhanced" "Detected in some" "AF22: 9.3;AN3-CA: 16.9;HUVEC TERT2: 20.0;NTERA-2: 10.3;SH-SY5Y: 58.2" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 9.7" "Group enriched" "Detected in many" 58 "dendritic cells: 9.7;granulocytes: 3.1" "HPA003243, HPA069824" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA003243: AB_1079877, HPA069824: " "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (1.37e-2)" "unprognostic (2.36e-5)" "prognostic favourable (2.80e-4)" "unprognostic (6.25e-2)" "unprognostic (4.56e-3)" "unprognostic (1.11e-1)" "unprognostic (7.81e-2)" "unprognostic (1.38e-1)" "unprognostic (6.45e-3)" "unprognostic (4.67e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-4)" "unprognostic (2.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.96e-1)" 6.1 3.9 30.1 1.5 22.0 2.0 1.9 23.9 55.0 3.7 3.6 21.1 0.0 2.2 4.7 2.0 4.2 3.4 3.0 65.9 29.6 17.9 3.5 1.9 3.1 1.7 22.8 24.1 1.8 1.6 1.4 6.0 10.3 15.6 6.2 2.3 0.7 2.9 2.6 54.5 1.4 1.9 5.9 28.9 5.1 2.0 2.7 24.3 0.0 2.0 7.6 1.6 1.9 0.6 0.0 9.7 3.1 0.0 0.1 0.0 0.1 0.0 0.0 9.3 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.3 0.1 3.9 20.0 0.0 0.0 1.2 0.0 0.0 0.0 10.3 0.0 0.0 1.9 0.0 0.4 0.0 0.0 58.2 0.0 0.0 0.0 0.0 1.0 3.7 0.2 0.5 0.1 0.8 0.7 0.0 0.0 0.2 0.7 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 9.7 0.0 0.1 30.1 22.0 23.9 28.9 29.6 17.9 22.8 24.1 15.6 24.3 SCIN KIAA1905 ENSG00000006747 Scinderin Q9Y6U3 7 12570577-12660179 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 37.7;SK-BR-3: 40.9" "Cancer enhanced" "Detected in many" "renal cancer: 13.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA020518, HPA024264" Enhanced Enhanced "Plasma membrane" "Plasma membrane" "HPA020518: AB_1856619, HPA024264: AB_1856621" "unprognostic (3.68e-1)" "unprognostic (4.98e-2)" "unprognostic (5.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (5.98e-2)" "unprognostic (3.64e-5)" "unprognostic (1.31e-2)" "unprognostic (3.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic favourable (4.26e-8)" "unprognostic (3.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.13e-2)" "unprognostic (3.18e-1)" 4.1 1.0 14.5 2.3 30.3 1.0 0.9 1.5 13.3 1.2 11.2 7.5 1.0 16.2 1.2 0.7 14.5 3.6 2.0 0.5 11.1 4.2 30.3 0.6 3.4 0.6 22.8 2.3 0.8 0.9 1.1 3.1 46.0 20.0 2.3 10.2 0.6 9.0 1.0 0.6 2.5 31.7 1.0 27.9 0.6 12.2 4.3 23.4 0.0 1.0 2.7 8.2 5.5 1.1 4.5 1.5 3.5 1.5 2.1 1.9 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.5 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.0 0.0 0.1 8.3 0.2 0.2 0.1 0.6 0.1 1.3 0.1 0.2 0.0 37.7 1.4 1.7 0.0 0.4 40.9 0.0 4.3 0.3 0.0 0.1 0.3 0.8 0.0 1.4 0.1 0.1 0.0 0.1 0.1 3.5 1.5 1.0 1.7 1.3 1.5 4.5 1.5 1.4 1.0 2.5 1.6 1.9 2.5 2.1 1.4 1.5 1.0 0.8 14.5 30.3 1.5 13.3 11.1 4.2 22.8 2.3 20.0 23.4 SCN1A "FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI" ENSG00000144285 "Sodium voltage-gated channel alpha subunit 1" P35498 2 165984641-166149214 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 33.9" "Group enriched" "Detected in some" 4 "ASC TERT1: 11.3;Hep G2: 6.0" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078664 Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA078664: " "unprognostic (9.25e-2)" "unprognostic (3.97e-2)" "unprognostic (6.88e-2)" "unprognostic (7.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "unprognostic (4.70e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-1)" "unprognostic (9.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.03e-9)" "unprognostic (6.92e-2)" "unprognostic (3.69e-2)" "unprognostic (5.06e-3)" "unprognostic (6.93e-1)" 1.1 1.3 5.2 1.1 13.6 1.0 1.1 10.3 26.6 1.1 1.1 2.3 0.0 1.0 1.1 1.1 1.0 6.8 1.0 1.1 6.9 8.3 1.1 1.1 5.6 1.0 5.7 9.7 1.0 1.0 1.1 2.9 1.2 33.9 1.1 1.1 0.3 1.0 1.0 1.2 1.1 1.1 1.1 3.6 1.1 1.1 1.4 4.2 0.0 1.1 0.0 1.0 1.1 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 11.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.2 13.6 10.3 26.6 6.9 8.3 5.7 9.7 33.9 4.2 SCN1B ENSG00000105711 "Sodium voltage-gated channel beta subunit 1" Q07699 19 35030466-35040449 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 78.5;skeletal muscle: 161.9" "Cell line enhanced" "Detected in many" "A549: 13.4;EFO-21: 10.0;TIME: 20.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 458.8" "Intracellular and membrane" "unprognostic (8.18e-2)" "unprognostic (1.30e-1)" "unprognostic (1.30e-2)" "unprognostic (6.40e-2)" "unprognostic (1.17e-2)" "unprognostic (2.69e-2)" "unprognostic (4.40e-2)" "unprognostic (1.20e-1)" "unprognostic (3.34e-2)" "unprognostic (4.72e-3)" "prognostic favourable (1.38e-4)" "unprognostic (2.25e-1)" "unprognostic (2.05e-2)" "unprognostic (9.68e-3)" "unprognostic (5.81e-2)" "unprognostic (4.12e-2)" "unprognostic (4.78e-2)" 5.0 5.4 9.3 2.6 16.4 2.1 2.9 45.8 78.5 5.2 2.8 4.5 0.3 2.0 2.7 3.5 5.0 4.3 3.3 24.9 12.7 7.3 2.2 3.3 2.7 2.4 14.3 7.4 2.6 2.4 10.5 2.6 3.5 33.6 2.7 2.4 3.5 2.5 2.9 161.9 2.1 2.5 3.2 7.0 6.7 2.7 2.0 3.0 0.0 2.4 16.1 1.6 3.9 1.5 1.3 1.5 7.0 0.8 1.7 1.7 1.8 0.3 13.4 0.1 0.7 4.2 6.4 0.2 5.4 4.8 2.7 0.7 0.5 0.1 0.2 10.0 5.4 0.2 0.8 0.5 1.3 0.1 0.7 0.2 1.9 3.4 5.5 0.1 0.1 2.0 0.1 0.3 0.2 9.0 0.3 0.1 1.7 1.3 0.1 0.1 0.7 3.9 0.7 1.4 0.1 0.4 0.1 6.3 3.4 0.6 0.1 1.0 1.3 0.4 20.1 5.3 5.3 0.2 3.4 0.3 0.4 0.8 3.1 0.6 3.8 7.0 0.8 0.9 1.1 0.4 1.7 0.6 0.6 0.4 1.5 1.3 0.5 0.7 3.1 1.7 0.4 1.1 0.7 1.8 9.3 16.4 45.8 78.5 12.7 7.3 14.3 7.4 33.6 3.0 SCN2A "HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2" ENSG00000136531 "Sodium voltage-gated channel alpha subunit 2" Q99250 2 165194993-165392310 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 68.0" "Cell line enhanced" "Detected in some" "HSkMC: 3.3;SH-SY5Y: 3.1;U-138 MG: 5.7;U-266/84: 11.8;U-87 MG: 3.5" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022567 Enhanced "CAB022567: " "unprognostic (1.16e-1)" "unprognostic (3.56e-4)" "unprognostic (5.28e-2)" "unprognostic (6.12e-3)" "unprognostic (2.97e-1)" "unprognostic (8.62e-3)" "unprognostic (1.18e-1)" "unprognostic (7.25e-3)" "unprognostic (1.40e-1)" "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (5.21e-2)" "unprognostic (3.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.05e-1)" "unprognostic (4.88e-2)" "unprognostic (2.14e-1)" 1.3 3.0 19.1 1.3 36.4 1.1 2.2 68.0 50.3 1.5 1.3 1.1 0.0 1.5 1.9 2.6 1.2 1.3 2.3 1.3 30.3 8.2 4.0 1.4 1.5 1.2 3.8 23.5 1.5 1.3 1.1 8.2 1.3 9.9 1.3 1.3 0.0 1.5 1.8 1.1 1.2 1.5 2.0 3.7 1.3 1.5 1.5 4.1 0.0 1.1 0.0 1.2 1.3 0.5 1.4 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.7 0.0 0.0 2.7 0.0 2.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.1 1.0 0.7 0.0 0.4 0.0 0.4 0.0 0.2 3.3 0.1 0.3 0.0 0.0 0.0 0.3 1.5 0.0 0.2 0.0 2.0 0.2 0.0 0.0 0.0 0.1 0.1 2.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.4 0.3 0.0 0.5 11.8 0.0 3.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 19.1 36.4 68.0 43.7 30.3 8.2 3.8 23.5 9.9 4.1 SCN2B ENSG00000149575 "Sodium voltage-gated channel beta subunit 2" O60939 11 118161951-118176673 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 37.0;heart muscle: 17.5;skeletal muscle: 9.7" "Group enriched" "Detected in some" 6 "HBEC3-KT: 1.5;U-2 OS: 2.5;U-2197: 5.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (9.01e-2)" "unprognostic (3.50e-2)" "unprognostic (7.58e-2)" "unprognostic (2.12e-2)" "unprognostic (1.41e-2)" "unprognostic (4.02e-1)" "unprognostic (2.71e-4)" "unprognostic (5.17e-2)" "unprognostic (8.59e-2)" "unprognostic (2.77e-1)" "unprognostic (7.89e-2)" "unprognostic (1.61e-2)" "unprognostic (3.51e-2)" "unprognostic (1.27e-2)" "unprognostic (4.35e-2)" "unprognostic (4.55e-1)" "unprognostic (2.88e-3)" 1.8 3.0 14.7 1.4 31.5 1.0 1.9 31.1 37.0 2.9 2.0 3.1 0.0 1.7 3.2 2.9 3.6 2.9 2.7 17.5 22.5 11.6 1.6 1.0 2.5 1.0 8.7 30.6 2.8 1.1 1.0 0.8 1.0 12.8 2.4 1.9 0.4 1.8 2.7 9.7 1.4 2.5 3.5 13.9 1.1 1.3 1.3 6.9 0.0 1.9 0.7 1.0 1.5 0.6 0.3 0.2 2.1 0.3 0.2 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 2.5 5.9 0.0 0.0 0.0 0.1 0.1 0.1 0.1 2.1 0.3 0.9 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.2 0.2 1.3 0.2 0.0 0.2 0.1 0.0 14.7 31.5 31.1 37.0 22.5 11.6 8.7 30.6 12.8 6.9 SCN3A Nav1.3 ENSG00000153253 "Sodium voltage-gated channel alpha subunit 3" Q9NY46 2 165087522-165204067 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 13.6;brain: 28.5;pituitary gland: 13.7" "Cell line enhanced" "Detected in some" "Karpas-707: 8.5;MOLT-4: 24.1;RPTEC TERT1: 12.1;SH-SY5Y: 5.4" "Cancer enriched" "Detected in some" 6 "glioma: 3.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "memory B-cell: 8.4;naive B-cell: 13.6" "Lineage enriched" "Detected in single" 38 "B-cells: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035396 Approved "HPA035396: " "unprognostic (1.80e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (1.50e-2)" "unprognostic (6.69e-2)" "unprognostic (1.10e-2)" "unprognostic (4.96e-4)" "unprognostic (2.46e-1)" "unprognostic (1.48e-1)" "unprognostic (1.90e-1)" "unprognostic (1.21e-4)" "unprognostic (4.55e-2)" "unprognostic (5.87e-3)" "unprognostic (2.88e-2)" "unprognostic (6.85e-2)" "unprognostic (2.66e-1)" "unprognostic (4.93e-2)" 2.6 4.0 16.7 1.9 28.5 1.0 2.5 19.6 19.7 2.1 2.1 0.8 0.0 1.2 1.4 0.7 1.5 1.4 1.8 2.1 9.8 11.3 1.8 1.0 1.0 2.7 4.8 9.8 1.8 1.7 2.3 13.7 0.8 9.1 0.9 2.1 0.0 0.7 1.4 0.9 0.5 1.9 1.7 4.0 1.8 2.7 1.8 4.9 2.0 1.3 0.0 3.5 1.7 0.5 13.6 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 2.3 0.0 0.0 0.1 0.0 0.0 0.2 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.1 0.0 24.1 0.0 0.0 2.0 0.1 1.1 0.0 12.1 0.0 3.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.7 0.0 1.3 0.4 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 13.6 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.1 16.7 28.5 19.6 17.2 9.8 11.3 4.8 9.8 9.1 4.9 SCN3B HSA243396 ENSG00000166257 "Sodium voltage-gated channel beta subunit 3" Q9NY72 11 123629187-123655244 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 70.3" "Group enriched" "Detected in some" 4 "CACO-2: 2.9;hTCEpi: 9.4;RH-30: 4.2;SCLC-21H: 9.4;SH-SY5Y: 7.0" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041707 Approved "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA041707: " "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (8.13e-4)" "unprognostic (3.93e-3)" "unprognostic (7.05e-2)" "unprognostic (3.29e-3)" "unprognostic (5.64e-2)" "unprognostic (3.34e-4)" "unprognostic (1.72e-1)" "unprognostic (1.13e-2)" "unprognostic (9.16e-4)" "unprognostic (4.01e-1)" "unprognostic (1.89e-4)" "unprognostic (2.01e-2)" "unprognostic (9.01e-2)" "unprognostic (8.23e-2)" "unprognostic (1.43e-2)" 2.2 8.5 17.7 1.5 23.5 1.3 2.0 2.8 70.3 1.6 1.5 1.2 0.0 1.6 1.5 1.5 1.5 1.8 1.4 1.9 26.2 13.2 1.6 1.0 1.4 1.2 5.2 18.8 1.7 1.9 3.9 12.6 1.1 3.8 1.8 1.6 3.7 1.2 1.4 5.8 1.7 1.5 2.1 1.5 1.3 1.4 2.2 1.2 0.0 3.7 0.0 1.2 1.1 0.4 1.2 1.3 2.7 0.6 1.1 0.8 0.1 0.0 0.2 0.3 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.0 2.9 0.1 0.3 1.4 0.4 0.2 1.0 0.1 0.1 0.1 0.6 0.0 0.5 0.3 0.1 0.0 0.5 0.4 9.4 0.1 0.1 0.3 0.4 0.5 0.0 0.1 0.1 0.2 0.8 0.1 0.2 4.2 0.0 0.0 0.2 9.4 7.0 0.6 0.1 0.0 0.0 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.6 0.6 0.5 0.6 0.4 0.4 0.7 0.7 0.7 0.3 1.2 0.5 0.8 2.7 1.1 0.5 1.3 0.4 0.1 17.7 23.5 2.8 39.5 26.2 13.2 5.2 18.8 3.8 1.2 SCN4B LQT10 ENSG00000177098 "Sodium voltage-gated channel beta subunit 4" Q8IWT1 11 118133377-118152888 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;skeletal muscle: 25.6" "Cell line enhanced" "Detected in some" "AN3-CA: 3.8;HBEC3-KT: 2.9;NTERA-2: 4.3;SH-SY5Y: 1.7;U-2 OS: 3.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 11 "basal ganglia: 731.2" "Region enhanced" "Detected in many" "basal ganglia: 122.8" HPA017293 Approved "HPA017293: AB_2184174" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.07e-1)" "unprognostic (9.82e-3)" "unprognostic (9.17e-3)" "unprognostic (1.20e-2)" "unprognostic (1.23e-2)" "unprognostic (1.03e-2)" "unprognostic (3.27e-2)" "unprognostic (1.07e-1)" "unprognostic (2.07e-2)" "unprognostic (2.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.31e-4)" 20.5 5.4 1.9 1.2 36.4 0.1 6.1 11.7 21.7 2.4 2.6 2.0 0.5 2.4 3.7 1.8 5.4 5.5 3.2 11.0 3.1 2.9 1.4 0.6 8.7 2.0 5.3 2.1 0.7 5.0 6.4 2.4 1.9 28.7 2.1 2.2 4.3 2.8 2.6 25.6 3.8 4.6 7.0 5.5 0.5 3.0 0.8 8.7 1.5 10.4 9.5 1.1 3.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.3 2.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 36.4 11.7 21.7 3.1 2.9 5.3 2.1 28.7 8.7 SCN8A "CerIII, CIAT, MED, NaCh6, Nav1.6, PN4" ENSG00000196876 "Sodium voltage-gated channel alpha subunit 8" Q9UQD0 12 51590266-51812864 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 27.6;pituitary gland: 9.7" "Cell line enhanced" "Detected in many" "AF22: 11.8;ASC TERT1: 12.4;BJ hTERT+: 11.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022169, HPA043937, HPA073590" Approved "Vesicles,Plasma membrane,Cell Junctions" "Plasma membrane" "Vesicles, Cell Junctions" "CAB022169: , HPA043937: , HPA073590: " "unprognostic (2.96e-2)" "unprognostic (8.49e-2)" "unprognostic (6.93e-2)" "unprognostic (3.52e-6)" "unprognostic (8.13e-2)" "unprognostic (1.51e-2)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.16e-1)" "unprognostic (4.73e-4)" "unprognostic (1.69e-2)" "unprognostic (1.29e-5)" "unprognostic (4.38e-1)" "unprognostic (1.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.75e-2)" 1.1 3.0 9.1 1.5 18.1 1.9 1.9 16.7 27.6 1.0 2.0 1.6 0.0 1.1 1.5 2.0 0.9 1.1 2.5 0.9 12.6 4.5 1.9 4.3 1.0 1.3 3.2 13.7 1.8 3.2 1.5 9.7 0.9 14.8 1.8 2.5 0.9 1.7 1.2 1.0 1.1 1.2 1.0 2.2 1.7 2.7 3.8 1.6 0.0 1.7 0.0 1.2 1.0 0.6 0.4 0.2 0.0 0.0 0.0 1.0 0.0 1.3 1.0 11.8 0.1 1.6 12.4 0.2 6.7 11.0 7.7 7.2 1.9 1.3 0.3 1.5 8.7 0.0 1.9 0.0 9.1 1.2 0.6 0.1 0.1 0.2 0.1 0.2 0.9 1.7 0.0 5.1 1.1 8.2 0.1 0.1 4.8 0.8 1.9 0.1 4.0 3.8 0.0 0.6 0.0 0.0 0.4 4.7 1.9 3.4 1.7 0.2 0.3 0.1 2.2 7.5 5.0 2.7 4.2 0.1 0.1 0.0 1.5 1.6 10.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 1.0 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 9.1 18.1 16.7 25.0 12.6 4.5 3.2 13.7 14.8 1.6 SCRG1 SCRG-1 ENSG00000164106 "Stimulator of chondrogenesis 1" O75711 4 173384701-173406380 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.4" "Group enriched" "Detected in some" 13 "HSkMC: 6.6;WM-115: 19.3" "Cancer enriched" "Detected in many" 6 "glioma: 35.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012882 Approved "Secreted in brain" "HPA012882: AB_1856635" "unprognostic (1.09e-1)" "unprognostic (1.83e-2)" "unprognostic (2.60e-5)" "unprognostic (2.58e-1)" "unprognostic (3.22e-2)" "unprognostic (7.51e-2)" "unprognostic (3.58e-2)" "unprognostic (1.14e-3)" "unprognostic (2.08e-1)" "unprognostic (2.25e-2)" "unprognostic (2.19e-1)" "unprognostic (1.49e-1)" "unprognostic (3.95e-10)" "unprognostic (4.86e-2)" "unprognostic (2.21e-1)" "unprognostic (4.34e-3)" "unprognostic (8.74e-4)" 5.8 3.1 19.2 2.6 18.6 2.2 2.3 6.0 30.6 2.1 2.9 15.9 4.0 2.5 2.5 7.7 2.3 2.1 5.1 3.6 19.9 12.0 1.5 1.4 1.5 1.5 24.9 12.9 1.6 1.8 1.2 1.1 1.6 20.5 6.4 2.7 0.0 3.4 11.6 1.9 2.0 2.0 15.6 33.4 2.4 2.8 16.3 22.5 0.0 1.5 0.3 1.3 4.1 1.0 1.4 1.3 4.4 1.8 1.6 1.0 0.4 0.1 0.0 0.9 0.2 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.7 0.1 0.2 6.6 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.2 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.3 0.1 0.0 0.1 0.1 0.1 19.3 3.9 1.8 1.2 0.8 1.2 0.6 0.8 0.6 0.7 0.7 1.4 0.8 1.0 4.4 1.6 1.3 1.3 0.5 0.4 19.2 18.6 6.0 16.7 19.9 12.0 24.9 12.9 20.5 22.5 SCRN1 KIAA0193 ENSG00000136193 "Secernin 1" Q12765 7 29920103-29990289 "Enzymes, Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.8" "Cell line enhanced" "Detected in many" "WM-115: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024517 Enhanced Approved Cytosol 110000 Cytosol "HPA024517: AB_2184811" "prognostic unfavourable (8.32e-4)" "prognostic unfavourable (8.46e-4)" "unprognostic (1.45e-1)" "prognostic unfavourable (4.00e-5)" "unprognostic (1.87e-2)" "unprognostic (2.43e-1)" "unprognostic (1.13e-3)" "unprognostic (1.10e-1)" "unprognostic (2.29e-1)" "prognostic unfavourable (7.27e-4)" "unprognostic (1.09e-2)" "unprognostic (1.02e-1)" "prognostic favourable (1.15e-5)" "unprognostic (2.57e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (2.60e-4)" 6.8 14.8 32.0 6.3 31.5 3.6 7.6 62.8 55.4 12.4 8.1 23.2 4.5 3.4 13.3 8.8 10.0 13.9 8.5 9.8 26.6 30.7 12.8 1.5 8.3 6.7 42.7 26.6 17.5 18.5 42.9 12.1 8.0 26.3 15.0 5.6 7.8 8.4 20.2 1.0 5.7 5.0 17.7 42.9 5.2 7.1 11.4 23.3 8.2 7.1 1.5 10.6 9.4 5.8 10.4 7.8 6.9 16.7 4.8 8.1 2.2 22.3 16.2 26.4 10.6 18.8 28.9 0.1 20.9 28.1 22.7 24.6 18.6 17.8 2.7 18.6 26.8 10.1 30.0 8.9 33.3 0.1 6.3 9.3 10.9 12.0 24.0 0.0 0.1 24.0 12.8 20.6 11.1 20.9 0.1 7.3 32.0 12.6 3.2 0.0 24.0 17.4 0.0 28.2 0.2 15.9 11.0 9.7 22.9 21.6 14.1 24.1 18.9 1.4 23.0 29.5 25.5 0.3 26.4 2.4 36.2 0.2 13.9 0.1 71.2 2.2 2.3 6.9 0.6 10.2 8.1 10.4 0.1 0.8 7.7 5.0 0.6 1.0 0.4 4.8 16.7 7.8 0.0 2.2 32.0 31.5 62.8 43.1 26.6 30.7 42.7 26.6 26.3 23.3 SCRT1 "DKFZp547F072, ZNF898" ENSG00000261678 "Scratch family transcriptional repressor 1" Q9BWW7 8 144330565-144336281 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 20.3" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 10.3" "Cancer enhanced" "Detected in single" "glioma: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045265 Uncertain Supported "Nuclear bodies" "Nuclear bodies" "HPA045265: AB_10959521" "unprognostic (7.70e-2)" "unprognostic (7.97e-2)" "unprognostic (6.96e-3)" "unprognostic (6.88e-4)" "unprognostic (2.43e-2)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (1.97e-1)" "unprognostic (8.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.83e-4)" "unprognostic (5.02e-2)" "unprognostic (7.05e-2)" "unprognostic (2.78e-1)" "unprognostic (2.35e-1)" "unprognostic (2.66e-3)" "unprognostic (1.04e-1)" 0.3 2.3 2.1 0.3 6.6 0.3 0.3 5.7 20.3 0.3 0.3 0.0 0.0 0.4 0.3 0.3 0.3 0.3 0.3 0.3 2.2 0.3 0.3 0.3 0.3 0.0 3.8 0.4 0.7 0.3 0.0 0.3 4.2 0.3 0.3 0.0 0.3 0.3 0.5 0.3 0.3 0.3 0.4 0.3 0.3 1.2 2.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCRT2 ZNF898B ENSG00000215397 "Scratch family transcriptional repressor 2" Q9NQ03 20 661596-676179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 17.9;retina: 6.1" "Group enriched" "Detected in some" 5 "Karpas-707: 3.9;NTERA-2: 3.6;RPMI-8226: 7.9;SCLC-21H: 3.8;SH-SY5Y: 4.2" "Cancer enriched" "Detected in single" 5 "glioma: 1.0" "Group enriched" "Detected in many" 4 "cerebellum: 8.8;cerebral cortex: 17.9" "Cell type enriched" "Detected in single" 25 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA067697 Approved Nucleoplasm Nucleoplasm "HPA067697: " "unprognostic (9.71e-2)" "unprognostic (2.03e-1)" "unprognostic (6.97e-2)" "unprognostic (9.70e-2)" "unprognostic (1.70e-1)" 0.3 0.3 0.7 0.3 0.7 0.3 0.3 8.8 17.9 0.3 0.3 0.6 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.7 0.6 0.3 0.3 0.3 0.3 1.9 0.0 0.3 1.3 0.3 0.0 0.4 3.2 0.3 0.3 6.1 0.3 0.3 0.3 0.3 0.3 0.3 1.1 0.6 0.3 0.7 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 7.9 0.0 0.0 3.8 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.7 8.8 17.9 0.7 0.6 1.9 0.0 3.2 0.0 SEC14L5 "KIAA0420, PRELID4B" ENSG00000103184 "SEC14 like lipid binding 5" O43304 16 4958317-5019158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 29.4;heart muscle: 7.5;skeletal muscle: 11.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;RPMI-8226: 4.1;SCLC-21H: 6.4;T-47d: 4.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041492, HPA041825" Uncertain "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA041492: AB_10794519, HPA041825: AB_10794526" "unprognostic (1.90e-3)" "unprognostic (4.08e-2)" "unprognostic (5.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (5.68e-2)" "unprognostic (7.33e-3)" "unprognostic (8.71e-4)" "unprognostic (6.87e-2)" "unprognostic (1.56e-4)" "unprognostic (1.01e-3)" "unprognostic (7.12e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" 1.1 1.7 7.4 1.3 17.5 1.5 1.2 2.2 22.1 2.8 1.7 29.4 0.0 1.4 0.9 1.2 2.0 2.2 1.1 7.5 13.5 6.1 1.1 0.8 1.0 1.4 25.8 8.8 1.7 1.8 0.8 1.7 1.3 15.2 1.7 2.1 0.3 1.9 1.1 11.0 2.9 1.1 0.9 25.2 1.2 3.7 1.4 15.6 0.0 0.9 0.5 1.7 0.9 0.4 0.1 0.4 1.6 0.0 0.1 0.2 2.9 0.0 0.4 0.6 0.3 0.6 4.1 0.5 0.1 0.0 0.1 0.0 0.5 0.2 0.2 0.3 0.5 0.6 0.2 0.1 0.0 0.0 0.5 1.9 0.4 1.0 0.2 0.0 0.4 0.6 0.8 0.1 0.1 0.1 0.2 0.4 0.1 0.3 0.0 0.2 1.3 0.3 0.1 0.4 4.1 0.3 0.1 6.4 0.2 0.4 0.3 0.4 4.2 0.0 0.5 0.2 0.4 0.3 0.0 0.2 0.0 0.2 1.1 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 1.6 0.1 0.0 0.4 0.0 2.9 7.4 17.5 2.2 20.0 13.5 6.1 25.8 8.8 15.2 15.6 SEC61A2 FLJ10578 ENSG00000065665 "Sec61 translocon alpha 2 subunit" Q9H9S3 10 12129637-12169961 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (6.83e-2)" "unprognostic (2.76e-2)" "unprognostic (1.48e-2)" "unprognostic (1.01e-3)" "unprognostic (4.18e-2)" "unprognostic (1.84e-2)" "unprognostic (1.28e-3)" "unprognostic (1.55e-2)" "unprognostic (2.97e-1)" "unprognostic (3.95e-2)" "prognostic favourable (1.08e-5)" "unprognostic (3.14e-2)" "prognostic unfavourable (2.22e-16)" "unprognostic (6.41e-2)" "unprognostic (4.95e-2)" "unprognostic (6.18e-2)" "prognostic favourable (8.75e-4)" 4.0 5.6 14.3 5.1 19.7 14.1 5.3 16.5 33.5 3.8 3.8 20.3 3.2 3.7 7.8 9.2 3.9 4.1 5.2 11.3 16.8 22.1 3.1 7.8 3.8 5.8 15.6 14.6 5.8 3.3 5.5 9.4 4.5 22.7 6.0 5.9 5.7 2.7 6.3 6.9 8.6 3.3 5.9 21.1 4.8 3.6 17.3 9.9 5.0 5.2 1.3 6.1 4.1 3.6 1.3 5.8 4.1 0.5 2.0 2.7 0.4 6.0 10.9 14.3 8.8 6.0 3.7 4.8 6.0 3.3 11.9 12.5 10.3 4.0 2.2 3.3 9.5 4.9 19.7 7.8 10.3 6.7 7.4 2.8 12.7 7.3 6.0 1.6 6.6 5.5 4.7 21.6 3.4 3.0 3.3 6.6 10.1 5.2 5.4 2.7 14.0 3.4 5.8 5.8 1.4 7.3 6.2 6.7 10.0 8.9 4.8 4.3 9.0 2.7 5.5 10.3 12.1 13.2 4.2 6.0 8.6 3.5 8.0 2.2 3.1 0.0 0.4 0.3 2.1 0.1 1.9 0.7 1.3 1.3 1.0 1.3 2.7 1.7 4.1 2.0 0.5 5.8 1.9 0.4 14.3 19.7 16.5 26.4 16.8 22.1 15.6 14.6 22.7 9.9 SECISBP2L KIAA0256 ENSG00000138593 "SECIS binding protein 2 like" Q93073 15 48988476-49046563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039875 Approved Approved Nucleoplasm Nucleoplasm "HPA039875: AB_10673365" "unprognostic (7.86e-3)" "unprognostic (2.53e-2)" "unprognostic (1.33e-1)" "unprognostic (3.19e-3)" "unprognostic (9.29e-2)" "unprognostic (5.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (9.58e-3)" "unprognostic (2.16e-1)" "unprognostic (3.08e-2)" "prognostic favourable (5.65e-8)" "unprognostic (1.87e-2)" "unprognostic (1.27e-1)" "unprognostic (2.01e-2)" "unprognostic (2.28e-1)" 13.2 12.6 30.1 8.5 32.2 14.4 14.3 18.1 38.0 15.2 10.8 40.7 12.1 7.2 14.1 17.4 13.2 14.4 11.1 11.1 38.4 23.8 19.3 13.9 27.3 9.5 38.8 24.8 15.5 10.9 42.0 12.7 29.4 36.7 16.3 9.2 8.1 30.8 14.8 10.1 8.3 8.5 11.5 66.1 10.6 13.6 9.9 35.6 6.7 18.2 6.7 9.8 10.8 10.3 14.7 8.1 14.6 6.0 7.8 11.1 4.0 4.8 5.1 11.6 9.7 16.6 12.9 6.8 17.0 14.3 14.4 17.9 5.8 4.3 3.3 8.1 12.9 4.0 14.6 4.2 17.1 19.4 3.5 9.6 7.4 4.6 8.7 5.3 10.9 10.1 5.5 12.3 6.9 13.6 5.8 8.6 16.6 2.0 5.4 5.1 4.1 4.6 5.6 12.7 13.2 18.6 10.3 2.0 7.9 11.0 20.2 16.1 5.9 6.2 16.3 12.7 6.0 12.0 7.8 7.1 12.5 6.1 10.0 7.7 16.7 9.3 5.1 14.6 9.0 4.9 8.5 12.2 8.1 6.1 3.6 14.7 11.1 8.7 9.2 7.8 6.0 8.1 5.8 4.0 30.1 32.2 18.1 31.5 38.4 23.8 38.8 24.8 36.7 35.6 SEMA4D "C9orf164, CD100, coll-4, FLJ39737, SEMAJ" ENSG00000187764 "Semaphorin 4D" Q92854 9 89360787-89498130 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.1;skeletal muscle: 43.3" "Cell line enhanced" "Detected in many" "HDLM-2: 42.9;HMC-1: 33.1;MOLT-4: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015662, HPA023277" Approved Supported "Endoplasmic reticulum,Vesicles" 4100000 Vesicles "Endoplasmic reticulum" "HPA015662: AB_1856671, HPA023277: AB_1856672" "unprognostic (2.94e-2)" "prognostic favourable (4.17e-4)" "unprognostic (1.12e-2)" "unprognostic (8.22e-2)" "unprognostic (1.41e-1)" "unprognostic (1.76e-3)" "unprognostic (1.27e-1)" "unprognostic (1.58e-1)" "unprognostic (7.79e-2)" "unprognostic (2.74e-1)" "unprognostic (3.18e-3)" "unprognostic (1.50e-2)" "unprognostic (2.29e-3)" "unprognostic (3.05e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-1)" "prognostic favourable (4.06e-5)" 3.9 5.6 18.0 18.6 20.7 14.3 3.6 7.7 20.9 4.0 5.9 54.0 3.1 6.1 3.9 7.4 9.3 6.6 7.2 4.9 28.2 18.8 8.4 2.0 6.7 32.0 42.6 15.0 4.1 4.6 4.9 5.3 3.2 27.5 4.9 5.8 2.9 6.7 4.2 43.3 8.8 9.6 3.3 107.1 19.2 9.4 6.1 23.3 25.3 4.9 3.1 27.6 8.3 5.3 2.6 4.6 21.2 4.1 4.7 14.0 7.8 4.0 3.0 2.8 4.1 0.1 0.2 6.5 0.4 0.2 0.8 0.6 2.0 4.6 15.5 1.7 0.0 2.1 2.5 1.2 0.3 42.9 2.5 6.5 1.0 0.2 0.5 8.6 33.1 0.1 0.9 0.2 0.1 1.6 1.5 10.6 0.0 6.7 38.9 10.8 6.9 0.1 12.4 0.9 4.3 5.5 4.2 6.7 4.4 1.1 3.6 0.1 3.4 4.7 1.0 0.0 2.6 0.3 2.0 11.9 5.1 2.2 2.0 10.5 2.5 7.3 4.1 20.4 13.3 3.8 8.0 2.6 10.6 11.1 1.5 1.6 12.2 14.0 21.2 4.7 4.1 4.6 9.5 7.8 18.0 20.7 7.7 20.9 28.2 18.8 42.6 15.0 27.5 23.3 SEMA5B "FLJ10372, KIAA1445, SEMAG, SemG" ENSG00000082684 "Semaphorin 5B" Q9P283 3 122909193-123028605 "Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;heart muscle: 11.7" "Cell line enhanced" "Detected in some" "AF22: 41.4;NTERA-2: 8.0;SH-SY5Y: 11.0" "Cancer enhanced" "Detected in many" "renal cancer: 18.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066548 Enhanced Supported Cytosol Cytosol "HPA066548: " "unprognostic (7.34e-2)" "unprognostic (1.84e-3)" "unprognostic (1.92e-4)" "unprognostic (3.01e-2)" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "unprognostic (4.72e-2)" "unprognostic (1.58e-2)" "unprognostic (7.66e-3)" "unprognostic (2.87e-2)" "unprognostic (4.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavourable (7.57e-4)" "unprognostic (1.31e-3)" "unprognostic (5.96e-2)" "unprognostic (6.12e-2)" "unprognostic (2.12e-1)" 1.5 1.2 12.0 0.7 12.3 0.3 1.1 0.8 13.6 2.1 1.5 4.3 0.4 1.9 2.8 5.5 1.5 3.0 4.7 11.7 13.0 3.3 6.1 1.4 2.2 1.1 2.5 3.3 1.3 3.1 1.1 2.5 5.0 2.0 1.8 1.8 6.0 0.9 3.1 1.6 1.2 1.3 3.8 1.7 0.5 0.7 1.1 5.7 0.1 2.2 2.5 1.3 3.3 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 41.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 11.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.0 12.3 0.8 13.2 13.0 3.3 2.5 3.3 2.0 5.7 SEMA6A "HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ" ENSG00000092421 "Semaphorin 6A" Q9H2E6 5 116443616-116574934 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.2" "Cell line enhanced" "Detected in some" "AF22: 14.5;AN3-CA: 17.3;BEWO: 15.1;HAP1: 20.3;NTERA-2: 45.2;RT4: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031264, HPA031265, HPA031267" Approved Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" 180000 Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA031264: , HPA031265: AB_10610423, HPA031267: " "unprognostic (3.79e-2)" "unprognostic (3.91e-1)" "unprognostic (1.82e-2)" "unprognostic (6.81e-2)" "unprognostic (2.69e-2)" "unprognostic (3.77e-1)" "prognostic unfavourable (4.39e-4)" "unprognostic (1.64e-1)" "unprognostic (4.71e-2)" "unprognostic (5.82e-2)" "unprognostic (1.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.62e-3)" "unprognostic (1.92e-1)" "unprognostic (6.21e-3)" "unprognostic (7.32e-3)" 12.7 37.4 12.6 4.9 34.7 3.6 10.6 18.7 26.5 6.9 19.6 31.2 0.8 19.2 6.1 3.4 3.9 6.2 12.8 5.0 17.2 12.9 6.1 6.0 17.8 4.5 35.9 13.9 13.1 10.3 2.2 4.4 30.2 32.2 6.6 17.5 2.6 15.1 3.2 7.6 5.6 24.0 6.3 48.2 8.2 5.4 6.6 31.4 0.5 6.7 1.6 2.7 4.6 5.9 1.6 0.7 0.1 0.4 0.0 1.3 0.0 0.1 0.0 14.5 17.3 0.1 0.0 15.1 0.2 0.1 0.0 0.1 0.8 0.6 0.6 0.6 0.2 0.1 20.3 0.0 0.0 0.6 3.0 0.2 0.2 4.9 0.2 0.2 1.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.2 1.4 45.2 0.1 2.6 9.5 0.6 7.5 12.9 4.1 1.5 0.1 0.2 7.7 5.6 1.0 0.3 1.4 1.2 0.1 0.5 0.2 0.2 0.3 0.2 0.7 5.3 0.0 0.4 0.0 1.2 0.0 0.1 1.6 1.3 0.0 0.3 1.2 0.4 0.5 0.1 0.0 0.2 0.7 0.1 0.0 12.6 34.7 18.7 24.0 17.2 12.9 35.9 13.9 32.2 31.4 SEMA6B "SEM-SEMA-Y, SEMA-VIB, SEMAN, semaZ" ENSG00000167680 "Semaphorin 6B" Q9H3T3 19 4542593-4559808 "Plasma proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.9" "Cell line enhanced" "Detected in some" "Hep G2: 35.6;HMC-1: 58.8;HUVEC TERT2: 24.0;TIME: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025157, HPA055778, HPA058523" Enhanced 180000 "CAB025157: , HPA055778: , HPA058523: " "unprognostic (4.03e-1)" "unprognostic (9.69e-3)" "unprognostic (6.38e-3)" "unprognostic (2.15e-1)" "unprognostic (1.15e-1)" "unprognostic (7.94e-2)" "unprognostic (2.10e-1)" "unprognostic (4.34e-3)" "unprognostic (6.61e-2)" "unprognostic (1.90e-1)" "unprognostic (4.21e-2)" "unprognostic (2.82e-1)" "prognostic unfavourable (3.29e-5)" "unprognostic (1.26e-1)" "unprognostic (1.81e-2)" "prognostic unfavourable (1.45e-4)" "unprognostic (9.55e-2)" 23.2 9.3 27.2 12.1 24.2 7.9 9.7 16.9 42.9 3.8 4.7 1.7 0.3 4.8 4.1 3.1 3.6 2.5 7.0 12.8 30.3 11.5 3.7 5.2 13.1 18.6 9.5 0.8 5.1 4.8 1.7 3.1 9.9 11.0 4.3 1.8 2.7 1.4 2.2 9.3 3.3 4.8 7.9 6.4 17.5 2.5 2.5 8.8 0.0 6.0 3.7 2.0 8.3 24.4 0.0 0.0 0.7 0.4 0.0 0.0 0.0 2.0 7.1 0.6 6.2 0.0 0.3 0.1 0.0 0.2 0.6 0.1 0.0 0.6 0.0 6.8 0.0 1.3 1.8 0.0 0.2 0.0 0.3 0.0 0.1 35.6 0.1 0.0 58.8 2.2 0.0 0.0 0.0 24.0 0.4 0.1 0.2 1.8 0.0 0.0 7.8 0.1 0.1 14.0 0.1 0.5 0.0 5.2 0.5 0.0 0.5 3.8 0.9 0.3 30.3 0.9 11.3 0.1 5.1 0.4 0.0 0.1 0.2 0.3 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 27.2 24.2 16.9 27.9 30.3 11.5 9.5 0.8 11.0 8.8 SEMA7A "CD108, H-Sema-L, SEMAL" ENSG00000138623 "Semaphorin 7A (John Milton Hagen blood group)" O75326 15 74409289-74433958 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Differentiation, Inflammatory response, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;lymphoid tissue: 34.7;placenta: 54.0" "Cell line enhanced" "Detected in many" "HMC-1: 99.7;hTEC/SVTERT24-B: 39.1;U-251 MG: 57.5;U-87 MG: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 8.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008210, HPA042273" Uncertain Uncertain Vesicles 29000000 Vesicles "HPA008210: , HPA042273: AB_10806234" "unprognostic (2.00e-1)" "unprognostic (2.72e-1)" "unprognostic (2.02e-2)" "unprognostic (5.81e-2)" "unprognostic (6.49e-2)" "unprognostic (8.61e-2)" "unprognostic (2.54e-2)" "unprognostic (4.18e-3)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (5.18e-3)" "unprognostic (1.44e-1)" "prognostic unfavourable (2.45e-11)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (6.25e-2)" "unprognostic (2.57e-2)" 2.2 1.9 5.4 10.4 13.8 12.8 1.4 22.9 27.3 1.3 1.8 19.9 1.4 2.7 4.3 1.8 3.2 1.2 3.3 1.4 10.8 5.7 1.4 1.5 4.4 19.0 28.5 5.7 5.9 0.9 6.4 1.9 54.0 28.6 1.4 1.8 7.8 1.7 3.5 1.4 4.7 6.0 2.0 36.4 34.7 3.7 23.6 15.4 9.0 1.1 0.4 19.7 4.6 1.7 1.4 1.8 8.9 0.0 0.8 0.2 0.0 5.7 0.0 1.7 0.5 2.2 7.4 14.3 26.5 10.7 5.6 8.6 2.2 9.4 0.0 1.5 12.0 1.7 0.5 1.7 5.8 0.4 0.3 10.3 0.0 2.8 0.5 0.3 99.7 5.2 0.0 39.1 2.2 0.0 5.9 3.6 18.1 0.4 1.4 3.4 1.8 4.0 0.2 1.1 1.5 2.3 2.4 0.1 0.1 0.2 4.8 2.1 0.3 2.1 1.0 10.5 7.0 5.0 57.5 0.6 0.4 0.1 33.6 1.2 0.5 3.9 0.0 8.9 0.2 0.0 0.2 1.4 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.8 0.0 1.8 0.0 0.0 5.4 13.8 22.9 27.3 10.8 5.7 28.5 5.7 28.6 15.4 SEPT3 SEP3 ENSG00000100167 "Septin 3" Q9UH03 22 41969475-41998221 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 101.6" "Cell line enhanced" "Detected in many" "AF22: 13.5;SCLC-21H: 36.5" "Cancer enhanced" "Detected in many" "glioma: 24.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 1.2;granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003548, CAB017633" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Actin filaments" "Nucleoplasm, Plasma membrane" "Actin filaments" "CAB017633: AB_2301476, HPA003548: AB_1079908" "unprognostic (2.10e-1)" "unprognostic (4.67e-2)" "unprognostic (1.16e-2)" "prognostic unfavourable (1.78e-4)" "unprognostic (4.56e-2)" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (2.37e-1)" "unprognostic (2.67e-3)" "unprognostic (3.09e-2)" "unprognostic (1.30e-2)" "unprognostic (6.30e-2)" "unprognostic (2.51e-2)" "unprognostic (9.15e-2)" "unprognostic (6.68e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" 1.3 4.4 31.3 1.4 26.9 1.3 2.0 35.9 101.6 1.4 1.5 5.6 0.0 1.4 1.4 2.2 1.3 1.2 1.5 1.2 28.9 17.2 1.4 1.2 1.7 1.5 13.2 24.3 1.2 2.0 10.7 1.0 4.9 13.4 2.1 1.5 1.0 1.3 1.2 1.2 2.2 1.4 1.4 7.3 1.3 1.5 2.4 5.3 0.0 1.7 0.0 1.5 1.4 0.1 0.3 1.2 2.1 0.0 0.1 0.2 0.0 0.7 0.8 13.5 10.1 0.1 0.0 6.7 0.1 0.1 0.9 0.4 0.2 1.5 10.9 0.4 0.1 0.0 7.0 0.0 0.3 4.5 2.3 0.0 0.2 0.0 0.1 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 1.7 0.0 1.1 1.8 0.1 9.2 0.3 8.7 0.0 0.6 0.0 1.3 36.5 7.6 5.4 0.0 8.9 1.3 3.3 0.0 0.0 4.8 0.4 0.5 7.2 6.2 0.1 0.1 4.4 1.4 2.1 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.0 1.2 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.2 0.0 31.3 26.9 35.9 42.1 28.9 17.2 13.2 24.3 13.4 5.3 SEPT4 "ARTS, CE5B3, H5, hCDCREL-2, hucep-7, MART, PNUTL2" ENSG00000108387 "Septin 4" O43236 17 58520250-58540818 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 77.8;brain: 94.8" "Cell line enhanced" "Detected in some" "Hep G2: 5.7;HHSteC: 11.4;HSkMC: 5.8;SK-MEL-30: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006855, HPA021587, HPA022905" Enhanced Supported Nucleoplasm Nucleoplasm "CAB006855: , HPA021587: AB_1856686, HPA022905: AB_1856687" "unprognostic (1.12e-1)" "unprognostic (5.54e-2)" "unprognostic (8.36e-3)" "unprognostic (8.01e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-2)" "unprognostic (6.88e-3)" "unprognostic (2.73e-2)" "unprognostic (2.76e-1)" "unprognostic (8.02e-2)" "unprognostic (1.97e-2)" "unprognostic (2.10e-1)" "prognostic unfavourable (3.28e-7)" "unprognostic (6.40e-3)" "unprognostic (1.58e-1)" "unprognostic (8.26e-2)" "unprognostic (8.75e-3)" 14.8 77.8 70.5 2.6 80.0 0.9 7.2 44.3 82.7 4.0 3.3 92.4 0.0 2.7 3.5 3.9 3.2 2.7 8.3 14.3 84.8 49.9 8.5 25.0 9.5 5.9 94.8 32.3 5.4 3.9 4.8 2.4 9.9 49.7 2.5 3.1 10.0 4.4 3.8 4.2 3.9 2.9 6.0 84.0 18.0 2.8 7.3 56.5 0.0 4.5 0.5 3.8 5.1 1.3 1.7 5.5 2.9 5.5 1.4 7.6 5.6 0.0 0.5 0.9 2.7 1.1 0.1 0.5 0.1 0.3 1.7 1.9 0.1 0.1 0.0 4.0 0.6 0.2 1.4 1.1 0.4 0.1 0.7 1.0 0.2 5.7 11.4 0.1 0.5 5.8 2.3 0.4 2.1 0.5 0.0 2.7 0.1 0.0 0.0 0.1 0.5 0.7 0.2 0.0 1.2 0.0 0.0 2.9 1.7 0.0 0.1 25.0 0.4 0.3 0.0 0.1 1.3 0.0 1.1 0.8 0.4 0.0 0.9 0.0 0.3 0.0 5.5 1.1 7.6 0.7 2.4 1.7 1.6 2.0 5.5 0.6 2.9 2.3 2.9 1.4 0.0 0.3 1.0 5.6 70.5 80.0 44.3 50.5 84.8 49.9 94.8 32.3 49.7 56.5 SEPT5 "H5, HCDCREL-1, PNUTL1" ENSG00000184702 "Septin 5" Q99719 22 19714464-19724224 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.2;parathyroid gland: 86.4" "Cell line enhanced" "Detected in many" "K-562: 65.7;THP-1: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "eosinophil: 11.9;neutrophil: 4.4" "Lineage enriched" "Detected in single" 46 "granulocytes: 11.9" "CAB016120, HPA029095, HPA063885" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" 1600000 "Nucleoplasm, Cytosol" "Actin filaments" "CAB016120: AB_628240, HPA029095: , HPA063885: " "unprognostic (4.07e-2)" "unprognostic (1.47e-1)" "unprognostic (6.78e-3)" "unprognostic (1.39e-2)" "unprognostic (3.92e-1)" "unprognostic (1.86e-1)" "unprognostic (2.50e-2)" "unprognostic (3.77e-1)" "unprognostic (5.66e-2)" "unprognostic (6.19e-2)" "unprognostic (1.88e-3)" "unprognostic (4.34e-1)" "prognostic unfavourable (6.87e-6)" "unprognostic (3.39e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (3.30e-2)" 4.2 6.4 60.7 2.3 62.9 12.5 5.1 31.2 86.2 12.2 3.0 5.5 1.1 2.2 7.4 17.0 15.0 14.1 5.5 50.9 52.9 14.6 2.0 1.1 3.7 3.0 12.4 38.7 9.0 5.5 86.4 11.1 4.4 14.9 4.3 2.7 5.3 3.6 4.0 2.8 42.9 2.5 6.4 3.6 2.2 3.4 6.2 9.5 1.9 6.7 4.1 3.1 3.5 5.6 0.0 0.2 11.9 0.1 0.0 0.2 6.3 0.1 3.0 12.0 18.5 1.1 3.9 0.1 4.6 5.8 5.2 3.0 0.2 1.6 0.4 1.8 10.2 1.7 8.7 1.7 2.6 3.1 1.0 0.2 0.6 0.0 4.8 0.2 12.7 5.2 2.1 1.7 0.7 2.1 65.7 0.1 8.1 1.2 1.3 7.3 1.6 3.2 13.3 0.3 2.0 0.3 0.4 19.2 15.6 0.6 0.9 0.8 4.8 21.1 0.8 13.7 18.4 0.5 0.9 1.3 0.0 0.1 1.7 0.6 4.4 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 4.4 0.0 0.0 0.2 0.0 6.3 60.7 62.9 31.2 86.2 52.9 14.6 12.4 38.7 14.9 9.5 SEPT8 "KIAA0202, SEP2" ENSG00000164402 "Septin 8" Q92599 5 132750817-132807241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "brain: 150.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005665, HPA036534" Approved Approved "Actin filaments,Cytosol" Cytosol "Actin filaments" "HPA005665: AB_1079910, HPA036534: " "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (9.24e-2)" "unprognostic (7.10e-3)" "unprognostic (2.70e-1)" "unprognostic (2.15e-2)" "unprognostic (2.86e-2)" "unprognostic (1.41e-2)" "unprognostic (1.58e-2)" "unprognostic (2.97e-2)" "unprognostic (2.38e-2)" "unprognostic (3.12e-1)" "prognostic unfavourable (6.98e-5)" "unprognostic (2.86e-2)" "unprognostic (4.30e-1)" "unprognostic (8.04e-3)" "unprognostic (2.70e-1)" 9.5 8.4 43.1 7.0 49.4 2.9 7.1 27.8 74.9 9.3 10.2 66.8 5.2 10.7 6.7 8.2 13.4 7.0 10.7 13.1 56.3 37.0 9.2 4.3 8.4 5.6 76.1 29.3 10.9 9.4 15.9 5.0 18.5 45.8 8.1 11.5 7.9 13.6 9.3 4.1 20.4 10.5 9.0 150.3 5.9 11.0 2.9 64.1 1.5 9.5 5.2 7.5 18.3 6.2 0.8 2.4 1.1 2.0 0.3 5.2 1.7 17.1 8.3 12.0 24.4 16.7 16.4 39.4 18.6 17.8 17.7 21.7 14.5 12.4 0.1 16.6 17.9 13.3 22.4 30.4 19.5 21.9 16.1 16.8 10.5 12.5 12.2 5.9 24.5 11.8 9.8 8.1 11.6 24.5 25.7 3.3 9.4 16.3 19.1 5.5 6.3 5.4 17.6 14.0 1.4 10.3 44.2 16.1 10.0 15.7 3.6 10.4 32.1 7.8 25.4 19.7 12.9 4.8 13.2 4.6 4.3 0.6 12.6 8.8 14.8 1.1 2.0 0.0 4.1 1.1 4.2 0.8 3.4 5.2 2.4 0.3 0.9 2.2 0.0 0.3 0.5 0.0 3.6 1.7 43.1 49.4 27.8 44.6 56.3 37.0 76.1 29.3 45.8 64.1 SERP2 "bA269C23.1, C13orf21" ENSG00000151778 "Stress associated endoplasmic reticulum protein family member 2" Q8N6R1 13 44373665-44397714 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.7" "Cell line enhanced" "Detected in some" "LHCN-M2: 5.8;SH-SY5Y: 8.1;U-2197: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "basophil: 6.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038970 Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA038970: " "unprognostic (6.55e-2)" "unprognostic (1.55e-1)" "unprognostic (4.10e-2)" "unprognostic (2.06e-1)" "unprognostic (9.62e-2)" "unprognostic (1.72e-2)" "unprognostic (2.85e-1)" "unprognostic (3.48e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (1.34e-3)" "unprognostic (1.12e-2)" "prognostic favourable (1.94e-4)" "unprognostic (1.48e-1)" "unprognostic (6.60e-2)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" 1.7 3.2 30.0 2.0 34.1 0.8 4.0 14.3 40.7 2.7 2.3 3.9 1.3 4.2 4.8 12.4 1.7 3.0 1.8 14.6 24.8 20.9 2.6 1.8 2.0 2.3 19.0 15.6 5.9 2.8 1.9 2.4 1.2 10.1 4.1 2.1 2.0 2.0 5.8 1.4 1.4 3.2 3.4 10.4 1.1 2.4 15.3 6.4 1.2 2.1 0.4 2.1 1.4 1.0 0.0 0.0 6.0 0.0 1.3 0.3 0.2 0.0 0.0 3.3 0.0 0.5 2.8 0.0 0.6 0.9 3.6 2.4 0.0 0.0 0.0 2.9 2.7 0.1 0.0 0.0 3.5 0.0 0.1 0.6 0.0 0.1 3.1 0.1 0.0 0.4 0.0 2.6 0.0 0.5 0.0 0.0 5.8 0.0 0.0 0.3 3.7 0.0 0.0 0.0 0.0 1.1 0.0 3.9 8.1 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.2 7.4 0.0 0.0 0.2 0.0 1.7 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.2 30.0 34.1 14.3 37.2 24.8 20.9 19.0 15.6 10.1 6.4 SERPINI1 "neuroserpin, PI12" ENSG00000163536 "Serpin family I member 1" Q99574 3 167735243-167825568 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 96.0" "Cell line enhanced" "Detected in many" "Daudi: 15.6;HeLa: 16.2;Karpas-707: 18.1;U-266/84: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001565, HPA056092" Enhanced Approved Cytosol "Secreted in brain" 200000 Cytosol "HPA001565: AB_1079924, HPA056092: " "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (4.09e-3)" "unprognostic (1.35e-1)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "prognostic unfavourable (4.25e-4)" "unprognostic (2.48e-1)" "unprognostic (2.61e-1)" "unprognostic (6.07e-3)" "unprognostic (2.18e-2)" "unprognostic (1.01e-1)" "unprognostic (1.58e-3)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (1.22e-1)" "unprognostic (1.11e-1)" 5.9 8.2 31.9 2.4 27.9 1.3 6.1 3.6 96.0 4.2 2.8 7.1 0.4 1.5 4.3 4.3 3.2 3.9 3.4 6.4 35.9 35.3 14.5 2.5 3.4 2.3 36.9 35.7 4.0 16.3 3.7 10.3 3.5 22.9 5.8 2.5 2.4 9.9 3.6 1.7 2.1 2.5 3.1 51.6 4.1 3.6 7.0 15.9 0.0 5.2 0.3 3.8 3.1 1.6 15.4 4.4 1.0 0.4 6.0 16.0 3.4 0.4 1.9 3.2 0.2 5.9 1.5 0.2 1.1 1.8 0.8 1.3 0.7 3.8 15.6 6.0 0.8 0.8 2.1 2.1 0.8 4.9 4.5 5.3 16.2 6.6 0.4 0.8 0.6 2.2 0.8 0.4 0.7 0.2 9.9 18.1 0.6 1.5 0.4 1.1 2.0 2.4 1.8 0.1 2.0 6.7 0.5 1.3 8.2 2.2 4.3 5.0 6.4 2.4 0.5 3.4 0.3 0.3 5.5 13.7 16.7 11.4 2.9 4.0 1.9 1.0 0.2 0.5 6.2 0.4 4.5 12.7 6.5 6.6 0.3 15.4 4.7 5.7 0.6 6.0 0.3 4.4 16.0 3.4 31.9 27.9 3.6 78.9 35.9 35.3 36.9 35.7 22.9 15.9 SERTM1 C13orf36 ENSG00000180440 "Serine rich and transmembrane domain containing 1" A2A2V5 13 36673912-36697839 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.2;endometrium 1: 30.9;fallopian tube: 25.3" "Group enriched" "Detected in some" 5 "HAP1: 2.6;HEK 293: 3.1;NTERA-2: 7.9;SH-SY5Y: 4.6" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.7" "Group enriched" "Detected in many" 7 "amygdala: 13.9;basal ganglia: 10.1;cerebral cortex: 21.6;hippocampal formation: 26.5;olfactory region: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054814, HPA070485" Uncertain Enhanced Vesicles Vesicles "HPA054814: , HPA070485: " "unprognostic (8.71e-2)" "unprognostic (2.11e-1)" "unprognostic (5.58e-3)" "unprognostic (4.66e-3)" "unprognostic (4.05e-3)" "unprognostic (5.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.63e-2)" "unprognostic (1.00e-8)" "unprognostic (2.51e-2)" "unprognostic (5.60e-2)" "unprognostic (4.44e-2)" 5.0 1.8 13.9 0.5 10.1 0.5 1.2 0.3 30.2 16.4 0.7 1.3 1.8 0.6 30.9 13.5 0.5 25.3 0.5 0.6 26.5 2.0 0.6 0.5 5.6 0.5 1.5 11.6 14.5 0.8 1.0 11.2 0.5 2.4 0.9 0.5 8.2 0.5 1.2 0.5 0.6 0.6 17.4 0.9 0.5 0.9 1.5 0.0 0.0 9.3 0.0 0.5 1.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 3.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 10.1 0.3 21.6 26.5 2.0 1.5 11.6 2.4 0.0 SEZ6 ENSG00000063015 "Seizure related 6 homolog" Q53EL9 17 28954901-29006440 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.3" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 36.1" "Cancer enriched" "Detected in many" 11 "glioma: 16.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 2.8;neutrophil: 5.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011777 Enhanced "HPA011777: AB_1856758" "unprognostic (3.99e-2)" "unprognostic (1.24e-1)" "unprognostic (5.75e-3)" "unprognostic (5.33e-3)" "unprognostic (1.84e-2)" "unprognostic (1.76e-3)" "unprognostic (2.82e-2)" "unprognostic (2.22e-2)" "unprognostic (3.07e-1)" "unprognostic (4.75e-2)" "unprognostic (1.22e-3)" "unprognostic (3.15e-3)" "unprognostic (3.63e-6)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (1.45e-1)" "unprognostic (3.15e-3)" 1.2 2.0 18.8 1.4 67.3 1.6 1.1 43.5 48.2 1.1 1.6 3.1 0.0 2.4 1.1 1.5 1.2 1.2 1.1 1.2 10.5 10.0 1.2 1.1 1.3 1.2 4.9 9.4 1.1 1.9 1.1 4.9 1.2 9.1 1.3 1.8 3.3 1.2 1.2 1.4 1.4 1.4 1.3 2.7 1.2 1.7 1.6 5.4 0.0 1.2 0.0 1.1 1.3 0.0 0.8 0.9 5.7 0.5 0.5 0.9 0.4 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 36.1 6.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.8 0.5 0.9 0.2 0.5 0.9 0.8 0.4 0.5 0.6 0.5 0.6 0.7 5.7 0.5 0.5 0.9 0.2 0.4 18.8 67.3 43.5 18.8 10.5 10.0 4.9 9.4 9.1 5.4 SEZ6L ENSG00000100095 "Seizure related 6 homolog like" Q9BYH1 22 26169474-26383597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 60.8" "Group enriched" "Detected in some" 7 "SCLC-21H: 30.0;SH-SY5Y: 8.0" "Group enriched" "Detected in some" 6 "glioma: 14.6;pancreatic cancer: 3.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 7.4;myeloid DC: 7.2;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 73 "dendritic cells: 7.2;monocytes: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045135 Approved Vesicles 2400000 Vesicles "HPA045135: " "unprognostic (1.01e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.49e-2)" "unprognostic (6.47e-2)" "unprognostic (4.19e-1)" "unprognostic (1.09e-2)" "unprognostic (5.02e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-3)" "unprognostic (7.80e-2)" "unprognostic (2.40e-6)" "unprognostic (4.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.39e-4)" "unprognostic (3.18e-1)" 1.2 12.5 26.4 1.6 11.3 1.3 1.1 20.1 60.8 2.4 1.3 4.3 0.0 1.5 1.1 1.1 1.1 1.1 1.2 2.5 39.1 23.6 1.1 1.1 1.3 1.1 11.2 25.5 1.1 2.7 1.0 3.8 1.1 15.0 1.3 1.4 0.0 1.3 1.2 1.1 1.2 1.6 1.4 5.3 1.3 2.9 1.4 5.4 0.0 1.2 0.0 1.1 1.2 0.2 0.0 7.2 0.0 7.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 30.0 8.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.5 26.4 11.3 20.1 29.3 39.1 23.6 11.2 25.5 15.0 5.4 SEZ6L2 "FLJ90517, PSK-1" ENSG00000174938 "Seizure related 6 homolog like 2" Q6UXD5 16 29871159-29899547 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.6;pituitary gland: 36.3" "Cell line enhanced" "Detected in many" "EFO-21: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064471 Enhanced 3900000 "HPA064471: " "unprognostic (2.56e-2)" "prognostic unfavourable (7.46e-4)" "prognostic unfavourable (1.31e-4)" "unprognostic (2.11e-1)" "prognostic unfavourable (5.24e-4)" "unprognostic (1.27e-1)" "unprognostic (1.67e-2)" "unprognostic (2.71e-2)" "unprognostic (8.22e-2)" "unprognostic (1.85e-1)" "unprognostic (1.43e-3)" "unprognostic (8.31e-2)" "unprognostic (1.04e-1)" "unprognostic (8.22e-2)" "unprognostic (2.30e-1)" "unprognostic (2.12e-1)" "unprognostic (1.08e-1)" 2.1 21.0 21.0 1.8 27.6 0.8 4.0 42.4 52.6 11.4 4.5 7.7 0.2 9.2 6.1 1.4 1.2 4.2 8.8 1.4 18.5 32.8 3.3 0.9 4.5 1.4 15.6 27.6 2.5 34.7 32.7 36.3 3.2 31.4 13.3 3.6 5.4 18.1 4.7 1.5 2.5 5.5 4.3 12.3 1.8 14.9 7.2 7.4 0.0 1.6 0.0 1.9 4.2 0.9 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.5 4.4 0.3 4.2 0.0 0.2 3.0 5.5 2.6 5.2 2.9 6.5 20.6 2.1 30.2 6.6 1.9 1.7 1.3 1.6 0.0 3.7 0.3 3.8 13.3 11.5 0.0 13.3 12.9 2.5 6.1 1.6 0.4 0.6 13.4 2.6 22.2 0.0 0.0 6.7 7.6 0.0 0.0 0.5 4.7 1.9 20.1 16.1 1.8 14.2 0.8 13.3 19.3 0.2 17.5 8.6 0.1 0.3 1.5 1.3 0.1 21.2 3.3 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.0 21.0 27.6 42.4 52.6 18.5 32.8 15.6 27.6 31.4 7.4 SFI1 "KIAA0542, PISD, PPP1R139" ENSG00000198089 "SFI1 centrin binding protein" A8K8P3 22 31488688-31618586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (7.17e-2)" "unprognostic (1.26e-3)" "unprognostic (1.71e-2)" "unprognostic (3.27e-2)" "unprognostic (1.73e-1)" "prognostic favourable (1.10e-4)" "unprognostic (9.82e-3)" "unprognostic (3.51e-2)" "unprognostic (2.56e-1)" "unprognostic (1.77e-1)" "prognostic favourable (5.80e-4)" "unprognostic (2.73e-1)" "unprognostic (2.22e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (2.11e-2)" "prognostic favourable (1.31e-4)" 3.9 7.3 6.9 14.4 12.1 17.9 5.6 34.0 9.2 5.1 5.7 5.6 11.9 12.7 6.3 6.5 5.1 7.3 5.7 3.2 6.3 6.5 6.7 3.8 5.9 16.0 6.7 6.1 6.5 6.1 6.7 17.5 3.9 7.7 6.4 4.0 10.0 6.9 7.2 2.2 8.9 11.0 5.5 5.5 11.9 8.3 13.6 7.3 22.2 7.6 2.4 22.1 5.7 5.1 4.0 1.7 6.0 4.5 9.6 11.0 4.9 9.5 6.0 5.7 7.0 3.1 3.3 3.5 7.6 3.3 5.5 6.6 5.5 6.7 14.7 3.1 2.4 9.0 2.8 4.9 3.8 12.4 8.9 3.6 13.2 6.6 4.2 14.0 11.9 2.2 3.2 5.9 4.2 4.7 4.6 7.3 4.4 14.5 10.0 8.9 2.5 3.6 11.1 6.7 10.6 3.4 9.6 8.7 4.7 6.7 9.6 6.2 7.2 6.1 9.1 7.8 7.0 6.8 5.4 8.8 6.4 7.8 7.7 7.9 6.0 5.7 1.2 3.1 9.7 1.3 4.5 4.0 7.9 11.0 1.4 3.7 10.7 9.4 6.0 9.6 4.5 1.7 6.0 4.9 6.9 12.1 34.0 9.2 6.3 6.5 6.7 6.1 7.7 7.3 SFMBT2 KIAA1617 ENSG00000198879 "Scm like with four mbt domains 2" Q5VUG0 10 7158624-7411486 "Predicted intracellular proteins" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.7" "Cell line enhanced" "Detected in many" "Karpas-707: 16.2;REH: 14.5;RPMI-8226: 13.5;THP-1: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035447, HPA035448, HPA070388" Uncertain Supported "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA035447: , HPA035448: AB_10669904, HPA070388: " "unprognostic (4.36e-2)" "unprognostic (2.29e-2)" "unprognostic (4.36e-2)" "unprognostic (1.42e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-3)" "unprognostic (4.65e-1)" "unprognostic (4.56e-1)" "unprognostic (1.03e-1)" "unprognostic (6.51e-2)" "unprognostic (5.57e-2)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (1.26e-1)" "unprognostic (9.17e-3)" "unprognostic (5.37e-3)" "unprognostic (7.29e-2)" 3.0 4.2 9.6 5.9 11.7 6.1 6.2 6.6 13.7 2.5 2.8 26.7 1.1 2.0 4.3 3.7 2.3 3.7 3.6 3.9 12.6 6.9 2.7 1.1 4.1 7.2 14.6 7.4 11.2 3.8 10.1 6.6 3.7 10.8 6.5 3.4 3.9 4.6 3.6 3.9 1.2 3.5 3.4 10.6 9.0 2.9 1.5 9.7 2.0 7.8 1.1 6.2 3.7 4.1 0.1 5.4 1.7 7.4 1.3 1.8 0.4 0.0 3.4 0.2 0.0 0.0 0.2 3.1 0.1 0.0 0.0 0.0 0.0 0.8 5.3 0.0 0.1 1.5 5.9 0.0 0.0 0.3 5.3 0.0 8.8 0.0 0.4 5.7 0.7 0.8 0.2 0.0 0.1 0.0 8.9 16.2 0.0 2.3 4.5 9.0 1.0 0.0 14.5 1.7 13.5 0.0 0.4 1.3 11.1 0.0 0.0 0.0 0.8 17.4 0.0 0.0 1.8 0.2 0.1 6.9 9.9 0.0 0.7 10.9 0.1 0.1 0.4 1.7 1.4 3.8 0.8 0.1 0.5 0.9 0.7 0.1 1.8 1.1 0.2 1.3 7.4 5.4 0.0 0.4 9.6 11.7 6.6 13.7 12.6 6.9 14.6 7.4 10.8 9.7 SFXN5 "BBG-TCC, SLC56A5" ENSG00000144040 "Sideroflexin 5" Q8TD22 2 72942036-73075619 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.3;liver: 31.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015473, HPA056866" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA015473: AB_1856794, HPA056866: " "unprognostic (7.75e-2)" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-3)" "unprognostic (1.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "prognostic favourable (2.26e-6)" "unprognostic (1.57e-1)" "unprognostic (8.51e-2)" "unprognostic (3.50e-1)" "unprognostic (3.23e-1)" "unprognostic (3.97e-1)" "unprognostic (1.43e-2)" 4.0 10.1 26.1 4.9 24.6 12.8 3.1 10.1 28.3 3.4 6.6 12.9 3.7 7.6 3.2 18.4 2.7 5.2 4.4 3.6 25.3 12.7 12.7 31.4 3.7 3.6 16.0 18.6 2.9 2.7 3.4 3.1 4.5 14.9 5.2 6.8 2.6 2.1 5.4 6.3 3.2 7.3 4.5 9.6 5.2 5.1 2.9 13.3 1.6 4.3 1.7 3.7 5.0 2.1 3.0 4.2 6.4 8.9 5.8 1.3 2.1 3.4 7.3 11.6 8.9 2.8 1.8 4.2 6.9 3.9 11.0 5.8 11.2 8.7 2.0 7.2 7.2 3.0 9.0 9.9 5.2 8.3 5.8 8.4 7.2 14.7 3.5 4.3 9.2 4.8 2.7 7.7 0.9 6.4 7.3 1.7 2.9 6.6 1.2 6.5 14.3 4.7 8.0 9.6 2.5 6.4 8.0 7.5 2.1 6.4 3.3 2.6 1.7 2.2 4.6 3.3 11.0 4.7 7.9 3.0 2.9 2.4 11.5 7.9 4.0 4.8 8.9 4.2 0.9 3.9 1.3 1.6 0.5 1.0 4.2 3.0 0.6 0.8 6.4 5.8 4.3 2.9 1.0 2.1 26.1 24.6 10.1 26.3 25.3 12.7 16.0 18.6 14.9 13.3 SGCZ ZSG1 ENSG00000185053 "Sarcoglycan zeta" Q96LD1 8 14089864-15238339 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.2;ovary: 11.3;pituitary gland: 7.3" "Cell line enhanced" "Detected in some" "Daudi: 2.2;REH: 2.5" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "amygdala: 5.6;basal ganglia: 9.5;cerebellum: 21.2;cerebral cortex: 6.8;pons and medulla: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA017585 Uncertain "HPA017585: AB_1856799" "unprognostic (3.83e-1)" "unprognostic (1.41e-1)" "unprognostic (5.87e-4)" "unprognostic (1.21e-1)" 1.1 0.4 5.6 0.5 9.5 0.6 2.6 21.2 6.8 0.8 0.7 0.0 0.0 0.7 0.9 1.4 0.4 0.5 0.7 0.5 1.4 2.2 1.0 0.7 0.4 0.4 1.3 2.3 11.3 0.7 0.4 7.3 0.5 5.3 0.8 0.5 0.1 0.4 0.6 0.4 0.9 0.5 0.9 3.2 0.5 0.7 1.4 1.1 0.0 0.4 0.0 0.5 1.5 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.6 9.5 21.2 6.8 1.4 2.2 1.3 2.3 5.3 1.1 SGIP1 DKFZp761D221 ENSG00000118473 "SH3 domain GRB2 like endophilin interacting protein 1" Q9BQI5 1 66533383-66748299 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.5" "Cell line enhanced" "Detected in some" "BJ: 16.8;BJ hTERT+: 21.7;fHDF/TERT166: 13.7;RPTEC TERT1: 16.0;SH-SY5Y: 8.7;U-138 MG: 15.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017963 Approved Approved Mitochondria Mitochondria "HPA017963: AB_10964882" "unprognostic (1.74e-2)" "unprognostic (2.77e-1)" "unprognostic (2.86e-1)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" "unprognostic (9.04e-2)" "unprognostic (9.51e-2)" "unprognostic (7.64e-2)" "unprognostic (1.86e-1)" "unprognostic (1.61e-1)" "unprognostic (1.83e-1)" "unprognostic (1.95e-1)" "unprognostic (3.48e-7)" "unprognostic (1.77e-2)" "unprognostic (1.29e-1)" "unprognostic (4.25e-2)" "unprognostic (9.63e-2)" 6.2 7.5 19.6 3.8 30.2 1.3 2.7 26.2 36.5 7.5 2.7 11.4 1.3 3.4 17.1 8.0 5.2 4.7 8.1 6.8 22.9 12.4 14.0 1.7 9.6 2.0 10.8 26.3 3.6 1.2 1.9 7.0 3.9 26.4 5.4 3.4 5.8 3.5 9.1 3.2 1.7 3.2 7.0 11.3 1.4 5.1 7.4 14.9 0.0 8.0 0.8 1.5 6.1 5.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.4 0.0 16.8 21.7 1.3 2.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 2.5 0.0 0.0 0.6 0.2 0.0 3.9 0.0 0.0 2.4 0.0 1.3 0.0 6.3 0.0 0.0 7.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.4 8.7 0.0 0.0 0.0 0.0 0.6 1.1 15.9 0.0 0.4 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 19.6 30.2 26.2 35.0 22.9 12.4 10.8 26.3 26.4 14.9 SGK2 ENSG00000101049 "SGK2, serine/threonine kinase 2" Q9HBY8 20 43558968-43588237 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.1;kidney: 39.1;liver: 32.9" "Group enriched" "Detected in some" 5 "A549: 13.5;CAPAN-2: 10.6;EFO-21: 5.4;Hep G2: 13.7;RPTEC TERT1: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008859, HPA011387" Uncertain Supported Nucleoplasm Nucleoplasm "HPA008859: , HPA011387: AB_1856744" "unprognostic (1.82e-1)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.86e-1)" "unprognostic (6.27e-2)" "unprognostic (2.98e-4)" "unprognostic (2.05e-2)" "unprognostic (1.35e-1)" "unprognostic (4.30e-2)" "unprognostic (2.60e-1)" "unprognostic (1.05e-1)" "unprognostic (5.72e-4)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (2.56e-1)" "unprognostic (3.11e-2)" "prognostic favourable (5.65e-4)" 11.4 0.7 2.8 4.3 9.9 0.2 3.1 1.0 10.2 1.4 21.3 33.1 0.9 17.8 1.0 19.7 0.7 1.6 7.9 0.7 4.3 2.5 39.1 32.9 0.6 0.5 6.9 5.1 3.2 14.1 0.5 1.7 0.5 13.7 1.4 23.4 0.0 0.9 1.8 0.4 3.2 20.7 1.0 14.2 0.7 11.9 1.0 6.0 0.0 1.0 0.2 0.2 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.6 10.6 0.0 5.4 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 13.7 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 19.4 2.2 0.1 0.5 0.0 0.9 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 9.9 1.0 10.2 4.3 2.5 6.9 5.1 13.7 6.0 SGK494 ENSG00000167524 "Uncharacterized serine/threonine-protein kinase SgK494" 17 28607964-28614200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: " "unprognostic (1.83e-1)" "unprognostic (9.42e-2)" "unprognostic (2.84e-2)" "unprognostic (2.30e-2)" "unprognostic (2.11e-1)" "unprognostic (2.06e-3)" "unprognostic (9.33e-3)" "unprognostic (2.63e-1)" "unprognostic (8.62e-4)" "unprognostic (2.09e-2)" "unprognostic (6.81e-2)" "unprognostic (3.45e-5)" "unprognostic (1.20e-7)" "unprognostic (2.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-3)" 1.6 4.7 10.3 3.5 25.3 10.6 2.3 17.8 25.8 1.9 1.8 0.9 0.4 0.7 2.0 4.5 1.3 2.4 0.8 2.1 8.6 3.7 5.6 1.6 3.2 3.3 2.5 10.7 3.7 1.3 2.0 5.6 3.1 11.2 2.3 4.0 6.3 1.9 3.2 3.8 6.3 2.3 1.9 2.9 3.4 1.3 8.5 4.1 0.1 2.5 0.1 3.5 1.9 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.4 5.2 6.2 5.7 2.0 2.5 4.5 0.8 0.4 2.1 1.9 6.2 0.7 7.1 0.9 2.9 3.1 4.6 2.5 2.7 4.0 6.8 7.4 4.0 3.6 0.2 9.9 5.2 1.2 7.4 7.5 4.2 2.3 7.1 0.6 1.3 7.2 2.5 6.6 6.2 1.0 7.2 8.8 4.7 1.2 6.8 3.8 3.5 4.4 2.4 3.7 3.7 5.5 3.1 4.2 3.6 4.2 5.0 3.9 3.6 8.6 3.1 7.3 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 25.3 17.8 25.8 8.6 3.7 2.5 10.7 11.2 4.1 SGSM1 "KIAA1941, RUTBC2" ENSG00000167037 "Small G protein signaling modulator 1" Q2NKQ1 22 24806169-24927578 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1;parathyroid gland: 20.7" "Cell line enhanced" "Detected in some" "HEK 293: 2.3;RPMI-8226: 5.4;SCLC-21H: 5.3;SH-SY5Y: 3.4;U-266/84: 2.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003986 Approved "HPA003986: AB_1856513" "unprognostic (6.66e-2)" "unprognostic (1.51e-1)" "unprognostic (1.97e-2)" "unprognostic (1.40e-4)" "unprognostic (4.79e-3)" "unprognostic (6.43e-2)" "unprognostic (1.39e-3)" "unprognostic (1.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.50e-2)" "unprognostic (2.23e-3)" "unprognostic (1.37e-1)" "unprognostic (2.61e-6)" "unprognostic (1.46e-1)" "unprognostic (4.66e-1)" "unprognostic (2.25e-2)" "unprognostic (3.93e-2)" 1.3 6.2 8.2 1.3 15.4 0.8 2.2 22.1 15.8 2.5 2.6 3.5 0.2 1.3 1.6 2.4 1.2 8.5 1.7 17.2 6.5 18.4 3.4 0.8 2.4 1.2 7.9 9.2 3.7 6.4 20.7 9.4 2.3 12.7 2.7 3.3 1.6 1.7 2.1 1.5 5.7 1.9 2.5 5.9 1.1 5.7 3.2 4.3 0.0 2.9 0.0 1.1 1.7 5.0 1.1 0.2 0.6 0.1 1.4 2.5 0.4 0.1 1.4 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.5 2.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.6 0.9 0.0 0.0 5.4 0.0 0.9 5.3 3.4 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.3 0.1 0.0 2.5 0.0 0.0 0.8 0.6 1.1 0.0 1.1 1.3 1.0 0.6 1.4 0.0 0.2 0.2 0.4 8.2 15.4 22.1 12.9 6.5 18.4 7.9 9.2 12.7 4.3 SGTB "FLJ39002, Sgt2" ENSG00000197860 "Small glutamine rich tetratricopeptide repeat containing beta" Q96EQ0 5 65665928-65723035 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044689, HPA063674" Enhanced Uncertain Nucleoplasm Nucleoplasm "HPA044689: AB_10960838, HPA063674: AB_2685084" "unprognostic (9.94e-2)" "unprognostic (2.28e-1)" "unprognostic (9.58e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (5.92e-5)" "unprognostic (4.27e-2)" "unprognostic (2.86e-1)" "unprognostic (2.41e-1)" "unprognostic (1.64e-2)" "unprognostic (5.35e-2)" "unprognostic (2.54e-3)" "unprognostic (6.82e-2)" "unprognostic (1.87e-1)" "unprognostic (6.34e-2)" "unprognostic (3.05e-3)" 5.9 4.0 14.5 9.4 17.1 11.1 4.0 14.0 40.8 4.6 3.2 4.2 0.2 2.4 6.5 3.2 4.3 2.9 4.4 5.6 13.4 13.4 3.8 3.7 5.3 9.3 14.8 11.9 4.4 2.8 3.7 3.9 5.1 16.9 6.8 3.8 3.0 2.4 3.3 3.5 3.1 2.6 7.2 12.2 6.0 2.7 2.8 4.9 3.1 5.8 0.9 6.4 5.1 3.0 1.5 2.4 8.5 6.6 1.0 13.4 3.1 4.6 3.0 5.8 5.9 8.7 11.5 5.7 19.7 6.1 6.7 9.1 4.0 2.0 6.4 10.7 15.3 4.8 8.2 7.5 10.8 4.7 8.0 2.8 8.3 8.1 22.6 2.1 4.7 8.5 6.6 14.3 19.0 6.3 4.7 4.4 10.3 1.7 4.5 3.3 3.8 1.6 5.3 10.1 6.6 2.9 1.7 9.1 4.9 8.1 1.4 9.2 2.0 3.1 9.5 8.7 9.4 9.3 4.3 3.5 5.3 8.6 4.5 6.0 3.4 8.5 5.7 1.3 2.9 6.6 2.7 1.5 6.8 3.8 2.4 1.4 7.4 4.2 6.1 1.0 5.5 0.6 13.4 3.1 14.5 17.1 14.0 29.9 13.4 13.4 14.8 11.9 16.9 4.9 SH2D5 ENSG00000189410 "SH2 domain containing 5" Q6ZV89 1 20719732-20732837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 19.5;placenta: 14.8;testis: 9.4" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.9;hTERT-HME1: 31.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA030182 Supported Cytosol Cytosol "HPA030182: AB_10670431" "unprognostic (2.32e-1)" "unprognostic (2.80e-2)" "unprognostic (3.85e-2)" "unprognostic (5.37e-3)" "unprognostic (1.20e-4)" "unprognostic (4.41e-2)" "unprognostic (1.80e-6)" "unprognostic (1.11e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-3)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.77e-2)" "unprognostic (2.55e-2)" "unprognostic (2.34e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-2)" 0.4 0.9 4.5 1.3 19.5 0.4 0.3 0.5 19.2 0.6 0.5 0.3 0.0 1.2 1.4 0.3 0.5 0.5 0.6 0.3 3.9 4.1 0.4 0.3 0.4 0.3 1.5 7.3 1.7 0.3 0.6 0.1 14.8 2.1 0.5 0.3 0.0 0.4 1.8 0.3 0.6 0.5 1.2 0.3 0.4 0.6 9.4 0.7 0.0 2.1 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.6 3.8 0.8 0.0 0.0 0.0 0.1 4.6 6.5 4.5 3.0 1.6 1.5 0.0 1.2 1.3 0.4 3.3 24.9 1.8 0.0 1.7 0.0 0.5 1.2 3.7 0.0 0.0 0.2 5.2 8.4 31.9 0.0 0.0 0.0 1.9 0.9 0.5 0.0 1.5 5.0 0.1 0.1 0.2 4.7 0.6 1.4 0.2 0.3 0.1 1.5 0.0 0.0 0.0 5.5 9.7 8.2 2.2 0.0 0.0 0.4 1.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.5 19.5 0.5 12.3 3.9 4.1 1.5 7.3 2.1 0.7 SH3GL2 "CNSA2, EEN-B1, SH3D2A, SH3P4" ENSG00000107295 "SH3 domain containing GRB2 like 2, endophilin A1" Q99962 9 17579082-17797129 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 83.0" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HeLa: 13.8;RT4: 26.7;SCLC-21H: 17.4" "Cancer enhanced" "Detected in many" "glioma: 8.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010056, HPA026685, HPA063573" Enhanced Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: " "unprognostic (4.78e-2)" "unprognostic (3.24e-2)" "unprognostic (1.68e-2)" "unprognostic (5.05e-5)" "unprognostic (4.23e-2)" "unprognostic (3.40e-1)" "unprognostic (1.21e-1)" "unprognostic (5.90e-2)" "unprognostic (3.90e-1)" "unprognostic (5.07e-3)" "unprognostic (8.76e-3)" "unprognostic (1.26e-1)" "prognostic favourable (6.68e-12)" "unprognostic (2.65e-2)" "unprognostic (8.29e-2)" "unprognostic (2.25e-2)" "unprognostic (8.44e-2)" 1.1 1.2 16.7 1.1 17.3 1.0 1.1 68.4 83.0 3.1 1.5 1.6 0.0 1.2 2.8 2.1 1.4 2.6 1.1 4.1 17.1 11.3 13.7 1.1 1.9 1.0 9.1 22.2 2.5 3.4 1.2 6.6 1.0 12.8 2.5 1.6 1.6 1.0 1.1 1.1 1.1 1.5 2.4 6.3 1.1 4.5 5.8 2.2 0.0 2.2 0.0 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 4.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.7 0.0 13.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 1.5 0.0 0.0 0.0 0.0 26.7 17.4 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.9 0.0 0.2 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 17.3 68.4 41.1 17.1 11.3 9.1 22.2 12.8 2.2 SH3GL3 "CNSA3, EEN-B2, HsT19371, SH3D2C, SH3P13" ENSG00000140600 "SH3 domain containing GRB2 like 3, endophilin A3" Q99963 15 83447228-83618743 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 30.3;testis: 31.6" "Group enriched" "Detected in some" 4 "HAP1: 21.7;HEK 293: 10.7;K-562: 16.9;RH-30: 6.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039381, HPA077877" Enhanced Approved Mitochondria Mitochondria "HPA039381: AB_10794635, HPA077877: " "unprognostic (1.10e-3)" "unprognostic (6.62e-2)" "unprognostic (4.25e-2)" "unprognostic (1.86e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-1)" "unprognostic (9.76e-2)" "unprognostic (2.26e-1)" "unprognostic (8.20e-3)" "unprognostic (2.72e-3)" "unprognostic (1.43e-6)" "unprognostic (4.42e-2)" "unprognostic (3.59e-2)" "unprognostic (2.93e-1)" "unprognostic (5.78e-4)" 1.1 1.3 12.5 1.1 26.6 1.4 1.3 6.3 30.3 1.2 1.1 28.2 0.0 1.2 1.8 2.0 2.9 3.5 1.1 1.2 14.2 9.9 2.3 1.1 4.1 1.3 25.5 14.6 1.2 1.0 1.1 0.7 1.8 17.6 1.7 1.2 0.0 1.0 1.8 1.0 1.6 1.2 1.2 16.7 1.1 1.2 31.6 26.0 1.2 1.2 0.5 1.9 1.6 0.7 0.4 0.7 0.7 0.3 0.0 0.4 0.3 0.0 0.0 1.8 1.3 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 21.7 1.3 0.0 0.0 10.7 3.2 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 16.9 0.0 0.0 0.6 1.3 0.0 2.6 0.8 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 1.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.2 0.1 0.1 0.3 0.0 0.0 0.4 0.4 0.3 0.7 0.0 0.1 0.7 0.2 0.3 12.5 26.6 6.3 18.5 14.2 9.9 25.5 14.6 17.6 26.0 SH3TC2 "CMT4C, KIAA1985" ENSG00000169247 "SH3 domain and tetratricopeptide repeats 2" Q8TF17 5 148923639-149063163 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 32.1;placenta: 22.7;testis: 14.4" "Cell line enhanced" "Detected in some" "CACO-2: 6.1;RT4: 9.7;SK-MEL-30: 8.7;WM-115: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037683, HPA037684" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA037683: , HPA037684: AB_10672603" "unprognostic (6.30e-2)" "unprognostic (4.07e-2)" "unprognostic (4.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.70e-1)" "unprognostic (1.92e-2)" "unprognostic (2.49e-1)" "unprognostic (2.17e-4)" "unprognostic (2.18e-2)" "unprognostic (4.53e-1)" "unprognostic (6.21e-3)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" "unprognostic (6.48e-2)" "unprognostic (1.84e-1)" "unprognostic (6.62e-2)" "unprognostic (1.40e-1)" 1.3 0.8 3.3 0.8 15.4 1.2 1.4 0.9 8.6 2.2 1.0 32.1 0.0 0.6 1.0 1.7 2.0 1.3 1.3 3.7 6.0 3.0 0.6 0.7 1.0 0.7 22.7 4.6 0.6 0.5 0.8 0.5 22.7 12.0 0.9 1.8 0.0 1.4 1.4 1.5 1.1 0.7 1.3 12.9 1.0 0.7 14.4 15.6 0.0 0.8 0.0 1.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.6 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.2 0.5 0.2 6.1 5.0 0.0 5.5 0.3 4.2 0.0 4.1 0.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.4 2.0 1.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 5.5 0.0 3.8 0.0 2.0 9.7 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.3 0.2 1.1 0.2 3.5 0.0 0.0 0.0 0.2 1.2 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.3 15.4 0.9 8.6 6.0 3.0 22.7 4.6 12.0 15.6 SHANK1 "SPANK-1, SSTRIP, synamon" ENSG00000161681 "SH3 and multiple ankyrin repeat domains 1" Q9Y566 19 50661827-50719450 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 35.7" "Cell line enhanced" "Detected in some" "REH: 7.3;SH-SY5Y: 3.5;U-138 MG: 4.1;U-2 OS: 10.4;U-87 MG: 3.9;U-937: 4.3" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA032129, HPA032130" Uncertain Supported "Plasma membrane" "Plasma membrane" "HPA032129: AB_10602796, HPA032130: " "unprognostic (1.62e-1)" "unprognostic (4.40e-2)" "unprognostic (7.83e-3)" "unprognostic (4.62e-2)" "unprognostic (1.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.35e-2)" "unprognostic (5.02e-2)" "unprognostic (1.61e-1)" "unprognostic (7.51e-2)" "unprognostic (3.27e-1)" "unprognostic (3.65e-2)" "unprognostic (1.61e-2)" "unprognostic (5.14e-2)" "unprognostic (4.66e-3)" "unprognostic (1.29e-3)" 0.9 2.6 27.9 0.9 10.0 1.2 0.9 13.6 35.7 1.3 0.9 1.1 0.0 0.9 1.3 1.0 0.9 2.2 1.1 0.9 25.6 12.3 0.9 0.8 0.8 0.9 6.0 11.1 0.9 0.9 2.1 2.8 1.0 4.1 1.0 0.8 0.2 0.9 1.0 1.0 1.2 0.9 1.1 2.2 0.9 0.8 1.4 3.5 0.4 0.9 0.0 0.9 0.9 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.5 0.0 1.2 1.2 0.1 0.1 0.0 0.0 0.0 1.9 0.7 0.0 0.2 0.0 0.1 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.1 0.6 0.0 0.0 0.7 0.1 0.1 0.8 1.2 0.1 7.3 0.0 0.7 0.0 0.0 0.0 3.5 0.0 0.0 1.1 0.0 3.1 2.2 4.1 10.4 0.0 0.0 0.0 0.0 0.0 3.9 4.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 27.9 10.0 13.6 23.0 25.6 12.3 6.0 11.1 4.1 3.5 SHANK2 "CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3" ENSG00000162105 "SH3 and multiple ankyrin repeat domains 2" Q9UPX8 11 70467856-71252577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Cell line enhanced" "Detected in many" "Karpas-707: 16.6;MCF7: 9.5;RT4: 15.4;T-47d: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.1" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008174, HPA017220" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles" "Nuclear speckles" "Nucleoplasm, Vesicles" "HPA008174: AB_1856822, HPA017220: " "unprognostic (3.08e-1)" "unprognostic (1.31e-3)" "unprognostic (1.79e-1)" "unprognostic (1.51e-2)" "unprognostic (1.51e-1)" "unprognostic (7.23e-5)" "unprognostic (1.24e-1)" "unprognostic (6.67e-2)" "unprognostic (1.83e-2)" "unprognostic (8.42e-2)" "unprognostic (4.87e-2)" "unprognostic (4.01e-1)" "prognostic favourable (1.94e-6)" "unprognostic (3.46e-2)" "unprognostic (2.34e-1)" "unprognostic (4.03e-2)" "unprognostic (4.80e-2)" 2.1 1.7 16.8 0.8 22.6 0.0 7.3 6.1 24.1 2.8 3.1 2.3 1.9 2.4 1.8 3.1 5.1 7.9 1.1 0.2 12.2 8.1 7.0 4.7 5.5 0.3 3.6 12.9 0.2 11.3 0.0 7.3 2.7 8.7 4.6 2.8 1.4 12.7 3.3 0.1 1.2 2.0 0.6 1.5 1.5 4.7 1.2 3.7 0.0 8.5 0.0 0.5 2.3 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 7.7 4.2 0.0 0.4 0.7 3.1 0.6 0.3 0.0 0.0 8.1 2.9 5.1 1.5 0.0 0.8 0.0 2.9 0.0 0.0 0.2 0.0 0.0 8.4 0.0 0.0 1.7 0.2 1.5 0.0 0.0 0.0 0.0 16.6 1.6 9.5 0.0 0.0 3.3 0.3 0.0 7.6 7.5 3.9 15.4 2.5 1.0 0.0 6.2 0.0 11.8 0.0 0.0 0.1 1.2 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.8 22.6 6.1 24.1 12.2 8.1 3.6 12.9 8.7 3.7 SHANK3 "KIAA1650, prosap2, PSAP2, SPANK-2" ENSG00000251322 "SH3 and multiple ankyrin repeat domains 3" 22 50674415-50733298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.4" "Cell line enhanced" "Detected in some" "HEL: 6.3;TIME: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003446 Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA003446: AB_1079958" "unprognostic (3.62e-1)" "unprognostic (1.08e-2)" "prognostic unfavourable (7.40e-4)" "unprognostic (6.02e-2)" "unprognostic (4.17e-1)" "unprognostic (1.72e-3)" "unprognostic (3.41e-2)" "unprognostic (3.13e-1)" "unprognostic (9.67e-2)" "unprognostic (5.62e-2)" "unprognostic (2.09e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (7.81e-2)" "unprognostic (1.19e-1)" "unprognostic (4.89e-2)" "unprognostic (1.41e-1)" 9.5 5.4 23.5 1.3 26.1 2.6 8.7 13.0 32.4 3.5 2.0 2.4 0.1 5.2 3.8 3.4 2.5 2.8 1.1 4.4 21.6 2.4 2.9 5.1 5.3 2.9 2.5 18.1 1.6 7.6 7.9 1.0 1.7 2.6 1.9 1.9 0.6 8.5 3.4 3.6 3.1 6.6 1.5 2.0 12.3 1.3 3.4 6.4 0.2 4.1 1.4 2.6 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.9 0.6 2.9 0.5 0.5 0.0 0.6 0.0 0.2 0.0 0.6 1.6 0.0 1.2 0.2 0.6 0.9 0.4 0.0 0.0 0.0 6.3 0.4 1.7 1.5 0.8 0.3 1.5 1.0 0.1 0.3 2.0 0.1 0.1 0.1 0.9 0.5 0.2 1.3 1.8 1.7 0.0 0.7 0.3 0.5 1.2 1.9 1.7 0.0 0.8 0.3 0.3 10.0 0.2 1.7 0.6 0.4 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 26.1 13.0 32.4 21.6 2.4 2.5 18.1 2.6 6.4 SHC3 "N-Shc, NSHC, SHCC" ENSG00000148082 "SHC adaptor protein 3" Q92529 9 89005771-89178767 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1" "Cell line enhanced" "Detected in some" "AF22: 19.0;RT4: 7.0;SH-SY5Y: 7.0;U-87 MG: 10.6" "Cancer enhanced" "Detected in some" "glioma: 5.1" "Group enriched" "Detected in many" 4 "amygdala: 15.7;basal ganglia: 20.8;cerebral cortex: 31.5;hippocampal formation: 14.2;olfactory region: 24.7" "Cell type enriched" "Detected in single" 14 "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 14 "B-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031427, HPA046656, HPA072448" Uncertain Supported Nucleoplasm Nucleoplasm "HPA031427: , HPA046656: , HPA072448: " "unprognostic (6.22e-2)" "unprognostic (5.86e-2)" "unprognostic (1.26e-1)" "unprognostic (2.43e-1)" "unprognostic (1.04e-1)" "unprognostic (9.07e-4)" "unprognostic (2.70e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (3.09e-1)" "unprognostic (2.72e-3)" "unprognostic (7.39e-2)" "unprognostic (1.53e-7)" "unprognostic (8.33e-2)" "unprognostic (1.05e-1)" "unprognostic (9.01e-2)" "unprognostic (9.84e-4)" 1.6 10.8 15.7 0.8 20.8 0.5 1.8 0.8 35.1 7.3 1.2 2.3 0.0 1.1 1.5 1.7 1.5 2.2 2.7 1.0 14.2 4.7 1.4 0.6 6.0 0.8 3.1 24.7 0.7 4.4 10.4 1.0 0.8 5.2 1.5 1.4 0.0 6.4 1.4 0.9 1.8 0.9 1.8 1.5 0.6 0.8 1.0 1.3 0.0 1.3 0.0 0.8 1.7 3.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 19.0 0.0 4.2 1.3 0.0 1.4 3.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.4 0.4 0.2 0.0 2.9 0.0 1.9 0.0 5.0 0.0 0.0 0.0 0.1 0.0 1.1 2.4 0.2 0.2 0.0 3.9 4.1 7.0 2.5 7.0 0.5 0.0 0.0 0.0 0.3 2.9 0.7 0.1 1.1 0.1 0.0 0.0 0.0 10.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 20.8 0.8 31.5 14.2 4.7 3.1 24.7 5.2 1.3 SHC4 "RaLP, SHCD" ENSG00000185634 "SHC adaptor protein 4" Q6S5L8 15 48823735-48963444 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7;testis: 19.5" "Cell line enhanced" "Detected in some" "AN3-CA: 9.3;SK-MEL-30: 17.5;WM-115: 15.0" "Cancer enhanced" "Detected in some" "melanoma: 9.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "eosinophil: 2.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.5" "Low region specificity" "Detected in all" HPA074146 Approved Cytosol Cytosol "HPA074146: " "unprognostic (4.34e-3)" "unprognostic (1.01e-3)" "unprognostic (6.70e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.05e-3)" "unprognostic (1.23e-2)" "unprognostic (3.47e-2)" "unprognostic (2.59e-1)" "unprognostic (2.21e-2)" "unprognostic (3.80e-2)" "unprognostic (3.71e-1)" "unprognostic (1.04e-5)" "unprognostic (9.84e-3)" "unprognostic (3.26e-2)" "unprognostic (3.49e-2)" "unprognostic (1.36e-2)" 1.5 2.3 9.0 2.3 24.8 0.7 3.7 2.0 15.8 2.5 2.5 18.9 0.3 1.1 1.3 2.5 1.5 1.9 3.2 6.6 11.2 6.2 1.2 0.8 1.2 1.1 25.7 9.4 1.6 0.9 0.7 1.1 1.3 13.2 1.3 1.6 1.7 4.8 3.3 2.0 1.3 1.1 1.9 16.2 0.9 1.0 19.5 23.8 0.0 1.1 0.0 0.8 1.7 0.9 0.0 0.0 2.5 0.0 0.0 0.3 0.0 0.0 0.3 0.9 9.3 0.4 1.3 0.0 1.3 2.6 0.6 1.1 0.0 0.2 0.1 2.3 0.5 0.0 0.2 0.4 0.8 1.8 0.1 0.6 0.0 0.0 1.0 0.0 0.1 1.8 0.0 1.2 0.1 0.1 0.0 0.2 1.3 1.5 0.3 0.2 0.1 3.5 0.2 2.5 0.3 2.0 0.3 0.5 0.7 0.2 0.1 17.5 0.0 0.1 0.0 0.8 0.4 0.5 0.9 0.7 0.1 0.0 0.8 0.5 15.0 0.2 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 24.8 2.0 13.4 11.2 6.2 25.7 9.4 13.2 23.8 SHD ENSG00000105251 "Src homology 2 domain containing transforming protein D" Q96IW2 19 4278601-4290724 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "blood: 14.8;brain: 23.1;heart muscle: 17.3" "Group enriched" "Detected in some" 46 "RH-30: 18.8;SH-SY5Y: 60.6" "Cancer enhanced" "Detected in some" "glioma: 11.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 148 "plasmacytoid DC: 14.8" "Lineage enriched" "Detected in single" 148 "dendritic cells: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017955 Uncertain Uncertain "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA017955: AB_1856828" "unprognostic (2.41e-3)" "unprognostic (7.68e-3)" "unprognostic (4.77e-3)" "unprognostic (3.67e-2)" "unprognostic (3.48e-2)" "unprognostic (3.42e-1)" "unprognostic (6.53e-2)" "unprognostic (1.43e-1)" "unprognostic (5.93e-2)" "unprognostic (3.73e-1)" "unprognostic (2.47e-2)" "unprognostic (3.76e-1)" "unprognostic (3.48e-1)" "unprognostic (1.21e-1)" "unprognostic (5.21e-2)" "unprognostic (9.69e-2)" "unprognostic (8.16e-4)" 0.5 0.7 4.0 1.4 2.5 1.2 0.4 4.1 23.1 0.4 0.9 2.4 0.0 0.7 0.4 0.4 0.4 0.4 0.6 17.3 3.3 4.5 0.4 1.7 0.5 1.2 4.7 2.3 0.4 0.5 0.4 0.2 0.4 6.1 0.5 0.7 0.0 0.5 0.4 0.8 0.4 0.6 0.4 2.5 0.6 0.4 0.5 1.1 0.0 0.4 0.0 0.8 0.5 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 18.8 0.0 0.0 0.0 0.1 60.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 4.0 2.5 4.1 20.4 3.3 4.5 4.7 2.3 6.1 1.1 SHF ENSG00000138606 "Src homology 2 domain containing F" Q7M4L6 15 45167214-45201175 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 84.3" "Cell line enhanced" "Detected in many" "SCLC-21H: 49.5;SH-SY5Y: 22.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 84.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 269.9" HPA057381 Approved Nucleoplasm Nucleoplasm "HPA057381: " "unprognostic (4.05e-2)" "unprognostic (2.02e-3)" "unprognostic (7.59e-2)" "unprognostic (1.54e-1)" "unprognostic (1.88e-2)" "unprognostic (2.18e-1)" "unprognostic (2.38e-1)" "unprognostic (7.61e-2)" "unprognostic (2.18e-1)" "unprognostic (3.50e-2)" "unprognostic (6.88e-2)" "unprognostic (5.12e-2)" "unprognostic (6.89e-2)" "unprognostic (2.83e-2)" "unprognostic (1.17e-1)" "unprognostic (5.09e-3)" "unprognostic (1.83e-2)" 2.9 19.3 6.9 3.3 10.4 0.6 3.3 84.3 14.5 7.3 6.3 3.9 2.2 10.5 8.5 4.0 4.1 6.2 5.3 4.5 5.9 7.2 1.8 18.9 2.9 1.8 4.5 6.7 20.5 2.5 2.5 3.5 1.5 7.1 5.3 4.4 6.3 5.3 5.2 2.6 6.5 7.9 6.3 5.2 2.3 2.9 4.1 3.2 1.6 4.9 2.4 1.8 5.8 5.5 3.3 2.6 2.5 1.9 5.1 4.2 1.5 0.0 0.5 9.7 0.3 0.7 0.4 4.6 1.2 0.8 2.7 3.9 1.4 4.6 0.5 3.9 1.6 0.8 3.7 0.3 1.3 0.8 1.7 0.3 0.8 9.6 0.4 0.0 3.2 0.9 0.2 0.3 0.0 2.1 1.9 0.2 3.8 1.6 2.1 0.3 3.8 0.2 5.8 7.7 0.2 0.9 0.2 49.5 22.1 0.3 0.3 0.1 0.4 0.9 0.1 0.3 4.2 0.3 0.1 0.4 0.3 0.4 0.1 0.2 1.5 0.3 1.9 1.2 3.8 1.7 4.2 2.4 1.6 2.4 1.8 3.3 2.2 1.7 2.5 5.1 1.7 2.6 0.3 1.5 6.9 10.4 84.3 12.1 5.9 7.2 4.5 6.7 7.1 3.2 SHISA6 FLJ45455 ENSG00000188803 "Shisa family member 6" Q6ZSJ9 17 11241263-11564063 "Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;cervix, uterine: 22.4" "Cell line enriched" "Detected in some" 7 "NTERA-2: 7.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023440 Uncertain "HPA023440: AB_1848945" "unprognostic (1.70e-1)" "unprognostic (2.78e-2)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "prognostic unfavourable (8.41e-4)" "unprognostic (3.11e-2)" "unprognostic (1.71e-1)" "unprognostic (8.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (9.63e-2)" "unprognostic (1.27e-1)" "unprognostic (2.40e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.20e-2)" "unprognostic (2.47e-2)" 2.2 0.7 5.8 0.6 5.5 0.2 1.2 9.8 7.5 22.4 0.9 2.5 1.9 0.4 4.2 2.4 0.9 1.7 0.5 1.1 12.1 9.9 2.5 0.2 1.5 0.2 11.8 2.9 0.6 1.4 6.0 0.0 0.3 13.6 5.9 0.8 0.8 0.2 10.1 1.0 0.5 0.4 1.2 9.6 0.2 6.0 2.9 2.1 0.0 0.7 0.0 0.2 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 9.8 4.9 12.1 9.9 11.8 2.9 13.6 2.1 SHISA7 ENSG00000187902 "Shisa family member 7" A6NL88 19 55428740-55442863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 24.9" "Group enriched" "Detected in some" 5 "HEL: 6.5;HMC-1: 6.9;THP-1: 3.5" "Cancer enriched" "Detected in single" 9 "glioma: 2.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058935 Uncertain Approved Cytosol Cytosol "HPA058935: " "unprognostic (3.98e-2)" "unprognostic (5.81e-2)" "unprognostic (1.16e-1)" "unprognostic (1.28e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.08e-1)" "unprognostic (4.40e-1)" "unprognostic (7.17e-2)" "unprognostic (2.11e-3)" "unprognostic (1.22e-2)" "unprognostic (6.87e-7)" "unprognostic (7.53e-3)" "unprognostic (2.82e-1)" "unprognostic (3.29e-4)" "unprognostic (4.04e-1)" 0.7 1.7 11.3 0.7 16.7 2.6 0.7 4.0 24.9 0.7 0.8 7.2 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 11.2 8.2 0.7 0.7 0.7 0.7 8.3 3.1 0.7 0.8 0.7 2.4 0.7 5.5 0.7 0.8 0.0 0.7 0.7 0.7 0.8 0.8 0.7 4.0 0.7 0.8 2.2 14.6 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 6.5 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 1.2 0.6 0.0 1.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 16.7 4.0 10.9 11.2 8.2 8.3 3.1 5.5 14.6 SHISA8 "C22orf17, Orf26" ENSG00000234965 "Shisa family member 8" B8ZZ34 22 41909554-41914667 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 42.2" "Cell line enriched" "Detected in some" 7 "HEK 293: 20.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 15 "cerebellum: 42.2" "Cell type enhanced" "Detected in single" "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 17 "B-cells: 1.7" "Group enriched" "Detected in some" 5 "cerebellum: 8.7;olfactory region: 19.4" "Group enriched" "Detected in all" 4 "cerebellum: 61.4;olfactory region: 45.2" HPA059173 Uncertain "HPA059173: " "unprognostic (8.76e-2)" "unprognostic (2.98e-4)" "unprognostic (1.03e-1)" "prognostic favourable (2.76e-4)" "unprognostic (4.42e-2)" "unprognostic (1.45e-3)" "unprognostic (4.40e-1)" "unprognostic (1.16e-2)" "unprognostic (2.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.45e-3)" "unprognostic (2.16e-1)" "unprognostic (1.12e-1)" "unprognostic (8.59e-2)" "unprognostic (2.60e-2)" "unprognostic (6.22e-4)" "unprognostic (7.84e-2)" 0.1 9.4 0.5 1.6 0.5 0.2 0.1 42.2 2.7 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.3 0.3 0.5 0.2 0.2 0.1 0.1 3.0 0.3 1.7 0.1 0.1 0.1 0.8 0.0 2.2 0.2 0.0 1.5 1.8 0.2 0.8 0.5 0.8 0.0 0.3 2.7 0.7 0.2 0.0 0.0 0.1 0.0 3.8 0.4 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 42.2 2.7 0.5 0.2 0.3 1.7 2.2 0.0 SHISA9 ENSG00000237515 "Shisa family member 9" B4DS77 16 12901620-13240413 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5" "Group enriched" "Detected in some" 4 "EFO-21: 29.1;LHCN-M2: 23.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.88e-2)" "unprognostic (3.04e-2)" "unprognostic (2.74e-1)" "unprognostic (1.69e-5)" "unprognostic (2.23e-2)" "unprognostic (2.03e-2)" "unprognostic (5.90e-5)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (1.19e-2)" "unprognostic (3.66e-1)" "unprognostic (1.38e-1)" "prognostic favourable (1.53e-4)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" 1.2 4.8 17.2 1.6 23.5 2.7 1.3 0.9 21.3 0.9 3.4 3.6 0.4 1.6 1.1 2.3 1.2 0.7 0.9 1.3 10.2 6.7 3.4 1.4 0.7 1.0 3.3 12.6 1.1 1.3 0.6 1.9 1.0 10.2 6.9 1.8 0.6 1.7 1.4 4.2 1.9 1.7 1.2 2.1 1.0 1.3 1.6 4.0 0.0 3.5 0.0 0.8 0.8 0.9 2.0 1.2 3.9 0.9 1.2 0.9 0.0 0.6 0.3 0.5 0.5 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.3 0.5 0.5 29.1 0.1 0.4 0.1 0.1 0.1 0.5 0.1 0.7 0.6 0.2 0.0 0.5 0.7 0.9 0.0 0.1 2.0 0.1 0.3 1.1 23.7 3.2 0.4 0.7 6.3 0.3 0.5 0.4 0.3 6.5 1.1 6.2 0.5 0.3 1.0 0.3 0.8 0.3 0.4 0.6 3.8 0.6 0.3 1.2 1.2 0.6 0.4 0.2 0.8 3.9 0.9 0.4 0.8 0.5 0.6 1.1 0.7 0.8 0.3 2.0 0.9 0.8 3.2 1.2 0.7 1.2 0.7 0.0 17.2 23.5 0.9 18.8 10.2 6.7 3.3 12.6 10.2 4.0 SHISAL2B FAM159B ENSG00000145642 "Shisa like 2B" A6NKW6 5 64690308-64718090 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 7.3;pancreas: 16.1;stomach 1: 7.7" "Group enriched" "Detected in some" 4 "NTERA-2: 5.8;RPTEC TERT1: 12.1" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 3.9" "Group enriched" "Detected in some" 14 "basal ganglia: 1.9;hypothalamus: 7.3;pons and medulla: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011778 Enhanced "HPA011778: AB_1848382" "unprognostic (5.83e-2)" "unprognostic (9.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.84e-2)" "unprognostic (3.25e-1)" "unprognostic (5.01e-2)" "unprognostic (1.49e-1)" "unprognostic (9.12e-2)" "unprognostic (2.97e-1)" "unprognostic (4.84e-2)" "unprognostic (5.36e-5)" "unprognostic (1.44e-1)" "unprognostic (1.98e-1)" "unprognostic (5.60e-1)" "unprognostic (6.99e-2)" 0.1 0.0 0.3 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.3 0.2 0.0 0.2 0.0 0.2 0.0 0.2 16.1 0.0 0.1 0.5 4.9 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.6 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 12.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.2 0.3 7.3 0.2 0.0 4.9 0.2 SHOX "GCFX, PHOG, SHOXY, SS" ENSG00000185960 "Short stature homeobox" O15266 X 624344-659411 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.3;breast: 13.9" "Group enriched" "Detected in some" 4 "BJ: 19.1;BJ hTERT+: 8.8" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 6.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA035141, HPA060931" Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA035141: , HPA060931: " "unprognostic (7.51e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-1)" "unprognostic (6.82e-2)" "unprognostic (2.45e-2)" "unprognostic (2.34e-1)" "unprognostic (9.24e-2)" "unprognostic (9.95e-2)" "unprognostic (5.67e-6)" "unprognostic (1.99e-1)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.38e-1)" 3.8 1.0 0.3 0.7 0.3 3.0 13.9 1.8 0.8 0.3 0.4 0.2 0.2 1.4 0.3 0.6 0.3 0.4 0.4 0.4 0.7 0.3 0.3 0.3 0.3 0.6 0.3 1.4 0.3 0.9 0.0 0.3 4.8 6.3 0.8 0.3 0.2 1.4 0.2 2.8 1.4 1.0 0.2 0.4 1.6 0.4 0.4 0.2 0.2 0.5 0.2 0.2 0.3 0.3 2.2 1.9 5.5 1.8 2.5 1.5 0.8 0.1 0.2 0.1 0.2 0.2 0.1 3.2 19.1 8.8 2.9 3.1 0.3 0.3 0.3 0.1 0.4 0.3 0.2 0.0 0.9 0.2 0.1 0.1 1.3 0.1 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.3 0.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.5 0.0 0.1 0.3 0.2 0.1 0.1 0.9 0.1 0.2 0.1 0.2 0.1 5.5 1.8 1.8 1.4 1.1 1.5 1.6 1.1 1.2 0.5 2.2 1.5 1.5 5.2 2.5 1.5 1.9 1.0 0.8 0.3 0.3 1.8 0.4 0.7 0.3 0.3 1.4 6.3 0.2 SHROOM4 KIAA1202 ENSG00000158352 "Shroom family member 4" Q9ULL8 X 50591647-50814302 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 27.3" "Cell line enhanced" "Detected in some" "EFO-21: 6.0;HUVEC TERT2: 22.8;RH-30: 4.4;RPTEC TERT1: 4.9;TIME: 8.6;WM-115: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "basophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010089, HPA010565" Uncertain Approved "Vesicles,Focal adhesion sites" "Focal adhesion sites" Vesicles "HPA010089: , HPA010565: AB_1079961" "unprognostic (2.55e-2)" "unprognostic (1.43e-1)" "unprognostic (5.56e-2)" "prognostic unfavourable (8.37e-4)" "unprognostic (1.34e-1)" "unprognostic (1.60e-2)" "unprognostic (4.30e-3)" "unprognostic (4.55e-2)" "unprognostic (2.13e-1)" "unprognostic (2.93e-1)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (4.66e-4)" "unprognostic (7.30e-2)" "unprognostic (2.83e-1)" "unprognostic (1.74e-2)" "unprognostic (2.75e-1)" 13.1 3.5 5.9 3.6 12.1 2.4 10.1 1.9 7.7 6.4 2.9 27.3 1.6 2.4 6.8 3.6 5.2 4.3 5.7 8.5 8.3 4.8 9.7 1.9 21.4 1.9 15.9 6.5 2.5 1.9 3.6 3.7 15.3 13.0 3.6 3.0 4.8 3.5 3.7 6.0 3.2 2.6 7.4 19.7 2.1 2.4 1.5 15.8 0.0 6.3 6.7 2.1 4.8 4.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.4 0.1 0.0 6.0 0.7 0.6 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.4 22.8 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 4.4 0.0 4.9 2.1 0.1 0.0 0.0 0.7 1.3 0.0 0.1 8.6 0.0 0.0 0.0 0.6 0.4 0.0 0.0 1.2 0.2 4.4 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 12.1 1.9 7.7 8.3 4.8 15.9 6.5 13.0 15.8 SHTN1 "KIAA1598, shootin-1, shootin1" ENSG00000187164 "Shootin 1" A0MZ66 10 116881482-117126586 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 14.0;intermediate monocyte: 8.8;myeloid DC: 13.2;non-classical monocyte: 4.0;plasmacytoid DC: 8.9" "Group enriched" "Detected in many" 43 "dendritic cells: 13.2;monocytes: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037942, HPA037943" Enhanced Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA037942: AB_2675748, HPA037943: AB_10671637" "unprognostic (1.00e-1)" "unprognostic (2.50e-2)" "unprognostic (6.77e-3)" "unprognostic (2.81e-1)" "unprognostic (7.85e-2)" "unprognostic (1.61e-1)" "unprognostic (2.42e-2)" "unprognostic (1.03e-1)" "unprognostic (2.56e-1)" "unprognostic (1.35e-1)" "unprognostic (2.49e-1)" "prognostic unfavourable (5.07e-4)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "prognostic unfavourable (5.08e-6)" 3.5 6.5 51.5 6.8 50.1 1.6 8.7 9.8 34.1 5.5 7.0 42.3 0.3 6.7 4.4 8.4 5.4 5.2 6.5 2.6 58.9 37.0 7.8 12.1 9.8 4.5 67.8 22.7 6.8 10.9 18.6 20.4 5.4 36.3 7.3 8.6 2.0 9.9 3.0 0.9 9.6 7.8 3.8 67.4 7.0 9.0 9.9 54.5 0.4 11.9 1.4 4.1 4.0 2.4 0.0 13.2 0.3 14.0 0.0 0.2 3.5 15.6 8.8 0.9 1.9 0.0 0.0 8.8 1.3 3.5 2.7 5.2 9.9 10.4 0.0 2.7 4.9 8.1 7.0 5.9 2.8 0.0 7.3 0.0 9.3 6.1 1.2 2.8 2.5 0.4 5.2 2.7 5.1 6.5 4.3 0.0 1.9 6.3 0.0 0.1 3.4 6.0 0.0 11.9 3.5 7.3 2.1 9.8 3.9 10.6 15.4 9.6 12.4 2.5 11.2 0.9 6.6 0.0 7.7 1.7 0.0 0.0 4.9 0.0 4.8 0.0 14.0 0.1 0.0 8.8 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.3 0.0 4.0 8.9 0.2 3.5 51.5 50.1 9.8 30.2 58.9 37.0 67.8 22.7 36.3 54.5 SIAH3 FLJ39203 ENSG00000215475 "Siah E3 ubiquitin protein ligase family member 3" Q8IW03 13 45777243-45851736 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.2;fallopian tube: 11.8" "Cell line enriched" "Detected in single" 8 "EFO-21: 4.9" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060576 Uncertain "HPA060576: " "unprognostic (1.07e-3)" "unprognostic (1.26e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (4.96e-2)" "unprognostic (1.00e-2)" "unprognostic (1.05e-1)" "unprognostic (7.53e-2)" "unprognostic (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (4.77e-3)" "unprognostic (3.24e-3)" "unprognostic (9.03e-4)" "unprognostic (2.03e-1)" "unprognostic (2.18e-1)" 0.6 1.3 5.1 0.9 8.3 0.9 0.6 5.6 10.2 4.1 0.6 0.0 0.1 0.8 1.7 2.0 0.6 11.8 0.7 0.6 4.0 2.8 1.7 0.6 0.8 0.8 3.4 6.6 0.7 0.6 0.5 0.4 0.5 8.9 0.6 0.7 2.8 1.7 3.6 0.6 0.8 0.8 0.8 1.3 0.8 0.7 0.8 0.7 0.4 0.6 0.0 0.9 0.7 0.4 0.1 0.1 0.5 0.1 0.2 1.5 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 4.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.5 0.7 0.5 0.2 0.0 0.1 0.0 0.0 5.1 8.3 5.6 10.2 4.0 2.8 3.4 6.6 8.9 0.7 SIRPA "BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2" ENSG00000198053 "Signal regulatory protein alpha" P78324 20 1894167-1940592 "CD markers, Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.2" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 42.3;RPTEC TERT1: 30.7;SK-MEL-30: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 10.1;eosinophil: 20.9;myeloid DC: 6.3;neutrophil: 23.5" "Group enriched" "Detected in many" 134 "dendritic cells: 6.3;granulocytes: 23.5;monocytes: 10.1" "CAB002776, CAB015122, HPA054437, HPA058511" Enhanced 170000000 "CAB002776: , CAB015122: AB_677430, HPA054437: AB_2682488, HPA058511: AB_2683738" "unprognostic (9.78e-2)" "unprognostic (2.67e-1)" "unprognostic (3.07e-1)" "unprognostic (1.23e-1)" "unprognostic (5.56e-2)" "unprognostic (1.58e-1)" "unprognostic (1.15e-3)" "unprognostic (4.19e-3)" "unprognostic (3.48e-2)" "unprognostic (2.84e-3)" "unprognostic (3.69e-1)" "unprognostic (3.33e-2)" "unprognostic (2.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.55e-2)" "unprognostic (3.55e-2)" "unprognostic (2.24e-2)" 23.2 21.7 36.9 24.9 38.8 19.9 14.0 39.1 69.2 9.5 6.7 22.8 3.0 14.1 6.4 11.2 7.2 9.1 14.6 11.9 29.3 18.5 9.6 16.1 22.0 10.3 18.8 50.3 9.7 6.1 2.2 5.5 13.8 14.7 4.9 8.2 9.5 15.0 8.9 5.5 13.6 11.7 11.4 18.0 9.6 5.2 3.9 20.4 1.0 4.1 2.2 8.8 13.2 6.9 0.0 6.3 23.5 10.1 0.0 0.0 3.4 3.4 7.5 3.8 7.0 9.1 8.6 0.5 18.1 15.4 4.9 1.5 4.7 0.1 0.0 4.4 42.3 3.4 3.0 21.0 2.0 0.0 2.1 0.0 0.9 2.6 11.1 7.0 8.7 7.7 9.9 4.2 5.1 15.3 0.4 4.7 6.6 0.2 0.0 9.8 4.2 3.4 0.0 6.7 4.7 30.7 0.0 0.5 1.1 2.4 0.0 35.6 1.2 22.6 22.8 21.9 11.4 14.1 8.9 0.0 0.0 0.0 6.8 22.7 2.4 0.1 10.1 20.9 0.0 2.7 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 23.5 0.0 1.0 0.4 0.0 3.4 36.9 38.8 39.1 68.6 29.3 18.5 18.8 50.3 14.7 20.4 SIRT2 SIR2L ENSG00000068903 "Sirtuin 2" Q8IXJ6 19 38878555-38899862 "Cancer-related genes, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation" Transferase "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.6;skeletal muscle: 108.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004573, HPA011165" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "CAB004573: AB_2188600, HPA011165: AB_1856900" "unprognostic (2.15e-2)" "unprognostic (2.24e-2)" "unprognostic (2.88e-1)" "prognostic unfavourable (7.20e-7)" "unprognostic (3.75e-3)" "unprognostic (1.28e-2)" "unprognostic (2.85e-2)" "unprognostic (2.44e-3)" "unprognostic (2.73e-1)" "unprognostic (4.83e-2)" "unprognostic (2.97e-3)" "unprognostic (1.02e-1)" "unprognostic (1.90e-1)" "unprognostic (3.60e-2)" "unprognostic (1.19e-1)" "unprognostic (8.73e-2)" "unprognostic (1.70e-1)" 14.1 11.0 30.2 8.1 36.0 10.7 9.1 14.3 38.8 11.0 8.4 78.1 4.0 9.3 9.7 7.8 17.1 12.9 10.7 20.3 36.9 23.5 9.0 12.0 10.8 8.8 52.3 20.5 17.3 9.5 10.1 6.2 7.7 40.8 9.8 7.6 5.8 14.9 11.2 108.7 13.7 9.3 12.8 86.6 9.9 9.0 7.9 46.3 3.2 10.1 23.4 8.9 10.6 7.1 13.2 21.5 28.0 33.0 16.6 23.5 22.1 8.1 5.1 4.4 11.0 25.3 17.4 3.0 6.0 10.7 9.4 12.2 9.2 5.2 2.8 13.1 11.2 4.4 8.0 12.9 5.7 13.0 8.3 5.5 5.8 5.5 17.8 3.8 12.2 18.1 15.6 7.7 9.2 16.4 5.2 22.6 14.3 4.6 7.7 3.0 0.7 7.2 10.2 12.4 7.8 7.5 7.3 11.1 5.0 7.0 9.4 6.6 4.2 9.9 15.6 12.7 2.8 19.6 8.9 9.3 4.5 6.5 10.2 9.6 11.7 19.5 27.3 28.0 23.5 33.0 14.6 12.2 11.4 16.1 21.1 13.2 7.5 12.5 20.7 16.6 25.8 21.5 15.5 22.1 30.2 36.0 14.3 38.8 36.9 23.5 52.3 20.5 40.8 46.3 SIX3 HPE2 ENSG00000138083 "SIX homeobox 3" O95343 2 44941898-44946077 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 40.2;parathyroid gland: 32.1;pituitary gland: 30.9;retina: 66.5" "Cell line enhanced" "Detected in some" "HAP1: 6.8;SCLC-21H: 36.7;SH-SY5Y: 14.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "basal ganglia: 40.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 38.7" HPA067988 Approved Nucleoplasm Nucleoplasm "HPA067988: " "unprognostic (1.19e-3)" "unprognostic (1.05e-2)" "unprognostic (4.76e-1)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.76e-2)" "unprognostic (1.31e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "unprognostic (6.82e-2)" "unprognostic (1.22e-1)" "unprognostic (2.49e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-2)" 0.4 0.4 3.7 0.5 40.2 0.5 0.5 0.7 0.7 1.5 0.4 1.5 0.0 0.5 0.4 0.4 0.5 0.4 0.5 0.4 1.6 7.2 0.4 0.4 0.5 0.5 1.1 2.7 0.4 1.0 32.1 30.9 0.4 0.1 0.4 0.4 66.5 0.4 0.4 1.1 0.5 0.4 0.4 0.0 0.4 0.5 0.8 6.5 0.0 0.4 0.0 0.4 0.4 0.0 1.1 1.1 4.5 2.2 1.9 1.7 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 6.8 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.2 0.1 0.0 0.2 0.0 0.0 0.0 36.7 14.7 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.6 1.2 1.0 1.1 1.7 1.1 1.1 0.8 0.8 1.1 1.3 1.4 1.7 1.9 2.2 1.1 1.3 0.7 3.7 40.2 0.7 0.7 1.6 7.2 1.1 2.7 0.1 6.5 SKI ENSG00000157933 "SKI proto-oncogene" P12755 1 2228695-2310119 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Craniosynostosis, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010449, HPA066567" Approved Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB010449: AB_2187342, HPA066567: " "unprognostic (3.99e-2)" "unprognostic (3.81e-2)" "unprognostic (1.44e-1)" "unprognostic (5.42e-2)" "unprognostic (4.66e-2)" "unprognostic (7.32e-2)" "unprognostic (1.88e-1)" "unprognostic (9.14e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (4.94e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-3)" "unprognostic (1.88e-1)" "unprognostic (7.82e-2)" "unprognostic (9.69e-2)" "unprognostic (5.24e-3)" 12.5 4.7 11.8 7.1 22.5 4.8 8.1 34.5 21.2 9.8 8.2 5.5 3.1 4.6 11.9 4.4 5.9 9.1 8.0 9.0 11.0 4.1 4.4 6.1 11.1 6.9 6.2 10.1 10.4 9.6 4.2 6.2 7.4 8.5 8.4 3.5 4.0 12.0 11.9 6.8 11.7 5.9 9.3 5.3 9.3 6.0 7.2 5.3 3.6 6.9 8.1 5.1 7.6 7.8 0.8 0.3 3.0 0.6 1.3 0.6 0.4 10.3 6.0 14.6 14.2 24.4 14.7 9.6 15.6 8.7 9.7 7.2 9.1 8.1 6.6 11.7 20.0 12.3 8.1 12.6 9.0 7.2 17.7 16.6 9.1 12.8 16.3 9.3 17.8 15.7 7.0 14.6 11.0 11.9 9.3 5.1 11.9 6.6 1.1 10.3 14.7 11.7 5.1 9.2 5.4 8.3 4.1 21.0 13.7 15.2 13.6 15.1 4.6 12.0 21.5 16.8 10.5 23.6 12.1 4.0 2.8 6.1 8.9 16.2 6.8 0.6 0.5 0.3 0.5 0.6 0.5 0.3 0.4 0.5 0.3 0.8 0.6 0.5 3.0 1.3 0.3 0.1 0.4 0.4 11.8 22.5 34.5 21.2 11.0 4.1 6.2 10.1 8.5 5.3 SKOR1 "CORL1, FUSSEL15, LBXCOR1" ENSG00000188779 "SKI family transcriptional corepressor 1" P84550 15 67819704-67834561 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 17.8" "Cell line enhanced" "Detected in some" "U-266/70: 5.8;U-266/84: 4.6;U-698: 5.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "cerebellum: 17.8;pons and medulla: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "cerebellum: 4.2;pons and medulla: 1.3" "Region enriched" "Detected in some" 6 "cerebellum: 9.0" HPA071150 Enhanced "HPA071150: " "unprognostic (8.98e-2)" "unprognostic (4.15e-2)" "unprognostic (5.44e-7)" "unprognostic (1.76e-1)" "unprognostic (2.90e-2)" "unprognostic (2.45e-3)" "unprognostic (8.40e-5)" "unprognostic (5.51e-3)" "unprognostic (1.00e-1)" "unprognostic (8.13e-2)" "unprognostic (9.31e-2)" "unprognostic (1.93e-1)" "unprognostic (4.28e-5)" "unprognostic (1.96e-1)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" 1.1 0.6 0.7 0.4 1.3 1.7 0.7 17.8 2.4 0.5 0.7 0.4 0.4 1.4 1.0 0.5 0.4 0.6 0.7 0.4 0.6 1.1 0.5 0.4 0.7 0.4 0.5 0.4 1.2 1.3 0.1 1.3 0.9 4.4 0.8 0.3 0.4 0.7 0.9 1.5 0.7 0.9 0.6 5.4 0.7 0.4 2.4 0.4 0.4 0.5 0.4 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.2 0.4 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.2 0.1 0.1 0.2 0.4 0.0 0.4 0.8 1.0 0.3 0.0 0.2 2.4 0.7 0.1 0.2 0.0 0.1 0.0 0.1 0.8 0.0 0.2 0.4 1.0 0.0 0.2 0.6 0.3 1.2 0.0 0.1 0.2 2.1 0.1 0.0 0.4 0.3 1.1 0.3 0.1 0.5 0.2 0.3 5.8 4.6 5.0 0.5 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 1.3 17.8 1.2 0.6 1.1 0.5 0.4 4.4 0.4 SKOR2 "CORL2, Fussel-18, FUSSEL18" ENSG00000215474 "SKI family transcriptional corepressor 2" Q2VWA4 18 47206322-47251603 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 1.5;testis: 3.3" "Cell line enriched" "Detected in some" 5 "NTERA-2: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 2.7" "Region enhanced" "Detected in single" "cerebellum: 1.3" HPA046206 Uncertain "HPA046206: " "unprognostic (1.53e-1)" "unprognostic (1.93e-1)" "unprognostic (1.92e-1)" "unprognostic (6.31e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLAIN1 "C13orf32, FLJ30046" ENSG00000139737 "SLAIN motif family member 1" Q8ND83 13 77697854-77764242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 89.3" "Cell line enhanced" "Detected in many" "HEK 293: 20.5;HL-60: 27.3;MOLT-4: 31.3;REH: 21.9;SCLC-21H: 21.7" "Cancer enhanced" "Detected in many" "glioma: 25.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 2.2;T-cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (8.76e-5)" "unprognostic (1.78e-2)" "unprognostic (3.11e-1)" "unprognostic (3.25e-3)" "unprognostic (1.60e-1)" "unprognostic (3.78e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-2)" "unprognostic (6.20e-2)" "prognostic favourable (9.07e-4)" "unprognostic (4.80e-3)" "unprognostic (3.83e-3)" "unprognostic (2.16e-2)" "unprognostic (4.53e-2)" "unprognostic (1.37e-1)" "unprognostic (3.34e-1)" "unprognostic (1.97e-2)" 1.4 6.0 27.6 3.0 41.5 8.7 4.1 14.2 73.1 3.6 1.7 74.8 0.3 1.9 4.4 7.4 2.6 10.2 2.4 3.7 39.1 20.7 5.1 4.5 6.0 5.8 56.7 19.6 4.8 6.5 7.5 2.7 2.4 38.3 4.5 2.0 1.3 5.6 3.8 1.9 1.3 1.6 3.2 89.3 4.6 6.6 17.6 51.9 4.1 6.5 0.0 6.0 2.5 1.0 0.7 2.2 0.0 0.2 0.8 4.7 1.0 0.1 1.2 15.1 0.3 0.0 0.0 2.6 0.1 0.0 0.0 0.0 1.4 3.1 11.5 0.7 0.0 0.1 14.3 0.0 0.0 14.3 20.5 9.8 2.8 0.2 0.4 27.3 0.7 0.0 0.0 0.0 0.0 0.5 0.3 15.4 0.0 0.3 31.3 2.7 5.7 4.6 21.9 1.3 0.0 7.0 1.2 21.7 11.0 0.0 4.2 2.8 0.0 12.4 0.1 0.1 0.6 0.1 3.9 14.9 6.8 13.8 1.7 3.2 0.9 0.0 0.1 0.0 2.1 0.2 3.0 0.7 2.5 2.3 0.2 0.6 2.7 4.2 0.0 0.8 0.2 2.2 4.7 1.0 27.6 41.5 14.2 26.2 39.1 20.7 56.7 19.6 38.3 51.9 SLC10A4 MGC29802 ENSG00000145248 "Solute carrier family 10 member 4" Q96EP9 4 48483343-48489196 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 12.3;brain: 19.0" "Cell line enhanced" "Detected in some" "HAP1: 10.4;K-562: 10.4;SH-SY5Y: 27.6" "Cancer enhanced" "Detected in many" "glioma: 5.9" "Group enriched" "Detected in many" 7 "basal ganglia: 7.3;cerebral cortex: 6.3;hypothalamus: 6.3;midbrain: 19.0;pons and medulla: 15.3" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Group enriched" "Detected in many" 5 "basal ganglia: 19.0;midbrain: 63.0;pons and medulla: 27.5" HPA028835 Uncertain Supported "HPA028835: AB_10603025" "unprognostic (4.06e-1)" "unprognostic (1.19e-1)" "unprognostic (1.06e-1)" "unprognostic (3.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.46e-2)" "unprognostic (5.41e-2)" "unprognostic (3.67e-1)" "unprognostic (1.86e-1)" "unprognostic (4.08e-3)" "unprognostic (9.98e-3)" "unprognostic (1.46e-1)" "unprognostic (3.50e-1)" "unprognostic (5.14e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (8.73e-2)" 0.4 12.3 1.4 2.7 7.3 3.4 0.5 0.5 6.4 2.9 1.6 0.7 0.0 0.8 0.4 0.2 0.4 0.4 0.6 0.6 1.2 6.3 0.3 0.2 1.1 0.3 19.0 0.8 0.3 0.3 0.4 7.5 0.4 15.3 0.4 1.5 4.0 4.9 0.9 0.9 0.4 1.3 0.6 1.1 0.4 0.8 1.2 0.7 0.0 1.5 0.0 0.3 0.4 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 10.4 0.0 0.1 0.0 2.2 4.5 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.2 3.0 0.3 0.0 0.0 0.0 0.0 0.5 0.7 27.6 0.5 0.0 0.1 0.0 4.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 7.3 0.5 6.3 1.2 6.3 19.0 0.8 15.3 0.7 SLC10A5 ENSG00000253598 "Solute carrier family 10 member 5" Q5PT55 8 81693607-81696174 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;liver: 10.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025966 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA025966: AB_1856959" "unprognostic (6.42e-2)" "unprognostic (3.89e-1)" "unprognostic (1.25e-2)" "unprognostic (2.34e-2)" "unprognostic (8.13e-3)" "unprognostic (1.91e-1)" "unprognostic (5.71e-2)" "unprognostic (5.63e-2)" "unprognostic (3.67e-1)" "unprognostic (2.41e-1)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" "unprognostic (8.95e-2)" "unprognostic (2.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-1)" "unprognostic (2.82e-7)" 0.0 0.3 0.9 0.1 2.3 0.0 0.2 5.1 1.8 0.3 2.5 2.9 0.3 0.9 0.2 0.3 1.4 0.1 0.9 2.1 1.8 10.3 0.3 0.0 0.8 0.4 1.0 0.3 1.9 0.0 0.5 3.5 0.3 0.2 0.1 0.4 3.5 0.2 0.3 0.3 3.4 0.0 0.8 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.9 0.4 1.0 1.1 0.9 1.7 0.9 1.1 0.5 0.4 0.7 0.4 0.6 1.1 1.6 0.3 1.1 1.3 0.9 1.6 0.8 2.9 2.2 3.0 1.7 0.5 0.1 0.3 0.4 2.6 0.8 2.0 0.5 1.9 1.4 1.6 0.8 0.6 1.4 0.5 0.6 0.4 0.4 0.7 1.4 3.7 2.6 1.1 0.8 0.8 0.4 1.9 0.7 1.1 1.3 1.8 1.7 1.7 1.8 2.6 0.2 1.3 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.5 0.0 0.0 SLC12A5 "KCC2, KIAA1176" ENSG00000124140 "Solute carrier family 12 member 5" Q9H2X9 20 46021690-46060152 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 64.6" "Cell line enhanced" "Detected in many" "Hep G2: 13.4;NB-4: 27.6;SK-BR-3: 14.0;U-2 OS: 16.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072058 Enhanced "HPA072058: " "unprognostic (2.01e-1)" "unprognostic (3.58e-1)" "unprognostic (7.55e-2)" "unprognostic (9.44e-4)" "prognostic unfavourable (5.60e-4)" "unprognostic (2.48e-1)" "unprognostic (5.16e-3)" "unprognostic (3.61e-1)" "unprognostic (2.49e-1)" "unprognostic (6.63e-2)" "unprognostic (3.72e-3)" "unprognostic (5.61e-4)" "unprognostic (8.78e-4)" "unprognostic (3.25e-2)" "unprognostic (9.22e-2)" "unprognostic (1.99e-1)" "unprognostic (2.34e-2)" 1.4 11.2 21.1 2.0 28.8 1.5 1.7 52.1 64.6 2.3 2.1 2.7 0.0 2.2 1.6 2.2 1.3 1.7 1.9 2.1 20.5 19.2 1.4 2.2 2.7 3.1 9.5 32.1 2.0 3.6 1.5 4.8 3.3 15.3 1.5 2.1 4.9 1.9 1.8 1.5 1.5 2.1 1.6 6.3 2.8 3.1 3.4 5.8 0.0 1.3 0.0 2.6 1.2 0.5 1.3 0.2 0.1 1.5 0.7 5.7 1.3 0.0 8.4 3.7 2.7 0.3 0.0 0.8 0.3 0.0 0.0 0.3 1.1 0.0 3.1 12.8 0.2 0.7 2.4 1.2 0.2 2.0 3.2 2.7 1.6 13.4 1.4 0.0 3.7 0.5 0.0 0.0 0.2 0.7 5.0 0.0 0.0 12.7 1.8 27.6 1.3 4.3 3.1 2.4 0.7 1.3 0.0 4.6 6.6 1.6 14.0 4.0 5.1 7.9 1.3 1.5 16.0 0.1 0.6 0.0 2.1 4.4 3.4 3.2 0.1 0.0 1.5 0.0 2.6 0.8 1.0 1.0 0.3 0.4 0.2 1.3 5.7 3.2 0.1 0.7 0.2 0.0 3.5 1.3 21.1 28.8 52.1 36.4 20.5 19.2 9.5 32.1 15.3 5.8 SLC12A8 CCC9 ENSG00000221955 "Solute carrier family 12 member 8" A0AV02 3 125082636-125212864 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;thyroid gland: 20.5" "Cell line enhanced" "Detected in many" "CACO-2: 10.9;HHSteC: 18.4;U-2197: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031123 Uncertain Supported Nucleoplasm Nucleoplasm "HPA031123: AB_2301872" "unprognostic (4.74e-2)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (5.91e-3)" "unprognostic (7.35e-3)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (3.76e-2)" "unprognostic (1.01e-1)" "unprognostic (7.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.13e-2)" "prognostic unfavourable (5.56e-4)" "unprognostic (7.18e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-2)" 1.1 1.1 11.1 0.7 19.4 0.0 2.0 0.8 7.0 1.2 3.0 1.7 0.4 4.9 0.4 2.9 3.5 1.7 8.1 0.5 3.8 1.2 2.1 5.7 1.9 0.4 1.0 3.6 0.5 9.0 8.2 1.9 2.2 8.6 2.5 4.1 6.2 10.0 0.4 1.8 1.0 3.4 0.4 1.3 0.4 3.8 4.6 2.0 0.4 20.5 0.4 0.7 1.9 1.7 0.2 0.2 1.8 0.5 0.0 0.2 0.0 8.3 0.0 1.4 0.0 1.8 2.5 4.1 0.4 1.0 0.5 0.9 10.9 4.0 0.0 1.0 3.7 5.1 0.0 0.0 0.2 0.0 0.0 0.0 3.7 0.0 18.4 0.0 0.6 4.7 5.0 1.4 0.6 0.0 0.0 0.3 0.7 2.2 0.0 0.0 5.7 0.4 0.0 0.1 0.0 4.2 0.6 2.4 0.0 4.9 5.1 0.1 9.2 0.2 0.1 0.1 0.7 35.7 0.0 0.1 1.0 2.8 1.7 0.0 0.7 1.8 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 19.4 0.8 7.0 3.8 1.2 1.0 3.6 8.6 2.0 SLC13A4 "SUT-1, SUT1" ENSG00000164707 "Solute carrier family 13 member 4" Q9UKG4 7 135681237-135729258 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 85.4;placenta: 44.8;retina: 23.5" "Cell line enriched" "Detected in some" 6 "HDLM-2: 25.1" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 85.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA048582 Approved "HPA048582: " "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (9.70e-3)" "unprognostic (1.78e-1)" "unprognostic (7.69e-2)" "unprognostic (3.96e-6)" "unprognostic (3.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.56e-3)" "unprognostic (9.23e-2)" "unprognostic (2.89e-1)" "unprognostic (1.87e-1)" "unprognostic (2.30e-6)" "unprognostic (1.53e-1)" "unprognostic (3.07e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" 0.3 0.4 0.7 0.3 1.4 0.3 0.4 4.0 8.9 1.2 0.3 34.0 0.0 0.3 0.4 0.3 4.1 0.8 0.4 0.4 12.3 0.8 0.3 0.4 0.4 0.3 1.4 5.4 0.4 0.5 0.4 1.4 44.8 85.4 0.3 0.3 23.5 1.0 0.4 0.3 0.4 0.3 0.4 5.1 0.3 0.3 5.4 0.5 0.0 0.3 0.0 1.9 0.3 1.8 0.0 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 25.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 1.4 4.0 8.9 12.3 0.8 1.4 5.4 85.4 0.5 SLC14A1 "HsT1341, JK, RACH1, RACH2" ENSG00000141469 "Solute carrier family 14 member 1 (Kidd blood group)" Q13336 18 45687025-45752520 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 44.5;prostate: 64.7;urinary bladder: 29.6" "Cell line enriched" "Detected in some" 14 "RT4: 49.9" "Group enriched" "Detected in many" 5 "glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 2.4;gdT-cell: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059570, HPA077233" Supported Supported "Plasma membrane" "Plasma membrane" "HPA059570: , HPA077233: " "unprognostic (2.04e-1)" "unprognostic (2.56e-3)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (6.86e-2)" "unprognostic (1.84e-2)" "unprognostic (1.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.17e-2)" "unprognostic (9.99e-2)" "unprognostic (2.69e-1)" "unprognostic (1.42e-1)" "unprognostic (3.02e-2)" "unprognostic (2.31e-1)" "unprognostic (1.52e-1)" "unprognostic (9.09e-2)" "unprognostic (6.93e-2)" 2.2 2.1 15.6 1.5 21.5 10.3 2.4 4.6 24.2 2.9 1.6 33.7 0.0 1.9 1.1 1.4 1.1 1.0 8.7 8.2 33.7 11.7 10.1 1.5 4.1 2.4 28.0 23.4 1.0 1.5 1.2 0.4 2.0 44.5 64.7 1.8 0.0 2.6 3.2 3.4 1.7 2.1 3.9 34.9 2.6 2.0 1.0 44.0 0.0 3.6 0.0 2.6 29.6 3.0 0.7 0.3 2.4 0.1 1.8 7.2 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 1.3 49.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.4 0.0 1.9 0.0 0.0 1.1 0.5 0.5 0.1 0.1 2.4 2.0 0.0 0.1 0.6 2.0 2.4 0.0 0.7 0.5 3.4 0.4 1.8 0.0 0.3 7.2 1.1 15.6 21.5 4.6 24.2 33.7 11.7 28.0 23.4 44.5 44.0 SLC15A5 ENSG00000188991 "Solute carrier family 15 member 5" A6NIM6 12 16188485-16277685 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 12 "adipose tissue: 1.9;brain: 1.6;breast: 1.2;testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041638 Uncertain "HPA041638: " "unprognostic (3.68e-3)" "unprognostic (1.64e-1)" "unprognostic (4.89e-6)" "unprognostic (1.34e-1)" "unprognostic (1.72e-3)" 1.9 0.0 1.1 0.0 0.7 0.0 1.2 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC17A6 "DNPI, VGLUT2" ENSG00000091664 "Solute carrier family 17 member 6" Q9P2U8 11 22338097-22379503 "Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 75.2" "Cell line enriched" "Detected in single" 222 "SCLC-21H: 26.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "hypothalamus: 20.2;pons and medulla: 75.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 54.1;hypothalamus: 163.2;midbrain: 206.4;pons and medulla: 90.5;thalamus: 180.7" "Low region specificity" "Detected in many" "CAB037130, HPA039226, CAB078204" Supported Supported "CAB037130: AB_477611, CAB078204: , HPA039226: " "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" 0.5 0.5 7.6 0.5 1.1 0.5 0.5 0.2 13.8 0.5 0.5 1.3 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 1.1 20.2 0.5 0.5 0.5 0.5 7.1 2.1 0.5 1.5 0.5 5.3 0.5 75.2 0.5 0.5 1.4 0.5 0.5 0.5 0.5 0.5 0.5 5.9 0.5 0.5 0.5 0.0 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 1.1 0.2 8.4 1.1 20.2 7.1 2.1 75.2 0.0 SLC17A7 "BNPI, VGLUT1" ENSG00000104888 "Solute carrier family 17 member 7" Q9P2U7 19 49429401-49442360 "Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "brain: 150.0" "Cell line enhanced" "Detected in some" "HMC-1: 20.7;K-562: 6.5;REH: 3.8;SCLC-21H: 4.8" "Cancer enriched" "Detected in some" 6 "glioma: 7.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 281.0;cerebellum: 378.0;cerebral cortex: 391.3;hippocampal formation: 626.6" "CAB037183, HPA050458, HPA063679" Enhanced Supported "CAB037183: AB_261840, HPA050458: , HPA063679: " "unprognostic (1.79e-1)" "unprognostic (3.35e-1)" "unprognostic (1.29e-1)" "unprognostic (1.52e-2)" "unprognostic (9.12e-2)" "unprognostic (3.03e-2)" "unprognostic (1.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.30e-1)" "unprognostic (2.70e-3)" "unprognostic (8.32e-2)" "unprognostic (6.61e-2)" "unprognostic (4.26e-12)" "unprognostic (8.36e-4)" "unprognostic (4.27e-1)" "unprognostic (1.35e-2)" "unprognostic (6.17e-3)" 2.1 1.2 58.3 1.0 27.6 1.0 1.7 52.7 150.0 1.3 1.3 1.5 0.0 1.1 1.2 1.2 1.4 1.3 1.3 1.4 74.3 1.7 1.1 1.0 1.1 1.3 6.0 36.4 1.0 1.0 1.0 0.1 1.0 20.0 1.0 1.2 9.1 1.1 1.1 1.4 1.6 1.3 1.2 0.9 1.0 1.1 1.5 0.0 0.0 1.2 0.0 1.2 1.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.4 1.6 0.3 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.2 0.3 0.5 0.1 1.8 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.1 0.3 0.0 0.0 6.5 0.9 0.0 0.2 0.0 0.1 0.0 0.3 3.8 0.1 0.1 0.0 0.0 4.8 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.3 2.3 0.8 0.0 0.4 0.3 0.3 0.6 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.3 27.6 52.7 76.0 74.3 1.7 6.0 36.4 20.0 0.0 SLC17A8 "DFNA25, VGLUT3" ENSG00000179520 "Solute carrier family 17 member 8" Q8NDX2 12 100357079-100422059 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Hearing, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 10.7;intestine: 12.4;lymphoid tissue: 3.9" "Cell line enhanced" "Detected in some" "AF22: 2.5;RPTEC TERT1: 1.3" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB079058 Supported "CAB079058: " "unprognostic (4.52e-3)" "unprognostic (2.18e-1)" "unprognostic (8.56e-2)" "unprognostic (1.32e-3)" "unprognostic (3.65e-1)" "unprognostic (7.67e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-2)" "unprognostic (8.89e-2)" "unprognostic (3.55e-1)" 0.1 0.3 2.0 0.1 3.7 0.1 0.1 0.0 10.7 0.1 1.1 0.0 0.0 1.8 0.4 0.2 0.1 1.0 0.1 0.1 6.9 2.2 0.3 1.2 0.2 0.1 0.8 1.0 0.2 0.2 0.1 0.4 1.0 3.6 0.1 1.0 1.7 0.1 0.1 0.1 0.1 12.4 0.1 0.5 0.1 0.2 0.4 0.1 3.9 0.1 0.0 0.1 0.6 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 2.0 3.7 0.0 10.7 6.9 2.2 0.8 1.0 3.6 0.1 SLC18A2 "SVAT, SVMT, VMAT2" ENSG00000165646 "Solute carrier family 18 member A2" Q05940 10 117241073-117279430 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.3;brain: 28.3;cervix, uterine: 31.2" "Cell line enriched" "Detected in some" 20 "HMC-1: 89.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 10 "hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5" "Cell type enriched" "Detected in some" 13 "basophil: 26.3" "Lineage enriched" "Detected in many" 13 "granulocytes: 26.3" "Region enhanced" "Detected in many" "midbrain: 75.4" "Group enriched" "Detected in all" 5 "midbrain: 143.8;pons and medulla: 34.7" HPA073224 Enhanced Supported Vesicles,Centrosome Vesicles Centrosome "HPA073224: " "unprognostic (1.49e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (9.00e-2)" "unprognostic (2.85e-1)" "unprognostic (5.33e-3)" "unprognostic (2.23e-1)" "unprognostic (1.71e-2)" "unprognostic (1.40e-1)" "unprognostic (4.55e-2)" "unprognostic (2.00e-1)" "unprognostic (6.06e-3)" "unprognostic (7.94e-5)" "unprognostic (2.95e-2)" "unprognostic (2.31e-1)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" 1.7 13.9 1.7 3.1 2.0 2.0 2.0 1.7 1.6 31.2 2.3 0.5 2.2 1.5 11.2 4.9 3.0 1.1 15.9 1.0 1.9 9.0 1.1 3.3 7.6 1.5 28.3 0.2 9.7 3.7 0.5 1.6 2.1 26.5 10.8 3.4 3.1 1.0 4.0 1.1 5.8 2.5 5.4 2.9 0.5 3.5 1.5 0.3 14.1 0.6 3.4 2.9 3.1 5.4 0.0 2.0 26.3 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.2 89.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.1 0.0 0.1 0.4 0.0 26.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 2.0 0.0 1.1 1.7 2.0 1.7 1.6 1.9 9.0 28.3 0.2 26.5 0.3 SLC18A3 VACHT ENSG00000187714 "Solute carrier family 18 member A3" Q16572 10 49610301-49612720 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.9" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 12.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 7 "basal ganglia: 8.8;hypothalamus: 3.4;pons and medulla: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 13 "basal ganglia: 17.7;pons and medulla: 20.9" CAB079011 Supported "CAB079011: " "unprognostic (2.14e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (9.39e-2)" "unprognostic (4.55e-2)" "unprognostic (3.00e-1)" "unprognostic (5.85e-3)" "unprognostic (7.56e-2)" "unprognostic (1.16e-1)" 0.1 0.3 0.0 2.2 8.8 0.1 0.1 0.0 0.5 0.1 1.5 0.0 1.1 1.3 0.3 0.1 0.1 0.1 0.2 0.1 0.0 3.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.7 3.4 11.9 0.4 0.3 1.4 0.4 0.6 0.2 0.1 1.9 1.5 3.1 0.1 1.2 0.2 1.2 0.2 0.1 0.0 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.8 0.0 0.5 0.0 3.4 0.1 0.0 11.9 1.2 SLC1A2 "EAAT2, GLT-1" ENSG00000110436 "Solute carrier family 1 member 2" P43004 11 35251205-35420063 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 160.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.4;BJ hTERT+: 4.8;fHDF/TERT166: 3.4;Hep G2: 5.6;NTERA-2: 6.2;SCLC-21H: 3.2" "Cancer enriched" "Detected in some" 5 "glioma: 28.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002574, HPA009172" Enhanced "CAB002574: AB_564087, HPA009172: AB_1849764" "unprognostic (8.00e-2)" "unprognostic (5.71e-3)" "unprognostic (1.39e-1)" "unprognostic (2.77e-2)" "unprognostic (1.33e-1)" "unprognostic (5.65e-3)" "unprognostic (1.39e-2)" "unprognostic (9.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.65e-2)" "unprognostic (1.79e-3)" "unprognostic (2.35e-1)" "unprognostic (8.33e-4)" "unprognostic (6.34e-2)" "unprognostic (8.06e-2)" "unprognostic (5.24e-2)" "unprognostic (3.49e-2)" 1.7 4.1 65.1 1.9 79.4 1.8 3.7 7.2 160.9 2.0 1.7 9.8 0.0 1.8 2.1 1.8 1.7 1.7 1.7 2.1 47.6 11.7 1.7 20.5 1.9 2.5 15.2 43.1 1.6 4.2 1.6 0.4 2.1 27.6 1.7 1.7 0.0 3.9 1.7 1.7 2.3 1.6 1.8 17.2 1.8 2.6 2.4 16.3 0.0 1.7 0.0 2.4 1.7 0.3 1.1 0.7 3.9 0.7 1.2 0.9 0.4 0.0 0.2 1.1 0.1 0.5 4.4 0.0 1.0 4.8 0.2 0.2 0.2 0.0 0.1 0.1 3.4 0.3 0.0 0.0 0.4 0.0 0.0 0.4 0.5 5.6 0.2 0.6 0.2 0.9 0.0 0.4 0.0 0.0 0.0 0.4 0.1 2.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.5 0.0 2.3 0.0 1.1 0.0 0.6 0.2 0.2 0.5 0.1 0.6 0.0 0.0 1.1 0.0 0.3 3.9 0.7 0.8 0.5 0.3 0.3 0.4 0.5 0.4 0.7 1.1 0.9 0.7 2.1 1.2 0.4 0.6 0.4 0.4 65.1 79.4 7.2 64.9 47.6 11.7 15.2 43.1 27.6 16.3 SLC1A3 "EA6, EAAT1, GLAST" ENSG00000079215 "Solute carrier family 1 member 3" P43003 5 36606355-36688334 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 188.6" "Cell line enhanced" "Detected in many" "AF22: 21.2;CACO-2: 34.1;HaCaT: 25.8" "Cancer enriched" "Detected in all" 21 "glioma: 168.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4" "Group enriched" "Detected in many" 39 "dendritic cells: 3.4;monocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002573, HPA037467, HPA037468" Enhanced Supported Approved Nucleoli,Mitochondria Mitochondria Nucleoli "CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371" "unprognostic (1.23e-1)" "unprognostic (2.15e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (7.70e-2)" "unprognostic (3.89e-3)" "unprognostic (2.36e-1)" "unprognostic (1.24e-1)" "unprognostic (2.84e-2)" "unprognostic (4.17e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.17e-2)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" 17.3 10.3 76.1 5.9 70.6 3.1 6.3 45.8 188.6 6.9 3.2 26.3 0.0 2.1 2.8 2.3 7.2 5.4 5.9 12.0 57.9 27.3 3.1 3.6 4.7 8.6 32.7 39.6 8.6 4.0 2.6 3.7 12.7 28.5 3.3 2.6 1.9 3.0 4.4 7.6 5.5 2.3 4.1 29.4 5.8 2.9 2.7 33.6 0.0 2.6 0.7 4.5 4.8 1.2 0.0 3.4 0.0 4.3 0.0 0.0 0.8 0.4 0.1 21.2 1.8 2.1 5.9 13.5 0.0 0.0 0.8 1.8 34.1 1.7 0.0 10.3 0.3 25.8 6.2 2.8 0.9 0.3 12.7 0.0 0.1 0.0 0.4 0.4 0.1 10.9 12.8 5.2 2.1 0.0 0.0 0.1 3.6 0.0 0.0 0.0 2.5 2.1 0.0 0.1 0.0 0.0 1.3 1.8 0.0 2.1 6.2 0.3 0.0 1.0 0.0 1.9 3.1 0.0 7.5 0.0 0.0 0.0 8.6 14.3 4.8 0.0 4.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.8 76.1 70.6 45.8 57.8 57.9 27.3 32.7 39.6 28.5 33.6 SLC1A6 EAAT4 ENSG00000105143 "Solute carrier family 1 member 6" P48664 19 14950034-15022990 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 52.1;testis: 23.3" "Cell line enhanced" "Detected in some" "HAP1: 6.4;NTERA-2: 5.3;U-698: 24.1" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 5.2" "Region enriched" "Detected in many" 5 "cerebellum: 52.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 152.9" "Low region specificity" "Detected in all" "HPA041505, HPA044066" Enhanced Supported "Plasma membrane,Intermediate filaments" "Plasma membrane" "Intermediate filaments" "HPA041505: , HPA044066: " "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.94e-3)" "unprognostic (8.90e-2)" "unprognostic (6.52e-4)" "unprognostic (1.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.11e-2)" "unprognostic (9.92e-2)" "unprognostic (1.35e-1)" "unprognostic (5.57e-2)" "prognostic unfavourable (6.88e-6)" 0.4 0.5 3.2 0.5 9.6 1.2 0.8 52.1 12.8 0.4 0.5 0.6 0.0 0.6 0.8 4.2 0.4 0.5 0.5 0.4 4.8 4.0 0.4 0.5 0.5 0.5 1.6 3.4 0.6 0.9 0.6 0.0 4.3 3.0 0.9 0.6 0.1 0.7 0.9 0.5 9.2 0.5 0.5 1.4 0.7 0.5 23.3 0.9 0.0 0.6 0.0 0.6 0.4 0.0 2.0 0.7 2.2 0.7 0.5 0.6 0.1 0.1 0.0 0.3 0.3 0.2 0.2 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 1.2 6.4 0.1 0.1 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.5 0.0 0.3 5.3 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.2 0.2 2.5 0.0 0.3 0.1 0.0 0.3 1.0 0.2 0.1 0.4 0.1 24.1 0.1 0.3 0.1 1.6 0.7 0.5 0.6 0.4 0.4 1.0 0.5 0.3 0.3 2.0 0.6 0.6 2.2 0.5 0.4 0.7 0.3 0.1 3.2 9.6 52.1 6.5 4.8 4.0 1.6 3.4 3.0 0.9 SLC22A15 FLIPT1 ENSG00000163393 "Solute carrier family 22 member 15" Q8IZD6 1 115976498-116070054 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.6;brain: 27.8" "Cell line enhanced" "Detected in many" "hTCEpi: 20.6;hTERT-HME1: 27.4;NB-4: 14.9;THP-1: 16.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Group enriched" "Detected in many" 7 "granulocytes: 3.9;monocytes: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019785 Approved "HPA019785: AB_1857011" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.01e-3)" "unprognostic (5.62e-2)" "unprognostic (5.22e-2)" "unprognostic (5.85e-5)" "unprognostic (8.91e-3)" "unprognostic (1.81e-1)" "unprognostic (4.97e-2)" "unprognostic (5.15e-2)" "unprognostic (9.06e-2)" "unprognostic (7.29e-3)" "unprognostic (8.78e-3)" "unprognostic (3.44e-1)" "unprognostic (9.97e-4)" "unprognostic (1.30e-1)" 2.9 4.5 7.0 3.2 14.1 34.6 2.3 8.6 11.1 2.6 2.1 27.8 0.7 1.7 1.9 2.2 5.5 2.4 2.9 6.1 9.9 8.0 4.9 1.3 6.3 1.7 20.0 8.1 2.0 4.2 7.5 4.5 2.9 15.1 2.8 2.7 2.5 4.6 2.7 0.8 11.8 1.7 1.7 14.1 3.5 4.8 1.8 17.6 0.0 4.0 0.8 1.9 2.5 4.6 0.5 0.3 3.9 2.9 0.2 0.0 0.3 1.6 0.1 1.2 0.0 2.1 2.6 0.8 2.6 3.9 1.6 2.9 0.0 0.3 1.8 2.9 1.3 2.5 2.0 5.4 1.6 0.0 1.3 1.7 1.8 0.2 7.2 2.7 2.4 2.6 20.6 0.0 27.4 0.0 0.1 0.0 2.6 1.4 0.0 14.9 1.7 1.3 0.0 0.0 0.0 2.2 0.9 1.2 1.1 4.5 0.9 7.6 0.2 16.2 0.0 2.9 1.6 0.5 0.6 2.7 2.5 0.2 3.0 4.4 4.5 1.0 2.5 0.9 0.0 0.7 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 3.9 0.2 2.9 0.0 0.0 0.3 7.0 14.1 8.6 11.1 9.9 8.0 20.0 8.1 15.1 17.6 SLC22A17 "BOCT, BOIT, NGALR" ENSG00000092096 "Solute carrier family 22 member 17" Q8WUG5 14 23346306-23352912 "Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 112.4" "Cell line enhanced" "Detected in many" "AN3-CA: 20.4;ASC diff: 17.0;SH-SY5Y: 23.7" "Cancer enhanced" "Detected in all" "glioma: 51.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.1;naive CD4 T-cell: 3.6;naive CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 26 "T-cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002728 Uncertain "HPA002728: AB_1079998" "unprognostic (9.34e-2)" "unprognostic (2.34e-1)" "unprognostic (2.31e-2)" "unprognostic (6.23e-3)" "unprognostic (2.85e-2)" "unprognostic (1.07e-1)" "unprognostic (2.31e-2)" "unprognostic (1.26e-2)" "unprognostic (4.23e-2)" "unprognostic (3.22e-1)" "prognostic favourable (1.73e-4)" "unprognostic (1.78e-1)" "unprognostic (1.07e-1)" "prognostic unfavourable (5.95e-4)" "unprognostic (3.50e-2)" "unprognostic (1.23e-2)" "unprognostic (3.87e-2)" 6.0 24.2 32.9 4.0 63.4 1.6 7.0 40.7 112.4 12.1 5.6 27.4 2.4 4.5 8.0 10.1 4.7 10.2 7.6 9.1 35.6 69.4 8.6 2.0 5.0 3.8 28.5 27.3 11.0 14.5 13.3 39.4 5.3 33.1 21.9 3.5 13.2 20.5 24.4 2.1 6.6 6.6 7.7 21.8 3.6 6.1 6.6 22.1 0.0 10.8 0.1 2.6 4.2 4.8 0.1 0.0 0.0 0.0 0.0 3.6 0.2 0.0 1.2 12.8 20.4 17.0 8.9 1.9 4.4 8.8 1.7 1.3 0.1 1.2 0.0 1.7 8.2 0.2 0.6 0.5 0.1 0.0 0.7 2.8 0.0 0.1 9.1 0.0 2.8 11.6 0.8 2.0 0.0 0.5 0.0 0.1 2.6 1.8 0.1 0.1 6.9 0.0 0.0 0.5 0.1 0.0 1.2 12.1 23.7 3.6 0.0 0.0 2.3 0.4 0.0 1.9 5.5 10.2 0.0 0.0 2.0 0.0 1.2 0.0 7.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.1 3.6 1.8 0.0 0.0 0.0 0.0 0.0 0.2 32.9 63.4 40.7 64.3 35.6 69.4 28.5 27.3 33.1 22.1 SLC22A31 ENSG00000259803 "Solute carrier family 22 member 31" 16 89195761-89201664 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 21 "brain: 39.3;lung: 50.7;pancreas: 69.7" "Group enriched" "Detected in some" 5 "BEWO: 23.2;Hep G2: 18.6;NB-4: 9.5;RPMI-8226: 11.2;THP-1: 6.1" "Group enriched" "Detected in many" 9 "liver cancer: 6.1;lung cancer: 26.2;thyroid cancer: 20.4" "Region enriched" "Detected in some" 23 "cerebellum: 39.3" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.71e-3)" "unprognostic (2.53e-1)" "unprognostic (5.02e-3)" "unprognostic (6.82e-2)" "unprognostic (8.20e-2)" "unprognostic (1.95e-1)" "unprognostic (3.00e-2)" "unprognostic (1.93e-2)" "unprognostic (2.12e-1)" "unprognostic (2.67e-1)" "unprognostic (8.98e-2)" "unprognostic (1.09e-1)" "unprognostic (8.26e-4)" "unprognostic (2.74e-1)" "unprognostic (2.05e-1)" "unprognostic (2.72e-3)" "unprognostic (1.89e-1)" 0.1 0.3 0.0 0.3 0.4 1.1 0.1 39.3 0.1 0.3 0.5 0.0 0.0 0.6 0.2 0.5 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.3 50.7 2.5 0.0 0.0 0.7 69.7 0.1 0.0 0.1 1.7 0.2 0.1 0.4 0.7 0.2 0.1 0.3 0.3 0.1 0.3 1.0 0.5 1.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.0 1.1 0.0 0.0 23.2 0.1 0.0 0.0 0.0 0.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 18.6 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 9.5 0.5 2.3 0.0 2.6 11.2 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 39.3 0.1 0.1 0.0 0.0 0.0 1.7 0.0 SLC22A8 OAT3 ENSG00000149452 "Solute carrier family 22 member 8" Q8TCC7 11 62989154-63015839 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Detoxification, Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 341 "brain: 33.7;kidney: 127.3;retina: 93.5" "Cell line enriched" "Detected in single" 13 "EFO-21: 1.2" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Region enriched" "Detected in some" 25 "pons and medulla: 33.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044174 Enhanced "HPA044174: AB_10963058" "unprognostic (5.35e-4)" "unprognostic (4.66e-1)" "unprognostic (6.88e-3)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 1.0 0.1 0.1 3.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 127.3 0.1 0.1 0.1 0.1 1.3 0.1 0.1 0.1 0.2 0.1 33.7 0.1 0.1 93.5 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 1.0 0.7 0.1 0.1 1.3 33.7 0.0 SLC24A2 NCKX2 ENSG00000155886 "Solute carrier family 24 member 2" Q9UI40 9 19507452-19786928 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 31.8" "Group enriched" "Detected in some" 6 "K-562: 5.6;NTERA-2: 1.9;SCLC-21H: 5.0;U-87 MG: 6.7" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.30e-1)" "unprognostic (8.57e-2)" "unprognostic (4.20e-1)" "unprognostic (1.05e-2)" "unprognostic (3.33e-2)" "unprognostic (1.48e-2)" "unprognostic (8.46e-2)" "unprognostic (8.37e-2)" "unprognostic (1.27e-1)" "unprognostic (1.50e-2)" "unprognostic (6.51e-2)" "unprognostic (1.57e-2)" "unprognostic (2.08e-4)" "unprognostic (1.58e-1)" "unprognostic (2.11e-3)" "unprognostic (1.51e-2)" 0.2 6.1 4.0 0.2 11.2 0.3 0.1 2.4 31.8 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.3 0.2 8.9 4.0 0.3 0.2 0.1 0.2 8.2 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 10.7 0.2 0.2 0.4 0.2 0.1 0.2 0.0 1.2 1.0 2.6 1.3 1.7 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 5.6 0.2 0.1 0.3 0.0 0.1 1.9 0.1 0.1 0.0 0.0 0.0 0.0 5.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.0 0.2 0.0 0.0 6.7 0.0 0.1 2.6 0.8 0.9 0.7 0.8 1.0 0.9 0.8 0.6 0.5 1.2 1.1 1.0 2.0 1.7 1.3 1.0 0.8 0.4 SLC24A4 NCKX4 ENSG00000140090 "Solute carrier family 24 member 4" Q8NFF2 14 92322581-92501483 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.6;brain: 28.1" "Cell line enhanced" "Detected in some" "Daudi: 2.6;SCLC-21H: 5.1" "Group enriched" "Detected in some" 5 "glioma: 0.5;melanoma: 0.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 7.9;intermediate monocyte: 11.6;non-classical monocyte: 9.4" "Lineage enriched" "Detected in many" 5 "monocytes: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.18e-1)" "unprognostic (1.06e-1)" "unprognostic (3.43e-3)" "unprognostic (1.34e-1)" "unprognostic (2.04e-3)" "unprognostic (3.40e-2)" "unprognostic (1.32e-1)" "unprognostic (2.48e-3)" "unprognostic (3.21e-1)" "unprognostic (1.48e-3)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-2)" "unprognostic (1.58e-2)" 1.8 1.0 4.9 3.8 6.0 8.6 0.6 1.1 11.7 0.8 0.9 9.6 6.3 0.9 0.6 0.7 0.8 0.8 1.9 0.9 4.7 3.2 0.5 0.7 2.3 2.7 10.8 4.7 1.0 0.6 0.5 1.8 1.2 28.1 0.7 1.0 4.6 0.7 1.2 2.4 0.8 1.2 1.4 14.2 5.0 0.9 2.9 5.7 0.0 0.6 0.0 1.4 1.5 0.8 0.1 2.3 1.3 11.6 0.2 0.2 2.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.6 2.6 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.7 0.3 0.4 0.2 0.0 0.2 0.3 0.0 0.2 0.3 0.0 0.0 0.1 0.6 0.0 0.4 0.0 0.3 1.1 0.3 0.1 0.1 0.3 0.0 0.3 5.1 0.0 0.2 0.2 0.5 0.3 1.1 0.6 0.2 1.5 0.3 0.1 0.4 0.1 0.1 0.2 0.3 0.3 0.2 7.9 0.0 0.0 11.6 0.2 0.0 0.0 0.0 2.3 0.1 0.0 0.0 1.3 0.2 9.4 0.4 0.0 2.0 4.9 6.0 1.1 7.3 4.7 3.2 10.8 4.7 28.1 5.7 SLC25A18 ENSG00000182902 "Solute carrier family 25 member 18" Q9H1K4 22 17563439-17590994 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adipose tissue: 13.1;brain: 49.0;liver: 50.0" "Cell line enhanced" "Detected in some" "ASC diff: 5.6;BEWO: 12.7;REH: 4.1" "Group enriched" "Detected in some" 5 "glioma: 10.6;liver cancer: 11.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "unprognostic (2.15e-1)" "unprognostic (6.07e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "unprognostic (3.79e-1)" "unprognostic (3.98e-2)" "unprognostic (1.00e-1)" "unprognostic (1.89e-1)" "unprognostic (1.45e-2)" "unprognostic (2.72e-2)" "unprognostic (8.70e-4)" "unprognostic (1.44e-1)" "unprognostic (3.92e-2)" "unprognostic (1.67e-2)" "unprognostic (1.29e-1)" "unprognostic (5.24e-2)" "unprognostic (1.62e-1)" 13.1 2.2 33.2 1.5 28.0 1.2 2.7 7.5 49.0 1.4 1.4 13.3 0.0 1.5 1.7 1.4 1.5 1.7 2.1 2.3 33.3 15.7 1.8 50.0 1.5 1.5 25.6 19.1 1.9 1.8 1.7 0.0 1.3 17.8 4.8 1.3 0.0 1.6 1.6 2.5 1.4 1.4 1.8 14.9 1.9 1.5 3.4 21.6 0.0 1.5 0.0 1.3 1.4 0.0 0.4 0.4 2.1 0.6 0.0 0.5 0.1 0.4 0.9 3.3 0.6 5.6 0.0 12.7 0.4 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.0 1.1 0.1 0.0 0.0 0.4 1.4 0.5 0.4 0.8 2.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.6 0.1 0.7 2.8 2.1 4.1 1.2 0.0 0.1 0.6 1.1 0.5 0.4 0.6 1.0 3.6 1.4 0.2 0.2 0.5 0.3 0.4 1.3 1.7 0.0 2.7 0.3 0.5 0.0 0.4 2.1 0.4 0.6 0.0 0.4 0.5 0.1 0.3 0.2 0.1 0.3 0.5 0.0 0.2 0.4 0.1 0.1 33.2 28.0 7.5 25.7 33.3 15.7 25.6 19.1 17.8 21.6 SLC25A22 "EIEE3, FLJ13044, GC1, NET44" ENSG00000177542 "Solute carrier family 25 member 22" Q9H936 11 790475-798333 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.0;pancreas: 43.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014662 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA014662: AB_10600808" "unprognostic (1.01e-2)" "unprognostic (2.12e-1)" "unprognostic (7.28e-2)" "unprognostic (4.68e-2)" "unprognostic (2.09e-3)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (8.67e-3)" "unprognostic (4.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.97e-3)" "unprognostic (2.61e-2)" "unprognostic (8.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" 4.9 5.2 23.3 8.3 19.0 5.7 2.7 32.2 45.0 3.5 4.1 3.4 2.5 10.3 3.2 2.3 4.4 5.0 3.8 3.2 27.8 13.2 4.1 14.2 4.6 7.5 9.6 22.8 4.8 43.0 4.0 13.4 4.4 13.5 5.2 2.9 4.6 11.4 4.2 1.1 5.8 8.5 3.3 2.8 5.3 6.8 6.6 2.6 3.5 3.1 3.0 5.1 4.5 2.4 2.5 3.1 4.0 5.7 3.6 7.2 2.3 23.2 15.1 8.9 7.9 3.7 6.8 8.4 11.1 9.4 12.4 7.9 14.9 16.0 7.0 8.4 9.3 20.6 9.8 13.4 2.8 13.1 17.9 6.4 7.4 9.1 16.1 10.3 10.8 6.8 8.1 9.4 10.1 5.7 13.0 11.0 5.5 14.1 10.7 9.7 19.2 23.2 12.7 4.8 16.5 7.4 3.9 43.9 19.7 6.4 15.4 7.9 7.4 5.2 5.5 13.9 9.3 6.4 10.4 9.7 5.6 8.9 16.7 9.2 8.3 0.0 2.4 4.0 6.6 5.6 4.2 2.5 4.1 7.2 3.1 2.1 2.5 4.2 1.5 3.6 5.7 0.9 2.2 2.3 23.3 19.0 32.2 37.4 27.8 13.2 9.6 22.8 13.5 2.6 SLC25A23 "APC2, FLJ30339, MGC2615" ENSG00000125648 "Solute carrier family 25 member 23" Q9BV35 19 6436079-6465203 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009675, HPA050883" Approved Supported Mitochondria Mitochondria "HPA009675: , HPA050883: " "unprognostic (3.51e-1)" "unprognostic (1.53e-3)" "unprognostic (1.52e-1)" "prognostic unfavourable (1.29e-4)" "unprognostic (2.05e-2)" "unprognostic (3.65e-3)" "unprognostic (3.43e-2)" "unprognostic (1.31e-3)" "unprognostic (1.27e-1)" "unprognostic (3.82e-1)" "unprognostic (1.30e-1)" "unprognostic (3.25e-1)" "prognostic favourable (1.10e-12)" "unprognostic (8.95e-2)" "unprognostic (3.20e-1)" "unprognostic (5.44e-2)" "unprognostic (4.22e-1)" 12.1 13.0 68.2 5.2 97.6 0.4 6.3 21.5 51.7 12.5 22.3 17.6 10.3 18.2 13.0 11.9 31.2 16.1 10.1 36.2 66.2 25.1 17.9 13.0 11.3 4.0 25.6 33.1 15.8 10.0 24.5 5.5 2.2 28.0 14.3 23.5 12.2 32.1 20.3 37.0 11.9 18.6 30.7 16.9 4.3 9.9 3.7 25.9 1.2 29.2 9.7 14.1 16.8 9.3 2.5 0.9 0.8 0.0 0.7 4.5 0.9 19.8 8.0 11.7 36.7 15.7 6.9 5.3 5.7 9.5 11.3 13.6 20.2 13.3 11.1 14.2 14.6 16.9 23.8 13.8 9.0 0.0 20.0 8.0 17.0 16.1 14.6 0.5 19.0 19.8 12.2 10.0 4.4 11.7 23.1 14.2 2.2 14.5 7.0 11.4 8.4 24.7 3.4 3.1 17.1 30.2 3.6 0.8 11.5 4.1 25.6 10.5 13.3 17.6 4.0 3.5 15.3 0.9 3.8 2.6 3.5 9.8 1.6 18.9 5.6 0.8 0.0 0.0 4.5 0.0 1.1 2.5 2.7 2.3 0.4 1.0 4.0 3.4 0.0 0.7 0.0 0.9 2.6 0.9 68.2 97.6 21.5 51.7 66.2 25.1 25.6 33.1 28.0 25.9 SLC25A41 "APC4, FLJ40442, MGC34725" ENSG00000181240 "Solute carrier family 25 member 41" Q8N5S1 19 6426037-6433779 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 8.1;testis: 26.5" "Cell line enhanced" "Detected in some" "HaCaT: 2.3;HMC-1: 6.9;U-937: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA043591 Uncertain "HPA043591: AB_10964585" "unprognostic (1.87e-3)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (8.75e-2)" "unprognostic (2.67e-1)" "unprognostic (8.29e-4)" "unprognostic (4.43e-3)" "unprognostic (2.81e-2)" "unprognostic (9.26e-2)" "unprognostic (6.85e-2)" "unprognostic (2.19e-3)" "unprognostic (3.11e-2)" "unprognostic (2.03e-1)" "unprognostic (1.56e-1)" "unprognostic (3.63e-2)" "unprognostic (2.11e-1)" "unprognostic (1.24e-1)" 0.3 0.2 2.4 0.3 6.3 0.0 0.5 8.1 3.2 0.3 0.5 0.3 0.3 0.4 0.3 0.8 1.7 0.4 0.3 1.6 2.6 1.3 0.3 0.3 0.3 0.3 0.6 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.5 0.9 1.3 1.2 0.3 0.5 0.6 0.3 0.0 26.5 0.3 0.3 0.4 0.3 0.3 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.1 0.4 0.0 0.0 0.7 0.0 0.0 0.4 0.2 0.0 0.0 0.3 0.4 0.0 2.3 1.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 6.9 0.7 1.7 0.0 0.0 0.0 2.1 0.0 0.0 0.8 0.0 1.7 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.4 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 6.3 8.1 2.7 2.6 1.3 0.6 0.3 0.3 0.3 SLC25A48 "FLJ44862, HDMCP" ENSG00000145832 "Solute carrier family 25 member 48" Q6ZT89 5 135579202-135889770 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.4;kidney: 11.7;skeletal muscle: 12.8" "Cell line enhanced" "Detected in some" "HAP1: 4.9;HEK 293: 4.1;HEL: 4.0;RPMI-8226: 3.6;SCLC-21H: 3.8;U-2 OS: 5.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA014674 Uncertain Approved "Intermediate filaments,Actin filaments" "Intermediate filaments" "Actin filaments" "HPA014674: AB_1859512" "unprognostic (2.09e-1)" "unprognostic (2.24e-1)" "unprognostic (6.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.96e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-7)" "unprognostic (9.13e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" 1.0 0.8 10.8 1.0 13.0 0.9 1.6 1.3 18.8 0.9 2.0 10.3 0.0 2.0 1.0 0.7 1.3 0.7 0.9 0.9 11.9 8.1 11.7 1.3 0.7 1.0 22.4 4.1 0.7 3.3 0.8 0.4 1.1 5.6 1.3 1.8 0.0 3.5 0.6 12.8 3.2 4.1 0.7 5.4 0.9 0.8 1.2 15.2 0.0 1.0 0.5 0.7 0.8 0.3 0.6 1.0 2.1 1.0 0.8 0.7 0.2 0.3 0.3 0.1 0.3 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.4 0.7 0.1 0.4 0.0 0.5 4.9 0.0 0.0 0.7 4.1 4.0 0.6 0.8 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.1 0.0 0.0 1.7 0.8 0.1 0.1 0.0 3.6 0.3 0.6 3.8 0.4 0.6 0.5 1.0 1.8 0.6 0.5 0.4 5.0 0.3 0.2 1.7 0.5 0.2 0.4 0.4 0.3 2.1 0.3 0.7 0.5 0.5 0.6 0.5 0.5 0.4 0.3 0.6 0.6 0.7 1.5 0.8 1.0 1.0 0.5 0.2 10.8 13.0 1.3 9.9 11.9 8.1 22.4 4.1 5.6 15.2 SLC26A5 "DFNB61, PRES" ENSG00000170615 "Solute carrier family 26 member 5" P58743 7 103352730-103446177 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell shape, Hearing" "Motor protein" "Deafness, Non-syndromic deafness" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 20.4" "Cell line enhanced" "Detected in some" "Karpas-707: 2.9;PC-3: 2.5;U-2197: 1.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 8 "cerebellum: 20.4" "Cell type enriched" "Detected in single" 8 "basophil: 2.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.7" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 8 "basal ganglia: 9.5" "unprognostic (3.86e-2)" "unprognostic (5.13e-2)" "unprognostic (6.38e-3)" "unprognostic (2.76e-2)" "unprognostic (1.02e-2)" "unprognostic (5.09e-2)" "unprognostic (2.36e-1)" "unprognostic (3.56e-4)" "unprognostic (4.21e-3)" "unprognostic (8.92e-3)" "unprognostic (2.82e-1)" "unprognostic (2.97e-1)" "unprognostic (3.67e-5)" "unprognostic (3.05e-1)" "unprognostic (2.81e-1)" "unprognostic (2.94e-2)" "unprognostic (2.69e-3)" 1.3 1.0 0.6 0.3 0.7 2.3 3.1 20.4 0.8 0.6 0.3 0.5 0.0 0.9 0.5 0.0 0.2 0.4 0.2 0.4 0.8 0.4 0.7 0.9 2.2 1.2 1.3 0.4 0.4 0.7 2.5 4.6 0.1 2.6 3.1 0.1 0.9 1.4 1.0 0.6 2.2 0.5 1.2 2.9 0.9 3.2 0.9 0.2 0.0 1.8 0.0 0.2 3.2 0.4 0.2 0.0 2.7 0.1 0.3 0.1 0.0 0.2 0.0 0.3 0.7 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.1 0.7 0.4 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.2 0.9 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.3 2.9 0.0 1.1 0.8 0.3 0.1 2.5 0.2 0.1 0.4 0.0 0.8 0.9 1.4 0.3 0.3 0.0 0.7 0.0 0.0 0.6 0.5 1.7 0.4 0.7 0.4 0.4 0.2 0.2 0.3 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.7 20.4 0.8 0.8 0.4 1.3 0.4 2.6 0.2 SLC2A13 HMIT ENSG00000151229 "Solute carrier family 2 member 13" Q96QE2 12 39755021-40106089 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.7;parathyroid gland: 43.0" "Cell line enhanced" "Detected in many" "ASC diff: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006584 Approved Approved "Nuclear membrane" "Nuclear membrane" "HPA006584: AB_1849755" "unprognostic (1.66e-1)" "unprognostic (2.52e-1)" "unprognostic (1.11e-1)" "unprognostic (9.62e-2)" "unprognostic (1.04e-1)" "unprognostic (3.31e-1)" "unprognostic (4.06e-2)" "unprognostic (1.20e-1)" "unprognostic (5.71e-2)" "unprognostic (1.83e-1)" "unprognostic (1.65e-1)" "unprognostic (2.25e-2)" "unprognostic (2.12e-3)" "unprognostic (4.07e-2)" "unprognostic (6.34e-2)" "unprognostic (1.24e-2)" "unprognostic (9.16e-2)" 3.8 7.2 9.8 3.3 18.0 1.2 3.0 4.0 27.7 13.0 7.4 2.8 0.3 6.0 5.9 5.3 3.7 2.9 4.0 4.9 8.2 14.1 10.7 6.2 3.7 1.9 14.9 11.0 3.1 5.0 43.0 11.1 4.6 4.8 3.0 6.8 2.4 4.2 2.6 1.2 2.1 8.3 4.7 2.7 2.3 5.6 2.0 4.1 0.6 2.2 0.9 1.4 3.9 3.9 2.0 0.1 1.5 0.5 0.6 0.9 0.0 0.6 3.5 2.5 1.1 18.2 7.5 5.2 5.7 4.0 2.6 3.3 0.0 1.7 2.1 4.2 4.5 0.3 1.7 1.8 2.1 1.9 5.4 1.7 9.0 1.2 2.9 4.9 2.9 3.7 1.7 1.1 2.2 1.2 0.6 5.6 5.8 0.6 0.7 4.0 2.8 2.4 0.0 3.9 1.2 4.7 2.2 3.3 3.4 2.3 4.5 1.4 2.5 4.3 1.0 3.4 1.3 12.2 3.3 4.4 0.1 1.4 6.2 2.8 2.2 0.0 0.5 1.5 0.4 0.2 0.3 0.1 0.4 0.9 0.0 2.0 0.2 0.5 0.8 0.6 0.1 0.1 0.1 0.0 9.8 18.0 4.0 19.8 8.2 14.1 14.9 11.0 4.8 4.1 SLC2A6 "GLUT6, GLUT9, HSA011372" ENSG00000160326 "Solute carrier family 2 member 6" Q9UGQ3 9 133471095-133479137 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.7;brain: 17.3" "Cell line enhanced" "Detected in many" "HDLM-2: 15.5;HMC-1: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 27.7" "Group enriched" "Detected in many" 4 "dendritic cells: 7.0;granulocytes: 15.6;monocytes: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042272, CAB046014" Uncertain "CAB046014: AB_2270444, HPA042272: AB_2677924" "unprognostic (2.12e-1)" "unprognostic (1.49e-1)" "unprognostic (1.87e-3)" "unprognostic (1.71e-3)" "prognostic unfavourable (1.39e-4)" "unprognostic (1.18e-1)" "prognostic unfavourable (8.82e-4)" "unprognostic (1.26e-1)" "unprognostic (2.23e-1)" "unprognostic (5.93e-2)" "unprognostic (1.05e-2)" "unprognostic (2.49e-1)" "prognostic unfavourable (1.02e-11)" "unprognostic (7.24e-2)" "unprognostic (3.43e-2)" "unprognostic (9.36e-2)" "unprognostic (6.28e-3)" 3.8 3.1 7.2 12.7 8.3 10.5 2.1 8.1 16.3 1.4 2.5 4.3 0.0 3.3 2.3 3.1 1.8 1.4 3.6 3.0 9.1 12.1 2.3 2.7 7.4 10.8 12.4 9.1 1.7 3.2 1.1 1.8 2.5 17.3 1.6 2.1 2.9 2.2 2.2 2.1 1.9 4.9 3.3 7.3 10.6 4.0 2.2 2.4 1.7 1.6 0.0 7.1 4.9 1.1 4.0 7.0 15.6 27.7 0.4 0.6 3.1 2.5 4.6 1.7 5.1 1.0 1.5 1.3 2.6 4.4 2.7 2.7 2.3 3.6 2.1 6.6 2.6 4.1 1.1 3.1 0.6 15.5 0.8 2.6 3.5 2.7 3.3 0.0 36.7 2.1 0.5 3.9 0.4 2.7 0.4 2.2 1.8 6.0 1.5 2.7 2.5 5.6 1.0 2.8 11.6 3.8 7.5 2.0 2.7 3.8 2.1 1.2 7.9 1.1 6.8 6.5 2.5 6.8 2.1 1.1 0.8 2.9 1.6 0.6 1.4 15.6 7.2 0.7 0.6 14.6 0.4 4.0 0.1 0.4 6.4 3.9 0.2 0.5 0.4 0.4 27.7 7.0 0.1 3.1 7.2 8.3 8.1 16.3 9.1 12.1 12.4 9.1 17.3 2.4 SLC30A3 ZNT3 ENSG00000115194 "Solute carrier family 30 member 3" Q99726 2 27253684-27275817 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 28.7;epididymis: 41.0;testis: 19.5" "Cell line enhanced" "Detected in some" "HAP1: 8.8;Hep G2: 11.7;REH: 18.9;RH-30: 9.8" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 9 "amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6" "Group enriched" "Detected in many" 7 "amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9" "HPA060505, HPA067637, CAB079044" Enhanced Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol Vesicles "Nucleoplasm, Nucleoli, Cytosol" "CAB079044: , HPA060505: , HPA067637: " "unprognostic (2.05e-4)" "unprognostic (1.17e-1)" "unprognostic (6.84e-4)" "unprognostic (5.26e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (1.43e-2)" "unprognostic (2.93e-2)" "unprognostic (2.64e-2)" "unprognostic (3.05e-1)" "unprognostic (2.20e-1)" "unprognostic (1.89e-1)" "unprognostic (4.65e-12)" "unprognostic (3.23e-2)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (2.63e-4)" 0.5 1.9 15.8 0.5 11.4 0.5 0.4 0.4 28.7 0.5 0.5 0.0 1.9 0.4 0.5 41.0 0.4 0.7 0.4 5.0 10.2 0.8 0.4 0.5 0.5 0.8 1.1 12.1 0.5 0.4 0.6 0.4 0.4 1.6 0.6 0.5 0.7 0.4 0.9 0.4 0.4 0.5 0.5 0.7 0.5 0.4 19.5 0.0 0.0 0.4 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 1.1 0.0 1.5 0.0 0.2 0.1 0.0 0.0 1.0 1.0 0.3 0.4 0.0 0.0 0.0 0.2 8.8 0.0 0.2 0.0 1.0 5.0 0.2 11.7 0.2 0.1 2.0 0.0 0.0 0.5 0.0 0.7 1.4 0.0 0.1 3.8 0.0 0.3 1.4 0.0 18.9 9.8 1.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.7 0.0 0.2 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 15.8 11.4 0.4 28.7 10.2 0.8 1.1 12.1 1.6 0.0 SLC32A1 "bA122O1.1, VGAT, VIAAT" ENSG00000101438 "Solute carrier family 32 member 1" Q9H598 20 38724462-38729372 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 38.3" "Group enriched" "Detected in some" 14 "MOLT-4: 5.4;SH-SY5Y: 1.6" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 20 "dendritic cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037156, HPA058859, HPA059985" Enhanced Supported "CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187" "unprognostic (1.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (6.57e-2)" 1.0 1.1 4.6 1.0 38.3 1.5 1.0 4.9 25.8 1.0 1.0 0.8 0.0 1.0 1.0 1.0 1.0 1.1 1.0 1.0 3.9 9.7 1.0 1.0 1.0 1.0 4.4 6.8 1.0 1.1 1.0 4.1 1.0 10.4 1.0 1.0 0.7 1.0 1.0 1.0 1.0 1.1 1.0 4.4 1.0 1.0 1.6 7.9 0.0 1.0 0.0 1.0 1.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 4.6 38.3 4.9 11.9 3.9 9.7 4.4 6.8 10.4 7.9 SLC35D3 FRCL1 ENSG00000182747 "Solute carrier family 35 member D3" Q5M8T2 6 136922264-136925639 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.9;retina: 16.4" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 18.3" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.3" "Group enriched" "Detected in some" 4 "basal ganglia: 9.9;hypothalamus: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 26.6;olfactory region: 10.4" "Region enriched" "Detected in some" 6 "basal ganglia: 24.4" "HPA030431, HPA067497" Uncertain Approved "Centriolar satellite" "Centriolar satellite" "HPA030431: AB_10601716, HPA067497: " "unprognostic (6.56e-2)" "unprognostic (2.97e-1)" "unprognostic (1.43e-1)" "unprognostic (5.45e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-2)" "unprognostic (2.48e-1)" "unprognostic (9.94e-2)" "unprognostic (7.36e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (4.45e-1)" "unprognostic (1.03e-1)" 0.1 4.9 0.0 0.4 9.9 1.2 0.1 0.0 0.4 2.0 0.4 0.4 0.0 0.7 0.1 0.0 0.6 0.1 0.1 0.4 0.0 4.8 4.0 0.0 2.1 0.0 1.7 0.0 0.8 1.2 0.0 0.0 0.1 0.5 4.3 0.6 16.4 0.2 0.1 0.0 0.2 1.3 0.3 0.0 0.2 3.2 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 4.2 18.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 9.9 0.0 0.4 0.0 4.8 1.7 0.0 0.5 0.2 SLC35F1 "C6orf169, dJ230I3.1" ENSG00000196376 "Solute carrier family 35 member F1" Q5T1Q4 6 117907526-118317676 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 41.9" "Group enriched" "Detected in some" 9 "AF22: 23.3;WM-115: 39.2" "Group enriched" "Detected in some" 16 "glioma: 15.1;melanoma: 3.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019576 Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" Nucleoplasm "Centriolar satellite, Cytosol" "HPA019576: AB_2190216" "unprognostic (1.46e-1)" "unprognostic (5.67e-2)" "unprognostic (7.08e-2)" "unprognostic (1.37e-3)" "unprognostic (3.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.39e-1)" "unprognostic (4.04e-1)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (4.44e-3)" "unprognostic (2.19e-1)" "unprognostic (8.83e-4)" "unprognostic (3.04e-3)" "unprognostic (6.03e-2)" "unprognostic (8.32e-2)" "unprognostic (2.02e-1)" 2.8 2.7 13.8 2.1 14.5 0.9 1.2 3.6 41.9 1.7 3.5 4.3 0.0 1.6 2.7 5.5 1.8 1.5 1.8 5.3 10.4 10.2 1.7 1.0 1.1 1.0 9.3 15.3 1.4 1.4 1.0 0.6 1.0 5.6 2.3 2.3 2.6 1.7 2.9 1.2 1.6 1.8 2.6 4.1 1.6 1.4 1.8 5.6 0.0 1.8 0.0 1.0 1.4 2.6 0.2 0.6 1.0 0.1 0.3 0.9 0.1 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 2.9 3.3 0.0 0.0 0.1 0.0 39.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.0 0.3 0.0 0.6 0.0 0.1 13.8 14.5 3.6 17.4 10.4 10.2 9.3 15.3 5.6 5.6 SLC35F3 FLJ37712 ENSG00000183780 "Solute carrier family 35 member F3" Q8IY50 1 233904933-234324516 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell line enriched" "Detected in some" 7 "HDLM-2: 48.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 49 "plasmacytoid DC: 7.1" "Lineage enriched" "Detected in single" 69 "dendritic cells: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051327, HPA061582" Uncertain Approved "Nucleoli,Golgi apparatus" "Golgi apparatus" Nucleoli "HPA051327: , HPA061582: " "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.26e-1)" "unprognostic (8.62e-2)" "unprognostic (2.69e-5)" "unprognostic (3.38e-2)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (3.86e-2)" "unprognostic (9.09e-2)" "unprognostic (1.57e-3)" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (3.62e-1)" "unprognostic (3.58e-1)" 0.8 3.5 4.6 1.3 26.0 0.7 6.8 25.1 16.7 1.4 0.8 0.5 0.0 0.8 1.0 2.5 1.6 1.7 0.8 0.6 5.4 4.6 1.6 0.6 1.2 2.4 4.8 6.6 0.6 3.6 4.6 2.8 0.7 4.1 2.0 0.8 0.0 6.6 1.1 1.1 0.8 0.9 1.1 4.8 1.0 2.5 1.1 4.3 0.5 1.9 0.3 1.9 0.8 0.6 0.0 7.1 0.0 0.1 0.0 0.0 0.0 1.4 3.8 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.2 0.0 3.5 0.0 48.3 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.3 0.0 0.0 0.0 3.6 0.0 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 7.1 0.0 0.0 4.6 26.0 25.1 11.6 5.4 4.6 4.8 6.6 4.1 4.3 SLC35F4 "C14orf36, FLJ37712" ENSG00000151812 "Solute carrier family 35 member F4" A4IF30 14 57563922-57982194 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 29.5;seminal vesicle: 10.5" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.4;U-87 MG: 6.1" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "cerebellum: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043853 Uncertain Approved "Nucleoli fibrillar center" "Nucleoli fibrillar center" "HPA043853: AB_10963083" "unprognostic (2.37e-1)" "unprognostic (2.10e-1)" "unprognostic (3.56e-1)" "unprognostic (2.66e-4)" "unprognostic (4.88e-2)" "unprognostic (8.64e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-2)" "unprognostic (3.94e-2)" "unprognostic (1.39e-1)" "unprognostic (4.03e-3)" "unprognostic (3.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.68e-3)" "unprognostic (9.23e-2)" 0.1 0.1 1.2 0.1 4.9 0.1 0.1 29.5 1.1 1.0 0.2 0.1 0.5 0.2 1.5 0.2 0.1 0.2 0.5 0.1 0.9 2.2 0.4 0.1 0.1 0.1 0.8 1.2 0.3 0.1 0.1 0.2 0.1 2.9 3.5 0.1 2.4 0.1 10.5 0.1 0.1 0.4 1.1 1.3 0.1 0.1 2.7 0.7 0.0 2.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 4.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.9 29.5 1.1 0.9 2.2 0.8 1.2 2.9 0.7 SLC36A1 "LYAAT-1, PAT1, TRAMD3" ENSG00000123643 "Solute carrier family 36 member 1" Q7Z2H8 5 151437046-151492381 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 15.9;classical monocyte: 6.6;neutrophil: 14.5" "Group enriched" "Detected in many" 5 "granulocytes: 15.9;monocytes: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035937 Approved "HPA035937: AB_10672995" "unprognostic (5.49e-2)" "unprognostic (4.04e-2)" "unprognostic (1.24e-1)" "unprognostic (8.27e-3)" "unprognostic (1.91e-1)" "unprognostic (2.02e-1)" "prognostic unfavourable (6.30e-5)" "unprognostic (1.86e-1)" "unprognostic (2.44e-1)" "unprognostic (1.29e-3)" "unprognostic (5.08e-2)" "unprognostic (2.78e-1)" "prognostic unfavourable (1.83e-6)" "unprognostic (2.66e-2)" "unprognostic (1.03e-2)" "unprognostic (2.49e-1)" "unprognostic (1.42e-1)" 5.6 4.7 5.1 6.0 11.1 19.3 4.4 43.3 15.3 3.8 11.1 5.0 11.6 32.5 4.6 3.8 5.4 3.8 8.3 3.7 4.2 4.1 7.3 3.5 6.0 4.5 6.0 6.8 4.0 6.5 32.1 6.3 4.4 13.9 9.9 17.5 4.1 5.1 7.6 7.6 3.9 28.7 5.2 4.1 9.2 4.8 11.2 5.0 7.1 3.7 3.6 4.2 7.2 4.5 1.7 2.1 15.9 6.6 0.3 1.9 0.8 3.8 6.7 3.5 2.3 8.9 6.5 19.1 11.3 6.4 7.9 8.9 15.4 5.7 9.0 6.7 13.5 9.6 11.1 7.0 7.8 2.5 9.7 2.8 10.9 5.1 11.4 6.6 15.3 4.7 8.2 6.6 4.4 6.9 6.3 7.9 6.6 4.2 1.9 3.3 3.5 6.3 0.0 8.5 3.5 2.0 5.8 3.2 6.1 7.0 8.5 4.0 6.4 9.7 6.9 10.5 5.9 17.0 6.3 3.7 5.2 5.8 6.7 11.6 6.9 15.9 6.6 2.5 1.2 2.8 0.8 1.6 1.1 1.9 2.1 1.7 0.9 0.8 14.5 0.3 2.8 0.4 1.1 0.8 5.1 11.1 43.3 15.3 4.2 4.1 6.0 6.8 13.9 5.0 SLC38A8 ENSG00000166558 "Solute carrier family 38 member 8" A6NNN8 16 84009667-84042636 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.1;liver: 4.5" "Cell line enhanced" "Detected in some" "CACO-2: 1.4;HMC-1: 2.1;SCLC-21H: 8.5;SK-MEL-30: 1.3" "Cancer enriched" "Detected in single" 14 "melanoma: 6.5" "Group enriched" "Detected in some" 5 "amygdala: 6.1;cerebral cortex: 2.6;hypothalamus: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "unprognostic (9.69e-2)" "unprognostic (6.16e-2)" "unprognostic (8.00e-3)" "unprognostic (6.40e-2)" "unprognostic (1.03e-1)" "unprognostic (8.20e-3)" "unprognostic (1.89e-1)" "unprognostic (7.70e-2)" "unprognostic (2.59e-1)" "unprognostic (2.16e-2)" "unprognostic (3.54e-2)" "unprognostic (1.37e-1)" "unprognostic (1.45e-1)" 0.2 0.1 6.1 0.2 0.6 0.0 0.2 0.2 2.9 0.2 0.2 0.2 0.2 0.3 0.2 2.2 0.2 0.0 0.2 1.4 0.6 2.5 0.2 4.5 0.2 0.2 0.7 0.2 0.2 1.3 0.5 1.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 2.3 2.4 0.2 2.1 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.6 0.2 2.6 0.6 2.5 0.7 0.2 0.2 0.2 SLC39A10 "DKFZp564L2123, FLJ90515, KIAA1265" ENSG00000196950 "Solute carrier family 39 member 10" Q9ULF5 2 195575977-195737702 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.0;thyroid gland: 39.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036512, HPA036513, HPA066087" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 49000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036512: , HPA036513: AB_10670801, HPA066087: " "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (5.33e-2)" "unprognostic (1.33e-3)" "prognostic favourable (1.46e-5)" "unprognostic (7.40e-2)" "prognostic unfavourable (4.39e-5)" "unprognostic (2.10e-2)" "unprognostic (8.73e-2)" "unprognostic (2.84e-2)" "prognostic unfavourable (3.23e-4)" "unprognostic (8.46e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-2)" "unprognostic (3.68e-1)" "unprognostic (2.47e-2)" "unprognostic (6.89e-2)" 6.6 10.9 16.0 6.0 24.8 3.7 6.2 10.8 41.0 9.8 3.8 4.2 4.9 3.6 9.4 3.3 3.5 8.5 7.6 4.7 15.0 11.2 7.8 2.1 6.3 6.5 8.5 24.4 7.4 5.7 5.8 5.7 10.7 15.7 16.7 4.0 1.4 4.8 6.5 3.3 5.7 5.7 6.7 10.2 14.4 4.3 7.9 6.2 10.6 39.9 1.7 6.4 6.1 4.9 9.4 18.4 19.3 2.7 11.0 4.6 1.5 3.1 10.5 20.2 5.5 3.9 9.4 10.4 14.6 7.1 7.1 3.5 15.7 11.3 4.3 22.3 8.3 4.5 12.3 13.5 8.9 2.3 9.1 4.9 16.4 12.9 4.4 17.9 2.1 5.5 2.0 7.8 9.0 15.8 14.1 6.1 11.3 3.0 5.1 5.6 23.5 8.3 12.0 7.1 10.8 30.7 5.2 7.8 10.7 14.6 29.9 7.6 4.8 11.1 15.4 12.9 14.9 8.4 7.6 2.1 1.3 2.6 10.4 8.4 13.0 19.3 2.7 1.9 4.5 2.5 3.5 6.8 4.0 3.7 3.3 9.4 3.5 4.6 0.5 11.0 1.8 18.4 3.9 1.5 16.0 24.8 10.8 39.7 15.0 11.2 8.5 24.4 15.7 6.2 SLC39A12 FLJ30499 ENSG00000148482 "Solute carrier family 39 member 12" Q504Y0 10 17951839-18043292 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "brain: 42.3;retina: 19.2" "Cell line enhanced" "Detected in single" "U-2 OS: 1.2" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.43e-2)" "unprognostic (2.67e-1)" "unprognostic (3.30e-1)" "unprognostic (8.70e-2)" "unprognostic (1.02e-1)" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.40e-6)" "unprognostic (1.94e-1)" "unprognostic (8.11e-2)" "unprognostic (3.76e-2)" 1.2 1.0 13.7 1.0 14.6 0.9 2.3 2.2 31.2 0.9 1.0 14.8 0.0 0.9 0.9 0.9 0.9 0.9 0.9 1.0 21.4 5.5 0.9 0.9 1.0 0.9 9.9 5.6 0.9 1.2 0.9 1.5 1.1 42.3 1.0 1.1 19.2 1.0 0.9 0.9 0.9 0.9 1.0 1.5 1.0 0.9 1.4 8.7 0.0 0.9 0.0 0.9 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.3 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 14.6 2.2 17.5 21.4 5.5 9.9 5.6 42.3 8.7 SLC44A1 "CD92, CDw92, CHTL1, CTL1" ENSG00000070214 "Solute carrier family 44 member 1" Q8WWI5 9 105244622-105439171 "CD markers, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 111.6" "Cell line enhanced" "Detected in many" "ASC diff: 71.8;ASC TERT1: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064714 Supported Nucleoplasm,Mitochondria 270000 Mitochondria Nucleoplasm "HPA064714: " "unprognostic (3.49e-1)" "unprognostic (2.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.54e-3)" "unprognostic (4.77e-2)" "unprognostic (1.74e-2)" "unprognostic (2.21e-2)" "prognostic unfavourable (4.49e-4)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (1.64e-3)" "unprognostic (6.20e-2)" "prognostic favourable (1.85e-4)" "unprognostic (2.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-2)" 8.7 7.4 40.0 6.4 48.8 5.3 14.6 7.2 37.0 9.9 26.7 69.5 10.2 12.0 8.8 18.4 10.1 8.5 11.0 6.9 50.0 29.6 12.0 20.3 9.8 4.6 64.3 21.3 8.0 8.0 20.5 3.9 12.3 38.2 6.6 26.9 4.6 6.0 14.8 4.8 11.4 14.0 9.5 111.6 4.8 18.9 2.3 59.4 2.3 24.0 5.1 7.9 12.4 7.9 2.4 3.7 2.5 5.4 8.7 1.8 1.6 6.7 5.7 1.5 1.9 71.8 56.8 4.9 5.7 14.9 3.7 5.0 6.0 18.0 9.0 2.9 21.5 13.5 4.6 8.2 6.4 7.8 3.8 11.2 4.0 7.5 4.8 2.2 5.8 31.5 6.8 7.1 6.5 11.7 0.3 18.8 4.2 9.6 8.9 2.5 8.7 5.5 1.8 6.0 6.8 5.1 15.9 7.5 2.9 8.0 8.9 8.0 8.8 6.8 10.0 3.7 3.4 4.0 4.1 14.5 9.5 6.8 7.2 4.9 4.9 2.5 5.4 1.1 1.1 2.1 0.8 2.0 1.2 0.8 3.7 2.4 1.8 0.6 1.0 8.7 1.2 1.3 1.1 1.6 40.0 48.8 7.2 29.8 50.0 29.6 64.3 21.3 38.2 59.4 SLC45A1 DNB5 ENSG00000162426 "Solute carrier family 45 member 1" Q9Y2W3 1 8317826-8344167 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Symport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.0" "Cell line enhanced" "Detected in some" "ASC diff: 5.8;HHSteC: 7.8;U-87 MG: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 7.1" "Group enriched" "Detected in many" 7 "monocytes: 7.1;T-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078818 Enhanced "HPA078818: " "unprognostic (1.77e-3)" "unprognostic (1.37e-2)" "unprognostic (4.32e-3)" "unprognostic (8.32e-2)" "unprognostic (3.22e-3)" "unprognostic (1.56e-1)" "unprognostic (4.96e-2)" "unprognostic (2.09e-1)" "unprognostic (1.20e-1)" "unprognostic (1.43e-1)" "unprognostic (1.39e-3)" "unprognostic (3.18e-1)" "unprognostic (5.67e-2)" "unprognostic (8.53e-3)" "unprognostic (2.16e-1)" "unprognostic (1.70e-1)" "unprognostic (2.51e-3)" 5.0 6.6 8.5 2.4 15.3 1.1 2.6 13.8 24.0 6.0 4.4 5.4 2.1 2.5 6.8 3.6 3.9 5.2 4.3 3.1 6.0 7.9 4.3 1.1 2.0 2.1 6.1 12.4 4.4 4.1 4.1 8.1 1.9 13.1 4.9 2.2 3.2 1.5 7.7 4.0 1.7 2.8 4.3 4.6 4.4 2.6 3.8 4.6 0.0 2.4 0.8 1.5 3.6 3.3 0.6 0.2 0.0 7.1 0.0 1.8 0.7 0.0 2.6 0.5 1.1 5.8 3.8 0.1 0.2 1.2 0.4 0.8 0.0 0.4 0.0 0.2 0.8 0.0 0.1 0.3 0.1 2.2 0.0 0.0 0.2 0.0 7.8 0.0 2.1 2.0 0.2 0.9 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 1.2 1.7 0.0 1.1 0.0 0.0 0.0 2.0 2.8 0.0 0.0 0.0 0.2 0.0 2.5 0.1 0.5 2.3 0.4 0.0 0.0 0.0 10.0 0.0 0.1 0.0 0.2 0.0 1.3 1.3 1.8 0.6 0.9 0.9 0.2 0.1 0.6 0.6 0.0 0.0 7.1 0.0 0.6 0.7 8.5 15.3 13.8 24.0 6.0 7.9 6.1 12.4 13.1 4.6 SLC48A1 "FLJ20489, hHRG-1, HRG1" ENSG00000211584 "Solute carrier family 48 member 1" Q6P1K1 12 47753916-47782753 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 90.7" "Cell line enhanced" "Detected in many" "EFO-21: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065396, HPA073994" Approved Supported Vesicles Vesicles "HPA065396: , HPA073994: " "unprognostic (9.60e-2)" "prognostic favourable (4.27e-4)" "unprognostic (1.13e-2)" "unprognostic (1.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "prognostic unfavourable (9.39e-5)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (9.88e-2)" "unprognostic (1.54e-2)" "unprognostic (6.63e-3)" "prognostic favourable (1.34e-6)" "unprognostic (1.45e-1)" "unprognostic (5.96e-2)" "unprognostic (1.52e-1)" "unprognostic (2.72e-2)" 16.2 13.5 27.8 5.0 33.5 7.7 10.7 12.5 39.5 13.1 8.3 90.7 6.7 5.6 11.9 12.7 13.9 21.9 11.5 12.8 32.7 20.8 18.5 6.3 11.7 4.9 44.1 27.9 35.6 10.6 24.3 6.4 13.2 38.6 9.3 8.2 7.4 13.2 18.1 16.7 14.7 5.3 12.7 44.5 11.3 7.7 5.1 39.7 4.9 35.6 6.1 6.0 9.9 7.6 7.1 8.5 23.7 11.9 1.2 5.4 4.0 4.5 14.0 2.2 16.7 14.7 6.3 4.9 3.2 7.1 3.1 3.2 4.4 12.2 2.7 42.0 8.9 17.9 2.8 3.7 2.4 22.7 2.8 19.0 11.7 6.0 8.4 5.0 11.3 3.7 7.6 4.4 5.4 8.6 4.9 11.1 1.9 9.3 2.4 5.2 1.5 6.9 2.3 0.6 14.8 12.4 12.0 2.9 1.3 4.3 5.4 3.0 18.0 4.7 4.7 4.4 5.9 8.3 2.3 9.0 5.5 0.8 5.7 24.1 2.6 0.0 11.9 7.8 3.6 8.5 3.2 7.1 4.4 3.7 8.5 6.3 5.4 4.4 23.7 1.2 4.8 1.6 3.4 4.0 27.8 33.5 12.5 39.5 32.7 20.8 44.1 27.9 38.6 39.7 SLC4A10 "NBCn2, NCBE" ENSG00000144290 "Solute carrier family 4 member 10" Q6U841 2 161424332-161985282 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 31.2;brain: 48.1" "Cell line enriched" "Detected in some" 11 "Karpas-707: 13.7" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "MAIT T-cell: 31.2" "Lineage enriched" "Detected in single" 78 "T-cells: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034755 Supported "HPA034755: AB_10670296" "unprognostic (4.64e-4)" "unprognostic (3.88e-1)" "unprognostic (2.88e-2)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "unprognostic (7.89e-3)" "unprognostic (5.99e-4)" "unprognostic (1.12e-1)" "unprognostic (2.27e-1)" "unprognostic (1.64e-1)" "unprognostic (2.50e-2)" "unprognostic (9.27e-2)" "unprognostic (5.65e-2)" "unprognostic (9.23e-3)" "unprognostic (1.87e-1)" "unprognostic (2.10e-3)" "unprognostic (2.26e-1)" 1.0 3.7 21.6 1.9 24.1 1.2 1.3 14.9 48.1 1.1 3.3 2.1 0.0 1.4 1.0 2.8 1.0 1.8 1.5 1.0 20.4 10.8 1.0 1.3 1.1 1.1 4.3 29.6 1.0 2.9 1.0 4.4 1.0 17.7 1.3 2.7 1.7 1.0 1.1 1.0 1.0 1.5 1.1 1.9 3.0 1.3 1.4 3.5 0.0 1.0 0.0 1.5 1.3 0.3 0.0 0.0 0.0 0.0 0.4 31.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.2 0.0 31.2 0.0 0.6 3.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 21.6 24.1 14.9 37.9 20.4 10.8 4.3 29.6 17.7 3.5 SLC4A8 NBC3 ENSG00000050438 "Solute carrier family 4 member 8" Q2Y0W8 12 51391317-51515763 "Predicted membrane proteins" "Anion exchange, Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;pituitary gland: 20.0;testis: 15.3" "Cell line enhanced" "Detected in many" "BEWO: 17.2;HMC-1: 12.1;SCLC-21H: 12.9" "Group enriched" "Detected in some" 6 "breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077895 Approved "Plasma membrane" "Plasma membrane" "HPA077895: " "unprognostic (4.01e-1)" "unprognostic (8.15e-2)" "unprognostic (2.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.96e-2)" "unprognostic (3.46e-2)" "unprognostic (7.72e-4)" "unprognostic (3.13e-2)" "unprognostic (7.03e-3)" "unprognostic (1.07e-4)" "unprognostic (1.70e-1)" "unprognostic (9.60e-6)" "unprognostic (1.35e-1)" "unprognostic (2.57e-1)" "unprognostic (3.21e-2)" "unprognostic (2.47e-1)" 1.0 6.5 5.8 2.2 13.3 1.7 3.1 9.2 22.9 2.7 1.1 9.8 0.0 1.4 1.2 5.4 0.7 3.7 1.1 1.0 10.9 5.6 3.2 0.8 2.8 3.0 6.0 9.3 7.3 2.4 1.0 20.0 1.0 28.6 1.4 1.4 2.2 1.5 1.7 0.8 1.0 2.0 1.1 4.7 2.2 3.0 15.3 5.1 0.0 0.8 0.0 2.7 1.0 0.7 1.1 2.6 3.4 3.1 1.7 1.7 0.7 0.2 0.8 9.7 0.1 0.4 0.5 17.2 2.6 4.4 4.3 2.7 5.7 0.2 3.5 0.4 3.5 0.1 3.8 0.2 4.0 0.7 0.5 1.7 0.3 0.0 0.0 0.6 12.1 0.1 0.2 2.1 0.4 4.9 0.1 6.3 2.1 2.0 5.1 1.1 4.2 2.9 0.1 0.0 0.0 0.5 0.1 12.9 8.7 1.0 1.3 0.0 1.6 0.4 4.6 2.7 1.5 0.2 3.3 3.2 1.0 0.2 3.8 0.5 0.4 1.3 2.1 3.4 1.7 1.4 0.4 0.6 0.6 1.6 2.6 1.1 0.6 1.0 2.3 1.7 3.1 1.0 0.3 0.7 5.8 13.3 9.2 22.9 10.9 5.6 6.0 9.3 28.6 5.1 SLC5A11 "KST1, SGLT6, SMIT2" ENSG00000158865 "Solute carrier family 5 member 11" Q8WWX8 16 24845841-24911628 "Predicted membrane proteins" "Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 48.0;intestine: 21.8" "Group enriched" "Detected in some" 6 "Hep G2: 18.4;Karpas-707: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035331 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA035331: AB_10601489" "unprognostic (2.57e-1)" "unprognostic (7.90e-3)" "unprognostic (1.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.90e-2)" "unprognostic (8.08e-2)" "unprognostic (2.85e-1)" "unprognostic (2.85e-3)" "unprognostic (6.68e-2)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (1.58e-1)" "unprognostic (8.07e-2)" "unprognostic (1.45e-3)" 0.6 0.6 4.3 0.6 21.8 0.5 2.8 1.9 11.2 0.6 1.7 29.7 0.0 10.9 0.6 0.5 0.5 0.6 1.4 0.7 12.1 7.4 9.9 1.0 0.6 0.7 48.0 2.4 0.6 0.5 0.5 0.2 0.5 18.3 0.6 0.8 0.0 0.6 0.8 0.7 0.5 21.8 0.5 34.7 0.6 0.6 0.8 22.9 0.0 0.6 0.0 0.7 0.6 0.1 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 5.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.3 21.8 1.9 8.0 12.1 7.4 48.0 2.4 18.3 22.9 SLC5A5 NIS ENSG00000105641 "Solute carrier family 5 member 5" Q92911 19 17871973-17895174 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 31.5;salivary gland: 66.8;stomach 1: 32.7" "Cell line enriched" "Detected in some" 4 "BEWO: 15.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 12 "pons and medulla: 31.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB022364, HPA049055" Enhanced "CAB022364: , HPA049055: " "unprognostic (2.72e-2)" "unprognostic (8.94e-2)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (1.81e-1)" "unprognostic (4.02e-2)" "unprognostic (2.57e-1)" "unprognostic (1.94e-2)" "unprognostic (3.07e-1)" "unprognostic (2.01e-2)" "unprognostic (3.03e-1)" "unprognostic (3.93e-2)" "unprognostic (5.51e-8)" "unprognostic (1.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.54e-2)" "unprognostic (3.23e-1)" 0.0 0.0 0.1 0.1 0.4 0.1 0.1 2.4 2.3 5.1 0.1 9.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.0 1.7 0.1 0.1 0.0 0.2 0.2 0.3 2.7 0.0 0.1 0.0 0.2 0.0 31.5 0.1 0.0 5.5 66.8 0.0 0.2 0.2 0.3 0.0 1.9 0.2 32.7 0.4 0.1 0.0 7.1 0.0 0.1 0.0 0.1 1.3 0.8 2.5 1.4 1.0 4.3 0.9 0.0 0.0 0.1 0.1 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.1 0.5 0.0 1.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 3.6 0.0 2.5 0.6 0.4 1.1 1.4 1.3 1.0 3.2 0.6 0.8 1.3 4.3 3.2 2.2 1.0 0.4 0.4 2.0 0.9 0.1 0.4 2.4 2.3 1.7 0.1 0.3 2.7 31.5 0.1 SLC5A7 "CHT1, hCHT" ENSG00000115665 "Solute carrier family 5 member 7" Q9GZV3 2 107986523-108013994 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport" "Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 45.1" "Group enriched" "Detected in some" 22 "RT4: 8.7;SCLC-21H: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Group enriched" "Detected in some" 13 "basal ganglia: 13.8;pons and medulla: 45.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1" "Group enriched" "Detected in some" 15 "basal ganglia: 20.7;hippocampal formation: 7.2;pons and medulla: 26.3" HPA046105 Approved "Nuclear bodies,Cell Junctions,Intermediate filaments" "Cell Junctions, Intermediate filaments" "Nuclear bodies" "HPA046105: " "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-3)" "unprognostic (7.10e-2)" "unprognostic (1.66e-1)" "unprognostic (3.39e-4)" "unprognostic (1.05e-2)" "unprognostic (9.78e-3)" "unprognostic (6.42e-2)" "unprognostic (1.61e-2)" 0.3 2.4 0.1 1.6 13.8 0.0 0.3 0.1 0.4 3.3 5.2 0.1 0.3 2.3 1.6 0.7 1.0 0.2 0.5 1.2 0.2 2.2 0.9 0.2 0.9 0.0 0.3 0.5 0.8 0.5 0.0 0.1 0.0 45.1 0.8 2.5 1.0 0.9 4.2 0.1 0.1 2.5 3.1 10.0 0.1 1.7 0.3 0.8 0.0 4.0 0.3 0.1 4.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 0.1 0.4 0.2 2.2 0.3 0.5 45.1 0.8 SLC6A1 "GABATHG, GABATR, GAT1" ENSG00000157103 "Solute carrier family 6 member 1" P30531 3 10992186-11039249 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 56.2;liver: 75.6" "Cell line enhanced" "Detected in many" "HeLa: 4.5" "Group enriched" "Detected in some" 16 "glioma: 16.1;liver cancer: 24.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013341, CAB022293" Enhanced Uncertain Mitochondria Mitochondria "CAB022293: , HPA013341: AB_1849509" "unprognostic (1.66e-3)" "unprognostic (1.30e-3)" "unprognostic (4.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.53e-1)" "unprognostic (2.53e-1)" "prognostic favourable (3.20e-4)" "unprognostic (1.05e-1)" "unprognostic (4.27e-2)" "unprognostic (8.26e-2)" "unprognostic (2.90e-1)" "unprognostic (2.69e-1)" "prognostic unfavourable (5.05e-6)" "unprognostic (7.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.35e-1)" "unprognostic (5.34e-2)" 1.8 2.1 32.2 1.6 31.0 3.0 1.8 15.1 56.2 2.0 1.7 25.4 0.0 1.7 1.9 3.9 4.3 2.4 2.3 3.3 22.2 16.6 2.1 75.6 2.5 1.7 22.7 25.3 2.4 1.4 9.3 1.0 2.0 17.0 2.1 1.8 1.7 1.6 5.0 3.3 1.7 1.7 1.8 13.7 1.9 1.7 4.4 14.3 0.5 1.9 0.0 1.7 1.9 0.9 1.0 0.8 1.2 0.3 0.2 0.8 0.2 0.8 0.6 1.8 1.3 1.5 0.4 1.0 0.7 0.2 0.8 1.1 1.4 1.0 1.6 0.3 0.4 1.3 2.3 0.9 0.7 0.2 1.7 1.3 4.5 2.7 0.7 2.2 2.2 1.1 0.2 0.2 1.2 0.3 1.1 3.6 0.2 1.0 0.7 1.7 0.8 1.4 1.2 0.2 0.1 0.6 1.7 0.8 0.3 1.0 0.6 0.2 1.0 1.0 0.3 0.8 0.5 0.7 0.6 1.1 0.3 1.2 0.9 1.7 0.4 0.3 0.3 1.1 0.5 0.1 0.8 0.9 0.6 0.5 0.3 1.0 0.3 0.5 1.2 0.2 0.3 0.8 0.3 0.2 32.2 31.0 15.1 41.5 22.2 16.6 22.7 25.3 17.0 14.3 SLC6A11 GAT3 ENSG00000132164 "Solute carrier family 6 member 11" P48066 3 10816200-10940733 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 37.0;esophagus: 10.5;skin 1: 11.5" "Cell line enhanced" "Detected in some" "A-431: 4.6;HaCaT: 12.4;Hep G2: 14.3;hTCEpi: 11.2;NTERA-2: 6.3;T-47d: 4.7" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037981 Supported Supported Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA037981: AB_10671383" "unprognostic (6.04e-2)" "unprognostic (8.01e-2)" "unprognostic (1.21e-7)" "unprognostic (8.60e-2)" "unprognostic (8.68e-2)" "unprognostic (9.72e-3)" "unprognostic (6.39e-3)" "unprognostic (9.77e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (8.78e-2)" "unprognostic (1.51e-3)" "unprognostic (6.06e-2)" "unprognostic (4.44e-2)" "unprognostic (9.83e-2)" "unprognostic (2.31e-2)" 0.8 0.8 11.5 0.7 14.1 0.8 2.9 3.1 23.0 0.9 0.8 5.0 0.0 0.7 1.7 1.1 10.5 1.8 0.7 0.8 8.4 24.5 0.7 0.9 0.8 0.7 37.0 5.9 0.8 1.0 0.7 0.2 1.6 35.4 2.3 0.8 0.4 1.1 0.7 1.0 11.5 0.8 1.0 10.4 1.5 0.7 3.4 9.2 0.0 0.8 0.2 1.1 1.3 0.7 0.5 0.3 1.2 0.4 0.2 0.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 2.0 0.0 0.0 0.2 0.2 0.0 14.3 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 2.8 1.8 4.3 3.6 0.1 0.0 4.7 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.5 0.2 0.2 1.2 0.2 0.4 0.3 0.3 0.0 11.5 14.1 3.1 14.7 8.4 24.5 37.0 5.9 35.4 9.2 SLC6A15 "FLJ10316, hv7-3, NTT73, SBAT1, V7-3" ENSG00000072041 "Solute carrier family 6 member 15" Q9H2J7 12 84859488-84913615 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0" "Cell line enhanced" "Detected in many" "ASC diff: 30.4;ASC TERT1: 18.8;hTERT-HME1: 43.0;SCLC-21H: 29.3;SK-MEL-30: 21.6" "Cancer enhanced" "Detected in some" "melanoma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008609 Uncertain Approved Nucleoli,Vesicles Nucleoli Vesicles "HPA008609: AB_1857190" "unprognostic (1.01e-4)" "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (6.65e-6)" "unprognostic (1.25e-2)" "unprognostic (2.92e-1)" "unprognostic (7.65e-3)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (7.69e-4)" "unprognostic (2.57e-2)" "unprognostic (3.80e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-3)" 1.4 4.5 18.0 2.2 16.2 1.0 2.3 17.8 31.0 1.7 2.2 5.4 0.0 1.4 2.8 1.1 6.7 1.2 1.3 1.0 10.9 18.2 1.5 1.0 1.3 1.1 10.3 16.9 2.1 1.0 1.0 5.6 8.9 14.7 1.8 1.8 9.2 1.4 1.5 1.0 4.9 2.1 1.6 4.9 1.1 1.3 3.6 12.8 0.0 2.0 1.8 1.8 1.1 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 3.6 0.0 30.4 18.8 0.0 0.0 6.4 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 8.1 0.0 0.0 9.3 0.0 1.5 0.0 11.2 0.0 0.2 10.5 15.7 4.1 43.0 0.1 0.0 0.0 7.7 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 7.6 0.0 9.7 21.6 0.0 0.0 0.0 4.6 2.5 0.0 0.0 0.0 0.0 0.0 8.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.0 16.2 17.8 18.6 10.9 18.2 10.3 16.9 14.7 12.8 SLC6A17 ENSG00000197106 "Solute carrier family 6 member 17" Q9H1V8 1 110150486-110202202 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 53.5" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 27.6" "Cancer enriched" "Detected in some" 9 "melanoma: 17.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007663, HPA008044" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA007663: AB_1857194, HPA008044: AB_1857192" "unprognostic (1.13e-1)" "unprognostic (1.37e-3)" "unprognostic (5.52e-3)" "unprognostic (3.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (6.11e-3)" "unprognostic (3.87e-3)" "unprognostic (1.70e-2)" "unprognostic (1.80e-1)" "unprognostic (1.68e-2)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (9.76e-2)" "unprognostic (1.38e-3)" "unprognostic (1.68e-3)" 1.4 7.8 9.3 1.2 18.3 1.1 1.3 21.8 53.5 1.0 1.1 2.3 0.0 1.0 1.0 2.1 1.3 1.0 1.1 1.0 11.2 14.9 2.1 0.9 1.0 0.9 6.0 16.2 1.0 2.6 1.0 12.4 1.8 19.5 1.0 1.0 2.6 1.2 1.0 1.0 7.6 1.1 1.1 1.8 1.0 1.8 2.4 0.7 0.0 1.3 0.0 0.9 1.0 0.1 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.2 0.4 1.6 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.6 4.7 1.4 27.6 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 5.6 0.0 2.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 9.3 18.3 21.8 37.3 11.2 14.9 6.0 16.2 19.5 0.7 SLC6A3 "DAT, DAT1" ENSG00000142319 "Solute carrier family 6 member 3" Q01959 5 1392790-1445430 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 48.4" "Group enriched" "Detected in some" 5 "NTERA-2: 1.2;RPMI-8226: 2.0;SCLC-21H: 3.7" "Cancer enriched" "Detected in some" 18 "renal cancer: 25.7" "Region enriched" "Detected in some" 47 "midbrain: 48.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "midbrain: 96.4;thalamus: 31.8" "Region enriched" "Detected in single" 139 "midbrain: 362.2" "HPA012763, HPA013602, CAB016249, CAB078172" Enhanced Supported Approved Vesicles Vesicles "CAB016249: AB_627402, CAB078172: , HPA012763: , HPA013602: AB_1847484" "unprognostic (2.25e-4)" "unprognostic (2.22e-1)" "unprognostic (8.45e-2)" "unprognostic (5.24e-2)" "unprognostic (7.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.64e-5)" "unprognostic (9.31e-2)" "unprognostic (7.89e-2)" "unprognostic (4.81e-2)" "unprognostic (1.30e-1)" "unprognostic (2.12e-2)" "prognostic unfavourable (3.40e-7)" "unprognostic (6.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.22e-2)" "unprognostic (4.74e-2)" 0.2 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.7 0.0 0.0 0.0 0.3 1.1 0.8 0.1 0.8 0.6 0.1 0.0 0.6 0.3 0.0 3.4 0.0 48.4 0.0 1.5 0.0 0.0 0.0 0.1 1.0 0.7 0.0 1.7 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.8 0.0 2.4 2.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 2.0 0.0 0.1 3.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.6 48.4 0.0 1.0 0.0 SLC6A5 "GLYT2, NET1" ENSG00000165970 "Solute carrier family 6 member 5" Q9Y345 11 20599400-20659285 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 21.3" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 2.5" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "pons and medulla: 21.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 9 "pons and medulla: 51.6" "Region enriched" "Detected in some" 9 "pons and medulla: 33.2" CAB079052 Supported "CAB079052: " "unprognostic (6.94e-2)" "unprognostic (2.28e-1)" "unprognostic (4.75e-2)" 0.0 0.1 0.1 0.1 0.0 0.0 0.0 3.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 5.1 0.1 0.1 0.0 0.0 0.0 0.0 2.2 0.0 21.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 6.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.4 0.3 0.1 0.1 0.0 21.3 0.0 SLC6A7 PROT ENSG00000011083 "Solute carrier family 6 member 7" Q99884 5 150189957-150222788 "Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 40.2" "Cell line enhanced" "Detected in some" "HeLa: 1.9;SK-BR-3: 1.5;U-87 MG: 1.1" "Cancer enhanced" "Detected in single" "colorectal cancer: 0.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028907 Uncertain "HPA028907: AB_10602404" "unprognostic (3.01e-1)" "unprognostic (1.97e-2)" "unprognostic (3.70e-2)" "unprognostic (1.42e-3)" "unprognostic (1.09e-2)" "unprognostic (1.82e-4)" "unprognostic (6.42e-2)" "unprognostic (1.35e-1)" "unprognostic (1.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.55e-1)" "unprognostic (3.50e-1)" "unprognostic (3.73e-4)" "unprognostic (8.11e-2)" "unprognostic (5.46e-2)" "unprognostic (2.73e-1)" "unprognostic (3.70e-3)" 0.5 0.4 3.9 1.0 9.7 0.4 0.5 40.2 22.4 0.6 5.7 0.3 0.0 2.6 0.5 0.6 0.4 0.4 0.5 0.5 6.5 4.5 0.4 0.4 0.5 0.7 1.3 14.5 0.4 0.5 0.4 0.2 0.4 1.6 0.4 7.7 0.0 0.8 0.4 0.5 0.5 4.9 0.7 1.4 0.4 0.4 0.5 0.0 0.0 0.4 0.0 0.7 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 9.7 40.2 22.4 6.5 4.5 1.3 14.5 1.6 0.0 SLC6A9 GLYT1 ENSG00000196517 "Solute carrier family 6 member 9" P48067 1 43991500-44031467 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.2;skin 1: 38.2" "Cell line enhanced" "Detected in many" "HaCaT: 23.5;hTCEpi: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 5 "T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013977 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA013977: AB_1849835" "unprognostic (2.73e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (9.50e-4)" "unprognostic (5.98e-2)" "unprognostic (6.83e-3)" "unprognostic (3.06e-2)" "unprognostic (9.72e-2)" "unprognostic (1.85e-2)" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (5.72e-2)" "prognostic unfavourable (5.93e-4)" "unprognostic (5.36e-3)" "unprognostic (1.59e-1)" "unprognostic (2.53e-1)" "unprognostic (1.20e-2)" 2.9 22.8 8.8 4.6 18.3 8.6 5.4 5.5 14.3 6.0 7.9 38.1 2.6 2.5 6.2 1.5 16.5 9.6 4.9 1.3 9.9 10.0 2.0 4.9 5.6 1.4 29.5 4.5 4.0 7.8 2.1 1.0 1.7 26.8 2.6 6.2 24.0 7.9 6.1 1.3 38.2 5.6 8.9 42.2 1.1 3.5 1.2 26.3 0.0 4.9 7.2 4.3 6.6 10.9 0.2 0.0 0.2 0.1 0.0 1.4 0.2 7.2 5.4 2.7 6.9 4.3 1.4 6.1 5.8 15.6 9.4 11.7 1.8 2.8 0.1 0.6 15.9 23.5 4.1 4.6 1.9 0.0 0.7 6.4 12.8 2.1 19.8 1.4 0.3 4.4 41.1 4.6 11.0 0.2 4.9 18.5 0.4 4.0 1.0 0.0 2.0 7.2 0.8 0.0 8.2 0.9 0.8 1.7 1.6 2.9 13.4 2.6 3.5 3.8 0.1 1.0 4.4 0.9 3.0 20.4 14.0 1.6 3.5 0.0 1.4 0.0 0.0 0.2 0.4 0.1 0.2 0.2 0.4 0.0 0.0 0.0 1.4 0.3 0.2 0.0 0.0 0.0 0.0 0.2 8.8 18.3 5.5 9.4 9.9 10.0 29.5 4.5 26.8 26.3 SLC7A10 asc-1 ENSG00000130876 "Solute carrier family 7 member 10" Q9NS82 19 33208664-33225850 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.9;brain: 13.6;breast: 15.6" "Group enriched" "Detected in some" 5 "BEWO: 4.2;HHSteC: 2.5;HSkMC: 3.6;THP-1: 8.2;U-2 OS: 2.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041884, HPA057036" Uncertain Uncertain Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA041884: AB_10794494, HPA057036: " "unprognostic (1.85e-2)" "unprognostic (1.69e-3)" "unprognostic (2.79e-2)" "unprognostic (1.79e-6)" "unprognostic (1.16e-1)" "unprognostic (2.08e-1)" "unprognostic (1.31e-1)" "unprognostic (4.98e-3)" "unprognostic (4.64e-2)" "unprognostic (1.96e-1)" "unprognostic (3.28e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-2)" "unprognostic (1.34e-3)" "unprognostic (8.91e-2)" "unprognostic (3.47e-1)" "unprognostic (2.18e-2)" 40.9 1.0 9.8 1.9 13.6 1.0 15.6 2.4 12.1 1.0 2.2 0.8 0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.1 4.7 6.2 1.3 1.0 1.0 1.2 7.6 5.0 1.0 1.2 1.0 0.0 1.2 9.0 1.0 1.0 8.4 2.3 1.0 1.0 1.1 1.0 1.1 0.8 1.0 1.0 1.4 1.8 0.0 1.4 0.0 1.4 1.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.2 8.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 9.8 13.6 2.4 12.1 4.7 6.2 7.6 5.0 9.0 1.8 SLC7A11 xCT ENSG00000151012 "Solute carrier family 7 member 11" Q9UPY5 4 138164097-138242349 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2" "Cell line enhanced" "Detected in many" "hTCEpi: 28.0;TIME: 30.7;WM-115: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 3.8" "Lineage enriched" "Detected in single" 8 "dendritic cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064215 Approved Vesicles Vesicles "HPA064215: " "unprognostic (3.55e-3)" "unprognostic (4.64e-3)" "unprognostic (2.43e-2)" "unprognostic (7.18e-3)" "unprognostic (2.59e-1)" "unprognostic (8.80e-3)" "unprognostic (2.07e-8)" "unprognostic (1.98e-2)" "unprognostic (1.09e-2)" "prognostic favourable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (4.07e-2)" "unprognostic (2.22e-8)" "unprognostic (3.81e-2)" "unprognostic (3.76e-2)" "unprognostic (2.29e-2)" "unprognostic (1.54e-2)" 1.1 0.9 16.3 4.7 15.8 2.2 1.5 8.2 26.0 2.4 2.0 17.9 0.0 1.5 1.3 13.4 3.3 8.9 3.8 2.5 17.4 6.9 0.9 0.9 2.3 1.5 12.6 16.8 1.7 5.4 1.0 1.2 2.1 17.2 2.0 2.8 0.3 1.6 1.0 0.8 1.9 1.4 1.0 27.2 1.4 9.2 2.2 14.0 0.0 8.9 6.0 2.2 4.0 0.8 0.1 3.8 0.4 0.0 0.1 0.0 0.0 1.6 13.5 6.1 4.7 1.3 1.7 1.6 7.5 5.2 1.7 3.9 1.5 5.7 3.1 9.8 26.0 2.2 3.2 6.4 7.2 5.8 0.6 2.2 12.8 3.4 20.2 5.6 2.1 4.0 28.0 4.8 21.6 21.2 2.9 8.0 8.9 1.2 0.7 0.5 1.2 3.9 0.9 2.0 3.5 1.0 6.4 2.5 0.5 3.2 0.9 11.5 1.4 12.1 30.7 2.2 6.3 3.3 5.9 6.8 3.1 3.1 3.8 3.1 45.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 3.8 0.0 0.0 16.3 15.8 8.2 15.9 17.4 6.9 12.6 16.8 17.2 14.0 SLC7A14 "KIAA1613, PPP1R142" ENSG00000013293 "Solute carrier family 7 member 14" Q8TBB6 3 170459584-170586074 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.4;pituitary gland: 14.5" "Cell line enhanced" "Detected in some" "LHCN-M2: 7.0;SCLC-21H: 7.0" "Group enriched" "Detected in some" 11 "glioma: 0.8;pancreatic cancer: 0.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045929 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Cytosol" "Nucleoplasm, Plasma membrane" "HPA045929: " "unprognostic (1.00e-1)" "unprognostic (9.56e-2)" "unprognostic (1.03e-1)" "unprognostic (4.15e-2)" "unprognostic (1.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.16e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-1)" "unprognostic (6.68e-3)" "unprognostic (6.36e-2)" "unprognostic (3.03e-6)" "unprognostic (1.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.71e-2)" "unprognostic (3.24e-3)" 1.1 5.8 12.1 1.9 17.7 1.4 1.1 14.9 33.4 1.0 1.8 8.0 0.0 1.6 1.1 1.2 1.1 1.1 1.3 1.1 11.5 12.1 1.3 1.2 1.1 1.1 6.7 12.8 1.3 2.4 1.1 14.5 1.1 11.8 1.2 1.9 0.1 1.1 1.1 1.2 1.3 1.7 1.3 9.0 1.1 1.5 1.3 6.3 0.0 1.1 0.0 1.1 1.1 0.3 1.0 0.6 2.1 0.5 0.7 0.6 0.1 0.0 0.0 0.4 0.1 1.2 2.0 0.1 0.6 0.2 0.8 0.8 0.1 0.1 0.1 0.0 0.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 1.8 0.0 0.1 1.2 0.2 0.0 0.2 7.0 0.0 0.0 0.2 0.9 0.1 0.1 0.0 0.1 0.0 0.1 7.0 2.0 0.0 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 2.1 0.5 0.5 0.4 0.3 0.3 0.8 0.3 0.3 0.1 1.0 0.6 0.5 1.2 0.7 0.3 0.6 0.3 0.1 12.1 17.7 14.9 16.9 11.5 12.1 6.7 12.8 11.8 6.3 SLC8A2 "KIAA1087, NCX2" ENSG00000118160 "Solute carrier family 8 member A2" Q9UPR5 19 47428017-47472168 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.9" "Group enriched" "Detected in some" 6 "NTERA-2: 4.3;SCLC-21H: 12.2;SH-SY5Y: 6.6;SiHa: 5.1;U-2 OS: 7.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 80.3;basal ganglia: 95.4;cerebral cortex: 125.2;hippocampal formation: 110.1" "Low region specificity" "Detected in all" "HPA050818, HPA054671" Enhanced "HPA050818: AB_2681248, HPA054671: AB_2682568" "unprognostic (3.75e-2)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (4.32e-2)" "unprognostic (1.34e-1)" "unprognostic (6.00e-3)" "unprognostic (1.38e-1)" "unprognostic (2.79e-1)" "unprognostic (1.34e-1)" "unprognostic (8.95e-2)" "unprognostic (4.77e-2)" "unprognostic (2.04e-2)" "unprognostic (2.81e-3)" "unprognostic (6.13e-2)" "unprognostic (9.40e-2)" "unprognostic (1.53e-1)" "unprognostic (1.63e-2)" 1.2 4.0 16.6 1.0 18.1 0.9 0.9 50.9 50.7 1.0 2.4 1.8 1.0 1.3 5.4 1.0 2.3 2.2 1.1 0.9 21.4 6.8 1.0 0.9 0.9 0.9 2.1 21.1 0.9 10.3 0.9 3.2 1.0 2.0 1.4 1.4 0.0 1.2 4.4 0.9 1.0 1.2 5.5 2.0 1.0 1.3 1.9 1.2 0.0 1.0 0.0 0.9 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.4 0.1 12.2 6.6 5.1 0.6 0.4 0.1 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 18.1 50.9 34.6 21.4 6.8 2.1 21.1 2.0 1.2 SLC8A3 NCX3 ENSG00000100678 "Solute carrier family 8 member A3" P57103 14 70044217-70189070 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 17.0;skeletal muscle: 32.1" "Cell line enhanced" "Detected in some" "AF22: 3.9;LHCN-M2: 7.2;SH-SY5Y: 23.3" "Cancer enriched" "Detected in single" 8 "glioma: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.65e-1)" "unprognostic (5.53e-2)" "unprognostic (1.18e-2)" "unprognostic (1.51e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.69e-1)" "unprognostic (3.46e-3)" "unprognostic (4.74e-2)" "unprognostic (1.64e-1)" "unprognostic (1.45e-3)" "unprognostic (8.53e-2)" "unprognostic (5.86e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (3.38e-1)" 0.7 2.8 6.1 1.2 6.1 1.0 0.9 3.8 17.0 1.4 1.1 3.1 0.0 1.1 0.9 1.0 1.1 0.7 1.3 1.5 5.8 8.2 0.6 0.6 1.6 1.0 4.7 7.1 0.6 1.0 0.6 1.5 0.7 6.4 1.2 1.1 1.5 0.6 0.8 32.1 0.8 1.2 1.2 2.8 0.7 1.2 0.8 1.9 0.0 0.6 4.9 0.9 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 23.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 6.1 6.1 3.8 10.6 5.8 8.2 4.7 7.1 6.4 1.9 SLC9A5 NHE5 ENSG00000135740 "Solute carrier family 9 member A5" Q14940 16 67237683-67272190 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5;lymphoid tissue: 14.5" "Cell line enhanced" "Detected in many" "U-138 MG: 8.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041004, HPA041329" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA041004: AB_10794433, HPA041329: AB_10794373" "unprognostic (8.90e-2)" "unprognostic (9.70e-2)" "unprognostic (3.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (5.17e-2)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-3)" "unprognostic (4.84e-2)" "unprognostic (9.85e-11)" "unprognostic (9.21e-2)" "unprognostic (1.95e-1)" "unprognostic (8.12e-3)" "unprognostic (9.07e-2)" 1.7 1.7 2.9 1.1 8.8 0.5 1.1 13.5 8.6 0.9 1.4 0.5 3.6 1.3 1.1 3.2 0.6 0.6 1.9 2.3 2.9 3.6 1.1 0.6 2.9 2.1 2.1 2.3 1.4 1.5 0.5 0.6 1.7 4.3 1.0 1.1 0.5 1.0 2.5 1.7 4.2 0.9 0.6 2.7 14.5 0.8 3.3 1.2 0.0 1.0 0.0 1.3 1.6 0.4 1.5 0.8 1.0 0.5 0.6 0.9 0.1 0.5 4.1 3.7 1.2 6.8 4.7 0.4 1.3 5.8 3.4 3.1 0.2 2.9 0.0 0.8 1.6 0.2 1.0 0.7 1.3 1.2 1.2 3.2 0.3 0.9 0.8 1.4 6.7 5.3 1.4 1.9 0.4 0.7 0.7 1.9 2.2 2.3 0.1 0.3 2.5 0.4 0.0 0.8 0.9 0.6 0.7 2.1 0.9 3.5 0.2 1.8 1.4 0.3 1.0 8.8 1.4 1.6 0.6 3.6 0.9 1.8 6.3 0.7 2.2 0.0 0.4 0.0 0.0 0.0 0.6 1.5 0.4 0.9 0.1 0.0 0.4 0.4 1.0 0.6 0.5 0.8 0.0 0.1 2.9 8.8 13.5 8.6 2.9 3.6 2.1 2.3 4.3 1.2 SLC9A6 "KIAA0267, NHE6" ENSG00000198689 "Solute carrier family 9 member A6" Q92581 X 135973841-136047269 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059445, HPA059590" Enhanced Supported Vesicles Vesicles "HPA059445: , HPA059590: " "unprognostic (1.35e-1)" "unprognostic (8.28e-3)" "unprognostic (4.36e-1)" "unprognostic (4.93e-2)" "unprognostic (1.84e-1)" "unprognostic (1.19e-1)" "unprognostic (2.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (7.07e-2)" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (4.49e-2)" "unprognostic (5.06e-2)" 4.3 5.7 16.4 4.7 27.6 4.0 3.1 15.3 35.1 5.2 5.2 7.8 1.6 7.5 5.7 3.2 5.6 5.2 4.8 7.2 19.1 24.3 6.2 3.9 5.7 4.7 15.0 15.6 7.4 3.3 9.3 8.6 4.0 22.3 3.6 5.5 4.6 3.3 4.6 5.5 4.1 6.5 6.5 9.5 4.8 5.2 5.1 4.0 3.6 5.9 1.7 5.8 4.7 3.2 5.3 6.8 3.2 8.4 5.9 13.9 6.0 13.0 6.9 7.3 2.7 10.4 10.1 13.1 10.5 11.3 9.1 19.3 6.0 10.5 9.7 24.1 12.1 7.8 9.4 9.4 13.2 7.6 8.6 2.6 11.0 3.5 5.5 7.6 9.2 5.6 8.4 15.0 7.5 7.7 4.8 14.0 10.0 5.8 10.0 2.2 4.1 9.4 6.8 10.9 9.9 6.5 6.6 6.5 4.9 7.6 0.8 6.1 3.2 5.9 10.9 11.3 8.1 16.8 13.6 6.7 14.9 8.6 6.9 13.0 6.3 2.2 6.0 3.2 8.1 8.4 13.9 5.3 9.5 7.9 6.8 4.0 10.6 7.9 2.6 5.9 6.6 4.3 8.0 6.0 16.4 27.6 15.3 25.9 19.1 24.3 15.0 15.6 22.3 4.0 SLC9A7 NHE7 ENSG00000065923 "Solute carrier family 9 member A7" Q96T83 X 46599252-46759172 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Potassium transport, Sodium transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 42.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048938, HPA075385" Approved Supported Vesicles Vesicles "HPA048938: , HPA075385: " "unprognostic (2.77e-1)" "unprognostic (4.68e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (8.58e-4)" "prognostic unfavourable (8.14e-4)" "unprognostic (2.16e-2)" "unprognostic (2.73e-3)" "unprognostic (5.26e-3)" "unprognostic (1.28e-2)" "unprognostic (9.25e-2)" "unprognostic (5.30e-2)" "unprognostic (1.11e-1)" "unprognostic (2.08e-1)" "unprognostic (7.20e-2)" "unprognostic (2.62e-1)" "unprognostic (1.57e-1)" "unprognostic (1.13e-1)" 1.7 7.2 4.4 3.8 42.0 4.4 7.9 7.0 12.4 1.8 1.2 1.8 1.2 1.7 1.2 3.8 3.2 2.5 2.2 2.3 3.3 7.1 3.3 4.1 1.8 7.8 3.6 4.3 6.3 4.6 11.5 13.6 1.4 12.7 6.5 1.3 2.3 7.3 2.9 10.0 2.9 2.7 1.0 2.7 4.7 8.2 1.3 8.2 2.8 6.9 1.7 8.2 2.3 2.2 4.3 6.0 2.1 0.6 1.4 0.7 0.5 7.3 5.6 0.8 2.4 0.9 5.6 3.2 7.0 8.7 4.2 3.4 5.7 7.9 16.1 2.2 11.1 3.4 5.4 7.9 7.7 8.4 2.9 1.6 2.2 2.3 3.5 0.8 13.3 3.5 1.0 11.9 7.9 5.9 0.1 0.3 5.7 11.0 1.8 0.9 3.9 6.7 7.1 0.3 0.2 3.2 8.2 6.1 0.7 3.6 5.4 1.5 7.1 0.3 0.3 9.0 3.0 1.4 4.1 1.7 0.4 8.1 12.8 0.1 2.9 1.0 0.6 0.3 0.6 0.6 0.4 3.4 0.7 0.3 2.4 4.3 0.4 0.5 2.1 1.4 0.6 6.0 0.7 0.5 4.4 42.0 7.0 8.3 3.3 7.1 3.6 4.3 12.7 8.2 SLCO1A2 "OATP, OATP-A, OATP1A2, SLC21A3" ENSG00000084453 "Solute carrier organic anion transporter family member 1A2" P46721 12 21264600-21419594 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5" "Cell line enhanced" "Detected in some" "NTERA-2: 13.7;RPMI-8226: 9.5;U-266/70: 20.5;U-266/84: 8.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071152 Supported "Plasma membrane" "Plasma membrane" "HPA071152: " "unprognostic (5.43e-3)" "unprognostic (2.33e-1)" "unprognostic (1.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.53e-1)" "unprognostic (3.82e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (8.82e-2)" "unprognostic (1.66e-4)" "unprognostic (2.52e-2)" "unprognostic (3.20e-1)" "unprognostic (1.24e-1)" 0.2 0.1 3.3 0.0 3.4 0.0 3.6 3.4 17.9 0.1 0.1 1.9 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.9 4.1 2.5 1.1 11.2 2.7 0.6 3.0 4.0 0.2 2.3 0.5 0.5 1.2 9.7 0.7 0.0 14.2 14.5 0.0 0.4 0.4 0.2 0.0 2.9 0.4 0.4 1.6 1.4 0.0 0.3 0.0 0.3 0.4 0.1 1.3 0.7 4.3 0.4 1.1 2.3 0.2 2.1 0.5 0.8 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 3.0 1.7 0.1 2.1 0.1 0.2 0.2 0.1 0.4 0.5 0.7 0.0 0.5 1.1 0.0 0.3 0.2 0.0 1.4 0.1 0.1 0.1 3.5 1.4 0.0 2.1 0.3 0.1 13.7 0.1 0.1 0.2 9.5 0.0 2.1 1.9 2.3 0.0 0.2 0.2 2.7 0.7 0.0 0.0 1.4 0.7 0.3 20.5 8.2 0.1 0.2 0.2 0.1 0.6 0.4 0.3 1.4 0.3 2.3 1.3 2.2 1.5 0.1 1.0 2.1 1.6 4.3 1.1 0.1 0.7 1.8 0.2 3.3 3.4 3.4 5.0 4.1 2.5 3.0 4.0 9.7 1.4 SLCO1C1 "OATP-F, OATP1, OATP1C1, SLC21A14" ENSG00000139155 "Solute carrier organic anion transporter family member 1C1" Q9NYB5 12 20695355-20753386 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 32.4;retina: 15.3" "Cell line enriched" "Detected in single" 13 "HeLa: 9.3" "Cancer enriched" "Detected in single" 17 "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "unprognostic (1.15e-1)" "unprognostic (8.18e-4)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (4.64e-1)" "unprognostic (3.16e-2)" "unprognostic (1.76e-1)" "unprognostic (7.32e-2)" "unprognostic (8.89e-2)" "unprognostic (1.23e-1)" "unprognostic (4.38e-2)" "unprognostic (2.70e-2)" "unprognostic (2.37e-4)" "unprognostic (1.56e-3)" "unprognostic (1.51e-1)" "unprognostic (3.35e-1)" "unprognostic (1.76e-2)" 3.5 1.2 11.6 1.0 16.2 0.9 1.2 1.1 32.4 0.9 1.4 6.2 0.0 1.1 0.9 1.3 1.2 0.9 2.1 1.5 10.4 2.8 1.1 0.9 1.2 1.2 6.5 8.0 0.9 1.0 1.5 5.5 1.0 20.3 1.0 1.3 15.3 1.1 1.0 0.9 1.2 1.6 1.2 4.9 0.9 1.0 3.3 8.1 0.0 1.7 0.2 1.4 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 16.2 1.1 11.5 10.4 2.8 6.5 8.0 20.3 8.1 SLIT1 "MEGF4, SLIL1, Slit-1, slit1, SLIT3" ENSG00000187122 "Slit guidance ligand 1" O75093 10 96998038-97185920 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 44.3" "Cell line enriched" "Detected in some" 15 "MOLT-4: 41.2" "Group enriched" "Detected in many" 10 "glioma: 9.2;prostate cancer: 2.2;thyroid cancer: 10.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006879 Approved "Plasma membrane" "Secreted in brain" "Plasma membrane" "HPA006879: AB_1078197" "unprognostic (2.72e-1)" "unprognostic (2.25e-2)" "unprognostic (5.67e-3)" "unprognostic (1.43e-5)" "unprognostic (8.40e-2)" "unprognostic (2.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.06e-2)" "unprognostic (2.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.66e-1)" "unprognostic (2.18e-1)" "unprognostic (1.21e-1)" "unprognostic (4.39e-3)" 1.2 0.8 13.4 0.9 16.1 0.9 0.8 0.4 44.3 0.8 0.9 0.5 0.0 0.9 0.8 0.7 0.8 1.0 0.8 0.8 13.9 10.5 0.8 0.7 1.0 0.9 4.6 13.2 0.8 1.4 0.8 8.0 0.8 2.2 1.1 0.8 0.3 0.8 0.7 0.9 0.8 0.9 0.8 1.4 0.9 1.1 2.0 0.3 3.3 3.6 0.0 0.9 0.8 0.0 0.0 1.6 0.4 0.7 0.0 0.0 0.2 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 41.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.6 1.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.4 1.6 0.0 0.2 13.4 16.1 0.4 24.8 13.9 10.5 4.6 13.2 2.2 0.3 SLITRK1 "KIAA1910, LRRC12" ENSG00000178235 "SLIT and NTRK like family member 1" Q96PX8 13 83877205-83882393 "Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 30.6" "Group enriched" "Detected in some" 4 "A-431: 7.4;AF22: 3.1;LHCN-M2: 2.7" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012414 Enhanced "Secreted in brain" 270000 "HPA012414: AB_1857229" "unprognostic (2.29e-1)" "unprognostic (4.32e-1)" "unprognostic (4.71e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (7.95e-2)" 0.9 1.3 16.7 0.9 9.5 0.9 1.0 2.0 30.6 1.2 1.0 6.3 0.0 1.0 1.0 1.0 0.9 0.9 1.0 0.9 16.9 7.3 1.0 0.9 0.9 0.9 7.3 14.9 0.9 3.1 0.9 3.1 0.9 5.8 0.9 1.0 0.1 1.0 1.4 1.0 0.9 0.9 0.9 3.7 0.9 1.0 1.0 8.5 0.0 0.9 0.0 0.9 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 3.1 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 9.5 2.0 21.5 16.9 7.3 7.3 14.9 5.8 8.5 SLITRK2 "CXorf1, CXorf2, KIAA1854, SLITL1, TMEM257" ENSG00000185985 "SLIT and NTRK like family member 2" "Q9H156, O96002" X 145817832-145829856 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.1" "Cell line enriched" "Detected in single" 35 "HAP1: 21.2" "Cancer enhanced" "Detected in some" "glioma: 5.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" 26000 "unprognostic (2.13e-1)" "unprognostic (1.12e-1)" "unprognostic (2.73e-3)" "unprognostic (6.79e-6)" "unprognostic (3.39e-1)" "unprognostic (1.68e-1)" "unprognostic (2.89e-4)" "unprognostic (6.23e-2)" "unprognostic (3.60e-1)" "unprognostic (1.29e-1)" "unprognostic (1.50e-2)" "unprognostic (3.53e-2)" "unprognostic (4.13e-8)" "unprognostic (3.12e-3)" "unprognostic (2.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.14e-2)" 1.6 1.5 12.8 1.2 16.4 0.9 1.2 4.3 25.1 1.7 1.2 13.3 0.0 1.1 1.1 1.1 1.1 4.9 1.1 1.6 12.1 3.5 1.4 1.0 2.2 1.6 11.3 9.2 1.1 1.8 0.9 1.1 0.9 10.4 1.4 1.4 5.6 1.3 8.5 1.2 3.9 1.3 1.5 12.6 7.4 1.0 1.2 11.5 0.0 1.1 0.0 0.9 1.3 1.1 0.3 0.3 1.5 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.4 0.2 0.2 0.3 0.1 0.2 0.2 0.0 0.3 0.3 0.2 0.6 0.4 0.3 0.3 0.2 0.0 12.8 16.4 4.3 14.6 12.1 3.5 11.3 9.2 10.4 11.5 SLITRK3 KIAA0848 ENSG00000121871 "SLIT and NTRK like family member 3" O94933 3 165186720-165197109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;liver: 12.8" "Cell line enhanced" "Detected in some" "AF22: 6.5;HAP1: 5.4;Karpas-707: 1.5;SCLC-21H: 3.5" "Cancer enriched" "Detected in single" 22 "glioma: 7.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017636, HPA048042" Enhanced Approved Mitochondria 1400000 Mitochondria "HPA017636: AB_1857232, HPA048042: " "unprognostic (8.91e-2)" "unprognostic (1.44e-1)" "unprognostic (4.08e-2)" "unprognostic (1.96e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-1)" "unprognostic (9.59e-2)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" "unprognostic (2.22e-1)" "unprognostic (6.74e-3)" "unprognostic (5.03e-1)" "unprognostic (2.38e-1)" "unprognostic (8.03e-4)" 0.6 0.6 7.4 2.0 12.0 0.4 0.5 10.6 17.4 9.9 3.0 1.5 0.3 1.1 12.1 2.0 7.6 12.6 0.8 1.0 13.2 5.5 0.6 12.8 0.9 0.5 3.7 6.5 2.5 0.4 0.4 0.3 0.4 4.2 3.3 3.1 0.3 0.8 9.6 0.9 0.5 1.5 6.2 2.3 0.4 0.8 1.0 2.4 0.0 0.6 0.0 0.5 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 1.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 12.0 10.6 15.7 13.2 5.5 3.7 6.5 4.2 2.4 SLITRK4 DKFZp547M2010 ENSG00000179542 "SLIT and NTRK like family member 4" Q8IW52 X 143622790-143635777 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 15.7;brain: 21.8" "Cell line enhanced" "Detected in some" "HeLa: 8.0;HHSteC: 4.2;LHCN-M2: 3.0;T-47d: 12.3;U-2 OS: 4.7" "Cancer enhanced" "Detected in many" "renal cancer: 3.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "basophil: 11.4;classical monocyte: 4.7;intermediate monocyte: 3.0;myeloid DC: 3.7;non-classical monocyte: 3.2" "Group enriched" "Detected in many" 67 "dendritic cells: 3.7;granulocytes: 11.4;monocytes: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000431 Enhanced Uncertain Microtubules 320000 Microtubules "HPA000431: " "unprognostic (1.72e-1)" "unprognostic (2.11e-2)" "unprognostic (2.63e-2)" "unprognostic (1.15e-3)" "unprognostic (4.09e-1)" "unprognostic (1.75e-2)" "unprognostic (3.79e-3)" "unprognostic (1.21e-1)" "unprognostic (1.97e-2)" "unprognostic (1.86e-1)" "unprognostic (3.64e-2)" "unprognostic (9.61e-2)" "unprognostic (6.02e-2)" "unprognostic (1.02e-5)" "unprognostic (1.29e-2)" "unprognostic (7.75e-2)" "unprognostic (9.23e-3)" 5.9 15.7 13.6 0.6 12.1 1.7 3.3 21.3 21.8 8.5 1.0 0.2 0.1 0.3 2.1 4.7 1.1 1.1 0.6 3.0 17.0 1.2 5.1 0.8 1.1 0.6 1.2 16.1 6.1 1.5 0.1 0.8 0.7 5.0 2.6 0.6 0.0 1.7 2.3 6.9 3.3 1.0 1.6 2.7 0.9 1.0 1.8 1.7 0.0 1.3 0.0 0.2 1.1 1.1 0.0 3.7 11.4 4.7 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 4.2 0.6 0.8 2.0 0.0 1.5 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.3 1.3 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 4.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.9 13.6 12.1 21.3 21.8 17.0 1.2 1.2 16.1 5.0 1.7 SLITRK5 "bA364G4.2, KIAA0918, LRRC11" ENSG00000165300 "SLIT and NTRK like family member 5" O94991 13 87672615-87696272 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4" "Cell line enhanced" "Detected in some" "AF22: 11.2;HeLa: 5.5;U-138 MG: 3.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013843 Uncertain Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA013843: AB_1857233" "unprognostic (1.92e-1)" "unprognostic (1.01e-2)" "unprognostic (3.82e-1)" "unprognostic (7.11e-4)" "unprognostic (6.94e-2)" "unprognostic (8.57e-3)" "unprognostic (1.63e-1)" "unprognostic (8.58e-3)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.10e-2)" "unprognostic (1.81e-2)" "unprognostic (2.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" 0.1 0.3 3.3 0.1 6.8 0.1 0.2 3.1 9.2 0.4 0.2 0.0 0.1 1.0 0.2 6.7 0.1 0.1 4.8 4.2 0.0 0.0 0.2 0.1 2.6 0.6 0.8 0.0 0.0 0.0 1.8 0.3 7.4 3.1 0.2 0.2 0.0 0.0 1.0 0.1 0.5 0.2 2.0 0.3 0.0 0.4 0.7 1.4 1.6 0.3 1.4 0.4 0.1 0.0 1.2 11.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 2.0 1.3 5.5 0.0 0.8 0.0 0.0 2.5 0.2 0.0 1.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 2.8 1.4 1.0 0.3 0.2 0.4 0.0 1.7 0.3 0.0 0.3 0.0 0.8 2.6 0.0 3.9 0.0 0.0 0.6 1.7 0.0 0.0 3.5 0.1 1.1 1.1 0.3 0.4 0.4 0.2 0.4 0.4 0.4 0.3 0.1 0.7 0.4 0.3 1.6 1.4 0.3 1.4 0.2 0.1 SLX4 "BTBD12, FANCP, KIAA1784, KIAA1987" ENSG00000188827 "SLX4 structure-specific endonuclease subunit" Q8IY92 16 3581181-3611598 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 19.9;testis: 25.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049421, HPA066238" Approved Supported "Nucleoplasm,Cell Junctions,Cytosol" Nucleoplasm "Cell Junctions, Cytosol" "HPA049421: , HPA066238: " "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-2)" "unprognostic (4.62e-1)" "unprognostic (6.08e-3)" "unprognostic (8.28e-5)" "unprognostic (6.52e-2)" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.97e-2)" "unprognostic (1.50e-1)" "unprognostic (4.32e-2)" "unprognostic (8.39e-3)" "unprognostic (1.20e-1)" "unprognostic (1.43e-3)" "unprognostic (5.74e-2)" 2.9 3.1 5.3 6.1 8.5 6.0 2.4 19.9 11.8 2.5 2.9 9.8 2.5 4.9 6.5 3.3 3.4 3.0 2.8 2.2 7.4 4.3 2.9 2.7 3.0 8.6 3.8 8.1 2.7 3.1 3.7 8.6 2.6 7.4 3.3 2.2 5.4 3.0 2.6 5.5 4.2 4.0 3.1 3.3 4.8 3.7 25.0 3.2 5.8 2.6 1.0 6.5 3.1 2.7 0.6 0.2 3.0 1.1 0.6 0.6 0.7 2.9 9.2 6.0 7.5 2.3 2.4 6.3 4.8 2.4 5.6 6.1 4.6 3.7 10.9 4.8 2.4 6.7 4.1 3.3 3.3 9.1 5.1 7.4 6.7 2.9 2.0 7.2 10.5 1.8 2.5 5.2 2.9 4.0 7.1 5.9 4.4 5.1 4.4 6.3 5.0 3.5 8.9 10.0 3.0 2.2 2.1 5.1 4.6 4.1 3.0 1.5 7.3 5.6 4.7 6.4 9.0 5.5 5.6 5.4 4.2 12.7 2.1 7.3 6.3 3.0 0.4 0.0 0.6 0.5 0.4 0.3 0.3 0.3 0.2 0.6 0.3 0.5 0.5 0.6 1.1 0.2 0.3 0.7 5.3 8.5 19.9 11.8 7.4 4.3 3.8 8.1 7.4 3.2 SMIM10L2A "LED, LINC00086, LINC0086, MGC39606, NCRNA00086" ENSG00000178947 "Small integral membrane protein 10 like 2A" P0DMW4 X 135421943-135428074 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 15.2;brain: 16.3;epididymis: 13.3" "Cell line enhanced" "Detected in some" "AN3-CA: 6.7;CACO-2: 3.3;HAP1: 13.5;hTCEpi: 7.2;PC-3: 3.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 15.5" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (4.22e-2)" "unprognostic (4.72e-2)" "unprognostic (4.50e-2)" "prognostic unfavourable (6.78e-4)" "unprognostic (8.62e-3)" "unprognostic (5.83e-2)" "unprognostic (2.16e-1)" "unprognostic (2.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (9.55e-3)" "unprognostic (1.36e-1)" "prognostic favourable (8.28e-8)" "unprognostic (5.29e-2)" "unprognostic (3.26e-1)" "unprognostic (7.37e-3)" "unprognostic (2.28e-2)" 0.4 15.2 3.6 0.1 9.6 0.0 1.4 1.6 16.3 0.9 0.0 1.9 0.2 0.0 1.1 13.3 0.6 1.9 0.2 2.4 4.5 3.8 0.0 1.6 0.2 0.4 7.2 4.1 2.5 2.1 0.2 0.0 5.7 1.7 0.1 0.7 2.3 1.5 0.0 1.8 0.0 0.5 1.3 2.3 0.7 5.3 1.4 0.0 3.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.3 6.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 1.0 0.1 0.0 13.5 1.7 0.0 0.0 1.2 0.2 0.0 0.0 0.2 0.0 0.5 0.6 7.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 1.4 3.1 0.1 0.0 0.0 2.0 0.2 0.4 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 SMIM10L2B "LINC00087, NCRNA00087, RP11-85L21.2" ENSG00000196972 "Small integral membrane protein 10 like 2B" P0DMW5 X 135094987-135098634 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 17.5;heart muscle: 9.5" "Cell line enhanced" "Detected in some" "ASC diff: 4.2;HHSteC: 4.4;HSkMC: 6.9;NTERA-2: 3.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (2.60e-2)" "unprognostic (3.08e-1)" "unprognostic (3.16e-2)" "unprognostic (1.18e-3)" "unprognostic (7.25e-3)" "unprognostic (9.55e-2)" "unprognostic (5.90e-2)" "unprognostic (6.02e-2)" "unprognostic (4.54e-2)" "unprognostic (7.05e-2)" "unprognostic (4.69e-2)" "unprognostic (1.13e-2)" "prognostic favourable (2.41e-5)" "unprognostic (2.03e-3)" "unprognostic (1.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.98e-2)" 1.0 3.6 4.9 0.2 8.6 0.0 1.0 2.8 17.5 1.8 0.4 1.3 0.0 0.2 2.2 2.2 0.9 2.7 0.6 9.5 6.6 2.9 0.5 1.2 0.1 0.0 7.5 5.0 0.7 5.0 0.0 0.1 12.3 3.4 0.2 1.3 3.0 2.3 0.6 1.5 0.1 1.3 1.6 0.6 0.5 3.6 0.9 0.0 1.5 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 3.0 2.7 4.2 0.6 1.4 0.9 0.5 0.4 0.7 1.3 0.0 0.0 0.5 0.5 0.3 1.0 1.0 0.1 0.0 0.9 0.1 0.2 0.1 4.4 0.0 0.2 6.9 0.4 0.1 0.3 0.3 0.1 0.0 0.3 0.1 0.8 0.1 3.7 0.4 0.0 0.8 0.1 1.7 0.5 1.4 0.4 0.6 0.3 0.0 0.0 0.5 0.0 0.2 1.1 0.4 0.1 0.3 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 SMIM13 C6orf228 ENSG00000224531 "Small integral membrane protein 13" P0DJ93 6 11094033-11138733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA065706 Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" "Nucleoplasm, Nuclear membrane, Golgi apparatus" "HPA065706: " "unprognostic (6.89e-2)" "unprognostic (1.22e-1)" "unprognostic (1.58e-1)" "unprognostic (7.11e-3)" "unprognostic (4.01e-1)" "unprognostic (2.57e-1)" "unprognostic (3.59e-2)" "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (6.66e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (1.03e-5)" "unprognostic (1.04e-2)" "unprognostic (2.76e-1)" "unprognostic (9.22e-2)" "unprognostic (3.45e-2)" 5.7 4.2 7.5 2.8 13.0 2.0 4.5 13.3 26.4 4.3 3.2 7.7 1.1 3.1 4.6 3.2 8.5 3.0 3.7 5.7 6.5 2.8 3.9 8.7 5.2 2.3 9.5 8.3 3.8 3.2 7.6 2.8 11.4 14.3 4.3 3.3 2.8 5.3 4.6 9.1 13.7 3.9 4.7 4.9 5.1 3.4 9.4 8.1 1.7 3.9 2.1 2.6 3.3 4.9 0.5 2.4 1.3 0.4 1.2 1.0 0.4 5.6 4.9 7.6 6.4 7.9 9.1 8.0 15.9 6.8 8.2 9.2 6.5 1.8 7.1 21.7 5.1 5.0 15.8 5.6 14.9 3.9 11.5 7.4 5.5 5.1 10.6 13.7 1.7 10.8 15.6 8.4 11.1 8.7 10.4 3.0 15.6 3.1 5.8 8.0 3.6 4.3 7.7 14.1 9.9 5.0 4.5 17.8 9.8 3.3 11.0 18.6 2.7 5.7 12.3 12.5 9.0 5.1 10.6 5.5 18.4 10.2 2.9 5.8 19.1 1.3 0.3 0.3 1.0 0.4 0.8 0.5 0.4 0.5 0.6 0.3 0.1 0.9 0.1 1.2 0.3 2.4 0.6 0.4 7.5 13.0 13.3 19.6 6.5 2.8 9.5 8.3 14.3 8.1 SMIM17 ENSG00000268182 "Small integral membrane protein 17" P0DL12 19 56643145-56655766 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in many" 6 "brain: 26.5" "Cell line enhanced" "Detected in some" "AF22: 5.3;HEK 293: 5.2;RH-30: 4.2;SCLC-21H: 4.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "HPA071857, HPA071861" Enhanced Approved Vesicles Vesicles "HPA071857: , HPA071861: " "unprognostic (1.32e-1)" "unprognostic (2.82e-1)" "unprognostic (1.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.62e-1)" "unprognostic (4.57e-2)" "unprognostic (5.84e-2)" "unprognostic (3.00e-2)" "unprognostic (2.51e-1)" "unprognostic (6.50e-2)" "unprognostic (4.64e-2)" "unprognostic (9.02e-3)" "unprognostic (3.46e-3)" "unprognostic (6.26e-2)" "unprognostic (1.01e-1)" "unprognostic (3.71e-3)" "unprognostic (7.51e-3)" 1.8 1.2 7.0 0.6 10.4 0.8 2.4 4.5 17.3 0.9 1.1 0.9 0.0 1.0 2.2 4.8 1.2 1.5 1.0 1.7 6.0 13.8 1.3 0.8 1.3 0.7 5.9 7.7 1.8 1.2 0.5 2.2 1.1 26.5 1.7 1.2 0.4 1.3 2.6 1.1 1.9 0.7 1.4 2.7 1.0 0.7 1.6 0.1 0.0 1.1 0.0 0.8 0.5 0.5 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.2 0.0 5.3 1.5 1.2 0.9 1.1 0.7 0.6 1.2 0.3 0.0 0.2 0.4 0.8 0.3 0.3 0.1 0.4 0.7 0.0 5.2 3.1 0.6 0.8 0.8 2.4 0.4 1.7 0.7 0.0 1.4 0.5 0.1 0.0 1.1 0.0 2.8 0.3 0.0 0.6 1.5 4.2 0.1 0.7 0.0 4.8 0.9 1.2 0.1 0.7 0.0 0.8 0.8 1.8 0.2 0.5 0.5 0.3 0.8 1.3 0.6 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 10.4 4.5 17.3 6.0 13.8 5.9 7.7 26.5 0.1 SMIM18 ENSG00000253457 "Small integral membrane protein 18" P0DKX4 8 30638600-30646064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 18.8;pituitary gland: 10.7" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 14.2" "Cancer enriched" "Detected in single" 8 "glioma: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066648 Supported Uncertain Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA066648: " "unprognostic (2.19e-2)" "unprognostic (9.37e-2)" "unprognostic (3.31e-1)" "unprognostic (4.24e-2)" "unprognostic (1.66e-1)" "unprognostic (2.60e-1)" "unprognostic (7.29e-2)" "unprognostic (4.70e-1)" "unprognostic (8.91e-3)" "unprognostic (1.05e-1)" "unprognostic (2.36e-1)" "unprognostic (6.08e-2)" "unprognostic (4.01e-3)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (4.14e-1)" 0.6 3.2 5.2 0.7 6.6 2.7 0.6 18.8 18.7 0.6 0.7 0.4 0.0 0.6 0.7 0.6 0.7 0.7 0.8 0.9 10.9 10.7 2.9 0.7 0.6 0.6 5.7 7.5 0.7 1.8 0.6 10.7 0.6 11.7 0.7 0.8 0.2 0.6 0.6 0.6 0.7 0.7 0.6 4.6 0.7 0.8 0.7 1.4 0.0 0.7 0.0 0.6 0.6 0.0 2.9 4.1 3.0 2.3 0.2 4.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.4 0.0 0.0 0.0 3.0 1.9 1.9 3.7 1.3 3.6 2.9 2.3 2.1 0.9 2.9 3.0 4.3 2.1 0.2 2.3 4.1 2.9 0.3 5.2 6.6 18.8 9.7 10.9 10.7 5.7 7.5 11.7 1.4 SMIM32 ENSG00000271824 "Small integral membrane protein 32" 5 136191468-136193134 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 9 "brain: 7.8;gallbladder: 9.8;intestine: 12.3;kidney: 26.2" "Group enriched" "Detected in some" 7 "HaCaT: 2.2;SCLC-21H: 6.0" "Cancer enhanced" "Detected in many" "renal cancer: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (2.35e-5)" "unprognostic (3.08e-1)" "unprognostic (7.74e-2)" "unprognostic (7.79e-2)" "unprognostic (2.11e-2)" "unprognostic (9.13e-2)" "prognostic favourable (1.63e-4)" "unprognostic (1.86e-2)" "unprognostic (1.75e-2)" "prognostic favourable (6.13e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-2)" "unprognostic (2.78e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-3)" "unprognostic (8.05e-2)" 0.0 0.0 0.0 1.2 2.2 0.0 0.0 0.0 7.8 0.0 5.1 0.0 0.0 12.3 0.0 0.0 0.0 0.0 9.8 0.0 0.6 26.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.4 0.1 0.0 0.0 0.2 0.0 8.3 0.0 0.0 0.0 1.5 0.0 1.4 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 2.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.0 0.0 6.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 SMOC1 ENSG00000198732 "SPARC related modular calcium binding 1" Q9H4F8 14 69854131-70032366 "Disease related genes, Predicted secreted proteins" Differentiation "Developmental protein" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.2;liver: 48.0" "Cell line enhanced" "Detected in some" "AF22: 19.4;HeLa: 53.3;HSkMC: 15.6;SiHa: 31.4;SK-BR-3: 13.8;U-266/70: 19.9;U-87 MG: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 4.9" "Lineage enriched" "Detected in single" 50 "dendritic cells: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004153, CAB034427" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" 27000 "Plasma membrane" "CAB034427: AB_2193382, HPA004153: AB_1080035" "unprognostic (3.31e-1)" "unprognostic (2.17e-3)" "unprognostic (8.17e-2)" "unprognostic (1.96e-2)" "unprognostic (1.89e-2)" "unprognostic (4.04e-1)" "unprognostic (6.75e-3)" "unprognostic (2.09e-3)" "unprognostic (4.76e-2)" "unprognostic (2.80e-2)" "unprognostic (5.10e-2)" "unprognostic (5.63e-2)" "unprognostic (4.09e-2)" "unprognostic (3.92e-1)" "unprognostic (2.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" 7.4 10.7 23.0 1.4 10.8 1.1 2.9 5.2 62.2 8.6 2.2 32.0 19.4 3.0 2.2 10.3 1.3 7.1 1.5 4.7 22.6 16.2 2.1 48.0 1.4 1.8 23.8 8.5 1.8 26.4 1.1 2.4 9.0 21.7 42.9 2.0 14.7 3.6 35.8 8.7 1.2 2.3 1.9 15.0 19.5 3.5 24.7 16.9 0.0 2.9 0.6 1.5 1.7 3.6 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 19.4 0.0 3.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 7.5 0.0 53.3 7.8 0.0 0.0 0.0 15.6 4.5 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.1 31.4 13.8 0.0 0.0 0.0 0.1 0.1 1.4 0.0 0.0 19.9 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 23.0 10.8 5.2 11.2 22.6 16.2 23.8 8.5 21.7 16.9 SNAP25 "bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25" ENSG00000132639 "Synaptosome associated protein 25" P60880 20 10218830-10307418 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 356.9" "Group enriched" "Detected in some" 4 "Karpas-707: 10.8;SCLC-21H: 35.7;SH-SY5Y: 21.3;U-87 MG: 25.7" "Group enriched" "Detected in many" 6 "glioma: 28.9;pancreatic cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000360, HPA001830, HPA071013" Enhanced Supported Approved "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: " "unprognostic (1.64e-3)" "unprognostic (7.26e-3)" "unprognostic (4.36e-2)" "unprognostic (2.49e-7)" "unprognostic (6.86e-3)" "unprognostic (5.87e-3)" "unprognostic (1.15e-2)" "unprognostic (9.94e-2)" "unprognostic (3.13e-1)" "unprognostic (5.82e-3)" "unprognostic (4.80e-3)" "unprognostic (8.06e-2)" "unprognostic (1.09e-1)" "unprognostic (6.18e-3)" "unprognostic (2.48e-1)" "unprognostic (6.28e-3)" "unprognostic (1.02e-2)" 2.2 16.4 81.0 3.3 60.0 2.1 3.4 202.9 356.9 2.2 2.8 3.4 3.7 3.2 4.6 6.4 2.2 4.0 2.8 2.4 86.5 37.1 2.5 2.3 2.6 2.2 46.7 65.2 3.7 4.1 2.1 5.5 2.3 97.7 3.1 2.8 4.0 2.2 11.9 2.1 2.2 3.3 4.7 13.9 2.1 4.3 3.2 7.4 0.0 2.3 0.0 2.2 2.6 0.1 0.0 1.6 0.7 0.0 0.0 0.6 0.3 0.0 2.1 1.7 0.0 0.2 0.0 0.0 0.9 0.0 2.2 0.6 0.0 0.0 0.0 1.9 0.0 0.4 0.2 0.0 4.4 0.2 0.1 0.0 2.9 0.3 1.6 0.0 0.2 2.0 0.0 1.8 0.0 0.0 0.0 10.8 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 35.7 21.3 0.3 0.0 0.0 0.0 2.9 0.0 2.3 3.1 0.0 1.0 0.0 5.5 0.0 25.7 0.0 2.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.6 0.3 81.0 60.0 202.9 163.5 86.5 37.1 46.7 65.2 97.7 7.4 SNAP91 "AP180, CALM, KIAA0656" ENSG00000065609 "Synaptosome associated protein 91" O60641 6 83552880-83709691 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 81.9" "Group enriched" "Detected in some" 13 "SCLC-21H: 21.3;SH-SY5Y: 13.3" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 6.3" "Lineage enriched" "Detected in single" 20 "dendritic cells: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009745, HPA029632, HPA029633" Enhanced Uncertain Centrosome,Cytosol "Centrosome, Cytosol" "CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615" "unprognostic (1.07e-2)" "unprognostic (1.74e-1)" "unprognostic (7.55e-3)" "unprognostic (3.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (4.54e-4)" "unprognostic (6.99e-2)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (2.15e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" 1.2 8.0 17.8 1.9 25.5 1.1 1.7 44.2 81.9 2.1 1.7 3.4 0.0 1.4 1.7 1.2 1.3 1.8 2.0 1.3 19.2 19.9 1.2 1.1 1.4 3.3 14.3 20.5 3.1 2.4 1.1 9.3 1.6 34.7 3.9 1.7 4.5 1.6 1.7 1.2 1.3 1.7 1.8 7.0 2.2 1.9 10.8 2.9 0.0 2.0 0.0 2.7 1.3 0.2 0.0 6.3 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 1.2 0.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.1 0.2 21.3 13.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.1 17.8 25.5 44.2 43.6 19.2 19.9 14.3 20.5 34.7 2.9 SNCA "NACP, PARK1, PARK4, PD1" ENSG00000145335 "Synuclein alpha" P37840 4 89724099-89838315 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Alzheimer disease, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 31.2;bone marrow: 91.0;brain: 121.3" "Cell line enhanced" "Detected in many" "HEL: 43.3;HUVEC TERT2: 52.7;RT4: 27.8;SK-MEL-30: 51.7;TIME: 60.3" "Cancer enriched" "Detected in many" 8 "melanoma: 37.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 25.4;plasmacytoid DC: 31.2" "Group enriched" "Detected in many" 4 "dendritic cells: 31.2;granulocytes: 10.1;monocytes: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005459, CAB010877" Enhanced "Intracellular and membrane" 23000000 "CAB010877: AB_261518, HPA005459: " "unprognostic (4.80e-2)" "unprognostic (1.52e-1)" "unprognostic (8.13e-2)" "unprognostic (1.05e-3)" "unprognostic (2.65e-2)" "unprognostic (1.54e-2)" "unprognostic (1.78e-2)" "unprognostic (3.44e-2)" "unprognostic (1.73e-2)" "unprognostic (3.85e-3)" "unprognostic (1.01e-3)" "unprognostic (2.09e-2)" "unprognostic (1.57e-1)" "unprognostic (2.51e-3)" "unprognostic (1.68e-1)" "unprognostic (3.93e-4)" "unprognostic (7.48e-3)" 3.9 5.4 38.9 4.7 26.1 91.0 4.3 41.7 121.3 6.2 4.7 9.0 0.0 2.3 15.5 2.5 4.5 3.2 3.2 9.0 35.2 22.5 4.2 1.9 4.5 1.8 36.2 49.6 13.6 1.6 1.2 5.4 12.1 26.3 4.6 3.9 5.3 4.9 5.3 1.1 7.6 2.9 15.1 21.4 4.0 1.7 2.2 15.1 0.0 5.2 1.2 2.9 4.1 4.4 0.9 31.2 10.1 20.5 4.8 0.6 19.5 0.1 0.1 8.2 0.0 0.1 0.0 0.1 0.0 8.6 0.3 0.6 0.0 0.0 0.0 2.4 0.0 1.8 10.6 19.7 0.3 0.0 4.8 43.3 24.4 0.0 17.7 0.0 0.3 0.4 7.6 0.0 22.3 52.7 0.3 0.1 0.0 0.0 0.3 0.0 2.1 0.9 0.0 3.2 0.0 0.0 27.8 4.6 3.1 0.0 0.0 51.7 0.0 0.0 60.3 0.2 1.6 0.0 0.1 0.0 0.0 0.0 1.7 0.0 17.3 10.1 20.5 0.0 0.0 8.1 0.0 0.9 0.6 0.1 25.4 0.5 0.3 0.2 3.7 4.8 2.3 31.2 0.0 19.5 38.9 26.1 41.7 55.1 35.2 22.5 36.2 49.6 26.3 15.1 SNCB ENSG00000074317 "Synuclein beta" Q16143 5 176620084-176630556 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 24 "brain: 134.8" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 36.1" "Cancer enriched" "Detected in some" 8 "glioma: 11.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "naive B-cell: 3.1" "Lineage enriched" "Detected in single" 12 "B-cells: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002681, HPA035876" Enhanced Supported "CAB002681: , HPA035876: AB_10670592" "unprognostic (3.55e-2)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" "unprognostic (1.46e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (3.41e-1)" "unprognostic (2.39e-1)" "unprognostic (2.29e-3)" "unprognostic (3.31e-1)" "unprognostic (5.41e-5)" "unprognostic (1.31e-3)" "unprognostic (8.57e-2)" "unprognostic (2.81e-1)" "unprognostic (8.42e-3)" 1.6 3.9 53.7 1.6 24.9 1.5 1.6 64.1 134.8 1.5 1.7 2.2 0.0 1.6 1.6 1.5 1.5 1.6 1.6 1.8 39.4 31.0 1.6 1.5 1.5 1.7 27.5 30.0 1.5 2.1 1.5 1.9 1.6 31.5 1.6 1.6 5.6 1.5 1.5 2.7 1.6 1.6 1.6 7.4 1.6 1.6 1.7 1.5 0.0 1.5 0.0 1.6 1.6 0.0 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.5 0.0 0.1 1.6 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 1.1 0.6 0.0 0.0 2.7 1.6 0.0 0.0 0.1 0.0 0.0 36.1 1.3 0.0 0.1 3.4 1.6 0.1 0.0 0.0 1.4 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 53.7 24.9 64.1 87.6 39.4 31.0 27.5 30.0 31.5 1.5 SNCG "BCSG1, persyn, SR" ENSG00000173267 "Synuclein gamma" O76070 10 86958618-86963260 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 74.1;adrenal gland: 78.3;brain: 100.1;urinary bladder: 76.6" "Group enriched" "Detected in some" 4 "CAPAN-2: 93.7;RT4: 77.2" "Group enriched" "Detected in all" 8 "ovarian cancer: 84.1;urothelial cancer: 301.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;naive CD4 T-cell: 1.8" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 292.8" "Low region specificity" "Detected in many" "CAB001452, HPA014404, CAB040581" Enhanced Supported Supported "Nuclear bodies,Centrosome" Centrosome "Nuclear bodies" "CAB001452: AB_564020, CAB040581: , HPA014404: AB_1857715" "unprognostic (2.06e-1)" "unprognostic (2.58e-1)" "unprognostic (6.87e-3)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (4.76e-3)" "unprognostic (8.99e-2)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-3)" "unprognostic (3.75e-1)" "prognostic unfavourable (2.29e-8)" "prognostic unfavourable (7.15e-4)" "unprognostic (2.35e-1)" "unprognostic (2.36e-2)" "unprognostic (3.77e-3)" 74.1 78.3 82.3 5.3 20.8 1.0 28.9 12.3 44.5 9.5 5.8 4.6 6.4 4.8 6.1 12.0 11.0 26.5 6.2 9.0 40.0 92.9 4.1 1.9 4.6 4.9 72.9 35.1 15.0 3.5 1.6 1.7 4.9 100.1 11.9 2.7 10.8 10.9 44.4 6.6 8.5 5.4 5.8 35.2 20.2 2.6 2.9 5.3 0.2 3.4 3.3 9.6 76.6 18.3 0.0 0.7 0.0 2.4 0.0 1.8 0.6 0.2 1.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 93.7 0.0 1.9 0.1 7.8 0.0 0.3 0.0 0.0 0.0 0.5 18.2 0.3 0.1 0.0 0.1 0.4 7.3 0.0 0.0 6.6 0.6 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 77.2 0.0 0.0 0.6 1.0 0.1 20.3 0.0 17.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.0 1.8 0.0 0.0 0.0 0.9 0.0 0.0 0.6 82.3 20.8 12.3 44.5 40.0 92.9 72.9 35.1 100.1 5.3 SNN ENSG00000184602 Stannin O75324 16 11668414-11679159 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Cell line enhanced" "Detected in many" "AF22: 30.9;REH: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011055 Approved Approved Cytosol Cytosol "HPA011055: AB_1857326" "unprognostic (1.94e-1)" "unprognostic (7.26e-2)" "unprognostic (2.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "prognostic unfavourable (1.85e-6)" "unprognostic (4.51e-2)" "unprognostic (3.45e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (2.14e-1)" "prognostic favourable (1.83e-5)" "unprognostic (4.91e-2)" "unprognostic (2.09e-1)" "unprognostic (3.58e-1)" "unprognostic (4.72e-2)" 29.2 16.6 34.7 10.0 51.5 11.0 13.7 27.2 52.2 6.9 4.4 11.2 1.8 4.9 6.8 11.5 10.5 5.9 12.0 13.2 33.0 15.5 7.0 5.1 9.2 15.0 29.8 25.2 9.8 4.7 4.5 4.6 4.5 15.6 8.1 3.3 6.9 9.9 12.9 29.1 4.5 4.4 6.6 15.2 17.4 4.6 2.2 11.4 6.1 9.5 4.8 14.2 9.3 6.1 7.0 9.0 24.1 20.3 0.3 3.0 7.4 2.9 2.9 30.9 8.4 20.5 5.8 3.0 1.2 2.7 3.7 3.8 4.7 2.1 3.1 12.7 4.2 5.9 9.2 3.6 2.9 0.8 2.1 10.2 3.1 6.1 5.5 0.7 6.2 5.1 16.8 2.0 4.2 6.8 1.6 4.9 3.4 5.0 8.1 2.3 16.0 2.1 28.9 4.1 21.2 3.5 8.8 18.4 7.4 7.0 9.3 4.5 3.7 6.1 6.1 4.3 9.0 25.2 1.3 1.9 1.2 7.3 2.5 8.7 5.4 0.0 9.5 6.9 0.3 16.3 0.3 7.0 1.6 0.7 9.0 6.8 3.0 2.1 24.1 0.3 20.3 3.6 0.9 7.4 34.7 51.5 27.2 39.3 33.0 15.5 29.8 25.2 15.6 11.4 SNORC "ASCL830, C2orf82, UNQ830" ENSG00000182600 "Secondary ossification center associated regulator of chondrocyte maturation" Q6UX34 2 232857270-232878708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.9;breast: 19.6" "Cell line enriched" "Detected in some" 14 "Hep G2: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "basophil: 6.3" "Lineage enriched" "Detected in single" 18 "granulocytes: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA052824 Uncertain Approved Nucleoplasm,Nucleoli "Intracellular and membrane" "Nucleoplasm, Nucleoli" "HPA052824: " "unprognostic (4.58e-3)" "unprognostic (1.31e-1)" "unprognostic (2.47e-2)" "prognostic unfavourable (3.56e-4)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (3.06e-1)" "unprognostic (4.71e-1)" "unprognostic (1.23e-3)" "unprognostic (3.52e-1)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (4.30e-7)" "unprognostic (1.83e-3)" "unprognostic (8.15e-2)" "unprognostic (1.58e-2)" "unprognostic (1.33e-2)" 1.4 1.5 4.8 0.8 6.4 1.5 19.6 2.8 9.0 0.3 2.4 9.3 0.0 2.7 0.7 2.0 0.3 0.4 0.3 0.4 8.8 7.8 1.2 2.1 1.3 1.7 11.9 7.0 0.5 4.2 0.7 0.3 0.9 9.1 3.0 1.1 0.0 3.2 0.6 2.8 10.8 2.0 0.6 27.9 1.4 1.3 6.2 7.4 0.0 0.9 0.0 0.5 0.5 0.0 0.0 0.0 6.3 0.0 0.0 0.3 0.0 0.5 0.0 0.2 0.8 0.6 1.0 1.5 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.4 1.3 0.3 0.2 35.5 0.5 0.0 1.0 0.0 0.8 0.2 0.5 0.9 0.1 0.1 0.1 0.1 0.1 0.3 0.0 1.4 0.2 0.3 0.2 0.0 0.5 0.1 0.5 0.2 0.0 1.3 0.0 1.6 0.5 0.1 0.5 0.5 0.4 2.3 2.5 0.1 0.0 0.8 0.2 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.4 2.8 9.0 8.8 7.8 11.9 7.0 9.1 7.4 SNPH bA314N13.5 ENSG00000101298 Syntaphilin O15079 20 1266316-1309328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.5;naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 9 "T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049393 Approved Uncertain "Cytokinetic bridge,Mitochondria" Mitochondria "Cytokinetic bridge" "HPA049393: " "unprognostic (1.43e-2)" "unprognostic (2.55e-2)" "unprognostic (2.28e-1)" "unprognostic (8.84e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.56e-2)" "unprognostic (5.33e-2)" "unprognostic (3.08e-2)" "unprognostic (3.15e-2)" "prognostic favourable (6.97e-5)" "unprognostic (1.03e-1)" "unprognostic (6.94e-3)" "unprognostic (2.45e-2)" "unprognostic (1.55e-1)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" 2.9 5.0 26.7 3.0 22.5 1.6 1.8 14.4 36.2 3.5 3.5 3.1 5.9 3.1 4.5 3.9 3.6 4.7 4.8 4.7 26.8 15.3 2.1 0.9 2.6 3.1 12.8 17.5 2.4 6.1 6.2 5.8 1.7 17.1 5.5 2.2 3.1 9.9 19.2 6.1 1.9 3.1 8.1 3.8 2.1 5.1 2.7 4.4 0.1 4.5 0.1 2.0 3.6 1.6 0.1 0.4 0.0 0.0 0.0 3.5 1.2 2.2 6.8 0.1 6.9 8.2 4.5 0.0 4.1 5.4 4.6 2.1 0.2 0.7 0.4 2.4 5.0 1.2 1.1 5.8 0.9 1.5 1.9 4.4 1.1 0.1 4.3 0.0 7.1 2.9 2.8 4.7 0.9 5.8 0.8 0.2 4.2 0.0 0.4 0.2 2.4 5.8 0.0 1.4 0.1 6.2 3.2 0.4 2.1 4.0 0.2 5.9 0.4 0.1 10.0 7.5 5.5 6.5 1.2 0.6 1.2 0.0 4.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.6 0.1 0.8 0.9 0.1 0.1 3.5 3.2 0.0 0.0 0.0 0.4 0.4 1.2 26.7 22.5 14.4 36.2 26.8 15.3 12.8 17.5 17.1 4.4 SNTG1 "G1SYN, SYN4" ENSG00000147481 "Syntrophin gamma 1" Q9NSN8 8 49909789-50796691 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 22.7;lymphoid tissue: 7.8;pituitary gland: 10.4" "Cell line enriched" "Detected in some" 8 "RH-30: 10.6" "Cancer enhanced" "Detected in single" "glioma: 2.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072282 Enhanced "HPA072282: " "unprognostic (4.60e-2)" "unprognostic (1.72e-2)" "unprognostic (2.47e-1)" "unprognostic (1.05e-2)" "unprognostic (6.94e-2)" "unprognostic (2.03e-1)" "unprognostic (1.16e-3)" 0.7 1.9 7.4 0.6 13.3 1.6 0.7 2.4 22.7 0.7 0.8 1.1 0.0 0.7 0.7 2.0 0.6 0.9 0.8 0.5 11.9 4.7 1.6 1.9 0.8 0.8 3.3 9.1 0.7 1.4 0.6 10.4 0.7 3.3 0.8 1.0 0.0 0.8 1.0 0.6 1.1 0.7 0.8 2.1 7.8 0.8 3.1 3.8 0.0 0.8 0.0 0.6 2.3 0.3 1.3 0.8 2.3 1.2 0.5 1.0 0.5 0.0 0.0 1.0 0.0 0.2 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.3 0.0 0.3 0.0 0.2 0.2 1.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.5 0.4 0.1 0.3 1.4 0.0 0.2 0.8 0.1 0.0 0.1 10.6 0.0 0.4 0.3 0.4 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.2 0.4 0.1 0.2 2.3 0.5 0.5 0.7 0.5 0.7 1.3 0.8 0.8 0.3 1.3 1.0 0.8 1.1 0.5 1.2 0.8 1.0 0.5 7.4 13.3 2.4 22.7 11.9 4.7 3.3 9.1 3.3 3.8 SNURF ENSG00000273173 "SNRPN upstream reading frame" Q9Y675 15 24954986-24977850 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 140.9" "Cell line enhanced" "Detected in many" "NTERA-2: 58.0;U-698: 30.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA065733 Supported "Nuclear speckles" "Nuclear speckles" "HPA065733: " "unprognostic (2.08e-1)" "unprognostic (2.88e-2)" "unprognostic (6.82e-2)" "unprognostic (4.59e-3)" "unprognostic (4.03e-2)" "unprognostic (1.40e-3)" "unprognostic (4.39e-2)" "unprognostic (6.89e-3)" "unprognostic (1.56e-2)" "unprognostic (6.74e-2)" "unprognostic (8.91e-4)" "unprognostic (3.77e-1)" "unprognostic (1.77e-2)" "unprognostic (6.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-2)" 11.9 20.8 47.6 10.9 50.2 16.7 9.7 59.3 140.9 8.1 19.1 16.7 13.7 5.5 13.2 72.6 9.9 8.1 20.4 32.1 47.7 47.8 23.6 20.1 15.5 14.8 45.6 40.9 15.4 19.4 23.9 40.9 6.4 44.4 21.8 6.3 16.0 12.3 13.9 69.6 7.6 10.8 7.9 28.4 23.9 17.8 7.3 18.9 9.5 40.4 6.5 11.3 9.7 6.7 13.4 11.8 6.1 1.4 10.1 22.0 9.5 0.0 3.6 19.3 13.2 0.9 1.2 0.0 11.1 1.0 1.2 0.8 1.9 10.5 0.1 6.1 0.7 4.2 0.0 2.4 1.0 3.8 0.0 20.0 14.5 0.5 3.4 21.0 7.4 3.0 0.6 2.2 0.0 1.4 2.0 0.0 2.1 0.0 15.1 0.1 58.0 0.5 15.3 23.9 0.2 0.8 24.1 11.3 8.7 0.0 1.0 5.5 11.4 2.0 20.6 8.4 8.9 0.2 2.4 16.9 20.7 30.7 12.7 9.3 7.0 6.1 0.8 3.0 8.3 0.4 16.2 11.1 17.3 14.9 1.5 13.4 22.0 20.0 0.9 10.1 1.4 11.8 17.1 9.5 47.6 50.2 59.3 65.9 47.7 47.8 45.6 40.9 44.4 18.9 SNX10 ENSG00000086300 "Sorting nexin 10" Q9Y5X0 7 26291895-26374329 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;brain: 39.0;liver: 37.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 26.6;U-937: 21.8;WM-115: 75.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 67.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015605, HPA064782" Approved Supported Nucleoplasm,Nucleoli,Microtubules "Nucleoplasm, Microtubules" Nucleoli "HPA015605: AB_1857342, HPA064782: " "unprognostic (6.42e-2)" "unprognostic (2.72e-3)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "prognostic unfavourable (1.16e-4)" "unprognostic (6.92e-2)" "unprognostic (2.48e-3)" "unprognostic (4.51e-2)" "unprognostic (4.87e-1)" "unprognostic (9.36e-2)" "unprognostic (1.59e-1)" "unprognostic (2.56e-1)" "prognostic unfavourable (8.06e-5)" "unprognostic (1.12e-2)" "unprognostic (3.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.50e-1)" 17.7 8.7 20.2 18.6 17.9 20.9 6.7 13.2 39.0 2.9 3.3 2.1 0.1 2.5 5.4 0.8 1.8 1.9 5.2 1.3 22.2 32.7 21.3 37.4 22.4 18.0 27.8 20.8 1.0 5.0 0.6 3.0 8.9 36.2 2.2 3.9 1.8 1.4 1.5 0.9 1.0 3.6 5.4 15.4 22.1 2.3 3.0 2.1 3.8 1.9 0.1 13.6 6.3 1.8 16.3 20.1 67.6 30.9 9.0 5.6 11.6 13.6 1.2 0.0 2.6 0.0 0.0 14.9 0.0 1.0 0.0 0.0 0.1 4.6 6.0 10.7 0.0 0.4 3.4 0.9 0.0 8.2 3.2 0.6 0.1 9.0 0.0 12.7 2.3 0.1 1.4 0.0 1.1 0.2 0.3 0.0 0.0 2.4 5.3 13.4 3.9 1.3 0.0 0.0 0.3 26.6 2.9 5.8 1.8 2.9 2.2 15.5 3.9 18.2 0.0 0.0 3.2 0.0 3.4 4.6 3.7 4.0 0.1 21.8 75.8 8.2 29.2 0.7 4.0 30.9 3.8 16.3 2.8 3.4 20.1 14.5 1.5 2.6 67.6 9.0 30.1 7.4 5.6 11.6 20.2 17.9 13.2 39.0 22.2 32.7 27.8 20.8 36.2 2.1 SNX22 FLJ13952 ENSG00000157734 "Sorting nexin 22" Q96L94 15 64151715-64157481 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;thyroid gland: 41.1" "Cell line enriched" "Detected in some" 4 "Daudi: 19.5" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 47.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 6.6;naive B-cell: 11.5" "Lineage enriched" "Detected in many" 9 "B-cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038470 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038470: AB_10673174" "prognostic favourable (2.89e-5)" "unprognostic (8.93e-3)" "unprognostic (2.89e-1)" "unprognostic (3.55e-2)" "unprognostic (3.24e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-1)" "unprognostic (3.05e-2)" "unprognostic (1.94e-1)" "unprognostic (5.29e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.27e-4)" "unprognostic (3.92e-1)" "unprognostic (2.52e-1)" "prognostic favourable (2.19e-4)" "unprognostic (1.74e-2)" 1.1 1.5 11.9 7.6 8.9 10.2 1.2 3.4 16.5 0.7 1.1 23.2 11.8 1.5 1.2 3.5 0.9 0.8 1.3 7.9 13.4 9.0 1.1 1.9 4.7 11.4 13.7 8.1 1.3 1.6 0.4 2.2 1.0 12.3 3.0 0.7 0.0 3.6 8.4 0.7 2.0 2.2 0.9 17.0 6.1 2.1 1.0 6.6 1.6 41.1 0.0 13.3 2.1 0.3 11.5 1.2 0.0 0.2 0.1 0.1 1.6 0.2 0.4 0.9 0.8 0.1 0.0 0.7 0.8 0.0 0.0 0.2 0.4 0.9 19.5 0.5 0.1 0.4 1.7 0.0 0.0 0.1 2.3 0.3 2.2 2.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.6 3.3 0.0 1.1 0.2 0.0 1.3 0.3 4.0 0.3 1.2 0.8 0.8 4.5 0.9 0.2 0.7 0.0 1.9 0.0 0.0 1.1 1.4 0.2 0.5 4.2 1.7 4.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 1.2 11.5 0.0 0.0 0.0 0.1 0.2 0.0 0.1 1.6 11.9 8.9 3.4 9.3 13.4 9.0 13.7 8.1 12.3 6.6 SNX32 "FLJ30934, SNX6B" ENSG00000172803 "Sorting nexin 32" Q86XE0 11 65833641-65856896 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.6" "Cell line enhanced" "Detected in some" "HHSteC: 6.0;HSkMC: 7.8;REH: 2.5;SH-SY5Y: 3.0;U-266/70: 9.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 1.0;dendritic cells: 1.2;T-cells: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041775 Uncertain Uncertain "Cell Junctions,Focal adhesion sites" "Cell Junctions, Focal adhesion sites" "HPA041775: AB_10797268" "unprognostic (6.74e-4)" "unprognostic (1.06e-1)" "unprognostic (1.67e-2)" "unprognostic (4.50e-5)" "unprognostic (1.00e-1)" "unprognostic (9.28e-2)" "unprognostic (7.30e-2)" "unprognostic (9.17e-3)" "unprognostic (2.70e-1)" "unprognostic (2.87e-1)" "unprognostic (5.08e-2)" "unprognostic (1.52e-1)" "unprognostic (3.64e-4)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (9.80e-2)" "unprognostic (5.36e-2)" 0.8 1.0 9.0 1.1 16.6 1.3 1.3 3.5 16.1 1.6 2.2 1.6 0.0 3.4 2.0 1.3 0.9 2.5 2.8 0.9 10.2 5.0 0.9 0.7 0.8 1.0 3.6 10.9 1.3 0.8 0.8 0.3 0.9 3.4 0.8 1.9 0.1 0.7 0.9 0.6 1.1 1.5 2.0 1.8 0.9 0.9 3.5 3.7 0.0 0.7 0.0 1.3 1.0 0.2 1.0 1.2 0.2 0.3 0.1 3.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.6 7.8 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.1 0.0 2.5 0.0 2.2 0.1 0.0 0.0 3.0 0.0 0.0 1.7 0.0 0.4 0.0 0.3 0.0 0.0 0.0 9.1 1.5 0.0 0.7 0.0 0.3 0.0 0.1 0.0 1.2 0.3 3.0 0.3 1.6 1.2 1.2 1.0 1.4 0.6 0.2 0.1 0.0 0.7 1.2 0.4 9.0 16.6 3.5 15.4 10.2 5.0 3.6 10.9 3.4 3.7 SOCS7 "NAP4, NCKAP4" ENSG00000274211 "Suppressor of cytokine signaling 7" O14512 17 38352228-38405593 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.9;testis: 19.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004475 Approved Approved Cytosol Cytosol "HPA004475: " "prognostic unfavourable (7.49e-4)" "unprognostic (7.93e-2)" "unprognostic (2.01e-1)" "prognostic unfavourable (7.87e-4)" "unprognostic (7.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.43e-3)" "unprognostic (1.23e-1)" "unprognostic (1.77e-1)" "unprognostic (4.12e-3)" "unprognostic (1.97e-3)" "unprognostic (6.62e-2)" "unprognostic (4.91e-3)" "unprognostic (1.55e-2)" "unprognostic (1.53e-1)" "unprognostic (6.65e-2)" "unprognostic (1.88e-1)" 2.4 1.9 6.1 2.5 6.7 2.1 3.2 22.9 7.8 2.6 2.3 3.5 3.3 2.2 3.6 4.2 3.5 3.2 2.3 2.7 5.1 2.4 0.9 2.6 1.8 3.3 5.1 5.1 9.1 5.1 0.9 2.2 2.9 3.1 2.7 2.9 3.6 3.2 6.0 5.2 2.1 3.6 1.4 1.7 1.4 19.7 4.3 4.7 5.2 1.8 2.8 2.4 2.4 0.8 1.0 0.2 0.9 0.7 2.6 0.3 8.7 9.9 11.2 8.6 6.3 5.3 9.2 3.8 3.3 4.7 3.8 7.7 2.7 6.0 5.9 6.1 5.9 9.5 2.7 6.0 11.2 8.5 6.4 11.2 8.0 2.1 14.0 11.0 3.3 11.1 4.9 6.8 4.0 5.2 4.1 5.8 4.8 12.0 9.2 3.6 1.5 12.0 18.7 5.5 3.1 10.8 19.7 10.7 9.5 6.2 6.8 11.5 7.9 3.9 4.7 4.2 8.5 11.8 14.5 10.0 8.9 6.4 7.1 9.5 0.2 0.9 0.1 2.1 0.5 2.6 0.8 0.7 0.3 0.4 0.7 0.4 0.6 0.2 0.7 0.5 1.0 1.1 0.3 SOGA1 "C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA" ENSG00000149639 "Suppressor of glucose, autophagy associated 1" O94964 20 36777442-36863686 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043992 Approved Approved Nucleoli,Cytosol "Secreted to blood" "Nucleoli, Cytosol" "HPA043992: " "unprognostic (2.34e-2)" "unprognostic (1.35e-1)" "unprognostic (6.58e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.48e-1)" "unprognostic (2.27e-3)" "unprognostic (1.37e-1)" "unprognostic (2.06e-1)" "prognostic unfavourable (8.28e-5)" "unprognostic (1.09e-3)" "unprognostic (2.85e-1)" "prognostic unfavourable (4.49e-4)" "unprognostic (6.99e-2)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (4.45e-3)" 6.2 11.4 10.8 4.5 10.6 1.4 6.0 55.5 12.5 11.3 8.3 20.5 7.2 2.5 8.8 5.3 7.2 9.4 9.9 6.7 9.9 7.5 4.7 1.3 6.1 3.0 12.7 8.9 12.6 3.7 11.5 4.4 7.9 8.7 10.7 3.9 6.7 4.4 12.3 2.9 11.0 4.6 14.1 7.9 5.3 5.3 14.8 14.7 0.9 16.0 4.7 4.1 8.0 10.5 1.0 2.1 1.4 0.7 0.7 0.2 0.2 7.4 10.2 12.4 13.3 7.2 6.6 3.2 6.6 7.1 9.3 5.6 4.1 1.2 3.3 2.4 11.5 10.1 9.9 6.1 9.8 0.5 1.9 5.3 9.5 5.4 3.8 1.2 5.2 3.7 7.5 8.9 6.4 6.1 3.7 0.7 10.2 7.2 3.7 2.8 3.1 7.9 8.9 11.5 1.2 5.5 2.2 14.8 9.2 13.6 15.0 4.3 19.1 8.0 9.2 23.5 4.6 11.5 14.3 1.4 0.3 3.3 10.0 1.6 14.8 1.4 0.7 0.2 0.1 0.4 0.2 1.0 0.1 0.1 0.4 1.0 0.2 0.2 1.4 0.7 0.3 2.1 0.1 0.2 10.8 10.6 55.5 12.0 9.9 7.5 12.7 8.9 8.7 14.7 SOGA3 "C6orf174, dJ403A15.3" ENSG00000214338 "SOGA family member 3" Q5TF21 6 127472794-127519191 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;pituitary gland: 11.9" "Cell line enhanced" "Detected in some" "AF22: 7.4;SCLC-21H: 23.9;SH-SY5Y: 13.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 6 "T-cells: 2.3" "HPA035388, HPA035389" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA035388: , HPA035389: AB_10669857" "unprognostic (1.70e-1)" "unprognostic (3.56e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (8.58e-3)" "unprognostic (8.45e-2)" "unprognostic (7.31e-4)" "unprognostic (5.65e-3)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" "unprognostic (1.59e-1)" "unprognostic (3.30e-2)" "unprognostic (1.72e-1)" "unprognostic (8.26e-3)" 0.8 2.8 5.0 1.8 5.3 0.4 0.4 11.4 15.3 1.0 0.8 3.7 0.0 0.5 2.1 0.2 2.0 1.0 1.9 0.8 4.2 4.5 0.6 0.6 1.7 0.8 6.7 5.0 3.3 1.7 0.2 11.9 1.2 7.9 1.1 0.6 0.7 1.1 0.5 0.3 1.0 1.9 0.6 11.4 1.4 3.9 1.8 4.3 0.0 1.9 0.0 0.3 1.6 0.8 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.2 3.3 7.4 1.1 0.0 0.6 0.3 0.7 0.9 0.9 2.3 0.2 0.3 0.4 0.2 0.1 0.0 0.8 0.0 0.6 0.7 0.1 0.6 0.0 0.1 0.0 0.2 0.1 1.2 0.0 3.6 0.0 0.0 0.3 0.2 0.5 0.5 4.8 0.0 3.3 0.8 0.4 1.8 0.0 0.1 0.0 23.9 13.7 0.0 0.0 0.1 0.0 0.3 0.2 5.9 1.2 0.4 1.7 0.2 0.1 0.1 4.5 1.1 5.8 0.0 0.0 0.0 0.3 0.0 0.4 0.3 2.3 0.8 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.0 5.3 11.4 8.2 4.2 4.5 6.7 5.0 7.9 4.3 SOHLH1 "bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2" ENSG00000165643 "Spermatogenesis and oogenesis specific basic helix-loop-helix 1" Q5JUK2 9 135693407-135699528 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "brain: 21.1;testis: 21.5" "Group enriched" "Detected in some" 46 "CACO-2: 14.4;U-266/84: 22.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebral cortex: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA059439 Approved "Nuclear speckles" "Nuclear speckles" "HPA059439: " "unprognostic (2.93e-1)" "unprognostic (1.23e-3)" "unprognostic (9.85e-3)" "unprognostic (2.84e-2)" "unprognostic (3.55e-1)" "unprognostic (2.59e-3)" "unprognostic (4.98e-3)" "unprognostic (2.17e-1)" "unprognostic (1.63e-1)" 0.2 0.1 4.4 0.2 3.2 0.1 0.2 1.7 21.1 0.2 0.2 0.2 0.2 0.1 0.2 0.6 0.2 0.1 0.2 0.2 9.4 1.4 0.2 0.2 0.2 0.2 2.0 0.2 0.3 0.2 0.3 1.3 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.7 0.2 0.2 0.4 0.2 0.2 21.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 3.2 1.7 21.1 9.4 1.4 2.0 0.2 0.2 0.2 SORCS2 KIAA1329 ENSG00000184985 "Sortilin related VPS10 domain containing receptor 2" Q96PQ0 4 7192538-7742836 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1" "Cell line enhanced" "Detected in some" "EFO-21: 6.5;HaCaT: 16.3;HMC-1: 12.3;RPMI-8226: 7.2;SiHa: 11.7;THP-1: 6.9;U-937: 7.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061916 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA061916: " "unprognostic (1.38e-1)" "unprognostic (6.32e-2)" "unprognostic (1.91e-2)" "unprognostic (4.37e-2)" "unprognostic (4.91e-3)" "unprognostic (1.82e-2)" "unprognostic (4.60e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-3)" "prognostic unfavourable (3.55e-4)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "prognostic unfavourable (3.09e-4)" "unprognostic (2.17e-3)" "unprognostic (5.37e-2)" "unprognostic (2.09e-1)" "unprognostic (7.27e-3)" 4.9 2.6 12.0 6.4 16.6 3.3 1.8 4.8 22.4 13.8 4.0 32.1 3.2 3.1 6.0 8.2 4.7 3.5 7.1 3.2 10.7 6.9 7.4 5.2 8.3 2.0 9.9 11.2 7.4 1.7 0.8 2.7 0.9 11.2 7.5 2.6 7.5 2.6 5.3 2.4 1.9 4.2 11.5 11.2 1.3 1.9 3.4 11.3 0.8 6.2 2.2 2.7 5.2 3.7 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.9 1.1 0.2 0.1 0.0 0.0 0.1 0.0 1.4 0.4 0.1 0.5 0.0 6.5 4.1 16.3 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.2 0.1 0.0 12.3 0.2 3.6 5.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.3 0.7 0.0 1.3 7.2 0.2 0.0 0.7 0.6 11.7 0.0 0.0 0.0 6.9 0.0 4.2 1.2 0.0 0.1 0.0 0.0 0.0 1.4 7.1 0.2 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 12.0 16.6 4.8 17.7 10.7 6.9 9.9 11.2 11.2 11.3 SORCS3 "KIAA1059, SORCS" ENSG00000156395 "Sortilin related VPS10 domain containing receptor 3" Q9UPU3 10 104641101-105265235 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 5.8;brain: 19.1" "Cell line enhanced" "Detected in some" "HaCaT: 1.7;RPTEC TERT1: 4.9;SH-SY5Y: 1.1" "Group enriched" "Detected in some" 13 "glioma: 1.8;renal cancer: 2.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "naive CD4 T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.39e-2)" "unprognostic (8.47e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-1)" "unprognostic (1.98e-1)" "unprognostic (3.63e-1)" "unprognostic (4.78e-1)" "unprognostic (1.84e-1)" "unprognostic (3.01e-1)" "prognostic unfavourable (5.72e-4)" "unprognostic (2.63e-2)" "unprognostic (1.97e-1)" 1.1 5.8 5.4 0.8 15.5 0.7 0.9 2.9 19.1 1.2 0.9 2.3 0.0 0.7 1.0 0.7 0.8 0.7 1.1 0.7 6.3 8.5 1.3 0.6 0.6 0.7 2.0 8.1 2.7 0.6 0.6 3.0 0.6 3.4 0.8 0.9 0.0 0.9 0.9 0.6 1.0 1.1 1.1 2.3 0.6 0.9 2.9 2.0 0.0 0.6 0.0 0.8 0.6 0.2 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.9 0.0 0.1 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.4 15.5 2.9 12.7 6.3 8.5 2.0 8.1 3.4 2.0 SORT1 "Gp95, NT3" ENSG00000134243 "Sortilin 1" Q99523 1 109309568-109397951 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Endocytosis, Osteogenesis, Transport" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.1;epididymis: 75.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 9.0;non-classical monocyte: 10.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006889, CAB011498" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Cytosol" "Plasma membrane" "CAB011498: AB_2192606, HPA006889: AB_1080056" "unprognostic (2.10e-2)" "unprognostic (7.46e-2)" "prognostic favourable (7.74e-6)" "unprognostic (4.12e-1)" "unprognostic (9.41e-2)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.23e-4)" "unprognostic (3.34e-3)" "unprognostic (4.27e-2)" "unprognostic (9.44e-2)" "unprognostic (2.42e-2)" "unprognostic (1.28e-2)" "unprognostic (1.23e-3)" "unprognostic (1.45e-2)" "unprognostic (2.15e-1)" "unprognostic (3.95e-1)" "unprognostic (4.46e-3)" 22.9 6.5 24.0 6.2 35.5 10.1 15.5 6.4 40.6 10.1 15.2 50.3 18.1 11.5 11.9 75.2 22.0 14.8 9.5 31.8 45.2 19.8 21.1 3.7 19.2 3.6 57.9 22.8 3.6 9.3 24.2 5.7 22.9 27.1 10.3 14.4 12.2 11.8 24.8 36.4 8.3 11.3 14.6 71.1 5.4 9.5 21.6 42.2 1.1 22.5 5.1 5.4 8.7 8.2 0.0 4.5 2.3 10.0 0.4 0.0 1.7 11.6 4.7 11.8 14.3 34.4 6.8 34.0 8.7 13.9 8.6 9.2 12.1 4.3 0.1 11.1 3.6 2.9 13.9 6.9 12.4 0.3 6.6 3.2 7.6 13.0 13.5 0.0 10.6 17.1 1.1 10.5 2.3 1.3 24.1 1.2 12.0 12.4 8.2 0.2 4.4 1.9 9.2 27.8 5.6 16.4 8.5 12.1 6.9 5.1 34.2 36.7 14.4 2.0 0.3 1.8 7.0 0.3 14.5 11.6 9.5 0.0 3.1 0.0 7.5 0.0 7.1 2.3 0.0 9.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.9 0.4 10.0 1.6 0.0 1.7 24.0 35.5 6.4 33.9 45.2 19.8 57.9 22.8 27.1 42.2 SOSTDC1 "DAND7, DKFZp564D206, USAG1" ENSG00000171243 "Sclerostin domain containing 1" Q6X4U4 7 16461481-16530580 "Predicted secreted proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.1;retina: 74.8;stomach 1: 32.3" "Cell line enhanced" "Detected in some" "AF22: 7.3;EFO-21: 10.9;HEL: 4.1;NTERA-2: 4.2;RPTEC TERT1: 20.3" "Cancer enhanced" "Detected in many" "renal cancer: 25.9" "Region enriched" "Detected in many" 9 "pons and medulla: 51.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 9.4;hippocampal formation: 20.4;pons and medulla: 15.8;thalamus: 12.8" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" "unprognostic (2.08e-2)" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.17e-3)" "unprognostic (5.59e-3)" "unprognostic (4.13e-2)" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (1.41e-2)" "prognostic favourable (8.69e-4)" "unprognostic (2.59e-1)" "unprognostic (2.62e-1)" "prognostic favourable (3.22e-5)" "unprognostic (7.01e-2)" "unprognostic (1.23e-1)" "unprognostic (3.50e-2)" "prognostic unfavourable (8.72e-4)" 0.4 0.4 2.0 1.4 1.9 0.0 9.5 0.5 5.8 2.6 5.9 7.0 0.2 6.1 2.5 2.4 2.7 2.7 0.4 3.7 3.5 1.6 12.8 0.2 22.0 0.1 0.7 5.3 0.6 1.1 0.0 2.9 0.0 51.1 1.1 8.4 74.8 12.5 6.4 0.3 13.7 4.8 0.5 1.0 0.2 32.3 1.9 0.0 0.0 4.7 3.1 4.9 1.0 3.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.9 0.0 0.2 0.4 0.0 0.0 0.1 2.2 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.0 1.9 0.5 5.8 3.5 1.6 0.7 5.3 51.1 0.0 SOWAHA ANKRD43 ENSG00000198944 "Sosondowah ankyrin repeat domain family member A" Q2M3V2 5 132813587-132816797 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 52.0;intestine: 35.0" "Group enriched" "Detected in some" 8 "SCLC-21H: 11.2;T-47d: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 59.1;basal ganglia: 89.2;cerebral cortex: 40.5;hippocampal formation: 66.1" "Low region specificity" "Detected in all" HPA064621 Approved "HPA064621: " "unprognostic (1.59e-1)" "unprognostic (5.58e-2)" "unprognostic (3.75e-3)" "unprognostic (5.34e-3)" "unprognostic (8.28e-2)" "unprognostic (3.05e-3)" "unprognostic (1.18e-1)" "unprognostic (5.99e-2)" "unprognostic (1.27e-1)" "unprognostic (2.65e-2)" "prognostic favourable (4.03e-4)" "unprognostic (3.92e-2)" "prognostic favourable (9.38e-5)" "unprognostic (4.36e-1)" "unprognostic (3.00e-1)" "unprognostic (2.53e-3)" "unprognostic (1.42e-1)" 0.7 1.2 27.5 1.0 52.0 0.4 0.9 5.1 16.3 0.7 7.9 3.4 2.2 33.4 0.5 6.5 0.5 1.8 2.0 0.4 20.1 3.1 5.1 2.1 0.5 0.5 6.0 11.1 0.6 2.3 2.4 0.8 0.6 2.8 2.9 6.7 0.7 3.4 3.3 0.4 0.5 35.0 0.5 3.7 0.4 5.2 0.6 11.0 0.1 1.6 0.0 0.5 1.1 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.3 1.2 0.0 0.6 0.0 0.0 2.1 0.3 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 11.2 0.4 0.1 0.0 0.0 26.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 52.0 5.1 16.3 20.1 3.1 6.0 11.1 2.8 11.0 SOX1 ENSG00000182968 "SRY-box 1" O00570 13 112067647-112070488 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.9;testis: 3.7" "Cell line enriched" "Detected in some" 5 "AF22: 31.1" "Group enriched" "Detected in some" 6 "colorectal cancer: 0.9;glioma: 2.3;melanoma: 2.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "unprognostic (1.12e-1)" "unprognostic (4.95e-2)" "unprognostic (1.71e-3)" "unprognostic (6.03e-2)" "unprognostic (6.41e-2)" "unprognostic (4.85e-1)" "unprognostic (5.93e-2)" 0.5 0.5 5.3 0.5 5.8 0.4 0.9 2.5 9.9 0.4 0.6 2.6 0.0 0.7 0.4 0.4 0.4 0.4 0.4 0.4 3.5 7.0 0.4 0.4 0.4 0.4 2.5 2.4 0.4 0.4 0.4 0.2 0.4 3.1 0.4 0.5 2.7 0.6 0.5 0.4 1.5 0.4 0.4 4.8 0.4 0.5 3.7 0.3 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.8 2.5 7.8 3.5 7.0 2.5 2.4 3.1 0.3 SOX10 "DOM, WS2E, WS4" ENSG00000100146 "SRY-box 10" P56693 22 37970686-37987422 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Deafness, Disease mutation, Hirschsprung disease, Kallmann syndrome, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 64.4;salivary gland: 98.4" "Group enriched" "Detected in some" 705 "SK-MEL-30: 61.4;WM-115: 88.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003171, HPA068898" Enhanced Supported Nucleoplasm Nucleoplasm "CAB003171: AB_2195374, HPA068898: " 3.3 4.0 21.0 3.7 33.1 1.6 18.7 3.2 32.8 3.2 8.1 64.4 0.5 2.9 1.8 2.8 2.8 1.9 3.4 3.9 26.9 15.2 1.7 1.7 1.6 1.6 41.3 13.7 2.4 2.2 1.7 0.7 1.6 24.7 2.3 3.9 22.8 98.4 7.1 1.8 15.8 3.8 3.2 46.6 1.8 2.4 3.1 42.5 0.0 1.7 0.0 1.6 2.5 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 88.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 33.1 3.2 24.6 26.9 15.2 41.3 13.7 24.7 42.5 SOX11 ENSG00000176887 "SRY-box 11" P35716 2 5692667-5701385 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 3.1;brain: 12.3;heart muscle: 5.3;intestine: 3.3;testis: 3.7" "Cell line enhanced" "Detected in some" "AF22: 25.9;NTERA-2: 12.7;REH: 9.2;RH-30: 9.9;SCLC-21H: 15.9;SH-SY5Y: 24.1" "Group enriched" "Detected in many" 6 "breast cancer: 2.0;glioma: 8.5;ovarian cancer: 1.8;testis cancer: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA000448, HPA000536, CAB056152, CAB056153" Approved Supported Nucleoplasm Nucleoplasm "CAB056152: , CAB056153: , HPA000448: , HPA000536: AB_1080060" "unprognostic (2.17e-2)" "unprognostic (2.02e-2)" "unprognostic (1.44e-2)" "unprognostic (7.35e-6)" "unprognostic (2.79e-1)" "unprognostic (1.19e-1)" "unprognostic (4.04e-8)" "unprognostic (2.79e-2)" "unprognostic (7.27e-2)" "unprognostic (3.17e-1)" "unprognostic (3.35e-3)" "unprognostic (2.42e-1)" "unprognostic (8.45e-8)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (5.50e-3)" "unprognostic (7.47e-2)" 0.5 0.5 4.2 0.5 7.1 0.6 0.6 0.3 12.3 0.4 3.3 5.8 0.0 0.6 0.7 0.6 0.5 0.5 0.6 5.3 4.4 5.1 0.5 0.5 0.6 0.5 3.3 5.0 0.5 0.4 0.5 0.7 0.5 4.5 0.5 0.8 0.0 0.9 0.4 1.0 0.6 0.7 1.3 6.3 1.0 0.6 3.7 3.6 0.0 0.6 0.0 0.6 0.5 0.1 1.1 0.8 3.1 1.5 1.6 1.1 0.5 0.0 0.0 25.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 12.7 0.0 9.2 9.9 0.3 0.0 0.0 15.9 24.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.8 0.3 0.6 0.0 0.0 6.0 3.1 0.5 1.0 0.5 0.8 1.1 1.1 0.6 0.7 0.6 0.7 0.9 0.9 1.6 1.6 1.5 0.8 0.9 0.5 4.2 7.1 0.3 6.4 4.4 5.1 3.3 5.0 4.5 3.6 SOX14 SOX28 ENSG00000168875 "SRY-box 14" O95416 3 137764284-137766338 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.4;placenta: 15.1;prostate: 3.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "prostate cancer: 2.8" "Group enriched" "Detected in many" 15 "hypothalamus: 5.4;midbrain: 1.6;pons and medulla: 4.4;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hypothalamus: 2.1;midbrain: 5.9" "Group enriched" "Detected in some" 7 "midbrain: 10.3;pons and medulla: 5.6;thalamus: 16.5" "unprognostic (1.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.88e-2)" "unprognostic (2.49e-3)" "unprognostic (5.08e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 15.1 4.4 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 5.4 1.6 0.0 4.4 3.3 SOX2 ENSG00000181449 "SRY-box 2" P48431 3 181711924-181714436 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 80.1" "Cell line enhanced" "Detected in some" "AF22: 67.5;HAP1: 28.7;NTERA-2: 55.0;U-251 MG: 12.6" "Cancer enhanced" "Detected in many" "glioma: 136.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045725, HPA062851, HPA071379, CAB079745" Enhanced Supported Enhanced Nucleoplasm Nucleoplasm "CAB079745: , HPA045725: , HPA062851: , HPA071379: " "unprognostic (1.80e-2)" "unprognostic (3.18e-3)" "unprognostic (5.69e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-3)" "unprognostic (1.60e-1)" "unprognostic (1.79e-2)" "unprognostic (4.48e-3)" "unprognostic (1.71e-1)" "unprognostic (4.38e-3)" "unprognostic (1.83e-1)" "unprognostic (7.68e-2)" "unprognostic (3.81e-9)" "unprognostic (1.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.12e-2)" 1.8 2.5 30.3 2.0 25.8 1.5 1.6 13.9 80.1 1.8 2.3 24.3 0.0 2.0 1.5 1.8 15.9 5.0 1.8 1.7 36.0 19.2 1.5 1.5 3.4 1.5 19.4 18.5 1.7 1.6 1.5 5.8 1.5 18.6 3.9 2.0 1.0 6.3 1.9 1.6 1.8 2.3 1.7 18.4 1.6 9.7 3.0 22.4 0.0 1.5 2.1 6.9 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 67.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 28.7 0.7 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 55.0 0.1 0.0 0.1 0.0 7.4 0.1 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 25.8 13.9 20.0 36.0 19.2 19.4 18.5 18.6 22.4 SOX21 SOX25 ENSG00000125285 "SRY-box 21" Q9Y651 13 94709622-94712399 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.2;skin 1: 18.3;stomach 1: 38.7" "Group enriched" "Detected in some" 4 "AF22: 41.6;NTERA-2: 11.2" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048337, HPA064084" Approved Approved Nucleoplasm Nucleoplasm "HPA048337: , HPA064084: " "unprognostic (3.33e-1)" "prognostic favourable (7.60e-4)" "unprognostic (7.96e-2)" "prognostic favourable (8.79e-5)" "unprognostic (1.54e-2)" "unprognostic (3.87e-1)" "unprognostic (9.02e-2)" "unprognostic (2.11e-1)" "unprognostic (1.50e-1)" "unprognostic (2.90e-2)" "unprognostic (1.93e-1)" "unprognostic (6.05e-2)" "unprognostic (1.11e-1)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" "unprognostic (1.35e-1)" 0.6 0.6 11.0 0.7 10.1 0.6 1.5 2.5 13.2 0.7 0.6 7.5 0.0 0.6 0.7 0.6 8.3 0.7 0.7 0.6 10.9 5.5 0.6 0.6 0.8 0.6 6.0 8.2 0.6 0.6 0.6 0.1 0.6 5.8 1.2 0.6 0.0 1.7 0.6 0.7 18.3 0.6 0.7 6.1 0.6 38.7 0.8 9.8 0.0 0.7 1.0 4.3 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 41.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 6.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.1 2.5 12.3 10.9 5.5 6.0 8.2 5.8 9.8 SOX8 ENSG00000005513 "SRY-box 8" P57073 16 981808-986979 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 64.9" "Cell line enriched" "Detected in some" 5 "RH-30: 50.5" "Cancer enriched" "Detected in many" 6 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.2;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 23 "T-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041640, HPA058665" Enhanced Nucleoplasm Nucleoplasm "HPA041640: AB_10964357, HPA058665: " "unprognostic (1.40e-2)" "unprognostic (2.56e-3)" "unprognostic (1.59e-1)" "unprognostic (3.10e-2)" "unprognostic (4.58e-2)" "unprognostic (7.16e-3)" "unprognostic (6.05e-3)" "unprognostic (3.01e-2)" "unprognostic (2.53e-1)" "unprognostic (1.16e-1)" "unprognostic (4.53e-3)" "unprognostic (4.46e-2)" "unprognostic (1.20e-3)" "unprognostic (8.50e-2)" "unprognostic (6.18e-2)" "unprognostic (5.47e-1)" "unprognostic (9.09e-2)" 1.6 1.5 18.4 1.8 25.1 1.0 2.5 3.2 64.9 1.2 1.4 20.9 0.0 1.1 1.1 1.1 1.2 1.1 1.5 1.8 22.6 14.5 1.0 1.0 1.0 2.7 26.5 5.4 1.0 1.5 1.0 0.1 1.4 12.0 1.3 1.5 0.9 8.6 1.4 1.3 1.3 1.2 1.2 27.1 1.8 1.7 1.9 30.4 0.0 1.1 0.0 3.1 1.1 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.2 1.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.1 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 50.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.2 18.4 25.1 3.2 11.8 22.6 14.5 26.5 5.4 12.0 30.4 SP7 "osterix, OSX" ENSG00000170374 "Sp7 transcription factor" Q8TDD2 12 53326575-53345315 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.0;lymphoid tissue: 3.3;testis: 4.2" "Cell line enhanced" "Detected in some" "AN3-CA: 1.7;HSkMC: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "olfactory region: 34.5" "Low region specificity" "Detected in all" HPA063202 Enhanced "HPA063202: " "unprognostic (6.02e-1)" "unprognostic (6.28e-3)" "unprognostic (6.37e-2)" "unprognostic (2.49e-2)" "unprognostic (7.75e-2)" "unprognostic (3.02e-1)" "unprognostic (1.49e-1)" "unprognostic (2.11e-1)" "unprognostic (1.04e-2)" "unprognostic (6.02e-1)" "unprognostic (3.93e-7)" "unprognostic (6.04e-2)" "unprognostic (1.65e-1)" "unprognostic (5.15e-2)" "unprognostic (1.95e-1)" 1.0 0.2 1.7 0.0 2.8 0.4 0.1 0.3 4.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.5 0.0 0.1 1.1 0.5 0.1 0.0 0.2 3.3 0.7 0.0 0.2 0.0 1.9 0.0 0.1 0.0 0.0 0.0 1.7 0.4 0.1 0.1 0.1 0.0 0.2 1.6 0.3 0.3 4.2 0.0 0.0 1.7 0.0 0.4 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 1.7 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.4 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.6 0.1 1.7 2.8 0.3 4.0 1.1 0.5 0.7 0.0 0.0 0.0 SP9 ZNF990 ENSG00000217236 "Sp9 transcription factor" P0CG40 2 174334946-174338492 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.4;fallopian tube: 5.1;skin 1: 4.5" "Cell line enhanced" "Detected in some" "A549: 8.8;fHDF/TERT166: 6.7;HEK 293: 2.7;THP-1: 14.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 6.0;olfactory region: 14.4" "Group enriched" "Detected in many" 5 "basal ganglia: 8.3;olfactory region: 44.8" HPA062616 Uncertain Approved Mitochondria Mitochondria "HPA062616: " "unprognostic (2.04e-2)" "unprognostic (6.94e-3)" "unprognostic (1.44e-1)" "unprognostic (3.95e-1)" "unprognostic (7.55e-3)" "unprognostic (8.54e-2)" "unprognostic (3.12e-1)" "unprognostic (1.01e-1)" 0.7 0.3 4.6 0.3 12.4 0.3 1.1 0.0 6.1 0.6 0.3 0.4 0.0 0.3 0.4 0.3 0.3 5.1 0.3 0.3 2.3 2.2 0.3 0.3 0.3 0.4 1.1 4.3 0.3 0.3 0.3 0.0 1.1 1.0 0.3 0.3 0.0 0.4 0.3 0.6 4.5 0.3 0.3 0.5 0.3 0.3 2.0 1.4 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 8.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 6.7 0.1 0.2 0.0 0.0 0.0 2.7 0.6 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 1.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 12.4 0.0 6.1 2.3 2.2 1.1 4.3 1.0 1.4 SPACA6 "LET7EH, LINC00085, NCRNA00085, SPACA6P" ENSG00000182310 "Sperm acrosome associated 6" W5XKT8 19 51689128-51712387 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.6;testis: 9.0" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 2.9;HEK 293: 6.3;U-87 MG: 4.4" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "memory CD4 T-cell: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.43e-1)" "unprognostic (6.12e-2)" "unprognostic (5.80e-2)" "prognostic unfavourable (2.73e-4)" "unprognostic (7.13e-2)" "unprognostic (1.45e-1)" "unprognostic (8.01e-3)" "unprognostic (1.96e-1)" "unprognostic (8.10e-3)" "unprognostic (1.06e-1)" "unprognostic (2.82e-3)" "unprognostic (9.29e-2)" "prognostic unfavourable (1.98e-10)" "unprognostic (6.64e-3)" "unprognostic (1.98e-1)" "unprognostic (6.05e-2)" "unprognostic (1.14e-2)" 1.3 0.7 2.3 0.2 2.8 0.2 0.2 6.6 1.8 0.6 0.5 2.0 0.0 0.2 4.0 0.9 0.8 0.7 0.6 0.2 2.5 0.7 0.2 1.4 0.5 2.3 0.8 1.3 1.7 0.2 2.9 3.2 3.1 1.6 0.4 0.0 0.5 1.3 1.6 0.2 0.6 1.4 1.2 0.7 0.5 9.0 1.2 0.0 0.3 0.3 0.2 0.4 1.3 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.9 0.7 0.6 0.0 0.0 0.0 0.3 0.7 0.0 0.6 2.9 0.0 1.0 0.0 0.4 0.0 2.1 0.2 0.6 0.0 0.0 6.3 0.7 2.2 0.0 0.8 0.0 0.7 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.1 0.0 0.0 1.1 0.6 1.3 0.8 1.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SPAG17 "CT143, FLJ34497, PF6, RP4-776P7.2" ENSG00000155761 "Sperm associated antigen 17" Q6Q759 1 117953861-118185223 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1;epididymis: 16.3;testis: 24.7" "Cell line enhanced" "Detected in some" "HL-60: 1.8;HMC-1: 1.6;RT4: 2.8;SCLC-21H: 3.3;U-2 OS: 1.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 24.1" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Region enhanced" "Detected in many" "midbrain: 12.2" "HPA028597, HPA028666" Enhanced "HPA028597: AB_10600221, HPA028666: AB_10602281" "unprognostic (3.67e-2)" "unprognostic (4.86e-3)" "unprognostic (3.42e-1)" "unprognostic (1.50e-2)" "unprognostic (1.56e-2)" "unprognostic (6.35e-3)" "unprognostic (2.36e-2)" "unprognostic (4.20e-2)" "unprognostic (3.19e-2)" "unprognostic (2.89e-2)" "unprognostic (1.40e-1)" "unprognostic (1.79e-1)" "unprognostic (2.76e-5)" "unprognostic (4.81e-1)" "unprognostic (9.90e-2)" "unprognostic (8.23e-2)" "unprognostic (9.67e-2)" 0.8 0.1 1.4 0.2 5.6 0.2 1.3 0.0 0.2 2.0 0.2 7.4 2.2 0.2 0.9 16.3 8.6 11.8 0.7 0.2 2.6 3.0 3.0 0.1 6.1 0.1 0.1 0.3 7.8 0.7 0.3 9.2 0.3 24.1 0.2 0.2 0.6 0.3 0.4 0.5 0.3 0.2 0.2 0.4 0.2 0.9 24.7 1.5 0.0 1.4 0.1 0.8 2.1 2.7 0.0 1.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.6 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 1.8 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.8 3.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.6 0.0 0.2 2.6 3.0 0.1 0.3 24.1 1.5 SPAG6 "CT141, pf16, Repro-SA-1" ENSG00000077327 "Sperm associated antigen 6" O75602 10 22345445-22454224 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 31.1;fallopian tube: 29.5;testis: 70.6" "Cell line enriched" "Detected in some" 28 "U-937: 47.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "pons and medulla: 31.1" "Cell type enhanced" "Detected in some" "eosinophil: 2.9" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 17.9" HPA038440 Enhanced "HPA038440: AB_10671742" "unprognostic (5.02e-2)" "unprognostic (9.52e-2)" "unprognostic (8.94e-6)" "unprognostic (2.21e-1)" "unprognostic (2.51e-2)" "unprognostic (4.91e-3)" "unprognostic (1.68e-1)" "unprognostic (2.38e-1)" "unprognostic (8.68e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.26e-1)" "unprognostic (2.71e-1)" "unprognostic (1.06e-3)" "unprognostic (3.10e-2)" "unprognostic (2.78e-4)" 0.3 0.3 2.8 0.3 5.2 0.5 1.4 0.0 2.0 1.1 0.3 8.6 0.0 0.3 0.4 8.7 0.3 29.5 0.3 0.3 5.0 5.1 0.5 0.4 5.3 0.3 0.7 0.6 3.1 0.5 0.3 12.4 0.3 31.1 0.8 0.3 0.5 0.3 0.3 0.3 0.3 0.3 0.3 1.1 0.3 0.3 70.6 1.6 0.0 0.3 0.0 0.3 0.3 0.1 0.0 1.2 2.9 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.1 0.0 47.7 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.5 0.0 2.8 5.2 0.0 2.0 5.0 5.1 0.7 0.6 31.1 1.6 SPAG8 "BS-84, CT142, HSD-1, hSMP-1, SPAG3" ENSG00000137098 "Sperm associated antigen 8" Q99932 9 35808045-35812272 "Predicted intracellular proteins" "Cell cycle, Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 32.7;epididymis: 9.7;fallopian tube: 30.0;testis: 23.6" "Cell line enhanced" "Detected in some" "ASC diff: 4.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 5 "basal ganglia: 8.6;pons and medulla: 32.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068012 Enhanced "HPA068012: " "unprognostic (1.01e-4)" "unprognostic (3.52e-3)" "unprognostic (6.36e-3)" "prognostic favourable (2.15e-4)" "unprognostic (2.62e-1)" "unprognostic (5.04e-2)" "unprognostic (1.65e-2)" "unprognostic (1.47e-2)" "unprognostic (1.59e-1)" "unprognostic (4.65e-2)" "unprognostic (1.37e-4)" "unprognostic (1.05e-1)" "unprognostic (1.22e-2)" "unprognostic (5.41e-2)" "unprognostic (1.33e-1)" "unprognostic (1.09e-1)" "unprognostic (3.22e-3)" 1.0 1.4 2.4 0.9 8.6 1.1 1.1 1.1 3.5 3.7 1.3 9.1 2.7 1.4 1.6 9.7 1.2 30.0 1.6 2.6 4.1 3.2 1.2 0.8 2.9 1.2 1.6 2.8 2.5 1.2 2.2 3.9 1.0 32.7 1.4 0.8 2.5 1.3 3.5 1.3 1.1 1.0 1.0 2.2 1.2 1.2 23.6 4.4 0.9 2.9 0.4 0.9 1.7 0.7 1.3 3.0 4.2 1.8 2.3 2.7 1.0 0.1 0.2 0.0 0.4 4.2 1.4 0.0 0.5 0.2 1.4 0.5 0.8 0.2 0.0 0.0 0.2 1.0 0.4 1.9 0.2 0.9 0.3 1.3 0.2 0.1 0.3 0.0 0.4 1.1 0.8 1.6 0.8 1.2 0.1 1.5 1.5 0.8 0.3 0.1 0.4 0.8 0.4 0.5 1.3 1.5 0.0 1.5 0.9 0.1 0.1 0.4 0.9 1.5 1.2 0.3 0.6 0.7 0.1 0.5 0.6 0.1 2.1 1.2 0.9 4.2 1.8 0.0 1.6 1.2 0.5 0.2 1.3 1.8 3.0 1.3 0.9 2.5 0.0 2.3 0.1 0.1 2.7 1.0 2.4 8.6 1.1 3.5 4.1 3.2 1.6 2.8 32.7 4.4 SPECC1 "CYTSB, FLJ36955, HCMOGT-1, NSP" ENSG00000128487 "Sperm antigen with calponin homology and coiled-coil domains 1" Q5M775 17 20009344-20319026 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9" "Cell line enhanced" "Detected in many" "SiHa: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021421, HPA021430, HPA061073" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Nucleoplasm, Vesicles" "Nucleoli fibrillar center, Cytosol" "HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: " "unprognostic (1.13e-3)" "unprognostic (2.39e-1)" "unprognostic (1.98e-2)" "unprognostic (8.10e-3)" "unprognostic (8.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "prognostic unfavourable (1.06e-5)" "unprognostic (9.29e-2)" "unprognostic (5.81e-2)" "unprognostic (6.23e-3)" "unprognostic (2.65e-1)" "unprognostic (3.15e-1)" "unprognostic (6.86e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" 10.7 8.3 21.3 7.2 38.0 29.9 8.1 16.0 30.8 7.0 14.9 49.9 0.7 9.5 15.4 6.1 11.4 7.3 20.0 4.1 23.1 15.4 4.3 2.0 5.6 5.7 35.8 21.2 17.0 8.3 3.0 6.8 4.8 29.3 7.3 15.5 3.0 5.9 4.9 4.3 4.8 11.4 11.5 28.2 17.3 9.8 25.8 41.5 0.2 6.7 1.4 6.0 7.0 4.2 2.9 14.7 18.9 9.4 8.5 3.4 3.0 17.2 18.0 9.8 3.2 7.4 3.8 21.1 7.0 5.8 7.1 8.8 29.3 15.4 1.0 22.9 6.0 12.9 7.4 16.7 3.5 5.2 7.9 7.1 19.7 3.2 2.7 0.7 4.2 4.0 17.0 10.0 11.3 0.1 0.8 8.7 5.5 14.7 0.2 3.9 7.8 4.3 4.2 19.7 9.9 17.3 8.7 3.2 3.2 36.8 17.7 7.8 15.6 4.6 0.5 0.9 10.8 1.0 19.0 3.4 4.3 1.4 10.4 5.9 4.1 18.9 9.4 17.8 3.1 5.3 2.9 2.4 1.9 3.4 14.7 2.9 1.8 2.4 8.1 8.5 4.6 4.4 0.9 3.0 21.3 38.0 16.0 30.8 23.1 15.4 35.8 21.2 29.3 41.5 SPEF1 "C20orf28, CLAMP, DKFZP434I114, SPEF1A" ENSG00000101222 "Sperm flagellar 1" Q9Y4P9 20 3777504-3781448 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.7;fallopian tube: 19.6;testis: 12.5" "Cell line enhanced" "Detected in some" "A549: 5.8;hTEC/SVTERT24-B: 3.0;MCF7: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050786 Enhanced "HPA050786: " "unprognostic (2.41e-2)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (4.91e-3)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (9.08e-3)" "unprognostic (8.12e-3)" "unprognostic (5.95e-2)" "unprognostic (8.41e-2)" "unprognostic (8.88e-3)" "unprognostic (1.69e-1)" "unprognostic (3.81e-3)" "unprognostic (1.83e-1)" "unprognostic (6.60e-2)" "prognostic unfavourable (9.87e-4)" "unprognostic (7.49e-2)" 0.4 0.7 4.0 0.4 16.7 0.5 0.6 0.0 3.9 1.0 0.4 3.2 0.0 0.4 0.7 6.0 0.4 19.6 0.5 0.4 6.9 3.0 1.8 0.4 4.3 0.4 1.7 1.7 1.8 0.8 1.0 1.4 0.4 11.5 0.4 0.4 1.3 0.5 0.6 0.4 0.4 0.4 0.4 0.4 0.4 0.5 12.5 1.7 0.0 2.6 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.2 2.4 5.8 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 1.5 0.5 0.5 0.2 0.6 0.2 0.5 0.2 0.7 0.3 0.0 0.0 1.1 0.0 0.1 0.0 0.3 0.7 3.0 0.0 0.0 0.1 0.1 0.0 4.3 1.2 0.6 0.5 0.5 0.0 0.4 0.4 1.6 0.0 1.1 0.9 0.2 1.2 1.6 1.5 0.0 0.0 0.9 0.4 1.3 0.3 0.4 0.1 0.4 2.1 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.5 0.0 0.0 0.0 0.0 0.5 0.2 4.0 16.7 0.0 3.9 6.9 3.0 1.7 1.7 11.5 1.7 SPHAR ENSG00000213029 "S-phase response (cyclin related)" Q15513 1 229304857-229305504 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 31 "brain: 3.1" "Cell line enriched" "Detected in single" 20 "Daudi: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPHKAP SKIP ENSG00000153820 "SPHK1 interactor, AKAP domain containing" Q2M3C7 2 227979950-228181645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "brain: 64.0;heart muscle: 33.2" "Cell line enriched" "Detected in some" 17 "BJ hTERT+: 31.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "cerebellum: 64.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042499, HPA048168" Enhanced "HPA042499: , HPA048168: " "unprognostic (4.91e-3)" "unprognostic (6.46e-2)" "unprognostic (1.33e-1)" "unprognostic (2.59e-2)" "unprognostic (2.95e-2)" "unprognostic (2.09e-1)" "unprognostic (1.01e-3)" 0.5 0.6 10.7 0.5 5.1 0.4 1.4 64.0 14.8 0.5 0.5 2.1 0.0 0.5 0.5 0.4 0.5 0.5 0.5 33.2 15.1 3.7 0.5 0.4 0.6 0.5 1.6 4.5 3.2 0.5 0.4 0.1 0.5 3.8 0.5 0.5 0.5 2.7 0.5 0.4 0.5 0.5 0.5 1.1 1.0 0.5 0.7 0.9 0.0 0.5 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 31.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 5.1 64.0 8.5 15.1 3.7 1.6 4.5 3.8 0.9 SPINK6 "BUSI2, MGC21394, UNQ844" ENSG00000178172 "Serine peptidase inhibitor, Kazal type 6" Q6UWN8 5 148202794-148215137 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;cervix, uterine: 7.2;tongue: 7.1;vagina: 8.6" "Group enriched" "Detected in some" 84 "HeLa: 239.2;SiHa: 114.9" "Group enriched" "Detected in many" 6 "cervical cancer: 21.4;head and neck cancer: 21.0" "Region enriched" "Detected in single" 78 "cerebellum: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011039 Uncertain "Secreted - unknown location" "HPA011039: " "unprognostic (2.92e-2)" "unprognostic (2.97e-2)" "unprognostic (2.65e-1)" "unprognostic (4.87e-2)" "prognostic favourable (7.16e-4)" "unprognostic (2.49e-2)" "unprognostic (4.04e-1)" "unprognostic (1.80e-2)" "unprognostic (2.09e-2)" "unprognostic (2.22e-2)" "unprognostic (1.29e-2)" "unprognostic (7.29e-2)" 1.9 1.1 0.1 0.1 0.1 0.0 0.9 10.6 0.1 7.2 1.6 0.1 0.1 0.0 0.1 3.7 5.9 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.6 0.1 0.1 0.8 0.1 5.0 0.2 0.1 0.5 0.1 0.9 0.1 0.1 0.0 0.2 0.1 1.6 0.1 7.1 0.1 0.4 8.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 239.2 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 10.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SPOCK1 "SPOCK, testican-1, TIC1" ENSG00000152377 "SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1" Q08629 5 136975298-137598379 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 92.2" "Cell line enhanced" "Detected in many" "AF22: 45.5;ASC diff: 90.4;HUVEC TERT2: 90.4;U-138 MG: 46.0" "Cancer enriched" "Detected in all" 7 "prostate cancer: 83.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 2.5;myeloid DC: 1.6" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;monocytes: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007450, HPA026770" Uncertain Approved Vesicles "Secreted to blood" Vesicles "HPA007450: AB_10603116, HPA026770: " "unprognostic (1.05e-1)" "unprognostic (9.25e-2)" "prognostic unfavourable (1.93e-4)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "prognostic unfavourable (1.93e-5)" "unprognostic (5.83e-3)" "prognostic unfavourable (9.08e-4)" "unprognostic (1.00e-2)" "prognostic unfavourable (4.72e-4)" "unprognostic (9.09e-3)" "unprognostic (1.60e-1)" "prognostic unfavourable (3.77e-5)" "prognostic unfavourable (9.40e-4)" "unprognostic (1.26e-1)" "unprognostic (2.21e-1)" "unprognostic (1.90e-2)" 11.3 31.0 20.6 4.0 30.4 1.5 9.3 68.2 92.2 20.5 7.4 36.0 5.1 2.1 20.5 26.1 5.6 6.8 14.3 38.6 29.9 16.6 18.0 1.4 1.9 1.7 35.5 29.0 3.2 3.7 1.4 3.7 7.6 19.6 48.9 3.6 5.2 2.9 20.7 5.6 3.2 2.6 23.2 21.7 6.8 3.7 15.9 36.0 0.1 3.3 0.0 1.6 8.1 11.5 0.0 1.6 0.4 2.5 0.0 0.0 0.6 0.6 0.1 45.5 0.0 90.4 18.5 0.0 14.8 13.7 32.2 18.1 0.0 0.0 0.0 0.0 30.9 0.6 0.2 10.6 10.1 2.5 0.0 0.0 2.7 0.0 0.6 0.0 0.0 32.2 4.3 19.8 3.5 90.4 0.0 0.0 9.1 0.0 0.0 0.0 2.9 4.2 0.0 0.0 0.0 21.4 1.4 0.5 2.1 7.3 0.1 0.0 0.0 0.1 14.5 46.0 1.6 15.6 4.2 0.0 0.0 0.0 24.9 0.6 20.8 0.0 2.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 20.6 30.4 68.2 28.5 29.9 16.6 35.5 29.0 19.6 36.0 SPOCK2 "KIAA0275, testican-2" ENSG00000107742 "SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2" Q92563 10 72059035-72089032 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.1;brain: 70.7;lung: 52.1" "Group enriched" "Detected in some" 7 "Hep G2: 24.8;SCLC-21H: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 27.5;MAIT T-cell: 47.1;memory CD4 T-cell: 27.7;memory CD8 T-cell: 21.9;naive CD4 T-cell: 21.5;naive CD8 T-cell: 21.2;T-reg: 37.5" "Lineage enriched" "Detected in many" 8 "T-cells: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044605 Enhanced "Secreted to blood" 42000 "HPA044605: AB_10965991" "prognostic favourable (4.05e-4)" "unprognostic (3.11e-3)" "unprognostic (2.92e-2)" "unprognostic (2.29e-1)" "unprognostic (2.77e-2)" "prognostic favourable (1.95e-5)" "unprognostic (4.18e-2)" "unprognostic (9.04e-2)" "prognostic favourable (4.72e-4)" "prognostic unfavourable (7.19e-4)" "unprognostic (4.53e-3)" "unprognostic (2.29e-1)" "unprognostic (1.46e-3)" "unprognostic (5.59e-2)" "unprognostic (5.49e-2)" "unprognostic (3.19e-3)" "unprognostic (2.24e-2)" 4.2 29.8 31.9 24.9 47.8 27.9 2.0 70.7 63.2 2.5 4.2 9.8 0.0 6.2 2.5 2.7 2.8 4.7 9.9 4.7 27.5 49.5 18.8 2.5 52.1 36.4 36.0 32.1 3.7 1.5 1.7 12.8 2.9 47.9 3.0 4.1 5.4 2.8 4.5 3.6 1.9 9.3 3.4 22.3 16.9 8.3 13.6 9.2 43.4 3.3 0.6 27.0 8.0 1.4 5.6 0.7 2.9 0.2 2.8 47.1 10.3 0.1 0.2 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.3 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.1 0.6 24.8 0.8 0.2 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 35.3 2.1 0.0 0.7 0.2 0.0 0.9 0.1 0.0 0.1 0.1 0.0 0.4 0.8 3.7 0.1 0.0 0.1 0.0 0.1 0.0 27.5 0.2 47.1 5.6 27.7 21.9 0.0 4.5 21.5 21.2 2.9 2.8 0.0 0.7 37.5 10.3 31.9 47.8 70.7 42.0 27.5 49.5 36.0 32.1 47.9 9.2 SPOCK3 testican-3 ENSG00000196104 "SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3" Q9BQ16 4 166733384-167234796 "Predicted intracellular proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 46.8;parathyroid gland: 184.6" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.5;PC-3: 4.3;RH-30: 11.4;SCLC-21H: 4.9" "Cancer enhanced" "Detected in many" "prostate cancer: 7.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 3.3;intermediate monocyte: 1.8;myeloid DC: 4.5;plasmacytoid DC: 1.4" "Group enriched" "Detected in many" 12 "dendritic cells: 4.5;monocytes: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" "unprognostic (3.54e-2)" "unprognostic (8.69e-2)" "unprognostic (2.90e-3)" "unprognostic (1.20e-1)" "unprognostic (4.09e-4)" "unprognostic (3.75e-1)" "unprognostic (1.97e-2)" "unprognostic (1.44e-1)" "unprognostic (1.88e-1)" "unprognostic (3.94e-4)" "unprognostic (8.92e-2)" "unprognostic (4.18e-3)" "unprognostic (2.62e-2)" "unprognostic (2.48e-1)" "unprognostic (3.60e-3)" "unprognostic (1.64e-1)" 1.2 10.0 21.7 1.3 30.4 1.1 1.1 5.8 23.2 1.4 1.4 32.2 2.2 1.4 2.2 8.0 1.2 1.5 1.2 1.2 31.3 21.4 1.2 1.2 1.2 1.2 45.4 15.9 7.8 1.3 184.6 0.3 1.1 27.4 28.1 1.3 0.0 1.2 14.1 1.2 1.1 1.6 2.1 46.8 1.2 1.4 1.3 42.9 0.0 1.1 0.9 1.2 1.9 0.3 0.0 4.5 0.0 3.3 0.3 0.0 1.1 0.0 2.6 0.3 0.0 0.0 0.0 0.4 0.0 3.5 0.1 0.6 0.4 0.0 0.1 0.0 0.0 0.1 1.6 0.1 0.7 0.2 0.4 0.0 1.8 0.3 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.5 4.3 0.0 11.4 0.6 0.0 1.7 4.9 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.0 3.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.0 1.1 21.7 30.4 5.8 22.8 31.3 21.4 45.4 15.9 27.4 42.9 SPRED3 ENSG00000188766 "Sprouty related EVH1 domain containing 3" Q2MJR0 19 38388421-38399587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.7" "Cell line enhanced" "Detected in many" "TIME: 15.0;U-87 MG: 9.6" "Cancer enhanced" "Detected in many" "glioma: 3.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071521 Uncertain "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA071521: " "unprognostic (1.09e-1)" "unprognostic (1.88e-3)" "unprognostic (8.71e-3)" "unprognostic (3.35e-3)" "unprognostic (3.70e-2)" "unprognostic (2.00e-3)" "unprognostic (2.09e-3)" "unprognostic (7.77e-3)" "unprognostic (1.49e-1)" "unprognostic (9.22e-3)" "unprognostic (1.69e-2)" "unprognostic (3.09e-2)" "unprognostic (1.40e-11)" "unprognostic (6.21e-4)" "unprognostic (3.67e-1)" "unprognostic (1.04e-3)" "unprognostic (8.45e-3)" 2.0 1.2 4.3 2.7 10.1 0.9 1.2 2.8 10.7 0.9 0.6 1.7 0.0 4.7 1.2 1.2 0.9 0.7 2.0 1.1 5.0 4.7 1.2 0.4 0.9 0.5 2.8 4.6 0.5 2.9 4.5 5.8 0.8 4.7 1.2 0.8 0.9 0.8 1.1 0.9 2.3 3.7 2.3 1.7 0.5 1.3 1.7 0.9 0.0 1.8 0.0 0.6 0.9 0.8 0.8 0.7 2.2 0.6 0.9 0.5 0.3 0.2 1.1 3.9 3.2 0.6 1.9 2.2 7.7 5.1 2.6 2.4 0.4 0.8 0.2 2.8 2.6 0.1 0.6 0.9 2.3 0.7 1.4 0.0 0.2 0.4 1.4 2.1 0.1 1.3 0.9 6.0 1.8 8.0 0.6 1.4 7.8 0.4 0.0 0.1 1.8 3.9 0.9 1.4 0.1 5.6 0.6 0.2 3.0 0.1 0.2 0.3 0.6 0.1 15.0 2.8 8.8 2.3 4.2 0.6 0.2 0.5 9.6 0.3 4.8 1.6 0.6 0.4 0.4 0.2 0.3 0.3 0.5 0.3 0.1 0.8 0.4 0.3 2.2 0.9 0.5 0.7 0.2 0.3 4.3 10.1 2.8 9.8 5.0 4.7 2.8 4.6 4.7 0.9 SPRN "bA108K14.1, FLJ41197, Shadoo, Sprn" ENSG00000203772 "Shadow of prion protein" Q5BIV9 10 133420666-133424572 "Predicted intracellular proteins, Transporters" Prion "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 20.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 4.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Intracellular and membrane" "unprognostic (2.66e-1)" "unprognostic (1.64e-3)" "unprognostic (3.38e-3)" "unprognostic (1.95e-1)" "unprognostic (1.35e-1)" "unprognostic (3.31e-2)" "unprognostic (1.07e-1)" "unprognostic (3.90e-3)" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "prognostic favourable (1.54e-6)" "unprognostic (1.88e-2)" "prognostic unfavourable (3.95e-4)" "unprognostic (1.76e-2)" "unprognostic (1.13e-1)" "unprognostic (7.17e-2)" "prognostic favourable (1.58e-7)" 0.5 2.5 4.3 1.5 3.8 0.8 0.1 7.4 20.7 0.4 0.5 3.3 1.1 0.0 1.0 0.2 1.3 0.8 6.1 2.7 1.1 6.9 0.6 1.6 1.7 1.0 1.7 0.0 1.7 0.8 1.2 0.0 2.0 0.1 2.3 2.0 2.2 0.4 0.9 1.7 2.2 1.9 0.9 0.0 0.9 0.1 1.1 1.0 0.4 4.5 0.2 1.2 0.6 2.6 5.1 3.8 7.6 0.0 0.0 6.2 4.2 0.0 1.0 0.1 6.2 1.9 3.8 1.4 2.1 3.3 0.6 0.0 0.0 2.5 7.2 3.6 5.9 6.9 0.3 3.8 3.2 0.5 0.0 0.0 0.0 0.0 3.9 2.7 0.5 2.7 2.2 7.2 3.7 2.0 5.3 2.5 0.7 0.0 3.1 2.3 3.4 1.4 3.7 4.6 2.3 2.8 2.7 2.2 2.9 1.6 3.1 3.2 1.6 2.9 1.6 2.6 1.2 0.4 0.3 0.0 0.4 0.9 0.8 0.3 0.9 1.2 0.2 1.1 1.0 0.4 0.0 0.2 4.5 1.0 0.6 0.6 SPRY3 HSPRY3 ENSG00000168939 "Sprouty RTK signaling antagonist 3" O43610 X 155767812-155782459 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Cell line enhanced" "Detected in many" "AN3-CA: 8.4;EFO-21: 4.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB013505 Uncertain Approved Nucleoli,Cytosol Cytosol Nucleoli "CAB013505: " "unprognostic (3.70e-2)" "unprognostic (4.39e-1)" "unprognostic (5.24e-2)" "unprognostic (3.37e-2)" "unprognostic (3.65e-1)" "unprognostic (1.20e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "unprognostic (3.68e-3)" "unprognostic (1.52e-4)" "unprognostic (1.21e-2)" "unprognostic (9.60e-2)" "unprognostic (5.26e-2)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (5.44e-2)" "unprognostic (3.49e-2)" 1.6 2.1 1.3 0.4 1.8 2.8 1.2 7.5 1.5 1.3 0.8 1.2 1.5 5.8 0.8 1.1 0.8 0.9 1.3 1.5 0.9 0.7 0.9 0.3 1.1 2.8 0.4 1.3 1.1 1.9 0.9 1.4 1.1 1.2 1.2 0.4 1.1 1.2 1.2 1.4 0.7 0.1 1.0 0.5 0.8 0.7 0.0 0.5 0.4 0.5 0.2 0.2 0.0 0.5 0.2 2.3 8.4 1.7 0.8 0.0 2.0 1.3 0.6 1.0 0.2 1.4 0.0 4.1 1.1 0.3 0.9 0.6 0.6 0.2 0.4 1.0 2.1 0.1 0.7 0.4 0.4 2.0 1.1 0.8 0.5 1.3 0.1 0.6 1.6 0.3 0.2 0.3 0.8 0.0 0.5 0.2 2.0 0.9 0.7 0.6 0.6 1.0 0.0 0.5 0.5 0.6 2.1 0.6 0.9 0.3 0.6 0.6 0.1 1.8 2.0 1.0 1.1 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.5 0.0 0.0 SPTB ENSG00000070182 "Spectrin beta, erythrocytic" P11277 14 64746283-64879907 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease mutation, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.2;brain: 25.2;skeletal muscle: 67.6" "Group enriched" "Detected in some" 5 "HEL: 23.0;K-562: 27.5;U-937: 8.3" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 5 "basal ganglia: 11.6;cerebellum: 25.2;cerebral cortex: 10.4;pons and medulla: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003394, HPA003398, CAB015169, CAB016232" Enhanced Approved Cytosol 43000000 Cytosol "CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074" "unprognostic (2.69e-1)" "unprognostic (4.72e-1)" "unprognostic (3.04e-2)" "unprognostic (2.19e-3)" "unprognostic (1.71e-1)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.30e-3)" "unprognostic (2.66e-1)" "unprognostic (2.28e-2)" "unprognostic (1.55e-3)" "unprognostic (2.11e-1)" "unprognostic (2.65e-1)" "unprognostic (1.39e-2)" "unprognostic (2.97e-1)" "unprognostic (3.44e-2)" "unprognostic (2.18e-2)" 1.9 1.6 3.2 0.7 11.6 32.2 0.7 25.2 10.4 0.8 0.7 0.8 0.3 0.6 0.7 5.2 1.8 0.8 0.8 14.7 3.1 3.2 1.2 0.6 0.9 0.6 2.8 3.5 0.7 2.2 6.5 4.7 4.7 16.4 1.5 0.7 1.1 1.9 1.3 67.6 0.7 0.7 1.0 1.7 1.1 0.7 1.0 1.4 0.0 0.7 17.4 0.6 0.8 0.5 0.0 0.6 0.9 0.0 0.0 0.2 1.5 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 1.4 3.8 0.1 0.0 0.2 2.2 23.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 27.5 0.0 0.0 0.2 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.0 0.1 3.7 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.2 4.2 0.0 0.4 0.9 4.3 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 1.5 3.2 11.6 25.2 10.4 3.1 3.2 2.8 3.5 16.4 1.4 SPTBN2 SCA5 ENSG00000173898 "Spectrin beta, non-erythrocytic 2" O15020 11 66685248-66729226 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.7;skin 1: 36.9" "Cell line enhanced" "Detected in many" "HeLa: 19.9;NTERA-2: 23.1;SCLC-21H: 23.5;T-47d: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009844, HPA039293, HPA043529" Enhanced Supported "Cell Junctions,Cytosol" 4800000 "Cell Junctions, Cytosol" "CAB009844: AB_2194521, HPA039293: , HPA043529: " "unprognostic (9.34e-2)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (3.41e-3)" "unprognostic (4.91e-1)" "unprognostic (6.05e-3)" "unprognostic (4.45e-2)" "unprognostic (1.38e-2)" "unprognostic (7.25e-2)" "unprognostic (1.67e-2)" "prognostic unfavourable (3.14e-5)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" "unprognostic (3.99e-2)" "unprognostic (1.00e-3)" 0.8 4.9 26.2 1.0 38.3 1.7 4.5 29.6 46.7 9.6 0.9 2.0 0.0 1.0 1.1 1.2 12.7 2.6 1.2 0.7 19.7 8.2 12.7 7.1 0.9 0.5 6.5 24.7 0.8 8.3 12.2 3.9 0.7 14.4 6.8 0.7 1.7 13.4 3.1 0.7 36.9 0.9 1.2 1.9 0.9 1.2 18.9 6.2 0.0 0.5 0.1 3.3 1.1 3.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 6.4 3.3 1.5 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 2.1 8.0 0.0 1.7 0.0 7.7 11.7 1.1 0.0 0.0 4.6 0.0 19.9 1.1 0.3 3.3 0.3 0.1 5.4 0.0 3.5 2.9 3.2 0.0 0.0 12.5 2.6 1.5 23.1 10.3 10.7 1.3 6.6 4.4 1.1 23.5 13.8 6.5 16.4 1.5 18.7 0.9 0.6 0.0 4.1 0.6 5.1 0.3 1.2 6.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 26.2 38.3 29.6 46.7 19.7 8.2 6.5 24.7 14.4 6.2 SPTBN4 "KIAA1642, SPTBN3" ENSG00000160460 "Spectrin beta, non-erythrocytic 4" Q9H254 19 40466241-40576464 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 36.3" "Cell line enhanced" "Detected in some" "K-562: 3.5;Karpas-707: 5.0;SCLC-21H: 7.9;SH-SY5Y: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054481 Enhanced Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA054481: " "unprognostic (1.97e-3)" "unprognostic (1.02e-1)" "unprognostic (5.65e-4)" "unprognostic (3.72e-4)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (2.62e-1)" "unprognostic (2.50e-2)" "unprognostic (3.19e-2)" "unprognostic (1.65e-1)" "unprognostic (1.78e-4)" "unprognostic (4.54e-1)" "unprognostic (2.55e-2)" "unprognostic (6.79e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.02e-1)" 3.1 5.9 13.4 1.2 15.3 1.2 1.2 36.3 27.1 1.4 1.3 1.8 0.0 1.7 2.3 1.3 1.6 2.0 1.8 3.3 9.8 10.8 1.9 1.3 1.2 1.0 7.5 13.0 4.1 3.0 3.3 8.0 1.0 10.4 2.8 1.1 2.6 2.2 2.0 5.1 1.3 1.5 1.8 2.8 1.3 2.5 3.5 3.7 0.0 1.6 0.0 1.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.5 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.4 2.3 1.9 0.4 0.0 0.0 0.0 0.0 0.4 2.3 0.5 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.0 0.0 0.0 3.5 5.0 0.0 1.3 0.0 0.0 0.2 0.8 0.5 0.0 1.1 0.0 0.0 7.9 4.8 0.1 0.2 0.0 0.7 0.0 0.0 0.0 1.4 0.8 0.0 0.2 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 15.3 36.3 22.7 9.8 10.8 7.5 13.0 10.4 3.7 SPTBN5 "BSPECV, HUBSPECV, HUSPECV" ENSG00000137877 "Spectrin beta, non-erythrocytic 5" Q9NRC6 15 41848144-41894077 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.0" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 4.5;SCLC-21H: 6.2;TIME: 16.1;WM-115: 5.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "cerebellum: 10.0;midbrain: 6.8;pons and medulla: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055283 Approved "HPA055283: " "unprognostic (5.46e-2)" "unprognostic (2.49e-1)" "unprognostic (3.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-2)" "unprognostic (5.84e-3)" "unprognostic (1.12e-1)" "unprognostic (6.84e-3)" "unprognostic (6.40e-3)" "unprognostic (2.25e-1)" "unprognostic (2.96e-2)" "unprognostic (6.92e-2)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.28e-1)" "unprognostic (1.37e-2)" "unprognostic (1.11e-2)" 1.4 0.3 0.7 1.4 0.7 0.7 1.2 10.0 0.8 0.7 0.7 0.7 0.7 0.6 0.7 1.8 2.0 0.2 1.9 4.6 0.7 0.3 1.2 1.9 1.2 1.2 6.8 0.7 1.2 2.6 1.8 2.3 0.7 3.7 1.8 0.2 7.4 6.8 0.7 1.4 1.8 0.7 0.7 1.0 0.7 1.2 1.9 0.7 0.7 2.6 0.7 0.7 4.4 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.7 0.0 1.0 0.0 0.5 0.0 0.3 0.0 0.9 0.1 0.0 1.6 0.0 0.0 0.0 1.7 0.0 0.1 0.1 0.1 4.5 0.0 0.1 0.3 0.0 0.0 0.1 0.5 0.5 0.0 0.3 0.0 0.4 1.7 6.2 0.1 0.2 0.5 0.1 1.0 0.0 16.1 0.0 1.7 0.4 2.0 1.8 2.6 0.0 0.0 0.1 5.1 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.7 10.0 0.8 0.7 0.3 6.8 0.7 3.7 0.7 SPX "C12orf39, MGC10946, NPQ, spexin" ENSG00000134548 "Spexin hormone" Q9BT56 12 21526307-21537377 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 34.3;brain: 14.4;breast: 23.1" "Cell line enhanced" "Detected in some" "CACO-2: 14.7;HBEC3-KT: 7.5;hTERT-HME1: 10.2;U-2 OS: 4.8" "Cancer enhanced" "Detected in many" "renal cancer: 13.5" "Region enriched" "Detected in some" 9 "pons and medulla: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 65.0;hippocampal formation: 70.8;olfactory region: 47.5;pons and medulla: 40.3" "Secreted to blood" 2650000 "unprognostic (2.78e-2)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (1.81e-2)" "unprognostic (2.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.86e-1)" "unprognostic (1.04e-1)" "unprognostic (2.11e-2)" "unprognostic (5.89e-2)" "unprognostic (1.21e-2)" "unprognostic (1.95e-1)" "prognostic favourable (1.31e-6)" "unprognostic (2.37e-3)" "unprognostic (9.78e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-2)" 34.3 0.0 0.2 0.0 0.3 0.0 23.1 0.1 1.4 0.0 2.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 1.5 0.4 0.7 7.1 0.7 0.2 0.5 1.5 0.0 0.0 7.8 0.0 0.0 12.7 14.4 0.0 0.0 0.0 6.4 0.0 1.3 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.2 1.3 2.7 0.4 0.0 0.1 0.0 0.1 0.6 0.5 0.0 0.0 0.2 1.5 0.0 0.5 0.3 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.8 14.7 0.0 0.6 0.2 0.0 0.0 0.0 7.5 0.8 0.0 0.0 2.8 0.0 0.0 0.7 0.0 0.0 3.1 0.4 0.1 10.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.7 0.0 0.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.8 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.6 0.0 1.5 0.2 0.3 0.1 0.3 0.4 0.7 1.5 0.0 14.4 0.2 SRARP "C1orf64, ERRF, MGC24047" ENSG00000183888 "Steroid receptor associated and regulated protein" Q8NEQ6 1 16004236-16008807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0;breast: 14.7" "Group enriched" "Detected in some" 12 "Hep G2: 9.0;SK-BR-3: 16.1;T-47d: 5.1" "Cancer enhanced" "Detected in some" "breast cancer: 7.7;prostate cancer: 6.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.3" "Low region specificity" "Detected in all" HPA026676 Uncertain Approved Nucleoplasm Nucleoplasm "HPA026676: AB_1853866" "unprognostic (8.55e-2)" "unprognostic (1.01e-1)" "prognostic favourable (1.68e-6)" "unprognostic (3.32e-2)" "unprognostic (1.09e-2)" "unprognostic (1.45e-2)" "unprognostic (1.41e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.40e-2)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (1.65e-3)" "unprognostic (6.32e-2)" 0.9 1.1 12.8 1.2 19.9 2.2 14.7 7.5 19.3 6.6 0.8 3.5 0.0 1.3 3.8 1.2 1.1 0.8 1.1 1.5 14.1 6.4 2.7 0.9 0.9 1.3 12.8 7.2 1.1 1.1 0.6 0.3 1.0 22.0 2.5 0.8 0.0 8.6 0.8 2.2 2.2 0.9 0.6 7.8 1.1 1.4 1.1 16.6 0.0 3.8 0.0 0.7 1.2 0.3 0.8 0.5 5.3 0.4 1.0 0.6 0.1 0.3 0.1 0.4 0.5 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.5 0.7 9.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.7 0.7 0.0 0.5 0.3 0.4 0.1 0.2 0.2 0.3 0.2 0.0 0.1 0.5 0.8 0.3 16.1 0.3 5.1 0.4 0.2 0.6 0.4 0.4 0.1 0.3 0.6 0.3 0.2 0.3 0.7 2.0 0.4 0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.1 0.8 0.6 0.6 5.3 1.0 0.3 0.5 0.2 0.1 12.8 19.9 7.5 19.3 14.1 6.4 12.8 7.2 22.0 16.6 SRCIN1 "KIAA1684, p140Cap, SNIP" ENSG00000277363 "SRC kinase signaling inhibitor 1" Q9C0H9 17 38530016-38605930 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 21.2;salivary gland: 11.7;skin 1: 6.1" "Cell line enhanced" "Detected in some" "Karpas-707: 5.1;SCLC-21H: 16.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009701, HPA063795" Enhanced Approved "Cell Junctions" "Cell Junctions" "HPA009701: AB_1857324, HPA063795: " "unprognostic (4.53e-1)" "unprognostic (4.05e-1)" "unprognostic (2.45e-2)" "unprognostic (3.24e-4)" "unprognostic (4.10e-2)" "unprognostic (3.72e-3)" "unprognostic (1.53e-1)" "unprognostic (2.84e-2)" "unprognostic (9.95e-2)" "unprognostic (1.80e-1)" "unprognostic (1.16e-4)" "unprognostic (1.00e-1)" "unprognostic (5.07e-3)" "unprognostic (9.51e-2)" "unprognostic (6.50e-2)" "unprognostic (2.67e-2)" "prognostic favourable (1.76e-4)" 1.3 2.6 7.9 0.5 9.5 0.6 1.7 16.3 21.2 1.3 0.8 18.4 0.0 1.2 1.0 1.3 0.5 2.1 0.4 0.6 7.0 0.5 1.8 0.8 0.6 9.0 10.5 0.4 1.6 2.2 0.0 0.6 10.2 0.8 0.7 0.5 11.7 1.7 0.9 6.1 0.9 0.5 5.5 0.6 0.9 0.8 10.7 0.0 0.8 0.0 0.4 0.9 0.0 0.3 0.3 1.3 0.2 0.2 0.2 0.0 0.5 0.5 1.2 3.4 0.2 0.0 0.1 0.0 0.1 0.2 0.1 0.6 0.6 1.0 1.1 0.0 1.2 1.5 0.2 0.1 1.2 1.4 0.0 0.5 1.4 0.2 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.1 5.1 0.0 3.1 0.0 0.0 1.6 0.1 0.1 0.0 0.1 0.5 2.5 16.1 2.3 0.0 1.4 0.9 2.5 0.5 0.0 0.0 1.6 0.0 0.0 1.1 0.2 0.1 0.1 0.7 0.7 1.3 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.2 0.2 0.6 0.2 0.0 0.3 0.0 0.0 SRGAP3 "ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP" ENSG00000196220 "SLIT-ROBO Rho GTPase activating protein 3" O43295 3 8980591-9363053 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.9" "Cell line enhanced" "Detected in some" "AF22: 9.5;HBEC3-KT: 8.2;hTCEpi: 8.2;RT4: 10.9;T-47d: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036959, HPA044074, HPA078079" Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: " "unprognostic (3.63e-3)" "unprognostic (1.12e-3)" "unprognostic (7.61e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.70e-2)" "unprognostic (5.58e-2)" "unprognostic (1.18e-3)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "unprognostic (2.75e-2)" "unprognostic (6.39e-3)" 1.8 6.1 10.6 1.7 20.4 1.2 3.2 32.4 34.9 9.7 2.1 10.5 0.0 1.9 4.4 3.4 2.6 18.5 2.3 2.7 10.0 11.2 4.9 1.4 2.2 2.3 7.5 9.8 7.2 2.4 2.7 5.7 1.9 15.5 4.7 2.5 4.8 5.7 3.2 2.5 4.0 1.7 2.0 6.1 1.7 2.9 4.4 4.8 0.4 3.3 0.6 2.1 6.7 1.4 0.0 1.9 1.9 0.4 1.0 1.3 0.1 0.5 0.5 9.5 0.4 0.6 1.3 1.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.5 0.0 4.8 0.2 8.2 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 5.1 0.8 8.2 0.7 0.8 0.0 0.0 0.0 0.0 0.1 0.2 2.0 0.9 0.7 1.1 0.0 0.0 4.1 10.9 1.1 1.2 0.2 2.9 0.1 10.6 0.0 0.0 0.0 0.4 0.1 0.1 2.8 0.1 0.0 0.8 1.7 0.3 1.2 0.4 1.9 0.0 0.1 0.0 0.0 0.2 0.0 1.9 0.0 0.2 0.0 0.0 1.0 0.1 0.5 1.3 0.1 10.6 20.4 32.4 34.9 10.0 11.2 7.5 9.8 15.5 4.8 SRRM3 FLJ37078 ENSG00000177679 "Serine/arginine repetitive matrix 3" 7 76201900-76287288 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 43.2" "Group enriched" "Detected in some" 11 "SCLC-21H: 14.1;SH-SY5Y: 10.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019337 Approved "Plasma membrane,Intermediate filaments,Microtubules" "Plasma membrane" "Intermediate filaments, Microtubules" "HPA019337: AB_1848909" "unprognostic (1.65e-1)" "unprognostic (1.96e-1)" "unprognostic (8.37e-3)" "unprognostic (4.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (6.51e-2)" "unprognostic (1.89e-3)" "unprognostic (1.62e-2)" "unprognostic (5.07e-3)" "unprognostic (6.37e-2)" "unprognostic (3.73e-3)" "unprognostic (5.05e-1)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.15e-2)" 0.6 6.2 8.1 0.7 18.1 0.4 0.4 43.2 14.6 0.4 0.6 0.0 0.0 0.9 0.7 1.1 0.5 0.5 0.5 0.5 5.1 0.5 0.4 0.5 0.4 0.0 10.9 0.6 0.5 0.5 4.4 0.4 10.0 0.5 0.7 1.8 0.6 0.5 0.6 0.5 0.6 0.5 0.6 0.4 1.6 2.9 2.9 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.2 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 14.1 10.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 SRRM4 "KIAA1853, nSR100" ENSG00000139767 "Serine/arginine repetitive matrix 4" A7MD48 12 118981495-119163051 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 62.1" "Group enriched" "Detected in some" 6 "HeLa: 6.5;SCLC-21H: 7.6;SH-SY5Y: 6.1" "Cancer enriched" "Detected in single" 7 "glioma: 1.3" "Region enhanced" "Detected in many" "cerebellum: 62.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052783 Uncertain "HPA052783: " "unprognostic (2.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.40e-2)" "unprognostic (1.25e-1)" "unprognostic (1.64e-1)" "unprognostic (1.37e-1)" "unprognostic (1.11e-1)" "unprognostic (1.61e-5)" "unprognostic (1.10e-2)" "unprognostic (1.75e-1)" "unprognostic (5.70e-3)" "unprognostic (2.23e-1)" "unprognostic (6.88e-2)" "unprognostic (1.61e-1)" 0.8 3.6 11.0 0.9 11.6 1.0 0.8 62.1 21.5 0.8 0.8 0.4 0.0 0.9 1.1 1.0 0.8 0.8 0.8 2.0 6.6 4.7 1.1 0.8 1.0 0.8 2.0 18.2 0.8 0.7 0.9 1.4 0.9 3.8 0.9 0.9 5.9 0.8 1.1 1.4 0.9 0.9 0.9 1.3 0.8 1.3 1.4 0.8 0.0 0.9 0.0 0.8 0.7 0.3 0.0 0.1 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.0 11.0 11.6 62.1 20.5 6.6 4.7 2.0 18.2 3.8 0.8 SSPO "FLJ36112, KIAA0543, SCO-spondin" ENSG00000197558 SCO-spondin 7 149776042-149833979 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.7;salivary gland: 1.7" "Cell line enhanced" "Detected in some" "AN3-CA: 1.2;RPMI-8226: 2.7;T-47d: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 13 "midbrain: 44.5" "Secreted in brain" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.95e-4)" "unprognostic (5.81e-3)" "unprognostic (3.50e-2)" "unprognostic (1.16e-2)" "unprognostic (2.41e-3)" "unprognostic (9.17e-2)" "unprognostic (2.97e-2)" "unprognostic (1.23e-1)" "unprognostic (7.59e-5)" "unprognostic (1.04e-1)" "unprognostic (2.65e-10)" "unprognostic (1.19e-1)" "unprognostic (2.94e-1)" "unprognostic (8.15e-3)" "unprognostic (2.46e-2)" 0.6 0.0 0.3 0.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 1.7 0.1 0.1 0.3 0.0 0.0 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.7 1.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.5 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.2 0.2 0.0 0.0 2.7 0.1 0.0 0.4 0.5 0.0 0.1 0.0 1.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SST SMST ENSG00000157005 Somatostatin P61278 3 187668906-187670399 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 102.8;intestine: 105.2;pancreas: 105.6;stomach 1: 90.4" "Cell line enhanced" "Detected in some" "EFO-21: 15.2;U-2 OS: 28.3;U-251 MG: 4.7;U-698: 5.9" "Group enriched" "Detected in many" 7 "ovarian cancer: 249.9;pancreatic cancer: 1039.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000075, HPA019472, CAB034105" Enhanced Supported "Secreted to blood" "CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360" "unprognostic (2.44e-1)" "unprognostic (2.05e-1)" "prognostic unfavourable (1.93e-5)" "unprognostic (5.12e-3)" "unprognostic (1.54e-2)" "unprognostic (4.69e-1)" "unprognostic (3.31e-2)" "unprognostic (8.16e-3)" "unprognostic (1.63e-1)" "unprognostic (1.07e-3)" "unprognostic (8.47e-2)" "unprognostic (4.19e-1)" "unprognostic (3.27e-1)" "unprognostic (1.45e-1)" 2.0 13.0 28.6 1.9 53.8 1.7 0.7 0.1 47.9 0.7 45.1 1.8 21.9 105.2 0.9 0.7 1.1 0.7 1.0 0.9 17.5 102.8 2.5 0.7 0.7 1.0 6.2 15.4 0.8 105.6 0.7 1.5 0.7 16.1 1.5 7.4 0.4 0.7 7.5 0.7 3.1 36.1 1.4 18.4 0.7 90.4 0.7 8.6 0.0 0.9 0.0 0.7 4.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.3 0.3 4.7 0.0 1.6 5.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 53.8 0.1 47.9 17.5 102.8 6.2 15.4 16.1 8.6 SSTR1 ENSG00000139874 "Somatostatin receptor 1" P30872 14 38207999-38213067 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.0;intestine: 14.3;stomach 1: 22.8" "Cell line enhanced" "Detected in some" "BJ: 46.8;BJ hTERT+: 13.0;BJ hTERT+ SV40 Large T+: 8.6;fHDF/TERT166: 27.6;HeLa: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003207, HPA031506" Approved Supported "Plasma membrane" "Plasma membrane" "HPA003207: , HPA031506: " "unprognostic (1.40e-1)" "unprognostic (1.37e-1)" "unprognostic (3.36e-1)" "unprognostic (2.50e-3)" "unprognostic (4.34e-2)" "unprognostic (9.90e-2)" "unprognostic (3.66e-3)" "unprognostic (1.91e-1)" "unprognostic (6.16e-3)" "unprognostic (3.20e-2)" "unprognostic (1.72e-2)" "unprognostic (9.19e-2)" "prognostic favourable (4.28e-4)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" "unprognostic (3.28e-2)" 0.7 0.4 6.8 0.6 6.9 0.0 0.6 0.5 15.0 0.9 3.7 0.6 0.1 14.3 1.0 0.6 0.4 0.7 0.5 0.8 4.3 10.4 2.2 6.7 5.5 0.1 6.8 4.0 0.6 3.8 0.1 1.4 2.8 2.8 1.2 2.5 0.2 0.2 0.5 0.7 0.4 8.2 0.6 1.3 0.7 22.8 0.1 0.7 0.1 0.3 0.1 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 46.8 13.0 8.6 0.7 0.4 0.0 0.0 0.0 27.6 0.1 0.0 0.0 6.3 0.0 0.0 0.0 10.6 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 1.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 6.9 0.5 15.0 4.3 10.4 6.8 4.0 2.8 0.7 SSTR2 ENSG00000180616 "Somatostatin receptor 2" P30874 17 73165012-73176633 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007264 Uncertain Supported Cytosol Cytosol "HPA007264: AB_1080053" "unprognostic (2.13e-3)" "unprognostic (2.61e-3)" "unprognostic (7.43e-2)" "unprognostic (9.37e-3)" "unprognostic (6.25e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-3)" "unprognostic (7.46e-2)" "unprognostic (2.96e-1)" "unprognostic (6.55e-2)" "prognostic favourable (6.63e-4)" "unprognostic (1.07e-1)" "prognostic unfavourable (9.04e-7)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (3.71e-3)" "unprognostic (2.95e-2)" 4.5 7.4 6.1 2.3 15.8 2.5 4.2 23.1 26.6 1.4 2.2 0.5 0.6 3.3 1.9 4.1 1.5 2.3 1.8 2.2 9.3 5.3 13.6 3.3 1.4 2.7 2.6 13.1 1.5 2.0 1.4 5.7 1.0 4.9 2.8 2.7 1.1 1.8 3.6 1.7 1.9 2.5 2.2 3.3 8.3 7.2 1.4 1.9 0.3 2.3 0.0 2.9 2.0 1.9 1.4 1.0 4.7 0.9 0.9 1.0 0.3 0.3 0.5 0.6 1.1 0.2 0.2 0.7 0.2 0.3 0.5 0.5 0.5 0.5 0.7 0.3 0.1 0.5 0.1 0.1 0.2 0.6 0.9 0.6 1.0 0.5 0.1 0.4 2.2 0.2 0.1 0.2 0.0 0.0 0.7 1.2 0.2 0.6 0.4 1.3 1.5 0.6 0.7 0.8 0.4 0.4 0.6 16.8 1.4 0.3 0.3 0.2 2.1 0.3 0.3 0.4 2.2 0.6 0.3 0.8 0.4 1.6 0.3 1.7 0.4 3.8 0.9 1.2 1.0 0.7 0.8 0.8 0.8 0.8 0.3 1.4 0.8 0.9 4.7 0.9 0.8 1.0 0.5 0.3 6.1 15.8 23.1 22.1 9.3 5.3 2.6 13.1 4.9 1.9 SSTR3 ENSG00000278195 "Somatostatin receptor 3" P32745 22 37204238-37212322 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.1;lymphoid tissue: 29.6;testis: 11.3" "Group enriched" "Detected in some" 11 "RPMI-8226: 21.8;SCLC-21H: 8.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.9" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.9;naive CD8 T-cell: 3.0" "Lineage enriched" "Detected in single" 10 "T-cells: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022647 Approved "CAB022647: " "unprognostic (1.63e-2)" "unprognostic (5.58e-3)" "unprognostic (1.32e-2)" "unprognostic (3.18e-2)" "unprognostic (7.03e-2)" "unprognostic (6.26e-5)" "unprognostic (1.11e-1)" "unprognostic (1.72e-2)" "unprognostic (1.90e-2)" "unprognostic (8.95e-2)" "unprognostic (3.88e-3)" "unprognostic (2.93e-1)" "unprognostic (1.51e-7)" "unprognostic (1.55e-1)" "unprognostic (1.24e-2)" "unprognostic (5.61e-3)" "unprognostic (1.06e-2)" 0.1 0.8 2.8 1.9 1.9 0.9 0.1 2.7 11.1 0.0 0.5 0.2 0.0 2.6 1.9 0.2 0.1 0.1 0.1 0.0 5.6 0.1 0.0 0.1 3.5 0.0 7.9 5.8 3.9 0.0 6.4 0.0 7.9 0.2 0.6 0.0 0.6 0.1 0.0 0.0 1.0 2.2 4.3 1.2 0.5 11.3 0.1 29.6 0.0 0.0 2.0 0.3 0.0 0.3 0.1 0.1 0.0 0.0 3.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 8.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 3.9 3.0 0.1 0.0 0.0 0.1 0.3 0.8 SSTR4 ENSG00000132671 "Somatostatin receptor 4" P31391 20 23035386-23036812 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 3.8" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA064252 Uncertain "HPA064252: " 0.0 0.0 1.7 0.0 1.1 0.0 0.0 3.0 3.8 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 1.3 0.4 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ST18 "KIAA0535, NZF3, ZC2H2C3, ZC2HC10, ZNF387" ENSG00000147488 "ST18, C2H2C-type zinc finger" O60284 8 52110839-52460959 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 47.8" "Cell line enhanced" "Detected in some" "HAP1: 4.0;SCLC-21H: 14.3;U-87 MG: 2.3" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "myeloid DC: 1.7" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.7" "Region enhanced" "Detected in many" "cerebellum: 45.1" "Low region specificity" "Detected in all" HPA044919 Uncertain "HPA044919: AB_10959756" "unprognostic (3.66e-1)" "unprognostic (4.34e-2)" "unprognostic (7.47e-2)" "unprognostic (2.04e-2)" "unprognostic (2.78e-1)" "unprognostic (2.42e-2)" "unprognostic (1.22e-1)" "unprognostic (7.11e-2)" "unprognostic (2.12e-1)" "unprognostic (1.58e-1)" "unprognostic (1.55e-3)" "unprognostic (2.82e-1)" "unprognostic (2.53e-5)" "unprognostic (3.29e-1)" "unprognostic (1.35e-1)" "unprognostic (9.34e-2)" "unprognostic (9.84e-3)" 1.0 3.4 7.6 1.2 40.5 1.0 0.9 27.8 20.8 1.1 1.4 31.1 0.0 2.3 0.9 0.9 1.0 0.9 1.4 0.9 11.0 5.8 1.9 1.0 1.2 1.0 47.8 8.8 0.9 6.1 0.9 3.1 1.2 23.8 1.3 1.8 0.0 0.9 0.9 0.9 0.9 2.2 0.9 38.0 1.0 5.2 1.7 41.6 0.0 1.0 0.0 1.2 1.1 0.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 40.5 27.8 19.7 11.0 5.8 47.8 8.8 23.8 41.6 ST6GAL2 "KIAA1877, SIAT2, St6gal2, St6GalII" ENSG00000144057 "ST6 beta-galactoside alpha-2,6-sialyltransferase 2" Q96JF0 2 106801600-106887108 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7;thyroid gland: 34.0" "Cell line enhanced" "Detected in some" "A549: 5.7;NTERA-2: 4.9;PC-3: 6.5;RPMI-8226: 10.2;SCLC-21H: 6.8;U-138 MG: 8.3;U-266/70: 10.9" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014459 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA014459: AB_1857528" "unprognostic (2.08e-1)" "unprognostic (5.80e-2)" "unprognostic (1.55e-1)" "unprognostic (4.63e-2)" "unprognostic (6.44e-3)" "unprognostic (1.62e-1)" "unprognostic (2.35e-2)" "unprognostic (1.10e-2)" "unprognostic (1.29e-4)" "unprognostic (4.56e-3)" "unprognostic (7.04e-2)" "unprognostic (1.84e-2)" "unprognostic (7.01e-4)" "unprognostic (4.70e-4)" "unprognostic (4.06e-2)" "unprognostic (2.83e-1)" "unprognostic (2.07e-2)" 1.2 0.7 14.1 0.7 5.6 1.5 1.3 2.3 16.7 2.1 1.5 4.1 1.7 0.7 3.7 1.9 2.7 1.2 12.7 1.9 5.4 4.0 1.1 3.4 1.2 0.9 3.8 7.1 0.9 0.5 0.5 0.3 2.3 4.2 1.6 3.3 0.0 1.6 1.6 0.7 1.3 0.7 2.8 1.9 0.6 0.9 7.9 1.5 0.0 34.0 1.6 0.8 1.5 1.4 0.7 0.6 1.8 0.5 1.0 0.7 0.5 0.0 5.7 3.2 0.1 0.0 0.0 0.1 0.3 0.0 1.3 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 4.9 6.5 0.0 0.0 10.2 0.2 0.0 6.8 4.4 0.0 0.1 0.0 0.0 0.1 0.0 8.3 0.1 0.2 0.0 10.9 0.2 0.1 0.0 0.0 0.0 1.4 0.5 0.4 0.6 0.3 0.5 0.4 0.4 0.5 0.2 0.7 0.5 0.7 1.8 1.0 0.3 0.6 0.5 0.5 14.1 5.6 2.3 14.8 5.4 4.0 3.8 7.1 4.2 1.5 ST6GALNAC5 "MGC3184, SIAT7E, ST6GalNAcV" ENSG00000117069 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5" Q9BVH7 1 76867441-77065711 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4" "Cell line enhanced" "Detected in some" "AF22: 9.0;fHDF/TERT166: 10.6;HaCaT: 5.1;SH-SY5Y: 7.7;U-2 OS: 8.8;U-251 MG: 4.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.9" "Group enriched" "Detected in many" 4 "amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065593, HPA070354" Uncertain Approved Vesicles "Intracellular and membrane" Vesicles "HPA065593: , HPA070354: " "unprognostic (1.32e-1)" "unprognostic (5.96e-2)" "unprognostic (1.72e-1)" "unprognostic (1.49e-2)" "unprognostic (2.82e-2)" "unprognostic (2.04e-2)" "unprognostic (4.67e-2)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-1)" "unprognostic (1.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.10e-2)" "unprognostic (5.90e-3)" "unprognostic (9.66e-2)" "unprognostic (6.88e-2)" "unprognostic (1.69e-2)" 0.7 10.1 22.1 5.2 22.3 0.4 4.2 0.6 12.7 2.9 3.4 0.3 0.0 1.4 0.9 0.7 3.7 6.9 12.6 1.4 29.4 2.7 0.7 0.6 12.1 1.6 3.0 14.2 6.5 0.8 0.4 8.5 0.9 4.7 4.2 2.7 5.8 1.5 1.6 0.6 1.0 2.1 10.2 0.8 1.0 3.7 1.2 0.2 0.0 0.6 0.0 1.4 4.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.3 0.0 9.0 0.0 0.0 0.0 0.0 0.8 3.1 2.6 0.8 0.0 0.2 0.0 0.0 10.6 5.1 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.6 0.0 0.0 0.7 0.6 0.0 0.1 2.5 7.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 8.8 0.0 4.9 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.1 22.3 0.6 12.7 29.4 2.7 3.0 14.2 4.7 0.2 ST8SIA1 "SIAT8, SIAT8A" ENSG00000111728 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1" Q92185 12 22063773-22437041 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.2" "Cell line enhanced" "Detected in some" "AF22: 9.0;ASC TERT1: 6.0;RPTEC TERT1: 4.6;SK-MEL-30: 8.3;WM-115: 8.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;T-cells: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026775 Approved "HPA026775: AB_1857534" "unprognostic (1.98e-1)" "unprognostic (5.76e-3)" "unprognostic (1.79e-1)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-3)" "unprognostic (1.76e-2)" "unprognostic (1.07e-2)" "unprognostic (3.07e-1)" "unprognostic (1.99e-1)" "unprognostic (6.37e-3)" "unprognostic (2.80e-2)" "unprognostic (1.07e-8)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (5.28e-2)" "unprognostic (3.16e-2)" 1.7 7.6 7.0 5.3 6.2 2.3 5.9 20.2 13.0 3.5 5.4 2.3 2.3 0.4 4.5 1.4 3.0 2.3 2.4 4.4 7.6 8.5 1.1 0.6 3.8 8.6 7.6 6.5 2.6 1.2 7.2 0.6 0.4 9.4 6.6 3.5 1.5 3.2 4.4 1.0 4.3 2.1 6.3 10.9 2.7 2.1 1.0 4.8 0.2 1.4 0.5 9.2 6.7 3.1 0.3 0.2 1.2 0.2 0.3 3.0 0.6 0.0 0.5 9.0 0.0 1.4 6.0 0.9 0.0 0.0 0.1 0.4 0.3 0.1 1.1 0.0 0.0 0.4 0.0 0.2 0.6 0.0 0.0 1.1 0.1 0.1 0.0 0.3 0.1 0.5 0.9 0.1 0.9 0.2 0.0 0.6 0.2 0.0 1.2 0.3 2.3 0.0 0.0 0.2 0.2 4.6 0.0 0.1 0.2 0.0 0.1 8.3 0.7 0.1 0.0 0.7 0.9 0.1 1.4 0.7 0.5 0.7 1.4 0.1 8.9 1.2 0.2 0.2 0.4 0.1 0.9 0.1 2.9 2.3 0.1 0.3 0.4 1.0 0.9 0.3 0.2 0.2 3.0 0.6 7.0 6.2 20.2 13.0 7.6 8.5 7.6 6.5 9.4 4.8 ST8SIA2 "HsT19690, SIAT8B, ST8SIA-II, STX" ENSG00000140557 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2" Q92186 15 92393828-92468728 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 17.7;heart muscle: 10.0" "Cell line enhanced" "Detected in some" "AF22: 21.8;LHCN-M2: 6.4;RH-30: 9.8;RPMI-8226: 7.1;WM-115: 6.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "pons and medulla: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054518 Approved Approved "Centriolar satellite" "Intracellular and membrane" "Centriolar satellite" "HPA054518: " "unprognostic (4.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.26e-1)" "unprognostic (9.32e-3)" "unprognostic (1.03e-1)" "unprognostic (2.87e-2)" "unprognostic (2.32e-1)" "unprognostic (1.28e-5)" "unprognostic (3.91e-2)" "unprognostic (5.39e-3)" "unprognostic (1.59e-2)" "unprognostic (4.44e-3)" "unprognostic (4.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-1)" "unprognostic (3.00e-1)" 0.3 1.1 1.3 0.2 2.2 0.1 1.2 1.5 3.7 2.6 0.3 0.0 0.0 0.1 1.3 2.5 0.4 0.1 0.7 10.0 3.0 3.6 0.3 0.1 0.1 0.2 2.2 1.4 0.1 0.1 0.1 0.9 0.1 17.7 0.3 0.2 1.0 0.8 0.5 2.1 0.1 0.4 0.2 0.2 0.1 0.2 0.8 0.1 2.5 0.2 1.5 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.2 0.0 3.5 0.0 0.0 9.8 7.1 0.0 0.0 0.5 4.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.2 1.5 2.6 3.0 3.6 2.2 1.4 17.7 0.1 ST8SIA3 SIAT8C ENSG00000177511 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3" O43173 18 57350813-57371731 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 24.0" "Group enriched" "Detected in some" 42 "NTERA-2: 5.9;SCLC-21H: 10.1;SH-SY5Y: 11.4" "Group enriched" "Detected in some" 11 "glioma: 0.9;pancreatic cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063398, HPA066783" Enhanced Supported "Golgi apparatus" "Golgi apparatus" "HPA063398: , HPA066783: " "unprognostic (1.75e-1)" "unprognostic (7.85e-2)" "unprognostic (1.41e-2)" "unprognostic (5.50e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.82e-1)" 0.1 4.5 3.4 0.1 12.0 0.0 0.0 7.9 24.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 1.1 0.0 3.8 4.8 0.1 0.2 0.1 0.0 1.2 0.0 4.2 0.0 3.5 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 10.1 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ST8SIA5 SIAT8E ENSG00000101638 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5" O15466 18 46667821-46759257 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 12.8;brain: 36.4" "Cell line enriched" "Detected in some" 8 "WM-115: 51.7" "Cancer enriched" "Detected in single" 8 "glioma: 2.6" "Region enhanced" "Detected in many" "cerebellum: 36.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043813, HPA046771" Approved Approved "Plasma membrane,Midbody" "Plasma membrane, Midbody" "HPA043813: , HPA046771: " "unprognostic (3.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-4)" "unprognostic (2.99e-2)" "unprognostic (4.83e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (1.36e-1)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.55e-2)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" 0.6 12.8 3.6 0.6 7.8 0.9 0.5 36.4 16.1 0.5 0.5 1.0 0.0 0.7 0.5 0.9 0.4 0.7 0.6 7.2 4.0 1.8 1.5 0.4 0.5 0.5 2.0 6.9 0.7 0.4 4.9 0.7 0.4 4.1 0.6 0.5 0.0 0.4 0.5 8.2 0.7 0.5 0.5 2.5 0.5 0.7 0.9 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.8 0.4 1.5 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.5 3.0 0.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 51.7 1.0 0.4 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.0 0.8 0.3 0.3 1.5 0.5 0.2 0.4 0.1 0.0 3.6 7.8 36.4 16.1 4.0 1.8 2.0 6.9 4.1 0.7 STEAP1B ENSG00000105889 "STEAP family member 1B" Q6NZ63 7 22419444-22632925 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.6" "Group enriched" "Detected in some" 4 "hTEC/SVTERT24-B: 29.1;HUVEC TERT2: 32.6;K-562: 18.9;WM-115: 35.9" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 88 "memory B-cell: 9.9;naive B-cell: 8.6" "Lineage enriched" "Detected in single" 94 "B-cells: 9.9" "unprognostic (7.35e-2)" "unprognostic (2.42e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-3)" "unprognostic (3.96e-2)" "unprognostic (2.18e-1)" "unprognostic (2.31e-5)" "unprognostic (2.29e-3)" "unprognostic (4.96e-2)" "unprognostic (7.37e-3)" "unprognostic (7.38e-2)" "unprognostic (1.27e-2)" "unprognostic (2.85e-10)" "unprognostic (1.06e-4)" "unprognostic (3.46e-2)" "unprognostic (1.35e-1)" "unprognostic (2.21e-3)" 3.5 1.8 5.3 3.9 14.5 0.6 1.8 0.6 9.3 2.3 1.6 13.5 0.8 0.5 0.7 1.4 1.7 1.0 2.2 1.4 5.2 2.9 0.4 0.7 1.4 5.9 14.9 2.7 0.5 1.1 0.8 1.0 3.6 9.0 1.5 1.5 1.0 1.4 2.1 3.2 1.1 1.0 1.9 8.6 6.4 1.1 7.5 15.6 0.6 0.8 0.3 5.5 2.1 3.6 9.9 0.0 0.0 0.0 0.0 0.1 0.4 4.0 0.0 2.9 0.0 1.8 1.9 0.0 2.8 0.4 0.0 0.1 0.0 0.1 0.4 0.9 5.5 0.0 4.1 0.0 0.2 0.3 0.4 0.0 0.1 0.0 0.2 0.0 0.0 3.4 0.0 29.1 0.0 32.6 18.9 1.6 0.0 0.0 0.0 0.0 6.6 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 2.4 0.0 0.0 3.3 0.4 0.1 4.4 0.0 0.4 3.7 3.8 6.9 0.0 35.9 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.1 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.3 14.5 0.6 9.3 5.2 2.9 14.9 2.7 9.0 15.6 STH MAPTIT ENSG00000256762 Saitohin Q8IWL8 17 45999250-45999694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.2;breast: 1.9;placenta: 1.6;skeletal muscle: 2.5" "Cell line enhanced" "Detected in some" "HAP1: 1.1;HDLM-2: 3.1;PC-3: 1.0;RT4: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.24e-1)" "unprognostic (3.22e-1)" 0.0 0.0 0.8 0.0 1.3 0.0 1.9 4.1 4.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.2 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 1.6 0.2 0.0 0.5 0.0 2.5 0.7 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.9 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STK32A "MGC22688, YANK1" ENSG00000169302 "Serine/threonine kinase 32A" Q8WU08 5 147234963-147387852 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 19.7;brain: 21.1;retina: 31.9" "Group enriched" "Detected in some" 5 "RT4: 9.6;SK-MEL-30: 33.8" "Cancer enhanced" "Detected in many" "melanoma: 11.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040236 Uncertain Approved Centrosome Centrosome "HPA040236: AB_10795416" "unprognostic (1.90e-1)" "unprognostic (4.71e-4)" "unprognostic (5.32e-2)" "unprognostic (3.49e-2)" "unprognostic (7.62e-2)" "unprognostic (6.82e-2)" "unprognostic (2.66e-2)" "unprognostic (2.96e-3)" "unprognostic (4.85e-2)" "unprognostic (2.36e-2)" "unprognostic (3.87e-1)" "unprognostic (8.38e-2)" "unprognostic (2.50e-3)" "unprognostic (5.53e-5)" "unprognostic (2.48e-1)" "unprognostic (3.20e-2)" "unprognostic (3.67e-3)" 2.1 19.7 4.8 1.3 7.1 0.4 2.3 21.1 7.7 1.2 1.8 6.2 0.6 1.2 1.6 5.6 1.0 1.3 4.3 1.6 4.9 12.6 6.3 0.6 2.1 0.5 12.1 2.2 5.1 4.2 0.4 8.5 0.7 20.7 2.1 1.1 31.9 1.2 1.8 0.6 2.9 1.1 1.4 12.4 0.8 1.4 2.1 6.9 0.0 15.7 0.5 0.5 4.1 2.1 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.1 3.7 9.6 0.9 0.4 0.0 0.1 33.8 0.0 0.0 0.1 0.0 0.6 0.4 0.3 1.1 0.2 0.0 1.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.8 7.1 21.1 2.3 4.9 12.6 12.1 2.2 20.7 6.9 STMN1 "C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN" ENSG00000117632 "Stathmin 1" P16949 1 25884181-25906991 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 143.4;lymphoid tissue: 117.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 79.3" "Group enriched" "Detected in all" 5 "dendritic cells: 79.3;T-cells: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010107 Enhanced Supported Cytosol 210000 Cytosol "CAB010107: AB_628297" "unprognostic (6.30e-2)" "unprognostic (2.40e-3)" "unprognostic (5.31e-2)" "unprognostic (7.94e-2)" "unprognostic (1.89e-1)" "unprognostic (5.02e-2)" "prognostic unfavourable (9.90e-7)" "unprognostic (9.45e-2)" "unprognostic (1.39e-2)" "unprognostic (1.61e-2)" "unprognostic (1.78e-1)" "unprognostic (3.33e-3)" "unprognostic (1.02e-2)" "unprognostic (1.68e-1)" "unprognostic (4.46e-2)" "unprognostic (1.05e-1)" "unprognostic (3.00e-2)" 7.3 13.2 91.7 17.5 47.4 40.7 10.9 54.1 124.8 6.2 16.7 47.0 2.5 12.7 24.7 7.8 13.0 7.3 9.4 9.5 67.9 88.4 13.2 6.4 11.0 42.8 86.5 58.0 33.6 3.5 4.6 12.1 21.7 43.4 5.2 20.7 7.7 5.3 6.3 3.8 9.5 15.9 18.8 143.4 10.9 9.7 58.2 27.1 117.1 6.1 7.2 43.1 13.0 8.1 8.6 79.3 4.0 1.5 10.1 26.2 9.3 67.5 15.2 151.7 60.6 9.1 8.8 15.4 52.7 41.9 75.3 72.9 10.4 69.5 83.1 29.6 38.4 20.7 42.0 30.5 113.3 25.1 20.8 51.5 26.9 36.3 3.6 64.8 36.8 5.4 4.5 30.3 34.6 56.6 69.5 82.9 97.5 17.6 213.2 95.3 93.0 20.5 126.2 118.3 49.3 36.4 6.1 102.8 89.2 47.9 24.0 42.0 34.4 82.6 27.2 50.6 60.1 43.8 43.9 48.9 77.6 103.2 24.9 126.8 54.5 2.0 0.7 4.0 10.4 1.5 6.3 6.4 9.3 13.1 4.2 8.6 15.3 13.7 0.3 10.1 0.7 79.3 26.2 9.3 91.7 47.4 54.1 124.8 67.9 88.4 86.5 58.0 43.4 27.1 STMN2 "SCG10, SCGN10" ENSG00000104435 "Stathmin 2" Q93045 8 79610814-79666175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 153.3" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 120.5" "Group enriched" "Detected in many" 5 "glioma: 26.1;pancreatic cancer: 10.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 5.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026922 Approved "Endoplasmic reticulum,Vesicles" Vesicles "Endoplasmic reticulum" "HPA026922: AB_1857605" "unprognostic (4.41e-1)" "unprognostic (3.35e-2)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (8.20e-2)" "unprognostic (9.48e-2)" "unprognostic (1.82e-1)" "unprognostic (6.08e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-13)" "unprognostic (1.14e-1)" "unprognostic (3.86e-1)" "unprognostic (5.77e-3)" "unprognostic (9.59e-2)" 1.7 35.4 35.2 5.6 35.0 1.4 2.5 99.8 153.3 5.3 10.7 4.2 0.0 7.7 1.9 1.3 1.8 1.4 3.0 1.3 40.3 71.9 1.4 1.8 1.5 1.6 44.7 60.4 1.4 3.2 1.4 1.5 1.4 102.4 2.5 14.2 2.6 1.7 2.1 1.3 6.4 9.8 4.3 19.0 3.1 2.4 2.2 6.6 0.0 1.3 0.0 1.9 1.5 0.9 0.0 5.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.4 120.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 5.6 0.0 0.0 35.2 35.0 99.8 68.3 40.3 71.9 44.7 60.4 102.4 6.6 STMN3 SCLIP ENSG00000197457 "Stathmin 3" Q9NZ72 20 63639705-63657682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 90.9" "Cell line enhanced" "Detected in many" "AN3-CA: 31.7;MOLT-4: 34.3;REH: 35.3;SCLC-21H: 49.5;SH-SY5Y: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 3.3;MAIT T-cell: 3.5;memory CD4 T-cell: 6.8;memory CD8 T-cell: 5.8;naive CD4 T-cell: 8.3;naive CD8 T-cell: 6.8" "Lineage enriched" "Detected in many" 6 "T-cells: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012947 Enhanced "HPA012947: AB_1857606" "unprognostic (7.59e-2)" "unprognostic (4.36e-1)" "unprognostic (5.28e-2)" "unprognostic (2.33e-1)" "unprognostic (3.60e-2)" "unprognostic (6.30e-2)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "unprognostic (4.35e-2)" "unprognostic (1.65e-3)" "unprognostic (7.52e-2)" "unprognostic (2.52e-3)" "unprognostic (2.73e-2)" "unprognostic (9.87e-2)" "unprognostic (4.08e-2)" "unprognostic (9.08e-3)" 9.0 21.0 53.5 13.1 52.7 6.9 7.7 48.8 90.9 10.9 5.3 6.7 1.2 4.2 10.9 4.2 5.9 10.3 7.6 5.0 48.9 47.7 4.6 1.6 6.2 15.2 34.2 63.6 19.8 7.6 6.2 18.6 7.0 45.8 8.2 4.2 6.2 7.5 9.5 3.3 11.6 6.5 10.1 29.5 20.3 6.5 4.1 12.3 11.0 20.9 1.9 8.4 6.6 3.5 1.0 1.3 1.2 0.1 0.0 8.3 2.5 2.5 2.9 19.0 31.7 0.5 1.9 1.3 3.0 0.1 9.2 4.3 18.2 3.4 0.1 9.3 1.1 17.2 13.2 0.3 2.8 1.2 3.5 1.2 4.0 6.7 2.6 0.9 10.8 4.0 0.0 2.9 0.7 0.3 23.8 0.5 2.4 2.8 34.3 4.3 19.5 20.7 35.3 3.1 14.1 15.5 0.5 49.5 37.7 1.4 0.8 3.6 0.5 6.4 0.4 0.2 5.3 0.2 0.6 1.2 2.5 0.8 0.5 3.5 12.3 1.0 0.1 1.2 3.3 0.1 3.5 0.3 6.8 5.8 0.1 1.0 8.3 6.8 0.2 0.0 0.1 1.3 1.1 2.5 53.5 52.7 48.8 74.0 48.9 47.7 34.2 63.6 45.8 12.3 STMN4 RB3 ENSG00000015592 "Stathmin 4" Q9H169 8 27235323-27258420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 132.2" "Cell line enriched" "Detected in some" 26 "SCLC-21H: 44.0" "Cancer enriched" "Detected in some" 27 "glioma: 14.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027765 Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA027765: AB_1857607" "unprognostic (1.52e-1)" "unprognostic (3.45e-2)" "unprognostic (2.37e-2)" "unprognostic (3.19e-6)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (8.27e-2)" "unprognostic (1.37e-1)" "unprognostic (3.57e-3)" "unprognostic (2.36e-1)" "unprognostic (2.31e-3)" "unprognostic (9.84e-2)" "unprognostic (1.68e-3)" "unprognostic (1.37e-2)" "unprognostic (5.96e-2)" "unprognostic (4.15e-1)" "unprognostic (7.63e-2)" 1.5 7.9 30.8 1.5 23.4 1.5 1.5 22.2 132.2 1.5 2.3 37.3 0.0 1.8 1.5 2.0 1.5 1.5 1.6 1.4 36.3 27.9 1.5 1.4 1.5 1.5 34.9 37.2 1.4 1.4 1.5 0.0 1.4 21.4 1.5 2.3 0.0 1.5 1.5 1.4 1.5 2.2 1.8 71.8 1.4 1.5 1.6 6.6 0.0 1.4 0.0 1.4 1.5 0.0 1.0 0.9 0.3 0.2 0.1 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.7 0.0 0.1 0.3 0.2 0.4 0.1 1.0 0.7 0.2 0.3 0.1 0.2 0.9 0.4 0.0 30.8 23.4 22.2 34.4 36.3 27.9 34.9 37.2 21.4 6.6 STOML1 "FLJ36370, hUNC-24, SLP-1, STORP" ENSG00000067221 "Stomatin like 1" Q9UBI4 15 73978923-73994622 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042353 Approved Approved Cytosol Cytosol "HPA042353: AB_10797387" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (7.76e-2)" "unprognostic (4.54e-3)" "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.78e-1)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.30e-3)" "unprognostic (2.26e-3)" "unprognostic (2.14e-1)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.67e-2)" 11.1 10.2 19.2 6.2 18.8 4.2 8.1 7.8 35.3 7.7 6.9 8.3 3.1 5.9 4.6 6.0 7.0 6.2 9.1 14.4 19.0 18.0 4.5 6.1 6.9 8.7 13.4 14.3 9.0 9.9 6.8 8.5 7.9 10.2 7.0 3.7 4.0 7.7 9.7 13.2 7.3 6.5 7.7 12.3 6.3 7.9 6.7 5.9 6.2 10.4 3.6 5.6 6.2 4.4 6.1 11.0 2.2 15.5 6.8 9.4 5.3 3.6 6.9 4.2 5.7 8.5 5.4 3.5 11.8 4.6 6.4 5.4 2.0 20.3 3.6 18.7 9.5 12.2 3.9 8.3 2.0 12.1 4.3 3.7 5.8 2.2 8.4 2.4 3.0 9.6 6.5 10.1 9.6 6.0 9.0 7.0 9.3 5.5 4.6 1.8 2.0 5.5 2.8 4.2 5.5 13.7 4.0 8.0 5.2 5.3 7.1 7.5 5.9 2.8 9.2 14.8 4.8 16.9 15.7 7.2 3.5 1.9 13.6 7.6 7.5 0.7 4.0 2.2 5.3 7.0 4.4 4.3 4.4 7.0 6.2 6.1 8.9 9.4 2.0 6.8 15.5 11.0 7.4 5.3 19.2 18.8 7.8 35.3 19.0 18.0 13.4 14.3 10.2 5.9 STOML3 "Epb7.2l, SRO" ENSG00000133115 "Stomatin like 3" Q8TAV4 13 38965925-38991066 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2" "Cell line enriched" "Detected in single" 39 "AF22: 18.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "olfactory region: 29.0" "Low region specificity" "Detected in all" "HPA012892, HPA071011" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA012892: AB_1857610, HPA071011: " "unprognostic (2.64e-1)" "unprognostic (1.91e-2)" "prognostic favourable (1.49e-4)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "unprognostic (4.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.14e-1)" "unprognostic (2.14e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-2)" "unprognostic (3.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.22e-1)" 0.1 0.1 2.9 0.1 3.8 0.1 0.2 0.0 0.2 1.7 0.2 6.6 0.0 0.2 1.1 8.1 0.1 31.7 0.1 0.1 4.4 4.1 0.1 0.1 9.2 0.1 0.0 0.0 7.6 0.1 0.1 0.0 0.3 9.7 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.6 2.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.8 0.0 0.2 4.4 4.1 0.0 0.0 9.7 2.1 STOX1 "C10orf24, FLJ25162" ENSG00000165730 "Storkhead box 1" Q6ZVD7 10 68827541-68895432 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8;fallopian tube: 19.1" "Cell line enhanced" "Detected in many" "AN3-CA: 10.9;HAP1: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;T-cells: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037844, HPA037845" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Intracellular and membrane" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA037844: , HPA037845: AB_10671369" "prognostic favourable (3.37e-5)" "unprognostic (5.53e-3)" "unprognostic (6.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.63e-3)" "unprognostic (1.95e-2)" "unprognostic (2.24e-3)" "prognostic favourable (2.08e-4)" "unprognostic (1.52e-1)" "unprognostic (2.45e-3)" "unprognostic (5.33e-3)" "unprognostic (5.29e-2)" "unprognostic (3.87e-2)" "unprognostic (8.77e-2)" "unprognostic (3.06e-2)" "unprognostic (2.33e-1)" "unprognostic (3.46e-2)" 8.7 6.4 17.8 1.7 13.4 0.6 4.8 1.8 13.4 2.0 2.6 6.8 1.3 2.0 2.8 11.9 2.5 19.1 1.7 0.9 16.1 9.3 4.5 0.9 2.2 1.8 11.5 10.2 1.9 1.6 6.1 8.8 1.5 5.6 2.3 2.8 5.0 2.6 2.1 1.9 1.4 2.8 2.5 2.4 0.9 2.2 3.8 7.3 3.3 8.7 0.0 1.7 1.6 0.9 0.7 3.5 0.0 0.0 0.2 3.0 0.2 2.2 2.4 5.4 10.9 2.3 0.0 3.2 0.2 0.1 1.6 1.7 2.3 3.3 2.1 3.1 0.0 0.6 10.1 0.0 0.8 2.5 4.2 0.2 0.5 3.1 0.3 2.7 3.9 0.2 0.2 0.3 0.0 0.1 0.5 0.3 0.2 2.2 4.6 3.4 1.8 1.5 3.4 0.1 0.0 3.2 5.7 1.7 4.9 3.9 1.0 0.7 2.4 2.2 0.0 0.0 0.2 0.0 1.5 1.0 1.9 2.2 0.0 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.4 0.8 0.6 0.0 0.7 3.0 1.4 0.0 0.2 0.0 3.5 0.3 0.2 17.8 13.4 1.8 12.5 16.1 9.3 11.5 10.2 5.6 7.3 STRC DFNB16 ENSG00000242866 Stereocilin Q7RTU9 15 43599563-43618800 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 22.9" "Cell line enhanced" "Detected in some" "HEK 293: 1.5;hTCEpi: 2.2;SCLC-21H: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048083 Enhanced "HPA048083: " "unprognostic (8.60e-3)" "unprognostic (5.77e-3)" "unprognostic (6.14e-2)" "unprognostic (1.60e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-3)" "unprognostic (1.65e-1)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.84e-2)" "unprognostic (5.92e-3)" "unprognostic (1.99e-4)" "unprognostic (1.58e-1)" "unprognostic (6.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.59e-4)" 0.2 0.5 1.7 0.2 4.2 0.1 0.8 22.9 5.1 0.0 0.2 0.4 0.1 4.7 0.1 0.3 0.2 0.0 2.3 3.2 0.0 0.1 0.1 0.0 1.6 0.4 0.5 0.1 1.7 0.0 0.7 0.2 1.5 0.1 0.4 2.7 0.4 0.0 1.1 0.2 0.2 3.3 0.6 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.0 0.1 1.0 1.5 0.0 0.7 0.0 0.0 0.5 0.6 0.5 2.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.3 0.5 0.0 0.0 0.1 0.1 1.9 0.1 0.0 0.4 0.9 0.4 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STRIP2 "FAM40B, FAR11B, KIAA1170" ENSG00000128578 "Striatin interacting protein 2" Q9ULQ0 7 129434433-129488399 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.6;retina: 55.6;skeletal muscle: 27.4" "Cell line enhanced" "Detected in many" "LHCN-M2: 20.9;U-2197: 23.8;U-87 MG: 21.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 36.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019657 Approved Approved Cytosol Cytosol "HPA019657: AB_1848399" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "unprognostic (2.11e-1)" "unprognostic (2.41e-1)" "unprognostic (4.32e-1)" "unprognostic (1.43e-2)" "unprognostic (2.80e-3)" "prognostic unfavourable (6.78e-4)" "unprognostic (9.05e-2)" "unprognostic (2.25e-1)" "unprognostic (8.99e-2)" "unprognostic (1.95e-1)" "unprognostic (2.87e-6)" "prognostic favourable (5.41e-4)" "unprognostic (4.06e-2)" "unprognostic (5.34e-2)" "unprognostic (7.50e-2)" 0.7 2.4 1.9 2.0 36.6 3.7 0.8 7.0 10.0 0.4 0.8 3.0 0.0 0.8 0.8 1.6 1.1 0.4 1.2 10.3 1.5 2.1 5.6 0.6 1.0 2.7 2.2 2.9 0.7 1.3 0.4 4.7 1.3 7.6 1.6 1.4 55.6 1.7 0.5 27.4 1.5 1.0 0.8 1.2 1.5 1.0 13.5 9.4 0.2 0.8 2.1 2.1 0.9 0.3 0.6 0.7 2.5 0.6 0.4 0.9 0.4 7.8 3.4 3.1 4.9 1.2 1.1 13.6 3.2 4.1 5.4 5.3 1.8 4.4 3.3 0.4 1.3 8.8 3.3 2.9 8.3 19.1 2.8 2.5 5.6 1.9 0.8 1.6 13.4 1.3 1.0 9.2 5.8 9.3 10.9 2.1 20.9 0.4 4.1 4.0 3.0 7.0 2.8 5.8 0.7 2.0 2.9 0.7 0.7 7.4 0.6 1.6 0.9 3.9 3.3 3.2 3.1 23.8 9.2 1.9 1.3 4.0 21.2 4.1 4.5 2.5 0.6 0.6 0.9 0.4 0.3 0.3 0.6 0.3 0.2 0.6 0.5 0.4 2.0 0.4 0.5 0.7 0.9 0.4 1.9 36.6 7.0 4.8 1.5 2.1 2.2 2.9 7.6 9.4 STUM "C1orf95, DKFZp761P211" ENSG00000203685 "Stum, mechanosensory transduction mediator homolog" Q69YW2 1 226548800-226609214 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.2" "Cell line enriched" "Detected in some" 6 "HEL: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 137.0;basal ganglia: 92.5;cerebral cortex: 117.9;hippocampal formation: 203.1;thalamus: 84.4" "Group enriched" "Detected in many" 4 "amygdala: 176.7;basal ganglia: 134.5;cerebral cortex: 191.4;hippocampal formation: 216.5" HPA074381 Approved Cytosol Cytosol "HPA074381: " "unprognostic (3.23e-3)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (1.94e-1)" "unprognostic (4.09e-2)" "unprognostic (2.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.41e-3)" "unprognostic (3.07e-1)" "unprognostic (5.15e-2)" "unprognostic (7.62e-2)" "unprognostic (3.28e-2)" "prognostic favourable (6.40e-4)" "unprognostic (1.14e-2)" "unprognostic (9.04e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-3)" 2.8 2.2 30.4 2.1 16.2 0.6 3.5 2.4 32.2 3.7 8.1 6.3 0.0 2.8 3.7 3.0 8.9 3.1 1.6 2.5 21.8 7.0 5.8 0.7 1.2 0.9 6.8 15.9 2.7 1.0 1.9 4.2 1.2 18.2 6.2 3.7 1.4 2.0 2.4 5.0 3.7 3.5 8.7 3.0 1.8 1.8 2.0 7.4 0.0 0.8 0.4 1.0 5.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 4.1 0.3 25.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.2 0.0 3.8 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 16.2 2.4 30.0 21.8 7.0 6.8 15.9 18.2 7.4 STX1A "HPC-1, p35-1, STX1" ENSG00000106089 "Syntaxin 1A" Q16623 7 73699206-73719672 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Neurotransmitter transport, Transport" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 73.7;pituitary gland: 26.9" "Cell line enhanced" "Detected in many" "SCLC-21H: 49.9;U-87 MG: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.5;T-reg: 2.4" "Lineage enriched" "Detected in single" 6 "T-cells: 2.5" "Group enriched" "Detected in many" 5 "amygdala: 253.0;basal ganglia: 94.3;cerebral cortex: 362.2;hippocampal formation: 251.5" "Group enriched" "Detected in all" 8 "amygdala: 69.4;cerebral cortex: 158.6;hippocampal formation: 149.3" "CAB008372, HPA069176" Enhanced "Intracellular and membrane" "CAB008372: AB_592786, HPA069176: " "unprognostic (5.12e-3)" "prognostic unfavourable (3.63e-4)" "unprognostic (3.94e-2)" "prognostic unfavourable (1.94e-5)" "unprognostic (3.12e-3)" "unprognostic (1.88e-1)" "unprognostic (3.02e-8)" "unprognostic (1.11e-2)" "unprognostic (6.97e-2)" "unprognostic (3.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.70e-3)" "unprognostic (4.18e-6)" "unprognostic (2.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-3)" "unprognostic (6.20e-2)" 1.4 5.6 27.4 2.4 20.9 7.6 1.4 33.7 73.7 1.7 2.6 1.3 0.8 3.7 2.8 1.8 1.7 2.3 5.5 1.2 22.0 8.3 1.1 1.2 1.8 1.4 4.0 28.0 2.2 5.7 1.5 26.9 2.2 2.6 1.9 2.1 0.1 1.9 1.8 1.1 1.9 3.5 2.6 1.3 1.3 6.2 2.0 0.7 0.0 1.6 0.0 1.1 2.8 1.1 0.4 0.0 0.1 0.2 0.0 2.5 2.7 1.5 7.3 1.2 3.5 1.6 4.2 0.8 5.0 3.3 2.1 1.4 2.5 4.3 1.9 0.7 3.5 1.3 1.7 3.1 1.6 3.4 1.3 0.6 2.6 1.4 1.8 0.8 1.8 2.5 1.4 14.6 5.1 3.6 1.6 2.3 3.9 3.7 0.6 7.1 0.9 16.7 0.0 0.8 1.9 1.7 1.3 49.9 7.9 1.5 4.2 1.0 1.4 0.6 13.6 10.3 3.4 7.9 13.3 1.3 0.8 0.9 33.2 0.7 12.1 0.0 0.2 0.0 2.5 0.0 0.9 0.4 0.4 0.6 0.0 0.1 0.8 0.3 0.1 0.0 0.0 0.0 2.4 2.7 27.4 20.9 33.7 49.9 22.0 8.3 4.0 28.0 2.6 0.7 STX1B "STX1B1, STX1B2" ENSG00000099365 "Syntaxin 1B" P61266 16 30989256-31010661 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 64.9" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 9.7;hTEC/SVTERT24-B: 11.8" "Cancer enriched" "Detected in some" 7 "glioma: 5.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079008" Supported Approved "CAB079008: , HPA069176: " "unprognostic (1.43e-3)" "unprognostic (5.27e-2)" "unprognostic (2.40e-4)" "unprognostic (3.90e-3)" "unprognostic (3.98e-2)" "unprognostic (1.90e-2)" "unprognostic (2.21e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-1)" "unprognostic (3.72e-3)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (7.93e-2)" "unprognostic (1.57e-2)" 1.6 1.9 12.7 1.9 31.8 1.3 1.8 45.8 64.9 1.2 1.4 2.9 0.0 1.4 2.7 4.2 1.9 1.4 1.3 2.1 10.5 10.0 1.4 2.5 1.2 2.4 6.8 26.2 1.3 1.3 1.3 2.2 1.2 39.3 1.8 1.4 1.0 1.9 2.8 1.3 4.0 1.8 2.5 3.8 2.2 1.3 3.2 4.5 0.0 1.3 0.0 2.3 1.3 0.7 0.6 0.3 1.3 0.4 0.5 1.7 0.1 0.1 3.2 5.0 0.8 0.5 0.2 0.2 4.4 6.7 5.5 9.7 0.0 3.6 0.8 0.2 5.8 0.8 2.2 0.6 6.6 2.6 0.4 0.4 2.6 2.5 0.4 0.2 3.1 1.8 0.2 11.8 1.1 0.0 0.5 0.2 5.8 1.3 2.0 0.2 2.5 0.3 7.2 0.2 0.2 0.5 0.0 6.8 4.3 0.5 0.2 0.0 0.8 0.1 0.9 3.2 2.6 0.4 0.2 0.3 0.2 0.3 3.5 0.3 0.1 0.9 0.4 0.7 0.3 0.2 0.1 0.5 1.7 0.3 0.1 0.6 0.3 0.4 1.3 0.5 0.1 0.3 0.2 0.1 12.7 31.8 45.8 60.5 10.5 10.0 6.8 26.2 39.3 4.5 STXBP1 "hUNC18, MUNC18-1, rbSec1, UNC18" ENSG00000136854 "Syntaxin binding protein 1" P61764 9 127579370-127696027 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 127.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 47.1;SK-MEL-30: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 3.4" "Lineage enriched" "Detected in single" 7 "T-cells: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008209, HPA023483, CAB034434" Enhanced Approved Nucleoplasm,Cytosol 6400 "Nucleoplasm, Cytosol" "CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625" "unprognostic (2.32e-2)" "unprognostic (7.33e-2)" "unprognostic (3.85e-2)" "prognostic unfavourable (4.78e-4)" "unprognostic (1.80e-1)" "prognostic unfavourable (1.47e-4)" "prognostic unfavourable (5.73e-4)" "unprognostic (2.87e-2)" "unprognostic (2.31e-1)" "unprognostic (3.08e-3)" "prognostic favourable (9.81e-4)" "unprognostic (1.30e-2)" "unprognostic (1.67e-1)" "unprognostic (2.68e-2)" "unprognostic (5.51e-2)" "unprognostic (7.66e-2)" "unprognostic (3.36e-3)" 14.1 16.0 32.4 4.7 42.2 1.5 5.1 86.8 127.4 8.1 4.6 6.5 1.9 3.7 13.2 4.7 6.3 17.9 6.7 12.7 35.0 31.5 7.1 2.7 16.8 3.7 24.6 55.5 14.3 13.2 8.1 22.3 7.9 61.9 6.5 5.3 12.6 8.1 6.6 5.0 5.6 4.6 11.7 13.3 5.9 5.2 5.4 5.3 0.0 10.7 0.9 4.3 5.7 7.6 0.0 0.5 0.0 0.4 0.0 3.4 0.6 4.0 8.5 8.2 9.2 18.6 16.0 7.4 14.3 7.3 8.6 7.6 0.4 4.8 4.0 8.0 9.3 1.4 7.2 8.8 10.6 9.2 4.8 5.4 23.1 1.5 9.4 0.5 4.7 12.1 4.9 22.6 11.0 10.2 5.4 6.2 14.5 7.5 3.8 1.7 7.0 11.8 2.3 3.9 9.7 7.1 0.2 47.1 22.9 24.1 11.9 40.8 1.8 1.7 15.2 9.8 5.0 19.2 5.3 13.4 22.1 5.4 19.2 5.8 9.0 0.0 0.4 0.0 0.8 0.1 0.3 0.0 2.2 3.4 0.5 0.0 1.4 1.7 0.0 0.0 0.1 0.3 0.3 0.6 32.4 42.2 86.8 87.7 35.0 31.5 24.6 55.5 61.9 5.3 STXBP5L "KIAA1006, LLGL4" ENSG00000145087 "Syntaxin binding protein 5 like" Q9Y2K9 3 120908072-121424761 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.2;ovary: 19.7" "Cell line enhanced" "Detected in some" "AF22: 8.1;HeLa: 5.9;MOLT-4: 7.7;RH-30: 4.0;SCLC-21H: 11.1;SH-SY5Y: 4.9;U-937: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.42e-1)" "unprognostic (9.47e-2)" "unprognostic (6.30e-2)" "unprognostic (2.85e-3)" "unprognostic (1.75e-1)" "unprognostic (2.89e-2)" "unprognostic (7.01e-2)" "unprognostic (1.41e-1)" "unprognostic (1.48e-1)" "unprognostic (6.73e-3)" "unprognostic (2.52e-1)" "unprognostic (6.52e-3)" "unprognostic (5.13e-2)" "unprognostic (3.58e-1)" "unprognostic (1.86e-3)" "unprognostic (8.61e-3)" 0.9 4.3 9.1 0.9 15.4 0.8 0.8 55.2 22.6 1.8 1.6 1.3 1.3 1.3 2.6 0.8 1.4 1.1 0.9 0.8 13.9 3.4 0.8 0.8 0.9 0.8 3.1 17.1 19.7 1.2 0.8 12.6 0.9 22.4 5.2 1.2 0.0 0.9 7.4 0.8 0.8 1.4 2.5 2.1 0.8 1.7 4.3 2.5 0.0 16.1 0.0 0.8 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 5.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.0 4.0 0.8 0.0 4.0 0.0 0.0 0.8 11.1 4.9 0.0 0.0 0.1 1.1 2.9 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.0 2.2 4.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 15.4 55.2 22.6 13.9 3.4 3.1 17.1 22.4 2.5 SULT4A1 "hBR-STL-1, SULTX3" ENSG00000130540 "Sulfotransferase family 4A member 1" Q9BR01 22 43824509-43862503 "Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "brain: 80.3" "Group enriched" "Detected in some" 4 "HEK 293: 2.5;THP-1: 3.8" "Cancer enhanced" "Detected in many" "testis cancer: 6.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003129 Enhanced "HPA003129: AB_1080130" "unprognostic (2.61e-3)" "unprognostic (1.05e-2)" "unprognostic (2.62e-1)" "unprognostic (6.30e-2)" "unprognostic (6.12e-3)" "unprognostic (1.32e-1)" "unprognostic (1.63e-1)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" "unprognostic (2.48e-4)" "unprognostic (1.91e-2)" "unprognostic (6.10e-2)" "unprognostic (7.59e-4)" "unprognostic (7.89e-2)" "unprognostic (1.22e-1)" "unprognostic (8.20e-3)" "unprognostic (8.34e-3)" 1.2 4.0 12.1 1.5 17.2 1.2 1.2 27.8 80.3 1.2 1.7 1.1 0.0 1.3 1.2 1.2 1.2 1.2 1.3 1.2 15.7 19.3 1.2 1.2 1.2 1.2 13.1 18.9 1.2 1.4 1.2 0.8 1.2 18.0 1.2 1.4 0.6 1.3 1.2 1.2 1.2 1.6 1.5 3.1 1.3 1.3 1.9 1.3 0.0 1.2 0.0 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 17.2 27.8 44.4 15.7 19.3 13.1 18.9 18.0 1.3 SUSD4 FLJ10052 ENSG00000143502 "Sushi domain containing 4" Q5VX71 1 223220819-223364202 "Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.0;esophagus: 33.8" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;RPTEC TERT1: 8.3;SCLC-21H: 28.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 7.4;naive CD4 T-cell: 11.7" "Lineage enriched" "Detected in single" 66 "T-cells: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058296 Uncertain Approved Vesicles "Intracellular and membrane" Vesicles "HPA058296: " "unprognostic (2.90e-1)" "unprognostic (2.90e-3)" "unprognostic (1.27e-3)" "prognostic unfavourable (4.28e-4)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (7.53e-3)" "unprognostic (1.82e-3)" "unprognostic (7.94e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-3)" "unprognostic (1.36e-1)" "unprognostic (6.51e-6)" "unprognostic (3.64e-2)" "unprognostic (5.11e-2)" "unprognostic (3.03e-1)" "unprognostic (7.11e-2)" 0.8 5.2 15.9 1.5 33.0 0.9 8.1 9.9 21.3 3.4 0.9 4.0 4.7 1.5 0.9 24.3 33.8 3.6 1.3 9.6 30.6 14.6 13.7 4.0 3.2 1.9 6.8 12.8 27.8 7.6 8.3 16.5 1.0 6.6 4.4 0.8 1.2 13.2 5.7 1.2 3.5 0.9 0.9 2.4 0.8 7.6 5.1 3.8 0.3 1.5 8.1 13.8 2.7 9.1 0.0 0.0 0.0 0.1 0.1 11.7 1.8 4.2 0.4 0.1 0.0 0.0 0.0 0.1 0.5 0.2 0.7 0.5 4.4 1.3 0.0 1.4 0.1 7.0 0.2 1.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.4 0.0 0.3 3.2 3.0 0.0 0.1 0.8 0.0 0.1 0.0 8.3 1.9 28.5 0.3 0.0 2.3 0.0 1.8 0.2 0.0 1.2 5.1 0.0 2.5 0.5 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.1 6.0 0.0 7.4 1.9 0.0 0.0 11.7 2.1 0.0 0.1 0.0 0.0 1.0 1.8 15.9 33.0 9.9 17.9 30.6 14.6 6.8 12.8 6.6 3.8 SV2A "KIAA0736, SV2" ENSG00000159164 "Synaptic vesicle glycoprotein 2A" Q7L0J3 1 149903318-149917882 "FDA approved drug targets, Predicted membrane proteins" "Neurotransmitter transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3;parathyroid gland: 34.0" "Cell line enhanced" "Detected in many" "NTERA-2: 26.0" "Cancer enriched" "Detected in many" 6 "glioma: 27.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002226, HPA007863" Enhanced Approved Cytosol Cytosol "CAB002226: AB_564144, HPA007863: AB_1080135" "unprognostic (8.05e-3)" "unprognostic (3.86e-3)" "unprognostic (2.24e-1)" "unprognostic (5.39e-2)" "unprognostic (2.66e-1)" "unprognostic (2.02e-1)" "unprognostic (6.24e-2)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (2.06e-1)" "unprognostic (9.00e-3)" "unprognostic (1.00e-1)" "prognostic unfavourable (3.22e-4)" "unprognostic (1.44e-2)" "unprognostic (9.86e-2)" "unprognostic (1.95e-2)" "unprognostic (4.81e-3)" 2.0 7.3 20.4 2.8 24.7 4.5 1.5 36.8 75.3 3.2 2.3 4.8 0.9 1.9 5.6 18.0 2.0 3.2 3.2 1.5 22.3 30.5 1.7 1.2 1.8 2.3 21.6 25.1 2.6 1.9 34.0 7.2 1.9 32.9 3.1 2.2 3.1 1.7 3.7 1.1 1.5 2.2 6.6 16.8 2.0 2.0 1.6 6.0 0.3 4.0 0.0 2.0 2.5 1.2 1.2 0.8 2.1 0.7 1.7 2.5 0.6 0.1 0.0 10.2 0.0 1.0 3.0 1.1 4.3 15.1 12.9 18.7 0.3 0.4 0.1 3.9 6.5 0.2 0.1 0.9 11.2 0.0 2.4 13.4 0.7 0.7 9.9 0.1 0.2 6.7 0.1 20.6 1.5 1.1 0.1 14.0 8.5 0.1 12.9 0.6 26.0 0.0 4.5 6.5 0.2 0.1 0.3 21.5 17.3 0.0 0.1 9.8 0.1 8.1 0.0 12.0 12.1 0.5 15.7 0.1 0.1 0.0 21.1 0.1 4.7 1.5 0.7 0.4 1.8 0.3 1.9 0.7 1.9 1.1 0.2 1.2 1.0 2.2 2.1 1.7 0.3 0.8 2.5 0.6 20.4 24.7 36.8 40.0 22.3 30.5 21.6 25.1 32.9 6.0 SV2B "HsT19680, KIAA0735" ENSG00000185518 "Synaptic vesicle glycoprotein 2B" Q7L1I2 15 91099950-91301309 "Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 44.2" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.6;SCLC-21H: 8.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046247 Approved "HPA046247: AB_10963538" "unprognostic (2.92e-1)" "unprognostic (7.92e-2)" "unprognostic (1.32e-3)" "unprognostic (4.01e-5)" "unprognostic (2.66e-3)" "unprognostic (7.77e-2)" "unprognostic (3.36e-2)" "unprognostic (1.01e-1)" "unprognostic (3.57e-2)" "unprognostic (9.89e-2)" "unprognostic (1.20e-2)" "unprognostic (2.49e-1)" "unprognostic (1.39e-1)" "unprognostic (3.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-2)" "unprognostic (3.10e-4)" 3.5 2.7 13.1 1.4 16.8 1.1 1.6 26.2 44.2 1.2 1.4 1.4 0.0 1.2 1.2 1.3 1.2 1.3 1.4 1.8 19.7 3.3 1.3 1.3 1.4 1.6 5.1 21.3 1.1 3.1 1.1 1.3 1.4 25.6 2.2 1.6 7.3 2.4 1.2 1.7 1.4 1.6 1.3 1.5 1.3 1.4 2.2 0.2 0.0 1.2 0.0 2.7 1.2 0.6 0.6 0.4 1.2 0.3 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 4.6 0.0 0.1 8.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.1 0.2 0.9 0.4 1.2 0.3 0.3 0.2 0.1 0.1 0.6 0.3 0.3 0.0 0.6 0.4 0.3 1.1 0.7 0.1 0.4 0.1 0.0 13.1 16.8 26.2 31.3 19.7 3.3 5.1 21.3 25.6 0.2 SV2C ENSG00000122012 "Synaptic vesicle glycoprotein 2C" Q496J9 5 76083172-76353939 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 52.2" "Group enriched" "Detected in some" 5 "Karpas-707: 11.9;SCLC-21H: 4.9;SH-SY5Y: 11.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 52.2;pons and medulla: 26.6" "Cell type enriched" "Detected in single" 14 "basophil: 4.2" "Lineage enriched" "Detected in single" 21 "granulocytes: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040722, HPA040770" Supported Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA040722: AB_10795624, HPA040770: AB_10805828" "unprognostic (7.91e-2)" "unprognostic (2.33e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-2)" "unprognostic (1.07e-1)" "unprognostic (9.93e-2)" "unprognostic (1.09e-2)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (2.34e-2)" "unprognostic (1.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" 0.5 5.5 0.8 1.3 52.2 0.7 1.2 1.2 9.5 0.7 0.8 0.5 0.0 1.0 0.7 0.9 0.6 1.8 0.6 0.8 0.6 8.3 0.4 0.4 0.4 0.5 5.6 1.9 2.6 0.8 0.9 0.8 0.4 26.6 1.0 1.1 1.1 1.7 1.2 0.3 0.7 1.3 1.0 5.8 0.6 1.6 1.0 6.7 0.0 0.5 0.0 0.4 0.6 0.4 0.1 0.1 4.2 0.2 0.1 0.2 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.3 4.9 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.2 0.8 52.2 1.2 9.5 0.6 8.3 5.6 1.9 26.6 6.7 SVIP DKFZp313A2432 ENSG00000198168 "Small VCP interacting protein" Q8NHG7 11 22813799-22830299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.1" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039807 Approved "HPA039807: AB_10795232" "unprognostic (1.18e-2)" "unprognostic (2.05e-1)" "unprognostic (2.21e-1)" "unprognostic (2.72e-2)" "unprognostic (1.66e-1)" "unprognostic (1.77e-2)" "unprognostic (2.34e-2)" "unprognostic (1.73e-1)" "unprognostic (8.80e-2)" "unprognostic (2.02e-2)" "unprognostic (9.31e-2)" "unprognostic (2.44e-1)" "prognostic favourable (1.77e-8)" "unprognostic (2.18e-2)" "unprognostic (1.24e-1)" "unprognostic (5.21e-2)" "unprognostic (1.16e-2)" 3.4 9.1 17.5 5.5 20.6 15.6 11.4 11.8 18.1 7.7 7.9 11.3 6.6 10.7 7.6 19.7 6.0 8.8 8.9 11.6 16.3 22.6 16.4 5.8 8.0 8.4 29.0 10.5 9.0 13.6 16.3 23.1 2.9 32.4 13.8 8.8 4.4 11.1 9.1 10.0 5.7 11.1 6.6 67.1 8.1 18.8 9.3 15.7 3.3 24.9 3.1 7.3 6.9 6.7 9.5 17.7 16.2 1.0 4.6 12.7 4.5 0.0 2.3 5.2 0.2 0.6 0.2 3.1 2.1 1.5 2.9 2.4 1.5 2.0 0.0 3.3 1.6 1.3 7.6 2.1 3.9 14.5 5.9 7.3 2.3 3.7 1.5 12.1 10.7 0.3 2.9 0.0 1.9 11.0 14.8 16.3 2.9 3.6 13.0 1.6 3.0 6.0 11.4 5.2 10.9 5.4 6.6 26.5 5.9 0.0 6.4 6.9 10.8 2.3 7.6 1.3 4.6 18.3 3.5 4.1 0.0 4.2 8.6 0.0 5.4 5.2 1.0 16.2 6.3 0.5 8.2 8.9 10.2 7.1 1.2 9.5 12.7 9.1 3.3 4.6 0.7 17.7 6.8 4.5 17.5 20.6 11.8 18.1 16.3 22.6 29.0 10.5 32.4 15.7 SVOP DKFZp761H039 ENSG00000166111 "SV2 related protein" Q8N4V2 12 108907741-109021240 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 30.3" "Group enriched" "Detected in some" 13 "Karpas-707: 6.1;RPMI-8226: 6.2;SCLC-21H: 3.4;SH-SY5Y: 3.0;U-266/84: 2.8" "Group enriched" "Detected in some" 9 "glioma: 0.6;pancreatic cancer: 1.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016573 Uncertain "HPA016573: AB_2197027" "unprognostic (6.88e-2)" "unprognostic (1.10e-1)" "unprognostic (2.09e-1)" "unprognostic (6.51e-3)" "unprognostic (2.18e-2)" "unprognostic (3.79e-1)" "unprognostic (1.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.38e-2)" "unprognostic (4.29e-3)" "unprognostic (3.07e-1)" "unprognostic (4.28e-3)" "unprognostic (3.94e-2)" "unprognostic (2.26e-2)" "unprognostic (6.17e-2)" 0.6 2.9 6.9 0.7 14.0 0.7 0.6 8.2 30.3 0.6 0.8 0.5 0.0 1.3 0.6 0.7 0.6 1.1 0.6 1.1 8.9 1.9 0.7 0.6 0.7 0.6 0.7 10.0 0.6 1.7 0.5 6.8 0.6 6.4 0.8 0.8 1.5 0.6 0.7 0.7 0.6 1.0 0.6 0.8 0.6 1.8 1.0 0.7 0.0 0.7 0.0 0.5 0.6 0.7 0.6 0.4 2.0 0.4 0.9 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 6.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.0 3.4 3.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 2.8 0.1 0.0 0.1 0.0 1.5 0.4 0.4 0.3 0.2 0.2 0.2 0.3 0.2 0.1 0.6 0.3 0.3 2.0 0.9 0.3 0.4 0.2 0.1 6.9 14.0 8.2 21.6 8.9 1.9 0.7 10.0 6.4 0.7 SYN1 ENSG00000008056 "Synapsin I" P17600 X 47571898-47619943 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 127.0" "Cell line enhanced" "Detected in some" "HaCaT: 6.9;HHSteC: 6.4;NTERA-2: 13.5;SCLC-21H: 23.6;SH-SY5Y: 6.1" "Cancer enhanced" "Detected in many" "glioma: 11.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000397, CAB021929" Enhanced "CAB021929: , HPA000397: AB_1080146" "unprognostic (1.22e-1)" "unprognostic (9.25e-2)" "unprognostic (2.16e-3)" "unprognostic (4.48e-3)" "unprognostic (3.05e-3)" "unprognostic (7.57e-2)" "unprognostic (1.63e-1)" "unprognostic (4.31e-1)" "unprognostic (3.49e-2)" "unprognostic (6.68e-2)" "unprognostic (3.97e-3)" "unprognostic (1.32e-1)" "unprognostic (2.64e-4)" "unprognostic (2.73e-3)" "unprognostic (5.79e-2)" "unprognostic (2.95e-3)" "unprognostic (5.27e-2)" 1.7 7.1 31.8 2.9 33.3 2.0 1.3 34.4 127.0 1.7 1.9 2.1 0.0 1.4 1.6 1.9 1.5 2.1 2.5 7.6 33.6 24.9 1.4 1.8 1.7 1.3 13.3 27.1 2.5 2.0 2.1 6.1 3.4 24.0 2.0 2.1 0.9 1.3 2.0 1.5 1.7 2.0 2.0 3.7 1.3 1.9 2.4 2.1 0.0 1.2 0.0 1.5 1.9 0.1 0.0 0.8 0.0 0.6 0.0 0.9 0.0 0.0 0.0 3.8 0.5 0.1 0.8 0.0 0.6 0.1 1.1 0.3 0.0 0.0 0.0 1.2 0.1 6.9 0.3 0.0 0.3 0.5 0.1 0.3 0.0 0.0 6.4 0.0 1.7 1.5 0.0 1.1 0.3 0.0 0.4 0.2 0.2 0.2 0.2 0.2 13.5 0.1 0.0 0.0 0.2 0.0 0.0 23.6 6.1 0.0 0.0 0.1 1.7 0.0 0.2 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.9 0.0 0.0 0.6 0.8 0.0 0.0 31.8 33.3 34.4 56.9 33.6 24.9 13.3 27.1 24.0 2.1 SYN2 "SYNII, SYNIIa, SYNIIb" ENSG00000157152 "Synapsin II" 3 12004402-12191400 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 20 "brain: 72.5" "Cell line enhanced" "Detected in some" "HAP1: 3.4;HEK 293: 3.3;HMC-1: 6.1;NTERA-2: 5.1;SCLC-21H: 4.1;SH-SY5Y: 16.2" "Cancer enhanced" "Detected in many" "glioma: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037012, CAB079005" Supported Approved Nucleoplasm Nucleoplasm "CAB079005: , HPA037012: " "unprognostic (1.62e-3)" "unprognostic (1.60e-2)" "unprognostic (7.54e-2)" "unprognostic (9.87e-3)" "unprognostic (1.73e-1)" "unprognostic (3.19e-1)" "unprognostic (6.32e-3)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-4)" "unprognostic (9.94e-2)" "unprognostic (7.35e-2)" "unprognostic (1.78e-2)" 3.7 2.7 28.2 0.7 23.3 0.5 1.4 9.2 72.5 1.0 0.8 0.2 0.0 0.8 1.2 1.2 0.5 0.8 0.7 0.7 15.4 1.4 0.4 0.8 0.5 0.0 33.4 1.5 0.5 1.8 0.0 2.3 15.3 0.7 0.9 0.0 0.9 0.6 0.9 0.9 1.2 1.9 2.2 0.8 1.2 2.4 1.6 0.0 0.5 0.0 0.5 0.5 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 0.7 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 3.4 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 6.1 0.1 0.0 0.1 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 5.1 0.4 0.0 0.0 0.0 0.0 0.2 4.1 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 SYN3 ENSG00000185666 "Synapsin III" O14994 22 32512552-33058372 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Cell line enhanced" "Detected in some" "HAP1: 8.1;Hep G2: 4.6;NTERA-2: 5.5;SCLC-21H: 10.8;WM-115: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 29 "naive B-cell: 7.2" "Lineage enriched" "Detected in single" 29 "B-cells: 7.2" "Low region specificity" "Detected in all" HPA034566 Uncertain "HPA034566: AB_10603120" "unprognostic (1.15e-2)" "unprognostic (1.55e-1)" "unprognostic (1.56e-1)" "unprognostic (3.03e-2)" "unprognostic (5.13e-3)" "unprognostic (2.34e-1)" "unprognostic (9.39e-2)" "unprognostic (3.24e-1)" "unprognostic (7.77e-2)" "unprognostic (8.91e-2)" "unprognostic (8.59e-2)" "unprognostic (7.44e-3)" "unprognostic (4.35e-3)" "unprognostic (1.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.40e-2)" "unprognostic (3.52e-1)" 1.2 2.1 23.9 1.0 13.8 3.6 2.1 4.9 20.2 0.8 1.5 0.3 0.0 1.1 1.2 1.3 1.2 1.6 2.3 1.4 7.9 5.6 1.5 1.1 1.8 2.4 3.8 12.3 1.2 2.1 0.6 3.9 6.2 15.3 1.5 1.4 0.4 1.4 1.3 0.8 3.0 1.8 1.3 3.6 3.4 1.6 8.7 3.3 0.0 2.0 0.0 1.4 0.9 0.8 7.2 0.1 0.2 0.0 0.0 0.0 0.2 0.3 0.3 0.4 2.8 0.3 1.0 0.5 0.6 0.2 0.1 0.4 1.6 0.2 0.8 0.2 0.1 0.7 8.1 0.0 0.0 0.2 1.4 0.5 0.9 4.6 0.0 0.8 0.5 0.3 1.9 0.1 0.0 0.3 0.7 0.5 0.2 0.0 0.6 0.6 5.5 0.0 0.3 1.0 0.6 0.0 1.4 10.8 1.0 0.2 0.1 1.7 0.1 0.3 0.0 0.2 1.0 0.6 0.2 0.6 0.8 0.2 0.5 0.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 23.9 13.8 4.9 20.2 7.9 5.6 3.8 12.3 15.3 3.3 SYNDIG1 "C20orf39, FLJ14220, IFITMD5, SynDIG1, TMEM90B" ENSG00000101463 "Synapse differentiation inducing 1" Q9H7V2 20 24469199-24666616 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.3;heart muscle: 28.2" "Cell line enhanced" "Detected in some" "Karpas-707: 8.0;RH-30: 22.8;RPMI-8226: 21.6;SCLC-21H: 5.3;U-87 MG: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044271, HPA059267" Enhanced Vesicles Vesicles "HPA044271: , HPA059267: " "unprognostic (9.33e-2)" "unprognostic (1.83e-2)" "unprognostic (2.17e-1)" "unprognostic (9.56e-2)" "unprognostic (5.03e-2)" "unprognostic (1.27e-1)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (1.62e-1)" "unprognostic (4.69e-2)" "unprognostic (4.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.94e-2)" "unprognostic (7.75e-3)" "unprognostic (2.21e-1)" "prognostic unfavourable (6.16e-6)" "unprognostic (1.40e-3)" 2.6 1.7 12.5 2.1 12.0 0.7 0.8 21.3 22.7 4.5 1.5 23.3 0.3 1.9 2.6 1.5 0.9 5.1 10.0 28.2 12.8 8.8 6.2 0.7 1.1 2.5 14.5 12.9 1.3 1.4 0.9 0.6 0.9 11.5 3.2 1.6 0.5 0.8 14.8 0.6 0.8 2.8 3.1 22.4 1.4 2.2 1.3 16.6 0.1 5.1 0.0 3.1 2.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 22.8 21.6 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 12.0 21.3 19.7 12.8 8.8 14.5 12.9 11.5 16.6 SYNDIG1L "capucin, IFITMD4, TMEM90A" ENSG00000183379 "Synapse differentiation inducing 1 like" A6NDD5 14 74405893-74426102 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 27 "brain: 78.1;epididymis: 20.1" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;U-266/70: 1.8;U-266/84: 2.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 78.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 8 "basal ganglia: 251.1" "Region enriched" "Detected in many" 6 "basal ganglia: 71.7" "HPA042594, HPA048487" Uncertain "HPA042594: , HPA048487: " "unprognostic (5.75e-2)" "unprognostic (9.96e-3)" "unprognostic (2.25e-2)" "unprognostic (5.51e-2)" "unprognostic (3.08e-3)" "unprognostic (5.72e-2)" "unprognostic (5.83e-2)" "unprognostic (4.51e-2)" "unprognostic (2.83e-2)" "unprognostic (5.74e-2)" "unprognostic (8.85e-2)" "unprognostic (1.63e-1)" "unprognostic (3.85e-2)" "unprognostic (8.56e-2)" "unprognostic (1.50e-1)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" 0.6 0.4 0.3 0.4 78.1 0.2 0.6 0.0 4.0 0.5 0.6 1.1 0.0 0.3 0.6 20.1 0.5 0.4 0.7 0.4 2.4 1.6 0.6 0.3 1.8 0.4 3.5 0.2 0.4 0.5 0.2 0.0 0.3 0.5 0.6 0.6 0.1 0.4 0.6 0.3 0.5 0.9 0.8 0.4 0.4 0.3 0.4 16.6 0.0 0.3 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.9 0.0 0.9 0.0 0.1 0.5 0.0 0.0 0.5 0.0 0.8 0.0 0.4 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.2 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.8 2.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.3 78.1 0.0 4.0 2.4 1.6 3.5 0.2 0.5 16.6 SYNGAP1 "KIAA1938, RASA5, SYNGAP" ENSG00000197283 "Synaptic Ras GTPase activating protein 1" Q96PV0 6 33419661-33457541 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Autism, Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell line enhanced" "Detected in many" "AF22: 20.7;HMC-1: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.9" "Group enriched" "Detected in many" 6 "B-cells: 1.5;T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038373 Enhanced Approved Nucleoplasm Nucleoplasm "HPA038373: AB_10670779" "unprognostic (3.72e-1)" "unprognostic (3.13e-2)" "unprognostic (4.74e-2)" "unprognostic (2.23e-2)" "unprognostic (4.35e-2)" "prognostic favourable (2.80e-4)" "unprognostic (3.66e-2)" "unprognostic (8.65e-2)" "unprognostic (4.02e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-2)" "unprognostic (9.81e-2)" "prognostic unfavourable (1.34e-6)" "unprognostic (9.48e-3)" "unprognostic (1.73e-1)" "unprognostic (1.83e-2)" "unprognostic (2.47e-2)" 4.5 5.0 29.7 11.9 28.6 6.2 4.3 27.2 33.7 7.8 5.9 5.5 2.4 6.0 13.0 5.3 4.2 11.9 6.1 4.4 37.9 7.6 4.0 2.2 5.9 10.3 4.1 38.9 12.8 3.5 10.0 26.1 6.2 7.9 6.3 4.7 3.2 3.7 7.1 2.3 6.2 5.7 11.1 8.7 9.7 4.9 8.7 9.3 8.9 5.6 0.2 7.0 6.9 6.4 1.5 0.1 0.1 0.2 0.0 1.9 0.0 2.0 0.9 20.7 7.7 4.3 4.5 2.6 5.0 3.2 2.8 2.2 8.6 0.8 5.8 1.3 2.4 3.0 2.6 2.9 2.0 3.3 1.6 14.5 2.3 0.5 2.9 2.2 17.0 3.1 0.9 5.2 2.5 2.0 4.5 2.7 2.0 4.3 3.5 3.4 10.4 2.2 13.6 0.5 2.4 2.1 1.5 5.0 4.0 1.9 3.6 1.6 7.9 2.1 0.6 5.9 5.8 2.3 0.9 3.2 1.1 4.3 3.4 2.6 1.4 0.0 0.2 0.1 0.3 0.0 0.8 0.1 1.9 0.9 0.0 1.5 0.9 0.2 0.1 0.0 0.1 0.1 0.1 0.0 29.7 28.6 27.2 33.7 37.9 7.6 4.1 38.9 7.9 9.3 SYNGR1 ENSG00000100321 "Synaptogyrin 1" O43759 22 39349925-39385588 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 21.0;monocytes: 18.9;T-cells: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029673, CAB034277" Enhanced Supported Cytosol Cytosol "CAB034277: AB_2255766, HPA029673: AB_10670430" "unprognostic (2.68e-3)" "unprognostic (1.84e-3)" "unprognostic (5.90e-2)" "unprognostic (8.51e-2)" "unprognostic (3.74e-1)" "unprognostic (5.98e-3)" "unprognostic (7.39e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-2)" "prognostic favourable (2.41e-4)" "unprognostic (1.16e-1)" "prognostic favourable (4.98e-7)" "unprognostic (1.32e-3)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" "unprognostic (1.04e-1)" 4.4 11.4 19.4 2.7 31.4 39.9 8.0 66.9 62.0 15.6 6.3 8.5 1.0 3.3 9.2 6.5 17.3 9.8 6.1 21.6 31.6 22.3 5.5 2.0 3.3 3.8 17.4 35.1 38.8 14.5 10.3 4.1 3.7 23.5 10.9 2.6 19.5 23.5 10.4 13.4 26.2 3.0 7.2 7.0 4.1 4.8 7.2 5.4 0.7 4.6 4.6 5.2 7.8 9.0 2.4 21.0 0.8 18.9 2.6 15.2 7.8 2.6 4.7 8.6 15.4 0.8 2.2 3.8 11.4 20.1 14.5 13.4 1.0 0.3 0.1 2.6 3.0 3.7 5.8 0.2 4.4 0.0 18.0 0.2 0.3 0.5 2.5 0.7 5.3 3.3 0.9 4.0 0.0 0.7 5.1 0.3 2.2 6.0 2.3 2.1 1.7 9.2 6.7 0.0 0.7 0.4 7.3 13.6 2.8 2.9 12.4 11.8 18.3 13.4 0.2 0.0 10.1 0.1 0.0 3.1 0.1 7.2 0.4 14.5 15.5 0.2 18.9 0.3 15.2 5.5 0.9 2.4 0.6 4.4 21.0 2.2 0.7 8.2 0.8 2.6 0.2 15.3 0.1 7.8 19.4 31.4 66.9 62.0 31.6 22.3 17.4 35.1 23.5 5.4 SYNGR3 ENSG00000127561 "Synaptogyrin 3" O43761 16 1989660-1994275 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.3" "Cell line enhanced" "Detected in many" "HDLM-2: 25.1;HMC-1: 16.2;Karpas-707: 13.7;SK-BR-3: 17.1;U-266/70: 21.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.7;NK-cells: 4.6;T-cells: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034278, HPA042842" Enhanced Approved "Plasma membrane" "Plasma membrane" "CAB034278: AB_2200905, HPA042842: " "unprognostic (8.89e-3)" "prognostic favourable (6.92e-4)" "unprognostic (6.07e-3)" "unprognostic (2.94e-3)" "unprognostic (2.92e-2)" "unprognostic (8.06e-3)" "unprognostic (2.52e-1)" "unprognostic (5.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.06e-1)" "unprognostic (3.69e-3)" "unprognostic (1.05e-1)" "prognostic favourable (7.12e-7)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.79e-1)" "unprognostic (8.78e-2)" 1.1 11.1 20.3 3.7 21.8 1.6 1.1 24.2 55.3 1.5 2.3 2.6 0.0 2.2 1.0 1.0 1.3 1.1 1.3 1.4 14.6 40.8 1.7 1.0 1.3 4.0 27.1 20.1 1.5 1.0 9.4 3.1 5.4 28.2 1.3 2.2 0.9 2.1 1.1 0.9 1.1 2.5 1.7 4.4 2.2 2.1 4.2 2.0 0.0 1.0 0.0 4.7 1.4 0.2 3.7 0.7 0.0 0.8 4.6 2.7 0.9 0.4 2.1 1.9 0.2 0.2 0.2 2.4 0.9 1.6 0.8 0.6 3.2 1.5 3.1 0.7 0.7 1.8 2.1 0.3 0.2 25.1 1.5 0.0 2.7 1.5 1.1 0.0 16.2 0.5 0.1 0.0 0.5 0.2 9.0 13.7 0.4 2.4 0.1 0.1 10.1 0.9 0.0 0.2 2.4 1.3 0.0 4.5 5.7 2.3 17.1 0.2 2.3 0.2 0.3 0.5 7.9 0.0 0.3 21.6 2.5 3.6 0.3 2.8 0.3 0.0 0.8 0.0 0.9 0.3 2.1 3.2 1.7 2.7 0.7 3.7 2.0 0.8 0.0 4.6 0.7 0.0 1.6 0.9 20.3 21.8 24.2 39.3 14.6 40.8 27.1 20.1 28.2 2.0 SYNJ1 "INPP5G, PARK20" ENSG00000159082 "Synaptojanin 1" O43426 21 32628759-32728048 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, RNA-binding" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011916 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA011916: AB_1857692" "unprognostic (6.84e-2)" "unprognostic (8.64e-2)" "unprognostic (5.76e-2)" "unprognostic (6.44e-2)" "unprognostic (1.27e-1)" "prognostic favourable (4.43e-4)" "unprognostic (1.45e-1)" "unprognostic (3.73e-3)" "unprognostic (1.63e-1)" "unprognostic (6.22e-3)" "unprognostic (1.84e-2)" "prognostic unfavourable (2.58e-4)" "unprognostic (1.28e-1)" "unprognostic (6.36e-2)" "unprognostic (5.97e-2)" "unprognostic (1.79e-1)" "unprognostic (2.92e-1)" 5.5 6.8 13.6 5.0 25.9 20.6 4.2 19.5 39.0 4.8 4.8 6.5 0.8 3.9 4.6 5.3 3.9 4.0 5.2 5.2 18.3 18.2 7.4 5.5 6.5 5.7 16.6 18.4 4.6 4.5 10.6 10.9 9.3 33.5 3.6 5.5 7.0 3.8 4.0 4.4 5.0 4.6 5.0 7.3 6.0 4.2 9.0 5.7 3.2 6.8 1.5 4.8 4.7 3.3 0.4 3.1 11.5 6.0 0.5 3.0 1.1 5.5 2.8 5.1 5.6 8.9 7.2 10.3 11.5 6.6 7.0 5.9 6.3 2.6 2.0 3.9 6.9 5.2 9.1 6.7 8.4 6.5 8.7 13.8 9.0 3.5 4.8 5.7 12.3 4.0 5.0 12.2 6.2 10.9 10.3 11.9 9.0 5.6 5.3 4.7 3.6 6.3 5.8 11.1 7.2 7.4 4.0 5.8 4.5 14.1 9.0 5.5 7.8 7.4 12.1 10.9 5.4 8.7 6.3 6.2 7.2 4.3 8.2 10.8 8.6 3.7 3.4 7.9 1.6 6.0 2.7 0.2 2.4 2.6 3.1 0.4 2.9 2.8 11.5 0.5 5.3 1.6 3.0 1.1 13.6 25.9 19.5 28.7 18.3 18.2 16.6 18.4 33.5 5.7 SYNJ2 INPP5H ENSG00000078269 "Synaptojanin 2" O15056 6 157981887-158099176 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 62.0" "Cell line enhanced" "Detected in many" "TIME: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031575 Approved Approved Microtubules,Cytosol Microtubules Cytosol "HPA031575: AB_10604101" "prognostic unfavourable (2.63e-4)" "unprognostic (1.94e-2)" "unprognostic (7.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.48e-2)" "unprognostic (7.68e-2)" "unprognostic (1.24e-1)" "unprognostic (7.06e-2)" "unprognostic (2.91e-1)" "unprognostic (7.29e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "prognostic unfavourable (4.02e-6)" "unprognostic (1.66e-2)" "unprognostic (3.75e-2)" "unprognostic (1.75e-1)" "unprognostic (9.45e-2)" 2.8 3.9 12.2 4.9 25.1 15.3 6.7 3.0 18.7 3.9 8.7 50.5 3.7 5.8 5.2 9.4 6.0 4.6 8.0 8.5 17.8 10.9 3.2 4.0 2.8 4.4 46.8 8.8 2.9 6.6 1.1 2.9 2.6 33.0 5.3 8.9 1.4 13.5 5.1 4.3 3.1 5.6 6.6 62.0 3.3 7.0 6.5 24.4 3.0 4.4 1.4 5.3 5.9 3.0 3.2 1.1 9.3 1.3 2.4 3.8 0.8 5.9 20.9 1.7 2.7 1.3 4.3 9.3 11.0 22.4 13.2 15.6 10.7 5.1 0.2 7.5 21.2 5.7 3.7 6.9 15.4 8.3 3.4 11.6 10.9 11.3 2.5 4.0 12.6 2.2 3.7 20.1 4.7 22.9 8.8 2.6 6.0 2.8 5.0 4.5 2.0 11.7 2.2 7.2 5.3 4.4 6.9 13.3 0.7 8.5 5.4 2.1 4.2 2.5 40.5 10.0 10.3 23.1 13.3 1.1 2.8 0.3 18.8 6.4 6.9 4.5 1.3 1.1 1.9 0.6 3.8 1.9 2.6 1.7 1.1 3.2 2.2 1.7 9.3 2.4 0.8 1.1 2.1 0.8 12.2 25.1 3.0 18.7 17.8 10.9 46.8 8.8 33.0 24.4 SYNPR "MGC26651, SPO" ENSG00000163630 Synaptoporin Q8TBG9 3 63228315-63616921 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 99.9" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;SCLC-21H: 4.6;SH-SY5Y: 1.2" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Region enhanced" "Detected in all" "basal ganglia: 99.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051368, HPA061671" Enhanced "HPA051368: AB_2681456, HPA061671: AB_2684582" "unprognostic (1.69e-1)" "unprognostic (3.77e-2)" "unprognostic (3.14e-3)" "unprognostic (3.02e-1)" "unprognostic (2.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.50e-1)" "unprognostic (5.32e-2)" "unprognostic (1.82e-1)" "unprognostic (1.89e-1)" 1.1 1.5 13.3 1.3 99.9 1.1 1.1 26.9 58.4 1.2 1.2 1.5 0.0 1.4 1.1 1.2 1.1 1.2 1.2 6.1 20.4 7.6 1.2 1.1 1.1 1.1 4.6 14.4 1.1 1.3 1.1 0.1 1.1 4.3 1.1 1.2 11.9 1.8 1.2 1.1 1.1 1.2 1.2 2.2 1.1 1.8 1.1 4.6 0.0 1.2 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 4.6 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 99.9 26.9 31.2 20.4 7.6 4.6 14.4 4.3 4.6 SYP MRX96 ENSG00000102003 Synaptophysin P08247 X 49187804-49200259 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 179.2" "Cell line enhanced" "Detected in some" "K-562: 8.5;SCLC-21H: 45.7;SH-SY5Y: 16.5" "Group enriched" "Detected in many" 6 "glioma: 12.8;pancreatic cancer: 5.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000076, HPA002858, CAB055505, CAB078999" Enhanced Supported "CAB000076: AB_2315411, CAB055505: AB_564017, CAB078999: , HPA002858: AB_1080153" "unprognostic (2.08e-1)" "unprognostic (8.72e-2)" "unprognostic (1.56e-1)" "unprognostic (5.37e-3)" "unprognostic (4.37e-2)" "unprognostic (2.11e-1)" "unprognostic (1.87e-1)" "unprognostic (6.46e-5)" "unprognostic (8.52e-3)" "unprognostic (1.62e-1)" "unprognostic (3.44e-3)" "unprognostic (8.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.95e-1)" "unprognostic (3.54e-1)" "unprognostic (1.79e-2)" "unprognostic (1.94e-1)" 2.7 21.4 34.5 3.2 42.5 1.9 1.9 53.8 179.2 2.0 3.6 7.2 0.0 7.4 2.2 2.6 2.2 2.0 2.0 2.3 44.4 45.3 2.7 1.8 2.8 2.0 25.5 39.0 2.1 5.2 1.9 17.4 2.0 46.7 2.1 3.5 11.5 2.0 2.1 2.4 2.3 8.1 2.5 15.5 2.4 3.9 2.0 4.0 0.0 2.1 0.0 1.9 1.8 0.2 1.3 1.6 5.3 0.8 0.5 0.7 0.1 0.4 1.7 1.3 2.6 1.4 0.2 0.2 0.1 0.0 0.3 0.3 1.5 0.9 1.3 0.2 0.0 1.3 1.3 0.1 0.3 2.7 1.5 2.1 0.5 0.5 0.0 0.2 4.7 0.2 0.0 0.2 0.3 0.1 8.5 3.3 0.3 0.5 0.7 0.1 4.2 0.3 0.3 0.2 0.6 0.1 0.2 45.7 16.5 0.5 0.2 0.6 0.8 0.8 0.2 0.3 1.4 0.4 0.2 0.2 2.8 0.3 0.7 0.5 1.4 1.7 0.8 0.4 0.2 0.7 0.4 0.7 0.5 0.7 0.4 1.3 0.5 0.5 5.3 0.5 0.4 1.6 0.3 0.1 34.5 42.5 53.8 84.8 44.4 45.3 25.5 39.0 46.7 4.0 SYT1 "P65, SVP65, SYT" ENSG00000067715 "Synaptotagmin 1" P21579 12 78863993-79452008 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 141.7" "Cell line enhanced" "Detected in many" "hTERT-HME1: 22.5;LHCN-M2: 18.0;SH-SY5Y: 17.4;WM-115: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.3;memory B-cell: 3.3;naive B-cell: 3.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008394, HPA064788" Enhanced Supported "HPA008394: AB_1857696, HPA064788: AB_2685351" "unprognostic (1.02e-3)" "unprognostic (2.55e-1)" "unprognostic (4.21e-3)" "unprognostic (3.77e-2)" "unprognostic (3.16e-2)" "unprognostic (3.68e-5)" "unprognostic (2.78e-2)" "unprognostic (1.83e-2)" "unprognostic (7.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-1)" "unprognostic (6.14e-3)" "unprognostic (3.05e-8)" "unprognostic (2.89e-2)" "unprognostic (8.26e-2)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" 1.3 11.5 23.9 2.1 31.8 1.3 1.4 44.3 141.7 1.8 2.3 1.8 0.0 1.8 5.6 1.4 1.4 1.4 1.7 1.1 32.4 22.9 2.0 2.0 1.5 1.2 23.1 38.6 3.6 1.2 1.1 1.4 2.3 28.9 4.3 2.5 2.7 1.2 3.8 1.1 1.2 2.6 12.9 2.5 2.2 1.8 1.4 3.6 0.0 1.2 0.0 1.2 1.3 0.7 3.4 0.9 0.0 2.3 0.0 0.0 0.1 0.0 10.5 7.9 0.0 0.8 2.3 0.0 0.7 0.9 0.6 0.6 0.5 0.3 0.0 1.6 0.1 0.3 0.1 1.2 0.9 0.1 0.4 0.6 0.2 0.0 2.0 0.0 0.1 0.6 0.8 2.9 22.5 7.5 0.4 1.2 18.0 1.6 1.0 0.0 5.8 3.0 0.0 8.2 0.0 0.0 3.0 10.5 17.4 0.0 1.3 0.2 3.9 0.0 3.0 1.1 0.4 0.0 3.3 1.9 4.2 0.0 2.6 0.0 16.2 0.0 2.3 0.0 0.0 0.2 0.0 3.3 0.0 0.0 0.9 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.9 31.8 44.3 74.8 32.4 22.9 23.1 38.6 28.9 3.6 SYT10 ENSG00000110975 "Synaptotagmin 10" Q6XYQ8 12 33374238-33439819 "Predicted membrane proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;fallopian tube: 8.1" "Cell line enhanced" "Detected in some" "AF22: 3.7;K-562: 2.2;MCF7: 7.5;NTERA-2: 1.9;RPTEC TERT1: 1.9;RT4: 3.0;SCLC-21H: 3.9" "Cancer enriched" "Detected in single" 5 "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA055426 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA055426: " "unprognostic (3.60e-1)" "unprognostic (4.93e-2)" "unprognostic (9.34e-4)" "unprognostic (5.53e-2)" "unprognostic (3.67e-1)" "unprognostic (4.74e-3)" "unprognostic (3.19e-1)" "unprognostic (1.97e-6)" "unprognostic (4.00e-1)" "unprognostic (2.39e-1)" "unprognostic (2.41e-1)" "unprognostic (1.91e-1)" 0.3 1.5 0.6 0.7 10.1 0.1 0.3 0.2 4.1 2.9 3.6 0.9 3.0 1.0 0.3 0.8 0.3 8.1 0.4 0.5 0.8 3.1 3.3 1.4 0.2 0.1 0.6 3.4 0.4 0.2 0.1 5.8 0.2 14.6 1.6 1.6 0.1 1.8 3.2 0.2 0.2 1.3 0.6 2.7 0.2 1.6 0.6 0.3 0.0 0.2 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 7.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.9 3.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.1 0.2 4.1 0.8 3.1 0.6 3.4 14.6 0.3 SYT11 "DKFZp781D015, KIAA0080, MGC10881, MGC17226" ENSG00000132718 "Synaptotagmin 11" Q9BT88 1 155859509-155885199 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 148.3" "Cell line enhanced" "Detected in many" "Karpas-707: 56.5;SCLC-21H: 22.5;SH-SY5Y: 24.6;U-87 MG: 27.2" "Cancer enriched" "Detected in all" 12 "glioma: 117.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064091 Enhanced "HPA064091: " "unprognostic (1.83e-1)" "unprognostic (5.99e-2)" "unprognostic (1.24e-1)" "prognostic unfavourable (2.93e-5)" "unprognostic (2.14e-1)" "unprognostic (8.02e-3)" "unprognostic (7.90e-2)" "unprognostic (4.43e-3)" "unprognostic (3.93e-1)" "unprognostic (1.16e-1)" "unprognostic (1.42e-2)" "unprognostic (9.65e-2)" "unprognostic (2.28e-2)" "unprognostic (1.66e-1)" "unprognostic (6.38e-2)" "unprognostic (1.10e-1)" "unprognostic (2.22e-3)" 6.0 13.3 34.4 6.2 52.0 3.3 2.7 35.4 148.3 9.3 5.1 44.5 0.0 3.4 11.5 8.6 4.7 5.2 7.9 8.9 32.9 32.3 4.5 2.4 6.0 7.2 35.9 32.2 9.6 3.2 2.4 11.8 7.0 48.3 8.7 5.4 4.4 2.6 11.3 2.8 2.3 4.3 12.7 42.0 6.9 3.8 4.7 29.0 0.0 2.8 0.0 6.5 7.3 3.3 1.6 5.6 4.1 6.1 5.8 14.4 5.7 0.0 0.2 14.5 0.3 10.6 5.7 0.0 2.7 7.3 2.8 5.2 0.0 0.3 2.8 1.2 9.6 0.2 1.2 0.0 4.3 13.5 0.2 2.7 0.4 0.0 3.0 1.5 8.4 3.5 0.0 10.4 0.2 9.2 0.0 56.5 3.9 0.0 0.1 0.7 9.4 0.0 0.5 1.4 0.0 0.4 0.0 22.5 24.6 0.4 0.0 3.2 0.0 0.3 6.8 5.4 3.4 3.6 3.4 15.1 7.3 5.7 27.2 0.0 4.1 4.1 3.8 0.1 14.4 4.8 4.0 1.6 7.6 9.9 5.6 1.4 0.8 7.8 2.1 5.8 6.1 0.3 13.3 5.7 34.4 52.0 35.4 59.4 32.9 32.3 35.9 32.2 48.3 29.0 SYT12 SRG1 ENSG00000173227 "Synaptotagmin 12" Q8IV01 11 67006778-67050863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 29.9;parathyroid gland: 59.4" "Cell line enhanced" "Detected in some" "HeLa: 25.7;MCF7: 17.7;SiHa: 22.8;SK-BR-3: 11.1;T-47d: 11.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011006, HPA074255" Enhanced "HPA011006: AB_2286996, HPA074255: " "unprognostic (2.72e-2)" "unprognostic (2.77e-2)" "unprognostic (2.23e-2)" "unprognostic (1.12e-3)" "unprognostic (4.47e-3)" "unprognostic (3.88e-2)" "unprognostic (1.20e-1)" "unprognostic (3.73e-2)" "unprognostic (2.04e-1)" "unprognostic (7.85e-3)" "prognostic unfavourable (4.13e-4)" "unprognostic (2.75e-1)" "unprognostic (9.86e-4)" "unprognostic (4.21e-2)" "unprognostic (7.38e-2)" "unprognostic (2.42e-2)" "unprognostic (9.85e-2)" 1.1 2.2 4.3 0.8 7.9 0.6 4.2 29.9 16.2 0.7 0.6 0.8 3.5 1.2 0.7 6.2 0.9 3.7 1.1 0.8 5.4 4.7 0.7 10.2 0.6 0.7 2.6 5.4 0.7 0.7 59.4 3.4 4.1 6.8 0.9 0.6 0.1 1.8 2.5 0.8 1.2 0.8 0.6 1.3 0.6 0.7 1.3 0.5 0.0 0.6 0.0 0.7 1.4 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.8 0.8 1.8 0.7 0.8 0.1 2.6 0.0 0.0 0.2 0.0 25.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 17.7 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.2 0.0 0.2 0.0 22.8 11.1 0.0 11.1 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 7.9 29.9 16.2 5.4 4.7 2.6 5.4 6.8 0.5 SYT13 KIAA1427 ENSG00000019505 "Synaptotagmin 13" Q7L8C5 11 45240301-45286319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.1;gallbladder: 18.8" "Cell line enhanced" "Detected in some" "A549: 11.2;NTERA-2: 5.2;RPTEC TERT1: 34.3;SCLC-21H: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046224, HPA056602" Uncertain Supported Vesicles Vesicles "HPA046224: AB_10961288, HPA056602: " "unprognostic (4.96e-2)" "unprognostic (1.06e-2)" "unprognostic (9.92e-2)" "prognostic unfavourable (7.79e-5)" "unprognostic (1.00e-2)" "unprognostic (4.17e-2)" "unprognostic (3.75e-2)" "unprognostic (9.83e-3)" "unprognostic (2.19e-1)" "unprognostic (7.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.47e-1)" "unprognostic (5.66e-3)" "unprognostic (2.94e-2)" "unprognostic (1.76e-1)" "unprognostic (8.70e-2)" "unprognostic (5.13e-2)" 0.4 4.5 15.8 1.5 15.1 0.4 0.5 19.0 38.1 0.3 10.6 1.2 0.0 10.9 0.6 0.3 0.4 0.5 18.8 4.5 11.8 19.5 8.0 0.6 0.8 0.4 10.6 15.1 0.4 6.4 0.4 9.4 0.4 27.9 2.0 11.2 0.9 1.4 0.4 0.5 0.5 11.1 1.1 2.2 0.5 9.2 1.8 0.3 0.0 1.8 0.0 0.3 0.4 0.2 0.2 0.0 1.4 0.0 0.2 0.2 0.0 0.0 11.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 5.2 0.1 0.0 0.0 0.0 34.3 0.0 9.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.9 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.0 15.8 15.1 19.0 31.1 11.8 19.5 10.6 15.1 27.9 0.3 SYT14 "FLJ34198, sytXIV" ENSG00000143469 "Synaptotagmin 14" Q8NB59 1 209938174-210171389 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.4;pituitary gland: 31.1;testis: 9.5;thyroid gland: 15.9" "Cell line enhanced" "Detected in some" "BJ hTERT+: 13.1;SCLC-21H: 6.8;TIME: 10.9;U-138 MG: 8.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036963 Supported Vesicles Vesicles "HPA036963: AB_10670378" "unprognostic (1.38e-4)" "unprognostic (8.62e-3)" "unprognostic (1.93e-1)" "unprognostic (3.90e-4)" "unprognostic (1.97e-1)" "unprognostic (4.43e-5)" "unprognostic (1.92e-1)" "unprognostic (1.88e-2)" "unprognostic (6.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.81e-1)" "unprognostic (4.85e-3)" "unprognostic (2.30e-4)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (3.33e-3)" 0.7 3.2 5.9 0.8 7.4 0.8 0.6 17.4 10.2 0.6 0.7 3.8 0.0 0.7 1.4 0.8 0.6 0.6 0.6 0.6 4.5 2.6 0.9 0.6 0.7 0.7 3.3 5.9 0.8 1.2 0.6 31.1 0.6 5.0 0.8 0.8 1.1 0.6 0.6 0.7 0.7 0.7 0.7 2.4 0.7 0.9 9.5 3.0 0.0 15.9 0.0 0.6 0.6 0.4 2.0 0.8 2.1 0.5 1.1 0.8 0.1 3.3 0.1 0.0 0.0 0.3 0.0 0.0 2.7 13.1 2.8 1.5 0.0 0.2 0.0 0.1 0.3 4.2 0.0 0.0 3.3 0.6 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 1.9 5.8 0.5 0.0 0.0 5.0 0.0 0.0 0.0 4.5 1.8 0.0 0.1 0.1 0.2 3.0 6.8 3.1 0.0 0.0 5.6 0.0 0.1 10.9 8.3 4.0 0.7 1.4 0.1 0.1 0.0 0.7 0.0 1.9 2.1 0.4 0.6 0.8 0.2 0.4 0.6 0.5 0.4 0.3 2.0 0.4 0.6 1.8 1.1 0.5 0.8 0.4 0.1 5.9 7.4 17.4 10.2 4.5 2.6 3.3 5.9 5.0 3.0 SYT16 "CHR14SYT, Strep14, SYT14L, yt14r" ENSG00000139973 "Synaptotagmin 16" Q17RD7 14 61811974-62112550 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.8;testis: 6.8" "Cell line enhanced" "Detected in some" "A-431: 10.4;PC-3: 5.4;RPTEC TERT1: 6.3;RT4: 16.7;U-2 OS: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004199, HPA076871" Enhanced Approved Cytosol Cytosol "HPA004199: AB_1080156, HPA076871: " "unprognostic (2.55e-2)" "unprognostic (1.43e-2)" "unprognostic (4.12e-1)" "unprognostic (8.88e-4)" "unprognostic (1.41e-1)" "unprognostic (9.08e-2)" "unprognostic (9.57e-2)" "unprognostic (9.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.38e-1)" "unprognostic (1.34e-1)" "unprognostic (3.41e-2)" "unprognostic (1.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.53e-3)" "unprognostic (2.15e-1)" 0.4 1.3 7.2 0.4 17.2 0.6 0.6 0.7 20.8 0.4 0.4 0.4 0.0 0.4 1.0 2.1 0.4 0.7 0.5 0.5 3.3 3.4 0.7 0.4 0.5 0.5 1.6 12.3 0.4 4.0 0.4 1.9 1.1 1.8 4.6 0.4 0.0 0.4 0.6 0.4 0.5 0.5 0.4 0.9 0.5 2.6 6.8 0.7 0.0 0.5 0.0 0.4 0.9 0.6 0.2 0.1 0.6 0.1 0.1 0.2 0.0 10.4 0.2 0.3 0.0 0.0 0.0 0.1 0.7 1.0 1.0 0.6 0.0 0.0 0.1 0.2 0.0 0.5 0.0 1.0 1.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 5.4 0.0 0.0 0.0 6.3 16.7 0.3 2.9 0.5 0.7 0.0 0.0 0.0 0.0 2.8 6.8 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.6 0.1 0.1 0.1 0.0 0.0 7.2 17.2 0.7 18.9 3.3 3.4 1.6 12.3 1.8 0.7 SYT17 ENSG00000103528 "Synaptotagmin 17" Q9BSW7 16 19167971-19268334 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.2" "Cell line enhanced" "Detected in some" "BEWO: 10.2;CAPAN-2: 19.9;Daudi: 8.7;MCF7: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 4.1;memory B-cell: 5.1;naive B-cell: 14.7;non-classical monocyte: 13.4" "Group enriched" "Detected in many" 8 "B-cells: 14.7;monocytes: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042059 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042059: " "unprognostic (3.43e-1)" "unprognostic (2.75e-1)" "unprognostic (2.29e-2)" "unprognostic (1.49e-2)" "unprognostic (2.74e-1)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" "unprognostic (2.43e-1)" "unprognostic (6.76e-2)" "unprognostic (1.97e-1)" "unprognostic (3.15e-1)" "unprognostic (6.59e-2)" "unprognostic (3.00e-3)" "unprognostic (4.53e-2)" "unprognostic (3.38e-1)" "unprognostic (7.32e-2)" "unprognostic (4.95e-3)" 3.8 5.2 16.5 1.4 9.2 0.4 4.7 1.0 25.2 3.5 2.4 6.1 1.2 4.3 1.2 3.1 4.0 2.5 1.3 1.3 15.5 16.5 3.8 12.1 7.8 3.2 13.9 10.2 0.8 2.5 21.3 13.4 3.9 7.5 9.7 3.0 7.6 1.5 3.8 0.4 9.9 2.1 1.0 5.5 1.4 4.3 0.6 7.4 0.0 7.1 0.8 4.7 4.2 3.8 14.7 1.6 0.4 13.4 0.0 0.0 0.6 0.0 7.3 0.1 0.0 0.2 0.5 10.2 0.0 0.0 0.0 0.0 0.3 19.9 8.7 2.4 0.0 3.5 0.5 0.3 0.0 0.0 1.4 0.0 7.3 0.1 0.0 0.0 0.0 0.7 1.8 0.1 0.0 0.3 0.0 0.0 0.0 15.0 0.0 0.0 0.8 4.1 0.0 0.8 0.6 2.5 4.4 1.5 0.9 2.8 7.9 0.4 7.8 1.8 0.0 0.0 5.2 0.1 0.0 1.4 0.0 8.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 4.1 0.0 5.1 0.0 0.0 1.6 14.7 0.0 0.0 0.1 0.0 13.4 0.2 0.0 0.6 16.5 9.2 1.0 22.9 15.5 16.5 13.9 10.2 7.5 7.4 SYT2 ENSG00000143858 "Synaptotagmin 2" Q8N9I0 1 202590596-202710417 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" Differentiation "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 40.1" "Cell line enhanced" "Detected in some" "AF22: 12.4;NTERA-2: 8.6;U-2 OS: 2.6" "Cancer enriched" "Detected in some" 7 "testis cancer: 3.8" "Group enriched" "Detected in many" 5 "cerebellum: 36.2;cerebral cortex: 14.7;pons and medulla: 40.1" "Cell type enriched" "Detected in single" 8 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA063655 Enhanced Supported "HPA063655: " "unprognostic (1.32e-2)" "unprognostic (4.99e-2)" "unprognostic (4.89e-2)" "unprognostic (1.03e-2)" "unprognostic (2.21e-1)" "unprognostic (2.24e-2)" "unprognostic (3.00e-1)" "unprognostic (2.35e-3)" "unprognostic (8.81e-3)" "unprognostic (1.17e-1)" "unprognostic (1.53e-2)" "unprognostic (6.33e-2)" "unprognostic (1.56e-2)" "unprognostic (6.23e-2)" "unprognostic (3.26e-1)" "unprognostic (2.54e-1)" "unprognostic (5.17e-3)" 1.1 6.1 0.4 1.1 5.9 0.5 0.3 36.2 14.7 0.6 0.7 0.3 0.0 1.1 1.7 4.1 0.4 0.8 1.1 1.5 0.6 1.5 0.5 0.4 0.6 0.7 5.5 0.4 3.1 0.4 0.2 0.3 0.5 40.1 0.9 0.7 1.6 1.1 0.5 1.1 0.7 1.3 0.5 7.1 1.2 0.7 2.4 1.1 0.0 0.6 0.0 0.5 1.0 0.3 0.1 0.0 2.4 0.1 0.1 0.2 0.0 0.0 0.2 12.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.2 1.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 8.6 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.4 5.9 36.2 14.7 0.6 1.5 5.5 0.4 40.1 1.1 SYT3 ENSG00000213023 "Synaptotagmin 3" Q9BQG1 19 50621307-50639827 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 24.2" "Cell line enhanced" "Detected in some" "HEK 293: 9.9;HMC-1: 7.0;NTERA-2: 7.2;SH-SY5Y: 8.1;U-2 OS: 5.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (5.17e-2)" "unprognostic (1.90e-1)" "unprognostic (3.86e-3)" "unprognostic (1.57e-1)" "unprognostic (6.62e-2)" "unprognostic (4.36e-3)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-1)" "unprognostic (1.19e-4)" "unprognostic (1.12e-1)" "unprognostic (3.49e-4)" "unprognostic (1.82e-4)" "unprognostic (3.40e-1)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" 0.9 1.8 8.7 1.0 8.8 0.7 0.8 16.1 24.2 1.0 0.9 1.0 0.0 1.0 0.9 1.1 0.9 0.9 0.8 0.7 10.9 8.9 1.2 0.8 1.1 0.9 6.7 6.6 0.7 2.1 1.0 2.2 2.3 6.3 1.2 0.8 0.3 1.4 1.7 0.8 0.8 1.0 0.9 2.4 0.8 0.8 2.7 2.2 0.0 1.3 0.0 0.9 1.0 0.0 0.0 1.3 0.1 0.0 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.1 0.0 0.1 0.4 0.0 0.0 0.1 9.9 0.0 0.0 0.0 0.4 0.0 7.0 0.3 0.0 0.0 0.0 0.2 1.2 0.0 0.0 2.9 0.0 0.0 7.2 0.0 2.4 0.0 0.1 0.0 0.0 0.1 8.1 0.4 0.0 0.2 0.2 2.3 0.0 0.0 5.1 0.0 0.0 0.8 0.1 0.0 0.3 3.6 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.1 8.7 8.8 16.1 16.3 10.9 8.9 6.7 6.6 6.3 2.2 SYT4 "HsT1192, KIAA1342" ENSG00000132872 "Synaptotagmin 4" Q9H2B2 18 43267878-43277650 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.8;pituitary gland: 31.5" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 72.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010574 Approved Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA010574: AB_2668309" "unprognostic (2.91e-3)" "unprognostic (2.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (7.67e-3)" "unprognostic (5.30e-3)" "unprognostic (3.95e-2)" "unprognostic (1.23e-3)" "unprognostic (3.61e-1)" "unprognostic (3.80e-2)" 1.4 17.5 5.7 2.2 24.1 1.0 0.9 60.8 54.6 0.9 1.7 0.9 0.0 1.7 0.9 0.9 1.0 0.9 1.0 1.4 12.9 19.9 1.0 0.9 1.8 1.0 5.9 16.0 1.3 4.7 0.9 31.5 1.0 22.3 1.5 1.7 0.4 1.0 9.8 0.9 1.0 1.7 1.5 5.0 0.9 4.6 2.4 1.4 0.0 1.3 0.0 0.9 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 72.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 24.1 60.8 35.7 12.9 19.9 5.9 16.0 22.3 1.4 SYT5 ENSG00000129990 "Synaptotagmin 5" O00445 19 55171199-55180441 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 73.0" "Group enriched" "Detected in some" 4 "EFO-21: 15.4;HMC-1: 34.1;K-562: 12.0;SCLC-21H: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA078390 Enhanced "HPA078390: " "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "unprognostic (9.76e-2)" "unprognostic (4.59e-2)" "prognostic unfavourable (6.54e-4)" "unprognostic (9.85e-2)" "unprognostic (3.24e-3)" "unprognostic (5.94e-2)" "unprognostic (1.36e-3)" "unprognostic (1.82e-1)" "prognostic favourable (5.54e-4)" "unprognostic (1.15e-3)" "unprognostic (3.71e-7)" "unprognostic (7.09e-2)" "unprognostic (5.21e-2)" "unprognostic (4.42e-2)" "unprognostic (3.55e-1)" 1.2 9.8 20.0 2.7 30.9 1.4 1.0 1.3 73.0 1.8 1.7 1.0 0.0 2.2 1.2 1.0 1.2 1.3 1.3 1.1 22.0 18.8 1.1 1.1 1.2 1.2 6.1 19.8 1.1 2.6 1.1 16.3 1.1 8.3 1.1 1.7 0.0 1.1 1.0 1.2 1.4 1.8 1.5 1.9 1.2 2.9 3.5 3.6 0.0 1.2 0.0 1.3 1.1 0.0 1.0 1.8 3.6 0.8 1.1 0.5 0.5 0.1 0.1 0.2 0.2 0.5 0.0 0.2 0.3 0.0 0.0 0.5 0.0 0.6 0.9 15.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.6 0.0 34.1 0.4 0.1 0.0 0.0 0.3 12.0 2.1 0.0 0.3 0.3 0.0 0.0 2.1 0.1 0.2 0.2 0.0 0.0 9.0 4.0 0.0 0.5 0.4 0.2 0.0 0.0 0.7 0.7 1.0 0.0 0.1 0.7 0.4 0.3 0.0 0.2 3.6 0.8 1.1 0.4 0.5 0.4 0.7 0.3 0.5 1.8 1.0 0.4 0.5 3.4 1.1 0.4 0.8 0.3 0.5 20.0 30.9 1.3 36.6 22.0 18.8 6.1 19.8 8.3 3.6 SYT6 ENSG00000134207 "Synaptotagmin 6" Q5T7P8 1 114089291-114153919 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.9;kidney: 3.7;pancreas: 11.1" "Group enriched" "Detected in some" 7 "NTERA-2: 20.6;WM-115: 14.6" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basal ganglia: 27.9;olfactory region: 87.2" "Low region specificity" "Detected in many" HPA058362 Approved Vesicles Vesicles "HPA058362: " "unprognostic (7.12e-2)" "unprognostic (2.03e-2)" "unprognostic (3.26e-3)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (2.49e-1)" "unprognostic (4.11e-2)" "unprognostic (3.60e-3)" "unprognostic (1.19e-1)" "unprognostic (4.71e-1)" "unprognostic (5.50e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-1)" "unprognostic (2.11e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-2)" "unprognostic (1.18e-1)" 0.3 2.2 2.6 0.8 6.5 0.3 2.1 0.2 10.4 0.4 0.3 5.1 0.0 0.9 0.4 0.2 0.2 0.3 0.5 0.3 2.3 14.9 3.7 0.3 0.4 0.3 2.8 1.3 2.3 11.1 0.7 0.3 1.4 3.9 1.5 0.6 0.9 1.1 0.2 0.4 0.4 0.5 0.3 4.2 0.3 0.3 0.9 3.3 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.1 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.6 6.5 0.2 9.3 2.3 14.9 2.8 1.3 3.9 3.3 SYT7 "IPCA-7, MGC150517, PCANAP7, SYT-VII" ENSG00000011347 "Synaptotagmin 7" O43581 11 61515313-61581148 "Predicted intracellular proteins, Predicted membrane proteins" Exocytosis Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.4;prostate: 36.9;salivary gland: 37.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 15.0;hTERT-HME1: 39.3;RT4: 16.0;SCLC-21H: 12.7;SK-BR-3: 17.9;T-47d: 17.5" "Cancer enhanced" "Detected in all" "prostate cancer: 54.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012869 Enhanced "HPA012869: AB_1857698" "unprognostic (7.09e-2)" "unprognostic (8.26e-2)" "unprognostic (2.43e-1)" "unprognostic (2.10e-2)" "unprognostic (5.42e-2)" "prognostic unfavourable (1.20e-4)" "unprognostic (4.37e-2)" "unprognostic (5.08e-2)" "unprognostic (2.74e-3)" "unprognostic (1.79e-2)" "unprognostic (1.02e-2)" "unprognostic (2.54e-2)" "prognostic unfavourable (1.16e-4)" "unprognostic (2.08e-1)" "unprognostic (1.69e-1)" "unprognostic (2.23e-3)" "unprognostic (2.47e-1)" 2.5 3.7 16.2 1.4 22.7 0.6 6.9 22.8 46.4 2.8 4.0 3.2 0.0 2.1 2.0 1.9 1.9 1.7 1.4 11.1 11.8 7.8 4.4 28.2 1.7 0.8 4.9 23.6 1.2 11.9 2.2 22.2 12.7 8.8 36.9 4.2 2.4 37.7 1.3 2.8 1.6 3.3 1.8 1.5 1.8 3.4 2.5 3.0 0.0 3.5 0.6 0.8 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.6 0.8 0.2 0.0 0.4 6.4 4.6 0.1 15.0 0.2 0.2 1.4 3.0 0.0 0.2 0.0 3.0 0.4 0.1 0.1 0.1 0.7 0.0 0.6 0.8 0.4 0.0 0.0 0.2 3.5 1.8 39.3 0.0 0.0 0.1 0.2 9.3 0.0 0.1 1.0 6.3 0.0 0.3 0.7 0.0 16.0 12.7 2.3 0.8 17.9 0.1 17.5 0.0 0.0 3.7 1.4 4.2 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 22.7 22.8 37.5 11.8 7.8 4.9 23.6 8.8 3.0 SYT9 ENSG00000170743 "Synaptotagmin 9" Q86SS6 11 7238778-7469042 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.6" "Group enriched" "Detected in some" 4 "HEK 293: 8.7;RT4: 15.2;SH-SY5Y: 11.4;TIME: 17.0" "Cancer enhanced" "Detected in some" "breast cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.47e-1)" "unprognostic (9.41e-2)" "unprognostic (1.39e-5)" "unprognostic (1.63e-1)" "unprognostic (1.12e-1)" "unprognostic (5.50e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.67e-2)" "unprognostic (1.64e-2)" "unprognostic (1.81e-1)" "unprognostic (3.31e-3)" "unprognostic (4.35e-2)" "unprognostic (1.92e-4)" "unprognostic (1.22e-4)" 0.5 6.0 7.5 0.7 7.4 0.5 2.8 23.6 10.2 1.7 0.8 15.5 5.6 0.5 3.8 0.6 0.5 0.9 0.9 1.4 7.5 5.3 6.0 9.8 0.7 0.5 11.1 5.6 0.8 4.0 1.2 5.1 0.5 7.1 3.5 0.7 3.3 0.7 10.5 0.5 0.7 0.8 1.0 7.9 0.5 0.7 2.8 11.5 0.0 3.6 0.0 0.5 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.9 0.0 0.0 0.0 0.0 15.2 2.7 11.4 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 7.4 23.6 6.4 7.5 5.3 11.1 5.6 7.1 11.5 TAC1 "NKNA, NPK, TAC2" ENSG00000006128 "Tachykinin precursor 1" P20366 7 97731908-97740472 "Predicted secreted proteins" "Neuropeptide, Neurotransmitter" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 61.3;lymphoid tissue: 62.9" "Cell line enriched" "Detected in some" 19 "U-266/70: 22.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 61.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 557.4" "Region enriched" "Detected in many" 9 "basal ganglia: 312.7" HPA014429 Enhanced "Secreted to blood" "HPA014429: AB_1857722" "unprognostic (9.24e-3)" "unprognostic (2.65e-2)" "unprognostic (1.84e-1)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (2.08e-1)" "unprognostic (7.95e-2)" "unprognostic (3.24e-1)" "unprognostic (1.70e-2)" "unprognostic (3.21e-2)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "unprognostic (3.86e-2)" 1.8 6.5 4.1 7.7 61.3 0.3 1.7 0.3 39.8 0.7 3.7 0.1 0.0 6.0 0.9 1.6 0.3 0.7 4.9 0.5 9.3 21.5 1.6 0.6 0.3 0.3 8.0 4.5 0.3 0.7 0.3 0.3 0.3 24.5 1.0 2.9 0.3 4.5 2.0 0.4 1.2 7.6 5.3 6.7 62.9 0.9 0.6 9.4 0.0 1.6 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 61.3 0.3 9.2 9.3 21.5 8.0 4.5 24.5 9.4 TACR3 NK3R ENSG00000169836 "Tachykinin receptor 3" P29371 4 103586031-103719816 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.4;urinary bladder: 5.5" "Cell line enriched" "Detected in single" 13 "BEWO: 12.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 14.4;hypothalamus: 4.1;pons and medulla: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA009418 Uncertain "HPA009418: AB_1857727" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (2.29e-1)" "unprognostic (3.50e-1)" "unprognostic (3.21e-1)" "unprognostic (5.52e-1)" "unprognostic (3.80e-1)" "unprognostic (3.42e-2)" "unprognostic (1.72e-2)" 0.1 0.1 14.4 0.1 1.4 0.1 0.4 0.0 2.6 0.1 0.4 0.0 0.0 0.1 0.2 0.4 0.2 0.3 0.3 0.1 1.1 4.1 2.0 0.1 0.9 0.1 1.4 1.0 0.1 0.1 0.1 0.1 0.6 6.3 0.2 0.5 3.2 0.1 0.1 0.7 0.3 0.1 0.1 2.5 0.1 0.5 0.6 0.0 0.0 0.5 0.9 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 1.4 0.0 1.5 1.1 4.1 1.4 1.0 6.3 0.0 TAGLN3 "NP22, NP25" ENSG00000144834 "Transgelin 3" Q9UI15 3 111998664-112013887 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 139.0" "Group enriched" "Detected in some" 5 "AF22: 38.5;RPTEC TERT1: 15.7;SCLC-21H: 21.0;SH-SY5Y: 35.5" "Cancer enhanced" "Detected in many" "glioma: 24.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062620 Enhanced "HPA062620: " "unprognostic (1.55e-2)" "unprognostic (2.28e-1)" "unprognostic (1.81e-1)" "unprognostic (1.36e-3)" "unprognostic (4.28e-1)" "unprognostic (4.07e-1)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (8.92e-2)" "unprognostic (6.82e-3)" "unprognostic (2.51e-1)" "unprognostic (5.49e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (8.60e-2)" "unprognostic (7.67e-3)" 1.7 21.9 47.3 2.4 40.6 1.5 1.6 40.2 139.0 1.5 2.7 4.6 0.0 1.9 1.6 1.5 1.6 1.6 1.7 1.7 32.9 37.9 4.2 1.5 1.8 1.6 30.5 33.2 1.6 4.6 1.6 13.5 1.5 29.8 1.7 2.9 2.3 1.5 1.7 1.5 1.6 2.2 2.2 8.3 1.5 3.7 1.6 2.7 0.0 1.8 0.0 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.1 0.1 0.0 1.4 0.0 0.2 0.0 2.7 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 1.4 3.4 5.3 1.0 0.0 15.7 0.0 21.0 35.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 40.6 40.2 65.7 32.9 37.9 30.5 33.2 29.8 2.7 TAS2R19 "T2R19, T2R23, TAS2R23, TAS2R48" ENSG00000212124 "Taste 2 receptor member 19" P59542 12 11021619-11022620 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.4" "Cell line enhanced" "Detected in some" "Daudi: 1.0;HBF TERT88: 1.3;HDLM-2: 1.1;hTERT-HME1: 2.9" "Cancer enhanced" "Detected in single" "testis cancer: 1.1" "Cell type enriched" "Detected in single" 5 "T-reg: 1.0" "Lineage enriched" "Detected in single" 5 "T-cells: 1.0" "unprognostic (1.90e-2)" "unprognostic (9.54e-2)" "unprognostic (1.83e-1)" "unprognostic (5.18e-3)" "unprognostic (1.84e-1)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (5.73e-2)" "unprognostic (2.35e-1)" "unprognostic (8.76e-2)" "unprognostic (8.26e-2)" "unprognostic (1.94e-2)" "unprognostic (1.57e-8)" "unprognostic (9.08e-2)" "unprognostic (1.58e-1)" "unprognostic (7.96e-2)" "unprognostic (4.32e-1)" 0.3 0.5 0.4 0.3 0.4 0.5 0.7 3.4 0.7 0.5 0.4 0.6 1.1 0.1 0.2 0.7 0.6 1.4 0.6 0.5 0.4 0.2 0.4 0.2 0.4 3.0 0.4 1.1 1.9 0.4 0.6 0.3 0.3 0.6 1.1 0.5 0.3 0.5 0.7 0.4 0.3 0.8 1.0 0.3 0.4 0.5 0.0 0.1 0.0 0.2 0.1 1.0 0.0 0.4 0.0 0.3 0.5 0.0 0.0 0.2 0.0 0.4 0.3 0.7 0.2 0.1 1.0 0.0 0.0 0.0 0.1 0.0 1.3 1.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 2.9 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.4 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 TAS2R4 T2R4 ENSG00000127364 "Taste 2 receptor member 4" Q9NYW5 7 141778442-141780819 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.9" "Cell line enhanced" "Detected in many" "HL-60: 3.8;NB-4: 4.2" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "basophil: 3.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "unprognostic (6.15e-3)" "unprognostic (5.80e-2)" "unprognostic (1.57e-1)" "unprognostic (1.39e-2)" "unprognostic (2.25e-1)" "unprognostic (1.55e-3)" "unprognostic (1.00e-2)" "unprognostic (3.86e-2)" "unprognostic (7.95e-3)" "unprognostic (2.06e-1)" "unprognostic (3.76e-3)" "unprognostic (6.15e-3)" "unprognostic (1.04e-5)" "unprognostic (5.58e-2)" "unprognostic (1.35e-1)" "unprognostic (9.87e-2)" "unprognostic (1.18e-1)" 0.2 0.4 0.9 0.5 2.9 0.5 2.6 6.9 1.6 0.6 0.5 0.2 1.7 4.3 0.4 1.3 0.5 0.1 0.9 1.2 0.4 0.2 0.6 1.0 0.7 2.8 0.9 0.5 1.2 0.6 0.6 0.9 1.0 0.6 2.6 4.4 0.9 0.3 0.7 0.8 0.8 0.8 1.0 1.0 0.5 0.6 1.0 0.5 3.6 0.8 1.1 0.8 0.6 0.5 1.5 1.1 0.6 1.0 2.0 0.8 0.4 0.1 0.0 0.4 1.2 0.7 0.9 0.5 0.2 0.9 1.6 0.8 0.1 0.8 1.0 0.2 1.1 1.3 1.0 3.8 0.8 1.1 1.9 0.1 1.6 0.4 1.1 0.3 0.5 0.7 1.4 4.2 1.1 0.2 0.6 0.5 1.0 0.3 0.7 1.1 0.9 0.3 0.4 0.3 0.3 1.3 0.8 0.6 0.7 0.4 0.7 1.0 0.4 1.1 0.3 1.5 0.4 3.6 0.8 1.4 0.6 0.3 0.4 0.5 0.5 0.3 0.2 1.0 0.5 0.8 2.4 1.1 0.6 0.5 0.1 0.6 TAS2R42 "hT2R55, T2R24, T2R55, TAS2R55" ENSG00000186136 "Taste 2 receptor member 42" Q7RTR8 12 11185993-11186937 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA036149 Uncertain Approved "Nucleoplasm,Actin filaments,Focal adhesion sites" "Nucleoplasm, Actin filaments" "Focal adhesion sites" "HPA036149: AB_10672080" "unprognostic (2.45e-2)" "unprognostic (4.17e-2)" 0.0 0.7 0.2 0.2 0.4 0.0 0.0 1.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.0 0.7 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.7 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 TAS2R50 T2R51 ENSG00000212126 "Taste 2 receptor member 50" P59544 12 10985913-10986912 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (6.55e-2)" "unprognostic (4.25e-1)" "unprognostic (1.14e-1)" "unprognostic (1.78e-1)" "unprognostic (2.53e-2)" "unprognostic (2.94e-1)" "unprognostic (2.24e-1)" "unprognostic (1.73e-1)" 0.3 0.1 0.0 0.2 0.1 0.4 0.6 1.7 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.6 0.2 0.0 0.3 0.4 0.1 0.0 0.2 0.0 1.0 0.3 0.3 0.1 0.1 0.4 0.1 0.2 0.3 0.3 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 TAS2R8 "T2R8, TRB5" ENSG00000121314 "Taste 2 receptor member 8" Q9NYW2 12 10806051-10807293 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.4 0.0 0.0 0.2 0.0 0.0 1.0 0.5 0.4 0.0 0.4 0.1 0.5 0.0 0.1 0.2 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D12 KIAA0608 ENSG00000108239 "TBC1 domain family member 12" O60347 10 94402504-94535930 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.2" "Group enriched" "Detected in many" 13 "B-cells: 1.4;dendritic cells: 2.2;monocytes: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038277, HPA038645" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA038277: AB_10672584, HPA038645: AB_10672650" "unprognostic (7.23e-3)" "unprognostic (1.58e-2)" "prognostic favourable (1.79e-5)" "unprognostic (7.83e-2)" "unprognostic (1.76e-1)" "unprognostic (4.91e-2)" "unprognostic (1.21e-2)" "unprognostic (7.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-1)" "unprognostic (2.27e-2)" "unprognostic (9.43e-2)" "unprognostic (3.71e-1)" "unprognostic (1.29e-1)" "unprognostic (1.12e-1)" 6.9 4.9 8.9 4.0 18.1 1.2 8.1 7.5 14.8 5.3 8.4 39.2 7.1 6.2 5.6 4.0 4.7 4.3 5.1 4.4 12.4 8.5 5.8 4.1 5.2 3.0 25.5 8.7 5.8 7.1 16.8 3.2 7.8 23.1 6.0 9.7 5.9 3.6 6.5 4.3 5.7 6.9 6.0 41.6 5.6 4.2 10.9 21.3 0.2 4.3 1.5 3.5 5.7 4.9 1.4 2.2 0.0 1.1 0.0 0.1 0.2 7.6 3.4 4.5 6.7 6.3 7.7 5.9 5.0 10.3 5.6 5.3 13.6 3.4 0.0 3.0 7.3 4.3 5.4 3.7 7.2 0.0 6.1 2.4 3.1 4.3 4.8 0.0 1.9 5.2 4.7 5.9 7.6 6.0 3.5 8.0 9.0 4.2 0.0 0.0 1.4 3.6 0.0 5.8 4.0 5.0 3.4 1.9 4.5 5.0 4.3 4.0 9.4 4.6 5.9 3.9 5.4 6.3 3.9 5.7 5.4 0.0 3.9 0.0 2.1 0.0 1.1 0.0 0.0 0.7 0.0 0.5 0.0 0.0 2.2 1.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 8.9 18.1 7.5 13.4 12.4 8.5 25.5 8.7 23.1 21.3 TBR1 ENSG00000136535 "T-box, brain 1" Q16650 2 161416094-161425870 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "brain: 34.9" "Cell line enhanced" "Detected in some" "HAP1: 1.6;HMC-1: 1.3;Karpas-707: 1.0;SCLC-21H: 1.7;U-266/84: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 45.6;basal ganglia: 28.5;cerebral cortex: 70.3;hippocampal formation: 50.1" "Region enhanced" "Detected in many" "cerebral cortex: 63.6" "HPA051256, HPA078644, HPA078657" Enhanced Supported "HPA051256: , HPA078644: AB_2732387, HPA078657: AB_2732388" "unprognostic (3.08e-2)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (1.35e-2)" "unprognostic (7.43e-3)" "unprognostic (1.95e-1)" "unprognostic (1.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.39e-9)" "unprognostic (5.72e-2)" "unprognostic (1.72e-1)" "unprognostic (5.37e-2)" 0.6 0.5 11.2 0.5 13.7 0.5 0.5 0.3 34.9 0.6 0.5 0.0 0.0 0.5 0.5 0.6 0.5 0.6 0.5 0.5 6.1 1.3 0.5 0.5 0.5 0.5 0.8 21.0 0.5 0.6 0.6 0.3 0.5 0.0 0.5 0.6 0.0 0.5 0.7 0.5 0.5 0.5 0.5 0.4 0.5 0.5 1.3 0.0 0.0 0.5 0.0 0.5 0.5 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.6 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.2 0.2 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.5 1.5 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 11.2 13.7 0.3 34.9 6.1 1.3 0.8 21.0 0.0 0.0 TCEAL2 "my048, MY0876G05, WEX1" ENSG00000184905 "Transcription elongation factor A like 2" Q9H3H9 X 102125688-102127711 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 84.0;ovary: 46.5" "Group enriched" "Detected in some" 4 "HAP1: 7.2;SCLC-21H: 7.9;U-2 OS: 14.2" "Cancer enhanced" "Detected in many" "glioma: 22.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 17 "T-cells: 2.1" HPA076317 Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA076317: " "unprognostic (2.34e-3)" "unprognostic (1.35e-2)" "unprognostic (7.59e-3)" "unprognostic (3.84e-3)" "unprognostic (2.07e-1)" "unprognostic (4.57e-2)" "unprognostic (4.27e-2)" "unprognostic (2.80e-2)" "unprognostic (3.47e-1)" "unprognostic (3.26e-1)" "unprognostic (7.07e-3)" "unprognostic (1.43e-1)" "unprognostic (1.56e-2)" "unprognostic (1.73e-2)" "unprognostic (7.76e-2)" "unprognostic (1.04e-1)" "unprognostic (4.11e-3)" 2.4 19.6 34.1 2.6 44.6 1.1 2.4 40.9 84.0 5.8 7.0 8.5 1.8 3.1 19.5 8.6 5.3 7.3 6.4 5.1 30.0 37.9 8.2 1.3 4.4 1.6 25.4 26.5 46.5 3.7 2.8 38.3 1.1 30.1 19.4 3.8 6.6 16.4 21.6 1.2 1.7 3.2 14.0 16.1 2.9 4.2 19.7 9.6 0.0 25.6 0.0 2.1 4.3 2.6 0.1 0.1 0.0 0.1 0.0 2.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.1 0.0 0.0 7.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.8 0.1 1.7 0.0 0.1 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.1 0.4 34.1 44.6 40.9 41.8 30.0 37.9 25.4 26.5 30.1 9.6 TCEAL5 WEX4 ENSG00000204065 "Transcription elongation factor A like 5" Q5H9L2 X 103273691-103276872 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.4;testis: 45.9" "Group enriched" "Detected in some" 7 "SCLC-21H: 7.3;SH-SY5Y: 22.8" "Cancer enhanced" "Detected in many" "glioma: 13.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045564, HPA058982, HPA072199" Supported Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA045564: , HPA058982: , HPA072199: " "unprognostic (1.30e-3)" "unprognostic (2.41e-1)" "prognostic unfavourable (9.09e-4)" "unprognostic (9.68e-2)" "unprognostic (8.75e-4)" "unprognostic (1.21e-1)" "unprognostic (8.11e-2)" "prognostic favourable (8.60e-4)" "unprognostic (1.28e-2)" "unprognostic (1.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.74e-1)" "unprognostic (6.30e-2)" "unprognostic (6.03e-4)" 2.0 11.2 21.9 2.1 31.8 1.3 3.3 32.7 56.4 4.7 2.2 6.6 0.0 1.9 6.0 7.8 1.5 1.6 2.0 2.0 22.3 23.1 1.5 1.3 1.5 1.3 13.0 24.0 5.0 2.1 1.3 23.1 1.3 19.8 3.7 2.0 1.4 2.3 5.4 1.4 1.3 2.4 4.3 11.0 1.3 1.5 45.9 8.4 0.0 3.4 0.0 1.3 2.1 1.1 0.7 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.0 0.2 0.0 0.1 0.0 0.0 21.9 31.8 32.7 31.9 22.3 23.1 13.0 24.0 19.8 8.4 TCEAL6 WEX2 ENSG00000204071 "Transcription elongation factor A like 6" Q6IPX3 X 102140476-102142970 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 14.3;brain: 48.4;pituitary gland: 20.7;testis: 21.9" "Cell line enhanced" "Detected in some" "BJ: 1.1;SCLC-21H: 1.9" "Cancer enriched" "Detected in single" 9 "glioma: 3.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "HPA045564, HPA058982" Supported "HPA045564: , HPA058982: " "unprognostic (5.43e-2)" "unprognostic (6.54e-2)" "unprognostic (1.87e-3)" "unprognostic (6.69e-3)" "unprognostic (1.39e-1)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (3.89e-2)" "unprognostic (1.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.33e-2)" "unprognostic (1.18e-1)" 1.1 14.3 16.6 1.3 15.2 1.0 1.1 31.4 48.4 1.2 1.4 2.5 0.0 1.3 5.3 2.8 1.1 3.2 1.1 1.1 11.3 26.0 1.2 1.0 1.0 1.0 15.2 7.5 6.1 1.3 1.1 20.7 1.0 12.5 1.9 1.3 2.0 3.1 1.9 1.0 1.0 1.3 1.9 7.5 1.0 1.0 21.9 2.8 0.0 1.8 0.0 1.0 1.0 1.7 0.7 0.6 0.1 0.5 1.3 0.7 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.0 0.0 0.7 0.0 0.3 0.1 0.5 0.1 0.5 0.3 0.7 0.4 0.2 0.3 0.5 0.7 0.4 0.6 0.0 1.3 0.0 0.6 0.6 0.6 16.6 15.2 31.4 26.0 11.3 26.0 15.2 7.5 12.5 2.8 TCEAL7 "MGC23947, WEX5" ENSG00000182916 "Transcription elongation factor A like 7" Q9BRU2 X 103330196-103332326 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 70.4" "Cell line enhanced" "Detected in some" "AF22: 23.2;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;hTEC/SVTERT24-B: 23.2;LHCN-M2: 19.6;SCLC-21H: 58.6;U-87 MG: 21.8" "Cancer enriched" "Detected in many" 10 "glioma: 39.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.3" "Lineage enhanced" "Detected in single" "NK-cells: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051507, HPA065080" Enhanced Supported Nucleoplasm Nucleoplasm "HPA051507: , HPA065080: " "unprognostic (1.09e-2)" "unprognostic (4.36e-2)" "unprognostic (5.54e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (4.52e-2)" "unprognostic (2.17e-1)" "unprognostic (2.23e-1)" "unprognostic (3.26e-2)" "unprognostic (1.12e-1)" "unprognostic (4.18e-1)" "unprognostic (1.12e-2)" "prognostic unfavourable (4.31e-4)" "prognostic unfavourable (3.53e-4)" "unprognostic (2.62e-1)" "unprognostic (2.28e-2)" "unprognostic (1.35e-3)" 4.9 22.1 31.7 3.8 33.4 1.0 7.8 33.0 70.4 16.8 6.4 20.1 1.8 3.9 36.4 14.7 5.1 5.4 9.7 9.5 31.1 44.2 4.6 2.6 3.8 2.5 34.4 27.4 23.2 1.3 1.3 14.0 2.5 51.8 10.3 6.9 2.0 2.9 11.3 2.9 1.5 4.9 23.3 45.1 5.0 2.6 3.2 19.4 0.0 3.0 2.2 1.9 7.5 5.7 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 23.2 0.0 10.2 15.8 4.1 3.3 17.0 7.3 20.9 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.4 12.6 0.0 0.2 0.1 0.0 0.0 5.1 0.0 0.0 13.2 0.0 23.2 0.0 7.5 0.1 0.0 19.6 0.0 0.0 0.0 0.1 0.0 0.0 14.7 0.0 0.0 0.0 58.6 15.7 0.0 0.1 0.0 0.0 0.0 0.0 10.8 0.4 0.1 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 31.7 33.4 33.0 46.7 31.1 44.2 34.4 27.4 51.8 19.4 TCERG1L FLJ38950 ENSG00000176769 "Transcription elongation regulator 1 like" Q5VWI1 10 131092391-131311721 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.7;thyroid gland: 24.1" "Cell line enhanced" "Detected in some" "BEWO: 9.5;NTERA-2: 1.4;RPMI-8226: 2.3;SCLC-21H: 1.2;U-2 OS: 2.4" "Cancer enriched" "Detected in some" 14 "thyroid cancer: 20.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "unprognostic (8.99e-2)" "unprognostic (1.45e-2)" "unprognostic (3.03e-1)" "unprognostic (6.69e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-1)" "unprognostic (9.71e-2)" "unprognostic (2.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.08e-5)" "unprognostic (1.28e-1)" "unprognostic (2.83e-1)" "unprognostic (2.96e-2)" "unprognostic (2.03e-1)" 0.4 1.9 2.7 0.4 4.1 0.4 0.6 3.0 9.7 0.5 0.4 0.0 0.0 0.4 0.6 1.1 0.6 0.4 0.4 0.4 3.8 3.5 0.4 0.4 0.5 0.4 0.9 3.9 5.5 0.8 0.4 4.8 0.4 1.5 1.4 0.4 3.8 0.3 1.3 0.3 1.2 0.4 0.4 2.2 0.6 0.5 1.8 0.0 0.6 24.1 0.0 0.6 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.7 4.1 3.0 9.7 3.8 3.5 0.9 3.9 1.5 0.0 TCFL5 "bHLHe82, CHA, E2BP-1, Figlb" ENSG00000101190 "Transcription factor like 5" Q9UL49 20 62841115-62861763 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.9;testis: 55.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055223 Enhanced Supported Nucleoplasm Nucleoplasm "HPA055223: AB_2682745" "unprognostic (4.05e-2)" "unprognostic (3.14e-1)" "unprognostic (2.19e-1)" "prognostic unfavourable (3.24e-4)" "unprognostic (2.78e-1)" "unprognostic (2.72e-3)" "unprognostic (3.95e-2)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "unprognostic (2.79e-1)" "unprognostic (1.14e-1)" "unprognostic (3.88e-1)" "unprognostic (1.54e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-1)" "unprognostic (1.33e-3)" "unprognostic (1.01e-2)" 5.4 3.9 18.6 4.0 18.9 3.7 6.4 4.6 14.8 6.5 4.1 22.5 6.1 3.2 5.7 6.6 6.0 5.9 5.0 5.5 20.0 15.5 5.0 4.6 3.6 4.7 25.4 10.7 8.3 4.8 7.5 3.0 4.8 17.0 4.9 3.8 6.3 4.9 6.3 4.5 10.9 3.5 5.5 32.9 4.1 3.7 55.7 12.0 8.3 14.9 2.1 5.0 4.6 3.2 1.4 1.9 2.9 1.6 1.2 3.2 0.7 12.7 3.8 8.5 9.7 18.2 18.5 7.5 8.2 11.4 16.1 9.0 9.4 7.8 6.4 9.5 7.2 14.0 8.4 9.3 14.1 4.5 7.0 5.3 11.0 13.7 7.2 7.7 6.4 6.8 13.9 4.5 9.5 7.3 5.9 2.4 7.4 15.4 34.0 9.8 5.5 12.1 18.8 14.8 9.0 4.3 3.7 12.2 6.6 14.6 5.9 22.2 10.1 14.5 7.7 12.9 8.4 11.1 9.6 6.3 4.2 5.4 7.7 9.7 7.0 0.5 1.6 2.9 3.2 1.5 1.9 1.3 2.3 2.1 1.2 1.4 2.5 1.7 2.8 1.2 1.5 1.9 2.3 0.7 18.6 18.9 4.6 14.8 20.0 15.5 25.4 10.7 17.0 12.0 TCTEX1D1 FLJ40873 ENSG00000152760 "Tctex1 domain containing 1" Q8N7M0 1 66752459-66778787 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.4;fallopian tube: 18.2;liver: 13.5" "Group enriched" "Detected in some" 6 "HEL: 13.8;HUVEC TERT2: 13.9;THP-1: 15.5" "Cancer enriched" "Detected in single" 10 "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028420 Uncertain "HPA028420: AB_10603995" "unprognostic (3.54e-2)" "unprognostic (2.32e-2)" "unprognostic (3.72e-4)" "unprognostic (1.22e-1)" "unprognostic (9.65e-3)" "unprognostic (1.81e-2)" "unprognostic (1.40e-1)" "unprognostic (3.60e-2)" "unprognostic (1.01e-1)" "unprognostic (2.15e-1)" "unprognostic (2.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.53e-6)" "unprognostic (9.28e-4)" "unprognostic (2.78e-2)" "unprognostic (6.13e-3)" "unprognostic (3.65e-2)" 1.8 1.1 5.3 1.2 7.2 7.4 1.1 2.1 3.7 1.5 1.0 9.5 0.0 0.8 0.8 7.5 0.8 18.2 1.1 1.9 8.2 10.4 0.7 13.5 4.0 0.4 3.3 2.4 3.4 0.8 0.7 0.9 11.5 28.4 0.8 1.1 0.7 0.5 1.7 1.9 1.3 1.1 1.3 2.6 0.4 0.8 0.5 2.2 0.0 0.6 0.2 0.6 1.5 0.8 0.0 0.1 0.9 0.6 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.3 2.5 0.0 0.3 0.7 0.3 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 13.9 0.0 0.0 2.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.6 5.3 7.2 2.1 3.7 8.2 10.4 3.3 2.4 28.4 2.2 TECTA "DFNA12, DFNA8, DFNB21" ENSG00000109927 "Tectorin alpha" O75443 11 121101173-121191493 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.5" "Cell line enhanced" "Detected in some" "AF22: 3.5;SCLC-21H: 2.4;SH-SY5Y: 5.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA018870 Approved "Secreted in other tissues" "HPA018870: AB_1857879" "unprognostic (1.12e-3)" "unprognostic (2.42e-1)" "unprognostic (1.42e-2)" "unprognostic (1.45e-2)" "unprognostic (4.30e-2)" "unprognostic (3.11e-1)" "unprognostic (3.00e-2)" "unprognostic (3.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.14e-1)" "unprognostic (1.39e-6)" "unprognostic (1.22e-1)" "unprognostic (4.15e-3)" "unprognostic (6.97e-3)" "unprognostic (1.12e-1)" "unprognostic (3.28e-2)" "unprognostic (4.19e-2)" 0.6 1.6 1.1 0.4 3.5 0.4 0.6 2.9 5.5 0.4 0.5 0.2 0.6 1.8 0.1 0.6 0.7 2.1 1.3 2.6 0.7 0.9 1.1 0.2 1.4 1.6 0.7 4.2 2.5 0.6 0.9 0.3 0.5 1.6 1.0 0.2 0.2 0.6 1.0 0.4 0.4 2.0 1.4 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 3.5 1.8 0.1 0.2 0.5 0.5 0.3 0.1 0.2 0.3 0.0 0.2 1.7 0.2 0.0 0.7 0.0 0.2 0.6 0.9 0.5 0.1 0.0 0.3 0.5 0.3 0.4 0.6 0.1 0.0 0.4 0.0 1.2 0.4 0.2 0.2 1.3 0.7 0.1 0.1 0.6 0.1 0.5 0.1 2.4 5.4 0.3 0.2 0.3 0.3 0.5 0.0 0.4 0.5 0.2 0.4 1.3 1.3 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 TENM1 "ODZ1, ODZ3, TEN-M1, TNM" ENSG00000009694 "Teneurin transmembrane protein 1" Q9UKZ4 X 124375903-124963817 "Predicted membrane proteins" "Stress response, Transcription, Transcription regulation" "Neuropeptide, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0;liver: 10.5" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.7;MOLT-4: 9.9;RPTEC TERT1: 3.5;SCLC-21H: 3.5;U-138 MG: 5.9" "Group enriched" "Detected in many" 5 "glioma: 1.6;prostate cancer: 2.2;renal cancer: 1.6;testis cancer: 1.4;thyroid cancer: 7.0" "Region enriched" "Detected in many" 4 "cerebellum: 17.0" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002848 Uncertain "HPA002848: AB_1079523" "unprognostic (1.71e-3)" "unprognostic (8.25e-2)" "unprognostic (3.14e-1)" "unprognostic (8.68e-4)" "unprognostic (5.76e-3)" "unprognostic (3.51e-2)" "unprognostic (7.07e-2)" "unprognostic (2.68e-4)" "unprognostic (6.58e-2)" "unprognostic (1.71e-1)" "unprognostic (4.49e-3)" "unprognostic (3.58e-1)" "unprognostic (2.71e-2)" "unprognostic (4.41e-2)" "unprognostic (1.99e-1)" "unprognostic (3.25e-3)" "unprognostic (4.44e-2)" 1.9 3.0 1.4 0.4 2.4 3.5 1.0 17.0 4.4 0.4 1.1 0.9 0.4 0.1 1.4 2.3 0.4 1.5 2.0 0.4 2.3 2.7 1.8 10.5 0.9 0.9 1.0 4.2 0.4 0.4 0.0 3.5 0.4 3.3 4.8 0.3 1.5 0.9 3.8 0.5 1.6 0.7 1.1 2.6 0.6 0.5 2.3 0.4 0.4 3.1 0.4 0.7 0.4 0.4 0.0 0.0 2.4 0.1 0.6 1.6 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.7 0.0 0.0 1.2 0.0 0.0 9.9 0.0 0.5 1.5 0.0 0.0 0.1 3.5 0.0 3.5 0.0 0.0 0.7 0.0 0.8 0.0 0.0 5.9 0.2 0.0 0.4 0.3 0.7 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.6 0.0 0.9 0.0 0.9 1.0 0.0 0.0 1.6 1.1 2.4 0.6 0.0 0.0 0.2 0.1 1.4 2.4 17.0 3.9 2.3 2.7 1.0 4.2 3.3 0.4 TENM2 "KIAA1127, ODZ2, Ten-M2" ENSG00000145934 "Teneurin transmembrane protein 2" Q9NT68 5 167284799-168264157 "Predicted membrane proteins" "Cell adhesion, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 15.1;heart muscle: 24.7" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 26.1;HBEC3-KT: 17.1;HDLM-2: 16.7;U-138 MG: 30.6;U-2 OS: 26.6;U-251 MG: 19.6" "Cancer enriched" "Detected in many" 6 "head and neck cancer: 15.4" "Region enhanced" "Detected in many" "cerebral cortex: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA038018, HPA038420, HPA068691" Uncertain Approved Nucleoli Nucleoli "HPA038018: , HPA038420: AB_10674682, HPA068691: " "unprognostic (6.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.94e-2)" "unprognostic (9.16e-3)" "unprognostic (3.88e-3)" "unprognostic (3.81e-3)" "unprognostic (5.81e-2)" "unprognostic (2.41e-1)" "unprognostic (4.62e-2)" "unprognostic (2.10e-2)" "unprognostic (3.68e-3)" "unprognostic (4.34e-2)" "unprognostic (4.69e-5)" "unprognostic (3.47e-2)" "unprognostic (1.03e-1)" "unprognostic (5.16e-4)" "prognostic unfavourable (7.52e-4)" 0.2 0.4 2.5 0.0 3.5 0.0 1.8 0.5 15.1 0.6 0.3 0.0 0.0 0.3 0.2 0.4 1.4 0.2 0.3 24.7 6.5 0.9 2.7 1.2 0.3 0.0 0.5 1.7 0.7 0.2 0.0 0.4 0.0 2.3 2.2 0.0 0.2 0.3 1.0 0.2 2.3 0.2 0.0 0.6 0.2 0.3 1.2 0.4 0.0 0.4 0.0 0.9 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 0.0 26.1 0.0 0.0 17.1 0.3 16.7 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.2 3.0 0.1 2.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 3.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 30.6 26.6 0.0 19.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.5 0.5 15.1 6.5 0.9 0.5 1.7 2.3 0.4 TESPA1 KIAA0748 ENSG00000135426 "Thymocyte expressed, positive selection associated 1" A2RU30 12 54948018-54984746 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 45.1;brain: 56.9;lymphoid tissue: 27.8" "Group enriched" "Detected in some" 6 "HEL: 66.4;HMC-1: 54.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 56.9" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 45.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA058823 Approved "HPA058823: " "unprognostic (1.98e-5)" "unprognostic (3.70e-4)" "unprognostic (3.87e-4)" "unprognostic (1.13e-3)" "unprognostic (3.20e-2)" "unprognostic (4.55e-4)" "unprognostic (2.29e-3)" "unprognostic (5.34e-4)" "unprognostic (3.83e-4)" "unprognostic (1.35e-2)" "unprognostic (3.97e-2)" "unprognostic (5.89e-2)" "unprognostic (4.50e-2)" "unprognostic (4.11e-1)" "unprognostic (1.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" 1.4 0.8 2.9 9.2 25.0 8.2 1.1 0.7 56.9 1.3 2.3 0.2 0.0 2.0 1.6 3.0 1.3 1.3 3.3 1.0 4.5 1.6 1.3 1.1 3.8 23.4 2.1 13.3 5.2 0.9 0.6 0.9 0.2 0.5 1.5 3.3 0.0 1.1 0.6 0.9 1.2 4.8 1.4 0.9 8.7 2.6 0.9 4.0 27.8 1.4 0.0 23.1 3.2 1.4 4.3 3.9 9.3 0.4 13.5 45.1 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 0.0 5.5 0.0 66.4 0.1 0.0 0.0 3.7 54.7 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 10.5 0.3 0.1 0.0 2.5 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 3.1 0.4 1.2 0.0 9.3 0.4 0.4 9.8 0.3 11.5 4.3 31.8 14.7 3.9 3.9 45.1 24.9 0.7 13.5 0.3 1.4 21.2 14.8 2.9 25.0 0.7 56.9 4.5 1.6 2.1 13.3 0.5 4.0 TET3 "hCG_40738, MGC22014" ENSG00000187605 "Tet methylcytosine dioxygenase 3" O43151 2 73986404-74108176 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050845 Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA050845: " "unprognostic (1.07e-2)" "unprognostic (1.21e-2)" "unprognostic (3.08e-1)" "unprognostic (1.12e-2)" "unprognostic (4.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.72e-3)" "unprognostic (1.46e-1)" "unprognostic (1.01e-1)" "unprognostic (9.83e-2)" "unprognostic (7.74e-2)" "unprognostic (2.03e-1)" "prognostic unfavourable (3.58e-5)" "unprognostic (2.05e-1)" "unprognostic (5.30e-1)" "unprognostic (1.55e-2)" "unprognostic (1.10e-1)" 2.9 2.3 7.2 6.1 10.8 20.9 3.9 26.0 17.1 3.2 5.1 20.6 0.5 6.7 2.9 1.9 10.2 3.0 3.3 1.6 7.1 3.3 2.6 5.1 5.6 4.3 12.0 9.5 2.9 3.6 3.5 4.2 5.7 12.4 3.6 5.5 5.9 5.9 1.8 1.8 18.9 7.2 2.7 5.3 5.5 5.3 2.1 11.7 0.6 3.4 1.7 5.1 4.0 5.0 1.1 1.4 2.5 2.2 0.4 0.9 0.9 6.1 5.4 10.4 6.3 0.9 1.0 19.1 1.3 1.7 2.5 1.9 11.6 5.8 10.3 2.5 1.7 6.6 9.2 3.6 2.6 4.4 3.6 13.2 4.5 3.9 3.8 13.8 8.2 1.5 9.7 3.0 7.2 3.7 9.0 3.4 1.4 10.2 6.8 9.0 5.8 1.9 10.3 6.5 3.6 2.7 11.5 13.0 11.1 2.8 7.4 3.5 4.7 11.2 4.7 2.6 11.2 1.2 4.6 3.0 1.3 9.0 1.7 9.7 3.4 0.5 2.0 1.0 0.4 2.2 0.9 1.1 0.5 0.5 1.4 0.9 0.7 0.6 2.5 0.4 0.7 1.4 0.0 0.9 7.2 10.8 26.0 17.1 7.1 3.3 12.0 9.5 12.4 11.7 TEX15 CT42 ENSG00000133863 "Testis expressed 15, meiosis and synapsis associated" Q9BXT5 8 30831544-30913003 "Predicted intracellular proteins" "Differentiation, DNA damage, DNA repair, Meiosis, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3" "Cell line enhanced" "Detected in some" "HAP1: 8.7;HEL: 19.7;K-562: 5.5;NTERA-2: 3.7;SCLC-21H: 4.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA036800 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036800: AB_10671714" "unprognostic (3.10e-1)" "unprognostic (2.56e-1)" "unprognostic (3.30e-4)" "unprognostic (3.54e-1)" "unprognostic (2.45e-2)" "unprognostic (2.15e-3)" "unprognostic (2.80e-3)" "unprognostic (4.52e-2)" "unprognostic (5.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.61e-5)" "unprognostic (8.88e-3)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (4.92e-1)" 0.1 0.1 0.7 0.2 5.4 0.1 0.1 0.1 1.1 1.2 0.1 0.0 0.0 0.1 10.0 0.6 0.2 0.1 0.8 0.1 1.7 0.5 0.1 0.1 0.1 0.1 0.3 0.3 0.4 0.1 0.1 6.9 0.1 0.9 0.1 0.1 0.3 0.1 0.5 0.1 0.1 0.2 8.5 0.4 0.4 0.9 21.3 1.4 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 8.7 1.1 0.0 1.1 3.1 19.7 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.1 0.1 0.1 3.7 0.3 0.0 0.0 0.0 0.0 0.0 4.3 1.4 0.0 0.0 3.7 0.2 1.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 5.4 0.1 1.1 1.7 0.5 0.3 0.3 0.9 1.4 TEX26 "C13orf26, MGC40178" ENSG00000175664 "Testis expressed 26" Q8N6G2 13 30932703-30975502 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 19.7;testis: 29.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "glioma: 2.6" "Region enhanced" "Detected in many" "pons and medulla: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (2.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (1.53e-2)" "unprognostic (9.27e-2)" 0.5 1.2 1.6 0.4 6.3 0.4 0.5 0.2 3.0 1.7 0.4 4.8 0.3 0.4 0.5 1.3 0.5 1.3 0.8 0.5 3.7 5.5 0.4 0.6 0.6 0.4 1.1 2.7 0.4 0.4 0.4 4.2 0.4 19.7 0.7 0.5 0.0 0.5 0.8 0.5 0.4 0.5 0.4 3.7 0.4 0.5 29.3 2.0 0.0 0.4 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 6.3 0.2 3.0 3.7 5.5 1.1 2.7 19.7 2.0 TFAP2D TFAP2BL1 ENSG00000008197 "Transcription factor AP-2 delta" Q7Z6R9 6 50713828-50772988 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 4.4" "Group enriched" "Detected in some" 5 "HAP1: 5.1;U-2197: 1.6" "Cancer enriched" "Detected in single" 10 "lung cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "midbrain: 14.1" "Region enriched" "Detected in some" 7 "midbrain: 16.3" 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFAP2E AP2E ENSG00000116819 "Transcription factor AP-2 epsilon" Q6VUC0 1 35573370-35595328 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 22.0;skin 1: 11.4" "Cell line enhanced" "Detected in some" "NB-4: 10.3;SK-MEL-30: 5.6;THP-1: 4.9;U-937: 8.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 22.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (7.06e-4)" "unprognostic (1.96e-2)" "unprognostic (9.05e-2)" "unprognostic (2.29e-2)" "unprognostic (2.81e-2)" "unprognostic (1.34e-2)" "unprognostic (1.05e-2)" "unprognostic (3.34e-2)" "unprognostic (3.27e-2)" "unprognostic (9.39e-2)" "unprognostic (4.02e-1)" "unprognostic (7.45e-2)" "unprognostic (1.67e-15)" "unprognostic (2.03e-1)" "unprognostic (4.83e-1)" "unprognostic (3.48e-2)" "unprognostic (7.40e-2)" 0.6 0.5 2.5 2.6 4.3 4.7 1.3 22.0 3.4 1.2 1.3 1.1 0.6 0.3 1.3 1.8 0.7 1.3 0.7 0.6 4.8 2.9 0.6 0.6 8.2 3.0 2.2 0.6 1.7 0.6 0.2 1.5 0.7 4.7 1.2 0.4 2.2 1.1 0.7 0.6 11.4 0.6 0.7 4.3 1.9 1.0 1.7 2.9 0.6 0.6 0.6 1.6 0.6 1.3 1.4 1.2 5.2 3.1 3.5 3.1 1.6 0.4 0.4 0.6 0.3 0.5 0.9 1.7 0.3 0.3 0.2 0.1 1.2 1.0 0.2 0.8 0.3 0.4 0.1 0.0 0.3 0.5 1.1 4.3 0.8 1.1 1.2 0.7 0.3 0.3 0.9 0.6 0.4 0.0 0.1 1.2 0.0 0.7 0.9 10.3 0.9 0.6 0.4 0.2 0.3 0.0 0.1 0.4 0.8 1.1 0.5 5.6 1.6 4.9 0.5 0.3 1.7 2.6 0.7 2.1 1.1 0.1 0.3 8.6 1.5 1.6 3.1 5.2 3.1 1.1 1.5 1.4 1.8 2.5 1.2 1.3 0.8 2.5 0.0 3.5 1.4 1.0 2.1 1.6 2.5 4.3 22.0 3.4 4.8 2.9 2.2 0.6 4.7 2.9 TFPT "amida, FB1, INO80F" ENSG00000105619 "TCF3 fusion partner" P0C1Z6 19 54107013-54115675 "Disease related genes, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034958, HPA058534" Approved Supported "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA034958: AB_10603036, HPA058534: " "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "prognostic unfavourable (5.13e-4)" "unprognostic (6.56e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (5.25e-4)" "unprognostic (3.85e-1)" "unprognostic (2.85e-1)" "unprognostic (2.71e-1)" "prognostic favourable (3.13e-4)" "unprognostic (1.80e-2)" "unprognostic (1.15e-1)" "unprognostic (2.00e-2)" "unprognostic (2.61e-1)" "unprognostic (3.43e-1)" "unprognostic (3.66e-2)" 5.9 6.5 33.4 8.9 17.0 7.9 5.1 9.6 22.9 7.9 5.3 8.7 4.3 10.1 5.9 5.3 4.1 5.1 7.1 7.7 24.4 15.5 4.3 3.6 7.9 11.6 18.3 16.1 4.2 4.0 3.3 4.2 6.4 10.8 15.9 2.9 4.8 12.9 5.2 10.8 6.8 10.7 4.7 9.7 14.1 14.5 4.6 12.8 9.6 5.2 3.2 4.8 5.3 3.9 4.4 24.7 5.0 3.9 10.4 13.3 5.5 2.5 2.2 2.2 4.3 0.4 0.8 2.1 2.4 1.7 2.2 2.6 2.6 8.1 2.5 6.0 2.3 2.7 0.8 1.3 0.7 6.5 11.7 3.0 4.0 3.3 6.2 4.0 6.5 1.7 0.8 1.5 1.1 3.4 2.7 3.6 3.4 9.3 7.1 12.5 2.4 4.9 5.9 1.5 3.4 1.6 11.8 5.9 5.0 0.8 9.5 12.9 2.5 14.1 7.8 16.2 3.3 1.2 3.3 6.3 6.7 1.9 6.9 11.0 13.7 5.0 3.7 3.6 8.1 3.9 7.7 4.4 11.6 10.7 9.5 4.2 9.0 9.5 2.4 10.4 1.2 24.7 13.3 5.5 33.4 17.0 9.6 22.9 24.4 15.5 18.3 16.1 10.8 12.8 TH DYT5b ENSG00000180176 "Tyrosine hydroxylase" P07101 11 2163929-2171877 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Catecholamine biosynthesis, Neurotransmitter biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 31 "adrenal gland: 83.5;brain: 41.4" "Group enriched" "Detected in some" 32 "PC-3: 35.1;SK-BR-3: 12.5" "Cancer enhanced" "Detected in some" "urothelial cancer: 4.0" "Group enriched" "Detected in many" 6 "hypothalamus: 15.5;midbrain: 41.4;pons and medulla: 41.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "olfactory region: 220.1" "Region enriched" "Detected in many" 19 "midbrain: 692.0" "CAB002522, HPA013768, HPA014010, HPA061003, CAB072340" Enhanced Supported Approved Cytosol Cytosol "CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: " "unprognostic (1.31e-1)" "unprognostic (1.30e-1)" "unprognostic (9.08e-2)" "unprognostic (1.75e-4)" "unprognostic (8.82e-3)" "unprognostic (5.88e-2)" "unprognostic (1.93e-1)" "unprognostic (1.74e-3)" "unprognostic (3.83e-2)" "unprognostic (4.39e-4)" "unprognostic (4.97e-1)" "unprognostic (3.61e-2)" "unprognostic (1.92e-1)" "unprognostic (1.60e-1)" "unprognostic (2.43e-1)" "unprognostic (2.70e-2)" "unprognostic (2.18e-2)" 1.3 83.5 0.0 0.3 5.4 0.2 0.2 0.0 0.7 1.8 0.2 6.2 0.0 0.2 0.3 0.3 0.2 0.3 0.4 0.2 0.3 15.5 0.2 0.2 0.2 0.2 41.4 0.0 0.3 0.3 0.2 0.2 0.9 41.2 0.6 0.2 0.3 0.2 2.0 0.2 0.5 0.4 0.2 0.0 0.3 0.2 0.3 1.5 0.0 0.2 0.0 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 35.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.7 0.3 15.5 41.4 0.0 41.2 1.5 THRA "AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3" ENSG00000126351 "Thyroid hormone receptor, alpha" P10827 17 40058290-40093867 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 90.7" "Cell line enhanced" "Detected in many" "ASC diff: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009654, CAB023349" Approved Supported Cytosol Cytosol "CAB023349: AB_619577, HPA009654: AB_1854603" "unprognostic (2.75e-2)" "unprognostic (2.20e-1)" "unprognostic (6.64e-2)" "unprognostic (4.22e-2)" "unprognostic (8.78e-2)" "unprognostic (1.64e-1)" "unprognostic (3.41e-3)" "prognostic favourable (1.84e-4)" "unprognostic (1.47e-1)" "unprognostic (5.47e-2)" "unprognostic (7.85e-2)" "unprognostic (2.65e-2)" "prognostic favourable (6.05e-8)" "unprognostic (3.05e-1)" "unprognostic (1.35e-1)" "unprognostic (4.21e-1)" "unprognostic (1.88e-3)" 17.1 20.7 58.6 5.7 90.7 9.9 12.9 37.4 73.1 19.8 12.6 24.1 8.2 15.1 19.3 11.5 9.7 29.3 12.7 30.1 43.8 38.1 12.1 2.7 11.6 4.5 34.3 45.5 46.5 12.3 13.0 10.7 8.5 29.6 12.4 9.6 10.4 13.7 18.8 38.5 10.0 16.7 17.4 29.4 6.1 11.9 7.8 43.6 1.8 12.5 7.9 3.3 10.0 18.6 1.0 1.5 3.7 0.7 5.1 4.7 1.4 2.1 17.2 5.4 13.4 37.1 13.6 1.9 8.8 10.6 9.2 8.6 14.3 12.5 2.5 14.7 17.2 5.2 10.5 5.4 5.0 0.9 9.9 4.6 20.5 6.1 12.5 7.5 5.2 21.6 4.4 8.6 3.3 12.3 9.3 2.4 7.6 3.2 10.0 12.4 4.9 5.4 14.4 10.6 12.4 3.1 1.5 9.1 8.3 6.8 10.9 15.4 12.7 8.9 8.5 9.2 9.2 8.2 2.6 5.6 3.9 1.5 5.7 8.7 4.9 0.3 0.6 3.7 4.7 0.3 2.0 0.6 1.9 2.8 0.8 1.0 3.4 4.1 2.5 5.1 0.7 1.5 2.2 1.4 58.6 90.7 37.4 41.8 43.8 38.1 34.3 45.5 29.6 43.6 THSD7B KIAA1679 ENSG00000144229 "Thrombospondin type 1 domain containing 7B" Q9C0I4 2 136765545-137677717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.2;epididymis: 11.6;retina: 14.9" "Group enriched" "Detected in some" 8 "Daudi: 10.1;SCLC-21H: 21.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051416, HPA056745" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051416: , HPA056745: " "unprognostic (4.65e-3)" "unprognostic (2.25e-1)" "unprognostic (8.98e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (6.50e-2)" "unprognostic (7.80e-3)" "unprognostic (2.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.20e-1)" "unprognostic (6.56e-2)" "unprognostic (4.47e-6)" "unprognostic (2.42e-3)" "unprognostic (1.89e-1)" "unprognostic (4.31e-2)" "unprognostic (4.30e-2)" 4.7 0.3 1.7 0.3 1.6 0.1 2.6 0.7 3.2 0.9 0.5 1.1 0.8 0.3 0.9 11.6 1.6 2.8 0.8 1.4 1.8 3.3 2.7 0.6 0.5 0.2 1.8 1.5 0.4 0.3 1.3 3.0 0.7 24.2 2.1 0.3 14.9 1.2 0.7 0.3 0.2 1.5 2.2 3.2 0.2 0.3 1.1 0.3 0.1 2.1 0.0 0.3 0.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.1 0.0 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 0.7 3.2 1.8 3.3 1.8 1.5 24.2 0.3 THY1 CD90 ENSG00000154096 "Thy-1 cell surface antigen" P04216 11 119417378-119424985 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.7;smooth muscle: 91.5" "Cell line enhanced" "Detected in many" "ASC diff: 52.6;BJ: 82.2;BJ hTERT+: 92.1;fHDF/TERT166: 144.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003733, CAB068243, CAB068244" Enhanced Approved "Nucleoplasm,Plasma membrane" 9800000 Nucleoplasm "Plasma membrane" "CAB068243: , CAB068244: , HPA003733: AB_1846340" "unprognostic (9.98e-2)" "unprognostic (2.71e-1)" "unprognostic (5.13e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (6.87e-4)" "unprognostic (7.43e-2)" "unprognostic (1.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-3)" "unprognostic (3.38e-2)" "unprognostic (3.52e-1)" "prognostic unfavourable (2.40e-6)" "unprognostic (1.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.03e-2)" "unprognostic (1.14e-2)" 28.7 5.9 42.0 23.2 72.4 0.4 7.0 17.6 97.7 26.9 9.0 7.2 2.1 3.5 20.3 13.9 9.8 7.5 31.6 4.3 63.4 41.1 46.6 2.6 6.5 10.9 29.8 34.8 3.2 5.0 7.3 5.5 19.1 53.8 4.6 13.6 8.5 2.9 15.7 1.4 4.2 4.6 91.5 9.3 6.7 5.7 4.0 6.9 3.1 12.0 1.0 10.8 36.9 7.2 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.3 12.3 0.0 52.6 38.1 0.0 82.2 92.1 29.5 32.7 0.0 0.0 0.0 0.0 144.0 0.0 0.4 0.1 22.6 7.0 0.0 4.4 1.5 0.0 16.3 0.0 0.0 28.2 0.0 37.4 1.3 0.0 0.0 0.0 22.7 0.0 0.0 0.0 19.7 0.1 0.0 5.8 0.0 0.0 0.0 2.1 5.6 0.0 0.0 0.0 0.1 0.2 0.0 42.4 14.1 12.2 12.1 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 42.0 72.4 17.6 97.7 63.4 41.1 29.8 34.8 53.8 6.9 TIAF1 ENSG00000221995 "TGFB1-induced anti-apoptotic factor 1" O95411 17 29073521-29078857 "Predicted intracellular proteins" Apoptosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.0" "Cell line enhanced" "Detected in many" "REH: 11.6" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "unprognostic (1.16e-1)" "unprognostic (8.34e-2)" "unprognostic (7.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.42e-1)" "unprognostic (9.03e-3)" "unprognostic (4.14e-2)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.07e-3)" "unprognostic (1.35e-1)" "unprognostic (3.97e-8)" "unprognostic (1.54e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" 1.0 1.4 2.5 1.7 3.3 1.9 1.1 10.0 4.7 1.1 1.3 2.5 1.5 4.2 1.8 0.7 1.7 3.0 3.8 2.7 0.8 4.7 0.7 2.2 4.3 1.1 0.8 1.8 1.2 1.1 1.5 2.0 1.8 1.5 8.3 7.4 1.9 1.8 4.7 1.7 1.4 1.1 0.7 2.8 0.6 1.8 1.8 1.9 3.0 1.1 0.9 1.5 0.2 1.0 0.5 1.8 1.0 1.1 1.2 1.3 1.2 0.5 0.7 0.8 1.4 1.4 0.9 0.9 1.5 2.9 1.3 1.1 1.5 1.2 0.8 0.3 2.0 1.1 0.5 1.4 1.3 1.0 0.8 1.9 0.6 0.4 3.1 2.0 1.0 0.8 1.3 3.2 0.2 1.0 11.6 0.9 1.3 2.1 0.8 1.2 0.6 0.6 5.8 0.6 0.9 4.9 0.4 1.1 1.1 0.5 0.9 0.8 1.4 0.6 1.4 1.4 0.9 1.1 0.9 0.4 1.1 0.4 1.5 0.9 1.2 0.8 0.4 1.8 0.8 1.1 3.0 0.9 1.1 1.9 0.3 0.2 TIAM1 ENSG00000156299 "T cell lymphoma invasion and metastasis 1" Q13009 21 31118416-31559977 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 110.1" "Cell line enhanced" "Detected in many" "BEWO: 18.9;HEL: 18.3;HMC-1: 16.0;RT4: 19.0;SCLC-21H: 17.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 8 "cerebellum: 110.1" "Group enriched" "Detected in many" 5 "classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 574.6" "CAB010416, HPA034853" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol" "Nucleoplasm, Cell Junctions" "Nuclear membrane, Cytokinetic bridge, Cytosol" "CAB010416: AB_2240410, HPA034853: " "unprognostic (9.59e-2)" "unprognostic (7.44e-3)" "unprognostic (5.64e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.81e-3)" "unprognostic (2.84e-2)" "unprognostic (3.73e-1)" "unprognostic (8.08e-2)" "unprognostic (2.70e-3)" "unprognostic (7.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.20e-3)" "unprognostic (2.38e-3)" "unprognostic (1.61e-1)" "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" 3.3 11.4 13.4 5.3 12.4 2.1 4.4 110.1 15.1 10.1 2.2 9.7 0.5 1.5 7.9 3.0 18.9 9.4 4.0 2.1 11.6 7.0 1.7 3.7 4.1 8.8 6.2 7.9 1.5 1.9 0.3 4.2 4.4 8.9 3.7 2.8 7.0 2.2 3.1 0.7 20.4 1.7 10.0 6.4 4.2 2.1 5.9 7.1 6.2 1.3 5.3 9.3 8.1 5.0 0.1 5.9 0.6 12.4 6.9 16.8 3.6 1.5 0.5 11.9 0.7 0.2 2.8 18.9 0.0 0.0 1.4 0.5 0.1 2.1 4.0 0.8 0.3 2.8 1.4 2.4 2.4 0.3 6.5 18.3 0.3 0.1 0.3 0.0 16.0 1.2 0.8 8.1 3.2 0.0 0.0 6.0 6.0 7.7 2.8 0.1 3.8 5.1 3.6 3.7 0.0 1.8 19.0 17.9 4.4 0.8 6.2 0.7 2.5 0.0 0.1 1.7 6.9 0.0 0.8 6.7 5.0 3.6 4.0 1.4 13.1 0.6 10.7 0.0 0.3 9.6 2.1 0.1 8.3 1.6 5.9 0.0 10.9 0.6 0.6 6.9 12.4 0.3 16.8 3.6 13.4 12.4 110.1 14.4 11.6 7.0 6.2 7.9 8.9 7.1 TIAM2 STEF ENSG00000146426 "T cell lymphoma invasion and metastasis 2" Q8IVF5 6 154832697-155257723 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8" "Cell line enhanced" "Detected in many" "AF22: 34.4;HDLM-2: 14.7;RH-30: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.3" "Group enriched" "Detected in many" 4 "B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3" "Group enriched" "Detected in many" 5 "amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6" "Low region specificity" "Detected in many" "HPA011134, HPA013903" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA011134: AB_1858005, HPA013903: AB_1858004" "unprognostic (9.14e-2)" "unprognostic (5.79e-2)" "unprognostic (1.44e-1)" "unprognostic (6.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (4.36e-2)" "unprognostic (1.89e-1)" "unprognostic (5.74e-2)" "unprognostic (1.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.38e-3)" "unprognostic (1.82e-1)" "unprognostic (8.13e-2)" "unprognostic (6.04e-2)" "unprognostic (1.05e-1)" 0.6 2.1 5.3 1.7 9.4 0.7 1.5 7.9 21.1 1.5 11.6 0.7 0.1 11.0 1.2 0.8 1.0 1.2 4.0 3.5 4.7 2.0 0.7 0.7 0.9 2.0 1.7 9.5 0.9 1.8 0.2 1.8 0.8 0.6 3.0 1.1 1.3 2.4 3.6 3.0 1.0 27.4 1.4 0.9 1.2 4.0 15.6 1.9 0.0 7.8 0.0 2.5 2.3 1.2 3.3 0.9 8.3 11.3 0.8 1.8 0.4 4.3 0.8 34.4 4.0 1.5 4.2 0.4 1.8 1.1 1.7 2.9 0.5 2.5 1.0 1.8 3.1 0.6 1.2 0.0 1.2 14.7 1.9 0.2 0.6 2.0 0.9 0.3 1.0 2.8 0.1 0.6 0.1 2.4 0.5 0.1 3.8 0.4 0.4 0.9 2.5 0.9 4.4 22.4 0.4 0.1 0.2 0.9 7.9 0.1 0.4 0.2 0.3 0.5 0.8 0.3 8.7 0.3 0.9 0.2 1.7 0.2 0.1 0.5 2.2 0.4 0.2 3.1 0.2 3.2 0.3 3.3 0.5 0.3 0.9 1.0 0.6 0.4 8.3 0.8 11.3 0.3 1.8 0.4 5.3 9.4 7.9 21.1 4.7 2.0 1.7 9.5 0.6 1.9 TIGD3 ENSG00000173825 "Tigger transposable element derived 3" Q6B0B8 11 65354767-65357613 "Predicted intracellular proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 14.9;brain: 8.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 6.5;eosinophil: 8.4;neutrophil: 14.9" "Lineage enriched" "Detected in many" 12 "granulocytes: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040016 Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA040016: AB_10805600" "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-3)" "unprognostic (9.04e-4)" "unprognostic (1.48e-4)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-3)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (7.55e-3)" "unprognostic (1.01e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-3)" 0.1 0.7 1.8 0.8 2.7 1.3 3.0 8.6 4.6 0.3 4.1 0.9 0.0 2.6 0.4 0.8 0.4 0.5 0.6 0.4 2.0 1.9 0.8 0.7 1.1 1.1 1.2 0.0 1.0 1.5 1.5 1.9 0.4 3.1 0.5 0.4 1.1 0.5 0.5 0.3 0.2 6.4 0.3 2.0 2.6 1.0 6.9 0.4 3.0 0.4 1.0 0.8 0.6 0.0 0.3 1.2 14.9 1.2 0.1 0.1 0.1 1.3 2.6 2.2 5.9 0.0 0.0 0.8 0.1 0.3 0.6 0.8 2.0 0.3 1.0 1.0 0.2 1.4 2.2 0.1 0.2 1.7 2.3 0.4 1.3 4.6 0.1 0.9 4.4 0.0 0.2 0.3 0.0 0.3 1.4 3.0 0.0 3.4 2.8 1.9 1.3 1.1 4.1 1.0 4.0 0.1 1.3 6.6 4.2 1.7 2.6 1.0 4.2 1.4 0.0 0.2 1.1 1.5 1.0 6.3 4.0 1.3 0.1 1.8 0.6 6.5 0.5 8.4 0.0 0.3 0.0 0.3 0.0 0.0 0.8 0.2 0.1 0.0 14.9 0.1 1.2 1.2 0.0 0.1 1.8 2.7 8.6 4.6 2.0 1.9 1.2 0.0 3.1 0.4 TLE2 "ESG, ESG2, FLJ41188, GRG2" ENSG00000065717 "Transducin like enhancer of split 2" Q04725 19 2997638-3047635 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 85.3" "Cell line enhanced" "Detected in many" "AN3-CA: 24.7;RT4: 19.6;T-47d: 14.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 85.3" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 3.1;T-cells: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049103 Enhanced Supported "Nuclear bodies,Focal adhesion sites" "Nuclear bodies" "Focal adhesion sites" "HPA049103: " "unprognostic (1.87e-3)" "unprognostic (1.42e-1)" "unprognostic (2.89e-1)" "prognostic favourable (2.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.01e-1)" "unprognostic (9.87e-3)" "unprognostic (6.40e-3)" "unprognostic (2.44e-1)" "unprognostic (1.81e-2)" "prognostic favourable (2.39e-6)" "unprognostic (2.12e-1)" "prognostic favourable (9.49e-6)" "unprognostic (2.66e-1)" "unprognostic (5.99e-2)" "unprognostic (2.60e-1)" "prognostic favourable (8.88e-4)" 13.4 9.6 9.2 4.6 5.7 1.3 38.3 85.3 16.5 10.9 11.4 4.9 28.6 8.1 15.7 6.6 5.5 13.3 8.5 19.9 5.5 7.6 11.9 3.5 12.5 5.4 8.3 5.3 12.4 16.5 13.8 6.4 7.3 9.7 12.9 4.6 20.6 55.5 27.1 38.5 6.4 5.3 26.2 13.3 10.9 7.4 6.3 4.8 1.1 17.5 5.7 3.2 19.2 27.6 3.1 0.0 0.3 0.0 0.0 3.4 0.7 0.3 1.6 0.1 24.7 3.9 0.6 5.4 0.2 0.0 1.2 0.6 7.6 2.7 0.1 3.5 1.7 4.3 4.1 1.5 0.3 0.7 1.2 0.0 1.8 0.3 5.0 0.0 0.2 5.5 0.7 2.8 0.0 9.9 8.9 0.1 0.1 8.3 0.2 0.1 0.1 1.6 1.9 1.2 2.2 3.2 19.6 1.2 6.4 1.6 12.3 0.6 14.3 0.0 6.5 8.1 8.5 0.4 0.2 0.3 0.2 1.6 0.2 1.8 1.5 0.0 0.0 0.3 3.2 0.0 2.3 3.1 2.0 1.0 0.0 0.5 3.4 2.1 0.0 0.0 0.0 0.0 0.7 0.7 9.2 5.7 85.3 16.5 5.5 7.6 8.3 5.3 9.7 4.8 TLL1 ENSG00000038295 "Tolloid like 1" O43897 4 165873258-166103895 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Differentiation "Developmental protein, Hydrolase, Metalloprotease, Protease" "Atrial septal defect, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6" "Group enriched" "Detected in some" 4 "HeLa: 8.5;Karpas-707: 13.3;PC-3: 4.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 40.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 10 "cerebellum: 132.6" HPA060767 Approved Vesicles "Secreted to extracellular matrix" Vesicles "HPA060767: " "unprognostic (2.17e-1)" "unprognostic (6.45e-4)" "unprognostic (8.60e-2)" "unprognostic (2.65e-5)" "unprognostic (9.85e-2)" "unprognostic (2.51e-4)" "unprognostic (3.37e-2)" "unprognostic (3.61e-2)" "unprognostic (1.56e-1)" "unprognostic (5.07e-4)" "unprognostic (2.86e-2)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (2.13e-3)" "unprognostic (7.76e-2)" "unprognostic (6.91e-3)" "unprognostic (1.21e-5)" 10.1 1.3 1.2 2.6 2.8 0.0 7.9 40.6 2.9 5.0 5.4 0.2 4.2 1.4 3.0 2.7 2.5 2.4 5.4 2.4 2.2 1.7 3.3 0.5 3.1 3.0 1.1 0.6 1.6 4.6 1.1 2.2 13.8 8.5 3.1 2.2 3.3 1.9 1.9 1.6 2.7 4.4 3.3 0.9 0.4 1.7 1.5 0.1 0.0 3.2 1.4 1.6 3.6 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.0 0.5 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.1 0.0 8.5 0.0 0.0 0.0 0.0 0.5 1.5 0.0 1.8 1.4 0.0 13.3 0.0 0.0 0.0 0.2 1.2 4.8 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.8 40.6 2.9 2.2 1.7 1.1 0.6 8.5 0.1 TLR10 CD290 ENSG00000174123 "Toll like receptor 10" Q9BXR5 4 38772239-38782990 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6" "Group enriched" "Detected in some" 55 "Daudi: 37.3;REH: 12.5;U-698: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory B-cell: 23.5;naive B-cell: 14.9" "Lineage enriched" "Detected in many" 6 "B-cells: 23.5" "Low region specificity" "Detected in all" HPA066755 Approved Centrosome,Cytosol Cytosol Centrosome "HPA066755: " "unprognostic (5.41e-5)" "unprognostic (2.41e-4)" "unprognostic (1.91e-3)" "unprognostic (8.22e-4)" "unprognostic (6.48e-2)" "unprognostic (9.98e-4)" "unprognostic (9.31e-2)" "unprognostic (8.76e-3)" "unprognostic (4.08e-3)" "unprognostic (7.26e-2)" "unprognostic (8.76e-2)" "unprognostic (6.90e-2)" "unprognostic (2.98e-3)" "unprognostic (3.90e-1)" "unprognostic (1.81e-2)" "unprognostic (3.14e-3)" "unprognostic (1.88e-2)" 0.8 0.5 4.2 24.5 9.4 0.9 0.6 0.6 3.5 0.6 1.0 2.5 0.0 0.9 0.5 0.3 1.7 0.9 1.0 0.5 3.2 1.8 0.8 0.7 1.2 27.0 5.5 0.5 0.5 0.6 0.1 0.7 0.2 4.8 0.8 1.4 0.0 2.6 0.3 0.5 0.5 11.2 0.3 11.3 24.4 1.8 0.4 7.4 2.7 0.9 0.0 31.6 3.2 0.6 23.5 4.0 0.7 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.1 0.2 0.4 0.0 1.5 0.0 23.5 0.0 0.0 3.6 14.9 0.0 0.0 0.7 0.0 1.8 4.0 0.0 0.9 4.2 9.4 0.6 3.5 3.2 1.8 5.5 0.5 4.8 7.4 TLR6 CD286 ENSG00000174130 "Toll like receptor 6" Q9Y2C9 4 38823715-38856817 "CD markers, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.2;brain: 16.0;lymphoid tissue: 16.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.0;RPMI-8226: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 14.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062733 Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA062733: " "unprognostic (9.82e-2)" "unprognostic (4.76e-2)" "unprognostic (3.30e-2)" "unprognostic (3.05e-2)" "unprognostic (1.91e-1)" "unprognostic (1.87e-2)" "unprognostic (1.83e-1)" "unprognostic (4.45e-2)" "unprognostic (9.26e-2)" "unprognostic (1.30e-1)" "unprognostic (1.05e-2)" "unprognostic (2.69e-1)" "unprognostic (7.62e-7)" "unprognostic (4.89e-2)" "unprognostic (1.02e-2)" "unprognostic (7.78e-2)" "unprognostic (2.12e-2)" 2.9 2.7 6.1 10.7 7.9 6.4 2.1 2.0 3.9 1.8 1.6 2.6 0.2 1.7 1.4 2.0 1.8 1.9 3.9 1.5 4.5 1.7 1.7 2.1 5.0 11.2 10.6 1.9 1.6 1.2 0.7 1.9 2.8 7.2 1.6 2.4 0.9 4.3 0.5 0.9 1.7 7.8 2.1 16.0 16.2 2.1 0.8 6.8 1.8 1.5 1.1 14.8 5.8 1.9 1.8 1.8 14.2 2.6 0.3 0.4 0.6 1.5 6.0 0.2 0.1 0.3 6.9 0.0 1.6 7.1 0.7 2.4 0.0 13.0 7.1 2.8 0.3 0.7 0.1 1.3 1.1 0.0 0.5 3.3 7.2 0.2 0.5 3.6 5.4 2.9 1.3 2.9 1.6 1.4 3.6 2.3 3.3 0.0 0.0 6.3 0.2 1.0 3.5 3.2 10.2 0.4 0.1 0.0 0.1 0.2 0.0 1.0 0.3 1.9 2.0 2.3 7.8 0.9 2.5 0.1 0.0 6.0 5.3 4.3 1.7 0.0 2.6 0.7 0.2 2.4 0.0 1.8 0.1 0.1 1.8 1.2 0.3 0.2 14.2 0.3 1.2 1.3 0.4 0.6 6.1 7.9 2.0 3.9 4.5 1.7 10.6 1.9 7.2 6.8 TLR7 ENSG00000196664 "Toll like receptor 7" Q9NYK1 X 12867083-12890380 "FDA approved drug targets, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5" "Group enriched" "Detected in some" 5 "Daudi: 15.6;U-266/70: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059613 Supported "HPA059613: " "unprognostic (1.22e-1)" "unprognostic (1.09e-2)" "unprognostic (2.36e-3)" "unprognostic (9.29e-2)" "unprognostic (2.06e-1)" "unprognostic (1.06e-2)" "unprognostic (8.27e-2)" "unprognostic (6.20e-3)" "unprognostic (3.75e-1)" "unprognostic (6.91e-2)" "unprognostic (3.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.54e-1)" "unprognostic (4.17e-3)" "unprognostic (1.19e-3)" "unprognostic (1.53e-3)" "unprognostic (1.34e-1)" 2.9 3.1 7.6 7.2 11.3 1.0 7.6 1.7 7.9 2.5 3.3 10.6 0.0 3.2 1.8 2.9 1.8 1.7 5.3 4.1 8.4 5.1 2.2 1.5 7.7 6.9 17.4 2.6 1.6 1.9 1.5 2.2 11.0 12.9 2.2 4.0 1.5 2.7 2.0 1.4 1.4 4.9 3.5 26.5 6.7 3.0 1.5 17.2 7.7 1.7 0.5 9.4 5.2 1.6 6.9 15.7 3.2 8.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 16.1 0.0 3.0 0.0 0.3 0.0 0.2 7.2 3.2 0.0 8.9 0.0 6.9 0.0 0.0 3.7 5.8 0.0 0.0 0.4 0.0 6.8 15.7 0.0 2.2 7.6 11.3 1.7 7.9 8.4 5.1 17.4 2.6 12.9 17.2 TLX2 "Enx, HOX11L1, NCX, Tlx2" ENSG00000115297 "T cell leukemia homeobox 2" O43763 2 74513463-74517147 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.0;brain: 4.3;retina: 3.8" "Cell line enriched" "Detected in some" 15 "SH-SY5Y: 37.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040969, HPA062254" Uncertain Approved Nucleoplasm Nucleoplasm "HPA040969: AB_10794431, HPA062254: " "unprognostic (7.30e-2)" "unprognostic (3.03e-4)" "unprognostic (9.54e-4)" "unprognostic (2.86e-2)" "unprognostic (2.33e-1)" "unprognostic (1.69e-2)" "unprognostic (6.77e-2)" "unprognostic (1.36e-1)" "unprognostic (9.00e-2)" "unprognostic (3.91e-2)" "unprognostic (1.39e-1)" "unprognostic (5.40e-1)" "unprognostic (3.92e-7)" "unprognostic (2.51e-1)" "unprognostic (6.86e-2)" "unprognostic (5.04e-2)" "unprognostic (1.18e-1)" 0.1 8.0 1.7 1.7 4.0 0.2 0.1 0.8 4.3 0.1 2.7 0.0 0.0 1.9 0.1 0.1 0.5 0.1 0.6 0.1 0.4 0.7 0.1 0.1 0.1 0.5 0.8 0.0 0.1 0.6 0.5 0.0 0.2 3.5 0.1 0.7 3.8 0.1 0.1 0.1 0.4 2.5 0.2 0.3 0.2 0.9 3.3 0.6 2.5 0.1 0.0 0.3 2.1 0.4 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.9 1.8 0.0 0.0 0.0 0.0 0.0 0.8 2.3 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.0 0.8 4.3 0.4 0.7 0.8 0.0 3.5 0.6 TLX3 "HOX11L2, RNX" ENSG00000164438 "T cell leukemia homeobox 3" O43711 5 171309284-171312134 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "brain: 46.6" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 24.0" "Cancer enhanced" "Detected in some" "cervical cancer: 1.7" "Region enriched" "Detected in some" 22 "cerebellum: 46.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "cerebellum: 2.5" "Region enriched" "Detected in some" 11 "cerebellum: 48.1" "HPA030504, HPA060957, HPA069359" Enhanced Enhanced Nucleoplasm Nucleoplasm "HPA030504: , HPA060957: , HPA069359: " "unprognostic (3.52e-2)" "unprognostic (2.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.11e-1)" "unprognostic (9.80e-2)" "unprognostic (2.76e-2)" "unprognostic (4.48e-2)" 0.4 0.5 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 24.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 TMC2 "C20orf145, dJ686C3.3" ENSG00000149488 "Transmembrane channel like 2" Q8TDI7 20 2536607-2641784 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 8.1;pituitary gland: 3.2" "Cell line enhanced" "Detected in single" "ASC diff: 3.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (4.73e-2)" "unprognostic (1.87e-1)" "unprognostic (5.88e-2)" "unprognostic (8.30e-4)" "unprognostic (2.86e-3)" "unprognostic (3.00e-1)" "unprognostic (1.13e-2)" "unprognostic (1.07e-2)" "unprognostic (4.54e-1)" "unprognostic (1.41e-2)" "unprognostic (4.05e-5)" "unprognostic (2.90e-1)" "unprognostic (3.21e-7)" "unprognostic (2.47e-2)" "unprognostic (2.56e-1)" "unprognostic (1.93e-1)" "unprognostic (5.74e-2)" 2.3 0.4 0.3 0.3 0.8 0.0 0.7 8.1 0.4 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.9 0.0 0.2 0.9 0.0 0.0 3.0 0.2 0.1 0.5 0.1 0.1 3.2 0.1 0.0 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.0 2.5 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.1 0.2 0.4 0.3 0.2 3.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 TMC6 "EVER1, EVIN1, LAK-4P" ENSG00000141524 "Transmembrane channel like 6" Q7Z403 17 78110458-78132407 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.6;brain: 43.1;lymphoid tissue: 41.4" "Cell line enhanced" "Detected in many" "K-562: 33.7;SK-BR-3: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051430 Uncertain "HPA051430: " "unprognostic (6.34e-2)" "unprognostic (5.14e-2)" "unprognostic (5.55e-2)" "unprognostic (2.81e-3)" "unprognostic (3.99e-2)" "unprognostic (1.06e-2)" "unprognostic (5.36e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-1)" "unprognostic (9.94e-2)" "unprognostic (1.74e-1)" "unprognostic (6.61e-2)" "unprognostic (1.16e-2)" "prognostic favourable (1.82e-4)" "unprognostic (2.70e-2)" "unprognostic (1.10e-2)" "prognostic favourable (3.20e-4)" 10.5 3.5 7.5 26.1 25.5 39.6 8.3 2.1 12.8 4.1 8.8 33.5 5.6 13.5 3.1 1.7 9.5 5.6 6.5 8.1 12.5 8.1 6.9 3.7 14.4 39.2 43.1 4.6 1.7 6.4 1.8 2.4 6.6 20.3 7.5 4.7 3.6 12.7 7.2 2.3 6.5 17.5 2.7 31.4 41.4 9.1 1.6 31.2 12.1 5.0 2.7 24.8 7.3 6.5 13.5 8.3 9.8 26.7 15.6 27.2 13.2 5.4 4.3 2.4 1.9 0.0 0.0 4.9 0.0 0.0 0.0 0.0 7.8 6.2 6.2 7.7 0.0 9.7 0.3 1.8 0.0 0.6 3.5 12.8 1.1 9.6 0.6 11.7 21.9 0.3 5.2 0.0 0.4 4.7 33.7 23.4 0.0 11.0 5.7 20.0 1.9 1.6 2.6 0.2 18.1 3.6 20.3 0.6 1.5 1.8 38.5 10.4 21.9 17.8 1.6 0.0 3.0 0.0 0.1 18.5 8.1 3.9 0.0 19.0 0.3 6.4 4.9 9.8 27.2 16.9 23.7 13.5 20.1 21.9 8.3 10.2 18.1 18.7 6.9 15.6 26.7 2.5 17.0 13.2 7.5 25.5 2.1 12.8 12.5 8.1 43.1 4.6 20.3 31.2 TMC7 FLJ21240 ENSG00000170537 "Transmembrane channel like 7" Q7Z402 16 18983934-19063942 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.8;testis: 14.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029465 Uncertain Approved Vesicles Vesicles "HPA029465: AB_10600914" "unprognostic (1.80e-4)" "unprognostic (6.13e-2)" "unprognostic (1.82e-1)" "unprognostic (2.07e-3)" "unprognostic (1.25e-1)" "unprognostic (1.19e-3)" "unprognostic (7.60e-5)" "prognostic unfavourable (3.20e-4)" "unprognostic (7.60e-2)" "unprognostic (1.29e-1)" "prognostic unfavourable (7.64e-4)" "unprognostic (3.39e-1)" "unprognostic (1.00e-1)" "unprognostic (1.75e-1)" "unprognostic (1.94e-1)" "unprognostic (5.66e-2)" "prognostic favourable (9.20e-4)" 3.6 0.7 6.2 1.9 11.4 0.7 2.0 8.5 11.1 1.1 6.7 24.8 0.0 4.4 1.5 1.3 0.9 1.0 2.6 1.6 9.7 5.3 1.0 0.7 5.2 0.7 15.7 6.6 0.7 0.9 1.4 0.7 7.7 12.8 2.8 8.2 0.6 0.7 1.9 1.6 2.0 4.9 2.2 15.7 1.1 5.4 14.9 12.8 0.0 1.6 0.0 0.6 9.6 1.3 1.6 1.2 2.9 0.8 1.6 1.0 0.2 2.0 4.1 1.2 2.0 0.2 1.8 5.5 0.7 1.2 0.7 1.8 1.3 9.6 0.2 9.2 0.7 7.6 3.3 3.2 1.0 0.1 2.4 0.2 3.4 5.9 0.3 0.2 0.1 0.4 4.6 7.4 8.4 3.1 2.3 0.8 3.3 4.6 0.3 0.3 3.5 6.1 0.2 3.6 0.3 1.4 10.0 0.7 2.1 2.3 6.3 0.6 1.8 0.7 2.7 1.2 2.1 1.5 3.6 0.6 1.0 0.3 6.4 0.3 1.1 2.5 0.8 0.8 0.9 0.6 0.5 0.9 0.9 0.7 0.3 1.6 0.9 1.0 2.9 1.6 0.4 1.2 0.5 0.2 6.2 11.4 8.5 8.3 9.7 5.3 15.7 6.6 12.8 12.8 TMCC2 "FLJ38497, HUCEP11" ENSG00000133069 "Transmembrane and coiled-coil domain family 2" O75069 1 205228176-205273343 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 83.6;brain: 25.9" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.8;WM-115: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.1" "Lineage enhanced" "Detected in single" "granulocytes: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014254 Approved "HPA014254: AB_1851326" "unprognostic (2.59e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (2.61e-2)" "unprognostic (4.18e-1)" "unprognostic (5.59e-2)" "unprognostic (2.46e-2)" "unprognostic (4.89e-2)" "unprognostic (2.53e-1)" "unprognostic (5.08e-2)" "unprognostic (1.05e-5)" "unprognostic (3.17e-1)" "unprognostic (1.39e-1)" "unprognostic (1.99e-3)" "unprognostic (3.06e-2)" "unprognostic (4.01e-1)" "unprognostic (3.43e-3)" 2.6 4.5 22.2 2.3 17.4 83.6 1.8 22.7 24.0 2.4 2.0 16.5 0.0 2.2 2.8 1.9 2.1 2.5 2.2 2.5 25.9 16.8 2.5 1.8 2.5 2.2 25.4 13.3 4.2 2.0 3.7 3.3 7.9 22.4 2.2 1.9 9.3 2.3 2.3 6.4 2.9 2.5 2.4 24.1 5.6 2.2 3.4 14.2 0.0 2.1 0.0 2.0 2.1 2.2 0.0 0.0 1.1 0.0 0.0 0.3 4.4 1.6 0.8 1.5 3.4 0.6 0.2 0.8 2.0 0.9 2.1 1.6 0.2 0.2 1.5 0.3 0.6 2.8 1.0 0.5 0.6 4.2 3.2 5.5 0.4 0.1 0.3 0.3 2.9 0.3 0.1 1.1 0.0 0.3 3.4 2.2 0.8 0.1 0.0 0.8 3.7 4.7 2.2 3.7 7.7 0.4 0.1 26.8 3.8 0.2 0.0 6.9 0.6 0.4 0.6 1.4 2.2 3.6 2.2 3.8 1.5 1.0 1.2 0.5 8.9 0.0 0.0 1.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 4.4 22.2 17.4 22.7 24.0 25.9 16.8 25.4 13.3 22.4 14.2 TMEFF1 "C9orf2, CT120.1, H7365" ENSG00000241697 "Transmembrane protein with EGF like and two follistatin like domains 1" Q8IYR6 9 100473113-100577636 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 21.1" "Cell line enhanced" "Detected in some" "AF22: 7.7;BEWO: 9.6;NTERA-2: 19.4;REH: 13.0;SCLC-21H: 16.6;SH-SY5Y: 11.1" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051501 Uncertain "HPA051501: " "unprognostic (1.96e-1)" "unprognostic (2.30e-1)" "unprognostic (9.69e-3)" "unprognostic (2.32e-2)" "unprognostic (9.02e-2)" "unprognostic (3.59e-2)" "unprognostic (2.87e-2)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (1.05e-1)" "unprognostic (5.04e-6)" "unprognostic (1.30e-4)" "unprognostic (1.52e-1)" "unprognostic (3.97e-2)" "unprognostic (3.44e-3)" 1.2 1.2 5.0 1.0 13.9 1.2 1.1 1.4 21.1 1.6 1.3 15.0 0.0 1.0 3.0 1.0 1.0 1.2 1.6 1.0 9.1 8.9 1.2 1.0 1.1 1.4 10.3 7.9 1.0 1.0 1.1 0.4 1.8 11.7 1.5 1.1 0.1 1.1 1.4 1.0 1.0 1.3 1.4 13.8 1.2 1.3 4.1 12.6 0.0 3.1 0.0 1.1 1.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.4 0.1 0.2 9.6 0.6 0.1 0.4 0.5 0.5 0.1 0.0 1.7 0.2 0.0 2.9 0.0 0.4 0.0 4.3 0.0 0.2 0.4 0.4 0.0 0.0 0.2 0.0 0.4 0.1 1.2 0.1 0.0 0.6 0.0 4.8 0.0 19.4 0.2 13.0 6.6 0.0 0.3 0.0 16.6 11.1 0.0 0.0 0.2 0.0 0.0 1.7 1.5 2.6 0.1 0.6 3.0 2.1 2.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.0 13.9 1.4 15.4 9.1 8.9 10.3 7.9 11.7 12.6 TMEFF2 "CT120.2, HPP1, TENB2, TPEF, TR" ENSG00000144339 "Transmembrane protein with EGF like and two follistatin like domains 2" Q9UIK5 2 191949043-192195709 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.6;prostate: 46.3;seminal vesicle: 17.5" "Group enriched" "Detected in some" 4 "AF22: 16.9;LHCN-M2: 48.4" "Cancer enriched" "Detected in some" 21 "prostate cancer: 57.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015587 Approved "Secreted in male reproductive system" "HPA015587: AB_1858069" "unprognostic (2.12e-3)" "unprognostic (5.37e-1)" "unprognostic (3.10e-1)" "unprognostic (5.89e-7)" "unprognostic (4.96e-2)" "unprognostic (1.27e-1)" "unprognostic (8.82e-2)" "unprognostic (1.64e-1)" "unprognostic (1.86e-1)" "unprognostic (5.55e-2)" "unprognostic (2.09e-2)" "unprognostic (3.79e-2)" "unprognostic (4.17e-3)" "unprognostic (1.55e-2)" "unprognostic (2.91e-1)" "unprognostic (1.81e-1)" "unprognostic (1.20e-1)" 1.1 3.8 20.2 1.1 14.7 1.0 1.1 7.4 29.6 1.1 2.0 18.4 1.7 1.7 1.0 11.1 2.4 1.1 3.0 1.4 17.7 18.5 1.0 1.0 1.1 1.0 15.7 17.7 1.1 1.1 1.1 0.4 1.0 11.1 46.3 2.8 2.8 1.1 17.5 1.3 1.1 1.7 1.1 11.1 1.1 1.4 1.8 15.9 0.0 1.1 0.0 1.2 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 16.9 0.0 2.6 2.7 0.0 0.0 0.3 0.8 1.0 0.0 0.0 0.0 0.0 4.6 0.0 1.0 0.0 3.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 7.3 0.0 0.9 5.0 0.0 0.0 0.0 48.4 0.0 0.0 0.0 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 1.2 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 14.7 7.4 22.7 17.7 18.5 15.7 17.7 11.1 15.9 TMEM120B ENSG00000188735 "Transmembrane protein 120B" A0PK00 12 121712752-121783001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 23.1;cerebellum: 35.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014066 Uncertain Approved "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" Cytosol "HPA014066: AB_1845296" "unprognostic (8.80e-3)" "unprognostic (3.31e-2)" "unprognostic (1.95e-2)" "unprognostic (1.40e-2)" "unprognostic (3.10e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (1.66e-5)" "unprognostic (3.62e-1)" "unprognostic (3.29e-1)" "unprognostic (5.54e-2)" "unprognostic (2.10e-2)" "unprognostic (1.25e-1)" "unprognostic (5.86e-2)" "unprognostic (8.02e-3)" "unprognostic (2.31e-1)" "unprognostic (2.13e-3)" "unprognostic (4.72e-2)" 7.9 7.0 5.6 4.7 23.1 9.3 5.6 35.6 6.9 11.1 4.4 3.3 8.6 4.2 10.0 5.4 2.8 12.2 4.5 3.9 5.9 3.8 4.5 4.7 5.3 4.0 4.5 4.3 5.0 14.3 5.9 11.6 2.4 6.0 5.2 3.1 5.5 14.9 6.2 17.2 5.7 3.8 8.0 2.9 4.3 4.9 3.4 5.8 1.9 10.6 4.0 3.8 3.6 7.1 4.1 4.0 3.6 1.6 2.4 3.4 1.3 4.8 16.6 3.9 11.4 4.8 6.4 8.0 6.4 7.4 6.2 5.0 10.5 5.6 5.2 4.0 6.5 8.3 9.1 7.7 3.3 3.1 8.4 7.2 5.2 6.4 6.7 5.1 5.7 6.0 6.9 7.0 5.1 3.8 6.4 3.8 3.7 7.8 8.4 7.0 7.0 10.2 10.0 16.1 6.9 3.2 5.3 15.0 10.7 6.3 5.0 5.6 11.2 4.1 5.3 8.3 9.4 5.3 5.5 8.9 3.1 3.8 10.6 6.6 8.3 3.1 1.4 1.7 3.4 1.6 2.8 2.9 3.3 2.7 1.6 4.1 2.4 2.8 3.6 2.4 1.5 4.0 2.8 1.3 5.6 23.1 35.6 6.9 5.9 3.8 4.5 4.3 6.0 5.8 TMEM121 "hole, MGC4659, TMEM121A" ENSG00000184986 "Transmembrane protein 121" Q9BTD3 14 105526603-105530202 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6" "Cell line enhanced" "Detected in some" "EFO-21: 9.4;MCF7: 8.7;PC-3: 11.4;REH: 7.3;SCLC-21H: 6.0;WM-115: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 1.8;MAIT T-cell: 2.6;memory B-cell: 4.7;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.6;naive B-cell: 1.7;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.2;NK-cell: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 4.7;NK-cells: 1.8;T-cells: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049857 Uncertain Approved Cytosol Cytosol "HPA049857: " "unprognostic (4.25e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-3)" "unprognostic (2.20e-2)" "unprognostic (1.31e-1)" "unprognostic (9.50e-2)" "unprognostic (1.88e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-3)" "unprognostic (5.31e-2)" "unprognostic (5.48e-4)" "unprognostic (2.83e-2)" "unprognostic (1.71e-1)" "prognostic unfavourable (5.87e-4)" "unprognostic (5.90e-2)" 3.2 2.6 7.2 2.5 8.8 1.5 1.7 3.3 12.6 2.5 1.6 7.9 1.9 1.5 3.0 2.9 1.6 3.1 1.3 2.3 7.4 6.0 2.5 3.0 1.9 2.5 5.0 3.9 2.7 2.9 2.5 3.5 1.6 3.0 3.8 0.8 2.7 2.8 2.7 1.1 2.1 1.9 1.6 4.3 7.1 3.4 1.6 1.6 0.0 2.9 0.4 1.0 1.1 4.7 4.7 0.5 0.0 0.0 1.8 3.1 0.6 0.0 4.4 0.4 4.1 0.0 0.2 0.8 2.8 0.6 0.4 0.0 0.0 1.5 1.3 9.4 0.0 0.4 0.4 0.1 0.0 0.6 2.2 0.1 0.4 1.5 0.7 0.0 1.6 0.3 0.0 0.1 0.0 0.4 0.1 0.0 0.2 8.7 0.2 0.0 1.4 11.4 7.3 0.0 0.1 0.1 0.0 6.0 2.2 0.5 0.0 2.1 2.7 0.3 1.6 1.3 2.4 0.2 0.4 0.6 0.0 0.0 0.1 0.5 6.1 0.0 0.0 0.0 1.8 0.0 2.6 4.7 3.1 1.6 0.5 1.7 1.9 1.2 0.0 1.8 0.0 0.0 0.2 0.6 7.2 8.8 3.3 8.2 7.4 6.0 5.0 3.9 3.0 1.6 TMEM121B CECR6 ENSG00000183307 "Transmembrane protein 121B" Q9BXQ6 22 17116299-17121367 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 14.1" "Cell line enhanced" "Detected in some" "AF22: 6.2;SCLC-21H: 14.7;THP-1: 11.8;U-937: 9.8" "Cancer enhanced" "Detected in some" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 7 "granulocytes: 4.3;monocytes: 3.2" "Group enriched" "Detected in many" 8 "amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0" "Low region specificity" "Detected in many" HPA068790 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" Vesicles "Nucleoplasm, Plasma membrane" "HPA068790: " "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (7.11e-3)" "unprognostic (4.49e-3)" "unprognostic (3.36e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-3)" "unprognostic (5.32e-2)" "unprognostic (1.97e-1)" "unprognostic (2.01e-2)" "unprognostic (6.88e-4)" "unprognostic (6.08e-2)" "unprognostic (3.10e-4)" "unprognostic (1.02e-2)" "unprognostic (4.37e-2)" "unprognostic (3.49e-3)" "unprognostic (1.71e-1)" 1.3 1.8 7.4 2.2 12.0 2.2 2.0 8.1 19.1 1.0 0.8 2.4 0.0 1.1 1.1 2.3 0.8 1.2 1.0 2.3 7.1 4.0 0.8 0.8 0.9 0.8 2.9 6.9 0.9 2.7 0.8 2.0 1.9 2.3 14.1 1.0 0.2 1.2 1.0 2.8 1.5 0.9 1.3 2.5 1.1 1.0 2.4 4.2 0.0 0.6 0.0 0.8 1.0 0.3 0.0 0.5 4.3 3.2 0.0 0.0 0.6 0.0 0.0 6.2 0.8 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.2 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.8 3.1 2.2 0.1 0.2 3.0 0.0 0.3 0.1 14.7 2.2 0.0 0.0 0.3 0.0 11.8 0.6 0.7 0.3 0.2 0.0 0.2 0.3 0.9 0.0 9.8 0.3 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.6 7.4 12.0 8.1 18.0 7.1 4.0 2.9 6.9 2.3 4.2 TMEM130 "DKFZp761L1417, FLJ42643" ENSG00000166448 "Transmembrane protein 130" Q8N3G9 7 98846488-98870771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 28.2;brain: 82.2;pituitary gland: 24.0;testis: 26.4" "Cell line enhanced" "Detected in some" "BJ: 3.9;BJ hTERT+: 8.8;EFO-21: 8.6;NTERA-2: 5.1;SH-SY5Y: 10.5" "Cancer enhanced" "Detected in many" "renal cancer: 9.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012928 Approved Supported "Golgi apparatus" "Golgi apparatus" "HPA012928: AB_1858085" "unprognostic (1.36e-2)" "unprognostic (1.33e-3)" "unprognostic (3.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.61e-3)" "unprognostic (3.23e-2)" "unprognostic (2.97e-1)" "prognostic favourable (7.84e-4)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "unprognostic (4.69e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-3)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.17e-2)" "unprognostic (1.73e-1)" 1.3 28.2 27.3 2.0 53.8 1.4 1.8 14.1 82.2 3.5 1.8 2.8 0.0 1.6 1.8 8.0 2.2 1.7 2.2 1.4 29.3 47.0 2.8 1.1 5.4 2.4 13.4 35.1 1.7 1.6 1.5 24.0 1.3 25.8 2.7 1.9 1.0 1.3 6.2 2.1 1.3 2.1 1.6 9.2 1.4 1.4 26.4 3.9 0.1 1.4 0.0 1.2 1.7 1.2 1.0 0.6 4.8 0.9 1.0 0.7 0.3 0.0 0.7 0.0 0.0 0.3 0.0 0.2 3.9 8.8 0.7 0.6 0.1 0.1 0.1 8.6 2.2 0.1 0.0 0.0 0.1 0.2 0.4 0.1 0.3 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.4 0.2 0.7 0.4 0.7 0.2 0.2 5.1 0.0 0.2 0.0 0.8 0.1 0.0 0.6 10.5 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.4 0.3 0.1 0.4 0.5 0.2 2.2 0.9 0.6 0.5 0.4 0.4 0.7 0.5 0.4 0.2 1.0 0.7 0.6 4.8 1.0 0.6 0.6 0.4 0.3 27.3 53.8 14.1 44.2 29.3 47.0 13.4 35.1 25.8 3.9 TMEM132A "FLJ20539, GBP, HSPA5BP1" ENSG00000006118 "Transmembrane protein 132A" Q24JP5 11 60924463-60937159 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.1" "Cell line enhanced" "Detected in many" "EFO-21: 45.3;MCF7: 44.8;SK-BR-3: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051979, HPA060492" Enhanced Approved Mitochondria 1900000 Mitochondria "HPA051979: , HPA060492: " "unprognostic (2.52e-2)" "unprognostic (2.01e-1)" "unprognostic (3.75e-2)" "prognostic favourable (1.98e-5)" "unprognostic (7.94e-3)" "unprognostic (3.74e-1)" "unprognostic (4.42e-3)" "unprognostic (2.39e-2)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (5.98e-2)" "prognostic unfavourable (1.55e-9)" "unprognostic (3.31e-1)" "unprognostic (9.74e-2)" "unprognostic (1.50e-1)" "unprognostic (8.41e-3)" 3.6 6.1 28.6 9.2 25.2 1.2 4.4 23.9 58.1 14.0 3.2 11.3 0.8 3.4 14.4 2.2 4.8 3.2 6.2 4.0 17.0 22.9 3.1 1.3 4.5 2.4 20.4 21.4 6.9 3.9 1.5 6.6 19.8 13.8 4.1 2.0 19.3 21.5 2.9 4.3 1.8 2.6 4.6 9.3 2.5 8.5 3.4 9.7 0.0 2.0 1.0 6.0 4.9 2.0 0.4 0.1 1.6 0.1 0.0 0.1 0.1 8.9 12.5 11.2 23.9 0.9 0.5 19.9 6.7 21.9 6.2 5.2 4.4 8.5 0.0 45.3 2.0 17.0 2.5 11.7 2.4 0.1 3.7 0.2 8.0 8.2 8.4 0.1 0.3 2.1 2.2 11.6 1.8 10.7 0.5 0.6 2.0 44.8 0.2 0.0 14.9 7.2 0.1 4.7 1.0 9.4 4.7 11.3 26.6 4.8 46.1 4.1 31.9 0.1 12.5 2.4 11.4 0.7 12.7 0.1 0.0 0.4 20.2 0.0 11.6 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.1 28.6 25.2 23.9 36.8 17.0 22.9 20.4 21.4 13.8 9.7 TMEM132B "KIAA1786, KIAA1906" ENSG00000139364 "Transmembrane protein 132B" Q14DG7 12 125186836-125662377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 19.3" "Cell line enhanced" "Detected in some" "HSkMC: 7.8;NTERA-2: 8.9;RPMI-8226: 3.8;U-138 MG: 13.9;U-937: 3.9" "Cancer enriched" "Detected in single" 7 "glioma: 3.3" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.0" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035661, HPA035662" Uncertain "HPA035661: AB_10669774, HPA035662: " "unprognostic (3.38e-3)" "unprognostic (4.39e-2)" "unprognostic (6.73e-2)" "unprognostic (6.33e-2)" "unprognostic (1.06e-1)" "unprognostic (7.46e-2)" "unprognostic (3.46e-1)" "unprognostic (1.26e-1)" "unprognostic (4.58e-1)" "unprognostic (1.12e-1)" "unprognostic (6.23e-3)" "unprognostic (1.29e-2)" "unprognostic (4.29e-4)" "unprognostic (1.20e-1)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (3.73e-3)" 0.2 0.2 6.1 0.1 7.5 0.0 0.1 0.2 19.3 0.6 0.3 0.2 0.8 1.0 0.5 0.2 0.3 0.7 5.1 2.6 0.1 0.0 0.0 0.1 2.6 0.1 0.2 0.0 1.1 0.2 0.4 0.4 2.8 0.6 0.5 2.4 0.2 0.2 0.5 0.0 0.3 0.8 2.7 0.3 0.1 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 2.6 2.8 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.1 0.0 0.0 2.9 0.3 0.0 0.0 0.0 8.9 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.9 0.0 0.1 0.0 0.0 0.2 0.0 2.2 3.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 TMEM132D "KIAA1944, MOLT, PPP1R153" ENSG00000151952 "Transmembrane protein 132D" Q14C87 12 129071725-129903666 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 18.0" "Cell line enhanced" "Detected in some" "AF22: 5.4;Karpas-707: 1.7;MOLT-4: 9.1;NTERA-2: 3.5;U-266/84: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 19.1;cerebral cortex: 57.9;hippocampal formation: 46.6" HPA010739 Approved 150000 "HPA010739: AB_2204753" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (2.07e-2)" "unprognostic (5.39e-1)" "unprognostic (1.47e-2)" "unprognostic (2.89e-1)" "unprognostic (3.07e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (4.31e-4)" 0.4 0.9 4.5 0.7 6.6 0.7 0.4 0.4 18.0 0.4 0.8 0.6 0.0 0.8 0.5 0.4 0.4 0.4 0.4 0.4 2.9 4.2 0.6 0.7 0.8 0.4 1.7 6.2 0.5 1.1 0.4 0.7 0.4 0.8 1.1 0.7 1.2 0.4 0.4 0.4 0.5 0.9 0.5 0.6 0.4 1.0 1.6 0.8 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 9.1 0.0 3.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 6.6 0.4 11.7 2.9 4.2 1.7 6.2 0.8 0.8 TMEM132E DFNB99 ENSG00000181291 "Transmembrane protein 132E" Q6IEE7 17 34579487-34639318 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.0;kidney: 8.8" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 30.9" "Group enriched" "Detected in some" 8 "glioma: 7.6;renal cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.6" "Group enriched" "Detected in many" 20 "NK-cells: 1.4;T-cells: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070608 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" 140000 "Nucleoplasm, Golgi apparatus" "Nuclear bodies, Cytosol" "HPA070608: " "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.29e-5)" "unprognostic (3.37e-1)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-3)" "unprognostic (1.72e-1)" "unprognostic (1.80e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.55e-4)" "unprognostic (1.67e-2)" "unprognostic (1.51e-2)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 0.4 0.5 4.9 0.4 4.1 0.2 0.3 17.3 8.7 1.2 0.4 1.7 0.3 4.9 0.6 0.5 0.4 0.4 0.8 0.5 2.9 5.1 8.8 1.3 0.4 0.7 4.5 2.8 0.5 0.2 0.3 0.0 0.9 5.3 0.4 0.5 0.0 0.8 0.8 0.3 0.8 2.8 0.6 20.0 0.7 0.6 2.4 2.2 0.0 0.4 0.0 0.6 0.7 0.1 0.0 0.0 0.0 0.0 1.4 2.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 3.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.4 0.5 0.0 0.0 2.6 1.8 0.0 1.4 0.0 0.0 0.0 0.4 4.9 4.1 17.3 6.9 2.9 5.1 4.5 2.8 5.3 2.2 TMEM144 FLJ11155 ENSG00000164124 "Transmembrane protein 144" Q7Z5S9 4 158201604-158255411 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 88.7" "Cell line enhanced" "Detected in many" "BEWO: 23.3;hTCEpi: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.3;intermediate monocyte: 1.4;myeloid DC: 3.7;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 10 "dendritic cells: 4.3;monocytes: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063554 Approved Mitochondria Mitochondria "HPA063554: " "unprognostic (1.26e-2)" "unprognostic (7.05e-2)" "unprognostic (2.06e-2)" "prognostic favourable (2.89e-4)" "unprognostic (2.90e-1)" "unprognostic (1.71e-5)" "unprognostic (8.27e-2)" "unprognostic (3.32e-1)" "unprognostic (2.21e-1)" "unprognostic (3.33e-2)" "prognostic unfavourable (8.48e-4)" "unprognostic (9.34e-2)" "unprognostic (1.13e-2)" "unprognostic (1.35e-1)" "unprognostic (9.26e-2)" "unprognostic (3.88e-2)" "unprognostic (4.05e-2)" 4.7 6.7 20.7 2.0 60.9 1.5 9.2 4.7 37.7 4.7 7.4 88.7 0.2 14.3 3.7 8.3 3.1 3.9 6.8 8.2 31.5 18.3 1.9 1.7 3.5 0.9 80.4 26.6 8.6 3.8 3.0 1.4 3.5 48.9 5.4 8.6 0.0 3.1 7.2 1.4 1.9 9.6 4.2 79.2 2.2 5.4 15.8 67.4 0.0 9.2 0.0 0.8 5.1 1.9 0.0 4.3 0.1 3.3 0.4 0.1 0.7 2.5 7.0 0.1 1.4 5.1 7.7 23.3 1.1 1.9 1.0 1.6 8.8 9.6 0.0 1.4 0.3 1.2 3.2 10.8 1.4 0.0 3.2 4.3 2.1 7.8 1.8 5.4 1.3 5.5 13.4 4.6 1.6 5.8 2.8 0.1 8.0 3.0 0.0 0.0 1.8 1.7 0.0 0.0 0.3 2.0 7.4 1.1 0.0 0.2 9.5 2.6 6.7 1.5 1.1 2.2 1.7 0.4 1.3 0.0 0.6 0.6 3.0 0.8 1.5 0.0 3.3 0.0 0.0 1.4 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.4 0.7 4.3 0.0 0.7 20.7 60.9 4.7 35.1 31.5 18.3 80.4 26.6 48.9 67.4 TMEM145 FLJ90805 ENSG00000167619 "Transmembrane protein 145" Q8NBT3 19 42313325-42325062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 74.5" "Cell line enhanced" "Detected in many" "HMC-1: 11.7;SCLC-21H: 22.2;SH-SY5Y: 10.6" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Region enriched" "Detected in all" 4 "cerebellum: 74.5" "Group enriched" "Detected in some" 8 "basophil: 4.5;neutrophil: 15.5" "Lineage enriched" "Detected in many" 12 "granulocytes: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060462 Enhanced Approved Approved Vesicles Vesicles "HPA060462: " "unprognostic (9.56e-3)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" "unprognostic (6.62e-2)" "unprognostic (2.14e-1)" "unprognostic (4.27e-3)" "unprognostic (1.53e-2)" "unprognostic (9.85e-2)" "unprognostic (4.20e-4)" "unprognostic (7.35e-2)" "unprognostic (7.64e-2)" "unprognostic (2.30e-1)" "unprognostic (6.31e-2)" 1.6 6.2 8.0 1.2 7.7 2.5 1.3 74.5 30.5 0.6 1.2 3.8 0.0 1.7 1.1 1.6 1.0 1.1 1.4 1.3 5.8 8.5 0.9 1.4 0.8 1.5 5.1 7.6 1.2 3.7 3.0 6.4 0.6 9.3 1.2 1.2 2.8 1.1 0.9 2.3 3.3 1.1 1.2 3.9 1.5 2.0 3.3 3.2 0.0 1.3 0.0 1.1 1.0 0.3 1.3 0.8 15.5 0.9 0.6 0.9 0.8 0.5 2.7 2.1 6.4 0.2 0.2 0.8 0.2 0.1 1.0 2.6 0.5 0.7 1.5 0.3 0.6 0.2 1.5 0.4 1.2 6.7 1.6 2.8 2.5 2.4 0.2 1.6 11.7 0.5 0.5 0.4 0.6 1.1 1.5 5.5 0.1 0.6 0.4 1.9 1.3 8.6 0.2 0.6 5.2 0.1 1.0 22.2 10.6 0.9 0.7 1.3 1.9 1.8 0.3 1.8 1.9 1.3 0.7 1.2 3.0 1.4 0.7 1.1 5.1 4.5 0.9 0.9 0.6 0.8 0.3 1.0 0.6 0.4 0.2 1.3 0.6 0.9 15.5 0.6 0.7 0.8 0.4 0.8 8.0 7.7 74.5 18.1 5.8 8.5 5.1 7.6 9.3 3.2 TMEM151A "MGC33486, TMEM151" ENSG00000179292 "Transmembrane protein 151A" Q8N4L1 11 66291870-66296664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 48.5" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 18.2" "Cancer enhanced" "Detected in some" "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041035 Uncertain Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA041035: AB_10794404" "unprognostic (1.20e-1)" "unprognostic (8.24e-3)" "unprognostic (4.80e-2)" "unprognostic (1.75e-2)" "unprognostic (3.44e-1)" "unprognostic (7.60e-2)" "unprognostic (9.48e-3)" "unprognostic (8.57e-2)" "unprognostic (8.73e-4)" "unprognostic (2.41e-3)" "unprognostic (2.02e-2)" "unprognostic (6.11e-3)" "unprognostic (1.69e-3)" "unprognostic (2.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.38e-2)" "unprognostic (2.67e-2)" 1.4 3.8 12.4 1.5 16.8 1.4 1.4 5.9 48.5 1.4 1.5 41.8 0.0 1.5 1.4 1.4 1.4 1.4 2.8 1.6 22.7 14.3 1.4 1.4 1.4 1.4 21.2 13.1 1.5 2.4 1.8 3.3 1.4 22.2 1.4 1.4 1.0 1.5 1.4 1.4 1.4 1.5 1.4 43.2 1.4 3.9 1.6 13.6 0.0 1.4 0.0 1.4 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.6 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 18.2 4.1 0.5 0.0 0.3 0.1 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.4 16.8 5.9 31.1 22.7 14.3 21.2 13.1 22.2 13.6 TMEM151B "bA444E17.5, C6orf137, TMEM193" ENSG00000178233 "Transmembrane protein 151B" Q8IW70 6 44270466-44307506 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 52.2" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 24.7" "Cancer enhanced" "Detected in single" "glioma: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 7 "T-cells: 1.0" "Low region specificity" "Detected in all" HPA055167 Uncertain "HPA055167: " "unprognostic (1.28e-3)" "unprognostic (6.25e-2)" "unprognostic (5.06e-2)" "unprognostic (7.02e-3)" "unprognostic (6.61e-2)" "unprognostic (1.22e-3)" "unprognostic (2.41e-2)" "unprognostic (3.01e-2)" "unprognostic (6.92e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-4)" "unprognostic (1.48e-1)" "unprognostic (4.56e-3)" "unprognostic (1.85e-1)" "unprognostic (9.15e-2)" "unprognostic (3.86e-2)" "unprognostic (1.66e-1)" 1.0 5.7 16.9 1.6 8.4 1.2 1.0 52.2 39.5 0.9 1.7 1.2 0.0 1.7 1.3 1.0 1.2 1.0 1.0 1.1 21.6 8.9 1.0 0.9 1.0 1.2 7.9 18.1 1.0 1.1 0.9 1.4 1.0 10.0 1.1 1.5 0.0 1.2 0.9 1.2 1.2 2.0 1.1 2.3 1.0 1.4 1.6 3.7 0.0 0.9 0.0 1.0 0.9 0.1 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 5.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.5 4.2 0.2 0.4 0.0 0.1 0.0 0.1 24.7 5.1 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.0 0.1 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 16.9 8.4 52.2 28.1 21.6 8.9 7.9 18.1 10.0 3.7 TMEM155 FLJ30834 ENSG00000164112 "Transmembrane protein 155" Q4W5P6 4 121758933-121765427 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 25.6" "Group enriched" "Detected in some" 5 "fHDF/TERT166: 7.2;HAP1: 3.3;LHCN-M2: 10.2;MOLT-4: 6.2" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "cerebral cortex: 25.6" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.3;T-reg: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 2.3" HPA077585 Approved "Secreted in brain" "HPA077585: " "unprognostic (9.67e-3)" "unprognostic (3.25e-3)" "unprognostic (3.13e-2)" "unprognostic (1.09e-1)" "unprognostic (1.61e-1)" "unprognostic (5.73e-3)" "unprognostic (3.63e-2)" "unprognostic (1.49e-2)" "unprognostic (1.19e-1)" "unprognostic (2.42e-3)" "unprognostic (4.40e-3)" "unprognostic (1.38e-1)" "unprognostic (3.82e-7)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.02e-2)" "unprognostic (2.04e-1)" 0.6 0.3 5.9 0.5 8.3 0.3 0.3 0.3 25.6 0.4 1.3 0.0 0.0 0.4 0.3 0.3 0.5 0.3 0.4 0.4 7.9 1.6 0.3 0.3 0.6 4.0 0.9 8.9 0.3 0.3 0.2 0.2 6.1 0.7 0.5 0.7 0.9 0.5 0.6 0.3 0.3 0.6 0.9 0.3 0.8 0.5 0.7 0.0 0.0 0.3 0.0 0.6 0.5 0.3 0.0 0.0 0.7 0.0 0.0 2.3 0.3 0.0 0.0 0.1 0.0 1.4 0.2 1.0 0.7 0.2 0.3 0.5 0.0 0.0 0.0 0.0 7.2 0.0 3.3 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.3 0.0 0.0 10.2 0.0 6.2 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.3 5.9 8.3 0.3 25.6 7.9 1.6 0.9 8.9 0.7 0.0 TMEM156 FLJ23235 ENSG00000121895 "Transmembrane protein 156" Q8N614 4 38966744-39032922 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "blood: 30.6;brain: 12.7;intestine: 8.3;lymphoid tissue: 23.7" "Cell line enhanced" "Detected in some" "Daudi: 16.1;HBEC3-KT: 34.4;hTERT-HME1: 27.1;NB-4: 14.0;PC-3: 15.3;U-698: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 30.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "prognostic favourable (4.09e-4)" "unprognostic (7.36e-3)" "unprognostic (3.31e-3)" "unprognostic (4.17e-3)" "unprognostic (1.82e-1)" "unprognostic (1.01e-3)" "unprognostic (4.10e-2)" "unprognostic (1.29e-1)" "unprognostic (1.03e-2)" "unprognostic (1.43e-1)" "unprognostic (9.45e-3)" "unprognostic (5.17e-2)" "unprognostic (8.73e-4)" "unprognostic (3.89e-1)" "unprognostic (1.74e-2)" "unprognostic (3.92e-4)" "unprognostic (9.06e-2)" 0.9 1.7 5.8 11.8 6.6 1.7 1.1 0.7 4.1 0.6 1.7 6.1 0.0 1.7 0.6 0.3 2.0 1.0 1.9 0.6 4.1 2.6 1.4 2.6 1.6 20.2 6.2 0.8 0.5 0.8 0.3 0.7 0.2 5.3 0.9 2.0 0.0 2.0 0.6 0.6 0.5 8.3 0.5 12.7 17.3 2.3 0.6 4.2 7.4 1.0 0.3 23.7 4.5 0.8 30.6 5.0 18.8 0.3 4.8 9.0 3.6 0.9 9.7 0.1 0.1 0.0 0.3 0.1 0.0 2.6 0.0 0.0 0.1 0.1 16.1 0.1 0.0 0.1 0.1 34.4 0.1 0.2 0.0 0.9 3.3 0.2 5.7 6.6 0.1 0.0 1.8 0.7 27.1 3.0 2.3 0.1 1.2 0.1 1.2 14.0 0.0 15.3 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.5 7.3 1.2 0.2 0.0 0.3 0.0 0.0 18.4 2.1 6.2 0.0 5.4 0.3 18.8 5.2 0.1 6.1 30.6 9.0 5.2 3.3 21.9 3.5 4.6 0.8 4.8 0.1 5.0 6.0 3.6 5.8 6.6 0.7 4.1 4.1 2.6 6.2 0.8 5.3 4.2 TMEM158 "p40BBp, RIS1" ENSG00000249992 "Transmembrane protein 158 (gene/pseudogene)" Q8WZ71 3 45224466-45226278 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.8;endometrium 1: 31.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 65.0;U-138 MG: 27.5;U-87 MG: 90.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 46.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 85.5" "Low region specificity" "Detected in all" HPA074974 Approved "HPA074974: " "unprognostic (3.84e-1)" "unprognostic (9.83e-3)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (3.77e-2)" "unprognostic (5.73e-2)" "unprognostic (3.31e-2)" "unprognostic (4.67e-3)" "unprognostic (6.23e-2)" "unprognostic (6.41e-2)" "unprognostic (1.84e-3)" "prognostic favourable (6.43e-5)" "prognostic unfavourable (5.42e-9)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (2.86e-2)" "unprognostic (4.49e-3)" 1.8 6.4 16.4 4.5 46.8 2.2 2.3 2.1 10.9 13.1 3.4 2.3 18.5 1.4 31.1 7.3 21.3 2.0 11.0 0.8 9.0 11.2 1.9 1.2 1.0 1.1 2.5 5.0 1.7 2.4 0.7 5.7 1.4 2.6 15.6 2.7 0.5 1.3 27.0 2.4 2.7 1.2 19.6 1.8 0.8 2.2 3.0 4.3 0.0 0.7 0.8 1.7 6.7 1.6 0.0 0.0 0.9 0.1 0.0 0.0 1.1 2.3 0.4 0.8 0.1 1.5 3.7 0.7 6.0 65.0 3.3 5.4 0.1 0.1 0.0 0.3 2.0 3.3 1.0 0.2 9.9 0.1 0.3 0.0 1.2 0.0 2.1 0.4 1.2 4.9 0.1 6.6 0.5 0.3 14.8 0.1 5.9 0.1 0.0 4.1 7.3 9.0 0.0 0.2 0.9 1.3 2.2 1.2 0.2 2.3 0.0 0.3 0.0 0.8 0.9 27.5 2.0 17.3 20.8 0.0 0.0 0.0 90.2 2.3 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 16.4 46.8 2.1 10.9 9.0 11.2 2.5 5.0 2.6 4.3 TMEM163 "DKFZP566N034, SV31" ENSG00000152128 "Transmembrane protein 163" Q8TC26 2 134455759-134719000 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.8;pancreas: 19.7" "Cell line enhanced" "Detected in some" "HEL: 10.5;RPTEC TERT1: 36.1;SCLC-21H: 16.4;U-937: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.6;NK-cells: 2.0;T-cells: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007224 Uncertain "HPA007224: " "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (7.25e-3)" "unprognostic (3.18e-1)" "unprognostic (1.47e-1)" "unprognostic (2.25e-1)" "unprognostic (6.08e-3)" "prognostic favourable (7.94e-4)" "unprognostic (9.05e-2)" "unprognostic (9.62e-2)" "unprognostic (6.02e-2)" "unprognostic (2.04e-1)" "unprognostic (2.60e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" "unprognostic (6.75e-3)" "prognostic favourable (3.15e-4)" 3.8 6.4 8.1 5.4 5.7 0.5 1.5 31.8 13.4 0.5 0.8 5.8 0.0 0.9 0.8 0.7 0.4 3.4 10.4 7.2 9.1 13.7 1.8 1.7 16.4 10.9 6.9 3.8 1.2 19.7 0.4 11.2 4.2 14.8 0.5 0.9 2.6 3.5 0.5 0.6 0.4 0.8 0.7 13.9 1.9 8.3 6.9 5.0 0.0 1.3 0.0 17.4 9.9 0.3 1.6 0.3 0.1 0.0 2.0 2.5 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.5 0.0 0.1 0.0 0.3 0.0 0.0 2.8 1.2 0.0 0.0 0.0 36.1 5.3 16.4 0.5 0.0 0.0 0.8 0.0 0.0 3.7 0.0 0.2 0.0 0.8 0.8 0.0 0.0 0.0 6.5 0.7 0.0 0.0 0.0 1.3 0.0 1.7 1.6 0.5 2.4 0.3 0.6 0.1 0.5 0.1 2.0 0.0 0.0 2.5 0.8 8.1 5.7 31.8 9.7 9.1 13.7 6.9 3.8 14.8 5.0 TMEM169 FLJ34263 ENSG00000163449 "Transmembrane protein 169" Q96HH4 2 216081866-216102783 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell line enhanced" "Detected in some" "AF22: 8.3;LHCN-M2: 6.7;RPTEC TERT1: 12.2;SCLC-21H: 10.5;SH-SY5Y: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062462, HPA062797, HPA070657, HPA074877" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA062462: , HPA062797: , HPA070657: , HPA074877: " "unprognostic (5.15e-2)" "unprognostic (2.93e-1)" "unprognostic (7.87e-3)" "unprognostic (4.69e-7)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (1.97e-1)" "unprognostic (4.43e-1)" "unprognostic (7.16e-2)" "unprognostic (5.72e-2)" "unprognostic (1.00e-1)" "unprognostic (1.35e-1)" "unprognostic (2.79e-2)" "unprognostic (7.51e-3)" "unprognostic (4.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.02e-1)" 1.7 2.9 5.9 2.5 6.2 1.3 0.9 9.7 16.8 2.1 1.3 3.9 1.6 1.9 1.1 1.9 0.9 2.9 2.5 1.1 5.5 6.3 4.9 4.2 2.1 2.4 5.5 4.8 1.1 1.0 0.8 2.4 0.7 9.1 1.4 1.2 4.9 0.9 1.1 1.5 1.6 1.7 1.2 6.6 2.6 1.0 1.3 2.5 0.7 6.7 0.0 2.0 1.1 0.7 3.0 0.2 4.3 5.7 0.7 6.3 1.3 0.1 0.4 8.3 0.2 0.9 0.1 0.0 0.3 0.2 0.2 0.8 0.4 2.4 0.1 6.1 0.3 0.2 1.1 0.0 0.2 1.2 0.4 2.7 0.1 1.5 1.8 0.2 0.6 0.6 0.6 0.6 0.8 0.0 0.0 0.4 6.7 0.7 0.2 0.3 4.3 0.1 1.5 2.4 0.2 12.2 0.0 10.5 15.1 0.2 0.2 6.0 0.4 1.1 0.1 0.2 0.4 0.2 0.4 1.9 2.0 0.4 1.9 0.2 1.5 1.3 1.8 0.3 2.3 1.5 1.7 2.4 4.0 2.7 0.0 3.0 4.2 1.9 4.3 0.7 5.7 0.2 6.3 1.3 5.9 6.2 9.7 11.5 5.5 6.3 5.5 4.8 9.1 2.5 TMEM178A "MGC33926, TMEM178" ENSG00000152154 "Transmembrane protein 178A" Q8NBL3 2 39664982-39717963 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 87.4" "Cell line enriched" "Detected in some" 5 "AF22: 55.0" "Cancer enhanced" "Detected in many" "prostate cancer: 19.0" "Region enriched" "Detected in all" 5 "cerebellum: 87.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052128 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA052128: " "unprognostic (3.35e-2)" "unprognostic (3.18e-1)" "unprognostic (5.94e-2)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (5.85e-2)" "unprognostic (3.24e-3)" "unprognostic (1.82e-3)" "unprognostic (2.22e-1)" "unprognostic (9.74e-2)" "unprognostic (5.11e-4)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.80e-3)" "unprognostic (3.46e-2)" "unprognostic (2.83e-2)" "unprognostic (3.01e-3)" 2.9 4.2 13.3 0.9 10.6 0.6 6.8 87.4 35.6 1.6 1.9 6.4 0.0 2.3 3.8 2.0 1.8 3.3 3.1 3.6 16.4 7.4 18.9 2.7 5.8 0.8 10.7 10.9 1.8 2.2 1.3 2.5 3.6 17.0 12.2 2.2 3.7 3.8 2.1 2.3 3.5 2.4 2.9 22.6 1.6 3.5 1.2 5.3 0.0 5.7 0.8 2.2 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 0.1 1.7 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 7.0 0.0 0.6 0.0 0.0 0.4 0.1 10.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 10.6 87.4 18.8 16.4 7.4 10.7 10.9 17.0 5.3 TMEM178B DKFZp547G036 ENSG00000261115 "Transmembrane protein 178B" H3BS89 7 141074232-141480380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5" "Cell line enhanced" "Detected in many" "HAP1: 6.9;HDLM-2: 6.3;NTERA-2: 5.9;RPTEC TERT1: 9.6;SCLC-21H: 7.6;WM-115: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA048771 Uncertain Approved Nucleoli,Vesicles Vesicles Nucleoli "HPA048771: " "unprognostic (7.33e-3)" "unprognostic (2.02e-2)" "unprognostic (2.83e-2)" "unprognostic (7.79e-4)" "unprognostic (1.94e-1)" "unprognostic (1.49e-1)" "unprognostic (2.95e-1)" "unprognostic (1.69e-2)" "unprognostic (6.94e-2)" "unprognostic (2.21e-2)" "unprognostic (7.17e-4)" "unprognostic (1.05e-1)" "prognostic favourable (4.10e-4)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (5.35e-3)" "unprognostic (8.98e-2)" 0.9 1.7 5.2 0.7 7.4 0.1 0.7 3.2 13.4 0.5 0.8 1.0 2.3 0.1 1.1 0.6 1.8 0.3 0.7 11.6 4.8 5.8 2.9 0.6 0.4 1.5 4.9 1.0 0.2 2.6 20.6 18.5 0.1 1.8 2.8 0.4 0.5 4.4 0.8 4.5 0.2 1.2 1.3 2.4 0.8 0.5 0.8 0.4 1.0 9.5 0.1 3.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.6 0.3 1.8 0.1 2.7 0.8 1.0 0.0 0.0 2.2 2.3 0.2 0.0 6.9 0.0 2.3 6.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 5.9 0.0 0.4 1.1 2.9 9.6 2.7 7.6 4.6 0.1 0.3 1.0 1.0 0.0 0.0 0.1 1.1 3.1 0.0 0.1 0.0 0.0 0.5 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 7.4 3.2 9.6 4.8 5.8 4.9 1.0 1.8 0.4 TMEM179 "C14orf90, FLJ42486, TMEM179A" ENSG00000258986 "Transmembrane protein 179" Q6ZVK1 14 104474678-104605647 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 20.2;brain: 30.4;pituitary gland: 23.0" "Cell line enhanced" "Detected in some" "NTERA-2: 6.4;SCLC-21H: 27.6;SH-SY5Y: 8.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002942 Uncertain Mitochondria Mitochondria "HPA002942: AB_1078113" "unprognostic (8.65e-2)" "unprognostic (8.24e-2)" "unprognostic (3.10e-2)" "unprognostic (1.29e-2)" "unprognostic (1.90e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (2.82e-3)" "unprognostic (1.09e-1)" "unprognostic (1.89e-4)" "unprognostic (8.68e-3)" "unprognostic (1.56e-1)" "unprognostic (9.71e-6)" "unprognostic (1.70e-2)" 1.1 20.2 11.8 1.5 18.9 0.9 0.9 10.3 30.4 1.0 1.8 3.4 0.0 1.4 1.0 1.6 1.1 1.1 1.1 1.2 12.4 21.7 1.0 1.1 0.9 0.9 13.7 7.2 1.0 4.8 1.0 23.0 2.3 8.3 1.4 1.4 2.2 1.1 1.3 1.0 1.0 1.8 1.4 6.1 0.9 1.8 3.1 4.5 0.0 1.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.1 0.0 0.0 27.6 8.7 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 18.9 10.3 16.7 12.4 21.7 13.7 7.2 8.3 4.5 TMEM181 "GPR178, KIAA1423" ENSG00000146433 "Transmembrane protein 181" Q9P2C4 6 158536436-158635428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040189 Approved Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA040189: AB_10793959" "unprognostic (1.93e-2)" "prognostic unfavourable (7.26e-4)" "unprognostic (9.87e-2)" "unprognostic (6.51e-2)" "unprognostic (3.09e-1)" "unprognostic (1.49e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" "prognostic unfavourable (1.09e-4)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (4.07e-2)" "unprognostic (1.46e-1)" "unprognostic (1.93e-1)" "unprognostic (4.36e-1)" "unprognostic (3.26e-1)" 7.1 5.6 32.4 4.8 49.2 3.1 8.6 5.3 36.6 13.4 10.1 4.2 6.5 10.9 8.4 3.9 6.3 5.8 7.3 5.3 18.5 8.7 3.3 6.4 6.7 3.4 5.5 23.3 5.6 18.5 8.1 21.5 6.5 11.2 9.4 11.5 4.3 22.4 10.0 4.9 7.0 12.6 7.8 7.3 7.6 16.3 16.0 8.5 2.3 9.7 2.1 3.2 9.9 7.0 1.0 2.1 7.7 3.4 3.9 4.7 1.4 10.3 6.0 8.5 13.1 22.5 20.7 16.3 23.5 13.8 12.3 14.1 10.2 12.8 4.3 12.2 19.5 15.4 12.6 15.5 19.6 6.4 9.0 8.1 8.9 21.4 18.5 10.1 7.8 17.1 15.3 13.6 18.6 19.6 15.4 5.5 20.0 6.2 4.4 12.7 6.6 7.6 4.4 9.8 4.9 11.7 8.1 25.2 17.3 17.2 16.2 11.2 6.1 14.3 18.7 12.7 8.6 21.0 20.2 3.2 2.2 4.8 15.3 12.7 12.1 7.7 2.2 5.7 4.7 2.3 3.6 0.9 2.7 3.7 1.6 1.0 2.4 3.2 1.6 3.9 3.4 2.1 2.6 1.4 32.4 49.2 5.3 36.6 18.5 8.7 5.5 23.3 11.2 8.5 TMEM196 MGC42090 ENSG00000173452 "Transmembrane protein 196" Q5HYL7 7 19719310-19773598 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 15.0;pituitary gland: 12.6" "Group enriched" "Detected in some" 9 "ASC diff: 8.6;ASC TERT1: 8.5" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043163 Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" "Nucleoplasm, Golgi apparatus" "HPA043163: AB_10794772" "unprognostic (6.08e-3)" "unprognostic (1.88e-2)" "unprognostic (2.14e-2)" "unprognostic (9.30e-2)" "unprognostic (5.63e-2)" 0.7 3.7 8.0 0.6 8.6 0.4 0.4 0.3 15.0 1.2 0.6 0.3 0.0 0.4 3.8 1.5 0.5 1.2 0.4 0.4 3.6 10.1 0.6 0.4 0.4 0.4 2.9 7.4 0.4 3.0 0.7 12.6 0.4 5.0 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 1.0 1.4 0.4 2.6 0.5 2.8 0.0 0.4 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 8.6 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 8.6 0.3 7.3 3.6 10.1 2.9 7.4 5.0 2.8 TMEM198 "MGC99813, TMEM198A" ENSG00000188760 "Transmembrane protein 198" Q66K66 2 219543663-219550595 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 16.9;SH-SY5Y: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042385, HPA062897" Enhanced Approved Vesicles Vesicles "HPA042385: , HPA062897: " "unprognostic (2.59e-2)" "unprognostic (8.51e-2)" "unprognostic (5.97e-3)" "unprognostic (2.77e-1)" "unprognostic (4.43e-2)" "unprognostic (8.09e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (4.28e-1)" "unprognostic (2.06e-1)" "prognostic favourable (6.89e-4)" "unprognostic (6.39e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" 3.0 9.4 14.4 3.1 10.3 0.9 2.3 14.2 22.0 3.3 2.6 4.1 1.4 16.1 4.0 2.5 2.7 2.5 3.9 3.4 16.5 5.2 3.0 2.6 2.4 1.8 4.1 11.9 10.9 20.0 5.2 13.0 2.6 6.2 4.0 1.8 3.0 7.0 4.3 3.5 2.2 6.4 3.5 7.5 1.8 4.7 5.0 4.9 0.0 4.0 0.5 1.9 3.8 1.2 0.2 2.6 0.1 0.0 0.8 0.4 0.4 0.5 0.1 4.7 8.0 1.0 0.9 4.2 2.4 1.3 2.0 1.7 10.3 1.3 2.1 2.4 1.5 2.8 1.7 1.1 0.4 7.0 2.0 1.7 2.1 8.4 1.4 0.6 4.0 2.1 0.6 0.9 2.3 0.0 6.1 6.8 1.2 1.0 0.1 0.5 6.1 0.7 0.2 2.9 2.4 1.2 1.1 16.9 14.7 0.6 1.7 4.0 0.2 3.3 0.1 2.2 0.9 2.0 1.0 6.6 1.9 2.2 2.0 0.1 2.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 2.6 0.0 0.4 14.4 10.3 14.2 22.0 16.5 5.2 4.1 11.9 6.2 4.9 TMEM206 "C1orf75, FLJ10874" ENSG00000065600 "Transmembrane protein 206" Q9H813 1 212363931-212414901 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008540 Uncertain "HPA008540: AB_10794083" "unprognostic (2.18e-1)" "unprognostic (2.22e-1)" "unprognostic (9.23e-2)" "unprognostic (1.02e-1)" "unprognostic (2.74e-2)" "unprognostic (3.09e-2)" "prognostic unfavourable (3.71e-5)" "unprognostic (1.14e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.06e-3)" "unprognostic (6.33e-2)" "unprognostic (1.02e-1)" "unprognostic (9.10e-2)" "unprognostic (6.98e-2)" 3.7 3.7 10.7 5.5 11.7 7.1 3.5 3.8 22.5 2.3 2.6 35.3 2.2 2.9 4.2 3.0 3.8 2.1 4.2 3.3 15.4 11.8 14.3 2.1 4.3 9.9 21.8 7.1 2.0 3.9 3.4 3.1 5.9 19.7 4.4 3.3 1.4 2.8 2.5 2.0 2.9 3.1 4.2 50.8 6.1 2.2 7.7 17.8 7.8 2.7 1.3 7.2 6.5 3.0 7.7 17.7 11.6 10.1 6.2 6.4 5.2 7.4 5.8 8.7 14.4 5.2 2.8 8.7 4.4 3.4 7.3 6.5 4.8 5.5 8.8 3.6 2.1 6.7 8.3 4.0 7.3 6.6 9.0 8.4 4.2 5.9 7.4 13.3 13.2 2.4 4.2 6.7 4.9 8.2 7.5 5.2 5.0 2.9 14.7 13.8 11.6 7.7 12.2 9.7 8.4 3.7 3.7 13.6 21.1 5.0 7.5 19.1 11.2 16.5 7.1 4.8 5.5 11.3 11.2 6.8 10.9 12.4 6.4 12.3 13.2 11.6 7.7 4.3 4.9 10.1 6.4 7.7 3.8 5.7 12.5 7.3 5.6 6.0 0.6 6.2 8.7 17.7 5.3 5.2 10.7 11.7 3.8 12.8 15.4 11.8 21.8 7.1 19.7 17.8 TMEM229A ENSG00000234224 "Transmembrane protein 229A" B2RXF0 7 124030916-124033023 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;intestine: 16.4;testis: 10.6" "Cell line enriched" "Detected in some" 44 "SH-SY5Y: 54.6" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA056391 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA056391: " "unprognostic (2.52e-2)" "unprognostic (3.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.50e-1)" "unprognostic (2.89e-2)" "unprognostic (8.21e-2)" "unprognostic (4.74e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 0.4 1.5 6.9 0.5 7.6 0.4 0.4 1.3 9.0 0.8 0.5 7.6 0.0 16.4 0.7 1.2 0.4 1.7 0.6 0.9 8.0 4.6 0.5 0.4 0.5 0.4 10.6 4.9 1.0 0.4 2.5 1.0 0.6 5.6 0.8 0.6 0.6 0.7 0.5 0.4 0.4 7.7 0.7 7.3 0.6 3.7 10.6 8.7 0.0 0.5 0.0 0.4 1.1 0.1 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.1 0.0 6.9 7.6 1.3 6.1 8.0 4.6 10.6 4.9 5.6 8.7 TMEM229B "C14orf83, FLJ33387" ENSG00000198133 "Transmembrane protein 229B" Q8NBD8 14 67447084-67533739 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.8;ductus deferens: 27.5" "Cell line enhanced" "Detected in some" "Daudi: 9.1;MCF7: 9.5;SK-MEL-30: 8.1;U-937: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046562 Approved "HPA046562: AB_10960265" "prognostic favourable (5.38e-4)" "unprognostic (6.55e-2)" "unprognostic (1.23e-1)" "prognostic favourable (1.21e-5)" "unprognostic (7.37e-2)" "unprognostic (1.08e-1)" "unprognostic (1.09e-1)" "unprognostic (2.01e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (2.76e-3)" "unprognostic (1.95e-2)" "unprognostic (5.18e-1)" "unprognostic (8.66e-2)" "unprognostic (1.22e-1)" "unprognostic (8.20e-2)" "prognostic favourable (1.79e-5)" 1.6 14.5 9.4 5.2 7.1 1.6 3.8 27.8 11.5 11.8 5.9 2.7 27.5 15.9 1.5 11.9 1.3 2.2 4.2 1.7 10.6 7.9 2.2 1.5 3.5 8.3 9.0 5.7 1.2 5.7 5.8 8.1 7.7 13.3 2.9 3.4 5.1 4.1 11.8 0.6 1.4 14.1 3.3 6.5 9.4 4.2 5.6 2.0 8.9 9.7 0.0 6.1 5.9 1.7 1.2 2.8 8.7 6.9 5.5 11.0 5.0 2.2 0.3 0.0 0.6 0.2 0.0 0.9 0.4 0.5 0.6 2.4 0.0 7.2 9.1 0.0 0.2 0.0 0.2 0.5 0.1 2.9 0.7 5.5 0.0 0.0 0.8 5.9 1.1 0.1 0.3 0.1 0.0 0.0 0.1 0.3 0.0 9.5 3.5 2.2 0.1 0.4 3.3 0.1 1.3 0.1 4.8 1.4 0.3 0.0 3.5 8.1 7.5 5.7 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.4 24.3 5.1 6.0 5.1 8.7 11.0 6.7 10.6 1.2 6.5 8.7 2.8 1.1 5.7 7.1 0.1 5.5 6.9 1.6 2.6 5.0 9.4 7.1 27.8 11.5 10.6 7.9 9.0 5.7 13.3 2.0 TMEM235 ENSG00000204278 "Transmembrane protein 235" A6NFC5 17 78231310-78240987 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 26 "brain: 33.0" "Cell line enhanced" "Detected in some" "Daudi: 1.0;HUVEC TERT2: 1.2" "Cancer enriched" "Detected in single" 15 "glioma: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA053939 Uncertain "HPA053939: " "unprognostic (1.47e-1)" "unprognostic (6.91e-3)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" 1.0 1.0 12.2 1.0 17.4 1.0 1.0 2.0 25.6 1.0 1.0 33.0 0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 20.9 9.7 1.0 1.0 1.0 1.1 18.3 8.6 1.1 1.0 1.0 0.0 1.2 10.3 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0 1.0 20.7 1.0 1.0 1.2 18.0 0.0 1.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 17.4 2.0 10.2 20.9 9.7 18.3 8.6 10.3 18.0 TMEM240 "C1orf70, SCA21" ENSG00000205090 "Transmembrane protein 240" Q5SV17 1 1535174-1540453 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.3" "Cell line enhanced" "Detected in many" "HEK 293: 9.4;HHSteC: 9.0;SCLC-21H: 10.6;SH-SY5Y: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066721 Supported "HPA066721: " "unprognostic (2.24e-1)" "unprognostic (1.87e-1)" "unprognostic (5.52e-5)" "unprognostic (2.31e-1)" "unprognostic (2.47e-1)" "unprognostic (1.01e-1)" "unprognostic (1.37e-1)" "unprognostic (3.85e-2)" "unprognostic (3.48e-2)" "unprognostic (1.21e-1)" "prognostic favourable (2.52e-4)" "unprognostic (9.13e-2)" "unprognostic (7.96e-3)" "unprognostic (9.50e-4)" "unprognostic (2.64e-1)" "unprognostic (8.38e-2)" "unprognostic (1.93e-1)" 3.8 4.7 10.8 1.7 17.1 0.8 1.7 24.3 21.8 4.6 5.1 1.8 0.9 1.2 9.1 2.2 1.7 4.2 2.5 3.5 12.2 7.9 1.5 0.8 2.4 1.2 5.6 10.3 10.3 2.1 3.3 3.9 3.7 5.0 4.7 1.5 2.5 4.1 7.9 6.9 2.8 2.9 5.1 2.8 2.6 1.7 2.1 4.9 0.3 1.5 0.2 0.9 2.8 5.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 1.0 6.6 0.7 1.2 4.9 1.5 4.1 2.2 4.2 2.3 0.0 0.4 0.8 0.8 2.0 2.4 0.1 0.2 0.7 4.0 9.4 0.5 3.0 1.2 9.0 0.0 0.9 6.2 1.9 1.5 0.3 4.3 1.3 0.3 0.1 0.2 0.6 0.8 4.2 1.5 3.8 1.2 0.9 0.4 0.0 10.6 13.1 1.4 0.5 4.2 0.6 0.0 2.2 0.6 1.9 0.8 1.8 2.0 0.5 0.4 2.3 2.7 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 17.1 24.3 16.5 12.2 7.9 5.6 10.3 5.0 4.9 TMEM255A "FAM70A, FLJ20716" ENSG00000125355 "Transmembrane protein 255A" Q5JRV8 X 120258650-120311556 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.4;ovary: 29.6" "Cell line enhanced" "Detected in some" "Karpas-707: 16.9;RPMI-8226: 10.8;SK-MEL-30: 17.7;U-2 OS: 7.6;U-87 MG: 19.3" "Group enriched" "Detected in many" 10 "glioma: 21.3;melanoma: 8.0;renal cancer: 7.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 10 "T-cells: 5.9" "Low region specificity" "Detected in all" HPA048470 Approved Uncertain "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA048470: AB_2680406" "unprognostic (3.41e-2)" "unprognostic (8.96e-2)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" "unprognostic (8.55e-4)" "unprognostic (7.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (2.02e-1)" "unprognostic (1.32e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.17e-2)" "unprognostic (2.55e-4)" 3.9 5.5 6.8 3.4 14.4 1.5 5.4 6.8 7.8 11.2 3.5 12.4 1.7 1.9 3.2 2.9 4.4 6.3 2.1 2.4 5.3 25.4 2.4 1.5 4.8 5.0 30.4 4.4 29.6 1.1 0.6 6.6 0.8 18.4 3.8 3.9 7.1 1.3 3.3 2.4 4.0 2.8 2.0 13.0 2.8 2.1 0.9 7.8 6.4 0.9 1.8 5.7 1.6 8.0 0.5 0.3 0.0 0.6 0.0 5.9 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.3 0.1 0.0 0.1 0.2 0.0 0.0 1.1 0.4 0.5 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 16.9 0.3 0.0 0.0 0.0 5.9 0.0 0.0 0.0 10.8 0.0 0.0 3.4 0.1 0.3 0.0 17.7 0.0 0.2 0.0 0.0 7.6 0.0 2.8 0.0 3.2 2.4 19.3 0.0 0.0 0.0 0.6 0.0 5.9 0.2 3.3 0.5 0.4 2.2 0.3 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.9 6.8 14.4 6.8 3.9 5.3 25.4 30.4 4.4 18.4 7.8 TMEM266 "C15orf27, FLJ38190" ENSG00000169758 "Transmembrane protein 266" Q2M3C6 15 76059837-76229121 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 50.7" "Cell line enhanced" "Detected in some" "HDLM-2: 1.9;HEK 293: 3.6;NTERA-2: 3.6;U-937: 3.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Region enriched" "Detected in many" 12 "cerebellum: 50.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 6 "cerebellum: 65.8" "Region enriched" "Detected in all" 6 "cerebellum: 66.4" "HPA041921, HPA049425" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041921: AB_10796789, HPA049425: " "unprognostic (8.63e-3)" "unprognostic (6.11e-3)" "unprognostic (3.44e-3)" "unprognostic (9.17e-5)" "unprognostic (4.67e-1)" "unprognostic (2.61e-2)" "unprognostic (9.34e-3)" "unprognostic (5.61e-2)" "unprognostic (8.48e-3)" "unprognostic (2.89e-2)" "unprognostic (1.18e-2)" "unprognostic (3.95e-2)" "unprognostic (1.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (7.86e-2)" 0.1 1.9 1.1 0.2 1.9 0.2 0.4 50.7 4.2 0.2 0.2 0.6 0.0 0.3 0.2 0.1 0.3 0.3 0.1 0.1 0.9 1.3 0.9 0.1 1.1 0.3 0.7 0.3 0.1 2.4 0.2 5.1 2.4 1.9 0.4 0.2 1.1 0.2 0.1 10.6 1.5 0.1 0.1 0.4 0.6 0.3 1.4 0.0 0.0 0.2 0.7 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.8 0.8 0.0 1.9 3.6 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 50.7 4.2 0.9 1.3 0.7 0.3 1.9 0.0 TMEM272 "FLJ37307, LINC00282, NCRNA00282" ENSG00000281106 "Transmembrane protein 272" 13 51813347-51845175 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 24.5;brain: 35.4" "Cell line enhanced" "Detected in some" "BEWO: 2.3;HEL: 1.5;SK-MEL-30: 6.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 54 "neutrophil: 24.5" "Lineage enriched" "Detected in single" 54 "granulocytes: 24.5" "unprognostic (2.27e-2)" "unprognostic (2.50e-1)" "unprognostic (5.12e-2)" "unprognostic (8.71e-7)" "unprognostic (4.52e-2)" "unprognostic (1.78e-4)" "unprognostic (6.16e-2)" "unprognostic (5.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.02e-1)" "unprognostic (3.73e-3)" "unprognostic (1.32e-5)" "unprognostic (2.12e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.58e-2)" 0.2 0.0 2.7 3.3 35.4 1.7 0.0 0.0 2.4 0.0 0.0 0.4 0.0 1.0 0.7 0.0 0.0 0.0 0.3 4.1 1.2 0.0 0.1 0.2 4.0 0.1 0.4 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.3 1.0 0.0 0.0 1.4 0.0 1.2 5.6 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.8 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.2 0.5 0.0 0.1 0.1 0.1 1.5 0.1 0.5 0.1 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.9 0.5 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 24.5 0.0 0.0 0.0 0.0 0.0 TMEM35A "FLJ14084, TMEM35" ENSG00000126950 "Transmembrane protein 35A" Q53FP2 X 101078720-101096364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;seminal vesicle: 46.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.3;HUVEC TERT2: 31.7;SH-SY5Y: 8.1" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048583 Enhanced Supported "Vesicles,Focal adhesion sites,Cytosol" Vesicles "Focal adhesion sites, Cytosol" "HPA048583: " "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-2)" "unprognostic (3.02e-2)" "unprognostic (3.89e-3)" "unprognostic (2.77e-2)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (3.34e-3)" "unprognostic (9.20e-2)" "unprognostic (4.72e-2)" "unprognostic (3.49e-4)" "unprognostic (5.91e-2)" "unprognostic (1.85e-1)" "unprognostic (1.48e-2)" "unprognostic (9.37e-3)" 3.6 6.7 12.8 1.7 28.2 0.7 1.3 21.2 28.6 3.3 17.3 2.5 6.8 3.5 7.4 3.9 10.4 4.3 3.6 1.1 14.4 33.8 1.1 0.7 2.6 0.8 12.2 10.0 7.7 0.9 6.1 1.5 0.8 30.0 20.5 9.1 2.9 1.0 46.4 1.3 0.9 4.1 11.8 3.9 1.3 3.4 1.8 2.3 0.0 1.3 0.0 0.9 13.3 2.7 0.2 0.0 0.2 0.1 0.6 0.8 0.4 0.0 0.0 3.3 0.0 2.4 6.3 0.0 0.6 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.9 0.0 2.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 2.1 0.0 1.1 0.0 31.7 0.0 0.0 4.0 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 1.4 8.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.5 0.2 0.5 0.2 0.0 0.0 0.6 0.4 0.2 0.6 0.1 0.0 0.8 0.4 12.8 28.2 21.2 28.6 14.4 33.8 12.2 10.0 30.0 2.3 TMEM59L "BSMAP, C19orf4" ENSG00000105696 "Transmembrane protein 59 like" Q9UK28 19 18607430-18621039 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 148.3" "Cell line enhanced" "Detected in some" "AN3-CA: 20.3;ASC diff: 24.7;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;SH-SY5Y: 12.0" "Cancer enriched" "Detected in many" 8 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010661, HPA070701" Approved Approved "Nucleoplasm,Actin filaments" "Actin filaments" Nucleoplasm "HPA010661: AB_1078338, HPA070701: " "unprognostic (3.24e-2)" "unprognostic (5.53e-2)" "unprognostic (1.24e-4)" "prognostic unfavourable (1.62e-4)" "unprognostic (1.70e-1)" "unprognostic (5.40e-3)" "unprognostic (3.53e-2)" "unprognostic (6.91e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-3)" "prognostic favourable (8.80e-4)" "unprognostic (4.65e-2)" "unprognostic (9.17e-7)" "unprognostic (1.47e-3)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-5)" 2.6 12.8 36.9 2.5 39.4 1.7 1.9 41.9 148.3 2.2 2.9 7.5 0.0 2.0 2.5 2.0 2.5 2.1 2.9 3.5 39.9 49.6 1.9 1.8 1.9 1.8 17.7 32.8 1.8 2.8 4.9 13.2 2.3 24.1 2.2 2.2 1.9 2.3 2.6 2.5 1.8 3.0 3.1 7.3 1.7 2.0 2.4 5.2 0.0 1.8 0.0 1.7 2.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.4 0.0 0.6 0.2 20.3 24.7 1.2 0.0 2.1 0.4 0.8 0.4 0.0 1.0 0.1 14.6 1.3 0.3 6.0 0.0 0.7 0.1 0.9 0.0 0.3 14.8 3.8 0.0 0.3 9.1 0.0 0.2 0.7 0.0 0.0 0.1 0.5 0.8 0.1 0.0 1.8 0.6 0.1 0.0 0.2 0.0 0.0 0.3 12.0 1.4 0.0 0.0 0.2 0.0 0.2 0.4 4.9 0.1 1.3 3.0 1.1 0.1 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.4 36.9 39.4 41.9 70.3 39.9 49.6 17.7 32.8 24.1 5.2 TMEM63A KIAA0792 ENSG00000196187 "Transmembrane protein 63A" O94886 1 225845536-225882369 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.4" "Cell line enhanced" "Detected in many" "RPMI-8226: 37.7;SK-BR-3: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066504, HPA066936, HPA068918" Enhanced "Vesicles,Centriolar satellite" 96000 "Vesicles, Centriolar satellite" "HPA066504: , HPA066936: , HPA068918: " "unprognostic (5.31e-2)" "unprognostic (3.46e-2)" "unprognostic (2.14e-2)" "prognostic favourable (8.79e-4)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-2)" "unprognostic (2.57e-1)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.92e-2)" 10.5 7.4 14.7 11.6 38.8 18.6 12.2 4.1 23.2 14.3 14.0 91.4 17.3 12.2 12.2 11.2 6.6 13.9 12.9 8.5 30.2 15.1 14.3 15.1 12.6 15.4 59.3 16.4 13.1 22.4 11.6 5.3 11.3 34.9 22.3 17.8 5.7 55.8 19.1 6.9 9.9 13.3 8.8 71.0 14.0 22.9 3.0 49.6 11.2 8.0 4.5 12.4 13.3 9.6 5.4 10.0 5.5 4.1 8.7 16.6 5.7 9.3 2.8 2.4 7.1 19.6 6.8 16.9 7.1 7.7 8.0 8.1 10.2 6.9 2.6 13.2 8.7 14.4 2.6 4.3 3.7 8.7 4.7 11.3 6.5 6.1 4.5 4.2 29.9 7.1 2.7 4.7 2.9 5.1 9.4 2.2 6.3 5.9 3.7 4.3 13.3 4.6 3.7 7.5 37.7 12.2 24.7 0.2 1.3 5.2 42.0 5.1 9.7 4.0 6.1 4.6 3.2 4.2 6.4 0.9 3.4 0.6 4.2 2.4 8.4 5.5 3.2 3.0 9.4 2.7 10.6 5.2 12.1 8.9 2.5 5.4 10.9 6.3 5.1 8.7 4.1 10.0 16.6 5.7 14.7 38.8 4.1 23.0 30.2 15.1 59.3 16.4 34.9 49.6 TMEM63C "C14orf171, CSC1, DKFZp434P0111, hsCSC1" ENSG00000165548 "Transmembrane protein 63C" Q9P1W3 14 77116568-77259495 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.8;pituitary gland: 21.1" "Cell line enhanced" "Detected in some" "Daudi: 11.6;Karpas-707: 15.6;RPMI-8226: 7.9;SCLC-21H: 21.2;SK-BR-3: 18.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 63.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030657 Uncertain Approved Centrosome Centrosome "HPA030657: AB_10601699" "unprognostic (2.74e-1)" "unprognostic (1.79e-2)" "unprognostic (2.30e-1)" "unprognostic (4.30e-8)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (2.68e-3)" "unprognostic (1.61e-3)" "unprognostic (2.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.90e-2)" "unprognostic (1.35e-3)" "unprognostic (3.72e-2)" "unprognostic (1.34e-7)" "unprognostic (5.90e-3)" 0.4 14.1 3.4 1.0 8.4 1.1 5.2 63.8 16.3 1.5 5.8 1.9 0.0 1.8 0.3 6.8 4.8 0.6 0.5 0.3 3.2 9.7 0.7 0.4 0.9 0.6 4.6 6.0 0.4 6.7 1.2 21.1 1.1 6.6 0.4 4.3 0.9 1.3 0.2 0.8 4.4 2.2 1.1 1.8 3.2 3.1 9.9 1.2 0.0 3.2 0.6 0.6 0.3 2.9 0.1 0.7 2.0 1.7 1.7 1.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 11.6 2.2 0.0 1.6 2.4 0.9 0.0 0.7 0.9 0.2 1.1 0.0 0.0 2.0 0.1 0.0 4.9 0.0 0.1 0.0 0.0 15.6 0.0 5.8 1.6 0.1 0.5 0.0 0.0 0.8 7.9 0.2 0.0 21.2 3.2 0.2 18.8 0.0 1.8 1.0 0.0 0.0 4.0 0.0 0.0 1.2 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.0 0.5 1.0 0.7 0.1 0.5 0.4 2.0 1.7 1.7 0.0 0.0 0.4 3.4 8.4 63.8 13.0 3.2 9.7 4.6 6.0 6.6 1.2 TMEM74 "FLJ30668, NET36" ENSG00000164841 "Transmembrane protein 74" Q96NL1 8 108606850-108787615 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1" "Cell line enhanced" "Detected in some" "HEK 293: 5.1;NTERA-2: 6.4;SCLC-21H: 14.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory B-cell: 1.4" "Lineage enriched" "Detected in single" 14 "B-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA015672 Uncertain Approved Cytosol Cytosol "HPA015672: AB_1858132" "unprognostic (8.99e-2)" "unprognostic (1.18e-1)" "unprognostic (4.25e-2)" "unprognostic (6.33e-2)" "unprognostic (2.05e-1)" "unprognostic (4.18e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-1)" "unprognostic (2.54e-1)" "unprognostic (1.44e-2)" "unprognostic (2.01e-2)" "unprognostic (3.97e-2)" "unprognostic (3.75e-4)" "unprognostic (8.77e-2)" "unprognostic (6.36e-2)" "unprognostic (5.95e-2)" "unprognostic (1.46e-3)" 1.3 1.4 4.8 1.1 4.2 0.4 0.9 13.1 12.0 0.7 2.7 10.4 0.0 0.9 0.7 0.7 2.9 1.0 0.9 7.5 5.9 2.8 0.7 2.2 0.8 0.8 3.2 6.1 0.9 2.7 0.4 1.1 0.5 9.3 1.0 1.3 1.0 0.9 1.1 5.5 2.0 1.4 2.9 14.1 0.6 0.9 2.7 6.8 0.7 0.8 0.8 0.9 0.9 1.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.1 0.3 0.0 1.5 0.0 0.1 0.1 2.9 0.7 0.0 0.4 5.1 1.9 0.8 0.3 0.1 0.5 0.7 0.0 0.0 0.1 0.1 0.5 0.0 0.2 0.0 0.0 0.2 0.0 6.4 3.7 0.0 3.6 0.0 0.0 0.0 14.0 0.1 0.0 0.5 0.0 0.2 0.2 0.0 1.7 3.0 0.0 0.3 0.5 0.1 0.0 2.7 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 4.2 13.1 7.3 5.9 2.8 3.2 6.1 9.3 6.8 TMEM74B "C20orf46, FLJ11190" ENSG00000125895 "Transmembrane protein 74B" Q9NUR3 20 1180561-1185415 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9;intestine: 16.0" "Cell line enhanced" "Detected in some" "CACO-2: 7.7;Hep G2: 9.7;K-562: 16.4;Karpas-707: 7.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045213 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA045213: AB_10961999" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.05e-3)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (6.91e-3)" "unprognostic (1.97e-1)" "unprognostic (1.77e-4)" "unprognostic (9.58e-2)" "prognostic favourable (3.07e-5)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.55e-7)" "unprognostic (1.20e-1)" "unprognostic (9.77e-2)" "unprognostic (8.37e-2)" "unprognostic (5.07e-3)" 2.3 0.3 4.3 0.3 13.9 0.0 1.1 2.3 7.3 0.1 0.7 12.5 0.6 0.3 0.7 3.9 2.5 3.9 2.3 6.9 0.6 1.0 9.4 0.9 2.3 0.0 0.6 0.2 3.5 12.2 0.5 0.9 3.3 11.3 2.9 4.6 16.0 1.1 1.1 0.6 2.7 0.9 1.6 0.4 0.7 0.0 1.6 0.1 0.0 0.1 0.0 0.5 0.3 0.0 4.8 2.7 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 7.7 0.7 0.1 0.9 0.0 0.3 3.6 0.5 0.1 0.0 4.6 1.1 0.0 9.7 0.0 0.0 1.3 0.0 1.0 0.0 0.2 0.1 16.4 7.4 0.0 0.1 0.1 0.1 3.3 0.4 0.0 0.2 0.0 0.8 0.7 0.7 2.1 0.1 0.0 0.1 0.0 0.1 2.0 0.0 3.2 0.1 0.1 3.2 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 TMEM81 "HC3107, KVLA2788, MGC75217, UNQ2788" ENSG00000174529 "Transmembrane protein 81" Q6P7N7 1 205083129-205084460 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052515 Approved "Intermediate filaments" "Intermediate filaments" "HPA052515: " "unprognostic (9.19e-3)" "unprognostic (3.53e-1)" "unprognostic (1.91e-3)" "unprognostic (6.48e-2)" "unprognostic (2.44e-1)" "unprognostic (2.08e-1)" "prognostic unfavourable (3.25e-6)" "unprognostic (3.66e-2)" "unprognostic (2.68e-2)" "unprognostic (6.18e-2)" "unprognostic (5.86e-2)" "unprognostic (2.48e-2)" "prognostic unfavourable (6.65e-9)" "unprognostic (8.91e-2)" "unprognostic (6.24e-2)" "unprognostic (2.42e-1)" "prognostic favourable (2.67e-4)" 1.5 2.7 2.8 1.6 3.8 2.0 2.1 11.2 5.3 2.1 1.3 1.2 1.5 3.5 1.4 1.2 1.1 2.2 3.3 2.7 4.2 3.3 1.5 2.3 2.8 2.3 1.0 3.4 2.2 2.0 1.8 1.7 1.4 2.1 4.6 4.1 1.2 1.7 2.4 3.0 1.0 6.1 1.4 2.7 0.9 1.6 1.5 1.5 4.3 1.4 0.2 4.6 0.9 2.4 3.7 6.2 8.2 9.1 3.6 3.2 4.5 2.7 2.3 1.4 6.6 1.7 4.5 3.2 2.5 2.1 10.0 3.8 4.1 3.9 3.9 3.7 5.2 3.3 6.3 1.9 2.1 3.7 6.9 3.6 1.8 4.6 8.4 1.9 2.9 4.7 4.4 8.2 4.8 5.4 3.0 7.2 4.7 5.4 2.3 3.9 6.1 2.8 3.4 7.2 2.5 8.1 2.1 4.4 2.3 5.6 4.9 4.3 5.3 3.6 6.3 2.9 7.4 4.3 1.2 0.2 4.6 1.4 0.2 1.5 2.3 1.1 1.5 1.4 2.5 4.0 2.5 0.2 1.4 1.5 2.7 0.9 TMEM88B ENSG00000205116 "Transmembrane protein 88B" A6NKF7 1 1426128-1427787 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 36.9" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;Hep G2: 9.0;SCLC-21H: 3.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065743 Enhanced "HPA065743: " "unprognostic (3.17e-2)" "unprognostic (1.42e-2)" "unprognostic (1.63e-4)" "unprognostic (1.11e-1)" "unprognostic (3.35e-2)" "unprognostic (2.67e-1)" "unprognostic (2.91e-2)" "unprognostic (5.30e-5)" "unprognostic (2.00e-1)" "unprognostic (2.64e-1)" "unprognostic (3.53e-2)" "unprognostic (7.19e-2)" "unprognostic (1.45e-1)" "unprognostic (7.95e-2)" 1.1 1.1 10.2 1.4 24.7 1.2 1.1 1.0 23.3 1.1 1.1 34.0 0.0 1.1 1.1 1.1 1.1 1.4 1.3 1.2 19.6 8.3 1.5 1.1 1.4 1.2 30.8 11.2 1.1 1.1 1.1 0.0 1.2 16.1 1.3 1.1 0.0 1.1 1.1 1.1 1.7 1.1 1.1 36.9 1.1 1.3 2.4 28.5 0.0 1.1 0.0 1.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 3.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 24.7 1.0 20.6 19.6 8.3 30.8 11.2 16.1 28.5 TMIE DFNB6 ENSG00000181585 "Transmembrane inner ear" Q8NEW7 3 46694528-46710886 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.7;brain: 11.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.3;EFO-21: 5.6;hTCEpi: 3.8;SH-SY5Y: 4.8" "Cancer enriched" "Detected in many" 5 "glioma: 6.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.1" "Lineage enriched" "Detected in single" 17 "T-cells: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038298 Uncertain Uncertain Vesicles,Cytosol "Vesicles, Cytosol" "HPA038298: AB_10675792" "unprognostic (6.59e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-3)" "unprognostic (2.48e-3)" "unprognostic (1.88e-2)" "unprognostic (5.40e-3)" "unprognostic (3.94e-2)" "unprognostic (8.80e-2)" "unprognostic (3.37e-2)" "unprognostic (6.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.35e-2)" "unprognostic (4.58e-2)" "unprognostic (1.23e-1)" "unprognostic (4.41e-2)" "unprognostic (5.29e-2)" "unprognostic (6.78e-2)" 1.2 11.7 6.7 0.7 2.9 0.0 0.5 2.7 7.0 0.8 0.9 2.3 0.4 0.6 0.8 1.2 2.2 1.0 0.4 1.0 5.9 11.4 1.4 0.9 1.8 1.2 5.8 4.8 2.8 0.4 0.0 8.1 0.7 3.8 0.9 0.6 1.1 0.8 1.8 5.8 1.3 0.6 0.7 5.2 1.2 0.3 1.6 1.0 0.4 0.8 1.7 1.3 0.8 0.4 0.0 0.3 0.0 0.1 0.0 6.1 1.2 2.0 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.2 0.0 6.3 0.0 5.6 0.0 0.2 0.4 0.5 0.0 0.0 0.0 1.6 0.1 0.0 1.8 0.0 0.0 0.0 3.8 0.0 2.5 1.0 0.0 0.5 0.0 0.3 0.1 0.0 0.4 0.3 2.4 0.0 0.5 0.2 0.1 0.7 4.8 0.7 0.8 0.1 0.2 1.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.0 1.8 1.0 0.3 0.0 6.1 0.9 0.0 0.0 0.0 0.0 1.0 1.2 6.7 2.9 2.7 7.0 5.9 11.4 5.8 4.8 3.8 1.0 TMIGD3 AD026 ENSG00000121933 "Transmembrane and immunoglobulin domain containing 3" P0DMS9 1 111483348-111563962 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 28.2;brain: 16.4;testis: 50.4" "Cell line enhanced" "Detected in some" "HDLM-2: 11.3;HMC-1: 3.0;Karpas-707: 2.2;NB-4: 6.1" "Cancer enriched" "Detected in all" 5 "glioma: 16.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 39 "eosinophil: 28.2" "Lineage enriched" "Detected in single" 39 "granulocytes: 28.2" "prognostic unfavourable (3.58e-4)" "unprognostic (7.64e-3)" "unprognostic (7.47e-3)" "unprognostic (2.11e-2)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (9.48e-2)" "unprognostic (5.70e-2)" "unprognostic (1.01e-1)" "unprognostic (2.07e-3)" "unprognostic (4.46e-2)" "unprognostic (9.50e-2)" "unprognostic (4.48e-2)" "unprognostic (5.69e-3)" "unprognostic (3.30e-1)" "unprognostic (1.44e-5)" "unprognostic (9.22e-2)" 5.4 4.1 8.4 1.9 14.4 2.4 1.4 1.2 8.1 1.5 1.5 12.6 0.0 0.9 1.3 0.6 1.4 1.4 1.4 1.4 7.3 1.5 1.3 3.0 2.8 2.9 15.0 3.3 1.3 1.3 0.8 1.3 5.1 8.4 1.4 1.2 0.9 1.3 2.0 1.3 1.3 2.1 1.3 16.4 2.0 1.4 50.4 13.5 0.0 1.4 0.0 1.0 1.4 1.3 0.0 0.3 28.2 0.7 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 11.3 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.7 28.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.2 8.4 14.4 1.2 8.1 7.3 1.5 15.0 3.3 8.4 13.5 TMOD2 NTMOD ENSG00000128872 "Tropomodulin 2" Q9NZR1 15 51751561-51816368 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 68.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.3" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.8" "Group enriched" "Detected in all" 4 "granulocytes: 12.8;monocytes: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041365 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA041365: AB_10794665" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-3)" "unprognostic (9.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-1)" "unprognostic (3.32e-1)" "unprognostic (5.33e-4)" "prognostic favourable (4.53e-4)" "unprognostic (2.82e-1)" "unprognostic (1.39e-3)" "unprognostic (2.36e-2)" "unprognostic (6.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.89e-1)" 5.9 6.3 25.4 6.1 29.6 1.6 5.1 22.0 68.6 7.0 6.1 9.1 4.6 3.1 6.0 4.4 4.9 6.0 5.2 4.9 21.6 18.1 3.5 2.2 4.5 4.9 16.9 22.6 6.5 3.1 6.7 4.4 3.0 29.5 3.7 5.1 2.9 3.8 9.6 2.7 4.6 4.7 6.7 11.4 4.5 3.7 3.1 9.6 1.2 4.3 0.2 4.7 4.7 4.6 2.5 1.6 12.8 8.8 1.3 2.2 1.1 0.8 0.5 1.7 4.0 8.2 8.8 0.3 4.5 1.5 3.4 3.7 0.0 0.4 3.6 0.1 3.5 2.3 7.1 4.0 1.1 0.0 3.5 0.0 0.7 0.0 1.4 1.4 0.2 5.1 5.4 0.5 1.0 0.7 0.0 0.1 4.2 0.6 2.9 0.5 1.1 0.8 2.2 1.0 0.1 0.5 1.2 26.3 6.4 4.2 0.0 1.2 1.0 0.2 1.6 9.3 0.7 5.8 3.2 0.0 0.0 0.0 2.9 9.7 4.2 0.1 5.9 7.8 2.2 2.3 1.0 2.5 1.3 1.0 1.6 1.8 1.7 0.7 12.8 1.3 8.8 1.2 0.4 1.1 25.4 29.6 22.0 38.3 21.6 18.1 16.9 22.6 29.5 9.6 TMPRSS5 "MGC141886, MGC148044" ENSG00000166682 "Transmembrane serine protease 5" Q9H3S3 11 113687546-113706373 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 24.0;salivary gland: 15.0;skeletal muscle: 6.0" "Cell line enhanced" "Detected in some" "AF22: 4.4;CAPAN-2: 7.1;WM-115: 5.8" "Cancer enhanced" "Detected in some" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010992 Approved Nucleoplasm Nucleoplasm "HPA010992: AB_1858152" "unprognostic (1.53e-2)" "unprognostic (3.81e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (2.99e-3)" "unprognostic (3.08e-1)" "unprognostic (5.19e-3)" "unprognostic (8.49e-2)" "unprognostic (8.13e-2)" "unprognostic (3.38e-2)" "unprognostic (1.96e-3)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (4.04e-3)" 2.1 1.7 10.8 1.0 24.0 3.2 2.2 2.1 14.8 1.2 1.0 21.6 0.0 1.0 1.2 0.9 1.8 1.1 2.2 1.2 11.5 5.7 0.9 0.9 0.9 1.1 11.6 12.7 1.4 1.2 0.6 1.5 1.2 16.5 1.2 1.3 0.9 15.0 1.4 6.0 2.7 0.7 1.2 16.9 1.1 2.4 2.3 8.8 0.0 1.1 0.4 1.3 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.8 4.4 2.5 0.5 0.4 0.6 1.2 0.5 0.6 0.9 2.5 7.1 0.3 3.2 0.5 0.8 0.4 0.4 0.3 0.5 1.3 1.0 0.6 0.0 0.3 1.0 0.8 0.6 0.6 0.6 1.2 0.8 0.8 0.5 0.9 0.0 0.8 1.2 0.5 0.2 0.9 0.5 0.0 0.7 0.4 0.6 1.0 0.5 0.1 3.5 0.5 0.6 0.5 0.9 1.7 0.6 0.7 0.5 0.2 0.1 0.4 0.9 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 24.0 2.1 12.3 11.5 5.7 11.6 12.7 16.5 8.8 TMSB4Y TB4Y ENSG00000154620 "Thymosin beta 4, Y-linked" O14604 Y 13703567-13706024 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.3" "Cell line enhanced" "Detected in some" "BEWO: 12.9;HEL: 10.4;RPTEC TERT1: 16.3;RT4: 6.0;SCLC-21H: 4.8;U-698: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "unprognostic (7.27e-2)" "unprognostic (1.31e-1)" "unprognostic (5.79e-2)" "unprognostic (1.39e-5)" "unprognostic (1.46e-2)" "unprognostic (2.84e-1)" "unprognostic (3.39e-2)" "unprognostic (1.89e-1)" "unprognostic (3.30e-2)" "unprognostic (8.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.64e-3)" "unprognostic (1.84e-1)" "unprognostic (1.27e-1)" "unprognostic (1.09e-1)" 1.2 1.2 4.3 1.9 6.8 3.7 1.1 2.2 9.8 0.1 4.6 12.3 3.0 1.6 0.1 5.5 3.5 0.1 1.6 3.7 4.6 4.7 2.5 1.9 4.3 1.0 4.2 0.0 0.1 2.2 0.1 2.0 0.8 8.3 6.7 10.5 2.0 2.2 6.5 0.4 1.4 4.7 4.9 4.9 2.2 2.1 6.1 0.0 4.7 2.2 0.0 2.9 2.7 0.0 2.4 6.0 1.8 2.9 1.8 3.4 2.5 0.0 0.8 0.0 0.0 0.0 0.0 12.9 0.5 0.8 0.0 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.1 1.4 0.0 0.0 0.0 1.9 16.3 6.0 4.8 0.0 0.0 0.0 0.8 0.0 0.6 0.3 0.6 0.0 0.1 0.1 1.4 2.7 6.1 0.0 0.0 0.0 0.1 2.9 1.1 3.1 2.6 1.8 2.4 3.4 0.7 6.0 1.9 2.3 1.1 1.8 1.8 1.0 1.8 1.1 2.5 4.3 6.8 2.2 9.8 4.6 4.7 4.2 0.0 8.3 0.0 TMTC4 "FLJ14624, FLJ22153" ENSG00000125247 "Transmembrane and tetratricopeptide repeat containing 4" Q5T4D3 13 100603927-100675093 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016489 Uncertain Approved Vesicles Vesicles "HPA016489: AB_1858157" "unprognostic (1.49e-1)" "unprognostic (1.87e-1)" "unprognostic (8.34e-2)" "unprognostic (1.35e-1)" "unprognostic (2.43e-2)" "unprognostic (1.96e-1)" "unprognostic (1.50e-2)" "unprognostic (1.96e-1)" "unprognostic (1.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.99e-1)" "unprognostic (6.04e-2)" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" 4.1 4.4 11.4 4.4 13.7 1.9 5.7 10.6 21.8 6.6 7.0 45.7 8.3 8.5 8.7 7.5 4.8 13.2 4.9 3.2 16.9 8.7 11.5 9.8 3.5 3.6 16.9 10.0 5.3 12.8 7.5 3.3 4.0 29.6 7.9 7.6 4.6 6.9 5.6 9.4 6.5 7.3 6.0 25.2 3.9 7.9 9.7 11.3 4.2 7.2 3.9 4.6 7.7 4.3 2.4 6.4 0.2 3.3 1.3 4.4 1.4 4.9 4.2 22.1 11.7 2.9 5.9 24.7 2.8 2.5 2.7 2.2 4.2 9.3 14.9 9.5 2.4 3.5 6.8 3.0 3.2 8.4 4.9 6.3 7.9 6.7 3.1 8.1 0.1 8.3 5.8 1.0 4.9 12.1 4.7 1.9 3.1 4.4 5.9 4.7 5.9 4.2 6.4 3.9 3.3 11.1 3.9 11.4 11.8 5.5 10.7 2.8 7.9 23.0 18.8 2.4 4.2 2.2 4.9 5.0 4.0 2.8 11.8 5.3 7.0 0.0 2.0 0.2 2.7 2.1 2.4 2.0 2.6 4.4 6.4 2.4 3.0 1.1 0.0 1.3 3.3 4.2 3.8 1.4 11.4 13.7 10.6 21.8 16.9 8.7 16.9 10.0 29.6 11.3 TNFRSF21 "CD358, DR6" ENSG00000146072 "TNF receptor superfamily member 21" O75509 6 47231532-47309905 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Apoptosis, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.4" "Cell line enhanced" "Detected in many" "RT4: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 35 "plasmacytoid DC: 31.6" "Lineage enriched" "Detected in single" 309 "dendritic cells: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006746, CAB009805" Approved Supported "Plasma membrane,Cytosol" 1300000 "Plasma membrane, Cytosol" "CAB009805: AB_2206956, HPA006746: AB_1078701" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (3.26e-1)" "unprognostic (7.85e-2)" "unprognostic (1.44e-1)" "unprognostic (3.41e-2)" "unprognostic (9.80e-3)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (7.53e-2)" "unprognostic (1.38e-3)" "unprognostic (1.74e-1)" "prognostic favourable (7.23e-6)" "unprognostic (1.48e-1)" "unprognostic (1.34e-1)" "unprognostic (9.78e-2)" "unprognostic (1.45e-2)" 25.9 3.7 9.7 8.7 13.6 5.9 7.8 7.4 20.8 9.6 19.3 26.9 1.0 6.4 9.1 3.0 21.8 9.9 18.7 4.1 13.8 16.0 26.2 4.6 9.5 11.5 26.8 7.9 5.0 17.9 35.6 4.4 17.0 29.5 10.2 18.5 3.0 15.2 2.4 3.5 2.7 10.2 8.2 63.4 11.6 30.4 5.8 10.1 11.5 2.9 19.2 16.5 41.2 11.6 0.0 31.6 0.1 0.0 0.0 0.0 0.2 29.9 9.7 9.5 3.0 26.1 7.7 10.8 3.5 6.9 1.1 0.4 16.8 21.2 2.2 14.2 2.5 18.1 1.4 12.9 0.6 0.0 2.9 0.0 1.2 16.9 15.3 0.4 0.1 13.7 15.5 0.6 11.8 5.1 0.7 0.0 0.3 5.9 2.6 0.2 7.4 10.1 5.6 2.9 3.2 18.1 102.3 6.8 1.5 3.0 2.8 2.4 2.2 2.1 1.0 2.8 2.6 0.1 3.2 0.0 0.0 3.1 4.7 2.1 7.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.2 9.7 13.6 7.4 20.8 13.8 16.0 26.8 7.9 29.5 10.1 TNFRSF25 "APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR" ENSG00000215788 "TNF receptor superfamily member 25" Q93038 1 6461151-6466195 "Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1" "Cell line enhanced" "Detected in many" "HDLM-2: 19.7;NB-4: 7.8;RPMI-8226: 19.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 11 "cerebellum: 19.2" "Cell type enhanced" "Detected in many" "T-reg: 9.5" "Lineage enriched" "Detected in single" 10 "T-cells: 9.5" "Group enriched" "Detected in some" 6 "amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3" "Not detected" "Not detected" HPA069834 Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" "Secreted - unknown location" "Plasma membrane, Actin filaments, Focal adhesion sites" Nucleoplasm "HPA069834: " "unprognostic (8.09e-3)" "unprognostic (6.91e-3)" "prognostic unfavourable (4.46e-4)" "unprognostic (1.97e-1)" "unprognostic (9.63e-3)" "prognostic favourable (3.09e-4)" "unprognostic (2.16e-1)" "unprognostic (1.46e-1)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (6.01e-2)" "unprognostic (3.98e-2)" "prognostic unfavourable (1.65e-7)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (3.44e-1)" "unprognostic (8.68e-3)" 2.2 1.6 1.2 20.3 1.6 0.4 1.4 19.2 1.8 1.4 13.4 0.7 0.6 2.8 1.2 0.6 4.1 2.4 2.1 2.3 1.8 0.9 1.4 2.3 6.3 13.9 1.1 0.6 1.1 0.6 1.4 14.0 4.1 1.3 1.9 1.3 1.1 10.5 2.3 0.8 24.1 11.2 0.6 0.6 18.9 0.8 1.0 0.8 11.7 1.1 3.2 26.0 3.2 1.5 0.0 0.4 0.0 0.9 0.6 9.5 1.3 1.4 0.3 0.8 1.5 0.0 0.4 0.8 0.6 0.4 0.2 0.0 1.2 2.1 0.0 2.9 0.0 3.1 0.4 3.6 0.0 19.7 1.4 0.8 1.1 0.0 0.6 0.0 0.0 0.0 2.4 1.2 3.1 3.1 0.0 0.0 0.0 1.6 0.0 7.8 1.0 5.3 0.6 0.2 19.3 0.8 0.5 3.8 5.2 0.0 1.9 0.1 1.6 2.1 1.6 1.0 1.5 0.0 1.5 0.0 3.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.7 0.3 8.0 0.0 6.9 3.2 0.4 0.0 6.4 1.1 0.0 0.6 0.9 0.0 9.5 1.3 1.2 1.6 19.2 1.8 1.8 0.9 1.1 0.6 1.3 0.8 TNFSF18 "AITRL, hGITRL, TL6" ENSG00000120337 "TNF superfamily member 18" Q9UNG2 1 173039960-173050963 "Predicted membrane proteins" "Adaptive immunity, Immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.3;tongue: 9.9" "Group enriched" "Detected in some" 11 "EFO-21: 20.6;HUVEC TERT2: 30.9;TIME: 42.8" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "hippocampal formation: 7.3" "Cell type enriched" "Detected in single" 19 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 19 "monocytes: 1.8" "Low region specificity" "Detected in many" "unprognostic (2.78e-1)" "unprognostic (7.40e-2)" "unprognostic (3.08e-3)" "unprognostic (1.32e-2)" "unprognostic (3.39e-2)" "unprognostic (5.72e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (2.22e-2)" "unprognostic (3.53e-2)" "unprognostic (1.13e-1)" "unprognostic (6.34e-2)" "unprognostic (2.71e-4)" "unprognostic (8.42e-3)" "unprognostic (6.21e-2)" "unprognostic (1.99e-1)" "unprognostic (8.74e-2)" 0.9 0.4 0.4 0.3 0.8 0.0 0.4 1.1 4.6 0.4 0.4 3.2 0.0 1.1 0.3 0.0 3.6 0.3 5.0 1.5 7.3 0.4 0.7 1.9 1.0 0.2 0.4 1.0 0.3 0.3 2.2 0.7 1.3 1.4 0.4 1.0 0.2 0.3 0.0 0.3 0.4 3.5 0.1 0.6 0.6 0.4 0.3 0.0 0.0 0.7 9.9 1.4 0.6 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.9 0.2 0.0 0.0 0.0 0.0 20.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 2.7 30.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.4 0.8 1.1 2.4 7.3 0.4 0.4 1.0 1.4 0.0 TNIK KIAA0551 ENSG00000154310 "TRAF2 and NCK interacting kinase" Q9UKE5 3 171061339-171460408 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9" "Cell line enhanced" "Detected in many" "AF22: 19.6;HEL: 26.6;HMC-1: 30.3;HUVEC TERT2: 19.5;WM-115: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 23 "basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3" "Group enriched" "Detected in many" 29 "granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012128, HPA012297" Approved Supported Nucleoplasm,Cytosol 9100 Nucleoplasm Cytosol "HPA012128: AB_1858226, HPA012297: AB_1858225" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (1.32e-1)" "unprognostic (5.90e-2)" "unprognostic (5.25e-2)" "unprognostic (9.23e-2)" "unprognostic (4.91e-2)" "unprognostic (2.41e-3)" "unprognostic (1.91e-1)" "unprognostic (7.81e-2)" "unprognostic (5.91e-2)" "unprognostic (1.96e-2)" "unprognostic (3.34e-3)" "unprognostic (2.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.13e-2)" "unprognostic (3.97e-2)" 2.2 5.4 29.0 7.4 30.9 4.9 3.6 21.1 26.1 1.9 10.9 12.2 4.1 25.8 4.3 2.1 5.6 4.3 7.1 11.2 30.9 14.8 5.6 4.6 11.3 7.9 11.4 18.3 2.6 5.2 0.7 9.0 3.1 13.6 5.6 9.5 3.5 2.9 7.3 23.2 1.6 25.6 6.0 14.5 5.8 9.2 10.7 21.1 3.7 7.1 2.2 6.9 6.4 2.6 0.2 0.0 10.5 0.1 2.7 6.7 1.1 0.3 0.5 19.6 2.0 0.3 0.0 4.6 4.1 1.1 3.2 2.2 17.5 7.3 0.0 1.4 3.7 6.0 2.8 1.1 3.5 0.1 4.3 26.6 1.5 0.0 9.4 5.2 30.3 2.8 2.9 1.9 0.4 19.5 9.6 0.0 0.5 0.4 1.6 6.7 8.0 7.6 0.0 5.0 7.0 6.3 0.0 0.9 1.0 2.5 0.2 4.3 8.8 1.3 0.2 0.0 3.4 8.9 3.0 0.0 0.0 0.0 0.9 5.9 22.7 4.4 0.1 10.5 4.2 0.0 5.2 0.0 5.0 3.7 0.0 0.2 6.7 3.8 0.1 2.7 0.1 0.0 5.3 1.1 29.0 30.9 21.1 22.2 30.9 14.8 11.4 18.3 13.6 21.1 TNR ENSG00000116147 "Tenascin R" Q92752 1 175315194-175743770 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "brain: 56.4" "Cell line enhanced" "Detected in some" "SH-SY5Y: 5.7;THP-1: 2.3;U-937: 4.2" "Cancer enriched" "Detected in single" 46 "glioma: 9.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022343, HPA027134, HPA027150, HPA029859" Enhanced "Secreted in brain" 230000 "CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916" "unprognostic (1.04e-1)" "unprognostic (7.43e-2)" "unprognostic (3.11e-2)" "unprognostic (1.12e-3)" "unprognostic (2.38e-1)" "unprognostic (1.51e-2)" "unprognostic (9.66e-2)" "unprognostic (2.57e-2)" "unprognostic (5.79e-2)" "unprognostic (5.06e-2)" "unprognostic (3.03e-3)" "unprognostic (7.26e-4)" "unprognostic (4.48e-4)" "unprognostic (3.26e-3)" "unprognostic (3.83e-1)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" 1.2 3.0 21.8 1.4 14.2 1.3 1.2 9.1 56.4 1.2 1.2 17.2 0.0 1.2 1.3 1.4 1.3 1.2 1.3 1.2 18.1 14.4 1.2 1.7 1.7 1.4 16.5 13.3 1.2 1.7 1.2 2.0 1.2 16.1 1.2 1.3 0.1 1.2 1.2 1.2 1.2 1.3 1.3 8.2 1.4 1.6 1.6 14.3 0.0 1.3 0.0 1.6 1.3 0.1 0.4 0.1 0.6 0.0 1.9 0.1 0.0 0.0 0.2 1.2 0.2 0.1 0.1 0.7 0.3 0.2 0.3 0.1 0.7 0.2 0.4 0.6 1.1 0.7 0.0 0.6 0.2 0.3 0.0 0.1 0.5 0.4 0.0 0.4 0.1 0.4 0.8 0.1 0.4 0.2 0.2 0.4 0.0 0.6 0.2 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.3 5.7 0.6 0.3 0.2 0.4 2.3 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.5 4.2 0.3 0.6 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.1 0.1 0.4 1.9 0.0 0.1 0.0 0.0 21.8 14.2 9.1 23.7 18.1 14.4 16.5 13.3 16.1 14.3 TOGARAM2 "Crescerin-2, FAM179A, FLJ43249, LOC165186" ENSG00000189350 "TOG array regulator of axonemal microtubules 2" Q6ZUX3 2 28956611-29061373 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2" "Cell line enhanced" "Detected in some" "HMC-1: 3.8;NB-4: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.7" "Lineage enriched" "Detected in single" 5 "T-cells: 3.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA037561, HPA037562" Uncertain "HPA037561: AB_10670384, HPA037562: " "unprognostic (8.35e-5)" "unprognostic (2.85e-3)" "unprognostic (1.41e-1)" "unprognostic (7.01e-3)" "unprognostic (6.41e-2)" "unprognostic (1.23e-2)" "unprognostic (1.11e-1)" "unprognostic (2.53e-3)" "unprognostic (3.93e-1)" "unprognostic (6.83e-2)" "unprognostic (2.32e-3)" "unprognostic (5.92e-2)" "unprognostic (3.94e-11)" "unprognostic (3.75e-2)" "unprognostic (4.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.81e-3)" 0.3 2.3 3.0 1.7 8.4 2.6 0.4 3.4 1.7 0.6 0.6 7.1 0.0 0.8 1.1 14.4 0.7 15.7 0.5 2.6 3.3 3.9 0.3 0.5 14.2 1.1 2.1 2.0 4.5 0.8 0.1 6.1 0.6 15.3 0.5 0.4 0.1 0.5 0.1 1.7 0.6 0.7 0.8 2.5 2.2 1.5 3.2 6.1 0.0 0.3 0.3 1.3 0.4 0.3 0.3 0.3 0.6 0.3 0.6 3.7 1.0 0.2 0.2 0.3 0.2 0.3 0.0 0.7 0.1 2.3 0.7 2.2 0.4 0.3 0.3 0.3 0.0 0.9 0.4 0.0 0.7 0.4 1.4 0.2 2.0 0.5 0.9 2.0 3.8 0.2 0.3 0.0 0.0 0.3 0.3 1.0 0.8 0.2 0.8 3.6 2.7 0.7 0.1 0.7 1.5 1.1 0.3 2.6 1.8 0.1 0.1 0.1 0.4 0.2 0.2 0.2 0.5 0.2 0.3 0.5 0.5 0.2 1.7 1.3 0.1 0.5 0.3 0.3 3.7 0.1 2.0 0.2 0.6 2.9 0.1 0.3 0.4 1.0 0.6 0.6 0.2 0.3 1.5 1.0 3.0 8.4 3.4 1.2 3.3 3.9 2.1 2.0 15.3 6.1 TOMM34 "HTOM34P, TOM34" ENSG00000025772 "Translocase of outer mitochondrial membrane 34" Q15785 20 44942130-44960486 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.2;testis: 53.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA018845, HPA056875" Enhanced "HPA018845: AB_1858184, HPA056875: " "unprognostic (4.96e-2)" "unprognostic (6.88e-2)" "unprognostic (5.05e-2)" "unprognostic (1.36e-3)" "unprognostic (4.91e-2)" "prognostic unfavourable (4.47e-5)" "prognostic unfavourable (8.71e-6)" "unprognostic (2.55e-1)" "unprognostic (5.04e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (2.11e-2)" "unprognostic (1.55e-2)" "unprognostic (3.04e-1)" "unprognostic (1.02e-1)" "prognostic favourable (5.45e-4)" "unprognostic (5.79e-3)" 4.4 17.9 14.9 6.4 56.2 8.7 7.3 4.2 18.1 7.2 7.1 5.3 5.6 5.8 7.1 25.6 7.2 24.9 6.8 6.3 35.3 11.0 11.9 7.9 5.9 8.8 8.6 14.4 13.9 8.2 11.2 10.5 15.1 13.9 7.6 9.3 8.0 6.3 9.0 6.3 5.5 5.6 7.7 5.7 5.8 7.0 53.2 5.6 7.0 8.3 7.2 10.4 8.8 6.3 18.8 26.1 9.5 11.5 8.7 12.3 10.7 32.6 11.5 10.2 21.8 9.5 9.4 23.2 19.0 27.8 23.9 17.4 46.5 12.3 22.4 16.4 14.8 20.7 25.0 41.2 27.8 3.9 11.7 17.7 15.3 32.7 12.1 11.5 10.9 10.1 11.6 33.3 59.9 24.2 20.0 9.3 22.6 21.5 12.1 16.0 12.0 43.9 10.6 10.8 24.2 19.4 18.4 17.6 10.4 26.0 18.1 22.5 13.6 10.1 14.3 31.6 20.8 15.1 28.3 8.0 9.5 18.6 28.8 13.8 12.2 8.3 11.1 9.5 10.4 11.5 11.0 17.3 10.9 11.0 26.1 18.8 12.3 9.7 3.1 8.7 11.2 13.7 12.3 10.7 14.9 56.2 4.2 18.1 35.3 11.0 8.6 14.4 13.9 5.6 TP53INP2 "C20orf110, dJ1181N3.1, DKFZp434B2411, DKFZp434O0827, DOR, FLJ21759, FLJ23500, PINH" ENSG00000078804 "Tumor protein p53 inducible nuclear protein 2" Q8IXH6 20 34704290-34713439 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 142.8" "Cell line enhanced" "Detected in many" "SK-BR-3: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.33e-2)" "unprognostic (2.57e-3)" "unprognostic (1.26e-1)" "unprognostic (3.08e-2)" "unprognostic (2.07e-1)" "unprognostic (1.86e-2)" "unprognostic (1.89e-1)" "unprognostic (3.03e-1)" "unprognostic (1.55e-1)" "unprognostic (6.63e-2)" "unprognostic (1.52e-2)" "unprognostic (2.57e-2)" "prognostic favourable (1.26e-8)" "unprognostic (8.03e-2)" "unprognostic (1.68e-1)" "unprognostic (1.93e-2)" "unprognostic (6.17e-2)" 9.3 13.2 57.8 5.1 82.9 38.9 3.1 10.1 43.7 5.9 19.3 131.9 3.7 9.5 11.1 8.1 31.9 5.9 11.8 36.6 70.5 51.2 13.4 22.3 7.1 2.5 107.3 19.4 3.8 8.3 22.8 5.0 5.1 65.3 16.8 18.9 8.0 5.9 16.1 22.7 2.9 9.9 17.1 142.8 2.6 6.7 9.0 65.3 0.0 10.6 11.8 8.0 9.2 5.0 0.1 0.4 6.2 0.2 0.0 0.1 0.0 0.7 0.9 3.1 4.0 7.2 5.9 1.3 3.0 9.6 4.0 3.4 5.3 0.4 2.3 2.1 6.0 0.6 6.5 1.4 4.5 0.7 0.8 4.3 2.4 5.1 9.3 0.6 3.4 17.5 2.2 3.2 0.4 6.3 1.7 7.8 4.5 1.0 0.4 1.4 0.4 2.3 2.2 2.0 3.7 5.1 2.7 6.8 7.7 2.7 69.2 4.7 5.0 3.1 4.7 11.3 3.9 1.4 1.2 3.1 3.8 1.9 7.2 9.7 3.9 1.2 0.2 1.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.4 0.0 0.0 57.8 82.9 10.1 43.7 70.5 51.2 107.3 19.4 65.3 65.3 TP53TG3 "P53TG3, TP53TG3A" ENSG00000183632 "TP53 target 3" Q9ULZ0 16 32673528-32676732 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.9;placenta: 1.4;testis: 4.3" "Cell line enhanced" "Detected in some" "HEL: 3.3;HMC-1: 1.5;SK-MEL-30: 1.2;U-2 OS: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 TP53TG3C ENSG00000205457 "TP53 target 3C" Q9ULZ0 16 33193659-33196858 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "brain: 3.0;epididymis: 4.3;testis: 3.9" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;REH: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.1 0.1 0.8 0.1 1.3 0.1 0.1 3.0 1.3 0.1 0.1 0.1 0.1 4.3 0.3 0.1 0.1 0.1 0.6 1.3 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.3 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 2.0 0.1 0.1 3.9 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.2 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 TP73 P73 ENSG00000078900 "Tumor protein p73" O15350 1 3652520-3736201 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell line enhanced" "Detected in many" "MOLT-4: 11.2;SCLC-21H: 14.3;U-698: 14.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 25.7" "Cell type enhanced" "Detected in some" "eosinophil: 1.2;memory B-cell: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002514, CAB003022, HPA027314, HPA044516" Enhanced Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "CAB002514: AB_563940, CAB003022: , HPA027314: , HPA044516: " "unprognostic (5.71e-3)" "prognostic favourable (2.98e-4)" "unprognostic (2.71e-1)" "prognostic favourable (1.82e-4)" "unprognostic (5.58e-2)" "prognostic favourable (9.50e-4)" "unprognostic (5.25e-2)" "unprognostic (2.18e-1)" "unprognostic (4.27e-1)" "unprognostic (1.99e-1)" "unprognostic (5.33e-2)" "unprognostic (3.99e-1)" "unprognostic (1.26e-7)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (7.33e-2)" "unprognostic (1.65e-1)" 0.5 0.3 1.1 3.4 2.3 1.0 1.1 25.7 0.4 1.5 0.7 2.4 1.3 0.3 0.4 6.2 4.8 12.8 1.4 0.3 1.9 1.2 0.2 2.1 3.8 2.0 0.5 0.0 2.6 1.5 0.3 0.7 1.7 3.2 3.6 0.4 0.4 5.5 1.4 0.4 11.9 0.5 0.3 0.9 4.2 0.8 9.8 0.3 2.5 0.4 0.8 7.1 0.6 3.9 1.4 0.1 1.2 0.1 0.0 0.6 0.1 1.9 0.1 0.2 6.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.4 3.2 2.0 1.6 0.0 3.3 2.1 0.7 0.0 0.6 6.8 0.1 3.2 1.9 0.0 0.0 2.3 0.0 1.4 0.0 0.1 0.0 4.2 0.0 0.6 1.5 11.2 1.5 0.4 0.1 0.0 9.2 0.1 0.2 2.9 14.3 6.7 0.3 0.0 0.6 8.6 7.0 0.0 2.3 6.1 0.0 4.5 2.7 0.5 14.4 0.4 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.5 1.4 0.4 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.1 2.3 25.7 0.3 1.9 1.2 0.5 0.0 3.2 0.3 TPBGL ENSG00000261594 "Trophoblast glycoprotein like" P0DKB5 11 75240905-75243697 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.2;testis: 10.8" "Cell line enhanced" "Detected in some" "AF22: 4.0;HMC-1: 5.0;SCLC-21H: 5.0;SK-MEL-30: 2.1;WM-115: 2.4" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (1.55e-2)" "unprognostic (4.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.70e-3)" "unprognostic (1.93e-2)" "unprognostic (5.52e-2)" "unprognostic (1.50e-1)" "unprognostic (2.27e-2)" "unprognostic (1.02e-1)" "unprognostic (3.73e-2)" "unprognostic (3.12e-2)" "unprognostic (3.47e-2)" "unprognostic (1.49e-14)" "unprognostic (3.04e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (4.62e-2)" 1.4 6.5 3.7 1.8 14.2 0.6 0.6 0.4 11.0 1.2 0.9 0.0 0.0 0.7 1.5 0.7 0.6 1.2 1.4 0.6 3.4 1.7 0.6 0.5 1.0 1.2 0.9 1.8 0.6 0.9 0.6 0.6 0.6 10.2 0.7 0.8 1.5 0.6 0.8 0.3 0.8 1.0 2.7 0.7 0.7 0.7 10.8 0.8 0.0 0.7 0.0 1.3 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 5.0 0.3 0.8 0.0 2.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 14.2 0.4 11.0 3.4 1.7 0.9 1.8 10.2 0.8 TPH1 "TPH, TPRH" ENSG00000129167 "Tryptophan hydroxylase 1" P17752 11 18017564-18042426 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Serotonin biosynthesis" "Monooxygenase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 4.2;intestine: 16.2;pituitary gland: 5.4;stomach 1: 13.3" "Cell line enhanced" "Detected in many" "HL-60: 4.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "cerebral cortex: 4.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB010767, HPA022483" Approved Uncertain Cytosol Cytosol "CAB010767: AB_261587, HPA022483: AB_1858378" "unprognostic (2.14e-4)" "unprognostic (9.97e-2)" "unprognostic (6.92e-2)" "unprognostic (6.78e-2)" "unprognostic (1.55e-1)" "unprognostic (6.26e-5)" "unprognostic (1.73e-1)" "unprognostic (5.33e-2)" "unprognostic (1.60e-1)" "unprognostic (2.12e-2)" "unprognostic (1.19e-4)" "unprognostic (6.72e-2)" "unprognostic (5.40e-8)" "unprognostic (3.76e-2)" "unprognostic (7.42e-2)" "unprognostic (3.10e-1)" "unprognostic (2.46e-5)" 0.7 0.0 0.7 0.7 0.7 0.6 0.9 0.7 4.2 0.7 7.1 0.7 0.7 8.2 0.7 0.7 0.7 1.5 0.7 0.7 0.7 0.3 0.7 0.7 0.7 0.7 0.7 0.7 1.0 0.7 0.0 5.4 0.7 0.7 1.3 16.2 0.7 0.7 0.7 0.7 1.0 9.1 0.7 0.7 1.0 13.3 0.9 0.7 0.7 0.7 0.7 0.7 0.7 0.7 1.4 0.8 1.5 0.5 0.9 1.6 0.2 0.4 0.1 1.7 1.5 0.1 0.0 0.6 0.6 0.5 0.2 1.1 1.8 0.3 1.4 0.3 0.0 0.6 0.4 1.5 0.7 1.3 3.1 2.2 0.8 3.5 0.0 4.5 1.2 0.0 1.8 0.2 0.6 0.7 0.9 0.8 0.1 0.5 1.0 0.7 0.5 0.3 1.7 0.3 0.0 0.0 1.0 1.3 0.9 0.2 0.4 0.9 0.3 2.9 0.2 0.4 1.3 0.5 1.7 0.2 0.3 1.1 0.2 1.0 1.4 1.5 0.4 0.4 1.6 0.2 0.8 0.5 0.5 0.4 0.1 1.4 0.6 0.6 1.5 0.9 0.5 0.8 0.6 0.2 0.7 0.7 0.7 4.2 0.7 0.3 0.7 0.7 0.7 0.7 TPH2 "FLJ37295, NTPH" ENSG00000139287 "Tryptophan hydroxylase 2" Q8IWU9 12 71938846-72186618 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Serotonin biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 46.2" "Group enriched" "Detected in some" 9 "EFO-21: 2.8;NTERA-2: 3.1;SCLC-21H: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 15 "pons and medulla: 46.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "midbrain: 127.6;pons and medulla: 36.3" "Group enriched" "Detected in some" 10 "midbrain: 95.6;pons and medulla: 91.5" CAB078198 Enhanced "CAB078198: " "unprognostic (1.19e-1)" "unprognostic (6.01e-1)" "unprognostic (3.46e-2)" "unprognostic (2.31e-1)" "unprognostic (5.91e-2)" "unprognostic (2.02e-1)" "unprognostic (5.01e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" 0.1 0.2 0.4 0.3 0.5 0.1 0.1 0.3 4.4 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.2 3.0 1.5 0.1 0.3 0.1 0.1 0.9 0.0 0.1 1.7 0.1 3.2 0.1 46.2 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.3 0.1 0.1 1.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.3 1.4 3.0 1.5 0.9 0.0 46.2 0.0 TPPP "p25, p25alpha, TPPP/p25, TPPP1" ENSG00000171368 "Tubulin polymerization promoting protein" O94811 5 659862-693395 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 77.5" "Cell line enhanced" "Detected in some" "A549: 8.4;AN3-CA: 6.2;SCLC-21H: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.5;NK-cell: 1.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036575, HPA036576" Enhanced Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA036575: AB_10673501, HPA036576: AB_2675200" "unprognostic (3.66e-2)" "unprognostic (3.70e-3)" "unprognostic (9.98e-3)" "unprognostic (7.82e-2)" "unprognostic (2.05e-2)" "unprognostic (3.20e-2)" "unprognostic (2.12e-1)" "unprognostic (3.80e-3)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-3)" "unprognostic (5.48e-2)" "prognostic favourable (5.40e-6)" "unprognostic (4.03e-2)" "unprognostic (2.30e-1)" "unprognostic (2.03e-2)" "unprognostic (3.31e-2)" 3.5 5.8 27.0 1.3 29.6 1.0 2.7 17.0 77.5 2.1 3.2 69.0 0.1 4.6 2.3 1.3 9.0 8.6 2.1 6.0 33.9 23.9 3.2 2.3 8.3 1.0 25.8 25.0 1.8 5.2 2.4 4.4 2.4 30.1 2.4 2.2 0.2 4.8 3.7 6.2 5.6 7.5 3.5 24.7 2.7 3.8 1.6 4.3 0.0 6.0 1.9 1.8 3.4 0.6 0.0 0.2 1.5 0.0 1.0 0.5 0.1 0.3 8.4 0.4 6.2 0.9 0.0 1.1 0.2 0.0 0.0 0.0 0.3 0.9 0.2 0.6 0.0 3.3 3.4 0.0 0.0 1.7 2.9 0.2 3.6 0.2 0.9 0.3 0.4 0.0 0.8 0.0 0.2 0.1 0.1 3.1 0.0 0.3 0.2 0.5 0.2 0.8 0.3 0.1 1.2 0.3 1.1 15.5 1.9 0.9 0.4 4.1 0.8 0.2 0.1 0.2 3.3 0.1 0.2 1.2 0.3 0.0 0.6 0.7 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.2 0.1 0.1 27.0 29.6 17.0 40.8 33.9 23.9 25.8 25.0 30.1 4.3 TPRN "C9orf75, DFNB79, FLJ90254" ENSG00000176058 Taperin Q4KMQ1 9 137191617-137204193 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.8;pancreas: 45.3" "Cell line enhanced" "Detected in many" "MCF7: 28.4;T-47d: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 5 "cerebellum: 40.9" "HPA020899, HPA076667" Approved Approved "Plasma membrane" "Plasma membrane" "HPA020899: AB_1845835, HPA076667: " "unprognostic (5.41e-2)" "prognostic favourable (2.13e-4)" "unprognostic (2.94e-1)" "unprognostic (9.28e-2)" "unprognostic (1.68e-1)" "unprognostic (2.61e-2)" "unprognostic (3.59e-3)" "unprognostic (8.20e-2)" "unprognostic (9.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.89e-2)" "unprognostic (4.77e-2)" "prognostic favourable (5.16e-9)" "unprognostic (1.96e-3)" "unprognostic (6.35e-2)" "unprognostic (1.51e-1)" "unprognostic (5.44e-2)" 3.2 3.8 8.5 5.0 16.8 3.2 3.3 26.1 17.9 3.4 18.5 32.8 2.3 23.6 2.8 1.8 8.2 4.2 4.8 3.6 11.2 7.0 12.1 10.0 5.8 3.0 25.3 7.1 4.7 45.3 2.8 2.7 4.3 11.0 4.4 8.1 13.1 8.7 4.8 5.0 8.0 29.0 2.4 11.9 3.7 10.8 4.7 21.7 0.2 2.5 2.3 3.5 3.8 2.7 1.2 2.3 0.2 2.9 2.9 2.2 0.6 4.6 5.3 1.8 8.1 2.5 2.7 14.4 3.3 2.0 3.3 1.8 17.8 5.7 8.6 4.9 1.6 14.2 3.7 1.8 0.4 5.4 5.2 4.0 8.0 11.6 3.8 6.1 5.2 2.3 3.6 3.0 2.0 2.1 7.2 3.0 1.0 28.4 4.0 13.2 6.4 7.0 12.0 4.3 13.0 7.5 9.8 11.7 4.3 5.0 23.6 5.8 27.4 9.7 2.3 6.2 2.9 9.6 6.9 2.5 4.9 4.4 4.4 5.6 3.4 0.0 2.9 0.2 1.3 2.6 0.4 1.1 1.3 1.8 2.1 1.2 0.6 1.2 0.0 2.9 1.5 2.3 2.2 0.6 8.5 16.8 26.1 17.9 11.2 7.0 25.3 7.1 11.0 21.7 TRAK2 "ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98" ENSG00000115993 "Trafficking kinesin protein 2" O60296 2 201377207-201451579 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 96.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015827, HPA062163" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA015827: AB_1858238, HPA062163: " "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-2)" "unprognostic (4.31e-2)" "unprognostic (2.78e-1)" "unprognostic (1.76e-1)" "unprognostic (2.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.24e-1)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "prognostic favourable (7.42e-5)" "unprognostic (1.48e-1)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "unprognostic (9.82e-3)" 16.9 13.4 20.4 9.9 23.9 28.0 14.5 11.8 19.4 11.3 14.1 31.5 5.4 7.8 9.1 9.4 10.6 8.9 11.5 42.7 25.6 21.8 15.8 9.2 12.9 9.8 43.1 12.2 6.7 9.0 17.2 11.8 15.0 31.0 8.4 15.5 9.6 14.0 10.2 8.4 5.9 9.4 13.1 96.9 10.8 8.0 4.7 23.2 5.6 22.1 7.1 8.6 10.1 18.8 14.6 3.9 4.6 6.4 10.3 11.3 5.3 3.8 5.6 3.7 13.7 25.5 36.8 4.0 14.2 12.5 10.4 12.2 8.2 3.6 2.5 5.8 19.6 3.9 7.8 4.4 17.9 7.2 4.2 5.6 10.2 6.1 14.1 4.3 6.8 19.7 4.4 10.9 8.8 15.2 4.4 10.9 22.1 5.6 3.4 2.6 4.1 11.3 4.4 9.2 3.9 8.9 5.5 6.9 9.0 7.7 6.2 23.9 4.4 4.6 17.7 16.8 6.3 11.5 8.8 6.0 10.3 3.1 14.2 6.9 8.6 1.8 4.7 4.6 7.6 6.4 6.9 8.0 9.6 6.5 3.9 14.6 6.5 7.0 2.6 10.3 5.4 2.2 11.3 5.3 20.4 23.9 11.8 19.4 25.6 21.8 43.1 12.2 31.0 23.2 TREM2 "TREM-2, Trem2a, Trem2b, Trem2c" ENSG00000095970 "Triggering receptor expressed on myeloid cells 2" Q9NZC2 6 41158506-41163186 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.6;brain: 34.8;lung: 24.6" "Group enriched" "Detected in some" 4 "hTCEpi: 36.5;THP-1: 20.2" "Cancer enhanced" "Detected in all" "glioma: 93.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.9" "Group enriched" "Detected in many" 6 "dendritic cells: 4.9;monocytes: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010917, HPA012571" Approved "Intracellular and membrane" 19000 "HPA010917: AB_1080365, HPA012571: AB_1858260" "unprognostic (3.89e-1)" "unprognostic (4.44e-3)" "unprognostic (2.77e-2)" "unprognostic (1.80e-2)" "unprognostic (1.29e-1)" "unprognostic (1.53e-1)" "prognostic unfavourable (4.24e-4)" "unprognostic (4.83e-2)" "unprognostic (1.07e-1)" "unprognostic (8.57e-3)" "unprognostic (1.33e-1)" "unprognostic (2.09e-1)" "unprognostic (3.58e-3)" "unprognostic (8.04e-2)" "unprognostic (1.04e-2)" "unprognostic (3.16e-3)" "unprognostic (1.85e-2)" 35.6 11.8 10.1 3.0 13.4 0.3 8.6 1.6 21.7 5.9 2.9 24.1 0.0 0.9 1.5 2.1 0.6 6.5 8.4 1.7 10.4 9.5 1.0 2.1 24.6 1.7 21.7 5.2 2.7 2.5 2.7 2.9 8.8 13.4 1.8 3.9 2.1 4.4 3.0 0.8 0.4 1.2 3.8 34.8 0.5 2.2 0.8 12.9 0.0 1.6 0.8 0.5 4.2 0.5 0.5 4.9 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.6 36.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.1 10.1 13.4 1.6 8.3 10.4 9.5 21.7 5.2 13.4 12.9 TRH ENSG00000170893 "Thyrotropin releasing hormone" P20396 3 129974305-129977938 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 33.9;cervix, uterine: 23.6;endometrium 1: 17.5" "Cell line enhanced" "Detected in some" "REH: 3.1;T-47d: 2.9" "Cancer enhanced" "Detected in some" "breast cancer: 13.3;endometrial cancer: 10.2" "Group enriched" "Detected in many" 14 "hypothalamus: 33.9;pons and medulla: 33.8" "Group enriched" "Detected in some" 11 "intermediate monocyte: 1.1;non-classical monocyte: 1.0" "Lineage enriched" "Detected in single" 12 "monocytes: 1.1" "Group enriched" "Detected in many" 5 "hypothalamus: 204.6;olfactory region: 182.2" "Low region specificity" "Detected in many" HPA035596 Enhanced "Secreted in other tissues" "HPA035596: " "unprognostic (1.22e-1)" "unprognostic (8.94e-2)" "unprognostic (5.82e-3)" "unprognostic (5.24e-2)" "unprognostic (2.82e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-1)" "unprognostic (4.44e-2)" "unprognostic (3.86e-2)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.95e-1)" "unprognostic (2.57e-2)" "unprognostic (2.82e-2)" 0.3 0.1 0.4 0.2 2.4 2.8 0.9 0.3 1.7 23.6 0.1 0.1 0.6 0.2 17.5 0.1 0.1 2.3 0.1 0.5 2.0 33.9 0.1 0.1 0.6 0.1 0.4 0.8 3.2 0.1 0.1 0.1 0.3 33.8 0.1 0.1 6.3 1.0 0.2 0.2 0.5 0.1 0.4 3.6 0.1 0.1 0.8 0.0 0.8 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.0 0.0 2.9 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 2.4 0.3 1.7 2.0 33.9 0.4 0.8 33.8 0.0 TRHDE "PAP-II, PGPEP2, TRH-DE" ENSG00000072657 "Thyrotropin releasing hormone degrading enzyme" Q9UKU6 12 72087266-72670757 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;pancreas: 19.4" "Cell line enhanced" "Detected in some" "BJ: 20.5;BJ hTERT+: 19.9;EFO-21: 10.7;HBF TERT88: 7.3" "Cancer enhanced" "Detected in some" "renal cancer: 1.9" "Region enhanced" "Detected in many" "cerebellum: 30.3" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" 6200000 "unprognostic (3.56e-2)" "unprognostic (4.06e-3)" "unprognostic (6.01e-2)" "unprognostic (1.44e-6)" "unprognostic (1.77e-1)" "unprognostic (6.37e-2)" "unprognostic (7.79e-2)" "unprognostic (6.96e-2)" "unprognostic (3.99e-2)" "unprognostic (1.48e-1)" "unprognostic (5.14e-4)" "unprognostic (2.40e-1)" "prognostic favourable (1.53e-7)" "unprognostic (2.55e-2)" "unprognostic (2.48e-1)" "unprognostic (8.91e-3)" "unprognostic (2.94e-2)" 6.2 2.2 2.9 1.0 4.7 1.0 7.6 30.3 12.3 10.2 2.4 0.1 2.5 4.8 2.7 1.7 0.9 2.5 2.5 2.2 7.3 2.8 9.9 1.5 3.0 0.6 1.2 5.5 6.5 19.4 0.4 1.6 0.7 1.5 5.5 1.5 1.0 2.4 5.8 0.7 0.8 4.2 1.2 0.9 4.8 1.1 1.7 0.5 0.0 0.5 0.4 1.0 2.8 7.6 0.2 0.0 1.0 0.3 0.3 0.0 0.0 2.4 0.0 0.4 0.0 1.1 0.0 6.6 20.5 19.9 2.0 1.3 0.0 0.0 0.0 10.7 2.9 0.2 3.7 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.9 0.0 0.0 0.0 6.8 4.5 2.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.1 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 2.9 4.7 30.3 12.3 7.3 2.8 1.2 5.5 1.5 0.5 TRHR ENSG00000174417 "Thyrotropin releasing hormone receptor" P34981 8 109086621-109119584 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 1.0;pituitary gland: 3.3;thyroid gland: 1.6" "Cell line enhanced" "Detected in some" "PC-3: 1.6;SH-SY5Y: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055162 Approved "HPA055162: " "unprognostic (1.92e-2)" "unprognostic (8.58e-2)" "unprognostic (1.17e-1)" 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 1.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.2 0.3 0.5 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIL KIAA0644 ENSG00000255690 "TLR4 interactor with leucine rich repeats" Q7L0X0 7 28953358-28958292 "Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.7" "Group enriched" "Detected in some" 5 "AF22: 13.6;SH-SY5Y: 24.7;SK-BR-3: 21.9;T-47d: 9.6" "Cancer enhanced" "Detected in many" "glioma: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.26e-3)" "unprognostic (3.29e-2)" "unprognostic (5.89e-2)" "prognostic unfavourable (3.23e-4)" "unprognostic (2.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-2)" "unprognostic (8.77e-2)" "prognostic unfavourable (8.52e-4)" "unprognostic (4.27e-3)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (2.07e-2)" 3.5 2.9 14.7 0.6 13.2 0.0 5.1 11.2 19.2 2.6 2.2 19.5 0.0 2.4 2.5 2.2 1.9 2.3 1.2 3.0 18.2 6.6 0.7 3.1 0.4 9.1 11.5 1.8 0.4 0.6 0.0 1.3 20.7 2.4 2.3 0.3 9.6 1.8 3.3 0.5 2.7 4.1 17.0 2.9 2.8 0.3 14.4 0.0 2.8 0.2 0.3 2.0 0.0 0.0 0.1 0.1 0.1 0.0 0.7 0.0 0.0 0.0 13.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.2 0.5 24.7 0.0 21.9 0.0 9.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 TRIM17 "RBCC, RNF16, terf" ENSG00000162931 "Tripartite motif containing 17" Q9Y577 1 228407940-228416861 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;testis: 18.3" "Cell line enhanced" "Detected in some" "BEWO: 7.6;HEL: 3.5;NTERA-2: 3.2;SH-SY5Y: 4.0;T-47d: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054908 Uncertain Approved Vesicles Vesicles "HPA054908: " "prognostic favourable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (3.06e-2)" "unprognostic (5.45e-2)" "unprognostic (1.25e-1)" "unprognostic (7.74e-3)" "unprognostic (7.42e-3)" "unprognostic (2.02e-1)" "unprognostic (1.17e-2)" "unprognostic (8.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.04e-1)" "unprognostic (5.96e-4)" "unprognostic (3.88e-1)" "unprognostic (4.88e-2)" "unprognostic (6.33e-2)" "unprognostic (3.64e-1)" 1.3 0.8 14.4 1.5 19.1 1.1 1.9 25.8 11.8 1.5 0.9 0.6 1.7 1.4 3.6 1.7 1.3 3.9 1.7 1.5 8.9 3.4 1.2 0.6 1.7 2.0 0.7 9.2 2.2 1.1 0.8 1.0 1.3 2.7 2.0 0.8 1.9 5.9 3.8 0.8 3.5 1.6 1.1 0.9 5.3 1.4 18.3 4.7 0.0 2.9 0.1 1.2 2.5 1.3 1.7 0.6 0.7 0.3 0.0 1.0 0.1 0.3 0.6 0.4 0.4 0.0 0.0 7.6 0.5 0.0 0.0 0.1 1.7 0.9 0.1 1.9 0.0 1.7 0.0 0.0 0.1 0.3 0.7 3.5 1.0 0.2 1.6 0.1 0.3 0.2 0.2 0.1 0.0 0.0 0.2 0.5 0.1 0.1 0.3 0.0 3.2 0.2 0.1 0.1 0.0 0.0 0.8 0.5 4.0 0.0 0.4 0.0 9.4 0.2 0.0 0.3 1.7 0.3 0.1 0.1 0.0 0.2 0.2 0.1 0.3 0.0 0.3 0.7 0.9 0.1 1.0 0.6 0.2 1.0 0.0 1.7 1.0 0.8 0.2 0.0 0.2 0.6 0.0 0.1 14.4 19.1 25.8 11.8 8.9 3.4 0.7 9.2 2.7 4.7 TRIM2 "CMT2R, KIAA0517, RNF86" ENSG00000109654 "Tripartite motif containing 2" Q9C040 4 153152342-153339320 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.0" "Cell line enhanced" "Detected in many" "AF22: 28.1;NTERA-2: 23.1;RPTEC TERT1: 26.3;SK-MEL-30: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 5.4" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035853, HPA035854" Enhanced Approved Centrosome Centrosome "HPA035853: AB_10669533, HPA035854: AB_10669659" "unprognostic (8.94e-2)" "unprognostic (7.89e-2)" "unprognostic (6.21e-3)" "unprognostic (7.51e-3)" "unprognostic (2.07e-2)" "unprognostic (2.32e-1)" "unprognostic (1.16e-2)" "unprognostic (2.30e-3)" "unprognostic (5.30e-2)" "unprognostic (6.77e-2)" "unprognostic (1.93e-2)" "unprognostic (1.42e-2)" "prognostic favourable (6.58e-14)" "unprognostic (5.89e-2)" "unprognostic (1.17e-2)" "unprognostic (4.19e-2)" "unprognostic (4.13e-2)" 4.2 9.9 28.4 4.4 35.7 0.6 12.2 28.9 56.9 19.6 17.8 67.0 5.9 13.5 9.7 15.1 8.5 12.9 10.3 6.2 38.9 25.3 22.1 6.4 5.9 2.3 39.4 34.6 10.9 8.2 1.0 10.9 2.5 45.3 11.5 19.2 4.6 30.1 11.8 1.8 3.8 14.4 6.6 44.2 8.8 23.5 1.9 44.7 0.0 38.9 0.6 4.3 7.6 5.5 1.9 0.8 0.3 0.6 0.3 5.4 0.7 4.7 0.2 28.1 12.3 10.6 12.2 0.4 6.3 8.6 1.8 2.6 2.7 0.3 0.2 4.0 10.9 4.3 13.1 2.4 1.8 0.1 4.9 0.2 2.9 0.6 12.4 0.2 0.1 7.9 1.4 3.6 2.3 1.6 0.2 0.1 2.2 0.4 1.3 0.0 23.1 5.6 0.8 5.1 0.0 26.3 6.2 9.1 17.9 3.0 11.4 25.2 1.2 0.2 2.4 7.9 2.3 6.1 3.0 0.1 0.0 0.1 11.8 0.1 9.7 0.3 0.6 0.1 0.1 0.0 0.0 1.6 5.4 0.1 0.8 1.9 1.6 1.0 0.2 0.3 0.0 0.1 2.6 0.7 28.4 35.7 28.9 41.1 38.9 25.3 39.4 34.6 45.3 44.7 TRIM3 "BERP, HAC1, RNF22, RNF97" ENSG00000110171 "Tripartite motif containing 3" O75382 11 6448613-6474459 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043396, HPA048233" Enhanced Approved Mitochondria Mitochondria "HPA043396: , HPA048233: " "unprognostic (1.24e-1)" "unprognostic (1.98e-1)" "unprognostic (2.31e-1)" "prognostic favourable (2.20e-4)" "unprognostic (4.01e-2)" "unprognostic (3.88e-2)" "unprognostic (1.61e-3)" "unprognostic (2.84e-1)" "unprognostic (2.24e-1)" "unprognostic (3.91e-1)" "prognostic favourable (5.49e-5)" "unprognostic (2.01e-1)" "prognostic unfavourable (1.07e-5)" "unprognostic (2.51e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (1.93e-1)" 6.9 5.4 9.0 5.8 8.8 1.6 6.2 34.0 17.1 6.3 8.1 9.4 3.4 22.6 8.7 2.6 3.7 5.9 5.3 6.1 6.8 7.0 3.9 3.8 6.2 3.0 8.1 9.6 5.8 5.3 2.8 3.8 5.3 14.3 7.7 6.5 6.1 9.2 7.7 9.3 7.1 19.5 8.9 7.3 4.9 8.6 3.0 7.0 0.7 4.2 2.5 2.1 6.6 5.8 0.5 3.9 1.8 3.0 2.0 1.9 1.5 4.2 7.4 2.9 5.0 5.0 4.9 4.0 6.1 3.7 4.7 5.3 4.4 3.0 2.3 2.2 4.6 3.0 3.0 4.5 1.8 2.8 4.6 0.7 7.4 3.0 3.0 0.2 2.5 4.1 2.2 3.7 1.9 4.7 1.0 2.8 4.6 8.8 0.2 0.5 2.1 6.4 1.4 2.6 2.9 1.1 2.2 3.1 4.8 3.4 33.3 3.9 12.6 0.8 8.0 12.5 5.9 9.1 4.0 3.3 2.0 0.4 6.8 1.0 4.6 0.0 3.0 1.8 1.7 2.9 1.3 0.4 1.4 1.4 3.9 0.5 0.5 1.9 0.0 2.0 0.8 0.8 1.5 1.5 9.0 8.8 34.0 17.1 6.8 7.0 8.1 9.6 14.3 7.0 TRIM41 "MGC1127, RINCK" ENSG00000146063 "Tripartite motif containing 41" Q8WV44 5 181222499-181235809 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.7" "Cell line enhanced" "Detected in all" "HDLM-2: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024204 Approved Supported "Nucleoli,Nuclear bodies" "Nucleoli, Nuclear bodies" "HPA024204: AB_1858299" "unprognostic (1.13e-1)" "unprognostic (7.05e-2)" "unprognostic (1.23e-2)" "unprognostic (7.93e-2)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (9.56e-2)" "unprognostic (7.24e-2)" "unprognostic (8.66e-2)" "unprognostic (6.87e-2)" "unprognostic (2.21e-3)" "unprognostic (2.07e-1)" "unprognostic (5.17e-3)" "unprognostic (2.45e-3)" "unprognostic (1.34e-1)" "prognostic unfavourable (4.22e-4)" "unprognostic (2.68e-2)" 10.0 8.3 25.5 9.4 24.3 9.3 5.4 7.3 17.0 6.9 6.5 19.8 8.8 11.2 6.1 8.3 7.3 8.4 7.0 9.8 26.9 20.4 10.7 7.6 6.9 6.0 37.3 12.5 5.9 12.3 18.8 7.6 7.3 17.0 7.0 4.0 7.8 8.3 8.4 30.0 9.0 9.0 5.3 43.7 7.5 9.5 19.1 18.3 10.6 11.3 7.2 7.2 5.8 5.2 2.2 2.4 3.9 2.3 1.9 4.3 1.4 4.6 12.1 4.5 7.5 5.4 5.4 10.6 6.8 3.7 5.0 4.7 10.2 7.0 7.8 11.1 4.6 8.8 4.7 16.3 2.7 38.5 14.9 8.9 11.9 5.8 5.2 6.5 6.1 4.7 8.4 6.2 2.2 2.8 11.1 9.7 2.8 16.6 9.8 7.3 4.2 5.8 9.3 6.9 10.2 2.9 7.4 7.0 6.6 6.3 7.4 9.5 14.8 7.4 5.9 6.9 4.7 4.1 5.1 21.4 13.5 11.1 7.2 7.7 5.8 0.9 1.4 2.2 2.4 1.1 3.6 1.9 2.5 4.3 1.6 2.2 2.6 3.1 3.9 1.9 2.3 2.4 3.2 1.4 25.5 24.3 7.3 17.0 26.9 20.4 37.3 12.5 17.0 18.3 TRIM43 TRIM43A ENSG00000144015 "Tripartite motif containing 43" Q96BQ3 2 95592018-95599778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.8;stomach 1: 1.5;testis: 2.8" "Cell line enriched" "Detected in single" 5 "U-2 OS: 3.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042223, HPA042772" Uncertain "HPA042223: AB_10962361, HPA042772: AB_10964436" "unprognostic (7.17e-3)" "unprognostic (1.42e-1)" "unprognostic (9.27e-2)" 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.9 0.0 0.0 0.0 0.0 2.8 0.0 0.0 TRIM46 "FLJ23229, TRIFIC" ENSG00000163462 "Tripartite motif containing 46" Q7Z4K8 1 155173787-155184971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4;epididymis: 11.0" "Cell line enhanced" "Detected in many" "SH-SY5Y: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055583 Enhanced "HPA055583: " "unprognostic (1.06e-1)" "unprognostic (5.07e-2)" "unprognostic (2.86e-2)" "prognostic unfavourable (2.61e-7)" "unprognostic (1.75e-1)" "unprognostic (7.26e-2)" "unprognostic (1.59e-2)" "unprognostic (4.65e-2)" "unprognostic (4.09e-1)" "unprognostic (2.88e-2)" "unprognostic (2.18e-3)" "unprognostic (1.24e-1)" "unprognostic (2.29e-12)" "unprognostic (8.58e-2)" "unprognostic (2.45e-1)" "unprognostic (2.70e-1)" "unprognostic (1.72e-2)" 1.3 1.7 6.0 2.4 12.6 1.7 1.7 21.4 15.5 1.7 1.2 6.5 0.0 1.6 3.4 11.0 1.1 2.9 2.0 1.0 7.8 7.4 1.1 0.9 1.7 2.3 5.1 7.3 1.0 2.1 0.8 4.5 1.1 7.4 1.7 1.4 0.5 0.9 3.6 1.0 1.2 1.8 3.9 5.8 1.8 1.6 2.5 3.5 6.7 0.9 0.0 1.7 1.3 0.8 0.4 0.5 1.5 0.4 0.8 3.0 0.6 2.0 2.8 2.1 0.2 0.4 1.8 0.1 2.1 2.2 2.5 3.1 0.0 1.2 0.9 1.5 2.5 2.4 0.0 1.0 0.7 5.0 0.9 1.7 3.0 0.1 1.1 0.5 6.2 1.9 0.5 2.6 0.9 3.8 0.0 4.4 1.3 1.4 3.3 0.3 7.6 3.1 5.1 0.2 1.0 0.6 0.0 5.7 13.1 0.9 0.7 1.5 4.1 4.1 4.5 4.9 1.9 0.3 1.0 4.1 1.6 0.8 5.2 0.8 1.4 1.5 0.1 0.1 1.2 0.4 1.1 0.3 2.1 2.0 0.2 0.4 0.8 1.0 0.8 0.8 0.3 0.5 3.0 0.6 6.0 12.6 21.4 14.2 7.8 7.4 5.1 7.3 7.4 3.5 TRIM59 "Mrf1, RNF104, TRIM57, TSBF1" ENSG00000213186 "Tripartite motif containing 59" Q8IWR1 3 160432445-160485773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6;lymphoid tissue: 24.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017750 Uncertain Approved "Rods & Rings" "Rods & Rings" "HPA017750: AB_1858312" "unprognostic (3.74e-1)" "prognostic favourable (4.36e-4)" "unprognostic (1.76e-1)" "unprognostic (1.03e-1)" "unprognostic (1.10e-1)" "unprognostic (3.02e-1)" "unprognostic (8.00e-4)" "unprognostic (1.88e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "prognostic unfavourable (1.15e-5)" "unprognostic (1.02e-3)" "unprognostic (2.44e-11)" "unprognostic (7.92e-2)" "unprognostic (2.42e-1)" "unprognostic (4.03e-2)" "unprognostic (5.91e-3)" 1.3 1.4 8.0 6.0 19.3 18.6 2.7 2.1 14.5 1.8 3.5 30.6 0.3 3.6 4.1 1.3 6.6 2.8 3.6 1.2 13.4 6.4 2.0 1.6 2.6 13.8 28.3 6.3 2.1 2.4 2.7 2.5 2.6 14.3 2.9 3.5 0.1 2.6 1.6 1.6 6.8 4.0 3.8 14.5 6.3 3.3 10.4 28.4 24.6 2.8 0.3 14.5 6.1 3.1 7.8 4.7 16.1 2.2 8.8 15.2 2.6 8.7 7.0 8.9 0.6 3.6 4.9 11.7 14.0 12.1 17.5 16.8 0.7 15.3 23.5 10.4 10.4 15.1 0.0 5.7 23.0 21.3 8.5 0.8 2.1 0.9 5.0 10.3 1.4 4.1 1.7 8.5 6.0 12.2 11.0 10.0 16.3 9.3 6.2 0.7 23.4 11.7 8.9 7.8 10.5 6.1 2.9 5.8 1.3 3.9 11.7 0.3 13.8 9.6 9.2 1.2 4.1 2.0 1.3 16.7 6.0 5.9 1.5 13.5 1.3 16.1 2.2 3.7 8.3 2.2 9.4 7.8 13.6 11.2 3.2 6.9 9.4 11.1 2.7 8.8 1.0 4.7 15.2 2.6 8.0 19.3 2.1 11.8 13.4 6.4 28.3 6.3 14.3 28.4 TRIM67 TNL ENSG00000119283 "Tripartite motif containing 67" Q6ZTA4 1 231162112-231221556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 14.4" "Cell line enhanced" "Detected in some" "ASC diff: 1.3;HMC-1: 1.6;HSkMC: 1.3;SCLC-21H: 7.0;SH-SY5Y: 1.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "cerebellum: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034776 Uncertain "HPA034776: AB_10603997" "unprognostic (1.56e-3)" "unprognostic (1.54e-1)" "unprognostic (5.20e-2)" "unprognostic (5.39e-3)" "unprognostic (2.95e-1)" "unprognostic (3.82e-2)" "unprognostic (6.02e-2)" "unprognostic (4.63e-3)" "unprognostic (1.84e-2)" "unprognostic (1.74e-1)" "unprognostic (4.93e-10)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (4.25e-2)" "unprognostic (1.53e-1)" "unprognostic (2.30e-2)" "unprognostic (5.10e-3)" 0.3 0.7 1.3 0.2 1.3 0.1 0.1 13.3 14.4 0.2 0.2 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.2 0.3 1.2 1.9 0.2 0.1 0.1 0.2 1.5 0.0 0.2 0.2 0.1 1.9 0.4 1.9 0.1 0.2 1.7 0.2 0.1 0.1 0.4 0.3 0.2 0.9 0.2 0.2 0.5 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 1.6 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.0 7.0 1.9 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 13.3 1.9 1.2 1.9 1.5 0.0 1.9 0.2 TRIM9 "RNF91, SPRING" ENSG00000100505 "Tripartite motif containing 9" Q9C026 14 50975262-51096061 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 61.5" "Cell line enhanced" "Detected in some" "AN3-CA: 19.3;HAP1: 13.7;HDLM-2: 21.0;SCLC-21H: 19.9" "Cancer enriched" "Detected in some" 8 "glioma: 25.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.22e-1)" "unprognostic (6.37e-2)" "unprognostic (1.17e-1)" "unprognostic (1.10e-3)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (2.24e-3)" "unprognostic (7.66e-2)" "unprognostic (1.88e-1)" "unprognostic (3.06e-2)" "unprognostic (2.38e-3)" "unprognostic (1.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.55e-1)" "unprognostic (9.00e-2)" "unprognostic (7.57e-6)" "unprognostic (1.85e-3)" 1.9 3.9 21.5 2.7 20.9 2.2 2.7 49.1 61.5 2.1 2.5 10.3 0.0 1.5 4.8 3.0 1.7 1.5 6.5 1.7 17.4 11.4 1.9 3.6 1.5 1.5 10.8 21.7 2.3 1.9 1.5 5.7 1.6 13.0 2.0 2.4 1.8 3.9 5.2 1.5 1.6 1.7 5.2 7.1 1.6 1.7 2.0 11.5 0.0 1.5 0.0 1.5 2.0 0.9 0.0 0.1 0.8 0.0 0.0 0.4 0.4 0.0 2.2 3.4 19.3 0.0 0.0 1.3 0.0 0.0 0.2 0.5 1.5 0.1 0.2 0.1 0.3 0.0 13.7 0.0 0.5 21.0 2.8 1.0 0.0 0.0 0.0 0.7 0.7 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 4.1 0.5 1.1 2.9 2.4 5.0 0.1 0.0 0.0 19.9 1.5 0.3 0.0 4.2 0.3 0.5 0.0 1.3 0.5 0.0 0.9 0.3 0.0 0.2 5.8 0.5 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.4 21.5 20.9 49.1 28.6 17.4 11.4 10.8 21.7 13.0 11.5 TRMT9B "C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L" ENSG00000250305 "TRNA methyltransferase 9B (putative)" Q9P272 8 12945642-13031503 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 64.7;thyroid gland: 26.5" "Cell line enhanced" "Detected in some" "AF22: 7.0;BJ: 10.0;fHDF/TERT166: 13.4;RPTEC TERT1: 4.7;SCLC-21H: 5.1;U-266/84: 4.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.2" "Group enriched" "Detected in all" 7 "cerebellum: 64.7;pons and medulla: 31.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 77.4" HPA024673 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA024673: AB_1845788" "unprognostic (9.85e-3)" "unprognostic (1.20e-1)" "unprognostic (5.54e-4)" "unprognostic (1.06e-2)" "unprognostic (4.08e-2)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.44e-1)" "unprognostic (1.93e-1)" "unprognostic (8.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.88e-1)" "prognostic favourable (2.77e-7)" "unprognostic (2.22e-1)" "unprognostic (4.63e-2)" "unprognostic (4.27e-3)" "unprognostic (3.34e-2)" 2.1 0.9 2.0 1.1 4.1 1.2 3.5 64.7 6.0 2.0 1.8 6.6 0.8 1.4 1.9 2.5 1.3 2.4 2.7 6.0 6.7 2.9 2.7 1.7 1.7 1.0 2.0 2.8 0.6 1.7 2.3 1.2 7.1 31.5 1.2 2.1 5.8 2.3 1.9 4.4 5.1 1.5 0.9 1.9 1.6 1.5 1.8 1.0 0.0 26.5 1.3 0.7 1.3 0.9 1.0 0.6 2.8 0.6 1.9 0.6 0.0 0.1 0.2 7.0 0.0 0.0 0.0 1.7 10.0 2.3 1.4 0.7 0.1 0.3 0.2 0.5 13.4 0.3 0.1 0.3 1.5 0.1 0.4 0.4 0.4 0.1 0.0 0.2 0.7 0.2 3.5 0.0 0.1 0.0 0.1 0.2 0.3 0.3 0.1 0.2 0.8 0.0 1.1 0.1 0.1 4.7 0.2 5.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.9 1.0 0.1 0.4 4.8 0.1 0.1 0.2 1.8 2.6 0.6 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.2 1.0 0.5 0.6 2.8 1.9 0.3 0.6 0.2 0.0 2.0 4.1 64.7 5.0 6.7 2.9 2.0 2.8 31.5 1.0 TRPC3 ENSG00000138741 "Transient receptor potential cation channel subfamily C member 3" Q13507 4 121879027-121951754 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.3;pituitary gland: 12.0;smooth muscle: 9.4" "Cell line enhanced" "Detected in some" "HEK 293: 3.7;HEL: 5.5;Karpas-707: 5.8;U-2 OS: 3.7;U-251 MG: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (2.39e-1)" "unprognostic (3.12e-2)" "unprognostic (5.57e-2)" "unprognostic (1.93e-2)" "unprognostic (7.12e-3)" "unprognostic (9.80e-2)" "unprognostic (4.80e-3)" "unprognostic (2.38e-1)" "unprognostic (3.26e-1)" "unprognostic (1.06e-1)" "unprognostic (4.33e-3)" "unprognostic (2.67e-3)" "unprognostic (1.39e-1)" "unprognostic (2.23e-1)" "unprognostic (8.42e-3)" 1.4 0.4 1.8 0.7 9.3 0.3 0.5 5.8 7.4 3.3 0.8 1.7 0.8 0.8 1.6 1.2 0.6 1.1 7.3 0.5 1.8 2.3 0.7 0.5 2.9 0.5 2.3 1.9 0.8 0.2 0.6 12.0 4.2 7.3 1.1 0.8 0.3 0.8 2.5 0.6 0.5 1.2 9.4 1.1 1.0 0.9 1.6 3.6 0.0 0.6 0.0 0.4 3.6 2.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.3 1.0 1.5 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.0 0.1 0.0 3.7 5.5 0.1 0.0 0.2 1.5 0.5 0.6 0.0 0.1 0.0 0.0 0.0 5.8 1.2 0.0 1.6 0.0 1.0 0.5 0.0 0.1 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.7 0.0 3.3 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 9.3 5.8 7.4 1.8 2.3 2.3 1.9 7.3 3.6 TRPC5 PPP1R159 ENSG00000072315 "Transient receptor potential cation channel subfamily C member 5" Q9UL62 X 111774315-112082776 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 5.3;liver: 3.2" "Cell line enriched" "Detected in single" 6 "NTERA-2: 6.2" "Group enriched" "Detected in some" 23 "testis cancer: 0.8;thyroid cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "unprognostic (3.29e-2)" "unprognostic (6.15e-2)" "unprognostic (7.32e-2)" "unprognostic (2.60e-3)" "unprognostic (3.68e-2)" "unprognostic (5.69e-2)" "unprognostic (5.09e-2)" "unprognostic (2.78e-2)" 0.0 0.2 0.6 0.0 0.3 0.0 0.0 0.6 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.3 0.4 3.2 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRPC7 ENSG00000069018 "Transient receptor potential cation channel subfamily C member 7" Q9HCX4 5 136213320-136365545 "Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4" "Cell line enhanced" "Detected in some" "EFO-21: 1.7;SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB022592, HPA031126" Uncertain Uncertain "Actin filaments,Focal adhesion sites" "Focal adhesion sites" "Actin filaments" "CAB022592: , HPA031126: AB_10603221" "unprognostic (1.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.89e-5)" "unprognostic (3.26e-1)" "unprognostic (2.75e-1)" "unprognostic (9.99e-2)" "unprognostic (1.77e-1)" "unprognostic (6.78e-2)" 0.0 2.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRPM3 "GON-2, KIAA1616, LTRPC3" ENSG00000083067 "Transient receptor potential cation channel subfamily M member 3" Q9HCF6 9 70529063-71446904 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 36.6;kidney: 28.0;retina: 105.2" "Cell line enriched" "Detected in some" 4 "HAP1: 19.0" "Cancer enhanced" "Detected in single" "renal cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "NK-cell: 2.1" "Lineage enriched" "Detected in single" 16 "NK-cells: 2.1" "Low region specificity" "Detected in all" "HPA072650, HPA074393" Enhanced Approved Vesicles Vesicles "HPA072650: , HPA074393: " "unprognostic (3.74e-1)" "unprognostic (6.30e-2)" "unprognostic (4.79e-2)" "unprognostic (4.81e-2)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-2)" "unprognostic (6.10e-2)" "unprognostic (1.15e-2)" "unprognostic (1.82e-7)" "unprognostic (3.51e-2)" "unprognostic (5.64e-2)" "unprognostic (1.74e-2)" "unprognostic (1.50e-2)" 0.9 1.7 6.0 0.7 4.5 1.1 0.8 36.6 5.1 0.8 0.7 9.6 2.1 1.8 2.4 3.0 0.7 1.3 1.3 1.4 9.4 6.0 28.0 0.9 0.8 0.7 8.3 3.5 5.3 1.5 0.7 6.8 0.8 34.8 1.4 0.7 105.2 0.8 5.0 1.1 0.8 0.7 1.0 8.1 1.1 1.6 5.3 5.9 0.0 2.1 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 1.0 0.1 1.2 2.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 19.0 0.0 0.1 0.0 0.1 0.1 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.1 4.4 0.0 0.0 0.0 1.3 0.1 0.0 0.2 0.0 0.9 0.0 1.3 0.0 0.2 0.0 0.3 0.0 0.0 3.5 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 6.0 4.5 36.6 3.8 9.4 6.0 8.3 3.5 34.8 5.9 TSC22D4 "THG-1, TILZ2" ENSG00000166925 "TSC22 domain family member 4" Q9Y3Q8 7 100463359-100479279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 97.2" "Cell line enhanced" "Detected in all" "NB-4: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006757 Uncertain Approved Cytosol Cytosol "HPA006757: AB_1080403" "unprognostic (2.34e-2)" "unprognostic (3.06e-2)" "prognostic unfavourable (2.66e-4)" "unprognostic (5.77e-2)" "unprognostic (1.69e-1)" "unprognostic (3.06e-1)" "prognostic unfavourable (9.45e-4)" "unprognostic (9.96e-2)" "unprognostic (1.27e-1)" "unprognostic (1.62e-2)" "unprognostic (2.31e-2)" "unprognostic (3.36e-1)" "unprognostic (1.09e-1)" "unprognostic (1.54e-2)" "unprognostic (3.84e-2)" "unprognostic (7.36e-2)" "unprognostic (3.81e-3)" 11.2 11.9 77.8 16.4 83.5 32.4 7.7 17.8 92.4 9.7 9.9 96.1 3.4 12.4 9.1 6.2 10.3 9.9 8.0 10.2 69.5 53.8 8.9 5.1 10.2 18.7 97.2 40.6 11.7 9.7 8.8 7.1 12.2 60.5 11.5 6.2 11.8 49.2 13.0 7.8 17.2 12.5 8.0 89.8 24.0 11.7 8.0 62.3 6.7 5.8 1.7 12.2 8.6 5.7 6.9 7.5 32.2 11.4 10.2 13.8 8.8 12.1 9.2 3.1 10.4 11.2 13.3 5.9 9.2 15.6 8.9 8.3 4.9 7.5 11.0 11.0 7.5 9.5 3.8 8.3 3.2 18.9 7.6 9.8 9.6 4.1 17.8 13.0 26.3 14.9 7.6 10.3 10.3 18.4 21.7 20.3 7.2 22.1 16.3 59.7 4.3 13.1 26.9 2.5 15.2 7.3 6.6 2.7 7.3 12.8 24.6 19.2 6.9 19.2 15.2 12.2 12.4 29.7 6.7 12.8 12.1 7.7 11.2 20.1 14.7 5.0 10.9 15.6 11.7 11.4 9.1 6.9 10.0 10.8 7.2 6.6 9.6 10.0 32.2 10.2 10.8 7.5 13.8 8.8 77.8 83.5 17.8 65.4 69.5 53.8 97.2 40.6 60.5 62.3 TSPAN5 "NET-4, TM4SF9, Tspan-5" ENSG00000168785 "Tetraspanin 5" P62079 4 98470367-98658629 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.5;ovary: 38.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 30 "B-cells: 2.5;NK-cells: 4.5;T-cells: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.29e-1)" "unprognostic (3.47e-1)" "unprognostic (1.17e-1)" "unprognostic (2.00e-3)" "unprognostic (2.65e-1)" "unprognostic (2.44e-3)" "unprognostic (1.41e-2)" "unprognostic (1.54e-2)" "unprognostic (9.27e-2)" "unprognostic (1.79e-1)" "unprognostic (3.30e-3)" "unprognostic (1.90e-1)" "prognostic unfavourable (7.83e-5)" "prognostic unfavourable (8.56e-4)" "unprognostic (2.15e-1)" "unprognostic (3.23e-3)" "unprognostic (1.23e-1)" 1.9 1.5 14.1 3.1 17.1 7.0 12.7 47.5 37.5 11.8 3.8 20.9 2.1 1.6 13.4 23.4 10.4 4.9 4.3 2.9 15.5 10.1 4.4 0.9 3.7 7.4 13.7 13.8 38.2 1.0 0.9 5.7 6.3 17.3 4.7 3.5 8.6 7.9 7.5 2.6 15.3 2.4 13.2 16.7 7.5 7.2 9.7 13.9 5.7 14.8 2.9 7.2 4.9 5.9 2.5 0.1 0.1 0.0 4.5 6.9 1.2 7.6 3.0 3.2 0.2 12.1 36.1 1.1 31.7 34.6 11.4 14.1 2.6 4.1 0.0 0.3 11.2 2.0 2.7 14.7 25.7 9.5 1.5 4.6 0.4 0.1 12.5 2.5 0.2 20.5 0.4 20.9 26.0 18.4 1.8 8.3 27.2 0.2 7.7 0.0 2.0 14.1 2.4 3.0 1.1 0.9 2.2 22.5 4.3 0.5 10.0 0.0 0.3 0.4 18.7 24.0 10.8 8.6 11.0 5.8 8.5 0.0 9.4 6.2 8.2 0.0 0.0 0.0 4.6 0.0 5.0 1.3 6.4 6.4 0.1 2.5 3.2 2.2 0.1 4.5 0.0 0.0 6.9 1.2 14.1 17.1 47.5 24.9 15.5 10.1 13.7 13.8 17.3 13.9 TSPAN7 "A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2" ENSG00000156298 "Tetraspanin 7" P41732 X 38561370-38688920 "CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 131.1" "Cell line enhanced" "Detected in some" "HDLM-2: 13.3;Hep G2: 10.6;MOLT-4: 55.3;SCLC-21H: 31.0;U-266/70: 20.5" "Cancer enhanced" "Detected in all" "glioma: 71.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.9" "Low lineage specificity" "Detected in single" "HPA003140, CAB062566, CAB068245" Enhanced "CAB062566: , CAB068245: , HPA003140: AB_1078454" "unprognostic (1.12e-2)" "unprognostic (1.42e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (3.40e-4)" "unprognostic (5.06e-2)" "unprognostic (3.90e-3)" "unprognostic (3.88e-3)" "unprognostic (1.37e-2)" "unprognostic (1.14e-1)" "unprognostic (2.01e-2)" "prognostic favourable (1.70e-4)" "unprognostic (1.54e-1)" "prognostic favourable (5.48e-7)" "unprognostic (5.65e-3)" "unprognostic (9.53e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-3)" 15.2 28.7 39.6 3.5 83.0 0.8 7.3 83.8 131.1 12.4 18.5 11.5 2.3 7.9 11.6 9.2 7.9 10.5 5.8 17.1 34.5 30.7 15.8 12.0 16.2 8.8 19.4 37.7 5.2 4.4 4.1 11.4 6.6 23.8 5.6 17.3 8.1 3.3 7.4 17.9 4.9 7.8 14.5 11.9 21.3 4.6 1.7 9.5 0.0 11.8 5.4 8.2 8.2 4.2 0.9 0.5 0.3 0.2 0.3 2.9 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.9 0.3 0.0 13.3 2.5 0.0 0.0 10.6 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 55.3 0.0 2.9 0.0 2.7 1.1 0.0 1.4 0.2 31.0 3.2 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.7 0.0 0.2 20.5 5.8 0.0 1.3 0.1 0.4 0.2 0.1 0.0 0.6 0.2 0.7 0.4 1.1 2.9 0.1 0.9 2.1 1.8 0.3 0.3 0.0 0.5 0.0 0.1 39.6 83.0 83.8 86.3 34.5 30.7 19.4 37.7 23.8 9.5 TSPAN9 NET-5 ENSG00000011105 "Tetraspanin 9" O75954 12 3077355-3286564 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.2;heart muscle: 58.5" "Cell line enhanced" "Detected in many" "RH-30: 62.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 58.2" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 125.3" HPA014002 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" 1900000 "Nucleoplasm, Golgi apparatus" Cytosol "HPA014002: AB_2304038" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-2)" "unprognostic (3.53e-2)" "unprognostic (3.11e-2)" "unprognostic (7.30e-2)" "prognostic unfavourable (4.67e-4)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" "unprognostic (1.26e-2)" "unprognostic (1.89e-1)" "unprognostic (6.70e-2)" "unprognostic (1.57e-1)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" 12.7 5.3 2.6 4.0 5.9 0.3 16.2 58.2 11.5 17.6 6.6 3.0 16.1 3.6 20.9 11.2 6.8 8.8 13.8 58.5 2.9 2.7 21.3 25.3 13.6 3.9 2.8 3.3 15.3 6.5 17.4 3.8 27.7 4.5 10.7 2.7 21.8 8.4 17.7 7.1 13.3 5.4 9.5 2.6 8.4 5.6 5.7 2.3 6.0 9.4 9.4 4.3 8.1 13.6 0.0 0.0 0.6 0.1 0.0 1.1 3.6 0.4 3.5 5.9 5.0 4.9 4.6 13.9 6.7 20.3 4.3 5.7 8.1 3.1 0.2 6.7 3.9 0.9 2.3 2.5 2.6 1.0 2.6 9.1 2.7 5.7 13.3 0.0 0.7 5.9 2.1 8.9 4.2 14.8 0.2 0.2 3.8 5.2 0.0 0.2 8.3 1.8 2.7 62.6 0.8 18.1 1.5 10.5 7.1 4.4 11.3 4.3 3.9 0.0 8.7 2.4 7.2 3.8 6.3 0.0 0.0 0.0 6.0 0.1 2.6 0.0 0.1 0.0 1.1 0.1 0.3 0.0 0.2 0.6 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 3.6 2.6 5.9 58.2 11.5 2.9 2.7 2.8 3.3 4.5 2.3 TSPOAP1 "BZRAP1, KIAA0612, PRAX-1, RIM-BP1, RIMBP1" ENSG00000005379 "TSPO associated protein 1" O95153 17 58301228-58328760 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 83.7" "Cell line enhanced" "Detected in some" "HDLM-2: 52.9;HL-60: 19.2;NB-4: 19.6;REH: 39.0;THP-1: 13.6;U-266/70: 13.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 5.4" "Group enriched" "Detected in many" 8 "NK-cells: 2.7;T-cells: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024662, HPA025244" Enhanced "HPA024662: AB_2066340, HPA025244: AB_1845509" "unprognostic (2.03e-2)" "unprognostic (5.32e-2)" "unprognostic (4.60e-2)" "unprognostic (2.23e-1)" "unprognostic (2.24e-1)" "unprognostic (8.23e-4)" "unprognostic (1.24e-1)" "unprognostic (3.03e-3)" "unprognostic (1.03e-1)" "unprognostic (1.05e-1)" "prognostic favourable (9.15e-7)" "unprognostic (1.62e-1)" "unprognostic (7.44e-2)" "unprognostic (1.05e-1)" "unprognostic (1.72e-1)" "unprognostic (3.82e-2)" "unprognostic (1.22e-2)" 2.3 9.7 76.9 5.2 59.1 26.1 6.4 46.5 83.7 8.0 6.7 10.2 0.7 3.4 16.0 6.2 5.2 21.6 5.7 6.1 65.3 13.0 5.9 2.8 8.2 8.1 12.0 47.9 22.0 11.1 13.9 15.9 1.5 18.6 13.5 3.3 1.5 17.9 16.6 7.1 5.0 4.4 6.9 14.3 8.5 7.4 1.1 23.2 10.3 10.0 0.6 4.2 4.8 4.8 0.0 0.0 0.5 0.0 2.7 5.4 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 1.2 1.3 0.3 0.1 0.0 0.0 0.0 52.9 0.4 0.2 0.5 0.0 0.0 19.2 2.0 0.0 0.2 0.0 0.0 0.0 0.6 3.5 0.0 0.0 6.5 19.6 0.3 0.0 39.0 0.0 5.5 0.2 0.0 2.9 2.1 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.5 0.0 0.0 13.8 2.6 3.4 0.0 0.6 0.0 0.5 0.0 0.1 5.4 0.0 2.2 0.0 0.5 1.2 0.0 0.0 0.5 1.2 0.0 2.7 0.0 0.0 0.1 1.0 76.9 59.1 46.5 83.7 65.3 13.0 12.0 47.9 18.6 23.2 TSPYL2 "CDA1, CINAP, CTCL, DENTT, HRIHFB2216, SE20-4, TSPX" ENSG00000184205 "TSPY like 2" Q9H2G4 X 53082367-53088540 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.4" "Cell line enhanced" "Detected in all" "U-2197: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044133 Approved "HPA044133: AB_10965838" "unprognostic (3.29e-2)" "unprognostic (2.68e-3)" "prognostic unfavourable (3.23e-4)" "unprognostic (3.87e-3)" "unprognostic (1.06e-1)" "unprognostic (9.58e-2)" "unprognostic (1.36e-1)" "unprognostic (5.99e-3)" "unprognostic (3.18e-2)" "unprognostic (1.59e-1)" "prognostic favourable (6.74e-8)" "unprognostic (1.29e-1)" "prognostic unfavourable (8.16e-7)" "unprognostic (6.50e-2)" "unprognostic (9.93e-2)" "unprognostic (2.31e-1)" "unprognostic (3.10e-2)" 15.2 34.9 27.9 12.6 91.4 31.8 11.2 49.3 46.6 16.3 14.5 9.6 18.4 5.5 32.5 34.5 12.2 16.5 17.7 14.0 26.2 27.7 7.3 7.6 11.3 17.3 14.1 33.4 68.0 11.7 10.8 46.5 6.3 23.8 24.4 7.1 12.6 8.0 32.9 13.4 10.2 11.0 17.9 8.3 15.9 12.7 40.7 18.2 4.8 17.7 3.7 12.2 15.2 12.4 7.0 12.5 2.8 1.0 6.1 12.7 4.8 1.7 5.6 5.8 23.9 4.5 5.5 8.3 12.2 13.0 8.1 7.9 8.2 3.9 12.9 2.3 6.4 5.1 4.7 4.8 7.4 3.2 10.3 3.2 22.0 10.6 13.2 5.2 4.1 10.6 8.9 10.9 18.6 5.7 2.5 12.1 4.4 7.7 7.4 6.3 8.7 10.5 5.9 7.3 9.4 1.4 9.6 7.1 4.3 9.7 3.6 6.3 5.3 1.6 8.3 3.7 6.2 47.6 2.3 13.1 8.1 12.2 6.2 8.7 7.6 2.8 0.1 1.7 6.6 0.6 8.1 5.3 9.2 5.2 0.1 7.0 12.7 9.0 1.0 6.1 1.0 12.5 6.6 4.8 27.9 91.4 49.3 46.6 26.2 27.7 14.1 33.4 23.8 18.2 TSPYL4 "dJ486I3.2, KIAA0721" ENSG00000187189 "TSPY like 4" Q9UJ04 6 116249961-116254140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044863 Approved "HPA044863: AB_10962578" "unprognostic (5.10e-2)" "unprognostic (2.05e-1)" "unprognostic (1.79e-1)" "unprognostic (1.65e-3)" "unprognostic (1.67e-1)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (1.80e-2)" "unprognostic (3.34e-1)" "unprognostic (7.41e-3)" "prognostic favourable (8.46e-5)" "unprognostic (1.30e-1)" "prognostic favourable (5.13e-7)" "unprognostic (3.34e-3)" "unprognostic (2.57e-1)" "unprognostic (3.61e-1)" "unprognostic (5.38e-2)" 5.3 24.5 24.2 4.8 43.6 6.0 9.6 42.2 51.2 10.3 4.9 12.0 5.4 4.0 14.5 12.6 6.9 14.5 7.2 13.5 23.6 35.5 10.4 4.9 6.9 6.3 18.3 28.7 17.7 8.2 25.6 16.9 7.2 29.2 15.6 5.7 6.3 5.0 13.2 3.0 6.9 4.3 10.7 13.3 7.0 9.4 9.5 14.0 5.8 9.8 1.5 6.0 5.7 8.1 6.5 5.7 5.4 4.9 6.9 8.4 5.8 2.9 1.6 23.3 19.3 9.6 8.3 4.3 11.7 7.9 15.0 9.0 4.5 2.8 2.3 4.4 17.8 6.5 10.0 10.3 22.7 9.7 3.4 4.7 8.1 10.7 7.6 8.8 3.1 8.0 4.9 11.6 5.9 10.1 7.2 8.0 12.4 9.0 17.0 5.5 5.6 3.9 9.8 1.3 2.2 4.5 4.2 27.5 18.5 10.3 4.4 2.0 7.9 4.9 11.6 12.6 10.5 7.1 6.6 3.2 3.7 0.4 5.8 5.9 7.8 0.9 3.6 4.3 6.3 3.5 7.5 4.7 7.6 6.3 3.4 6.5 8.4 5.9 5.4 6.9 4.9 5.7 6.6 5.8 24.2 43.6 42.2 48.7 23.6 35.5 18.3 28.7 29.2 14.0 TTBK1 KIAA1855 ENSG00000146216 "Tau tubulin kinase 1" Q5TCY1 6 43243680-43288259 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.9" "Group enriched" "Detected in some" 9 "SCLC-21H: 20.8;SH-SY5Y: 7.9" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031735, HPA031736" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA031735: , HPA031736: AB_10670294" "unprognostic (1.68e-1)" "unprognostic (7.88e-3)" "unprognostic (7.01e-2)" "unprognostic (1.62e-3)" "unprognostic (2.18e-1)" "unprognostic (2.24e-4)" "unprognostic (2.46e-3)" "unprognostic (3.01e-2)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (3.01e-2)" "unprognostic (2.12e-4)" "unprognostic (7.42e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (2.64e-3)" "unprognostic (3.04e-4)" 1.1 3.9 12.4 1.3 12.9 0.9 1.0 14.9 28.9 1.0 1.4 8.2 0.0 4.6 1.0 1.0 1.0 1.1 1.4 1.3 10.3 7.5 1.7 3.5 1.1 1.2 7.1 12.5 1.0 1.4 1.6 7.7 1.0 9.0 1.3 1.3 0.7 1.0 1.2 1.0 1.0 6.8 1.1 6.2 1.2 1.3 2.3 8.3 0.0 1.0 0.0 1.3 1.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 20.8 7.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 12.4 12.9 14.9 21.7 10.3 7.5 7.1 12.5 9.0 8.3 TTC25 DKFZP434H0115 ENSG00000204815 "Tetratricopeptide repeat domain 25" Q96NG3 17 41930635-41965651 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 7.7;fallopian tube: 24.6;pituitary gland: 10.6;testis: 29.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.9;U-87 MG: 8.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023908 Enhanced "HPA023908: AB_2241243" "unprognostic (3.08e-3)" "unprognostic (4.51e-2)" "unprognostic (6.96e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-1)" "unprognostic (4.57e-2)" "unprognostic (4.11e-2)" "unprognostic (1.41e-1)" "unprognostic (2.05e-1)" "unprognostic (1.05e-1)" "unprognostic (3.31e-4)" "unprognostic (2.95e-2)" "unprognostic (2.99e-2)" "unprognostic (2.10e-2)" "unprognostic (9.21e-3)" "unprognostic (3.76e-1)" "unprognostic (2.71e-1)" 0.3 0.8 2.0 0.1 5.3 2.3 0.7 0.5 4.0 1.5 0.3 3.8 1.5 0.3 2.1 4.1 0.3 24.6 0.7 0.5 2.0 1.5 0.3 2.8 0.6 0.6 2.5 2.9 0.8 4.0 10.6 2.2 7.7 0.7 0.3 2.8 0.3 0.8 0.9 0.3 0.2 0.9 0.6 0.2 0.5 29.6 1.7 0.0 1.8 0.0 0.2 0.4 0.0 0.5 1.8 0.0 0.5 0.0 1.0 0.3 0.1 2.7 3.5 4.6 0.7 0.8 0.5 0.1 1.9 0.8 1.5 0.4 3.2 0.3 1.6 0.7 0.6 0.6 0.4 0.8 0.7 0.6 1.3 0.8 0.1 0.9 0.0 2.0 0.6 0.6 2.5 0.2 0.1 0.1 2.6 0.5 1.8 1.8 0.5 0.8 0.3 0.0 0.1 1.7 4.5 0.3 6.9 5.4 0.0 0.9 3.5 1.9 0.7 0.0 0.2 2.0 1.6 0.9 2.6 2.6 0.2 8.3 0.1 1.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 1.0 0.0 1.1 0.5 1.0 0.2 0.0 0.0 0.0 1.8 0.0 0.3 TTC39B "C9orf52, FLJ33868" ENSG00000155158 "Tetratricopeptide repeat domain 39B" Q5VTQ0 9 15163622-15307360 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.9" "Cell line enhanced" "Detected in many" "HEL: 26.7;RT4: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 2.0;gdT-cell: 4.1;MAIT T-cell: 5.4;memory CD4 T-cell: 5.6;memory CD8 T-cell: 6.3;naive CD4 T-cell: 6.7;naive CD8 T-cell: 4.1;NK-cell: 7.6;T-reg: 4.9" "Group enriched" "Detected in many" 5 "granulocytes: 2.0;NK-cells: 7.6;T-cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063162 Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA063162: " "unprognostic (1.64e-1)" "unprognostic (9.32e-3)" "unprognostic (1.47e-2)" "unprognostic (7.89e-2)" "unprognostic (7.47e-2)" "unprognostic (1.06e-1)" "unprognostic (4.12e-2)" "prognostic favourable (9.64e-6)" "unprognostic (5.99e-2)" "unprognostic (4.77e-2)" "unprognostic (1.59e-1)" "unprognostic (6.89e-2)" "prognostic favourable (4.08e-7)" "unprognostic (3.31e-3)" "unprognostic (2.12e-2)" "unprognostic (5.19e-2)" "unprognostic (1.48e-1)" 7.3 4.9 3.6 7.2 7.9 2.3 7.7 35.9 12.9 8.2 10.5 1.7 1.8 9.0 10.0 4.4 14.2 6.1 11.2 3.0 3.6 5.6 14.6 8.5 8.6 8.9 5.3 6.4 6.6 6.3 3.7 13.5 2.2 20.8 4.6 9.3 3.8 6.3 3.4 3.7 15.1 15.2 6.9 5.9 6.8 8.8 8.5 2.9 1.3 4.7 4.7 9.3 6.2 8.1 1.0 0.6 2.0 0.9 7.6 6.7 3.4 2.5 0.5 0.8 3.8 3.7 6.9 0.8 3.3 6.1 2.7 6.4 0.5 1.0 0.0 0.4 4.1 2.3 0.6 4.1 2.3 2.9 0.5 26.7 1.2 4.8 6.1 0.0 0.6 6.7 3.2 5.5 6.2 3.7 0.1 6.1 6.7 0.8 1.4 0.1 1.0 0.8 0.3 2.0 1.2 5.7 15.2 2.0 0.4 0.8 2.0 0.5 8.5 1.6 2.8 1.5 1.3 2.1 0.9 0.0 0.0 0.0 1.4 0.3 0.7 2.0 0.9 1.2 4.1 0.7 5.4 0.3 5.6 6.3 0.6 1.0 6.7 4.1 0.7 7.6 0.9 0.1 4.9 3.4 3.6 7.9 35.9 12.9 3.6 5.6 5.3 6.4 20.8 2.9 TTC9B FLJ30373 ENSG00000174521 "Tetratricopeptide repeat domain 9B" Q8N6N2 19 40216058-40218399 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 47.9" "Cell line enriched" "Detected in some" 19 "SCLC-21H: 24.5" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042496 Approved "Secreted in brain" "HPA042496: AB_10795506" "unprognostic (2.31e-1)" "unprognostic (1.39e-4)" "unprognostic (5.09e-2)" "unprognostic (5.24e-2)" "unprognostic (8.47e-2)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (7.95e-2)" "unprognostic (2.78e-1)" "unprognostic (1.54e-2)" "unprognostic (3.69e-1)" "unprognostic (8.75e-6)" "unprognostic (1.39e-1)" "unprognostic (8.23e-2)" "unprognostic (1.95e-1)" "unprognostic (5.24e-2)" 1.0 1.8 45.5 1.4 10.3 1.0 1.0 24.6 47.9 1.0 1.2 1.2 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 22.3 14.0 1.0 1.0 1.0 1.0 7.5 9.9 1.0 1.0 1.0 0.0 1.0 7.1 1.0 1.0 0.3 1.0 1.0 1.0 1.0 1.2 1.1 2.5 1.0 1.1 1.1 1.0 0.0 1.0 0.0 1.0 1.0 0.0 0.1 0.5 0.0 1.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 24.5 1.3 0.1 0.0 0.9 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.3 0.0 45.5 10.3 24.6 31.3 22.3 14.0 7.5 9.9 7.1 1.0 TTLL11 "bA244O19.1, C9orf20" ENSG00000175764 "Tubulin tyrosine ligase like 11" Q8NHH1 9 121821928-122093606 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021828 Approved "Intracellular and membrane" "HPA021828: " "unprognostic (2.34e-2)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (5.56e-3)" "unprognostic (7.72e-2)" "unprognostic (1.92e-1)" "unprognostic (1.59e-3)" "unprognostic (2.30e-1)" "unprognostic (1.10e-1)" "unprognostic (3.71e-2)" "unprognostic (5.27e-3)" "unprognostic (3.88e-2)" "unprognostic (3.61e-6)" "unprognostic (1.32e-1)" "unprognostic (2.48e-1)" "unprognostic (5.62e-2)" "unprognostic (3.53e-2)" 4.9 5.8 8.5 3.3 14.4 1.6 4.6 15.7 17.2 5.3 8.3 35.5 4.1 3.4 6.2 4.0 9.0 6.5 4.4 6.4 10.9 6.8 3.8 6.7 4.8 2.9 15.6 10.5 5.7 6.2 7.7 5.2 5.5 17.3 5.9 5.3 2.7 6.0 7.0 26.6 5.0 3.6 11.7 19.9 3.8 4.6 13.4 16.1 1.3 4.5 3.7 3.2 6.4 4.2 2.0 1.5 0.0 1.0 1.7 0.5 0.2 2.7 1.4 4.6 6.2 6.5 7.9 1.8 5.2 6.4 9.1 5.2 4.1 1.6 6.1 1.6 10.6 6.6 7.9 6.2 5.6 4.2 6.4 3.0 6.0 4.2 7.5 5.2 3.4 5.6 9.0 3.6 5.8 3.2 9.0 6.2 3.1 4.2 3.7 4.2 2.4 9.6 3.8 8.0 9.5 4.7 2.2 9.6 4.0 3.1 5.9 3.8 4.6 4.6 3.6 4.3 0.8 7.6 6.8 6.8 8.6 2.6 3.9 5.8 1.2 0.0 1.0 0.0 0.0 0.5 0.1 2.0 0.2 0.0 0.4 0.4 0.2 0.5 0.0 1.7 0.7 1.5 0.1 0.2 8.5 14.4 15.7 17.2 10.9 6.8 15.6 10.5 17.3 16.1 TTLL7 FLJ23033 ENSG00000137941 "Tubulin tyrosine ligase like 7" Q6ZT98 1 83865028-83999150 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Ligase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.8" "Cell line enhanced" "Detected in many" "HDLM-2: 20.5;RH-30: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 32 "basophil: 3.3" "Lineage enriched" "Detected in single" 32 "granulocytes: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052249 Uncertain "HPA052249: " "unprognostic (9.68e-2)" "unprognostic (3.78e-1)" "unprognostic (3.15e-1)" "unprognostic (2.82e-2)" "unprognostic (6.56e-2)" "unprognostic (1.30e-1)" "unprognostic (1.25e-3)" "unprognostic (1.95e-1)" "unprognostic (3.06e-1)" "unprognostic (3.63e-2)" "unprognostic (7.93e-4)" "unprognostic (4.34e-1)" "unprognostic (1.84e-3)" "unprognostic (3.32e-1)" "unprognostic (2.67e-2)" "unprognostic (3.77e-3)" "unprognostic (1.04e-3)" 7.4 3.7 20.6 3.1 33.6 1.4 2.8 12.4 47.8 4.1 4.3 24.7 0.7 3.9 7.0 3.6 6.4 8.0 7.6 5.2 19.4 11.7 2.5 3.1 6.0 1.5 33.1 17.2 2.7 4.9 7.8 11.3 1.4 24.2 10.2 4.9 2.8 5.1 5.8 4.0 1.7 3.9 12.9 24.9 2.0 4.9 8.7 41.3 0.0 3.8 0.5 1.6 6.9 3.1 0.0 0.0 3.3 0.0 0.0 0.1 0.0 2.4 0.1 1.9 3.3 1.7 3.9 0.0 5.3 2.1 1.9 3.6 0.0 0.4 0.0 1.5 4.8 0.0 3.7 1.8 2.9 20.5 2.6 2.9 3.8 0.1 0.9 0.1 0.4 1.2 0.1 2.9 0.1 2.1 0.0 7.7 7.7 0.0 0.0 0.0 1.5 2.6 0.0 16.7 0.0 0.3 1.3 10.6 6.8 2.8 1.6 1.7 2.3 0.1 0.2 2.9 1.2 0.4 5.6 2.6 4.7 0.1 3.9 0.0 4.2 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 33.6 12.4 26.8 19.4 11.7 33.1 17.2 24.2 41.3 TTLL9 "C20orf125, dJ310O13.1" ENSG00000131044 "Tubulin tyrosine ligase like 9" Q3SXZ7 20 31870702-31944963 "Cancer-related genes, Predicted intracellular proteins" Ligase "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.0;epididymis: 8.9;fallopian tube: 9.2;testis: 11.0" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;REH: 2.0" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041772, HPA055676" Uncertain Uncertain Nucleoplasm,Microtubules "Nucleoplasm, Microtubules" "HPA041772: AB_10959904, HPA055676: " "unprognostic (8.77e-2)" "unprognostic (8.19e-3)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (4.63e-1)" "unprognostic (1.53e-3)" "unprognostic (1.80e-1)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.05e-3)" "unprognostic (6.17e-2)" "unprognostic (8.35e-3)" "unprognostic (1.84e-1)" "unprognostic (1.70e-1)" "unprognostic (1.25e-3)" "unprognostic (2.23e-2)" 0.4 0.6 3.4 0.5 8.9 0.4 1.3 1.0 2.8 0.6 0.5 10.9 1.8 0.6 1.1 8.9 0.6 9.2 0.8 0.5 4.8 3.7 0.8 0.5 1.7 0.7 5.2 0.6 1.8 0.4 2.8 2.8 0.7 16.0 0.6 0.5 0.0 0.5 1.8 0.4 0.6 0.4 0.6 4.5 0.5 0.6 11.0 4.0 0.0 2.1 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.3 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.3 0.0 0.4 0.8 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.6 0.3 0.0 0.1 0.5 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 8.9 1.0 2.7 4.8 3.7 5.2 0.6 16.0 4.0 TTR "CTS, CTS1, HsT2651, PALB" ENSG00000118271 Transthyretin P02766 18 31591726-31599021 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" Transport "Hormone, Thyroid hormone" "Amyloidosis, Cancer-related genes, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 1008.0;liver: 680.8;retina: 332.4" "Cell line enhanced" "Detected in some" "CACO-2: 30.7;EFO-21: 10.8;Hep G2: 47.1;U-2 OS: 14.2" "Group enriched" "Detected in many" 28 "liver cancer: 928.2;pancreatic cancer: 666.0" "Region enriched" "Detected in many" 9 "pons and medulla: 1008.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 1513.1;hippocampal formation: 5269.0;pons and medulla: 5831.5;thalamus: 3501.9" "Region enhanced" "Detected in many" "pons and medulla: 1006.9" "CAB002517, HPA002550, CAB062567, CAB073406" Supported Approved "Golgi apparatus" "Secreted to blood" 345350000000 180000000000 "Golgi apparatus" "CAB002517: AB_563965, CAB062567: , CAB073406: , HPA002550: AB_1080419" "unprognostic (6.79e-3)" "unprognostic (3.38e-2)" "unprognostic (4.10e-1)" "unprognostic (1.74e-1)" "unprognostic (1.84e-2)" "unprognostic (8.15e-2)" "unprognostic (3.74e-2)" "unprognostic (9.66e-3)" "unprognostic (8.72e-2)" "unprognostic (1.23e-2)" "unprognostic (8.35e-3)" "unprognostic (5.26e-1)" "unprognostic (3.52e-2)" 0.5 0.4 3.6 0.4 3.0 0.6 0.4 5.8 60.8 0.4 0.6 361.3 0.0 0.9 0.4 0.4 0.4 0.4 3.3 0.4 115.6 4.4 1.0 680.8 0.4 0.4 7.1 0.0 0.4 62.3 1.6 0.5 0.4 1008.0 0.4 0.5 332.4 0.4 0.4 0.4 1.0 0.6 0.4 4.9 0.5 2.0 0.4 0.6 0.0 0.4 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.6 10.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 47.1 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 14.2 0.0 1.0 0.0 0.6 4.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.0 5.8 60.8 115.6 4.4 7.1 0.0 1008.0 0.6 TTYH1 ENSG00000167614 "Tweety family member 1" Q9H313 19 54415219-54436900 "Predicted membrane proteins, Transporters" "Cell adhesion, Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 66.9" "Group enriched" "Detected in some" 4 "AF22: 6.2;AN3-CA: 19.2;U-2 OS: 7.1" "Cancer enriched" "Detected in many" 15 "glioma: 63.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023617, HPA050655" Approved "HPA023617: AB_10600836, HPA050655: " "prognostic favourable (3.64e-4)" "unprognostic (1.71e-1)" "unprognostic (1.24e-2)" "unprognostic (1.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.50e-3)" "unprognostic (8.93e-2)" "unprognostic (1.51e-2)" "unprognostic (5.94e-3)" "unprognostic (1.11e-1)" "unprognostic (3.66e-1)" "unprognostic (1.60e-1)" "unprognostic (0.00e+0)" "unprognostic (2.09e-1)" "unprognostic (1.41e-1)" "unprognostic (4.45e-2)" "unprognostic (1.69e-1)" 2.2 2.7 49.5 2.1 55.4 2.1 2.3 17.9 66.9 2.4 2.3 33.9 0.0 2.4 2.6 2.1 2.2 4.4 2.3 2.3 31.0 23.4 2.1 2.1 2.1 2.1 39.3 24.4 2.2 10.4 2.1 1.9 2.1 19.7 2.5 2.1 1.9 2.8 2.4 3.0 2.2 2.1 2.2 29.7 2.4 2.2 7.4 18.0 0.0 2.1 0.0 2.1 2.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.2 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 49.5 55.4 17.9 42.9 31.0 23.4 39.3 24.4 19.7 18.0 TTYH2 C17orf29 ENSG00000141540 "Tweety family member 2" Q9BSA4 17 74213514-74262020 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 84.1" "Cell line enhanced" "Detected in many" "HSkMC: 11.5;SK-MEL-30: 40.1" "Group enriched" "Detected in all" 6 "glioma: 16.7;melanoma: 20.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 16.6" "Group enriched" "Detected in many" 5 "dendritic cells: 11.5;monocytes: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.19e-1)" "unprognostic (5.08e-1)" "unprognostic (1.58e-3)" "unprognostic (3.51e-4)" "unprognostic (1.59e-1)" "unprognostic (2.44e-1)" "unprognostic (1.67e-2)" "unprognostic (5.90e-2)" "unprognostic (8.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.81e-2)" "unprognostic (2.87e-1)" "prognostic unfavourable (9.74e-5)" "unprognostic (8.98e-3)" "unprognostic (5.70e-3)" "unprognostic (2.50e-3)" "unprognostic (3.51e-3)" 4.6 4.4 20.7 5.8 32.1 2.8 2.9 4.6 63.5 3.8 3.1 84.1 0.0 2.6 4.4 3.4 3.1 4.8 4.5 12.8 31.6 15.9 1.8 1.9 4.3 5.9 59.3 19.0 12.9 4.9 5.4 3.1 8.2 28.7 2.8 2.6 8.5 5.4 3.9 10.5 4.5 3.2 3.6 48.6 8.8 2.3 9.2 45.6 0.7 8.5 2.1 4.8 3.0 2.1 0.2 11.5 0.8 16.6 0.1 3.1 3.8 0.1 0.9 4.6 4.3 0.5 0.6 0.1 0.2 0.0 0.2 0.0 2.9 0.0 2.6 0.6 0.1 7.2 4.5 0.1 0.1 6.0 2.5 2.8 0.1 0.2 3.2 0.3 1.9 11.5 2.3 0.1 0.8 0.1 0.5 1.3 0.1 0.5 1.3 0.2 0.9 7.9 4.3 8.2 4.9 0.1 0.3 1.6 5.6 0.0 2.8 40.1 1.5 0.5 0.1 0.0 2.3 0.0 0.1 0.2 0.1 0.0 0.1 0.8 2.4 0.6 8.0 0.7 1.6 13.9 0.2 0.2 3.1 2.6 9.0 0.2 0.5 1.1 0.8 0.1 16.6 11.5 2.7 3.8 20.7 32.1 4.6 29.8 31.6 15.9 59.3 19.0 28.7 45.6 TUB rd5 ENSG00000166402 "Tubby bipartite transcription factor" P50607 11 8019244-8106112 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Sensory transduction" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4" "Cell line enhanced" "Detected in many" "HEK 293: 17.8;HeLa: 23.9;SCLC-21H: 27.1;SH-SY5Y: 20.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017997, HPA049019" Uncertain Approved "Nucleoli,Centriolar satellite" "Intracellular and membrane" "Centriolar satellite" Nucleoli "HPA017997: AB_1858449, HPA049019: " "unprognostic (2.53e-1)" "unprognostic (7.23e-2)" "unprognostic (1.80e-2)" "unprognostic (4.06e-2)" "unprognostic (9.62e-2)" "unprognostic (1.47e-2)" "unprognostic (1.53e-2)" "unprognostic (2.53e-1)" "unprognostic (9.71e-2)" "unprognostic (5.08e-2)" "prognostic favourable (2.85e-4)" "unprognostic (4.18e-1)" "prognostic favourable (2.35e-5)" "unprognostic (8.37e-3)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (1.39e-2)" 5.0 18.3 18.9 2.8 16.1 0.7 4.5 12.4 36.4 18.2 4.2 6.3 2.8 2.5 24.3 10.7 3.6 20.8 5.5 10.2 20.5 17.9 11.7 1.0 3.4 2.2 25.1 22.6 17.9 5.1 11.0 18.4 4.6 17.7 8.7 2.9 11.3 5.6 9.0 3.1 6.5 2.4 12.0 9.2 2.1 2.4 5.1 9.1 0.5 10.5 2.9 1.3 5.2 8.7 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.8 7.0 8.7 6.5 2.2 0.0 4.7 1.2 5.1 6.7 0.0 0.0 0.0 0.4 6.3 0.0 13.0 1.0 4.5 0.0 17.8 0.0 23.9 2.8 1.0 0.0 0.1 3.4 1.1 2.3 0.0 0.4 0.0 0.0 2.3 0.6 0.0 0.0 4.8 0.0 6.4 0.1 0.0 0.0 0.2 27.1 20.2 3.4 0.0 1.3 0.7 0.1 0.0 2.8 6.8 0.4 2.0 0.0 0.0 0.0 2.4 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.2 1.2 0.0 0.7 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.9 16.1 12.4 36.4 20.5 17.9 25.1 22.6 17.7 9.1 TUBA1A "B-ALPHA-1, FLJ25113, TUBA3" ENSG00000167552 "Tubulin alpha 1a" Q71U36 12 49184796-49189324 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, FDA approved drug targets, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 270.7;smooth muscle: 166.4" "Cell line enhanced" "Detected in many" "AF22: 222.1;SCLC-21H: 149.7" "Cancer enriched" "Detected in all" 9 "glioma: 942.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 151.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008686, HPA039247, HPA043684, HPA063394" Enhanced Enhanced Microtubules Microtubules "CAB008686: AB_1624202, HPA039247: , HPA043684: , HPA063394: " "unprognostic (3.11e-1)" "unprognostic (1.61e-1)" "unprognostic (3.77e-1)" "unprognostic (1.14e-1)" "unprognostic (4.73e-1)" "unprognostic (1.15e-2)" "unprognostic (2.56e-2)" "unprognostic (2.12e-1)" "unprognostic (3.49e-2)" "unprognostic (3.80e-1)" "unprognostic (1.11e-3)" "unprognostic (9.79e-2)" "prognostic unfavourable (2.90e-4)" "unprognostic (1.07e-2)" "unprognostic (4.27e-2)" "unprognostic (1.12e-2)" "unprognostic (1.27e-3)" 27.8 25.5 82.1 29.4 81.3 24.7 35.4 63.2 163.0 40.6 48.8 210.9 6.9 9.9 71.7 34.8 27.7 65.3 37.9 26.3 99.3 118.3 10.3 4.2 39.8 13.4 131.0 50.2 35.7 9.9 16.0 20.6 23.1 165.2 35.1 26.7 16.7 13.6 53.4 5.9 20.0 14.5 166.4 270.7 11.6 18.3 15.7 50.4 19.4 7.4 7.3 10.6 35.1 14.5 14.8 28.9 151.2 69.2 7.5 15.7 38.4 0.2 10.0 222.1 31.6 20.2 48.9 0.8 18.7 24.0 12.3 28.7 0.6 4.0 7.9 23.3 60.5 0.4 26.3 6.8 9.6 6.6 9.0 2.6 2.0 2.2 3.9 4.7 0.2 27.5 2.6 24.2 2.5 72.9 3.1 9.0 65.9 4.4 20.1 3.8 23.4 7.4 16.2 15.9 1.0 55.0 0.9 149.7 81.9 5.2 0.3 7.1 15.7 6.4 62.0 13.2 8.3 1.5 5.4 3.1 8.7 15.9 7.2 7.7 13.1 38.8 23.0 73.1 15.7 48.9 11.5 14.8 13.9 14.3 28.9 14.6 13.6 12.5 151.2 7.5 69.2 9.3 15.2 38.4 82.1 81.3 63.2 126.2 99.3 118.3 131.0 50.2 165.2 50.4 TUBB2A "dJ40E16.7, TUBB, TUBB2" ENSG00000137267 "Tubulin beta 2A class IIa" Q13885 6 3153669-3157526 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 158.3" "Cell line enhanced" "Detected in many" "AF22: 53.3;CACO-2: 53.8;WM-115: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 6.0;monocytes: 2.6;T-cells: 5.5" "Low region specificity" "Detected in all" "CAB015339, HPA043640, HPA046280" Supported Supported Microtubules Microtubules "CAB015339: AB_2210539, HPA043640: , HPA046280: " "unprognostic (2.57e-1)" "unprognostic (9.86e-3)" "unprognostic (5.90e-3)" "unprognostic (7.98e-3)" "unprognostic (4.02e-3)" "unprognostic (1.67e-1)" "unprognostic (1.82e-3)" "unprognostic (7.53e-2)" "unprognostic (1.48e-3)" "unprognostic (9.99e-2)" "unprognostic (1.24e-2)" "unprognostic (1.42e-2)" "prognostic favourable (4.65e-4)" "unprognostic (2.39e-2)" "unprognostic (1.79e-1)" "unprognostic (3.10e-2)" "prognostic unfavourable (1.61e-4)" 19.6 9.1 59.4 8.7 46.9 26.8 7.9 46.5 158.3 5.4 8.7 9.1 1.2 11.1 6.7 13.5 17.2 4.8 10.9 6.1 56.5 76.0 7.7 16.9 4.1 5.4 58.4 43.3 2.6 14.3 1.6 6.9 11.0 78.6 6.1 4.5 4.6 5.8 8.0 7.3 24.7 13.8 17.7 24.3 2.3 17.6 2.9 5.4 0.1 1.9 10.4 4.7 5.4 5.8 6.0 0.9 0.7 2.6 0.6 5.5 1.8 11.4 9.7 53.3 12.0 6.7 7.5 3.1 25.5 9.5 17.5 25.4 53.8 3.9 5.7 15.8 24.1 5.5 18.8 5.8 6.1 27.6 12.5 1.9 2.8 16.2 7.0 0.3 1.9 7.8 6.8 18.3 1.2 8.0 6.8 2.0 15.6 5.1 3.0 0.6 45.6 12.5 2.6 5.0 4.3 5.9 5.9 13.3 12.2 6.4 1.9 36.5 4.1 0.4 16.0 11.8 12.9 25.5 13.7 0.8 0.9 3.8 4.3 1.5 59.5 0.0 1.9 0.0 4.0 2.6 4.4 6.0 3.9 5.5 0.9 1.2 2.1 3.7 0.7 0.6 2.0 0.3 5.3 1.8 59.4 46.9 46.5 89.2 56.5 76.0 58.4 43.3 78.6 5.4 TUBB2B "bA506K6.1, DKFZp566F223, MGC8685" ENSG00000137285 "Tubulin beta 2B class IIb" Q9BVA1 6 3224261-3231730 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 125.4" "Cell line enhanced" "Detected in some" "AF22: 72.9;CACO-2: 53.5;NTERA-2: 35.7;RPMI-8226: 36.6;SCLC-21H: 109.3;SH-SY5Y: 53.1" "Cancer enriched" "Detected in many" 9 "glioma: 216.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 21 "B-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Supported "HPA043640: , HPA046280: " "unprognostic (2.66e-2)" "unprognostic (3.41e-1)" "unprognostic (5.92e-3)" "prognostic unfavourable (1.94e-4)" "unprognostic (6.81e-2)" "unprognostic (3.26e-2)" "unprognostic (9.03e-3)" "unprognostic (8.33e-2)" "unprognostic (1.08e-1)" "unprognostic (2.02e-1)" "unprognostic (3.78e-3)" "unprognostic (3.34e-2)" "unprognostic (2.03e-2)" "unprognostic (6.24e-3)" "unprognostic (6.04e-2)" "unprognostic (3.58e-4)" "unprognostic (2.30e-3)" 3.8 5.9 53.6 5.9 63.1 1.5 4.4 23.2 125.4 4.7 4.6 22.6 0.0 2.8 4.0 29.7 2.5 2.0 3.6 2.1 34.3 48.6 6.6 1.4 1.6 6.0 56.7 18.6 1.5 2.9 1.4 4.8 3.9 36.1 2.1 3.1 2.3 3.6 4.3 4.5 3.0 4.7 5.5 80.5 1.8 3.3 1.7 16.2 0.0 1.6 0.0 4.6 2.1 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 72.9 22.0 0.0 0.0 0.0 0.4 0.8 2.7 5.9 53.5 0.2 0.0 0.7 0.5 0.0 28.4 0.0 1.6 0.0 13.0 0.0 0.0 4.1 0.2 0.0 0.8 0.4 0.0 0.3 0.0 0.0 0.8 0.1 0.7 0.0 0.1 0.0 35.7 2.3 0.0 3.5 36.6 0.3 0.0 109.3 53.1 0.0 0.2 0.3 0.4 0.0 0.0 0.0 12.4 0.6 0.0 7.2 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 53.6 63.1 23.2 39.2 34.3 48.6 56.7 18.6 36.1 16.2 TUBB3 "beta-4, CFEOM3, CFEOM3A, FEOM3" ENSG00000258947 "Tubulin beta 3 class III" Q13509 16 89921392-89938761 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 85.1" "Cell line enhanced" "Detected in many" "A549: 65.2;SCLC-21H: 66.4;SH-SY5Y: 67.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive B-cell: 5.2" "Lineage enriched" "Detected in single" 7 "B-cells: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Approved 250000000 "HPA043640: , HPA046280: " "unprognostic (7.08e-2)" "unprognostic (3.37e-4)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (8.01e-2)" "unprognostic (3.12e-2)" "unprognostic (4.04e-3)" "unprognostic (1.12e-3)" "unprognostic (1.22e-2)" "unprognostic (6.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.38e-2)" "unprognostic (7.57e-2)" "unprognostic (1.27e-3)" "unprognostic (3.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.91e-2)" 5.1 19.4 23.9 8.9 23.3 3.2 1.2 24.1 85.1 2.4 4.1 7.8 0.0 3.6 7.9 1.1 2.2 1.0 7.3 1.8 25.0 66.5 1.1 1.1 1.6 5.7 44.5 15.9 1.1 2.5 1.0 9.9 2.2 60.9 1.6 2.8 5.5 1.9 1.3 1.0 4.1 4.8 9.3 12.9 1.1 2.5 11.2 3.3 0.0 1.0 1.7 4.4 5.3 0.6 5.2 0.7 0.2 0.3 0.0 0.2 0.2 4.5 65.2 24.3 27.6 2.9 28.0 1.0 27.9 4.8 16.9 7.7 8.8 8.4 13.8 14.6 21.1 17.2 23.4 4.1 4.3 3.4 2.3 0.1 5.5 57.7 0.9 0.0 10.8 16.0 1.2 25.8 2.2 13.8 1.4 0.4 19.2 43.4 0.1 4.6 42.6 35.8 0.0 8.5 1.4 20.9 1.3 66.4 67.0 39.2 0.7 19.0 2.1 0.2 17.4 23.1 24.9 30.9 28.2 0.2 2.8 5.2 23.9 1.7 40.8 0.2 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.2 0.0 5.2 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.2 23.9 23.3 24.1 51.0 25.0 66.5 44.5 15.9 60.9 3.3 TUBB4A "beta-5, DYT4, TUBB4" ENSG00000104833 "Tubulin beta 4A class IVa" P04350 19 6494319-6502848 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Dystonia, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 62.6;brain: 197.8" "Cell line enhanced" "Detected in some" "AN3-CA: 35.5;HAP1: 20.4;HEL: 29.8;PC-3: 14.8;REH: 14.7" "Group enriched" "Detected in many" 9 "glioma: 50.1;melanoma: 83.2;testis cancer: 49.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 12 "B-cells: 5.3;T-cells: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010768, HPA043640, HPA046280" Approved Supported Microtubules 360000000 Microtubules "CAB010768: AB_261775, HPA043640: , HPA046280: " "unprognostic (4.05e-1)" "unprognostic (1.97e-1)" "unprognostic (2.72e-1)" "prognostic unfavourable (8.42e-7)" "unprognostic (3.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.11e-1)" "unprognostic (8.08e-2)" "unprognostic (6.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.58e-1)" "unprognostic (2.06e-1)" "unprognostic (2.30e-1)" 2.3 62.6 41.3 2.9 52.4 2.2 2.3 115.3 197.8 2.2 2.9 115.2 0.0 2.7 2.3 2.3 2.5 2.3 2.4 2.3 56.8 36.9 2.8 2.2 2.3 2.6 73.7 34.5 2.6 2.8 2.1 0.2 2.5 72.0 2.2 2.5 2.7 2.7 2.3 3.9 4.6 3.2 2.5 73.2 4.8 2.2 31.3 43.0 0.0 2.1 0.0 2.4 2.3 0.1 5.3 0.1 0.2 0.0 0.4 6.5 1.6 0.0 10.5 0.0 35.5 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.1 0.0 10.4 0.0 0.3 20.4 0.0 0.2 0.0 3.4 29.8 0.7 0.3 0.0 0.0 1.9 0.0 0.0 0.8 0.0 0.0 2.8 0.2 0.0 1.0 5.9 1.3 2.6 14.8 14.7 0.0 7.0 3.8 0.0 0.1 11.8 0.1 0.1 10.4 0.3 0.7 0.0 0.0 4.4 0.0 0.1 0.8 0.5 4.0 0.4 0.0 0.2 0.0 0.0 0.0 6.3 0.0 4.6 5.3 1.0 6.5 0.0 1.6 2.2 4.7 0.2 0.4 0.0 0.1 0.0 1.6 41.3 52.4 115.3 79.7 56.8 36.9 73.7 34.5 72.0 43.0 TUBG2 ENSG00000037042 "Tubulin gamma 2" Q9NRH3 17 42659305-42667006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011495 Approved Supported "Centriolar satellite" "Centriolar satellite" "CAB011495: AB_443396" "unprognostic (2.60e-1)" "unprognostic (5.85e-3)" "unprognostic (6.21e-3)" "unprognostic (5.79e-2)" "unprognostic (1.33e-3)" "unprognostic (5.11e-2)" "prognostic unfavourable (4.68e-5)" "unprognostic (3.53e-2)" "unprognostic (2.20e-2)" "unprognostic (7.88e-3)" "unprognostic (1.82e-3)" "unprognostic (1.46e-1)" "prognostic unfavourable (3.49e-4)" "unprognostic (2.31e-2)" "unprognostic (3.59e-2)" "unprognostic (3.73e-1)" "unprognostic (7.61e-3)" 15.4 17.7 32.9 5.8 34.5 2.8 10.3 21.7 55.7 13.3 9.6 24.2 5.5 5.8 13.9 14.2 9.9 14.4 10.2 17.2 34.5 24.3 12.6 5.2 10.9 6.6 25.7 29.2 20.7 29.9 17.6 14.2 8.7 30.4 13.5 5.4 11.7 15.7 22.5 6.6 11.2 5.3 13.5 19.4 9.1 9.5 8.3 20.8 1.0 13.0 3.1 5.2 12.2 9.7 2.1 7.1 0.5 1.4 1.4 5.9 2.7 5.0 10.5 5.1 7.7 20.2 11.2 3.3 9.0 10.1 7.3 7.2 5.8 3.7 2.5 5.4 12.9 18.9 0.1 8.2 5.9 4.9 6.0 1.8 13.3 11.5 8.8 0.2 6.8 12.3 8.7 8.4 9.0 5.2 0.5 5.6 13.8 10.5 4.8 4.3 1.8 2.7 3.7 3.2 5.6 7.6 5.2 5.9 4.1 5.7 9.2 5.9 17.6 2.4 5.8 23.2 1.6 5.8 5.1 29.4 5.2 0.8 8.1 0.2 13.5 0.0 1.4 0.3 5.0 0.9 2.3 2.1 5.4 1.9 1.5 0.9 5.9 3.9 0.5 1.4 0.3 7.1 2.4 2.7 32.9 34.5 21.7 55.7 34.5 24.3 25.7 29.2 30.4 20.8 TUNAR "HI-LNC78, LINC00617, TUNA" ENSG00000250366 "TCL1 upstream neural differentiation-associated RNA" 14 95876392-95925571 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 28.7" "Group enriched" "Detected in some" 4 "AF22: 4.8;EFO-21: 2.8;NTERA-2: 10.0;SCLC-21H: 10.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (1.28e-3)" "unprognostic (3.94e-1)" "unprognostic (4.10e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-2)" "unprognostic (1.34e-1)" "prognostic favourable (1.55e-4)" "unprognostic (5.33e-2)" "unprognostic (2.92e-2)" "unprognostic (1.18e-1)" 0.2 0.2 0.9 0.2 18.6 0.5 0.4 1.2 8.8 0.4 0.3 1.3 0.0 0.5 3.7 0.2 0.2 5.1 0.5 0.3 6.0 0.3 0.2 0.2 0.4 0.0 3.7 0.2 6.1 0.2 0.0 0.3 28.7 0.2 0.4 0.7 0.2 3.4 0.2 0.7 0.2 0.3 1.3 0.2 0.3 1.1 6.8 0.0 0.9 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 1.6 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 10.0 0.0 0.4 0.0 0.0 0.2 0.0 10.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 TVP23A "FAM18A, YDR084C" ENSG00000166676 "Trans-golgi network vesicle protein 23 homolog A" A6NH52 16 10760919-10818794 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.3" "Cell line enhanced" "Detected in some" "NTERA-2: 3.5;SH-SY5Y: 6.0" "Cancer enhanced" "Detected in some" "glioma: 2.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060582 Uncertain Approved Vesicles Vesicles "HPA060582: " "unprognostic (6.70e-4)" "unprognostic (1.64e-3)" "unprognostic (2.38e-2)" "unprognostic (8.24e-3)" "unprognostic (2.72e-2)" "unprognostic (4.39e-5)" "unprognostic (4.96e-2)" "unprognostic (4.68e-2)" "unprognostic (4.42e-2)" "unprognostic (9.22e-2)" "unprognostic (1.73e-2)" "unprognostic (2.42e-1)" "unprognostic (8.78e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.87e-2)" "unprognostic (2.87e-4)" 1.9 4.3 10.1 3.3 11.0 5.5 1.1 5.6 13.3 1.7 1.4 2.3 1.6 2.4 2.4 2.3 1.2 2.3 3.2 2.5 9.4 8.0 1.3 1.5 2.3 6.1 6.6 11.8 8.7 2.0 0.5 3.6 0.8 5.7 4.6 1.4 3.1 2.1 3.7 1.9 2.5 2.6 2.8 2.9 3.2 2.1 2.8 3.1 1.3 1.5 0.0 2.6 2.4 1.4 1.6 3.8 0.8 0.8 0.5 0.8 0.4 0.3 0.8 0.9 1.0 0.0 0.3 0.7 0.2 0.0 0.0 0.1 0.2 0.7 1.3 0.4 0.2 1.1 0.0 0.0 0.0 2.7 0.6 0.4 1.7 1.2 0.0 0.3 1.5 0.4 0.0 0.4 0.0 0.0 0.4 1.2 0.0 0.8 0.8 1.1 3.5 0.1 1.9 0.3 0.3 0.1 1.3 0.5 6.0 0.2 0.6 0.1 0.6 0.5 0.9 1.0 0.8 1.1 0.5 3.2 0.5 0.8 0.9 1.1 0.5 0.6 0.8 0.2 0.6 0.6 0.4 0.9 0.8 0.2 3.8 1.6 0.4 0.4 0.8 0.5 0.6 0.8 0.2 0.4 10.1 11.0 5.6 13.3 9.4 8.0 6.6 11.8 5.7 3.1 TYRO3 "Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif" ENSG00000092445 "TYRO3 protein tyrosine kinase" Q06418 15 41557675-41583586 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.2;ovary: 48.2" "Cell line enhanced" "Detected in many" "BEWO: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071245 Approved 6400000 "HPA071245: " "unprognostic (1.26e-1)" "unprognostic (6.34e-2)" "unprognostic (1.47e-1)" "unprognostic (2.68e-1)" "unprognostic (3.29e-1)" "unprognostic (6.77e-2)" "unprognostic (1.56e-3)" "unprognostic (5.41e-2)" "unprognostic (3.72e-1)" "unprognostic (3.21e-1)" "unprognostic (2.69e-1)" "unprognostic (1.37e-1)" "unprognostic (1.92e-10)" "unprognostic (7.59e-2)" "unprognostic (5.22e-1)" "unprognostic (4.04e-3)" "unprognostic (1.84e-2)" 18.3 4.1 18.7 2.1 16.6 1.5 7.7 27.3 39.2 2.3 1.8 25.6 1.2 2.3 5.0 4.2 12.7 11.7 3.1 2.5 15.1 7.8 6.4 1.6 3.2 1.9 19.6 18.2 48.2 9.5 1.3 0.8 5.9 14.0 3.3 1.7 1.7 2.4 6.7 1.4 13.0 2.9 4.8 23.1 5.4 3.6 17.9 16.6 0.0 1.8 2.2 4.1 2.9 2.8 1.2 1.0 5.0 0.9 1.0 0.8 0.2 4.7 3.1 9.9 10.8 9.3 6.4 33.5 6.9 4.4 6.9 6.4 17.6 1.6 0.1 8.9 5.6 11.2 11.1 1.7 3.2 2.7 7.4 1.4 10.0 8.3 6.6 2.4 0.2 2.0 3.5 5.2 1.8 5.1 8.7 2.0 3.7 4.5 1.1 0.4 22.9 3.2 14.7 9.0 1.7 0.6 9.2 11.9 3.4 6.5 10.3 7.7 8.5 2.8 3.9 13.7 6.0 10.1 10.4 0.8 1.6 1.4 8.3 15.8 8.2 2.6 0.9 0.8 0.6 0.5 0.6 0.7 0.6 0.8 0.3 1.2 0.7 0.7 5.0 1.0 0.5 1.0 0.5 0.2 18.7 16.6 27.3 32.7 15.1 7.8 19.6 18.2 14.0 16.6 UBASH3B "KIAA1959, STS-1, TULA-2, TULA2" ENSG00000154127 "Ubiquitin associated and SH3 domain containing B" Q8TF42 11 122655675-122814473 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.5;lymphoid tissue: 27.7" "Cell line enhanced" "Detected in many" "HEL: 41.7;HMC-1: 31.7;hTEC/SVTERT24-B: 25.9;REH: 24.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 32.5;pons and medulla: 21.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038605, HPA038607" Approved Approved "Plasma membrane" 2200000 "Plasma membrane" "HPA038605: AB_10669648, HPA038607: " "unprognostic (4.94e-2)" "unprognostic (6.03e-3)" "unprognostic (1.34e-1)" "unprognostic (2.98e-1)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.09e-2)" "unprognostic (4.67e-3)" "unprognostic (1.21e-1)" "unprognostic (1.95e-1)" "unprognostic (1.46e-3)" "unprognostic (6.20e-2)" "unprognostic (9.02e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (2.72e-3)" "unprognostic (1.53e-1)" 4.3 1.3 2.8 5.5 4.0 7.2 1.5 32.5 4.9 4.0 1.5 0.7 0.0 1.7 1.3 0.3 1.8 1.1 2.4 1.3 3.4 3.5 1.5 1.7 5.5 10.9 5.1 1.9 0.8 1.2 0.6 0.9 16.8 21.2 1.3 1.8 0.9 1.3 0.9 1.8 4.1 2.4 2.3 2.1 27.7 1.7 2.1 0.2 23.9 2.9 1.7 3.8 3.4 1.3 1.0 1.7 9.8 11.0 6.5 4.9 1.8 4.4 10.9 2.0 2.6 0.8 1.6 10.3 15.8 8.8 6.4 5.0 4.3 2.4 1.8 1.2 8.4 2.2 0.0 5.6 10.3 0.0 0.3 41.7 0.3 3.6 2.4 5.0 31.7 1.4 0.3 25.9 9.6 4.3 0.0 0.0 6.2 0.1 6.1 3.2 0.8 2.6 24.9 1.2 0.2 10.2 3.8 4.5 0.1 4.2 0.3 3.5 0.0 1.3 11.2 8.4 4.5 4.9 6.5 0.3 0.0 5.3 4.4 7.1 15.2 0.0 1.3 9.8 2.0 6.5 2.2 0.3 2.6 1.8 1.7 1.0 3.0 1.6 2.8 6.5 11.0 0.2 4.9 1.8 2.8 4.0 32.5 4.9 3.4 3.5 5.1 1.9 21.2 0.2 UBE2QL1 FLJ25076 ENSG00000215218 "Ubiquitin conjugating enzyme E2 Q family like 1" A1L167 5 6448623-6494909 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3" "Cell line enhanced" "Detected in some" "Karpas-707: 17.8;PC-3: 14.9;SCLC-21H: 13.9;U-266/70: 33.3;U-266/84: 29.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "eosinophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057414 Supported "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA057414: " "unprognostic (1.45e-2)" "unprognostic (1.58e-2)" "unprognostic (1.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-2)" "unprognostic (7.43e-2)" "unprognostic (1.15e-2)" "unprognostic (1.36e-1)" "unprognostic (3.10e-1)" "unprognostic (7.16e-2)" "unprognostic (2.15e-3)" "unprognostic (8.41e-2)" "prognostic favourable (6.81e-8)" "unprognostic (3.18e-3)" "unprognostic (2.81e-1)" "unprognostic (1.27e-2)" "unprognostic (1.41e-2)" 0.6 2.3 8.6 0.8 4.2 0.3 0.9 20.7 28.1 1.0 1.8 1.0 0.5 0.7 1.4 1.8 1.0 0.5 0.8 11.3 12.6 8.2 2.6 1.1 0.4 0.7 5.2 4.6 3.6 0.8 0.3 1.3 0.3 8.7 3.1 0.8 8.2 1.0 8.6 21.3 2.4 1.0 1.3 1.4 0.4 2.2 0.9 0.0 0.0 1.9 2.0 0.5 0.5 0.9 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.8 0.0 3.0 0.0 0.0 0.2 14.9 0.1 0.0 6.6 0.0 0.0 13.9 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 33.3 29.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 4.2 20.7 19.4 12.6 8.2 5.2 4.6 8.7 0.0 UCHL1 "PARK5, PGP9.5, Uch-L1" ENSG00000154277 "Ubiquitin C-terminal hydrolase L1" P09936 4 41256413-41268455 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 225.8" "Cell line enhanced" "Detected in many" "EFO-21: 97.1;SCLC-21H: 96.9;U-251 MG: 88.7;U-266/84: 85.5;U-87 MG: 94.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 3.6" "Lineage enriched" "Detected in single" 37 "B-cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002580, HPA005993, CAB079024" Enhanced Supported Supported Nucleoplasm,Cytosol 440000 Cytosol Nucleoplasm "CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560" "unprognostic (1.54e-1)" "unprognostic (1.96e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (4.08e-5)" "unprognostic (2.34e-1)" "unprognostic (1.98e-1)" "unprognostic (6.28e-3)" "unprognostic (1.09e-2)" "unprognostic (4.31e-2)" "unprognostic (8.77e-3)" "unprognostic (3.56e-3)" "unprognostic (3.70e-2)" "unprognostic (1.82e-3)" "unprognostic (1.24e-2)" "unprognostic (7.12e-3)" "unprognostic (2.10e-2)" "prognostic unfavourable (1.93e-4)" 8.2 40.2 52.4 8.9 65.1 2.0 3.1 17.5 225.8 4.5 6.3 11.5 0.0 5.5 6.0 1.8 2.7 5.7 6.5 5.4 53.4 97.4 14.0 2.0 2.7 6.5 62.0 57.1 15.4 6.3 1.8 30.5 2.7 100.6 5.3 4.7 6.0 3.0 4.4 7.5 2.7 8.6 5.2 38.6 2.3 2.8 8.0 8.3 0.0 3.9 0.0 4.5 5.6 2.8 3.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 55.0 11.4 0.0 1.5 1.9 0.0 57.6 29.7 20.4 20.6 11.1 0.0 0.0 97.1 29.3 0.1 21.0 0.0 8.3 0.1 8.6 0.0 0.3 0.0 44.0 0.0 0.0 10.6 0.2 16.3 0.0 0.1 0.0 0.2 10.8 0.0 0.0 0.9 32.9 62.2 0.0 24.4 0.0 30.8 0.0 96.9 60.9 0.3 0.2 0.1 0.0 0.4 0.3 1.3 0.4 0.0 88.7 45.5 85.5 0.2 94.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 52.4 65.1 17.5 92.6 53.4 97.4 62.0 57.1 100.6 8.3 UCMA C10orf49 ENSG00000165623 "Upper zone of growth plate and cartilage matrix associated" Q8WVF2 10 13221767-13234334 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 6.2;heart muscle: 3.2;ovary: 5.4;pituitary gland: 2.4" "Cell line enhanced" "Detected in single" "THP-1: 3.5" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Group enriched" "Detected in some" 6 "amygdala: 6.2;basal ganglia: 3.7;cerebral cortex: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046718 Uncertain "Secreted to extracellular matrix" "HPA046718: " "unprognostic (4.25e-1)" 0.0 0.0 6.2 0.2 3.7 0.0 0.0 0.2 6.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 3.2 0.7 0.2 0.0 0.1 0.5 0.0 0.1 0.9 5.4 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 3.7 0.2 6.1 0.7 0.2 0.1 0.9 0.0 0.0 UGT8 CGT ENSG00000174607 "UDP glycosyltransferase 8" Q16880 4 114598455-114678224 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 96.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.3;RH-30: 12.1;RPTEC TERT1: 25.0;SCLC-21H: 14.2;U-87 MG: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 7.3;naive B-cell: 10.6" "Lineage enriched" "Detected in single" 12 "B-cells: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014405, HPA065785" Enhanced Approved Mitochondria Mitochondria "HPA014405: AB_1858606, HPA065785: " "unprognostic (7.38e-3)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (2.38e-1)" "unprognostic (1.63e-1)" "unprognostic (1.63e-2)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-3)" "unprognostic (4.49e-2)" "unprognostic (2.76e-1)" "prognostic favourable (8.55e-5)" "unprognostic (2.80e-1)" "unprognostic (1.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.49e-1)" 0.9 0.8 13.2 2.8 30.0 1.0 3.1 2.7 44.8 4.9 15.5 66.6 0.0 18.4 2.7 0.6 1.2 3.0 7.1 0.9 24.2 12.4 20.1 0.8 1.0 3.2 53.9 15.9 0.8 4.8 0.3 0.9 0.5 38.3 0.9 17.3 0.0 4.5 0.8 0.8 1.8 16.1 1.5 96.6 1.3 10.0 3.3 42.6 0.0 8.5 0.0 3.4 0.8 1.0 10.6 0.0 0.9 0.0 0.0 0.6 0.3 0.3 0.1 2.0 0.3 0.1 0.0 0.3 0.1 0.0 0.0 1.5 6.8 25.3 7.6 0.6 0.1 10.7 0.0 0.0 0.0 0.1 5.3 0.1 11.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 6.4 1.5 0.0 0.1 0.1 0.8 3.0 3.8 0.7 12.1 0.2 25.0 0.3 14.2 2.1 0.1 2.2 0.3 0.4 2.4 0.5 0.5 8.6 0.3 7.9 2.5 0.4 0.2 12.5 0.4 7.8 0.2 0.0 0.9 0.0 0.0 0.6 7.3 0.1 0.0 0.0 10.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.3 13.2 30.0 2.7 24.4 24.2 12.4 53.9 15.9 38.3 42.6 ULBP1 RAET1I ENSG00000111981 "UL16 binding protein 1" Q9BZM6 6 149964007-149973710 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.9;lung: 9.7;testis: 10.5" "Cell line enhanced" "Detected in many" "HAP1: 23.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 13.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA007547, HPA071005" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA007547: AB_1079430, HPA071005: " "unprognostic (8.94e-3)" "unprognostic (2.44e-1)" "unprognostic (2.85e-2)" "unprognostic (2.33e-2)" "unprognostic (3.28e-4)" "unprognostic (6.69e-3)" "unprognostic (5.27e-2)" "unprognostic (2.47e-2)" "unprognostic (5.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.57e-12)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 0.7 0.6 2.0 0.4 0.6 0.5 0.5 13.9 1.5 0.4 0.7 0.2 0.0 0.4 0.5 0.5 0.8 0.9 0.5 1.2 1.5 0.3 1.2 0.9 9.7 0.2 0.3 0.0 1.2 0.4 0.6 0.6 1.3 1.0 0.8 0.4 0.5 1.0 0.2 1.6 0.6 0.3 0.3 1.2 0.3 0.9 10.5 0.2 0.2 3.8 0.6 0.5 0.7 4.9 0.7 0.1 0.9 1.8 0.3 3.5 0.3 2.7 1.3 2.7 1.4 2.7 7.9 2.8 3.7 1.1 1.7 2.9 1.8 3.2 2.8 2.9 12.8 2.7 23.7 4.6 4.4 12.4 3.9 0.2 0.9 0.0 14.0 0.1 1.0 8.6 5.8 11.7 3.1 2.4 2.3 0.0 4.1 3.3 2.9 0.0 1.0 4.3 1.2 2.4 0.4 5.0 2.1 0.9 0.3 5.4 3.4 0.8 2.7 5.5 1.9 1.3 2.3 5.2 3.2 0.4 0.4 2.5 8.2 4.1 3.4 0.1 0.2 0.1 2.4 1.3 3.5 0.7 1.2 2.8 0.1 0.2 0.7 1.2 0.9 0.3 1.8 0.0 1.9 0.3 2.0 0.6 13.9 1.5 1.5 0.3 0.3 0.0 1.0 0.2 UNC13A "KIAA1032, Munc13-1" ENSG00000130477 "Unc-13 homolog A" Q9UPW8 19 17601328-17688365 "Predicted intracellular proteins" "Differentiation, Exocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 48.4;pituitary gland: 16.7" "Cell line enhanced" "Detected in some" "HMC-1: 11.1;NTERA-2: 16.0;SCLC-21H: 26.5;SH-SY5Y: 6.3" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.50e-1)" "unprognostic (2.61e-1)" "unprognostic (1.02e-1)" "unprognostic (4.96e-3)" "unprognostic (1.69e-1)" "unprognostic (3.98e-3)" "unprognostic (2.13e-3)" "unprognostic (2.40e-1)" "unprognostic (2.32e-1)" "unprognostic (1.89e-1)" "unprognostic (4.33e-3)" "unprognostic (1.40e-2)" "unprognostic (8.19e-3)" "unprognostic (1.94e-1)" "unprognostic (4.83e-2)" "unprognostic (2.14e-2)" "unprognostic (2.00e-1)" 1.3 4.9 15.8 1.7 25.3 1.2 1.2 24.6 48.4 1.3 1.4 1.9 0.0 1.5 1.3 1.3 1.2 1.3 1.3 1.1 16.8 7.5 1.3 1.1 1.3 1.5 4.1 16.3 1.3 2.5 1.3 16.7 1.4 8.2 1.2 1.5 1.2 1.2 1.3 1.1 1.2 1.4 1.4 1.9 3.8 2.4 2.1 1.6 0.0 1.2 0.0 1.6 1.2 0.1 0.4 0.3 1.1 0.2 0.2 0.3 0.0 0.0 1.6 1.4 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 1.6 0.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.1 0.0 0.0 0.0 1.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 16.0 0.4 0.4 0.0 0.2 0.0 0.0 26.5 6.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.4 0.2 0.3 1.1 0.2 0.1 0.3 0.0 0.0 15.8 25.3 24.6 35.4 16.8 7.5 4.1 16.3 8.2 1.6 UNC13C "DKFZp547H074, Munc13-3" ENSG00000137766 "Unc-13 homolog C" Q8NB66 15 54012904-54633414 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 19.7;testis: 11.6" "Group enriched" "Detected in some" 9 "Karpas-707: 31.4;U-266/70: 41.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 8 "cerebellum: 419.8" "unprognostic (4.85e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.13e-1)" "unprognostic (1.45e-1)" "unprognostic (6.90e-3)" "unprognostic (1.58e-2)" "unprognostic (9.69e-2)" "unprognostic (2.42e-2)" "unprognostic (1.26e-1)" 0.2 0.4 13.3 0.3 2.6 0.5 0.3 19.7 16.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.7 0.4 3.5 2.6 1.1 0.2 0.2 0.5 8.3 0.9 1.4 0.2 0.1 0.2 0.2 1.5 0.2 0.2 0.5 0.3 0.2 1.5 0.3 0.2 0.2 1.4 0.2 0.3 11.6 1.1 0.2 1.0 0.2 0.6 0.2 0.2 2.2 0.4 1.4 0.4 0.6 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 41.8 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.3 0.3 0.1 0.2 2.2 0.3 0.3 0.0 0.6 0.3 0.4 1.2 0.6 0.2 0.4 0.2 0.3 13.3 2.6 19.7 11.1 3.5 2.6 8.3 0.9 1.5 1.1 UNC5A "KIAA1976, UNC5H1" ENSG00000113763 "Unc-5 netrin receptor A" Q6ZN44 5 176810477-176880898 "Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.9;brain: 35.3" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 43.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.8;eosinophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 2.8" "Group enriched" "Detected in all" 4 "amygdala: 42.5;basal ganglia: 24.9;cerebral cortex: 36.4;hippocampal formation: 44.5;hypothalamus: 19.1" "Low region specificity" "Detected in all" HPA071450 Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA071450: " "unprognostic (5.95e-2)" "unprognostic (1.15e-1)" "unprognostic (4.18e-3)" "prognostic unfavourable (2.23e-4)" "unprognostic (5.26e-2)" "unprognostic (2.23e-1)" "unprognostic (6.66e-3)" "unprognostic (5.06e-3)" "unprognostic (3.52e-1)" "unprognostic (1.36e-1)" "unprognostic (5.07e-1)" "unprognostic (9.95e-2)" "unprognostic (3.77e-5)" "unprognostic (6.39e-2)" "unprognostic (2.89e-1)" "unprognostic (2.27e-1)" "unprognostic (5.17e-2)" 0.9 11.9 10.5 1.1 11.1 1.2 1.4 35.3 30.9 1.1 0.7 0.4 0.0 1.3 0.8 0.9 0.7 1.5 1.0 0.7 7.6 4.6 0.7 0.7 0.9 1.7 1.6 12.6 0.9 3.2 0.6 5.1 0.6 2.1 0.8 0.7 0.3 0.9 0.7 0.6 0.7 0.9 0.8 0.8 0.6 1.2 1.3 0.5 0.0 0.8 0.0 0.7 0.9 0.2 0.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 1.2 5.0 0.0 43.3 1.9 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.3 1.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 10.5 11.1 35.3 22.2 7.6 4.6 1.6 12.6 2.1 0.5 UNC5C ENSG00000182168 "Unc-5 netrin receptor C" O95185 4 95162504-95549206 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.3" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 41.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 6.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" 230000 "unprognostic (1.55e-1)" "unprognostic (2.72e-1)" "unprognostic (1.35e-2)" "unprognostic (8.45e-2)" "unprognostic (3.03e-1)" "unprognostic (3.20e-1)" "unprognostic (3.48e-1)" "unprognostic (3.40e-1)" "unprognostic (3.12e-1)" "unprognostic (1.11e-3)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (2.70e-5)" "unprognostic (1.25e-2)" "unprognostic (1.16e-1)" "unprognostic (1.86e-1)" "unprognostic (3.62e-4)" 3.2 17.4 13.5 2.4 16.2 0.7 3.2 4.7 14.2 4.2 5.9 31.3 1.8 3.0 5.1 4.1 1.9 4.3 4.4 5.8 10.7 7.3 2.9 2.6 5.0 1.5 13.7 10.8 6.2 1.3 1.0 2.6 3.8 19.6 7.2 7.0 6.4 11.4 8.3 0.8 1.0 4.0 5.1 13.1 7.9 4.4 5.3 19.9 0.0 22.7 0.0 1.3 4.7 7.9 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.2 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 2.1 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.1 0.1 6.2 0.0 0.0 0.6 0.0 3.8 0.0 0.0 0.0 0.0 4.4 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 13.5 16.2 4.7 14.2 10.7 7.3 13.7 10.8 19.6 19.9 UNC5D "KIAA1777, Unc5h4" ENSG00000156687 "Unc-5 netrin receptor D" Q6UXZ4 8 35235457-35796550 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.4;intestine: 11.7;pituitary gland: 14.2;prostate: 10.6" "Group enriched" "Detected in some" 4 "HEK 293: 4.1;HeLa: 3.9;NTERA-2: 13.5;SH-SY5Y: 4.8;U-251 MG: 4.1" "Cancer enhanced" "Detected in some" "prostate cancer: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042940 Uncertain "HPA042940: AB_10959525" "unprognostic (7.88e-2)" "unprognostic (1.28e-1)" "unprognostic (1.41e-2)" "unprognostic (2.29e-1)" "unprognostic (7.60e-2)" "unprognostic (1.87e-1)" "unprognostic (8.47e-2)" "unprognostic (3.82e-2)" "unprognostic (2.04e-1)" "unprognostic (4.13e-2)" "unprognostic (1.99e-1)" "unprognostic (4.48e-8)" "unprognostic (1.34e-1)" "unprognostic (9.15e-2)" "unprognostic (4.28e-1)" 0.3 3.9 8.4 0.4 13.5 0.3 0.4 2.8 15.4 5.0 0.9 0.5 0.1 11.7 3.8 0.5 0.4 0.6 0.3 0.3 3.6 9.4 5.0 0.3 0.5 0.3 1.3 8.1 0.3 0.6 0.4 14.2 0.3 4.7 10.6 1.5 3.3 0.4 0.8 0.3 0.4 3.9 2.4 0.8 0.4 0.6 1.6 0.8 0.0 2.1 0.0 0.3 0.3 0.4 0.0 0.0 0.8 0.2 0.3 0.1 0.0 0.0 1.4 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.5 1.4 0.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.3 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 8.4 13.5 2.8 15.4 3.6 9.4 1.3 8.1 4.7 0.8 UNC79 KIAA1409 ENSG00000133958 "Unc-79 homolog, NALCN channel complex subunit" Q9P2D8 14 93333219-93707876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.6;pituitary gland: 18.9" "Group enriched" "Detected in some" 5 "REH: 8.3;SCLC-21H: 6.1;SH-SY5Y: 3.9;U-937: 3.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071881 Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA071881: " "unprognostic (8.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.70e-2)" "unprognostic (6.91e-2)" "unprognostic (1.06e-1)" "unprognostic (7.73e-2)" "unprognostic (2.99e-2)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.73e-3)" "unprognostic (8.03e-3)" "unprognostic (2.87e-1)" "unprognostic (3.39e-2)" "unprognostic (2.66e-2)" "unprognostic (5.57e-2)" "unprognostic (3.03e-2)" "unprognostic (7.47e-2)" 1.1 3.9 7.1 1.0 12.1 0.9 1.0 17.6 14.6 1.0 1.1 4.5 0.0 1.1 1.1 1.1 1.2 2.0 1.1 1.2 6.7 5.8 1.4 1.1 1.0 1.0 3.2 9.1 1.1 5.0 1.4 18.9 1.0 6.8 1.0 1.1 1.3 1.0 1.0 1.6 1.0 1.1 1.2 3.0 0.9 1.9 7.0 3.5 0.0 1.3 0.0 1.0 1.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 8.3 0.0 0.0 0.2 0.2 6.1 3.9 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 7.1 12.1 17.6 14.6 6.7 5.8 3.2 9.1 6.8 3.5 UNC80 "C2orf21, FLJ33496, KIAA1843, UNC-80" ENSG00000144406 "Unc-80 homolog, NALCN channel complex subunit" Q8N2C7 2 209771993-209999300 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 10.0;brain: 27.2;pituitary gland: 20.1;testis: 6.9" "Group enriched" "Detected in some" 5 "AF22: 5.1;SCLC-21H: 8.3;SH-SY5Y: 4.7" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042472, HPA050959" Enhanced Approved "Nuclear bodies,Vesicles" "Nuclear bodies" Vesicles "HPA042472: AB_10965318, HPA050959: " "unprognostic (7.91e-3)" "unprognostic (2.25e-4)" "unprognostic (1.44e-2)" "unprognostic (3.20e-4)" "unprognostic (1.92e-1)" "unprognostic (3.40e-2)" "unprognostic (3.31e-3)" "unprognostic (5.36e-2)" "unprognostic (5.16e-1)" "unprognostic (7.85e-2)" "unprognostic (5.24e-3)" "unprognostic (8.94e-2)" "unprognostic (1.50e-2)" "unprognostic (1.51e-2)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" "unprognostic (7.40e-3)" 0.9 10.0 10.2 0.9 19.3 0.9 0.9 27.2 23.4 1.0 1.0 2.1 0.0 1.0 1.3 1.8 0.9 1.7 3.6 1.0 8.0 7.4 1.0 0.9 1.1 0.8 5.4 13.5 2.1 3.2 1.4 20.1 0.9 14.5 3.2 1.1 3.0 0.9 1.5 0.8 1.2 1.1 1.3 2.2 1.1 1.9 6.9 4.9 0.0 1.5 0.0 0.8 1.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 1.1 0.0 0.0 0.0 8.3 4.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 19.3 27.2 20.2 8.0 7.4 5.4 13.5 14.5 4.9 UNCX Uncx4.1 ENSG00000164853 "UNC homeobox" A6NJT0 7 1232907-1237318 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 44.8" "Cell line enriched" "Detected in some" 20 "NB-4: 46.1" "Not detected" "Not detected" "Region enriched" "Detected in some" 20 "cerebellum: 44.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Region enriched" "Detected in many" 9 "cerebellum: 19.3" HPA063294 Approved Nucleoplasm Nucleoplasm "HPA063294: " "unprognostic (1.15e-1)" "unprognostic (9.71e-2)" 0.1 0.1 0.0 0.2 0.0 0.1 0.1 44.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 3.5 0.1 0.1 0.1 0.9 0.0 0.1 0.1 0.1 0.3 0.1 2.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 1.1 0.9 0.0 2.2 0.5 USH1G "ANKS4A, FLJ33924, Sans" ENSG00000182040 "USH1 protein network component sans" Q495M9 17 74916084-74923256 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9;epididymis: 11.4;esophagus: 11.8" "Cell line enhanced" "Detected in some" "HaCaT: 4.7;hTCEpi: 4.3;K-562: 3.2;MCF7: 5.0;U-2 OS: 2.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.6" "Region enriched" "Detected in single" 20 "cerebellum: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "olfactory region: 12.1" "Low region specificity" "Detected in some" HPA024360 Uncertain "HPA024360: AB_1858660" "unprognostic (2.95e-1)" "unprognostic (6.17e-2)" "unprognostic (6.34e-4)" "unprognostic (2.92e-2)" "unprognostic (8.74e-2)" "unprognostic (1.74e-1)" "unprognostic (5.59e-4)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (8.64e-2)" "unprognostic (1.69e-1)" "unprognostic (2.11e-1)" "unprognostic (3.10e-4)" "unprognostic (1.57e-1)" "unprognostic (8.48e-2)" "unprognostic (2.25e-1)" "unprognostic (3.35e-2)" 0.0 1.4 0.0 0.0 0.4 0.3 0.0 13.9 0.2 1.4 0.0 0.0 1.1 0.3 1.9 11.4 11.8 0.2 0.0 0.1 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 3.6 0.4 0.0 0.0 0.0 0.5 0.1 0.0 1.3 0.9 0.1 0.0 4.2 0.7 1.5 0.0 0.0 0.0 2.6 0.0 0.5 0.0 1.2 0.8 0.5 1.7 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.4 0.1 0.0 0.0 4.7 1.0 0.2 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.1 4.3 0.0 0.0 0.1 3.2 0.4 0.0 5.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.5 0.0 0.7 0.1 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 13.9 0.2 0.7 0.0 0.0 0.0 0.5 0.0 USP11 UHX1 ENSG00000102226 "Ubiquitin specific peptidase 11" P51784 X 47232690-47248328 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 74.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003103, HPA037536" Enhanced Supported Supported Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA003103: AB_10671088, HPA037536: AB_10672904" "unprognostic (1.60e-1)" "unprognostic (2.77e-3)" "unprognostic (5.84e-2)" "prognostic unfavourable (2.95e-4)" "unprognostic (3.08e-2)" "unprognostic (2.02e-1)" "unprognostic (6.11e-3)" "unprognostic (9.21e-2)" "unprognostic (3.18e-2)" "unprognostic (3.52e-1)" "unprognostic (3.29e-3)" "unprognostic (3.74e-2)" "prognostic favourable (4.13e-5)" "unprognostic (3.14e-2)" "unprognostic (9.23e-2)" "unprognostic (9.51e-2)" "unprognostic (7.11e-2)" 11.5 17.3 32.9 11.5 55.0 4.9 9.4 35.7 74.0 17.5 9.1 19.9 5.8 6.0 22.6 12.7 9.7 26.6 12.8 20.6 27.0 44.0 13.6 6.7 12.5 13.8 23.1 47.4 38.2 13.8 28.4 32.3 12.6 27.8 15.7 7.6 17.9 9.3 21.3 13.7 7.8 7.3 19.1 17.0 13.5 9.1 19.2 14.6 19.0 27.2 4.3 14.3 11.0 9.8 21.0 20.6 22.8 8.7 19.8 31.7 16.4 14.3 22.6 38.9 26.5 14.7 9.9 10.8 11.0 17.3 21.9 24.5 21.5 11.8 9.5 8.7 19.8 17.1 31.5 7.7 19.5 14.7 23.9 11.1 17.9 19.1 17.1 12.4 23.2 14.2 3.2 23.1 9.9 8.7 8.3 1.3 17.0 21.8 24.1 13.3 28.9 20.2 27.2 38.1 7.9 10.7 19.8 22.0 37.8 20.1 4.1 11.9 8.5 7.2 9.1 18.5 19.5 26.0 12.5 17.7 11.1 16.6 11.4 15.5 16.4 22.8 3.5 7.4 22.6 7.4 19.9 20.1 10.2 22.1 4.6 21.0 15.4 31.7 2.2 19.8 8.7 20.6 12.7 16.4 32.9 55.0 35.7 74.0 27.0 44.0 23.1 47.4 27.8 14.6 USP17L1 USP17L1P ENSG00000230549 "Ubiquitin specific peptidase 17-like family member 1" Q7RTZ2 8 7332387-7333979 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "brain: 2.1" "Cell line enhanced" "Detected in single" "AN3-CA: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain "HPA045642: " 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L15 ENSG00000223569 "Ubiquitin specific peptidase 17-like family member 15" C9J2P7 4 9234385-9236334 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 1.0;epididymis: 1.0" "Cell line enhanced" "Detected in single" "U-87 MG: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain "HPA045642: " 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.2 1.0 0.0 0.3 0.0 0.1 0.3 0.4 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP54 "bA137L10.3, bA137L10.4, C10orf29, FLJ37318" ENSG00000166348 "Ubiquitin specific peptidase 54" Q70EL1 10 73497538-73625953 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5" "Cell line enhanced" "Detected in many" "PC-3: 24.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047663 Approved Approved Mitochondria Mitochondria "HPA047663: " "unprognostic (2.46e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-2)" "unprognostic (1.89e-2)" "unprognostic (2.48e-2)" "unprognostic (4.89e-3)" "unprognostic (6.63e-4)" "prognostic favourable (7.00e-4)" "unprognostic (6.24e-2)" "unprognostic (4.35e-2)" "unprognostic (8.91e-3)" "unprognostic (3.49e-1)" "unprognostic (1.95e-3)" "unprognostic (8.18e-2)" "unprognostic (6.88e-2)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" 2.9 1.7 12.3 2.5 33.8 0.5 7.7 7.9 21.3 7.9 7.8 43.8 1.8 2.5 4.2 4.5 10.2 7.7 3.1 4.0 14.1 6.8 2.7 1.6 9.0 0.6 49.5 14.2 4.0 6.3 7.1 3.4 1.2 28.6 5.8 11.1 3.4 8.8 3.6 12.0 6.1 2.9 4.0 25.4 1.5 11.3 4.7 42.8 0.4 24.3 1.2 3.6 5.6 4.0 2.4 2.2 1.3 2.4 1.5 3.2 2.3 6.6 6.8 10.6 10.0 2.9 3.4 3.3 3.5 7.0 5.9 6.9 5.7 10.9 5.0 4.2 3.7 9.2 6.8 2.5 7.9 2.4 6.3 3.1 5.0 3.8 2.3 3.4 1.2 2.6 2.4 6.8 6.9 2.7 4.9 0.7 4.1 3.3 3.3 2.2 4.9 24.9 5.0 9.4 1.9 4.2 6.5 3.5 3.3 6.8 8.3 8.0 10.8 3.2 3.7 2.3 6.9 4.5 4.4 1.8 3.3 3.5 5.6 3.2 2.1 0.8 2.3 1.3 1.6 1.9 3.1 2.4 2.7 2.5 1.9 1.0 3.2 1.9 0.1 1.5 2.4 2.2 3.0 2.3 12.3 33.8 7.9 21.3 14.1 6.8 49.5 14.2 28.6 42.8 UTS2 "PRO1068, U-II, UCN2, UII" ENSG00000049247 "Urotensin 2" O95399 1 7843083-7853512 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 25.4;brain: 19.8" "Cell line enhanced" "Detected in some" "CACO-2: 16.4;HEL: 5.7;HMC-1: 4.9;THP-1: 21.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 19 "hypothalamus: 5.2;pons and medulla: 19.8" "Cell type enriched" "Detected in many" 6 "T-reg: 25.4" "Lineage enriched" "Detected in many" 6 "T-cells: 25.4" HPA017000 Uncertain "Secreted to blood" 2591990 "HPA017000: AB_1858656" "unprognostic (2.10e-3)" "unprognostic (1.35e-1)" "unprognostic (3.89e-3)" "unprognostic (1.33e-3)" "unprognostic (2.32e-5)" "unprognostic (1.09e-4)" "unprognostic (4.95e-2)" "unprognostic (6.69e-2)" "unprognostic (1.40e-1)" "unprognostic (2.65e-2)" "unprognostic (1.28e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-5)" "unprognostic (1.75e-1)" "unprognostic (1.44e-1)" "unprognostic (2.47e-1)" "unprognostic (3.30e-3)" 1.0 6.3 0.3 0.6 0.3 5.2 0.3 0.3 0.3 0.5 1.2 0.4 1.2 1.1 0.3 0.3 0.3 0.6 0.9 0.3 0.6 5.2 0.3 0.3 0.6 2.9 0.3 0.3 0.4 0.3 0.0 0.3 0.3 19.8 2.0 2.4 0.3 0.3 0.3 0.3 0.5 1.0 2.3 12.7 2.1 0.2 0.3 0.3 0.6 0.3 0.3 0.3 0.9 0.3 0.0 0.4 4.1 0.0 3.2 25.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.1 0.0 0.3 3.0 0.0 4.0 0.0 2.7 2.8 0.4 0.0 0.2 0.8 0.0 3.2 0.0 0.0 25.4 0.9 0.3 0.3 0.3 0.3 0.6 5.2 0.3 0.3 19.8 0.3 UTS2B "U2B, URP, UTS2D" ENSG00000188958 "Urotensin 2B" Q765I0 3 191267168-191330536 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 19.0" "Cell line enhanced" "Detected in many" "PC-3: 7.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "amygdala: 19.0" "Cell type enhanced" "Detected in some" "memory B-cell: 6.2;naive B-cell: 3.0" "Lineage enriched" "Detected in many" 5 "B-cells: 6.2" HPA026992 Uncertain "Secreted - unknown location" "HPA026992: AB_1858703" "unprognostic (1.73e-2)" "unprognostic (4.38e-2)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (1.92e-1)" "unprognostic (2.17e-2)" "unprognostic (2.77e-2)" "unprognostic (2.14e-2)" "unprognostic (3.09e-1)" "unprognostic (2.63e-2)" "unprognostic (3.39e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (7.58e-2)" "unprognostic (2.08e-1)" "unprognostic (1.29e-1)" "unprognostic (3.10e-2)" 1.1 1.5 19.0 0.7 0.8 0.2 1.6 0.5 2.5 0.6 0.6 0.8 0.5 7.7 1.5 0.5 0.6 1.0 3.0 0.9 1.5 1.2 0.5 4.8 0.6 0.9 0.8 0.5 1.7 4.1 0.0 0.5 0.5 1.0 0.5 0.1 0.5 0.5 0.5 0.5 1.3 4.2 0.5 1.1 1.1 1.9 2.9 0.5 0.5 0.5 0.5 0.8 0.9 0.7 6.2 1.2 0.1 0.1 0.0 0.1 0.1 0.9 2.1 2.9 1.4 0.8 3.8 0.9 2.2 1.2 0.8 0.4 1.5 1.1 1.4 1.1 1.0 1.2 0.9 0.0 3.6 1.4 1.0 1.3 2.9 6.2 0.7 1.6 0.9 1.5 0.4 0.5 0.6 0.8 0.9 1.5 1.1 1.3 0.4 1.2 1.7 7.3 1.8 3.4 0.5 0.4 3.6 1.6 1.1 1.4 1.6 0.8 1.2 1.0 3.0 1.7 0.9 2.8 0.9 2.4 1.3 1.4 2.0 1.1 1.1 0.0 0.0 0.1 0.1 0.0 0.0 6.2 0.1 0.0 0.0 3.0 0.1 0.1 0.1 0.0 0.1 1.2 0.1 0.1 19.0 0.8 0.5 2.5 1.5 1.2 0.8 0.5 1.0 0.5 VAMP1 "SYB1, VAMP-1" ENSG00000139190 "Vesicle associated membrane protein 1" P23763 12 6462237-6470987 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.7;brain: 85.2" "Cell line enriched" "Detected in many" 6 "U-698: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002779, CAB016119, CAB079000" Approved Supported "CAB002779: , CAB016119: AB_628309, CAB079000: " "unprognostic (2.33e-1)" "unprognostic (6.72e-3)" "prognostic unfavourable (6.37e-5)" "unprognostic (8.09e-3)" "unprognostic (2.17e-1)" "unprognostic (1.14e-3)" "prognostic unfavourable (6.97e-4)" "unprognostic (1.22e-2)" "unprognostic (6.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.40e-3)" "unprognostic (3.48e-2)" "prognostic unfavourable (1.04e-11)" "unprognostic (1.47e-2)" "unprognostic (5.99e-2)" "unprognostic (1.62e-1)" "unprognostic (3.65e-2)" 3.4 6.8 10.2 13.7 12.8 38.7 4.2 9.8 53.1 5.7 8.0 11.1 1.6 4.7 8.7 5.4 3.9 5.1 5.2 4.0 14.1 25.4 3.2 4.3 5.3 24.3 33.5 10.0 3.8 2.4 1.1 3.1 2.4 85.2 8.6 8.8 4.8 6.3 7.6 4.0 4.2 7.9 7.7 31.3 12.4 5.4 3.7 8.3 3.7 7.9 0.8 23.0 5.0 4.7 5.5 2.5 13.4 1.0 2.1 7.0 2.5 0.9 3.4 1.8 2.6 5.6 6.4 2.2 1.8 3.4 1.9 5.4 1.1 3.1 9.7 0.4 4.4 2.9 2.3 1.0 2.8 7.6 5.4 1.5 10.2 1.2 2.6 3.7 3.7 4.7 0.4 2.4 1.4 1.7 0.5 2.8 4.2 1.0 4.9 4.3 9.2 1.5 5.4 3.0 1.8 1.2 1.3 0.4 0.8 3.7 1.9 1.4 0.6 1.4 2.0 0.8 2.9 1.9 1.2 2.5 1.0 66.4 3.5 7.8 0.7 6.9 1.0 13.4 6.7 0.4 5.3 5.5 5.5 6.2 1.1 1.3 5.8 4.8 5.5 2.1 0.5 2.5 7.0 2.5 10.2 12.8 9.8 53.1 14.1 25.4 33.5 10.0 85.2 8.3 VAMP2 "SYB2, VAMP-2" ENSG00000220205 "Vesicle associated membrane protein 2" P63027 17 8159149-8163546 "FDA approved drug targets, Predicted membrane proteins, Transporters" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 168.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" CAB078785 Supported "CAB078785: " "unprognostic (8.25e-2)" "unprognostic (4.41e-2)" "unprognostic (1.58e-2)" "prognostic favourable (1.08e-4)" "unprognostic (2.81e-2)" "unprognostic (1.15e-1)" "unprognostic (1.43e-2)" "unprognostic (7.28e-2)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "prognostic favourable (3.83e-6)" "unprognostic (8.27e-2)" "prognostic favourable (9.76e-8)" "unprognostic (1.21e-2)" "unprognostic (7.00e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" 22.0 38.3 65.1 16.2 111.7 57.4 20.2 72.2 168.0 20.1 16.3 51.6 11.6 15.7 27.4 24.1 11.6 26.8 14.4 22.1 61.7 56.5 23.5 11.4 21.0 23.1 52.7 71.1 48.4 22.6 52.2 40.6 15.4 88.4 25.1 19.3 37.5 19.5 27.0 33.6 25.0 17.9 25.2 30.7 27.2 17.4 15.1 35.1 9.2 22.0 8.8 22.8 11.7 16.0 25.1 15.4 37.8 8.8 25.1 33.4 9.3 14.1 10.6 26.5 14.1 23.2 18.2 11.9 13.3 16.9 13.6 18.8 4.2 9.7 16.2 9.5 21.3 17.3 17.3 14.3 15.8 18.7 18.9 11.3 27.3 5.8 20.9 7.5 17.5 20.1 21.6 15.6 23.6 13.2 8.7 18.9 23.0 7.5 19.6 10.4 6.1 7.8 24.9 12.0 12.7 17.6 9.6 12.3 19.6 10.4 5.9 13.0 13.3 9.7 20.2 8.3 11.5 15.1 12.3 20.7 11.7 11.7 21.1 13.1 18.8 13.7 7.4 24.5 28.4 6.9 24.4 25.1 28.2 30.0 5.7 22.1 33.4 30.8 37.8 25.1 8.8 15.4 20.1 9.3 65.1 111.7 72.2 168.0 61.7 56.5 52.7 71.1 88.4 35.1 VAT1L KIAA1576 ENSG00000171724 "Vesicle amine transport 1 like" Q9HCJ6 16 77788530-77980107 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 57.3;brain: 47.1;retina: 32.1" "Cell line enhanced" "Detected in some" "AF22: 9.2;BJ hTERT+: 27.1;fHDF/TERT166: 14.8;NTERA-2: 31.9;U-87 MG: 33.5" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044061, CAB046032, HPA061138" Enhanced Approved Cytosol Cytosol "CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: " "unprognostic (1.49e-2)" "unprognostic (8.74e-3)" "unprognostic (8.80e-3)" "unprognostic (3.39e-2)" "unprognostic (3.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.86e-1)" "unprognostic (7.65e-2)" "unprognostic (8.57e-3)" "unprognostic (2.46e-1)" "prognostic unfavourable (3.01e-6)" "unprognostic (2.50e-2)" "unprognostic (6.53e-2)" "unprognostic (1.19e-1)" "unprognostic (5.96e-2)" 1.1 57.3 7.9 3.0 41.3 1.2 1.0 28.4 20.1 1.3 3.4 5.7 0.0 2.4 1.8 6.3 2.0 1.4 3.8 12.7 3.8 47.1 5.3 1.4 0.9 1.0 8.4 12.7 0.9 2.1 0.6 1.5 2.0 27.2 0.8 5.2 32.1 0.9 1.0 0.6 0.6 3.1 2.6 15.4 0.7 1.7 2.1 5.8 0.0 2.0 0.0 2.4 1.4 0.4 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 3.2 0.0 0.0 1.1 27.1 0.3 0.2 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 31.9 0.0 0.7 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.4 0.0 0.0 7.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 41.3 28.4 9.1 3.8 47.1 8.4 12.7 27.2 5.8 VAX1 ENSG00000148704 "Ventral anterior homeobox 1" Q5SQQ9 10 117128521-117138301 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 21.8" "Group enriched" "Detected in some" 7 "A-431: 7.5;WM-115: 5.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 5.8;hypothalamus: 3.8;olfactory region: 1.8" "Low region specificity" "Detected in many" HPA028946 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA028946: AB_10602679" "unprognostic (1.08e-2)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (2.96e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (2.99e-1)" 0.4 0.4 1.4 0.4 21.8 0.4 0.4 0.0 7.0 0.5 0.5 9.5 0.0 0.4 0.4 0.4 0.5 0.4 0.5 0.4 1.5 5.2 0.4 0.4 0.4 0.4 0.7 4.3 0.4 0.4 0.7 0.5 0.4 1.2 0.4 0.5 0.0 0.4 0.5 0.7 0.4 0.5 0.4 1.3 0.4 0.4 2.1 2.9 0.0 0.4 0.0 0.4 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.5 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 21.8 0.0 7.0 1.5 5.2 0.7 4.3 1.2 2.9 VAX2 DRES93 ENSG00000116035 "Ventral anterior homeobox 2" Q9UIW0 2 70900590-70965373 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.4;retina: 21.2" "Cell line enhanced" "Detected in many" "AN3-CA: 6.5;MCF7: 7.4;RH-30: 6.4;SCLC-21H: 6.4;SH-SY5Y: 7.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basal ganglia: 2.1;hypothalamus: 4.7" HPA009708 Approved "Nuclear speckles" "Nuclear speckles" "HPA009708: " "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.96e-2)" "unprognostic (3.16e-2)" "unprognostic (1.63e-2)" "unprognostic (2.17e-1)" "unprognostic (3.52e-2)" "unprognostic (7.23e-3)" "unprognostic (2.42e-1)" "unprognostic (1.98e-1)" "unprognostic (3.81e-1)" "unprognostic (2.16e-1)" "unprognostic (7.74e-3)" "unprognostic (6.63e-3)" "unprognostic (4.65e-1)" "unprognostic (6.67e-3)" "unprognostic (2.18e-2)" 2.7 2.6 4.4 1.4 1.9 0.4 2.1 16.4 7.9 1.9 0.8 1.1 0.0 0.5 3.6 0.8 1.8 1.1 0.6 1.5 2.5 4.1 0.6 0.3 0.9 0.6 1.4 1.1 2.3 6.9 0.9 2.2 1.2 0.8 2.3 0.6 21.2 4.5 0.6 2.0 1.5 0.5 1.9 1.6 0.4 0.4 0.8 1.0 0.0 0.7 1.2 0.4 1.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 4.9 1.2 6.5 1.8 1.0 3.6 1.2 0.5 0.1 0.0 0.1 0.0 0.0 0.0 2.9 0.3 2.5 0.0 0.2 0.0 4.0 0.0 0.1 2.7 0.8 0.0 0.0 1.8 0.0 0.3 0.0 0.6 0.0 0.0 2.4 7.4 0.0 0.1 2.8 0.1 0.0 6.4 0.0 2.0 1.6 6.4 7.7 5.0 0.0 2.7 2.8 0.2 1.2 3.1 0.7 1.5 1.3 0.0 0.0 0.0 1.5 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.9 16.4 2.7 2.5 4.1 1.4 1.1 0.8 1.0 VGF "SCG7, SgVII" ENSG00000128564 "VGF nerve growth factor inducible" O15240 7 101162509-101165593 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 59.4;pituitary gland: 30.4" "Cell line enhanced" "Detected in some" "SH-SY5Y: 35.9;SK-MEL-30: 96.8;U-2 OS: 17.6;WM-115: 29.0" "Cancer enriched" "Detected in many" 6 "melanoma: 236.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055177, HPA072505" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" 1273770 2800000 "Golgi apparatus, Vesicles" "HPA055177: AB_2682728, HPA072505: AB_2686528" "unprognostic (3.04e-2)" "unprognostic (3.45e-1)" "unprognostic (3.19e-3)" "prognostic unfavourable (4.25e-4)" "prognostic unfavourable (3.31e-4)" "unprognostic (1.51e-2)" "unprognostic (2.86e-2)" "unprognostic (1.66e-3)" "unprognostic (2.25e-2)" "unprognostic (8.77e-2)" "unprognostic (3.84e-3)" "unprognostic (3.70e-3)" "unprognostic (9.82e-3)" "unprognostic (3.79e-1)" "unprognostic (7.23e-2)" "unprognostic (4.36e-3)" "unprognostic (2.21e-1)" 3.8 3.1 10.9 2.3 25.2 1.3 1.1 1.3 59.4 1.1 1.5 1.3 0.0 1.3 2.2 1.1 1.1 1.1 1.2 1.2 12.2 51.0 1.4 1.1 1.1 1.1 3.9 22.8 1.1 6.2 1.1 30.4 1.2 41.2 1.2 1.2 0.5 1.1 1.1 1.1 1.4 1.3 1.5 6.6 1.2 3.6 1.4 0.5 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 1.9 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.7 0.4 0.0 4.6 0.0 0.4 3.6 0.4 0.1 0.0 0.0 0.0 0.0 2.9 35.9 0.0 0.1 96.8 0.0 0.0 0.0 0.0 17.6 0.0 0.4 0.0 0.1 0.9 2.8 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 25.2 1.3 59.4 12.2 51.0 3.9 22.8 41.2 0.5 VHLL "VHLP, VLP" ENSG00000189030 "VHL like" Q6RSH7 1 156298624-156299299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6;pancreas: 1.6;skeletal muscle: 1.5" "Cell line enhanced" "Detected in some" "ASC diff: 1.9;Daudi: 2.4;hTCEpi: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.61e-1)" "unprognostic (2.45e-1)" 0.1 0.1 0.1 0.0 0.3 0.0 0.0 2.6 0.2 0.0 0.1 0.0 0.3 0.0 1.2 0.1 0.8 0.1 0.2 0.2 0.0 0.4 0.1 0.1 0.0 0.2 1.6 0.0 0.1 0.1 0.2 0.1 0.0 0.0 1.5 0.3 0.0 0.2 0.1 0.2 0.1 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.5 0.7 0.0 3.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VN1R1 "V1RL1, VNR19I1, ZVNH1, ZVNR1" ENSG00000178201 "Vomeronasal 1 receptor 1" Q9GZP7 19 57454790-57457142 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell line enhanced" "Detected in some" "HEK 293: 6.1;U-266/70: 5.5;U-266/84: 6.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" HPA062209 Uncertain Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA062209: " "unprognostic (7.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (1.51e-2)" "unprognostic (5.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.21e-2)" "unprognostic (5.41e-2)" "unprognostic (5.68e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-2)" "unprognostic (4.59e-5)" 0.1 1.4 2.0 0.3 2.9 0.3 1.5 9.2 3.5 0.2 0.7 0.0 0.5 5.3 0.9 0.8 0.6 1.9 1.9 2.0 0.8 0.9 0.9 0.7 1.5 1.6 0.4 3.6 3.5 1.1 2.0 0.4 0.8 1.3 3.6 4.0 0.5 0.5 1.5 1.1 0.9 1.4 2.7 0.4 0.5 0.3 2.3 0.3 0.5 0.3 0.6 0.4 0.1 0.5 0.1 1.8 1.9 0.1 0.5 0.9 0.4 0.7 0.4 1.8 0.0 0.2 0.2 0.9 0.2 0.0 0.4 0.2 0.7 0.0 6.1 0.9 0.0 0.6 0.3 0.4 1.2 0.7 0.6 0.1 0.4 0.2 0.3 0.9 0.9 0.3 0.4 2.0 0.5 0.6 0.4 1.2 0.9 0.6 1.0 3.3 1.4 0.0 0.5 0.1 0.9 0.6 0.1 1.5 0.2 0.4 0.6 5.5 6.5 0.5 0.5 0.1 1.1 0.5 0.3 0.3 0.4 0.0 0.2 1.3 0.3 0.3 0.2 2.3 0.4 0.3 0.5 0.6 0.2 0.3 0.0 0.1 VSNL1 "HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1" ENSG00000163032 "Visinin like 1" P62760 2 17539126-17657018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 165.7" "Group enriched" "Detected in some" 5 "HaCaT: 43.2;Hep G2: 43.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053808 Approved Cytosol Cytosol "HPA053808: " "unprognostic (1.04e-1)" "unprognostic (7.90e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (6.90e-4)" "unprognostic (4.90e-2)" "unprognostic (5.48e-2)" "unprognostic (2.81e-2)" "unprognostic (4.66e-2)" "unprognostic (2.99e-1)" "unprognostic (1.65e-1)" "unprognostic (2.18e-1)" "unprognostic (5.14e-4)" "unprognostic (3.26e-2)" "unprognostic (1.23e-1)" "unprognostic (6.19e-3)" "unprognostic (1.51e-2)" 1.4 13.6 36.5 1.7 48.8 1.2 3.9 91.6 165.7 1.8 3.0 3.3 0.0 1.3 1.7 1.2 18.0 1.9 1.3 17.5 34.8 27.9 2.0 10.5 2.4 1.2 19.9 66.1 2.8 1.7 1.2 0.2 3.4 64.0 3.0 3.6 0.1 3.2 1.5 1.7 5.2 1.3 1.6 7.1 1.3 1.7 1.5 1.4 0.0 1.5 3.1 4.1 2.3 3.4 0.1 0.7 0.2 0.1 0.1 0.5 0.1 0.2 0.0 0.5 7.8 0.9 1.3 0.0 0.0 0.0 0.0 0.2 0.1 4.7 0.0 0.0 0.0 43.2 0.3 1.5 0.0 0.0 0.2 0.0 0.0 43.6 0.0 0.0 0.1 0.3 2.3 0.0 1.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.1 3.5 3.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.5 0.1 0.2 0.1 0.1 0.7 0.0 0.1 36.5 48.8 91.6 138.6 34.8 27.9 19.9 66.1 64.0 1.4 VSTM2A "MGC33530, VSTM2" ENSG00000170419 "V-set and transmembrane domain containing 2A" Q8TAG5 7 54542325-54571080 "Plasma proteins, Predicted secreted proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 13.7;brain: 51.7;prostate: 13.7" "Group enriched" "Detected in some" 6 "Karpas-707: 3.3;SCLC-21H: 10.2;SH-SY5Y: 7.1" "Cancer enhanced" "Detected in some" "breast cancer: 4.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" "unprognostic (1.15e-1)" "unprognostic (1.02e-1)" "unprognostic (1.89e-1)" "unprognostic (1.14e-2)" "unprognostic (4.66e-1)" "prognostic favourable (5.34e-4)" "unprognostic (4.34e-2)" "unprognostic (6.79e-2)" "unprognostic (7.15e-2)" 0.7 13.7 18.4 0.7 22.7 0.7 1.1 0.5 51.7 0.7 6.0 1.4 0.0 2.4 0.7 0.7 0.7 0.7 0.9 0.7 9.4 15.5 0.8 0.7 0.8 0.7 4.4 13.6 0.7 1.8 0.7 0.4 0.7 6.7 13.7 5.8 1.1 0.7 0.7 0.8 0.7 1.1 0.8 3.2 0.7 7.2 1.2 3.0 0.0 0.7 0.0 0.7 0.9 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 10.2 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.4 22.7 0.5 51.7 9.4 15.5 4.4 13.6 6.7 3.0 VSTM2B ENSG00000187135 "V-set and transmembrane domain containing 2B" A6NLU5 19 29526499-29564479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 40.8" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 13.1" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.8;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 19 "T-cells: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.74e-1)" "unprognostic (1.87e-3)" "unprognostic (6.64e-2)" "unprognostic (1.08e-2)" "unprognostic (5.35e-2)" 1.0 1.2 16.2 1.0 17.0 0.9 1.0 13.4 40.8 3.1 1.0 8.6 0.0 1.0 1.0 1.6 0.9 1.0 1.0 1.0 14.2 9.4 1.0 0.9 0.9 1.1 12.5 9.2 1.0 0.9 0.9 0.0 0.9 4.5 0.9 1.0 0.3 0.9 1.0 0.9 1.0 1.0 1.3 11.7 1.0 1.0 1.0 2.2 0.0 0.9 0.0 1.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 17.0 13.4 16.6 14.2 9.4 12.5 9.2 4.5 2.2 VSTM2L "C20orf102, dJ1118M15.2" ENSG00000132821 "V-set and transmembrane domain containing 2 like" Q96N03 20 37903104-37945350 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 26.3;HDLM-2: 36.0;hTCEpi: 9.3;SK-BR-3: 32.2" "Group enriched" "Detected in all" 5 "lung cancer: 23.6;pancreatic cancer: 34.4;prostate cancer: 72.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043832 Uncertain "Secreted - unknown location" "HPA043832: AB_10968449" "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.33e-2)" "prognostic unfavourable (1.63e-5)" "unprognostic (4.96e-3)" "unprognostic (1.56e-1)" "unprognostic (1.83e-2)" "unprognostic (1.39e-1)" "unprognostic (1.52e-1)" "unprognostic (2.34e-3)" "unprognostic (9.86e-2)" "unprognostic (2.00e-1)" "unprognostic (1.85e-3)" "unprognostic (1.29e-3)" "unprognostic (1.68e-1)" "unprognostic (9.66e-2)" "prognostic unfavourable (8.14e-4)" 1.6 7.5 29.3 1.6 22.7 0.8 1.4 7.0 44.8 14.0 1.8 1.8 21.4 2.0 1.6 11.5 1.6 17.5 18.9 25.6 34.9 23.5 1.1 2.5 4.5 1.2 10.7 17.6 0.9 3.5 0.9 6.9 1.6 9.7 6.0 1.3 3.6 3.8 19.8 1.0 1.0 1.4 1.7 6.2 18.6 8.9 2.5 1.5 0.0 1.3 0.0 1.8 1.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.1 0.1 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.1 26.3 0.0 0.1 0.2 0.0 0.0 1.2 0.0 36.0 0.6 0.0 0.0 0.0 1.4 0.0 0.9 1.3 9.3 0.0 0.2 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.1 0.0 0.0 1.0 8.7 1.0 32.2 0.3 0.1 0.0 1.6 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 22.7 7.0 44.8 34.9 23.5 10.7 17.6 9.7 1.5 VSTM5 "C11orf90, LOC387804" ENSG00000214376 "V-set and transmembrane domain containing 5" A8MXK1 11 93818232-93850531 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 9.9;placenta: 10.7" "Cell line enhanced" "Detected in some" "A-431: 1.8;HaCaT: 2.5;PC-3: 10.5;SH-SY5Y: 4.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029525, HPA063591" Uncertain Uncertain "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA029525: AB_10600789, HPA063591: " "unprognostic (1.26e-1)" "unprognostic (4.48e-3)" "unprognostic (2.78e-1)" "unprognostic (1.54e-4)" "unprognostic (2.45e-2)" "unprognostic (9.91e-2)" "unprognostic (8.56e-2)" "unprognostic (1.37e-2)" "unprognostic (1.68e-2)" "unprognostic (1.04e-1)" "unprognostic (2.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.31e-1)" "unprognostic (3.53e-2)" "unprognostic (2.37e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" 0.5 0.6 3.1 0.4 2.9 0.1 1.1 2.2 8.2 2.8 3.0 0.4 0.6 0.5 0.9 3.2 0.5 0.5 1.5 0.8 3.2 9.9 2.1 0.1 0.3 0.2 4.7 3.5 0.3 1.3 0.1 1.2 10.7 4.9 1.6 4.4 0.3 1.4 1.3 0.2 0.3 1.3 1.9 1.3 0.1 4.9 0.4 0.0 0.0 0.4 0.0 0.3 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.9 0.2 1.1 0.0 0.0 0.2 2.5 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.3 0.0 0.3 0.3 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.9 2.2 8.2 3.2 9.9 4.7 3.5 4.9 0.0 VSX1 "PPCD, PPCD1, PPD" ENSG00000100987 "Visual system homeobox 1" Q9NZR4 20 25070885-25082365 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Developmental protein, DNA-binding" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 17.0;retina: 20.7" "Cell line enriched" "Detected in some" 6 "Karpas-707: 9.8" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "cerebellum: 17.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.93e-1)" "unprognostic (6.63e-2)" "unprognostic (9.68e-3)" "unprognostic (4.33e-2)" "unprognostic (2.27e-1)" "unprognostic (1.97e-1)" "unprognostic (4.01e-1)" "unprognostic (8.64e-3)" "unprognostic (2.70e-2)" "unprognostic (1.35e-1)" "unprognostic (2.31e-9)" "unprognostic (1.53e-2)" "unprognostic (2.35e-1)" "unprognostic (3.07e-4)" "unprognostic (2.38e-1)" 0.4 3.0 2.3 0.4 1.6 1.6 0.4 17.0 2.8 0.4 0.4 0.4 0.4 0.1 1.0 0.4 0.4 0.4 0.4 0.5 1.9 2.1 0.4 0.4 0.4 0.4 2.1 0.4 4.6 1.2 1.1 2.7 0.4 0.5 0.5 0.1 20.7 0.4 1.0 1.0 0.6 0.5 0.4 1.5 0.4 0.3 0.7 0.4 0.4 0.7 0.4 0.4 0.4 0.4 1.0 1.5 2.4 0.3 1.3 0.6 0.1 0.1 1.5 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.1 0.4 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 9.8 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.5 0.1 0.0 0.3 0.0 0.8 0.3 0.1 0.3 0.0 0.1 0.0 0.3 0.0 0.3 0.9 0.1 0.1 2.4 0.3 0.3 0.6 0.3 0.5 0.7 0.4 0.3 0.0 1.0 0.4 0.5 2.1 1.3 0.2 1.5 0.1 0.1 2.3 1.6 17.0 1.4 1.9 2.1 2.1 0.4 0.5 0.4 VWA3A "FLJ40941, FLJ46765" ENSG00000175267 "Von Willebrand factor A domain containing 3A" A6NCI4 16 22092538-22156966 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.8;fallopian tube: 27.0" "Cell line enhanced" "Detected in some" "SK-MEL-30: 1.5;U-266/70: 1.2;U-266/84: 2.4;WM-115: 1.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041696, HPA042044" Uncertain "Secreted - unknown location" "HPA041696: AB_10964202, HPA042044: AB_10968997" "unprognostic (2.69e-2)" "unprognostic (1.54e-1)" "unprognostic (9.75e-4)" "prognostic favourable (8.15e-4)" "unprognostic (2.70e-1)" "unprognostic (4.46e-2)" "unprognostic (1.65e-2)" "unprognostic (6.79e-3)" "unprognostic (5.55e-2)" "unprognostic (2.67e-1)" "unprognostic (6.81e-2)" "unprognostic (1.40e-1)" "unprognostic (2.16e-5)" "unprognostic (1.08e-1)" "unprognostic (2.97e-1)" "unprognostic (6.24e-2)" "unprognostic (3.06e-4)" 1.0 1.1 3.6 0.7 8.3 1.1 0.9 0.3 12.2 8.1 0.8 13.2 0.0 0.8 2.3 9.6 0.8 27.0 0.7 0.9 4.8 5.8 0.9 0.7 5.5 0.8 0.7 6.7 3.0 1.0 0.9 10.0 0.8 26.8 0.9 0.8 0.0 0.8 0.8 0.8 2.3 1.1 0.7 3.8 1.0 0.9 5.0 3.6 0.0 0.9 0.0 0.9 0.9 0.1 0.2 0.1 0.0 0.5 0.0 0.4 0.0 0.1 1.0 0.6 0.7 0.2 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.1 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 1.2 2.4 0.0 0.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 3.6 8.3 0.3 12.2 4.8 5.8 0.7 6.7 26.8 3.6 VWA5B1 FLJ32784 ENSG00000158816 "Von Willebrand factor A domain containing 5B1" Q5TIE3 1 20290919-20354894 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.6;epididymis: 6.4;testis: 6.9" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 5.2" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 5 "pons and medulla: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA027496, HPA028405, HPA064829" Enhanced Approved "Plasma membrane,Mitochondria,Cytosol" "Secreted in male reproductive system" Mitochondria "Plasma membrane, Cytosol" "HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: " "unprognostic (2.34e-1)" "unprognostic (2.91e-1)" "unprognostic (7.78e-2)" "unprognostic (1.16e-2)" "unprognostic (4.73e-2)" "unprognostic (1.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.86e-2)" "unprognostic (4.39e-2)" "unprognostic (1.73e-1)" "unprognostic (5.41e-4)" "unprognostic (7.43e-4)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" 0.0 1.2 0.7 0.2 3.3 0.0 0.0 0.0 0.5 0.0 0.0 6.1 0.0 0.0 0.0 6.4 0.1 0.7 0.5 0.1 2.8 3.3 2.0 0.0 0.1 0.2 0.2 0.4 0.0 0.1 2.2 5.6 0.2 17.6 0.2 0.0 0.0 4.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.9 0.5 0.0 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.3 0.0 0.5 2.8 3.3 0.2 0.4 17.6 0.5 VWA5B2 "DKFZp761K032, LOC90113" ENSG00000145198 "Von Willebrand factor A domain containing 5B2" Q8N398 3 184230429-184242329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 35.9;brain: 10.1;pancreas: 11.0" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 26.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036823, HPA036824, HPA061412" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA036823: AB_10672269, HPA036824: , HPA061412: " "unprognostic (3.92e-4)" "unprognostic (1.70e-1)" "unprognostic (1.69e-2)" "unprognostic (2.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.60e-1)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (3.80e-1)" "unprognostic (1.21e-1)" "unprognostic (4.32e-3)" "unprognostic (3.73e-2)" "unprognostic (1.12e-4)" "unprognostic (3.13e-1)" "unprognostic (3.65e-2)" "unprognostic (2.36e-1)" "unprognostic (1.83e-1)" 0.4 35.9 9.2 0.4 4.8 0.2 0.4 9.8 10.1 0.5 2.5 0.4 0.4 1.7 0.4 0.4 0.4 1.2 0.4 0.4 9.5 3.3 0.4 0.4 2.4 0.4 1.9 0.4 3.7 11.0 1.6 3.4 0.4 0.4 0.9 0.4 0.4 0.5 2.4 0.4 0.1 2.4 0.4 0.4 0.4 2.8 1.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 1.5 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.0 0.0 26.5 1.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.7 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 4.8 9.8 10.1 9.5 3.3 1.9 0.4 0.4 0.4 VWC2 "PSST739, UNQ739" ENSG00000188730 "Von Willebrand factor C domain containing 2" Q2TAL6 7 49773661-49921950 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 17.0;heart muscle: 12.8;ovary: 12.5" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;U-266/70: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA055243 Approved "Secreted to extracellular matrix" "HPA055243: " "unprognostic (3.30e-1)" "unprognostic (1.04e-1)" "unprognostic (8.90e-4)" "unprognostic (8.97e-2)" "unprognostic (8.77e-2)" "unprognostic (1.56e-3)" "unprognostic (3.41e-2)" "unprognostic (4.11e-1)" "unprognostic (6.65e-2)" "unprognostic (1.69e-4)" "unprognostic (1.60e-2)" "unprognostic (2.09e-2)" "unprognostic (1.52e-1)" "unprognostic (1.94e-1)" "unprognostic (9.70e-3)" 0.5 0.3 3.6 0.4 3.9 0.4 0.5 17.0 6.9 0.6 0.5 1.4 0.0 0.5 1.9 0.4 0.5 0.8 0.5 12.8 1.7 2.8 0.4 0.3 0.6 0.4 2.1 1.8 12.5 0.3 0.3 0.2 0.3 3.8 0.4 0.5 0.6 0.4 0.5 0.4 1.2 0.7 1.5 0.8 0.6 0.4 0.5 0.8 0.0 0.4 0.0 0.3 0.4 0.2 0.1 0.0 0.9 0.4 1.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.9 1.0 0.2 0.0 0.0 0.0 3.6 3.9 17.0 6.9 1.7 2.8 2.1 1.8 3.8 0.8 VWC2L ENSG00000174453 "Von Willebrand factor C domain containing protein 2 like" B2RUY7 2 214411065-214578959 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 8.9;pituitary gland: 2.3" "Cell line enhanced" "Detected in single" "AF22: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044815, HPA059414" Uncertain "Secreted - unknown location" "HPA044815: AB_10962359, HPA059414: " "unprognostic (8.77e-2)" "unprognostic (2.83e-3)" "unprognostic (2.05e-2)" "unprognostic (8.49e-2)" "unprognostic (1.51e-3)" "unprognostic (4.36e-1)" "unprognostic (2.56e-2)" "unprognostic (2.05e-1)" "unprognostic (3.89e-1)" 0.3 0.3 1.9 0.3 3.2 0.3 0.3 0.2 8.9 0.3 0.3 0.0 0.0 0.3 0.3 0.5 0.3 0.4 0.3 0.3 2.4 6.6 0.3 0.3 0.5 0.3 3.9 2.9 0.3 0.3 0.3 2.3 0.3 6.6 0.4 0.3 0.1 0.3 0.4 0.5 0.4 0.3 0.3 1.0 0.3 0.4 0.5 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.2 0.2 8.5 2.4 6.6 3.9 2.9 6.6 0.0 WASF1 "KIAA0269, SCAR1, WAVE, WAVE1" ENSG00000112290 "WAS protein family member 1" Q92558 6 110099819-110180004 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 63.3;ovary: 17.7;testis: 55.4" "Cell line enhanced" "Detected in many" "hTERT-HME1: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "memory B-cell: 3.9;naive B-cell: 5.9;plasmacytoid DC: 10.7" "Group enriched" "Detected in many" 10 "B-cells: 5.9;dendritic cells: 10.7" "Low region specificity" "Detected in all" "HPA004105, CAB022161" Approved Supported "CAB022161: , HPA004105: AB_1080583" "unprognostic (8.22e-2)" "unprognostic (1.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.30e-3)" "unprognostic (5.50e-2)" "unprognostic (2.28e-1)" "prognostic unfavourable (2.82e-8)" "unprognostic (9.20e-2)" "unprognostic (5.06e-2)" "unprognostic (2.52e-1)" "unprognostic (3.33e-3)" "unprognostic (2.73e-1)" "prognostic unfavourable (2.79e-5)" "unprognostic (1.95e-2)" "unprognostic (3.09e-2)" "unprognostic (9.03e-2)" "unprognostic (3.38e-1)" 5.4 7.6 19.8 3.4 44.3 7.1 5.5 18.0 63.3 5.4 3.9 10.9 0.5 2.3 9.9 5.1 6.1 4.9 6.6 1.8 43.8 10.3 6.5 4.6 2.6 3.3 10.6 26.7 17.7 4.6 4.1 5.8 2.8 17.0 4.3 3.5 0.9 3.3 4.3 1.3 4.3 2.7 10.5 12.8 2.4 3.0 55.4 9.3 1.0 2.3 0.6 3.4 4.6 2.8 5.9 10.7 0.1 0.8 0.6 0.3 0.5 3.3 3.8 20.2 16.4 8.7 11.3 2.2 7.1 8.2 6.1 10.7 6.5 3.2 19.3 4.6 11.1 3.8 31.4 9.7 10.6 0.3 14.8 37.7 7.4 5.9 15.7 2.2 5.8 8.9 13.8 8.4 41.8 9.2 14.2 4.5 7.0 2.8 19.8 0.6 18.2 5.0 18.3 7.4 0.7 9.8 3.9 16.3 25.3 5.0 3.7 4.6 4.7 9.7 6.8 5.6 5.8 16.4 9.5 0.1 3.0 16.9 6.3 16.3 4.1 0.0 0.7 0.0 0.1 0.2 0.3 3.9 0.3 0.0 0.8 5.9 0.1 0.1 0.1 0.6 0.8 10.7 0.0 0.5 19.8 44.3 18.0 48.9 43.8 10.3 10.6 26.7 17.0 9.3 WASF3 "KIAA0900, SCAR3, WAVE3" ENSG00000132970 "WAS protein family member 3" Q9UPY6 13 26557703-26688948 "Cancer-related genes, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.1" "Cell line enhanced" "Detected in many" "ASC diff: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037086, HPA066228" Enhanced "CAB037086: AB_1080585, HPA066228: " "unprognostic (1.42e-1)" "unprognostic (3.65e-2)" "unprognostic (2.25e-1)" "unprognostic (7.57e-2)" "unprognostic (8.23e-2)" "unprognostic (3.34e-1)" "unprognostic (6.19e-2)" "unprognostic (8.37e-2)" "unprognostic (8.98e-2)" "unprognostic (2.99e-1)" "prognostic favourable (2.21e-4)" "unprognostic (8.86e-3)" "unprognostic (2.93e-3)" "unprognostic (6.35e-2)" "unprognostic (2.12e-2)" "unprognostic (2.69e-3)" "unprognostic (9.18e-2)" 18.7 17.3 27.3 3.4 33.2 1.1 11.8 30.9 55.1 7.1 3.4 18.6 2.0 1.9 8.7 6.0 4.8 7.1 4.6 7.3 22.7 19.7 8.0 7.6 7.9 3.0 22.1 22.5 22.4 6.0 6.8 4.5 1.3 18.4 10.1 4.1 8.9 6.6 10.8 7.4 3.7 2.5 8.4 17.1 5.5 5.3 12.9 14.1 0.0 17.7 0.7 2.4 4.3 5.0 0.2 0.0 1.3 0.0 0.0 0.0 0.8 0.0 0.1 17.5 0.0 38.6 7.5 1.6 6.7 10.2 10.0 5.2 0.0 1.6 6.6 0.9 15.4 1.5 4.9 5.0 8.7 0.0 4.1 0.3 0.0 6.6 5.8 2.2 5.0 15.8 4.9 2.5 7.9 15.5 0.1 0.0 3.7 1.4 0.0 0.0 4.8 1.6 0.0 9.8 0.0 1.3 2.8 4.1 8.2 3.4 3.2 5.1 0.0 0.2 7.8 7.9 3.2 3.8 3.6 0.0 0.0 6.4 4.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.8 27.3 33.2 30.9 30.7 22.7 19.7 22.1 22.5 18.4 14.1 WDR17 ENSG00000150627 "WD repeat domain 17" Q8IZU2 4 176065834-176182818 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9;parathyroid gland: 19.0;pituitary gland: 22.5" "Cell line enhanced" "Detected in many" "AF22: 8.9;SCLC-21H: 10.3;SH-SY5Y: 7.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042766, HPA054501" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA042766: AB_10806372, HPA054501: " "unprognostic (3.41e-4)" "unprognostic (1.72e-1)" "unprognostic (1.20e-1)" "unprognostic (6.43e-7)" "unprognostic (3.53e-1)" "unprognostic (1.40e-1)" "unprognostic (2.07e-1)" "unprognostic (1.91e-1)" "unprognostic (8.62e-2)" "unprognostic (1.42e-1)" "unprognostic (1.39e-3)" "unprognostic (6.04e-4)" "unprognostic (3.66e-4)" "unprognostic (9.25e-3)" "unprognostic (4.63e-2)" "unprognostic (7.32e-3)" "unprognostic (8.24e-3)" 2.1 5.8 12.4 2.2 22.1 1.5 3.3 12.2 23.9 2.0 2.9 3.4 0.0 1.6 4.5 6.2 1.9 3.5 3.0 1.3 9.7 7.1 6.2 1.0 3.6 1.8 4.4 16.3 4.0 3.0 19.0 22.5 0.7 7.9 2.3 3.1 6.0 1.7 2.2 0.7 1.2 1.8 2.8 4.0 2.9 3.1 4.1 6.9 0.1 10.2 0.0 1.6 1.9 1.5 1.1 0.7 2.6 1.6 1.3 0.8 0.2 0.0 3.7 8.9 0.1 0.2 0.6 0.3 0.2 0.0 0.8 3.1 0.2 0.1 6.1 0.0 0.1 0.1 3.9 2.0 0.8 0.0 3.2 0.0 0.7 0.0 0.3 3.3 4.8 1.4 1.2 0.1 0.5 0.0 0.0 0.3 0.6 1.6 3.4 0.1 2.0 1.9 0.0 3.8 0.0 0.5 0.0 10.3 7.4 0.0 2.4 6.2 0.4 0.0 0.0 1.2 1.7 0.1 5.8 4.4 2.9 3.5 7.0 0.0 2.4 2.6 0.6 0.3 0.6 1.6 0.3 1.1 0.6 0.4 0.2 0.8 0.7 0.8 1.7 1.3 0.3 0.7 0.3 0.2 12.4 22.1 12.2 21.8 9.7 7.1 4.4 16.3 7.9 6.9 WDR47 KIAA0893 ENSG00000085433 "WD repeat domain 47" O94967 1 108970214-109042113 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027287, HPA027289" Approved Approved "Nucleoplasm,Actin filaments" "Actin filaments" Nucleoplasm "HPA027287: AB_10599416, HPA027289: AB_10601862" "unprognostic (8.55e-2)" "unprognostic (3.36e-2)" "unprognostic (7.51e-2)" "unprognostic (2.44e-1)" "unprognostic (4.90e-1)" "prognostic favourable (9.86e-4)" "unprognostic (4.05e-3)" "unprognostic (2.83e-2)" "unprognostic (2.87e-1)" "unprognostic (3.67e-2)" "unprognostic (2.71e-2)" "unprognostic (1.93e-1)" "unprognostic (8.39e-3)" "unprognostic (7.90e-3)" "unprognostic (9.23e-2)" "unprognostic (2.73e-2)" "unprognostic (8.09e-2)" 7.1 7.2 17.7 5.1 24.0 10.1 6.4 19.9 42.6 8.0 5.6 9.5 3.4 3.7 9.4 5.8 13.7 8.4 7.1 7.5 20.1 20.6 7.5 3.6 6.7 5.0 14.8 21.0 7.6 5.6 10.4 4.4 6.3 24.8 7.3 5.4 5.8 4.7 7.2 14.2 20.3 4.1 9.8 12.7 5.3 5.6 19.9 11.3 5.5 6.1 4.8 7.0 6.8 6.3 3.5 5.6 18.8 5.0 2.2 4.6 2.0 10.6 3.2 6.2 7.8 12.4 10.9 3.4 12.2 7.5 8.2 9.2 3.2 1.6 4.8 6.6 11.6 12.0 8.8 5.3 10.8 8.9 4.9 4.0 7.2 3.5 7.1 6.2 6.0 6.7 8.9 12.7 6.2 9.6 2.4 6.8 13.8 6.3 6.0 4.9 2.6 6.5 8.5 15.9 2.6 13.6 9.2 11.1 10.1 10.7 5.7 8.5 2.6 6.4 16.4 10.9 5.0 19.0 10.0 4.4 3.6 3.9 12.7 6.2 16.2 11.4 4.7 5.8 3.2 5.0 2.8 2.0 2.9 3.4 5.1 3.5 2.6 2.2 18.8 2.2 4.5 5.6 4.6 2.0 17.7 24.0 19.9 32.4 20.1 20.6 14.8 21.0 24.8 11.3 WDR49 FLJ33620 ENSG00000174776 "WD repeat domain 49" Q8IV35 3 167478684-167653983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 21.6;fallopian tube: 20.7" "Cell line enhanced" "Detected in some" "AF22: 3.3;NTERA-2: 3.7;THP-1: 16.7;U-937: 8.8" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 5.6;myeloid DC: 4.1;plasmacytoid DC: 5.2" "Group enriched" "Detected in many" 24 "dendritic cells: 5.2;monocytes: 5.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036225, HPA036226" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA036225: AB_10696652, HPA036226: " "unprognostic (1.68e-3)" "unprognostic (1.24e-3)" "unprognostic (2.48e-2)" "unprognostic (1.96e-1)" "unprognostic (5.67e-2)" "unprognostic (5.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.02e-2)" "unprognostic (9.28e-3)" "unprognostic (1.34e-1)" "unprognostic (4.60e-9)" "unprognostic (1.79e-4)" "unprognostic (3.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.07e-1)" 0.5 0.7 6.5 1.1 6.8 3.6 0.6 12.6 5.0 1.2 0.9 8.5 0.0 3.9 1.2 4.4 2.1 20.7 0.7 4.7 12.3 5.4 1.0 0.4 4.0 0.9 7.6 2.8 3.2 0.9 0.4 1.7 0.4 21.6 0.7 0.6 0.0 0.7 0.4 0.4 0.5 8.0 0.7 17.6 1.1 0.8 1.5 14.2 0.0 0.5 0.0 1.0 0.8 0.6 0.2 5.2 0.0 5.6 0.0 0.0 0.7 0.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.8 0.0 0.0 5.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.7 6.5 6.8 12.6 3.7 12.3 5.4 7.6 2.8 21.6 14.2 WDR63 "DIC3, FLJ30067, NYD-SP29" ENSG00000162643 "WD repeat domain 63" Q8IWG1 1 84999147-85133138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 21.3;brain: 39.7;testis: 31.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.7;HBEC3-KT: 5.2;HSkMC: 7.1;hTCEpi: 8.5;LHCN-M2: 7.6" "Cancer enhanced" "Detected in some" "melanoma: 2.9" "Region enriched" "Detected in many" 9 "pons and medulla: 39.7" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2" "Lineage enriched" "Detected in single" 4 "T-cells: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038526 Enhanced "HPA038526: AB_2676063" "unprognostic (3.12e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.61e-2)" "unprognostic (1.09e-4)" "unprognostic (1.10e-3)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.56e-1)" "unprognostic (2.53e-1)" "unprognostic (1.82e-3)" "unprognostic (2.31e-1)" "unprognostic (1.14e-5)" "unprognostic (8.57e-3)" "unprognostic (2.60e-1)" "unprognostic (2.35e-2)" "unprognostic (1.82e-1)" 0.3 21.3 2.0 0.4 4.6 0.1 0.9 0.1 0.9 1.3 0.6 4.2 1.0 0.3 0.7 11.7 0.6 14.0 0.4 0.9 3.0 2.9 2.5 0.1 3.7 0.3 0.4 0.9 4.9 0.5 3.9 14.6 0.5 39.7 0.3 0.6 0.3 1.8 0.3 0.3 1.9 0.2 0.4 0.9 0.2 0.2 31.0 1.9 0.0 1.1 1.0 0.2 0.7 0.3 0.0 0.5 0.0 0.0 0.0 2.2 0.4 0.2 0.5 0.1 0.4 3.8 10.7 2.0 2.0 4.2 0.7 1.1 0.0 0.6 0.5 0.0 0.4 0.0 0.4 5.2 0.9 0.1 0.4 0.3 0.0 0.0 0.6 0.0 0.0 7.1 8.5 3.5 0.2 0.1 0.0 0.0 7.6 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.2 0.2 0.0 0.0 0.2 1.2 0.0 3.4 0.0 0.6 0.3 0.0 0.5 0.0 0.0 0.4 4.1 0.2 1.4 0.0 0.0 0.0 2.2 0.0 1.3 0.0 1.2 0.9 0.1 0.0 0.8 1.9 0.0 0.0 0.0 0.5 0.0 0.4 2.0 4.6 0.1 0.9 3.0 2.9 0.4 0.9 39.7 1.9 WDR97 KIAA1875 ENSG00000179698 "WD repeat domain 97" A6NE52 8 144107726-144118315 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 4.1;testis: 7.8" "Cell line enhanced" "Detected in some" "HeLa: 1.2;PC-3: 2.7;U-2 OS: 1.2" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 7 "pons and medulla: 4.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA059409 Uncertain "HPA059409: " "unprognostic (3.95e-2)" "unprognostic (1.31e-2)" "unprognostic (3.58e-3)" "unprognostic (1.70e-1)" "unprognostic (2.70e-1)" "unprognostic (3.01e-4)" "unprognostic (3.10e-2)" "unprognostic (2.40e-1)" "unprognostic (6.20e-2)" "unprognostic (1.40e-1)" "unprognostic (2.97e-3)" "unprognostic (6.92e-2)" "unprognostic (6.11e-6)" "unprognostic (2.79e-3)" "unprognostic (4.95e-2)" "unprognostic (2.51e-1)" "unprognostic (3.73e-4)" 0.1 0.5 0.2 0.2 0.1 0.6 0.0 0.2 0.6 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.5 0.0 0.2 0.0 0.1 0.6 0.0 0.1 0.0 4.1 0.1 0.2 0.0 0.0 0.0 0.5 0.4 0.1 0.0 0.1 0.1 0.2 7.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.6 0.9 0.3 1.3 0.8 0.1 0.2 1.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.5 0.4 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.3 0.3 1.2 0.1 0.2 0.1 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.2 2.7 0.2 0.4 0.2 0.0 0.5 0.4 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.6 0.3 0.2 0.4 0.1 0.7 0.3 0.4 0.2 0.0 0.7 0.8 0.4 0.9 1.3 0.2 0.6 0.1 0.1 0.2 0.1 0.2 0.6 0.2 0.1 0.2 0.0 4.1 0.0 WFIKKN1 "C16orf12, RJD2, WFDC20A, WFIKKN" ENSG00000127578 "WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1" Q96NZ8 16 629239-634116 "Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.8;lymphoid tissue: 5.1" "Cell line enhanced" "Detected in some" "EFO-21: 9.7;Hep G2: 2.1;NTERA-2: 2.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in other tissues" "unprognostic (3.12e-1)" "unprognostic (2.57e-1)" "unprognostic (3.17e-2)" "unprognostic (1.59e-2)" "unprognostic (3.55e-1)" "unprognostic (2.28e-2)" "unprognostic (3.36e-2)" "unprognostic (4.45e-2)" "unprognostic (8.53e-2)" "unprognostic (2.43e-1)" "unprognostic (3.78e-3)" "unprognostic (1.19e-1)" "unprognostic (5.56e-3)" "unprognostic (1.53e-1)" "unprognostic (3.02e-1)" "unprognostic (2.50e-3)" "unprognostic (4.70e-5)" 0.7 0.2 1.3 0.3 2.4 0.4 0.3 5.8 1.9 0.7 1.4 0.3 0.3 0.2 1.3 0.3 0.3 0.2 0.3 0.3 1.0 0.2 1.3 0.6 1.3 0.3 0.4 2.3 0.5 1.2 0.2 1.5 0.5 0.3 0.6 0.2 0.3 0.5 0.3 1.0 0.7 0.4 0.3 0.3 1.6 1.2 1.0 0.3 5.1 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.6 0.7 0.0 0.0 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.6 2.9 0.5 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.3 0.0 0.1 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 1.3 2.4 5.8 1.9 1.0 0.2 0.4 2.3 0.3 0.3 WFIKKN2 "WFDC20B, WFIKKNRP" ENSG00000173714 "WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2" Q8TEU8 17 50834650-50842348 "Predicted intracellular proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "brain: 89.1;ovary: 56.4" "Cell line enhanced" "Detected in some" "NTERA-2: 1.6;T-47d: 3.7;U-87 MG: 3.8" "Group enriched" "Detected in some" 5 "glioma: 0.7;testis cancer: 2.2" "Region enriched" "Detected in some" 10 "pons and medulla: 89.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "Secreted in other tissues" 1700000 "unprognostic (7.31e-2)" "unprognostic (7.31e-2)" "unprognostic (1.31e-2)" "unprognostic (4.80e-2)" "unprognostic (3.46e-2)" "unprognostic (5.72e-2)" "unprognostic (5.42e-3)" "unprognostic (2.54e-3)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (2.19e-1)" "unprognostic (4.08e-3)" "unprognostic (1.42e-3)" "unprognostic (2.17e-1)" "unprognostic (2.75e-2)" "unprognostic (1.14e-1)" 0.1 0.5 0.2 0.1 0.3 0.0 0.0 0.8 0.5 0.2 0.3 6.8 0.0 0.1 0.7 0.4 0.2 0.6 0.2 0.3 9.1 0.2 0.1 0.0 1.0 0.0 0.4 0.0 56.4 0.3 0.1 0.8 0.0 89.1 0.3 0.1 4.5 0.1 0.5 1.3 0.6 0.1 0.2 0.3 0.1 0.1 1.6 0.5 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.5 9.1 0.2 0.4 0.0 89.1 0.5 WIF1 ENSG00000156076 "WNT inhibitory factor 1" Q9Y5W5 12 65050626-65121566 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;lung: 67.7;retina: 29.6" "Cell line enhanced" "Detected in some" "HEK 293: 5.2;LHCN-M2: 2.4;NTERA-2: 6.8;SCLC-21H: 1.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 16.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" "unprognostic (5.96e-3)" "unprognostic (2.00e-1)" "unprognostic (4.29e-3)" "unprognostic (3.26e-3)" "unprognostic (9.66e-2)" "unprognostic (1.91e-1)" "unprognostic (1.26e-2)" "unprognostic (7.94e-2)" "unprognostic (2.44e-1)" "unprognostic (2.92e-2)" "unprognostic (3.17e-1)" "unprognostic (2.30e-5)" "unprognostic (3.02e-1)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (7.24e-3)" 0.9 2.4 23.3 0.8 35.2 0.6 14.2 1.6 20.6 1.6 0.8 1.0 1.9 0.6 5.5 14.5 3.4 1.5 0.6 0.7 10.4 3.9 1.0 0.6 67.7 0.7 1.4 8.2 0.8 0.8 0.6 21.4 0.6 0.4 9.5 0.8 29.6 24.8 2.3 0.6 4.2 1.8 1.2 0.7 0.7 0.9 1.0 3.5 0.0 0.6 3.6 0.6 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.1 0.0 0.9 6.8 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 35.2 1.6 20.6 10.4 3.9 1.4 8.2 0.4 3.5 WIPF3 "CR16, FLJ36931" ENSG00000122574 "WAS/WASL interacting protein family member 3" A6NGB9 7 29806486-29917066 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6;ovary: 44.7" "Cell line enhanced" "Detected in some" "HAP1: 18.1;HEK 293: 4.1;K-562: 6.2;NTERA-2: 5.1;RPMI-8226: 10.9;SK-MEL-30: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 234.6" "HPA041145, HPA041211" Uncertain Uncertain Mitochondria Mitochondria "HPA041145: AB_10795001, HPA041211: AB_10795003" "prognostic favourable (7.93e-4)" "unprognostic (1.35e-1)" "unprognostic (1.37e-3)" "unprognostic (2.12e-3)" "unprognostic (3.65e-3)" "unprognostic (1.53e-1)" "unprognostic (8.95e-3)" "unprognostic (4.53e-2)" "unprognostic (3.49e-1)" "unprognostic (1.19e-2)" "unprognostic (1.08e-2)" "unprognostic (7.49e-2)" "unprognostic (1.61e-2)" "unprognostic (1.35e-1)" "unprognostic (2.27e-2)" "unprognostic (3.33e-2)" "unprognostic (1.41e-1)" 1.8 6.6 13.4 1.6 40.6 1.1 1.9 5.5 15.1 1.2 1.4 3.8 1.0 3.6 4.2 21.8 2.1 9.9 3.5 4.6 30.0 5.1 3.3 1.3 1.3 1.4 4.0 12.1 44.7 2.4 1.6 5.6 1.0 1.5 5.5 1.3 0.8 4.5 5.9 23.0 1.7 3.5 5.2 1.7 1.7 6.3 27.6 7.8 0.0 2.8 2.9 2.3 3.2 0.8 0.8 2.1 2.6 1.2 0.9 1.3 0.2 0.3 1.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.0 18.1 0.0 0.0 0.0 4.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.1 0.0 0.1 5.1 3.5 0.0 0.0 10.9 0.0 0.0 1.8 1.5 0.1 0.1 4.4 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.6 0.5 0.9 0.3 0.7 0.6 0.7 0.9 0.3 0.3 0.8 1.3 0.8 1.2 0.9 1.2 2.1 0.5 0.2 13.4 40.6 5.5 15.1 30.0 5.1 4.0 12.1 1.5 7.8 WNT1 INT1 ENSG00000125084 "Wnt family member 1" P04628 12 48978453-48981676 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease mutation, Osteogenesis imperfecta, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 7.7;brain: 6.5;placenta: 17.5" "Cell line enhanced" "Detected in single" "CACO-2: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basal ganglia: 6.5;cerebral cortex: 1.8" "Group enriched" "Detected in some" 8 "gdT-cell: 5.3;MAIT T-cell: 7.7;memory CD4 T-cell: 3.0;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 24 "T-cells: 7.7" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebral cortex: 1.3;hippocampal formation: 1.5;midbrain: 3.5;olfactory region: 2.1" "Secreted to extracellular matrix" "unprognostic (2.02e-2)" "unprognostic (5.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-3)" "unprognostic (5.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.63e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-2)" "unprognostic (4.97e-2)" "unprognostic (1.32e-2)" "unprognostic (1.67e-2)" "unprognostic (1.70e-1)" "unprognostic (7.35e-3)" "unprognostic (2.76e-2)" 0.3 0.1 0.4 1.5 6.5 2.3 0.3 0.3 2.9 0.3 0.3 0.3 0.3 1.5 0.3 0.3 0.5 0.1 0.7 0.3 0.6 0.5 0.3 0.3 0.7 2.9 0.3 0.3 0.3 0.3 0.0 0.3 17.5 0.3 0.3 0.0 0.3 1.2 0.3 0.3 0.0 1.8 0.3 0.3 1.9 1.2 1.4 0.3 0.3 0.3 0.3 0.3 0.6 0.3 0.3 0.0 0.0 0.0 0.0 7.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.7 0.2 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 7.7 0.3 3.0 4.8 0.0 0.0 0.5 3.2 0.0 0.0 0.0 0.0 0.4 0.8 0.4 6.5 0.3 1.8 0.6 0.5 0.3 0.3 0.3 0.3 WNT10B "SHFM6, WNT-12" ENSG00000169884 "Wnt family member 10B" O00744 12 48965340-48971763 "Disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.4" "Cell line enhanced" "Detected in many" "K-562: 8.0;T-47d: 9.5;U-266/84: 8.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA055048, HPA062539" Enhanced Approved "Golgi apparatus" "Secreted to extracellular matrix" "Golgi apparatus" "HPA055048: , HPA062539: " "unprognostic (1.13e-1)" "unprognostic (2.14e-2)" "unprognostic (5.73e-4)" "unprognostic (2.27e-2)" "unprognostic (3.09e-2)" "unprognostic (3.33e-2)" "unprognostic (6.08e-2)" "unprognostic (1.38e-1)" "unprognostic (2.12e-1)" "unprognostic (1.14e-1)" "unprognostic (4.99e-3)" "unprognostic (3.05e-2)" "unprognostic (5.39e-6)" "unprognostic (4.29e-2)" "unprognostic (3.74e-2)" "unprognostic (4.50e-1)" "unprognostic (1.25e-1)" 2.3 0.6 10.9 2.6 23.4 2.1 1.8 0.0 14.3 0.5 1.7 0.5 3.0 2.8 0.4 3.2 1.5 0.6 1.1 1.2 7.3 4.9 0.2 0.3 1.3 3.0 3.0 7.2 1.2 0.0 0.1 1.1 7.0 4.1 1.0 1.6 0.7 1.7 1.4 1.6 5.0 3.3 2.0 0.8 2.9 2.0 1.7 0.3 0.2 0.5 1.2 2.9 1.8 1.6 0.0 0.0 0.0 0.0 0.0 1.6 0.2 2.1 1.3 0.0 2.0 0.0 0.0 5.3 1.5 2.8 0.6 0.2 4.1 4.6 0.0 0.4 0.3 2.5 5.5 0.4 0.2 1.2 7.2 2.4 1.7 0.1 0.0 0.8 3.4 0.0 0.4 0.1 2.5 0.0 8.0 0.3 0.8 2.7 0.1 2.8 0.0 2.9 0.0 0.7 2.5 0.0 0.5 0.1 0.0 0.3 0.2 0.7 9.5 3.1 0.0 3.0 5.9 0.4 0.7 3.0 8.5 0.0 1.2 6.1 0.2 0.0 0.0 0.0 1.6 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.2 10.9 23.4 0.0 13.9 7.3 4.9 3.0 7.2 4.1 0.3 WNT6 ENSG00000115596 "Wnt family member 6" Q9Y6F9 2 218859821-218874233 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.4" "Cell line enriched" "Detected in some" 7 "BEWO: 27.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 8.7" "Group enriched" "Detected in many" 7 "basal ganglia: 23.4;thalamus: 7.4" "Cell type enhanced" "Detected in some" "myeloid DC: 1.1;NK-cell: 1.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070759 Approved "Secreted to extracellular matrix" "HPA070759: " "unprognostic (1.86e-2)" "unprognostic (6.03e-2)" "unprognostic (5.14e-2)" "unprognostic (2.06e-1)" "unprognostic (5.32e-2)" "unprognostic (7.34e-2)" "unprognostic (8.08e-3)" "unprognostic (4.73e-2)" "unprognostic (1.27e-2)" "unprognostic (1.19e-1)" "unprognostic (1.21e-2)" "unprognostic (2.66e-1)" "unprognostic (1.24e-3)" "unprognostic (5.26e-2)" "unprognostic (4.82e-2)" "unprognostic (1.55e-1)" "unprognostic (2.07e-1)" 2.5 3.5 0.8 1.4 23.4 0.6 15.0 0.9 2.1 4.0 5.7 0.2 1.1 1.3 2.3 2.0 3.1 2.3 2.1 4.8 0.9 0.3 1.6 0.7 0.7 1.3 2.1 0.1 2.9 1.7 0.6 1.7 9.8 1.4 4.0 0.9 4.3 1.9 2.1 2.4 2.3 2.3 2.0 2.4 6.4 2.3 3.7 7.4 0.0 0.7 0.8 1.2 1.5 11.1 0.7 1.1 0.0 0.6 1.5 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 27.5 0.0 0.0 0.0 0.0 2.6 0.4 0.0 3.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 4.0 1.3 0.0 0.0 0.1 3.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.0 1.5 0.0 0.7 0.0 0.0 0.8 23.4 0.9 0.9 0.9 0.3 2.1 0.1 1.4 7.4 WNT7A ENSG00000154764 "Wnt family member 7A" O00755 3 13816258-13880121 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.5;gallbladder: 8.7;placenta: 19.4" "Cell line enhanced" "Detected in some" "BEWO: 24.7;EFO-21: 23.2;PC-3: 8.1;RPTEC TERT1: 41.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 4.4;naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 45 "T-cells: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA015719, CAB025894" Approved "Secreted to extracellular matrix" "CAB025894: , HPA015719: AB_1858856" "unprognostic (1.26e-2)" "unprognostic (4.60e-1)" "unprognostic (2.98e-1)" "prognostic unfavourable (2.96e-5)" "unprognostic (3.02e-1)" "unprognostic (1.14e-3)" "unprognostic (2.49e-1)" "unprognostic (3.32e-4)" "unprognostic (2.20e-1)" "unprognostic (1.97e-1)" "prognostic unfavourable (3.03e-6)" "unprognostic (7.89e-2)" "unprognostic (3.78e-2)" "unprognostic (6.49e-4)" "unprognostic (1.90e-1)" "unprognostic (3.74e-1)" "unprognostic (8.88e-3)" 0.4 0.4 7.8 0.6 6.1 0.7 0.4 1.2 11.5 1.1 0.4 2.1 0.0 0.4 3.4 1.0 1.6 0.7 8.7 0.4 3.3 2.8 0.7 0.5 5.7 1.4 3.1 3.2 0.4 0.8 0.4 0.2 19.4 3.9 0.5 0.4 0.0 0.5 1.4 0.4 2.8 0.4 0.5 4.4 3.1 0.4 2.3 2.3 0.0 0.4 0.0 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.0 4.4 0.5 3.4 0.0 0.3 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 3.1 0.0 23.2 0.0 4.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.6 41.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.6 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.5 7.8 6.1 1.2 7.2 3.3 2.8 3.1 3.2 3.9 2.3 WNT8A WNT8D ENSG00000061492 "Wnt family member 8A" Q9H1J5 5 138083892-138092365 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.5;testis: 3.2" "Cell line enhanced" "Detected in some" "HEK 293: 1.1;Hep G2: 2.5" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Region enhanced" "Detected in single" "basal ganglia: 2.5" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038539 Uncertain "Secreted to extracellular matrix" "HPA038539: AB_10669646" "unprognostic (1.11e-5)" "unprognostic (4.11e-2)" "unprognostic (4.11e-2)" "unprognostic (5.32e-2)" 0.1 0.0 0.2 0.1 2.5 0.1 0.4 0.7 0.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.6 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 3.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 2.5 0.7 0.8 0.3 0.3 0.1 0.1 0.1 0.1 WSCD1 KIAA0523 ENSG00000179314 "WSC domain containing 1" Q658N2 17 6057807-6124427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;lymphoid tissue: 16.7" "Cell line enhanced" "Detected in some" "AF22: 21.9;HUVEC TERT2: 13.3;PC-3: 13.5;RH-30: 27.7;SCLC-21H: 8.5" "Group enriched" "Detected in many" 7 "glioma: 18.8;renal cancer: 4.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015919 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" Nucleoplasm "Golgi apparatus" "HPA015919: AB_2216211" "unprognostic (1.50e-1)" "unprognostic (7.10e-2)" "unprognostic (5.32e-2)" "unprognostic (1.15e-2)" "unprognostic (2.61e-1)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-1)" "unprognostic (3.46e-4)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" 3.9 2.6 11.2 1.6 7.3 0.4 1.3 17.1 24.7 1.5 8.7 11.2 0.0 4.7 1.5 1.4 1.2 1.7 1.6 3.8 10.5 9.7 6.2 1.1 1.8 1.9 11.9 5.3 0.8 2.4 2.3 2.7 6.5 8.5 1.2 5.4 1.1 1.8 1.3 13.3 2.0 5.7 2.1 12.2 16.7 1.4 12.9 10.5 0.6 1.3 0.0 1.6 1.0 2.3 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 3.1 21.9 1.7 0.1 0.0 1.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 5.4 0.1 0.0 0.0 7.3 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.3 13.3 0.0 0.5 0.6 0.4 0.0 0.0 7.3 13.5 0.0 27.7 0.8 4.6 1.1 8.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.2 7.3 17.1 7.3 10.5 9.7 11.9 5.3 8.5 10.5 WSCD2 KIAA0789 ENSG00000075035 "WSC domain containing 2" Q2TBF2 12 108129471-108250537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;seminal vesicle: 18.2;thyroid gland: 21.8" "Cell line enriched" "Detected in some" 21 "RT4: 26.9" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.6" "Region enhanced" "Detected in all" "cerebellum: 44.0" "Cell type enhanced" "Detected in single" "T-reg: 2.5" "Lineage enhanced" "Detected in single" "T-cells: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013346, HPA048133" Approved Uncertain Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA013346: AB_1858865, HPA048133: " "unprognostic (1.50e-1)" "unprognostic (1.64e-3)" "unprognostic (1.50e-2)" "unprognostic (4.27e-3)" "unprognostic (1.68e-1)" "unprognostic (3.43e-1)" "unprognostic (1.80e-2)" "unprognostic (3.43e-3)" "unprognostic (3.03e-2)" "unprognostic (3.05e-1)" "unprognostic (3.15e-1)" "unprognostic (7.43e-2)" "unprognostic (5.99e-2)" "unprognostic (3.73e-2)" "unprognostic (2.11e-1)" "unprognostic (2.32e-3)" "unprognostic (7.62e-3)" 1.4 1.2 6.5 0.5 12.5 0.4 1.0 44.0 15.2 5.4 1.7 1.6 0.0 0.7 6.9 3.0 3.8 2.0 0.5 0.5 10.0 3.0 1.3 0.4 0.8 0.5 1.3 6.0 0.6 2.1 0.4 0.9 0.6 1.9 6.0 0.7 9.9 0.5 18.2 0.5 0.6 0.9 9.2 1.5 0.5 2.0 0.6 2.0 0.0 21.8 0.2 0.5 3.0 0.9 0.8 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 26.9 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 6.5 12.5 44.0 15.2 10.0 3.0 1.3 6.0 1.9 2.0 XKR4 KIAA1889 ENSG00000206579 "XK related 4" Q5GH76 8 55102389-55542054 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.7" "Group enriched" "Detected in some" 11 "REH: 3.6;RPTEC TERT1: 14.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA025072, HPA028083" Uncertain Approved Vesicles Vesicles "HPA025072: AB_1858886, HPA028083: AB_10601025" "unprognostic (7.15e-4)" "unprognostic (1.28e-3)" "unprognostic (6.98e-2)" "unprognostic (5.63e-3)" "unprognostic (7.39e-2)" "unprognostic (5.68e-3)" "unprognostic (6.33e-2)" "unprognostic (5.14e-2)" "unprognostic (1.88e-1)" "unprognostic (2.63e-1)" "unprognostic (2.38e-3)" "unprognostic (6.63e-2)" "unprognostic (3.46e-4)" "unprognostic (2.08e-2)" "unprognostic (2.39e-2)" "unprognostic (7.36e-2)" "unprognostic (4.96e-2)" 1.2 1.4 18.7 4.3 5.6 0.8 0.7 4.4 12.1 2.1 5.1 0.6 0.3 1.5 1.0 1.4 2.5 1.1 1.4 2.6 8.6 4.5 0.9 0.7 0.7 2.0 2.0 8.8 0.9 1.1 0.5 5.3 0.6 2.0 1.2 2.2 2.5 2.0 2.9 0.8 1.4 2.0 3.5 1.2 0.9 1.5 0.9 3.4 0.6 0.7 0.6 2.3 1.0 1.6 0.8 0.3 2.2 0.2 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.6 0.0 0.0 14.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.3 0.2 0.1 0.1 0.6 0.2 0.1 0.0 0.8 0.2 0.3 1.2 0.7 0.1 0.3 0.1 0.1 18.7 5.6 4.4 11.5 8.6 4.5 2.0 8.8 2.0 3.4 XKR6 "C8orf21, C8orf5, C8orf7" ENSG00000171044 "XK related 6" Q5GH73 8 10896045-11201366 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Cell line enhanced" "Detected in many" "Karpas-707: 6.2;U-266/84: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA024828, HPA064769" Uncertain Approved "Actin filaments" "Actin filaments" "HPA024828: AB_2215165, HPA064769: " "unprognostic (8.63e-3)" "unprognostic (8.45e-2)" "unprognostic (1.50e-1)" "unprognostic (9.92e-6)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (1.18e-1)" "unprognostic (8.75e-3)" "unprognostic (8.65e-2)" "unprognostic (7.09e-2)" "unprognostic (2.87e-1)" "unprognostic (1.31e-1)" "unprognostic (3.78e-2)" "unprognostic (3.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.58e-1)" "unprognostic (3.29e-3)" 2.0 2.9 3.0 4.8 13.1 4.1 2.5 21.4 6.3 1.9 2.7 1.4 1.9 1.7 2.4 1.3 3.8 2.2 2.0 1.5 3.4 1.6 2.3 1.0 2.7 3.9 1.3 4.4 0.9 5.1 3.3 8.8 1.2 5.3 3.2 2.1 1.1 5.2 5.0 0.8 3.9 3.3 1.6 1.4 3.8 3.3 7.5 2.4 0.1 3.0 0.2 3.6 3.0 2.3 1.3 0.6 0.0 0.0 1.2 0.3 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.0 0.6 0.6 1.7 0.0 0.5 4.9 0.0 1.0 0.2 2.2 2.7 0.9 0.1 0.6 1.6 0.2 0.0 0.9 0.0 4.2 0.5 1.8 0.0 2.1 1.1 0.1 6.2 0.8 0.5 0.0 0.0 3.2 1.2 0.0 0.0 1.2 2.3 1.8 3.2 1.8 1.0 0.1 0.0 0.0 0.8 0.0 2.6 1.2 0.0 0.9 1.7 10.0 4.6 1.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 0.2 1.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 1.2 0.0 0.6 0.2 0.1 3.0 13.1 21.4 6.3 3.4 1.6 1.3 4.4 5.3 2.4 XKR7 "C20orf159, dJ310O13.4" ENSG00000260903 "XK related 7" Q5GH72 20 31968002-32003387 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 28.0;pituitary gland: 12.3" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 21.2" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 25.6" HPA040854 Uncertain "HPA040854: AB_10795481" "unprognostic (2.74e-2)" "unprognostic (5.60e-3)" "unprognostic (8.03e-2)" "unprognostic (3.74e-7)" "unprognostic (4.29e-2)" "unprognostic (9.34e-2)" "unprognostic (1.45e-1)" "unprognostic (2.69e-2)" "unprognostic (4.47e-2)" "unprognostic (2.68e-3)" "unprognostic (2.12e-1)" "unprognostic (1.26e-3)" "unprognostic (3.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.82e-5)" "unprognostic (1.99e-1)" 0.5 1.5 2.9 0.6 4.4 0.5 0.4 28.0 10.0 0.4 0.5 0.0 0.0 0.6 0.4 0.5 0.4 0.5 0.5 0.4 1.2 1.5 0.5 0.4 0.5 0.4 0.8 4.6 0.4 1.8 0.4 12.3 0.4 3.5 0.4 0.6 2.0 0.4 0.5 0.4 0.5 0.5 0.4 0.6 0.5 1.7 1.2 0.0 0.0 0.4 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 21.2 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.9 4.4 28.0 8.7 1.2 1.5 0.8 4.6 3.5 0.0 YJEFN3 "FLJ44968, hYjeF_N3-19p13.11" ENSG00000250067 "YjeF N-terminal domain containing 3" A6XGL0 19 19528861-19537581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.8" "Cell line enhanced" "Detected in some" "BEWO: 11.2;HEK 293: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA060789 Enhanced Approved Mitochondria Mitochondria "HPA060789: " "unprognostic (2.59e-2)" "unprognostic (2.50e-1)" "unprognostic (5.99e-6)" "unprognostic (1.65e-1)" "unprognostic (3.16e-1)" "unprognostic (2.28e-2)" "unprognostic (4.37e-4)" "unprognostic (2.38e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "prognostic favourable (7.25e-4)" "unprognostic (2.11e-2)" "prognostic unfavourable (1.30e-7)" "unprognostic (1.17e-2)" "unprognostic (8.26e-2)" "unprognostic (2.48e-1)" "unprognostic (9.49e-3)" 1.2 0.9 24.2 1.4 47.8 0.8 1.0 0.8 26.5 1.1 1.3 1.1 0.0 1.0 1.3 6.6 1.0 1.6 0.9 0.8 29.5 8.3 1.0 0.8 1.4 1.4 7.7 10.2 1.1 1.0 1.7 0.8 1.3 3.6 2.0 1.6 4.1 0.9 1.5 1.6 3.0 1.6 1.2 1.0 1.1 1.4 7.1 5.1 0.0 1.7 0.0 1.3 1.5 0.0 0.5 0.5 0.3 1.1 0.0 2.2 0.3 0.2 0.8 1.9 0.8 0.3 0.5 11.2 0.5 0.1 0.4 0.7 0.9 0.6 0.4 1.4 0.1 1.1 0.3 0.2 0.0 0.1 13.1 0.0 1.5 0.0 0.1 0.3 0.5 0.1 0.5 0.2 0.4 0.0 0.9 0.6 0.0 0.9 0.0 0.1 3.5 2.6 2.1 0.4 0.4 0.0 0.1 0.3 3.1 0.2 0.0 0.2 1.2 1.6 0.7 0.3 0.7 3.4 0.7 3.2 2.1 0.6 0.2 1.7 0.4 0.0 0.7 0.0 0.7 1.1 0.8 0.3 1.2 0.6 0.5 0.5 0.7 1.1 0.3 0.0 0.7 0.0 2.2 0.3 24.2 47.8 0.8 26.5 29.5 8.3 7.7 10.2 3.6 5.1 YPEL1 ENSG00000100027 "Yippee like 1" O60688 22 21697544-21735834 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.8;testis: 44.2" "Cell line enhanced" "Detected in many" "AF22: 9.2;MOLT-4: 12.1;REH: 10.9;SCLC-21H: 10.9;U-266/70: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 35.6;basal ganglia: 12.9;cerebral cortex: 29.3;hippocampal formation: 33.9;olfactory region: 12.4" "Low region specificity" "Detected in all" "HPA030501, HPA045621" Uncertain "HPA030501: AB_10602683, HPA045621: " "unprognostic (1.36e-1)" "unprognostic (2.47e-3)" "unprognostic (2.10e-1)" "prognostic unfavourable (3.09e-5)" "unprognostic (3.82e-3)" "unprognostic (1.06e-4)" "unprognostic (1.44e-1)" "unprognostic (1.10e-2)" "unprognostic (2.38e-1)" "unprognostic (1.61e-1)" "unprognostic (4.68e-3)" "unprognostic (2.06e-1)" "unprognostic (1.27e-1)" "unprognostic (6.03e-2)" "unprognostic (1.55e-1)" "unprognostic (2.51e-2)" "unprognostic (5.16e-3)" 2.6 1.8 9.7 2.2 23.8 3.6 3.5 10.5 12.8 1.9 2.2 3.0 0.1 1.2 4.9 2.3 1.8 2.9 2.4 6.1 7.7 4.7 2.0 2.1 4.7 3.9 2.6 6.7 7.6 2.3 1.8 2.5 1.1 3.1 2.7 2.3 2.6 2.2 1.6 10.1 1.9 1.7 2.6 2.9 7.6 2.4 44.2 4.9 7.9 2.3 2.2 3.8 2.1 1.0 1.6 3.0 2.3 0.4 4.5 2.8 0.7 0.8 0.0 9.2 5.1 0.7 0.5 0.5 0.5 0.1 0.8 1.0 0.0 0.6 1.4 1.3 0.3 0.1 0.7 0.3 0.8 4.7 1.7 0.1 0.1 0.5 0.6 0.4 1.6 0.9 0.1 0.2 0.0 1.4 0.3 4.9 0.4 0.3 12.1 2.2 0.3 0.5 10.9 2.2 0.5 0.2 0.0 10.9 7.5 0.8 0.9 1.0 0.6 0.9 1.5 0.2 2.1 0.2 0.3 9.4 3.7 3.7 0.6 1.2 1.1 0.4 0.3 0.3 2.8 0.4 2.7 0.4 0.8 2.7 0.3 1.6 0.3 1.5 2.3 4.5 0.3 3.0 1.1 0.7 9.7 23.8 10.5 10.0 7.7 4.7 2.6 6.7 3.1 4.9 YPEL4 FLJ30213 ENSG00000166793 "Yippee like 4" Q96NS1 11 57645087-57649944 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.4" "Cell line enhanced" "Detected in some" "AF22: 6.1;ASC diff: 3.8;ASC TERT1: 3.5;SK-MEL-30: 7.2;U-87 MG: 3.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.6" "Lineage enriched" "Detected in single" 5 "T-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045621 Uncertain "HPA045621: " "unprognostic (6.91e-3)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (8.62e-3)" "unprognostic (2.40e-1)" "unprognostic (7.50e-2)" "unprognostic (2.11e-2)" "unprognostic (2.47e-1)" "unprognostic (4.28e-2)" "unprognostic (1.04e-1)" "unprognostic (2.14e-1)" "unprognostic (4.18e-1)" "unprognostic (1.34e-6)" "unprognostic (1.50e-4)" "unprognostic (9.56e-2)" "unprognostic (1.86e-3)" "unprognostic (2.92e-1)" 2.1 7.5 17.8 1.5 13.5 12.3 2.4 27.4 26.3 5.0 1.7 6.0 0.0 1.9 5.1 1.3 1.9 1.8 3.1 1.9 9.8 10.6 1.1 1.1 1.9 1.3 8.0 17.7 8.7 1.6 1.0 3.5 2.2 8.5 1.3 1.4 0.2 1.4 2.0 1.0 1.6 1.9 3.5 5.3 1.8 1.3 2.5 8.9 0.0 1.1 0.0 1.2 1.6 1.9 0.0 0.0 0.0 0.3 0.0 1.6 0.1 0.7 0.1 6.1 0.3 3.8 3.5 0.7 0.2 2.8 0.0 0.0 0.4 0.1 0.1 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.0 3.2 1.5 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.4 2.5 0.0 2.4 0.7 0.4 0.1 0.0 0.0 1.6 0.3 0.6 7.2 0.5 0.0 0.0 0.4 1.6 0.0 0.0 2.7 0.0 0.0 3.6 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.4 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.1 17.8 13.5 27.4 23.1 9.8 10.6 8.0 17.7 8.5 8.9 YWHAG PPP1R170 ENSG00000170027 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma" P61981 7 76326794-76359031 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 117.8;skeletal muscle: 91.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013274, CAB018389, HPA026918, HPA061603" Approved Approved Supported Nucleoplasm,Nucleoli,Cytosol 160000000 Cytosol "Nucleoplasm, Nucleoli" "CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: " "unprognostic (3.71e-2)" "prognostic unfavourable (4.53e-4)" "unprognostic (3.88e-2)" "unprognostic (1.25e-2)" "unprognostic (6.28e-3)" "unprognostic (2.40e-3)" "unprognostic (8.98e-3)" "prognostic unfavourable (5.34e-4)" "unprognostic (1.63e-1)" "unprognostic (1.64e-1)" "prognostic unfavourable (7.44e-4)" "unprognostic (3.03e-2)" "prognostic unfavourable (4.01e-4)" "unprognostic (9.31e-2)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (1.70e-1)" 52.4 31.2 46.3 17.7 54.6 7.3 17.2 36.2 117.8 13.4 14.2 13.3 4.6 14.4 15.0 7.0 18.6 9.0 17.0 33.1 50.2 56.2 15.9 22.0 12.9 12.1 45.9 49.8 13.3 18.0 14.8 7.8 16.6 74.6 14.7 14.0 8.6 10.0 13.3 91.8 11.7 12.5 20.2 22.8 12.7 11.2 8.9 13.5 6.8 8.8 13.8 14.3 14.7 13.2 3.1 5.9 3.2 5.0 1.1 3.3 1.7 37.1 46.7 41.4 52.5 42.4 24.5 18.7 43.2 21.4 26.8 29.2 29.3 40.0 52.4 14.9 38.3 34.8 51.8 47.7 37.8 35.5 22.6 49.6 32.0 32.5 38.7 60.5 48.6 26.8 45.8 31.3 64.9 42.6 68.1 59.3 40.0 35.0 43.2 44.7 45.9 32.8 50.7 41.9 57.9 42.1 25.4 22.2 61.7 47.9 61.4 30.6 42.7 36.7 44.9 52.4 30.5 46.4 57.7 19.7 36.9 80.7 47.1 57.3 55.8 3.2 5.0 1.1 2.1 4.6 3.3 3.1 2.4 2.6 5.2 1.8 1.8 2.0 1.1 1.1 3.8 5.9 2.0 1.7 46.3 54.6 36.2 88.9 50.2 56.2 45.9 49.8 74.6 13.5 YWHAH YWHA1 ENSG00000128245 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta" Q04917 22 31944461-31957603 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 154.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025918, HPA061603" Uncertain Approved Nucleoli,Cytosol 130000000 Cytosol Nucleoli "CAB025918: , HPA061603: " "unprognostic (3.77e-1)" "unprognostic (6.13e-2)" "unprognostic (1.67e-2)" "unprognostic (1.86e-2)" "unprognostic (1.13e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (1.59e-5)" "unprognostic (8.62e-2)" "unprognostic (1.63e-1)" "unprognostic (4.51e-2)" "unprognostic (3.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.40e-1)" "unprognostic (1.59e-1)" "unprognostic (5.60e-2)" "unprognostic (7.00e-2)" "unprognostic (6.81e-2)" 21.5 18.6 87.9 20.6 47.4 16.3 19.3 41.9 154.3 13.7 24.4 10.0 4.3 17.2 13.1 14.1 14.0 16.4 18.6 15.2 78.8 59.1 11.7 11.5 25.0 13.5 35.5 101.6 10.0 16.7 5.2 10.4 22.4 49.5 12.3 20.1 6.8 9.9 15.6 13.9 9.9 17.4 25.9 19.4 12.8 26.9 3.7 9.1 6.3 10.5 5.5 15.1 18.5 10.6 8.1 16.6 14.9 14.4 17.7 12.8 9.6 67.9 27.2 30.4 17.7 18.5 17.1 19.3 66.1 32.7 38.1 43.6 28.8 23.7 40.1 16.1 60.6 32.9 36.4 36.3 36.0 35.5 31.7 23.7 21.4 25.7 18.7 76.3 26.5 15.5 19.4 32.1 22.9 31.1 32.7 29.4 29.0 27.4 23.1 35.1 36.2 29.8 33.2 41.9 21.3 24.0 29.4 65.4 21.5 37.6 26.3 23.5 15.0 18.9 49.7 38.5 38.5 28.2 41.9 16.4 25.3 50.2 27.9 30.8 33.8 7.8 14.4 14.9 5.7 11.8 8.1 8.1 7.0 8.1 16.6 7.6 2.8 3.6 8.7 17.7 12.2 4.5 12.8 9.6 87.9 47.4 41.9 126.3 78.8 59.1 35.5 101.6 49.5 9.1 Z82190.2 ENSG00000285404 22 31754899-31956243 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.9;brain: 1.3;liver: 1.7" "Cell line enhanced" "Detected in some" "HDLM-2: 1.0;REH: 1.1;U-2197: 2.5;U-251 MG: 1.4;U-698: 1.0" "Cell type enhanced" "Detected in some" "non-classical monocyte: 1.9" "Group enriched" "Detected in many" 6 "granulocytes: 1.1;monocytes: 1.9" "HPA054969, HPA055619" Uncertain "HPA054969: , HPA055619: " 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.4 0.0 0.2 1.0 0.0 0.0 0.0 0.3 0.2 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.0 1.9 0.0 0.0 0.1 ZAR1 Z3CXXC6 ENSG00000182223 "Zygote arrest 1" Q86SH2 4 48490252-48494389 "Plasma proteins, Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 2.0;brain: 2.7;salivary gland: 1.3;testis: 4.2" "Cell line enhanced" "Detected in some" "HAP1: 1.2;HeLa: 1.5;K-562: 1.2;SCLC-21H: 2.4;SH-SY5Y: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basal ganglia: 1.7;hypothalamus: 1.1;midbrain: 2.7;pons and medulla: 0.5" "unprognostic (9.71e-2)" "unprognostic (2.58e-1)" "unprognostic (4.59e-3)" "unprognostic (2.47e-2)" "unprognostic (6.83e-2)" "unprognostic (2.41e-1)" "unprognostic (3.54e-1)" "unprognostic (1.08e-1)" "unprognostic (6.35e-2)" "unprognostic (6.32e-5)" "unprognostic (4.51e-1)" 0.0 0.0 0.0 0.0 0.8 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 2.7 0.4 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.6 0.0 0.4 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.2 1.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 3.1 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZAR1L Z3CXXC7 ENSG00000189167 "Zygote arrest 1 like" A6NP61 13 32303700-32315344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.2;gallbladder: 2.7;testis: 3.5" "Cell line enhanced" "Detected in some" "CACO-2: 3.0;MCF7: 2.1;U-698: 2.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "cerebral cortex: 2.2;thalamus: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 1.0;basal ganglia: 1.8;cerebral cortex: 2.8;hippocampal formation: 2.2" "Low region specificity" "Detected in many" HPA041319 Uncertain "HPA041319: AB_10794407" "unprognostic (4.03e-1)" "unprognostic (1.79e-1)" "unprognostic (4.38e-2)" "unprognostic (2.26e-1)" "unprognostic (2.25e-1)" "unprognostic (8.33e-3)" "unprognostic (6.08e-2)" "unprognostic (1.47e-2)" "unprognostic (1.66e-1)" "unprognostic (8.34e-2)" "unprognostic (3.73e-1)" "unprognostic (7.51e-2)" 0.2 0.1 0.1 0.1 0.1 0.8 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 2.7 0.0 0.1 0.2 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.1 0.2 0.0 3.5 1.3 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.8 0.5 0.3 0.2 0.0 0.1 0.0 0.1 0.4 0.3 0.0 0.2 0.2 0.0 0.6 0.5 3.0 0.3 1.2 0.4 0.0 0.3 1.2 0.2 0.4 0.6 0.0 0.3 0.4 0.3 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.2 0.4 0.4 0.2 2.1 0.3 0.6 1.1 0.7 1.2 1.0 0.3 0.0 0.3 0.1 0.2 0.0 0.4 0.2 0.1 1.0 0.0 0.4 0.0 0.9 0.0 0.8 0.5 2.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.2 0.1 0.2 0.0 0.0 0.0 1.3 ZBBX FLJ23049 ENSG00000169064 "Zinc finger B-box domain containing" A8MT70 3 167240287-167381346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.0;epididymis: 14.2;fallopian tube: 23.4;testis: 33.3" "Cell line enhanced" "Detected in some" "AF22: 2.9;CAPAN-2: 2.2;NTERA-2: 1.5;PC-3: 1.2;SCLC-21H: 1.9;U-138 MG: 1.4;U-87 MG: 2.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036327, HPA036328" Enhanced "HPA036327: AB_10672240, HPA036328: AB_2675063" "unprognostic (2.68e-3)" "unprognostic (4.49e-2)" "unprognostic (6.94e-2)" "unprognostic (3.99e-1)" "unprognostic (4.08e-2)" "unprognostic (7.61e-2)" "unprognostic (1.24e-1)" "unprognostic (1.75e-3)" "unprognostic (1.29e-1)" "unprognostic (2.30e-3)" "unprognostic (1.15e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" 0.3 0.6 2.5 0.3 12.9 0.3 0.3 0.0 3.3 1.3 0.4 4.5 0.0 0.3 1.1 14.2 0.3 23.4 0.3 0.3 4.7 3.9 0.5 0.3 7.2 0.4 0.4 2.6 6.9 0.3 0.8 5.3 0.4 22.0 0.4 0.3 0.0 0.3 0.4 0.4 0.3 0.3 0.4 0.5 0.3 0.4 33.3 3.4 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.5 1.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.4 0.7 0.0 0.1 0.8 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 12.9 0.0 3.3 4.7 3.9 0.4 2.6 22.0 3.4 ZBTB18 "C2H2-171, RP58, TAZ-1, ZNF238" ENSG00000179456 "Zinc finger and BTB domain containing 18" Q99592 1 244048939-244057476 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 114.4;skeletal muscle: 40.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 114.4" "Cell type enhanced" "Detected in many" "neutrophil: 5.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024656 Supported "Nuclear speckles" "Nuclear speckles" "HPA024656: " "unprognostic (3.48e-3)" "unprognostic (9.17e-3)" "unprognostic (3.69e-3)" "prognostic favourable (1.34e-4)" "unprognostic (6.83e-2)" "unprognostic (4.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.15e-2)" "unprognostic (1.15e-2)" "unprognostic (8.43e-2)" "unprognostic (1.01e-2)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.54e-3)" "prognostic favourable (6.78e-6)" 4.1 3.4 20.1 7.3 14.7 13.4 4.7 114.4 26.0 4.1 4.7 5.4 8.1 6.9 3.5 10.3 3.0 4.6 3.8 7.4 24.8 6.3 6.4 10.0 5.1 8.8 7.1 19.1 4.0 13.0 3.1 2.7 4.9 11.7 5.5 5.8 4.6 5.2 6.7 40.3 4.1 6.2 5.9 7.5 10.0 5.8 11.4 4.6 16.4 4.4 2.8 8.1 6.5 9.3 2.4 2.2 5.8 1.5 0.3 1.4 0.2 11.5 4.1 15.9 0.6 2.1 2.2 11.1 6.5 4.8 10.5 6.4 3.1 9.4 8.8 0.6 12.5 1.2 10.1 3.2 13.2 3.1 8.9 1.5 1.4 1.5 3.3 1.8 4.7 1.8 2.7 6.3 3.9 11.3 1.1 3.8 12.4 0.1 15.1 7.4 8.2 1.8 4.4 10.8 2.5 6.6 4.0 23.5 23.0 2.7 0.1 7.1 0.2 13.4 16.8 5.4 6.6 3.3 13.7 1.6 0.2 3.5 5.5 5.7 10.9 0.2 0.7 2.9 0.3 0.7 0.4 1.6 0.7 0.5 0.9 2.4 1.4 0.9 5.8 0.3 1.5 2.2 0.5 0.2 20.1 14.7 114.4 24.1 24.8 6.3 7.1 19.1 11.7 4.6 ZC3H12B "CXorf32, MCPIP2" ENSG00000102053 "Zinc finger CCCH-type containing 12B" Q5HYM0 X 65366638-65507887 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 6.1" "Cell line enhanced" "Detected in many" "AF22: 5.2;Karpas-707: 4.2" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA000836 Uncertain Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" "Endoplasmic reticulum" "Golgi apparatus, Vesicles" "HPA000836: AB_2217374" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (1.38e-1)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (7.44e-3)" "unprognostic (7.86e-3)" "unprognostic (5.46e-2)" "unprognostic (3.32e-1)" "unprognostic (5.76e-2)" "unprognostic (1.12e-3)" "unprognostic (1.28e-1)" "unprognostic (2.61e-1)" "unprognostic (1.11e-2)" "unprognostic (5.08e-2)" "unprognostic (1.45e-2)" "unprognostic (1.71e-2)" 0.3 0.9 2.6 0.5 3.9 0.1 0.5 2.8 6.1 1.9 1.1 0.9 2.6 0.8 0.4 2.0 1.1 0.5 2.8 2.5 1.2 0.5 0.6 0.7 1.7 3.3 0.1 2.7 2.7 0.0 1.8 1.1 0.3 2.4 0.0 0.3 0.9 1.8 1.5 0.4 1.3 0.0 1.5 0.2 1.0 0.7 1.3 0.8 0.7 0.4 0.8 1.8 0.2 0.3 0.4 5.2 0.8 0.0 0.0 0.7 1.3 2.8 0.0 0.8 0.7 0.5 0.8 0.3 1.4 0.8 1.3 0.0 0.1 0.8 3.8 1.7 2.4 0.7 0.1 1.6 0.4 0.2 0.0 0.1 0.0 0.0 0.9 4.2 0.1 0.0 2.2 0.6 2.1 1.1 2.5 0.2 1.0 0.1 0.2 0.2 2.5 0.0 0.2 0.2 0.1 1.3 0.0 0.1 1.0 1.7 0.5 0.9 1.0 1.7 3.3 2.2 0.0 0.6 0.4 0.1 0.6 0.2 0.5 0.9 0.8 0.8 0.2 1.3 1.8 0.8 0.7 0.8 0.2 0.8 0.4 0.2 ZCCHC12 "FLJ16123, PNMA7A, SIZN, SIZN1" ENSG00000174460 "Zinc finger CCHC-type containing 12" Q6PEW1 X 118823790-118826968 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 51.3;endometrium 1: 53.4;fallopian tube: 60.7;smooth muscle: 72.5" "Cell line enhanced" "Detected in some" "HAP1: 5.4;HEK 293: 13.9;NTERA-2: 4.4;SH-SY5Y: 3.5" "Cancer enriched" "Detected in many" 76 "thyroid cancer: 256.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "naive CD8 T-cell: 4.1" "Lineage enriched" "Detected in single" 6 "T-cells: 4.1" "HPA031016, HPA034940" Uncertain Approved "Nuclear bodies" "Nuclear bodies" "HPA031016: AB_2673698, HPA034940: AB_10671098" "unprognostic (1.29e-1)" "unprognostic (7.48e-3)" "unprognostic (1.96e-1)" "unprognostic (1.28e-1)" "unprognostic (1.27e-2)" "unprognostic (1.28e-1)" "unprognostic (5.66e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-1)" "unprognostic (3.44e-1)" "unprognostic (8.36e-3)" "unprognostic (5.34e-4)" "unprognostic (9.18e-13)" "unprognostic (4.14e-3)" "unprognostic (1.63e-1)" "prognostic favourable (3.42e-5)" "unprognostic (1.18e-1)" 0.9 4.8 30.5 1.2 20.2 0.8 1.0 20.3 17.3 9.7 1.1 1.6 0.9 1.0 53.4 11.6 0.8 60.7 1.0 0.8 28.7 51.3 0.8 0.8 0.9 1.1 4.4 11.6 6.7 0.8 0.8 7.9 0.8 14.7 1.0 1.0 1.1 0.8 1.1 0.8 0.8 1.1 72.5 4.5 0.9 0.8 1.0 0.8 0.0 2.9 0.0 1.1 0.8 1.7 0.6 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.7 0.0 0.0 0.4 0.0 0.0 5.4 0.0 0.2 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.2 4.4 0.0 0.1 0.0 0.0 0.0 0.0 1.9 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.7 4.1 0.0 0.0 0.0 0.0 0.0 0.2 30.5 20.2 20.3 17.3 28.7 51.3 4.4 11.6 14.7 0.8 ZCCHC18 "PNMA7B, SIZN2" ENSG00000166707 "Zinc finger CCHC-type containing 18" P0CG32 X 104112131-104115846 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 9.6;ovary: 9.4" "Cell line enhanced" "Detected in some" "Daudi: 4.5;Karpas-707: 8.4;SH-SY5Y: 5.7" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 19 "B-cells: 3.0;T-cells: 2.2" "Low region specificity" "Detected in all" "HPA034940, HPA078516" Uncertain Approved Vesicles Vesicles "HPA034940: AB_10671098, HPA078516: " "unprognostic (7.20e-2)" "unprognostic (7.71e-4)" "unprognostic (8.29e-2)" "unprognostic (4.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-3)" "unprognostic (2.20e-2)" "unprognostic (3.22e-2)" "unprognostic (7.59e-2)" "unprognostic (3.34e-1)" "unprognostic (4.44e-6)" "unprognostic (4.05e-2)" "unprognostic (1.02e-6)" "unprognostic (3.82e-2)" "unprognostic (4.02e-1)" "unprognostic (3.91e-2)" "unprognostic (4.14e-3)" 0.9 2.3 3.4 3.3 9.4 1.1 2.6 9.6 9.2 1.7 0.9 1.2 0.5 1.1 3.6 1.1 1.0 1.6 1.4 1.2 3.1 7.7 0.5 0.3 1.0 4.9 3.8 4.9 9.4 2.6 0.3 2.3 0.7 4.7 1.5 1.1 1.2 0.5 1.8 1.0 0.5 2.6 1.9 2.5 3.4 1.4 2.2 2.2 0.0 0.4 0.2 5.1 2.0 1.1 3.0 0.0 0.0 0.0 0.1 2.2 0.3 0.0 0.2 3.5 2.4 0.3 0.0 0.2 0.7 0.1 0.6 0.6 0.1 0.0 4.5 0.1 0.2 0.0 2.1 0.0 0.3 1.3 1.7 0.8 0.2 0.0 0.4 2.5 0.8 0.2 0.0 0.4 0.0 0.7 0.0 8.4 0.2 0.0 0.0 0.1 1.9 0.6 3.0 0.8 0.0 0.5 0.3 2.4 5.7 0.2 0.0 0.0 0.0 0.3 1.5 0.1 1.1 0.2 1.0 0.2 0.0 2.2 0.1 2.5 0.7 0.0 0.0 0.0 1.4 0.0 2.2 2.5 1.1 1.7 0.0 3.0 1.2 1.6 0.0 0.1 0.0 0.0 0.8 0.3 3.4 9.4 9.6 7.2 3.1 7.7 3.8 4.9 4.7 2.2 ZCCHC24 "C10orf56, FLJ90798, Z3CXXC8" ENSG00000165424 "Zinc finger CCHC-type containing 24" Q8N2G6 10 79382325-79445627 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell line enhanced" "Detected in many" "ASC diff: 42.7;ASC TERT1: 36.7;BJ hTERT+: 28.0;HSkMC: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038348 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA038348: AB_10669538" "unprognostic (3.47e-3)" "unprognostic (8.70e-3)" "unprognostic (3.35e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (7.28e-2)" "unprognostic (2.17e-2)" "unprognostic (2.25e-2)" "unprognostic (2.62e-1)" "prognostic unfavourable (3.76e-4)" "unprognostic (4.77e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (5.35e-6)" "unprognostic (1.84e-2)" "unprognostic (5.52e-2)" "unprognostic (2.85e-2)" "unprognostic (2.95e-3)" 27.9 9.0 30.9 9.5 54.4 1.8 9.8 11.1 36.0 22.9 19.8 56.8 4.2 4.6 18.0 6.9 10.3 15.5 16.8 19.1 30.6 19.7 3.5 13.5 10.2 4.8 56.7 23.5 20.1 4.0 3.9 3.0 11.4 36.2 14.5 6.8 4.5 6.2 20.7 34.8 5.0 5.4 25.6 36.8 7.0 9.0 6.6 51.9 0.0 6.0 2.5 3.2 14.9 7.3 0.0 3.4 0.6 2.4 0.7 0.9 0.5 0.9 0.9 3.2 2.7 42.7 36.7 0.7 7.4 28.0 4.4 5.1 0.8 0.0 0.0 4.0 14.8 0.0 0.5 0.1 3.7 1.8 1.9 0.3 2.2 0.9 11.1 1.1 0.6 38.1 0.4 3.9 1.0 0.9 1.4 1.6 3.7 0.3 0.0 4.4 0.7 9.2 0.1 3.8 0.6 0.5 1.2 0.1 4.0 2.3 0.3 9.2 1.1 2.1 0.6 4.2 3.9 11.5 2.5 2.8 1.8 0.0 8.7 1.4 15.0 0.0 2.4 0.6 0.9 1.1 0.2 0.0 0.0 0.3 1.6 0.0 0.0 0.2 0.6 0.7 0.1 3.4 0.4 0.5 30.9 54.4 11.1 36.0 30.6 19.7 56.7 23.5 36.2 51.9 ZDBF2 "FLJ45338, KIAA1571, Slx9" ENSG00000204186 "Zinc finger DBF-type containing 2" Q9HCK1 2 206274663-206314428 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.9" "Cell line enhanced" "Detected in many" "BEWO: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA039121, HPA050311" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039121: , HPA050311: " "unprognostic (8.32e-2)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "unprognostic (2.86e-2)" "unprognostic (3.27e-2)" "unprognostic (4.52e-2)" "unprognostic (2.01e-1)" "unprognostic (2.98e-1)" "unprognostic (7.73e-3)" "unprognostic (7.59e-2)" "unprognostic (4.41e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (9.59e-2)" "unprognostic (3.08e-1)" "unprognostic (3.09e-1)" "unprognostic (1.40e-1)" 4.4 12.0 8.6 3.5 26.9 2.2 4.2 14.7 12.7 5.4 3.7 2.1 5.1 2.0 7.2 6.1 3.1 5.1 4.4 4.5 8.9 8.3 4.9 3.6 3.2 3.8 3.7 10.8 14.8 8.3 5.6 20.9 7.5 9.0 4.7 2.6 3.8 3.7 5.3 5.4 3.9 3.0 5.1 4.0 4.2 3.4 5.4 3.1 2.5 6.5 2.9 3.3 3.7 3.5 0.7 0.5 0.3 0.0 0.3 1.4 0.2 1.9 0.3 6.6 1.2 2.2 1.9 9.3 1.9 2.2 0.9 1.4 1.0 1.5 0.1 0.9 2.3 0.5 4.2 1.4 1.7 2.3 3.9 0.0 3.7 0.2 2.9 2.0 4.2 2.0 2.4 1.6 3.9 2.4 0.3 2.6 2.8 0.3 0.5 0.0 8.9 1.9 0.0 6.9 0.0 1.1 1.0 3.4 8.2 3.3 0.0 2.7 0.2 0.0 3.6 0.8 3.2 0.7 1.5 6.0 1.5 0.3 4.6 0.0 2.2 0.3 0.0 0.0 0.3 0.0 0.9 0.5 1.0 0.6 0.0 0.7 1.1 0.7 0.0 0.3 0.0 0.5 1.4 0.2 8.6 26.9 14.7 12.7 8.9 8.3 3.7 10.8 9.0 3.1 ZDHHC11 "FLJ13153, ZNF399" ENSG00000188818 "Zinc finger DHHC-type containing 11" Q9H8X9 5 795606-850986 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.2" "Cell line enhanced" "Detected in many" "T-47d: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA057886, HPA069008" Uncertain Approved "Lipid droplets" "Lipid droplets" "HPA057886: , HPA069008: " "unprognostic (2.67e-1)" "unprognostic (9.76e-3)" "unprognostic (4.47e-5)" "unprognostic (5.43e-2)" "unprognostic (7.46e-2)" "unprognostic (4.68e-2)" "unprognostic (3.71e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-2)" "unprognostic (2.32e-1)" "unprognostic (2.28e-2)" "unprognostic (2.65e-1)" "unprognostic (5.23e-5)" "unprognostic (4.80e-2)" "unprognostic (3.98e-1)" "unprognostic (1.86e-2)" "unprognostic (3.51e-2)" 1.8 1.4 3.4 1.0 4.2 0.7 2.7 11.0 3.8 1.6 1.5 6.3 1.0 9.5 1.7 2.9 3.2 10.3 1.2 6.4 4.2 3.8 2.0 2.6 7.5 1.0 15.2 1.9 1.5 1.9 1.8 7.8 1.2 10.9 2.7 1.2 1.0 1.4 3.4 2.1 2.7 1.7 1.0 5.0 2.4 5.9 6.3 6.1 1.0 1.1 2.3 1.8 1.0 1.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.3 7.4 4.1 0.8 1.3 0.3 5.5 0.3 0.1 0.2 0.1 1.0 0.3 3.0 0.8 0.1 6.9 2.2 0.0 0.1 9.0 4.8 0.3 2.6 3.7 0.3 4.3 0.3 0.4 0.3 0.9 1.0 0.0 0.7 1.7 0.2 3.3 0.4 2.6 7.3 2.9 4.5 2.8 4.1 0.2 1.5 4.1 0.7 0.2 0.1 3.1 11.5 0.7 0.4 0.2 6.9 3.9 0.1 5.5 7.7 0.9 0.3 8.9 0.2 0.0 0.0 0.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.2 11.0 3.8 4.2 3.8 15.2 1.9 10.9 6.1 ZDHHC11B ENSG00000206077 "Zinc finger DHHC-type containing 11B" P0C7U3 5 710360-766952 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 11.7" "Cell line enhanced" "Detected in some" "HAP1: 5.0;RPMI-8226: 4.4;SCLC-21H: 6.5;THP-1: 7.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "HPA057886, HPA069008" Uncertain Approved "Lipid droplets" "Lipid droplets" "HPA057886: , HPA069008: " "unprognostic (2.81e-1)" "unprognostic (8.38e-3)" "unprognostic (3.79e-2)" "unprognostic (5.11e-3)" "unprognostic (7.18e-2)" "unprognostic (4.02e-3)" "unprognostic (1.19e-1)" "prognostic favourable (3.98e-4)" "unprognostic (4.39e-3)" "unprognostic (1.29e-1)" "unprognostic (1.45e-4)" "unprognostic (6.94e-2)" "unprognostic (1.43e-2)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (2.31e-1)" 0.3 1.8 2.9 0.0 3.7 0.0 0.6 11.7 5.3 0.0 1.1 3.8 0.5 0.4 2.8 3.4 0.5 3.8 3.9 2.9 0.4 0.6 5.3 0.0 2.8 0.8 2.4 1.5 3.7 0.1 0.6 1.9 1.0 0.4 3.3 4.8 5.9 0.0 2.5 3.3 3.8 0.8 0.7 0.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.9 0.8 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.2 1.0 0.3 0.0 2.4 5.0 0.2 0.0 3.0 2.3 0.0 1.9 0.9 0.0 1.5 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.2 0.0 0.0 4.4 0.1 1.5 6.5 1.9 0.1 0.0 0.6 0.1 7.0 0.1 0.0 2.5 0.0 0.0 2.4 0.8 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 ZDHHC20 "DHHC20, FLJ25952" ENSG00000180776 "Zinc finger DHHC-type containing 20" Q5W0Z9 13 21372573-21459370 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014483, HPA014702" Approved Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA014483: AB_1859000, HPA014702: AB_1859001" "unprognostic (1.31e-1)" "unprognostic (2.16e-3)" "unprognostic (7.31e-3)" "unprognostic (8.89e-2)" "unprognostic (3.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.24e-2)" "unprognostic (1.26e-2)" "prognostic unfavourable (6.55e-4)" "unprognostic (1.10e-1)" "prognostic unfavourable (1.01e-4)" "unprognostic (3.76e-2)" "unprognostic (7.65e-2)" "unprognostic (6.15e-2)" "unprognostic (1.13e-2)" 7.5 7.0 8.3 9.4 33.6 14.9 11.3 6.4 15.3 10.3 10.9 21.0 7.6 10.8 9.3 5.6 18.4 7.1 10.0 5.4 12.7 11.8 3.8 7.6 10.6 12.3 47.4 4.9 6.5 6.1 4.0 5.3 10.8 26.1 9.2 9.6 3.1 10.4 9.9 5.5 12.2 15.4 8.9 45.0 8.6 23.1 22.0 35.8 10.4 10.0 5.1 10.9 16.2 9.6 4.6 7.8 8.8 15.2 10.1 10.2 11.1 13.5 7.8 11.4 7.2 10.6 11.2 27.9 14.8 14.9 9.9 8.9 14.2 41.5 14.4 8.0 18.1 22.0 13.1 11.4 18.8 15.7 8.3 25.3 4.9 7.8 6.0 17.1 11.0 10.2 8.0 9.8 6.9 15.3 7.0 6.1 14.7 11.4 23.9 6.5 9.3 7.7 19.2 20.5 5.0 11.8 25.2 10.9 5.0 19.5 12.2 8.0 11.2 8.7 26.6 10.5 10.0 17.6 11.0 6.3 7.7 15.0 7.5 9.9 29.5 8.8 15.2 3.4 10.2 14.2 9.4 4.6 8.8 8.7 7.8 3.7 8.3 8.5 2.7 10.1 12.0 3.9 9.3 11.1 8.3 33.6 6.4 15.3 12.7 11.8 47.4 4.9 26.1 35.8 ZDHHC22 C14orf59 ENSG00000177108 "Zinc finger DHHC-type containing 22" Q8N966 14 77131270-77142734 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 52.3" "Group enriched" "Detected in some" 4 "AF22: 5.2;NTERA-2: 5.5;RH-30: 9.2;SCLC-21H: 10.2" "Cancer enriched" "Detected in single" 40 "glioma: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049471, HPA072213" Enhanced "Plasma membrane" "Plasma membrane" "HPA049471: , HPA072213: " "unprognostic (1.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.22e-4)" "unprognostic (1.66e-1)" "unprognostic (8.86e-2)" "unprognostic (2.68e-1)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "unprognostic (6.94e-4)" "unprognostic (3.05e-1)" "unprognostic (6.30e-2)" "unprognostic (1.16e-1)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" "unprognostic (4.79e-1)" 1.1 1.5 11.2 1.1 12.6 1.1 1.1 8.4 52.3 1.1 1.2 6.7 0.0 1.1 1.1 1.4 1.3 1.2 1.1 1.2 14.5 18.4 1.1 1.1 1.1 1.1 10.7 19.5 1.1 1.1 1.1 3.1 1.1 9.2 1.1 1.3 0.5 1.1 1.1 1.3 1.1 1.1 1.2 3.6 1.1 1.3 1.4 5.1 0.0 1.3 0.0 1.1 1.4 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 5.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 5.5 0.7 0.0 9.2 0.0 0.0 0.0 10.2 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 11.2 12.6 8.4 29.5 14.5 18.4 10.7 19.5 9.2 5.1 ZDHHC9 "CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380" ENSG00000188706 "Zinc finger DHHC-type containing 9" Q9Y397 X 129803288-129843909 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031814 Uncertain Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" "Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA031814: AB_10610700" "prognostic unfavourable (9.77e-5)" "prognostic unfavourable (4.64e-5)" "unprognostic (2.83e-2)" "unprognostic (7.53e-3)" "unprognostic (2.68e-1)" "prognostic unfavourable (2.45e-4)" "unprognostic (4.01e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-1)" "unprognostic (3.49e-2)" "unprognostic (9.70e-3)" "unprognostic (4.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-2)" "unprognostic (4.11e-2)" 18.2 7.3 16.7 6.7 24.7 3.2 14.2 7.8 33.9 14.1 14.7 78.3 5.1 21.1 8.4 8.4 9.8 7.9 10.4 7.4 24.1 15.2 25.4 27.0 15.6 3.0 24.9 13.9 8.0 17.4 19.6 7.1 11.5 28.4 13.4 17.3 3.8 13.2 8.3 7.4 19.7 22.2 10.4 32.7 2.4 12.8 2.8 25.3 1.2 9.6 5.7 4.3 10.8 9.4 4.6 7.8 2.6 6.8 3.4 7.6 3.3 15.2 8.0 11.5 23.2 39.9 31.4 9.4 15.1 17.3 7.2 9.1 12.6 19.9 0.5 25.8 16.0 10.3 13.0 15.1 10.5 0.8 8.1 3.0 8.4 16.6 15.8 2.0 5.5 34.1 24.7 11.8 17.6 13.6 3.3 6.1 11.7 13.3 2.9 3.8 6.2 13.9 2.7 7.4 9.0 10.5 8.5 9.1 7.7 4.3 22.3 7.0 9.5 3.4 11.1 7.4 2.5 17.3 12.1 5.7 4.1 1.8 13.3 8.4 3.7 0.0 3.3 2.6 4.8 2.9 6.1 4.6 5.8 4.7 3.7 2.7 7.6 4.3 0.0 3.4 6.8 7.8 2.5 3.3 16.7 24.7 7.8 33.9 24.1 15.2 24.9 13.9 28.4 25.3 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144524583 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.6" "Cell line enhanced" "Detected in many" "HEL: 38.4;THP-1: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavourable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 30.2 23.7 48.0 27.8 42.4 55.5 16.6 6.7 36.6 29.4 12.3 72.9 3.4 11.3 15.6 11.1 14.4 11.1 22.6 22.5 52.5 28.8 9.9 11.6 20.7 19.6 54.4 26.4 37.5 3.6 5.0 3.1 31.5 37.6 10.9 16.3 15.7 5.7 12.5 9.6 7.7 12.8 17.2 76.6 32.6 9.3 8.2 38.7 1.9 8.3 7.5 12.4 21.5 14.8 5.0 12.7 9.7 21.6 3.6 10.7 7.4 0.4 0.5 22.1 0.0 26.4 13.5 0.0 9.1 9.2 10.2 9.9 0.0 0.2 1.6 0.0 9.8 0.1 3.7 0.0 12.8 9.4 2.6 38.4 1.6 0.0 5.9 6.6 30.5 11.0 0.2 12.6 6.1 7.7 10.7 1.1 12.0 0.0 0.0 20.1 3.2 0.5 11.3 15.2 0.0 0.1 0.2 0.1 5.8 1.1 0.0 23.9 0.0 45.7 11.9 11.7 0.2 22.8 2.8 12.5 0.0 1.9 17.6 19.9 31.6 9.7 21.6 5.7 10.7 20.8 1.0 4.4 1.4 5.3 12.7 5.0 1.1 4.0 7.5 3.6 19.5 10.2 0.3 7.4 48.0 42.4 6.7 35.6 52.5 28.8 54.4 26.4 37.6 38.7 ZFHX2 "KIAA1056, KIAA1762, ZFH-5, ZNF409" ENSG00000136367 "Zinc finger homeobox 2" Q9C0A1 14 23520855-23556192 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.5;testis: 17.9" "Cell line enhanced" "Detected in many" "AN3-CA: 8.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000720, HPA005146" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA000720: AB_10603462, HPA005146: AB_1859250" "unprognostic (7.54e-3)" "unprognostic (2.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (6.12e-3)" "unprognostic (1.40e-1)" "unprognostic (5.40e-2)" "unprognostic (3.94e-2)" "unprognostic (3.71e-2)" "unprognostic (5.08e-4)" "unprognostic (2.39e-1)" "unprognostic (5.33e-3)" "unprognostic (3.75e-1)" "unprognostic (7.35e-2)" "unprognostic (1.76e-1)" "unprognostic (1.90e-2)" 1.7 2.6 5.1 1.9 5.8 0.9 1.7 15.5 12.4 1.7 1.6 3.9 1.2 1.1 1.9 2.0 1.2 6.6 1.9 1.2 6.8 4.9 3.0 1.1 2.1 1.5 4.5 6.3 2.0 1.9 7.4 8.1 1.2 5.4 2.0 1.2 1.6 1.8 4.0 2.3 2.1 1.2 2.4 3.2 1.1 1.8 17.9 6.1 0.0 2.1 0.0 1.4 1.8 0.7 0.3 0.5 2.3 0.4 0.0 0.9 0.0 0.2 5.3 4.2 8.4 2.9 0.4 0.3 1.2 0.4 0.6 2.1 0.5 0.4 0.4 0.5 0.1 0.1 2.2 0.3 0.9 3.7 1.3 4.3 0.0 1.0 0.5 0.7 3.0 0.6 0.2 0.9 0.3 0.6 0.6 0.7 0.1 1.4 0.5 0.5 5.1 1.2 2.3 0.1 0.0 2.3 2.0 4.6 3.0 0.7 1.1 0.3 1.7 1.1 0.1 0.0 2.1 1.3 0.5 0.5 1.7 0.2 0.1 0.3 0.2 0.0 0.4 0.0 0.1 0.3 0.9 0.0 0.0 0.2 0.5 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 5.1 5.8 15.5 12.4 6.8 4.9 4.5 6.3 5.4 6.1 ZFP57 "bA145L22, bA145L22.2, C6orf40, ZNF698" ENSG00000204644 "ZFP57 zinc finger protein" Q9NU63 6 29672392-29681110 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.7;heart muscle: 14.4" "Cell line enriched" "Detected in single" 22 "BEWO: 11.9" "Cancer enriched" "Detected in many" 10 "testis cancer: 18.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "basophil: 3.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.8" "Low region specificity" "Detected in all" HPA047172 Uncertain "HPA047172: AB_10960886" "unprognostic (1.35e-1)" "unprognostic (1.74e-1)" "unprognostic (5.02e-2)" "unprognostic (6.40e-2)" "unprognostic (1.58e-1)" "unprognostic (4.72e-3)" "unprognostic (4.65e-2)" "unprognostic (1.38e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-4)" "prognostic favourable (1.95e-4)" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (2.29e-2)" "unprognostic (8.56e-2)" "unprognostic (7.45e-2)" "unprognostic (6.11e-2)" 0.9 0.6 3.8 0.3 4.1 1.1 4.2 0.1 2.3 0.5 0.4 0.4 2.4 0.3 0.5 0.5 0.9 0.3 1.9 14.4 5.5 3.2 0.5 0.3 0.9 6.1 7.6 0.1 0.7 5.2 0.3 0.1 1.5 0.5 0.7 0.6 0.2 2.3 2.1 0.4 0.7 1.2 1.5 12.7 0.8 0.3 1.4 0.1 1.2 0.3 0.7 1.1 1.5 5.5 0.3 0.7 3.8 0.5 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.5 0.0 0.6 0.3 0.3 0.3 0.4 0.5 0.7 0.0 0.2 0.4 0.0 0.3 0.2 0.0 0.6 0.3 3.8 4.1 0.1 1.4 5.5 3.2 7.6 0.1 0.5 0.1 ZFP69B "FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B" ENSG00000187801 "ZFP69 zinc finger protein B" Q9UJL9 1 40450102-40463718 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044289 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044289: AB_10962717" "unprognostic (2.01e-2)" "unprognostic (2.38e-2)" "unprognostic (1.17e-2)" "unprognostic (1.73e-2)" "unprognostic (1.58e-1)" "unprognostic (1.36e-2)" "unprognostic (6.44e-9)" "unprognostic (2.05e-1)" "unprognostic (7.10e-2)" "unprognostic (1.02e-2)" "unprognostic (6.85e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-5)" "unprognostic (1.64e-1)" "unprognostic (8.05e-2)" "unprognostic (7.88e-2)" "unprognostic (1.89e-1)" 1.6 1.7 7.8 4.6 11.1 1.1 2.8 8.2 12.8 3.1 2.5 1.8 0.1 2.6 4.3 2.4 2.2 1.6 3.3 1.8 6.3 4.9 1.6 2.4 1.6 3.7 3.6 5.8 2.0 3.5 3.2 3.6 1.1 4.7 2.0 3.1 1.2 1.9 1.8 1.2 1.4 1.8 3.0 3.2 2.3 2.5 4.0 3.8 5.0 2.7 0.9 5.5 3.8 1.7 2.1 1.2 0.9 2.1 1.3 4.1 1.0 3.3 1.3 5.6 13.9 2.1 5.7 1.6 3.2 3.1 1.4 2.8 1.6 2.2 6.3 3.1 2.8 1.2 2.9 2.8 3.2 5.5 1.2 2.6 3.2 4.7 1.5 0.4 4.2 1.3 4.7 5.1 6.8 2.0 6.8 6.3 4.4 2.3 8.4 0.6 7.7 1.4 4.8 5.6 3.0 2.9 3.2 7.7 8.0 5.1 4.4 2.1 2.3 7.3 4.3 4.7 10.0 4.3 4.6 9.8 9.3 13.7 6.3 0.9 4.9 0.0 0.3 0.9 2.6 2.1 3.5 2.0 1.8 1.4 1.2 2.1 3.4 3.0 0.2 1.3 0.7 0.5 4.1 1.0 7.8 11.1 8.2 12.8 6.3 4.9 3.6 5.8 4.7 3.8 ZFPM2 "FOG2, hFOG-2, ZC2HC11B, ZNF89B" ENSG00000169946 "Zinc finger protein, FOG family member 2" Q8WW38 8 104590733-105804532 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Gonadal differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.0;ovary: 37.8" "Cell line enhanced" "Detected in some" "AF22: 6.3;BJ hTERT+: 13.6;HHSteC: 9.9;HUVEC TERT2: 10.4;K-562: 5.6;TIME: 6.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 67.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004094 Approved Supported Nucleoplasm Nucleoplasm "HPA004094: AB_1859058" "unprognostic (4.48e-2)" "unprognostic (3.24e-2)" "unprognostic (7.77e-3)" "unprognostic (1.36e-2)" "unprognostic (3.51e-1)" "unprognostic (1.53e-1)" "unprognostic (8.37e-2)" "unprognostic (8.35e-3)" "unprognostic (1.97e-2)" "unprognostic (1.04e-1)" "unprognostic (1.97e-1)" "unprognostic (5.74e-2)" "unprognostic (1.69e-6)" "unprognostic (4.10e-3)" "unprognostic (5.41e-2)" "unprognostic (1.63e-4)" "unprognostic (2.61e-2)" 10.7 3.8 7.9 3.9 2.7 0.6 15.4 67.0 8.2 8.4 4.2 0.7 2.0 1.1 16.6 7.3 5.5 14.2 6.8 11.2 14.8 3.5 1.8 3.5 5.6 8.2 3.4 4.9 37.8 1.4 1.2 2.5 5.0 9.3 3.3 2.9 0.9 1.5 2.9 23.3 2.0 2.3 19.8 3.5 3.5 3.5 4.9 2.0 0.0 8.0 6.5 2.1 7.6 9.9 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 6.3 0.0 5.5 1.8 0.0 0.5 13.6 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 4.9 1.6 0.0 0.0 9.9 0.0 0.0 0.5 0.0 5.5 0.0 10.4 5.6 0.0 1.3 0.0 1.4 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 4.3 0.0 6.3 0.3 0.9 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 2.7 67.0 8.2 14.8 3.5 3.4 4.9 9.3 2.0 ZFR2 KIAA1086 ENSG00000105278 "Zinc finger RNA binding protein 2" Q9UPR6 19 3804024-3869032 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0;pituitary gland: 19.8;testis: 20.3" "Group enriched" "Detected in some" 12 "HMC-1: 17.4;NTERA-2: 29.9;SiHa: 8.8" "Cancer enhanced" "Detected in some" "cervical cancer: 2.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043275, HPA055678" Uncertain Uncertain Nucleoplasm Nucleoplasm "HPA043275: , HPA055678: " "unprognostic (1.74e-3)" "unprognostic (2.32e-3)" "unprognostic (4.05e-3)" "unprognostic (1.51e-2)" "unprognostic (6.60e-3)" "unprognostic (5.47e-4)" "unprognostic (9.12e-2)" "unprognostic (3.87e-2)" "unprognostic (1.18e-2)" "unprognostic (4.92e-2)" "unprognostic (1.97e-3)" "unprognostic (4.29e-2)" "unprognostic (3.58e-1)" "unprognostic (3.58e-1)" "unprognostic (5.81e-2)" "unprognostic (9.20e-2)" "unprognostic (2.18e-2)" 1.0 6.8 13.0 1.2 17.0 1.3 1.3 2.2 16.9 1.5 0.9 1.9 0.0 0.9 0.9 0.8 0.8 2.4 1.2 1.1 7.6 12.2 0.9 0.9 1.4 1.1 4.9 10.9 1.0 1.7 0.8 19.8 0.8 7.4 1.3 1.0 5.7 1.2 1.1 0.9 1.2 1.4 0.8 3.9 1.3 1.3 20.3 2.3 0.0 1.2 0.0 1.4 0.8 0.2 0.9 0.2 1.5 0.2 1.7 4.5 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 29.9 0.0 0.0 0.0 0.0 1.4 0.0 1.0 0.6 8.8 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.5 0.2 0.2 3.4 0.0 4.5 0.2 2.6 1.9 0.0 0.9 3.9 3.4 0.5 1.7 0.0 0.2 0.8 1.4 13.0 17.0 2.2 15.0 7.6 12.2 4.9 10.9 7.4 2.3 ZFYVE28 KIAA1643 ENSG00000159733 "Zinc finger FYVE-type containing 28" Q9HCC9 4 2269582-2418663 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 63.6" "Cell line enhanced" "Detected in many" "HMC-1: 11.0;NB-4: 11.9;U-266/70: 12.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 63.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038175, HPA057587" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA038175: AB_10697244, HPA057587: " "unprognostic (1.59e-1)" "unprognostic (4.60e-2)" "unprognostic (7.68e-2)" "unprognostic (3.08e-3)" "unprognostic (9.89e-3)" "unprognostic (3.79e-2)" "unprognostic (3.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.64e-2)" "prognostic favourable (1.35e-6)" "unprognostic (6.05e-2)" "unprognostic (5.27e-2)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" 4.5 8.6 7.7 5.1 15.8 3.1 3.7 63.6 15.1 3.7 7.4 4.6 1.8 10.4 4.1 3.1 3.4 4.3 5.9 2.4 7.1 5.5 5.7 4.2 4.4 6.1 7.9 8.0 3.4 7.3 7.9 7.5 1.8 9.9 2.9 5.1 5.8 9.5 5.4 4.3 5.7 11.9 2.8 9.4 7.0 7.5 7.9 6.7 1.2 5.3 3.1 4.0 4.5 3.2 3.1 0.7 0.9 0.4 0.3 4.4 1.3 0.8 1.0 0.2 3.7 2.1 0.7 0.1 1.8 3.1 1.0 0.3 0.1 6.6 0.0 1.9 3.2 3.8 1.2 0.3 0.6 9.5 1.3 0.2 4.2 0.3 4.3 0.7 11.0 3.0 0.6 1.1 0.1 3.0 1.8 8.1 0.9 2.2 0.1 11.9 0.1 8.1 0.0 0.0 3.9 1.5 0.5 5.8 0.4 1.8 0.1 1.0 2.4 0.3 0.5 1.7 0.0 5.4 0.1 12.6 9.1 0.1 5.3 2.3 1.8 0.9 0.4 0.1 4.4 0.0 1.9 0.9 2.3 3.2 0.7 3.1 3.2 3.2 0.1 0.3 0.3 0.2 4.0 1.3 7.7 15.8 63.6 15.1 7.1 5.5 7.9 8.0 9.9 6.7 ZIC1 "ZIC, ZNF201" ENSG00000152977 "Zic family member 1" Q15915 3 147393422-147510293 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 124.7" "Cell line enriched" "Detected in many" 4 "AF22: 60.8" "Cancer enhanced" "Detected in many" "glioma: 9.5" "Region enriched" "Detected in all" 8 "cerebellum: 124.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 232.6" "Region enriched" "Detected in many" 9 "cerebellum: 491.0" HPA004098 Supported Supported Nucleoplasm Nucleoplasm "HPA004098: AB_1859065" "unprognostic (1.33e-2)" "unprognostic (1.82e-1)" "unprognostic (4.01e-2)" "unprognostic (2.36e-1)" "unprognostic (9.32e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-2)" "unprognostic (2.19e-1)" "unprognostic (5.01e-1)" "unprognostic (2.61e-7)" "unprognostic (2.95e-3)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" 0.7 0.6 1.5 0.5 8.6 0.5 0.8 124.7 25.5 0.5 0.7 12.3 0.0 0.9 0.6 3.8 1.0 0.5 0.8 0.5 6.2 5.2 0.5 7.3 0.7 0.7 5.2 8.0 0.9 0.5 0.6 0.6 0.5 15.3 0.5 0.7 3.0 0.5 0.6 7.4 4.1 1.9 0.5 10.0 0.5 0.5 1.0 4.5 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 60.8 0.0 6.4 7.0 3.4 3.9 4.7 4.2 3.5 0.0 0.0 0.0 3.2 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.0 1.0 0.0 3.7 14.7 0.0 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 3.5 0.0 0.0 0.0 6.3 0.0 9.9 3.7 0.0 0.0 0.0 4.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 8.6 124.7 5.2 6.2 5.2 5.2 8.0 15.3 4.5 ZIC2 HPE5 ENSG00000043355 "Zic family member 2" O95409 13 99981772-99986773 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "brain: 63.0" "Cell line enhanced" "Detected in many" "AF22: 27.0;HDLM-2: 13.0;HEK 293: 20.5;NTERA-2: 25.2;SCLC-21H: 56.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 63.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 214.5" HPA055031 Supported "Nuclear bodies" "Nuclear bodies" "HPA055031: " "unprognostic (6.43e-6)" "prognostic favourable (2.64e-4)" "unprognostic (5.73e-2)" "unprognostic (1.99e-2)" "unprognostic (4.39e-1)" "unprognostic (3.12e-2)" "prognostic unfavourable (2.91e-4)" "unprognostic (4.66e-2)" "unprognostic (3.10e-1)" "unprognostic (1.59e-1)" "unprognostic (9.36e-3)" "unprognostic (7.42e-2)" "unprognostic (0.00e+0)" "unprognostic (3.26e-1)" "unprognostic (2.11e-1)" "unprognostic (5.36e-3)" 0.6 0.5 3.9 0.5 2.9 0.5 0.7 63.0 14.7 0.5 0.8 7.7 0.0 0.6 0.8 0.5 0.8 0.5 0.5 0.5 6.1 2.1 0.6 0.5 0.7 0.6 1.7 7.4 0.5 0.6 0.5 0.5 0.5 13.4 0.6 0.6 3.8 0.5 0.5 0.5 0.8 0.5 0.6 2.2 0.5 0.6 2.5 1.0 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.5 27.0 1.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 1.7 0.0 2.3 0.0 0.0 1.2 0.0 0.0 13.0 20.5 1.9 1.2 1.3 0.0 0.0 1.3 0.0 1.9 0.0 1.2 0.0 1.9 0.0 0.0 0.8 0.1 10.3 25.2 0.6 5.9 1.0 0.0 0.1 0.6 56.7 0.0 0.8 0.1 0.0 1.3 10.1 0.0 6.4 0.0 1.1 1.7 0.2 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 2.9 63.0 7.1 6.1 2.1 1.7 7.4 13.4 1.0 ZIC3 "HTX, HTX1, ZNF203" ENSG00000156925 "Zic family member 3" O60481 X 137566142-137577691 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 50.6" "Group enriched" "Detected in some" 40 "AF22: 24.4;NTERA-2: 27.3" "Cancer enriched" "Detected in single" 14 "testis cancer: 5.0" "Region enriched" "Detected in all" 8 "cerebellum: 50.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052936, HPA069523" Uncertain Supported Nucleoplasm Nucleoplasm "HPA052936: , HPA069523: " "unprognostic (3.55e-5)" "unprognostic (3.82e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" 0.3 0.2 1.4 0.4 2.5 1.1 0.4 50.6 5.8 0.3 0.4 2.7 0.0 0.5 0.5 0.2 0.3 0.3 0.4 0.3 1.9 2.2 0.3 0.3 0.4 0.4 2.4 1.2 0.4 0.5 0.4 1.1 0.4 6.1 0.5 0.3 3.9 0.7 0.3 0.5 0.8 0.5 0.2 1.9 0.5 0.4 3.9 2.2 0.0 0.5 0.0 0.4 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 2.5 50.6 2.6 1.9 2.2 2.4 1.2 6.1 2.2 ZIC4 ENSG00000174963 "Zic family member 4" Q8N9L1 3 147386046-147406860 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 52.2" "Cell line enhanced" "Detected in some" "AF22: 18.2;ASC diff: 5.2;MCF7: 5.2;SH-SY5Y: 5.5;U-2197: 4.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 18 "cerebellum: 52.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 118.4" HPA030194 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030194: " "unprognostic (1.12e-1)" "unprognostic (9.95e-2)" "unprognostic (5.59e-3)" "unprognostic (1.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-1)" "unprognostic (2.20e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-10)" "unprognostic (3.50e-2)" "unprognostic (8.69e-2)" 0.2 0.0 0.2 0.0 0.4 0.0 0.0 52.2 7.9 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 1.0 0.0 0.0 3.7 3.5 0.5 0.0 1.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.2 0.0 5.2 2.1 3.9 1.9 0.4 0.2 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.2 0.0 0.4 5.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.5 0.0 0.0 2.5 0.0 0.0 0.0 1.3 0.0 4.3 1.9 0.0 0.0 0.0 1.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 52.2 0.4 0.3 0.8 0.3 0.4 2.9 0.3 ZIC5 ENSG00000139800 "Zic family member 5" Q96T25 13 99962964-99971909 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 48.9" "Cell line enhanced" "Detected in some" "AF22: 10.9;HEK 293: 6.3;NTERA-2: 7.5;SCLC-21H: 42.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 24 "cerebellum: 48.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 19.3;cerebellum: 20.7;thalamus: 5.7" "Region enriched" "Detected in many" 6 "cerebellum: 53.2" HPA074045 Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA074045: " "unprognostic (2.78e-5)" "unprognostic (1.71e-2)" "unprognostic (2.44e-2)" "unprognostic (2.29e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.38e-4)" "unprognostic (2.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "unprognostic (3.87e-2)" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (4.94e-2)" 0.1 0.0 1.2 0.0 0.5 0.0 0.1 48.9 4.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.5 0.1 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 10.9 0.9 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 1.6 0.0 0.0 2.2 0.0 0.0 1.9 6.3 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 1.5 0.0 0.0 0.8 0.0 0.8 7.5 0.1 0.9 0.4 0.0 0.0 0.0 42.8 0.0 1.1 1.0 0.0 0.0 1.3 0.0 0.6 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.5 48.9 1.3 1.5 0.5 0.4 0.3 2.0 0.0 ZIM2 ZNF656 ENSG00000269699 "Zinc finger imprinted 2" Q9NZV7 19 56774552-56840729 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;ovary: 35.4" "Cell line enhanced" "Detected in some" "BEWO: 8.2;Hep G2: 9.6;NTERA-2: 2.8;RH-30: 2.9;U-2 OS: 2.0;U-266/84: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA071856 Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA071856: " "unprognostic (9.01e-4)" "unprognostic (8.77e-2)" "unprognostic (5.09e-2)" "unprognostic (4.60e-2)" "unprognostic (2.45e-2)" "unprognostic (3.01e-1)" "unprognostic (2.33e-1)" "unprognostic (8.68e-3)" "unprognostic (4.12e-1)" "unprognostic (1.00e-1)" 1.6 13.1 8.5 1.6 44.0 1.4 2.5 8.2 19.1 2.2 1.7 4.8 0.0 1.6 3.2 1.2 1.7 2.8 1.4 2.6 8.1 6.5 2.0 1.7 1.4 1.5 3.0 13.7 35.4 1.5 1.8 21.1 18.3 18.2 2.0 1.5 0.1 3.7 2.0 1.3 1.4 1.8 2.2 3.9 1.7 1.5 11.4 6.1 0.0 2.2 0.0 2.0 1.9 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 2.9 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 44.0 8.2 19.1 8.1 6.5 3.0 13.7 18.2 6.1 ZMAT4 FLJ13842 ENSG00000165061 "Zinc finger matrin-type 4" Q9H898 8 40530590-40897833 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.5;brain: 21.6;thyroid gland: 29.1" "Group enriched" "Detected in some" 5 "AF22: 20.6;U-2197: 12.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 115 "NK-cell: 11.5" "Lineage enriched" "Detected in single" 115 "NK-cells: 11.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA069813, HPA071585" Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA069813: , HPA071585: " "unprognostic (1.25e-2)" "unprognostic (9.29e-2)" "unprognostic (2.80e-1)" "unprognostic (2.83e-3)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (1.07e-1)" "unprognostic (9.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-2)" "unprognostic (4.46e-4)" "unprognostic (5.44e-2)" "unprognostic (2.04e-1)" "prognostic unfavourable (3.51e-4)" "unprognostic (4.79e-3)" 0.8 2.0 4.4 0.9 15.3 0.8 0.9 0.6 20.4 3.3 1.0 0.9 0.0 0.7 1.4 1.0 0.7 0.9 1.0 1.5 6.1 4.0 1.2 0.7 0.8 0.9 3.3 7.8 1.6 0.7 0.7 5.3 1.0 21.6 1.6 1.2 1.4 0.8 1.5 0.7 0.7 0.8 0.8 1.0 1.3 1.0 2.9 3.9 0.0 29.1 0.0 0.9 0.8 0.2 0.0 0.0 0.0 0.0 11.5 0.0 0.1 0.0 1.2 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.1 0.0 0.0 0.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.6 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.1 4.4 15.3 0.6 20.4 6.1 4.0 3.3 7.8 21.6 3.9 ZNF138 pHZ-32 ENSG00000197008 "Zinc finger protein 138" P52744 7 64794388-64833681 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "unprognostic (1.12e-2)" "unprognostic (3.25e-1)" "unprognostic (1.10e-2)" "unprognostic (3.12e-3)" "unprognostic (2.12e-1)" "unprognostic (1.60e-1)" "unprognostic (5.56e-3)" "unprognostic (1.29e-1)" "unprognostic (4.81e-3)" "unprognostic (1.25e-2)" "unprognostic (1.43e-1)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (1.78e-1)" "unprognostic (3.40e-1)" "unprognostic (1.23e-3)" "unprognostic (5.04e-2)" 6.2 10.3 15.3 6.5 24.7 5.7 15.0 41.5 18.7 7.6 6.0 5.9 1.5 5.5 4.5 8.2 7.7 4.3 5.5 5.7 14.2 9.7 8.3 8.9 5.0 11.0 16.2 12.6 5.9 4.3 3.1 10.5 5.1 16.3 7.2 8.0 3.5 7.8 5.4 7.0 15.2 5.5 5.4 16.6 6.2 7.9 9.5 17.1 10.0 7.4 5.6 11.2 5.5 6.4 9.6 6.9 11.2 3.9 4.0 8.9 3.3 4.0 3.0 5.9 11.2 4.1 4.9 6.2 2.6 2.5 3.5 6.1 5.3 6.5 16.0 6.3 1.6 2.5 9.3 2.8 6.5 6.2 6.0 4.8 4.2 3.6 1.9 9.6 4.8 2.8 2.9 6.1 4.9 3.2 12.4 6.1 4.1 7.1 9.3 6.0 13.4 6.3 7.1 6.6 5.5 4.8 9.0 9.8 10.0 4.4 7.5 5.9 11.6 9.0 1.7 4.0 4.6 3.6 6.3 9.1 10.6 19.3 2.6 6.4 3.0 11.2 2.2 4.0 5.3 3.9 5.9 9.5 8.3 8.4 2.7 9.6 8.9 8.3 3.4 4.0 3.6 6.9 7.6 3.3 15.3 24.7 41.5 18.7 14.2 9.7 16.2 12.6 16.3 17.1 ZNF157 HZF22 ENSG00000147117 "Zinc finger protein 157" P51786 X 47370583-47414305 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.4;epididymis: 4.4" "Cell line enhanced" "Detected in some" "Karpas-707: 3.5;SH-SY5Y: 2.9;U-266/84: 6.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003319 Uncertain "HPA003319: AB_1080677" "unprognostic (1.85e-1)" "unprognostic (3.99e-1)" "unprognostic (7.24e-4)" "unprognostic (1.17e-2)" "unprognostic (1.02e-2)" "unprognostic (7.38e-4)" "unprognostic (2.99e-1)" "unprognostic (2.32e-1)" "unprognostic (4.59e-4)" "unprognostic (5.36e-2)" "unprognostic (6.51e-2)" "unprognostic (1.80e-2)" "unprognostic (3.51e-2)" "unprognostic (7.15e-2)" "unprognostic (4.92e-2)" 0.1 0.3 0.8 0.2 1.0 0.4 0.3 4.4 1.6 0.6 0.1 0.2 0.7 4.4 0.2 3.8 0.1 0.1 0.8 1.0 0.6 0.0 0.1 1.4 0.8 1.0 0.1 2.3 3.0 0.0 0.5 0.1 0.2 0.7 0.1 0.3 0.2 0.5 0.9 0.4 0.1 0.8 1.4 0.8 0.3 0.3 1.4 0.7 1.3 0.3 0.7 2.8 0.9 0.0 0.3 1.0 0.1 0.3 0.3 0.2 0.0 0.0 0.2 0.5 0.1 0.3 1.4 0.7 0.3 0.0 2.5 1.3 0.2 0.1 1.1 0.5 0.4 0.0 0.0 0.0 0.5 0.3 0.0 1.4 0.1 0.0 0.1 3.5 0.4 0.0 1.0 0.3 2.1 0.1 0.3 0.0 0.0 0.5 0.2 2.6 2.9 0.0 0.3 0.2 1.6 0.3 0.0 1.1 1.1 0.1 0.1 1.9 6.0 1.7 0.3 0.1 0.0 0.7 0.3 0.4 0.4 0.3 0.2 1.4 0.5 2.2 0.1 1.2 2.8 1.8 1.3 0.7 0.3 0.7 0.8 0.9 ZNF221 ENSG00000159905 "Zinc finger protein 221" 19 43951223-43967709 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 22.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA059435 Uncertain Approved "Nuclear bodies" "Nuclear bodies" "HPA059435: " "unprognostic (2.06e-1)" "unprognostic (8.35e-2)" "unprognostic (2.65e-2)" "unprognostic (1.63e-1)" "unprognostic (3.17e-3)" "unprognostic (2.11e-1)" "unprognostic (1.81e-2)" "unprognostic (3.06e-1)" "unprognostic (1.73e-2)" "unprognostic (3.17e-2)" "unprognostic (5.02e-2)" "unprognostic (1.91e-1)" "unprognostic (1.84e-2)" "unprognostic (3.67e-2)" "unprognostic (1.50e-1)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" 3.8 5.4 7.9 2.0 7.5 2.0 4.3 22.4 9.5 4.2 3.2 4.2 1.9 1.7 4.5 3.2 2.9 4.6 2.3 3.8 7.9 3.9 4.0 3.5 3.5 2.2 7.3 6.0 7.1 3.0 10.4 10.1 4.5 7.0 5.4 2.7 2.5 3.4 4.3 2.1 3.7 2.6 4.8 7.8 3.4 3.4 3.5 11.3 1.2 6.0 1.2 2.4 4.9 3.3 1.6 1.9 1.6 1.2 3.5 1.7 0.9 2.0 1.8 5.7 4.3 2.1 3.8 1.4 2.2 3.3 1.8 3.2 2.4 0.9 0.0 1.2 2.3 0.9 2.3 1.5 3.7 0.0 4.1 5.7 7.3 0.8 1.5 0.6 2.7 4.5 1.2 3.3 1.3 3.6 0.2 0.0 2.5 0.1 0.0 1.0 5.0 1.8 0.1 6.5 0.7 1.4 6.8 4.8 3.8 4.3 0.4 0.5 1.6 4.8 5.9 2.5 5.7 1.3 1.9 3.0 3.8 0.0 0.8 2.4 2.7 1.5 0.8 1.2 1.1 1.2 1.5 0.6 1.7 1.7 1.9 1.6 1.1 0.7 1.6 3.5 0.9 1.8 0.7 0.9 7.9 7.5 22.4 9.5 7.9 3.9 7.3 6.0 7.0 11.3 ZNF30 "DKFZp686N19164, FLJ20562, KOX28" ENSG00000168661 "Zinc finger protein 30" P17039 19 34926903-34945170 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA030400 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030400: AB_10603245" "unprognostic (3.04e-1)" "unprognostic (9.77e-2)" "unprognostic (9.69e-2)" "unprognostic (3.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.49e-2)" "unprognostic (5.10e-3)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (3.42e-1)" "prognostic favourable (1.16e-4)" "unprognostic (5.84e-2)" "unprognostic (4.40e-2)" "unprognostic (2.21e-1)" "unprognostic (1.44e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-2)" 3.4 5.2 11.1 2.6 10.9 0.7 5.9 21.4 11.6 5.3 3.9 5.0 2.9 4.2 4.5 3.4 3.4 7.0 2.6 5.0 7.0 5.4 4.6 6.5 6.0 5.1 10.0 6.5 5.6 6.9 6.4 7.7 3.3 6.6 5.8 4.5 5.8 4.6 5.2 5.3 5.6 3.9 5.1 7.2 5.4 4.8 3.9 8.3 2.4 4.4 2.0 5.1 3.8 4.0 3.4 1.3 2.8 0.4 6.9 7.2 1.8 3.7 8.2 3.5 8.8 6.4 4.1 0.1 3.6 2.6 3.4 3.7 5.8 1.2 0.0 4.8 2.3 2.3 10.1 5.2 4.2 0.0 4.8 2.7 4.5 4.4 3.2 3.6 2.5 3.5 4.6 3.4 4.5 5.2 8.8 0.0 5.3 2.8 2.6 1.6 4.9 4.3 3.4 2.7 0.9 2.5 3.2 4.6 6.7 0.0 0.1 3.4 3.3 1.0 3.8 7.1 3.7 2.6 4.9 2.4 11.6 1.0 1.4 0.0 4.1 2.8 0.1 0.1 4.8 0.4 4.7 3.4 3.8 2.2 1.3 2.1 7.2 7.2 0.0 6.9 0.0 1.2 3.4 1.8 11.1 10.9 21.4 11.6 7.0 5.4 10.0 6.5 6.6 8.3 ZNF365 "KIAA0844, UAN" ENSG00000138311 "Zinc finger protein 365" "Q70YC4, Q70YC5" 10 62374192-62672011 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.3" "Cell line enhanced" "Detected in many" "HaCaT: 17.2;PC-3: 11.1;U-251 MG: 14.3;U-87 MG: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 3.4;memory CD4 T-cell: 3.1;memory CD8 T-cell: 3.5;naive CD8 T-cell: 3.7;NK-cell: 7.4;T-reg: 7.5" "Group enriched" "Detected in many" 51 "NK-cells: 7.4;T-cells: 7.5" "Group enriched" "Detected in all" 4 "amygdala: 328.0;basal ganglia: 309.9;cerebral cortex: 424.1;hippocampal formation: 348.1;thalamus: 127.9" "Low region specificity" "Detected in all" HPA052446 Enhanced Supported "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "HPA052446: " "unprognostic (7.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.36e-1)" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (4.05e-3)" "unprognostic (1.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.15e-2)" "unprognostic (3.11e-3)" "unprognostic (3.06e-2)" "unprognostic (7.90e-2)" "unprognostic (1.12e-6)" "unprognostic (2.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-4)" "unprognostic (2.89e-2)" 0.9 2.5 11.8 1.0 19.4 1.0 1.3 8.4 41.3 2.0 0.9 13.1 0.0 1.1 1.2 1.5 11.7 1.0 4.0 2.0 9.6 7.4 1.1 1.2 3.1 1.1 7.5 16.0 1.0 1.3 9.0 1.8 1.2 6.9 3.0 1.1 1.0 1.2 3.3 1.0 2.6 0.9 0.9 10.5 1.3 1.0 1.6 9.1 0.0 1.6 0.0 2.2 1.9 1.2 0.1 0.0 0.1 0.1 7.4 7.5 1.0 5.7 0.8 0.5 0.7 0.6 0.3 0.3 4.3 4.5 2.2 1.9 0.6 1.4 0.4 0.7 2.6 17.2 0.5 0.3 2.9 0.2 0.4 0.3 1.5 0.4 0.2 0.3 1.4 0.3 0.3 5.8 0.8 0.7 0.4 0.6 4.2 2.1 0.7 0.5 0.8 11.1 0.4 0.5 0.4 0.5 2.6 0.2 0.9 1.1 0.9 0.4 0.1 0.3 3.1 1.2 5.6 0.6 14.3 0.2 0.5 0.3 10.2 0.6 1.9 0.0 0.0 0.0 3.4 0.1 0.0 0.0 3.1 3.5 0.0 0.1 0.6 3.7 0.1 7.4 0.1 0.0 7.5 1.0 11.8 19.4 8.4 32.3 9.6 7.4 7.5 16.0 6.9 9.1 ZNF382 "FLJ14686, KS1" ENSG00000161298 "Zinc finger protein 382" Q96SR6 19 36604817-36634113 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 27.6" "Cell line enhanced" "Detected in many" "HDLM-2: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049259 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA049259: " "unprognostic (5.43e-3)" "unprognostic (5.16e-2)" "unprognostic (1.17e-1)" "unprognostic (2.68e-3)" "unprognostic (6.13e-2)" "unprognostic (1.85e-3)" "unprognostic (5.63e-2)" "unprognostic (6.64e-2)" "unprognostic (1.12e-2)" "unprognostic (5.76e-2)" "unprognostic (4.43e-3)" "unprognostic (3.07e-3)" "unprognostic (1.76e-5)" "unprognostic (8.71e-2)" "unprognostic (2.06e-2)" "unprognostic (2.53e-1)" "unprognostic (6.22e-2)" 3.3 5.9 6.7 3.5 10.5 1.9 3.3 27.6 13.8 4.2 3.9 4.9 2.3 1.3 4.8 4.2 3.1 5.8 3.0 7.5 6.2 6.2 3.8 1.5 2.7 5.1 5.6 11.2 4.7 2.6 4.8 11.0 4.6 9.4 3.6 1.9 4.4 3.3 3.1 1.7 1.4 2.8 4.3 5.5 5.5 2.2 6.7 5.3 3.6 5.7 2.0 6.3 4.0 2.0 9.0 2.4 3.5 0.7 4.5 9.0 2.7 0.2 0.1 4.6 6.4 1.9 2.6 1.5 2.0 0.6 5.9 6.1 0.2 0.4 3.9 4.3 2.4 0.1 5.8 0.1 3.8 10.9 2.7 6.4 0.3 1.6 5.2 0.9 7.7 3.6 0.2 3.3 0.2 0.7 0.1 0.2 3.9 0.6 8.8 2.1 3.0 2.2 0.4 1.9 1.7 1.6 0.2 0.6 8.7 0.3 0.3 3.6 2.7 0.7 0.2 1.4 0.3 0.3 5.8 10.1 0.7 0.4 0.1 0.1 3.5 2.1 0.6 3.5 5.6 0.7 9.0 9.0 8.8 6.2 2.3 6.6 7.6 8.4 1.2 4.5 0.7 2.4 5.0 2.7 6.7 10.5 27.6 13.8 6.2 6.2 5.6 11.2 9.4 5.3 ZNF385B "FLJ25270, ZNF533" ENSG00000144331 "Zinc finger protein 385B" Q569K4 2 179441982-179861505 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0" "Cell line enhanced" "Detected in some" "Daudi: 8.0;HAP1: 15.9;U-698: 43.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046086 Approved "Nucleoli fibrillar center" "Nucleoli fibrillar center" "HPA046086: " "prognostic favourable (4.86e-8)" "unprognostic (8.05e-3)" "unprognostic (1.14e-1)" "unprognostic (3.91e-2)" "unprognostic (3.49e-1)" "unprognostic (1.51e-2)" "unprognostic (3.49e-3)" "unprognostic (1.14e-1)" "unprognostic (8.99e-3)" "unprognostic (3.56e-2)" "unprognostic (4.59e-2)" "unprognostic (2.69e-1)" "prognostic favourable (1.04e-9)" "unprognostic (7.76e-2)" "unprognostic (2.94e-2)" "unprognostic (3.35e-2)" "unprognostic (1.20e-3)" 1.7 4.2 3.2 1.1 14.4 0.9 8.3 33.0 23.2 2.4 1.8 0.9 1.1 1.0 2.1 5.2 1.6 1.2 1.2 23.1 4.2 2.1 9.5 21.3 20.1 2.1 2.7 9.5 18.4 0.8 0.5 0.8 2.9 15.6 14.4 1.3 10.1 1.4 1.1 11.2 1.9 1.2 1.0 1.3 1.0 8.5 10.6 6.1 0.0 1.0 2.9 1.1 1.4 2.9 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 3.4 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 8.0 0.0 0.0 0.0 15.9 0.0 0.2 0.0 2.0 0.0 0.4 0.5 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.6 0.9 0.0 0.6 0.5 0.8 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.1 0.1 0.6 0.0 0.0 43.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.2 14.4 33.0 23.2 4.2 2.1 2.7 9.5 15.6 6.1 ZNF385C ENSG00000187595 "Zinc finger protein 385C" 17 42025576-42098479 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 19.0;testis: 21.9" "Cell line enhanced" "Detected in some" "HDLM-2: 3.9;MOLT-4: 6.7;SCLC-21H: 5.5;T-47d: 3.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 9 "cerebellum: 19.0" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 3.2" "Region enriched" "Detected in single" 12 "cerebellum: 31.8" "Region enriched" "Detected in all" 7 "cerebellum: 44.2" "unprognostic (1.58e-3)" "unprognostic (3.38e-2)" "unprognostic (2.02e-3)" "unprognostic (3.95e-2)" "unprognostic (3.95e-2)" "unprognostic (2.61e-1)" "unprognostic (3.07e-1)" "unprognostic (2.64e-1)" "unprognostic (2.48e-1)" "unprognostic (8.67e-3)" "unprognostic (1.10e-1)" "unprognostic (8.90e-2)" "unprognostic (2.59e-1)" "unprognostic (8.71e-2)" "unprognostic (1.50e-1)" "unprognostic (6.22e-2)" "unprognostic (6.05e-2)" 0.4 0.0 0.7 1.6 0.7 0.5 1.6 19.0 0.8 0.5 0.4 0.4 0.4 0.1 1.0 0.5 0.4 2.0 0.4 0.4 0.5 0.4 0.6 0.4 0.8 0.4 2.0 0.4 3.4 3.1 0.6 2.1 0.4 1.4 1.4 0.2 0.4 2.3 0.5 2.9 0.7 0.4 0.4 0.9 0.6 0.5 21.9 0.4 0.9 0.4 0.9 1.5 0.4 0.5 0.4 3.2 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.5 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.5 2.4 0.0 1.2 0.0 0.8 0.3 0.0 0.0 3.9 2.4 0.0 0.0 0.8 0.1 0.0 1.0 0.0 2.9 0.0 1.3 0.0 0.2 0.0 0.0 0.5 6.7 0.1 0.5 0.0 0.5 0.0 1.0 0.1 0.4 5.5 0.5 0.2 0.5 0.3 3.1 1.2 0.0 0.0 0.4 0.0 0.0 2.6 0.5 0.4 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.7 0.7 19.0 0.8 0.5 0.4 2.0 0.4 1.4 0.4 ZNF385D "FLJ22419, ZNF659" ENSG00000151789 "Zinc finger protein 385D" Q9H6B1 3 21412222-22373321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 17.7;brain: 59.5;testis: 18.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.8;fHDF/TERT166: 2.4;RPTEC TERT1: 6.6;U-87 MG: 12.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 7 "cerebellum: 59.5" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA036190 Uncertain "HPA036190: AB_10602355" "unprognostic (4.07e-2)" "unprognostic (1.26e-1)" "unprognostic (5.44e-2)" "unprognostic (3.23e-2)" "unprognostic (1.64e-1)" "unprognostic (1.74e-1)" "unprognostic (8.20e-2)" "unprognostic (6.60e-2)" "unprognostic (7.84e-2)" "unprognostic (3.73e-1)" "unprognostic (2.35e-1)" "unprognostic (9.01e-2)" "unprognostic (3.49e-7)" "unprognostic (8.70e-3)" "unprognostic (5.38e-2)" "unprognostic (7.76e-3)" "unprognostic (2.15e-5)" 17.7 1.1 4.0 2.2 5.9 1.1 5.3 59.5 9.1 4.3 2.2 0.1 1.2 1.2 2.3 3.9 4.0 2.3 4.7 3.9 3.9 3.6 3.2 0.9 1.9 2.0 7.4 4.0 1.7 2.5 1.3 0.5 0.7 4.1 3.0 1.8 4.1 1.9 3.2 2.8 2.4 1.3 3.5 1.9 1.3 1.3 18.5 1.7 0.1 1.5 5.2 2.0 4.0 5.7 0.7 0.3 2.0 0.2 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.5 4.8 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.3 1.4 0.0 0.0 0.0 6.6 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.4 0.2 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.7 0.0 0.1 2.0 0.1 0.0 0.3 0.0 0.2 4.0 5.9 59.5 9.1 3.9 3.6 7.4 4.0 4.1 1.7 ZNF454 FLJ37444 ENSG00000178187 "Zinc finger protein 454" Q8N9F8 5 178941191-178966433 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.6" "Cell line enhanced" "Detected in some" "AF22: 2.6;EFO-21: 5.0;HHSteC: 3.8;HSkMC: 4.5;NTERA-2: 3.7;RPTEC TERT1: 2.3;SH-SY5Y: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024556 Uncertain "HPA024556: AB_1859283" "unprognostic (1.27e-1)" "unprognostic (9.10e-2)" "unprognostic (1.32e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-2)" "unprognostic (4.21e-2)" "unprognostic (1.41e-1)" "unprognostic (8.35e-2)" "unprognostic (3.72e-2)" "unprognostic (2.34e-2)" "unprognostic (9.52e-3)" "unprognostic (1.52e-1)" "unprognostic (3.95e-2)" "unprognostic (9.58e-2)" "unprognostic (3.68e-2)" "unprognostic (8.43e-3)" "unprognostic (2.78e-1)" 3.4 2.6 7.5 1.5 7.5 0.6 4.6 20.6 8.7 5.9 3.3 3.6 1.7 1.6 6.2 3.1 2.2 7.1 4.7 3.6 6.5 4.6 3.4 1.2 3.1 1.0 5.7 5.2 8.3 3.5 1.0 18.1 3.5 6.7 6.3 2.8 3.9 3.5 5.7 1.0 2.3 2.1 6.1 2.5 2.2 3.1 7.7 7.2 0.0 5.4 0.0 1.5 3.8 3.3 0.2 0.0 0.7 0.0 0.3 0.3 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.6 0.0 1.7 0.4 0.0 0.0 0.0 5.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.1 4.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.0 2.3 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.6 0.3 0.0 0.0 0.1 0.0 7.5 7.5 20.6 8.7 6.5 4.6 5.7 5.2 6.7 7.2 ZNF474 "4933409D10Rik, FLJ32921" ENSG00000164185 "Zinc finger protein 474" Q6S9Z5 5 122129513-122153571 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 11.4;fallopian tube: 21.4;testis: 22.9" "Cell line enhanced" "Detected in some" "BJ: 3.4;CAPAN-2: 3.3;TIME: 4.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 7 "pons and medulla: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "unprognostic (9.98e-2)" "unprognostic (2.13e-1)" "unprognostic (7.42e-2)" "unprognostic (5.90e-3)" "unprognostic (7.82e-2)" "unprognostic (2.49e-2)" "unprognostic (3.94e-2)" "unprognostic (7.61e-2)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (2.06e-1)" "unprognostic (1.06e-2)" "unprognostic (1.51e-3)" "unprognostic (1.12e-3)" "unprognostic (9.74e-2)" "unprognostic (2.20e-1)" "unprognostic (4.09e-4)" 0.3 0.1 1.4 0.3 1.5 0.1 0.3 0.2 0.2 1.2 0.5 6.3 0.6 0.2 1.1 4.9 0.5 21.4 0.7 0.1 1.5 1.1 0.1 0.1 7.9 0.1 0.4 0.2 7.1 0.1 0.2 0.7 0.6 11.4 0.3 0.2 0.0 0.1 0.2 0.0 0.3 0.3 0.3 0.4 0.1 0.2 22.9 0.9 0.0 1.3 0.0 0.2 0.4 0.2 0.2 0.9 0.0 0.0 0.0 0.6 0.0 0.1 1.3 0.5 0.2 0.8 0.4 0.1 3.4 0.8 0.4 0.1 0.1 3.3 0.0 0.2 2.2 0.6 0.2 0.0 1.3 0.3 0.3 1.2 0.7 0.0 0.7 1.1 0.1 0.4 1.4 0.9 0.5 0.1 0.0 0.1 0.1 2.0 0.8 0.4 0.0 0.0 0.9 0.1 0.9 0.5 0.1 0.8 0.2 1.0 0.1 0.4 0.5 0.5 4.0 1.2 0.8 2.2 0.8 0.3 0.6 0.4 2.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.9 0.0 0.0 1.4 1.5 0.2 0.2 1.5 1.1 0.4 0.2 11.4 0.9 ZNF483 "KIAA1962, ZKSCAN16, ZSCAN48" ENSG00000173258 "Zinc finger protein 483" Q8TF39 9 111525159-111577844 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.3;pituitary gland: 40.4" "Cell line enhanced" "Detected in many" "NTERA-2: 11.5;SCLC-21H: 6.7" "Cancer enhanced" "Detected in some" "testis cancer: 1.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055041 Approved Nucleoli Nucleoli "HPA055041: " "unprognostic (4.33e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (2.34e-1)" "unprognostic (4.11e-2)" "unprognostic (5.95e-3)" "unprognostic (9.18e-5)" "unprognostic (2.02e-1)" "unprognostic (9.50e-2)" "unprognostic (4.44e-3)" "unprognostic (5.49e-2)" "unprognostic (5.19e-4)" "unprognostic (7.19e-3)" "unprognostic (1.74e-1)" "unprognostic (4.30e-2)" "unprognostic (6.17e-2)" 3.2 10.1 13.9 2.1 30.5 7.7 5.6 35.9 36.3 6.1 4.0 8.6 2.9 2.0 10.0 11.9 2.4 7.0 4.9 4.7 18.1 7.3 5.1 2.5 3.9 3.4 9.5 23.0 12.6 4.3 13.6 40.4 1.8 24.4 7.2 2.4 5.9 3.2 7.7 2.3 3.5 2.9 5.5 9.8 4.8 3.9 11.8 10.3 0.0 12.5 0.0 3.1 4.7 4.8 2.5 1.0 4.6 1.0 2.1 6.5 1.5 0.3 3.2 3.1 4.7 0.4 0.6 1.0 0.4 1.5 3.1 2.9 0.3 1.5 0.5 0.5 1.3 0.9 1.5 1.6 1.9 0.2 1.8 1.6 4.4 2.5 0.9 0.6 0.4 1.2 0.6 1.7 0.9 2.9 1.3 0.8 0.7 3.0 0.2 0.8 11.5 1.1 0.3 4.8 0.4 1.2 1.3 6.7 3.2 1.2 0.6 0.8 1.9 0.4 0.5 0.9 1.6 1.4 2.2 0.7 1.9 0.4 1.0 0.5 0.7 4.6 1.0 0.6 4.8 0.5 2.7 1.5 3.3 2.3 0.3 2.5 5.9 6.5 3.4 2.1 0.7 1.0 1.6 1.5 13.9 30.5 35.9 36.3 18.1 7.3 9.5 23.0 24.4 10.3 ZNF484 "BA526D8.4, FLJ33884" ENSG00000127081 "Zinc finger protein 484" Q5JVG2 9 92845031-92878038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA028973 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" Nucleoplasm "Nuclear membrane, Cytosol" "HPA028973: AB_10610703" "unprognostic (5.52e-2)" "unprognostic (3.05e-2)" "unprognostic (1.72e-1)" "unprognostic (6.05e-2)" "unprognostic (5.69e-2)" "unprognostic (3.86e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-1)" "unprognostic (6.04e-2)" "unprognostic (9.84e-2)" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (4.03e-2)" "unprognostic (3.74e-1)" "unprognostic (4.77e-1)" "unprognostic (6.49e-2)" "unprognostic (1.51e-1)" 6.5 6.6 9.9 5.4 14.6 10.1 6.5 33.0 13.9 7.7 4.8 7.8 4.7 3.7 7.0 5.3 4.2 6.2 4.7 4.9 11.7 7.0 7.3 5.2 5.8 6.6 12.5 7.1 9.1 4.5 12.1 14.0 7.9 12.6 7.0 5.2 4.6 5.0 6.3 3.7 4.2 5.0 6.2 17.1 7.7 6.0 4.8 13.5 2.8 9.0 1.9 7.9 7.3 5.8 5.6 2.5 5.3 3.5 4.5 7.4 3.0 4.0 5.0 6.6 4.2 3.4 4.2 0.0 3.3 5.4 6.0 6.5 1.6 3.1 3.5 3.0 2.7 6.7 4.8 5.0 6.3 5.6 2.1 3.0 4.0 3.3 5.3 2.5 5.5 4.7 3.8 6.5 6.9 5.1 3.2 14.2 6.4 4.1 3.6 1.1 5.4 2.5 3.0 8.0 2.6 3.2 4.6 4.6 4.1 5.9 1.7 3.3 0.4 2.0 5.5 5.4 5.1 2.8 2.4 5.4 2.7 2.1 3.5 2.0 4.2 1.4 2.5 5.3 5.3 3.5 6.5 3.7 5.4 4.4 2.2 5.6 7.4 6.7 1.4 4.5 3.1 2.5 4.4 3.0 9.9 14.6 33.0 13.9 11.7 7.0 12.5 7.1 12.6 13.5 ZNF488 FLJ32104 ENSG00000265763 "Zinc finger protein 488" Q96MN9 10 47365496-47384273 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 29.7;intestine: 25.8" "Cell line enhanced" "Detected in some" "HaCaT: 23.1;HDLM-2: 33.5;RT4: 18.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035957, HPA035958" Supported Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA035957: AB_10672234, HPA035958: " "unprognostic (3.29e-2)" "unprognostic (1.05e-2)" "unprognostic (7.87e-2)" "unprognostic (1.49e-4)" "unprognostic (1.16e-1)" "unprognostic (8.85e-2)" "unprognostic (1.60e-3)" "unprognostic (2.13e-2)" "unprognostic (3.11e-1)" "unprognostic (2.45e-1)" "prognostic unfavourable (4.02e-7)" "unprognostic (3.60e-1)" "unprognostic (6.62e-5)" "unprognostic (2.76e-1)" "unprognostic (4.47e-1)" "unprognostic (8.10e-2)" "unprognostic (3.18e-2)" 0.4 0.4 5.7 0.4 18.5 0.3 1.2 2.9 14.2 0.5 3.2 17.0 0.0 25.8 0.5 2.3 0.9 0.5 0.6 0.4 15.1 1.1 0.3 0.5 0.3 19.8 6.0 0.7 0.3 0.3 0.0 4.1 21.4 0.6 1.1 0.0 0.6 0.4 0.3 2.2 12.5 0.4 29.7 0.3 0.6 1.2 12.8 0.0 0.3 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 6.7 1.1 0.3 0.0 0.0 0.1 0.2 0.3 0.4 0.4 2.6 6.2 0.1 0.4 0.0 23.1 0.6 2.5 0.3 33.5 0.7 0.1 0.7 0.2 0.0 0.0 0.3 0.0 6.1 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 1.7 0.6 0.0 2.9 0.0 0.1 18.6 5.5 1.0 1.6 0.2 0.0 0.5 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF519 "FLJ36809, HsT2362" ENSG00000175322 "Zinc finger protein 519" Q8TB69 18 14057457-14132490 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA028982 Uncertain Approved Nucleoli Nucleoli "HPA028982: AB_10610705" "unprognostic (1.85e-2)" "unprognostic (4.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.15e-3)" "unprognostic (1.90e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (3.43e-1)" "unprognostic (2.31e-2)" "unprognostic (1.18e-1)" "unprognostic (6.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.16e-5)" "unprognostic (1.40e-2)" "unprognostic (1.58e-1)" "unprognostic (2.38e-1)" "unprognostic (3.65e-4)" 1.8 1.4 2.8 1.9 7.6 1.4 2.8 13.7 14.4 5.7 4.6 0.7 0.8 1.2 7.0 2.6 3.4 4.5 1.8 1.9 3.4 1.6 0.8 1.0 2.7 6.6 1.7 4.0 8.7 1.2 1.1 1.5 1.2 3.0 2.6 2.6 2.0 1.6 2.7 1.0 2.0 2.1 6.0 2.1 2.2 1.4 3.0 2.5 1.1 2.0 0.9 1.9 4.3 3.8 1.7 0.1 0.0 0.6 0.5 3.5 0.7 1.3 0.3 5.9 6.2 0.8 1.2 1.6 1.6 0.9 3.5 3.1 2.6 1.2 3.1 1.6 1.2 0.9 4.8 1.2 4.0 1.8 3.3 5.4 1.7 1.1 0.2 11.1 2.4 0.6 1.5 2.8 1.2 0.6 2.7 4.6 2.0 1.8 6.7 4.4 2.6 1.4 7.2 5.7 3.8 0.9 1.8 9.1 2.4 2.3 0.7 1.8 0.7 3.0 0.4 5.6 7.5 2.5 1.8 1.8 1.2 4.5 1.8 4.3 4.7 0.0 0.3 0.0 1.1 0.6 1.8 1.7 1.4 1.5 0.1 0.8 3.5 2.2 0.0 0.5 0.5 0.1 2.0 0.7 2.8 7.6 13.7 14.4 3.4 1.6 1.7 4.0 3.0 2.5 ZNF521 "EHZF, Evi3" ENSG00000198795 "Zinc finger protein 521" Q96K83 18 25061926-25352190 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.1" "Cell line enhanced" "Detected in many" "AF22: 31.4;fHDF/TERT166: 14.7;HUVEC TERT2: 21.5;THP-1: 17.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 69.1" "Group enriched" "Detected in some" 5 "basophil: 8.8;plasmacytoid DC: 9.8" "Group enriched" "Detected in many" 5 "dendritic cells: 9.8;granulocytes: 8.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 105.4" "HPA023056, HPA023849" Enhanced Approved Nucleoplasm Nucleoplasm "HPA023056: AB_1859315, HPA023849: AB_1859316" "unprognostic (8.80e-3)" "unprognostic (9.68e-2)" "unprognostic (2.05e-1)" "unprognostic (3.40e-2)" "unprognostic (5.43e-2)" "unprognostic (3.73e-3)" "unprognostic (1.52e-3)" "unprognostic (6.17e-2)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (8.18e-2)" "unprognostic (1.83e-1)" "unprognostic (1.19e-3)" "unprognostic (1.16e-3)" "unprognostic (2.43e-1)" "unprognostic (2.52e-3)" "unprognostic (7.82e-4)" 9.2 11.3 5.2 2.8 7.0 1.9 9.1 69.1 11.5 11.0 3.4 9.1 4.7 1.7 19.8 5.9 3.8 9.0 10.0 7.0 5.8 5.1 3.1 1.2 6.4 4.0 8.4 2.8 20.5 1.4 1.4 16.8 8.0 12.2 4.4 3.5 6.7 8.7 3.0 3.8 4.6 3.2 13.3 12.2 18.5 2.4 3.4 8.9 0.5 5.3 6.9 2.6 7.4 5.4 0.0 9.8 8.8 0.1 1.7 0.0 0.1 0.0 0.0 31.4 0.0 5.0 8.8 0.1 4.5 6.6 1.6 1.0 0.0 0.0 0.0 0.0 14.7 0.1 0.0 0.0 1.3 0.0 1.8 6.2 0.3 0.2 0.9 0.0 9.4 10.9 0.0 0.1 0.0 21.5 0.1 0.0 2.8 0.0 4.0 0.0 2.1 0.0 0.0 7.1 0.5 0.0 0.0 4.1 2.6 0.4 0.0 0.0 0.0 17.5 12.2 12.5 1.0 3.6 0.6 0.0 0.0 0.1 4.7 0.0 10.2 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 9.8 0.0 0.1 5.2 7.0 69.1 4.3 5.8 5.1 8.4 2.8 12.2 8.9 ZNF534 "FLJ25344, KRBO3" ENSG00000198633 "Zinc finger protein 534" Q76KX8 19 52429187-52452315 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.8;testis: 8.9" "Cell line enhanced" "Detected in some" "K-562: 2.1;THP-1: 1.1" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.2" "unprognostic (2.66e-1)" "unprognostic (3.35e-1)" "unprognostic (2.35e-1)" "unprognostic (2.35e-1)" "unprognostic (7.65e-4)" "unprognostic (7.25e-2)" "unprognostic (9.42e-2)" "unprognostic (2.02e-1)" "unprognostic (9.36e-2)" "unprognostic (1.33e-1)" "unprognostic (1.02e-1)" "unprognostic (2.22e-1)" "unprognostic (9.57e-4)" "unprognostic (3.04e-2)" "unprognostic (4.51e-2)" "unprognostic (1.59e-1)" "unprognostic (5.80e-2)" 0.3 0.6 1.5 0.3 3.8 0.0 1.2 3.7 2.5 0.3 0.3 0.3 0.3 0.0 0.3 0.7 0.7 0.9 0.3 0.8 1.6 1.6 0.3 0.3 0.5 0.3 0.8 0.3 1.0 0.3 0.0 0.3 0.8 0.3 1.0 0.1 0.3 0.3 0.8 1.4 0.2 0.3 0.3 1.1 0.3 0.1 8.9 0.3 0.3 1.9 2.0 0.3 0.3 0.3 0.2 0.0 1.2 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.9 0.6 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.3 0.3 0.3 0.0 0.2 0.4 0.6 0.0 0.8 0.7 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.2 0.0 0.0 0.5 0.5 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 1.2 0.2 0.0 0.0 0.1 0.0 1.5 3.8 3.7 1.6 1.6 1.6 0.8 0.3 0.3 0.3 ZNF536 KIAA0390 ENSG00000198597 "Zinc finger protein 536" O15090 19 30228290-30713538 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 44.5" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.9;HAP1: 8.7;SH-SY5Y: 23.8;U-937: 5.8;WM-115: 10.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077341 Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA077341: " "unprognostic (1.98e-1)" "unprognostic (4.11e-1)" "unprognostic (1.92e-2)" "unprognostic (1.70e-2)" "unprognostic (2.09e-1)" "unprognostic (1.03e-1)" "unprognostic (4.70e-2)" "unprognostic (4.68e-1)" "unprognostic (5.50e-2)" "unprognostic (1.74e-2)" "unprognostic (1.25e-2)" "unprognostic (4.46e-4)" "unprognostic (1.58e-1)" "unprognostic (2.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.45e-1)" 1.1 6.0 9.9 2.0 21.0 0.6 0.8 14.3 24.1 4.2 4.0 44.5 0.0 2.7 1.7 1.3 6.9 1.0 1.3 2.9 13.3 7.7 0.8 0.7 1.0 0.7 20.9 9.6 0.9 0.9 0.7 3.4 0.7 18.3 3.7 4.1 4.8 1.6 2.4 1.4 1.2 4.2 1.2 23.1 1.5 2.1 5.0 18.4 0.0 6.9 0.0 0.7 2.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 8.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 23.8 0.0 0.0 1.5 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 5.8 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.9 21.0 14.3 15.1 13.3 7.7 20.9 9.6 18.3 18.4 ZNF556 FLJ11637 ENSG00000172000 "Zinc finger protein 556" Q9HAH1 19 2867335-2883445 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.6;brain: 22.3;ovary: 11.3" "Cell line enhanced" "Detected in some" "CACO-2: 7.1;HBEC3-KT: 7.6;Hep G2: 11.8;RH-30: 17.6;THP-1: 6.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 16 "cerebellum: 22.3" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 14.6" "Lineage enriched" "Detected in many" 11 "dendritic cells: 14.6" HPA060593 Approved Nucleoplasm Nucleoplasm "HPA060593: " "unprognostic (1.36e-1)" "unprognostic (9.07e-2)" "unprognostic (2.70e-3)" "unprognostic (1.01e-1)" "unprognostic (1.58e-1)" "unprognostic (1.98e-2)" "unprognostic (3.12e-3)" "unprognostic (3.23e-1)" "unprognostic (4.81e-1)" "unprognostic (2.17e-1)" "unprognostic (6.14e-4)" "unprognostic (2.85e-1)" "unprognostic (2.61e-2)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (5.26e-3)" "unprognostic (5.54e-3)" 0.3 0.2 0.5 0.3 0.5 1.0 0.5 22.3 0.5 0.7 0.3 0.0 1.7 0.1 1.6 0.7 3.1 4.2 0.8 0.2 0.4 0.3 2.6 0.1 0.4 0.3 0.4 0.1 11.3 2.6 0.4 1.6 0.8 1.3 0.4 0.1 0.1 1.0 0.1 4.5 0.7 0.2 0.3 0.5 0.3 0.3 3.5 0.0 0.6 0.2 8.7 0.9 0.2 0.2 0.4 14.6 1.2 0.2 0.6 0.2 0.1 1.8 0.3 0.0 3.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 7.1 0.1 2.3 1.2 0.1 0.1 0.0 7.6 0.0 0.1 0.0 0.1 3.1 11.8 0.1 0.2 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.2 0.0 0.1 0.0 17.6 1.5 0.0 0.3 0.1 2.9 0.0 0.3 0.0 3.6 6.4 0.0 0.1 0.1 4.6 0.1 2.1 3.8 0.1 0.2 0.1 0.1 1.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.2 0.2 1.2 0.6 0.1 14.6 0.1 0.1 0.5 0.5 22.3 0.5 0.4 0.3 0.4 0.1 1.3 0.0 ZNF680 FLJ90430 ENSG00000173041 "Zinc finger protein 680" Q8NEM1 7 64519884-64563106 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA003173 Approved Nucleoplasm Nucleoplasm "HPA003173: AB_1080744" "unprognostic (1.65e-1)" "unprognostic (3.21e-2)" "unprognostic (6.88e-2)" "unprognostic (7.41e-2)" "unprognostic (1.52e-3)" "unprognostic (3.62e-2)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (1.07e-2)" "unprognostic (1.20e-1)" "unprognostic (2.46e-1)" "unprognostic (5.72e-2)" "unprognostic (1.35e-1)" "unprognostic (8.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.26e-1)" "unprognostic (8.05e-3)" 6.4 15.8 18.7 4.2 24.4 2.6 15.4 37.0 23.7 7.7 4.4 7.1 3.3 3.4 5.9 7.0 4.4 6.2 6.2 12.1 20.0 10.8 9.8 21.6 5.7 6.9 23.4 14.6 13.1 5.8 4.0 10.0 5.3 19.9 12.0 6.2 3.9 5.4 6.8 11.6 6.6 3.9 7.1 25.9 7.3 7.0 4.7 24.4 5.4 28.5 6.6 6.0 6.8 5.2 4.3 1.7 4.2 1.3 8.3 4.4 1.7 3.7 2.2 8.9 10.7 4.4 5.0 5.7 3.1 2.6 5.6 7.0 3.0 7.4 7.2 7.7 2.9 2.6 7.2 3.3 9.2 1.3 5.2 5.5 4.4 2.8 2.0 7.2 5.0 3.3 4.1 5.0 5.6 5.2 9.8 0.0 7.7 2.9 11.1 11.6 10.5 2.7 8.8 9.1 21.6 7.8 12.4 7.2 9.9 9.3 8.8 3.2 8.9 3.2 2.8 6.8 3.4 3.2 5.3 6.4 8.2 20.4 0.3 6.7 5.9 4.2 1.0 1.1 3.0 1.3 2.5 4.3 4.1 3.5 1.7 3.4 4.4 4.0 0.5 8.3 1.1 1.4 1.2 1.7 18.7 24.4 37.0 23.7 20.0 10.8 23.4 14.6 19.9 24.4 ZNF708 "KOX8, ZNF15, ZNF15L1" ENSG00000182141 "Zinc finger protein 708" P17019 19 21291160-21329425 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "unprognostic (4.18e-2)" "unprognostic (3.67e-1)" "unprognostic (1.96e-2)" "unprognostic (3.98e-2)" "prognostic favourable (7.16e-4)" "unprognostic (2.96e-3)" "unprognostic (1.11e-2)" "unprognostic (1.67e-3)" "unprognostic (2.05e-2)" "prognostic favourable (3.53e-4)" "unprognostic (4.00e-3)" "unprognostic (1.22e-2)" "unprognostic (5.39e-2)" "unprognostic (2.94e-2)" "unprognostic (9.30e-2)" "unprognostic (8.21e-2)" "unprognostic (1.22e-3)" 4.4 6.5 11.2 9.2 44.3 7.5 10.0 14.2 24.0 9.2 5.4 14.5 3.0 5.9 6.6 6.9 4.3 6.6 5.5 6.2 11.5 8.9 4.9 3.5 6.5 12.1 46.0 9.8 18.4 8.3 5.5 9.3 5.3 25.7 9.0 5.6 4.8 7.8 5.7 3.7 4.6 6.1 3.7 32.1 7.4 8.3 6.3 35.7 8.6 10.8 2.9 9.5 5.9 5.2 6.3 3.1 11.2 2.7 6.1 8.4 3.3 1.6 1.2 10.8 5.9 3.2 2.8 9.5 3.1 1.4 2.0 3.6 3.1 2.6 0.1 4.7 2.3 1.7 3.7 2.1 3.3 1.4 5.8 8.6 4.2 2.3 1.4 7.6 2.3 2.4 2.3 1.3 2.1 2.9 5.9 0.6 3.6 2.3 6.4 5.9 14.9 3.5 7.9 5.4 4.1 1.3 11.1 8.5 5.0 2.8 0.1 2.6 4.0 5.3 4.3 2.9 1.7 3.9 3.3 5.2 4.6 10.9 0.2 3.1 2.2 10.8 2.7 5.7 5.3 2.6 7.7 5.4 6.9 7.9 3.1 6.3 8.4 7.6 11.2 6.1 2.3 2.9 4.6 3.3 11.2 44.3 14.2 24.0 11.5 8.9 46.0 9.8 25.7 35.7 ZNF729 ENSG00000196350 "Zinc finger protein 729" A6NN14 19 22286408-22317176 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.6;testis: 9.7" "Group enriched" "Detected in some" 4 "NTERA-2: 7.6;T-47d: 1.9" "Cancer enriched" "Detected in single" 41 "testis cancer: 5.3" "Group enriched" "Detected in many" 5 "amygdala: 1.2;cerebral cortex: 1.1;hippocampal formation: 3.6;olfactory region: 1.5;pons and medulla: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.84e-1)" "unprognostic (2.14e-3)" "unprognostic (3.05e-4)" "unprognostic (1.30e-1)" "unprognostic (1.74e-1)" 0.2 0.1 1.2 0.1 0.3 0.0 0.5 0.1 1.1 0.1 0.1 0.0 1.2 0.0 0.2 0.0 0.1 0.1 0.0 0.1 3.6 0.1 0.7 0.1 0.1 0.0 0.1 1.5 0.2 0.1 0.4 0.1 0.8 1.5 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 1.5 0.1 0.1 9.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 7.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.3 0.1 1.1 3.6 0.1 0.1 1.5 1.5 0.0 ZNF804A C2orf10 ENSG00000170396 "Zinc finger protein 804A" Q7Z570 2 184598366-184939492 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 31.6;lymphoid tissue: 9.6" "Cell line enhanced" "Detected in many" "Daudi: 20.4;RH-30: 14.0;THP-1: 10.3;U-698: 15.2" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Region enriched" "Detected in many" 4 "cerebellum: 31.6" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029195 Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA029195: AB_10603011" "unprognostic (1.10e-1)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "unprognostic (2.05e-2)" "unprognostic (1.08e-2)" "unprognostic (1.26e-2)" "unprognostic (1.50e-1)" "unprognostic (2.41e-1)" "unprognostic (4.45e-1)" "unprognostic (2.38e-2)" "unprognostic (2.83e-2)" "unprognostic (5.20e-2)" "unprognostic (4.98e-4)" "unprognostic (6.21e-2)" "unprognostic (4.04e-1)" "unprognostic (8.45e-2)" "unprognostic (4.93e-2)" 0.4 1.0 4.3 9.6 7.2 1.8 0.4 31.6 10.7 0.6 0.8 0.1 0.8 1.5 0.4 0.3 0.6 0.4 4.8 0.3 5.2 7.3 1.8 0.6 1.2 2.7 2.2 3.0 0.8 0.3 0.2 0.4 0.5 5.4 4.1 1.1 2.4 1.1 4.4 0.3 0.3 3.3 0.5 1.5 1.8 1.2 0.9 0.4 0.0 4.4 0.0 2.9 1.8 2.1 2.0 1.2 1.0 1.7 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.1 4.8 1.6 1.5 0.0 0.0 20.4 0.0 0.0 0.0 0.3 0.0 3.6 0.1 0.0 5.4 0.8 0.1 8.0 5.1 0.0 2.5 0.0 0.0 1.3 3.8 0.0 0.9 0.0 0.0 0.0 4.8 0.0 3.3 0.0 14.0 0.8 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 10.3 0.0 5.1 0.1 0.2 2.0 2.2 0.0 15.2 5.9 1.5 1.7 0.0 1.1 0.0 0.0 1.7 0.0 2.0 0.0 0.0 1.2 0.3 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.3 4.3 7.2 31.6 7.5 5.2 7.3 2.2 3.0 5.4 0.4 ZNF821 ENSG00000102984 "Zinc finger protein 821" O75541 16 71859680-71895336 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;testis: 23.7" "Cell line enhanced" "Detected in many" "AF22: 13.8;SCLC-21H: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.3;naive B-cell: 11.5" "Group enriched" "Detected in many" 8 "B-cells: 11.5;T-cells: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036372, HPA042742" Enhanced Supported "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA036372: AB_10669790, HPA042742: " "unprognostic (3.16e-1)" "unprognostic (1.77e-1)" "unprognostic (6.50e-2)" "unprognostic (1.12e-2)" "prognostic favourable (1.20e-4)" "unprognostic (1.69e-2)" "unprognostic (2.28e-2)" "unprognostic (7.72e-2)" "unprognostic (5.25e-2)" "unprognostic (3.04e-2)" "prognostic favourable (4.27e-5)" "unprognostic (2.83e-2)" "prognostic favourable (6.32e-10)" "unprognostic (1.82e-2)" "unprognostic (1.79e-1)" "unprognostic (7.97e-2)" "unprognostic (1.02e-1)" 2.0 4.2 6.3 3.7 7.5 3.1 4.8 26.9 13.4 4.3 3.8 5.1 2.3 2.1 5.8 11.1 2.5 3.5 3.9 2.9 5.7 7.6 5.9 2.6 3.4 6.0 5.2 6.0 7.3 2.4 5.6 9.2 2.5 7.1 4.4 5.0 5.2 5.2 5.1 4.0 6.0 4.3 3.0 4.8 3.7 3.3 23.7 3.4 2.2 6.1 0.7 7.3 2.4 4.0 11.5 0.9 0.4 0.5 1.0 5.1 0.7 1.1 0.9 13.8 6.7 2.8 3.6 2.4 1.4 3.1 3.1 4.9 1.9 0.8 2.6 2.4 2.7 1.9 4.6 2.0 3.8 3.9 5.2 0.5 1.0 0.7 1.7 0.9 3.0 3.1 3.5 2.1 1.3 2.3 1.6 1.9 3.3 3.3 1.4 0.9 5.5 0.6 6.0 2.9 4.5 3.5 0.4 13.9 6.6 1.8 1.2 1.5 4.7 3.0 4.6 3.3 3.4 1.2 0.9 4.7 2.3 10.5 1.1 2.6 3.1 0.0 0.5 0.4 2.2 0.0 1.9 9.3 2.3 1.6 0.9 11.5 1.4 0.5 0.4 1.0 0.5 0.0 5.1 0.7 6.3 7.5 26.9 13.4 5.7 7.6 5.2 6.0 7.1 3.4 ZP2 ZPA ENSG00000103310 "Zona pellucida glycoprotein 2" Q05996 16 21197450-21214510 "Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 35.2" "Cell line enriched" "Detected in single" 35 "HDLM-2: 8.9" "Not detected" "Not detected" "Region enriched" "Detected in some" 22 "cerebellum: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA011296 Approved "Secreted in female reproductive system" "HPA011296: AB_1859485" "unprognostic (2.35e-2)" "unprognostic (3.12e-2)" "unprognostic (6.60e-2)" "unprognostic (9.83e-2)" "unprognostic (3.44e-3)" "unprognostic (3.12e-1)" "unprognostic (1.66e-1)" "unprognostic (4.41e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 1.1 35.2 0.1 0.8 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.9 1.6 0.0 0.1 0.0 3.1 0.0 0.0 0.1 1.5 0.1 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.1 0.0 0.0 0.0 0.0 1.6 0.0 ZSCAN1 "FLJ33779, ZNF915" ENSG00000152467 "Zinc finger and SCAN domain containing 1" Q8NBB4 19 58034032-58054631 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.7;epididymis: 16.4;pituitary gland: 15.8" "Cell line enhanced" "Detected in some" "EFO-21: 6.2;HMC-1: 4.3;NTERA-2: 4.4;T-47d: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA007938 Uncertain Approved Nucleoli Nucleoli "HPA007938: AB_1080768" "unprognostic (1.60e-3)" "unprognostic (2.44e-1)" "unprognostic (2.21e-1)" "unprognostic (3.58e-1)" "unprognostic (1.49e-1)" "unprognostic (1.82e-2)" "unprognostic (1.97e-2)" "unprognostic (1.29e-1)" "unprognostic (3.34e-1)" "prognostic favourable (7.36e-4)" "unprognostic (1.41e-2)" "unprognostic (3.81e-2)" "unprognostic (1.26e-2)" "unprognostic (1.09e-2)" "unprognostic (1.32e-1)" "unprognostic (2.47e-2)" "unprognostic (3.60e-1)" 0.9 2.2 7.0 0.7 9.5 0.9 3.2 4.0 13.7 2.2 0.8 6.5 1.0 0.8 1.7 16.4 0.8 4.3 1.3 1.6 6.3 9.7 2.8 0.7 1.4 0.8 6.0 6.7 0.9 2.1 7.3 15.8 1.3 8.2 3.7 0.7 3.4 1.6 3.0 0.8 0.8 1.0 1.1 3.7 0.9 1.0 13.3 2.4 0.9 8.1 0.0 0.7 1.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.0 1.5 0.1 0.0 0.0 0.0 6.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 4.4 0.0 0.0 0.0 0.0 0.0 1.3 0.4 1.3 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 9.5 4.0 13.7 6.3 9.7 6.0 6.7 8.2 2.4